Summary

1. Notes


2. Result Statistics

Figure 1. False discovery rate (FDR) curve. X axis is the number of peptide-spectrum matches (PSM) being kept. Y axis is the corresponding FDR.



Figure 2. PSM score distribution. (a) Distribution of PEAKS peptide score; (b) Scatterplot of PEAKS peptide score versus precursor mass error.

(a)
(b)

Figure 3. De novo result validation. Distribution of residue local confidence: (a) Residues in de novo sequences validated by confident database peptide assignment; (b) Residues in "de novo only" sequences.

(a)
(b)
Table 1. Statistics of data.
# of MS scans8833
# of MS/MS scans176637
Table 2. Result filtration parameters.
Peptide -10lgP≥15
Peptide Ascore≥0
Protein -10lgP≥23
Proteins unique peptides≥1
De novo ALC Score≥50%
Table 3. Statistics of filtered result.
Peptide-Spectrum Matches47021
Peptide sequences19379
Protein groups1175
Proteins1175
Proteins (#Unique Peptides)677 (>2); 184 (=2); 314 (=1);
FDR (Peptide-Spectrum Matches)12.6%
FDR (Peptide Sequences)26.5%
FDR (Protein)38.6%
De Novo Only Spectra25265
Table 4. PTM profile.
Name ∆Mass Position #PSM -10lgP Area AScore
Carbamidomethyl57.02C4364200.002.07E61000.00
Methylation(KR)14.02KR3851124.977.44E518.61
Deamidation.98NQ3126200.003.92E517.01
Oxidation15.99M1825160.331.01E61000.00
Methylation(others)14.02DEHST1482145.773.1E511.06
Pyro-glu from Q-17.03N-term765154.805.96E51000.00
Dehydration-18.01DSTY,C-term58989.949.43E40.00
Acetylation42.01Protein N-term572175.491.69E51000.00
Acetylation42.01N-term56197.514.46E51000.00
Phosphorylation79.97STY425112.971.31E50.00
Acetylation42.01K361100.711.02E5157.67
Didehydro-2.02STY,C-term32594.89 0.00
Carbamylation43.01K,N-term31376.43 90.97
Dihydroxy31.99FKPRWY23198.895.34E490.79
Amidation-.98C-term20855.99 1000.00
Sodium21.98DE,C-term19268.412.13E50.00
Dimethylation(KR)28.03KR17886.494.03E571.25
Formylation27.99K,N-term16642.297.71E470.36
Dethiomethyl-48.00M11772.631.89E51000.00
Carboxylation43.99DKW9760.623.45E438.32
Ethyl28.03DE,N-term,C-term9189.031.08E50.00
Lysaminoadipicsealde-1.03K8981.173.59E41000.00
Oxidation15.99HW8680.551.48E51000.00
Deamidation.98R8396.551.27E53.38
Biotin226.08K,N-term7939.72 0.00
Ammonia loss-17.03N7781.607.08E41000.00
O-Diisopropylphosphate164.06KSTY,N-term6668.731.01E50.00
Carboxymethyl58.01C6280.201.17E51000.00
Sulfation79.96STY5761.942.87E517.01
Hexose162.05NSY5448.883.11E51000.00
Amidine41.03K,N-term4456.91 30.64
Guanidination42.02K42149.581.46E5276.80
Diethylation56.06K,N-term3176.885.62E4207.12
MethylamineST13.03ST2951.56 18.01
Cation:Li6.01DE,C-term2982.92 15.43
Propionamide71.04K,N-term2643.641.15E549.83
Methyl+Deamidated15.00NQ2566.426.05E422.05
Ubiquitin114.04KST2560.291.31E528.36
Carboxylation43.99E2277.571.41E511.10
Methylation(C-term)14.02C-term2256.186.05E51000.00
Pyro-glu from E-18.01N-term2180.738.1E41000.00
Met->Aha-4.99M2157.031.56E51000.00
Cation:K37.96DE,C-term1839.571.21E50.00
EtOH44.03KR1234.909.18E413.38
Sulphone31.99M1156.653.73E51000.00
PEITC163.05K,N-term1056.512.37E512.28
Ammonium17.03DE,C-term1055.121.55E519.39
Acetyl42.01ST928.61 9.40
SMA127.06N-term934.51 88.88
Oxidation15.99DKNPR840.414.44E40.00
Propionald+4040.03HK846.561.39E537.14
Deoxy-15.99DST863.68 46.87
Im_biotin225.09N-term844.582.18E569.82
HNE156.12HK858.481.85E5126.79
Aminotyrosine15.01Y846.222.97E51000.00
ISD_z+2_ion-15.01N-term819.25 1000.00
Propargylamine37.03DE,C-term832.995.79E485.10
LeuArgGlyGly383.23K752.122.84E51000.00
LG-pyrrole316.20N-term736.352.15E552.58
Cation:Ni[II]55.92DE739.64 14.04
MercaptoEthanol60.00S731.08 5.47
Formylation27.99Protein N-term721.962.09E51000.00
Kynurenin3.99W637.642.01E51000.00
Iodination125.90Y677.801.37E517.01
MG-H154.01R627.10 6.65
Pyrrole78.05K635.865.65E4122.77
Carboxymethyl58.01K,N-term632.951.81E464.77
MDA5454.01K630.302.09E50.00
azole-20.03S642.681.46E443.47
Myristoylation210.20CK,N-term653.301.7E41000.00
ethylamino27.05ST565.754.24E57.03
Crotonyl68.03K518.74 18.00
Carboxyethyl72.02K533.501.15E51000.00
Ammonia loss-17.03Protein N-term544.61 1000.00
NeuAc291.10ST543.65 14.04
Pyridylacetyl119.04K,N-term532.295.96E567.12
BITC149.03K,N-term543.501.06E51000.00
EtOH44.03C534.562.42E51000.00
CAMthiopropanoyl145.02K537.99 80.99
LG-anhyropyrrole298.19N-term417.818.19E41000.00
p-guanosine345.05K422.05 0.00
NMM111.03K431.927.03E324.44
AEC-MAEC59.02ST463.801.77E57.77
O-Ethylphosphate108.00K,N-term426.642.52E514.62
B-methylthiol45.99DN416.782.58E428.13
NDA175.04K,N-term423.457.96E419.27
Acetald+2626.02HK459.873.43E423.70
Octanoyl126.10ST419.85 0.00
Ethanolamine43.04DE,C-term444.765.63E416.76
Cytopiloyne362.14K,N-term444.286.02E40.00
DSP88.00N-term424.241.99E51000.00
Arg->Npo80.99R422.508.38E546.57
Lipoyl188.03K434.38 56.47
Carbofuran58.03S434.211.2E51000.00
Phosphopropargyl117.00T425.851.57E51000.00

3. Experiment Control

Figure 4. Precursor mass error of peptide-spectrum matches (PSM) in filtered result. (a) Distribution of precursor mass error in ppm; (b) Scatterplot of precursor m/z versus precursor mass error in ppm.

(a)
(b)

Table 5. Number of identified peptides in each sample by the number of missed cleavages

Missed Cleavages01234+
Virulento10923622118224130

4. Other Information

Table 6. Search parameters.
Search Engine Name: PEAKS
Parent Mass Error Tolerance: 0.07 Da
Fragment Mass Error Tolerance: 0.07 Da
Precursor Mass Search Type: monoisotopic
Enzyme: Trypsin
Max Missed Cleavages: 3
Non-specific Cleavage: none
Fixed Modifications:
  Carbamidomethylation: 57.02
Variable Modifications:
  Oxidation (M): 15.99
  Acetylation (K): 42.01
  Acetylation (Protein N-term): 42.01
  Acetylation (N-term): 42.01
  Amidation: -0.98
  Beta-methylthiolation: 45.99
  Biotinylation: 226.08
  Carbamylation: 43.01
  and 304 more...
Max Variable PTM Per Peptide: 3
Database: Paracoccidioides_Pb18
Taxon: All
Searched Entry: 7000
FDR Estimation: Enabled
De novo score (ALC%) threshold: 15
Peptide hit threshold (-10logP): 30.0
Peaks run ID: 13
Different data refine parameters are used for this search:
Table 7. Instrument parameters.
Fractions: VEV_1_3_RA4_01_1235.d, VEV_2_3_RA5_01_1236.d, VEV_3_
3_RA6_01_1237.d
Ion Source: ESI(nano-spray)
Fragmentation Mode: CID, CAD(y and b ions)
MS Scan Mode: Quadrupole
MS/MS Scan Mode: Time of Flight (TOF)

Protein List

Protein Accession Contains:
Protein Description Contains:
Protein Sample Area >= 0E0
Protein Ptm Contains:
Protein Group Protein ID Accession -10lgP Coverage (%) Coverage (%) Virulento Area Virulento #Peptides #Unique #Spec Virulento PTM Avg. Mass Description
1 26 C1GM00 777.46 62 62 4.57E8 115 112 1845 Y 100508 Plasma membrane ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08391 PE=3 SV=1
2 1 C1G0D4 736.83 98 98 3.78E8 78 78 1412 Y 54454 Catalase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00324 PE=3 SV=2
4 3 C1G5F6 720.75 100 100 2.31E8 59 58 1072 Y 36427 Glyceraldehyde-3-phosphate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02411 PE=3 SV=1
7 18 C1G065 617.52 72 72 4.47E7 138 135 445 Y 231710 Malonyl-CoA:ACP transacylase (MAT) domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00255 PE=3 SV=1
12 10 C1GEN5 613.13 91 91 1.21E8 66 66 623 Y 40135 Ribos_L4_asso_C domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05721 PE=3 SV=1
9 12 C1G1F2 608.26 97 97 1.67E8 89 89 658 Y 50191 Elongation factor 1-alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00692 PE=3 SV=1
32 11 C1GHS5 603.59 87 87 5.42E7 64 63 394 Y 65365 amidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06811 PE=3 SV=1
29 5 C1GLI2 600.85 88 88 5.24E7 75 70 402 Y 70822 Hsp72-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08118 PE=3 SV=1
15 9 C1G712 596.23 85 85 8.37E7 84 81 520 Y 61968 PH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02967 PE=4 SV=1
13 6 C1GKC9 593.66 85 85 8.96E7 99 97 599 Y 80305 Hsp90-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07715 PE=3 SV=2
20 2 C1G810 551.19 95 95 9.16E7 64 64 553 Y 29317 40S ribosomal protein S4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03315 PE=3 SV=1
8 15 A0A0A0HUJ5 549.15 68 68 1.1E8 76 74 648 Y 61077 60S ribosomal protein L3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12253 PE=3 SV=1
17 16 C1GLI9 548.15 78 78 4.18E7 94 92 408 Y 92235 Elongation factor 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08125 PE=3 SV=2
37 37 C1GMV8 541.88 93 93 7.88E7 53 53 423 Y 28389 40S ribosomal protein S2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08602 PE=3 SV=1
11 39 C1G3Y8 541.21 90 90 1.38E8 62 59 722 Y 27179 40S ribosomal protein S6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01654 PE=3 SV=1
22 4 C1GLX8 540.39 96 96 4.02E7 85 85 356 Y 62389 Hsp60-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08369 PE=3 SV=1
5 20 C1G064 539.73 62 62 4.04E7 147 146 458 Y 208196 Fatty acid synthase subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00254 PE=3 SV=2
41 7 C1G9P8 535.18 88 88 4.5E7 76 74 335 Y 76077 glutamine--fructose-6-phosphate transaminase (isomerizing) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03984 PE=4 SV=2
31 24 C1GA17 532.41 57 57 2.93E7 82 82 299 Y 131218 Pyruvate carboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04103 PE=4 SV=1
51 119 C1GCT8 522.15 99 99 9.62E7 39 39 404 Y 23898 GTP-binding nuclear protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04810 PE=3 SV=1
36 29 C1GGT8 513.78 93 93 7.47E7 57 56 417 Y 28973 40S ribosomal protein S1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=RPS1 PE=3 SV=1
38 60 A0A0A0HS69 510.97 64 64 5.5E7 57 55 372 Y 51973 40S ribosomal protein S8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12365 PE=3 SV=1
25 28 C1G391 510.62 97 97 8.89E7 49 47 490 Y 29627 40S ribosomal protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01407 PE=3 SV=1
14 75 A0A0A0HT80 503.98 49 49 7.51E7 70 68 424 Y 83060 60S ribosomal protein L13 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11227 PE=3 SV=1
27 150 C1FYW9 500.21 82 82 7.65E6 26 9 517 Y 17639 Ubiquitin-40S ribosomal protein S27a OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00995 PE=3 SV=1
94 61 C1G3L4 499.67 87 87 3.89E7 36 36 243 Y 35072 Guanine nucleotide-binding protein subunit beta-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01530 PE=3 SV=2
72 123 C1GLU6 493.20 93 93 5.62E7 32 31 327 Y 21587 GTP-binding protein rhoA OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08337 PE=4 SV=1
98 80 A0A0A0HWK8 485.56 89 89 2.81E7 34 28 249 Y 37162 Actin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12077 PE=3 SV=1
109 154 C1GFA3 484.90 93 93 3.97E7 31 31 203 Y 16752 60S ribosomal protein L27a OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05939 PE=3 SV=1
58 213 C1G0E5 480.44 87 87 6.68E7 27 27 332 Y 16054 40S ribosomal protein S14 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00335 PE=3 SV=1
10 21 C1G1T5 477.58 59 59 2.5E7 141 140 313 Y 234384 glutamate synthase (NADH) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02101 PE=3 SV=2
67 66 C1GMU5 473.90 76 76 3.57E7 50 49 258 Y 34595 t-SNARE coiled-coil homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08589 PE=4 SV=2
66 62 C1GIX7 473.41 74 74 2.21E7 54 52 196 Y 55479 Acetyltransferase component of pyruvate dehydrogenase complex OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07213 PE=3 SV=2
54 100 C1G6T3 471.68 97 97 3.96E7 50 50 271 Y 22928 60S ribosomal protein L6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02888 PE=3 SV=1
48 14 C1G002 470.52 71 71 2.19E7 62 61 221 Y 87744 ATP-dependent 6-phosphofructokinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00192 PE=3 SV=1
80 43 C1GM03 464.95 75 75 1.64E7 45 44 158 Y 48812 Cytochrome b-c1 complex subunit 2, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08394 PE=4 SV=1
82 8 C1GBJ2 464.83 76 76 1.88E7 53 52 185 Y 72098 ATP citrate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04993 PE=4 SV=1
64 115 C1GHJ0 461.99 84 84 3.38E7 38 37 212 Y 27037 60S ribosomal protein L17 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06726 PE=3 SV=2
56 124 C1GG76 458.36 64 64 5.78E7 32 31 297 Y 23316 40S ribosomal protein S18 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06313 PE=3 SV=2
55 130 C1G0E3 457.39 94 94 5.45E7 35 35 321 Y 15855 40S ribosomal protein S16 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00333 PE=3 SV=1
65 58 C1GII4 457.18 78 78 1.69E7 54 53 182 Y 59144 Septin-type G domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07070 PE=3 SV=1
110 59 C1FYR6 453.14 89 89 2.87E7 38 37 224 Y 22696 40S ribosomal protein S7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00942 PE=3 SV=1
24 91 C1GA14 451.34 58 58 1.78E7 96 93 242 Y 192367 Clathrin heavy chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04100 PE=3 SV=2
16 34 C1FYJ9 449.41 66 66 1.83E7 110 108 235 Y 173937 Pentafunctional AROM polypeptide OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00875 PE=3 SV=2
33 216 C1G3T9 449.22 37 37 7.59E5 24 8 467 Y 35358 Polyubiquitin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01605 PE=4 SV=2
84 55 C1G3C4 448.84 82 82 2.13E7 42 42 180 Y 33617 ADP/ATP translocase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01440 PE=3 SV=2
115 30 C1G9X3 448.07 86 86 1.42E7 46 45 146 Y 47270 Enolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04059 PE=3 SV=1
50 54 C1G821 445.84 90 90 7.93E7 39 39 346 Y 22091 40S ribosomal protein S9 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03326 PE=3 SV=1
53 1154 C1FZR3 445.51 48 48 1.66E7 65 63 188 Y 141862 ABC multidrug transporter SidT OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00103 PE=3 SV=1
35 185 C1GLA5 441.98 70 70 2.53E6 24 9 455 Y 19698 Ubiquitin-60S ribosomal protein L40 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07891 PE=3 SV=2
30 33 C1G5V6 440.61 79 79 3.44E7 71 70 306 Y 60213 ATP synthase subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02561 PE=3 SV=1
45 167 C1GAM9 440.34 64 64 7.95E7 40 40 348 Y 25175 40S ribosomal protein S24 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04315 PE=3 SV=2
97 31 C1GLV8 439.96 78 78 1.42E7 40 40 139 Y 55279 ATP synthase subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08349 PE=3 SV=1
156 133 A0A0A0HWY2 439.57 75 75 1.48E7 26 26 112 Y 21405 Ribosomal_L6 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11413 PE=3 SV=1
92 13 C1GA13 439.35 83 83 1.25E7 47 45 140 Y 69049 Phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04099 PE=3 SV=1
28 38 C1G942 435.15 93 93 9.35E7 53 53 470 Y 25717 60S ribosomal protein L10-A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03778 PE=3 SV=1
40 88 C1G2V1 434.94 94 94 1.1E8 43 42 415 Y 18480 40S ribosomal protein S11 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01267 PE=3 SV=1
118 48 C1G2J3 430.45 92 92 1.72E7 38 37 167 Y 39228 Septin-type G domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02359 PE=3 SV=1
70 19 C1GMZ1 429.07 74 74 1.2E7 65 65 165 Y 96879 Peroxisomal hydratase-dehydrogenase-epimerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08651 PE=3 SV=1
68 50 C1G4N0 426.43 88 88 1.92E7 48 48 180 Y 44988 Phosphoglycerate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01896 PE=3 SV=1
101 113 C1GDK2 425.99 93 93 4.33E7 38 38 226 Y 21550 60S ribosomal protein L18-B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05338 PE=3 SV=2
77 102 C1G371 425.98 89 89 4.58E7 41 41 256 Y 28554 60S ribosomal protein L7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01387 PE=3 SV=1
138 85 C1FZT8 422.48 77 77 1.37E7 33 33 114 Y 50087 Tubulin alpha chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00128 PE=3 SV=1
123 73 C1FYX6 420.25 69 69 1.62E7 29 29 131 Y 39139 PHB domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01002 PE=3 SV=2
43 57 C1G0X4 420.13 93 93 7.04E7 53 52 356 Y 23111 60S ribosomal protein L16 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00514 PE=3 SV=1
62 49 C1GB47 420.11 82 82 3.86E7 48 47 248 Y 27882 60S ribosomal protein L8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04848 PE=3 SV=2
89 70 C1GA20 419.60 95 95 5.04E7 37 36 241 Y 19799 60S ribosomal protein L11 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04106 PE=3 SV=1
49 78 C1G283 419.08 91 91 5.48E7 43 43 291 Y 27502 60S ribosomal protein L2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02249 PE=3 SV=2
106 86 C1G0N2 417.37 96 96 1.51E7 33 32 131 Y 28339 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00422 PE=4 SV=1
125 283 C1GK98 415.01 40 40 1.16E7 23 23 104 Y 56238 Chromate ion transporter OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07684 PE=3 SV=1
195 207 C1GKG3 414.33 67 67 1.07E7 16 16 95 Y 22203 NAD(P)H:quinone oxidoreductase, type IV OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07749 PE=3 SV=2
135 67 C1GE52 413.93 73 73 6.71E6 33 32 86 Y 47829 Actin family OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05538 PE=3 SV=1
3 117 A0A0A0HV62 412.82 34 34 8.82E7 121 118 507 Y 315855 Ribosomal protein L19 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11904 PE=3 SV=1
63 79 C1GHV2 412.09 97 97 4.63E7 42 41 283 Y 23799 40S ribosomal protein S5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06838 PE=3 SV=2
69 41 C1GCI0 411.43 76 76 1.76E7 54 54 188 Y 60924 Malate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04702 PE=3 SV=2
95 44 C1GBZ4 410.80 80 80 1.55E7 45 44 148 Y 50173 Glutamate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04516 PE=3 SV=2
44 17 C1G989 410.43 60 60 2.08E7 72 70 198 Y 126127 NAD-specific glutamate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03825 PE=3 SV=1
78 71 C1GLM2 409.56 95 95 2.68E7 31 31 188 Y 31838 Mitochondrial outer membrane protein porin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08263 PE=4 SV=2
23 2287 C1FZR2 407.32 41 41 9.29E6 85 85 152 Y 231196 Carrier domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00102 PE=4 SV=1
112 98 A0A0A0HV09 406.79 61 61 1.67E7 37 35 163 Y 44851 ATP-dependent RNA helicase eIF4A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11711 PE=3 SV=1
52 27 C1G3T6 405.96 50 50 1.29E7 61 60 151 Y 125155 Potassium/sodium efflux P-type ATPase, fungal-type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01602 PE=4 SV=2
87 22 C1GAG4 403.58 58 58 1.57E7 59 59 153 Y 112048 Formyltetrahydrofolate synthetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04250 PE=3 SV=2
116 171 C1GCK9 403.54 97 97 2.93E7 30 29 184 Y 16669 KOW domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04731 PE=3 SV=1
73 202 C1GFG5 402.37 94 94 2.15E7 49 48 158 Y 21076 Histone H1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06001 PE=3 SV=1
93 84 C1GJS2 402.02 86 86 1.69E7 40 40 153 Y 49332 Phosphatidylinositol transfer protein SFH5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07508 PE=3 SV=2
146 219 C1GEX7 400.05 40 40 1.19E7 21 21 126 Y 61338 ZIP family zinc transporter OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05813 PE=4 SV=1
47 25 C1FZI7 399.75 40 40 1.25E7 65 64 129 Y 167827 Vacuolar protein sorting/targeting protein 10 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=VPS10 PE=3 SV=1
79 76 C1GAG3 398.75 76 76 1.53E7 51 49 147 Y 54368 Isocitrate dehydrogenase [NADP] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04249 PE=3 SV=2
71 135 C1GB65 398.42 62 62 5.35E7 39 38 243 Y 28374 S10_plectin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04866 PE=3 SV=2
85 106 C1G6F6 394.24 63 63 1.05E7 43 41 116 Y 67200 Hsp75-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02761 PE=3 SV=1
75 99 C1G9C0 389.21 83 83 3.33E7 36 35 195 Y 24184 Ribosomal protein L15 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03856 PE=3 SV=1
127 217 C1GC65 389.09 100 100 2.39E7 27 27 168 Y 22440 Glutathione peroxidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04587 PE=3 SV=1
81 51 C1GML7 388.39 70 70 1.18E7 45 45 128 Y 71766 Phosphoenolpyruvate carboxykinase (ATP) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08503 PE=3 SV=2
129 94 C1G1C8 386.06 67 67 1.54E7 24 24 116 Y 39659 Fructose-bisphosphate aldolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00668 PE=3 SV=1
114 32 C1GAT8 383.91 65 65 8.8E6 47 45 118 Y 56578 UTP--glucose-1-phosphate uridylyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04374 PE=3 SV=1
150 65 C1G6U5 380.05 59 59 1.06E7 26 26 104 Y 50837 Tubulin beta chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02900 PE=3 SV=2
100 93 C1GHD6 374.61 48 48 7.26E6 45 45 108 Y 115045 Potassium/sodium efflux P-type ATPase, fungal-type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06672 PE=4 SV=1
199 140 C1GBT4 374.47 64 64 9.53E6 32 32 85 Y 62696 Multifunctional fusion protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05085 PE=3 SV=1
153 68 A0A0A0HVP8 374.17 58 58 6.61E6 30 28 85 Y 48954 Mitogen-activated protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11275 PE=3 SV=1
103 36 C1G411 372.85 56 56 1.2E7 48 48 126 Y 73519 Acetyl-coenzyme A synthetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01677 PE=3 SV=2
144 128 C1G1D9 369.47 45 45 1.7E7 31 31 144 Y 74563 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00679 PE=3 SV=2
227 69 C1GCX5 368.91 72 72 8.39E6 35 32 84 Y 52007 Serine hydroxymethyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05111 PE=3 SV=1
170 131 C1GF71 367.86 94 94 1.76E7 26 26 128 Y 15067 Histone H2B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05907 PE=3 SV=1
128 87 C1GL73 367.32 31 31 7.27E6 59 58 123 Y 243261 Dedicator of cytokinesis protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07859 PE=3 SV=1
189 153 C1GHE4 367.18 95 95 2.2E7 22 22 119 Y 14737 40S ribosomal protein S22 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06680 PE=3 SV=1
183 82 C1GEM8 367.00 72 72 1.55E7 31 29 116 Y 44496 Septin-type G domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05714 PE=3 SV=1
239 233 C1GE03 366.21 67 67 9.9E6 22 22 103 Y 27447 Ras-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05489 PE=4 SV=2
176 35 C1GAF5 365.19 46 46 7.38E6 47 46 93 Y 131482 Coatomer subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04241 PE=4 SV=2
238 125 A0A0A0HYV6 365.03 46 46 6.08E6 27 26 69 Y 60969 60S ribosomal protein L5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11379 PE=3 SV=1
142 114 C1GK99 362.88 77 77 5.24E7 21 21 191 Y 16851 40S ribosomal protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07685 PE=3 SV=1
131 92 C1G9D7 362.51 85 85 4.24E7 29 29 217 Y 21120 60S ribosomal protein L20 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03873 PE=3 SV=2
269 340 C1GN52 362.30 44 44 1.18E7 12 12 76 Y 24405 GPR1 FUN34 yaaH family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08696 PE=3 SV=2
200 47 A0A0A0HWS3 361.95 51 51 6.79E6 30 26 74 Y 78445 Vacuolar protein sorting-associated protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11982 PE=3 SV=1
215 83 C1GMI6 359.74 44 44 7.68E6 33 32 76 Y 73691 Lysine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08472 PE=3 SV=2
384 456 C1GL34 357.96 27 27 6.18E6 15 15 46 Y 56898 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08041 PE=4 SV=2
76 107 C1GBM4 357.95 83 83 8.33E7 29 28 348 Y 15198 Ribosomal protein L24 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05025 PE=3 SV=1
271 136 C1GJ83 357.48 60 60 8.31E6 25 25 69 Y 44688 Septin-type G domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07319 PE=3 SV=2
207 214 C1GB13 357.27 91 91 2.45E7 21 20 107 Y 12299 60S ribosomal protein L23 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04449 PE=3 SV=2
222 319 C1GGI0 356.21 26 26 3.18E7 11 11 114 Y 53065 Zinc/iron permease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06417 PE=4 SV=1
206 660 C1GCJ6 356.00 60 60 5.25E6 30 30 68 Y 61914 2-methylcitrate dehydratase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04718 PE=3 SV=2
154 77 C1G7L4 355.33 20 20 6.66E6 40 39 104 Y 272427 alpha-1,3-glucan synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03169 PE=3 SV=2
280 143 C1G1P4 352.82 62 62 1.35E7 19 19 76 Y 31933 40S ribosomal protein S0 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=RPS0 PE=3 SV=1
214 345 C1GB62 352.41 39 39 3.5E6 40 40 56 Y 126936 leucine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04863 PE=4 SV=2
235 191 C1G0G4 351.93 89 89 1.57E7 22 19 99 Y 16308 40S ribosomal protein S17 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00354 PE=3 SV=1
140 89 C1G9T0 351.60 41 41 8.08E6 44 43 114 Y 122880 Eukaryotic translation initiation factor 3 subunit A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=TIF32 PE=3 SV=2
151 116 C1FZ57 350.83 61 61 2.13E7 29 29 148 Y 23267 60S ribosomal protein L32 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01083 PE=3 SV=2
211 45 C1G8H6 350.62 56 56 6.26E6 40 37 84 Y 73876 Endoplasmic reticulum chaperone BiP OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03562 PE=3 SV=1
205 173 C1GN84 350.20 52 52 1.07E7 27 27 105 Y 73193 FAD-binding FR-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08719 PE=4 SV=2
203 46 A0A0A0HU84 350.09 29 29 6.94E6 28 28 69 Y 123319 PCI domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12029 PE=3 SV=1
246 165 C1G0P4 349.56 56 56 6.11E6 33 33 77 Y 75511 AMP-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00434 PE=4 SV=2
261 186 C1G9D5 348.12 38 38 5.89E6 30 29 67 Y 84319 Urease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03871 PE=3 SV=2
217 104 C1GN83 347.30 59 59 8.95E6 24 24 80 Y 45298 CMGC/GSK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08722 PE=3 SV=2
186 42 C1G4M5 346.58 40 40 1.23E7 32 32 107 Y 84548 Translation initiation factor RLI1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01891 PE=4 SV=2
288 118 C1G2S7 345.38 52 52 4.94E6 24 23 63 Y 52227 Rab GDP dissociation inhibitor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01243 PE=3 SV=1
209 52 C1GJI0 344.83 43 43 5.8E6 34 34 80 Y 94357 Probable endonuclease LCL3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07416 PE=3 SV=2
346 323 C1GEW2 342.48 87 87 8.41E6 14 14 56 Y 14932 SsDNA binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05798 PE=4 SV=1
309 379 C1G8S5 339.43 29 29 8.91E6 24 23 72 Y 61020 AA_permease domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03661 PE=4 SV=1
136 23 C1GDJ1 337.47 32 32 6.83E6 64 62 96 Y 257187 Biotin carboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05327 PE=4 SV=2
373 534 C1GCG8 336.96 66 66 5.08E6 11 11 47 Y 12556 V-SNARE coiled-coil homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04690 PE=4 SV=2
290 2320 C1G0T1 336.54 35 35 5.03E6 21 20 50 Y 86736 Glycogenin-1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00471 PE=4 SV=2
299 162 A0A0A0HT22 335.67 38 38 3.04E6 18 17 47 Y 56630 AMPK1_CBM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12447 PE=4 SV=1
236 294 C1G0C5 334.21 85 85 1.05E7 19 18 89 Y 20343 Carbonic anhydrase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00315 PE=3 SV=1
137 120 C1GKR7 334.10 78 78 3.62E7 32 32 196 Y 16267 60S ribosomal protein L24 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07924 PE=3 SV=2
283 40 C1GBT0 332.67 58 58 5.51E6 22 20 60 Y 52074 Aldehyde dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05081 PE=3 SV=2
148 53 C1G820 330.53 97 97 3.74E7 35 35 182 Y 18252 60S ribosomal protein L21-A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03325 PE=3 SV=1
266 97 C1GHN2 330.09 74 74 4.91E6 27 25 61 Y 32618 rRNA 2'-O-methyltransferase fibrillarin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06768 PE=3 SV=2
247 265 C1GI70 329.81 57 57 2.89E6 24 23 46 Y 56135 Vacuolar proton pump subunit B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06956 PE=3 SV=1
177 244 C1G9R9 327.54 21 21 4.97E6 38 36 60 Y 226392 1-phosphatidylinositol 4-kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04005 PE=3 SV=2
274 341 C1G8F8 327.53 43 43 3.46E6 26 26 52 Y 78724 DUF2433 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03544 PE=4 SV=1
219 72 C1GBE8 326.08 39 39 6.46E6 29 28 69 Y 86803 threonine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04949 PE=3 SV=2
349 193 C1GGQ1 325.82 54 54 3.88E6 17 16 45 Y 41130 PPIase cyclophilin-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06488 PE=3 SV=1
213 63 C1G496 325.74 33 33 5.39E6 36 35 63 Y 120889 oxoglutarate dehydrogenase (succinyl-transferring) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01762 PE=3 SV=1
225 121 C1G4K1 325.35 48 48 7.48E6 26 24 89 Y 36835 HMG box domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01867 PE=4 SV=2
161 56 C1G766 324.05 29 29 4.02E6 42 40 71 Y 181050 Myosin-1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03021 PE=3 SV=2
303 486 C1GE98 322.72 70 70 8.37E6 13 13 71 Y 17194 DUF4045 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05584 PE=4 SV=2
339 241 C1FZ06 322.34 47 47 4.97E6 17 17 48 Y 43930 Xaa-Pro aminopeptidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01032 PE=3 SV=2
356 142 C1GBG9 322.00 41 41 2.78E6 16 16 43 Y 45885 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04970 PE=3 SV=1
390 111 C1G8F9 318.63 20 20 1.19E6 20 20 27 Y 140020 SSD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03545 PE=3 SV=2
184 95 C1G5M9 316.47 27 27 4.87E6 30 30 69 Y 119012 valine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02484 PE=3 SV=1
248 152 C1GN78 316.02 92 92 1.15E7 20 20 86 Y 16706 Ribosomal_L28e domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08715 PE=3 SV=1
314 158 C1GHB9 314.57 52 52 3.06E6 20 20 43 Y 57706 Coatomer subunit delta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06655 PE=3 SV=2
292 126 C1G9F5 314.57 42 42 5.33E6 26 25 53 Y 61835 FCP1 homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03891 PE=4 SV=2
297 74 C1G570 313.28 41 41 3.88E6 21 20 45 Y 70689 proline--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03440 PE=3 SV=2
305 174 C1G3V5 312.16 62 62 3.87E6 26 24 56 Y 47055 Aspartate aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01621 PE=3 SV=1
229 346 C1G5J0 311.55 67 67 1.91E7 15 15 107 Y 17600 40S ribosomal protein S15 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02445 PE=3 SV=1
363 333 C1G653 310.01 66 66 3.99E6 20 20 45 Y 38619 NAD(P)-bd_dom domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02658 PE=4 SV=2
389 225 C1G388 310.00 55 55 4.55E6 18 18 42 Y 50766 Aspartate aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01404 PE=3 SV=1
268 260 C1G5Y7 309.98 34 34 4.61E6 19 19 50 Y 67784 Cytochrome b5 heme-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02592 PE=4 SV=1
252 863 C1G0S7 308.55 26 26 2.9E6 25 25 47 Y 103345 EF-hand domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00467 PE=4 SV=1
451 187 C1GB79 307.19 46 46 2.12E6 14 14 27 Y 40359 Mitogen-activated protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04880 PE=3 SV=1
208 246 C1GLJ7 305.14 75 75 2.17E7 18 18 111 Y 13684 40S ribosomal protein S26 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08238 PE=3 SV=1
291 181 A0A0A0HQN9 304.94 92 92 6.41E6 21 20 69 Y 16366 40S ribosomal protein S19 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12324 PE=3 SV=1
300 276 C1G561 301.90 41 41 1.74E6 17 17 40 Y 48348 tRNA-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03431 PE=4 SV=2
256 146 C1GEU2 299.99 34 34 5.53E6 26 25 64 Y 80380 Glycogen [starch] synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05778 PE=3 SV=1
381 266 C1G3D9 299.98 51 51 2.56E6 16 16 33 Y 38588 RNA-binding protein rnc1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01455 PE=4 SV=2
202 282 C1GGR5 299.79 80 80 2.66E7 22 22 118 Y 13150 40S ribosomal protein S20 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06502 PE=3 SV=1
285 268 C1FYN4 298.10 25 25 2.91E6 20 19 50 Y 92747 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00910 PE=3 SV=1
221 148 C1FYE5 298.09 36 36 5.44E6 35 34 66 Y 80157 glutamate--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00821 PE=3 SV=1
614 493 C1GC66 297.90 75 75 1.97E6 11 11 17 Y 14069 60S ribosomal protein L22 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04588 PE=3 SV=2
294 240 C1G172 297.32 72 72 1.03E7 18 18 78 Y 17102 60S ribosomal protein L27 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00612 PE=3 SV=2
310 218 C1G9U8 296.99 41 41 3.25E6 17 16 52 Y 45397 Chaperone DnaJ OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04034 PE=3 SV=1
436 327 C1G6M8 296.47 86 86 2.7E6 15 14 29 Y 20942 ADP-ribosylation factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02833 PE=3 SV=1
196 96 C1G6U8 296.37 24 24 6.15E6 34 31 63 Y 157446 Calcium-transporting ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02903 PE=3 SV=2
316 310 C1GGG3 295.65 25 25 1.02E7 14 13 60 Y 60925 Phosphate transporter OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06400 PE=3 SV=2
325 81 C1G248 295.48 48 48 6.91E6 20 20 59 Y 55039 4-aminobutyrate aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02214 PE=3 SV=2
293 230 A0A0A0HV38 294.85 23 23 2.66E6 21 20 41 Y 107296 cysteine desulfurase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12043 PE=3 SV=1
351 325 C1GFB1 294.26 37 37 8.37E6 16 16 56 Y 33530 Nicotinate-nucleotide pyrophosphorylase [carboxylating] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05947 PE=3 SV=1
237 292 C1G9X9 293.78 53 53 1.89E7 15 14 101 Y 11822 60S ribosomal protein L36 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04065 PE=3 SV=2
319 198 C1GAY4 292.22 76 76 4.99E6 16 16 56 Y 21977 peptide-methionine (S)-S-oxide reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04420 PE=3 SV=2
327 428 C1G5E8 290.04 36 36 4.24E6 15 15 49 Y 52981 Acid phosphatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02403 PE=4 SV=1
311 267 C1GIP8 289.67 59 59 2.66E6 16 4 72 Y 16321 Histone H4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07134 PE=3 SV=2
298 242 C1G6S0 288.86 26 26 2.52E6 24 22 36 Y 106529 Coatomer subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02875 PE=4 SV=1
302 517 C1GBU2 288.78 55 55 4.7E6 18 17 50 Y 50217 CK1/CK1/CK1-G protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04464 PE=3 SV=2
357 20953 C1GM11 288.58 64 64 6.5E6 18 18 51 Y 24518 Nucleotidyl transferase AbiEii/AbiGii toxin family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08402 PE=1 SV=1
434 224 C1GC48 288.21 37 37 2.04E6 14 14 28 Y 45619 Branched-chain-amino-acid aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04570 PE=3 SV=2
307 335 C1FZ00 288.15 92 92 1.39E7 12 12 72 Y 7072 60S ribosomal protein L43 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01026 PE=3 SV=2
365 149 C1GKE7 287.40 61 61 2.46E6 15 15 36 Y 36556 Arp2/3 complex 34 kDa subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07733 PE=3 SV=1
424 161 C1GFM6 286.33 37 37 3.42E6 17 17 37 Y 63891 Sulfate adenylyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=MET3 PE=3 SV=2
447 321 C1G233 285.44 24 24 2.43E6 13 13 29 Y 55858 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02199 PE=4 SV=2
326 137 C1G631 285.04 45 45 3.78E6 20 20 43 Y 51144 AAA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02636 PE=3 SV=2
270 196 C1G0P0 282.96 38 38 3.83E6 23 21 53 Y 73736 Hsp7-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00430 PE=3 SV=1
402 279 C1G945 282.87 85 85 3.65E6 12 12 43 Y 11575 60S ribosomal protein L30 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03781 PE=3 SV=1
284 192 C1GF12 281.54 41 41 3.82E6 24 24 46 Y 74398 glycine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05848 PE=3 SV=1
335 141 C1GK89 281.28 23 23 3.52E6 21 21 49 Y 132103 Cellular morphogenesis protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07675 PE=4 SV=2
193 396 C1FZC6 281.06 26 26 3.43E6 35 34 59 Y 165348 Actin cytoskeleton-regulatory complex protein PAN1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01152 PE=3 SV=1
262 705 C1GBT3 280.15 33 33 2.76E7 12 12 74 Y 20325 Copper transport protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05084 PE=3 SV=2
328 105 C1G349 278.36 34 34 2.84E6 17 17 38 Y 81576 Thioredoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01365 PE=4 SV=1
241 342 A0A0A0HRG7 277.81 72 72 1.24E7 12 7 96 Y 18343 Actin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12076 PE=3 SV=1
438 452 C1GK66 277.61 30 30 1.57E6 13 12 32 Y 49736 CAMK/CAMK1/CAMK1-CMK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07652 PE=3 SV=2
304 259 C1FYJ6 277.57 46 46 1.46E6 14 2 69 Y 15867 Histone H4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00872 PE=3 SV=2
331 109 A0A0A0HS42 277.31 25 25 4.01E6 21 21 46 Y 132248 Cytoskeletal adapter protein sagA OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12437 PE=4 SV=1
172 248 C1GDA8 276.56 59 59 3.7E7 20 20 147 Y 15119 60S ribosomal protein L44 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05244 PE=3 SV=2
168 180 C1GKQ6 276.01 24 24 4.07E6 36 35 56 Y 206916 chitin synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07913 PE=3 SV=1
382 157 C1GLV1 275.24 64 64 3.75E6 15 10 46 Y 20989 GTP-binding protein ypt1 (Fragment) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08342 PE=4 SV=2
313 132 A0A0A0HVT2 274.97 60 60 3.36E6 20 18 48 Y 47132 AAA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11128 PE=3 SV=1
420 442 C1G9U4 274.81 48 48 2.53E6 15 15 34 Y 33714 60S acidic ribosomal protein P0 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04030 PE=3 SV=1
204 280 C1GKW0 274.63 25 25 3.47E6 36 36 58 Y 168282 Phospholipid-transporting ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07967 PE=3 SV=1
380 309 C1FYR1 273.95 60 60 2.78E6 15 14 42 Y 29963 Rab family, other OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00937 PE=4 SV=1
427 421 C1GDQ2 273.66 33 33 2.22E6 18 18 38 Y 65973 asparagine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05388 PE=4 SV=2
355 168 C1GAC4 273.50 60 60 4.73E6 21 21 54 Y 34393 eIF2B_5 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04210 PE=3 SV=1
340 206 C1GHF5 272.64 32 32 3.87E6 15 15 41 Y 56858 Aamy domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06691 PE=3 SV=2
336 354 C1G9A5 272.54 37 37 4.25E6 17 17 43 Y 58572 Protein disulfide-isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03841 PE=3 SV=1
394 322 C1FYL2 271.92 40 40 2.8E6 16 16 37 Y 46457 argininosuccinate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00888 PE=3 SV=2
329 138 C1GM08 271.42 63 63 4.64E6 19 18 58 Y 23595 GTP-binding protein ypt3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08399 PE=4 SV=1
228 155 C1G1M5 270.62 36 36 3.44E6 34 32 55 Y 102854 Hsp98-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00765 PE=3 SV=2
257 127 C1FYM2 269.22 37 37 2.39E6 26 25 42 Y 93921 Vesicular-fusion protein SEC18 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00898 PE=3 SV=2
279 367 C1GGQ7 269.13 45 45 4.05E6 29 29 55 Y 55066 Dihydrolipoyl dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06494 PE=3 SV=1
224 221 C1G1G2 268.16 24 24 2.66E6 26 26 45 Y 140255 Protein EFR3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00702 PE=3 SV=2
334 103 C1FZL1 267.60 53 53 4.41E6 24 23 49 Y 49100 26S protease regulatory subunit 7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00051 PE=3 SV=1
547 370 C1GJT8 265.97 58 58 2.59E6 8 7 24 Y 16804 Nucleoside diphosphate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07524 PE=3 SV=1
412 64 C1GH49 265.96 54 54 1.73E6 24 24 39 Y 60184 GMP synthase [glutamine-hydrolyzing] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06585 PE=3 SV=2
272 166 C1G373 265.89 27 27 2.51E6 20 19 41 Y 97200 Eukaryotic translation initiation factor 3 subunit C OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=NIP1 PE=3 SV=1
296 189 C1GAW6 264.71 67 67 9.67E6 18 18 77 Y 13614 60S ribosomal protein L34-A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04402 PE=3 SV=1
463 201 C1G6E6 264.07 44 44 1.88E6 12 11 27 Y 41192 acetyl-CoA C-acetyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02751 PE=3 SV=1
446 223 C1G5P1 263.72 46 46 1.69E6 16 16 26 Y 46416 NAK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02496 PE=3 SV=1
317 318 A0A0A0HT57 263.40 34 34 1.03E7 9 9 64 Y 15757 60S ribosomal protein L37 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11585 PE=3 SV=1
350 336 C1GED5 262.46 53 53 3.62E6 14 12 57 Y 38649 Guanine nucleotide-binding protein subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05621 PE=3 SV=2
341 444 C1GG81 260.52 47 47 2.73E6 24 23 38 Y 59673 PHD-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06318 PE=4 SV=2
243 227 C1FYJ7 259.36 88 88 1.48E7 19 18 90 Y 15389 Histone H3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00873 PE=3 SV=1
440 590 C1GKM7 259.00 36 36 1.89E6 11 10 26 Y 32524 ATP synthase subunit gamma OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07813 PE=3 SV=2
387 110 C1G7C1 258.49 20 20 3.23E6 19 18 40 Y 124300 26S proteasome regulatory subunit RPN2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03076 PE=3 SV=1
370 176 C1G2F3 257.99 21 21 3.41E6 19 19 42 Y 93653 PhoD_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02319 PE=4 SV=2
369 170 C1GKL8 257.16 23 23 2.27E6 12 12 25 Y 88784 Protein transport protein SEC23 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07804 PE=3 SV=2
457 215 C1GCF0 256.66 32 32 4.17E6 13 13 32 Y 49720 ATP-dependent RNA helicase SUB2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04672 PE=4 SV=2
295 986 C1G035 256.50 34 34 3.52E6 21 21 39 Y 82246 Catalase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00225 PE=3 SV=2
216 139 A0A0A0HVH2 255.78 80 80 1.95E7 25 25 112 Y 13932 60S ribosomal protein L31 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11832 PE=3 SV=1
347 296 C1FZL2 255.03 26 26 9.14E5 17 17 22 Y 73905 Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00052 PE=3 SV=2
361 190 C1GLB8 255.02 59 59 4.94E6 16 15 41 Y 37979 malate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08054 PE=3 SV=2
187 129 C1GFT4 254.82 34 34 3.53E6 38 38 60 Y 124864 Sla2 Src like adaptor 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06120 PE=3 SV=2
464 353 C1G092 254.54 55 55 1.32E6 13 8 30 Y 22860 GTP-binding protein ypt2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00282 PE=4 SV=1
492 403 C1GGQ3 254.40 40 40 1.51E6 11 11 23 Y 42319 Acetamidase/Formamidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06490 PE=4 SV=2
408 829 A0A0A0HYY2 254.19 89 89 5.2E6 6 6 45 Y 8536 Hva1_TUDOR domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11401 PE=4 SV=1
462 351 C1GIR0 253.44 47 47 1.61E6 14 14 28 Y 35515 Pyrroline-5-carboxylate reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07146 PE=3 SV=2
354 645 C1GEJ7 253.33 38 38 2.95E6 22 22 34 Y 90238 Cell division control protein 48 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05683 PE=4 SV=1
383 433 C1GIE3 252.73 40 40 1.44E6 13 13 18 Y 51549 acetylornithine transaminase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07029 PE=3 SV=1
471 317 C1GCK7 252.20 72 72 2.15E6 12 12 26 Y 19653 ATP synthase subunit d, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04729 PE=3 SV=1
499 1558 C1G6B0 251.75 17 17 1.94E6 7 7 23 Y 46395 DUF914-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02715 PE=3 SV=2
472 349 C1GA89 248.55 30 30 2.08E6 14 14 29 Y 51073 inorganic diphosphatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04175 PE=3 SV=2
413 182 C1GHF6 248.44 63 63 2.44E6 14 14 33 Y 33622 Mitochondrial thiamine pyrophosphate carrier 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06692 PE=3 SV=1
315 197 C1G9X0 247.94 42 42 2.98E6 14 12 49 Y 34679 14-3-3 family protein epsilon OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04056 PE=3 SV=2
385 464 C1G4K3 247.25 70 70 4.76E6 8 7 45 Y 10785 4F5 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01869 PE=4 SV=1
401 209 C1G647 246.13 54 54 1.75E6 17 16 36 Y 35039 RNA-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02652 PE=4 SV=1
458 258 C1GLM4 246.02 40 40 8.99E5 16 15 25 Y 48916 Methionine aminopeptidase 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08265 PE=3 SV=1
368 208 C1GGZ4 245.24 45 45 2.57E6 18 17 36 Y 48675 phosphoserine transaminase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06213 PE=3 SV=1
541 302 C1G1Y1 245.00 45 45 1.28E6 13 13 23 Y 40845 Guanine nucleotide-binding protein alpha-3 subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02147 PE=3 SV=1
419 1040 C1GCI8 243.15 32 32 4.34E6 12 12 36 N 51562 Citrate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04710 PE=3 SV=1
377 784 C1G5T0 242.84 20 20 5.15E6 8 7 51 Y 20352 Cdp-alcohol phosphatidyltransferase protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02535 PE=4 SV=2
344 371 C1GEV1 242.13 44 44 1.89E6 17 16 30 Y 49514 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05787 PE=3 SV=2
505 275 C1GBN3 240.41 36 36 2.58E6 10 10 30 Y 33204 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05034 PE=4 SV=2
768 2427 C1G506 239.73 40 40 7.03E5 6 6 12 N 26619 Clathrin light chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02022 PE=3 SV=1
400 90 C1G9M3 237.78 42 42 3.83E6 17 17 36 Y 44924 Actin-related protein 2/3 complex subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03959 PE=3 SV=2
158 278 C1GA97 237.69 36 36 2.7E7 14 14 158 Y 20540 60S ribosomal protein L33-A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04183 PE=3 SV=2
429 226 C1G3P9 237.61 25 25 1.35E6 14 14 26 Y 63025 Calnexin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01565 PE=3 SV=1
406 269 A0A0A0HU09 237.50 18 18 1.74E6 17 16 23 Y 103981 KH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11652 PE=4 SV=1
514 203 C1G159 237.21 27 27 1.51E6 10 10 20 Y 51639 26S protease regulatory subunit 6A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00599 PE=3 SV=1
428 234 C1GBG1 237.11 30 30 2.05E6 11 11 25 Y 60089 aspartate--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04962 PE=3 SV=1
306 243 A0A0A0HX63 236.48 29 29 2.96E6 16 16 32 Y 72313 Acetolactate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11114 PE=3 SV=1
360 264 C1GB04 235.54 55 55 1.94E6 17 15 34 Y 27181 14_3_3 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04440 PE=3 SV=1
157 330 C1G675 235.25 20 20 2.98E6 32 30 53 Y 169131 PH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02680 PE=4 SV=1
483 270 C1GKG2 234.78 40 40 2.08E6 11 11 27 Y 36491 Estradiol 17-beta-dehydrogenase 12 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07748 PE=3 SV=1
498 316 C1GMI8 234.15 26 26 5.27E6 11 11 17 Y 48435 Mannose-1-phosphate guanyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08474 PE=3 SV=1
399 211 C1G5X0 234.00 22 22 2.05E6 19 19 28 N 138377 Carrier domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02575 PE=4 SV=2
376 271 C1GMC5 233.70 67 67 3.06E6 15 15 31 Y 32667 Mitochondrial thiamine pyrophosphate carrier 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08211 PE=3 SV=1
343 145 C1GG28 233.58 58 58 1.96E6 21 21 32 Y 45816 Elongation factor 1-gamma OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06265 PE=4 SV=1
456 263 C1G635 233.08 29 29 1.8E6 18 18 32 Y 70066 ABC transporter ATP-binding protein ARB1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02640 PE=4 SV=2
433 229 C1G6I0 232.53 32 32 1.76E6 16 16 25 Y 78133 Heat shock protein Hsp88 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02785 PE=4 SV=2
568 356 C1GLT7 231.48 28 28 2.25E6 14 14 23 N 87261 5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08328 PE=3 SV=1
414 199 C1GJB5 231.19 19 19 2.87E6 15 15 37 Y 80198 Glucan endo-1,3-beta-glucosidase btgC OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07351 PE=4 SV=2
513 122 C1GEX6 229.61 23 23 1.88E6 10 10 21 Y 62935 CTP synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05812 PE=3 SV=2
444 400 C1GI58 228.18 34 34 2.71E6 15 15 34 Y 52981 Aminotran_5 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06944 PE=4 SV=1
388 144 C1GAA3 227.97 25 25 3.63E6 19 19 40 Y 112848 Msb1-Mug8_dom domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04189 PE=4 SV=1
583 1822 C1G7F7 226.91 16 16 2.36E6 8 8 17 Y 69763 Lysophospholipase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03112 PE=3 SV=1
337 235 C1GCV9 226.56 32 32 2.11E6 17 17 29 Y 57807 Nucleolar protein 58 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05095 PE=3 SV=1
648 3215 C1GKF2 225.08 21 21 7.65E5 5 4 13 Y 32739 FAR-17a/AIG1-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07738 PE=4 SV=1
318 249 C1G547 223.38 49 49 3.78E6 19 19 44 Y 45115 Pyruvate dehydrogenase (Acetyl-transferring) E1 component, alpha subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02063 PE=4 SV=1
431 1560 C1GLJ8 223.03 19 19 1.42E6 12 12 20 Y 72600 Meiotically up-regulated gene 70 protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08239 PE=4 SV=2
453 159 C1GA81 222.78 25 25 1.63E6 12 12 22 Y 65353 Aspartyl aminopeptidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04167 PE=3 SV=1
359 172 C1G8E5 221.76 24 24 4.01E6 16 16 37 Y 80276 Eukaryotic peptide chain release factor GTP-binding subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03531 PE=3 SV=1
485 291 C1FZG1 221.47 47 47 3.87E6 8 7 30 Y 19835 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00001 PE=3 SV=1
626 665 C1G9D6 220.48 52 52 1.95E6 12 12 20 Y 36432 NADH-cytochrome b5 reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03872 PE=3 SV=1
597 253 C1G606 219.68 26 26 1.38E6 7 7 16 Y 33774 Parasitic phase-specific protein PSP-1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02611 PE=4 SV=1
535 612 C1GJJ9 219.24 23 23 2E6 9 9 21 Y 31349 Reductase with broad range of substrate specificity OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07435 PE=3 SV=1
558 272 C1G7K8 219.06 44 44 2.45E6 14 13 20 Y 41381 Peroxidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03163 PE=3 SV=1
338 239 C1G4P8 218.45 75 75 9.67E6 16 16 56 Y 14760 60S ribosomal protein L35 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01914 PE=3 SV=2
527 377 C1GM22 217.35 21 21 7.64E5 7 6 12 Y 50121 Tubulin alpha chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08413 PE=3 SV=2
644 231 C1G3M0 217.10 39 39 1.07E6 8 7 15 Y 47881 Glutamine synthetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01536 PE=3 SV=2
660 482 C1G1R3 216.73 16 16 1.55E6 6 6 19 Y 32296 Chitin synthase export chaperone OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02079 PE=3 SV=2
426 222 A0A0A0HRM2 216.40 25 25 1.95E6 14 13 28 Y 85327 H(+)-transporting two-sector ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11981 PE=3 SV=1
593 108 C1G479 215.30 38 38 1.72E6 13 13 22 Y 41706 Mannose-1-phosphate guanyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01745 PE=3 SV=2
534 538 C1G6F9 214.78 52 52 2.56E6 9 9 23 Y 24718 Thioredoxin-like_fold domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02764 PE=4 SV=2
489 807 C1GJY9 213.84 18 18 2.9E6 8 8 34 Y 56389 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07575 PE=4 SV=2
468 473 A0A0A0HUI8 212.96 29 29 2.98E6 11 10 24 Y 44289 Histone H2A.Z OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11421 PE=3 SV=1
504 112 C1G9U1 212.86 33 33 2.32E6 11 11 24 Y 48365 Endoplasmic reticulum-Golgi intermediate compartment protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04027 PE=3 SV=2
479 458 C1GLX7 211.48 57 57 2.92E6 7 7 25 Y 18715 Cofilin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08368 PE=3 SV=2
421 238 C1FYH3 210.95 24 24 1.76E6 13 12 22 Y 56811 Nuclear segregation protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00849 PE=4 SV=1
482 179 C1GHN0 210.45 30 30 1.53E6 13 13 24 Y 53179 Mitochondrial-processing peptidase subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06766 PE=3 SV=1
599 539 C1G1M0 209.65 17 17 1.25E6 6 5 18 N 34706 Autophagy-related protein 27 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00760 PE=3 SV=1
465 178 C1G0B0 208.48 34 34 5.61E5 12 10 21 Y 43468 26S protease regulatory subunit 8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00300 PE=3 SV=2
493 938 C1GKL7 208.30 50 50 2.51E6 8 7 27 Y 20771 60S ribosomal protein L12 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07803 PE=3 SV=2
578 281 C1G1P0 208.28 32 32 1.04E6 10 10 16 Y 49054 Pribosyltran_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00780 PE=3 SV=1
212 391 C1G4I0 208.28 21 21 1.88E6 27 24 40 Y 128464 HTH La-type RNA-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01846 PE=4 SV=2
720 273 C1G7V1 207.85 13 13 4.66E5 6 6 8 N 71008 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03256 PE=3 SV=2
690 1767 C1GDK8 207.56 44 44 8.78E5 8 8 15 Y 23958 Thioredoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05344 PE=4 SV=2
609 220 C1GAA6 206.70 35 35 1.95E6 11 9 20 Y 43252 Mitochondrial phosphate carrier protein 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04192 PE=3 SV=2
629 821 C1G7W6 205.98 13 13 7.11E5 6 5 9 N 64218 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03271 PE=3 SV=1
445 183 C1G4D1 205.95 40 40 2.76E6 13 13 34 Y 53532 Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01797 PE=3 SV=2
563 20955 C1G9J2 205.84 16 16 1.17E6 8 8 20 Y 64240 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03928 PE=4 SV=1
524 101 C1G736 205.50 25 25 1.46E6 13 13 22 Y 76251 Acyl-coenzyme A oxidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02991 PE=3 SV=2
526 160 C1G3N7 205.41 13 13 8.65E5 8 8 13 Y 94007 P/Homo B domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01553 PE=3 SV=1
548 1299 C1G5A0 205.19 29 29 1.17E6 7 7 16 Y 32375 MARVEL domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03470 PE=4 SV=1
345 262 C1GF47 205.02 54 54 6.58E6 14 14 56 Y 17522 60S ribosomal protein L25 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05883 PE=3 SV=2
658 1188 C1GAG5 203.54 33 33 6.62E5 7 7 8 Y 38048 Eukaryotic translation initiation factor 3 subunit I OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=TIF34 PE=3 SV=1
529 555 C1GF70 203.00 46 46 1.44E6 8 7 16 Y 14228 Histone H2A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05906 PE=3 SV=1
515 255 C1GIR8 202.37 24 24 2.3E6 10 10 24 N 67481 AGC/PKA protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07154 PE=4 SV=2
575 286 C1GAQ4 201.84 14 14 8.85E5 13 12 20 Y 142579 DNA-directed RNA polymerase subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04340 PE=3 SV=1
374 460 C1GFL2 201.69 30 30 5.9E6 8 8 48 Y 15652 40S ribosomal protein S27 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06048 PE=3 SV=2
226 983 C1GD55 200.30 26 26 4.71E6 27 27 38 Y 146898 5-oxoprolinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05191 PE=3 SV=2
557 251 C1GB82 199.01 15 15 7.28E5 10 10 16 Y 103019 Protein transport protein SEC24 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04883 PE=3 SV=1
497 931 C1G596 198.70 29 29 8.79E5 8 8 15 Y 36801 3-hydroxyisobutyrate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03466 PE=4 SV=1
466 783 C1G7E0 198.51 57 57 4.81E6 12 12 35 Y 24889 Thioredoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03095 PE=3 SV=1
544 359 C1GC82 198.18 18 18 1.89E6 9 9 18 Y 79273 transketolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04604 PE=3 SV=2
439 334 C1FYE8 197.47 29 29 1.41E6 12 12 23 Y 36713 HABP4_PAI-RBP1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00824 PE=4 SV=2
487 454 C1GJD4 196.76 21 21 1.58E6 13 12 19 Y 61611 methylcrotonoyl-CoA carboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07370 PE=3 SV=1
562 418 C1G584 196.01 15 15 1.56E6 8 8 19 Y 58860 AA_permease domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03454 PE=4 SV=1
542 363 C1G5Z8 195.84 12 12 1.16E6 12 12 22 Y 136866 chitin synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02603 PE=4 SV=1
407 409 C1FZF8 195.37 16 16 2.6E6 12 12 23 Y 97768 RhoGAP and Fes/CIP4 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01184 PE=4 SV=1
751 254 C1GEG2 194.97 18 18 1.4E6 7 7 14 Y 55258 Integral membrane protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05648 PE=3 SV=2
718 362 C1GEE2 194.84 27 27 8.06E5 7 7 16 N 41332 Protein disulfide-isomerase domain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05628 PE=3 SV=1
533 147 C1G1L3 194.59 17 17 1.8E6 12 12 18 Y 79345 Hsp70 family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00753 PE=4 SV=2
656 627 C1G620 193.02 23 23 9.22E5 9 9 12 Y 63861 Phenylacetyl-CoA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02625 PE=4 SV=1
613 408 C1G7B3 192.57 25 25 1.41E6 6 6 19 Y 36287 YeeE/YedE family integral membrane protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03068 PE=4 SV=2
628 561 C1G532 192.46 38 38 1.57E6 8 7 19 Y 25437 Nitroreductase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02048 PE=4 SV=2
643 426 C1GEA4 192.43 12 12 6.97E5 9 8 15 N 124948 AGC/PKC protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05590 PE=3 SV=2
580 710 C1GCI7 190.98 19 19 1.09E6 10 10 16 Y 67010 Isocitrate lyase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04709 PE=3 SV=2
581 200 C1G2H4 190.95 17 17 1.12E6 9 8 17 Y 72804 methionine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02340 PE=3 SV=2
430 381 C1G1C6 189.04 9 9 1.61E6 7 7 18 Y 111449 DUF221-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00666 PE=3 SV=1
342 305 C1GDL1 188.24 17 17 1.86E6 20 20 29 Y 153254 Phospholipid-transporting ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05347 PE=3 SV=1
506 1143 C1GLD2 187.53 22 22 2.33E6 9 9 24 Y 46024 Lem3/Cdc50 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08068 PE=3 SV=2
704 423 C1G6K0 187.43 20 20 1.39E6 8 8 14 Y 41535 isocitrate dehydrogenase (NAD(+)) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02805 PE=3 SV=2
488 347 C1GKU6 185.76 41 41 3.82E6 6 6 28 Y 16365 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07953 PE=3 SV=2
752 343 C1G4R2 185.72 24 24 1.15E6 7 7 15 Y 43086 S-adenosylmethionine synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01928 PE=3 SV=1
766 574 C1GI69 185.26 18 18 5.18E5 8 8 12 Y 78620 Tryptophan synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06955 PE=3 SV=1
543 134 C1G437 185.03 16 16 1.88E6 12 12 24 N 97745 V-type proton ATPase subunit a OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01703 PE=3 SV=2
467 448 C1GJ45 184.00 32 32 2.61E6 13 13 29 Y 40764 Guanine nucleotide-binding protein subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07281 PE=3 SV=1
577 151 C1GHM0 183.84 24 24 1.16E6 13 13 19 Y 93079 Histidine biosynthesis trifunctional protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06756 PE=3 SV=1
415 1051 C1FYQ2 183.65 21 21 5.85E5 9 9 12 Y 59164 T-complex protein 1 subunit gamma OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00928 PE=3 SV=1
731 164 A0A0A0HV89 183.07 24 24 5.59E5 10 10 12 Y 65311 Alkaline phosphatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11766 PE=3 SV=1
821 472 C1G645 182.55 20 20 5.83E5 4 4 12 Y 33816 MARVEL domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02650 PE=4 SV=2
473 888 C1G0A1 182.24 20 20 4.9E5 10 10 13 Y 60123 Regulator of chromosome condensation OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00291 PE=4 SV=1
693 621 C1FZD4 181.70 15 15 7.11E5 5 5 12 Y 53700 Eukaryotic translation initiation factor 3 subunit M OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01160 PE=3 SV=1
372 389 A0A0A0HR72 181.38 8 8 1.06E6 18 18 30 Y 258855 Sorting nexin-41 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12261 PE=3 SV=1
610 378 C1GF83 181.36 28 28 1.33E6 9 9 18 Y 42547 Uncharacterized protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05919 PE=4 SV=1
647 495 C1GKU3 181.20 18 18 1.22E6 7 7 14 Y 54993 Phosphotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07950 PE=3 SV=1
584 537 C1G7G9 180.78 17 17 1.65E6 10 10 23 Y 62309 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03124 PE=3 SV=1
459 256 C1GBC4 179.75 17 17 1.36E6 12 12 20 Y 97907 alpha-1,2-Mannosidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04925 PE=3 SV=1
437 163 C1FYF6 179.30 41 41 2.13E6 13 13 21 Y 46328 Adenylosuccinate synthetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00832 PE=3 SV=1
611 1713 C1GB53 179.22 15 15 1.62E6 7 7 12 Y 61241 anthranilate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04854 PE=3 SV=2
518 290 C1G785 178.31 39 39 1.77E6 9 8 25 Y 23698 GTP-binding protein ypt5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03040 PE=4 SV=1
576 175 C1G1V9 178.08 47 47 1.13E6 12 12 22 Y 43703 Actin-related protein 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02125 PE=3 SV=1
517 195 C1GDE1 178.07 14 14 5.87E5 8 5 20 Y 58625 Serine hydroxymethyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05277 PE=3 SV=1
627 365 C1GG77 177.38 18 18 1.81E6 8 8 21 Y 61910 Carboxypeptidase Y homolog A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=CPYA PE=3 SV=1
395 236 C1GBG4 176.45 18 18 2.07E6 16 16 31 Y 101351 Coatomer subunit gamma OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04965 PE=3 SV=1
469 845 C1GLJ3 174.92 24 24 1.01E6 13 13 18 Y 61015 T-complex protein 1 subunit eta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08234 PE=3 SV=1
403 3100 C1GJD0 173.55 23 23 1.12E6 14 14 16 Y 79126 3-methylcrotonyl-CoA carboxylase subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07366 PE=4 SV=2
546 494 C1GCV8 173.26 19 19 1.62E6 9 9 19 Y 58874 T-complex protein 1 subunit zeta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05094 PE=3 SV=1
894 2430 C1FYF5 172.99 22 22 1.25E6 3 3 6 N 28267 Mid2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00831 PE=4 SV=1
674 293 C1GAW5 172.94 3 3 8.32E5 7 6 11 Y 336927 Pre-mRNA-processing-splicing factor 8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04401 PE=4 SV=1
612 298 C1GC92 172.84 29 29 5.55E5 9 8 15 Y 30935 Prohibitin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04614 PE=3 SV=1
595 394 C1G9P1 172.77 25 25 2.72E6 10 10 22 Y 42196 isocitrate dehydrogenase (NAD(+)) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03977 PE=3 SV=1
721 1163 C1GF14 171.01 8 8 2.52E5 5 5 9 Y 95000 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05850 PE=3 SV=2
847 1029 C1G8X1 170.68 17 17 7.97E5 5 5 8 Y 58448 Endo/exonuclease/phosphatase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03707 PE=3 SV=1
596 375 C1GI20 170.64 37 37 1.15E6 8 8 22 Y 30503 Triosephosphate isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06906 PE=3 SV=2
452 445 C1G6E7 170.60 17 17 1.17E6 14 12 31 N 110646 116 kDa U5 small nuclear ribonucleoprotein component OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02752 PE=3 SV=2
484 314 C1GDK4 168.76 44 44 3.12E6 10 9 22 Y 23127 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05340 PE=4 SV=1
673 2300 A0A0A0HSK3 168.56 28 28 3.16E6 9 9 11 N 44360 mRNA stability protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11717 PE=4 SV=1
594 502 C1GGK1 167.78 15 15 1.09E6 10 9 16 Y 95393 Chitin synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06438 PE=3 SV=2
659 427 C1GA32 167.55 58 58 1.16E6 5 5 19 Y 9141 60S ribosomal protein L38 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04118 PE=3 SV=1
999 2423 C1GD34 167.48 13 13 7.46E5 4 4 9 N 39986 Transmembrane protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05170 PE=4 SV=2
536 331 C1GE74 166.65 7 7 8.32E5 6 5 17 N 100692 26S proteasome regulatory subunit RPN1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05560 PE=3 SV=2
559 257 C1GKQ4 165.71 6 6 1.18E6 11 11 20 Y 197249 chitin synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07911 PE=4 SV=2
516 232 C1G5P0 165.54 5 5 1.05E6 12 12 19 Y 330928 Pre-mRNA splicing helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02495 PE=4 SV=1
767 688 C1GB99 165.01 24 24 8.29E5 9 8 13 Y 57490 Trehalose-6-phosphate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04900 PE=3 SV=1
645 457 C1GN32 164.04 11 11 6.74E5 12 11 14 Y 149067 Vigilin 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08676 PE=4 SV=2
646 303 C1GJ98 163.37 40 40 9.26E5 8 8 17 Y 31137 Beta-lactamase-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07334 PE=4 SV=1
545 364 C1GAM5 162.41 40 40 2.49E6 9 9 25 Y 26646 Related to hexamer-binding protein HEXBP OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04311 PE=4 SV=2
579 383 C1G452 162.10 31 31 1.7E6 11 11 22 Y 49603 Saccharopine dehydrogenase [NADP+, L-glutamate-forming] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01718 PE=4 SV=1
657 312 C1G5Y3 161.87 18 18 1.13E6 6 6 16 N 52385 Protein phosphatase PP2A regulatory subunit B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02588 PE=3 SV=2
525 188 C1FYK9 161.73 10 10 2.61E6 7 7 18 Y 100462 MHD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00885 PE=4 SV=2
491 289 C1G255 161.34 17 17 1.23E6 13 13 28 Y 130474 Filamentation protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02221 PE=4 SV=1
833 21180 C1G9Y1 160.69 22 22 3.72E5 4 4 7 Y 27736 Proteasome subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04067 PE=3 SV=2
846 474 C1G2Y7 160.28 9 9 6.61E5 6 6 10 Y 121419 ABC transporter domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01303 PE=4 SV=1
795 2075 C1GAK7 159.71 30 30 4.8E5 4 4 10 Y 22920 adenine phosphoribosyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04293 PE=3 SV=1
582 865 C1FZL0 159.49 24 24 1.01E6 11 10 17 Y 57336 T-complex protein 1 subunit delta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00050 PE=3 SV=2
478 401 C1GE86 157.52 16 16 2.88E6 6 6 29 Y 43772 Survival factor 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05572 PE=3 SV=2
701 969 C1GLA6 157.04 16 16 2.17E6 4 4 19 Y 34079 Protein YIP OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07892 PE=3 SV=2
672 210 C1GAE3 156.30 17 17 1.62E6 8 8 15 Y 73260 Uncharacterized protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04229 PE=4 SV=1
819 1337 C1G241 155.36 22 22 2.84E6 5 5 5 Y 40218 GTP-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02207 PE=4 SV=2
1108 690 C1GDN3 155.07 15 15 8.31E5 3 3 6 Y 27326 Cell division control protein 42 homolog OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05369 PE=3 SV=2
772 384 C1G194 154.83 18 18 1.22E6 5 5 14 Y 43821 Vacuolar protease A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00634 PE=3 SV=1
675 337 C1G0F2 154.24 16 16 1.5E6 6 6 13 N 54956 Eukaryotic translation initiation factor 3 subunit L OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00342 PE=3 SV=1
432 489 C1GEX3 153.58 8 8 6.26E5 12 11 16 Y 172940 P-loop containing nucleoside triphosphate hydrolase protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05809 PE=3 SV=2
601 2818 C1GMY9 153.13 15 15 4.96E6 6 6 22 Y 32921 DUF1774 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08640 PE=4 SV=1
1212 927 C1G750 152.59 29 29 2.96E5 2 2 6 Y 15718 Dynein light chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03005 PE=4 SV=1
1313 2424 C1G760 151.91 32 32 1.7E5 2 2 5 Y 16845 CFEM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03015 PE=4 SV=2
560 352 C1GBS0 151.80 8 8 9.03E5 13 13 14 Y 252184 Protein pyrABCN OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05071 PE=3 SV=1
549 3584 C1G3J3 150.95 9 9 5.46E5 6 6 11 N 81905 TRP_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01509 PE=3 SV=1
708 1055 C1G0L9 150.80 10 10 7.59E5 5 5 9 Y 56782 MFS general substrate transporter OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00409 PE=4 SV=1
616 373 C1GH63 150.72 43 43 1.41E6 8 8 19 Y 15748 40S ribosomal protein S25 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06599 PE=3 SV=2
571 1172 A0A0A0HU99 150.67 13 13 3.15E5 8 7 10 N 63016 RSC complex subunit Sfh1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11886 PE=3 SV=1
741 20992 C1FZ44 150.24 14 14 6E5 5 5 8 Y 57781 Rhomboid-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01070 PE=3 SV=1
1261 250 C1GEC6 148.32 16 16 3.39E5 4 4 5 N 46373 Glycosyl transferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05612 PE=3 SV=1
753 529 A0A0A0HUB3 147.84 6 6 3.84E5 5 5 9 N 194622 PH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11735 PE=3 SV=1
881 5440 C1G4J8 147.81 16 16 1.21E6 4 4 9 N 35007 Kynurenine formamidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01864 PE=3 SV=1
642 177 C1GA10 147.68 19 19 1.25E6 9 9 19 Y 73175 ATP-dependent RNA helicase DED1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04096 PE=3 SV=1
598 245 C1G413 147.14 25 25 4.46E5 9 9 12 Y 56772 NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01679 PE=3 SV=1
829 304 C1G2I2 146.82 9 9 2.54E5 4 4 7 N 70987 Pheromone-processing carboxypeptidase KEX1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=KEX1 PE=3 SV=1
691 978 C1G5A5 146.45 58 58 8.81E5 9 8 18 Y 21075 ADP-ribosylation factor 6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03475 PE=3 SV=1
490 20973 C1GEM3 146.27 15 15 1.44E5 7 7 11 Y 48805 Histone acetyltransferase type B subunit 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05709 PE=4 SV=2
1009 7220 C1G025 146.00 11 11 9.84E4 4 3 6 Y 59645 Aromatic-L-amino-acid decarboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00215 PE=3 SV=2
965 6469 C1GHK4 145.85 19 19 4.31E5 5 5 6 Y 51504 Aldedh domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06740 PE=3 SV=1
707 510 C1GLU1 145.50 23 23 2.42E5 4 4 6 Y 25484 GOLD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08332 PE=3 SV=1
739 603 A0A0A0HT52 144.67 23 23 7.92E5 6 6 11 Y 35923 Uracil-regulated protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12145 PE=3 SV=1
550 970 C1GFA5 144.11 5 5 1.21E6 9 9 15 Y 211804 phospholipase D OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05941 PE=4 SV=2
890 548 C1GMC8 143.04 27 27 5.23E5 3 3 8 N 21080 Rick_17kDa_Anti domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08214 PE=4 SV=1
706 1552 C1GL49 142.99 12 12 3.38E5 5 5 13 Y 67346 Replication protein A subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07835 PE=3 SV=1
886 20965 C1GF62 142.95 26 26 7.27E5 4 4 8 Y 20990 Rheb small monomeric GTPase RhbA OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05898 PE=4 SV=1
848 524 C1GDU8 142.75 6 6 2.68E5 4 4 5 Y 102516 Chloride channel protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05434 PE=3 SV=2
824 1003 C1GIR6 142.73 24 24 3.34E5 8 8 9 N 38930 L-type lectin-like domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07152 PE=4 SV=2
771 287 C1GI12 142.68 15 15 1E6 5 5 7 N 46463 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06898 PE=4 SV=1
775 506 C1GL26 142.61 12 12 5.6E5 8 8 10 N 84747 Eukaryotic translation initiation factor 3 subunit B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PRT1 PE=3 SV=1
770 392 C1G1H4 142.12 13 13 6.92E5 6 6 14 Y 63390 Pyruvate decarboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00714 PE=3 SV=1
696 338 A0A0A0HVY3 142.02 7 7 8.41E5 4 4 11 Y 88685 CULLIN_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11387 PE=3 SV=1
859 573 Q1XA91 141.49 16 16 3.55E5 4 4 8 Y 29382 Cytochrome c oxidase subunit 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=cox2 PE=3 SV=1
630 882 A0A0A0HVP9 140.93 56 56 1.53E6 7 7 18 Y 6946 40S ribosomal protein S30 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12373 PE=3 SV=1
732 284 C1G9Z7 140.00 23 23 5.79E5 8 8 13 Y 56725 protein-synthesizing GTPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04083 PE=4 SV=1
849 288 C1G673 139.59 27 27 7.38E5 5 5 10 Y 34164 S-adenosyl-L-methionine-dependent methyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02678 PE=4 SV=2
528 1895 C1GEZ9 139.40 8 8 9.21E5 8 8 12 Y 149415 P-loop containing nucleoside triphosphate hydrolase protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05835 PE=3 SV=1
841 361 C1G696 139.30 20 20 3.71E5 7 7 11 N 47536 Ferrochelatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02701 PE=3 SV=2
843 1449 C1G885 139.18 16 16 5.25E5 6 6 6 Y 75046 Molybdopterin molybdenumtransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03390 PE=3 SV=1
877 20954 C1GLF9 139.09 36 36 4.99E5 7 7 10 N 40087 26S proteasome regulatory subunit rpn-8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08095 PE=3 SV=1
689 247 C1GFR7 138.64 20 20 7.74E5 8 8 15 N 74888 Rho-GAP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06103 PE=4 SV=2
615 465 C1GHZ8 138.25 19 19 9.02E5 7 7 12 Y 59052 Translation initiation factor eIF-2B subunit delta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06884 PE=3 SV=1
634 1271 C1GI49 137.90 6 6 4.66E5 4 4 8 Y 89724 Phosphatidylinositol 4-kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06935 PE=3 SV=1
882 720 C1G2D0 137.71 21 21 8.31E5 4 4 9 N 37432 Eukaryotic translation initiation factor 3 subunit F OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02296 PE=3 SV=1
1067 512 C1G0H6 137.36 23 23 3.65E5 5 5 7 N 31759 NAD(P)-bd_dom domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00366 PE=4 SV=2
816 204 A0A0A0HWJ2 137.32 23 23 9.43E5 7 7 10 Y 49486 Amidase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12055 PE=4 SV=1
920 299 A0A0A0HST0 136.83 24 24 2.12E5 3 3 4 N 21431 F-type H+-transporting ATPase subunit G OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12152 PE=3 SV=1
851 344 C1GAW1 136.56 28 28 8.17E5 4 4 8 Y 23834 Cytochrome c oxidase subunit 4, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04397 PE=4 SV=2
631 1076 A0A0A0HQS4 136.33 13 13 1.9E5 5 5 6 Y 81750 LisH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12349 PE=3 SV=1
569 477 C1GE91 136.01 8 8 1.61E6 7 7 15 N 111934 WD_REPEATS_REGION domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05577 PE=4 SV=2
976 21031 C1GBY7 135.87 21 21 4.67E5 4 4 7 Y 15575 GPI anchored cell wall protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04509 PE=4 SV=1
1179 6521 C1GA36 135.61 7 7 1.83E5 3 3 5 Y 56016 Phospholipase D/nuclease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04122 PE=4 SV=1
793 636 C1GF18 135.55 6 6 5.48E5 5 5 7 Y 140347 TPR-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05854 PE=4 SV=1
818 369 C1G7G3 135.46 29 29 6.94E5 6 6 9 Y 34670 Glucose-6-phosphate 1-epimerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03118 PE=3 SV=1
494 469 C1G6V7 134.74 18 18 8.77E5 6 6 12 Y 44390 V-type proton ATPase subunit C OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02912 PE=3 SV=1
1010 4122 C1G8V5 134.60 15 15 5.74E5 4 4 8 Y 44857 Glycosidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03691 PE=3 SV=2
817 484 C1G351 134.27 12 12 7.56E5 6 6 10 Y 94098 Coatomer subunit beta' OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01367 PE=3 SV=1
722 366 C1G957 134.26 11 11 1.84E5 5 4 11 N 56516 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03793 PE=3 SV=1
740 796 C1GJI6 134.13 13 13 9.87E5 5 5 11 Y 53202 Peptidase S8/S53 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07422 PE=3 SV=1
736 1347 C1GBH1 133.65 6 6 2.24E5 7 7 10 N 164801 Cell polarity protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04972 PE=4 SV=2
561 805 C1G6J5 133.43 16 16 1.61E6 6 6 21 Y 57036 Adenylyl cyclase-associated protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02800 PE=3 SV=2
676 1207 C1GBJ3 133.14 15 15 1.37E6 6 6 17 N 52888 ATP citrate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04994 PE=4 SV=1
755 2435 C1GLZ6 133.10 17 17 1.05E6 6 6 10 Y 52044 Citrate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08387 PE=3 SV=1
734 332 C1GJD3 131.99 26 26 7.12E5 8 8 14 Y 46946 Isovaleryl-CoA dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07369 PE=3 SV=2
733 1387 C1G0C7 131.56 22 22 1.04E6 8 8 12 Y 50289 Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00317 PE=3 SV=2
1077 1687 C1G114 131.27 32 32 3.31E5 4 4 7 Y 24130 GTP-binding protein rho2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00554 PE=4 SV=2
878 1523 C1GEC2 131.25 31 31 9.52E5 5 5 8 Y 20266 Ras-like protein Rab7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05608 PE=4 SV=2
850 348 A0A0A0HTQ5 131.20 11 11 5.87E5 4 4 5 N 50813 Protein-serine/threonine kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12250 PE=3 SV=1
1005 1768 C1GHV0 131.17 6 6 5.34E5 7 7 8 Y 206070 DMAP1-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06836 PE=4 SV=1
600 237 C1G1J4 131.02 9 9 1.07E6 8 7 15 Y 136977 Urea carboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00734 PE=4 SV=1
978 432 C1G6Q5 130.86 26 26 1.71E5 3 3 4 N 25221 GOLD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02860 PE=3 SV=2
974 1292 C1G5X3 130.72 20 20 4.07E5 5 5 7 N 26755 ATP synthase subunit 4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02578 PE=3 SV=1
842 2348 C1GG11 129.81 17 17 2.99E5 7 7 9 Y 66579 Vacuolar protein sorting-associated protein 45 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06248 PE=3 SV=1
692 420 C1G6S1 127.47 13 13 1.2E6 6 6 11 N 56580 DAGKc domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02876 PE=4 SV=2
1020 6214 C1G2H2 127.31 23 23 4.27E5 4 4 7 N 19201 Smr domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02338 PE=4 SV=1
879 1308 C1GIX4 127.06 26 26 7.33E5 5 4 9 N 36002 Malate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07210 PE=3 SV=1
916 490 C1G445 126.86 25 25 4.87E5 5 5 7 N 36027 Aha1_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01711 PE=3 SV=2
888 632 C1GE31 126.79 21 21 1.66E6 4 4 9 N 22305 Rho-gdp dissociation inhibitor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05517 PE=3 SV=2
754 2046 C1GKV7 126.67 19 19 2.65E5 6 6 7 Y 36005 Vacuolar ATP synthase subunit E OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07964 PE=3 SV=2
1034 395 C1G3U9 126.63 7 7 4.43E5 2 2 5 Y 48405 homocitrate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01615 PE=3 SV=2
805 1084 C1GLA9 126.59 6 6 3.67E5 4 4 9 N 118994 Eukaryotic translation initiation factor 5B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07895 PE=4 SV=1
537 1587 C1GL71 126.56 6 6 1.16E5 6 6 7 N 156352 Sec3-PIP2_bind domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07857 PE=3 SV=1
796 20957 C1GCX3 126.06 15 15 9E5 6 6 10 Y 57367 phosphoglycerate mutase (2,3-diphosphoglycerate-independent) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05109 PE=3 SV=1
966 358 C1GF52 125.80 17 17 4.53E5 5 5 8 Y 58395 Aspartokinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05888 PE=3 SV=1
587 959 C1G0R1 124.61 22 22 7.11E5 9 9 12 Y 63156 Glucose-6-phosphate isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00451 PE=3 SV=1
769 388 C1GDK5 124.48 12 12 5.25E5 6 6 10 Y 72410 Ca2+-binding actin-bundling protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05341 PE=4 SV=2
800 779 C1G3V2 124.18 25 25 8.85E5 5 5 12 Y 28906 Peptidyl-tRNA hydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01618 PE=4 SV=1
694 955 C1GAU3 124.07 12 12 9.34E5 6 6 13 N 63540 Heat shock protein STI1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04379 PE=4 SV=1
893 1563 A0A0A0HVC6 123.65 10 10 4.19E5 3 3 9 N 40403 Sulfite efflux pump SSU1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11376 PE=3 SV=1
391 398 C1G0X9 122.80 17 17 1.11E6 15 15 22 Y 92835 AP-1 complex subunit gamma OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00519 PE=3 SV=1
880 953 C1GMG0 122.43 37 37 8.77E5 5 5 9 Y 26095 NAD(P)-bd_dom domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08446 PE=4 SV=1
827 463 C1GMS3 122.23 6 6 1.28E6 5 5 12 Y 45037 ZIP zinc/iron transport family OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08567 PE=4 SV=2
1071 704 C1GGE5 122.14 9 9 4.72E5 3 3 4 N 46325 acetyl-CoA C-acetyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06382 PE=3 SV=1
705 414 C1G1Y7 122.07 18 18 6.42E5 5 4 14 Y 43017 Mitogen-activated protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02153 PE=3 SV=2
822 261 C1GHV7 121.97 11 11 1.01E6 4 4 8 N 40569 V-type proton ATPase subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06843 PE=3 SV=1
773 480 C1GA06 121.79 46 46 6.82E5 8 7 10 Y 22946 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04092 PE=3 SV=1
1008 156 C1G4C0 121.50 6 6 1.99E5 3 3 4 N 96116 N-terminal acetyltransferase A complex subunit nat1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01786 PE=4 SV=1
799 413 C1GAM1 121.31 17 17 3.31E5 5 5 8 Y 42682 mRNA binding post-transcriptional regulator OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04307 PE=4 SV=2
802 994 C1G887 121.25 21 21 3.89E5 5 3 11 Y 26250 Ras-related protein Rab-6A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03392 PE=4 SV=2
883 1345 C1G3N9 120.61 19 19 3.71E5 4 4 8 N 58494 Sorting nexin-4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01555 PE=4 SV=2
695 585 C1GF68 120.59 17 17 7.18E5 5 5 13 Y 50902 dihydrolipoyllysine-residue succinyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05904 PE=3 SV=2
1076 2436 C1G347 120.58 43 43 4.04E5 4 4 6 N 11835 ACB domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01363 PE=4 SV=1
774 412 C1G9A3 120.50 14 14 5.2E5 5 5 9 Y 51407 Uracil-DNA glycosylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03839 PE=3 SV=1
912 326 C1GF88 120.03 11 11 5.32E5 5 5 9 Y 57760 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05924 PE=3 SV=2
797 405 C1G0I9 119.66 8 8 1.03E6 5 5 9 Y 64078 Glucosidase 2 subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00379 PE=4 SV=1
776 438 C1FYW7 119.42 7 7 1.84E6 4 4 13 Y 65995 MFS peptide transporter Ptr2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00993 PE=3 SV=1
679 579 A0A0A0HQC4 119.30 10 10 3.16E5 6 5 10 Y 67455 ENTH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12478 PE=4 SV=1
820 406 C1G390 119.20 10 10 6.68E5 5 5 9 N 68092 phenylalanine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01406 PE=3 SV=2
586 622 C1GM91 118.60 7 7 1.55E5 5 5 7 N 90458 Ras-GAP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08177 PE=4 SV=2
1472 21184 C1GJK4 118.59 7 7 2.7E5 2 2 4 N 63407 AA_permease domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07440 PE=4 SV=2
969 864 C1GIC8 118.54 25 25 5.62E5 6 6 8 Y 32686 Vesicular-fusion protein sec17 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07014 PE=3 SV=1
856 1526 C1GMV5 118.31 10 10 6.4E5 4 4 9 N 54941 J domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08599 PE=4 SV=1
719 417 C1FYK2 118.01 10 10 8.68E5 10 10 11 Y 123778 isoleucine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00878 PE=3 SV=1
1120 387 C1G4F7 118.00 12 12 3.44E5 2 2 6 Y 34835 Mitochondrial thiamine pyrophosphate carrier 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01823 PE=3 SV=2
963 719 C1FZK1 117.72 15 15 4.82E5 5 5 9 Y 55410 Ran GTPase-activating protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00041 PE=4 SV=1
570 380 C1G6F7 117.65 11 11 1.57E5 6 6 9 N 81484 Bromodomain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02762 PE=4 SV=2
1024 713 A0A0A0HYM8 117.57 15 15 3.47E5 4 4 7 N 31655 ribose-phosphate diphosphokinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11296 PE=3 SV=1
1007 357 C1G6M3 117.26 22 22 5.48E5 4 4 6 Y 24100 Ribosomal protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02828 PE=3 SV=1
1069 1037 C1G9X5 116.95 12 12 2.37E5 4 4 6 Y 79983 alpha-1,2-Mannosidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04061 PE=3 SV=1
1082 939 C1GBM3 116.82 18 18 1.28E5 2 2 4 N 28615 Synaptobrevin homolog YKT6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05024 PE=3 SV=2
794 1940 C1GJI4 116.77 24 24 8.82E5 7 7 13 Y 35718 Transaldolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07420 PE=3 SV=2
970 350 C1GA71 116.56 8 8 4.46E5 3 3 7 Y 52462 Cytochrome b561 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04157 PE=4 SV=1
844 584 C1GIB2 115.03 7 7 7.6E5 5 5 9 N 137434 Protein transport protein SEC31 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06998 PE=3 SV=2
929 743 C1GF61 114.88 12 12 1.31E5 4 4 5 N 55865 serine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05897 PE=4 SV=1
1089 601 C1FYR9 114.63 35 35 6.52E5 3 3 7 N 20546 Actin-related protein 2/3 complex subunit 5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00945 PE=3 SV=1
1159 212 C1GGA8 113.78 8 8 1.31E5 4 4 4 N 77118 AMP-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06345 PE=4 SV=2
804 2687 C1G6V8 113.23 30 30 5.12E5 5 5 8 N 23876 Adenylyl-sulfate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02913 PE=3 SV=1
724 274 C1FZH6 112.59 3 3 5.91E5 3 1 9 Y 88297 Dynamin-related protein DNM1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00016 PE=3 SV=2
1681 416 C1G054 112.15 16 16 6.97E4 3 3 3 Y 44993 Enoyl reductase (ER) domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00244 PE=4 SV=1
1125 7599 C1G1D6 112.07 4 4 2.82E5 2 2 4 N 95540 CUE domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00676 PE=4 SV=1
923 2335 C1GJH8 111.93 13 13 2.52E5 3 3 8 N 31745 RPA43_OB domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07414 PE=4 SV=1
830 1000 C1G3F2 111.82 31 31 1.17E5 3 2 6 Y 13660 Tubulin alpha chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01468 PE=3 SV=2
845 1120 C1GHR9 111.78 18 18 7.83E5 5 5 9 Y 47649 Acyl-CoA dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06805 PE=3 SV=1
924 782 C1G6S5 111.78 7 7 2.37E5 5 5 6 N 120828 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02880 PE=4 SV=1
798 909 C1G2P3 111.46 20 20 1.15E6 4 4 8 Y 31312 Enoyl-CoA hydratase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01209 PE=3 SV=1
1154 824 C1GH26 111.42 26 26 1.83E5 5 5 6 Y 32020 FYVE-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06562 PE=4 SV=1
915 1453 C1GIJ9 111.02 9 9 3.82E5 4 4 5 N 80452 SWI/SNF complex subunit SMARCC2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07085 PE=4 SV=1
854 6098 C1G4T3 110.73 17 17 5.08E5 5 5 8 N 48626 Elongation factor Tu OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01949 PE=3 SV=1
826 1208 C1G240 109.85 15 15 4.05E5 4 4 5 N 39431 J domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02206 PE=4 SV=1
862 446 C1G6G2 109.79 7 7 2.74E5 3 3 8 Y 44581 DUF3844 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02767 PE=4 SV=2
1080 308 C1GJD9 109.52 9 9 4.28E4 3 3 7 Y 52424 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit WBP1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07375 PE=3 SV=1
677 916 C1GJ85 109.06 7 7 5.9E5 7 6 12 Y 136908 Rho1 guanine nucleotide exchange factor 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07321 PE=4 SV=2
507 1130 C1FZ53 108.74 14 14 8.25E5 9 8 12 N 62388 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01079 PE=4 SV=2
735 3533 C1GEE9 108.66 6 6 3.31E5 5 5 9 Y 129876 GPI-anchored cell surface glycoprotein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05635 PE=4 SV=2
1329 747 C1FZ84 108.37 7 7 1.77E5 2 2 4 N 29569 Translocon-associated protein subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01110 PE=3 SV=1
1479 1717 C1GB68 107.83 21 21 1.36E5 2 2 4 N 15014 HIT domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04869 PE=4 SV=1
737 940 C1G1H9 107.45 7 7 3.77E5 4 4 5 Y 114383 Lgl_C domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00719 PE=3 SV=2
633 450 C1GIL9 107.39 11 11 3.58E5 4 4 8 Y 81430 arginine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07105 PE=3 SV=1
853 20960 C1GG29 107.35 16 16 6.07E5 4 4 5 N 37096 37S ribosomal protein S9, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06266 PE=3 SV=2
1017 368 C1G4I1 107.10 13 13 3.37E5 3 3 7 N 48730 PHB domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01847 PE=3 SV=1
1074 553 C1GKI5 106.88 23 23 2.47E5 3 3 5 Y 29172 6-phosphogluconolactonase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07771 PE=3 SV=1
1014 487 C1GE23 106.34 10 10 3.34E4 4 4 5 N 40281 eIF-2B GDP-GTP exchange factor subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05509 PE=3 SV=2
738 998 C1GHL1 106.23 5 5 7.66E5 6 4 11 Y 192806 DNA-directed RNA polymerase subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06747 PE=3 SV=2
1013 429 C1GA79 106.09 12 12 3.48E5 3 3 8 N 43538 Peripheral subunit-binding (PSBD) domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04165 PE=3 SV=2
884 386 C1GGE1 106.05 20 20 3.82E5 4 4 9 Y 34559 Mitochondrial thiamine pyrophosphate carrier 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06378 PE=3 SV=2
1723 2623 C1G022 105.75 4 4 2.52E5 2 2 3 Y 104627 Hydantoinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00212 PE=4 SV=1
1006 2493 C1GMH9 105.20 21 21 5.82E5 5 5 7 N 46597 Fumarylacetoacetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08465 PE=3 SV=1
927 1330 C1GDG5 104.96 9 9 1.4E5 4 4 7 Y 57587 Cystathionine beta-synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05301 PE=3 SV=2
756 4834 C1G9G6 104.72 11 11 1.55E6 3 3 12 Y 38884 UPF0658 Golgi apparatus membrane protein C23H3.04 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03902 PE=4 SV=1
1161 184 C1G7A3 104.23 11 11 3.13E5 4 4 5 Y 53440 Succinate-semialdehyde dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03058 PE=3 SV=1
1268 295 A0A0A0HT88 104.12 9 9 2.94E4 3 3 4 Y 74219 Fatty acid transporter protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11240 PE=3 SV=1
1157 715 C1G421 103.86 16 16 2.11E5 4 4 6 Y 43336 acetyl-CoA C-acetyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01687 PE=3 SV=1
1431 802 C1FYD8 103.52 3 3 1.03E5 1 1 2 N 65497 Branchpoint-bridging protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00814 PE=3 SV=1
1213 1024 C1G080 103.41 13 13 7.38E5 2 2 6 N 28006 Similar to OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00270 PE=4 SV=1
962 1083 C1FZU0 102.53 15 15 5.48E5 6 6 8 Y 72839 Abhydro_lipase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00130 PE=4 SV=1
953 21484 C1GJ63 102.20 11 11 9.49E5 3 3 10 Y 32905 High osmolarity signaling protein SHO1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=SHO1 PE=3 SV=2
1127 1022 C1GEJ5 101.83 7 7 4.24E5 2 2 5 Y 37096 Arrestin_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05681 PE=4 SV=1
1025 624 C1GJN5 101.66 10 10 2.31E5 2 2 4 N 35583 NMO domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07471 PE=4 SV=2
1325 1898 C1G2M4 101.56 14 14 3.24E5 3 3 4 N 42145 Protein YIP OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01190 PE=3 SV=2
865 504 C1G0U1 101.16 7 7 6.06E5 3 3 7 Y 40462 MRH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00481 PE=4 SV=2
1018 169 A0A0A0HWQ9 100.94 10 10 4.2E5 4 4 5 Y 64141 NADH-ubiquinone oxidoreductase 78 kDa subunit, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12148 PE=3 SV=1
1696 1772 C1GC10 100.80 7 7 2.14E5 2 2 2 N 43481 PH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04532 PE=4 SV=2
1182 606 A0A0A0HYS7 100.72 6 6 4.29E5 2 2 3 N 52879 Oligouridylate-binding protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11347 PE=4 SV=1
1724 205 C1GE59 100.67 6 6 7.25E4 2 2 3 Y 87463 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05545 PE=3 SV=1
975 1744 C1GJW2 100.66 13 13 4.48E5 4 3 5 N 38763 IF4E-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07548 PE=3 SV=1
914 328 C1GB27 100.56 14 14 4.13E5 6 6 8 Y 54588 Adenylosuccinate lyase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04828 PE=3 SV=1
825 382 C1GBN1 100.30 30 30 7.76E5 4 4 8 Y 23445 CS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05032 PE=3 SV=2
972 20985 C1G9M7 99.01 13 13 2.5E5 3 3 5 Y 26702 SHSP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03963 PE=3 SV=2
1317 2073 C1GA21 98.83 18 18 3.57E5 2 2 5 Y 21940 U6 snRNA-associated Sm-like protein LSm6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04107 PE=4 SV=2
1019 6350 C1GL11 97.97 12 12 5.53E5 4 4 5 Y 45916 Glycerol-3-phosphate dehydrogenase [NAD(+)] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08018 PE=3 SV=1
1174 652 C1GA42 97.78 7 7 2.3E5 3 2 5 Y 57804 Cation efflux protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04128 PE=4 SV=1
834 4861 C1GGZ6 97.47 2 2 1.06E5 2 1 6 N 92540 Homoaconitase, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06215 PE=3 SV=1
1012 568 C1GHZ3 97.33 14 14 2.75E5 3 3 6 N 41406 CRAL-TRIO domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06879 PE=4 SV=1
1314 602 C1GC74 97.14 32 32 2.04E5 2 2 5 Y 16342 V-type proton ATPase proteolipid subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04596 PE=3 SV=2
855 608 C1GDE6 96.41 15 15 9.45E5 3 3 12 N 26529 Ras family, other OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05282 PE=4 SV=1
885 525 C1G7L5 96.29 16 16 6.58E5 4 4 8 Y 46060 Serum paraoxonase/arylesterase 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03170 PE=3 SV=1
1094 817 C1FZN1 95.43 13 13 1.99E5 3 3 5 Y 32229 VWFA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00071 PE=4 SV=2
980 1864 C1GDU4 95.04 8 8 1.01E6 3 3 8 N 35497 Rad60-SLD_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05430 PE=4 SV=1
913 306 C1G017 94.96 16 16 5.9E5 5 5 7 N 50673 J domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00207 PE=4 SV=1
1070 1656 C1GAU7 94.83 7 7 3.11E5 5 5 5 N 164775 Tricalbin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04383 PE=4 SV=2
1051 1361 C1G9I8 94.40 16 16 9.23E5 2 2 7 Y 19403 PRA1 family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03924 PE=3 SV=1
932 892 C1GLY2 94.01 53 53 3.51E5 3 3 6 N 7783 Mitochondrial ATP synthase epsilon chain domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08373 PE=3 SV=1
1016 315 C1GB89 93.89 13 13 4.92E5 3 3 8 N 43119 Altered inheritance of mitochondria protein 24, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04890 PE=3 SV=2
2139 5837 C1G3R8 93.82 6 6 8.4E4 2 2 2 N 40994 RGS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01584 PE=4 SV=1
1068 447 C1GJN2 93.77 14 14 3.62E5 5 5 6 N 50551 MHD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07468 PE=3 SV=2
1011 3601 C1GJM4 93.48 9 9 4.45E5 4 4 7 Y 56285 Aspartyl aminopeptidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07460 PE=3 SV=1
971 285 C1G2W2 93.15 13 13 2.08E5 5 5 6 N 58958 Pyruvate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01278 PE=3 SV=1
1417 434 C1GEQ8 92.95 8 8 1.29E5 2 2 3 Y 46564 Glycosyltransferase family 15 protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05744 PE=3 SV=1
663 1018 C1GDK6 92.62 3 3 7.53E5 3 3 14 N 118810 DDHD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05342 PE=4 SV=2
1262 693 C1G7X8 91.99 9 9 2.96E5 4 4 4 N 55293 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03283 PE=3 SV=2
1852 1624 C1GMW4 91.71 12 12 1.78E5 1 1 3 N 17915 Tropomyosin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08615 PE=4 SV=2
1402 497 C1GAS0 91.69 15 15 2.13E5 3 3 3 Y 45556 Trans-sulfuration enzyme OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04356 PE=3 SV=1
1555 1090 C1GFI8 91.43 3 3 1.31E5 1 1 4 N 81585 Eukaryotic translation initiation factor 2A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06024 PE=3 SV=1
1216 4542 C1G0Y7 91.25 6 6 2.03E5 2 2 4 N 66414 Mucin-5AC OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00527 PE=4 SV=2
1163 804 C1GGW8 91.19 8 8 1.36E5 3 3 3 Y 59792 6PF2K domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06187 PE=4 SV=1
1856 862 C1G6P0 90.97 6 6 1.6E5 2 2 2 N 34699 CORD and CS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02845 PE=4 SV=1
744 599 C1GD04 90.63 12 12 5.39E5 3 3 14 N 27784 SUR7/PalI family-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05140 PE=4 SV=2
1175 951 C1G4X7 90.42 4 4 2.53E5 3 3 4 N 79830 Acetoacetate-CoA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01993 PE=3 SV=1
1036 2239 C1GDV0 90.33 14 14 4.27E5 3 3 6 N 27114 Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05436 PE=3 SV=1
1265 1421 C1GL70 89.99 9 9 1.95E5 3 3 3 N 52153 SRP40_C domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07856 PE=4 SV=1
925 1600 C1GFE3 89.66 3 3 2.28E4 3 3 3 N 157326 Transcription elongation factor Spt6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05979 PE=3 SV=2
852 1386 C1GBB1 89.41 33 33 7.69E5 4 4 10 Y 20352 Redoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04912 PE=3 SV=2
1096 1060 C1G4I6 89.07 11 11 6.25E4 2 2 2 Y 37388 SGTA_dimer domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01852 PE=3 SV=1
2193 2673 C1G763 88.89 13 13 4.01E4 1 1 2 Y 20695 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03018 PE=4 SV=2
757 500 C1G6Y4 88.80 5 5 4.75E5 4 4 8 Y 95371 Carn_acyltransf domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02939 PE=3 SV=2
1682 646 C1FZG2 88.79 4 4 1.13E5 3 3 3 N 117917 Alanine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=ALA1 PE=3 SV=2
919 2573 C1GAK2 88.78 48 48 7.03E5 4 4 9 Y 13374 Endoribonuclease L-PSP OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04288 PE=3 SV=2
1156 774 C1GFJ7 88.76 11 11 4.1E5 5 5 5 N 46068 Nipsnap family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06033 PE=3 SV=1
891 300 C1FYX3 88.72 16 16 2.54E6 4 4 9 Y 20752 Perilipin MPL1-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00999 PE=4 SV=1
964 376 C1G0X3 88.59 10 10 5.47E5 4 4 6 Y 64678 AMP-binding domain protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00513 PE=4 SV=1
1475 2016 C1GJI2 88.50 19 19 3.08E5 2 2 3 N 17359 Superoxide dismutase [Cu-Zn] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07418 PE=4 SV=2
917 1482 C1GC24 88.12 8 8 2.51E5 3 3 4 N 58557 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04546 PE=4 SV=1
1733 4586 C1GMJ8 87.92 7 7 2.5E5 2 2 3 Y 59838 T-complex protein 1 subunit epsilon OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08484 PE=3 SV=2
1155 6514 C1G0Q6 87.76 26 26 2.23E5 4 4 5 Y 38855 NMO domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00446 PE=4 SV=2
1173 2272 C1G0Q2 87.75 7 7 5.11E4 3 2 4 N 51900 Arf-GAP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00442 PE=4 SV=2
1725 21327 C1GHB7 87.66 9 9 1.18E5 2 2 3 N 41387 DUF803 domain membrane protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06653 PE=4 SV=2
1267 3102 C1G6C1 87.65 13 13 2.32E5 3 3 3 N 40592 Cysteine synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02726 PE=4 SV=1
981 1354 C1GF00 87.61 50 50 1.77E6 3 3 7 N 4358 60S ribosomal protein L39 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05836 PE=3 SV=2
895 541 C1FZM8 87.50 2 2 7.28E5 2 2 5 N 135435 Rho-type GTPase-activating protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00068 PE=4 SV=2
1081 542 C1GCH9 87.43 9 9 1.87E5 3 3 4 Y 45525 Enoyl reductase (ER) domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04701 PE=3 SV=2
777 297 C1GD94 87.39 5 5 9.28E4 3 3 7 N 85007 Bactericidal permeability-increasing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05230 PE=4 SV=1
1735 2657 C1GG56 87.37 14 14 3.15E5 2 2 3 N 19037 UPF0220-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06293 PE=3 SV=1
930 3258 C1GJR5 87.35 7 7 2.72E5 2 2 5 Y 47160 Similar to OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07501 PE=4 SV=1
1316 424 C1G389 87.07 5 5 1.24E5 2 2 5 N 68785 Protein phosphatase PP2A regulatory subunit A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01405 PE=4 SV=2
922 516 C1GLD3 86.64 6 6 3.77E5 5 5 5 N 115222 FACT complex subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08069 PE=3 SV=2
926 451 C1GBX3 86.14 7 7 2.41E5 3 3 4 Y 55888 Acetyl-CoA synthetase-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04495 PE=3 SV=1
967 1125 C1G5Z2 85.97 9 9 4.53E5 3 3 5 N 58275 Acetyl-CoA hydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02597 PE=3 SV=1
1176 475 C1FZ18 85.67 3 3 2.57E5 2 2 5 N 119621 DNA polymerase delta subunit 3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01044 PE=4 SV=2
918 1061 A0A0A0HX82 84.86 9 9 2.91E5 3 3 5 N 60473 phosphoglucomutase (alpha-D-glucose-1,6-bisphosphate-dependent) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11132 PE=3 SV=1
2130 1210 C1G188 84.83 3 3 1.18E5 2 2 2 N 119059 ARID domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00628 PE=4 SV=1
889 503 C1GDR6 84.74 39 39 3.2E5 3 3 5 N 11232 Mitochondrial F1F0 ATP synthase-like protein subunit F OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05402 PE=4 SV=2
1315 1119 C1GM45 84.17 6 6 4E5 2 2 5 N 59676 DUF805 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08131 PE=4 SV=2
1403 765 C1GGB6 84.09 8 8 2.42E5 3 3 3 Y 72864 Transmembrane 9 superfamily member OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06353 PE=3 SV=1
1285 1185 C1G5N0 83.27 9 9 1.97E5 2 2 4 N 39448 CMGC/CK2 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02485 PE=3 SV=1
1269 643 C1GBD3 82.87 7 7 2.37E5 3 3 5 N 50934 RNP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04934 PE=4 SV=2
1445 393 C1G2Z9 82.78 3 3 2.4E5 2 2 3 Y 106308 AP-2 complex subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01315 PE=3 SV=1
1072 812 C1GH68 82.66 11 11 1.52E5 4 4 6 Y 61437 Acid phosphatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06604 PE=4 SV=2
1705 5433 C1GDX9 82.65 5 5 4.4E4 1 1 1 N 39365 Pantoate--beta-alanine ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05465 PE=3 SV=2
977 1815 C1GKB8 82.09 7 7 4.57E5 3 3 4 N 53285 CMGC/CDK/CDK5 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07704 PE=3 SV=1
1480 545 C1GBD6 81.95 18 18 3.51E5 3 3 4 N 21497 NADH-ubiquinone oxidoreductase 213 kDa subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04937 PE=4 SV=1
823 277 A0A0A0HXV1 81.67 5 5 5.85E5 3 3 7 N 82567 AP complex subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11728 PE=3 SV=1
1099 439 C1GL06 81.50 8 8 1.43E5 2 2 5 N 32126 Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08013 PE=3 SV=2
1288 360 C1GHR8 81.43 5 5 2.72E5 2 2 4 N 55717 Senescence domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06804 PE=4 SV=1
860 21036 C1GFK5 81.28 20 20 1.28E6 4 4 10 Y 16632 GTP-binding protein rho3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06041 PE=4 SV=2
1090 1978 C1GGC0 81.08 4 4 1.59E5 2 2 4 Y 75036 5'-nucleotidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06357 PE=3 SV=1
801 443 C1G0J6 80.84 12 12 8.79E5 4 4 10 N 42120 Phospho-2-dehydro-3-deoxyheptonate aldolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00386 PE=3 SV=1
1026 6934 A0A0A0HRT0 80.49 6 6 1.62E5 3 3 3 Y 55219 General stress response protein Whi2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11887 PE=4 SV=1
1436 533 A0A0A0HW80 80.24 6 6 2.74E5 2 2 3 Y 40711 TIGR00267 family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11487 PE=3 SV=1
1084 1372 C1GMY3 80.18 8 8 3.24E5 3 3 6 N 70255 Protein scd2/ral3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08634 PE=4 SV=2
892 7125 A0A0A0HYT2 80.15 13 13 4.09E4 4 3 4 N 71522 Signal recognition particle subunit SRP72 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11353 PE=3 SV=1
2982 839 C1GFX9 80.12 7 7 5.11E4 1 1 1 N 22916 GLTP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06165 PE=4 SV=1
832 355 C1GIW6 80.09 8 8 7.07E4 3 2 4 N 49812 6PF2K domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07202 PE=4 SV=2
1556 1199 C1GB60 79.76 6 6 3.4E5 1 1 4 Y 40428 DUF1751-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04861 PE=4 SV=1
1853 2429 C1G021 79.58 13 13 2.58E5 1 1 3 N 11877 NTP_transf_9 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00211 PE=4 SV=1
2196 1115 C1GCW3 79.57 7 7 2.39E4 2 2 2 N 46605 CAMK/CAMK1 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05099 PE=3 SV=2
2194 1875 C1GD03 79.43 3 3 8.72E4 1 1 2 N 62021 Hsp70 protein-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05139 PE=3 SV=1
1085 933 C1GLZ5 79.28 4 4 8.42E4 2 2 3 N 81416 Glycos_transf_1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08386 PE=4 SV=1
1277 6290 C1G9V0 79.13 4 4 8.88E4 2 2 3 N 91618 STAS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04036 PE=3 SV=2
968 834 C1G8R5 78.34 10 10 2.97E5 3 3 5 Y 55996 6-phosphogluconate dehydrogenase, decarboxylating OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03651 PE=3 SV=2
1022 1181 C1G6I9 78.22 3 3 1.16E5 2 2 2 N 138320 LIM zinc-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02794 PE=4 SV=2
803 521 C1G106 78.03 17 17 9.42E5 4 4 9 N 30685 3-oxoacyl-(Acyl-carrier-protein) reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00546 PE=3 SV=1
1684 5698 C1G8P5 77.81 18 18 1.31E5 3 3 3 N 37812 Phosphoglycerate mutase family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03631 PE=4 SV=2
1126 628 C1GF57 77.78 7 7 2.98E5 2 2 7 N 46638 Nucleosome assembly protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05893 PE=3 SV=1
1160 3647 C1G6X9 77.41 9 9 4.81E5 4 4 5 Y 57234 High affinity methionine permease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02934 PE=4 SV=2
1687 6875 C1GD67 77.16 15 15 9.92E4 2 2 2 N 24015 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05203 PE=4 SV=2
1409 228 C1GFU1 77.15 12 12 2.48E5 4 4 4 N 45271 Endoplasmic reticulum-Golgi intermediate compartment protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06127 PE=3 SV=2
1406 1212 C1G162 77.14 10 10 1.91E5 3 3 4 N 39890 Methyltransf_25 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00602 PE=4 SV=1
1272 856 C1GGW7 76.84 8 8 1.34E5 3 3 3 N 38075 Mitochondrial import receptor subunit tom-40 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06186 PE=3 SV=1
1263 651 A0A0A0HVN3 76.43 10 10 1.95E5 3 3 3 N 50705 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11254 PE=3 SV=1
1333 21437 C1FYP5 76.05 8 8 2.27E5 1 1 3 N 25268 Nucleolin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00921 PE=4 SV=2
1686 515 A0A0A0HRQ4 76.03 7 7 7.4E4 2 2 2 Y 46802 Glutaryl-CoA dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12025 PE=3 SV=1
1075 313 C1FYE6 75.98 8 8 2.4E5 4 4 6 Y 101925 Glutaminase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00822 PE=4 SV=1
2195 3227 C1GMH1 75.86 3 3 3.41E4 1 1 2 N 42134 biotin synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08457 PE=3 SV=1
957 906 C1G833 75.83 4 4 3.82E5 2 1 8 N 56329 UPF0016-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03338 PE=3 SV=1
1086 1298 C1GEQ4 75.75 12 12 1.35E5 3 2 5 N 28649 t-SNARE coiled-coil homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05740 PE=4 SV=1
2132 2497 C1GMH8 75.54 12 12 1.79E5 2 2 2 Y 26671 Maleylacetoacetate isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08464 PE=3 SV=1
1167 2638 C1GJA6 75.48 12 12 1.93E5 3 3 4 Y 52988 Palmitoyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07342 PE=3 SV=1
887 527 C1G136 74.97 13 13 1.22E6 4 4 8 Y 35199 Pre-mRNA-splicing factor srp2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00576 PE=4 SV=1
1727 746 C1G5G4 74.94 6 6 2.47E5 3 3 3 Y 53930 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02419 PE=4 SV=1
1487 2129 C1G764 74.77 7 7 2.99E5 2 2 3 N 32361 Vacuolar protein sorting-associated protein 29 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03019 PE=3 SV=2
1508 2472 C1GK52 74.21 20 20 3E5 1 1 3 Y 12034 UPF0136 domain protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07638 PE=3 SV=2
810 453 C1GLD8 74.08 5 5 3.61E5 2 2 5 N 35678 Ras-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08074 PE=4 SV=1
1215 1231 C1G801 73.76 6 6 2.72E5 2 2 4 N 42260 Glycosyltransferase family 62 protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03306 PE=4 SV=1
1282 535 C1FYX7 73.73 7 7 7.07E4 2 2 4 N 57379 SWIB/MDM2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01003 PE=4 SV=1
1710 1881 C1G3R7 73.01 14 14 1.08E5 2 2 2 N 35733 PCI domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01583 PE=3 SV=2
1680 1760 A0A0A0HVE7 72.88 28 28 1.69E5 3 3 3 Y 18084 NADH-ubiquinone oxidoreductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11513 PE=3 SV=1
1521 623 C1G6U1 72.84 8 8 1.55E5 1 1 3 N 25053 EF1_GNE domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02896 PE=3 SV=2
1162 320 C1G5K1 72.14 17 17 3.01E5 4 4 5 N 44478 Cystathionine gamma-lyase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02456 PE=3 SV=1
1486 2778 A0A0A0HU35 72.07 10 10 4.2E4 2 1 3 N 47331 Chitin synthase C OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12130 PE=4 SV=1
1214 1565 C1GJX3 72.01 11 11 5.12E5 2 2 6 Y 23965 GOLD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07559 PE=3 SV=1
866 671 C1GK68 71.96 3 3 1.98E5 1 1 3 N 53614 NADH-ubiquinone oxidoreductase 49 kDa subunit, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07654 PE=3 SV=1
921 422 C1G164 71.93 7 7 8.52E5 3 3 6 N 64489 Phosphoacetylglucosamine mutase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00604 PE=3 SV=2
1524 1204 C1FZ88 71.93 4 4 1.53E5 1 1 3 N 60765 Importin subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01114 PE=3 SV=2
1405 21189 C1G312 71.91 7 7 5.03E4 2 2 2 N 49947 Ornithine aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01328 PE=3 SV=1
1158 3519 C1GLP7 71.88 25 25 1.02E5 4 4 6 N 30798 t-SNARE coiled-coil homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08288 PE=3 SV=1
1030 1264 C1FYT2 71.75 9 9 3.32E5 3 3 8 Y 55176 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00958 PE=4 SV=2
1087 1159 C1G970 71.66 8 8 2.45E5 3 3 6 N 64135 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03806 PE=4 SV=2
1490 2676 C1GE87 71.57 18 18 3.14E4 2 2 2 N 16470 Ribosomal protein L11 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05573 PE=3 SV=1
857 791 C1GBQ7 71.52 23 23 1.12E6 5 5 10 N 30899 Chorismate mutase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05058 PE=4 SV=1
1015 20994 C1G6D0 71.48 18 18 1.32E5 3 3 3 N 29264 Proteasome subunit alpha type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02735 PE=3 SV=1
1172 2808 C1G4I7 70.50 5 5 2.58E5 2 2 5 Y 59895 Tim44 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01853 PE=3 SV=1
861 703 C1GH64 70.11 14 14 1.48E5 3 3 4 Y 32401 Cytochrome b5 heme-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06600 PE=4 SV=1
1231 756 C1FZB5 69.93 1 1 1.79E5 1 1 3 Y 203901 MINDY_DUB domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01141 PE=4 SV=2
1408 2524 C1G0S4 69.51 7 7 3.75E5 3 3 4 Y 79133 Biotin-[acetyl-CoA-carboxylase] ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00464 PE=3 SV=1
1692 21256 C1G589 69.39 9 9 4.09E4 1 1 1 N 34387 RPA_C domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03459 PE=3 SV=2
1442 21383 A0A0A0HWP2 69.23 10 10 8.14E4 1 1 2 N 17275 Phytanoyl-CoA dioxygenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12126 PE=4 SV=1
1293 1672 C1G790 68.83 6 6 3.19E5 2 2 4 N 45043 AB hydrolase-1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03045 PE=4 SV=1
1685 2432 C1GHH0 67.65 6 6 2.98E5 2 2 2 N 48713 ZT_dimer domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06706 PE=4 SV=1
1164 4724 C1GL41 67.60 8 8 2.73E5 4 4 4 Y 61263 CCT-beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08048 PE=3 SV=2
2133 21516 C1GCK8 67.26 12 12 8.5E4 2 2 2 N 22512 Nascent polypeptide-associated complex subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04730 PE=3 SV=1
1421 1435 C1G3B6 67.11 20 20 1.28E5 2 2 3 N 13751 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01432 PE=3 SV=1
1424 1307 C1GI75 67.07 3 3 1.95E5 1 1 2 N 79051 Usp domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06961 PE=4 SV=2
979 4087 A0A0A0HTR8 66.65 11 11 4.23E5 3 2 6 Y 32423 CN hydrolase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11833 PE=4 SV=1
1334 2282 C1GMM3 66.45 3 3 2.81E5 1 1 4 N 56553 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08509 PE=3 SV=2
973 1046 C1G9H9 66.37 5 5 2.18E5 4 4 6 Y 105809 CAMK/CAMKL/MARK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03915 PE=4 SV=2
1198 3608 C1G798 66.35 2 2 1.33E5 2 1 4 N 78668 Pescadillo homolog OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=NOP7 PE=3 SV=1
1274 3010 C1G4X6 66.26 4 4 2.2E5 2 2 2 N 63866 Mitochondrial processing peptidase alpha subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01992 PE=3 SV=2
1181 1646 C1G654 66.23 1 1 3.26E4 2 2 2 N 287106 THO complex subunit 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02659 PE=3 SV=1
1803 21701 C1G1W8 66.13 5 5 4.9E4 1 1 2 N 31931 Coatomer subunit epsilon OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02134 PE=3 SV=1
1278 2233 C1FYT6 65.91 4 4 2.38E5 3 2 4 Y 82839 Zinc metalloproteinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00962 PE=4 SV=2
1728 21498 C1GDM0 65.81 15 15 2.28E5 2 2 3 N 26905 Isochorismatase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05356 PE=3 SV=1
1266 631 C1GLB3 65.77 6 6 2.63E5 3 3 4 N 69605 Signal recognition particle subunit SRP68 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07899 PE=3 SV=2
2983 844 C1GLE5 65.48 14 14 2.82E4 1 1 1 Y 19519 Cellular nucleic acid-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08081 PE=4 SV=1
1415 2304 C1GIQ5 65.20 6 6 3.41E4 2 2 2 N 59994 DUF155 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07141 PE=3 SV=1
1707 3986 C1G1E5 65.17 8 8 0E0 2 2 2 Y 52961 Hydroxymethylglutaryl-CoA synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00685 PE=3 SV=2
1806 5217 C1GI54 64.99 5 5 2.92E3 1 1 2 N 57880 RING-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06940 PE=4 SV=2
1404 21038 C1GD28 64.94 12 12 1.31E5 3 3 4 N 33738 Protein transport protein SEC13 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05164 PE=3 SV=1
1683 655 C1G3P2 64.64 7 7 9.41E4 3 3 3 N 60254 histidine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01558 PE=3 SV=2
1855 462 C1G560 64.24 3 3 8.19E4 1 1 3 N 52823 Mannan polymerase II complex ANP1 subunit Anp1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03430 PE=4 SV=1
1420 21291 C1G0Q3 64.21 5 5 1.77E4 2 2 2 N 67282 Dihydropteroate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00443 PE=3 SV=2
1481 960 C1G4D4 64.17 7 7 3.32E5 2 2 3 N 39748 Vacuolar protein sorting-associated protein 26 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01800 PE=3 SV=1
1093 950 C1G3B1 64.02 13 13 6.41E5 2 2 5 N 17144 40S ribosomal protein S12 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01427 PE=3 SV=2
1361 2477 C1G8S4 63.68 3 3 5.6E5 1 1 5 N 38073 Pyroglutamyl-peptidase I OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03660 PE=3 SV=1
760 808 A0A0A0HVZ1 63.62 2 2 1.87E5 5 3 5 Y 303981 Myosin motor domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12281 PE=3 SV=1
1073 436 C1G650 63.56 6 6 1.4E5 3 3 3 N 99090 Ribosome-releasing factor 2, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=MEF2 PE=3 SV=1
2131 2443 C1GM32 63.48 4 4 1.37E5 2 2 2 N 51325 RuvB-like helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08423 PE=3 SV=1
1184 1220 C1GC97 63.09 4 4 7.82E4 3 1 4 N 79517 Glutamine-dependent NAD(+) synthetase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04619 PE=3 SV=2
1342 430 C1G0X0 62.86 2 2 8.7E4 1 1 3 N 110052 Vacuolar membrane protease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00510 PE=3 SV=1
1557 1416 C1GD88 62.82 8 8 3.2E5 1 1 4 Y 16203 Glutathione S-transferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05224 PE=4 SV=1
1426 1818 C1GLR3 62.80 10 10 9.63E4 2 2 3 N 36898 Acetolactate synthase, small subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08304 PE=3 SV=1
1097 1518 C1GMF6 62.45 6 6 7.46E4 1 1 3 N 27830 Proteasome subunit alpha type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08442 PE=3 SV=1
1273 21152 C1GBW5 62.44 11 11 9.75E4 2 2 3 Y 43498 Chorismate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04487 PE=3 SV=1
1532 3480 C1GIF6 62.12 5 5 1.18E5 1 1 3 N 24476 ATP synthase subunit 5, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07042 PE=3 SV=1
1264 6474 C1GCD3 62.12 15 15 1.32E5 4 4 4 N 42789 Short-chain dehydrogenase/reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04655 PE=4 SV=1
1483 2306 C1GF19 61.49 6 6 4.11E5 2 2 3 Y 43076 SGL domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05855 PE=4 SV=1
1455 1068 C1GJZ6 61.48 5 5 1.51E5 1 1 2 N 59181 phenylalanine--tRNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07582 PE=3 SV=2
2169 2182 C1G4S4 61.06 3 3 4.42E4 1 1 1 N 47581 TFIIS N-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01940 PE=4 SV=1
1289 1222 A0A0A0HTY8 60.85 3 3 0E0 1 1 2 N 70405 Nucleolar protein 58 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12196 PE=3 SV=1
1166 21067 C1GJ38 60.79 7 7 3.13E5 4 4 4 Y 83743 Multifunctional tryptophan biosynthesis protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07274 PE=3 SV=1
1688 558 C1GIY1 60.72 5 5 1.32E5 2 2 2 Y 60646 ribose-phosphate diphosphokinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07217 PE=3 SV=2
1541 1405 C1GMP5 60.68 4 4 1.43E5 2 2 3 N 35710 AN1-type zinc finger protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08531 PE=4 SV=1
1284 1594 A0A0A0HWU6 60.49 4 4 5.61E4 2 2 4 N 88157 Tubulin gamma chain OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11375 PE=3 SV=1
1078 759 C1G356 60.40 14 14 4.19E5 4 4 5 N 43018 Mannitol-1-phosphate 5-dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01372 PE=3 SV=1
2984 2240 C1G5J3 60.27 3 3 2.51E4 1 1 1 N 48594 ATP-dependent (S)-NAD(P)H-hydrate dehydratase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02448 PE=3 SV=2
1168 2003 C1FYS5 59.78 13 13 1.46E5 3 3 6 N 30716 EB1 C-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00951 PE=4 SV=2
1029 2263 C1G792 59.62 6 6 1.7E5 2 2 4 Y 61464 Threonine dehydratase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03047 PE=3 SV=1
1558 1049 C1GER4 59.54 13 13 1.63E5 1 1 3 N 18837 Cytochrome c oxidase subunit 6, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05750 PE=3 SV=2
1731 1586 C1G0Y9 58.95 19 19 1.21E5 2 2 3 N 11525 Glutaredoxin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00529 PE=4 SV=1
1270 1512 C1G953 58.46 6 6 1.84E5 2 2 3 N 34131 Prohibitin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03789 PE=3 SV=1
2197 1585 C1GBE6 58.45 8 8 9.23E4 1 1 2 N 29507 CDP-diacylglycerol--serine O-phosphatidyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04947 PE=3 SV=2
1091 777 C1GDI1 58.31 2 2 1.31E5 2 2 4 N 161618 Guanyl-nucleotide exchange factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05317 PE=4 SV=2
1522 4815 C1G2M7 58.02 2 2 2.24E5 1 1 3 N 82032 Zn(2)-C6 fungal-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01193 PE=4 SV=2
1857 2261 C1G8M6 57.94 11 11 1.16E5 1 1 2 N 21518 Skin secretory protein xP2-like OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03612 PE=4 SV=1
1695 556 C1GF39 57.91 6 6 8.64E4 2 2 2 Y 54497 H/ACA ribonucleoprotein complex subunit CBF5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05875 PE=3 SV=1
1286 1787 C1G0R5 57.89 4 4 1.82E5 2 1 3 N 54645 Protein arginine methyltransferase NDUFAF7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00455 PE=3 SV=1
807 1249 C1FYF8 57.58 3 3 8.34E4 2 2 2 N 80672 RNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00834 PE=3 SV=2
1757 1129 C1G3R3 57.52 3 3 1.02E5 1 1 2 N 60591 Metallophos domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01579 PE=4 SV=2
1495 2017 C1GLG2 57.41 13 13 4.27E5 2 2 4 N 30385 Adenylate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=ADK1 PE=3 SV=1
1079 1638 A0A0A0HUM5 57.30 7 7 2.61E5 4 3 4 N 79610 Aconitate hydratase, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11845 PE=3 SV=1
2985 2070 C1GIU3 57.25 3 3 7.16E4 1 1 1 N 50754 TPR_REGION domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07179 PE=4 SV=2
2198 1619 C1GI92 57.06 9 9 2.9E5 1 1 2 N 17629 Cytochrome c OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06978 PE=3 SV=2
1750 3502 C1GAB4 57.02 4 4 6.6E4 2 2 2 Y 57529 Glucose-6-phosphate 1-dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04200 PE=3 SV=2
1698 1344 C1GA11 56.98 2 2 1.04E5 1 1 1 N 131904 Ino eighty subunit 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04097 PE=4 SV=1
928 410 C1G651 56.97 9 9 6.69E5 4 4 5 N 64315 Vacuolar protein sorting-associated protein 17 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02656 PE=3 SV=1
1863 329 C1GDR7 56.64 10 10 2.59E5 2 2 3 N 25057 NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05403 PE=3 SV=1
2199 21844 C1G1Z9 56.38 3 3 2.37E5 1 1 2 N 63241 Uracil permease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02165 PE=3 SV=2
1023 3521 C1GAI2 56.14 4 4 3.05E4 3 3 3 Y 109773 DUF4045 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04268 PE=4 SV=2
2152 932 C1FZ10 56.06 4 4 5.25E4 1 1 1 N 47207 L-type lectin-like domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01036 PE=4 SV=1
1484 21520 C1G6Y8 55.89 5 5 3.59E5 2 2 4 N 60513 Polyamine transporter TPO5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02943 PE=4 SV=2
2151 922 C1G4L1 55.85 2 2 3.75E4 1 1 1 N 81758 Pre-mRNA-splicing factor CLF1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01877 PE=3 SV=2
942 1848 A0A0A0HVY6 55.59 2 2 0E0 3 1 5 N 102908 Response regulatory domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12275 PE=4 SV=1
2986 5167 C1GBS3 55.45 3 3 4.03E4 1 1 1 N 71743 Exocyst complex component EXO84 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05074 PE=3 SV=2
2135 2900 C1GIJ4 55.26 5 5 2.59E4 2 2 2 Y 44529 Ribosome biogenesis protein C8F11.04 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07080 PE=4 SV=1
1033 3933 C1G3Z9 55.11 5 5 2.41E5 2 2 4 N 47809 Aminotran_1_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01665 PE=4 SV=2
1411 1663 C1G0P8 55.01 10 10 9.9E4 2 2 2 Y 32152 Eukaryotic translation initiation factor 3 subunit G OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=TIF35 PE=3 SV=1
2200 6128 C1G7R6 54.73 3 3 1.72E5 1 1 1 N 81483 Mitochondrial intermediate peptidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03221 PE=3 SV=2
2146 1601 C1GMM4 54.66 5 5 4.18E4 1 1 1 N 26373 Peroxisomal biogenesis factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08510 PE=4 SV=1
1100 4206 C1G294 54.61 9 9 1.82E5 2 2 5 N 34674 Succinate--CoA ligase [ADP-forming] subunit alpha, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02260 PE=3 SV=1
1021 3255 C1GBR3 54.59 2 2 5.76E4 3 3 3 N 199136 Kinesin motor domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05064 PE=3 SV=2
1771 2426 C1GE18 54.54 26 26 0E0 1 1 1 Y 12658 Thioredoxin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05504 PE=3 SV=1
2987 21720 C1GKG6 54.36 4 4 3.1E4 1 1 1 N 47279 Protein phosphatase methylesterase 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07752 PE=3 SV=1
2150 1280 C1G5B1 54.30 2 2 1.47E5 1 1 1 N 95519 DNA replication licensing factor MCM2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03481 PE=3 SV=2
1178 2131 C1GLM1 54.10 5 5 2.05E5 2 2 2 N 62646 Asparagine synthase (Glutamine-hydrolyzing) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08262 PE=4 SV=2
1028 1357 C1GCX1 54.04 4 4 2.5E5 1 1 4 N 47948 vesicle-fusing ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05107 PE=3 SV=1
1407 2519 C1G3Q1 53.92 7 7 2.67E5 3 3 3 N 64935 PX domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01567 PE=4 SV=2
1083 3395 C1GFG3 53.69 6 6 2.58E5 3 3 4 N 107446 PIPK domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05999 PE=4 SV=1
1423 2972 C1GF04 53.61 3 3 3.12E5 2 2 3 N 92960 CAMKK/CAMKK-META protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05840 PE=4 SV=2
1491 2487 C1GJ51 53.43 7 7 1.24E5 1 1 2 N 32729 WD_REPEATS_REGION domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07287 PE=4 SV=2
983 562 C1GG46 53.06 1 1 1.68E5 2 2 3 N 169292 Hypercellular protein HypA OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06283 PE=4 SV=1
1743 2164 C1GAY3 53.05 5 5 1.75E5 2 2 2 Y 57339 Proline dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04419 PE=3 SV=1
1858 431 C1G726 53.00 6 6 2.73E5 1 1 3 N 24404 DJ-1_PfpI domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02981 PE=4 SV=1
2153 2462 C1G6B9 52.92 2 2 9.87E4 1 1 1 N 66522 Ribonuclease H-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02724 PE=4 SV=1
1535 790 C1G3H0 52.83 9 9 1.83E5 1 1 3 N 27578 NAD(P)-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01486 PE=3 SV=1
1210 5911 C1G154 52.75 2 2 1.67E5 1 1 3 N 63986 Nuclear localization protein NPL6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00594 PE=4 SV=1
1165 1198 C1G3I9 52.44 9 9 1.21E5 3 3 3 Y 42884 Actin-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01505 PE=3 SV=1
2988 1580 C1GF96 52.13 3 3 0E0 1 1 1 N 53811 Oxysterol-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05932 PE=3 SV=2
1171 990 C1GM97 52.03 3 3 9.2E4 2 2 3 Y 105332 DNA mismatch repair protein MSH3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08183 PE=3 SV=1
1441 4397 C1GHH4 51.77 5 5 0E0 2 2 3 N 60172 GAT domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06710 PE=4 SV=2
1762 2433 C1GCP2 51.74 7 7 3.25E4 1 1 2 N 24379 Protein transport protein SEC22 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04764 PE=3 SV=2
1276 2342 C1GLI3 51.41 3 3 2.02E5 2 2 2 N 62763 fumarate hydratase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08119 PE=3 SV=2
1185 528 C1GLX6 51.27 7 7 8.88E4 1 1 1 N 22213 Cytochrome c oxidase subunit V OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08367 PE=4 SV=2
2138 1928 C1FYS2 51.03 5 5 1.33E5 2 2 2 N 45743 GFO_IDH_MocA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00948 PE=4 SV=1
2989 1380 C1GC37 50.71 13 13 6.19E4 1 1 1 N 13323 Cytochrome b5 heme-binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04559 PE=4 SV=1
2990 2431 C1G8P1 50.54 3 3 1.22E4 1 1 1 N 42587 Transket_pyr domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03627 PE=4 SV=1
1783 1043 C1GIE5 50.53 4 4 1.58E5 1 1 2 Y 38238 hydroxymethylglutaryl-CoA lyase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07031 PE=3 SV=1
1860 1246 C1GAG0 50.41 1 1 2.09E5 1 1 2 N 91460 VID27-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04246 PE=4 SV=1
903 1938 C1FZ48 50.38 2 2 3.48E5 4 2 10 Y 221642 B-block_TFIIIC domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01074 PE=4 SV=2
1861 21775 C1GIT4 49.83 2 2 1.98E5 1 1 3 N 75286 GH16 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07170 PE=3 SV=2
2201 2425 C1G8T9 49.68 18 18 1.92E5 1 1 2 Y 11739 Rhodopsin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03675 PE=4 SV=2
1362 1771 C1GGY2 49.65 4 4 5.93E5 1 1 3 N 27220 NAD(P)-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06201 PE=3 SV=1
2991 21845 C1G8G5 49.48 4 4 9.06E4 1 1 1 N 30017 F-actin-capping protein subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03551 PE=3 SV=1
1410 21164 C1G175 49.29 11 11 0E0 2 2 2 N 27923 Proteasome subunit alpha type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00615 PE=3 SV=2
2202 974 C1GN02 49.25 4 4 1.37E5 1 1 2 Y 48105 Cystathionine beta-lyase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08662 PE=3 SV=1
1776 4250 C1FZJ8 49.04 2 2 9.17E4 1 1 2 N 98027 Exocyst complex component Sec10 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00038 PE=3 SV=1
1468 435 C1GIN4 49.04 3 3 1.16E5 1 1 2 N 52366 Annexin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07120 PE=3 SV=2
2992 5353 C1G4A2 48.85 2 2 5.48E4 1 1 1 Y 74703 F-box protein YLR352W OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01768 PE=4 SV=2
1772 1746 C1G2X0 48.84 3 3 4.85E4 1 1 1 N 38530 Iso_dh domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01286 PE=3 SV=1
1336 402 C1G2R2 48.82 5 5 1.19E5 1 1 2 N 34292 3-hydroxybutyryl-CoA dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01228 PE=3 SV=1
1736 1121 A0A0A0HT60 48.31 6 6 1.92E5 2 2 3 N 47878 DFP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11590 PE=4 SV=1
1416 1062 C1GL98 48.27 4 4 1.08E5 3 2 3 N 86638 Polyadenylate-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07884 PE=3 SV=2
2163 21488 C1GA04 47.98 3 3 9.57E4 1 1 1 N 52079 Ribosome biogenesis protein YTM1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=YTM1 PE=3 SV=1
1413 21208 C1G215 47.95 10 10 2.8E5 2 2 3 Y 30614 HAD superfamily hydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02181 PE=4 SV=2
2203 2458 C1G4Y3 47.86 8 8 2.27E5 1 1 2 N 12910 Small nuclear ribonucleoprotein Sm D3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01999 PE=3 SV=1
1752 2128 C1GJT3 47.82 7 7 3.48E5 2 2 3 Y 32491 Ribosomal protein L1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07519 PE=4 SV=1
2993 21691 C1G5E4 47.79 8 8 0E0 1 1 1 N 20081 CBP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02399 PE=4 SV=1
2134 1995 A0A0A0HRF5 47.72 27 27 5.98E4 2 2 2 Y 11072 DUF4158 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12054 PE=4 SV=1
2994 2186 C1GHU1 47.67 2 2 4.11E4 1 1 1 N 66254 D-arabinono-1,4-lactone oxidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06827 PE=3 SV=1
1027 1856 C1G4Y9 47.52 1 1 2.62E5 2 2 3 N 192758 Phospholipid-transporting ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02005 PE=3 SV=2
1271 1057 C1FZP0 47.15 5 5 1.23E5 2 2 2 N 66003 Eukaryotic translation initiation factor 3 subunit D OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00080 PE=3 SV=1
1764 1314 C1GLH5 47.15 5 5 1.22E5 1 1 2 N 33216 Mitochondrial GTP/GDP carrier protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08111 PE=3 SV=2
1438 935 C1G0G7 47.12 1 1 4.34E4 2 2 3 Y 268135 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00357 PE=3 SV=1
1110 1897 A0A0A0HW92 46.77 19 19 4.96E5 2 2 4 N 19523 NTF2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11111 PE=4 SV=1
1748 399 C1GCN9 46.60 1 1 4.49E4 1 1 1 N 93234 Mannosyl-oligosaccharide glucosidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04761 PE=3 SV=2
2142 2181 C1G548 46.56 4 4 4.64E4 1 1 1 N 56912 S4 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02064 PE=3 SV=1
1693 664 C1G5V0 46.33 13 13 1.38E5 2 2 2 N 33500 Nucleic acid-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02555 PE=4 SV=2
1169 1651 C1G056 46.32 11 11 1.44E4 3 3 4 Y 40709 Pyruvate dehydrogenase E1 component subunit beta OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00246 PE=4 SV=1
1275 866 C1GDT0 46.24 4 4 1.6E5 2 2 3 N 73430 Sec1 family superfamily OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05416 PE=3 SV=2
2147 648 C1GML4 46.11 4 4 0E0 1 1 1 N 33320 Mitochondrial thiamine pyrophosphate carrier 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08500 PE=3 SV=2
2995 1904 C1GMN0 45.75 9 9 4.99E4 1 1 1 N 48234 AmmeMemoRadiSam system protein B OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08516 PE=3 SV=2
1753 21577 C1FZC5 45.67 9 9 3.94E4 2 1 2 N 19129 RNA_pol_L_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01151 PE=3 SV=2
1039 2289 C1GMD9 45.45 4 4 1.29E5 2 2 3 N 59582 Protein SDS23 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08225 PE=3 SV=2
1098 1827 C1G2E6 45.39 2 2 1.78E5 1 1 5 N 88308 Ribosome biogenesis protein ERB1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=ERB1 PE=3 SV=1
1694 21239 C1GLP0 45.27 7 7 1.94E5 2 2 2 N 55391 Acyl-CoA thioester hydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08281 PE=4 SV=2
1425 4829 C1GIL5 45.15 5 5 6.06E4 3 2 3 Y 64240 Serine/threonine-protein kinase RIO1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07101 PE=3 SV=1
1414 5522 C1G8K9 45.12 6 6 1.15E5 2 2 3 N 55277 Xaa-Pro aminopeptidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03595 PE=3 SV=2
982 6066 C1GHW5 45.03 3 3 7.45E4 1 1 2 N 47344 PCI domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06851 PE=3 SV=1
2137 441 C1GBX5 44.60 10 10 9.86E4 2 2 2 N 45933 Glycosyltransferase family 62 protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04497 PE=4 SV=2
2996 4655 C1G109 44.54 4 4 6.52E4 1 1 1 Y 31721 Dolichol-phosphate mannosyltransferase subunit 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00549 PE=3 SV=2
2998 372 C1GAM6 44.43 4 4 3.31E4 1 1 1 N 56657 UDP-N-acetylglucosamine pyrophosphorylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04312 PE=4 SV=1
2155 415 C1GJX2 44.36 2 2 0E0 1 1 1 Y 131473 ubiquitinyl hydrolase 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07558 PE=3 SV=2
1446 738 A0A0A0HV97 44.31 6 6 2.17E5 2 2 3 N 54053 RanBD1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11950 PE=4 SV=1
1412 1123 C1GEB6 44.23 4 4 1.5E5 3 3 4 Y 116675 DNA ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05602 PE=3 SV=2
1689 21224 C1G1J5 44.21 22 22 7.07E5 3 3 3 N 22697 Lactam utilization protein lamB OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00735 PE=4 SV=2
2205 3621 C1GEE6 44.18 5 5 8.24E4 1 1 2 N 41549 rRNA-processing protein EBP2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05632 PE=3 SV=1
1035 2201 A0A0A0HVR3 44.11 14 14 7.84E5 2 2 5 N 16365 Golgi apparatus membrane protein TVP18 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11110 PE=3 SV=1
2999 4722 C1G1C3 43.97 6 6 4.8E4 1 1 1 N 39368 Homoserine dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00663 PE=3 SV=1
2997 1808 C1GCG3 43.77 3 3 6.38E4 1 1 1 N 43557 Similar to OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04685 PE=4 SV=1
1252 2137 C1G5E1 43.64 1 1 0E0 3 1 4 N 226616 SANT domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02396 PE=4 SV=2
1170 21203 C1GGY3 43.60 10 10 9.87E4 4 4 4 Y 36050 NodB homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06202 PE=4 SV=1
1308 21466 C1G5M0 43.59 2 2 0E0 2 1 2 N 126417 Actin cytoskeleton-regulatory complex protein SLA1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02475 PE=3 SV=1
3000 5671 C1GIS8 43.49 3 3 6.55E4 1 1 1 N 69217 Exocyst complex protein EXO70 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07164 PE=3 SV=1
1180 920 A0A0A0HV88 43.43 4 4 1.92E5 2 2 3 N 64083 AGC/RSK/RSK-UNCLASSIFIED protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11939 PE=4 SV=1
1691 2445 C1FZD3 43.38 9 9 2.41E5 2 2 2 N 28943 Uridylate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01159 PE=3 SV=2
1703 1400 C1G7P8 43.34 12 12 1.24E5 2 2 2 N 32944 BAR domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03203 PE=4 SV=2
1292 2482 C1GN69 43.30 5 5 3.29E4 3 2 4 N 98717 Transcription factor BYE1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08705 PE=3 SV=2
2136 1364 C1GIS2 43.30 7 7 2.65E5 2 2 2 N 48101 Zinc/iron permease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07158 PE=4 SV=2
2207 21755 C1G837 43.10 2 2 1.18E5 1 1 2 N 83314 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03342 PE=4 SV=2
1312 635 C1GMI0 42.90 4 4 1.73E5 2 2 4 N 50549 homogentisate 1,2-dioxygenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08466 PE=3 SV=1
1778 1113 C1GF72 42.84 3 3 0E0 1 1 2 N 57196 Cysteine protease OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05908 PE=3 SV=1
2208 993 A0A0A0HTA9 42.76 2 2 1.31E5 1 1 1 N 96802 Cytochrome c1, heme protein, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12401 PE=3 SV=1
1560 3005 C1FZQ1 42.44 3 3 3.23E4 1 1 2 N 44861 Transcriptional activator hap2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00091 PE=4 SV=1
1766 1045 C1G4P9 42.37 1 1 9.97E4 1 1 2 N 102205 Mediator of RNA polymerase II transcription subunit 16 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=MED16 PE=3 SV=2
3001 615 C1GCM9 42.26 1 1 6.12E4 1 1 1 N 144546 Phospholipid-transporting ATPase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04751 PE=3 SV=2
1702 21353 C1G8C8 42.03 7 7 2.38E5 2 2 2 Y 50637 2-oxoisovalerate dehydrogenase subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03514 PE=3 SV=2
3003 2828 C1G1V7 41.99 3 3 7.06E4 1 1 1 N 39612 Aldo_ket_red domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02123 PE=4 SV=1
2209 825 C1GKQ0 41.92 2 2 6.11E4 1 1 2 N 66149 Pyruvate decarboxylase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07907 PE=3 SV=2
1418 696 C1G7W8 41.88 1 1 8.72E4 1 1 1 N 98706 Rho-GAP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03273 PE=4 SV=1
1519 1574 C1GC81 41.82 4 4 3.49E5 1 1 3 N 31275 Spermidine synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04603 PE=3 SV=2
2159 6225 C1G2W9 41.67 2 2 1.11E4 1 1 1 N 68481 EH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01285 PE=4 SV=1
717 1551 C1GGA2 41.67 2 2 5.31E4 5 2 5 N 216152 DNA topoisomerase 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06339 PE=3 SV=2
3004 1094 C1GE99 41.63 1 1 3.44E4 1 1 1 N 98801 Pre-mRNA-splicing factor syf1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05585 PE=3 SV=1
1449 4462 C1G282 41.49 4 4 5.4E4 2 2 2 N 75699 WHIM1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02248 PE=4 SV=2
2210 5770 C1G9W2 41.43 6 6 6.61E4 1 1 2 N 21242 Small COPII coat GTPase SAR1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04048 PE=3 SV=2
2157 5169 C1GI19 41.41 3 3 3.12E4 2 1 2 N 63753 Vacuolar protein 8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06905 PE=3 SV=2
1470 21475 C1G7I8 41.37 3 3 1.22E5 1 1 2 N 48711 acidPPc domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03143 PE=3 SV=2
3002 21852 C1G815 41.27 4 4 7.55E4 1 1 1 N 44140 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03320 PE=3 SV=2
2224 692 C1G6E0 41.18 8 8 6.34E4 2 2 2 Y 23194 zf-CHCC domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02745 PE=4 SV=1
1473 1052 C1GBE7 40.97 8 8 1.09E5 1 1 1 N 20940 H/ACA ribonucleoprotein complex subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04948 PE=3 SV=1
1831 21653 C1GEM6 40.67 3 3 4E4 1 1 1 N 54636 ACT_7 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05712 PE=4 SV=2
1699 732 C1G972 40.50 3 3 2.14E5 3 3 3 N 116527 Cation_ATPase_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03808 PE=4 SV=1
1137 857 C1GMK0 40.32 3 3 8.41E4 2 1 2 N 67260 Low temperature requirement A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08486 PE=4 SV=2
1864 2447 A0A0A0HVJ6 40.25 2 2 5.08E5 1 1 3 N 65913 AA_permease domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11589 PE=4 SV=1
1427 2478 C1G1Q6 40.19 2 2 1.01E5 1 1 2 N 109521 Armadillo repeat-containing protein 8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02072 PE=4 SV=1
1865 2453 C1G9W1 40.16 8 8 2.47E5 1 1 3 N 17441 Serine/threonine-protein phosphatase PP1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04047 PE=4 SV=1
1208 532 C1GGX7 40.12 6 6 7.73E4 2 2 2 N 42920 Oxidored_FMN domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06196 PE=4 SV=2
2177 21331 C1GJK9 39.95 4 4 1.08E4 1 1 1 N 55382 Conserved fungal protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07445 PE=4 SV=2
1708 2160 C1G8H9 39.88 2 2 1.35E5 1 1 1 N 71223 EH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03565 PE=4 SV=1
1866 2817 C1GKX0 39.82 11 11 7.74E4 1 1 3 N 17276 Eukaryotic translation initiation factor 4C OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07977 PE=3 SV=1
2140 21592 C1GG39 39.76 10 10 1.02E5 2 2 2 N 39198 tRNA N6-adenosine threonylcarbamoyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=KAE1 PE=3 SV=1
1690 879 C1GHD0 39.74 3 3 5.21E4 1 1 1 N 67894 RNA splicing factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06666 PE=4 SV=1
897 1166 C1GIX9 39.31 1 1 2.35E5 2 2 2 Y 226817 SEC7 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07215 PE=4 SV=2
1345 2945 C1GJB9 39.24 1 1 0E0 2 1 4 N 161917 Serine-rich protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07355 PE=4 SV=1
1444 1735 C1G6V9 39.22 3 3 0E0 1 1 1 N 53244 Aminomethyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02914 PE=3 SV=2
1729 6630 C1G3X8 39.17 5 5 7.19E4 1 1 1 N 25848 t-SNARE coiled-coil homology domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01644 PE=3 SV=1
3005 21857 C1GIF1 39.15 1 1 1.48E4 1 1 1 Y 119851 Glyco_hydro_63 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07037 PE=3 SV=2
1701 837 C1GF56 39.11 2 2 1.91E5 2 2 2 N 178956 Class V myosin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05892 PE=3 SV=1
1279 1701 C1G112 39.10 3 3 3.34E4 2 2 3 N 99818 Vacuolar protein sorting-associated protein 35 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00552 PE=3 SV=1
1466 1399 C1G3I3 39.06 2 2 8.79E4 2 1 2 N 129267 ISWI chromatin-remodeling complex ATPase ISW1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01499 PE=3 SV=2
3006 3239 C1GDK9 38.99 3 3 7.6E4 1 1 1 N 54981 Nickel/cobalt efflux system OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05345 PE=3 SV=2
2149 8174 A0A0A0HVG0 38.90 4 4 6.54E4 1 1 1 N 59809 Folylpolyglutamate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11535 PE=3 SV=1
1769 21624 C1GKT9 38.75 8 8 7.05E4 2 2 3 N 17936 Thioredoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07946 PE=3 SV=1
2162 3899 C1G471 38.74 3 3 0E0 2 1 2 N 53197 Aminotran_1_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01737 PE=4 SV=2
1511 2527 C1GLM8 38.71 8 8 9.44E4 2 2 2 Y 32232 MSP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08269 PE=4 SV=2
1869 1561 C1GE65 38.66 3 3 6.53E4 1 1 2 N 47624 Autophagy-related protein 18 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05551 PE=4 SV=1
1196 843 C1GB11 38.52 2 2 2.25E5 2 2 2 Y 112981 Polarized growth protein Boi2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04447 PE=4 SV=2
2144 2331 C1GB77 38.41 9 9 4.67E4 2 2 2 N 43984 NADH-ubiquinone oxidoreductase 40 kDa subunit, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04878 PE=3 SV=2
1796 2192 C1G1Z1 38.29 3 3 0E0 1 1 1 N 46353 Endocytosis protein 3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02157 PE=3 SV=1
1281 758 C1GID7 37.88 7 7 1.75E5 3 3 3 N 72463 Carn_acyltransf domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07023 PE=3 SV=2
1810 2437 C1GGL3 37.82 8 8 1.48E5 2 1 3 N 41789 54S ribosomal protein L22, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06450 PE=3 SV=1
989 1009 C1FYP7 37.80 2 2 3.06E5 2 2 3 Y 224611 Histone transcription regulator 3 homolog OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00923 PE=3 SV=2
2213 5878 C1G9Y0 37.75 2 2 2.38E5 1 1 2 N 57282 UBX domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04066 PE=4 SV=1
3007 4438 C1FZC3 37.70 2 2 3E4 1 1 1 N 76409 Btz domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01149 PE=4 SV=2
2214 2227 A0A0A0HUN4 37.70 4 4 7.63E4 1 1 2 N 40503 WD_REPEATS_REGION domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11857 PE=4 SV=1
3009 21864 C1G9N1 37.69 7 7 0E0 1 1 1 N 29110 N-terminal nucleophile aminohydrolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03967 PE=4 SV=1
1437 1091 C1G1S4 37.60 1 1 1.6E5 1 1 2 N 92058 SPX domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02090 PE=4 SV=2
3008 6055 C1FZH9 37.51 3 3 0E0 1 1 1 N 83595 ELMO domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00019 PE=4 SV=2
2141 21422 A0A0A0HTB4 37.41 6 6 8.92E4 1 1 1 N 27484 Peptidyl-prolyl cis-trans isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12323 PE=3 SV=1
984 1336 A0A0A0HUV5 37.19 1 1 2.76E5 2 2 2 N 207995 DNA helicase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11664 PE=3 SV=1
2166 21727 C1GD32 37.05 2 2 3.21E4 1 1 1 N 83003 P-loop containing nucleoside triphosphate hydrolase protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05168 PE=4 SV=1
1697 2189 A0A0A0HW94 37.05 3 3 2.09E5 2 2 2 N 129745 Phosphatase tensin-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12247 PE=4 SV=1
3011 1221 C1GLA2 36.87 5 5 5.51E4 1 1 1 N 17787 Eukaryotic translation initiation factor 5A OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07888 PE=3 SV=2
1718 1980 C1GHP8 36.82 1 1 0E0 1 1 1 N 115327 Carrier domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06784 PE=4 SV=1
1500 1374 C1GCP8 36.64 1 1 1.97E4 2 1 2 N 226635 HEAT repeat protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04770 PE=3 SV=2
2215 21425 C1G8C3 36.59 2 2 3.62E4 1 1 1 N 60508 Arf-GAP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03509 PE=4 SV=2
3010 6207 C1GI15 36.51 3 3 4.87E4 1 1 1 N 50753 Pre-mRNA-processing factor 19 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06901 PE=3 SV=1
2160 1732 C1G784 36.45 4 4 3.07E4 1 1 1 N 74961 MICOS complex subunit MIC60 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=MIC60 PE=3 SV=2
2180 21791 C1G020 36.43 1 1 0E0 1 1 1 N 115117 Glycine cleavage system P protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00210 PE=3 SV=2
2170 339 C1G0N4 36.28 1 1 0E0 1 1 1 N 118674 Importin N-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00424 PE=4 SV=2
1872 2627 C1GFV7 36.24 3 3 5.95E4 1 1 3 N 57626 Regulator of cytoskeleton and endocytosis OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06143 PE=4 SV=2
1476 1989 C1G5C2 36.15 2 2 2.38E5 2 2 2 Y 115012 Phosphatidylserine decarboxylase proenzyme 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PSD2 PE=3 SV=2
1485 2502 C1GAT1 36.13 2 2 3.01E5 1 1 2 N 64500 Amidase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04367 PE=4 SV=2
1422 7213 C1GFL5 36.10 5 5 3.73E5 2 2 3 N 56755 PCI domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06051 PE=3 SV=2
2217 2202 C1GD24 35.99 2 2 5.04E4 1 1 2 N 86347 Dipeptidyl peptidase 3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05160 PE=3 SV=2
2174 7206 C1GFV3 35.76 3 3 1.41E4 1 1 1 N 55192 indoleamine 2,3-dioxygenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06139 PE=3 SV=1
1531 21565 A0A0A0HTS8 35.58 1 1 0E0 1 1 1 N 95081 DUF5917 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12265 PE=3 SV=1
1536 21723 C1G182 35.27 6 6 0E0 2 1 3 N 37428 ATPase GET3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=GET3 PE=3 SV=1
3014 2355 C1GJL5 35.13 3 3 0E0 1 1 1 N 84026 Terpene cyclase/mutase family member OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07451 PE=3 SV=1
2148 6518 C1GE04 35.09 6 6 6.54E4 1 1 1 N 37316 MoCF_biosynth domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05490 PE=4 SV=1
2154 21670 C1GCG5 35.06 6 6 4.06E4 1 1 1 N 29419 Short-chain dehydrogenase/reductase family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04687 PE=3 SV=2
944 2362 C1FZE7 35.02 1 1 3.43E4 1 1 3 N 137724 VPS37 C-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01173 PE=4 SV=2
1188 630 C1G9P6 34.95 7 7 6.84E4 3 3 4 N 34080 PROTEASOME_ALPHA_1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03982 PE=3 SV=2
1364 21891 C1FZQ5 34.82 2 2 3.59E5 1 1 4 N 64669 Siderophore iron transporter OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00095 PE=4 SV=1
3012 21876 C1GHU8 34.82 3 3 3.46E4 1 1 1 N 71781 2-isopropylmalate synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06834 PE=3 SV=2
906 4135 C1G8I3 34.80 2 2 5.14E4 2 1 8 N 106276 Autophagy-related protein 13 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03569 PE=3 SV=2
2161 21266 C1G4V8 34.80 6 6 1.79E5 2 2 2 Y 36984 Chitin synthase export chaperone OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01974 PE=3 SV=1
3016 1358 C1GFJ0 34.56 4 4 9.46E3 1 1 1 N 65517 FAD-binding FR-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06026 PE=4 SV=1
1720 2883 C1G1D3 34.42 5 5 7.3E5 2 2 2 N 71017 USP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00673 PE=4 SV=1
1428 2771 C1GI31 34.40 5 5 6.95E4 3 3 3 N 72682 UV radiation resistance-associated gene protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06917 PE=4 SV=2
3017 8036 C1FZA0 34.40 8 8 0E0 1 1 1 N 20839 Molybdopterin synthase catalytic subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=cnxH PE=3 SV=1
2220 2076 C1GJW7 34.28 2 2 3.03E5 1 1 2 N 51640 Protein-serine/threonine kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07553 PE=3 SV=1
3013 1377 C1G5D4 34.21 2 2 0E0 1 1 1 N 74396 SAM_MT_RSMB_NOP domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02389 PE=3 SV=2
2143 8287 C1G0D5 34.09 2 2 6.95E4 1 1 1 N 62401 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00325 PE=3 SV=2
1716 4469 C1G8N0 34.03 4 4 0E0 3 2 3 Y 53203 Cytochrome P450 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03616 PE=4 SV=2
3018 3540 C1GGB5 33.91 6 6 7.58E4 1 1 1 N 21992 Calcium-binding protein NCS-1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06352 PE=4 SV=2
3015 2254 C1G553 33.89 3 3 3.95E4 1 1 1 N 45260 GST N-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03423 PE=4 SV=2
2218 21888 C1GLE2 33.88 3 3 1.71E5 1 1 2 N 32838 D-xylose reductase [NAD(P)H] OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08078 PE=4 SV=1
1818 3407 C1G8V0 33.82 3 3 9.48E4 1 1 2 N 48612 Aspartate aminotransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03686 PE=3 SV=1
1346 1661 C1G380 33.63 5 5 4.91E5 2 2 3 N 50708 Usp domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01396 PE=4 SV=1
1881 6147 C1GH87 33.46 2 2 7.63E4 1 1 1 N 65077 Mannose-1-phosphate guanylyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06623 PE=4 SV=1
2145 4151 C1GI40 33.45 2 2 5.94E4 1 1 1 N 52375 Membrane protein TMS1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06926 PE=3 SV=2
1294 21402 C1GIV4 33.44 6 6 1.67E5 2 2 2 N 29736 Proteasome subunit alpha type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07190 PE=3 SV=2
1939 2030 C1GA60 33.41 6 6 1.74E5 2 2 2 N 20625 Copper transport protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04146 PE=3 SV=1
3020 5077 C1G072 33.12 3 3 3.32E4 1 1 1 N 33028 Inositol-1-monophosphatase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00262 PE=3 SV=1
2298 4704 C1G774 33.02 2 2 6.13E4 2 2 2 Y 86344 DNA_mis_repair domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03029 PE=3 SV=2
1429 1615 C1GHY9 32.97 8 8 5.64E4 2 2 2 N 33861 50S ribosomal protein L4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06875 PE=3 SV=2
2305 1942 C1GFI3 32.86 3 3 4.5E5 2 2 2 N 64475 SEC7 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06019 PE=4 SV=2
2156 1919 C1GN20 32.82 1 1 0E0 1 1 1 Y 128116 DNA mismatch repair protein MSH3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08606 PE=3 SV=1
3019 21897 C1G4X8 32.80 10 10 5.24E4 1 1 1 N 14964 Mitochondrial import receptor subunit tom22 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01994 PE=3 SV=2
1807 619 C1G6T6 32.69 7 7 6.39E4 2 2 3 N 35627 NAGLU_C domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02891 PE=4 SV=2
2221 2870 C1G5K5 32.68 7 7 5.87E5 1 1 1 N 23253 Ser-Thr-rich glycosyl-phosphatidyl-inositol-anchored membrane family-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02460 PE=4 SV=2
936 1073 C1GLJ0 32.61 1 1 1.74E5 2 2 3 N 364045 Fermentation associated protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08126 PE=4 SV=2
1569 4452 C1GM93 32.58 1 1 6.16E5 1 1 3 N 91979 HRDC domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08179 PE=4 SV=1
1299 6184 C1FZH1 32.55 3 3 3.02E4 2 1 2 N 86658 Actin binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00011 PE=4 SV=1
1562 21870 C1GAA4 32.54 6 6 2.02E4 2 1 3 N 29129 Uncharacterized protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04190 PE=4 SV=2
1320 2104 C1GBC8 32.52 5 5 3.43E4 2 1 3 Y 59292 WD repeat-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04929 PE=4 SV=1
3021 787 C1GE44 32.46 2 2 1.1E5 1 1 1 N 64453 Phosphoglycerate mutase-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05530 PE=4 SV=1
3026 21923 C1GC91 32.43 10 10 4.11E4 1 1 1 N 10789 Cytochrome b-c1 complex subunit 8 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04613 PE=3 SV=1
1302 4599 C1GCG7 32.35 2 2 2.32E5 1 1 2 N 99458 Arginine-requiring protein 2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04689 PE=3 SV=2
1805 3205 C1GFE0 32.33 2 2 1.15E5 1 1 2 N 108611 Oxysterol binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05976 PE=3 SV=1
2228 1059 C1GFZ5 32.16 2 2 1.03E5 1 1 2 Y 75130 STAS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06232 PE=3 SV=1
1186 771 C1G2R8 32.10 2 2 2.17E5 2 2 2 N 161451 Pre-mRNA-splicing factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01234 PE=3 SV=1
1840 21807 C1GI29 32.06 4 4 7.87E4 1 1 2 N 66337 PPM-type phosphatase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06915 PE=3 SV=1
1549 967 C1GCS1 31.82 2 2 1.16E5 1 1 2 Y 80699 Transmembrane 9 superfamily member OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04793 PE=3 SV=2
1193 3738 A0A0A0HR13 31.79 5 5 4.39E4 2 1 3 N 38763 Enoyl reductase (ER) domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12214 PE=4 SV=1
3022 2294 C1G029 31.72 2 2 6.31E4 1 1 1 N 76424 Chromatin remodeling complex subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00219 PE=3 SV=1
1792 1319 C1GFR3 31.69 5 5 6.53E4 1 1 1 Y 21980 Ras-related C3 botulinum toxin substrate 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06099 PE=4 SV=2
2226 2074 C1G6V3 31.55 12 12 1.32E5 1 1 2 N 10600 Ubiquitin-like domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02908 PE=4 SV=1
2229 4768 C1G845 31.43 3 3 1.14E5 1 1 2 N 52218 Pantothenate kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03350 PE=4 SV=1
3023 1640 C1GC00 31.42 4 4 4.37E4 1 1 1 N 36823 Homoserine kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04522 PE=3 SV=2
3024 2471 C1GN28 31.38 4 4 4.77E4 1 1 1 N 44107 SH3 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08672 PE=3 SV=2
1777 407 A0A0A0HW75 31.32 2 2 4.97E4 1 1 2 Y 49137 HAL protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11474 PE=4 SV=1
3027 7677 C1G6T2 31.32 4 4 9.06E4 1 1 1 Y 42864 Pru domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02887 PE=4 SV=1
2232 4146 C1GMG5 31.16 3 3 3.5E4 1 1 2 N 47298 VHS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08451 PE=4 SV=2
750 8019 C1GJ21 31.15 1 1 4.34E4 2 1 5 N 162818 TRAPPC10 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07257 PE=4 SV=2
3025 5502 C1GET2 31.11 2 2 0E0 1 1 1 N 84782 Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05768 PE=3 SV=2
2171 21752 C1GEE1 31.11 3 3 2.02E5 2 2 2 N 81569 XPGN domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05627 PE=3 SV=1
1789 800 A0A0A0HXB0 31.06 10 10 0E0 1 1 1 N 18488 Uncharacterized protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11842 PE=4 SV=1
1190 1794 C1GK54 30.94 1 1 2.22E6 1 1 3 N 114818 Pre-mRNA-splicing factor ATP-dependent RNA helicase prp16 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07640 PE=4 SV=2
3028 324 C1GAH4 30.91 2 2 3.85E4 1 1 1 N 108772 NIMA-interacting protein TinC OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04260 PE=4 SV=2
1439 6776 C1GMQ0 30.86 5 5 1.19E5 1 1 1 N 64310 AA_permease domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08544 PE=3 SV=2
1467 476 C1GL57 30.84 1 1 0E0 1 1 1 Y 77852 Ubiquitin-like modifier-activating enzyme ATG7 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07843 PE=3 SV=1
2184 7741 C1G4V0 30.76 4 4 4.33E4 1 1 1 N 43300 Glutamine amidotransferase type-2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01966 PE=4 SV=1
2167 1810 C1GJU9 30.53 2 2 0E0 1 1 1 N 198061 Lid2 complex component lid2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07535 PE=4 SV=2
2173 21756 C1G4T8 30.53 9 9 1.32E5 2 2 2 N 23833 Superoxide dismutase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01954 PE=3 SV=2
2181 1774 C1GJ13 30.44 5 5 1.03E5 2 2 2 N 64095 Coronin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07249 PE=3 SV=1
1528 2000 A0A0A0HTY3 30.43 2 2 8.26E4 1 1 2 N 72628 1,4-alpha-glucan-branching enzyme OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12426 PE=3 SV=1
2178 1407 C1G2G2 30.40 9 9 6.39E4 2 2 2 N 25161 Glutaredoxin domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02328 PE=4 SV=1
1760 2927 C1GI72 30.38 3 3 0E0 2 2 2 N 73149 SGNH_hydro domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06958 PE=4 SV=2
3032 2952 C1G5N9 30.29 1 1 4.79E5 1 1 1 N 111514 DNA mismatch repair protein MSH3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02494 PE=3 SV=2
3030 2498 C1GJ91 30.22 4 4 1.51E5 1 1 1 N 42139 Glycosyltransferase family 32 protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07327 PE=3 SV=1
3031 21935 C1G3P7 30.15 9 9 6.6E4 1 1 1 N 24333 LCCL domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01563 PE=4 SV=1
2165 2772 C1FZT6 30.15 2 2 0E0 1 1 1 N 57733 Gamma-butyrobetaine dioxygenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00126 PE=3 SV=1
2237 2513 C1G6I7 30.05 4 4 1.58E5 1 1 2 N 39234 Transmembrane protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02792 PE=4 SV=1
1893 2788 C1G095 30.05 4 4 0E0 1 1 1 N 40013 RRM domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00285 PE=4 SV=1
1440 21346 C1FYI5 29.98 2 2 2.38E4 2 1 2 Y 65238 U4/U5/U6 small nuclear ribonucleoprotein prp3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00861 PE=4 SV=2
2360 2494 C1G6G4 29.89 6 6 4.91E4 2 2 2 N 46966 RING-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02769 PE=4 SV=1
2240 3428 C1G581 29.88 3 3 1.62E5 1 1 2 N 68439 MATE efflux family protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03451 PE=3 SV=2
1054 895 C1GKQ8 29.75 2 2 6.97E4 2 1 3 N 110283 KH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07915 PE=4 SV=1
1434 2490 C1G4I3 29.64 8 8 7.81E4 2 2 2 N 43681 Obg-like ATPase 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01849 PE=3 SV=1
3036 1178 C1GCN2 29.64 3 3 6.73E4 1 1 1 N 59057 Amidase domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04754 PE=4 SV=1
3033 2969 C1GIL6 29.63 1 1 1.85E4 1 1 1 N 137540 Structural maintenance of chromosomes protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07102 PE=3 SV=1
3034 5598 C1GG53 29.62 5 5 1.35E5 1 1 1 N 28908 PROTEASOME_ALPHA_1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06290 PE=3 SV=1
3035 4863 C1GD74 29.61 2 2 0E0 1 1 1 N 69049 tRNA pseudouridine(38-40) synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05210 PE=3 SV=2
3037 4281 C1G8R6 29.40 4 4 1.41E4 1 1 1 N 34700 AD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03652 PE=3 SV=1
3038 6592 C1G5R3 29.20 3 3 0E0 1 1 1 N 38588 ATP_transf domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02518 PE=4 SV=1
1109 6212 C1GET9 29.12 4 4 3.97E4 2 2 2 N 80046 DNA replication licensing factor MCM5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05775 PE=3 SV=1
1785 5086 C1G7X1 28.98 4 4 1.02E5 1 1 1 N 39904 S-(hydroxymethyl)glutathione dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03276 PE=3 SV=2
1603 5629 C1G1W2 28.94 4 4 7.39E3 2 1 3 N 63903 BZIP transcription factor OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02128 PE=4 SV=1
940 1398 C1G733 28.89 2 2 1.2E6 2 2 5 N 116228 Mitotic control protein dis3 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02988 PE=3 SV=1
1908 21762 C1FZT5 28.85 4 4 1.35E5 1 1 3 N 29731 Grx4 family monothiol glutaredoxin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00125 PE=4 SV=1
3040 4804 C1GEY4 28.83 2 2 7.46E4 1 1 1 N 68632 Probable Xaa-Pro aminopeptidase P OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=AMPP PE=3 SV=2
3042 21974 C1GDA6 28.81 3 3 0E0 1 1 1 N 28287 Similar to OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05242 PE=4 SV=1
1448 3559 C1G5P3 28.68 25 25 2.33E5 2 2 2 Y 21560 3-hydroxyanthranilate 3,4-dioxygenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=BNA1 PE=3 SV=1
1242 1228 C1G7M3 28.63 3 3 5.05E4 2 1 3 Y 74868 Nucleolar GTP-binding protein 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03178 PE=3 SV=1
1219 1023 C1G7Y9 28.61 2 2 2.62E5 1 1 2 Y 118245 Potassium/sodium efflux P-type ATPase, fungal-type OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03294 PE=4 SV=2
1590 7954 C1GN14 28.56 1 1 7.46E4 2 1 4 N 132557 PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PAN2 PE=3 SV=1
2182 958 C1G4W6 28.50 3 3 2.61E4 1 1 1 Y 65824 Pyr_redox_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01982 PE=3 SV=2
2191 6126 A0A0A0HXG7 28.38 2 2 7.62E4 2 2 2 N 140588 PolyA_pol domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11199 PE=3 SV=1
1963 877 C1GHR3 28.36 2 2 0E0 2 1 3 N 133560 CAMK/CAMKL/KIN4 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06799 PE=4 SV=2
792 2292 A0A0A0HWT6 28.36 4 4 3.21E4 2 1 5 Y 59657 Nuclear protein DGCR14 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11999 PE=3 SV=1
1799 2747 C1GFE4 28.27 2 2 0E0 1 1 2 N 58983 STE/STE7/MEK1 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05980 PE=4 SV=1
1793 1134 C1G4M6 28.25 3 3 7.24E4 2 1 2 N 97868 Formin binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01892 PE=4 SV=2
3043 3211 C1GE77 28.12 2 2 5.26E4 1 1 1 N 101742 Lon protease homolog 2, peroxisomal OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05563 PE=3 SV=1
2254 21986 C1GCZ7 28.08 14 14 8.14E4 1 1 1 N 12597 RTC domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05133 PE=4 SV=2
2186 867 C1G486 28.05 4 4 3.43E4 1 1 1 N 33792 Transmembrane protein 69 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01752 PE=4 SV=1
1913 21987 C1G6Q3 28.01 7 7 6.62E4 1 1 3 N 18324 DUF3237 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02858 PE=4 SV=1
1712 3830 C1GGW3 27.92 4 4 4.5E4 2 2 2 Y 64134 Tup_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06182 PE=4 SV=2
1454 2027 C1G4M0 27.92 5 5 4.18E4 2 2 2 N 48507 Adenosylhomocysteinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01886 PE=3 SV=2
1952 4612 C1G8A8 27.90 1 1 2.74E4 2 1 2 N 88215 Spindle pole body component OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03413 PE=3 SV=1
3039 739 C1GF82 27.86 3 3 3.43E4 1 1 1 N 68071 Cystathionine gamma-synthase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05918 PE=4 SV=2
3041 5716 C1GKX2 27.79 4 4 1.03E5 1 1 1 N 45592 Chitin biosynthesis protein CHS5 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07979 PE=4 SV=1
1253 4753 A0A0A0HTE6 27.77 0 0 4.44E4 2 1 4 N 573330 Carrier domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11912 PE=4 SV=1
1704 8337 C1G571 27.74 5 5 5.07E5 2 2 2 N 61733 T-complex protein 1 subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03441 PE=3 SV=1
2248 3609 C1FZZ3 27.63 6 6 0E0 1 1 1 N 18224 Profilin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00183 PE=3 SV=2
3044 4067 C1G855 27.63 2 2 2.5E4 1 1 1 N 64115 Acetyl-coenzyme A transporter 1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03360 PE=4 SV=2
2158 1955 C1G6U3 27.47 1 1 2.64E4 1 1 1 N 155121 MAP kinase kinase kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02898 PE=3 SV=1
3045 21997 C1GC76 27.46 5 5 1.24E5 1 1 1 N 41158 Guanine nucleotide-binding protein subunit alpha OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04598 PE=3 SV=1
1580 21979 A0A0A0HTN8 27.46 5 5 2.53E5 1 1 3 N 28724 Abhydrolase_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11804 PE=4 SV=1
1700 3274 C1GG95 27.43 2 2 0E0 1 1 1 N 113504 Pro-apoptotic serine protease NMA111 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06332 PE=3 SV=2
3046 4666 C1G1U8 27.36 6 6 0E0 1 1 1 N 31988 Glyco_hydro_cc domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02114 PE=4 SV=2
1257 3378 C1G243 27.22 1 1 2.06E5 2 1 2 N 179637 non-specific serine/threonine protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02209 PE=4 SV=2
1756 3838 C1FZX8 27.18 4 4 0E0 2 1 2 N 68070 CMGC/SRPK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00168 PE=4 SV=2
1447 2755 C1GF30 27.09 5 5 1.32E5 2 2 2 N 75282 Cora family metal ion transporter-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05866 PE=3 SV=2
1107 543 C1GGE8 27.04 3 3 2.52E4 2 2 2 N 105630 Kinesin-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06385 PE=3 SV=1
1721 4995 C1G3E7 27.01 1 1 0E0 1 1 1 N 105398 Dual-specificity kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01463 PE=4 SV=2
1207 2230 C1FYU0 26.93 1 1 6.46E5 2 2 4 N 181559 STE/STE11/BCK1 protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00966 PE=4 SV=2
1873 2681 C1GFZ8 26.81 2 2 1.61E5 1 1 2 N 79318 Serine-rich protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06235 PE=4 SV=2
1928 6346 C1G914 26.64 2 2 0E0 2 1 3 N 58134 Cortical protein KAR9-domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03750 PE=4 SV=1
1938 21646 C1G7K1 26.60 2 2 1.33E3 2 1 2 N 91037 Diphthine--ammonia ligase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03156 PE=4 SV=2
1923 899 A0A0A0HV65 26.59 2 2 0E0 1 1 1 Y 51859 Ubiquitin-conjugating enzyme variant MMS2 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11319 PE=4 SV=1
1456 2365 C1FZR4 26.57 6 6 0E0 2 2 2 N 46166 Pyr_redox_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00104 PE=4 SV=1
3055 22082 A0A0A0HY15 26.49 8 8 3.46E3 1 1 1 N 6535 Enolase_N domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11768 PE=4 SV=1
3048 5708 C1GE38 26.49 4 4 1.33E5 1 1 1 N 54533 Argonaute complex, subunit Arb1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05524 PE=4 SV=2
1804 1962 C1G3P8 26.49 2 2 0E0 1 1 1 N 62688 methylmalonate-semialdehyde dehydrogenase (CoA acylating) OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01564 PE=4 SV=2
3047 3713 C1G003 26.36 3 3 6.9E4 1 1 1 N 44953 Mannan endo-1,6-alpha-mannosidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00193 PE=3 SV=2
1218 1990 A0A0A0HTT8 26.33 1 1 4.71E4 2 1 2 N 181195 CCHC-type domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12503 PE=4 SV=1
1924 2634 C1G462 26.17 2 2 2.29E5 1 1 2 N 53107 MFS domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01728 PE=4 SV=1
1879 1186 C1GB51 26.16 6 6 8.49E4 2 2 3 N 63657 ENTH domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04852 PE=3 SV=1
1886 2036 C1GCL9 26.08 2 2 0E0 2 2 2 N 148810 UBA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04741 PE=4 SV=2
1523 836 C1G632 25.97 8 8 0E0 2 2 2 N 28386 E2 ubiquitin-conjugating enzyme OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02637 PE=3 SV=1
3049 22038 C1GIL8 25.96 6 6 4.22E4 1 1 1 N 36535 NADH-cytochrome b5 reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07104 PE=3 SV=2
3051 742 C1GFA1 25.83 3 3 4.64E4 1 1 1 N 84229 HCP-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05937 PE=4 SV=1
2187 307 C1GCZ4 25.78 2 2 1.86E4 1 1 1 N 49453 Acyl-CoA dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05130 PE=3 SV=2
1827 874 C1GHI4 25.69 1 1 2.07E5 1 1 1 N 82427 C6 finger domain transcription factor nscR OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06720 PE=4 SV=2
1709 1034 C1GEK5 25.52 4 4 2.22E5 2 2 2 N 79918 Sorting nexin MVP1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05691 PE=3 SV=1
3056 7492 C1GGY0 25.51 2 2 6.31E4 1 1 1 Y 71105 FAD binding domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06199 PE=3 SV=2
3052 2683 C1G3Y3 25.47 8 8 0E0 1 1 1 N 35559 S5A_REDUCTASE domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01649 PE=3 SV=1
3057 22091 C1G4P6 25.38 3 3 1.32E5 1 1 1 N 38941 Mitochondrial ATPase complex subunit ATP10 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01912 PE=4 SV=2
2188 1606 C1GFA4 25.30 4 4 4.9E4 1 1 1 N 40152 AB hydrolase-1 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05940 PE=4 SV=1
3053 22066 C1GES0 25.29 4 4 4.54E4 1 1 1 N 42766 Pyr_redox_2 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05756 PE=4 SV=1
1937 5026 C1G6C3 25.26 3 3 1.34E5 1 1 2 N 48571 Sulfite oxidase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_02728 PE=4 SV=2
2257 7113 C1G857 25.23 2 2 0E0 1 1 1 N 141708 SCD domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03362 PE=4 SV=1
1469 21452 A0A0A0HU08 25.23 7 7 1.98E5 1 1 2 N 32343 Dihydroneopterin aldolase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_11117 PE=4 SV=1
2176 1167 C1GKC8 25.19 4 4 0E0 1 1 1 N 58561 G3BP-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07714 PE=4 SV=2
3054 2312 C1GL08 24.91 4 4 6E4 1 1 1 N 60882 Adenylyltransferase and sulfurtransferase uba4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=uba4 PE=3 SV=1
2289 7939 C1G9C9 24.70 5 5 5.94E4 1 1 2 Y 35013 Uncharacterized protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03865 PE=4 SV=1
2179 6332 C1GHB2 24.66 1 1 8.74E4 1 1 1 Y 104302 Importin N-terminal domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06648 PE=4 SV=1
1548 2746 A0A0A0HU64 24.63 1 1 0E0 2 1 3 N 155269 STE/STE20/YSK protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_12331 PE=4 SV=1
3061 22104 C1G1B6 24.60 19 19 2.1E4 1 1 1 N 8080 Non-histone chromosomal protein 6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_00656 PE=4 SV=2
1714 3244 C1G9Q3 24.57 7 7 9.34E4 1 1 1 Y 40893 Methylthioribose-1-phosphate isomerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=MRI1 PE=3 SV=1
3059 6984 C1GKI8 24.57 7 7 1E5 1 1 1 N 31974 Calmodulin OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07774 PE=4 SV=1
3058 2078 C1GIM6 24.48 3 3 2.28E5 1 1 1 N 69782 ATP-dependent RNA helicase DBP9 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07112 PE=4 SV=2
3062 1553 C1G481 24.38 2 2 2.29E4 1 1 1 N 88786 AAA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01747 PE=3 SV=1
1744 21548 C1GHL6 24.33 8 8 9.8E4 2 1 2 N 32363 Transcription initiation factor TFIID subunit 9 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06752 PE=3 SV=1
2175 21772 C1GE06 24.32 6 6 4.32E4 1 1 1 N 28203 Oxidoreductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05492 PE=3 SV=2
3060 6892 C1GIX1 24.32 1 1 0E0 1 1 1 N 91516 HbrB-like protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07207 PE=4 SV=1
1844 519 C1G352 24.31 2 2 6.25E4 1 1 2 N 71571 AGC/AKT protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01368 PE=4 SV=2
3064 1567 C1GKS3 24.15 9 9 0E0 1 1 1 N 19428 Actin-related protein 2/3 complex subunit 4 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07930 PE=3 SV=1
3063 1664 C1GA86 24.13 3 3 0E0 1 1 1 N 43896 AAA domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04172 PE=3 SV=1
3065 7139 C1GMD2 24.00 5 5 4.6E4 1 1 1 N 39527 Vacuolar protein sorting-associated protein 74 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_08218 PE=3 SV=1
1850 21625 C1GBA0 23.75 3 3 8.81E4 1 1 1 N 26501 Nucleic acid-binding protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04901 PE=3 SV=1
3067 3793 C1GGS9 23.72 2 2 1.78E5 1 1 1 N 62377 DNA primase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06516 PE=3 SV=2
3066 22125 C1GKK3 23.69 18 18 4.68E4 1 1 1 N 17593 ATP synthase subunit delta, mitochondrial OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07789 PE=3 SV=1
1598 4431 C1GJZ9 23.62 1 1 1.08E5 1 1 2 N 58260 Inosine-5'-monophosphate dehydrogenase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07585 PE=3 SV=1
2183 5549 C1G3G3 23.61 2 2 1.1E5 1 1 1 Y 64420 Gamma-glutamyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_01479 PE=4 SV=2
2172 910 C1GDU6 23.58 1 1 0E0 1 1 1 N 145603 Pentatricopeptide repeat protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05432 PE=4 SV=1
1363 2299 C1GE89 23.50 1 1 2.3E5 1 1 3 N 94709 HAL protein kinase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05575 PE=4 SV=2
1847 374 C1G8N6 23.38 1 1 1.19E5 1 1 2 N 110918 WD_REPEATS_REGION domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03622 PE=3 SV=2
1205 1648 C1GFT8 23.36 1 1 6.03E4 1 1 1 N 193754 DNA polymerase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_06124 PE=3 SV=2
3071 21981 C1GKC3 23.35 6 6 0E0 1 1 1 N 26101 MIND kinetochore complex component Nnf1 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_07709 PE=4 SV=1
2227 6840 C1G7L7 23.24 2 2 5.19E4 1 1 1 N 71460 Methylenetetrahydrofolate reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_03172 PE=3 SV=1
3078 1053 C1GF34 23.22 2 2 7.24E4 1 1 1 N 72461 SMI1_KNR4 domain-containing protein OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05870 PE=3 SV=2
2301 859 C1GCZ3 23.17 1 1 4.66E4 1 1 1 N 167660 UDP-glucose:Glycoprotein Glucosyltransferase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_05129 PE=3 SV=1
2345 6381 C1GBY8 23.11 1 1 6.02E4 1 1 1 N 101128 Ribonucleoside-diphosphate reductase OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04510 PE=3 SV=2
2318 22137 C1GAQ6 23.03 18 18 5.22E4 1 1 1 N 7043 TOM core complex subunit Tom6 OS=Paracoccidioides brasiliensis (strain Pb18) OX=502780 GN=PADG_04342 PE=4 SV=1
total 1175 proteins

C1GM00
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 200.00 2907.3816 27 -7.1 1454.6877 2 90.87 6 51767 VEV_3_3_RA6_01_1237.d 1.72E6 13 13 397 423 Carbamidomethylation
K.TVEEDHAIPEDVDNAYKNKVAEFATR.G Y 179.27 2960.4150 26 -10.7 987.8017 3 72.08 5 40553 VEV_2_3_RA5_01_1236.d 4.6E6 13 13 492 517
R.LTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 173.73 2945.5232 28 -9.0 1473.7556 2 88.15 6 50319 VEV_3_3_RA6_01_1237.d 4.66E6 13 13 197 224
K.TVEEDHAIPEDVDNAYKNK.V Y 172.26 2186.0127 19 -15.7 729.6667 3 59.84 6 30349 VEV_3_3_RA6_01_1237.d 1.06E7 18 18 492 510
R.NGRLTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 172.26 3272.6887 31 -8.1 1091.8947 3 84.98 6 48470 VEV_3_3_RA6_01_1237.d 1.74E6 9 9 194 224
R.GQHIPPNHLGTSVPSGAFPGKPTESVPEEK.K Y 166.37 3093.5518 30 -11.3 774.3865 4 65.47 5 35639 VEV_2_3_RA5_01_1236.d 2.09E7 45 45 11 40
R.IVTEDAFLQVDQSAITGESLAVDKHKGDTC(+57.02)YASSAVK.R Y 162.97 3952.9363 37 -6.8 989.2346 4 77.87 5 44627 VEV_2_3_RA5_01_1236.d 1.82E6 7 7 225 261 Carbamidomethylation
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 160.68 3149.5195 29 -7.7 1050.8390 3 86.75 5 50171 VEV_2_3_RA5_01_1236.d 3.24E6 10 10 395 423 Carbamidomethylation
K.TVEEDHAIPEDVDNAYK.N Y 157.91 1943.8748 17 -12.4 648.9575 3 62.70 6 32427 VEV_3_3_RA6_01_1237.d 6E6 12 12 492 508
R.SAADIVFLAPGLSAIIDALKTSR.Q Y 157.18 2328.3052 23 -13.5 777.0985 3 95.85 6 53951 VEV_3_3_RA6_01_1237.d 3.92E6 14 14 669 691
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASRK.K Y 155.65 3277.6145 30 -8.8 820.4037 4 84.02 5 48575 VEV_2_3_RA5_01_1236.d 4.2E5 3 3 395 424 Carbamidomethylation
K.LSLAEPYC(+57.02)VAGVDPDDLM(+15.99)LTAC(+57.02)LAASR.K Y 151.11 2923.3765 27 -6.7 1462.6857 2 87.82 5 50746 VEV_2_3_RA5_01_1236.d 6.63E5 8 8 397 423 Carbamidomethylation; Oxidation (M)
R.GYLVAMTGDGVNDAPSLK.K Y 150.55 1806.8822 18 -12.8 904.4368 2 77.20 6 43157 VEV_3_3_RA6_01_1237.d 3.54E6 11 11 635 652
K.NKLSLAEPYC(+57.02)VAGVDPDDLM(+15.99)LTAC(+57.02)LAASR.K Y 149.71 3165.5144 29 -10.8 1056.1674 3 84.03 6 47865 VEV_3_3_RA6_01_1237.d 4.83E5 4 4 395 423 Carbamidomethylation; Oxidation (M)
R.IVTEDAFLQVDQSAITGESLAVDK.H Y 149.67 2548.2908 24 -8.7 1275.1416 2 84.30 6 48029 VEV_3_3_RA6_01_1237.d 1.49E6 12 12 225 248
R.LGLGGGGTMPGSEVYDFVEAADGFAEVFPQHK.Y Y 148.60 3281.5339 32 -12.4 1094.8384 3 92.71 6 52649 VEV_3_3_RA6_01_1237.d 1.03E6 7 7 593 624
R.LGLGGGGTMPGSEVYDFVEAADGFAEVFPQHKYNVVEILQQR.G Y 147.28 4524.2061 42 -2.8 1132.0557 4 93.76 4 55695 VEV_1_3_RA4_01_1235.d 2.75E6 9 9 593 634
R.N(+.98)GRLTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 146.57 3273.6729 31 -5.5 1092.2256 3 88.10 4 52586 VEV_1_3_RA4_01_1235.d 1.13E6 6 6 194 224 Deamidation (NQ)
K.SVLTQYKVLEFHPFDPVSK.K Y 146.27 2233.1782 19 -10.3 745.3923 3 80.43 5 46349 VEV_2_3_RA5_01_1236.d 2.05E6 8 8 447 465
R.LTEVEAPEVVPGDILQVE(+14.02)EGTIIPADGR.I Y 145.77 2959.5388 28 -9.9 1480.7620 2 92.57 6 52587 VEV_3_3_RA6_01_1237.d 2.12E6 12 12 197 224 Methylation(others)
R.ETSRQLGLGTNVYNAER.L Y 145.01 1906.9497 17 -13.6 636.6486 3 62.35 6 32174 VEV_3_3_RA6_01_1237.d 2.67E6 10 10 576 592
R.GYLVAMTGDGVNDAPSLKKADTGIAVEGASDAAR.S Y 144.23 3319.6353 34 -9.1 830.9085 4 76.18 5 43430 VEV_2_3_RA5_01_1236.d 4.07E5 3 3 635 668
R.LGLGGGGTMPGSEVYD(+14.02)FVEAADGFAEVFPQHKYNVVEILQQR.G Y 143.64 4538.2217 42 6.2 908.6572 5 93.84 5 53731 VEV_2_3_RA5_01_1236.d 0 1 1 593 634 Methylation(others)
R.IVTEDAFLQVDQSAITGESLAVDKHK.G Y 143.48 2813.4446 26 -10.2 704.3613 4 79.03 5 45404 VEV_2_3_RA5_01_1236.d 8.81E5 5 5 225 250
R.GYLVAMTGDGVNDAPSLKK.A Y 143.18 1934.9772 19 -14.4 645.9904 3 71.29 6 38852 VEV_3_3_RA6_01_1237.d 2.9E6 10 10 635 653
K.RGEAFMVITSTGDNTFVGR.A Y 142.48 2057.0000 19 -14.8 686.6638 3 77.27 6 43220 VEV_3_3_RA6_01_1237.d 2.69E6 9 9 262 280
K.KADTGIAVEGASDAAR.S Y 141.18 1530.7638 16 -14.1 766.3784 2 43.08 6 20351 VEV_3_3_RA6_01_1237.d 5.83E6 40 40 653 668
R.GYLVAM(+15.99)TGDGVNDAPSLK.K Y 140.87 1822.8771 18 -12.3 912.4346 2 71.31 6 38917 VEV_3_3_RA6_01_1237.d 1.21E6 8 8 635 652 Oxidation (M)
R.LTEVEAPEVVPGDILQVEE(+14.02)GTIIPADGR.I Y 137.18 2959.5388 28 -6.1 1480.7677 2 89.98 5 51872 VEV_2_3_RA5_01_1236.d 1.27E6 5 5 197 224 Methylation(others)
K.LSAIESLAGVEILC(+57.02)SDKTGTLTK.N Y 136.51 2405.2722 23 -14.7 802.7529 3 82.03 6 46559 VEV_3_3_RA6_01_1237.d 2.5E6 7 7 372 394 Carbamidomethylation
R.LTEVE(+14.02)APEVVPGDILQVEEGTIIPADGR.I Y 134.55 2959.5388 28 -8.1 1480.7646 2 88.95 6 50781 VEV_3_3_RA6_01_1237.d 2.49E6 7 7 197 224 Methylation(others)
R.SAADIVFLAPGLSAIIDALK.T Y 133.53 1984.1244 20 -7.5 662.3771 3 97.71 4 57438 VEV_1_3_RA4_01_1235.d 1.47E6 11 11 669 688
R.GEAFMVITSTGDNTFVGR.A Y 131.93 1900.8989 18 -19.8 634.6277 3 80.59 6 45628 VEV_3_3_RA6_01_1237.d 8.97E5 5 5 263 280
R.LGLGGGGTM(+15.99)PGSEVYDFVEAADGFAEVFPQHKYNVVEILQQR.G Y 129.70 4540.2007 42 -2.4 1136.0547 4 92.90 6 52714 VEV_3_3_RA6_01_1237.d 1.05E6 4 4 593 634 Oxidation (M)
K.LSLAE(+14.02)PYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 129.68 2921.3972 27 -6.0 1461.6971 2 92.08 5 52923 VEV_2_3_RA5_01_1236.d 4.82E5 5 5 397 423 Methylation(others); Carbamidomethylation
K.NKLSLAEPYC(+57.02)VAGVDPDD(+14.02)LMLTAC(+57.02)LAASR.K Y 129.59 3163.5352 29 -5.4 1055.5133 3 87.24 5 50447 VEV_2_3_RA5_01_1236.d 1.44E5 2 2 395 423 Carbamidomethylation; Methylation(others)
K.ADTGIAVEGASDAAR.S Y 129.17 1402.6688 15 -13.0 702.3326 2 54.90 6 27134 VEV_3_3_RA6_01_1237.d 7.93E6 26 26 654 668
R.LGLGGGGTM(+15.99)PGSEVYDFVEAADGFAEVFPQHK.Y Y 126.99 3297.5288 32 -1.1 1100.1824 3 91.27 4 54372 VEV_1_3_RA4_01_1235.d 3.8E5 2 2 593 624 Oxidation (M)
K.AIVQKLSAIESLAGVEILC(+57.02)SDK.T Y 126.50 2343.2720 22 -7.4 782.0922 3 85.65 5 49542 VEV_2_3_RA5_01_1236.d 9.43E4 3 3 367 388 Carbamidomethylation
R.QLGLGTNVYNAER.L Y 126.13 1433.7263 13 -14.8 717.8598 2 66.66 6 35409 VEV_3_3_RA6_01_1237.d 6.38E6 11 11 580 592
R.LTE(+14.02)VEAPEVVPGDILQVEEGTIIPADGR.I Y 125.82 2959.5388 28 -6.4 1480.7672 2 89.22 5 51494 VEV_2_3_RA5_01_1236.d 1.9E6 4 4 197 224 Methylation(others)
R.GQHIPPNHLGTSVPSGAFPGKPTESVPEEK(+14.02).K Y 124.97 3107.5676 30 -17.0 622.5103 5 67.35 6 35891 VEV_3_3_RA6_01_1237.d 2.68E6 23 23 11 40 Methylation(KR)
K.LSAIESLAGVEILC(+57.02)SDK.T Y 122.78 1803.9287 17 -9.9 902.9627 2 84.14 5 48680 VEV_2_3_RA5_01_1236.d 1.65E6 12 12 372 388 Carbamidomethylation
R.KRGEGSWEILGIMPC(+57.02)SDPPRHDTAK.T Y 120.75 2836.3748 25 -11.2 710.0930 4 69.29 5 38476 VEV_2_3_RA5_01_1236.d 1.16E6 3 3 527 551 Carbamidomethylation
K.LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASRK.K Y 120.21 3035.4766 28 -8.7 1012.8240 3 87.26 5 50467 VEV_2_3_RA5_01_1236.d 3.21E5 2 2 397 424 Carbamidomethylation
R.NGRLTEVE(+14.02)APEVVPGDILQVEEGTIIPADGR.I Y 119.49 3286.7043 31 -12.9 1096.5613 3 85.73 6 48974 VEV_3_3_RA6_01_1237.d 2.34E5 1 1 194 224 Methylation(others)
K.RGEAFM(+15.99)VITSTGDNTFVGR.A Y 118.25 2072.9949 19 -11.1 691.9979 3 74.23 5 42045 VEV_2_3_RA5_01_1236.d 2.14E5 4 4 262 280 Oxidation (M)
R.GYLVAM(+15.99)TGDGVNDAPSLKK.A Y 118.05 1950.9720 19 -9.2 651.3253 3 65.34 5 35536 VEV_2_3_RA5_01_1236.d 5.02E5 4 4 635 653 Oxidation (M)
R.NGR(+14.02)LTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 117.39 3286.7043 31 -10.5 1096.5638 3 85.76 5 49647 VEV_2_3_RA5_01_1236.d 4.08E5 2 2 194 224 Methylation(KR)
R.LGLGGGGTMPGSEVYDFVE(+14.02)AADGFAEVFPQHKYNVVEILQQR.G Y 116.37 4538.2217 42 -8.3 908.6440 5 94.49 5 54037 VEV_2_3_RA5_01_1236.d 2.76E5 1 1 593 634 Methylation(others)
R.IVTEDAFLQ(+.98)VDQ(+.98)SAITGESLAVDKHKGDTC(+57.02)YASSAVK.R Y 114.69 3954.9043 37 -3.0 791.9858 5 77.93 6 43676 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 225 261 Deamidation (NQ); Carbamidomethylation
K.VLEFHPFDPVSKK.V Y 113.56 1541.8241 13 -10.7 771.9111 2 68.94 5 38244 VEV_2_3_RA5_01_1236.d 5.16E6 13 13 454 466
R.LGLGGGGTMPGSE(+14.02)VYDFVEAADGFAEVFPQHK.Y Y 113.56 3295.5496 32 -9.7 1099.5132 3 94.80 4 56208 VEV_1_3_RA4_01_1235.d 4.28E5 3 3 593 624 Methylation(others)
R.SAADIVFLAPGLSAIIDALKTSRQIFHR.M Y 113.27 3009.6763 28 -3.9 602.9402 5 95.54 5 54477 VEV_2_3_RA5_01_1236.d 1.66E5 2 2 669 696
K.VLEFHPFDPVSK.K Y 113.21 1413.7292 12 -13.4 707.8624 2 75.07 5 42675 VEV_2_3_RA5_01_1236.d 6.18E6 12 12 454 465
R.LTEVEAPEVVPGDILQVEEGTIIPADGR(+14.02).I Y 112.47 2959.5388 28 -8.7 1480.7638 2 88.39 5 51054 VEV_2_3_RA5_01_1236.d 4.35E5 6 6 197 224 Methylation(KR)
K.LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+14.02).K Y 111.81 2921.3972 27 -8.6 1461.6934 2 91.63 5 52715 VEV_2_3_RA5_01_1236.d 3.13E5 4 4 397 423 Carbamidomethylation; Methylation(KR)
R.SLEDFVVSLQR.V Y 110.94 1291.6771 11 -13.8 646.8369 2 82.67 6 47000 VEV_3_3_RA6_01_1237.d 9.73E6 17 17 910 920
K.KVSAVVISPQGER.I Y 110.07 1368.7725 13 -13.8 685.3840 2 47.90 6 23081 VEV_3_3_RA6_01_1237.d 6.85E6 20 20 466 478
R.GQHIPPNHLGTSVPSGAFPGKPTESVPEEKK.Q Y 109.57 3221.6467 31 -12.8 645.3284 5 62.51 5 33419 VEV_2_3_RA5_01_1236.d 0 2 2 11 41
K.TINEAKTLGLSIKMLTGDAVGIAR.E Y 106.89 2471.3782 24 -12.8 618.8439 4 82.89 5 47885 VEV_2_3_RA5_01_1236.d 1.09E5 1 1 552 575
K.HKGDTC(+57.02)YASSAVK.R Y 106.43 1422.6561 13 -15.0 475.2189 3 17.15 6 6093 VEV_3_3_RA6_01_1237.d 9.79E5 8 8 249 261 Carbamidomethylation
K.VLEFHPFDPVSKKVSAVVISPQGER.I Y 106.24 2764.4912 25 -7.9 692.1246 4 77.67 5 44485 VEV_2_3_RA5_01_1236.d 2.23E5 2 2 454 478
K.NKLSLAE(+14.02)PYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 105.50 3163.5352 29 -3.7 1055.5151 3 88.02 4 52568 VEV_1_3_RA4_01_1235.d 4.57E5 3 3 395 423 Methylation(others); Carbamidomethylation
K.YNVVEILQQR.G Y 104.93 1260.6826 10 -16.9 631.3380 2 77.12 6 43115 VEV_3_3_RA6_01_1237.d 2.65E6 9 9 625 634
K.TINEAKTLGLSIK.M Y 104.31 1386.8082 13 -18.5 694.3986 2 65.29 5 35495 VEV_2_3_RA5_01_1236.d 1.47E6 6 6 552 564
R.LGLGGGGTMPGSEVYDFVEAADGFAEVFPQHK(+14.02)YNVVEILQQR.G Y 102.50 4538.2217 42 -8.1 1135.5535 4 93.80 5 53715 VEV_2_3_RA5_01_1236.d 1.65E5 1 1 593 634 Methylation(KR)
K.N(+.98)KLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 101.82 3150.5034 29 -9.6 1051.1650 3 87.82 5 50743 VEV_2_3_RA5_01_1236.d 3.11E5 4 4 395 423 Deamidation (NQ); Carbamidomethylation
K.TLGLSIKMLTGDAVGIAR.E Y 101.38 1815.0288 18 -20.2 606.0046 3 82.60 5 47735 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 558 575
R.Q(-17.03)LGLGTNVYNAER.L Y 101.31 1416.6997 13 -14.2 709.3470 2 78.23 6 43913 VEV_3_3_RA6_01_1237.d 5.8E6 9 9 580 592 Pyro-glu from Q
K.NKLSLAEPYC(+57.02)VAGVD(+14.02)PDDLMLTAC(+57.02)LAASR.K Y 99.82 3163.5352 29 -5.2 1055.5135 3 86.71 5 50140 VEV_2_3_RA5_01_1236.d 2.06E5 2 2 395 423 Carbamidomethylation; Methylation(others)
K.TVEEDHAIPEDVDNAYKNK(+14.02).V Y 99.34 2200.0283 19 -9.5 734.3431 3 62.48 5 33395 VEV_2_3_RA5_01_1236.d 1.46E6 6 6 492 510 Methylation(KR)
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+14.02).K Y 99.08 3163.5352 29 -1.7 1055.5172 3 87.51 4 52263 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 395 423 Carbamidomethylation; Methylation(KR)
K.MLTGDAVGIAR.E Y 98.17 1102.5804 11 -10.2 552.2919 2 63.88 5 34463 VEV_2_3_RA5_01_1236.d 7.75E6 11 11 565 575
K.KVSAVVISPQGERITC(+57.02)VK.G Y 97.93 1970.0983 18 -8.6 493.5276 4 61.97 5 33016 VEV_2_3_RA5_01_1236.d 6.69E5 4 4 466 483 Carbamidomethylation
R.L(+42.01)GLGGGGTM(+15.99)PGSEVYDFVEAADGFAEVFPQHK.Y Y 97.51 3339.5393 32 -7.7 835.8857 4 87.44 6 49912 VEV_3_3_RA6_01_1237.d 4.46E5 1 1 593 624 Acetylation (N-term); Oxidation (M)
R.GQHIPPN(+.98)HLGTSVPSGAFPGKPTESVPEEK.K Y 96.84 3094.5359 30 -5.0 619.9114 5 67.88 6 36292 VEV_3_3_RA6_01_1237.d 1.53E6 3 3 11 40 Deamidation (NQ)
R.LTEVEAPE(+14.02)VVPGDILQVEEGTIIPADGR.I Y 96.51 2959.5388 28 -8.9 1480.7635 2 89.39 6 50993 VEV_3_3_RA6_01_1237.d 1.5E6 3 3 197 224 Methylation(others)
R.ITC(+57.02)VKGAPLFVLK.T Y 95.91 1444.8475 13 -21.1 723.4158 2 72.96 5 41148 VEV_2_3_RA5_01_1236.d 3.44E5 2 2 479 491 Carbamidomethylation
R.GQHIPPNHLGTSVPS(-2.02)GAFPGKPTESVPEEK.K Y 94.89 3091.5361 30 -9.7 619.3085 5 66.19 5 36169 VEV_2_3_RA5_01_1236.d 1.04E6 8 8 11 40 2-amino-3-oxo-butanoic_acid
K.GIDAIDKAFLK.S Y 94.86 1189.6707 11 -12.1 595.8354 2 72.49 5 40847 VEV_2_3_RA5_01_1236.d 1.02E7 16 16 427 437
R.LTEVEAPEVVPGDILQ(+.98)VEEGTIIPADGR.I Y 94.44 2946.5073 28 -4.2 983.1722 3 88.19 6 50346 VEV_3_3_RA6_01_1237.d 2.53E5 2 2 197 224 Deamidation (NQ)
K.VSAVVISPQGERITC(+57.02)VK.G Y 94.37 1842.0033 17 -15.5 614.9988 3 65.98 6 34872 VEV_3_3_RA6_01_1237.d 3.73E5 2 2 467 483 Carbamidomethylation
R.GYLVAMTGDGVN(+.98)DAPSLK.K Y 93.90 1807.8662 18 -13.0 904.9286 2 77.99 6 43730 VEV_3_3_RA6_01_1237.d 8.6E5 5 5 635 652 Deamidation (NQ)
K.VSAVVISPQGER.I Y 93.83 1240.6775 12 -14.4 621.3371 2 57.92 6 29024 VEV_3_3_RA6_01_1237.d 9.09E6 12 12 467 478
R.NGRLTEVEAPEVVPGDILQVE(+14.02)EGTIIPADGR.I Y 93.72 3286.7043 31 -10.0 1096.5645 3 88.94 5 51349 VEV_2_3_RA5_01_1236.d 9.97E4 3 3 194 224 Methylation(others)
R.AKSVLTQYKVLEFHPFDPVSK.K Y 93.13 2432.3103 21 -12.1 609.0775 4 77.45 5 44346 VEV_2_3_RA5_01_1236.d 1.71E5 2 2 445 465
R.GYLVAMTGDGVNDAPSLK(+14.02).K Y 92.86 1820.8978 18 -8.6 911.4484 2 79.01 4 46329 VEV_1_3_RA4_01_1235.d 4.1E5 2 2 635 652 Methylation(KR)
R.GYLVAMTGD(+14.02)GVNDAPSLK.K Y 91.34 1820.8978 18 -14.0 911.4434 2 78.80 6 44315 VEV_3_3_RA6_01_1237.d 4.31E5 2 2 635 652 Methylation(others)
R.NGRLTEVEAPE(+14.02)VVPGDILQVEEGTIIPADGR.I Y 91.01 3286.7043 31 -7.8 1096.5669 3 86.08 5 49779 VEV_2_3_RA5_01_1236.d 2.37E5 1 1 194 224 Methylation(others)
K.M(+15.99)LTGDAVGIAR.E Y 90.35 1118.5753 11 -11.8 560.2883 2 58.04 5 30138 VEV_2_3_RA5_01_1236.d 9.72E6 37 37 565 575 Oxidation (M)
R.GQHIPPNHLGTSVPS(-18.01)GAFPGK(+14.02)PTESVPEEK.K Y 89.94 3089.5569 30 -36.9 618.8959 5 65.48 6 34487 VEV_3_3_RA6_01_1237.d 4.89E5 6 6 11 40 Dehydration; Methylation(KR)
R.Q(-17.03)LGLGTNVYNAER(+14.02).L Y 89.83 1430.7153 13 -9.7 716.3580 2 81.33 5 46937 VEV_2_3_RA5_01_1236.d 1.94E6 10 10 580 592 Pyro-glu from Q; Methylation(KR)
R.SLEDFVVSLQR(+14.02).V Y 89.81 1305.6929 11 -13.9 653.8446 2 83.89 6 47777 VEV_3_3_RA6_01_1237.d 1.46E6 7 7 910 920 Methylation(KR)
K.GDTC(+57.02)YASSAVK.R Y 89.59 1157.5023 11 -13.1 579.7509 2 30.35 5 13465 VEV_2_3_RA5_01_1236.d 8.59E5 3 3 251 261 Carbamidomethylation
K.KKGIDAIDKAFLK.S Y 89.14 1445.8605 13 -5.9 482.9579 3 60.88 5 32195 VEV_2_3_RA5_01_1236.d 6.75E5 3 3 425 437
R.LTEVEAPEVVPGDILQVEE(+28.03)GTIIPADGR.I Y 89.03 2973.5544 28 -7.8 1487.7729 2 94.57 6 53427 VEV_3_3_RA6_01_1237.d 6.27E5 7 7 197 224 Ethylation
K.MLTGDAVGIARETSR.Q Y 87.82 1575.8038 15 -11.3 788.9003 2 63.48 5 34155 VEV_2_3_RA5_01_1236.d 1.14E6 5 5 565 579
K.TVEEDHAIPEDVDNAYK(+14.02).N Y 87.58 1957.8905 17 -14.0 653.6283 3 65.12 6 34212 VEV_3_3_RA6_01_1237.d 1.69E6 6 6 492 508 Methylation(KR)
K.LSAIESLAGVE(+14.02)ILC(+57.02)SDKTGTLTK.N Y 87.20 2419.2878 23 -6.5 1210.6433 2 83.93 5 48517 VEV_2_3_RA5_01_1236.d 5.72E5 7 7 372 394 Methylation(others); Carbamidomethylation
K.SVLTQYKVLEFHPFDPVSKK.V Y 86.93 2361.2732 20 -18.2 591.3148 4 77.75 5 44544 VEV_2_3_RA5_01_1236.d 1.19E6 6 6 447 466
K.TVEED(+14.02)HAIPEDVDNAYKNK.V Y 86.91 2200.0283 19 -9.6 734.3430 3 62.94 5 33740 VEV_2_3_RA5_01_1236.d 1.87E6 7 7 492 510 Methylation(others)
K.TVE(+14.02)EDHAIPEDVDNAYK.N Y 86.20 1957.8905 17 -9.9 979.9429 2 64.74 6 33915 VEV_3_3_RA6_01_1237.d 6.31E5 5 5 492 508 Methylation(others)
K.KGIDAIDKAFLK.S Y 85.43 1317.7656 12 -12.0 659.8822 2 66.74 5 36636 VEV_2_3_RA5_01_1236.d 8.06E5 6 6 426 437
K.ADTGIAVEGASDAAR(+14.02).S Y 85.09 1416.6844 15 -11.7 709.3412 2 59.97 5 31523 VEV_2_3_RA5_01_1236.d 2.65E6 6 6 654 668 Methylation(KR)
K.ADTGIAVE(+14.02)GASDAAR.S Y 84.36 1416.6844 15 -14.1 709.3395 2 60.37 6 30704 VEV_3_3_RA6_01_1237.d 2.52E6 5 5 654 668 Methylation(others)
K.KADTGIAVE(+14.02)GASDAAR.S Y 84.31 1544.7794 16 -13.5 773.3865 2 50.00 5 25225 VEV_2_3_RA5_01_1236.d 3.41E6 7 7 653 668 Methylation(others)
K.TVEEDHAIPEDVDNAY(-18.01)K(+14.02)NKVAEFATR.G Y 83.99 2956.4202 26 -0.1 740.1122 4 72.09 5 40529 VEV_2_3_RA5_01_1236.d 7.3E4 4 4 492 517 Dehydration; Methylation(KR)
K.TVEEDHAIPEDVD(+14.02)NAYK.N Y 83.86 1957.8905 17 -11.6 979.9412 2 65.19 6 34269 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 492 508 Methylation(others)
K.Q(-17.03)RSLEDFVVSLQR.V Y 83.44 1558.8103 13 -11.1 780.4038 2 84.03 5 48598 VEV_2_3_RA5_01_1236.d 6.3E5 6 6 908 920 Pyro-glu from Q
K.K(+14.02)ADTGIAVEGASDAAR.S Y 83.19 1544.7794 16 -12.4 515.9274 3 47.30 6 22727 VEV_3_3_RA6_01_1237.d 8.75E5 5 5 653 668 Methylation(KR)
K.AVVLRN(+.98)GRLTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 82.94 3812.0320 36 -9.9 954.0058 4 85.81 5 49627 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 189 224 Deamidation (NQ)
R.RGLMDQEVLSR.R Y 82.57 1302.6714 11 7.9 435.2345 3 62.11 5 33120 VEV_2_3_RA5_01_1236.d 2.01E6 9 9 95 105
R.SAADIVFLAPGLSAIIDALK(+14.02).T Y 81.95 1998.1400 20 -14.6 667.0443 3 97.77 6 54603 VEV_3_3_RA6_01_1237.d 2.5E5 6 6 669 688 Methylation(KR)
R.QLGLGTNVYN(+.98)AER.L Y 81.93 1434.7103 13 2.7 718.3644 2 66.80 5 36624 VEV_2_3_RA5_01_1236.d 1.45E6 4 4 580 592 Deamidation (NQ)
K.GAPLFVLKTVEEDHAIPEDVDNAYKNK.V Y 81.33 3011.5239 27 -13.4 1004.8351 3 78.32 5 44937 VEV_2_3_RA5_01_1236.d 2.32E4 1 1 484 510
K.TVEEDHAIPEDVDNAYKNKVAEFATR(+14.02).G Y 81.21 2974.4307 26 -7.8 992.4764 3 72.59 5 40895 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 492 517 Methylation(KR)
K.KADTGIAVEGASDAAR(+14.02).S Y 81.16 1544.7794 16 -14.1 515.9265 3 50.90 6 24840 VEV_3_3_RA6_01_1237.d 5.49E6 20 20 653 668 Methylation(KR)
K.TVEE(+14.02)DHAIPEDVDNAYKNK.V Y 81.05 2200.0283 19 -14.0 551.0067 4 62.99 5 33772 VEV_2_3_RA5_01_1236.d 2.65E5 2 2 492 510 Methylation(others)
K.GIDAIDKAFLK(+14.02).S Y 80.70 1203.6863 11 -16.2 602.8406 2 75.08 5 42677 VEV_2_3_RA5_01_1236.d 1.14E6 5 5 427 437 Methylation(KR)
R.N(+.98)GRLTEVEAPEVVPGDILQVEEGTIIPADGR(+14.02).I Y 80.57 3287.6885 31 -9.5 1096.8931 3 88.14 5 50917 VEV_2_3_RA5_01_1236.d 5.19E5 4 4 194 224 Deamidation (NQ); Methylation(KR)
K.TVEEDHAIPE(+14.02)DVDNAYKNK.V Y 80.30 2200.0283 19 -10.6 551.0085 4 61.76 4 32807 VEV_1_3_RA4_01_1235.d 2.58E6 6 6 492 510 Methylation(others)
R.Q(+.98)LGLGTNVYNAER.L Y 80.05 1434.7103 13 -15.7 718.3512 2 68.31 6 36647 VEV_3_3_RA6_01_1237.d 1.14E6 4 4 580 592 Deamidation (NQ)
R.GQHIPPN(+.98)HLGTSVPSGAFPGKPTESVPEEK(+14.02).K Y 79.75 3108.5515 30 -6.9 622.7133 5 68.62 5 37991 VEV_2_3_RA5_01_1236.d 2.16E6 5 5 11 40 Deamidation (NQ); Methylation(KR)
R.GLM(+15.99)DQEVLSR.R Y 79.27 1162.5652 10 -9.8 582.2842 2 57.11 4 29383 VEV_1_3_RA4_01_1235.d 5.23E6 31 31 96 105 Oxidation (M)
K.R(+14.02)GEAFMVITSTGDNTFVGR.A Y 79.18 2071.0156 19 -16.4 691.3345 3 78.63 6 44174 VEV_3_3_RA6_01_1237.d 5.68E5 6 6 262 280 Methylation(KR)
K.QRSLEDFVVSLQR.V Y 79.04 1575.8369 13 -1.1 394.9661 4 78.05 4 45522 VEV_1_3_RA4_01_1235.d 3.97E5 5 5 908 920
R.SLEDFVVSLQ(+.98)R.V Y 78.98 1292.6611 11 -12.5 647.3298 2 85.00 6 48491 VEV_3_3_RA6_01_1237.d 1.95E6 9 9 910 920 Deamidation (NQ)
K.VLEFHPFDPVSK(+14.02).K Y 78.77 1427.7449 12 -11.2 714.8717 2 75.39 5 42865 VEV_2_3_RA5_01_1236.d 1.03E6 4 4 454 465 Methylation(KR)
R.SAADIVFLAPGLSAIIDALKTSR(+14.02).Q Y 78.70 2342.3208 23 -20.8 781.7646 3 96.55 6 54182 VEV_3_3_RA6_01_1237.d 3.12E5 3 3 669 691 Methylation(KR)
R.AKSVLTQYK.V Y 78.66 1036.5917 9 -11.4 519.2972 2 29.95 5 13232 VEV_2_3_RA5_01_1236.d 2.62E6 8 8 445 453
R.GQHIPPNHLGTS(-2.02)VPSGAFPGKPTESVPEEK.K Y 78.06 3091.5361 30 -21.3 619.3013 5 67.08 6 35690 VEV_3_3_RA6_01_1237.d 5.88E4 2 2 11 40 2-amino-3-oxo-butanoic_acid
K.TVEEDHAIPEDVD(+14.02)NAYKNK.V Y 77.75 2200.0283 19 -24.8 551.0007 4 63.40 5 34085 VEV_2_3_RA5_01_1236.d 8.56E5 6 6 492 510 Methylation(others)
K.GDTC(+57.02)YASSAVKR.G Y 76.91 1313.6034 12 -12.7 657.8007 2 26.39 5 11298 VEV_2_3_RA5_01_1236.d 7.9E4 2 2 251 262 Carbamidomethylation
R.LGLGGGGTMPGSEVYDFVE(+14.02)AADGFAEVFPQHK.Y Y 76.19 3295.5496 32 -1.7 1099.5220 3 93.78 4 55718 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 593 624 Methylation(others)
K.LSAIESLAGVEILC(+57.02)SDK(+14.02).T Y 76.18 1817.9445 17 -12.2 909.9684 2 84.73 6 48305 VEV_3_3_RA6_01_1237.d 3.01E5 4 4 372 388 Carbamidomethylation; Methylation(KR)
R.GLMDQEVLSR.R Y 75.84 1146.5703 10 -9.4 574.2870 2 68.48 4 38054 VEV_1_3_RA4_01_1235.d 4.65E6 14 14 96 105
R.IVTEDAFLQ(+.98)VDQ(+.98)SAITGESLAVDKHK.G Y 75.46 2815.4126 26 2.9 704.8625 4 79.11 5 45461 VEV_2_3_RA5_01_1236.d 6.58E4 1 1 225 250 Deamidation (NQ)
K.TVEEDHAIPED(+14.02)VDNAYK.N Y 75.39 1957.8905 17 -7.8 653.6323 3 65.51 5 35727 VEV_2_3_RA5_01_1236.d 3.69E5 1 1 492 508 Methylation(others)
R.SLEDFVVSLQ(+.98)R(+14.02).V Y 75.28 1306.6769 11 -11.2 654.3384 2 89.55 5 51663 VEV_2_3_RA5_01_1236.d 5.67E5 5 5 910 920 Deamidation (NQ); Methylation(KR)
R.IVTE(+14.02)DAFLQVDQSAITGESLAVDK.H Y 75.25 2562.3064 24 -9.4 1282.1484 2 86.39 6 49307 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 225 248 Methylation(others)
R.Q(-17.03)LGLGTNVYN(+.98)AER.L Y 75.04 1417.6837 13 -8.1 709.8434 2 79.65 5 45825 VEV_2_3_RA5_01_1236.d 1.88E5 2 2 580 592 Pyro-glu from Q; Deamidation (NQ)
R.NGRLTEVEAPEVVPGDILQVEEGTIIPADGR(+14.02).I Y 74.99 3286.7043 31 -8.5 1096.5660 3 85.26 5 49319 VEV_2_3_RA5_01_1236.d 3.13E4 1 1 194 224 Methylation(KR)
K.T(+14.02)VEEDHAIPEDVDNAYKNKVAEFATR.G Y 74.97 2974.4307 26 -11.1 992.4732 3 73.03 5 41197 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 492 517 Methylation(others)
K.AD(+14.02)TGIAVEGASDAAR.S Y 74.90 1416.6844 15 -11.0 709.3417 2 58.28 5 30328 VEV_2_3_RA5_01_1236.d 4.05E5 3 3 654 668 Methylation(others)
K.MLTGDAVGIAR(+14.02).E Y 74.56 1116.5961 11 -13.6 559.2977 2 66.87 5 36710 VEV_2_3_RA5_01_1236.d 1.5E6 3 3 565 575 Methylation(KR)
R.Q(-17.03)LGLGTN(+.98)VYNAER.L Y 74.13 1417.6837 13 -15.7 709.8380 2 79.83 6 45065 VEV_3_3_RA6_01_1237.d 4.24E5 2 2 580 592 Pyro-glu from Q; Deamidation (NQ)
R.GYLVAMTGDGVNDAPSLK(+14.02)K.A Y 74.04 1948.9928 19 -13.4 650.6628 3 71.88 5 40372 VEV_2_3_RA5_01_1236.d 6.86E4 1 1 635 653 Methylation(KR)
K.HKGDTC(+57.02)YASSAVKR.G Y 73.95 1578.7572 14 -14.6 527.2520 3 16.85 5 6019 VEV_2_3_RA5_01_1236.d 2.62E5 4 4 249 262 Carbamidomethylation
K.N(+.98)KLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+14.02).K Y 72.94 3164.5190 29 -3.4 1055.8434 3 87.64 5 50648 VEV_2_3_RA5_01_1236.d 1.04E4 1 1 395 423 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
R.IVTEDAFLQVDQSAITGE(+14.02)SLAVDK.H Y 72.83 2562.3064 24 -3.7 1282.1558 2 86.63 5 50096 VEV_2_3_RA5_01_1236.d 4.41E4 1 1 225 248 Methylation(others)
K.Q(-17.03)RSLEDFVVSLQRVSTQHEKST Y 72.71 2556.2932 22 -8.8 640.0750 4 81.66 5 47129 VEV_2_3_RA5_01_1236.d 4.92E5 4 4 908 929 Pyro-glu from Q
K.K(+43.01)(+14.02)ADTGIAVEGASDAAR.S Y 72.51 1587.7852 16 -10.9 794.8912 2 44.09 5 21576 VEV_2_3_RA5_01_1236.d 7.1E5 8 8 653 668 Carbamylation; Methylation(KR)
R.QLGLGTNVYNAER(+14.02).L Y 72.17 1447.7419 13 -13.3 724.8687 2 71.18 5 39860 VEV_2_3_RA5_01_1236.d 1.87E6 8 8 580 592 Methylation(KR)
R.NGRLTEVEAPEVVPGDILQVEE(+14.02)GTIIPADGR.I Y 72.13 3286.7043 31 -10.7 1096.5637 3 86.48 6 49358 VEV_3_3_RA6_01_1237.d 9.44E4 1 1 194 224 Methylation(others)
R.SLE(+14.02)DFVVSLQR.V Y 71.83 1305.6929 11 -13.6 653.8448 2 85.05 6 48492 VEV_3_3_RA6_01_1237.d 2.31E6 10 10 910 920 Methylation(others)
K.VSAVVISPQGER(+14.02).I Y 71.43 1254.6931 12 -10.2 628.3474 2 63.38 5 34127 VEV_2_3_RA5_01_1236.d 1.74E6 7 7 467 478 Methylation(KR)
R.ETSRQLGLGTNVYNAER(+14.02).L Y 71.25 1920.9653 17 -10.6 641.3223 3 64.06 5 34571 VEV_2_3_RA5_01_1236.d 3.9E5 4 4 576 592 Methylation(KR)
R.LTEVE(+28.03)APEVVPGDILQVEEGTIIPADGR.I Y 71.20 2973.5544 28 -9.1 992.1831 3 90.07 5 51914 VEV_2_3_RA5_01_1236.d 5.51E5 4 4 197 224 Ethylation
R.GQHIPPNHLGTSVPSGAFPGKPTES(+14.02)VPEEK.K Y 71.19 3107.5676 30 -11.0 777.8906 4 67.62 5 37238 VEV_2_3_RA5_01_1236.d 1.17E6 1 1 11 40 Methylation(others)
R.GYLVAMTGDGVN(+.98)DAPSLKK.A Y 70.98 1935.9612 19 -11.9 646.3200 3 72.61 5 40911 VEV_2_3_RA5_01_1236.d 4.54E4 2 2 635 653 Deamidation (NQ)
K.TVEE(+14.02)DHAIPEDVDNAYK.N Y 70.26 1957.8905 17 -6.4 979.9463 2 66.03 5 36055 VEV_2_3_RA5_01_1236.d 2.56E5 3 3 492 508 Methylation(others)
K.TVEEDHAIPE(+14.02)DVDNAYK.N Y 70.07 1957.8905 17 -7.6 979.9451 2 65.45 4 35631 VEV_1_3_RA4_01_1235.d 1.06E6 3 3 492 508 Methylation(others)
K.YNVVEILQQR(+14.02).G Y 69.92 1274.6982 10 -9.0 425.9029 3 79.11 4 46334 VEV_1_3_RA4_01_1235.d 8.44E4 1 1 625 634 Methylation(KR)
R.GYLVAMTGD(-18.01)GVNDAPSLK.K Y 69.91 1788.8716 18 -9.4 895.4347 2 77.82 5 44598 VEV_2_3_RA5_01_1236.d 1.62E5 3 3 635 652 Dehydration
R.GLMDQEVLSRR.K Y 69.49 1302.6714 11 -11.9 652.3352 2 63.49 5 34171 VEV_2_3_RA5_01_1236.d 2.59E6 6 6 96 106
R.S(-2.02)AADIVFLAPGLSAIIDALKTSR.Q Y 69.06 2326.2896 23 -46.8 776.4008 3 95.80 5 54561 VEV_2_3_RA5_01_1236.d 0 3 3 669 691 2-amino-3-oxo-butanoic_acid
K.VLEFHPFD(+14.02)PVSK.K Y 68.58 1427.7449 12 -10.4 476.9173 3 76.84 4 44566 VEV_1_3_RA4_01_1235.d 9.38E5 3 3 454 465 Methylation(others)
R.LTEVEAPEVVPGD(+21.98)ILQ(+.98)VEEGTIIPADGR.I Y 68.41 2968.4893 28 -16.4 990.4874 3 89.28 6 50937 VEV_3_3_RA6_01_1237.d 2.74E5 2 2 197 224 Sodium adduct; Deamidation (NQ)
R.ETSR(+14.02)QLGLGTNVYNAER.L Y 68.38 1920.9653 17 -7.7 641.3241 3 63.14 5 33940 VEV_2_3_RA5_01_1236.d 1.73E5 2 2 576 592 Methylation(KR)
R.LTEVEAPE(+28.03)VVPGDILQVEEGTIIPADGR.I Y 68.35 2973.5544 28 -7.4 1487.7736 2 90.07 5 51917 VEV_2_3_RA5_01_1236.d 7.02E5 5 5 197 224 Ethylation
R.QLGLGTN(+.98)VYNAER.L Y 68.23 1434.7103 13 -6.6 718.3577 2 68.98 4 38420 VEV_1_3_RA4_01_1235.d 1.14E6 3 3 580 592 Deamidation (NQ)
K.NKLSLAEPY(-2.02)C(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 68.11 3147.5039 29 7.5 1050.1831 3 86.71 5 50143 VEV_2_3_RA5_01_1236.d 4.74E4 2 2 395 423 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.GQHIPPN(+.98)HLGTS(-18.01)VPSGAFPGKPTESVPEEK.K Y 68.02 3076.5254 30 -7.8 616.3076 5 65.19 6 34267 VEV_3_3_RA6_01_1237.d 0 1 1 11 40 Deamidation (NQ); Dehydration
K.LSAIESLAGVEILC(+57.02)SDKTGTLTK(+14.02).N Y 67.73 2419.2878 23 -10.7 807.4279 3 82.51 5 47652 VEV_2_3_RA5_01_1236.d 2.5E5 3 3 372 394 Carbamidomethylation; Methylation(KR)
R.SLED(+14.02)FVVSLQR.V Y 67.70 1305.6929 11 -10.8 436.2336 3 80.94 5 46686 VEV_2_3_RA5_01_1236.d 4.46E5 4 4 910 920 Methylation(others)
K.KVSAVVISPQGER(+14.02).I Y 67.26 1382.7881 13 -19.4 692.3879 2 54.50 5 27955 VEV_2_3_RA5_01_1236.d 2.13E6 19 19 466 478 Methylation(KR)
R.N(+.98)GR(+14.02)LTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 67.16 3287.6885 31 -4.3 1096.8987 3 88.91 6 50738 VEV_3_3_RA6_01_1237.d 9.78E4 2 2 194 224 Deamidation (NQ); Methylation(KR)
R.QLGLGTNVYNAER(+28.03).L Y 66.74 1461.7576 13 -15.1 731.8750 2 73.36 6 40350 VEV_3_3_RA6_01_1237.d 1.5E5 3 3 580 592 Dimethylation(KR)
K.KVSAVVISPQ(+.98)GER.I Y 66.68 1369.7565 13 -9.9 685.8787 2 51.74 4 25988 VEV_1_3_RA4_01_1235.d 1.59E6 11 11 466 478 Deamidation (NQ)
K.TVEEDHAIPEDVDNAYKNKVAE(+14.02)FATR.G Y 66.41 2974.4307 26 17.0 744.6276 4 72.50 5 40835 VEV_2_3_RA5_01_1236.d 0 1 1 492 517 Methylation(others)
R.RGLM(+15.99)DQEVLSR.R Y 66.40 1318.6663 11 -16.0 440.5557 3 47.29 6 22811 VEV_3_3_RA6_01_1237.d 1.71E6 11 11 95 105 Oxidation (M)
K.NKVAEFATR.G Y 66.30 1034.5509 9 -6.7 345.8553 3 31.32 4 13610 VEV_1_3_RA4_01_1235.d 1.47E6 9 9 509 517
R.SLEDFVVSLQRVSTQHEKST Y 66.05 2289.1602 20 -1.9 764.0592 3 80.63 5 46461 VEV_2_3_RA5_01_1236.d 4.75E5 2 2 910 929
R.SAADIVFLAPGLSAIIDALK(+14.02)TSR.Q Y 65.97 2342.3208 23 -6.1 1172.1605 2 96.41 5 54796 VEV_2_3_RA5_01_1236.d 1.08E5 3 3 669 691 Methylation(KR)
R.IVTEDAFLQVD(+14.02)QSAITGESLAVDK.H Y 65.82 2562.3064 24 -6.5 1282.1521 2 88.43 6 50477 VEV_3_3_RA6_01_1237.d 0 1 1 225 248 Methylation(others)
K.TVEEDHAIPEDVDNAYK(+14.02)NK.V Y 65.75 2200.0283 19 -12.4 734.3409 3 62.47 6 32243 VEV_3_3_RA6_01_1237.d 7.39E4 1 1 492 510 Methylation(KR)
K.TVEED(+14.02)HAIPEDVDNAYK.N Y 65.62 1957.8905 17 -5.4 653.6339 3 66.13 4 36165 VEV_1_3_RA4_01_1235.d 0 1 1 492 508 Methylation(others)
R.LGLGGGGTMPGSEVYDFVEAAD(+14.02)GFAEVFPQHK.Y Y 65.52 3295.5496 32 0.7 1099.5245 3 95.27 5 54345 VEV_2_3_RA5_01_1236.d 1.52E5 2 2 593 624 Methylation(others)
R.GLM(+15.99)DQEVLSRR.K Y 65.10 1318.6663 11 -14.9 440.5562 3 48.97 5 24545 VEV_2_3_RA5_01_1236.d 1.08E6 4 4 96 106 Oxidation (M)
R.NGRLTEVEAPEVVPGDILQ(+.98)VEEGTIIPADGR.I Y 64.69 3273.6729 31 -8.8 1092.2219 3 85.49 6 48767 VEV_3_3_RA6_01_1237.d 6.79E4 1 1 194 224 Deamidation (NQ)
R.GLMDQ(+.98)EVLSR.R Y 64.68 1147.5543 10 -15.1 574.7758 2 70.14 6 37994 VEV_3_3_RA6_01_1237.d 7.74E5 5 5 96 105 Deamidation (NQ)
R.LGLGGGGTMPGSEVYDFVEAADGFAEVFPQ(+.98)HK.Y Y 64.23 3282.5178 32 13.0 1095.1941 3 93.16 4 55380 VEV_1_3_RA4_01_1235.d 2.93E5 1 1 593 624 Deamidation (NQ)
K.VLE(+14.02)FHPFDPVSK.K Y 64.08 1427.7449 12 -11.9 476.9166 3 76.16 5 43409 VEV_2_3_RA5_01_1236.d 1.26E6 6 6 454 465 Methylation(others)
R.GEGSWEILGIMPC(+57.02)SDPPRHDTAK.T Y 63.78 2552.1787 23 -6.1 851.7283 3 77.10 5 44091 VEV_2_3_RA5_01_1236.d 5.7E4 1 1 529 551 Carbamidomethylation
K.GIDAIDKAFLKSLKYYPR.A Y 63.61 2097.1621 18 -21.3 420.4308 5 79.35 6 44692 VEV_3_3_RA6_01_1237.d 1.57E5 3 3 427 444
R.GYLVAM(+15.99)TGDGVN(+.98)DAPSLK.K Y 63.31 1823.8611 18 2.3 912.9399 2 71.53 4 40425 VEV_1_3_RA4_01_1235.d 2.68E5 1 1 635 652 Oxidation (M); Deamidation (NQ)
R.IVTE(+14.02)DAFLQVDQSAITGESLAVDKHK.G Y 63.17 2827.4602 26 -5.7 707.8683 4 80.87 5 46623 VEV_2_3_RA5_01_1236.d 7.8E4 1 1 225 250 Methylation(others)
R.SAADIVFLAPGLSAIIDALK(+43.01)TSR(+14.02).Q Y 63.16 2385.3267 23 -6.2 796.1113 3 95.69 5 54514 VEV_2_3_RA5_01_1236.d 5.17E4 1 1 669 691 Carbamylation; Methylation(KR)
K.TVEEDH(+14.02)AIPEDVDNAYKNK.V Y 62.85 2200.0283 19 -9.4 734.3431 3 63.11 4 33845 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 492 510 Methylation(others)
K.TVEEDHAIPEDVDN(+.98)AYKNK.V Y 62.30 2186.9968 19 -6.1 547.7532 4 61.16 5 32408 VEV_2_3_RA5_01_1236.d 5.17E5 3 3 492 510 Deamidation (NQ)
R.KRGEGSWEILGIMPC(+57.02)SDPPR.H Y 62.28 2284.1091 20 -3.4 572.0326 4 77.02 6 43022 VEV_3_3_RA6_01_1237.d 6.16E4 2 2 527 546 Carbamidomethylation
R.ETSRQLGLGTN(+.98)VYNAER.L Y 62.19 1907.9337 17 -8.4 636.9799 3 64.07 6 33420 VEV_3_3_RA6_01_1237.d 4.88E5 2 2 576 592 Deamidation (NQ)
K.VSAVVISPQGER(+14.02)ITC(+57.02)VK.G Y 61.77 1856.0189 17 -1.9 619.6791 3 70.07 5 39042 VEV_2_3_RA5_01_1236.d 1.4E5 4 4 467 483 Methylation(KR); Carbamidomethylation
K.VSAVVISPQ(+.98)GER.I Y 61.59 1241.6615 12 -10.3 621.8316 2 60.37 5 31820 VEV_2_3_RA5_01_1236.d 2.77E5 1 1 467 478 Deamidation (NQ)
R.K(+14.02)RGEGSWEILGIMPC(+57.02)SDPPRHDTAK.T Y 61.15 2850.3904 25 -8.0 571.0808 5 70.84 5 39625 VEV_2_3_RA5_01_1236.d 2.73E5 1 1 527 551 Methylation(KR); Carbamidomethylation
R.GYLVAM(+15.99)TGDGVNDAPSLK(+14.02).K Y 60.69 1836.8927 18 -7.3 919.4469 2 74.29 4 42583 VEV_1_3_RA4_01_1235.d 2.86E5 3 3 635 652 Oxidation (M); Methylation(KR)
R.LGLGGGGTMPGSEVYDFVEAADGFAE(+14.02)VFPQHK.Y Y 60.59 3295.5496 32 -6.5 1099.5166 3 93.28 4 55446 VEV_1_3_RA4_01_1235.d 3.82E5 3 3 593 624 Methylation(others)
R.LGLGGGGT(+14.02)MPGSEVYDFVEAADGFAEVFPQHK.Y Y 60.56 3295.5496 32 -12.3 1099.5103 3 91.24 6 51946 VEV_3_3_RA6_01_1237.d 5.88E4 1 1 593 624 Methylation(others)
R.N(-17.03)GRLTEVEAPEVVPGDILQVEEGTIIPADGR.I Y 60.56 3255.6621 31 -7.8 1086.2195 3 85.45 6 48739 VEV_3_3_RA6_01_1237.d 6.1E4 1 1 194 224 Ammonia-loss (N)
K.TVEEDHAIPEDVDNAYKN(+.98)K.V Y 59.85 2186.9968 19 -15.4 547.7480 4 60.71 6 30959 VEV_3_3_RA6_01_1237.d 3.57E5 5 5 492 510 Deamidation (NQ)
K.LSAIE(+14.02)SLAGVEILC(+57.02)SDKTGTLTK.N Y 59.72 2419.2878 23 -4.7 807.4328 3 83.12 4 49305 VEV_1_3_RA4_01_1235.d 9.92E4 2 2 372 394 Methylation(others); Carbamidomethylation
K.SLKYYPR.A Y 59.53 925.5021 7 -16.6 463.7506 2 33.13 6 14597 VEV_3_3_RA6_01_1237.d 1.3E7 27 27 438 444
R.GEAFM(+15.99)VITSTGDNTFVGR.A Y 58.81 1916.8938 18 0.8 639.9724 3 78.02 6 43784 VEV_3_3_RA6_01_1237.d 2.49E4 2 2 263 280 Oxidation (M)
K.SVLTQYK.V Y 58.67 837.4596 7 -14.5 419.7310 2 42.52 5 20624 VEV_2_3_RA5_01_1236.d 9.68E6 11 11 447 453
R.GYLVAMTGDGVND(+14.02)APSLKK.A Y 58.66 1948.9928 19 -10.6 650.6647 3 73.79 5 41732 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 635 653 Methylation(others)
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLT(+59.02)AC(+57.02)LAASR.K Y 58.47 3208.5388 29 -10.8 803.1333 4 81.50 6 46209 VEV_3_3_RA6_01_1237.d 8.88E4 1 1 395 423 Carbamidomethylation; Aminoethylcysteine
K.T(+14.02)VEEDHAIPEDVDNAYKNK.V Y 58.42 2200.0283 19 -35.1 550.9951 4 62.17 4 33123 VEV_1_3_RA4_01_1235.d 0 1 1 492 510 Methylation(others)
K.VLE(+14.02)FHPFDPVSKK.V Y 58.15 1555.8398 13 -7.6 519.6166 3 70.26 5 39209 VEV_2_3_RA5_01_1236.d 3.79E5 4 4 454 466 Methylation(others)
R.LTEVEAPEVVPGDILQVEEGTIIPAD(-18.01)GR.I Y 57.50 2927.5127 28 -2.7 976.8422 3 88.61 5 51175 VEV_2_3_RA5_01_1236.d 0 1 1 197 224 Dehydration
K.NK(-1.03)LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASRK.K Y 57.46 3276.5828 30 11.2 1093.2137 3 84.15 4 50018 VEV_1_3_RA4_01_1235.d 3.49E4 1 1 395 424 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
R.N(+.98)GR(+14.02)LTEVEAPEVVPGDILQ(+.98)VEEGTIIPADGR.I Y 57.36 3288.6724 31 1.2 1097.2327 3 88.78 5 51270 VEV_2_3_RA5_01_1236.d 9.6E4 3 3 194 224 Deamidation (NQ); Methylation(KR)
K.R(+14.02)GEAFMVITSTGDN(+.98)TFVGR.A Y 57.34 2071.9998 19 -0.3 691.6736 3 78.69 4 46007 VEV_1_3_RA4_01_1235.d 7.64E3 1 1 262 280 Methylation(KR); Deamidation (NQ)
K.TVEEDHAIPEDVDNAYKN(+.98)KVAEFATR.G Y 57.23 2961.3992 26 -10.2 741.3495 4 73.42 5 41470 VEV_2_3_RA5_01_1236.d 2.74E5 2 2 492 517 Deamidation (NQ)
K.KADTGIAVEGASD(+14.02)AAR.S Y 56.62 1544.7794 16 -14.5 515.9263 3 49.71 5 24978 VEV_2_3_RA5_01_1236.d 0 1 1 653 668 Methylation(others)
K.QRSLEDFVVSLQRVSTQHEKST Y 56.45 2573.3198 22 -27.9 515.6569 5 76.90 5 43949 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 908 929
K.NK(+14.02)LSLAEPYC(+57.02)VAGVDPDDLM(+15.99)LTAC(+57.02)LAASR.K Y 55.81 3179.5300 29 -9.6 1060.8405 3 85.21 6 48594 VEV_3_3_RA6_01_1237.d 1.03E5 2 2 395 423 Methylation(KR); Carbamidomethylation; Oxidation (M)
K.LSAIE(+14.02)SLAGVEILC(+57.02)SDK.T Y 55.34 1817.9445 17 -10.0 909.9705 2 85.32 5 49354 VEV_2_3_RA5_01_1236.d 1.87E5 2 2 372 388 Methylation(others); Carbamidomethylation
R.GLMDQE(+14.02)VLSR.R Y 55.18 1160.5859 10 -13.4 581.2925 2 72.79 5 41057 VEV_2_3_RA5_01_1236.d 1.56E6 6 6 96 105 Methylation(others)
K.NK(+14.02)LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 54.71 3163.5352 29 -4.1 1055.5146 3 88.10 5 50888 VEV_2_3_RA5_01_1236.d 1.68E5 1 1 395 423 Methylation(KR); Carbamidomethylation
K.VAEFATR.G Y 54.67 792.4130 7 -16.0 397.2074 2 31.21 5 13967 VEV_2_3_RA5_01_1236.d 1.33E7 18 18 511 517
K.YNVVEILQ(+.98)QR.G Y 54.57 1261.6666 10 -20.8 421.5541 3 79.63 4 46740 VEV_1_3_RA4_01_1235.d 2.26E5 4 4 625 634 Deamidation (NQ)
R.LGLGGGGTMPGSEVYDFVEAADGFAEVFPQHK(+14.02).Y Y 54.54 3295.5496 32 -6.3 1099.5168 3 92.04 4 54799 VEV_1_3_RA4_01_1235.d 1.74E4 1 1 593 624 Methylation(KR)
K.GDTC(+57.02)YASSAVKRGEAFMVITSTGDNTFVGR.A Y 54.45 3196.4917 30 -37.4 800.1003 4 79.45 6 44770 VEV_3_3_RA6_01_1237.d 0 1 1 251 280 Carbamidomethylation
K.AIVQKLSAIES(-2.02)LAGVEILC(+57.02)SDKTGTLTK.N Y 54.18 2942.5999 28 -30.5 981.8439 3 84.16 5 48669 VEV_2_3_RA5_01_1236.d 7E3 1 1 367 394 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.RGLMDQEVLSR(+14.02).R Y 54.04 1316.6870 11 -11.0 439.8981 3 65.17 4 35412 VEV_1_3_RA4_01_1235.d 3.29E5 3 3 95 105 Methylation(KR)
K.LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+.98).K Y 53.99 2908.3657 27 -1.6 970.4609 3 90.96 5 52379 VEV_2_3_RA5_01_1236.d 4.72E5 2 2 397 423 Carbamidomethylation; Deamidation (R)
R.GEGSWEILGIMPC(+57.02)SDPPR.H Y 53.68 1999.9131 18 28.6 1000.9924 2 84.39 4 50235 VEV_1_3_RA4_01_1235.d 1.02E5 3 3 529 546 Carbamidomethylation
K.YGLNQMKEEKENLILK.F Y 53.62 1949.0292 16 -14.1 488.2577 4 67.02 4 36861 VEV_1_3_RA4_01_1235.d 5.33E5 3 3 109 124
R.LTEVEAPEVVPGDILQVE(+28.03)EGTIIPADGR.I Y 53.46 2973.5544 28 -3.6 992.1885 3 94.67 4 56135 VEV_1_3_RA4_01_1235.d 1.32E6 9 9 197 224 Ethylation
K.GAPLFVLK.T Y 53.40 843.5218 8 -14.6 422.7620 2 72.59 5 40931 VEV_2_3_RA5_01_1236.d 1.15E7 12 12 484 491
K.Q(-17.03)R(+14.02)SLEDFVVSLQR.V Y 53.19 1572.8259 13 -8.1 525.2783 3 86.40 4 51502 VEV_1_3_RA4_01_1235.d 2.25E5 4 4 908 920 Pyro-glu from Q; Methylation(KR)
R.LTEVEAPEVVPGDILQVEEGTIIPADGR(+28.03).I Y 52.67 2973.5544 28 -20.2 1487.7544 2 92.65 6 52600 VEV_3_3_RA6_01_1237.d 2.81E4 1 1 197 224 Dimethylation(KR)
R.GLMDQEVLSR(+14.02).R Y 52.67 1160.5859 10 -11.5 581.2936 2 71.50 5 40091 VEV_2_3_RA5_01_1236.d 1.5E6 6 6 96 105 Methylation(KR)
K.YGLNQMK.E Y 52.64 852.4164 7 -8.6 427.2118 2 42.68 4 20336 VEV_1_3_RA4_01_1235.d 1.11E6 7 7 109 115
K.M(+15.99)LTGDAVGIAR(+14.02).E Y 52.44 1132.5911 11 -15.4 567.2941 2 62.40 4 33289 VEV_1_3_RA4_01_1235.d 8.81E5 3 3 565 575 Oxidation (M); Methylation(KR)
K.V(+41.03)LEFHPFDPVSK.K Y 52.40 1454.7557 12 -43.1 485.9050 3 75.10 6 41613 VEV_3_3_RA6_01_1237.d 5.36E4 1 1 454 465 Amidination of lysines or N-terminal amines with methyl acetimidate
R.LGLGGGGTMPGS(+14.02)EVYDFVEAADGFAEVFPQHK.Y Y 52.27 3295.5496 32 -1.9 1099.5217 3 95.06 4 56311 VEV_1_3_RA4_01_1235.d 1.76E5 2 2 593 624 Methylation(others)
R.N(+.98)GRLTEVEAPEVVPGD(+21.98)ILQVEEGTIIPADGR.I Y 52.07 3295.6548 31 -25.4 824.9000 4 88.93 5 51344 VEV_2_3_RA5_01_1236.d 1.63E4 1 1 194 224 Deamidation (NQ); Sodium adduct
R.GLM(+15.99)DQEVLSR(+14.02).R Y 51.92 1176.5808 10 6.5 589.3015 2 61.72 6 31695 VEV_3_3_RA6_01_1237.d 3.77E5 4 4 96 105 Oxidation (M); Methylation(KR)
R.AKSVLTQYKVLEFHPFDPVSKK.V Y 51.78 2560.4053 22 -17.1 513.0796 5 74.68 5 42363 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 445 466
K.TVEEDHAIPEDVDN(+.98)AYKNKVAEFATR.G Y 51.71 2961.3992 26 32.0 593.3061 5 72.99 6 40083 VEV_3_3_RA6_01_1237.d 0 1 1 492 517 Deamidation (NQ)
R.Q(+.98)LGLGTNVYNAER(+14.02).L Y 51.70 1448.7260 13 -14.0 725.3601 2 73.05 5 41209 VEV_2_3_RA5_01_1236.d 2.8E5 4 4 580 592 Deamidation (NQ); Methylation(KR)
K.TVEEDHAIPED(+14.02)VDNAYKNK.V Y 51.39 2200.0283 19 -8.2 1101.0125 2 61.57 5 32716 VEV_2_3_RA5_01_1236.d 1.08E4 1 1 492 510 Methylation(others)
K.V(+163.05)LEFHPFDPVSKK.V Y 51.26 1704.8698 13 27.6 427.2365 4 69.26 4 38636 VEV_1_3_RA4_01_1235.d 8.41E5 1 1 454 466 Phenethyl isothiocyanate
K.KAD(+14.02)TGIAVEGASDAAR.S Y 51.23 1544.7794 16 -11.0 773.3885 2 47.26 6 22708 VEV_3_3_RA6_01_1237.d 9.4E4 1 1 653 668 Methylation(others)
K.YNVVE(+14.02)ILQQR.G Y 51.16 1274.6982 10 -13.2 425.9011 3 77.15 6 43118 VEV_3_3_RA6_01_1237.d 4.67E5 6 6 625 634 Methylation(others)
R.Q(+.98)LGLGTN(+.98)VYNAER.L Y 51.14 1435.6943 13 -19.7 718.8403 2 70.10 6 37933 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 580 592 Deamidation (NQ)
R.LTEVEAPEVVPGDILQ(+15.00)VEEGTIIPADGR.I Y 51.13 2960.5229 28 -3.2 1481.2640 2 93.27 6 52880 VEV_3_3_RA6_01_1237.d 1.68E5 3 3 197 224 Deamidation followed by a methylation
R.LGLGGGGTM(+15.99)P(+31.99)GSEVYDFVEAADGFAEVFPQHK.Y Y 51.12 3329.5186 32 33.4 833.4147 4 87.69 4 52311 VEV_1_3_RA4_01_1235.d 7.75E4 1 1 593 624 Oxidation (M); Dihydroxy
R.GY(-2.02)LVAMTGDGVNDAPSLKK.A Y 50.95 1932.9614 19 50.2 645.3601 3 71.55 6 39029 VEV_3_3_RA6_01_1237.d 1.59E4 1 1 635 653 2-amino-3-oxo-butanoic_acid
K.TLALKAVVLR.N Y 50.72 1082.7175 10 -16.0 361.9073 3 67.40 5 37089 VEV_2_3_RA5_01_1236.d 3.07E5 3 3 184 193
K.ADTGIAVEGASDAAR(+.98).S Y 50.60 1403.6528 15 0.9 702.8344 2 54.53 5 27917 VEV_2_3_RA5_01_1236.d 1.96E6 2 2 654 668 Deamidation (R)
R.S(+14.02)LEDFVVSLQR.V Y 50.52 1305.6929 11 -18.0 436.2304 3 85.46 6 48747 VEV_3_3_RA6_01_1237.d 3.34E5 1 1 910 920 Methylation(others)
K.GAPLFVLK(+14.02).T Y 50.50 857.5374 8 -14.8 429.7697 2 76.62 5 43766 VEV_2_3_RA5_01_1236.d 8.48E5 3 3 484 491 Methylation(KR)
M.SDSITSGPR.G Y 50.45 918.4407 9 -11.5 460.2224 2 21.81 5 8738 VEV_2_3_RA5_01_1236.d 1.88E6 10 10 2 10
R.GQHIPPNHLGTSVPS(+13.03)GAFPGKPTESVPEEK.K Y 50.24 3106.5835 30 -26.2 622.3077 5 66.01 6 34891 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 11 40 Michael addition with methylamine
K.ADTGIAVEGASDAAR(+28.03).S Y 50.18 1430.7001 15 -5.0 716.3538 2 63.68 5 34298 VEV_2_3_RA5_01_1236.d 2.31E5 2 2 654 668 Dimethylation(KR)
R.LTEVEAPEVVPGD(+21.98)ILQVEEGTIIPADGR.I Y 49.64 2967.5051 28 -18.4 990.1575 3 89.20 6 50900 VEV_3_3_RA6_01_1237.d 4.26E5 2 2 197 224 Sodium adduct
R.NGR(+14.02)LTEVEAPEVVPGDILQVEEGTIIPADGR(+14.02).I Y 49.50 3300.7200 31 -11.6 1101.2345 3 87.32 5 50484 VEV_2_3_RA5_01_1236.d 2.21E5 2 2 194 224 Methylation(KR)
K.KVSAVVISPQ(+.98)GERITC(+57.02)VK.G Y 49.48 1971.0823 18 -2.6 493.7766 4 62.06 5 33090 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 466 483 Deamidation (NQ); Carbamidomethylation
K.T(+164.06)VEEDHAIPEDVDNAYKNK.V Y 49.27 2350.0730 19 -5.6 588.5222 4 58.26 5 30287 VEV_2_3_RA5_01_1236.d 6.18E5 6 6 492 510 O-Diisopropylphosphorylation
K.TVEEDHAIPE(+6.01)DVDNAYKNK.V Y 49.16 2192.0208 19 8.3 731.6869 3 59.84 5 31434 VEV_2_3_RA5_01_1236.d 5.59E4 1 1 492 510 Replacement of proton by lithium
R.ETSRQ(+.98)LGLGTNVYNAER.L Y 49.05 1907.9337 17 -6.2 954.9683 2 63.86 5 34434 VEV_2_3_RA5_01_1236.d 7.21E4 1 1 576 592 Deamidation (NQ)
K.YNVVEILQQ(+.98)R.G Y 48.84 1261.6666 10 -16.3 631.8303 2 78.06 6 43768 VEV_3_3_RA6_01_1237.d 7.64E4 1 1 625 634 Deamidation (NQ)
R.GQHIPPNHLGTSVPSGAFPGK(-1.03)PTESVPEEKK.Q Y 48.49 3220.6152 31 -1.6 645.1293 5 62.94 5 33736 VEV_2_3_RA5_01_1236.d 0 1 1 11 41 Lysine oxidation to aminoadipic semialdehyde
R.SAADIVFLAPGLSAIID(+14.02)ALKTSR.Q Y 48.40 2342.3208 23 -14.0 781.7700 3 95.86 5 54582 VEV_2_3_RA5_01_1236.d 1.2E5 1 1 669 691 Methylation(others)
K.LSAIES(+14.02)LAGVEILC(+57.02)SDKTGTLTK.N Y 48.33 2419.2878 23 -8.3 807.4299 3 82.97 6 47170 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 372 394 Methylation(others); Carbamidomethylation
K.RGEAFMVITSTGDN(+.98)TFVGR.A Y 47.35 2057.9839 19 2.6 687.0037 3 78.12 6 43814 VEV_3_3_RA6_01_1237.d 5.93E5 2 2 262 280 Deamidation (NQ)
K.GIDAID(+14.02)KAFLK.S Y 47.19 1203.6863 11 -14.2 402.2303 3 78.43 5 45008 VEV_2_3_RA5_01_1236.d 2.55E5 3 3 427 437 Methylation(others)
K.SVLTQ(+.98)YKVLEFHPFDPVSK.K Y 46.91 2234.1624 19 -16.9 559.5385 4 81.34 5 46918 VEV_2_3_RA5_01_1236.d 0 1 1 447 465 Deamidation (NQ)
R.LGLGGGGTMPGSEVY(-2.02)DFVEAADGFAEVFPQHK.Y Y 46.88 3279.5181 32 -3.6 1094.1760 3 93.07 5 53376 VEV_2_3_RA5_01_1236.d 2.4E5 1 1 593 624 2-amino-3-oxo-butanoic_acid
K.SVLTQYK(+14.02).V Y 46.76 851.4753 7 -24.1 852.4620 1 56.71 5 29230 VEV_2_3_RA5_01_1236.d 9.72E5 6 6 447 453 Methylation(KR)
K.Q(-17.03)RSLEDFVVSLQR(+14.02).V Y 46.71 1572.8259 13 -16.5 525.2739 3 85.02 6 48477 VEV_3_3_RA6_01_1237.d 9.24E4 3 3 908 920 Pyro-glu from Q; Methylation(KR)
R.LTEVEAPEVVPGDILQVEEGTIIPADGR(-.98).I Y 46.51 2944.5393 28 -12.1 1473.2592 2 88.29 4 52679 VEV_1_3_RA4_01_1235.d 5.45E5 2 2 197 224 Amidation
R.KRGEGSWEILGIM(+15.99)PC(+57.02)SDPPRHDTAK.T Y 46.49 2852.3696 25 -24.8 571.4670 5 65.21 5 35436 VEV_2_3_RA5_01_1236.d 7.98E4 1 1 527 551 Oxidation (M); Carbamidomethylation
K.ADTGIAVE(+28.03)GASDAAR.S Y 46.37 1430.7001 15 -4.3 716.3542 2 63.84 4 34394 VEV_1_3_RA4_01_1235.d 9.72E4 1 1 654 668 Ethylation
K.NKLSLAEPY(+15.01)C(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 46.22 3164.5303 29 -8.2 1055.8420 3 88.84 5 51298 VEV_2_3_RA5_01_1236.d 2.97E5 1 1 395 423 Tyrosine oxidation to 2-aminotyrosine; Carbamidomethylation
R.G(+42.01)YLVAM(+15.99)TGDGVNDAPSLK.K Y 46.02 1864.8877 18 -3.3 622.6345 3 64.53 6 33761 VEV_3_3_RA6_01_1237.d 5.01E5 3 3 635 652 Acetylation (N-term); Oxidation (M)
K.M(+15.99)LTGDAVGIARETSR.Q Y 45.90 1591.7988 15 -13.5 531.5997 3 59.82 5 31420 VEV_2_3_RA5_01_1236.d 3.52E5 2 2 565 579 Oxidation (M)
K.VAEFATR(+14.02).G Y 45.41 806.4286 7 -10.9 404.2172 2 40.83 5 19596 VEV_2_3_RA5_01_1236.d 1.33E6 3 3 511 517 Methylation(KR)
K.NKLSLAEPYC(+57.02)VAGVDPDDLM(+15.99)LTAC(+57.02)LAASR(+14.02).K Y 45.19 3179.5300 29 -23.6 1060.8256 3 84.69 5 48980 VEV_2_3_RA5_01_1236.d 2.62E5 2 2 395 423 Carbamidomethylation; Oxidation (M); Methylation(KR)
R.GYLVAM(+15.99)TGDGVNDAPSLKKADTGIAVEGASDAAR.S Y 45.06 3335.6304 34 -7.3 834.9088 4 72.38 6 39644 VEV_3_3_RA6_01_1237.d 5.51E4 1 1 635 668 Oxidation (M)
R.S(-2.02)LEDFVVSLQR.V Y 44.91 1289.6615 11 -14.8 645.8285 2 83.61 4 49641 VEV_1_3_RA4_01_1235.d 3.92E4 2 2 910 920 2-amino-3-oxo-butanoic_acid
R.GYLVAMTGD(+43.04)GVNDAPSLK.K Y 44.76 1849.9243 18 -28.7 925.9429 2 72.71 6 39879 VEV_3_3_RA6_01_1237.d 1.57E5 2 2 635 652 Carboxyl modification with ethanolamine
R.GQHIPPNHLGTSVPSGAFPGK(+14.02)PTESVPEEK.K Y 44.46 3107.5676 30 -12.0 777.8899 4 67.30 6 35856 VEV_3_3_RA6_01_1237.d 9.21E5 2 2 11 40 Methylation(KR)
R.L(+164.06)TEVEAPEVVPGDILQVEEGTIIPADGR.I Y 44.34 3109.5835 28 -19.3 1037.5151 3 87.33 6 49869 VEV_3_3_RA6_01_1237.d 2.8E5 1 1 197 224 O-Diisopropylphosphorylation
K.QR(+14.02)SLEDFVVSLQR.V Y 43.90 1589.8525 13 -8.2 530.9538 3 80.24 5 46208 VEV_2_3_RA5_01_1236.d 4.26E4 1 1 908 920 Methylation(KR)
K.KADTGIAVEGAS(+164.06)DAAR.S Y 43.90 1694.8240 16 -10.5 848.4104 2 40.45 5 19382 VEV_2_3_RA5_01_1236.d 3.06E5 3 3 653 668 O-Diisopropylphosphorylation
R.L(+71.04)GLGGGGTMPGSEVYDFVEAADGFAEVFPQHK.Y Y 43.64 3352.5710 32 -13.2 839.1390 4 89.43 6 51014 VEV_3_3_RA6_01_1237.d 1.15E5 1 1 593 624 Propionamide (K, X@N-term)
R.G(+149.03)EAFMVITSTGDNTFVGR.A Y 43.50 2049.9287 18 22.8 684.3325 3 77.61 6 43446 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 263 280 Benzyl isothiocyanate
R.ETSRQLGLGTNVY(-18.01)NAER(+14.02).L Y 43.00 1902.9547 17 4.7 635.3285 3 62.31 5 33264 VEV_2_3_RA5_01_1236.d 1.91E4 1 1 576 592 Dehydration; Methylation(KR)
R.KRGEGSWEILGIM(-4.99)PC(+57.02)SDPPRHDTAK.T Y 42.82 2831.3884 25 11.1 567.2913 5 69.50 5 38635 VEV_2_3_RA5_01_1236.d 7.26E3 1 1 527 551 Methionine replacement by azido homoalanine; Carbamidomethylation
K.KADTGIAVEGASDAAR(+.98).S Y 42.59 1531.7478 16 -1.6 511.5891 3 43.63 6 20590 VEV_3_3_RA6_01_1237.d 4.86E6 2 2 653 668 Deamidation (R)
R.S(+14.02)AADIVFLAPGLSAIIDALKTSR.Q Y 42.48 2342.3208 23 -7.2 781.7753 3 95.95 4 56726 VEV_1_3_RA4_01_1235.d 9.06E4 1 1 669 691 Methylation(others)
R.Q(+15.00)LGLGTNVYNAER.L Y 42.23 1448.7260 13 -10.0 725.3630 2 70.59 5 39446 VEV_2_3_RA5_01_1236.d 0 1 1 580 592 Deamidation followed by a methylation
R.GLMDQEVLS(+164.06)R.R Y 42.03 1310.6305 10 -7.5 656.3176 2 66.27 5 36229 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 96 105 O-Diisopropylphosphorylation
K.LSAIESLAGVE(+14.02)ILC(+57.02)SDK.T Y 41.96 1817.9445 17 -10.2 909.9703 2 86.14 5 49815 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 372 388 Methylation(others); Carbamidomethylation
K.R(+.98)GEAFMVITSTGDNTFVGR.A Y 41.78 2057.9839 19 5.8 687.0059 3 77.92 6 43672 VEV_3_3_RA6_01_1237.d 2.89E5 1 1 262 280 Deamidation (R)
R.GQHIPPNHLGTSVPSGAFPGK(+163.05)PTESVPEEK.K Y 41.76 3256.5974 30 -0.2 652.3267 5 64.46 5 34876 VEV_2_3_RA5_01_1236.d 0 1 1 11 40 Phenethyl isothiocyanate
R.GQHIPPNHLGTSVPSGAFPGKPTES(+13.03)VPEEK.K Y 41.60 3106.5835 30 -24.4 622.3088 5 67.90 5 37526 VEV_2_3_RA5_01_1236.d 8.6E5 2 2 11 40 Michael addition with methylamine
K.NK(+14.02)LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+14.02).K Y 41.32 3177.5508 29 17.9 1060.2098 3 88.50 5 51112 VEV_2_3_RA5_01_1236.d 0 1 1 395 423 Methylation(KR); Carbamidomethylation
K.RGEGSWEILGIMPC(+57.02)SDPPR.H Y 41.28 2156.0142 19 -3.6 719.6761 3 80.49 5 46376 VEV_2_3_RA5_01_1236.d 9.77E4 1 1 528 546 Carbamidomethylation
K.KVSAVVISPQ(+.98)GER(+14.02).I Y 41.04 1383.7721 13 -21.8 462.2546 3 59.14 6 29812 VEV_3_3_RA6_01_1237.d 1.68E5 2 2 466 478 Deamidation (NQ); Methylation(KR)
M.S(+42.01)DSITSGPR(+14.02).G Y 41.03 974.4669 9 -11.0 488.2354 2 57.92 5 30080 VEV_2_3_RA5_01_1236.d 1.17E6 4 4 2 10 Acetylation (Protein N-term); Methylation(KR)
R.IVTEDAFLQVDQSAITGESLAVDKHKGDTC(+57.02)YASSAVKR.G Y 40.52 4109.0376 38 -6.1 822.8098 5 76.18 5 43427 VEV_2_3_RA5_01_1236.d 3.25E4 1 1 225 262 Carbamidomethylation
K.TPVKWNLPK.L Y 40.36 1081.6284 9 -18.4 361.5435 3 60.03 6 30458 VEV_3_3_RA6_01_1237.d 2.33E5 1 1 755 763
K.M(-48.00)LTGDAVGIAR.E Y 40.30 1054.5771 11 -15.7 528.2876 2 45.36 6 21615 VEV_3_3_RA6_01_1237.d 3.08E6 14 14 565 575 Dethiomethyl
K.TLGLSIK.M Y 40.30 730.4589 7 -14.5 366.2314 2 61.76 4 32804 VEV_1_3_RA4_01_1235.d 1.15E7 14 14 558 564
M.S(+42.01)DSITSGPR.G Y 40.22 960.4512 9 -10.2 481.2280 2 45.06 4 21842 VEV_1_3_RA4_01_1235.d 1.14E7 22 22 2 10 Acetylation (Protein N-term)
K.VSAVVISPQ(+.98)GERITC(+57.02)VK.G Y 40.19 1842.9873 17 -12.7 615.3286 3 68.59 5 37972 VEV_2_3_RA5_01_1236.d 3.58E4 1 1 467 483 Deamidation (NQ); Carbamidomethylation
K.VAE(+14.02)FATR.G Y 40.01 806.4286 7 -18.4 404.2142 2 42.33 6 19849 VEV_3_3_RA6_01_1237.d 3.17E6 8 8 511 517 Methylation(others)
K.MLTGDAVGIAR(+14.02)ETSR.Q Y 39.93 1589.8195 15 -12.3 530.9406 3 66.89 6 35542 VEV_3_3_RA6_01_1237.d 5.63E4 2 2 565 579 Methylation(KR)
K.GID(+14.02)AIDKAFLK.S Y 39.72 1203.6863 11 -27.0 402.2252 3 72.24 6 39566 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 427 437 Methylation(others)
K.R(+14.02)GEAFMVIT(-18.01)STGDNTFVGR.A Y 39.45 2053.0051 19 4.1 685.3452 3 77.38 5 44287 VEV_2_3_RA5_01_1236.d 3.35E4 1 1 262 280 Methylation(KR); Dehydration
R.ETSR(+14.02)QLGLGTN(+.98)VYNAER.L Y 39.39 1921.9493 17 -2.6 641.6554 3 63.34 5 34040 VEV_2_3_RA5_01_1236.d 3.84E4 1 1 576 592 Methylation(KR); Deamidation (NQ)
R.NGRLTEVEAPEVVPGD(-18.01)ILQVEEGTIIPADGR.I Y 39.34 3254.6782 31 -42.0 1085.8545 3 85.46 5 49430 VEV_2_3_RA5_01_1236.d 0 1 1 194 224 Dehydration
K.GAPLFVLKTVEEDHAIPEDVDNAYKNKVAEFATR.G Y 39.10 3785.9263 34 -15.4 758.1808 5 81.21 5 46845 VEV_2_3_RA5_01_1236.d 0 2 2 484 517
K.K(+43.01)(+14.02)VSAVVISPQGER.I Y 39.04 1425.7939 13 -28.7 476.2583 3 47.59 6 22906 VEV_3_3_RA6_01_1237.d 1.32E5 3 3 466 478 Carbamylation; Methylation(KR)
R.GLM(-48.00)DQEVLSR.R Y 38.56 1098.5669 10 -23.5 367.1877 3 37.54 6 17138 VEV_3_3_RA6_01_1237.d 3.93E6 7 7 96 105 Dethiomethyl
K.SVLTQYKVLE(+14.02)FHPFDPVSK.K Y 38.36 2247.1938 19 -11.4 562.7993 4 81.20 6 45998 VEV_3_3_RA6_01_1237.d 3.96E5 2 2 447 465 Methylation(others)
K.TVEEDHAIPEDVDN(+.98)AYK.N Y 38.13 1944.8588 17 -7.1 649.2889 3 64.27 5 34728 VEV_2_3_RA5_01_1236.d 4.95E4 1 1 492 508 Deamidation (NQ)
K.SLKYYPR(+14.02).A Y 38.13 939.5178 7 -16.7 470.7583 2 40.25 6 18671 VEV_3_3_RA6_01_1237.d 1.28E6 6 6 438 444 Methylation(KR)
K.G(+41.03)IDAIDKAFLK.S Y 38.07 1230.6971 11 -21.4 411.2309 3 72.55 5 40871 VEV_2_3_RA5_01_1236.d 2.52E5 3 3 427 437 Amidination of lysines or N-terminal amines with methyl acetimidate
R.LGLGGGGTMPGSEVY(+29.97)DFVEAADGFAEVFPQHK.Y Y 37.41 3311.5081 32 -12.4 1104.8296 3 93.14 6 52823 VEV_3_3_RA6_01_1237.d 6.56E4 1 1 593 624 Quinone
K.R(+43.01)(+14.02)GEAFMVITSTGDNTFVGR.A Y 37.40 2114.0215 19 -9.5 705.6744 3 68.80 5 38125 VEV_2_3_RA5_01_1236.d 3.25E5 2 2 262 280 Carbamylation; Methylation(KR)
K.VLEFH(+14.02)PFDPVSKK.V Y 37.28 1555.8398 13 -16.8 389.9607 4 70.33 6 38169 VEV_3_3_RA6_01_1237.d 1.92E5 1 1 454 466 Methylation(others)
K.T(+164.06)VEEDHAIPEDVDNAYK.N Y 37.27 2107.9351 17 -8.3 703.6465 3 61.28 6 31357 VEV_3_3_RA6_01_1237.d 1.77E5 1 1 492 508 O-Diisopropylphosphorylation
K.RGEAFM(+15.99)VITSTGDN(+.98)TFVGR.A Y 37.16 2073.9790 19 -1.1 692.3328 3 76.14 6 42374 VEV_3_3_RA6_01_1237.d 2.22E4 1 1 262 280 Oxidation (M); Deamidation (NQ)
R.G(+43.01)LMDQEVLSR.R Y 37.16 1189.5760 10 -9.2 595.7899 2 60.32 5 31846 VEV_2_3_RA5_01_1236.d 1.04E5 2 2 96 105 Carbamylation
R.GQ(+.98)HIPPN(+.98)HLGTSVPSGAFPGKPTESVPEEK.K Y 36.93 3095.5200 30 -20.9 774.8711 4 66.05 4 36097 VEV_1_3_RA4_01_1235.d 0 1 1 11 40 Deamidation (NQ)
R.ETSRQLGLGTN(+.98)VYNAER(+14.02).L Y 36.92 1921.9493 17 -43.7 641.6290 3 64.30 4 34732 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 576 592 Deamidation (NQ); Methylation(KR)
R.GQHIPPNHLGTSVPSGAFPGKPTESVPEEK(-.98)(+14.02).K Y 36.75 3106.5835 30 -22.2 622.3102 5 68.63 5 38005 VEV_2_3_RA5_01_1236.d 0 1 1 11 40 Amidation; Methylation(KR)
R.GLM(-48.00)DQEVLSRR.K Y 36.20 1254.6680 11 -15.7 419.2234 3 32.79 6 14408 VEV_3_3_RA6_01_1237.d 2.76E6 3 3 96 106 Dethiomethyl
R.QLGLGTNVY(+164.06)NAER.L Y 36.20 1597.7865 13 -3.1 799.8980 2 65.24 5 35458 VEV_2_3_RA5_01_1236.d 2.42E4 1 1 580 592 O-Diisopropylphosphorylation
K.NKLS(+13.03)LAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 35.92 3162.5510 29 -2.3 1055.1885 3 88.21 5 50959 VEV_2_3_RA5_01_1236.d 3.34E4 1 1 395 423 Michael addition with methylamine; Carbamidomethylation
K.YGLNQM(-48.00)K.E Y 35.64 804.4130 7 -16.3 403.2072 2 13.50 6 4202 VEV_3_3_RA6_01_1237.d 7.21E5 3 3 109 115 Dethiomethyl
K.KADTGIAVEGASD(-18.01)AAR(+14.02).S Y 35.47 1526.7688 16 -23.5 509.9183 3 43.48 5 21201 VEV_2_3_RA5_01_1236.d 2.24E5 4 4 653 668 Dehydration; Methylation(KR)
R.LTEVEAPE(+21.98)VVPGDILQ(+.98)VEEGTIIPADGR.I Y 35.25 2968.4893 28 -15.1 990.4888 3 89.16 5 51464 VEV_2_3_RA5_01_1236.d 3.84E3 1 1 197 224 Sodium adduct; Deamidation (NQ)
R.GLMDQ(+.98)EVLSRR.K Y 35.04 1303.6554 11 -9.7 435.5548 3 65.38 5 35602 VEV_2_3_RA5_01_1236.d 4.49E4 1 1 96 106 Deamidation (NQ)
K.Y(+42.01)NVVEILQQR.G Y 34.63 1302.6931 10 46.0 435.2583 3 77.29 4 44929 VEV_1_3_RA4_01_1235.d 2.14E4 1 1 625 634 Acetylation (N-term)
R.GLMD(+14.02)QEVLSR.R Y 34.56 1160.5859 10 -7.7 581.2958 2 70.42 4 39569 VEV_1_3_RA4_01_1235.d 2.08E5 4 4 96 105 Methylation(others)
K.KADTGIAVEGASDAAR(+28.03).S Y 34.46 1558.7950 16 -5.0 780.4009 2 56.91 5 29367 VEV_2_3_RA5_01_1236.d 2.72E5 2 2 653 668 Dimethylation(KR)
R.R(+14.02)GLM(+15.99)DQEVLSRR.K Y 34.27 1488.7831 12 -29.9 497.2535 3 65.57 4 35725 VEV_1_3_RA4_01_1235.d 1.14E6 7 7 95 106 Methylation(KR); Oxidation (M)
K.LSAIES(+14.02)LAGVEILC(+57.02)SDK.T Y 34.22 1817.9445 17 -0.7 909.9789 2 85.42 4 50871 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 372 388 Methylation(others); Carbamidomethylation
K.NQKQRS(+79.97)LEDFVVSLQR.V Y 33.90 2025.9996 16 12.4 676.3489 3 83.66 5 48358 VEV_2_3_RA5_01_1236.d 0 1 1 905 920 Phosphorylation (STY)
R.S(+41.03)LEDFVVSLQR.V Y 33.63 1332.7037 11 -50.1 445.2196 3 82.74 6 47031 VEV_3_3_RA6_01_1237.d 0 2 2 910 920 Amidination of lysines or N-terminal amines with methyl acetimidate
K.TLALK.A N 33.54 544.3584 5 -15.8 545.3571 1 24.42 5 10151 VEV_2_3_RA5_01_1236.d 2.34E5 2 2 184 188
K.KADTGIAVE(+28.03)GASDAAR.S Y 33.22 1558.7950 16 -14.9 520.5979 3 57.02 6 28379 VEV_3_3_RA6_01_1237.d 6.25E4 1 1 653 668 Ethylation
K.M(+42.01)LTGDAVGIAR.E Y 32.92 1144.5911 11 -18.4 573.2923 2 59.94 6 30412 VEV_3_3_RA6_01_1237.d 8.92E4 3 3 565 575 Acetylation (N-term)
R.G(+56.06)LMDQEVLSR.R Y 32.88 1202.6329 10 -32.8 602.3040 2 68.31 6 36629 VEV_3_3_RA6_01_1237.d 6.35E5 2 2 96 105 Diethylation
R.GYLVAMT(+13.03)GDGVNDAPSLKK.A Y 32.75 1948.0088 19 -32.0 650.3228 3 65.30 6 34351 VEV_3_3_RA6_01_1237.d 0 1 1 635 653 Michael addition with methylamine
R.AKSVLTQYK(+14.02).V Y 32.27 1050.6073 9 -45.5 526.2870 2 41.79 5 20194 VEV_2_3_RA5_01_1236.d 3E4 2 2 445 453 Methylation(KR)
R.SLEDFVVSLQ(+.98)R(+28.03).V Y 31.93 1320.6925 11 -11.3 661.3461 2 91.23 6 51942 VEV_3_3_RA6_01_1237.d 8.58E4 1 1 910 920 Deamidation (NQ); Dimethylation(KR)
R.LGLGGGGTM(+15.99)PGSEVYDFVEAADGFAEVFPQ(+.98)HKYNVVEILQQR.G Y 31.93 4541.1846 42 -1.9 1136.3013 4 92.89 4 55240 VEV_1_3_RA4_01_1235.d 9.27E4 1 1 593 634 Oxidation (M); Deamidation (NQ)
K.K(+14.02)ADT(-18.01)GIAVEGASDAAR.S Y 31.81 1526.7688 16 -30.1 509.9149 3 43.85 6 20727 VEV_3_3_RA6_01_1237.d 6.03E4 2 2 653 668 Methylation(KR); Dehydration
K.KADTGIAVEGASDAARSAADIVFLAPGLSAIIDALK.T Y 31.34 3496.8777 36 -39.0 875.1926 4 96.04 4 56769 VEV_1_3_RA4_01_1235.d 0 1 1 653 688
R.QLGLGTNVYN(+.98)AER(+14.02).L Y 31.12 1448.7260 13 -13.3 725.3606 2 73.03 6 40112 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 580 592 Deamidation (NQ); Methylation(KR)
R.GYLVAM(+15.99)T(-18.01)GDGVNDAPSLK.K Y 31.03 1804.8665 18 26.7 903.4646 2 78.25 4 45674 VEV_1_3_RA4_01_1235.d 4.2E4 1 1 635 652 Oxidation (M); Dehydration
K.TIN(+162.05)EAKTLGLSIK.M Y 30.43 1548.8610 13 -32.0 388.2101 4 61.60 5 32737 VEV_2_3_RA5_01_1236.d 0 1 1 552 564 Hexose (NSY)
R.SLGVAR.K Y 30.42 601.3547 6 -21.3 301.6783 2 19.71 6 7394 VEV_3_3_RA6_01_1237.d 2.05E6 5 5 521 526
K.TVE(+14.02)EDHAIPEDVDNAYKNK.V Y 30.40 2200.0283 19 -30.7 734.3275 3 62.15 4 33110 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 492 510 Methylation(others)
K.KVSAVVISPQGER(+14.02)ITC(+57.02)VK.G Y 30.28 1984.1139 18 -40.8 662.3516 3 65.59 5 35735 VEV_2_3_RA5_01_1236.d 0 1 1 466 483 Methylation(KR); Carbamidomethylation
K.VAEFATRGFR.S Y 29.84 1152.6040 10 -12.5 385.2038 3 56.86 5 29363 VEV_2_3_RA5_01_1236.d 3.55E5 1 1 511 520
R.G(+56.06)YLVAMTGDGVNDAPSLK.K Y 29.75 1862.9448 18 -62.3 932.4217 2 77.52 6 43383 VEV_3_3_RA6_01_1237.d 0 1 1 635 652 Diethylation
K.K(+14.02)AD(-18.01)TGIAVEGASDAAR.S Y 29.75 1526.7688 16 -22.3 509.9189 3 44.33 4 21346 VEV_1_3_RA4_01_1235.d 0 1 1 653 668 Methylation(KR); Dehydration
K.TVE(+28.03)EDHAIPEDVDNAYKNK.V Y 29.37 2214.0439 19 1.5 739.0230 3 63.90 5 34461 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 492 510 Ethylation
R.KRGEGSWEILGIM(+15.99)PC(+57.02)SDPPR.H Y 29.34 2300.1040 20 2.7 576.0349 4 72.90 6 40018 VEV_3_3_RA6_01_1237.d 1.44E4 1 1 527 546 Oxidation (M); Carbamidomethylation
K.VLEFHPFDPVSKK(+14.02).V Y 29.15 1555.8398 13 -18.1 389.9602 4 68.96 5 38265 VEV_2_3_RA5_01_1236.d 1.02E5 2 2 454 466 Methylation(KR)
K.LSAIESLAGVEILC(+57.02)SDK(+28.03).T Y 29.02 1831.9601 17 -14.7 916.9739 2 86.99 4 51880 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 372 388 Carbamidomethylation; Dimethylation(KR)
R.R(+14.02)GLM(+15.99)DQEVLSR(+14.02)R.K Y 28.97 1502.7987 12 -30.3 501.9250 3 70.14 4 39317 VEV_1_3_RA4_01_1235.d 8.69E5 2 2 95 106 Methylation(KR); Oxidation (M)
R.LTEVEAPEVVPGD(+28.03)ILQVEEGTIIPADGR.I Y 28.95 2973.5544 28 -3.9 1487.7787 2 93.89 4 55760 VEV_1_3_RA4_01_1235.d 5.32E5 3 3 197 224 Ethylation
K.NKLSLAEPYC(+57.02)VAGVDPDD(+43.99)LMLTAC(+57.02)LAASR(+14.02).K Y 28.94 3207.5249 29 -4.9 802.8846 4 81.50 5 47032 VEV_2_3_RA5_01_1236.d 4.38E5 1 1 395 423 Carbamidomethylation; Carboxylation (DKW); Methylation(KR)
K.M(+42.01)(+15.99)LTGDAVGIAR.E Y 28.82 1160.5859 11 3.4 581.3022 2 45.34 5 22339 VEV_2_3_RA5_01_1236.d 1.35E5 2 2 565 575 Acetylation (N-term); Oxidation (M)
K.K(+42.01)VSAVVISPQGER.I Y 28.70 1410.7831 13 -79.2 471.2310 3 47.86 5 23847 VEV_2_3_RA5_01_1236.d 0 1 1 466 478 Acetylation (N-term)
K.LSLAE(+37.03)PYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 28.67 2944.4133 27 -10.1 737.1031 4 91.08 4 54257 VEV_1_3_RA4_01_1235.d 0 1 1 397 423 Propargylamine; Carbamidomethylation
K.TVEEDHAIPEDVDNAYK(+43.01)NK(+14.02).V Y 28.66 2243.0342 19 4.8 561.7685 4 60.15 4 31595 VEV_1_3_RA4_01_1235.d 1.99E5 1 1 492 510 Carbamylation; Methylation(KR)
K.GAPLFVLK(-1.03)TVEEDHAIPEDVDNAYKNK.V Y 28.59 3010.4922 27 20.7 753.6459 4 78.24 5 44884 VEV_2_3_RA5_01_1236.d 0 1 1 484 510 Lysine oxidation to aminoadipic semialdehyde
R.LGLGGGGTMPGSEVY(+15.01)DFVEAADGFAEVFPQHK.Y Y 28.44 3296.5447 32 -7.8 1099.8469 3 91.09 6 51873 VEV_3_3_RA6_01_1237.d 0 1 1 593 624 Tyrosine oxidation to 2-aminotyrosine
K.LS(+13.03)LAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 28.44 2920.4133 27 -16.2 974.4626 3 91.97 6 52295 VEV_3_3_RA6_01_1237.d 0 2 2 397 423 Michael addition with methylamine; Carbamidomethylation
K.R(+43.01)GEAFMVITSTGDNTFVGR.A Y 28.31 2100.0059 19 -1.9 701.0079 3 75.56 5 42994 VEV_2_3_RA5_01_1236.d 7.8E4 1 1 262 280 Carbamylation
K.LSLAEPYC(+57.02)VAGVDPDD(+55.92)LMLTAC(+57.02)LAASRK.K Y 28.25 3091.3962 28 5.5 773.8606 4 81.75 6 46374 VEV_3_3_RA6_01_1237.d 0 1 1 397 424 Carbamidomethylation; Replacement of 2 protons by nickel
R.S(+60.00)LEDFVVSLQR.V Y 28.25 1351.6805 11 -14.9 676.8375 2 83.46 5 48231 VEV_2_3_RA5_01_1236.d 6.46E4 1 1 910 920 2-OH-ethyl thio-Ser
K.N(+.98)QKQRSLEDFVVSLQ(+.98)R.V Y 28.06 1948.0013 16 -84.2 650.2864 3 82.81 4 49093 VEV_1_3_RA4_01_1235.d 0 1 1 905 920 Deamidation (NQ)
K.TLGLSIK(+14.02).M Y 27.75 744.4745 7 -23.7 373.2357 2 67.53 6 36031 VEV_3_3_RA6_01_1237.d 2.72E5 1 1 558 564 Methylation(KR)
R.SLGVARK.R Y 27.52 729.4497 7 -15.8 365.7263 2 13.21 5 4076 VEV_2_3_RA5_01_1236.d 2.73E5 3 3 521 527
R.LTEVEAPEVVP(+29.04)GDILQVEEGTIIPADGR.I Y 27.46 2974.5625 28 -28.9 992.4995 3 90.16 4 53742 VEV_1_3_RA4_01_1235.d 1.8E4 1 1 197 224 Dimethylation of proline residue
K.TVEED(+14.02)HAIPEDVDNAYKNKVAEFATR.G Y 26.80 2974.4307 26 10.5 744.6227 4 73.98 6 40802 VEV_3_3_RA6_01_1237.d 0 1 1 492 517 Methylation(others)
K.VLEFHPFDPVSK(-.98).K Y 26.66 1412.7452 12 -21.0 707.3651 2 75.45 4 43483 VEV_1_3_RA4_01_1235.d 3.26E5 2 2 454 465 Amidation
R.ET(+238.23)SRQLGLGTNVYNAER.L Y 26.57 2145.1794 17 -83.7 716.0073 3 67.50 6 36012 VEV_3_3_RA6_01_1237.d 0 1 1 576 592 Palmitoylation
K.ADTGIAVEGAS(+164.06)DAAR.S Y 26.54 1566.7290 15 0.7 784.3723 2 52.23 5 26521 VEV_2_3_RA5_01_1236.d 2.57E5 3 3 654 668 O-Diisopropylphosphorylation
K.TLALK(+14.02).A N 25.91 558.3741 5 -26.3 559.3667 1 39.28 6 18079 VEV_3_3_RA6_01_1237.d 6.49E4 1 1 184 188 Methylation(KR)
K.G(+127.06)IDAIDKAFLK.S Y 25.53 1316.7339 11 -27.7 439.9064 3 72.66 5 40942 VEV_2_3_RA5_01_1236.d 7.06E4 1 1 427 437 N-Succinimidyl-2-morpholine acetate
R.LTEVEAPEVVPGDILQ(+.98)VEEGTIIPAD(-18.01)GR.I Y 25.40 2928.4968 28 8.0 977.1807 3 88.73 4 52949 VEV_1_3_RA4_01_1235.d 6.83E4 1 1 197 224 Deamidation (NQ); Dehydration
K.VLEFHPFDPVS(+79.96)KK(+14.02).V Y 25.35 1635.7966 13 -49.4 409.9362 4 69.00 5 38276 VEV_2_3_RA5_01_1236.d 0 1 1 454 466 Sulfation; Methylation(KR)
R.NGRLT(+13.03)EVEAPEVVPGDILQVEEGTIIPADGR.I Y 25.18 3285.7205 31 17.6 1096.2667 3 89.12 5 51441 VEV_2_3_RA5_01_1236.d 0 1 1 194 224 Michael addition with methylamine
M.SDSITSGPR(+14.02).G Y 25.08 932.4563 9 -17.6 467.2272 2 32.08 6 14015 VEV_3_3_RA6_01_1237.d 3.92E5 3 3 2 10 Methylation(KR)
K.NQK(-1.03)QRSLEDFVVSLQR.V Y 24.61 1945.0017 16 -0.4 649.3409 3 83.35 4 49462 VEV_1_3_RA4_01_1235.d 2.02E5 1 1 905 920 Lysine oxidation to aminoadipic semialdehyde
K.RGEGSWEILGIM(+15.99)PC(+57.02)S(-18.01)DPPRHDTAK.T Y 24.39 2706.2642 24 43.9 677.6030 4 73.52 4 41988 VEV_1_3_RA4_01_1235.d 0 2 2 528 551 Oxidation (M); Carbamidomethylation; Dehydration
K.T(+43.01)LGLSIK(+14.02)MLTGDAVGIAR.E Y 24.36 1872.0503 18 -5.4 469.0173 4 75.01 5 42600 VEV_2_3_RA5_01_1236.d 6.11E4 1 1 558 575 Carbamylation; Methylation(KR)
K.N(+42.01)K(+42.01)VAEFATR.G Y 24.16 1118.5720 9 6.4 373.8670 3 31.17 6 13510 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 509 517 Acetylation (N-term); Acetylation (K)
R.SLGVAR(+14.02).K Y 24.04 615.3704 6 -9.1 308.6897 2 27.85 4 11659 VEV_1_3_RA4_01_1235.d 6.95E5 3 3 521 526 Methylation(KR)
K.MLT(+14.02)GDAVGIAR.E Y 24.00 1116.5961 11 -20.2 559.2940 2 64.26 6 33553 VEV_3_3_RA6_01_1237.d 1.82E5 2 2 565 575 Methylation(others)
K.SVLTQYKVLEFHPFDPVSK(+14.02).K Y 23.98 2247.1938 19 -10.3 562.7999 4 80.27 5 46224 VEV_2_3_RA5_01_1236.d 9.21E4 1 1 447 465 Methylation(KR)
K.GAPLFVLKTVEEDHAIPEDVDNAYK.N Y 23.89 2769.3860 25 7.8 924.1431 3 80.31 5 46252 VEV_2_3_RA5_01_1236.d 7.36E4 1 1 484 508
K.MLTGDAVGIAR(+28.03).E Y 23.86 1130.6118 11 -26.4 566.2983 2 69.26 6 37312 VEV_3_3_RA6_01_1237.d 1.49E4 1 1 565 575 Dimethylation(KR)
K.K(+14.02)ADTGIAVEGASDAAR(+14.02).S Y 23.86 1558.7950 16 -14.4 520.5981 3 53.98 5 27586 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 653 668 Methylation(KR)
K.NKLSLAEPYC(+57.02)VAGVDPDD(+55.92)LMLTAC(+57.02)LAASRK.K Y 23.75 3333.5342 30 28.8 834.4149 4 79.20 5 45523 VEV_2_3_RA5_01_1236.d 0 1 1 395 424 Carbamidomethylation; Replacement of 2 protons by nickel
K.YGLNQMKEEK.E Y 23.72 1238.5964 10 -9.4 620.2997 2 38.56 5 18267 VEV_2_3_RA5_01_1236.d 1.92E5 2 2 109 118
K.RGEAFMVITS(+14.02)TGDNTFVGR.A Y 23.72 2071.0156 19 -7.8 691.3405 3 78.96 4 46216 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 262 280 Methylation(others)
K.TLGLSIK(+31.99)MLTGDAVGIAR.E Y 23.57 1847.0186 18 -88.0 616.6260 3 82.86 5 47865 VEV_2_3_RA5_01_1236.d 0 1 1 558 575 Dihydroxy
K.KADTGIAVEGASD(-18.01)AAR.S Y 23.30 1512.7532 16 -19.5 505.2485 3 43.17 5 21025 VEV_2_3_RA5_01_1236.d 2.79E5 1 1 653 668 Dehydration
R.GLMD(+28.03)QEVLSR.R Y 23.23 1174.6016 10 -18.0 588.2975 2 73.57 5 41570 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 96 105 Ethylation
K.KAD(-18.01)T(+79.97)GIAVEGASDAAR.S Y 22.83 1592.7195 16 26.2 531.9277 3 43.12 5 20997 VEV_2_3_RA5_01_1236.d 0 1 1 653 668 Dehydration; Phosphorylation (STY)
R.HD(-18.01)TAKTINEAKTLGLSIK.M Y 22.83 1921.0632 18 -13.5 385.2147 5 61.86 4 32885 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 547 564 Dehydration
R.QIFHR.M Y 22.81 699.3816 5 0.4 700.3892 1 105.67 6 56949 VEV_3_3_RA6_01_1237.d 4.33E5 3 3 692 696
R.IVTEDAFLQVDQ(+.98)SAITGESLAVDK.H Y 22.65 2549.2747 24 26.0 1275.6777 2 101.32 5 56441 VEV_2_3_RA5_01_1236.d 0 1 1 225 248 Deamidation (NQ)
K.KGIDAID(+21.98)K.A Y 22.42 880.4630 8 -33.8 441.2239 2 46.64 6 22356 VEV_3_3_RA6_01_1237.d 9.97E4 1 1 426 433 Sodium adduct
R.SNGIVTILEFTLAITIIGVPVGLPAVVTTTM(+15.99)AVGAAYLAK.K Y 22.19 4000.2573 40 -2.1 1001.0695 4 118.10 6 60109 VEV_3_3_RA6_01_1237.d 0 1 1 325 364 Oxidation (M)
R.RGLM(-48.00)DQEVLSR.R Y 22.19 1254.6680 11 1.5 314.6747 4 33.91 6 15019 VEV_3_3_RA6_01_1237.d 3.5E5 3 3 95 105 Dethiomethyl
K.ADTGIAVEGASDAARS(+79.97)AAD(+43.99)IVFLAPGLSAIIDALK.T Y 22.06 3492.7388 35 9.2 874.2000 4 95.93 5 54611 VEV_2_3_RA5_01_1236.d 0 1 1 654 688 Phosphorylation (STY); Carboxylation (DKW)
K.LSLAEPYC(+57.02)VAGVD(+14.02)PDDLMLTAC(+57.02)LAASR.K Y 21.73 2921.3972 27 -18.9 974.7880 3 90.88 5 52342 VEV_2_3_RA5_01_1236.d 5.11E4 1 1 397 423 Carbamidomethylation; Methylation(others)
K.QR(+14.02)S(-18.01)LEDFVVSLQR.V Y 21.53 1571.8419 13 -18.2 524.9451 3 77.98 6 43710 VEV_3_3_RA6_01_1237.d 0 1 1 908 920 Methylation(KR); Dehydration
R.RGLMDQE(+14.02)VLSR.R Y 21.38 1316.6870 11 -11.5 659.3432 2 65.90 5 35957 VEV_2_3_RA5_01_1236.d 4.49E4 1 1 95 105 Methylation(others)
K.R(+14.02)GEAFMVITSTGDNTFVGR(-.98).A Y 21.36 2070.0317 19 -19.0 691.0048 3 78.53 5 45076 VEV_2_3_RA5_01_1236.d 0 1 1 262 280 Methylation(KR); Amidation
K.ADTGIAVEGAS(-18.01)DAAR(+14.02).S Y 21.33 1398.6738 15 5.7 467.2346 3 48.63 4 24016 VEV_1_3_RA4_01_1235.d 8.1E4 1 1 654 668 Dehydration; Methylation(KR)
K.YGLNQM(+15.99)K.E Y 21.30 868.4113 7 -14.2 435.2067 2 23.42 5 9624 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 109 115 Oxidation (M)
K.GIDAIDK.A Y 21.28 730.3861 7 -14.4 731.3829 1 79.20 4 46396 VEV_1_3_RA4_01_1235.d 4.75E4 3 3 427 433
R.SLEDFVVSLQRVSTQHEK.S Y 21.23 2101.0803 18 -11.3 526.2714 4 80.65 5 46491 VEV_2_3_RA5_01_1236.d 6.48E4 1 1 910 927
K.KGIDAIDK.A Y 21.15 858.4810 8 -35.8 430.2324 2 63.58 4 34194 VEV_1_3_RA4_01_1235.d 0 1 1 426 433
K.AVVLR.N N 21.07 556.3696 5 -14.7 557.3687 1 23.21 6 9247 VEV_3_3_RA6_01_1237.d 4.4E5 1 1 189 193
K.LSLAEPYC(+57.02)VAGVDPDD(+14.02)LMLTAC(+57.02)LAASR.K Y 21.03 2921.3972 27 -38.2 974.7691 3 91.59 4 54547 VEV_1_3_RA4_01_1235.d 0 1 1 397 423 Carbamidomethylation; Methylation(others)
K.TINE(+14.02)AKTLGLSIK.M Y 20.96 1400.8239 13 -12.3 467.9428 3 70.50 5 39360 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 552 564 Methylation(others)
K.K(+42.01)GIDAIDK.A Y 20.89 900.4916 8 -11.2 451.2480 2 49.87 4 24796 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 426 433 Acetylation (N-term)
R.NGRLTEVEAPEVVPGDILQVEEGT(+14.02)IIPADGR.I Y 20.80 3286.7043 31 -41.0 1096.5305 3 89.75 4 53516 VEV_1_3_RA4_01_1235.d 0 1 1 194 224 Methylation(others)
R.L(+27.99)TEVEAPEVVPGDILQVEEGTIIPADGR(+14.02).I Y 20.63 2987.5339 28 4.9 1494.7815 2 94.49 6 53394 VEV_3_3_RA6_01_1237.d 5.53E4 1 1 197 224 Formylation; Methylation(KR)
R.RGLMD(-18.01)QEVLSRR.K Y 20.63 1440.7620 12 -29.8 481.2469 3 27.33 6 11452 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 95 106 Dehydration
K.TVEEDHAIPEDVDN(+.98)AYK(+14.02)NK.V Y 20.54 2201.0125 19 -0.2 734.6779 3 63.57 5 34216 VEV_2_3_RA5_01_1236.d 7.42E4 1 1 492 510 Deamidation (NQ); Methylation(KR)
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+.98).K Y 20.50 3150.5034 29 -8.6 1051.1660 3 88.18 4 52615 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 395 423 Carbamidomethylation; Deamidation (R)
K.AFLK(+14.02)S(-18.01)LKYYPR.A Y 20.16 1380.7917 11 -44.3 461.2508 3 33.11 5 15064 VEV_2_3_RA5_01_1236.d 3.23E5 2 2 434 444 Methylation(KR); Dehydration
K.LS(-2.02)LAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 20.01 2905.3660 27 3.2 969.4657 3 91.46 4 54478 VEV_1_3_RA4_01_1235.d 3.39E4 1 1 397 423 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.Y(+79.97)NVVEILQQR(+28.03)GYLVAMTGDGVNDAPSLK.K Y 20.00 3157.5518 28 -11.4 1053.5126 3 95.34 5 54360 VEV_2_3_RA5_01_1236.d 4.25E4 1 1 625 652 Phosphorylation (STY); Dimethylation(KR)
R.S(+42.01)LGVAR.K Y 19.83 643.3653 6 -75.8 644.3238 1 60.98 5 32282 VEV_2_3_RA5_01_1236.d 0 1 1 521 526 Acetylation (N-term)
K.A(+43.01)DT(+79.97)GIAVEGASDAAR.S Y 19.82 1525.6409 15 65.9 509.5878 3 43.45 6 20490 VEV_3_3_RA6_01_1237.d 1.51E4 1 1 654 668 Carbamylation; Phosphorylation (STY)
K.T(+13.03)VEEDHAIPEDVDNAYK.N Y 19.50 1956.9065 17 15.5 653.3196 3 66.03 6 34974 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 492 508 Michael addition with methylamine
R.LGLGGGGTMP(+29.04)GSEVYDFVEAADGFAEVFPQHK.Y Y 19.44 3310.5730 32 -14.5 1104.5156 3 93.17 4 55391 VEV_1_3_RA4_01_1235.d 1.34E4 1 1 593 624 Dimethylation of proline residue
K.M(+42.01)(+31.99)LTGDAVGIAR.E Y 19.41 1176.5808 11 1.4 589.2985 2 61.32 6 31382 VEV_3_3_RA6_01_1237.d 1.93E5 1 1 565 575 Acetylation (N-term); Sulphone
R.AKSVLTQYK(-1.03)VLEFHPFDPVSK.K Y 19.33 2431.2786 21 -15.5 487.2554 5 77.50 5 44431 VEV_2_3_RA5_01_1236.d 2.23E5 1 1 445 465 Lysine oxidation to aminoadipic semialdehyde
K.VSAVVISPQGER(+28.03).I Y 19.33 1268.7089 12 -82.1 635.3096 2 66.88 5 36687 VEV_2_3_RA5_01_1236.d 0 1 1 467 478 Dimethylation(KR)
R.LTEVEAPEVVP(+31.99)GDILQ(+.98)VEEGTIIPADGR.I Y 19.27 2978.4971 28 -21.1 993.8187 3 93.39 6 52928 VEV_3_3_RA6_01_1237.d 0 1 1 197 224 Dihydroxy; Deamidation (NQ)
R.S(+164.06)LEDFVVSLQR.V Y 19.06 1455.7374 11 5.7 486.2559 3 80.57 5 46424 VEV_2_3_RA5_01_1236.d 2.18E4 1 1 910 920 O-Diisopropylphosphorylation
R.G(+42.01)LM(+15.99)DQEVLSR.R Y 18.97 1204.5758 10 6.2 603.2989 2 38.17 5 18034 VEV_2_3_RA5_01_1236.d 7.34E5 4 4 96 105 Acetylation (N-term); Oxidation (M)
K.VSAVVIS(+79.97)PQGER.I Y 18.96 1320.6438 12 19.9 441.2307 3 52.70 5 26806 VEV_2_3_RA5_01_1236.d 2.12E5 1 1 467 478 Phosphorylation (STY)
R.QLGLGTN(+.98)VYNAER(+14.02).L Y 18.73 1448.7260 13 -32.9 725.3464 2 60.63 5 32015 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 580 592 Deamidation (NQ); Methylation(KR)
K.NQK(+14.02)QRS(-18.01)LEDFVVSLQR.V Y 18.66 1942.0385 16 -18.2 648.3416 3 83.31 5 48143 VEV_2_3_RA5_01_1236.d 0 1 1 905 920 Methylation(KR); Dehydration
R.NGRLTEVEAPEVVPGDILQVEEGTIIPADGR(-.98).I Y 18.63 3271.7048 31 -9.7 1091.5649 3 85.44 6 48733 VEV_3_3_RA6_01_1237.d 0 1 1 194 224 Amidation
R.RGLM(+15.99)DQEVLSR(+14.02).R Y 18.61 1332.6820 11 -9.1 445.2306 3 55.59 5 28505 VEV_2_3_RA5_01_1236.d 2.11E5 1 1 95 105 Oxidation (M); Methylation(KR)
K.ADTGIAVEGAS(-18.01)DAAR.S Y 18.55 1384.6582 15 -0.2 693.3362 2 50.88 5 25682 VEV_2_3_RA5_01_1236.d 3.24E4 1 1 654 668 Dehydration
K.QRS(-18.01)LEDFVVSLQR.V Y 18.36 1557.8263 13 -32.7 520.2657 3 84.44 6 48107 VEV_3_3_RA6_01_1237.d 7.16E4 1 1 908 920 Dehydration
K.SVLTQ(+.98)YK.V Y 18.32 838.4436 7 -26.2 420.2181 2 46.23 4 22529 VEV_1_3_RA4_01_1235.d 3.77E5 1 1 447 453 Deamidation (NQ)
R.R(+42.01)GLMDQEVLS(+79.97)R.R Y 18.31 1424.6483 11 38.8 357.1832 4 16.56 5 5863 VEV_2_3_RA5_01_1236.d 0 1 1 95 105 Acetylation (N-term); Phosphorylation (STY)
K.K(+14.02)VS(-18.01)AVVISPQGER.I Y 18.27 1364.7776 13 -69.0 455.9017 3 48.16 5 24015 VEV_2_3_RA5_01_1236.d 9.58E4 1 1 466 478 Methylation(KR); Dehydration
K.KVSAVVISP(+31.99)Q(+.98)GER.I Y 18.27 1401.7463 13 -36.8 468.2389 3 47.86 5 23842 VEV_2_3_RA5_01_1236.d 3E5 1 1 466 478 Dihydroxy; Deamidation (NQ)
K.T(+163.05)VEEDHAIPEDVDNAYKNK.V Y 18.26 2349.0583 19 15.4 588.2809 4 57.75 5 29940 VEV_2_3_RA5_01_1236.d 0 1 1 492 510 Phenethyl isothiocyanate
K.SLKYYPR(+.98).A Y 18.24 926.4861 7 6.6 464.2534 2 32.97 5 14981 VEV_2_3_RA5_01_1236.d 4.61E5 1 1 438 444 Deamidation (R)
R.V(+42.01)STQHEKST(-.98) Y 18.17 1056.5200 9 -7.2 1057.5197 1 96.19 4 56829 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 921 929 Acetylation (N-term); Amidation
K.TVEEDHAIPEDVDNAY(+164.06)KNK.V Y 18.12 2350.0730 19 -3.1 588.5237 4 58.68 5 30588 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 492 510 O-Diisopropylphosphorylation
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLT(+14.02)AC(+57.02)LAASR.K Y 18.02 3163.5352 29 -2.7 1055.5161 3 88.53 5 51130 VEV_2_3_RA5_01_1236.d 1.68E5 1 1 395 423 Carbamidomethylation; Methylation(others)
K.VS(+162.05)AVVISPQGER.I Y 17.96 1402.7303 12 -34.9 468.5677 3 48.13 5 23998 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 467 478 Hexose (NSY)
R.GQHIPPNHLGTSVPSGAFPGKPTES(+162.05)VPEEK.K Y 17.93 3255.6047 30 -6.8 652.1238 5 64.81 4 35125 VEV_1_3_RA4_01_1235.d 0 1 1 11 40 Hexose (NSY)
K.N(+43.01)K(+14.02)LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 17.79 3206.5410 29 -4.2 802.6392 4 81.60 4 48239 VEV_1_3_RA4_01_1235.d 2.65E5 1 1 395 423 Carbamylation; Methylation(KR); Carbamidomethylation
K.ADT(+79.97)GIAVEGASDAAR.S Y 17.74 1482.6351 15 69.3 495.2532 3 59.73 6 30251 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 654 668 Phosphorylation (STY)
R.ITC(+57.02)VK.G N 17.60 619.3363 5 -27.6 620.3265 1 12.39 6 3597 VEV_3_3_RA6_01_1237.d 0 1 1 479 483 Carbamidomethylation
R.G(+298.19)YLVAMTGDGVNDAPSLK.K Y 17.55 2105.0754 18 -17.7 1053.5264 2 95.21 4 56382 VEV_1_3_RA4_01_1235.d 8.32E4 1 1 635 652 Levuglandinyl-lysine anhyropyrrole adduct
K.N(+42.01)(+.98)K(+14.02)LSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR.K Y 17.48 3206.5298 29 -5.7 802.6351 4 81.52 5 47042 VEV_2_3_RA5_01_1236.d 2.78E5 1 1 395 423 Acetylation (N-term); Deamidation (NQ); Methylation(KR); Carbamidomethylation
R.GQHIPPNHLGTSVPSGAFPGKPTESVPEEKK(-.98).Q Y 17.28 3220.6628 31 -16.4 645.1293 5 62.95 6 32604 VEV_3_3_RA6_01_1237.d 0 1 1 11 41 Amidation
K.QRSLEDFVVSLQ(+.98)R.V Y 17.17 1576.8209 13 40.1 395.2283 4 45.80 4 22265 VEV_1_3_RA4_01_1235.d 0 1 1 908 920 Deamidation (NQ)
K.NKLSLAEPYC(+57.02)VAGVDPDDLMLTAC(+57.02)LAASR(+14.02)K(+43.01).K Y 17.16 3334.6360 30 -14.0 667.9251 5 79.19 5 45512 VEV_2_3_RA5_01_1236.d 1.58E5 1 1 395 424 Carbamidomethylation; Methylation(KR); Carbamylation
K.Y(+44.99)NVVEILQQR.G Y 17.13 1305.6677 10 -43.7 436.2108 3 77.36 6 43275 VEV_3_3_RA6_01_1237.d 2.68E5 1 1 625 634 Oxidation to nitro
R.HD(-18.01)TAK.T Y 17.07 552.2656 5 -28.4 553.2572 1 25.61 4 10454 VEV_1_3_RA4_01_1235.d 0 1 1 547 551 Dehydration
M.S(+42.01)DS(+79.97)ITSGPR.G Y 16.92 1040.4176 9 54.5 521.2444 2 55.49 6 27426 VEV_3_3_RA6_01_1237.d 0 1 1 2 10 Acetylation (Protein N-term); Phosphorylation (STY)
K.YGLNQM(+15.99)KEEK.E Y 16.83 1254.5914 10 -24.2 628.2878 2 20.99 4 7929 VEV_1_3_RA4_01_1235.d 0 1 1 109 118 Oxidation (M)
K.SPKKNQKQR.S Y 16.73 1112.6414 9 -14.7 371.8823 3 36.97 4 16914 VEV_1_3_RA4_01_1235.d 5.23E5 1 1 901 909
K.KADTGIAVEGAS(-18.01)DAAR(+14.02).S Y 16.72 1526.7688 16 35.7 509.9484 3 72.59 4 41262 VEV_1_3_RA4_01_1235.d 0 1 1 653 668 Dehydration; Methylation(KR)
R.G(+42.01)LMDQEVLSR.R Y 16.69 1188.5808 10 -6.0 595.2941 2 60.42 6 30742 VEV_3_3_RA6_01_1237.d 1.13E3 1 1 96 105 Acetylation (N-term)
R.R(+44.03)GLMDQEVLSRR.K Y 16.69 1502.7987 12 -31.6 376.6951 4 43.32 5 21109 VEV_2_3_RA5_01_1236.d 5.31E5 1 1 95 106 Ethanolation (KR)
K.AVVLR(+14.02).N N 16.64 570.3853 5 -16.9 571.3829 1 36.11 5 16838 VEV_2_3_RA5_01_1236.d 9.76E4 1 1 189 193 Methylation(KR)
K.KADTGIAVEGASDAAR(+31.99).S Y 16.63 1562.7535 16 -10.9 521.9194 3 57.18 6 28485 VEV_3_3_RA6_01_1237.d 7.53E4 1 1 653 668 Dihydroxy
K.RGEGSWEILGIMPC(+57.02)S(-2.02)DPPRHDTAK.T Y 16.58 2706.2642 24 39.4 903.1309 3 73.36 5 41429 VEV_2_3_RA5_01_1236.d 0 1 1 528 551 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.GLMDQEVLSR(+28.03).R Y 16.52 1174.6016 10 -12.9 588.3005 2 75.70 5 43096 VEV_2_3_RA5_01_1236.d 0 1 1 96 105 Dimethylation(KR)
K.SVLT(+79.97)QYK(+43.01).V Y 16.33 960.4318 7 16.7 481.2312 2 17.04 5 6132 VEV_2_3_RA5_01_1236.d 0 1 1 447 453 Phosphorylation (STY); Carbamylation
K.VAEFAT(+164.06)R.G Y 16.23 956.4732 7 -0.4 479.2437 2 27.66 5 11953 VEV_2_3_RA5_01_1236.d 1.88E5 1 1 511 517 O-Diisopropylphosphorylation
R.LT(+117.00)EVEAPEVVPGDILQVEEGTIIPADGR.I Y 16.07 3062.5212 28 20.2 1021.8683 3 87.87 5 50774 VEV_2_3_RA5_01_1236.d 7.41E4 1 1 197 224 Phospho-propargylamine
K.TINEAK(+14.02).T Y 15.98 688.3755 6 -38.1 689.3566 1 16.46 6 5691 VEV_3_3_RA6_01_1237.d 0 1 1 552 557 Methylation(KR)
K.VSAVVISPQGERITC(+57.02)VK(+42.01).G Y 15.92 1884.0138 17 -40.8 377.7947 5 20.28 6 7694 VEV_3_3_RA6_01_1237.d 2.51E5 1 1 467 483 Carbamidomethylation; Acetylation (K)
K.NKLSLAEPYC(+57.02)VAGVDPDDLM(+15.99)LTAC(+57.02)LAASRKK.K Y 15.75 3421.7043 31 55.7 856.4810 4 97.62 4 57423 VEV_1_3_RA4_01_1235.d 0 1 1 395 425 Carbamidomethylation; Oxidation (M)
R.G(+56.06)EAFMVITSTGDNTFVGR.A Y 15.71 1956.9614 18 -7.7 653.3228 3 71.83 5 40333 VEV_2_3_RA5_01_1236.d 0 1 1 263 280 Diethylation
K.T(+43.01)GTLTK.N Y 15.65 662.3599 6 -29.1 663.3479 1 32.17 5 14520 VEV_2_3_RA5_01_1236.d 0 1 1 389 394 Carbamylation
K.Q(-17.03)RSLEDFVVSLQ(+.98)R.V Y 15.51 1559.7943 13 -9.8 780.8968 2 86.26 5 49884 VEV_2_3_RA5_01_1236.d 2.21E5 1 1 908 920 Pyro-glu from Q; Deamidation (NQ)
K.ADTGIAVEGASDAAR(-.98).S Y 15.44 1401.6848 15 69.9 701.8987 2 56.09 5 28817 VEV_2_3_RA5_01_1236.d 3.89E4 1 1 654 668 Amidation
R.ITC(+57.02)VK(+43.01).G N 15.38 662.3422 5 -44.6 663.3199 1 98.69 6 54880 VEV_3_3_RA6_01_1237.d 1.51E4 1 1 479 483 Carbamidomethylation; Carbamylation
K.TVEED(+28.03)HAIPEDVDNAYKNK.V Y 15.37 2214.0439 19 9.7 739.0291 3 64.18 4 34649 VEV_1_3_RA4_01_1235.d 0 1 1 492 510 Ethylation
K.V(+42.01)S(+79.97)AVVISPQGER(+14.02).I Y 15.35 1376.6700 12 -17.0 689.3306 2 57.09 4 29371 VEV_1_3_RA4_01_1235.d 4.7E4 1 1 467 478 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.L(+42.01)TEVEAPEVVPGDILQVEEGTIIPADGR.I Y 15.30 2987.5339 28 6.4 996.8583 3 95.47 4 56507 VEV_1_3_RA4_01_1235.d 2.17E5 1 1 197 224 Acetylation (N-term)
K.G(+42.01)IDAIDK.A Y 15.29 772.3967 7 14.2 387.2111 2 30.97 6 13410 VEV_3_3_RA6_01_1237.d 9.58E4 1 1 427 433 Acetylation (N-term)
R.KKYGLNQMK.E Y 15.22 1108.6063 9 -12.4 370.5381 3 45.16 6 21499 VEV_3_3_RA6_01_1237.d 2.51E5 1 1 107 115
K.TINEAK.T Y 15.06 674.3599 6 -2.2 675.3657 1 110.71 6 58281 VEV_3_3_RA6_01_1237.d 0 1 1 552 557
K.YGLNQMK(+28.03).E Y 15.06 880.4477 7 3.2 441.2325 2 67.56 4 37291 VEV_1_3_RA4_01_1235.d 0 1 1 109 115 Dimethylation(KR)
K.GDTC(+57.02)YASSAVK(-1.03)RGEAFMVITSTGDNTFVGR.A Y 15.00 3195.4600 30 -9.9 799.8644 4 79.44 5 45680 VEV_2_3_RA5_01_1236.d 0 1 1 251 280 Carbamidomethylation; Lysine oxidation to aminoadipic semialdehyde
total 519 peptides
C1G0D4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GAGAYGEFEVLDDISDITVIDMLLGVGKK.T Y 200.00 3024.5364 29 -10.3 1009.1757 3 97.53 6 54498 VEV_3_3_RA6_01_1237.d 1.48E6 16 16 43 71
R.VGVKGPLLLQDFHLIDLLAHFDRER.I Y 174.93 2900.6023 25 -12.2 581.1207 5 89.18 6 50963 VEV_3_3_RA6_01_1237.d 6.3E6 20 20 9 33
K.VLGRQPGQQENFVHNVSVHLC(+57.02)GAQEK.V Y 173.39 2930.4570 26 -9.1 733.6149 4 67.20 5 36920 VEV_2_3_RA5_01_1236.d 4.26E6 8 8 414 439 Carbamidomethylation
K.GAGAYGEFEVLDDISDITVIDMLLGVGKKTK.C Y 171.00 3253.6792 31 -9.5 814.4193 4 94.94 5 54227 VEV_2_3_RA5_01_1236.d 1.36E6 6 6 43 73
K.AC(+57.02)QEHEQWAGAALSK.Q Y 167.35 1684.7627 15 -12.8 562.5876 3 51.58 6 25286 VEV_3_3_RA6_01_1237.d 8.57E6 15 15 382 396 Carbamidomethylation
K.M(+15.99)AADNPDWHTEDLFK.A Y 160.33 1804.7726 15 -15.2 602.5890 3 71.86 6 39302 VEV_3_3_RA6_01_1237.d 3.25E6 10 10 218 232 Oxidation (M)
K.TDQGNKTFNNEEATK.M Y 155.32 1695.7700 15 -12.9 566.2567 3 20.59 6 7933 VEV_3_3_RA6_01_1237.d 9.15E6 28 28 203 217
K.MAADNPDWHTEDLFK.A Y 155.17 1788.7777 15 -13.1 597.2587 3 74.39 6 41099 VEV_3_3_RA6_01_1237.d 5E6 12 12 218 232
R.Q(-17.03)PGQQENFVHNVSVHLC(+57.02)GAQEK.V Y 154.80 2488.1553 22 -9.3 830.3846 3 73.41 5 41477 VEV_2_3_RA5_01_1236.d 2.45E6 10 10 418 439 Pyro-glu from Q; Carbamidomethylation
R.GEYPSWTC(+57.02)YVQVLSPEQAEKFR.W Y 153.21 2673.2532 22 -6.6 1337.6250 2 83.85 6 47732 VEV_3_3_RA6_01_1237.d 7.21E5 5 5 237 258 Carbamidomethylation
K.FYTEQGNWDWVFNNTPVFFLRDPSKFPIFIHTQK.R Y 146.26 4218.0791 34 -12.2 844.6128 5 92.51 6 52591 VEV_3_3_RA6_01_1237.d 7.72E5 5 5 101 134
K.DATMFWDYLSTHQESAHQVMHLFSDR.G Y 144.18 3151.3916 26 -11.8 631.2781 5 86.02 6 49079 VEV_3_3_RA6_01_1237.d 9.27E5 6 6 143 168
K.GAGAYGEFEVLDDISDITVIDMLLGVGK.K Y 143.65 2896.4414 28 -6.6 1449.2184 2 97.78 6 54607 VEV_3_3_RA6_01_1237.d 3.6E4 2 2 43 70
R.QPGQQENFVHNVSVHLC(+57.02)GAQEK.V Y 142.70 2505.1819 22 -6.5 627.2987 4 66.36 6 35178 VEV_3_3_RA6_01_1237.d 1.71E6 7 7 418 439 Carbamidomethylation
K.GAGAYGEFEVLDDISDITVIDM(+15.99)LLGVGKK.T Y 142.10 3040.5315 29 -7.1 1014.5106 3 95.74 4 56639 VEV_1_3_RA4_01_1235.d 1.39E6 11 11 43 71 Oxidation (M)
K.AIERGEYPSWTC(+57.02)YVQVLSPEQAEKFR.W Y 140.46 3142.5181 26 -9.4 786.6294 4 81.50 6 46204 VEV_3_3_RA6_01_1237.d 4.55E5 3 3 233 258 Carbamidomethylation
R.VGVKGPLLLQDFHLIDLLAHFDRERIPER.V Y 137.45 3395.8828 29 -14.3 680.1741 5 88.53 6 50530 VEV_3_3_RA6_01_1237.d 1.12E6 7 7 9 37
R.FTLC(+57.02)ENPQNYFAEIEQAAFSPSHMVPGVEPSADPVLQSR.L Y 136.73 4362.0361 39 -6.8 1455.0094 3 91.92 4 54749 VEV_1_3_RA4_01_1235.d 3.71E6 15 15 281 319 Carbamidomethylation
K.GPLLLQDFHLIDLLAHFDRER.I Y 136.50 2517.3491 21 -8.5 504.4728 5 90.64 4 54035 VEV_1_3_RA4_01_1235.d 4.82E6 17 17 13 33
R.FGRFTLC(+57.02)ENPQNYFAEIEQAAFSPSHMVPGVEPSADPVLQSR.L Y 136.09 4722.2271 42 -4.3 1181.5590 4 90.35 5 52062 VEV_2_3_RA5_01_1236.d 8.76E5 7 7 278 319 Carbamidomethylation
K.AIERGEYPSWTC(+57.02)YVQVLSPEQAEK.F Y 135.85 2839.3486 24 -7.5 947.4498 3 81.72 5 47172 VEV_2_3_RA5_01_1236.d 6.87E5 4 4 233 256 Carbamidomethylation
R.WNVFDLTKVWPQAEVPLRR.F Y 135.05 2353.2695 19 -15.1 589.3158 4 86.51 6 49394 VEV_3_3_RA6_01_1237.d 2.35E6 10 10 259 277
R.GEYPSWTC(+57.02)YVQVLSPEQAEK.F Y 134.04 2370.0837 20 -5.2 1186.0430 2 84.66 4 50384 VEV_1_3_RA4_01_1235.d 8.7E5 6 6 237 256 Carbamidomethylation
K.GPLLLQDFHLIDLLAHFDRERIPER.V Y 133.67 3012.6296 25 -5.3 603.5300 5 89.03 4 53153 VEV_1_3_RA4_01_1235.d 2.11E6 10 10 13 37
R.VGVKGPLLLQDFHLIDLLAHFDR.E Y 131.27 2615.4587 23 -17.0 654.8608 4 90.72 5 52254 VEV_2_3_RA5_01_1236.d 1.75E6 11 11 9 31
K.FYTEQGNWDWVFNNTPVFFLR.D Y 130.98 2679.2546 21 -1.8 1340.6322 2 95.96 4 56735 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 101 121
K.WTKPDGTFNYVQIHC(+57.02)K.T Y 129.43 1992.9515 16 -7.7 499.2413 4 66.70 4 36626 VEV_1_3_RA4_01_1235.d 3.39E6 11 11 187 202 Carbamidomethylation
K.QIPVTDEDFVQPNGLWK.V Y 129.24 1984.9894 17 -12.9 993.4891 2 81.72 6 46371 VEV_3_3_RA6_01_1237.d 1.59E6 6 6 397 413
K.GPLLLQDFHLIDLLAHFDR.E Y 128.55 2232.2056 19 -9.1 559.0536 4 93.33 4 55485 VEV_1_3_RA4_01_1235.d 1.01E6 8 8 13 31
K.VLGRQPGQQENFVHNVSVHLC(+57.02)GAQEKVR.K Y 123.50 3185.6265 28 -8.0 638.1274 5 67.28 5 36983 VEV_2_3_RA5_01_1236.d 3.32E5 2 2 414 441 Carbamidomethylation
R.DGAMAINGNYGANPNYPSTFRPMEFKPVK.A Y 122.84 3185.5061 29 -12.4 638.1006 5 77.77 4 45299 VEV_1_3_RA4_01_1235.d 6.52E5 7 7 353 381
K.FRWNVFDLTKVWPQAEVPLRR.F Y 122.42 2656.4390 21 -9.5 532.2900 5 85.49 4 50909 VEV_1_3_RA4_01_1235.d 1.16E6 6 6 257 277
R.NPQTNLKDATMFWDYLSTHQESAHQVMHLFSDR.G Y 121.48 3946.8154 33 29.5 790.3937 5 85.35 4 50825 VEV_1_3_RA4_01_1235.d 1.39E5 3 3 136 168
R.WNVFDLTKVWPQAEVPLR.R Y 121.18 2197.1685 18 -19.3 733.3826 3 90.27 4 53818 VEV_1_3_RA4_01_1235.d 5.71E5 5 5 259 276
R.LGVNYQQIPVNC(+57.02)PLR.A Y 117.66 1769.9247 15 -12.0 885.9590 2 75.90 6 42234 VEV_3_3_RA6_01_1237.d 8.79E6 14 14 331 345 Carbamidomethylation
R.DGAMAIN(+.98)GNYGANPNYPSTFRPMEFKPVK.A Y 117.59 3186.4902 29 -5.2 638.3020 5 78.36 4 45762 VEV_1_3_RA4_01_1235.d 0 1 1 353 381 Deamidation (NQ)
K.MAADNPDWHTEDLFKAIER.G Y 114.41 2258.0425 19 -14.4 565.5098 4 79.20 6 44590 VEV_3_3_RA6_01_1237.d 4.16E5 4 4 218 236
R.Q(-17.03)PGQQENFVHNVSVHLC(+57.02)GAQEKVR.K Y 113.60 2743.3250 24 -8.2 686.8329 4 72.24 4 41010 VEV_1_3_RA4_01_1235.d 1.06E6 5 5 418 441 Pyro-glu from Q; Carbamidomethylation
R.FSTVGGEKGSADSAR.D Y 110.63 1467.6953 15 -8.4 734.8488 2 26.58 4 10969 VEV_1_3_RA4_01_1235.d 3.01E6 13 13 78 92
R.FSTVGGEKGSADSARDPR.G Y 110.60 1835.8761 18 -9.8 612.9600 3 32.23 5 14599 VEV_2_3_RA5_01_1236.d 1.39E7 25 25 78 95
R.QPGQQENFVHNVSVHLC(+57.02)GAQEKVR.K Y 110.31 2760.3513 24 -15.1 691.0847 4 66.45 5 36354 VEV_2_3_RA5_01_1236.d 4.2E5 3 3 418 441 Carbamidomethylation
R.HRLGVNYQQIPVNC(+57.02)PLR.A Y 109.34 2063.0847 17 -17.5 516.7694 4 67.60 6 36083 VEV_3_3_RA6_01_1237.d 1.07E6 6 6 329 345 Carbamidomethylation
R.LFSYPDTHR.H Y 106.23 1134.5458 9 -18.6 379.1822 3 53.76 6 26504 VEV_3_3_RA6_01_1237.d 1.87E7 37 37 320 328
R.FTLC(+57.02)ENPQNYFAEIEQAAFSPSHM(+15.99)VPGVEPSADPVLQSR.L Y 105.83 4378.0308 39 4.4 1095.5198 4 90.39 4 53870 VEV_1_3_RA4_01_1235.d 1.05E6 8 8 281 319 Carbamidomethylation; Oxidation (M)
K.FRWNVFDLTKVWPQAEVPLR.R Y 105.40 2500.3379 20 -8.3 626.0865 4 88.32 4 52699 VEV_1_3_RA4_01_1235.d 8.49E4 2 2 257 276
R.Q(-17.03)PGQQ(+.98)ENFVHNVSVHLC(+57.02)GAQEK.V Y 104.73 2489.1394 22 -2.8 830.7181 3 73.58 4 42037 VEV_1_3_RA4_01_1235.d 1.67E5 3 3 418 439 Pyro-glu from Q; Deamidation (NQ); Carbamidomethylation
K.AC(+57.02)QEHEQ(+.98)WAGAALSK.Q Y 104.53 1685.7467 15 -12.5 562.9158 3 55.54 6 27495 VEV_3_3_RA6_01_1237.d 3.45E6 7 7 382 396 Carbamidomethylation; Deamidation (NQ)
K.DATM(+15.99)FWDYLSTHQESAHQVMHLFSDR.G Y 103.24 3167.3865 26 0.8 634.4851 5 85.04 4 50615 VEV_1_3_RA4_01_1235.d 2.62E5 2 2 143 168 Oxidation (M)
K.AC(+57.02)QEHEQWAGAALSK(+14.02).Q Y 102.93 1698.7783 15 -9.7 567.2612 3 58.50 5 30452 VEV_2_3_RA5_01_1236.d 1.43E6 9 9 382 396 Carbamidomethylation; Methylation(KR)
K.Q(-17.03)IPVTDEDFVQPNGLWK.V Y 99.45 1967.9629 17 -11.1 984.9778 2 88.94 6 50780 VEV_3_3_RA6_01_1237.d 3.42E6 8 8 397 413 Pyro-glu from Q
K.AC(+57.02)QEHE(+14.02)QWAGAALSK.Q Y 99.36 1698.7783 15 -12.1 567.2599 3 59.53 6 30137 VEV_3_3_RA6_01_1237.d 1.3E6 7 7 382 396 Carbamidomethylation; Methylation(others)
K.AC(+57.02)QEHEQW(+31.99)AGAALSK.Q Y 98.89 1716.7526 15 -4.3 859.3799 2 34.09 4 15245 VEV_1_3_RA4_01_1235.d 3.6E5 7 7 382 396 Carbamidomethylation; Dihydroxy
R.DPSKFPIFIHTQK.R Y 98.66 1556.8351 13 -5.9 519.9492 3 68.21 4 37803 VEV_1_3_RA4_01_1235.d 2.52E6 9 9 122 134
K.GAGAYGEFEVLD(+14.02)DISDITVIDMLLGVGKK.T Y 98.09 3038.5520 29 -5.9 1013.8519 3 97.56 5 55233 VEV_2_3_RA5_01_1236.d 2.93E5 2 2 43 71 Methylation(others)
R.LGVNYQ(+.98)QIPVNC(+57.02)PLR.A Y 97.65 1770.9087 15 -13.0 886.4501 2 76.87 6 42926 VEV_3_3_RA6_01_1237.d 1.48E6 5 5 331 345 Deamidation (NQ); Carbamidomethylation
K.AC(+57.02)Q(+.98)EHEQWAGAALSK.Q Y 97.23 1685.7467 15 -11.1 562.9166 3 55.18 5 28272 VEV_2_3_RA5_01_1236.d 2.78E6 8 8 382 396 Carbamidomethylation; Deamidation (NQ)
K.TDQ(+.98)GNKTFNNEEATK.M Y 97.02 1696.7540 15 -16.6 566.5826 3 23.42 6 9348 VEV_3_3_RA6_01_1237.d 2.95E6 5 5 203 217 Deamidation (NQ)
R.MVASQPQSHL Y 94.78 1096.5336 10 -15.6 549.2655 2 44.27 6 20981 VEV_3_3_RA6_01_1237.d 9.44E6 24 24 466 475
K.VWPQAEVPLRR.F Y 93.70 1349.7567 11 -15.0 675.8755 2 66.10 6 34988 VEV_3_3_RA6_01_1237.d 7.28E6 9 9 267 277
R.M(+15.99)VASQPQSHL Y 93.12 1112.5284 10 -10.0 557.2659 2 34.14 5 15731 VEV_2_3_RA5_01_1236.d 1.88E7 56 56 466 475 Oxidation (M)
K.M(+15.99)AADNPDWHTEDLFKAIER.G Y 92.44 2274.0376 19 -6.6 569.5129 4 78.34 4 45746 VEV_1_3_RA4_01_1235.d 1.59E5 3 3 218 236 Oxidation (M)
R.KATYC(+57.02)MFTR.I Y 92.36 1176.5420 9 -15.9 393.1817 3 50.68 5 25601 VEV_2_3_RA5_01_1236.d 4.34E6 15 15 442 450 Carbamidomethylation
K.Q(-17.03)IPVTDEDFVQPN(+.98)GLWK.V Y 92.19 1968.9469 17 -6.3 985.4745 2 90.35 5 52061 VEV_2_3_RA5_01_1236.d 3.44E6 11 11 397 413 Pyro-glu from Q; Deamidation (NQ)
K.AC(+57.02)QE(+14.02)HEQWAGAALSK.Q Y 91.96 1698.7783 15 -8.7 567.2618 3 57.89 4 29933 VEV_1_3_RA4_01_1235.d 7.53E5 7 7 382 396 Carbamidomethylation; Methylation(others)
R.Q(-17.03)PGQQENFVHNVSVHLC(+57.02)GAQEK(+14.02).V Y 91.95 2502.1709 22 -6.6 835.0587 3 75.04 4 43178 VEV_1_3_RA4_01_1235.d 2.88E5 3 3 418 439 Pyro-glu from Q; Carbamidomethylation; Methylation(KR)
R.DGAM(+15.99)AINGNYGANPNYPSTFRPMEFKPVK.A Y 91.59 3201.5012 29 -9.2 801.3752 4 76.00 4 43915 VEV_1_3_RA4_01_1235.d 4.65E5 3 3 353 381 Oxidation (M)
K.TDQGNKTFNNEEATK(+14.02).M Y 90.92 1709.7856 15 -8.5 855.8928 2 28.82 6 12249 VEV_3_3_RA6_01_1237.d 1.78E6 15 15 203 217 Methylation(KR)
R.HMN(+.98)GYSGHTYK.W Y 90.46 1294.5400 11 -13.8 648.2684 2 19.51 6 7329 VEV_3_3_RA6_01_1237.d 1.01E5 4 4 176 186 Deamidation (NQ)
K.TDQGNKTFN(+.98)NEEATK.M Y 90.14 1696.7540 15 -13.9 566.5841 3 22.55 5 9092 VEV_2_3_RA5_01_1236.d 1.11E6 11 11 203 217 Deamidation (NQ)
R.HMNGYSGHTYK.W Y 90.14 1293.5560 11 -15.1 647.7755 2 17.68 6 6340 VEV_3_3_RA6_01_1237.d 2.17E5 4 4 176 186
R.LGVNYQQIPVNC(+57.02)PLR(+14.02).A Y 89.83 1783.9403 15 -8.9 892.9695 2 77.49 5 44375 VEV_2_3_RA5_01_1236.d 1.17E6 7 7 331 345 Carbamidomethylation; Methylation(KR)
K.GAGAYGEFE(+14.02)VLDDISDITVIDMLLGVGKK.T Y 89.76 3038.5520 29 -21.8 1013.8358 3 97.62 6 54537 VEV_3_3_RA6_01_1237.d 0 1 1 43 71 Methylation(others)
R.VGVKGPLLLQDFHLIDLLAHFDR(+14.02)ER.I Y 89.67 2914.6179 25 -8.5 583.9259 5 90.72 6 51683 VEV_3_3_RA6_01_1237.d 4.7E5 3 3 9 33 Methylation(KR)
K.VLGRQPGQQENFVHNVSVHLC(+57.02)GAQEK(+14.02).V Y 88.91 2944.4727 26 -9.0 589.8965 5 68.65 5 38012 VEV_2_3_RA5_01_1236.d 6.96E5 4 4 414 439 Carbamidomethylation; Methylation(KR)
K.TFNNEEATK.M Y 88.88 1052.4774 9 -8.4 527.2416 2 18.31 4 6533 VEV_1_3_RA4_01_1235.d 4.37E6 16 16 209 217
K.TDQGN(+.98)KTFNNEEATK.M Y 87.67 1696.7540 15 -7.9 566.5875 3 24.04 4 9578 VEV_1_3_RA4_01_1235.d 1.17E6 7 7 203 217 Deamidation (NQ)
R.LGVNYQQIPVN(+.98)C(+57.02)PLR.A Y 86.74 1770.9087 15 -11.1 886.4518 2 77.62 5 44502 VEV_2_3_RA5_01_1236.d 5.87E5 5 5 331 345 Deamidation (NQ); Carbamidomethylation
R.FGRFTLC(+57.02)ENPQNYFAEIEQAAFSPSHM(+15.99)VPGVEPSADPVLQSR.L Y 85.85 4738.2222 42 -6.2 948.6459 5 88.79 5 51273 VEV_2_3_RA5_01_1236.d 3.62E5 2 2 278 319 Carbamidomethylation; Oxidation (M)
K.QIPVTDEDFVQPN(+.98)GLWK.V Y 85.83 1985.9734 17 -9.8 993.9843 2 82.48 6 46853 VEV_3_3_RA6_01_1237.d 1.85E6 10 10 397 413 Deamidation (NQ)
R.HM(+15.99)NGYSGHTYK.W Y 84.31 1309.5510 11 -12.6 437.5188 3 12.77 4 3678 VEV_1_3_RA4_01_1235.d 2.08E5 4 4 176 186 Oxidation (M)
R.LFSYPDTHRHR.L Y 84.28 1427.7058 11 -9.2 714.8536 2 37.80 5 17813 VEV_2_3_RA5_01_1236.d 7.59E6 15 15 320 330
R.WNVFDLTK.V Y 83.66 1021.5233 8 -8.7 1022.5216 1 81.69 5 47150 VEV_2_3_RA5_01_1236.d 4.65E6 9 9 259 266
R.INQDLGARIEKATER.M Y 83.47 1712.9169 15 -12.9 429.2310 4 60.51 5 31943 VEV_2_3_RA5_01_1236.d 7.1E5 2 2 451 465
K.TDQGNKTFNNE(+14.02)EATK.M Y 83.07 1709.7856 15 -7.9 570.9313 3 29.87 4 12771 VEV_1_3_RA4_01_1235.d 2.6E6 11 11 203 217 Methylation(others)
K.FRWNVFDLTK.V Y 81.63 1324.6927 10 -12.9 442.5658 3 80.81 5 46602 VEV_2_3_RA5_01_1236.d 1.86E6 6 6 257 266
R.DGAMAINGN(+.98)YGANPNYPSTFRPMEFKPVK.A Y 81.57 3186.4902 29 -7.4 1063.1628 3 78.37 4 45771 VEV_1_3_RA4_01_1235.d 3.69E5 2 2 353 381 Deamidation (NQ)
K.VWPQAEVPLR.R Y 79.58 1193.6556 10 -16.0 597.8256 2 73.01 6 40093 VEV_3_3_RA6_01_1237.d 1.13E6 5 5 267 276
K.AIER(+14.02)GEYPSWTC(+57.02)YVQVLSPEQAEK.F Y 78.87 2853.3643 24 -13.4 952.1160 3 82.26 4 48719 VEV_1_3_RA4_01_1235.d 2.55E5 1 1 233 256 Methylation(KR); Carbamidomethylation
R.INQDLGARIEK.A Y 78.44 1255.6884 11 -7.8 628.8466 2 44.93 4 21720 VEV_1_3_RA4_01_1235.d 5.76E6 14 14 451 461
K.GPLLLQDFHLIDLLAHFDR(+14.02)ER.I Y 77.36 2531.3647 21 -17.8 633.8372 4 92.76 6 52655 VEV_3_3_RA6_01_1237.d 5.73E5 5 5 13 33 Methylation(KR)
K.VLGRQPGQQ(+.98)EN(+.98)FVHNVSVHLC(+57.02)GAQEK(+14.02).V Y 76.71 2946.4407 26 0.4 590.2957 5 68.73 5 38072 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 414 439 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.ATYC(+57.02)MFTR.I Y 76.08 1048.4470 8 -0.8 525.2303 2 61.66 4 32743 VEV_1_3_RA4_01_1235.d 1.49E6 6 6 443 450 Carbamidomethylation
K.MAADNPDWHTEDLFKAIERGEYPSWTC(+57.02)YVQVLSPEQAEK.F Y 75.80 4610.1157 39 -7.2 1153.5280 4 88.87 4 53034 VEV_1_3_RA4_01_1235.d 7.65E4 1 1 218 256 Carbamidomethylation
K.VLGRQPGQ(+.98)Q(+.98)ENFVHNVSVHLC(+57.02)GAQEK.V Y 75.14 2932.4250 26 2.6 734.1155 4 67.27 5 36979 VEV_2_3_RA5_01_1236.d 5.06E4 1 1 414 439 Deamidation (NQ); Carbamidomethylation
K.Q(+.98)IPVTDEDFVQPN(+.98)GLWK.V Y 74.90 1986.9574 17 -3.6 994.4824 2 83.41 4 49504 VEV_1_3_RA4_01_1235.d 4.42E5 2 2 397 413 Deamidation (NQ)
R.FSTVGGEKGSADSAR(+14.02)DPR.G Y 74.70 1849.8918 18 -10.2 463.4755 4 36.58 5 17117 VEV_2_3_RA5_01_1236.d 1.99E6 6 6 78 95 Methylation(KR)
K.MAADNPDWHTEDLFK(+14.02).A Y 74.37 1802.7933 15 -12.4 601.9309 3 76.59 5 43725 VEV_2_3_RA5_01_1236.d 7.88E5 5 5 218 232 Methylation(KR)
R.LGVNYQQIPVNC(+57.02)PLRAFNPYQR.D Y 74.10 2646.3489 22 -6.0 883.1183 3 80.82 5 46603 VEV_2_3_RA5_01_1236.d 2.19E5 2 2 331 352 Carbamidomethylation
K.VLGRQ(+.98)PGQQENFVHNVSVHLC(+57.02)GAQEK.V Y 74.01 2931.4409 26 -9.1 733.8608 4 68.45 5 37870 VEV_2_3_RA5_01_1236.d 1.13E6 4 4 414 439 Deamidation (NQ); Carbamidomethylation
K.TD(+14.02)QGNKTFNNEEATK.M Y 73.56 1709.7856 15 -13.1 570.9283 3 23.25 6 9308 VEV_3_3_RA6_01_1237.d 4.54E5 3 3 203 217 Methylation(others)
R.DGAMAINGNYGANPNYPSTFRPM(+15.99)EFKPVK.A Y 71.95 3201.5012 29 -8.1 641.3023 5 76.09 4 43984 VEV_1_3_RA4_01_1235.d 2.08E5 1 1 353 381 Oxidation (M)
K.QIPVTDEDFVQ(+.98)PNGLWK.V Y 71.85 1985.9734 17 -10.6 993.9834 2 82.22 6 46692 VEV_3_3_RA6_01_1237.d 4.06E5 1 1 397 413 Deamidation (NQ)
K.GAGAYGEFEVLDDISDITVIDMLLGVGK(+43.01)K(+14.02).T Y 70.98 3081.5579 29 -5.1 771.3928 4 91.81 4 54695 VEV_1_3_RA4_01_1235.d 1.72E6 6 6 43 71 Carbamylation; Methylation(KR)
R.D(+42.01)GAM(+15.99)AINGNYGANPNYPSTFRPMEFKPVK.A Y 68.82 3243.5117 29 -14.5 649.7002 5 73.56 5 41562 VEV_2_3_RA5_01_1236.d 5.84E5 2 2 353 381 Acetylation (N-term); Oxidation (M)
K.TDQGNKTFNNEEATK(+164.06).M Y 68.73 1859.8302 15 -5.5 620.9473 3 19.20 5 7315 VEV_2_3_RA5_01_1236.d 4.32E5 3 3 203 217 O-Diisopropylphosphorylation
K.ATERMVASQPQSHL Y 68.38 1553.7620 14 -12.4 518.9215 3 46.88 5 23251 VEV_2_3_RA5_01_1236.d 2.47E5 1 1 462 475
K.GAGAYGEFEVLDDIS(-2.02)DITVIDMLLGVGKK.T Y 67.17 3022.5208 29 9.5 1008.5237 3 97.52 4 57343 VEV_1_3_RA4_01_1235.d 2.73E5 1 1 43 71 2-amino-3-oxo-butanoic_acid
K.ATERM(+15.99)VASQPQSHL Y 66.58 1569.7570 14 -6.9 785.8803 2 34.99 4 15744 VEV_1_3_RA4_01_1235.d 4.17E5 7 7 462 475 Oxidation (M)
K.AC(+57.02)Q(+15.00)EHEQWAGAALSK.Q Y 66.42 1699.7623 15 0.7 567.5951 3 57.98 4 30000 VEV_1_3_RA4_01_1235.d 3.74E5 3 3 382 396 Carbamidomethylation; Deamidation followed by a methylation
R.WNVFDLTKVWPQAEVPLR(+14.02)R.F Y 66.17 2367.2852 19 -9.7 592.8228 4 87.78 6 50138 VEV_3_3_RA6_01_1237.d 4.3E5 3 3 259 277 Methylation(KR)
K.TFNNEEATK(+14.02).M Y 65.90 1066.4930 9 -10.4 534.2482 2 27.37 5 11783 VEV_2_3_RA5_01_1236.d 3.28E6 7 7 209 217 Methylation(KR)
K.M(+15.99)AADNPDWHTEDLFK(+14.02).A Y 65.66 1818.7882 15 -13.1 607.2621 3 74.60 6 41250 VEV_3_3_RA6_01_1237.d 2.21E5 2 2 218 232 Oxidation (M); Methylation(KR)
R.WNVFDLTKVWPQAEVPLRR(+14.02).F Y 65.11 2367.2852 19 -12.0 592.8215 4 87.73 5 50700 VEV_2_3_RA5_01_1236.d 1.88E5 2 2 259 277 Methylation(KR)
R.M(+15.99)VASQPQ(+.98)SHL Y 65.08 1113.5125 10 -8.4 557.7589 2 37.61 5 17705 VEV_2_3_RA5_01_1236.d 2.1E6 12 12 466 475 Oxidation (M); Deamidation (NQ)
R.LGVNYQQ(+.98)IPVNC(+57.02)PLR.A Y 64.79 1770.9087 15 -13.9 886.4493 2 77.31 6 43234 VEV_3_3_RA6_01_1237.d 6.03E5 2 2 331 345 Deamidation (NQ); Carbamidomethylation
K.RNPQTNLK.D Y 64.47 969.5356 8 -10.0 485.7702 2 12.14 4 3365 VEV_1_3_RA4_01_1235.d 2.9E5 4 4 135 142
R.FSTVGGEKGSADSARDPR(+14.02).G Y 64.42 1849.8918 18 -9.2 925.9447 2 36.61 5 17135 VEV_2_3_RA5_01_1236.d 1.85E6 10 10 78 95 Methylation(KR)
K.WT(-18.01)K(+14.02)PDGTFNYVQIHC(+57.02)K.T Y 64.37 1988.9567 16 21.5 498.2571 4 66.65 5 36505 VEV_2_3_RA5_01_1236.d 3.84E5 3 3 187 202 Dehydration; Methylation(KR); Carbamidomethylation
K.FPIFIHTQK.R Y 64.23 1129.6284 9 -12.2 377.5455 3 67.63 4 37343 VEV_1_3_RA4_01_1235.d 5.59E5 4 4 126 134
K.AIERGEYPSWTC(+57.02)YVQVLSPEQ(+.98)AEK.F Y 64.17 2840.3328 24 -1.9 947.7831 3 82.21 4 48677 VEV_1_3_RA4_01_1235.d 8.58E4 1 1 233 256 Carbamidomethylation; Deamidation (NQ)
R.IPERVVHAK.G Y 64.17 1047.6189 9 -14.1 524.8093 2 19.08 5 7249 VEV_2_3_RA5_01_1236.d 1.65E6 8 8 34 42
R.DGAM(+15.99)AINGNYGANPNYPSTFRPM(+15.99)EFKPVK.A Y 63.92 3217.4961 29 -5.8 805.3766 4 72.71 4 41360 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 353 381 Oxidation (M)
K.GAGAYGEFEVLDDISDIT(+59.02)VIDMLLGVGKK.T Y 63.80 3083.5559 29 -4.0 771.8932 4 91.84 4 54689 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 43 71 Aminoethylcysteine
R.LGVNYQ(+.98)QIPVN(+.98)C(+57.02)PLR.A Y 63.60 1771.8927 15 -10.2 886.9446 2 78.55 6 44113 VEV_3_3_RA6_01_1237.d 1.88E5 4 4 331 345 Deamidation (NQ); Carbamidomethylation
R.Q(-17.03)PGQQENFVHNVSVHLC(+57.02)GAQ(+.98)EK.V Y 63.53 2489.1394 22 -11.4 830.7109 3 75.31 5 42815 VEV_2_3_RA5_01_1236.d 5.32E5 4 4 418 439 Pyro-glu from Q; Carbamidomethylation; Deamidation (NQ)
R.MVASQPQ(+.98)SHL Y 63.32 1097.5176 10 -9.6 549.7608 2 47.83 4 23522 VEV_1_3_RA4_01_1235.d 1.52E6 8 8 466 475 Deamidation (NQ)
K.AC(+57.02)QEHEQW(+15.99)AGAALSK.Q Y 63.31 1700.7577 15 -2.8 851.3837 2 47.12 4 23077 VEV_1_3_RA4_01_1235.d 5.43E5 5 5 382 396 Carbamidomethylation; Oxidation (HW)
R.GTPYSYR.H Y 62.93 842.3922 7 -8.5 422.1998 2 29.78 4 12770 VEV_1_3_RA4_01_1235.d 6.29E6 10 10 169 175
R.QP(+421.07)GQQENFVHNVSVHLC(+57.02)GAQEK.V Y 62.58 2926.2551 22 40.2 586.2818 5 67.47 6 35988 VEV_3_3_RA6_01_1237.d 0 1 1 418 439 Fluorescein-5-thiosemicarbazide; Carbamidomethylation
K.VLGRQPGQQEN(+.98)FVHNVSVHLC(+57.02)GAQEK.V Y 61.98 2931.4409 26 -4.9 587.2926 5 68.93 4 38378 VEV_1_3_RA4_01_1235.d 7.48E5 1 1 414 439 Deamidation (NQ); Carbamidomethylation
R.LGVNYQ(+.98)QIPVNC(+57.02)PLR(+14.02).A Y 61.80 1784.9243 15 -11.7 893.4590 2 78.38 5 44974 VEV_2_3_RA5_01_1236.d 1.69E5 2 2 331 345 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
R.VGVK(-1.03)GPLLLQDFHLIDLLAHFDRER.I Y 61.30 2899.5708 25 -3.0 725.8978 4 88.51 4 52820 VEV_1_3_RA4_01_1235.d 0 1 1 9 33 Lysine oxidation to aminoadipic semialdehyde
R.INQDLGAR.I Y 60.49 885.4668 8 -13.1 443.7349 2 25.80 5 10943 VEV_2_3_RA5_01_1236.d 8.35E6 15 15 451 458
R.AFNPYQR.D Y 60.37 894.4348 7 -16.1 448.2174 2 42.03 6 19658 VEV_3_3_RA6_01_1237.d 2.33E7 16 16 346 352
R.FSTVGGEK(+14.02)GSADSAR.D Y 59.99 1481.7109 15 -11.1 494.9054 3 35.47 5 16447 VEV_2_3_RA5_01_1236.d 3.01E5 3 3 78 92 Methylation(KR)
K.AIERGEYPSWTC(+57.02)YVQVLSPEQAEK(+14.02).F Y 59.36 2853.3643 24 -9.8 952.1194 3 82.62 5 47726 VEV_2_3_RA5_01_1236.d 1.6E5 1 1 233 256 Carbamidomethylation; Methylation(KR)
R.MVASQ(+.98)PQSHL Y 58.09 1097.5176 10 -11.1 549.7599 2 49.38 4 24488 VEV_1_3_RA4_01_1235.d 3.29E6 11 11 466 475 Deamidation (NQ)
R.LFSYPDTHR(+14.02).H Y 57.45 1148.5614 9 -16.2 383.8549 3 56.30 5 28982 VEV_2_3_RA5_01_1236.d 2.18E6 10 10 320 328 Methylation(KR)
R.M(+15.99)VASQ(+.98)PQSHL Y 57.26 1113.5125 10 -10.4 557.7577 2 39.10 6 17979 VEV_3_3_RA6_01_1237.d 1.89E6 12 12 466 475 Oxidation (M); Deamidation (NQ)
K.T(+79.97)FNNEEATK.M Y 57.21 1132.4437 9 65.9 567.2665 2 23.26 6 9273 VEV_3_3_RA6_01_1237.d 9.32E4 2 2 209 217 Phosphorylation (STY)
R.FSTVGGEK(+14.02)GSADSARDPR.G Y 57.14 1849.8918 18 -6.6 617.6339 3 39.81 4 18611 VEV_1_3_RA4_01_1235.d 1.89E6 6 6 78 95 Methylation(KR)
R.M(+31.99)VASQPQSHL Y 56.65 1128.5233 10 -11.5 565.2625 2 37.80 5 17814 VEV_2_3_RA5_01_1236.d 8.52E5 5 5 466 475 Sulphone
R.HRLGVNYQ(+.98)QIPVNC(+57.02)PLR.A Y 56.63 2064.0686 17 24.3 517.0370 4 68.74 5 38079 VEV_2_3_RA5_01_1236.d 0 1 1 329 345 Deamidation (NQ); Carbamidomethylation
R.DPSKFPIFIHTQKR.N Y 56.60 1712.9362 14 -13.2 343.5900 5 63.07 4 33813 VEV_1_3_RA4_01_1235.d 7.58E5 3 3 122 135
R.MVASQPQSHL(+14.02) Y 56.18 1110.5492 10 -15.0 556.2736 2 54.15 5 27682 VEV_2_3_RA5_01_1236.d 1.45E6 4 4 466 475 Methylation(C-term)
K.TFN(+.98)NEEATK.M Y 56.14 1053.4614 9 -8.3 527.7336 2 22.05 5 8833 VEV_2_3_RA5_01_1236.d 6.52E5 7 7 209 217 Deamidation (NQ)
K.VLGRQPGQ(+.98)QENFVHNVSVHLC(+57.02)GAQEK.V Y 55.82 2931.4409 26 -13.8 587.2874 5 68.60 6 36840 VEV_3_3_RA6_01_1237.d 0 1 1 414 439 Deamidation (NQ); Carbamidomethylation
R.WNVFDLTK(+14.02).V Y 55.73 1035.5389 8 -14.8 518.7691 2 83.07 6 47255 VEV_3_3_RA6_01_1237.d 4.05E5 3 3 259 266 Methylation(KR)
K.QIPVTDEDFVQPNGLWK(+14.02).V Y 55.44 1999.0050 17 -12.8 1000.4969 2 83.07 6 47261 VEV_3_3_RA6_01_1237.d 2.42E5 4 4 397 413 Methylation(KR)
K.GAGAYGEFEVLDDISDITVID(+17.03)MLLGVGKK.T Y 55.12 3041.5630 29 -15.2 1014.8462 3 95.83 4 56675 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 43 71 Replacement of proton with ammonium ion
K.VWPQ(+.98)AEVPLRR.F Y 54.82 1350.7407 11 -18.3 451.2459 3 67.71 6 36164 VEV_3_3_RA6_01_1237.d 7E5 4 4 267 277 Deamidation (NQ)
R.FSTVGGEK.G Y 54.44 823.4075 8 -9.7 412.7070 2 22.82 4 8906 VEV_1_3_RA4_01_1235.d 4.5E6 9 9 78 85
K.QIPVTDE(+14.02)DFVQPNGLWK.V Y 54.14 1999.0050 17 -7.9 1000.5019 2 83.59 4 49653 VEV_1_3_RA4_01_1235.d 2.82E4 1 1 397 413 Methylation(others)
R.M(+43.01)VASQPQSHL Y 54.01 1139.5393 10 -8.7 570.7720 2 36.77 5 17226 VEV_2_3_RA5_01_1236.d 2.85E5 3 3 466 475 Carbamylation
K.VLGRQPGQQ(+.98)ENFVHNVSVHLC(+57.02)GAQEK(+14.02).V Y 53.86 2945.4565 26 -13.4 590.0907 5 68.74 6 36938 VEV_3_3_RA6_01_1237.d 1.96E4 1 1 414 439 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.TFNN(+.98)EEATK.M Y 53.64 1053.4614 9 -14.9 527.7302 2 22.75 6 8999 VEV_3_3_RA6_01_1237.d 6.52E5 3 3 209 217 Deamidation (NQ)
R.HM(+15.99)N(+.98)GYSGHTYK.W Y 53.63 1310.5350 11 -7.2 656.2701 2 13.41 6 4136 VEV_3_3_RA6_01_1237.d 2.56E5 4 4 176 186 Oxidation (M); Deamidation (NQ)
R.FSTVGGEK(+14.02).G Y 53.21 837.4232 8 -9.4 419.7149 2 33.59 4 14913 VEV_1_3_RA4_01_1235.d 1.66E6 3 3 78 85 Methylation(KR)
K.T(+14.02)DQGNKTFNNEEATK.M Y 53.13 1709.7856 15 -10.2 855.8914 2 23.44 5 9588 VEV_2_3_RA5_01_1236.d 4.33E4 1 1 203 217 Methylation(others)
R.AFNPYQR(+14.02).D Y 52.65 908.4504 7 -15.9 455.2253 2 46.05 6 22053 VEV_3_3_RA6_01_1237.d 2.82E6 8 8 346 352 Methylation(KR)
K.MAAD(+14.02)NPDWHTEDLFK.A Y 52.28 1802.7933 15 -9.2 601.9329 3 76.30 4 44145 VEV_1_3_RA4_01_1235.d 7.69E4 2 2 218 232 Methylation(others)
K.FYTEQGN(+.98)WDWVFNNTPVFFLR.D Y 52.26 2680.2385 21 5.0 894.4246 3 95.89 5 54596 VEV_2_3_RA5_01_1236.d 1.6E4 1 1 101 121 Deamidation (NQ)
R.AFNPYQ(+.98)R.D Y 52.04 895.4188 7 -12.0 448.7113 2 43.40 5 21149 VEV_2_3_RA5_01_1236.d 3.28E6 10 10 346 352 Deamidation (NQ)
K.TFNNE(+14.02)EATK.M Y 51.83 1066.4930 9 -14.4 534.2461 2 27.79 5 12014 VEV_2_3_RA5_01_1236.d 3.28E6 5 5 209 217 Methylation(others)
K.FPIFIHTQKR.N Y 51.23 1285.7295 10 -8.2 322.4370 4 61.87 4 32925 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 126 135
K.FRWNVFDLTK(+14.02).V Y 51.04 1338.7084 10 -9.7 447.2391 3 81.86 4 48432 VEV_1_3_RA4_01_1235.d 2.9E5 3 3 257 266 Methylation(KR)
R.DPSKFPIFIHTQ(+.98)K.R Y 50.57 1557.8191 13 -16.5 390.4556 4 68.96 6 37094 VEV_3_3_RA6_01_1237.d 8.82E4 1 1 122 134 Deamidation (NQ)
R.WNVFDLTKVWPQ(+.98)AEVPLRR.F Y 49.84 2354.2534 19 -3.4 589.5686 4 87.20 6 49774 VEV_3_3_RA6_01_1237.d 9.66E4 1 1 259 277 Deamidation (NQ)
K.Q(-17.03)IPVTDEDFVQ(+.98)PNGLWK.V Y 49.80 1968.9469 17 -9.9 985.4710 2 90.74 6 51713 VEV_3_3_RA6_01_1237.d 9.08E5 1 1 397 413 Pyro-glu from Q; Deamidation (NQ)
K.Q(-17.03)IPVTDEDFVQPNGLWK(+14.02).V Y 49.56 1981.9785 17 -7.6 991.9890 2 90.51 5 52148 VEV_2_3_RA5_01_1236.d 8.62E5 4 4 397 413 Pyro-glu from Q; Methylation(KR)
K.GPLLLQDFHLIDLLAHFDRER(+14.02).I Y 49.03 2531.3647 21 -14.7 507.2728 5 92.03 6 52319 VEV_3_3_RA6_01_1237.d 2.07E5 2 2 13 33 Methylation(KR)
K.MAADN(+.98)PDWHTEDLFKAIER.G Y 48.71 2259.0266 19 6.7 565.7677 4 79.34 6 44735 VEV_3_3_RA6_01_1237.d 7.41E4 2 2 218 236 Deamidation (NQ)
R.INQ(+.98)DLGAR.I Y 48.65 886.4508 8 -15.3 444.2259 2 33.04 5 15017 VEV_2_3_RA5_01_1236.d 2.64E6 8 8 451 458 Deamidation (NQ)
R.VGVKGPLLLQDFHLIDLLAHFDRER(+14.02).I Y 48.33 2914.6179 25 3.5 583.9329 5 91.15 5 52468 VEV_2_3_RA5_01_1236.d 0 1 1 9 33 Methylation(KR)
R.VGVKGPLLLQDFHLIDLLAHFDR(+14.02).E Y 48.22 2629.4744 23 -22.4 526.8904 5 92.31 6 52449 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 9 31 Methylation(KR)
K.TDQGNKTFNN(+.98)EEATK.M Y 47.85 1696.7540 15 -10.8 849.3751 2 24.83 5 10388 VEV_2_3_RA5_01_1236.d 1.29E5 1 1 203 217 Deamidation (NQ)
R.WNVFDLT(+14.02)K.V Y 47.30 1035.5389 8 -8.9 518.7722 2 83.11 5 48031 VEV_2_3_RA5_01_1236.d 1.94E5 1 1 259 266 Methylation(others)
K.M(+42.01)(+15.99)AADNPDWHTEDLFK.A Y 47.29 1846.7832 15 2.6 924.4012 2 66.77 5 36602 VEV_2_3_RA5_01_1236.d 2.63E4 1 1 218 232 Acetylation (N-term); Oxidation (M)
K.GAGAYGEFEVLDDISDITVIDM(+15.99)LLGVGK.K Y 47.21 2912.4365 28 -10.1 971.8097 3 97.67 5 55247 VEV_2_3_RA5_01_1236.d 2.94E4 1 1 43 70 Oxidation (M)
R.LGVNYQQ(+.98)IPVN(+.98)C(+57.02)PLR.A Y 47.09 1771.8927 15 -6.5 886.9479 2 78.66 4 45986 VEV_1_3_RA4_01_1235.d 0 1 1 331 345 Deamidation (NQ); Carbamidomethylation
R.GTPYSYR(+14.02).H Y 46.73 856.4079 7 0.3 429.2114 2 38.87 5 18443 VEV_2_3_RA5_01_1236.d 9.38E5 6 6 169 175 Methylation(KR)
K.TDQGNKTFNNEEAT(+164.06)K.M Y 46.63 1859.8302 15 -6.1 620.9469 3 19.17 6 7180 VEV_3_3_RA6_01_1237.d 4.96E5 5 5 203 217 O-Diisopropylphosphorylation
R.V(+43.01)GVK(+14.02)GPLLLQDFHLIDLLAHFDRER.I Y 46.47 2957.6238 25 -2.4 592.5306 5 88.86 5 51307 VEV_2_3_RA5_01_1236.d 8.99E4 1 1 9 33 Carbamylation; Methylation(KR)
K.MAADNPDW(+31.99)HTEDLFK.A Y 46.45 1820.7676 15 -8.4 607.9247 3 68.01 4 37643 VEV_1_3_RA4_01_1235.d 6.19E4 1 1 218 232 Dihydroxy
R.QPGQQ(+.98)ENFVHNVSVHLC(+57.02)GAQEK.V Y 44.94 2506.1658 22 32.4 836.4230 3 66.75 4 36650 VEV_1_3_RA4_01_1235.d 0 1 1 418 439 Deamidation (NQ); Carbamidomethylation
R.DGAM(+15.99)AIN(+.98)GNYGANPNYPSTFRPMEFKPVK.A Y 44.36 3202.4851 29 -0.8 641.5038 5 76.76 4 44508 VEV_1_3_RA4_01_1235.d 2.41E5 1 1 353 381 Oxidation (M); Deamidation (NQ)
R.LGVNYQ(+.98)Q(+.98)IPVNC(+57.02)PLRAFNPYQR.D Y 44.22 2648.3169 22 5.6 883.7845 3 80.85 5 46610 VEV_2_3_RA5_01_1236.d 4.06E4 1 1 331 352 Deamidation (NQ); Carbamidomethylation
K.GAGAYGEFEVLDDISDITVIDMLLGVGKK(-.98).T Y 44.07 3023.5525 29 -2.9 1008.8552 3 97.51 5 55170 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 43 71 Amidation
K.VWPQAEVPLR(+14.02)R.F Y 43.93 1363.7725 11 -17.3 455.5902 3 66.69 6 35435 VEV_3_3_RA6_01_1237.d 1.05E6 5 5 267 277 Methylation(KR)
R.INQDLGAR(+14.02).I Y 43.83 899.4825 8 -12.2 450.7430 2 34.75 5 16028 VEV_2_3_RA5_01_1236.d 1.87E6 7 7 451 458 Methylation(KR)
K.QIPVTD(+14.02)EDFVQPNGLWK.V Y 43.74 1999.0050 17 -11.2 1000.4985 2 83.48 5 48246 VEV_2_3_RA5_01_1236.d 2.11E5 3 3 397 413 Methylation(others)
R.FSTVGGEKGSADSAR(+14.02).D Y 43.62 1481.7109 15 -8.7 494.9066 3 34.30 5 15761 VEV_2_3_RA5_01_1236.d 2.2E5 2 2 78 92 Methylation(KR)
R.LGVNY(-2.02)QQIPVNC(+57.02)PLR.A Y 42.72 1767.9091 15 -17.2 590.3002 3 76.21 4 44066 VEV_1_3_RA4_01_1235.d 1.1E5 3 3 331 345 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.ATYC(+57.02)M(+15.99)FTR.I Y 42.55 1064.4419 8 -9.1 533.2234 2 45.16 4 21866 VEV_1_3_RA4_01_1235.d 9.24E5 8 8 443 450 Carbamidomethylation; Oxidation (M)
R.AFN(+.98)PYQR.D Y 42.24 895.4188 7 10.6 448.7214 2 41.60 4 19669 VEV_1_3_RA4_01_1235.d 2.48E6 3 3 346 352 Deamidation (NQ)
K.WTKPDGTFNYVQIHC(+57.02)K(+14.02).T Y 42.23 2006.9673 16 -10.1 502.7440 4 67.19 6 35768 VEV_3_3_RA6_01_1237.d 2.37E5 2 2 187 202 Carbamidomethylation; Methylation(KR)
R.IN(+.98)QDLGAR.I Y 41.83 886.4508 8 -6.7 444.2297 2 29.66 5 13070 VEV_2_3_RA5_01_1236.d 1.24E6 5 5 451 458 Deamidation (NQ)
R.HR(+14.02)LGVNY(-18.01)QQIPVNC(+57.02)PLR.A Y 41.52 2059.0898 17 -15.1 515.7720 4 67.49 5 37138 VEV_2_3_RA5_01_1236.d 1.6E5 2 2 329 345 Methylation(KR); Dehydration; Carbamidomethylation
K.TDQGNKTFN(+.98)NEEATK(+14.02).M Y 41.39 1710.7697 15 -9.4 571.2585 3 33.99 6 15071 VEV_3_3_RA6_01_1237.d 1.05E6 6 6 203 217 Deamidation (NQ); Methylation(KR)
R.HRLGVNY(-2.02)QQIPVNC(+57.02)PLR.A Y 41.31 2061.0691 17 -14.7 516.2670 4 68.85 4 38311 VEV_1_3_RA4_01_1235.d 9.86E4 1 1 329 345 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.MAADNPD(+14.02)WHTEDLFK.A Y 40.92 1802.7933 15 -9.7 601.9326 3 75.58 4 43582 VEV_1_3_RA4_01_1235.d 9.01E4 2 2 218 232 Methylation(others)
R.LGVNYQQIPVNC(+57.02)PLR(+.98).A Y 40.74 1770.9087 15 -14.3 591.3018 3 77.73 6 43537 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 331 345 Carbamidomethylation; Deamidation (R)
K.VW(+15.99)PQAEVPLRR.F Y 40.68 1365.7517 11 -21.1 456.2483 3 62.81 6 32493 VEV_3_3_RA6_01_1237.d 5.06E5 3 3 267 277 Oxidation (HW)
R.FTLC(+57.02)ENPQNYFAE(+14.02)IEQAAFSPSHMVPGVEPSADPVLQSR.L Y 40.40 4376.0518 39 -0.4 876.2173 5 92.85 5 53280 VEV_2_3_RA5_01_1236.d 1.79E5 1 1 281 319 Carbamidomethylation; Methylation(others)
R.LFSYPDTHR(+.98).H Y 40.35 1135.5298 9 -1.4 379.5167 3 53.39 6 26303 VEV_3_3_RA6_01_1237.d 4.97E6 5 5 320 328 Deamidation (R)
K.TDQGNKTFNNEEATK(+28.03).M Y 39.77 1723.8013 15 -7.1 575.6036 3 39.39 5 18763 VEV_2_3_RA5_01_1236.d 1.26E5 2 2 203 217 Dimethylation(KR)
K.G(+380.15)PLLLQDFHLIDLLAHFDRER.I Y 39.56 2897.4963 21 -21.1 725.3661 4 88.87 4 53037 VEV_1_3_RA4_01_1235.d 0 1 1 13 33 Nucleophilic addition to cytopiloyne+H2O
R.Q(-17.03)PGQQEN(+.98)FVHNVSVHLC(+57.02)GAQEK.V Y 39.48 2489.1394 22 -9.7 830.7124 3 74.97 6 41516 VEV_3_3_RA6_01_1237.d 4.68E5 3 3 418 439 Pyro-glu from Q; Deamidation (NQ); Carbamidomethylation
R.IEKATER.M Y 39.38 845.4606 7 -15.5 423.7310 2 9.25 5 2230 VEV_2_3_RA5_01_1236.d 1.76E5 4 4 459 465
R.DGAMAINGNYGANPNYPSTFR(+14.02)PMEFK(+43.01)PVK.A Y 39.17 3242.5276 29 -9.0 649.5070 5 71.24 6 38793 VEV_3_3_RA6_01_1237.d 3.25E5 2 2 353 381 Methylation(KR); Carbamylation
K.TD(+37.95)QGNKTFNNEEATK.M Y 39.05 1733.7169 15 -12.1 578.9059 3 21.01 4 7934 VEV_1_3_RA4_01_1235.d 2.68E4 1 1 203 217 Replacement of 2 protons by calcium
K.QIPVTDEDFVQPNGLW(+15.99)K.V Y 38.05 2000.9843 17 -12.3 1001.4871 2 80.69 6 45648 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 397 413 Oxidation (HW)
R.KATYC(+57.02)M(+15.99)FTR.I Y 37.65 1192.5369 9 -11.3 597.2690 2 34.86 6 15571 VEV_3_3_RA6_01_1237.d 1.33E6 9 9 442 450 Carbamidomethylation; Oxidation (M)
K.AC(+57.02)QEHEQW(+3.99)AGAALSK.Q Y 37.64 1688.7577 15 -3.2 563.9247 3 46.05 4 22415 VEV_1_3_RA4_01_1235.d 2.01E5 2 2 382 396 Carbamidomethylation; Tryptophan oxidation to kynurenin
K.F(+43.01)R(+14.02)WNVFDLTK.V Y 37.56 1381.7142 10 -12.5 461.5729 3 82.60 4 48944 VEV_1_3_RA4_01_1235.d 3.08E4 1 1 257 266 Carbamylation; Methylation(KR)
R.INQD(+14.02)LGAR.I Y 37.51 899.4825 8 -38.1 450.7314 2 30.50 6 13190 VEV_3_3_RA6_01_1237.d 8.77E5 4 4 451 458 Methylation(others)
K.AC(+57.02)QEHEQWAGAALS(-18.01)K(+14.02).Q Y 37.41 1680.7678 15 -7.9 841.3845 2 52.66 4 26597 VEV_1_3_RA4_01_1235.d 7.39E3 2 2 382 396 Carbamidomethylation; Dehydration; Methylation(KR)
R.FTLC(+57.02)ENPQNYFAEIEQAAFSPSHM(-4.99)VPGVEPSADPVLQSR.L Y 37.31 4357.0498 39 -14.0 1090.2545 4 95.68 4 56600 VEV_1_3_RA4_01_1235.d 8.33E2 1 1 281 319 Carbamidomethylation; Methionine replacement by azido homoalanine
R.LGVN(+.98)YQQIPVNC(+57.02)PLR(+14.02).A Y 37.05 1784.9243 15 -13.1 893.4578 2 78.37 6 43988 VEV_3_3_RA6_01_1237.d 3.65E4 1 1 331 345 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.GAGAYGEFEVLDDISDITVIDMLLGVGKKTKC(+57.02)ITR.F Y 35.85 3783.9426 35 -0.5 757.7954 5 92.63 5 53182 VEV_2_3_RA5_01_1236.d 6.59E4 1 1 43 77 Carbamidomethylation
R.L(+41.03)FSYPDTHR.H Y 35.76 1175.5723 9 -17.9 392.8577 3 53.29 6 26239 VEV_3_3_RA6_01_1237.d 0 1 1 320 328 Amidination of lysines or N-terminal amines with methyl acetimidate
K.QIPVTDEDFVQPN(+.98)GLWK(+14.02).V Y 35.55 1999.9890 17 0.0 1001.0018 2 83.72 5 48389 VEV_2_3_RA5_01_1236.d 1.75E5 3 3 397 413 Deamidation (NQ); Methylation(KR)
R.M(-48.00)VASQPQSHL Y 35.38 1048.5302 10 -14.5 525.2648 2 22.86 6 9054 VEV_3_3_RA6_01_1237.d 3.3E6 7 7 466 475 Dethiomethyl
R.D(+55.92)GAMAINGNYGANPNYPSTFRPMEFKPVK.A Y 35.34 3241.4258 29 11.7 811.3732 4 73.60 5 41596 VEV_2_3_RA5_01_1236.d 0 1 1 353 381 Replacement of 2 protons by nickel
K.ATYC(+57.02)MFTR(+14.02).I Y 34.89 1062.4626 8 -9.3 532.2336 2 64.67 4 35015 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 443 450 Carbamidomethylation; Methylation(KR)
R.IN(+.98)QDLGARIEK.A Y 34.81 1256.6724 11 -8.3 629.3383 2 49.93 5 25106 VEV_2_3_RA5_01_1236.d 4.07E4 2 2 451 461 Deamidation (NQ)
R.Q(-17.03)PGQQENFVHN(+.98)VSVHLC(+57.02)GAQEK.V Y 34.62 2489.1394 22 -17.6 830.7058 3 76.61 4 44392 VEV_1_3_RA4_01_1235.d 8.09E4 1 1 418 439 Pyro-glu from Q; Deamidation (NQ); Carbamidomethylation
K.RNPQTNLK(+14.02).D Y 34.48 983.5512 8 -8.3 492.7788 2 18.07 4 6400 VEV_1_3_RA4_01_1235.d 8.43E4 3 3 135 142 Methylation(KR)
R.Q(+.98)PGQQENFVHNVSVHLC(+57.02)GAQEK.V Y 34.04 2506.1658 22 -3.5 627.5465 4 67.82 4 37496 VEV_1_3_RA4_01_1235.d 2.06E5 1 1 418 439 Deamidation (NQ); Carbamidomethylation
K.FRWNVFD(+14.02)LTK.V Y 33.93 1338.7084 10 -20.2 447.2344 3 80.65 4 47521 VEV_1_3_RA4_01_1235.d 3.1E4 1 1 257 266 Methylation(others)
R.FSTVGGEKGSADSARDPRGFSTK.F Y 33.88 2356.1406 23 -11.5 590.0356 4 48.23 5 24061 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 78 100
R.A(+43.01)FNPYQR.D Y 33.50 937.4406 7 -1.7 469.7268 2 41.59 6 19431 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 346 352 Carbamylation
K.M(+15.99)AADNPDW(+31.99)HTEDLFK.A Y 33.38 1836.7625 15 15.3 613.2708 3 64.86 6 34011 VEV_3_3_RA6_01_1237.d 0 2 2 218 232 Oxidation (M); Dihydroxy
K.M(-48.00)AADNPDWHTEDLFK.A Y 33.11 1740.7743 15 -12.9 436.1953 4 66.86 4 36734 VEV_1_3_RA4_01_1235.d 1.28E6 3 3 218 232 Dethiomethyl
R.GEYPSWTC(+57.02)YVQVLSPEQAEK(+14.02).F Y 32.78 2384.0994 20 5.6 1193.0636 2 85.73 4 51067 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 237 256 Carbamidomethylation; Methylation(KR)
K.TDQ(+.98)GNKTFNNEEATK(+14.02).M Y 32.65 1710.7697 15 -10.1 856.3834 2 32.06 6 14004 VEV_3_3_RA6_01_1237.d 8.32E4 1 1 203 217 Deamidation (NQ); Methylation(KR)
K.GPLLLQ(+.98)DFHLIDLLAHFDRER.I Y 32.20 2518.3333 21 -4.0 504.6719 5 91.67 5 52727 VEV_2_3_RA5_01_1236.d 0 1 1 13 33 Deamidation (NQ)
K.QIPVTDEDFVQPN(-17.03)GLWK.V Y 32.09 1967.9629 17 -7.7 984.9811 2 83.10 5 48016 VEV_2_3_RA5_01_1236.d 1.65E5 2 2 397 413 Ammonia-loss (N)
R.DGAM(+15.99)AIN(+.98)GNYGANPNYPSTFRPM(+15.99)EFKPVK.A Y 31.86 3218.4800 29 -0.8 805.6266 4 73.36 4 41868 VEV_1_3_RA4_01_1235.d 1.67E5 1 1 353 381 Oxidation (M); Deamidation (NQ)
K.TDQGNK(+14.02)TFNNEEATK.M Y 31.76 1709.7856 15 -11.5 855.8903 2 23.28 6 9281 VEV_3_3_RA6_01_1237.d 3.11E4 1 1 203 217 Methylation(KR)
K.C(+57.02)ITRFSTVGGEKGSADSARDPR.G Y 31.66 2366.1396 22 -1.6 592.5413 4 47.61 5 23701 VEV_2_3_RA5_01_1236.d 8.87E4 1 1 74 95 Carbamidomethylation
R.WN(+.98)VFDLTK.V Y 31.60 1022.5073 8 -2.9 512.2594 2 82.82 5 47847 VEV_2_3_RA5_01_1236.d 1.08E4 1 1 259 266 Deamidation (NQ)
R.AFNPYQ(+.98)R(+14.02).D Y 31.27 909.4344 7 -14.1 455.7181 2 49.91 5 25099 VEV_2_3_RA5_01_1236.d 6.25E5 2 2 346 352 Deamidation (NQ); Methylation(KR)
R.F(+71.04)TLC(+57.02)ENPQNYFAEIEQAAFSPSHMVPGVEPSADPVLQSR.L Y 31.12 4433.0732 39 -4.8 887.6177 5 88.24 6 50383 VEV_3_3_RA6_01_1237.d 1.84E5 1 1 281 319 Propionamide (K, X@N-term); Carbamidomethylation
R.L(+42.01)FSYPDTHR(+14.02).H Y 30.70 1190.5720 9 -20.6 397.8564 3 56.75 4 29132 VEV_1_3_RA4_01_1235.d 7.97E4 1 1 320 328 Acetylation (N-term); Methylation(KR)
K.DATM(-4.99)FWDYLSTHQESAHQVMHLFSDR.G Y 30.67 3146.4053 26 45.3 630.3168 5 86.15 6 49160 VEV_3_3_RA6_01_1237.d 0 1 1 143 168 Methionine replacement by azido homoalanine
R.QPGQQENFVHNVSVHLC(+57.02)GAQEK(+14.02).V Y 30.56 2519.1975 22 -10.1 840.7313 3 68.44 4 37989 VEV_1_3_RA4_01_1235.d 1.37E5 2 2 418 439 Carbamidomethylation; Methylation(KR)
K.GAGAYGEFEVLDDIS(+58.03)DITVIDMLLGVGK.K Y 30.50 2954.4707 28 -11.8 985.8192 3 95.39 5 54385 VEV_2_3_RA5_01_1236.d 2.47E5 2 2 43 70 2,3-dihydro-2,2-dimethyl-7-benzofuranol N-methyl carbamate
K.FRWNVFDLTKVWPQAEVPLR(+14.02)R.F Y 30.09 2670.4546 21 25.2 535.1116 5 86.46 5 49999 VEV_2_3_RA5_01_1236.d 0 1 1 257 277 Methylation(KR)
R.KATYC(+57.02)MFTR(+.98).I Y 29.79 1177.5260 9 1.5 393.5165 3 50.87 5 25677 VEV_2_3_RA5_01_1236.d 4.66E5 2 2 442 450 Carbamidomethylation; Deamidation (R)
K.MAADNPDW(+15.99)HTEDLFK.A Y 29.58 1804.7726 15 3.3 602.6001 3 71.41 5 40032 VEV_2_3_RA5_01_1236.d 0 1 1 218 232 Oxidation (HW)
R.D(+42.01)PR(+14.02)GFSTK.F Y 28.48 962.4821 8 -23.2 482.2372 2 36.30 5 16980 VEV_2_3_RA5_01_1236.d 0 1 1 93 100 Acetylation (N-term); Methylation(KR)
R.DGAMAIN(+.98)GNYGANPN(+.98)YPSTFRPMEFKPVK.A Y 28.09 3187.4741 29 -0.7 797.8752 4 78.92 4 46188 VEV_1_3_RA4_01_1235.d 0 1 1 353 381 Deamidation (NQ)
K.GSADSARDPR.G Y 28.00 1030.4791 10 -12.9 516.2402 2 10.17 6 2570 VEV_3_3_RA6_01_1237.d 2.82E4 1 1 86 95
R.FSTVGGEK(+14.02)GSADSARDPR(+14.02).G Y 27.90 1863.9075 18 -15.6 622.3000 3 45.28 5 22299 VEV_2_3_RA5_01_1236.d 9.48E4 1 1 78 95 Methylation(KR)
K.TFNNEEAT(+164.06)K.M Y 27.87 1216.5376 9 -6.0 609.2724 2 17.14 6 6058 VEV_3_3_RA6_01_1237.d 2.65E5 2 2 209 217 O-Diisopropylphosphorylation
R.H(+42.01)M(+15.99)NGYSGHTYK.W Y 27.75 1351.5615 11 -5.9 676.7841 2 11.17 6 2994 VEV_3_3_RA6_01_1237.d 2.45E4 1 1 176 186 Acetylation (N-term); Oxidation (M)
R.FTLC(+57.02)ENPQNYFAEIEQAAFSPS(+13.03)HMVPGVEPSADPVLQSR.L Y 27.61 4375.0679 39 3.5 876.0239 5 92.45 6 52511 VEV_3_3_RA6_01_1237.d 2.03E4 1 1 281 319 Carbamidomethylation; Michael addition with methylamine
R.MVASQ(+.98)PQ(+.98)SHL Y 27.57 1098.5016 10 3.0 550.2597 2 47.36 6 22776 VEV_3_3_RA6_01_1237.d 7.46E4 1 1 466 475 Deamidation (NQ)
K.TFNNEEATK(+28.03).M Y 27.56 1080.5088 9 -7.7 541.2575 2 38.31 4 17691 VEV_1_3_RA4_01_1235.d 3.42E5 1 1 209 217 Dimethylation(KR)
R.FSTVGGEK(+164.06)GSADSARDPR.G Y 27.54 1999.9364 18 -8.0 667.6474 3 30.19 5 13374 VEV_2_3_RA5_01_1236.d 9.37E4 1 1 78 95 O-Diisopropylphosphorylation
R.KATYC(+57.02)M(-48.00)FTR.I Y 27.46 1128.5386 9 -15.4 377.1810 3 21.36 5 8465 VEV_2_3_RA5_01_1236.d 4.07E6 3 3 442 450 Carbamidomethylation; Dethiomethyl
R.VGVKGPLLLQ(+.98)DFHLIDLLAHFDR.E Y 27.21 2616.4426 23 -9.0 524.2911 5 92.18 6 52386 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 9 31 Deamidation (NQ)
R.G(+42.01)TPYSYR.H Y 26.52 884.4028 7 25.1 443.2198 2 29.58 6 12642 VEV_3_3_RA6_01_1237.d 0 2 2 169 175 Acetylation (N-term)
K.QIPVT(-2.02)DEDFVQPNGLWK.V Y 26.45 1982.9738 17 9.3 662.0047 3 81.89 4 48451 VEV_1_3_RA4_01_1235.d 6.15E4 1 1 397 413 2-amino-3-oxo-butanoic_acid
R.D(+42.01)PSK(+42.01)FPIFIHTQK.R Y 26.10 1640.8562 13 24.1 411.2312 4 68.18 4 37778 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 122 134 Acetylation (N-term); Acetylation (K)
R.FS(-18.01)TVGGEK(+14.02)GSADSARDPR.G Y 26.02 1831.8812 18 28.0 458.9904 4 32.68 5 14815 VEV_2_3_RA5_01_1236.d 3.89E4 1 1 78 95 Dehydration; Methylation(KR)
K.VLGRQPGQQENFVHNVSVHLC(+57.02)GAQEK(-.98).V Y 25.90 2929.4729 26 -21.8 733.3596 4 67.15 5 36883 VEV_2_3_RA5_01_1236.d 8.54E4 2 2 414 439 Carbamidomethylation; Amidation
K.M(-4.99)AADNPDWHTEDLFK.A Y 25.81 1783.7914 15 72.8 595.6477 3 74.91 4 43056 VEV_1_3_RA4_01_1235.d 0 1 1 218 232 Methionine replacement by azido homoalanine
R.INQDLGARIEK(+14.02).A Y 25.63 1269.7041 11 -10.9 635.8524 2 53.02 4 26817 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 451 461 Methylation(KR)
K.T(+164.06)DQGNKTFNNEEATK.M Y 25.59 1859.8302 15 -9.4 620.9448 3 17.97 6 6489 VEV_3_3_RA6_01_1237.d 1.95E5 3 3 203 217 O-Diisopropylphosphorylation
R.IEKATER(+14.02).M Y 25.54 859.4763 7 -15.9 430.7386 2 11.62 6 3218 VEV_3_3_RA6_01_1237.d 4.14E4 1 1 459 465 Methylation(KR)
K.Q(+.98)IPVTDEDFVQPNGLWK(+14.02).V Y 25.46 1999.9890 17 -20.9 1000.9809 2 83.16 5 48050 VEV_2_3_RA5_01_1236.d 7.84E4 1 1 397 413 Deamidation (NQ); Methylation(KR)
R.FSTVGGEK(+164.06).G Y 25.24 987.4678 8 -4.5 494.7390 2 20.94 6 8098 VEV_3_3_RA6_01_1237.d 1.81E5 1 1 78 85 O-Diisopropylphosphorylation
R.FSTVGGE(+14.02)KGSADSAR.D Y 25.19 1481.7109 15 -16.6 494.9027 3 35.43 6 15903 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 78 92 Methylation(others)
R.DPS(-18.01)K(+14.02)FPIFIHTQK.R Y 24.96 1552.8401 13 -40.0 518.5999 3 68.17 5 37671 VEV_2_3_RA5_01_1236.d 7.81E4 1 1 122 134 Dehydration; Methylation(KR)
R.MVAS(+14.02)QPQSHL Y 24.83 1110.5492 10 13.1 556.2891 2 37.66 5 17743 VEV_2_3_RA5_01_1236.d 4.21E4 1 1 466 475 Methylation(others)
R.M(+15.99)VASQ(+.98)PQ(+.98)SHL Y 24.72 1114.4965 10 13.6 558.2631 2 39.24 4 18242 VEV_1_3_RA4_01_1235.d 9.26E5 3 3 466 475 Oxidation (M); Deamidation (NQ)
R.GE(+14.02)YPSWTC(+57.02)YVQVLSPEQAEK.F Y 24.56 2384.0994 20 -6.2 795.7021 3 85.42 4 50868 VEV_1_3_RA4_01_1235.d 7E4 1 1 237 256 Methylation(others); Carbamidomethylation
K.TDQGNKT(+164.06)FNNEEATK.M Y 24.50 1859.8302 15 -9.0 930.9140 2 19.26 6 7181 VEV_3_3_RA6_01_1237.d 5.19E4 1 1 203 217 O-Diisopropylphosphorylation
R.DGAMAINGN(+.98)YGANPN(+.98)YPSTFRPMEFKPVK.A Y 24.15 3187.4741 29 -1.7 797.8745 4 78.85 5 45283 VEV_2_3_RA5_01_1236.d 0 1 1 353 381 Deamidation (NQ)
K.AC(+57.02)QEHEQ(+.98)W(+31.99)AGAALSK.Q Y 23.95 1717.7366 15 0.3 573.5863 3 40.60 4 19052 VEV_1_3_RA4_01_1235.d 7.16E4 1 1 382 396 Carbamidomethylation; Deamidation (NQ); Dihydroxy
R.HRLGVNYQQIPVNC(+57.02)PLR(+14.02).A Y 23.93 2077.1003 17 -33.1 520.2652 4 69.72 5 38797 VEV_2_3_RA5_01_1236.d 1.83E5 1 1 329 345 Carbamidomethylation; Methylation(KR)
K.TD(-18.01)QGNK(+14.02)TFNNEEATK.M Y 23.81 1691.7750 15 16.4 564.9415 3 21.40 5 8495 VEV_2_3_RA5_01_1236.d 0 1 1 203 217 Dehydration; Methylation(KR)
R.M(-4.99)VASQPQSHL Y 23.65 1091.5472 10 -12.1 546.7743 2 43.91 5 21460 VEV_2_3_RA5_01_1236.d 4.75E5 1 1 466 475 Methionine replacement by azido homoalanine
R.DGAMAINGNYGANPNYPSTFR(+14.02)PME(+43.99)FKPVK.A Y 23.59 3243.5117 29 -14.8 811.8732 4 72.07 5 40513 VEV_2_3_RA5_01_1236.d 3.1E5 2 2 353 381 Methylation(KR); Carboxylation (E)
K.T(+79.96)FNNEEATK.M Y 23.31 1132.4342 9 55.8 567.2560 2 22.72 6 8986 VEV_3_3_RA6_01_1237.d 3.99E4 1 1 209 217 Sulfation
K.GAGAYGEFEVLDDISDITVIDM(+15.99)LLGVGKKTK.C Y 23.23 3269.6741 31 -4.0 818.4225 4 92.81 6 52676 VEV_3_3_RA6_01_1237.d 2.9E5 1 1 43 73 Oxidation (M)
R.FTLC(+57.02)ENPQNYFAEIEQAAFS(+58.03)PSHMVPGVEPSADPVLQSR.L Y 23.20 4420.0654 39 -12.5 1106.0098 4 88.56 5 51142 VEV_2_3_RA5_01_1236.d 0 1 1 281 319 Carbamidomethylation; 2,3-dihydro-2,2-dimethyl-7-benzofuranol N-methyl carbamate
R.MVASQPQS(+14.02)HL Y 23.02 1110.5492 10 -18.9 556.2714 2 55.44 5 28425 VEV_2_3_RA5_01_1236.d 6.05E5 1 1 466 475 Methylation(others)
R.QPGQQENFVHNVSVH(+14.02)LC(+57.02)GAQEK.V Y 23.02 2519.1975 22 -10.3 840.7311 3 68.25 5 37733 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 418 439 Methylation(others); Carbamidomethylation
K.ATERMVASQPQSHL(-.98) Y 22.95 1552.7780 14 -4.2 777.3930 2 46.88 5 23257 VEV_2_3_RA5_01_1236.d 0 1 1 462 475 Amidation
K.TDQGNK(+14.02)T(-18.01)FNNEEATK.M Y 22.83 1691.7750 15 16.8 564.9418 3 22.81 4 8901 VEV_1_3_RA4_01_1235.d 1.88E4 1 1 203 217 Methylation(KR); Dehydration
R.GFSTK.F Y 22.79 538.2751 5 1.5 539.2831 1 11.42 4 3044 VEV_1_3_RA4_01_1235.d 9.49E3 1 1 96 100
K.AT(+79.97)ER(+31.99)MVASQPQSHL Y 22.70 1665.7181 14 57.0 556.2783 3 41.52 5 20033 VEV_2_3_RA5_01_1236.d 9.57E3 1 1 462 475 Phosphorylation (STY); Dihydroxy
R.D(+56.06)GAMAINGNYGANPNYPSTFRPMEFKPVK.A Y 22.63 3241.5688 29 14.1 649.3302 5 72.51 5 40840 VEV_2_3_RA5_01_1236.d 7.86E2 1 1 353 381 Diethylation
K.TDQGNK(+14.02).T Y 22.49 675.3188 6 10.6 676.3332 1 112.59 4 61849 VEV_1_3_RA4_01_1235.d 3.35E4 2 2 203 208 Methylation(KR)
R.L(+43.01)FSYPDTHR(+14.02).H Y 22.18 1191.5673 9 -21.5 398.1878 3 56.39 6 27963 VEV_3_3_RA6_01_1237.d 2.08E5 1 1 320 328 Carbamylation; Methylation(KR)
R.KATYC(+57.02)MFTR(+14.02).I Y 22.17 1190.5576 9 -13.4 397.8545 3 56.48 5 29071 VEV_2_3_RA5_01_1236.d 1.65E5 2 2 442 450 Carbamidomethylation; Methylation(KR)
R.INQD(+14.02)LGARIEK.A Y 22.06 1269.7041 11 -17.0 424.2348 3 47.02 5 23336 VEV_2_3_RA5_01_1236.d 8.77E4 1 1 451 461 Methylation(others)
R.DGAMAINGNYGANPNYPSTFR(+14.02)PMEFK(+42.01)PVK.A Y 21.95 3241.5325 29 43.7 649.3421 5 72.10 5 40535 VEV_2_3_RA5_01_1236.d 0 1 1 353 381 Methylation(KR); Acetylation (K)
K.TFNNEEATKMAADNPDWHTEDLFK.A Y 21.28 2823.2446 24 9.4 706.8251 4 76.34 5 43550 VEV_2_3_RA5_01_1236.d 0 1 1 209 232
K.TFNNEE(+28.03)ATK.M Y 21.26 1080.5088 9 -13.6 541.2543 2 37.79 6 17228 VEV_3_3_RA6_01_1237.d 3.02E5 1 1 209 217 Ethylation
R.FSTVGGEKGSADSARDPR(+.98).G Y 21.05 1836.8601 18 2.7 613.2957 3 32.67 4 14383 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 78 95 Deamidation (R)
R.GFSTK(+14.02).F Y 20.95 552.2908 5 -17.2 553.2886 1 16.38 6 5656 VEV_3_3_RA6_01_1237.d 9.31E3 1 1 96 100 Methylation(KR)
R.FST(+79.97)VGGEKGSADSARDPR.G Y 20.80 1915.8425 18 -11.2 958.9178 2 32.51 5 14721 VEV_2_3_RA5_01_1236.d 3.9E4 1 1 78 95 Phosphorylation (STY)
R.INQDLGAR(+14.02)IEK.A Y 20.56 1269.7041 11 -16.5 424.2350 3 53.94 5 27554 VEV_2_3_RA5_01_1236.d 4.12E5 1 1 451 461 Methylation(KR)
R.INQDLGARIEKATER(+14.02).M Y 20.34 1726.9325 15 -7.9 576.6469 3 62.49 5 33398 VEV_2_3_RA5_01_1236.d 5.2E4 1 1 451 465 Methylation(KR)
R.DPSKFPIFIHTQK(+14.02).R Y 20.25 1570.8507 13 -0.1 393.7199 4 68.45 4 37992 VEV_1_3_RA4_01_1235.d 2.28E5 2 2 122 134 Methylation(KR)
K.C(+57.02)ITRFSTVGGEK.G Y 20.09 1353.6710 12 -19.7 452.2220 3 51.84 6 25373 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 74 85 Carbamidomethylation
K.TDQGNKTFNNE(+28.03)EATK.M Y 19.85 1723.8013 15 -2.5 575.6063 3 39.78 4 18569 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 203 217 Ethylation
K.G(+56.06)PLLLQDFHLIDLLAHFDRER.I Y 19.77 2573.4116 21 -10.2 644.3536 4 90.54 4 53952 VEV_1_3_RA4_01_1235.d 4.67E4 2 2 13 33 Diethylation
R.DPRGFSTK.F Y 19.77 906.4559 8 -4.3 454.2333 2 31.06 5 13874 VEV_2_3_RA5_01_1236.d 0 1 1 93 100
K.A(+71.04)C(+57.02)QEHEQWAGAALSK.Q Y 19.76 1755.7998 15 -9.1 586.2686 3 51.21 4 25638 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 382 396 Propionamide (K, X@N-term); Carbamidomethylation
R.FS(-18.01)TVGGEK(+14.02)GSADSAR.D Y 19.57 1463.7004 15 -5.7 488.9047 3 26.76 5 11484 VEV_2_3_RA5_01_1236.d 2.72E4 1 1 78 92 Dehydration; Methylation(KR)
K.GSADSARD(+14.02)PR.G Y 19.45 1044.4948 10 -8.7 523.2501 2 12.54 4 3568 VEV_1_3_RA4_01_1235.d 7.48E4 1 1 86 95 Methylation(others)
K.AC(+57.02)QEHEQWAGAALSK(+71.04).Q Y 19.27 1755.7998 15 -9.4 586.2684 3 50.86 5 25675 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 382 396 Carbamidomethylation; Propionamide (K, X@N-term)
K.AC(+57.02)QEH(+14.02)EQWAGAALSK.Q Y 19.10 1698.7783 15 -5.7 567.2635 3 58.17 5 30225 VEV_2_3_RA5_01_1236.d 0 1 1 382 396 Carbamidomethylation; Methylation(others)
K.WTKPDGTFNYVQ(+.98)IHC(+57.02)K.T Y 18.89 1993.9357 16 -9.9 499.4863 4 68.66 5 38027 VEV_2_3_RA5_01_1236.d 4.91E4 1 1 187 202 Deamidation (NQ); Carbamidomethylation
R.AFN(+.98)PYQ(+.98)R.D Y 18.85 896.4028 7 28.0 449.2212 2 41.79 5 20199 VEV_2_3_RA5_01_1236.d 2.25E4 1 1 346 352 Deamidation (NQ)
R.I(+41.03)NQDLGAR.I Y 18.84 926.4933 8 -15.2 464.2469 2 25.88 5 10975 VEV_2_3_RA5_01_1236.d 0 1 1 451 458 Amidination of lysines or N-terminal amines with methyl acetimidate
K.C(+57.02)(+226.08)ITRFSTVGGEKGSADSAR.D Y 18.72 2224.0364 19 20.9 742.3682 3 78.12 6 43850 VEV_3_3_RA6_01_1237.d 1.5E6 1 1 74 92 Carbamidomethylation; Biotinylation
K.GSADSARDPR(+14.02).G Y 18.44 1044.4948 10 -8.7 523.2501 2 12.96 4 3786 VEV_1_3_RA4_01_1235.d 2.76E5 3 3 86 95 Methylation(KR)
K.T(+43.01)DQGNK(+14.02)TFNNEEATK.M Y 18.36 1752.7915 15 -9.9 877.3943 2 20.76 5 8148 VEV_2_3_RA5_01_1236.d 2.79E4 1 1 203 217 Carbamylation; Methylation(KR)
R.FST(-18.01)VGGEK(+14.02)GSADSARDPR.G Y 18.14 1831.8812 18 -5.9 458.9749 4 32.77 4 14439 VEV_1_3_RA4_01_1235.d 0 1 1 78 95 Dehydration; Methylation(KR)
R.QPGQQENFVHNVS(-18.01)VHLC(+57.02)GAQ(+.98)EK.V Y 17.97 2488.1553 22 -2.2 830.3905 3 74.41 6 41117 VEV_3_3_RA6_01_1237.d 6.81E5 1 1 418 439 Dehydration; Carbamidomethylation; Deamidation (NQ)
R.FST(+14.02)VGGEKGSADSARDPR.G Y 17.85 1849.8918 18 -11.0 463.4751 4 38.22 5 18065 VEV_2_3_RA5_01_1236.d 5.72E5 1 1 78 95 Methylation(others)
R.LGVN(+.98)YQQIPVNC(+57.02)PLR.A Y 17.67 1770.9087 15 -5.6 591.3069 3 76.68 6 42769 VEV_3_3_RA6_01_1237.d 2.86E5 1 1 331 345 Deamidation (NQ); Carbamidomethylation
R.Q(-17.03)PGQQ(+.98)ENFVHNVSVHLC(+57.02)GAQEKVR.K Y 17.66 2744.3088 24 -13.5 687.0752 4 74.68 5 42366 VEV_2_3_RA5_01_1236.d 2.31E5 1 1 418 441 Pyro-glu from Q; Deamidation (NQ); Carbamidomethylation
R.INQ(+.98)DLGARIEK.A Y 17.60 1256.6724 11 -14.3 419.8921 3 51.58 4 25884 VEV_1_3_RA4_01_1235.d 4.17E5 1 1 451 461 Deamidation (NQ)
R.GE(+6.01)YPSWTC(+57.02)YVQVLSPEQAEK.F Y 17.58 2376.0920 20 7.7 793.0441 3 84.71 6 48275 VEV_3_3_RA6_01_1237.d 4.57E4 1 1 237 256 Replacement of proton by lithium; Carbamidomethylation
K.TDQGNKTFNN(+15.00)EEATK.M Y 17.50 1710.7697 15 -5.0 571.2610 3 33.65 4 14962 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 203 217 Deamidation followed by a methylation
K.FYTEQ(+.98)GNWDWVFNNTPVFFLR.D Y 17.26 2680.2385 21 -1.5 894.4188 3 95.99 6 53987 VEV_3_3_RA6_01_1237.d 2.22E4 1 1 101 121 Deamidation (NQ)
R.I(+43.01)NQDLGAR.I Y 17.23 928.4726 8 5.8 465.2463 2 25.84 6 10643 VEV_3_3_RA6_01_1237.d 2.81E5 1 1 451 458 Carbamylation
R.NPQ(+.98)TNLK(+42.01).D Y 17.21 856.4290 7 5.2 429.2240 2 47.00 4 23009 VEV_1_3_RA4_01_1235.d 0 1 1 136 142 Deamidation (NQ); Acetylation (K)
R.DP(+31.99)SK(+14.02)FPIFIHTQK.R Y 17.21 1602.8406 13 26.6 401.7281 4 68.35 4 37917 VEV_1_3_RA4_01_1235.d 5.99E4 1 1 122 134 Dihydroxy; Methylation(KR)
K.AC(+57.02)QEHEQWAGAALSK(-.98).Q Y 16.85 1683.7787 15 -27.7 842.8733 2 52.44 5 26656 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 382 396 Carbamidomethylation; Amidation
K.QIPVTDEDFVQ(+.98)PNGLWK(+14.02).V Y 16.85 1999.9890 17 -25.4 1000.9764 2 85.09 5 49220 VEV_2_3_RA5_01_1236.d 2.15E4 1 1 397 413 Deamidation (NQ); Methylation(KR)
R.NPQ(+.98)TNLK.D Y 16.82 814.4185 7 13.7 408.2221 2 33.60 4 14924 VEV_1_3_RA4_01_1235.d 0 1 1 136 142 Deamidation (NQ)
R.LFS(+126.10)YPDTHR.H Y 16.80 1260.6503 9 7.4 421.2271 3 53.40 5 27251 VEV_2_3_RA5_01_1236.d 6.31E4 1 1 320 328 Octanoyl
K.VW(+44.99)PQAEVPLRR.F Y 16.42 1394.7418 11 4.8 465.9234 3 66.47 5 36371 VEV_2_3_RA5_01_1236.d 7.81E4 1 1 267 277 Oxidation to nitro
K.QIPVTDED(+14.02)FVQPNGLWK.V Y 16.34 1999.0050 17 0.4 667.3425 3 82.92 4 49171 VEV_1_3_RA4_01_1235.d 9.35E4 1 1 397 413 Methylation(others)
K.WTK(+14.02)PDGTFNYVQIHC(+57.02)K.T Y 15.92 2006.9673 16 -2.5 502.7479 4 66.75 5 36590 VEV_2_3_RA5_01_1236.d 8.37E4 1 1 187 202 Methylation(KR); Carbamidomethylation
R.F(+43.01)ST(+79.97)VGGEKGSADSARDPR.G Y 15.89 1958.8483 18 30.9 490.7345 4 34.32 6 15263 VEV_3_3_RA6_01_1237.d 6.43E4 1 1 78 95 Carbamylation; Phosphorylation (STY)
R.FS(+79.97)TVGGEKGSADSARDPR.G Y 15.47 1915.8425 18 -14.5 958.9147 2 32.53 4 14299 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 78 95 Phosphorylation (STY)
R.KATYC(+57.02)M(+15.99)FTRINQDLGAR.I Y 15.30 2059.9932 17 3.2 687.6739 3 54.66 4 27845 VEV_1_3_RA4_01_1235.d 8.99E4 1 1 442 458 Carbamidomethylation; Oxidation (M)
K.GSADSAR(+14.02)DPR.G Y 15.27 1044.4948 10 -11.9 349.1681 3 12.35 5 3626 VEV_2_3_RA5_01_1236.d 2.03E5 1 1 86 95 Methylation(KR)
R.DPRGFSTK(-.98).F Y 15.26 905.4719 8 -0.7 906.4785 1 93.25 6 52903 VEV_3_3_RA6_01_1237.d 0 1 1 93 100 Amidation
K.QIPVTDEDFVQPN(+.98)GLW(+15.99)K.V Y 15.25 2001.9684 17 -3.2 1001.9882 2 80.72 5 46523 VEV_2_3_RA5_01_1236.d 4.27E4 1 1 397 413 Deamidation (NQ); Oxidation (HW)
K.AIER(+14.02)GEYPSWTC(+57.02)YVQVLSPEQAEKFR(-.98).W Y 15.13 3155.5498 26 -7.2 789.8890 4 81.88 6 46466 VEV_3_3_RA6_01_1237.d 3.23E4 1 1 233 258 Methylation(KR); Carbamidomethylation; Amidation
K.WTKPDGTFNYVQIHC(+57.02)K(+14.02)TDQGNK(+14.02).T Y 15.04 2664.2754 22 12.9 667.0847 4 74.75 6 41358 VEV_3_3_RA6_01_1237.d 6.61E4 1 1 187 208 Carbamidomethylation; Methylation(KR)
total 351 peptides
C1G5F6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YDSTHGQFKGDIEHSGGNNLTVNNK.T Y 200.00 2731.2585 25 -11.6 683.8140 4 56.07 6 27821 VEV_3_3_RA6_01_1237.d 1.08E7 23 23 48 72
K.YDSTHGQFKGDIEHSGGN(+.98)NLTVNNK.T Y 200.00 2732.2427 25 -14.3 684.0582 4 57.34 6 28583 VEV_3_3_RA6_01_1237.d 3.14E6 8 8 48 72 Deamidation (NQ)
K.SYRPDISVLSNASC(+57.02)TTNC(+57.02)LAPLAK.V Y 200.00 2637.2891 24 -12.8 880.0923 3 78.33 6 44060 VEV_3_3_RA6_01_1237.d 9.09E6 18 18 139 162 Carbamidomethylation
K.VIHDNFGIAEGLMTTIHSYTATQK.T Y 200.00 2646.3113 24 -11.3 883.1011 3 83.07 6 47256 VEV_3_3_RA6_01_1237.d 6.49E6 15 15 163 186
R.NAVEHDDVEIVAVNDPFIETNYAAYMLK.Y Y 200.00 3179.5120 28 -10.9 1060.8330 3 86.75 6 49542 VEV_3_3_RA6_01_1237.d 2.71E6 12 12 20 47
K.KVIISAPSADAPMFVMGVNEK.S Y 170.78 2203.1379 21 -17.4 735.3738 3 79.04 6 44501 VEV_3_3_RA6_01_1237.d 2.33E6 10 10 118 138
K.AASEGELKGILGYSEDALVSTDLNGDPR.S Y 164.70 2876.4038 28 -3.9 1439.2036 2 83.60 4 49647 VEV_1_3_RA4_01_1235.d 6.2E6 48 48 264 291
R.VPTANVSVVDLTC(+57.02)RTEKPVTYDQIK.A Y 161.53 2832.4690 25 -10.4 709.1171 4 73.76 5 41729 VEV_2_3_RA5_01_1236.d 4.25E6 9 9 235 259 Carbamidomethylation
K.GILGYSEDALVSTDLNGDPR.S Y 151.69 2091.0120 20 -12.2 1046.5005 2 81.84 6 46454 VEV_3_3_RA6_01_1237.d 1.37E6 7 7 272 291
K.HGVDYVVESTGVFTTTEK.A Y 146.57 1967.9476 18 -3.2 984.9780 2 73.52 6 40472 VEV_3_3_RA6_01_1237.d 4.73E6 20 20 90 107
K.HGVDYVVESTGVFTTTEKAK.A Y 144.24 2167.0796 20 -8.3 1084.5381 2 69.80 5 38848 VEV_2_3_RA5_01_1236.d 2.92E6 11 11 90 109
R.VPTANVSVVDLTC(+57.02)RTEKPVTYDQIKAAVK.A Y 140.71 3201.7068 29 -14.5 641.3394 5 75.47 4 43493 VEV_1_3_RA4_01_1235.d 1.72E5 2 2 235 263 Carbamidomethylation
K.KVIISAPSADAPM(+15.99)FVMGVNEK.S Y 139.59 2219.1331 21 -12.0 740.7094 3 76.26 4 44126 VEV_1_3_RA4_01_1235.d 3.86E5 3 3 118 138 Oxidation (M)
K.VIHDNFGIAEGLM(+15.99)TTIHSYTATQK.T Y 138.40 2662.3062 24 -7.7 533.4644 5 78.85 4 46139 VEV_1_3_RA4_01_1235.d 6.51E5 3 3 163 186 Oxidation (M)
R.VPTANVSVVDLTC(+57.02)R.T Y 138.13 1529.7871 14 -14.6 765.8896 2 72.95 6 40070 VEV_3_3_RA6_01_1237.d 4.56E6 16 16 235 248 Carbamidomethylation
K.VIISAPSADAPMFVMGVNEK.S Y 135.55 2075.0430 20 -8.9 1038.5195 2 82.86 6 47106 VEV_3_3_RA6_01_1237.d 2.09E6 6 6 119 138
K.GDIEHSGGNNLTVNNK.T Y 128.57 1667.7863 16 -10.2 556.9304 3 36.06 5 16802 VEV_2_3_RA5_01_1236.d 3.53E6 7 7 57 72
R.SSIFDASAGIALNDRFVK.L Y 128.35 1909.9897 18 -9.6 955.9930 2 80.17 4 47169 VEV_1_3_RA4_01_1235.d 5.01E6 15 15 292 309
R.NAVEHDDVEIVAVNDPFIETNYAAYM(+15.99)LK.Y Y 127.74 3195.5071 28 -6.9 1066.1689 3 83.96 6 47806 VEV_3_3_RA6_01_1237.d 2.97E5 3 3 20 47 Oxidation (M)
K.AASEGELKGILGYSEDALVSTDLNGDPR(+14.02).S Y 123.37 2890.4194 28 -6.5 964.4741 3 84.03 4 49961 VEV_1_3_RA4_01_1235.d 6E5 5 5 264 291 Methylation(KR)
K.SYRPDISVLSNASC(+57.02)TTN(+.98)C(+57.02)LAPLAK.V Y 123.20 2638.2729 24 -5.9 880.4264 3 79.38 4 46559 VEV_1_3_RA4_01_1235.d 2.38E6 9 9 139 162 Carbamidomethylation; Deamidation (NQ)
R.GGRTAAQNIIPSSTGAAK.A Y 122.60 1698.9012 18 -8.8 850.4504 2 49.78 5 25015 VEV_2_3_RA5_01_1236.d 2.97E6 18 18 198 215
K.VIISAPSADAPM(+15.99)FVMGVNEK.S Y 121.55 2091.0381 20 -7.3 1046.5187 2 79.98 4 47000 VEV_1_3_RA4_01_1235.d 3.04E5 2 2 119 138 Oxidation (M)
R.RVLDLIAYIAKVDAGK Y 120.52 1744.0247 16 -19.3 437.0050 4 84.59 6 48218 VEV_3_3_RA6_01_1237.d 1.05E6 7 7 323 338
K.LISWYDNEWGYSR.R Y 118.12 1687.7631 13 -9.6 844.8807 2 81.18 4 47945 VEV_1_3_RA4_01_1235.d 4.2E5 3 3 310 322
K.AASEGELKGILGYSEDALVSTDLN(+.98)GDPR.S Y 115.66 2877.3879 28 -5.2 960.1316 3 83.89 5 48491 VEV_2_3_RA5_01_1236.d 7.31E5 11 11 264 291 Deamidation (NQ)
K.SYRPDISVLSNASC(+57.02)TTNC(+57.02)LAPLAK(+14.02).V Y 113.47 2651.3047 24 -13.6 884.7635 3 79.29 6 44648 VEV_3_3_RA6_01_1237.d 8.54E5 5 5 139 162 Carbamidomethylation; Methylation(KR)
K.LISWYDNEWGYSRRVLDLIAYIAKVDAGK Y 112.65 3413.7771 29 -4.2 683.7598 5 93.93 4 55778 VEV_1_3_RA4_01_1235.d 1.18E6 6 6 310 338
K.LISWYDNEWGYSRR.V Y 112.07 1843.8641 14 -10.8 615.6220 3 76.84 4 44585 VEV_1_3_RA4_01_1235.d 1.09E6 5 5 310 323
K.AVGKVIPALNGK.L Y 109.86 1165.7183 12 -18.7 583.8555 2 56.39 5 29006 VEV_2_3_RA5_01_1236.d 1.5E6 7 7 216 227
R.NAVEHDDVEIVAVNDPFIE(+14.02)TNYAAYMLK.Y Y 109.21 3193.5278 28 -3.3 1065.5131 3 88.30 4 52768 VEV_1_3_RA4_01_1235.d 3.3E5 2 2 20 47 Methylation(others)
K.SYR(+14.02)PDISVLSNASC(+57.02)TTNC(+57.02)LAPLAK.V Y 108.91 2651.3047 24 -2.5 884.7733 3 78.25 5 44901 VEV_2_3_RA5_01_1236.d 4.29E5 3 3 139 162 Methylation(KR); Carbamidomethylation
R.VLDLIAYIAKVDAGK Y 108.07 1587.9236 15 -5.7 794.9645 2 85.62 4 50991 VEV_1_3_RA4_01_1235.d 2.15E6 9 9 324 338
K.KVIISAPSADAPM(+15.99)FVM(+15.99)GVNEK.S Y 107.70 2235.1279 21 -1.5 746.0488 3 72.35 4 41084 VEV_1_3_RA4_01_1235.d 5.01E5 3 3 118 138 Oxidation (M)
R.TEKPVTYDQIK.A Y 107.36 1320.6925 11 -12.0 441.2328 3 38.89 5 18503 VEV_2_3_RA5_01_1236.d 5.44E6 20 20 249 259
R.NAVEHDDVEIVAVN(+.98)DPFIETNYAAYMLK.Y Y 106.61 3180.4961 28 -6.1 1061.1661 3 86.85 6 49578 VEV_3_3_RA6_01_1237.d 1.88E5 2 2 20 47 Deamidation (NQ)
K.TIHFYQERDPTNIPWGKHGVDYVVESTGVFTTTEK.A Y 106.31 4050.9751 35 4.0 1013.7551 4 80.16 5 46158 VEV_2_3_RA5_01_1236.d 5.47E4 1 1 73 107
R.DPTNIPWGKHGVDYVVESTGVFTTTEK.A Y 106.12 2976.4504 27 -37.9 745.0917 4 81.47 4 48137 VEV_1_3_RA4_01_1235.d 0 2 2 81 107
K.AASEGE(+14.02)LKGILGYSEDALVSTDLNGDPR.S Y 104.98 2890.4194 28 -10.1 964.4707 3 85.11 5 49229 VEV_2_3_RA5_01_1236.d 2.07E6 5 5 264 291 Methylation(others)
K.AASEGELKGILGYSE(+14.02)DALVSTDLNGDPR.S Y 104.59 2890.4194 28 -1.8 964.4787 3 85.80 4 51225 VEV_1_3_RA4_01_1235.d 2.28E6 8 8 264 291 Methylation(others)
R.TAAQNIIPSSTGAAKAVGK.V Y 104.05 1783.9791 19 -10.5 595.6608 3 60.58 5 32006 VEV_2_3_RA5_01_1236.d 5.62E5 4 4 201 219
R.NAVEHDDVE(+14.02)IVAVNDPFIETNYAAYMLK.Y Y 102.47 3193.5278 28 -8.2 1065.5078 3 87.54 6 49986 VEV_3_3_RA6_01_1237.d 3.21E5 3 3 20 47 Methylation(others)
K.TIHFYQERDPTNIPWGK.H Y 102.22 2101.0381 17 -10.1 526.2615 4 71.83 5 40364 VEV_2_3_RA5_01_1236.d 2.33E6 19 19 73 89
R.VPTANVSVVDLTC(+57.02)R(+14.02)TEKPVTYDQIK.A Y 102.17 2846.4849 25 7.3 712.6337 4 76.09 4 43976 VEV_1_3_RA4_01_1235.d 0 2 2 235 259 Carbamidomethylation; Methylation(KR)
R.TAAQNIIPSSTGAAK.A Y 101.87 1428.7572 15 -10.8 715.3782 2 56.94 5 29486 VEV_2_3_RA5_01_1236.d 2.33E7 21 21 201 215
K.VIHDNFGIAE(+14.02)GLMTTIHSYTATQK.T Y 100.67 2660.3269 24 -9.7 666.0826 4 83.31 4 49436 VEV_1_3_RA4_01_1235.d 1.43E6 5 5 163 186 Methylation(others)
R.RVLDLIAYIAK.V Y 100.63 1273.7758 11 -20.7 425.5904 3 82.55 6 46896 VEV_3_3_RA6_01_1237.d 8.8E5 5 5 323 333
K.AASEGELK(+14.02)GILGYSEDALVSTDLNGDPR.S Y 100.14 2890.4194 28 -11.0 964.4698 3 84.41 6 48115 VEV_3_3_RA6_01_1237.d 3.17E5 3 3 264 291 Methylation(KR)
K.VIISAPSADAPMFVM(+15.99)GVNEK.S Y 100.10 2091.0381 20 -8.4 1046.5176 2 79.68 4 46773 VEV_1_3_RA4_01_1235.d 4.25E5 3 3 119 138 Oxidation (M)
K.YDSTHGQFK.G Y 98.90 1081.4829 9 -13.5 541.7415 2 18.38 6 6702 VEV_3_3_RA6_01_1237.d 1.46E6 8 8 48 56
K.YDSTHGQFKGDIEHSGGNNLTVNNK(+14.02).T Y 98.63 2745.2742 25 -4.5 687.3228 4 58.12 5 30190 VEV_2_3_RA5_01_1236.d 7.83E5 5 5 48 72 Methylation(KR)
K.VIISAPSADAPMFVMGVNEK(+14.02).S Y 94.08 2089.0588 20 -5.8 697.3562 3 84.34 4 50152 VEV_1_3_RA4_01_1235.d 6.59E5 8 8 119 138 Methylation(KR)
K.AAVKAASEGELKGILGYSEDALVSTDLNGDPR.S Y 93.89 3245.6414 32 -7.8 812.4113 4 81.59 5 47088 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 260 291
R.VLDLIAYIAK.V Y 93.81 1117.6747 10 -10.3 1118.6704 1 85.01 4 50593 VEV_1_3_RA4_01_1235.d 2.02E6 8 8 324 333
R.VPTAN(+.98)VSVVDLTC(+57.02)RTEKPVTYDQIK.A Y 93.44 2833.4531 25 -4.8 709.3671 4 73.91 5 41817 VEV_2_3_RA5_01_1236.d 3.88E5 1 1 235 259 Deamidation (NQ); Carbamidomethylation
K.GILGYSEDALVSTDLN(+.98)GDPR.S Y 93.28 2091.9961 20 -9.8 1046.9951 2 82.28 6 46728 VEV_3_3_RA6_01_1237.d 7.6E5 6 6 272 291 Deamidation (NQ)
K.TVDGPSHKDWR.G Y 91.70 1296.6211 11 -11.0 649.3107 2 24.23 5 10104 VEV_2_3_RA5_01_1236.d 9.32E6 29 29 187 197
R.NAVEH(+14.02)DDVEIVAVNDPFIETNYAAYMLK.Y Y 91.49 3193.5278 28 -15.4 1065.5001 3 87.24 4 52032 VEV_1_3_RA4_01_1235.d 4.21E4 1 1 20 47 Methylation(others)
K.LTGMAMRVPTANVSVVDLTC(+57.02)RTEKPVTYDQIK.A Y 91.01 3592.8416 32 -2.9 899.2150 4 77.85 5 44619 VEV_2_3_RA5_01_1236.d 5.43E4 1 1 228 259 Carbamidomethylation
K.HGVDYVVESTGVFTTTEK(+14.02).A Y 90.91 1981.9633 18 -10.6 661.6547 3 76.11 4 43997 VEV_1_3_RA4_01_1235.d 1.12E6 8 8 90 107 Methylation(KR)
K.LTGMAM(+15.99)RVPTANVSVVDLTC(+57.02)R.T Y 90.68 2306.1545 21 -14.6 769.7142 3 75.95 4 43881 VEV_1_3_RA4_01_1235.d 9.67E4 1 1 228 248 Oxidation (M); Carbamidomethylation
K.GILGYSEDALVSTDLNGDPR(+14.02).S Y 90.55 2105.0276 20 -7.3 1053.5134 2 82.60 4 49000 VEV_1_3_RA4_01_1235.d 1.61E5 4 4 272 291 Methylation(KR)
K.GILGYSE(+14.02)DALVSTDLNGDPR.S Y 90.31 2105.0276 20 -8.0 1053.5127 2 84.64 5 48958 VEV_2_3_RA5_01_1236.d 5.76E5 3 3 272 291 Methylation(others)
K.SYRPDISVLSN(+.98)ASC(+57.02)TTN(+.98)C(+57.02)LAPLAK.V Y 89.01 2639.2571 24 -1.6 880.7582 3 79.48 5 45713 VEV_2_3_RA5_01_1236.d 1.03E6 3 3 139 162 Deamidation (NQ); Carbamidomethylation
R.RVLDLIAYIAKVDAGK(+14.02) Y 88.22 1758.0403 16 -3.8 440.5157 4 85.29 5 49338 VEV_2_3_RA5_01_1236.d 6.47E4 2 2 323 338 Methylation(KR)
K.AASEGELKGILGYSED(+14.02)ALVSTDLNGDPR.S Y 87.22 2890.4194 28 -4.4 964.4762 3 84.48 4 50236 VEV_1_3_RA4_01_1235.d 5.8E5 4 4 264 291 Methylation(others)
R.VPTANVSVVDLTC(+57.02)R(+14.02).T Y 86.72 1543.8029 14 -11.2 772.9000 2 74.75 5 42445 VEV_2_3_RA5_01_1236.d 6.36E5 6 6 235 248 Carbamidomethylation; Methylation(KR)
K.HGVDYVVESTGVFTTTEKAKAHLSGGAK.K Y 86.59 2888.4668 28 -14.8 578.6921 5 70.24 5 39171 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 90 117
R.NAVE(+14.02)HDDVEIVAVNDPFIETNYAAYMLK.Y Y 85.94 3193.5278 28 -15.5 1065.5000 3 87.07 6 49703 VEV_3_3_RA6_01_1237.d 5.92E4 1 1 20 47 Methylation(others)
K.YDSTHGQFKGDIE(+14.02)HSGGNNLTVNNK.T Y 85.31 2745.2742 25 -8.8 687.3198 4 58.94 4 30686 VEV_1_3_RA4_01_1235.d 6.58E5 4 4 48 72 Methylation(others)
K.LTGM(+15.99)AM(+15.99)RVPTANVSVVDLTC(+57.02)R.T Y 84.64 2322.1494 21 4.5 775.0605 3 71.90 4 40714 VEV_1_3_RA4_01_1235.d 1.24E5 2 2 228 248 Oxidation (M); Carbamidomethylation
R.SSIFDASAGIALNDR.F Y 84.47 1535.7579 15 -7.3 512.9229 3 78.67 4 45994 VEV_1_3_RA4_01_1235.d 3.25E5 3 3 292 306
R.VPTANVSVVDLTC(+57.02)R(+.98).T Y 84.06 1530.7712 14 -9.9 766.3853 2 74.91 4 43054 VEV_1_3_RA4_01_1235.d 4.57E5 3 3 235 248 Carbamidomethylation; Deamidation (R)
R.VPTANVSVVDLTC(+57.02)RTEKPVTYDQIK(+14.02).A Y 83.97 2846.4849 25 -8.4 712.6225 4 75.42 4 43453 VEV_1_3_RA4_01_1235.d 2.56E5 3 3 235 259 Carbamidomethylation; Methylation(KR)
K.LTGMAMRVPTANVSVVDLTC(+57.02)R.T Y 82.50 2290.1597 21 -4.9 764.3901 3 79.35 5 45618 VEV_2_3_RA5_01_1236.d 0 1 1 228 248 Carbamidomethylation
K.VIPALN(+.98)GKLTGMAMR.V Y 80.68 1571.8528 15 -4.8 524.9557 3 75.75 4 43745 VEV_1_3_RA4_01_1235.d 6.43E5 4 4 220 234 Deamidation (NQ)
K.HGVDYVVE(+14.02)STGVFTTTEK.A Y 80.41 1981.9633 18 -5.4 991.9835 2 75.43 4 43470 VEV_1_3_RA4_01_1235.d 5.77E5 5 5 90 107 Methylation(others)
R.VPTAN(+.98)VSVVDLTC(+57.02)R.T Y 79.40 1530.7712 14 2.9 766.3951 2 73.16 5 41285 VEV_2_3_RA5_01_1236.d 7.05E5 3 3 235 248 Deamidation (NQ); Carbamidomethylation
K.VIHDN(+.98)FGIAEGLMTTIHSYTATQK.T Y 79.26 2647.2952 24 -4.2 662.8283 4 83.17 6 47298 VEV_3_3_RA6_01_1237.d 1.27E6 6 6 163 186 Deamidation (NQ)
K.AASEGELK(+14.02)GILGYSEDALVSTDLN(+.98)GDPR.S Y 78.61 2891.4036 28 -19.6 964.7896 3 85.29 5 49341 VEV_2_3_RA5_01_1236.d 4.53E5 5 5 264 291 Methylation(KR); Deamidation (NQ)
K.KVIISAPSADAPMFVMGVNEK(+14.02).S Y 78.43 2217.1538 21 -5.3 740.0546 3 79.50 4 46630 VEV_1_3_RA4_01_1235.d 6.55E5 7 7 118 138 Methylation(KR)
K.AASEGELKGILGYS(+14.02)EDALVSTDLNGDPR.S Y 78.20 2890.4194 28 -4.9 1446.2100 2 85.83 4 51127 VEV_1_3_RA4_01_1235.d 3.31E5 2 2 264 291 Methylation(others)
R.TAAQNIIPSSTGAAK(+14.02).A Y 77.77 1442.7728 15 -11.9 722.3851 2 61.30 4 32531 VEV_1_3_RA4_01_1235.d 2.24E6 6 6 201 215 Methylation(KR)
K.YDSTHGQFKGDIEH(+14.02)SGGNNLTVNNK.T Y 77.76 2745.2742 25 -8.2 550.0576 5 58.93 4 30683 VEV_1_3_RA4_01_1235.d 6.46E5 1 1 48 72 Methylation(others)
K.VIISAPSADAPM(+15.99)FVM(+15.99)GVNEK.S Y 76.53 2107.0330 20 -9.1 1054.5142 2 76.88 4 44602 VEV_1_3_RA4_01_1235.d 1.7E5 2 2 119 138 Oxidation (M)
K.AKAHLSGGAK.K Y 76.37 938.5297 10 -23.8 470.2610 2 9.14 6 2191 VEV_3_3_RA6_01_1237.d 3.01E4 3 3 108 117
K.KVIISAPSAD(+14.02)APMFVMGVNEK.S Y 75.16 2217.1538 21 -10.4 740.0508 3 80.31 4 47256 VEV_1_3_RA4_01_1235.d 2.81E5 1 1 118 138 Methylation(others)
R.DPTNIPWGK.H Y 74.62 1026.5134 9 -7.5 514.2601 2 65.95 4 36061 VEV_1_3_RA4_01_1235.d 1.02E6 5 5 81 89
R.VLDLIAYIAKVDAGK(+14.02) Y 74.58 1601.9392 15 -8.6 534.9824 3 86.11 4 51306 VEV_1_3_RA4_01_1235.d 2.75E5 4 4 324 338 Methylation(KR)
K.SYRPDISVLSNASC(+57.02)TTN(+.98)C(+57.02)LAPLAK(+14.02).V Y 74.25 2652.2888 24 -2.0 885.1017 3 80.31 4 47258 VEV_1_3_RA4_01_1235.d 7.23E5 5 5 139 162 Carbamidomethylation; Deamidation (NQ); Methylation(KR)
R.SSIFDASAGIALNDRFVK(+14.02).L Y 73.80 1924.0054 18 -12.3 642.3345 3 81.24 4 47966 VEV_1_3_RA4_01_1235.d 3.48E5 4 4 292 309 Methylation(KR)
K.TIHFYQER.D Y 73.76 1092.5352 8 -17.9 365.1791 3 44.24 6 21002 VEV_3_3_RA6_01_1237.d 5.61E6 19 19 73 80
K.VIHDNFGIAEGLMTTIHSYTATQK(+14.02).T Y 73.00 2660.3269 24 -10.5 887.7736 3 83.31 5 48138 VEV_2_3_RA5_01_1236.d 6.05E5 2 2 163 186 Methylation(KR)
K.GDIEHSGGNNLTVN(+.98)NK.T Y 71.42 1668.7703 16 -5.9 835.3875 2 40.13 4 18773 VEV_1_3_RA4_01_1235.d 8.41E4 1 1 57 72 Deamidation (NQ)
K.SYRPDISVLSNASC(+57.02)T(-2.02)TNC(+57.02)LAPLAK.V Y 71.30 2635.2734 24 -24.1 879.4106 3 79.31 6 44666 VEV_3_3_RA6_01_1237.d 1.93E5 3 3 139 162 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.TAAQ(+.98)NIIPSSTGAAK.A Y 70.73 1429.7412 15 -9.6 715.8710 2 59.38 4 31063 VEV_1_3_RA4_01_1235.d 3.06E6 5 5 201 215 Deamidation (NQ)
R.NAVEHDDVEIVAVNDPFIET(-2.02)NYAAYMLK.Y Y 69.74 3177.4963 28 39.7 795.4129 4 86.95 4 51858 VEV_1_3_RA4_01_1235.d 0 1 1 20 47 2-amino-3-oxo-butanoic_acid
K.SYRPDISVLSNAS(-2.02)C(+57.02)TTNC(+57.02)LAPLAK.V Y 69.67 2635.2734 24 -8.1 879.4247 3 78.60 4 45941 VEV_1_3_RA4_01_1235.d 2.77E5 2 2 139 162 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.GDIEH(+14.02)SGGNNLTVNNK.T Y 69.47 1681.8020 16 -11.6 561.6014 3 45.51 5 22437 VEV_2_3_RA5_01_1236.d 7.65E4 1 1 57 72 Methylation(others)
K.YDSTHGQFKGDIEHSGGNN(+.98)LTVNNK.T Y 69.21 2732.2427 25 -7.5 547.4517 5 57.22 5 29574 VEV_2_3_RA5_01_1236.d 1.84E6 3 3 48 72 Deamidation (NQ)
R.VPTANVSVVDLTC(+57.02)RTEK(+14.02)PVTYDQIK.A Y 68.82 2846.4849 25 -8.2 949.8278 3 75.83 5 43195 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 235 259 Carbamidomethylation; Methylation(KR)
K.HGVDYVVESTGVFTTTEK(+14.02)AK.A Y 68.28 2181.0952 20 -10.1 546.2756 4 71.38 4 40303 VEV_1_3_RA4_01_1235.d 9.96E4 3 3 90 109 Methylation(KR)
K.AVGKVIPALN(+.98)GK.L Y 67.47 1166.7023 12 -31.8 584.3398 2 58.88 5 30789 VEV_2_3_RA5_01_1236.d 9.9E5 9 9 216 227 Deamidation (NQ)
K.HGVDYVVE(+14.02)STGVFTTTEKAK.A Y 66.72 2181.0952 20 -16.0 546.2723 4 71.54 6 39023 VEV_3_3_RA6_01_1237.d 2.85E5 1 1 90 109 Methylation(others)
K.GDIEHSGGNN(+.98)LTVNNK.T Y 65.78 1668.7703 16 -10.4 835.3837 2 39.26 6 18073 VEV_3_3_RA6_01_1237.d 8.23E4 2 2 57 72 Deamidation (NQ)
R.TAAQN(+.98)IIPSSTGAAK.A Y 65.74 1429.7412 15 -9.6 715.8710 2 60.31 4 31715 VEV_1_3_RA4_01_1235.d 3.12E6 10 10 201 215 Deamidation (NQ)
R.T(+14.02)EKPVTYDQIK.A Y 65.57 1334.7081 11 -8.3 445.9063 3 47.29 4 23186 VEV_1_3_RA4_01_1235.d 8.86E5 3 3 249 259 Methylation(others)
K.VGINGFGR.I Y 65.31 818.4399 8 -16.7 410.2204 2 56.71 6 28226 VEV_3_3_RA6_01_1237.d 4.31E6 11 11 5 12
K.YDSTHGQ(+.98)FKGDIEHSGGN(+.98)N(+.98)LTVNNK.T Y 64.92 2734.2107 25 4.4 547.8518 5 56.04 6 27757 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 48 72 Deamidation (NQ)
K.AKAHLSGGAKK.V Y 64.83 1066.6246 11 -31.8 534.3026 2 8.91 6 2111 VEV_3_3_RA6_01_1237.d 4.92E4 4 4 108 118
K.GDIEHSGGNNLTVNNK(+14.02).T Y 64.71 1681.8020 16 -8.1 561.6034 3 43.09 4 20631 VEV_1_3_RA4_01_1235.d 3.66E5 3 3 57 72 Methylation(KR)
R.GGRTAAQN(+.98)IIPSSTGAAK.A Y 64.69 1699.8853 18 -0.5 567.6354 3 49.73 5 24988 VEV_2_3_RA5_01_1236.d 1.52E5 2 2 198 215 Deamidation (NQ)
K.GDIEHSGGN(+.98)NLTVNNK.T Y 64.08 1668.7703 16 -7.0 835.3865 2 39.12 4 18165 VEV_1_3_RA4_01_1235.d 1.53E5 3 3 57 72 Deamidation (NQ)
R.NAVEHDDVEIVAVND(-15.99)PFIETNYAAYMLK.Y Y 63.68 3163.5171 28 12.5 791.8964 4 86.77 6 49537 VEV_3_3_RA6_01_1237.d 0 1 1 20 47 Deoxy
K.SYRPDISVLSN(+.98)ASC(+57.02)TTNC(+57.02)LAPLAK(+14.02).V Y 63.67 2652.2888 24 -6.9 885.0974 3 79.25 6 44624 VEV_3_3_RA6_01_1237.d 2.19E5 2 2 139 162 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.AHLSGGAKK.V Y 63.52 867.4926 9 -7.4 434.7504 2 8.38 4 1976 VEV_1_3_RA4_01_1235.d 3.06E4 3 3 110 118
M.VVKVGINGFGR.I Y 62.89 1144.6716 11 -9.7 573.3375 2 61.61 5 32745 VEV_2_3_RA5_01_1236.d 3.48E5 4 4 2 12
K.AASEGELKGILGYSEDALVSTDLN(+.98)GD(-18.01)PR.S Y 62.41 2859.3774 28 -2.7 954.1306 3 84.61 4 50320 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 264 291 Deamidation (NQ); Dehydration
R.SSIFDASAGIALNDR(+14.02)FVK.L Y 62.06 1924.0054 18 -12.9 642.3341 3 81.21 5 46887 VEV_2_3_RA5_01_1236.d 3.11E5 3 3 292 309 Methylation(KR)
R.RVLDLIAYIAK(+14.02).V Y 61.28 1287.7914 11 -20.1 430.2625 3 84.50 6 48143 VEV_3_3_RA6_01_1237.d 6.46E4 2 2 323 333 Methylation(KR)
K.VIPALNGK.L Y 61.14 810.4963 8 -16.4 406.2488 2 45.75 6 21842 VEV_3_3_RA6_01_1237.d 3.86E6 12 12 220 227
K.T(+42.01)VDGPSHKDWR.G Y 61.09 1338.6316 11 7.5 447.2212 3 24.48 5 10185 VEV_2_3_RA5_01_1236.d 0 1 1 187 197 Acetylation (N-term)
K.AASEGELKGILGYSEDALVSTDLN(+.98)GDPR(+14.02).S Y 60.76 2891.4036 28 -5.3 964.8033 3 84.34 5 48772 VEV_2_3_RA5_01_1236.d 3.02E4 1 1 264 291 Deamidation (NQ); Methylation(KR)
R.SSIFDASAGIALN(+.98)DRFVK.L Y 60.57 1910.9738 18 -6.7 637.9943 3 80.11 6 45237 VEV_3_3_RA6_01_1237.d 2.32E5 5 5 292 309 Deamidation (NQ)
K.H(+14.02)GVDYVVESTGVFTTTEK.A Y 60.03 1981.9633 18 -28.6 661.6428 3 73.91 5 41816 VEV_2_3_RA5_01_1236.d 0 1 1 90 107 Methylation(others)
R.VPTAN(+.98)VSVVDLTC(+57.02)RTEKPVTYDQIK(+14.02).A Y 59.84 2847.4688 25 -2.6 712.8726 4 75.92 4 43856 VEV_1_3_RA4_01_1235.d 2.21E4 1 1 235 259 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.LISWYDNE(+14.02)WGYSR.R Y 59.76 1701.7787 13 -8.6 851.8893 2 83.13 4 49316 VEV_1_3_RA4_01_1235.d 1.27E5 3 3 310 322 Methylation(others)
K.HGVDYVVES(-2.02)TGVFTTTEKAK.A Y 59.69 2165.0640 20 -11.1 542.2673 4 69.88 5 38902 VEV_2_3_RA5_01_1236.d 2.3E5 2 2 90 109 2-amino-3-oxo-butanoic_acid
R.TEKPVTYDQ(+.98)IK.A Y 59.67 1321.6765 11 -13.2 661.8368 2 42.17 5 20419 VEV_2_3_RA5_01_1236.d 1.5E6 9 9 249 259 Deamidation (NQ)
R.VPTANVSVVDLTC(+57.02)R(+14.02)T(-18.01)EKPVTYDQIK.A Y 59.54 2828.4741 25 -15.0 708.1152 4 74.10 4 42431 VEV_1_3_RA4_01_1235.d 0 1 1 235 259 Carbamidomethylation; Methylation(KR); Dehydration
R.VPTANVSVVDLTC(+57.02)RTEKPVTYDQ(+.98)IK.A Y 59.45 2833.4531 25 -11.1 945.4811 3 74.68 5 42368 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 235 259 Carbamidomethylation; Deamidation (NQ)
R.TAAQ(+.98)NIIPSSTGAAK(+14.02).A Y 59.16 1443.7568 15 -9.1 722.8792 2 62.68 5 33541 VEV_2_3_RA5_01_1236.d 2.68E5 3 3 201 215 Deamidation (NQ); Methylation(KR)
K.AASEGELK(+14.02)GILGYSEDALVSTDLNGDPR(+14.02).S Y 57.65 2904.4351 28 -6.7 969.1458 3 84.95 4 50557 VEV_1_3_RA4_01_1235.d 4.95E5 3 3 264 291 Methylation(KR)
K.AHLSGGAK.K Y 57.02 739.3976 8 -19.6 370.6989 2 8.88 5 2105 VEV_2_3_RA5_01_1236.d 2.3E4 3 3 110 117
K.VIHDNFGIAEGLM(+15.99)T(-18.01)TIHSYTATQK.T Y 57.02 2644.2954 24 -75.3 529.8265 5 83.58 4 49619 VEV_1_3_RA4_01_1235.d 0 1 1 163 186 Oxidation (M); Dehydration
R.VLDLIAYIAK(+14.02).V Y 56.81 1131.6903 10 -6.7 566.8486 2 86.49 4 51557 VEV_1_3_RA4_01_1235.d 8.5E4 1 1 324 333 Methylation(KR)
K.YDSTHGQFKGDIEHSGGNNLTVN(+.98)NK.T Y 56.62 2732.2427 25 -11.4 547.4496 5 57.76 6 28920 VEV_3_3_RA6_01_1237.d 1.12E6 2 2 48 72 Deamidation (NQ)
K.AASEGELKGILGYSEDALVSTDLNGDPR(-.98).S Y 55.99 2875.4199 28 32.7 959.5119 3 84.21 5 48696 VEV_2_3_RA5_01_1236.d 0 2 2 264 291 Amidation
K.SYRPD(+14.02)ISVLSNASC(+57.02)TTNC(+57.02)LAPLAK.V Y 55.47 2651.3047 24 -3.5 1326.6550 2 78.32 5 44938 VEV_2_3_RA5_01_1236.d 1.93E4 1 1 139 162 Methylation(others); Carbamidomethylation
K.T(+114.04)VDGPSHKDWR.G Y 55.47 1410.6641 11 66.9 353.6969 4 24.51 4 9855 VEV_1_3_RA4_01_1235.d 1.98E5 2 2 187 197 Ubiquitin
K.TVDGPSHKDW(+31.99)R.G Y 55.32 1328.6108 11 -8.3 665.3072 2 13.17 5 4063 VEV_2_3_RA5_01_1236.d 1.97E5 7 7 187 197 Dihydroxy
K.HGVDYVVESTGVFTTTEKAK(+14.02).A Y 54.71 2181.0952 20 -8.0 546.2767 4 71.22 5 39892 VEV_2_3_RA5_01_1236.d 0 1 1 90 109 Methylation(KR)
K.AAVKAASEGELK.G Y 54.36 1172.6400 12 -6.7 587.3234 2 24.74 5 10340 VEV_2_3_RA5_01_1236.d 2.32E5 4 4 260 271
K.LISWYDNEW(+31.99)GYSR.R Y 54.03 1719.7528 13 -7.5 860.8773 2 76.45 4 44264 VEV_1_3_RA4_01_1235.d 3.55E4 1 1 310 322 Dihydroxy
K.GDIE(+14.02)HSGGNNLTVNNK.T Y 53.52 1681.8020 16 -8.3 561.6033 3 45.69 4 22199 VEV_1_3_RA4_01_1235.d 3.34E5 3 3 57 72 Methylation(others)
K.GILGYSEDALVSTDLN(+.98)GDPR(+14.02).S Y 52.40 2106.0117 20 -7.3 1054.0055 2 83.39 4 49491 VEV_1_3_RA4_01_1235.d 1.64E4 1 1 272 291 Deamidation (NQ); Methylation(KR)
R.TAAQ(+.98)N(+.98)IIPSSTGAAK.A Y 51.37 1430.7252 15 -11.6 716.3616 2 61.88 4 32906 VEV_1_3_RA4_01_1235.d 1.37E5 3 3 201 215 Deamidation (NQ)
K.VIISAPSADAPMFVMGVN(+.98)EK.S Y 51.29 2076.0271 20 -2.5 1039.0182 2 83.78 4 49762 VEV_1_3_RA4_01_1235.d 1.51E5 2 2 119 138 Deamidation (NQ)
K.TVDGPSHKDWRGGR.T Y 50.82 1566.7651 14 -11.9 784.3806 2 23.46 5 9593 VEV_2_3_RA5_01_1236.d 6.1E5 5 5 187 200
K.T(+87.05)VDGPSHKDWR.G Y 50.31 1383.6718 11 -2.1 346.9245 4 24.47 5 10174 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 187 197 Phosphorylation to amine thiol
R.T(-18.01)EK(+14.02)PVTYDQIK.A Y 50.15 1316.6976 11 -16.8 439.8991 3 38.97 6 17897 VEV_3_3_RA6_01_1237.d 0 2 2 249 259 Dehydration; Methylation(KR)
K.HGVDYVVES(-2.02)TGVFTTTEK.A Y 49.47 1965.9320 18 30.3 656.3378 3 73.63 5 41620 VEV_2_3_RA5_01_1236.d 4.99E4 2 2 90 107 2-amino-3-oxo-butanoic_acid
K.TVDGPSHKDW(+15.99)R.G Y 48.59 1312.6160 11 -7.0 438.5428 3 19.34 4 7061 VEV_1_3_RA4_01_1235.d 4.35E5 8 8 187 197 Oxidation (HW)
K.GILGYSED(+14.02)ALVSTDLNGDPR.S Y 47.61 2105.0276 20 -7.7 1053.5129 2 83.32 5 48148 VEV_2_3_RA5_01_1236.d 1.06E5 3 3 272 291 Methylation(others)
K.HGVDYVVESTGVFTT(-18.01)TEK(+14.02).A Y 47.59 1963.9526 18 -10.6 655.6512 3 73.78 4 42189 VEV_1_3_RA4_01_1235.d 0 1 1 90 107 Dehydration; Methylation(KR)
K.AAS(+14.02)EGELKGILGYSEDALVSTDLNGDPR.S Y 47.48 2890.4194 28 -1.5 1446.2148 2 85.24 4 50755 VEV_1_3_RA4_01_1235.d 4.65E4 1 1 264 291 Methylation(others)
K.GILGYS(+14.02)EDALVSTDLNGDPR.S Y 46.70 2105.0276 20 -22.8 702.6671 3 84.80 4 50452 VEV_1_3_RA4_01_1235.d 0 1 1 272 291 Methylation(others)
R.TEKPVTYD(+14.02)QIK.A Y 45.65 1334.7081 11 -4.8 445.9078 3 46.88 4 22934 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 249 259 Methylation(others)
K.S(+43.01)YR(+14.02)PDISVLSNASC(+57.02)TTNC(+57.02)LAPLAK.V Y 45.49 2694.3105 24 -3.5 899.1076 3 79.16 4 46367 VEV_1_3_RA4_01_1235.d 3.71E5 3 3 139 162 Carbamylation; Methylation(KR); Carbamidomethylation
K.VGIN(+.98)GFGR(+14.02).I Y 45.21 833.4395 8 -15.8 417.7205 2 62.34 4 33247 VEV_1_3_RA4_01_1235.d 5.1E5 6 6 5 12 Deamidation (NQ); Methylation(KR)
K.VGIN(+.98)GFGR.I Y 44.93 819.4239 8 -18.4 410.7117 2 59.24 6 29886 VEV_3_3_RA6_01_1237.d 5.7E6 18 18 5 12 Deamidation (NQ)
K.VIHDNFGIAEGLMTTIHSYTATQ(+.98)K(+14.02).T Y 44.50 2661.3108 24 -7.2 666.3302 4 79.01 4 46296 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 163 186 Deamidation (NQ); Methylation(KR)
R.GGRTAAQNIIPSSTGAAK(+14.02).A Y 44.18 1712.9169 18 -4.0 571.9773 3 56.50 4 28952 VEV_1_3_RA4_01_1235.d 2.06E5 3 3 198 215 Methylation(KR)
K.TVDGPSHKDWR(+14.02).G Y 44.13 1310.6367 11 -3.9 656.3231 2 33.34 5 15197 VEV_2_3_RA5_01_1236.d 1.02E6 9 9 187 197 Methylation(KR)
R.IGRIVFR.N Y 43.39 859.5392 7 -8.1 430.7734 2 54.21 4 27562 VEV_1_3_RA4_01_1235.d 4.41E5 3 3 13 19
K.TIHFYQERDPTNIPWGK(+14.02).H Y 42.92 2115.0537 17 -1.3 529.7700 4 72.95 4 41584 VEV_1_3_RA4_01_1235.d 8.24E5 4 4 73 89 Methylation(KR)
K.LTGMAM(+15.99)R.V Y 42.80 794.3779 7 -13.8 398.1907 2 22.75 4 8865 VEV_1_3_RA4_01_1235.d 2.27E6 7 7 228 234 Oxidation (M)
R.TEK(+14.02)PVTYDQIK.A Y 42.73 1334.7081 11 -10.3 445.9054 3 47.02 5 23334 VEV_2_3_RA5_01_1236.d 5.81E5 2 2 249 259 Methylation(KR)
K.VIIS(-2.02)APSADAPMFVMGVNEK.S Y 41.74 2073.0273 20 -11.7 692.0083 3 82.88 6 47113 VEV_3_3_RA6_01_1237.d 0 1 1 119 138 2-amino-3-oxo-butanoic_acid
K.GILGYSEDALVS(+14.02)TDLNGDPR.S Y 41.64 2105.0276 20 -2.9 1053.5181 2 84.44 4 50211 VEV_1_3_RA4_01_1235.d 2.81E5 1 1 272 291 Methylation(others)
K.TIHFYQERDPTNIPW(+15.99)GK.H Y 41.42 2117.0330 17 0.2 530.2656 4 70.21 4 39377 VEV_1_3_RA4_01_1235.d 3.51E5 2 2 73 89 Oxidation (HW)
R.TEKPVTYDQIKAAVK.A Y 41.32 1689.9301 15 -35.2 564.2975 3 59.09 4 30802 VEV_1_3_RA4_01_1235.d 0 1 1 249 263
R.NAVEHDDVEIVAVNDPFIETNYAAYM(-4.99)LK.Y Y 41.09 3174.5256 28 -28.0 1059.1528 3 86.93 5 50273 VEV_2_3_RA5_01_1236.d 5.45E4 1 1 20 47 Methionine replacement by azido homoalanine
K.YDSTHGQFKGDIEHSGGNN(-17.03)LTVNNK.T Y 41.03 2714.2319 25 -8.5 543.8491 5 57.58 4 29707 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 48 72 Ammonia-loss (N)
K.AHLSGGAKK(+14.02).V Y 40.11 881.5082 9 -7.7 441.7580 2 10.35 4 2600 VEV_1_3_RA4_01_1235.d 1.08E4 2 2 110 118 Methylation(KR)
K.VIPALN(+.98)GK.L Y 39.98 811.4803 8 -19.0 406.7397 2 50.40 6 24552 VEV_3_3_RA6_01_1237.d 5.75E6 21 21 220 227 Deamidation (NQ)
K.AASEGELKGILGYSED(+37.96)ALVSTDLNGDPR.S Y 39.57 2914.3599 28 -5.0 729.5936 4 83.66 4 49678 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 264 291 Replacement of proton by potassium
R.TEKPVTYDQIK(+14.02).A Y 39.39 1334.7081 11 -41.0 668.3340 2 51.76 4 26003 VEV_1_3_RA4_01_1235.d 3.09E5 4 4 249 259 Methylation(KR)
K.LISWYDNEWGY(+31.99)SR.R Y 39.25 1719.7528 13 -12.2 860.8732 2 76.35 6 42521 VEV_3_3_RA6_01_1237.d 1.52E4 1 1 310 322 Dihydroxy
R.S(+41.03)SIFDASAGIALNDRFVK.L Y 38.65 1951.0162 18 -19.2 651.3336 3 80.21 5 46250 VEV_2_3_RA5_01_1236.d 0 1 1 292 309 Amidination of lysines or N-terminal amines with methyl acetimidate
K.VGINGFGR(+14.02).I Y 38.52 832.4555 8 -12.0 417.2300 2 59.38 4 31020 VEV_1_3_RA4_01_1235.d 6.68E5 4 4 5 12 Methylation(KR)
K.KVIISAPSADAPMFVMGVN(+.98)EK.S Y 37.81 2204.1221 21 1.8 735.7159 3 79.61 4 46725 VEV_1_3_RA4_01_1235.d 3.42E5 1 1 118 138 Deamidation (NQ)
K.AASEGELK(+14.02).G Y 37.77 817.4181 8 -7.9 409.7131 2 23.11 4 9058 VEV_1_3_RA4_01_1235.d 6.73E5 2 2 264 271 Methylation(KR)
K.VIHDNFGIAEGLMTTIHSYTATQK(-.98).T Y 37.77 2645.3271 24 -4.1 530.0706 5 83.57 4 49613 VEV_1_3_RA4_01_1235.d 2.26E5 1 1 163 186 Amidation
K.YDSTHGQFKGDIEHSGGNN(+.98)LTVN(+.98)NK.T Y 37.27 2733.2266 25 -23.2 547.6399 5 58.72 4 30519 VEV_1_3_RA4_01_1235.d 1.71E5 1 1 48 72 Deamidation (NQ)
K.AASE(+28.03)GELKGILGYSEDALVSTDLNGDPR.S Y 37.13 2904.4351 28 -5.6 969.1469 3 86.07 4 51289 VEV_1_3_RA4_01_1235.d 4.08E5 1 1 264 291 Ethylation
K.VIHDNFGIAEGLMT(-18.01)TIHSYTATQK.T Y 36.67 2628.3005 24 -2.5 526.6661 5 83.06 5 47994 VEV_2_3_RA5_01_1236.d 7.49E4 1 1 163 186 Dehydration
K.LTGMAMR.V Y 35.99 778.3830 7 -9.9 390.1949 2 39.30 5 18698 VEV_2_3_RA5_01_1236.d 9.59E5 5 5 228 234
K.YDSTHGQFK(+14.02).G Y 35.32 1095.4985 9 12.2 548.7632 2 29.57 5 13019 VEV_2_3_RA5_01_1236.d 3.15E4 2 2 48 56 Methylation(KR)
R.TAAQN(+.98)IIPSSTGAAK(+14.02).A Y 34.82 1443.7568 15 -9.7 722.8787 2 63.26 6 32832 VEV_3_3_RA6_01_1237.d 0 2 2 201 215 Deamidation (NQ); Methylation(KR)
R.S(+43.01)SIFDASAGIALNDRFVK.L Y 34.72 1952.9955 18 -42.2 651.9783 3 80.06 6 45201 VEV_3_3_RA6_01_1237.d 0 1 1 292 309 Carbamylation
R.TE(+14.02)KPVTYDQIK.A Y 34.34 1334.7081 11 -14.1 668.3519 2 47.57 4 23366 VEV_1_3_RA4_01_1235.d 9.16E4 1 1 249 259 Methylation(others)
K.VIHDNFGIAEGLMTTIHS(+58.03)YTATQK.T Y 34.21 2704.3403 24 0.4 541.8755 5 72.11 4 40880 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 163 186 2,3-dihydro-2,2-dimethyl-7-benzofuranol N-methyl carbamate
K.TIHFYQER(+14.02)DPTNIPWGK.H Y 34.05 2115.0537 17 -3.6 529.7688 4 74.99 4 43122 VEV_1_3_RA4_01_1235.d 8.54E5 3 3 73 89 Methylation(KR)
R.SSIFD(+43.99)ASAGIALNDRFVK.L Y 33.95 1953.9795 18 -21.3 652.3199 3 80.26 4 47224 VEV_1_3_RA4_01_1235.d 0 1 1 292 309 Carboxylation (DKW)
K.SYRPDISVLSNASC(+57.02)TTN(+15.00)C(+57.02)LAPLAK.V Y 33.85 2652.2888 24 -13.4 885.0917 3 80.79 6 45717 VEV_3_3_RA6_01_1237.d 8.34E4 1 1 139 162 Carbamidomethylation; Deamidation followed by a methylation
R.GGRTAAQ(+.98)NIIPSSTGAAK.A Y 33.78 1699.8853 18 -15.5 567.6269 3 53.12 5 27080 VEV_2_3_RA5_01_1236.d 2.81E5 2 2 198 215 Deamidation (NQ)
K.TIHFYQER(+14.02).D Y 33.70 1106.5509 8 -17.1 369.8513 3 56.57 6 28084 VEV_3_3_RA6_01_1237.d 1.13E6 7 7 73 80 Methylation(KR)
R.TAAQNIIPSSTGAAK(+164.06).A Y 33.46 1592.8175 15 -3.2 797.4135 2 53.48 5 27288 VEV_2_3_RA5_01_1236.d 4.62E5 5 5 201 215 O-Diisopropylphosphorylation
K.VIHDN(+15.00)FGIAEGLMTTIHSYTATQK.T Y 33.31 2661.3108 24 2.9 888.1135 3 83.27 4 49406 VEV_1_3_RA4_01_1235.d 7.05E4 1 1 163 186 Deamidation followed by a methylation
M.VVKVGIN(+.98)GFGR.I Y 33.05 1145.6556 11 -17.3 382.8859 3 62.99 5 33771 VEV_2_3_RA5_01_1236.d 8.26E5 4 4 2 12 Deamidation (NQ)
R.T(+58.01)AAQNIIPSSTGAAK.A Y 32.95 1486.7627 15 -23.0 744.3715 2 64.42 6 33683 VEV_3_3_RA6_01_1237.d 1.08E5 3 3 201 215 Carboxymethyl (KW, X@N-term)
M.V(+42.01)VKVGINGFGR.I Y 32.94 1186.6823 11 -60.3 396.5442 3 61.87 4 32895 VEV_1_3_RA4_01_1235.d 0 1 1 2 12 Acetylation (Protein N-term)
K.T(+79.97)VDGPSHKDWR.G Y 32.89 1376.5874 11 118.6 345.1949 4 25.12 5 10554 VEV_2_3_RA5_01_1236.d 0 1 1 187 197 Phosphorylation (STY)
K.VIPALN(+.98)GK(+14.02).L Y 32.41 825.4960 8 -54.7 413.7327 2 59.28 6 29910 VEV_3_3_RA6_01_1237.d 0 2 2 220 227 Deamidation (NQ); Methylation(KR)
K.AASEGELK(+28.03)GILGYSEDALVSTDLNGDPR.S Y 32.34 2904.4351 28 -7.3 969.1452 3 85.93 5 49695 VEV_2_3_RA5_01_1236.d 2.02E5 1 1 264 291 Dimethylation(KR)
K.T(+119.04)VDGPSHKDWR.G Y 32.29 1415.6582 11 92.2 354.9545 4 24.74 4 9977 VEV_1_3_RA4_01_1235.d 5.96E5 1 1 187 197 Pyridylacetyl
K.T(+43.01)VDGPSHKDWR.G Y 32.13 1339.6268 11 20.5 447.5587 3 24.85 4 10038 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 187 197 Carbamylation
K.KVIISAPSAD(+55.92)APMFVMGVNEK.S Y 31.58 2259.0579 21 15.2 565.7803 4 71.72 4 40577 VEV_1_3_RA4_01_1235.d 0 2 2 118 138 Replacement of 2 protons by nickel
R.T(+164.06)EKPVTYDQIK.A Y 31.06 1484.7527 11 -9.1 743.3768 2 36.46 5 17046 VEV_2_3_RA5_01_1236.d 3.38E4 1 1 249 259 O-Diisopropylphosphorylation
K.LTGM(+15.99)AMR.V Y 30.45 794.3779 7 -9.3 398.1925 2 19.64 6 7408 VEV_3_3_RA6_01_1237.d 1.55E6 8 8 228 234 Oxidation (M)
K.AVGKVIPALN(+.98)GKLTGMAMR.V Y 30.29 1927.0747 19 -5.2 482.7735 4 74.00 5 41880 VEV_2_3_RA5_01_1236.d 7.78E4 1 1 216 234 Deamidation (NQ)
K.TIHFYQ(+.98)ERDPTNIPWGK.H Y 30.09 2102.0220 17 -4.6 526.5104 4 73.38 4 41884 VEV_1_3_RA4_01_1235.d 8.68E5 1 1 73 89 Deamidation (NQ)
R.TAAQ(+.98)NIIPSSTGAAKAVGK.V Y 29.78 1784.9631 19 -3.4 595.9930 3 61.92 5 32981 VEV_2_3_RA5_01_1236.d 3.79E4 1 1 201 219 Deamidation (NQ)
K.VIHDNFGIAEGLMTT(+13.03)IHSYTATQK.T Y 29.58 2659.3428 24 3.9 887.4583 3 83.27 5 48111 VEV_2_3_RA5_01_1236.d 0 1 1 163 186 Michael addition with methylamine
K.TVDGPSHKDWR(+.98).G Y 29.46 1297.6051 11 1.0 433.5428 3 24.66 5 10290 VEV_2_3_RA5_01_1236.d 1.48E5 1 1 187 197 Deamidation (R)
R.TEKPVT(+14.02)YDQIK.A Y 29.31 1334.7081 11 -21.2 668.3472 2 46.27 6 22147 VEV_3_3_RA6_01_1237.d 3.58E4 1 1 249 259 Methylation(others)
R.NAVEHDDVEIVAVNDPFIETNYAAYMLK(+54.01).Y Y 29.21 3233.5227 28 14.5 809.3997 4 81.14 6 45957 VEV_3_3_RA6_01_1237.d 0 1 1 20 47 MDA adduct +54
R.VPTANVSVVDLTC(+57.02)RT(+13.03)EKPVTYDQIK.A Y 28.70 2845.5007 25 -4.0 712.3796 4 76.02 5 43325 VEV_2_3_RA5_01_1236.d 0 1 1 235 259 Carbamidomethylation; Michael addition with methylamine
K.Y(+42.01)DSTHGQ(+.98)FK(+14.02)GDIEHSGGNNLTVNNK.T Y 28.27 2788.2688 25 -4.9 698.0710 4 57.20 5 29562 VEV_2_3_RA5_01_1236.d 4.02E4 1 1 48 72 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
K.AHLSGGAK(+14.02)K.V Y 28.07 881.5082 9 -15.1 441.7547 2 10.26 6 2607 VEV_3_3_RA6_01_1237.d 9.21E3 1 1 110 118 Methylation(KR)
K.TIHFYQERDPTNIPW(+31.99)GK.H Y 28.04 2133.0278 17 -8.3 534.2598 4 67.52 4 37253 VEV_1_3_RA4_01_1235.d 9.45E4 1 1 73 89 Dihydroxy
K.TVDGPSHK(+31.99)DWR.G Y 27.95 1328.6108 11 -11.8 443.8723 3 12.76 6 3787 VEV_3_3_RA6_01_1237.d 7.4E4 1 1 187 197 Dihydroxy
R.NAVEHDDVEIVAVNDPFIET(+13.03)NYAAYMLK.Y Y 27.36 3192.5437 28 -22.3 1065.1648 3 88.15 5 50923 VEV_2_3_RA5_01_1236.d 5.86E4 1 1 20 47 Michael addition with methylamine
M(+15.99)VVKVGIN(+.98)GFGR.I Y 26.72 1292.6910 12 -39.1 431.8875 3 59.40 5 31109 VEV_2_3_RA5_01_1236.d 0 1 1 1 12 Oxidation (M); Deamidation (NQ)
K.H(+42.01)(+15.99)GVDYVVESTGVFTTTEK.A Y 25.52 2025.9531 18 12.2 1013.9962 2 80.29 4 47242 VEV_1_3_RA4_01_1235.d 5.28E4 1 1 90 107 Acetylation (N-term); Oxidation (HW)
K.YDSTHGQFKGDIEHS(+13.03)GGNNLTVNNK.T Y 25.34 2744.2903 25 6.3 687.0842 4 58.77 5 30653 VEV_2_3_RA5_01_1236.d 7.83E3 1 1 48 72 Michael addition with methylamine
R.SS(-2.02)IFDASAGIALNDRFVK.L Y 25.08 1907.9740 18 16.4 637.0090 3 98.71 4 57775 VEV_1_3_RA4_01_1235.d 8.13E3 1 1 292 309 2-amino-3-oxo-butanoic_acid
K.VIHDNFGIAEGLMT(-18.01)TIHSYTATQK(+14.02).T Y 25.04 2642.3162 24 -29.2 661.5670 4 83.20 5 48072 VEV_2_3_RA5_01_1236.d 0 1 1 163 186 Dehydration; Methylation(KR)
K.KVIISAPSADAPMFVMGVNEK(+114.04).S Y 25.03 2317.1809 21 -9.9 580.2968 4 64.20 4 34660 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 118 138 Ubiquitin
K.LTGMAMRVPTANVS(-2.02)VVDLTC(+57.02)R.T Y 25.03 2288.1440 21 -14.0 573.0353 4 79.39 4 46542 VEV_1_3_RA4_01_1235.d 0 1 1 228 248 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.VPTANVS(-18.01)VVDLTC(+57.02)R(+14.02).T Y 25.01 1525.7922 14 -16.3 509.5964 3 73.42 5 41472 VEV_2_3_RA5_01_1236.d 6.15E4 1 1 235 248 Dehydration; Carbamidomethylation; Methylation(KR)
K.TIHFYQERDPTN(+.98)IPWGK.H Y 24.68 2102.0220 17 -6.6 526.5093 4 73.39 6 40366 VEV_3_3_RA6_01_1237.d 4.92E5 1 1 73 89 Deamidation (NQ)
R.TAAQ(+15.00)NIIPSSTGAAK.A Y 24.64 1443.7568 15 -10.5 722.8781 2 63.32 5 34025 VEV_2_3_RA5_01_1236.d 3.46E4 1 1 201 215 Deamidation followed by a methylation
K.YDSTHGQFKGDIEHSGGN(+.98)NLTVNNK(+14.02).T Y 24.62 2746.2583 25 -10.7 550.2531 5 59.35 6 29973 VEV_3_3_RA6_01_1237.d 0 1 1 48 72 Deamidation (NQ); Methylation(KR)
K.SYRPDISVLSNASC(+57.02)TTNC(+57.02)LAPLAK(-.98).V Y 24.25 2636.3049 24 -12.2 879.7649 3 80.51 5 46389 VEV_2_3_RA5_01_1236.d 0 1 1 139 162 Carbamidomethylation; Amidation
R.T(+56.06)AAQNIIPSSTGAAK.A Y 24.20 1484.8198 15 -35.3 743.3910 2 57.82 6 28914 VEV_3_3_RA6_01_1237.d 0 1 1 201 215 Diethylation
K.VIPALNGK(+14.02).L Y 24.01 824.5120 8 -17.9 413.2559 2 56.83 4 29187 VEV_1_3_RA4_01_1235.d 3.35E5 2 2 220 227 Methylation(KR)
K.AASEGELKGILGYSE(+28.03)DALVSTDLNGDPR.S Y 23.40 2904.4351 28 -5.3 969.1472 3 86.78 5 50185 VEV_2_3_RA5_01_1236.d 6.1E5 3 3 264 291 Ethylation
K.HGVDYVVESTGVFT(+79.97)T(+79.97)TEK(+42.01).A Y 23.38 2169.8909 18 71.0 724.3556 3 69.74 6 37672 VEV_3_3_RA6_01_1237.d 7.9E4 1 1 90 107 Phosphorylation (STY); Acetylation (K)
R.S(-2.02)SIFDASAGIALNDR.F Y 23.14 1533.7423 15 29.7 512.2699 3 78.87 4 46152 VEV_1_3_RA4_01_1235.d 4.57E4 1 1 292 306 2-amino-3-oxo-butanoic_acid
K.T(+41.03)IHFYQER.D Y 22.81 1133.5618 8 -33.8 378.8484 3 44.70 5 21960 VEV_2_3_RA5_01_1236.d 0 1 1 73 80 Amidination of lysines or N-terminal amines with methyl acetimidate
K.HGVDYVVESTGVFTTTEKAK(-.98).A Y 22.75 2166.0957 20 -22.9 723.0226 3 69.75 6 37663 VEV_3_3_RA6_01_1237.d 0 1 1 90 109 Amidation
K.V(+42.01)GINGFGR.I Y 22.33 860.4504 8 -28.3 431.2203 2 56.76 6 28209 VEV_3_3_RA6_01_1237.d 4.32E4 1 1 5 12 Acetylation (Protein N-term)
R.SSIFD(+14.02)ASAGIALNDRFVK.L Y 22.32 1924.0054 18 -19.1 642.3301 3 79.47 6 44783 VEV_3_3_RA6_01_1237.d 5.02E4 1 1 292 309 Methylation(others)
K.V(+27.99)GIN(+.98)GFGR.I Y 21.96 847.4188 8 -13.9 424.7108 2 59.76 5 31377 VEV_2_3_RA5_01_1236.d 2.09E5 1 1 5 12 Formylation (Protein N-term); Deamidation (NQ)
K.VIHDN(-17.03)FGIAEGLMTTIHSYTATQK.T Y 21.95 2629.2847 24 13.1 658.3370 4 83.18 4 49346 VEV_1_3_RA4_01_1235.d 2.54E4 1 1 163 186 Ammonia-loss (N)
K.VIHDNFGIAEGLMTTIHSYTAT(-18.01)QK(+14.02).T Y 21.72 2642.3162 24 -17.9 661.5745 4 83.28 4 49418 VEV_1_3_RA4_01_1235.d 0 1 1 163 186 Dehydration; Methylation(KR)
K.YDSTHGQFKGD(+14.02)IEHSGGNNLTVNNK.T Y 21.69 2745.2742 25 -10.2 916.0894 3 59.07 4 30785 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 48 72 Methylation(others)
R.SSIFDASAGIALNDRFVKLISWYDNEWGYSRR.V Y 21.65 3735.8433 32 -4.6 748.1725 5 91.31 5 52554 VEV_2_3_RA5_01_1236.d 7.72E4 1 1 292 323
R.S(-15.99)SIFDASAGIALNDR.F Y 21.57 1519.7631 15 20.3 507.6053 3 76.45 6 42593 VEV_3_3_RA6_01_1237.d 5.65E4 1 1 292 306 Deoxy
K.HGVDYVVESTGVFT(+79.97)TT(+79.97)EK(+42.01).A Y 21.44 2169.8909 18 85.2 724.3658 3 69.76 5 38816 VEV_2_3_RA5_01_1236.d 2.03E5 1 1 90 107 Phosphorylation (STY); Acetylation (K)
R.DPTN(+.98)IPWGK.H Y 21.26 1027.4974 9 51.1 514.7822 2 66.39 4 36361 VEV_1_3_RA4_01_1235.d 0 1 1 81 89 Deamidation (NQ)
K.AASEGELK(+27.99)GILGYSEDALVSTDLNGDPR.S Y 21.08 2904.3987 28 9.4 969.1493 3 85.94 6 49042 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 264 291 Formylation
M(+226.08)VVK(+14.02)VGINGFGR.I Y 20.84 1515.8054 12 -1.3 379.9581 4 61.61 6 31613 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 1 12 Biotinylation; Methylation(KR)
K.V(+42.01)D(-18.01)AGK N 20.73 512.2595 5 -4.7 513.2643 1 44.86 4 21678 VEV_1_3_RA4_01_1235.d 0 1 1 334 338 Acetylation (N-term); Dehydration
K.VIPALN(-17.03)GK.L Y 20.69 793.4698 8 -21.2 397.7338 2 54.77 4 27917 VEV_1_3_RA4_01_1235.d 1.21E5 2 2 220 227 Ammonia-loss (N)
K.V(+42.01)IH(+15.99)DNFGIAEGLMTTIHSYTATQK.T Y 20.68 2704.3167 24 7.7 677.0917 4 83.96 5 48537 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 163 186 Acetylation (N-term); Oxidation (HW)
K.YDSTHGQFKGDIEHS(-18.01)GGNNLTVNNK.T Y 20.65 2713.2480 25 -13.5 543.6495 5 56.07 6 27769 VEV_3_3_RA6_01_1237.d 2.14E5 1 1 48 72 Dehydration
K.VIPALNGKLTGMAMRVPTAN(+.98)VSVVDLTC(+57.02)R.T Y 20.51 3083.6294 29 -20.6 771.8987 4 83.59 5 48312 VEV_2_3_RA5_01_1236.d 8.85E4 1 1 220 248 Deamidation (NQ); Carbamidomethylation
K.VIHDNFGIAEGLM(+15.99)TTIHSYTATQK(-.98).T Y 20.44 2661.3220 24 -6.3 666.3336 4 83.55 5 48289 VEV_2_3_RA5_01_1236.d 1.39E5 1 1 163 186 Oxidation (M); Amidation
R.NAVEHDDVEIVAVNDPFIETNYAAYMLK(-.98).Y Y 20.20 3178.5281 28 -4.2 1060.5122 3 87.74 4 52339 VEV_1_3_RA4_01_1235.d 2.37E5 1 1 20 47 Amidation
K.KVIISAPSADAPM(+31.99)FVMGVNEK(+42.01).S Y 19.71 2277.1384 21 -4.0 570.2896 4 68.07 6 36447 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 118 138 Sulphone; Acetylation (K)
K.KVIISAPSADAPMFVM(+15.99)GVN(+.98)EK(+14.02).S Y 19.66 2234.1326 21 -6.1 745.7136 3 77.22 5 44182 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 118 138 Oxidation (M); Deamidation (NQ); Methylation(KR)
K.LISWYDNEWGYSR(+14.02)R.V Y 19.55 1857.8798 14 -1.2 620.2998 3 76.55 4 44341 VEV_1_3_RA4_01_1235.d 2.15E5 2 2 310 323 Methylation(KR)
K.TVDGPS(-18.01)HKDWR.G Y 19.30 1278.6105 11 -7.4 320.6575 4 24.37 4 9800 VEV_1_3_RA4_01_1235.d 2.3E5 1 1 187 197 Dehydration
K.VDAGK N 18.81 488.2594 5 -16.0 489.2589 1 54.99 6 27180 VEV_3_3_RA6_01_1237.d 0 1 1 334 338
K.VGINGFGR(+.98).I Y 18.69 819.4239 8 -13.2 410.7138 2 61.46 6 31495 VEV_3_3_RA6_01_1237.d 4.58E5 1 1 5 12 Deamidation (R)
K.YDSTHGQ(+.98)FKGDIEHSGGNN(+.98)LTVNNK.T Y 18.07 2733.2266 25 -8.1 684.3084 4 58.78 4 30574 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 48 72 Deamidation (NQ)
K.KVIISAPSAD(+6.01)APMFVMGVNEK.S Y 18.00 2209.1462 21 -25.8 737.3704 3 79.49 5 45716 VEV_2_3_RA5_01_1236.d 4.79E4 1 1 118 138 Replacement of proton by lithium
K.VDAGK(+43.01) N 17.97 531.2653 5 24.8 532.2857 1 72.24 5 40643 VEV_2_3_RA5_01_1236.d 1.23E5 2 2 334 338 Carbamylation
K.TVDGPSHK(+42.01).D Y 17.81 881.4243 8 9.5 882.4399 1 103.43 6 56343 VEV_3_3_RA6_01_1237.d 7.4E4 1 1 187 194 Acetylation (K)
K.VDAGK(+31.99) N 17.61 520.2493 5 -18.2 521.2471 1 38.14 6 17428 VEV_3_3_RA6_01_1237.d 0 1 1 334 338 Dihydroxy
K.V(+42.01)IHDNFGIAEGLM(+15.99)TTIHSYTATQK.T Y 17.44 2704.3167 24 -65.0 541.8354 5 83.96 4 49886 VEV_1_3_RA4_01_1235.d 0 1 1 163 186 Acetylation (N-term); Oxidation (M)
R.TEKPVTYDQIK(+42.02).A Y 17.26 1362.7144 11 14.0 455.2518 3 38.34 4 17719 VEV_1_3_RA4_01_1235.d 0 1 1 249 259 Guanidination
K.AASEGELKGILGYSEDALVS(-2.02)TDLNGDPR.S Y 17.14 2874.3882 28 -10.9 959.1262 3 84.56 6 48182 VEV_3_3_RA6_01_1237.d 1.03E5 1 1 264 291 2-amino-3-oxo-butanoic_acid
K.HGVDYVVEST(-2.02)GVFTTTEKAK.A Y 16.87 2165.0640 20 1.3 542.2740 4 70.43 6 38176 VEV_3_3_RA6_01_1237.d 7.08E4 1 1 90 109 2-amino-3-oxo-butanoic_acid
K.YD(+14.02)STHGQFKGDIEHSGGNNLTVNNK.T Y 16.74 2745.2742 25 -11.7 550.0557 5 56.65 6 28140 VEV_3_3_RA6_01_1237.d 2E5 1 1 48 72 Methylation(others)
K.V(+27.99)DAGK N 16.72 516.2543 5 11.1 517.2673 1 55.92 4 28579 VEV_1_3_RA4_01_1235.d 0 1 1 334 338 Formylation
R.DPTNIPWGK(+14.02).H Y 16.69 1040.5291 9 -9.1 521.2671 2 69.28 4 38650 VEV_1_3_RA4_01_1235.d 0 1 1 81 89 Methylation(KR)
K.AASEGE(+14.02)LK.G Y 16.50 817.4181 8 -13.8 409.7107 2 19.94 5 7695 VEV_2_3_RA5_01_1236.d 8.25E4 1 1 264 271 Methylation(others)
K.KVIISAP(+31.99)S(+79.97)ADAPMFVMGVNEK.S Y 16.43 2315.0942 21 41.3 464.0453 5 64.15 4 34624 VEV_1_3_RA4_01_1235.d 0 1 1 118 138 Dihydroxy; Phosphorylation (STY)
K.H(+15.99)GVDYVVESTGVFTTTEKAK.A Y 16.38 2183.0747 20 5.1 546.7787 4 71.61 4 40487 VEV_1_3_RA4_01_1235.d 2.06E5 1 1 90 109 Oxidation (HW)
K.AASEGELKGILGYS(-2.02)EDALVSTDLNGDPR.S Y 16.33 2874.3882 28 -22.3 959.1153 3 102.27 4 58937 VEV_1_3_RA4_01_1235.d 0 1 1 264 291 2-amino-3-oxo-butanoic_acid
K.VDAGK(+27.99) N 16.29 516.2543 5 24.1 517.2740 1 37.58 4 17274 VEV_1_3_RA4_01_1235.d 0 1 1 334 338 Formylation
K.A(+298.19)ASEGELK.G Y 16.28 1101.5957 8 -29.1 368.1952 3 33.45 6 14768 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 264 271 Levuglandinyl-lysine anhyropyrrole adduct
K.VIHDNFGIAEGLMTTIH(+15.99)SYTATQK(+14.02).T Y 16.25 2676.3218 24 -18.4 670.0754 4 78.71 4 46025 VEV_1_3_RA4_01_1235.d 8.12E4 1 1 163 186 Oxidation (HW); Methylation(KR)
K.TVDGPSHKDWR(+72.02).G Y 16.21 1368.6422 11 -4.5 685.3253 2 22.83 5 9259 VEV_2_3_RA5_01_1236.d 2.41E4 1 1 187 197 Dihydroxy methylglyoxal adduct
K.LTGMAMRVPTANVSVVDLTC(+57.02)R(-.98).T Y 16.05 2289.1755 21 -7.1 573.2971 4 79.35 5 45624 VEV_2_3_RA5_01_1236.d 2.3E5 1 1 228 248 Carbamidomethylation; Amidation
K.VIISAPS(+114.04)ADAPMFVMGVNEK.S Y 15.55 2189.0859 20 -14.9 548.2706 4 67.07 6 35684 VEV_3_3_RA6_01_1237.d 5.17E5 1 1 119 138 Ubiquitin
K.YDSTHGQFKGDIEHSGGNNLTVNNK(-.98).T Y 15.26 2730.2747 25 4.4 547.0646 5 58.22 4 30167 VEV_1_3_RA4_01_1235.d 9.3E4 1 1 48 72 Amidation
R.RVLDLIAYIAK(+43.99).V Y 15.05 1317.7656 11 -67.1 440.2330 3 52.27 4 26339 VEV_1_3_RA4_01_1235.d 0 1 1 323 333 Carboxylation (DKW)
K.AHLS(+79.97)GGAKK(+14.02).V Y 15.00 961.4746 9 37.3 321.5108 3 10.42 4 2628 VEV_1_3_RA4_01_1235.d 2.36E4 1 1 110 118 Phosphorylation (STY); Methylation(KR)
total 293 peptides
C1G065
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.Q(-17.03)AIAEAEGVDDDRWEDTYKGPAGGVITVR.S Y 151.04 3100.4736 29 -8.2 1034.4900 3 79.87 4 46918 VEV_1_3_RA4_01_1235.d 4.29E5 3 3 830 858 Pyro-glu from Q
R.FTSVAGQPSLLQSYSELDTPYPSVEK.I Y 144.17 2842.3911 26 -4.3 1422.1968 2 83.48 4 49553 VEV_1_3_RA4_01_1235.d 5.37E5 6 6 970 995
K.ILSAYPEAASQLISAQDVQHFLLLC(+57.02)QR.R Y 140.60 3070.5908 27 -4.1 768.6519 4 89.01 4 53114 VEV_1_3_RA4_01_1235.d 4.6E5 7 7 996 1022 Carbamidomethylation
R.NFVVTGPPISLYGLNLR.L Y 139.56 1859.0305 17 -16.0 620.6742 3 87.35 6 49856 VEV_3_3_RA6_01_1237.d 9.11E5 6 6 388 404
R.DNFSASLPAPTDELAQDDEPSSVEELVAR.Y Y 131.64 3101.4312 29 -1.7 1551.7202 2 85.94 4 51208 VEV_1_3_RA4_01_1235.d 1.11E5 4 4 50 78
R.NSAGDTVDLEDMTYTEVVHR.M Y 131.48 2251.0063 20 -6.6 751.3378 3 76.97 4 44670 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 918 937
R.GFATIPLKGIDVPFHSTFLR.S Y 131.47 2215.2153 20 -8.0 554.8067 4 83.41 4 49521 VEV_1_3_RA4_01_1235.d 8.83E5 6 6 1992 2011
R.TSLAPSILQDSIENGEGVPTPMLSIR.D Y 129.44 2724.4004 26 -1.6 1363.2053 2 87.80 5 50732 VEV_2_3_RA5_01_1236.d 9.79E4 2 2 329 354
R.ADGVPIEGLTIGAGVPSIEVANEYIQTLGIK.H Y 125.66 3123.6702 31 -9.2 1042.2211 3 95.04 5 54246 VEV_2_3_RA5_01_1236.d 8.6E5 8 8 682 712
R.DSDSQPDTDYLVSAPVSLPLIGLVQLAHFMTTC(+57.02)K.V Y 124.40 3717.8269 34 -0.7 1240.2821 3 97.75 4 57459 VEV_1_3_RA4_01_1235.d 2.64E4 2 2 233 266 Carbamidomethylation
K.LRADGVPIEGLTIGAGVPSIEVANEYIQTLGIK.H Y 123.33 3392.8555 33 -4.0 1131.9546 3 92.45 4 55022 VEV_1_3_RA4_01_1235.d 3.09E5 3 3 680 712
R.VFSSYANLPGTITHGMYTSAAVR.S Y 123.27 2442.2002 23 -5.1 815.0699 3 79.19 4 46391 VEV_1_3_RA4_01_1235.d 4.33E5 3 3 1595 1617
R.IFKDVNENSTSYTYR.S Y 122.79 1835.8689 15 -8.4 612.9584 3 60.71 4 32048 VEV_1_3_RA4_01_1235.d 1.01E6 8 8 1780 1794
K.ATVTSQAIADFVHAVGNTGEAFVDRPGK.E Y 116.77 2857.4358 28 -4.6 715.3629 4 86.20 4 51368 VEV_1_3_RA4_01_1235.d 4.24E5 4 4 1314 1341
R.FLPITAPFHSQYLASAFEQITEDLDDLVIPSK.S Y 115.87 3604.8340 32 -2.4 1202.6157 3 97.67 4 57418 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 432 463
R.SPTGLLSATQFTQPALTLMEK.A Y 114.67 2233.1665 21 -6.5 1117.5833 2 87.12 4 51957 VEV_1_3_RA4_01_1235.d 8.87E5 7 7 1795 1815
R.ILAPTPGMFVEIQYPNDAKR.T Y 114.24 2259.1721 20 -7.6 754.0590 3 80.74 4 47589 VEV_1_3_RA4_01_1235.d 6.77E5 4 4 1195 1214
R.DGKPIMEVTSQFLYR.G Y 111.10 1782.8975 15 -11.4 595.2997 3 80.41 4 47409 VEV_1_3_RA4_01_1235.d 3.36E5 3 3 1423 1437
R.MITRDPVNWEHATVFPNATHLLDFGPGGISGLGVLTNR.N Y 111.02 4102.0845 38 -12.3 1026.5157 4 87.59 4 52246 VEV_1_3_RA4_01_1235.d 2.85E5 4 4 492 529
R.IPVYDTNTGEDLRAKDEDIVPALIR.M Y 110.18 2812.4607 25 -12.6 704.1136 4 78.95 4 46205 VEV_1_3_RA4_01_1235.d 4.36E5 2 2 467 491
R.GGGHHSFEDFHQPILLMYSR.I Y 110.08 2327.0906 20 -6.1 466.4225 5 75.60 4 43602 VEV_1_3_RA4_01_1235.d 4.46E5 4 4 748 767
R.TTGDREISLTLFEGR.T Y 109.84 1693.8635 15 -16.3 565.6193 3 75.72 5 43153 VEV_2_3_RA5_01_1236.d 5.48E5 5 5 1236 1250
R.IWFSDRDVPFDTPATATFDGGK.A Y 108.71 2442.1492 22 -18.4 815.0420 3 82.67 6 46983 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 1292 1313
R.GNDVHAIAGC(+57.02)LPGISAK.K Y 107.33 1678.8461 17 -11.3 560.6163 3 69.54 4 38886 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 116 132 Carbamidomethylation
R.ALDTLTNVLNVLK.A Y 101.37 1412.8239 13 -9.4 707.4125 2 87.19 4 51999 VEV_1_3_RA4_01_1235.d 2.12E5 4 4 1935 1947
R.GSYNDFETTFQR.K Y 101.17 1463.6317 12 -8.4 732.8170 2 69.62 4 38918 VEV_1_3_RA4_01_1235.d 3.43E5 8 8 1438 1449
R.TAEGGVVPLC(+57.02)FR.F Y 100.56 1304.6547 12 -9.1 653.3287 2 73.54 4 42003 VEV_1_3_RA4_01_1235.d 8.96E5 6 6 1251 1262 Carbamidomethylation
R.DSSFAGHSLGEYSALAALADVMSIESLVSVVFYR.G Y 99.68 3590.7603 34 -2.1 1197.9248 3 97.93 4 57525 VEV_1_3_RA4_01_1235.d 0 1 1 1830 1863
K.HIGFKPGSMDAIQQVINIAK.A Y 98.93 2166.1619 20 -9.7 542.5425 4 80.79 4 47632 VEV_1_3_RA4_01_1235.d 1.62E5 3 3 713 732
R.LDEPDVDLLGQTLTFR.L Y 98.01 1830.9363 16 -5.1 611.3163 3 86.61 6 49439 VEV_3_3_RA6_01_1237.d 5.41E5 5 5 1476 1491
K.DSLWQSEDLEAVVGQDVGR.V Y 96.27 2101.9917 19 -6.0 1051.9968 2 85.20 4 50726 VEV_1_3_RA4_01_1235.d 2.65E4 1 1 1045 1063
R.VSGDYNPIHVSR.V Y 92.82 1342.6630 12 -12.0 448.5562 3 55.40 4 28313 VEV_1_3_RA4_01_1235.d 1.92E6 5 5 1583 1594
K.TSVGQTFVDTK.M Y 92.76 1181.5928 11 -14.8 591.7949 2 54.24 5 27785 VEV_2_3_RA5_01_1236.d 1.33E6 10 10 583 593
R.GITVNLIYVNPR.A Y 92.21 1357.7717 12 -10.2 679.8862 2 78.46 5 45030 VEV_2_3_RA5_01_1236.d 3.9E5 6 6 657 668
K.EWFRLDEPDVDLLGQTLTFR.L Y 91.91 2449.2278 20 -3.1 817.4140 3 90.24 4 53784 VEV_1_3_RA4_01_1235.d 4.97E4 2 2 1472 1491
R.IPVYDTNTGEDLR.A Y 91.04 1491.7205 13 -9.3 746.8606 2 65.84 4 35957 VEV_1_3_RA4_01_1235.d 2.66E5 3 3 467 479
R.APASNETYAR.V Y 89.90 1078.5043 10 -7.0 540.2556 2 19.14 4 6996 VEV_1_3_RA4_01_1235.d 6.89E5 7 7 1573 1582
R.SFHASLVGMVLPNDDLVVVLQHVGMVAGR.K Y 89.54 3059.6047 29 -10.5 765.9005 4 91.53 5 52675 VEV_2_3_RA5_01_1236.d 1.94E5 2 2 1634 1662
R.SLVETWAAENNIGR.V Y 85.73 1558.7739 14 -6.7 780.3890 2 76.41 4 44232 VEV_1_3_RA4_01_1235.d 4.88E5 5 5 1618 1631
K.EYFEDVYR.L Y 85.55 1119.4873 8 -8.7 560.7460 2 68.05 4 37676 VEV_1_3_RA4_01_1235.d 3.72E5 3 3 2053 2060
R.VIDGDLLKLVHLSNGFR.M Y 84.98 1895.0629 17 -12.3 474.7672 4 82.74 4 49042 VEV_1_3_RA4_01_1235.d 2.95E5 3 3 1366 1382
K.YSNTVDEPVKDILDGIHNDHIK.G Y 84.72 2521.2449 22 -11.2 841.4128 3 76.81 5 43885 VEV_2_3_RA5_01_1236.d 8.84E5 4 4 1075 1096
R.FSGTTGHSQGIVTAALISTATTWDSFEK.A Y 83.56 2912.4192 28 -13.0 971.8011 3 86.58 4 51615 VEV_1_3_RA4_01_1235.d 1.95E5 2 2 279 306
R.SNYSMC(+57.02)AVNPSR.I Y 83.26 1384.5864 12 3.2 693.3027 2 53.65 4 27266 VEV_1_3_RA4_01_1235.d 2.56E5 7 7 1879 1890 Carbamidomethylation
R.ILAPTPGMFVEIQYPNDAK.R Y 83.07 2103.0710 19 -5.2 702.0273 3 84.00 5 48565 VEV_2_3_RA5_01_1236.d 6.99E4 2 2 1195 1213
R.QNYMSMTFETVNADGSIKSER.I Y 78.75 2407.0784 21 -5.1 803.3626 3 75.77 4 43733 VEV_1_3_RA4_01_1235.d 0 1 1 1759 1779
R.RC(+57.02)DNIVLVAGSGFGGSQDTYPYLTGSWSR.Q Y 78.33 3162.4829 29 -2.9 1055.1652 3 83.94 4 49870 VEV_1_3_RA4_01_1235.d 4.63E4 1 1 770 798 Carbamidomethylation
K.NNPQELTIHFGGPR.G Y 77.07 1578.7903 14 -9.8 790.3947 2 66.38 5 36307 VEV_2_3_RA5_01_1236.d 9.42E5 7 7 1740 1753
K.ANPTFPVIMQWTGGR.G Y 76.56 1673.8347 15 -7.3 837.9185 2 83.89 4 49837 VEV_1_3_RA4_01_1235.d 3.07E5 3 3 733 747
K.HIGFKPGSMDAIQ(+.98)QVINIAK.A Y 75.95 2167.1460 20 -1.3 542.7931 4 80.98 4 47775 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 713 732 Deamidation (NQ)
R.SPTGLLSATQFTQPALTLMEK(+14.02).A Y 75.83 2247.1821 21 -17.2 1124.5790 2 88.38 4 52740 VEV_1_3_RA4_01_1235.d 0 1 1 1795 1815 Methylation(KR)
R.IGSVLANWAKYEEAGVGEKV Y 75.56 2119.0950 20 -8.4 707.3663 3 80.82 4 47652 VEV_1_3_RA4_01_1235.d 2.15E5 3 3 2067 2086
R.IFKDVN(+.98)ENSTSYTYR.S Y 75.33 1836.8530 15 1.8 613.2927 3 60.82 4 32107 VEV_1_3_RA4_01_1235.d 2.74E5 1 1 1780 1794 Deamidation (NQ)
R.SNYSM(+15.99)C(+57.02)AVNPSR.I Y 74.71 1400.5813 12 -14.2 701.2880 2 35.96 6 16218 VEV_3_3_RA6_01_1237.d 1.57E5 3 3 1879 1890 Oxidation (M); Carbamidomethylation
K.YEEAGVGEKV Y 74.47 1079.5134 10 -6.9 540.7603 2 43.76 4 20984 VEV_1_3_RA4_01_1235.d 3.79E5 4 4 2077 2086
K.AITKPIFPR.V Y 73.24 1041.6334 9 -12.7 348.2140 3 57.97 4 29991 VEV_1_3_RA4_01_1235.d 5.96E5 6 6 1357 1365
R.DVPFDTPATATFDGGK.A Y 68.61 1637.7573 16 -10.4 819.8774 2 77.50 4 45150 VEV_1_3_RA4_01_1235.d 6.99E4 1 1 1298 1313
R.SEM(+15.99)GEPIHK.L Y 68.59 1042.4753 9 -4.4 522.2427 2 13.52 4 4062 VEV_1_3_RA4_01_1235.d 8.18E4 3 3 859 867 Oxidation (M)
K.SLRIPVYDTNTGEDLR.A Y 68.07 1847.9377 16 -27.2 616.9698 3 71.77 6 39190 VEV_3_3_RA6_01_1237.d 1.01E6 4 4 464 479
R.TTGDREISLTLFEGR(+14.02).T Y 66.85 1707.8792 15 -0.3 570.3002 3 77.88 4 45386 VEV_1_3_RA4_01_1235.d 1.92E5 2 2 1236 1250 Methylation(KR)
R.AMAWQIPLIGK.L Y 66.31 1226.6846 11 -13.9 614.3411 2 83.34 5 48155 VEV_2_3_RA5_01_1236.d 8.03E4 1 1 669 679
R.LSPSTSASLPDLDR.W Y 66.00 1457.7361 14 -15.8 729.8638 2 69.22 6 37284 VEV_3_3_RA6_01_1237.d 7.5E4 1 1 1146 1159
K.APTGLDQNRIPYTQRK.V Y 65.81 1856.9856 16 -13.1 465.2476 4 53.81 4 27325 VEV_1_3_RA4_01_1235.d 2.15E5 3 3 410 425
K.SM(+15.99)TEALNKIEK.N Y 64.83 1278.6489 11 -4.4 640.3289 2 36.02 4 16350 VEV_1_3_RA4_01_1235.d 3.8E4 1 1 640 650 Oxidation (M)
K.SLRIPVY(-2.02)DTNTGEDLRAKDEDIVPALIR.M Y 63.78 3166.6621 28 -8.2 634.3345 5 79.87 4 46919 VEV_1_3_RA4_01_1235.d 0 1 1 464 491 2-amino-3-oxo-butanoic_acid
R.VIDGDLLKLVHLSN(+.98)GFR.M Y 62.83 1896.0469 17 -0.1 475.0190 4 83.86 5 48471 VEV_2_3_RA5_01_1236.d 2.52E5 4 4 1366 1382 Deamidation (NQ)
R.HGSAIEQPVHFENPIPLSGK.T Y 61.46 2156.1013 20 -10.2 540.0271 4 71.95 6 39325 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 1547 1566
R.VFS(-2.02)SYANLPGTITHGMYTSAAVR.S Y 59.91 2440.1846 23 28.7 814.4255 3 79.16 4 46368 VEV_1_3_RA4_01_1235.d 4.33E3 1 1 1595 1617 2-amino-3-oxo-butanoic_acid
R.FTSVAGQPSLLQSYSELDTPYPSVEK(+14.02).I Y 59.82 2856.4067 26 -7.2 1429.2003 2 84.68 4 50371 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 970 995 Methylation(KR)
K.ILSAYPEAASQLISAQ(+.98)DVQHFLLLC(+57.02)QR.R Y 59.02 3071.5750 27 -7.6 768.8951 4 89.51 4 53432 VEV_1_3_RA4_01_1235.d 3.61E4 1 1 996 1022 Deamidation (NQ); Carbamidomethylation
R.TFISVREPSQSGR.L Y 58.69 1462.7528 13 -12.6 488.5854 3 56.55 5 29124 VEV_2_3_RA5_01_1236.d 7.03E5 5 5 1215 1227
R.IFKDVNEN(+.98)STSYTYR.S Y 57.64 1836.8530 15 1.4 613.2925 3 60.64 5 32022 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 1780 1794 Deamidation (NQ)
R.AAANRPTKPHESALLR.A Y 57.42 1730.9540 16 -9.3 433.7418 4 31.93 4 13970 VEV_1_3_RA4_01_1235.d 5.59E5 2 2 145 160
R.FTYHPETGYAPIR.E Y 57.15 1550.7517 13 -6.7 776.3779 2 64.96 5 35246 VEV_2_3_RA5_01_1236.d 1.32E5 2 2 1263 1275
R.MIPGAEPLKVGDVLETTAQVNAVINQDSGK.M Y 54.56 3093.6016 30 -5.2 1032.2024 3 85.15 4 50687 VEV_1_3_RA4_01_1235.d 7.7E4 1 1 1383 1412
K.EVWDRADKHFIENYGLSIINIVK.N Y 53.57 2758.4441 23 -15.7 552.6874 5 84.65 4 50347 VEV_1_3_RA4_01_1235.d 2.5E5 3 3 1717 1739
R.ILAPT(-2.02)PGMFVEIQYPNDAKR.T Y 52.37 2257.1565 20 -27.4 753.3722 3 80.81 4 47648 VEV_1_3_RA4_01_1235.d 0 1 1 1195 1214 2-amino-3-oxo-butanoic_acid
R.GFATIPLK.G Y 52.29 845.5010 8 -11.6 423.7529 2 68.11 4 37718 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 1992 1999
R.KIIKVEASNQATEEK.V Y 52.17 1686.9152 15 -21.2 563.3004 3 34.21 6 15203 VEV_3_3_RA6_01_1237.d 2.17E4 1 1 1663 1677
K.NALTMLFWIGMR.S Y 50.60 1451.7417 12 1.1 726.8789 2 93.57 4 55593 VEV_1_3_RA4_01_1235.d 5.36E4 1 1 310 321
R.HGSAIEQPVHFENPIPLSGK(-.98).T Y 50.47 2155.1174 20 0.9 539.7871 4 71.78 4 40619 VEV_1_3_RA4_01_1235.d 3.46E5 1 1 1547 1566 Amidation
R.DPVNWEHATVFPNATHLLDFGPGGISGLGVLTNR.N Y 48.62 3600.8113 34 -9.5 721.1627 5 89.91 6 51269 VEV_3_3_RA6_01_1237.d 9.21E4 1 1 496 529
R.VFSSYANLPGTITHGM(+15.99)YTSAAVR.S Y 48.46 2458.1951 23 -11.5 820.3962 3 76.03 4 43945 VEV_1_3_RA4_01_1235.d 1.28E5 3 3 1595 1617 Oxidation (M)
R.Q(-17.03)FGYPPMPFDGC(+57.02)LFGSR.M Y 48.23 1957.8491 17 -16.9 979.9153 2 94.70 6 53493 VEV_3_3_RA6_01_1237.d 3.16E5 3 3 799 815 Pyro-glu from Q; Carbamidomethylation
K.SLRIPVY(-2.02)DTNTGEDLR.A Y 48.14 1845.9220 16 2.2 616.3160 3 71.81 4 40651 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 464 479 2-amino-3-oxo-butanoic_acid
K.TSVGQTFVDTK(+14.02).M Y 47.78 1195.6084 11 -2.5 598.8100 2 61.79 4 32829 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 583 593 Methylation(KR)
K.GPAGGVITVR.S Y 46.82 925.5345 10 -17.7 463.7663 2 49.46 4 24539 VEV_1_3_RA4_01_1235.d 4.72E4 1 1 849 858
K.ATVTSQAIADFVHAVGNTGEAFVDRPGKEVFAPMDFAIVVGWK.A Y 45.08 4547.2944 43 -5.5 910.4611 5 94.90 4 56243 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 1314 1356
R.HGSAIEQPVHFENPIPLS(-18.01)GK(+14.02).T Y 44.42 2152.1064 20 -37.3 539.0138 4 71.84 6 39241 VEV_3_3_RA6_01_1237.d 0 1 1 1547 1566 Dehydration; Methylation(KR)
R.HGSAIEQPVHFENPIPLSGKTPLNLRAPASNETYAR.V Y 43.65 3911.0078 36 -7.4 783.2031 5 76.39 4 44215 VEV_1_3_RA4_01_1235.d 3.18E4 1 1 1547 1582
K.SMTEALNKIEK.N Y 43.21 1262.6541 11 -11.1 421.8873 3 58.62 4 30506 VEV_1_3_RA4_01_1235.d 3.74E5 2 2 640 650
R.LSPSTSASLPDLDRWLR.L Y 42.61 1913.0006 17 -12.3 638.6663 3 81.32 4 48031 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 1146 1162
K.YIPNVSAKPFALTK.E Y 41.63 1547.8711 14 8.5 774.9494 2 71.29 4 40235 VEV_1_3_RA4_01_1235.d 4.09E5 2 2 2039 2052
R.LTGDFIR.R Y 41.43 820.4443 7 -20.1 411.2212 2 59.41 4 31042 VEV_1_3_RA4_01_1235.d 9.69E5 5 5 958 964
K.LVHLSNGFR.M Y 41.08 1041.5719 9 -15.5 348.1925 3 54.90 4 27999 VEV_1_3_RA4_01_1235.d 3.13E5 3 3 1374 1382
K.VKAPTGLDQNRIPYTQR.K Y 39.72 1956.0541 17 -15.3 490.0133 4 60.85 5 32177 VEV_2_3_RA5_01_1236.d 6.89E4 2 2 408 424
R.TFISVR.E Y 38.57 721.4122 6 -15.0 361.7080 2 53.99 4 27432 VEV_1_3_RA4_01_1235.d 5.1E5 4 4 1215 1220
R.TTGDR(+14.02)EISLTLFEGR.T Y 38.25 1707.8792 15 -15.3 570.2916 3 77.55 5 44404 VEV_2_3_RA5_01_1236.d 1.87E5 1 1 1236 1250 Methylation(KR)
K.QPGEVLER.F Y 37.78 926.4821 8 -5.1 464.2460 2 34.51 4 15464 VEV_1_3_RA4_01_1235.d 1.44E5 4 4 271 278
R.AKDEDIVPALIR.M Y 37.50 1338.7506 12 -44.7 447.2375 3 69.94 6 37803 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 480 491
R.WIDDSLKR.L Y 36.73 1031.5399 8 -3.6 344.8527 3 53.39 6 26304 VEV_3_3_RA6_01_1237.d 3.74E5 4 4 950 957
R.AMAWQIPLIGK(+14.02).L Y 36.41 1240.7002 11 -13.7 621.3489 2 84.02 4 49923 VEV_1_3_RA4_01_1235.d 2.55E4 1 1 669 679 Methylation(KR)
M(+42.01)YGTSTGPQTGINTPR.S Y 36.17 1721.8043 16 -7.5 861.9030 2 72.26 4 41004 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 1 16 Acetylation (Protein N-term)
R.QFGYPPMPFDGC(+57.02)LFGSR.M Y 35.33 1974.8756 17 10.1 988.4551 2 87.16 4 51980 VEV_1_3_RA4_01_1235.d 6.34E4 1 1 799 815 Carbamidomethylation
R.NFVVTGPPISLY(-2.02)GLNLR.L Y 35.30 1857.0148 17 42.7 620.0386 3 87.57 4 52232 VEV_1_3_RA4_01_1235.d 8.9E4 1 1 388 404 2-amino-3-oxo-butanoic_acid
R.SEM(-48.00)GEPIHK.L Y 34.98 978.4771 9 -16.7 490.2376 2 9.79 6 2412 VEV_3_3_RA6_01_1237.d 3.43E4 2 2 859 867 Dethiomethyl
R.IPVYDTNTGEDLR(+14.02).A Y 34.65 1505.7362 13 -10.2 753.8677 2 69.55 4 38863 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 467 479 Methylation(KR)
K.LLLNEFER.A Y 32.89 1032.5603 8 -13.2 345.1895 3 25.01 6 10203 VEV_3_3_RA6_01_1237.d 1.51E5 2 2 104 111
K.YIPNVSAKPFALTKEYFEDVYR.L Y 32.58 2649.3479 22 -8.4 884.1158 3 82.02 4 48549 VEV_1_3_RA4_01_1235.d 6.32E4 2 2 2039 2060
R.VSGDYNPIHVSR(+14.02).V Y 32.56 1356.6786 12 -0.8 453.2331 3 58.40 4 30286 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 1583 1594 Methylation(KR)
R.N(+.98)SAGDTVDLEDMTYTEVVHR.M Y 31.93 2251.9902 20 11.3 751.6792 3 77.22 4 44867 VEV_1_3_RA4_01_1235.d 3.96E4 1 1 918 937 Deamidation (NQ)
K.TTIDPSKLVGK.Y Y 31.49 1157.6655 11 -12.3 386.8911 3 63.04 4 33791 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 2028 2038
K.MVEVC(+57.02)GTIKR.D Y 31.08 1191.6104 10 -9.0 398.2072 3 45.07 4 21808 VEV_1_3_RA4_01_1235.d 1.87E5 2 2 1413 1422 Carbamidomethylation
R.TSLAPSILQDS(-2.02)IENGEGVPTPMLSIR.D Y 31.06 2722.3848 26 7.8 908.4760 3 87.86 4 52420 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 329 354 2-amino-3-oxo-butanoic_acid
K.TPLNLR.A Y 30.98 712.4232 6 -12.1 357.2145 2 41.53 4 19637 VEV_1_3_RA4_01_1235.d 6.08E5 3 3 1567 1572
R.IWFSDR(+.98)DVPFDTPATATFDGGK.A Y 30.20 2443.1331 22 21.5 815.4025 3 82.76 4 49060 VEV_1_3_RA4_01_1235.d 0 1 1 1292 1313 Deamidation (R)
R.IKEFYYR.I Y 30.13 1017.5283 7 -20.6 340.1764 3 48.88 6 23657 VEV_3_3_RA6_01_1237.d 3.5E5 2 2 1285 1291
K.ASFEDMR.S Y 30.09 854.3593 7 27.8 428.1988 2 44.01 4 21147 VEV_1_3_RA4_01_1235.d 0 3 3 1816 1822
R.HISISLVNSAR.N Y 29.99 1195.6672 11 -46.7 598.8130 2 62.17 5 33167 VEV_2_3_RA5_01_1236.d 0 1 1 377 387
K.MVEVC(+57.02)GTIK.R Y 29.77 1035.5093 9 -13.6 518.7549 2 54.78 4 27942 VEV_1_3_RA4_01_1235.d 1.57E5 1 1 1413 1421 Carbamidomethylation
R.NFVVT(-2.02)GPPISLYGLNLR.L Y 29.41 1857.0148 17 -19.7 620.0000 3 87.28 6 49821 VEV_3_3_RA6_01_1237.d 3.7E4 1 1 388 404 2-amino-3-oxo-butanoic_acid
K.VGDVLETTAQVNAVINQDSGK.M Y 29.27 2157.0913 21 -23.7 720.0207 3 79.58 4 46701 VEV_1_3_RA4_01_1235.d 0 1 1 1392 1412
R.GLTMQVAVERDEQGR.S Y 28.85 1687.8312 15 -11.5 563.6112 3 61.47 4 32584 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 1864 1878
K.TPLNLRAPASNETYAR.V Y 28.73 1772.9169 16 -10.9 887.4561 2 62.87 4 33660 VEV_1_3_RA4_01_1235.d 5.39E4 2 2 1567 1582
K.Q(-17.03)AIAEAEGVDDDR(+14.02)WEDTYKGPAGGVITVR.S Y 28.53 3114.4893 29 -3.7 1039.1665 3 80.97 4 47768 VEV_1_3_RA4_01_1235.d 5.45E4 1 1 830 858 Pyro-glu from Q; Methylation(KR)
R.GS(-2.02)YNDFETTFQR.K Y 27.98 1461.6161 12 40.9 731.8452 2 69.85 4 39099 VEV_1_3_RA4_01_1235.d 6.21E4 1 1 1438 1449 2-amino-3-oxo-butanoic_acid
R.SEMGEPIHK.L Y 27.65 1026.4805 9 -10.7 514.2420 2 23.88 4 9482 VEV_1_3_RA4_01_1235.d 1.69E5 1 1 859 867
R.SGVKPFR.S Y 27.24 789.4497 7 -9.6 395.7283 2 20.05 4 7459 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 2012 2018
K.DILDGIHNDH(+15.99)IK.G Y 27.10 1404.6997 12 -0.8 703.3566 2 86.37 5 49952 VEV_2_3_RA5_01_1236.d 2.51E5 2 2 1085 1096 Oxidation (HW)
K.LVHLSN(+.98)GFR.M Y 26.97 1042.5559 9 -16.4 522.2767 2 59.05 5 30855 VEV_2_3_RA5_01_1236.d 5.91E4 1 1 1374 1382 Deamidation (NQ)
R.GSYNDFE(+14.02)TTFQR.K Y 26.88 1477.6473 12 18.5 739.8446 2 73.76 4 42168 VEV_1_3_RA4_01_1235.d 0 1 1 1438 1449 Methylation(others)
K.EHGPR.L Y 26.80 594.2874 5 -12.8 595.2870 1 56.61 4 29039 VEV_1_3_RA4_01_1235.d 2.71E4 2 2 575 579
R.KEEVPMQLHLGSSK.D Y 25.89 1581.8185 14 -8.7 396.4585 4 59.59 4 31178 VEV_1_3_RA4_01_1235.d 8.16E4 1 1 1450 1463
R.T(+117.00)AEGGVVPLC(+57.02)FR.F Y 25.85 1421.6526 12 18.3 711.8466 2 61.37 5 32574 VEV_2_3_RA5_01_1236.d 7.02E5 3 3 1251 1262 Phospho-propargylamine; Carbamidomethylation
K.KLNADFQK.V Y 25.44 962.5185 8 -2.6 482.2653 2 26.17 4 10756 VEV_1_3_RA4_01_1235.d 9.82E4 1 1 905 912
K.VKAPTGLDQNRIPYTQRK.V Y 24.85 2084.1489 18 9.5 417.8410 5 56.39 4 28882 VEV_1_3_RA4_01_1235.d 0 1 1 408 425
R.ADGVPIEGLTIGAGVPSIEVANEYIQTLGIKHIGFKPGSMDAIQQVINIAK.A Y 24.57 5271.8218 51 -3.2 1055.3683 5 93.77 4 55702 VEV_1_3_RA4_01_1235.d 7.82E4 1 1 682 732
K.HIGFKPGSMDAIQQVINIAK(-.98).A Y 24.51 2165.1780 20 -4.6 722.7300 3 80.80 4 47638 VEV_1_3_RA4_01_1235.d 1.16E4 1 1 713 732 Amidation
K.IFSLDKAK.R Y 24.37 920.5331 8 -20.2 307.8454 3 46.15 6 22070 VEV_3_3_RA6_01_1237.d 7.59E4 1 1 883 890
R.APASNETYAR(+14.02).V Y 24.29 1092.5199 10 -11.6 547.2609 2 28.18 5 12234 VEV_2_3_RA5_01_1236.d 1.51E5 2 2 1573 1582 Methylation(KR)
K.VM(+15.99)GKQPGEVLER.F Y 24.26 1357.7024 12 2.6 679.8602 2 76.47 5 43661 VEV_2_3_RA5_01_1236.d 3.3E5 1 1 267 278 Oxidation (M)
K.RLTGDFIR.R Y 23.44 976.5454 8 -7.2 326.5201 3 30.48 4 13109 VEV_1_3_RA4_01_1235.d 1.36E6 1 1 957 964
K.DVAVLQSK(+27.99).E Y 22.90 886.4760 8 -34.3 887.4528 1 89.62 6 51114 VEV_3_3_RA6_01_1237.d 1.99E4 1 1 1464 1471 Formylation
K.YAVDWVKEHGPR.L Y 22.57 1455.7258 12 -30.9 364.9275 4 60.31 6 30666 VEV_3_3_RA6_01_1237.d 5.73E4 1 1 568 579
K.A(+42.01)PTGLDQNR.I Y 22.33 1012.4938 9 -0.5 507.2539 2 39.96 5 19097 VEV_2_3_RA5_01_1236.d 6.99E4 1 1 410 418 Acetylation (N-term)
R.ADKHFIENYGLSIINIVK.N Y 21.99 2073.1257 18 -2.4 692.0475 3 82.45 4 48863 VEV_1_3_RA4_01_1235.d 7.75E4 1 1 1722 1739
K.NIPPGR.G Y 21.69 652.3656 6 26.9 327.1989 2 20.13 4 7463 VEV_1_3_RA4_01_1235.d 3.6E4 2 2 651 656
R.AM(+15.99)AWQIPLIGK.L Y 21.07 1242.6794 11 -16.6 622.3367 2 81.04 4 47821 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 669 679 Oxidation (M)
R.M(+15.99)IPGAEPLK.V Y 20.48 970.5157 9 -14.5 486.2581 2 60.66 6 30922 VEV_3_3_RA6_01_1237.d 2.4E5 3 3 1383 1391 Oxidation (M)
R.SFLLK.K N 20.46 606.3741 5 -17.2 304.1891 2 57.36 5 29667 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 2019 2023
K.ISYRLSPSTSASLPDLDR(+14.02).W Y 20.27 1991.0323 18 16.1 399.2202 5 64.39 6 33659 VEV_3_3_RA6_01_1237.d 0 1 1 1142 1159 Methylation(KR)
K.GPAGGVIT(+79.97)VR.S Y 20.14 1005.5008 10 -4.6 336.1727 3 14.97 5 5007 VEV_2_3_RA5_01_1236.d 0 1 1 849 858 Phosphorylation (STY)
R.SNYSM(-4.99)C(+57.02)AVNPSR.I Y 20.07 1379.6001 12 5.6 690.8112 2 53.70 4 27253 VEV_1_3_RA4_01_1235.d 8.33E4 1 1 1879 1890 Methionine replacement by azido homoalanine; Carbamidomethylation
R.I(+41.03)LAPTPGMFVEIQYPNDAKR.T Y 19.93 2300.1987 20 -11.0 576.0507 4 80.76 4 47610 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 1195 1214 Amidination of lysines or N-terminal amines with methyl acetimidate
K.IFSLDK.A Y 19.92 721.4010 6 -11.5 361.7036 2 57.78 4 29852 VEV_1_3_RA4_01_1235.d 8.97E4 1 1 883 888
K.G(+42.01)LVQR.D N 19.74 613.3547 5 -9.2 307.6818 2 20.05 4 7422 VEV_1_3_RA4_01_1235.d 0 1 1 1825 1829 Acetylation (N-term)
K.ASFEDM(+15.99)R.S Y 19.65 870.3541 7 41.3 436.2023 2 22.54 4 8745 VEV_1_3_RA4_01_1235.d 0 1 1 1816 1822 Oxidation (M)
K.INK(+136.03)TTIDPSK.L Y 19.62 1251.6476 10 -12.9 418.2178 3 37.39 5 17582 VEV_2_3_RA5_01_1236.d 0 1 1 2025 2034 O-Diethylphosphorylation
K.APTGLDQNRIPY(-18.01)TQR.K Y 19.60 1710.8801 15 -6.9 428.7244 4 14.49 5 4756 VEV_2_3_RA5_01_1236.d 4.86E4 1 1 410 424 Dehydration
K.T(+42.01)PLNLR.A Y 19.42 754.4337 6 -24.3 378.2150 2 41.98 4 19901 VEV_1_3_RA4_01_1235.d 0 1 1 1567 1572 Acetylation (N-term)
R.V(+226.08)C(+57.02)ILQGPMAVK.Y Y 19.23 1440.7291 11 -8.0 481.2465 3 39.72 5 18956 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 1064 1074 Biotinylation; Carbamidomethylation
K.DVAVLQSK(+21.98).E Y 19.22 880.4630 8 5.2 881.4749 1 80.94 5 46671 VEV_2_3_RA5_01_1236.d 4.33E5 2 2 1464 1471 Sodium adduct
R.GF(+31.99)ATIPLK(+42.01).G Y 19.10 919.5015 8 9.5 920.5175 1 103.44 5 57077 VEV_2_3_RA5_01_1236.d 0 1 1 1992 1999 Dihydroxy; Acetylation (K)
K.SMTEALNKIE(+21.98)K.N Y 18.99 1284.6360 11 -12.3 643.3174 2 76.46 6 42603 VEV_3_3_RA6_01_1237.d 8.81E4 1 1 640 650 Sodium adduct
R.NSAGDTVDLEDMTYTEVVHR(+14.02).M Y 18.90 2265.0220 20 -11.3 756.0061 3 79.18 4 46387 VEV_1_3_RA4_01_1235.d 1.57E4 1 1 918 937 Methylation(KR)
R.MIPGAEPLK(+21.98)(+14.02).V Y 18.62 990.5184 9 -17.0 331.1744 3 30.52 6 13152 VEV_3_3_RA6_01_1237.d 1.82E5 1 1 1383 1391 Sodium adduct; Methylation(KR)
R.LTGDFIRR(+14.02)VEER.F Y 18.49 1503.8157 12 -8.9 502.2747 3 57.78 4 29849 VEV_1_3_RA4_01_1235.d 0 1 1 958 969 Methylation(KR)
K.I(+42.01)FSLDKAK(+42.01).R Y 18.45 1004.5542 8 -49.1 503.2597 2 66.21 6 35040 VEV_3_3_RA6_01_1237.d 0 1 1 883 890 Acetylation (N-term); Acetylation (K)
R.LQSLVR(+21.98).F Y 18.35 736.4208 6 -72.6 369.1909 2 18.69 5 7071 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 1492 1497 Sodium adduct
R.L(+42.01)QS(+79.97)LVR.F Y 18.34 836.4157 6 -8.5 419.2116 2 57.77 4 29845 VEV_1_3_RA4_01_1235.d 0 1 1 1492 1497 Acetylation (N-term); Phosphorylation (STY)
R.I(+42.01)PVYDT(+79.97)NTGEDLR.A Y 18.00 1613.6974 13 40.9 404.4481 4 61.61 6 31617 VEV_3_3_RA6_01_1237.d 5.23E4 1 1 467 479 Acetylation (N-term); Phosphorylation (STY)
R.TFISVREPSQS(-18.01)GR.L Y 17.82 1444.7422 13 -16.9 723.3661 2 96.02 4 56759 VEV_1_3_RA4_01_1235.d 6.93E4 1 1 1215 1227 Dehydration
R.TSLAPSILQDSIENGEGVPTPMLSIR(+44.03).D Y 17.76 2768.4265 26 -66.0 693.0682 4 79.26 4 46447 VEV_1_3_RA4_01_1235.d 0 1 1 329 354 Ethanolation (KR)
K.QPGEVLER(+31.99).F Y 17.73 958.4719 8 -6.4 959.4731 1 87.75 5 50711 VEV_2_3_RA5_01_1236.d 0 1 1 271 278 Dihydroxy
K.SERIFKDVNENSTSYTYR.S Y 17.58 2208.0447 18 -9.1 442.6122 5 56.60 5 29154 VEV_2_3_RA5_01_1236.d 2.24E5 1 1 1777 1794
R.VC(+57.02)ILQGPMAVK(+28.03).Y Y 17.45 1242.6829 11 1.2 415.2354 3 37.69 4 17330 VEV_1_3_RA4_01_1235.d 7.61E4 1 1 1064 1074 Carbamidomethylation; Dimethylation(KR)
R.TAEGGVVPLC(+57.02)FR(+14.02).F Y 17.43 1318.6703 12 -15.8 660.3320 2 76.49 6 42621 VEV_3_3_RA6_01_1237.d 7.61E4 1 1 1251 1262 Carbamidomethylation; Methylation(KR)
K.R(+42.01)LTGDFIR(+31.99).R Y 17.37 1050.5458 8 -8.8 1051.5438 1 97.73 4 57451 VEV_1_3_RA4_01_1235.d 4.58E4 1 1 957 964 Acetylation (N-term); Dihydroxy
R.NKDGTGVR.I Y 17.33 845.4355 8 -0.2 846.4426 1 100.24 5 56093 VEV_2_3_RA5_01_1236.d 4.06E5 1 1 530 537
R.TFISVR(+14.02)EPS(+79.97)QSGR.L Y 17.23 1556.7347 13 43.8 390.2080 4 55.71 4 28455 VEV_1_3_RA4_01_1235.d 0 1 1 1215 1227 Methylation(KR); Phosphorylation (STY)
R.VIDGDLLK.L Y 17.17 871.5015 8 -42.8 436.7393 2 67.64 4 37357 VEV_1_3_RA4_01_1235.d 6.01E4 2 2 1366 1373
R.MMTAK.E Y 17.04 580.2713 5 -24.4 581.2644 1 21.01 4 7935 VEV_1_3_RA4_01_1235.d 1.61E4 1 1 816 820
R.IGSVLAN(+.98)WAK(+21.98).Y Y 17.00 1080.5580 10 9.6 361.1967 3 11.98 4 3293 VEV_1_3_RA4_01_1235.d 0 1 1 2067 2076 Deamidation (NQ); Sodium adduct
R.DYIIK.K Y 16.96 650.3639 5 -13.0 326.1850 2 41.04 4 19320 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 900 904
R.MVELMYVKHESR.W Y 16.90 1520.7479 12 -14.2 381.1889 4 57.83 5 29997 VEV_2_3_RA5_01_1236.d 8.65E4 1 1 938 949
R.LTNSPR.I Y 16.80 686.3711 6 -38.7 687.3518 1 85.91 6 49026 VEV_3_3_RA6_01_1237.d 2.16E5 1 1 2061 2066
K.L(+42.01)VHLSN(+.98)GFR.M Y 16.78 1084.5665 9 -3.1 362.5283 3 59.27 4 30943 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 1374 1382 Acetylation (N-term); Deamidation (NQ)
K.FQTN(+.98)PMK(+14.02).R Y 16.70 879.4160 7 24.1 880.4445 1 86.18 5 49840 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 1187 1193 Deamidation (NQ); Methylation(KR)
K.APTGLDQNRIPYT(+79.97)QR(+28.03).K Y 16.69 1836.8883 15 13.4 613.3116 3 77.57 4 45145 VEV_1_3_RA4_01_1235.d 6.62E4 1 1 410 424 Phosphorylation (STY); Dimethylation(KR)
R.GITVN(+.98)LIYVNPR.A Y 16.40 1358.7557 12 -52.1 680.3497 2 80.17 4 47220 VEV_1_3_RA4_01_1235.d 0 1 1 657 668 Deamidation (NQ)
R.LSP(-30.01)STSASLPDLDRWLR.L Y 16.31 1882.9901 17 -12.7 377.6005 5 50.03 5 25166 VEV_2_3_RA5_01_1236.d 0 1 1 1146 1162 Proline oxidation to pyrrolidinone
R.LPELK(+21.98).K N 16.29 620.3510 5 -4.3 311.1814 2 21.29 5 8441 VEV_2_3_RA5_01_1236.d 0 1 1 892 896 Sodium adduct
R.LTNSPR(+14.02).I Y 16.26 700.3868 6 -22.3 351.1929 2 45.62 6 21770 VEV_3_3_RA6_01_1237.d 0 1 1 2061 2066 Methylation(KR)
K.IEKNIPPGR.G Y 16.22 1022.5872 9 -55.8 341.8506 3 34.28 6 15244 VEV_3_3_RA6_01_1237.d 2.09E4 1 1 648 656
R.LTNS(+79.97)PR.I Y 16.13 766.3375 6 55.3 767.3871 1 83.74 5 48403 VEV_2_3_RA5_01_1236.d 0 1 1 2061 2066 Phosphorylation (STY)
R.LS(+79.97)PSTSASLPDLDR.W Y 16.11 1537.7025 14 -10.5 769.8505 2 80.99 4 47788 VEV_1_3_RA4_01_1235.d 0 1 1 1146 1159 Phosphorylation (STY)
K.E(+42.01)WFRLDEPD(+21.98)VDLLGQTLTFR.L Y 16.09 2513.2202 20 -13.3 629.3040 4 52.90 5 26925 VEV_2_3_RA5_01_1236.d 3.65E5 1 1 1472 1491 Acetylation (N-term); Sodium adduct
K.SLRIPVYDTNTGEDLRAK.D Y 16.01 2047.0698 18 -6.1 410.4188 5 66.38 4 36359 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 464 481
K.DILDGIHNDHIK(+14.02).G Y 16.00 1402.7205 12 -34.0 468.5648 3 79.36 6 44709 VEV_3_3_RA6_01_1237.d 6.54E4 1 1 1085 1096 Methylation(KR)
R.TTGD(-18.01)R(+14.02)EISLTLFEGR.T Y 15.98 1689.8685 15 -25.2 564.2826 3 75.73 5 43120 VEV_2_3_RA5_01_1236.d 1.09E4 1 1 1236 1250 Dehydration; Methylation(KR)
R.DIDGLT(+79.96)VSEDANK(+14.02)ISYR.L Y 15.93 1988.8997 17 17.5 498.2409 4 71.89 6 39283 VEV_3_3_RA6_01_1237.d 2.74E4 1 1 1129 1145 Sulfation; Methylation(KR)
R.IGSVLANW(+43.99)AK(+42.01).Y Y 15.90 1143.5924 10 -24.1 382.1956 3 16.14 5 5641 VEV_2_3_RA5_01_1236.d 4.58E4 1 1 2067 2076 Carboxylation (DKW); Acetylation (K)
K.RDGKPIMEVTSQFLYR.G Y 15.85 1938.9985 16 -29.6 647.3210 3 72.73 6 39893 VEV_3_3_RA6_01_1237.d 0 1 1 1422 1437
R.AK(+28.03)DEDIVPALIR.M Y 15.82 1366.7820 12 -17.2 342.6969 4 44.18 6 20932 VEV_3_3_RA6_01_1237.d 0 1 1 480 491 Dimethylation(KR)
K.APTGLDQNRIPYTQR.K Y 15.81 1728.8907 15 7.6 577.3086 3 85.78 6 48948 VEV_3_3_RA6_01_1237.d 3.95E4 1 1 410 424
K.EVWD(-18.01)R.A Y 15.77 685.3184 5 5.9 686.3297 1 23.67 5 9719 VEV_2_3_RA5_01_1236.d 5.17E4 1 1 1717 1721 Dehydration
R.AAADGNAR(+14.02).L Y 15.69 758.3671 8 -10.7 380.1868 2 12.80 6 3809 VEV_3_3_RA6_01_1237.d 0 1 1 161 168 Methylation(KR)
K.Q(+.98)PGEVLER(+14.02).F Y 15.65 941.4818 8 -27.4 471.7353 2 43.83 4 21031 VEV_1_3_RA4_01_1235.d 2.93E5 1 1 271 278 Deamidation (NQ); Methylation(KR)
R.LPELK.K N 15.56 598.3690 5 1.5 300.1922 2 47.06 5 23367 VEV_2_3_RA5_01_1236.d 1.37E6 1 1 892 896
K.RDGK(+31.99)PIMEVTSQFLYR.G Y 15.40 1970.9884 16 1.5 395.2055 5 37.85 5 17848 VEV_2_3_RA5_01_1236.d 0 1 1 1422 1437 Dihydroxy
R.IPVYD(+28.03)TNTGEDLR.A Y 15.31 1519.7518 13 3.6 380.9466 4 59.50 5 31182 VEV_2_3_RA5_01_1236.d 0 1 1 467 479 Ethylation
R.ADGVPIEGLTIGAGVPSIEVAN(+15.00)EYIQTLGIK.H Y 15.28 3138.6699 31 0.5 1047.2311 3 95.67 5 54507 VEV_2_3_RA5_01_1236.d 4.18E3 1 1 682 712 Deamidation followed by a methylation
K.FQTNPMK.R Y 15.23 864.4164 7 -48.2 433.1946 2 17.93 6 6468 VEV_3_3_RA6_01_1237.d 0 1 1 1187 1193
R.IPVYDTNTGEDLR(-.98).A Y 15.16 1490.7365 13 28.5 373.7020 4 26.39 4 10868 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 467 479 Amidation
R.MVELMY(+79.97)VK(+14.02).H Y 15.09 1105.4952 8 13.2 1106.5171 1 87.80 4 52380 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 938 945 Phosphorylation (STY); Methylation(KR)
R.L(+43.01)SPSTSASLPDLDR.W Y 15.02 1500.7419 14 18.5 376.1997 4 39.99 4 18689 VEV_1_3_RA4_01_1235.d 2.97E5 1 1 1146 1159 Carbamylation
R.SLVETWAAEN(+.98)NIGR(+28.03).V Y 15.01 1587.7893 14 5.9 530.2735 3 75.27 6 41737 VEV_3_3_RA6_01_1237.d 0 1 1 1618 1631 Deamidation (NQ); Dimethylation(KR)
total 217 peptides
C1GEN5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.A(+42.01)SRPTVTIANAEGKPSGETHPLPAVFTSPIRPDIVQSVHTGIAK.N Y 175.49 4588.4399 44 -8.5 918.6875 5 78.56 5 45090 VEV_2_3_RA5_01_1236.d 1.69E5 1 1 2 45 Acetylation (Protein N-term)
R.FIVWTSSAFAALDAIYGSTTTPSALK.K Y 155.50 2717.3953 26 -4.8 1359.6984 2 94.83 4 56222 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 254 279
R.NIPGVETSSVFSLNLLQLAPGGHLGR.F Y 151.63 2675.4395 26 -20.0 669.8538 4 88.52 6 50549 VEV_3_3_RA6_01_1237.d 2.98E6 15 15 228 253
R.GPLVVYNPDVDGKDLVK.A Y 150.88 1826.9778 17 -14.0 609.9913 3 73.26 6 40301 VEV_3_3_RA6_01_1237.d 3.13E6 6 6 208 224
R.FIVWTSSAFAALDAIYGSTTTPSALKK.D Y 147.35 2845.4902 27 -7.6 949.4968 3 90.89 4 54161 VEV_1_3_RA4_01_1235.d 5.68E5 7 7 254 280
R.FATASALAASSVPALLFAR.G Y 141.58 1863.0254 19 -12.9 932.5079 2 87.76 6 50087 VEV_3_3_RA6_01_1237.d 5.46E6 14 14 121 139
R.RGPLVVYNPDVDGKDLVK.A Y 131.79 1983.0789 18 -15.8 496.7692 4 68.83 6 37025 VEV_3_3_RA6_01_1237.d 3.13E6 12 12 207 224
K.DFLLPSNLVSNADITR.L Y 130.11 1773.9260 16 -11.3 592.3093 3 85.25 6 48618 VEV_3_3_RA6_01_1237.d 7.44E6 18 18 281 296
K.AGEQTSAESWGTGR.A Y 129.45 1435.6328 14 -11.2 718.8157 2 44.02 6 20855 VEV_3_3_RA6_01_1237.d 2.98E6 11 11 57 70
R.RGPLVVYNPDVDGKDLVKAFR.N Y 125.78 2357.2854 21 -18.2 590.3179 4 75.91 5 43244 VEV_2_3_RA5_01_1236.d 1.96E5 3 3 207 227
K.NVGAGPDLVKVEESR.K Y 124.03 1568.8158 15 -12.1 785.4057 2 61.91 6 31863 VEV_3_3_RA6_01_1237.d 5.11E6 7 7 175 189
K.AAIALLKNVGAGPDLVKVEESR.K Y 121.47 2249.2742 22 -11.1 563.3196 4 77.09 5 44082 VEV_2_3_RA5_01_1236.d 2.8E5 4 4 168 189
R.LINSSEVQSALREPK.G Y 117.36 1669.8999 15 -11.6 835.9476 2 66.22 5 36248 VEV_2_3_RA5_01_1236.d 7.93E6 11 11 297 311
K.KDFLLPSNLVSNADITR.L Y 113.89 1902.0210 17 -10.0 635.0079 3 79.17 4 46372 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 280 296
R.LINSSEVQSALREPKGYAK.T Y 112.80 2089.1167 19 -9.8 1045.5554 2 65.80 5 35886 VEV_2_3_RA5_01_1236.d 9.05E5 5 5 297 315
R.RGPLVVYNPDVDGK.D Y 111.63 1527.8044 14 -18.9 510.2658 3 63.36 6 32889 VEV_3_3_RA6_01_1237.d 7.82E5 5 5 207 220
K.NKRQPYAVSEKAGEQTSAESWGTGR.A Y 111.56 2736.3215 25 3.6 548.2736 5 53.01 5 27030 VEV_2_3_RA5_01_1236.d 1.08E6 6 6 46 70
R.GPLVVYNPDVDGK.D Y 109.95 1371.7034 13 -13.1 686.8500 2 68.84 6 37008 VEV_3_3_RA6_01_1237.d 2.42E5 3 3 208 220
R.GHRVASVPEVPLVVDSK.A Y 109.04 1787.9894 17 -6.9 596.9996 3 66.54 5 36421 VEV_2_3_RA5_01_1236.d 6.16E4 3 3 140 156
R.VASVPEVPLVVDSKAFENNAIVKTK.A Y 108.23 2653.4690 25 -8.4 664.3690 4 79.13 5 45468 VEV_2_3_RA5_01_1236.d 1.37E5 2 2 143 167
R.VASVPEVPLVVDSKAFENNAIVK.T Y 107.44 2424.3264 23 -9.1 809.1088 3 81.60 5 47126 VEV_2_3_RA5_01_1236.d 1.15E6 5 5 143 165
R.AGQAAFGNQC(+57.02)R.A Y 104.63 1178.5250 11 -6.5 590.2659 2 25.04 5 10544 VEV_2_3_RA5_01_1236.d 5.26E6 16 16 86 96 Carbamidomethylation
R.QPYAVSEKAGEQTSAESWGTGR.A Y 104.51 2338.0825 22 -8.9 780.3612 3 62.05 4 33027 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 49 70
K.RFATASALAASSVPALLFAR.G Y 99.01 2019.1265 20 25.1 674.0663 3 84.30 4 50151 VEV_1_3_RA4_01_1235.d 4.44E4 3 3 120 139
K.AAIALLKNVGAGPDLVK.V Y 98.47 1648.9875 17 -14.9 550.6616 3 76.80 5 43874 VEV_2_3_RA5_01_1236.d 3.23E4 1 1 168 184
K.NVGAGPDLVKVEESRK.I Y 95.22 1696.9108 16 -10.3 566.6384 3 55.76 5 28607 VEV_2_3_RA5_01_1236.d 1.73E6 11 11 175 190
R.NIPGVETSSVFSLNLLQLAPGGHLGRFIVWTSSAFAALDAIYGSTTTPSALK.K Y 94.33 5374.8242 52 -0.8 1344.7123 4 97.67 4 57422 VEV_1_3_RA4_01_1235.d 0 1 1 228 279
K.DFLLPSNLVSN(+.98)ADITR.L Y 93.80 1774.9100 16 -7.3 888.4558 2 86.67 4 51662 VEV_1_3_RA4_01_1235.d 9.45E5 3 3 281 296 Deamidation (NQ)
R.Q(-17.03)PYAVSEKAGEQTSAESWGTGR.A Y 93.46 2321.0559 22 -6.3 1161.5280 2 70.57 5 39411 VEV_2_3_RA5_01_1236.d 1.45E5 2 2 49 70 Pyro-glu from Q
R.VASVPEVPLVVDSK.A Y 92.50 1437.8079 14 -10.1 719.9039 2 76.06 5 43367 VEV_2_3_RA5_01_1236.d 4.23E6 6 6 143 156
K.NKRQPYAVSEK.A Y 91.71 1318.6993 11 -14.0 440.5676 3 15.13 5 5105 VEV_2_3_RA5_01_1236.d 1.73E6 9 9 46 56
K.RQPYAVSEKAGEQTSAESWGTGR.A Y 88.48 2494.1836 23 -4.9 832.3977 3 58.34 5 30344 VEV_2_3_RA5_01_1236.d 8.63E4 1 1 48 70
K.DFLLPSNLVSNADITR(+14.02).L Y 87.47 1787.9418 16 -12.5 894.9670 2 85.98 6 49058 VEV_3_3_RA6_01_1237.d 1.35E6 8 8 281 296 Methylation(KR)
R.RGPLVVYNPD(+14.02)VDGKDLVK.A Y 87.36 1997.0945 18 -6.8 500.2775 4 70.69 4 39755 VEV_1_3_RA4_01_1235.d 3.49E5 3 3 207 224 Methylation(others)
R.GPLVVYNPDVDGKDLVK(+14.02).A Y 85.17 1840.9934 17 -13.5 614.6635 3 75.86 4 43833 VEV_1_3_RA4_01_1235.d 3.4E5 3 3 208 224 Methylation(KR)
R.GPLVVYNPDVDGKDLVKAFR.N Y 84.95 2201.1843 20 -20.2 551.2922 4 78.58 5 45160 VEV_2_3_RA5_01_1236.d 1.03E5 2 2 208 227
R.RGPLVVYNPDVDGKDLVK(+14.02).A Y 84.12 1997.0945 18 -7.9 500.2769 4 71.51 4 40406 VEV_1_3_RA4_01_1235.d 5.95E5 4 4 207 224 Methylation(KR)
K.LGQKGLDTGKPDR.A Y 82.54 1383.7469 13 -14.2 692.8709 2 23.67 5 9722 VEV_2_3_RA5_01_1236.d 6.24E5 5 5 348 360
K.AGEQTSAESWGTGR(+14.02).A Y 82.46 1449.6484 14 -8.9 725.8251 2 51.24 4 25687 VEV_1_3_RA4_01_1235.d 9.2E5 7 7 57 70 Methylation(KR)
R.LNPYAAAFSK.Q Y 82.31 1080.5603 10 -12.0 541.2809 2 66.78 5 36606 VEV_2_3_RA5_01_1236.d 5.1E6 8 8 336 345
K.AFENNAIVK.T Y 82.13 1004.5291 9 -12.0 503.2658 2 48.07 6 23249 VEV_3_3_RA6_01_1237.d 6.81E6 13 13 157 165
K.AFENNAIVKTK.A Y 80.92 1233.6718 11 -9.7 617.8372 2 40.63 5 19493 VEV_2_3_RA5_01_1236.d 1.04E6 6 6 157 167
R.LINSSEVQSALR.E Y 80.14 1315.7096 12 -7.4 658.8572 2 67.31 4 37089 VEV_1_3_RA4_01_1235.d 2.97E5 3 3 297 308
R.FATASALAASSVPALLFAR(+14.02).G Y 80.08 1877.0410 19 -7.7 939.5206 2 88.77 5 51263 VEV_2_3_RA5_01_1236.d 2.41E5 4 4 121 139 Methylation(KR)
R.AGQAAFGN(+.98)QC(+57.02)R.A Y 78.26 1179.5090 11 -7.6 590.7573 2 28.56 4 12098 VEV_1_3_RA4_01_1235.d 1.14E6 7 7 86 96 Deamidation (NQ); Carbamidomethylation
R.AGQ(+.98)AAFGNQC(+57.02)R.A Y 76.92 1179.5090 11 -13.3 590.7540 2 29.86 6 12793 VEV_3_3_RA6_01_1237.d 9.07E5 6 6 86 96 Deamidation (NQ); Carbamidomethylation
K.AGEQ(+.98)TSAESWGTGR.A Y 76.46 1436.6168 14 4.5 719.3189 2 44.30 5 21706 VEV_2_3_RA5_01_1236.d 2.31E5 6 6 57 70 Deamidation (NQ)
R.AGETFHKILAQE Y 76.12 1342.6881 12 -11.0 672.3439 2 61.19 5 32430 VEV_2_3_RA5_01_1236.d 8.67E5 3 3 361 372
K.AGEQTSAESW(+15.99)GTGR.A Y 75.99 1451.6277 14 -5.3 726.8173 2 39.19 4 18256 VEV_1_3_RA4_01_1235.d 6.45E5 11 11 57 70 Oxidation (HW)
K.AGE(+14.02)QTSAESWGTGR.A Y 75.45 1449.6484 14 -10.3 725.8240 2 53.48 5 27325 VEV_2_3_RA5_01_1236.d 5.51E5 5 5 57 70 Methylation(others)
M.A(+42.01)SRPTVTIANAEGK(+14.02)PSGETHPLPAVFTSPIRPDIVQSVHTGIAK.N Y 74.85 4602.4556 44 -3.3 921.4954 5 79.04 5 45409 VEV_2_3_RA5_01_1236.d 1E5 2 2 2 45 Acetylation (Protein N-term); Methylation(KR)
R.NIPGVE(+14.02)TSSVFSLNLLQLAPGGHLGR.F Y 74.38 2689.4551 26 -6.3 673.3668 4 89.51 4 53386 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 228 253 Methylation(others)
K.DFLLPSN(+.98)LVSNADITR.L Y 74.26 1774.9100 16 -12.0 888.4516 2 86.47 6 49353 VEV_3_3_RA6_01_1237.d 1.02E6 8 8 281 296 Deamidation (NQ)
R.LINSSEVQSALR(+14.02)EPK.G Y 73.67 1683.9155 15 -11.1 562.3062 3 69.65 5 38732 VEV_2_3_RA5_01_1236.d 2.74E6 12 12 297 311 Methylation(KR)
R.GPLVVYN(+.98)PDVDGK.D Y 73.03 1372.6874 13 0.4 687.3513 2 68.85 6 37016 VEV_3_3_RA6_01_1237.d 4.35E4 1 1 208 220 Deamidation (NQ)
K.AGEQTSAE(+14.02)SWGTGR.A Y 72.46 1449.6484 14 -9.9 725.8243 2 55.17 4 28184 VEV_1_3_RA4_01_1235.d 3.81E5 5 5 57 70 Methylation(others)
R.AGQAAFGNQC(+57.02)R(+14.02).A Y 71.41 1192.5408 11 2.5 597.2792 2 33.56 6 14854 VEV_3_3_RA6_01_1237.d 1.5E6 8 8 86 96 Carbamidomethylation; Methylation(KR)
R.NIPGVET(+14.02)SSVFSLNLLQLAPGGHLGR.F Y 70.43 2689.4551 26 -11.8 897.4817 3 89.59 4 53460 VEV_1_3_RA4_01_1235.d 8.84E4 1 1 228 253 Methylation(others)
K.NVGAGPDLVKVE(+14.02)ESR.K Y 69.66 1582.8314 15 -15.1 528.6098 3 68.06 6 36437 VEV_3_3_RA6_01_1237.d 4.85E5 2 2 175 189 Methylation(others)
K.NVGAGPDLVKVEESR(+14.02).K Y 69.51 1582.8314 15 -11.9 528.6115 3 64.74 4 35102 VEV_1_3_RA4_01_1235.d 1.16E6 10 10 175 189 Methylation(KR)
R.RGPLVVYNPDVDGK(+14.02)DLVK.A Y 69.14 1997.0945 18 -12.7 500.2745 4 69.81 4 39065 VEV_1_3_RA4_01_1235.d 2.8E5 1 1 207 224 Methylation(KR)
R.LIN(+.98)SSEVQSALREPK.G Y 67.75 1670.8839 15 -3.6 557.9666 3 69.08 4 38497 VEV_1_3_RA4_01_1235.d 7E5 3 3 297 311 Deamidation (NQ)
K.TKAAIALLK.N Y 67.62 927.6117 9 -24.2 464.8019 2 51.28 4 25685 VEV_1_3_RA4_01_1235.d 1.12E6 8 8 166 174
R.NIPGVETSS(+14.02)VFSLNLLQLAPGGHLGR.F Y 67.35 2689.4551 26 -15.0 673.3610 4 89.35 6 50971 VEV_3_3_RA6_01_1237.d 9.54E4 1 1 228 253 Methylation(others)
K.D(+14.02)FLLPSNLVSNADITR.L Y 65.48 1787.9418 16 -16.1 894.9638 2 84.78 5 49033 VEV_2_3_RA5_01_1236.d 2.28E4 2 2 281 296 Methylation(others)
R.NIPGVETSSVFSLNLLQLAPGGHLGRFIVWTSSAFAALDAIYGSTTTPSALKK.D Y 65.21 5502.9189 53 -4.7 1101.5859 5 97.55 4 57354 VEV_1_3_RA4_01_1235.d 2.3E5 3 3 228 280
R.VASVPEVPLVVDSK(+14.02).A Y 65.15 1451.8235 14 -9.5 726.9121 2 77.05 4 44735 VEV_1_3_RA4_01_1235.d 8.72E5 5 5 143 156 Methylation(KR)
K.GLDTGKPDR.A Y 64.52 957.4879 9 -8.0 479.7474 2 14.73 4 4686 VEV_1_3_RA4_01_1235.d 1.47E6 9 9 352 360
R.AGQAAFGNQ(+.98)C(+57.02)R.A Y 63.49 1179.5090 11 -6.3 590.7581 2 29.08 4 12334 VEV_1_3_RA4_01_1235.d 9.02E5 8 8 86 96 Deamidation (NQ); Carbamidomethylation
R.RGPLVVY(-2.02)NPDVDGKDLVK.A Y 63.40 1981.0632 18 8.9 496.2775 4 69.08 6 37181 VEV_3_3_RA6_01_1237.d 1.35E5 2 2 207 224 2-amino-3-oxo-butanoic_acid
K.NVGAGPDLVK.V Y 63.23 968.5291 10 -16.6 485.2638 2 48.46 5 24236 VEV_2_3_RA5_01_1236.d 2.07E6 7 7 175 184
R.MFAPTKVWR.K Y 62.29 1134.6008 9 -8.0 379.2045 3 65.38 4 35604 VEV_1_3_RA4_01_1235.d 3.97E5 6 6 100 108
R.TGVQKKNPLK.N Y 59.15 1111.6713 10 -14.6 556.8348 2 14.68 5 4865 VEV_2_3_RA5_01_1236.d 1.55E5 4 4 319 328
R.NIPGVETSSVFSLNLLQLAPGGHLGR(+14.02).F Y 59.05 2689.4551 26 -23.3 673.3554 4 88.07 4 52573 VEV_1_3_RA4_01_1235.d 3.46E4 3 3 228 253 Methylation(KR)
R.AGQAAFGNQC(+57.02)R(+.98).A Y 58.90 1179.5090 11 -14.2 590.7534 2 30.90 6 13364 VEV_3_3_RA6_01_1237.d 1.7E5 1 1 86 96 Carbamidomethylation; Deamidation (R)
R.NIPGVETS(+14.02)SVFSLNLLQLAPGGHLGR.F Y 58.21 2689.4551 26 -5.8 673.3671 4 89.39 5 51576 VEV_2_3_RA5_01_1236.d 7.72E4 1 1 228 253 Methylation(others)
R.GPLVVYNPD(+14.02)VDGKDLVK.A Y 58.10 1840.9934 17 -17.5 614.6610 3 75.19 6 41733 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 208 224 Methylation(others)
K.RQPYAVSEK.A Y 57.56 1076.5614 9 -14.3 539.2803 2 18.95 6 7018 VEV_3_3_RA6_01_1237.d 4.55E5 5 5 48 56
R.LINSSEVQSALREPK(+14.02).G Y 57.55 1683.9155 15 -11.7 842.9552 2 68.36 6 36655 VEV_3_3_RA6_01_1237.d 2.17E4 1 1 297 311 Methylation(KR)
K.NVGAGPDLVK(+14.02)VEESR.K Y 57.25 1582.8314 15 -9.7 528.6126 3 68.32 4 37888 VEV_1_3_RA4_01_1235.d 4.46E5 2 2 175 189 Methylation(KR)
K.NVGAGPD(+14.02)LVKVEESR.K Y 56.70 1582.8314 15 -9.7 528.6126 3 62.84 4 33629 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 175 189 Methylation(others)
R.LIN(+.98)SSEVQSALREPK(+14.02).G Y 56.00 1684.8995 15 -0.3 562.6403 3 69.86 5 38890 VEV_2_3_RA5_01_1236.d 4.12E4 1 1 297 311 Deamidation (NQ); Methylation(KR)
K.NKRQPYAVSEKAGEQTSAE(+14.02)SWGTGR.A Y 55.67 2750.3372 25 -5.9 688.5875 4 57.84 5 30009 VEV_2_3_RA5_01_1236.d 6.5E4 1 1 46 70 Methylation(others)
R.GPLVVYNPDVDGK(+14.02)DLVK.A Y 55.56 1840.9934 17 -52.1 614.6398 3 74.23 4 42598 VEV_1_3_RA4_01_1235.d 9.53E4 2 2 208 224 Methylation(KR)
R.LINSSEVQ(+.98)SALREPK.G Y 55.20 1670.8839 15 -12.5 557.9616 3 69.13 6 37217 VEV_3_3_RA6_01_1237.d 1.03E6 5 5 297 311 Deamidation (NQ)
R.LINSSEVQ(+.98)SALR(+14.02)EPK.G Y 52.36 1684.8995 15 2.2 562.6417 3 70.04 4 39245 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 297 311 Deamidation (NQ); Methylation(KR)
R.GPLVVY(-2.02)NPDVDGKDLVK.A Y 51.31 1824.9622 17 -54.2 609.2950 3 73.53 5 41541 VEV_2_3_RA5_01_1236.d 4.25E6 3 3 208 224 2-amino-3-oxo-butanoic_acid
M.A(+42.01)SRPTVTIANAEGKPSGETHPLPAVFTSPIRPDIVQSVHTGIAK(-.98).N Y 50.88 4587.4561 44 -38.4 918.4633 5 78.73 4 46057 VEV_1_3_RA4_01_1235.d 4.16E5 2 2 2 45 Acetylation (Protein N-term); Amidation
K.AGEQTSAESW(+31.99)GTGR.A Y 50.40 1467.6226 14 -6.0 734.8141 2 23.37 4 9198 VEV_1_3_RA4_01_1235.d 3.63E4 2 2 57 70 Dihydroxy
R.RGPLVVYNPDVD(-18.01)GKDLVK.A Y 49.87 1965.0682 18 -10.2 492.2693 4 68.40 4 37954 VEV_1_3_RA4_01_1235.d 2.14E5 1 1 207 224 Dehydration
R.LINSSEVQSALR(+28.03)EPK.G Y 48.93 1697.9312 15 -7.0 566.9803 3 72.00 4 40789 VEV_1_3_RA4_01_1235.d 1.76E5 1 1 297 311 Dimethylation(KR)
R.LINSSE(+14.02)VQSALREPK.G Y 48.82 1683.9155 15 -16.2 562.3033 3 69.11 4 38591 VEV_1_3_RA4_01_1235.d 6.51E5 1 1 297 311 Methylation(others)
R.TGVQKKNPLKNR.Q Y 48.13 1381.8153 12 -13.3 461.6062 3 15.79 5 5468 VEV_2_3_RA5_01_1236.d 3.06E5 3 3 319 330
R.LIN(+.98)SSEVQSALR(+14.02)EPK.G Y 48.04 1684.8995 15 -3.3 562.6386 3 68.51 5 37918 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 297 311 Deamidation (NQ); Methylation(KR)
R.AGQ(+.98)AAFGNQ(+.98)C(+57.02)R.A Y 47.95 1180.4930 11 -5.5 591.2505 2 33.31 4 14756 VEV_1_3_RA4_01_1235.d 2.71E5 7 7 86 96 Deamidation (NQ); Carbamidomethylation
K.ILAQE Y 47.82 572.3170 5 -14.7 573.3158 1 28.83 6 12238 VEV_3_3_RA6_01_1237.d 2.47E5 9 9 368 372
R.M(+15.99)FAPTK.V Y 47.56 709.3469 6 -3.3 710.3518 1 19.96 5 7707 VEV_2_3_RA5_01_1236.d 6.23E5 4 4 100 105 Oxidation (M)
R.VASVPE(+14.02)VPLVVDSK.A Y 46.81 1451.8235 14 -9.9 726.9119 2 77.97 5 44690 VEV_2_3_RA5_01_1236.d 1.45E5 1 1 143 156 Methylation(others)
K.INLGQK(+114.04)RFATASALAASSVPALLFAR.G Y 46.12 2786.5554 26 -50.3 929.8123 3 88.40 5 51056 VEV_2_3_RA5_01_1236.d 0 1 1 114 139 Ubiquitin
R.N(+15.00)IPGVETSSVFSLNLLQLAPGGHLGR.F Y 44.86 2690.4392 26 0.5 897.8208 3 89.60 4 53438 VEV_1_3_RA4_01_1235.d 4.2E3 1 1 228 253 Deamidation followed by a methylation
R.G(+362.14)HRVASVPEVPLVVDSK.A Y 44.28 2150.1260 17 -4.7 717.7126 3 76.10 5 43374 VEV_2_3_RA5_01_1236.d 6.02E4 1 1 140 156 Nucleophilic addtion to cytopiloyne
K.AAIALLKNVGAGPDLVKVEESR(+14.02).K Y 43.67 2263.2898 22 -10.8 566.8236 4 78.47 5 45038 VEV_2_3_RA5_01_1236.d 5.76E4 1 1 168 189 Methylation(KR)
K.DFLLPSN(+.98)LVSNADITR(+14.02).L Y 43.55 1788.9258 16 -31.8 895.4417 2 87.16 6 49749 VEV_3_3_RA6_01_1237.d 4.71E5 2 2 281 296 Deamidation (NQ); Methylation(KR)
R.LNPYAAAFSK(+14.02).Q Y 42.83 1094.5760 10 -17.6 548.2856 2 68.87 6 37031 VEV_3_3_RA6_01_1237.d 4.44E5 3 3 336 345 Methylation(KR)
R.LINSSEVQSALREPK(+27.99).G Y 42.29 1697.8948 15 20.4 566.9838 3 71.88 5 40373 VEV_2_3_RA5_01_1236.d 7.71E4 1 1 297 311 Formylation
R.LINSSEVQ(+.98)SALREPK(+14.02).G Y 42.06 1684.8995 15 -19.3 562.6296 3 71.13 6 38707 VEV_3_3_RA6_01_1237.d 3.98E5 3 3 297 311 Deamidation (NQ); Methylation(KR)
R.VASVPE(+14.02)VPLVVDSKAFENNAIVK.T Y 41.58 2438.3420 23 -4.0 813.7847 3 82.68 4 49002 VEV_1_3_RA4_01_1235.d 5E4 2 2 143 165 Methylation(others)
K.AAIALLK.N Y 40.86 698.4690 7 -17.0 350.2358 2 61.01 5 32321 VEV_2_3_RA5_01_1236.d 3.92E6 8 8 168 174
K.NPLKNR.Q Y 40.27 740.4293 6 -21.9 371.2138 2 11.11 6 2965 VEV_3_3_RA6_01_1237.d 8.27E4 2 2 325 330
R.AGQAAFGN(+.98)Q(+.98)C(+57.02)R.A Y 39.52 1180.4930 11 10.3 591.2599 2 29.11 4 12348 VEV_1_3_RA4_01_1235.d 8E4 3 3 86 96 Deamidation (NQ); Carbamidomethylation
K.DFLLPSNLVSN(+.98)ADITR(+14.02).L Y 39.07 1788.9258 16 -14.0 895.4576 2 87.54 4 52218 VEV_1_3_RA4_01_1235.d 2.51E5 1 1 281 296 Deamidation (NQ); Methylation(KR)
R.NIPGVETSSVFSLN(+.98)LLQLAPGGHLGR.F Y 38.95 2676.4233 26 -5.7 670.1093 4 90.83 4 54124 VEV_1_3_RA4_01_1235.d 1.71E5 1 1 228 253 Deamidation (NQ)
K.DFLLPSNLVSNADITRLINSSEVQSALREPK.G Y 38.60 3425.8154 31 -38.2 1142.9021 3 89.49 5 51626 VEV_2_3_RA5_01_1236.d 0 1 1 281 311
R.AGQAAFGN(+.98)QC(+57.02)R(+14.02).A Y 37.84 1193.5248 11 1.2 597.7704 2 37.45 4 17196 VEV_1_3_RA4_01_1235.d 4.37E5 3 3 86 96 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.GLDTGKPDRAGETFHK.I Y 37.82 1727.8590 16 -6.3 576.9567 3 33.33 5 15194 VEV_2_3_RA5_01_1236.d 5.27E5 3 3 352 367
R.AGQ(+.98)AAFGN(+.98)QC(+57.02)R.A Y 36.88 1180.4930 11 13.2 591.2616 2 30.08 4 12894 VEV_1_3_RA4_01_1235.d 3.84E5 6 6 86 96 Deamidation (NQ); Carbamidomethylation
K.DFLLPSNLVSNADITR(+28.03).L Y 36.45 1801.9574 16 -10.2 901.9767 2 86.84 6 49574 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 281 296 Dimethylation(KR)
K.AFEN(+.98)NAIVK.T Y 35.85 1005.5131 9 -5.5 503.7610 2 54.12 4 27515 VEV_1_3_RA4_01_1235.d 3.15E5 2 2 157 165 Deamidation (NQ)
K.ILAQ(+.98)E Y 35.34 573.3010 5 -27.1 574.2927 1 33.39 6 14739 VEV_3_3_RA6_01_1237.d 0 1 1 368 372 Deamidation (NQ)
K.INLGQKR.F Y 34.58 827.4977 7 -15.0 414.7499 2 17.21 6 6134 VEV_3_3_RA6_01_1237.d 5.53E5 3 3 114 120
R.AGETFHK.I Y 34.54 788.3817 7 -15.1 395.1921 2 11.55 4 3110 VEV_1_3_RA4_01_1235.d 1.14E5 3 3 361 367
R.RGPLVVYNPDVDGKD(-18.01)LVK.A Y 34.45 1965.0682 18 -19.7 492.2646 4 68.16 6 36510 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 207 224 Dehydration
R.AGQAAFGNQ(+.98)C(+57.02)R(+14.02).A Y 33.80 1193.5248 11 8.8 597.7749 2 37.05 4 16959 VEV_1_3_RA4_01_1235.d 2.03E5 3 3 86 96 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
R.FATAS(+162.05)ALAASSVPALLFAR.G Y 33.54 2025.0781 19 -4.1 676.0305 3 84.24 5 48714 VEV_2_3_RA5_01_1236.d 5.41E4 1 1 121 139 Hexose (NSY)
R.AGETFHKILAQE(+14.02) Y 31.87 1356.7037 12 -19.5 679.3459 2 67.99 5 37521 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 361 372 Methylation(others)
K.AAIALLKNVGAGPDLVKVEESRK.I Y 31.63 2377.3691 23 -18.9 476.4721 5 74.03 5 41901 VEV_2_3_RA5_01_1236.d 7.21E4 1 1 168 190
K.NVGAGPDLVKVEESR(+28.03).K Y 31.29 1596.8470 15 -10.7 533.2839 3 71.57 4 40453 VEV_1_3_RA4_01_1235.d 1.5E5 1 1 175 189 Dimethylation(KR)
K.KDFLLPSNLVS(-2.02)NADITR.L Y 31.26 1900.0054 17 -15.4 634.3326 3 79.24 4 46430 VEV_1_3_RA4_01_1235.d 0 1 1 280 296 2-amino-3-oxo-butanoic_acid
K.AFE(+14.02)NNAIVK.T Y 31.19 1018.5447 9 -15.4 510.2718 2 58.91 5 30747 VEV_2_3_RA5_01_1236.d 3.46E5 2 2 157 165 Methylation(others)
K.KNPLKNR.Q Y 30.70 868.5242 7 -13.7 435.2634 2 10.65 5 2799 VEV_2_3_RA5_01_1236.d 1.56E5 2 2 324 330
K.RQPYAVSEK(-1.03)AGEQTSAESWGTGR.A Y 30.15 2493.1521 23 12.2 624.3029 4 58.30 5 30309 VEV_2_3_RA5_01_1236.d 0 1 1 48 70 Lysine oxidation to aminoadipic semialdehyde
K.INLGQK.R Y 30.05 671.3966 6 -11.9 336.7016 2 22.68 4 8825 VEV_1_3_RA4_01_1235.d 6.56E5 6 6 114 119
R.A(+42.01)GQAAFGNQC(+57.02)R.A Y 29.78 1220.5356 11 -0.8 611.2746 2 36.01 4 16344 VEV_1_3_RA4_01_1235.d 6.15E4 1 1 86 96 Acetylation (N-term); Carbamidomethylation
R.RGPLVVYNPD(+43.99)VDGKDLVK.A Y 29.74 2027.0687 18 27.3 507.7883 4 69.11 4 38523 VEV_1_3_RA4_01_1235.d 0 2 2 207 224 Carboxylation (DKW)
R.MFAPTK.V Y 28.10 693.3520 6 -11.0 347.6794 2 31.58 4 13759 VEV_1_3_RA4_01_1235.d 3.53E5 1 1 100 105
R.A(+56.06)GQAAFGNQC(+57.02)R.A Y 28.08 1234.5876 11 -26.6 618.2847 2 26.05 4 10686 VEV_1_3_RA4_01_1235.d 0 1 1 86 96 Diethylation; Carbamidomethylation
R.LNPY(-18.01)AAAFSK.Q Y 27.79 1062.5498 10 2.7 532.2836 2 64.25 4 34697 VEV_1_3_RA4_01_1235.d 8.9E4 1 1 336 345 Dehydration
R.F(+163.05)ATASALAASSVPALLFAR.G Y 27.32 2026.0709 19 -9.5 676.3578 3 84.38 6 48069 VEV_3_3_RA6_01_1237.d 3.15E4 1 1 121 139 Phenethyl isothiocyanate
K.AGEQ(+.98)TSAESWGTGR(+14.02).A Y 27.19 1450.6324 14 5.4 726.3274 2 58.83 4 30608 VEV_1_3_RA4_01_1235.d 5.01E4 1 1 57 70 Deamidation (NQ); Methylation(KR)
R.VAS(-2.02)VPEVPLVVDSKAFENNAIVK.T Y 27.08 2422.3108 23 -54.9 808.3998 3 81.84 4 48422 VEV_1_3_RA4_01_1235.d 0 1 1 143 165 2-amino-3-oxo-butanoic_acid
R.LIN(+.98)SSEVQSALR.E Y 26.68 1316.6936 12 -27.0 659.3363 2 67.15 6 35742 VEV_3_3_RA6_01_1237.d 0 1 1 297 308 Deamidation (NQ)
K.G(+41.03)LDTGKPDR.A Y 25.22 998.5145 9 -10.5 333.8419 3 14.53 5 4776 VEV_2_3_RA5_01_1236.d 2.44E5 2 2 352 360 Amidination of lysines or N-terminal amines with methyl acetimidate
R.GPLVVYNPDVD(-18.01)GKDLVK.A Y 24.98 1808.9672 17 -11.1 603.9896 3 72.78 4 41484 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 208 224 Dehydration
R.LIN(+.98)SSEVQSALREPKGYAK.T Y 24.69 2090.1008 19 24.5 523.5453 4 65.67 6 34622 VEV_3_3_RA6_01_1237.d 0 1 1 297 315 Deamidation (NQ)
K.NVGAGPDLVK(+21.98).V Y 24.37 990.5110 10 -46.2 496.2399 2 15.39 6 5145 VEV_3_3_RA6_01_1237.d 4.3E4 3 3 175 184 Sodium adduct
K.DFLLPSNLVSN(+.98)ADIT(-18.01)R.L Y 24.18 1756.8995 16 -6.9 879.4510 2 87.19 4 51995 VEV_1_3_RA4_01_1235.d 0 1 1 281 296 Deamidation (NQ); Dehydration
K.ILAQE(+14.02) Y 24.03 586.3326 5 -11.4 587.3332 1 42.19 4 20028 VEV_1_3_RA4_01_1235.d 5.3E4 1 1 368 372 Methylation(others)
R.LINSSEVQSALR(+14.02)EPK(+43.01).G Y 23.81 1726.9213 15 11.5 576.6543 3 65.99 4 36054 VEV_1_3_RA4_01_1235.d 0 1 1 297 311 Methylation(KR); Carbamylation
R.QRR(+14.02)GPLVVY(+162.05)NPDVDGKDLVK.A Y 23.53 2443.3069 20 -27.2 611.8174 4 73.54 5 41554 VEV_2_3_RA5_01_1236.d 0 1 1 205 224 Methylation(KR); Hexose (NSY)
K.RFATASALAASS(-2.02)VPALLFAR.G Y 23.33 2017.1108 20 -54.9 673.3406 3 84.30 5 48752 VEV_2_3_RA5_01_1236.d 3.65E4 2 2 120 139 2-amino-3-oxo-butanoic_acid
K.NVGAGPDLVKVEESR(+14.02)K.I Y 22.87 1710.9264 16 -17.8 428.7313 4 60.32 5 31784 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 175 190 Methylation(KR)
K.IN(+.98)LGQK.R Y 22.60 672.3806 6 -37.3 673.3628 1 22.35 6 8791 VEV_3_3_RA6_01_1237.d 0 1 1 114 119 Deamidation (NQ)
R.FATASALAASS(-18.01)VPALLFAR(+14.02).G Y 22.45 1859.0304 19 -49.7 930.4763 2 87.98 5 50831 VEV_2_3_RA5_01_1236.d 5.02E4 1 1 121 139 Dehydration; Methylation(KR)
R.LN(+.98)PYAAAFSK.Q Y 22.00 1081.5443 10 -4.4 541.7770 2 68.04 5 37563 VEV_2_3_RA5_01_1236.d 0 1 1 336 345 Deamidation (NQ)
R.QVLLR.L Y 21.86 627.4068 5 -11.7 314.7070 2 32.48 4 14283 VEV_1_3_RA4_01_1235.d 3.57E5 2 2 331 335
R.LINS(-2.02)SEVQSALREPK.G Y 21.84 1667.8842 15 -33.4 556.9501 3 68.56 5 37954 VEV_2_3_RA5_01_1236.d 4.13E4 1 1 297 311 2-amino-3-oxo-butanoic_acid
R.QPYAVSE(+21.98)K.A Y 21.79 942.4423 8 12.8 943.4616 1 81.91 4 48468 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 49 56 Sodium adduct
K.AAIALLK(+14.02).N Y 21.24 712.4847 7 -41.6 357.2348 2 66.40 6 35180 VEV_3_3_RA6_01_1237.d 0 3 3 168 174 Methylation(KR)
R.M(+15.99)FAPTK(+42.01).V Y 21.10 751.3574 6 0.7 752.3652 1 86.31 4 51436 VEV_1_3_RA4_01_1235.d 3.81E4 1 1 100 105 Oxidation (M); Acetylation (K)
K.VEESR.K Y 20.37 618.2973 5 -6.7 619.3004 1 56.40 4 28894 VEV_1_3_RA4_01_1235.d 0 1 1 185 189
K.L(+42.01)GQK(+42.01)GLDTGKPDR.A Y 20.34 1467.7681 13 4.3 490.2654 3 50.88 6 24801 VEV_3_3_RA6_01_1237.d 0 1 1 348 360 Acetylation (N-term); Acetylation (K)
K.DFLLPSNLVSNAD(-18.01)ITR(+14.02).L Y 19.78 1769.9312 16 -27.5 590.9681 3 85.66 4 51017 VEV_1_3_RA4_01_1235.d 0 1 1 281 296 Dehydration; Methylation(KR)
K.RQ(+.98)PYAVSEK(-.98).A Y 19.61 1076.5614 9 -14.7 539.2801 2 22.10 4 8515 VEV_1_3_RA4_01_1235.d 0 1 1 48 56 Deamidation (NQ); Amidation
K.NKRQPYAVSEK(+14.02).A Y 19.40 1332.7150 11 -55.9 667.3275 2 21.55 4 8230 VEV_1_3_RA4_01_1235.d 0 1 1 46 56 Methylation(KR)
R.VAS(+79.97)VPEVPLVVDSKAFEN(+.98)NAIVKT(+79.97)K.A Y 19.01 2814.3857 25 -14.3 704.5936 4 84.27 5 48735 VEV_2_3_RA5_01_1236.d 7.73E4 1 1 143 167 Phosphorylation (STY); Deamidation (NQ)
K.G(+71.04)LDTGKPDR.A Y 18.91 1028.5250 9 -10.0 343.8455 3 23.51 6 9408 VEV_3_3_RA6_01_1237.d 0 1 1 352 360 Propionamide (K, X@N-term)
R.TGVQK.K Y 18.87 531.3016 5 -46.3 532.2843 1 83.67 6 47616 VEV_3_3_RA6_01_1237.d 2.73E4 1 1 319 323
K.DFLLPSN(+.98)LVSNADITR(+28.03).L Y 18.71 1802.9414 16 -6.5 902.4721 2 87.04 4 51905 VEV_1_3_RA4_01_1235.d 0 1 1 281 296 Deamidation (NQ); Dimethylation(KR)
R.AGQAAFGNQCR(+14.02).A Y 18.64 1135.5193 11 -8.2 568.7623 2 20.39 4 7598 VEV_1_3_RA4_01_1235.d 3.34E4 1 1 86 96 Methylation(KR)
K.GLDTGKPDR(+.98).A Y 18.58 958.4719 9 6.9 480.2465 2 14.73 5 4887 VEV_2_3_RA5_01_1236.d 5.16E4 1 1 352 360 Deamidation (R)
R.L(+42.01)INS(+79.97)SEVQSALR.E Y 18.41 1437.6864 12 33.6 480.2522 3 34.90 6 15598 VEV_3_3_RA6_01_1237.d 6.16E4 2 2 297 308 Acetylation (N-term); Phosphorylation (STY)
R.VSGGGTHR.A Y 18.39 769.3831 8 38.0 385.7134 2 16.61 5 5886 VEV_2_3_RA5_01_1236.d 1.64E5 2 2 78 85
R.L(+28.03)INSSEVQSALR.E Y 18.12 1343.7408 12 -13.5 448.9149 3 62.09 5 33109 VEV_2_3_RA5_01_1236.d 0 1 1 297 308 Ethylation
R.RGPLVVYN(-17.03)PDVDGKDLVK.A Y 17.95 1966.0524 18 26.5 492.5334 4 68.96 6 37095 VEV_3_3_RA6_01_1237.d 0 1 1 207 224 Ammonia-loss (N)
R.LINSSEVQS(+79.97)ALR(+14.02).E Y 17.83 1409.6915 12 8.7 353.4332 4 54.25 4 27597 VEV_1_3_RA4_01_1235.d 4.12E5 1 1 297 308 Phosphorylation (STY); Methylation(KR)
K.NVGAGPD(+14.02)LVK.V Y 17.65 982.5447 10 -27.0 492.2664 2 58.77 4 30565 VEV_1_3_RA4_01_1235.d 4.88E4 1 1 175 184 Methylation(others)
K.A(+42.01)AIALLK.N Y 17.40 740.4796 7 -88.2 371.2144 2 61.44 4 32564 VEV_1_3_RA4_01_1235.d 0 1 1 168 174 Acetylation (N-term)
R.QPYAVSEK.A Y 17.19 920.4603 8 -24.9 461.2260 2 13.35 5 4152 VEV_2_3_RA5_01_1236.d 3.69E4 1 1 49 56
R.LNPYAAAFS(+79.97)KQK.L Y 17.15 1416.6802 12 76.5 473.2701 3 69.08 6 37178 VEV_3_3_RA6_01_1237.d 3.56E4 1 1 336 347 Phosphorylation (STY)
R.LINSSEVQSALREPK(+43.99).G Y 17.15 1713.8896 15 -22.8 572.2908 3 67.06 4 36896 VEV_1_3_RA4_01_1235.d 4.37E3 1 1 297 311 Carboxylation (DKW)
K.NVGAGPD(+21.98)LVK.V Y 17.03 990.5110 10 -12.7 496.2565 2 31.49 6 13692 VEV_3_3_RA6_01_1237.d 1.72E5 3 3 175 184 Sodium adduct
K.GLD(+37.03)TGKPDR.A Y 16.99 994.5195 9 -22.1 332.5065 3 14.53 6 4713 VEV_3_3_RA6_01_1237.d 6.22E4 1 1 352 360 Propargylamine
R.QPYAVSEK(+14.02).A Y 16.98 934.4760 8 -13.6 468.2389 2 35.10 6 15717 VEV_3_3_RA6_01_1237.d 0 1 1 49 56 Methylation(KR)
K.N(+45.99)VGAGPDLVKVEESRK.I Y 16.78 1742.8984 16 -59.0 436.7062 4 56.27 4 28810 VEV_1_3_RA4_01_1235.d 2.58E4 1 1 175 190 Beta-methylthiolation (ND)
R.VASVPEVPLVVDSK(-.98).A Y 16.70 1436.8239 14 -46.5 360.1965 4 56.74 5 29248 VEV_2_3_RA5_01_1236.d 3.64E4 1 1 143 156 Amidation
R.QPYAVS(+79.97)EK.A Y 16.45 1000.4266 8 20.9 334.4898 3 27.80 6 11701 VEV_3_3_RA6_01_1237.d 1.73E5 1 1 49 56 Phosphorylation (STY)
R.AGQAAFGNQC(+57.02)R(+31.99).A Y 16.39 1210.5149 11 74.7 606.3099 2 31.11 4 13478 VEV_1_3_RA4_01_1235.d 0 1 1 86 96 Carbamidomethylation; Dihydroxy
K.GLDTGKPDRAGETFHK(+14.02).I Y 16.37 1741.8746 16 -45.0 581.6060 3 69.80 6 37705 VEV_3_3_RA6_01_1237.d 0 1 1 352 367 Methylation(KR)
K.KDFLLPSN(+.98)LVSNADITR.L Y 16.13 1903.0050 17 -26.2 476.7461 4 57.53 5 29788 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 280 296 Deamidation (NQ)
R.V(+42.01)SGGGTHR(-.98).A Y 16.10 810.4097 8 -27.3 406.2010 2 10.56 6 2727 VEV_3_3_RA6_01_1237.d 3.44E4 1 1 78 85 Acetylation (N-term); Amidation
K.QKLGQK(+43.01)GLDTGK(+14.02)PDR.A Y 16.04 1696.9220 15 -27.7 425.2260 4 55.51 4 28344 VEV_1_3_RA4_01_1235.d 0 1 1 346 360 Carbamylation; Methylation(KR)
K.DFLLPSNLVSNAD(+37.96)ITR.L Y 15.96 1811.8820 16 -29.6 604.9501 3 85.34 5 49367 VEV_2_3_RA5_01_1236.d 0 1 1 281 296 Replacement of proton by potassium
K.RQPYAVSEK(+14.02).A Y 15.75 1090.5770 9 -11.1 546.2897 2 29.13 4 12366 VEV_1_3_RA4_01_1235.d 4.05E4 1 1 48 56 Methylation(KR)
R.LINS(+79.96)SEVQSALR.E Y 15.35 1395.6664 12 8.2 466.2332 3 23.83 5 9804 VEV_2_3_RA5_01_1236.d 0 1 1 297 308 Sulfation
K.N(+.98)VGAGPDLVK(+42.01).V Y 15.35 1011.5236 10 -6.3 338.1797 3 40.16 4 18792 VEV_1_3_RA4_01_1235.d 1.48E5 1 1 175 184 Deamidation (NQ); Acetylation (K)
R.QPY(-18.01)AVSEK.A Y 15.32 902.4498 8 28.2 452.2449 2 54.32 6 26852 VEV_3_3_RA6_01_1237.d 1.81E4 1 1 49 56 Dehydration
K.AFRNIPGVETSSVFSLNLLQLAPGGHLGR.F Y 15.19 3049.6460 29 -37.4 763.3903 4 86.56 5 50055 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 225 253
K.GLDTGK(+42.01)PDR(+14.02).A Y 15.18 1013.5142 9 34.7 338.8571 3 54.65 4 27842 VEV_1_3_RA4_01_1235.d 0 1 1 352 360 Acetylation (K); Methylation(KR)
K.K(-15.01)DFLLPSNLVSNADITR.L Y 15.09 1887.0101 17 -12.6 944.5005 2 89.99 4 53664 VEV_1_3_RA4_01_1235.d 1.71E5 1 1 280 296 ISD (z+2)-series
K.GLD(+14.02)TGKPDR.A Y 15.06 971.5036 9 -11.3 324.8382 3 17.91 6 6457 VEV_3_3_RA6_01_1237.d 3.3E4 1 1 352 360 Methylation(others)
total 200 peptides
C1G1F2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVEMHHQQLTAGNPGDNVGFNVK.N Y 167.16 2478.1709 23 -5.9 1240.0854 2 64.25 5 34737 VEV_2_3_RA5_01_1236.d 5.8E6 14 14 290 312
K.TLLEAIDAIEPPTRPTDKPLRLPLQDVYK.I Y 161.18 3301.8284 29 -11.3 1101.6042 3 83.47 6 47527 VEV_3_3_RA6_01_1237.d 9.82E6 16 16 226 254
R.VETGVIKPGMVVTFAPANVTTEVK.S Y 151.77 2486.3455 24 -9.4 829.7813 3 79.57 4 46685 VEV_1_3_RA4_01_1235.d 3.14E6 9 9 266 289
K.VGYNPK(+42.02)TVPFVPISGFEGDNMIEPSANC(+57.02)PWYK.G Y 149.58 3654.7275 32 3.8 1219.2544 3 85.85 4 51160 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 180 211 Guanidination; Carbamidomethylation
K.NMITGTSQADC(+57.02)AILIIAAGTGEFEAGISK.D Y 141.57 2938.4417 29 -7.8 1470.2167 2 92.50 6 52534 VEV_3_3_RA6_01_1237.d 1.02E6 9 9 102 130 Carbamidomethylation
K.SVEM(+15.99)HHQQLTAGNPGDNVGFNVK.N Y 136.85 2494.1660 23 -12.1 624.5413 4 61.37 6 31440 VEV_3_3_RA6_01_1237.d 1.94E6 7 7 290 312 Oxidation (M)
K.YSGKTLLEAIDAIEPPTRPTDKPLRLPLQDVYK.I Y 134.06 3737.0403 33 -15.7 748.4036 5 83.74 5 48410 VEV_2_3_RA5_01_1236.d 3.12E5 4 4 222 254
R.VETGVIKPGM(+15.99)VVTFAPANVTTEVK.S Y 132.48 2502.3403 24 -13.5 835.1095 3 77.10 6 43094 VEV_3_3_RA6_01_1237.d 5.1E5 3 3 266 289 Oxidation (M)
K.M(+15.99)IPSKPMC(+57.02)VEAFTEYPPLGR.F Y 129.55 2338.1160 20 -8.4 780.3727 3 78.63 5 45132 VEV_2_3_RA5_01_1236.d 4.19E5 4 4 403 422 Oxidation (M); Carbamidomethylation
K.GC(+57.02)DSFNAQVIVLNHPGQVGAGYAPVLDC(+57.02)HTAHIAC(+57.02)K.F Y 127.68 3875.8293 36 -11.6 776.1642 5 77.39 6 43305 VEV_3_3_RA6_01_1237.d 3.06E5 2 2 335 370 Carbamidomethylation
K.FETPKYNVTVIDAPGHRDFIK.N Y 121.45 2446.2644 21 -7.8 612.5686 4 71.72 5 40259 VEV_2_3_RA5_01_1236.d 2.77E6 10 10 81 101
K.THINLVVIGHVDSGKSTTTGHLIYK.C Y 119.95 2689.4551 25 -14.1 673.3616 4 68.59 5 37970 VEV_2_3_RA5_01_1236.d 6.73E5 5 5 7 31
K.ISGIGTVPVGRVETGVIKPGMVVTFAPANVTTEVK.S Y 119.90 3522.9482 35 -10.3 881.7352 4 82.03 6 46561 VEV_3_3_RA6_01_1237.d 9.43E5 5 5 255 289
K.MIPSKPMC(+57.02)VEAFTEYPPLGR.F Y 119.79 2322.1211 20 -6.3 775.0428 3 79.60 4 46748 VEV_1_3_RA4_01_1235.d 2.2E6 7 7 403 422 Carbamidomethylation
R.EHALLAFTLGVK.Q Y 116.54 1297.7394 12 -13.1 433.5814 3 78.05 4 45530 VEV_1_3_RA4_01_1235.d 6.26E5 4 4 136 147
K.YNVTVIDAPGHRDFIK.N Y 115.61 1843.9580 16 -15.3 615.6505 3 67.68 6 36144 VEV_3_3_RA6_01_1237.d 3.65E6 8 8 86 101
K.YNVTVIDAPGHR.D Y 114.92 1340.6837 12 -17.1 447.8942 3 59.61 6 30200 VEV_3_3_RA6_01_1237.d 1.85E6 5 5 86 97
K.THINLVVIGHVDSGK.S Y 111.83 1587.8733 15 -10.9 794.9352 2 65.08 5 35332 VEV_2_3_RA5_01_1236.d 2.53E6 12 12 7 21
K.FETPKYNVTVIDAPGHR.D Y 111.18 1942.9901 17 -16.5 486.7468 4 67.31 6 35914 VEV_3_3_RA6_01_1237.d 1.77E6 6 6 81 97
M.G(+42.01)KEEKTHINLVVIGHVDSGKSTTTGHLIYK.C Y 108.68 3302.7622 30 15.5 661.5699 5 64.74 5 35073 VEV_2_3_RA5_01_1236.d 2.55E5 2 2 2 31 Acetylation (Protein N-term)
R.FNEIIKEVTNFIKK.V Y 104.96 1721.9716 14 -14.8 431.4938 4 80.44 6 45489 VEV_3_3_RA6_01_1237.d 2.9E5 3 3 166 179
R.VETGVIKPGMVVTFAPANVTTEVKSVEMHHQQLTAGNPGDNVGFNVK.N Y 103.78 4946.5059 47 -4.8 990.3037 5 81.33 4 48055 VEV_1_3_RA4_01_1235.d 3.56E5 2 2 266 312
K.TLLEAIDAIE(+14.02)PPTRPTDKPLRLPLQDVYK.I Y 103.64 3315.8442 29 -9.6 1106.2781 3 85.32 4 50804 VEV_1_3_RA4_01_1235.d 2.02E6 5 5 226 254 Methylation(others)
K.STTTGHLIYK.C Y 101.65 1119.5924 10 -14.4 560.7954 2 33.36 6 14744 VEV_3_3_RA6_01_1237.d 7.07E6 16 16 22 31
K.VGYNPK(+42.01)TVPFVPISGFEGDNMIEPSANC(+57.02)PWYK.G Y 100.71 3654.7163 32 -0.2 1219.2458 3 85.68 6 48888 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 180 211 Acetylation (K); Carbamidomethylation
R.VETGVIKPGMVVTFAPANVTTEVK(+14.02).S Y 95.26 2500.3611 24 -8.7 1251.1769 2 80.70 5 46510 VEV_2_3_RA5_01_1236.d 7.19E5 6 6 266 289 Methylation(KR)
R.EHALLAFTLGVKQLIVAINKMDTTK.W Y 95.02 2753.5513 25 -6.4 551.7140 5 92.73 4 55192 VEV_1_3_RA4_01_1235.d 2.4E5 3 3 136 160
K.SVEMHHQQLTAGN(+.98)PGDNVGFNVK.N Y 92.24 2479.1550 23 -0.2 620.7959 4 64.35 4 34775 VEV_1_3_RA4_01_1235.d 0 3 3 290 312 Deamidation (NQ)
K.SVE(+14.02)MHHQQLTAGNPGDNVGFNVK.N Y 92.19 2492.1865 23 -21.5 624.0405 4 65.01 6 34127 VEV_3_3_RA6_01_1237.d 2.53E5 1 1 290 312 Methylation(others)
R.GNVAGDSKNDPPK.G Y 91.90 1297.6262 13 -6.7 649.8160 2 12.42 4 3507 VEV_1_3_RA4_01_1235.d 3.9E5 6 6 322 334
R.VE(+14.02)TGVIKPGMVVTFAPANVTTEVK.S Y 91.55 2500.3611 24 -11.3 834.4515 3 80.11 4 47105 VEV_1_3_RA4_01_1235.d 4.59E5 4 4 266 289 Methylation(others)
K.MIPSKPM(+15.99)C(+57.02)VEAFTEYPPLGR.F Y 90.88 2338.1160 20 -7.0 780.3738 3 77.24 4 44889 VEV_1_3_RA4_01_1235.d 7.58E5 6 6 403 422 Oxidation (M); Carbamidomethylation
K.TLLEAIDAIEPPTRPTDKPLR.L Y 90.62 2345.2954 21 -21.2 587.3187 4 78.51 6 44082 VEV_3_3_RA6_01_1237.d 4.35E5 4 4 226 246
K.DGQTREHALLAFTLGVK.Q Y 89.94 1854.9951 17 -15.1 464.7491 4 77.03 6 43033 VEV_3_3_RA6_01_1237.d 3.56E5 3 3 131 147
K.SFK(+28.03)YAWVLDKLKAER.E Y 86.49 1881.0511 15 -20.6 377.2097 5 76.70 6 42800 VEV_3_3_RA6_01_1237.d 1.67E6 9 9 54 68 Dimethylation(KR)
K.SVEM(+15.99)HHQQ(+.98)LTAGNPGDNVGFNVK.N Y 85.14 2495.1499 23 -9.3 624.7889 4 62.59 6 32326 VEV_3_3_RA6_01_1237.d 2.26E5 1 1 290 312 Oxidation (M); Deamidation (NQ)
K.TLLEAIDAIEPPTRPTDKPLRLPLQDVYKISGIGTVPVGR.V Y 83.69 4338.4312 40 -7.3 1085.6072 4 86.38 5 49957 VEV_2_3_RA5_01_1236.d 6.4E5 4 4 226 265
R.RGNVAGDSKNDPPK.G Y 83.44 1453.7273 14 -8.9 485.5787 3 11.42 4 3042 VEV_1_3_RA4_01_1235.d 5.74E5 8 8 321 334
R.FNEIIKEVTNFIK.K Y 83.06 1593.8766 13 -7.2 532.2957 3 83.90 4 49838 VEV_1_3_RA4_01_1235.d 8.38E4 1 1 166 178
R.GITIDIALWK.F Y 82.86 1128.6543 10 -13.0 1129.6469 1 83.90 5 48498 VEV_2_3_RA5_01_1236.d 1.13E6 6 6 71 80
K.NMITGTSQADC(+57.02)AILIIAAGTGEFEAGISKDGQTR.E Y 82.36 3495.6973 34 -8.7 874.9240 4 89.79 4 53539 VEV_1_3_RA4_01_1235.d 6.34E4 2 2 102 135 Carbamidomethylation
K.SVVKSDKAGGKVTK.A Y 82.34 1402.8143 14 -7.4 702.4092 2 12.11 5 3500 VEV_2_3_RA5_01_1236.d 5.13E5 4 4 439 452
R.VETGVIKPGMVVTFAPAN(+.98)VTTEVK.S Y 79.50 2487.3293 24 -6.4 830.1118 3 80.36 4 47295 VEV_1_3_RA4_01_1235.d 1.78E5 3 3 266 289 Deamidation (NQ)
K.SVEM(+15.99)HHQQLTAGN(+.98)PGDNVGFNVK.N Y 78.38 2495.1499 23 -6.1 624.7910 4 62.35 4 33252 VEV_1_3_RA4_01_1235.d 3.76E5 2 2 290 312 Oxidation (M); Deamidation (NQ)
K.MIPSKPMC(+57.02)VEAFTE(+14.02)YPPLGR.F Y 78.18 2336.1367 20 -8.5 779.7129 3 80.66 4 47527 VEV_1_3_RA4_01_1235.d 4.21E5 1 1 403 422 Carbamidomethylation; Methylation(others)
K.ISGIGTVPVGR.V Y 75.36 1054.6135 11 -16.5 528.3054 2 63.20 6 32825 VEV_3_3_RA6_01_1237.d 9.71E6 8 8 255 265
R.ERGITIDIALWK.F Y 73.55 1413.7980 12 -14.3 472.2665 3 79.82 5 45934 VEV_2_3_RA5_01_1236.d 2.25E5 3 3 69 80
K.GWSKETAQGKYSGK.T Y 73.19 1525.7524 14 -10.9 509.5859 3 24.05 4 9592 VEV_1_3_RA4_01_1235.d 1.39E5 3 3 212 225
K.SVEMHHQQ(+.98)LTAGNPGDN(+.98)VGFNVK.N Y 72.20 2480.1389 23 -0.5 621.0417 4 65.51 4 35679 VEV_1_3_RA4_01_1235.d 2.86E5 1 1 290 312 Deamidation (NQ)
K.TLLEAIDAIEPPTRPTDKPLRLPLQ(+.98)DVYK.I Y 70.79 3302.8125 29 -8.6 661.5641 5 84.22 6 47968 VEV_3_3_RA6_01_1237.d 0 2 2 226 254 Deamidation (NQ)
K.SVEM(+15.99)HHQQ(+.98)LTAGN(+.98)PGDNVGFNVK.N Y 70.52 2496.1340 23 6.2 625.0447 4 61.53 4 32629 VEV_1_3_RA4_01_1235.d 2.04E5 1 1 290 312 Oxidation (M); Deamidation (NQ)
K.SFK(+28.03)YAWVLDKLK.A Y 69.90 1524.8704 12 -13.2 382.2198 4 77.64 4 45236 VEV_1_3_RA4_01_1235.d 1.71E6 8 8 54 65 Dimethylation(KR)
R.GITIDIALWKFETPK.Y Y 69.05 1730.9607 15 -8.9 577.9890 3 84.36 6 48056 VEV_3_3_RA6_01_1237.d 2.81E5 4 4 71 85
K.M(+15.99)IPSKPM(+15.99)C(+57.02)VEAFTEYPPLGR.F Y 68.02 2354.1108 20 -12.4 785.7012 3 75.62 6 41997 VEV_3_3_RA6_01_1237.d 2.75E5 2 2 403 422 Oxidation (M); Carbamidomethylation
R.EHALLAFTLGVK(+14.02).Q Y 67.30 1311.7550 12 -14.5 438.2526 3 79.88 4 46929 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 136 147 Methylation(KR)
K.GWSKETAQGK.Y Y 65.94 1090.5406 10 -7.2 546.2737 2 15.46 4 5028 VEV_1_3_RA4_01_1235.d 1.33E5 4 4 212 221
K.S(+27.05)GDAAIVKMIPSKPMC(+57.02)VEAFTEYPPLGR.F Y 65.75 3090.5703 28 -4.2 773.6466 4 79.65 4 46749 VEV_1_3_RA4_01_1235.d 4.24E5 1 1 395 422 Ethyl amino; Carbamidomethylation
R.TGKSVENNPK(+42.01)FIK.S Y 65.41 1502.8092 13 11.6 501.9495 3 29.04 5 12709 VEV_2_3_RA5_01_1236.d 1.96E6 7 7 382 394 Acetylation (K)
K.SVENNPK(+42.02)FIK.S Y 65.21 1216.6564 10 10.6 609.3419 2 36.43 5 17055 VEV_2_3_RA5_01_1236.d 2.38E7 22 22 385 394 Guanidination
K.DGQTREHALLAFTLGVKQLIVAINK.M Y 64.17 2734.5493 25 4.3 547.9195 5 89.40 4 53330 VEV_1_3_RA4_01_1235.d 6.9E4 1 1 131 155
K.FAELLEKIDR.R Y 64.07 1232.6764 10 -15.9 411.8929 3 71.35 5 39986 VEV_2_3_RA5_01_1236.d 8.45E5 3 3 371 380
R.LPLQDVYK.I Y 63.91 974.5436 8 -14.0 488.2723 2 65.52 4 35723 VEV_1_3_RA4_01_1235.d 1.17E6 6 6 247 254
K.FAELLEKIDRR.T Y 63.17 1388.7776 11 -12.0 348.1975 4 67.98 4 37635 VEV_1_3_RA4_01_1235.d 2.07E6 10 10 371 381
K.SVEMHHQQLTAGNPGD(+14.02)NVGFNVK.N Y 62.66 2492.1865 23 -16.4 624.0437 4 65.98 4 36040 VEV_1_3_RA4_01_1235.d 2.22E5 3 3 290 312 Methylation(others)
K.SFK(+28.03)YAWVLDKLKAER(+14.02).E Y 62.10 1895.0668 15 -15.3 380.0148 5 78.69 6 44213 VEV_3_3_RA6_01_1237.d 2.15E5 4 4 54 68 Dimethylation(KR); Methylation(KR)
R.V(+43.01)ETGVIK(+14.02)PGMVVTFAPANVTTEVK.S Y 61.92 2543.3669 24 -10.8 636.8422 4 72.50 5 40827 VEV_2_3_RA5_01_1236.d 1.6E6 6 6 266 289 Carbamylation; Methylation(KR)
K.MIPSKPMC(+57.02)VEAFT(+14.02)EYPPLGR.F Y 61.86 2336.1367 20 -7.1 1169.0674 2 80.73 4 47586 VEV_1_3_RA4_01_1235.d 3.4E5 3 3 403 422 Carbamidomethylation; Methylation(others)
K.SGDAAIVK.M Y 61.44 759.4127 8 -15.6 380.7077 2 18.31 5 6806 VEV_2_3_RA5_01_1236.d 1.49E6 5 5 395 402
K.WSETRFNEIIKEVTNFIKK.V Y 60.07 2381.2742 19 -11.7 596.3188 4 86.79 4 51748 VEV_1_3_RA4_01_1235.d 9.54E5 5 5 161 179
K.SGDAAIVK(+26.02)MIPSKPMC(+57.02)VEAFTEYPPLGR.F Y 59.87 3089.5388 28 7.7 773.3979 4 79.56 5 45763 VEV_2_3_RA5_01_1236.d 3.43E4 1 1 395 422 Acetaldehyde +26; Carbamidomethylation
K.SVEMHHQQLTAGNPGDNVGFNVK(+43.99)NVSVK(+42.01).E Y 59.81 3091.4780 28 10.1 619.3091 5 64.24 5 34708 VEV_2_3_RA5_01_1236.d 0 1 1 290 317 Carboxylation (DKW); Acetylation (K)
R.TGKSVENNPKFIK(+42.01).S Y 59.61 1502.8092 13 8.8 752.4185 2 29.45 5 12957 VEV_2_3_RA5_01_1236.d 1.55E6 3 3 382 394 Acetylation (K)
R.VETGVIK(+14.02)PGMVVTFAPANVTTEVK.S Y 59.05 2500.3611 24 -40.1 834.4276 3 77.38 4 44993 VEV_1_3_RA4_01_1235.d 8.79E4 3 3 266 289 Methylation(KR)
K.THINLVVIGHVDSGK(+14.02).S Y 58.50 1601.8889 15 7.8 534.9744 3 66.15 4 36171 VEV_1_3_RA4_01_1235.d 0 1 1 7 21 Methylation(KR)
K.FAELLEK.I Y 58.23 848.4644 7 -8.4 849.4645 1 62.62 5 33495 VEV_2_3_RA5_01_1236.d 4.19E6 12 12 371 377
K.SVEMHHQQLTAGNPGDNVGFN(+.98)VK.N Y 57.63 2479.1550 23 -5.8 827.3875 3 65.27 4 35490 VEV_1_3_RA4_01_1235.d 8.31E4 1 1 290 312 Deamidation (NQ)
K.MIPSK(+14.02)PMC(+57.02)VEAFTEYPPLGR.F Y 57.08 2336.1367 20 -18.8 779.7049 3 78.48 5 45043 VEV_2_3_RA5_01_1236.d 4.36E3 1 1 403 422 Methylation(KR); Carbamidomethylation
R.VETGVIKPGM(-4.99)VVTFAPANVTTEVK.S Y 57.03 2481.3591 24 -53.8 828.0825 3 79.55 5 45759 VEV_2_3_RA5_01_1236.d 1.56E5 1 1 266 289 Methionine replacement by azido homoalanine
R.TVAVGVIK.S Y 56.43 785.5011 8 -20.8 393.7497 2 48.79 6 23606 VEV_3_3_RA6_01_1237.d 9.18E6 14 14 431 438
M.G(+42.01)KEEKTHINLVVIGHVDSGK.S Y 56.34 2201.1804 20 3.4 551.3043 4 58.94 5 30771 VEV_2_3_RA5_01_1236.d 8.92E5 3 3 2 21 Acetylation (Protein N-term)
K.TLLEAIDAIEP(+13.98)PTRPTDKPLR.L Y 55.96 2359.2747 21 -8.8 590.8207 4 80.89 6 45786 VEV_3_3_RA6_01_1237.d 8.98E4 1 1 226 246 Proline oxidation to pyroglutamic acid
R.TGKSVENNPK(+42.02)FIK.S Y 55.51 1502.8204 13 10.2 501.9525 3 29.07 4 12330 VEV_1_3_RA4_01_1235.d 6.49E5 2 2 382 394 Guanidination
K.Q(-17.03)LIVAINK.M Y 54.84 880.5382 8 -27.0 881.5217 1 78.32 6 43959 VEV_3_3_RA6_01_1237.d 1.85E5 4 4 148 155 Pyro-glu from Q
R.EH(+14.02)ALLAFTLGVK.Q Y 54.25 1311.7550 12 -12.1 438.2536 3 78.99 4 46242 VEV_1_3_RA4_01_1235.d 3.9E4 1 1 136 147 Methylation(others)
K.SFK(+28.03)YAWVLDK.L Y 54.23 1283.6914 10 -9.9 428.9002 3 73.98 4 42359 VEV_1_3_RA4_01_1235.d 1.33E6 7 7 54 63 Dimethylation(KR)
K.SVENNPK(+28.03)FIK.S Y 52.08 1202.6659 10 -5.0 602.3372 2 37.29 6 16931 VEV_3_3_RA6_01_1237.d 2.02E6 5 5 385 394 Dimethylation(KR)
K.STTTGHLIYKC(+57.02)GGIDSR.T Y 51.55 1864.9102 17 -7.3 467.2314 4 50.94 5 25742 VEV_2_3_RA5_01_1236.d 1.2E5 1 1 22 38 Carbamidomethylation
R.VETGVIK(+14.02)PGMVVTFAPANVTTEVK(+14.02).S Y 50.23 2514.3767 24 -4.7 839.1289 3 81.27 4 47991 VEV_1_3_RA4_01_1235.d 8.73E4 2 2 266 289 Methylation(KR)
K.FETPK(+14.02)YNVTVIDAPGHR.D Y 49.93 1957.0057 17 -18.3 490.2498 4 67.79 6 36219 VEV_3_3_RA6_01_1237.d 0 2 2 81 97 Methylation(KR)
K.FETPK(+14.02)Y(+31.99)NVTVIDAPGHR.D Y 49.51 1988.9955 17 -9.3 498.2515 4 67.72 4 37414 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 81 97 Methylation(KR); Dihydroxy
R.GITIDIALWKFETPKYNVTVIDAPGHR.D Y 48.97 3053.6338 27 -13.7 611.7256 5 83.42 4 49513 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 71 97
K.MIPSKPMC(+57.02)VEAFTEYPPLGR(+14.02).F Y 48.91 2336.1367 20 -20.3 779.7037 3 79.85 4 46905 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 403 422 Carbamidomethylation; Methylation(KR)
K.M(+15.99)IPSK(+14.02)PMC(+57.02)VEAFTEYPPLGR.F Y 48.62 2352.1316 20 -3.1 785.0487 3 79.82 4 46877 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 403 422 Oxidation (M); Methylation(KR); Carbamidomethylation
K.SVEMHHQ(+.98)QLTAGNPGDNVGFNVK.N Y 48.38 2479.1550 23 -2.7 827.3901 3 65.67 4 35804 VEV_1_3_RA4_01_1235.d 8.31E4 1 1 290 312 Deamidation (NQ)
K.NMITGTSQ(+.98)ADC(+57.02)AILIIAAGTGEFEAGISKDGQTR.E Y 48.13 3496.6814 34 7.5 1166.5765 3 89.71 4 53495 VEV_1_3_RA4_01_1235.d 0 1 1 102 135 Deamidation (NQ); Carbamidomethylation
R.LPLQDVYKISGIGTVPVGR.V Y 47.45 2011.1466 19 -30.9 671.3688 3 81.16 4 47907 VEV_1_3_RA4_01_1235.d 0 1 1 247 265
K.ISGIGTVPVGR(+14.02).V Y 47.12 1068.6292 11 -10.3 535.3163 2 65.33 4 35534 VEV_1_3_RA4_01_1235.d 1.11E6 4 4 255 265 Methylation(KR)
R.RT(+79.97)GKS(+79.97)VENNPK(+42.01)FIK.S Y 46.41 1818.8430 14 -1.1 607.2876 3 36.44 6 16464 VEV_3_3_RA6_01_1237.d 0 1 1 381 394 Phosphorylation (STY); Acetylation (K)
K.Q(-17.03)LIVAINKM(+15.99)DTTK.W Y 45.91 1472.7909 13 -13.1 737.3931 2 71.44 4 40351 VEV_1_3_RA4_01_1235.d 2.09E4 1 1 148 160 Pyro-glu from Q; Oxidation (M)
K.SVEN(+.98)NPK(+42.01)FIK.S Y 45.81 1217.6292 10 16.9 609.8322 2 42.73 6 20084 VEV_3_3_RA6_01_1237.d 6.34E5 4 4 385 394 Deamidation (NQ); Acetylation (K)
K.ETAQGKYSGK(+14.02).T Y 45.59 1081.5404 10 -11.8 541.7711 2 12.18 5 3541 VEV_2_3_RA5_01_1236.d 1.44E4 1 1 216 225 Methylation(KR)
K.S(+43.01)FK(+42.01)YAWVLDKLKAER.E Y 45.50 1938.0363 15 14.9 388.6203 5 76.49 4 44295 VEV_1_3_RA4_01_1235.d 3.92E5 3 3 54 68 Carbamylation; Acetylation (K)
K.FETPK.Y Y 45.38 620.3170 5 -31.5 621.3047 1 23.08 4 9046 VEV_1_3_RA4_01_1235.d 8.52E5 7 7 81 85
K.TLLEAIDAIEPPTR(+14.02)PTDKPLRLPLQ(+.98)DVYK.I Y 44.80 3316.8281 29 -12.2 664.3648 5 86.08 4 51292 VEV_1_3_RA4_01_1235.d 0 1 1 226 254 Methylation(KR); Deamidation (NQ)
K.TLLEAIDAIE(+14.02)PPTRPTDKPLR.L Y 44.54 2359.3110 21 -6.0 590.8315 4 80.94 5 46672 VEV_2_3_RA5_01_1236.d 6.63E4 1 1 226 246 Methylation(others)
R.TIEKFEK.E Y 44.48 893.4858 7 -9.6 447.7459 2 22.28 4 8613 VEV_1_3_RA4_01_1235.d 1.51E6 8 8 39 45
K.FETPK(-1.03)YNVTVIDAPGHRDFIK.N Y 44.01 2445.2327 21 -3.4 612.3134 4 71.75 6 39170 VEV_3_3_RA6_01_1237.d 1.55E5 2 2 81 101 Lysine oxidation to aminoadipic semialdehyde
K.SFK(+28.03)YAWVLDK(+14.02)LK.A Y 43.48 1538.8860 12 -13.2 385.7237 4 79.55 4 46671 VEV_1_3_RA4_01_1235.d 8.71E4 2 2 54 65 Dimethylation(KR); Methylation(KR)
K.FETPKYNVT(-2.02)VIDAPGHR.D Y 43.44 1940.9744 17 -17.8 486.2422 4 67.47 4 37286 VEV_1_3_RA4_01_1235.d 2.06E5 3 3 81 97 2-amino-3-oxo-butanoic_acid
K.SVENNPK(+42.01)FIKSGDAAIVK.M Y 42.61 1958.0472 18 6.5 653.6939 3 58.40 5 30379 VEV_2_3_RA5_01_1236.d 2.34E5 2 2 385 402 Acetylation (K)
K.YNVTVIDAPGHRDFIK(+14.02).N Y 42.21 1857.9736 16 -4.2 465.4987 4 70.30 4 39447 VEV_1_3_RA4_01_1235.d 1.15E5 3 3 86 101 Methylation(KR)
K.FAELLEK(+14.02).I Y 41.52 862.4800 7 -27.9 432.2352 2 67.05 6 35660 VEV_3_3_RA6_01_1237.d 2.79E5 1 1 371 377 Methylation(KR)
K.QLIVAINK.M Y 40.86 897.5647 8 -9.5 449.7853 2 62.03 4 33014 VEV_1_3_RA4_01_1235.d 2.84E5 2 2 148 155
K.M(+42.01)IPS(-18.01)KPMC(+57.02)VEAFTEYPPLGR.F Y 40.52 2346.1211 20 -2.1 783.0460 3 78.47 6 44055 VEV_3_3_RA6_01_1237.d 3.81E4 1 1 403 422 Acetylation (N-term); Dehydration; Carbamidomethylation
K.S(+42.01)TTTGHLIYK.C Y 40.46 1161.6030 10 2.6 388.2093 3 34.20 4 15291 VEV_1_3_RA4_01_1235.d 2.7E5 1 1 22 31 Acetylation (N-term)
R.VETGVIKPGMVVTFAPAN(+15.99)VTTEVK.S Y 40.41 2502.3403 24 1.0 835.1215 3 80.82 4 47661 VEV_1_3_RA4_01_1235.d 4.44E4 1 1 266 289 Oxidation or Hydroxylation
K.EEKTHINLVVIGHVDSGK(+226.08)STTTGHLIYK.C Y 39.72 3301.7129 28 -14.2 661.3405 5 64.76 5 35085 VEV_2_3_RA5_01_1236.d 0 1 1 4 31 Biotinylation
K.MIPSKPMC(+57.02)VE(+14.02)AFTEYPPLGR.F Y 39.53 2336.1367 20 -11.3 779.7107 3 80.81 5 46585 VEV_2_3_RA5_01_1236.d 1.33E5 1 1 403 422 Carbamidomethylation; Methylation(others)
K.SGD(+21.98)AAIVKMIPSKPMC(+57.02)VEAFTEYPPLGR.F Y 39.39 3085.5051 28 23.6 772.4017 4 79.68 6 44931 VEV_3_3_RA6_01_1237.d 0 1 1 395 422 Sodium adduct; Carbamidomethylation
K.ISGIGTVPVGRVETGVIKPGMVVTFAPANVTTEVK(+14.02).S Y 39.30 3536.9639 35 -6.6 885.2424 4 82.82 6 47075 VEV_3_3_RA6_01_1237.d 2.96E4 1 1 255 289 Methylation(KR)
K.SVEMH(+14.02)HQQLTAGNPGDNVGFNVK.N Y 39.24 2492.1865 23 -4.7 831.7322 3 64.96 5 35245 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 290 312 Methylation(others)
K.SVEM(-48.00)HHQQLTAGNPGDNVGFNVK.N Y 39.23 2430.1677 23 -15.2 487.0334 5 58.25 6 29218 VEV_3_3_RA6_01_1237.d 4.68E5 1 1 290 312 Dethiomethyl
K.T(-2.02)LLEAIDAIEPPTRPTDKPLR.L Y 38.99 2343.2798 21 30.9 586.8453 4 78.57 6 44125 VEV_3_3_RA6_01_1237.d 0 1 1 226 246 2-amino-3-oxo-butanoic_acid
K.M(+43.01)IPSK(+14.02)PMC(+57.02)VEAFTEYPPLGR.F Y 38.52 2379.1426 20 -18.8 794.0399 3 72.02 5 40477 VEV_2_3_RA5_01_1236.d 2.16E6 8 8 403 422 Carbamylation; Methylation(KR); Carbamidomethylation
K.Y(+42.01)NVTVIDAPGHR.D Y 37.56 1382.6942 12 -8.8 461.9013 3 59.75 4 31305 VEV_1_3_RA4_01_1235.d 5.6E4 1 1 86 97 Acetylation (N-term)
K.FAE(+14.02)LLEKIDR.R Y 37.31 1246.6921 10 -10.5 416.5670 3 71.91 4 40726 VEV_1_3_RA4_01_1235.d 3.56E5 3 3 371 380 Methylation(others)
K.SGDAAIVK(+14.02).M Y 37.21 773.4283 8 -17.2 387.7148 2 30.32 5 13444 VEV_2_3_RA5_01_1236.d 9.57E5 6 6 395 402 Methylation(KR)
K.WSETRFNEIIKEVTNFIK.K Y 36.32 2253.1792 18 -2.3 564.3008 4 89.47 4 53366 VEV_1_3_RA4_01_1235.d 4.28E5 4 4 161 178
R.TVAVGVIK(+14.02).S Y 35.51 799.5167 8 -17.9 400.7585 2 60.10 6 30500 VEV_3_3_RA6_01_1237.d 4.51E5 3 3 431 438 Methylation(KR)
K.MIPSK(+27.99)PMC(+57.02)VEAFTEYPPLGR.F Y 35.06 2350.1160 20 1.9 784.3807 3 75.83 6 42157 VEV_3_3_RA6_01_1237.d 1.98E5 1 1 403 422 Formylation; Carbamidomethylation
K.SVENNPK(+44.03)FIK.S Y 34.90 1218.6608 10 10.8 610.3442 2 36.61 5 17136 VEV_2_3_RA5_01_1236.d 9.18E4 1 1 385 394 Ethanolation (KR)
K.SVENNPK(+42.01)FIK(+14.02).S Y 34.78 1230.6608 10 1.6 616.3386 2 46.88 5 23254 VEV_2_3_RA5_01_1236.d 1.61E5 4 4 385 394 Acetylation (K); Methylation(KR)
K.S(+43.01)FK(+42.01)YAWVLDKLK.A Y 34.74 1581.8555 12 9.1 396.4747 4 77.43 5 44325 VEV_2_3_RA5_01_1236.d 3.01E5 3 3 54 65 Carbamylation; Acetylation (K)
R.VETGVIKPGMVVTFAP(+15.99)ANVTTEVK.S Y 33.43 2502.3403 24 -3.6 835.1177 3 80.66 6 45625 VEV_3_3_RA6_01_1237.d 2.19E4 1 1 266 289 Oxidation or Hydroxylation
K.SDK(+31.99)AGGK.V Y 33.38 693.3293 7 -13.8 694.3270 1 32.08 5 14467 VEV_2_3_RA5_01_1236.d 0 1 1 443 449 Dihydroxy
K.FAE(+14.02)LLEK.I Y 33.26 862.4800 7 -16.4 432.2402 2 67.24 4 37067 VEV_1_3_RA4_01_1235.d 3.82E5 2 2 371 377 Methylation(others)
K.MIPSK(+14.96)PMC(+57.02)VEAFTEYPPLGR.F Y 32.91 2337.0842 20 -0.3 780.0351 3 76.89 5 43937 VEV_2_3_RA5_01_1236.d 1.92E4 1 1 403 422 Alpha-amino adipic acid; Carbamidomethylation
K.ETAQGK.Y Y 32.90 632.3129 6 -30.9 633.3007 1 33.41 5 15234 VEV_2_3_RA5_01_1236.d 0 2 2 216 221
K.NVSVK(+42.01)EVR.R Y 32.49 971.5400 8 28.1 324.8630 3 20.49 4 7667 VEV_1_3_RA4_01_1235.d 1.92E6 1 1 313 320 Acetylation (K)
K.S(+75.98)TTTGHLIYK.C Y 32.36 1195.5730 10 14.6 399.5374 3 33.86 4 15072 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 22 31 EDT
K.FAELLEK(+14.02)IDR.R Y 32.18 1246.6921 10 -13.4 416.5657 3 73.23 5 41333 VEV_2_3_RA5_01_1236.d 4.22E5 3 3 371 380 Methylation(KR)
R.RTVAVGVIK.S Y 32.10 941.6022 9 -10.9 471.8032 2 38.78 4 17980 VEV_1_3_RA4_01_1235.d 5.82E5 4 4 430 438
K.FETPKYN(+.98)VTVIDAPGHRDFIK.N Y 31.95 2447.2485 21 -0.4 612.8192 4 71.98 4 40779 VEV_1_3_RA4_01_1235.d 1.31E5 1 1 81 101 Deamidation (NQ)
K.NVSVK(+42.02)EVR.R Y 31.87 971.5512 8 9.2 324.8607 3 20.20 5 7856 VEV_2_3_RA5_01_1236.d 6.27E6 6 6 313 320 Guanidination
K.FAELLEKIDR(+14.02).R Y 31.75 1246.6921 10 -18.3 416.5637 3 73.94 4 42309 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 371 380 Methylation(KR)
K.S(+42.01)FK(+43.01)YAWVLDKLKAER.E Y 31.73 1938.0363 15 5.5 485.5190 4 76.50 4 44300 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 54 68 Acetylation (N-term); Carbamylation
K.S(-18.01)TTTGHLIYK.C Y 30.55 1101.5819 10 6.2 551.8016 2 64.69 5 35032 VEV_2_3_RA5_01_1236.d 2.07E4 1 1 22 31 Dehydration
K.Y(+43.01)NVTVIDAPGHR.D Y 30.15 1383.6895 12 -0.3 462.2370 3 59.58 6 30142 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 86 97 Carbamylation
R.RGNVAGDSKNDPPK(-.98).G Y 29.95 1452.7433 14 -19.5 485.2456 3 11.63 6 3225 VEV_3_3_RA6_01_1237.d 1.7E4 1 1 321 334 Amidation
K.FAELLEKIDR(+14.02)R.T Y 29.86 1402.7932 11 -15.7 351.7001 4 68.91 5 38207 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 371 381 Methylation(KR)
K.FAELLEK(+28.03).I Y 29.84 876.4956 7 -15.8 439.2481 2 71.53 5 40116 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 371 377 Dimethylation(KR)
R.DFIKNMITGTSQADC(+57.02)AILIIAAGTGEFEAGISK.D Y 29.70 3441.7158 33 13.4 1148.2612 3 96.73 4 57052 VEV_1_3_RA4_01_1235.d 2.76E4 1 1 98 130 Carbamidomethylation
K.FAELLE(+14.02)KIDR.R Y 28.54 1246.6921 10 -23.5 416.5616 3 73.15 6 40201 VEV_3_3_RA6_01_1237.d 2.77E5 1 1 371 380 Methylation(others)
K.SVENNPK(+14.02)FIK.S Y 28.18 1188.6503 10 -10.2 595.3264 2 37.27 4 17083 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 385 394 Methylation(KR)
K.NMITGTS(-2.02)QADC(+57.02)AILIIAAGTGEFEAGISKDGQTR.E Y 26.91 3493.6816 34 -11.2 1165.5548 3 89.59 6 51103 VEV_3_3_RA6_01_1237.d 5.09E4 1 1 102 135 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.SFK(+156.12)YAWVLDKLKAER.E Y 26.84 2009.1349 15 13.2 402.8395 5 72.69 4 41341 VEV_1_3_RA4_01_1235.d 0 1 1 54 68 4-hydroxynonenal (HNE)
K.SVENN(+.98)PK(+42.01)FIK.S Y 26.81 1217.6292 10 15.4 609.8312 2 41.42 6 19310 VEV_3_3_RA6_01_1237.d 5.51E5 3 3 385 394 Deamidation (NQ); Acetylation (K)
K.FE(+14.02)TPK.Y Y 26.68 634.3326 5 -16.1 635.3297 1 25.81 5 10934 VEV_2_3_RA5_01_1236.d 8.11E4 2 2 81 85 Methylation(others)
K.VGYNPK(+42.01)TVPFVPISGFEGDNMIEPSANC(+57.02)PWYK(-.98).G Y 26.31 3653.7322 32 0.3 1218.9183 3 85.74 5 49589 VEV_2_3_RA5_01_1236.d 0 1 1 180 211 Acetylation (K); Carbamidomethylation; Amidation
K.SVEMHHQ(+15.00)QLTAGNPGDNVGFNVK.N Y 26.17 2493.1707 23 -2.1 624.2986 4 62.74 4 33553 VEV_1_3_RA4_01_1235.d 0 1 1 290 312 Deamidation followed by a methylation
K.K(+27.99)SFKYAWVLDKLK.A Y 25.72 1652.9290 13 -1.6 331.5925 5 73.63 6 40546 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 53 65 Formylation
M.GK(+42.01)EEKTHINLVVIGHVDSGK.S Y 25.64 2201.1804 20 6.4 734.7388 3 59.06 5 30863 VEV_2_3_RA5_01_1236.d 5.02E4 1 1 2 21 Acetylation (K)
K.NDPPK(+43.99).G Y 25.63 613.2708 5 9.2 614.2837 1 43.16 5 21019 VEV_2_3_RA5_01_1236.d 0 1 1 330 334 Carboxylation (DKW)
K.ETAQ(+.98)GK(+28.03).Y Y 25.41 661.3282 6 -18.6 662.3232 1 86.34 6 49275 VEV_3_3_RA6_01_1237.d 6.36E4 1 1 216 221 Deamidation (NQ); Dimethylation(KR)
R.RGNVAGDSK(+14.02)ND(-18.01)PPK.G Y 25.40 1449.7324 14 -26.0 484.2388 3 11.25 6 3037 VEV_3_3_RA6_01_1237.d 1.12E4 1 1 321 334 Methylation(KR); Dehydration
K.S(+114.04)TTTGHLIYK.C Y 24.96 1233.6354 10 1.6 412.2197 3 64.67 4 35020 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 22 31 Ubiquitin
K.SVENNPK(+42.01)FIK.S Y 24.59 1216.6451 10 12.1 609.3372 2 37.52 6 17065 VEV_3_3_RA6_01_1237.d 2.2E6 1 1 385 394 Acetylation (K)
K.S(+79.96)VVKSDK.A Y 24.58 841.3851 7 20.4 842.4095 1 103.81 5 57183 VEV_2_3_RA5_01_1236.d 4.41E4 1 1 439 445 Sulfation
K.SVENNPK(+14.02)FIK(+42.01).S Y 24.52 1230.6608 10 -2.0 616.3364 2 46.32 6 22159 VEV_3_3_RA6_01_1237.d 0 1 1 385 394 Methylation(KR); Acetylation (K)
K.SFK(+28.03)YAWVLDKLK(+14.02).A Y 24.29 1538.8860 12 -31.9 385.7165 4 79.57 6 44851 VEV_3_3_RA6_01_1237.d 5.77E4 1 1 54 65 Dimethylation(KR); Methylation(KR)
R.VETGVIK(+42.01)PGM(+15.99)VVTFAPANVTTEVK(+14.02).S Y 24.26 2558.3665 24 -29.9 640.5798 4 74.66 4 42868 VEV_1_3_RA4_01_1235.d 0 1 1 266 289 Acetylation (K); Oxidation (M); Methylation(KR)
K.SVVKSDKAGGK.V Y 24.10 1074.6033 11 -39.2 359.1943 3 9.10 6 2169 VEV_3_3_RA6_01_1237.d 5.2E3 1 1 439 449
K.F(+43.01)ETPK.Y Y 24.09 663.3228 5 -14.2 664.3206 1 75.76 6 42104 VEV_3_3_RA6_01_1237.d 0 1 1 81 85 Carbamylation
K.FETPK(-1.03)YNVTVIDAPGHR.D Y 23.86 1941.9584 17 -18.0 648.3151 3 67.39 5 37064 VEV_2_3_RA5_01_1236.d 4.72E4 1 1 81 97 Lysine oxidation to aminoadipic semialdehyde
K.S(+42.01)VEM(+15.99)HHQQLTAGNPGDNVGFNVK.N Y 23.78 2536.1765 23 -20.5 635.0384 4 59.41 6 30020 VEV_3_3_RA6_01_1237.d 5.48E4 1 1 290 312 Acetylation (N-term); Oxidation (M)
K.FETPKYNVTVIDAPGHRDFIK(+14.02).N Y 23.72 2460.2800 21 -1.1 493.0627 5 73.63 4 42070 VEV_1_3_RA4_01_1235.d 1.31E5 1 1 81 101 Methylation(KR)
K.Y(+43.01)NVTVIDAPGHRDFIK(+14.02).N Y 23.35 1900.9795 16 -16.2 476.2444 4 87.80 6 50112 VEV_3_3_RA6_01_1237.d 6.14E4 1 1 86 101 Carbamylation; Methylation(KR)
K.SVEN(+.98)NPK(+42.01)FIKSGDAAIVK.M Y 23.08 1959.0312 18 15.1 490.7725 4 58.42 5 30399 VEV_2_3_RA5_01_1236.d 6.54E4 1 1 385 402 Deamidation (NQ); Acetylation (K)
K.IDRRTGK(+14.02)SVENNPK(+42.01).F Y 23.06 1668.8907 14 -11.2 557.2980 3 68.97 5 38253 VEV_2_3_RA5_01_1236.d 0 1 1 378 391 Methylation(KR); Acetylation (K)
K.MIPS(+27.05)KPMC(+57.02)VEAFTEYPPLGR.F Y 22.99 2349.1682 20 -19.0 784.0485 3 75.94 4 43868 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 403 422 Ethyl amino; Carbamidomethylation
R.T(+79.97)IEK(+43.01)FEKEAEELGKK.S Y 22.97 1900.9182 15 65.7 381.2159 5 61.08 5 32353 VEV_2_3_RA5_01_1236.d 0 1 1 39 53 Phosphorylation (STY); Carbamylation
K.WSETR.F Y 22.96 677.3133 5 -11.0 678.3131 1 43.50 5 21216 VEV_2_3_RA5_01_1236.d 5.66E4 1 1 161 165
K.IS(+79.96)GIGTVPVGR(+14.02).V Y 22.84 1148.5859 11 5.3 383.8713 3 53.92 6 26605 VEV_3_3_RA6_01_1237.d 0 1 1 255 265 Sulfation; Methylation(KR)
R.R(+14.02)GNVAGDSKN(+.98)DPPK.G Y 22.73 1468.7269 14 -10.8 368.1851 4 22.79 6 9021 VEV_3_3_RA6_01_1237.d 1.89E5 1 1 321 334 Methylation(KR); Deamidation (NQ)
K.Y(+42.01)N(+.98)VTVIDAPGHRDFIK.N Y 22.70 1886.9526 16 -20.4 472.7358 4 67.88 5 37434 VEV_2_3_RA5_01_1236.d 3.18E4 1 1 86 101 Acetylation (N-term); Deamidation (NQ)
R.LPLQDVYK(+158.13)ISGIGTVPVGR.V Y 22.69 2169.2773 19 -37.4 724.0727 3 86.43 5 49982 VEV_2_3_RA5_01_1236.d 2.82E5 1 1 247 265 Reduced 4-Hydroxynonenal
K.S(-18.01)TTTGHLIYK(+14.02).C Y 22.58 1115.5975 10 -41.2 558.7831 2 33.69 6 14900 VEV_3_3_RA6_01_1237.d 0 1 1 22 31 Dehydration; Methylation(KR)
K.C(+58.01)GGIDSR.T Y 22.58 764.3123 7 22.2 383.1719 2 15.68 6 5298 VEV_3_3_RA6_01_1237.d 0 1 1 32 38 Carboxymethyl
R.TIEKFEKEAEELGKK.S Y 22.33 1777.9460 15 -32.6 445.4793 4 64.35 5 34783 VEV_2_3_RA5_01_1236.d 2.49E5 1 1 39 53
K.S(+42.01)FK(+43.01)YAWVLDK.L Y 21.98 1340.6764 10 20.9 447.9088 3 73.89 4 42270 VEV_1_3_RA4_01_1235.d 8.81E4 1 1 54 63 Acetylation (N-term); Carbamylation
R.TGK(+42.02)SVENNPK.F Y 21.72 1114.5730 10 -6.5 558.2902 2 75.66 5 43068 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 382 391 Guanidination
R.LPLQDVY(+79.97)K(+14.02)ISGIGTVPVGR.V Y 21.67 2105.1284 19 -41.9 527.2673 4 64.31 4 34744 VEV_1_3_RA4_01_1235.d 0 1 1 247 265 Phosphorylation (STY); Methylation(KR)
K.FEKEAEELGK(+14.02)K.S Y 21.46 1320.6925 11 -25.8 1321.6658 1 93.71 6 53066 VEV_3_3_RA6_01_1237.d 2.96E5 1 1 43 53 Methylation(KR)
K.MIPSK(-1.03)PMC(+57.02)VEAFTEYPPLGR.F Y 21.34 2321.0894 20 5.2 774.7078 3 79.42 5 45673 VEV_2_3_RA5_01_1236.d 2.06E4 1 1 403 422 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
K.MIPSK(+14.02)PM(+15.99)C(+57.02)VEAFTEYPPLGR.F Y 21.04 2352.1316 20 -23.7 785.0326 3 75.67 4 43657 VEV_1_3_RA4_01_1235.d 0 1 1 403 422 Methylation(KR); Oxidation (M); Carbamidomethylation
K.FETPK(+14.02).Y Y 20.86 634.3326 5 -5.5 318.1718 2 37.26 4 17077 VEV_1_3_RA4_01_1235.d 2.59E5 1 1 81 85 Methylation(KR)
R.TIEK(+14.02)FEK.E Y 20.84 907.5015 7 -15.0 454.7512 2 31.95 6 13949 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 39 45 Methylation(KR)
K.MIPSKPMC(+57.02)VEAFTE(+28.03)YPPLGR.F Y 20.76 2350.1523 20 -6.1 784.3866 3 81.85 5 47246 VEV_2_3_RA5_01_1236.d 8.88E4 1 1 403 422 Carbamidomethylation; Ethylation
K.TLLEAIDAIEPPTR(+14.02)PTDKPLRLPLQDVYK.I Y 20.76 3315.8442 29 -23.0 829.9493 4 83.49 5 48252 VEV_2_3_RA5_01_1236.d 9.44E4 1 1 226 254 Methylation(KR)
K.SVE(+21.98)MHHQQLTAGNPGDNVGFNVK.N Y 20.47 2500.1528 23 -14.2 626.0366 4 62.13 4 33096 VEV_1_3_RA4_01_1235.d 0 1 1 290 312 Sodium adduct
K.STTTGHLIYK(+14.02).C Y 20.09 1133.6080 10 -11.2 378.8724 3 41.85 6 19558 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 22 31 Methylation(KR)
R.GITIDIALWKFETPKYNVTVIDAPGHRDFIK.N Y 19.70 3556.9082 31 -21.8 712.3734 5 83.34 6 47407 VEV_3_3_RA6_01_1237.d 6.26E4 1 1 71 101
R.GNVAGDSK.N Y 19.55 746.3558 8 -31.7 747.3395 1 25.96 6 10708 VEV_3_3_RA6_01_1237.d 8.38E4 1 1 322 329
K.FAELLE(+14.02)K.I Y 19.43 862.4800 7 -17.9 432.2396 2 68.04 4 37674 VEV_1_3_RA4_01_1235.d 4.67E5 1 1 371 377 Methylation(others)
K.NVSVK(+42.01)EVR(+14.02).R Y 19.32 985.5556 8 14.4 329.5305 3 28.56 6 12077 VEV_3_3_RA6_01_1237.d 3.63E5 2 2 313 320 Acetylation (K); Methylation(KR)
K.YNVTVIDAPGHR(+14.02).D Y 19.27 1354.6993 12 -12.2 452.5682 3 59.86 4 31383 VEV_1_3_RA4_01_1235.d 9.09E4 1 1 86 97 Methylation(KR)
K.SVENN(+.98)PK(+14.02).F Y 19.14 801.3868 7 -9.0 802.3869 1 77.95 4 45442 VEV_1_3_RA4_01_1235.d 0 1 1 385 391 Deamidation (NQ); Methylation(KR)
R.LPLQDVY(+164.06)KISGIGTVPVGR.V Y 19.11 2175.2068 19 -8.5 726.0700 3 86.48 4 51550 VEV_1_3_RA4_01_1235.d 0 1 1 247 265 O-Diisopropylphosphorylation
K.S(+225.09)TTTGHLIYK.C Y 19.07 1344.6860 10 8.4 449.2397 3 68.94 6 37084 VEV_3_3_RA6_01_1237.d 2.82E5 1 1 22 31 Iminobiotinylation
K.NVSVK(+42.02)EVRR.G Y 19.07 1127.6523 9 5.1 376.8933 3 17.65 6 6344 VEV_3_3_RA6_01_1237.d 1.1E6 1 1 313 321 Guanidination
R.TGKSVENN(-17.03)PK.F Y 18.91 1055.5247 10 -11.1 1056.5203 1 88.05 6 50256 VEV_3_3_RA6_01_1237.d 1.44E3 1 1 382 391 Ammonia-loss (N)
K.WSETRFNEIIK(+14.02)EVTNFIK.K Y 18.70 2267.1951 18 -16.8 567.7965 4 91.43 4 54466 VEV_1_3_RA4_01_1235.d 1.94E5 1 1 161 178 Methylation(KR)
R.T(+79.97)VAVGVIK(+14.02)SVVK(+42.01)SDK.A Y 18.56 1664.9114 15 -4.0 417.2335 4 40.69 4 19103 VEV_1_3_RA4_01_1235.d 6.27E4 1 1 431 445 Phosphorylation (STY); Methylation(KR); Acetylation (K)
K.K(+28.03)SFKYAWVLDKLK.A Y 18.55 1652.9653 13 -13.2 414.2431 4 73.17 4 41712 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 53 65 Dimethylation(KR)
K.ISGIGT(-18.01)VPVGR(+14.02).V Y 18.45 1050.6185 11 32.6 351.2249 3 56.01 4 28640 VEV_1_3_RA4_01_1235.d 0 1 1 255 265 Dehydration; Methylation(KR)
K.FETPK(+43.99)YN(+.98)VTVIDAPGHR.D Y 18.39 1987.9639 17 11.0 498.0037 4 67.50 5 37146 VEV_2_3_RA5_01_1236.d 0 1 1 81 97 Carboxylation (DKW); Deamidation (NQ)
K.SVVKS(+79.97)DKAGGK(+42.01)VTK.A Y 18.33 1524.7913 14 -15.7 509.2631 3 19.49 5 7469 VEV_2_3_RA5_01_1236.d 1.49E4 1 1 439 452 Phosphorylation (STY); Acetylation (K)
K.IDRRTGKSVENN(+.98)PK.F Y 18.28 1613.8485 14 1.7 404.4701 4 58.52 4 30376 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 378 391 Deamidation (NQ)
K.SVEMHHQQ(+.98)LTAGN(+.98)PGDNVGFNVK.N Y 18.21 2480.1389 23 12.2 827.7303 3 81.48 5 47018 VEV_2_3_RA5_01_1236.d 0 1 1 290 312 Deamidation (NQ)
K.N(+42.01)DPPK.G Y 18.17 611.2914 5 24.3 612.3136 1 64.67 6 33866 VEV_3_3_RA6_01_1237.d 7.17E4 2 2 330 334 Acetylation (N-term)
K.VGYNPK(+42.02).T Y 18.16 718.3762 6 0.2 360.1955 2 17.93 6 6473 VEV_3_3_RA6_01_1237.d 2.78E5 1 1 180 185 Guanidination
K.FAELLEKIDRR(+14.02).T Y 17.77 1402.7932 11 -10.9 351.7018 4 69.09 4 38514 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 371 381 Methylation(KR)
K.T(+79.96)HINLVVIGHVDSGK.S Y 17.76 1667.8301 15 45.2 417.9836 4 65.38 6 34443 VEV_3_3_RA6_01_1237.d 5.39E5 1 1 7 21 Sulfation
K.SDKAGGKVTK(+14.02)AAQ(+.98)K.A Y 17.73 1402.7780 14 15.9 351.7073 4 12.34 4 3456 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 443 456 Methylation(KR); Deamidation (NQ)
K.S(+42.01)GDAAIVK.M Y 17.65 801.4232 8 -39.7 401.7030 2 18.87 4 6812 VEV_1_3_RA4_01_1235.d 6.07E4 1 1 395 402 Acetylation (N-term)
R.TGK(+28.03)SVENNPK.F Y 17.60 1100.5825 10 -28.2 551.2830 2 68.19 5 37683 VEV_2_3_RA5_01_1236.d 7.77E4 1 1 382 391 Dimethylation(KR)
K.SVEMHHQ(+.98)Q(+.98)LTAGNPGDNVGFNVK.N Y 17.52 2480.1389 23 3.7 827.7233 3 81.58 4 48233 VEV_1_3_RA4_01_1235.d 0 1 1 290 312 Deamidation (NQ)
R.TGK(+14.02)SVEN(+.98)NPK.F Y 17.40 1087.5509 10 -20.2 544.7717 2 36.39 6 16441 VEV_3_3_RA6_01_1237.d 6.25E4 1 1 382 391 Methylation(KR); Deamidation (NQ)
K.MIPSK(+71.04)PMC(+57.02)VEAFTEYPPLGR.F Y 17.30 2393.1582 20 9.3 599.3024 4 70.51 4 39610 VEV_1_3_RA4_01_1235.d 0 1 1 403 422 Propionamide (K, X@N-term); Carbamidomethylation
R.FNEIIK.E Y 17.24 762.4276 6 -21.8 382.2127 2 50.08 6 24343 VEV_3_3_RA6_01_1237.d 3.15E5 1 1 166 171
K.TLLEAIDAIEPPTRPTDKPLRLPLQDVYK(-.98)(+14.02).I Y 17.23 3314.8601 29 -31.3 1105.9260 3 84.04 4 49938 VEV_1_3_RA4_01_1235.d 0 1 1 226 254 Amidation; Methylation(KR)
K.IDRRTGKSVENNPK(+21.98)(+14.02).F Y 17.00 1648.8621 14 -18.1 413.2153 4 14.56 5 4795 VEV_2_3_RA5_01_1236.d 0 1 1 378 391 Sodium adduct; Methylation(KR)
K.YNVTVIDAPGHR(+14.02)DFIK.N Y 16.99 1857.9736 16 -6.9 465.4975 4 70.08 6 37915 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 86 101 Methylation(KR)
K.Y(+41.03)NVTVIDAPGHR.D Y 16.97 1381.7102 12 -41.5 461.5582 3 59.60 5 31258 VEV_2_3_RA5_01_1236.d 3.61E4 1 1 86 97 Amidination of lysines or N-terminal amines with methyl acetimidate
K.M(+42.01)IPSK(+14.02)PMC(+57.02)VEAFTEYPPLGR.F Y 16.96 2378.1472 20 2.7 793.7252 3 75.77 5 43149 VEV_2_3_RA5_01_1236.d 9.6E4 1 1 403 422 Acetylation (N-term); Methylation(KR); Carbamidomethylation
K.WS(-18.01)ETR(+14.02)FNEIIKEVTNFIK.K Y 16.68 2249.1843 18 28.2 563.3192 4 89.57 4 53420 VEV_1_3_RA4_01_1235.d 3.05E4 1 1 161 178 Dehydration; Methylation(KR)
K.ID(+21.98)RRTGKSVENNPK.F Y 16.61 1634.8464 14 -18.8 409.7112 4 17.29 5 6265 VEV_2_3_RA5_01_1236.d 0 1 1 378 391 Sodium adduct
R.RGNVAGDSK(+229.01).N Y 16.59 1131.4709 9 35.7 566.7629 2 8.66 6 2042 VEV_3_3_RA6_01_1237.d 1.11E4 1 1 321 329 Pyridoxal phosphate
R.ER(+14.02)GITIDIALWK.F Y 16.55 1427.8136 12 20.1 357.9679 4 60.70 6 30953 VEV_3_3_RA6_01_1237.d 0 1 1 69 80 Methylation(KR)
K.SDKAGGKVTK(+43.01)AAQK(+14.02).A Y 16.35 1444.7997 14 22.1 362.2152 4 62.97 5 33760 VEV_2_3_RA5_01_1236.d 4.08E4 1 1 443 456 Carbamylation; Methylation(KR)
K.SVVKSDKAGGK(+226.08).V Y 16.33 1300.6809 11 -1.9 326.1769 4 28.19 6 11883 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 439 449 Biotinylation
K.FETPKYNVTVIDAPGHR(+14.02).D Y 16.31 1957.0057 17 -4.5 490.2565 4 69.78 4 39049 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 81 97 Methylation(KR)
K.SVENNPKFIKSGDAAIVK.M Y 16.24 1916.0366 18 -36.4 384.2007 5 55.26 6 27312 VEV_3_3_RA6_01_1237.d 0 1 1 385 402
R.RGN(+.98)VAGDSK.N Y 16.21 903.4410 9 -9.0 452.7237 2 20.15 6 7631 VEV_3_3_RA6_01_1237.d 8.92E4 1 1 321 329 Deamidation (NQ)
R.R(+42.01)GNVAGDSKNDPPK.G Y 16.17 1495.7379 14 -19.5 748.8616 2 61.94 5 32990 VEV_2_3_RA5_01_1236.d 3.68E3 1 1 321 334 Acetylation (N-term)
K.AGGKVTK(+31.99)AAQ(+.98)K.A Y 16.15 1090.5981 11 0.0 364.5400 3 36.55 5 17118 VEV_2_3_RA5_01_1236.d 7.16E5 1 1 446 456 Dihydroxy; Deamidation (NQ)
K.NMITGTSQ(+.98)ADC(+57.02)AILIIAAGTGEFEAGISK(+14.02).D Y 16.15 2953.4412 29 12.4 1477.7462 2 95.53 4 56531 VEV_1_3_RA4_01_1235.d 7.84E4 1 1 102 130 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.YN(+45.99)VTVIDAPGHR.D Y 15.90 1386.6714 12 -17.0 463.2232 3 60.00 4 31493 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 86 97 Beta-methylthiolation (ND)
K.SVENNPK(+43.01)FIK(+42.01).S Y 15.66 1259.6510 10 15.9 630.8428 2 36.85 6 16685 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 385 394 Carbamylation; Acetylation (K)
K.SVEN(+.98)NPKFIK(+42.01).S Y 15.58 1217.6292 10 13.2 406.8890 3 42.73 6 20080 VEV_3_3_RA6_01_1237.d 2.06E5 1 1 385 394 Deamidation (NQ); Acetylation (K)
K.FETPKYNVTVIDAP(+31.99)GHR(+14.02).D Y 15.46 1988.9955 17 -21.1 498.2457 4 71.86 4 40688 VEV_1_3_RA4_01_1235.d 3.19E4 1 1 81 97 Dihydroxy; Methylation(KR)
K.DGQTR(+44.03).E Y 15.44 619.2925 5 13.6 620.3082 1 27.95 5 12096 VEV_2_3_RA5_01_1236.d 0 1 1 131 135 Ethanolation (KR)
K.SGD(+14.02)AAIVK.M Y 15.32 773.4283 8 -15.2 387.7155 2 27.92 4 11699 VEV_1_3_RA4_01_1235.d 1.58E6 1 1 395 402 Methylation(others)
K.FETPKYNVTVIDAPGHR(+31.99).D Y 15.25 1974.9799 17 0.9 659.3345 3 80.29 5 46242 VEV_2_3_RA5_01_1236.d 0 1 1 81 97 Dihydroxy
K.T(+42.01)HINLVVIGHVDSGK.S Y 15.17 1629.8838 15 26.3 408.4890 4 65.49 4 35663 VEV_1_3_RA4_01_1235.d 2.23E5 1 1 7 21 Acetylation (Protein N-term)
K.FET(-18.01)PK.Y Y 15.04 602.3064 5 -7.2 603.3093 1 71.28 4 40228 VEV_1_3_RA4_01_1235.d 1.97E5 1 1 81 85 Dehydration
total 256 peptides
C1GHS5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DGLGYYTSADYHALYLSGELTPTAVVEALLPLIR.R Y 162.54 3680.8977 34 0.0 1227.9731 3 97.68 5 55255 VEV_2_3_RA5_01_1236.d 2.22E5 4 4 105 138
R.NPHHEDYYTGGSSGGSGYAVGVGLVPIALGADGGGSIR.I Y 158.95 3643.7290 38 -6.8 911.9333 4 80.71 4 47568 VEV_1_3_RA4_01_1235.d 8.52E5 6 6 251 288
R.DGEGMLGFDAAATDTSTAATPK.G Y 152.67 2125.9473 22 -10.5 1063.9697 2 77.33 6 43266 VEV_3_3_RA6_01_1237.d 6.34E5 3 3 566 587
R.RDTNPC(+57.02)GEYSIGFLETKADIAR.A Y 152.45 2512.2017 22 -11.1 629.0507 4 75.21 5 42739 VEV_2_3_RA5_01_1236.d 2.57E5 2 2 139 160 Carbamidomethylation
R.VSGHPTVGIASTTGVIGPMASNLDDLALSYR.I Y 152.43 3098.5706 31 -9.4 1033.8544 3 85.09 5 49247 VEV_2_3_RA5_01_1236.d 2.18E6 10 10 306 336
R.IMAAPDPSSMTSSSFPDPLTTIPSSQSLSSRPK.V Y 149.70 3419.6587 33 -8.1 1140.8843 3 82.56 5 47715 VEV_2_3_RA5_01_1236.d 6.05E5 4 4 337 369
K.AHALTILAEIESHLSLDQISK.L Y 142.69 2288.2375 21 -16.8 573.0571 4 87.50 6 49941 VEV_3_3_RA6_01_1237.d 5.69E5 5 5 418 438
R.RDTNPC(+57.02)GEYSIGFLETK.A Y 139.05 1985.9153 17 -8.1 662.9737 3 72.87 5 41079 VEV_2_3_RA5_01_1236.d 4.41E5 4 4 139 155 Carbamidomethylation
K.TSMHELGLDTTNNNPNVGTPR.N Y 137.96 2267.0601 21 -12.4 756.6846 3 64.95 6 34107 VEV_3_3_RA6_01_1237.d 1.36E6 5 5 230 250
R.YDPTVTPIANPSEAK.H Y 136.76 1601.7937 15 -13.6 801.8932 2 65.39 6 34463 VEV_3_3_RA6_01_1237.d 3.64E6 11 11 79 93
R.DGLGYYTSADYHALYLSGELTPTAVVEALLPLIRR.D Y 133.72 3836.9988 35 -7.3 960.2499 4 97.35 5 55107 VEV_2_3_RA5_01_1236.d 2.92E5 2 2 105 139
R.DTNPC(+57.02)GEYSIGFLETKADIAR.A Y 132.67 2356.1006 21 -6.9 1179.0494 2 79.38 5 45646 VEV_2_3_RA5_01_1236.d 5.09E5 4 4 140 160 Carbamidomethylation
K.TSM(+15.99)HELGLDTTNNNPNVGTPR.N Y 131.46 2283.0549 21 -10.5 762.0176 3 60.33 6 30706 VEV_3_3_RA6_01_1237.d 5.42E5 6 6 230 250 Oxidation (M)
R.VSGHPTVGIASTTGVIGPM(+15.99)ASNLDDLALSYR.I Y 120.38 3114.5654 31 -14.4 1039.1808 3 81.28 6 46056 VEV_3_3_RA6_01_1237.d 2.3E5 2 2 306 336 Oxidation (M)
R.DTNPC(+57.02)GEYSIGFLETK.A Y 116.89 1829.8141 16 -14.7 915.9009 2 79.26 6 44649 VEV_3_3_RA6_01_1237.d 4.15E5 3 3 140 155 Carbamidomethylation
R.KGPNVPFNYLPSSNPLIR.G Y 115.93 2012.0842 18 -7.4 1007.0420 2 79.30 5 45616 VEV_2_3_RA5_01_1236.d 1.9E6 5 5 19 36
R.ADPAVLALFNK.A Y 115.02 1157.6444 11 -10.6 579.8234 2 80.44 4 47357 VEV_1_3_RA4_01_1235.d 6.49E5 5 5 381 391
K.NGNPLGPLDGVPVAVKDEVDIEGYKR.T Y 112.34 2750.4238 26 -3.3 688.6110 4 80.06 4 47066 VEV_1_3_RA4_01_1235.d 6.06E5 4 4 172 197
R.DGEGM(+15.99)LGFDAAATDTSTAATPK.G Y 109.98 2141.9421 22 -12.9 1071.9645 2 71.30 6 38838 VEV_3_3_RA6_01_1237.d 3.12E5 2 2 566 587 Oxidation (M)
R.TLGSKLDFTGAENR.T Y 108.84 1507.7631 14 -11.0 503.5894 3 63.97 4 34485 VEV_1_3_RA4_01_1235.d 1.4E6 10 10 198 211
K.VIGVFPDWVNRADPAVLALFNK.A Y 107.89 2440.3267 22 -34.0 611.0682 4 90.48 5 52145 VEV_2_3_RA5_01_1236.d 5.28E5 6 6 370 391
R.YKNGNPLGPLDGVPVAVKDEVDIEGYKR.T Y 106.84 3041.5820 28 7.0 761.4081 4 77.95 5 44682 VEV_2_3_RA5_01_1236.d 3.54E5 4 4 170 197
R.IPASFC(+57.02)GIYGLKPSHGR.V Y 104.49 1858.9512 17 -11.5 930.4722 2 68.25 5 37732 VEV_2_3_RA5_01_1236.d 1.27E6 6 6 289 305 Carbamidomethylation
R.ADPAVLALFNKAIDYYR.N Y 104.25 1939.0203 17 -11.4 647.3400 3 87.14 5 50382 VEV_2_3_RA5_01_1236.d 8.09E4 4 4 381 397
R.NVPGLNDYQPR.Y Y 103.74 1271.6259 11 -10.5 636.8135 2 63.32 5 34064 VEV_2_3_RA5_01_1236.d 2.02E6 6 6 68 78
R.YKN(+.98)GNPLGPLDGVPVAVKDEVDIEGYKR.T Y 101.51 3042.5662 28 -14.8 609.5115 5 79.20 6 44586 VEV_3_3_RA6_01_1237.d 7.35E5 2 2 170 197 Deamidation (NQ)
K.VIGVFPDWVNRADPAVLALFNKAIDYYR.N Y 100.47 3221.7024 28 -7.9 806.4265 4 93.46 5 53554 VEV_2_3_RA5_01_1236.d 4.44E5 5 5 370 397
R.YKNGN(+.98)PLGPLDGVPVAVKDEVDIEGYKR.T Y 99.40 3042.5662 28 -10.0 609.5144 5 79.17 5 45510 VEV_2_3_RA5_01_1236.d 1.55E5 1 1 170 197 Deamidation (NQ)
K.AHALTILAEIESHLSLDQISKLTPANR.I Y 98.47 2940.6033 27 -24.0 589.1138 5 87.89 5 50785 VEV_2_3_RA5_01_1236.d 1.29E5 3 3 418 444
K.GGLKAPDTTNGGKWVDVIGK.V Y 97.79 2012.0691 20 -11.2 671.6895 3 68.96 5 38248 VEV_2_3_RA5_01_1236.d 4.89E5 3 3 588 607
K.VIGVFPDWVNR.A Y 96.00 1300.6927 11 -10.3 651.3469 2 81.80 4 48409 VEV_1_3_RA4_01_1235.d 9.98E5 5 5 370 380
K.HSSLPSPSQRR.D Y 92.30 1250.6479 11 -13.7 417.8842 3 17.95 5 6617 VEV_2_3_RA5_01_1236.d 2.15E6 15 15 94 104
K.GGLKAPDTTN(+.98)GGKWVDVIGK.V Y 87.27 2013.0531 20 -10.1 1007.5237 2 71.92 5 40398 VEV_2_3_RA5_01_1236.d 7.46E5 6 6 588 607 Deamidation (NQ)
R.VSGHPTVGIASTTGVIGPMASNLDDLALSYR(+14.02).I Y 86.94 3112.5862 31 -17.8 1038.5176 3 86.24 6 49216 VEV_3_3_RA6_01_1237.d 3.23E5 3 3 306 336 Methylation(KR)
R.NNQGYTVVDISIPLLPEGQK.A Y 85.42 2184.1426 20 -8.0 729.0490 3 85.55 5 49481 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 398 417
K.TSMHELGLDTTNNNPNVGTPR(+14.02).N Y 83.59 2281.0757 21 -7.4 761.3602 3 67.29 4 37107 VEV_1_3_RA4_01_1235.d 1.26E5 3 3 230 250 Methylation(KR)
R.IIMAVGGNPTR.A Y 82.23 1127.6121 11 -9.8 564.8078 2 60.60 4 31964 VEV_1_3_RA4_01_1235.d 1.58E6 6 6 445 455
R.YDPTVTPIANPSEAK(+14.02).H Y 82.19 1615.8093 15 -10.7 808.9033 2 67.72 5 37340 VEV_2_3_RA5_01_1236.d 8.26E5 6 6 79 93 Methylation(KR)
R.DGE(+14.02)GMLGFDAAATDTSTAATPK.G Y 81.16 2139.9629 22 -5.4 1070.9829 2 79.17 5 45500 VEV_2_3_RA5_01_1236.d 1.07E5 2 2 566 587 Methylation(others)
R.RDTNPC(+57.02)GEYSIGFLETK(+14.02).A Y 79.91 1999.9309 17 -15.4 667.6406 3 75.46 5 42923 VEV_2_3_RA5_01_1236.d 4.09E4 2 2 139 155 Carbamidomethylation; Methylation(KR)
K.GGLKAPDTTN(+.98)GGK.W Y 77.24 1215.6095 13 -11.7 608.8049 2 23.63 5 9698 VEV_2_3_RA5_01_1236.d 2.1E5 6 6 588 600 Deamidation (NQ)
R.NNQGYTVVDISIPLLPEGQKAHALTILAEIESHLSLDQISK.L Y 74.21 4454.3696 41 -16.8 891.8663 5 93.94 6 53184 VEV_3_3_RA6_01_1237.d 1.36E5 1 1 398 438
R.IM(+15.99)AAPDPSSMTSSSFPDPLTTIPSSQSLSSRPK.V Y 74.16 3435.6538 33 -1.6 1146.2234 3 81.26 4 47985 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 337 369 Oxidation (M)
K.GGLKAPDTTNGGK.W Y 73.21 1214.6255 13 -5.1 608.3169 2 21.26 4 8082 VEV_1_3_RA4_01_1235.d 3.41E5 5 5 588 600
K.KWEEAGAVVIGK.T Y 72.19 1285.7030 12 -18.1 429.5672 3 61.97 6 31880 VEV_3_3_RA6_01_1237.d 7.23E5 3 3 218 229
K.ILKGNADLAR.G Y 68.70 1069.6244 10 -14.1 535.8120 2 34.18 6 15186 VEV_3_3_RA6_01_1237.d 2.34E6 10 10 497 506
R.YDPTVTPIAN(+.98)PSEAK.H Y 68.17 1602.7777 15 3.4 802.3989 2 65.59 5 35737 VEV_2_3_RA5_01_1236.d 1.02E5 2 2 79 93 Deamidation (NQ)
R.IIM(+15.99)AVGGNPTR.A Y 67.89 1143.6071 11 -11.1 572.8044 2 45.74 5 22577 VEV_2_3_RA5_01_1236.d 1.7E6 21 21 445 455 Oxidation (M)
K.TSMHE(+14.02)LGLDTTNNNPNVGTPR.N Y 67.87 2281.0757 21 -7.5 761.3601 3 67.64 4 37356 VEV_1_3_RA4_01_1235.d 1.37E5 3 3 230 250 Methylation(others)
R.RDTN(+.98)PC(+57.02)GEYSIGFLETKADIAR.A Y 67.86 2513.1855 22 -2.5 629.3021 4 75.30 5 42807 VEV_2_3_RA5_01_1236.d 5.32E3 1 1 139 160 Deamidation (NQ); Carbamidomethylation
R.FYNYPIPR.K Y 67.22 1068.5392 8 -9.7 535.2717 2 69.07 4 38496 VEV_1_3_RA4_01_1235.d 2.22E6 8 8 11 18
R.RDGLGYYTSADYHALYLSGELTPTAVVEALLPLIRR.D Y 66.54 3993.0999 36 -33.8 999.2485 4 94.03 5 53809 VEV_2_3_RA5_01_1236.d 0 1 1 104 139
R.ARDFLAAQKLR.N Y 65.87 1287.7411 11 -16.4 430.2473 3 51.49 5 26071 VEV_2_3_RA5_01_1236.d 1.28E5 3 3 456 466
R.RFYNYPIPR.K Y 64.58 1224.6404 9 -9.7 409.2168 3 63.85 5 34425 VEV_2_3_RA5_01_1236.d 3.49E5 2 2 10 18
K.HSSLPSPSQR.R Y 63.78 1094.5469 10 -10.5 548.2750 2 22.73 5 9204 VEV_2_3_RA5_01_1236.d 5.61E5 6 6 94 103
R.GVSDVDSSTR.S Y 62.33 1021.4676 10 -12.8 511.7346 2 21.02 5 8299 VEV_2_3_RA5_01_1236.d 5.4E5 7 7 507 516
R.NVPGLNDYQPRYDPTVTPIANPSEAK.H Y 61.77 2855.4089 26 -10.8 952.8000 3 76.42 5 43602 VEV_2_3_RA5_01_1236.d 3.73E4 1 1 68 93
R.VSGHPTVGIASTTGVIGPMASNLDD(+14.02)LALSYR.I Y 60.58 3112.5862 31 -8.3 1038.5273 3 85.93 5 49696 VEV_2_3_RA5_01_1236.d 1.6E5 1 1 306 336 Methylation(others)
K.TSMHELGLDTTNNN(+.98)PNVGTPR.N Y 59.20 2268.0442 21 -16.2 757.0098 3 66.27 4 36267 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 230 250 Deamidation (NQ)
K.GGLKAPDTTN(+.98)GGKWVDVIGKVR.D Y 58.71 2268.2227 22 -27.5 568.0474 4 73.56 5 41569 VEV_2_3_RA5_01_1236.d 0 1 1 588 609 Deamidation (NQ)
R.YDPTVTPIANPSEAKHSSLPSPSQRR.D Y 58.28 2834.4312 26 0.6 709.6155 4 62.01 5 33045 VEV_2_3_RA5_01_1236.d 7.95E4 1 1 79 104
R.AAAAASTERYK.N Y 58.01 1137.5778 11 -14.3 569.7880 2 13.94 6 4401 VEV_3_3_RA6_01_1237.d 1.08E5 3 3 161 171
R.RDTNPC(+57.02)GE(+14.02)YSIGFLETK.A Y 57.86 1999.9309 17 -33.9 667.6283 3 75.15 5 42705 VEV_2_3_RA5_01_1236.d 0 1 1 139 155 Carbamidomethylation; Methylation(others)
R.DTNPC(+57.02)GE(+14.02)YSIGFLETK.A Y 57.29 1843.8298 16 -13.9 922.9094 2 80.82 6 45735 VEV_3_3_RA6_01_1237.d 8.1E4 2 2 140 155 Carbamidomethylation; Methylation(others)
R.IAGFDVVR.N Y 57.11 875.4865 8 -12.2 438.7452 2 67.51 4 37277 VEV_1_3_RA4_01_1235.d 1.2E6 4 4 60 67
R.NVPGLN(+.98)DYQPR.Y Y 54.87 1272.6099 11 1.0 637.3129 2 63.51 6 33007 VEV_3_3_RA6_01_1237.d 2.76E5 4 4 68 78 Deamidation (NQ)
R.DTNPC(+57.02)GEYSIGFLETK(+14.02).A Y 54.12 1843.8298 16 1.6 922.9237 2 81.19 4 47936 VEV_1_3_RA4_01_1235.d 9.84E4 3 3 140 155 Carbamidomethylation; Methylation(KR)
K.LDFTGAENR.T Y 53.18 1021.4828 9 -23.1 511.7369 2 53.39 5 27240 VEV_2_3_RA5_01_1236.d 1.49E6 6 6 203 211
R.TLGSKLDFTGAENR(+14.02).T Y 50.88 1521.7787 14 -7.6 508.2630 3 65.71 4 35833 VEV_1_3_RA4_01_1235.d 3.61E5 3 3 198 211 Methylation(KR)
R.NVPGLNDYQPR(+14.02).Y Y 50.13 1285.6415 11 -11.4 643.8207 2 66.39 4 36408 VEV_1_3_RA4_01_1235.d 3.44E5 3 3 68 78 Methylation(KR)
K.GGLKAPDTTNGGKWVDVIGKVR.D Y 48.56 2267.2385 22 -21.2 567.8049 4 70.42 5 39299 VEV_2_3_RA5_01_1236.d 2.86E4 1 1 588 609
K.WVDVIGK.V Y 48.30 815.4541 7 -13.1 408.7290 2 64.88 4 35178 VEV_1_3_RA4_01_1235.d 8.92E5 3 3 601 607
R.VSGHPTVGIASTTGVIGPMASN(+.98)LDDLALSYR.I Y 48.19 3099.5547 31 15.7 1034.2084 3 86.45 5 49994 VEV_2_3_RA5_01_1236.d 0 1 1 306 336 Deamidation (NQ)
R.VSGHPTVGIASTTGVIGPMASN(+15.00)LDDLALSYR.I Y 47.24 3113.5703 31 -7.1 1038.8567 3 81.31 5 46904 VEV_2_3_RA5_01_1236.d 0 1 1 306 336 Deamidation followed by a methylation
K.AHALTILAEIE(+14.02)SHLSLDQISK.L Y 46.50 2302.2532 21 -0.9 576.5701 4 90.87 4 54149 VEV_1_3_RA4_01_1235.d 7.11E4 1 1 418 438 Methylation(others)
R.NVPGLNDYQ(+.98)PR.Y Y 46.27 1272.6099 11 -11.8 637.3047 2 65.64 6 34599 VEV_3_3_RA6_01_1237.d 5.81E5 4 4 68 78 Deamidation (NQ)
K.HSSLPSPSQ(+.98)R.R Y 46.04 1095.5309 10 -16.2 548.7639 2 25.39 5 10704 VEV_2_3_RA5_01_1236.d 5.68E4 1 1 94 103 Deamidation (NQ)
K.AHALTILAE(+14.02)IESHLSLDQISK.L Y 42.80 2302.2532 21 -28.4 576.5542 4 88.22 5 50963 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 418 438 Methylation(others)
R.GRVLEIAASVLPYFGFIQSALWRIAGFDVVR.N Y 41.12 3449.8975 31 -11.6 863.4716 4 97.85 4 57496 VEV_1_3_RA4_01_1235.d 2.56E4 1 1 37 67
R.D(+71.04)GEGMLGFDAAATDTSTAATPK.G Y 38.31 2196.9844 22 -3.4 733.3329 3 67.84 4 37515 VEV_1_3_RA4_01_1235.d 4.79E4 1 1 566 587 Propionamide (K, X@N-term)
K.T(+13.03)SMHELGLDTTNNNPNVGTPR.N Y 37.19 2280.0918 21 9.3 761.0449 3 60.44 5 31875 VEV_2_3_RA5_01_1236.d 0 1 1 230 250 Michael addition with methylamine
R.R(+14.02)D(-18.01)TNPC(+57.02)GEYSIGFLETKADIAR.A Y 36.92 2508.2065 22 61.1 628.0972 4 75.32 4 43375 VEV_1_3_RA4_01_1235.d 0 1 1 139 160 Methylation(KR); Dehydration; Carbamidomethylation
R.KGPNVPFNYLPSSNPLIR(+14.02).G Y 36.35 2026.1000 18 -21.6 676.3593 3 80.08 5 46111 VEV_2_3_RA5_01_1236.d 7.62E4 1 1 19 36 Methylation(KR)
K.TSMHELGLDTTNNNPNVGTPR(-.98).N Y 34.77 2266.0759 21 -17.0 756.3531 3 66.03 5 36056 VEV_2_3_RA5_01_1236.d 0 1 1 230 250 Amidation
K.AHALTILAEIESHLSLDQISK(-.98).L Y 34.40 2287.2537 21 -19.7 572.8094 4 87.43 6 49905 VEV_3_3_RA6_01_1237.d 0 1 1 418 438 Amidation
K.HSSLPSPSQ(+.98)RR.D Y 33.89 1251.6320 11 -14.1 626.8145 2 19.93 5 7686 VEV_2_3_RA5_01_1236.d 3.33E4 1 1 94 104 Deamidation (NQ)
R.GVSDVDSSTR(+14.02).S Y 33.33 1035.4833 10 -12.3 518.7426 2 32.14 5 14500 VEV_2_3_RA5_01_1236.d 4.22E5 3 3 507 516 Methylation(KR)
R.TLGS(-18.01)K(+14.02)LDFTGAENR.T Y 33.20 1503.7681 14 -8.8 502.2589 3 64.11 4 34596 VEV_1_3_RA4_01_1235.d 3.51E5 1 1 198 211 Dehydration; Methylation(KR)
R.IIMAVGGN(+.98)PTR.A Y 32.69 1128.5961 11 -32.0 565.2872 2 63.04 4 33794 VEV_1_3_RA4_01_1235.d 6.01E4 2 2 445 455 Deamidation (NQ)
R.IPAS(-2.02)FC(+57.02)GIYGLKPSHGR.V Y 31.66 1856.9355 17 -9.1 465.2369 4 68.10 6 36469 VEV_3_3_RA6_01_1237.d 0 1 1 289 305 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.FYNYPIPR(+14.02).K Y 31.49 1082.5549 8 -28.7 542.2692 2 72.35 6 39622 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 11 18 Methylation(KR)
K.APDTTNGGKWVDVIGK.V Y 30.05 1656.8470 16 -1.2 553.2889 3 67.34 4 37120 VEV_1_3_RA4_01_1235.d 0 1 1 592 607
R.YDPTVTPIANPS(+164.06)EAK.H Y 29.29 1765.8539 15 -2.1 883.9324 2 64.15 5 34638 VEV_2_3_RA5_01_1236.d 8.31E4 1 1 79 93 O-Diisopropylphosphorylation
R.VSGHPTVGIASTTGVIGPMASNLDDLALSYR(-.98).I Y 29.15 3097.5867 31 -21.1 1033.5144 3 85.11 4 50661 VEV_1_3_RA4_01_1235.d 0 1 1 306 336 Amidation
R.Y(-2.02)DPTVTPIANPSEAK.H Y 28.69 1599.7780 15 2.8 534.2681 3 65.82 4 35926 VEV_1_3_RA4_01_1235.d 2.29E4 1 1 79 93 2-amino-3-oxo-butanoic_acid
R.TAWC(+57.02)VKKWEEAGAVVIGK.T Y 27.32 2031.0612 18 -3.1 508.7710 4 76.50 5 43664 VEV_2_3_RA5_01_1236.d 1.33E5 1 1 212 229 Carbamidomethylation
R.IIM(+15.99)AVGGN(+.98)PTR.A Y 27.26 1144.5911 11 -3.5 573.3008 2 45.74 4 22266 VEV_1_3_RA4_01_1235.d 0 1 1 445 455 Oxidation (M); Deamidation (NQ)
R.ARDFLAAQK.L Y 26.94 1018.5559 9 -19.5 340.5193 3 33.14 6 14602 VEV_3_3_RA6_01_1237.d 1.51E5 1 1 456 464
K.I(+43.01)LKGNADLAR.G Y 26.15 1112.6301 10 -79.7 371.8544 3 34.41 5 15826 VEV_2_3_RA5_01_1236.d 8.72E4 1 1 497 506 Carbamylation
K.LTPANR(+21.98).I Y 25.84 692.3582 6 14.9 347.1915 2 43.16 4 20635 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 439 444 Sodium adduct
K.GGLKAPDTTN(+.98)GGKWVDVIGK(+14.02).V Y 25.54 2027.0687 20 -5.9 507.7715 4 74.09 5 41948 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 588 607 Deamidation (NQ); Methylation(KR)
R.IIM(-48.00)AVGGNPTR.A Y 25.29 1079.6088 11 -11.0 360.8729 3 32.61 4 14349 VEV_1_3_RA4_01_1235.d 5.11E5 2 2 445 455 Dethiomethyl
R.YDPTVTPIANPSEAK(+28.03).H Y 24.73 1629.8250 15 -13.3 815.9089 2 70.01 5 38997 VEV_2_3_RA5_01_1236.d 1.62E4 1 1 79 93 Dimethylation(KR)
K.ADIARAAAAASTER.Y Y 23.31 1372.7058 14 -9.3 344.1805 4 11.33 5 3126 VEV_2_3_RA5_01_1236.d 0 1 1 156 169
R.N(+.98)VPGLNDYQPR.Y Y 22.89 1272.6099 11 -8.1 637.3071 2 67.07 5 36821 VEV_2_3_RA5_01_1236.d 1.86E5 2 2 68 78 Deamidation (NQ)
K.A(+43.01)PDTTNGGK.W Y 22.79 902.4094 9 -4.0 452.2101 2 11.49 6 3150 VEV_3_3_RA6_01_1237.d 0 1 1 592 600 Carbamylation
R.TAWC(+57.02)VK.K Y 22.56 763.3687 6 -16.3 382.6854 2 36.17 6 16330 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 212 217 Carbamidomethylation
K.ADIAR(+37.96).A N 22.54 582.2527 5 6.0 583.2635 1 29.93 6 12831 VEV_3_3_RA6_01_1237.d 2.03E4 1 1 156 160 Replacement of proton by potassium
R.TLGSK(+226.08).L Y 22.42 730.3683 5 -23.5 731.3585 1 79.10 6 44519 VEV_3_3_RA6_01_1237.d 2.5E4 2 2 198 202 Biotinylation
K.ADIAR.A N 22.19 544.2969 5 -15.4 545.2958 1 82.77 4 49068 VEV_1_3_RA4_01_1235.d 2.81E4 2 2 156 160
K.HSSLPS(-18.01)PSQR.R Y 21.86 1076.5363 10 14.6 359.8579 3 11.73 4 3182 VEV_1_3_RA4_01_1235.d 1.77E4 1 1 94 103 Dehydration
K.I(+41.03)LKGNADLAR.G Y 21.78 1110.6509 10 -88.1 371.1916 3 34.37 5 15801 VEV_2_3_RA5_01_1236.d 3.74E4 1 1 497 506 Amidination of lysines or N-terminal amines with methyl acetimidate
K.GGLKAPDTT(-2.02)NGGKWVDVIGKVR.D Y 21.58 2265.2229 22 -38.6 567.2911 4 73.57 5 41577 VEV_2_3_RA5_01_1236.d 5.27E4 1 1 588 609 2-amino-3-oxo-butanoic_acid
K.KWEEAGAVVIGK(-1.03).T Y 21.50 1284.6714 12 -19.2 429.2228 3 61.93 6 31852 VEV_3_3_RA6_01_1237.d 6.43E4 1 1 218 229 Lysine oxidation to aminoadipic semialdehyde
K.G(+42.01)GLK(+42.01)APDTTNGGK.W Y 21.25 1298.6466 13 -34.7 433.8745 3 47.14 5 23436 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 588 600 Acetylation (N-term); Acetylation (K)
R.IIMAVGGNPTRAR.D Y 21.16 1354.7504 13 12.8 339.6992 4 62.88 6 32547 VEV_3_3_RA6_01_1237.d 3.66E4 1 1 445 457
R.D(+42.01)FLAAQK.L Y 21.07 833.4283 7 -10.0 417.7173 2 15.62 4 5110 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 458 464 Acetylation (N-term)
K.G(+71.04)NADLAR.G Y 20.71 786.3984 7 -22.7 787.3878 1 79.39 6 44725 VEV_3_3_RA6_01_1237.d 0 1 1 500 506 Propionamide (K, X@N-term)
R.I(+226.08)IMAVGGNPTR.A Y 20.39 1353.6897 11 -0.9 452.2368 3 63.17 6 32757 VEV_3_3_RA6_01_1237.d 0 1 1 445 455 Biotinylation
R.TLGSK(-1.03)LDFTGAENR.T Y 20.26 1506.7314 14 -1.4 503.2504 3 64.34 4 34769 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 198 211 Lysine oxidation to aminoadipic semialdehyde
R.IAGFD(+43.99)VVR.N Y 19.98 919.4763 8 -31.8 307.4896 3 35.11 6 15719 VEV_3_3_RA6_01_1237.d 7.53E4 1 1 60 67 Carboxylation (DKW)
R.NNQGYTVVDISIPLLPEGQ(+.98)K.A Y 19.77 2185.1267 20 -11.1 729.3748 3 85.80 6 48961 VEV_3_3_RA6_01_1237.d 8.57E4 1 1 398 417 Deamidation (NQ)
R.IAGFDVVR(+14.02).N Y 19.53 889.5021 8 -18.1 445.7503 2 71.58 5 40158 VEV_2_3_RA5_01_1236.d 2.23E5 3 3 60 67 Methylation(KR)
K.VIGVFPDW(+3.99)VNRADPAVLALFNK.A Y 19.40 2444.3215 22 8.8 815.7883 3 90.48 6 51565 VEV_3_3_RA6_01_1237.d 0 1 1 370 391 Tryptophan oxidation to kynurenin
R.TLGSK(+31.99).L Y 19.34 536.2806 5 -29.3 537.2722 1 34.13 5 15650 VEV_2_3_RA5_01_1236.d 4.98E5 4 4 198 202 Dihydroxy
K.HSSLPSPSQR(+31.99).R Y 18.93 1126.5366 10 -5.2 564.2726 2 44.53 5 21842 VEV_2_3_RA5_01_1236.d 5.79E5 1 1 94 103 Dihydroxy
K.LTPANR(+14.02).I Y 18.77 684.3918 6 -27.1 343.1939 2 60.72 4 32025 VEV_1_3_RA4_01_1235.d 1.43E5 1 1 439 444 Methylation(KR)
K.I(+175.04)LKGNADLAR.G Y 18.30 1244.6665 10 -19.3 415.8881 3 61.06 5 32340 VEV_2_3_RA5_01_1236.d 0 1 1 497 506 Naphthalene-2,3-dicarboxaldehyde
K.APDTTN(+.98)GGK(+14.02)WVDVIGK.V Y 18.13 1671.8468 16 -1.4 558.2888 3 71.98 5 40446 VEV_2_3_RA5_01_1236.d 1.55E5 1 1 592 607 Deamidation (NQ); Methylation(KR)
K.A(+42.01)DIAR.A N 17.72 586.3074 5 -25.8 587.2996 1 68.07 5 37587 VEV_2_3_RA5_01_1236.d 1.64E5 1 1 156 160 Acetylation (N-term)
R.TLGSKLDFTGAENRTAWC(+57.02)VK(+21.98).K Y 17.69 2275.1030 20 17.6 759.3883 3 81.57 5 47077 VEV_2_3_RA5_01_1236.d 3.03E4 1 1 198 217 Carbamidomethylation; Sodium adduct
R.I(+42.01)IM(+15.99)AVGGNPTR.A Y 17.42 1185.6176 11 -27.9 396.2021 3 26.11 5 11104 VEV_2_3_RA5_01_1236.d 9.22E4 1 1 445 455 Acetylation (N-term); Oxidation (M)
R.TLGSK(+97.02).L Y 17.24 601.3071 5 -16.4 602.3046 1 78.54 6 44148 VEV_3_3_RA6_01_1237.d 1.13E3 1 1 198 202 Maleimide
R.I(+43.01)IMAVGGNPTR.A Y 17.05 1170.6179 11 -2.0 586.3151 2 79.28 5 45577 VEV_2_3_RA5_01_1236.d 0 1 1 445 455 Carbamylation
K.N(+.98)GNPLGPLDGVPVAVK(+27.99)DEVDIEGYKR.T Y 16.21 2779.4028 26 2.1 695.8594 4 77.44 6 43326 VEV_3_3_RA6_01_1237.d 8.47E4 1 1 172 197 Deamidation (NQ); Formylation
K.V(+27.99)RDSGV Y 16.08 659.3239 6 3.7 660.3336 1 68.94 5 38232 VEV_2_3_RA5_01_1236.d 0 1 1 608 613 Formylation
R.TLGSKLDFTGAENR(-.98).T Y 15.87 1506.7791 14 -13.8 377.6968 4 42.44 6 19923 VEV_3_3_RA6_01_1237.d 2.88E5 1 1 198 211 Amidation
K.DEVDIEGYK.R Y 15.68 1066.4818 9 1.6 534.2490 2 28.97 4 12284 VEV_1_3_RA4_01_1235.d 1.17E6 1 1 188 196
M(+15.99)TGASETHR.R Y 15.45 1004.4346 9 8.1 503.2286 2 14.10 6 4480 VEV_3_3_RA6_01_1237.d 6.59E4 1 1 1 9 Oxidation (M)
K.A(+42.01)PDTTNGGK(+14.02).W Y 15.29 915.4297 9 6.4 916.4429 1 88.68 5 51212 VEV_2_3_RA5_01_1236.d 0 1 1 592 600 Acetylation (N-term); Methylation(KR)
K.GGLKAPDTTNGGK(+42.01).W Y 15.28 1256.6360 13 -4.9 419.8839 3 36.09 5 16823 VEV_2_3_RA5_01_1236.d 1.67E5 1 1 588 600 Acetylation (K)
R.T(+42.01)LGSK(+31.99).L Y 15.27 578.2911 5 -54.5 579.2669 1 51.78 6 25346 VEV_3_3_RA6_01_1237.d 3.43E4 1 1 198 202 Acetylation (N-term); Dihydroxy
K.HSSLPS(+79.97)PSQRR.D Y 15.26 1330.6143 11 37.4 333.6733 4 27.28 4 11343 VEV_1_3_RA4_01_1235.d 4.39E5 1 1 94 104 Phosphorylation (STY)
R.ADPAVLALFN(+.98)K.A Y 15.26 1158.6284 11 -29.8 580.3042 2 81.57 6 46257 VEV_3_3_RA6_01_1237.d 3.48E4 1 1 381 391 Deamidation (NQ)
K.GGLK(+42.01)APDTTN(+.98)GGK.W Y 15.01 1257.6201 13 13.6 420.2197 3 24.12 4 9628 VEV_1_3_RA4_01_1235.d 0 1 1 588 600 Acetylation (K); Deamidation (NQ)
R.AAAAASTE(+43.99)R.Y Y 15.01 890.4094 9 26.2 446.2236 2 20.81 5 8183 VEV_2_3_RA5_01_1236.d 9.14E4 1 1 161 169 Carboxylation (E)
total 146 peptides
C1GLI2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SINPDEAVAYGAAVQAAILSGDTTSK.S Y 163.88 2548.2656 26 -12.6 850.4185 3 87.65 6 50047 VEV_3_3_RA6_01_1237.d 2.17E6 9 9 360 385
K.STAGDTHLGGEDFDNR.L Y 155.41 1690.7183 16 -10.8 846.3572 2 49.52 6 24090 VEV_3_3_RA6_01_1237.d 3.51E6 12 12 219 234
R.IINEPTAAAIAYGLDKKAEGER.N Y 152.66 2329.2278 22 -15.8 583.3050 4 73.84 6 40700 VEV_3_3_RA6_01_1237.d 1.18E6 7 7 170 191
K.STNEILLLDVAPLSVGIETAGGVMTPLIKR.N Y 149.82 3106.7312 30 -7.5 1036.5765 3 93.48 5 53573 VEV_2_3_RA5_01_1236.d 4.71E5 5 5 386 415
K.FYGAGGEGGAPGAGFPGAGGPGGFPGAGASGAHSGGDDGPTVEEVD Y 145.60 3973.7051 46 -10.3 1325.5620 3 80.50 6 45530 VEV_3_3_RA6_01_1237.d 7.57E5 4 4 609 654
K.MRETAESYLGGTVNNAVVTVPAYFNDSQR.Q Y 129.44 3188.5195 29 -12.8 1063.8335 3 81.32 6 46100 VEV_3_3_RA6_01_1237.d 5.43E5 3 3 125 153
K.SETFSTFADNQPGVLIQVFEGER.A Y 129.24 2570.2288 23 -11.1 857.7407 3 89.10 6 50845 VEV_3_3_RA6_01_1237.d 3.28E5 4 4 424 446
R.TLSSAAQTSIEIDSLYEGIDFYTSITR.A Y 128.58 2980.4553 27 -4.9 1491.2277 2 93.44 5 53547 VEV_2_3_RA5_01_1236.d 1.04E6 15 15 271 297
K.IDKSSVHEIVLVGGSTR.I Y 123.24 1795.9791 17 -13.4 599.6589 3 63.47 6 32976 VEV_3_3_RA6_01_1237.d 2.34E5 3 3 324 340
R.IINEPTAAAIAYGLDKK.A Y 123.04 1786.9828 17 -16.8 596.6582 3 73.87 6 40721 VEV_3_3_RA6_01_1237.d 2.52E6 9 9 170 186
K.LVSDFFN(+.98)GKEPNKSINPDEAVAYGAAVQAAILSGDTTSK.S Y 120.77 4024.9905 39 -11.4 1007.2434 4 87.50 6 49942 VEV_3_3_RA6_01_1237.d 3.22E5 1 1 347 385 Deamidation (NQ)
K.NQVAMNPSNTVFDAKR.L Y 120.01 1790.8733 16 -8.4 597.9600 3 62.40 5 33336 VEV_2_3_RA5_01_1236.d 8.69E5 4 4 55 70
K.KSETFSTFADNQPGVLIQVFEGER.A Y 118.45 2698.3237 24 -9.4 900.4401 3 85.12 6 48536 VEV_3_3_RA6_01_1237.d 5.35E5 3 3 423 446
R.TTPSFVAFTDTER.L Y 118.06 1470.6991 13 -14.2 736.3464 2 74.15 6 40973 VEV_3_3_RA6_01_1237.d 2.1E6 8 8 35 47
K.STNEILLLDVAPLSVGIETAGGVMTPLIK.R Y 115.43 2950.6299 29 -11.6 1476.3051 2 97.18 4 57203 VEV_1_3_RA4_01_1235.d 4.87E4 2 2 386 414
R.IINEPTAAAIAYGLDK.K Y 113.24 1658.8879 16 -13.0 830.4404 2 78.23 6 43914 VEV_3_3_RA6_01_1237.d 1.19E6 5 5 170 185
K.LVSDFFNGKEPNKSINPDEAVAYGAAVQAAILSGDTTSK.S Y 110.64 4024.0063 39 -8.9 1342.3308 3 86.59 6 49423 VEV_3_3_RA6_01_1237.d 7.49E4 1 1 347 385
K.M(+15.99)RETAESYLGGTVNNAVVTVPAYFNDSQR.Q Y 110.63 3204.5146 29 -5.9 1069.1725 3 80.88 5 46629 VEV_2_3_RA5_01_1236.d 2.26E5 3 3 125 153 Oxidation (M)
K.SSVHEIVLVGGSTRIPR.I Y 109.41 1806.0111 17 -16.2 452.5027 4 65.71 6 34653 VEV_3_3_RA6_01_1237.d 3.45E5 4 4 327 343
R.TTPSFVAFTDTERLIGDAAK.N Y 107.32 2139.0847 20 -11.5 714.0273 3 82.54 5 47673 VEV_2_3_RA5_01_1236.d 5.97E5 5 5 35 54
K.IDKSSVHEIVLVGGSTRIPR.I Y 103.45 2162.2170 20 -3.9 541.5594 4 67.54 6 36040 VEV_3_3_RA6_01_1237.d 5.14E5 3 3 324 343
R.ARFEELC(+57.02)QDLFR.S Y 103.38 1582.7561 12 -16.0 528.5842 3 77.37 6 43333 VEV_3_3_RA6_01_1237.d 2.3E6 9 9 298 309 Carbamidomethylation
K.SETFSTFADNQPGVLIQVFEGERAR.T Y 102.64 2797.3669 25 0.6 933.4634 3 85.77 5 49648 VEV_2_3_RA5_01_1236.d 3.64E5 3 3 424 448
K.NQVAM(+15.99)NPSNTVFDAKR.L Y 102.04 1806.8683 16 -13.9 603.2883 3 53.76 6 26508 VEV_3_3_RA6_01_1237.d 3.07E5 3 3 55 70 Oxidation (M)
K.SSVHEIVLVGGSTR.I Y 100.95 1439.7732 14 -10.8 720.8861 2 60.24 6 30615 VEV_3_3_RA6_01_1237.d 7.1E5 7 7 327 340
K.SINPDEAVAYGAAVQ(+.98)AAILSGDTTSK.S Y 100.79 2549.2495 26 -5.9 850.7521 3 87.73 6 50072 VEV_3_3_RA6_01_1237.d 4.41E5 5 5 360 385 Deamidation (NQ)
R.LVNHFVNEFKR.K Y 96.28 1401.7517 11 -26.3 468.2456 3 60.42 6 30769 VEV_3_3_RA6_01_1237.d 1.39E6 5 5 235 245
R.ETAESYLGGTVNNAVVTVPAYFNDSQR.Q Y 95.22 2901.3779 27 -9.8 968.1238 3 84.09 6 47893 VEV_3_3_RA6_01_1237.d 7.42E4 1 1 127 153
R.LVNHFVNEFK.R Y 94.45 1245.6506 10 -13.1 623.8245 2 64.10 6 33440 VEV_3_3_RA6_01_1237.d 9.34E5 3 3 235 244
K.FADPEVQSDMK.H Y 94.32 1265.5598 11 -7.3 633.7826 2 58.88 4 30651 VEV_1_3_RA4_01_1235.d 6.77E4 1 1 76 86
R.Q(-17.03)ATKDAGLIAGLNVLR.I Y 93.13 1621.9152 16 -14.2 811.9534 2 81.90 6 46497 VEV_3_3_RA6_01_1237.d 1.4E6 7 7 154 169 Pyro-glu from Q
K.NQVAMNPSNTVFDAK.R Y 92.97 1634.7722 15 -8.2 818.3867 2 67.40 4 37157 VEV_1_3_RA4_01_1235.d 4.89E5 3 3 55 69
K.DNNLLGKFELTGIPPAPR.G N 92.55 1951.0526 18 -15.0 651.3484 3 82.62 4 48975 VEV_1_3_RA4_01_1235.d 4.19E5 8 8 451 468
R.FEELC(+57.02)QDLFR.S Y 91.30 1355.6179 10 -14.2 678.8066 2 78.23 6 43895 VEV_3_3_RA6_01_1237.d 2.28E5 3 3 300 309 Carbamidomethylation
K.SINPD(+14.02)EAVAYGAAVQAAILSGDTTSK.S Y 90.52 2562.2812 26 -6.4 1282.1396 2 89.24 6 50920 VEV_3_3_RA6_01_1237.d 2.39E5 2 2 360 385 Methylation(others)
R.QATKDAGLIAGLNVLR.I Y 89.10 1638.9417 16 -11.7 547.3148 3 76.18 5 43431 VEV_2_3_RA5_01_1236.d 7.8E5 5 5 154 169
K.DAGLIAGLNVLR.I Y 89.04 1210.7034 12 -15.6 606.3495 2 82.97 6 47189 VEV_3_3_RA6_01_1237.d 1.91E6 8 8 158 169
R.TKDNNLLGKFELTGIPPAPR.G Y 89.00 2180.1953 20 -12.2 546.0494 4 77.81 5 44608 VEV_2_3_RA5_01_1236.d 1.32E6 6 6 449 468
K.SINPDEAVAYGAAVQAAILSGDTTSK(+14.02).S Y 85.90 2562.2812 26 -5.8 1282.1405 2 88.03 4 52521 VEV_1_3_RA4_01_1235.d 2.29E5 4 4 360 385 Methylation(KR)
R.MLAEAEKYKAEDEAEASR.I Y 85.40 2039.9469 18 -17.7 510.9850 4 54.80 6 27117 VEV_3_3_RA6_01_1237.d 2.58E5 4 4 517 534
K.STAGDTHLGGEDFDNRLVNHFVNEFK.R Y 83.19 2918.3584 26 -5.0 584.6760 5 79.41 4 46561 VEV_1_3_RA4_01_1235.d 1.36E6 4 4 219 244
K.NQVAM(+15.99)NPSNTVFDAK.R Y 78.67 1650.7672 15 -8.7 826.3837 2 60.30 5 31770 VEV_2_3_RA5_01_1236.d 2.82E5 3 3 55 69 Oxidation (M)
K.SINPDE(+14.02)AVAYGAAVQAAILSGDTTSK.S Y 76.81 2562.2812 26 -1.9 1282.1455 2 88.70 4 52936 VEV_1_3_RA4_01_1235.d 3.22E4 2 2 360 385 Methylation(others)
K.STAGDTHLGGEDFDNRLVNHFVNEFKR.K Y 75.97 3074.4595 27 -33.1 615.8788 5 77.76 6 43557 VEV_3_3_RA6_01_1237.d 0 1 1 219 245
K.LVSDFFNGKEPNK.S Y 75.52 1493.7513 13 -9.3 498.9197 3 65.10 6 34192 VEV_3_3_RA6_01_1237.d 1.15E6 4 4 347 359
K.KSETFSTFADNQPGVLIQVFEGERAR.T Y 74.23 2925.4619 26 -8.9 732.3662 4 82.66 5 47746 VEV_2_3_RA5_01_1236.d 1.16E5 2 2 423 448
R.DAKIDKSSVHEIVLVGGSTR.I Y 72.82 2110.1382 20 -24.9 423.0244 5 63.87 6 33267 VEV_3_3_RA6_01_1237.d 1.78E5 2 2 321 340
K.FYGAGGEGGAPGAGFPGAGGPGGFPGAGASGAHSGGDDGPTVEE(+14.02)VD Y 72.24 3987.7207 46 -9.7 1330.2346 3 81.65 5 47124 VEV_2_3_RA5_01_1236.d 8.62E4 1 1 609 654 Methylation(others)
R.TLSSAAQTSIE(+14.02)IDSLYEGIDFYTSITR.A Y 72.18 2994.4709 27 -10.2 1498.2275 2 96.06 6 54015 VEV_3_3_RA6_01_1237.d 4.94E5 3 3 271 297 Methylation(others)
K.NGLESYAYSLR.N Y 72.14 1271.6146 11 -15.7 636.8046 2 72.00 6 39357 VEV_3_3_RA6_01_1237.d 4.99E5 4 4 539 549
R.STMDPVER.V Y 70.26 933.4225 8 -15.9 467.7112 2 33.61 6 14849 VEV_3_3_RA6_01_1237.d 5.5E5 2 2 310 317
K.STAGDTHLGGE(+14.02)DFDNR.L Y 67.84 1704.7339 16 -11.2 569.2455 3 58.67 6 29486 VEV_3_3_RA6_01_1237.d 1.93E5 1 1 219 234 Methylation(others)
K.Q(-17.03)FTPEEISSMVLTK.M Y 67.21 1591.7804 14 -1.5 796.8962 2 90.58 4 53974 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 111 124 Pyro-glu from Q
R.IINEPTAAAIAYGLDK(+14.02).K Y 66.03 1672.9036 16 -23.1 837.4397 2 79.59 6 44863 VEV_3_3_RA6_01_1237.d 1.99E5 3 3 170 185 Methylation(KR)
R.ARFEELC(+57.02)Q(+.98)DLFR.S Y 65.48 1583.7402 12 -10.4 528.9152 3 78.22 6 43924 VEV_3_3_RA6_01_1237.d 1.1E5 5 5 298 309 Carbamidomethylation; Deamidation (NQ)
R.IINEPTAAAIAYGLDKKAEGER(+14.02).N Y 64.95 2343.2434 22 -16.6 586.8084 4 75.57 6 41962 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 170 191 Methylation(KR)
K.LVSDFFN(+.98)GKEPNK.S Y 64.37 1494.7354 13 -9.6 499.2476 3 66.27 4 36270 VEV_1_3_RA4_01_1235.d 8.82E5 6 6 347 359 Deamidation (NQ)
K.STAGDTHLGGEDFDNR(+14.02).L Y 64.06 1704.7339 16 -3.5 569.2499 3 55.97 6 27744 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 219 234 Methylation(KR)
R.IEIIANDQGNR.T Y 63.90 1241.6364 11 -13.8 621.8169 2 53.37 6 26289 VEV_3_3_RA6_01_1237.d 5.7E4 1 1 24 34
R.AR(+14.02)FEELC(+57.02)QDLFR.S Y 62.25 1596.7719 12 -6.4 533.2612 3 77.94 5 44672 VEV_2_3_RA5_01_1236.d 6.19E5 5 5 298 309 Methylation(KR); Carbamidomethylation
R.IQKLVSDFFNGKEPNK.S Y 61.25 1862.9890 16 -18.4 466.7460 4 68.15 6 36501 VEV_3_3_RA6_01_1237.d 5.87E5 2 2 344 359
R.NTISDSKVDEKLDASDKEK.L Y 60.13 2121.0437 19 -12.6 531.2615 4 39.24 6 18063 VEV_3_3_RA6_01_1237.d 4.07E5 6 6 550 568
K.TNKIVITNDKGR.L Y 60.00 1357.7677 12 -12.7 453.5908 3 20.89 5 8223 VEV_2_3_RA5_01_1236.d 1.48E5 3 3 497 508
R.IINEPTAAAIAYGLDK(+14.02)K.A Y 59.11 1800.9985 17 -15.1 601.3311 3 75.27 6 41730 VEV_3_3_RA6_01_1237.d 3.25E5 4 4 170 186 Methylation(KR)
R.NTTIPTKKSETFSTFADNQPGVLIQVFEGER.A Y 58.29 3453.7415 31 -7.6 864.4360 4 82.53 5 47669 VEV_2_3_RA5_01_1236.d 0 1 1 416 446
R.NTISDSKVDEK.L Y 58.08 1234.6041 11 -14.7 618.3003 2 17.95 6 6483 VEV_3_3_RA6_01_1237.d 9.99E4 3 3 550 560
K.N(+.98)GLESYAYSLR.N Y 56.94 1272.5986 11 -7.6 637.3018 2 78.06 6 43789 VEV_3_3_RA6_01_1237.d 3.91E5 4 4 539 549 Deamidation (NQ)
K.IVITNDKGR.L Y 56.43 1014.5822 9 -27.5 508.2844 2 20.78 6 7969 VEV_3_3_RA6_01_1237.d 3.22E5 5 5 500 508
K.DAGLIAGLNVLR(+14.02).I Y 54.56 1224.7190 12 -23.3 409.2374 3 84.79 6 48333 VEV_3_3_RA6_01_1237.d 1.93E5 4 4 158 169 Methylation(KR)
R.STM(+15.99)DPVER.V Y 54.11 949.4175 8 -14.6 475.7091 2 19.07 6 7081 VEV_3_3_RA6_01_1237.d 4.41E5 5 5 310 317 Oxidation (M)
K.STNEILLLDVAPLSVGIE(+14.02)TAGGVMTPLIKR.N Y 53.33 3120.7468 30 -6.3 1041.2496 3 94.56 5 54036 VEV_2_3_RA5_01_1236.d 9.32E4 1 1 386 415 Methylation(others)
K.AGKPVISVEFKGEEKQFTPEEISSMVLTK.M Y 53.18 3207.6736 29 -1.0 642.5414 5 79.71 6 44951 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 96 124
K.SETFSTFADN(+.98)Q(+.98)PGVLIQVFEGER.A Y 52.54 2572.1968 23 30.2 858.4321 3 89.39 4 53327 VEV_1_3_RA4_01_1235.d 0 1 1 424 446 Deamidation (NQ)
K.S(-2.02)TAGDTHLGGEDFDNRLVNHFVNEFK.R Y 52.15 2916.3425 26 26.9 584.2914 5 79.48 4 46617 VEV_1_3_RA4_01_1235.d 0 1 1 219 244 2-amino-3-oxo-butanoic_acid
K.IDKSSVHE(+14.02)IVLVGGSTRIPR.I Y 51.81 2176.2327 20 -21.7 436.2444 5 69.84 6 37728 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 324 343 Methylation(others)
R.LVNHFVNE(+14.02)FK.R Y 50.30 1259.6663 10 -22.4 420.8866 3 68.68 6 36900 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 235 244 Methylation(others)
R.LRTAC(+57.02)ER.A N 49.83 904.4549 7 -20.3 453.2255 2 11.20 6 3026 VEV_3_3_RA6_01_1237.d 2.07E5 4 4 261 267 Carbamidomethylation
R.IINE(+14.02)PTAAAIAYGLDK.K Y 48.66 1672.9036 16 -9.7 837.4509 2 81.01 5 46745 VEV_2_3_RA5_01_1236.d 4.07E4 1 1 170 185 Methylation(others)
R.NTTIPTKK.S N 48.40 901.5233 8 -13.2 451.7630 2 12.90 5 3909 VEV_2_3_RA5_01_1236.d 5.22E4 1 1 416 423
R.ARFEELC(+57.02)QDLFR(+14.02).S Y 44.59 1596.7719 12 38.8 533.2852 3 79.27 6 44637 VEV_3_3_RA6_01_1237.d 0 1 1 298 309 Carbamidomethylation; Methylation(KR)
R.STM(-48.00)DPVER.V Y 42.43 885.4192 8 -7.6 443.7135 2 11.68 4 3175 VEV_1_3_RA4_01_1235.d 6.61E5 3 3 310 317 Dethiomethyl
K.HKKDLSSNAR.A Y 42.07 1154.6156 10 -16.0 385.8730 3 9.51 6 2313 VEV_3_3_RA6_01_1237.d 6.4E4 1 1 247 256
K.SETFSTFADNQPGVLIQVFEGER(+14.02).A Y 40.96 2584.2444 23 35.8 1293.1758 2 90.75 6 51702 VEV_3_3_RA6_01_1237.d 3.93E4 5 5 424 446 Methylation(KR)
R.Q(-17.03)ATKDAGLIAGLNVLR(+14.02).I Y 40.69 1635.9308 16 -32.9 818.9457 2 83.46 6 47488 VEV_3_3_RA6_01_1237.d 0 1 1 154 169 Pyro-glu from Q; Methylation(KR)
K.STNEILLLDVAPLS(+13.03)VGIETAGGVMTPLIKR.N Y 39.50 3119.7627 30 -24.7 1040.9025 3 96.31 5 54757 VEV_2_3_RA5_01_1236.d 0 1 1 386 415 Michael addition with methylamine
R.IINEPTAAAIAY(-18.01)GLDK(+14.02)KAEGER.N Y 38.26 2325.2327 22 -13.9 582.3074 4 74.07 6 40871 VEV_3_3_RA6_01_1237.d 7.48E3 1 1 170 191 Dehydration; Methylation(KR)
R.TTPSFVAFTDTER(+14.02).L Y 37.26 1484.7147 13 -5.8 743.3604 2 75.60 6 42003 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 35 47 Methylation(KR)
R.LVNHFVNE(+14.02)FKR.K Y 37.05 1415.7673 11 -22.2 354.9413 4 64.88 6 34023 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 235 245 Methylation(others)
K.STNEILLLD(+6.01)VAPLSVGIETAGGVMTPLIKR.N Y 36.19 3112.7393 30 -43.9 1038.5415 3 93.82 4 55728 VEV_1_3_RA4_01_1235.d 4.58E3 1 1 386 415 Replacement of proton by lithium
R.IIN(+.98)EPTAAAIAYGLDKK.A Y 35.70 1787.9668 17 -19.8 596.9844 3 75.75 6 42094 VEV_3_3_RA6_01_1237.d 7.3E4 1 1 170 186 Deamidation (NQ)
R.LRT(+79.96)AC(+57.02)ER.A N 35.00 984.4117 7 94.2 329.1754 3 11.20 6 3010 VEV_3_3_RA6_01_1237.d 0 1 1 261 267 Sulfation; Carbamidomethylation
K.STAGDTHLGGEDFDNRLVNHFVN(+.98)EFK.R Y 33.62 2919.3423 26 -23.0 584.8623 5 80.14 6 45261 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 219 244 Deamidation (NQ)
K.STAGDTHLGGE(+14.02)DFDNRLVNHFVNEFK.R Y 33.33 2932.3740 26 4.3 587.4846 5 80.51 6 45567 VEV_3_3_RA6_01_1237.d 0 1 1 219 244 Methylation(others)
K.STAGDTHLGGEDFDN(+.98)R.L Y 33.10 1691.7023 16 -28.1 564.8922 3 52.73 6 25899 VEV_3_3_RA6_01_1237.d 0 1 1 219 234 Deamidation (NQ)
K.STAGD(+14.02)THLGGEDFDNRLVNHFVNEFK.R Y 33.10 2932.3740 26 -6.5 587.4783 5 82.23 6 46700 VEV_3_3_RA6_01_1237.d 8.22E4 1 1 219 244 Methylation(others)
K.DNNLLGKFELTGIPPAPR(+.98).G N 32.59 1952.0366 18 -22.1 651.6718 3 82.43 5 47606 VEV_2_3_RA5_01_1236.d 0 1 1 451 468 Deamidation (R)
R.AR(+14.02)FEELC(+57.02)QDLFR(+14.02).S Y 31.94 1610.7875 12 -4.8 537.9338 3 79.71 6 44948 VEV_3_3_RA6_01_1237.d 7.83E4 1 1 298 309 Methylation(KR); Carbamidomethylation
R.LIGDAAK.N Y 30.58 686.3962 7 -26.0 687.3857 1 21.09 6 8142 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 48 54
K.FADPEVQSDMKHFPFK.V Y 30.41 1921.9032 16 -21.6 481.4727 4 72.48 5 40815 VEV_2_3_RA5_01_1236.d 8.19E4 1 1 76 91
K.STNEILLLDVAPLS(+14.02)VGIETAGGVMTPLIKR.N Y 29.92 3120.7468 30 2.9 1041.2593 3 94.58 4 56097 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 386 415 Methylation(others)
R.IQ(+.98)KLVSDFFNGKEPNK.S Y 29.37 1863.9730 16 0.4 467.0007 4 68.32 4 37893 VEV_1_3_RA4_01_1235.d 2.19E5 1 1 344 359 Deamidation (NQ)
K.ELESVANPIMM(+15.99)K.F Y 28.74 1376.6680 12 12.3 459.9023 3 66.57 6 35308 VEV_3_3_RA6_01_1237.d 0 1 1 597 608 Oxidation (M)
K.L(+42.01)VSDFFN(+.98)GKEPNK.S Y 28.25 1536.7460 13 8.6 513.2603 3 66.07 6 34933 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 347 359 Acetylation (N-term); Deamidation (NQ)
K.N(+42.01)QVAM(+15.99)NPSNTVFDAKR.L Y 27.98 1848.8788 16 -1.9 617.2990 3 42.63 6 20027 VEV_3_3_RA6_01_1237.d 8.21E4 1 1 55 70 Acetylation (N-term); Oxidation (M)
K.QFTPEEISSMVLTK.M Y 27.92 1608.8069 14 -7.5 805.4047 2 82.02 4 48548 VEV_1_3_RA4_01_1235.d 8.56E4 1 1 111 124
K.LDASDK(+42.01).E Y 27.46 689.3232 6 -4.4 690.3274 1 26.23 5 11171 VEV_2_3_RA5_01_1236.d 3.76E4 1 1 561 566 Acetylation (K)
K.ST(-2.02)AGDTHLGGEDFDNRLVNHFVNEFK.R Y 26.67 2916.3425 26 39.9 584.2991 5 79.42 5 45672 VEV_2_3_RA5_01_1236.d 0 1 1 219 244 2-amino-3-oxo-butanoic_acid
R.TKDNNLLGK(-1.03)FELTGIPPAPR.G Y 26.40 2179.1636 20 -16.2 545.7894 4 78.36 4 45764 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 449 468 Lysine oxidation to aminoadipic semialdehyde
K.M(+43.01)R(+14.02)ETAESYLGGTVNNAVVTVPAYFNDSQR.Q Y 25.76 3245.5410 29 -5.2 812.3883 4 78.69 4 46005 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 125 153 Carbamylation; Methylation(KR)
R.LIGD(-18.01)AAK(+14.02)NQVAMNPSNTVFDAKR.L Y 25.42 2455.2642 23 -35.0 614.8018 4 68.67 6 36893 VEV_3_3_RA6_01_1237.d 0 1 1 48 70 Dehydration; Methylation(KR)
K.STAGDTHLGGEDFDNRLVNHFVNE(+14.02)FK.R Y 25.21 2932.3740 26 -2.7 587.4805 5 81.23 6 46036 VEV_3_3_RA6_01_1237.d 1.51E5 1 1 219 244 Methylation(others)
R.LRTAC(+57.02)ER(+14.02).A N 24.98 918.4705 7 -17.9 307.1586 3 15.11 6 5002 VEV_3_3_RA6_01_1237.d 3.31E5 2 2 261 267 Carbamidomethylation; Methylation(KR)
K.DNNLLGK(+226.08)FELTGIPPAPR.G N 24.58 2177.1301 18 -6.5 545.2863 4 77.62 4 45183 VEV_1_3_RA4_01_1235.d 3.24E4 1 1 451 468 Biotinylation
R.LSKEEIER.M Y 24.42 1002.5345 8 -14.3 335.1807 3 22.52 6 8886 VEV_3_3_RA6_01_1237.d 5.1E5 3 3 509 516
K.S(+14.02)INPDEAVAYGAAVQAAILSGDTTSK.S Y 24.15 2562.2812 26 14.8 855.1136 3 89.32 6 50954 VEV_3_3_RA6_01_1237.d 0 1 1 360 385 Methylation(others)
R.IINEPT(-2.02)AAAIAYGLDKKAEGER.N Y 23.94 2327.2119 22 -11.7 582.8035 4 74.43 6 41135 VEV_3_3_RA6_01_1237.d 7.58E4 1 1 170 191 2-amino-3-oxo-butanoic_acid
K.DLSS(+14.02)NAR.A Y 23.92 775.3824 7 -18.2 388.6914 2 23.60 6 9456 VEV_3_3_RA6_01_1237.d 1.95E5 1 1 250 256 Methylation(others)
K.NQVAM(+15.99)NPS(-18.01)NTVFDAKR.L Y 23.71 1788.8577 16 62.5 597.3304 3 62.67 4 33507 VEV_1_3_RA4_01_1235.d 3.33E4 2 2 55 70 Oxidation (M); Dehydration
K.I(+42.01)VITNDKGR.L Y 23.62 1056.5928 9 -54.9 353.1855 3 21.15 4 8011 VEV_1_3_RA4_01_1235.d 0 1 1 500 508 Acetylation (N-term)
R.Q(-17.03)ATKDAGLIAGLN(+.98)VLR.I Y 23.41 1622.8992 16 -54.7 812.4125 2 83.14 6 47284 VEV_3_3_RA6_01_1237.d 2.4E4 1 1 154 169 Pyro-glu from Q; Deamidation (NQ)
K.FELTGIPPAPR.G N 23.40 1196.6553 11 -22.5 300.1644 4 12.44 4 3520 VEV_1_3_RA4_01_1235.d 0 2 2 458 468
K.AEGER(-.98).N Y 23.37 559.2714 5 -14.8 560.2704 1 70.76 5 39548 VEV_2_3_RA5_01_1236.d 6.13E4 1 1 187 191 Amidation
K.AGKPVISVEFKGEEK.Q Y 23.09 1616.8773 15 -11.6 405.2219 4 56.14 4 28737 VEV_1_3_RA4_01_1235.d 3.24E5 2 2 96 110
R.L(+43.01)VN(+.98)HFVNEFK.R Y 22.82 1289.6404 10 -13.1 430.8818 3 64.26 6 33554 VEV_3_3_RA6_01_1237.d 3.2E4 1 1 235 244 Carbamylation; Deamidation (NQ)
R.Q(+.98)ATKDAGLIAGLNVLR.I Y 22.55 1639.9257 16 -64.1 547.6141 3 77.31 6 43235 VEV_3_3_RA6_01_1237.d 0 1 1 154 169 Deamidation (NQ)
R.TLSSAAQTS(+13.03)IEIDSLYEGIDFYTSITR.A Y 22.50 2993.4868 27 -22.8 1497.7166 2 96.08 5 54676 VEV_2_3_RA5_01_1236.d 3.92E3 1 1 271 297 Michael addition with methylamine
R.L(+135.98)VNHFVNEFKR.K Y 22.14 1537.7347 11 -22.1 513.5742 3 79.18 6 44578 VEV_3_3_RA6_01_1237.d 2.48E4 1 1 235 245 Sulfonation of N-terminus
R.MLAEAEK.Y Y 21.74 790.3895 7 0.4 396.2021 2 23.88 5 9839 VEV_2_3_RA5_01_1236.d 7.22E5 1 1 517 523
R.LVNH(+72.02)FVNEFKRK.H Y 21.47 1601.8678 12 -70.0 534.9258 3 76.35 6 42523 VEV_3_3_RA6_01_1237.d 0 1 1 235 246 Ethoxyformylation
K.LVSDFFN(+.98)GKEPNK(+14.02).S Y 21.47 1508.7511 13 -6.8 503.9209 3 68.55 6 36802 VEV_3_3_RA6_01_1237.d 3.93E5 1 1 347 359 Deamidation (NQ); Methylation(KR)
K.AGK(+27.99)PVISVEFKGEEK.Q Y 20.78 1644.8722 15 -28.1 549.2826 3 73.07 4 41641 VEV_1_3_RA4_01_1235.d 9.62E4 1 1 96 110 Formylation
R.NTISDSK.V Y 20.73 763.3712 7 2.4 382.6938 2 34.01 6 15082 VEV_3_3_RA6_01_1237.d 2.68E5 1 1 550 556
R.STMDPVER(+14.02).V Y 20.71 947.4382 8 -7.7 474.7227 2 42.01 4 19921 VEV_1_3_RA4_01_1235.d 1.77E5 2 2 310 317 Methylation(KR)
K.M(+42.01)R(+14.02)ETAESYLGGTVN(+.98)NAVVTVPAYFNDSQR.Q Y 19.91 3245.5298 29 -1.1 812.3888 4 78.65 5 45147 VEV_2_3_RA5_01_1236.d 1.45E5 1 1 125 153 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
K.NGLESYAYSLR(+21.98).N Y 19.75 1293.5966 11 -3.6 647.8032 2 40.09 6 18543 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 539 549 Sodium adduct
K.TEIDK(+104.03).T Y 19.57 708.3330 5 -1.5 709.3392 1 67.46 5 37116 VEV_2_3_RA5_01_1236.d 0 1 1 571 575 Benzoyl
R.FEELC(+57.02)Q(+.98)DLFR.S Y 19.55 1356.6019 10 99.7 679.3759 2 80.86 6 45766 VEV_3_3_RA6_01_1237.d 0 1 1 300 309 Carbamidomethylation; Deamidation (NQ)
K.ELESVANPIM(+15.99)MK.F Y 19.32 1376.6680 12 2.1 689.3427 2 68.62 4 38133 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 597 608 Oxidation (M)
K.QFT(-18.01)PEEISSMVLTK(+14.02).M Y 19.19 1604.8120 14 -18.8 803.3982 2 92.23 6 52410 VEV_3_3_RA6_01_1237.d 0 1 1 111 124 Dehydration; Methylation(KR)
R.VLRDAKIDK.S Y 19.14 1056.6292 9 -12.4 529.3153 2 20.65 6 7905 VEV_3_3_RA6_01_1237.d 4.98E4 1 1 318 326
K.RLIGR.K N 19.03 613.4023 5 -22.7 307.7015 2 17.13 6 6051 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 70 74
R.TTPSFVAFTDT(-18.01)ER(+14.02).L Y 19.03 1466.7041 13 -17.3 734.3466 2 74.24 6 40992 VEV_3_3_RA6_01_1237.d 0 1 1 35 47 Dehydration; Methylation(KR)
R.NTISDSKVD(-18.01)EK.L Y 18.98 1216.5935 11 30.3 305.1649 4 28.70 4 12119 VEV_1_3_RA4_01_1235.d 1.15E6 1 1 550 560 Dehydration
K.SETFSTFADNQPGVLIQVFEGER(-.98).A Y 18.66 2569.2449 23 -9.8 1285.6171 2 89.22 4 53229 VEV_1_3_RA4_01_1235.d 9.21E4 2 2 424 446 Amidation
K.STNEILLLDVAPLSVGIETAGGVMTPLIKR(-.98).N Y 18.53 3105.7471 30 -14.1 1036.2417 3 93.83 5 53726 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 386 415 Amidation
R.IINE(+14.02)PTAAAIAYGLDKKAEGER.N Y 18.50 2343.2434 22 -16.6 586.8084 4 76.89 6 42921 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 170 191 Methylation(others)
K.AEGER.N Y 18.11 560.2554 5 -17.1 561.2531 1 98.70 6 54885 VEV_3_3_RA6_01_1237.d 3.42E4 1 1 187 191
K.IDK(-1.03)SSVHEIVLVGGSTR.I Y 18.01 1794.9475 17 4.5 599.3258 3 63.42 6 32943 VEV_3_3_RA6_01_1237.d 0 1 1 324 340 Lysine oxidation to aminoadipic semialdehyde
K.KDLSSN(+.98)AR(+21.98).A Y 17.52 912.4277 8 -23.8 457.2103 2 14.76 5 4902 VEV_2_3_RA5_01_1236.d 8.76E4 1 1 249 256 Deamidation (NQ); Sodium adduct
R.KFADPEVQSDMKHFPFK.V Y 17.04 2049.9980 17 -4.2 411.0052 5 68.98 4 38423 VEV_1_3_RA4_01_1235.d 6.18E4 1 1 75 91
R.IINEPT(+14.02)AAAIAYGLDK.K Y 16.86 1672.9036 16 -9.4 837.4512 2 81.11 4 47864 VEV_1_3_RA4_01_1235.d 4.83E4 1 1 170 185 Methylation(others)
R.TTPSFVAFTDTER(-.98).L Y 16.86 1469.7151 13 28.9 490.9265 3 66.49 4 36444 VEV_1_3_RA4_01_1235.d 0 1 1 35 47 Amidation
R.D(-18.01)AKIDK.S Y 16.77 670.3649 6 -5.6 671.3685 1 101.77 4 58773 VEV_1_3_RA4_01_1235.d 0 1 1 321 326 Dehydration
R.NTISDSKVDEKLD(+21.98)ASDKEK.L Y 16.75 2143.0256 19 14.4 536.7714 4 59.57 6 30133 VEV_3_3_RA6_01_1237.d 8.57E4 1 1 550 568 Sodium adduct
R.TTPSFVAFTDTER(+14.02)LIGDAAK.N Y 16.68 2153.1003 20 -38.5 718.6797 3 83.41 5 48237 VEV_2_3_RA5_01_1236.d 0 1 1 35 54 Methylation(KR)
K.DLSSNAR.A Y 16.43 761.3668 7 -31.0 762.3504 1 64.04 5 34560 VEV_2_3_RA5_01_1236.d 0 1 1 250 256
K.SETFST(+13.03)FADNQPGVLIQVFEGER.A Y 16.43 2583.2605 23 -10.6 862.0850 3 89.95 6 51294 VEV_3_3_RA6_01_1237.d 0 1 1 424 446 Michael addition with methylamine
K.HFP(+31.99)FKVIDK.A Y 16.37 1161.6182 9 -1.0 388.2130 3 24.62 5 10258 VEV_2_3_RA5_01_1236.d 9.6E4 1 1 87 95 Dihydroxy
R.IIN(+.98)EPTAAAIAYGLDK(+27.99)K.A Y 16.32 1815.9618 17 -46.1 606.3000 3 75.03 6 41564 VEV_3_3_RA6_01_1237.d 3.88E4 1 1 170 186 Deamidation (NQ); Formylation
K.DAGLIAGL(+53.97)NVLR.I Y 16.12 1264.6750 12 20.7 317.1826 4 29.51 5 12987 VEV_2_3_RA5_01_1236.d 0 1 1 158 169 Trifluoroleucine
K.GRLS(+79.97)K(+31.99)EEIER.M Y 15.99 1327.6133 10 48.9 332.9268 4 9.86 6 2446 VEV_3_3_RA6_01_1237.d 0 1 1 507 516 Phosphorylation (STY); Dihydroxy
K.LVSDFFNGK(+43.01)EPNK(+42.01).S Y 15.98 1578.7678 13 -14.7 790.3796 2 76.34 4 44176 VEV_1_3_RA4_01_1235.d 7.36E4 1 1 347 359 Carbamylation; Acetylation (K)
MAPAIGIDLGTTYSC(+57.02)VGIFR.D Y 15.96 2141.0649 20 -31.2 536.2568 4 78.23 6 43893 VEV_3_3_RA6_01_1237.d 4.02E5 1 1 1 20 Carbamidomethylation
K.F(+27.99)ELTGIPPAPR.G N 15.74 1224.6503 11 -40.6 409.2075 3 15.35 4 4969 VEV_1_3_RA4_01_1235.d 3.9E4 1 1 458 468 Formylation
K.TVSWLDENQTAT(-18.01)K.E Y 15.72 1473.7100 13 0.7 492.2443 3 63.63 5 34266 VEV_2_3_RA5_01_1236.d 4.73E4 1 1 576 588 Dehydration
K.Q(+42.01)FTPEEISSMVLT(+79.97)K(+14.02).M Y 15.51 1744.7994 14 30.8 873.4338 2 82.88 6 47115 VEV_3_3_RA6_01_1237.d 2.19E5 1 1 111 124 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.ARFEELC(+57.02)QDLFR(-.98).S Y 15.21 1581.7721 12 5.0 528.2673 3 77.27 4 44912 VEV_1_3_RA4_01_1235.d 0 1 1 298 309 Carbamidomethylation; Amidation
K.IDK(+14.02)S(+79.97)SVHEIVLVGGSTRIPR.I Y 15.11 2256.1990 20 -4.1 565.0547 4 72.02 4 40812 VEV_1_3_RA4_01_1235.d 0 1 1 324 343 Methylation(KR); Phosphorylation (STY)
total 168 peptides
C1G712
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KPEEALEASAVEANASPATKDK.R Y 153.41 2255.1279 22 -12.1 564.7824 4 57.04 6 28398 VEV_3_3_RA6_01_1237.d 5.8E5 5 5 444 465
K.EKKPEVTSDGEQAGDEEAKSK.S Y 143.89 2261.0659 21 -10.8 754.6877 3 21.81 6 8533 VEV_3_3_RA6_01_1237.d 3.35E6 17 17 478 498
K.KPEEALEASAVEANASPATK.D Y 141.45 2012.0061 20 -12.0 1006.9982 2 60.36 6 30700 VEV_3_3_RA6_01_1237.d 1E6 6 6 444 463
K.ATPTGIVNLADISDIVKESGHEFQFK.V Y 140.73 2815.4392 26 -13.7 704.8574 4 86.89 6 49710 VEV_3_3_RA6_01_1237.d 2.14E6 7 7 141 166
K.HVFQAGSDDERASWIAALEAK.A Y 140.58 2300.1184 21 -4.3 576.0344 4 76.96 5 44018 VEV_2_3_RA5_01_1236.d 5.83E5 5 5 172 192
R.AEDKATPTGIVNLADISDIVKESGHEFQFK.V Y 137.82 3258.6406 30 -13.2 652.7268 5 84.95 6 48428 VEV_3_3_RA6_01_1237.d 5.21E5 3 3 137 166
K.KPEVTSDGEQAGDEEAKSK.S Y 135.36 2003.9282 19 -11.5 501.9836 4 22.63 5 9139 VEV_2_3_RA5_01_1236.d 2.62E6 17 17 480 498
K.DKETAPAATPAESEPIPEGAEKPEPVSK.D Y 134.21 2874.4133 28 -9.6 719.6037 4 61.10 6 31253 VEV_3_3_RA6_01_1237.d 7.42E5 5 5 522 549
K.EKKPEVTSDGEQAGDEEAK.S Y 132.97 2045.9388 19 -10.2 1023.9662 2 23.55 6 9427 VEV_3_3_RA6_01_1237.d 5.86E5 8 8 478 496
K.ANDKVEKKPEEALEASAVEANASPATK.D Y 130.84 2796.4141 27 -4.0 560.2878 5 60.29 4 31701 VEV_1_3_RA4_01_1235.d 5.66E5 3 3 437 463
K.LSIAHPTAAWASQTGK.G Y 130.33 1637.8525 16 -7.7 819.9272 2 65.39 5 35598 VEV_2_3_RA5_01_1236.d 1.23E6 8 8 113 128
K.RAEDKATPTGIVNLADISDIVKESGHEFQFK.V Y 128.05 3414.7419 31 6.1 854.6979 4 83.29 4 49426 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 136 166
R.EKETVTSSEGYKAELEK.L Y 124.49 1926.9421 17 -15.1 643.3116 3 44.68 6 21256 VEV_3_3_RA6_01_1237.d 1.73E6 9 9 199 215
K.KPEVTSDGEQAGDEEAK.S Y 119.24 1788.8013 17 -13.7 597.2662 3 24.78 6 10105 VEV_3_3_RA6_01_1237.d 6.1E5 6 6 480 496
K.ATPTGIVNLADISDIVK.E Y 113.74 1725.9512 17 -12.6 863.9720 2 85.43 6 48724 VEV_3_3_RA6_01_1237.d 3.42E5 3 3 141 157
K.LTKPPVVAAAAPK.K Y 112.13 1261.7758 13 -17.0 421.5920 3 52.14 6 25601 VEV_3_3_RA6_01_1237.d 2.26E6 12 12 216 228
K.EKKPEVTSDGEQAGDEEAKSKSSASSPLPK.L Y 109.14 3115.5156 30 -11.2 624.1034 5 43.92 5 21465 VEV_2_3_RA5_01_1236.d 3.68E5 3 3 478 507
K.EGEEPVASPTSAK.N Y 107.73 1300.6146 13 1.3 651.3154 2 33.37 6 14723 VEV_3_3_RA6_01_1237.d 1.4E6 5 5 407 419
R.FFWFSDDAVEVK.Q Y 107.66 1488.6925 12 -6.8 745.3484 2 85.45 4 50887 VEV_1_3_RA4_01_1235.d 3.53E5 4 4 91 102
K.AEEKKPEAKPESPTAGR.S Y 103.43 1823.9376 17 -8.8 608.9811 3 16.30 6 5618 VEV_3_3_RA6_01_1237.d 1.32E5 2 2 322 338
K.VSNQDKVEKDSAVK.N Y 102.96 1545.7998 14 -11.0 773.8987 2 15.56 5 5345 VEV_2_3_RA5_01_1236.d 1.26E6 9 9 352 365
K.KPEAKPESPTAGR.S Y 101.30 1366.7205 13 -11.4 456.5756 3 14.13 5 4601 VEV_2_3_RA5_01_1236.d 2.07E6 10 10 326 338
R.AEDKATPTGIVNLADISDIVK.E Y 101.23 2169.1528 21 -11.6 724.0499 3 82.52 6 46881 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 137 157
K.ANDKVEKKPEEALEASAVEANASPATKDK.R Y 99.96 3039.5359 29 -11.0 760.8829 4 58.24 5 30277 VEV_2_3_RA5_01_1236.d 4.59E4 1 1 437 465
K.HVFQAGSDDER.A Y 98.53 1259.5530 11 -7.4 630.7791 2 25.96 4 10640 VEV_1_3_RA4_01_1235.d 3.48E5 4 4 172 182
K.TEGKEEPEVAAPAVETSAPVAEAAETPVPTPAAEEPK.A Y 94.67 3698.8049 37 -4.4 1233.9368 3 75.72 6 42076 VEV_3_3_RA6_01_1237.d 4.2E4 1 1 285 321
K.NTETHVSSTAPQLGDPVDVSTSEPTKPETVTAAAEPPQPAKEGEEPVASPTSAK.N Y 92.84 5466.6436 54 -10.8 1094.3242 5 70.98 5 39714 VEV_2_3_RA5_01_1236.d 9.01E4 1 1 366 419
K.KPEVTSDGEQAGDEEAKSKSSASSPLPK.L Y 91.45 2858.3779 28 -17.2 953.7836 3 46.13 5 22800 VEV_2_3_RA5_01_1236.d 4.43E5 4 4 480 507
K.RFFWFSDDAVEVK.Q Y 90.92 1644.7936 13 -5.5 549.2688 3 81.53 4 48185 VEV_1_3_RA4_01_1235.d 1.89E5 2 2 90 102
K.DTPAEPTAAVNGSEAPEEIKDDAAAVPAASSSQPVQAAA Y 90.70 3732.7600 39 -3.2 1245.2566 3 77.42 4 45023 VEV_1_3_RA4_01_1235.d 1.27E5 2 2 550 588
K.Q(-17.03)LAAYFQNEKLSIAHPTAAWASQTGK.G Y 90.29 2813.4136 26 -19.3 938.7937 3 82.05 6 46573 VEV_3_3_RA6_01_1237.d 2.04E5 2 2 103 128 Pyro-glu from Q
K.EKKPEVTS(+79.97)DGEQAGDEEAKSK.S Y 89.80 2341.0322 21 -9.1 586.2600 4 26.06 5 11109 VEV_2_3_RA5_01_1236.d 3.57E5 7 7 478 498 Phosphorylation (STY)
K.AT(-2.02)PTGIVNLADISDIVKESGHEFQFK.V Y 89.27 2813.4236 26 9.8 704.3701 4 87.01 4 51891 VEV_1_3_RA4_01_1235.d 0 1 1 141 166 2-amino-3-oxo-butanoic_acid
R.RTSLFGTLGKK.E Y 88.72 1206.7084 11 -17.3 403.2365 3 51.95 5 26402 VEV_2_3_RA5_01_1236.d 7.23E5 8 8 467 477
K.ESGHEFQFK.V Y 88.08 1107.4985 9 -13.2 554.7492 2 39.22 6 18048 VEV_3_3_RA6_01_1237.d 1.07E6 8 8 158 166
R.ASIFGSFLGK.K Y 87.89 1025.5546 10 -9.8 1026.5518 1 80.79 5 46574 VEV_2_3_RA5_01_1236.d 1.08E6 5 5 266 275
K.TEGKEEPEVAAPAVETSAPVAEAAETPVPTPAAEEPKAEEK.K Y 85.32 4156.0220 41 -10.2 1040.0022 4 73.09 4 41658 VEV_1_3_RA4_01_1235.d 7.78E4 1 1 285 325
K.REKETVTSSEGYKAELEK.L Y 84.89 2083.0432 18 -6.8 521.7645 4 39.11 4 18221 VEV_1_3_RA4_01_1235.d 6.24E4 1 1 198 215
R.AEDKATPTGIVNLAD(+6.01)ISDIVKESGHEFQFK.V Y 82.92 3264.6489 30 7.6 653.9420 5 84.98 5 49154 VEV_2_3_RA5_01_1236.d 0 1 1 137 166 Replacement of proton by lithium
K.KPEEALEASAVEANASPATKDKRR.T Y 81.92 2567.3303 24 -11.1 642.8328 4 46.98 5 23316 VEV_2_3_RA5_01_1236.d 7.57E4 1 1 444 467
K.LTKPPVVAAAAPKK.S Y 79.68 1389.8707 14 -51.8 464.2735 3 40.94 5 19722 VEV_2_3_RA5_01_1236.d 5.86E5 5 5 216 229
R.ASWIAALEAK.A Y 78.85 1058.5760 10 -18.2 530.2856 2 77.03 6 43031 VEV_3_3_RA6_01_1237.d 6.23E5 4 4 183 192
K.QLAAYFQNEKLSIAHPTAAWASQTGK.G Y 78.80 2830.4402 26 5.3 708.6211 4 76.90 4 44615 VEV_1_3_RA4_01_1235.d 0 2 2 103 128
R.ASIFGNIFHK.V Y 77.12 1132.6029 10 -19.7 378.5341 3 74.67 6 41330 VEV_3_3_RA6_01_1237.d 5.54E6 13 13 342 351
K.K(+14.02)PEEALEASAVEANASPATK.D Y 76.44 2026.0217 20 -8.2 676.3423 3 62.84 6 32517 VEV_3_3_RA6_01_1237.d 1.78E5 4 4 444 463 Methylation(KR)
K.RASIFGNIFHK.V Y 75.95 1288.7040 11 -16.9 323.1778 4 68.85 5 38164 VEV_2_3_RA5_01_1236.d 5.77E5 6 6 341 351
K.Q(-17.03)LAAYFQNEK.L Y 75.94 1193.5717 10 -15.4 597.7839 2 79.38 6 44713 VEV_3_3_RA6_01_1237.d 3.95E5 3 3 103 112 Pyro-glu from Q
K.EKKPEVTSDGEQAGDE(+14.02)EAKSK.S Y 75.78 2275.0815 21 -7.6 569.7733 4 26.14 4 10762 VEV_1_3_RA4_01_1235.d 7.39E4 1 1 478 498 Methylation(others)
R.FFWFSDDAVEVKQLAAYFQNEK.L Y 75.34 2681.2800 22 -7.6 894.7605 3 91.52 5 52651 VEV_2_3_RA5_01_1236.d 2.07E5 3 3 91 112
K.NTETHVSSTAPQLGDPVDVSTSEPTKPETVTAAAEPPQPAK.E Y 74.57 4184.0396 41 1.4 837.8163 5 70.73 4 39792 VEV_1_3_RA4_01_1235.d 5.44E4 1 1 366 406
K.K(+14.02)PEVTSDGEQAGDEEAKSK.S Y 74.32 2017.9440 19 5.0 505.4958 4 24.59 4 9902 VEV_1_3_RA4_01_1235.d 4.97E4 1 1 480 498 Methylation(KR)
K.LSIAHPTAAWASQ(+.98)TGK.G Y 71.14 1638.8365 16 -16.4 547.2772 3 66.52 6 35265 VEV_3_3_RA6_01_1237.d 8.78E4 1 1 113 128 Deamidation (NQ)
R.TSLFGTLGKKEK.K Y 70.35 1307.7449 12 -12.0 436.9170 3 50.96 5 25728 VEV_2_3_RA5_01_1236.d 1.47E6 8 8 468 479
K.KPEVTSDGEQ(+.98)AGDEEAKSK.S Y 69.67 2004.9124 19 -4.0 669.3087 3 24.28 6 9827 VEV_3_3_RA6_01_1237.d 4.98E4 3 3 480 498 Deamidation (NQ)
K.KPEVTSDGEQAGD(+14.02)EEAKSK.S Y 69.30 2017.9440 19 -5.4 505.4905 4 27.59 5 11921 VEV_2_3_RA5_01_1236.d 8.57E4 1 1 480 498 Methylation(others)
R.TSLFGTLGK.K Y 69.12 922.5123 9 -20.1 462.2542 2 69.83 6 37720 VEV_3_3_RA6_01_1237.d 7.43E5 4 4 468 476
K.KPEVTSDGEQAGDEEAK(+14.02)SK.S Y 68.87 2017.9440 19 -9.6 505.4884 4 28.93 6 12296 VEV_3_3_RA6_01_1237.d 2.11E5 3 3 480 498 Methylation(KR)
K.ATPTGIVNLADISDIVKESGHEFQFK(+14.02).V Y 68.34 2829.4548 26 -1.1 708.3702 4 88.56 5 51143 VEV_2_3_RA5_01_1236.d 9.06E5 7 7 141 166 Methylation(KR)
R.ASIFGSFLGKK.E Y 67.72 1153.6495 11 -20.6 385.5492 3 73.90 6 40765 VEV_3_3_RA6_01_1237.d 4.36E5 3 3 266 276
R.TSLFGTLGKK.E Y 67.09 1050.6073 10 -12.8 526.3042 2 60.10 5 31649 VEV_2_3_RA5_01_1236.d 4.66E6 9 9 468 477
K.NSFLNFIKK.H Y 66.63 1109.6233 9 -12.9 555.8118 2 71.10 5 39797 VEV_2_3_RA5_01_1236.d 1.68E6 6 6 420 428
K.RASIFGSFLGK.K Y 65.45 1181.6556 11 -6.6 394.8899 3 75.38 4 43428 VEV_1_3_RA4_01_1235.d 1.63E4 1 1 265 275
K.EKKPEVT(+79.97)SDGEQAGDEEAKSK.S Y 65.16 2341.0322 21 -10.5 781.3431 3 26.03 5 11059 VEV_2_3_RA5_01_1236.d 3.84E5 2 2 478 498 Phosphorylation (STY)
K.EKKPEVTSDGEQ(+.98)AGDEEAK.S Y 64.52 2046.9229 19 -20.4 683.3010 3 25.41 6 10410 VEV_3_3_RA6_01_1237.d 3.84E4 1 1 478 496 Deamidation (NQ)
K.SSASSPLPK.L Y 62.90 872.4603 9 -15.5 437.2307 2 25.55 5 10796 VEV_2_3_RA5_01_1236.d 5.67E6 14 14 499 507
K.QLAAYFQNEK.L Y 62.83 1210.5981 10 -12.3 606.2989 2 62.37 6 32175 VEV_3_3_RA6_01_1237.d 8.18E5 4 4 103 112
K.EKK(+14.02)PEVTSDGEQAGDEEAKSK.S Y 62.20 2275.0815 21 -11.3 759.3593 3 27.00 5 11592 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 478 498 Methylation(KR)
R.AEDKATPT(-2.02)GIVNLADISDIVKESGHEFQFK.V Y 61.48 3256.6250 30 -19.6 652.3195 5 84.92 6 48414 VEV_3_3_RA6_01_1237.d 0 1 1 137 166 2-amino-3-oxo-butanoic_acid
K.DTPAEPTAAVN(+.98)GSEAPEEIKDDAAAVPAASSSQPVQAAA Y 59.65 3733.7441 39 -9.2 1245.5771 3 77.76 6 43562 VEV_3_3_RA6_01_1237.d 9.1E4 1 1 550 588 Deamidation (NQ)
K.ANDK(+14.02)VEKKPEEALEASAVEANASPATK.D Y 59.31 2810.4297 27 -16.0 563.0842 5 62.29 4 33217 VEV_1_3_RA4_01_1235.d 2.33E5 2 2 437 463 Methylation(KR)
K.ETVTSSEGYKAELEK.L Y 59.02 1669.8046 15 -13.2 557.6014 3 51.10 5 25818 VEV_2_3_RA5_01_1236.d 1.01E6 7 7 201 215
K.KPEVTSDGEQAGDE(+14.02)EAKSK.S Y 57.98 2017.9440 19 -6.3 505.4901 4 27.55 4 11503 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 480 498 Methylation(others)
K.KPEEALEASAVE(+14.02)ANASPATK.D Y 57.90 2026.0217 20 -11.3 676.3402 3 64.01 5 34555 VEV_2_3_RA5_01_1236.d 1.69E5 2 2 444 463 Methylation(others)
K.SKSSASSPLPK.L Y 57.89 1087.5873 11 -15.3 544.7926 2 17.48 4 6079 VEV_1_3_RA4_01_1235.d 2.72E5 4 4 497 507
K.NSFLNFIK.K Y 56.02 981.5283 8 -13.1 491.7650 2 79.03 5 45425 VEV_2_3_RA5_01_1236.d 2.67E6 6 6 420 427
K.GLLFYAK.R Y 55.76 810.4639 7 -20.7 406.2308 2 69.99 6 37844 VEV_3_3_RA6_01_1237.d 2.54E6 8 8 129 135
K.AEEGEEKKEEEKKPEQK.E Y 55.57 2043.9960 17 -8.7 512.0018 4 9.67 5 2387 VEV_2_3_RA5_01_1236.d 6.78E4 3 3 239 255
K.KPEVTSDGEQAGDEEAKSK(+14.02).S Y 55.50 2017.9440 19 -11.8 673.6473 3 29.02 6 12345 VEV_3_3_RA6_01_1237.d 5.1E4 1 1 480 498 Methylation(KR)
K.EKKPEVTSD(+14.02)GEQAGDEEAKSK.S Y 54.05 2275.0815 21 -11.3 456.0184 5 27.08 5 11642 VEV_2_3_RA5_01_1236.d 3.14E5 1 1 478 498 Methylation(others)
K.KHDDKKEIK.A Y 53.79 1139.6299 9 -12.6 570.8151 2 8.42 6 1980 VEV_3_3_RA6_01_1237.d 8.68E3 1 1 428 436
K.ATPTGIVNLADISDIVKE(+14.02)SGHEFQFK.V Y 53.44 2829.4548 26 -9.5 708.3643 4 87.54 4 52220 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 141 166 Methylation(others)
K.E(+14.02)GEEPVASPTSAK.N Y 52.65 1314.6302 13 -13.9 658.3133 2 39.36 5 18746 VEV_2_3_RA5_01_1236.d 9.22E4 2 2 407 419 Methylation(others)
K.LGGVFHR.V Y 51.67 784.4344 7 -17.8 393.2175 2 36.16 6 16319 VEV_3_3_RA6_01_1237.d 6.21E6 12 12 508 514
K.ATPTGIVNLADISDIVK(+14.02)ESGHEFQFK.V Y 51.44 2829.4548 26 -15.5 708.3600 4 87.66 5 50660 VEV_2_3_RA5_01_1236.d 1.48E5 1 1 141 166 Methylation(KR)
R.EK(+14.02)ETVTSSEGYKAELEK.L Y 50.81 1940.9578 17 -12.9 647.9849 3 48.41 6 23386 VEV_3_3_RA6_01_1237.d 2.75E5 4 4 199 215 Methylation(KR)
K.N(+.98)SFLNFIK.K Y 50.39 982.5123 8 -16.5 492.2553 2 84.59 6 48198 VEV_3_3_RA6_01_1237.d 7.37E5 6 6 420 427 Deamidation (NQ)
K.RAEDK(-1.03)ATPTGIVNLADISDIVKESGHEFQFK.V Y 50.30 3413.7102 31 6.1 854.4401 4 83.16 5 48052 VEV_2_3_RA5_01_1236.d 0 1 1 136 166 Lysine oxidation to aminoadipic semialdehyde
K.EKK(+14.02)PEVT(-18.01)SDGEQAGDEEAKSK.S Y 48.28 2257.0708 21 -10.7 565.2689 4 21.95 4 8437 VEV_1_3_RA4_01_1235.d 0 1 1 478 498 Methylation(KR); Dehydration
K.KPEVT(+79.97)SDGEQAGDEEAKSK.S Y 46.17 2083.8945 19 -5.5 521.9780 4 27.16 4 11284 VEV_1_3_RA4_01_1235.d 2.11E5 2 2 480 498 Phosphorylation (STY)
K.KPEAKPESPT(-18.01)AGR.S Y 45.79 1348.7098 13 -15.9 338.1794 4 14.32 5 4690 VEV_2_3_RA5_01_1236.d 2.1E6 5 5 326 338 Dehydration
K.EKKPEVT(+79.97)SDGEQAGDEEAK.S Y 45.67 2125.9053 19 -12.9 709.6332 3 28.32 6 11948 VEV_3_3_RA6_01_1237.d 5.39E4 1 1 478 496 Phosphorylation (STY)
K.SPGLVKGFR.F Y 44.92 959.5552 9 -13.1 320.8548 3 47.84 4 23531 VEV_1_3_RA4_01_1235.d 9.01E4 2 2 78 86
K.VSNQ(+.98)DKVEKDSAVK.N Y 44.17 1546.7838 14 -10.7 516.5964 3 17.96 6 6486 VEV_3_3_RA6_01_1237.d 5.07E4 1 1 352 365 Deamidation (NQ)
K.EKKPEVTSDGEQAGDEEAKSK(+14.02).S Y 43.61 2275.0815 21 -12.1 759.3586 3 27.93 5 12089 VEV_2_3_RA5_01_1236.d 3.79E4 1 1 478 498 Methylation(KR)
K.KPEEALEAS(-2.02)AVEANASPATKDK.R Y 43.58 2253.1123 22 -12.9 564.2781 4 57.39 4 29584 VEV_1_3_RA4_01_1235.d 0 1 1 444 465 2-amino-3-oxo-butanoic_acid
K.ANDKVEKKPEEALEASAVEANASPATK(-.98).D Y 43.01 2795.4299 27 -16.8 560.0839 5 60.21 6 30588 VEV_3_3_RA6_01_1237.d 0 1 1 437 463 Amidation
R.ASWIAALEAK(+14.02).A Y 42.21 1072.5917 10 -17.9 537.2935 2 80.53 6 45537 VEV_3_3_RA6_01_1237.d 1.07E5 2 2 183 192 Methylation(KR)
R.ASWIAALE(+14.02)AK.A Y 42.02 1072.5917 10 -14.6 537.2953 2 80.65 5 46478 VEV_2_3_RA5_01_1236.d 5.6E4 1 1 183 192 Methylation(others)
R.TSLFGTLGKK(+14.02).E Y 41.74 1064.6229 10 -12.1 355.8773 3 62.64 4 33479 VEV_1_3_RA4_01_1235.d 3.56E5 3 3 468 477 Methylation(KR)
K.KPEVTSDGEQAGDEEAKSK(-.98).S Y 41.58 2002.9442 19 -34.8 501.7259 4 23.07 5 9375 VEV_2_3_RA5_01_1236.d 0 1 1 480 498 Amidation
K.N(+.98)SFLNFIKK.H Y 41.01 1110.6073 9 -12.8 371.2050 3 77.65 5 44473 VEV_2_3_RA5_01_1236.d 1.32E5 4 4 420 428 Deamidation (NQ)
K.KPEAKPESPTAGR(+14.02).S Y 39.91 1380.7361 13 -28.7 461.2394 3 17.73 6 6367 VEV_3_3_RA6_01_1237.d 7.88E4 2 2 326 338 Methylation(KR)
K.EKKPEVTSDGEQ(+.98)AGDEEAKSK.S Y 39.83 2262.0498 21 -8.6 453.4134 5 23.57 4 9312 VEV_1_3_RA4_01_1235.d 1.64E5 4 4 478 498 Deamidation (NQ)
K.ANDKVEKK(+14.02)PEEALEAS(-18.01)AVEANASPATK.D Y 39.73 2792.4192 27 -12.7 699.1032 4 60.30 4 31705 VEV_1_3_RA4_01_1235.d 0 1 1 437 463 Methylation(KR); Dehydration
K.KPEEALEASAVEAN(+.98)ASPATK.D Y 39.16 2012.9901 20 -9.8 671.9974 3 62.27 5 33240 VEV_2_3_RA5_01_1236.d 2.24E4 1 1 444 463 Deamidation (NQ)
R.ASIFGNIFHK(+14.02).V Y 38.81 1146.6185 10 -16.8 383.2070 3 73.95 4 42362 VEV_1_3_RA4_01_1235.d 3.49E5 3 3 342 351 Methylation(KR)
K.KPEVTS(+79.97)DGEQAGDEEAKSK.S Y 38.79 2083.8945 19 -14.7 695.6286 3 27.46 6 11498 VEV_3_3_RA6_01_1237.d 7.11E4 1 1 480 498 Phosphorylation (STY)
R.ASIFGN(+.98)IFHK.V Y 38.66 1133.5869 10 -17.5 378.8630 3 77.07 5 44068 VEV_2_3_RA5_01_1236.d 8.99E4 3 3 342 351 Deamidation (NQ)
K.NSFLNFIK(+14.02).K Y 38.33 995.5440 8 -20.4 498.7691 2 81.26 6 46038 VEV_3_3_RA6_01_1237.d 3.24E5 3 3 420 427 Methylation(KR)
K.EKKPEVTSDGEQAGD(+14.02)EEAKSK.S Y 38.20 2275.0815 21 -17.0 569.7680 4 26.37 6 10929 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 478 498 Methylation(others)
K.EGEE(+14.02)PVASPTSAK.N Y 38.03 1314.6302 13 -16.5 658.3115 2 43.51 5 21219 VEV_2_3_RA5_01_1236.d 1.71E5 3 3 407 419 Methylation(others)
K.KEKKPEVTSDGEQAGDEEAKSK.S Y 37.91 2389.1609 22 15.4 478.8468 5 18.95 4 6862 VEV_1_3_RA4_01_1235.d 0 1 1 477 498
K.GLLFYAKR.A Y 35.72 966.5651 8 -14.4 323.1910 3 62.14 4 33103 VEV_1_3_RA4_01_1235.d 3.2E5 3 3 129 136
K.LTKPPVVAAAAPK(+14.02).K Y 33.48 1275.7914 13 -39.5 426.2543 3 58.20 5 30246 VEV_2_3_RA5_01_1236.d 0 2 2 216 228 Methylation(KR)
K.K(-1.03)PEVTSDGEQAGDEEAKSK.S Y 33.08 2002.8966 19 -15.3 501.7238 4 22.49 5 9059 VEV_2_3_RA5_01_1236.d 0 1 1 480 498 Lysine oxidation to aminoadipic semialdehyde
R.EKETVTSSEGYK.A Y 32.89 1356.6409 12 -13.1 453.2150 3 20.63 5 8079 VEV_2_3_RA5_01_1236.d 2.23E5 3 3 199 210
K.KPEAKPESPT(+164.06)AGR.S Y 32.67 1530.7806 13 -8.3 511.2632 3 13.47 6 4174 VEV_3_3_RA6_01_1237.d 3.84E4 1 1 326 338 O-Diisopropylphosphorylation
K.KPEVTSDGEQAGDEE(+14.02)AKSK.S Y 31.73 2017.9440 19 -4.3 505.4911 4 31.41 5 14081 VEV_2_3_RA5_01_1236.d 7.55E4 1 1 480 498 Methylation(others)
R.VSKPGK(+14.02)K.D Y 31.37 756.4857 7 -10.6 379.2461 2 8.67 5 2046 VEV_2_3_RA5_01_1236.d 3.74E3 1 1 515 521 Methylation(KR)
K.KPEAK(+14.02)PESPTAGR.S Y 31.12 1380.7361 13 -16.2 691.3641 2 16.87 6 5919 VEV_3_3_RA6_01_1237.d 2.2E4 1 1 326 338 Methylation(KR)
R.R(+226.08)T(+79.97)SLFGTLGKK.E Y 30.95 1512.7523 11 59.5 379.2179 4 60.49 4 31856 VEV_1_3_RA4_01_1235.d 4.63E4 2 2 467 477 Biotinylation; Phosphorylation (STY)
R.A(+41.03)SIFGNIFHK.V Y 30.11 1173.6294 10 -23.6 392.2079 3 74.83 5 42477 VEV_2_3_RA5_01_1236.d 3.86E4 1 1 342 351 Amidination of lysines or N-terminal amines with methyl acetimidate
K.EKKPEVTSDGEQAGDEEAK(+14.02).S Y 29.72 2059.9546 19 -17.0 515.9872 4 30.26 5 13412 VEV_2_3_RA5_01_1236.d 4.17E4 1 1 478 496 Methylation(KR)
K.KPEEALEASAVEAN(+.98)ASPATKDK.R Y 29.65 2256.1121 22 0.4 753.0449 3 57.18 4 29434 VEV_1_3_RA4_01_1235.d 2.93E4 1 1 444 465 Deamidation (NQ)
R.EKETVTSSEGYK(+14.02)AELEK.L Y 29.30 1940.9578 17 -6.6 486.2435 4 52.91 4 26742 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 199 215 Methylation(KR)
R.ASIFGSFLGK(+14.02).K Y 29.20 1039.5702 10 -12.4 520.7859 2 81.28 4 48023 VEV_1_3_RA4_01_1235.d 5.72E4 1 1 266 275 Methylation(KR)
K.K(+42.01)(+210.20)PEVTSDGEQAGDEEAKSK.S Y 28.95 2256.1372 19 -36.5 565.0210 4 22.25 5 8941 VEV_2_3_RA5_01_1236.d 0 1 1 480 498 Acetylation (N-term); Myristoylation
R.EKETVT(+42.01)SSEGYKAELEK.L Y 28.61 1968.9528 17 -23.9 493.2337 4 44.78 6 21281 VEV_3_3_RA6_01_1237.d 0 1 1 199 215 Acetylation (TSCYH)
K.EKK(+14.02)PEVTSD(-18.01)GEQAGDEEAKSK.S Y 28.41 2257.0708 21 62.4 565.3102 4 21.85 5 8732 VEV_2_3_RA5_01_1236.d 0 1 1 478 498 Methylation(KR); Dehydration
K.SPGLVK.G Y 27.46 599.3643 6 -14.9 600.3626 1 19.19 6 7152 VEV_3_3_RA6_01_1237.d 6.86E5 2 2 78 83
K.NSFLNFIK(+14.02)K.H Y 27.42 1123.6389 9 -17.1 375.5472 3 72.50 5 40836 VEV_2_3_RA5_01_1236.d 9.02E4 2 2 420 428 Methylation(KR)
K.L(+43.01)TK(+42.01)PPVVAAAAPKK.S Y 27.32 1474.8871 14 -54.4 369.7090 4 41.29 5 19895 VEV_2_3_RA5_01_1236.d 0 2 2 216 229 Carbamylation; Acetylation (K)
K.KPEAKPES(-18.01)PTAGR.S Y 26.53 1348.7098 13 -10.9 338.1811 4 14.28 4 4433 VEV_1_3_RA4_01_1235.d 7.11E5 1 1 326 338 Dehydration
R.EKE(+14.02)TVTSSEGYKAELEK.L Y 26.48 1940.9578 17 -3.8 647.9907 3 51.69 4 25954 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 199 215 Methylation(others)
K.E(-18.01)K(+14.02)KPEVTSDGEQAGDEEAKSK.S Y 26.11 2257.0708 21 68.7 565.3137 4 21.79 6 8496 VEV_3_3_RA6_01_1237.d 0 1 1 478 498 Pyro-glu from E; Methylation(KR)
K.L(+42.01)GGVFHR.V Y 25.63 826.4449 7 -12.7 414.2245 2 36.37 5 16998 VEV_2_3_RA5_01_1236.d 3.53E4 2 2 508 514 Acetylation (N-term)
R.EKETVTSSEGYKAELEK(+14.02).L Y 25.24 1940.9578 17 -4.2 486.2447 4 50.78 5 25622 VEV_2_3_RA5_01_1236.d 1.88E5 1 1 199 215 Methylation(KR)
K.L(+233.05)SIAHPTAAWASQTGK.G Y 24.34 1870.9036 16 15.3 936.4734 2 82.08 6 46597 VEV_3_3_RA6_01_1237.d 1.18E4 1 1 113 128 5-dimethylaminonaphthalene-1-sulfonyl
K.K(+42.01)(+42.01)PEQK.E Y 24.25 712.3755 5 9.0 713.3892 1 29.14 4 12369 VEV_1_3_RA4_01_1235.d 0 1 1 251 255 Acetylation (N-term); Acetylation (K)
K.ATPTGIVNLADISD(+14.02)IVKESGHEFQFK.V Y 24.09 2829.4548 26 -15.2 708.3602 4 86.85 5 50231 VEV_2_3_RA5_01_1236.d 1.48E5 1 1 141 166 Methylation(others)
R.SKRASIFGNIFHK.V Y 23.38 1503.8309 13 -2.2 376.9642 4 63.98 5 34516 VEV_2_3_RA5_01_1236.d 8.77E4 1 1 339 351
K.SKSSASSPLPK(-.98).L Y 23.30 1086.6033 11 -40.4 363.1937 3 14.08 5 4544 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 497 507 Amidation
K.QLAAYFQNEK(+14.02).L Y 22.71 1224.6139 10 -6.5 613.3102 2 68.00 4 37642 VEV_1_3_RA4_01_1235.d 7.05E4 2 2 103 112 Methylation(KR)
K.KPEAKPES(+79.97)PTAGR.S Y 22.17 1446.6868 13 -16.9 483.2280 3 14.68 6 4785 VEV_3_3_RA6_01_1237.d 4.38E4 1 1 326 338 Phosphorylation (STY)
K.DDAAAVPAAS(+79.97)SSQPVQ(+.98)AAA Y 22.14 1806.7672 19 45.0 452.7194 4 58.49 5 30496 VEV_2_3_RA5_01_1236.d 1.53E5 1 1 570 588 Phosphorylation (STY); Deamidation (NQ)
K.LTKPPVVAAAAPK(+345.05)K.S Y 22.05 1734.9181 14 -29.7 434.7239 4 52.61 6 25824 VEV_3_3_RA6_01_1237.d 4.95E5 4 4 216 229 Phospho-guanosine
K.EEEK(+31.99)KEEK.T Y 22.04 1079.4982 8 -8.1 540.7520 2 22.08 5 8850 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 277 284 Dihydroxy
R.SK(+43.01)RAS(+79.97)IFGNIFHK.V Y 21.78 1626.8031 13 54.6 407.7303 4 74.74 6 41357 VEV_3_3_RA6_01_1237.d 4.52E4 1 1 339 351 Carbamylation; Phosphorylation (STY)
K.D(+27.99)SAVK.N N 21.62 546.2649 5 12.5 547.2790 1 64.70 5 35044 VEV_2_3_RA5_01_1236.d 0 1 1 361 365 Formylation
K.VSNQDKVEK.D Y 21.36 1045.5404 9 -9.2 523.7726 2 9.58 6 2341 VEV_3_3_RA6_01_1237.d 6.56E3 1 1 352 360
R.R(+362.14)TSLFGTLGKK.E Y 21.36 1568.8450 11 -11.8 393.2139 4 60.32 5 31790 VEV_2_3_RA5_01_1236.d 0 2 2 467 477 Nucleophilic addtion to cytopiloyne
K.S(+14.02)SASSPLPKLGGVFHR.V Y 21.16 1652.8998 16 -23.9 414.2224 4 36.67 6 16587 VEV_3_3_RA6_01_1237.d 0 1 1 499 514 Methylation(others)
K.ANDKVEK(+14.02)KPEEALEAS(-18.01)AVEANASPATK.D Y 20.76 2792.4192 27 -12.3 699.1035 4 60.12 5 31641 VEV_2_3_RA5_01_1236.d 0 1 1 437 463 Methylation(KR); Dehydration
R.ASIFGSFLGK(+14.02)K(+21.98).E Y 19.68 1189.6471 11 2.4 397.5573 3 73.71 5 41677 VEV_2_3_RA5_01_1236.d 2.67E6 1 1 266 276 Methylation(KR); Sodium adduct
K.NSFLNFIKK(+14.02).H Y 19.61 1123.6389 9 -22.9 375.5450 3 72.51 6 39741 VEV_3_3_RA6_01_1237.d 4.61E4 1 1 420 428 Methylation(KR)
K.S(+42.01)SASSPLPK(+42.01)LGGVFHR.V Y 19.40 1722.9053 16 -28.3 862.4355 2 84.83 6 48355 VEV_3_3_RA6_01_1237.d 5.39E3 1 1 499 514 Acetylation (N-term); Acetylation (K)
K.LS(-2.02)IAHPTAAWASQTGK.G Y 19.40 1635.8369 16 -8.9 546.2814 3 65.62 6 34587 VEV_3_3_RA6_01_1237.d 1.02E4 2 2 113 128 2-amino-3-oxo-butanoic_acid
K.RFFWFSDDAVEVK(-.98).Q Y 19.37 1643.8096 13 -3.0 548.9421 3 81.41 5 46970 VEV_2_3_RA5_01_1236.d 0 1 1 90 102 Amidation
K.KPEVTSDGEQAGDEEAK(+14.02)SK(-.98).S Y 19.13 2016.9600 19 -10.9 673.3199 3 29.06 4 12325 VEV_1_3_RA4_01_1235.d 0 1 1 480 498 Methylation(KR); Amidation
K.S(+42.01)PGLVKGFR(+28.03).F Y 19.06 1029.5970 9 -4.1 1030.6001 1 107.30 6 57380 VEV_3_3_RA6_01_1237.d 8.02E4 1 1 78 86 Acetylation (N-term); Dimethylation(KR)
K.KPEQKEKSR.S Y 18.67 1128.6251 9 -45.3 377.1986 3 43.41 4 20784 VEV_1_3_RA4_01_1235.d 1.97E5 1 1 251 259
R.TSLFGTLGK(+31.99).K Y 18.03 954.5022 9 -15.1 319.1699 3 31.89 6 13920 VEV_3_3_RA6_01_1237.d 0 1 1 468 476 Dihydroxy
K.K(+42.01)PEAK(+27.99)PESPTAGR.S Y 18.02 1436.7260 13 -11.8 360.1845 4 9.36 5 2276 VEV_2_3_RA5_01_1236.d 0 1 1 326 338 Acetylation (N-term); Formylation
K.ANDKVEK.K Y 18.00 802.4185 7 -20.9 803.4090 1 86.77 6 49539 VEV_3_3_RA6_01_1237.d 9.46E4 1 1 437 443
K.KEIK(+42.01)ANDK(+42.01).V Y 17.85 1028.5502 8 -11.5 343.8534 3 39.99 4 18688 VEV_1_3_RA4_01_1235.d 0 1 1 433 440 Acetylation (K)
K.DSAVK.N N 17.76 518.2700 5 3.9 519.2793 1 67.19 4 36995 VEV_1_3_RA4_01_1235.d 0 1 1 361 365
K.KPEAKPESPT(-18.01)AGR(+14.02).S Y 17.61 1362.7255 13 -20.6 341.6816 4 17.68 5 6474 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 326 338 Dehydration; Methylation(KR)
K.R(+149.03)RTSLFGTLGK.K Y 17.54 1383.7445 11 -3.0 462.2541 3 70.26 6 38058 VEV_3_3_RA6_01_1237.d 0 2 2 466 476 Benzyl isothiocyanate
K.HVFQAGSDDER(+14.02).A Y 17.50 1273.5687 11 -11.2 637.7845 2 36.46 4 16611 VEV_1_3_RA4_01_1235.d 5.19E4 1 1 172 182 Methylation(KR)
R.TSLFGT(+79.97)LGK.K Y 17.09 1002.4787 9 20.7 502.2570 2 40.87 6 18991 VEV_3_3_RA6_01_1237.d 5.6E4 1 1 468 476 Phosphorylation (STY)
K.LGGVFHR(+14.02).V Y 17.00 798.4500 7 -15.8 400.2260 2 39.91 6 18441 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 508 514 Methylation(KR)
K.SKSSASSPLPK(+14.02)LGGVF(+31.99)HR.V Y 16.96 1900.0166 18 -42.5 380.9944 5 45.33 5 22327 VEV_2_3_RA5_01_1236.d 4.09E5 1 1 497 514 Methylation(KR); Dihydroxy
K.VEKKPEEALEASAVEANAS(+79.97)PATK.D Y 16.66 2448.1785 23 -5.8 490.6401 5 76.42 5 43600 VEV_2_3_RA5_01_1236.d 5.93E4 1 1 441 463 Phosphorylation (STY)
K.LTK(+42.01)PPVVAAAAPK(+14.02).K Y 16.55 1317.8020 13 -27.5 440.2625 3 58.44 4 30319 VEV_1_3_RA4_01_1235.d 0 1 1 216 228 Acetylation (K); Methylation(KR)
K.L(+42.01)TKPPVVAAAAPK.K Y 16.46 1303.7864 13 -85.8 435.5654 3 53.04 6 26079 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 216 228 Acetylation (N-term)
K.QLAAY(-18.01)FQNEK.L Y 16.20 1192.5876 10 8.4 597.3061 2 79.48 6 44790 VEV_3_3_RA6_01_1237.d 0 1 1 103 112 Dehydration
K.EEEK(+28.03)KPEQK(+14.02).E Y 16.17 1185.6240 9 20.2 396.2233 3 64.72 4 35059 VEV_1_3_RA4_01_1235.d 2.16E4 1 1 247 255 Dimethylation(KR); Methylation(KR)
K.DDAAAVPAASS(-18.01)SQPVQAAA Y 16.09 1707.8063 19 4.0 570.2783 3 63.39 5 34079 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 570 588 Dehydration
K.L(+43.01)SIAHPTAAWASQTGK(+42.01).G Y 16.05 1722.8689 16 0.6 575.2972 3 38.49 4 17801 VEV_1_3_RA4_01_1235.d 0 1 1 113 128 Carbamylation; Acetylation (K)
R.A(+42.01)S(+162.05)WIAALEAK.A Y 15.92 1262.6394 10 -6.0 632.3232 2 75.27 6 41731 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 183 192 Acetylation (N-term); Hexose (NSY)
R.ASIFGNIFHKVSNQDKVEKDSAVK.N Y 15.84 2660.3921 24 4.1 533.0879 5 108.59 4 60750 VEV_1_3_RA4_01_1235.d 0 1 1 342 365
K.L(+43.01)GGVFHR.V Y 15.77 827.4402 7 -3.4 414.7260 2 36.58 5 17123 VEV_2_3_RA5_01_1236.d 0 1 1 508 514 Carbamylation
K.GFRFSK(-.98).R Y 15.76 739.4129 6 -31.2 370.7022 2 70.80 5 39583 VEV_2_3_RA5_01_1236.d 6.48E4 1 1 84 89 Amidation
K.AAEAK.R N 15.29 488.2594 5 -43.6 489.2454 1 46.40 6 22203 VEV_3_3_RA6_01_1237.d 0 1 1 193 197
K.Q(+42.01)LAAYFQN(+162.05)EK.L Y 15.25 1414.6616 10 -12.8 354.6682 4 9.82 6 2428 VEV_3_3_RA6_01_1237.d 8.75E4 1 1 103 112 Acetylation (N-term); Hexose (NSY)
K.KPEVTSDGEQAGDEEAK(-.98).S Y 15.16 1787.8173 17 -11.5 596.9395 3 25.32 4 10295 VEV_1_3_RA4_01_1235.d 4.32E4 1 1 480 496 Amidation
R.SQ(+.98)SRK.R N 15.07 605.3133 5 -35.9 606.2988 1 62.79 6 32481 VEV_3_3_RA6_01_1237.d 0 1 1 260 264 Deamidation (NQ)
K.VAGHKHVFQAGSDDER.A Y 15.04 1751.8339 16 -20.9 438.9566 4 27.71 6 11622 VEV_3_3_RA6_01_1237.d 7.31E4 1 1 167 182
K.AELEK(+21.98)(+14.02).L Y 15.03 624.3094 5 -6.1 313.1601 2 16.14 5 5640 VEV_2_3_RA5_01_1236.d 0 1 1 211 215 Sodium adduct; Methylation(KR)
total 189 peptides
C1GKC9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NPADITQEEYASFYK.T Y 147.80 1774.8049 15 -12.4 888.3987 2 75.39 6 41876 VEV_3_3_RA6_01_1237.d 1.95E6 6 6 275 289
K.TLTIQDTGIGMTKADLVNNLGTIAR.S Y 142.77 2615.3953 25 -7.1 872.7995 3 82.29 4 48747 VEV_1_3_RA4_01_1235.d 9.76E5 7 7 74 98
K.TKPIWTRNPADITQEEYASFYK.T Y 141.98 2657.3125 22 -12.1 665.3274 4 77.39 6 43352 VEV_3_3_RA6_01_1237.d 2.86E5 3 3 268 289
K.HNDDEQYIWESSAGGTFK.I Y 136.95 2082.8918 18 -10.2 1042.4426 2 72.23 6 39536 VEV_3_3_RA6_01_1237.d 7.21E5 5 5 140 157
K.SGDETTSLADYVTR.M Y 130.27 1513.6896 14 -14.1 757.8414 2 70.13 6 37991 VEV_3_3_RA6_01_1237.d 3.18E6 10 10 445 458
K.SITQLLFETSLLVSGFTIEEPAGFAER.I Y 129.45 2954.5276 27 -14.3 1478.2500 2 97.80 6 54613 VEV_3_3_RA6_01_1237.d 1.34E5 4 4 636 662
K.LVDITKDFELEETDEEKKTR.E Y 128.72 2437.2224 20 -10.8 610.3063 4 70.82 5 39610 VEV_2_3_RA5_01_1236.d 2.07E6 8 8 516 535
K.NFEVLFLVDPIDEYAMTQLKEFDGKK.L Y 127.56 3088.5466 26 -4.4 773.1406 4 92.73 4 55153 VEV_1_3_RA4_01_1235.d 9.68E5 6 6 490 515
R.FNSTKSGDETTSLADYVTR.M Y 122.87 2090.9756 19 -14.6 697.9890 3 67.78 6 36210 VEV_3_3_RA6_01_1237.d 4.29E5 3 3 440 458
R.RVFITDDATDLIPEWLSFVK.G Y 122.40 2364.2366 20 -6.9 789.0807 3 92.93 4 55254 VEV_1_3_RA4_01_1235.d 1.13E6 8 8 342 361
K.TLELFTEIAEDREQFDKFYSAFSK.N Y 120.48 2913.4072 24 -5.4 972.1378 3 90.09 4 53701 VEV_1_3_RA4_01_1235.d 2.1E6 11 11 395 418
M.A(+42.01)SETFEFQAEISQLLSLIINTVYSNKEIFLR.E Y 118.05 3644.8977 31 -6.3 1215.9656 3 98.19 4 57605 VEV_1_3_RA4_01_1235.d 6.8E4 2 2 2 32 Acetylation (Protein N-term)
R.VFITDDATDLIPEWLSFVK.G Y 117.22 2208.1353 19 -11.0 1105.0627 2 97.29 6 54413 VEV_3_3_RA6_01_1237.d 5.37E5 4 4 343 361
R.TGQFGWSANMER.I Y 116.85 1382.6038 12 -12.4 692.3006 2 67.87 6 36311 VEV_3_3_RA6_01_1237.d 6.79E5 5 5 575 586
K.GVVDSEDLPLNLSR.E Y 116.69 1512.7783 14 -14.4 757.3856 2 77.37 6 43304 VEV_3_3_RA6_01_1237.d 2.63E6 7 7 362 375
R.YEALSDPSKLDSNKDLR.I Y 113.15 1949.9694 17 -11.4 650.9896 3 60.93 5 32239 VEV_2_3_RA5_01_1236.d 1.67E6 8 8 47 63
K.AQALRDTSMSSYMSSK.K Y 110.33 1761.8026 16 -8.3 588.2700 3 60.06 5 31592 VEV_2_3_RA5_01_1236.d 2.76E5 3 3 590 605
R.EAEEKEFEGLAK.A Y 110.24 1378.6615 12 -7.8 690.3326 2 56.25 4 28793 VEV_1_3_RA4_01_1235.d 3.86E6 12 12 536 547
R.RVFITDDATDLIPEWLSFVKGVVDSEDLPLNLSR.E Y 109.74 3859.0042 34 1.3 965.7595 4 97.64 4 57404 VEV_1_3_RA4_01_1235.d 0 1 1 342 375
K.ITQDTDGESLGR.G Y 106.67 1290.6051 12 -13.9 646.3008 2 37.25 6 16991 VEV_3_3_RA6_01_1237.d 2.94E6 16 16 158 169
K.TLTIQDTGIGMTK.A Y 106.18 1377.7174 13 -14.5 689.8560 2 70.74 6 38433 VEV_3_3_RA6_01_1237.d 2.56E6 8 8 74 86
K.LGIHEDAQNR.S Y 104.97 1151.5684 10 -14.9 576.7829 2 25.93 6 10692 VEV_3_3_RA6_01_1237.d 4.6E6 14 14 422 431
K.HSEFISYPIYLHVVK.E Y 104.00 1830.9668 15 -15.0 611.3204 3 76.50 6 42633 VEV_3_3_RA6_01_1237.d 4.57E5 3 3 197 211
K.TLTIQDTGIGM(+15.99)TK.A Y 100.40 1393.7123 13 -10.5 697.8561 2 65.29 6 34346 VEV_3_3_RA6_01_1237.d 4.6E5 5 5 74 86 Oxidation (M)
K.KVEADGENDRTVK.S Y 96.46 1459.7267 13 -12.4 487.5768 3 13.05 5 4011 VEV_2_3_RA5_01_1236.d 2.86E5 5 5 623 635
R.ELISNC(+57.02)SDALDKIR.Y Y 95.38 1632.8141 14 -14.5 545.2708 3 67.69 6 36212 VEV_3_3_RA6_01_1237.d 5.05E5 4 4 33 46 Carbamidomethylation
K.VEEVDDEEEEKKK.E Y 94.17 1604.7417 13 -14.2 535.9136 3 15.48 6 5211 VEV_3_3_RA6_01_1237.d 7.73E5 9 9 236 248
K.TLSNDWEDHLAVK.H Y 92.30 1526.7365 13 -1.5 509.9186 3 69.24 4 38622 VEV_1_3_RA4_01_1235.d 6.5E5 6 6 290 302
K.ADLVNNLGTIAR.S Y 92.13 1255.6885 12 -14.8 628.8422 2 71.57 6 39062 VEV_3_3_RA6_01_1237.d 2.62E6 6 6 87 98
K.KTLELFTEIAEDREQFDKFYSAFSK.N Y 91.32 3041.5022 25 -10.8 609.3011 5 87.10 4 51940 VEV_1_3_RA4_01_1235.d 7.19E4 2 2 394 418
K.RAPFDLFETK.K Y 90.90 1222.6345 10 -19.2 408.5443 3 73.93 6 40763 VEV_3_3_RA6_01_1237.d 9.26E5 7 7 321 330
R.TGQFGWSANM(+15.99)ER.I Y 88.23 1398.5986 12 -6.1 700.3023 2 61.11 4 32317 VEV_1_3_RA4_01_1235.d 2.34E5 3 3 575 586 Oxidation (M)
K.HFSVEGQLEFR.A Y 86.68 1347.6571 11 -19.0 450.2178 3 69.67 6 37616 VEV_3_3_RA6_01_1237.d 3.62E5 5 5 303 313
K.VEEVDDEEEEK.K Y 86.57 1348.5518 11 -10.2 675.2763 2 27.84 6 11691 VEV_3_3_RA6_01_1237.d 1.77E5 2 2 236 246
K.MILHLKDEQTEYLNESK.I Y 86.55 2090.0354 17 -9.1 697.6794 3 67.30 4 37147 VEV_1_3_RA4_01_1235.d 2.52E5 3 3 173 189
K.IKESKIEEEELNK.T Y 85.37 1587.8354 13 -15.7 530.2775 3 37.99 6 17351 VEV_3_3_RA6_01_1237.d 3.89E5 3 3 255 267
R.ELISNC(+57.02)SDALDK.I Y 84.40 1363.6289 12 -10.5 682.8146 2 60.62 6 30916 VEV_3_3_RA6_01_1237.d 4.9E5 4 4 33 44 Carbamidomethylation
K.NFEVLFLVDPIDEYAMTQLK.E Y 84.36 2384.1973 20 -7.9 1193.0964 2 96.19 4 56830 VEV_1_3_RA4_01_1235.d 2.25E5 4 4 490 509
K.ESKIEEEELNK.T Y 82.14 1346.6565 11 -8.7 674.3297 2 32.88 4 14508 VEV_1_3_RA4_01_1235.d 6.72E5 6 6 257 267
R.NPADITQE(+14.02)EYASFYK.T Y 80.30 1788.8206 15 -13.1 895.4058 2 77.44 6 43375 VEV_3_3_RA6_01_1237.d 2.83E5 2 2 275 289 Methylation(others)
K.ITQDTDGESLGRGTK.M Y 80.27 1576.7693 15 -12.4 526.5905 3 30.52 6 13149 VEV_3_3_RA6_01_1237.d 5.86E5 4 4 158 172
K.IRYEALSDPSKLDSNKDLR.I Y 79.99 2219.1545 19 -28.0 444.8257 5 63.16 6 32747 VEV_3_3_RA6_01_1237.d 2.54E5 1 1 45 63
R.VFITDDATDLIPE(+14.02)WLSFVK.G Y 79.83 2222.1511 19 -12.9 1112.0685 2 97.63 6 54566 VEV_3_3_RA6_01_1237.d 6.59E4 2 2 343 361 Methylation(others)
R.NPADITQEE(+14.02)YASFYK.T Y 77.83 1788.8206 15 -12.4 895.4064 2 79.82 6 45051 VEV_3_3_RA6_01_1237.d 2.8E5 4 4 275 289 Methylation(others)
K.VEEVDDEEEEKKKEK.K Y 76.74 1861.8792 15 -5.0 621.6306 3 14.59 4 4578 VEV_1_3_RA4_01_1235.d 2.88E5 5 5 236 250
K.ITQDTDGESLGR(+14.02).G Y 75.03 1304.6208 12 -6.8 653.3132 2 43.31 4 20750 VEV_1_3_RA4_01_1235.d 7.61E5 9 9 158 169 Methylation(KR)
K.ALKNVLGDKVEK.V Y 74.81 1312.7714 12 -10.9 657.3858 2 44.02 5 21530 VEV_2_3_RA5_01_1236.d 2.51E6 14 14 548 559
R.IDIIPDKANK.T Y 74.24 1125.6393 10 -11.7 563.8203 2 52.33 6 25665 VEV_3_3_RA6_01_1237.d 5.55E6 13 13 64 73
R.VFITDDATDLIPEWLSFVKGVVDSEDLPLNLSR.E Y 73.75 3702.9031 33 -4.4 1235.3029 3 97.81 5 55299 VEV_2_3_RA5_01_1236.d 4.04E4 1 1 343 375
K.AVQKSPFLDTLKEK.N Y 72.48 1602.8981 14 -17.2 401.7249 4 60.23 6 30604 VEV_3_3_RA6_01_1237.d 1.57E5 1 1 476 489
R.YEALSDPSK.L Y 72.17 1008.4763 9 -6.2 505.2423 2 36.65 4 16725 VEV_1_3_RA4_01_1235.d 6.69E5 7 7 47 55
K.Q(-17.03)MYYITGESLK.A Y 72.15 1314.6166 11 -16.0 658.3051 2 81.23 6 46015 VEV_3_3_RA6_01_1237.d 2.77E5 3 3 465 475 Pyro-glu from Q
K.RAPFDLFETKK.T Y 72.13 1350.7295 11 16.2 338.6951 4 66.35 6 35137 VEV_3_3_RA6_01_1237.d 3.61E5 4 4 321 331
K.NIKLGIHEDAQNR.S Y 71.17 1506.7903 13 -14.8 503.2633 3 42.09 6 19705 VEV_3_3_RA6_01_1237.d 1.55E6 10 10 419 431
K.ITQ(+.98)DTDGESLGR.G Y 70.32 1291.5891 12 -11.5 646.7944 2 43.10 5 20986 VEV_2_3_RA5_01_1236.d 3.59E5 4 4 158 169 Deamidation (NQ)
K.GVVDSEDLPLNLSR(+14.02).E Y 69.94 1526.7939 14 -16.4 764.3917 2 78.33 6 43978 VEV_3_3_RA6_01_1237.d 3.09E5 3 3 362 375 Methylation(KR)
R.APFDLFETKK.T Y 69.44 1194.6284 10 -23.3 399.2075 3 70.30 6 38117 VEV_3_3_RA6_01_1237.d 4.14E5 3 3 322 331
K.EIEKEVVDEDAEEVKEDDEDKAPK.V Y 69.12 2787.2820 24 -8.1 697.8221 4 60.78 6 31016 VEV_3_3_RA6_01_1237.d 7.93E4 2 2 212 235
K.H(+14.02)NDDEQYIWESSAGGTFK.I Y 69.07 2096.9075 18 -11.7 699.9683 3 75.46 6 41878 VEV_3_3_RA6_01_1237.d 5.94E4 1 1 140 157 Methylation(others)
R.NPADITQ(+.98)EEYASFYK.T Y 68.15 1775.7889 15 1.7 888.9033 2 75.57 4 43574 VEV_1_3_RA4_01_1235.d 2.72E5 1 1 275 289 Deamidation (NQ)
K.QMYYITGESLK.A Y 68.14 1331.6431 11 -7.6 666.8237 2 69.92 4 39147 VEV_1_3_RA4_01_1235.d 7.65E5 5 5 465 475
K.TFEISPR.S Y 68.13 848.4392 7 -17.7 425.2194 2 53.36 6 26315 VEV_3_3_RA6_01_1237.d 2.84E6 11 11 607 613
K.SGDETTSLADYVTR(+14.02).M Y 67.85 1527.7052 14 -14.1 764.8491 2 73.42 6 40387 VEV_3_3_RA6_01_1237.d 7.49E5 3 3 445 458 Methylation(KR)
K.SGDETTSLADYVTR(+.98).M Y 67.69 1514.6736 14 4.3 758.3473 2 70.46 4 39578 VEV_1_3_RA4_01_1235.d 5.35E5 2 2 445 458 Deamidation (R)
R.AILFVPK.R Y 66.99 786.5003 7 -18.6 787.4929 1 69.10 5 38334 VEV_2_3_RA5_01_1236.d 2.04E6 7 7 314 320
K.LIGSPC(+57.02)AIR.T Y 66.94 985.5378 9 -14.0 493.7693 2 57.71 6 28859 VEV_3_3_RA6_01_1237.d 2.39E6 7 7 566 574 Carbamidomethylation
K.KKVEADGENDRTVK.S Y 66.89 1587.8215 14 -10.4 530.2756 3 11.74 4 3185 VEV_1_3_RA4_01_1235.d 4.6E5 7 7 622 635
K.EVVDEDAEEVKEDDEDKAPK.V Y 66.53 2288.0178 20 -15.8 573.0027 4 52.52 6 25775 VEV_3_3_RA6_01_1237.d 1.64E5 3 3 216 235
K.ADLVNNLGTIAR(+14.02).S Y 66.44 1269.7041 12 -13.8 635.8506 2 74.83 6 41415 VEV_3_3_RA6_01_1237.d 9.51E4 1 1 87 98 Methylation(KR)
K.SPFLDTLKEK.N Y 65.69 1176.6390 10 -10.7 589.3205 2 63.19 5 33920 VEV_2_3_RA5_01_1236.d 1.6E6 6 6 480 489
K.EKNFEVLFLVDPIDEYAMTQLKEFDGKK.L Y 64.55 3345.6841 28 -59.7 670.1041 5 89.64 6 51126 VEV_3_3_RA6_01_1237.d 4.35E4 2 2 488 515
K.HNDDEQYIWE(+14.02)SSAGGTFK.I Y 63.91 2096.9075 18 -1.6 699.9753 3 74.31 6 41042 VEV_3_3_RA6_01_1237.d 1.02E5 2 2 140 157 Methylation(others)
R.TGQFGWSANMER(+14.02).I Y 63.83 1396.6194 12 -1.9 699.3157 2 71.92 4 40730 VEV_1_3_RA4_01_1235.d 8.96E4 2 2 575 586 Methylation(KR)
R.ETLQQNKIM(+15.99)K.V Y 62.95 1247.6544 10 -12.9 624.8264 2 21.28 6 8231 VEV_3_3_RA6_01_1237.d 3.61E4 2 2 376 385 Oxidation (M)
K.LVDITKDFELEETDEEKK.T Y 62.82 2180.0735 18 -13.1 546.0185 4 74.01 4 42361 VEV_1_3_RA4_01_1235.d 2.32E5 1 1 516 533
K.DFELEETDEEKKTR.E Y 62.54 1767.8162 14 -14.3 590.2709 3 49.55 6 24052 VEV_3_3_RA6_01_1237.d 1.55E5 2 2 522 535
R.IDIIPDKANKTLTIQDTGIGMTKADLVNNLGTIAR.S Y 62.28 3723.0239 35 3.4 745.6146 5 81.92 5 47298 VEV_2_3_RA5_01_1236.d 4.69E4 1 1 64 98
K.GVVDSE(+14.02)DLPLNLSR.E Y 60.82 1526.7939 14 -16.8 764.3914 2 79.79 6 45005 VEV_3_3_RA6_01_1237.d 4.63E5 4 4 362 375 Methylation(others)
R.MQEHQKQMYYITGESLK.A Y 59.96 2112.9973 17 -8.7 705.3336 3 61.49 5 32652 VEV_2_3_RA5_01_1236.d 7.92E4 2 2 459 475
K.IEEEELNK.T Y 59.70 1002.4869 8 -15.5 502.2430 2 30.23 6 12988 VEV_3_3_RA6_01_1237.d 1.15E6 9 9 260 267
R.DTSMSSYMSSK.K Y 59.04 1222.4846 11 13.0 612.2575 2 54.48 4 27758 VEV_1_3_RA4_01_1235.d 0 3 3 595 605
K.QM(+15.99)YYITGESLK.A Y 58.93 1347.6381 11 -12.5 674.8179 2 65.24 6 34301 VEV_3_3_RA6_01_1237.d 2.72E5 2 2 465 475 Oxidation (M)
K.IEEEELNKTKPIWTR.N Y 58.90 1884.9945 15 -11.0 472.2507 4 63.82 5 34403 VEV_2_3_RA5_01_1236.d 2.26E5 3 3 260 274
K.LGIHEDAQNR(+14.02).S Y 56.95 1165.5840 10 -11.6 389.5308 3 32.89 5 14934 VEV_2_3_RA5_01_1236.d 3.97E5 2 2 422 431 Methylation(KR)
K.ADLVN(+.98)NLGTIAR.S Y 56.48 1256.6725 12 -13.8 629.3348 2 72.08 4 40855 VEV_1_3_RA4_01_1235.d 3.53E5 8 8 87 98 Deamidation (NQ)
K.ITQD(+14.02)TDGESLGR.G Y 55.34 1304.6208 12 -6.2 653.3137 2 45.35 5 22344 VEV_2_3_RA5_01_1236.d 1.52E5 3 3 158 169 Methylation(others)
K.NNIKLYVR.R Y 54.57 1018.5923 8 -16.2 510.2952 2 45.54 5 22452 VEV_2_3_RA5_01_1236.d 1.63E5 2 2 334 341
R.EAEEKEFE(+14.02)GLAK.A Y 54.19 1392.6772 12 -9.9 697.3390 2 59.77 5 31384 VEV_2_3_RA5_01_1236.d 4.89E5 4 4 536 547 Methylation(others)
K.TLELFTEIAEDR(+14.02)EQFDKFYSAFSK.N Y 52.75 2927.4229 24 -1.8 732.8617 4 90.66 4 54027 VEV_1_3_RA4_01_1235.d 3.36E5 2 2 395 418 Methylation(KR)
K.GVVDSEDLPLN(+.98)LSR.E Y 52.41 1513.7623 14 -14.3 757.8776 2 78.51 6 44084 VEV_3_3_RA6_01_1237.d 1.24E5 2 2 362 375 Deamidation (NQ)
K.L(+42.01)GIHEDAQNR.S Y 52.30 1193.5789 10 -29.2 398.8553 3 25.75 6 10602 VEV_3_3_RA6_01_1237.d 2.43E5 2 2 422 431 Acetylation (N-term)
K.ITQDTD(-18.01)GESLGR.G Y 51.19 1272.5946 12 -14.0 637.2957 2 39.56 6 18239 VEV_3_3_RA6_01_1237.d 1.28E5 2 2 158 169 Dehydration
R.ETLQQNKIMK.V Y 50.77 1231.6594 10 -10.4 616.8306 2 32.91 5 14945 VEV_2_3_RA5_01_1236.d 1.58E5 3 3 376 385
K.ITQDTD(+14.02)GESLGR.G Y 50.69 1304.6208 12 -8.2 653.3124 2 46.59 5 23079 VEV_2_3_RA5_01_1236.d 3.68E5 4 4 158 169 Methylation(others)
K.SGD(+14.02)ETTSLADYVTR.M Y 49.98 1527.7052 14 -10.7 764.8517 2 71.09 6 38722 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 445 458 Methylation(others)
K.Q(-17.03)M(+15.99)YYITGESLK.A Y 49.50 1330.6115 11 4.5 666.3160 2 75.83 4 43780 VEV_1_3_RA4_01_1235.d 4.89E4 3 3 465 475 Pyro-glu from Q; Oxidation (M)
K.NFEVLFLVDPIDEYAMTQLKEFDGK.K Y 49.33 2960.4517 25 3.1 987.8275 3 95.82 4 56668 VEV_1_3_RA4_01_1235.d 1.32E5 2 2 490 514
K.ITQDTDGE(+14.02)SLGR.G Y 48.49 1304.6208 12 -10.4 653.3109 2 49.48 4 24559 VEV_1_3_RA4_01_1235.d 1.75E5 1 1 158 169 Methylation(others)
K.GVVD(+14.02)SEDLPLNLSR.E Y 48.22 1526.7939 14 -12.2 764.3950 2 78.19 4 45628 VEV_1_3_RA4_01_1235.d 2.24E5 3 3 362 375 Methylation(others)
R.I(+42.01)DIIPDKANK.T Y 48.04 1167.6499 10 -44.7 390.2065 3 52.42 6 25716 VEV_3_3_RA6_01_1237.d 4.03E4 1 1 64 73 Acetylation (N-term)
K.SGDETTSLAD(+14.02)YVTR.M Y 47.96 1527.7052 14 11.4 764.8686 2 70.26 4 39444 VEV_1_3_RA4_01_1235.d 9.18E4 1 1 445 458 Methylation(others)
R.SPIIKELKK.K Y 47.20 1054.6749 9 -37.5 528.3250 2 32.95 5 14969 VEV_2_3_RA5_01_1236.d 0 2 2 614 622
R.SPIIKELK.K Y 46.55 926.5800 8 -14.7 464.2905 2 42.96 5 20888 VEV_2_3_RA5_01_1236.d 9.92E5 7 7 614 621
R.EAEEK(+14.02)EFEGLAK.A Y 46.40 1392.6772 12 -11.0 465.2279 3 61.56 5 32702 VEV_2_3_RA5_01_1236.d 3.86E5 2 2 536 547 Methylation(KR)
K.SGDE(+14.02)TTSLADYVTR.M Y 46.20 1527.7052 14 -12.8 764.8501 2 73.89 6 40780 VEV_3_3_RA6_01_1237.d 5.44E5 2 2 445 458 Methylation(others)
K.VEEVDDEEEEK(+14.02).K Y 46.08 1362.5674 11 -7.3 682.2860 2 37.85 4 17420 VEV_1_3_RA4_01_1235.d 3.42E5 4 4 236 246 Methylation(KR)
K.TLSNDWEDHLAVKHFSVEGQLEFR.A Y 45.29 2856.3831 24 -14.3 572.2757 5 78.94 6 44439 VEV_3_3_RA6_01_1237.d 2.44E5 1 1 290 313
R.APFDLFETK.K Y 44.78 1066.5334 9 -16.7 534.2651 2 78.24 6 43899 VEV_3_3_RA6_01_1237.d 2.16E5 1 1 322 330
K.SGDETTSLADYVTRMQEHQK.Q Y 44.09 2295.0437 20 -18.2 574.7578 4 72.03 5 40480 VEV_2_3_RA5_01_1236.d 1.16E5 2 2 445 464
R.DTSMSSYMSSKK.T Y 43.76 1350.5796 12 -4.3 676.2942 2 41.16 4 19397 VEV_1_3_RA4_01_1235.d 2.81E4 1 1 595 606
K.ITQ(+.98)DTDGESLGR(+14.02).G Y 43.26 1305.6049 12 -12.9 653.8013 2 48.88 4 24171 VEV_1_3_RA4_01_1235.d 6.96E4 2 2 158 169 Deamidation (NQ); Methylation(KR)
K.RAPFDLFETK(+14.02).K Y 43.23 1236.6503 10 -2.9 413.2228 3 75.38 4 43426 VEV_1_3_RA4_01_1235.d 3E5 4 4 321 330 Methylation(KR)
K.KTFEISPR.S Y 42.44 976.5341 8 -15.3 489.2668 2 39.32 5 18713 VEV_2_3_RA5_01_1236.d 9.17E5 7 7 606 613
K.DLRIDIIPDKANK.T Y 42.16 1509.8514 13 -17.1 378.4637 4 68.30 4 37880 VEV_1_3_RA4_01_1235.d 5.87E4 1 1 61 73
K.TKPIWTR.N Y 40.39 900.5181 7 -22.9 451.2560 2 35.33 6 15837 VEV_3_3_RA6_01_1237.d 8.4E5 5 5 268 274
R.E(+14.02)AEEKEFEGLAK.A Y 40.22 1392.6772 12 -14.3 465.2264 3 62.29 6 32113 VEV_3_3_RA6_01_1237.d 5.83E5 4 4 536 547 Methylation(others)
R.ELISNC(+57.02)SDALDK(+14.02).I Y 39.00 1377.6445 12 -13.8 689.8201 2 64.84 4 35152 VEV_1_3_RA4_01_1235.d 8.92E4 1 1 33 44 Carbamidomethylation; Methylation(KR)
R.AILFVPKR.A Y 38.79 942.6014 8 -27.4 315.1992 3 61.15 4 32350 VEV_1_3_RA4_01_1235.d 4.17E5 3 3 314 321
K.AQ(+.98)ALRDTSMSSYM(+15.99)SSK.K Y 38.13 1778.7815 16 5.4 593.9376 3 45.40 4 22007 VEV_1_3_RA4_01_1235.d 9.27E4 1 1 590 605 Deamidation (NQ); Oxidation (M)
K.LDSNKDLR.I Y 37.92 959.5036 8 -15.0 480.7519 2 15.03 6 4961 VEV_3_3_RA6_01_1237.d 8.8E4 2 2 56 63
K.SPFLDTLK.E Y 37.79 919.5015 8 -16.5 460.7504 2 68.95 5 38273 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 480 487
K.T(+42.01)LTIQ(+.98)DTGIGMTK(+14.02)ADLVNNLGTIAR.S Y 37.53 2672.4055 25 -6.0 669.1046 4 77.42 5 44316 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 74 98 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
K.ITQDT(+14.02)DGESLGR.G Y 35.29 1304.6208 12 -10.6 653.3108 2 46.81 4 22886 VEV_1_3_RA4_01_1235.d 9.37E4 1 1 158 169 Methylation(others)
K.TLELFTE(+14.02)IAEDREQFDKFYSAFSK.N Y 35.00 2927.4229 24 -6.6 732.8582 4 91.70 4 54652 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 395 418 Methylation(others)
K.T(+43.01)LTIQDTGIGMTK(+14.02)ADLVNNLGTIAR.S Y 34.24 2672.4167 25 -16.9 669.1002 4 77.44 6 43327 VEV_3_3_RA6_01_1237.d 1.56E5 1 1 74 98 Carbamylation; Methylation(KR)
K.QMYYITGESLK(+14.02).A Y 33.87 1345.6588 11 -8.9 673.8307 2 73.37 6 40357 VEV_3_3_RA6_01_1237.d 1.66E4 1 1 465 475 Methylation(KR)
R.FNSTK.S Y 31.72 595.2966 5 -22.9 596.2902 1 27.03 4 11204 VEV_1_3_RA4_01_1235.d 4.09E4 1 1 440 444
K.ANK(+383.23)TLTIQDTGIGMTK.A Y 31.68 2074.1204 16 -94.4 692.3154 3 71.05 4 40041 VEV_1_3_RA4_01_1235.d 2.17E5 3 3 71 86 Ubiquitination
K.TLTIQDT(+59.02)GIGMTKADLVNNLGTIAR.S Y 30.75 2674.4146 25 14.0 669.6203 4 77.54 6 43396 VEV_3_3_RA6_01_1237.d 0 1 1 74 98 Aminoethylcysteine
K.TLTIQDTGIGMTK(-.98).A Y 30.37 1376.7334 13 -45.8 689.3425 2 70.68 6 38363 VEV_3_3_RA6_01_1237.d 0 1 1 74 86 Amidation
K.SGDETTSLADYVT(-18.01)R(+14.02).M Y 30.24 1509.6947 14 14.5 755.8655 2 70.58 5 39417 VEV_2_3_RA5_01_1236.d 0 1 1 445 458 Dehydration; Methylation(KR)
K.LLRFNSTK.S Y 30.03 977.5658 8 -14.3 489.7832 2 38.54 5 18254 VEV_2_3_RA5_01_1236.d 2.23E5 2 2 437 444
K.VEEVDDE(+14.02)EEEKKK.E Y 29.76 1618.7573 13 -8.0 540.5887 3 22.29 4 8623 VEV_1_3_RA4_01_1235.d 5.12E4 1 1 236 248 Methylation(others)
K.TLTIQ(+.98)DTGIGMTK.A Y 29.58 1378.7014 13 -35.0 690.3339 2 72.52 5 40870 VEV_2_3_RA5_01_1236.d 1.25E5 2 2 74 86 Deamidation (NQ)
K.LVDITK(+14.02)DFELEETDEEKKTR.E Y 28.86 2451.2380 20 -0.2 491.2548 5 72.38 5 40742 VEV_2_3_RA5_01_1236.d 2.62E5 2 2 516 535 Methylation(KR)
K.LGIHE(+14.02)DAQNR.S Y 28.57 1165.5840 10 -17.3 583.7892 2 38.34 6 17546 VEV_3_3_RA6_01_1237.d 2.99E5 2 2 422 431 Methylation(others)
R.IDIIPDK.A Y 28.10 812.4644 7 -18.9 407.2318 2 62.59 6 32324 VEV_3_3_RA6_01_1237.d 2E5 1 1 64 70
R.EAEEKEFEGLAK(+14.02).A Y 27.82 1392.6772 12 -14.6 465.2262 3 61.45 6 31481 VEV_3_3_RA6_01_1237.d 6.55E5 2 2 536 547 Methylation(KR)
R.EAE(+14.02)EKEFEGLAK.A Y 27.49 1392.6772 12 -10.6 465.2281 3 62.57 4 33420 VEV_1_3_RA4_01_1235.d 2.69E5 2 2 536 547 Methylation(others)
K.EIEK(-1.03)EVVDEDAEEVKEDDEDKAPK.V Y 27.28 2786.2505 24 5.4 697.5737 4 60.80 5 32145 VEV_2_3_RA5_01_1236.d 0 1 1 212 235 Lysine oxidation to aminoadipic semialdehyde
K.NFEVLFLVD(+6.01)PIDEYAMTQLKEFDGK.K Y 26.86 2966.4600 25 -50.9 989.7770 3 95.84 5 54576 VEV_2_3_RA5_01_1236.d 0 1 1 490 514 Replacement of proton by lithium
R.RVFITDDATDLIPEWLSFVK(+14.02).G Y 26.39 2378.2522 20 -13.9 793.7470 3 94.78 6 53516 VEV_3_3_RA6_01_1237.d 1.33E5 2 2 342 361 Methylation(KR)
K.LDSNK.D N 26.34 575.2915 5 -5.4 576.2957 1 56.82 5 29304 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 56 60
K.AQALRDTSMSSYMSSKK.T Y 26.31 1889.8975 17 -51.1 473.4575 4 52.74 4 26643 VEV_1_3_RA4_01_1235.d 0 1 1 590 606
K.IKEVVKK.H Y 25.90 842.5589 7 -34.6 422.2722 2 11.37 6 3093 VEV_3_3_RA6_01_1237.d 0 1 1 190 196
K.TFE(+14.02)ISPR.S Y 25.85 862.4548 7 -11.6 432.2297 2 59.15 5 30923 VEV_2_3_RA5_01_1236.d 3.47E5 4 4 607 613 Methylation(others)
K.VEEVDDEEEEK(+14.02)KK.E Y 25.22 1618.7573 13 -11.7 810.3765 2 21.51 6 8354 VEV_3_3_RA6_01_1237.d 5.73E4 2 2 236 248 Methylation(KR)
K.KT(+79.96)FEISPR.S Y 24.94 1056.4910 8 80.1 353.1991 3 39.17 6 18047 VEV_3_3_RA6_01_1237.d 2.9E5 1 1 606 613 Sulfation
K.LGIHEDAQN(+.98)R.S Y 24.66 1152.5524 10 -8.9 385.1880 3 28.71 4 12121 VEV_1_3_RA4_01_1235.d 2.83E5 1 1 422 431 Deamidation (NQ)
R.RVFITDDATD(+14.02)LIPEWLSFVK.G Y 24.35 2378.2522 20 -9.2 793.7507 3 93.79 5 53745 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 342 361 Methylation(others)
K.Q(+.98)MYYITGESLK.A Y 23.95 1332.6271 11 4.4 667.3237 2 70.24 4 39401 VEV_1_3_RA4_01_1235.d 6.48E4 1 1 465 475 Deamidation (NQ)
K.NFEVLFLVDPIDEYAM(+15.99)TQLKEFDGKK.L Y 23.34 3104.5415 26 -30.3 777.1191 4 91.30 6 51979 VEV_3_3_RA6_01_1237.d 0 1 1 490 515 Oxidation (M)
R.IDIIPDKAN(+.98)K.T Y 23.05 1126.6233 10 0.6 376.5486 3 52.82 5 26875 VEV_2_3_RA5_01_1236.d 2.92E5 1 1 64 73 Deamidation (NQ)
K.LVDITK(-1.03)DFELEETDEEKK.T Y 22.72 2179.0420 18 61.6 545.8013 4 73.82 6 40684 VEV_3_3_RA6_01_1237.d 0 1 1 516 533 Lysine oxidation to aminoadipic semialdehyde
K.NVLGDK(-2.02).V Y 22.57 642.3337 6 -7.2 643.3363 1 66.36 6 35152 VEV_3_3_RA6_01_1237.d 1.76E4 1 1 551 556 2-amino-3-oxo-butanoic_acid
K.VVVS(-2.02)HKLIGSPC(+57.02)AIR.T Y 22.09 1632.9133 15 -23.0 409.2262 4 59.94 5 31504 VEV_2_3_RA5_01_1236.d 2.03E5 1 1 560 574 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.AILFVPK(+14.02).R Y 22.05 800.5160 7 -25.3 401.2551 2 73.32 6 40344 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 314 320 Methylation(KR)
R.RVFITDDATDLIPE(+14.02)WLSFVK.G Y 22.05 2378.2522 20 -5.4 1190.1270 2 93.99 6 53188 VEV_3_3_RA6_01_1237.d 5.91E4 1 1 342 361 Methylation(others)
K.LIGSPC(+57.02)AIR(+14.02).T Y 21.69 999.5535 9 -14.0 500.7770 2 64.12 5 34615 VEV_2_3_RA5_01_1236.d 8.77E4 1 1 566 574 Carbamidomethylation; Methylation(KR)
R.I(+42.01)D(-18.01)IIPDK.A Y 21.42 836.4644 7 -39.5 419.2229 2 34.30 6 15254 VEV_3_3_RA6_01_1237.d 0 1 1 64 70 Acetylation (N-term); Dehydration
K.N(+42.01)VLGD(-18.01)K.V Y 21.21 668.3493 6 -40.6 669.3295 1 75.01 6 41550 VEV_3_3_RA6_01_1237.d 0 1 1 551 556 Acetylation (N-term); Dehydration
K.VE(+14.02)EVDDEEEEK.K Y 21.13 1362.5674 11 27.5 682.3097 2 36.88 4 16860 VEV_1_3_RA4_01_1235.d 0 1 1 236 246 Methylation(others)
K.LGIHEDAQ(+.98)NR.S Y 20.92 1152.5524 10 -13.4 385.1862 3 28.73 5 12521 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 422 431 Deamidation (NQ)
K.IEE(+14.02)EELNK.T Y 20.70 1016.5026 8 -11.3 509.2528 2 45.58 6 21738 VEV_3_3_RA6_01_1237.d 1.52E5 3 3 260 267 Methylation(others)
K.VE(+14.02)EVDDEEEEKKK.E Y 20.66 1618.7573 13 -9.3 540.5880 3 21.04 5 8310 VEV_2_3_RA5_01_1236.d 1.76E4 1 1 236 248 Methylation(others)
K.VEEVDD(+14.02)EEEEKKK.E Y 19.81 1618.7573 13 -11.4 810.3767 2 21.93 6 8565 VEV_3_3_RA6_01_1237.d 2.82E3 1 1 236 248 Methylation(others)
R.N(+.98)PADITQEEYASFYK(+14.02).T Y 19.45 1789.8046 15 6.1 895.9150 2 80.18 6 45288 VEV_3_3_RA6_01_1237.d 4.44E4 1 1 275 289 Deamidation (NQ); Methylation(KR)
R.NPADITQE(+28.03)EYASFYK.T Y 19.42 1802.8362 15 -12.0 902.4146 2 81.45 6 46170 VEV_3_3_RA6_01_1237.d 1.72E5 1 1 275 289 Ethylation
R.APFD(-18.01)LFETK.K Y 19.15 1048.5229 9 -9.2 525.2639 2 19.09 6 7096 VEV_3_3_RA6_01_1237.d 1.18E4 1 1 322 330 Dehydration
R.RVFITDDAT(-2.02)DLIPEWLSFVK.G Y 19.12 2362.2209 20 -6.3 788.4093 3 93.25 4 55431 VEV_1_3_RA4_01_1235.d 0 1 1 342 361 2-amino-3-oxo-butanoic_acid
K.NVLGDKVEK.V Y 18.92 1000.5553 9 -42.1 334.5117 3 28.07 4 11785 VEV_1_3_RA4_01_1235.d 0 1 1 551 559
K.L(+42.01)DSNKDLR.I Y 18.71 1001.5142 8 -5.8 1002.5156 1 112.20 4 61734 VEV_1_3_RA4_01_1235.d 6.57E3 1 1 56 63 Acetylation (N-term)
K.MILHLK(+14.02)DEQTEYLNESK.I Y 18.54 2104.0510 17 -0.5 527.0198 4 70.83 4 39866 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 173 189 Methylation(KR)
K.HSEFISY(-18.01)PIYLHVVK(+14.02).E Y 18.38 1826.9719 15 5.0 610.0010 3 76.45 6 42592 VEV_3_3_RA6_01_1237.d 0 1 1 197 211 Dehydration; Methylation(KR)
K.LVDITKDFELEETDE(+14.02)EKKTR.E Y 18.32 2451.2380 20 -19.7 491.2452 5 73.62 6 40534 VEV_3_3_RA6_01_1237.d 1.51E5 1 1 516 535 Methylation(others)
K.TFEISPR(+14.02).S Y 17.83 862.4548 7 4.1 432.2365 2 15.83 6 5389 VEV_3_3_RA6_01_1237.d 7.47E4 1 1 607 613 Methylation(KR)
K.NIK(+78.05)LGIHEDAQNR.S Y 17.65 1584.8372 13 -35.7 397.2024 4 25.72 5 10887 VEV_2_3_RA5_01_1236.d 0 1 1 419 431 2,5-dimethypyrrole
K.L(+43.01)IGSPC(+57.02)AIR.T Y 17.60 1028.5437 9 -14.3 343.8503 3 9.69 4 2356 VEV_1_3_RA4_01_1235.d 1.29E4 1 1 566 574 Carbamylation; Carbamidomethylation
R.ELISNC(+57.02)SDALDK(+14.02)IR.Y Y 17.38 1646.8297 14 -0.2 549.9504 3 71.97 4 40766 VEV_1_3_RA4_01_1235.d 5.52E4 1 1 33 46 Carbamidomethylation; Methylation(KR)
K.NVLGDK(+42.01).V Y 17.08 686.3599 6 -18.4 687.3545 1 23.20 4 9092 VEV_1_3_RA4_01_1235.d 1.13E4 1 1 551 556 Acetylation (K)
K.NIKLGIHEDAQNR(+14.02).S Y 16.81 1520.8059 13 -7.5 507.9388 3 47.91 5 23875 VEV_2_3_RA5_01_1236.d 0 1 1 419 431 Methylation(KR)
K.A(+42.01)QALR(+21.98).D Y 16.71 621.3210 5 -2.5 622.3268 1 83.75 6 47664 VEV_3_3_RA6_01_1237.d 6.76E4 1 1 590 594 Acetylation (N-term); Sodium adduct
K.TFEISPR(+132.02).S Y 16.57 980.4603 7 16.7 491.2456 2 71.84 4 40669 VEV_1_3_RA4_01_1235.d 6.21E4 1 1 607 613 Hydroxyphenylglyoxal arginine
K.EIFLR.E N 16.31 676.3907 5 -23.1 339.1948 2 56.46 6 28010 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 28 32
K.I(+226.08)RYEALSDPSK.L Y 16.09 1503.7391 11 -11.6 502.2478 3 56.15 5 28854 VEV_2_3_RA5_01_1236.d 2.66E4 1 1 45 55 Biotinylation
K.FYSAFSKNIKLGIHEDAQNRS(+162.05)ALAK.L Y 16.08 2969.5247 25 6.6 594.9161 5 73.86 4 42252 VEV_1_3_RA4_01_1235.d 5.78E4 1 1 412 436 Hexose (NSY)
K.TFEISPRS(+79.97)PIIK.E Y 15.66 1466.7534 12 -18.4 489.9161 3 54.10 4 27500 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 607 618 Phosphorylation (STY)
K.T(+43.01)LELFTEIAEDR(+14.02).E Y 15.60 1492.7408 12 -8.6 747.3713 2 80.67 5 46489 VEV_2_3_RA5_01_1236.d 4.53E3 1 1 395 406 Carbamylation; Methylation(KR)
R.SALAK(+43.01).L Y 15.55 531.3016 5 -0.6 532.3086 1 63.37 4 34031 VEV_1_3_RA4_01_1235.d 3.9E4 1 1 432 436 Carbamylation
K.AVQKSPFLDTLK(+175.04).E Y 15.47 1520.8027 12 5.0 305.1693 5 22.60 4 8772 VEV_1_3_RA4_01_1235.d 0 1 1 476 487 Naphthalene-2,3-dicarboxaldehyde
R.E(-18.01)AEEK(+14.02)EFEGLAK.A Y 15.45 1374.6666 12 35.7 459.2458 3 56.40 4 28890 VEV_1_3_RA4_01_1235.d 0 1 1 536 547 Pyro-glu from E; Methylation(KR)
K.A(+42.01)LKN(+.98)VLGDK(+42.01).V Y 15.45 1041.5706 9 -27.6 348.1879 3 55.44 6 27401 VEV_3_3_RA6_01_1237.d 0 1 1 548 556 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
R.AILFVPKRAPFDLFETK.K Y 15.32 1991.1243 17 -19.6 498.7786 4 81.94 6 46503 VEV_3_3_RA6_01_1237.d 4.38E4 1 1 314 330
R.A(+42.01)ILFVPK.R Y 15.21 828.5109 7 -79.4 415.2298 2 69.16 6 37241 VEV_3_3_RA6_01_1237.d 5.22E4 1 1 314 320 Acetylation (N-term)
R.S(+79.96)ALAK.L Y 15.18 568.2526 5 9.2 569.2651 1 112.50 6 58775 VEV_3_3_RA6_01_1237.d 0 1 1 432 436 Sulfation
total 195 peptides
C1G810
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HDGGFNIVHIKDAIDNSFATR.E Y 157.88 2326.1455 21 -5.2 582.5406 4 78.42 4 45804 VEV_1_3_RA4_01_1235.d 2.45E6 10 10 201 221
R.ERHDGGFNIVHIKDAIDNSFATR.E Y 156.27 2611.2891 23 -8.7 653.8239 4 76.84 5 43900 VEV_2_3_RA5_01_1236.d 1.38E6 6 6 199 221
R.VQLGKGGIPFLVTHDAR.T Y 131.93 1807.0104 17 -37.5 603.3215 3 72.12 5 40554 VEV_2_3_RA5_01_1236.d 1.54E6 9 9 129 145
R.ESNVFIIGQEKPWISLPK.G Y 130.02 2084.1306 18 -9.4 695.7109 3 82.44 4 48848 VEV_1_3_RA4_01_1235.d 3.35E6 11 11 222 239
K.ITSFIKFDTGVIAMATGGR.N Y 129.75 1984.0452 19 -7.1 993.0228 2 84.38 4 50193 VEV_1_3_RA4_01_1235.d 1.28E6 10 10 169 187
R.TIRYPDPAIKVNDTVKVDLATGK.I Y 126.97 2513.3853 23 -2.1 503.6833 5 71.72 4 40575 VEV_1_3_RA4_01_1235.d 3.78E5 1 1 146 168
K.VDLATGKITSFIKFDTGVIAMATGGR.N Y 126.74 2668.4258 26 -7.1 668.1090 4 87.91 6 50174 VEV_3_3_RA6_01_1237.d 5.11E5 5 5 162 187
R.LSAPSHWLLDKLSGSYAPRPSPGPHK.L Y 125.23 2797.4663 26 -9.8 560.4951 5 74.68 4 42885 VEV_1_3_RA4_01_1235.d 1.29E6 7 7 12 37
K.VRTDSTYPAGFMDVISIEK.T Y 121.01 2128.0510 19 -9.6 710.3508 3 80.71 4 47567 VEV_1_3_RA4_01_1235.d 1.18E6 7 7 76 94
R.TDSTYPAGFMDVISIEKTGENFR.L Y 120.61 2577.2056 23 -5.1 860.0714 3 83.68 4 49709 VEV_1_3_RA4_01_1235.d 3.5E5 3 3 78 100
R.IQAEEAEYKLC(+57.02)K.V Y 120.33 1480.7231 12 -10.7 741.3610 2 51.57 5 26150 VEV_2_3_RA5_01_1236.d 5.45E6 17 17 114 125 Carbamidomethylation
K.LRDC(+57.02)LPLVVFIR.N Y 111.15 1499.8646 12 -9.3 500.9575 3 82.30 4 48764 VEV_1_3_RA4_01_1235.d 2.31E6 7 7 38 49 Carbamidomethylation
K.TGENFRLVYDTK.G Y 111.05 1441.7201 12 -11.0 721.8594 2 63.48 5 34149 VEV_2_3_RA5_01_1236.d 1.96E6 10 10 95 106
K.VNDTVKVDLATGK.I Y 109.76 1358.7405 13 -15.7 680.3669 2 53.05 6 26106 VEV_3_3_RA6_01_1237.d 1.56E6 12 12 156 168
K.RVQLGKGGIPFLVTHDAR.T Y 108.05 1963.1115 18 -19.7 393.6218 5 68.85 5 38163 VEV_2_3_RA5_01_1236.d 4.87E5 3 3 128 145
K.VNDTVKVDLATGKITSFIKFDTGVIAMATGGR.N Y 101.28 3324.7751 32 6.9 665.9669 5 87.11 4 51978 VEV_1_3_RA4_01_1235.d 4.31E5 3 3 156 187
R.TDSTYPAGFMDVISIEK.T Y 99.28 1872.8815 17 -11.3 625.2941 3 84.26 6 47998 VEV_3_3_RA6_01_1237.d 1.84E6 9 9 78 94
R.DC(+57.02)LPLVVFIR.N Y 98.65 1230.6794 10 -23.0 411.2243 3 86.76 6 49529 VEV_3_3_RA6_01_1237.d 9.89E5 5 5 40 49 Carbamidomethylation
K.FDTGVIAMATGGR.N Y 97.95 1294.6339 13 -16.0 648.3138 2 76.42 6 42569 VEV_3_3_RA6_01_1237.d 8.26E5 5 5 175 187
K.GGIPFLVTHDAR.T Y 95.46 1281.6830 12 -9.9 641.8424 2 69.84 4 39104 VEV_1_3_RA4_01_1235.d 5.54E6 12 12 134 145
K.LSGSYAPRPSPGPHK.L Y 91.79 1549.8000 15 -5.1 388.4553 4 31.71 4 13843 VEV_1_3_RA4_01_1235.d 1.56E6 8 8 23 37
K.VRTDSTYPAGFMDVISIEK(+14.02).T Y 91.59 2142.0667 19 -3.9 715.0267 3 83.26 4 49399 VEV_1_3_RA4_01_1235.d 9.05E4 1 1 76 94 Methylation(KR)
R.HDGGFNIVHIKDAIDN(+.98)SFATR.E Y 90.80 2327.1294 21 5.5 466.4357 5 78.44 4 45824 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 201 221 Deamidation (NQ)
R.TIRYPDPAIKVNDTVK.V Y 89.01 1829.0046 16 -10.6 610.6690 3 63.74 5 34340 VEV_2_3_RA5_01_1236.d 1.74E6 6 6 146 161
R.TDSTYPAGFMDVISIEKTGENFRLVYDTK.G Y 85.70 3296.5911 29 -13.2 825.1442 4 85.91 4 51183 VEV_1_3_RA4_01_1235.d 4.04E5 5 5 78 106
R.IQAEEAEYK.L Y 85.51 1079.5134 9 -11.6 540.7578 2 32.77 5 14865 VEV_2_3_RA5_01_1236.d 9.74E5 7 7 114 122
R.RAVALAGH Y 83.80 793.4558 8 -14.5 397.7294 2 18.45 5 6891 VEV_2_3_RA5_01_1236.d 4.5E5 4 4 255 262
R.ETNAILM(+15.99)QR.L Y 80.37 1090.5441 9 -7.7 546.2751 2 40.84 4 19238 VEV_1_3_RA4_01_1235.d 3.33E6 33 33 60 68 Oxidation (M)
R.ETNAILMQR.L Y 77.55 1074.5492 9 -11.2 538.2759 2 54.01 4 27491 VEV_1_3_RA4_01_1235.d 2.35E6 14 14 60 68
R.ESNVFIIGQEK(+14.02)PWISLPK.G Y 77.32 2098.1462 18 -14.0 700.3796 3 84.08 6 47885 VEV_3_3_RA6_01_1237.d 7.11E5 8 8 222 239 Methylation(KR)
R.TDSTYPAGFM(+15.99)DVISIEK.T Y 77.25 1888.8765 17 -7.7 945.4382 2 79.60 4 46713 VEV_1_3_RA4_01_1235.d 2.26E5 3 3 78 94 Oxidation (M)
R.ESNVFIIGQEKPWISLPK(+14.02).G Y 75.42 2098.1462 18 -8.7 700.3833 3 83.62 4 49649 VEV_1_3_RA4_01_1235.d 3.66E5 4 4 222 239 Methylation(KR)
R.LSAPSHWLLDK.L Y 75.31 1265.6768 11 -13.9 422.8936 3 70.82 4 39949 VEV_1_3_RA4_01_1235.d 6.45E5 6 6 12 22
K.DAIDNSFATR.E Y 71.55 1108.5149 10 20.3 555.2760 2 57.83 6 28941 VEV_3_3_RA6_01_1237.d 8.79E5 7 7 212 221
R.IQAEEAEYKLC(+57.02)K(+14.02).V Y 71.08 1494.7388 12 -15.5 499.2458 3 56.21 6 27853 VEV_3_3_RA6_01_1237.d 4.65E5 3 3 114 125 Carbamidomethylation; Methylation(KR)
K.LRDC(+57.02)LPLVVFIR(+14.02).N Y 70.37 1513.8802 12 -9.5 505.6292 3 83.90 4 49842 VEV_1_3_RA4_01_1235.d 1.06E5 3 3 38 49 Carbamidomethylation; Methylation(KR)
R.E(+14.02)SNVFIIGQEKPWISLPK.G Y 68.95 2098.1462 18 -6.1 1050.0740 2 82.87 4 49136 VEV_1_3_RA4_01_1235.d 2.79E5 3 3 222 239 Methylation(others)
R.IQAE(+14.02)EAEYKLC(+57.02)K.V Y 67.86 1494.7388 12 -7.9 499.2496 3 58.09 4 30075 VEV_1_3_RA4_01_1235.d 5.23E5 6 6 114 125 Methylation(others); Carbamidomethylation
R.IQAEE(+14.02)AEYKLC(+57.02)K.V Y 67.06 1494.7388 12 -10.3 499.2484 3 58.51 4 30368 VEV_1_3_RA4_01_1235.d 1.3E6 6 6 114 125 Methylation(others); Carbamidomethylation
R.ERHDGGFNIVHIK(-1.03)DAIDNSFATR.E Y 66.84 2610.2573 23 13.5 523.0658 5 76.84 4 44565 VEV_1_3_RA4_01_1235.d 0 1 1 199 221 Lysine oxidation to aminoadipic semialdehyde
K.LR(+14.02)DC(+57.02)LPLVVFIR.N Y 66.77 1513.8802 12 -12.6 505.6277 3 84.32 4 50140 VEV_1_3_RA4_01_1235.d 7.48E4 1 1 38 49 Methylation(KR); Carbamidomethylation
R.TIRYPDPAIK.V Y 66.71 1172.6553 10 -11.6 391.8878 3 57.23 4 29466 VEV_1_3_RA4_01_1235.d 4.69E6 15 15 146 155
K.GGIPFLVTHDAR(+14.02).T Y 63.95 1295.6986 12 -14.9 432.9004 3 71.14 4 40113 VEV_1_3_RA4_01_1235.d 8.92E5 6 6 134 145 Methylation(KR)
R.IQAEEAE(+14.02)YKLC(+57.02)K.V Y 63.65 1494.7388 12 -9.6 748.3695 2 59.13 5 30911 VEV_2_3_RA5_01_1236.d 5.11E5 6 6 114 125 Methylation(others); Carbamidomethylation
K.RLSAPSHWLLDK.L Y 62.56 1421.7778 12 -4.2 474.9312 3 66.60 4 36525 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 11 22
R.VGVITHRER.H Y 61.68 1065.6042 9 -13.4 533.8022 2 17.59 6 6347 VEV_3_3_RA6_01_1237.d 1.64E6 7 7 192 200
R.HDGGFNIVHIKDAIDNSFATR(+14.02).E Y 60.16 2340.1611 21 -23.8 469.0284 5 79.29 5 45583 VEV_2_3_RA5_01_1236.d 6.25E4 1 1 201 221 Methylation(KR)
R.VGVITHR.E Y 59.27 780.4606 7 -40.5 391.2218 2 18.83 5 7100 VEV_2_3_RA5_01_1236.d 6.11E5 8 8 192 198
K.LR(+.98)DC(+57.02)LPLVVFIR.N Y 58.98 1500.8486 12 -2.8 501.2888 3 84.52 4 50266 VEV_1_3_RA4_01_1235.d 1.6E5 3 3 38 49 Deamidation (R); Carbamidomethylation
K.FDTGVIAM(+15.99)ATGGR.N Y 58.13 1310.6289 13 -9.5 656.3155 2 69.68 4 38961 VEV_1_3_RA4_01_1235.d 3E5 2 2 175 187 Oxidation (M)
R.LKYALNAR.E Y 58.06 947.5552 8 -19.8 316.8528 3 38.25 6 17496 VEV_3_3_RA6_01_1237.d 1.58E6 5 5 52 59
R.ETNAILMQ(+.98)R.L Y 55.67 1075.5332 9 -23.4 538.7613 2 57.37 5 29745 VEV_2_3_RA5_01_1236.d 5.67E5 6 6 60 68 Deamidation (NQ)
R.ESN(+.98)VFIIGQEKPWISLPK.G Y 55.25 2085.1145 18 -15.5 696.0347 3 83.21 6 47372 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 222 239 Deamidation (NQ)
K.LSIAEERDR.R Y 54.56 1087.5621 9 -17.9 544.7786 2 31.39 6 13674 VEV_3_3_RA6_01_1237.d 5.34E6 12 12 245 253
K.ITSFIKFDTGVIAMATGGR(+14.02).N Y 53.92 1998.0608 19 3.4 667.0298 3 85.29 4 50783 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 169 187 Methylation(KR)
R.ES(-2.02)NVFIIGQEKPWISLPK.G Y 52.05 2082.1150 18 -42.8 695.0159 3 82.73 6 47023 VEV_3_3_RA6_01_1237.d 1.14E5 2 2 222 239 2-amino-3-oxo-butanoic_acid
R.YPDPAIK.V Y 51.36 802.4225 7 -16.5 803.4165 1 43.49 6 20509 VEV_3_3_RA6_01_1237.d 1.51E6 9 9 149 155
K.G(+41.03)GIPFLVTHDAR.T Y 51.07 1322.7095 12 -0.4 441.9103 3 69.92 4 39152 VEV_1_3_RA4_01_1235.d 1.96E5 2 2 134 145 Amidination of lysines or N-terminal amines with methyl acetimidate
R.VQLGKGGIP(+31.99)FLVTHDAR.T Y 50.89 1839.0002 17 -8.3 460.7535 4 72.27 4 41012 VEV_1_3_RA4_01_1235.d 0 1 1 129 145 Dihydroxy
R.IQ(+.98)AEEAEYKLC(+57.02)K.V Y 50.49 1481.7072 12 -11.1 494.9042 3 54.99 4 28055 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 114 125 Deamidation (NQ); Carbamidomethylation
K.GRFTVHR.I Y 50.05 871.4777 7 -11.0 436.7413 2 17.52 4 6097 VEV_1_3_RA4_01_1235.d 9.97E5 6 6 107 113
K.GVKLSIAEERDR.R Y 49.36 1371.7469 12 -13.2 458.2502 3 41.78 5 20189 VEV_2_3_RA5_01_1236.d 1.02E6 6 6 242 253
R.ESNVFIIGQEKPWISLP(+31.99)K.G Y 49.35 2116.1204 18 -23.8 706.3640 3 79.25 6 44627 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 222 239 Dihydroxy
R.HDGGFNIVHIK.D Y 49.23 1235.6411 11 -15.1 309.9129 4 58.98 4 30717 VEV_1_3_RA4_01_1235.d 8.2E4 1 1 201 211
K.FDTGVIAMATGGR(+14.02).N Y 48.17 1308.6497 13 -8.0 655.3268 2 78.29 4 45702 VEV_1_3_RA4_01_1235.d 2.01E5 2 2 175 187 Methylation(KR)
R.FTVHR.I Y 47.26 658.3551 5 -16.6 330.1794 2 16.83 5 6008 VEV_2_3_RA5_01_1236.d 1.51E6 3 3 109 113
R.VQ(+.98)LGKGGIPFLVTHDAR.T Y 47.14 1807.9944 17 -38.2 603.6490 3 72.29 4 41025 VEV_1_3_RA4_01_1235.d 8.26E4 2 2 129 145 Deamidation (NQ)
K.VDLATGKITSFIK(-1.03)FDTGVIAMATGGR.N Y 47.02 2667.3940 26 -14.4 667.8462 4 87.85 5 50760 VEV_2_3_RA5_01_1236.d 4.87E4 1 1 162 187 Lysine oxidation to aminoadipic semialdehyde
R.HDGGFNIVHIK(+14.02)DAIDNSFATR.E Y 46.74 2340.1611 21 -0.3 469.0394 5 79.94 4 46971 VEV_1_3_RA4_01_1235.d 5.49E4 2 2 201 221 Methylation(KR)
R.AVALAGH Y 45.79 637.3547 7 -20.5 319.6781 2 21.93 6 8584 VEV_3_3_RA6_01_1237.d 1.2E6 8 8 256 262
R.TDSTYPAGFMDVISIEK(+14.02)TGENFR.L Y 45.72 2591.2214 23 -5.7 864.7428 3 86.81 4 51759 VEV_1_3_RA4_01_1235.d 6.46E3 1 1 78 100 Methylation(KR)
R.ERHDGGFNIVHIK.D Y 44.84 1520.7848 13 -14.7 381.1979 4 55.04 4 28081 VEV_1_3_RA4_01_1235.d 1.5E5 2 2 199 211
K.LSIAEER.D Y 44.52 816.4341 7 -21.4 409.2156 2 37.60 6 17159 VEV_3_3_RA6_01_1237.d 1.84E6 7 7 245 251
R.IQAEEAE(+14.02)YK.L Y 44.19 1093.5291 9 -5.3 547.7689 2 41.09 4 19359 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 114 122 Methylation(others)
R.TDSTYPAGFMDVISIEK(+14.02).T Y 44.18 1886.8971 17 0.4 944.4562 2 85.41 4 50882 VEV_1_3_RA4_01_1235.d 3.68E5 4 4 78 94 Methylation(KR)
R.ESNVFIIGQEK(+14.02)PWISLPK(+14.02).G Y 43.52 2112.1619 18 15.5 705.0721 3 85.26 4 50762 VEV_1_3_RA4_01_1235.d 0 1 1 222 239 Methylation(KR)
K.VDLATGK(-1.03)ITSFIKFDTGVIAMATGGR.N Y 42.95 2667.3940 26 3.9 890.1421 3 87.97 5 50873 VEV_2_3_RA5_01_1236.d 9.79E3 1 1 162 187 Lysine oxidation to aminoadipic semialdehyde
K.ITSFIK.F Y 42.33 707.4218 6 -14.3 354.7131 2 51.54 4 25854 VEV_1_3_RA4_01_1235.d 7.14E5 6 6 169 174
R.ESNVFIIGQEKP(+31.99)WISLPK.G Y 42.29 2116.1204 18 -15.0 706.3702 3 79.33 4 46500 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 222 239 Dihydroxy
R.LVYDTK.G Y 41.99 737.3959 6 -11.5 369.7010 2 26.65 4 11008 VEV_1_3_RA4_01_1235.d 9.39E5 3 3 101 106
K.TGEN(+.98)FRLVYDTK.G Y 40.89 1442.7041 12 4.4 722.3625 2 63.69 4 34271 VEV_1_3_RA4_01_1235.d 5.08E4 1 1 95 106 Deamidation (NQ)
K.YALNAR.E Y 39.95 706.3762 6 -19.8 354.1884 2 27.82 6 11678 VEV_3_3_RA6_01_1237.d 1.55E6 6 6 54 59
R.IQ(+.98)AEEAEYKLC(+57.02)K(+14.02).V Y 39.44 1495.7228 12 1.2 499.5822 3 56.79 4 29163 VEV_1_3_RA4_01_1235.d 6.99E4 1 1 114 125 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
R.VQLGKGGIPFLVTHDAR(+14.02).T Y 39.42 1821.0260 17 -13.1 456.2578 4 73.96 4 42328 VEV_1_3_RA4_01_1235.d 5.86E5 4 4 129 145 Methylation(KR)
R.YPDPAIKVNDTVKVDLATGK.I Y 38.47 2143.1523 20 -11.9 536.7890 4 71.09 6 38672 VEV_3_3_RA6_01_1237.d 3.27E5 2 2 149 168
R.TIRYPDPAIKVNDTVK(+14.02).V Y 38.23 1843.0203 16 -8.0 461.7587 4 66.71 4 36614 VEV_1_3_RA4_01_1235.d 8.33E4 1 1 146 161 Methylation(KR)
K.G(+43.01)GIPFLVTHDAR(+14.02).T Y 38.18 1338.7043 12 -13.4 447.2361 3 71.07 4 40123 VEV_1_3_RA4_01_1235.d 2.31E5 2 2 134 145 Carbamylation; Methylation(KR)
R.IQAE(+14.02)EAEYK.L Y 38.15 1093.5291 9 -9.0 547.7669 2 42.01 4 19919 VEV_1_3_RA4_01_1235.d 1.47E5 3 3 114 122 Methylation(others)
R.LVKVDGK.V Y 37.64 757.4697 7 -17.8 379.7354 2 15.28 6 5086 VEV_3_3_RA6_01_1237.d 6.03E5 3 3 69 75
K.TGENFR.L Y 36.36 722.3347 6 3.5 362.1759 2 16.02 6 5539 VEV_3_3_RA6_01_1237.d 0 1 1 95 100
R.TIR(+14.02)YPD(-18.01)PAIKVNDTVK.V Y 35.88 1825.0098 16 -27.5 457.2472 4 63.61 6 33084 VEV_3_3_RA6_01_1237.d 0 1 1 146 161 Methylation(KR); Dehydration
R.LVKVDGKVR.T Y 35.82 1012.6393 9 -23.8 507.3148 2 23.08 5 9383 VEV_2_3_RA5_01_1236.d 7.08E4 4 4 69 77
R.ESNVFIIGQEK(+27.99)PWISLPK.G Y 35.26 2112.1255 18 4.6 705.0524 3 85.06 6 48499 VEV_3_3_RA6_01_1237.d 2.89E4 1 1 222 239 Formylation
R.IQAEEAEYK(+14.02).L Y 34.97 1093.5291 9 0.3 547.7720 2 43.43 4 20796 VEV_1_3_RA4_01_1235.d 2.78E5 2 2 114 122 Methylation(KR)
R.E(+14.02)TNAILMQR.L Y 33.56 1088.5648 9 -8.8 545.2849 2 59.29 4 30958 VEV_1_3_RA4_01_1235.d 1.89E5 1 1 60 68 Methylation(others)
K.TGENFRLVYDTK(+14.02).G Y 31.90 1455.7357 12 -12.8 728.8658 2 66.03 5 36057 VEV_2_3_RA5_01_1236.d 3.78E5 2 2 95 106 Methylation(KR)
R.VQLGK(+14.02)GGIPFLVTHDAR.T Y 31.89 1821.0260 17 -4.5 456.2617 4 70.23 4 39388 VEV_1_3_RA4_01_1235.d 0 1 1 129 145 Methylation(KR)
K.VRTDSTYPAGFMDVIS(-18.01)IEK(+14.02).T Y 31.89 2124.0562 19 -17.6 709.0135 3 80.75 6 45687 VEV_3_3_RA6_01_1237.d 0 1 1 76 94 Dehydration; Methylation(KR)
R.VQLGK(+43.01)GGIPFLVTHDAR.T Y 31.45 1850.0162 17 -93.1 463.4683 4 72.29 4 41027 VEV_1_3_RA4_01_1235.d 7.74E4 1 1 129 145 Carbamylation
R.ESNVFIIGQEKPW(+15.99)ISLPK.G Y 31.34 2100.1255 18 -11.8 701.0408 3 81.07 5 46754 VEV_2_3_RA5_01_1236.d 5.19E4 1 1 222 239 Oxidation (HW)
K.GGIPFLVTHD(-18.01)AR.T Y 30.92 1263.6724 12 -19.3 422.2233 3 71.53 6 39012 VEV_3_3_RA6_01_1237.d 0 1 1 134 145 Dehydration
R.AVALAGH(+15.99) Y 29.95 653.3497 7 0.9 654.3575 1 99.19 4 57935 VEV_1_3_RA4_01_1235.d 7.6E3 2 2 256 262 Oxidation (HW)
K.T(+43.01)GENFRLVYDTK.G Y 29.45 1484.7260 12 -7.1 495.9124 3 63.75 4 34324 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 95 106 Carbamylation
K.GGIPFLVTHDARTIR.Y Y 28.97 1651.9158 15 -25.9 413.9755 4 35.58 6 15988 VEV_3_3_RA6_01_1237.d 1.06E6 3 3 134 148
K.VDLATGK.I Y 28.91 702.3912 7 -12.7 703.3895 1 22.32 6 8776 VEV_3_3_RA6_01_1237.d 1.1E5 2 2 162 168
R.E(+42.01)TNAILMQR.L Y 27.58 1116.5597 9 -10.8 373.1898 3 54.12 4 27516 VEV_1_3_RA4_01_1235.d 2.16E5 3 3 60 68 Acetylation (N-term)
K.VRTDSTYPAGFM(-4.99)DVISIEK.T Y 27.53 2123.0647 19 -67.8 708.6475 3 80.71 4 47637 VEV_1_3_RA4_01_1235.d 9.67E4 1 1 76 94 Methionine replacement by azido homoalanine
K.YALN(+.98)AR.E Y 27.25 707.3602 6 -14.0 708.3576 1 40.55 5 19439 VEV_2_3_RA5_01_1236.d 6.95E4 3 3 54 59 Deamidation (NQ)
K.TGENFRLVYDTKGR.F Y 27.13 1654.8427 14 20.3 414.7263 4 59.14 4 30837 VEV_1_3_RA4_01_1235.d 0 1 1 95 108
R.IQAEE(+14.02)AEYK.L Y 26.82 1093.5291 9 -14.0 547.7642 2 43.20 5 21041 VEV_2_3_RA5_01_1236.d 4.85E5 1 1 114 122 Methylation(others)
K.LSIAEERDRR.R Y 26.63 1243.6632 10 -14.1 415.5558 3 26.45 5 11301 VEV_2_3_RA5_01_1236.d 2.02E5 1 1 245 254
R.NMGRVGVITHR.E Y 25.77 1238.6666 11 -3.4 413.8947 3 51.44 5 26037 VEV_2_3_RA5_01_1236.d 0 1 1 188 198
K.LSIAEERDR(+14.02).R Y 25.57 1101.5778 9 -9.1 551.7911 2 39.39 5 18760 VEV_2_3_RA5_01_1236.d 3.72E5 3 3 245 253 Methylation(KR)
K.VKRVQLGKGGIPFLVTHDAR.T Y 25.25 2190.2749 20 -94.0 439.0211 5 66.55 5 36426 VEV_2_3_RA5_01_1236.d 0 1 1 126 145
K.GVK(+87.03)LSIAEERDR.R Y 24.83 1458.7791 12 -6.1 365.6998 4 41.97 4 19894 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 242 253 Glycidamide adduct
R.ETNAILMQR(+14.02).L Y 24.56 1088.5648 9 8.2 545.2941 2 60.66 4 31979 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 60 68 Methylation(KR)
R.LVYDTKGR.F Y 24.17 950.5185 8 -35.2 476.2498 2 22.16 5 8932 VEV_2_3_RA5_01_1236.d 9.16E4 2 2 101 108
R.VGVIT(+79.97)HR(+14.02).E Y 24.07 874.4426 7 4.0 438.2303 2 40.85 5 19614 VEV_2_3_RA5_01_1236.d 9.62E5 2 2 192 198 Phosphorylation (STY); Methylation(KR)
K.LSIAEER(+14.02)DR.R Y 23.83 1101.5778 9 -14.1 368.1947 3 44.63 5 21909 VEV_2_3_RA5_01_1236.d 2.33E5 3 3 245 253 Methylation(KR)
K.LSIAEER(+14.02).D Y 23.19 830.4498 7 -17.3 416.2250 2 52.97 4 26781 VEV_1_3_RA4_01_1235.d 4.98E5 3 3 245 251 Methylation(KR)
R.VQLGK(+154.10)GGIPFLVTHDAR.T Y 22.63 1961.1097 17 4.7 393.2310 5 69.09 4 38513 VEV_1_3_RA4_01_1235.d 0 1 1 129 145 4-Oxononenal (ONE)
R.LSAPSHWLLDK(-1.03)LSGSYAPRPSPGPHK.L Y 22.62 2796.4346 26 -7.0 560.2903 5 74.62 5 42334 VEV_2_3_RA5_01_1236.d 7.05E4 1 1 12 37 Lysine oxidation to aminoadipic semialdehyde
K.T(+14.02)GENFRLVYDTK.G Y 21.92 1455.7357 12 -13.0 728.8657 2 67.66 4 37371 VEV_1_3_RA4_01_1235.d 5.11E4 1 1 95 106 Methylation(others)
R.ESNVFIIGQ(+.98)EK(+14.02)PWISLPK.G Y 21.48 2099.1301 18 -5.9 700.7132 3 85.10 4 50652 VEV_1_3_RA4_01_1235.d 4.36E4 1 1 222 239 Deamidation (NQ); Methylation(KR)
K.VDLATGK(+27.99).I Y 20.75 730.3861 7 -43.9 731.3613 1 84.63 4 50337 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 162 168 Formylation
K.RLSAPSHWLLD(+21.98)K.L Y 20.71 1443.7599 12 -12.0 361.9429 4 19.62 5 7530 VEV_2_3_RA5_01_1236.d 0 1 1 11 22 Sodium adduct
R.VQLGK(+21.98).G Y 20.63 565.3199 5 -66.9 566.2894 1 67.96 6 36361 VEV_3_3_RA6_01_1237.d 2.24E4 1 1 129 133 Sodium adduct
R.ETNAILM(+15.99)Q(+.98)R.L Y 20.57 1091.5281 9 16.9 546.7805 2 39.92 6 18452 VEV_3_3_RA6_01_1237.d 0 1 1 60 68 Oxidation (M); Deamidation (NQ)
R.I(+43.01)Q(+.98)AEEAEYKLC(+57.02)K.V Y 20.55 1524.7130 12 15.2 509.2527 3 51.70 5 26204 VEV_2_3_RA5_01_1236.d 9.05E3 1 1 114 125 Carbamylation; Deamidation (NQ); Carbamidomethylation
K.LSGS(-15.99)YAPRPSPGPHK.L Y 20.34 1533.8052 15 -29.0 512.2609 3 31.41 4 13668 VEV_1_3_RA4_01_1235.d 0 1 1 23 37 Deoxy
R.ETN(+.98)AILM(+15.99)QR.L Y 20.25 1091.5281 9 -7.7 546.7671 2 45.83 6 21890 VEV_3_3_RA6_01_1237.d 8.47E3 2 2 60 68 Deamidation (NQ); Oxidation (M)
K.GVKLSIAEER.D Y 19.57 1100.6189 10 -13.2 367.8754 3 48.88 5 24472 VEV_2_3_RA5_01_1236.d 8.33E4 1 1 242 251
R.NMGRVGVITH(+15.99)R.E Y 19.51 1254.6615 11 46.4 314.6872 4 33.85 4 15068 VEV_1_3_RA4_01_1235.d 0 1 1 188 198 Oxidation (HW)
K.VRTDSTYPAGFMD(+17.03)VISIEK.T Y 19.40 2145.0776 19 -21.4 716.0179 3 76.44 4 44250 VEV_1_3_RA4_01_1235.d 8.32E4 1 1 76 94 Replacement of proton with ammonium ion
R.A(+226.08)VALAGH Y 19.21 863.4323 7 -8.6 864.4321 1 93.19 4 55400 VEV_1_3_RA4_01_1235.d 7.01E4 1 1 256 262 Biotinylation
K.V(+42.01)N(+.98)DTVK(+42.01).V Y 19.12 759.3651 6 -20.2 760.3570 1 57.54 6 28724 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 156 161 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
R.ESNVFIIGQEK(-1.03)PWISLPK.G Y 19.00 2083.0989 18 -27.8 695.3542 3 83.09 4 49282 VEV_1_3_RA4_01_1235.d 4.26E5 2 2 222 239 Lysine oxidation to aminoadipic semialdehyde
R.AVALAGH(+14.02) Y 18.98 651.3704 7 -18.3 652.3657 1 26.41 4 10878 VEV_1_3_RA4_01_1235.d 2.89E4 1 1 256 262 Methylation(others)
K.LSGS(+79.97)YAPRPSPGPHK(+27.99).L Y 18.93 1657.7614 15 -52.7 553.5652 3 9.78 6 2411 VEV_3_3_RA6_01_1237.d 1.38E4 1 1 23 37 Phosphorylation (STY); Formylation
R.ESNVFIIGQ(+.98)EKPWISLPK.G Y 18.90 2085.1145 18 -15.1 696.0350 3 83.18 5 48089 VEV_2_3_RA5_01_1236.d 1.71E5 1 1 222 239 Deamidation (NQ)
R.F(+42.01)TVHR.I Y 18.58 700.3657 5 -20.6 351.1829 2 17.23 4 5953 VEV_1_3_RA4_01_1235.d 0 1 1 109 113 Acetylation (N-term)
K.ITSFIK(+42.01)FDTGVIAMATGGR.N Y 18.48 2026.0557 19 -14.1 676.3496 3 87.00 6 49676 VEV_3_3_RA6_01_1237.d 0 1 1 169 187 Acetylation (K)
R.NM(-4.99)GRVGVITHR.E Y 18.42 1233.6803 11 -82.8 412.2000 3 19.11 6 7111 VEV_3_3_RA6_01_1237.d 1.98E4 1 1 188 198 Methionine replacement by azido homoalanine
K.YALN(+.98)AR(+28.03).E Y 18.02 735.3915 6 -0.8 736.3983 1 106.40 4 60153 VEV_1_3_RA4_01_1235.d 0 1 1 54 59 Deamidation (NQ); Dimethylation(KR)
R.V(+27.99)QLGK(+42.01)GGIPFLVTHDAR.T Y 17.98 1877.0159 17 44.5 470.2821 4 70.02 4 39227 VEV_1_3_RA4_01_1235.d 7E4 1 1 129 145 Formylation; Acetylation (K)
K.GKGVKLSIAEERDR.R Y 17.95 1556.8634 14 -29.3 390.2117 4 31.72 6 13830 VEV_3_3_RA6_01_1237.d 0 1 1 240 253
K.R(+14.02)LSAPS(+79.97)HWLLDK.L Y 17.61 1515.7599 12 17.4 506.2693 3 76.01 6 42288 VEV_3_3_RA6_01_1237.d 2.19E5 1 1 11 22 Methylation(KR); Phosphorylation (STY)
R.ETN(+.98)AILMQR.L Y 17.58 1075.5332 9 -1.3 538.7732 2 53.59 6 26415 VEV_3_3_RA6_01_1237.d 1.59E5 1 1 60 68 Deamidation (NQ)
K.TGENFR(+14.02).L Y 17.43 736.3504 6 -6.8 369.1800 2 27.06 4 11219 VEV_1_3_RA4_01_1235.d 0 1 1 95 100 Methylation(KR)
R.TD(+14.02)STYPAGFMDVISIEK.T Y 17.43 1886.8971 17 16.5 944.4714 2 83.95 4 49875 VEV_1_3_RA4_01_1235.d 0 1 1 78 94 Methylation(others)
R.YPDPAIKVNDTVK(+149.03).V Y 16.82 1607.8018 13 -6.2 804.9032 2 43.62 4 20915 VEV_1_3_RA4_01_1235.d 6.69E4 1 1 149 161 Benzyl isothiocyanate
R.V(+163.05)GVITHRER.H Y 16.78 1228.6499 9 23.6 308.1770 4 17.49 5 6422 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 192 200 Phenethyl isothiocyanate
K.VDLATGK(+71.04).I Y 16.74 773.4283 7 1.3 774.4366 1 100.06 4 58221 VEV_1_3_RA4_01_1235.d 0 1 1 162 168 Propionamide (K, X@N-term)
R.FTVHRIQAEEAEYKLC(+57.02)K.V Y 16.41 2121.0676 17 -7.7 531.2701 4 62.49 5 33404 VEV_2_3_RA5_01_1236.d 0 1 1 109 125 Carbamidomethylation
R.LKYALNAR(+14.02).E Y 16.40 961.5709 8 -14.1 321.5264 3 47.16 5 23433 VEV_2_3_RA5_01_1236.d 2.8E4 1 1 52 59 Methylation(KR)
R.LSAPSHWLLDKLSGSYAPR(+.98)PSPGPHK.L Y 16.36 2798.4502 26 -3.4 560.6954 5 74.84 5 42479 VEV_2_3_RA5_01_1236.d 5.1E4 1 1 12 37 Deamidation (R)
R.TIRYPD(+21.98)PAIK.V Y 16.24 1194.6372 10 -26.4 399.2092 3 43.40 4 20782 VEV_1_3_RA4_01_1235.d 0 1 1 146 155 Sodium adduct
R.YPDPAIKVN(+.98)DTVK(+14.02).V Y 16.08 1473.7715 13 -20.6 492.2543 3 29.49 6 12594 VEV_3_3_RA6_01_1237.d 0 1 1 149 161 Deamidation (NQ); Methylation(KR)
R.ETNAILMQRLVK(+226.08).V Y 15.97 1640.8741 12 -10.5 411.2215 4 55.29 6 27327 VEV_3_3_RA6_01_1237.d 0 1 1 60 71 Biotinylation
K.VDLATGK(+21.98).I Y 15.95 724.3731 7 -4.2 725.3773 1 56.37 6 27949 VEV_3_3_RA6_01_1237.d 2.26E4 1 1 162 168 Sodium adduct
K.VDLATGKITSFIK.F Y 15.93 1391.8024 13 5.4 464.9439 3 74.81 4 42976 VEV_1_3_RA4_01_1235.d 3.12E4 2 2 162 174
R.ES(-18.01)NVFIIGQEKPWISLPK.G Y 15.51 2066.1201 18 -29.5 1034.0369 2 86.49 6 49369 VEV_3_3_RA6_01_1237.d 1.2E4 1 1 222 239 Dehydration
R.HDGGFNIVHIKD(+6.01)AIDNSFATR.E Y 15.22 2332.1536 21 -28.8 584.0289 4 78.74 6 44252 VEV_3_3_RA6_01_1237.d 0 1 1 201 221 Replacement of proton by lithium
R.LVYDTK(+21.98).G Y 15.22 759.3779 6 -7.9 760.3792 1 81.64 4 48276 VEV_1_3_RA4_01_1235.d 0 1 1 101 106 Sodium adduct
total 164 peptides
A0A0A0HUJ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IGKGSDEGNASTEFDVSKK.Q Y 149.64 1967.9436 19 -7.7 984.9715 2 41.62 6 19473 VEV_3_3_RA6_01_1237.d 4.72E6 12 12 438 456
R.IGKGSDEGNASTEFDVSK.K Y 147.31 1839.8486 18 -9.5 614.2843 3 50.53 6 24635 VEV_3_3_RA6_01_1237.d 2.07E6 9 9 438 455
K.GSDEGNASTEFDVSK.K Y 147.10 1541.6481 15 -10.6 771.8231 2 51.43 6 25160 VEV_3_3_RA6_01_1237.d 1.99E6 11 11 441 455
R.KVAC(+57.02)IGAWHPSHVQWTVAR.A Y 133.65 2202.1270 19 -11.1 551.5329 4 67.89 5 37447 VEV_2_3_RA5_01_1236.d 1.93E6 7 7 401 419 Carbamidomethylation
R.YGEVKNDYVMLKGSVPGVK.K Y 131.73 2082.0820 19 -9.2 1042.0387 2 69.41 5 38565 VEV_2_3_RA5_01_1236.d 1.44E6 7 7 467 485
K.VAC(+57.02)IGAWHPSHVQWTVAR.A Y 122.66 2074.0320 18 -6.3 519.5120 4 71.47 4 40429 VEV_1_3_RA4_01_1235.d 1.01E6 7 7 402 419 Carbamidomethylation
K.GSDEGNASTEFDVSKK.Q Y 119.37 1669.7430 16 -7.8 557.5839 3 40.52 4 19007 VEV_1_3_RA4_01_1235.d 3.95E6 13 13 441 456
K.WIDTSSKFGHGAFQTPAEKR.A Y 118.36 2262.1182 20 -8.7 566.5319 4 63.59 5 34232 VEV_2_3_RA5_01_1236.d 2.32E6 7 7 511 530
K.NHSENTGASVSR.E Y 113.05 1257.5698 12 -11.5 420.1924 3 10.80 5 2861 VEV_2_3_RA5_01_1236.d 4.48E5 6 6 288 299
R.YGEVKNDYVMLK.G Y 111.87 1457.7224 12 -16.9 486.9066 3 63.59 6 33098 VEV_3_3_RA6_01_1237.d 2.84E6 8 8 467 478
R.IGKGSDEGNASTEFDVSKKQITPMGGFVR.Y Y 111.27 3054.5081 29 -3.5 764.6316 4 70.05 5 39027 VEV_2_3_RA5_01_1236.d 3.36E5 3 3 438 466
K.YAKNHSENTGASVSR.E Y 111.02 1619.7651 15 -8.9 540.9242 3 12.67 5 3805 VEV_2_3_RA5_01_1236.d 5.9E5 8 8 285 299
R.SLTTVWAEHLSDEVK.R Y 108.85 1713.8573 15 -9.5 572.2876 3 77.23 4 44880 VEV_1_3_RA4_01_1235.d 8.57E5 6 6 253 267
R.SLTTVWAEHLSDEVKR.R Y 107.97 1869.9585 16 -7.8 624.3219 3 74.21 4 42546 VEV_1_3_RA4_01_1235.d 1.85E6 7 7 253 268
K.FGHGAFQTPAEK.R Y 107.88 1288.6200 12 -11.3 645.3100 2 50.01 4 24888 VEV_1_3_RA4_01_1235.d 2.2E6 12 12 518 529
K.FGHGAFQTPAEKR.A Y 107.82 1444.7211 13 -6.9 482.5776 3 41.96 4 19932 VEV_1_3_RA4_01_1235.d 6.69E6 28 28 518 530
K.GHGFNGVTSR.W Y 107.60 1030.4944 10 -14.6 516.2469 2 22.87 6 9095 VEV_3_3_RA6_01_1237.d 2.37E6 10 10 376 385
K.WIDTSSKFGHGAFQTPAEK.R Y 98.49 2106.0171 19 -2.5 527.5103 4 66.97 4 36817 VEV_1_3_RA4_01_1235.d 4.38E5 2 2 511 529
K.NHSENTGASVSRELER.I Y 97.70 1784.8401 16 -3.4 447.2158 4 34.75 4 15652 VEV_1_3_RA4_01_1235.d 1.2E6 10 10 288 303
R.TSC(+57.02)NHKIYR.I Y 96.04 1177.5662 9 -9.6 589.7847 2 12.10 5 3512 VEV_2_3_RA5_01_1236.d 1.26E6 7 7 429 437 Carbamidomethylation
R.HGSLAFLPR.K Y 93.84 996.5505 9 -19.3 499.2729 2 63.28 6 32846 VEV_3_3_RA6_01_1237.d 4.14E6 15 15 163 171
R.SLTTVWAEHLSDEVKRR.F Y 87.51 2026.0596 17 -5.4 507.5194 4 72.10 4 40870 VEV_1_3_RA4_01_1235.d 1.28E6 5 5 253 269
K.GSDEGNASTEFDVSKKQITPMGGFVR.Y Y 87.33 2756.3076 26 -17.6 690.0720 4 72.56 6 39776 VEV_3_3_RA6_01_1237.d 2.21E5 3 3 441 466
K.KQITPMGGFVR.Y Y 82.57 1232.6699 11 -13.8 411.8916 3 60.69 6 30937 VEV_3_3_RA6_01_1237.d 1.03E6 7 7 456 466
R.AGQDGYHHR.T Y 82.44 1039.4584 9 -12.1 520.7302 2 8.48 5 1997 VEV_2_3_RA5_01_1236.d 2.84E4 3 3 420 428
K.GHGFN(+.98)GVTSR.W Y 81.56 1031.4784 10 -12.8 516.7399 2 25.45 5 10777 VEV_2_3_RA5_01_1236.d 2.83E6 22 22 376 385 Deamidation (NQ)
R.YGEVKNDYVM(+15.99)LK.G Y 81.48 1473.7173 12 -10.5 492.2412 3 60.29 4 31694 VEV_1_3_RA4_01_1235.d 1.02E6 6 6 467 478 Oxidation (M)
K.NHSE(+14.02)NTGASVSR.E Y 79.99 1271.5854 12 -13.7 636.7913 2 14.60 6 4746 VEV_3_3_RA6_01_1237.d 4.17E5 5 5 288 299 Methylation(others)
K.NHSENTGASVSR(+14.02).E Y 77.43 1271.5854 12 -10.0 636.7936 2 13.42 5 4196 VEV_2_3_RA5_01_1236.d 3.64E5 6 6 288 299 Methylation(KR)
R.LLAHTQIRK.T Y 76.84 1078.6611 9 -10.3 540.3323 2 25.76 5 10907 VEV_2_3_RA5_01_1236.d 1.09E6 8 8 313 321
R.LLAHTQIR.K Y 75.75 950.5662 8 -9.5 476.2858 2 34.52 4 15500 VEV_1_3_RA4_01_1235.d 5.32E6 16 16 313 320
K.SFPKDDPKKPVHLTAAMGYK.A Y 73.63 2229.1616 20 -13.6 558.2901 4 59.66 4 31235 VEV_1_3_RA4_01_1235.d 1.14E6 4 4 183 202
K.AGMTTVVRDLERPGAK.M Y 73.05 1699.9039 16 -10.7 425.9787 4 63.74 5 34358 VEV_2_3_RA5_01_1236.d 2.14E6 8 8 203 218
K.GSDEGNASTEFDVSK(+14.02).K Y 72.04 1555.6638 15 -10.9 778.8307 2 59.35 4 31002 VEV_1_3_RA4_01_1235.d 3.04E5 3 3 441 455 Methylation(KR)
R.IGKGSDEGNASTEFDVSK(+14.02).K Y 71.48 1853.8643 18 -6.0 618.9583 3 57.26 4 29490 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 438 455 Methylation(KR)
K.TLYPQVSR.K Y 70.75 962.5185 8 -11.9 482.2608 2 52.73 4 26630 VEV_1_3_RA4_01_1235.d 3.57E6 15 15 494 501
K.GSDEGNASTEFDVSK(+14.02)K.Q Y 70.35 1683.7587 16 -4.6 562.2576 3 48.59 4 24009 VEV_1_3_RA4_01_1235.d 3.8E5 4 4 441 456 Methylation(KR)
K.FGHGAFQ(+.98)TPAEKR.A Y 70.24 1445.7051 13 -7.5 482.9054 3 43.76 4 20987 VEV_1_3_RA4_01_1235.d 6.67E5 5 5 518 530 Deamidation (NQ)
R.IGKGSDEGNASTEFDVSK(+14.02)K.Q Y 68.35 1981.9592 19 -9.8 661.6539 3 48.57 4 23976 VEV_1_3_RA4_01_1235.d 5.3E5 6 6 438 456 Methylation(KR)
R.IGKGSD(+14.02)EGNASTEFDVSKK.Q Y 66.10 1981.9592 19 -14.7 661.6506 3 49.65 6 24123 VEV_3_3_RA6_01_1237.d 4.62E4 1 1 438 456 Methylation(others)
R.YGE(+14.02)VKNDYVMLK.G Y 64.41 1471.7380 12 -18.9 491.5773 3 65.68 4 35810 VEV_1_3_RA4_01_1235.d 6.29E5 4 4 467 478 Methylation(others)
K.KPVHLTAAMGYK.A Y 62.72 1314.7118 12 -13.4 439.2386 3 46.66 4 22796 VEV_1_3_RA4_01_1235.d 2.71E5 2 2 191 202
R.DLERPGAK.M Y 62.31 884.4716 8 -9.3 443.2389 2 17.38 4 6029 VEV_1_3_RA4_01_1235.d 1.08E6 7 7 211 218
K.Q(-17.03)ITPMGGFVR.Y Y 60.78 1087.5485 10 -7.2 544.7776 2 81.08 4 47841 VEV_1_3_RA4_01_1235.d 3.53E5 3 3 457 466 Pyro-glu from Q
K.YC(+57.02)TVVR.L Y 59.74 796.3901 6 -18.1 399.1951 2 27.63 6 11574 VEV_3_3_RA6_01_1237.d 3.25E6 9 9 307 312 Carbamidomethylation
R.IGKGSDEGNASTE(+14.02)FDVSK.K Y 59.61 1853.8643 18 -5.9 927.9340 2 58.84 5 30700 VEV_2_3_RA5_01_1236.d 5.56E5 5 5 438 455 Methylation(others)
R.KTLYPQVSR.K Y 59.26 1090.6135 9 -10.1 546.3085 2 38.67 5 18338 VEV_2_3_RA5_01_1236.d 4.14E6 20 20 493 501
R.TSC(+57.02)NHKIYR(+14.02).I Y 58.90 1191.5819 9 -10.7 596.7919 2 15.61 5 5368 VEV_2_3_RA5_01_1236.d 1.78E4 1 1 429 437 Carbamidomethylation; Methylation(KR)
R.KALEKVELK.W Y 58.61 1056.6543 9 -23.2 529.3221 2 29.18 5 12791 VEV_2_3_RA5_01_1236.d 1.07E6 7 7 502 510
K.AGM(+15.99)TTVVRDLERPGAK.M Y 58.32 1715.8988 16 -12.2 572.9666 3 48.86 4 24154 VEV_1_3_RA4_01_1235.d 9.23E5 5 5 203 218 Oxidation (M)
R.KTLYPQVSRK.A Y 58.30 1218.7084 10 -19.7 407.2354 3 27.39 4 11409 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 493 502
R.AFMGTLK.K Y 55.55 766.4047 7 -10.8 767.4037 1 55.70 4 28453 VEV_1_3_RA4_01_1235.d 2.97E5 3 3 531 537
R.IGKGSDEGN(+.98)ASTEFDVSK.K Y 53.98 1840.8326 18 0.6 614.6185 3 50.50 5 25445 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 438 455 Deamidation (NQ)
K.TLYPQVSRK.A Y 53.70 1090.6135 9 -14.8 546.3060 2 36.73 6 16616 VEV_3_3_RA6_01_1237.d 2.35E6 12 12 494 502
K.FGHGAFQTPAEK(+14.02).R Y 53.00 1302.6356 12 -8.5 652.3195 2 56.25 4 28790 VEV_1_3_RA4_01_1235.d 2.65E5 3 3 518 529 Methylation(KR)
R.IGK(+14.02)GSDEGNASTEFDVSKK.Q Y 52.15 1981.9592 19 -11.6 661.6527 3 49.67 5 24958 VEV_2_3_RA5_01_1236.d 7.17E4 1 1 438 456 Methylation(KR)
R.AFMGTLKK.D Y 51.66 894.4997 8 -10.4 448.2525 2 37.76 4 17369 VEV_1_3_RA4_01_1235.d 8.06E5 5 5 531 538
K.GSDEGNASTE(+14.02)FDVSK.K Y 51.20 1555.6638 15 -8.7 778.8324 2 61.05 4 32270 VEV_1_3_RA4_01_1235.d 2.31E5 3 3 441 455 Methylation(others)
R.IGKGSDEGNASTE(+14.02)FDVSKK.Q Y 50.88 1981.9592 19 -9.3 661.6542 3 50.33 5 25335 VEV_2_3_RA5_01_1236.d 5.11E5 4 4 438 456 Methylation(others)
K.ALEKVELK.W Y 50.57 928.5593 8 -19.7 465.2778 2 36.89 4 16868 VEV_1_3_RA4_01_1235.d 8.43E5 7 7 503 510
K.QITPMGGFVR.Y Y 50.44 1104.5750 10 -13.4 553.2874 2 69.02 5 38285 VEV_2_3_RA5_01_1236.d 5.38E5 5 5 457 466
K.SFPKDDPK.K Y 50.18 932.4603 8 -14.6 467.2307 2 17.54 5 6392 VEV_2_3_RA5_01_1236.d 4.59E5 6 6 183 190
R.IKKYC(+57.02)TVVR.L Y 50.16 1165.6642 9 -11.8 583.8325 2 24.76 4 9990 VEV_1_3_RA4_01_1235.d 5.03E5 6 6 304 312 Carbamidomethylation
K.GSDEGNASTE(+14.02)FDVSKK.Q Y 50.02 1683.7587 16 -7.7 562.2559 3 51.16 4 25647 VEV_1_3_RA4_01_1235.d 4.99E5 2 2 441 456 Methylation(others)
R.IGK(+14.02)GSDEGNASTEFDVSK.K Y 49.21 1853.8643 18 -6.3 618.9581 3 58.20 4 30145 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 438 455 Methylation(KR)
K.AGM(+15.99)TTVVR.D Y 48.95 849.4379 8 -11.2 425.7215 2 16.87 4 5757 VEV_1_3_RA4_01_1235.d 1.68E6 7 7 203 210 Oxidation (M)
R.TSC(+57.02)N(+.98)HKIYR.I Y 48.92 1178.5503 9 -1.3 590.2817 2 13.96 5 4470 VEV_2_3_RA5_01_1236.d 9.8E4 4 4 429 437 Carbamidomethylation; Deamidation (NQ)
K.VAC(+57.02)IGAWHPSHVQ(+.98)WTVAR.A Y 46.73 2075.0159 18 -2.1 519.7601 4 71.48 4 40383 VEV_1_3_RA4_01_1235.d 4.11E5 2 2 402 419 Carbamidomethylation; Deamidation (NQ)
K.AGMTTVVR.D Y 46.40 833.4429 8 -11.2 417.7241 2 34.98 4 15773 VEV_1_3_RA4_01_1235.d 1.31E6 7 7 203 210
R.FYKNWYK.S Y 45.67 1047.5178 7 -3.5 350.1786 3 53.24 4 26945 VEV_1_3_RA4_01_1235.d 2.57E6 6 6 270 276
K.DDPKKPVHLTAAMGYK.A Y 45.47 1769.9133 16 -2.9 590.9767 3 53.50 4 27122 VEV_1_3_RA4_01_1235.d 1.43E5 2 2 187 202
K.WIDTSSK.F Y 45.28 835.4076 7 -18.0 418.7036 2 30.72 6 13253 VEV_3_3_RA6_01_1237.d 2.44E6 11 11 511 517
K.NHSENTGASVSRELER(+14.02).I Y 44.14 1798.8557 16 11.8 450.7265 4 44.29 4 21324 VEV_1_3_RA4_01_1235.d 0 2 2 288 303 Methylation(KR)
R.SLTTVWAEHLSDEVK(+14.02)RR.F Y 44.06 2040.0752 17 -8.5 409.0189 5 75.77 4 43732 VEV_1_3_RA4_01_1235.d 7.52E4 1 1 253 269 Methylation(KR)
R.GLRS(+291.10)LTTVWAEHLSDEVKR.R Y 43.65 2487.2605 19 -0.1 622.8223 4 74.21 4 42521 VEV_1_3_RA4_01_1235.d 0 1 1 250 268 N-acetyl neuraminic acid
K.FGHGAFQTPAEK(+14.02)R.A Y 43.34 1458.7367 13 -9.5 365.6880 4 51.28 4 25686 VEV_1_3_RA4_01_1235.d 8.12E5 5 5 518 530 Methylation(KR)
R.HGSLAFLPR(+14.02).K Y 41.64 1010.5661 9 -15.8 337.8573 3 67.14 6 35740 VEV_3_3_RA6_01_1237.d 1.85E5 2 2 163 171 Methylation(KR)
K.KQITPM(+15.99)GGFVR.Y Y 41.53 1248.6648 11 -17.5 625.3287 2 44.26 6 20978 VEV_3_3_RA6_01_1237.d 1.72E5 2 2 456 466 Oxidation (M)
K.QITPM(+15.99)GGFVR.Y Y 41.24 1120.5699 10 -11.4 561.2859 2 59.58 4 31170 VEV_1_3_RA4_01_1235.d 7.12E5 3 3 457 466 Oxidation (M)
R.AFM(+15.99)GTLKK.D Y 41.11 910.4946 8 -20.2 456.2454 2 21.06 6 8129 VEV_3_3_RA6_01_1237.d 6.59E5 3 3 531 538 Oxidation (M)
R.YGEVKNDYVMLK(+14.02).G Y 40.23 1471.7380 12 -8.4 736.8701 2 67.41 4 37166 VEV_1_3_RA4_01_1235.d 9.75E4 2 2 467 478 Methylation(KR)
R.SLTTVWAE(+14.02)HLSDEVK.R Y 40.01 1727.8730 15 7.4 576.9692 3 77.96 4 45448 VEV_1_3_RA4_01_1235.d 0 1 1 253 267 Methylation(others)
K.TLYPQ(+.98)VSR.K Y 39.84 963.5025 8 -7.5 482.7549 2 54.52 4 27765 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 494 501 Deamidation (NQ)
R.RFYKNWYK.S Y 39.81 1203.6189 8 -13.0 402.2083 3 49.25 4 24404 VEV_1_3_RA4_01_1235.d 3.68E5 1 1 269 276
K.Q(-17.03)ITPM(+15.99)GGFVR.Y Y 39.78 1103.5433 10 -7.0 552.7751 2 73.50 4 41989 VEV_1_3_RA4_01_1235.d 3.69E5 3 3 457 466 Pyro-glu from Q; Oxidation (M)
R.KFEAPRHGSLAFLPR.K Y 39.70 1724.9474 15 -12.7 432.2386 4 65.34 5 35564 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 157 171
K.FEAPR.H N 39.50 618.3125 5 -28.0 619.3025 1 26.84 5 11508 VEV_2_3_RA5_01_1236.d 6.52E5 5 5 158 162
K.GSVPGVKKR.V Y 39.18 926.5661 9 -31.0 464.2760 2 11.68 5 3283 VEV_2_3_RA5_01_1236.d 0 2 2 479 487
K.AGM(-4.99)TTVVRDLERPGAK.M Y 37.72 1694.9176 16 -6.3 424.7340 4 64.06 4 34553 VEV_1_3_RA4_01_1235.d 0 1 1 203 218 Methionine replacement by azido homoalanine
K.GSD(+14.02)EGNASTEFDVSKK.Q Y 37.45 1683.7587 16 -2.8 562.2586 3 49.79 4 24750 VEV_1_3_RA4_01_1235.d 0 1 1 441 456 Methylation(others)
K.GSDEGNAST(+14.02)EFDVSK.K Y 36.70 1555.6638 15 -9.6 778.8317 2 56.18 4 28747 VEV_1_3_RA4_01_1235.d 8.21E4 1 1 441 455 Methylation(others)
K.DLVTAA Y 35.94 588.3119 6 -13.9 589.3110 1 50.72 4 25324 VEV_1_3_RA4_01_1235.d 1.92E4 2 2 539 544
R.KTPLKQKK.A Y 35.62 969.6335 8 -13.8 485.8173 2 8.73 5 2064 VEV_2_3_RA5_01_1236.d 5.34E3 1 1 321 328
K.GSDE(+14.02)GNASTEFDVSKK.Q Y 35.09 1683.7587 16 -7.3 842.8805 2 49.49 4 24564 VEV_1_3_RA4_01_1235.d 3.25E5 3 3 441 456 Methylation(others)
R.IGKGSDEGN(+.98)ASTEFDVSKK.Q Y 34.83 1968.9276 19 -0.9 657.3159 3 45.04 4 21793 VEV_1_3_RA4_01_1235.d 3.05E5 3 3 438 456 Deamidation (NQ)
R.KTPLKQK.K Y 34.58 841.5385 7 -10.7 421.7720 2 8.94 4 2126 VEV_1_3_RA4_01_1235.d 3.29E4 3 3 321 327
K.Q(+.98)ITPMGGFVR.Y Y 34.40 1105.5590 10 -9.3 553.7816 2 70.75 6 38479 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 457 466 Deamidation (NQ)
K.EIVEAVTIVETPPMIAVGVVGYIETPR.G Y 33.33 2881.5510 27 -1.8 961.5226 3 99.24 4 57951 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 223 249
K.V(+127.06)AC(+57.02)IGAWHPSHVQWTVAR.A Y 33.28 2201.0952 18 8.2 441.2299 5 68.08 6 36453 VEV_3_3_RA6_01_1237.d 1.14E5 2 2 402 419 N-Succinimidyl-2-morpholine acetate; Carbamidomethylation
R.IGKGSDEGNASTEFDVSKK(+14.02).Q Y 33.27 1981.9592 19 -19.8 496.4873 4 48.09 5 23971 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 438 456 Methylation(KR)
K.WIDTSSK(+14.02).F Y 33.01 849.4232 7 -9.1 850.4228 1 42.84 4 20433 VEV_1_3_RA4_01_1235.d 2.98E5 3 3 511 517 Methylation(KR)
R.KFEAPR.H Y 32.72 746.4075 6 -17.6 374.2044 2 17.31 6 6155 VEV_3_3_RA6_01_1237.d 1.9E6 5 5 157 162
R.VLTLR.K N 32.24 600.3959 5 -22.6 301.1984 2 37.17 6 16909 VEV_3_3_RA6_01_1237.d 1.3E6 8 8 488 492
R.SLTTVWAEHLSDEVKR(+14.02).R Y 31.89 1883.9741 16 -14.9 471.9938 4 77.46 4 45055 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 253 268 Methylation(KR)
R.DLERPGAK(+14.02).M Y 31.84 898.4872 8 -20.6 450.2416 2 22.24 6 8786 VEV_3_3_RA6_01_1237.d 1.92E5 3 3 211 218 Methylation(KR)
K.GSDE(+14.02)GNASTEFDVSK.K Y 29.62 1555.6638 15 -10.7 778.8309 2 59.41 5 31118 VEV_2_3_RA5_01_1236.d 6.68E4 1 1 441 455 Methylation(others)
R.L(+87.03)LAHTQIR.K Y 29.48 1037.5981 8 -8.7 346.8703 3 34.69 5 15997 VEV_2_3_RA5_01_1236.d 0 1 1 313 320 Glycidamide adduct
K.NDYVMLKGSVPGVK.K Y 28.56 1505.7911 14 -19.1 753.8885 2 67.72 5 37315 VEV_2_3_RA5_01_1236.d 3.3E4 1 1 472 485
K.WIDTSSKFGHGAFQ(+.98)TPAEKR.A Y 28.48 2263.1021 20 -42.9 453.6083 5 64.55 5 34936 VEV_2_3_RA5_01_1236.d 0 2 2 511 530 Deamidation (NQ)
R.LLAHTQ(+.98)IR.K Y 26.77 951.5502 8 -26.4 318.1823 3 37.29 6 16933 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 313 320 Deamidation (NQ)
K.FGHGAFQTPAEK(-.98).R Y 26.60 1287.6360 12 12.8 430.2248 3 49.13 5 24679 VEV_2_3_RA5_01_1236.d 1.71E5 1 1 518 529 Amidation
R.L(+41.03)LAHTQIRK.T Y 26.47 1119.6876 9 -104.6 374.1974 3 25.86 5 10964 VEV_2_3_RA5_01_1236.d 6.96E4 1 1 313 321 Amidination of lysines or N-terminal amines with methyl acetimidate
K.FGHGAFQ(+.98)TPAEK.R Y 26.43 1289.6040 12 -6.3 430.8726 3 50.98 4 25501 VEV_1_3_RA4_01_1235.d 1.53E5 1 1 518 529 Deamidation (NQ)
K.AHLMEVQVNGGS(+79.97)IADK.V Y 26.17 1747.7964 16 -13.8 350.5617 5 14.34 5 4665 VEV_2_3_RA5_01_1236.d 4.4E5 1 1 329 344 Phosphorylation (STY)
K.AGM(-48.00)TTVVR.D Y 26.05 785.4396 8 -11.2 393.7227 2 10.75 4 2753 VEV_1_3_RA4_01_1235.d 3.23E5 3 3 203 210 Dethiomethyl
R.IGKGSDE(+14.02)GNASTEFDVSKK.Q Y 25.79 1981.9592 19 -0.3 496.4969 4 49.79 6 24178 VEV_3_3_RA6_01_1237.d 9.32E4 1 1 438 456 Methylation(others)
K.S(-2.02)FPKDDPKKPVHLTAAMGYK.A Y 25.52 2227.1460 20 -11.3 557.7875 4 59.65 4 31227 VEV_1_3_RA4_01_1235.d 0 1 1 183 202 2-amino-3-oxo-butanoic_acid
K.GSDEGNASTEFDVSKK(+14.02).Q Y 25.48 1683.7587 16 -7.8 842.8801 2 48.23 6 23279 VEV_3_3_RA6_01_1237.d 4.76E4 1 1 441 456 Methylation(KR)
K.GSVPGVK.K Y 25.33 642.3701 7 -16.5 322.1870 2 20.18 4 7478 VEV_1_3_RA4_01_1235.d 9.49E5 6 6 479 485
K.QITPM(+15.99)GGFVRYGEVK.N Y 25.11 1696.8606 15 2.8 425.2236 4 51.47 5 26055 VEV_2_3_RA5_01_1236.d 6.09E4 2 2 457 471 Oxidation (M)
R.I(+43.01)GK(+14.02)GSDEGNASTEFDVSKK.Q Y 25.06 2024.9650 19 12.3 676.0039 3 43.56 4 20873 VEV_1_3_RA4_01_1235.d 0 1 1 438 456 Carbamylation; Methylation(KR)
R.IGKGSDEGNAST(+13.03)EFDVSKK.Q Y 24.97 1980.9752 19 -9.0 496.2466 4 51.02 4 25525 VEV_1_3_RA4_01_1235.d 0 1 1 438 456 Michael addition with methylamine
K.KPVHLTAAM(+15.99)GYK.A Y 24.30 1330.7067 12 6.3 444.5790 3 74.05 6 40857 VEV_3_3_RA6_01_1237.d 9.87E4 1 1 191 202 Oxidation (M)
K.AFTKYAK.N Y 24.14 827.4541 7 -16.8 414.7274 2 19.24 5 7341 VEV_2_3_RA5_01_1236.d 0 1 1 281 287
K.GSDEGNASTEFD(+14.02)VSK.K Y 23.87 1555.6638 15 -11.0 778.8306 2 55.87 6 27653 VEV_3_3_RA6_01_1237.d 6.45E4 1 1 441 455 Methylation(others)
R.TDGWTKGPK.S Y 23.12 988.4978 9 25.7 495.2689 2 63.61 5 34245 VEV_2_3_RA5_01_1236.d 0 1 1 133 141
K.V(+43.01)AC(+57.02)IGAWHPSHVQWTVAR.A Y 22.75 2117.0378 18 23.7 530.2793 4 71.39 5 40020 VEV_2_3_RA5_01_1236.d 0 1 1 402 419 Carbamylation; Carbamidomethylation
K.AFTKYAK(+21.98).N Y 22.11 849.4360 7 -0.7 850.4427 1 99.02 5 55683 VEV_2_3_RA5_01_1236.d 0 1 1 281 287 Sodium adduct
R.AFM(+15.99)GTLK.K Y 22.07 782.3997 7 -12.2 392.2023 2 59.31 6 29940 VEV_3_3_RA6_01_1237.d 8.36E4 1 1 531 537 Oxidation (M)
K.RAFMGTLKK.D Y 21.98 1050.6008 9 -7.3 351.2050 3 32.14 4 14076 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 530 538
R.SLTTVWAEHLSDEVKR(+.98).R Y 21.82 1870.9425 16 0.1 468.7430 4 74.24 4 42542 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 253 268 Deamidation (R)
K.D(+43.01)DPK(+14.02)KPVHLTAAMGYK.A Y 21.61 1826.9348 16 -19.9 914.4565 2 86.79 6 49575 VEV_3_3_RA6_01_1237.d 1.32E5 1 1 187 202 Carbamylation; Methylation(KR)
R.LLAHTQIR(+14.02).K Y 21.54 964.5818 8 -13.5 322.5302 3 48.00 4 23631 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 313 320 Methylation(KR)
K.FGHGAFQT(-18.01)PAEK(+14.02)R.A Y 21.34 1440.7262 13 13.6 361.1937 4 42.07 4 19956 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 518 530 Dehydration; Methylation(KR)
K.AHLMEVQ(+.98)VNGGSIADK.V Y 21.07 1668.8141 16 45.5 418.2298 4 49.39 5 24784 VEV_2_3_RA5_01_1236.d 0 1 1 329 344 Deamidation (NQ)
K.KQITPM(-48.00)GGFVR.Y Y 21.02 1184.6665 11 -18.0 395.8890 3 31.53 6 13715 VEV_3_3_RA6_01_1237.d 6.13E5 1 1 456 466 Dethiomethyl
K.KQIT(-18.01)PM(+15.99)GGFVR.Y Y 20.87 1230.6543 11 -9.1 411.2216 3 60.74 4 32035 VEV_1_3_RA4_01_1235.d 0 1 1 456 466 Dehydration; Oxidation (M)
K.FEAPRHGSLAFLPR.K Y 20.81 1596.8524 14 20.5 400.2286 4 71.10 4 40089 VEV_1_3_RA4_01_1235.d 0 1 1 158 171
K.YAKN(+.98)HSENTGASVSR.E Y 20.45 1620.7491 15 30.4 541.2734 3 14.37 5 4682 VEV_2_3_RA5_01_1236.d 0 1 1 285 299 Deamidation (NQ)
K.AGMTTVVRDLER(+14.02)PGAK.M Y 20.32 1713.9196 16 -12.7 572.3065 3 69.09 4 38512 VEV_1_3_RA4_01_1235.d 0 1 1 203 218 Methylation(KR)
K.AGMT(-18.01)TVVR(+14.02)DLERPGAK.M Y 19.95 1695.9089 16 -14.6 424.9783 4 63.82 6 33231 VEV_3_3_RA6_01_1237.d 0 1 1 203 218 Dehydration; Methylation(KR)
K.GHGFN(+.98)GVTSR(+14.02).W Y 19.95 1045.4941 10 -2.9 523.7528 2 34.39 4 15382 VEV_1_3_RA4_01_1235.d 6.75E4 1 1 376 385 Deamidation (NQ); Methylation(KR)
R.L(+88.00)LAHTQIR.K Y 19.93 1038.5645 8 -3.2 347.1943 3 34.62 4 15535 VEV_1_3_RA4_01_1235.d 0 2 2 313 320 3-sulfanylpropanoyl
K.K(+42.01)(+42.01)AHLMEVQVNGGSIADK.V Y 19.90 1879.9462 17 -12.6 470.9879 4 62.93 6 32587 VEV_3_3_RA6_01_1237.d 4.6E4 1 1 328 344 Acetylation (N-term); Acetylation (K)
R.K(+43.99)TLYPQVSR.K Y 19.62 1134.6033 9 -14.2 379.2030 3 39.36 4 18310 VEV_1_3_RA4_01_1235.d 5.6E4 1 1 493 501 Carboxylation (DKW)
K.T(+79.97)LYPQVSRK.A Y 19.37 1170.5798 9 1.9 391.2013 3 29.89 6 12816 VEV_3_3_RA6_01_1237.d 8.71E4 1 1 494 502 Phosphorylation (STY)
K.AGMTTVVR(+14.02).D Y 19.27 847.4586 8 -4.9 424.7345 2 48.04 4 23659 VEV_1_3_RA4_01_1235.d 3.85E4 1 1 203 210 Methylation(KR)
K.AGMTTVVR(+14.02)DLERPGAK.M Y 19.12 1713.9196 16 -13.4 572.3062 3 68.97 5 38250 VEV_2_3_RA5_01_1236.d 9.56E4 1 1 203 218 Methylation(KR)
R.HGSLAFLPRK(+108.00)R.S Y 18.88 1388.7441 11 -11.0 348.1895 4 63.56 4 34177 VEV_1_3_RA4_01_1235.d 9.68E4 1 1 163 173 O-Ethylphosphorylation
R.KALEK(+14.02)VELK.W Y 18.84 1070.6699 9 -33.5 536.3243 2 35.23 4 15927 VEV_1_3_RA4_01_1235.d 3.36E4 1 1 502 510 Methylation(KR)
R.YGEVKNDYVM(-48.00)LK.G Y 18.76 1409.7190 12 -15.7 470.9062 3 54.01 6 26672 VEV_3_3_RA6_01_1237.d 6.3E5 1 1 467 478 Dethiomethyl
K.WIDTSSKFGHGAFQ(+.98)TPAEK.R Y 18.75 2107.0010 19 -6.7 527.7540 4 66.94 6 35580 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 511 529 Deamidation (NQ)
K.NHSENT(-18.01)GASVSR.E Y 18.60 1239.5592 12 -6.7 414.1909 3 11.05 4 2881 VEV_1_3_RA4_01_1235.d 2.75E4 1 1 288 299 Dehydration
R.VLTLRK.T Y 18.42 728.4908 6 -39.2 365.2384 2 23.93 4 9542 VEV_1_3_RA4_01_1235.d 0 1 1 488 493
R.K(+14.02)TLYPQVSRK.A Y 18.41 1232.7241 10 -18.9 309.1825 4 30.95 5 13842 VEV_2_3_RA5_01_1236.d 0 1 1 493 502 Methylation(KR)
K.FGHGAFQTPAEKRAFM(+15.99)GTLK.K Y 18.35 2209.1101 20 -11.8 737.3687 3 93.81 6 53108 VEV_3_3_RA6_01_1237.d 0 1 1 518 537 Oxidation (M)
K.FGHGAFQTPAEKR(+14.02).A Y 18.28 1458.7367 13 -13.2 365.6866 4 51.17 5 25866 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 518 530 Methylation(KR)
K.D(+21.98)LVTAA Y 18.18 610.2938 6 -12.9 611.2932 1 49.93 5 25104 VEV_2_3_RA5_01_1236.d 7.98E4 1 1 539 544 Sodium adduct
R.DLERPGAKMHKK(+27.99).E Y 18.15 1436.7557 12 -12.2 360.1918 4 43.36 6 20445 VEV_3_3_RA6_01_1237.d 0 1 1 211 222 Formylation
K.GS(+79.96)VPGVKK.R Y 17.85 850.4218 8 -5.8 426.2157 2 46.75 5 23171 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 479 486 Sulfation
K.G(+42.01)SVPGVK.K Y 17.84 684.3806 7 -17.8 343.1915 2 20.00 4 7401 VEV_1_3_RA4_01_1235.d 0 2 2 479 485 Acetylation (N-term)
K.LISPASLEELSVYTFGR(+28.03).K Y 17.48 1909.0197 17 -7.4 637.3425 3 76.39 6 42551 VEV_3_3_RA6_01_1237.d 7.45E4 1 1 62 78 Dimethylation(KR)
K.K(+14.02)Q(+.98)ITPM(+15.99)GGFVR.Y Y 17.45 1263.6646 11 23.3 422.2386 3 34.58 5 15925 VEV_2_3_RA5_01_1236.d 0 1 1 456 466 Methylation(KR); Deamidation (NQ); Oxidation (M)
R.KTHKGLR.K Y 17.28 838.5137 7 -37.4 839.4896 1 105.55 5 57654 VEV_2_3_RA5_01_1236.d 2.83E5 1 1 394 400
K.K(+42.01)AHLMEVQVN(+.98)GGSIADK(+42.01).V Y 17.18 1880.9302 17 2.2 471.2408 4 36.71 5 17193 VEV_2_3_RA5_01_1236.d 0 1 1 328 344 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
K.QITPMGGFVR(+21.98)(+14.02).Y Y 17.07 1140.5726 10 -6.2 571.2900 2 75.09 4 43194 VEV_1_3_RA4_01_1235.d 1.5E5 1 1 457 466 Sodium adduct; Methylation(KR)
R.IGKGSDEGNAS(+79.97)TEFDVSK(+43.01).K Y 16.99 1962.8208 18 56.8 491.7403 4 41.68 6 19467 VEV_3_3_RA6_01_1237.d 0 1 1 438 455 Phosphorylation (STY); Carbamylation
K.FGHGAFQTPAE(+14.02)KR.A Y 16.65 1458.7367 13 -11.8 365.6871 4 51.12 6 24940 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 518 530 Methylation(others)
K.S(+79.97)FPKDDPK.K Y 16.51 1012.4266 8 -8.6 1013.4252 1 112.15 4 61718 VEV_1_3_RA4_01_1235.d 0 1 1 183 190 Phosphorylation (STY)
R.IGKGSDEGNASTEFDVSKKQITPM(+15.99)GGFVR.Y Y 16.09 3070.5029 29 -5.4 615.1046 5 66.10 4 36133 VEV_1_3_RA4_01_1235.d 8.63E4 1 1 438 466 Oxidation (M)
R.A(+226.08)FMGTLK.K Y 15.62 992.4823 7 -27.0 497.2350 2 16.67 5 5913 VEV_2_3_RA5_01_1236.d 0 1 1 531 537 Biotinylation
K.GSVPGVK(+37.96).K Y 15.60 680.3259 7 -15.4 681.3228 1 34.72 6 15495 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 479 485 Replacement of proton by potassium
R.K(+42.01)(+42.01)ALEKVELK.W Y 15.52 1140.6754 9 -65.3 381.2076 3 29.33 5 12889 VEV_2_3_RA5_01_1236.d 0 1 1 502 510 Acetylation (N-term); Acetylation (K)
K.GSIAVR(+31.99).V Y 15.49 633.3445 6 4.3 634.3546 1 99.23 4 57949 VEV_1_3_RA4_01_1235.d 0 1 1 48 53 Dihydroxy
K.VELKWIDTSSK.F Y 15.48 1304.6976 11 -10.8 435.9018 3 66.60 5 36473 VEV_2_3_RA5_01_1236.d 8.08E4 1 1 507 517
K.SFPK(+14.02)DDPK.K Y 15.13 946.4760 8 30.5 474.2597 2 26.96 6 11231 VEV_3_3_RA6_01_1237.d 0 1 1 183 190 Methylation(KR)
K.FGHGAFQTPAEK(+27.99).R Y 15.05 1316.6149 12 37.4 659.3394 2 46.17 4 22488 VEV_1_3_RA4_01_1235.d 0 1 1 518 529 Formylation
total 177 peptides
C1GLI9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FIEPIEDVPAGNILGLVGVDQFLLK.S Y 149.86 2695.4836 25 -10.0 1348.7356 2 97.41 6 54456 VEV_3_3_RA6_01_1237.d 2.57E5 6 6 429 453
K.KFLPAADALMEMMVLHLPSPVTAQK.Y Y 131.74 2737.4368 25 -16.1 685.3555 4 91.07 4 54246 VEV_1_3_RA4_01_1235.d 5.55E5 5 5 314 338
R.LYVTAEPLNEEVSKDIESGKIGPR.D Y 130.99 2643.3755 24 -13.8 661.8420 4 77.41 6 43306 VEV_3_3_RA6_01_1237.d 3.46E5 3 3 574 597
R.TIESVNVIIATYFDKALGDVQVYPYK.G Y 128.86 2945.5425 26 -11.9 982.8431 3 94.04 6 53221 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 170 195
R.LYVTAEPLNEEVSKDIESGK.I Y 126.24 2220.1162 20 -11.0 741.0378 3 75.69 6 42067 VEV_3_3_RA6_01_1237.d 7.78E5 5 5 574 593
K.AYLPVNESFGFTADLR.G Y 122.42 1798.8889 16 -11.9 900.4410 2 83.53 6 47547 VEV_3_3_RA6_01_1237.d 7.13E5 4 4 758 773
R.AFNQFILDPIFKIFNAITHSK.T Y 120.62 2463.3313 21 -6.8 616.8359 4 96.44 4 56933 VEV_1_3_RA4_01_1235.d 2.38E5 2 2 260 280
K.GIKEVVPGVDNYYDKL Y 119.97 1807.9355 16 -11.9 603.6453 3 76.61 6 42718 VEV_3_3_RA6_01_1237.d 5.34E5 4 4 816 831
K.FLPAADALMEMMVLHLPSPVTAQK.Y Y 119.19 2609.3418 24 -6.9 653.3382 4 94.41 5 53973 VEV_2_3_RA5_01_1236.d 1.9E6 12 12 315 338
K.AVQYLHEIKDSVVSGFQWATR.E Y 115.37 2433.2441 21 -8.4 609.3132 4 82.20 5 47472 VEV_2_3_RA5_01_1236.d 3.35E5 2 2 640 660
K.YRAETLYEGPPDDEAC(+57.02)IGIR.D Y 111.11 2324.0742 20 -12.5 775.6890 3 72.99 6 40077 VEV_3_3_RA6_01_1237.d 2.17E5 3 3 339 358 Carbamidomethylation
R.AFNQFILDPIFK.I Y 106.07 1451.7812 12 -9.4 726.8911 2 86.83 5 50217 VEV_2_3_RA5_01_1236.d 5.24E5 5 5 260 271
R.KIWC(+57.02)FGPDTTGANLLVDQTK.A Y 105.45 2263.1306 20 -9.1 755.3773 3 80.42 5 46329 VEV_2_3_RA5_01_1236.d 4.07E5 3 3 620 639 Carbamidomethylation
K.YRAETLYEGPPDDEAC(+57.02)IGIRDC(+57.02)DPK.A Y 104.97 2939.3064 25 -3.5 735.8313 4 70.11 4 39297 VEV_1_3_RA4_01_1235.d 2.19E5 3 3 339 363 Carbamidomethylation
R.ALLELQVTKEDLYQSFSR.T Y 102.55 2139.1211 18 -2.2 714.0461 3 81.49 4 48156 VEV_1_3_RA4_01_1235.d 4.4E5 3 3 152 169
R.AETLYEGPPDDEAC(+57.02)IGIR.D Y 101.66 2004.9098 18 -5.4 1003.4568 2 75.44 5 42901 VEV_2_3_RA5_01_1236.d 2.16E5 4 4 341 358 Carbamidomethylation
R.TIESVNVIIATYFDK.A Y 100.96 1711.9032 15 -8.8 856.9514 2 88.39 6 50471 VEV_3_3_RA6_01_1237.d 2.92E5 4 4 170 184
R.KGIKEVVPGVDNYYDKL Y 98.25 1936.0305 17 -13.4 485.0084 4 72.27 5 40658 VEV_2_3_RA5_01_1236.d 6.46E5 5 5 815 831
K.GTVAFGSGLHGWAFTVR.Q Y 97.70 1761.8950 17 -17.0 588.2957 3 79.70 6 44943 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 196 212
K.ALGDVQVYPYK.G Y 97.39 1251.6499 11 -9.7 626.8262 2 69.47 4 38796 VEV_1_3_RA4_01_1235.d 3.24E5 4 4 185 195
K.SGTLTTSETAHNLK.V Y 95.88 1458.7314 14 -10.1 487.2462 3 34.17 5 15669 VEV_2_3_RA5_01_1236.d 2.42E6 10 10 454 467
K.IWC(+57.02)FGPDTTGANLLVDQTK.A Y 92.75 2135.0356 19 -10.2 712.6786 3 84.11 6 47919 VEV_3_3_RA6_01_1237.d 1.85E5 3 3 621 639 Carbamidomethylation
K.NGEYEGKPLER.A Y 91.68 1290.6204 11 -15.8 646.3073 2 27.41 5 11835 VEV_2_3_RA5_01_1236.d 1.47E6 19 19 249 259
R.LWGDNYFNPK.T Y 90.37 1252.5876 10 -6.6 627.2969 2 75.92 4 43875 VEV_1_3_RA4_01_1235.d 9.37E5 3 3 233 242
K.APLMLYVSK.M Y 88.98 1020.5677 9 -13.1 511.2845 2 70.53 5 39379 VEV_2_3_RA5_01_1236.d 5.79E5 3 3 364 372
R.NMSVIAHVDHGKSTLTDSLVQR.A Y 88.37 2407.2278 22 -4.8 602.8113 4 67.58 4 37306 VEV_1_3_RA4_01_1235.d 2.86E5 3 3 9 30
R.IKPVC(+57.02)IINKVDR.A Y 87.33 1453.8439 12 -17.4 364.4619 4 59.61 6 30158 VEV_3_3_RA6_01_1237.d 4.03E5 4 4 140 151 Carbamidomethylation
R.AETLYEGPPDDEAC(+57.02)IGIRDC(+57.02)DPK.A Y 86.05 2620.1421 23 -5.5 874.3832 3 71.54 4 40433 VEV_1_3_RA4_01_1235.d 3.41E5 3 3 341 363 Carbamidomethylation
K.FSVSPVVQR.S Y 82.55 1017.5607 9 -12.1 509.7814 2 62.32 5 33308 VEV_2_3_RA5_01_1236.d 1.52E6 6 6 471 479
R.LYVTAEPLNEEVSK.D Y 82.17 1590.8141 14 -8.1 796.4079 2 70.86 4 39897 VEV_1_3_RA4_01_1235.d 1.74E5 3 3 574 587
R.ILADEHGWDVTDAR.K Y 81.22 1596.7532 14 -14.3 533.2507 3 67.18 6 35766 VEV_3_3_RA6_01_1237.d 3.73E5 3 3 606 619
K.VQGNEFLINLIDSPGHVDFSSEVTAALR.V Y 80.94 3027.5300 28 -4.2 1010.1797 3 90.76 4 54078 VEV_1_3_RA4_01_1235.d 3.47E5 3 3 82 109
R.GHVFAEEQRPGTPLFNVK.A Y 79.55 2025.0431 18 -11.4 507.2623 4 67.78 5 37363 VEV_2_3_RA5_01_1236.d 7.75E5 4 4 740 757
R.DC(+57.02)DPKAPLMLYVSK.M Y 78.07 1635.8000 14 -6.9 546.2702 3 74.42 4 42678 VEV_1_3_RA4_01_1235.d 8.78E4 1 1 359 372 Carbamidomethylation
R.SVEVKNANDLPK.L Y 75.91 1312.6986 12 11.3 657.3640 2 39.39 6 18144 VEV_3_3_RA6_01_1237.d 9.68E5 14 14 480 491
R.ETVGDKSSITALSK.S Y 75.38 1434.7566 14 -12.3 479.2536 3 50.05 4 24910 VEV_1_3_RA4_01_1235.d 7.68E5 6 6 553 566
K.N(+.98)GEYEGKPLER.A Y 73.76 1291.6044 11 -7.5 646.8046 2 36.72 4 16768 VEV_1_3_RA4_01_1235.d 1.42E6 9 9 249 259 Deamidation (NQ)
K.LTAEEKEQEGKPLLK.S Y 66.04 1711.9355 15 -8.7 428.9874 4 39.82 4 18589 VEV_1_3_RA4_01_1235.d 6.66E5 5 5 295 309
R.GGGQIIPTAR.R N 64.56 968.5403 10 -10.2 485.2725 2 46.16 5 22871 VEV_2_3_RA5_01_1236.d 1.63E6 10 10 689 698
R.RGHVFAEEQRPGTPLFNVK.A Y 62.88 2181.1443 19 -8.7 437.2323 5 65.50 4 35664 VEV_1_3_RA4_01_1235.d 2.52E5 1 1 739 757
R.FTDTRQDEQDR.C Y 61.78 1409.6171 11 -11.9 470.8740 3 16.88 5 6040 VEV_2_3_RA5_01_1236.d 3.12E5 6 6 44 54
R.IQGPNYTPGRKEDLYIK.A Y 61.00 1991.0476 17 -9.9 664.6832 3 62.02 4 33009 VEV_1_3_RA4_01_1235.d 4.54E5 4 4 401 417
R.VSDPVVSYRETVGDKSSITALSK.S Y 60.55 2437.2700 23 -12.7 813.4203 3 69.41 5 38570 VEV_2_3_RA5_01_1236.d 1.14E5 3 3 544 566
K.SGTLTTSETAHNLKVMK.F Y 58.91 1816.9353 17 -17.6 606.6417 3 52.83 4 26691 VEV_1_3_RA4_01_1235.d 1.15E5 3 3 454 470
R.FTDTRQDEQDRC(+57.02)ITIK.S Y 57.11 2024.9585 16 -9.2 1013.4772 2 49.13 5 24630 VEV_2_3_RA5_01_1236.d 2.78E6 9 9 44 59 Carbamidomethylation
R.VSDPVVSYR.E Y 56.06 1020.5240 9 -11.5 511.2634 2 52.97 5 26968 VEV_2_3_RA5_01_1236.d 1.18E6 6 6 544 552
K.EDLYQSFSR.T Y 54.16 1143.5197 9 -10.2 572.7613 2 65.82 6 34746 VEV_3_3_RA6_01_1237.d 7.27E4 1 1 161 169
R.VSDPVVSYRETVGDK.S Y 54.01 1649.8260 15 -6.6 550.9457 3 60.96 4 32199 VEV_1_3_RA4_01_1235.d 3.18E5 3 3 544 558
K.SGTLTTSETAHNLK(+14.02).V Y 53.61 1472.7471 14 -7.9 737.3750 2 45.32 4 21958 VEV_1_3_RA4_01_1235.d 1.84E5 5 5 454 467 Methylation(KR)
K.YR(+14.02)AETLYEGPPDDEAC(+57.02)IGIR.D Y 53.47 2338.0898 20 -3.1 780.3682 3 75.07 4 43216 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 339 358 Methylation(KR); Carbamidomethylation
K.SSITALSK.S Y 51.36 805.4545 8 -20.1 403.7264 2 33.19 6 14667 VEV_3_3_RA6_01_1237.d 2.92E5 2 2 559 566
K.NANDLPKLVEGLK(+42.01)R.L Y 50.08 1607.8994 14 6.3 402.9846 4 67.93 6 36334 VEV_3_3_RA6_01_1237.d 4.68E5 3 3 485 498 Acetylation (K)
R.LYVTAE(+14.02)PLNEEVSKDIESGK.I Y 49.74 2234.1318 20 -4.9 745.7142 3 76.99 4 44684 VEV_1_3_RA4_01_1235.d 4.94E4 2 2 574 593 Methylation(others)
R.VFAGTVR.S Y 48.62 748.4232 7 -18.3 375.2120 2 33.13 6 14598 VEV_3_3_RA6_01_1237.d 1.53E6 13 13 388 394
K.AYLPVNESFGFTADLR(+14.02).G Y 46.55 1812.9045 16 -6.6 907.4536 2 85.00 5 49165 VEV_2_3_RA5_01_1236.d 1.68E5 2 2 758 773 Methylation(KR)
K.APLM(+15.99)LYVSK.M Y 45.36 1036.5626 9 -12.5 519.2821 2 65.57 4 35727 VEV_1_3_RA4_01_1235.d 1.3E5 2 2 364 372 Oxidation (M)
R.LYVT(-2.02)AEPLNEEVSKDIESGKIGPR.D Y 44.39 2641.3599 24 -8.3 661.3417 4 77.49 4 45079 VEV_1_3_RA4_01_1235.d 2.33E4 1 1 574 597 2-amino-3-oxo-butanoic_acid
R.IQGPNYTPGR.K Y 43.56 1101.5566 10 2.6 551.7870 2 44.80 4 21634 VEV_1_3_RA4_01_1235.d 1.3E6 7 7 401 410
K.WTKN(+.98)GEYEGKPLER.A Y 42.90 1706.8263 14 -10.8 427.7092 4 43.48 5 21203 VEV_2_3_RA5_01_1236.d 0 1 1 246 259 Deamidation (NQ)
K.FLPAADALME(+14.02)MMVLHLPSPVTAQK.Y Y 42.62 2623.3577 24 -27.8 656.8284 4 95.26 5 54331 VEV_2_3_RA5_01_1236.d 0 1 1 315 338 Methylation(others)
R.FYAFGR.V Y 42.39 759.3704 6 -23.0 380.6837 2 62.12 6 31987 VEV_3_3_RA6_01_1237.d 1.18E6 6 6 382 387
K.MVPTSDKGR.F Y 41.98 989.4964 9 -15.8 495.7477 2 13.03 6 3935 VEV_3_3_RA6_01_1237.d 3.52E5 5 5 373 381
R.AGIISAAK.A Y 41.29 729.4385 8 -10.6 365.7227 2 30.10 4 12903 VEV_1_3_RA4_01_1235.d 1.02E6 11 11 31 38
R.TIESVNVIIATYFDK(-1.03)ALGDVQVYPYK.G Y 41.19 2944.5110 26 -4.1 982.5070 3 94.05 4 55853 VEV_1_3_RA4_01_1235.d 0 1 1 170 195 Lysine oxidation to aminoadipic semialdehyde
K.YRAETLYE(+14.02)GPPDDEAC(+57.02)IGIR.D Y 40.98 2338.0898 20 -6.4 780.3656 3 75.04 6 41575 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 339 358 Methylation(others); Carbamidomethylation
K.SGTLTTSE(+14.02)TAHNLK.V Y 40.79 1472.7471 14 -9.7 737.3737 2 44.70 4 21584 VEV_1_3_RA4_01_1235.d 1.1E5 3 3 454 467 Methylation(others)
K.FSVSPVVQ(+.98)R.S Y 40.38 1018.5447 9 -18.9 510.2700 2 63.78 6 33205 VEV_3_3_RA6_01_1237.d 7.39E4 2 2 471 479 Deamidation (NQ)
K.AYLPVNE(+14.02)SFGFTADLR.G Y 39.79 1812.9045 16 -12.9 907.4479 2 85.63 6 48848 VEV_3_3_RA6_01_1237.d 1.11E4 1 1 758 773 Methylation(others)
K.Y(-18.01)R(+14.02)AETLYEGPPDDEAC(+57.02)IGIRDC(+57.02)DPK.A Y 39.78 2935.3115 25 35.1 734.8609 4 70.12 4 39301 VEV_1_3_RA4_01_1235.d 5.05E4 1 1 339 363 Dehydration; Methylation(KR); Carbamidomethylation
K.NGEYEGK(+14.02)PLER.A Y 39.23 1304.6360 11 -12.8 653.3169 2 35.11 5 16247 VEV_2_3_RA5_01_1236.d 2.24E5 3 3 249 259 Methylation(KR)
R.ILADEHGWDVTDARK.I Y 39.06 1724.8481 15 0.3 432.2194 4 62.25 4 33190 VEV_1_3_RA4_01_1235.d 3.91E5 3 3 606 620
K.EVVPGVDNYYDKL Y 37.14 1509.7351 13 -9.7 755.8675 2 77.42 5 44318 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 819 831
R.GGGQIIPTARR.V N 37.02 1124.6414 11 -10.7 563.3220 2 35.26 5 16323 VEV_2_3_RA5_01_1236.d 3.57E5 4 4 689 699
R.NMSVIAHVDHGK.S Y 36.83 1306.6451 12 -14.0 436.5496 3 38.14 6 17421 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 9 20
R.Q(-17.03)DEQDRC(+57.02)ITIK.S Y 34.08 1387.6401 11 -12.9 694.8184 2 52.73 6 25901 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 49 59 Pyro-glu from Q; Carbamidomethylation
R.EGPIAEEPM(+15.99)R.S Y 33.78 1143.5229 10 -1.4 572.7679 2 38.22 4 17650 VEV_1_3_RA4_01_1235.d 3.09E5 3 3 661 670 Oxidation (M)
R.K(+14.02)IWC(+57.02)FGPDT(-18.01)TGANLLVDQTK.A Y 32.13 2259.1357 20 -26.5 754.0326 3 80.53 4 47433 VEV_1_3_RA4_01_1235.d 0 1 1 620 639 Methylation(KR); Carbamidomethylation; Dehydration
K.STAISLYAHLPDEEDLKDIPQK.V Y 31.78 2482.2590 22 -11.3 828.4176 3 77.63 4 45189 VEV_1_3_RA4_01_1235.d 6.76E4 1 1 60 81
K.EQEGKPLLK.S Y 31.29 1040.5865 9 -16.9 521.2917 2 21.38 6 8290 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 301 309
K.NGE(+14.02)YEGKPLER.A Y 30.99 1304.6360 11 -8.1 653.3200 2 35.52 4 16060 VEV_1_3_RA4_01_1235.d 1.61E5 2 2 249 259 Methylation(others)
R.TIES(-2.02)VNVIIATYFDKALGDVQVYPYK.G Y 29.02 2943.5269 26 9.4 736.8959 4 94.06 4 55842 VEV_1_3_RA4_01_1235.d 3.18E5 1 1 170 195 2-amino-3-oxo-butanoic_acid
R.KIWC(+57.02)FGPDTTGANLLVDQT(-18.01)K(+14.02).A Y 29.02 2259.1357 20 -27.4 754.0319 3 80.43 6 45464 VEV_3_3_RA6_01_1237.d 4.03E4 1 1 620 639 Carbamidomethylation; Dehydration; Methylation(KR)
K.AVQYLHEIK(-1.03)DSVVSGFQWATR.E Y 28.65 2432.2124 21 -0.4 609.0601 4 82.43 4 48836 VEV_1_3_RA4_01_1235.d 0 1 1 640 660 Lysine oxidation to aminoadipic semialdehyde
K.YRAETLY(-2.02)EGPPDDEAC(+57.02)IGIR.D Y 28.29 2322.0586 20 33.3 775.0526 3 73.20 6 40236 VEV_3_3_RA6_01_1237.d 2.78E4 1 1 339 358 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.N(+42.01)GEYEGKPLER.A Y 28.18 1332.6310 11 -4.3 445.2157 3 36.80 4 16816 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 249 259 Acetylation (N-term)
R.EGPIAEEPMR.S Y 27.83 1127.5281 10 14.4 564.7794 2 52.23 6 25612 VEV_3_3_RA6_01_1237.d 0 2 2 661 670
R.LYVTAEPLNEEVSK(+14.02).D Y 27.66 1604.8297 14 -21.5 803.4049 2 74.98 4 43111 VEV_1_3_RA4_01_1235.d 7.19E3 1 1 574 587 Methylation(KR)
R.EGPIAEE(+14.02)PMR.S Y 27.18 1141.5437 10 -6.0 571.7757 2 61.85 4 32875 VEV_1_3_RA4_01_1235.d 2.68E4 1 1 661 670 Methylation(others)
K.NANDLPK.L Y 25.14 770.3922 7 -6.1 771.3948 1 91.16 4 54302 VEV_1_3_RA4_01_1235.d 3.01E5 3 3 485 491
R.GHVFAEEQR(+14.02)PGT(-18.01)PLFNVK.A Y 24.69 2021.0482 18 -8.2 506.2652 4 68.01 4 37648 VEV_1_3_RA4_01_1235.d 0 1 1 740 757 Methylation(KR); Dehydration
R.IQ(+.98)GPNYTPGR.K Y 24.41 1102.5406 10 -23.3 552.2648 2 45.79 6 21871 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 401 410 Deamidation (NQ)
R.ALLELQVTK(+14.02)EDLYQSFSR.T Y 23.24 2153.1367 18 -31.1 718.6972 3 82.56 6 46907 VEV_3_3_RA6_01_1237.d 2.73E4 1 1 152 169 Methylation(KR)
R.V(+27.99)SDPVVSYR.E Y 22.64 1048.5189 9 -2.9 525.2652 2 30.84 6 13328 VEV_3_3_RA6_01_1237.d 0 1 1 544 552 Formylation
K.LT(-18.01)AEEK(+14.02)EQEGKPLLK.S Y 22.37 1707.9407 15 -12.1 570.3140 3 39.58 6 18249 VEV_3_3_RA6_01_1237.d 0 1 1 295 309 Dehydration; Methylation(KR)
K.LTAEEK.E Y 22.18 689.3596 6 -31.3 690.3453 1 72.17 6 39494 VEV_3_3_RA6_01_1237.d 2.77E4 1 1 295 300
R.QALGER.I Y 21.99 672.3555 6 -21.5 673.3483 1 18.80 6 6930 VEV_3_3_RA6_01_1237.d 1.41E3 1 1 134 139
R.TILMMGR.F Y 21.87 820.4299 7 -11.2 411.2177 2 63.92 4 34453 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 422 428
K.YAKKFGVDRNK.M Y 21.58 1324.7251 11 -31.6 332.1781 4 16.30 5 5726 VEV_2_3_RA5_01_1236.d 9.68E4 1 1 218 228
K.SGTLT(-18.01)TSETAHNLK.V Y 21.47 1440.7208 14 12.6 361.1920 4 40.14 6 18570 VEV_3_3_RA6_01_1237.d 1.74E5 1 1 454 467 Dehydration
K.DIESGKIGPR.D Y 21.43 1070.5720 10 -13.1 536.2863 2 37.16 4 17025 VEV_1_3_RA4_01_1235.d 0 1 1 588 597
K.M(+15.99)VPTSDKGR.F Y 21.03 1005.4913 9 -14.5 503.7457 2 11.38 4 3021 VEV_1_3_RA4_01_1235.d 3.76E4 2 2 373 381 Oxidation (M)
K.MVPTSD(-18.01)K.G Y 21.00 758.3633 7 -16.4 759.3581 1 23.18 4 9089 VEV_1_3_RA4_01_1235.d 0 1 1 373 379 Dehydration
R.QDEQ(+.98)D(-18.01)RC(+57.02)ITIK.S Y 20.52 1387.6401 11 -6.1 694.8231 2 53.51 4 27128 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 49 59 Deamidation (NQ); Dehydration; Carbamidomethylation
R.ARILADEHGWDVTDAR.K Y 20.00 1823.8914 16 -22.7 456.9698 4 12.62 6 3717 VEV_3_3_RA6_01_1237.d 1.07E4 1 1 604 619
K.FGVDR(+14.02).N Y 19.98 606.3126 5 -12.5 607.3123 1 98.96 6 54968 VEV_3_3_RA6_01_1237.d 0 1 1 222 226 Methylation(KR)
R.ETVGDKSSITALSKSPNK.H Y 19.62 1860.9792 18 -12.2 621.3261 3 65.88 6 34791 VEV_3_3_RA6_01_1237.d 2.51E4 2 2 553 570
K.AYLPVN(+.98)ESFGFTADLR.G Y 19.59 1799.8729 16 1.1 900.9448 2 84.71 6 48273 VEV_3_3_RA6_01_1237.d 2.37E2 1 1 758 773 Deamidation (NQ)
K.AGEARFTD(-18.01)TR.Q Y 19.52 1104.5311 10 -0.8 369.1840 3 45.37 6 21626 VEV_3_3_RA6_01_1237.d 0 1 1 39 48 Dehydration
K.MVPTSDKGRFYAFGR.V Y 19.49 1730.8562 15 8.3 347.1814 5 62.05 4 33032 VEV_1_3_RA4_01_1235.d 0 1 1 373 387
K.DIESGK.I Y 19.45 647.3126 6 29.1 648.3387 1 84.07 6 47879 VEV_3_3_RA6_01_1237.d 0 1 1 588 593
K.S(+226.08)GTLTTSETAHNLK(+42.01).V Y 19.40 1726.8196 14 -7.5 432.7089 4 49.86 5 25062 VEV_2_3_RA5_01_1236.d 6.38E4 1 1 454 467 Biotinylation; Acetylation (K)
R.FYAFGR(+.98).V Y 19.33 760.3544 6 17.5 381.1911 2 81.85 6 46447 VEV_3_3_RA6_01_1237.d 2.79E4 1 1 382 387 Deamidation (R)
K.LVEGLK(+28.03).R Y 19.32 685.4374 6 -16.8 686.4331 1 100.16 6 55377 VEV_3_3_RA6_01_1237.d 1.63E4 1 1 492 497 Dimethylation(KR)
K.DIPQK.V Y 19.32 599.3279 5 -13.8 600.3269 1 53.03 6 26069 VEV_3_3_RA6_01_1237.d 9.85E4 2 2 77 81
K.AGEAR.F Y 19.29 502.2499 5 -7.7 503.2534 1 13.79 4 4197 VEV_1_3_RA4_01_1235.d 7.95E4 3 3 39 43
K.FSVSPVVQR(-.98).S Y 19.29 1016.5767 9 -23.4 339.8582 3 43.34 5 21119 VEV_2_3_RA5_01_1236.d 2.82E4 1 1 471 479 Amidation
R.VSDPVVS(-18.01)YRETVGDK.S Y 19.01 1631.8154 15 -21.0 544.9343 3 64.46 6 33713 VEV_3_3_RA6_01_1237.d 0 1 1 544 558 Dehydration
R.S(+42.01)VEVK(+14.02)NANDLPK.L Y 18.83 1368.7249 12 -6.9 457.2457 3 45.65 5 22521 VEV_2_3_RA5_01_1236.d 8.42E4 1 1 480 491 Acetylation (N-term); Methylation(KR)
M(+15.99)DRPAN(+.98)IR.N Y 18.70 988.4760 8 2.8 495.2466 2 45.37 5 22356 VEV_2_3_RA5_01_1236.d 0 1 1 1 8 Oxidation (M); Deamidation (NQ)
K.I(+43.01)FNAITHSK.T Y 18.54 1072.5665 9 31.5 358.5407 3 54.97 4 28046 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 272 280 Carbamylation
R.IQGPN(+.98)YTPGR.K Y 18.54 1102.5406 10 -15.5 552.2690 2 46.20 6 22100 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 401 410 Deamidation (NQ)
K.APLMLYVSK(+14.02).M Y 18.12 1034.5834 9 -40.1 518.2782 2 72.76 5 41008 VEV_2_3_RA5_01_1236.d 1.32E5 1 1 364 372 Methylation(KR)
R.LYVTAEPLNEEVSKDIESGK(+14.02).I Y 18.11 2234.1318 20 -7.9 745.7120 3 77.41 4 45013 VEV_1_3_RA4_01_1235.d 9.17E4 1 1 574 593 Methylation(KR)
K.MVPTSDK(+42.01)GR(-.98).F Y 18.10 1030.5229 9 -5.4 516.2660 2 29.28 5 12858 VEV_2_3_RA5_01_1236.d 0 1 1 373 381 Acetylation (K); Amidation
K.VMKFSVSPVVQR(+31.99)SVEVK.N Y 18.10 1950.0608 17 -56.1 488.4951 4 73.72 4 42144 VEV_1_3_RA4_01_1235.d 0 1 1 468 484 Dihydroxy
K.FGVDR.N Y 17.73 592.2969 5 -16.0 593.2947 1 25.04 4 10140 VEV_1_3_RA4_01_1235.d 1.55E4 1 1 222 226
K.KFGVD(+21.98)RNK.M Y 17.63 984.5117 8 -12.4 985.5067 1 82.17 4 48650 VEV_1_3_RA4_01_1235.d 0 1 1 221 228 Sodium adduct
R.AFN(+.98)Q(+.98)FILDPIFK.I Y 17.34 1453.7493 12 -38.5 727.8539 2 87.30 6 49829 VEV_3_3_RA6_01_1237.d 7.11E4 1 1 260 271 Deamidation (NQ)
R.ETVGD(-18.01)K(+14.02).S Y 17.26 643.3177 6 -5.6 644.3214 1 19.67 4 7241 VEV_1_3_RA4_01_1235.d 4.35E4 1 1 553 558 Dehydration; Methylation(KR)
K.FGVDRNK.M Y 16.86 834.4348 7 -15.9 418.2180 2 35.77 4 16197 VEV_1_3_RA4_01_1235.d 4.41E5 1 1 222 228
R.Q(+.98)FAVKY(+79.97)AK.K Y 16.80 1034.4838 8 33.1 518.2663 2 11.35 5 3137 VEV_2_3_RA5_01_1236.d 0 1 1 213 220 Deamidation (NQ); Phosphorylation (STY)
R.SVEVKN(+.98)AN(+.98)DLPK.L Y 16.75 1314.6666 12 4.1 658.3433 2 32.95 6 14504 VEV_3_3_RA6_01_1237.d 6.51E4 1 1 480 491 Deamidation (NQ)
R.ET(+79.97)VGDKSSITALS(+79.97)K(+14.02).S Y 16.74 1608.7048 14 45.2 537.2665 3 62.60 6 32338 VEV_3_3_RA6_01_1237.d 0 1 1 553 566 Phosphorylation (STY); Methylation(KR)
K.VMKFSVSPVVQ(+.98)R(+21.98).S Y 16.69 1398.7305 12 -13.7 467.2444 3 75.06 6 41588 VEV_3_3_RA6_01_1237.d 0 1 1 468 479 Deamidation (NQ); Sodium adduct
R.NMS(-18.01)VIAHVDHGK(+14.02)STLTDSLVQR.A Y 16.65 2403.2329 22 -11.3 601.8087 4 67.50 6 36011 VEV_3_3_RA6_01_1237.d 4.2E4 1 1 9 30 Dehydration; Methylation(KR)
K.S(+42.01)SITALSKSPNK(+14.02).H Y 16.60 1287.7034 12 -24.6 430.2312 3 49.37 4 24485 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 559 570 Acetylation (N-term); Methylation(KR)
R.SVEVKNANDLPK(+27.99).L Y 16.53 1340.6936 12 -20.3 671.3405 2 73.24 4 41775 VEV_1_3_RA4_01_1235.d 6.39E4 1 1 480 491 Formylation
K.IGPRDDFK.A Y 16.31 946.4872 8 -13.0 474.2447 2 53.19 5 27102 VEV_2_3_RA5_01_1236.d 1.94E4 1 1 594 601
K.APLMLYVSK(+42.01).M Y 16.28 1062.5784 9 -18.3 355.1936 3 31.05 4 13446 VEV_1_3_RA4_01_1235.d 1.71E5 1 1 364 372 Acetylation (K)
K.SSITALS(-18.01)K(+14.02).S Y 16.21 801.4596 8 -6.8 802.4614 1 100.17 4 58250 VEV_1_3_RA4_01_1235.d 8.42E3 1 1 559 566 Dehydration; Methylation(KR)
K.A(+42.01)GEARFTDTR.Q Y 16.16 1164.5524 10 4.4 389.1931 3 47.72 6 22988 VEV_3_3_RA6_01_1237.d 0 1 1 39 48 Acetylation (N-term)
R.ALLELQVTK.E Y 16.13 1013.6121 9 -40.9 507.7926 2 71.05 5 39763 VEV_2_3_RA5_01_1236.d 0 1 1 152 160
K.F(+42.01)GVD(-18.01)R.N Y 16.08 616.2969 5 4.0 617.3066 1 27.38 4 11403 VEV_1_3_RA4_01_1235.d 0 1 1 222 226 Acetylation (N-term); Dehydration
R.DDFK(+28.03)AR.A Y 16.08 778.3973 6 -16.2 390.1996 2 13.40 5 4179 VEV_2_3_RA5_01_1236.d 7.65E4 1 1 598 603 Dimethylation(KR)
R.A(+226.08)LLELQVTK.E Y 15.88 1239.6897 9 -15.6 414.2307 3 67.69 4 37396 VEV_1_3_RA4_01_1235.d 0 1 1 152 160 Biotinylation
R.N(+.98)MSVIAHVDHGK.S Y 15.81 1307.6292 12 22.7 436.8936 3 66.20 5 36175 VEV_2_3_RA5_01_1236.d 3.73E4 1 1 9 20 Deamidation (NQ)
R.SGLKVR.I Y 15.72 658.4126 6 -72.9 330.1896 2 13.50 6 4189 VEV_3_3_RA6_01_1237.d 0 1 1 395 400
R.FNILDVTLH(+142.11)ADAIHR.G Y 15.66 1876.0319 15 -8.0 626.3463 3 76.86 5 43915 VEV_2_3_RA5_01_1236.d 8.56E4 1 1 674 688 Diphthamide
R.IKPVC(+57.02)IINKVDR(+14.02).A Y 15.62 1467.8595 12 -7.8 367.9693 4 62.39 6 32190 VEV_3_3_RA6_01_1237.d 0 2 2 140 151 Carbamidomethylation; Methylation(KR)
K.A(+42.01)GEAR.F Y 15.60 544.2605 5 1.9 545.2688 1 58.36 5 30353 VEV_2_3_RA5_01_1236.d 2.24E4 1 1 39 43 Acetylation (N-term)
K.DIPQK(+21.98).V Y 15.53 621.3098 5 0.8 622.3176 1 81.76 4 48360 VEV_1_3_RA4_01_1235.d 4.52E4 1 1 77 81 Sodium adduct
R.AGIISAAK(+43.99).A Y 15.50 773.4283 8 -25.4 774.4159 1 88.07 4 52547 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 31 38 Carboxylation (DKW)
R.EGPIAEEPM(-48.00)R.S Y 15.44 1079.5247 10 -14.2 540.7620 2 28.03 5 12151 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 661 670 Dethiomethyl
K.LT(-2.02)AEEKEQEGKPLLK.S Y 15.39 1709.9199 15 -75.8 570.9374 3 39.72 6 18330 VEV_3_3_RA6_01_1237.d 3.18E4 1 1 295 309 2-amino-3-oxo-butanoic_acid
K.N(+42.01)ANDLPK.L Y 15.31 812.4028 7 -13.2 813.3994 1 81.22 5 46847 VEV_2_3_RA5_01_1236.d 4.51E4 1 1 485 491 Acetylation (N-term)
K.STAISLY(+31.99)AHLPDEEDLK.D Y 15.18 1932.9316 17 25.4 484.2524 4 72.53 4 41215 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 60 76 Dihydroxy
total 156 peptides
C1GMV8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLQLAGVHDIYTSSSGSTK.T Y 169.82 1976.0215 19 -11.5 989.0067 2 72.20 6 39545 VEV_3_3_RA6_01_1237.d 5.6E6 12 12 194 212
K.RLLQLAGVHDIYTSSSGSTK.T Y 147.26 2132.1226 20 -17.3 534.0287 4 70.12 6 38016 VEV_3_3_RA6_01_1237.d 1.41E6 7 7 193 212
R.GYWGSNLGEPHSLPTKESGK.C Y 135.67 2143.0334 20 -9.1 536.7607 4 64.35 4 34800 VEV_1_3_RA4_01_1235.d 1.66E6 7 7 149 168
K.TLENTLKATFVAVANTYSFLTPNLWK.E Y 133.62 2941.5588 26 -14.0 981.5132 3 97.53 6 54499 VEV_3_3_RA6_01_1237.d 2.02E5 3 3 213 238
K.LIRSPLDEFGDVLR.E Y 127.63 1628.8885 14 -16.6 543.9611 3 81.65 6 46349 VEV_3_3_RA6_01_1237.d 2.21E6 6 6 242 255
K.ATFVAVANTYSFLTPNLWK.E Y 125.64 2142.1150 19 -7.1 1072.0571 2 89.61 4 53468 VEV_1_3_RA4_01_1235.d 1.19E6 7 7 220 238
R.GYWGSNLGEPHSLPTK.E Y 123.88 1741.8423 16 -15.9 581.6121 3 68.33 6 36668 VEV_3_3_RA6_01_1237.d 2.85E6 7 7 149 164
R.SPLDEFGDVLR.E Y 116.34 1246.6193 11 -15.5 624.3073 2 81.54 6 46265 VEV_3_3_RA6_01_1237.d 3.36E6 7 7 245 255
K.AVVVIGDSEGHVGLGIK.T Y 110.30 1648.9148 17 -11.4 550.6393 3 72.65 4 41312 VEV_1_3_RA4_01_1235.d 1.23E6 11 11 107 123
K.ATFVAVANTYSFLTPNLWKETK.L Y 109.84 2500.3000 22 -8.5 1251.1467 2 85.67 4 51027 VEV_1_3_RA4_01_1235.d 3.33E5 4 4 220 241
K.SEEKEWQPVTK.L Y 108.69 1359.6670 11 -11.0 680.8333 2 36.79 6 16676 VEV_3_3_RA6_01_1237.d 3.52E6 12 12 37 47
K.ISNMEQIYLHSLPIKEYQIVDFFLPNLKDEVMK.I Y 106.43 3994.0623 33 -5.0 799.8157 5 91.20 4 54350 VEV_1_3_RA4_01_1235.d 2.23E6 8 8 57 89
K.TLENTLKATFVAVANTYSFLTPNLWKETK.L Y 103.84 3299.7441 29 -10.2 825.9349 4 94.52 6 53405 VEV_3_3_RA6_01_1237.d 7.02E5 6 6 213 241
R.RGYWGSNLGEPHSLPTK.E Y 101.80 1897.9435 17 -4.7 475.4909 4 64.37 4 34850 VEV_1_3_RA4_01_1235.d 4.71E5 2 2 148 164
K.EYQIVDFFLPNLKDEVMK.I Y 97.34 2227.1235 18 -6.8 743.3767 3 89.12 4 53177 VEV_1_3_RA4_01_1235.d 2.29E5 3 3 72 89
R.SPLDEFGDVLREGK.K Y 93.19 1560.7783 14 -18.2 521.2573 3 79.50 5 45762 VEV_2_3_RA5_01_1236.d 6.4E5 5 5 245 258
R.LLQ(+.98)LAGVHDIYTSSSGSTK.T Y 91.99 1977.0055 19 -7.1 989.5031 2 74.13 4 42454 VEV_1_3_RA4_01_1235.d 1.37E6 5 5 194 212 Deamidation (NQ)
R.GPKSEEKEWQPVTK.L Y 91.29 1641.8362 14 -10.5 548.2803 3 33.93 4 15111 VEV_1_3_RA4_01_1235.d 3.73E5 4 4 34 47
K.EVATAIRAAIIIAKLSVLPVRR.G Y 90.04 2359.4790 22 -5.3 590.8739 4 86.27 4 51417 VEV_1_3_RA4_01_1235.d 4.53E5 6 6 127 148
R.SPLDEFGDVLREGKKY Y 89.62 1851.9366 16 -10.2 926.9661 2 78.42 5 45003 VEV_2_3_RA5_01_1236.d 9.22E5 6 6 245 260
K.ISNMEQIYLHSLPIK.E Y 88.86 1784.9495 15 -15.9 595.9810 3 78.67 4 45995 VEV_1_3_RA4_01_1235.d 6.1E4 1 1 57 71
R.RGPKSEEKEWQPVTK.L Y 88.36 1797.9373 15 -4.9 450.4894 4 31.39 4 13652 VEV_1_3_RA4_01_1235.d 2.11E6 9 9 33 47
R.FKAVVVIGDSEGHVGLGIK.T Y 85.68 1924.0781 19 -23.4 482.0155 4 74.59 4 42884 VEV_1_3_RA4_01_1235.d 6.55E5 4 4 105 123
R.GTGLVASPAVKR.L Y 85.59 1154.6771 12 -11.9 578.3390 2 39.63 6 18272 VEV_3_3_RA6_01_1237.d 1.06E7 24 24 182 193
K.ESGKC(+57.02)GSVTVR.L Y 83.70 1178.5714 11 -10.6 590.2867 2 14.30 5 4664 VEV_2_3_RA5_01_1236.d 6.94E5 6 6 165 175 Carbamidomethylation
K.LIRSPLDE(+14.02)FGDVLR.E Y 79.26 1642.9042 14 -8.2 548.6375 3 84.03 4 49977 VEV_1_3_RA4_01_1235.d 4.48E5 3 3 242 255 Methylation(others)
R.SPLDE(+14.02)FGDVLR.E Y 76.27 1260.6350 11 -13.1 631.3165 2 84.08 6 47886 VEV_3_3_RA6_01_1237.d 4.64E5 2 2 245 255 Methylation(others)
R.RGYWGSNLGEPHSLPTKESGK.C Y 75.64 2299.1345 21 -2.1 575.7897 4 60.74 5 32099 VEV_2_3_RA5_01_1236.d 9.15E4 1 1 148 168
K.LIRSPLDEFGDVLR(+14.02).E Y 75.37 1642.9042 14 -10.5 548.6362 3 83.20 6 47319 VEV_3_3_RA6_01_1237.d 1.92E5 3 3 242 255 Methylation(KR)
R.LLQLAGVHDIYTSSSGSTK(+14.02).T Y 73.72 1990.0371 19 -6.5 996.0194 2 73.07 4 41639 VEV_1_3_RA4_01_1235.d 1.03E6 6 6 194 212 Methylation(KR)
R.SPLDEFGDVLR(+14.02).E Y 72.99 1260.6350 11 -11.7 631.3174 2 83.69 4 49690 VEV_1_3_RA4_01_1235.d 6.27E5 4 4 245 255 Methylation(KR)
K.LIRSPLDEFGDVLREGK.K Y 71.72 1943.0476 17 -17.1 486.7609 4 80.00 6 45164 VEV_3_3_RA6_01_1237.d 5.61E5 4 4 242 258
R.GTGLVASPAVK.R Y 67.47 998.5760 11 -15.0 500.2878 2 49.74 5 24993 VEV_2_3_RA5_01_1236.d 3.16E6 13 13 182 192
R.G(+42.01)TGLVASPAVKR.L Y 65.83 1196.6877 12 -26.0 399.8928 3 39.47 5 18807 VEV_2_3_RA5_01_1236.d 0 1 1 182 193 Acetylation (N-term)
K.TLENTLKATFVAVANT(-2.02)YSFLTPNLWK.E Y 65.13 2939.5432 26 4.1 980.8590 3 97.47 4 57317 VEV_1_3_RA4_01_1235.d 7.66E4 1 1 213 238 2-amino-3-oxo-butanoic_acid
K.ISNMEQIYLHSLPIKEYQIVDFFLPNLKDEVM(+15.99)K.I Y 65.08 4010.0571 33 -9.1 1003.5124 4 90.24 4 53789 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 57 89 Oxidation (M)
R.AAIIIAKLSVLPVRR.G Y 64.39 1619.0609 15 -6.7 405.7698 4 75.55 6 41942 VEV_3_3_RA6_01_1237.d 4.26E4 2 2 134 148
K.SEEKEWQ(+.98)PVTK.L Y 63.78 1360.6510 11 -11.8 681.3248 2 41.08 5 19794 VEV_2_3_RA5_01_1236.d 7.15E5 6 6 37 47 Deamidation (NQ)
K.TSKEVATAIR.A Y 63.74 1074.6033 10 -26.8 538.2945 2 22.26 6 8759 VEV_3_3_RA6_01_1237.d 1.78E6 14 14 124 133
R.GTGLVASPAVKR(+14.02).L Y 63.66 1168.6927 12 -12.1 585.3466 2 43.89 6 20751 VEV_3_3_RA6_01_1237.d 4.41E5 6 6 182 193 Methylation(KR)
R.GYWGSN(+.98)LGEPHSLPTK.E Y 63.00 1742.8264 16 -2.5 581.9479 3 68.47 6 36737 VEV_3_3_RA6_01_1237.d 3.96E4 1 1 149 164 Deamidation (NQ)
K.LSVLPVRR.G Y 57.52 938.6025 8 -16.2 470.3009 2 55.06 5 28205 VEV_2_3_RA5_01_1236.d 2.74E6 11 11 141 148
R.SPLDEFGDVLREGK(+14.02).K Y 57.26 1574.7939 14 -7.1 525.9349 3 81.45 4 48124 VEV_1_3_RA4_01_1235.d 4.83E5 5 5 245 258 Methylation(KR)
R.GGAR(+28.03)GGFGSR.G Y 57.17 948.4889 10 -7.1 317.1680 3 15.19 6 5063 VEV_3_3_RA6_01_1237.d 5.42E5 6 6 7 16 Dimethylation(KR)
R.GTGLVASPAVKRLLQLAGVHDIYTSSSGSTK.T Y 56.63 3112.6880 31 -18.2 623.5336 5 82.81 6 47067 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 182 212
K.LIRSPLDEFGDVLREGKK(+163.05).Y Y 56.51 2234.1880 18 3.6 447.8465 5 79.10 4 46373 VEV_1_3_RA4_01_1235.d 8.38E5 5 5 242 259 Phenethyl isothiocyanate
K.C(+57.02)GSVTVR.L Y 55.38 777.3803 7 -10.6 389.6933 2 15.89 4 5257 VEV_1_3_RA4_01_1235.d 1.85E5 2 2 169 175 Carbamidomethylation
K.C(+58.01)GSVTVR.L Y 55.08 778.3643 7 -8.6 390.1861 2 21.03 4 7941 VEV_1_3_RA4_01_1235.d 7.4E5 7 7 169 175 Carboxymethyl
K.SEE(+14.02)KEWQPVTK.L Y 53.55 1373.6826 11 -9.0 687.8424 2 45.78 4 22251 VEV_1_3_RA4_01_1235.d 8.22E4 2 2 37 47 Methylation(others)
K.IKPVQKQTR.A Y 53.33 1096.6716 9 -19.3 549.3325 2 10.81 5 2872 VEV_2_3_RA5_01_1236.d 1.97E5 6 6 90 98
K.TLENTLK.A Y 51.51 817.4545 7 -18.4 409.7270 2 32.53 6 14261 VEV_3_3_RA6_01_1237.d 3.13E6 11 11 213 219
K.LIRSPLD(+14.02)EFGDVLR.E Y 51.33 1642.9042 14 -16.6 548.6329 3 80.88 5 46633 VEV_2_3_RA5_01_1236.d 5.01E4 1 1 242 255 Methylation(others)
R.LLQLAGVHD(+14.02)IYTSSSGSTK.T Y 50.41 1990.0371 19 -27.1 664.3350 3 74.47 4 42825 VEV_1_3_RA4_01_1235.d 0 1 1 194 212 Methylation(others)
K.AVVVIGDSEGH(+14.02)VGLGIK.T Y 50.14 1662.9304 17 -13.1 555.3102 3 75.07 4 43182 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 107 123 Methylation(others)
K.ESGKC(+57.02)GSVTVR(+14.02).L Y 45.44 1192.5870 11 -10.1 597.2948 2 22.20 5 8964 VEV_2_3_RA5_01_1236.d 0 1 1 165 175 Carbamidomethylation; Methylation(KR)
K.SE(+14.02)EKEWQPVTK.L Y 44.24 1373.6826 11 -7.6 687.8434 2 44.85 5 22048 VEV_2_3_RA5_01_1236.d 3.71E4 1 1 37 47 Methylation(others)
R.LIPAPR.G Y 43.92 665.4224 6 -15.3 333.7134 2 36.93 5 17309 VEV_2_3_RA5_01_1236.d 2.78E6 8 8 176 181
K.AVVVIGDS(+14.02)EGHVGLGIK.T Y 42.51 1662.9304 17 -20.6 555.3060 3 74.86 6 41441 VEV_3_3_RA6_01_1237.d 8.48E4 1 1 107 123 Methylation(others)
K.SEEK(+14.02)EWQPVTK.L Y 41.38 1373.6826 11 -8.8 458.8975 3 45.84 4 22284 VEV_1_3_RA4_01_1235.d 1.98E5 1 1 37 47 Methylation(KR)
R.AAIIIAK.L Y 41.17 698.4690 7 -10.0 699.4693 1 43.49 4 20830 VEV_1_3_RA4_01_1235.d 2.62E6 9 9 134 140
K.S(+14.02)EEKEWQPVTK.L Y 41.14 1373.6826 11 -6.8 687.8439 2 45.10 4 21831 VEV_1_3_RA4_01_1235.d 7.72E4 1 1 37 47 Methylation(others)
K.RLLQ(+.98)LAGVHDIYTSSSGSTK.T Y 40.87 2133.1064 20 -17.2 534.2747 4 71.38 4 40306 VEV_1_3_RA4_01_1235.d 6.76E4 1 1 193 212 Deamidation (NQ)
R.GT(+438.09)GLVASPAVKR.L Y 40.69 1592.7711 12 -2.7 399.1990 4 39.31 6 18096 VEV_3_3_RA6_01_1237.d 0 1 1 182 193 O3-(riboflavin phosphoryl)
K.TSKEVATAIRAAIIIAKLSVLPVR.R Y 40.24 2519.5525 24 -28.6 504.9034 5 90.96 6 51806 VEV_3_3_RA6_01_1237.d 6E4 1 1 124 147
K.TLENTLK(+14.02)AT(-18.01)FVAVANTYSFLTPNLWKETK.L Y 39.36 3295.7493 29 -8.6 824.9375 4 94.15 5 53869 VEV_2_3_RA5_01_1236.d 9.2E4 1 1 213 241 Methylation(KR); Dehydration
K.EVATAIR.A Y 38.44 758.4286 7 -14.8 380.2160 2 25.90 6 10680 VEV_3_3_RA6_01_1237.d 3.27E5 6 6 127 133
R.GYWGSNLGE(+14.02)PHSLPTK.E Y 37.39 1755.8580 16 -6.2 586.2897 3 71.53 5 40114 VEV_2_3_RA5_01_1236.d 1.09E4 1 1 149 164 Methylation(others)
R.GGAR(+28.03)GGFGSRGDR.G Y 36.91 1276.6384 13 -5.0 426.5513 3 15.11 4 4840 VEV_1_3_RA4_01_1235.d 3.69E5 3 3 7 19 Dimethylation(KR)
R.GGFGSRGDR.G Y 36.86 907.4260 9 -13.4 303.4785 3 12.06 5 3468 VEV_2_3_RA5_01_1236.d 6.71E5 5 5 11 19
K.E(+316.20)VATAIRAAIIIAKLSVLPVRR.G Y 36.35 2675.6829 22 -29.7 536.1279 5 86.57 4 51608 VEV_1_3_RA4_01_1235.d 5.36E5 5 5 127 148 Levuglandinyl-lysine pyrrole adduct
K.LSVLPVR.R Y 36.22 782.5014 7 -15.6 392.2519 2 64.69 5 35030 VEV_2_3_RA5_01_1236.d 1.02E6 4 4 141 147
R.LLQ(+.98)LAGVHDIYTSSSGSTKTLENTLK.A Y 35.93 2776.4495 26 -18.6 926.4732 3 77.62 5 44453 VEV_2_3_RA5_01_1236.d 2.51E4 1 1 194 219 Deamidation (NQ)
K.C(+57.02)GSVTVR(+14.02).L Y 35.74 791.3960 7 -7.3 396.7024 2 26.22 4 10786 VEV_1_3_RA4_01_1235.d 6.3E4 1 1 169 175 Carbamidomethylation; Methylation(KR)
K.IKPVQK.Q Y 35.16 711.4643 6 -20.7 356.7321 2 10.48 6 2690 VEV_3_3_RA6_01_1237.d 2.35E5 3 3 90 95
R.GGAR(+14.02)GGFGSR.G Y 34.00 934.4733 10 -10.8 312.4950 3 14.34 4 4455 VEV_1_3_RA4_01_1235.d 1.72E5 3 3 7 16 Methylation(KR)
K.E(+14.02)SGKC(+57.02)GSVTVR.L Y 32.22 1192.5870 11 -17.3 597.2905 2 17.84 5 6567 VEV_2_3_RA5_01_1236.d 3.65E4 1 1 165 175 Methylation(others); Carbamidomethylation
K.LIRSPLDEFGDVLR(+14.02)EGK.K Y 31.67 1957.0632 17 -29.2 490.2588 4 82.06 4 48568 VEV_1_3_RA4_01_1235.d 0 1 1 242 258 Methylation(KR)
R.T(+380.15)RFKAVVVIGDSEGHVGLGIK.T Y 31.12 2561.3740 21 -7.7 641.3458 4 74.87 4 43026 VEV_1_3_RA4_01_1235.d 6.11E4 1 1 103 123 Nucleophilic addition to cytopiloyne+H2O
R.SPLDE(+14.02)FGDVLREGK.K Y 30.29 1574.7939 14 -17.9 525.9292 3 81.67 5 47141 VEV_2_3_RA5_01_1236.d 6.8E4 1 1 245 258 Methylation(others)
K.T(+42.01)SKEVATAIR.A Y 29.90 1116.6139 10 -3.0 373.2108 3 23.00 4 9004 VEV_1_3_RA4_01_1235.d 0 1 1 124 133 Acetylation (N-term)
R.GGAR(+14.02)GGFGSRGDR.G Y 29.18 1262.6228 13 -10.5 316.6597 4 14.24 4 4412 VEV_1_3_RA4_01_1235.d 5.1E5 4 4 7 19 Methylation(KR)
K.SEEK(+14.02)EWQ(+.98)PVTK.L Y 27.81 1374.6666 11 -4.2 688.3377 2 49.17 4 24357 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 37 47 Methylation(KR); Deamidation (NQ)
R.GYWGSN(+.98)LGEPHSLPTKESGK(+14.02).C Y 27.73 2158.0330 20 -10.4 540.5099 4 64.37 4 34788 VEV_1_3_RA4_01_1235.d 9.84E4 1 1 149 168 Deamidation (NQ); Methylation(KR)
R.SPLDEFGDVLREGK(+14.02)KY Y 27.32 1865.9523 16 -34.0 467.4795 4 80.00 6 45159 VEV_3_3_RA6_01_1237.d 0 2 2 245 260 Methylation(KR)
K.TLE(+6.01)NTLKATFVAVANTYSFLTPNLWKETK.L Y 27.05 3305.7522 29 -23.4 827.4260 4 94.07 4 55848 VEV_1_3_RA4_01_1235.d 0 1 1 213 241 Replacement of proton by lithium
K.LIRS(-2.02)PLDEFGDVLR.E Y 25.71 1626.8729 14 -21.8 543.2864 3 81.67 4 48295 VEV_1_3_RA4_01_1235.d 4.48E4 1 1 242 255 2-amino-3-oxo-butanoic_acid
R.LLQLAGVHDIYTSSSGSTKTLENTLK.A Y 25.37 2775.4653 26 -6.4 694.8691 4 77.71 6 43520 VEV_3_3_RA6_01_1237.d 4.78E4 1 1 194 219
K.E(+21.98)WQPVTK.L Y 25.32 908.4368 7 7.4 455.2290 2 37.03 4 16951 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 41 47 Sodium adduct
R.SPLDE(+14.02)FGDVLREGKKY Y 24.37 1865.9523 16 -14.4 467.4886 4 80.48 4 47386 VEV_1_3_RA4_01_1235.d 1.93E5 1 1 245 260 Methylation(others)
K.ATFVAVAN(+.98)TYSFLTPNLWKETK.L Y 24.06 2501.2842 22 -19.9 834.7521 3 85.82 4 51120 VEV_1_3_RA4_01_1235.d 0 1 1 220 241 Deamidation (NQ)
K.ES(+14.02)GKC(+57.02)GSVTVR.L Y 23.97 1192.5870 11 -10.8 597.2944 2 18.10 4 6419 VEV_1_3_RA4_01_1235.d 1.95E4 1 1 165 175 Methylation(others); Carbamidomethylation
R.GY(-2.02)WGSNLGEPHSLPTK.E Y 23.63 1739.8267 16 21.8 580.9622 3 69.05 4 38480 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 149 164 2-amino-3-oxo-butanoic_acid
K.EVATAIR(+21.98).A Y 22.85 780.4106 7 -13.9 781.4070 1 94.41 4 56018 VEV_1_3_RA4_01_1235.d 0 1 1 127 133 Sodium adduct
R.RGPKSEEKEWQPVT(-2.02)K.L Y 22.66 1795.9216 15 8.5 360.1946 5 31.25 4 13574 VEV_1_3_RA4_01_1235.d 0 1 1 33 47 2-amino-3-oxo-butanoic_acid
K.TLENTLK(-1.03)ATFVAVANTYSFLTPNLWKETK.L Y 22.57 3298.7124 29 -34.6 1100.5400 3 94.13 5 53860 VEV_2_3_RA5_01_1236.d 3.08E4 1 1 213 241 Lysine oxidation to aminoadipic semialdehyde
MADTPR.G Y 22.19 689.3167 6 -12.5 690.3153 1 44.00 5 21522 VEV_2_3_RA5_01_1236.d 2.67E5 2 2 1 6
K.CGSVTVR(+14.02).L Y 22.04 734.3745 7 4.2 368.1961 2 35.25 4 15896 VEV_1_3_RA4_01_1235.d 0 1 1 169 175 Methylation(KR)
R.GGFGSR(+14.02)GDR.G Y 21.84 921.4417 9 -8.8 461.7240 2 13.85 4 4227 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 11 19 Methylation(KR)
K.QTRAGQ(+.98)RT(-18.01)R.F Y 21.72 1055.5585 9 -34.2 352.8481 3 23.95 6 9644 VEV_3_3_RA6_01_1237.d 7.59E4 1 1 96 104 Deamidation (NQ); Dehydration
M(+15.99)ADTPR.G Y 21.37 705.3116 6 16.8 706.3307 1 65.75 6 34692 VEV_3_3_RA6_01_1237.d 0 1 1 1 6 Oxidation (M)
M.A(+42.01)DTPR(+14.02)GGAR.G Y 21.25 955.4835 9 -10.9 478.7438 2 16.52 6 5756 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 2 10 Acetylation (Protein N-term); Methylation(KR)
K.ATFVAVANTYSFLTP(+31.99)NLWK.E Y 21.18 2174.1047 19 -11.6 1088.0470 2 86.81 4 51763 VEV_1_3_RA4_01_1235.d 2.93E4 1 1 220 238 Dihydroxy
R.GTGLVASPAVK(+43.01)R(+14.02).L Y 21.05 1211.6986 12 -20.4 606.8442 2 39.63 4 18479 VEV_1_3_RA4_01_1235.d 7.89E4 1 1 182 193 Carbamylation; Methylation(KR)
R.GGFGSR(+14.02)GDR(+31.99)GGDR.G Y 20.59 1338.6024 13 -21.8 670.2939 2 15.58 6 5247 VEV_3_3_RA6_01_1237.d 8.25E4 1 1 11 23 Methylation(KR); Dihydroxy
M.A(+42.01)DTPRGGAR.G Y 20.34 941.4678 9 -7.7 471.7376 2 14.96 4 4772 VEV_1_3_RA4_01_1235.d 2.26E5 2 2 2 10 Acetylation (Protein N-term)
R.LIPAPR(+28.03).G Y 20.14 693.4537 6 -4.2 694.4581 1 99.35 4 57984 VEV_1_3_RA4_01_1235.d 1.92E4 1 1 176 181 Dimethylation(KR)
R.GTGLVASPAVK(+42.01).R Y 20.07 1040.5865 11 -6.6 347.8672 3 46.16 5 22823 VEV_2_3_RA5_01_1236.d 6.45E4 2 2 182 192 Acetylation (K)
R.L(+56.06)LQLAGVHDIYTSSSGSTK.T Y 19.94 2032.0840 19 -40.3 678.3413 3 74.23 4 42534 VEV_1_3_RA4_01_1235.d 2.59E5 1 1 194 212 Diethylation
R.GY(-2.02)WGSNLGEPHSLPTKESGK.C Y 19.80 2141.0178 20 -2.8 536.2603 4 64.62 4 34977 VEV_1_3_RA4_01_1235.d 1.7E5 1 1 149 168 2-amino-3-oxo-butanoic_acid
R.GYWGSNLGEPHSLPTK(+14.02)ESGK.C Y 19.67 2157.0491 20 -3.2 720.0214 3 66.56 4 36495 VEV_1_3_RA4_01_1235.d 8.6E4 1 1 149 168 Methylation(KR)
R.SPLDEFGDVLR(+14.02)EGKKY Y 19.32 1865.9523 16 -12.8 622.9834 3 80.41 5 46320 VEV_2_3_RA5_01_1236.d 0 1 1 245 260 Methylation(KR)
K.T(+42.01)SK(+42.01)EVATAIR.A Y 19.07 1158.6244 10 24.2 387.2248 3 32.41 4 14243 VEV_1_3_RA4_01_1235.d 0 1 1 124 133 Acetylation (N-term); Acetylation (K)
R.G(+42.01)TGLVAS(+79.97)PAVKR.L Y 18.77 1276.6541 12 -11.7 320.1671 4 15.30 5 5198 VEV_2_3_RA5_01_1236.d 0 1 1 182 193 Acetylation (N-term); Phosphorylation (STY)
R.G(+42.01)GFGSR.G Y 18.52 621.2870 6 -4.0 622.2918 1 24.60 4 9907 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 11 16 Acetylation (Protein N-term)
R.G(+225.09)PKSEEKEWQPVTK.L Y 18.35 1866.9298 14 -21.5 467.7297 4 37.30 4 17107 VEV_1_3_RA4_01_1235.d 0 1 1 34 47 Iminobiotinylation
R.GTGLVASPAVK(+27.99)R.L Y 18.03 1182.6720 12 -12.4 395.2264 3 48.10 4 23698 VEV_1_3_RA4_01_1235.d 0 1 1 182 193 Formylation
R.GTGLVASPAVK(+27.99).R Y 17.70 1026.5709 11 -34.8 343.1857 3 26.24 5 11176 VEV_2_3_RA5_01_1236.d 3E5 1 1 182 192 Formylation
R.L(+298.19)LQLAGVHDIYTSSSGSTK.T Y 17.30 2274.2146 19 -1.4 759.0778 3 72.32 5 40698 VEV_2_3_RA5_01_1236.d 0 1 1 194 212 Levuglandinyl-lysine anhyropyrrole adduct
K.T(+43.01)SKEVATAIR.A Y 17.22 1117.6091 10 -31.9 373.5318 3 22.78 4 8888 VEV_1_3_RA4_01_1235.d 2.58E5 1 1 124 133 Carbamylation
K.ATFVAVANTYSFLTPNLW(+31.99)K.E Y 16.97 2174.1047 19 -8.0 1088.0509 2 86.39 4 51492 VEV_1_3_RA4_01_1235.d 2.93E4 1 1 220 238 Dihydroxy
R.SPLD(+14.02)EFGDVLR.E Y 16.76 1260.6350 11 -15.3 631.3151 2 80.28 6 45359 VEV_3_3_RA6_01_1237.d 1.99E5 1 1 245 255 Methylation(others)
R.GGARGGFGS(-18.01)R(+14.02).G Y 16.52 916.4627 10 -8.3 459.2348 2 19.49 4 7152 VEV_1_3_RA4_01_1235.d 8.14E4 1 1 7 16 Dehydration; Methylation(KR)
M.A(+42.01)DTPR(+28.03)GGAR.G Y 16.23 969.4991 9 -12.4 485.7508 2 18.52 5 6932 VEV_2_3_RA5_01_1236.d 6.63E5 1 1 2 10 Acetylation (Protein N-term); Dimethylation(KR)
K.EWQPVTK.L Y 16.05 886.4548 7 -2.5 444.2336 2 39.31 5 18702 VEV_2_3_RA5_01_1236.d 2.57E5 2 2 41 47
K.SEEKEWQPVTK(-.98).L Y 15.71 1358.6830 11 13.1 680.3577 2 36.83 5 17262 VEV_2_3_RA5_01_1236.d 3.35E4 1 1 37 47 Amidation
K.RLLQLAGVHDIYTSSSGSTK(-.98).T Y 15.66 2131.1384 20 -26.9 533.7775 4 70.19 5 39130 VEV_2_3_RA5_01_1236.d 0 1 1 193 212 Amidation
R.GGFGSR(+14.02).G Y 15.42 593.2921 6 -18.8 594.2882 1 48.71 5 24359 VEV_2_3_RA5_01_1236.d 5.53E4 1 1 11 16 Methylation(KR)
K.T(+42.01)(-18.01)SKEVATAIR.A Y 15.37 1098.6033 10 -19.5 367.2012 3 50.01 4 24890 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 124 133 Acetylation (N-term); Dehydration
K.TSKE(+14.02)VATAIR.A Y 15.25 1088.6189 10 -54.0 545.2874 2 30.04 4 12869 VEV_1_3_RA4_01_1235.d 0 1 1 124 133 Methylation(others)
K.DEVMK.I Y 15.23 620.2839 5 20.4 621.3039 1 56.64 5 29187 VEV_2_3_RA5_01_1236.d 0 1 1 85 89
R.GGFGS(-18.01)R.G Y 15.20 561.2659 6 10.6 562.2792 1 59.51 4 31115 VEV_1_3_RA4_01_1235.d 0 1 1 11 16 Dehydration
total 131 peptides
C1G3Y8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GAITNFDLSVLALSIIKQGEGEIPGLTDVVNPK.R Y 168.48 3407.8550 33 -5.3 1136.9529 3 97.48 4 57332 VEV_1_3_RA4_01_1235.d 1.09E6 8 8 99 131
R.M(+15.99)GTEVPGDSLGDEFKGYLFK.I Y 147.48 2205.0300 20 -13.1 736.0077 3 81.14 6 45951 VEV_3_3_RA6_01_1237.d 1.81E6 11 11 32 51 Oxidation (M)
R.MGTEVPGDSLGDEFKGYLFK.I Y 136.57 2189.0349 20 -13.6 730.6757 3 82.19 6 46664 VEV_3_3_RA6_01_1237.d 3.05E6 7 7 32 51
R.GAITNFDLSVLALSIIK.Q Y 133.62 1774.0239 17 -15.6 592.3394 3 94.67 6 53468 VEV_3_3_RA6_01_1237.d 8.2E6 30 30 99 115
R.GAITNFDLSVLALSIIKQGE(+14.02)GEIPGLTDVVNPK.R Y 125.38 3421.8708 33 -5.2 1141.6250 3 97.56 5 55211 VEV_2_3_RA5_01_1236.d 9.01E4 1 1 99 131 Methylation(others)
K.SVRGAITNFDLSVLALSIIK.Q Y 125.18 2116.2256 20 -9.3 706.4092 3 90.87 5 52335 VEV_2_3_RA5_01_1236.d 1.22E5 4 4 96 115
R.VRLLLSDGHSC(+57.02)YRPR.R Y 123.96 1827.9526 15 -4.4 457.9934 4 58.73 5 30691 VEV_2_3_RA5_01_1236.d 1.51E6 5 5 73 87 Carbamidomethylation
R.RAESAKEQANEYAK.L Y 123.35 1593.7747 14 -14.3 532.2579 3 16.58 6 5777 VEV_3_3_RA6_01_1237.d 5.35E6 19 19 198 211
R.AESAKEQANEYAK.L Y 121.61 1437.6736 13 -13.7 719.8342 2 18.90 6 6997 VEV_3_3_RA6_01_1237.d 2.49E6 10 10 199 211
K.ITGGNDKQGFPMKQGVLVPTR.V Y 118.39 2242.1892 21 -9.8 561.5491 4 65.31 4 35514 VEV_1_3_RA4_01_1235.d 1E6 6 6 52 72
R.LLLSDGHSC(+57.02)YRPR.R Y 116.48 1572.7831 13 -17.3 394.1962 4 54.78 6 27123 VEV_3_3_RA6_01_1237.d 1.43E7 36 36 75 87 Carbamidomethylation
K.SVRGAITNFDLSVLALSIIKQGEGEIPGLTDVVNPK.R Y 115.14 3750.0566 36 -8.5 938.5135 4 94.98 4 56282 VEV_1_3_RA4_01_1235.d 6.88E5 6 6 96 131
K.QGEGEIPGLTDVVNPKR.L Y 113.15 1807.9427 17 -11.5 603.6479 3 71.80 4 40660 VEV_1_3_RA4_01_1235.d 5.32E5 3 3 116 132
K.RMGTEVPGDSLGDEFKGYLFK.I Y 111.61 2345.1362 21 -12.2 782.7098 3 79.52 4 46646 VEV_1_3_RA4_01_1235.d 1.32E6 7 7 31 51
K.FFGLDPKDDVRK.F Y 106.00 1435.7458 12 -7.9 718.8745 2 65.34 5 35539 VEV_2_3_RA5_01_1236.d 4.35E6 9 9 144 155
K.QGEGEIPGLTDVVNPK.R Y 104.93 1651.8417 16 -12.0 826.9182 2 75.97 6 42279 VEV_3_3_RA6_01_1237.d 1.37E6 6 6 116 131
R.RRAESAKEQANEYAK.L Y 103.53 1749.8757 15 -9.3 438.4721 4 17.83 4 6260 VEV_1_3_RA4_01_1235.d 2.57E6 16 16 197 211
R.GAITNFDLSVLALSIIKQGEGEIPGLTDVVNPKR.L Y 97.39 3563.9563 34 -2.1 891.9945 4 95.22 4 56387 VEV_1_3_RA4_01_1235.d 9.86E5 5 5 99 132
MKLNISYPANGSQK.L Y 95.76 1549.7922 14 -11.2 517.5989 3 61.65 4 32720 VEV_1_3_RA4_01_1235.d 1.9E6 5 5 1 14
K.LIEIDDERKLRPFMEKR.M Y 95.47 2187.1833 17 -12.4 438.4385 5 67.17 5 36965 VEV_2_3_RA5_01_1236.d 5.8E5 3 3 15 31
MKLNISYPAN(+.98)GSQK.L Y 93.25 1550.7762 14 -9.6 776.3879 2 63.97 5 34550 VEV_2_3_RA5_01_1236.d 3.57E6 13 13 1 14 Deamidation (NQ)
K.FFGLDPKDDVR.K Y 93.12 1307.6509 11 -17.2 436.8834 3 71.53 6 39063 VEV_3_3_RA6_01_1237.d 1.39E6 8 8 144 154
K.ITGGNDKQGFPMK.Q Y 90.18 1391.6868 13 -4.5 696.8475 2 41.30 4 19514 VEV_1_3_RA4_01_1235.d 2.72E6 12 12 52 64
R.GAITNFDLSVLALSIIK(+14.02).Q Y 87.85 1788.0397 17 -6.0 597.0169 3 96.49 4 56956 VEV_1_3_RA4_01_1235.d 4.96E5 6 6 99 115 Methylation(KR)
K.Q(-17.03)GEGEIPGLTDVVNPKR.L Y 87.71 1790.9163 17 -9.3 896.4571 2 78.26 4 45719 VEV_1_3_RA4_01_1235.d 7.65E5 3 3 116 132 Pyro-glu from Q
M(+15.99)KLNISYPANGSQK.L Y 87.17 1565.7871 14 -7.3 522.9325 3 51.33 4 25711 VEV_1_3_RA4_01_1235.d 1.92E6 10 10 1 14 Oxidation (M)
K.LNISYPANGSQK.L Y 85.77 1290.6567 12 -9.2 646.3297 2 58.34 4 30248 VEV_1_3_RA4_01_1235.d 1.66E6 8 8 3 14
R.KFFGLDPKDDVRK.F Y 84.58 1563.8408 13 -11.8 391.9629 4 60.75 4 32106 VEV_1_3_RA4_01_1235.d 3.31E6 16 16 143 155
K.Q(-17.03)GEGEIPGLTDVVNPK.R Y 82.35 1634.8151 16 -9.4 818.4071 2 82.20 4 48701 VEV_1_3_RA4_01_1235.d 2.45E6 8 8 116 131 Pyro-glu from Q
K.ITGGNDKQGFPM(+15.99)KQGVLVPTR.V Y 79.89 2258.1841 21 -6.2 565.5498 4 60.21 4 31634 VEV_1_3_RA4_01_1235.d 5.15E5 3 3 52 72 Oxidation (M)
K.ITGGNDKQ(+.98)GFPMKQGVLVPTR.V Y 79.70 2243.1731 21 -3.0 561.7989 4 65.22 5 35445 VEV_2_3_RA5_01_1236.d 3.49E5 3 3 52 72 Deamidation (NQ)
MKLNISYPANGSQ(+.98)KLIEIDDER.K Y 79.59 2534.2686 22 -3.8 634.5720 4 77.12 5 44105 VEV_2_3_RA5_01_1236.d 5.57E4 1 1 1 22 Deamidation (NQ)
R.GAITN(+.98)FDLSVLALSIIK.Q Y 77.99 1775.0081 17 -5.7 592.6733 3 95.99 4 56744 VEV_1_3_RA4_01_1235.d 5.81E5 3 3 99 115 Deamidation (NQ)
R.TVTGKN(+.98)GKEYTKAPK.I Y 76.63 1621.8674 15 -10.6 811.9324 2 18.16 5 6740 VEV_2_3_RA5_01_1236.d 4.36E5 6 6 161 175 Deamidation (NQ)
R.MGTEVPGDSLGDEFK.G Y 75.93 1580.7028 15 -4.6 791.3550 2 72.88 4 41490 VEV_1_3_RA4_01_1235.d 1.73E5 2 2 32 46
M(+15.99)KLNISYPAN(+.98)GSQK.L Y 75.45 1566.7711 14 -8.2 523.2600 3 56.19 4 28752 VEV_1_3_RA4_01_1235.d 2.59E6 21 21 1 14 Oxidation (M); Deamidation (NQ)
R.AESAKEQ(+.98)ANEYAK.L Y 75.08 1438.6576 13 -8.8 480.5556 3 24.01 4 9558 VEV_1_3_RA4_01_1235.d 5.22E5 6 6 199 211 Deamidation (NQ)
R.MGTEVPGDSLGDEFK(+14.02)GYLFK.I Y 73.52 2203.0505 20 -5.8 735.3532 3 84.51 4 50257 VEV_1_3_RA4_01_1235.d 6.68E5 6 6 32 51 Methylation(KR)
R.KFFGLDPKDDVR.K Y 73.17 1435.7458 12 -13.0 479.5830 3 65.78 5 35870 VEV_2_3_RA5_01_1236.d 3.92E6 5 5 143 154
K.ITGGNDKQGFPM(+15.99)K.Q Y 72.74 1407.6816 13 -8.2 704.8423 2 29.24 4 12425 VEV_1_3_RA4_01_1235.d 2.63E6 19 19 52 64 Oxidation (M)
R.AESAKEQANEYAK(+14.02).L Y 72.41 1451.6892 13 -9.4 726.8451 2 27.02 5 11604 VEV_2_3_RA5_01_1236.d 6.82E5 7 7 199 211 Methylation(KR)
K.NGKEYTKAPK.I Y 72.29 1134.6033 10 -13.7 568.3011 2 10.48 5 2719 VEV_2_3_RA5_01_1236.d 1.5E5 3 3 166 175
R.AE(+14.02)SAKEQANEYAK.L Y 68.83 1451.6892 13 -14.1 726.8417 2 24.23 6 9800 VEV_3_3_RA6_01_1237.d 4.03E5 5 5 199 211 Methylation(others)
R.RAESAKEQ(+.98)ANEYAK.L Y 68.45 1594.7587 14 -6.5 399.6944 4 20.54 4 7709 VEV_1_3_RA4_01_1235.d 6.72E5 6 6 198 211 Deamidation (NQ)
R.M(+15.99)GTEVPGDSLGDEFK(+14.02)GYLFK.I Y 67.28 2219.0457 20 -13.1 740.6794 3 83.59 4 49626 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 32 51 Oxidation (M); Methylation(KR)
R.M(+42.01)(+15.99)GTEVPGDSLGDEFKGYLFK.I Y 67.20 2247.0405 20 -0.8 562.7670 4 78.24 6 43900 VEV_3_3_RA6_01_1237.d 6.89E4 1 1 32 51 Acetylation (N-term); Oxidation (M)
K.Q(+.98)GEGEIPGLTDVVNPK.R Y 66.51 1652.8257 16 -7.5 827.4139 2 77.04 4 44775 VEV_1_3_RA4_01_1235.d 3.33E5 3 3 116 131 Deamidation (NQ)
R.RAESAKEQANEYAK(+14.02).L Y 65.91 1607.7903 14 -10.3 804.8941 2 23.59 5 9676 VEV_2_3_RA5_01_1236.d 4.78E5 6 6 198 211 Methylation(KR)
R.LLLSDGHSC(+57.02)YRPR(+14.02).R Y 65.28 1586.7987 13 -16.0 397.7006 4 59.13 6 29803 VEV_3_3_RA6_01_1237.d 4.78E5 2 2 75 87 Carbamidomethylation; Methylation(KR)
K.LIEIDDER.K Y 64.62 1001.5029 8 -10.5 501.7535 2 57.94 4 30011 VEV_1_3_RA4_01_1235.d 2.64E6 9 9 15 22
K.QGE(+14.02)GEIPGLTDVVNPK.R Y 64.22 1665.8573 16 -8.1 833.9291 2 77.89 4 45428 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 116 131 Methylation(others)
K.LIEIDDERK.L Y 63.80 1129.5979 9 -9.1 565.8011 2 44.20 4 21260 VEV_1_3_RA4_01_1235.d 3.55E6 15 15 15 23
R.MGTEVPGDSLGDEFKGYLFK(+14.02).I Y 63.16 2203.0505 20 -6.8 735.3525 3 83.31 4 49438 VEV_1_3_RA4_01_1235.d 3.72E5 3 3 32 51 Methylation(KR)
R.AESAKEQANE(+14.02)YAK.L Y 63.13 1451.6892 13 -7.2 726.8467 2 21.52 4 8220 VEV_1_3_RA4_01_1235.d 8.35E4 3 3 199 211 Methylation(others)
R.MGTE(+14.02)VPGDSLGDEFKGYLFK.I Y 62.94 2203.0505 20 -6.1 735.3530 3 82.91 4 49163 VEV_1_3_RA4_01_1235.d 2.06E5 3 3 32 51 Methylation(others)
R.TVTGKNGKEYTK.A Y 62.73 1324.6986 12 -11.4 663.3490 2 10.84 5 2888 VEV_2_3_RA5_01_1236.d 6.96E4 3 3 161 172
R.RR(+14.02)AESAKEQANEYAK.L Y 62.54 1763.8914 15 -9.8 441.9758 4 21.10 4 7991 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 197 211 Methylation(KR)
K.Q(-17.03)GVLVPTRVR.L Y 62.19 1106.6560 10 -13.4 554.3279 2 65.53 5 35682 VEV_2_3_RA5_01_1236.d 1.06E6 3 3 65 74 Pyro-glu from Q
R.RAESAKEQANE(+14.02)YAK.L Y 61.62 1607.7903 14 -8.6 402.9514 4 18.53 4 6639 VEV_1_3_RA4_01_1235.d 3.13E5 5 5 198 211 Methylation(others)
R.RRAESAKEQAN(+.98)EYAK.L Y 60.62 1750.8597 15 -2.5 438.7211 4 18.15 5 6735 VEV_2_3_RA5_01_1236.d 2.61E4 1 1 197 211 Deamidation (NQ)
K.R(+.98)MGTEVPGDSLGDEFKGYLFK.I Y 60.24 2346.1201 21 -2.0 587.5361 4 79.48 5 45711 VEV_2_3_RA5_01_1236.d 7.26E4 1 1 31 51 Deamidation (R)
R.TVTGKN(+.98)GKEYTK.A Y 59.79 1325.6826 12 -9.5 442.8973 3 12.41 5 3656 VEV_2_3_RA5_01_1236.d 5.1E5 8 8 161 172 Deamidation (NQ)
R.R(+14.02)AESAKEQANEYAK.L Y 59.63 1607.7903 14 -11.4 536.9313 3 20.72 5 8132 VEV_2_3_RA5_01_1236.d 6.35E5 6 6 198 211 Methylation(KR)
K.IRKFFGLDPKDDVR.K Y 59.58 1704.9310 14 -14.3 427.2339 4 65.18 5 35410 VEV_2_3_RA5_01_1236.d 1.45E5 3 3 141 154
K.N(+.98)GKEYTKAPK.I Y 59.55 1135.5873 10 -13.1 568.7935 2 13.36 6 4122 VEV_3_3_RA6_01_1237.d 3.74E5 5 5 166 175 Deamidation (NQ)
R.RAESAKE(+14.02)QANEYAK.L Y 59.30 1607.7903 14 -6.7 536.9338 3 19.14 4 6965 VEV_1_3_RA4_01_1235.d 2.42E5 4 4 198 211 Methylation(others)
R.RAESAKEQAN(+.98)EYAK.L Y 58.10 1594.7587 14 -6.0 532.5903 3 19.89 4 7339 VEV_1_3_RA4_01_1235.d 2.58E5 3 3 198 211 Deamidation (NQ)
R.MGTEVPGDSLGDE(+14.02)FKGYLFK.I Y 57.75 2203.0505 20 -6.8 1102.5250 2 84.55 4 50281 VEV_1_3_RA4_01_1235.d 3.64E5 3 3 32 51 Methylation(others)
K.ITGGNDKQGFPMK(+14.02).Q Y 57.38 1405.7024 13 -8.0 469.5710 3 51.64 4 25921 VEV_1_3_RA4_01_1235.d 2.67E5 1 1 52 64 Methylation(KR)
K.FFGLDPK.D Y 57.13 822.4276 7 -10.9 412.2166 2 71.88 4 40700 VEV_1_3_RA4_01_1235.d 5.85E5 4 4 144 150
K.ITGGN(+.98)DKQGFPMK.Q Y 57.12 1392.6708 13 -7.6 465.2273 3 48.99 4 24240 VEV_1_3_RA4_01_1235.d 1.1E6 6 6 52 64 Deamidation (NQ)
R.TVTGKNGKEYTKAPK.I Y 56.61 1620.8834 15 -12.2 541.2952 3 15.17 6 5032 VEV_3_3_RA6_01_1237.d 4.7E5 8 8 161 175
R.AESAKEQAN(+.98)EYAK.L Y 56.54 1438.6576 13 -11.6 720.3277 2 23.28 5 9492 VEV_2_3_RA5_01_1236.d 8.45E4 3 3 199 211 Deamidation (NQ)
R.LLLSDGHSC(+57.02)YR(+.98)PR.R Y 55.96 1573.7671 13 -9.3 394.4454 4 59.08 4 30790 VEV_1_3_RA4_01_1235.d 5.29E5 3 3 75 87 Carbamidomethylation; Deamidation (R)
R.M(+43.01)(+15.99)GTEVPGDSLGDEFKGYLFK.I Y 55.03 2248.0356 20 11.9 563.0229 4 78.22 5 44870 VEV_2_3_RA5_01_1236.d 2.38E4 1 1 32 51 Carbamylation; Oxidation (M)
MKLNISYPAN(+.98)GSQ(+.98)K.L Y 54.42 1551.7603 14 -6.9 776.8821 2 64.81 5 35128 VEV_2_3_RA5_01_1236.d 1.49E4 3 3 1 14 Deamidation (NQ)
R.LLLSDGHSC(+57.02)YRPRR.T Y 53.29 1728.8842 14 -13.2 433.2226 4 48.18 5 24028 VEV_2_3_RA5_01_1236.d 1.7E6 9 9 75 88 Carbamidomethylation
K.Q(-17.03)GEGEIPGLTDVVNPK(+14.02).R Y 53.14 1648.8308 16 -8.7 825.4155 2 83.16 4 49336 VEV_1_3_RA4_01_1235.d 2.77E5 3 3 116 131 Pyro-glu from Q; Methylation(KR)
MKLN(+.98)ISYPANGSQK.L Y 53.07 1550.7762 14 0.1 517.9327 3 61.52 5 32675 VEV_2_3_RA5_01_1236.d 3.22E5 1 1 1 14 Deamidation (NQ)
K.Q(-17.03)GFPMKQGVLVPTR.V Y 52.82 1539.8231 14 -10.6 770.9107 2 76.45 4 44261 VEV_1_3_RA4_01_1235.d 6.52E4 1 1 59 72 Pyro-glu from Q
R.GAITNFD(+14.02)LSVLALSIIK.Q Y 52.52 1788.0397 17 -14.7 597.0117 3 97.63 6 54545 VEV_3_3_RA6_01_1237.d 4.44E4 2 2 99 115 Methylation(others)
MKLNISYPANGSQKLIEIDDER.K Y 49.06 2533.2847 22 -28.3 634.3105 4 77.27 4 44971 VEV_1_3_RA4_01_1235.d 1.74E5 3 3 1 22
K.R(+42.01)(+14.02)MGTEVPGDSLGDEFKGYLFK.I Y 48.44 2401.1624 21 21.0 601.3105 4 75.81 5 43182 VEV_2_3_RA5_01_1236.d 1.35E4 2 2 31 51 Acetylation (N-term); Methylation(KR)
K.Q(-17.03)GVLVPTR.V Y 47.69 851.4865 8 -12.8 426.7451 2 67.24 4 37028 VEV_1_3_RA4_01_1235.d 7.58E5 6 6 65 72 Pyro-glu from Q
K.FFGLDPKDDVR(+14.02).K Y 47.40 1321.6666 11 -10.7 441.5581 3 75.10 6 41617 VEV_3_3_RA6_01_1237.d 1.11E5 3 3 144 154 Methylation(KR)
K.ITGGNDK(-1.03)QGFPMKQGVLVPTR.V Y 47.13 2241.1575 21 -18.4 561.2863 4 65.50 4 35668 VEV_1_3_RA4_01_1235.d 9.66E4 1 1 52 72 Lysine oxidation to aminoadipic semialdehyde
K.QGVLVPTR.V Y 46.58 868.5131 8 -8.0 435.2603 2 45.66 4 22178 VEV_1_3_RA4_01_1235.d 2.16E6 3 3 65 72
K.QGVLVPTRVR.L Y 46.22 1123.6825 10 -16.3 562.8394 2 49.92 5 25100 VEV_2_3_RA5_01_1236.d 6.34E5 5 5 65 74
M(+15.99)KLNISYPANGSQ(+.98)K.L Y 45.48 1566.7711 14 -7.1 523.2606 3 56.91 5 29385 VEV_2_3_RA5_01_1236.d 1.24E6 2 2 1 14 Oxidation (M); Deamidation (NQ)
K.ITGGNDKQ(+.98)GFPMK.Q Y 45.30 1392.6708 13 -6.4 465.2279 3 45.50 4 22077 VEV_1_3_RA4_01_1235.d 4.2E5 4 4 52 64 Deamidation (NQ)
MKLN(+.98)ISYPAN(+.98)GSQKLIEIDDER.K Y 43.80 2535.2527 22 1.7 846.0930 3 77.14 5 44120 VEV_2_3_RA5_01_1236.d 6.76E4 1 1 1 22 Deamidation (NQ)
K.LNISYPANGSQ(+.98)K.L Y 43.05 1291.6407 12 -8.1 646.8224 2 61.02 4 32245 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 3 14 Deamidation (NQ)
K.QGFPMKQGVLVPTR.V Y 41.94 1556.8497 14 45.3 519.9807 3 68.00 4 37640 VEV_1_3_RA4_01_1235.d 0 1 1 59 72
R.M(+15.99)GTEVPGDSLGDEFKGYLFK(+14.02).I Y 41.40 2219.0457 20 -14.7 740.6783 3 82.22 4 48683 VEV_1_3_RA4_01_1235.d 2.55E5 2 2 32 51 Oxidation (M); Methylation(KR)
MKLNISYPANGSQ(+.98)K.L Y 40.96 1550.7762 14 -7.0 517.9291 3 62.49 5 33397 VEV_2_3_RA5_01_1236.d 3.83E5 3 3 1 14 Deamidation (NQ)
K.RM(+15.99)GTEVPGDSLGDEFKGYLFK.I Y 40.68 2361.1311 21 -0.4 591.2898 4 78.59 4 45935 VEV_1_3_RA4_01_1235.d 2.42E5 1 1 31 51 Oxidation (M)
K.R(+43.01)(+14.02)MGTEVPGDSLGDEFKGYLFK.I Y 40.40 2402.1575 21 -3.5 481.4371 5 75.73 5 43118 VEV_2_3_RA5_01_1236.d 1.85E5 2 2 31 51 Carbamylation; Methylation(KR)
K.ITGGNDKQGFPMKQ(+.98)GVLVPTR.V Y 39.64 2243.1731 21 -14.0 561.7927 4 66.75 5 36635 VEV_2_3_RA5_01_1236.d 2.74E5 2 2 52 72 Deamidation (NQ)
R.R(+43.01)(+14.02)AESAKEQANEYAK.L Y 39.62 1650.7961 14 -14.3 551.2648 3 17.80 4 6252 VEV_1_3_RA4_01_1235.d 0 1 1 198 211 Carbamylation; Methylation(KR)
K.LIEIDDER(+14.02).K Y 39.48 1015.5186 8 -10.4 508.7613 2 64.74 4 35073 VEV_1_3_RA4_01_1235.d 5.51E5 3 3 15 22 Methylation(KR)
R.RRAESAKEQ(+.98)ANEYAK.L Y 39.46 1750.8597 15 -17.4 438.7146 4 21.39 5 8486 VEV_2_3_RA5_01_1236.d 2.39E5 2 2 197 211 Deamidation (NQ)
R.TVTGKN(+.98)GK(+14.02)EYTK.A Y 39.39 1339.6984 12 -9.5 447.5692 3 15.21 4 4901 VEV_1_3_RA4_01_1235.d 3.26E4 1 1 161 172 Deamidation (NQ); Methylation(KR)
K.ITGGNDKQGFPM(-48.00)K.Q Y 39.02 1343.6833 13 -8.2 448.8981 3 20.74 4 7793 VEV_1_3_RA4_01_1235.d 3.76E6 6 6 52 64 Dethiomethyl
K.QGEGE(+14.02)IPGLTDVVNPK.R Y 38.70 1665.8573 16 -10.3 833.9274 2 77.85 5 44635 VEV_2_3_RA5_01_1236.d 1.8E5 2 2 116 131 Methylation(others)
R.LVTPQR.L Y 38.55 712.4232 6 -11.5 357.2148 2 21.66 4 8318 VEV_1_3_RA4_01_1235.d 4.81E6 7 7 179 184
K.LIE(+14.02)IDDER.K Y 38.27 1015.5186 8 -11.0 508.7610 2 61.86 5 32933 VEV_2_3_RA5_01_1236.d 6.9E5 5 5 15 22 Methylation(others)
R.KFFGLDPK.D Y 35.96 950.5225 8 -14.7 317.8434 3 63.63 4 34255 VEV_1_3_RA4_01_1235.d 3.21E5 3 3 143 150
R.G(+56.06)AITNFDLSVLALSIIK.Q Y 35.07 1830.0865 17 -62.3 915.9935 2 94.35 6 53337 VEV_3_3_RA6_01_1237.d 0 1 1 99 115 Diethylation
MKLN(+.98)ISYPANGSQ(+.98)K.L Y 34.99 1551.7603 14 8.0 518.2648 3 66.26 5 36225 VEV_2_3_RA5_01_1236.d 1.53E5 1 1 1 14 Deamidation (NQ)
K.FFGLDPKDDVR(+14.02)K.F Y 34.73 1449.7616 12 -11.8 484.2555 3 67.24 5 36952 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 144 155 Methylation(KR)
K.RMGTEVPGDSLGDEFKGYLFK(+14.02).I Y 34.23 2359.1519 21 -4.9 590.7924 4 80.29 5 46237 VEV_2_3_RA5_01_1236.d 1.84E5 2 2 31 51 Methylation(KR)
K.SVRGAITNFDLSVLALSIIKQGEGEIPGLTDVVNPKR.L Y 33.52 3906.1577 37 -32.4 782.2135 5 93.13 5 53406 VEV_2_3_RA5_01_1236.d 0 1 1 96 132
M(+42.01)K(+14.02)LNISYPANGSQK.L Y 32.81 1605.8185 14 -21.1 536.2688 3 38.95 5 18497 VEV_2_3_RA5_01_1236.d 4.62E5 3 3 1 14 Acetylation (Protein N-term); Methylation(KR)
K.LIEIDDERKLRPFMEK.R Y 32.35 2031.0823 16 -9.4 407.2199 5 70.26 4 39421 VEV_1_3_RA4_01_1235.d 3.73E5 1 1 15 30
R.LVTPQRLQR.K Y 31.43 1109.6669 9 -12.2 370.8917 3 38.53 5 18293 VEV_2_3_RA5_01_1236.d 3.86E6 8 8 179 187
R.GAITN(+.98)FDLSVLALSIIK(+14.02).Q Y 31.29 1789.0237 17 -66.1 895.4600 2 96.43 6 54138 VEV_3_3_RA6_01_1237.d 0 1 1 99 115 Deamidation (NQ); Methylation(KR)
R.VRLLLS(-2.02)DGHSC(+57.02)YRPR.R Y 30.18 1825.9369 15 69.7 366.2201 5 58.93 4 30681 VEV_1_3_RA4_01_1235.d 0 1 1 73 87 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.RAESAKEQANEY(-18.01)AK(+14.02).L Y 30.09 1589.7797 14 -11.6 398.4476 4 17.15 4 5909 VEV_1_3_RA4_01_1235.d 0 1 1 198 211 Dehydration; Methylation(KR)
K.L(+41.03)IEIDDERK.L Y 29.80 1170.6244 9 5.8 391.2177 3 43.85 4 21044 VEV_1_3_RA4_01_1235.d 0 1 1 15 23 Amidination of lysines or N-terminal amines with methyl acetimidate
K.LRPFMEKR.M Y 29.71 1075.5961 8 -12.2 359.5349 3 34.08 4 15253 VEV_1_3_RA4_01_1235.d 4.78E5 3 3 24 31
K.LIEIDDER(+14.02)K.L Y 29.57 1143.6135 9 -6.0 382.2095 3 50.98 4 25497 VEV_1_3_RA4_01_1235.d 3.68E5 4 4 15 23 Methylation(KR)
K.LNISYPAN(+.98)GSQK.L Y 29.07 1291.6407 12 -13.5 646.8189 2 60.77 6 31009 VEV_3_3_RA6_01_1237.d 5.37E4 1 1 3 14 Deamidation (NQ)
K.F(+41.03)FGLDPKDDVRK.F Y 28.89 1476.7725 12 -19.5 370.1932 4 65.27 6 34331 VEV_3_3_RA6_01_1237.d 1.14E5 2 2 144 155 Amidination of lysines or N-terminal amines with methyl acetimidate
R.MGTEVPGD(+14.02)SLGDEFKGYLFK.I Y 28.63 2203.0505 20 4.6 735.3608 3 81.78 4 48377 VEV_1_3_RA4_01_1235.d 0 1 1 32 51 Methylation(others)
K.FFGLDPK(+14.02).D Y 28.60 836.4432 7 -19.7 419.2206 2 74.14 6 40917 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 144 150 Methylation(KR)
R.RAESAKEQANEY(+164.06)AK.L Y 27.98 1757.8348 14 -4.2 586.9498 3 15.81 5 5478 VEV_2_3_RA5_01_1236.d 2.38E4 1 1 198 211 O-Diisopropylphosphorylation
K.Q(+.98)GVLVPTR.V Y 27.31 869.4971 8 -14.8 435.7494 2 48.52 5 24240 VEV_2_3_RA5_01_1236.d 8.32E5 4 4 65 72 Deamidation (NQ)
R.LVTPQR(+14.02).L Y 26.93 726.4388 6 -12.0 364.2223 2 29.27 4 12437 VEV_1_3_RA4_01_1235.d 7.89E5 5 5 179 184 Methylation(KR)
K.FFGLD(+14.02)PKDDVRK.F Y 26.92 1449.7616 12 -14.3 363.4425 4 64.45 6 33700 VEV_3_3_RA6_01_1237.d 1.78E5 2 2 144 155 Methylation(others)
R.LLLSDGHSC(+57.02)YR(+14.02)PR.R Y 26.66 1586.7987 13 -11.5 397.7024 4 58.86 5 30712 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 75 87 Carbamidomethylation; Methylation(KR)
R.LVTPQ(+.98)R.L Y 25.85 713.4072 6 -10.0 357.7073 2 24.01 4 9557 VEV_1_3_RA4_01_1235.d 1.08E6 5 5 179 184 Deamidation (NQ)
K.ITGGNDKQGFPMKQGVLVPTRVR.L Y 25.80 2497.3586 23 -11.8 500.4731 5 64.91 5 35205 VEV_2_3_RA5_01_1236.d 7.47E4 1 1 52 74
M(-48.00)KLNISYPANGSQK.L Y 25.63 1501.7888 14 -14.3 501.5964 3 39.22 6 18050 VEV_3_3_RA6_01_1237.d 2.01E5 1 1 1 14 Dethiomethyl
M(+15.99)KLN(+.98)ISYPANGSQ(+.98)K.L Y 25.13 1567.7551 14 -0.4 523.5921 3 56.92 4 29244 VEV_1_3_RA4_01_1235.d 2.39E5 2 2 1 14 Oxidation (M); Deamidation (NQ)
R.LLLSDGHSC(+57.02)YRPR(+.98).R Y 25.03 1573.7671 13 -9.3 525.5914 3 58.88 5 30727 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 75 87 Carbamidomethylation; Deamidation (R)
K.QGFPMK.Q Y 24.87 706.3472 6 4.0 707.3573 1 75.84 4 43789 VEV_1_3_RA4_01_1235.d 0 1 1 59 64
R.K(+14.02)FFGLD(+21.98)PK.D Y 24.81 986.5201 8 -26.9 494.2540 2 28.96 6 12318 VEV_3_3_RA6_01_1237.d 0 1 1 143 150 Methylation(KR); Sodium adduct
K.ITGGNDK(+14.02).Q Y 24.67 717.3657 7 -5.5 718.3690 1 77.33 4 44953 VEV_1_3_RA4_01_1235.d 0 1 1 52 58 Methylation(KR)
R.LLLSD(+14.02)GHSC(+57.02)YRPR.R Y 24.60 1586.7987 13 -11.5 397.7024 4 58.11 5 30185 VEV_2_3_RA5_01_1236.d 1.29E5 1 1 75 87 Methylation(others); Carbamidomethylation
R.KLRPFMEKR.M Y 24.52 1203.6910 9 -18.8 301.9244 4 32.20 4 14120 VEV_1_3_RA4_01_1235.d 2.69E5 1 1 23 31
K.QGVLVPTR(+14.02).V Y 23.57 882.5287 8 -47.2 442.2508 2 53.73 4 27267 VEV_1_3_RA4_01_1235.d 0 1 1 65 72 Methylation(KR)
R.L(+42.01)LLSDGHSC(+57.02)YRPR.R Y 23.25 1614.7936 13 61.8 404.7306 4 54.37 4 27677 VEV_1_3_RA4_01_1235.d 0 1 1 75 87 Acetylation (N-term); Carbamidomethylation
M(+15.99)KLN(+.98)ISYPAN(+.98)GSQK.L Y 22.97 1567.7551 14 1.0 523.5928 3 56.63 5 29183 VEV_2_3_RA5_01_1236.d 1.53E5 3 3 1 14 Oxidation (M); Deamidation (NQ)
K.F(+42.01)FGLDPKDDVRK.F Y 22.64 1477.7565 12 80.3 370.4761 4 65.57 5 35715 VEV_2_3_RA5_01_1236.d 0 2 2 144 155 Acetylation (N-term)
K.E(+37.03)QANEYAK.L Y 22.32 988.4614 8 16.5 495.2461 2 19.17 4 6985 VEV_1_3_RA4_01_1235.d 2.13E4 1 1 204 211 Propargylamine
K.LN(+.98)ISYPANGSQ(+.98)K.L Y 22.07 1292.6248 12 8.0 647.3248 2 60.72 5 32087 VEV_2_3_RA5_01_1236.d 6.63E4 1 1 3 14 Deamidation (NQ)
R.TVTGKN(+.98)GK(+21.98).E Y 22.02 826.4161 8 3.0 414.2166 2 22.23 4 8581 VEV_1_3_RA4_01_1235.d 0 1 1 161 168 Deamidation (NQ); Sodium adduct
R.MGTEVPGDSLGDEFKGY(+15.01)LFK.I Y 21.43 2204.0459 20 -5.4 735.6853 3 84.56 4 50288 VEV_1_3_RA4_01_1235.d 1.53E5 2 2 32 51 Tyrosine oxidation to 2-aminotyrosine
K.ITGGNDK(+42.01)Q(+.98)GFPMK(+14.02)QGVLVPTR.V Y 21.39 2299.1995 21 -7.6 575.8028 4 54.16 5 27687 VEV_2_3_RA5_01_1236.d 4.89E5 1 1 52 72 Acetylation (K); Deamidation (NQ); Methylation(KR)
R.AESAK(+14.02)EQANEYAK.L Y 21.29 1451.6892 13 -14.4 726.8414 2 22.90 4 8945 VEV_1_3_RA4_01_1235.d 1.4E5 2 2 199 211 Methylation(KR)
K.RLGPKR.A Y 21.18 725.4660 6 -14.3 363.7351 2 10.65 5 2797 VEV_2_3_RA5_01_1236.d 6.46E4 1 1 132 137
K.F(+127.06)FGLDPKDDVR.K Y 21.04 1434.7142 11 0.2 479.2455 3 65.64 6 34650 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 144 154 N-Succinimidyl-2-morpholine acetate
R.GAITNFDLSVLALS(-18.01)IIK(+14.02).Q Y 20.98 1770.0291 17 -47.5 885.9797 2 94.49 4 56056 VEV_1_3_RA4_01_1235.d 0 1 1 99 115 Dehydration; Methylation(KR)
MKLNISYPANGSQK(+226.08).L Y 20.86 1775.8699 14 -18.2 592.9531 3 73.92 4 42294 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 1 14 Biotinylation
K.ITGGND(-18.01)K.Q Y 20.83 685.3395 7 -38.1 686.3206 1 75.13 6 41638 VEV_3_3_RA6_01_1237.d 1.8E5 3 3 52 58 Dehydration
R.AESAKEQANEYAKLLAARVHEEK.A Y 20.59 2584.3245 23 -12.1 647.0806 4 110.25 6 58161 VEV_3_3_RA6_01_1237.d 0 1 1 199 221
K.ITGGN(+.98)DK.Q Y 20.31 704.3340 7 15.6 705.3523 1 70.88 4 39909 VEV_1_3_RA4_01_1235.d 5.93E4 1 1 52 58 Deamidation (NQ)
K.ITGGNDK.Q Y 20.28 703.3500 7 -17.0 704.3453 1 75.21 4 43296 VEV_1_3_RA4_01_1235.d 4.72E5 6 6 52 58
MKLNISYPANGSQKLIEIDDERK.L Y 20.24 2661.3796 23 -11.8 666.3444 4 73.98 5 41867 VEV_2_3_RA5_01_1236.d 0 1 1 1 23
K.GYLFK.I N 20.24 626.3428 5 -52.2 627.3174 1 55.27 4 28201 VEV_1_3_RA4_01_1235.d 0 1 1 47 51
K.Q(+.98)GVLVPT(+79.97)R(+14.02).V Y 19.91 963.4790 8 36.6 322.1787 3 41.41 5 19967 VEV_2_3_RA5_01_1236.d 0 1 1 65 72 Deamidation (NQ); Phosphorylation (STY); Methylation(KR)
MK(+14.02)LN(+.98)ISYPANGSQK.L Y 19.87 1564.7919 14 25.7 783.4233 2 51.17 4 25669 VEV_1_3_RA4_01_1235.d 7.79E4 1 1 1 14 Methylation(KR); Deamidation (NQ)
MKLNISYPAN(+.98)GSQKLIEIDDER.K Y 19.75 2534.2686 22 -12.8 845.7527 3 77.25 5 44199 VEV_2_3_RA5_01_1236.d 6.71E2 1 1 1 22 Deamidation (NQ)
K.LNISYPANGS(+42.01)QK.L Y 19.47 1332.6674 12 -5.1 445.2275 3 15.05 6 4970 VEV_3_3_RA6_01_1237.d 4.49E3 1 1 3 14 Acetylation (TSCYH)
K.I(+43.01)TGGNDK.Q Y 18.96 746.3558 7 20.4 747.3784 1 78.40 5 44987 VEV_2_3_RA5_01_1236.d 4.79E4 1 1 52 58 Carbamylation
R.MGTEVPGDSLGD(+15.99)EFKGYLFK.I Y 18.78 2205.0300 20 5.7 736.0215 3 84.62 4 50328 VEV_1_3_RA4_01_1235.d 7.17E4 1 1 32 51 Oxidation or Hydroxylation
K.R(+43.01)MGTEVPGDSLGDEFK.G Y 18.68 1779.8097 16 28.9 594.2943 3 29.42 5 12936 VEV_2_3_RA5_01_1236.d 0 1 1 31 46 Carbamylation
K.Q(-15.01)GEGEIPGLTDVVNPK.R Y 18.60 1636.8308 16 -15.5 819.4100 2 82.16 5 47452 VEV_2_3_RA5_01_1236.d 7.1E4 1 1 116 131 ISD (z+2)-series
K.FVIRR.T Y 18.39 689.4337 5 -18.5 345.7177 2 27.71 5 11972 VEV_2_3_RA5_01_1236.d 1.8E6 1 1 156 160
R.IALKR.R N 18.14 599.4119 5 -14.9 300.7087 2 15.46 4 5022 VEV_1_3_RA4_01_1235.d 7.22E5 2 2 192 196
M(+43.01)K(+14.02)LNISYPANGSQK.L Y 18.10 1606.8137 14 -10.7 804.4055 2 39.13 6 17997 VEV_3_3_RA6_01_1237.d 4.28E4 1 1 1 14 Carbamylation; Methylation(KR)
K.F(+42.01)FGLDPKDDVRK(+42.01).F Y 17.88 1519.7671 12 21.1 380.9571 4 66.82 5 36642 VEV_2_3_RA5_01_1236.d 0 1 1 144 155 Acetylation (N-term); Acetylation (K)
K.F(+42.01)FGLDPK(+14.02).D Y 17.87 878.4537 7 -20.2 879.4432 1 93.94 5 53768 VEV_2_3_RA5_01_1236.d 0 1 1 144 150 Acetylation (N-term); Methylation(KR)
R.MGT(+13.03)EVPGDSLGDEFKGYLFK.I Y 17.51 2202.0667 20 -13.1 735.0199 3 81.63 6 46298 VEV_3_3_RA6_01_1237.d 2.05E4 1 1 32 51 Michael addition with methylamine
R.RAESAK(+14.02)EQANEYAK.L Y 17.43 1607.7903 14 -2.2 804.9006 2 19.20 4 6993 VEV_1_3_RA4_01_1235.d 1.03E4 1 1 198 211 Methylation(KR)
K.EYTKAPKIQR.L Y 17.29 1232.6876 10 -6.8 309.1771 4 24.86 5 10399 VEV_2_3_RA5_01_1236.d 1.88E5 1 1 169 178
R.K(+14.02)FFGLDPKDDVRK.F Y 17.21 1577.8564 13 9.7 395.4752 4 59.98 5 31537 VEV_2_3_RA5_01_1236.d 0 1 1 143 155 Methylation(KR)
R.VHEEKAKRTELR.K Y 17.19 1494.8267 12 -16.9 374.7076 4 13.36 5 4177 VEV_2_3_RA5_01_1236.d 8.47E4 1 1 217 228
K.LIE(+43.99)IDDERK.L Y 17.14 1173.5876 9 11.9 392.2078 3 43.84 4 21038 VEV_1_3_RA4_01_1235.d 2.51E5 2 2 15 23 Carboxylation (E)
K.LNISYPANGSQ(+.98)K(+14.02)LIEIDDER.K Y 16.72 2289.1487 20 14.1 573.3025 4 74.84 4 43002 VEV_1_3_RA4_01_1235.d 5.63E4 1 1 3 22 Deamidation (NQ); Methylation(KR)
K.ITGGNDK(+21.98)(+14.02).Q Y 16.57 739.3477 7 -11.9 740.3461 1 29.14 5 12766 VEV_2_3_RA5_01_1236.d 4.7E3 1 1 52 58 Sodium adduct; Methylation(KR)
MKLN(+.98)ISYPAN(+.98)GSQK.L Y 16.37 1551.7603 14 0.4 518.2609 3 66.39 4 36364 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 1 14 Deamidation (NQ)
K.I(+42.01)TGGNDK(+42.01).Q Y 16.23 787.3712 7 64.7 788.4294 1 30.01 5 13272 VEV_2_3_RA5_01_1236.d 2.09E4 1 1 52 58 Acetylation (N-term); Acetylation (K)
R.T(+42.01)VTGKNGKEYTK(+42.01).A Y 16.17 1408.7197 12 -12.0 353.1830 4 19.31 5 7383 VEV_2_3_RA5_01_1236.d 1E5 1 1 161 172 Acetylation (N-term); Acetylation (K)
K.EYTK(+43.01)APK.I Y 16.05 878.4498 7 3.6 440.2337 2 50.21 4 25007 VEV_1_3_RA4_01_1235.d 3.71E5 1 1 169 175 Carbamylation
K.ITGGN(+.98)D(-18.01)K.Q Y 15.75 686.3235 7 10.8 687.3382 1 72.55 5 40872 VEV_2_3_RA5_01_1236.d 6.08E4 2 2 52 58 Deamidation (NQ); Dehydration
R.R(+164.06)AESAKEQANEYAK.L Y 15.67 1757.8348 14 -5.1 586.9492 3 15.11 5 5088 VEV_2_3_RA5_01_1236.d 0 1 1 198 211 O-Diisopropylphosphorylation
K.LNIS(+14.02)YPANGSQK.L Y 15.43 1304.6725 12 3.4 327.1765 4 41.39 5 19960 VEV_2_3_RA5_01_1236.d 0 1 1 3 14 Methylation(others)
K.R(+14.02)MGT(-18.01)EVPGDSLGDEFKGYLFK.I Y 15.43 2341.1411 21 -7.4 586.2882 4 79.60 6 44869 VEV_3_3_RA6_01_1237.d 4.84E4 1 1 31 51 Methylation(KR); Dehydration
K.ITGGNDKQGFPM(+31.99)K(+42.01).Q Y 15.34 1465.6871 13 8.3 733.8569 2 69.90 4 39138 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 52 64 Sulphone; Acetylation (K)
K.LN(+.98)ISYPANGSQK(+43.01)LIEIDDER.K Y 15.31 2318.1389 20 -10.0 464.6304 5 44.20 4 21267 VEV_1_3_RA4_01_1235.d 0 1 1 3 22 Deamidation (NQ); Carbamylation
K.I(+42.01)TGGN(+.98)DK.Q Y 15.30 746.3446 7 -22.7 747.3350 1 52.16 4 26270 VEV_1_3_RA4_01_1235.d 5.48E4 1 1 52 58 Acetylation (N-term); Deamidation (NQ)
R.T(+42.01)VTGK(+21.98).N Y 15.14 568.2833 5 -5.9 569.2872 1 44.16 6 20915 VEV_3_3_RA6_01_1237.d 1.15E5 1 1 161 165 Acetylation (N-term); Sodium adduct
K.RLGPK.R N 15.12 569.3649 5 -17.4 570.3622 1 10.45 5 2702 VEV_2_3_RA5_01_1236.d 3.91E4 1 1 132 136
K.LIEIDD(+14.02)ERK.L Y 15.07 1143.6135 9 -4.1 382.2102 3 50.59 5 25500 VEV_2_3_RA5_01_1236.d 0 1 1 15 23 Methylation(others)
K.I(+27.99)RKFFGLDPK.D Y 15.02 1247.7026 10 9.4 312.9359 4 36.42 5 17027 VEV_2_3_RA5_01_1236.d 2.26E4 1 1 141 150 Formylation
total 196 peptides
C1GLX8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLQDVASKTNEVAGDGTTTATVLAR.A Y 160.58 2530.3237 25 -12.3 844.4381 3 73.67 6 40595 VEV_3_3_RA6_01_1237.d 6.23E5 6 6 113 137
K.SILGDIGILTNATVFTDELDLKLEK.A Y 139.68 2717.4739 25 -3.5 1359.7395 2 94.16 5 53873 VEV_2_3_RA5_01_1236.d 1E6 6 6 327 351
R.GIQSAVEAVVEYLQANKR.D Y 137.71 1974.0533 18 -15.7 659.0147 3 88.55 6 50570 VEV_3_3_RA6_01_1237.d 1.34E6 11 11 159 176
R.TALVDASGVASLLGTTEVAIVEAPEEK.V Y 129.91 2669.4011 27 -22.0 1335.6785 2 91.23 6 51945 VEV_3_3_RA6_01_1237.d 8.25E4 2 2 547 573
R.SVISDPATSDYEKEKLQER.L Y 124.07 2194.0752 19 -13.5 549.5187 4 60.73 6 30999 VEV_3_3_RA6_01_1237.d 1.57E6 7 7 391 409
R.GYVSPYFITDTK.A Y 112.97 1389.6816 12 -14.5 695.8380 2 74.82 6 41435 VEV_3_3_RA6_01_1237.d 1.25E6 5 5 238 249
K.TNEVAGDGTTTATVLAR.A Y 111.62 1675.8376 17 -10.9 838.9169 2 62.28 6 32179 VEV_3_3_RA6_01_1237.d 8.56E5 4 4 121 137
R.AAVEEGILPGGGTALLK.A Y 109.87 1594.8929 17 -32.3 798.4280 2 78.25 6 43915 VEV_3_3_RA6_01_1237.d 3.12E5 5 5 446 462
K.KISAVQDIIPALEASTSLR.R Y 108.62 2011.1313 19 -17.2 671.3729 3 83.02 6 47237 VEV_3_3_RA6_01_1237.d 3.35E5 3 3 266 284
R.NVLIESPYGSPK.I Y 107.87 1302.6819 12 -14.2 652.3390 2 66.78 6 35492 VEV_3_3_RA6_01_1237.d 1.34E6 6 6 77 88
K.LTDDFASDFNR.G Y 104.91 1299.5731 11 -10.9 650.7867 2 70.37 6 38161 VEV_3_3_RA6_01_1237.d 4.16E5 3 3 511 521
K.AVNLQDKFENLGAR.L Y 99.90 1573.8212 14 -12.8 525.6076 3 67.52 5 37174 VEV_2_3_RA5_01_1236.d 1.95E6 5 5 99 112
K.ISAVQDIIPALEASTSLR.R Y 98.05 1883.0364 18 -12.0 942.5142 2 86.76 6 49562 VEV_3_3_RA6_01_1237.d 4.82E5 8 8 267 284
R.TIVENSGLEGSVIVGK.L Y 96.94 1600.8672 16 -9.1 801.4336 2 71.97 4 40787 VEV_1_3_RA4_01_1235.d 5.78E5 5 5 495 510
R.RPLVIIAEDIEGEALAVC(+57.02)ILNKLRGQLQVAAVK.A Y 95.80 3599.0596 33 -9.4 720.8124 5 93.99 4 55807 VEV_1_3_RA4_01_1235.d 2.06E5 2 2 285 317 Carbamidomethylation
K.GRNVLIESPYGSPK.I Y 94.84 1515.8044 14 -12.0 506.2693 3 61.04 5 32324 VEV_2_3_RA5_01_1236.d 1.49E5 2 2 75 88
R.SVISDPATSDYEKEK.L Y 94.72 1667.7889 15 -10.4 556.9312 3 54.91 4 28018 VEV_1_3_RA4_01_1235.d 5.95E5 5 5 391 405
R.FDRGYVSPYFITDTK.A Y 91.79 1807.8781 15 -0.5 603.6330 3 74.65 6 41354 VEV_3_3_RA6_01_1237.d 6.21E4 3 3 235 249
K.VGGASEIEVGEKKDR.V Y 90.75 1572.8107 15 -9.2 787.4054 2 31.37 4 13646 VEV_1_3_RA4_01_1235.d 1.61E6 10 10 422 436
R.RPLVIIAEDIEGEALAVC(+57.02)ILNKLR.G Y 88.92 2704.5308 24 -9.4 677.1336 4 92.63 6 52592 VEV_3_3_RA6_01_1237.d 6.68E4 1 1 285 308 Carbamidomethylation
R.KSILGDIGILTNATVFTDELDLKLEK.A Y 88.43 2845.5688 26 -18.9 712.3860 4 89.67 5 51712 VEV_2_3_RA5_01_1236.d 3.89E4 1 1 326 351
K.AAANGLTSLNPTNFDQK.L Y 86.71 1760.8693 17 -9.0 881.4340 2 73.47 4 41985 VEV_1_3_RA4_01_1235.d 6.04E5 6 6 463 479
R.RGIQSAVEAVVEYLQANKR.D Y 83.12 2130.1545 19 -33.7 533.5280 4 85.40 6 48704 VEV_3_3_RA6_01_1237.d 0 1 1 158 176
R.LLQDVASKTNE(+14.02)VAGDGTTTATVLAR.A Y 78.86 2544.3394 25 -10.7 849.1113 3 74.49 6 41176 VEV_3_3_RA6_01_1237.d 5.77E4 2 2 113 137 Methylation(others)
K.AAANGLTSLNPTNFDQKLGISIIK.N Y 75.17 2485.3540 24 -10.8 829.4496 3 82.94 6 47192 VEV_3_3_RA6_01_1237.d 5.68E5 7 7 463 486
R.SVISDPATSDYEK.E Y 73.13 1410.6514 13 -9.3 706.3264 2 59.52 6 30101 VEV_3_3_RA6_01_1237.d 1.56E5 2 2 391 403
K.AQKVEFEKPLILLSEK.K Y 72.80 1871.0767 16 -12.6 468.7706 4 73.87 5 41792 VEV_2_3_RA5_01_1236.d 5.26E5 4 4 250 265
R.GFDSAKGEYVDMIGAGIVDPLKVVR.T Y 72.39 2635.3679 25 -7.6 879.4566 3 83.79 4 49766 VEV_1_3_RA4_01_1235.d 6.9E4 2 2 522 546
K.VGGASEIEVGEK.K Y 72.13 1173.5876 12 -14.5 587.7926 2 46.81 6 22444 VEV_3_3_RA6_01_1237.d 2.65E5 5 5 422 433
K.VGGASEIEVGEKK.D Y 70.31 1301.6826 13 -12.8 651.8403 2 34.94 6 15624 VEV_3_3_RA6_01_1237.d 2.66E4 1 1 422 434
K.NVAAGC(+57.02)NPMDLRR.G Y 69.16 1472.6976 13 -8.6 737.3498 2 56.25 5 28917 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 146 158 Carbamidomethylation
R.VVDALNATR.A Y 65.51 957.5243 9 -17.0 479.7613 2 42.09 6 19700 VEV_3_3_RA6_01_1237.d 1.59E6 4 4 437 445
K.TIDDELEVTEGMR.F Y 64.28 1506.6871 13 -2.9 754.3486 2 73.19 4 41736 VEV_1_3_RA4_01_1235.d 1.46E5 3 3 222 234
K.TNEVAGDGTTTATVLAR(+14.02).A Y 63.47 1689.8533 17 -14.2 845.9219 2 65.37 6 34398 VEV_3_3_RA6_01_1237.d 1.18E5 3 3 121 137 Methylation(KR)
R.TIVENSGLEGSVIVGKLTDDFASDFNR.G Y 63.16 2882.4297 27 -15.0 961.8028 3 87.33 6 49849 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 495 521
K.LTDDFASDFNRGFDSAKGEYVDMIGAGIVDPLKVVR.T Y 60.13 3916.9304 36 -24.4 980.2159 4 87.73 4 52336 VEV_1_3_RA4_01_1235.d 1.15E5 3 3 511 546
K.AVTTTLGPK.G Y 59.30 886.5124 9 -13.0 444.2577 2 34.83 5 16072 VEV_2_3_RA5_01_1236.d 1.58E6 7 7 66 74
R.GYVSPYFITDTK(+14.02).A Y 58.85 1403.6973 12 -7.2 702.8508 2 76.66 4 44443 VEV_1_3_RA4_01_1235.d 4.58E5 4 4 238 249 Methylation(KR)
K.LRGQLQVAAVK.A Y 58.69 1181.7244 11 -19.6 591.8578 2 47.76 6 23021 VEV_3_3_RA6_01_1237.d 3.11E4 1 1 307 317
K.AVTTTLGPKGR.N Y 57.22 1099.6349 11 -9.3 550.8196 2 27.40 5 11807 VEV_2_3_RA5_01_1236.d 3.57E4 1 1 66 76
K.AVNLQ(+.98)DKFENLGAR.L Y 57.15 1574.8052 14 -13.7 525.9351 3 69.36 6 37385 VEV_3_3_RA6_01_1237.d 3.26E5 3 3 99 112 Deamidation (NQ)
K.AVN(+.98)LQDKFENLGAR.L Y 56.88 1574.8052 14 -4.7 788.4061 2 67.72 4 37418 VEV_1_3_RA4_01_1235.d 6.42E4 1 1 99 112 Deamidation (NQ)
K.TNE(+14.02)VAGDGTTTATVLAR.A Y 55.99 1689.8533 17 -5.7 845.9291 2 65.18 4 35414 VEV_1_3_RA4_01_1235.d 8E4 2 2 121 137 Methylation(others)
R.GQLQVAAVK.A Y 55.91 912.5392 9 -44.0 457.2568 2 42.19 6 19787 VEV_3_3_RA6_01_1237.d 7.14E5 8 8 309 317
K.VGGASEIEVGEKKDRVVDALNATR.A Y 55.49 2512.3245 24 -15.3 503.4645 5 65.79 6 34723 VEV_3_3_RA6_01_1237.d 1.99E5 2 2 422 445
K.APGFGDNR.K Y 54.79 832.3828 8 -14.6 417.1926 2 24.37 6 9872 VEV_3_3_RA6_01_1237.d 1.88E5 2 2 318 325
R.TIVEN(+.98)SGLEGSVIVGKLTDDFASDFNR.G Y 54.41 2883.4138 27 -2.9 721.8586 4 87.45 5 50552 VEV_2_3_RA5_01_1236.d 6.65E4 1 1 495 521 Deamidation (NQ)
K.ATPDMLGSTGSITITK.E Y 53.86 1591.8127 16 -8.6 796.9068 2 73.41 4 41909 VEV_1_3_RA4_01_1235.d 2.82E4 1 1 352 367
K.AVNLQDK(+14.02)FENLGAR.L Y 51.49 1587.8369 14 -17.6 530.2769 3 70.22 5 39153 VEV_2_3_RA5_01_1236.d 2.06E5 1 1 99 112 Methylation(KR)
K.AVNLQDKFENLGAR(+14.02).L Y 51.15 1587.8369 14 -14.2 530.2787 3 69.39 4 38736 VEV_1_3_RA4_01_1235.d 3.29E5 3 3 99 112 Methylation(KR)
K.ISAVQDIIPALE(+14.02)ASTSLR.R Y 51.15 1897.0520 18 -24.3 633.3426 3 89.00 6 50798 VEV_3_3_RA6_01_1237.d 3.6E4 1 1 267 284 Methylation(others)
R.LLQDVASK.T Y 50.63 872.4967 8 -14.2 437.2494 2 39.49 5 18820 VEV_2_3_RA5_01_1236.d 1.44E6 6 6 113 120
K.NAITRPAR.T Y 49.56 897.5144 8 -17.2 449.7568 2 14.53 6 4728 VEV_3_3_RA6_01_1237.d 1.24E6 6 6 487 494
R.GIQSAVEAVVE(+14.02)YLQANKR.D Y 49.51 1988.0691 18 -8.1 663.6916 3 89.03 4 53128 VEV_1_3_RA4_01_1235.d 3.42E5 2 2 159 176 Methylation(others)
K.LISNAMEK.V Y 48.31 904.4688 8 -16.1 453.2344 2 36.45 4 16635 VEV_1_3_RA4_01_1235.d 4.87E5 5 5 201 208
R.AAVEE(+14.02)GILPGGGTALLK.A Y 47.59 1608.9086 17 -14.8 805.4496 2 80.02 6 45175 VEV_3_3_RA6_01_1237.d 2.66E5 3 3 446 462 Methylation(others)
K.LSGGVAVIK.V Y 46.98 842.5225 9 -19.6 422.2603 2 50.96 6 24845 VEV_3_3_RA6_01_1237.d 6.21E5 5 5 413 421
K.VGKEGVITVK.D Y 46.62 1028.6229 10 -38.2 515.2991 2 33.48 6 14789 VEV_3_3_RA6_01_1237.d 0 1 1 209 218
R.GIQSAVEAVVEYLQANKR(+14.02).D Y 45.48 1988.0691 18 -19.4 663.6841 3 88.74 6 50684 VEV_3_3_RA6_01_1237.d 2.84E5 1 1 159 176 Methylation(KR)
R.AIFSETVK.N Y 43.71 893.4858 8 -45.7 447.7298 2 56.96 4 29298 VEV_1_3_RA4_01_1235.d 0 3 3 138 145
K.KISAVQDIIPALE(+14.02)ASTSLR.R Y 43.16 2025.1470 19 -39.1 676.0298 3 85.03 6 48481 VEV_3_3_RA6_01_1237.d 0 1 1 266 284 Methylation(others)
K.APGFGDNRK.S Y 42.53 960.4777 9 -12.1 481.2403 2 16.15 4 5386 VEV_1_3_RA4_01_1235.d 8.87E5 9 9 318 326
R.TIVENSGLE(+14.02)GSVIVGK.L Y 42.51 1614.8828 16 -36.5 808.4192 2 75.64 4 43699 VEV_1_3_RA4_01_1235.d 3.6E4 2 2 495 510 Methylation(others)
K.TIDDELEVTEGMRFDR.G Y 42.33 1924.8837 16 -14.7 642.6257 3 76.76 6 42823 VEV_3_3_RA6_01_1237.d 1.59E5 2 2 222 237
K.GEYVDMIGAGIVDPLKVVR.T Y 42.23 2030.0870 19 -15.7 677.6923 3 84.25 6 47988 VEV_3_3_RA6_01_1237.d 1.72E5 1 1 528 546
K.AAANGLTSLNPTNFDQ(+.98)K.L Y 41.68 1761.8533 17 -8.9 881.9261 2 74.05 4 42397 VEV_1_3_RA4_01_1235.d 1.69E5 3 3 463 479 Deamidation (NQ)
R.TIVENSGLEGSVIVGK(+14.02).L Y 41.11 1614.8828 16 -50.3 808.4081 2 74.08 4 42419 VEV_1_3_RA4_01_1235.d 1.95E4 2 2 495 510 Methylation(KR)
R.GIQSAVE(+14.02)AVVEYLQANKR.D Y 40.37 1988.0691 18 -12.7 663.6885 3 89.11 6 50856 VEV_3_3_RA6_01_1237.d 2.84E5 2 2 159 176 Methylation(others)
K.VGKEGVITVKDGK.T Y 39.57 1328.7664 13 -19.9 443.9206 3 28.41 4 11973 VEV_1_3_RA4_01_1235.d 2.04E5 2 2 209 221
K.VEFEKPLILLSEKK.I Y 38.17 1671.9811 14 -15.4 418.9961 4 73.33 6 40325 VEV_3_3_RA6_01_1237.d 0 1 1 253 266
R.S(-2.02)VISDPATSDYEKEK.L Y 38.07 1665.7733 15 10.8 556.2711 3 54.52 6 26952 VEV_3_3_RA6_01_1237.d 0 1 1 391 405 2-amino-3-oxo-butanoic_acid
K.AQKVEFEKPLILLSEKK.I Y 37.65 1999.1716 17 -9.1 400.8380 5 69.27 4 38642 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 250 266
K.EGVITVKDGK.T Y 37.08 1044.5815 10 -28.1 523.2834 2 27.39 6 11454 VEV_3_3_RA6_01_1237.d 5.57E4 1 1 212 221
K.AVN(+.98)LQDKFEN(+.98)LGAR.L Y 36.48 1575.7892 14 3.9 526.2724 3 69.38 4 38773 VEV_1_3_RA4_01_1235.d 8.67E4 1 1 99 112 Deamidation (NQ)
K.ITKDGVTVAK.A Y 36.36 1030.6023 10 -53.0 516.2811 2 24.02 4 9601 VEV_1_3_RA4_01_1235.d 0 3 3 89 98
K.FGVEAR.A Y 35.92 677.3496 6 -12.5 339.6779 2 30.52 4 13129 VEV_1_3_RA4_01_1235.d 8.8E5 4 4 48 53
K.AAANGLTSLN(+.98)PTNFDQKLGISIIK.N Y 34.90 2486.3379 24 -10.8 829.7776 3 84.09 6 47888 VEV_3_3_RA6_01_1237.d 1.57E5 1 1 463 486 Deamidation (NQ)
R.DITTT(+14.02)EEIAQVATISANGDTHVGK.L Y 33.56 2484.2344 24 20.5 829.1024 3 81.20 4 47940 VEV_1_3_RA4_01_1235.d 0 1 1 177 200 Methylation(others)
K.AVNLQDKFEN(+.98)LGAR.L Y 31.63 1574.8052 14 1.5 525.9431 3 69.19 5 38397 VEV_2_3_RA5_01_1236.d 8.99E4 1 1 99 112 Deamidation (NQ)
K.LGISIIK.N Y 31.58 742.4952 7 -18.0 372.2482 2 68.75 6 36948 VEV_3_3_RA6_01_1237.d 7.31E5 5 5 480 486
R.SAGVGLQQQR.F Y 31.38 1042.5519 10 3.8 348.5259 3 29.81 6 12770 VEV_3_3_RA6_01_1237.d 8.83E5 2 2 31 40
K.T(+14.02)NEVAGDGTTTATVLAR.A Y 30.85 1689.8533 17 6.4 845.9393 2 64.96 5 35243 VEV_2_3_RA5_01_1236.d 3.28E4 1 1 121 137 Methylation(others)
K.VGGASEIEVGEK(+14.02)KDR.V Y 30.35 1586.8263 15 -9.6 397.7100 4 40.46 4 18969 VEV_1_3_RA4_01_1235.d 3.03E5 1 1 422 436 Methylation(KR)
K.GIDTLAK.A Y 30.35 716.4069 7 -9.3 717.4075 1 33.07 4 14616 VEV_1_3_RA4_01_1235.d 7.86E5 4 4 59 65
R.SVISDPATSDYEKEK(+14.02)LQER.L Y 29.75 2208.0908 19 -21.6 553.0181 4 62.38 6 32181 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 391 409 Methylation(KR)
K.FENLGAR(+54.01).L Y 26.56 859.4188 7 21.1 860.4442 1 112.07 4 61695 VEV_1_3_RA4_01_1235.d 7.11E3 1 1 106 112 Methylglyoxal-derived hydroimidazolone
K.SILGDIGILTNATVFTDELDLKLEK(+14.02).A Y 25.75 2731.4895 25 -23.4 911.4825 3 95.49 6 53787 VEV_3_3_RA6_01_1237.d 3.13E4 1 1 327 351 Methylation(KR)
K.N(+.98)AIT(+79.96)RPAR.T Y 24.92 978.4553 8 22.2 327.1663 3 14.59 6 4740 VEV_3_3_RA6_01_1237.d 0 1 1 487 494 Deamidation (NQ); Sulfation
R.AAVEEGILPGGGTALLK(-.98).A Y 24.69 1593.9089 17 -24.7 797.9421 2 78.44 4 45825 VEV_1_3_RA4_01_1235.d 0 1 1 446 462 Amidation
K.LGISIIK(+14.02).N Y 24.47 756.5109 7 -44.2 379.2460 2 72.74 4 41381 VEV_1_3_RA4_01_1235.d 0 2 2 480 486 Methylation(KR)
K.LISNAM(+15.99)EK.V Y 23.97 920.4637 8 24.6 461.2505 2 42.62 4 20301 VEV_1_3_RA4_01_1235.d 2.46E5 3 3 201 208 Oxidation (M)
R.NVLIESPYGSPK(+14.02).I Y 23.35 1316.6976 12 -15.2 659.3461 2 69.13 5 38354 VEV_2_3_RA5_01_1236.d 3.38E4 2 2 77 88 Methylation(KR)
K.SILGDIGILTNATVFTDE(+14.02)LDLKLEK.A Y 22.99 2731.4895 25 -8.5 911.4960 3 96.14 6 54041 VEV_3_3_RA6_01_1237.d 1.66E4 1 1 327 351 Methylation(others)
K.NVAAGC(+57.02)NPM(+15.99)DLR.R Y 22.89 1332.5914 12 -27.0 667.2850 2 46.07 6 22024 VEV_3_3_RA6_01_1237.d 0 1 1 146 157 Carbamidomethylation; Oxidation (M)
R.ASLLKGIDTLAK.A Y 22.74 1228.7390 12 -10.7 410.5826 3 69.95 4 39173 VEV_1_3_RA4_01_1235.d 1.67E5 3 3 54 65
K.TIDDELEVTEGM(+15.99)RFDR.G Y 22.63 1940.8785 16 -9.4 647.9607 3 70.51 6 38233 VEV_3_3_RA6_01_1237.d 1.7E4 1 1 222 237 Oxidation (M)
K.KDR(+80.99)VVDALNATR.A Y 22.50 1437.7324 12 -6.3 480.2484 3 42.94 6 20206 VEV_3_3_RA6_01_1237.d 8.38E5 1 1 434 445 Arginine replacement by Nitropyrimidyl ornithine
R.ALVLSSASSASSTRAPLSR(+.98).F Y 22.43 1860.9905 19 11.0 466.2600 4 72.93 5 41125 VEV_2_3_RA5_01_1236.d 0 1 1 10 28 Deamidation (R)
R.ASLLK(+42.01)GIDTLAK(+42.01).A Y 22.01 1312.7601 12 19.9 329.2038 4 41.49 4 19606 VEV_1_3_RA4_01_1235.d 0 1 1 54 65 Acetylation (K)
K.NVAAGC(+57.02)NPM(+15.99)DLRR.G Y 21.86 1488.6925 13 -12.0 497.2321 3 38.60 6 17696 VEV_3_3_RA6_01_1237.d 7.5E4 1 1 146 158 Carbamidomethylation; Oxidation (M)
K.EGVITVKDGK(+42.01).T Y 21.79 1086.5920 10 -6.0 363.2025 3 50.90 4 25445 VEV_1_3_RA4_01_1235.d 3.77E5 2 2 212 221 Acetylation (K)
R.GIQSAVEAVVEYLQANK(+21.98).R Y 21.38 1839.9342 17 -34.5 920.9426 2 93.38 5 53521 VEV_2_3_RA5_01_1236.d 8.04E4 1 1 159 175 Sodium adduct
K.AVNLQDKFE(+14.02)NLGAR.L Y 21.21 1587.8369 14 -19.6 530.2759 3 70.49 4 39594 VEV_1_3_RA4_01_1235.d 3.63E5 2 2 99 112 Methylation(others)
K.ITKDGVTVAK(+27.99).A Y 20.96 1058.5972 10 -31.3 530.2893 2 30.53 6 13157 VEV_3_3_RA6_01_1237.d 5.62E4 1 1 89 98 Formylation
K.AAAN(+.98)GLTSLNPTNFDQK.L Y 20.75 1761.8533 17 -8.7 881.9263 2 75.18 6 41674 VEV_3_3_RA6_01_1237.d 4.56E5 2 2 463 479 Deamidation (NQ)
R.FRSAGVGLQ(+.98)QQR.F Y 20.52 1346.7054 12 -5.4 337.6818 4 24.27 4 9708 VEV_1_3_RA4_01_1235.d 7.31E4 1 1 29 40 Deamidation (NQ)
R.GFDSAKGEYVD(-18.01)M(+15.99)IGAGIVDPLK.V Y 20.22 2279.1143 22 -12.4 760.7026 3 83.17 6 47299 VEV_3_3_RA6_01_1237.d 9.75E4 1 1 522 543 Dehydration; Oxidation (M)
K.EGVIT(+79.97)VK.D Y 20.12 824.4045 7 -10.4 825.4032 1 92.40 6 52489 VEV_3_3_RA6_01_1237.d 0 1 1 212 218 Phosphorylation (STY)
K.EDTIILNGEGSK.D Y 20.09 1274.6354 12 -12.3 638.3171 2 58.17 4 30130 VEV_1_3_RA4_01_1235.d 4.21E4 1 1 368 379
R.LLQDVASK(+226.08).T Y 19.91 1098.5743 8 19.5 550.3052 2 53.82 4 27333 VEV_1_3_RA4_01_1235.d 3.93E4 1 1 113 120 Biotinylation
K.A(+43.01)AANGLTSLNPTNFDQK.L Y 19.08 1803.8751 17 -5.9 602.2954 3 72.88 4 41491 VEV_1_3_RA4_01_1235.d 0 1 1 463 479 Carbamylation
K.A(+42.01)VNLQ(+.98)DK.F Y 18.89 829.4182 7 3.4 830.4282 1 87.70 6 50055 VEV_3_3_RA6_01_1237.d 6.26E4 1 1 99 105 Acetylation (N-term); Deamidation (NQ)
K.AVN(+162.05)LQDK.F Y 18.69 948.4763 7 -37.1 949.4484 1 88.84 5 51300 VEV_2_3_RA5_01_1236.d 4.62E4 2 2 99 105 Hexose (NSY)
R.FDRGYVSPYFITDTK(+14.02).A Y 18.69 1821.8937 15 -21.5 608.2921 3 73.37 6 40356 VEV_3_3_RA6_01_1237.d 6.25E4 1 1 235 249 Methylation(KR)
K.ISAVQDIIPALEASTSLR(+21.98).R Y 18.42 1905.0183 18 0.6 477.2621 4 73.19 5 41304 VEV_2_3_RA5_01_1236.d 5.87E4 1 1 267 284 Sodium adduct
K.AVTT(+79.97)TLGPK.G Y 18.40 966.4787 9 -15.2 967.4713 1 87.27 4 52049 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 66 74 Phosphorylation (STY)
K.GIDTLAKAVTTTLGPK.G Y 18.37 1584.9087 16 -78.5 397.2033 4 51.76 5 26244 VEV_2_3_RA5_01_1236.d 0 1 1 59 74
R.SAGVGLQQQR(+31.99).F Y 17.86 1074.5417 10 -8.9 359.1847 3 14.01 5 4501 VEV_2_3_RA5_01_1236.d 1.84E4 1 1 31 40 Dihydroxy
R.A(+42.01)LVLSSASSASS(-18.01)TR.A Y 17.84 1359.6993 14 -27.2 454.2281 3 32.69 6 14353 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 10 23 Acetylation (Protein N-term); Dehydration
K.DRVVDALNATR.A Y 17.81 1228.6523 11 0.8 308.1706 4 21.68 4 8303 VEV_1_3_RA4_01_1235.d 0 1 1 435 445
K.EDTIILN(+.98)GEGSK.D Y 17.76 1275.6194 12 -35.3 426.1987 3 30.30 5 13436 VEV_2_3_RA5_01_1236.d 0 1 1 368 379 Deamidation (NQ)
R.AFTSSR(+21.98).A Y 17.45 689.3109 6 1.0 690.3188 1 59.84 5 31433 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 4 9 Sodium adduct
K.VGGASEIEVGEK(+43.01)K.D Y 17.37 1344.6885 13 -13.2 449.2308 3 69.56 6 37537 VEV_3_3_RA6_01_1237.d 0 1 1 422 434 Carbamylation
R.NVLIESPYGSPK(+27.99).I Y 17.04 1330.6769 12 -7.3 666.3409 2 71.64 5 40205 VEV_2_3_RA5_01_1236.d 7.67E4 1 1 77 88 Formylation
R.S(+42.01)AGVGLQQQR.F Y 17.04 1084.5625 10 -0.4 543.2883 2 52.53 5 26708 VEV_2_3_RA5_01_1236.d 0 1 1 31 40 Acetylation (N-term)
K.SILGDIGILTN(+.98)ATVFTDELDLKLEK(+14.02).A Y 16.94 2732.4734 25 0.6 911.8323 3 96.25 4 56857 VEV_1_3_RA4_01_1235.d 9.46E4 1 1 327 351 Deamidation (NQ); Methylation(KR)
R.T(+42.01)IVEN(+.98)SGLEGSVIVGK.L Y 16.79 1643.8617 16 -25.3 822.9173 2 91.27 4 54373 VEV_1_3_RA4_01_1235.d 8.77E4 1 1 495 510 Acetylation (N-term); Deamidation (NQ)
K.R(+14.02)DIT(+79.97)TTEEIAQVATISANGDTHVGK.L Y 16.78 2720.3018 25 2.2 681.0842 4 65.75 6 34689 VEV_3_3_RA6_01_1237.d 0 1 1 176 200 Methylation(KR); Phosphorylation (STY)
R.A(+42.01)S(+162.05)LLKGIDTLAK.A Y 16.53 1432.8024 12 20.8 359.2153 4 47.07 6 22608 VEV_3_3_RA6_01_1237.d 0 1 1 54 65 Acetylation (N-term); Hexose (NSY)
R.F(+71.04)AHKELK.F Y 16.48 942.5287 7 -2.0 315.1829 3 34.64 6 15456 VEV_3_3_RA6_01_1237.d 0 1 1 41 47 Propionamide (K, X@N-term)
K.IT(+79.96)KDGVTVAK.A Y 16.37 1110.5591 10 62.8 371.2169 3 24.11 4 9620 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 89 98 Sulfation
K.A(+42.01)VTTT(-18.01)LGPKGR.N Y 16.36 1123.6349 11 14.7 375.5577 3 50.22 6 24419 VEV_3_3_RA6_01_1237.d 3.66E4 1 1 66 76 Acetylation (N-term); Dehydration
R.SAGVGLQQQR(+14.02).F Y 16.24 1056.5676 10 13.2 353.2011 3 39.33 5 18718 VEV_2_3_RA5_01_1236.d 4.69E5 1 1 31 40 Methylation(KR)
K.F(+71.04)GVEAR.A Y 16.08 748.3868 6 -12.8 375.1959 2 17.11 5 6164 VEV_2_3_RA5_01_1236.d 1.88E4 1 1 48 53 Propionamide (K, X@N-term)
K.AVT(+79.97)TTLGPK(+42.01).G Y 16.03 1008.4893 9 35.2 337.1822 3 26.21 4 10780 VEV_1_3_RA4_01_1235.d 1.97E5 1 1 66 74 Phosphorylation (STY); Acetylation (K)
K.N(+.98)AITR(+31.99)PAR.T Y 16.03 930.4883 8 8.5 466.2554 2 32.57 5 14754 VEV_2_3_RA5_01_1236.d 0 1 1 487 494 Deamidation (NQ); Dihydroxy
R.A(+43.01)IFSETVK.N Y 16.02 936.4916 8 -34.9 469.2368 2 34.88 4 15683 VEV_1_3_RA4_01_1235.d 0 1 1 138 145 Carbamylation
R.VVDALN(+.98)ATR.A Y 15.94 958.5084 9 6.7 480.2647 2 47.70 5 23755 VEV_2_3_RA5_01_1236.d 0 1 1 437 445 Deamidation (NQ)
K.GIDTLAKAVTTTLGPK(+43.99).G Y 15.94 1628.8984 16 2.8 408.2330 4 68.05 4 37678 VEV_1_3_RA4_01_1235.d 4.97E3 1 1 59 74 Carboxylation (DKW)
K.AVTTTLGPK(+43.01).G Y 15.92 929.5182 9 -2.1 310.8460 3 21.17 4 8026 VEV_1_3_RA4_01_1235.d 5.43E4 1 1 66 74 Carbamylation
K.DGVTVAK(+42.01)AVNLQDK(+42.01).F Y 15.91 1540.8097 14 -2.1 309.1686 5 23.62 6 9469 VEV_3_3_RA6_01_1237.d 0 1 1 92 105 Acetylation (K)
K.A(+42.01)VTTTLGPK.G Y 15.89 928.5229 9 -46.0 465.2474 2 46.01 5 22742 VEV_2_3_RA5_01_1236.d 0 1 1 66 74 Acetylation (N-term)
K.AVTT(+42.01)TLGPK.G Y 15.81 928.5229 9 -24.6 465.2573 2 59.25 4 30938 VEV_1_3_RA4_01_1235.d 0 1 1 66 74 Acetylation (TSCYH)
K.DRVVDALNAT(+79.96)R.A Y 15.79 1308.6091 11 5.0 655.3151 2 32.83 6 14435 VEV_3_3_RA6_01_1237.d 0 1 1 435 445 Sulfation
K.DAIAQR(+54.01).C Y 15.79 726.3660 6 -13.4 727.3636 1 111.85 4 61627 VEV_1_3_RA4_01_1235.d 7.87E4 1 1 380 385 Methylglyoxal-derived hydroimidazolone
K.GEYVDMIGAGIVDPLK.V Y 15.63 1675.8491 16 4.9 838.9359 2 84.32 4 50137 VEV_1_3_RA4_01_1235.d 1.75E5 1 1 528 543
K.EDTIILNGEGSKDAIAQRC(+57.02)EQIR.S Y 15.61 2615.2974 23 38.3 654.8567 4 78.21 6 43883 VEV_3_3_RA6_01_1237.d 0 1 1 368 390 Carbamidomethylation
R.F(+42.01)RSAGVGLQQ(+.98)QRFAHK.E Y 15.58 1871.9755 16 -26.5 624.9825 3 68.64 6 36868 VEV_3_3_RA6_01_1237.d 0 1 1 29 44 Acetylation (N-term); Deamidation (NQ)
K.ITKDGVTVAK(+188.03).A Y 15.52 1218.6353 10 -3.5 407.2176 3 26.11 4 10766 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 89 98 Lipoyl
K.V(+28.03)GGASEIEVGEK.K Y 15.52 1201.6190 12 -9.4 601.8112 2 67.66 5 37275 VEV_2_3_RA5_01_1236.d 0 1 1 422 433 Ethylation
R.L(+42.01)AKLSGGVAVIK(+27.99).V Y 15.48 1224.7441 12 -18.9 307.1875 4 46.13 5 22801 VEV_2_3_RA5_01_1236.d 3.02E4 1 1 410 421 Acetylation (N-term); Formylation
R.FRSAGVGLQQ(+.98)Q(+.98)R.F Y 15.44 1347.6895 12 10.7 674.8592 2 60.21 6 30592 VEV_3_3_RA6_01_1237.d 1.97E4 1 1 29 40 Deamidation (NQ)
K.AVNLQDK.F Y 15.42 786.4235 7 -28.8 394.2077 2 38.48 6 17615 VEV_3_3_RA6_01_1237.d 8.01E4 1 1 99 105
R.AFTSSR(+28.03).A Y 15.33 695.3602 6 -39.2 696.3403 1 44.68 5 21945 VEV_2_3_RA5_01_1236.d 0 1 1 4 9 Dimethylation(KR)
K.EDTIILNGEGSKDAIAQR.C Y 15.29 1928.9802 18 -15.1 965.4828 2 88.36 4 52730 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 368 385
K.D(+42.01)GVTVAK(+14.02).A Y 15.28 744.4017 7 -9.5 745.4019 1 30.08 5 13310 VEV_2_3_RA5_01_1236.d 3.55E4 1 1 92 98 Acetylation (N-term); Methylation(KR)
R.LLQDVASK(+14.02).T Y 15.15 886.5123 8 -6.9 444.2604 2 51.33 5 25965 VEV_2_3_RA5_01_1236.d 2.28E4 1 1 113 120 Methylation(KR)
K.L(+27.99)ISNAMEK.V Y 15.12 932.4637 8 -33.3 467.2236 2 43.88 5 21445 VEV_2_3_RA5_01_1236.d 7.76E4 1 1 201 208 Formylation
K.AVTTT(-18.01)LGPK(+42.01).G Y 15.11 910.5124 9 -68.9 456.2321 2 30.27 5 13417 VEV_2_3_RA5_01_1236.d 0 1 1 66 74 Dehydration; Acetylation (K)
K.V(+27.99)GGASEIEVGEK.K Y 15.05 1201.5826 12 42.1 401.5517 3 35.18 6 15760 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 422 433 Formylation
total 160 peptides
C1G064
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GFETRPAQVILPLSPNHGTFGNDGLYSESK.L Y 137.50 3230.5996 30 -6.1 808.6523 4 78.81 4 46101 VEV_1_3_RA4_01_1235.d 2.35E5 1 1 810 839
K.AMAEGGPISEYSNR.T Y 128.57 1480.6616 14 -8.0 741.3322 2 60.98 4 32218 VEV_1_3_RA4_01_1235.d 4.73E5 4 4 539 552
R.AHGDKVEVFEIPDSSEYTVR.L Y 126.77 2277.0913 20 -6.3 570.2765 4 73.27 4 41792 VEV_1_3_RA4_01_1235.d 1.04E6 5 5 1143 1162
K.GAAGGFMFNGALQVLNSGLVPGNR.N Y 125.94 2346.1902 24 -8.8 783.0638 3 89.94 5 51854 VEV_2_3_RA5_01_1236.d 5.91E5 5 5 1585 1608
R.NADNIDKVMEKFDYIVYPSR.S Y 114.97 2416.1733 20 -25.0 605.0355 4 81.70 4 48345 VEV_1_3_RA4_01_1235.d 5.01E5 5 5 1609 1628
K.NGLGWDLDYIVPFAAISENGR.E Y 106.30 2306.1331 21 -4.0 769.7152 3 93.37 4 55488 VEV_1_3_RA4_01_1235.d 5.35E5 5 5 755 775
K.KLTGIYLDVLESAAR.A Y 106.12 1647.9196 15 -21.6 550.3019 3 81.10 6 45953 VEV_3_3_RA6_01_1237.d 1.53E5 3 3 652 666
K.NVLMTGAGAGSIGAAVLQGMISGGAK.V Y 102.76 2330.2085 26 -8.2 1166.1019 2 89.43 4 53347 VEV_1_3_RA4_01_1235.d 1.6E5 3 3 675 700
R.FVAGQIPTGWNPK.H Y 102.56 1413.7405 13 -17.0 707.8655 2 74.51 6 41185 VEV_3_3_RA6_01_1237.d 1.53E5 2 2 1180 1192
K.GAAGGFMFN(+.98)GALQVLNSGLVPGNR.N Y 100.67 2347.1743 24 -5.5 1174.5880 2 89.64 4 53461 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 1585 1608 Deamidation (NQ)
R.EAIRQEKDAAFSLGNNFWR.Q Y 100.55 2251.1133 19 -9.2 563.7804 4 75.66 4 43643 VEV_1_3_RA4_01_1235.d 3.33E5 2 2 1495 1513
K.YEAYDAATSVQR.Q Y 99.57 1372.6259 12 -0.6 687.3198 2 56.55 4 28990 VEV_1_3_RA4_01_1235.d 6.58E4 1 1 65 76
R.SNPLLLEFMQYHIDNC(+57.02)PTER.G Y 98.55 2476.1514 20 -3.0 826.3886 3 84.45 4 50217 VEV_1_3_RA4_01_1235.d 0 1 1 454 473 Carbamidomethylation
K.YVHISEVGNC(+57.02)IGSGIGGSHALR.G Y 98.43 2282.1226 22 -13.2 761.7048 3 69.94 4 39165 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 1233 1254 Carbamidomethylation
K.LTGIYLDVLESAAR.A Y 97.74 1519.8246 14 -8.2 760.9133 2 84.73 4 50402 VEV_1_3_RA4_01_1235.d 8.87E4 2 2 653 666
R.YFHNGLINNSLFVAK.D Y 96.87 1735.9045 15 -12.1 579.6351 3 76.92 4 44629 VEV_1_3_RA4_01_1235.d 2.45E5 2 2 1686 1700
R.RTIASKYEAYDAATSVQR.Q Y 93.16 2029.0228 18 -10.4 508.2577 4 58.28 4 30205 VEV_1_3_RA4_01_1235.d 1.46E5 3 3 59 76
R.AFFKQQLELTAR.Y Y 92.92 1450.7932 12 -14.8 484.5978 3 69.82 5 38856 VEV_2_3_RA5_01_1236.d 5.12E5 4 4 348 359
R.SVPAPGKGVLTTAR.E Y 92.89 1352.7776 14 -11.9 677.3880 2 53.04 5 27008 VEV_2_3_RA5_01_1236.d 5.69E5 5 5 1413 1426
R.VC(+57.02)LVGGFDDFQEEGSYEFANMQATSNAEKEFAHGR.T Y 90.54 3939.7104 35 -8.2 985.9268 4 83.05 4 49255 VEV_1_3_RA4_01_1235.d 1.5E4 1 1 1322 1356 Carbamidomethylation
R.IVEIGPADTLGGMAR.R Y 90.38 1498.7814 15 -10.3 750.3903 2 76.38 4 44208 VEV_1_3_RA4_01_1235.d 1.79E5 3 3 44 58
K.DVAIPTGPQTVIDSR.G Y 90.09 1567.8206 15 -9.9 784.9098 2 75.20 4 43284 VEV_1_3_RA4_01_1235.d 2.6E5 2 2 503 517
K.DAAFSLGNNFWR.Q Y 89.92 1396.6523 12 -6.1 699.3292 2 83.01 4 49227 VEV_1_3_RA4_01_1235.d 1.86E5 4 4 1502 1513
R.GAPSPQASFAGR.W Y 89.80 1144.5625 12 -11.8 573.2818 2 47.39 5 23564 VEV_2_3_RA5_01_1236.d 1.8E6 10 10 1810 1821
K.TEAEDVQMQQTR.Q Y 89.63 1434.6409 12 -7.5 718.3223 2 36.20 4 16454 VEV_1_3_RA4_01_1235.d 1.81E5 2 2 1750 1761
K.VLLQEVILQEDLDAFEASKETAEEFKR.A Y 89.46 3149.6130 27 -11.8 788.4012 4 87.53 4 52213 VEV_1_3_RA4_01_1235.d 0 1 1 1116 1142
K.AFSVTSFGFGQK.G Y 89.32 1274.6295 12 -0.5 425.8836 3 78.38 5 44978 VEV_2_3_RA5_01_1236.d 2.56E5 4 4 1637 1648
K.VVDREIVSQC(+57.02)IR.I Y 88.74 1472.7770 12 -9.3 491.9283 3 57.23 4 29470 VEV_1_3_RA4_01_1235.d 4.38E5 5 5 438 449 Carbamidomethylation
R.Q(-17.03)KGNALLGIFQK.Y Y 87.80 1298.7346 12 -10.1 650.3680 2 79.54 4 46667 VEV_1_3_RA4_01_1235.d 2.85E5 4 4 1566 1577 Pyro-glu from Q
K.TGEPVNDRDVK.A Y 85.48 1228.6047 11 -8.6 615.3044 2 18.69 4 6750 VEV_1_3_RA4_01_1235.d 9.83E5 8 8 1076 1086
R.GNINYSEIPR.T Y 84.59 1161.5778 10 -11.4 581.7896 2 61.93 5 33019 VEV_2_3_RA5_01_1236.d 1.36E6 5 5 518 527
K.AM(+15.99)AEGGPISEYSNR.T Y 84.06 1496.6565 14 -8.3 749.3293 2 52.54 4 26509 VEV_1_3_RA4_01_1235.d 2.2E5 2 2 539 552 Oxidation (M)
K.Q(-17.03)KTEAEDVQMQQTR.Q Y 83.41 1673.7679 14 -6.7 837.8856 2 46.28 4 22558 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 1748 1761 Pyro-glu from Q
R.GSQLVVVPFNQGSK.Q Y 82.02 1458.7831 14 -9.6 730.3918 2 72.76 4 41396 VEV_1_3_RA4_01_1235.d 3.99E5 6 6 727 740
R.WIETQDVILQEK.R Y 80.35 1500.7823 12 -11.4 751.3899 2 75.52 4 43538 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 28 39
R.EVTGYYQTMYTR.Y Y 79.25 1510.6763 12 -8.7 756.3388 2 66.43 4 36399 VEV_1_3_RA4_01_1235.d 2.63E5 3 3 711 722
R.TPQEMSRPTTTTR.S Y 79.01 1504.7303 13 -6.5 502.5808 3 28.00 4 11764 VEV_1_3_RA4_01_1235.d 7.28E5 5 5 1357 1369
R.AHGDK(+14.02)VEVFEIPDSSEYTVR.L Y 77.69 2291.1069 20 -3.8 573.7819 4 75.01 4 43139 VEV_1_3_RA4_01_1235.d 3.45E5 3 3 1143 1162 Methylation(KR)
K.GMVNLDKVVVVTGFAEIGPWGNSR.T Y 77.20 2544.3159 24 -5.3 637.0829 4 87.23 4 52028 VEV_1_3_RA4_01_1235.d 1.11E5 2 2 1007 1030
K.ELGQQLIENC(+57.02)KEVLHANPVYKDVAIPTGPQTVIDSR.G Y 76.88 4031.0786 36 -2.1 1008.7748 4 81.25 4 47977 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 482 517 Carbamidomethylation
K.FPSPLLDIKYR.R Y 76.39 1347.7550 11 -15.6 450.2520 3 76.96 6 42973 VEV_3_3_RA6_01_1237.d 1.84E5 3 3 1432 1442
K.MPGGFNITAVRK.Y Y 75.86 1289.6914 12 -13.5 430.8986 3 65.60 4 35745 VEV_1_3_RA4_01_1235.d 3.78E5 2 2 251 262
R.NFTASEQKYC(+57.02)R.G Y 75.14 1402.6299 11 -6.2 702.3179 2 34.37 4 15369 VEV_1_3_RA4_01_1235.d 3.09E5 3 3 1799 1809 Carbamidomethylation
K.SSQLQFTSLYR.E Y 72.85 1328.6725 11 -10.3 665.3367 2 73.68 4 42108 VEV_1_3_RA4_01_1235.d 9.42E5 7 7 575 585
R.ENAGKFPSPLLDIKYR.R Y 72.27 1846.9940 16 -9.3 462.7515 4 73.43 4 41924 VEV_1_3_RA4_01_1235.d 4.24E5 2 2 1427 1442
K.Q(-17.03)DVQALVNYIYDPK.N Y 70.73 1647.8145 14 31.8 824.9407 2 91.22 5 52502 VEV_2_3_RA5_01_1236.d 7.01E4 2 2 741 754 Pyro-glu from Q
K.LKKPLADVPVTK.A Y 70.31 1307.8176 12 -13.0 654.9076 2 47.81 6 23057 VEV_3_3_RA6_01_1237.d 3.72E5 4 4 173 184
K.MPGGFNITAVR.K Y 69.53 1161.5964 11 -13.2 581.7979 2 73.38 4 41882 VEV_1_3_RA4_01_1235.d 4.15E5 3 3 251 261
R.VYDSSWNWAR.Q Y 67.79 1282.5731 10 10.9 642.3008 2 71.91 4 40724 VEV_1_3_RA4_01_1235.d 0 2 2 412 421
R.QKGNALLGIFQK.Y Y 67.68 1315.7612 12 -11.0 439.5895 3 72.44 4 41143 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 1566 1577
R.FLDKPLQK.D Y 66.36 987.5753 8 -16.2 494.7869 2 42.95 6 20209 VEV_3_3_RA6_01_1237.d 5.67E5 4 4 1261 1268
K.KPLADVPVTK.A Y 65.08 1066.6385 10 -34.4 534.3082 2 40.89 4 19224 VEV_1_3_RA4_01_1235.d 0 1 1 175 184
K.LRSEITETSTVR.Q Y 64.92 1390.7416 12 -7.6 464.5843 3 42.58 4 20277 VEV_1_3_RA4_01_1235.d 4E5 8 8 939 950
K.AYLDDVANK.Y Y 62.97 1007.4923 9 -12.9 504.7469 2 50.43 5 25397 VEV_2_3_RA5_01_1236.d 8.3E5 3 3 299 307
R.SEITETSTVR.Q Y 62.52 1121.5564 10 4.0 561.7877 2 34.38 4 15419 VEV_1_3_RA4_01_1235.d 5.21E5 5 5 941 950
R.EIDSIDSKSELAHR.V Y 61.29 1598.7899 14 -7.3 533.9333 3 45.76 4 22232 VEV_1_3_RA4_01_1235.d 4.25E5 4 4 776 789
K.AQAVEPFNEDEYMQER.V Y 61.03 1954.8367 16 -2.6 978.4230 2 71.57 4 40459 VEV_1_3_RA4_01_1235.d 0 1 1 1473 1488
R.EVTGYYQTM(+15.99)YTR.Y Y 60.77 1526.6711 12 -7.5 764.3372 2 60.12 4 31578 VEV_1_3_RA4_01_1235.d 5.48E4 2 2 711 722 Oxidation (M)
K.SSQLQFTSLYREVLR.A Y 60.70 1825.9686 15 -21.4 609.6505 3 79.98 5 46037 VEV_2_3_RA5_01_1236.d 1.91E5 2 2 575 589
K.TEAEDVQM(+15.99)QQTR.Q Y 60.65 1450.6359 12 9.7 726.3322 2 22.84 6 9049 VEV_3_3_RA6_01_1237.d 3.8E4 2 2 1750 1761 Oxidation (M)
K.VVNGESSEALYK.K Y 60.17 1294.6405 12 -12.2 648.3196 2 47.40 4 23258 VEV_1_3_RA4_01_1235.d 9.58E4 3 3 963 974
K.DKSPYAEEMESK.V Y 59.80 1412.6129 12 -5.9 707.3096 2 38.49 4 17796 VEV_1_3_RA4_01_1235.d 3.23E5 5 5 1701 1712
K.GTQAIGIHPK.Y Y 57.61 1020.5716 10 -25.0 511.2803 2 27.00 4 11221 VEV_1_3_RA4_01_1235.d 3.49E5 5 5 1649 1658
R.YFHN(+.98)GLINNSLFVAK.D Y 56.73 1736.8885 15 11.3 579.9767 3 79.74 4 46817 VEV_1_3_RA4_01_1235.d 0 1 1 1686 1700 Deamidation (NQ)
K.ALKFDRFVAGQIPTGWNPK.H Y 56.61 2144.1531 19 -27.4 537.0309 4 78.25 4 45751 VEV_1_3_RA4_01_1235.d 0 2 2 1174 1192
MRPEVEQELAHTLLVELLAYQFASPVR.W Y 56.55 3138.6536 27 6.4 628.7420 5 94.64 6 53456 VEV_3_3_RA6_01_1237.d 0 1 1 1 27
R.Q(-17.03)DALSMYYDIIFGRLK.V Y 56.31 1914.9550 16 -2.1 958.4827 2 95.66 4 56602 VEV_1_3_RA4_01_1235.d 1.53E5 2 2 422 437 Pyro-glu from Q
R.Q(-17.03)DALSMYYDIIFGR.L Y 56.22 1673.7759 14 -7.8 837.8887 2 97.81 4 57485 VEV_1_3_RA4_01_1235.d 1.29E4 1 1 422 435 Pyro-glu from Q
R.QDALSMYYDIIFGRLK.V Y 54.43 1931.9814 16 13.3 645.0096 3 90.52 5 52154 VEV_2_3_RA5_01_1236.d 0 1 1 422 437
R.GFETRPAQVILPLSPNHGTFGNDGLYSESK(+14.02).L Y 53.87 3244.6152 30 -12.1 812.1513 4 79.67 4 46765 VEV_1_3_RA4_01_1235.d 6.89E4 1 1 810 839 Methylation(KR)
R.SLQTDGIKAFSVTSFGFGQK.G Y 53.22 2117.0793 20 -5.8 530.2740 4 81.58 4 48228 VEV_1_3_RA4_01_1235.d 1.41E5 3 3 1629 1648
R.AHGDKVEVFEIPDS(-2.02)SEYTVR.L Y 51.40 2275.0757 20 62.8 569.8119 4 73.27 4 41796 VEV_1_3_RA4_01_1235.d 0 1 1 1143 1162 2-amino-3-oxo-butanoic_acid
K.YILAHSGIR.L Y 50.40 1028.5767 9 -13.8 343.8614 3 49.76 4 24784 VEV_1_3_RA4_01_1235.d 1.2E6 8 8 1092 1100
R.TIASKYE(+14.02)AYDAATSVQR.Q Y 50.02 1886.9374 17 -3.4 629.9843 3 65.08 4 35341 VEV_1_3_RA4_01_1235.d 4.1E4 1 1 60 76 Methylation(others)
R.AGLSFYGK.N Y 49.30 841.4333 8 -11.1 421.7193 2 60.62 4 31949 VEV_1_3_RA4_01_1235.d 5.76E5 3 3 667 674
R.GSQLVVVPFNQGSKQDVQALVNYIYDPK.N Y 49.22 3105.6135 28 -5.5 1036.2061 3 87.17 4 51983 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 727 754
K.VMEKFDYIVYPSR.S Y 49.00 1645.8174 13 -4.4 549.6107 3 73.91 4 42284 VEV_1_3_RA4_01_1235.d 3.08E4 1 1 1616 1628
K.GKPYSGWVDAK.T Y 47.40 1206.6033 11 -14.5 604.3002 2 49.16 6 23832 VEV_3_3_RA6_01_1237.d 1.48E6 8 8 1065 1075
R.Q(-17.03)ILC(+57.02)YNKDAK.E Y 47.02 1234.6016 10 -10.1 618.3018 2 61.07 4 32284 VEV_1_3_RA4_01_1235.d 1.94E5 3 3 77 86 Pyro-glu from Q; Carbamidomethylation
K.D(+42.01)VAIPTGPQTVIDSR.G Y 46.43 1609.8311 15 -46.0 805.8857 2 81.34 4 48045 VEV_1_3_RA4_01_1235.d 0 1 1 503 517 Acetylation (N-term)
R.VMLTNIYR.L Y 45.41 1008.5426 8 -8.9 505.2741 2 67.29 4 37072 VEV_1_3_RA4_01_1235.d 1.91E5 2 2 790 797
R.AHGDKVEVFE(+14.02)IPDSSEYTVR.L Y 45.23 2291.1069 20 -3.5 573.7820 4 74.39 4 42659 VEV_1_3_RA4_01_1235.d 2.39E5 2 2 1143 1162 Methylation(others)
R.QKGN(-17.03)ALLGIFQK.Y Y 45.12 1298.7346 12 -24.1 433.9084 3 79.44 6 44758 VEV_3_3_RA6_01_1237.d 4.63E4 1 1 1566 1577 Ammonia-loss (N)
K.GAAGGFM(+15.99)FNGALQVLNSGLVPGNR.N Y 44.60 2362.1851 24 -6.4 788.3972 3 87.11 4 51944 VEV_1_3_RA4_01_1235.d 0 1 1 1585 1608 Oxidation (M)
R.TIASK(+14.02)YEAYDAATSVQR.Q Y 43.90 1886.9374 17 -10.3 629.9799 3 64.95 5 35238 VEV_2_3_RA5_01_1236.d 1.19E5 2 2 60 76 Methylation(KR)
R.ENAGKFPSPLLDIK.Y Y 42.23 1527.8296 14 -26.9 510.2701 3 74.39 6 41165 VEV_3_3_RA6_01_1237.d 4.1E5 2 2 1427 1440
K.TGEPVNDRDVK(+14.02).A Y 42.01 1242.6204 11 9.7 622.3235 2 29.84 4 12761 VEV_1_3_RA4_01_1235.d 0 1 1 1076 1086 Methylation(KR)
K.LGLETLFNR.W Y 41.52 1061.5869 9 -4.3 531.7985 2 80.40 4 47324 VEV_1_3_RA4_01_1235.d 3.77E4 1 1 840 848
R.LLKGANLLIPK.A Y 41.40 1178.7750 11 -25.2 393.9224 3 69.78 6 37683 VEV_3_3_RA6_01_1237.d 2.24E5 2 2 1163 1173
K.Q(-17.03)DVQALVNYIYDPK(+14.02).N Y 41.09 1661.8301 14 9.6 831.9303 2 91.60 4 54569 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 741 754 Pyro-glu from Q; Methylation(KR)
R.GAPSPQASFAGR(+14.02).W Y 40.18 1158.5781 12 -13.8 580.2883 2 54.69 5 28045 VEV_2_3_RA5_01_1236.d 1.89E5 2 2 1810 1821 Methylation(KR)
K.GANLLIPK.A Y 40.12 824.5120 8 -23.6 413.2535 2 61.10 6 31251 VEV_3_3_RA6_01_1237.d 1.41E5 4 4 1166 1173
K.AMAEGGPISE(+14.02)YSNR.T Y 39.63 1494.6772 14 -7.0 748.3407 2 64.43 4 34834 VEV_1_3_RA4_01_1235.d 4.98E4 1 1 539 552 Methylation(others)
K.VFLNPDIR.V Y 39.48 972.5392 8 -17.9 487.2682 2 67.82 6 36249 VEV_3_3_RA6_01_1237.d 3.51E5 2 2 1713 1720
MRPEVEQELAHTLLVELLAY(-2.02)QFASPVR.W Y 39.34 3136.6379 27 3.5 785.1695 4 94.11 5 53851 VEV_2_3_RA5_01_1236.d 1.23E5 2 2 1 27 2-amino-3-oxo-butanoic_acid
R.KLEHYVK.A Y 38.52 915.5178 7 -10.1 458.7615 2 16.57 4 5643 VEV_1_3_RA4_01_1235.d 8.05E4 1 1 532 538
K.QKTEAEDVQM(+15.99)QQTR.Q Y 37.97 1706.7893 14 -6.7 569.9332 3 18.79 4 6776 VEV_1_3_RA4_01_1235.d 1.72E4 1 1 1748 1761 Oxidation (M)
R.S(+43.01)VPAPGKGVLTTAR.E Y 37.50 1395.7833 14 -83.7 466.2294 3 53.53 4 27186 VEV_1_3_RA4_01_1235.d 1.84E5 1 1 1413 1426 Carbamylation
K.ELGQQLIENC(+57.02)K.E Y 37.47 1330.6550 11 -7.1 666.3301 2 63.99 4 34508 VEV_1_3_RA4_01_1235.d 3.19E5 1 1 482 492 Carbamidomethylation
R.ANIKFEFPKLPNWKEEIEPLNANLK.G Y 37.32 2981.6013 25 4.8 597.3304 5 82.61 6 46939 VEV_3_3_RA6_01_1237.d 0 1 1 982 1006
K.LRSEITE(+14.02)TSTVR.Q Y 36.94 1404.7572 12 -28.9 469.2462 3 50.86 5 25671 VEV_2_3_RA5_01_1236.d 0 1 1 939 950 Methylation(others)
K.GAAGGFMFNGALQVLNS(-2.02)GLVPGNR.N Y 36.54 2344.1746 24 7.2 782.4044 3 90.07 4 53735 VEV_1_3_RA4_01_1235.d 0 1 1 1585 1608 2-amino-3-oxo-butanoic_acid
K.VFLN(+.98)PDIRVELN(+.98)EMTSTLGYAGNDR.N Y 35.78 2825.3540 25 10.0 942.8013 3 87.81 4 52389 VEV_1_3_RA4_01_1235.d 2.41E5 1 1 1713 1737 Deamidation (NQ)
R.EVTGYYQTMYTR(+14.02).Y Y 35.28 1524.6919 12 -5.9 763.3488 2 68.84 4 38304 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 711 722 Methylation(KR)
K.VFLNPDIRVELNEMTSTLGYAGNDR.N Y 35.12 2823.3860 25 7.0 706.8587 4 87.79 4 52371 VEV_1_3_RA4_01_1235.d 7.53E4 1 1 1713 1737
R.QILC(+57.02)YNKDAK.E Y 35.01 1251.6282 10 -10.6 626.8148 2 35.33 5 16371 VEV_2_3_RA5_01_1236.d 2.96E4 1 1 77 86 Carbamidomethylation
R.SVPAPGK.G N 34.84 654.3701 7 -8.6 655.3717 1 14.02 4 4304 VEV_1_3_RA4_01_1235.d 7.73E4 3 3 1413 1419
R.SLQTDGIK.A Y 34.82 860.4603 8 -11.0 431.2327 2 30.58 4 13170 VEV_1_3_RA4_01_1235.d 1.05E6 6 6 1629 1636
R.TPQEM(+15.99)SRPTTTTR.S Y 34.11 1520.7253 13 -8.2 507.9116 3 16.99 4 5822 VEV_1_3_RA4_01_1235.d 1.73E5 2 2 1357 1369 Oxidation (M)
K.N(+.98)VLMTGAGAGSIGAAVLQGMISGGAK.V Y 33.93 2331.1926 26 7.7 778.0775 3 89.55 4 53413 VEV_1_3_RA4_01_1235.d 3.54E4 1 1 675 700 Deamidation (NQ)
K.QD(-18.01)VQALVNYIYDPK.N Y 33.70 1646.8303 14 -4.8 824.4185 2 91.27 4 54371 VEV_1_3_RA4_01_1235.d 1.15E4 2 2 741 754 Dehydration
K.GNALLGIFQK.Y Y 33.54 1059.6077 10 -31.7 530.7943 2 79.07 5 45431 VEV_2_3_RA5_01_1236.d 0 1 1 1568 1577
R.WGLQSGRQDGLLLLALTMEPASR.L Y 33.25 2511.3267 23 -26.0 838.0944 3 90.46 4 53905 VEV_1_3_RA4_01_1235.d 0 1 1 268 290
R.EAIRQEK(+14.02)D(-18.01)AAFSLGNNFWR.Q Y 33.09 2247.1184 19 -4.9 562.7841 4 75.66 4 43649 VEV_1_3_RA4_01_1235.d 4E4 1 1 1495 1513 Methylation(KR); Dehydration
K.SSQLQ(+.98)FTSLYR.E Y 32.73 1329.6565 11 -16.8 665.8243 2 74.81 4 42979 VEV_1_3_RA4_01_1235.d 3.28E4 1 1 575 585 Deamidation (NQ)
K.QSSSLVAR.L Y 32.65 846.4559 8 -13.0 424.2297 2 20.37 4 7587 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 238 245
K.QDVQALVNYIYDPK.N Y 32.59 1664.8409 14 -10.4 833.4191 2 82.27 5 47519 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 741 754
K.DKSPYAEEM(-48.00)ESK.V Y 32.28 1364.6095 12 -4.6 455.8750 3 13.01 4 3810 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 1701 1712 Dethiomethyl
R.GNINYSEIPRTSAR.K Y 32.12 1576.7958 14 -8.3 526.6015 3 56.76 5 29266 VEV_2_3_RA5_01_1236.d 2.55E5 2 2 518 531
R.QDALSMYYDIIFGR.L Y 32.02 1690.8025 14 -1.4 846.4073 2 92.87 6 52702 VEV_3_3_RA6_01_1237.d 2.43E4 1 1 422 435
K.ETAEEFKR.A Y 31.70 1008.4875 8 -15.6 505.2432 2 18.69 6 6896 VEV_3_3_RA6_01_1237.d 1.51E5 3 3 1135 1142
R.SLQ(+.98)TDGIKAFSVTSFGFGQK.G Y 31.49 2118.0632 20 2.3 707.0300 3 81.49 5 47026 VEV_2_3_RA5_01_1236.d 5.78E4 1 1 1629 1648 Deamidation (NQ)
K.SELAHR.V Y 31.31 711.3663 6 -24.7 712.3560 1 81.96 4 48505 VEV_1_3_RA4_01_1235.d 1.67E5 5 5 784 789
R.GAPSPQ(+.98)ASFAGR.W Y 31.18 1145.5465 12 -9.6 573.7750 2 51.98 4 26157 VEV_1_3_RA4_01_1235.d 1.69E5 2 2 1810 1821 Deamidation (NQ)
K.GVLTTAR.E Y 31.12 716.4181 7 -11.8 359.2121 2 26.72 4 11052 VEV_1_3_RA4_01_1235.d 1.56E5 1 1 1420 1426
R.VEHIKR.E Y 30.65 780.4606 6 -15.7 391.2314 2 9.81 6 2425 VEV_3_3_RA6_01_1237.d 9.82E3 2 2 1489 1494
K.AFSVTSFGFGQKGTQAIGIHPK.Y Y 29.55 2277.1904 22 -12.8 570.2976 4 76.21 4 44068 VEV_1_3_RA4_01_1235.d 6.67E4 1 1 1637 1658
R.ENAGK.F Y 29.30 517.2496 5 3.9 518.2589 1 26.99 5 11590 VEV_2_3_RA5_01_1236.d 0 1 1 1427 1431
R.T(+79.97)IASK(-.98).Y Y 28.95 597.2887 5 8.9 598.3013 1 28.50 5 12406 VEV_2_3_RA5_01_1236.d 4.94E4 1 1 60 64 Phosphorylation (STY); Amidation
K.KVITEPR.A Y 28.76 841.5021 7 -29.4 421.7460 2 17.98 6 6544 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 975 981
R.SRMN(+.98)GNINGNTRPGK(+42.01).V Y 28.62 1657.7954 15 9.2 553.6108 3 75.37 6 41811 VEV_3_3_RA6_01_1237.d 8.93E4 1 1 616 630 Deamidation (NQ); Acetylation (K)
K.VITEPR(-.98).A Y 28.61 712.4232 6 -19.3 357.2120 2 17.98 6 6497 VEV_3_3_RA6_01_1237.d 0 1 1 976 981 Amidation
R.GNINYSEIPR(+14.02).T Y 28.54 1175.5935 10 -10.6 588.7978 2 65.37 4 35569 VEV_1_3_RA4_01_1235.d 1.67E5 5 5 518 527 Methylation(KR)
R.Q(+.98)ILC(+57.02)YNK.D Y 27.66 938.4531 7 17.1 470.2419 2 43.06 4 20576 VEV_1_3_RA4_01_1235.d 0 1 1 77 83 Deamidation (NQ); Carbamidomethylation
K.VETVPFLHLR.K Y 27.41 1209.6870 10 -12.1 404.2314 3 74.94 5 42553 VEV_2_3_RA5_01_1236.d 5.04E4 1 1 631 640
R.GAPSPQ(+.98)ASFAGR(+14.02).W Y 27.39 1159.5621 12 6.5 580.7921 2 54.57 5 27940 VEV_2_3_RA5_01_1236.d 7.4E4 1 1 1810 1821 Deamidation (NQ); Methylation(KR)
K.NGLGWDLDYIVPFAAISENGR(+14.02).E Y 27.22 2320.1487 21 2.3 774.3920 3 94.39 4 56007 VEV_1_3_RA4_01_1235.d 1.38E4 1 1 755 775 Methylation(KR)
K.QD(-15.99)VQALVNYIYDPK.N Y 26.64 1648.8461 14 -28.1 825.4072 2 91.28 4 54380 VEV_1_3_RA4_01_1235.d 1.88E5 1 1 741 754 Deoxy
K.A(+42.01)TAAENSK.V Y 25.55 832.3926 8 11.9 833.4098 1 93.21 4 55459 VEV_1_3_RA4_01_1235.d 5.02E4 1 1 1770 1777 Acetylation (N-term)
K.Q(-17.03)QLELTAR.Y Y 25.31 940.4978 8 24.6 471.2678 2 67.68 4 37416 VEV_1_3_RA4_01_1235.d 0 1 1 352 359 Pyro-glu from Q
K.FDYIVYPSR.S Y 24.98 1158.5709 9 -12.0 580.2858 2 73.38 4 41886 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 1620 1628
K.DLVGGK(+15.99).S Y 24.45 603.3228 6 -24.4 604.3153 1 76.90 6 42931 VEV_3_3_RA6_01_1237.d 7.75E4 2 2 188 193 Oxidation or Hydroxylation
R.ENAGK(-1.03)FPSPLLDIKYR.R Y 24.19 1845.9624 16 -14.7 616.3190 3 73.36 5 41430 VEV_2_3_RA5_01_1236.d 0 1 1 1427 1442 Lysine oxidation to aminoadipic semialdehyde
K.SPYAEEMESK.V Y 23.87 1169.4910 10 38.5 585.7753 2 38.90 4 18049 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 1703 1712
K.DLVGGK.S Y 23.41 587.3279 6 -39.0 588.3123 1 31.53 6 13712 VEV_3_3_RA6_01_1237.d 0 1 1 188 193
K.EAVFKSLGVEGK.G Y 23.38 1262.6870 12 -8.9 316.6762 4 21.06 4 7962 VEV_1_3_RA4_01_1235.d 2E5 1 1 1826 1837
R.G(+42.01)SQLVVVPFNQGS(-18.01)K.Q Y 23.15 1482.7831 14 -24.9 495.2560 3 14.76 5 4905 VEV_2_3_RA5_01_1236.d 5.75E4 1 1 727 740 Acetylation (N-term); Dehydration
R.LVS(+79.97)SK.M Y 23.08 612.2884 5 -19.8 613.2836 1 28.40 4 11969 VEV_1_3_RA4_01_1235.d 0 1 1 246 250 Phosphorylation (STY)
K.YEKY(+31.99)ILAHSGIR.L Y 23.07 1480.7673 12 40.7 371.2142 4 49.50 5 24847 VEV_2_3_RA5_01_1236.d 4.93E5 1 1 1089 1100 Dihydroxy
K.F(+42.01)DYIVYPSR.S Y 22.84 1200.5815 9 2.7 601.2997 2 81.67 6 46322 VEV_3_3_RA6_01_1237.d 2.81E4 1 1 1620 1628 Acetylation (N-term)
K.SLGVEGKGAGAPLR.D Y 22.79 1310.7306 14 -79.3 328.6639 4 33.87 5 15491 VEV_2_3_RA5_01_1236.d 2.94E4 2 2 1831 1844
K.TE(+14.02)AEDVQMQQTR.Q Y 22.52 1448.6565 12 -6.7 725.3307 2 45.56 4 22113 VEV_1_3_RA4_01_1235.d 0 1 1 1750 1761 Methylation(others)
K.DVAIPTGPQTVIDS(+79.97)R.G Y 22.31 1647.7869 15 23.8 412.9638 4 64.59 4 34954 VEV_1_3_RA4_01_1235.d 0 1 1 503 517 Phosphorylation (STY)
R.WGLQS(-2.02)GRQDGLLLLALTMEPASR.L Y 22.07 2509.3110 23 -23.8 837.4244 3 89.68 4 53483 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 268 290 2-amino-3-oxo-butanoic_acid
R.VYDSSWNWAR(+14.02).Q Y 21.55 1296.5887 10 10.8 649.3087 2 74.89 4 43040 VEV_1_3_RA4_01_1235.d 4.58E4 1 1 412 421 Methylation(KR)
R.G(+27.99)SQLVVVPFNQGSK(+42.01).Q Y 21.46 1528.7886 14 21.5 383.2126 4 59.38 5 31094 VEV_2_3_RA5_01_1236.d 2.7E5 1 1 727 740 Formylation; Acetylation (K)
K.G(+42.01)K(+14.02)PYSGWVDAK(+42.01).T Y 21.29 1304.6400 11 -11.6 435.8822 3 35.63 4 16115 VEV_1_3_RA4_01_1235.d 2.2E5 1 1 1065 1075 Acetylation (N-term); Methylation(KR); Acetylation (K)
R.FVAGQIPTGWNPK(-.98).H Y 21.22 1412.7565 13 -16.8 354.1905 4 32.44 5 14691 VEV_2_3_RA5_01_1236.d 9.24E4 1 1 1180 1192 Amidation
K.DRFLDK(+42.01)PLQK(+27.99).D Y 21.20 1328.7087 10 9.1 333.1875 4 12.28 5 3595 VEV_2_3_RA5_01_1236.d 1.63E4 1 1 1259 1268 Acetylation (K); Formylation
K.ATAAENSK.V Y 21.14 790.3821 8 -9.8 791.3816 1 78.74 4 46047 VEV_1_3_RA4_01_1235.d 0 1 1 1770 1777
K.Y(+162.05)ILAHSGIR.L Y 21.08 1190.6295 9 2.7 397.8849 3 68.00 6 36391 VEV_3_3_RA6_01_1237.d 9.46E4 1 1 1092 1100 Hexose (NSY)
R.N(+.98)ADNIDKVMEK.F Y 21.01 1276.5969 11 26.9 639.3229 2 41.27 4 19461 VEV_1_3_RA4_01_1235.d 0 1 1 1609 1619 Deamidation (NQ)
K.VVVTT(-18.01)SR.F Y 21.00 742.4337 7 -7.9 372.2212 2 27.12 5 11660 VEV_2_3_RA5_01_1236.d 0 1 1 701 707 Dehydration
K.YVHISEVGN(+.98)C(+57.02)IGSGIGGSHALR.G Y 20.94 2283.1067 22 21.6 571.7963 4 70.09 4 39278 VEV_1_3_RA4_01_1235.d 0 1 1 1233 1254 Deamidation (NQ); Carbamidomethylation
K.NVLM(+15.99)TGAGAGS(-18.01)IGAAVLQGMISGGAK.V Y 20.93 2328.1929 26 3.7 777.0745 3 89.70 4 53491 VEV_1_3_RA4_01_1235.d 0 1 1 675 700 Oxidation (M); Dehydration
R.WGLQSGR.Q Y 20.92 802.4086 7 -12.3 803.4059 1 91.09 4 54261 VEV_1_3_RA4_01_1235.d 8.86E4 1 1 268 274
K.QKTEAEDVQMQQTRQMVESLAK.A Y 20.90 2577.2527 22 -1.7 645.3193 4 75.70 6 42058 VEV_3_3_RA6_01_1237.d 0 1 1 1748 1769
K.ETTLEN(+.98)K.V Y 20.83 834.3970 7 8.2 418.2092 2 14.51 6 4699 VEV_3_3_RA6_01_1237.d 0 1 1 956 962 Deamidation (NQ)
K.EVLHANPVY(+162.05)K.D Y 20.75 1330.6768 10 -31.5 666.3247 2 62.92 5 33725 VEV_2_3_RA5_01_1236.d 8.1E4 1 1 493 502 Hexose (NSY)
K.KEANGWEYSK.K Y 20.68 1210.5618 10 0.9 1211.5702 1 94.30 5 53930 VEV_2_3_RA5_01_1236.d 3.74E4 1 1 642 651
R.AFFKQQLE(+14.02)LTAR.Y Y 20.66 1464.8088 12 -16.4 489.2689 3 71.39 4 40311 VEV_1_3_RA4_01_1235.d 0 1 1 348 359 Methylation(others)
K.SLGVEGK(+21.98).G Y 20.59 710.3575 7 -43.8 711.3337 1 69.85 4 39102 VEV_1_3_RA4_01_1235.d 0 1 1 1831 1837 Sodium adduct
K.QQ(+.98)LELTAR.Y Y 20.54 958.5084 8 1.7 480.2623 2 49.89 4 24808 VEV_1_3_RA4_01_1235.d 0 1 1 352 359 Deamidation (NQ)
K.QSSSLVAR(+14.02).L Y 20.30 860.4716 8 -2.9 431.2418 2 68.91 4 38367 VEV_1_3_RA4_01_1235.d 0 1 1 238 245 Methylation(KR)
K.AYLDDVANK(-.98).Y Y 20.10 1006.5083 9 -14.8 504.2540 2 52.71 4 26624 VEV_1_3_RA4_01_1235.d 0 1 1 299 307 Amidation
R.QMVESLAK(+14.02).A Y 20.08 918.4844 8 -10.7 460.2446 2 64.60 4 34964 VEV_1_3_RA4_01_1235.d 2.7E5 1 1 1762 1769 Methylation(KR)
R.LLGFVK.T Y 20.03 675.4319 6 -44.7 338.7081 2 66.37 5 36298 VEV_2_3_RA5_01_1236.d 0 1 1 798 803
R.S(+13.03)EITETSTVR.Q Y 19.38 1134.5880 10 -52.7 568.2714 2 45.36 4 21982 VEV_1_3_RA4_01_1235.d 6.59E4 1 1 941 950 Michael addition with methylamine
R.ENAGK(+21.98)(+14.02).F Y 19.37 553.2472 5 -1.1 554.2538 1 53.78 6 26520 VEV_3_3_RA6_01_1237.d 4.39E4 1 1 1427 1431 Sodium adduct; Methylation(KR)
K.SLGVEGK(+42.01).G Y 19.30 730.3861 7 -29.7 731.3717 1 81.27 4 47993 VEV_1_3_RA4_01_1235.d 7.62E4 1 1 1831 1837 Acetylation (K)
K.DLVGGK(+42.01).S Y 19.27 629.3384 6 -27.8 630.3282 1 37.67 6 17156 VEV_3_3_RA6_01_1237.d 1.7E4 2 2 188 193 Acetylation (K)
K.DLVGGK(+21.98).S Y 19.22 609.3098 6 0.1 610.3171 1 67.14 6 35732 VEV_3_3_RA6_01_1237.d 3.35E4 2 2 188 193 Sodium adduct
R.IVEIGPADT(+79.97)LGGMAR.R Y 18.76 1578.7477 15 20.2 790.3971 2 83.36 5 48168 VEV_2_3_RA5_01_1236.d 0 1 1 44 58 Phosphorylation (STY)
K.VITEPR(+31.99)ANIK(+42.01).F Y 18.74 1213.6666 10 -3.7 405.5613 3 32.01 4 14010 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 976 985 Dihydroxy; Acetylation (K)
K.AK(+68.03)YEKYILAHSGIR.L Y 18.74 1715.9358 14 -49.5 572.9576 3 68.14 5 37639 VEV_2_3_RA5_01_1236.d 0 1 1 1087 1100 Crotonylation
R.ENAGK(-.98).F Y 18.73 516.2656 5 5.7 517.2758 1 106.35 4 60140 VEV_1_3_RA4_01_1235.d 0 1 1 1427 1431 Amidation
R.SVPAPGK(+43.01)GVLTTAR.E Y 18.67 1395.7833 14 -43.2 349.9380 4 32.72 6 14376 VEV_3_3_RA6_01_1237.d 6.58E4 1 1 1413 1426 Carbamylation
R.QAVM(+15.99)KETTLENK.V Y 18.55 1406.7075 12 16.6 704.3727 2 111.85 5 59334 VEV_2_3_RA5_01_1236.d 0 1 1 951 962 Oxidation (M)
R.ENAGKFPS(-2.02)PLLDIKYR.R Y 18.14 1844.9784 16 -70.1 462.2195 4 73.49 4 41968 VEV_1_3_RA4_01_1235.d 0 1 1 1427 1442 2-amino-3-oxo-butanoic_acid
K.LPNWK.E Y 18.09 656.3646 5 -58.0 657.3338 1 108.98 4 60855 VEV_1_3_RA4_01_1235.d 0 1 1 991 995
K.S(+42.01)LGVEGK(+43.01).G Y 18.07 773.3919 7 -8.5 774.3926 1 89.69 4 53484 VEV_1_3_RA4_01_1235.d 2.05E5 2 2 1831 1837 Acetylation (N-term); Carbamylation
K.GMVNLDK(+43.01).V Y 17.83 818.3956 7 -14.9 410.1990 2 15.69 6 5312 VEV_3_3_RA6_01_1237.d 0 1 1 1007 1013 Carbamylation
K.R(+42.01)TERIVEIGPADTLGGMAR.R Y 17.67 2083.0845 19 -6.6 695.3642 3 71.86 5 40358 VEV_2_3_RA5_01_1236.d 4.78E4 1 1 40 58 Acetylation (N-term)
R.TPQ(+.98)EMSRPTT(-18.01)TTR.S Y 17.56 1487.7039 13 -19.3 744.8448 2 57.00 6 28366 VEV_3_3_RA6_01_1237.d 3.77E4 1 1 1357 1369 Deamidation (NQ); Dehydration
K.EAVFK.S Y 17.53 592.3220 5 -49.2 593.3002 1 20.39 6 7762 VEV_3_3_RA6_01_1237.d 2.79E4 1 1 1826 1830
R.SRM(+15.99)NGNINGNTRPGK.V Y 17.45 1630.7958 15 -26.2 408.6956 4 34.01 4 15153 VEV_1_3_RA4_01_1235.d 2.43E5 1 1 616 630 Oxidation (M)
K.ARVYDSSWNWARQDALSM(+15.99)YYDIIFGR.L Y 17.42 3198.4980 26 -6.7 800.6265 4 85.12 5 49242 VEV_2_3_RA5_01_1236.d 3.35E4 1 1 410 435 Oxidation (M)
R.FVAGQ(+.98)IPTGWNPK.H Y 17.41 1414.7245 13 -13.7 708.3598 2 75.93 4 43862 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 1180 1192 Deamidation (NQ)
K.DLVGGK(+43.01).S Y 17.34 630.3337 6 2.7 316.1750 2 49.66 6 24114 VEV_3_3_RA6_01_1237.d 2.09E5 1 1 188 193 Carbamylation
K.FEFPK.L Y 17.33 666.3376 5 -5.6 667.3412 1 91.31 4 54399 VEV_1_3_RA4_01_1235.d 2.82E5 3 3 986 990
K.DLVGGK(+14.96).S Y 17.25 602.2911 6 21.1 603.3111 1 76.55 4 44344 VEV_1_3_RA4_01_1235.d 7.68E4 1 1 188 193 Alpha-amino adipic acid
R.WSAKEAVFK.S Y 17.20 1064.5654 9 -6.9 355.8600 3 57.62 4 29773 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 1822 1830
R.V(+42.01)MLTN(+.98)IYR.L Y 17.13 1051.5372 8 15.6 351.5251 3 32.62 4 14352 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 790 797 Acetylation (N-term); Deamidation (NQ)
R.ENAGK(+42.02).F Y 17.10 559.2714 5 -2.9 560.2771 1 14.61 6 4753 VEV_3_3_RA6_01_1237.d 0 1 1 1427 1431 Guanidination
K.GK(+27.99)PYSGWVDAK.T Y 17.08 1234.5981 11 -25.8 618.2904 2 61.57 4 32688 VEV_1_3_RA4_01_1235.d 4.54E4 1 1 1065 1075 Formylation
R.ENAGK(+42.01).F Y 17.06 559.2602 5 -0.2 560.2673 1 32.53 5 14734 VEV_2_3_RA5_01_1236.d 4.57E4 1 1 1427 1431 Acetylation (K)
K.YLTGHPK.G Y 17.02 814.4337 7 -17.2 408.2171 2 14.16 6 4504 VEV_3_3_RA6_01_1237.d 3.52E5 1 1 1578 1584
K.S(+79.97)LGVEGKGAGAPLR(+14.02).D Y 16.98 1404.7125 14 23.7 352.1937 4 38.54 4 17835 VEV_1_3_RA4_01_1235.d 0 1 1 1831 1844 Phosphorylation (STY); Methylation(KR)
R.VM(+15.99)LTNIYR.L Y 16.97 1024.5376 8 -16.6 513.2676 2 63.16 6 32754 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 790 797 Oxidation (M)
K.ETTLENK(-1.03)VVNGESSEALYK.K Y 16.90 2109.0112 19 17.4 704.0233 3 65.99 4 36056 VEV_1_3_RA4_01_1235.d 0 1 1 956 974 Lysine oxidation to aminoadipic semialdehyde
K.V(+226.08)FLNPDIR(+14.02).V Y 16.76 1212.6324 8 -26.7 304.1573 4 10.41 5 2685 VEV_2_3_RA5_01_1236.d 4.88E4 1 1 1713 1720 Biotinylation; Methylation(KR)
K.YLETR.W Y 16.74 680.3493 5 -49.4 681.3229 1 57.55 6 28728 VEV_3_3_RA6_01_1237.d 2.15E4 1 1 263 267
R.TPQ(+.98)EMSRPTTTT(-18.01)R.S Y 16.71 1487.7039 13 -12.4 744.8500 2 56.93 5 29377 VEV_2_3_RA5_01_1236.d 7.54E4 1 1 1357 1369 Deamidation (NQ); Dehydration
R.TKVQNDLR.S Y 16.71 972.5352 8 -20.3 487.2650 2 15.71 4 5158 VEV_1_3_RA4_01_1235.d 2.61E5 2 2 553 560
R.E(+43.99)AIRQEK.D Y 16.68 916.4614 7 -11.9 917.4578 1 96.04 4 56766 VEV_1_3_RA4_01_1235.d 2.23E5 1 1 1495 1501 Carboxylation (E)
R.A(+42.01)GLSFYGK(+43.01).N Y 16.68 926.4498 8 4.4 927.4611 1 81.60 4 48240 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 667 674 Acetylation (N-term); Carbamylation
K.QD(-18.01)VQALVNYIYDPK(+14.02).N Y 16.55 1660.8461 14 -7.8 831.4238 2 92.03 4 54797 VEV_1_3_RA4_01_1235.d 0 1 1 741 754 Dehydration; Methylation(KR)
K.SLGVEGKGAGAPLR(+31.99).D Y 16.42 1342.7205 14 -17.9 336.6814 4 53.62 6 26428 VEV_3_3_RA6_01_1237.d 0 1 1 1831 1844 Dihydroxy
R.EIDSIDSK(+14.02).S Y 16.39 919.4498 8 5.9 460.7349 2 38.12 4 17581 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 776 783 Methylation(KR)
R.Q(-17.03)LELR.K Y 16.29 640.3544 5 -23.0 321.1771 2 53.04 4 26832 VEV_1_3_RA4_01_1235.d 8.36E4 1 1 1445 1449 Pyro-glu from Q
R.AHGD(-18.01)K.V Y 16.26 508.2394 5 18.3 509.2560 1 37.31 4 17110 VEV_1_3_RA4_01_1235.d 0 1 1 1143 1147 Dehydration
K.AFSVTSFGFGQK(+14.02).G Y 16.22 1288.6451 12 -17.2 645.3188 2 78.51 4 45876 VEV_1_3_RA4_01_1235.d 6.19E4 1 1 1637 1648 Methylation(KR)
K.Y(-2.02)ILAHSGIR.L Y 16.12 1026.5610 9 -23.6 343.1862 3 49.74 6 24159 VEV_3_3_RA6_01_1237.d 4.88E4 1 1 1092 1100 2-amino-3-oxo-butanoic_acid
R.L(+42.01)GSEADAK(+42.01).A Y 16.08 873.4080 8 12.3 874.4260 1 93.19 6 52845 VEV_3_3_RA6_01_1237.d 6.38E4 1 1 291 298 Acetylation (N-term); Acetylation (K)
R.NGNGNGRNNKQK(+42.01).T Y 15.97 1341.6498 12 -14.9 671.8221 2 59.41 5 31119 VEV_2_3_RA5_01_1236.d 0 1 1 1738 1749 Acetylation (K)
R.G(+43.01)APSPQASFAGR.W Y 15.95 1187.5682 12 -30.4 594.7733 2 13.44 4 4061 VEV_1_3_RA4_01_1235.d 4.87E4 1 1 1810 1821 Carbamylation
K.FDR(+14.02)FVAGQIPTGWNPK.H Y 15.94 1845.9525 16 -15.8 616.3151 3 73.55 4 42013 VEV_1_3_RA4_01_1235.d 0 1 1 1177 1192 Methylation(KR)
K.G(+42.01)MVNLD(-18.01)K.V Y 15.88 799.3898 7 -23.7 800.3782 1 79.54 5 45749 VEV_2_3_RA5_01_1236.d 2.68E4 1 1 1007 1013 Acetylation (N-term); Dehydration
R.QAVMK(+42.01)ETTLENK(+226.08).V Y 15.86 1658.8008 12 5.9 830.4126 2 71.87 5 40361 VEV_2_3_RA5_01_1236.d 6.15E4 1 1 951 962 Acetylation (K); Biotinylation
R.N(+42.01)ADN(+.98)IDK.V Y 15.62 831.3610 7 34.6 832.3971 1 84.54 6 48174 VEV_3_3_RA6_01_1237.d 0 1 1 1609 1615 Acetylation (N-term); Deamidation (NQ)
K.GVLTTAREN(+.98)AGK.F Y 15.60 1216.6411 12 -7.9 609.3230 2 39.00 4 18102 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 1420 1431 Deamidation (NQ)
K.A(+56.06)MAEGGPISEYSNR.T Y 15.60 1536.7242 14 36.3 513.2673 3 37.68 4 17319 VEV_1_3_RA4_01_1235.d 2.79E5 1 1 539 552 Diethylation
K.EAVFKSLGVEGK(+43.01).G Y 15.55 1305.6929 12 -10.7 436.2336 3 50.97 6 24853 VEV_3_3_RA6_01_1237.d 2.82E4 1 1 1826 1837 Carbamylation
K.GAGAPLR.D Y 15.51 640.3656 7 -32.1 321.1798 2 52.40 6 25703 VEV_3_3_RA6_01_1237.d 3.63E4 1 1 1838 1844
K.LTGIYLDVLES(+79.97)AAR.A Y 15.44 1599.7909 14 -9.6 800.8951 2 89.76 5 51758 VEV_2_3_RA5_01_1236.d 2.04E5 1 1 653 666 Phosphorylation (STY)
R.GAPS(-18.01)PQASFAGR.W Y 15.41 1126.5519 12 -6.6 564.2795 2 57.95 6 29013 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 1810 1821 Dehydration
K.EVLHANPVY(-18.01)K(+14.02).D Y 15.39 1164.6292 10 -33.5 389.2040 3 55.89 6 27660 VEV_3_3_RA6_01_1237.d 1.67E5 1 1 493 502 Dehydration; Methylation(KR)
K.G(+42.01)SRNVSRSRMNGNINGNTRPGK(+42.01).V Y 15.37 2455.2209 22 -12.4 614.8049 4 74.55 4 42788 VEV_1_3_RA4_01_1235.d 0 1 1 609 630 Acetylation (N-term); Acetylation (K)
K.LR(+14.02)SEITETS(+79.97)TVR.Q Y 15.36 1484.7235 12 -1.4 372.1876 4 43.38 5 21137 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 939 950 Methylation(KR); Phosphorylation (STY)
K.G(+42.01)VLTTARENAGK.F Y 15.34 1257.6677 12 -15.2 420.2235 3 8.96 4 2128 VEV_1_3_RA4_01_1235.d 6.95E3 1 1 1420 1431 Acetylation (N-term)
R.WGLQSGR(+39.99).Q Y 15.25 842.4035 7 31.1 843.4370 1 73.93 4 42306 VEV_1_3_RA4_01_1235.d 4.26E4 1 1 268 274 Glyoxal-derived hydroimiadazolone
R.FVAGQIPTGWNPK(+21.98).H Y 15.15 1435.7224 13 23.0 479.5924 3 50.46 5 25421 VEV_2_3_RA5_01_1236.d 1.95E5 1 1 1180 1192 Sodium adduct
R.FSREVTGYYQTM(+15.99)YTR.Y Y 15.14 1916.8727 15 -78.0 480.1881 4 9.86 4 2412 VEV_1_3_RA4_01_1235.d 0 1 1 708 722 Oxidation (M)
K.Q(+.98)QLELT(+79.97)AR.Y Y 15.13 1038.4746 8 -2.0 520.2435 2 30.74 6 13270 VEV_3_3_RA6_01_1237.d 0 1 1 352 359 Deamidation (NQ); Phosphorylation (STY)
R.AFFK(+14.02)QQLELTARY(+79.97)LK.R Y 15.13 1949.0176 15 -25.4 650.6633 3 84.28 5 48740 VEV_2_3_RA5_01_1236.d 0 1 1 348 362 Methylation(KR); Phosphorylation (STY)
K.GAGAP(+31.99)LR.D Y 15.13 672.3555 7 -0.8 337.1848 2 23.24 6 9265 VEV_3_3_RA6_01_1237.d 0 1 1 1838 1844 Dihydroxy
R.YGAR(+14.02)GSQLVVVPFNQGSK(+226.08).Q Y 15.09 2146.0994 18 7.3 430.2303 5 12.27 5 3589 VEV_2_3_RA5_01_1236.d 4.13E4 1 1 723 740 Methylation(KR); Biotinylation
K.C(+44.03)KVEAR.Q Y 15.06 748.3901 6 -20.2 375.1948 2 19.76 4 7273 VEV_1_3_RA4_01_1235.d 0 1 1 1674 1679 Ethanolation (C)
K.EAVFK(+14.02)S(+79.97)LGVEGKGAGAPLR.D Y 15.03 1979.0240 19 -3.9 495.7614 4 54.52 4 27769 VEV_1_3_RA4_01_1235.d 7.45E4 1 1 1826 1844 Methylation(KR); Phosphorylation (STY)
total 249 peptides
C1G9P8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AFLSDDGIPQPAEFFLSSDPSAIVEHTKK.V Y 144.63 3145.5608 29 -4.6 787.3939 4 86.32 4 51475 VEV_1_3_RA4_01_1235.d 1.63E6 7 7 256 284
K.MKVDFVDVEFSEDGALPAER.A Y 138.99 2253.0623 20 -14.2 752.0174 3 81.25 6 46035 VEV_3_3_RA6_01_1237.d 7.29E5 6 6 207 226
R.GRPIVIC(+57.02)NTGDEEFPASETER.I Y 135.98 2376.1016 21 -2.5 793.0392 3 67.36 4 37181 VEV_1_3_RA4_01_1235.d 6.56E5 5 5 616 636 Carbamidomethylation
R.GVFEELTEIPIAVELASDFLDR.Q Y 131.80 2462.2581 22 -2.9 1232.1327 2 97.87 5 55316 VEV_2_3_RA5_01_1236.d 3.82E5 5 5 398 419
K.TFDSHAGIAHTR.W Y 129.23 1311.6320 12 -13.9 656.8141 2 28.89 6 12267 VEV_3_3_RA6_01_1237.d 5.4E6 20 20 76 87
K.GFRFETETDTEC(+57.02)IAK.L Y 127.71 1802.8145 15 -12.6 601.9379 3 66.37 6 35157 VEV_3_3_RA6_01_1237.d 7.09E5 6 6 132 146 Carbamidomethylation
K.HGVLALVDENLPIIMILTR.D Y 119.97 2116.2078 19 -13.6 706.4003 3 95.37 6 53741 VEV_3_3_RA6_01_1237.d 5.08E5 4 4 579 597
R.AFLSDDGIPQPAEFFLSSDPSAIVEHTK.K Y 115.07 3017.4658 28 -7.7 1006.8215 3 89.10 6 50846 VEV_3_3_RA6_01_1237.d 5.46E5 3 3 256 283
K.AVVKELQGAFGLLLK.S Y 113.21 1584.9602 15 -7.6 529.3233 3 83.69 4 49689 VEV_1_3_RA4_01_1235.d 3.32E5 5 5 166 180
K.AYTSQFVAMIMFALSLSEDR.A Y 112.95 2279.0967 20 -0.6 1140.5549 2 97.78 4 57475 VEV_1_3_RA4_01_1235.d 0 1 1 489 508
R.SYILQTLVNGLSR.L Y 112.53 1462.8143 13 -14.6 732.4037 2 85.79 6 48953 VEV_3_3_RA6_01_1237.d 1.98E5 5 5 17 29
K.SATSLLAPPDKSLLHR.S Y 112.51 1704.9523 16 -12.7 569.3175 3 68.18 5 37676 VEV_2_3_RA5_01_1236.d 2.88E6 8 8 236 251
K.YLYDQHPDIDFTVLAKAVVKELQGAFGLLLK.S Y 110.09 3503.9067 31 -4.5 701.7855 5 97.71 4 57441 VEV_1_3_RA4_01_1235.d 6.24E4 2 2 150 180
K.VLYLEDDDIAHIHEGQLNIHR.L Y 109.32 2499.2505 21 -12.4 625.8121 4 74.29 5 42094 VEV_2_3_RA5_01_1236.d 1.84E6 9 9 285 305
K.EIFEQPESVVNTMR.G Y 104.51 1677.8032 14 -8.6 839.9017 2 76.46 4 44292 VEV_1_3_RA4_01_1235.d 4.82E5 3 3 340 353
K.YLYDQHPDIDFTVLAK.A Y 103.38 1936.9570 16 -9.8 969.4763 2 80.63 4 47560 VEV_1_3_RA4_01_1235.d 3.39E5 5 5 150 165
K.SVHYPHEVIAAR.K Y 101.73 1377.7153 12 -22.8 460.2353 3 45.48 6 21677 VEV_3_3_RA6_01_1237.d 2.99E6 19 19 181 192
K.VDFVDVEFSEDGALPAER.A Y 101.43 1993.9268 18 -5.1 997.9656 2 82.74 4 49044 VEV_1_3_RA4_01_1235.d 2.89E5 3 3 209 226
K.SLNAYQQVIAR.R Y 100.58 1261.6779 11 -10.6 631.8395 2 66.26 4 36290 VEV_1_3_RA4_01_1235.d 1.3E6 6 6 604 614
R.AIQTIELELQEIMKGTFDHFMQK.E Y 98.32 2749.3818 23 -6.2 688.3484 4 93.46 5 53558 VEV_2_3_RA5_01_1236.d 2.45E5 3 3 317 339
R.AIQTIELELQEIMK.G Y 97.34 1657.8960 14 -8.0 829.9486 2 87.97 4 52483 VEV_1_3_RA4_01_1235.d 1.69E5 2 2 317 330
K.M(+15.99)KVDFVDVEFSEDGALPAER.A Y 96.43 2269.0571 20 -6.5 757.3547 3 78.81 6 44303 VEV_3_3_RA6_01_1237.d 5.94E4 2 2 207 226 Oxidation (M)
R.IEVPQTVDC(+57.02)LQGLLNVIPLQLIAYWLAVAEGLNVDFPR.N Y 96.25 4276.2969 38 -1.1 1426.4380 3 98.28 4 57633 VEV_1_3_RA4_01_1235.d 7.55E4 1 1 637 674 Carbamidomethylation
K.LKDLIDSSKLDLSK.T Y 92.10 1573.8926 14 -13.4 787.9431 2 67.92 5 37470 VEV_2_3_RA5_01_1236.d 1.69E6 9 9 62 75
R.QAPVFRDDTC(+57.02)VFVSQSGETADSLMALR.Y Y 90.25 2999.4116 27 -6.5 1000.8047 3 82.80 4 49087 VEV_1_3_RA4_01_1235.d 8.06E4 2 2 420 446 Carbamidomethylation
R.LTKHDGTSNVR.A Y 87.79 1226.6367 11 -6.0 614.3220 2 11.22 4 2954 VEV_1_3_RA4_01_1235.d 4.33E5 6 6 306 316
R.Q(-17.03)APVFRDDTC(+57.02)VFVSQSGETADSLMALR.Y Y 80.35 2982.3850 27 -6.6 995.1290 3 87.53 5 50594 VEV_2_3_RA5_01_1236.d 6.75E4 1 1 420 446 Pyro-glu from Q; Carbamidomethylation
R.GALTVGIVNVVGSSISLLTHC(+57.02)GVHINAGPEIGVASTK.A Y 77.76 3626.9453 37 -13.0 907.7318 4 92.74 6 52654 VEV_3_3_RA6_01_1237.d 4.26E5 5 5 452 488 Carbamidomethylation
R.GYDSAGLAVDGDKKNEVFAFK.E Y 76.92 2230.0906 21 -1.6 744.3696 3 71.33 5 39972 VEV_2_3_RA5_01_1236.d 4.69E5 4 4 34 54
R.INC(+57.02)HPHR.S Y 76.12 932.4399 7 -13.4 467.2210 2 9.76 5 2419 VEV_2_3_RA5_01_1236.d 5.79E5 7 7 97 103 Carbamidomethylation
K.VSDQFKQILK.L Y 75.19 1204.6815 10 -12.8 603.3403 2 60.58 5 32007 VEV_2_3_RA5_01_1236.d 1.24E6 5 5 525 534
R.KGSPLVVGVR.T Y 74.06 1010.6237 10 -29.1 506.3044 2 44.90 5 22073 VEV_2_3_RA5_01_1236.d 1.25E6 11 11 193 202
K.SATSLLAPPDK.S Y 73.95 1098.5920 11 -16.7 550.2941 2 61.18 6 31292 VEV_3_3_RA6_01_1237.d 1.01E6 4 4 236 246
R.FETETDTEC(+57.02)IAK.L Y 71.00 1442.6235 12 -8.2 722.3131 2 56.04 6 27754 VEV_3_3_RA6_01_1237.d 2.15E5 3 3 135 146 Carbamidomethylation
R.WATHGTPSR.I Y 69.40 1011.4886 9 -11.5 506.7458 2 20.36 5 7940 VEV_2_3_RA5_01_1236.d 1.97E6 6 6 88 96
R.GYDSAGLAVDGDKK.N Y 68.73 1394.6677 14 -15.3 698.3304 2 43.01 6 20243 VEV_3_3_RA6_01_1237.d 6.42E5 6 6 34 47
R.GYDSAGLAVDGDKKNEVFAFKEVGK.V Y 68.44 2643.3179 25 -7.2 661.8320 4 70.16 6 37977 VEV_3_3_RA6_01_1237.d 7.71E4 1 1 34 58
K.SLNAYQQVIARR.G Y 68.41 1417.7789 12 -13.8 473.5937 3 62.22 5 33205 VEV_2_3_RA5_01_1236.d 5.39E5 5 5 604 615
R.GVFEE(+14.02)LTEIPIAVELASDFLDR.Q Y 61.82 2476.2737 22 -5.1 1239.1378 2 97.98 4 57542 VEV_1_3_RA4_01_1235.d 5.49E4 1 1 398 419 Methylation(others)
K.GFRFETETDT(+14.02)EC(+57.02)IAK.L Y 60.33 1816.8301 15 -16.9 606.6071 3 69.32 6 37355 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 132 146 Methylation(others); Carbamidomethylation
K.GFRFETETDTE(+14.02)C(+57.02)IAK.L Y 59.91 1816.8301 15 -8.9 606.6119 3 69.58 4 38887 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 132 146 Methylation(others); Carbamidomethylation
K.SLNAYQQVIAR(+14.02).R Y 59.51 1275.6935 11 -15.2 638.8443 2 69.22 4 38604 VEV_1_3_RA4_01_1235.d 8.77E4 3 3 604 614 Methylation(KR)
K.DLIDSSKLDLSK.T Y 58.50 1332.7136 12 -10.8 445.2404 3 70.70 4 39760 VEV_1_3_RA4_01_1235.d 1.85E5 1 1 64 75
K.KMKVDFVDVEFSEDGALPAER.A Y 57.84 2381.1572 21 7.9 596.3013 4 78.04 5 44737 VEV_2_3_RA5_01_1236.d 0 4 4 206 226
R.GVFEELTEIPIAVE(+14.02)LASDFLDR.Q Y 56.72 2476.2737 22 -2.3 826.4299 3 97.93 4 57526 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 398 419 Methylation(others)
K.LSEPIKEMC(+57.02)AK.F Y 56.46 1304.6469 11 -16.5 653.3199 2 49.89 4 24806 VEV_1_3_RA4_01_1235.d 1.23E6 6 6 535 545 Carbamidomethylation
R.GVFEELTEIPIAVELASDFLDR(+14.02).Q Y 56.39 2476.2737 22 -2.3 1239.1412 2 97.95 5 55340 VEV_2_3_RA5_01_1236.d 5.26E4 1 1 398 419 Methylation(KR)
R.SDPNWEFSVVHNGIITNYRELK.A Y 54.21 2617.2925 22 -16.7 655.3195 4 79.46 6 44774 VEV_3_3_RA6_01_1237.d 5.15E5 4 4 104 125
K.EIFEQPESVVNTM(+15.99)R.G Y 52.65 1693.7981 14 -6.3 847.9010 2 70.34 4 39479 VEV_1_3_RA4_01_1235.d 5.79E4 1 1 340 353 Oxidation (M)
K.GFRFETE(+14.02)TDTEC(+57.02)IAK.L Y 48.85 1816.8301 15 -5.6 606.6139 3 69.82 4 39071 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 132 146 Methylation(others); Carbamidomethylation
K.LSEPIKEM(+15.99)C(+57.02)AK.F Y 46.77 1320.6417 11 -8.1 661.3228 2 31.62 4 13797 VEV_1_3_RA4_01_1235.d 7.58E4 2 2 535 545 Oxidation (M); Carbamidomethylation
K.VLY(-2.02)LEDDDIAHIHEGQLNIHR.L Y 46.62 2497.2349 21 3.7 625.3183 4 74.29 5 42091 VEV_2_3_RA5_01_1236.d 3.13E5 3 3 285 305 2-amino-3-oxo-butanoic_acid
K.LK(+40.03)DLIDSSKLDLSK.T Y 46.56 1613.9240 14 -42.5 404.4711 4 68.05 4 37683 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 62 75 Propionaldehyde +40
K.MKVDFVDVEFSE(+6.01)DGALPAER.A Y 45.33 2259.0706 20 8.1 754.0369 3 81.31 6 46069 VEV_3_3_RA6_01_1237.d 0 1 1 207 226 Replacement of proton by lithium
R.Q(-17.03)APVFRDDTC(+57.02)VFVSQ(+.98)SGETADSLMALR.Y Y 43.39 2983.3691 27 17.3 995.4808 3 87.61 4 52257 VEV_1_3_RA4_01_1235.d 0 1 1 420 446 Pyro-glu from Q; Carbamidomethylation; Deamidation (NQ)
R.GRLDVANKK.V Y 43.08 999.5825 9 -9.0 500.7940 2 13.84 5 4414 VEV_2_3_RA5_01_1236.d 2.92E5 4 4 354 362
K.KVLYLEDDDIAHIHEGQLNIHR.L Y 42.36 2627.3455 22 -0.2 657.8435 4 71.11 5 39802 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 284 305
K.MKVDFVDVEFS(-2.02)EDGALPAER.A Y 42.19 2251.0466 20 9.3 751.3631 3 81.40 6 46134 VEV_3_3_RA6_01_1237.d 7.64E4 2 2 207 226 2-amino-3-oxo-butanoic_acid
R.AFLSDDGIPQPAEFFLSSDPSAIVEHTK(+14.02)K.V Y 38.35 3159.5764 29 2.6 790.9034 4 86.86 4 51789 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 256 284 Methylation(KR)
K.ALLESK.G N 36.80 659.3854 6 -26.2 660.3754 1 23.46 5 9594 VEV_2_3_RA5_01_1236.d 2.08E4 1 1 126 131
R.REDIMDGLSK.V Y 35.28 1162.5652 10 -9.4 582.2844 2 54.56 4 27789 VEV_1_3_RA4_01_1235.d 0 2 2 515 524
K.VTLGGLR.Q Y 34.57 714.4388 7 -22.8 358.2185 2 50.68 6 24680 VEV_3_3_RA6_01_1237.d 1.07E6 6 6 363 369
K.AVVK(+14.02)ELQGAFGLLLK.S Y 33.92 1598.9760 15 38.6 534.0198 3 85.40 4 50858 VEV_1_3_RA4_01_1235.d 0 1 1 166 180 Methylation(KR)
R.YC(+57.02)LER.G N 32.09 739.3323 5 -17.7 370.6669 2 28.92 6 12287 VEV_3_3_RA6_01_1237.d 7.48E5 4 4 447 451 Carbamidomethylation
R.GYDSAGLAVDGDK(+14.02).K Y 31.48 1280.5884 13 20.9 641.3148 2 61.39 4 32528 VEV_1_3_RA4_01_1235.d 0 1 1 34 46 Methylation(KR)
K.KSATSLLAPPDKSLLHR.S Y 31.20 1833.0471 17 -54.3 367.5968 5 63.94 6 33322 VEV_3_3_RA6_01_1237.d 0 1 1 235 251
K.RREDIMDGLSK.V Y 30.81 1318.6663 11 -13.4 440.5568 3 46.07 5 22773 VEV_2_3_RA5_01_1236.d 3.45E5 3 3 514 524
K.LKDLIDSSKLDLSK(+14.02).T Y 30.63 1587.9083 14 -8.4 397.9810 4 70.33 4 39467 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 62 75 Methylation(KR)
K.VTLGGLRQYITTIRR.C Y 30.29 1746.0264 15 -17.9 437.5060 4 75.65 5 43066 VEV_2_3_RA5_01_1236.d 4.72E4 2 2 363 377
R.SDPNWEFSVVHNGIITNYR.E Y 30.19 2247.0708 19 -4.6 750.0275 3 80.09 4 47088 VEV_1_3_RA4_01_1235.d 1.51E5 2 2 104 122
K.FFKNQK.S Y 29.55 810.4388 6 -17.0 406.2198 2 14.21 6 4562 VEV_3_3_RA6_01_1237.d 7.85E4 1 1 546 551
K.S(-2.02)LNAYQQVIAR.R Y 29.31 1259.6622 11 -32.3 630.8181 2 66.85 4 36729 VEV_1_3_RA4_01_1235.d 6.74E4 1 1 604 614 2-amino-3-oxo-butanoic_acid
K.GSPLVVGVR.T Y 28.33 882.5287 9 -5.5 442.2692 2 59.47 4 31090 VEV_1_3_RA4_01_1235.d 0 1 1 194 202
R.ASQ(+.98)NAAIK(+43.01).K Y 28.03 845.4243 8 -3.3 846.4287 1 86.10 6 49133 VEV_3_3_RA6_01_1237.d 0 1 1 227 234 Deamidation (NQ); Carbamylation
K.SVHYPHEVIAAR(+.98).K Y 28.00 1378.6993 12 -4.5 345.6806 4 45.57 6 21733 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 181 192 Deamidation (R)
K.SATSLLAPPDK(+14.02).S Y 27.78 1112.6077 11 2.9 557.3127 2 64.87 6 34017 VEV_3_3_RA6_01_1237.d 5.86E5 3 3 236 246 Methylation(KR)
K.GFRFETETDT(-2.02)EC(+57.02)IAK.L Y 26.37 1800.7988 15 39.5 601.2972 3 66.85 4 36726 VEV_1_3_RA4_01_1235.d 3.1E4 1 1 132 146 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.GR(+31.99)LDVANK.K Y 25.49 903.4774 8 -24.1 904.4629 1 88.53 4 52834 VEV_1_3_RA4_01_1235.d 0 1 1 354 361 Dihydroxy
R.DGIFK.K Y 24.42 578.3064 5 -39.6 579.2908 1 36.85 6 16686 VEV_3_3_RA6_01_1237.d 0 1 1 598 602
R.QYITTIR(+21.98).R Y 24.09 915.4790 7 -6.0 306.1651 3 31.94 5 14384 VEV_2_3_RA5_01_1236.d 0 1 1 370 376 Sodium adduct
K.S(-18.01)ATSLLAPPDK(+14.02)SLLHR.S Y 24.00 1700.9573 16 -27.9 426.2347 4 68.44 4 37986 VEV_1_3_RA4_01_1235.d 5.05E4 1 1 236 251 Dehydration; Methylation(KR)
K.LDLSKTFDSHAGIAHTR(-.98).W Y 23.60 1866.9700 17 -14.0 934.4792 2 92.25 4 54909 VEV_1_3_RA4_01_1235.d 0 1 1 71 87 Amidation
K.VSDQFK.Q Y 23.45 722.3599 6 -8.7 362.1841 2 19.13 4 6959 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 525 530
K.SLLHR.S Y 23.34 624.3707 5 -24.1 313.1851 2 19.43 6 7264 VEV_3_3_RA6_01_1237.d 3.78E5 3 3 247 251
K.L(+42.01)DLSK(+14.02).T Y 23.31 630.3588 5 4.2 631.3688 1 15.62 5 5374 VEV_2_3_RA5_01_1236.d 1.2E4 1 1 71 75 Acetylation (N-term); Methylation(KR)
K.S(+27.99)ATSLLAPPDK.S Y 22.93 1126.5869 11 -13.9 1127.5785 1 89.17 4 53202 VEV_1_3_RA4_01_1235.d 3.58E5 2 2 236 246 Formylation
R.REDIMDGLSKVSD(-18.01)Q(+.98)FK.Q Y 21.93 1849.8879 16 -7.4 463.4758 4 38.10 4 17630 VEV_1_3_RA4_01_1235.d 6.15E5 1 1 515 530 Dehydration; Deamidation (NQ)
K.EIFEQPESVVN(+.98)TMRGR(+14.02).L Y 21.75 1905.9254 16 -21.8 636.3019 3 52.00 6 25472 VEV_3_3_RA6_01_1237.d 5.45E4 1 1 340 355 Deamidation (NQ); Methylation(KR)
K.S(+42.01)LNAYQ(+.98)QVIAR.R Y 21.38 1304.6725 11 15.1 435.9047 3 62.21 4 33154 VEV_1_3_RA4_01_1235.d 2.69E5 1 1 604 614 Acetylation (N-term); Deamidation (NQ)
K.SATSLLAPPD(+14.02)K.S Y 21.20 1112.6077 11 -3.3 557.3093 2 65.04 4 35305 VEV_1_3_RA4_01_1235.d 6.46E4 1 1 236 246 Methylation(others)
K.KVLY(-2.02)LEDDDIAHIHEGQLNIHR.L Y 21.16 2625.3298 22 2.8 526.0747 5 71.15 5 39840 VEV_2_3_RA5_01_1236.d 0 1 1 284 305 2-amino-3-oxo-butanoic_acid
R.SY(-2.02)ILQTLVNGLSR.L Y 20.74 1460.7987 13 -45.9 731.3731 2 86.01 6 49076 VEV_3_3_RA6_01_1237.d 2.21E5 1 1 17 29 2-amino-3-oxo-butanoic_acid
K.S(+88.00)ATSLLAPPDKSLLHR.S Y 20.73 1792.9504 16 -30.3 449.2313 4 68.48 4 38024 VEV_1_3_RA4_01_1235.d 0 1 1 236 251 3-sulfanylpropanoyl
K.EIFE(+14.02)QPESVVNTMR.G Y 20.55 1691.8188 14 0.1 846.9167 2 78.05 4 45518 VEV_1_3_RA4_01_1235.d 1.46E4 1 1 340 353 Methylation(others)
R.GVFEELTEIPIAVELASDFLDR(-.98)(+14.02).Q Y 19.87 2475.2896 22 -15.0 1238.6335 2 97.91 4 57518 VEV_1_3_RA4_01_1235.d 8.27E4 1 1 398 419 Amidation; Methylation(KR)
K.SAT(+126.10)SLLAPPDKSLLHR.S Y 19.85 1831.0566 16 -10.9 367.2146 5 63.87 5 34440 VEV_2_3_RA5_01_1236.d 0 1 1 236 251 Octanoyl
R.W(+42.01)(+15.99)ATHGTPSR.I Y 19.66 1069.4941 9 -36.1 535.7350 2 30.44 4 13096 VEV_1_3_RA4_01_1235.d 3.94E4 1 1 88 96 Acetylation (N-term); Oxidation (HW)
K.TFDSHAGIAHTR(+.98).W Y 19.44 1312.6160 12 -0.8 438.5456 3 28.82 6 12232 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 76 87 Deamidation (R)
K.S(+42.01)ATSLLAPPDK(+42.01).S Y 19.32 1182.6132 11 7.3 395.2145 3 38.89 4 18073 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 236 246 Acetylation (N-term); Acetylation (K)
K.T(+41.03)FDSHAGIAHTR.W Y 19.31 1352.6586 12 23.9 339.1800 4 29.01 5 12693 VEV_2_3_RA5_01_1236.d 0 1 1 76 87 Amidination of lysines or N-terminal amines with methyl acetimidate
K.KSAT(+79.97)SLLAPPDK(+42.01).S Y 18.96 1348.6639 12 5.8 338.1752 4 18.94 4 6857 VEV_1_3_RA4_01_1235.d 8.25E4 1 1 235 246 Phosphorylation (STY); Acetylation (K)
R.LEYRGYDSAGLAVDGDK.K Y 18.86 1827.8639 17 15.7 610.3048 3 65.85 4 35944 VEV_1_3_RA4_01_1235.d 0 1 1 30 46
R.ASQNAAIK.K Y 18.72 801.4344 8 -46.3 401.7059 2 67.13 6 35729 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 227 234
R.L(+27.99)TKHDGTSNVR.A Y 18.72 1254.6316 11 -14.2 419.2119 3 58.64 6 29469 VEV_3_3_RA6_01_1237.d 3.69E5 1 1 306 316 Formylation
K.SATSLLAPPDK(+14.02)SLLHR.S Y 18.72 1718.9679 16 -18.7 430.7412 4 70.43 6 38177 VEV_3_3_RA6_01_1237.d 4.74E4 1 1 236 251 Methylation(KR)
R.AIQTIELELQEIMK(+21.98).G Y 18.40 1679.8779 14 -8.0 840.9395 2 88.14 4 52622 VEV_1_3_RA4_01_1235.d 4.21E4 1 1 317 330 Sodium adduct
K.SVT(-18.01)VE Y 18.39 515.2591 5 -14.9 516.2587 1 61.67 6 31655 VEV_3_3_RA6_01_1237.d 4.7E4 1 1 679 683 Dehydration
R.LDVANK(+27.99)K(+42.01)VTLGGLR.Q Y 18.11 1552.8937 14 2.2 389.2316 4 68.65 4 38155 VEV_1_3_RA4_01_1235.d 4.85E4 1 1 356 369 Formylation; Acetylation (K)
K.SATS(-18.01)LLAPPDKSLLHR.S Y 17.69 1686.9417 16 -7.1 422.7397 4 68.45 4 37994 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 236 251 Dehydration
K.YLYDQ(+.98)HPDIDFTVLAK.A Y 17.67 1937.9410 16 -6.7 646.9833 3 81.07 6 45912 VEV_3_3_RA6_01_1237.d 7.91E4 1 1 150 165 Deamidation (NQ)
K.S(+42.01)VTVE Y 17.66 575.2803 5 -35.1 576.2673 1 30.09 5 13312 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 679 683 Acetylation (N-term)
K.KSLN(+.98)AYQQVIAR(+28.03).R Y 17.38 1418.7881 12 -22.1 355.6964 4 46.74 5 23166 VEV_2_3_RA5_01_1236.d 1.35E6 1 1 603 614 Deamidation (NQ); Dimethylation(KR)
R.L(+42.01)DVANK(+42.01).K Y 17.32 742.3861 6 -3.7 372.1989 2 37.31 5 17570 VEV_2_3_RA5_01_1236.d 0 1 1 356 361 Acetylation (N-term); Acetylation (K)
R.LDVANK.K Y 17.29 658.3650 6 43.3 659.4008 1 99.43 6 55125 VEV_3_3_RA6_01_1237.d 0 1 1 356 361
K.K(+14.02)NEVFAFK(+42.01)EVGKVAK.L Y 17.24 1748.9824 15 -52.8 438.2298 4 72.99 6 40082 VEV_3_3_RA6_01_1237.d 0 1 1 47 61 Methylation(KR); Acetylation (K)
R.QAPVFRDDTC(+57.02)VFVSQS(-18.01)GETADSLMALR.Y Y 16.61 2981.4011 27 -1.9 994.8058 3 87.52 6 49956 VEV_3_3_RA6_01_1237.d 1.3E4 1 1 420 446 Carbamidomethylation; Dehydration
R.L(+42.01)TKHDGTSNVR.A Y 16.49 1268.6473 11 38.7 423.9061 3 11.16 6 2989 VEV_3_3_RA6_01_1237.d 4.6E4 1 1 306 316 Acetylation (N-term)
K.LK(+43.01)DLIDSS(+79.97)K.L Y 16.28 1140.5427 9 48.8 381.2067 3 33.52 5 15301 VEV_2_3_RA5_01_1236.d 1.72E5 1 1 62 70 Carbamylation; Phosphorylation (STY)
R.DGIFK(+27.99).K Y 16.25 606.3013 5 -42.2 607.2830 1 49.74 5 25000 VEV_2_3_RA5_01_1236.d 0 1 1 598 602 Formylation
K.LDLS(+79.96)K.T Y 16.23 654.2894 5 1.8 655.2979 1 22.32 6 8778 VEV_3_3_RA6_01_1237.d 2.02E4 1 1 71 75 Sulfation
K.KSATSLLAPPDK(+42.01).S Y 16.10 1268.6975 12 -31.4 318.1717 4 27.06 5 11626 VEV_2_3_RA5_01_1236.d 0 1 1 235 246 Acetylation (K)
R.G(+42.01)RLDVANK(+42.01).K Y 16.05 955.5087 8 -22.3 319.5031 3 9.55 6 2327 VEV_3_3_RA6_01_1237.d 0 1 1 354 361 Acetylation (N-term); Acetylation (K)
R.SDPN(+.98)WEFSVVHNGIITNYR.E Y 15.98 2248.0549 19 16.7 563.0304 4 79.91 6 45100 VEV_3_3_RA6_01_1237.d 7.1E2 1 1 104 122 Deamidation (NQ)
R.AIQTIELELQEIMKGTFDHFMQKEIFEQPESVVNTMR.G Y 15.72 4409.1743 37 -11.7 1103.2880 4 95.14 4 56352 VEV_1_3_RA4_01_1235.d 1.14E4 1 1 317 353
R.LEYR(+14.02)GYDSAGLAVDGD(+21.98)KK.N Y 15.36 1991.9564 18 0.8 498.9968 4 59.56 6 30122 VEV_3_3_RA6_01_1237.d 3.66E5 1 1 30 47 Methylation(KR); Sodium adduct
K.GS(+162.05)PLVVGVRT(+79.97)GKK.M Y 15.15 1538.8069 13 -27.2 513.9290 3 51.69 5 26198 VEV_2_3_RA5_01_1236.d 0 1 1 194 206 Hexose (NSY); Phosphorylation (STY)
R.DGIFKK.S Y 15.15 706.4014 6 -18.8 354.2013 2 21.76 5 8678 VEV_2_3_RA5_01_1236.d 1.95E5 1 1 598 603
K.LSEPIK.E Y 15.02 685.4010 6 -18.5 686.3956 1 45.10 5 22196 VEV_2_3_RA5_01_1236.d 0 1 1 535 540
K.MKVDFVDVEFSE(+14.02)DGALPAER.A Y 15.00 2267.0779 20 -19.8 756.6849 3 82.66 4 48987 VEV_1_3_RA4_01_1235.d 0 1 1 207 226 Methylation(others)
total 129 peptides
C1GA17
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ITTEDPTKGFQPDTGKIEVYR.S Y 140.71 2394.2065 21 -11.3 599.5521 4 69.42 6 37424 VEV_3_3_RA6_01_1237.d 7.08E5 6 6 387 407
R.IAVQHGVQLVHPGYGFLSENAEFAR.N Y 140.57 2738.3928 25 3.2 685.6077 4 77.97 4 45468 VEV_1_3_RA4_01_1235.d 5.38E5 3 3 114 138
R.FEEVKAFTDEYGFPIIIK.A Y 134.73 2145.1033 18 -13.2 716.0322 3 84.52 6 48156 VEV_3_3_RA6_01_1237.d 4.86E5 4 4 186 203
K.AGLVFVGPTPDTIDALGDKVSAR.R Y 130.08 2298.2219 23 -14.4 767.0702 3 81.81 6 46413 VEV_3_3_RA6_01_1237.d 3.86E5 5 5 143 165
R.GANGVAYSSLPDNAIYHFC(+57.02)K.Q Y 119.73 2183.0105 20 -17.9 728.6644 3 75.70 4 43706 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 663 682 Carbamidomethylation
K.RGQFTPVGAYLAGDEIIR.I Y 118.80 1962.0322 18 -11.5 655.0105 3 78.60 5 45114 VEV_2_3_RA5_01_1236.d 3.22E5 4 4 96 113
K.VVEIAPAKDLPVEVRDSILADAVK.L Y 117.05 2546.4319 24 -1.0 637.6146 4 81.92 4 48470 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 283 306
R.NVEKAGLVFVGPTPDTIDALGDKVSAR.R Y 113.60 2768.4707 27 -2.3 923.8287 3 79.27 5 45569 VEV_2_3_RA5_01_1236.d 1.32E5 2 2 139 165
R.GQFTPVGAYLAGDEIIR.I Y 112.88 1805.9312 17 -8.5 602.9792 3 82.59 4 48937 VEV_1_3_RA4_01_1235.d 4.3E5 5 5 97 113
K.AFTDEYGFPIIIK.A Y 110.28 1512.7864 13 -17.2 757.3875 2 84.65 6 48281 VEV_3_3_RA6_01_1237.d 7.51E5 6 6 191 203
K.AGLVFVGPTPDTIDALGDKVSARR.L Y 109.35 2454.3230 24 -7.0 614.5837 4 79.44 4 46581 VEV_1_3_RA4_01_1235.d 2.05E5 2 2 143 166
R.KAVPNVPFQMLLR.G Y 107.96 1511.8646 13 1.3 504.9628 3 78.93 5 45363 VEV_2_3_RA5_01_1236.d 2.28E5 3 3 650 662
K.MIIDEQGPAAFAK.A Y 107.12 1389.6962 13 -6.7 695.8507 2 72.52 5 40849 VEV_2_3_RA5_01_1236.d 8.69E5 6 6 561 573
K.EGDSVDGQDLIC(+57.02)K.I Y 106.96 1434.6296 13 -3.5 718.3196 2 61.49 5 32649 VEV_2_3_RA5_01_1236.d 8.47E4 4 4 1179 1191 Carbamidomethylation
K.VVEIAPAKDLPVEVR.D Y 106.48 1633.9402 15 -17.5 545.6445 3 71.94 6 39319 VEV_3_3_RA6_01_1237.d 2.73E5 3 3 283 297
R.TAHELSLQTVAVYSYEDR.L Y 102.15 2081.0066 18 -17.4 694.6641 3 75.42 4 43457 VEV_1_3_RA4_01_1235.d 9.01E4 2 2 62 79
K.LLAYLGDVAVNGSR.I Y 96.82 1446.7831 14 -13.5 724.3890 2 77.44 6 43328 VEV_3_3_RA6_01_1237.d 1.97E5 5 5 509 522
K.AVPNVPFQMLLR.G Y 95.82 1383.7697 12 -12.3 692.8836 2 84.21 6 47967 VEV_3_3_RA6_01_1237.d 4.59E5 4 4 651 662
R.VFDALNDIDQLEVGMK.A Y 95.50 1805.8870 16 -4.9 903.9464 2 85.77 4 51171 VEV_1_3_RA4_01_1235.d 3.33E5 3 3 694 709
K.AGLVFVGPTPDTIDALGDK.V Y 94.20 1884.9833 19 -9.7 943.4897 2 83.59 4 49628 VEV_1_3_RA4_01_1235.d 2.38E5 4 4 143 161
K.M(+15.99)IIDEQGPAAFAK.A Y 93.81 1405.6912 13 -15.6 703.8419 2 67.75 6 36189 VEV_3_3_RA6_01_1237.d 9.38E4 1 1 561 573 Oxidation (M)
R.GAN(+.98)GVAYSSLPDNAIYHFC(+57.02)K.Q Y 92.68 2183.9946 20 -6.9 729.0005 3 77.13 4 44800 VEV_1_3_RA4_01_1235.d 4.26E5 5 5 663 682 Deamidation (NQ); Carbamidomethylation
K.GFQPDTGKIEVYR.S Y 92.33 1508.7623 13 -4.8 503.9257 3 64.66 4 35010 VEV_1_3_RA4_01_1235.d 8.07E5 6 6 395 407
R.QVTVDDNMAAVDDTSR.V Y 91.78 1735.7683 16 -12.2 868.8809 2 63.46 6 32968 VEV_3_3_RA6_01_1237.d 1.61E5 3 3 1101 1116
K.KAYEQANDLLGDIVK.V Y 90.03 1675.8781 15 -9.6 559.6279 3 75.58 4 43581 VEV_1_3_RA4_01_1235.d 2.16E5 1 1 907 921
K.AAFGNGTVFVER.F Y 89.41 1266.6356 12 -12.5 634.3171 2 69.22 5 38454 VEV_2_3_RA5_01_1236.d 1.19E6 8 8 235 246
R.VVRDQESLRDSFER.A Y 89.37 1734.8649 14 -14.5 434.7172 4 51.97 6 25524 VEV_3_3_RA6_01_1237.d 2.12E6 10 10 215 228
R.Q(-17.03)KADEAYVIGKR.G Y 87.74 1359.7146 12 -14.7 680.8546 2 49.57 6 24103 VEV_3_3_RA6_01_1237.d 9.71E5 9 9 85 96 Pyro-glu from Q
R.NAGTAEFLVDQQNR.Y Y 82.90 1561.7484 14 -6.3 521.5868 3 65.34 4 35538 VEV_1_3_RA4_01_1235.d 4.5E5 8 8 315 328
R.NAGTAEFLVDQQNRYYFIEINPR.I Y 81.07 2757.3511 23 -13.4 690.3358 4 82.00 6 46541 VEV_3_3_RA6_01_1237.d 1.36E5 4 4 315 337
R.AQKLLAYLGDVAVNGSR.I Y 80.44 1773.9736 17 -25.0 592.3170 3 77.93 6 43685 VEV_3_3_RA6_01_1237.d 3.98E4 2 2 506 522
R.Q(-17.03)KADEAYVIGK.R Y 79.98 1203.6135 11 -13.5 602.8059 2 57.84 6 28944 VEV_3_3_RA6_01_1237.d 4.54E5 3 3 85 95 Pyro-glu from Q
K.ILVANRGEIPIR.I Y 78.03 1349.8142 12 -11.1 450.9404 3 64.75 6 33921 VEV_3_3_RA6_01_1237.d 3.31E5 2 2 47 58
K.YNLDYYLSLVDKVVK.I Y 77.84 1830.9767 15 -8.8 611.3275 3 87.62 6 50011 VEV_3_3_RA6_01_1237.d 1.2E5 2 2 735 749
K.AAFGN(+.98)GTVFVER.F Y 75.18 1267.6196 12 -9.2 634.8113 2 73.48 4 41962 VEV_1_3_RA4_01_1235.d 1.23E6 8 8 235 246 Deamidation (NQ)
K.HIEVQLLGDNHGNIVHLYER.D Y 74.31 2355.2083 20 -24.8 472.0372 5 74.66 4 42867 VEV_1_3_RA4_01_1235.d 0 1 1 253 272
K.LLAYLGDVAVN(+.98)GSR.I Y 73.46 1447.7671 14 -8.4 724.8848 2 79.03 4 46269 VEV_1_3_RA4_01_1235.d 3.48E5 5 5 509 522 Deamidation (NQ)
K.YGDLSVLPTK.Y Y 73.23 1091.5862 10 -7.6 546.7962 2 68.97 4 38415 VEV_1_3_RA4_01_1235.d 2.58E5 2 2 1041 1050
K.HIEVQLLGDN(+.98)HGNIVHLYER.D Y 70.68 2356.1924 20 -6.8 472.2426 5 74.66 6 41298 VEV_3_3_RA6_01_1237.d 4.04E4 1 1 253 272 Deamidation (NQ)
K.MIIDEQ(+.98)GPAAFAK.A Y 69.92 1390.6802 13 -5.2 696.3438 2 72.49 6 39730 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 561 573 Deamidation (NQ)
R.AGELDFPGSVLEFFEGLMGQPYGGFPEPLR.S Y 67.83 3255.5586 30 -3.9 1086.1892 3 97.92 4 57523 VEV_1_3_RA4_01_1235.d 3.23E4 1 1 950 979
K.AFTDE(+14.02)YGFPIIIK.A Y 67.46 1526.8020 13 -9.0 764.4014 2 86.31 4 51433 VEV_1_3_RA4_01_1235.d 1.84E5 2 2 191 203 Methylation(others)
R.AQKLLAYLGDVAVN(+.98)GSR.I Y 66.20 1774.9576 17 -25.5 592.6447 3 78.20 5 44854 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 506 522 Deamidation (NQ)
R.YYFIEINPR.I Y 63.53 1213.6132 9 -14.1 607.8053 2 77.35 6 43267 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 329 337
R.ANNGC(+57.02)LIMDTTWR.D Y 63.21 1550.6970 13 -0.6 776.3553 2 75.10 4 43209 VEV_1_3_RA4_01_1235.d 6.36E4 1 1 577 589 Carbamidomethylation
K.AAFGNGTVFVER(+14.02).F Y 62.83 1280.6512 12 -20.9 641.3195 2 73.28 6 40288 VEV_3_3_RA6_01_1237.d 4.12E5 3 3 235 246 Methylation(KR)
R.AIDSYWAQLR.L Y 61.74 1221.6141 10 -15.5 611.8049 2 76.25 6 42444 VEV_3_3_RA6_01_1237.d 6.49E5 4 4 850 859
K.AAFGGGGR.G Y 61.38 691.3401 8 -18.8 346.6709 2 15.02 6 4991 VEV_3_3_RA6_01_1237.d 2.97E5 3 3 204 211
R.TVDLLNIAK.E Y 56.98 985.5807 9 -15.7 493.7899 2 73.82 6 40682 VEV_3_3_RA6_01_1237.d 3.28E5 4 4 602 610
R.FLYEDPWDR.L Y 56.45 1239.5560 9 -14.0 620.7766 2 77.80 4 45328 VEV_1_3_RA4_01_1235.d 2.55E4 1 1 636 644
R.ITTEDPTKGFQ(+.98)PDTGKIEVYR.S Y 56.28 2395.1907 21 -1.4 599.8041 4 69.80 4 39056 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 387 407 Deamidation (NQ)
R.FLYEDPWDRLR.K Y 55.18 1508.7412 11 -15.9 503.9130 3 78.36 6 43983 VEV_3_3_RA6_01_1237.d 9.43E4 2 2 636 646
R.ISTRGFAIQC(+57.02)R.I Y 53.81 1307.6768 11 -10.8 436.8948 3 57.10 5 29493 VEV_2_3_RA5_01_1236.d 6.19E4 2 2 376 386 Carbamidomethylation
R.FEEVKAFTDEY(-2.02)GFPIIIK.A Y 53.32 2143.0876 18 -6.1 715.3655 3 84.72 4 50396 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 186 203 2-amino-3-oxo-butanoic_acid
K.YGVDIFR.V Y 51.39 868.4443 7 -19.3 435.2210 2 71.49 6 38983 VEV_3_3_RA6_01_1237.d 1.73E5 2 2 687 693
R.GSTYEIVR.R Y 50.71 923.4712 8 -10.5 462.7380 2 44.95 4 21737 VEV_1_3_RA4_01_1235.d 2.3E5 4 4 442 449
R.QKADEAYVIGKR.G Y 50.02 1376.7412 12 -2.2 459.9200 3 30.93 4 13371 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 85 96
R.GFAIQC(+57.02)R.I Y 49.45 850.4119 7 -10.5 426.2088 2 44.93 4 21716 VEV_1_3_RA4_01_1235.d 1.28E6 7 7 380 386 Carbamidomethylation
K.AAFGN(+.98)GTVFVER(+14.02).F Y 46.77 1281.6353 12 -25.3 641.8087 2 75.72 6 42092 VEV_3_3_RA6_01_1237.d 1.61E5 2 2 235 246 Deamidation (NQ); Methylation(KR)
R.DSILADAVK.L Y 43.80 930.5022 9 -9.8 466.2538 2 66.75 4 36690 VEV_1_3_RA4_01_1235.d 1.44E6 5 5 298 306
R.VVRDQESLR.D Y 41.94 1100.5938 9 -14.2 551.2963 2 20.06 6 7581 VEV_3_3_RA6_01_1237.d 2.52E4 1 1 215 223
R.FLDKPK.H Y 40.75 746.4326 6 -18.5 747.4261 1 21.12 5 8355 VEV_2_3_RA5_01_1236.d 5.33E5 5 5 247 252
R.ASSTIMHFTK.I Y 39.44 1121.5540 10 -8.1 561.7797 2 46.10 4 22453 VEV_1_3_RA4_01_1235.d 3.66E5 3 3 37 46
R.NVEKAGLVFVGPTPDTIDALGDK.V Y 38.69 2355.2322 23 -12.4 786.0750 3 79.95 6 45121 VEV_3_3_RA6_01_1237.d 8.01E3 1 1 139 161
R.DQESLRDSFER.A Y 38.12 1380.6270 11 -17.7 461.2081 3 53.66 6 26446 VEV_3_3_RA6_01_1237.d 7.62E4 2 2 218 228
K.ILVANRGEIPIRIFR.T Y 36.99 1766.0679 15 25.8 442.5356 4 76.34 6 42514 VEV_3_3_RA6_01_1237.d 0 1 1 47 61
K.GFQPDTGKIEVYR(+14.02).S Y 35.31 1522.7780 13 -7.1 508.5963 3 66.44 4 36406 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 395 407 Methylation(KR)
R.ALIEFR.I Y 34.37 747.4279 6 -20.0 374.7137 2 65.69 6 34637 VEV_3_3_RA6_01_1237.d 4.1E5 3 3 455 460
R.IAVQHGVQLVHPGYGFLSENAEFAR(-.98).N Y 34.02 2737.4087 25 -8.7 685.3535 4 77.91 6 43664 VEV_3_3_RA6_01_1237.d 0 1 1 114 138 Amidation
K.C(+58.01)GVPVVPGTPGPVGR.F Y 33.99 1448.7445 15 -9.3 725.3728 2 71.84 4 40670 VEV_1_3_RA4_01_1235.d 2E5 1 1 171 185 Carboxymethyl
K.VVE(+6.01)IAPAKDLPVEVRDSILADAVK.L Y 32.66 2552.4399 24 -44.6 639.0888 4 81.87 4 48437 VEV_1_3_RA4_01_1235.d 0 1 1 283 306 Replacement of proton by lithium
K.AGLVFVGPT(-2.02)PDTIDALGDKVSAR.R Y 30.41 2296.2063 23 -48.8 766.3720 3 81.76 6 46381 VEV_3_3_RA6_01_1237.d 6.97E4 2 2 143 165 2-amino-3-oxo-butanoic_acid
K.LTPDDVVAR.A Y 30.02 984.5240 9 1.5 493.2700 2 34.13 4 15233 VEV_1_3_RA4_01_1235.d 1.44E5 2 2 941 949
K.MIIDEQGPAAFAK(+14.02).A Y 29.50 1403.7118 13 -32.7 702.8402 2 74.93 6 41488 VEV_3_3_RA6_01_1237.d 8.11E4 1 1 561 573 Methylation(KR)
K.KYGVDIFR.V Y 29.49 996.5392 8 -13.1 499.2704 2 64.53 4 34911 VEV_1_3_RA4_01_1235.d 6.64E5 2 2 686 693
R.ANNGC(+57.02)LIMDTTWRDAHQSLLATR.V Y 29.11 2643.2646 23 22.3 882.1151 3 77.22 5 44180 VEV_2_3_RA5_01_1236.d 0 1 1 577 599 Carbamidomethylation
K.VFEDYRK.F Y 28.56 955.4763 7 -12.7 478.7394 2 28.49 6 12037 VEV_3_3_RA6_01_1237.d 4.77E5 3 3 1030 1036
R.GQ(+.98)FTPVGAYLAGDEIIR.I Y 27.43 1806.9152 17 7.0 603.3165 3 82.51 4 48888 VEV_1_3_RA4_01_1235.d 5.65E4 1 1 97 113 Deamidation (NQ)
K.GQIGEPK.F Y 26.65 727.3864 7 -18.1 728.3805 1 33.70 6 14903 VEV_3_3_RA6_01_1237.d 6.73E4 2 2 525 531
K.YNLDYYLSLVDK.V Y 25.88 1504.7449 12 4.5 753.3831 2 85.60 4 50984 VEV_1_3_RA4_01_1235.d 1.62E5 2 2 735 746
K.AGLVFVGPTPDTIDALGDK(+14.02)VSAR.R Y 25.40 2312.2375 23 -23.9 771.7347 3 82.16 6 46661 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 143 165 Methylation(KR)
K.VVGDLAQFM(+15.99)VSNK.L Y 25.11 1422.7177 13 -11.3 712.3581 2 67.69 6 36153 VEV_3_3_RA6_01_1237.d 0 1 1 928 940 Oxidation (M)
K.GFQPDTGK.I Y 24.85 848.4028 8 2.3 425.2097 2 22.64 5 9168 VEV_2_3_RA5_01_1236.d 1.95E5 3 3 395 402
K.V(+42.01)VGDLAQ(+.98)FMVSNK(+14.02).L Y 24.43 1463.7330 13 -3.9 366.9391 4 19.61 5 7521 VEV_2_3_RA5_01_1236.d 9.04E4 1 1 928 940 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
K.G(+27.99)QIGEPK(+42.01).F Y 23.96 797.3919 7 -1.5 798.3980 1 110.85 4 61353 VEV_1_3_RA4_01_1235.d 0 1 1 525 531 Formylation; Acetylation (K)
R.Q(+56.06)VTVDDNMAAVDDTSR.V Y 23.38 1791.8309 16 -11.8 598.2772 3 36.30 6 16398 VEV_3_3_RA6_01_1237.d 0 1 1 1101 1116 Diethylation
K.MIIDEQGPAAFAK(-.98).A Y 23.16 1388.7122 13 -84.5 695.3047 2 72.63 6 39820 VEV_3_3_RA6_01_1237.d 0 1 1 561 573 Amidation
R.FLYEDPWDRLRK.L Y 23.05 1636.8361 12 -14.0 410.2106 4 73.90 4 42280 VEV_1_3_RA4_01_1235.d 3.38E4 1 1 636 647
R.KLNSRPGLHLEPLDLAK.I Y 22.39 1900.0894 17 -9.6 381.0215 5 67.95 4 37599 VEV_1_3_RA4_01_1235.d 1.68E5 2 2 988 1004
K.IGTHVLGIK(+43.99).D Y 22.05 980.5654 9 -33.8 327.8514 3 39.14 5 18610 VEV_2_3_RA5_01_1236.d 1.85E5 1 1 750 758 Carboxylation (DKW)
R.V(+226.08)FDALNDIDQLEVGMK.A Y 21.59 2031.9645 16 39.0 509.0182 4 68.72 6 36925 VEV_3_3_RA6_01_1237.d 7.04E4 1 1 694 709 Biotinylation
R.NVEK(-1.03)AGLVFVGPTPDTIDALGDKVSAR.R Y 21.35 2767.4392 27 -22.6 692.8514 4 79.15 6 44555 VEV_3_3_RA6_01_1237.d 0 1 1 139 165 Lysine oxidation to aminoadipic semialdehyde
K.LTP(+31.99)DDVVAR.A Y 21.19 1016.5138 9 -9.9 509.2592 2 60.63 4 31950 VEV_1_3_RA4_01_1235.d 0 1 1 941 949 Dihydroxy
K.GDPLAVLSAMK.M Y 20.50 1100.5900 11 -7.3 551.2982 2 57.47 6 28678 VEV_3_3_RA6_01_1237.d 4.79E4 1 1 1149 1159
K.AAFGGGGR(+44.03).G Y 20.32 735.3663 8 -45.3 736.3403 1 77.38 6 43291 VEV_3_3_RA6_01_1237.d 1.09E4 1 1 204 211 Ethanolation (KR)
K.LLAVGPLSEQTGQREVFYEMNGEVR.Q Y 20.07 2821.4067 25 12.3 706.3676 4 109.01 5 58580 VEV_2_3_RA5_01_1236.d 0 2 2 1076 1100
K.VVEIAPAK(-1.03)DLPVEVRDSILADAVK.L Y 19.68 2545.4001 24 12.2 849.4844 3 81.87 4 48441 VEV_1_3_RA4_01_1235.d 0 1 1 283 306 Lysine oxidation to aminoadipic semialdehyde
K.QAK(+42.01)K(+14.02)YGVDIFR.V Y 19.59 1379.7561 11 0.1 345.9464 4 57.36 5 29669 VEV_2_3_RA5_01_1236.d 5.29E4 1 1 683 693 Acetylation (K); Methylation(KR)
R.AGELDFPGSVLEFFEGLMGQPY(-2.02)GGFPEPLR.S Y 19.53 3253.5430 30 23.1 1627.8164 2 97.95 4 57531 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 950 979 2-amino-3-oxo-butanoic_acid
K.C(+57.02)GVPVVPGTPGPVGR.F Y 19.46 1447.7605 15 -53.7 483.5682 3 27.13 5 11666 VEV_2_3_RA5_01_1236.d 9.57E3 1 1 171 185 Carbamidomethylation
K.GQ(+.98)IGEPK.F Y 19.45 728.3704 7 -20.4 729.3629 1 76.31 5 43524 VEV_2_3_RA5_01_1236.d 7.36E4 1 1 525 531 Deamidation (NQ)
R.I(+43.01)STRGFAIQC(+57.02)R.I Y 19.31 1350.6826 11 17.8 676.3606 2 31.68 6 13822 VEV_3_3_RA6_01_1237.d 5.2E5 2 2 376 386 Carbamylation; Carbamidomethylation
R.DSILAD(-18.01)AVK(+42.01).L Y 18.75 954.5022 9 17.1 319.1801 3 57.96 5 30090 VEV_2_3_RA5_01_1236.d 1.62E4 1 1 298 306 Dehydration; Acetylation (K)
K.YGVDIFRVFDALNDIDQLEVGMK.A Y 18.42 2656.3206 23 -0.5 886.4470 3 96.35 4 56897 VEV_1_3_RA4_01_1235.d 5.98E4 2 2 687 709
R.ITTEDPTKGFQ(+.98)PDTGK(+14.02).I Y 18.39 1748.8468 16 -7.8 438.2156 4 35.10 6 15718 VEV_3_3_RA6_01_1237.d 0 1 1 387 402 Deamidation (NQ); Methylation(KR)
R.ATSEAK.A Y 18.23 605.3020 6 -30.6 606.2908 1 49.77 5 25011 VEV_2_3_RA5_01_1236.d 4.42E4 1 1 229 234
R.VFDALNDIDQLEVGMK(-.98).A Y 18.21 1804.9030 16 -5.0 903.4543 2 85.63 4 51001 VEV_1_3_RA4_01_1235.d 8.45E4 1 1 694 709 Amidation
R.LSMHRQKADEAY(-18.01)VIGK(+42.01)R.G Y 17.62 2025.0577 17 -6.0 507.2687 4 71.52 4 40412 VEV_1_3_RA4_01_1235.d 3.65E4 1 1 80 96 Dehydration; Acetylation (K)
K.LN(+.98)SRPGLHLEPLDLAK(+14.02).I Y 17.49 1786.9940 16 -3.0 447.7545 4 66.94 5 36729 VEV_2_3_RA5_01_1236.d 4.78E4 1 1 989 1004 Deamidation (NQ); Methylation(KR)
R.VFDALN(-17.03)DIDQLEVGMK.A Y 17.35 1788.8604 16 -5.2 448.2200 4 41.33 4 19523 VEV_1_3_RA4_01_1235.d 0 1 1 694 709 Ammonia-loss (N)
R.Q(+316.20)KADEAYVIGK.R Y 17.29 1536.8439 11 5.0 385.2202 4 61.68 6 31666 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 85 95 Levuglandinyl-lysine pyrrole adduct
K.AAFGGGGRGMR(-.98).V Y 17.15 1034.5192 11 -9.2 518.2621 2 34.80 4 15635 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 204 214 Amidation
R.A(+41.03)TSEAKAAFGNGTVFVER.F Y 17.08 1894.9536 18 -5.3 632.6552 3 69.04 6 37149 VEV_3_3_RA6_01_1237.d 0 1 1 229 246 Amidination of lysines or N-terminal amines with methyl acetimidate
R.FLYE(+14.02)DPWDRLR.K Y 17.03 1522.7568 11 -11.9 508.5869 3 80.05 4 47061 VEV_1_3_RA4_01_1235.d 1.57E4 1 1 636 646 Methylation(others)
K.LT(+79.97)PDDVVAR.A Y 16.83 1064.4904 9 -1.8 355.8368 3 12.24 6 3521 VEV_3_3_RA6_01_1237.d 2.43E4 1 1 941 949 Phosphorylation (STY)
R.AIDSYW(+15.99)AQLR.L Y 16.62 1237.6091 10 -27.1 619.7950 2 72.00 5 40462 VEV_2_3_RA5_01_1236.d 4.12E4 1 1 850 859 Oxidation (HW)
R.D(+42.01)S(-18.01)ILADAVK.L Y 16.55 954.5022 9 -39.4 478.2396 2 21.59 6 8386 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 298 306 Acetylation (N-term); Dehydration
K.IEVYR(+14.02)S(+79.97)SGGNGVR.L Y 16.54 1486.6929 13 -4.7 744.3502 2 60.15 5 31666 VEV_2_3_RA5_01_1236.d 2.44E3 1 1 403 415 Methylation(KR); Phosphorylation (STY)
K.DLPVEVRDSILADAVK(+42.01).L Y 16.36 1780.9570 16 -3.1 357.1976 5 56.76 4 29145 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 291 306 Acetylation (K)
K.VTPTS(-18.01)K.V Y 16.32 613.3435 6 -27.9 614.3337 1 83.27 6 47363 VEV_3_3_RA6_01_1237.d 2.56E4 1 1 922 927 Dehydration
K.MIIDEQGPAAFAK(+43.01).A Y 16.19 1432.7020 13 16.4 359.1887 4 15.79 4 5198 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 561 573 Carbamylation
K.GFQPDTGK(+14.02).I Y 16.13 862.4185 8 -10.8 432.2119 2 43.78 5 21367 VEV_2_3_RA5_01_1236.d 2.08E5 1 1 395 402 Methylation(KR)
K.S(+42.01)VNYR.N Y 15.64 679.3289 5 12.8 680.3449 1 80.28 5 46234 VEV_2_3_RA5_01_1236.d 7.32E4 1 1 310 314 Acetylation (N-term)
K.VTPTSK.V Y 15.56 631.3541 6 -90.1 632.3044 1 64.21 4 34671 VEV_1_3_RA4_01_1235.d 0 1 1 922 927
R.LSM(+15.99)HRQKADEAY(+79.97)VIGK.R Y 15.30 1940.9178 16 -21.2 389.1826 5 65.93 6 34826 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 80 95 Oxidation (M); Phosphorylation (STY)
K.M(+27.99)IIDEQGPAAFAK.A Y 15.10 1417.6912 13 -22.3 709.8370 2 65.50 6 34503 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 561 573 Formylation
R.IS(+162.05)TRGFAIQC(+57.02)R.I Y 15.06 1469.7296 11 -12.4 490.9111 3 48.52 6 23452 VEV_3_3_RA6_01_1237.d 0 1 1 376 386 Hexose (NSY); Carbamidomethylation
K.KGDPLAVLSAM(+15.99)K.M Y 15.06 1244.6798 12 -24.9 623.3317 2 77.51 4 45100 VEV_1_3_RA4_01_1235.d 0 1 1 1148 1159 Oxidation (M)
total 128 peptides
C1GCT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FGGLRDGYYINGQC(+57.02)GIIMFDVTSR.I Y 162.41 2738.2944 24 -8.6 913.7643 3 84.02 6 47861 VEV_3_3_RA6_01_1237.d 1.07E6 5 5 70 93 Carbamidomethylation
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVKER.K Y 155.36 2227.1453 19 -15.6 557.7849 4 67.07 6 35702 VEV_3_3_RA6_01_1237.d 3.17E6 9 9 109 127 Carbamidomethylation
K.SNYNFEKPFLWLAR.K Y 143.30 1783.9045 14 -15.3 595.6330 3 82.20 6 46706 VEV_3_3_RA6_01_1237.d 6.18E6 11 11 151 164
K.FQTNLGAIQFDVWDTAGQEK.F Y 136.42 2267.0859 20 -11.8 756.6937 3 85.70 6 48911 VEV_3_3_RA6_01_1237.d 1.31E6 9 9 50 69
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVK.E Y 129.97 1942.0016 17 -14.7 648.3316 3 70.74 6 38432 VEV_3_3_RA6_01_1237.d 3.74E6 9 9 109 125 Carbamidomethylation
K.YIATLGVEVHPLKFQTNLGAIQFDVWDTAGQEK.F Y 121.59 3687.8936 33 6.1 1230.3126 3 87.43 5 50542 VEV_2_3_RA5_01_1236.d 1.55E6 6 6 37 69
K.LVLVGDGGTGKTTFVKR.H Y 116.64 1746.9991 17 -10.9 437.7523 4 62.56 5 33457 VEV_2_3_RA5_01_1236.d 6.97E5 7 7 11 27
M.A(+42.01)AQAPPTFKLVLVGDGGTGKTTFVKR.H Y 114.57 2700.4961 26 -12.6 676.1228 4 77.54 5 44398 VEV_2_3_RA5_01_1236.d 2.92E5 2 2 2 27 Acetylation (Protein N-term)
R.DGYYINGQC(+57.02)GIIMFDVTSR.I Y 113.81 2207.9980 19 -6.1 1104.9995 2 85.67 5 49549 VEV_2_3_RA5_01_1236.d 3.41E5 5 5 75 93 Carbamidomethylation
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVKERK.V Y 111.84 2355.2402 20 -25.5 472.0433 5 63.08 5 33835 VEV_2_3_RA5_01_1236.d 2.55E5 3 3 109 128 Carbamidomethylation
K.YIATLGVEVHPLK.F Y 110.02 1438.8184 13 -9.3 720.4098 2 71.70 4 40557 VEV_1_3_RA4_01_1235.d 9.67E5 6 6 37 49
R.VC(+57.02)ENVPIVLC(+57.02)GNK.V Y 109.89 1500.7429 13 -15.2 751.3673 2 69.06 6 37195 VEV_3_3_RA6_01_1237.d 1.08E6 7 7 109 121 Carbamidomethylation
K.FGGLRDGYYINGQC(+57.02)GIIM(+15.99)FDVTSR.I Y 106.84 2754.2893 24 -7.1 919.0972 3 82.01 4 48541 VEV_1_3_RA4_01_1235.d 3.86E5 3 3 70 93 Carbamidomethylation; Oxidation (M)
R.KKNLQYYDISAK.S Y 102.53 1469.7878 12 -11.0 735.8931 2 43.56 6 20544 VEV_3_3_RA6_01_1237.d 7.68E6 19 19 139 150
R.VC(+57.02)EN(+.98)VPIVLC(+57.02)GNKVDVKER.K Y 95.30 2228.1294 19 -4.3 558.0372 4 67.31 5 37004 VEV_2_3_RA5_01_1236.d 1.08E6 6 6 109 127 Carbamidomethylation; Deamidation (NQ)
R.HITGEFEKK.Y Y 93.25 1087.5662 9 -12.7 544.7834 2 20.84 6 8046 VEV_3_3_RA6_01_1237.d 4.02E6 15 15 28 36
K.SNYNFEKPFLWLARK.L Y 92.60 1911.9995 15 -12.3 479.0013 4 78.62 4 45951 VEV_1_3_RA4_01_1235.d 7.72E5 4 4 151 165
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVKER(+14.02).K Y 90.34 2241.1609 19 -9.7 561.2921 4 70.11 4 39295 VEV_1_3_RA4_01_1235.d 7.8E5 4 4 109 127 Carbamidomethylation; Methylation(KR)
M.A(+42.01)AQAPPTFKLVLVGDGGTGK.T Y 89.42 1968.0680 20 -12.8 985.0287 2 81.56 6 46266 VEV_3_3_RA6_01_1237.d 1E6 3 3 2 21 Acetylation (Protein N-term)
R.KLVGNPGLEFVADIALAPPETAVDAAAIAAAEAEMKEAAQMPLPDEEDADF Y 88.90 5221.5361 51 -1.3 1306.3896 4 97.59 4 57375 VEV_1_3_RA4_01_1235.d 0 1 1 165 215
K.FGGLRDGYYIN(+.98)GQC(+57.02)GIIMFDVTSR.I Y 88.85 2739.2786 24 -7.4 914.0934 3 84.96 5 49143 VEV_2_3_RA5_01_1236.d 9.13E5 6 6 70 93 Deamidation (NQ); Carbamidomethylation
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVK(+14.02)ER.K Y 87.68 2241.1609 19 -10.3 561.2917 4 69.93 5 38938 VEV_2_3_RA5_01_1236.d 3.3E5 6 6 109 127 Carbamidomethylation; Methylation(KR)
K.LVLVGDGGTGK.T Y 86.59 1014.5709 11 -25.2 508.2799 2 56.33 5 29045 VEV_2_3_RA5_01_1236.d 8.63E6 15 15 11 21
K.NLQYYDISAK.S Y 86.56 1213.5979 10 -16.4 607.7963 2 64.72 6 33917 VEV_3_3_RA6_01_1237.d 5.5E6 9 9 141 150
K.SNYNFEKPFLWLAR(+14.02).K Y 86.00 1797.9202 14 -7.8 600.3093 3 82.99 5 47948 VEV_2_3_RA5_01_1236.d 4.04E5 5 5 151 164 Methylation(KR)
R.DGYYIN(+.98)GQC(+57.02)GIIMFDVTSR.I Y 82.96 2208.9819 19 -3.3 1105.4946 2 86.86 4 51793 VEV_1_3_RA4_01_1235.d 2.4E5 6 6 75 93 Deamidation (NQ); Carbamidomethylation
R.DLVRVC(+57.02)ENVPIVLC(+57.02)GNKVDVK.E Y 82.49 2425.2820 21 -24.8 607.3127 4 77.12 6 43097 VEV_3_3_RA6_01_1237.d 6.05E4 1 1 105 125 Carbamidomethylation
K.SNYNFEKPFLW(+15.99)LAR.K Y 80.55 1799.8994 14 -13.3 600.9658 3 81.50 6 46206 VEV_3_3_RA6_01_1237.d 2.84E5 5 5 151 164 Oxidation (HW)
R.VC(+57.02)ENVPIVLC(+57.02)GN(+.98)KVDVK.E Y 79.38 1942.9856 17 0.7 648.6696 3 71.07 4 40058 VEV_1_3_RA4_01_1235.d 7.43E5 5 5 109 125 Carbamidomethylation; Deamidation (NQ)
K.SNYN(+.98)FEKPFLWLAR.K Y 79.24 1784.8885 14 -11.8 595.9631 3 83.96 6 47799 VEV_3_3_RA6_01_1237.d 5.59E5 6 6 151 164 Deamidation (NQ)
R.VC(+57.02)E(+14.02)NVPIVLC(+57.02)GNKVDVKER.K Y 78.86 2241.1609 19 -19.4 561.2866 4 70.74 5 39535 VEV_2_3_RA5_01_1236.d 2.87E5 5 5 109 127 Carbamidomethylation; Methylation(others)
R.VC(+57.02)E(+14.02)NVPIVLC(+57.02)GNKVDVK.E Y 78.19 1956.0172 17 -8.6 653.0074 3 74.57 4 42800 VEV_1_3_RA4_01_1235.d 8.36E5 4 4 109 125 Carbamidomethylation; Methylation(others)
K.SNYNFEK(+14.02)PFLWLAR.K Y 77.97 1797.9202 14 -9.8 600.3081 3 84.21 6 47966 VEV_3_3_RA6_01_1237.d 1.24E6 7 7 151 164 Methylation(KR)
K.KYIATLGVEVHPLK.F Y 72.60 1566.9133 14 -40.2 392.7198 4 67.00 6 35676 VEV_3_3_RA6_01_1237.d 7.92E4 3 3 36 49
K.SNY(+125.90)NFEKPFLWLAR.K Y 71.25 1909.8011 14 -10.3 637.6011 3 84.85 6 48366 VEV_3_3_RA6_01_1237.d 3.24E5 3 3 151 164 Iodination
K.FQTNLGAIQFDVWDTAGQEK(+14.02).F Y 70.27 2281.1016 20 -9.9 1141.5468 2 86.53 6 49389 VEV_3_3_RA6_01_1237.d 7.96E5 6 6 50 69 Methylation(KR)
R.ITYKNVPSWHRDLVR.V Y 70.20 1883.0166 15 -11.4 471.7560 4 62.43 5 33361 VEV_2_3_RA5_01_1236.d 1.52E5 2 2 94 108
K.KNLQYYDISAK.S Y 69.81 1341.6929 11 -9.4 671.8474 2 54.13 5 27728 VEV_2_3_RA5_01_1236.d 1.36E6 6 6 140 150
R.HITGEFEK.K Y 68.24 959.4712 8 -14.1 480.7361 2 27.74 6 11636 VEV_3_3_RA6_01_1237.d 1.78E6 11 11 28 35
K.NVPSWHRDLVR.V Y 66.84 1377.7266 11 -14.9 345.4338 4 55.69 5 28606 VEV_2_3_RA5_01_1236.d 1.58E6 9 9 98 108
K.SN(+.98)YNFEKPFLWLAR.K Y 65.09 1784.8885 14 -10.4 595.9639 3 83.56 6 47551 VEV_3_3_RA6_01_1237.d 1.86E5 2 2 151 164 Deamidation (NQ)
K.SNYNFEKPFLW(+31.99)LAR.K Y 65.00 1815.8944 14 -8.4 606.3004 3 79.50 5 45722 VEV_2_3_RA5_01_1236.d 4.36E5 3 3 151 164 Dihydroxy
R.KLVGNPGLEFVADIALAPPETAVDAAAIAAAEAEMK.E Y 64.47 3562.8591 36 -7.5 1188.6180 3 95.86 4 56686 VEV_1_3_RA4_01_1235.d 4.8E5 5 5 165 200
R.KKNLQ(+.98)YYDISAK.S Y 60.52 1470.7719 12 -13.7 736.3831 2 46.52 6 22281 VEV_3_3_RA6_01_1237.d 1.66E5 3 3 139 150 Deamidation (NQ)
K.FQTNLGAIQ(+.98)FDVWDTAGQEK.F Y 59.94 2268.0698 20 -5.0 757.0268 3 85.94 6 49040 VEV_3_3_RA6_01_1237.d 1.42E4 1 1 50 69 Deamidation (NQ)
R.ITYKNVPSWHR.D Y 59.39 1399.7361 11 -12.5 467.5801 3 56.28 4 28817 VEV_1_3_RA4_01_1235.d 7.74E5 6 6 94 104
M.A(+42.01)AQAPPTFKLVLVGDGGTGK(+14.02).T Y 59.14 1982.0836 20 -9.4 992.0397 2 81.18 6 45982 VEV_3_3_RA6_01_1237.d 4.28E4 2 2 2 21 Acetylation (Protein N-term); Methylation(KR)
M.A(+42.01)AQ(+.98)APPTFKLVLVGDGGTGK.T Y 57.25 1969.0520 20 -11.5 985.5220 2 82.46 6 46838 VEV_3_3_RA6_01_1237.d 9.84E4 2 2 2 21 Acetylation (Protein N-term); Deamidation (NQ)
R.KKNLQYYDISAK(+14.02).S Y 57.24 1483.8035 12 -10.5 742.9012 2 51.15 5 25850 VEV_2_3_RA5_01_1236.d 3.38E5 4 4 139 150 Methylation(KR)
K.EAAQMPLPDEEDADF Y 55.58 1676.6875 15 -0.1 839.3510 2 81.06 4 47835 VEV_1_3_RA4_01_1235.d 1.8E5 2 2 201 215
K.RHITGEFEKK.Y Y 55.06 1243.6672 10 -22.9 311.9170 4 21.07 6 8151 VEV_3_3_RA6_01_1237.d 4.42E5 3 3 27 36
K.NVPSWHR.D Y 53.96 894.4460 7 -10.3 448.2257 2 32.61 6 14306 VEV_3_3_RA6_01_1237.d 4.26E6 12 12 98 104
R.VC(+57.02)ENVPIVLC(+57.02)GN(+.98)K.V Y 52.72 1501.7269 13 1.6 751.8719 2 70.63 4 39708 VEV_1_3_RA4_01_1235.d 9.46E4 1 1 109 121 Carbamidomethylation; Deamidation (NQ)
K.NLQYYDISAK(+14.02).S Y 51.83 1227.6135 10 -14.9 614.8049 2 67.85 6 36271 VEV_3_3_RA6_01_1237.d 9.63E5 6 6 141 150 Methylation(KR)
K.FGGLRDGYYIN(+.98)GQC(+57.02)GIIMFDVTSR(+14.02).I Y 49.49 2753.2942 24 -40.9 918.7345 3 86.22 4 51382 VEV_1_3_RA4_01_1235.d 0 1 1 70 93 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.LVLVGDGGTGK(+14.02).T Y 48.74 1028.5865 11 -20.2 515.2902 2 59.97 6 30452 VEV_3_3_RA6_01_1237.d 7.17E5 3 3 11 21 Methylation(KR)
R.VC(+57.02)EN(+.98)VPIVLC(+57.02)GNKVDVK.E Y 48.65 1942.9856 17 -17.3 648.6580 3 73.54 6 40492 VEV_3_3_RA6_01_1237.d 3.42E5 2 2 109 125 Carbamidomethylation; Deamidation (NQ)
R.KLVGNPGLEFVADIALAPPETAVDAAAIAAAEAEM(+15.99)K.E Y 47.03 3578.8540 36 -4.8 1193.9529 3 95.26 6 53696 VEV_3_3_RA6_01_1237.d 4.29E4 1 1 165 200 Oxidation (M)
R.KKNLQYYD(+14.02)ISAK.S Y 44.88 1483.8035 12 -37.3 742.8813 2 47.23 5 23474 VEV_2_3_RA5_01_1236.d 0 1 1 139 150 Methylation(others)
K.FGGLRDGYYINGQ(+.98)C(+57.02)GIIMFDVTSR.I Y 44.42 2739.2786 24 -1.0 685.8262 4 84.14 4 50011 VEV_1_3_RA4_01_1235.d 4.32E4 1 1 70 93 Deamidation (NQ); Carbamidomethylation
M.A(+42.01)AQAPPTFKLVLVGDGGTGKTTFVK.R Y 44.09 2544.3950 25 -12.1 849.1287 3 80.69 5 46502 VEV_2_3_RA5_01_1236.d 5.11E4 1 1 2 26 Acetylation (Protein N-term)
K.N(+.98)LQYYDISAK.S Y 43.87 1214.5819 10 -9.7 608.2924 2 68.83 5 38152 VEV_2_3_RA5_01_1236.d 1.81E5 2 2 141 150 Deamidation (NQ)
K.EAAQM(+15.99)PLPDEEDADF Y 43.70 1692.6825 15 -8.0 847.3417 2 74.95 6 41530 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 201 215 Oxidation (M)
K.SN(-17.03)YNFEKPFLWLAR.K Y 43.64 1766.8779 14 -2.6 884.4439 2 87.68 4 52306 VEV_1_3_RA4_01_1235.d 0 2 2 151 164 Ammonia-loss (N)
K.TITFHR.K Y 42.50 773.4184 6 -20.0 387.7087 2 26.44 6 10987 VEV_3_3_RA6_01_1237.d 5.19E6 6 6 133 138
R.HITGEFE(+14.02)KK.Y Y 42.44 1101.5818 9 -6.7 551.7945 2 29.08 4 12337 VEV_1_3_RA4_01_1235.d 7.74E4 1 1 28 36 Methylation(others)
K.TTFVKR.H Y 42.26 750.4388 6 -16.1 376.2206 2 15.05 4 4832 VEV_1_3_RA4_01_1235.d 2.05E6 5 5 22 27
K.SNYN(+.98)FEKPFLW(+31.99)LAR.K Y 41.64 1816.8784 14 -6.2 606.6296 3 79.71 4 46800 VEV_1_3_RA4_01_1235.d 6.04E4 1 1 151 164 Deamidation (NQ); Dihydroxy
R.HITGEFEKK(+14.02).Y Y 41.62 1101.5818 9 -12.9 551.7911 2 29.23 6 12459 VEV_3_3_RA6_01_1237.d 7.62E4 1 1 28 36 Methylation(KR)
K.AKTITFHR.K Y 41.28 972.5505 8 -16.7 325.1854 3 21.68 5 8634 VEV_2_3_RA5_01_1236.d 1.69E6 7 7 131 138
R.VC(+57.02)E(+14.02)NVPIVLC(+57.02)GNK.V Y 39.07 1514.7585 13 -5.1 758.3827 2 74.23 4 42536 VEV_1_3_RA4_01_1235.d 2.56E5 2 2 109 121 Carbamidomethylation; Methylation(others)
K.NLQ(+.98)YYDISAK.S Y 38.61 1214.5819 10 5.7 608.3017 2 65.45 4 35632 VEV_1_3_RA4_01_1235.d 7.08E5 4 4 141 150 Deamidation (NQ)
K.NLQYYD(+14.02)ISAK.S Y 37.92 1227.6135 10 -14.9 614.8049 2 66.92 6 35561 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 141 150 Methylation(others)
R.VC(+57.02)ENVPIVLC(+57.02)GN(+.98)KVDVKER.K Y 36.38 2228.1294 19 -6.9 558.0358 4 68.72 6 36922 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 109 127 Carbamidomethylation; Deamidation (NQ)
K.LVLVGD(+14.02)GGTGK.T Y 36.04 1028.5865 11 -10.2 515.2953 2 61.66 4 32723 VEV_1_3_RA4_01_1235.d 2.33E5 2 2 11 21 Methylation(others)
M.A(+42.01)AQAPPTFK.L Y 35.68 971.5076 9 -13.3 486.7546 2 62.34 5 33287 VEV_2_3_RA5_01_1236.d 6.91E6 12 12 2 10 Acetylation (Protein N-term)
K.FQTNLGAIQ(+.98)FDVWDTAGQEK(+14.02).F Y 33.83 2282.0854 20 -3.4 761.6998 3 85.88 6 49007 VEV_3_3_RA6_01_1237.d 5.63E4 1 1 50 69 Deamidation (NQ); Methylation(KR)
K.RHITGEFEK.K Y 33.39 1115.5723 9 -11.7 372.8604 3 24.87 5 10407 VEV_2_3_RA5_01_1236.d 3.98E5 2 2 27 35
K.FGGLRDGYYIN(+.98)GQ(+.98)C(+57.02)GIIMFDVTSR.I Y 33.27 2740.2625 24 5.4 914.4330 3 85.65 6 48862 VEV_3_3_RA6_01_1237.d 0 2 2 70 93 Deamidation (NQ); Carbamidomethylation
K.TTFVKR(+14.02).H Y 32.14 764.4545 6 -12.5 383.2297 2 20.08 4 7442 VEV_1_3_RA4_01_1235.d 8.41E4 1 1 22 27 Methylation(KR)
K.KNLQ(+.98)YYDISAK.S Y 30.45 1342.6769 11 5.2 672.3492 2 54.05 6 26679 VEV_3_3_RA6_01_1237.d 0 1 1 140 150 Deamidation (NQ)
K.LVLVGDGGTGKTTFVK.R Y 30.45 1590.8981 16 -28.9 796.4333 2 67.61 5 37231 VEV_2_3_RA5_01_1236.d 1.19E5 2 2 11 26
K.FQTN(+15.99)LGAIQFDVWDTAGQEK.F Y 30.09 2283.0808 20 3.6 762.0370 3 85.39 4 50856 VEV_1_3_RA4_01_1235.d 4.56E4 1 1 50 69 Oxidation or Hydroxylation
K.TTFVK.R Y 29.55 594.3377 5 -17.1 595.3348 1 18.54 6 6794 VEV_3_3_RA6_01_1237.d 4.66E4 2 2 22 26
K.SNYN(+.98)FEKPFLW(+15.99)LAR.K Y 28.14 1800.8834 14 -10.0 901.4399 2 81.64 4 48275 VEV_1_3_RA4_01_1235.d 5.53E4 1 1 151 164 Deamidation (NQ); Oxidation (HW)
R.HITGEFEK(+14.02)K.Y Y 26.39 1101.5818 9 -16.4 368.1952 3 29.22 6 12455 VEV_3_3_RA6_01_1237.d 8.87E4 1 1 28 36 Methylation(KR)
K.TTFVK(+14.02)R.H Y 26.22 764.4545 6 -14.2 383.2291 2 19.77 5 7611 VEV_2_3_RA5_01_1236.d 9.13E4 1 1 22 27 Methylation(KR)
K.SNYNFEK(+43.01)PFLWLAR(+14.02).K Y 25.60 1840.9260 14 -18.7 614.6378 3 82.27 4 48725 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 151 164 Carbamylation; Methylation(KR)
K.SN(+.98)YNFEKPFLW(+15.99)LAR.K Y 25.56 1800.8834 14 0.4 601.3020 3 80.40 5 46314 VEV_2_3_RA5_01_1236.d 7.56E4 1 1 151 164 Deamidation (NQ); Oxidation (HW)
R.VC(+57.02)EN(+.98)VPIVLC(+57.02)GNKVDVK(+14.02).E Y 25.53 1957.0012 17 -9.7 653.3347 3 74.06 5 41926 VEV_2_3_RA5_01_1236.d 0 1 1 109 125 Carbamidomethylation; Deamidation (NQ); Methylation(KR)
R.KKN(+.98)LQYYDISAK.S Y 24.24 1470.7719 12 -18.1 736.3799 2 47.23 5 23473 VEV_2_3_RA5_01_1236.d 6.41E4 1 1 139 150 Deamidation (NQ)
M.A(+42.01)AQAPPTFK(+14.02).L Y 23.57 985.5233 9 -11.4 493.7633 2 68.08 4 37700 VEV_1_3_RA4_01_1235.d 8.61E5 3 3 2 10 Acetylation (Protein N-term); Methylation(KR)
R.VC(+57.02)ENVPIVLC(+57.02)GNKVDVK(+143.06).E Y 21.72 2085.0598 17 -0.7 522.2719 4 80.68 6 45640 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 109 125 Carbamidomethylation; Nethylmaleimidehydrolysis
M(+42.01)AAQAPPTFK(+14.02).L Y 21.61 1116.5637 10 -12.7 559.2820 2 70.98 6 38589 VEV_3_3_RA6_01_1237.d 0 1 1 1 10 Acetylation (Protein N-term); Methylation(KR)
K.F(+27.99)QTNLGAIQFDVWDTAGQEK.F Y 20.59 2295.0808 20 -32.3 574.7590 4 57.12 6 28441 VEV_3_3_RA6_01_1237.d 0 1 1 50 69 Formylation
R.VC(+57.02)ENVPIVLC(+57.02)GN(+162.05)K.V Y 20.29 1662.7957 13 -19.9 555.2615 3 67.45 4 37203 VEV_1_3_RA4_01_1235.d 0 1 1 109 121 Carbamidomethylation; Hexose (NSY)
K.LVLVGDGGT(-18.01)GK.T Y 20.18 996.5604 11 -45.0 499.2650 2 57.70 4 29831 VEV_1_3_RA4_01_1235.d 0 1 1 11 21 Dehydration
K.A(+42.01)K(+42.01)TITFHR.K Y 20.18 1056.5717 8 -32.3 353.1865 3 21.49 6 8344 VEV_3_3_RA6_01_1237.d 0 1 1 131 138 Acetylation (N-term); Acetylation (K)
K.SNYNFEK(-1.03)PFLWLARK.L Y 20.13 1910.9679 15 -2.0 478.7483 4 78.52 6 44091 VEV_3_3_RA6_01_1237.d 9.92E4 1 1 151 165 Lysine oxidation to aminoadipic semialdehyde
K.FQTNLGAIQFDVWDTAGQEK(-.98).F Y 19.95 2266.1018 20 0.0 756.3745 3 85.65 6 48866 VEV_3_3_RA6_01_1237.d 1.49E5 1 1 50 69 Amidation
K.N(+.98)VPSWHRDLVR.V Y 19.68 1378.7106 11 -13.2 345.6804 4 56.11 5 28829 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 98 108 Deamidation (NQ)
K.R(+14.02)HITGEFEKK.Y Y 18.49 1257.6830 10 -4.6 315.4266 4 21.06 5 8363 VEV_2_3_RA5_01_1236.d 4.59E5 1 1 27 36 Methylation(KR)
R.HITGEFEKK(-.98)(+42.01).Y Y 17.83 1128.5928 9 -65.0 377.1804 3 20.87 6 8045 VEV_3_3_RA6_01_1237.d 2.59E6 2 2 28 36 Amidation; Acetylation (K)
K.S(-2.02)NYNFEKPFLWLAR.K Y 17.60 1781.8889 14 21.1 594.9828 3 84.86 6 48373 VEV_3_3_RA6_01_1237.d 0 1 1 151 164 2-amino-3-oxo-butanoic_acid
R.DGYYINGQ(+.98)C(+57.02)GIIMFDVTSR.I Y 16.56 2208.9819 19 19.1 737.3486 3 86.89 5 50249 VEV_2_3_RA5_01_1236.d 0 1 1 75 93 Deamidation (NQ); Carbamidomethylation
K.SNYNFEKPF(+31.99)LWLAR.K Y 15.64 1815.8944 14 -6.8 606.3013 3 79.86 6 45070 VEV_3_3_RA6_01_1237.d 2.23E5 1 1 151 164 Dihydroxy
M.A(+42.01)AQ(+.98)APPTFK.L Y 15.54 972.4916 9 -18.9 487.2439 2 64.75 6 33922 VEV_3_3_RA6_01_1237.d 1.65E5 1 1 2 10 Acetylation (Protein N-term); Deamidation (NQ)
M.A(+43.01)AQAPPTFK.L Y 15.50 972.5028 9 -5.6 487.2560 2 62.33 5 33284 VEV_2_3_RA5_01_1236.d 2.5E5 1 1 2 10 Carbamylation
total 108 peptides
C1GGT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ATHGIYPLQNVHIR.K Y 145.22 1617.8739 14 -10.1 540.2932 3 64.58 4 34947 VEV_1_3_RA4_01_1235.d 3.03E6 6 6 199 212
R.IFEVSLADLQNDEDHAFRK.V Y 141.78 2246.0967 19 -10.6 562.5255 4 79.14 4 46371 VEV_1_3_RA4_01_1235.d 1.79E6 8 8 65 83
K.NC(+57.02)LTNFHGLDFTSDKLR.S Y 140.40 2036.9738 17 -14.1 510.2435 4 75.17 6 41687 VEV_3_3_RA6_01_1237.d 2.16E6 10 10 95 111 Carbamidomethylation
R.IFEVSLADLQNDEDHAFR.K Y 134.94 2118.0017 18 -0.3 1060.0078 2 82.28 4 48745 VEV_1_3_RA4_01_1235.d 1.24E6 8 8 65 82
K.TTDDYLLRLFAIAFTK.R Y 134.88 1887.0142 16 -13.6 630.0034 3 93.60 6 53027 VEV_3_3_RA6_01_1237.d 1.92E6 11 11 129 144
K.FDLGALLALHGESSTDDKGQKVER.E Y 132.02 2585.3083 24 -8.0 518.0648 5 77.47 4 45112 VEV_1_3_RA4_01_1235.d 1.01E6 6 6 222 245
K.FDLGALLALHGESSTDDKGQK.V Y 126.41 2201.0964 21 -9.9 551.2759 4 79.73 4 46814 VEV_1_3_RA4_01_1235.d 7.94E5 4 4 222 242
R.IFEVSLADLQNDEDHAFRKVK.L Y 117.30 2473.2600 21 -9.5 619.3164 4 77.82 5 44637 VEV_2_3_RA5_01_1236.d 1.24E6 6 6 65 85
R.EIEKATHGIYPLQNVHIR.K Y 115.70 2117.1382 18 -14.9 530.2839 4 65.93 5 35977 VEV_2_3_RA5_01_1236.d 7.66E5 9 9 195 212
R.TTGLKNANDALKGR.I Y 102.92 1457.7950 14 -9.8 486.9342 3 33.50 4 14926 VEV_1_3_RA4_01_1235.d 5.34E6 19 19 51 64
R.TQDPFSRKDEYSVK.A Y 101.98 1698.8213 14 -12.6 567.2739 3 50.99 6 24867 VEV_3_3_RA6_01_1237.d 4.35E6 15 15 20 33
K.KTTYAQSSQIR.A Y 100.71 1281.6677 11 -15.6 641.8311 2 20.37 6 7773 VEV_3_3_RA6_01_1237.d 1.08E6 10 10 152 162
K.TTYAQSSQIR.A Y 97.27 1153.5728 10 -13.6 577.7858 2 30.17 5 13359 VEV_2_3_RA5_01_1236.d 3.92E6 12 12 153 162
K.APSTFAIRDVGK.T Y 93.61 1260.6826 12 -9.4 631.3427 2 57.86 4 29971 VEV_1_3_RA4_01_1235.d 1.31E6 8 8 34 45
K.ATHGIYPLQ(+.98)NVHIR.K Y 92.17 1618.8579 14 -6.6 405.7191 4 64.42 6 33682 VEV_3_3_RA6_01_1237.d 1.07E6 4 4 199 212 Deamidation (NQ)
K.TTDDYLLRLFAIAFTKR.R Y 85.94 2043.1152 17 -14.8 682.0356 3 90.03 4 53666 VEV_1_3_RA4_01_1235.d 5.7E5 5 5 129 145
K.LIPEVIGREIEKATHGIYPLQNVHIR.K Y 85.30 2994.6765 26 -6.0 599.9390 5 83.62 4 49705 VEV_1_3_RA4_01_1235.d 7.53E5 5 5 187 212
R.IFEVSLADLQNDED(+14.02)HAFR.K Y 84.23 2132.0173 18 -6.1 711.6754 3 85.86 4 51201 VEV_1_3_RA4_01_1235.d 2.92E5 3 3 65 82 Methylation(others)
K.TTDDYLLR.L Y 83.14 995.4924 8 -10.8 498.7481 2 60.21 4 31631 VEV_1_3_RA4_01_1235.d 2.1E6 6 6 129 136
K.SPKFDLGALLALHGESSTDDKGQK.V Y 82.72 2513.2761 24 -14.7 503.6551 5 77.09 5 44084 VEV_2_3_RA5_01_1236.d 3.03E5 4 4 219 242
K.FDLGALLALHGESSTDDK.G Y 82.54 1887.9214 18 -11.4 630.3073 3 83.13 6 47277 VEV_3_3_RA6_01_1237.d 2.03E5 3 3 222 239
K.ATHGIYPLQNVHIRK.V Y 80.88 1745.9689 15 -10.5 350.1974 5 58.63 4 30522 VEV_1_3_RA4_01_1235.d 6.2E5 2 2 199 213
R.TTGLKNANDALK.G Y 80.31 1244.6725 12 -13.0 623.3354 2 32.09 6 14018 VEV_3_3_RA6_01_1237.d 1.08E6 9 9 51 62
R.IFE(+14.02)VSLADLQNDEDHAFRK.V Y 80.03 2260.1123 19 -18.3 566.0250 4 79.90 4 46937 VEV_1_3_RA4_01_1235.d 6E5 3 3 65 83 Methylation(others)
R.KWQTLIEANVTVK.T Y 76.81 1528.8613 13 -10.1 510.6226 3 72.18 4 40934 VEV_1_3_RA4_01_1235.d 4.68E5 4 4 116 128
K.TTDDYLLRLFAIAFTK(+14.02).R Y 76.02 1901.0298 16 -8.4 634.6785 3 94.85 4 56224 VEV_1_3_RA4_01_1235.d 2.71E5 2 2 129 144 Methylation(KR)
R.TQDPFSRKDEYSVKAPSTFAIR.D Y 73.92 2542.2815 22 -15.5 509.4557 5 69.71 6 37681 VEV_3_3_RA6_01_1237.d 5.59E5 3 3 20 41
R.KDEYSVKAPSTFAIR.D Y 73.01 1710.8940 15 -10.7 428.7262 4 64.25 4 34696 VEV_1_3_RA4_01_1235.d 2.88E5 3 3 27 41
R.IFEVSLADLQNDE(+14.02)DHAFRK.V Y 70.76 2260.1123 19 -16.3 566.0261 4 82.64 6 46981 VEV_3_3_RA6_01_1237.d 5.96E5 3 3 65 83 Methylation(others)
R.IFEVSLADLQNDE(+14.02)DHAFR.K Y 69.54 2132.0173 18 -3.8 1067.0118 2 85.85 4 51146 VEV_1_3_RA4_01_1235.d 3.71E4 1 1 65 82 Methylation(others)
K.NC(+57.02)LTN(+.98)FHGLDFTSDKLR.S Y 68.02 2037.9578 17 -5.9 510.4937 4 77.24 4 44954 VEV_1_3_RA4_01_1235.d 3.05E5 3 3 95 111 Carbamidomethylation; Deamidation (NQ)
K.NANDALKGR.I Y 67.94 957.4991 9 -17.6 479.7484 2 12.99 6 3930 VEV_3_3_RA6_01_1237.d 5.14E5 5 5 56 64
K.TTYAQSSQ(+.98)IR.A Y 67.62 1154.5568 10 -8.3 578.2809 2 32.95 4 14542 VEV_1_3_RA4_01_1235.d 7.07E5 6 6 153 162 Deamidation (NQ)
K.LRVDEVQGK.N Y 66.31 1042.5770 9 -14.1 522.2885 2 30.10 5 13316 VEV_2_3_RA5_01_1236.d 4.94E6 10 10 86 94
R.LFAIAFTKR.R Y 66.22 1065.6334 9 -9.7 356.2150 3 70.39 4 39549 VEV_1_3_RA4_01_1235.d 1.46E5 2 2 137 145
R.IFE(+14.02)VSLADLQNDEDHAFR.K Y 65.46 2132.0173 18 -10.7 711.6721 3 83.13 4 49313 VEV_1_3_RA4_01_1235.d 3.56E5 4 4 65 82 Methylation(others)
R.IFEVSLADLQ(+.98)NDEDHAFRK.V Y 65.16 2247.0808 19 -10.6 562.7715 4 80.45 4 47361 VEV_1_3_RA4_01_1235.d 1.29E5 2 2 65 83 Deamidation (NQ)
R.TQDPFSR.K Y 61.89 849.3981 7 -7.1 425.7033 2 37.69 4 17327 VEV_1_3_RA4_01_1235.d 1.74E6 7 7 20 26
K.APSTFAIR.D Y 61.06 861.4708 8 -18.0 431.7350 2 52.73 6 25895 VEV_3_3_RA6_01_1237.d 3.31E6 10 10 34 41
K.TTYAQSSQIR(+14.02).A Y 60.71 1167.5884 10 -10.2 584.7955 2 43.56 5 21300 VEV_2_3_RA5_01_1236.d 5.38E5 4 4 153 162 Methylation(KR)
K.MVEIIQR.E Y 59.75 887.4899 7 -18.0 444.7442 2 57.90 6 28962 VEV_3_3_RA6_01_1237.d 9.26E5 9 9 168 174
K.LIPEVIGR.E Y 58.74 895.5491 8 -6.2 448.7790 2 66.96 5 36752 VEV_2_3_RA5_01_1236.d 1.62E6 3 3 187 194
R.LFAIAFTK.R Y 58.50 909.5323 8 -12.9 455.7676 2 77.50 4 45111 VEV_1_3_RA4_01_1235.d 1.32E6 4 4 137 144
K.GRIFEVSLADLQNDEDHAFR.K Y 56.33 2331.1243 20 -6.3 583.7847 4 80.08 5 46107 VEV_2_3_RA5_01_1236.d 1.64E5 1 1 63 82
K.GRIFEVSLADLQNDEDHAFRK.V Y 55.78 2459.2192 21 -22.6 492.8400 5 77.56 4 45139 VEV_1_3_RA4_01_1235.d 7.59E4 1 1 63 83
K.TTYAQ(+.98)SSQIR.A Y 55.43 1154.5568 10 -9.9 578.2800 2 33.82 4 15043 VEV_1_3_RA4_01_1235.d 1.04E6 5 5 153 162 Deamidation (NQ)
K.A(+43.01)PSTFAIRDVGK.T Y 54.53 1303.6884 12 -9.0 435.5662 3 57.86 4 29911 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 34 45 Carbamylation
R.EFKETVLESV Y 54.34 1179.6023 10 -10.3 590.8024 2 72.58 5 40892 VEV_2_3_RA5_01_1236.d 3.21E5 2 2 246 255
R.DVGKTLVNR.T Y 53.65 1000.5665 9 -11.4 334.5256 3 32.21 5 14539 VEV_2_3_RA5_01_1236.d 4.05E5 5 5 42 50
K.N(+.98)C(+57.02)LTN(+.98)FHGLDFTSDKLR.S Y 51.01 2038.9418 17 10.5 680.6617 3 75.37 4 43423 VEV_1_3_RA4_01_1235.d 1.71E5 1 1 95 111 Deamidation (NQ); Carbamidomethylation
K.ATHGIYPLQNVHIR(+14.02).K Y 50.79 1631.8895 14 -14.2 408.9739 4 67.50 4 37240 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 199 212 Methylation(KR)
K.M(+15.99)VEIIQR.E Y 50.63 903.4848 7 -15.4 452.7427 2 44.90 6 21341 VEV_3_3_RA6_01_1237.d 4.82E5 9 9 168 174 Oxidation (M)
K.WQTLIEANVTVK.T Y 48.68 1400.7664 12 -45.4 701.3586 2 75.97 6 42260 VEV_3_3_RA6_01_1237.d 0 1 1 117 128
R.IFEVSLADLQNDEDHAFR(+14.02)K.V Y 48.59 2260.1123 19 -20.2 566.0239 4 79.09 4 46310 VEV_1_3_RA4_01_1235.d 1.8E5 3 3 65 83 Methylation(KR)
R.IFEVS(-2.02)LADLQNDEDHAFR.K Y 48.16 2115.9861 18 38.1 706.3629 3 82.47 4 48861 VEV_1_3_RA4_01_1235.d 8.71E4 1 1 65 82 2-amino-3-oxo-butanoic_acid
K.LIPEVIGREIEK.A Y 47.93 1394.8132 12 -10.9 465.9399 3 71.40 4 40323 VEV_1_3_RA4_01_1235.d 1.59E6 8 8 187 198
R.TTGLKNANDALK(+14.02)GR.I Y 45.91 1471.8107 14 -13.7 491.6041 3 42.34 5 20524 VEV_2_3_RA5_01_1236.d 3.21E4 1 1 51 64 Methylation(KR)
R.SLAQLTK.L Y 42.48 759.4490 7 -9.9 760.4488 1 37.75 4 17365 VEV_1_3_RA4_01_1235.d 5.34E6 13 13 180 186
K.FDLGALLALHGESS(+14.02)TDDKGQK.V Y 42.44 2215.1121 21 -10.9 554.7792 4 80.90 4 47741 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 222 242 Methylation(others)
R.SLVRKWQTLIEANVTVK.T Y 41.76 1984.1470 17 4.9 497.0464 4 78.85 5 45287 VEV_2_3_RA5_01_1236.d 0 1 1 112 128
K.APSTFAIR(+14.02).D Y 41.74 875.4865 8 -12.2 438.7452 2 62.92 4 33695 VEV_1_3_RA4_01_1235.d 9.66E4 1 1 34 41 Methylation(KR)
K.N(+.98)C(+57.02)LTNFHGLDFTSDKLR.S Y 41.40 2037.9578 17 -4.5 510.4944 4 77.72 4 45264 VEV_1_3_RA4_01_1235.d 1.7E5 2 2 95 111 Deamidation (NQ); Carbamidomethylation
K.NC(+57.02)LTNFHGLD(+14.02)FTSDKLR.S Y 40.63 2050.9895 17 -16.0 513.7465 4 74.67 4 42870 VEV_1_3_RA4_01_1235.d 7.67E4 1 1 95 111 Carbamidomethylation; Methylation(others)
R.K(+14.02)DEYSVK(+43.01)APSTFAIRDVGK.T Y 39.08 2167.1272 19 36.2 434.4484 5 58.02 4 30024 VEV_1_3_RA4_01_1235.d 9.61E4 1 1 27 45 Methylation(KR); Carbamylation
R.KDEYSVK(-1.03)APSTFAIRDVGK.T Y 38.78 2109.0742 19 12.4 528.2823 4 64.12 5 34611 VEV_2_3_RA5_01_1236.d 0 1 1 27 45 Lysine oxidation to aminoadipic semialdehyde
R.IFEVSLADLQN(+.98)DEDHAFR.K Y 37.69 2118.9858 18 17.5 707.3483 3 81.69 6 46402 VEV_3_3_RA6_01_1237.d 1.18E5 2 2 65 82 Deamidation (NQ)
K.RTQDPFSR.K Y 36.37 1005.4991 8 -11.9 503.7509 2 27.35 4 11390 VEV_1_3_RA4_01_1235.d 6.92E4 1 1 19 26
K.NC(+57.02)LT(-2.02)NFHGLDFTSDKLR.S Y 35.54 2034.9581 17 8.6 679.3325 3 75.43 4 43463 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 95 111 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
K.ATHGIYPLQNVH(+14.02)IR.K Y 35.23 1631.8895 14 -6.5 408.9770 4 67.32 5 37013 VEV_2_3_RA5_01_1236.d 6.35E4 1 1 199 212 Methylation(others)
K.TLVNR.T Y 35.06 601.3547 5 -10.9 301.6814 2 15.99 4 5296 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 46 50
K.NC(+57.02)LTNFHGLDFTSDK(+14.02)LR.S Y 35.05 2050.9895 17 -2.2 513.7535 4 77.03 4 44720 VEV_1_3_RA4_01_1235.d 1.83E5 1 1 95 111 Carbamidomethylation; Methylation(KR)
R.TQDPFSR(+14.02).K Y 34.96 863.4137 7 -7.8 432.7108 2 41.76 4 19808 VEV_1_3_RA4_01_1235.d 2.59E5 2 2 20 26 Methylation(KR)
K.NC(+57.02)LTNFHGLDFTSDKLR(+14.02).S Y 34.39 2050.9895 17 -7.2 513.7510 4 77.16 6 43124 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 95 111 Carbamidomethylation; Methylation(KR)
K.FDLGALLALHGESSTDDK(+14.02)GQK.V Y 32.76 2215.1121 21 -9.3 554.7802 4 80.72 6 45662 VEV_3_3_RA6_01_1237.d 1.98E5 2 2 222 242 Methylation(KR)
R.TTGLKNANDALKGR(+14.02).I Y 32.67 1471.8107 14 -25.8 368.9504 4 42.36 6 19872 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 51 64 Methylation(KR)
K.VKLRVDEVQGK.N Y 30.32 1269.7405 11 -9.6 635.8714 2 37.60 6 17115 VEV_3_3_RA6_01_1237.d 2.51E4 1 1 84 94
K.A(+42.01)PSTFAIRDVGK.T Y 30.20 1302.6931 12 -44.0 435.2192 3 57.58 6 28763 VEV_3_3_RA6_01_1237.d 3.78E4 1 1 34 45 Acetylation (N-term)
R.SLAQLTK(+14.02).L Y 29.65 773.4647 7 -23.2 774.4540 1 47.97 4 23619 VEV_1_3_RA4_01_1235.d 5.89E5 6 6 180 186 Methylation(KR)
K.LLKSPK.F N 29.29 684.4534 6 -15.6 685.4500 1 14.86 5 4949 VEV_2_3_RA5_01_1236.d 4.65E5 5 5 216 221
K.LIPE(+14.02)VIGR.E Y 28.65 909.5647 8 -8.8 455.7856 2 70.48 4 39590 VEV_1_3_RA4_01_1235.d 1.92E5 2 2 187 194 Methylation(others)
R.TTGLKN(+.98)ANDALKGR.I Y 28.65 1458.7791 14 -3.9 365.7006 4 41.51 6 19358 VEV_3_3_RA6_01_1237.d 2.02E5 2 2 51 64 Deamidation (NQ)
R.TQ(+.98)DPFSR.K Y 28.61 850.3821 7 14.5 426.2045 2 37.00 5 17359 VEV_2_3_RA5_01_1236.d 5.67E5 3 3 20 26 Deamidation (NQ)
K.KMVEIIQR.E Y 28.50 1015.5848 8 -15.2 339.5304 3 48.53 5 24243 VEV_2_3_RA5_01_1236.d 1.48E5 2 2 167 174
R.EAGTRSLAQLTK(+138.10)LIPEVIGREIEK.A Y 28.39 2788.6062 24 -17.8 698.1464 4 71.26 5 39924 VEV_2_3_RA5_01_1236.d 0 1 1 175 198 Dehydrated 4-hydroxynonenal
R.SLAQ(+.98)LTK.L Y 27.93 760.4330 7 -20.3 381.2161 2 40.25 6 18629 VEV_3_3_RA6_01_1237.d 6.85E5 5 5 180 186 Deamidation (NQ)
R.IFEVSLADLQND(+28.03)EDHAFR.K Y 27.16 2146.0330 18 -3.0 716.3494 3 86.56 4 51601 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 65 82 Ethylation
R.S(+42.01)LAQLTK.L Y 26.09 801.4596 7 -43.3 401.7197 2 36.72 5 17198 VEV_2_3_RA5_01_1236.d 8.86E4 1 1 180 186 Acetylation (N-term)
R.T(-18.01)TGLK(+14.02)NANDALKGR.I Y 25.95 1453.8000 14 -41.3 364.4423 4 33.70 5 15399 VEV_2_3_RA5_01_1236.d 2.07E5 1 1 51 64 Dehydration; Methylation(KR)
K.FDLGALLALHGESSTD(-18.01)DK(+14.02)GQKVER.E Y 25.04 2581.3135 24 17.6 517.2791 5 77.48 6 43355 VEV_3_3_RA6_01_1237.d 0 1 1 222 245 Dehydration; Methylation(KR)
MAVGK(+43.01).N Y 24.40 547.2788 5 16.4 548.2950 1 75.27 4 43342 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 1 5 Carbamylation
K.TTYAQSSQ(+.98)IR(+14.02).A Y 24.28 1168.5724 10 12.9 585.3010 2 41.97 6 19632 VEV_3_3_RA6_01_1237.d 0 2 2 153 162 Deamidation (NQ); Methylation(KR)
R.SLAQLTKLIPEVIGREIEK.A Y 24.01 2136.2517 19 -9.8 428.2534 5 69.11 6 37203 VEV_3_3_RA6_01_1237.d 0 1 1 180 198
R.DVGKT(+79.96)LVNR.T Y 23.30 1080.5233 9 36.6 361.1949 3 59.68 6 30213 VEV_3_3_RA6_01_1237.d 3.92E4 1 1 42 50 Sulfation
K.E(+27.99)TVLESV Y 21.64 803.3912 7 -5.9 804.3937 1 112.85 5 59612 VEV_2_3_RA5_01_1236.d 1.57E4 1 1 249 255 Formylation
R.TQD(+14.02)PFSR.K Y 21.29 863.4137 7 -7.0 432.7111 2 52.08 4 26241 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 20 26 Methylation(others)
M(+15.99)AVGK.N Y 21.19 520.2679 5 -11.1 521.2694 1 64.81 4 35133 VEV_1_3_RA4_01_1235.d 4.47E4 2 2 1 5 Oxidation (M)
K.L(+41.03)IPEVIGREIEK.A Y 20.96 1435.8398 12 -26.2 479.6080 3 71.33 6 38856 VEV_3_3_RA6_01_1237.d 0 1 1 187 198 Amidination of lysines or N-terminal amines with methyl acetimidate
K.LRVDEVQ(+.98)GK.N Y 20.94 1043.5610 9 -11.7 522.7817 2 35.37 5 16383 VEV_2_3_RA5_01_1236.d 9.75E4 1 1 86 94 Deamidation (NQ)
K.LR(+39.99)SLVRKWQTLIEANVTVK.T Y 20.74 2293.3269 19 -25.3 765.4302 3 72.13 5 40564 VEV_2_3_RA5_01_1236.d 1.78E4 1 1 110 128 Glyoxal-derived hydroimiadazolone
R.EAGT(-18.01)R.S Y 20.67 514.2499 5 10.2 515.2625 1 29.36 6 12523 VEV_3_3_RA6_01_1237.d 6.62E4 2 2 175 179 Dehydration
R.K(+27.99)WQTLIEANVTVK.T Y 20.65 1556.8562 13 -27.5 390.2106 4 68.46 5 37879 VEV_2_3_RA5_01_1236.d 3.42E5 1 1 116 128 Formylation
K.NAN(+.98)DALKGR.I Y 20.39 958.4832 9 -9.8 480.2441 2 16.43 4 5533 VEV_1_3_RA4_01_1235.d 1.33E4 1 1 56 64 Deamidation (NQ)
R.TTGLKN(+.98)ANDALK.G Y 20.23 1245.6565 12 -25.4 623.8197 2 40.31 4 18877 VEV_1_3_RA4_01_1235.d 2.48E4 1 1 51 62 Deamidation (NQ)
R.TTGLKNAN(+.98)DALKGR.I Y 20.21 1458.7791 14 -3.7 365.7007 4 41.69 5 20127 VEV_2_3_RA5_01_1236.d 1.38E5 1 1 51 64 Deamidation (NQ)
K.RTQDPFSRKDEYSVK.A Y 20.00 1854.9224 15 12.3 464.7436 4 43.53 4 20857 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 19 33
R.KDEYSVKAPSTFAIR(+.98).D Y 19.88 1711.8781 15 11.2 428.9816 4 63.98 5 34520 VEV_2_3_RA5_01_1236.d 9.34E4 1 1 27 41 Deamidation (R)
K.KTTYAQSSQ(+.98)IR.A Y 19.79 1282.6517 11 -25.4 642.3168 2 22.70 6 8979 VEV_3_3_RA6_01_1237.d 2.82E4 2 2 152 162 Deamidation (NQ)
K.LRVDE(+14.02)VQGK.N Y 19.79 1056.5928 9 -6.4 529.3003 2 39.41 4 18343 VEV_1_3_RA4_01_1235.d 4.24E5 2 2 86 94 Methylation(others)
R.RPNQIKK.T Y 19.69 882.5399 7 -10.1 442.2728 2 9.03 5 2151 VEV_2_3_RA5_01_1236.d 1.58E4 2 2 146 152
R.TQDPFSRKDEYSVK(+14.02).A Y 19.68 1712.8369 14 -5.6 429.2141 4 58.84 4 30625 VEV_1_3_RA4_01_1235.d 7.44E4 1 1 20 33 Methylation(KR)
K.M(+15.99)VEIIQR(+14.02).E Y 19.61 917.5004 7 -25.5 918.4843 1 88.30 4 52686 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 168 174 Oxidation (M); Methylation(KR)
K.LIPEVIGR(+14.02).E Y 19.26 909.5647 8 -17.2 455.7818 2 70.16 6 37972 VEV_3_3_RA6_01_1237.d 2.14E5 2 2 187 194 Methylation(KR)
R.EAGTR.S Y 19.05 532.2605 5 -20.2 533.2570 1 55.69 5 28575 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 175 179
K.KTTYAQ(+.98)SSQIR.A Y 18.95 1282.6517 11 -38.1 642.3087 2 23.27 6 9276 VEV_3_3_RA6_01_1237.d 0 1 1 152 162 Deamidation (NQ)
K.N(+.98)ANDALKGR.I Y 18.83 958.4832 9 -22.7 480.2380 2 13.49 4 4047 VEV_1_3_RA4_01_1235.d 0 1 1 56 64 Deamidation (NQ)
K.TLVNRTTGLKNANDALKGR.I Y 18.29 2041.1392 19 -17.9 409.2278 5 55.63 5 28524 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 46 64
K.KTTYAQ(+.98)SSQIR(+14.02).A Y 17.35 1296.6674 11 -10.1 433.2254 3 31.73 4 13846 VEV_1_3_RA4_01_1235.d 0 1 1 152 162 Deamidation (NQ); Methylation(KR)
R.EIEK(-1.03)ATHGIYPLQNVHIR.K Y 17.18 2116.1064 18 -6.6 424.2258 5 66.14 4 36170 VEV_1_3_RA4_01_1235.d 3E5 1 1 195 212 Lysine oxidation to aminoadipic semialdehyde
K.TTDDYLLR(+14.02).L Y 16.99 1009.5080 8 -15.4 505.7535 2 66.12 6 34975 VEV_3_3_RA6_01_1237.d 1.91E5 1 1 129 136 Methylation(KR)
K.W(+42.01)Q(+.98)TLIEANVT(+79.97)VK.T Y 16.94 1523.7273 12 -17.0 762.8580 2 94.63 6 53453 VEV_3_3_RA6_01_1237.d 3.74E4 1 1 117 128 Acetylation (N-term); Deamidation (NQ); Phosphorylation (STY)
MAVGKNK.R Y 16.71 746.4109 7 -56.8 747.3757 1 92.27 5 53017 VEV_2_3_RA5_01_1236.d 3.04E5 2 2 1 7
K.TLVN(+.98)R(+14.02).T Y 16.56 616.3544 5 -13.0 617.3537 1 84.52 4 50260 VEV_1_3_RA4_01_1235.d 9.27E3 1 1 46 50 Deamidation (NQ); Methylation(KR)
K.LIPE(+14.02)VIGREIEK.A Y 16.50 1408.8289 12 -17.0 470.6089 3 71.72 6 39148 VEV_3_3_RA6_01_1237.d 6.41E4 1 1 187 198 Methylation(others)
R.K(+314.19)DEYSVKAPSTFAIR.D Y 15.82 2025.0823 15 47.4 507.3018 4 69.58 5 38753 VEV_2_3_RA5_01_1236.d 0 1 1 27 41 Levuglandinyl-lysine anhydrolactam adduct
R.EAGTRSLAQLTK(+43.99).L Y 15.72 1317.6888 12 2.7 440.2381 3 35.55 4 16074 VEV_1_3_RA4_01_1235.d 0 1 1 175 186 Carboxylation (DKW)
R.DVGK(+41.03)TLVNR.T Y 15.70 1041.5930 9 -20.0 348.1980 3 32.35 4 14208 VEV_1_3_RA4_01_1235.d 0 1 1 42 50 Amidination of lysines or N-terminal amines with methyl acetimidate
M(+27.99)AVGK.N Y 15.35 532.2679 5 -21.8 533.2635 1 20.78 5 8165 VEV_2_3_RA5_01_1236.d 1.73E4 1 1 1 5 Formylation (Protein N-term)
total 127 peptides
A0A0A0HS69
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VDGYILEGEELAFYQR.A Y 156.82 1900.9207 16 -10.9 634.6406 3 84.03 6 47862 VEV_3_3_RA6_01_1237.d 1.13E6 8 8 432 447
K.SAVVQVDAAPFRQWYEAHYGQTLGR.R Y 154.92 2848.4045 25 -8.9 950.4670 3 80.37 5 46308 VEV_2_3_RA5_01_1236.d 4.27E6 11 11 348 372
R.FAAQGKVDPALEKQFEAGR.L Y 146.04 2061.0642 19 -16.0 516.2651 4 65.40 6 34442 VEV_3_3_RA6_01_1237.d 5.01E5 7 7 399 417
K.VRVIVVSYHPSNNELVR.T Y 145.23 1980.0905 17 -13.8 496.0231 4 67.13 4 36941 VEV_1_3_RA4_01_1235.d 9.05E5 3 3 325 341
R.LYAVISSRPGQSGRVDGYILEGEELAFYQR.A Y 134.03 3372.7102 30 -10.4 675.5423 5 83.02 5 47970 VEV_2_3_RA5_01_1236.d 1.16E6 5 5 418 447
R.VIVVSYHPSNNELVR.T Y 123.92 1724.9209 15 -12.4 863.4570 2 66.65 6 35392 VEV_3_3_RA6_01_1237.d 6.05E6 12 12 327 341
R.ALRLESGNFSWGSEGISR.K Y 117.95 1964.9703 18 -8.3 983.4843 2 75.87 5 43243 VEV_2_3_RA5_01_1236.d 1.53E6 9 9 306 323
R.LESGNFSWGSEGISR.K Y 105.96 1624.7480 15 -12.4 813.3712 2 73.15 6 40219 VEV_3_3_RA6_01_1237.d 1.43E6 4 4 309 323
R.Q(-17.03)WYEAHYGQTLGR.R Y 103.50 1590.7216 13 -8.0 796.3617 2 74.68 4 42886 VEV_1_3_RA4_01_1235.d 8.47E5 4 4 360 372 Pyro-glu from Q
R.FAAQGKVDPALEK.Q Y 101.47 1372.7350 13 -17.4 458.5776 3 50.48 6 24593 VEV_3_3_RA6_01_1237.d 4.29E6 14 14 399 411
R.LYAVISSRPGQSGR.V Y 100.07 1489.8000 14 -11.7 497.6015 3 55.04 4 28121 VEV_1_3_RA4_01_1235.d 2.59E6 7 7 418 431
R.LYAVISSR(+.98)PGQSGRVDGYILEGEELAFYQR.A Y 96.55 3373.6941 30 -3.3 844.4280 4 83.17 4 49344 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 418 447 Deamidation (R)
K.VDPALEKQFEAGR.L Y 95.93 1458.7466 13 -7.8 730.3749 2 61.68 4 32744 VEV_1_3_RA4_01_1235.d 8.85E5 8 8 405 417
R.VDGYILEGEE(+14.02)LAFYQR.A Y 94.32 1914.9363 16 -7.7 639.3145 3 86.61 6 49460 VEV_3_3_RA6_01_1237.d 3.09E5 5 5 432 447 Methylation(others)
R.QWYEAHYGQTLGR.R Y 93.41 1607.7480 13 -7.0 536.9196 3 64.79 4 35115 VEV_1_3_RA4_01_1235.d 5.32E5 4 4 360 372
K.SAVVQVDAAPFRQWYEAHYGQ(+.98)TLGR.R Y 89.56 2849.3884 25 -4.6 713.3511 4 80.87 4 47693 VEV_1_3_RA4_01_1235.d 1.21E5 5 5 348 372 Deamidation (NQ)
R.VDGYILEGEELAFYQRAIRK Y 88.58 2369.2378 20 -9.6 593.3110 4 80.90 4 47750 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 432 451
R.Q(-17.03)QKLGTENTEEKKSK.S Y 87.88 1729.8846 15 -6.7 577.6317 3 14.60 4 4589 VEV_1_3_RA4_01_1235.d 3.33E5 6 6 375 389 Pyro-glu from Q
R.ALRLESGNFSWGSEGISRK.V Y 85.04 2093.0654 19 -13.8 524.2664 4 70.84 6 38477 VEV_3_3_RA6_01_1237.d 6.37E5 6 6 306 324
K.SAVVQ(+.98)VDAAPFRQWYEAHYGQTLGR.R Y 81.73 2849.3884 25 -2.2 713.3528 4 80.54 5 46404 VEV_2_3_RA5_01_1236.d 4.07E5 4 4 348 372 Deamidation (NQ)
R.VDGYILEGE(+14.02)ELAFYQR.A Y 81.63 1914.9363 16 -4.9 639.3162 3 87.83 5 50753 VEV_2_3_RA5_01_1236.d 3.33E5 3 3 432 447 Methylation(others)
R.LESGNFSWGSEGISRK.V Y 79.64 1752.8430 16 -7.5 585.2839 3 66.87 4 36820 VEV_1_3_RA4_01_1235.d 1.23E5 2 2 309 324
K.LGTENTEEKKSK.S Y 79.24 1362.6990 12 -9.3 455.2360 3 9.98 4 2461 VEV_1_3_RA4_01_1235.d 8.82E5 9 9 378 389
K.SAVVQVDAAPFRQWYEAHYGQTLGRR.R Y 77.80 3004.5056 26 -4.8 601.9055 5 78.30 5 44922 VEV_2_3_RA5_01_1236.d 3.14E5 2 2 348 373
K.SAVVQVDAAPFRQWYEAHY(+125.90)GQTLGR.R Y 77.80 2974.3010 25 -9.7 744.5753 4 83.13 4 49314 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 348 372 Iodination
K.SAVVQVDAAPFR(+14.02)QWYEAHYGQTLGR.R Y 76.62 2862.4202 25 -11.4 716.6041 4 80.32 6 45385 VEV_3_3_RA6_01_1237.d 1.65E6 3 3 348 372 Methylation(KR)
K.LGTENTEEK.K Y 75.16 1019.4771 9 -13.7 510.7389 2 14.88 6 4897 VEV_3_3_RA6_01_1237.d 7.18E5 8 8 378 386
R.VIVVSYHPSNNELVR(+14.02).T Y 74.38 1738.9366 15 -10.0 580.6470 3 69.63 4 38921 VEV_1_3_RA4_01_1235.d 1.33E6 9 9 327 341 Methylation(KR)
R.AFEKGRQPANTR.I Y 73.52 1373.7163 12 -13.0 458.9067 3 13.86 6 4391 VEV_3_3_RA6_01_1237.d 2.64E6 9 9 275 286
K.SAVVQVDAAPFR.Q Y 73.26 1258.6670 12 -9.6 630.3347 2 69.51 4 38831 VEV_1_3_RA4_01_1235.d 1.32E6 5 5 348 359
K.LGTENTEEKK.S Y 70.70 1147.5720 10 -6.9 574.7893 2 11.64 4 3152 VEV_1_3_RA4_01_1235.d 6.22E5 6 6 378 387
R.VIVVSYHPSN(+.98)NELVR.T Y 70.44 1725.9049 15 -10.5 576.3029 3 69.03 4 38464 VEV_1_3_RA4_01_1235.d 8.59E5 8 8 327 341 Deamidation (NQ)
R.VDGYILE(+14.02)GEELAFYQR.A Y 70.31 1914.9363 16 -12.5 639.3114 3 86.56 5 50056 VEV_2_3_RA5_01_1236.d 8.38E4 3 3 432 447 Methylation(others)
R.Q(-17.03)QKLGTENTEEKK.S Y 69.59 1514.7576 13 -8.6 758.3795 2 18.80 5 7089 VEV_2_3_RA5_01_1236.d 2.73E5 4 4 375 387 Pyro-glu from Q
R.VIVVSYHPSNN(+.98)ELVR.T Y 68.59 1725.9049 15 -7.8 576.3044 3 68.21 4 37805 VEV_1_3_RA4_01_1235.d 2.77E5 2 2 327 341 Deamidation (NQ)
R.VDGYILEGEELAFYQR(+14.02).A Y 66.57 1914.9363 16 -10.8 639.3125 3 84.89 4 50516 VEV_1_3_RA4_01_1235.d 4.32E5 5 5 432 447 Methylation(KR)
K.VDPALEKQFEAGR(+14.02).L Y 66.22 1472.7623 13 6.7 491.9313 3 64.82 4 35135 VEV_1_3_RA4_01_1235.d 0 3 3 405 417 Methylation(KR)
R.QQKLGTENTEEKK.S Y 64.13 1531.7842 13 -9.7 511.5970 3 12.07 4 3337 VEV_1_3_RA4_01_1235.d 3.59E4 2 2 375 387
R.ALRLESGNFSWGSE(+14.02)GISR.K Y 63.21 1978.9861 18 -9.1 660.6633 3 77.78 5 44568 VEV_2_3_RA5_01_1236.d 4.47E4 1 1 306 323 Methylation(others)
K.SAVVQVDAAPFRQ(+.98)WYEAHYGQTLGR.R Y 62.81 2849.3884 25 -11.3 713.3463 4 81.16 6 45972 VEV_3_3_RA6_01_1237.d 3.55E5 1 1 348 372 Deamidation (NQ)
R.FAAQGK(+14.02)VD(-18.01)PALEKQFEAGR.L Y 62.70 2057.0693 19 -12.8 515.2680 4 65.41 6 34432 VEV_3_3_RA6_01_1237.d 4.98E5 3 3 399 417 Methylation(KR); Dehydration
R.LESGNFSW(+15.99)GSEGISR.K Y 62.69 1640.7430 15 -5.7 821.3741 2 69.88 4 39119 VEV_1_3_RA4_01_1235.d 4.95E4 1 1 309 323 Oxidation (HW)
R.QQKLGTENTEEKKSK.S Y 61.17 1746.9111 15 -8.9 583.3058 3 10.45 5 2704 VEV_2_3_RA5_01_1236.d 6.21E3 2 2 375 389
R.LESGNFSWGS(+14.02)EGISR.K Y 61.02 1638.7638 15 -6.8 820.3836 2 76.72 4 44501 VEV_1_3_RA4_01_1235.d 0 1 1 309 323 Methylation(others)
K.LGTENTEEKKSK(+14.02).S Y 60.98 1376.7147 12 -16.7 689.3531 2 11.78 5 3337 VEV_2_3_RA5_01_1236.d 9.2E4 3 3 378 389 Methylation(KR)
R.LYAVISSRPGQSGR(+14.02).V Y 59.80 1503.8157 14 -14.8 502.2718 3 56.80 6 28230 VEV_3_3_RA6_01_1237.d 8.19E4 2 2 418 431 Methylation(KR)
R.FAAQGKVDPALEK(+14.02)QFEAGR.L Y 59.18 2075.0798 19 -10.7 519.7717 4 68.61 4 38119 VEV_1_3_RA4_01_1235.d 3.73E5 2 2 399 417 Methylation(KR)
R.FAAQ(+.98)GKVDPALEK.Q Y 58.86 1373.7190 13 -6.3 687.8624 2 55.31 4 28222 VEV_1_3_RA4_01_1235.d 2.77E5 3 3 399 411 Deamidation (NQ)
K.LGTENTEEKK(+14.02).S Y 58.42 1161.5876 10 -12.4 581.7939 2 15.08 6 4983 VEV_3_3_RA6_01_1237.d 4.77E5 3 3 378 387 Methylation(KR)
R.LESGNFSWGSEGISR(+14.02).K Y 55.73 1638.7638 15 -6.7 820.3837 2 76.62 5 43750 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 309 323 Methylation(KR)
K.LGTENTEEK(+14.02)KSK.S Y 55.12 1376.7147 12 -13.9 459.9058 3 12.16 5 3531 VEV_2_3_RA5_01_1236.d 1.09E5 3 3 378 389 Methylation(KR)
R.ALRLESGNFSW(+15.99)GSEGISR.K Y 54.74 1980.9653 18 0.1 661.3291 3 73.30 4 41819 VEV_1_3_RA4_01_1235.d 0 2 2 306 323 Oxidation (HW)
R.LE(+14.02)SGNFSWGSEGISR.K Y 54.69 1638.7638 15 -7.5 820.3830 2 75.36 4 43414 VEV_1_3_RA4_01_1235.d 2.28E5 2 2 309 323 Methylation(others)
R.FAAQ(+.98)GKVDPALEKQFEAGR.L Y 53.77 2062.0483 19 -5.2 688.3531 3 65.76 5 35859 VEV_2_3_RA5_01_1236.d 5.62E4 2 2 399 417 Deamidation (NQ)
R.ALRLESGNFS(-2.02)WGSEGISR.K Y 53.66 1962.9547 18 -4.2 655.3228 3 75.93 6 42231 VEV_3_3_RA6_01_1237.d 0 2 2 306 323 2-amino-3-oxo-butanoic_acid
R.TRGGNQKFR.A Y 53.09 1062.5682 9 -11.3 532.2854 2 10.23 5 2629 VEV_2_3_RA5_01_1236.d 7.16E5 7 7 297 305
R.Q(-17.03)WYEAHYGQTLGR(+14.02).R Y 51.95 1604.7372 13 -8.7 803.3689 2 75.05 6 41578 VEV_3_3_RA6_01_1237.d 4.04E4 1 1 360 372 Pyro-glu from Q; Methylation(KR)
R.F(+41.03)AAQGKVDPALEK.Q Y 50.55 1413.7616 13 -58.5 472.2336 3 50.95 4 25484 VEV_1_3_RA4_01_1235.d 0 1 1 399 411 Amidination of lysines or N-terminal amines with methyl acetimidate
K.SAVVQVDAAPF(+31.99)RQWYEAHYGQTLGR.R Y 49.76 2880.3943 25 -16.8 721.0938 4 76.62 6 42726 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 348 372 Dihydroxy
R.TNTLTKSAVVQVDAAPFRQWYEAHYGQTLGR.R Y 47.55 3506.7695 31 -10.4 702.3539 5 79.64 5 45819 VEV_2_3_RA5_01_1236.d 9.38E4 1 1 342 372
K.LGTENTEEK(+14.02).K Y 46.93 1033.4928 9 -7.8 517.7496 2 23.64 4 9353 VEV_1_3_RA4_01_1235.d 5.63E5 4 4 378 386 Methylation(KR)
R.ALRLESGNFSWGS(+14.02)EGISR.K Y 46.44 1978.9861 18 -9.8 660.6628 3 77.83 4 45413 VEV_1_3_RA4_01_1235.d 1.3E4 1 1 306 323 Methylation(others)
R.LYAVISSRPGQSGRVDGYILEGEE(+14.02)LAFYQR.A Y 46.38 3386.7258 30 3.6 678.3549 5 84.11 4 49988 VEV_1_3_RA4_01_1235.d 8.62E4 1 1 418 447 Methylation(others)
K.LGTENTEEK(+14.02)K.S Y 46.03 1161.5876 10 -9.6 581.7955 2 15.10 5 5086 VEV_2_3_RA5_01_1236.d 5.07E5 4 4 378 387 Methylation(KR)
K.RIHLVR.T Y 45.78 792.5082 6 -24.9 397.2515 2 30.22 6 12981 VEV_3_3_RA6_01_1237.d 1.92E6 8 8 291 296
K.VDPALEK(+14.02).Q Y 45.76 784.4330 7 -11.7 785.4312 1 35.80 4 16210 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 405 411 Methylation(KR)
K.VDPALEK.Q Y 43.63 770.4174 7 -8.7 386.2126 2 24.86 4 10040 VEV_1_3_RA4_01_1235.d 1.29E6 7 7 405 411
K.LGTENTE(+14.02)EKKSK.S Y 42.73 1376.7147 12 -9.9 689.3578 2 12.17 5 3537 VEV_2_3_RA5_01_1236.d 1.65E5 3 3 378 389 Methylation(others)
R.VDGY(-18.01)ILEGEELAFYQR.A Y 42.42 1882.9100 16 -6.4 942.4563 2 91.96 4 54761 VEV_1_3_RA4_01_1235.d 0 1 1 432 447 Dehydration
R.LESGN(+.98)FSWGSEGISR.K Y 40.69 1625.7322 15 -11.5 813.8640 2 75.27 4 43340 VEV_1_3_RA4_01_1235.d 2.3E4 1 1 309 323 Deamidation (NQ)
R.IHLVR.T N 40.56 636.4071 5 -11.5 319.2072 2 25.51 4 10397 VEV_1_3_RA4_01_1235.d 7.76E5 1 1 292 296
R.FAAQGKVDPALEKQFEAGR(+14.02).L Y 40.36 2075.0798 19 -10.6 519.7717 4 67.35 6 35897 VEV_3_3_RA6_01_1237.d 2.3E5 2 2 399 417 Methylation(KR)
R.VDGYILE(+28.03)GEELAFYQR.A Y 40.12 1928.9519 16 -3.3 643.9891 3 89.59 4 53431 VEV_1_3_RA4_01_1235.d 1.66E5 2 2 432 447 Ethylation
R.Q(-17.03)WYEAHYGQTLGRR.R Y 38.72 1746.8226 14 0.0 583.2815 3 68.90 4 38357 VEV_1_3_RA4_01_1235.d 0 1 1 360 373 Pyro-glu from Q
K.VDPALEK(+14.02)QFEAGR.L Y 36.94 1472.7623 13 -3.6 491.9263 3 66.03 4 36085 VEV_1_3_RA4_01_1235.d 0 1 1 405 417 Methylation(KR)
K.LGTENTEE(+14.02)KKSK.S Y 36.86 1376.7147 12 -13.9 689.3551 2 12.67 5 3794 VEV_2_3_RA5_01_1236.d 1.82E4 1 1 378 389 Methylation(others)
R.QPANTR.I Y 36.42 685.3507 6 21.3 686.3726 1 111.78 5 59316 VEV_2_3_RA5_01_1236.d 6E4 4 4 281 286
K.LGTENT(+14.02)EEK.K Y 35.12 1033.4928 9 -7.2 517.7499 2 21.73 4 8321 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 378 386 Methylation(others)
K.SAVVQVD(+14.02)AAPFRQWYEAHYGQTLGR.R Y 34.86 2862.4202 25 -13.7 955.1343 3 81.26 4 47981 VEV_1_3_RA4_01_1235.d 3.08E5 2 2 348 372 Methylation(others)
R.LESGNFSW(+31.99)GSEGISR.K Y 34.81 1656.7379 15 -5.2 829.3719 2 65.13 4 35380 VEV_1_3_RA4_01_1235.d 5.48E4 1 1 309 323 Dihydroxy
R.Q(-17.03)QKLGTENTEEK.K Y 33.89 1386.6627 12 -9.4 694.3321 2 26.99 4 11187 VEV_1_3_RA4_01_1235.d 0 1 1 375 386 Pyro-glu from Q
K.SAVVQ(+.98)VDAAPFR.Q Y 33.41 1259.6510 12 -16.9 630.8221 2 70.67 6 38353 VEV_3_3_RA6_01_1237.d 7.42E4 1 1 348 359 Deamidation (NQ)
R.RQQKLGTENTEEK.K Y 32.73 1559.7903 13 -8.1 520.9332 3 13.16 4 3884 VEV_1_3_RA4_01_1235.d 2.05E4 1 1 374 386
R.ALR(+14.02)LES(-18.01)GNFSWGSEGISRK.V Y 32.72 2089.0703 19 1.5 523.2756 4 71.05 4 40038 VEV_1_3_RA4_01_1235.d 6.98E4 1 1 306 324 Methylation(KR); Dehydration
R.KVRVIVVSYHPSNNELVR(-.98).T Y 32.53 2107.2014 18 -37.0 422.4319 5 63.97 5 34508 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 324 341 Amidation
R.FAAQGKVDPALE(+14.02)KQFEAGR.L Y 32.17 2075.0798 19 -13.1 519.7704 4 68.42 5 37849 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 399 417 Methylation(others)
R.ALRLESGNFSW(+3.99)GSEGISR.K Y 30.61 1968.9653 18 -28.9 657.3101 3 75.88 4 43822 VEV_1_3_RA4_01_1235.d 0 1 1 306 323 Tryptophan oxidation to kynurenin
R.Q(+.98)WYEAHYGQTLGR.R Y 30.33 1608.7321 13 3.5 805.3761 2 64.58 5 34962 VEV_2_3_RA5_01_1236.d 2.9E4 1 1 360 372 Deamidation (NQ)
R.AFEKGRQ(+.98)PANTR.I Y 29.39 1374.7003 12 -6.8 459.2376 3 15.26 5 5174 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 275 286 Deamidation (NQ)
R.NERRDGER(+14.02)QR.Q Y 28.07 1328.6658 10 -6.8 333.1714 4 33.32 6 14692 VEV_3_3_RA6_01_1237.d 0 1 1 192 201 Methylation(KR)
MSTATPK.E Y 26.60 734.3633 7 -11.0 368.1849 2 31.33 4 13622 VEV_1_3_RA4_01_1235.d 1.35E5 2 2 1 7
K.RAHYR.K Y 25.17 701.3721 5 -17.3 351.6873 2 8.81 5 2086 VEV_2_3_RA5_01_1236.d 0 1 1 267 271
R.VDGYILEGEELAFYQ(+.98)R.A Y 24.78 1901.9047 16 33.7 951.9917 2 84.79 5 49041 VEV_2_3_RA5_01_1236.d 0 1 1 432 447 Deamidation (NQ)
R.LYAVISSRPGQ(+.98)SGR.V Y 24.72 1490.7841 14 -12.6 497.9290 3 56.98 5 29415 VEV_2_3_RA5_01_1236.d 4.61E4 1 1 418 431 Deamidation (NQ)
R.QQKLGTENTEEK.K Y 24.52 1403.6892 12 -12.2 468.8979 3 14.77 6 4822 VEV_3_3_RA6_01_1237.d 3.14E4 1 1 375 386
K.VDPALEK(+31.99).Q Y 24.48 802.4072 7 -1.7 402.2102 2 33.62 6 14861 VEV_3_3_RA6_01_1237.d 1.25E6 1 1 405 411 Dihydroxy
R.TNT(+79.97)LTK(+21.98).S Y 24.43 778.3239 6 -22.2 779.3138 1 112.60 4 61844 VEV_1_3_RA4_01_1235.d 0 1 1 342 347 Phosphorylation (STY); Sodium adduct
R.VIVVS(-2.02)YHPSNNELVR.T Y 24.41 1722.9053 15 -38.5 575.2869 3 66.69 6 35400 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 327 341 2-amino-3-oxo-butanoic_acid
R.QQK(+156.12)LGTENTEEKKSK.S Y 24.12 1903.0261 15 -20.6 476.7540 4 10.57 5 2763 VEV_2_3_RA5_01_1236.d 2.31E4 1 1 375 389 4-hydroxynonenal (HNE)
K.LGTENTEEKK(+14.02)SK.S Y 23.74 1376.7147 12 -6.0 459.9094 3 12.63 6 3725 VEV_3_3_RA6_01_1237.d 4.43E4 1 1 378 389 Methylation(KR)
R.F(+31.99)AAQ(+.98)GKVDPALEK.Q Y 22.99 1405.7089 13 5.2 469.5793 3 51.10 4 25573 VEV_1_3_RA4_01_1235.d 0 1 1 399 411 Dihydroxy; Deamidation (NQ)
R.AFEKGRQPANTR(+14.02).I Y 22.91 1387.7321 12 -12.0 463.5791 3 19.18 5 7299 VEV_2_3_RA5_01_1236.d 6.8E4 2 2 275 286 Methylation(KR)
R.ALRLESGN(+.98)FSWGSEGISR.K Y 22.55 1965.9543 18 4.5 656.3283 3 75.79 5 43169 VEV_2_3_RA5_01_1236.d 1.9E5 2 2 306 323 Deamidation (NQ)
K.LE(+43.99)INLDVEVELK.A Y 22.39 1456.7660 12 39.6 365.2132 4 49.12 4 24380 VEV_1_3_RA4_01_1235.d 0 1 1 149 160 Carboxylation (E)
K.LGTE(+14.02)NTEEK.K Y 22.33 1033.4928 9 -10.7 517.7482 2 21.48 5 8535 VEV_2_3_RA5_01_1236.d 1.94E5 2 2 378 386 Methylation(others)
R.AFE(+14.02)KGRQPANTR.I Y 22.25 1387.7321 12 -11.7 463.5792 3 18.72 5 7040 VEV_2_3_RA5_01_1236.d 4.82E4 1 1 275 286 Methylation(others)
K.EYTVRAAIMGISR.D Y 22.02 1465.7711 13 7.7 367.4529 4 43.34 4 20736 VEV_1_3_RA4_01_1235.d 1.57E4 1 1 242 254
R.TRGGNQ(+.98)KFR.A Y 20.66 1063.5522 9 2.6 355.5256 3 10.24 5 2614 VEV_2_3_RA5_01_1236.d 3.31E4 1 1 297 305 Deamidation (NQ)
R.FAAQGK(+42.01).V Y 20.52 662.3387 6 -26.7 663.3283 1 63.43 5 34110 VEV_2_3_RA5_01_1236.d 1.93E5 1 1 399 404 Acetylation (K)
R.VD(+14.02)GYILEGEELAFYQR.A Y 20.32 1914.9363 16 3.4 639.3215 3 87.17 4 51985 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 432 447 Methylation(others)
R.T(+43.01)RGGNQK.F Y 20.13 802.4045 7 -17.1 803.3981 1 99.50 6 55145 VEV_3_3_RA6_01_1237.d 0 1 1 297 303 Carbamylation
K.LGTE(+14.02)NTEEKK.S Y 20.06 1161.5876 10 -6.2 388.2007 3 15.11 4 4834 VEV_1_3_RA4_01_1235.d 3.61E5 1 1 378 387 Methylation(others)
R.S(+42.01)ATGAK(-.98).R N 19.89 574.3074 6 -12.6 575.3075 1 66.43 5 36340 VEV_2_3_RA5_01_1236.d 0 1 1 261 266 Acetylation (N-term); Amidation
K.Q(-17.03)FEAGR.L Y 19.86 689.3132 6 -7.9 690.3151 1 44.74 5 21982 VEV_2_3_RA5_01_1236.d 2.67E5 1 1 412 417 Pyro-glu from Q
R.T(+42.01)NTLTK.S Y 18.97 718.3861 6 -18.3 719.3802 1 87.00 6 49661 VEV_3_3_RA6_01_1237.d 0 1 1 342 347 Acetylation (N-term)
R.GGNQKFR.A Y 18.59 805.4194 7 -10.7 403.7127 2 9.89 4 2421 VEV_1_3_RA4_01_1235.d 5.83E3 1 1 299 305
R.SATGAKRAHYRK.K Y 18.55 1344.7374 12 -21.2 337.1845 4 50.66 6 24669 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 261 272
R.AFEK(+42.01)GR(+14.02)QPANTR.I Y 18.30 1429.7426 12 35.2 477.6049 3 68.83 4 38298 VEV_1_3_RA4_01_1235.d 2.05E4 1 1 275 286 Acetylation (K); Methylation(KR)
R.QQRHASPC(+57.02)TQLST(+79.97)ADHPVTFSVK.E Y 18.24 2674.2322 23 13.7 892.4302 3 85.65 6 48861 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 219 241 Carbamidomethylation; Phosphorylation (STY)
K.LGTEN(+.98)TEEK(+14.02).K Y 18.18 1034.4768 9 2.0 518.2467 2 18.56 4 6656 VEV_1_3_RA4_01_1235.d 7.6E4 1 1 378 386 Deamidation (NQ); Methylation(KR)
K.TAEKPK(+43.99).E Y 17.75 716.3704 6 32.9 359.2043 2 33.28 5 15157 VEV_2_3_RA5_01_1236.d 4.9E5 1 1 133 138 Carboxylation (DKW)
R.FAAQGK(+42.02).V Y 17.59 662.3500 6 11.0 332.1859 2 29.91 4 12802 VEV_1_3_RA4_01_1235.d 8.48E4 1 1 399 404 Guanidination
K.SAVVQVD(-18.01)AAPFR(+14.02)QWYEAHYGQTLGR.R Y 17.46 2844.4094 25 -12.7 712.1006 4 81.16 6 45967 VEV_3_3_RA6_01_1237.d 0 1 1 348 372 Dehydration; Methylation(KR)
K.Q(+.98)AVRFAAQGK(+43.01).V Y 17.13 1118.5833 10 14.0 373.8736 3 59.61 4 31196 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 395 404 Deamidation (NQ); Carbamylation
R.SATGAK(+27.99).R N 17.03 561.2758 6 9.1 562.2882 1 38.27 5 18091 VEV_2_3_RA5_01_1236.d 6.8E4 1 1 261 266 Formylation
R.TRGGN(-17.03)QK.F Y 16.98 742.3722 7 60.4 743.4243 1 56.94 6 28325 VEV_3_3_RA6_01_1237.d 1.7E0 1 1 297 303 Ammonia-loss (N)
R.F(+27.99)AAQGK.V Y 16.98 648.3231 6 -7.3 649.3257 1 32.69 4 14400 VEV_1_3_RA4_01_1235.d 2.1E5 1 1 399 404 Formylation
R.ALR(+14.02)LESGN(+.98)FSWGSEGISR.K Y 16.29 1979.9701 18 13.5 661.0062 3 77.57 6 43417 VEV_3_3_RA6_01_1237.d 8.72E4 1 1 306 323 Methylation(KR); Deamidation (NQ)
K.LGTENTEEK(+42.01)K(+42.01).S Y 16.23 1231.5931 10 16.8 308.9107 4 14.57 4 4570 VEV_1_3_RA4_01_1235.d 3.6E4 1 1 378 387 Acetylation (K)
R.QWYEAHYGQTLGR(+14.02).R Y 16.15 1621.7637 13 2.6 541.5966 3 65.71 4 35840 VEV_1_3_RA4_01_1235.d 2.75E4 1 1 360 372 Methylation(KR)
R.AAIMGISRDSRHK.R Y 16.13 1440.7620 13 -32.9 361.1859 4 43.79 4 21008 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 247 259
K.VDPALEK(+42.01).Q Y 16.09 812.4280 7 39.5 407.2373 2 45.68 5 22533 VEV_2_3_RA5_01_1236.d 0 1 1 405 411 Acetylation (K)
R.GGNQK.F Y 16.09 502.2499 5 -44.5 503.2349 1 14.23 4 4409 VEV_1_3_RA4_01_1235.d 6.27E4 1 1 299 303
K.VDP(+31.99)ALEK.Q Y 15.96 802.4072 7 -10.1 803.4064 1 81.39 4 48079 VEV_1_3_RA4_01_1235.d 2.46E2 1 1 405 411 Dihydroxy
MSTATPKENAPQP(+31.99)QR.Q Y 15.95 1686.7996 15 15.4 563.2825 3 26.35 5 11245 VEV_2_3_RA5_01_1236.d 0 1 1 1 15 Dihydroxy
R.SATGAK.R N 15.94 533.2809 6 -51.4 534.2607 1 18.01 5 6656 VEV_2_3_RA5_01_1236.d 0 2 2 261 266
R.QQQQQQQQRQQR(+14.02).H Y 15.71 1624.8142 12 -1.5 407.2102 4 60.57 6 30849 VEV_3_3_RA6_01_1237.d 0 1 1 210 221 Methylation(KR)
K.VD(+37.03)PALEKQFEAGR.L Y 15.62 1495.7783 13 -18.0 499.5911 3 61.69 4 32749 VEV_1_3_RA4_01_1235.d 1.9E5 1 1 405 417 Propargylamine
K.E(-18.01)NAPQPQR.Q Y 15.33 920.4464 8 8.2 461.2343 2 16.24 6 5586 VEV_3_3_RA6_01_1237.d 0 1 1 8 15 Pyro-glu from E
K.VDPALEK(+43.01).Q Y 15.27 813.4232 7 -13.8 407.7133 2 27.46 6 11494 VEV_3_3_RA6_01_1237.d 5.05E4 1 1 405 411 Carbamylation
R.S(+314.19)ATGAKRAHYRK.K Y 15.18 1658.9257 12 -31.9 415.7255 4 67.83 4 37542 VEV_1_3_RA4_01_1235.d 4.52E4 1 1 261 272 Levuglandinyl-lysine anhydrolactam adduct
K.ENAPQPQR(+42.05).Q Y 15.09 980.5039 8 -22.5 491.2482 2 28.06 5 12167 VEV_2_3_RA5_01_1236.d 0 1 1 8 15 Trimethylation
R.VWALC(+57.02)EIHPR.R Y 15.07 1279.6495 10 -1.9 640.8308 2 16.85 6 5912 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 181 190 Carbamidomethylation
R.QQRQQQQQQQQR.Q Y 15.06 1610.7986 12 -47.2 537.9148 3 14.12 5 4557 VEV_2_3_RA5_01_1236.d 0 1 1 207 218
K.GRQPAN(+.98)TRIGPK(+226.08).R Y 15.05 1520.7881 12 13.3 507.9434 3 61.11 5 32374 VEV_2_3_RA5_01_1236.d 0 1 1 279 290 Deamidation (NQ); Biotinylation
R.R(+14.02)DGERQR(+14.02).Q Y 15.01 943.4948 7 -22.0 472.7443 2 30.26 5 13415 VEV_2_3_RA5_01_1236.d 0 1 1 195 201 Methylation(KR)
total 146 peptides
C1G391
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLPDSVTIIDPKEEEPVLHPISQDYGAK.A Y 148.31 3076.5603 28 -7.4 1026.5198 3 78.72 5 45217 VEV_2_3_RA5_01_1236.d 3.76E6 10 10 206 233
R.FKFPENSVSLYAAK.V Y 134.28 1599.8296 14 -8.3 534.2794 3 73.32 4 41876 VEV_1_3_RA4_01_1235.d 5.55E6 14 14 80 93
K.FVADGVFYAELNEFFQR.E Y 131.31 2050.9788 17 -11.2 684.6592 3 92.94 6 52733 VEV_3_3_RA6_01_1237.d 6.67E5 6 6 14 30
K.ALAAQQLAEQQRLAEQQEAEAAGQGVGPDGQVVEGQE Y 130.98 3802.8357 37 -6.8 1268.6106 3 77.72 5 44545 VEV_2_3_RA5_01_1236.d 9.72E5 6 6 234 270
R.LAEQQEAEAAGQGVGPDGQVVEGQE Y 129.15 2495.1411 25 -9.7 1248.5657 2 69.25 6 37323 VEV_3_3_RA6_01_1237.d 2.63E6 10 10 246 270
R.ATHTQEVLGEQGRR.I Y 125.06 1580.8019 14 -14.3 527.9337 3 23.54 6 9452 VEV_3_3_RA6_01_1237.d 5.21E6 16 16 55 68
K.ALAAQQLAEQQR.L Y 124.33 1325.7051 12 -13.2 663.8511 2 53.97 6 26651 VEV_3_3_RA6_01_1237.d 6.37E6 17 17 234 245
K.FTDGFMIHSGQPVRDFIDSATR.H Y 123.29 2496.1855 22 -10.1 625.0474 4 80.55 4 47442 VEV_1_3_RA4_01_1235.d 1.17E6 6 6 155 176
R.ELAEEGYSGVEVR.V Y 123.20 1436.6782 13 -13.9 719.3364 2 63.79 6 33247 VEV_3_3_RA6_01_1237.d 1.04E6 4 4 31 43
R.FIMESGAKGC(+57.02)EVVVSGK.L Y 116.54 1796.8800 17 -4.5 599.9646 3 64.39 4 34803 VEV_1_3_RA4_01_1235.d 9.99E5 6 6 128 144 Carbamidomethylation
K.ALAAQQLAEQQ(+.98)RLAEQQEAEAAGQGVGPDGQVVEGQE Y 114.42 3803.8198 37 -6.9 1268.9385 3 79.33 5 45607 VEV_2_3_RA5_01_1236.d 9.77E4 2 2 234 270 Deamidation (NQ)
K.ALAAQQLAEQ(+.98)QRLAEQQEAEAAGQGVGPDGQVVEGQE Y 114.25 3803.8198 37 -11.0 1268.9332 3 79.27 6 44641 VEV_3_3_RA6_01_1237.d 5.19E4 1 1 234 270 Deamidation (NQ)
K.FVADGVFYAELNEFFQRELAEEGYSGVEVR.V Y 108.25 3469.6465 30 -4.9 1157.5504 3 94.15 4 55884 VEV_1_3_RA4_01_1235.d 5.2E5 5 5 14 43
R.ATHTQEVLGEQGR.R Y 106.56 1424.7008 13 13.9 713.3676 2 28.37 5 12331 VEV_2_3_RA5_01_1236.d 2.17E6 12 12 55 67
K.SLPDSVTIIDPKEE(+14.02)EPVLHPISQDYGAK.A Y 103.01 3090.5759 28 -6.2 773.6465 4 80.66 4 47525 VEV_1_3_RA4_01_1235.d 1.25E6 5 5 206 233 Methylation(others)
R.GLSAVAQC(+57.02)ESLR.Y Y 102.77 1289.6398 12 -9.6 645.8210 2 61.73 4 32805 VEV_1_3_RA4_01_1235.d 2.64E6 9 9 98 109 Carbamidomethylation
K.ALAAQQLAEQQRLAEQQEAEAAGQGVGPDGQVVE(+14.02)GQE Y 101.05 3816.8513 37 -6.2 1273.2832 3 78.72 5 45191 VEV_2_3_RA5_01_1236.d 1.86E5 2 2 234 270 Methylation(others)
R.KFVADGVFYAELNEFFQR.E Y 100.51 2179.0737 18 -2.8 545.7742 4 88.84 4 53020 VEV_1_3_RA4_01_1235.d 2.47E5 3 3 13 30
K.ALAAQQLAEQQRLAEQQEAEAAGQGVGPDGQ(+.98)VVEGQE Y 99.64 3803.8198 37 -4.0 1268.9421 3 78.19 4 45620 VEV_1_3_RA4_01_1235.d 3.5E5 3 3 234 270 Deamidation (NQ)
R.KFVADGVFYAELNEFFQRELAEEGYSGVEVR.V Y 97.81 3597.7415 31 -1.0 900.4418 4 91.14 5 52460 VEV_2_3_RA5_01_1236.d 4.63E4 2 2 13 43
K.EEEPVLHPISQDYGAK.A Y 97.79 1810.8737 16 -8.2 906.4366 2 64.26 4 34708 VEV_1_3_RA4_01_1235.d 1.25E5 3 3 218 233
R.GLSAVAQC(+57.02)ESLRYK.L Y 97.72 1580.7981 14 -9.8 527.9348 3 62.45 4 33329 VEV_1_3_RA4_01_1235.d 8.22E5 5 5 98 111 Carbamidomethylation
K.SMKFTDGFMIHSGQPVRDFIDSATR.H Y 97.63 2842.3530 25 -9.5 569.4725 5 80.57 4 47455 VEV_1_3_RA4_01_1235.d 1.42E5 1 1 152 176
K.RFKFPENSVSLYAAK.V Y 94.59 1755.9308 15 -12.1 439.9847 4 69.14 4 38542 VEV_1_3_RA4_01_1235.d 1.74E5 2 2 79 93
K.ALAAQQLAEQQRLAEQQEAEAAGQ(+.98)GVGPDGQVVEGQE Y 92.28 3803.8198 37 -8.0 1268.9371 3 78.15 6 43837 VEV_3_3_RA6_01_1237.d 6.17E4 1 1 234 270 Deamidation (NQ)
K.ALAAQQLAEQQRLAEQQE(+14.02)AEAAGQGVGPDGQVVEGQE Y 92.24 3816.8513 37 -10.1 1273.2782 3 80.38 4 47312 VEV_1_3_RA4_01_1235.d 5.62E4 1 1 234 270 Methylation(others)
K.SLPDSVTIIDPK.E Y 87.48 1283.6973 12 -12.6 642.8478 2 73.51 6 40449 VEV_3_3_RA6_01_1237.d 2.99E5 4 4 206 217
R.VTPTVTDIIIR.A Y 84.70 1226.7234 11 -11.5 614.3619 2 75.87 5 43241 VEV_2_3_RA5_01_1236.d 3.66E6 10 10 44 54
K.SLPDSVTIIDPK(+14.02)EEEPVLHPISQDYGAK.A Y 84.02 3090.5759 28 -6.9 1031.1921 3 79.56 5 45829 VEV_2_3_RA5_01_1236.d 3.79E5 5 5 206 233 Methylation(KR)
R.ATHTQEVLGEQ(+.98)GR.R Y 83.58 1425.6848 13 -3.5 713.8472 2 31.83 4 13914 VEV_1_3_RA4_01_1235.d 4.98E5 6 6 55 67 Deamidation (NQ)
K.GC(+57.02)EVVVSGK.L Y 83.40 933.4589 9 -13.5 467.7304 2 25.22 5 10607 VEV_2_3_RA5_01_1236.d 1.29E6 6 6 136 144 Carbamidomethylation
R.FKFPEN(+.98)SVSLYAAK.V Y 80.32 1600.8136 14 -15.1 534.6038 3 75.34 6 41786 VEV_3_3_RA6_01_1237.d 6.34E5 2 2 80 93 Deamidation (NQ)
K.SLPDSVTIIDPKEEE(+14.02)PVLHPISQDYGAK.A Y 79.78 3090.5759 28 -4.8 773.6476 4 80.10 5 46118 VEV_2_3_RA5_01_1236.d 1.73E5 1 1 206 233 Methylation(others)
R.YKLLNGLAVR.R Y 79.58 1145.6920 10 -13.1 382.8996 3 68.04 4 37698 VEV_1_3_RA4_01_1235.d 6.19E5 4 4 110 119
R.IRELTSLIQKR.F Y 78.35 1355.8248 11 5.6 452.9514 3 61.36 6 31419 VEV_3_3_RA6_01_1237.d 1.67E6 8 8 69 79
K.ALAAQQLAEQQ(+.98)R.L Y 77.74 1326.6891 12 -12.3 664.3436 2 57.75 6 28860 VEV_3_3_RA6_01_1237.d 1.72E6 6 6 234 245 Deamidation (NQ)
R.ATHTQEVLGE(+14.02)QGR.R Y 77.68 1438.7164 13 -16.5 720.3536 2 37.35 6 16968 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 55 67 Methylation(others)
R.ATHTQ(+.98)EVLGEQGR.R Y 76.08 1425.6848 13 -6.3 713.8452 2 32.40 4 14238 VEV_1_3_RA4_01_1235.d 2.6E5 5 5 55 67 Deamidation (NQ)
K.S(+14.02)LPDSVTIIDPKEEEPVLHPISQDYGAK.A Y 75.80 3090.5759 28 -15.3 773.6395 4 78.75 6 44263 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 206 233 Methylation(others)
K.ALAAQQLAE(+14.02)QQR.L Y 75.68 1339.7208 12 -23.8 670.8517 2 59.01 6 29724 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 234 245 Methylation(others)
R.LAEQQEAEAAGQGVGPDGQ(+.98)VVEGQE Y 75.40 2496.1252 25 -2.0 1249.0674 2 70.39 4 39519 VEV_1_3_RA4_01_1235.d 1.15E6 5 5 246 270 Deamidation (NQ)
R.LAEQ(+.98)QEAEAAGQGVGPDGQVVEGQE Y 75.36 2496.1252 25 -5.0 1249.0636 2 70.78 4 39828 VEV_1_3_RA4_01_1235.d 7E5 2 2 246 270 Deamidation (NQ)
K.SLPDS(+14.02)VTIIDPKEEEPVLHPISQDYGAK.A Y 75.02 3090.5759 28 -11.9 773.6421 4 79.52 6 44817 VEV_3_3_RA6_01_1237.d 3.4E5 1 1 206 233 Methylation(others)
R.ATHTQEVLGEQ(+.98)GRR.I Y 74.81 1581.7859 14 -14.7 528.2615 3 27.04 6 11279 VEV_3_3_RA6_01_1237.d 1.19E6 8 8 55 68 Deamidation (NQ)
K.ALAAQ(+.98)QLAEQQR.L Y 74.32 1326.6891 12 -11.6 664.3441 2 58.96 6 29686 VEV_3_3_RA6_01_1237.d 4.48E5 5 5 234 245 Deamidation (NQ)
R.FKFPE(+14.02)NSVSLYAAK.V Y 74.27 1613.8453 14 -15.7 538.9473 3 75.85 6 42171 VEV_3_3_RA6_01_1237.d 8.02E5 6 6 80 93 Methylation(others)
K.ALAAQQLAEQQRLAEQQEAE(+14.02)AAGQGVGPDGQVVEGQE Y 74.06 3816.8513 37 -5.4 1273.2842 3 78.46 4 45841 VEV_1_3_RA4_01_1235.d 4.24E4 1 1 234 270 Methylation(others)
K.SLPDSVTIIDPKEEEPVLHPISQ(+.98)DYGAK.A Y 73.09 3077.5444 28 -8.0 1026.8472 3 79.25 5 45558 VEV_2_3_RA5_01_1236.d 3.74E4 2 2 206 233 Deamidation (NQ)
R.FKFPENSVSLYAAK(+14.02).V Y 72.91 1613.8453 14 -9.4 538.9507 3 74.83 6 41414 VEV_3_3_RA6_01_1237.d 8.11E5 6 6 80 93 Methylation(KR)
R.ATHTQEVLGEQGR(+14.02).R Y 72.07 1438.7164 13 -4.3 720.3624 2 37.45 4 17199 VEV_1_3_RA4_01_1235.d 1.04E6 12 12 55 67 Methylation(KR)
K.ALAAQQLAEQ(+.98)QR.L Y 70.74 1326.6891 12 -15.0 664.3419 2 57.12 6 28438 VEV_3_3_RA6_01_1237.d 8.32E5 5 5 234 245 Deamidation (NQ)
R.ELTSLIQKR.F Y 69.74 1086.6396 9 -10.9 544.3212 2 55.77 4 28484 VEV_1_3_RA4_01_1235.d 1.14E6 10 10 71 79
R.AC(+57.02)YGVLR.F Y 67.22 837.4167 7 -11.3 419.7109 2 45.84 4 22283 VEV_1_3_RA4_01_1235.d 3.37E6 10 10 121 127 Carbamidomethylation
R.ATHTQE(+14.02)VLGEQGR.R Y 66.93 1438.7164 13 -7.8 720.3599 2 34.24 4 15301 VEV_1_3_RA4_01_1235.d 2.45E5 4 4 55 67 Methylation(others)
K.ALAAQQLAEQQR(+14.02).L Y 65.88 1339.7208 12 -4.1 670.8649 2 59.05 5 30856 VEV_2_3_RA5_01_1236.d 2.53E5 4 4 234 245 Methylation(KR)
R.LAEQQEAEAAGQGVGPDGQVVE(+14.02)GQE Y 65.62 2509.1567 25 -15.1 837.3802 3 72.04 4 40849 VEV_1_3_RA4_01_1235.d 1.87E5 3 3 246 270 Methylation(others)
R.ATHTQEVLGEQGR(+14.02)R.I Y 65.51 1594.8175 14 -14.6 532.6053 3 30.90 6 13359 VEV_3_3_RA6_01_1237.d 1.13E6 10 10 55 68 Methylation(KR)
R.IRELTSLIQK.R Y 65.50 1199.7238 10 -8.7 400.9117 3 65.38 4 35602 VEV_1_3_RA4_01_1235.d 3.36E5 3 3 69 78
K.ALAAQQ(+.98)LAEQQR.L Y 65.39 1326.6891 12 -11.3 664.3443 2 58.15 6 29127 VEV_3_3_RA6_01_1237.d 2.97E5 1 1 234 245 Deamidation (NQ)
R.RKFVADGVFYAELNEFFQR.E Y 65.18 2335.1748 19 31.7 584.8195 4 85.76 4 51085 VEV_1_3_RA4_01_1235.d 0 1 1 12 30
R.LAEQQEAEAAGQGVGPDGQVVEGQE(+14.02) Y 63.93 2509.1567 25 -9.7 1255.5735 2 72.29 6 39583 VEV_3_3_RA6_01_1237.d 1.54E6 6 6 246 270 Methylation(others)
R.LAEQQ(+.98)EAEAAGQGVGPDGQVVEGQE Y 63.02 2496.1252 25 -5.0 1249.0636 2 70.60 6 38297 VEV_3_3_RA6_01_1237.d 6.8E5 3 3 246 270 Deamidation (NQ)
R.GLSAVAQC(+57.02)ESLR(+14.02).Y Y 63.01 1303.6554 12 -9.3 652.8289 2 67.57 4 37298 VEV_1_3_RA4_01_1235.d 8.97E5 4 4 98 109 Carbamidomethylation; Methylation(KR)
R.RAC(+57.02)YGVLR.F Y 61.72 993.5178 8 -16.1 332.1746 3 34.71 5 16006 VEV_2_3_RA5_01_1236.d 1.18E6 6 6 120 127 Carbamidomethylation
R.GLSAVAQ(+.98)C(+57.02)ESLR.Y Y 60.20 1290.6238 12 1.4 646.3201 2 61.62 6 31620 VEV_3_3_RA6_01_1237.d 8.68E5 6 6 98 109 Deamidation (NQ); Carbamidomethylation
R.ELAEE(+14.02)GYSGVEVR.V Y 60.04 1450.6940 13 -8.7 726.3480 2 67.94 4 37615 VEV_1_3_RA4_01_1235.d 6.37E5 3 3 31 43 Methylation(others)
R.LAE(+14.02)QQEAEAAGQGVGPDGQVVEGQE Y 59.31 2509.1567 25 -6.1 1255.5780 2 72.84 4 41458 VEV_1_3_RA4_01_1235.d 9.2E5 2 2 246 270 Methylation(others)
R.YKLLN(+.98)GLAVR.R Y 58.83 1146.6760 10 -11.6 383.2282 3 68.89 4 38348 VEV_1_3_RA4_01_1235.d 4.78E5 4 4 110 119 Deamidation (NQ)
R.ELAEEGYSGVEVR(+14.02).V Y 57.37 1450.6940 13 -9.1 726.3477 2 66.33 4 36319 VEV_1_3_RA4_01_1235.d 1.71E5 4 4 31 43 Methylation(KR)
R.HVLLR.Q N 56.64 636.4071 5 -20.6 319.2043 2 24.39 4 9809 VEV_1_3_RA4_01_1235.d 1.83E6 3 3 177 181
R.LAEQQEAE(+14.02)AAGQGVGPDGQVVEGQE Y 56.46 2509.1567 25 -6.5 1255.5775 2 71.22 4 40182 VEV_1_3_RA4_01_1235.d 6.06E5 5 5 246 270 Methylation(others)
R.VTPTVTDIIIR(+14.02).A Y 56.42 1240.7390 11 -19.4 621.3647 2 78.51 6 44081 VEV_3_3_RA6_01_1237.d 9.76E4 2 2 44 54 Methylation(KR)
R.LAEQQEAEAAGQGVGPDGQVVEGQ(+.98)E Y 56.24 2496.1252 25 -9.9 833.0408 3 70.21 6 38014 VEV_3_3_RA6_01_1237.d 3.47E5 1 1 246 270 Deamidation (NQ)
K.FPENSVSLYAAK.V Y 55.91 1324.6663 12 -11.0 663.3331 2 68.77 4 38255 VEV_1_3_RA4_01_1235.d 1.82E5 2 2 82 93
R.E(+14.02)LAEEGYSGVEVR.V Y 55.72 1450.6940 13 -12.9 726.3449 2 65.55 4 35705 VEV_1_3_RA4_01_1235.d 1E5 1 1 31 43 Methylation(others)
R.ELAE(+14.02)EGYSGVEVR.V Y 53.93 1450.6940 13 -12.8 726.3450 2 68.04 6 36419 VEV_3_3_RA6_01_1237.d 2.26E5 1 1 31 43 Methylation(others)
K.ALAAQQLAEQ(+.98)Q(+.98)R.L Y 53.52 1327.6731 12 -9.0 664.8378 2 60.13 4 31579 VEV_1_3_RA4_01_1235.d 5.65E4 3 3 234 245 Deamidation (NQ)
K.GC(+57.02)EVVVSGK(+14.02).L Y 51.62 947.4746 9 -8.6 474.7405 2 35.42 4 15991 VEV_1_3_RA4_01_1235.d 4.74E5 4 4 136 144 Carbamidomethylation; Methylation(KR)
K.S(+13.03)LPDSVTIIDPKEEEPVLHPISQDYGAK.A Y 51.56 3089.5920 28 -2.7 773.4032 4 78.94 4 46246 VEV_1_3_RA4_01_1235.d 0 2 2 206 233 Michael addition with methylamine
K.GC(+57.02)E(+14.02)VVVSGK.L Y 51.43 947.4746 9 -8.9 474.7404 2 34.17 4 15275 VEV_1_3_RA4_01_1235.d 5.72E5 3 3 136 144 Carbamidomethylation; Methylation(others)
M.A(+42.01)AVQGVISK.R Y 50.64 913.5233 9 -21.5 914.5109 1 66.40 5 36321 VEV_2_3_RA5_01_1236.d 1.46E6 6 6 2 10 Acetylation (Protein N-term)
K.ALAAQQLAEQ(+.98)QR(+14.02).L Y 49.34 1340.7048 12 -16.0 671.3489 2 62.67 4 33502 VEV_1_3_RA4_01_1235.d 5.32E4 1 1 234 245 Deamidation (NQ); Methylation(KR)
R.LAEQQE(+14.02)AEAAGQGVGPDGQVVEGQE Y 48.46 2509.1567 25 -8.2 1255.5753 2 72.70 6 39876 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 246 270 Methylation(others)
K.LLNGLAVR.R Y 48.15 854.5338 8 -12.6 428.2688 2 64.61 4 34968 VEV_1_3_RA4_01_1235.d 6.47E5 3 3 112 119
M.A(+42.01)AVQGVISKR.R Y 47.86 1069.6244 10 -13.0 535.8125 2 61.02 4 32279 VEV_1_3_RA4_01_1235.d 2.45E6 4 4 2 11 Acetylation (Protein N-term)
R.FIMESGAK.G Y 47.52 881.4316 8 4.1 441.7249 2 43.29 5 21088 VEV_2_3_RA5_01_1236.d 7.47E5 4 4 128 135
R.ATHTQEVLGEQGRR(+14.02).I Y 45.26 1594.8175 14 -7.9 532.6089 3 29.98 4 12838 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 55 68 Methylation(KR)
R.Q(-17.03)GVLGIKVK.I Y 44.68 923.5804 9 -10.7 462.7925 2 68.84 4 38307 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 182 190 Pyro-glu from Q
K.E(+225.09)EEPVLHPISQDYGAK.A Y 44.58 2035.9673 16 14.5 510.0065 4 59.83 4 31356 VEV_1_3_RA4_01_1235.d 4.42E5 4 4 218 233 Iminobiotinylation
R.IR(+14.02)ELTSLIQKR.F Y 44.12 1369.8405 11 -43.2 457.6010 3 64.01 5 34535 VEV_2_3_RA5_01_1236.d 2.21E5 3 3 69 79 Methylation(KR)
R.ELAEEGYSGVEVR(+.98).V Y 43.01 1437.6624 13 3.5 719.8410 2 64.07 4 34565 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 31 43 Deamidation (R)
K.SLPDSVT(-18.01)IIDPK(+42.01)EEEPVLHPISQDYGAK.A Y 41.65 3100.5603 28 -10.7 776.1390 4 80.70 4 47554 VEV_1_3_RA4_01_1235.d 0 1 1 206 233 Dehydration; Acetylation (K)
K.SLPDSVTIIDPKEEEPVLH(+14.02)PISQDYGAK.A Y 41.41 3090.5759 28 -3.3 1031.1958 3 78.89 5 45315 VEV_2_3_RA5_01_1236.d 5.81E4 1 1 206 233 Methylation(others)
R.DFIDSATR.H Y 40.50 923.4348 8 -8.5 462.7208 2 57.85 4 29909 VEV_1_3_RA4_01_1235.d 5.24E5 3 3 169 176
R.ELTSLIQK.R Y 38.92 930.5386 8 -52.5 466.2521 2 62.33 6 32146 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 71 78
R.F(+42.01)K(+14.02)FPEN(+.98)SVSLYAAK.V Y 38.07 1656.8398 14 -8.8 553.2823 3 75.45 4 43477 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 80 93 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
K.GC(+57.02)EVVVSGKLR.A Y 36.70 1202.6442 11 -16.5 401.8820 3 44.53 5 21844 VEV_2_3_RA5_01_1236.d 1.9E5 1 1 136 146 Carbamidomethylation
K.ALAAQQLAEQQRLAEQ(+.98)QEAEAAGQGVGPDGQVVEGQE Y 36.27 3803.8198 37 -9.6 951.9531 4 78.15 6 43835 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 234 270 Deamidation (NQ)
R.AC(+57.02)YGVLR(+14.02).F Y 36.07 851.4323 7 -18.7 426.7155 2 54.96 6 27177 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 121 127 Carbamidomethylation; Methylation(KR)
R.F(+42.01)IMESGAK(+27.99)GC(+57.02)EVVVSGK.L Y 35.84 1866.8855 17 -0.1 467.7286 4 25.00 6 10188 VEV_3_3_RA6_01_1237.d 0 1 1 128 144 Acetylation (N-term); Formylation; Carbamidomethylation
R.IRELTSLIQ(+.98)KR.F Y 34.87 1356.8088 11 -17.2 340.2036 4 62.92 5 33723 VEV_2_3_RA5_01_1236.d 1.36E5 4 4 69 79 Deamidation (NQ)
R.LAE(+28.03)QQEAEAAGQGVGPDGQVVEGQE Y 34.40 2523.1724 25 -13.3 842.0535 3 76.16 4 44037 VEV_1_3_RA4_01_1235.d 0 1 1 246 270 Ethylation
R.QGVLGIK.V Y 34.12 713.4435 7 -22.9 357.7209 2 47.60 5 23692 VEV_2_3_RA5_01_1236.d 1.39E6 5 5 182 188
K.IMRGSDPEGK.S Y 32.93 1088.5284 10 -6.9 545.2678 2 16.17 4 5404 VEV_1_3_RA4_01_1235.d 2.32E5 6 6 191 200
R.RIRELTSLIQKR.F Y 32.56 1511.9259 12 -8.8 378.9854 4 61.44 5 32685 VEV_2_3_RA5_01_1236.d 6.05E4 1 1 68 79
R.LAEQQEAEAAGQGVGPD(+14.02)GQVVEGQE Y 32.18 2509.1567 25 -13.1 837.3819 3 72.45 6 39703 VEV_3_3_RA6_01_1237.d 2.95E5 1 1 246 270 Methylation(others)
R.YKLLN(+.98)GLAVRR.A Y 31.36 1302.7771 11 -17.1 326.6960 4 63.62 4 34241 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 110 120 Deamidation (NQ)
R.FIM(+15.99)ESGAK.G Y 30.29 897.4266 8 -0.5 449.7203 2 36.42 4 16595 VEV_1_3_RA4_01_1235.d 0 1 1 128 135 Oxidation (M)
R.GLS(+291.10)AVAQC(+57.02)ESLR.Y Y 29.77 1580.7352 12 36.5 527.9382 3 62.24 4 33184 VEV_1_3_RA4_01_1235.d 3.51E5 1 1 98 109 N-acetyl neuraminic acid; Carbamidomethylation
R.A(+42.01)THTQEVLGEQGR.R Y 29.64 1466.7113 13 -6.3 489.9080 3 28.32 5 12306 VEV_2_3_RA5_01_1236.d 9.36E4 1 1 55 67 Acetylation (N-term)
R.KFVADGVFYAE(+14.02)LNEFFQR.E Y 28.97 2193.0894 18 -17.5 732.0243 3 92.57 4 55079 VEV_1_3_RA4_01_1235.d 4.5E4 1 1 13 30 Methylation(others)
R.LAEQQEAEAAGQGVGPDGQ(+15.00)VVEGQE Y 28.95 2510.1409 25 -5.0 1256.0714 2 73.47 4 41955 VEV_1_3_RA4_01_1235.d 2.39E5 2 2 246 270 Deamidation followed by a methylation
R.F(+226.08)IMESGAK(+14.02).G Y 28.56 1121.5249 8 13.8 374.8541 3 19.84 5 7649 VEV_2_3_RA5_01_1236.d 0 1 1 128 135 Biotinylation; Methylation(KR)
K.ALAAQQ(+.98)LAEQQR(+14.02).L Y 28.44 1340.7048 12 -47.6 671.3278 2 61.89 4 32907 VEV_1_3_RA4_01_1235.d 0 1 1 234 245 Deamidation (NQ); Methylation(KR)
R.GLSAVAQC(+57.02)ESLRYKLLNGLAVRR.A Y 27.89 2573.4224 23 -17.9 515.6826 5 76.45 5 43626 VEV_2_3_RA5_01_1236.d 4.32E4 1 1 98 120 Carbamidomethylation
R.GLSAVAQC(+57.02)ES(-18.01)LR(+14.02).Y Y 27.14 1285.6449 12 -33.1 643.8085 2 61.57 6 31578 VEV_3_3_RA6_01_1237.d 5.83E4 1 1 98 109 Carbamidomethylation; Dehydration; Methylation(KR)
R.Q(+.98)GVLGIK.V Y 26.58 714.4276 7 -19.3 358.2142 2 52.60 6 25816 VEV_3_3_RA6_01_1237.d 2.1E4 1 1 182 188 Deamidation (NQ)
K.IM(+15.99)RGSDPEGK.S Y 25.86 1104.5233 10 -5.5 553.2659 2 11.37 4 3016 VEV_1_3_RA4_01_1235.d 9.21E4 3 3 191 200 Oxidation (M)
K.LLNGLAVRR.A Y 25.56 1010.6349 9 -13.3 337.8811 3 56.35 5 29024 VEV_2_3_RA5_01_1236.d 6.24E5 4 4 112 120
R.GLSAVAQC(+57.02)ESLR(+.98).Y Y 25.18 1290.6238 12 -12.5 646.3111 2 65.05 5 35311 VEV_2_3_RA5_01_1236.d 6.91E4 1 1 98 109 Carbamidomethylation; Deamidation (R)
K.SMK(-1.03)FTDGFMIHSGQPVRDFIDSATR.H Y 24.99 2841.3213 25 11.6 569.2781 5 80.60 4 47484 VEV_1_3_RA4_01_1235.d 0 1 1 152 176 Lysine oxidation to aminoadipic semialdehyde
R.LAEQQEAE(+28.03)AAGQGVGPDGQVVEGQE Y 24.97 2523.1724 25 -7.9 842.0581 3 74.23 4 42531 VEV_1_3_RA4_01_1235.d 3.68E4 1 1 246 270 Ethylation
R.Q(-17.03)GVLGIK.V Y 24.79 696.4170 7 -15.9 697.4132 1 69.83 4 39084 VEV_1_3_RA4_01_1235.d 8.93E5 3 3 182 188 Pyro-glu from Q
R.FIM(-48.00)ESGAK.G Y 24.58 833.4283 8 -16.9 417.7144 2 15.20 6 5043 VEV_3_3_RA6_01_1237.d 7.9E4 1 1 128 135 Dethiomethyl
R.YKLLNGLAVRR.A Y 22.58 1301.7931 11 -16.6 326.4501 4 62.74 6 32437 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 110 120
R.K(+42.01)FVADGVFYAELNEFFQR(+21.98).E Y 22.43 2243.0662 18 -2.2 561.7726 4 67.95 6 36346 VEV_3_3_RA6_01_1237.d 0 1 1 13 30 Acetylation (Protein N-term); Sodium adduct
R.FKFPENS(+14.02)VSLYAAK.V Y 22.26 1613.8453 14 -1.5 538.9549 3 76.34 4 44238 VEV_1_3_RA4_01_1235.d 3.24E5 1 1 80 93 Methylation(others)
R.E(+14.02)LTSLIQKR.F Y 22.11 1100.6553 9 6.1 367.8946 3 57.78 4 29848 VEV_1_3_RA4_01_1235.d 0 1 1 71 79 Methylation(others)
R.G(+42.01)LSAVAQCESLR.Y Y 20.93 1274.6289 12 6.6 638.3259 2 72.04 6 39392 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 98 109 Acetylation (N-term)
K.FVADGVFYAELN(+.98)EFFQR.E Y 20.75 2051.9629 17 59.1 685.0353 3 93.73 4 55681 VEV_1_3_RA4_01_1235.d 0 1 1 14 30 Deamidation (NQ)
K.SMKFTDGFMIHSGQPVR.D Y 20.09 1936.9287 17 -0.9 485.2390 4 69.85 4 39097 VEV_1_3_RA4_01_1235.d 7.32E4 1 1 152 168
K.GC(+57.02)EVVVSGK(+226.08).L Y 19.86 1159.5365 9 -27.3 580.7597 2 15.22 6 5057 VEV_3_3_RA6_01_1237.d 2.7E5 1 1 136 144 Carbamidomethylation; Biotinylation
R.E(+43.01)LT(+79.97)SLIQKR.F Y 19.62 1209.6118 9 -48.1 303.3957 4 24.51 5 10203 VEV_2_3_RA5_01_1236.d 7.37E5 1 1 71 79 Carbamylation; Phosphorylation (STY)
K.SLPDSVT(+13.03)IIDPKEEEPVLHPISQDYGAK.A Y 19.57 3089.5920 28 -12.4 773.3957 4 78.88 6 44355 VEV_3_3_RA6_01_1237.d 0 1 1 206 233 Michael addition with methylamine
R.ELT(+79.97)SLIQK(+14.02).R Y 18.94 1024.5205 8 -14.7 513.2600 2 20.17 4 7476 VEV_1_3_RA4_01_1235.d 0 1 1 71 78 Phosphorylation (STY); Methylation(KR)
K.S(+27.99)GPQK.S N 18.91 543.2653 5 8.6 544.2772 1 58.49 4 30351 VEV_1_3_RA4_01_1235.d 0 1 1 201 205 Formylation
K.ALAAQ(+.98)QLAEQ(+.98)QR.L Y 18.76 1327.6731 12 -19.8 664.8307 2 61.44 4 32618 VEV_1_3_RA4_01_1235.d 8.69E4 1 1 234 245 Deamidation (NQ)
K.ALAAQQLAEQQR(+28.03).L Y 17.81 1353.7365 12 -6.2 452.2499 3 62.58 4 33471 VEV_1_3_RA4_01_1235.d 0 1 1 234 245 Dimethylation(KR)
R.ELT(-18.01)SLIQKR.F Y 17.48 1068.6292 9 15.2 357.2224 3 55.43 4 28289 VEV_1_3_RA4_01_1235.d 0 1 1 71 79 Dehydration
K.SGPQK(+21.98).S N 17.40 537.2523 5 -3.9 538.2574 1 21.02 4 7938 VEV_1_3_RA4_01_1235.d 0 1 1 201 205 Sodium adduct
R.RAC(+57.02)YGVLR(+14.02).F Y 17.02 1007.5334 8 -7.1 336.8494 3 43.68 4 20950 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 120 127 Carbamidomethylation; Methylation(KR)
K.SGPQKSLPDSVTIIDPK.E Y 16.73 1780.9570 17 -23.4 357.1903 5 39.46 5 18803 VEV_2_3_RA5_01_1236.d 4.05E4 1 1 201 217
R.GLSAVAQC(+57.02)ESLR(+14.02)YK.L Y 16.69 1594.8137 14 -24.9 532.5986 3 66.91 4 36831 VEV_1_3_RA4_01_1235.d 1E5 1 1 98 111 Carbamidomethylation; Methylation(KR)
K.EEEPVLHPISQDYGAK(+14.02).A Y 16.45 1824.8893 16 -3.4 609.3016 3 66.10 4 36140 VEV_1_3_RA4_01_1235.d 0 1 1 218 233 Methylation(KR)
R.G(+42.01)LSAVAQC(+57.02)ESLR.Y Y 16.34 1331.6503 12 7.9 333.9225 4 14.27 6 4565 VEV_3_3_RA6_01_1237.d 5.91E4 1 1 98 109 Acetylation (N-term); Carbamidomethylation
MAAVQGVISK.R Y 16.15 1002.5532 10 -41.2 502.2632 2 32.38 6 14184 VEV_3_3_RA6_01_1237.d 3.29E4 1 1 1 10
R.G(+42.01)LSAVAQCESLRYK.L Y 15.87 1565.7871 14 -16.4 522.9277 3 73.81 6 40679 VEV_3_3_RA6_01_1237.d 5.06E5 1 1 98 111 Acetylation (N-term)
R.ELT(+79.96)SLIQKR.F Y 15.53 1166.5964 9 20.7 389.8808 3 55.53 6 27461 VEV_3_3_RA6_01_1237.d 1E5 1 1 71 79 Sulfation
K.I(+42.01)MRGSDPEGK(+42.01).S Y 15.43 1172.5496 10 0.1 587.2821 2 30.69 6 13243 VEV_3_3_RA6_01_1237.d 1.29E5 1 1 191 200 Acetylation (N-term); Acetylation (K)
K.IMRGSDPEGK(-.98).S Y 15.11 1087.5444 10 -3.3 544.7777 2 53.79 4 27314 VEV_1_3_RA4_01_1235.d 0 1 1 191 200 Amidation
total 150 peptides
A0A0A0HT80
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KLDSSADEIKAAQDSFSK.S Y 149.21 1938.9534 18 -16.1 485.7378 4 63.35 6 32909 VEV_3_3_RA6_01_1237.d 2.84E6 11 11 670 687
K.LDSSADEIKAAQDSFSK.S Y 144.70 1810.8584 17 -9.0 906.4283 2 66.68 5 36544 VEV_2_3_RA5_01_1236.d 1.98E6 9 9 671 687
R.AEAISEISKNDLPAGEAAAYRR.L Y 142.93 2331.1819 22 -14.0 583.7946 4 65.85 6 34799 VEV_3_3_RA6_01_1237.d 3.6E6 13 13 701 722
R.AEAISEISKNDLPAGEAAAYR.R Y 133.86 2175.0806 21 -10.4 726.0266 3 69.37 6 37403 VEV_3_3_RA6_01_1237.d 8.73E5 8 8 701 721
K.AAAVAPRPVDKLRPIVR.C Y 131.60 1828.1158 17 -13.4 458.0301 4 59.96 5 31565 VEV_2_3_RA5_01_1236.d 5.19E6 10 10 578 594
R.VNASTESLTANVAR.L Y 124.06 1431.7317 14 -9.0 478.2469 3 59.51 6 30116 VEV_3_3_RA6_01_1237.d 5.2E6 12 12 637 650
R.KLAQTIGIAVDHR.R Y 117.03 1420.8151 13 -12.0 474.6066 3 58.71 5 30655 VEV_2_3_RA5_01_1236.d 9.23E5 9 9 623 635
R.AGRGFTLQELKEAGIPR.K Y 111.37 1842.0111 17 -14.2 461.5035 4 70.81 5 39588 VEV_2_3_RA5_01_1236.d 9.19E5 6 6 606 622
R.GFTLQELKEAGIPR.K Y 103.45 1557.8514 14 -10.0 779.9252 2 75.76 5 43138 VEV_2_3_RA5_01_1236.d 2.65E6 12 12 609 622
R.RVNASTESLTANVAR.L Y 98.84 1587.8329 15 -19.4 530.2747 3 51.94 6 25434 VEV_3_3_RA6_01_1237.d 1.24E6 15 15 636 650
K.SIESLLPISNISRAEAISEISKNDLPAGEAAAYRR.L Y 97.64 3740.9695 35 -5.1 749.1974 5 82.43 4 48831 VEV_1_3_RA4_01_1235.d 4.76E5 3 3 688 722
K.SIESLLPISNISR.A Y 92.51 1427.7983 13 -8.5 714.9004 2 81.97 4 48533 VEV_1_3_RA4_01_1235.d 3.53E6 6 6 688 700
R.VHFDQPGRK.H Y 92.05 1082.5621 9 -15.1 542.2802 2 20.03 6 7606 VEV_3_3_RA6_01_1237.d 3.14E6 9 9 559 567
K.AAAVAPRPVDK.L Y 90.24 1093.6244 11 -12.9 547.8124 2 22.99 5 9327 VEV_2_3_RA5_01_1236.d 4.08E6 9 9 578 588
K.NDLPAGEAAAYR.R Y 85.16 1246.5941 12 -8.1 624.2993 2 56.09 4 28691 VEV_1_3_RA4_01_1235.d 3.22E5 4 4 710 721
R.VRVHFDQPGRK.H Y 84.81 1337.7316 11 -12.3 446.9123 3 29.39 5 12959 VEV_2_3_RA5_01_1236.d 1.8E6 14 14 557 567
R.AEAISEISKN(+.98)DLPAGEAAAYRR.L Y 81.38 2332.1658 22 -19.1 584.0376 4 65.55 6 34534 VEV_3_3_RA6_01_1237.d 5.36E5 4 4 701 722 Deamidation (NQ)
R.KLAQTIGIAVDHRR.V Y 80.96 1576.9161 14 -10.4 395.2322 4 52.97 4 26843 VEV_1_3_RA4_01_1235.d 2.86E6 11 11 623 636
K.KLDSSADEIKAAQDSFSKSIESLLPISNISR.A Y 80.04 3348.7412 31 -17.3 670.7440 5 87.22 5 50424 VEV_2_3_RA5_01_1236.d 2.27E5 3 3 670 700
R.AEAISEISKNDLPAGEAAAYR(+14.02)R.L Y 79.95 2345.1975 22 -25.4 587.2917 4 66.70 4 36607 VEV_1_3_RA4_01_1235.d 6.74E5 6 6 701 722 Methylation(KR)
K.NHFHKDWAR.R Y 79.66 1209.5791 9 -12.1 605.7895 2 24.47 6 9928 VEV_3_3_RA6_01_1237.d 3.33E6 14 14 547 555
K.KLDSSADE(+14.02)IKAAQDSFSK.S Y 79.05 1952.9690 18 -9.3 489.2450 4 68.44 4 38065 VEV_1_3_RA4_01_1235.d 6.36E5 4 4 670 687 Methylation(others)
R.VNASTE(+14.02)SLTANVAR.L Y 76.53 1445.7474 14 -10.7 723.8732 2 62.80 5 33665 VEV_2_3_RA5_01_1236.d 1E6 3 3 637 650 Methylation(others)
R.GFTLQELK(+14.02)EAGIPR.K Y 76.20 1571.8671 14 -10.9 524.9573 3 77.15 4 44817 VEV_1_3_RA4_01_1235.d 2.66E5 2 2 609 622 Methylation(KR)
R.AE(+14.02)AISEISKNDLPAGEAAAYR.R Y 76.10 2189.0964 21 -8.6 730.6998 3 71.51 4 40409 VEV_1_3_RA4_01_1235.d 2.64E5 2 2 701 721 Methylation(others)
R.VN(+.98)ASTESLTANVAR.L Y 74.94 1432.7158 14 -10.0 717.3580 2 62.62 4 33460 VEV_1_3_RA4_01_1235.d 6.31E5 4 4 637 650 Deamidation (NQ)
K.KLDSSADEIK.A Y 74.85 1104.5662 10 -10.1 553.2848 2 26.18 5 11137 VEV_2_3_RA5_01_1236.d 5.3E5 7 7 670 679
R.RVNASTE(+14.02)SLTANVAR.L Y 74.01 1601.8485 15 -6.2 534.9535 3 57.48 4 29636 VEV_1_3_RA4_01_1235.d 2.35E5 2 2 636 650 Methylation(others)
K.A(+42.01)AAVAPRPVDKLRPIVR.C Y 72.19 1870.1265 17 2.0 375.0333 5 60.10 5 31623 VEV_2_3_RA5_01_1236.d 2.07E4 1 1 578 594 Acetylation (N-term)
R.VHFDQPGR.K Y 71.85 954.4672 8 -12.0 478.2351 2 29.30 4 12464 VEV_1_3_RA4_01_1235.d 1.22E6 10 10 559 566
R.VNASTESLTAN(+.98)VAR.L Y 71.48 1432.7158 14 -10.8 717.3574 2 62.22 4 33161 VEV_1_3_RA4_01_1235.d 3.09E5 1 1 637 650 Deamidation (NQ)
K.NDLPAGEAAAYRR.L Y 70.24 1402.6953 13 -6.9 468.5692 3 46.47 4 22726 VEV_1_3_RA4_01_1235.d 1.02E6 4 4 710 722
K.SIESLLPISNISR(+14.02).A Y 69.60 1441.8140 13 -13.4 721.9046 2 82.25 6 46710 VEV_3_3_RA6_01_1237.d 2.92E5 3 3 688 700 Methylation(KR)
R.AGRGFTLQ(+.98)ELKEAGIPR.K Y 67.21 1842.9951 17 -4.1 461.7542 4 70.92 5 39673 VEV_2_3_RA5_01_1236.d 7.37E4 1 1 606 622 Deamidation (NQ)
R.AE(+14.02)AISEISKNDLPAGEAAAYRR.L Y 66.87 2345.1975 22 -21.3 587.2942 4 67.71 6 36186 VEV_3_3_RA6_01_1237.d 1.18E5 4 4 701 722 Methylation(others)
R.VNASTES(+14.02)LTANVAR.L Y 64.25 1445.7474 14 -12.2 723.8722 2 62.78 6 32470 VEV_3_3_RA6_01_1237.d 2.45E5 1 1 637 650 Methylation(others)
R.GFTLQELKEAGIPR(+14.02).K Y 63.13 1571.8671 14 -17.5 524.9538 3 77.53 6 43389 VEV_3_3_RA6_01_1237.d 1.02E5 3 3 609 622 Methylation(KR)
K.LDSSADE(+14.02)IKAAQDSFSK.S Y 62.14 1824.8740 17 -10.6 913.4346 2 71.91 5 40391 VEV_2_3_RA5_01_1236.d 7.56E5 2 2 671 687 Methylation(others)
K.LDSSADEIK.A Y 61.65 976.4713 9 -7.3 489.2393 2 32.38 4 14227 VEV_1_3_RA4_01_1235.d 1.57E6 11 11 671 679
K.AAAVAPRPVDK(+14.02).L Y 58.77 1107.6400 11 -12.9 554.8201 2 30.20 4 12972 VEV_1_3_RA4_01_1235.d 3.55E5 4 4 578 588 Methylation(KR)
K.LDSSADEIKAAQDSFSKSIESLLPISNISR.A Y 58.16 3220.6462 30 -9.9 1074.5454 3 89.88 4 53590 VEV_1_3_RA4_01_1235.d 9.68E3 1 1 671 700
R.GFTLQELK.E Y 57.20 934.5123 8 -0.5 468.2632 2 69.06 4 38516 VEV_1_3_RA4_01_1235.d 1.42E6 5 5 609 616
R.AEAISEIS(-18.01)K(+14.02)NDLPAGEAAAYRR.L Y 55.73 2327.1868 22 -36.6 582.7827 4 65.90 6 34804 VEV_3_3_RA6_01_1237.d 1.68E5 3 3 701 722 Dehydration; Methylation(KR)
K.LRPIVR.C Y 54.69 752.5021 6 -16.1 377.2523 2 26.68 4 11069 VEV_1_3_RA4_01_1235.d 1.41E6 6 6 589 594
R.AEAISEISK.N Y 54.61 946.4971 9 -11.0 474.2506 2 38.15 4 17601 VEV_1_3_RA4_01_1235.d 9.42E5 8 8 701 709
K.LAQTIGIAVDHRR.V Y 54.15 1448.8212 13 -16.5 483.9397 3 52.31 4 26358 VEV_1_3_RA4_01_1235.d 6.22E5 6 6 624 636
R.VNASTESLTANVAR(+14.02).L Y 53.97 1445.7474 14 -11.5 482.9175 3 62.81 6 32492 VEV_3_3_RA6_01_1237.d 1.26E5 2 2 637 650 Methylation(KR)
K.ARLILFPR.R Y 53.68 984.6232 8 -18.0 329.2091 3 69.18 4 38577 VEV_1_3_RA4_01_1235.d 2.86E4 1 1 656 663
R.AGRGFTLQELKE(+14.02)AGIPR.K Y 53.53 1856.0267 17 -27.2 465.0013 4 72.58 4 41256 VEV_1_3_RA4_01_1235.d 0 1 1 606 622 Methylation(others)
R.AEAISE(+14.02)ISKNDLPAGEAAAYRR.L Y 52.44 2345.1975 22 -16.3 782.7271 3 67.54 4 37270 VEV_1_3_RA4_01_1235.d 4.39E4 1 1 701 722 Methylation(others)
R.RVNASTESLTANVAR(+14.02).L Y 52.29 1601.8485 15 -4.8 534.9542 3 57.90 4 29941 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 636 650 Methylation(KR)
R.AGRGFTLQELK.E Y 48.89 1218.6720 11 -15.5 407.2250 3 61.71 5 32846 VEV_2_3_RA5_01_1236.d 5.31E5 4 4 606 616
R.VHFDQ(+.98)PGRK.H Y 48.08 1083.5461 9 -14.8 542.7723 2 23.57 5 9667 VEV_2_3_RA5_01_1236.d 7.74E4 1 1 559 567 Deamidation (NQ)
R.VRVHFDQPGR.K Y 43.53 1209.6366 10 -17.8 404.2123 3 37.65 6 17141 VEV_3_3_RA6_01_1237.d 6.49E5 4 4 557 566
R.AGRGFTLQELKEAGIPR(+14.02).K Y 43.06 1856.0267 17 1.7 465.0148 4 73.34 4 41849 VEV_1_3_RA4_01_1235.d 2.37E5 2 2 606 622 Methylation(KR)
R.VNASTESLT(+164.06)ANVAR.L Y 42.16 1595.7920 14 -7.0 798.8977 2 57.43 6 28644 VEV_3_3_RA6_01_1237.d 1.65E5 2 2 637 650 O-Diisopropylphosphorylation
R.GFTLQ(+.98)ELKEAGIPR.K Y 42.07 1558.8354 14 -42.1 780.3922 2 75.79 4 43753 VEV_1_3_RA4_01_1235.d 0 1 1 609 622 Deamidation (NQ)
K.KLDSSADEIKAAQDSFSK(+14.02).S Y 41.00 1952.9690 18 -8.2 489.2455 4 63.74 4 34311 VEV_1_3_RA4_01_1235.d 4.55E4 1 1 670 687 Methylation(KR)
K.LDSSADEIKAAQDSFSK(+14.02).S Y 37.87 1824.8740 17 -6.1 609.2949 3 69.08 4 38504 VEV_1_3_RA4_01_1235.d 1.68E5 3 3 671 687 Methylation(KR)
R.LILFPR.R Y 36.05 757.4850 6 -12.9 379.7449 2 73.36 4 41918 VEV_1_3_RA4_01_1235.d 4.05E6 9 9 658 663
K.KLDSSADEIKAAQ(+.98)DSFSK.S Y 35.82 1939.9374 18 -6.1 485.9886 4 68.00 4 37641 VEV_1_3_RA4_01_1235.d 2.04E5 2 2 670 687 Deamidation (NQ)
K.AAAVAPRPVDKLRPIVR(+14.02).C Y 35.72 1842.1315 17 -33.0 369.4214 5 63.05 6 32670 VEV_3_3_RA6_01_1237.d 8.98E4 2 2 578 594 Methylation(KR)
R.R(+14.02)VNAS(-18.01)TESLTANVAR.L Y 32.39 1583.8379 15 -38.4 528.9330 3 51.97 5 26363 VEV_2_3_RA5_01_1236.d 6.37E4 1 1 636 650 Methylation(KR); Dehydration
R.VNASTESLTAN(+.98)VAR(+14.02).L Y 32.10 1446.7314 14 -45.2 724.3403 2 66.21 4 36224 VEV_1_3_RA4_01_1235.d 0 2 2 637 650 Deamidation (NQ); Methylation(KR)
R.LILFPR(+14.02).R Y 31.49 771.5007 6 -12.5 386.7528 2 76.06 5 43347 VEV_2_3_RA5_01_1236.d 2.23E5 2 2 658 663 Methylation(KR)
R.LILFPRR.A Y 31.42 913.5861 7 -23.1 457.7898 2 64.40 5 34824 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 658 664
R.SYKHQGQ(+.98)GHSR(+28.03).G Y 31.39 1312.6272 11 -9.3 329.1610 4 10.49 4 2652 VEV_1_3_RA4_01_1235.d 5.59E4 1 1 336 346 Deamidation (NQ); Dimethylation(KR)
R.VHFDQ(+.98)PGR.K Y 31.15 955.4512 8 -8.6 478.7288 2 33.55 5 15319 VEV_2_3_RA5_01_1236.d 5.95E4 1 1 559 566 Deamidation (NQ)
R.KLAQT(-18.01)IGIAVDHR.R Y 30.96 1402.8044 13 -13.3 351.7037 4 58.79 4 30578 VEV_1_3_RA4_01_1235.d 9.1E5 3 3 623 635 Dehydration
K.KLDSS(+79.97)ADEIK.A Y 30.22 1184.5326 10 26.0 395.8617 3 26.13 6 10792 VEV_3_3_RA6_01_1237.d 0 1 1 670 679 Phosphorylation (STY)
R.GFTLQELKEAGIPRK.L Y 30.04 1685.9464 15 -14.9 422.4876 4 69.79 5 38842 VEV_2_3_RA5_01_1236.d 9.8E4 1 1 609 623
R.GTHSLSSLPVTPQR.S Y 30.02 1478.7842 14 -17.2 370.6970 4 31.99 4 14000 VEV_1_3_RA4_01_1235.d 6.36E5 2 2 347 360
K.AAQDSFSK.S Y 29.92 852.3977 8 -8.0 427.2027 2 16.58 4 5613 VEV_1_3_RA4_01_1235.d 1.06E5 2 2 680 687
R.C(+57.02)PTVKYNR.R Y 29.36 1036.5123 8 -14.9 519.2557 2 19.25 5 7345 VEV_2_3_RA5_01_1236.d 4.37E5 4 4 595 602 Carbamidomethylation
R.LKEYKAR.L Y 28.08 906.5287 7 -27.0 454.2594 2 11.62 6 3221 VEV_3_3_RA6_01_1237.d 1.06E5 3 3 651 657
R.AE(+356.19)AISEISKNDLPAGEAAAYRR.L Y 28.05 2687.3701 22 12.2 538.4879 5 67.97 6 36367 VEV_3_3_RA6_01_1237.d 0 1 1 701 722 Biotin polyethyleneoxide amine
K.S(+42.01)PELSPK.T Y 27.20 798.4123 7 -11.9 400.2087 2 47.47 4 23297 VEV_1_3_RA4_01_1235.d 0 2 2 196 202 Acetylation (N-term)
R.AGRGFTLQELK(+14.02)EAGIPR.K Y 27.05 1856.0267 17 -1.5 465.0132 4 72.30 5 40686 VEV_2_3_RA5_01_1236.d 8.09E4 1 1 606 622 Methylation(KR)
K.LDSSADEIKAAQ(+.98)DSFSK.S Y 26.98 1811.8424 17 -5.4 604.9515 3 71.65 4 40514 VEV_1_3_RA4_01_1235.d 6.05E4 1 1 671 687 Deamidation (NQ)
R.L(+43.01)ILFPR.R Y 26.33 800.4908 6 -2.9 401.2515 2 73.63 4 42069 VEV_1_3_RA4_01_1235.d 0 2 2 658 663 Carbamylation
K.NHFHKDWARR.V Y 26.30 1365.6803 10 2.7 456.2353 3 24.32 5 10089 VEV_2_3_RA5_01_1236.d 0 1 1 547 556
K.S(-18.01)SSILQSK(+14.02).L Y 26.26 844.4654 8 -14.7 423.2338 2 16.99 6 5973 VEV_3_3_RA6_01_1237.d 0 1 1 461 468 Dehydration; Methylation(KR)
R.LAK(+108.00)AAAVAPRPVDK.L Y 25.45 1513.8381 14 -87.9 379.4335 4 23.14 5 9419 VEV_2_3_RA5_01_1236.d 8.99E4 1 1 575 588 O-Ethylphosphorylation
R.ASLSAS(+79.97)PDR(+28.03)PAIDQNSSIPDK.L Y 25.37 2276.0686 21 7.8 759.7028 3 68.06 4 37685 VEV_1_3_RA4_01_1235.d 0 1 1 32 52 Phosphorylation (STY); Dimethylation(KR)
R.G(+42.01)FTLQELK(+14.02)EAGIPR.K Y 24.95 1613.8777 14 -53.5 538.9377 3 77.67 4 45220 VEV_1_3_RA4_01_1235.d 0 1 1 609 622 Acetylation (N-term); Methylation(KR)
K.L(+43.01)AQT(+79.97)IGIAVDHRR.V Y 23.93 1571.7933 13 44.2 393.9730 4 52.61 5 26752 VEV_2_3_RA5_01_1236.d 0 1 1 624 636 Carbamylation; Phosphorylation (STY)
R.LVGVR.E N 23.75 542.3540 5 -17.7 543.3517 1 23.02 6 9144 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 732 736
K.N(+.98)DLPAGEAAAYR.R Y 23.02 1247.5781 12 -1.3 624.7955 2 56.19 6 27844 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 710 721 Deamidation (NQ)
K.K(+42.01)LDSSADEIK(+14.02).A Y 23.02 1160.5924 10 -6.3 387.8690 3 11.51 5 3208 VEV_2_3_RA5_01_1236.d 2.4E4 1 1 670 679 Acetylation (N-term); Methylation(KR)
R.GTHSLS(+14.02)SLPVTPQR.S Y 22.78 1492.7998 14 14.0 374.2125 4 44.66 5 21934 VEV_2_3_RA5_01_1236.d 0 1 1 347 360 Methylation(others)
K.TPPSDATLK.R Y 22.76 928.4865 9 4.5 465.2526 2 21.26 6 8224 VEV_3_3_RA6_01_1237.d 1.77E5 2 2 203 211
R.VHFD(+14.02)QPGR.K Y 22.73 968.4828 8 -26.4 485.2359 2 32.88 4 14507 VEV_1_3_RA4_01_1235.d 7.1E4 1 1 559 566 Methylation(others)
R.K(+14.02)LAQT(-18.01)IGIAVDHRR.V Y 22.69 1572.9211 14 -41.2 394.2213 4 52.66 4 26593 VEV_1_3_RA4_01_1235.d 0 1 1 623 636 Methylation(KR); Dehydration
R.VNASTESLTANVAR(+28.03).L Y 22.41 1459.7631 14 -12.3 730.8798 2 65.80 4 35909 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 637 650 Dimethylation(KR)
K.LAQ(+.98)TIGIAVDHR.R Y 22.26 1293.7041 12 5.9 432.2445 3 64.54 4 34921 VEV_1_3_RA4_01_1235.d 0 1 1 624 635 Deamidation (NQ)
K.A(+42.01)KAD(-18.01)EAAATK.K Y 22.09 998.5032 10 -13.2 500.2523 2 53.35 6 26296 VEV_3_3_RA6_01_1237.d 0 1 1 742 751 Acetylation (N-term); Dehydration
R.K(+43.01)LAQT(+79.97)IGIAVDHR.R Y 22.08 1543.7871 13 18.5 386.9612 4 58.94 4 30690 VEV_1_3_RA4_01_1235.d 0 1 1 623 635 Carbamylation; Phosphorylation (STY)
R.GFTLQELK(+14.02).E Y 22.05 948.5280 8 -13.9 475.2647 2 74.42 4 42679 VEV_1_3_RA4_01_1235.d 4.99E3 1 1 609 616 Methylation(KR)
K.EAGIPR.K Y 21.85 641.3496 6 -44.5 642.3284 1 79.56 5 45767 VEV_2_3_RA5_01_1236.d 0 1 1 617 622
R.SSQ(+.98)SSLGSPADIR.I Y 21.66 1304.6207 13 28.3 327.1717 4 18.45 4 6596 VEV_1_3_RA4_01_1235.d 2.73E5 1 1 10 22 Deamidation (NQ)
K.R(+14.02)TPDAR(+21.98).H Y 21.65 750.3749 6 43.7 751.4149 1 95.09 4 56324 VEV_1_3_RA4_01_1235.d 1.73E4 1 1 377 382 Methylation(KR); Sodium adduct
R.RAGQHK(-.98).K Y 21.30 694.3987 6 -2.3 695.4044 1 99.22 6 55053 VEV_3_3_RA6_01_1237.d 0 1 1 664 669 Amidation
K.LQ(+.98)HS(+79.97)LLSLTSSEAVK.R Y 20.96 1692.8335 15 -4.5 565.2826 3 76.15 4 44031 VEV_1_3_RA4_01_1235.d 0 1 1 150 164 Deamidation (NQ); Phosphorylation (STY)
R.AEVE(+14.02)QQLAR.R Y 20.62 1056.5564 9 -8.3 529.2811 2 71.84 5 40341 VEV_2_3_RA5_01_1236.d 1.14E5 1 1 166 174 Methylation(others)
R.AEAISEISK(+31.99).N Y 20.28 978.4869 9 -14.5 490.2437 2 23.89 6 9613 VEV_3_3_RA6_01_1237.d 0 1 1 701 709 Dihydroxy
R.AEAIS(-18.01)EISK.N Y 20.20 928.4865 9 49.6 310.5181 3 9.30 5 2252 VEV_2_3_RA5_01_1236.d 3.8E4 1 1 701 709 Dehydration
K.S(+226.08)PELSPK.T Y 20.09 982.4793 7 21.4 983.5076 1 84.70 5 48986 VEV_2_3_RA5_01_1236.d 2.02E4 1 1 196 202 Biotinylation
K.HNQTIPK.N Y 20.02 836.4504 7 37.4 837.4890 1 108.78 4 60802 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 540 546
R.AE(+14.02)AISEISK.N Y 19.73 960.5128 9 -3.5 481.2620 2 49.89 4 24807 VEV_1_3_RA4_01_1235.d 8.4E5 1 1 701 709 Methylation(others)
K.LDS(+126.10)SADEIKAAQDSFSK.S Y 19.66 1936.9629 17 0.6 485.2483 4 63.63 5 34265 VEV_2_3_RA5_01_1236.d 0 1 1 671 687 Octanoyl
R.GLSVEKSPELSPK.T Y 19.62 1369.7452 13 -11.7 457.5837 3 78.92 6 44385 VEV_3_3_RA6_01_1237.d 6.63E4 1 1 190 202
K.RTPDAR.H Y 19.58 714.3773 6 -40.6 715.3555 1 88.49 5 51105 VEV_2_3_RA5_01_1236.d 7.91E3 1 1 377 382
K.ATSSAT(-18.01)R.Y Y 19.22 674.3347 7 14.6 675.3518 1 31.28 5 14007 VEV_2_3_RA5_01_1236.d 2.17E4 1 1 286 292 Dehydration
K.R(+14.02)TPDARHHNHSVSLSNR.E Y 19.06 1997.0051 17 -8.9 500.2541 4 30.43 5 13511 VEV_2_3_RA5_01_1236.d 0 1 1 377 393 Methylation(KR)
K.EIAAK(+27.99).K Y 18.96 558.3013 5 -1.9 559.3075 1 76.51 6 42639 VEV_3_3_RA6_01_1237.d 0 1 1 500 504 Formylation
R.K(+27.99)LAQTIGIAVDHR.R Y 18.81 1448.8099 13 -9.8 363.2062 4 51.78 5 26254 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 623 635 Formylation
R.AGRGFTLQELK(+42.01).E Y 18.76 1260.6826 11 -24.5 421.2245 3 67.27 4 37061 VEV_1_3_RA4_01_1235.d 9.94E4 1 1 606 616 Acetylation (K)
R.VN(+162.05)ASTESLTANVAR.L Y 18.57 1593.7845 14 -4.1 532.2666 3 52.15 4 26264 VEV_1_3_RA4_01_1235.d 1.53E5 1 1 637 650 Hexose (NSY)
K.L(+226.08)FGQVK.K Y 18.52 916.4840 6 -39.3 306.4899 3 12.98 5 3962 VEV_2_3_RA5_01_1236.d 0 1 1 469 474 Biotinylation
R.LVGVREK.R N 18.51 799.4916 7 -14.2 400.7474 2 17.96 5 6623 VEV_2_3_RA5_01_1236.d 9.88E4 1 1 732 738
R.KATSSAT(+79.97)R.Y Y 17.92 900.4066 8 33.3 451.2256 2 23.25 4 9201 VEV_1_3_RA4_01_1235.d 2.79E5 1 1 285 292 Phosphorylation (STY)
K.LQHS(+79.97)LLSLTSSEAVK(-.98).R Y 17.41 1690.8655 15 3.6 339.1816 5 23.78 4 9438 VEV_1_3_RA4_01_1235.d 0 1 1 150 164 Phosphorylation (STY); Amidation
K.L(+43.01)AQTIGIAVDHRR.V Y 17.23 1491.8270 13 -70.8 498.2477 3 52.25 4 26330 VEV_1_3_RA4_01_1235.d 2.43E5 1 1 624 636 Carbamylation
R.RVNASTESLTANVAR(-.98).L Y 17.21 1586.8489 15 -69.4 529.9202 3 53.00 4 26805 VEV_1_3_RA4_01_1235.d 0 1 1 636 650 Amidation
K.AT(-18.01)SSATR.Y Y 17.05 674.3347 7 -37.9 675.3164 1 61.99 5 33028 VEV_2_3_RA5_01_1236.d 8.31E4 1 1 286 292 Dehydration
K.SS(+79.97)SYGND(-18.01)K.E Y 16.93 918.3120 8 -32.5 919.2894 1 117.62 4 63036 VEV_1_3_RA4_01_1235.d 2.69E4 1 1 492 499 Phosphorylation (STY); Dehydration
K.SPELSPKT(+79.97)PPSDATLKR.I Y 16.79 1902.9452 17 1.3 476.7442 4 56.91 4 29232 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 196 212 Phosphorylation (STY)
R.A(+71.04)GQHK.K Y 16.77 610.3187 5 -44.5 611.2988 1 22.73 6 8988 VEV_3_3_RA6_01_1237.d 1.34E4 1 1 665 669 Propionamide (K, X@N-term)
R.L(+42.01)VGVR(+14.02).E N 16.76 598.3802 5 -9.5 300.1945 2 56.28 4 28812 VEV_1_3_RA4_01_1235.d 3.86E4 1 1 732 736 Acetylation (N-term); Methylation(KR)
K.SSS(-18.01)ILQSK.L Y 16.61 830.4498 8 25.8 416.2429 2 12.16 6 3473 VEV_3_3_RA6_01_1237.d 0 1 1 461 468 Dehydration
R.KLAQT(-18.01)IGIAVDHRR.V Y 16.53 1558.9055 14 -11.3 520.6366 3 52.70 4 26614 VEV_1_3_RA4_01_1235.d 2.34E5 1 1 623 636 Dehydration
R.AGQH(+15.99)K(+14.02).K Y 16.50 569.2921 5 -13.1 570.2919 1 67.82 5 37386 VEV_2_3_RA5_01_1236.d 0 1 1 665 669 Oxidation (HW); Methylation(KR)
K.AAQDSFSK(+14.02).S Y 16.49 866.4134 8 -3.1 434.2126 2 24.52 4 9861 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 680 687 Methylation(KR)
R.AEAISEIS(+114.04)K.N Y 16.44 1060.5400 9 -20.4 531.2665 2 38.31 6 17527 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 701 709 Ubiquitin
K.LD(+14.02)SSADEIK.A Y 16.28 990.4869 9 3.4 496.2524 2 48.53 5 24245 VEV_2_3_RA5_01_1236.d 2.69E5 1 1 671 679 Methylation(others)
K.K(+44.03)LDSSADEIK.A Y 16.28 1148.5924 10 9.8 575.3091 2 25.99 6 10721 VEV_3_3_RA6_01_1237.d 0 1 1 670 679 Ethanolation (KR)
R.EVEILQSVEYRHRR.G Y 16.23 1812.9595 14 -0.6 454.2469 4 66.07 5 36087 VEV_2_3_RA5_01_1236.d 0 1 1 176 189
K.LR(+31.99)PIVR.C Y 16.03 784.4919 6 -10.1 393.2492 2 10.74 5 2838 VEV_2_3_RA5_01_1236.d 5.7E4 1 1 589 594 Dihydroxy
R.VNASTES(-18.01)LTANVAR.L Y 15.97 1413.7212 14 -11.6 472.2422 3 18.56 5 6960 VEV_2_3_RA5_01_1236.d 0 1 1 637 650 Dehydration
K.K(+43.99)LDSSADEIK.A Y 15.94 1148.5560 10 10.2 575.2911 2 36.24 4 16478 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 670 679 Carboxylation (DKW)
K.HQGQGHSR.G Y 15.70 905.4216 8 -4.6 453.7160 2 54.93 6 27152 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 339 346
K.S(+79.97)SSE(+21.98)R.S Y 15.65 666.1986 5 -0.9 667.2053 1 118.86 6 60309 VEV_3_3_RA6_01_1237.d 0 1 1 5 9 Phosphorylation (STY); Sodium adduct
R.GLS(+79.96)VEKSPELSPK.T Y 15.64 1449.7020 13 -10.7 484.2361 3 33.86 6 14992 VEV_3_3_RA6_01_1237.d 8.59E4 1 1 190 202 Sulfation
R.C(+58.01)PTVKYNR.R Y 15.56 1037.4963 8 0.0 519.7554 2 25.05 5 10506 VEV_2_3_RA5_01_1236.d 8.85E4 1 1 595 602 Carboxymethyl
K.HQGQGHSR(+28.03).G Y 15.35 933.4529 8 -4.6 312.1568 3 33.25 5 15138 VEV_2_3_RA5_01_1236.d 0 1 1 339 346 Dimethylation(KR)
K.AKADEAAATK(+42.01).K Y 15.34 1016.5138 10 -25.2 509.2514 2 41.04 6 19083 VEV_3_3_RA6_01_1237.d 8E4 1 1 742 751 Acetylation (K)
R.AGQHK(+117.02)KLDSSADEIKAAQDSFSK.S Y 15.26 2577.2493 23 13.8 645.3285 4 63.36 5 34060 VEV_2_3_RA5_01_1236.d 0 1 1 665 687 N-Homocysteine thiolactone
R.TPDARHHN(+.98)HSVSLSNR.E Y 15.14 1827.8724 16 -6.2 457.9725 4 12.94 5 3929 VEV_2_3_RA5_01_1236.d 3.51E5 1 1 378 393 Deamidation (NQ)
R.AEAISEISK(+43.99).N Y 15.12 990.4869 9 -11.0 496.2453 2 53.47 6 26347 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 701 709 Carboxylation (DKW)
total 149 peptides
C1FYW9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
MQIFVKTLTGKTITLEVESSDTIDNVK.S Y 172.26 3009.5945 27 -14.9 753.3947 4 82.46 6 46920 VEV_3_3_RA6_01_1237.d 1.29E6 7 7 1 27
R.TLSDYNIQKESTLHLVLR.L N 159.30 2129.1479 18 -16.7 533.2854 4 74.48 6 41183 VEV_3_3_RA6_01_1237.d 4.69E6 15 15 55 72
K.Q(-17.03)LEDGRTLSDYNIQKESTLHLVLR.L N 141.80 2810.4563 24 -16.4 703.6098 4 79.17 6 44565 VEV_3_3_RA6_01_1237.d 7.4E5 3 3 49 72 Pyro-glu from Q
R.EC(+57.02)PTPEC(+57.02)GAGVFMASMTNR.Q Y 140.66 2113.8689 19 -9.0 705.6239 3 77.88 6 43645 VEV_3_3_RA6_01_1237.d 4.1E5 6 6 120 138 Carbamidomethylation
K.TITLEVESSDTIDNVK.S N 137.72 1762.8837 16 -16.9 588.6252 3 74.04 6 40897 VEV_3_3_RA6_01_1237.d 3.46E6 24 24 12 27
K.TLTGKTITLEVESSDTIDNVK.S N 136.65 2263.1794 21 -15.1 755.3890 3 74.33 5 42129 VEV_2_3_RA5_01_1236.d 4.75E5 5 5 7 27
K.TITLEVESSDTIDNVKSK.I N 131.66 1978.0106 18 -16.7 660.3331 3 68.40 6 36710 VEV_3_3_RA6_01_1237.d 1.22E6 8 8 12 29
K.IQDKEGIPPDQQR.L N 112.68 1522.7739 13 -9.4 762.3871 2 33.45 5 15253 VEV_2_3_RA5_01_1236.d 1.73E7 87 87 30 42
K.YYKVDGDGKIER.L Y 108.79 1441.7201 12 -14.2 481.5738 3 39.10 6 17978 VEV_3_3_RA6_01_1237.d 4.07E6 15 15 105 116
K.TLTGKTITLEVESSDTIDNVKSK.I N 102.46 2478.3064 23 -3.9 827.1062 3 70.31 5 39218 VEV_2_3_RA5_01_1236.d 3.34E4 1 1 7 29
K.C(+57.02)HLTYVFDESK Y 101.93 1397.6285 11 -7.5 466.8800 3 63.08 5 33836 VEV_2_3_RA5_01_1236.d 5.57E5 5 5 144 154 Carbamidomethylation
K.QLEDGRTLSDYNIQKESTLHLVLR.L N 101.60 2827.4827 24 -9.9 566.4982 5 75.29 5 42801 VEV_2_3_RA5_01_1236.d 3.72E5 2 2 49 72
K.SKIQDKEGIPPDQQR.L N 98.76 1737.9009 15 -7.0 869.9516 2 29.38 6 12531 VEV_3_3_RA6_01_1237.d 6.91E6 52 52 28 42
R.TLSDYNIQKESTLHLVLR(+14.02).L N 96.35 2143.1636 18 -12.0 536.7917 4 76.06 6 42318 VEV_3_3_RA6_01_1237.d 2.76E5 2 2 55 72 Methylation(KR)
R.LIFAGKQLEDGR.T N 96.30 1345.7354 12 -11.3 673.8674 2 63.79 5 34379 VEV_2_3_RA5_01_1236.d 6.99E5 4 4 43 54
K.ESTLHLVLR.L N 90.92 1066.6135 9 -8.7 534.3094 2 63.78 4 34342 VEV_1_3_RA4_01_1235.d 2.15E6 11 11 64 72
K.QLEDGRTLSDYNIQK.E N 82.96 1778.8799 15 -11.8 593.9603 3 62.37 4 33270 VEV_1_3_RA4_01_1235.d 2.33E5 2 2 49 63
K.Q(-17.03)LEDGRTLSDYNIQK.E N 80.22 1761.8533 15 -9.3 588.2863 3 71.63 6 39086 VEV_3_3_RA6_01_1237.d 3.29E5 4 4 49 63 Pyro-glu from Q
R.TLSDYNIQ(+.98)KESTLHLVLR.L N 79.14 2130.1321 18 -5.8 533.5372 4 76.10 5 43372 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 55 72 Deamidation (NQ)
R.TLSDYN(+.98)IQ(+.98)KESTLHLVLR.L N 77.87 2131.1160 18 2.0 533.7874 4 74.73 6 41348 VEV_3_3_RA6_01_1237.d 2.48E5 3 3 55 72 Deamidation (NQ)
M(+15.99)QIFVKTLTGKTITLEVESSDTIDNVK.S Y 75.54 3025.5894 27 -17.2 757.3916 4 80.00 6 45158 VEV_3_3_RA6_01_1237.d 2.41E5 2 2 1 27 Oxidation (M)
R.TLSDYNIQK.E N 70.15 1080.5452 9 -10.8 541.2740 2 49.71 4 24740 VEV_1_3_RA4_01_1235.d 2.84E6 12 12 55 63
K.EGIPPDQQR.L N 67.65 1038.5094 9 -15.7 520.2538 2 25.46 5 10742 VEV_2_3_RA5_01_1236.d 2.88E6 35 35 34 42
R.TLSDYNIQKE(+14.02)STLHLVLR.L N 63.33 2143.1636 18 -16.1 536.7896 4 76.90 6 42930 VEV_3_3_RA6_01_1237.d 1.81E5 1 1 55 72 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVKSK.I N 60.94 1992.0262 18 -8.7 665.0103 3 72.08 6 39422 VEV_3_3_RA6_01_1237.d 2.35E5 3 3 12 29 Methylation(others)
R.TLSD(+43.99)YNIQKESTLHLVLR.L N 60.62 2173.1379 18 -20.6 544.2806 4 74.60 4 42826 VEV_1_3_RA4_01_1235.d 3.45E4 1 1 55 72 Carboxylation (DKW)
R.TLSDYNIQK(+114.04)ESTLHLVLR.L N 60.29 2243.1909 18 -8.8 561.8000 4 75.33 4 43389 VEV_1_3_RA4_01_1235.d 4.52E5 4 4 55 72 Ubiquitin
MQIFVK.T N 56.88 764.4255 6 -28.0 383.2093 2 60.29 6 30725 VEV_3_3_RA6_01_1237.d 4.48E6 10 10 1 6
K.TITLEVESS(+14.02)DTIDNVK.S N 56.56 1776.8993 16 -9.1 889.4489 2 77.18 5 44192 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 12 27 Methylation(others)
K.IQDKEGIPPDQ(+.98)QR.L N 55.65 1523.7579 13 -2.8 508.9252 3 34.09 5 15624 VEV_2_3_RA5_01_1236.d 5.98E6 21 21 30 42 Deamidation (NQ)
R.LIFAGK(+114.04)QLEDGR.T N 54.12 1459.7783 12 -19.0 487.5908 3 64.99 6 34106 VEV_3_3_RA6_01_1237.d 7.64E5 4 4 43 54 Ubiquitin
K.LAVLKYYKVDGDGKIER.L Y 53.50 1966.0886 17 -11.8 394.2204 5 64.93 5 35219 VEV_2_3_RA5_01_1236.d 1.25E5 2 2 100 116
R.LIFAGK(+383.23)QLEDGR.T N 52.12 1728.9634 12 -18.5 433.2401 4 64.27 6 33560 VEV_3_3_RA6_01_1237.d 9.35E5 4 4 43 54 Ubiquitination
K.IQDKEGIPPDQQ(+.98)R.L N 51.34 1523.7579 13 -11.3 508.9208 3 37.29 6 16932 VEV_3_3_RA6_01_1237.d 2.87E6 13 13 30 42 Deamidation (NQ)
K.C(+58.01)HLTYVFDESK Y 51.20 1398.6125 11 -13.8 467.2050 3 67.75 6 36190 VEV_3_3_RA6_01_1237.d 1.35E5 4 4 144 154 Carboxymethyl
M(+42.01)QIFVKTLTGK(+14.02)TITLEVESSDTIDNVK.S Y 49.29 3065.6206 27 13.0 767.4224 4 83.21 5 48082 VEV_2_3_RA5_01_1236.d 0 1 1 1 27 Acetylation (Protein N-term); Methylation(KR)
K.IQ(+.98)DKEGIPPDQ(+.98)QR.L N 48.15 1524.7419 13 5.2 763.3822 2 34.57 6 15407 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 30 42 Deamidation (NQ)
K.IQ(+.98)DKEGIPPDQQR.L N 47.47 1523.7579 13 -5.1 508.9240 3 36.66 5 17161 VEV_2_3_RA5_01_1236.d 2.97E6 4 4 30 42 Deamidation (NQ)
K.IQDK(+14.02)EGIPPDQQR.L N 46.46 1536.7896 13 -9.9 513.2654 3 41.87 4 19819 VEV_1_3_RA4_01_1235.d 3.22E6 21 21 30 42 Methylation(KR)
K.IQD(+14.02)KEGIPPDQQR.L N 46.06 1536.7896 13 -14.7 513.2629 3 44.66 5 21930 VEV_2_3_RA5_01_1236.d 1.44E6 2 2 30 42 Methylation(others)
R.LIFAGK.Q N 45.36 647.4006 6 -23.3 648.3928 1 51.12 5 25833 VEV_2_3_RA5_01_1236.d 1.07E7 12 12 43 48
R.TLSDYN(+.98)IQKESTLHLVLR.L N 44.22 2130.1321 18 -0.5 533.5400 4 76.12 4 44001 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 55 72 Deamidation (NQ)
K.SKIQDKEGIPPDQ(+.98)QR.L N 43.56 1738.8849 15 -2.5 580.6341 3 30.82 5 13731 VEV_2_3_RA5_01_1236.d 5.87E5 4 4 28 42 Deamidation (NQ)
K.IQDKEGIPPDQQR(+14.02).L N 43.21 1536.7896 13 -15.8 513.2624 3 40.86 4 19197 VEV_1_3_RA4_01_1235.d 1.83E6 13 13 30 42 Methylation(KR)
MQIFVK(+14.02)TLTGK(+42.01)TITLEVESSDTIDNVK.S Y 42.60 3065.6206 27 2.0 767.4139 4 83.38 4 49486 VEV_1_3_RA4_01_1235.d 0 1 1 1 27 Methylation(KR); Acetylation (K)
K.VDGDGKIER.L Y 40.88 987.4985 9 -15.9 494.7487 2 14.36 5 4701 VEV_2_3_RA5_01_1236.d 1.78E5 4 4 108 116
M(+15.99)QIFVK.T N 38.90 780.4204 6 -15.7 391.2114 2 40.39 5 19345 VEV_2_3_RA5_01_1236.d 4.06E6 11 11 1 6 Oxidation (M)
K.TLTGKTITLEVES(+14.02)SDTIDNVK.S N 38.82 2277.1951 21 -23.1 760.0547 3 76.81 6 42859 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 7 27 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVK.S N 37.48 1776.8993 16 -4.0 593.3047 3 77.42 6 43315 VEV_3_3_RA6_01_1237.d 4.47E5 2 2 12 27 Methylation(others)
K.QLEDGRTLSDYNIQK(-1.03)ESTLHLVLR.L N 37.12 2826.4512 24 -40.3 566.2747 5 75.36 5 42849 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 49 72 Lysine oxidation to aminoadipic semialdehyde
K.LAVLK(-1.03)YYKVDGDGKIER.L Y 37.10 1965.0570 17 -23.6 492.2599 4 64.94 5 35225 VEV_2_3_RA5_01_1236.d 0 1 1 100 116 Lysine oxidation to aminoadipic semialdehyde
K.TITLE(+14.02)VESSDTIDNVKSK.I N 36.89 1992.0262 18 -2.3 665.0145 3 70.44 6 38186 VEV_3_3_RA6_01_1237.d 0 1 1 12 29 Methylation(others)
K.SKIQ(+.98)DKEGIPPDQQR.L N 35.45 1738.8849 15 -2.4 870.4476 2 31.76 6 13855 VEV_3_3_RA6_01_1237.d 5.6E5 2 2 28 42 Deamidation (NQ)
K.ESTLHLVLR(+14.02).L N 34.55 1080.6292 9 -16.3 361.2111 3 67.59 4 37312 VEV_1_3_RA4_01_1235.d 0 1 1 64 72 Methylation(KR)
K.TITLEVESSD(-18.01)TIDNVK(+14.02).S N 33.66 1758.8887 16 11.3 587.3101 3 74.25 6 40996 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 12 27 Dehydration; Methylation(KR)
K.E(-18.01)GIPPDQQR.L N 33.32 1020.4988 9 -6.9 511.2532 2 35.23 6 15790 VEV_3_3_RA6_01_1237.d 0 1 1 34 42 Pyro-glu from E
K.LAVLK.Y N 32.66 542.3792 5 -15.6 543.3780 1 34.38 6 15303 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 100 104
K.IQD(-18.01)K(+14.02)EGIPPDQQR.L N 32.44 1518.7791 13 5.7 507.2698 3 33.68 4 14973 VEV_1_3_RA4_01_1235.d 2.93E5 7 7 30 42 Dehydration; Methylation(KR)
R.TLSDY(-18.01)NIQK(+14.02)ESTLHLVLR.L N 31.34 2125.1531 18 -30.4 532.2794 4 76.08 6 42334 VEV_3_3_RA6_01_1237.d 5.28E4 1 1 55 72 Dehydration; Methylation(KR)
R.TLS(-18.01)DYNIQK(+14.02)ESTLHLVLR.L N 30.27 2125.1531 18 -36.0 532.2764 4 74.44 6 41139 VEV_3_3_RA6_01_1237.d 7.97E4 1 1 55 72 Dehydration; Methylation(KR)
K.IQDKE(+14.02)GIPPDQQR.L N 28.37 1536.7896 13 -14.0 513.2633 3 43.09 4 20592 VEV_1_3_RA4_01_1235.d 1.4E6 2 2 30 42 Methylation(others)
MQ(+.98)IFVK.T N 26.85 765.4095 6 -13.8 383.7067 2 62.91 4 33690 VEV_1_3_RA4_01_1235.d 1.88E5 2 2 1 6 Deamidation (NQ)
R.L(+108.00)IFAGKQLEDGR.T N 26.64 1453.7329 12 -20.6 485.5749 3 65.04 6 34170 VEV_3_3_RA6_01_1237.d 4.89E5 2 2 43 54 O-Ethylphosphorylation
R.LIFAGK(+14.02).Q N 26.06 661.4163 6 -20.9 331.7085 2 58.65 6 29475 VEV_3_3_RA6_01_1237.d 8.4E5 5 5 43 48 Methylation(KR)
K.YYKVDGDGKIER(+14.02).L Y 26.04 1455.7357 12 -29.0 486.2385 3 43.44 6 20486 VEV_3_3_RA6_01_1237.d 1.49E5 2 2 105 116 Methylation(KR)
K.TITLEVESSDTIDNVKSK(+14.02).I N 25.84 1992.0262 18 6.0 665.0200 3 70.39 5 39276 VEV_2_3_RA5_01_1236.d 0 1 1 12 29 Methylation(KR)
K.SKIQD(-18.01)K(+14.02)EGIPPDQQR.L N 24.63 1733.9060 15 8.1 434.4873 4 30.43 4 13088 VEV_1_3_RA4_01_1235.d 0 1 1 28 42 Dehydration; Methylation(KR)
K.VYTTPK.K Y 24.13 707.3854 6 -53.4 708.3549 1 107.45 5 58164 VEV_2_3_RA5_01_1236.d 1.7E5 3 3 84 89
R.TLSD(+37.03)YNIQKESTLHLVLR.L N 23.66 2166.1797 18 9.8 542.5575 4 74.51 5 42259 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 55 72 Propargylamine
K.TITLE(+14.02)VESSDTIDNVK.S N 22.92 1776.8993 16 -11.7 593.3001 3 76.06 6 42319 VEV_3_3_RA6_01_1237.d 1.76E5 1 1 12 27 Methylation(others)
MQIFVKTL(+53.97)TGKTITLEVESSDTIDNVK.S Y 21.61 3063.5662 27 -25.9 766.8790 4 83.48 4 49552 VEV_1_3_RA4_01_1235.d 7.35E4 1 1 1 27 Trifluoroleucine
K.TITLEVESSDTIDNVK(+14.02)SK.I N 21.55 1992.0262 18 -14.1 665.0067 3 71.01 6 38615 VEV_3_3_RA6_01_1237.d 9.51E4 1 1 12 29 Methylation(KR)
K.Q(-17.03)LEDGRTLSDYNIQ(+.98)K.E N 21.37 1762.8373 15 -13.7 882.4138 2 73.11 6 40171 VEV_3_3_RA6_01_1237.d 0 1 1 49 63 Pyro-glu from Q; Deamidation (NQ)
K.Q(-17.03)LEDGR.T N 21.10 699.3187 6 -17.4 700.3138 1 31.50 6 13696 VEV_3_3_RA6_01_1237.d 1.08E6 2 2 49 54 Pyro-glu from Q
K.YYK(+14.02)VDGDGKIER(+14.02)LR.R Y 20.66 1738.9365 14 -0.3 435.7413 4 59.89 5 31475 VEV_2_3_RA5_01_1236.d 0 1 1 105 118 Methylation(KR)
K.SKIQDK(-1.03)EGIPPDQQR.L N 20.63 1736.8693 15 -34.0 435.2098 4 29.93 5 13221 VEV_2_3_RA5_01_1236.d 0 1 1 28 42 Lysine oxidation to aminoadipic semialdehyde
K.VY(-18.01)TTPK.K Y 20.50 689.3748 6 -51.7 690.3464 1 84.39 5 48799 VEV_2_3_RA5_01_1236.d 3.2E4 1 1 84 89 Dehydration
R.L(+41.03)IFAGK.Q N 19.93 688.4272 6 -34.3 345.2091 2 49.95 5 25113 VEV_2_3_RA5_01_1236.d 0 1 1 43 48 Amidination of lysines or N-terminal amines with methyl acetimidate
R.T(-18.01)LSDYNIQK(+14.02)ESTLHLVLR.L N 19.72 2125.1531 18 -24.8 532.2823 4 74.54 4 42776 VEV_1_3_RA4_01_1235.d 0 1 1 55 72 Dehydration; Methylation(KR)
K.VDGDGKIER(+21.98).L Y 19.42 1009.4804 9 -19.6 505.7376 2 27.65 5 11948 VEV_2_3_RA5_01_1236.d 3.2E4 1 1 108 116 Sodium adduct
K.YY(+31.99)KVDGDGKIER.L Y 19.12 1473.7100 12 4.0 492.2459 3 62.79 4 33589 VEV_1_3_RA4_01_1235.d 7.67E4 1 1 105 116 Dihydroxy
K.QLEDGR.T N 18.77 716.3453 6 43.4 717.3837 1 45.77 5 22589 VEV_2_3_RA5_01_1236.d 8.79E4 1 1 49 54
K.IQDK(+164.06)EGIPPDQQR.L N 18.75 1686.8341 13 -7.0 563.2814 3 32.26 5 14630 VEV_2_3_RA5_01_1236.d 0 1 1 30 42 O-Diisopropylphosphorylation
K.EGIPPDQQR(+14.02).L N 18.59 1052.5250 9 1.0 527.2703 2 34.20 6 15197 VEV_3_3_RA6_01_1237.d 0 2 2 34 42 Methylation(KR)
K.IQDKEGIPPDQQ(+.98)R(+14.02).L N 18.22 1537.7736 13 -68.3 769.8416 2 37.73 5 17783 VEV_2_3_RA5_01_1236.d 7.79E4 1 1 30 42 Deamidation (NQ); Methylation(KR)
K.VDGDGK(+42.01)IER(+31.99).L Y 17.92 1061.4989 9 2.5 1062.5088 1 112.43 5 59503 VEV_2_3_RA5_01_1236.d 0 1 1 108 116 Acetylation (K); Dihydroxy
K.IQDK(+210.20)EGIPPDQQR.L N 17.58 1732.9723 13 -63.9 434.2227 4 30.13 5 13335 VEV_2_3_RA5_01_1236.d 0 1 1 30 42 Myristoylation
K.VYTTPK(+28.03).K Y 16.80 735.4167 6 -22.0 368.7075 2 37.02 5 17419 VEV_2_3_RA5_01_1236.d 0 2 2 84 89 Dimethylation(KR)
MQIFVKTLTGKTITLEVESSDTIDNVK(+14.02).S Y 16.27 3023.6101 27 -14.9 756.8986 4 83.36 6 47417 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 1 27 Methylation(KR)
K.T(+43.01)ITLEVESSDTIDNVK.S N 16.26 1805.8894 16 4.1 362.1866 5 44.85 6 21323 VEV_3_3_RA6_01_1237.d 0 1 1 12 27 Carbamylation
K.IQDK(+43.01)EGIPPDQQR.L N 15.42 1565.7798 13 27.0 314.1717 5 11.16 6 2993 VEV_3_3_RA6_01_1237.d 0 1 1 30 42 Carbamylation
K.VDGDGK(+42.02).I Y 15.21 631.2925 6 34.6 632.3217 1 81.20 5 46837 VEV_2_3_RA5_01_1236.d 0 1 1 108 113 Guanidination
total 92 peptides
C1G3L4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SREPEC(+57.02)ISLAWSADGQTLFAGYTDNKIR.A Y 160.69 3184.5247 28 -15.7 797.1260 4 81.23 6 46013 VEV_3_3_RA6_01_1237.d 5E5 5 5 281 308 Carbamidomethylation
R.GTLEGHNGWVTSLATSLENPNMLLSASR.D Y 152.16 2954.4556 28 -10.2 985.8157 3 87.16 4 51998 VEV_1_3_RA4_01_1235.d 9.02E5 4 4 9 36
R.IQTDHIGHTGYINTVTISPDGSLC(+57.02)ASGGK.D Y 134.97 2998.4453 29 -5.7 750.6143 4 71.83 4 40659 VEV_1_3_RA4_01_1235.d 6.42E5 5 5 184 212 Carbamidomethylation
R.FSPNPQNPVIVSAGWDKLVK.V Y 131.60 2195.1738 20 -15.3 732.7207 3 79.67 6 44921 VEV_3_3_RA6_01_1237.d 9.47E5 4 4 156 175
R.TFVGHTNDVLSVSFSADNR.Q Y 124.74 2064.9863 19 -8.1 1033.4921 2 74.98 5 42582 VEV_2_3_RA5_01_1236.d 3.06E6 27 27 100 118
K.FTITDKGHTEWVSC(+57.02)VR.F Y 113.24 1934.9309 16 -9.5 645.9781 3 66.88 5 36690 VEV_2_3_RA5_01_1236.d 1.19E6 6 6 140 155 Carbamidomethylation
R.FSPNPQNPVIVSAGWDK.L Y 112.49 1854.9264 17 -9.0 928.4622 2 77.16 4 44839 VEV_1_3_RA4_01_1235.d 6.74E5 6 6 156 172
R.SLHGHSHIVSDC(+57.02)VISSDGAYALSSSWDK.T Y 109.91 3014.3828 28 -4.6 754.5995 4 73.81 4 42208 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 58 85 Carbamidomethylation
R.SLHGHSHIVSDC(+57.02)VISSDGAYALSSSWDKTLR.L Y 108.47 3384.6157 31 20.6 677.9443 5 75.76 5 43140 VEV_2_3_RA5_01_1236.d 0 1 1 58 88 Carbamidomethylation
R.DKTLIIWNLTRDDTAYGYPKR.S Y 104.83 2538.3230 21 -9.3 635.5822 4 77.24 5 44190 VEV_2_3_RA5_01_1236.d 1.14E6 5 5 37 57
R.DKTLIIWNLTRDDTAYGYPK.R Y 102.79 2382.2219 20 -16.2 596.5531 4 80.11 6 45236 VEV_3_3_RA6_01_1237.d 6.67E5 4 4 37 56
R.TFVGHTNDVLSVSFSADNRQIVSGSRDR.T Y 102.73 3063.5122 28 -9.6 613.7039 5 72.35 5 40723 VEV_2_3_RA5_01_1236.d 2.75E5 2 2 100 127
K.SKVDELKPEYVEK.G Y 102.69 1562.8191 13 -11.6 521.9409 3 49.88 4 24803 VEV_1_3_RA4_01_1235.d 3.16E6 15 15 265 277
R.TFVGHTNDVLSVSFSADNRQIVSGSR.D Y 95.94 2792.3840 26 -8.9 931.7936 3 75.23 5 42755 VEV_2_3_RA5_01_1236.d 1.17E5 3 3 100 125
K.SREPEC(+57.02)ISLAWSADGQ(+.98)TLFAGYTDNKIR.A Y 93.90 3185.5088 28 0.0 797.3845 4 81.45 4 48126 VEV_1_3_RA4_01_1235.d 7.03E5 4 4 281 308 Carbamidomethylation; Deamidation (NQ)
R.IQTDHIGHTGYINTVTISPDGSLC(+57.02)ASGGK(+14.02).D Y 93.67 3012.4612 29 -13.6 754.1123 4 72.13 4 40891 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 184 212 Carbamidomethylation; Methylation(KR)
K.VDELKPEYVEK.G Y 93.57 1347.6921 11 -12.1 674.8452 2 51.78 5 26252 VEV_2_3_RA5_01_1236.d 2.44E6 14 14 267 277
R.TIKLWNTLGDC(+57.02)K.F Y 91.53 1447.7493 12 -3.6 483.5886 3 70.48 4 39588 VEV_1_3_RA4_01_1235.d 5.88E5 4 4 128 139 Carbamidomethylation
R.DDTAYGYPKR.S Y 89.97 1184.5461 10 -8.2 593.2755 2 33.06 4 14603 VEV_1_3_RA4_01_1235.d 1.24E6 12 12 48 57
R.GTLEGHNGWVTSLATSLENPNM(+15.99)LLSASR.D Y 85.23 2970.4504 28 -9.3 991.1482 3 85.44 6 48736 VEV_3_3_RA6_01_1237.d 3.24E4 1 1 9 36 Oxidation (M)
K.DGTTMLWDLNESK.H Y 80.36 1508.6816 13 15.1 755.3595 2 79.64 4 46752 VEV_1_3_RA4_01_1235.d 5.54E4 2 2 213 225
R.LWELATGNTTR.T Y 78.14 1260.6462 11 -16.7 631.3199 2 68.87 6 37028 VEV_3_3_RA6_01_1237.d 1.44E6 5 5 89 99
R.DKTLIIWNLTR.D Y 75.55 1371.7874 11 -17.9 458.2615 3 79.14 6 44544 VEV_3_3_RA6_01_1237.d 5.33E5 4 4 37 47
K.LWNTLGDC(+57.02)K.F Y 74.10 1105.5226 9 -9.7 553.7632 2 63.33 4 34005 VEV_1_3_RA4_01_1235.d 4.15E5 3 3 131 139 Carbamidomethylation
R.EPEC(+57.02)ISLAWSADGQTLFAGYTDNKIR.A Y 72.43 2941.3916 26 -6.1 981.4652 3 84.40 4 50189 VEV_1_3_RA4_01_1235.d 8.69E4 1 1 283 308 Carbamidomethylation
K.SREPEC(+57.02)ISLAWS(-2.02)ADGQTLFAGYTDNKIR.A Y 72.11 3182.5090 28 -15.9 796.6219 4 81.19 5 46830 VEV_2_3_RA5_01_1236.d 0 1 1 281 308 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
K.VWELSSC(+57.02)R.I Y 64.93 1035.4807 8 -13.5 518.7407 2 60.51 6 30830 VEV_3_3_RA6_01_1237.d 1.74E6 4 4 176 183 Carbamidomethylation
R.FSPNPQ(+.98)NPVIVSAGWDKLVK.V Y 61.06 2196.1580 20 -13.7 733.0499 3 80.67 4 47529 VEV_1_3_RA4_01_1235.d 2.09E5 3 3 156 175 Deamidation (NQ)
R.DKTLIIWN(+.98)LTRDDTAYGYPK.R Y 60.00 2383.2058 20 -2.1 596.8075 4 80.28 4 47236 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 37 56 Deamidation (NQ)
R.TFVGHTN(+.98)DVLSVSFSADNR.Q Y 59.84 2065.9705 19 -32.4 517.4832 4 74.92 5 42537 VEV_2_3_RA5_01_1236.d 0 3 3 100 118 Deamidation (NQ)
K.TLIIWNLTR.D Y 55.93 1128.6655 9 -10.1 565.3344 2 81.93 4 48480 VEV_1_3_RA4_01_1235.d 1.67E5 2 2 39 47
R.DDTAYGYPK.R Y 52.66 1028.4451 9 33.4 515.2470 2 43.15 5 21015 VEV_2_3_RA5_01_1236.d 1.09E5 5 5 48 56
R.IQTDHIGHTGYINTVTISPDGSLC(+57.02)ASGGK(-.98).D Y 51.96 2997.4614 29 1.2 750.3735 4 71.79 4 40635 VEV_1_3_RA4_01_1235.d 3.85E5 1 1 184 212 Carbamidomethylation; Amidation
R.AWGVVSRT Y 49.19 874.4661 8 -10.6 438.2357 2 52.59 4 26546 VEV_1_3_RA4_01_1235.d 3.56E6 9 9 309 316
K.KSKVDELKPEYVEK.G Y 49.05 1690.9141 14 -8.6 423.7321 4 42.73 4 20373 VEV_1_3_RA4_01_1235.d 5.46E5 2 2 264 277
R.FSPNPQ(+.98)NPVIVSAGWDK.L Y 48.44 1855.9104 17 -6.7 928.9563 2 78.14 6 43827 VEV_3_3_RA6_01_1237.d 7.09E4 2 2 156 172 Deamidation (NQ)
R.QIVSGSRDR.T Y 45.02 1016.5363 9 -13.8 509.2684 2 12.93 6 3869 VEV_3_3_RA6_01_1237.d 2.16E5 4 4 119 127
R.DKTLIIWNLT(-2.02)RDDTAYGYPKR.S Y 44.93 2536.3074 21 0.5 508.2690 5 77.38 4 44997 VEV_1_3_RA4_01_1235.d 0 1 1 37 57 2-amino-3-oxo-butanoic_acid
R.LWE(+14.02)LATGNTTR.T Y 43.40 1274.6619 11 -11.7 638.3307 2 72.05 5 40547 VEV_2_3_RA5_01_1236.d 4.79E5 4 4 89 99 Methylation(others)
K.VDELKPE(+14.02)YVEK.G Y 42.61 1361.7078 11 -5.4 454.9074 3 57.60 4 29718 VEV_1_3_RA4_01_1235.d 1.62E5 2 2 267 277 Methylation(others)
K.TLIIWNLTRDDTAYGYPK.R Y 41.49 2139.1001 18 2.8 714.0427 3 81.89 4 48454 VEV_1_3_RA4_01_1235.d 1.71E5 2 2 39 56
K.VDE(+14.02)LKPEYVEK.G Y 40.69 1361.7078 11 -10.7 681.8539 2 59.64 4 31219 VEV_1_3_RA4_01_1235.d 2.85E4 1 1 267 277 Methylation(others)
R.TFVGHTNDVLSVSFSAD(+6.01)NR.Q Y 39.20 2070.9946 19 -50.4 691.3040 3 74.97 5 42571 VEV_2_3_RA5_01_1236.d 0 1 1 100 118 Replacement of proton by lithium
R.LWELATGNTTR(+14.02).T Y 39.14 1274.6619 11 -35.3 638.3157 2 70.63 6 38325 VEV_3_3_RA6_01_1237.d 0 1 1 89 99 Methylation(KR)
R.DKTLIIWNLTR(+14.02).D Y 38.48 1385.8031 11 12.6 462.9474 3 80.29 4 47247 VEV_1_3_RA4_01_1235.d 0 1 1 37 47 Methylation(KR)
K.VDELKPEYVEK(+14.02).G Y 35.98 1361.7078 11 -18.3 681.8487 2 59.44 6 30045 VEV_3_3_RA6_01_1237.d 3.75E4 1 1 267 277 Methylation(KR)
R.AWGVVSR.T Y 35.38 773.4184 7 -11.4 387.7121 2 49.19 4 24405 VEV_1_3_RA4_01_1235.d 7.49E5 5 5 309 315
K.LWNTLGDC(+57.02)K(+188.03)FTITDKGHTEWVSC(+57.02)VR.F Y 34.38 3210.4758 25 21.3 643.1161 5 66.77 6 35460 VEV_3_3_RA6_01_1237.d 0 1 1 131 155 Carbamidomethylation; Lipoyl
R.GTLEGHN(+.98)GWVTSLATSLENPNMLLSASR.D Y 32.43 2955.4397 28 -0.5 986.1534 3 87.97 5 50825 VEV_2_3_RA5_01_1236.d 1.94E5 2 2 9 36 Deamidation (NQ)
M.A(+42.01)EQLVHR.G Y 30.88 893.4719 7 -18.1 447.7352 2 49.16 6 23837 VEV_3_3_RA6_01_1237.d 5.33E6 14 14 2 8 Acetylation (Protein N-term)
M.A(+42.01)EQLVHR(+14.02).G Y 30.44 907.4875 7 -13.2 454.7451 2 53.30 5 27178 VEV_2_3_RA5_01_1236.d 1.89E5 1 1 2 8 Acetylation (Protein N-term); Methylation(KR)
K.S(-2.02)KVDELKPEYVEK.G Y 28.49 1560.8035 13 -31.7 521.2586 3 49.96 4 24859 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 265 277 2-amino-3-oxo-butanoic_acid
R.TFVGHTNDVLS(-2.02)VSFSADNRQIVSGSRDR.T Y 26.91 3061.4966 28 7.8 613.3113 5 72.45 4 41151 VEV_1_3_RA4_01_1235.d 0 1 1 100 127 2-amino-3-oxo-butanoic_acid
R.IQTDHIGHTGYINTVTISPD(+14.02)GSLC(+57.02)ASGGK.D Y 26.44 3012.4612 29 -9.2 754.1157 4 73.24 6 40265 VEV_3_3_RA6_01_1237.d 8.44E4 1 1 184 212 Methylation(others); Carbamidomethylation
R.DK(-1.03)TLIIWNLTRDDTAYGYPK.R Y 26.24 2381.1902 20 3.0 596.3066 4 80.06 6 45202 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 37 56 Lysine oxidation to aminoadipic semialdehyde
R.Q(-17.03)IVSGSRDR.T Y 25.66 999.5097 9 -7.5 500.7584 2 28.95 4 12268 VEV_1_3_RA4_01_1235.d 6.69E5 4 4 119 127 Pyro-glu from Q
R.GTLEGHNGWVTSLATSLENPNMLLSASRDK.T Y 24.80 3197.5774 30 -3.4 800.3989 4 84.65 4 50353 VEV_1_3_RA4_01_1235.d 9.8E4 1 1 9 38
R.Q(+.98)IVSGSR(+14.02).D Y 24.69 760.4079 7 -12.2 381.2066 2 19.66 6 7374 VEV_3_3_RA6_01_1237.d 4.53E5 2 2 119 125 Deamidation (NQ); Methylation(KR)
K.VWELSSC(+57.02)R(+14.02).I Y 23.65 1049.4965 8 -14.1 525.7481 2 64.58 6 33801 VEV_3_3_RA6_01_1237.d 1.46E5 1 1 176 183 Carbamidomethylation; Methylation(KR)
K.VDELK(+14.02)PEYVEK.G Y 23.47 1361.7078 11 -7.8 454.9063 3 57.43 5 29722 VEV_2_3_RA5_01_1236.d 1E5 1 1 267 277 Methylation(KR)
K.VW(+31.99)ELSSC(+57.02)R.I Y 23.23 1067.4706 8 -1.6 534.7417 2 41.52 4 19632 VEV_1_3_RA4_01_1235.d 3.94E4 1 1 176 183 Dihydroxy; Carbamidomethylation
R.DKT(-2.02)LIIWNLTRDDTAYGYPKR.S Y 22.84 2536.3074 21 -35.8 508.2506 5 77.47 6 43351 VEV_3_3_RA6_01_1237.d 2.78E4 1 1 37 57 2-amino-3-oxo-butanoic_acid
K.FTITDK(+28.03)GHTEWVSC(+57.02)VR.F Y 21.91 1962.9622 16 -12.9 655.3196 3 81.73 6 46360 VEV_3_3_RA6_01_1237.d 0 1 1 140 155 Dimethylation(KR); Carbamidomethylation
K.V(+42.01)DELKPEYVEK.G Y 21.85 1389.7028 11 7.2 464.2448 3 58.87 5 30723 VEV_2_3_RA5_01_1236.d 9.13E4 1 1 267 277 Acetylation (N-term)
R.GTLEGHNGWVT(+13.03)SLATSLENPNMLLSASR.D Y 21.25 2967.4873 28 -12.4 990.1574 3 87.81 4 52383 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 9 36 Michael addition with methylamine
K.VDELKPEYVEK(+27.99)GK.K Y 19.32 1560.8035 13 -33.0 521.2579 3 49.92 6 24253 VEV_3_3_RA6_01_1237.d 9.28E4 1 1 267 279 Formylation
R.QIVSGSR(-.98).D Y 17.48 744.4242 7 -25.8 745.4123 1 48.86 6 23643 VEV_3_3_RA6_01_1237.d 1.83E4 1 1 119 125 Amidation
K.DGTTM(+15.99)LWDLNESK.H Y 17.08 1524.6766 13 1.4 763.3467 2 75.20 4 43289 VEV_1_3_RA4_01_1235.d 9.24E4 1 1 213 225 Oxidation (M)
K.VD(+212.01)ELKPEYVEK.G Y 16.66 1559.7007 11 21.8 520.9188 3 49.51 5 24859 VEV_2_3_RA5_01_1236.d 0 1 1 267 277 phosphate-ribosylation
K.TLRLWELATGNTTR(-.98).T Y 16.19 1629.8950 14 -5.8 544.3025 3 77.75 4 45282 VEV_1_3_RA4_01_1235.d 3.16E5 1 1 86 99 Amidation
R.TFVGHTNDVLS(-18.01)VSFSADNR(+14.02).Q Y 15.65 2060.9915 19 14.4 516.2626 4 75.13 6 41639 VEV_3_3_RA6_01_1237.d 0 1 1 100 118 Dehydration; Methylation(KR)
R.FSPNPQNPVIVSAGWDK(+172.05).L Y 15.40 2026.9789 17 -21.2 676.6526 3 73.65 5 41628 VEV_2_3_RA5_01_1236.d 8.43E3 1 1 156 172 Menadione hydroquinone derivative
R.AWGVVSRT(+21.98) Y 15.27 896.4481 8 -14.2 449.2249 2 44.96 4 21742 VEV_1_3_RA4_01_1235.d 0 1 1 309 316 Sodium adduct
K.VDELKPEYVEKGK(+226.08).K Y 15.19 1758.8861 13 -19.9 587.2910 3 64.47 6 33770 VEV_3_3_RA6_01_1237.d 6.58E5 1 1 267 279 Biotinylation
K.DGT(-18.01)TMLWDLNESK(+14.02).H Y 15.12 1504.6868 13 46.3 753.3855 2 79.77 4 46843 VEV_1_3_RA4_01_1235.d 5.44E4 1 1 213 225 Dehydration; Methylation(KR)
K.DGTT(+14.02)MLWDLNESK.H Y 15.02 1522.6974 13 9.6 762.3633 2 74.76 6 41366 VEV_3_3_RA6_01_1237.d 2.79E4 1 1 213 225 Methylation(others)
total 76 peptides
C1GLU6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HVELALWDTAGQEDYDR.L Y 169.65 2016.9177 17 -12.6 673.3047 3 76.54 6 42654 VEV_3_3_RA6_01_1237.d 1.31E6 9 9 52 68
K.TSQKPVTTEQGEEVR.K Y 155.24 1687.8376 15 -13.8 563.6121 3 25.33 6 10418 VEV_3_3_RA6_01_1237.d 4.32E6 13 13 134 148
K.GTFPEVYVPTVFENYVADVEVDGK.H Y 150.06 2673.2849 24 -10.4 1337.6359 2 92.06 6 52355 VEV_3_3_RA6_01_1237.d 1.6E6 9 9 28 51
K.WISEVLHFC(+57.02)QGHPIILVGC(+57.02)K.K Y 137.10 2392.2183 20 -15.3 599.0527 4 81.75 6 46372 VEV_3_3_RA6_01_1237.d 1.03E6 5 5 99 118 Carbamidomethylation
R.LRPLSYPDSHVILIC(+57.02)FAIDSPDSLDNVQEK.W Y 127.01 3440.7285 30 -5.8 861.1844 4 84.88 4 50508 VEV_1_3_RA4_01_1235.d 3.67E5 3 3 69 98 Carbamidomethylation
R.TNDGVREVFESATR.A Y 125.23 1579.7590 14 -15.9 527.5853 3 64.90 6 34096 VEV_3_3_RA6_01_1237.d 4.43E6 13 13 163 176
K.TSQKPVTTEQGEEVRK.K Y 122.10 1815.9326 16 -14.3 606.3095 3 19.26 5 7436 VEV_2_3_RA5_01_1236.d 3.96E6 14 14 134 149
K.TSQKPVTTEQGEEVRKK.I Y 119.10 1944.0276 17 -11.0 649.0093 3 15.70 5 5483 VEV_2_3_RA5_01_1236.d 4.72E6 17 17 134 150
K.IGAYKYLEC(+57.02)SAR.T Y 105.98 1429.7024 12 -14.7 477.5677 3 60.86 5 32216 VEV_2_3_RA5_01_1236.d 1.96E6 7 7 151 162 Carbamidomethylation
K.TSQ(+.98)KPVTTEQGEEVR.K Y 96.25 1688.8217 15 -6.2 563.9443 3 28.58 4 12101 VEV_1_3_RA4_01_1235.d 7.99E5 6 6 134 148 Deamidation (NQ)
R.KTSQKPVTTEQGEEVR.K Y 88.29 1815.9326 16 -7.8 606.3134 3 19.35 4 7072 VEV_1_3_RA4_01_1235.d 2.94E5 1 1 133 148
K.TSQ(+.98)KPVTTEQGEEVRK.K Y 85.49 1816.9166 16 -11.3 606.6393 3 22.14 5 8882 VEV_2_3_RA5_01_1236.d 5.58E5 6 6 134 149 Deamidation (NQ)
K.HVELALWDTAGQE(+14.02)DYDR.L Y 84.05 2030.9333 17 -19.7 677.9717 3 78.15 6 43832 VEV_3_3_RA6_01_1237.d 1.87E5 2 2 52 68 Methylation(others)
R.TNDGVRE(+14.02)VFESATR.A Y 83.04 1593.7747 14 -12.2 532.2590 3 66.33 5 36269 VEV_2_3_RA5_01_1236.d 2.99E5 2 2 163 176 Methylation(others)
K.GTFPEVYVPTVFENYVADVE(+14.02)VDGK.H Y 82.67 2687.3005 24 -9.4 1344.6449 2 94.21 5 53896 VEV_2_3_RA5_01_1236.d 2.08E5 2 2 28 51 Methylation(others)
K.TSQKPVTTEQGEEVR(+14.02).K Y 82.33 1701.8533 15 -8.8 568.2867 3 31.08 5 13886 VEV_2_3_RA5_01_1236.d 9.11E5 11 11 134 148 Methylation(KR)
K.HVELALWDTAGQ(+.98)EDYDR.L Y 81.32 2017.9017 17 -4.1 673.6384 3 76.67 4 44435 VEV_1_3_RA4_01_1235.d 8.03E4 2 2 52 68 Deamidation (NQ)
K.TSQKPVTTEQ(+.98)GEEVR.K Y 80.85 1688.8217 15 -12.8 563.9406 3 28.79 6 12206 VEV_3_3_RA6_01_1237.d 6.65E5 9 9 134 148 Deamidation (NQ)
K.DLRDDPRTIEELRK.T Y 79.72 1754.9275 14 -11.8 439.7340 4 60.20 5 31692 VEV_2_3_RA5_01_1236.d 6.15E5 4 4 120 133
K.TC(+57.02)LLIVFSK.G Y 78.93 1079.6049 9 -10.9 540.8038 2 79.62 5 45805 VEV_2_3_RA5_01_1236.d 1.1E6 4 4 19 27 Carbamidomethylation
R.TNDGVREVFE(+14.02)SATR.A Y 78.50 1593.7747 14 -8.4 532.2610 3 65.34 5 35534 VEV_2_3_RA5_01_1236.d 7.42E5 4 4 163 176 Methylation(others)
K.TSQKPVTTE(+14.02)QGEEVR.K Y 78.28 1701.8533 15 -13.4 568.2841 3 32.71 6 14367 VEV_3_3_RA6_01_1237.d 2.52E5 5 5 134 148 Methylation(others)
K.WISEVLHFC(+57.02)QGHPIILVGC(+57.02)KK.D Y 78.10 2520.3132 21 -16.1 505.0618 5 79.08 6 44502 VEV_3_3_RA6_01_1237.d 4.26E5 4 4 99 119 Carbamidomethylation
K.GTFPEVYVPTVFENYVADVEVDGK(+14.02).H Y 78.03 2687.3005 24 -6.0 1344.6495 2 92.77 4 55178 VEV_1_3_RA4_01_1235.d 5.16E5 6 6 28 51 Methylation(KR)
R.KTSQKPVTTEQGEEVRK.K Y 77.65 1944.0276 17 -11.1 487.0088 4 15.48 5 5296 VEV_2_3_RA5_01_1236.d 8.46E5 1 1 133 149
K.LVIVGDGAC(+57.02)GK.T Y 77.18 1087.5696 11 -11.2 544.7859 2 56.61 5 29172 VEV_2_3_RA5_01_1236.d 8.37E5 7 7 8 18 Carbamidomethylation
K.TSQKPVTTEQGE(+14.02)EVR.K Y 76.76 1701.8533 15 -9.0 568.2866 3 33.37 4 14850 VEV_1_3_RA4_01_1235.d 4.97E5 3 3 134 148 Methylation(others)
K.HVE(+14.02)LALWDTAGQEDYDR.L Y 72.03 2030.9333 17 -12.6 677.9765 3 77.73 6 43541 VEV_3_3_RA6_01_1237.d 1.29E5 1 1 52 68 Methylation(others)
R.KLVIVGDGAC(+57.02)GK.T Y 71.69 1215.6646 12 -9.2 608.8340 2 46.93 4 22960 VEV_1_3_RA4_01_1235.d 2.74E5 3 3 7 18 Carbamidomethylation
K.HVELALWDTAGQEDYDR(+14.02).L Y 71.14 2030.9333 17 -5.3 677.9814 3 77.34 5 44259 VEV_2_3_RA5_01_1236.d 9.08E4 1 1 52 68 Methylation(KR)
K.KIGAYKYLEC(+57.02)SAR.T Y 69.88 1557.7972 13 -13.1 520.2662 3 57.38 5 29678 VEV_2_3_RA5_01_1236.d 2.58E5 3 3 150 162 Carbamidomethylation
R.TNDGVR(+14.02)EVFESATR.A Y 69.55 1593.7747 14 -14.7 532.2577 3 66.29 6 35095 VEV_3_3_RA6_01_1237.d 9.17E5 5 5 163 176 Methylation(KR)
K.TSQKPVTTEQGEEVR(+14.02)K.K Y 68.63 1829.9482 16 -6.0 610.9864 3 23.95 4 9526 VEV_1_3_RA4_01_1235.d 6.38E5 7 7 134 149 Methylation(KR)
R.TNDGVREVFESATR(+14.02).A Y 67.37 1593.7747 14 -9.4 532.2605 3 68.08 4 37701 VEV_1_3_RA4_01_1235.d 6.72E5 3 3 163 176 Methylation(KR)
K.TSQKPVTTEQ(+.98)GEEVRK.K Y 66.83 1816.9166 16 -13.0 606.6383 3 22.49 6 8871 VEV_3_3_RA6_01_1237.d 3.51E5 3 3 134 149 Deamidation (NQ)
K.TSQKPVTTEQGE(+14.02)EVRKK.I Y 64.64 1958.0432 17 -11.6 490.5124 4 19.76 5 7646 VEV_2_3_RA5_01_1236.d 4.47E5 2 2 134 150 Methylation(others)
K.YLEC(+57.02)SAR.T Y 64.62 897.4014 7 -13.8 449.7018 2 23.34 5 9516 VEV_2_3_RA5_01_1236.d 2.26E6 3 3 156 162 Carbamidomethylation
K.TSQKPVTTEQGEEVR(+14.02)KK.I Y 63.58 1958.0432 17 -9.0 653.6825 3 19.03 5 7219 VEV_2_3_RA5_01_1236.d 3.94E5 5 5 134 150 Methylation(KR)
K.TSQKPVTTEQGE(+14.02)EVRK.K Y 62.06 1829.9482 16 -10.0 458.4897 4 25.50 5 10781 VEV_2_3_RA5_01_1236.d 2.65E5 1 1 134 149 Methylation(others)
K.GTFPEVYVPTVFE(+14.02)NYVADVEVDGK.H Y 61.26 2687.3005 24 -9.6 1344.6447 2 93.48 6 52966 VEV_3_3_RA6_01_1237.d 2.78E5 2 2 28 51 Methylation(others)
K.IGAYKYLE(+14.02)C(+57.02)SAR.T Y 60.90 1443.7180 12 -7.0 722.8612 2 64.02 5 34545 VEV_2_3_RA5_01_1236.d 2.48E5 2 2 151 162 Methylation(others); Carbamidomethylation
K.TSQKPVTTEQGEEVRK(+14.02).K Y 60.50 1829.9482 16 -7.4 610.9855 3 25.39 4 10337 VEV_1_3_RA4_01_1235.d 2.99E5 3 3 134 149 Methylation(KR)
K.GTFPEVYVPTVFENYVAD(+14.02)VEVDGK.H Y 59.29 2687.3005 24 -4.1 1344.6520 2 93.27 4 55439 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 28 51 Methylation(others)
K.TSQKPVTTE(+14.02)QGEEVRK.K Y 59.28 1829.9482 16 -12.0 458.4888 4 25.08 5 10526 VEV_2_3_RA5_01_1236.d 1.06E6 6 6 134 149 Methylation(others)
K.T(-18.01)SQK(+14.02)PVTTEQGEEVR.K Y 58.78 1683.8428 15 -30.2 562.2712 3 25.42 6 10414 VEV_3_3_RA6_01_1237.d 0 2 2 134 148 Dehydration; Methylation(KR)
K.TSQ(+.98)KPVTTEQGEEVRKK.I Y 56.79 1945.0116 17 -13.0 649.3361 3 17.69 5 6494 VEV_2_3_RA5_01_1236.d 2.38E5 4 4 134 150 Deamidation (NQ)
R.DDPRTIEELRK.T Y 55.98 1370.7153 11 -11.4 457.9072 3 44.44 5 21785 VEV_2_3_RA5_01_1236.d 7.54E5 4 4 123 133
R.EVFESATR(+14.02).A Y 54.50 951.4661 8 -14.2 476.7336 2 44.04 6 20838 VEV_3_3_RA6_01_1237.d 8.34E5 2 2 169 176 Methylation(KR)
K.GTFPE(+14.02)VYVPTVFENYVADVEVDGK.H Y 54.18 2687.3005 24 -6.0 1344.6495 2 93.31 5 53489 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 28 51 Methylation(others)
K.TSQKPVTTEQGEEVRK(+14.02)K.I Y 52.64 1958.0432 17 -11.0 490.5127 4 19.07 6 7084 VEV_3_3_RA6_01_1237.d 7.99E4 2 2 134 150 Methylation(KR)
R.KTSQKPVTTEQGEEVRKK.I Y 50.76 2072.1226 18 -13.0 415.4264 5 13.57 5 4271 VEV_2_3_RA5_01_1236.d 9.31E4 2 2 133 150
K.T(-18.01)SQK(+14.02)PVTTEQGEEVRKK.I Y 50.34 1940.0327 17 -40.0 485.9961 4 15.79 6 5369 VEV_3_3_RA6_01_1237.d 4.2E4 1 1 134 150 Dehydration; Methylation(KR)
R.TN(+.98)DGVREVFESATR.A Y 50.00 1580.7430 14 -14.8 527.9138 3 68.72 5 38064 VEV_2_3_RA5_01_1236.d 6.57E4 2 2 163 176 Deamidation (NQ)
R.EVFESATR.A Y 49.82 937.4505 8 -16.9 469.7246 2 35.07 6 15716 VEV_3_3_RA6_01_1237.d 9.08E5 6 6 169 176
K.TSQKPVTTEQ(+.98)GEEVRKK.I Y 47.57 1945.0116 17 -20.1 649.3314 3 18.55 5 6951 VEV_2_3_RA5_01_1236.d 4.34E4 2 2 134 150 Deamidation (NQ)
K.GTFPEVYVPT(+14.02)VFENYVADVEVDGK.H Y 44.72 2687.3005 24 -26.7 896.7502 3 93.39 6 52934 VEV_3_3_RA6_01_1237.d 8.31E4 1 1 28 51 Methylation(others)
K.TSQKPVTTEQ(+.98)GEEVR(+14.02).K Y 44.55 1702.8373 15 -8.6 568.6148 3 36.52 5 17087 VEV_2_3_RA5_01_1236.d 2.45E5 3 3 134 148 Deamidation (NQ); Methylation(KR)
R.EVFE(+14.02)SATR.A Y 44.12 951.4661 8 -10.1 476.7355 2 43.50 4 20838 VEV_1_3_RA4_01_1235.d 9.9E5 4 4 169 176 Methylation(others)
K.TSQKPVTTEQ(+.98)GEEVR(+14.02)K.K Y 44.11 1830.9323 16 -10.2 611.3118 3 28.32 5 12305 VEV_2_3_RA5_01_1236.d 5.15E4 1 1 134 149 Deamidation (NQ); Methylation(KR)
R.LRPLSYPDSHVILIC(+57.02)FAIDSPDSLDNVQEK(-.98).W Y 44.11 3439.7444 30 -21.2 1147.5645 3 84.80 5 49045 VEV_2_3_RA5_01_1236.d 2.43E4 1 1 69 98 Carbamidomethylation; Amidation
K.TSQKPVTTE(+14.02)QGEEVRKK.I Y 43.89 1958.0432 17 -8.7 653.6827 3 19.75 5 7599 VEV_2_3_RA5_01_1236.d 6.1E5 4 4 134 150 Methylation(others)
K.TSQKPVTTEQ(+.98)GEEVRK(+14.02).K Y 42.51 1830.9323 16 4.5 458.7424 4 24.79 4 10003 VEV_1_3_RA4_01_1235.d 5.79E4 1 1 134 149 Deamidation (NQ); Methylation(KR)
K.TSQ(+.98)K(+42.01)PVTTEQGEEVRKK.I Y 41.24 1987.0221 17 -50.9 497.7375 4 15.99 5 5571 VEV_2_3_RA5_01_1236.d 5.67E4 1 1 134 150 Deamidation (NQ); Acetylation (K)
K.TSQKPVTTEQGEE(+21.98)VR(+14.02)K.K Y 40.50 1851.9302 16 -26.6 618.3009 3 24.25 5 10068 VEV_2_3_RA5_01_1236.d 1.29E5 2 2 134 149 Sodium adduct; Methylation(KR)
R.TIEELRK.T Y 40.09 887.5076 7 -16.1 444.7539 2 22.38 6 8801 VEV_3_3_RA6_01_1237.d 2.88E6 9 9 127 133
K.TSQKPVTTEQGE(+21.98)EVR(+14.02)K.K Y 37.85 1851.9302 16 -25.7 618.3015 3 23.81 4 9449 VEV_1_3_RA4_01_1235.d 5.66E4 1 1 134 149 Sodium adduct; Methylation(KR)
K.DLRDDPRTIEELR(+14.02)K.T Y 37.55 1768.9431 14 -23.3 354.7877 5 62.17 5 33165 VEV_2_3_RA5_01_1236.d 1.49E5 2 2 120 133 Methylation(KR)
K.YLEC(+57.02)SAR(+14.02).T Y 37.47 911.4171 7 -16.2 456.7084 2 32.94 6 14492 VEV_3_3_RA6_01_1237.d 8.73E5 4 4 156 162 Carbamidomethylation; Methylation(KR)
K.GTFPEVYVPTVFEN(+.98)YVADVEVDGK.H Y 36.34 2674.2690 24 -23.9 1338.1099 2 92.98 6 52752 VEV_3_3_RA6_01_1237.d 0 1 1 28 51 Deamidation (NQ)
K.HVELALW(+31.99)DTAGQEDYDR.L Y 35.14 2048.9075 17 4.7 683.9796 3 70.52 6 38274 VEV_3_3_RA6_01_1237.d 5.71E4 1 1 52 68 Dihydroxy
R.AALLAK.K Y 34.77 585.3849 6 -15.1 586.3834 1 24.39 5 10136 VEV_2_3_RA5_01_1236.d 2.8E5 2 2 177 182
R.TIEELR.K N 34.19 759.4127 6 -17.6 380.7069 2 34.16 6 15172 VEV_3_3_RA6_01_1237.d 1.17E6 4 4 127 132
R.TNDGVR(+14.02)EVFESATR(+14.02).A Y 34.09 1607.7903 14 -10.7 536.9316 3 67.03 6 35648 VEV_3_3_RA6_01_1237.d 9.4E4 1 1 163 176 Methylation(KR)
R.AALLAKK.E Y 34.03 713.4799 7 -22.9 357.7391 2 15.13 5 5107 VEV_2_3_RA5_01_1236.d 2.27E5 3 3 177 183
K.TSQKPVTTEQGEEVRK(+21.98)(+14.02).K Y 33.80 1851.9302 16 -32.5 618.2972 3 23.53 6 9417 VEV_3_3_RA6_01_1237.d 9.16E4 1 1 134 149 Sodium adduct; Methylation(KR)
R.TNDGVR(+.98)EVFESATR.A Y 32.42 1580.7430 14 -14.6 527.9139 3 67.75 6 36192 VEV_3_3_RA6_01_1237.d 7.49E4 1 1 163 176 Deamidation (R)
R.RKLVIVGDGAC(+57.02)GK.T Y 31.65 1371.7656 13 -19.2 458.2537 3 40.26 5 19268 VEV_2_3_RA5_01_1236.d 2.14E5 2 2 6 18 Carbamidomethylation
K.YLE(+14.02)C(+57.02)SAR.T Y 31.50 911.4171 7 -10.9 456.7108 2 32.64 5 14789 VEV_2_3_RA5_01_1236.d 8.73E5 2 2 156 162 Methylation(others); Carbamidomethylation
K.DLRDDPR.T Y 31.49 885.4304 7 -15.7 443.7155 2 17.81 6 6408 VEV_3_3_RA6_01_1237.d 8.31E5 5 5 120 126
K.TSQKPVTTEQGEE(+14.02)VRKK.I Y 30.69 1958.0432 17 -5.3 490.5155 4 19.25 4 7017 VEV_1_3_RA4_01_1235.d 5.82E4 1 1 134 150 Methylation(others)
K.DLRDDPRTIEELRK(+14.02).T Y 30.34 1768.9431 14 -12.9 443.2373 4 62.28 5 33249 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 120 133 Methylation(KR)
R.E(+14.02)VFESATR.A Y 29.17 951.4661 8 -13.4 476.7339 2 43.51 6 20520 VEV_3_3_RA6_01_1237.d 4.35E5 1 1 169 176 Methylation(others)
K.TSQK(-1.03)PVTTEQGEEVR.K Y 28.15 1686.8060 15 -1.7 563.2750 3 28.86 4 12221 VEV_1_3_RA4_01_1235.d 1.88E5 3 3 134 148 Lysine oxidation to aminoadipic semialdehyde
R.AALLAK(+14.02).K Y 28.06 599.4006 6 -8.6 600.4028 1 35.53 5 16485 VEV_2_3_RA5_01_1236.d 4.65E4 2 2 177 182 Methylation(KR)
K.GTFPEVY(+15.01)VPTVFENYVADVEVDGK.H Y 25.68 2688.2959 24 4.0 897.1095 3 93.42 4 55516 VEV_1_3_RA4_01_1235.d 9.21E4 1 1 28 51 Tyrosine oxidation to 2-aminotyrosine
R.DDPRTIEELR.K Y 23.49 1242.6204 10 -5.0 415.2120 3 56.73 5 29238 VEV_2_3_RA5_01_1236.d 7.51E4 1 1 123 132
K.GT(-2.02)FPEVYVPTVFENYVADVEVDGK.H Y 23.35 2671.2693 24 30.7 891.4577 3 92.16 4 54863 VEV_1_3_RA4_01_1235.d 1.15E4 1 1 28 51 2-amino-3-oxo-butanoic_acid
R.T(+77.99)IEELRK.T Y 20.71 965.4947 7 14.3 322.8434 3 22.24 5 8936 VEV_2_3_RA5_01_1236.d 9.09E4 1 1 127 133 Methylphosphonylation
K.TSQK(+14.02)PVTTEQGEEVRKK.I Y 19.78 1958.0432 17 -19.1 392.6084 5 19.90 6 7501 VEV_3_3_RA6_01_1237.d 1.48E5 1 1 134 150 Methylation(KR)
K.HVELALWDTAGQEDYDR(-.98)(+14.02).L Y 19.76 2029.9493 17 -23.4 677.6412 3 77.46 4 45059 VEV_1_3_RA4_01_1235.d 0 1 1 52 68 Amidation; Methylation(KR)
K.K(+42.01)IGAYK.Y Y 19.19 720.4170 6 13.6 721.4341 1 99.56 5 55868 VEV_2_3_RA5_01_1236.d 0 1 1 150 155 Acetylation (N-term)
R.TNDGVR.E Y 18.27 660.3191 6 -7.4 661.3215 1 61.30 5 32508 VEV_2_3_RA5_01_1236.d 6.52E4 1 1 163 168
K.GTFPEVYVPTVFENYVADVEVD(-18.01)GK(+14.02).H Y 17.15 2669.2900 24 27.0 890.7946 3 92.17 5 52969 VEV_2_3_RA5_01_1236.d 0 1 1 28 51 Dehydration; Methylation(KR)
K.GTFPEVYVPT(-2.02)VFENYVADVEVDGK.H Y 16.97 2671.2693 24 5.2 891.4350 3 92.31 6 52446 VEV_3_3_RA6_01_1237.d 1.66E4 1 1 28 51 2-amino-3-oxo-butanoic_acid
R.TIEE(+14.02)LRK.T Y 16.13 901.5233 7 -15.5 451.7619 2 30.62 5 13621 VEV_2_3_RA5_01_1236.d 3.34E5 1 1 127 133 Methylation(others)
R.KK(+14.02)IGAYKY(+79.97)LEC(+57.02)SAR.T Y 16.01 1779.8743 14 15.3 445.9827 4 23.43 6 9360 VEV_3_3_RA6_01_1237.d 0 1 1 149 162 Methylation(KR); Phosphorylation (STY); Carbamidomethylation
R.K(+43.01)TSQKPVTTEQGEEVR(+14.02).K Y 15.92 1872.9541 16 -4.8 469.2435 4 77.33 6 43248 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 133 148 Carbamylation; Methylation(KR)
K.IGAYK.Y Y 15.72 550.3115 5 16.3 551.3277 1 103.94 6 56487 VEV_3_3_RA6_01_1237.d 0 1 1 151 155
total 98 peptides
A0A0A0HWK8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LC(+57.02)YVALDFQQEIQTASQSSTLEK.S Y 154.25 2658.2847 23 -7.9 1330.1392 2 84.83 5 49068 VEV_2_3_RA5_01_1236.d 4.23E5 6 6 173 195 Carbamidomethylation
R.TTGIVLDSGDGVTHVVPIYEGFALPHAISR.I Y 152.74 3120.6243 30 -10.0 1041.2050 3 83.71 6 47652 VEV_3_3_RA6_01_1237.d 2.15E6 10 10 105 134
R.FRAPEALFQPSVLGLESGGIHATTYNAIMK.C Y 143.17 3217.6594 30 -15.2 805.4099 4 83.80 6 47714 VEV_3_3_RA6_01_1237.d 1.08E6 7 7 212 241
R.VAPEEHPVLLTEAPINPK.S Y 142.37 1953.0570 18 -20.6 977.5156 2 70.61 6 38330 VEV_3_3_RA6_01_1237.d 3.63E6 9 9 53 70
K.SYELPDGQVITIGNER.F Y 140.76 1789.8846 16 -15.1 895.9361 2 78.93 6 44438 VEV_3_3_RA6_01_1237.d 2.87E6 11 11 196 211
K.DLYGNIVMSGGTTMYPGISDR.M Y 131.63 2246.0347 21 -8.0 1124.0156 2 84.03 4 49944 VEV_1_3_RA4_01_1235.d 3.2E5 4 4 249 269
R.APEALFQPSVLGLESGGIHATTYNAIMK.C Y 109.24 2914.4897 28 -8.1 972.4960 3 84.25 5 48733 VEV_2_3_RA5_01_1236.d 1.73E5 3 3 214 241
K.ILAERGYSFSTTAER.E Y 107.00 1699.8529 15 -10.2 567.6191 3 63.67 4 34270 VEV_1_3_RA4_01_1235.d 2.73E5 4 4 149 163
R.MQKEITALAPSSMK.V Y 102.92 1533.7894 14 -12.4 512.2641 3 62.32 4 33266 VEV_1_3_RA4_01_1235.d 7.21E5 6 6 270 283
K.DSYVGDEAQSKR.G N 101.44 1353.6160 12 -11.0 677.8078 2 24.53 5 10211 VEV_2_3_RA5_01_1236.d 2.12E6 13 13 8 19
R.GYSFSTTAER.E Y 97.27 1117.5040 10 -9.2 559.7542 2 51.73 4 25979 VEV_1_3_RA4_01_1235.d 2.75E6 7 7 154 163
K.Q(-17.03)EYDESGPSIVHR.K Y 95.52 1498.6688 13 -9.2 750.3348 2 62.85 4 33670 VEV_1_3_RA4_01_1235.d 3.74E5 4 4 317 329 Pyro-glu from Q
K.SYELPDGQVITIGNER(+14.02).F Y 87.81 1803.9003 16 -16.5 902.9425 2 80.33 6 45387 VEV_3_3_RA6_01_1237.d 5.08E5 12 12 196 211 Methylation(KR)
K.DSYVGDEAQSK.R N 87.47 1197.5149 11 -8.5 599.7596 2 28.42 6 12036 VEV_3_3_RA6_01_1237.d 4.69E5 10 10 8 18
K.SYE(+14.02)LPDGQVITIGNER.F Y 83.68 1803.9003 16 -10.7 902.9478 2 79.55 5 45783 VEV_2_3_RA5_01_1236.d 4.77E5 4 4 196 211 Methylation(others)
K.C(+57.02)DVDVRKDLYGN(-17.03)IVMSGGTTMYPGISDR.M Y 81.60 3101.4255 28 -5.8 1034.8098 3 83.62 5 48331 VEV_2_3_RA5_01_1236.d 1.94E5 3 3 242 269 Carbamidomethylation; Ammonia-loss (N)
R.TTGIVLDSGDGVTHVVPIYE(+14.02)GFALPHAISR.I Y 80.23 3134.6399 30 -10.1 1045.8767 3 84.93 5 49124 VEV_2_3_RA5_01_1236.d 4.27E5 5 5 105 134 Methylation(others)
R.GYSFSTTAEREIVR.D Y 76.19 1614.8002 14 -14.9 539.2660 3 66.51 6 35261 VEV_3_3_RA6_01_1237.d 3.56E5 2 2 154 167
K.EITALAPSSMK.V Y 75.52 1146.5955 11 -11.6 574.2983 2 63.42 5 34106 VEV_2_3_RA5_01_1236.d 8.33E5 4 4 273 283
K.QEYDESGPSIVHR.K Y 74.50 1515.6953 13 -14.9 758.8436 2 49.60 6 24077 VEV_3_3_RA6_01_1237.d 1.15E5 2 2 317 329
K.EITALAPSSM(+15.99)K.V Y 70.16 1162.5903 11 -9.9 582.2967 2 50.27 4 25039 VEV_1_3_RA4_01_1235.d 7.71E5 9 9 273 283 Oxidation (M)
R.M(+15.99)QKEITALAPSSMK.V Y 65.35 1549.7844 14 -10.3 775.8915 2 58.03 5 30133 VEV_2_3_RA5_01_1236.d 4.94E4 1 1 270 283 Oxidation (M)
R.VAPEE(+14.02)HPVLLTEAPINPK.S Y 65.01 1967.0728 18 -16.8 656.6872 3 73.45 6 40408 VEV_3_3_RA6_01_1237.d 0 1 1 53 70 Methylation(others)
R.DLTNYLMKILAERGYSFSTTAER.E Y 63.97 2678.3374 23 3.5 670.5940 4 88.36 5 51038 VEV_2_3_RA5_01_1236.d 0 1 1 141 163
R.DLTNYLMK.I Y 60.21 996.4950 8 -10.9 499.2493 2 75.17 4 43263 VEV_1_3_RA4_01_1235.d 5.62E5 4 4 141 148
R.IDMAGRDLTNYLMK.I Y 58.49 1639.8062 14 -9.8 547.6039 3 77.36 5 44272 VEV_2_3_RA5_01_1236.d 3.97E5 4 4 135 148
R.VAPEEH(+156.12)PVLLTEAPINPK.S Y 58.48 2109.1721 18 -23.4 528.2880 4 67.35 6 35895 VEV_3_3_RA6_01_1237.d 4.67E5 5 5 53 70 4-hydroxynonenal (HNE)
K.VKIIAPPERK.Y Y 58.34 1149.7233 10 -13.8 575.8610 2 35.02 5 16182 VEV_2_3_RA5_01_1236.d 1.21E5 3 3 284 293
R.MQKEITALAPSSM(+15.99)K.V Y 58.16 1549.7844 14 -11.6 517.5961 3 53.18 5 27123 VEV_2_3_RA5_01_1236.d 2.67E5 2 2 270 283 Oxidation (M)
K.Q(-17.03)EYDESGPSIVHRK.C Y 55.77 1626.7638 14 -6.0 543.2586 3 53.28 4 26971 VEV_1_3_RA4_01_1235.d 4.86E5 3 3 317 330 Pyro-glu from Q
R.TTGIVLDSGDGVTHVVPIYEGFALPHAISR(+14.02).I Y 52.13 3134.6399 30 -11.8 784.6580 4 83.57 6 47554 VEV_3_3_RA6_01_1237.d 1.04E5 2 2 105 134 Methylation(KR)
R.VAPE(+14.02)EHPVLLTEAPINPK.S Y 51.43 1967.0728 18 -8.6 656.6926 3 72.75 5 40996 VEV_2_3_RA5_01_1236.d 4.26E5 3 3 53 70 Methylation(others)
R.DIKEKLC(+57.02)YVALDFQQEIQTASQSSTLEK.S Y 51.02 3271.6282 28 -8.5 818.9073 4 86.94 6 49625 VEV_3_3_RA6_01_1237.d 2.62E4 1 1 168 195 Carbamidomethylation
K.DSYVGDEAQ(+.98)SKR.G N 50.44 1354.6001 12 -9.8 678.3007 2 28.08 5 12176 VEV_2_3_RA5_01_1236.d 1.39E5 3 3 8 19 Deamidation (NQ)
R.GYSFSTTAER(+14.02).E Y 50.14 1131.5197 10 -10.9 566.7609 2 58.10 6 29091 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 154 163 Methylation(KR)
K.DSYVGDEAQSK(+14.02)R.G N 48.46 1367.6317 12 -9.2 684.8168 2 32.19 5 14527 VEV_2_3_RA5_01_1236.d 8.87E4 2 2 8 19 Methylation(KR)
K.IIAPPER.K Y 46.35 794.4650 7 -19.6 398.2320 2 38.25 6 17495 VEV_3_3_RA6_01_1237.d 1.59E6 7 7 286 292
K.VKIIAPPER.K Y 46.21 1021.6284 9 -20.2 511.8112 2 47.29 4 23191 VEV_1_3_RA4_01_1235.d 7.14E4 1 1 284 292
K.YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.K Y 44.39 4099.0146 36 15.8 1025.7771 4 95.17 5 54292 VEV_2_3_RA5_01_1236.d 0 2 2 294 329
K.IIAPPERK.Y Y 42.64 922.5599 8 -10.2 308.5241 3 25.50 4 10420 VEV_1_3_RA4_01_1235.d 2.12E6 13 13 286 293
K.SYELPDGQ(+.98)VITIGNER(+14.02).F Y 41.62 1804.8843 16 -15.5 903.4354 2 80.69 6 45646 VEV_3_3_RA6_01_1237.d 1.73E5 2 2 196 211 Deamidation (NQ); Methylation(KR)
K.RGILTLR.Y N 40.48 827.5341 7 -15.4 414.7680 2 53.39 5 27241 VEV_2_3_RA5_01_1236.d 5.23E5 4 4 19 25
R.DLTNYLM(+15.99)K.I Y 40.21 1012.4899 8 -4.8 507.2498 2 68.32 4 37889 VEV_1_3_RA4_01_1235.d 2.03E5 1 1 141 148 Oxidation (M)
K.LC(+57.02)YVALDFQQE(+14.02)IQTASQSSTLEK.S Y 36.82 2672.3003 23 -41.2 891.7373 3 87.66 5 50662 VEV_2_3_RA5_01_1236.d 0 1 1 173 195 Carbamidomethylation; Methylation(others)
R.VAPEEHPVLLTEAPINPK(+14.02).S Y 36.81 1967.0728 18 -11.3 656.6908 3 72.33 5 40704 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 53 70 Methylation(KR)
K.SYELPDGQVITIGNER(+28.03).F Y 34.24 1817.9159 16 -6.1 909.9597 2 80.95 5 46675 VEV_2_3_RA5_01_1236.d 8.7E4 3 3 196 211 Dimethylation(KR)
R.MQK(+14.02)EITALAPSSMK.V Y 33.25 1547.8052 14 -14.1 516.9351 3 65.01 4 35287 VEV_1_3_RA4_01_1235.d 2.35E5 1 1 270 283 Methylation(KR)
R.VAPEEHPVLLTEAPIN(+.98)PK.S Y 31.34 1954.0410 18 -17.5 652.3429 3 72.08 5 40536 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 53 70 Deamidation (NQ)
K.DSYVGDEAQSK(+14.02).R N 29.56 1211.5305 11 -7.8 606.7678 2 38.65 5 18326 VEV_2_3_RA5_01_1236.d 5.61E4 1 1 8 18 Methylation(KR)
R.GILTLR.Y N 28.40 671.4330 6 -18.6 336.7175 2 62.91 5 33713 VEV_2_3_RA5_01_1236.d 5.59E5 5 5 20 25
R.YPIEHGVVTNWDDMEKIWHHTFYNELR.V N 27.30 3428.6035 27 -40.2 686.7004 5 83.41 6 47450 VEV_3_3_RA6_01_1237.d 0 1 1 26 52
K.E(+14.02)ITALAPSSMK.V Y 25.32 1160.6111 11 -11.9 581.3059 2 65.39 4 35579 VEV_1_3_RA4_01_1235.d 9.79E4 2 2 273 283 Methylation(others)
K.IIAPPER(+14.02).K Y 24.44 808.4807 7 -25.0 405.2375 2 49.81 5 25037 VEV_2_3_RA5_01_1236.d 1.46E5 2 2 286 292 Methylation(KR)
R.VAPEEH(+14.02)PVLLTEAPINPK.S Y 23.34 1967.0728 18 -32.8 492.7593 4 42.85 4 20440 VEV_1_3_RA4_01_1235.d 0 2 2 53 70 Methylation(others)
K.DSYVGDE(+14.02)AQSKR.G N 23.22 1367.6317 12 -11.3 684.8154 2 34.82 6 15552 VEV_3_3_RA6_01_1237.d 8.62E4 1 1 8 19 Methylation(others)
R.FRAPEALFQPSVLGLESGGIHATTYNAIM(-4.99)K.C Y 23.17 3212.6731 30 9.6 1071.9086 3 83.86 5 48473 VEV_2_3_RA5_01_1236.d 5.87E3 1 1 212 241 Methionine replacement by azido homoalanine
R.FRAPEALFQPSVLGLE(+6.01)SGGIHATTYNAIMK.C Y 22.85 3223.6675 30 -35.3 806.8957 4 85.65 6 48863 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 212 241 Replacement of proton by lithium
R.IDM(+15.99)AGR.D Y 22.84 677.3167 6 -13.8 678.3146 1 43.94 5 21482 VEV_2_3_RA5_01_1236.d 5.66E4 1 1 135 140 Oxidation (M)
K.DSYVGDEAQSKR(+14.02).G N 22.50 1367.6317 12 -6.3 684.8188 2 34.98 4 15741 VEV_1_3_RA4_01_1235.d 5.96E4 1 1 8 19 Methylation(KR)
K.ILAERGYS(-18.01)FSTTAER(+14.02).E Y 22.32 1695.8580 15 -32.1 566.2751 3 60.01 4 31498 VEV_1_3_RA4_01_1235.d 0 1 1 149 163 Dehydration; Methylation(KR)
R.MQK(+14.02)EIT(-18.01)ALAPSSMK.V Y 22.10 1529.7946 14 -21.9 510.9276 3 62.35 4 33255 VEV_1_3_RA4_01_1235.d 2.27E5 1 1 270 283 Methylation(KR); Dehydration
R.I(+27.99)DMAGR(+14.02).D Y 21.42 703.3323 6 -12.0 704.3311 1 53.83 4 27338 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 135 140 Formylation; Methylation(KR)
K.ILAER.G N 20.91 600.3595 5 -28.0 301.1786 2 18.52 6 6785 VEV_3_3_RA6_01_1237.d 1.5E5 2 2 149 153
K.E(+42.01)ITALAPSSM(+15.99)K.V Y 20.83 1204.6010 11 21.7 302.1641 4 24.35 4 9761 VEV_1_3_RA4_01_1235.d 2.73E5 1 1 273 283 Acetylation (N-term); Oxidation (M)
K.SYELPDGQVITIGN(+.98)ER.F Y 20.54 1790.8687 16 -11.7 896.4311 2 80.63 6 45603 VEV_3_3_RA6_01_1237.d 2.61E4 1 1 196 211 Deamidation (NQ)
K.SYELPDGQ(+.98)VITIGNER.F Y 19.65 1790.8687 16 -5.3 597.9603 3 79.37 5 45638 VEV_2_3_RA5_01_1236.d 6.56E4 1 1 196 211 Deamidation (NQ)
K.DSYVGD(+14.02)EAQSKR.G N 19.64 1367.6317 12 -7.9 456.8809 3 34.97 4 15736 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 8 19 Methylation(others)
K.EIT(-2.02)ALAPSSMKVK.I Y 17.66 1371.7432 13 -10.0 458.2504 3 62.96 5 33754 VEV_2_3_RA5_01_1236.d 1.65E5 1 1 273 285 2-amino-3-oxo-butanoic_acid
R.IDMAGR(-.98).D Y 17.52 660.3377 6 -71.2 661.2980 1 16.16 5 5649 VEV_2_3_RA5_01_1236.d 1.79E4 1 1 135 140 Amidation
R.GY(+15.01)SFSTTAER.E Y 15.97 1132.5149 10 30.8 567.2822 2 63.51 6 33009 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 154 163 Tyrosine oxidation to 2-aminotyrosine
R.MQ(+.98)K(+14.02)EITALAPSSMK.V Y 15.83 1548.7892 14 -7.9 517.2662 3 58.45 4 30322 VEV_1_3_RA4_01_1235.d 7.44E4 1 1 270 283 Deamidation (NQ); Methylation(KR)
MIGM(+15.99)GQK.D Y 15.59 779.3670 7 32.5 780.3996 1 85.63 4 50999 VEV_1_3_RA4_01_1235.d 8.66E4 1 1 1 7 Oxidation (M)
R.V(+164.06)APEEHPVLLTEAPINPK.S Y 15.57 2117.1172 18 -13.8 706.7032 3 68.82 6 36997 VEV_3_3_RA6_01_1237.d 2.93E4 1 1 53 70 O-Diisopropylphosphorylation
K.RGILT(+79.97)LR.Y N 15.33 907.5004 7 -15.6 303.5027 3 33.18 4 14734 VEV_1_3_RA4_01_1235.d 3.32E5 1 1 19 25 Phosphorylation (STY)
R.M(+15.99)QKEITALAPSSMKVK.I Y 15.20 1776.9478 16 21.8 445.2539 4 19.02 5 7212 VEV_2_3_RA5_01_1236.d 0 1 1 270 285 Oxidation (M)
R.M(+15.99)Q(+.98)KEITALAPSSMK.V Y 15.15 1550.7684 14 -20.1 517.9197 3 59.89 5 31474 VEV_2_3_RA5_01_1236.d 4.73E4 1 1 270 283 Oxidation (M); Deamidation (NQ)
K.ILAERGYSFSTTAER(+14.02).E Y 15.15 1713.8685 15 -15.4 572.2880 3 66.44 5 36349 VEV_2_3_RA5_01_1236.d 8.57E4 1 1 149 163 Methylation(KR)
K.IIAPPER(+14.02)K.Y Y 15.07 936.5756 8 -63.8 313.1792 3 30.55 4 13202 VEV_1_3_RA4_01_1235.d 0 1 1 286 293 Methylation(KR)
total 78 peptides
C1GFA3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TQNQFWKPVINLDKLWSLVPAETR.D Y 200.00 2882.5442 24 -13.7 721.6335 4 88.83 6 50717 VEV_3_3_RA6_01_1237.d 1.78E6 12 12 64 87
K.KADTVPVLDLLPLGYSK.V Y 148.06 1828.0345 17 -9.8 915.0156 2 84.46 5 48870 VEV_2_3_RA5_01_1236.d 5.6E6 10 10 95 111
R.DAYVNNKKADTVPVLDLLPLGYSK.V Y 126.31 2632.4111 24 -2.6 1317.2095 2 83.09 5 48011 VEV_2_3_RA5_01_1236.d 1.5E6 9 9 88 111
R.TNLDKYHPGYFGK.V Y 121.88 1538.7517 13 -9.8 770.3756 2 57.52 5 29802 VEV_2_3_RA5_01_1236.d 1.19E7 18 18 43 55
K.GRLPQIPVVVR.A Y 121.66 1232.7717 11 -18.6 617.3817 2 69.54 5 38705 VEV_2_3_RA5_01_1236.d 3.8E6 9 9 116 126
K.ADTVPVLDLLPLGYSK.V Y 115.73 1699.9396 16 -11.1 850.9677 2 88.98 6 50801 VEV_3_3_RA6_01_1237.d 2.35E6 9 9 96 111
K.TQNQFWKPVINLDKLWSLVPAETR(+14.02).D Y 102.92 2896.5598 24 -2.6 725.1453 4 90.25 5 52031 VEV_2_3_RA5_01_1236.d 4.25E5 3 3 64 87 Methylation(KR)
R.GHVSAGYGR.V Y 101.85 902.4359 9 -15.4 452.2183 2 13.12 6 3992 VEV_3_3_RA6_01_1237.d 1.17E6 9 9 13 21
K.SRGHVSAGYGR.V Y 100.16 1145.5690 11 -9.4 573.7864 2 13.05 5 4016 VEV_2_3_RA5_01_1236.d 1.01E6 6 6 11 21
R.GMAGGQHHHR.T Y 96.23 1086.4890 10 -12.8 544.2448 2 8.81 6 2081 VEV_3_3_RA6_01_1237.d 2.83E5 6 6 33 42
R.LPQIPVVVR.A Y 91.35 1019.6491 9 -17.4 510.8229 2 75.00 5 42590 VEV_2_3_RA5_01_1236.d 1.07E6 4 4 118 126
K.KADTVPVLDLLPLGYSK(+14.02).V Y 80.89 1842.0502 17 -8.3 615.0189 3 84.33 5 48766 VEV_2_3_RA5_01_1236.d 4.96E5 5 5 95 111 Methylation(KR)
K.VLGKGRLPQIPVVVR.A Y 76.69 1630.0405 15 -9.8 408.5134 4 70.67 5 39482 VEV_2_3_RA5_01_1236.d 4.4E5 4 4 112 126
R.TNLDKYHPGYFGK(+14.02).V Y 75.90 1552.7673 13 -15.7 518.5883 3 59.56 4 31175 VEV_1_3_RA4_01_1235.d 1.22E6 6 6 43 55 Methylation(KR)
R.YFSKEAER.K Y 75.04 1028.4927 8 -13.0 515.2469 2 19.38 5 7415 VEV_2_3_RA5_01_1236.d 1.59E6 8 8 129 136
R.GM(+15.99)AGGQHHHR.T Y 74.57 1102.4839 10 -7.7 552.2450 2 7.77 4 1829 VEV_1_3_RA4_01_1235.d 2.58E4 5 5 33 42 Oxidation (M)
K.TQNQFWKPVIN(+.98)LDKLWSLVPAETR.D Y 68.29 2883.5283 24 -0.2 962.1832 3 88.99 4 53104 VEV_1_3_RA4_01_1235.d 2.73E4 1 1 64 87 Deamidation (NQ)
R.ARYFSKEAER.K Y 67.39 1255.6309 10 -15.3 419.5445 3 22.28 5 8954 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 127 136
K.KADTVPVLD(+14.02)LLPLGYSK.V Y 66.46 1842.0502 17 -12.3 615.0164 3 84.73 5 48997 VEV_2_3_RA5_01_1236.d 6.24E5 3 3 95 111 Methylation(others)
K.IKDAGGAVELVA Y 62.10 1141.6343 12 -10.2 571.8186 2 65.68 4 35809 VEV_1_3_RA4_01_1235.d 1.77E5 2 2 138 149
R.DAYVNN(+.98)KKADTVPVLDLLPLGYSK.V Y 58.69 2633.3953 24 -8.5 659.3505 4 84.97 5 49146 VEV_2_3_RA5_01_1236.d 1.63E5 5 5 88 111 Deamidation (NQ)
K.DAGGAVELVA Y 54.72 900.4552 10 -13.4 901.4504 1 72.48 4 41176 VEV_1_3_RA4_01_1235.d 6.01E4 1 1 140 149
K.GRLPQ(+.98)IPVVVR.A Y 53.91 1233.7557 11 -7.5 412.2561 3 70.91 4 39927 VEV_1_3_RA4_01_1235.d 2.61E5 4 4 116 126 Deamidation (NQ)
K.ADTVPVLDLLPLGYSK(+14.02).V Y 53.81 1713.9552 16 -4.4 857.9811 2 89.12 4 53176 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 96 111 Methylation(KR)
R.DAYVN(+.98)NKKADTVPVLDLLPLGYSK.V Y 52.84 2633.3953 24 -17.3 659.3447 4 84.73 6 48289 VEV_3_3_RA6_01_1237.d 3.39E5 4 4 88 111 Deamidation (NQ)
R.YFSKEAERK.I Y 51.60 1156.5876 9 -12.4 579.2939 2 14.68 5 4861 VEV_2_3_RA5_01_1236.d 3.92E5 3 3 129 137
R.KIKDAGGAVELVA Y 51.56 1269.7292 13 -18.3 424.2426 3 61.09 4 32301 VEV_1_3_RA4_01_1235.d 2.76E5 3 3 137 149
K.GRLPQIPVVVR(+14.02).A Y 47.20 1246.7874 11 -42.7 416.5853 3 72.54 4 41290 VEV_1_3_RA4_01_1235.d 0 2 2 116 126 Methylation(KR)
R.GM(-48.00)AGGQHHHR.T Y 46.85 1038.4856 10 -10.1 520.2448 2 7.70 6 1808 VEV_3_3_RA6_01_1237.d 1.84E4 1 1 33 42 Dethiomethyl
R.DAYVNNKK(+14.02)AD(-18.01)TVPVLDLLPLGYSK.V Y 45.34 2628.4163 24 -20.2 877.1284 3 83.18 5 48064 VEV_2_3_RA5_01_1236.d 0 1 1 88 111 Methylation(KR); Dehydration
K.TQNQ(+.98)FWKPVINLDKLWSLVPAETR.D Y 44.32 2883.5283 24 -9.6 721.8824 4 89.75 4 53514 VEV_1_3_RA4_01_1235.d 0 1 1 64 87 Deamidation (NQ)
R.KSRGHVSAGYGR.V Y 44.27 1273.6639 12 -8.0 425.5585 3 12.22 5 3562 VEV_2_3_RA5_01_1236.d 8.19E4 2 2 10 21
R.T(+41.03)NLDKYHPGYFGK.V Y 43.59 1579.7783 13 -45.4 395.9339 4 57.67 5 29887 VEV_2_3_RA5_01_1236.d 0 1 1 43 55 Amidination of lysines or N-terminal amines with methyl acetimidate
R.G(+42.01)MAGGQHHHR.T Y 37.44 1128.4995 10 -27.2 377.1635 3 9.01 6 2142 VEV_3_3_RA6_01_1237.d 0 1 1 33 42 Acetylation (N-term)
K.LWSLVPAETR.D Y 33.66 1170.6396 10 -54.7 586.2951 2 77.17 4 44911 VEV_1_3_RA4_01_1235.d 0 1 1 78 87
R.GHVSAGYGR(+14.02).V Y 33.29 916.4515 9 -9.6 459.2286 2 16.24 4 5432 VEV_1_3_RA4_01_1235.d 1.61E5 3 3 13 21 Methylation(KR)
K.G(+43.01)R(+14.02)LPQIPVVVR.A Y 32.98 1289.7931 11 -5.4 430.9360 3 69.83 5 38866 VEV_2_3_RA5_01_1236.d 2.58E4 1 1 116 126 Carbamylation; Methylation(KR)
R.T(-18.01)NLDK.Y Y 30.35 571.2966 5 -6.6 572.3000 1 68.53 6 36789 VEV_3_3_RA6_01_1237.d 0 3 3 43 47 Dehydration
K.TQNQFWKPVINLDK.L Y 28.39 1729.9152 14 -9.8 577.6400 3 75.53 4 43539 VEV_1_3_RA4_01_1235.d 7.14E4 1 1 64 77
K.T(-18.01)QNQFWK(+14.02)PVINLDKLWSLVPAETR.D Y 28.33 2878.5493 24 -51.7 720.6074 4 89.72 4 53502 VEV_1_3_RA4_01_1235.d 3.6E4 1 1 64 87 Dehydration; Methylation(KR)
R.TNLDK(+14.02)YHPGYFGK.V Y 27.10 1552.7673 13 -13.5 777.3805 2 60.02 5 31562 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 43 55 Methylation(KR)
R.T(-2.02)NLDKYHPGYFGK.V Y 26.88 1536.7361 13 27.5 513.2667 3 58.38 4 30276 VEV_1_3_RA4_01_1235.d 0 1 1 43 55 2-amino-3-oxo-butanoic_acid
R.YFSKEAER(+14.02).K Y 25.90 1042.5083 8 -11.7 522.2553 2 26.77 4 11081 VEV_1_3_RA4_01_1235.d 2.63E5 2 2 129 136 Methylation(KR)
K.HPGGR.G Y 25.62 522.2662 5 -14.0 523.2662 1 63.61 5 34246 VEV_2_3_RA5_01_1236.d 6.73E5 6 6 28 32
R.GHVSAGYGRVGK.H Y 24.83 1186.6206 12 -24.1 396.5380 3 18.00 5 6668 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 13 24
K.TQNQFWKPVINLDK(+14.02).L Y 24.10 1743.9308 14 -4.9 436.9879 4 55.79 5 28636 VEV_2_3_RA5_01_1236.d 0 1 1 64 77 Methylation(KR)
R.DAYVNNK(+14.02)K.A Y 22.42 964.4977 8 -13.1 483.2498 2 13.82 4 4215 VEV_1_3_RA4_01_1235.d 2.9E4 2 2 88 95 Methylation(KR)
K.SR(+14.02)GHVSAGYGRVGK(+42.01).H Y 22.13 1485.7800 14 -7.2 496.2637 3 72.91 4 41512 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 11 24 Methylation(KR); Acetylation (K)
K.HPGGR(-.98).G Y 21.70 521.2822 5 -42.9 522.2672 1 58.21 5 30254 VEV_2_3_RA5_01_1236.d 0 1 1 28 32 Amidation
MPTRLSK(-.98).T Y 21.25 830.4796 7 -51.5 831.4442 1 97.43 6 54463 VEV_3_3_RA6_01_1237.d 3.9E4 1 1 1 7 Amidation
K.S(+43.01)RGHVSAGYGR.V Y 21.13 1188.5748 11 8.9 397.2024 3 13.04 5 3997 VEV_2_3_RA5_01_1236.d 0 1 1 11 21 Carbamylation
R.ARYFSK.E Y 19.76 770.4075 6 -11.2 386.2067 2 16.82 5 6009 VEV_2_3_RA5_01_1236.d 0 1 1 127 132
R.G(+210.20)M(+15.99)AGGQHHHR.T Y 18.23 1312.6823 10 -44.2 329.1633 4 21.70 5 8699 VEV_2_3_RA5_01_1236.d 0 1 1 33 42 Myristoylation; Oxidation (M)
R.KHPGGR(+80.99)GMAGGQHHHR.T Y 18.03 1799.8247 16 69.5 360.9972 5 8.85 5 2096 VEV_2_3_RA5_01_1236.d 0 1 1 27 42 Arginine replacement by Nitropyrimidyl ornithine
R.GHVS(+79.97)AGYGRVGKHR(+31.99).K Y 17.76 1591.7368 14 12.5 398.9465 4 66.55 4 36492 VEV_1_3_RA4_01_1235.d 0 1 1 13 26 Phosphorylation (STY); Dihydroxy
K.ADTVPVLD(+14.02)LLPLGYSK.V Y 17.71 1713.9552 16 -27.4 857.9614 2 89.47 6 51039 VEV_3_3_RA6_01_1237.d 1.64E4 1 1 96 111 Methylation(others)
K.YHPGYFGK.V Y 16.56 967.4551 8 -9.0 484.7305 2 37.95 5 17911 VEV_2_3_RA5_01_1236.d 3.05E5 2 2 48 55
K.DAGGAVELVA(-.98) Y 16.49 899.4712 10 -12.3 900.4674 1 31.28 4 13586 VEV_1_3_RA4_01_1235.d 9.63E4 1 1 140 149 Amidation
R.TN(+.98)LDKYHPGYFGK.V Y 16.31 1539.7357 13 -2.6 514.2512 3 61.10 4 32307 VEV_1_3_RA4_01_1235.d 0 1 1 43 55 Deamidation (NQ)
R.Y(+79.97)FSKEAER.K Y 16.16 1108.4590 8 73.1 370.5206 3 19.76 4 7276 VEV_1_3_RA4_01_1235.d 9.2E4 1 1 129 136 Phosphorylation (STY)
K.TQ(+.98)NQFWKPVINLDKLWSLVPAETR.D Y 15.85 2883.5283 24 -15.0 721.8785 4 90.61 6 51632 VEV_3_3_RA6_01_1237.d 2.37E4 1 1 64 87 Deamidation (NQ)
K.H(+42.01)PGGRGMAGGQHHHR.T Y 15.65 1632.7552 15 -26.7 545.2445 3 37.93 6 17303 VEV_3_3_RA6_01_1237.d 3.76E4 1 1 28 42 Acetylation (N-term)
R.GHVSAGYGR(+43.04).V Y 15.10 945.4780 9 20.7 316.1731 3 13.19 6 4019 VEV_3_3_RA6_01_1237.d 6.09E4 1 1 13 21 Carboxyl modification with ethanolamine
K.TQNQFWK(-1.03)PVINLDKLWSLVPAETR.D Y 15.10 2881.5127 24 -25.9 721.3668 4 90.59 4 53982 VEV_1_3_RA4_01_1235.d 8.78E4 1 1 64 87 Lysine oxidation to aminoadipic semialdehyde
total 64 peptides
C1G0E5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VERPATENISLGPLAGDGKLVFGVAR.I Y 143.76 2665.4551 26 -10.2 667.3643 4 80.01 5 46056 VEV_2_3_RA5_01_1236.d 1.07E6 5 5 7 32
K.ADRDESSPYAAMLAAQDVAAR.C Y 142.18 2207.0276 21 -12.4 736.6740 3 75.71 6 42087 VEV_3_3_RA6_01_1237.d 1.54E6 9 9 64 84
K.KVERPATENISLGPLAGDGKLVFGVAR.I Y 141.48 2793.5500 27 -16.2 559.7083 5 77.82 4 45341 VEV_1_3_RA4_01_1235.d 1.02E6 3 3 6 32
R.ATGGNGTKTPGPGAQSALR.A Y 139.86 1739.8914 19 -13.0 580.9635 3 33.53 6 14850 VEV_3_3_RA6_01_1237.d 2.32E6 13 13 99 117
K.VKADRDESSPYAAMLAAQDVAAR.C Y 133.36 2434.1909 23 -6.3 609.5511 4 71.73 4 40616 VEV_1_3_RA4_01_1235.d 2.08E6 7 7 62 84
K.KKVERPATENISLGPLAGDGKLVFGVAR.I Y 131.62 2921.6450 28 -25.4 585.3214 5 75.67 5 43147 VEV_2_3_RA5_01_1236.d 3.97E5 4 4 5 32
R.IFASFNDTFVHVTDLSGRETIC(+57.02)R.V Y 127.85 2684.3018 23 -13.8 672.0735 4 80.65 6 45614 VEV_3_3_RA6_01_1237.d 1.78E6 5 5 33 55 Carbamidomethylation
R.IGRIEDVTPTPSDSTR.R Y 124.44 1742.8799 16 -5.6 872.4423 2 59.60 5 31292 VEV_2_3_RA5_01_1236.d 6.63E6 12 12 126 141
K.ADRDESSPYAAM(+15.99)LAAQDVAAR.C Y 121.01 2223.0225 21 -0.6 742.0143 3 66.88 4 36750 VEV_1_3_RA4_01_1235.d 3.62E5 4 4 64 84 Oxidation (M)
K.VERPATENISLGPLAGDGK.L Y 117.61 1923.0061 19 -12.8 642.0011 3 69.19 6 37263 VEV_3_3_RA6_01_1237.d 4.73E5 2 2 7 25
R.IFASFNDTFVHVTDLSGR.E Y 117.40 2024.9956 18 -3.7 676.0033 3 82.33 4 48769 VEV_1_3_RA4_01_1235.d 1.05E6 7 7 33 50
R.ATGGN(+.98)GTKTPGPGAQSALR.A Y 116.21 1740.8755 19 -10.4 581.2931 3 40.07 6 18608 VEV_3_3_RA6_01_1237.d 7.14E6 38 38 99 117 Deamidation (NQ)
K.KVERPATENISLGPLAGDGK.L Y 114.54 2051.1011 20 -7.5 513.7787 4 65.25 4 35474 VEV_1_3_RA4_01_1235.d 5.68E5 3 3 6 25
R.IGRIEDVTPTPSDSTRR.K Y 112.09 1898.9810 17 -16.5 475.7447 4 55.76 6 27638 VEV_3_3_RA6_01_1237.d 8.25E6 14 14 126 142
R.IEDVTPTPSDSTR.R Y 108.93 1416.6732 13 -8.3 709.3380 2 47.76 5 23817 VEV_2_3_RA5_01_1236.d 1.52E6 11 11 129 141
K.KKVERPATENISLGPLAGDGK.L Y 100.71 2179.1960 21 -4.0 436.8447 5 61.24 4 32496 VEV_1_3_RA4_01_1235.d 7.35E5 3 3 5 25
K.TPGPGAQSALR.A Y 100.18 1053.5566 11 -11.5 527.7795 2 36.11 5 16907 VEV_2_3_RA5_01_1236.d 6.47E6 13 13 107 117
K.IRATGGNGTKTPGPGAQSALR.A Y 98.39 2009.0765 21 -11.1 503.2708 4 39.96 5 19096 VEV_2_3_RA5_01_1236.d 3.95E5 6 6 97 117
K.IRATGGN(+.98)GTKTPGPGAQSALR.A Y 96.62 2010.0605 21 -7.7 503.5186 4 45.75 4 22223 VEV_1_3_RA4_01_1235.d 1.2E6 7 7 97 117 Deamidation (NQ)
R.DESSPYAAMLAAQDVAAR.C Y 91.88 1864.8624 18 -3.1 933.4356 2 80.48 4 47390 VEV_1_3_RA4_01_1235.d 1.83E5 4 4 67 84
R.IEDVTPTPSDSTRR.K Y 88.94 1572.7743 14 -11.0 787.3857 2 42.15 4 20026 VEV_1_3_RA4_01_1235.d 1.34E6 9 9 129 142
R.C(+57.02)KELGINALHIK.I Y 87.93 1394.7704 12 -11.4 465.9254 3 61.89 4 32909 VEV_1_3_RA4_01_1235.d 1.14E6 7 7 85 96 Carbamidomethylation
K.ADRDESSPYAAMLAAQ(+.98)DVAAR.C Y 87.49 2208.0117 21 -5.4 737.0072 3 78.21 4 45679 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 64 84 Deamidation (NQ)
K.K(+14.02)VERPATENISLGPLAGDGKLVFGVAR.I Y 81.92 2807.5657 27 -4.4 562.5179 5 79.04 4 46280 VEV_1_3_RA4_01_1235.d 8.24E4 1 1 6 32 Methylation(KR)
K.VKADRDESSPYAAMLAAQ(+.98)DVAAR.C Y 78.88 2435.1750 23 -3.4 609.7990 4 71.68 5 40229 VEV_2_3_RA5_01_1236.d 2.26E5 3 3 62 84 Deamidation (NQ)
K.VK(+14.02)ADRDESSPYAAMLAAQDVAAR.C Y 77.48 2448.2065 23 -18.1 613.0479 4 73.63 4 42067 VEV_1_3_RA4_01_1235.d 3.49E5 2 2 62 84 Methylation(KR)
K.ELGINALHIK.I Y 77.00 1106.6448 10 -14.5 554.3217 2 68.36 5 37803 VEV_2_3_RA5_01_1236.d 6.25E5 5 5 87 96
R.IGR(+14.02)IEDVTPTPSDSTR.R Y 76.16 1756.8955 16 -8.3 586.6343 3 62.36 5 33333 VEV_2_3_RA5_01_1236.d 2.01E6 8 8 126 141 Methylation(KR)
R.ATGGN(+.98)GTK(+14.02)TPGPGAQSALR.A Y 74.38 1754.8911 19 -2.1 585.9697 3 38.47 4 17784 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 99 117 Deamidation (NQ); Methylation(KR)
K.IR(+.98)ATGGNGTKTPGPGAQSALR.A Y 74.06 2010.0605 21 -2.9 503.5210 4 45.30 5 22307 VEV_2_3_RA5_01_1236.d 3.46E5 1 1 97 117 Deamidation (R)
R.IGR(+14.02)IEDVTPTPSDSTRR.K Y 73.53 1912.9966 17 -11.6 479.2509 4 59.10 4 30810 VEV_1_3_RA4_01_1235.d 1.22E6 8 8 126 142 Methylation(KR)
R.ATGGNGTKTPGPGAQ(+.98)SALR.A Y 68.53 1740.8755 19 -11.5 581.2924 3 38.00 5 17990 VEV_2_3_RA5_01_1236.d 1.9E6 4 4 99 117 Deamidation (NQ)
R.C(+58.01)KELGINALHIK.I Y 65.71 1395.7544 12 -3.7 466.2570 3 65.59 5 35766 VEV_2_3_RA5_01_1236.d 1.08E6 5 5 85 96 Carboxymethyl
K.TPGPGAQSALR(+14.02).A Y 65.60 1067.5723 11 -10.4 534.7878 2 47.24 4 23145 VEV_1_3_RA4_01_1235.d 7.33E5 6 6 107 117 Methylation(KR)
R.ATGGNGTKTPGPGAQSALR(+14.02).A Y 65.12 1753.9071 19 -9.9 585.6372 3 41.60 5 20087 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 99 117 Methylation(KR)
K.ADRDESSPYAAMLAAQDVAAR(+14.02).C Y 63.98 2221.0432 21 -5.0 741.3513 3 77.48 4 45072 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 64 84 Methylation(KR)
R.IFASFNDTFVHVTDLSGR(+14.02)ETIC(+57.02)R.V Y 63.88 2698.3174 23 -10.4 675.5796 4 81.97 6 46521 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 33 55 Methylation(KR); Carbamidomethylation
R.IGRIEDVTPTPSDSTR(+14.02)R.K Y 62.16 1912.9966 17 -10.4 479.2515 4 55.97 4 28608 VEV_1_3_RA4_01_1235.d 2.57E5 2 2 126 142 Methylation(KR)
R.ATGGN(+.98)GTKTPGPGAQ(+.98)SALR.A Y 60.89 1741.8595 19 -7.7 871.9303 2 45.14 4 21857 VEV_1_3_RA4_01_1235.d 6.38E5 4 4 99 117 Deamidation (NQ)
R.IGRIEDVT(+14.02)PTPSDSTR.R Y 59.10 1756.8955 16 -13.6 879.4431 2 62.44 6 32225 VEV_3_3_RA6_01_1237.d 3.04E4 1 1 126 141 Methylation(others)
K.VKADR(+14.02)DESSPYAAMLAAQDVAAR.C Y 58.23 2448.2065 23 1.9 817.0776 3 73.58 5 41580 VEV_2_3_RA5_01_1236.d 2.24E5 2 2 62 84 Methylation(KR)
R.IGRIEDVTPTPSDSTRR(+14.02).K Y 57.55 1912.9966 17 -18.1 479.2478 4 58.98 6 29697 VEV_3_3_RA6_01_1237.d 3.22E5 1 1 126 142 Methylation(KR)
R.IFASFNDTFVHVTDLSGR(+14.02).E Y 57.53 2039.0112 18 -41.9 680.6492 3 82.52 4 48898 VEV_1_3_RA4_01_1235.d 0 2 2 33 50 Methylation(KR)
K.KVERPATENIS(-2.02)LGPLAGDGKLVFGVAR.I Y 56.17 2791.5344 27 -39.7 559.2920 5 78.05 4 45521 VEV_1_3_RA4_01_1235.d 7.21E4 2 2 6 32 2-amino-3-oxo-butanoic_acid
R.IGRIE(+14.02)DVTPTPSDSTR.R Y 55.78 1756.8955 16 -10.0 879.4462 2 62.37 5 33310 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 126 141 Methylation(others)
K.ADRDESSPYAAM(-4.99)LAAQDVAAR.C Y 55.48 2202.0413 21 22.2 735.0373 3 75.83 5 43194 VEV_2_3_RA5_01_1236.d 1.53E5 2 2 64 84 Methionine replacement by azido homoalanine
R.ATGGN(+.98)GT(-18.01)KTPGPGAQSALR.A Y 54.42 1722.8649 19 -9.5 575.2901 3 36.20 5 16890 VEV_2_3_RA5_01_1236.d 1.97E5 3 3 99 117 Deamidation (NQ); Dehydration
R.ATGGN(+.98)GTKTPGPGAQSALR(+14.02).A Y 54.14 1754.8911 19 -25.5 878.4305 2 49.44 4 24528 VEV_1_3_RA4_01_1235.d 1.33E5 3 3 99 117 Deamidation (NQ); Methylation(KR)
K.LVFGVAR.I Y 51.63 760.4595 7 -15.8 381.2310 2 62.78 5 33645 VEV_2_3_RA5_01_1236.d 8.43E5 4 4 26 32
K.VERPATENIS(-2.02)LGPLAGDGK.L Y 51.13 1920.9905 19 22.7 641.3520 3 69.44 4 38776 VEV_1_3_RA4_01_1235.d 0 1 1 7 25 2-amino-3-oxo-butanoic_acid
R.VTGGMKVKADRDESSPYAAMLAAQDVAAR.C Y 48.39 3007.4854 29 -12.0 752.8696 4 70.94 5 39687 VEV_2_3_RA5_01_1236.d 5.33E4 1 1 56 84
R.IGRIEDVTPTPSDSTR(+14.02).R Y 48.03 1756.8955 16 -13.0 586.6315 3 60.62 5 32012 VEV_2_3_RA5_01_1236.d 6.46E4 1 1 126 141 Methylation(KR)
K.ADRDESSPYAAMLAAQD(-18.01)VAAR(+14.02).C Y 45.55 2203.0327 21 24.3 735.3694 3 75.78 6 42118 VEV_3_3_RA6_01_1237.d 7.76E4 1 1 64 84 Dehydration; Methylation(KR)
R.IGRIED(+14.02)VTPTPSDSTR.R Y 43.57 1756.8955 16 -10.2 879.4461 2 61.33 5 32529 VEV_2_3_RA5_01_1236.d 4.29E4 1 1 126 141 Methylation(others)
R.I(+43.01)GR(+14.02)IEDVTPTPSDSTR.R Y 43.27 1799.9014 16 -5.0 600.9714 3 60.38 5 31864 VEV_2_3_RA5_01_1236.d 9.22E4 1 1 126 141 Carbamylation; Methylation(KR)
K.ADR(+14.02)DESSPYAAMLAAQDVAAR.C Y 41.68 2221.0432 21 -6.1 741.3505 3 75.29 4 43356 VEV_1_3_RA4_01_1235.d 3.36E5 4 4 64 84 Methylation(KR)
K.IRATGGNGTKT(-2.02)PGPGAQSALR.A Y 41.13 2007.0609 21 -26.7 502.7591 4 45.89 4 22319 VEV_1_3_RA4_01_1235.d 0 1 1 97 117 2-amino-3-oxo-butanoic_acid
R.IGRIEDVTPTPSD(+14.02)STR.R Y 40.45 1756.8955 16 -9.9 586.6333 3 62.79 5 33637 VEV_2_3_RA5_01_1236.d 5.74E5 1 1 126 141 Methylation(others)
R.I(+164.06)GRIEDVTPTPSDSTR.R Y 40.18 1906.9401 16 -10.0 636.6476 3 56.80 6 28235 VEV_3_3_RA6_01_1237.d 6.83E4 1 1 126 141 O-Diisopropylphosphorylation
R.IGRIED(+37.96)VTPTPSDSTRR.K Y 37.83 1936.9369 17 -4.0 485.2396 4 55.74 5 28598 VEV_2_3_RA5_01_1236.d 9.61E4 1 1 126 142 Replacement of proton by potassium
K.A(+226.08)DRDESSPYAAMLAAQDVAAR.C Y 37.70 2433.1052 21 11.2 609.2904 4 71.83 6 39233 VEV_3_3_RA6_01_1237.d 7.15E5 2 2 64 84 Biotinylation
K.ADRDESSPYAAMLAAQD(+6.01)VAAR.C Y 37.19 2213.0359 21 -8.6 738.6796 3 75.98 4 43904 VEV_1_3_RA4_01_1235.d 6.52E3 1 1 64 84 Replacement of proton by lithium
R.IGRIEDVTPTPSDST(-18.01)R.R Y 37.17 1724.8693 16 -13.7 575.9558 3 59.59 6 30152 VEV_3_3_RA6_01_1237.d 4.39E4 1 1 126 141 Dehydration
K.IRATGGNGTK(+14.02)T(-18.01)PGPGAQSALR.A Y 37.15 2005.0817 21 -58.5 502.2484 4 45.50 5 22442 VEV_2_3_RA5_01_1236.d 0 1 1 97 117 Methylation(KR); Dehydration
K.VKADRDESSPYAAMLAAQ(+.98)DVAAR(+14.02).C Y 37.11 2449.1907 23 3.9 817.4073 3 74.19 5 42020 VEV_2_3_RA5_01_1236.d 3.15E4 1 1 62 84 Deamidation (NQ); Methylation(KR)
R.IFASFN(+.98)DTFVHVTDLSGR(+14.02)ETIC(+57.02)R.V Y 36.47 2699.3013 23 -0.7 675.8322 4 82.05 4 48564 VEV_1_3_RA4_01_1235.d 6.07E4 1 1 33 55 Deamidation (NQ); Methylation(KR); Carbamidomethylation
R.AT(-2.02)GGNGTKTPGPGAQSALR.A Y 35.68 1737.8757 19 -45.4 580.2729 3 40.68 6 18879 VEV_3_3_RA6_01_1237.d 5.41E4 1 1 99 117 2-amino-3-oxo-butanoic_acid
K.VKADRDESSPY(+15.01)AAMLAAQDVAAR.C Y 35.57 2449.2019 23 -11.1 613.3010 4 63.89 4 34425 VEV_1_3_RA4_01_1235.d 1.63E4 1 1 62 84 Tyrosine oxidation to 2-aminotyrosine
R.IGRIEDVTPTPS(+14.02)DSTRR.K Y 34.52 1912.9966 17 -14.6 479.2495 4 55.84 6 27641 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 126 142 Methylation(others)
K.TPGPGAQ(+.98)SALR.A Y 31.83 1054.5406 11 -23.2 528.2654 2 41.66 6 19453 VEV_3_3_RA6_01_1237.d 0 1 1 107 117 Deamidation (NQ)
R.ATGGN(+15.00)GTKTPGPGAQSALR.A Y 31.65 1754.8911 19 29.1 585.9880 3 38.24 6 17489 VEV_3_3_RA6_01_1237.d 0 1 1 99 117 Deamidation followed by a methylation
R.C(+57.02)KELGINALHIKIR.A Y 30.65 1663.9556 14 10.5 417.0005 4 66.48 5 36385 VEV_2_3_RA5_01_1236.d 0 1 1 85 98 Carbamidomethylation
K.TPGPGAQ(+.98)SALR(+14.02).A Y 30.45 1068.5564 11 -18.5 535.2756 2 51.76 6 25334 VEV_3_3_RA6_01_1237.d 6.19E4 2 2 107 117 Deamidation (NQ); Methylation(KR)
K.VKADRDESSPYAAMLAAQDVAAR(-.98).C Y 28.63 2433.2070 23 -7.1 609.3047 4 71.65 4 40515 VEV_1_3_RA4_01_1235.d 0 1 1 62 84 Amidation
R.IGRIED(+14.02)VTPTPSDSTRR.K Y 28.20 1912.9966 17 -16.6 479.2485 4 59.33 5 31111 VEV_2_3_RA5_01_1236.d 4.33E5 1 1 126 142 Methylation(others)
K.KVERPATENISLGPLAGDGK(-1.03)LVFGVAR.I Y 27.68 2792.5183 27 1.4 931.8480 3 77.80 5 44578 VEV_2_3_RA5_01_1236.d 0 1 1 6 32 Lysine oxidation to aminoadipic semialdehyde
R.C(+57.02)KELGIN(-17.03)ALHIK.I Y 26.37 1377.7438 12 -15.0 460.2483 3 71.81 4 40680 VEV_1_3_RA4_01_1235.d 2.4E6 3 3 85 96 Carbamidomethylation; Ammonia-loss (N)
K.ADRDESSPYAAMLAAQDVAAR(-.98).C Y 25.81 2206.0437 21 -9.1 736.3485 3 76.29 4 44139 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 64 84 Amidation
R.IGRIEDVT(-2.02)PTPSDSTRR.K Y 25.76 1896.9653 17 -7.1 475.2452 4 56.59 6 28103 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 126 142 2-amino-3-oxo-butanoic_acid
K.VKADRDESSPYAAM(-4.99)LAAQDVAAR.C Y 25.23 2429.2046 23 8.1 608.3134 4 71.65 4 40518 VEV_1_3_RA4_01_1235.d 0 1 1 62 84 Methionine replacement by azido homoalanine
R.C(+57.02)KELGIN(-17.03)ALHIKIR.A Y 25.14 1646.9290 14 -9.3 412.7357 4 74.18 5 42012 VEV_2_3_RA5_01_1236.d 7.81E4 1 1 85 98 Carbamidomethylation; Ammonia-loss (N)
K.ADRDES(+238.23)SPYAAMLAAQDVAAR.C Y 25.03 2445.2573 21 2.3 612.3230 4 72.03 4 40816 VEV_1_3_RA4_01_1235.d 0 1 1 64 84 Palmitoylation
R.C(+57.02)K(+14.02)ELGINALHIK.I Y 25.00 1408.7860 12 -2.8 470.6013 3 64.43 5 34850 VEV_2_3_RA5_01_1236.d 2.1E5 2 2 85 96 Carbamidomethylation; Methylation(KR)
K.VERPATENISLGPLAGDGK(+72.02).L Y 24.09 1995.0272 19 -12.0 666.0084 3 80.10 6 45232 VEV_3_3_RA6_01_1237.d 0 1 1 7 25 Carboxyethyl
R.ATGGNGTK(+42.02).T Y 23.96 746.3671 8 -16.1 747.3624 1 98.23 6 54750 VEV_3_3_RA6_01_1237.d 2.31E4 1 1 99 106 Guanidination
R.IGR(+14.02)IEDVTPTPSDSTR(+14.02).R Y 23.72 1770.9111 16 4.2 591.3135 3 64.83 4 35148 VEV_1_3_RA4_01_1235.d 3.33E4 1 1 126 141 Methylation(KR)
R.IE(+14.02)DVTPTPSDSTRR.K Y 23.60 1586.7900 14 -13.0 794.3920 2 49.94 4 24842 VEV_1_3_RA4_01_1235.d 4.05E4 1 1 129 142 Methylation(others)
R.VTGGM(+15.99)K.V Y 23.59 607.2999 6 19.2 608.3188 1 74.41 5 42179 VEV_2_3_RA5_01_1236.d 0 2 2 56 61 Oxidation (M)
K.ADR(+14.02)D(-18.01)ESSPYAAMLAAQDVAAR.C Y 23.55 2203.0327 21 46.3 1102.5746 2 75.89 5 43235 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 64 84 Methylation(KR); Dehydration
R.IEDVTPTPSDSTR(+14.02).R Y 23.04 1430.6888 13 -9.9 716.3446 2 52.02 4 26182 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 129 141 Methylation(KR)
K.IRAT(+79.97)GGNGT(+79.96)KTPGPGAQSALR.A Y 21.27 2168.9998 21 9.3 434.8113 5 62.51 5 33416 VEV_2_3_RA5_01_1236.d 0 1 1 97 117 Phosphorylation (STY); Sulfation
K.K(+14.02)VERPATENISLGPLAGDGK.L Y 21.20 2065.1167 20 -14.0 517.2792 4 68.23 5 37716 VEV_2_3_RA5_01_1236.d 8.12E4 2 2 6 25 Methylation(KR)
R.ATGGNGT(+79.97)K(+28.03).T Y 20.91 812.3430 8 13.7 813.3613 1 59.43 4 31058 VEV_1_3_RA4_01_1235.d 1.71E4 1 1 99 106 Phosphorylation (STY); Dimethylation(KR)
R.IGRIEDVTPT(-2.02)PSDSTR.R Y 20.89 1740.8643 16 -12.2 581.2883 3 51.30 5 25969 VEV_2_3_RA5_01_1236.d 0 1 1 126 141 2-amino-3-oxo-butanoic_acid
R.VTGGMK.V Y 20.85 591.3051 6 -19.4 592.3008 1 49.00 5 24548 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 56 61
R.IEDVTPTPSDST(-18.01)R(+14.02).R Y 20.23 1412.6783 13 0.5 707.3468 2 47.80 6 23028 VEV_3_3_RA6_01_1237.d 3.57E4 1 1 129 141 Dehydration; Methylation(KR)
R.ATGGNGT(-2.02)KTPGPGAQSALR.A Y 20.08 1737.8757 19 -27.8 580.2831 3 37.73 4 17351 VEV_1_3_RA4_01_1235.d 0 1 1 99 117 2-amino-3-oxo-butanoic_acid
K.IRATGGNGTK(-1.03)TPGPGAQSALR.A Y 19.99 2008.0449 21 -19.0 670.3429 3 45.60 4 22134 VEV_1_3_RA4_01_1235.d 3.88E4 1 1 97 117 Lysine oxidation to aminoadipic semialdehyde
K.VK(+43.01)ADR(+14.02)DESSPYAAMLAAQDVAAR.C Y 19.00 2491.2124 23 -4.5 623.8076 4 57.03 5 29454 VEV_2_3_RA5_01_1236.d 9.74E4 1 1 62 84 Carbamylation; Methylation(KR)
R.IFASFN(+.98)DTFVHVTDLSGRETIC(+57.02)R.V Y 18.49 2685.2856 23 -2.3 896.1004 3 81.61 5 47103 VEV_2_3_RA5_01_1236.d 5.61E4 1 1 33 55 Deamidation (NQ); Carbamidomethylation
R.V(+42.01)TGGMKVK(+226.08).A Y 18.14 1086.5565 8 -16.8 363.1867 3 32.95 4 14546 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 56 63 Acetylation (N-term); Biotinylation
R.A(+42.01)TGGNGTK(+28.03).T Y 17.92 774.3871 8 -1.1 775.3936 1 92.45 5 53103 VEV_2_3_RA5_01_1236.d 2.28E5 1 1 99 106 Acetylation (N-term); Dimethylation(KR)
K.TPGPGAQS(+164.06)ALR.A Y 17.71 1217.6169 11 -5.8 609.8122 2 34.81 5 16063 VEV_2_3_RA5_01_1236.d 2.42E4 1 1 107 117 O-Diisopropylphosphorylation
R.IGRIEDVTPT(+13.03)PSDSTR.R Y 17.66 1755.9115 16 -29.1 586.2941 3 63.00 4 33761 VEV_1_3_RA4_01_1235.d 7.65E4 1 1 126 141 Michael addition with methylamine
R.A(+42.01)TGGNGTK(+14.02).T Y 16.57 760.3715 8 -15.3 761.3672 1 87.41 6 49893 VEV_3_3_RA6_01_1237.d 0 1 1 99 106 Acetylation (N-term); Methylation(KR)
R.IEDVTPTPSDSTRRK.G Y 16.49 1700.8693 15 -5.5 851.4372 2 93.69 6 53058 VEV_3_3_RA6_01_1237.d 0 1 1 129 143
K.K(+43.99)VERPAT(+79.97)ENISLGPLAGDGK.L Y 15.63 2175.0571 20 -6.1 544.7682 4 61.12 6 31247 VEV_3_3_RA6_01_1237.d 7.87E4 1 1 6 25 Carboxylation (DKW); Phosphorylation (STY)
K.V(+43.01)KADRDESSPYAAM(+15.99)LAAQDVAAR.C Y 15.49 2493.1917 23 -14.9 624.2959 4 80.44 5 46340 VEV_2_3_RA5_01_1236.d 0 1 1 62 84 Carbamylation; Oxidation (M)
K.L(+226.08)VFGVAR.I Y 15.39 986.5371 7 -35.5 987.5094 1 89.30 6 50943 VEV_3_3_RA6_01_1237.d 0 1 1 26 32 Biotinylation
total 109 peptides
C1G1T5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VC(+57.02)PAPC(+57.02)EGAC(+57.02)VLGINEDPVGIK.S Y 121.77 2354.1069 22 -5.1 1178.0547 2 79.09 4 46314 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 1711 1732 Carbamidomethylation
K.DKHVIVIGGGDTGNDC(+57.02)IGTSVR.H Y 119.93 2269.1121 22 -7.6 568.2810 4 65.10 4 35350 VEV_1_3_RA4_01_1235.d 1.61E5 2 2 1900 1921 Carbamidomethylation
K.GSAGQSFGAFLAPGVTLELEGDANDYVGK.G Y 110.15 2869.3770 29 -2.5 1435.6921 2 89.00 4 53107 VEV_1_3_RA4_01_1235.d 1.88E5 3 3 1353 1381
R.NSGATAVVEGVGDHGC(+57.02)EYMTGGR.V Y 107.35 2322.9956 23 15.1 775.3508 3 67.78 4 37468 VEV_1_3_RA4_01_1235.d 0 1 1 1433 1455 Carbamidomethylation
R.DGGEPHINDPVSIANIQDAVR.T Y 106.00 2216.0820 21 -12.6 739.6920 3 78.50 4 45867 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 861 881
R.VRGMTFEQIAEDAFAFHEK.G Y 101.56 2225.0574 19 -4.1 557.2693 4 82.80 4 49088 VEV_1_3_RA4_01_1235.d 2.55E4 1 1 820 838
K.SLLDSELSDGQYISAK.D Y 99.21 1724.8468 16 -8.3 863.4235 2 77.70 5 44508 VEV_2_3_RA5_01_1236.d 3.33E5 3 3 1884 1899
K.C(+57.02)HLNTC(+57.02)PVGIATQDPVLR.Q Y 99.09 2050.0088 18 9.3 684.3499 3 70.62 4 39699 VEV_1_3_RA4_01_1235.d 0 1 1 1188 1205 Carbamidomethylation
R.GMTFEQIAEDAFAFHEK.G Y 96.68 1969.8879 17 -9.1 657.6306 3 85.62 4 50993 VEV_1_3_RA4_01_1235.d 1.66E5 2 2 822 838
R.KC(+57.02)HLNTC(+57.02)PVGIATQDPVLR.Q Y 94.96 2178.1038 19 -2.3 727.0402 3 66.29 4 36284 VEV_1_3_RA4_01_1235.d 3.17E5 3 3 1187 1205 Carbamidomethylation
R.DRNDAVVIATGATVAR.D Y 94.46 1627.8641 16 -21.5 543.6170 3 64.40 6 33718 VEV_3_3_RA6_01_1237.d 4.28E5 3 3 1844 1859
R.LTEDELKYQSAR.C Y 91.00 1451.7256 12 -9.9 726.8629 2 50.30 4 25062 VEV_1_3_RA4_01_1235.d 8.01E5 8 8 1647 1658
R.SEHEQIKNC(+57.02)TLR.G Y 86.94 1513.7307 12 -14.2 505.5770 3 22.94 5 9308 VEV_2_3_RA5_01_1236.d 6.68E5 7 7 894 905 Carbamidomethylation
K.ADHILISGHDGGTGASR.W Y 85.65 1662.8074 17 -18.1 832.3959 2 37.07 4 16966 VEV_1_3_RA4_01_1235.d 3.67E5 5 5 1098 1114
K.INMEMVEVSGVEDPAEIAFLR.G Y 84.05 2348.1392 21 -6.8 1175.0688 2 88.46 4 52786 VEV_1_3_RA4_01_1235.d 8.67E4 1 1 1488 1508
K.FVTNTSVGPGEDISLQELR.D Y 83.04 2061.0378 19 -2.3 1031.5238 2 79.01 4 46251 VEV_1_3_RA4_01_1235.d 6.67E4 2 2 1825 1843
K.FVTNTSVGPGEDISLQELRDRNDAVVIATGATVAR.D Y 82.06 3670.8914 35 -8.9 918.7219 4 80.26 4 47219 VEV_1_3_RA4_01_1235.d 3.09E5 2 2 1825 1859
R.FSTNTFPSWDR.A Y 78.61 1356.6099 11 -8.0 679.3068 2 74.23 5 42046 VEV_2_3_RA5_01_1236.d 7.03E4 2 2 274 284
R.GLLDFDFEQRIPVPIDQVEPWTEIVRR.F Y 78.48 3266.7087 27 29.1 817.7083 4 90.93 4 54183 VEV_1_3_RA4_01_1235.d 0 1 1 906 932
R.LLLKSPILSLSEFNAIK.N Y 76.94 1885.1288 17 -15.8 629.3736 3 85.06 4 50626 VEV_1_3_RA4_01_1235.d 2.62E4 1 1 612 628
K.SPILSLSEFNAIK.N Y 76.76 1417.7816 13 -16.1 709.8867 2 82.16 4 48642 VEV_1_3_RA4_01_1235.d 1.12E5 2 2 616 628
R.LGGKSNTGEGGEDATR.S Y 76.59 1547.7175 16 -7.2 516.9094 3 15.72 4 5164 VEV_1_3_RA4_01_1235.d 1.54E5 4 4 958 973
R.IIDDTELKSTVASR.Q Y 76.49 1546.8202 14 -10.6 774.4092 2 61.99 5 33030 VEV_2_3_RA5_01_1236.d 3.9E5 4 4 464 477
R.VLEDEAAKTAASK.K Y 76.14 1331.6932 13 -7.8 666.8487 2 33.33 4 14769 VEV_1_3_RA4_01_1235.d 1.73E5 4 4 1548 1560
R.ATHVLGLANWFYLC(+57.02)SLSNR.N Y 75.16 2221.1101 19 -4.1 556.2825 4 86.34 4 51464 VEV_1_3_RA4_01_1235.d 5.87E4 1 1 220 238 Carbamidomethylation
K.KAEFSLPFSSGNPAKK.T Y 73.79 1706.8990 16 -11.3 427.7272 4 65.47 4 35646 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 1561 1576
R.DLKIPGRELDGIHLATEFLHR.N Y 73.50 2429.3179 21 -9.1 486.8664 5 80.76 4 47607 VEV_1_3_RA4_01_1235.d 1.66E5 3 3 1860 1880
R.GLLDFDFEQR.I Y 72.66 1238.5931 10 -9.5 620.2980 2 83.01 6 47199 VEV_3_3_RA6_01_1237.d 1.26E5 3 3 906 915
R.VIVQTDGQLR.T Y 71.99 1127.6299 10 -11.0 564.8160 2 54.55 4 27786 VEV_1_3_RA4_01_1235.d 6.76E5 6 6 1145 1154
R.LLMTNNFPEFTGR.V Y 71.47 1538.7551 13 -9.5 770.3776 2 80.08 4 47111 VEV_1_3_RA4_01_1235.d 8.95E5 2 2 1698 1710
K.MGISTLQSYKGAQIFEALGIDDSVIDR.C Y 70.89 2926.4746 27 -10.7 976.4884 3 88.11 4 52575 VEV_1_3_RA4_01_1235.d 9.38E4 1 1 785 811
K.C(+57.02)HLN(-17.03)TC(+57.02)PVGIATQDPVLR.Q Y 70.29 2032.9823 18 -7.6 1017.4907 2 78.08 4 45539 VEV_1_3_RA4_01_1235.d 1.43E5 2 2 1188 1205 Carbamidomethylation; Ammonia-loss (N)
K.KSDILDIEDTISDLKTEK.K Y 69.69 2062.0681 18 -6.9 516.5208 4 78.89 4 46166 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 1590 1607
K.EALGSMGNDAPLAC(+57.02)LAQQPR.L Y 69.00 2097.9934 20 -1.4 700.3375 3 78.45 4 45833 VEV_1_3_RA4_01_1235.d 3.83E4 1 1 543 562 Carbamidomethylation
R.ELDGIHLATEFLHR.N Y 66.92 1649.8525 14 -9.1 413.4667 4 80.10 4 47100 VEV_1_3_RA4_01_1235.d 4.37E4 1 1 1867 1880
K.TVAIIGSGPAGLAAADQLNHVGHSVTVYER.A Y 66.29 3002.5574 30 0.8 751.6472 4 78.84 6 44324 VEV_3_3_RA6_01_1237.d 8.57E4 1 1 1760 1789
K.YAGLPWELGLAETHQTLVLNDLR.G Y 66.06 2608.3650 23 -13.2 870.4508 3 87.48 4 52180 VEV_1_3_RA4_01_1235.d 2.2E4 1 1 1120 1142
R.TRDWAELSTR.L Y 62.64 1233.6102 10 -11.9 412.2058 3 54.60 4 27814 VEV_1_3_RA4_01_1235.d 2.86E5 3 3 1637 1646
R.DSTLLGPAALSR.E Y 60.96 1199.6510 12 -9.0 600.8274 2 72.68 4 41330 VEV_1_3_RA4_01_1235.d 2.06E5 1 1 164 175
K.TPPGQYSTNVPGVFAAGDC(+57.02)RR.G Y 60.84 2249.0647 21 -7.1 750.6902 3 68.48 4 38023 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 2050 2070 Carbamidomethylation
R.WAAHNGEINTLR.G Y 60.03 1380.6898 12 -13.1 691.3431 2 53.98 5 27588 VEV_2_3_RA5_01_1236.d 4.54E5 5 5 290 301
K.MLLVDTIAGR.I Y 58.78 1087.6060 10 -11.6 544.8040 2 76.73 6 42822 VEV_3_3_RA6_01_1237.d 2.9E5 4 4 454 463
K.YAGLPWELGLAETHQTLVLNDLRGR.V Y 58.60 2821.4875 25 -7.2 706.3741 4 84.58 4 50305 VEV_1_3_RA4_01_1235.d 9.43E4 1 1 1120 1144
K.MAQGAKPGEGGELPGHK.V Y 57.22 1662.8147 17 19.3 555.2896 3 28.93 5 12642 VEV_2_3_RA5_01_1236.d 1.23E4 2 2 1012 1028
R.NLLC(+57.02)NMTHR.G Y 57.15 1157.5435 9 -13.5 579.7712 2 54.36 5 27814 VEV_2_3_RA5_01_1236.d 1.23E5 3 3 73 81 Carbamidomethylation
K.AKADHILISGHDGGTGASR.W Y 56.35 1861.9395 19 -9.9 466.4875 4 34.28 4 15317 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 1096 1114
K.HVIVIGGGDTGNDC(+57.02)IGTSVR.H Y 55.98 2025.9901 20 -7.8 676.3320 3 67.06 4 36889 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 1902 1921 Carbamidomethylation
K.VLPTDYKR.V Y 55.86 990.5498 8 -18.1 331.1846 3 33.05 5 15024 VEV_2_3_RA5_01_1236.d 6.43E5 10 10 1540 1547
R.TKNDKSYEAYAR.S Y 54.46 1444.6946 12 -11.1 723.3466 2 21.42 4 8167 VEV_1_3_RA4_01_1235.d 2.26E5 3 3 882 893
R.FGVTSNYLADADELQIK.M Y 52.83 1882.9312 17 -42.8 628.6241 3 81.84 4 48417 VEV_1_3_RA4_01_1235.d 0 1 1 995 1011
K.GSAGQSFGAFLAPGVTLELEGDANDYVGKGLSGGR.L Y 51.55 3396.6584 35 21.1 1133.2506 3 87.81 4 52384 VEV_1_3_RA4_01_1235.d 0 1 1 1353 1387
R.GLIEDHHHYTGSELAAR.I Y 51.54 1904.9128 17 -8.6 381.9866 5 56.00 4 28626 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 1509 1525
R.IEC(+57.02)DIVNTDR.A Y 51.28 1233.5659 10 -11.3 617.7833 2 53.31 6 26250 VEV_3_3_RA6_01_1237.d 1.95E5 3 3 1314 1323 Carbamidomethylation
R.GLLDFDFEQRIPVPIDQVEPWTEIVR.R Y 50.80 3110.6077 26 7.7 778.6652 4 93.84 4 55738 VEV_1_3_RA4_01_1235.d 1.03E5 2 2 906 931
R.VLILGPTGR.N Y 49.47 924.5756 9 -27.1 463.2826 2 65.13 5 35368 VEV_2_3_RA5_01_1236.d 2.24E5 2 2 1456 1464
R.ILLDFTR.A Y 49.39 876.5069 7 -20.2 439.2519 2 74.60 6 41248 VEV_3_3_RA6_01_1237.d 5.42E5 4 4 1526 1532
K.KAEFSLPFSSGNPAK.K Y 45.08 1578.8042 15 -10.0 527.2701 3 70.79 5 39570 VEV_2_3_RA5_01_1236.d 7.2E5 6 6 1561 1575
R.ALPHFVK.V Y 44.80 810.4752 7 -10.9 811.4736 1 47.20 6 22672 VEV_3_3_RA6_01_1237.d 2.26E4 2 2 1533 1539
R.ALGATLSYQISRR.Y Y 43.57 1434.7943 13 -9.3 479.2676 3 64.90 5 35253 VEV_2_3_RA5_01_1236.d 8.08E4 1 1 1324 1336
R.VIVQTDGQ(+.98)LR.T Y 42.90 1128.6139 10 -15.4 565.3055 2 57.60 4 29722 VEV_1_3_RA4_01_1235.d 5.91E4 1 1 1145 1154 Deamidation (NQ)
K.EFVGGN(+.98)GVVK.G Y 42.36 1005.5131 10 -5.7 503.7609 2 57.74 4 29827 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 1979 1988 Deamidation (NQ)
R.YC(+57.02)GANLDR.N Y 41.99 967.4182 8 -0.6 484.7161 2 30.20 4 12966 VEV_1_3_RA4_01_1235.d 3.17E5 4 4 404 411 Carbamidomethylation
K.GINTTRVEWTK.S Y 41.90 1303.6885 11 -11.0 652.8444 2 53.03 5 27006 VEV_2_3_RA5_01_1236.d 2.32E5 3 3 1989 1999
R.SAIKQIASGR.F Y 39.22 1029.5930 10 -19.5 515.7938 2 28.38 5 12334 VEV_2_3_RA5_01_1236.d 1.97E5 2 2 985 994
K.VLILSDR.A Y 38.35 814.4912 7 -21.8 408.2440 2 60.03 6 30456 VEV_3_3_RA6_01_1237.d 5.02E4 1 1 676 682
R.SWVDSQLLRLPSIQK.S Y 37.80 1768.9835 15 -17.0 590.6584 3 81.42 6 46151 VEV_3_3_RA6_01_1237.d 3.01E4 1 1 482 496
K.ASHKIVSDAR.N Y 37.13 1082.5833 10 -12.7 361.8638 3 12.94 6 3878 VEV_3_3_RA6_01_1237.d 1.46E4 1 1 63 72
K.VKGVEGYLDALDGIC(+57.02)NAATEGIENGYK.V Y 36.54 2855.3647 27 -30.1 952.7668 3 86.49 6 49365 VEV_3_3_RA6_01_1237.d 0 1 1 649 675 Carbamidomethylation
R.HGAKSVTNFELLPQPPPER.A Y 36.17 2116.1064 19 -12.2 706.3675 3 81.26 5 46872 VEV_2_3_RA5_01_1236.d 5.29E4 1 1 1922 1940
R.SWVDSQLLR.L Y 36.17 1102.5771 9 -10.5 552.2900 2 74.99 4 43120 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 482 490
R.LIVYPPR.S Y 35.98 856.5170 7 -13.4 429.2601 2 61.55 4 32643 VEV_1_3_RA4_01_1235.d 2.65E5 5 5 1388 1394
K.M(+15.99)LLVDTIAGR.I Y 35.76 1103.6008 10 -10.3 552.8020 2 71.16 6 38733 VEV_3_3_RA6_01_1237.d 5.92E4 1 1 454 463 Oxidation (M)
K.GQLAPVQVYEYYHDLVSVDYEGHFALVHSR.F Y 35.58 3490.6946 30 4.1 873.6845 4 85.46 4 50897 VEV_1_3_RA4_01_1235.d 7.92E4 1 1 244 273
K.TIDITFEK.V Y 34.70 965.5070 8 -18.6 483.7518 2 67.63 4 37342 VEV_1_3_RA4_01_1235.d 7.75E5 2 2 641 648
K.VSAEIGKTR.H Y 33.56 959.5400 9 -38.8 480.7587 2 18.59 6 6816 VEV_3_3_RA6_01_1237.d 0 1 1 1029 1037
R.KC(+57.02)HLNTC(+57.02)PVGIATQ(+.98)DPVLR.Q Y 31.32 2179.0879 19 -3.9 545.7771 4 66.22 6 35046 VEV_3_3_RA6_01_1237.d 0 1 1 1187 1205 Carbamidomethylation; Deamidation (NQ)
R.RVDFMAAEGVK.F Y 30.48 1221.6176 11 -3.7 408.2116 3 61.49 4 32598 VEV_1_3_RA4_01_1235.d 1.67E5 2 2 1814 1824
K.TPPGQYSTNVPGVFAAGDC(+57.02)R.R Y 29.52 2092.9636 20 1.2 698.6627 3 73.33 5 41408 VEV_2_3_RA5_01_1236.d 7.62E4 1 1 2050 2069 Carbamidomethylation
R.AQAVGA Y 29.40 515.2703 6 -13.3 516.2708 1 64.06 5 34570 VEV_2_3_RA5_01_1236.d 3.16E4 1 1 2120 2125
K.VSAEIGK.T Y 28.94 702.3912 7 7.9 352.2056 2 38.88 4 18029 VEV_1_3_RA4_01_1235.d 9.8E4 1 1 1029 1035
K.GLPC(+57.02)RIEC(+57.02)DIVNTDR.A Y 28.37 1816.8560 15 -16.9 606.6157 3 69.09 4 38511 VEV_1_3_RA4_01_1235.d 2.6E5 3 3 1309 1323 Carbamidomethylation
K.G(+42.01)INTT(-18.01)R.V Y 28.24 684.3555 6 -29.6 685.3425 1 70.77 5 39561 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 1989 1994 Acetylation (N-term); Dehydration
K.MRDDLPSSK.M Y 27.51 1047.5018 9 -16.8 524.7494 2 24.43 4 9805 VEV_1_3_RA4_01_1235.d 0 1 1 1250 1258
K.EFVGGNGVVK.G Y 27.46 1004.5291 10 -19.5 503.2620 2 50.82 6 24761 VEV_3_3_RA6_01_1237.d 1.67E5 1 1 1979 1988
R.L(+42.01)DNKLIAES(+79.97)ELALEK.G Y 26.22 1806.9016 15 36.5 452.7491 4 74.13 4 42461 VEV_1_3_RA4_01_1235.d 0 1 1 1294 1308 Acetylation (N-term); Phosphorylation (STY)
K.M(+15.99)GISTLQSYK.G Y 26.12 1142.5642 10 -9.0 572.2842 2 57.61 4 29724 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 785 794 Oxidation (M)
R.SWVDSQ(+.98)LLRLPSIQK.S Y 26.01 1769.9675 15 30.6 591.0145 3 81.44 6 46164 VEV_3_3_RA6_01_1237.d 0 1 1 482 496 Deamidation (NQ)
R.R(+42.01)(+28.03)PAIDAVPAVR.A Y 25.65 1233.7194 11 -23.2 309.4300 4 48.89 4 24174 VEV_1_3_RA4_01_1235.d 4.78E5 1 1 2109 2119 Acetylation (N-term); Dimethylation(KR)
K.LSDEK.I N 25.55 590.2911 5 -10.3 591.2924 1 19.38 4 7139 VEV_1_3_RA4_01_1235.d 0 1 1 761 765
K.THM(+15.99)GK.D Y 25.55 588.2690 5 13.6 589.2842 1 69.31 6 37345 VEV_3_3_RA6_01_1237.d 5.02E4 1 1 1964 1968 Oxidation (M)
R.A(+42.01)TSANR.V Y 25.25 660.3191 6 -6.1 661.3223 1 81.72 6 46352 VEV_3_3_RA6_01_1237.d 0 2 2 683 688 Acetylation (N-term)
R.IIDDTELK(+42.01)STVAS(+79.97)R.Q Y 25.22 1668.7971 14 40.1 557.2953 3 77.71 6 43527 VEV_3_3_RA6_01_1237.d 9.43E4 1 1 464 477 Acetylation (K); Phosphorylation (STY)
R.GQ(+.98)SLIVWGINEGR.Q Y 25.09 1428.7361 13 -40.7 715.3463 2 78.89 6 44363 VEV_3_3_RA6_01_1237.d 1.1E4 1 1 2071 2083 Deamidation (NQ)
K.VMSKM(+15.99)GISTLQSYK.G Y 24.96 1587.8000 14 10.6 794.9157 2 83.88 4 49832 VEV_1_3_RA4_01_1235.d 0 1 1 781 794 Oxidation (M)
K.GYGWAEALPLR.Q Y 24.54 1231.6349 11 13.7 308.9202 4 17.83 4 6266 VEV_1_3_RA4_01_1235.d 4.7E4 1 1 28 38
K.WNELVFQNQWRDALNRLLMTNNFPEFTGR.V Y 24.43 3608.7734 29 -1.6 903.1992 4 92.97 4 55282 VEV_1_3_RA4_01_1235.d 6.65E3 1 1 1682 1710
K.THMGKDPR(+14.02).E Y 23.99 954.4705 8 -19.6 478.2332 2 52.67 5 26787 VEV_2_3_RA5_01_1236.d 7.35E4 1 1 1964 1971 Methylation(KR)
K.GRLQPGK.M Y 23.60 754.4449 7 105.9 755.5321 1 98.79 5 55598 VEV_2_3_RA5_01_1236.d 1.56E4 1 1 447 453
R.NDAVVIATGATVAR.D Y 23.60 1356.7361 14 -23.2 340.1834 4 35.80 6 16121 VEV_3_3_RA6_01_1237.d 7.73E4 1 1 1846 1859
R.AQ(+.98)AVGA Y 23.57 516.2543 6 -23.7 517.2494 1 26.82 4 11104 VEV_1_3_RA4_01_1235.d 1.36E5 2 2 2120 2125 Deamidation (NQ)
R.VIVQ(+.98)TDGQLR.T Y 23.44 1128.6139 10 -35.9 565.2939 2 54.60 5 27958 VEV_2_3_RA5_01_1236.d 7.36E4 3 3 1145 1154 Deamidation (NQ)
K.SLLD(+6.01)SELSDGQYISAK.D Y 23.42 1730.8550 16 -24.0 866.4140 2 77.74 4 45275 VEV_1_3_RA4_01_1235.d 2.52E4 1 1 1884 1899 Replacement of proton by lithium
K.YQ(+.98)SAR.C Y 22.67 624.2867 5 14.7 625.3032 1 43.41 5 21160 VEV_2_3_RA5_01_1236.d 0 1 1 1654 1658 Deamidation (NQ)
R.SEHEQIK(-1.03)NC(+57.02)TLR.G Y 22.64 1512.6991 12 5.0 505.2428 3 22.85 5 9261 VEV_2_3_RA5_01_1236.d 9.75E3 1 1 894 905 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
K.WNELVF(+31.99)QNQ(+.98)WRDALNR.L Y 22.61 2121.0027 16 23.5 531.2704 4 71.08 5 39786 VEV_2_3_RA5_01_1236.d 0 1 1 1682 1697 Dihydroxy; Deamidation (NQ)
K.SVTNFELLPQPPPER.A Y 22.50 1722.8940 15 -18.7 575.2946 3 78.42 6 44027 VEV_3_3_RA6_01_1237.d 5.42E4 1 1 1926 1940
R.NDAVVIATGATVARDLK.I Y 22.37 1712.9420 17 -19.4 429.2345 4 59.66 4 31234 VEV_1_3_RA4_01_1235.d 7.32E4 2 2 1846 1862
R.HITETPGLTESGEYHWR(+.98).D Y 21.97 2012.9227 17 6.8 504.2414 4 64.99 4 35269 VEV_1_3_RA4_01_1235.d 5.09E4 1 1 844 860 Deamidation (R)
K.NWMRAREGVLR.S Y 21.94 1386.7302 11 1.5 347.6904 4 45.71 6 21825 VEV_3_3_RA6_01_1237.d 2.94E5 2 2 305 315
K.G(+43.01)LSGGR.L Y 21.92 588.2980 6 9.3 589.3107 1 44.73 6 21247 VEV_3_3_RA6_01_1237.d 0 1 1 1382 1387 Carbamylation
K.S(+42.01)DILDIEDTISDLK(+27.99).T Y 21.68 1645.7933 14 23.9 823.9236 2 92.56 5 53146 VEV_2_3_RA5_01_1236.d 9.04E4 1 1 1591 1604 Acetylation (N-term); Formylation
K.IIENY(+79.97)K(+14.02)ASVDGGILK.V Y 21.42 1712.8750 15 -10.1 429.2217 4 59.14 5 30917 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 766 780 Phosphorylation (STY); Methylation(KR)
K.ASVDGGILK.V Y 21.11 858.4811 9 -14.9 430.2414 2 59.38 4 31022 VEV_1_3_RA4_01_1235.d 1.65E5 2 2 772 780
R.ENLFR.K Y 21.11 677.3497 5 -3.8 678.3544 1 87.19 5 50408 VEV_2_3_RA5_01_1236.d 6.75E4 2 2 754 758
R.GRVIVQTDGQLRTGR.D Y 21.07 1654.9226 15 -3.0 414.7367 4 62.47 5 33388 VEV_2_3_RA5_01_1236.d 5.46E5 1 1 1143 1157
R.ARDNPWPQWPR.I Y 20.89 1421.6952 11 6.4 474.9087 3 69.32 4 38679 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 1941 1951
R.VLEDEAAK(+31.99)TAASK.K Y 20.78 1363.6830 13 1.9 455.5691 3 12.52 4 3551 VEV_1_3_RA4_01_1235.d 5.32E5 4 4 1548 1560 Dihydroxy
R.A(+42.01)TSANR(-.98).V Y 20.77 659.3351 6 -33.3 660.3204 1 60.95 5 32255 VEV_2_3_RA5_01_1236.d 4.65E4 1 1 683 688 Acetylation (N-term); Amidation
K.G(+42.01)LSGGR.L Y 20.74 587.3027 6 -38.0 588.2877 1 72.48 6 39727 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 1382 1387 Acetylation (N-term)
K.AEFSLPFSSGNPAKK.T Y 20.35 1578.8042 15 -14.3 527.2678 3 71.09 6 38674 VEV_3_3_RA6_01_1237.d 1.95E5 1 1 1562 1576
R.RGQ(+.98)S(+79.97)LIVWGINEGR.Q Y 20.09 1664.8036 14 9.2 417.2120 4 52.48 4 26529 VEV_1_3_RA4_01_1235.d 2.94E5 1 1 2070 2083 Deamidation (NQ); Phosphorylation (STY)
R.A(+42.01)QAVGA Y 19.66 557.2809 6 -42.0 558.2648 1 37.92 4 17469 VEV_1_3_RA4_01_1235.d 5.68E4 1 1 2120 2125 Acetylation (N-term)
K.TAAS(-18.01)K.K Y 19.65 458.2489 5 -16.9 459.2484 1 56.82 4 29182 VEV_1_3_RA4_01_1235.d 2.69E2 2 2 1556 1560 Dehydration
K.LIAESELALEK(+114.04).G Y 19.57 1328.7188 11 -23.5 333.1792 4 33.62 5 15357 VEV_2_3_RA5_01_1236.d 0 1 1 1298 1308 Ubiquitin
K.TKGFM(+15.99)K.Y Y 19.50 726.3734 6 3.3 727.3831 1 89.87 6 51247 VEV_3_3_RA6_01_1237.d 4.55E4 1 1 1617 1622 Oxidation (M)
R.ALGATLSYQIS(+79.97)R.R Y 19.48 1358.6595 12 -5.9 453.8911 3 28.25 5 12270 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 1324 1335 Phosphorylation (STY)
K.TIDIT(+79.97)FEK.V Y 19.45 1045.4733 8 36.8 523.7631 2 48.31 5 24116 VEV_2_3_RA5_01_1236.d 1.39E5 1 1 641 648 Phosphorylation (STY)
R.SLAAIIVETAEAR.E Y 19.38 1342.7456 13 -14.4 336.6888 4 24.24 5 10046 VEV_2_3_RA5_01_1236.d 4.29E4 1 1 711 723
R.DSTLLGPAALS(+77.99)R.E Y 19.06 1277.6381 12 -17.8 320.4111 4 9.70 5 2397 VEV_2_3_RA5_01_1236.d 4.38E4 1 1 164 175 Methylphosphonylation
K.T(+42.01)AASK(+42.01).K Y 19.06 560.2806 5 4.7 561.2905 1 31.82 6 13879 VEV_3_3_RA6_01_1237.d 1.71E3 1 1 1556 1560 Acetylation (N-term); Acetylation (K)
K.KAEFSLPFSSGNPAK(+43.99).K Y 18.85 1622.7939 15 25.7 541.9525 3 71.75 5 40277 VEV_2_3_RA5_01_1236.d 0 1 1 1561 1575 Carboxylation (DKW)
R.GAVGSDAR.D Y 18.84 731.3562 8 -10.6 732.3557 1 76.27 4 44121 VEV_1_3_RA4_01_1235.d 3.65E4 1 1 82 89
K.QLIYDLK(+27.99).C Y 18.82 919.5015 7 -30.7 920.4805 1 85.56 5 49489 VEV_2_3_RA5_01_1236.d 0 1 1 1062 1068 Formylation
R.IIDDTELKSTVASRQDFR.S Y 18.81 2093.0752 18 -15.8 524.2678 4 66.51 5 36402 VEV_2_3_RA5_01_1236.d 0 1 1 464 481
R.VLEDEAAK(+226.08).T Y 18.67 1099.5220 8 12.5 550.7751 2 43.71 5 21333 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 1548 1555 Biotinylation
K.M(+42.01)AQGAK(+42.01)PGEGGELPGHK.V Y 18.54 1746.8358 17 18.1 437.7242 4 21.15 5 8366 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 1012 1028 Acetylation (N-term); Acetylation (K)
K.T(+42.01)AASK.K Y 18.52 518.2700 5 -12.0 519.2711 1 65.72 6 34664 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 1556 1560 Acetylation (N-term)
K.T(+42.01)AASK(+14.02).K Y 18.47 532.2856 5 -16.1 533.2844 1 72.24 4 40981 VEV_1_3_RA4_01_1235.d 6.64E4 1 1 1556 1560 Acetylation (N-term); Methylation(KR)
K.AEFSLPFSSGNPAK.K Y 18.47 1450.7092 14 -10.2 726.3545 2 77.30 4 44936 VEV_1_3_RA4_01_1235.d 6.27E4 1 1 1562 1575
R.LP(+31.99)SIQK.S Y 18.36 716.4068 6 -10.1 717.4069 1 26.96 4 11169 VEV_1_3_RA4_01_1235.d 0 1 1 491 496 Dihydroxy
K.Q(+.98)IASGR(+31.99).F Y 18.28 663.3187 6 -5.4 664.3224 1 44.51 4 21457 VEV_1_3_RA4_01_1235.d 2.27E4 1 1 989 994 Deamidation (NQ); Dihydroxy
K.GINTTR(+31.99).V Y 18.25 692.3453 6 22.1 347.1876 2 13.57 5 4320 VEV_2_3_RA5_01_1236.d 7.48E4 1 1 1989 1994 Dihydroxy
R.YGEAGLPQ(+.98)DTIHANIK.G Y 18.04 1726.8525 16 -9.2 576.6195 3 65.05 6 34159 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 1337 1352 Deamidation (NQ)
R.AIMAKLGIR.T Y 18.03 971.5950 9 -17.4 324.8666 3 56.43 5 29039 VEV_2_3_RA5_01_1236.d 1.67E4 1 1 1228 1236
K.V(+27.99)SAEIGK.T Y 17.87 730.3861 7 -23.9 731.3759 1 39.28 5 18686 VEV_2_3_RA5_01_1236.d 1.53E4 2 2 1029 1035 Formylation
K.IVSDAR(+21.98).N Y 17.86 681.3422 6 -17.7 682.3374 1 70.14 6 37965 VEV_3_3_RA6_01_1237.d 9.9E4 1 1 67 72 Sodium adduct
R.LLYEYFR.Q Y 17.61 1002.5175 7 -12.2 502.2599 2 75.50 5 42950 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 563 569
R.QGLYNPELEK.D Y 17.55 1189.5979 10 11.7 595.8132 2 43.37 6 20450 VEV_3_3_RA6_01_1237.d 9.87E3 1 1 39 48
K.G(+43.01)KASHK.I Y 17.52 669.3558 6 2.5 670.3647 1 97.93 4 57524 VEV_1_3_RA4_01_1235.d 4.22E4 1 1 61 66 Carbamylation
R.GAVGSD(-18.01)AR(+14.02).D Y 17.49 727.3613 8 -9.3 728.3618 1 78.95 4 46208 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 82 89 Dehydration; Methylation(KR)
K.ASVDGGILKVM(+15.99)SKM(+15.99)GISTLQSYK.G Y 17.47 2444.2654 23 49.8 612.1041 4 78.10 5 44783 VEV_2_3_RA5_01_1236.d 0 1 1 772 794 Oxidation (M)
K.G(+42.01)K(+42.01)ASHK.I Y 17.40 710.3711 6 -15.1 711.3676 1 82.62 5 47722 VEV_2_3_RA5_01_1236.d 0 1 1 61 66 Acetylation (N-term); Acetylation (K)
K.KLSDEKIIE(+21.98)NYK.A Y 17.40 1500.7799 12 12.3 376.2069 4 31.34 4 13627 VEV_1_3_RA4_01_1235.d 0 1 1 760 771 Sodium adduct
R.A(+42.01)QPLR.W Y 17.28 625.3547 5 -32.1 626.3419 1 100.59 5 56206 VEV_2_3_RA5_01_1236.d 1.19E4 1 1 285 289 Acetylation (N-term)
K.SVTNFELLPQ(+.98)PPPER.A Y 17.27 1723.8781 15 1.7 862.9478 2 96.74 4 57056 VEV_1_3_RA4_01_1235.d 1.92E5 1 1 1926 1940 Deamidation (NQ)
R.G(+42.01)VAAER.F Y 17.20 643.3289 6 -22.6 644.3217 1 54.51 6 26943 VEV_3_3_RA6_01_1237.d 0 1 1 1423 1428 Acetylation (N-term)
K.GLSGGR(+15.99).L Y 17.16 561.2870 6 -49.9 562.2663 1 73.09 6 40156 VEV_3_3_RA6_01_1237.d 8.57E4 1 1 1382 1387 Oxidation or Hydroxylation
K.T(+43.01)AASK(+42.01).K Y 17.09 561.2758 5 9.1 562.2882 1 18.66 4 6699 VEV_1_3_RA4_01_1235.d 0 1 1 1556 1560 Carbamylation; Acetylation (K)
R.IYRVDYGHTEVKTHM(+15.99)GKDPR.E Y 17.07 2417.1909 20 -10.0 605.2990 4 82.52 6 46882 VEV_3_3_RA6_01_1237.d 6.8E4 1 1 1952 1971 Oxidation (M)
R.WAAHN(-17.03)GEINTLRGNK.N Y 17.00 1662.8226 15 -19.6 555.2706 3 35.99 4 16336 VEV_1_3_RA4_01_1235.d 0 1 1 290 304 Ammonia-loss (N)
R.DSTLLGPAALS(+79.97)R(+14.02).E Y 16.99 1293.6329 12 2.9 432.2195 3 44.54 5 21851 VEV_2_3_RA5_01_1236.d 1.92E5 1 1 164 175 Phosphorylation (STY); Methylation(KR)
R.ND(-15.99)AVVIATGATVAR.D Y 16.90 1340.7412 14 9.3 336.1957 4 34.23 6 15209 VEV_3_3_RA6_01_1237.d 1.46E5 1 1 1846 1859 Deoxy
K.GLS(-18.01)GGR.L Y 16.86 527.2816 6 11.2 528.2947 1 12.98 4 3797 VEV_1_3_RA4_01_1235.d 0 1 1 1382 1387 Dehydration
K.EFVGGNGVVK(+31.99).G Y 16.72 1036.5189 10 -12.7 519.2601 2 62.83 4 33626 VEV_1_3_RA4_01_1235.d 0 1 1 1979 1988 Dihydroxy
K.ASVDGGILKVMS(+79.97)K(+42.01).M Y 16.48 1425.6938 13 13.4 476.2449 3 53.50 5 27300 VEV_2_3_RA5_01_1236.d 0 1 1 772 784 Phosphorylation (STY); Acetylation (K)
R.RVDFM(+15.99)AAEGVK.F Y 16.46 1237.6124 11 -20.0 619.8011 2 49.17 5 24651 VEV_2_3_RA5_01_1236.d 0 1 1 1814 1824 Oxidation (M)
R.TKNDK(+14.02)SYEAYAR(+14.02).S Y 16.39 1472.7260 12 4.2 369.1903 4 45.48 4 22063 VEV_1_3_RA4_01_1235.d 0 1 1 882 893 Methylation(KR)
R.AREGVLR(+31.99).S Y 16.29 831.4562 7 0.3 832.4637 1 80.26 4 47216 VEV_1_3_RA4_01_1235.d 0 1 1 309 315 Dihydroxy
K.AE(+14.02)FSLPFSSGNPAK.K Y 16.29 1464.7249 14 -11.7 489.2432 3 17.64 6 6318 VEV_3_3_RA6_01_1237.d 1.11E4 1 1 1562 1575 Methylation(others)
K.QIASGR(+31.99)FGVTSNYLADADELQIK(+42.01).M Y 16.25 2569.2659 23 -11.3 643.3165 4 85.40 5 49399 VEV_2_3_RA5_01_1236.d 0 1 1 989 1011 Dihydroxy; Acetylation (K)
K.K(+14.02)SDILDIEDTISDLK(+28.03).T Y 16.12 1745.9298 15 5.2 350.1951 5 51.73 5 26267 VEV_2_3_RA5_01_1236.d 7.53E4 1 1 1590 1604 Methylation(KR); Dimethylation(KR)
K.TIDITFEK(+43.01)VK.G Y 16.10 1235.6761 10 -15.9 309.9214 4 39.76 5 18979 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 641 650 Carbamylation
K.K(+42.01)LSDEKIIENYK.A Y 16.09 1520.8086 12 9.3 381.2130 4 58.23 5 30267 VEV_2_3_RA5_01_1236.d 0 1 1 760 771 Acetylation (N-term)
R.LLM(+15.99)TNNFPEFTGR.V Y 16.09 1554.7500 13 -10.9 778.3738 2 76.05 6 42314 VEV_3_3_RA6_01_1237.d 2.56E4 1 1 1698 1710 Oxidation (M)
R.GVAAER(-.98).F Y 15.94 600.3344 6 -13.1 301.1705 2 26.25 6 10863 VEV_3_3_RA6_01_1237.d 0 1 1 1423 1428 Amidation
K.T(+42.01)IDIT(+79.97)FEKVK(+42.01).G Y 15.87 1356.6577 10 21.6 340.1790 4 49.87 4 24798 VEV_1_3_RA4_01_1235.d 0 1 1 641 650 Acetylation (N-term); Phosphorylation (STY); Acetylation (K)
K.M(+42.01)LLVD(+43.99)TIAGR.I Y 15.82 1173.6063 10 -4.6 392.2076 3 25.16 5 10574 VEV_2_3_RA5_01_1236.d 0 1 1 454 463 Acetylation (N-term); Carboxylation (DKW)
K.L(+42.01)IAESELALEK(+43.01).G Y 15.76 1299.6921 11 -17.3 434.2305 3 72.63 5 40923 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 1298 1308 Acetylation (N-term); Carbamylation
R.V(+42.01)LGWR.D Y 15.68 671.3755 5 16.6 336.7006 2 55.47 4 28310 VEV_1_3_RA4_01_1235.d 7.34E5 1 1 155 159 Acetylation (N-term)
K.ADHILISGHD(+43.99)GGTGASR.W Y 15.67 1706.7972 17 -25.3 854.3843 2 73.56 5 41582 VEV_2_3_RA5_01_1236.d 3.77E5 2 2 1098 1114 Carboxylation (DKW)
R.W(+71.04)AAHNGEINTLR.G Y 15.60 1451.7269 12 18.0 363.9456 4 43.38 5 21136 VEV_2_3_RA5_01_1236.d 1.49E5 1 1 290 301 Propionamide (K, X@N-term)
R.F(+42.01)GVTSNYLADADELQ(+.98)IK(+42.01).M Y 15.59 1967.9364 17 -38.4 656.9609 3 46.71 5 23153 VEV_2_3_RA5_01_1236.d 3.96E4 1 1 995 1011 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
R.ILLDFT(+79.97)R.A Y 15.48 956.4732 7 -27.7 957.4540 1 88.41 5 51064 VEV_2_3_RA5_01_1236.d 4.87E4 1 1 1526 1532 Phosphorylation (STY)
K.ASVDGGILK(-.98).V Y 15.48 857.4970 9 -14.8 429.7494 2 11.46 5 3180 VEV_2_3_RA5_01_1236.d 2.53E4 1 1 772 780 Amidation
K.E(-18.01)FVGGNGVVK.G Y 15.46 986.5185 10 -30.7 494.2514 2 57.42 4 29600 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 1979 1988 Pyro-glu from E
R.AQPLRWAAHNGEINT(+79.97)LR.G Y 15.40 2025.9897 17 -7.3 406.2023 5 49.05 5 24582 VEV_2_3_RA5_01_1236.d 1.24E4 1 1 285 301 Phosphorylation (STY)
R.ATSANR.V Y 15.35 618.3085 6 -12.5 619.3081 1 108.65 4 60766 VEV_1_3_RA4_01_1235.d 7.74E4 1 1 683 688
R.NDAVVIAT(+79.97)GATVAR.D Y 15.26 1436.7024 14 5.7 360.1849 4 20.88 4 7884 VEV_1_3_RA4_01_1235.d 2.71E5 1 1 1846 1859 Phosphorylation (STY)
K.AE(+28.03)FSLPFSSGNPAK.K Y 15.22 1478.7405 14 2.2 370.6932 4 36.64 4 16724 VEV_1_3_RA4_01_1235.d 3.89E5 1 1 1562 1575 Ethylation
K.GFM(+15.99)KYQRRSEK.Y Y 15.19 1444.7245 11 -20.9 362.1808 4 28.27 6 11915 VEV_3_3_RA6_01_1237.d 0 1 1 1619 1629 Oxidation (M)
R.A(+42.01)DRIGGLLMYGIPNMK(+14.02).L Y 15.17 1803.9375 16 19.7 452.0005 4 58.36 5 30352 VEV_2_3_RA5_01_1236.d 0 1 1 1790 1805 Acetylation (N-term); Methylation(KR)
R.VIVQTDGQ(+.98)LR(+31.99).T Y 15.15 1160.6036 10 -27.6 581.2931 2 70.45 6 38196 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 1145 1154 Deamidation (NQ); Dihydroxy
K.YQS(+60.00)AR.C Y 15.14 683.3061 5 11.9 684.3215 1 78.02 4 45494 VEV_1_3_RA4_01_1235.d 0 1 1 1654 1658 2-OH-ethyl thio-Ser
R.V(+42.01)DYGHTEVK(+42.01)THMGK.D Y 15.12 1684.7878 14 4.2 422.2060 4 40.43 5 19372 VEV_2_3_RA5_01_1236.d 0 1 1 1955 1968 Acetylation (N-term); Acetylation (K)
R.A(+43.01)QAVGA Y 15.05 558.2761 6 7.5 559.2876 1 45.99 4 22382 VEV_1_3_RA4_01_1235.d 0 1 1 2120 2125 Carbamylation
total 195 peptides
C1GMU5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IVRPDATDAEVKEAVQDPSNQQIFSQALIQSDR.R Y 146.93 3667.8440 33 -8.4 734.5699 5 78.66 6 44188 VEV_3_3_RA6_01_1237.d 4E5 3 3 165 197
K.EAVQDPSNQQIFSQALIQSDR.R Y 133.49 2373.1560 21 -6.9 1187.5771 2 78.16 4 45600 VEV_1_3_RA4_01_1235.d 7.18E5 6 6 177 197
R.GIDDVDGYIEQIKGLYR.R Y 132.56 1952.9843 17 -12.1 651.9941 3 84.08 6 47883 VEV_3_3_RA6_01_1237.d 8.83E5 7 7 60 76
R.GIDDVDGYIEQIKGLYRR.L Y 118.73 2109.0854 18 -11.5 528.2726 4 81.75 5 47210 VEV_2_3_RA5_01_1236.d 1.63E6 7 7 60 77
R.DLLELAQMFQDLDTLVVQQEAAVER.I Y 110.19 2873.4480 25 -5.6 958.8179 3 97.92 4 57521 VEV_1_3_RA4_01_1235.d 0 2 2 221 245
R.IDQQAEDVNANMQK.G Y 103.27 1602.7307 14 -7.9 802.3663 2 45.71 4 22241 VEV_1_3_RA4_01_1235.d 1.03E6 10 10 246 259
R.GIDDVDGYIEQIK.G Y 102.78 1463.7144 13 -6.9 732.8594 2 78.92 4 46181 VEV_1_3_RA4_01_1235.d 5.95E5 4 4 60 72
K.Q(-17.03)SPGSGETMNTAQIGKVER.R Y 100.13 1971.9320 19 -11.4 986.9620 2 64.10 5 34600 VEV_2_3_RA5_01_1236.d 3.78E5 4 4 117 135 Pyro-glu from Q
R.DIERGIDDVDGYIEQIKGLYR.R Y 97.32 2466.2390 21 -6.8 617.5629 4 85.36 5 49377 VEV_2_3_RA5_01_1236.d 1.61E5 2 2 56 76
R.AEADELASETKR.L Y 92.75 1318.6365 12 -8.9 660.3196 2 34.27 5 15775 VEV_2_3_RA5_01_1236.d 1.96E6 12 12 92 103
R.DIERGIDDVDGYIEQIKGLYRR.L Y 92.54 2622.3401 22 -10.6 656.5853 4 83.31 5 48144 VEV_2_3_RA5_01_1236.d 7.32E4 1 1 56 77
K.Q(-17.03)SPGSGETMNTAQIGK.V Y 87.56 1587.7198 16 -11.8 794.8578 2 63.03 6 32654 VEV_3_3_RA6_01_1237.d 2.07E5 3 3 117 132 Pyro-glu from Q
R.IVRPDATDAEVK.E Y 87.37 1312.6986 12 -12.4 438.5681 3 42.71 4 20354 VEV_1_3_RA4_01_1235.d 2.89E6 14 14 165 176
K.AIKQSPGSGETMNTAQIGKVER.R Y 87.00 2301.1746 22 -2.3 768.0637 3 54.41 5 27844 VEV_2_3_RA5_01_1236.d 3.84E4 1 1 114 135
R.LLSDADPARENAIR.A Y 86.18 1539.8004 14 -17.4 514.2651 3 58.50 6 29403 VEV_3_3_RA6_01_1237.d 1.29E6 7 7 78 91
R.AEADELASETKRLYQNLIQR.M Y 80.98 2347.2131 20 -6.7 587.8066 4 81.46 5 47001 VEV_2_3_RA5_01_1236.d 3.44E5 3 3 92 111
R.RLLSDADPARENAIR.A Y 80.82 1695.9016 15 -21.9 424.9734 4 57.61 5 29844 VEV_2_3_RA5_01_1236.d 2.37E5 1 1 77 91
R.LLSDADPARENAIRAEADELASETKR.L Y 80.28 2840.4263 26 -21.1 711.0989 4 74.18 6 40948 VEV_3_3_RA6_01_1237.d 1.15E6 5 5 78 103
K.GNEEITGAIAK.A Y 78.27 1101.5665 11 -15.0 551.7823 2 48.69 6 23546 VEV_3_3_RA6_01_1237.d 1.37E6 7 7 260 270
R.LKAAITNYQR.V Y 76.65 1176.6615 10 -15.8 393.2216 3 39.74 5 18966 VEV_2_3_RA5_01_1236.d 2.1E6 14 14 137 146
K.RLYQNLIQR.M Y 73.98 1202.6884 9 -14.5 401.8976 3 59.48 5 31170 VEV_2_3_RA5_01_1236.d 3.48E5 3 3 103 111
K.Q(-17.03)SPGSGETM(+15.99)NTAQIGKVER.R Y 73.85 1987.9269 19 -10.8 994.9600 2 57.51 6 28703 VEV_3_3_RA6_01_1237.d 1.48E5 2 2 117 135 Pyro-glu from Q; Oxidation (M)
R.ARHDEILKIER.D Y 71.79 1378.7681 11 -14.8 460.5898 3 41.43 6 19315 VEV_3_3_RA6_01_1237.d 9.72E5 8 8 210 220
R.RGDAQKVSQIVR.A Y 71.33 1355.7633 12 -12.9 452.9225 3 33.10 5 15061 VEV_2_3_RA5_01_1236.d 7.83E5 7 7 198 209
R.DIERGIDDVDGYIEQIK.G Y 71.02 1976.9690 17 -16.3 659.9862 3 81.02 6 45871 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 56 72
K.AIKQSPGSGETMNTAQIGK.V Y 70.12 1916.9625 19 -3.9 639.9923 3 47.20 6 22674 VEV_3_3_RA6_01_1237.d 4.23E4 1 1 114 132
R.LYQNLIQR.M Y 69.92 1046.5873 8 -12.9 524.2942 2 62.40 5 33331 VEV_2_3_RA5_01_1236.d 1.76E6 6 6 104 111
R.IDQQAEDVNANMQKGNEEITGAIAK.A Y 68.47 2686.2869 25 -8.9 896.4283 3 69.83 5 38870 VEV_2_3_RA5_01_1236.d 5.94E4 1 1 246 270
K.QSPGSGETMNTAQIGK.V Y 67.06 1604.7465 16 -10.4 803.3722 2 47.94 5 23888 VEV_2_3_RA5_01_1236.d 1.34E5 3 3 117 132
K.EAVQDPSNQQIFSQALIQSDRRGDAQKVSQIVR.A Y 60.50 3710.9087 33 -24.7 743.1707 5 75.34 4 43398 VEV_1_3_RA4_01_1235.d 0 1 1 177 209
K.QSPGSGETMNTAQIGKVER.R Y 60.33 1988.9585 19 -5.8 663.9896 3 56.20 4 28763 VEV_1_3_RA4_01_1235.d 3.29E5 3 3 117 135
R.LLSDADPAR.E Y 60.08 956.4927 9 -7.7 479.2499 2 42.64 4 20311 VEV_1_3_RA4_01_1235.d 1.41E6 6 6 78 86
K.E(+14.02)AVQDPSNQQIFSQALIQSDR.R Y 59.36 2387.1716 21 -13.4 796.7205 3 78.75 6 44264 VEV_3_3_RA6_01_1237.d 5.57E4 1 1 177 197 Methylation(others)
R.HAILNQC(+57.02)R.D Y 58.71 1010.5080 8 -13.7 506.2543 2 20.80 5 8172 VEV_2_3_RA5_01_1236.d 4.49E5 6 6 48 55 Carbamidomethylation
K.Q(-17.03)SPGSGETM(+15.99)NTAQIGKVERR.L Y 58.36 2144.0281 20 -13.8 715.6735 3 50.68 6 24686 VEV_3_3_RA6_01_1237.d 1.29E5 3 3 117 136 Pyro-glu from Q; Oxidation (M)
R.DLLELAQM(+15.99)FQDLDTLVVQQEAAVER.I Y 56.31 2889.4429 25 -5.3 964.1498 3 97.72 4 57447 VEV_1_3_RA4_01_1235.d 8.6E4 1 1 221 245 Oxidation (M)
K.AAITNYQR.V Y 55.67 935.4825 8 -9.4 468.7441 2 28.55 4 12038 VEV_1_3_RA4_01_1235.d 1.63E6 7 7 139 146
R.IDQQAEDVNANMQ(+.98)K.G Y 55.46 1603.7147 14 -14.8 802.8528 2 48.34 6 23341 VEV_3_3_RA6_01_1237.d 3.98E4 2 2 246 259 Deamidation (NQ)
R.GIDDVDGYIE(+14.02)QIKGLYR.R Y 55.44 1967.0000 17 -17.5 656.6625 3 83.88 5 48503 VEV_2_3_RA5_01_1236.d 2.54E5 3 3 60 76 Methylation(others)
R.IDQQAEDVNANM(+15.99)QK.G Y 52.50 1618.7257 14 -12.2 810.3602 2 31.00 6 13429 VEV_3_3_RA6_01_1237.d 3.62E5 5 5 246 259 Oxidation (M)
K.GNE(+14.02)EITGAIAK.A Y 52.05 1115.5823 11 -13.0 558.7911 2 56.99 6 28356 VEV_3_3_RA6_01_1237.d 1.79E5 2 2 260 270 Methylation(others)
R.AEADELASETK(+14.02)R.L Y 45.79 1332.6521 12 -15.9 667.3228 2 41.17 6 19167 VEV_3_3_RA6_01_1237.d 1.24E5 4 4 92 103 Methylation(KR)
R.LYQNLIQ(+.98)R.M Y 44.93 1047.5713 8 -11.7 524.7868 2 63.68 5 34296 VEV_2_3_RA5_01_1236.d 2.57E5 2 2 104 111 Deamidation (NQ)
R.VQSDFRKGLEAQMAR.Q Y 44.92 1734.8835 15 4.5 434.7301 4 60.29 5 31760 VEV_2_3_RA5_01_1236.d 2.49E4 2 2 147 161
R.VQSDFRK.G Y 42.82 878.4610 7 -15.5 440.2310 2 13.49 5 4245 VEV_2_3_RA5_01_1236.d 2.66E5 2 2 147 153
R.LLSDADPAR(+.98)ENAIR.A Y 42.74 1540.7844 14 -0.2 514.6020 3 58.63 5 30549 VEV_2_3_RA5_01_1236.d 9.82E4 1 1 78 91 Deamidation (R)
K.Q(-17.03)SPGSGETMNTAQIGKVERR.L Y 41.49 2128.0332 20 -10.6 710.3442 3 60.27 5 31752 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 117 136 Pyro-glu from Q
R.HAILNQC(+57.02)RDIER.G Y 41.16 1523.7627 12 -34.6 381.9348 4 39.90 5 19053 VEV_2_3_RA5_01_1236.d 8.9E5 5 5 48 59 Carbamidomethylation
K.QSPGSGETM(+15.99)NTAQIGK.V Y 41.01 1620.7413 16 -13.0 811.3674 2 32.49 6 14238 VEV_3_3_RA6_01_1237.d 1.24E5 2 2 117 132 Oxidation (M)
K.GLEAQM(+15.99)AR.Q Y 39.25 890.4280 8 -3.0 446.2199 2 17.77 4 6275 VEV_1_3_RA4_01_1235.d 2.67E5 3 3 154 161 Oxidation (M)
R.AEADELASETK.R Y 38.80 1162.5353 11 5.1 582.2779 2 37.04 4 16957 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 92 102
R.DIERGIDDVDGY(-2.02)IEQIKGLYRR.L Y 37.79 2620.3245 22 -16.4 525.0636 5 83.31 5 48139 VEV_2_3_RA5_01_1236.d 0 1 1 56 77 2-amino-3-oxo-butanoic_acid
R.AEADE(+14.02)LASETKR.L Y 36.88 1332.6521 12 -9.7 667.3268 2 40.24 5 19253 VEV_2_3_RA5_01_1236.d 3.1E5 3 3 92 103 Methylation(others)
R.GIDDVDGYIEQIK(+14.02)GLYRR.L Y 35.14 2123.1011 18 -19.7 531.7721 4 81.92 5 47296 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 60 77 Methylation(KR)
K.AAITNYQ(+.98)R.V Y 31.88 936.4665 8 -18.5 469.2319 2 32.96 6 14515 VEV_3_3_RA6_01_1237.d 8.99E4 1 1 139 146 Deamidation (NQ)
R.ENAIRAEADELASETKR.L Y 28.95 1901.9442 17 -3.3 476.4918 4 66.35 6 35145 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 87 103
K.VSQIVR.A Y 28.03 700.4232 6 -20.9 351.2115 2 20.54 6 7841 VEV_3_3_RA6_01_1237.d 4.14E5 3 3 204 209
R.D(+56.06)LLELAQMFQDLDTLVVQQEAAVER.I Y 27.29 2929.5105 25 -23.9 733.3674 4 93.07 6 52792 VEV_3_3_RA6_01_1237.d 0 1 1 221 245 Diethylation
K.QS(-20.03)PGSGETMNTAQIGKVER.R Y 26.78 1968.9324 19 21.2 657.3320 3 64.17 6 33492 VEV_3_3_RA6_01_1237.d 1.89E4 1 1 117 135 Formation of five membered aromatic heterocycle
K.GLEAQMAR(+14.02).Q Y 26.69 888.4487 8 -9.7 445.2273 2 47.67 5 23734 VEV_2_3_RA5_01_1236.d 1.94E5 1 1 154 161 Methylation(KR)
R.LYQ(+.98)NLIQR.M Y 26.63 1047.5713 8 -15.1 524.7850 2 65.11 6 34200 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 104 111 Deamidation (NQ)
R.IDQ(+.98)QAEDVNANMQ(+.98)K.G Y 26.48 1604.6989 14 10.9 803.3655 2 48.68 4 24045 VEV_1_3_RA4_01_1235.d 7.32E4 1 1 246 259 Deamidation (NQ)
R.GIDDVDGYIEQIKGLYR(+14.02)R.L Y 26.27 2123.1011 18 -17.6 531.7732 4 81.91 6 46485 VEV_3_3_RA6_01_1237.d 9.12E4 1 1 60 77 Methylation(KR)
R.LKAAITNYQR(+14.02).V Y 25.82 1190.6771 10 -56.1 596.3124 2 44.68 5 21944 VEV_2_3_RA5_01_1236.d 0 1 1 137 146 Methylation(KR)
R.D(+42.01)LLELAQMFQDLD(+21.98)TLVVQQEAAVER.I Y 25.08 2937.4404 25 -11.3 980.1431 3 93.15 6 52828 VEV_3_3_RA6_01_1237.d 0 1 1 221 245 Acetylation (N-term); Sodium adduct
R.IVRPDATDAEVKEAVQDPSNQQIFSQALIQSDRRGDAQK(+264.19).V Y 24.87 4587.3721 39 -28.5 918.4555 5 78.64 6 44175 VEV_3_3_RA6_01_1237.d 0 1 1 165 203 Didehydroretinylidene
R.VQSDFR.K Y 24.13 750.3660 6 -19.3 376.1830 2 19.71 6 7413 VEV_3_3_RA6_01_1237.d 0 1 1 147 152
K.EAVQDPSNQQIFSQ(+.98)ALIQSDR.R Y 24.12 2374.1401 21 -2.5 792.3854 3 79.26 4 46442 VEV_1_3_RA4_01_1235.d 2.43E5 1 1 177 197 Deamidation (NQ)
R.KGLEAQMAR.Q Y 24.07 1002.5280 9 -36.0 502.2532 2 26.25 5 11193 VEV_2_3_RA5_01_1236.d 0 1 1 153 161
R.LLSDADPARENAIRAEADELASETK.R Y 23.96 2684.3252 25 -47.2 672.0569 4 76.10 6 42343 VEV_3_3_RA6_01_1237.d 0 1 1 78 102
K.GNEE(+14.02)ITGAIAK.A Y 23.54 1115.5823 11 -1.2 558.7977 2 56.82 4 29179 VEV_1_3_RA4_01_1235.d 1.43E5 2 2 260 270 Methylation(others)
K.EAVQDPSN(+.98)Q(+.98)Q(+.98)IFSQALIQSDR.R Y 23.36 2376.1082 21 -7.7 793.0372 3 77.99 6 43719 VEV_3_3_RA6_01_1237.d 4.38E4 1 1 177 197 Deamidation (NQ)
R.VQSDFR(+14.02)K.G Y 23.24 892.4766 7 -16.6 447.2382 2 18.50 5 6922 VEV_2_3_RA5_01_1236.d 4.35E4 1 1 147 153 Methylation(KR)
R.IVRPDATDAE(+14.02)VK.E Y 22.88 1326.7142 12 -32.8 664.3427 2 50.03 4 24904 VEV_1_3_RA4_01_1235.d 0 1 1 165 176 Methylation(others)
R.HAILN(+.98)QC(+57.02)R.D Y 22.61 1011.4920 8 -2.0 338.1706 3 21.06 4 7961 VEV_1_3_RA4_01_1235.d 6.14E5 1 1 48 55 Deamidation (NQ); Carbamidomethylation
R.IDQQAEDVNANMQK(+14.02).G Y 22.09 1616.7465 14 20.1 539.9336 3 30.93 5 13789 VEV_2_3_RA5_01_1236.d 1.52E5 1 1 246 259 Methylation(KR)
R.R(+42.01)(+14.02)LLSDADPAR.E Y 21.14 1168.6200 10 -28.9 390.5360 3 48.72 5 24369 VEV_2_3_RA5_01_1236.d 0 1 1 77 86 Acetylation (N-term); Methylation(KR)
R.H(+42.01)AILNQC(+57.02)R.D Y 21.08 1052.5186 8 27.3 351.8564 3 20.94 6 8071 VEV_3_3_RA6_01_1237.d 0 1 1 48 55 Acetylation (N-term); Carbamidomethylation
K.GNEEITGAIAKAR.A Y 20.76 1328.7048 13 -15.7 333.1783 4 30.53 6 13156 VEV_3_3_RA6_01_1237.d 0 1 1 260 272
R.HDEILKIER.D Y 19.52 1151.6299 9 -12.8 384.8790 3 45.37 6 21623 VEV_3_3_RA6_01_1237.d 8.72E4 1 1 212 220
R.RGDAQK(-1.03)VSQIVR.A Y 19.50 1354.7317 12 -29.5 452.5712 3 33.51 5 15292 VEV_2_3_RA5_01_1236.d 2.2E6 1 1 198 209 Lysine oxidation to aminoadipic semialdehyde
R.RLLSDAD(-18.01)PAR(+14.02)ENAIR.A Y 19.45 1691.9066 15 -34.7 423.9693 4 57.60 5 29837 VEV_2_3_RA5_01_1236.d 1.62E5 1 1 77 91 Dehydration; Methylation(KR)
R.LLVMGYVQSGGDR.H Y 18.97 1393.7024 13 2.2 1394.7128 1 91.21 6 51931 VEV_3_3_RA6_01_1237.d 6.16E3 1 1 35 47
K.GN(+.98)EEITGAIAK.A Y 18.84 1102.5505 11 -29.8 552.2661 2 49.58 5 24903 VEV_2_3_RA5_01_1236.d 0 1 1 260 270 Deamidation (NQ)
K.AAITNYQR(+31.99).V Y 18.31 967.4723 8 23.6 484.7548 2 64.73 5 35069 VEV_2_3_RA5_01_1236.d 1.43E5 1 1 139 146 Dihydroxy
K.GLEAQMAR(+37.03).Q Y 18.09 911.4647 8 -20.7 912.4531 1 93.55 4 55585 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 154 161 Propargylamine
R.IVRPDATDAEVK(+14.02).E Y 17.53 1326.7142 12 -54.4 443.2213 3 49.64 6 24095 VEV_3_3_RA6_01_1237.d 0 1 1 165 176 Methylation(KR)
K.GNEEITGAIAK(+14.02).A Y 17.43 1115.5823 11 -18.6 1116.5688 1 88.11 5 50899 VEV_2_3_RA5_01_1236.d 2.11E5 1 1 260 270 Methylation(KR)
R.MKAIK(+31.99).Q Y 17.07 621.3520 5 -22.8 311.6762 2 24.76 5 10348 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 112 116 Dihydroxy
K.EAVQDPSNQQIFSQALIQSD(+45.99)R.R Y 16.20 2419.1438 21 -34.4 605.7724 4 12.58 5 3742 VEV_2_3_RA5_01_1236.d 4.75E5 1 1 177 197 Beta-methylthiolation (ND)
R.LLSDADPARE(+43.99)NAIR.A Y 16.01 1583.7903 14 -8.1 528.9331 3 60.86 5 32187 VEV_2_3_RA5_01_1236.d 9.05E4 1 1 78 91 Carboxylation (E)
R.L(+42.01)LSDADPARENAIR.A Y 15.84 1581.8110 14 -37.6 528.2578 3 58.59 5 30526 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 78 91 Acetylation (N-term)
R.G(+42.01)DAQK.V Y 15.44 559.2602 5 4.6 560.2700 1 98.71 6 54887 VEV_3_3_RA6_01_1237.d 4.35E3 1 1 199 203 Acetylation (N-term)
R.IDQQAEDVNANMQK(+54.01).G Y 15.43 1656.7413 14 2.2 553.2556 3 19.74 4 7265 VEV_1_3_RA4_01_1235.d 8.39E3 1 1 246 259 MDA adduct +54
R.IVR(+14.02)PD(-18.01)ATDAEVK.E Y 15.25 1308.7037 12 -6.1 437.2392 3 42.45 4 20193 VEV_1_3_RA4_01_1235.d 6.87E4 1 1 165 176 Methylation(KR); Dehydration
R.ENAIR.A N 15.05 601.3184 5 -18.3 602.3146 1 83.85 6 47730 VEV_3_3_RA6_01_1237.d 0 1 1 87 91
total 96 peptides
C1GIX7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VAPAAPKEESTPAAEEEPVSTGER.L Y 148.23 2451.1765 24 -10.0 818.0580 3 56.92 6 28333 VEV_3_3_RA6_01_1237.d 1.94E6 8 8 196 219
K.LKPEEYIGGTFTISNMGMNHAVER.F Y 130.77 2693.2942 24 -7.8 674.3256 4 77.56 4 45132 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 414 437
R.FTAVINPPQSAILAVGTTR.K Y 128.98 1955.0840 19 -14.6 978.5350 2 81.13 6 45992 VEV_3_3_RA6_01_1237.d 1.01E6 4 4 438 456
R.NAHTLGLSSISSQIKDLGK.R Y 128.15 1968.0640 19 -7.2 493.0197 4 74.09 4 42422 VEV_1_3_RA4_01_1235.d 6.23E5 3 3 389 407
R.ENPHYFVTSNLSVTK.L Y 126.42 1734.8577 15 -10.6 579.2870 3 67.52 4 37256 VEV_1_3_RA4_01_1235.d 6.17E5 5 5 299 313
R.NAHTLGLSSISSQIKDLGKR.A Y 121.01 2124.1650 20 -9.4 532.0435 4 71.11 5 39800 VEV_2_3_RA5_01_1236.d 1.65E6 8 8 389 408
K.YQPAGTAVSGPPYEDIPASSMR.K Y 110.99 2293.0684 22 -4.7 1147.5360 2 74.70 4 42896 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 265 286
K.VPAVNSSWVEENGQVVIR.Q Y 101.26 1982.0221 18 -8.5 992.0099 2 77.30 4 44932 VEV_1_3_RA4_01_1235.d 2.41E4 1 1 348 365
K.NDVEKYQPAGTAVSGPPYEDIPASSMR.K Y 99.63 2878.3442 27 -0.7 960.4547 3 73.56 4 42020 VEV_1_3_RA4_01_1235.d 1.65E5 1 1 260 286
R.NAHTLGLSSISSQIK.D Y 97.73 1554.8365 15 -9.3 519.2813 3 67.29 4 37069 VEV_1_3_RA4_01_1235.d 7.52E5 3 3 389 403
K.EESTPAAEEEPVSTGER.L Y 94.54 1816.7963 17 -11.4 909.3950 2 48.72 6 23571 VEV_3_3_RA6_01_1237.d 2.29E5 3 3 203 219
R.FTAVINPPQSAILAVGTTRK.V Y 92.98 2083.1790 20 -22.6 695.3846 3 77.35 6 43288 VEV_3_3_RA6_01_1237.d 2.25E5 5 5 438 457
R.LLQSMRENPHYFVTSNLSVTK.L Y 87.63 2463.2581 21 -8.5 822.0863 3 72.48 5 40818 VEV_2_3_RA5_01_1236.d 6.49E4 1 1 293 313
K.VAPAAPKEESTPAAEEEPVSTGER(+14.02).L Y 87.29 2465.1921 24 -8.0 822.7314 3 59.81 4 31340 VEV_1_3_RA4_01_1235.d 2.56E5 5 5 196 219 Methylation(KR)
K.YQPAGTAVSGPPYEDIPASSMRK.T Y 87.14 2421.1633 23 -11.0 808.0529 3 69.03 6 37144 VEV_3_3_RA6_01_1237.d 5.54E5 3 3 265 287
R.ELKQIVENPLELLL Y 85.11 1649.9603 14 -8.2 825.9807 2 92.88 4 55253 VEV_1_3_RA4_01_1235.d 1.31E6 5 5 498 511
K.Q(-17.03)IVENPLELLL Y 80.14 1262.7122 11 -18.9 1263.6956 1 98.84 6 54927 VEV_3_3_RA6_01_1237.d 1.95E5 5 5 501 511 Pyro-glu from Q
K.QIVENPLELLL Y 76.46 1279.7388 11 -14.9 1280.7269 1 96.56 6 54183 VEV_3_3_RA6_01_1237.d 3E5 6 6 501 511
R.LQPSLDRESFIAPAVK.A Y 74.86 1769.9675 16 -7.8 885.9841 2 71.63 4 40506 VEV_1_3_RA4_01_1235.d 2.28E6 10 10 220 235
R.NAHTLGLSSISSQ(+.98)IKDLGKR.A Y 71.99 2125.1492 20 -6.6 426.0343 5 71.18 5 39864 VEV_2_3_RA5_01_1236.d 1.83E5 2 2 389 408 Deamidation (NQ)
K.VAPAAPKEESTPAAE(+14.02)EEPVSTGER.L Y 70.97 2465.1921 24 -8.1 822.7313 3 60.34 4 31798 VEV_1_3_RA4_01_1235.d 7.13E5 3 3 196 219 Methylation(others)
K.VAPAAPKEESTPAAEEE(+14.02)PVSTGER.L Y 70.67 2465.1921 24 -7.5 1233.5941 2 60.52 4 31876 VEV_1_3_RA4_01_1235.d 5.66E4 1 1 196 219 Methylation(others)
R.GVPLKDIKGTGPGGR.V Y 68.24 1450.8256 15 -21.1 726.4047 2 41.80 6 19539 VEV_3_3_RA6_01_1237.d 7.01E5 7 7 242 256
K.TADISIAVATSVGLITPIVR.N Y 67.22 1996.1567 20 -16.9 666.3816 3 90.57 5 52175 VEV_2_3_RA5_01_1236.d 1.26E5 3 3 369 388
K.IVDGAVGAEWMR.E Y 66.31 1302.6390 12 -7.0 652.3222 2 73.01 4 41586 VEV_1_3_RA4_01_1235.d 5.66E5 4 4 486 497
K.LREALNTSANGK.Y Y 60.52 1272.6786 12 -18.4 425.2256 3 26.34 6 10906 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 317 328
K.Q(-17.03)PEQPKEELK.V Y 60.31 1207.6084 10 -11.8 604.8043 2 41.79 6 19576 VEV_3_3_RA6_01_1237.d 2.83E5 3 3 186 195 Pyro-glu from Q
K.YQPAGTAVSGPPYEDIPASSM(+15.99)RK.T Y 59.24 2437.1582 23 -3.5 813.3905 3 66.01 4 36073 VEV_1_3_RA4_01_1235.d 7.48E4 1 1 265 287 Oxidation (M)
R.VTKNDVEKYQPAGTAVSGPPYEDIPASSMR.K Y 59.14 3206.5554 30 33.0 802.6725 4 71.31 4 40251 VEV_1_3_RA4_01_1235.d 0 1 1 257 286
K.YKLSVNDFLVK.A Y 56.88 1324.7390 11 -20.5 442.5779 3 75.91 6 42214 VEV_3_3_RA6_01_1237.d 1.72E5 3 3 329 339
K.AC(+57.02)AVALLK.V Y 53.41 844.4840 8 -19.5 423.2411 2 58.61 6 29444 VEV_3_3_RA6_01_1237.d 4.94E5 2 2 340 347 Carbamidomethylation
K.LSVNDFLVK.A Y 52.84 1033.5808 9 -9.9 517.7925 2 78.81 4 46100 VEV_1_3_RA4_01_1235.d 3.49E5 3 3 331 339
K.AC(+57.02)AVALLKVPAVNSSWVEENGQVVIR.Q Y 51.26 2808.4956 26 -13.7 937.1597 3 83.10 4 49287 VEV_1_3_RA4_01_1235.d 1.78E4 1 1 340 365 Carbamidomethylation
K.VAIPVEGEDSTSVK.W Y 50.32 1429.7300 14 -5.7 715.8682 2 63.14 4 33865 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 458 471
R.VTKNDVEK(+14.02)Y(-18.01)QPAGTAVSGPPYEDIPASSMRK.T Y 49.80 3330.6553 31 -20.3 667.1248 5 68.15 4 37755 VEV_1_3_RA4_01_1235.d 0 1 1 257 287 Methylation(KR); Dehydration
R.ENPHYFVTSNLSVTK(+14.02).L Y 48.03 1748.8733 15 2.6 583.9666 3 69.31 4 38675 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 299 313 Methylation(KR)
K.VAPAAPKEESTPAAEE(+14.02)EPVSTGER.L Y 44.45 2465.1921 24 -11.3 822.7287 3 60.54 6 30825 VEV_3_3_RA6_01_1237.d 2.14E5 1 1 196 219 Methylation(others)
K.SYPPHTIISMPALSPTMTAGNIGAWQK.K Y 44.25 2868.4302 27 -10.8 957.1404 3 83.09 4 49283 VEV_1_3_RA4_01_1235.d 9.68E4 1 1 79 105
R.ELKQIVE(+14.02)NPLELLL Y 43.15 1663.9760 14 -8.2 832.9885 2 94.07 5 53826 VEV_2_3_RA5_01_1236.d 2.59E5 3 3 498 511 Methylation(others)
R.E(+6.01)NPHYFVTSNLSVTK.L Y 42.03 1740.8658 15 -10.8 581.2896 3 67.65 4 37373 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 299 313 Replacement of proton by lithium
K.VAPAAPKEES(+164.06)TPAAEEEPVSTGER.L Y 38.84 2615.2366 24 -6.7 872.7469 3 55.03 6 27195 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 196 219 O-Diisopropylphosphorylation
K.ALALER.G Y 37.66 671.3966 6 -14.2 336.7008 2 35.23 5 16299 VEV_2_3_RA5_01_1236.d 1.32E6 8 8 236 241
R.KVAIPVEGEDSTSVK.W Y 36.66 1557.8250 15 -14.6 520.2747 3 57.06 4 29343 VEV_1_3_RA4_01_1235.d 1.25E5 2 2 457 471
R.ELK(+14.02)QIVENPLELLL Y 35.61 1663.9760 14 8.9 833.0027 2 92.04 5 52902 VEV_2_3_RA5_01_1236.d 4.76E4 2 2 498 511 Methylation(KR)
R.NAHTLGLS(-18.01)SISSQIK(+14.02)DLGK.R Y 35.52 1964.0691 19 -42.7 492.0036 4 74.18 6 40945 VEV_3_3_RA6_01_1237.d 5.34E4 1 1 389 407 Dehydration; Methylation(KR)
R.N(+.98)AHTLGLSSISSQIKDLGKR.A Y 35.26 2125.1492 20 -14.1 426.0311 5 74.50 6 41181 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 389 408 Deamidation (NQ)
R.LQPS(-2.02)LDRESFIAPAVK.A Y 34.48 1767.9519 16 9.1 590.3300 3 71.75 4 40601 VEV_1_3_RA4_01_1235.d 4.18E4 3 3 220 235 2-amino-3-oxo-butanoic_acid
K.VAPAAPKEESTPAAEEEPVSTGERLQPSLDRESFIAPAVK.A Y 32.16 4203.1333 40 -11.8 1051.7782 4 73.83 5 41762 VEV_2_3_RA5_01_1236.d 1E5 2 2 196 235
R.GVPLKDIK.G Y 32.15 868.5381 8 -20.6 435.2674 2 35.10 6 15711 VEV_3_3_RA6_01_1237.d 7.22E5 5 5 242 249
R.ESFIAPAVK.A Y 30.93 960.5280 9 -28.8 481.2574 2 61.85 6 31805 VEV_3_3_RA6_01_1237.d 1.65E5 1 1 227 235
R.ELKQIVENPLELLL(+14.02) Y 30.04 1663.9760 14 -9.4 832.9874 2 94.99 6 53595 VEV_3_3_RA6_01_1237.d 2.74E5 2 2 498 511 Methylation(C-term)
R.ENPHYFVT(-2.02)SNLSVTK.L Y 26.35 1732.8420 15 -5.3 578.6182 3 67.31 5 37010 VEV_2_3_RA5_01_1236.d 2.02E4 1 1 299 313 2-amino-3-oxo-butanoic_acid
K.VAPAAPKEEST(+164.06)PAAEEEPVSTGER.L Y 26.20 2615.2366 24 -5.2 872.7482 3 55.56 4 28369 VEV_1_3_RA4_01_1235.d 7.96E4 1 1 196 219 O-Diisopropylphosphorylation
R.G(+42.01)VPLKDIKGTGPGGR.V Y 25.62 1492.8362 15 -55.8 374.1955 4 41.77 6 19522 VEV_3_3_RA6_01_1237.d 0 1 1 242 256 Acetylation (N-term)
R.LLQSM(+15.99)R.E Y 25.20 762.4058 6 -13.4 382.2051 2 18.04 4 6379 VEV_1_3_RA4_01_1235.d 6.38E4 1 1 293 298 Oxidation (M)
K.GTGPGGRVTK.N Y 24.02 928.5090 10 -21.8 465.2517 2 11.27 4 2975 VEV_1_3_RA4_01_1235.d 2.14E4 1 1 250 259
R.ELKQIVENPLE(+14.02)LLL Y 22.78 1663.9760 14 11.2 833.0046 2 95.09 4 56325 VEV_1_3_RA4_01_1235.d 9.21E4 3 3 498 511 Methylation(others)
R.E(-18.01)ALNTSANGK.Y Y 22.03 985.4828 10 -25.5 493.7361 2 13.71 6 4284 VEV_3_3_RA6_01_1237.d 3.19E4 1 1 319 328 Pyro-glu from E
R.L(+42.01)LQSMR(+14.02)ENPHYFVTSNLSVTK.L Y 21.96 2519.2842 21 -8.8 630.8228 4 65.15 4 35397 VEV_1_3_RA4_01_1235.d 0 1 1 293 313 Acetylation (N-term); Methylation(KR)
R.ARENK.L N 21.22 616.3292 5 -22.2 617.3228 1 79.55 5 45757 VEV_2_3_RA5_01_1236.d 0 1 1 409 413
R.ELKQIVENPLELLL(+17.03) Y 20.70 1666.9868 14 -34.7 834.4717 2 95.14 4 56353 VEV_1_3_RA4_01_1235.d 0 1 1 498 511 Replacement of proton with ammonium ion
K.APTLKQPEQPK.E Y 19.92 1235.6874 11 0.5 412.9033 3 69.17 5 38387 VEV_2_3_RA5_01_1236.d 7.83E4 1 1 181 191
K.GTGPGGR(-.98)(+14.02).V Y 19.55 613.3296 7 -15.6 307.6673 2 59.30 6 29933 VEV_3_3_RA6_01_1237.d 0 1 1 250 256 Amidation; Methylation(KR)
K.D(+27.99)IKGTGPGGRVT(+79.97)K.N Y 19.31 1392.6761 13 -42.8 465.2128 3 108.24 6 57631 VEV_3_3_RA6_01_1237.d 0 1 1 247 259 Formylation; Phosphorylation (STY)
R.FT(-2.02)AVINPPQSAILAVGTTRK.V Y 19.04 2081.1633 20 -51.5 521.2713 4 77.46 4 45058 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 438 457 2-amino-3-oxo-butanoic_acid
R.EALNTSANGKYK.L Y 18.44 1294.6517 12 -16.4 648.3225 2 22.84 6 9048 VEV_3_3_RA6_01_1237.d 3.62E4 1 1 319 330
K.IVD(-18.01)GAVGAEWMR.E Y 18.44 1284.6284 12 -1.1 643.3208 2 66.12 5 36115 VEV_2_3_RA5_01_1236.d 4.35E4 1 1 486 497 Dehydration
K.VAP(+31.99)AAPK.E Y 18.18 684.3806 7 -16.3 685.3767 1 63.40 6 32928 VEV_3_3_RA6_01_1237.d 0 2 2 196 202 Dihydroxy
R.EALNTSANGK(-.98)(+14.02).Y Y 18.13 1016.5250 10 0.6 509.2701 2 58.27 4 30196 VEV_1_3_RA4_01_1235.d 0 1 1 319 328 Amidation; Methylation(KR)
K.APTLK.Q Y 17.95 528.3271 5 -26.5 529.3204 1 83.55 5 48286 VEV_2_3_RA5_01_1236.d 2.77E4 1 1 181 185
K.TIANR(+21.98).L Y 17.87 595.3054 5 -17.6 596.3022 1 76.63 6 42733 VEV_3_3_RA6_01_1237.d 0 1 1 288 292 Sodium adduct
R.ELKQ(+.98)IVENPLELLL Y 17.64 1650.9443 14 -10.8 826.4705 2 93.74 6 53079 VEV_3_3_RA6_01_1237.d 0 1 1 498 511 Deamidation (NQ)
K.GTGPGGR(+21.98).V Y 17.60 622.2799 7 56.1 623.3221 1 67.94 5 37485 VEV_2_3_RA5_01_1236.d 2.12E5 1 1 250 256 Sodium adduct
R.N(+42.01)AHT(+79.97)LGLSSISSQIK(+14.02).D Y 17.59 1690.8291 15 -8.4 423.7110 4 40.33 5 19311 VEV_2_3_RA5_01_1236.d 7.55E4 1 1 389 403 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
K.DIKGTGPGGR(-.98).V Y 17.01 955.5199 10 -29.6 319.5045 3 50.60 4 25234 VEV_1_3_RA4_01_1235.d 0 1 1 247 256 Amidation
K.GTGPGGR.V Y 16.95 600.2980 7 15.9 301.1610 2 16.35 4 5484 VEV_1_3_RA4_01_1235.d 0 1 1 250 256
K.VAPAAPKEES(+27.05)TPAAEEEPVSTGER.L Y 16.76 2478.2236 24 -17.2 827.0676 3 63.06 4 33805 VEV_1_3_RA4_01_1235.d 3.71E4 1 1 196 219 Ethyl amino
K.KVGD(+21.98)ALAPGDVLVEIETDK(+42.01).A Y 16.70 2032.0339 19 -2.3 678.3503 3 68.23 5 37714 VEV_2_3_RA5_01_1236.d 6.96E4 1 1 106 124 Sodium adduct; Acetylation (K)
K.GTGPGGR(+31.99).V Y 16.65 632.2878 7 3.6 633.2973 1 57.86 6 28932 VEV_3_3_RA6_01_1237.d 0 1 1 250 256 Dihydroxy
R.EAGEK(-.98).D Y 16.62 531.2653 5 2.2 532.2737 1 69.58 5 38691 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 143 147 Amidation
K.NDVEK(+27.99).Y Y 16.14 631.2813 5 -41.0 632.2627 1 21.63 6 8412 VEV_3_3_RA6_01_1237.d 0 1 1 260 264 Formylation
K.LLKLR.E N 16.11 641.4588 5 45.3 642.4951 1 108.48 6 57699 VEV_3_3_RA6_01_1237.d 0 1 1 314 318
R.Q(+42.01)LPAFAALAR.F Y 16.10 1098.6185 10 -66.2 367.1892 3 49.49 6 24015 VEV_3_3_RA6_01_1237.d 1.83E5 1 1 64 73 Acetylation (N-term)
R.K(+14.96)VAIPVEGEDSTSVK.W Y 15.73 1572.7882 15 -1.7 525.2691 3 65.07 4 35328 VEV_1_3_RA4_01_1235.d 1.48E5 1 1 457 471 Alpha-amino adipic acid
K.QPEQPK.E Y 15.70 725.3708 6 -22.1 726.3621 1 90.43 5 52109 VEV_2_3_RA5_01_1236.d 0 1 1 186 191
R.EALNTSAN(+.98)GK.Y Y 15.48 1004.4774 10 33.6 503.2629 2 18.19 5 6761 VEV_2_3_RA5_01_1236.d 0 1 1 319 328 Deamidation (NQ)
K.QPEQ(+.98)PK.E Y 15.36 726.3548 6 -10.8 727.3542 1 74.16 5 41995 VEV_2_3_RA5_01_1236.d 0 1 1 186 191 Deamidation (NQ)
R.ENPHYFVTSNLSVT(-18.01)K(+14.02).L Y 15.33 1730.8628 15 2.8 577.9631 3 67.85 4 37524 VEV_1_3_RA4_01_1235.d 6.57E4 1 1 299 313 Dehydration; Methylation(KR)
R.RQLPAFAALAR(-.98).F Y 15.16 1211.7251 11 0.3 404.9158 3 76.94 5 43980 VEV_2_3_RA5_01_1236.d 8.82E4 1 1 63 73 Amidation
K.APT(+79.97)LK(+14.02)Q(+.98)PEQPK.E Y 15.10 1330.6533 11 7.3 333.6730 4 32.78 4 14447 VEV_1_3_RA4_01_1235.d 9.19E4 1 1 181 191 Phosphorylation (STY); Methylation(KR); Deamidation (NQ)
R.Q(-17.03)LPAFAALAR.F Y 15.10 1039.5814 10 11.3 347.5383 3 43.88 5 21444 VEV_2_3_RA5_01_1236.d 5.68E4 1 1 64 73 Pyro-glu from Q
total 91 peptides
C1G6T3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASKWYPTEDEPQPK.K Y 138.99 1674.7889 14 -14.1 559.2624 3 55.65 6 27575 VEV_3_3_RA6_01_1237.d 2.82E6 13 13 28 41
K.AIDRPLLATIKKEQFLASYLSTSFSLR.K Y 131.68 3067.7070 27 -9.5 767.9268 4 87.15 4 52000 VEV_1_3_RA4_01_1235.d 1.5E6 7 7 168 194
R.ASLQPGTILILLAGR.F Y 123.07 1521.9242 15 -11.4 761.9607 2 89.35 6 50990 VEV_3_3_RA6_01_1237.d 1.89E6 9 9 54 68
R.YVIATSSKVDLTGIDDK.V Y 121.11 1823.9517 17 -14.4 608.9824 3 70.58 6 38287 VEV_3_3_RA6_01_1237.d 3.2E5 2 2 105 121
R.YVIATSSKVDLTGIDDKVLEK.A Y 116.84 2293.2417 21 -9.1 574.3125 4 75.28 4 43346 VEV_1_3_RA4_01_1235.d 1.07E6 4 4 105 125
K.HLPQGVLLVTGPFKLNGVPLR.R Y 115.81 2254.3313 21 0.0 564.5901 4 82.55 4 48939 VEV_1_3_RA4_01_1235.d 5.5E4 1 1 79 99
K.VDLTGIDDKVLEKASESEYFTR.E Y 113.76 2514.2488 22 -6.7 629.5652 4 80.01 4 47043 VEV_1_3_RA4_01_1235.d 4.01E5 5 5 113 134
K.HLPQGVLLVTGPFK.L Y 109.96 1504.8766 14 -20.9 502.6223 3 78.34 4 45782 VEV_1_3_RA4_01_1235.d 7.64E5 3 3 79 92
R.YVIATSSKVDLTGIDDKVLEKASESEYFTR.E Y 104.17 3363.7085 30 -5.0 673.7456 5 80.17 5 46160 VEV_2_3_RA5_01_1236.d 3.75E5 4 4 105 134
K.HLPQGVLLVTGPFKLNGVPLRR.V Y 103.97 2410.4324 22 -14.1 483.0870 5 79.82 6 45029 VEV_3_3_RA6_01_1237.d 2.59E5 3 3 79 100
R.ASLQPGTILILLAGRFR.G Y 100.55 1825.0938 17 -7.5 609.3673 3 89.95 4 53617 VEV_1_3_RA4_01_1235.d 4.09E5 4 4 54 70
K.KEQFLASYLSTSFSLR.K Y 100.09 1875.9730 16 -8.8 626.3261 3 82.03 4 48551 VEV_1_3_RA4_01_1235.d 3.2E5 3 3 179 194
K.VDLTGIDDKVLEK.A Y 98.64 1443.7820 13 -8.9 722.8918 2 71.25 4 40200 VEV_1_3_RA4_01_1235.d 1.24E6 7 7 113 125
K.AIDRPLLATIKK.E Y 98.03 1337.8394 12 -4.4 446.9518 3 59.18 4 30873 VEV_1_3_RA4_01_1235.d 1.35E6 5 5 168 179
K.WYPTEDEPQPK.K Y 96.14 1388.6248 11 -10.3 695.3125 2 61.44 6 31502 VEV_3_3_RA6_01_1237.d 1.64E6 5 5 31 41
K.EQFLASYLSTSFSLR.K Y 94.72 1747.8781 15 -3.1 583.6315 3 86.71 4 51694 VEV_1_3_RA4_01_1235.d 8.3E5 6 6 180 194
K.ASESEYFTR.E Y 93.31 1088.4774 9 -6.3 545.2426 2 45.92 6 22010 VEV_3_3_RA6_01_1237.d 4.63E6 14 14 126 134
K.ASESEYFTREK.K Y 81.48 1345.6150 11 -7.4 673.8098 2 37.37 4 17151 VEV_1_3_RA4_01_1235.d 4.67E5 3 3 126 136
K.ASKWYPTEDEPQ(+.98)PK.K Y 80.58 1675.7729 14 -9.2 559.5931 3 57.72 4 29807 VEV_1_3_RA4_01_1235.d 2E5 3 3 28 41 Deamidation (NQ)
R.KTIHPAKPR.A Y 77.99 1046.6349 9 -9.6 524.3197 2 10.97 4 2841 VEV_1_3_RA4_01_1235.d 1.1E6 6 6 45 53
K.AIDRPLLAT(-18.01)IK(+14.02)KEQFLASYLSTSFSLR.K Y 76.96 3063.7119 27 -53.2 766.8945 4 87.25 4 52038 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 168 194 Dehydration; Methylation(KR)
K.TIHPAKPR.A Y 76.46 918.5399 8 -14.2 460.2707 2 11.72 5 3321 VEV_2_3_RA5_01_1236.d 1.24E6 8 8 46 53
K.HLPQGVLLVTGPFKLN(+.98)GVPLR.R Y 74.92 2255.3154 21 -8.2 564.8315 4 83.42 4 49508 VEV_1_3_RA4_01_1235.d 4.21E4 1 1 79 99 Deamidation (NQ)
M.S(+42.01)ATLDSKSVGQTK.K Y 72.32 1362.6991 13 -10.2 682.3499 2 42.50 5 20651 VEV_2_3_RA5_01_1236.d 5.14E5 6 6 2 14 Acetylation (Protein N-term)
K.KGEEAFFKQGEKPEK.K Y 71.26 1750.8889 15 -9.4 438.7254 4 35.04 4 15777 VEV_1_3_RA4_01_1235.d 5.96E5 3 3 141 155
K.ASKWYPTEDE(+14.02)PQPK.K Y 69.92 1688.8046 14 -7.5 563.9379 3 61.87 4 32892 VEV_1_3_RA4_01_1235.d 4.73E5 3 3 28 41 Methylation(others)
R.YVIATSSK.V Y 69.37 867.4702 8 -15.7 434.7355 2 30.55 5 13569 VEV_2_3_RA5_01_1236.d 1.24E6 5 5 105 112
R.ASLQ(+.98)PGTILILLAGR.F Y 67.38 1522.9082 15 -7.6 762.4556 2 90.32 6 51475 VEV_3_3_RA6_01_1237.d 2.67E4 3 3 54 68 Deamidation (NQ)
K.WYPTEDEPQPKK.V Y 67.26 1516.7197 12 -23.6 506.5686 3 52.31 4 26362 VEV_1_3_RA4_01_1235.d 1.83E5 3 3 31 42
K.ASKWYPTE(+14.02)DEPQPK.K Y 65.81 1688.8046 14 -9.7 563.9366 3 61.04 4 32260 VEV_1_3_RA4_01_1235.d 2.69E5 2 2 28 41 Methylation(others)
K.HLPQGVLLVTGPFKLN(+.98)GVPLRR.V Y 64.65 2411.4165 22 -7.3 483.2870 5 80.45 4 47366 VEV_1_3_RA4_01_1235.d 9.26E4 1 1 79 100 Deamidation (NQ)
K.KGEEAFFK.Q Y 63.16 954.4810 8 -16.2 478.2401 2 38.69 6 17751 VEV_3_3_RA6_01_1237.d 2.75E6 17 17 141 148
K.VLEKASESEYFTR.E Y 63.06 1557.7675 13 -15.3 520.2551 3 59.60 4 31247 VEV_1_3_RA4_01_1235.d 2.18E5 2 2 122 134
K.WYPTEDEPQ(+.98)PK.K Y 61.91 1389.6088 11 -8.5 695.8058 2 63.00 4 33763 VEV_1_3_RA4_01_1235.d 6.71E5 5 5 31 41 Deamidation (NQ)
K.ASESEYFTR(+14.02).E Y 55.89 1102.4930 9 -9.1 552.2488 2 54.87 4 27979 VEV_1_3_RA4_01_1235.d 4.47E5 6 6 126 134 Methylation(KR)
K.VDLTGIDDK.V Y 53.63 974.4920 9 -13.5 488.2467 2 59.70 6 30225 VEV_3_3_RA6_01_1237.d 5.45E5 3 3 113 121
K.SVGQTKKFGKGER.T Y 51.88 1420.7786 13 -15.8 356.1963 4 13.54 5 4249 VEV_2_3_RA5_01_1236.d 1.45E5 2 2 9 21
K.ASKWYPTEDEPQPK(+14.02).K Y 51.58 1688.8046 14 -2.6 563.9407 3 59.77 5 31382 VEV_2_3_RA5_01_1236.d 4.07E5 3 3 28 41 Methylation(KR)
K.ASESE(+14.02)YFTR.E Y 49.93 1102.4930 9 -8.4 552.2491 2 53.12 4 26924 VEV_1_3_RA4_01_1235.d 7.43E5 3 3 126 134 Methylation(others)
K.LNGVPLR.R Y 49.27 767.4653 7 -20.6 384.7320 2 47.83 6 23041 VEV_3_3_RA6_01_1237.d 9.9E5 4 4 93 99
K.T(+42.01)IHPAKPR.A Y 48.92 960.5505 8 -20.3 321.1843 3 11.80 5 3347 VEV_2_3_RA5_01_1236.d 0 1 1 46 53 Acetylation (N-term)
K.AIDRPLLATIK.K Y 47.49 1209.7445 11 -11.5 404.2508 3 65.65 4 35790 VEV_1_3_RA4_01_1235.d 5.23E5 3 3 168 178
K.ASE(+14.02)SEYFTR.E Y 46.58 1102.4930 9 -5.6 552.2507 2 59.90 4 31441 VEV_1_3_RA4_01_1235.d 3.42E5 3 3 126 134 Methylation(others)
M.S(+42.01)ATLDSKSVGQTKK.F Y 46.46 1490.7939 14 -10.1 746.3967 2 31.59 5 14189 VEV_2_3_RA5_01_1236.d 5.67E5 6 6 2 15 Acetylation (Protein N-term)
K.VDLTGIDDK(+14.02)VLEK.A Y 46.45 1457.7977 13 1.1 486.9404 3 73.35 4 41861 VEV_1_3_RA4_01_1235.d 1.93E5 3 3 113 125 Methylation(KR)
K.WYPTEDEPQPK(+14.02).K Y 45.54 1402.6405 11 -7.7 702.3221 2 64.44 6 33695 VEV_3_3_RA6_01_1237.d 4.41E5 5 5 31 41 Methylation(KR)
K.ASES(+14.02)EYFTR.E Y 45.29 1102.4930 9 -14.2 552.2460 2 52.66 6 25857 VEV_3_3_RA6_01_1237.d 2.33E5 1 1 126 134 Methylation(others)
K.ASK(+31.99)WYPTEDEPQPK.K Y 43.18 1706.7787 14 -8.3 569.9288 3 39.34 4 18301 VEV_1_3_RA4_01_1235.d 8.99E4 1 1 28 41 Dihydroxy
R.ASLQPGTILILLAGRFRGK.R Y 43.02 2010.2102 19 -10.8 503.5544 4 86.50 4 51567 VEV_1_3_RA4_01_1235.d 3.35E4 1 1 54 72
K.AIDRPLLATIK(-1.03)KEQFLASYLSTSFSLR.K Y 42.78 3066.6753 27 -3.8 767.6732 4 87.39 4 52127 VEV_1_3_RA4_01_1235.d 0 1 1 168 194 Lysine oxidation to aminoadipic semialdehyde
K.AIDRPLLATIKKEQ(+.98)FLASYLSTSFSLR.K Y 42.08 3068.6909 27 11.9 1023.9164 3 87.11 5 50366 VEV_2_3_RA5_01_1236.d 6.06E4 1 1 168 194 Deamidation (NQ)
R.YVIATSSK(-1.03)VDLTGIDDKVLEK.A Y 41.81 2292.2100 21 1.9 1147.1144 2 75.28 5 42797 VEV_2_3_RA5_01_1236.d 9.4E2 1 1 105 125 Lysine oxidation to aminoadipic semialdehyde
K.WYPTE(+14.02)DEPQPK.K Y 41.21 1402.6405 11 -10.9 702.3199 2 65.55 4 35707 VEV_1_3_RA4_01_1235.d 3.24E5 2 2 31 41 Methylation(others)
K.KAEKKGEEAFFK.Q Y 40.08 1410.7506 12 -17.0 471.2495 3 24.50 6 9941 VEV_3_3_RA6_01_1237.d 9.05E4 1 1 137 148
K.ASKW(+15.99)YPTEDEPQPK.K Y 36.37 1690.7838 14 -7.5 564.5977 3 53.42 4 27072 VEV_1_3_RA4_01_1235.d 1.82E5 2 2 28 41 Oxidation (HW)
K.W(+31.99)YPTEDEPQPK.K Y 35.40 1420.6146 11 -6.9 711.3097 2 52.86 4 26711 VEV_1_3_RA4_01_1235.d 8.77E4 4 4 31 41 Dihydroxy
R.ASLQPGTILILLAGRFRGKR.V Y 31.98 2166.3113 20 -18.6 434.2615 5 83.66 4 49673 VEV_1_3_RA4_01_1235.d 3.1E4 1 1 54 73
K.KFGKGER.T Y 31.15 820.4555 7 -12.8 411.2298 2 9.51 5 2333 VEV_2_3_RA5_01_1236.d 9.33E4 3 3 15 21
K.W(+3.99)YPTEDEPQPK.K Y 30.48 1392.6198 11 25.3 697.3348 2 61.47 5 32632 VEV_2_3_RA5_01_1236.d 1.55E5 1 1 31 41 Tryptophan oxidation to kynurenin
K.GERTIPSQK.A Y 29.91 1014.5458 9 -42.3 508.2587 2 15.06 4 4817 VEV_1_3_RA4_01_1235.d 2.76E4 1 1 19 27
K.ASKWYPTEDEPQPKK.V Y 28.95 1802.8838 15 -14.1 451.7219 4 45.34 5 22335 VEV_2_3_RA5_01_1236.d 1.93E5 1 1 28 42
K.TIHPAK(+14.02)PR.A Y 28.49 932.5555 8 -50.0 467.2617 2 15.72 6 5329 VEV_3_3_RA6_01_1237.d 0 1 1 46 53 Methylation(KR)
K.VDLTGIDDK(-1.03)VLEKASESEYFTR.E Y 27.14 2513.2173 22 30.7 629.3309 4 79.94 5 46017 VEV_2_3_RA5_01_1236.d 0 1 1 113 134 Lysine oxidation to aminoadipic semialdehyde
K.Q(+42.01)GEK(+14.02)PEK.K Y 26.31 870.4446 7 -0.1 871.4518 1 89.30 4 53271 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 149 155 Acetylation (N-term); Methylation(KR)
R.TIPSQKASK.W Y 26.07 958.5447 9 -19.9 480.2701 2 10.57 5 2761 VEV_2_3_RA5_01_1236.d 1.4E4 1 1 22 30
K.KGEEAFFK(+14.02).Q Y 25.43 968.4967 8 -17.0 485.2474 2 50.36 6 24493 VEV_3_3_RA6_01_1237.d 1.32E5 1 1 141 148 Methylation(KR)
R.VVLLK(+14.02)HLP(+31.99)QGVLLVTGPFK.L Y 25.41 2103.2820 19 -7.9 702.0957 3 96.27 6 54090 VEV_3_3_RA6_01_1237.d 6.93E4 1 1 74 92 Methylation(KR); Dihydroxy
K.WYPTED(+14.02)EPQPK.K Y 25.31 1402.6405 11 -9.2 702.3210 2 65.15 4 35395 VEV_1_3_RA4_01_1235.d 7.55E4 1 1 31 41 Methylation(others)
K.EQFLASYLSTSFSLRK.G Y 25.00 1875.9730 16 -21.9 626.3179 3 81.80 6 46409 VEV_3_3_RA6_01_1237.d 3.8E4 2 2 180 195
K.SVGQ(+.98)T(-18.01)K.K Y 24.81 601.3071 6 -9.3 602.3088 1 64.79 6 33952 VEV_3_3_RA6_01_1237.d 3.1E3 1 1 9 14 Deamidation (NQ); Dehydration
K.E(-18.01)QFLASYLSTSFSLR.K Y 24.48 1729.8674 15 -24.8 346.9722 5 53.07 6 26099 VEV_3_3_RA6_01_1237.d 2.79E4 1 1 180 194 Pyro-glu from E
R.KT(-18.01)IHPAKPR.A Y 24.47 1028.6243 9 -19.7 515.3093 2 11.07 4 2892 VEV_1_3_RA4_01_1235.d 1.27E4 1 1 45 53 Dehydration
K.T(+43.01)(+79.97)IHPAKPR.A Y 24.20 1041.5121 8 0.5 348.1782 3 10.93 6 2887 VEV_3_3_RA6_01_1237.d 8.64E4 1 1 46 53 Carbamylation; Phosphorylation (STY)
K.TIHPAKPR(+14.02).A Y 24.09 932.5555 8 -34.3 467.2690 2 15.80 4 5204 VEV_1_3_RA4_01_1235.d 0 2 2 46 53 Methylation(KR)
K.AIDRPLLATIKKEQFLASY(-2.02)LSTSFSLR.K Y 23.97 3065.6912 27 8.6 614.1508 5 87.57 6 49982 VEV_3_3_RA6_01_1237.d 0 1 1 168 194 2-amino-3-oxo-butanoic_acid
K.K(+14.02)EQFLASYLSTSFSLR.K Y 23.68 1889.9886 16 -28.8 630.9854 3 83.20 4 49363 VEV_1_3_RA4_01_1235.d 6.68E4 1 1 179 194 Methylation(KR)
K.LN(-17.03)GVPLRR.V Y 23.65 906.5399 8 -26.2 454.2654 2 62.19 4 33182 VEV_1_3_RA4_01_1235.d 3.09E5 1 1 93 100 Ammonia-loss (N)
M(+42.01)S(-18.01)ATLDSK.S Y 23.52 875.4059 8 11.8 876.4235 1 21.31 6 8245 VEV_3_3_RA6_01_1237.d 7.47E4 2 2 1 8 Acetylation (Protein N-term); Dehydration
K.ASES(+14.02)EYFTREK.K Y 22.10 1359.6306 11 -13.8 680.8132 2 51.02 5 25767 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 126 136 Methylation(others)
K.FGKGER.T Y 21.61 692.3605 6 9.9 347.1910 2 9.70 4 2376 VEV_1_3_RA4_01_1235.d 6.1E4 2 2 16 21
K.LNGVPLRR.V Y 20.93 923.5665 8 -19.6 308.8567 3 36.66 6 16578 VEV_3_3_RA6_01_1237.d 5.42E5 2 2 93 100
K.SVGQTK.K Y 19.52 618.3337 6 -39.4 619.3166 1 69.25 4 38628 VEV_1_3_RA4_01_1235.d 2.76E4 1 1 9 14
K.WYPTEDE(+14.02)PQPK.K Y 18.78 1402.6405 11 -6.5 702.3230 2 64.94 5 35233 VEV_2_3_RA5_01_1236.d 8.02E4 1 1 31 41 Methylation(others)
K.AEKKGEEAFFK.Q Y 17.57 1282.6556 11 0.9 642.3357 2 29.76 6 12742 VEV_3_3_RA6_01_1237.d 4.77E4 1 1 138 148
K.VDLTGID(-18.01)DK.V Y 16.95 956.4814 9 1.8 319.8350 3 27.60 6 11555 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 113 121 Dehydration
K.VVSARANDQK.A Y 16.81 1086.5781 10 -19.6 544.2857 2 63.89 6 33342 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 158 167
K.S(+42.01)(-18.01)VGQTK.K Y 16.53 642.3337 6 -20.4 322.1676 2 12.21 5 3557 VEV_2_3_RA5_01_1236.d 0 1 1 9 14 Acetylation (Protein N-term); Dehydration
K.QGEKPEK(+42.01)K(+42.01).K Y 16.52 1026.5345 8 9.7 514.2795 2 10.38 6 2651 VEV_3_3_RA6_01_1237.d 1.27E4 1 1 149 156 Acetylation (K)
K.L(+27.99)NGVPLR.R Y 16.49 795.4603 7 -0.9 796.4669 1 99.49 4 58032 VEV_1_3_RA4_01_1235.d 0 1 1 93 99 Formylation
K.GDKPHEMKW(-.98) Y 16.40 1125.5389 9 -20.2 1126.5234 1 93.10 5 53392 VEV_2_3_RA5_01_1236.d 7.91E4 1 1 196 204 Amidation
K.FGKGER(+14.02).T Y 16.18 706.3762 6 -24.6 354.1867 2 13.25 4 3934 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 16 21 Methylation(KR)
K.VDLTGIDDK(+42.01)VLEK.A Y 15.93 1485.7926 13 -18.9 743.8895 2 57.02 6 28384 VEV_3_3_RA6_01_1237.d 5.11E4 1 1 113 125 Acetylation (K)
R.VVLLK(+43.99)HLPQGVLLVTGPFK.L Y 15.70 2101.2664 19 -78.7 701.3743 3 93.10 4 55349 VEV_1_3_RA4_01_1235.d 0 1 1 74 92 Carboxylation (DKW)
K.EQFLAS(+79.96)YLSTSFSLR.K Y 15.35 1827.8348 15 46.4 610.3138 3 81.49 6 46199 VEV_3_3_RA6_01_1237.d 6.44E4 1 1 180 194 Sulfation
K.FGKGERTIPSQK.A Y 15.07 1346.7306 12 -12.2 674.3644 2 22.68 5 9175 VEV_2_3_RA5_01_1236.d 0 1 1 16 27
total 95 peptides
C1G002
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IAIIHVGAPAGGMNPATR.A Y 142.32 1744.9407 18 -10.1 582.6483 3 69.83 5 38879 VEV_2_3_RA5_01_1236.d 6.45E5 5 5 406 423
K.AVLEAKPGDPSPLITLR.E Y 125.36 1776.0144 17 -9.0 593.0068 3 74.91 4 43057 VEV_1_3_RA4_01_1235.d 1.91E5 2 2 323 339
R.GGTAC(+57.02)AYDRWLGTLQGIEAVK.A Y 124.95 2265.1211 21 -5.4 756.0436 3 82.43 4 48832 VEV_1_3_RA4_01_1235.d 3.15E5 3 3 302 322 Carbamidomethylation
K.GGEVVFGPMSGEGGLEETDTDWER.R Y 123.85 2553.0964 24 -2.4 1277.5525 2 82.15 4 48633 VEV_1_3_RA4_01_1235.d 3.49E4 1 1 726 749
R.VAVLTSGGDAPGMNGVVR.A Y 116.54 1698.8723 18 -9.6 850.4352 2 70.84 4 39902 VEV_1_3_RA4_01_1235.d 1.69E5 3 3 18 35
R.MSIHC(+57.02)GC(+57.02)EAYAVHEGYEGLVR.G Y 108.77 2437.0613 21 -7.8 813.3547 3 69.27 4 38640 VEV_1_3_RA4_01_1235.d 7.83E4 2 2 40 60 Carbamidomethylation
R.IAIIHVGAPAGGM(+15.99)NPATR.A Y 108.28 1760.9355 18 -9.1 587.9805 3 65.42 4 35606 VEV_1_3_RA4_01_1235.d 7E4 1 1 406 423 Oxidation (M)
K.TYTTQVVADMIKEEAK.G Y 108.26 1825.9131 16 -14.6 609.6361 3 77.64 4 45196 VEV_1_3_RA4_01_1235.d 2.03E5 3 3 648 663
R.GHTPIAIYNGFPGLC(+57.02)R.H Y 108.15 1771.8828 16 -1.8 591.6338 3 76.96 4 44717 VEV_1_3_RA4_01_1235.d 5.55E5 4 4 433 448 Carbamidomethylation
K.C(+57.02)VQHIEQFQGR.S Y 103.56 1400.6619 11 -8.7 467.8905 3 41.59 4 19663 VEV_1_3_RA4_01_1235.d 7.49E5 6 6 697 707 Carbamidomethylation
R.SKNEIAADPMSSVVIGIK.G Y 100.63 1857.9869 18 -11.6 620.3291 3 75.74 4 43708 VEV_1_3_RA4_01_1235.d 1.95E5 1 1 708 725
R.IC(+57.02)EAVDEVFDTAASHQR.G Y 97.85 1946.8792 17 -22.2 649.9526 3 72.90 4 41501 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 185 201 Carbamidomethylation
K.IPLVILPATISNNVPGTEYSLGSDTC(+57.02)LNTLVNFC(+57.02)DVIR.Q Y 97.31 4175.1284 38 -5.1 1392.7097 3 96.39 4 56914 VEV_1_3_RA4_01_1235.d 2.76E5 4 4 530 567 Carbamidomethylation
K.WLESDSWVNEGGSEIGTNR.G Y 95.02 2134.9556 19 -2.3 712.6575 3 78.11 6 43804 VEV_3_3_RA6_01_1237.d 5.08E5 4 4 463 481
K.TVGQALKDRDFATALSMR.D Y 89.14 1979.0258 18 -6.7 495.7604 4 72.02 4 40810 VEV_1_3_RA4_01_1235.d 2.57E5 2 2 357 374
R.GIDALVVC(+57.02)GGDGSLTGADIFR.S Y 88.20 2092.0259 21 -10.5 1047.0093 2 85.78 5 49610 VEV_2_3_RA5_01_1236.d 3.28E5 3 3 109 129 Carbamidomethylation
R.AYINTATPHHPK.M Y 87.49 1348.6887 12 -11.3 450.5651 3 27.35 4 11386 VEV_1_3_RA4_01_1235.d 1.2E6 6 6 384 395
K.NDFWLTLK.S Y 83.47 1035.5389 8 -14.4 518.7693 2 80.04 5 46076 VEV_2_3_RA5_01_1236.d 3.83E5 3 3 754 761
R.VFVIETQGGR.S Y 82.77 1104.5928 10 -11.6 553.2972 2 61.43 4 32553 VEV_1_3_RA4_01_1235.d 5.03E5 5 5 577 586
R.AAVAYC(+57.02)LAR.G Y 81.51 993.5065 9 -12.7 497.7542 2 54.42 5 27869 VEV_2_3_RA5_01_1236.d 1.18E6 8 8 424 432 Carbamidomethylation
R.HHADTPIGSVR.E Y 78.30 1188.6000 11 -11.0 595.3007 2 26.07 5 11076 VEV_2_3_RA5_01_1236.d 4.74E5 10 10 449 459
R.TIVIVAEGAQDANLNK.I Y 76.26 1654.8889 16 -14.5 552.6289 3 70.47 4 39631 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 258 273
M.A(+42.01)NVTNMSPVSQSK.R Y 75.88 1403.6715 13 -10.9 702.8354 2 66.80 4 36759 VEV_1_3_RA4_01_1235.d 1.93E5 4 4 2 14 Acetylation (Protein N-term)
R.GHTPIAIYN(+.98)GFPGLC(+57.02)R.H Y 73.85 1772.8668 16 -4.7 591.9601 3 77.72 4 45290 VEV_1_3_RA4_01_1235.d 1.8E5 3 3 433 448 Deamidation (NQ); Carbamidomethylation
K.C(+57.02)VQ(+.98)HIEQFQGR.S Y 73.27 1401.6459 11 -10.6 468.2176 3 50.23 4 25016 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 697 707 Carbamidomethylation; Deamidation (NQ)
K.ISSSSVKDVLNNR.L Y 65.61 1417.7524 13 -11.1 709.8756 2 59.30 5 31033 VEV_2_3_RA5_01_1236.d 2.85E4 2 2 274 286
M.A(+42.01)NVTNMSPVSQSKR.R Y 57.16 1559.7726 14 -11.2 780.8848 2 61.07 4 32287 VEV_1_3_RA4_01_1235.d 2.18E5 2 2 2 15 Acetylation (Protein N-term)
K.TYTTQVVADMIK(+14.02)EEAK.G Y 56.93 1839.9288 16 -10.1 614.3107 3 79.03 4 46272 VEV_1_3_RA4_01_1235.d 7.95E4 4 4 648 663 Methylation(KR)
R.GFVIEVMGR.N Y 55.36 1006.5270 9 -10.7 504.2654 2 76.51 4 44393 VEV_1_3_RA4_01_1235.d 3.23E5 2 2 202 210
R.GLPSADMAK.T Y 54.78 888.4375 9 -2.6 445.2249 2 44.48 5 21824 VEV_2_3_RA5_01_1236.d 1.12E6 4 4 482 490
R.VTVLGHTQR.G Y 53.29 1009.5669 9 -26.6 505.7773 2 28.03 6 11809 VEV_3_3_RA6_01_1237.d 9.32E5 11 11 293 301
R.IAIIHVGAPAGGMNPATR(+14.02).A Y 52.89 1758.9563 18 -21.7 587.3133 3 70.91 4 39932 VEV_1_3_RA4_01_1235.d 3.56E4 1 1 406 423 Methylation(KR)
R.SEWPGLLDELVK.R Y 49.97 1384.7238 12 -5.1 693.3656 2 86.46 4 51539 VEV_1_3_RA4_01_1235.d 7.05E5 4 4 130 141
K.IILRNETVSK.T Y 49.24 1171.6924 10 -12.2 586.8463 2 40.25 6 18634 VEV_3_3_RA6_01_1237.d 1.53E5 5 5 638 647
R.VAVLTSGGDAPGMN(+.98)GVVR.A Y 48.66 1699.8563 18 -9.9 850.9270 2 71.26 5 39921 VEV_2_3_RA5_01_1236.d 4.48E4 2 2 18 35 Deamidation (NQ)
R.MHWEDVRGWLSR.G Y 45.96 1570.7463 12 -9.7 393.6901 4 76.80 4 44533 VEV_1_3_RA4_01_1235.d 3.61E4 1 1 68 79
R.SSLVEAVR.V Y 41.55 859.4763 8 -11.3 430.7406 2 47.21 4 23178 VEV_1_3_RA4_01_1235.d 7.74E5 5 5 346 353
R.EQYPAFK.I Y 39.05 881.4283 7 -17.8 441.7136 2 45.68 6 21803 VEV_3_3_RA6_01_1237.d 1.98E5 1 1 523 529
M.A(+42.01)NVTNM(+15.99)SPVSQSK.R Y 37.77 1419.6664 13 -9.6 710.8337 2 55.59 4 28385 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 2 14 Acetylation (Protein N-term); Oxidation (M)
R.DIEYLR.H N 35.15 807.4127 6 -9.7 404.7097 2 58.88 4 30642 VEV_1_3_RA4_01_1235.d 4.62E5 4 4 618 623
K.IER(+31.99)SSLVEAVR.V Y 32.28 1289.6938 11 -13.5 430.8994 3 47.03 5 23345 VEV_2_3_RA5_01_1236.d 2.44E5 1 1 343 353 Dihydroxy
R.GWLSRGGTLIGSAR.C Y 30.64 1429.7789 14 22.1 358.4599 4 32.62 4 14389 VEV_1_3_RA4_01_1235.d 2.73E5 1 1 75 88
K.I(+43.01)ERSSLVEAVRVT(+79.97)K.T Y 30.29 1708.8872 14 -1.1 428.2286 4 66.22 4 36232 VEV_1_3_RA4_01_1235.d 2.07E4 2 2 343 356 Carbamylation; Phosphorylation (STY)
R.IAIIHVGAPAGGMNPAT(-2.02)R.A Y 30.19 1742.9249 18 -59.5 581.9477 3 70.03 4 39235 VEV_1_3_RA4_01_1235.d 7.97E4 1 1 406 423 2-amino-3-oxo-butanoic_acid
R.VAVLTSGGDAPGM(+31.99)NGVVR.A Y 30.14 1730.8621 18 -13.0 433.7172 4 28.88 5 12620 VEV_2_3_RA5_01_1236.d 0 1 1 18 35 Sulphone
R.HNFATDR.G Y 29.22 859.3937 7 -6.6 430.7013 2 14.50 5 4774 VEV_2_3_RA5_01_1236.d 1.87E5 3 3 624 630
K.N(+.98)DFWLTLK.S Y 29.00 1036.5229 8 -7.8 519.2647 2 85.00 4 50588 VEV_1_3_RA4_01_1235.d 2.02E4 1 1 754 761 Deamidation (NQ)
K.ISSS(-18.01)SVK(+14.02)DVLNNRLK.L Y 27.39 1654.9365 15 9.4 414.7453 4 63.43 5 34111 VEV_2_3_RA5_01_1236.d 0 1 1 274 288 Dehydration; Methylation(KR)
R.GLPSADMAK(+14.02).T Y 26.77 902.4531 9 -6.2 903.4548 1 85.98 5 49726 VEV_2_3_RA5_01_1236.d 1.89E5 1 1 482 490 Methylation(KR)
R.AAVAYCLAR(+14.02).G Y 25.90 950.5007 9 -5.3 476.2551 2 23.35 5 9532 VEV_2_3_RA5_01_1236.d 1.57E5 2 2 424 432 Methylation(KR)
R.IAIIHVGAPAGGMNPAT(-18.01)R(+14.02).A Y 25.73 1740.9457 18 -51.4 581.2927 3 70.04 4 39240 VEV_1_3_RA4_01_1235.d 5.21E4 2 2 406 423 Dehydration; Methylation(KR)
R.A(+42.01)AVAYC(+57.02)LAR.G Y 25.14 1035.5171 9 22.1 346.1873 3 52.42 5 26646 VEV_2_3_RA5_01_1236.d 0 2 2 424 432 Acetylation (N-term); Carbamidomethylation
R.VTKTVGQALK(+27.99).D Y 25.03 1071.6288 10 -9.8 358.2134 3 30.72 5 13678 VEV_2_3_RA5_01_1236.d 0 1 1 354 363 Formylation
K.M(+15.99)QLPENMR.M Y 24.95 1033.4685 8 15.6 517.7496 2 40.05 5 19150 VEV_2_3_RA5_01_1236.d 1.04E5 2 2 396 403 Oxidation (M)
R.AAVAYC(+57.02)LAR(+14.02).G Y 24.24 1007.5222 9 -10.8 504.7629 2 60.61 5 32004 VEV_2_3_RA5_01_1236.d 9.54E4 1 1 424 432 Carbamidomethylation; Methylation(KR)
R.QSAS(-18.01)SSR.R Y 23.88 703.3249 7 -17.2 704.3201 1 112.46 6 58763 VEV_3_3_RA6_01_1237.d 0 1 1 568 574 Dehydration
R.IAIIHVGAPAGGMN(+.98)PATR.A Y 23.55 1745.9247 18 19.4 582.9935 3 69.70 5 38775 VEV_2_3_RA5_01_1236.d 0 1 1 406 423 Deamidation (NQ)
R.GLPSADM(+15.99)AK.T Y 23.55 904.4324 9 18.3 453.2317 2 27.25 4 11325 VEV_1_3_RA4_01_1235.d 1.91E6 3 3 482 490 Oxidation (M)
K.T(+27.99)YTTQVVADMIK(+42.01).E Y 22.80 1438.7014 12 -1.5 720.3569 2 111.99 6 58628 VEV_3_3_RA6_01_1237.d 7.84E3 1 1 648 659 Formylation; Acetylation (K)
K.TYTTQVVADMIK.E Y 22.77 1368.6959 12 -17.0 685.3436 2 76.37 4 44198 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 648 659
R.GIDALVVC(+57.02)GGDGS(-2.02)LTGADIFRSEWPGLLDELVK.R Y 21.98 3456.7234 33 15.2 865.2013 4 94.92 4 56252 VEV_1_3_RA4_01_1235.d 0 1 1 109 141 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.TIVIVAEGAQDANLNKISSSSVK.D Y 21.88 2343.2644 23 -14.5 782.0841 3 73.74 4 42159 VEV_1_3_RA4_01_1235.d 1.01E4 1 1 258 280
K.TYTTQVVADM(+15.99)IK.E Y 21.88 1384.6908 12 17.8 347.1861 4 62.38 6 32184 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 648 659 Oxidation (M)
R.HNFATDRGASHAGK.I Y 21.80 1467.6967 14 -12.0 490.2336 3 13.90 5 4442 VEV_2_3_RA5_01_1236.d 2.9E4 1 1 624 637
R.VAVLTSGGDAPGM(+15.99)N(+.98)GVVR.A Y 21.44 1715.8512 18 10.4 429.9745 4 48.54 6 23460 VEV_3_3_RA6_01_1237.d 1.81E5 1 1 18 35 Oxidation (M); Deamidation (NQ)
R.GGTLIGSAR.C Y 21.33 830.4610 9 -17.4 416.2306 2 32.82 4 14473 VEV_1_3_RA4_01_1235.d 4.98E5 3 3 80 88
R.DGWEDDMC(+57.02)DIITQNR.K Y 20.73 1866.7512 15 48.2 934.4279 2 83.17 4 49343 VEV_1_3_RA4_01_1235.d 0 1 1 237 251 Carbamidomethylation
K.IS(-18.01)SSSVK(+14.02)DVLNNRLK.L Y 20.27 1654.9365 15 -34.4 414.7272 4 63.70 4 34283 VEV_1_3_RA4_01_1235.d 0 1 1 274 288 Dehydration; Methylation(KR)
K.R(+14.02)GDLTDEQVMHFK(+28.03).T Y 20.23 1616.7981 13 -15.6 405.2005 4 19.62 4 7218 VEV_1_3_RA4_01_1235.d 3.13E5 1 1 142 154 Methylation(KR); Dimethylation(KR)
K.WLES(-2.02)DSWVNEGGSEIGTNR.G Y 19.73 2132.9399 19 39.0 712.0150 3 78.14 5 44810 VEV_2_3_RA5_01_1236.d 0 1 1 463 481 2-amino-3-oxo-butanoic_acid
R.A(+28.03)YINTATPHHPK.M Y 19.71 1376.7201 12 -3.5 459.9124 3 67.22 6 35815 VEV_3_3_RA6_01_1237.d 2.69E5 1 1 384 395 Ethylation
R.RRVFVIETQGGR.S Y 19.71 1416.7949 12 -7.9 355.2032 4 51.68 6 25281 VEV_3_3_RA6_01_1237.d 5.98E4 1 1 575 586
K.D(+27.99)VLNNR.L Y 19.59 757.3718 6 -4.6 758.3756 1 111.26 4 61461 VEV_1_3_RA4_01_1235.d 0 1 1 281 286 Formylation
R.DFATALSMR.D Y 19.49 1010.4855 9 3.6 506.2518 2 18.83 4 6795 VEV_1_3_RA4_01_1235.d 5.63E4 2 2 366 374
M.A(+42.01)NVTNM(+15.99)SPVSQSKR.R Y 18.96 1575.7675 14 -2.4 788.8891 2 46.15 4 22481 VEV_1_3_RA4_01_1235.d 5.44E4 1 1 2 15 Acetylation (Protein N-term); Oxidation (M)
R.AYIN(+.98)TATPHHPK(+42.01)M(+15.99)QLPENMR.M Y 18.94 2407.1414 20 5.3 602.7958 4 75.08 4 43186 VEV_1_3_RA4_01_1235.d 2.4E5 1 1 384 403 Deamidation (NQ); Acetylation (K); Oxidation (M)
R.NETVSKTYTTQVVADMIK.E Y 18.89 2027.0245 18 -11.1 507.7578 4 76.66 6 42752 VEV_3_3_RA6_01_1237.d 6.36E4 1 1 642 659
R.G(+42.01)GTLIGSAR.C Y 18.82 872.4716 9 -72.7 873.4154 1 92.20 4 54881 VEV_1_3_RA4_01_1235.d 2.29E4 2 2 80 88 Acetylation (N-term)
K.T(+42.01)YTTQVVADMIKEEAK.G Y 18.80 1867.9237 16 -15.2 374.5863 5 47.44 6 22855 VEV_3_3_RA6_01_1237.d 0 1 1 648 663 Acetylation (N-term)
R.AYINTATPHHPKM(+15.99)QLPENM(+15.99)RM(+15.99)R.I Y 18.65 2683.2781 22 24.8 895.4555 3 88.88 5 51318 VEV_2_3_RA5_01_1236.d 2.91E4 1 1 384 405 Oxidation (M)
K.T(+27.99)VGQ(+.98)ALK.D Y 18.47 744.4017 7 -20.0 745.3941 1 85.23 4 50745 VEV_1_3_RA4_01_1235.d 2.11E4 1 1 357 363 Formylation; Deamidation (NQ)
R.T(+43.01)IVIVAEGAQDANLN(+.98)K.I Y 18.38 1698.8788 16 -15.2 425.7205 4 45.52 5 22446 VEV_2_3_RA5_01_1236.d 1.64E5 1 1 258 273 Carbamylation; Deamidation (NQ)
R.S(+27.99)SLVEAVR.V Y 18.25 887.4712 8 -12.6 888.4673 1 99.94 4 58183 VEV_1_3_RA4_01_1235.d 0 1 1 346 353 Formylation
R.GLPSADM(+15.99)AK(+21.98).T Y 18.25 926.4143 9 -22.5 464.2040 2 11.37 6 3087 VEV_3_3_RA6_01_1237.d 0 1 1 482 490 Oxidation (M); Sodium adduct
R.NETVSKTYTTQVVADM(+15.99)IK.E Y 18.05 2043.0194 18 -17.2 409.6041 5 57.61 6 28775 VEV_3_3_RA6_01_1237.d 5.07E5 1 1 642 659 Oxidation (M)
R.VTVLGHTQR(+14.02).G Y 17.98 1023.5825 9 -68.7 512.7634 2 35.99 4 16334 VEV_1_3_RA4_01_1235.d 0 1 1 293 301 Methylation(KR)
R.GGTLIGSARCK(+42.01).S Y 17.92 1103.5757 11 -17.2 368.8595 3 16.34 5 5745 VEV_2_3_RA5_01_1236.d 6.8E4 1 1 80 90 Acetylation (K)
R.GFVIEVMGR(+14.02).N Y 17.40 1020.5426 9 -14.9 511.2710 2 60.57 4 31911 VEV_1_3_RA4_01_1235.d 4.67E4 1 1 202 210 Methylation(KR)
K.N(+.98)MVLR.G Y 16.94 632.3316 5 3.4 317.1742 2 22.70 4 8839 VEV_1_3_RA4_01_1235.d 6.63E4 1 1 104 108 Deamidation (NQ)
R.A(+43.01)AVAYC(+57.02)LAR.G Y 16.70 1036.5123 9 -11.2 519.2576 2 55.46 4 28308 VEV_1_3_RA4_01_1235.d 4.24E3 1 1 424 432 Carbamylation; Carbamidomethylation
R.DFAT(+75.98)ALSMR.D Y 16.65 1086.4661 9 31.4 544.2574 2 60.05 6 30477 VEV_3_3_RA6_01_1237.d 7.74E4 1 1 366 374 EDT
R.G(+27.99)GTLIGSAR.C Y 16.62 858.4559 9 -18.0 859.4478 1 80.57 5 46426 VEV_2_3_RA5_01_1236.d 1.89E4 1 1 80 88 Formylation
R.M(+15.99)SIHC(+57.02)GC(+57.02)EAYAVHEGYEGLVR.G Y 16.59 2453.0562 21 5.0 614.2744 4 65.88 5 35942 VEV_2_3_RA5_01_1236.d 0 1 1 40 60 Oxidation (M); Carbamidomethylation
R.H(+42.01)HADTPIGSVR(+21.98).E Y 16.49 1252.5924 11 0.4 627.3037 2 79.44 5 45686 VEV_2_3_RA5_01_1236.d 2.28E4 1 1 449 459 Acetylation (N-term); Sodium adduct
R.DFATALSMRDAEFK.A Y 16.26 1600.7555 14 -6.9 801.3795 2 80.53 4 47427 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 366 379
R.VFVIET(-18.01)QGGR.S Y 16.26 1086.5822 10 -22.3 363.1932 3 14.52 5 4781 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 577 586 Dehydration
K.I(+27.99)SSSSVK.D Y 16.21 734.3810 7 24.6 368.2068 2 21.46 4 8193 VEV_1_3_RA4_01_1235.d 7.96E4 1 1 274 280 Formylation
K.GRFESR.A Y 16.20 750.3773 6 -15.7 376.1900 2 11.32 5 3118 VEV_2_3_RA5_01_1236.d 7.65E4 1 1 664 669
M.A(+43.01)NVTNM(+15.99)SPVSQSK.R Y 15.95 1420.6616 13 0.4 711.3384 2 55.46 5 28433 VEV_2_3_RA5_01_1236.d 2.94E4 1 1 2 14 Carbamylation; Oxidation (M)
R.S(+226.08)SLVEAVR.V Y 15.86 1085.5540 8 12.1 362.8630 3 44.24 5 21666 VEV_2_3_RA5_01_1236.d 0 1 1 346 353 Biotinylation
R.AYINTATPHHPKM(+15.99)QLPENMRM(+15.99)R.I Y 15.83 2667.2832 22 -3.2 667.8259 4 69.71 5 38785 VEV_2_3_RA5_01_1236.d 2.28E3 1 1 384 405 Oxidation (M)
R.GGTLIGS(+79.97)AR.C Y 15.48 910.4273 9 37.2 304.4943 3 65.14 6 34228 VEV_3_3_RA6_01_1237.d 3.68E4 1 1 80 88 Phosphorylation (STY)
R.GGTLIGSARC(+57.02)KSFM(+15.99)ER.D Y 15.44 1784.8661 16 -23.8 595.9485 3 34.95 5 16136 VEV_2_3_RA5_01_1236.d 2.49E5 1 1 80 95 Carbamidomethylation; Oxidation (M)
K.TYTTQVVADMIK(+42.01).E Y 15.43 1410.7064 12 -13.5 353.6791 4 62.40 5 33338 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 648 659 Acetylation (K)
K.RGDLTDE(+17.03)QVMHFK.T Y 15.27 1591.7776 13 -2.6 398.9506 4 69.16 5 38373 VEV_2_3_RA5_01_1236.d 4.61E4 1 1 142 154 Replacement of proton with ammonium ion
R.GASHAGK(+114.04).I Y 15.21 740.3565 7 11.0 741.3719 1 85.68 5 49565 VEV_2_3_RA5_01_1236.d 2.15E5 1 1 631 637 Ubiquitin
K.C(+105.06)VQHIEQFQGR.S Y 15.03 1448.6982 11 -6.8 363.1794 4 20.18 5 7828 VEV_2_3_RA5_01_1236.d 1.54E5 1 1 697 707 S-pyridylethylation
R.DFATALSM(+15.99)R.D Y 15.01 1026.4805 9 5.6 514.2504 2 30.90 5 13786 VEV_2_3_RA5_01_1236.d 7.54E4 1 1 366 374 Oxidation (M)
total 108 peptides
C1GM03
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YVETEGIAAFAQGAYSKPSIAIVSSGPSTTALSK.W Y 168.17 3400.7402 34 -7.2 1134.5792 3 82.62 4 49014 VEV_1_3_RA4_01_1235.d 2.32E5 4 4 200 233
K.GLVANPTAQALDSTHNVAFHR.G Y 147.48 2218.1243 21 -8.6 555.5336 4 70.01 4 39251 VEV_1_3_RA4_01_1235.d 1.21E6 5 5 163 183
R.SLEAADHATSFLEFTGSR.L Y 132.24 1937.9119 18 -7.6 646.9730 3 77.32 4 44942 VEV_1_3_RA4_01_1235.d 5.48E5 4 4 388 405
K.YSQHELDELVLDLVK.Y Y 122.95 1799.9304 15 -16.4 600.9742 3 86.33 6 49268 VEV_3_3_RA6_01_1237.d 2.45E5 3 3 144 158
R.KYVETEGIAAFAQGAYSKPSIAIVSSGPSTTALSK.W Y 102.84 3528.8350 35 -18.9 883.1993 4 79.97 6 45140 VEV_3_3_RA6_01_1237.d 8.81E4 3 3 199 233
R.DIPTTSSSGPFSPK.A Y 97.51 1419.6881 14 -11.5 710.8432 2 65.73 5 35831 VEV_2_3_RA5_01_1236.d 1.29E6 7 7 241 254
R.YQPFPGYSDLLEK.F Y 96.48 1555.7559 13 -9.9 778.8775 2 80.12 4 47107 VEV_1_3_RA4_01_1235.d 2.64E5 2 2 71 83
K.ASEPSKYFGGEER.I Y 96.09 1455.6630 13 -9.0 486.2239 3 42.54 6 20016 VEV_3_3_RA6_01_1237.d 1.32E6 11 11 255 267
K.ASVSAVGDLHALPFAAEIGLTV Y 94.65 2137.1418 22 -7.8 1069.5698 2 90.95 4 54204 VEV_1_3_RA4_01_1235.d 5.82E5 7 7 442 463
K.GLVAN(+.98)PTAQALDSTHNVAFHR.G Y 94.36 2219.1084 21 0.2 555.7845 4 70.15 4 39326 VEV_1_3_RA4_01_1235.d 5.35E5 3 3 163 183 Deamidation (NQ)
R.GLGENLIPC(+57.02)ASSPFRK.Y Y 89.05 1744.8929 16 -12.7 582.6309 3 75.14 6 41677 VEV_3_3_RA6_01_1237.d 3.97E5 3 3 184 199 Carbamidomethylation
K.VAAGNVSSEDIKK.A Y 80.43 1316.6936 13 3.1 659.3561 2 30.33 5 13488 VEV_2_3_RA5_01_1236.d 5.26E5 8 8 367 379
R.YQPFPGYSDLLEKFAFK.S Y 80.04 2049.0247 17 -13.0 684.0066 3 87.13 6 49730 VEV_3_3_RA6_01_1237.d 5.64E5 3 3 71 87
K.GFEYEVGEAAGVK.F Y 77.93 1354.6404 13 2.0 678.3288 2 68.76 4 38287 VEV_1_3_RA4_01_1235.d 1.88E4 1 1 36 48
K.VAAGNVSSEDIK.K Y 72.20 1188.5986 12 -17.6 595.2961 2 39.81 6 18389 VEV_3_3_RA6_01_1237.d 2.91E5 5 5 367 378
R.ESELLGGELSASHSR.E Y 71.49 1570.7587 15 -11.7 786.3774 2 61.85 4 32883 VEV_1_3_RA4_01_1235.d 1.2E5 3 3 100 114
K.FRSLEAADHATSFLEFTGSR.L Y 71.37 2241.0813 20 4.3 748.0376 3 77.34 5 44264 VEV_2_3_RA5_01_1236.d 9.57E4 1 1 386 405
R.ESELLGGELSASHSRENLVLTAK.F Y 66.58 2439.2605 23 -5.5 814.0896 3 72.31 5 40691 VEV_2_3_RA5_01_1236.d 8.45E4 2 2 100 122
R.SLEAADHATSFLE(+14.02)FTGSR.L Y 64.27 1951.9275 18 -8.1 651.6445 3 78.24 6 43903 VEV_3_3_RA6_01_1237.d 1.42E5 2 2 388 405 Methylation(others)
R.TTTLSLVAK.A Y 59.41 932.5543 9 -28.2 467.2712 2 58.17 5 30263 VEV_2_3_RA5_01_1236.d 5.52E5 6 6 58 66
R.YQPFPGYSDLLEKFAFKSTIKR.S Y 56.76 2634.3845 22 3.3 527.8859 5 82.40 5 47592 VEV_2_3_RA5_01_1236.d 4.89E4 1 1 71 92
R.S(-2.02)LEAADHATSFLEFTGSR.L Y 45.86 1935.8962 18 38.9 646.3311 3 77.33 4 44956 VEV_1_3_RA4_01_1235.d 2.26E5 3 3 388 405 2-amino-3-oxo-butanoic_acid
R.LVHGGKPLQISDIGQGIEK.V Y 45.58 1988.1055 19 -13.3 498.0270 4 66.68 6 35388 VEV_3_3_RA6_01_1237.d 1.44E5 1 1 406 424
R.LVHGGKPLQISDIGQGIEKVTEQQVK.A Y 45.39 2800.5447 26 -2.8 561.1146 5 75.48 5 42929 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 406 431
R.SLE(+6.01)AADHATSFLEFTGSR.L Y 44.19 1943.9200 18 19.7 648.9934 3 77.25 5 44200 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 388 405 Replacement of proton by lithium
R.DIPTTSSSGPFSPK(+14.02).A Y 43.84 1433.7037 14 -3.3 717.8568 2 68.06 5 37574 VEV_2_3_RA5_01_1236.d 2.31E6 3 3 241 254 Methylation(KR)
K.ASVSAVGDLHALPFAAE(+14.02)IGLTV Y 42.41 2151.1575 22 -9.6 1076.5757 2 93.03 4 55319 VEV_1_3_RA4_01_1235.d 1.28E5 3 3 442 463 Methylation(others)
K.FANREVAGR.T Y 41.76 1018.5308 9 -12.5 510.2663 2 19.97 5 7753 VEV_2_3_RA5_01_1236.d 1.33E5 3 3 49 57
K.WVGQLC(+57.02)R.D Y 40.95 917.4542 7 -14.0 459.7279 2 54.50 5 27893 VEV_2_3_RA5_01_1236.d 9.61E5 4 4 234 240 Carbamidomethylation
K.SLLSGK.A Y 34.16 603.3591 6 -22.9 604.3526 1 25.53 5 10787 VEV_2_3_RA5_01_1236.d 3.3E4 2 2 436 441
R.ENLVLTAK.F Y 29.25 886.5123 8 -14.1 444.2572 2 49.58 5 24914 VEV_2_3_RA5_01_1236.d 0 3 3 115 122
K.GLVANPTAQALDSTHN(+.98)VAFHR.G Y 28.97 2219.1084 21 -3.9 555.7822 4 71.20 4 40165 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 163 183 Deamidation (NQ)
R.Y(-2.02)QPFPGYSDLLEKFAFK.S Y 27.37 2047.0090 17 29.4 683.3636 3 87.22 5 50421 VEV_2_3_RA5_01_1236.d 0 1 1 71 87 2-amino-3-oxo-butanoic_acid
K.GLVANPTAQ(+.98)ALDSTHNVAFHR.G Y 26.04 2219.1084 21 -7.3 555.7803 4 70.17 6 37983 VEV_3_3_RA6_01_1237.d 2.53E5 1 1 163 183 Deamidation (NQ)
R.EVAGR(+21.98).T N 24.45 552.2632 5 -4.2 553.2681 1 56.73 4 29120 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 53 57 Sodium adduct
R.EVAGR.T N 24.37 530.2812 5 -14.3 531.2809 1 33.74 5 15420 VEV_2_3_RA5_01_1236.d 0 1 1 53 57
R.EVAGR(+14.02)TTTLSLVAK.A Y 22.32 1458.8406 14 10.9 365.7214 4 64.92 6 34060 VEV_3_3_RA6_01_1237.d 8.76E4 1 1 53 66 Methylation(KR)
K.VAAGNVSSED(-18.01)IK.K Y 22.10 1170.5880 12 6.3 586.3050 2 63.70 6 33150 VEV_3_3_RA6_01_1237.d 0 1 1 367 378 Dehydration
K.SIVETIEK(+14.02).V Y 21.96 931.5226 8 -11.4 466.7632 2 64.93 6 34065 VEV_3_3_RA6_01_1237.d 8.61E4 1 1 359 366 Methylation(KR)
K.ASEPSK(+14.02)Y(-18.01)FGGEER.I Y 21.53 1451.6681 13 8.6 363.9274 4 17.91 6 6454 VEV_3_3_RA6_01_1237.d 7.63E4 1 1 255 267 Methylation(KR); Dehydration
R.EVAGR(+.98).T N 21.33 531.2653 5 12.5 532.2792 1 60.47 5 31895 VEV_2_3_RA5_01_1236.d 5.73E4 1 1 53 57 Deamidation (R)
K.A(+43.01)QSVAAASK.S Y 20.93 874.4508 9 -2.2 438.2317 2 12.67 6 3745 VEV_3_3_RA6_01_1237.d 0 1 1 350 358 Carbamylation
K.AQS(-18.01)VAAASK.S Y 20.82 813.4344 9 46.6 814.4796 1 99.67 6 55208 VEV_3_3_RA6_01_1237.d 0 1 1 350 358 Dehydration
K.AGS(+79.97)RYQPFPGY(+31.99)SDLLEK.F Y 20.29 2038.9037 17 30.1 510.7485 4 23.76 5 9762 VEV_2_3_RA5_01_1236.d 0 1 1 67 83 Phosphorylation (STY); Dihydroxy
K.AQ(+.98)SVAAASK(+42.01).S Y 19.29 874.4396 9 -22.4 438.2173 2 17.01 4 5880 VEV_1_3_RA4_01_1235.d 0 1 1 350 358 Deamidation (NQ); Acetylation (K)
K.A(+42.01)SALAK(+21.98).F Y 19.03 623.3254 6 -23.3 624.3182 1 79.28 5 45579 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 380 385 Acetylation (N-term); Sodium adduct
R.C(+57.02)(+42.01)LRKQ(+.98)C(+57.02)IAQPSTR.R Y 18.96 1659.8185 13 1.7 554.2811 3 71.08 6 38667 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 14 26 Carbamidomethylation; Acetylation (Protein N-term); Deamidation (NQ)
R.RGMAAAANK(+42.01).G Y 18.73 930.4705 9 -37.6 466.2250 2 20.39 6 7760 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 27 35 Acetylation (K)
K.AQSVAAASK(+43.01).S Y 18.44 874.4508 9 -17.4 438.2251 2 20.28 5 7905 VEV_2_3_RA5_01_1236.d 9.89E4 1 1 350 358 Carbamylation
K.YFGGEER.I Y 18.25 856.3715 7 43.4 429.2116 2 29.01 5 12698 VEV_2_3_RA5_01_1236.d 0 1 1 261 267
R.GTSLLAK(+42.01).A Y 18.19 730.4225 7 -27.4 366.2085 2 32.94 4 14539 VEV_1_3_RA4_01_1235.d 1.89E5 2 2 313 319 Acetylation (K)
R.GMAAAANKGFEYEVGEAAGVK.F Y 18.01 2068.9888 21 -6.6 518.2510 4 51.11 5 25827 VEV_2_3_RA5_01_1236.d 0 1 1 28 48
R.E(+43.01)VAGR.T N 17.90 573.2870 5 -17.9 574.2841 1 34.43 4 15411 VEV_1_3_RA4_01_1235.d 0 1 1 53 57 Carbamylation
R.KQC(+57.02)IAQPST(-18.01)R.R Y 17.82 1169.5975 10 -10.9 390.8689 3 34.95 5 16139 VEV_2_3_RA5_01_1236.d 0 1 1 17 26 Carbamidomethylation; Dehydration
K.AQSVAAASK(+14.02)SIVET(+79.97)IEK.V Y 17.38 1824.9233 17 -25.0 457.2267 4 11.63 5 3264 VEV_2_3_RA5_01_1236.d 0 1 1 350 366 Methylation(KR); Phosphorylation (STY)
K.A(+28.03)QSVAAASK.S Y 17.10 859.4763 9 11.3 860.4933 1 99.68 4 58102 VEV_1_3_RA4_01_1235.d 1.39E4 1 1 350 358 Ethylation
R.R(+42.01)(+14.02)GMAAAANK.G Y 16.74 944.4861 9 -40.8 473.2311 2 18.30 6 6667 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 27 35 Acetylation (N-term); Methylation(KR)
K.AQSVAAASK.S Y 16.68 831.4450 9 16.9 832.4663 1 101.84 6 55877 VEV_3_3_RA6_01_1237.d 0 1 1 350 358
K.QC(+57.02)IAQ(+.98)PSTR.R Y 16.67 1060.4972 9 4.1 531.2581 2 54.01 5 27602 VEV_2_3_RA5_01_1236.d 4.48E4 1 1 18 26 Carbamidomethylation; Deamidation (NQ)
R.T(+79.96)T(+79.97)TLSLVAK.A Y 16.55 1092.4774 9 89.6 365.1990 3 24.00 6 9669 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 58 66 Sulfation; Phosphorylation (STY)
R.G(+42.01)TSLLAK.A Y 16.54 730.4225 7 25.0 366.2277 2 27.75 5 11996 VEV_2_3_RA5_01_1236.d 0 1 1 313 319 Acetylation (N-term)
K.A(+42.01)SEPSK(-.98).Y Y 16.45 658.3286 6 -19.3 659.3231 1 65.81 6 34733 VEV_3_3_RA6_01_1237.d 0 1 1 255 260 Acetylation (N-term); Amidation
R.S(-17.03)AFGR.N Y 16.29 519.2441 5 -45.3 520.2279 1 23.48 6 9385 VEV_3_3_RA6_01_1237.d 0 2 2 5 9 Ammonia-loss (Protein N-term)
R.R(+28.03)GMAAAANK.G Y 16.21 916.4913 9 -29.5 459.2394 2 50.76 4 25395 VEV_1_3_RA4_01_1235.d 2.02E5 1 1 27 35 Dimethylation(KR)
R.RGMAAAANK(+21.98).G Y 16.18 910.4419 9 -23.4 456.2176 2 26.75 5 11475 VEV_2_3_RA5_01_1236.d 6.45E4 1 1 27 35 Sodium adduct
R.TTTLSLVAK(+170.04).A Y 16.18 1102.5911 9 -10.0 368.5340 3 29.13 4 12363 VEV_1_3_RA4_01_1235.d 9.38E4 1 1 58 66 Menadione quinone derivative
R.EVAGRTTT(-18.01)LSLVAK(+42.01).A Y 16.15 1468.8250 14 -31.6 368.2019 4 64.50 6 33743 VEV_3_3_RA6_01_1237.d 1.56E5 1 1 53 66 Dehydration; Acetylation (K)
R.S(+42.01)AFGRNAPR.C Y 16.02 1016.5151 9 -17.8 509.2558 2 19.50 6 7301 VEV_3_3_RA6_01_1237.d 2.31E4 1 1 5 13 Acetylation (Protein N-term)
R.K(+42.01)QC(+57.02)IAQPSTR.R Y 15.99 1229.6187 10 -20.6 410.8717 3 35.81 6 16124 VEV_3_3_RA6_01_1237.d 0 1 1 17 26 Acetylation (Protein N-term); Carbamidomethylation
R.YQPFPGYSDLLEK(+14.02).F Y 15.89 1569.7715 13 -12.4 785.8833 2 81.34 6 46148 VEV_3_3_RA6_01_1237.d 0 1 1 71 83 Methylation(KR)
R.GLGENLIPC(+57.02)ASSPFR(+14.02).K Y 15.86 1630.8137 15 -18.9 408.7030 4 19.61 5 7523 VEV_2_3_RA5_01_1236.d 2.11E5 1 1 184 198 Carbamidomethylation; Methylation(KR)
R.S(+42.01)AFGRNAPRC(+57.02)LR.K Y 15.74 1445.7310 12 -10.5 362.4362 4 19.65 5 7542 VEV_2_3_RA5_01_1236.d 1.71E5 1 1 5 16 Acetylation (Protein N-term); Carbamidomethylation
R.TT(+79.97)TLSLVAK.A Y 15.29 1012.5206 9 -16.3 507.2593 2 43.21 5 21045 VEV_2_3_RA5_01_1236.d 1E5 1 1 58 66 Phosphorylation (STY)
R.TTTLSLVAK(-1.03).A Y 15.23 931.5226 9 9.4 932.5386 1 97.64 4 57398 VEV_1_3_RA4_01_1235.d 9.25E3 1 1 58 66 Lysine oxidation to aminoadipic semialdehyde
K.AQ(+.98)SVAAASK.S Y 15.16 832.4290 9 24.2 833.4564 1 83.37 6 47424 VEV_3_3_RA6_01_1237.d 6.26E3 1 1 350 358 Deamidation (NQ)
K.FANR(+28.03)EVAGR.T Y 15.06 1046.5621 9 -56.0 524.2590 2 17.01 6 5988 VEV_3_3_RA6_01_1237.d 2.58E5 1 1 49 57 Dimethylation(KR)
R.ENLVLTAK(+21.98).F Y 15.04 908.4943 8 -56.3 909.4504 1 94.63 6 53451 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 115 122 Sodium adduct
R.G(+210.20)MAAAANK.G Y 15.02 942.5572 8 -49.6 315.1774 3 31.23 6 13545 VEV_3_3_RA6_01_1237.d 0 1 1 28 35 Myristoylation
total 78 peptides
C1GBJ2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.PSAAPLSSTANGNLSANDNIR.R Y 136.54 2069.0137 21 -17.0 690.6668 3 64.98 6 34129 VEV_3_3_RA6_01_1237.d 5.39E5 5 5 2 22
R.AGKDLISALVSGLLTIGSR.F Y 134.03 1870.0887 19 -13.1 936.0394 2 95.75 6 53888 VEV_3_3_RA6_01_1237.d 1.86E6 8 8 462 480
R.ESGIHVPDTFEELPR.V Y 130.80 1724.8369 15 -11.7 575.9462 3 75.91 6 42212 VEV_3_3_RA6_01_1237.d 7.51E5 6 6 327 341
K.GITIIGPATVGGIKPGAFK.I Y 124.23 1796.0559 19 -11.8 599.6855 3 78.18 5 44837 VEV_2_3_RA5_01_1236.d 8.32E5 6 6 163 181
R.FGGALDGAAEEFTK.A Y 121.30 1411.6619 14 -13.5 706.8287 2 74.67 6 41331 VEV_3_3_RA6_01_1237.d 6.84E5 6 6 481 494
R.SVYSSTMELMQYPQIK.L Y 121.24 1903.9060 16 -17.4 635.6316 3 81.99 4 48536 VEV_1_3_RA4_01_1235.d 4.28E5 6 6 123 138
K.IGNTGGMMDNIVASK.L Y 110.58 1506.7170 15 -9.1 754.3589 2 69.13 4 38539 VEV_1_3_RA4_01_1235.d 3.69E5 3 3 182 196
K.IPIDYAWAQELGLIR.K Y 108.99 1756.9512 15 -17.2 586.6476 3 89.87 6 51244 VEV_3_3_RA6_01_1237.d 2.5E5 3 3 367 381
R.STPSVAGIIYTFGGQFVSK.M Y 106.85 1958.0149 19 -11.3 980.0037 2 89.83 6 51221 VEV_3_3_RA6_01_1237.d 1.29E6 6 6 68 86
K.EKGITIIGPATVGGIKPGAFK.I Y 103.91 2053.1934 21 -5.5 514.3028 4 75.07 4 43252 VEV_1_3_RA4_01_1235.d 3.57E5 3 3 161 181
K.AMSKHPDVDTVVNFASSR.S Y 101.06 1959.9473 18 -20.0 490.9843 4 67.34 4 37109 VEV_1_3_RA4_01_1235.d 4.01E5 3 3 105 122
K.LIAIIAEGVPERR.A Y 92.56 1435.8511 13 -9.3 479.6199 3 71.19 4 40154 VEV_1_3_RA4_01_1235.d 6.96E5 5 5 139 151
M.PSAAPLSSTANGNLSANDNIRR.F Y 89.94 2225.1147 22 -10.5 742.7044 3 60.63 5 32095 VEV_2_3_RA5_01_1236.d 7.44E5 5 5 2 23
K.HPDVDTVVNFASSR.S Y 86.29 1542.7427 14 -5.5 515.2520 3 69.57 4 38879 VEV_1_3_RA4_01_1235.d 7.1E5 4 4 109 122
K.LIAIIAEGVPER.R Y 85.36 1279.7499 12 -9.2 640.8763 2 76.97 4 44671 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 139 150
R.AVQGMLDFDFIC(+57.02)KR.S Y 82.58 1698.8221 14 -8.5 567.2765 3 80.46 5 46351 VEV_2_3_RA5_01_1236.d 3.28E5 3 3 54 67 Carbamidomethylation
K.MYWGTSETLLPVYQEVEK.A Y 80.78 2172.0449 18 -7.9 1087.0211 2 85.04 4 50614 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 87 104
M.PSAAPLSSTAN(+.98)GNLSANDNIR.R Y 79.74 2069.9978 21 -4.2 691.0037 3 66.06 4 36150 VEV_1_3_RA4_01_1235.d 4.62E5 3 3 2 22 Deamidation (NQ)
R.FGGALDGAAEEFTKAFDR.G Y 78.64 1900.8955 18 -1.5 634.6382 3 83.23 4 49382 VEV_1_3_RA4_01_1235.d 3.41E4 2 2 481 498
M.PSAAPLSSTAN(+.98)GNLSANDNIRR.F Y 74.74 2226.0989 22 -11.9 743.0314 3 61.36 6 31443 VEV_3_3_RA6_01_1237.d 1.39E6 9 9 2 23 Deamidation (NQ)
R.C(+57.02)FVYGMQPR.A Y 71.73 1156.5157 9 -6.0 579.2617 2 64.80 4 35117 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 45 53 Carbamidomethylation
R.AGKDLISALVSGLLTIGSR(+14.02).F Y 71.48 1884.1044 19 -10.0 629.0358 3 96.64 5 54878 VEV_2_3_RA5_01_1236.d 9.02E4 3 3 462 480 Methylation(KR)
K.IGNTGGM(+15.99)M(+15.99)DNIVASK.L Y 71.37 1538.7069 15 -7.0 770.3553 2 44.58 4 21501 VEV_1_3_RA4_01_1235.d 6.79E4 1 1 182 196 Oxidation (M)
R.ESGIHVPDTFE(+14.02)ELPR.V Y 70.50 1738.8525 15 -27.9 580.6086 3 77.78 6 43587 VEV_3_3_RA6_01_1237.d 8.09E4 3 3 327 341 Methylation(others)
R.FSAPSRPLTPLEHTLFHDKTR.C Y 68.30 2449.2866 21 -4.7 490.8623 5 70.17 4 39338 VEV_1_3_RA4_01_1235.d 3.53E5 2 2 24 44
R.KPAAFISTISDDR.G Y 68.00 1419.7357 13 -6.2 710.8707 2 63.33 4 34050 VEV_1_3_RA4_01_1235.d 3.45E5 3 3 382 394
K.ILLLLGEVGGVEEYR.V Y 66.66 1658.9243 15 -12.9 830.4587 2 85.70 6 48896 VEV_3_3_RA6_01_1237.d 2.06E4 1 1 258 272
R.HPWDDITYLLPTLQK.G Y 63.81 1838.9567 15 -9.5 613.9870 3 86.81 4 51761 VEV_1_3_RA4_01_1235.d 4.28E4 1 1 632 646
M.PSAAPLSSTANGNLSAN(+.98)DNIRR.F Y 61.70 2226.0989 22 -9.6 743.0331 3 62.74 4 33584 VEV_1_3_RA4_01_1235.d 1.87E5 2 2 2 23 Deamidation (NQ)
R.STPSVAGIIYTFGGQ(+.98)FVSK.M Y 61.30 1958.9989 19 -12.7 980.4943 2 90.68 6 51670 VEV_3_3_RA6_01_1237.d 4.33E4 3 3 68 86 Deamidation (NQ)
K.IPIDYAWAQE(+14.02)LGLIR.K Y 52.72 1770.9668 15 -6.4 591.3257 3 92.59 4 55090 VEV_1_3_RA4_01_1235.d 0 1 1 367 381 Methylation(others)
R.SVYSSTMELMQ(+.98)YPQIK.L Y 52.64 1904.8900 16 1.3 953.4535 2 82.50 5 47647 VEV_2_3_RA5_01_1236.d 5.21E4 1 1 123 138 Deamidation (NQ)
R.ES(+14.02)GIHVPDTFEELPR.V Y 51.35 1738.8525 15 -21.1 580.6125 3 76.57 4 44362 VEV_1_3_RA4_01_1235.d 8.22E4 1 1 327 341 Methylation(others)
R.SIGLIAHFLDQK.R Y 50.66 1340.7452 12 -14.7 447.9158 3 80.48 4 47393 VEV_1_3_RA4_01_1235.d 5.38E4 2 2 612 623
R.SIGLIAHFLDQKR.L Y 50.50 1496.8463 13 -19.2 375.2117 4 76.85 5 43911 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 612 624
R.KGSVGYVSK.S Y 47.33 923.5076 9 -16.3 462.7535 2 13.75 6 4314 VEV_3_3_RA6_01_1237.d 1.09E5 3 3 200 208
K.SGGMSNELNNIISQNTDGVYEGVAIGGDRYPGTTFIDHLLR.Y Y 44.64 4380.1079 41 39.9 877.0638 5 89.22 4 53225 VEV_1_3_RA4_01_1235.d 1.27E5 3 3 209 249
K.Q(-17.03)GTIKPEPEPVPPK.I Y 43.50 1498.8031 14 9.3 750.4158 2 60.40 4 31785 VEV_1_3_RA4_01_1235.d 0 2 2 353 366 Pyro-glu from Q
R.E(+14.02)SGIHVPDTFEELPR.V Y 39.32 1738.8525 15 -34.8 580.6046 3 76.49 6 42623 VEV_3_3_RA6_01_1237.d 0 1 1 327 341 Methylation(others)
K.IGNTGGM(+15.99)MDNIVASK.L Y 38.32 1522.7119 15 -1.2 762.3623 2 60.90 4 32159 VEV_1_3_RA4_01_1235.d 2.89E4 2 2 182 196 Oxidation (M)
R.VLADVYK.K Y 36.88 806.4538 7 -39.2 404.2184 2 48.00 4 23628 VEV_1_3_RA4_01_1235.d 0 3 3 342 348
R.ESGIHVPDT(-2.02)FEELPR.V Y 36.14 1722.8213 15 10.9 575.2873 3 75.89 6 42198 VEV_3_3_RA6_01_1237.d 9.22E4 2 2 327 341 2-amino-3-oxo-butanoic_acid
R.YPGTTFIDHLLR.Y Y 35.99 1431.7510 12 -11.6 478.2521 3 80.03 6 45179 VEV_3_3_RA6_01_1237.d 1.19E5 1 1 238 249
K.GAPGAEGRVEVSM Y 34.76 1258.5975 13 -1.6 630.3051 2 60.35 4 31750 VEV_1_3_RA4_01_1235.d 1.78E5 2 2 647 659
K.LLDYAIAVETVTTSK.K Y 34.28 1622.8767 15 -26.0 812.4246 2 81.66 4 48288 VEV_1_3_RA4_01_1235.d 2.67E4 1 1 549 563
M(+15.99)PSAAPLSSTANGNLSANDNIR.R Y 32.83 2216.0491 22 -28.2 555.0039 4 16.57 4 5607 VEV_1_3_RA4_01_1235.d 1.04E6 3 3 1 22 Oxidation (M)
R.TGLYRHPWDDITYLLPTLQK.G Y 31.79 2429.2742 20 -3.2 608.3239 4 85.19 6 48586 VEV_3_3_RA6_01_1237.d 0 1 1 627 646
R.VLADVYKK.L Y 27.02 934.5487 8 -9.0 312.5207 3 33.89 4 15122 VEV_1_3_RA4_01_1235.d 4.27E5 2 2 342 349
R.ESGIHVPDTFEELPR(+14.02).V Y 26.86 1738.8525 15 -20.6 580.6129 3 78.24 6 43923 VEV_3_3_RA6_01_1237.d 0 1 1 327 341 Methylation(KR)
R.AVQGM(+15.99)LDFDFIC(+57.02)K.R Y 26.80 1558.7159 13 30.7 390.6982 4 33.51 4 14879 VEV_1_3_RA4_01_1235.d 7.06E4 1 1 54 66 Oxidation (M); Carbamidomethylation
R.GLSP(+31.99)R.D N 22.43 560.2918 5 -18.7 561.2886 1 70.46 6 38201 VEV_3_3_RA6_01_1237.d 0 1 1 499 503 Dihydroxy
R.EDIGIGGVM(+15.99)SLLWFR.R Y 21.54 1707.8654 15 -19.6 570.2845 3 77.62 6 43458 VEV_3_3_RA6_01_1237.d 2.24E4 1 1 411 425 Oxidation (M)
R.VEVSM Y 21.37 563.2625 5 5.7 564.2730 1 82.14 5 47439 VEV_2_3_RA5_01_1236.d 6.51E4 3 3 655 659
R.FSAPSRPLTPLEHTLFHDK.T Y 21.24 2192.1377 19 1.4 439.4354 5 73.28 4 41807 VEV_1_3_RA4_01_1235.d 8.38E4 1 1 24 42
R.EIMVAAK(+226.08).E Y 19.61 986.4929 7 6.2 494.2567 2 47.65 6 22944 VEV_3_3_RA6_01_1237.d 0 1 1 154 160 Biotinylation
K.GSVGYVSK.S Y 19.11 795.4127 8 -28.5 398.7023 2 23.21 6 9246 VEV_3_3_RA6_01_1237.d 4.93E4 1 1 201 208
K.NFPSHK.L Y 18.82 728.3605 6 -5.8 729.3636 1 91.55 6 52095 VEV_3_3_RA6_01_1237.d 6.79E4 3 3 543 548
K.G(+43.01)SVGYVSK.S Y 18.61 838.4185 8 -10.5 420.2121 2 22.16 5 8894 VEV_2_3_RA5_01_1236.d 6.96E4 1 1 201 208 Carbamylation
K.GSVGYVS(-18.01)K.S Y 18.07 777.4021 8 -11.2 778.4006 1 87.75 4 52347 VEV_1_3_RA4_01_1235.d 0 1 1 201 208 Dehydration
R.VEVS(+14.02)M Y 17.41 577.2781 5 -1.4 578.2846 1 36.45 4 16607 VEV_1_3_RA4_01_1235.d 8.13E4 1 1 655 659 Methylation(others)
R.DFVD(-18.01)TMRR.E Y 17.23 1020.4811 8 12.8 511.2543 2 41.47 5 20003 VEV_2_3_RA5_01_1236.d 9.92E4 1 1 504 511 Dehydration
K.GAPGAEGR(+21.98).V Y 17.19 735.3276 8 19.4 736.3491 1 76.11 6 42355 VEV_3_3_RA6_01_1237.d 6.21E4 2 2 647 654 Sodium adduct
R.E(+42.01)IMVAAK(+14.02).E Y 17.18 816.4415 7 -27.2 409.2169 2 29.13 6 12402 VEV_3_3_RA6_01_1237.d 0 1 1 154 160 Acetylation (N-term); Methylation(KR)
R.YQAD(-18.01)PKC(+57.02)K.I Y 16.87 990.4593 8 27.3 331.1694 3 18.44 6 6731 VEV_3_3_RA6_01_1237.d 0 1 1 250 257 Dehydration; Carbamidomethylation
K.GAPGAEGR.V Y 16.83 713.3456 8 -5.9 714.3486 1 110.16 4 61168 VEV_1_3_RA4_01_1235.d 4.99E4 1 1 647 654
R.GLSPR.D N 16.82 528.3020 5 -66.7 529.2740 1 53.12 5 27059 VEV_2_3_RA5_01_1236.d 8.8E4 2 2 499 503
R.KPAAFISTISDD(-18.01)R.G Y 16.76 1401.7252 13 -17.4 468.2409 3 41.14 6 19150 VEV_3_3_RA6_01_1237.d 4.58E4 1 1 382 394 Dehydration
R.FGGALDGAAEEFT(-18.01)K(+14.02).A Y 16.44 1407.6670 14 5.0 470.2319 3 32.06 6 14045 VEV_3_3_RA6_01_1237.d 4.51E5 1 1 481 494 Dehydration; Methylation(KR)
R.YQADPK(-.98).C Y 16.40 719.3602 6 -2.8 720.3655 1 111.57 4 61544 VEV_1_3_RA4_01_1235.d 0 1 1 250 255 Amidation
R.EIMVAAK(+111.03).E Y 16.39 871.4473 7 -16.4 872.4403 1 92.37 6 52473 VEV_3_3_RA6_01_1237.d 5.05E4 1 1 154 160 Nmethylmaleimide
M(+15.99)PS(+162.05)AAPLSSTANGNLSANDNIR.R Y 16.32 2378.1018 22 -27.5 595.5164 4 15.88 5 5522 VEV_2_3_RA5_01_1236.d 1.39E5 1 1 1 22 Oxidation (M); Hexose (NSY)
R.KPAAFIS(+79.97)TISDDR(+31.99).G Y 16.29 1531.6919 13 -26.3 511.5578 3 73.88 6 40732 VEV_3_3_RA6_01_1237.d 0 1 1 382 394 Phosphorylation (STY); Dihydroxy
R.ANPDLRVELVKEFVHK.N Y 16.26 1893.0471 16 -20.6 379.6089 5 74.00 6 40815 VEV_3_3_RA6_01_1237.d 7.62E4 1 1 527 542
R.EIMVAAK.E Y 16.19 760.4153 7 -17.0 761.4097 1 102.79 5 56887 VEV_2_3_RA5_01_1236.d 3.85E4 1 1 154 160
K.M(+15.99)YWGTSETLLPVYQEVEKAM(+15.99)SK.H Y 16.00 2621.2393 22 -30.8 656.2969 4 58.05 6 29064 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 87 108 Oxidation (M)
R.E(+42.01)NK(+43.01)LIPGIGHK.V Y 15.99 1289.7091 11 -67.7 645.8182 2 66.39 6 35171 VEV_3_3_RA6_01_1237.d 7.68E4 1 1 512 522 Acetylation (N-term); Carbamylation
R.EIM(+15.99)VAAK.E Y 15.96 776.4102 7 -22.1 389.2038 2 42.11 6 19716 VEV_3_3_RA6_01_1237.d 0 1 1 154 160 Oxidation (M)
R.LPIYASK.F Y 15.70 790.4589 7 -38.8 396.2214 2 45.17 4 21872 VEV_1_3_RA4_01_1235.d 0 1 1 428 434
K.YMRESGIHVPDTFEELPR.V Y 15.58 2175.0417 18 -48.8 725.9858 3 84.76 4 50420 VEV_1_3_RA4_01_1235.d 0 1 1 324 341
R.RENKLIPGIGH(+72.02)K.V Y 15.45 1432.8149 12 -7.5 359.2083 4 12.86 5 3892 VEV_2_3_RA5_01_1236.d 0 1 1 511 522 Ethoxyformylation
K.AMS(-18.01)KHPDVDTVVNFASSR.S Y 15.36 1941.9366 18 -8.7 648.3138 3 66.95 4 36805 VEV_1_3_RA4_01_1235.d 1.48E4 1 1 105 122 Dehydration
MPSAAPLSSTANGNLSANDNIR.R Y 15.13 2200.0542 22 -28.0 551.0054 4 24.50 4 9851 VEV_1_3_RA4_01_1235.d 8.83E5 1 1 1 22
R.SVYSSTMELMQYPQ(+.98)IK.L Y 15.11 1904.8900 16 5.4 953.4575 2 59.82 5 31425 VEV_2_3_RA5_01_1236.d 6.06E4 1 1 123 138 Deamidation (NQ)
total 83 peptides
C1GHJ0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.INPYMSSPC(+57.02)HIELILTEGSEEVQKPSTEIK.A Y 157.36 3428.6843 30 -6.5 1143.8947 3 81.10 4 47887 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 194 223 Carbamidomethylation
K.NAEANADTKGLDTSNLIVQHIQVNQAPK.Q Y 151.70 2988.5264 28 -12.8 748.1293 4 72.29 5 40679 VEV_2_3_RA5_01_1236.d 1.46E6 7 7 155 182
K.GLDTSNLIVQHIQVNQAPK.Q Y 149.89 2074.1172 19 -11.5 1038.0540 2 74.40 5 42170 VEV_2_3_RA5_01_1236.d 5.27E6 13 13 164 182
K.GLDTSNLIVQHIQVNQAPKQR.R Y 119.89 2358.2769 21 -20.0 590.5647 4 69.96 5 38959 VEV_2_3_RA5_01_1236.d 9.27E4 2 2 164 184
R.WPVKSAEFLLSLLK.N Y 115.27 1629.9493 14 -10.5 544.3180 3 89.52 4 53426 VEV_1_3_RA4_01_1235.d 5.74E5 4 4 141 154
K.SAEFLLSLLKNAEANADTK.G Y 113.35 2034.0632 19 -11.8 679.0204 3 86.32 5 49920 VEV_2_3_RA5_01_1236.d 9.23E5 6 6 145 163
R.AVAYLENVMAHK.E Y 100.71 1344.6860 12 -13.5 673.3412 2 67.41 5 37109 VEV_2_3_RA5_01_1236.d 1.31E6 8 8 102 113
K.ARWPVKSAEFLLSLLK.N Y 99.33 1857.0875 16 -3.8 465.2774 4 87.55 4 52253 VEV_1_3_RA4_01_1235.d 1.35E6 10 10 139 154
R.INPYM(+15.99)SSPC(+57.02)HIELILTEGSEEVQKPSTEIK.A Y 96.72 3444.6792 30 -12.2 862.1666 4 79.36 4 46521 VEV_1_3_RA4_01_1235.d 1.52E5 2 2 194 223 Oxidation (M); Carbamidomethylation
R.AVAYLENVMAHKEAVPMRR.Y Y 96.18 2184.1296 19 -11.0 437.8284 5 67.76 4 37445 VEV_1_3_RA4_01_1235.d 5.11E5 2 2 102 120
R.WPVKSAEFLLSLLKNAEANADTK.G Y 93.00 2544.3586 23 -10.3 637.0904 4 89.32 5 51539 VEV_2_3_RA5_01_1236.d 1.64E5 2 2 141 163
R.YAAQSIQSTK.S Y 91.36 1095.5560 10 -12.7 548.7783 2 27.53 5 11909 VEV_2_3_RA5_01_1236.d 1.87E6 9 9 62 71
K.SAEFLLSLLK.N Y 89.53 1119.6539 10 -15.0 560.8259 2 86.74 6 49541 VEV_3_3_RA6_01_1237.d 3.38E6 12 12 145 154
K.GLDTSNLIVQHIQ(+.98)VNQAPK.Q Y 78.73 2075.1011 19 -6.6 692.7031 3 75.36 4 43411 VEV_1_3_RA4_01_1235.d 9.2E5 5 5 164 182 Deamidation (NQ)
K.NAEANADTKGLDTSNLIVQHIQVN(+.98)QAPK.Q Y 78.41 2989.5105 28 -7.4 748.3793 4 73.30 4 41867 VEV_1_3_RA4_01_1235.d 2.61E5 2 2 155 182 Deamidation (NQ)
K.NAEANADTKGLDT(-2.02)SNLIVQHIQVNQAPK.Q Y 78.03 2986.5107 28 -14.3 598.3009 5 72.23 6 39540 VEV_3_3_RA6_01_1237.d 5.47E4 1 1 155 182 2-amino-3-oxo-butanoic_acid
R.AVAYLENVM(+15.99)AHK.E Y 75.22 1360.6809 12 -9.7 681.3411 2 57.09 4 29374 VEV_1_3_RA4_01_1235.d 5.92E5 5 5 102 113 Oxidation (M)
K.GLDTSNLIVQHIQVN(+.98)QAPK.Q Y 73.35 2075.1011 19 -10.2 692.7006 3 75.38 5 42921 VEV_2_3_RA5_01_1236.d 3.31E5 1 1 164 182 Deamidation (NQ)
R.ETAQAINGWKLQR.A Y 73.28 1513.8000 13 -10.7 505.6019 3 63.01 4 33825 VEV_1_3_RA4_01_1235.d 5.65E5 3 3 89 101
R.ETAQAINGWK.L Y 72.54 1116.5564 10 -9.0 559.2805 2 52.50 4 26483 VEV_1_3_RA4_01_1235.d 1.14E6 6 6 89 98
R.ETAQAIN(+.98)GWKLQR.A Y 71.61 1514.7841 13 5.1 505.9379 3 62.66 4 33497 VEV_1_3_RA4_01_1235.d 5.96E5 7 7 89 101 Deamidation (NQ)
K.SAEFLLSLLK(+14.02).N Y 71.25 1133.6696 10 -8.7 567.8371 2 88.93 4 53070 VEV_1_3_RA4_01_1235.d 2.53E5 3 3 145 154 Methylation(KR)
R.AVAYLENVMAHKEAVPMR.R Y 68.50 2028.0284 18 -4.4 677.0138 3 71.55 4 40442 VEV_1_3_RA4_01_1235.d 1.89E5 3 3 102 119
R.C(+58.01)AQGKQFGVSK.A Y 64.43 1209.5812 11 -14.7 605.7890 2 26.21 5 11158 VEV_2_3_RA5_01_1236.d 5.56E5 4 4 128 138 Carboxymethyl
R.ETAQAIN(+.98)GWK.L Y 63.64 1117.5404 10 -2.3 559.7762 2 50.91 4 25454 VEV_1_3_RA4_01_1235.d 7.75E5 5 5 89 98 Deamidation (NQ)
K.NAEAN(+.98)ADTKGLDTSN(+.98)LIVQHIQVNQAPK.Q Y 60.16 2990.4944 28 2.5 599.1077 5 72.36 5 40730 VEV_2_3_RA5_01_1236.d 2.48E4 1 1 155 182 Deamidation (NQ)
R.YAAQ(+.98)SIQSTK.S Y 59.59 1096.5400 10 -11.9 549.2708 2 31.21 4 13548 VEV_1_3_RA4_01_1235.d 2.36E5 3 3 62 71 Deamidation (NQ)
K.ARWPVKSAEFLLSLLKNAEANADTK.G Y 59.28 2771.4968 25 -3.2 693.8793 4 88.71 5 51229 VEV_2_3_RA5_01_1236.d 7.54E5 3 3 139 163
R.VSFKNTR.E Y 55.72 850.4661 7 -14.4 426.2342 2 15.86 5 5525 VEV_2_3_RA5_01_1236.d 8.62E5 5 5 82 88
K.SAE(+14.02)FLLSLLK.N Y 55.06 1133.6696 10 -16.2 567.8329 2 87.83 6 50129 VEV_3_3_RA6_01_1237.d 4.32E5 3 3 145 154 Methylation(others)
K.GLDTSNLIVQ(+.98)HIQVNQAPK.Q Y 52.86 2075.1011 19 -14.1 692.6979 3 75.67 6 42047 VEV_3_3_RA6_01_1237.d 2.28E5 1 1 164 182 Deamidation (NQ)
K.NAE(+14.02)ANADTKGLDTSNLIVQHIQVNQAPK.Q Y 51.70 3002.5420 28 4.9 751.6465 4 73.58 4 42032 VEV_1_3_RA4_01_1235.d 0 1 1 155 182 Methylation(others)
R.YAAQSIQSTK(+14.02).S Y 49.87 1109.5717 10 3.5 555.7950 2 38.58 4 17856 VEV_1_3_RA4_01_1235.d 2.17E5 3 3 62 71 Methylation(KR)
R.AVAYLE(+14.02)NVMAHK.E Y 49.20 1358.7017 12 -11.2 453.9028 3 70.00 4 39212 VEV_1_3_RA4_01_1235.d 1.88E5 2 2 102 113 Methylation(others)
R.SRGSYLR.V Y 48.39 837.4457 7 -13.3 419.7245 2 15.49 5 5315 VEV_2_3_RA5_01_1236.d 9.91E5 6 6 75 81
K.GLDTSNLIVQHIQVNQAPK(+14.02).Q Y 48.34 2088.1328 19 -15.1 523.0326 4 75.87 4 43813 VEV_1_3_RA4_01_1235.d 2.25E5 1 1 164 182 Methylation(KR)
R.YAAQSIQ(+.98)STK.S Y 44.63 1096.5400 10 -11.9 549.2708 2 33.46 4 14878 VEV_1_3_RA4_01_1235.d 1.66E5 3 3 62 71 Deamidation (NQ)
K.GLDTSN(+.98)LIVQHIQVNQAPK.Q Y 44.32 2075.1011 19 -1.8 519.7816 4 74.59 5 42312 VEV_2_3_RA5_01_1236.d 4.59E4 1 1 164 182 Deamidation (NQ)
R.WPVK(+14.02)S(+162.05)AEFLLSLLKNAEANADTK.G Y 43.62 2720.4272 23 -61.0 681.0726 4 86.47 4 51543 VEV_1_3_RA4_01_1235.d 0 1 1 141 163 Methylation(KR); Hexose (NSY)
K.ARWPVKSAE(+43.99)FLLSLLK.N Y 40.29 1901.0774 16 -70.7 476.2430 4 87.89 5 50787 VEV_2_3_RA5_01_1236.d 1.09E5 2 2 139 154 Carboxylation (E)
K.QFGVSK.A Y 37.44 664.3544 6 -11.7 333.1806 2 22.65 4 8801 VEV_1_3_RA4_01_1235.d 6.65E5 3 3 133 138
R.ETAQ(+.98)AINGWKLQR.A Y 34.94 1514.7841 13 -17.1 505.9266 3 64.28 6 33565 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 89 101 Deamidation (NQ)
R.INPYMSSPC(+57.02)HIELILTEGSE(+14.02)EVQKPSTEIK.A Y 33.94 3442.7000 30 -11.5 861.6724 4 81.48 4 48148 VEV_1_3_RA4_01_1235.d 7.2E4 1 1 194 223 Carbamidomethylation; Methylation(others)
K.GLDTSN(+.98)LIVQHIQVN(+.98)QAPK.Q Y 33.22 2076.0852 19 4.4 520.0309 4 75.60 4 43600 VEV_1_3_RA4_01_1235.d 2.98E5 1 1 164 182 Deamidation (NQ)
K.GLD(+37.03)TSNLIVQHIQVNQAPK.Q Y 32.99 2111.1487 19 20.0 528.8050 4 74.47 4 42724 VEV_1_3_RA4_01_1235.d 5.79E4 1 1 164 182 Propargylamine
R.AVAYLENVMAHK(+14.02).E Y 32.73 1358.7017 12 -14.1 680.3485 2 69.45 5 38594 VEV_2_3_RA5_01_1236.d 6.11E5 2 2 102 113 Methylation(KR)
K.NAEANADTKGLDTSNLIVQ(+.98)HIQVNQAPK.Q Y 32.54 2989.5105 28 -43.3 748.3525 4 73.75 4 42182 VEV_1_3_RA4_01_1235.d 0 1 1 155 182 Deamidation (NQ)
R.Q(-17.03)RGAQIR.R Y 31.19 810.4460 7 -13.7 406.2247 2 17.52 4 6096 VEV_1_3_RA4_01_1235.d 2.27E5 2 2 230 236 Pyro-glu from Q
R.AVAYLEN(+.98)VMAHK.E Y 29.67 1345.6700 12 3.1 449.5653 3 67.73 4 37422 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 102 113 Deamidation (NQ)
R.YAAQSIQSTKSAR.S Y 26.87 1409.7263 13 -15.7 470.9087 3 25.22 5 10613 VEV_2_3_RA5_01_1236.d 3.32E4 1 1 62 74
M(+15.99)VGPHTVTNK.A Y 26.20 1098.5492 10 -21.4 550.2701 2 60.21 5 31708 VEV_2_3_RA5_01_1236.d 6.17E4 2 2 1 10 Oxidation (M)
R.ETAQAINGW(+31.99)K.L Y 25.15 1148.5461 10 -13.2 575.2728 2 27.80 6 11672 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 89 98 Dihydroxy
R.WDASLT(+79.97)YVSRTQVR.Y Y 24.91 1760.8247 14 6.8 881.4256 2 78.90 6 44372 VEV_3_3_RA6_01_1237.d 7.01E4 1 1 48 61 Phosphorylation (STY)
R.Q(-17.03)RGAQIRR.A Y 24.49 966.5471 8 -10.7 323.1862 3 14.71 4 4671 VEV_1_3_RA4_01_1235.d 2.81E5 1 1 230 237 Pyro-glu from Q
R.GAQIR.R N 24.22 543.3129 5 -35.3 544.3010 1 37.76 5 17797 VEV_2_3_RA5_01_1236.d 1.8E5 1 1 232 236
R.E(+14.02)TAQAINGWKLQR.A Y 23.75 1527.8158 13 -49.9 510.2538 3 64.73 4 35078 VEV_1_3_RA4_01_1235.d 5.4E5 2 2 89 101 Methylation(others)
K.EAVPMRR.Y Y 22.84 857.4541 7 -5.2 429.7321 2 18.73 4 6726 VEV_1_3_RA4_01_1235.d 8.63E4 1 1 114 120
R.AVAYLENVM(-48.00)AHK.E Y 22.67 1296.6826 12 -8.3 433.2312 3 42.58 4 20268 VEV_1_3_RA4_01_1235.d 5.65E5 1 1 102 113 Dethiomethyl
K.L(+42.01)QRAVAYLENVMAHK.E Y 22.62 1783.9403 15 -36.5 892.9449 2 84.59 4 50309 VEV_1_3_RA4_01_1235.d 1.06E4 1 1 99 113 Acetylation (N-term)
R.WDASLTYVSRTQVR.Y Y 22.05 1680.8584 14 -16.1 421.2151 4 40.42 4 18935 VEV_1_3_RA4_01_1235.d 8.09E4 1 1 48 61
K.EAVPMR(+54.01).R Y 21.32 755.3636 6 11.1 756.3793 1 81.32 5 46908 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 114 119 Methylglyoxal-derived hydroimidazolone
R.AITAA Y 19.95 445.2536 5 -19.8 446.2521 1 36.18 4 16438 VEV_1_3_RA4_01_1235.d 7.67E4 2 2 238 242
R.GPSFT(+79.97)TTTVPR.W Y 19.80 1242.5646 11 19.8 622.3019 2 55.45 4 28305 VEV_1_3_RA4_01_1235.d 0 1 1 37 47 Phosphorylation (STY)
MVGPHTVTNK(+21.98).A Y 19.26 1104.5363 10 -9.4 553.2702 2 73.60 6 40526 VEV_3_3_RA6_01_1237.d 7.47E4 1 1 1 10 Sodium adduct
R.R(+42.01)R(+31.99)GPSFTTTTVPR.W Y 18.19 1548.8008 13 -2.9 388.2064 4 40.80 6 18952 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 35 47 Acetylation (N-term); Dihydroxy
R.R(+14.02)GPSFTTTTVPR.W Y 17.90 1332.7150 12 36.5 334.1982 4 37.46 6 17030 VEV_3_3_RA6_01_1237.d 0 1 1 36 47 Methylation(KR)
R.IN(+.98)PYMSSPC(+57.02)HIELILTEGSEEVQKPSTEIK.A Y 17.84 3429.6682 30 5.4 858.4290 4 81.51 4 48170 VEV_1_3_RA4_01_1235.d 0 1 1 194 223 Deamidation (NQ); Carbamidomethylation
K.GLDTSN(+.98)LIVQHIQ(+.98)VNQAPK.Q Y 17.73 2076.0852 19 8.4 520.0330 4 75.61 5 43032 VEV_2_3_RA5_01_1236.d 4.73E5 2 2 164 182 Deamidation (NQ)
R.ETAQAINGW(+15.99)K.L Y 17.59 1132.5513 10 -5.7 567.2797 2 45.72 4 22236 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 89 98 Oxidation (HW)
R.A(+42.01)IT(+79.97)AA Y 17.53 567.2305 5 25.0 568.2520 1 34.33 4 15348 VEV_1_3_RA4_01_1235.d 4.99E4 1 1 238 242 Acetylation (N-term); Phosphorylation (STY)
R.R(+14.02)YAGSTGR(+14.02).C Y 17.42 894.4672 8 -17.5 448.2330 2 23.05 6 9156 VEV_3_3_RA6_01_1237.d 0 1 1 120 127 Methylation(KR)
K.S(+13.03)AEFLLSLLK.N Y 17.41 1132.6855 10 -59.7 567.3162 2 88.50 4 52832 VEV_1_3_RA4_01_1235.d 0 1 1 145 154 Michael addition with methylamine
R.WPVK(+14.02)S(-18.01)AEFLLSLLK.N Y 17.37 1625.9545 14 -84.5 542.9463 3 89.93 6 51280 VEV_3_3_RA6_01_1237.d 0 1 1 141 154 Methylation(KR); Dehydration
K.N(+42.01)TRETAQAIN(+.98)GWK(+14.02).L Y 17.29 1544.7583 13 9.1 387.2004 4 15.56 5 5343 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 86 98 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
M(+42.01)VGPHTVTNK.A Y 17.20 1124.5648 10 -12.0 563.2830 2 45.39 5 22365 VEV_2_3_RA5_01_1236.d 0 1 1 1 10 Acetylation (Protein N-term)
R.TQVRYAAQSIQ(+.98)STK(+43.99).S Y 17.19 1624.8057 14 3.4 813.4129 2 83.89 4 49872 VEV_1_3_RA4_01_1235.d 2.01E4 1 1 58 71 Deamidation (NQ); Carboxylation (DKW)
R.A(+42.01)ITAA Y 16.60 487.2642 5 11.9 488.2773 1 99.83 5 55962 VEV_2_3_RA5_01_1236.d 0 1 1 238 242 Acetylation (N-term)
R.YAAQSIQ(+.98)STK(+14.02).S Y 16.09 1110.5557 10 -17.4 556.2755 2 44.97 6 21394 VEV_3_3_RA6_01_1237.d 2.43E4 1 1 62 71 Deamidation (NQ); Methylation(KR)
K.Q(+.98)FGVS(+79.97)K(+42.01)AR.W Y 16.02 1014.4536 8 57.5 508.2632 2 64.78 5 35104 VEV_2_3_RA5_01_1236.d 9.68E4 1 1 133 140 Deamidation (NQ); Phosphorylation (STY); Acetylation (K)
R.A(+27.99)ITAA Y 16.02 473.2485 5 -42.1 474.2359 1 65.37 5 35566 VEV_2_3_RA5_01_1236.d 2.4E4 1 1 238 242 Formylation
R.YAAQSIQSTK(-.98).S Y 16.00 1094.5720 10 0.6 548.2936 2 68.34 4 37912 VEV_1_3_RA4_01_1235.d 0 1 1 62 71 Amidation
R.WDASLTYVSR.T Y 15.22 1196.5825 10 -7.7 599.2939 2 76.68 6 42766 VEV_3_3_RA6_01_1237.d 5.5E4 1 1 48 57
R.ETAQAINGWK(+14.02).L Y 15.06 1130.5720 10 6.8 566.2971 2 49.61 5 24923 VEV_2_3_RA5_01_1236.d 1.96E5 1 1 89 98 Methylation(KR)
total 83 peptides
C1GG76
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IVTIIQNPTQYKIPTWFLNR.Q Y 167.32 2444.3579 20 -13.9 612.0883 4 85.66 6 48871 VEV_3_3_RA6_01_1237.d 2.66E6 10 10 115 134
R.DITDGKDTQVLANQMESK.L Y 153.46 1991.9470 18 -7.4 996.9734 2 67.53 4 37278 VEV_1_3_RA4_01_1235.d 2.77E6 10 10 137 154
R.AGEITTEELERIVTIIQNPTQYKIPTWFLNR.Q Y 133.13 3672.9514 31 -9.6 735.5905 5 93.84 6 53132 VEV_3_3_RA6_01_1237.d 2E6 13 13 104 134
R.QRDITDGKDTQVLANQMESK.L Y 130.44 2276.1067 20 -13.4 570.0263 4 61.02 5 32302 VEV_2_3_RA5_01_1236.d 7.59E5 6 6 135 154
R.AGEITTEELERIVTIIQNPTQYK.I Y 114.52 2645.3911 23 -15.9 662.3445 4 88.60 6 50571 VEV_3_3_RA6_01_1237.d 8.9E5 8 8 104 126
R.IVTIIQNPTQYK.I Y 106.12 1416.7976 12 -24.7 709.3885 2 71.06 4 40049 VEV_1_3_RA4_01_1235.d 1.71E6 8 8 115 126
R.DITDGKDTQ(+.98)VLANQMESK.L Y 93.48 1992.9310 18 10.5 665.3246 3 68.77 4 38288 VEV_1_3_RA4_01_1235.d 1.09E5 3 3 137 154 Deamidation (NQ)
K.DTQVLANQMESK.L Y 91.77 1362.6449 12 -7.0 682.3250 2 55.71 4 28504 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 143 154
R.Q(-17.03)RDITDGKDTQVLANQMESK.L Y 91.43 2259.0801 20 -9.1 754.0271 3 67.28 5 36985 VEV_2_3_RA5_01_1236.d 1.22E6 6 6 135 154 Pyro-glu from Q
R.AGEITTEELER.I Y 90.65 1246.6041 11 -11.0 624.3025 2 57.42 5 29738 VEV_2_3_RA5_01_1236.d 4.68E6 11 11 104 114
R.QRDITDGKDTQVLANQM(+15.99)ESK.L Y 89.11 2292.1016 20 -16.1 574.0234 4 49.42 4 24512 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 135 154 Oxidation (M)
R.DITDGKDTQVLANQMESKLREDLER.L Y 82.70 2903.4294 25 -20.5 581.6813 5 79.82 5 45930 VEV_2_3_RA5_01_1236.d 2.27E5 2 2 137 161
R.LLNTNVDGKQK.I Y 81.40 1228.6775 11 -26.1 615.3300 2 28.57 5 12519 VEV_2_3_RA5_01_1236.d 3.28E6 9 9 63 73
R.IVTIIQN(+.98)PTQYKIPTWFLNR.Q Y 80.74 2445.3420 20 -3.6 612.3406 4 86.31 4 51434 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 115 134 Deamidation (NQ)
R.IVTIIQ(+.98)NPTQYKIPTWFLNR.Q Y 78.99 2445.3420 20 -10.4 612.3364 4 86.18 5 49837 VEV_2_3_RA5_01_1236.d 2.88E5 2 2 115 134 Deamidation (NQ)
R.YSNLVC(+57.02)KK.A Y 78.70 1010.5219 8 -8.4 506.2640 2 20.25 4 7524 VEV_1_3_RA4_01_1235.d 6.51E5 4 4 88 95 Carbamidomethylation
R.YSNLVC(+57.02)K.K Y 77.11 882.4269 7 -15.6 442.2139 2 31.56 6 13736 VEV_3_3_RA6_01_1237.d 2.13E6 6 6 88 94 Carbamidomethylation
R.AGEITTEELERIVT(+14.02)IIQNPTQYKIPTWFLNR.Q Y 76.44 3686.9670 31 -22.3 738.3842 5 93.79 4 55711 VEV_1_3_RA4_01_1235.d 2.42E5 1 1 104 134 Methylation(others)
K.TNFQFILR.L Y 74.53 1037.5658 8 -11.0 519.7845 2 77.02 4 44732 VEV_1_3_RA4_01_1235.d 1.57E6 6 6 55 62
R.Q(-17.03)RDITDGKDTQVLANQMESK(+14.02).L Y 72.70 2273.0957 20 -7.2 758.7004 3 70.06 4 39258 VEV_1_3_RA4_01_1235.d 3.94E5 2 2 135 154 Pyro-glu from Q; Methylation(KR)
K.IPTWFLNR.Q Y 71.64 1045.5709 8 -17.4 523.7836 2 78.66 6 44207 VEV_3_3_RA6_01_1237.d 1.61E6 7 7 127 134
R.DITDGKDTQVLANQMESK(+14.02).L Y 70.36 2005.9626 18 -9.0 1003.9796 2 70.20 5 39138 VEV_2_3_RA5_01_1236.d 7.3E5 4 4 137 154 Methylation(KR)
R.AGEITTEELER(+14.02).I Y 69.92 1260.6198 11 -14.5 631.3080 2 63.15 6 32741 VEV_3_3_RA6_01_1237.d 3.33E6 11 11 104 114 Methylation(KR)
R.DITDGKDTQVLAN(+.98)QMESK.L Y 67.30 1992.9310 18 -9.4 665.3114 3 70.04 6 37888 VEV_3_3_RA6_01_1237.d 4.05E4 1 1 137 154 Deamidation (NQ)
R.Q(-17.03)RDITDGKDTQVLANQM(+15.99)ESK.L Y 66.92 2275.0750 20 -12.3 759.3563 3 60.13 6 30525 VEV_3_3_RA6_01_1237.d 3.64E5 3 3 135 154 Pyro-glu from Q; Oxidation (M)
R.LLNTNVDGK.Q Y 65.13 972.5240 9 -9.5 487.2646 2 40.07 4 18776 VEV_1_3_RA4_01_1235.d 3.52E6 13 13 63 71
K.DTQVLANQM(+15.99)ESK.L Y 63.19 1378.6399 12 -1.9 690.3259 2 32.22 4 14129 VEV_1_3_RA4_01_1235.d 8.49E4 2 2 143 154 Oxidation (M)
K.Q(-17.03)KIMYALTK.I Y 62.37 1077.5892 9 -11.8 539.7955 2 69.70 4 38979 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 72 80 Pyro-glu from Q
K.KADVDLNKR.A Y 53.75 1057.5880 9 -9.3 529.7964 2 14.08 4 4352 VEV_1_3_RA4_01_1235.d 1.24E6 7 7 95 103
R.AGEITT(+14.02)EELER.I Y 53.74 1260.6198 11 -14.3 631.3082 2 61.88 6 31838 VEV_3_3_RA6_01_1237.d 1.05E6 2 2 104 114 Methylation(others)
R.LLN(+.98)TNVDGKQK.I Y 53.59 1229.6615 11 2.9 410.8956 3 28.80 4 12191 VEV_1_3_RA4_01_1235.d 2.48E5 1 1 63 73 Deamidation (NQ)
R.IVTIIQNPTQ(+.98)YK.I Y 53.25 1417.7816 12 -42.6 709.8679 2 71.72 4 40590 VEV_1_3_RA4_01_1235.d 0 1 1 115 126 Deamidation (NQ)
R.Q(-17.03)RDITDGKDTQ(+.98)VLANQMESK.L Y 50.53 2260.0642 20 -10.3 754.3542 3 68.33 6 36640 VEV_3_3_RA6_01_1237.d 1.92E5 3 3 135 154 Pyro-glu from Q; Deamidation (NQ)
R.DITD(-18.01)GKDTQVLANQMESK.L Y 50.29 1973.9364 18 -2.8 658.9843 3 64.78 4 35101 VEV_1_3_RA4_01_1235.d 9.2E4 1 1 137 154 Dehydration
K.IMYALTK.I Y 49.12 838.4623 7 -11.9 420.2334 2 58.43 4 30307 VEV_1_3_RA4_01_1235.d 8.2E5 5 5 74 80
R.AGE(+14.02)ITTEELERIVTIIQNPTQYK.I Y 49.01 2659.4067 23 -24.9 665.8424 4 89.14 6 50874 VEV_3_3_RA6_01_1237.d 3.74E5 2 2 104 126 Methylation(others)
K.ADVDLNKR.A Y 47.15 929.4930 8 -9.1 465.7496 2 18.82 4 6787 VEV_1_3_RA4_01_1235.d 5.13E5 4 4 96 103
R.AGEITTEELER(+14.02)IVTIIQNPTQYK.I Y 46.44 2659.4067 23 -15.5 665.8486 4 89.57 5 51666 VEV_2_3_RA5_01_1236.d 3.68E5 3 3 104 126 Methylation(KR)
R.Q(+.98)RDITDGKDTQVLANQMESK.L Y 46.33 2277.0906 20 -9.5 570.2745 4 62.22 4 33185 VEV_1_3_RA4_01_1235.d 1.95E5 2 2 135 154 Deamidation (NQ)
R.AGEITTE(+14.02)ELER.I Y 46.21 1260.6198 11 -12.1 631.3095 2 62.08 4 33100 VEV_1_3_RA4_01_1235.d 9.35E5 1 1 104 114 Methylation(others)
R.DITDGKDTQVLANQM(+15.99)ESK(+14.02).L Y 45.70 2021.9575 18 -8.8 674.9872 3 62.43 4 33314 VEV_1_3_RA4_01_1235.d 4.39E4 2 2 137 154 Oxidation (M); Methylation(KR)
K.TNFQFILR(+14.02).L Y 44.81 1051.5814 8 -7.0 526.7943 2 79.56 4 46687 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 55 62 Methylation(KR)
K.IM(+15.99)YALTK.I Y 42.98 854.4572 7 -16.2 428.2289 2 47.58 5 23677 VEV_2_3_RA5_01_1236.d 1.78E6 10 10 74 80 Oxidation (M)
R.IVTIIQ(+.98)NPTQYK.I Y 42.30 1417.7816 12 -40.1 709.8696 2 72.10 4 40874 VEV_1_3_RA4_01_1235.d 0 2 2 115 126 Deamidation (NQ)
R.DITDGKDTQVLANQMES(-18.01)K(+14.02).L Y 42.09 1987.9520 18 -26.5 663.6404 3 67.62 4 37336 VEV_1_3_RA4_01_1235.d 4.4E4 1 1 137 154 Dehydration; Methylation(KR)
K.LREDLER.L Y 41.07 929.4930 7 -16.3 310.8332 3 24.89 5 10418 VEV_2_3_RA5_01_1236.d 3.49E6 9 9 155 161
R.RYSNLVC(+57.02)K.K Y 40.15 1038.5281 8 -19.1 520.2614 2 28.41 6 11994 VEV_3_3_RA6_01_1237.d 1.29E6 8 8 87 94 Carbamidomethylation
R.DITDGKDTQVLANQMESK(+28.03).L Y 40.03 2019.9783 18 -1.1 674.3326 3 73.02 4 41595 VEV_1_3_RA4_01_1235.d 7.69E4 1 1 137 154 Dimethylation(KR)
R.AGEITTEELER(+28.03).I Y 37.82 1274.6354 11 -15.5 638.3151 2 67.25 6 35814 VEV_3_3_RA6_01_1237.d 8.03E5 5 5 104 114 Dimethylation(KR)
K.ADVDLNK.R Y 37.02 773.3919 7 -1.6 774.3979 1 78.42 5 45002 VEV_2_3_RA5_01_1236.d 2.32E4 2 2 96 102
R.LLNTNVDGK(+14.02).Q Y 36.77 986.5397 9 -39.7 494.2575 2 48.34 4 23882 VEV_1_3_RA4_01_1235.d 1.54E5 3 3 63 71 Methylation(KR)
R.HYWGLR.V Y 36.57 830.4188 6 -12.3 416.2115 2 50.20 6 24406 VEV_3_3_RA6_01_1237.d 2.26E6 9 9 173 178
K.IPTWFLNR(+14.02).Q Y 34.83 1059.5865 8 -7.6 530.7965 2 79.44 5 45681 VEV_2_3_RA5_01_1236.d 2.59E5 3 3 127 134 Methylation(KR)
R.Q(-17.03)RDITDGKDTQVLAN(+.98)QMESK.L Y 34.24 2260.0642 20 -9.0 754.3552 3 69.79 6 37692 VEV_3_3_RA6_01_1237.d 5.63E4 1 1 135 154 Pyro-glu from Q; Deamidation (NQ)
R.IVTIIQNPTQYK(+14.02).I Y 31.02 1430.8134 12 -49.7 716.3784 2 74.04 4 42384 VEV_1_3_RA4_01_1235.d 0 2 2 115 126 Methylation(KR)
K.LREDLERLK.K Y 30.19 1170.6720 9 -16.5 391.2249 3 42.99 5 20964 VEV_2_3_RA5_01_1236.d 5.88E5 3 3 155 163
R.DITDGKDTQ(+.98)VLANQMESK(+14.02).L Y 28.73 2006.9467 18 -0.4 669.9892 3 71.89 4 40710 VEV_1_3_RA4_01_1235.d 8.67E4 1 1 137 154 Deamidation (NQ); Methylation(KR)
R.GLRHYWGLR.V Y 28.58 1156.6254 9 -25.2 386.5394 3 59.91 5 31481 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 170 178
K.IM(-48.00)YALTK.I Y 28.09 790.4589 7 -14.4 396.2310 2 32.64 5 14786 VEV_2_3_RA5_01_1236.d 9.06E5 2 2 74 80 Dethiomethyl
R.QRDITD(-18.01)GKDTQVLANQMESK.L Y 27.65 2258.0962 20 -8.4 753.6997 3 67.24 5 36953 VEV_2_3_RA5_01_1236.d 7.07E4 1 1 135 154 Dehydration
R.DITDGKDTQVLANQM(-48.00)ESK.L Y 27.50 1943.9436 18 -11.8 648.9808 3 50.72 6 24700 VEV_3_3_RA6_01_1237.d 1.44E5 1 1 137 154 Dethiomethyl
K.KADVDLNK(+14.02)R.A Y 26.18 1071.6036 9 -76.3 536.7682 2 20.32 5 7903 VEV_2_3_RA5_01_1236.d 3.15E5 2 2 95 103 Methylation(KR)
K.IPTWFLN(+.98)R.Q Y 25.88 1046.5549 8 -13.6 524.2776 2 79.79 5 45914 VEV_2_3_RA5_01_1236.d 8.37E4 1 1 127 134 Deamidation (NQ)
R.IVTIIQNPT(-18.01)QYK(+14.02)IPTWFLNR.Q Y 25.41 2440.3630 20 -45.0 611.0706 4 86.22 4 51381 VEV_1_3_RA4_01_1235.d 0 2 2 115 134 Dehydration; Methylation(KR)
K.A(+42.01)DVDLN(+.98)KR.A Y 25.34 972.4876 8 -8.7 973.4865 1 91.63 5 52707 VEV_2_3_RA5_01_1236.d 3.12E3 1 1 96 103 Acetylation (N-term); Deamidation (NQ)
K.TN(+.98)FQ(+.98)FILR.L Y 24.95 1039.5338 8 -4.3 520.7720 2 77.16 6 43186 VEV_3_3_RA6_01_1237.d 9.66E4 1 1 55 62 Deamidation (NQ)
R.LLNTNVDGK(+14.02)QK.I Y 24.28 1242.6932 11 -37.2 622.3308 2 35.45 6 15918 VEV_3_3_RA6_01_1237.d 0 1 1 63 73 Methylation(KR)
K.IPTW(+15.99)FLNR.Q Y 23.93 1061.5658 8 -6.7 531.7866 2 77.02 4 44707 VEV_1_3_RA4_01_1235.d 4.75E4 1 1 127 134 Oxidation (HW)
R.LLN(+.98)TN(+.98)VDGK.Q Y 22.67 974.4920 9 20.3 488.2632 2 39.85 6 18406 VEV_3_3_RA6_01_1237.d 2.6E5 1 1 63 71 Deamidation (NQ)
K.LREDLER(+14.02).L Y 22.58 943.5087 7 -8.0 472.7578 2 32.97 4 14561 VEV_1_3_RA4_01_1235.d 2.66E5 3 3 155 161 Methylation(KR)
R.TVGVSK(+31.99).K Y 21.79 621.3333 6 -38.7 622.3165 1 79.36 4 46526 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 193 198 Dihydroxy
R.DITDGK(+14.02)DTQ(+.98)VLANQMESK.L Y 20.59 2006.9467 18 2.9 669.9915 3 68.56 4 38086 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 137 154 Methylation(KR); Deamidation (NQ)
R.LLN(+.98)TNVDGK.Q Y 19.89 973.5080 9 -17.5 487.7527 2 44.85 6 21350 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 63 71 Deamidation (NQ)
K.QKIMYALTK.I Y 19.69 1094.6157 9 -16.9 548.3059 2 52.45 5 26665 VEV_2_3_RA5_01_1236.d 0 1 1 72 80
R.GLRHYWGLRVR.G Y 19.60 1411.7949 11 -15.8 353.9504 4 62.00 5 33038 VEV_2_3_RA5_01_1236.d 6.57E4 1 1 170 180
R.A(+28.03)GEITTEELER.I Y 19.58 1274.6354 11 -9.1 425.8819 3 62.36 5 33304 VEV_2_3_RA5_01_1236.d 9.62E4 1 1 104 114 Ethylation
R.Y(+42.01)SNLVC(+57.02)K.K Y 19.31 924.4375 7 -0.1 463.2260 2 31.67 4 13816 VEV_1_3_RA4_01_1235.d 0 1 1 88 94 Acetylation (N-term); Carbamidomethylation
R.IVTIIQN(+.98)PTQYK.I Y 18.90 1417.7816 12 -84.1 709.8384 2 71.70 5 40241 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 115 126 Deamidation (NQ)
R.DITDGKDT(-18.01)QVLANQMESK.L Y 18.70 1973.9364 18 10.6 658.9930 3 64.61 5 34979 VEV_2_3_RA5_01_1236.d 0 1 1 137 154 Dehydration
R.DITDGKDTQVLANQMESKLR(+14.02)EDLER.L Y 18.20 2917.4451 25 1.9 730.3699 4 81.94 5 47310 VEV_2_3_RA5_01_1236.d 1.52E5 1 1 137 161 Methylation(KR)
K.IMYALT(+79.97)K(+14.02).I Y 18.17 932.4442 7 -6.7 311.8199 3 17.53 4 6136 VEV_1_3_RA4_01_1235.d 0 1 1 74 80 Phosphorylation (STY); Methylation(KR)
R.AGEITTE(+14.02)ELERIVTIIQNPTQYK.I Y 17.83 2659.4067 23 -1.9 665.8577 4 89.54 6 51078 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 104 126 Methylation(others)
R.LLNTNVDGKQK(+104.03)IMYALTK.I Y 17.78 2153.1555 18 -49.8 539.2693 4 69.52 6 37581 VEV_3_3_RA6_01_1237.d 0 1 1 63 80 Benzoyl
R.DITDGKDTQVLANQM(+15.99)ESK.L Y 17.54 2007.9419 18 -1.3 670.3204 3 61.29 6 31369 VEV_3_3_RA6_01_1237.d 3.75E4 1 1 137 154 Oxidation (M)
R.DIT(-2.02)DGKDTQVLANQMESK.L Y 17.18 1989.9313 18 7.5 664.3227 3 67.64 5 37253 VEV_2_3_RA5_01_1236.d 7.39E4 1 1 137 154 2-amino-3-oxo-butanoic_acid
R.L(+42.01)LN(+.98)TNVDGKQK.I Y 16.95 1271.6721 11 -39.4 424.8813 3 28.18 5 12255 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 63 73 Acetylation (N-term); Deamidation (NQ)
R.T(+42.01)VGVSK.K Y 16.82 631.3541 6 -29.1 316.6751 2 34.03 4 15187 VEV_1_3_RA4_01_1235.d 4.88E5 1 1 193 198 Acetylation (N-term)
K.LRE(+14.02)DLER.L Y 16.79 943.5087 7 -8.9 315.5074 3 39.71 4 18525 VEV_1_3_RA4_01_1235.d 4.73E5 1 1 155 161 Methylation(others)
R.A(+42.01)GEITTEELER(+14.02).I Y 16.75 1302.6302 11 3.2 652.3245 2 64.43 4 34859 VEV_1_3_RA4_01_1235.d 9.6E4 1 1 104 114 Acetylation (N-term); Methylation(KR)
R.GQHTK.T N 16.24 569.2922 5 -27.3 570.2839 1 27.73 5 11986 VEV_2_3_RA5_01_1236.d 0 1 1 181 185
K.LREDLE(+14.02)R.L Y 15.97 943.5087 7 -18.1 472.7531 2 33.79 6 14961 VEV_3_3_RA6_01_1237.d 9.97E4 1 1 155 161 Methylation(others)
K.RAGE(+14.02)ITTEELER.I Y 15.92 1416.7208 12 -20.8 355.1801 4 23.80 5 9785 VEV_2_3_RA5_01_1236.d 0 1 1 103 114 Methylation(others)
R.DITDGKDTQ(+.98)VLANQ(+.98)MESK.L Y 15.80 1993.9150 18 -3.4 665.6434 3 68.64 5 38007 VEV_2_3_RA5_01_1236.d 3.68E4 1 1 137 154 Deamidation (NQ)
K.Q(+42.01)KIMYALTK(+28.03).I Y 15.75 1164.6576 9 -0.2 389.2264 3 53.76 4 27292 VEV_1_3_RA4_01_1235.d 0 1 1 72 80 Acetylation (N-term); Dimethylation(KR)
K.ADVDLNK(+111.03).R Y 15.69 884.4240 7 -25.0 885.4091 1 88.95 5 51354 VEV_2_3_RA5_01_1236.d 0 1 1 96 102 Nmethylmaleimide
R.LLNTN(+.98)VDGK(+42.01).Q Y 15.67 1015.5186 9 -10.6 508.7612 2 16.36 5 5763 VEV_2_3_RA5_01_1236.d 0 1 1 63 71 Deamidation (NQ); Acetylation (K)
R.YSNLVC(+57.02)K(+14.02)KADVDLN(+.98)KR.A Y 15.52 1937.0040 16 -9.0 485.2539 4 69.28 4 38646 VEV_1_3_RA4_01_1235.d 4.81E4 1 1 88 103 Carbamidomethylation; Methylation(KR); Deamidation (NQ)
R.GQ(+.98)HTKTTGR(+31.99).R Y 15.27 1017.4839 9 -0.9 340.1683 3 9.31 5 2259 VEV_2_3_RA5_01_1236.d 3.98E4 1 1 181 189 Deamidation (NQ); Dihydroxy
total 98 peptides
C1G0E3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FKVYEPLLIVGLDKFAGVDIR.V Y 159.16 2391.3564 21 -13.1 598.8386 4 88.22 6 50381 VEV_3_3_RA6_01_1237.d 3.13E6 13 13 46 66
K.VNGQPLALTQPEILR.F Y 143.05 1647.9308 15 -13.6 824.9614 2 77.27 6 43221 VEV_3_3_RA6_01_1237.d 1.41E6 4 4 31 45
R.VTGGGHTSQIYAIR.Q Y 121.99 1458.7579 14 -8.1 730.3803 2 49.06 4 24302 VEV_1_3_RA4_01_1235.d 3.31E6 20 20 69 82
K.VYEPLLIVGLDKFAGVDIR.V Y 121.00 2116.1931 19 -5.4 706.4012 3 89.32 4 53280 VEV_1_3_RA4_01_1235.d 5.98E5 6 6 48 66
K.GLIKVNGQPLALTQPEILR.F Y 120.99 2059.2153 19 -9.5 687.4059 3 79.65 5 45845 VEV_2_3_RA5_01_1236.d 7.35E5 3 3 27 45
K.GLIKVN(+.98)GQPLALTQPEILR.F Y 103.91 2060.1992 19 -5.4 1031.1013 2 80.91 5 46645 VEV_2_3_RA5_01_1236.d 1.24E6 5 5 27 45 Deamidation (NQ)
K.KKTATAVAQC(+57.02)K.A Y 102.48 1204.6598 11 -5.5 603.3339 2 10.61 4 2696 VEV_1_3_RA4_01_1235.d 3.83E5 7 7 13 23 Carbamidomethylation
R.FKVYEPLLIVGLDK.F Y 101.95 1632.9490 14 -14.3 545.3158 3 83.35 6 47421 VEV_3_3_RA6_01_1237.d 2.98E5 4 4 46 59
K.GLIKVNGQ(+.98)PLALTQPEILR.F Y 100.84 2060.1992 19 -11.0 687.7328 3 80.81 5 46643 VEV_2_3_RA5_01_1236.d 1.05E6 2 2 27 45 Deamidation (NQ)
K.YVDEHAKNQLK.Q Y 94.35 1343.6833 11 -11.7 672.8411 2 19.44 4 7118 VEV_1_3_RA4_01_1235.d 1.07E6 8 8 96 106
R.VRVTGGGHTSQIYAIR.Q Y 88.07 1713.9274 16 -11.4 429.4842 4 54.23 4 27585 VEV_1_3_RA4_01_1235.d 3E5 2 2 67 82
K.VN(+.98)GQPLALTQPEILR.F Y 87.75 1648.9148 15 -8.4 825.4578 2 79.03 4 46265 VEV_1_3_RA4_01_1235.d 5.24E5 4 4 31 45 Deamidation (NQ)
K.AGKGLIKVN(+.98)GQPLALTQPEILR.F Y 85.44 2316.3528 22 -9.6 580.0899 4 77.15 5 44124 VEV_2_3_RA5_01_1236.d 2.32E5 2 2 24 45 Deamidation (NQ)
K.TATAVAQC(+57.02)KAGK.G Y 84.39 1204.6234 12 -8.5 603.3138 2 13.06 5 4004 VEV_2_3_RA5_01_1236.d 1.12E5 6 6 15 26 Carbamidomethylation
R.VTGGGHTSQ(+.98)IYAIR.Q Y 83.38 1459.7419 14 2.5 487.5891 3 49.15 4 24347 VEV_1_3_RA4_01_1235.d 1.03E6 6 6 69 82 Deamidation (NQ)
R.FK(+14.02)VYEPLLIVGLDKFAGVDIR.V Y 78.05 2405.3721 21 -8.2 602.3453 4 89.99 4 53640 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 46 66 Methylation(KR)
K.VYEPLLIVGLDK.F Y 77.70 1357.7856 12 0.4 679.9004 2 83.80 4 49776 VEV_1_3_RA4_01_1235.d 3.35E4 1 1 48 59
K.QALVQYDR.T Y 76.80 991.5087 8 -11.0 496.7562 2 43.87 4 21107 VEV_1_3_RA4_01_1235.d 2.63E6 14 14 107 114
R.VTGGGHTSQIYAIR(+14.02).Q Y 76.69 1472.7736 14 -7.6 737.3884 2 58.96 4 30700 VEV_1_3_RA4_01_1235.d 1.7E5 2 2 69 82 Methylation(KR)
R.FKVYEPLLIVGLDKFAGVDIRVR.V Y 76.54 2646.5261 23 -10.4 530.3070 5 86.62 5 50088 VEV_2_3_RA5_01_1236.d 4.31E5 4 4 46 68
R.F(+43.01)K(+14.02)VYEPLLIVGLDKFAGVDIR.V Y 76.43 2448.3779 21 -27.6 613.0848 4 90.12 4 53722 VEV_1_3_RA4_01_1235.d 0 1 1 46 66 Carbamylation; Methylation(KR)
K.AGKGLIKVNGQPLALTQPEILR.F Y 75.04 2315.3689 22 -8.7 579.8445 4 76.06 5 43349 VEV_2_3_RA5_01_1236.d 6.31E4 1 1 24 45
K.NQLKQALVQYDR.T Y 74.24 1474.7892 12 -28.2 738.3811 2 59.95 5 31517 VEV_2_3_RA5_01_1236.d 0 2 2 103 114
K.VN(-17.03)GQPLALTQPEILR.F Y 74.11 1630.9042 15 -11.8 816.4498 2 84.79 5 49058 VEV_2_3_RA5_01_1236.d 8.39E5 6 6 31 45 Ammonia-loss (N)
K.VNGQ(+.98)PLALTQPEILR.F Y 73.86 1648.9148 15 -28.1 825.4415 2 78.37 6 43985 VEV_3_3_RA6_01_1237.d 6.22E5 5 5 31 45 Deamidation (NQ)
K.Q(-17.03)ALVQYDR.T Y 69.57 974.4821 8 -11.6 488.2427 2 66.04 5 36059 VEV_2_3_RA5_01_1236.d 1.44E6 6 6 107 114 Pyro-glu from Q
R.FKVYEPLLIVGLDKFAGVDIR(+14.02).V Y 69.39 2405.3721 21 -28.9 602.3329 4 89.36 6 50977 VEV_3_3_RA6_01_1237.d 0 1 1 46 66 Methylation(KR)
K.VNGQPLALTQPE(+14.02)ILR.F Y 68.83 1661.9464 15 -6.6 831.9750 2 79.09 4 46311 VEV_1_3_RA4_01_1235.d 1E5 2 2 31 45 Methylation(others)
M.ATTQSVQC(+57.02)FGK.K Y 68.76 1225.5762 11 -7.2 613.7910 2 38.68 4 18010 VEV_1_3_RA4_01_1235.d 5.07E5 3 3 2 12 Carbamidomethylation
K.TATAVAQC(+57.02)K.A Y 68.32 948.4698 9 -9.1 475.2379 2 13.90 4 4247 VEV_1_3_RA4_01_1235.d 4.37E5 3 3 15 23 Carbamidomethylation
K.GLIKVNGQ(+.98)PLALTQPEILR(+14.02).F Y 67.08 2074.2151 19 -46.7 692.3800 3 81.69 6 46334 VEV_3_3_RA6_01_1237.d 0 1 1 27 45 Deamidation (NQ); Methylation(KR)
K.SIVAYYQKYVDEHAK.N Y 65.30 1812.9045 15 -2.5 454.2323 4 71.02 4 40013 VEV_1_3_RA4_01_1235.d 3.6E5 3 3 88 102
M.A(+42.01)TTQSVQC(+57.02)FGK.K Y 64.17 1267.5867 11 -14.3 634.7916 2 63.52 6 33014 VEV_3_3_RA6_01_1237.d 4E6 11 11 2 12 Acetylation (Protein N-term); Carbamidomethylation
K.SIVAYYQK.Y Y 64.05 970.5123 8 -17.9 486.2548 2 53.64 6 26483 VEV_3_3_RA6_01_1237.d 3.31E6 12 12 88 95
R.TLLVADNR.R Y 63.32 900.5029 8 -15.3 451.2518 2 46.39 5 22955 VEV_2_3_RA5_01_1236.d 5.28E6 15 15 115 122
K.GLIKVNGQPLALTQPEILR(+14.02).F Y 62.69 2073.2310 19 -25.8 692.0664 3 80.61 4 47486 VEV_1_3_RA4_01_1235.d 0 1 1 27 45 Methylation(KR)
R.TLLVADNRR.A Y 57.77 1056.6040 9 -12.8 529.3025 2 34.64 5 15963 VEV_2_3_RA5_01_1236.d 3.46E6 9 9 115 123
K.GLIKVN(-17.03)GQPLALTQPEILR.F Y 57.72 2042.1887 19 -41.8 681.7084 3 80.94 6 45820 VEV_3_3_RA6_01_1237.d 0 2 2 27 45 Ammonia-loss (N)
K.Q(-17.03)ALVQYDRTLLVADNR.R Y 55.75 1856.9744 16 6.9 620.0030 3 80.11 5 46128 VEV_2_3_RA5_01_1236.d 3.3E4 1 1 107 122 Pyro-glu from Q
K.KFGGPGAR.A Y 55.05 788.4293 8 -18.2 395.2147 2 13.67 6 4286 VEV_3_3_RA6_01_1237.d 1.95E6 6 6 128 135
K.GLIKVN(+.98)GQ(+.98)PLALTQPEILR.F Y 53.80 2061.1833 19 -7.8 688.0630 3 81.69 6 46335 VEV_3_3_RA6_01_1237.d 0 1 1 27 45 Deamidation (NQ)
K.FGGPGAR.A Y 53.37 660.3344 7 -14.6 331.1696 2 17.39 5 6323 VEV_2_3_RA5_01_1236.d 1.62E6 8 8 129 135
M.A(+42.01)TTQSVQC(+57.02)FGKK.K Y 53.03 1395.6816 12 -11.0 698.8405 2 53.09 5 27092 VEV_2_3_RA5_01_1236.d 1.46E6 7 7 2 13 Acetylation (Protein N-term); Carbamidomethylation
K.VYE(+14.02)PLLIVGLDKFAGVDIR.V Y 50.93 2130.2087 19 3.9 711.0796 3 90.88 4 54155 VEV_1_3_RA4_01_1235.d 8.24E4 2 2 48 66 Methylation(others)
K.TATAVAQC(+57.02)K(+14.02).A Y 48.94 962.4855 9 -13.0 482.2438 2 20.84 6 8005 VEV_3_3_RA6_01_1237.d 3.81E5 3 3 15 23 Carbamidomethylation; Methylation(KR)
K.FAGVDIR.V Y 48.36 776.4180 7 -18.7 389.2090 2 60.71 6 30957 VEV_3_3_RA6_01_1237.d 6.38E5 4 4 60 66
R.FK(+14.02)VYEPLLIVGLDK.F Y 46.59 1646.9647 14 -15.4 549.9871 3 85.36 6 48680 VEV_3_3_RA6_01_1237.d 3.24E4 2 2 46 59 Methylation(KR)
M.A(+42.01)TTQ(+.98)SVQC(+57.02)FGK.K Y 45.90 1268.5707 11 -13.0 635.2844 2 65.60 6 34572 VEV_3_3_RA6_01_1237.d 4.54E5 3 3 2 12 Acetylation (Protein N-term); Deamidation (NQ); Carbamidomethylation
M.A(+42.01)TTQSVQ(+.98)C(+57.02)FGK.K Y 45.58 1268.5707 11 -6.3 635.2886 2 66.81 4 36693 VEV_1_3_RA4_01_1235.d 7.33E5 5 5 2 12 Acetylation (Protein N-term); Deamidation (NQ); Carbamidomethylation
R.AEPKKFGGPGAR.A Y 43.03 1213.6567 12 -34.5 607.8147 2 16.46 5 5813 VEV_2_3_RA5_01_1236.d 5.3E4 2 2 124 135
K.AGKGLIKVNGQPLALT(-2.02)QPEILR.F Y 42.55 2313.3533 22 -77.3 579.3009 4 75.97 5 43295 VEV_2_3_RA5_01_1236.d 3.51E4 1 1 24 45 2-amino-3-oxo-butanoic_acid
R.TLLVADNR(+14.02).R Y 42.34 914.5185 8 -14.8 458.2598 2 54.87 4 27978 VEV_1_3_RA4_01_1235.d 6.27E5 5 5 115 122 Methylation(KR)
K.Q(+.98)ALVQYDR.T Y 40.86 992.4927 8 -14.6 497.2464 2 46.90 6 22563 VEV_3_3_RA6_01_1237.d 1.12E6 6 6 107 114 Deamidation (NQ)
M.A(+42.01)TTQSVQ(+.98)C(+57.02)FGKK.K Y 40.68 1396.6656 12 -16.3 699.3287 2 58.12 6 29106 VEV_3_3_RA6_01_1237.d 2E5 5 5 2 13 Acetylation (Protein N-term); Deamidation (NQ); Carbamidomethylation
K.QALVQYDR(+14.02).T Y 39.88 1005.5243 8 -10.7 503.7640 2 52.08 4 26212 VEV_1_3_RA4_01_1235.d 6.64E5 4 4 107 114 Methylation(KR)
K.QALVQ(+.98)YDR.T Y 38.14 992.4927 8 -8.3 497.2495 2 46.58 4 22748 VEV_1_3_RA4_01_1235.d 7.56E5 5 5 107 114 Deamidation (NQ)
R.FKVYEPLLIVGLDKFAGVDIR(+.98).V Y 36.78 2392.3406 21 -1.0 798.4533 3 88.34 4 52717 VEV_1_3_RA4_01_1235.d 9.22E4 1 1 46 66 Deamidation (R)
M.A(+42.01)TTQSVQC(+57.02)FGK(+14.02)K.K Y 36.61 1409.6973 12 -9.8 705.8490 2 57.39 4 29583 VEV_1_3_RA4_01_1235.d 6.43E4 1 1 2 13 Acetylation (Protein N-term); Carbamidomethylation; Methylation(KR)
K.FGGPGAR(+14.02).A Y 36.34 674.3500 7 -16.1 338.1768 2 24.78 5 10357 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 129 135 Methylation(KR)
M.ATTQSVQ(+.98)C(+57.02)FGK.K Y 36.10 1226.5602 11 -2.8 614.2856 2 44.26 4 21315 VEV_1_3_RA4_01_1235.d 2.74E5 3 3 2 12 Deamidation (NQ); Carbamidomethylation
M.A(+42.01)TTQSVQC(+57.02)FGK(+14.02).K Y 34.79 1281.6023 11 -13.6 641.7997 2 66.43 6 35200 VEV_3_3_RA6_01_1237.d 3.24E5 2 2 2 12 Acetylation (Protein N-term); Carbamidomethylation; Methylation(KR)
M.A(+42.01)TTQSVQC(+57.02)FGKK(+14.02).K Y 33.64 1409.6973 12 -11.2 705.8480 2 57.14 5 29524 VEV_2_3_RA5_01_1236.d 4.57E4 1 1 2 13 Acetylation (Protein N-term); Carbamidomethylation; Methylation(KR)
M.A(+42.01)TTQ(+.98)SVQC(+57.02)FGKK.K Y 32.08 1396.6656 12 -8.0 699.3345 2 57.15 4 29413 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 2 13 Acetylation (Protein N-term); Deamidation (NQ); Carbamidomethylation
K.TATAVAQ(+.98)C(+57.02)K.A Y 29.69 949.4539 9 -2.5 475.7330 2 15.49 5 5302 VEV_2_3_RA5_01_1236.d 1.79E4 1 1 15 23 Deamidation (NQ); Carbamidomethylation
M.A(+42.01)TTQSVQC(+57.02)FGKKK.T Y 28.12 1523.7766 13 -11.2 762.8870 2 41.35 5 19939 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 2 14 Acetylation (Protein N-term); Carbamidomethylation
M.ATTQ(+.98)SVQC(+57.02)FGK.K Y 27.27 1226.5602 11 -10.6 614.2809 2 43.63 5 21287 VEV_2_3_RA5_01_1236.d 3.09E5 3 3 2 12 Deamidation (NQ); Carbamidomethylation
R.TLLVADNRRAEPK.K Y 26.74 1481.8314 13 -24.8 494.9388 3 37.90 5 17877 VEV_2_3_RA5_01_1236.d 6.36E5 4 4 115 127
R.T(+42.01)LLVADNRR.A Y 25.29 1098.6145 9 -46.5 367.1951 3 34.51 6 15378 VEV_3_3_RA6_01_1237.d 9.37E5 4 4 115 123 Acetylation (N-term)
R.TLLVADN(+.98)RR.A Y 24.93 1057.5880 9 -13.5 353.5319 3 44.64 4 21538 VEV_1_3_RA4_01_1235.d 9.04E4 1 1 115 123 Deamidation (NQ)
K.KKT(+79.97)AT(+79.97)AVAQC(+57.02)K.A Y 23.83 1364.5924 11 58.8 342.1754 4 23.53 4 9282 VEV_1_3_RA4_01_1235.d 0 1 1 13 23 Phosphorylation (STY); Carbamidomethylation
R.TLLVADN(+.98)R.R Y 23.62 901.4869 8 -18.5 451.7424 2 50.27 5 25294 VEV_2_3_RA5_01_1236.d 5.57E4 1 1 115 122 Deamidation (NQ)
K.TATAVAQC(+57.02)KAGK(+42.01).G Y 23.20 1246.6339 12 -25.8 416.5412 3 67.12 6 35721 VEV_3_3_RA6_01_1237.d 9.07E4 1 1 15 26 Carbamidomethylation; Acetylation (K)
R.TLLVADNR(+14.02)R.A Y 22.51 1070.6196 9 -51.9 536.2893 2 42.74 4 20376 VEV_1_3_RA4_01_1235.d 8.67E4 2 2 115 123 Methylation(KR)
K.KFGGPGAR(+14.02).A Y 21.55 802.4449 8 -16.8 402.2230 2 19.07 6 7083 VEV_3_3_RA6_01_1237.d 6.94E4 1 1 128 135 Methylation(KR)
K.KK(+43.99)TATAVAQC(+57.02)K.A Y 21.45 1248.6497 11 -16.6 417.2169 3 10.37 5 2665 VEV_2_3_RA5_01_1236.d 0 1 1 13 23 Carboxylation (DKW); Carbamidomethylation
K.TATAVAQ(+.98)CK.A Y 20.97 892.4324 9 30.1 447.2369 2 22.71 5 9193 VEV_2_3_RA5_01_1236.d 0 1 1 15 23 Deamidation (NQ)
R.QAIAKSIVAYYQK(+21.98).Y Y 20.62 1503.8062 13 -3.8 376.9574 4 60.03 4 31514 VEV_1_3_RA4_01_1235.d 0 1 1 83 95 Sodium adduct
R.AEPKK(+43.99)FGGPGAR.A Y 19.82 1257.6465 12 13.7 420.2285 3 21.85 5 8733 VEV_2_3_RA5_01_1236.d 0 1 1 124 135 Carboxylation (DKW)
K.K(+42.01)TATAVAQC(+57.02)KAGK(+42.01).G Y 19.75 1416.7395 13 -5.2 355.1903 4 44.89 4 21704 VEV_1_3_RA4_01_1235.d 0 1 1 14 26 Acetylation (Protein N-term); Carbamidomethylation; Acetylation (K)
K.F(+43.01)GGPGAR.A Y 19.34 703.3401 7 -8.1 352.6745 2 25.25 4 10256 VEV_1_3_RA4_01_1235.d 2.68E5 2 2 129 135 Carbamylation
MATTQSVQC(+57.02)FGK(+119.04).K Y 19.18 1475.6537 12 -11.4 492.8862 3 22.72 4 8851 VEV_1_3_RA4_01_1235.d 1.19E4 1 1 1 12 Carbamidomethylation; Pyridylacetyl
R.QAIAK.S Y 18.72 529.3224 5 -4.1 530.3275 1 13.35 5 4150 VEV_2_3_RA5_01_1236.d 9.29E3 1 1 83 87
K.TATAVAQCKAGK(+42.01).G Y 17.33 1189.6125 12 3.5 397.5462 3 59.72 5 31346 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 15 26 Acetylation (K)
K.FAGVDIR(+28.03).V Y 17.32 804.4493 7 -20.7 403.2236 2 65.20 6 34349 VEV_3_3_RA6_01_1237.d 8.67E4 1 1 60 66 Dimethylation(KR)
K.T(+42.01)ATAVAQC(+57.02)KAGK(+27.99)GLIK.V Y 17.18 1685.9135 16 -22.5 338.1824 5 51.17 4 25617 VEV_1_3_RA4_01_1235.d 0 1 1 15 30 Acetylation (Protein N-term); Carbamidomethylation; Formylation
R.T(+79.97)LLVADNR(-.98).R Y 17.11 979.4852 8 25.0 327.5105 3 31.95 4 13978 VEV_1_3_RA4_01_1235.d 3.41E4 1 1 115 122 Phosphorylation (STY); Amidation
R.Q(+43.01)AIAK.S Y 17.11 572.3282 5 -13.0 573.3280 1 15.05 6 4972 VEV_3_3_RA6_01_1237.d 1.63E4 1 1 83 87 Carbamylation
K.KFGGPGAR(+31.99).A Y 16.70 820.4191 8 -3.0 411.2156 2 22.60 4 8776 VEV_1_3_RA4_01_1235.d 0 1 1 128 135 Dihydroxy
K.Q(-17.03)ALVQYDR(+14.02).T Y 16.40 988.4977 8 -13.3 495.2496 2 66.68 4 36594 VEV_1_3_RA4_01_1235.d 2.9E5 2 2 107 114 Pyro-glu from Q; Methylation(KR)
K.KTATAVAQC(+57.02)KAGKGLIK(+329.05).V Y 16.33 2073.0554 17 -16.4 519.2626 4 74.79 6 41386 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 14 30 Carbamidomethylation; Phosphoadenosine
K.K(+42.01)FGGPGAR(-.98).A Y 15.73 829.4558 8 -9.8 830.4550 1 99.28 6 55075 VEV_3_3_RA6_01_1237.d 0 1 1 128 135 Acetylation (N-term); Amidation
K.TATAVAQ(+.98)C(+57.02)K(+14.02).A Y 15.68 963.4695 9 -23.5 482.7307 2 23.46 6 9378 VEV_3_3_RA6_01_1237.d 5.44E4 1 1 15 23 Deamidation (NQ); Carbamidomethylation; Methylation(KR)
K.GLIK(+14.02)VNGQ(+.98)PLALTQPEILR.F Y 15.40 2074.2151 19 -89.4 692.3505 3 81.12 4 47880 VEV_1_3_RA4_01_1235.d 0 1 1 27 45 Methylation(KR); Deamidation (NQ)
R.FK(-1.03)VYEPLLIVGLDKFAGVDIRVR.V Y 15.18 2645.4944 23 -28.9 662.3618 4 86.84 4 51780 VEV_1_3_RA4_01_1235.d 0 1 1 46 68 Lysine oxidation to aminoadipic semialdehyde
total 94 peptides
C1GII4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VPFAVVGANSEVTSSEGGKVR.G Y 148.17 2089.0803 21 -14.4 697.3574 3 67.40 6 35956 VEV_3_3_RA6_01_1237.d 6.56E5 6 6 346 366
K.VPFAVVGANSEVTSSEGGK.V Y 139.83 1833.9108 19 -7.8 917.9555 2 70.55 4 39671 VEV_1_3_RA4_01_1235.d 5.51E5 3 3 346 364
R.SNPMGQGAAQTVTSKNPK.A Y 130.41 1814.8945 18 -9.8 605.9662 3 40.94 5 19700 VEV_2_3_RA5_01_1236.d 1.18E6 8 8 91 108
K.ADTLTDEEIALFKQR.I Y 110.20 1748.8944 15 -12.7 583.9647 3 77.26 5 44207 VEV_2_3_RA5_01_1236.d 5.71E5 4 4 296 310
R.SNPMGQGAAQTVTSK.N Y 109.33 1475.7039 15 -5.4 738.8552 2 43.11 4 20634 VEV_1_3_RA4_01_1235.d 4.67E5 5 5 91 105
K.STLVNTLFNTSLYPPKER.K Y 108.40 2079.1001 18 -6.4 694.0362 3 81.10 4 47862 VEV_1_3_RA4_01_1235.d 1.04E6 8 8 162 179
R.LTVVDTPGFGDFVNNDDSWRPIVENIEQRFDAYLEAENKVNR.M Y 102.52 4881.3633 42 -14.7 977.2656 5 94.46 4 56039 VEV_1_3_RA4_01_1235.d 4.88E5 2 2 209 250
K.ADTLTDEEIALFK.Q Y 102.41 1464.7347 13 -17.2 733.3621 2 81.20 6 45993 VEV_3_3_RA6_01_1237.d 3.66E5 3 3 296 308
K.LTGYVGFANLPNQWHR.K Y 102.23 1871.9431 16 -6.8 624.9841 3 77.99 4 45471 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 125 140
K.LKQSEDELYAR.H Y 96.17 1350.6779 11 -7.3 676.3412 2 39.26 5 18717 VEV_2_3_RA5_01_1236.d 1.08E6 10 10 471 481
K.VNLIPVIAK.A Y 92.43 965.6273 9 -11.6 483.8153 2 75.55 4 43556 VEV_1_3_RA4_01_1235.d 1.08E6 3 3 287 295
R.SNPM(+15.99)GQGAAQTVTSK.N Y 88.29 1491.6987 15 -7.8 746.8508 2 25.48 4 10387 VEV_1_3_RA4_01_1235.d 1.69E5 3 3 91 105 Oxidation (M)
K.STLVNTLFNTSLYPPK.E Y 88.27 1793.9563 16 -11.4 897.9752 2 84.34 6 48043 VEV_3_3_RA6_01_1237.d 3.96E5 5 5 162 177
R.SNPM(+15.99)GQGAAQTVTSKNPK.A Y 85.54 1830.8894 18 -1.5 611.3029 3 27.07 4 11228 VEV_1_3_RA4_01_1235.d 2.21E5 9 9 91 108 Oxidation (M)
K.AAAQAASDMR.N Y 81.78 990.4553 10 -6.3 496.2318 2 18.67 4 6702 VEV_1_3_RA4_01_1235.d 4.37E5 5 5 109 118
R.THMEELKEHTNNALYENYR.S Y 81.28 2391.0913 19 -10.3 598.7739 4 60.79 4 32080 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 395 413
R.YPWGVIEVDNEEHC(+57.02)DFVKLR.Q Y 77.18 2504.1794 20 -33.9 627.0309 4 79.56 4 46680 VEV_1_3_RA4_01_1235.d 0 1 1 370 389 Carbamidomethylation
K.VPFAVVGANSE(+14.02)VTSSEGGK.V Y 74.31 1847.9265 19 -7.9 924.9632 2 73.62 4 42062 VEV_1_3_RA4_01_1235.d 1.52E5 3 3 346 364 Methylation(others)
K.EVNPAVKQEEER.T Y 74.00 1426.7052 12 -5.5 714.3560 2 25.16 5 10579 VEV_2_3_RA5_01_1236.d 2.88E5 4 4 431 442
K.TVAIESISADIEENGVR.L Y 71.56 1801.9058 17 -10.7 901.9505 2 78.68 5 45167 VEV_2_3_RA5_01_1236.d 1.72E5 3 3 190 206
R.KGFNFNVMVVGESGLGK.S Y 71.14 1781.9135 17 -6.1 594.9748 3 79.04 5 45408 VEV_2_3_RA5_01_1236.d 1.82E5 2 2 145 161
R.SNPM(-48.00)GQGAAQTVTSKNPK.A Y 67.29 1766.8911 18 -9.9 589.9651 3 17.96 5 6620 VEV_2_3_RA5_01_1236.d 4.37E5 4 4 91 108 Dethiomethyl
K.VPFAVVGANSEVTSSEGGK(+14.02)VR.G Y 64.93 2103.0959 21 -21.0 702.0245 3 70.91 4 39933 VEV_1_3_RA4_01_1235.d 4.13E4 1 1 346 366 Methylation(KR)
R.LESGRPLEDKIKR.K Y 64.48 1539.8732 13 -11.5 385.9711 4 36.49 5 17061 VEV_2_3_RA5_01_1236.d 3.9E5 3 3 503 515
K.TVAIESISADIEENGVRLR.L Y 61.93 2071.0908 19 -11.9 691.3627 3 79.85 5 45952 VEV_2_3_RA5_01_1236.d 3.45E5 3 3 190 208
R.S(-18.01)NPM(+15.99)GQGAAQTVTSKNPK.A Y 61.28 1812.8788 18 -20.9 605.2876 3 41.40 4 19544 VEV_1_3_RA4_01_1235.d 6.79E4 1 1 91 108 Dehydration; Oxidation (M)
K.S(-2.02)TLVNTLFNTSLYPPKER.K Y 61.07 2077.0845 18 -27.7 693.3496 3 80.66 6 45627 VEV_3_3_RA6_01_1237.d 0 1 1 162 179 2-amino-3-oxo-butanoic_acid
R.ILADIQHHSIQIFEGPR.Y Y 57.74 1973.0482 17 -18.3 494.2603 4 74.83 6 41417 VEV_3_3_RA6_01_1237.d 0 1 1 311 327
R.SNPMGQ(+.98)GAAQTVTSKNPK.A Y 56.30 1815.8785 18 -17.9 606.2893 3 44.75 4 21615 VEV_1_3_RA4_01_1235.d 0 1 1 91 108 Deamidation (NQ)
R.LESGRPLEDK.I Y 52.22 1142.5931 10 -4.1 572.3015 2 23.87 6 9600 VEV_3_3_RA6_01_1237.d 5.65E5 7 7 503 512
K.AAAQAASDM(+15.99)R.N Y 50.83 1006.4502 10 -16.6 504.2240 2 13.35 4 3982 VEV_1_3_RA4_01_1235.d 0 1 1 109 118 Oxidation (M)
R.SNPMGQ(+.98)GAAQTVTSK.N Y 50.47 1476.6879 15 -8.0 739.3453 2 47.57 4 23368 VEV_1_3_RA4_01_1235.d 7.02E4 1 1 91 105 Deamidation (NQ)
K.VPFAVVGANSE(+14.02)VTSSEGGKVR.G Y 50.45 2103.0959 21 -2.9 702.0372 3 70.51 4 39612 VEV_1_3_RA4_01_1235.d 3.78E4 1 1 346 366 Methylation(others)
R.FDAYLEAENKVNR.M Y 49.55 1567.7631 13 -14.2 523.5875 3 62.70 6 32407 VEV_3_3_RA6_01_1237.d 3.98E5 3 3 238 250
K.ADTLTDEE(+14.02)IALFKQR.I Y 48.89 1762.9100 15 -18.9 588.6329 3 83.13 4 49319 VEV_1_3_RA4_01_1235.d 3.35E5 3 3 296 310 Methylation(others)
K.GPSLDIIPK.T Y 48.70 938.5436 9 -43.2 470.2588 2 70.04 6 37887 VEV_3_3_RA6_01_1237.d 0 1 1 181 189
R.FDAYLEAENK.V Y 47.89 1198.5505 10 -4.7 600.2797 2 61.99 4 32987 VEV_1_3_RA4_01_1235.d 5.16E4 1 1 238 247
R.SNPM(-48.00)GQGAAQTVTSK.N Y 43.60 1427.7004 15 -5.9 476.9046 3 15.13 4 4856 VEV_1_3_RA4_01_1235.d 2.75E5 2 2 91 105 Dethiomethyl
K.ADTLTDEE(+14.02)IALFK.Q Y 42.80 1478.7504 13 -15.5 740.3710 2 84.85 5 49075 VEV_2_3_RA5_01_1236.d 1.69E5 3 3 296 308 Methylation(others)
R.SDKLTQM(+15.99)GVAQDPSVFK.E Y 42.19 1865.9193 17 -1.8 622.9792 3 63.26 5 33978 VEV_2_3_RA5_01_1236.d 2.89E4 1 1 414 430 Oxidation (M)
R.S(+13.03)NPMGQGAAQTVTSKNPK.A Y 40.45 1827.9261 18 23.8 610.3305 3 27.43 5 11818 VEV_2_3_RA5_01_1236.d 0 1 1 91 108 Michael addition with methylamine
K.ADT(-2.02)LTDEEIALFKQR.I Y 40.07 1746.8788 15 -27.9 583.2839 3 77.42 6 43317 VEV_3_3_RA6_01_1237.d 7.24E4 1 1 296 310 2-amino-3-oxo-butanoic_acid
K.ADTLTDE(+14.02)EIALFK.Q Y 39.30 1478.7504 13 -11.9 740.3737 2 84.76 6 48313 VEV_3_3_RA6_01_1237.d 5.21E4 1 1 296 308 Methylation(others)
K.LKQSEDE(+14.02)LYAR.H Y 37.08 1364.6936 11 -3.6 455.9035 3 47.53 4 23340 VEV_1_3_RA4_01_1235.d 0 1 1 471 481 Methylation(others)
K.STLVNTLFNTSLYPPK(+14.02)ER.K Y 37.02 2093.1157 18 -26.6 698.6940 3 81.76 5 47248 VEV_2_3_RA5_01_1236.d 0 1 1 162 179 Methylation(KR)
R.SNPMGQGAAQ(+.98)TVTSK.N Y 33.23 1476.6879 15 -7.4 739.3458 2 46.90 5 23267 VEV_2_3_RA5_01_1236.d 3.3E4 2 2 91 105 Deamidation (NQ)
R.SNPMGQGAAQ(+.98)TVTSKNPK.A Y 32.51 1815.8785 18 -13.5 606.2919 3 44.71 5 21964 VEV_2_3_RA5_01_1236.d 5.33E4 1 1 91 108 Deamidation (NQ)
R.LESGRPLEDKIK.R Y 29.59 1383.7721 12 -15.5 692.8826 2 39.41 6 18154 VEV_3_3_RA6_01_1237.d 7.56E4 2 2 503 514
R.HREMKDQLER.Q Y 26.96 1340.6619 10 -14.3 336.1679 4 19.17 5 7291 VEV_2_3_RA5_01_1236.d 2.13E5 1 1 482 491
K.E(+42.01)R(+14.02)KGPSLDIIPK.T Y 26.93 1407.8085 12 -11.8 470.2712 3 70.16 5 39108 VEV_2_3_RA5_01_1236.d 0 1 1 178 189 Acetylation (N-term); Methylation(KR)
R.KGFNFNVMVVGESGLGK(+14.02).S Y 26.69 1795.9291 17 -19.9 599.6384 3 80.95 5 46673 VEV_2_3_RA5_01_1236.d 5.65E4 1 1 145 161 Methylation(KR)
R.VAAPK(+21.98).Q N 23.83 506.2828 5 -34.4 507.2727 1 43.84 4 21037 VEV_1_3_RA4_01_1235.d 0 1 1 8 12 Sodium adduct
K.LK(+14.02)QSEDELYAR.H Y 23.33 1364.6936 11 -8.5 455.9013 3 50.69 5 25566 VEV_2_3_RA5_01_1236.d 7.34E4 1 1 471 481 Methylation(KR)
R.K(+42.01)LTGYVGFAN(+.98)LPNQWHR.K Y 23.32 2043.0326 17 -18.3 409.6063 5 58.06 6 29070 VEV_3_3_RA6_01_1237.d 5.07E5 1 1 124 140 Acetylation (N-term); Deamidation (NQ)
R.Q(-17.03)RAELEEK.K Y 23.22 984.4876 8 -13.4 493.2445 2 28.38 5 12340 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 492 499 Pyro-glu from Q
R.S(+56.06)NPMGQGAAQTVTSKNPK.A Y 23.08 1870.9570 18 -11.4 468.7412 4 18.03 5 6671 VEV_2_3_RA5_01_1236.d 0 1 1 91 108 Diethylation
K.AAAQ(+.98)AASDMR.N Y 23.00 991.4393 10 -51.7 496.7013 2 20.97 4 7948 VEV_1_3_RA4_01_1235.d 4.14E4 2 2 109 118 Deamidation (NQ)
R.LE(+21.98)SGRPLEDK.I Y 22.26 1164.5751 10 23.1 389.2079 3 49.72 4 24709 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 503 512 Sodium adduct
R.Q(-17.03)RAELEEKKSR.L Y 22.03 1355.7157 11 -14.7 339.9312 4 16.82 6 5892 VEV_3_3_RA6_01_1237.d 5.59E4 1 1 492 502 Pyro-glu from Q
R.LESGR(+14.02)PLEDKIK.R Y 21.83 1397.7877 12 -25.7 466.9246 3 44.77 5 22002 VEV_2_3_RA5_01_1236.d 8.27E4 1 1 503 514 Methylation(KR)
R.SN(+.98)PM(+15.99)GQGAAQTVTSK.N Y 21.30 1492.6827 15 -0.2 747.3485 2 25.94 4 10624 VEV_1_3_RA4_01_1235.d 6.09E4 1 1 91 105 Deamidation (NQ); Oxidation (M)
R.LES(+79.97)GRPLEDK(+42.01).I Y 20.70 1264.5699 10 -3.4 317.1487 4 10.45 6 2681 VEV_3_3_RA6_01_1237.d 0 1 1 503 512 Phosphorylation (STY); Acetylation (K)
K.LQGPS(+79.97)IALC(+57.02)TPVR.K Y 20.54 1490.7316 13 22.8 746.3901 2 83.79 4 49764 VEV_1_3_RA4_01_1235.d 7.96E4 1 1 31 43 Phosphorylation (STY); Carbamidomethylation
K.QSEDELYARHR.E Y 20.36 1402.6589 11 0.8 702.3373 2 95.18 6 53665 VEV_3_3_RA6_01_1237.d 0 1 1 473 483
K.V(+225.09)NLIPVIAKADTLTDEEIALFKQR.I Y 20.17 2921.6047 24 -26.9 585.3125 5 77.58 4 45153 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 287 310 Iminobiotinylation
K.GPSLD(+21.98)IIPK.T Y 19.64 960.5256 9 -9.7 321.1794 3 45.27 5 22290 VEV_2_3_RA5_01_1236.d 2.3E5 2 2 181 189 Sodium adduct
K.L(+27.99)QGPSIALC(+57.02)TPVR.K Y 19.47 1438.7603 13 -32.0 480.5787 3 65.19 6 34264 VEV_3_3_RA6_01_1237.d 0 1 1 31 43 Formylation; Carbamidomethylation
K.VNRMN(+.98)IVDNR.V Y 19.34 1230.6139 10 -23.5 616.2997 2 61.26 6 31341 VEV_3_3_RA6_01_1237.d 7.05E4 1 1 248 257 Deamidation (NQ)
R.KLTGYVGFANLPNQWHR.K Y 19.29 2000.0381 17 8.3 501.0209 4 75.09 5 42661 VEV_2_3_RA5_01_1236.d 9.98E4 1 1 124 140
R.Q(+.98)MLIR.T Y 19.13 660.3629 5 -17.2 661.3588 1 87.25 5 50470 VEV_2_3_RA5_01_1236.d 0 1 1 390 394 Deamidation (NQ)
R.LTVVDTPGFGDFVNNDDSWRPIVENIEQR.F Y 18.70 3331.6108 29 -8.7 1111.5345 3 87.44 6 49911 VEV_3_3_RA6_01_1237.d 6.33E4 1 1 209 237
K.EVN(+.98)PAVK(+42.01).Q Y 18.29 798.4123 7 -1.3 400.2129 2 25.56 5 10803 VEV_2_3_RA5_01_1236.d 1.72E5 1 1 431 437 Deamidation (NQ); Acetylation (K)
K.SRLESGRPLE(+21.98)DK(+14.02).I Y 17.88 1421.7239 12 -27.8 474.9021 3 31.25 5 13995 VEV_2_3_RA5_01_1236.d 8.42E4 1 1 501 512 Sodium adduct; Methylation(KR)
K.ISKLQ(+.98)GPSIALCTPVR.K Y 17.82 1682.9388 16 -35.4 421.7271 4 60.41 6 30731 VEV_3_3_RA6_01_1237.d 0 1 1 28 43 Deamidation (NQ)
R.Q(-17.03)RAELEEKK.S Y 17.62 1112.5825 9 -10.4 557.2927 2 20.09 4 7446 VEV_1_3_RA4_01_1235.d 1.88E4 1 1 492 500 Pyro-glu from Q
R.MNIVDNR.V Y 17.54 860.4174 7 -14.8 431.2096 2 23.51 4 9277 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 251 257
R.A(+42.01)ELEEK.K Y 17.34 759.3650 6 -14.5 760.3613 1 79.49 6 44793 VEV_3_3_RA6_01_1237.d 6.11E4 1 1 494 499 Acetylation (N-term)
R.SDKLT(-18.01)QM(+15.99)GVAQDPSVFKEVNPAVK.Q Y 17.27 2585.3159 24 -15.1 647.3265 4 73.58 4 42036 VEV_1_3_RA4_01_1235.d 0 1 1 414 437 Dehydration; Oxidation (M)
K.ADT(-2.02)LTDEEIALFK.Q Y 17.19 1462.7191 13 7.2 732.3721 2 81.42 5 46973 VEV_2_3_RA5_01_1236.d 0 1 1 296 308 2-amino-3-oxo-butanoic_acid
R.VHAC(+57.02)VYFIQPTGHSLKPLDIEVMR.R Y 16.83 2809.4407 24 -4.4 703.3644 4 78.60 4 45944 VEV_1_3_RA4_01_1235.d 5.93E4 1 1 258 281 Carbamidomethylation
K.M(+15.99)VFQQK.V Y 16.67 795.3949 6 -16.5 398.6982 2 17.90 6 6453 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 458 463 Oxidation (M)
K.DQLER(+44.03).Q Y 16.51 703.3500 5 -0.5 704.3570 1 78.52 5 45066 VEV_2_3_RA5_01_1236.d 3.52E4 1 1 487 491 Ethanolation (KR)
K.E(+21.98)VNPAVKQEEER.T Y 16.23 1448.6871 12 -20.6 725.3359 2 45.77 6 21858 VEV_3_3_RA6_01_1237.d 5.6E4 1 1 431 442 Sodium adduct
K.EHTNNALYENY(+79.97)RSDK.L Y 15.77 1932.8003 15 38.1 484.2258 4 28.50 6 12049 VEV_3_3_RA6_01_1237.d 1.7E5 1 1 402 416 Phosphorylation (STY)
K.ADTLTDEEIALFK(+14.02)QR.I Y 15.39 1762.9100 15 -25.4 882.4399 2 80.77 4 47614 VEV_1_3_RA4_01_1235.d 9.86E4 1 1 296 310 Methylation(KR)
K.EVNPAVKQEEERTLHEQK(+14.02).L Y 15.28 2177.1077 18 -13.1 545.2770 4 70.09 5 39054 VEV_2_3_RA5_01_1236.d 2.17E5 1 1 431 448 Methylation(KR)
R.KGFSLR Y 15.25 706.4126 6 -24.1 354.2051 2 28.69 6 12146 VEV_3_3_RA6_01_1237.d 2.15E5 1 1 516 521
K.GFNFNVMVVGESGLGK.S Y 15.20 1653.8185 16 -1.2 552.2794 3 58.41 4 30295 VEV_1_3_RA4_01_1235.d 0 1 1 146 161
K.NPKAAAQAASDMRNVVR.R Y 15.06 1797.9268 17 -7.6 600.3116 3 73.12 4 41675 VEV_1_3_RA4_01_1235.d 2.03E5 1 1 106 122
total 89 peptides
C1FYR6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.QHPSELETAIAGALSDLEANTPDLK.A Y 144.82 2619.3027 25 -7.9 655.8278 4 90.67 4 54039 VEV_1_3_RA4_01_1235.d 1.58E6 15 15 15 39
R.TLTAVHDAILTDIVYPVEIVGKR.L Y 132.07 2522.4106 23 -9.0 631.6042 4 84.28 5 48746 VEV_2_3_RA5_01_1236.d 1.22E6 4 4 125 147
R.Q(-17.03)HPSELETAIAGALSDLEANTPDLK.A Y 131.26 2602.2761 25 -9.4 1302.1331 2 95.29 6 53720 VEV_3_3_RA6_01_1237.d 3.46E6 19 19 15 39 Pyro-glu from Q
R.TLTAVHDAILTDIVYPVEIVGK.R Y 127.64 2366.3096 22 -5.2 1184.1559 2 86.99 4 51878 VEV_1_3_RA4_01_1235.d 7.33E5 7 7 125 146
K.AIVIFVPVPLLQGFHK.I Y 125.89 1777.0654 16 -15.6 593.3531 3 89.15 6 50885 VEV_3_3_RA6_01_1237.d 2.24E6 9 9 61 76
R.Q(-17.03)HPSELETAIAGALSDLEANTPDLKAALRPLQFVSAR.E Y 124.72 3912.0381 37 0.4 979.0172 4 97.06 4 57165 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 15 51 Pyro-glu from Q
R.GVRFEFPQSSATEF Y 120.16 1600.7521 14 -9.2 801.3759 2 79.59 5 45782 VEV_2_3_RA5_01_1236.d 1.14E6 3 3 188 201
K.KAIVIFVPVPLLQGFHK.I Y 119.61 1905.1604 17 -16.3 477.2896 4 84.43 6 48116 VEV_3_3_RA6_01_1237.d 6.14E5 5 5 60 76
K.AALRPLQFVSAR.E Y 110.04 1327.7725 12 -11.3 443.5931 3 69.76 4 39092 VEV_1_3_RA4_01_1235.d 2.66E6 6 6 40 51
R.SRTLTAVHDAILTDIVYPVEIVGKR.L Y 107.09 2765.5439 25 -17.4 554.1064 5 82.77 6 47045 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 123 147
R.GGVDHRLDAYGEVYR.R Y 105.59 1705.8171 15 -5.9 569.6096 3 60.76 4 32053 VEV_1_3_RA4_01_1235.d 6.75E5 6 6 168 182
R.QHPS(+14.02)ELETAIAGALSDLEANTPDLK.A Y 99.44 2633.3184 25 -12.1 878.7695 3 91.79 5 52803 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 15 39 Methylation(others)
K.FSDRHVLIIASR.R Y 92.42 1412.7888 12 -7.3 471.9334 3 61.37 4 32513 VEV_1_3_RA4_01_1235.d 8.07E5 6 6 89 100
R.Q(+.98)HPSELETAIAGALSDLEANTPDLK.A Y 90.82 2620.2866 25 -6.7 874.4303 3 91.52 5 52649 VEV_2_3_RA5_01_1236.d 2.4E5 3 3 15 39 Deamidation (NQ)
K.AIVIFVPVPLLQ(+.98)GFHK.I Y 87.97 1778.0494 16 -12.4 593.6830 3 90.01 6 51334 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 61 76 Deamidation (NQ)
R.Q(-17.03)HPSELETAIAGALSDLEANTPDLK(+14.02).A Y 85.65 2616.2917 25 -9.8 1309.1404 2 97.53 6 54500 VEV_3_3_RA6_01_1237.d 1.76E6 16 16 15 39 Pyro-glu from Q; Methylation(KR)
R.SRTLTAVHDAILTDIVYPVEIVGK.R Y 82.79 2609.4429 24 -15.8 653.3577 4 84.58 4 50302 VEV_1_3_RA4_01_1235.d 6.9E4 2 2 123 146
K.AIVIFVPVPLLQGFHKIQQR.L Y 79.22 2302.3677 20 -2.2 576.5979 4 86.31 4 51437 VEV_1_3_RA4_01_1235.d 4.67E4 1 1 61 80
R.GGVDHRLDAYGEVYRR.L Y 76.71 1861.9183 16 -16.7 466.4791 4 57.84 6 28921 VEV_3_3_RA6_01_1237.d 6.14E5 3 3 168 183
K.IAANSPSRQHPSELETAIAGALSDLEANTPDLK.A Y 76.60 3415.7219 33 -44.8 854.8995 4 87.23 5 50429 VEV_2_3_RA5_01_1236.d 0 1 1 7 39
R.QHPSELE(+14.02)TAIAGALSDLEANTPDLK.A Y 76.52 2633.3184 25 -9.9 659.3303 4 91.88 4 54708 VEV_1_3_RA4_01_1235.d 4.47E5 2 2 15 39 Methylation(others)
R.Q(-17.03)HPSELETAIAGALSDLEAN(+.98)TPDLK.A Y 75.50 2603.2603 25 -5.4 868.7560 3 95.32 6 53722 VEV_3_3_RA6_01_1237.d 8.52E5 3 3 15 39 Pyro-glu from Q; Deamidation (NQ)
R.EIEVGHGKK.A Y 72.44 995.5400 9 -12.2 498.7712 2 10.81 5 2873 VEV_2_3_RA5_01_1236.d 1.08E5 3 3 52 60
R.QHPSELETAIAGALSDLE(+14.02)ANTPDLK.A Y 68.20 2633.3184 25 -10.2 878.7711 3 92.73 4 55152 VEV_1_3_RA4_01_1235.d 7.45E5 4 4 15 39 Methylation(others)
M.A(+42.01)ALNKIAANSPSR.Q Y 66.35 1353.7365 13 -13.5 677.8663 2 63.23 6 32808 VEV_3_3_RA6_01_1237.d 3.69E5 3 3 2 14 Acetylation (Protein N-term)
R.QHPSELETAIAGALSDLEANTPDLK(+14.02).A Y 65.86 2633.3184 25 -16.6 659.3259 4 91.94 6 52285 VEV_3_3_RA6_01_1237.d 1.91E5 2 2 15 39 Methylation(KR)
K.AALRPLQFVSAR(+14.02).E Y 64.99 1341.7881 12 -27.9 448.2575 3 71.71 6 39147 VEV_3_3_RA6_01_1237.d 2.11E5 2 2 40 51 Methylation(KR)
K.VILHEKER.G Y 62.97 1022.5872 8 -13.9 512.2938 2 15.65 6 5316 VEV_3_3_RA6_01_1237.d 9.55E5 6 6 160 167
R.LDAYGEVYR.R Y 62.53 1084.5189 9 -15.3 543.2584 2 60.77 6 31001 VEV_3_3_RA6_01_1237.d 1.34E4 1 1 174 182
R.TLTAVHDAILTDIVYPVE(+14.02)IVGKR.L Y 62.44 2536.4265 23 -15.6 635.1040 4 85.49 6 48766 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 125 147 Methylation(others)
R.QHPSELET(+14.02)AIAGALSDLEANTPDLK.A Y 62.12 2633.3184 25 -17.4 878.7648 3 91.86 4 54707 VEV_1_3_RA4_01_1235.d 1.93E5 1 1 15 39 Methylation(others)
R.FEFPQSSATEF Y 61.55 1288.5612 11 22.4 645.3023 2 82.11 5 47432 VEV_2_3_RA5_01_1236.d 0 2 2 191 201
K.AALRPLQ(+.98)FVSAR.E Y 58.44 1328.7565 12 -1.9 443.9253 3 71.28 5 39934 VEV_2_3_RA5_01_1236.d 3.4E4 2 2 40 51 Deamidation (NQ)
R.QHPSELETAIAGALSDLEANTPDLKAALRPLQFVSAR.E Y 53.81 3929.0645 37 -12.8 983.2609 4 94.85 6 53556 VEV_3_3_RA6_01_1237.d 8.87E4 1 1 15 51
R.GVRFEFPQ(+.98)SSATEF Y 53.72 1601.7361 14 -10.1 801.8672 2 80.43 6 45465 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 188 201 Deamidation (NQ)
R.QHPSELETAIAGALS(-2.02)DLEANTPDLK.A Y 53.43 2617.2871 25 19.3 873.4532 3 90.91 4 54174 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 15 39 2-amino-3-oxo-butanoic_acid
R.GVR(+14.02)FEFPQSSATEF Y 51.50 1614.7678 14 -7.0 808.3855 2 80.48 4 47456 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 188 201 Methylation(KR)
R.EIEVGHGK.K Y 50.79 867.4450 8 -10.7 434.7252 2 13.68 4 4146 VEV_1_3_RA4_01_1235.d 4.96E4 3 3 52 59
K.IAANSPSRQHPSELETAIAGALS(-2.02)DLEANTPDLK.A Y 48.57 3413.7063 33 0.9 854.4346 4 87.42 5 50538 VEV_2_3_RA5_01_1236.d 0 1 1 7 39 2-amino-3-oxo-butanoic_acid
R.QHPS(-18.01)ELETAIAGALSDLEANTPDLK.A Y 47.02 2601.2922 25 -19.7 868.0876 3 95.21 5 54308 VEV_2_3_RA5_01_1236.d 1.83E3 3 3 15 39 Dehydration
R.QHPSELET(-2.02)AIAGALSDLEANTPDLK.A Y 46.50 2617.2871 25 6.3 873.4418 3 91.55 5 52666 VEV_2_3_RA5_01_1236.d 6.22E4 1 1 15 39 2-amino-3-oxo-butanoic_acid
R.HVLIIASR.R Y 45.85 907.5603 8 -26.7 454.7753 2 47.75 6 22998 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 93 100
K.IAANSPSR.Q Y 45.59 814.4297 8 -15.8 408.2157 2 13.74 6 4307 VEV_3_3_RA6_01_1237.d 1.04E6 5 5 7 14
R.TKEDGSKLLK.V Y 44.77 1117.6343 10 -13.6 559.8168 2 17.14 6 6055 VEV_3_3_RA6_01_1237.d 2.53E5 4 4 150 159
K.FSDRHVLIIASRR.I Y 44.68 1568.8899 13 -14.3 393.2242 4 57.22 5 29573 VEV_2_3_RA5_01_1236.d 5.76E5 3 3 89 101
R.QHPSELETAIAGALSD(+14.02)LEANTPDLK.A Y 40.00 2633.3184 25 5.1 659.3402 4 92.34 4 54954 VEV_1_3_RA4_01_1235.d 3.06E5 1 1 15 39 Methylation(others)
R.Q(+.98)HPSELETAIAGALSDLEAN(+.98)TPDLK.A Y 39.80 2621.2708 25 -1.9 874.7626 3 91.65 4 54578 VEV_1_3_RA4_01_1235.d 7.7E4 1 1 15 39 Deamidation (NQ)
K.I(+42.01)AANSPSRQHPSE(+43.99)LETAIAGALSDLEANTPDLK.A Y 38.58 3501.7222 33 -21.5 876.4190 4 91.61 5 52698 VEV_2_3_RA5_01_1236.d 0 1 1 7 39 Acetylation (Protein N-term); Carboxylation (E)
K.KAIVIFVPVPLLQ(+.98)GFHK.I Y 38.55 1906.1444 17 -25.3 636.3727 3 84.49 5 48863 VEV_2_3_RA5_01_1236.d 0 1 1 60 76 Deamidation (NQ)
R.TLTAVHDAILTDIVYPVEIVGK(+14.02).R Y 38.13 2380.3252 22 -51.9 794.4078 3 88.25 4 52655 VEV_1_3_RA4_01_1235.d 0 1 1 125 146 Methylation(KR)
R.GVRFEFPQSSATE(+14.02)F Y 35.13 1614.7678 14 -7.8 808.3849 2 81.41 4 48094 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 188 201 Methylation(others)
R.ILPRPK.R Y 35.08 722.4802 6 -33.0 362.2355 2 21.90 5 8759 VEV_2_3_RA5_01_1236.d 7.56E5 4 4 102 107
R.RILPRPK.R Y 33.99 878.5814 7 -27.3 440.2859 2 29.85 6 12786 VEV_3_3_RA6_01_1237.d 3.01E5 3 3 101 107
K.AIVIFVPVPLLQGFHK(+14.02).I Y 31.58 1791.0811 16 -14.3 598.0258 3 87.80 6 50111 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 61 76 Methylation(KR)
R.LDAYGEVYRR.L Y 28.96 1240.6200 10 -7.1 414.5443 3 53.81 5 27474 VEV_2_3_RA5_01_1236.d 6.53E5 5 5 174 183
R.E(-18.01)IEVGHGKK.A Y 28.51 977.5294 9 -10.5 326.8470 3 11.05 4 2900 VEV_1_3_RA4_01_1235.d 3.34E5 2 2 52 60 Pyro-glu from E
R.QHPS(-18.01)ELETAIAGALSDLEANTPDLK(+14.02).A Y 28.06 2615.3079 25 -12.4 1308.6450 2 97.52 4 57340 VEV_1_3_RA4_01_1235.d 3.11E4 2 2 15 39 Dehydration; Methylation(KR)
K.A(+41.03)ALRPLQFVSAR.E Y 25.75 1368.7990 12 -78.7 457.2377 3 69.86 4 39107 VEV_1_3_RA4_01_1235.d 0 1 1 40 51 Amidination of lysines or N-terminal amines with methyl acetimidate
R.QHPSELET(-18.01)AIAGALSDLEANTPDLK.A Y 25.61 2601.2922 25 -31.3 868.0775 3 95.19 6 53671 VEV_3_3_RA6_01_1237.d 0 1 1 15 39 Dehydration
K.KFSDRHVLIIASR.R Y 24.63 1540.8838 13 -9.1 386.2247 4 59.18 4 30874 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 88 100
K.IAANSPSRQHPSE(+37.96)LETAIAGALSDLEANTPDLK.A Y 23.35 3453.6777 33 -15.8 864.4130 4 95.68 5 54511 VEV_2_3_RA5_01_1236.d 0 1 1 7 39 Replacement of proton by potassium
K.EDGSK.L N 23.22 534.2285 5 24.8 535.2490 1 27.36 5 11779 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 152 156
R.LT(+79.96)GRGVR(+14.02).F Y 23.06 851.4283 7 4.3 852.4393 1 87.21 4 52010 VEV_1_3_RA4_01_1235.d 2.95E4 1 1 184 190 Sulfation; Methylation(KR)
R.TLT(+79.97)AVHDAILTDIVY(+162.05)PVEIVGK.R Y 22.46 2608.3289 22 11.0 653.0967 4 84.52 4 50264 VEV_1_3_RA4_01_1235.d 0 1 1 125 146 Phosphorylation (STY); Hexose (NSY)
K.VILHEK.E Y 21.26 737.4435 6 -47.0 369.7117 2 15.52 6 5217 VEV_3_3_RA6_01_1237.d 0 1 1 160 165
R.EIEVGH(+15.99)GK(+42.01).K Y 21.09 925.4505 8 8.6 926.4658 1 103.01 5 56948 VEV_2_3_RA5_01_1236.d 4.99E4 1 1 52 59 Oxidation (HW); Acetylation (K)
K.IAANSPSRQHPSELETAIAGALSDLEANTPDLK(-.98).A Y 21.01 3414.7378 33 -14.6 1139.2366 3 87.32 6 49843 VEV_3_3_RA6_01_1237.d 0 1 1 7 39 Amidation
R.QHPSELETAIAGALS(+13.03)DLEANTPDLK.A Y 20.83 2632.3345 25 -22.7 878.4322 3 92.76 4 55170 VEV_1_3_RA4_01_1235.d 0 1 1 15 39 Michael addition with methylamine
R.H(+42.01)VLIIASR.R Y 20.79 949.5709 8 -28.8 475.7791 2 74.94 4 43081 VEV_1_3_RA4_01_1235.d 2.47E4 1 1 93 100 Acetylation (N-term)
K.I(+42.01)AANSPSR(+21.98).Q Y 20.55 878.4222 8 -3.7 879.4262 1 94.54 4 56079 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 7 14 Acetylation (Protein N-term); Sodium adduct
MAALNK(+31.99)IAANSPSR(+14.02).Q Y 19.47 1488.7719 14 19.3 373.2074 4 14.27 6 4561 VEV_3_3_RA6_01_1237.d 8.51E4 1 1 1 14 Dihydroxy; Methylation(KR)
R.Q(+316.20)HPSELETAIAGALSDLEANTPDLK.A Y 19.26 2935.5066 25 -19.6 979.4903 3 95.46 4 56501 VEV_1_3_RA4_01_1235.d 0 1 1 15 39 Levuglandinyl-lysine pyrrole adduct
R.QHPSE(+6.01)LETAIAGALSDLEANTPDLK.A Y 19.03 2625.3108 25 -0.9 876.1101 3 96.48 4 56951 VEV_1_3_RA4_01_1235.d 1.65E5 1 1 15 39 Replacement of proton by lithium
K.EDGS(-18.01)K.L N 18.58 516.2180 5 6.1 517.2284 1 108.72 6 57759 VEV_3_3_RA6_01_1237.d 2.59E4 2 2 152 156 Dehydration
R.TLTAVHDAILTDIVYPVEIVGK(+158.13).R Y 18.31 2524.4404 22 -46.6 842.4482 3 84.46 5 48843 VEV_2_3_RA5_01_1236.d 0 1 1 125 146 Reduced 4-Hydroxynonenal
R.HVLIIASR(-.98).R Y 17.93 906.5763 8 -66.1 303.1794 3 47.85 4 23536 VEV_1_3_RA4_01_1235.d 0 1 1 93 100 Amidation
R.T(-18.01)K(+14.02)EDGSK.L Y 17.33 759.3763 7 11.2 760.3921 1 112.75 5 59588 VEV_2_3_RA5_01_1236.d 0 1 1 150 156 Dehydration; Methylation(KR)
R.TKEDGSK(+54.01).L Y 17.19 817.3817 7 29.1 818.4128 1 88.33 4 52708 VEV_1_3_RA4_01_1235.d 0 1 1 150 156 MDA adduct +54
R.Q(+15.00)HPSELETAIAGALSDLEANTPDLK.A Y 17.15 2634.3025 25 -25.8 659.5659 4 92.92 6 52726 VEV_3_3_RA6_01_1237.d 0 1 1 15 39 Deamidation followed by a methylation
K.AIVIFVPVPLLQ(+.98)GFHKIQQR.L Y 17.05 2303.3518 20 17.8 576.8555 4 86.15 5 49819 VEV_2_3_RA5_01_1236.d 0 1 1 61 80 Deamidation (NQ)
K.I(+42.01)AANSPS(+79.97)R.Q Y 16.92 936.4066 8 -26.7 937.3889 1 112.01 5 59383 VEV_2_3_RA5_01_1236.d 0 1 1 7 14 Acetylation (Protein N-term); Phosphorylation (STY)
R.TLTAVHDAILTDIVYPVEIVGK(+43.99)RLRT(+79.97)K.E Y 16.87 3144.6948 27 -44.8 787.1458 4 86.78 5 50187 VEV_2_3_RA5_01_1236.d 4.55E4 1 1 125 151 Carboxylation (DKW); Phosphorylation (STY)
MAALNK.I Y 16.52 646.3472 6 -39.6 647.3289 1 17.72 4 6213 VEV_1_3_RA4_01_1235.d 1.56E4 1 1 1 6
R.TK(+42.01)EDGSK.L Y 16.42 805.3817 7 -29.2 806.3655 1 112.61 4 61845 VEV_1_3_RA4_01_1235.d 1.18E4 1 1 150 156 Acetylation (K)
R.G(+71.04)GVDHR.L Y 15.99 710.3459 6 -24.5 711.3358 1 45.63 5 22509 VEV_2_3_RA5_01_1236.d 0 1 1 168 173 Propionamide (K, X@N-term)
K.ERGGVDHR.L Y 15.93 924.4525 8 2.3 463.2346 2 32.58 4 14336 VEV_1_3_RA4_01_1235.d 1.83E4 1 1 166 173
total 86 peptides
C1GA14
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ILLPFLENTLAIGNQQQAVYNALAK.I Y 120.49 2741.5115 25 -17.9 1371.7385 2 93.04 6 52781 VEV_3_3_RA6_01_1237.d 4.83E5 4 4 872 896
K.FSDLLGPTNLINLLEKYR.T Y 115.48 2105.1521 18 -11.4 702.7167 3 90.51 6 51596 VEV_3_3_RA6_01_1237.d 1.31E5 2 2 703 720
R.EASQQKEEDNTPVLGGSR.L Y 111.52 1943.9185 18 -8.1 648.9749 3 38.90 5 18464 VEV_2_3_RA5_01_1236.d 1.08E6 11 11 1639 1656
R.THQNSQVIEGQAAAFGTIR.V Y 109.83 2027.0184 19 -20.5 676.6663 3 66.55 6 35293 VEV_3_3_RA6_01_1237.d 2.79E4 1 1 201 219
K.NLLASVDAASIPIDDLVSEVESR.N Y 106.16 2412.2383 23 -7.9 1207.1169 2 93.75 6 53116 VEV_3_3_RA6_01_1237.d 2.73E5 3 3 845 867
K.KAVDLFFPPEAVLDFPTAIQVSK.R Y 101.90 2531.3674 23 -8.9 844.7889 3 90.07 6 51350 VEV_3_3_RA6_01_1237.d 2.46E5 3 3 259 281
R.AGDPSNYNEVIETATHAGKDEDLVEFLK.M Y 101.75 3061.4517 28 -3.5 1021.4875 3 82.90 4 49156 VEV_1_3_RA4_01_1235.d 1.3E5 2 2 1146 1173
K.IYIDSNNNPEK.F Y 97.37 1305.6201 11 -9.6 653.8110 2 44.57 5 22001 VEV_2_3_RA5_01_1236.d 6.69E5 8 8 897 907
R.ALENTDDPTVIMR.N Y 95.88 1473.7134 13 -12.0 737.8551 2 68.51 5 37932 VEV_2_3_RA5_01_1236.d 5.67E5 3 3 640 652
R.YNLNDFSMPYMINLLSQQVR.T Y 93.70 2445.1821 20 -4.6 816.0643 3 94.13 4 55918 VEV_1_3_RA4_01_1235.d 2.22E5 3 3 1604 1623
R.SLVDQVIATAVPESAEPDKVSVAVK.A Y 93.68 2551.3745 25 -17.0 851.4510 3 82.55 6 46898 VEV_3_3_RA6_01_1237.d 2.27E5 2 2 984 1008
R.ISQLC(+57.02)ENAQLYQR.A Y 88.95 1621.7882 13 -14.2 811.8898 2 64.10 6 33446 VEV_3_3_RA6_01_1237.d 4.52E5 3 3 627 639 Carbamidomethylation
K.Q(-17.03)AGYQPDYIQLLQHIVR.V Y 88.09 2024.0480 17 -1.5 1013.0297 2 89.34 4 53298 VEV_1_3_RA4_01_1235.d 4.03E5 6 6 520 536 Pyro-glu from Q
K.AVDLFFPPEAVLDFPTAIQVSK.R Y 87.26 2403.2725 22 -15.6 1202.6248 2 94.52 6 53442 VEV_3_3_RA6_01_1237.d 6.96E4 3 3 260 281
R.QQTGNQQQIVVVNPHNPVEVTRR.S Y 86.35 2640.3845 23 -9.1 661.0974 4 62.95 4 33720 VEV_1_3_RA4_01_1235.d 4.25E4 1 1 44 66
K.AQLDGLRVSDSIASYIR.A Y 85.74 1862.9850 17 15.0 622.0116 3 79.75 5 45887 VEV_2_3_RA5_01_1236.d 0 1 1 1129 1145
R.KTLREPAVDTALAFAYAR.L Y 84.66 1992.0792 18 -12.8 499.0207 4 75.10 4 43203 VEV_1_3_RA4_01_1235.d 0 2 2 1177 1194
R.ISSKPIFVTVPDSDSAGLVGVNR.H Y 83.27 2357.2590 23 5.1 786.7643 3 77.88 4 45385 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 311 333
R.VSDSIASYIR.A Y 82.93 1109.5717 10 -17.8 555.7832 2 69.07 6 37219 VEV_3_3_RA6_01_1237.d 4.97E5 5 5 1136 1145
R.YLLDRADPEIWAFVLNANNIHRR.S Y 80.71 2795.4619 23 -21.6 560.0876 5 84.41 5 48829 VEV_2_3_RA5_01_1236.d 4.41E5 3 3 961 983
R.GFLRTPATINILK.N Y 80.58 1442.8608 13 -9.9 481.9561 3 76.74 5 43829 VEV_2_3_RA5_01_1236.d 1.17E5 2 2 403 415
K.QAGYQPDYIQLLQHIVR.V Y 76.92 2041.0745 17 -11.9 681.3574 3 84.58 4 50299 VEV_1_3_RA4_01_1235.d 1.77E5 2 2 520 536
R.TPATINILK.N Y 76.54 969.5859 9 -14.6 485.7932 2 65.46 6 34467 VEV_3_3_RA6_01_1237.d 6.85E5 5 5 407 415
R.TDKLNPEWLMNYFGR.L Y 75.83 1882.9036 15 9.7 628.6479 3 84.61 4 50340 VEV_1_3_RA4_01_1235.d 1.02E5 3 3 657 671
K.RQFDTLVSQGQYTEAAK.V Y 73.05 1940.9591 17 -13.2 647.9851 3 64.72 4 35056 VEV_1_3_RA4_01_1235.d 2.46E5 2 2 379 395
R.QFDTLVSQGQYTEAAK.V Y 72.89 1784.8580 16 -11.0 893.4265 2 69.46 6 37461 VEV_3_3_RA6_01_1237.d 1.62E5 3 3 380 395
K.AVNNAINDLLIEEEDYK.T Y 69.03 1961.9581 17 -7.7 981.9788 2 81.69 6 46337 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 1477 1493
R.HGQVLAVSVDENKIIPYILEK.L Y 66.75 2364.3052 21 -3.6 592.0814 4 80.88 4 47706 VEV_1_3_RA4_01_1235.d 5.99E4 1 1 334 354
K.AVNNAINDLLIEEEDYKTLR.D Y 64.55 2332.1909 20 -2.9 778.4020 3 80.84 5 46607 VEV_2_3_RA5_01_1236.d 2.76E5 3 3 1477 1496
K.VVAGFAETGQFDKILAYSK.Q Y 63.93 2043.0676 19 -8.7 682.0239 3 80.17 6 45281 VEV_3_3_RA6_01_1237.d 7.28E4 2 2 501 519
K.MNQLTEVER.I Y 63.73 1118.5391 9 -9.4 560.2715 2 48.52 4 23946 VEV_1_3_RA4_01_1235.d 4.37E5 5 5 752 760
R.E(+14.02)ASQQKEEDNTPVLGGSR.L Y 62.31 1957.9341 18 -9.2 653.6460 3 41.22 4 19425 VEV_1_3_RA4_01_1235.d 4.27E4 1 1 1639 1656 Methylation(others)
K.RDPNLAYVAYSK.G Y 60.49 1395.7146 12 -16.8 466.2376 3 59.17 5 30940 VEV_2_3_RA5_01_1236.d 3.3E5 2 2 927 938
R.ALENTDDPTVIM(+15.99)R.N Y 58.86 1489.7083 13 -2.9 745.8593 2 60.66 4 31978 VEV_1_3_RA4_01_1235.d 1.48E5 3 3 640 652 Oxidation (M)
R.EASQQK(+14.02)EEDNTPVLGGSR.L Y 56.95 1957.9341 18 -5.0 653.6487 3 47.38 4 23246 VEV_1_3_RA4_01_1235.d 2.78E5 3 3 1639 1656 Methylation(KR)
K.IFYTSISNWAK.L Y 56.40 1328.6765 11 -8.6 665.3398 2 78.10 6 43791 VEV_3_3_RA6_01_1237.d 2.69E5 4 4 1231 1241
K.IFTFAVR.S Y 55.51 852.4857 7 -21.9 427.2408 2 72.33 6 39609 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 229 235
R.EASQQKEE(+14.02)DNTPVLGGSR.L Y 54.56 1957.9341 18 -11.1 653.6447 3 47.03 6 22587 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 1639 1656 Methylation(others)
R.TTEDHNWSALVAIQR.K Y 53.26 1739.8591 15 -20.2 435.9633 4 72.75 4 41384 VEV_1_3_RA4_01_1235.d 7.41E4 2 2 171 185
K.M(+15.99)NQLTEVER.I Y 52.16 1134.5339 9 -12.4 568.2672 2 38.63 6 17717 VEV_3_3_RA6_01_1237.d 2.61E5 3 3 752 760 Oxidation (M)
K.LNNPGLAVR.L Y 51.30 952.5454 9 -13.8 477.2734 2 51.18 6 24974 VEV_3_3_RA6_01_1237.d 4.6E5 4 4 355 363
K.SDNIPLIKPFLLNVQPQNKK.A Y 50.84 2305.3157 20 -57.3 577.3032 4 79.44 5 45684 VEV_2_3_RA5_01_1236.d 6.24E4 2 2 1457 1476
K.GGLPGADDLLKR.Q Y 50.53 1210.6670 12 -22.7 404.5538 3 67.08 6 35691 VEV_3_3_RA6_01_1237.d 4.97E4 1 1 368 379
R.HGQVLAVSVDEN(+.98)KIIPYILEKLNNPGLAVR.L Y 50.43 3299.8240 30 7.0 825.9691 4 87.27 5 50455 VEV_2_3_RA5_01_1236.d 0 1 1 334 363 Deamidation (NQ)
R.Q(-17.03)QTGNQQQIVVVNPHNPVEVTRR.S Y 50.36 2623.3579 23 -22.8 656.8318 4 68.06 4 37690 VEV_1_3_RA4_01_1235.d 1.21E5 2 2 44 66 Pyro-glu from Q
K.FSDLLGPTNLINLLEK.Y Y 48.58 1785.9875 16 -13.5 893.9890 2 91.41 6 52029 VEV_3_3_RA6_01_1237.d 2.11E4 1 1 703 718
R.ESNYYNPEKVK.N Y 46.81 1369.6514 11 -12.8 685.8242 2 35.55 5 16499 VEV_2_3_RA5_01_1236.d 4.52E4 1 1 764 774
R.TAEGLYYYLGSIVNLSEDPDVHFK.Y Y 46.47 2729.3223 24 -3.2 910.7784 3 90.37 6 51503 VEV_3_3_RA6_01_1237.d 9.08E4 1 1 721 744
R.LLEMNLVNAPQVADAILGNEMFTHYDKGR.I Y 45.16 3258.6165 29 -7.7 652.7255 5 88.84 6 50703 VEV_3_3_RA6_01_1237.d 8.7E4 1 1 598 626
K.DGEFDESKKWQITHYR.T Y 44.48 2037.9543 16 -46.9 408.5790 5 63.42 6 32938 VEV_3_3_RA6_01_1237.d 0 1 1 155 170
K.SQPIEASTLR.E Y 44.45 1100.5825 10 -13.1 551.2913 2 47.14 4 23091 VEV_1_3_RA4_01_1235.d 2.03E5 5 5 140 149
K.SQPIEASTLREPIKK.D Y 41.53 1695.9519 15 -25.9 566.3099 3 51.78 6 25386 VEV_3_3_RA6_01_1237.d 4.88E5 4 4 140 154
K.ILLPFLENTLAIGN(+.98)Q(+.98)QQAVYNALAK.I Y 41.11 2743.4795 25 -14.5 915.4872 3 93.31 4 55461 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 872 896 Deamidation (NQ)
K.AFLDADLPGELIELLEK.I Y 38.68 1885.0083 17 -14.3 943.4980 2 97.53 6 54501 VEV_3_3_RA6_01_1237.d 4.5E4 1 1 1009 1025
K.VANLEIYYR.A Y 38.03 1139.5974 9 -14.7 570.7976 2 68.97 6 37106 VEV_3_3_RA6_01_1237.d 4.76E4 1 1 1413 1421
R.ALE(+14.02)NTDDPTVIMR.N Y 37.51 1487.7290 13 -11.9 744.8629 2 72.11 4 40883 VEV_1_3_RA4_01_1235.d 1E5 1 1 640 652 Methylation(others)
K.RYDIAYIVTKFGFIHLYDLETGNC(+57.02)LFLSR.I Y 33.65 3523.7961 29 -7.8 705.7610 5 93.38 4 55493 VEV_1_3_RA4_01_1235.d 1.7E5 1 1 282 310 Carbamidomethylation
K.IYIDSN(+.98)NNPEK.F Y 33.43 1306.6041 11 -3.6 654.3070 2 47.55 5 23661 VEV_2_3_RA5_01_1236.d 4.44E4 2 2 897 907 Deamidation (NQ)
K.FLKENDLYDTLTVGK.Y Y 31.30 1754.9091 15 -34.2 585.9570 3 76.42 5 43603 VEV_2_3_RA5_01_1236.d 0 1 1 908 922
K.IYIDSNNNPEK(+14.02).F Y 30.84 1319.6357 11 14.1 660.8345 2 57.39 5 29692 VEV_2_3_RA5_01_1236.d 1.43E4 1 1 897 907 Methylation(KR)
K.Q(-17.03)VSEAC(+57.02)VSKK.E Y 29.72 1117.5437 10 -16.6 559.7698 2 31.30 6 13583 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 1270 1279 Pyro-glu from Q; Carbamidomethylation
K.IYIDSNN(+.98)NPEK.F Y 29.48 1306.6041 11 -7.0 654.3047 2 47.44 6 22825 VEV_3_3_RA6_01_1237.d 9.39E4 1 1 897 907 Deamidation (NQ)
K.AQLDGLR.V Y 28.27 771.4239 7 -16.7 386.7128 2 37.40 6 16997 VEV_3_3_RA6_01_1237.d 2.62E5 2 2 1129 1135
R.IYHWDVFEEK.S Y 27.38 1364.6400 10 -15.7 455.8801 3 73.65 6 40563 VEV_3_3_RA6_01_1237.d 3.38E4 1 1 130 139
R.QIAASIYR.K Y 25.73 920.5079 8 -68.7 921.4520 1 93.02 6 52770 VEV_3_3_RA6_01_1237.d 5.61E4 1 1 1524 1531
R.THQNSQVIEGQAAAFGTIR(-.98).V Y 25.41 2026.0344 19 -21.6 676.3375 3 66.55 6 35294 VEV_3_3_RA6_01_1237.d 7.52E4 1 1 201 219 Amidation
K.IQLYSR.T Y 24.66 778.4337 6 -24.5 390.2146 2 44.20 6 20940 VEV_3_3_RA6_01_1237.d 2.09E5 1 1 195 200
R.H(+42.01)GQVLAVSVDENK.I Y 24.63 1436.7260 13 18.6 360.1954 4 50.38 6 24511 VEV_3_3_RA6_01_1237.d 0 1 1 334 346 Acetylation (N-term)
R.VNPEK.G N 24.34 585.3122 5 21.0 586.3318 1 99.47 5 55836 VEV_2_3_RA5_01_1236.d 7.35E3 2 2 537 541
K.QAGY(-18.01)QPDYIQLLQHIVR.V Y 24.30 2023.0638 17 -22.2 675.3469 3 89.36 5 51563 VEV_2_3_RA5_01_1236.d 4.09E4 1 1 520 536 Dehydration
R.QIAASIYRKNK(+27.99).R Y 24.06 1318.7357 11 -4.2 330.6898 4 37.37 5 17569 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 1524 1534 Formylation
K.HDLVFFR(+31.99).Q Y 23.86 964.4766 7 -12.0 483.2398 2 27.64 5 11943 VEV_2_3_RA5_01_1236.d 0 1 1 1517 1523 Dihydroxy
K.DNKPEHAHLQTR.L Y 23.65 1444.7170 12 -9.6 362.1831 4 19.64 4 7232 VEV_1_3_RA4_01_1235.d 0 1 1 586 597
K.SIEVYVQ(+.98)R(+14.02).V Y 23.47 1007.5287 8 -31.0 1008.5048 1 90.06 6 51376 VEV_3_3_RA6_01_1237.d 8.77E4 1 1 813 820 Deamidation (NQ); Methylation(KR)
K.SIEVYVQR.V Y 23.42 992.5291 8 -17.2 497.2633 2 57.68 5 29897 VEV_2_3_RA5_01_1236.d 5.17E4 1 1 813 820
K.A(+42.01)NNAK(+42.01).V Y 23.10 600.2867 5 -10.3 601.2878 1 54.64 4 27838 VEV_1_3_RA4_01_1235.d 2.68E4 1 1 1262 1266 Acetylation (N-term); Acetylation (K)
K.E(+42.01)ED(-18.01)NTPVLGGSR.L Y 23.04 1296.5946 12 13.1 649.3130 2 38.93 4 18059 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 1645 1656 Acetylation (N-term); Dehydration
K.SISLSKQDK.L Y 22.65 1004.5502 9 -32.4 335.8465 3 26.03 4 10674 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 1539 1547
K.QVSEAC(+57.02)VSKKEFR.L Y 22.64 1566.7823 13 19.3 523.2781 3 60.09 4 31550 VEV_1_3_RA4_01_1235.d 0 1 1 1270 1282 Carbamidomethylation
K.Q(-17.03)AGYQ(+.98)PDYIQLLQHIVR.V Y 22.46 2025.0320 17 -4.7 676.0148 3 89.40 6 51003 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 520 536 Pyro-glu from Q; Deamidation (NQ)
K.TLREPAVDTALAFAYAR(-.98).L Y 22.30 1863.0002 17 -43.4 621.9804 3 79.21 6 44593 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 1178 1194 Amidation
R.LEKHDLVFFR.Q Y 21.99 1302.7084 10 -24.5 326.6764 4 66.33 6 35129 VEV_3_3_RA6_01_1237.d 3.6E4 1 1 1514 1523
K.S(+27.99)ISLSKQDK.L Y 21.91 1032.5452 9 -2.7 517.2784 2 72.78 5 41018 VEV_2_3_RA5_01_1236.d 1.62E5 1 1 1539 1547 Formylation
R.VNPSR(+61.92).T Y 21.72 633.2296 5 59.0 634.2742 1 30.82 6 13313 VEV_3_3_RA6_01_1237.d 2.23E5 1 1 821 825 Replacement of proton by copper
R.EASQQK.E Y 21.59 689.3344 6 8.8 690.3478 1 40.26 6 18635 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 1639 1644
R.TIEM(+15.99)LKKDNEER.K Y 21.06 1520.7504 12 -1.2 761.3815 2 85.70 6 48897 VEV_3_3_RA6_01_1237.d 6.82E4 1 1 1624 1635 Oxidation (M)
R.LMDYIHK.L Y 21.04 918.4633 7 -1.9 919.4689 1 97.49 4 57326 VEV_1_3_RA4_01_1235.d 0 1 1 1055 1061
R.YDIAYIVTK(+27.99).F Y 20.81 1112.5753 9 -9.9 371.8621 3 46.15 5 22810 VEV_2_3_RA5_01_1236.d 6.63E5 1 1 283 291 Formylation
K.A(+42.01)NNAK.V Y 20.60 558.2762 5 -14.0 559.2756 1 28.11 6 11836 VEV_3_3_RA6_01_1237.d 0 1 1 1262 1266 Acetylation (N-term)
R.S(+42.01)ATGAK(-.98).L N 19.89 574.3074 6 -12.6 575.3075 1 66.43 5 36340 VEV_2_3_RA5_01_1236.d 0 1 1 236 241 Acetylation (N-term); Amidation
R.Q(-17.03)QTGNQQQIVVVNPHNPVEVTR.R Y 19.88 2467.2568 22 -39.9 823.3934 3 72.19 4 40947 VEV_1_3_RA4_01_1235.d 0 1 1 44 65 Pyro-glu from Q
R.Y(+42.01)LLDR(+28.03).A N 19.85 748.4119 5 -11.4 375.2090 2 55.71 5 28577 VEV_2_3_RA5_01_1236.d 2.46E4 1 1 961 965 Acetylation (N-term); Dimethylation(KR)
K.HDLVFFR.Q Y 19.73 932.4868 7 -14.0 467.2442 2 24.33 4 9743 VEV_1_3_RA4_01_1235.d 1.36E4 1 1 1517 1523
R.T(+79.97)IEMLKKDNEER.K Y 19.71 1584.7218 12 64.8 397.2134 4 49.90 4 24815 VEV_1_3_RA4_01_1235.d 4.31E4 1 1 1624 1635 Phosphorylation (STY)
R.Q(+226.08)IAASIYR.K Y 19.70 1146.5856 8 8.1 383.2056 3 30.56 5 13576 VEV_2_3_RA5_01_1236.d 3.59E4 1 1 1524 1531 Biotinylation
R.WEKSISLSK(+14.02)Q(+.98)DK(+42.01).L Y 19.58 1504.7773 12 -12.2 377.1970 4 33.74 5 15418 VEV_2_3_RA5_01_1236.d 2.41E5 1 1 1536 1547 Methylation(KR); Deamidation (NQ); Acetylation (K)
K.FSDLLGPTN(+.98)LIN(+.98)LLEK(+14.02)YR.T Y 19.55 2121.1357 18 -1.6 531.2903 4 70.97 4 39979 VEV_1_3_RA4_01_1235.d 0 1 1 703 720 Deamidation (NQ); Methylation(KR)
K.I(+27.99)QLYSR.T Y 19.46 806.4286 6 -23.2 807.4172 1 84.31 5 48755 VEV_2_3_RA5_01_1236.d 0 2 2 195 200 Formylation
R.AQEYAER.V Y 18.96 865.3929 7 32.1 433.7176 2 32.02 5 14436 VEV_2_3_RA5_01_1236.d 0 1 1 1110 1116
K.YIEAATK(+14.02).M Y 18.95 808.4330 7 -53.8 405.2021 2 12.83 4 3713 VEV_1_3_RA4_01_1235.d 4.69E4 1 1 745 751 Methylation(KR)
K.SISLSK(+27.99)QDK.L Y 18.64 1032.5452 9 -27.9 345.1794 3 40.35 6 18686 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 1539 1547 Formylation
K.L(+43.01)FKDAIETAAISGK(+14.02).T Y 18.51 1519.8246 14 -10.2 507.6103 3 76.36 5 43564 VEV_2_3_RA5_01_1236.d 0 1 1 1548 1561 Carbamylation; Methylation(KR)
R.QIAASIYR(+21.98)(+14.02).K Y 18.22 956.5056 8 -31.0 957.4832 1 94.91 4 56277 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 1524 1531 Sodium adduct; Methylation(KR)
R.KANN(+162.05)AK.V Y 18.09 806.4133 6 3.2 807.4232 1 14.33 6 4597 VEV_3_3_RA6_01_1237.d 1.39E4 1 1 1261 1266 Hexose (NSY)
K.LNNPGLAVR(+14.02).L Y 17.92 966.5610 9 21.1 323.2011 3 41.05 6 19114 VEV_3_3_RA6_01_1237.d 2.38E5 2 2 355 363 Methylation(KR)
R.KEDNSIT(-2.02)GK.I Y 17.89 988.4825 9 -12.5 495.2423 2 42.07 6 19692 VEV_3_3_RA6_01_1237.d 0 1 1 186 194 2-amino-3-oxo-butanoic_acid
K.WQ(+.98)ITHYR(-.98).T Y 17.81 1002.5035 7 -29.4 502.2443 2 57.28 6 28546 VEV_3_3_RA6_01_1237.d 6.99E4 1 1 164 170 Deamidation (NQ); Amidation
K.IYIDSNNNPEK(-.98).F Y 17.74 1304.6361 11 17.0 653.3364 2 44.59 5 21882 VEV_2_3_RA5_01_1236.d 0 1 1 897 907 Amidation
R.V(+42.01)NPEK(-.98).G N 17.69 626.3387 5 -40.7 627.3206 1 26.12 4 10726 VEV_1_3_RA4_01_1235.d 0 1 1 537 541 Acetylation (N-term); Amidation
R.YLLDR(+14.02).A N 17.51 692.3857 5 11.9 347.2042 2 54.38 5 27823 VEV_2_3_RA5_01_1236.d 0 1 1 961 965 Methylation(KR)
R.LDQLSELEDFLHGINVADVEASGDKAYEEGFHQAAK.I Y 17.35 3944.8704 36 -0.8 789.9807 5 88.16 5 50929 VEV_2_3_RA5_01_1236.d 7E4 1 1 1195 1230
K.QVSEAC(+57.02)VSK(+28.03).K Y 17.30 1034.5066 9 -4.7 518.2581 2 60.01 4 31499 VEV_1_3_RA4_01_1235.d 0 1 1 1270 1278 Carbamidomethylation; Dimethylation(KR)
K.FLKENDLYDTLT(+79.97)VGKYCEK.R Y 17.27 2358.0854 19 -12.7 590.5212 4 24.64 4 9924 VEV_1_3_RA4_01_1235.d 2.77E4 1 1 908 926 Phosphorylation (STY)
K.KAVN(+.98)NAINDLLIEEEDYK.T Y 17.15 2091.0371 18 8.0 698.0252 3 83.65 6 47601 VEV_3_3_RA6_01_1237.d 7.84E4 1 1 1476 1493 Deamidation (NQ)
R.SATGAK(+27.99).L N 17.03 561.2758 6 9.1 562.2882 1 38.27 5 18091 VEV_2_3_RA5_01_1236.d 6.8E4 1 1 236 241 Formylation
K.SQPIEAS(+79.97)TLREPIKK.D Y 16.99 1775.9182 15 -2.8 356.1899 5 54.20 5 27717 VEV_2_3_RA5_01_1236.d 0 1 1 140 154 Phosphorylation (STY)
K.MNQLTE(+14.02)VER.I Y 16.94 1132.5547 9 -22.2 567.2720 2 59.36 6 29983 VEV_3_3_RA6_01_1237.d 0 1 1 752 760 Methylation(others)
K.D(-18.01)GEFDESK(+14.02)KWQITHYR.T Y 16.81 2033.9595 16 46.3 407.8180 5 63.42 5 34121 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 155 170 Dehydration; Methylation(KR)
R.Q(+43.01)IAASIYR.K Y 16.72 963.5137 8 -7.8 322.1760 3 12.24 6 3519 VEV_3_3_RA6_01_1237.d 5.72E4 1 1 1524 1531 Carbamylation
K.E(+21.98)EDNTPVLGGSR.L Y 16.48 1294.5765 12 20.3 648.3087 2 41.82 5 20214 VEV_2_3_RA5_01_1236.d 6.49E4 1 1 1645 1656 Sodium adduct
R.QIAAS(-20.03)IYR.K Y 16.41 900.4817 8 -22.3 451.2381 2 11.69 6 3252 VEV_3_3_RA6_01_1237.d 0 1 1 1524 1531 Formation of five membered aromatic heterocycle
K.LNN(+.98)P(+31.99)GLAVR.L Y 16.36 985.5192 9 9.1 493.7714 2 14.68 6 4823 VEV_3_3_RA6_01_1237.d 0 1 1 355 363 Deamidation (NQ); Dihydroxy
K.FGFIHLYDLETGNC(+57.02)LFLS(-18.01)R.I Y 16.23 2283.1145 19 7.5 1142.5731 2 81.80 5 47223 VEV_2_3_RA5_01_1236.d 5.35E4 1 1 292 310 Carbamidomethylation; Dehydration
K.AQLDGLR(+.98).V Y 16.20 772.4079 7 2.5 773.4171 1 99.27 4 57960 VEV_1_3_RA4_01_1235.d 0 1 1 1129 1135 Deamidation (R)
K.AFLDADLPGELIELLEK(+14.02).I Y 16.17 1899.0240 17 -17.0 950.5032 2 97.72 6 54588 VEV_3_3_RA6_01_1237.d 1.53E4 1 1 1009 1025 Methylation(KR)
R.TPAVVGGLLDVDC(+57.02)DESVIKNLLASVDAASIPIDDLVSEVESR.N Y 16.02 4380.2256 42 -32.7 1461.0347 3 97.83 4 57492 VEV_1_3_RA4_01_1235.d 0 1 1 826 867 Carbamidomethylation
K.RDPNLAYVAY(-18.01)SK.G Y 15.96 1377.7041 12 -8.3 460.2382 3 18.06 5 6686 VEV_2_3_RA5_01_1236.d 5.91E4 1 1 927 938 Dehydration
R.SATGAK.L N 15.94 533.2809 6 -51.4 534.2607 1 18.01 5 6656 VEV_2_3_RA5_01_1236.d 0 2 2 236 241
R.HGQVLAVSVD(-18.01)ENK.I Y 15.87 1376.7048 13 -26.0 459.8969 3 65.73 5 35836 VEV_2_3_RA5_01_1236.d 7.31E4 1 1 334 346 Dehydration
K.F(+31.99)LKENDLYDTLT(+79.97)VGK.Y Y 15.83 1866.8652 15 41.4 934.4785 2 89.57 4 53423 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 908 922 Dihydroxy; Phosphorylation (STY)
K.L(+226.08)HIVEIDNQN(+.98)PSKK.F Y 15.80 1860.9403 14 -12.5 466.2365 4 50.62 5 25525 VEV_2_3_RA5_01_1236.d 4.83E4 1 1 242 255 Biotinylation; Deamidation (NQ)
R.I(+43.01)DVNR.V Y 15.78 658.3398 5 -31.5 659.3264 1 39.08 6 17968 VEV_3_3_RA6_01_1237.d 0 1 1 1445 1449 Carbamylation
K.DAIETAAISGKTD(+43.99)VVEELLR.Y Y 15.65 2173.1113 20 -4.2 544.2828 4 72.58 4 41253 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 1551 1570 Carboxylation (DKW)
R.ISQLC(+57.02)ENAQLYQRALENTDDP(+31.99)TVIMR.N Y 15.45 3109.4807 26 4.4 1037.5054 3 87.85 5 50763 VEV_2_3_RA5_01_1236.d 3.41E3 1 1 627 652 Carbamidomethylation; Dihydroxy
K.AN(+.98)VPHK.V Y 15.42 665.3497 6 -11.0 666.3496 1 91.25 5 52518 VEV_2_3_RA5_01_1236.d 8.88E4 1 1 495 500 Deamidation (NQ)
K.VWK(+43.01)QVSEAC(+57.02)VS(+79.97)K.K Y 15.42 1542.6902 12 56.9 515.2666 3 55.98 6 27718 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 1267 1278 Carbamylation; Carbamidomethylation; Phosphorylation (STY)
R.T(+27.99)LALVTGDR(+14.02).I Y 15.36 986.5396 9 -23.0 494.2657 2 49.93 4 24850 VEV_1_3_RA4_01_1235.d 0 1 1 121 129 Formylation; Methylation(KR)
K.LFKDAIET(+79.96)AAISGK(+42.01).T Y 15.30 1584.7705 14 21.8 397.2085 4 52.91 4 26746 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 1548 1561 Sulfation; Acetylation (K)
K.LFKDAIE(+43.99)TAAISGK(+42.01).T Y 15.28 1548.8035 14 -3.3 388.2069 4 42.95 6 20213 VEV_3_3_RA6_01_1237.d 0 1 1 1548 1561 Carboxylation (E); Acetylation (K)
R.QIAAS(+79.96)IYR.K Y 15.27 1000.4647 8 -21.1 334.4885 3 42.85 5 20825 VEV_2_3_RA5_01_1236.d 0 1 1 1524 1531 Sulfation
R.TLALVT(+79.97)GDRIYHWDVFEEK(+42.01).S Y 15.26 2413.1355 19 -21.4 604.2783 4 57.81 4 29879 VEV_1_3_RA4_01_1235.d 0 1 1 121 139 Phosphorylation (STY); Acetylation (K)
R.KEDNSITGK.I Y 15.25 990.4982 9 12.6 496.2626 2 44.95 5 22109 VEV_2_3_RA5_01_1236.d 6.49E4 1 1 186 194
K.Q(+.98)VSEACVSK.K Y 15.24 950.4379 9 20.4 476.2359 2 37.07 5 17395 VEV_2_3_RA5_01_1236.d 1.61E5 1 1 1270 1278 Deamidation (NQ)
R.YLLDR(+28.03).A N 15.15 706.4014 5 -7.4 354.2054 2 11.32 6 3069 VEV_3_3_RA6_01_1237.d 5.13E4 1 1 961 965 Dimethylation(KR)
K.DAIETAAISGK.T Y 15.00 1074.5557 11 -34.3 538.2667 2 45.83 4 22279 VEV_1_3_RA4_01_1235.d 0 1 1 1551 1561
total 145 peptides
C1FYJ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FAIEVLRPMGC(+57.02)TVNQTDFSTSVTGTAGGK.L Y 128.34 3043.4744 29 -5.9 1015.4927 3 81.10 4 47859 VEV_1_3_RA4_01_1235.d 1.88E5 1 1 677 705 Carbamidomethylation
R.ASTVSNEDLQVVLAPSIEVYPGFPK.S Y 122.99 2659.3745 25 -10.1 1330.6812 2 87.05 6 49691 VEV_3_3_RA6_01_1237.d 3.2E5 4 4 379 403
R.GVYKNPAEYVVESDASSATYPLAIAAMTGTSC(+57.02)TIPNIGSK.S Y 113.18 4132.9971 40 -7.1 1378.6632 3 87.30 4 52068 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 630 669 Carbamidomethylation
R.AAIFALNSMSYSPIYIVGR.S Y 104.44 2072.0764 19 -5.7 1037.0396 2 88.48 4 52800 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 1436 1454
R.LVGGKPVSQLYVDMTTAMMR.S Y 102.78 2196.1106 20 1.2 733.0450 3 83.54 4 49589 VEV_1_3_RA4_01_1235.d 1.71E5 3 3 590 609
K.TAAISSEEKFAALENDADVILAAVK.S Y 99.15 2575.3381 25 -13.9 859.4414 3 88.06 6 50258 VEV_3_3_RA6_01_1237.d 3.85E5 4 4 198 222
K.VSSQYVSSLLMC(+57.02)APYAKEPVTLR.L Y 96.98 2598.3186 23 -4.5 867.1096 3 81.92 4 48476 VEV_1_3_RA4_01_1235.d 2.38E5 3 3 567 589 Carbamidomethylation
R.MGSEFVDLELSFPEQLLR.T Y 93.91 2109.0452 18 -10.8 1055.5184 2 91.96 5 52870 VEV_2_3_RA5_01_1236.d 3.08E5 2 2 1150 1167
R.ALVLAALGSGTC(+57.02)R.I Y 92.15 1287.6969 13 -12.1 644.8480 2 73.76 5 41710 VEV_2_3_RA5_01_1236.d 3.72E5 4 4 421 433 Carbamidomethylation
K.ELYLGNAGTASR.F Y 89.69 1250.6255 12 -8.8 626.3145 2 58.34 4 30284 VEV_1_3_RA4_01_1235.d 6.73E5 7 7 482 493
K.ALQRPFIDLDDELEKSEGMTIPEMIK.Q Y 85.08 3017.5088 26 -4.7 755.3809 4 85.05 4 50618 VEV_1_3_RA4_01_1235.d 0 1 1 890 915
R.FVQVPTTLLAMVDSSIGGK.T Y 79.33 1962.0496 19 -9.8 982.0225 2 91.59 4 54542 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 134 152
K.NLIGAIWQPQR.I Y 79.11 1294.7146 11 -22.9 432.5689 3 79.24 4 46428 VEV_1_3_RA4_01_1235.d 4.38E4 2 2 162 172
K.GSVASSVLTGNAR.M Y 77.56 1217.6364 13 -9.2 609.8198 2 57.29 4 29550 VEV_1_3_RA4_01_1235.d 4.97E5 4 4 505 517
K.SLNVTC(+57.02)TPPGSK.S Y 75.01 1259.6179 12 -8.6 630.8108 2 48.36 4 23839 VEV_1_3_RA4_01_1235.d 1.48E6 3 3 404 415 Carbamidomethylation
R.IYLDMEFLNTLPER.E Y 73.65 1752.8756 14 -13.6 877.4332 2 87.45 4 52162 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 173 186
R.VSVPLVFTIR.T Y 72.29 1129.6859 10 -13.9 565.8424 2 82.12 5 47422 VEV_2_3_RA5_01_1236.d 1.7E5 2 2 1115 1124
K.SAASIFIIGMR.G Y 67.46 1164.6324 11 -11.6 583.3168 2 80.95 4 47757 VEV_1_3_RA4_01_1235.d 6.71E4 1 1 866 876
K.AAPGQLSAR.E Y 67.00 869.4719 9 -8.4 435.7396 2 23.67 4 9368 VEV_1_3_RA4_01_1235.d 5.65E5 6 6 1271 1279
K.HC(+57.02)SVEQIITYMGVDKK.N Y 66.96 1906.9281 16 14.5 477.7462 4 73.62 4 42059 VEV_1_3_RA4_01_1235.d 0 1 1 342 357 Carbamidomethylation
R.RKPWYQEC(+57.02)SNIQYYSR.I Y 65.33 2177.0112 16 -3.9 545.2579 4 65.04 4 35311 VEV_1_3_RA4_01_1235.d 0 2 2 1003 1018 Carbamidomethylation
R.EHDDGLEIDGIDR.S Y 64.39 1482.6586 13 27.6 495.2404 3 64.39 5 34817 VEV_2_3_RA5_01_1236.d 0 1 1 772 784
R.DIKEVMDFLK.I Y 64.17 1236.6423 10 -10.7 413.2170 3 81.98 4 48517 VEV_1_3_RA4_01_1235.d 8.17E4 2 2 975 984
K.TWPGWWNTLAQTFK.V Y 64.14 1734.8518 14 -2.3 868.4312 2 90.73 4 54065 VEV_1_3_RA4_01_1235.d 0 1 1 828 841
K.IIASHHDPEGLLSWAN(+.98)GSWIQIYNK.A Y 63.25 2849.4136 25 -2.2 713.3591 4 84.37 4 50201 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 1178 1202 Deamidation (NQ)
R.VDLLKDPQSDSEIPSVDYVAEQISVLR.S Y 62.66 3014.5447 27 -11.7 1005.8438 3 87.88 4 52435 VEV_1_3_RA4_01_1235.d 4.7E4 1 1 1086 1112
K.VITGQLDSLAQMR.R Y 60.77 1430.7551 13 -19.9 716.3706 2 75.63 4 43678 VEV_1_3_RA4_01_1235.d 3.04E5 4 4 1038 1050
K.ITASGGFAGGEMR.L Y 59.84 1252.5870 13 -5.0 627.2977 2 58.62 6 29456 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 550 562
R.IC(+57.02)GIANQR.V Y 59.72 930.4705 8 -13.9 466.2361 2 29.42 6 12548 VEV_3_3_RA6_01_1237.d 8.45E5 6 6 742 749 Carbamidomethylation
K.ANGADIEYLENPK.S Y 56.81 1432.6833 13 -5.6 717.3450 2 66.21 4 36222 VEV_1_3_RA4_01_1235.d 6.23E4 1 1 532 544
R.ELLTQYHK.T Y 53.95 1030.5447 8 -12.5 516.2732 2 37.92 6 17289 VEV_3_3_RA6_01_1237.d 2.95E5 3 3 957 964
K.FAVIGKPVSSSR.S Y 53.67 1246.7034 12 -18.2 416.5675 3 53.76 6 26507 VEV_3_3_RA6_01_1237.d 3.51E5 3 3 1296 1307
R.KAVMGVSSSDDTIS Y 52.69 1395.6552 14 -13.0 698.8258 2 57.72 5 29923 VEV_2_3_RA5_01_1236.d 1.41E5 2 2 1585 1598
K.ALQYGDVIK.L Y 52.34 1005.5494 9 -9.5 503.7772 2 63.61 4 34213 VEV_1_3_RA4_01_1235.d 1.38E5 3 3 1203 1211
K.KSETEEHTYHIPR.G Y 51.65 1625.7798 13 -14.2 407.4464 4 27.95 6 11747 VEV_3_3_RA6_01_1237.d 9.22E4 1 1 617 629
R.FSSIQETLKR.T Y 51.11 1207.6560 10 -13.5 604.8271 2 55.87 4 28570 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 232 241
R.LLTYEIPPGESSK.S Y 47.27 1432.7449 13 -12.4 717.3708 2 68.50 4 38039 VEV_1_3_RA4_01_1235.d 8.21E5 9 9 72 84
K.TTSGVWVSK.A Y 45.88 963.5026 9 -13.4 482.7521 2 40.15 6 18594 VEV_3_3_RA6_01_1237.d 5.19E5 4 4 881 889
K.VVLLSAIGR.T Y 45.84 926.5912 9 -28.9 464.2895 2 72.82 4 41437 VEV_1_3_RA4_01_1235.d 0 3 3 365 373
R.GWEGFRDSELALLR.R Y 44.88 1647.8368 14 -8.7 550.2814 3 80.63 4 47506 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 918 931
K.HDVPLIAINMGYK.G Y 44.49 1469.7700 13 -28.2 490.9168 3 75.72 6 42074 VEV_3_3_RA6_01_1237.d 3.21E4 1 1 1236 1248
R.KPWYQEC(+57.02)SNIQYYSR.I Y 43.77 2020.9102 15 -14.7 674.6341 3 68.64 5 38009 VEV_2_3_RA5_01_1236.d 8.27E4 1 1 1004 1018 Carbamidomethylation
R.FLTTVATLAQK.G Y 43.50 1191.6863 11 -24.6 398.2263 3 71.56 5 40140 VEV_2_3_RA5_01_1236.d 3.08E4 1 1 494 504
R.FAIEVLRPMGC(+57.02)TVNQTDFSTSVTGTAGGKLK.S Y 42.24 3284.6533 31 -3.4 822.1678 4 79.57 5 45770 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 677 707 Carbamidomethylation
R.IETDNVEDVK.E Y 41.84 1160.5560 10 -46.4 581.2584 2 18.75 5 7055 VEV_2_3_RA5_01_1236.d 2.28E4 2 2 1328 1337
K.AEIEDWMLAR.Q Y 40.73 1232.5859 10 -1.7 617.2992 2 78.56 4 45914 VEV_1_3_RA4_01_1235.d 5.54E4 1 1 90 99
R.VMTEKPM(+15.99)GY(-18.01)IFAC(+57.02)GGGVVELPEAR.E Y 39.07 2608.2488 24 5.0 870.4279 3 81.90 4 48464 VEV_1_3_RA4_01_1235.d 0 1 1 933 956 Oxidation (M); Dehydration; Carbamidomethylation
R.IYLDMEFLNTLPEREFINGMAEVIK.T Y 34.56 2984.5027 25 -1.7 995.8398 3 94.93 4 56256 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 173 197
R.TILSSAEFK.A Y 33.99 994.5334 9 -16.7 498.2657 2 65.01 6 34128 VEV_3_3_RA6_01_1237.d 9.06E4 2 2 242 250
K.ITASGGFAGGEM(+15.99)R.L Y 33.98 1268.5819 13 5.8 635.3019 2 43.64 6 20654 VEV_3_3_RA6_01_1237.d 1.73E5 2 2 550 562 Oxidation (M)
K.GSVASSVLTGN(+.98)AR.M Y 32.68 1218.6204 13 -10.3 610.3112 2 59.21 5 30967 VEV_2_3_RA5_01_1236.d 8.86E4 1 1 505 517 Deamidation (NQ)
R.ITQPDGMAQVLHGFNR.F Y 30.64 1782.8835 16 0.3 595.3019 3 74.83 4 42994 VEV_1_3_RA4_01_1235.d 0 1 1 1019 1034
R.SPAMHNALFK.Q Y 29.81 1114.5593 10 -11.3 558.2806 2 51.06 4 25550 VEV_1_3_RA4_01_1235.d 0 1 1 1308 1317
K.GLSLMGE(+43.99)IK(+14.02).A Y 28.54 1004.5212 9 -15.8 503.2599 2 26.66 6 11080 VEV_3_3_RA6_01_1237.d 8.92E4 1 1 1284 1292 Carboxylation (E); Methylation(KR)
R.TVTEM(+15.99)KGFSK.I Y 27.68 1142.5641 10 9.5 572.2947 2 19.55 6 7328 VEV_3_3_RA6_01_1237.d 2.68E4 1 1 1168 1177 Oxidation (M)
K.SLPTIDMEPMTDAFLTASVLAAVAR.G Y 27.19 2619.3289 25 6.2 874.1223 3 97.60 5 55212 VEV_2_3_RA5_01_1236.d 4.73E4 1 1 708 732
R.K(+42.01)TGIT(+79.97)PK.R Y 27.12 865.4310 7 5.4 433.7251 2 14.62 4 4597 VEV_1_3_RA4_01_1235.d 4.94E3 1 1 1523 1529 Acetylation (N-term); Phosphorylation (STY)
R.MVASPK.E Y 26.12 631.3363 6 6.7 632.3478 1 33.49 4 14867 VEV_1_3_RA4_01_1235.d 0 1 1 476 481
R.VDLLK(-1.03)DPQSDSEIPSVDYVAEQISVLR.S Y 25.71 3013.5132 27 7.0 1005.5187 3 87.84 4 52405 VEV_1_3_RA4_01_1235.d 8.73E3 1 1 1086 1112 Lysine oxidation to aminoadipic semialdehyde
K.T(+42.01)RPAYVEDMMSVWLR.R Y 24.96 1894.9070 15 0.2 632.6431 3 68.44 6 36721 VEV_3_3_RA6_01_1237.d 8.37E4 1 1 988 1002 Acetylation (N-term)
R.M(+15.99)VASPK(+42.01).E Y 23.61 689.3418 6 -11.7 690.3410 1 62.18 4 33137 VEV_1_3_RA4_01_1235.d 3.39E4 1 1 476 481 Oxidation (M); Acetylation (K)
K.GLSLMGEIK.A Y 23.25 946.5157 9 -12.7 474.2591 2 72.05 5 40497 VEV_2_3_RA5_01_1236.d 2.31E5 2 2 1284 1292
K.SLN(+.98)VTC(+57.02)TPPGSK.S Y 22.81 1260.6021 12 7.3 631.3129 2 48.35 5 24140 VEV_2_3_RA5_01_1236.d 0 1 1 404 415 Deamidation (NQ); Carbamidomethylation
K.EPVTLR.L Y 22.45 713.4072 6 -57.7 714.3733 1 81.40 5 46960 VEV_2_3_RA5_01_1236.d 4.1E4 1 1 584 589
R.L(+42.01)LTYEIPPGE(+21.98)SSK.S Y 22.25 1496.7374 13 27.4 375.2019 4 44.80 4 21640 VEV_1_3_RA4_01_1235.d 2.53E5 1 1 72 84 Acetylation (N-term); Sodium adduct
K.NDGPK(+43.99).K Y 22.02 573.2394 5 62.9 574.2828 1 48.90 6 23673 VEV_3_3_RA6_01_1237.d 3.63E4 1 1 358 362 Carboxylation (DKW)
R.HLGILNNVSVAR.I Y 21.97 1291.7361 12 -43.9 323.9271 4 45.62 5 22499 VEV_2_3_RA5_01_1236.d 9.67E4 1 1 304 315
R.FLTTVATLAQKGSVASSVLTGNAR.M Y 21.92 2391.3120 24 -24.1 598.8209 4 80.63 4 47505 VEV_1_3_RA4_01_1235.d 3.08E4 1 1 494 517
K.FAVIGK(-1.03)PVSSSR.S Y 21.82 1245.6716 12 -35.3 416.2165 3 53.79 4 27310 VEV_1_3_RA4_01_1235.d 0 1 1 1296 1307 Lysine oxidation to aminoadipic semialdehyde
K.VITGQLDSLAQMR(+14.02).R Y 21.69 1444.7708 13 6.6 362.2024 4 19.67 6 7379 VEV_3_3_RA6_01_1237.d 0 1 1 1038 1050 Methylation(KR)
K.QRPIGDLVD(-18.01)ALKANGADIEYLENPK.S Y 21.44 2720.4133 25 -6.4 907.8059 3 87.37 4 52118 VEV_1_3_RA4_01_1235.d 2.66E4 1 1 520 544 Dehydration
K.FGVTC(+57.02)R.E Y 21.27 738.3483 6 -4.2 370.1799 2 30.82 6 13316 VEV_3_3_RA6_01_1237.d 1.93E5 1 1 766 771 Carbamidomethylation
K.TWAEAK.H Y 21.26 704.3493 6 -15.1 705.3459 1 74.07 5 41937 VEV_2_3_RA5_01_1236.d 9.94E4 1 1 1230 1235
R.ELLTQYHK(+43.99).T Y 20.74 1074.5345 8 0.0 538.2745 2 65.82 4 35958 VEV_1_3_RA4_01_1235.d 2.48E5 3 3 957 964 Carboxylation (DKW)
K.ANVEAERK.T Y 20.47 915.4774 8 -12.6 458.7402 2 28.18 5 12228 VEV_2_3_RA5_01_1236.d 3.18E5 1 1 1516 1523
M(+15.99)GVPTK(+42.01).I Y 20.35 689.3418 6 -13.7 690.3397 1 61.93 5 32984 VEV_2_3_RA5_01_1236.d 3.92E4 1 1 1 6 Oxidation (M); Acetylation (K)
K.R(+42.01)T(+79.97)ILSSAEFK.A Y 20.27 1272.6115 10 9.2 319.1631 4 29.23 6 12460 VEV_3_3_RA6_01_1237.d 0 1 1 241 250 Acetylation (N-term); Phosphorylation (STY)
K.SEGMTIPEMIK.Q Y 20.11 1234.5938 11 -74.1 618.2584 2 25.88 6 10668 VEV_3_3_RA6_01_1237.d 2.66E5 1 1 905 915
K.I(+42.01)TASGGFAGGEMR.L Y 19.97 1294.5975 13 26.9 648.3235 2 54.35 6 26871 VEV_3_3_RA6_01_1237.d 0 1 1 550 562 Acetylation (N-term)
K.G(+42.01)SVASSVLTGNAR.M Y 19.85 1259.6470 13 7.6 630.8356 2 37.05 4 16962 VEV_1_3_RA4_01_1235.d 4.69E4 1 1 505 517 Acetylation (N-term)
K.SQ(+.98)GGR.F Y 19.72 504.2292 5 -3.7 505.2346 1 23.60 4 9322 VEV_1_3_RA4_01_1235.d 0 1 1 1127 1131 Deamidation (NQ)
K.DELAK(+21.98)(+14.02).F N 19.52 610.2938 5 -2.7 611.2994 1 27.27 5 11736 VEV_2_3_RA5_01_1236.d 6.75E4 1 1 761 765 Sodium adduct; Methylation(KR)
K.AQVVSADE(+28.03)REGGLR.N Y 19.32 1513.7848 14 -13.2 757.8896 2 78.92 5 45330 VEV_2_3_RA5_01_1236.d 3.36E4 1 1 251 264 Ethylation
K.S(+42.01)EGMTIPEMIK.Q Y 19.26 1276.6042 11 -1.8 639.3082 2 64.76 6 33928 VEV_3_3_RA6_01_1237.d 1.19E5 1 1 905 915 Acetylation (N-term)
K.ELYLGNAGTASR(+14.02).F Y 19.16 1264.6411 12 -14.6 633.3186 2 61.80 4 32838 VEV_1_3_RA4_01_1235.d 1.31E5 1 1 482 493 Methylation(KR)
K.A(+42.01)NVEAER.K Y 19.12 829.3929 7 5.6 830.4048 1 87.76 5 50715 VEV_2_3_RA5_01_1236.d 0 1 1 1516 1522 Acetylation (N-term)
R.RKPWYQEC(+57.02)SN(+.98)IQYYSR.I Y 19.09 2177.9951 16 12.3 727.0146 3 64.92 5 35212 VEV_2_3_RA5_01_1236.d 5.32E4 1 1 1003 1018 Carbamidomethylation; Deamidation (NQ)
K.EVMDFLK.I Y 19.09 880.4364 7 -2.1 881.4418 1 110.36 6 58189 VEV_3_3_RA6_01_1237.d 0 1 1 978 984
K.TGIT(+79.97)PK.R Y 18.99 695.3255 6 6.8 696.3375 1 53.88 6 26582 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 1524 1529 Phosphorylation (STY)
R.KGLSLMGEIK(+226.08).A Y 18.89 1300.6882 10 -33.3 326.1685 4 41.80 5 20201 VEV_2_3_RA5_01_1236.d 0 1 1 1283 1292 Biotinylation
K.TAAISSEE(+21.98)K(+42.01).F Y 18.83 998.4532 9 22.4 999.4829 1 92.49 4 55033 VEV_1_3_RA4_01_1235.d 8.28E4 1 1 198 206 Sodium adduct; Acetylation (K)
K.I(+43.01)TASGGFAGGEMRLDAK.V Y 18.73 1722.8358 17 -7.7 575.2814 3 39.18 6 18027 VEV_3_3_RA6_01_1237.d 7.38E4 2 2 550 566 Carbamylation
K.TLDDNASLKK.F Y 18.60 1103.5823 10 -11.4 368.8638 3 23.57 5 9662 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 1218 1227
R.GAGKTTSGVWVS(+79.97)K(+42.01).A Y 18.58 1398.6544 13 -12.3 467.2197 3 26.58 6 11038 VEV_3_3_RA6_01_1237.d 0 1 1 877 889 Phosphorylation (STY); Acetylation (K)
R.D(-18.01)IKEVMDFLK.I Y 18.53 1218.6318 10 -6.6 407.2152 3 71.34 6 38868 VEV_3_3_RA6_01_1237.d 4.84E4 1 1 975 984 Dehydration
K.GSVAS(+79.97)SVLTGNAR(+14.02).M Y 18.49 1311.6184 13 -5.7 438.2109 3 43.24 6 20381 VEV_3_3_RA6_01_1237.d 0 1 1 505 517 Phosphorylation (STY); Methylation(KR)
K.SQ(+.98)GGR(-.98).F Y 18.45 503.2452 5 -11.4 504.2467 1 18.20 4 6467 VEV_1_3_RA4_01_1235.d 0 1 1 1127 1131 Deamidation (NQ); Amidation
R.IC(+57.02)GIANQRVKEC(+57.02)NRIK(+43.01).A Y 18.42 2001.0360 16 -7.5 501.2625 4 61.83 4 32859 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 742 757 Carbamidomethylation; Carbamylation
K.S(+56.06)LPTIDMEPMTDAFLTASVLAAVAR.G Y 18.40 2675.3914 25 -20.2 892.7864 3 90.13 4 53723 VEV_1_3_RA4_01_1235.d 1E5 1 1 708 732 Diethylation
K.ITASGGFAGGEMR(+14.02).L Y 18.38 1266.6027 13 -32.2 634.2882 2 13.72 5 4345 VEV_2_3_RA5_01_1236.d 1.65E4 1 1 550 562 Methylation(KR)
K.AVM(+15.99)GVSSSDDTIS Y 18.37 1283.5551 13 -1.2 642.7841 2 58.09 6 29085 VEV_3_3_RA6_01_1237.d 3.73E4 1 1 1586 1598 Oxidation (M)
K.AMKDELAK(+43.01).F Y 18.28 947.4746 8 -9.9 948.4725 1 99.37 4 57991 VEV_1_3_RA4_01_1235.d 0 1 1 758 765 Carbamylation
K.G(+43.01)SVASSVLTGNAR.M Y 18.23 1260.6422 13 12.4 631.3362 2 34.91 6 15602 VEV_3_3_RA6_01_1237.d 0 1 1 505 517 Carbamylation
K.TAAIS(-18.01)SEEK.F Y 18.20 916.4501 9 -10.6 917.4477 1 92.45 6 52514 VEV_3_3_RA6_01_1237.d 3.48E5 1 1 198 206 Dehydration
K.E(+42.01)VTLGS(+79.97)DAVELR.V Y 18.17 1409.6439 12 15.9 705.8405 2 63.52 4 34146 VEV_1_3_RA4_01_1235.d 4.97E4 1 1 1074 1085 Acetylation (N-term); Phosphorylation (STY)
R.E(+43.01)SIVADFGIWR.N Y 18.15 1334.6619 11 16.0 668.3489 2 47.21 6 22678 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 13 23 Carbamylation
R.ICGIAN(+.98)QR.V Y 18.05 874.4330 8 -15.3 438.2171 2 28.12 4 11814 VEV_1_3_RA4_01_1235.d 4.87E4 1 1 742 749 Deamidation (NQ)
K.ANVEAER(-.98)(+14.02).K Y 17.98 800.4141 7 -13.9 401.2087 2 49.87 6 24222 VEV_3_3_RA6_01_1237.d 8.75E4 1 1 1516 1522 Amidation; Methylation(KR)
K.T(-18.01)K(+42.01)GNVILAMR.D Y 17.88 1125.6328 10 -10.6 376.2142 3 47.50 6 22860 VEV_3_3_RA6_01_1237.d 4.65E3 1 1 965 974 Dehydration; Acetylation (K)
R.M(+15.99)VASPK.E Y 17.64 647.3312 6 -17.2 648.3274 1 54.32 5 27783 VEV_2_3_RA5_01_1236.d 1.14E6 1 1 476 481 Oxidation (M)
K.TGITPK(+42.01).R Y 17.61 657.3698 6 -0.9 658.3764 1 105.90 5 57748 VEV_2_3_RA5_01_1236.d 0 1 1 1524 1529 Acetylation (K)
K.TGIT(+79.97)PK(+14.02).R Y 17.56 709.3411 6 12.3 710.3571 1 86.68 5 50123 VEV_2_3_RA5_01_1236.d 0 1 1 1524 1529 Phosphorylation (STY); Methylation(KR)
K.AN(+162.05)VEAER(+14.02).K Y 17.55 963.4509 7 -1.8 964.4564 1 82.37 4 48797 VEV_1_3_RA4_01_1235.d 6.45E4 1 1 1516 1522 Hexose (NSY); Methylation(KR)
K.A(-15.01)QVVSADEREGGLR.N Y 17.52 1470.7427 14 -6.0 368.6907 4 41.39 4 19539 VEV_1_3_RA4_01_1235.d 9.4E4 1 1 251 264 ISD (z+2)-series
K.TAIDTPNGK(+71.04).N Y 17.52 986.5032 9 9.1 329.8447 3 27.48 4 11454 VEV_1_3_RA4_01_1235.d 0 1 1 153 161 Propionamide (K, X@N-term)
R.TILSSAE(+21.98)FK.A Y 17.36 1016.5154 9 3.2 509.2666 2 52.94 5 26962 VEV_2_3_RA5_01_1236.d 0 1 1 242 250 Sodium adduct
R.MGSEFVDLELSFPEQLLR(+14.02).T Y 17.19 2123.0608 18 -11.2 1062.5258 2 93.56 4 55587 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 1150 1167 Methylation(KR)
R.ESIVADFGIWRNYVAK.D Y 17.15 1866.9628 16 -11.8 934.4776 2 91.82 6 52223 VEV_3_3_RA6_01_1237.d 2.8E5 1 1 13 28
K.V(+42.01)ITGQLDSLAQ(+.98)MRR.K Y 17.13 1629.8508 14 -21.7 815.9150 2 85.47 4 50900 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 1038 1051 Acetylation (N-term); Deamidation (NQ)
K.HC(+57.02)SVEQIITYMGVDK(+42.01).K Y 17.01 1820.8438 15 31.8 911.4581 2 87.84 5 50755 VEV_2_3_RA5_01_1236.d 0 1 1 342 356 Carbamidomethylation; Acetylation (K)
K.TLDDN(+.98)ASLK.K Y 16.93 976.4713 9 6.8 489.2462 2 15.77 5 5459 VEV_2_3_RA5_01_1236.d 1.82E4 1 1 1218 1226 Deamidation (NQ)
K.DELAKFGVTC(+57.02)R.E Y 16.88 1294.6339 11 7.0 648.3287 2 64.48 5 34889 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 761 771 Carbamidomethylation
K.SEGMTIPEMIK(+14.02).Q Y 16.71 1248.6094 11 11.8 625.3193 2 75.76 6 42105 VEV_3_3_RA6_01_1237.d 0 1 1 905 915 Methylation(KR)
K.SLNVT(-18.01)C(+57.02)TPPGSKSISNR.A Y 16.57 1798.8995 17 -9.9 450.7277 4 14.40 5 4700 VEV_2_3_RA5_01_1236.d 2.05E4 1 1 404 420 Dehydration; Carbamidomethylation
R.I(+42.01)KAMKDELAK(+27.99).F Y 16.52 1215.6533 10 -20.2 608.8217 2 60.99 6 31158 VEV_3_3_RA6_01_1237.d 0 1 1 756 765 Acetylation (N-term); Formylation
R.E(+42.01)IRK(+31.99)GLSLMGEIK.A Y 16.24 1546.8389 13 1.7 387.7177 4 46.39 4 22634 VEV_1_3_RA4_01_1235.d 4.65E4 1 1 1280 1292 Acetylation (N-term); Dihydroxy
K.RLTAGKHC(+57.02)SVEQIITYM(+15.99)GVDK.K Y 16.18 2421.2144 21 -9.6 606.3051 4 78.43 6 44035 VEV_3_3_RA6_01_1237.d 0 1 1 336 356 Carbamidomethylation; Oxidation (M)
K.TAAISSEEK(+14.02).F Y 16.17 948.4764 9 7.9 475.2492 2 23.96 6 9648 VEV_3_3_RA6_01_1237.d 0 1 1 198 206 Methylation(KR)
R.QPPC(+57.02)GR(+17.03).D Y 16.16 730.3544 6 -7.5 731.3562 1 111.72 5 59295 VEV_2_3_RA5_01_1236.d 1.95E4 1 1 100 105 Carbamidomethylation; Replacement of proton with ammonium ion
K.AAPGQLS(+79.96)AR.E Y 16.16 949.4287 9 4.1 475.7236 2 31.59 6 13754 VEV_3_3_RA6_01_1237.d 1.36E5 1 1 1271 1279 Sulfation
K.EAELAR.H N 16.14 687.3551 6 -7.1 344.6824 2 13.82 5 4404 VEV_2_3_RA5_01_1236.d 9.82E4 1 1 298 303
K.TAIDTPNGK(+68.03).N Y 16.09 983.4924 9 -13.0 984.4869 1 112.66 4 61859 VEV_1_3_RA4_01_1235.d 3.66E4 1 1 153 161 Crotonylation
K.GSVASSVLT(-18.01)GNARMK.Q Y 16.09 1458.7612 15 -25.3 487.2487 3 32.47 5 14708 VEV_2_3_RA5_01_1236.d 2.89E4 1 1 505 519 Dehydration
K.AQVVSADER(+28.03).E Y 16.05 1001.5142 9 -5.8 1002.5156 1 86.93 4 51842 VEV_1_3_RA4_01_1235.d 1.2E5 2 2 251 259 Dimethylation(KR)
MGVPTK.I Y 16.02 631.3363 6 -8.6 316.6727 2 20.88 6 8034 VEV_3_3_RA6_01_1237.d 0 1 1 1 6
R.GQGSNHTTR.I Y 15.96 956.4424 9 1.5 957.4511 1 87.01 6 49669 VEV_3_3_RA6_01_1237.d 8.92E4 1 1 733 741
K.IDKTRPAYVEDMM(+15.99)SVWLR.R Y 15.96 2225.0972 18 18.8 446.0351 5 76.70 5 43804 VEV_2_3_RA5_01_1236.d 0 1 1 985 1002 Oxidation (M)
K.V(+42.01)ITGQLDSLAQMR(+21.98).R Y 15.90 1494.7477 13 -14.8 499.2491 3 73.04 5 41202 VEV_2_3_RA5_01_1236.d 6.57E4 1 1 1038 1050 Acetylation (N-term); Sodium adduct
K.ECVGK.T Y 15.88 534.2472 5 11.2 535.2604 1 59.13 5 30905 VEV_2_3_RA5_01_1236.d 3.06E4 1 1 823 827
R.IVDD(-18.01)VK.A Y 15.87 669.3697 6 -6.4 670.3727 1 112.33 6 58730 VEV_3_3_RA6_01_1237.d 0 1 1 1474 1479 Dehydration
K.ND(-18.01)GPK(+14.02).K Y 15.83 525.2547 5 12.1 526.2683 1 63.07 5 33827 VEV_2_3_RA5_01_1236.d 0 1 1 358 362 Dehydration; Methylation(KR)
R.AET(-18.01)NGVAHLDK.S Y 15.83 1135.5621 11 -23.2 568.7751 2 55.83 5 28662 VEV_2_3_RA5_01_1236.d 0 1 1 855 865 Dehydration
K.AAPGQ(+.98)LSAR.E Y 15.83 870.4559 9 -7.5 436.2320 2 14.48 4 4525 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 1271 1279 Deamidation (NQ)
K.VKLDGKEVEVEER.A Y 15.78 1528.8096 13 15.7 510.6185 3 73.95 5 41845 VEV_2_3_RA5_01_1236.d 0 1 1 842 854
K.VITGQLDS(+79.97)LAQMRR(+31.99).K Y 15.72 1698.8124 14 20.2 567.2895 3 71.17 6 38740 VEV_3_3_RA6_01_1237.d 6.4E4 1 1 1038 1051 Phosphorylation (STY); Dihydroxy
K.HDVPLIAINMGYK(+226.08).G Y 15.71 1695.8477 13 -0.3 566.2897 3 69.11 5 38341 VEV_2_3_RA5_01_1236.d 7.52E4 1 1 1236 1248 Biotinylation
K.TAAISSEEK(+43.99).F Y 15.71 978.4506 9 -1.2 490.2320 2 42.37 6 19874 VEV_3_3_RA6_01_1237.d 2.33E4 1 1 198 206 Carboxylation (DKW)
R.LDAKVSSQYVSSLLMC(+57.02)APY(+31.99)AK.E Y 15.69 2362.1548 21 -55.2 591.5134 4 26.37 6 10926 VEV_3_3_RA6_01_1237.d 5.73E4 1 1 563 583 Carbamidomethylation; Dihydroxy
K.NTPDR(+28.03).L Y 15.58 629.3133 5 -17.7 630.3094 1 57.09 5 29484 VEV_2_3_RA5_01_1236.d 0 1 1 225 229 Dimethylation(KR)
R.ICGIANQ(+.98)RVK.E Y 15.58 1101.5964 10 6.4 368.2084 3 13.40 6 4132 VEV_3_3_RA6_01_1237.d 0 1 1 742 751 Deamidation (NQ)
R.FAIEVLR(+14.02)PMGC(+57.02)T(-18.01)VNQTDFSTSVTGTAGGK.L Y 15.52 3039.4792 29 -31.5 1014.1351 3 81.17 4 47918 VEV_1_3_RA4_01_1235.d 3.12E4 1 1 677 705 Methylation(KR); Carbamidomethylation; Dehydration
R.EIRKGLS(+79.97)LMGEIK(+14.02).A Y 15.42 1566.8204 13 -11.0 392.7081 4 68.31 5 37773 VEV_2_3_RA5_01_1236.d 0 1 1 1280 1292 Phosphorylation (STY); Methylation(KR)
K.TGIT(+79.97)PK(+42.01).R Y 15.36 737.3361 6 28.0 738.3640 1 85.64 5 49532 VEV_2_3_RA5_01_1236.d 0 1 1 1524 1529 Phosphorylation (STY); Acetylation (K)
K.ELYLGNAGT(+42.01)ASR.F Y 15.28 1292.6360 12 36.5 324.1781 4 24.65 5 10285 VEV_2_3_RA5_01_1236.d 0 1 1 482 493 Acetylation (TSCYH)
K.SQ(+.98)GGR(+14.02).F Y 15.28 518.2449 5 11.9 519.2583 1 62.56 5 33453 VEV_2_3_RA5_01_1236.d 0 1 1 1127 1131 Deamidation (NQ); Methylation(KR)
K.AAP(+31.99)GQLSAREIR.K Y 15.27 1299.6895 12 -21.4 434.2278 3 64.80 6 33963 VEV_3_3_RA6_01_1237.d 8.72E4 1 1 1271 1282 Dihydroxy
K.ANVEAERK(+14.02)TGITPK(+14.02).R Y 15.17 1540.8573 14 -42.4 386.2053 4 65.27 5 35486 VEV_2_3_RA5_01_1236.d 0 1 1 1516 1529 Methylation(KR)
K.TAIDTPNGK(+14.02).N Y 15.09 929.4818 9 15.7 310.8394 3 40.27 4 18854 VEV_1_3_RA4_01_1235.d 7.65E4 1 1 153 161 Methylation(KR)
total 158 peptides
C1G3T9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLSDYNIQKESTLHLVLR.L N 159.30 2129.1479 18 -16.7 533.2854 4 74.48 6 41183 VEV_3_3_RA6_01_1237.d 4.69E6 15 15 65 82
K.Q(-17.03)LEDGRTLSDYNIQKESTLHLVLR.L N 141.80 2810.4563 24 -16.4 703.6098 4 79.17 6 44565 VEV_3_3_RA6_01_1237.d 7.4E5 3 3 59 82 Pyro-glu from Q
K.TITLEVESSDTIDNVK.S N 137.72 1762.8837 16 -16.9 588.6252 3 74.04 6 40897 VEV_3_3_RA6_01_1237.d 3.46E6 24 24 98 113
K.TLTGKTITLEVESSDTIDNVK.S N 136.65 2263.1794 21 -15.1 755.3890 3 74.33 5 42129 VEV_2_3_RA5_01_1236.d 4.75E5 5 5 93 113
K.TITLEVESSDTIDNVKSK.I N 131.66 1978.0106 18 -16.7 660.3331 3 68.40 6 36710 VEV_3_3_RA6_01_1237.d 1.22E6 8 8 98 115
K.IQDKEGIPPDQQR.L N 112.68 1522.7739 13 -9.4 762.3871 2 33.45 5 15253 VEV_2_3_RA5_01_1236.d 1.73E7 87 87 40 52
K.TITLEVESVDTIDSVK.S Y 108.77 1747.9091 16 -16.8 874.9471 2 79.35 6 44695 VEV_3_3_RA6_01_1237.d 1.48E5 2 2 22 37
K.TLTGKTITLEVESSDTIDNVKSK.I N 102.46 2478.3064 23 -3.9 827.1062 3 70.31 5 39218 VEV_2_3_RA5_01_1236.d 3.34E4 1 1 93 115
K.QLEDGRTLSDYNIQKESTLHLVLR.L N 101.60 2827.4827 24 -9.9 566.4982 5 75.29 5 42801 VEV_2_3_RA5_01_1236.d 3.72E5 2 2 59 82
K.SKIQDKEGIPPDQQR.L N 98.76 1737.9009 15 -7.0 869.9516 2 29.38 6 12531 VEV_3_3_RA6_01_1237.d 6.91E6 52 52 38 52
R.TLSDYNIQKESTLHLVLR(+14.02).L N 96.35 2143.1636 18 -12.0 536.7917 4 76.06 6 42318 VEV_3_3_RA6_01_1237.d 2.76E5 2 2 65 82 Methylation(KR)
R.LIFAGKQLEDGR.T N 96.30 1345.7354 12 -11.3 673.8674 2 63.79 5 34379 VEV_2_3_RA5_01_1236.d 6.99E5 4 4 53 64
K.ESTLHLVLR.L N 90.92 1066.6135 9 -8.7 534.3094 2 63.78 4 34342 VEV_1_3_RA4_01_1235.d 2.15E6 11 11 74 82
K.QLEDGRTLSDYNIQK.E N 82.96 1778.8799 15 -11.8 593.9603 3 62.37 4 33270 VEV_1_3_RA4_01_1235.d 2.33E5 2 2 59 73
K.Q(-17.03)LEDGRTLSDYNIQK.E N 80.22 1761.8533 15 -9.3 588.2863 3 71.63 6 39086 VEV_3_3_RA6_01_1237.d 3.29E5 4 4 59 73 Pyro-glu from Q
K.TITLEVESVDTIDSVKSK.I Y 79.27 1963.0361 18 -18.5 655.3406 3 75.38 6 41817 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 22 39
R.TLSDYNIQ(+.98)KESTLHLVLR.L N 79.14 2130.1321 18 -5.8 533.5372 4 76.10 5 43372 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 65 82 Deamidation (NQ)
R.TLSDYN(+.98)IQ(+.98)KESTLHLVLR.L N 77.87 2131.1160 18 2.0 533.7874 4 74.73 6 41348 VEV_3_3_RA6_01_1237.d 2.48E5 3 3 65 82 Deamidation (NQ)
R.TLSDYNIQK.E N 70.15 1080.5452 9 -10.8 541.2740 2 49.71 4 24740 VEV_1_3_RA4_01_1235.d 2.84E6 12 12 65 73
K.EGIPPDQQR.L N 67.65 1038.5094 9 -15.7 520.2538 2 25.46 5 10742 VEV_2_3_RA5_01_1236.d 2.88E6 35 35 44 52
R.TLSDYNIQKE(+14.02)STLHLVLR.L N 63.33 2143.1636 18 -16.1 536.7896 4 76.90 6 42930 VEV_3_3_RA6_01_1237.d 1.81E5 1 1 65 82 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVKSK.I N 60.94 1992.0262 18 -8.7 665.0103 3 72.08 6 39422 VEV_3_3_RA6_01_1237.d 2.35E5 3 3 98 115 Methylation(others)
R.TLSD(+43.99)YNIQKESTLHLVLR.L N 60.62 2173.1379 18 -20.6 544.2806 4 74.60 4 42826 VEV_1_3_RA4_01_1235.d 3.45E4 1 1 65 82 Carboxylation (DKW)
R.TLSDYNIQK(+114.04)ESTLHLVLR.L N 60.29 2243.1909 18 -8.8 561.8000 4 75.33 4 43389 VEV_1_3_RA4_01_1235.d 4.52E5 4 4 65 82 Ubiquitin
MQIFVK.T N 56.88 764.4255 6 -28.0 383.2093 2 60.29 6 30725 VEV_3_3_RA6_01_1237.d 4.48E6 10 10 1 6
K.TITLEVESS(+14.02)DTIDNVK.S N 56.56 1776.8993 16 -9.1 889.4489 2 77.18 5 44192 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 98 113 Methylation(others)
K.IQDKEGIPPDQ(+.98)QR.L N 55.65 1523.7579 13 -2.8 508.9252 3 34.09 5 15624 VEV_2_3_RA5_01_1236.d 5.98E6 21 21 40 52 Deamidation (NQ)
R.LIFAGK(+114.04)QLEDGR.T N 54.12 1459.7783 12 -19.0 487.5908 3 64.99 6 34106 VEV_3_3_RA6_01_1237.d 7.64E5 4 4 53 64 Ubiquitin
R.LIFAGK(+383.23)QLEDGR.T N 52.12 1728.9634 12 -18.5 433.2401 4 64.27 6 33560 VEV_3_3_RA6_01_1237.d 9.35E5 4 4 53 64 Ubiquitination
K.IQDKEGIPPDQQ(+.98)R.L N 51.34 1523.7579 13 -11.3 508.9208 3 37.29 6 16932 VEV_3_3_RA6_01_1237.d 2.87E6 13 13 40 52 Deamidation (NQ)
K.IQ(+.98)DKEGIPPDQ(+.98)QR.L N 48.15 1524.7419 13 5.2 763.3822 2 34.57 6 15407 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 40 52 Deamidation (NQ)
K.IQ(+.98)DKEGIPPDQQR.L N 47.47 1523.7579 13 -5.1 508.9240 3 36.66 5 17161 VEV_2_3_RA5_01_1236.d 2.97E6 4 4 40 52 Deamidation (NQ)
K.IQDK(+14.02)EGIPPDQQR.L N 46.46 1536.7896 13 -9.9 513.2654 3 41.87 4 19819 VEV_1_3_RA4_01_1235.d 3.22E6 21 21 40 52 Methylation(KR)
K.IQD(+14.02)KEGIPPDQQR.L N 46.06 1536.7896 13 -14.7 513.2629 3 44.66 5 21930 VEV_2_3_RA5_01_1236.d 1.44E6 2 2 40 52 Methylation(others)
R.LIFAGK.Q N 45.36 647.4006 6 -23.3 648.3928 1 51.12 5 25833 VEV_2_3_RA5_01_1236.d 1.07E7 12 12 53 58
R.TLSDYN(+.98)IQKESTLHLVLR.L N 44.22 2130.1321 18 -0.5 533.5400 4 76.12 4 44001 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 65 82 Deamidation (NQ)
K.SKIQDKEGIPPDQ(+.98)QR.L N 43.56 1738.8849 15 -2.5 580.6341 3 30.82 5 13731 VEV_2_3_RA5_01_1236.d 5.87E5 4 4 38 52 Deamidation (NQ)
K.IQDKEGIPPDQQR(+14.02).L N 43.21 1536.7896 13 -15.8 513.2624 3 40.86 4 19197 VEV_1_3_RA4_01_1235.d 1.83E6 13 13 40 52 Methylation(KR)
M(+15.99)QIFVK.T N 38.90 780.4204 6 -15.7 391.2114 2 40.39 5 19345 VEV_2_3_RA5_01_1236.d 4.06E6 11 11 1 6 Oxidation (M)
K.TLTGKTITLEVES(+14.02)SDTIDNVK.S N 38.82 2277.1951 21 -23.1 760.0547 3 76.81 6 42859 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 93 113 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVK.S N 37.48 1776.8993 16 -4.0 593.3047 3 77.42 6 43315 VEV_3_3_RA6_01_1237.d 4.47E5 2 2 98 113 Methylation(others)
K.QLEDGRTLSDYNIQK(-1.03)ESTLHLVLR.L N 37.12 2826.4512 24 -40.3 566.2747 5 75.36 5 42849 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 59 82 Lysine oxidation to aminoadipic semialdehyde
K.TITLE(+14.02)VESSDTIDNVKSK.I N 36.89 1992.0262 18 -2.3 665.0145 3 70.44 6 38186 VEV_3_3_RA6_01_1237.d 0 1 1 98 115 Methylation(others)
R.ITDQPSAAVTGK(+78.05)TITLEVESVDTIDSVK.S Y 35.86 2994.5649 28 8.4 749.6548 4 84.90 5 49101 VEV_2_3_RA5_01_1236.d 5.65E4 1 1 10 37 2,5-dimethypyrrole
K.SKIQ(+.98)DKEGIPPDQQR.L N 35.45 1738.8849 15 -2.4 870.4476 2 31.76 6 13855 VEV_3_3_RA6_01_1237.d 5.6E5 2 2 38 52 Deamidation (NQ)
K.ESTLHLVLR(+14.02).L N 34.55 1080.6292 9 -16.3 361.2111 3 67.59 4 37312 VEV_1_3_RA4_01_1235.d 0 1 1 74 82 Methylation(KR)
K.TITLEVESSD(-18.01)TIDNVK(+14.02).S N 33.66 1758.8887 16 11.3 587.3101 3 74.25 6 40996 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 98 113 Dehydration; Methylation(KR)
K.E(-18.01)GIPPDQQR.L N 33.32 1020.4988 9 -6.9 511.2532 2 35.23 6 15790 VEV_3_3_RA6_01_1237.d 0 1 1 44 52 Pyro-glu from E
K.IQD(-18.01)K(+14.02)EGIPPDQQR.L N 32.44 1518.7791 13 5.7 507.2698 3 33.68 4 14973 VEV_1_3_RA4_01_1235.d 2.93E5 7 7 40 52 Dehydration; Methylation(KR)
R.TLSDY(-18.01)NIQK(+14.02)ESTLHLVLR.L N 31.34 2125.1531 18 -30.4 532.2794 4 76.08 6 42334 VEV_3_3_RA6_01_1237.d 5.28E4 1 1 65 82 Dehydration; Methylation(KR)
R.TLS(-18.01)DYNIQK(+14.02)ESTLHLVLR.L N 30.27 2125.1531 18 -36.0 532.2764 4 74.44 6 41139 VEV_3_3_RA6_01_1237.d 7.97E4 1 1 65 82 Dehydration; Methylation(KR)
K.IQDKE(+14.02)GIPPDQQR.L N 28.37 1536.7896 13 -14.0 513.2633 3 43.09 4 20592 VEV_1_3_RA4_01_1235.d 1.4E6 2 2 40 52 Methylation(others)
MQ(+.98)IFVK.T N 26.85 765.4095 6 -13.8 383.7067 2 62.91 4 33690 VEV_1_3_RA4_01_1235.d 1.88E5 2 2 1 6 Deamidation (NQ)
R.L(+108.00)IFAGKQLEDGR.T N 26.64 1453.7329 12 -20.6 485.5749 3 65.04 6 34170 VEV_3_3_RA6_01_1237.d 4.89E5 2 2 53 64 O-Ethylphosphorylation
R.LIFAGK(+14.02).Q N 26.06 661.4163 6 -20.9 331.7085 2 58.65 6 29475 VEV_3_3_RA6_01_1237.d 8.4E5 5 5 53 58 Methylation(KR)
K.TITLEVESSDTIDNVKSK(+14.02).I N 25.84 1992.0262 18 6.0 665.0200 3 70.39 5 39276 VEV_2_3_RA5_01_1236.d 0 1 1 98 115 Methylation(KR)
K.SKIQD(-18.01)K(+14.02)EGIPPDQQR.L N 24.63 1733.9060 15 8.1 434.4873 4 30.43 4 13088 VEV_1_3_RA4_01_1235.d 0 1 1 38 52 Dehydration; Methylation(KR)
R.GGMQIF(+31.99)VK.T Y 24.31 910.4582 8 -18.9 456.2278 2 52.95 6 26025 VEV_3_3_RA6_01_1237.d 5.6E4 1 1 85 92 Dihydroxy
R.TLSD(+37.03)YNIQKESTLHLVLR.L N 23.66 2166.1797 18 9.8 542.5575 4 74.51 5 42259 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 65 82 Propargylamine
R.LRGGH Y 23.20 538.2975 5 -50.1 539.2778 1 75.19 6 41682 VEV_3_3_RA6_01_1237.d 3E4 2 2 311 315
K.TITLE(+14.02)VESSDTIDNVK.S N 22.92 1776.8993 16 -11.7 593.3001 3 76.06 6 42319 VEV_3_3_RA6_01_1237.d 1.76E5 1 1 98 113 Methylation(others)
K.TITLEVESSDTIDNVK(+14.02)SK.I N 21.55 1992.0262 18 -14.1 665.0067 3 71.01 6 38615 VEV_3_3_RA6_01_1237.d 9.51E4 1 1 98 115 Methylation(KR)
K.Q(-17.03)LEDGRTLSDYNIQ(+.98)K.E N 21.37 1762.8373 15 -13.7 882.4138 2 73.11 6 40171 VEV_3_3_RA6_01_1237.d 0 1 1 59 73 Pyro-glu from Q; Deamidation (NQ)
K.Q(-17.03)LEDGR.T N 21.10 699.3187 6 -17.4 700.3138 1 31.50 6 13696 VEV_3_3_RA6_01_1237.d 1.08E6 2 2 59 64 Pyro-glu from Q
K.SKIQDK(-1.03)EGIPPDQQR.L N 20.63 1736.8693 15 -34.0 435.2098 4 29.93 5 13221 VEV_2_3_RA5_01_1236.d 0 1 1 38 52 Lysine oxidation to aminoadipic semialdehyde
R.L(+41.03)IFAGK.Q N 19.93 688.4272 6 -34.3 345.2091 2 49.95 5 25113 VEV_2_3_RA5_01_1236.d 0 1 1 53 58 Amidination of lysines or N-terminal amines with methyl acetimidate
R.T(-18.01)LSDYNIQK(+14.02)ESTLHLVLR.L N 19.72 2125.1531 18 -24.8 532.2823 4 74.54 4 42776 VEV_1_3_RA4_01_1235.d 0 1 1 65 82 Dehydration; Methylation(KR)
R.ITDQPSAAVTGK.T Y 19.22 1186.6194 12 -20.6 396.5389 3 18.35 4 6542 VEV_1_3_RA4_01_1235.d 6.78E4 1 1 10 21
R.ITD(+21.98)QPSAAVTGK(+42.01).T Y 18.79 1250.6118 12 -12.2 417.8728 3 30.06 4 12885 VEV_1_3_RA4_01_1235.d 1.87E5 1 1 10 21 Sodium adduct; Acetylation (K)
K.QLEDGR.T N 18.77 716.3453 6 43.4 717.3837 1 45.77 5 22589 VEV_2_3_RA5_01_1236.d 8.79E4 1 1 59 64
K.IQDK(+164.06)EGIPPDQQR.L N 18.75 1686.8341 13 -7.0 563.2814 3 32.26 5 14630 VEV_2_3_RA5_01_1236.d 0 1 1 40 52 O-Diisopropylphosphorylation
K.TITLEVES(+79.97)VDTIDSVKSK(+42.01)IQDK.E Y 18.64 2569.2776 22 5.4 643.3301 4 83.42 4 49514 VEV_1_3_RA4_01_1235.d 0 1 1 22 43 Phosphorylation (STY); Acetylation (K)
K.EGIPPDQQR(+14.02).L N 18.59 1052.5250 9 1.0 527.2703 2 34.20 6 15197 VEV_3_3_RA6_01_1237.d 0 2 2 44 52 Methylation(KR)
K.IQDKEGIPPDQQ(+.98)R(+14.02).L N 18.22 1537.7736 13 -68.3 769.8416 2 37.73 5 17783 VEV_2_3_RA5_01_1236.d 7.79E4 1 1 40 52 Deamidation (NQ); Methylation(KR)
K.IQDK(+210.20)EGIPPDQQR.L N 17.58 1732.9723 13 -63.9 434.2227 4 30.13 5 13335 VEV_2_3_RA5_01_1236.d 0 1 1 40 52 Myristoylation
R.GGMQIFVKTLTGK.T Y 17.48 1378.7643 13 -29.0 460.5820 3 65.50 4 35670 VEV_1_3_RA4_01_1235.d 4.17E4 1 1 85 97
R.I(+42.01)TDQPSAAVTGK(+27.99).T Y 17.15 1256.6249 12 32.7 315.1738 4 18.38 4 6562 VEV_1_3_RA4_01_1235.d 3.56E4 1 1 10 21 Acetylation (Protein N-term); Formylation
K.T(+27.99)ITLEVES(+79.97)VDTIDSVKSK.I Y 16.49 2070.9973 18 10.0 518.7618 4 67.71 5 37311 VEV_2_3_RA5_01_1236.d 0 1 1 22 39 Formylation; Phosphorylation (STY)
K.T(+43.01)ITLEVESSDTIDNVK.S N 16.26 1805.8894 16 4.1 362.1866 5 44.85 6 21323 VEV_3_3_RA6_01_1237.d 0 1 1 98 113 Carbamylation
K.IQDK(+43.01)EGIPPDQQR.L N 15.42 1565.7798 13 27.0 314.1717 5 11.16 6 2993 VEV_3_3_RA6_01_1237.d 0 1 1 40 52 Carbamylation
total 80 peptides
C1G3C4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GVAGAGVLSIYDQVQLLLFGK.A Y 151.43 2147.1990 21 -13.3 716.7307 3 97.66 6 54563 VEV_3_3_RA6_01_1237.d 4.14E5 6 6 286 306
K.WMAGNLASGGAAGATSLLFVYSLDYAR.T Y 133.58 2761.3533 27 -9.2 1381.6711 2 93.04 6 52778 VEV_3_3_RA6_01_1237.d 6.24E5 7 7 117 143
R.YFPTQALNFAFR.D Y 125.20 1473.7405 12 -12.1 737.8686 2 84.12 6 47972 VEV_3_3_RA6_01_1237.d 5.74E5 3 3 87 98
R.GVAGAGVLSIYDQVQLLLFGKAFK Y 118.49 2493.3994 24 -8.2 624.3520 4 96.03 5 54665 VEV_2_3_RA5_01_1236.d 4.95E5 11 11 286 309
K.LLIQNQDEMLK.T Y 115.76 1343.7119 11 -15.3 672.8530 2 69.91 6 37782 VEV_3_3_RA6_01_1237.d 6.25E5 3 3 39 49
R.YFPTQALNFAFRDTYK.S Y 109.42 1980.9734 16 -7.3 991.4868 2 81.74 4 48347 VEV_1_3_RA4_01_1235.d 1.39E6 7 7 87 102
K.TLASDGIAGLYR.G Y 104.25 1235.6510 12 -16.0 618.8229 2 72.89 6 40028 VEV_3_3_RA6_01_1237.d 1.94E6 8 8 171 182
R.SFFKGAGANILR.G Y 96.67 1279.7036 12 -10.8 427.5706 3 69.42 4 38791 VEV_1_3_RA4_01_1235.d 8.66E5 4 4 274 285
R.GFGPSVLGIVVYR.G Y 93.97 1362.7659 13 -17.1 682.3785 2 84.02 6 47841 VEV_3_3_RA6_01_1237.d 3.41E5 4 4 183 195
R.KYNGIMDC(+57.02)FSR.T Y 93.08 1389.6169 11 -2.7 464.2117 3 65.26 4 35477 VEV_1_3_RA4_01_1235.d 2.1E5 2 2 56 66 Carbamidomethylation
K.YSSSFDAAR.Q Y 92.76 1002.4406 9 -15.2 502.2200 2 37.25 6 16907 VEV_3_3_RA6_01_1237.d 1.9E6 7 7 256 264
R.MMMTSGEAVKYSSSFDAAR.Q Y 87.82 2067.9062 19 -3.6 690.3069 3 70.28 4 39434 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 246 264
R.IKLLIQNQDEMLK.T Y 79.72 1584.8909 13 -8.1 793.4463 2 72.30 5 40687 VEV_2_3_RA5_01_1236.d 5.51E5 4 4 37 49
R.MM(+15.99)MTSGEAVKYSSSFDAAR.Q Y 75.41 2083.9014 19 5.3 695.6447 3 67.46 4 37210 VEV_1_3_RA4_01_1235.d 7.05E4 1 1 246 264 Oxidation (M)
R.KTLASDGIAGLYR.G Y 69.66 1363.7460 13 -25.4 455.5777 3 65.47 6 34474 VEV_3_3_RA6_01_1237.d 1.84E5 2 2 170 182
K.LLIQNQDEM(+15.99)LK.T Y 68.81 1359.7068 11 -14.2 680.8510 2 63.10 6 32751 VEV_3_3_RA6_01_1237.d 7.45E4 1 1 39 49 Oxidation (M)
R.Q(-17.03)FN(+.98)GLVDVYRK.T Y 68.42 1321.6666 11 -15.6 661.8303 2 78.71 6 44229 VEV_3_3_RA6_01_1237.d 5.12E5 5 5 160 170 Pyro-glu from Q; Deamidation (NQ)
K.YNGIMDC(+57.02)FSR.T Y 68.17 1261.5220 10 -10.2 631.7618 2 71.17 4 40138 VEV_1_3_RA4_01_1235.d 1.06E5 4 4 57 66 Carbamidomethylation
R.GNTANVIR.Y Y 67.96 843.4562 8 -8.2 422.7319 2 21.03 4 7940 VEV_1_3_RA4_01_1235.d 6.76E5 3 3 79 86
K.TAAAPIER.I Y 66.21 827.4501 8 -8.3 414.7289 2 23.05 4 9033 VEV_1_3_RA4_01_1235.d 2.58E6 11 11 29 36
R.QFNGLVDVYRK.T Y 63.62 1337.7091 11 -16.4 446.9030 3 65.63 6 34591 VEV_3_3_RA6_01_1237.d 7.01E5 6 6 160 170
R.GVAGAGVLSIYDQ(+.98)VQ(+.98)LLLFGKAFK Y 63.25 2495.3674 24 5.0 832.8005 3 96.03 5 54655 VEV_2_3_RA5_01_1236.d 4.99E4 1 1 286 309 Deamidation (NQ)
K.GAGANILRGVAGAGVLSIYDQVQLLLFGKAFK Y 62.47 3245.8289 32 -2.7 812.4623 4 97.54 4 57351 VEV_1_3_RA4_01_1235.d 0 1 1 278 309
R.Q(-17.03)FNGLVDVYRK.T Y 62.40 1320.6826 11 -15.8 661.3381 2 77.97 6 43703 VEV_3_3_RA6_01_1237.d 6.26E5 5 5 160 170 Pyro-glu from Q
R.M(+15.99)MMTSGEAVKYSSSFDAAR.Q Y 59.29 2083.9014 19 18.7 695.6541 3 67.17 6 35758 VEV_3_3_RA6_01_1237.d 0 1 1 246 264 Oxidation (M)
R.QFNGLVDVYR.K Y 58.79 1209.6141 10 -10.4 605.8080 2 73.14 4 41690 VEV_1_3_RA4_01_1235.d 2.48E5 3 3 160 169
M.A(+42.01)QDKSFMGMPGFVVDFMMGGVSAAVSK.T Y 49.72 2835.3103 27 -3.0 1418.6582 2 97.69 4 57430 VEV_1_3_RA4_01_1235.d 3.1E4 1 1 2 28 Acetylation (Protein N-term)
K.SFMGMPGFVVDFMMGGVSAAVSKTAAAPIER.I Y 47.11 3160.5217 31 22.3 1054.5380 3 97.03 4 57155 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 6 36
R.KYN(+.98)GIMDC(+57.02)FSR.T Y 44.99 1390.6010 11 -20.1 464.5316 3 69.02 6 37139 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 56 66 Deamidation (NQ); Carbamidomethylation
K.S(-17.03)FM(+15.99)GMPGFVVDFMMGGVSAAVSK.T Y 44.61 2350.0505 23 34.6 1176.0732 2 97.65 4 57411 VEV_1_3_RA4_01_1235.d 0 1 1 6 28 Ammonia-loss (Protein N-term); Oxidation (M)
R.TMKNEGIVSLWR(+14.02).G Y 44.42 1446.7653 12 -15.3 483.2550 3 73.53 4 42000 VEV_1_3_RA4_01_1235.d 1.41E5 2 2 67 78 Methylation(KR)
K.SFM(+15.99)GMPGFVVDFMMGGVSAAVSK.T Y 41.84 2367.0771 23 -3.8 1184.5414 2 95.96 4 56732 VEV_1_3_RA4_01_1235.d 3.88E4 1 1 6 28 Oxidation (M)
K.GAGANILR.G Y 39.26 770.4399 8 -19.9 386.2195 2 35.92 6 16194 VEV_3_3_RA6_01_1237.d 1.36E6 9 9 278 285
R.Q(-17.03)IAAKEGVR.S Y 39.08 953.5294 9 -10.8 477.7668 2 35.29 5 16342 VEV_2_3_RA5_01_1236.d 7.56E4 2 2 265 273 Pyro-glu from Q
K.YSSSFDAAR(+14.02).Q Y 38.51 1016.4563 9 -7.4 509.2317 2 47.07 4 23044 VEV_1_3_RA4_01_1235.d 3.64E5 4 4 256 264 Methylation(KR)
R.TMKNEGIVSLWR.G Y 38.14 1432.7496 12 -8.1 478.5866 3 71.60 4 40479 VEV_1_3_RA4_01_1235.d 2.84E5 1 1 67 78
R.TM(+15.99)KNEGIVSLWR.G Y 37.92 1448.7446 12 20.4 483.9320 3 68.50 4 38038 VEV_1_3_RA4_01_1235.d 0 1 1 67 78 Oxidation (M)
K.TLASDGIAGLYR(+.98).G Y 35.12 1236.6350 12 2.0 619.3260 2 73.20 5 41315 VEV_2_3_RA5_01_1236.d 7.17E4 1 1 171 182 Deamidation (R)
K.T(-18.01)AAAPIERIKLLIQNQDEMLK.T Y 33.09 2376.3198 21 -12.3 793.1041 3 72.49 4 41179 VEV_1_3_RA4_01_1235.d 5.6E2 1 1 29 49 Dehydration
R.YFPTQALNFAFRDTYKSMFNFKK.E Y 32.96 2863.4155 23 3.2 573.6922 5 84.23 4 50079 VEV_1_3_RA4_01_1235.d 5.67E4 1 1 87 109
K.LLIQNQD(+14.02)EMLK.T Y 30.26 1357.7275 11 3.9 679.8737 2 73.11 4 41673 VEV_1_3_RA4_01_1235.d 4.69E4 1 1 39 49 Methylation(others)
R.YFPTQ(+.98)ALNFAFR.D Y 29.40 1474.7245 12 -10.6 738.3617 2 85.24 6 48660 VEV_3_3_RA6_01_1237.d 1.49E5 2 2 87 98 Deamidation (NQ)
K.G(+42.01)AGANILR.G Y 27.67 812.4504 8 -30.9 407.2199 2 35.88 5 16701 VEV_2_3_RA5_01_1236.d 3.25E4 1 1 278 285 Acetylation (N-term)
R.QFN(+.98)GLVDVYRK.T Y 27.55 1338.6931 11 -11.2 447.2333 3 67.58 4 37301 VEV_1_3_RA4_01_1235.d 2.39E5 1 1 160 170 Deamidation (NQ)
K.GTGERQFN(+.98)GLVDVYRK.T Y 26.42 1838.9275 16 -21.4 460.7293 4 63.36 5 34058 VEV_2_3_RA5_01_1236.d 9.7E4 1 1 155 170 Deamidation (NQ)
K.LLIQNQDEMLK(+14.02).T Y 25.93 1357.7275 11 19.1 679.8840 2 72.91 5 41111 VEV_2_3_RA5_01_1236.d 1.61E4 1 1 39 49 Methylation(KR)
K.TAAAPIERIK.L Y 25.28 1068.6292 10 -50.5 535.2949 2 36.89 5 17293 VEV_2_3_RA5_01_1236.d 0 1 1 29 38
R.GN(+.98)TANVIR.Y Y 25.26 844.4402 8 -63.1 423.2008 2 20.69 5 8113 VEV_2_3_RA5_01_1236.d 0 2 2 79 86 Deamidation (NQ)
R.DGYAKWMAGNLASGGAAGATSLLFVYSLDYAR.T Y 23.63 3295.5972 32 -13.7 1099.5247 3 93.07 6 52793 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 112 143
K.T(+127.06)LASDGIAGLYR.G Y 22.99 1362.7144 12 -40.2 455.2271 3 65.44 6 34457 VEV_3_3_RA6_01_1237.d 0 1 1 171 182 N-Succinimidyl-2-morpholine acetate
K.GAGANILR(+14.02).G Y 22.34 784.4555 8 -22.8 393.2261 2 46.53 6 22288 VEV_3_3_RA6_01_1237.d 7.36E4 1 1 278 285 Methylation(KR)
R.LANDAK(+42.01)SAK(+14.02)GTGER.Q Y 22.01 1472.7583 14 -41.6 491.9063 3 78.80 6 44297 VEV_3_3_RA6_01_1237.d 0 1 1 146 159 Acetylation (K); Methylation(KR)
R.SFFKGAGANILR(+14.02).G Y 20.47 1293.7194 12 -18.1 432.2393 3 72.00 5 40457 VEV_2_3_RA5_01_1236.d 3.8E4 1 1 274 285 Methylation(KR)
K.LLIQ(+.98)NQDEMLK.T Y 19.22 1344.6959 11 -11.2 673.3477 2 71.81 4 40645 VEV_1_3_RA4_01_1235.d 3.72E4 1 1 39 49 Deamidation (NQ)
MAQDK.S Y 19.18 591.2686 5 7.9 592.2806 1 62.73 4 33565 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 1 5
R.QFN(+.98)GLVDVYR(+14.02).K Y 18.95 1224.6139 10 -11.8 613.3070 2 40.69 5 19516 VEV_2_3_RA5_01_1236.d 2.37E5 1 1 160 169 Deamidation (NQ); Methylation(KR)
K.SMFNFKK.E Y 18.44 900.4528 7 -8.5 451.2298 2 51.63 4 25919 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 103 109
K.TAAAPIER(+14.02).I Y 18.19 841.4658 8 -19.1 421.7321 2 31.49 6 13690 VEV_3_3_RA6_01_1237.d 1.69E5 1 1 29 36 Methylation(KR)
K.GAGAN(+.98)ILR.G Y 17.81 771.4239 8 13.7 386.7245 2 41.18 6 19170 VEV_3_3_RA6_01_1237.d 2.88E4 1 1 278 285 Deamidation (NQ)
K.G(+71.04)TGER.Q Y 17.49 589.2820 5 1.2 590.2900 1 69.23 4 38615 VEV_1_3_RA4_01_1235.d 0 1 1 155 159 Propionamide (K, X@N-term)
K.GAGANILR(+44.03).G Y 17.46 814.4661 8 -16.7 408.2335 2 9.37 5 2278 VEV_2_3_RA5_01_1236.d 4.52E3 1 1 278 285 Ethanolation (KR)
R.SFFK(+28.03)GAGANILR.G Y 17.24 1307.7350 12 -0.3 327.9409 4 51.23 4 25649 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 274 285 Dimethylation(KR)
R.LANDAKS(+79.96)AKGT(+79.97)GER.Q Y 17.12 1576.6552 14 85.4 395.2047 4 28.84 5 12592 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 146 159 Sulfation; Phosphorylation (STY)
R.QIAAKEGVRS(+79.97)FFKGAGAN(+.98)ILR.G Y 17.08 2313.1995 21 -7.1 579.3030 4 83.64 4 49659 VEV_1_3_RA4_01_1235.d 7.93E4 1 1 265 285 Phosphorylation (STY); Deamidation (NQ)
K.T(-18.01)LASDGIAGLYR.G Y 16.65 1217.6404 12 13.7 406.8929 3 43.78 4 21004 VEV_1_3_RA4_01_1235.d 3.5E5 1 1 171 182 Dehydration
R.GNTAN(+.98)VIR.Y Y 16.64 844.4402 8 -18.3 423.2197 2 62.15 4 33109 VEV_1_3_RA4_01_1235.d 0 1 1 79 86 Deamidation (NQ)
R.L(+27.99)ANDAK(+14.02).S Y 16.61 672.3442 6 15.7 673.3621 1 16.92 6 5942 VEV_3_3_RA6_01_1237.d 0 1 1 146 151 Formylation; Methylation(KR)
R.TRLAN(+.98)DAK(-.98).S Y 16.57 887.4824 8 -15.9 888.4756 1 96.02 6 54001 VEV_3_3_RA6_01_1237.d 0 1 1 144 151 Deamidation (NQ); Amidation
R.LANDAKSAKGT(-18.01)GER.Q Y 16.55 1398.7214 14 -38.9 700.3408 2 79.67 5 45837 VEV_2_3_RA5_01_1236.d 2.59E4 1 1 146 159 Dehydration
K.N(+43.01)EGIVSLWR.G Y 16.51 1115.5724 9 -12.4 558.7866 2 74.15 5 41993 VEV_2_3_RA5_01_1236.d 2.5E4 1 1 70 78 Carbamylation
K.G(+42.01)T(-18.01)GER.Q Y 16.39 542.2449 5 -16.8 543.2430 1 14.81 4 4702 VEV_1_3_RA4_01_1235.d 1.41E4 1 1 155 159 Acetylation (N-term); Dehydration
K.TLASD(+14.02)GIAGLYR.G Y 16.28 1249.6666 12 -3.0 625.8387 2 75.09 5 42659 VEV_2_3_RA5_01_1236.d 1.65E4 1 1 171 182 Methylation(others)
K.Y(-2.02)SSSFDAAR.Q Y 16.22 1000.4250 9 49.4 501.2445 2 37.96 6 17317 VEV_3_3_RA6_01_1237.d 2.07E5 1 1 256 264 2-amino-3-oxo-butanoic_acid
K.GTGER(+14.02)QFNGLVDVYR.K Y 15.88 1723.8641 15 5.2 431.9756 4 40.12 5 19184 VEV_2_3_RA5_01_1236.d 8.3E4 1 1 155 169 Methylation(KR)
K.SM(+15.99)FNFKKER(+14.02)DGYAK.W Y 15.83 1749.8508 14 0.2 584.2910 3 18.92 6 7005 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 103 116 Oxidation (M); Methylation(KR)
K.LLIQ(+.98)NQDEMLK(+14.02).T Y 15.73 1358.7115 11 -32.3 680.3411 2 72.85 5 41067 VEV_2_3_RA5_01_1236.d 0 1 1 39 49 Deamidation (NQ); Methylation(KR)
R.G(+42.01)NT(-18.01)ANVIRYFPTQALNFAFR.D Y 15.60 2323.1860 20 2.0 581.8049 4 77.07 5 44070 VEV_2_3_RA5_01_1236.d 0 1 1 79 98 Acetylation (N-term); Dehydration
K.TAAAPIER(+31.99).I Y 15.27 859.4399 8 -20.3 860.4297 1 90.07 4 53692 VEV_1_3_RA4_01_1235.d 9.87E4 1 1 29 36 Dihydroxy
MAQDK(-.98).S Y 15.18 590.2846 5 -31.6 591.2733 1 13.64 6 4258 VEV_3_3_RA6_01_1237.d 2.52E4 1 1 1 5 Amidation
total 79 peptides
C1G9X3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YGQSAGNVGDEGGVAPDIQTPEEALDLITEAIEQAGYTGQVK.I Y 143.36 4290.0449 42 -4.1 1431.0164 3 97.64 6 54551 VEV_3_3_RA6_01_1237.d 5.17E4 3 3 201 242
R.SGETEDVTIADVVVGLR.A Y 132.52 1758.8999 17 -9.8 880.4486 2 83.79 5 48430 VEV_2_3_RA5_01_1236.d 9.98E5 6 6 377 393
R.GNPTVEVDVVTETGLHR.A Y 126.25 1821.9221 17 -12.6 608.3070 3 70.41 6 38159 VEV_3_3_RA6_01_1237.d 6.45E5 6 6 16 32
K.TC(+57.02)DLQVVADDLTVTNPIR.I Y 117.60 2029.0150 18 -14.6 1015.4999 2 82.81 6 47070 VEV_3_3_RA6_01_1237.d 4.35E5 4 4 314 331 Carbamidomethylation
R.IEEELGSNAVYAGDKFR.A Y 116.18 1896.9216 17 -11.1 633.3075 3 67.90 6 36313 VEV_3_3_RA6_01_1237.d 5.29E5 5 5 417 433
K.LGANAILGVSLAIAK.A Y 111.43 1409.8606 15 -11.4 705.9296 2 83.75 5 48408 VEV_2_3_RA5_01_1236.d 2.89E5 3 3 106 120
R.AIVPSGASTGQHEAC(+57.02)ELR.D Y 109.78 1881.9003 18 -8.2 628.3022 3 58.53 4 30392 VEV_1_3_RA4_01_1235.d 8.63E5 6 6 33 50 Carbamidomethylation
R.LAFQEFMIVPTAAPSFSEALR.Q Y 105.55 2324.1875 21 -20.2 775.7208 3 91.23 4 54398 VEV_1_3_RA4_01_1235.d 4.31E5 5 5 164 184
K.LNQILRIEEELGSNAVYAGDKFR.A Y 104.51 2634.3765 23 -7.4 879.1263 3 82.19 5 47470 VEV_2_3_RA5_01_1236.d 5.24E4 1 1 411 433
R.SVYDSRGNPTVEVDVVTETGLHR.A Y 104.13 2529.2458 23 -11.5 633.3115 4 72.44 5 40786 VEV_2_3_RA5_01_1236.d 8.15E5 5 5 10 32
K.VNQIGTLTESIQAAK.D Y 97.95 1571.8518 15 -14.0 786.9222 2 72.22 6 39528 VEV_3_3_RA6_01_1237.d 2.2E5 3 3 348 362
K.KPYVLPVPFQNVLNGGSHAGGR.L Y 94.60 2306.2283 22 12.0 577.5713 4 78.18 4 45618 VEV_1_3_RA4_01_1235.d 2.6E4 2 2 142 163
K.WLTYEQLADLYKK.L Y 90.52 1669.8715 13 -21.9 557.6189 3 80.68 6 45638 VEV_3_3_RA6_01_1237.d 1.69E5 2 2 274 286
K.KPYVLPVPFQNVLN(+.98)GGSHAGGR.L Y 81.43 2307.2124 22 -6.3 577.8068 4 78.59 4 45932 VEV_1_3_RA4_01_1235.d 3.92E5 3 3 142 163 Deamidation (NQ)
K.NVNSIIGPAIIK.E Y 81.39 1237.7394 12 -6.8 619.8727 2 75.13 5 42687 VEV_2_3_RA5_01_1236.d 4.38E4 1 1 68 79
K.IALDIASSEFYKADEK.K Y 78.79 1798.8988 16 -9.4 900.4482 2 75.60 5 43024 VEV_2_3_RA5_01_1236.d 2.37E5 2 2 243 258
K.IALDIASSEFYK.A Y 77.51 1355.6973 12 -18.8 678.8431 2 78.80 6 44292 VEV_3_3_RA6_01_1237.d 1.62E5 2 2 243 254
K.GVPLYAHVSDLAGTK.K Y 75.28 1526.8092 15 -4.0 509.9417 3 69.36 6 37384 VEV_3_3_RA6_01_1237.d 1.42E5 3 3 127 141
K.SC(+57.02)NALLLK.V Y 72.86 917.5004 8 -14.9 459.7506 2 55.59 6 27491 VEV_3_3_RA6_01_1237.d 1.18E6 4 4 340 347 Carbamidomethylation
R.LAFQEFMIVPTAAPSFSEALR(+14.02).Q Y 65.38 2338.2031 21 -10.2 1170.0969 2 92.00 4 54781 VEV_1_3_RA4_01_1235.d 1.67E5 3 3 164 184 Methylation(KR)
K.NVN(+.98)SIIGPAIIK.E Y 63.43 1238.7234 12 -34.3 620.3477 2 75.07 6 41595 VEV_3_3_RA6_01_1237.d 0 1 1 68 79 Deamidation (NQ)
K.VDEFLNKLDGTPNK.S Y 63.40 1588.8097 14 -17.0 530.6015 3 66.55 6 35288 VEV_3_3_RA6_01_1237.d 3.1E5 2 2 90 103
K.N(+.98)VNSIIGPAIIK.E Y 51.86 1238.7234 12 -39.9 620.3442 2 75.21 4 43353 VEV_1_3_RA4_01_1235.d 0 2 2 68 79 Deamidation (NQ)
K.DSYAAGWGVMVSHR.S Y 45.78 1534.6987 14 -16.1 512.5653 3 71.59 6 39071 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 363 376
R.AIVPSGASTGQHEAC(+57.02)ELR(+14.02).D Y 45.77 1895.9159 18 -7.5 632.9745 3 60.99 4 32223 VEV_1_3_RA4_01_1235.d 4.29E4 1 1 33 50 Carbamidomethylation; Methylation(KR)
R.AGQIKTGAPAR.S Y 36.82 1068.6040 11 -19.8 535.2987 2 16.24 5 5687 VEV_2_3_RA5_01_1236.d 5.76E3 1 1 394 404
K.VNQIGTLTESIQAAKDSYAAGWGVMVSHR.S Y 36.60 3088.5400 29 -45.0 773.1075 4 84.32 4 50143 VEV_1_3_RA4_01_1235.d 0 1 1 348 376
K.LNQILR.I Y 35.81 755.4653 6 -17.6 378.7333 2 40.91 6 19011 VEV_3_3_RA6_01_1237.d 1.2E5 4 4 411 416
R.LAFQEFMIVPTAAPSFSEALRQGSEVYHK.L Y 34.33 3252.6277 29 -11.0 814.1553 4 86.48 6 49357 VEV_3_3_RA6_01_1237.d 8.47E4 1 1 164 192
R.LAFQEFM(+15.99)IVPTAAPSFSEALR.Q Y 33.66 2340.1824 21 -72.4 781.0116 3 88.38 6 50450 VEV_3_3_RA6_01_1237.d 0 1 1 164 184 Oxidation (M)
R.AIVPSGASTGQ(+.98)HEAC(+57.02)ELR.D Y 33.41 1882.8843 18 -11.8 628.6280 3 60.47 6 30778 VEV_3_3_RA6_01_1237.d 0 1 1 33 50 Deamidation (NQ); Carbamidomethylation
K.LNQILRIEEELGS(-2.02)NAVYAGDKFR.A Y 33.09 2632.3608 23 8.5 659.1031 4 82.22 6 46690 VEV_3_3_RA6_01_1237.d 0 1 1 411 433 2-amino-3-oxo-butanoic_acid
R.IEEE(+14.02)LGSNAVYAGDKFR.A Y 32.44 1910.9374 17 -2.4 637.9849 3 70.20 4 39371 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 417 433 Methylation(others)
K.AGAAEK.G Y 31.58 545.2809 6 -8.2 546.2837 1 15.95 4 5282 VEV_1_3_RA4_01_1235.d 0 2 2 121 126
K.GVPLYAHVSDLAGTKKPYVLPVPFQNVLNGGSHAGGR.L Y 31.17 3815.0271 37 -12.0 764.0035 5 81.04 5 46731 VEV_2_3_RA5_01_1236.d 7.78E4 1 1 127 163
R.Q(-17.03)GSEVYHKLK.A Y 31.04 1170.6033 10 -11.8 586.3020 2 37.77 5 17800 VEV_2_3_RA5_01_1236.d 2.26E5 2 2 185 194 Pyro-glu from Q
R.SVYDSRGNPTVEVDVVTETGLHR(+14.02).A Y 29.46 2543.2615 23 -9.0 636.8169 4 75.14 5 42695 VEV_2_3_RA5_01_1236.d 8.81E4 1 1 10 32 Methylation(KR)
K.LDGTPN(-17.03)K.S Y 28.06 726.3548 7 -1.8 727.3608 1 81.09 5 46766 VEV_2_3_RA5_01_1236.d 3.37E5 1 1 97 103 Ammonia-loss (N)
R.GNPTVEVDVVTE(+14.02)TGLHR.A Y 27.35 1835.9377 17 -8.6 612.9813 3 74.01 5 41890 VEV_2_3_RA5_01_1236.d 8.59E4 1 1 16 32 Methylation(others)
R.SGET(+14.02)EDVTIADVVVGLR.A Y 26.77 1772.9155 17 -33.0 887.4358 2 84.78 4 50500 VEV_1_3_RA4_01_1235.d 5.52E4 1 1 377 393 Methylation(others)
K.A(+226.08)GAAEK(+14.02)GVPLYAHVSDLAGTK.K Y 25.27 2294.1729 21 -85.2 765.6664 3 69.43 5 38593 VEV_2_3_RA5_01_1236.d 2.5E4 1 1 121 141 Biotinylation; Methylation(KR)
R.AGQ(+.98)IKTGAPAR(+14.02).S Y 24.96 1083.6036 11 -24.0 362.1998 3 74.84 6 41427 VEV_3_3_RA6_01_1237.d 8.26E4 1 1 394 404 Deamidation (NQ); Methylation(KR)
K.AIELK.S N 23.10 572.3533 5 -59.5 573.3265 1 24.74 6 10066 VEV_3_3_RA6_01_1237.d 0 1 1 335 339
R.AAINM(+15.99) Y 22.46 534.2472 5 35.3 535.2733 1 56.29 6 27904 VEV_3_3_RA6_01_1237.d 0 1 1 434 438 Oxidation (M)
K.GVLNAVK.N Y 22.29 699.4279 7 -18.7 350.7147 2 38.59 6 17684 VEV_3_3_RA6_01_1237.d 2.79E5 2 2 61 67
K.VNQ(+.98)IGTLTESIQAAK.D Y 21.95 1572.8358 15 2.8 394.2173 4 41.10 5 19778 VEV_2_3_RA5_01_1236.d 0 1 1 348 362 Deamidation (NQ)
R.GNPTVEVDVVTETGLHR(+14.02).A Y 21.60 1835.9377 17 -1.3 612.9857 3 70.56 5 39404 VEV_2_3_RA5_01_1236.d 8.39E4 1 1 16 32 Methylation(KR)
K.G(+43.01)VLNAVK.N Y 21.48 742.4337 7 -12.7 372.2194 2 62.15 4 33138 VEV_1_3_RA4_01_1235.d 1.63E5 2 2 61 67 Carbamylation
K.VDEFLNK.L Y 20.97 863.4388 7 -8.3 432.7231 2 45.99 6 21977 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 90 96
R.AAINM Y 20.88 518.2523 5 4.0 519.2616 1 42.27 4 20073 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 434 438
K.TGAP(+31.99)AR.S Y 20.16 603.2976 6 -0.3 604.3047 1 76.57 4 44355 VEV_1_3_RA4_01_1235.d 1.39E5 2 2 399 404 Dihydroxy
K.SKWLTYEQLADLYK.K Y 20.02 1756.9036 14 -17.4 440.2255 4 35.89 4 16274 VEV_1_3_RA4_01_1235.d 8.88E4 1 1 272 285
K.ENIDVK(+31.99)DQSK(+42.01).V Y 19.76 1248.5834 10 9.2 625.3047 2 60.50 4 31865 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 80 89 Dihydroxy; Acetylation (K)
R.G(+43.01)N(+.98)PTVEVDVVTETGLHR.A Y 19.71 1865.9119 17 -49.1 622.9474 3 70.81 4 39854 VEV_1_3_RA4_01_1235.d 0 1 1 16 32 Carbamylation; Deamidation (NQ)
M(+42.01)AITK.I Y 19.39 604.3254 5 -28.0 605.3158 1 73.02 6 40104 VEV_3_3_RA6_01_1237.d 0 1 1 1 5 Acetylation (Protein N-term)
K.V(+27.99)DEFLNK.L Y 19.07 891.4338 7 6.4 892.4467 1 83.78 4 49760 VEV_1_3_RA4_01_1235.d 0 1 1 90 96 Formylation
K.VNQIGTLTES(+42.01)IQAAK.D Y 19.07 1613.8624 15 -6.8 404.4702 4 57.60 5 29834 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 348 362 Acetylation (TSCYH)
K.VNQ(+.98)IGTLTESIQAAK(+42.01).D Y 19.03 1614.8464 15 -5.8 404.7166 4 44.54 5 21854 VEV_2_3_RA5_01_1236.d 0 1 1 348 362 Deamidation (NQ); Acetylation (K)
K.TGAPAR.S Y 18.20 571.3078 6 -50.2 572.2864 1 71.92 6 39304 VEV_3_3_RA6_01_1237.d 4.58E4 1 1 399 404
K.LDGTPNK(-.98).S Y 18.04 742.3973 7 6.5 743.4094 1 42.31 4 20097 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 97 103 Amidation
K.LDGTPNKSK.L Y 17.83 958.5083 9 7.2 480.2649 2 36.68 5 17173 VEV_2_3_RA5_01_1236.d 0 1 1 97 105
K.WLGKGVLNAVK.N Y 17.73 1183.7076 11 -35.9 395.5623 3 70.19 5 39134 VEV_2_3_RA5_01_1236.d 3.31E4 2 2 57 67
K.AGAAEK(+43.99).G Y 17.61 589.2708 6 15.5 590.2872 1 42.78 4 20391 VEV_1_3_RA4_01_1235.d 0 1 1 121 126 Carboxylation (DKW)
K.FRAAINM(+15.99) Y 17.60 837.4167 7 -10.9 838.4149 1 46.58 6 22319 VEV_3_3_RA6_01_1237.d 2.69E5 1 1 432 438 Oxidation (M)
K.VNQIGTLTESIQ(+.98)AAK.D Y 17.57 1572.8358 15 -12.6 394.2113 4 59.27 5 31010 VEV_2_3_RA5_01_1236.d 0 1 1 348 362 Deamidation (NQ)
K.VN(+.98)QIGTLTESIQ(+.98)AAK(+14.02).D Y 17.35 1587.8356 15 -32.0 530.2689 3 69.48 6 37536 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 348 362 Deamidation (NQ); Methylation(KR)
K.LDGTPNK(+42.01).S Y 17.31 785.3919 7 -13.6 786.3885 1 48.41 4 23874 VEV_1_3_RA4_01_1235.d 0 1 1 97 103 Acetylation (K)
K.VDEFLNK(+14.02)LDGTPNK.S Y 16.98 1602.8253 14 -16.5 535.2736 3 72.39 5 40752 VEV_2_3_RA5_01_1236.d 8.07E4 1 1 90 103 Methylation(KR)
K.TGAPAR(+31.99).S Y 16.89 603.2976 6 -4.9 604.3019 1 75.53 4 43613 VEV_1_3_RA4_01_1235.d 2.11E4 1 1 399 404 Dihydroxy
K.T(+27.99)GAPAR.S Y 16.85 599.3027 6 -42.5 600.2845 1 57.30 6 28560 VEV_3_3_RA6_01_1237.d 0 1 1 399 404 Formylation
K.GVPLYAH(+15.99)VSDLAGTK(+14.02).K Y 16.39 1556.8198 15 2.8 390.2133 4 59.49 6 30078 VEV_3_3_RA6_01_1237.d 1.68E6 1 1 127 141 Oxidation (HW); Methylation(KR)
K.EN(+.98)IDVK.D Y 16.37 717.3544 6 2.9 718.3638 1 43.73 4 20975 VEV_1_3_RA4_01_1235.d 0 1 1 80 85 Deamidation (NQ)
K.LDGTPNK(+14.02)SK(+43.99).L Y 16.37 1016.5138 9 -1.1 339.8448 3 40.84 5 19609 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 97 105 Methylation(KR); Carboxylation (DKW)
R.AGQIKTGAPARSER.L Y 16.32 1440.7797 14 -23.0 361.1939 4 53.59 6 26416 VEV_3_3_RA6_01_1237.d 0 1 1 394 407
K.VDEFLNK(+43.01).L Y 16.18 906.4446 7 51.8 303.1711 3 17.11 5 6162 VEV_2_3_RA5_01_1236.d 0 1 1 90 96 Carbamylation
K.ENIDVK(+42.01).D Y 16.15 758.3810 6 -13.9 759.3777 1 104.30 4 59556 VEV_1_3_RA4_01_1235.d 4.67E4 1 1 80 85 Acetylation (K)
K.TGAPAR(+28.03).S Y 15.97 599.3391 6 16.1 600.3560 1 32.85 4 14488 VEV_1_3_RA4_01_1235.d 0 1 1 399 404 Dimethylation(KR)
K.T(+42.01)GAPAR.S Y 15.71 613.3184 6 -20.5 614.3130 1 80.72 6 45666 VEV_3_3_RA6_01_1237.d 2.14E5 1 1 399 404 Acetylation (N-term)
MAITK.I Y 15.67 562.3149 5 -57.1 563.2900 1 79.86 6 45060 VEV_3_3_RA6_01_1237.d 1.54E5 1 1 1 5
K.E(+27.99)NIDVKDQS(+79.97)KVDEFLNK.L Y 15.58 2127.9724 17 -5.3 710.3276 3 68.80 4 38272 VEV_1_3_RA4_01_1235.d 4.98E4 1 1 80 96 Formylation; Phosphorylation (STY)
M(+27.99)AITK.I Y 15.49 590.3098 5 -34.5 591.2967 1 67.55 5 37190 VEV_2_3_RA5_01_1236.d 4.91E4 1 1 1 5 Formylation (Protein N-term)
K.IALDIASS(-18.01)EFYKADEKK.Y Y 15.27 1908.9832 17 -5.0 478.2507 4 57.76 4 29834 VEV_1_3_RA4_01_1235.d 0 1 1 243 259 Dehydration
R.IEEELGSNAVYAGDK(+42.01).F Y 15.08 1635.7627 15 -25.6 546.2476 3 45.49 6 21686 VEV_3_3_RA6_01_1237.d 0 1 1 417 431 Acetylation (K)
K.DQSKVDEFLNK(+14.02).L Y 15.08 1335.6670 11 13.0 446.2354 3 53.71 5 27412 VEV_2_3_RA5_01_1236.d 2.4E5 1 1 86 96 Methylation(KR)
total 84 peptides
C1G821
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LDSQKHIDFALTSPFGGGRPGR.V Y 149.07 2355.2083 22 -14.3 589.8009 4 70.98 6 38637 VEV_3_3_RA6_01_1237.d 3.98E6 13 13 148 169
R.LDSELKIVGTYGLR.N Y 124.21 1562.8667 14 -14.7 521.9552 3 75.25 6 41750 VEV_3_3_RA6_01_1237.d 1.91E6 9 9 22 35
R.MKLDYVLALTVEDFLER.R Y 122.40 2054.0757 17 -10.4 1028.0344 2 95.86 6 53939 VEV_3_3_RA6_01_1237.d 1.31E6 9 9 89 105
K.HIDFALTSPFGGGRPGR.V Y 121.97 1783.9117 17 -18.5 595.6335 3 73.50 6 40576 VEV_3_3_RA6_01_1237.d 3.37E6 12 12 153 169
K.SKAAEKGGEDEEEEDEE Y 118.65 1879.7443 17 -9.1 940.8708 2 14.36 6 4643 VEV_3_3_RA6_01_1237.d 9.11E5 8 8 175 191
R.LQTQVYQLGLAK.S Y 117.59 1360.7715 12 -15.0 681.3828 2 70.85 6 38516 VEV_3_3_RA6_01_1237.d 1.42E6 5 5 107 118
R.MKLDYVLALTVEDFLERRLQTQVYQLGLAK.S Y 114.04 3552.9377 30 -7.8 711.5893 5 95.61 4 56599 VEV_1_3_RA4_01_1235.d 2.6E5 1 1 89 118
R.RLQTQVYQLGLAK.S Y 108.24 1516.8726 13 -10.8 506.6260 3 66.51 4 36459 VEV_1_3_RA4_01_1235.d 2.25E6 7 7 106 118
R.M(+15.99)KLDYVLALTVEDFLER.R Y 97.90 2070.0706 17 -5.9 691.0267 3 92.19 4 54878 VEV_1_3_RA4_01_1235.d 4.69E5 5 5 89 105 Oxidation (M)
R.MKLDYVLALTVEDFLERR.L Y 94.01 2210.1768 18 -10.7 553.5455 4 92.15 4 54854 VEV_1_3_RA4_01_1235.d 1.15E6 7 7 89 106
R.VGKQIVNVPSFVVR.L Y 92.66 1540.9089 14 -10.5 514.6382 3 73.03 4 41604 VEV_1_3_RA4_01_1235.d 1.16E6 7 7 134 147
K.QIVNVPSFVVR.L Y 86.19 1256.7241 11 -16.4 629.3590 2 77.91 6 43661 VEV_3_3_RA6_01_1237.d 1.21E6 8 8 137 147
K.AAEKGGEDEEEEDEE Y 85.80 1664.6172 15 -4.7 833.3120 2 17.70 4 6218 VEV_1_3_RA4_01_1235.d 1.8E6 10 10 177 191
R.M(+15.99)KLDYVLALTVEDFLERR.L Y 81.92 2226.1719 18 -26.1 557.5357 4 89.40 6 51001 VEV_3_3_RA6_01_1237.d 1.35E5 2 2 89 106 Oxidation (M)
K.Q(-17.03)IVNVPSFVVR.L Y 80.95 1239.6975 11 -17.3 620.8453 2 86.24 6 49226 VEV_3_3_RA6_01_1237.d 5.95E5 1 1 137 147 Pyro-glu from Q
K.HIDFALTSPFGGGRPGR(+14.02).V Y 80.32 1797.9274 17 -6.3 450.4863 4 72.87 4 41480 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 153 169 Methylation(KR)
R.LQTQVYQLGLAK(+14.02).S Y 78.72 1374.7871 12 -8.7 688.3948 2 73.22 4 41756 VEV_1_3_RA4_01_1235.d 5.79E4 2 2 107 118 Methylation(KR)
R.MKLDYVLALTVEDFLER(+14.02).R Y 76.41 2068.0913 17 -6.8 690.3663 3 96.69 4 57038 VEV_1_3_RA4_01_1235.d 3.82E5 2 2 89 105 Methylation(KR)
K.LDYVLALTVEDFLER.R Y 75.89 1794.9403 15 -6.5 898.4716 2 95.20 4 56390 VEV_1_3_RA4_01_1235.d 1.36E5 2 2 91 105
R.RLQTQVYQLGLAK(+14.02).S Y 75.36 1530.8882 13 -25.3 511.2904 3 68.79 4 38334 VEV_1_3_RA4_01_1235.d 1.7E5 3 3 106 118 Methylation(KR)
R.ELLTLDEKDPKR.L Y 75.20 1455.7932 12 -16.6 486.2636 3 51.72 6 25308 VEV_3_3_RA6_01_1237.d 2.65E6 15 15 56 67
R.LQ(+.98)TQVYQLGLAK.S Y 75.10 1361.7555 12 -8.7 681.8791 2 72.45 4 41149 VEV_1_3_RA4_01_1235.d 2.19E5 2 2 107 118 Deamidation (NQ)
K.RLFEGNALIR.R Y 69.93 1187.6775 10 -11.9 396.8951 3 67.38 4 37172 VEV_1_3_RA4_01_1235.d 1.1E6 6 6 67 76
R.ELLTLDEKDPK.R Y 68.41 1299.6921 11 -10.0 650.8469 2 59.77 4 31315 VEV_1_3_RA4_01_1235.d 2.19E6 9 9 56 66
R.LDS(-18.01)QK(+14.02)HIDFALTSPFGGGRPGR.V Y 67.51 2351.2134 22 -23.1 588.7971 4 71.00 5 39726 VEV_2_3_RA5_01_1236.d 5.23E4 1 1 148 169 Dehydration; Methylation(KR)
R.LFEGNALIR.R Y 65.28 1031.5763 9 -12.4 516.7890 2 70.65 5 39461 VEV_2_3_RA5_01_1236.d 2.71E6 7 7 68 76
R.RLQTQ(+.98)VYQLGLAK.S Y 63.74 1517.8566 13 -3.9 506.9575 3 66.44 6 35210 VEV_3_3_RA6_01_1237.d 1.29E5 1 1 106 118 Deamidation (NQ)
K.AAEK(+14.02)GGEDEEEEDEE Y 62.36 1678.6329 15 -7.1 840.3178 2 23.91 5 9893 VEV_2_3_RA5_01_1236.d 1.33E6 7 7 177 191 Methylation(KR)
R.ELLTLDEKDPKRLFEGNALIR.R Y 61.90 2469.3591 21 -16.8 494.8708 5 78.72 6 44237 VEV_3_3_RA6_01_1237.d 5.1E4 2 2 56 76
R.MKLDYVLALTVEDFLERR(+14.02).L Y 61.66 2224.1926 18 -13.7 557.0478 4 93.06 4 55327 VEV_1_3_RA4_01_1235.d 3.97E4 1 1 89 106 Methylation(KR)
K.Q(-17.03)IVNVPSFVVR(+14.02).L Y 60.23 1253.7131 11 -14.3 627.8549 2 87.87 6 50150 VEV_3_3_RA6_01_1237.d 4E4 1 1 137 147 Pyro-glu from Q; Methylation(KR)
R.LDSQ(+.98)KHIDFALTSPFGGGRPGR.V Y 59.91 2356.1924 22 -9.6 472.2412 5 72.00 4 40796 VEV_1_3_RA4_01_1235.d 1.42E5 1 1 148 169 Deamidation (NQ)
R.VGVLDESR.M Y 59.71 873.4556 8 -12.7 437.7295 2 40.49 5 19406 VEV_2_3_RA5_01_1236.d 5.09E6 14 14 81 88
R.EVWRVQLTLSK.I Y 59.29 1357.7717 11 -12.7 453.5921 3 72.88 5 41085 VEV_2_3_RA5_01_1236.d 2.29E5 3 3 39 49
R.LDSE(+14.02)LKIVGTYGLR.N Y 59.00 1576.8824 14 -11.6 526.6287 3 78.23 4 45656 VEV_1_3_RA4_01_1235.d 1E5 1 1 22 35 Methylation(others)
R.LDS(-2.02)QKHIDFALTSPFGGGRPGR.V Y 58.82 2353.1926 22 -10.0 589.2996 4 71.29 4 40236 VEV_1_3_RA4_01_1235.d 4.05E4 1 1 148 169 2-amino-3-oxo-butanoic_acid
K.AAEKGGE(+14.02)DEEEEDEE Y 58.52 1678.6329 15 -6.5 840.3183 2 25.24 4 10276 VEV_1_3_RA4_01_1235.d 1.99E6 2 2 177 191 Methylation(others)
K.RLFEGNALIR(+14.02).R Y 55.45 1201.6931 10 -9.3 401.5679 3 71.13 4 40108 VEV_1_3_RA4_01_1235.d 4.56E4 1 1 67 76 Methylation(KR)
K.TYKVPR.R Y 54.99 762.4388 6 -17.2 382.2201 2 18.64 5 6995 VEV_2_3_RA5_01_1236.d 1.57E6 4 4 9 14
K.IVGTYGLR.N Y 54.80 877.5021 8 -12.3 439.7530 2 57.14 4 29402 VEV_1_3_RA4_01_1235.d 3.34E6 8 8 28 35
R.LDSQKHIDFALT(-18.01)SPFGGGRPGR.V Y 54.75 2337.1978 22 -9.2 468.4425 5 70.99 5 39720 VEV_2_3_RA5_01_1236.d 9.41E4 1 1 148 169 Dehydration
K.AAEKGGEDEEE(+14.02)EDEE Y 54.34 1678.6329 15 -6.3 840.3184 2 26.14 4 10735 VEV_1_3_RA4_01_1235.d 1.12E6 1 1 177 191 Methylation(others)
R.LQTQ(+.98)VYQLGLAK.S Y 53.16 1361.7555 12 -12.8 681.8763 2 72.57 6 39783 VEV_3_3_RA6_01_1237.d 1.42E5 2 2 107 118 Deamidation (NQ)
K.HIDFALT(-18.01)SPFGGGR(+14.02)PGR.V Y 52.82 1779.9169 17 -15.3 445.9797 4 73.34 6 40334 VEV_3_3_RA6_01_1237.d 4.43E4 1 1 153 169 Dehydration; Methylation(KR)
R.VQLTLSK.I Y 51.53 787.4803 7 -14.5 394.7417 2 48.79 4 24110 VEV_1_3_RA4_01_1235.d 3.11E6 6 6 43 49
K.AAEKGGEDEEEE(+14.02)DEE Y 51.32 1678.6329 15 -12.5 840.3133 2 26.12 6 10776 VEV_3_3_RA6_01_1237.d 2.8E6 5 5 177 191 Methylation(others)
K.AAEKGGEDEEEEDEE(+14.02) Y 50.79 1678.6329 15 -5.3 840.3193 2 27.39 4 11407 VEV_1_3_RA4_01_1235.d 3.62E5 4 4 177 191 Methylation(others)
K.SKAAEKGGEDEEEE(+14.02)DEE Y 49.67 1893.7599 17 -9.5 632.2546 3 20.47 5 7982 VEV_2_3_RA5_01_1236.d 4.77E5 2 2 175 191 Methylation(others)
K.AAEKGGEDE(+14.02)EEEDEE Y 49.32 1678.6329 15 -10.6 840.3148 2 25.70 6 10566 VEV_3_3_RA6_01_1237.d 1.68E6 2 2 177 191 Methylation(others)
R.LDSELKIVGTYGLR(+14.02).N Y 47.52 1576.8824 14 -8.8 526.6301 3 77.48 4 45071 VEV_1_3_RA4_01_1235.d 7.22E4 1 1 22 35 Methylation(KR)
K.HID(+14.02)FALTSPFGGGRPGR.V Y 46.86 1797.9274 17 -4.0 450.4873 4 73.90 4 42278 VEV_1_3_RA4_01_1235.d 2.91E4 1 1 153 169 Methylation(others)
R.LFEGNALIR(+14.02).R Y 46.32 1045.5920 9 -12.3 523.7969 2 74.74 4 42929 VEV_1_3_RA4_01_1235.d 1.31E5 2 2 68 76 Methylation(KR)
K.SKAAEKGGEDEEEEDEE(+14.02) Y 45.67 1893.7599 17 -5.5 632.2571 3 20.57 4 7689 VEV_1_3_RA4_01_1235.d 5.45E5 2 2 175 191 Methylation(others)
K.SKAAEK(+14.02)GGEDEEEEDEE Y 43.84 1893.7599 17 -3.6 632.2583 3 18.85 4 6803 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 175 191 Methylation(KR)
K.HIDFALTS(-18.01)PFGGGR(+14.02)PGR.V Y 43.52 1779.9169 17 -7.6 445.9831 4 73.73 6 40623 VEV_3_3_RA6_01_1237.d 0 1 1 153 169 Dehydration; Methylation(KR)
R.LFEGNALIRR.L Y 43.41 1187.6775 10 -11.6 396.8952 3 63.97 5 34527 VEV_2_3_RA5_01_1236.d 1.18E6 7 7 68 77
R.LDSQKHIDFALTS(-20.03)PFGGGRPGR.V Y 42.68 2335.1821 22 4.1 468.0456 5 71.03 4 40026 VEV_1_3_RA4_01_1235.d 1.46E4 1 1 148 169 Formation of five membered aromatic heterocycle
K.SKAAEKGGEDEEEEDE(+14.02)E Y 42.32 1893.7599 17 -4.5 632.2578 3 21.42 6 8314 VEV_3_3_RA6_01_1237.d 8.19E5 2 2 175 191 Methylation(others)
R.ELLTLDEK.D Y 42.31 959.5175 8 -11.7 480.7604 2 64.41 4 34821 VEV_1_3_RA4_01_1235.d 2.14E5 1 1 56 63
K.Q(+.98)IVNVPSFVVR.L Y 42.31 1257.7081 11 -19.5 629.8491 2 78.92 6 44453 VEV_3_3_RA6_01_1237.d 4.54E4 1 1 137 147 Deamidation (NQ)
R.MKLDYVLALTVE(+14.02)DFLERR.L Y 42.23 2224.1926 18 6.1 557.0588 4 93.66 4 55639 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 89 106 Methylation(others)
K.SKAAEKGGEDEEEED(+14.02)EE Y 42.16 1893.7599 17 -9.4 947.8784 2 20.50 6 7819 VEV_3_3_RA6_01_1237.d 1.6E5 2 2 175 191 Methylation(others)
R.LDSQKHIDFALT(-18.01)SPFGGGR(+14.02)PGR.V Y 41.50 2351.2134 22 3.2 471.2515 5 71.00 6 38602 VEV_3_3_RA6_01_1237.d 6.01E4 2 2 148 169 Dehydration; Methylation(KR)
R.RPYGSAR.L Y 41.38 805.4194 7 -11.2 403.7125 2 9.98 5 2504 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 15 21
R.LQ(+.98)TQVYQ(+.98)LGLAK.S Y 40.79 1362.7395 12 -19.3 682.3639 2 72.42 4 41130 VEV_1_3_RA4_01_1235.d 0 1 1 107 118 Deamidation (NQ)
K.Q(-17.03)IVNVPSFVVRLDSQK.H Y 40.48 1810.9941 16 -20.8 604.6594 3 85.77 6 48959 VEV_3_3_RA6_01_1237.d 1.39E5 4 4 137 152 Pyro-glu from Q
K.AAEKGGEDEEEEDE(+14.02)E Y 40.14 1678.6329 15 -8.2 840.3169 2 26.58 4 10973 VEV_1_3_RA4_01_1235.d 2.11E6 4 4 177 191 Methylation(others)
K.SKAAEKGGEDEE(+14.02)EEDEE Y 40.06 1893.7599 17 -3.9 632.2581 3 20.64 6 7950 VEV_3_3_RA6_01_1237.d 8.19E5 2 2 175 191 Methylation(others)
R.VGVLDESR(+14.02).M Y 37.78 887.4712 8 -19.9 444.7340 2 56.41 6 27976 VEV_3_3_RA6_01_1237.d 1.67E6 6 6 81 88 Methylation(KR)
R.SYSKTYKVPR.R Y 37.71 1227.6611 10 -12.2 307.9188 4 25.27 5 10642 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 5 14
R.VGVLDE(+14.02)SR.M Y 37.45 887.4712 8 -11.0 444.7380 2 56.72 4 29109 VEV_1_3_RA4_01_1235.d 6.04E5 2 2 81 88 Methylation(others)
R.LFE(+14.02)GNALIR.R Y 37.13 1045.5920 9 -11.8 523.7971 2 73.82 4 42212 VEV_1_3_RA4_01_1235.d 2.97E5 2 2 68 76 Methylation(others)
R.RPYGSAR(+14.02).L Y 35.81 819.4351 7 -10.9 410.7204 2 13.43 4 4019 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 15 21 Methylation(KR)
R.MKLDYVLALTVEDFLER(+14.02)R.L Y 33.74 2224.1926 18 -18.2 557.0453 4 93.83 6 53118 VEV_3_3_RA6_01_1237.d 2.05E5 3 3 89 106 Methylation(KR)
K.AAEKGGEDEEEED(+28.03)EE Y 32.00 1692.6486 15 -6.1 847.3264 2 35.95 4 16301 VEV_1_3_RA4_01_1235.d 1.1E6 2 2 177 191 Ethylation
K.AAEKGGEDE(+28.03)EEEDEE Y 31.84 1692.6486 15 -4.8 847.3275 2 35.54 4 16070 VEV_1_3_RA4_01_1235.d 1.1E6 2 2 177 191 Ethylation
K.Q(+.98)IVN(+.98)VPSFVVR.L Y 31.56 1258.6921 11 -19.1 630.3413 2 78.93 4 46190 VEV_1_3_RA4_01_1235.d 0 1 1 137 147 Deamidation (NQ)
K.IVGTYGLR(+14.02).N Y 29.31 891.5178 8 -21.4 446.7566 2 62.55 6 32301 VEV_3_3_RA6_01_1237.d 1.57E5 2 2 28 35 Methylation(KR)
K.AAEKGGEDEEEE(+28.03)DEE Y 29.16 1692.6486 15 -4.3 847.3279 2 35.14 4 15838 VEV_1_3_RA4_01_1235.d 2.54E6 4 4 177 191 Ethylation
R.RPYGSARLDSELK.I Y 26.74 1490.7841 13 -9.1 497.9308 3 46.80 4 22884 VEV_1_3_RA4_01_1235.d 2.18E5 2 2 15 27
R.VQLTLSK(+14.02).I Y 26.26 801.4960 7 -20.2 401.7472 2 56.49 4 28942 VEV_1_3_RA4_01_1235.d 2.14E5 2 2 43 49 Methylation(KR)
K.SK(+14.02)AAEKGGEDEEEEDEE Y 26.23 1893.7599 17 -2.4 632.2590 3 18.68 5 7024 VEV_2_3_RA5_01_1236.d 7.07E4 1 1 175 191 Methylation(KR)
R.R(+127.06)PYGSARLDSELKIVGTYGLRNK.R Y 25.99 2719.4768 23 -4.1 907.4958 3 97.68 4 57425 VEV_1_3_RA4_01_1235.d 1.93E4 1 1 15 37 N-Succinimidyl-2-morpholine acetate
K.QIVNVPSFVVRLDSQK.H Y 25.89 1828.0206 16 -39.0 610.3237 3 79.41 4 46565 VEV_1_3_RA4_01_1235.d 0 1 1 137 152
R.VGVLD(+14.02)ESR.M Y 25.59 887.4712 8 -15.7 444.7359 2 45.06 4 21804 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 81 88 Methylation(others)
R.MK(-1.03)LDYVLALTVEDFLERR.L Y 25.48 2209.1453 18 -19.6 737.3746 3 92.22 4 54893 VEV_1_3_RA4_01_1235.d 0 1 1 89 106 Lysine oxidation to aminoadipic semialdehyde
K.AAEKGGEDEEEEDE(+28.03)E Y 25.25 1692.6486 15 -8.3 847.3245 2 36.50 5 17065 VEV_2_3_RA5_01_1236.d 1.93E6 3 3 177 191 Ethylation
R.LDSQK(+14.02)HIDFALTSPFGGGRPGR.V Y 24.22 2369.2239 22 -9.9 474.8474 5 71.84 4 40671 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 148 169 Methylation(KR)
K.AAEKGGEDEEEED(+14.02)EE Y 24.09 1678.6329 15 -6.2 840.3185 2 26.97 4 11177 VEV_1_3_RA4_01_1235.d 1.12E6 1 1 177 191 Methylation(others)
K.SKAAEKGGEDEEE(+28.03)EDEE Y 24.07 1907.7755 17 -2.0 636.9312 3 27.86 4 11664 VEV_1_3_RA4_01_1235.d 2.7E5 1 1 175 191 Ethylation
R.RPYGS(+14.02)AR.L Y 23.67 819.4351 7 -20.4 410.7165 2 13.50 6 4186 VEV_3_3_RA6_01_1237.d 8E4 1 1 15 21 Methylation(others)
R.LQTQ(+.98)VYQ(+.98)LGLAK.S Y 23.57 1362.7395 12 -27.3 682.3584 2 72.85 4 41468 VEV_1_3_RA4_01_1235.d 0 1 1 107 118 Deamidation (NQ)
R.MK(-1.03)LDYVLALTVEDFLER.R Y 23.53 2053.0442 17 0.4 1027.5298 2 95.73 4 56625 VEV_1_3_RA4_01_1235.d 4.63E4 1 1 89 105 Lysine oxidation to aminoadipic semialdehyde
K.AAEKGGEDEE(+28.03)EEDEE Y 23.52 1692.6486 15 -7.3 847.3254 2 35.64 5 16553 VEV_2_3_RA5_01_1236.d 1.44E6 2 2 177 191 Ethylation
R.VLIKQR.H Y 23.00 755.5017 6 -19.6 378.7507 2 16.97 5 6092 VEV_2_3_RA5_01_1236.d 2.62E5 2 2 125 130
MAPRSYSK.T Y 22.02 938.4644 8 -4.9 939.4670 1 96.11 6 54029 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 1 8
R.MK(-1.03)LDYVLALTVEDFLERRLQTQVYQLGLAK.S Y 21.91 3551.9060 30 -0.8 711.3879 5 96.00 4 56788 VEV_1_3_RA4_01_1235.d 7.76E4 1 1 89 118 Lysine oxidation to aminoadipic semialdehyde
K.AAEKGGEDEEEEDEE(+28.03) Y 21.83 1692.6486 15 -10.4 847.3228 2 37.02 6 16783 VEV_3_3_RA6_01_1237.d 6.09E5 1 1 177 191 Ethylation
R.VGVLDESR(+28.03).M Y 21.31 901.4869 8 -23.5 451.7401 2 61.75 4 32796 VEV_1_3_RA4_01_1235.d 1.83E5 1 1 81 88 Dimethylation(KR)
K.HID(+43.99)FALTSPFGGGRPGR.V Y 21.16 1827.9016 17 9.6 457.9871 4 73.84 4 42229 VEV_1_3_RA4_01_1235.d 0 1 1 153 169 Carboxylation (DKW)
K.D(+21.98)PK(+42.01)RLFEGNALIR.R Y 20.80 1591.8446 13 -44.4 398.9507 4 69.41 4 38753 VEV_1_3_RA4_01_1235.d 0 1 1 64 76 Sodium adduct; Acetylation (K)
R.VGKQ(+.98)IVN(+.98)VPSFVVR.L Y 20.79 1542.8770 14 -15.7 515.2915 3 74.53 4 42775 VEV_1_3_RA4_01_1235.d 9.22E4 1 1 134 147 Deamidation (NQ)
R.AARE(+129.04)LLTLDEKDPK.R Y 20.73 1726.9100 14 -19.5 432.7263 4 59.84 4 31372 VEV_1_3_RA4_01_1235.d 4.17E4 1 1 53 66 Monoglutamyl
K.SKAAEKGGEDEE(+28.03)EEDEE Y 20.60 1907.7755 17 -3.9 636.9300 3 28.27 4 11899 VEV_1_3_RA4_01_1235.d 2.7E5 1 1 175 191 Ethylation
R.VQ(+.98)LTLSK.I Y 20.54 788.4644 7 -39.1 395.2240 2 51.31 6 25115 VEV_3_3_RA6_01_1237.d 5.5E4 2 2 43 49 Deamidation (NQ)
R.MK(+14.02)LDYVLALTVEDFLER.R Y 20.47 2068.0913 17 -19.7 1035.0326 2 92.18 4 54910 VEV_1_3_RA4_01_1235.d 0 1 1 89 105 Methylation(KR)
K.SKAAEKGGEDEEE(+14.02)EDEE Y 20.22 1893.7599 17 -9.2 947.8785 2 20.31 5 7896 VEV_2_3_RA5_01_1236.d 9.62E4 1 1 175 191 Methylation(others)
K.SKAAEK(+164.06)GGEDEEEEDEE Y 19.95 2043.8044 17 -0.2 682.2753 3 13.74 4 4175 VEV_1_3_RA4_01_1235.d 4E4 1 1 175 191 O-Diisopropylphosphorylation
R.RLQTQVYQLGLAK(-.98).S Y 19.21 1515.8885 13 -71.9 506.2672 3 66.68 5 36530 VEV_2_3_RA5_01_1236.d 0 1 1 106 118 Amidation
R.ELLTLDEK(+42.01)DPK(+14.02).R Y 19.13 1355.7184 11 -21.6 339.9296 4 16.71 5 5934 VEV_2_3_RA5_01_1236.d 2.64E5 1 1 56 66 Acetylation (K); Methylation(KR)
M(+28.03)APRSYSK.T Y 18.94 966.4957 8 -7.4 484.2515 2 18.15 4 6439 VEV_1_3_RA4_01_1235.d 0 1 1 1 8 Ethylation
K.SKAAEKGGED(+28.03)EEEEDEE Y 18.73 1907.7755 17 -18.9 636.9204 3 28.65 5 12489 VEV_2_3_RA5_01_1236.d 2.22E5 1 1 175 191 Ethylation
R.VGVLDESR(+31.99).M Y 18.15 905.4454 8 -12.3 906.4415 1 90.81 5 52304 VEV_2_3_RA5_01_1236.d 8E4 1 1 81 88 Dihydroxy
K.H(+42.01)(+15.99)IDFALTSPFGGGRPGR.V Y 17.69 1841.9172 17 11.1 921.9761 2 87.22 4 52016 VEV_1_3_RA4_01_1235.d 3.39E4 1 1 153 169 Acetylation (N-term); Oxidation (HW)
R.LD(-18.01)SQK.H Y 17.34 571.2966 5 -27.8 572.2880 1 33.85 4 15065 VEV_1_3_RA4_01_1235.d 0 1 1 148 152 Dehydration
R.LDSQKHIDFALTSPFGGGRPGR(+14.02).V Y 17.13 2369.2239 22 -19.6 593.3016 4 70.59 5 39423 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 148 169 Methylation(KR)
R.AARELLTLDEKDPK(-1.03).R Y 17.11 1596.8358 14 -73.4 533.2468 3 56.84 5 29372 VEV_2_3_RA5_01_1236.d 0 1 1 53 66 Lysine oxidation to aminoadipic semialdehyde
R.LDSQK(+14.02)HIDFALTS(-18.01)PFGGGRPGR.V Y 16.90 2351.2134 22 -1.9 471.2491 5 71.93 6 39311 VEV_3_3_RA6_01_1237.d 0 1 1 148 169 Methylation(KR); Dehydration
K.LDY(-18.01)VLALTVEDFLER.R Y 16.86 1776.9297 15 -9.5 445.2355 4 64.89 4 35184 VEV_1_3_RA4_01_1235.d 0 1 1 91 105 Dehydration
R.RPY(-18.01)GSAR(+14.02)LDSELKIVGTYGLR.N Y 16.62 2346.2808 21 -70.3 783.0459 3 75.28 5 42791 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 15 35 Dehydration; Methylation(KR)
K.SKAAEK.G Y 16.59 632.3493 6 -19.0 633.3445 1 67.48 4 37223 VEV_1_3_RA4_01_1235.d 0 1 1 175 180
R.ELLTLDEKDPK(+14.02).R Y 16.36 1313.7078 11 -28.0 438.8976 3 63.76 6 33195 VEV_3_3_RA6_01_1237.d 1.49E5 1 1 56 66 Methylation(KR)
R.LFE(+14.02)GNALIRR.L Y 16.33 1201.6931 10 -10.3 401.5675 3 66.83 5 36654 VEV_2_3_RA5_01_1236.d 6.18E4 1 1 68 77 Methylation(others)
R.R(+42.01)AARELLTLDEK(-.98).D Y 16.01 1454.8204 12 -5.5 364.7104 4 64.90 4 35196 VEV_1_3_RA4_01_1235.d 7.02E4 1 1 52 63 Acetylation (N-term); Amidation
R.LDSQK.H Y 15.91 589.3071 5 -9.5 590.3088 1 76.67 4 44439 VEV_1_3_RA4_01_1235.d 1.92E5 1 1 148 152
R.V(+42.01)GVLDESR(+14.02)MKLDYVLALTVEDFLER.R Y 15.61 2965.5469 25 -16.3 742.3819 4 94.45 6 53380 VEV_3_3_RA6_01_1237.d 0 1 1 81 105 Acetylation (N-term); Methylation(KR)
total 126 peptides
C1FZR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KPQLLLLDESTSALDAESEQLLQAGLETATR.G Y 125.71 3339.7410 31 13.3 1114.2690 3 92.25 5 53004 VEV_2_3_RA5_01_1236.d 2.62E5 3 3 1241 1271
R.AAQIQGPEVVEIVELVQK.A Y 123.59 1949.0833 18 -16.6 650.6909 3 86.04 5 49755 VEV_2_3_RA5_01_1236.d 2.76E5 3 3 512 529
R.LYDPTDGEVLFDSHNIKELNVR.S Y 118.35 2573.2761 22 -8.9 644.3206 4 78.70 5 45202 VEV_2_3_RA5_01_1236.d 2.99E5 3 3 429 450
R.LKDGYGTLVGSSGSLISGGQK.Q Y 115.50 2023.0586 21 -12.9 675.3514 3 70.76 5 39547 VEV_2_3_RA5_01_1236.d 2.04E5 2 2 543 563
R.SILENIALGLINSPAHSHLTATLLGQK.L Y 114.92 2810.5654 27 -11.3 703.6407 4 89.45 5 51623 VEV_2_3_RA5_01_1236.d 2.96E5 4 4 469 495
R.LYSPSSGSVQIDGQDISKR.E Y 114.06 2036.0173 19 -6.1 1019.0097 2 65.49 5 35658 VEV_2_3_RA5_01_1236.d 7.24E5 7 7 1133 1151
K.LLILDEATAALDSASQQR.V Y 98.67 1914.0057 18 -10.9 957.9998 2 87.51 5 50595 VEV_2_3_RA5_01_1236.d 3E5 4 4 578 595
R.LTGDITTIQQGTSEK.V Y 98.53 1590.8101 15 -7.0 796.4067 2 61.49 4 32602 VEV_1_3_RA4_01_1235.d 4.44E5 5 5 154 168
R.EGVSFRDNISLVPQDSVLFDGTIR.F Y 97.33 2663.3555 24 -12.5 888.7814 3 84.77 5 49038 VEV_2_3_RA5_01_1236.d 3.07E5 3 3 1152 1175
R.DNISLVPQDSVLFDGTIR.F Y 97.13 1988.0215 18 -9.6 995.0085 2 85.99 5 49728 VEV_2_3_RA5_01_1236.d 2.98E5 3 3 1158 1175
R.VKPGQFAALVGPSGAGK.S Y 96.08 1582.8831 17 -12.4 528.6284 3 66.33 5 36271 VEV_2_3_RA5_01_1236.d 6.98E5 6 6 1107 1123
R.LYSPSSGSVQIDGQDISK.R Y 94.33 1879.9163 18 -15.5 940.9509 2 69.42 5 38573 VEV_2_3_RA5_01_1236.d 1.01E5 2 2 1133 1150
K.AAALADAGIFIGR.L Y 92.56 1244.6876 13 -18.4 623.3397 2 78.29 6 43936 VEV_3_3_RA6_01_1237.d 5.2E4 1 1 530 542
K.FSYPARPDVPVLHGLNLR.V Y 87.80 2050.1111 18 -44.1 684.3475 3 78.01 5 44715 VEV_2_3_RA5_01_1236.d 0 1 1 1089 1106
R.SNFSLVQQEPSLLDR.S Y 82.92 1731.8792 15 -8.0 866.9399 2 78.71 5 45188 VEV_2_3_RA5_01_1236.d 1.77E5 3 3 454 468
K.FSSPIQPLGR.G Y 80.87 1100.5978 10 -13.4 551.2988 2 69.23 5 38434 VEV_2_3_RA5_01_1236.d 3.78E5 4 4 1048 1057
R.NLPEGYDTNC(+57.02)GPGGNK.L Y 76.71 1691.7209 16 3.2 846.8704 2 53.45 5 27273 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 1208 1223 Carbamidomethylation
R.LANIHDTIR.N Y 74.72 1051.5774 9 -12.6 526.7894 2 42.68 5 20727 VEV_2_3_RA5_01_1236.d 9.79E5 6 6 1199 1207
R.GLNDVEANADSKEK.L Y 72.81 1488.7056 14 -10.6 745.3522 2 34.30 5 15763 VEV_2_3_RA5_01_1236.d 4.71E5 5 5 1058 1071
R.FNVALGARPGHIPTDAEIEEAC(+57.02)R.L Y 67.24 2522.2336 23 -7.1 631.5612 4 72.98 5 41163 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 1176 1198 Carbamidomethylation
R.SESYKINALHQAFE Y 65.76 1635.7892 14 -12.2 546.2637 3 67.25 5 36964 VEV_2_3_RA5_01_1236.d 2.22E5 2 2 1312 1325
K.HTAIVGLSGSGK.S Y 63.59 1125.6143 12 -11.8 563.8077 2 37.03 5 17375 VEV_2_3_RA5_01_1236.d 1.71E5 2 2 408 419
K.LSDVAAAIRDGHDLTR.A Y 62.12 1708.8856 16 -18.5 428.2208 4 65.15 6 34234 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 496 511
R.IMNLLDLGSTKK.F Y 61.99 1331.7483 12 -2.8 444.9221 3 73.85 4 42240 VEV_1_3_RA4_01_1235.d 2.78E5 2 2 1036 1047
K.LYSLNHGGIGVYFDNVK.F Y 60.78 1894.9578 17 -14.8 632.6505 3 77.67 4 45218 VEV_1_3_RA4_01_1235.d 7.95E4 2 2 1072 1088
K.STIISLIER.L Y 59.76 1030.6023 9 -12.5 516.3020 2 77.34 5 44291 VEV_2_3_RA5_01_1236.d 3.56E5 3 3 1124 1132
R.GLTLPNSVGDIELK.N Y 59.42 1454.7980 14 -11.3 728.3981 2 79.95 5 46015 VEV_2_3_RA5_01_1236.d 2.02E5 3 3 368 381
K.NVSFSFPSRPENAVLK.G Y 58.97 1790.9315 16 -8.2 896.4657 2 74.32 5 42115 VEV_2_3_RA5_01_1236.d 5.24E5 4 4 382 397
R.NLPEGYDTNC(+57.02)GPGGNKLSGGQK.Q Y 56.63 2262.0334 22 -9.8 755.0110 3 57.85 6 28930 VEV_3_3_RA6_01_1237.d 3.81E5 4 4 1208 1229 Carbamidomethylation
R.LYSPSSGSVQIDGQ(+.98)DISKR.E Y 51.89 2037.0015 19 -6.5 680.0034 3 66.32 6 35118 VEV_3_3_RA6_01_1237.d 2.08E5 2 2 1133 1151 Deamidation (NQ)
K.LSDVAAAIR.D Y 51.51 914.5185 9 -18.0 458.2583 2 56.82 6 28248 VEV_3_3_RA6_01_1237.d 3.76E5 2 2 496 504
K.GVSISC(+57.02)PAGK.H Y 50.76 974.4855 10 -18.3 488.2411 2 36.73 6 16619 VEV_3_3_RA6_01_1237.d 5.5E5 7 7 398 407 Carbamidomethylation
K.DGAYAGLVR.L Y 49.46 920.4716 9 -12.5 461.2373 2 58.14 5 30204 VEV_2_3_RA5_01_1236.d 7.28E5 3 3 646 654
R.NLPEGYDTNC(+57.02)GPGGNKLSGGQKQR.L Y 46.38 2546.1931 24 -0.2 637.5554 4 51.79 5 26262 VEV_2_3_RA5_01_1236.d 9.03E4 2 2 1208 1231 Carbamidomethylation
K.LLILDEAT(-2.02)AALDSASQQR.V Y 41.58 1911.9901 18 -44.0 638.3093 3 87.37 6 49872 VEV_3_3_RA6_01_1237.d 6.36E3 1 1 578 595 2-amino-3-oxo-butanoic_acid
R.LYDPTDGEVLFDSHNIK.E Y 41.40 1961.9370 17 -4.6 654.9833 3 76.74 6 42810 VEV_3_3_RA6_01_1237.d 3.41E4 1 1 429 445
K.VTHSSPVVEGR.L Y 40.95 1166.6044 11 -14.7 389.8697 3 20.14 6 7626 VEV_3_3_RA6_01_1237.d 2.81E5 2 2 685 695
R.AFTALAR.I Y 36.01 748.4232 7 -19.0 375.2118 2 46.56 6 22306 VEV_3_3_RA6_01_1237.d 2.28E5 1 1 1029 1035
R.LDEKHS(+79.97)FEAPTPK.E Y 35.76 1577.7126 13 -9.0 526.9067 3 49.12 4 24328 VEV_1_3_RA4_01_1235.d 2.18E5 2 2 696 708 Phosphorylation (STY)
R.AAQIQGPE(+14.02)VVEIVELVQK.A Y 35.06 1963.0989 18 -30.8 655.3534 3 87.70 6 50059 VEV_3_3_RA6_01_1237.d 0 1 1 512 529 Methylation(others)
K.STIISLIER(+14.02).L Y 35.00 1044.6179 9 -7.4 523.3124 2 80.72 5 46525 VEV_2_3_RA5_01_1236.d 3.62E4 2 2 1124 1132 Methylation(KR)
R.GLTLPN(+.98)SVGDIELK.N Y 29.46 1455.7820 14 11.4 728.9066 2 79.97 6 45134 VEV_3_3_RA6_01_1237.d 7.59E3 1 1 368 381 Deamidation (NQ)
R.LTGDITTIQQ(+.98)GT(+79.97)SEK.V Y 28.66 1671.7604 15 2.7 836.8897 2 87.90 5 50791 VEV_2_3_RA5_01_1236.d 1.8E5 1 1 154 168 Deamidation (NQ); Phosphorylation (STY)
R.VQSAIESVMGGK.T Y 28.26 1204.6122 12 -16.6 603.3033 2 65.32 4 35530 VEV_1_3_RA4_01_1235.d 2.34E4 1 1 596 607
R.EGVSFR.D Y 27.38 693.3445 6 16.5 347.6853 2 32.76 4 14432 VEV_1_3_RA4_01_1235.d 2.99E5 2 2 1152 1157
R.IMNLLDLGST(-18.01)K.K Y 26.61 1185.6427 11 -14.4 396.2158 3 63.10 6 32704 VEV_3_3_RA6_01_1237.d 4.2E4 1 1 1036 1046 Dehydration
K.TLITIAHR.L N 25.57 923.5552 8 -14.9 308.8544 3 49.05 5 24581 VEV_2_3_RA5_01_1236.d 5.69E4 2 2 608 615
K.HSFEAPTPK(+42.01).E Y 24.37 1054.5083 9 -34.2 352.4980 3 14.42 5 4727 VEV_2_3_RA5_01_1236.d 3.44E5 1 1 700 708 Acetylation (K)
K.G(+43.01)VSISC(+57.02)PAGK.H Y 24.10 1017.4913 10 1.6 509.7538 2 45.58 4 22128 VEV_1_3_RA4_01_1235.d 8.87E4 1 1 398 407 Carbamylation; Carbamidomethylation
R.SESYK.I Y 23.91 612.2755 5 -0.1 613.2827 1 55.42 6 27393 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 1312 1316
K.DGYGTLVGSSGSLISGGQ(+.98)K(+42.01).Q Y 23.74 1824.8741 19 -16.6 609.2886 3 59.37 4 31016 VEV_1_3_RA4_01_1235.d 4.48E4 1 1 545 563 Deamidation (NQ); Acetylation (K)
K.LSGGQK.Q Y 21.71 588.3231 6 -21.5 589.3177 1 45.25 5 22277 VEV_2_3_RA5_01_1236.d 0 2 2 1224 1229
R.GLTLPNSVGDIELK(+14.02).N Y 21.38 1468.8137 14 -43.2 735.3824 2 81.07 6 45913 VEV_3_3_RA6_01_1237.d 0 1 1 368 381 Methylation(KR)
K.STVAGLITR.L Y 21.10 916.5342 9 -45.4 459.2535 2 60.26 5 31737 VEV_2_3_RA5_01_1236.d 0 1 1 420 428
R.SILSTLR.A Y 20.98 788.4756 7 -21.7 395.2365 2 64.77 6 33941 VEV_3_3_RA6_01_1237.d 1.87E5 2 2 720 726
K.IDGTVDDR.G Y 20.81 889.4141 8 -5.5 890.4165 1 71.45 4 40358 VEV_1_3_RA4_01_1235.d 2.53E3 2 2 360 367
K.A(+42.01)AALADAGIFIGR.L Y 20.05 1286.6982 13 -21.8 429.8973 3 59.88 6 30362 VEV_3_3_RA6_01_1237.d 7.97E4 2 2 530 542 Acetylation (N-term)
R.LTGDITTIQ(+.98)QGT(+79.97)SEK.V Y 19.90 1671.7604 15 12.8 836.8981 2 87.80 4 52378 VEV_1_3_RA4_01_1235.d 1.84E5 1 1 154 168 Deamidation (NQ); Phosphorylation (STY)
R.L(+43.01)AN(+.98)IHDTIR.N Y 19.78 1095.5673 9 30.0 366.2073 3 44.18 5 21629 VEV_2_3_RA5_01_1236.d 1.57E4 1 1 1199 1207 Carbamylation; Deamidation (NQ)
R.LAN(+.98)IHDTIR.N Y 19.64 1052.5614 9 -29.2 1053.5380 1 88.64 6 50601 VEV_3_3_RA6_01_1237.d 1.28E3 1 1 1199 1207 Deamidation (NQ)
R.LANIHDT(+79.96)IR.N Y 19.63 1131.5342 9 49.9 378.2042 3 42.58 4 20273 VEV_1_3_RA4_01_1235.d 0 1 1 1199 1207 Sulfation
R.L(+42.01)TGDITTIQ(+.98)QGTSEK(+42.01).V Y 19.56 1675.8152 15 -25.2 419.9505 4 12.98 5 3957 VEV_2_3_RA5_01_1236.d 0 1 1 154 168 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
K.MPDSIRSAGR.F Y 19.46 1088.5397 10 -21.6 545.2654 2 43.57 6 20613 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 772 781
K.GVS(+79.97)ISC(+57.02)PAGK(+14.02).H Y 19.19 1068.4675 10 6.0 357.1653 3 9.16 4 2188 VEV_1_3_RA4_01_1235.d 0 1 1 398 407 Phosphorylation (STY); Carbamidomethylation; Methylation(KR)
R.VQSAIESVMGGK(+42.02).T Y 18.92 1246.6339 12 -3.8 624.3218 2 72.91 4 41532 VEV_1_3_RA4_01_1235.d 0 1 1 596 607 Guanidination
K.DM(+15.99)NRESKIDGTVDDR(+28.03).G Y 18.92 1793.8214 15 -15.2 598.9387 3 77.08 4 44763 VEV_1_3_RA4_01_1235.d 7.22E4 1 1 353 367 Oxidation (M); Dimethylation(KR)
K.L(+42.01)SD(+43.99)VAAAIR.D Y 18.49 1000.5189 9 -23.8 501.2548 2 31.49 4 13715 VEV_1_3_RA4_01_1235.d 0 1 1 496 504 Acetylation (N-term); Carboxylation (DKW)
R.ESKIDGTVD(-18.01)DR.G Y 18.24 1215.5731 11 48.0 304.9151 4 12.09 5 3488 VEV_2_3_RA5_01_1236.d 3.99E5 1 1 357 367 Dehydration
K.L(+27.99)SDVAAAIR.D Y 18.15 942.5134 9 28.3 315.1873 3 34.70 5 15999 VEV_2_3_RA5_01_1236.d 0 1 1 496 504 Formylation
K.SLGITVEAVSLIK.T Y 18.14 1328.7915 13 -126.9 665.3187 2 82.28 5 47523 VEV_2_3_RA5_01_1236.d 5.48E4 1 1 921 933
R.VMTMTR.F Y 17.91 737.3564 6 5.6 738.3679 1 85.03 4 50607 VEV_1_3_RA4_01_1235.d 0 1 1 904 909
R.VK(+31.99)PGQFAALVGPSGAGK(+42.01).S Y 17.76 1656.8834 17 -25.3 415.2177 4 60.60 5 31993 VEV_2_3_RA5_01_1236.d 2.46E4 1 1 1107 1123 Dihydroxy; Acetylation (K)
K.L(+42.01)DKDMNR.E Y 17.73 932.4385 7 -19.7 467.2173 2 27.99 6 11771 VEV_3_3_RA6_01_1237.d 4.06E4 1 1 350 356 Acetylation (N-term)
K.R(+14.02)EGVSFR.D Y 17.64 863.4613 7 -40.8 864.4333 1 85.45 5 49422 VEV_2_3_RA5_01_1236.d 7.46E4 1 1 1151 1157 Methylation(KR)
K.G(+42.01)VSISC(+57.02)PAGK.H Y 17.44 1016.4960 10 -5.2 509.2526 2 45.20 5 22251 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 398 407 Acetylation (N-term); Carbamidomethylation
K.L(+27.99)SGGQK.Q Y 17.41 616.3180 6 -11.6 617.3181 1 49.24 5 24692 VEV_2_3_RA5_01_1236.d 0 1 1 1224 1229 Formylation
K.DGYGTLVGSSGSLIS(+79.97)GGQK(+14.02).Q Y 17.31 1875.8615 19 13.6 469.9790 4 24.47 4 9832 VEV_1_3_RA4_01_1235.d 2.06E5 1 1 545 563 Phosphorylation (STY); Methylation(KR)
K.VAGIK(+42.01).K Y 17.28 528.3271 5 -3.8 529.3324 1 24.56 5 10231 VEV_2_3_RA5_01_1236.d 2.61E5 1 1 265 269 Acetylation (K)
R.I(+43.01)S(+79.97)IAR.A N 17.09 681.3210 5 9.3 682.3347 1 71.64 4 40509 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 566 570 Carbamylation; Phosphorylation (STY)
K.INALHQAFE(-.98) Y 16.86 1040.5403 9 -16.7 521.2687 2 78.49 6 44069 VEV_3_3_RA6_01_1237.d 5.03E4 1 1 1317 1325 Amidation
K.GVSISC(+57.02)PAGK(+44.03).H Y 16.61 1018.5117 10 -8.5 510.2588 2 40.53 4 19013 VEV_1_3_RA4_01_1235.d 2.03E5 1 1 398 407 Carbamidomethylation; Ethanolation (KR)
K.D(+42.01)GAYAGLVR.L Y 16.59 962.4821 9 -3.8 482.2465 2 39.17 4 18203 VEV_1_3_RA4_01_1235.d 4.77E4 1 1 646 654 Acetylation (N-term)
K.SLGITVEAVSLIK(+188.03).T Y 16.54 1516.8245 13 -4.4 380.2117 4 26.59 4 10982 VEV_1_3_RA4_01_1235.d 0 1 1 921 933 Lipoyl
K.SLGITVE(+43.99)AVSLIK.T Y 16.49 1372.7812 13 38.4 344.2158 4 57.71 4 29796 VEV_1_3_RA4_01_1235.d 0 1 1 921 933 Carboxylation (E)
R.LYSPSSGSVQIDGQDISK(+188.03)R.E Y 16.45 2224.0503 19 12.2 742.3664 3 78.60 6 44144 VEV_3_3_RA6_01_1237.d 3.81E3 1 1 1133 1151 Lipoyl
K.LYSLNHGGIGVYFDNVK(+14.02).F Y 16.36 1908.9734 17 -46.4 478.2285 4 33.14 5 15083 VEV_2_3_RA5_01_1236.d 0 1 1 1072 1088 Methylation(KR)
R.V(+27.99)KPGQFAALVGPSGAGK(+42.01).S Y 16.23 1652.8885 17 1.0 414.2298 4 31.97 5 14403 VEV_2_3_RA5_01_1236.d 0 1 1 1107 1123 Formylation; Acetylation (K)
R.VM(+15.99)TMT(+79.97)R.F Y 16.22 833.3177 6 -34.4 834.2963 1 4.26 5 997 VEV_2_3_RA5_01_1236.d 0 1 1 904 909 Oxidation (M); Phosphorylation (STY)
K.FSYPARPDVPVLHGLN(+.98)LR.V Y 16.11 2051.0952 18 -21.6 411.2175 5 44.00 6 20817 VEV_3_3_RA6_01_1237.d 0 1 1 1089 1106 Deamidation (NQ)
R.LYSPSSGSVQ(+.98)IDGQDIS(+79.97)K.R Y 16.05 1960.8666 18 48.1 491.2475 4 48.70 4 24061 VEV_1_3_RA4_01_1235.d 0 1 1 1133 1150 Deamidation (NQ); Phosphorylation (STY)
R.GLNDVEANADSK(-.98)(+42.01).E Y 15.99 1272.5946 12 9.6 425.2096 3 18.21 6 6619 VEV_3_3_RA6_01_1237.d 8.7E4 1 1 1058 1069 Amidation; Acetylation (K)
R.LYSPSSGSVQIDGQ(+.98)DISK(+42.01).R Y 15.91 1922.9109 18 -12.3 481.7291 4 72.71 4 41357 VEV_1_3_RA4_01_1235.d 2.75E4 1 1 1133 1150 Deamidation (NQ); Acetylation (K)
R.G(+42.01)ITVIAIAHR(+31.99).L Y 15.79 1123.6349 10 -8.3 1124.6328 1 98.53 6 54826 VEV_3_3_RA6_01_1237.d 0 1 1 1272 1281 Acetylation (N-term); Dihydroxy
R.LYSPSSGSVQIDGQDISK(+87.07)REGVSFR.D Y 15.79 2798.4199 25 -14.0 933.8009 3 87.14 4 51970 VEV_1_3_RA4_01_1235.d 2.43E5 1 1 1133 1157 Hypusine
K.DGAY(+79.96)AGLVR.L Y 15.74 1000.4283 9 22.4 334.4909 3 28.27 6 11911 VEV_3_3_RA6_01_1237.d 0 1 1 646 654 Sulfation
K.HSFEAPTPK.E Y 15.62 1012.4977 9 -43.7 507.2340 2 11.30 5 3106 VEV_2_3_RA5_01_1236.d 4.41E3 1 1 700 708
R.VKPGQFAALVGPSGAGK(+14.02).S Y 15.48 1596.8987 17 -12.6 400.2269 4 53.76 4 27295 VEV_1_3_RA4_01_1235.d 0 1 1 1107 1123 Methylation(KR)
K.TVSALS(-18.01)LEHEILK.T Y 15.38 1420.7926 13 -10.6 356.2017 4 63.04 4 33793 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 934 946 Dehydration
R.LREQYFK.S Y 15.29 982.5236 7 -17.4 492.2605 2 36.34 5 16973 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 126 132
K.SLGITVEAVS(-20.03)LIK.T Y 15.28 1308.7653 13 -38.0 328.1862 4 28.77 5 12546 VEV_2_3_RA5_01_1236.d 0 1 1 921 933 Formation of five membered aromatic heterocycle
K.HS(+79.96)FEAPTPK.E Y 15.20 1092.4546 9 60.7 547.2677 2 50.70 4 25339 VEV_1_3_RA4_01_1235.d 2.83E5 1 1 700 708 Sulfation
K.HTAIVGLS(+79.97)GSGK.S Y 15.05 1205.5806 12 -14.7 603.7887 2 43.56 6 20547 VEV_3_3_RA6_01_1237.d 6.28E5 1 1 408 419 Phosphorylation (STY)
K.F(+42.01)AVLLGNAK(+42.01).V Y 15.04 1015.5702 9 -35.7 508.7742 2 43.60 5 21270 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 256 264 Acetylation (N-term); Acetylation (K)
K.ELNVRSIR.S Y 15.02 985.5668 8 -15.7 986.5587 1 101.06 5 56384 VEV_2_3_RA5_01_1236.d 7.72E3 1 1 446 453
total 104 peptides
C1GLA5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLSDYNIQKESTLHLVLR.L N 159.30 2129.1479 18 -16.7 533.2854 4 74.48 6 41183 VEV_3_3_RA6_01_1237.d 4.69E6 15 15 100 117
K.Q(-17.03)LEDGRTLSDYNIQKESTLHLVLR.L N 141.80 2810.4563 24 -16.4 703.6098 4 79.17 6 44565 VEV_3_3_RA6_01_1237.d 7.4E5 3 3 94 117 Pyro-glu from Q
K.TITLEVESSDTIDNVK.S N 137.72 1762.8837 16 -16.9 588.6252 3 74.04 6 40897 VEV_3_3_RA6_01_1237.d 3.46E6 24 24 57 72
K.TLTGKTITLEVESSDTIDNVK.S N 136.65 2263.1794 21 -15.1 755.3890 3 74.33 5 42129 VEV_2_3_RA5_01_1236.d 4.75E5 5 5 52 72
K.TITLEVESSDTIDNVKSK.I N 131.66 1978.0106 18 -16.7 660.3331 3 68.40 6 36710 VEV_3_3_RA6_01_1237.d 1.22E6 8 8 57 74
K.IQDKEGIPPDQQR.L N 112.68 1522.7739 13 -9.4 762.3871 2 33.45 5 15253 VEV_2_3_RA5_01_1236.d 1.73E7 87 87 75 87
K.TLTGKTITLEVESSDTIDNVKSK.I N 102.46 2478.3064 23 -3.9 827.1062 3 70.31 5 39218 VEV_2_3_RA5_01_1236.d 3.34E4 1 1 52 74
K.QLEDGRTLSDYNIQKESTLHLVLR.L N 101.60 2827.4827 24 -9.9 566.4982 5 75.29 5 42801 VEV_2_3_RA5_01_1236.d 3.72E5 2 2 94 117
K.SKIQDKEGIPPDQQR.L N 98.76 1737.9009 15 -7.0 869.9516 2 29.38 6 12531 VEV_3_3_RA6_01_1237.d 6.91E6 52 52 73 87
R.TLSDYNIQKESTLHLVLR(+14.02).L N 96.35 2143.1636 18 -12.0 536.7917 4 76.06 6 42318 VEV_3_3_RA6_01_1237.d 2.76E5 2 2 100 117 Methylation(KR)
R.LIFAGKQLEDGR.T N 96.30 1345.7354 12 -11.3 673.8674 2 63.79 5 34379 VEV_2_3_RA5_01_1236.d 6.99E5 4 4 88 99
K.ESTLHLVLR.L N 90.92 1066.6135 9 -8.7 534.3094 2 63.78 4 34342 VEV_1_3_RA4_01_1235.d 2.15E6 11 11 109 117
K.QLEDGRTLSDYNIQK.E N 82.96 1778.8799 15 -11.8 593.9603 3 62.37 4 33270 VEV_1_3_RA4_01_1235.d 2.33E5 2 2 94 108
K.Q(-17.03)LEDGRTLSDYNIQK.E N 80.22 1761.8533 15 -9.3 588.2863 3 71.63 6 39086 VEV_3_3_RA6_01_1237.d 3.29E5 4 4 94 108 Pyro-glu from Q
R.TLSDYNIQ(+.98)KESTLHLVLR.L N 79.14 2130.1321 18 -5.8 533.5372 4 76.10 5 43372 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 100 117 Deamidation (NQ)
R.TLSDYN(+.98)IQ(+.98)KESTLHLVLR.L N 77.87 2131.1160 18 2.0 533.7874 4 74.73 6 41348 VEV_3_3_RA6_01_1237.d 2.48E5 3 3 100 117 Deamidation (NQ)
K.C(+57.02)GHTNQLRPK.K Y 73.07 1209.6036 10 -10.4 404.2043 3 12.68 4 3636 VEV_1_3_RA4_01_1235.d 9.91E4 3 3 160 169 Carbamidomethylation
R.TLSDYNIQK.E N 70.15 1080.5452 9 -10.8 541.2740 2 49.71 4 24740 VEV_1_3_RA4_01_1235.d 2.84E6 12 12 100 108
K.EGIPPDQQR.L N 67.65 1038.5094 9 -15.7 520.2538 2 25.46 5 10742 VEV_2_3_RA5_01_1236.d 2.88E6 35 35 79 87
K.C(+58.01)GHTNQLRPK.K Y 65.26 1210.5876 10 -16.3 606.2913 2 14.35 5 4674 VEV_2_3_RA5_01_1236.d 6.59E4 2 2 160 169 Carboxymethyl
R.TLSDYNIQKE(+14.02)STLHLVLR.L N 63.33 2143.1636 18 -16.1 536.7896 4 76.90 6 42930 VEV_3_3_RA6_01_1237.d 1.81E5 1 1 100 117 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVKSK.I N 60.94 1992.0262 18 -8.7 665.0103 3 72.08 6 39422 VEV_3_3_RA6_01_1237.d 2.35E5 3 3 57 74 Methylation(others)
R.TLSD(+43.99)YNIQKESTLHLVLR.L N 60.62 2173.1379 18 -20.6 544.2806 4 74.60 4 42826 VEV_1_3_RA4_01_1235.d 3.45E4 1 1 100 117 Carboxylation (DKW)
R.TLSDYNIQK(+114.04)ESTLHLVLR.L N 60.29 2243.1909 18 -8.8 561.8000 4 75.33 4 43389 VEV_1_3_RA4_01_1235.d 4.52E5 4 4 100 117 Ubiquitin
K.C(+57.02)GHTN(-17.03)QLRPK.K Y 59.27 1192.5771 10 -11.9 597.2888 2 22.94 5 9335 VEV_2_3_RA5_01_1236.d 1.4E6 8 8 160 169 Carbamidomethylation; Ammonia-loss (N)
K.TITLEVESS(+14.02)DTIDNVK.S N 56.56 1776.8993 16 -9.1 889.4489 2 77.18 5 44192 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 57 72 Methylation(others)
K.IQDKEGIPPDQ(+.98)QR.L N 55.65 1523.7579 13 -2.8 508.9252 3 34.09 5 15624 VEV_2_3_RA5_01_1236.d 5.98E6 21 21 75 87 Deamidation (NQ)
R.LIFAGK(+114.04)QLEDGR.T N 54.12 1459.7783 12 -19.0 487.5908 3 64.99 6 34106 VEV_3_3_RA6_01_1237.d 7.64E5 4 4 88 99 Ubiquitin
R.ALASKYNC(+57.02)DK.M Y 54.04 1168.5547 10 -14.9 390.5197 3 17.31 5 6297 VEV_2_3_RA5_01_1236.d 1.31E5 2 2 129 138 Carbamidomethylation
R.LIFAGK(+383.23)QLEDGR.T N 52.12 1728.9634 12 -18.5 433.2401 4 64.27 6 33560 VEV_3_3_RA6_01_1237.d 9.35E5 4 4 88 99 Ubiquitination
K.IQDKEGIPPDQQ(+.98)R.L N 51.34 1523.7579 13 -11.3 508.9208 3 37.29 6 16932 VEV_3_3_RA6_01_1237.d 2.87E6 13 13 75 87 Deamidation (NQ)
K.IQ(+.98)DKEGIPPDQ(+.98)QR.L N 48.15 1524.7419 13 5.2 763.3822 2 34.57 6 15407 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 75 87 Deamidation (NQ)
K.IQ(+.98)DKEGIPPDQQR.L N 47.47 1523.7579 13 -5.1 508.9240 3 36.66 5 17161 VEV_2_3_RA5_01_1236.d 2.97E6 4 4 75 87 Deamidation (NQ)
K.IQDK(+14.02)EGIPPDQQR.L N 46.46 1536.7896 13 -9.9 513.2654 3 41.87 4 19819 VEV_1_3_RA4_01_1235.d 3.22E6 21 21 75 87 Methylation(KR)
K.IQD(+14.02)KEGIPPDQQR.L N 46.06 1536.7896 13 -14.7 513.2629 3 44.66 5 21930 VEV_2_3_RA5_01_1236.d 1.44E6 2 2 75 87 Methylation(others)
R.LIFAGK.Q N 45.36 647.4006 6 -23.3 648.3928 1 51.12 5 25833 VEV_2_3_RA5_01_1236.d 1.07E7 12 12 88 93
R.ALASKYNC(+57.02)DKMIC(+57.02)R.K Y 44.96 1728.8109 14 -12.9 577.2701 3 47.19 5 23454 VEV_2_3_RA5_01_1236.d 6.3E4 1 1 129 142 Carbamidomethylation
R.TLSDYN(+.98)IQKESTLHLVLR.L N 44.22 2130.1321 18 -0.5 533.5400 4 76.12 4 44001 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 100 117 Deamidation (NQ)
K.SKIQDKEGIPPDQ(+.98)QR.L N 43.56 1738.8849 15 -2.5 580.6341 3 30.82 5 13731 VEV_2_3_RA5_01_1236.d 5.87E5 4 4 73 87 Deamidation (NQ)
K.IQDKEGIPPDQQR(+14.02).L N 43.21 1536.7896 13 -15.8 513.2624 3 40.86 4 19197 VEV_1_3_RA4_01_1235.d 1.83E6 13 13 75 87 Methylation(KR)
K.TLTGKTITLEVES(+14.02)SDTIDNVK.S N 38.82 2277.1951 21 -23.1 760.0547 3 76.81 6 42859 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 52 72 Methylation(others)
K.TITLEVE(+14.02)SSDTIDNVK.S N 37.48 1776.8993 16 -4.0 593.3047 3 77.42 6 43315 VEV_3_3_RA6_01_1237.d 4.47E5 2 2 57 72 Methylation(others)
K.QLEDGRTLSDYNIQK(-1.03)ESTLHLVLR.L N 37.12 2826.4512 24 -40.3 566.2747 5 75.36 5 42849 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 94 117 Lysine oxidation to aminoadipic semialdehyde
K.TITLE(+14.02)VESSDTIDNVKSK.I N 36.89 1992.0262 18 -2.3 665.0145 3 70.44 6 38186 VEV_3_3_RA6_01_1237.d 0 1 1 57 74 Methylation(others)
K.SKIQ(+.98)DKEGIPPDQQR.L N 35.45 1738.8849 15 -2.4 870.4476 2 31.76 6 13855 VEV_3_3_RA6_01_1237.d 5.6E5 2 2 73 87 Deamidation (NQ)
K.C(+57.02)GHT(-18.01)N(+.98)QLRPK.K Y 35.11 1192.5771 10 -9.4 398.5292 3 23.21 4 9095 VEV_1_3_RA4_01_1235.d 6.27E5 1 1 160 169 Carbamidomethylation; Dehydration; Deamidation (NQ)
K.ESTLHLVLR(+14.02).L N 34.55 1080.6292 9 -16.3 361.2111 3 67.59 4 37312 VEV_1_3_RA4_01_1235.d 0 1 1 109 117 Methylation(KR)
K.TITLEVESSD(-18.01)TIDNVK(+14.02).S N 33.66 1758.8887 16 11.3 587.3101 3 74.25 6 40996 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 57 72 Dehydration; Methylation(KR)
K.E(-18.01)GIPPDQQR.L N 33.32 1020.4988 9 -6.9 511.2532 2 35.23 6 15790 VEV_3_3_RA6_01_1237.d 0 1 1 79 87 Pyro-glu from E
K.IQD(-18.01)K(+14.02)EGIPPDQQR.L N 32.44 1518.7791 13 5.7 507.2698 3 33.68 4 14973 VEV_1_3_RA4_01_1235.d 2.93E5 7 7 75 87 Dehydration; Methylation(KR)
R.TLSDY(-18.01)NIQK(+14.02)ESTLHLVLR.L N 31.34 2125.1531 18 -30.4 532.2794 4 76.08 6 42334 VEV_3_3_RA6_01_1237.d 5.28E4 1 1 100 117 Dehydration; Methylation(KR)
R.TLS(-18.01)DYNIQK(+14.02)ESTLHLVLR.L N 30.27 2125.1531 18 -36.0 532.2764 4 74.44 6 41139 VEV_3_3_RA6_01_1237.d 7.97E4 1 1 100 117 Dehydration; Methylation(KR)
K.KC(+57.02)GHTNQLRPK.K Y 29.41 1337.6986 11 -45.4 446.8866 3 11.77 5 3335 VEV_2_3_RA5_01_1236.d 0 1 1 159 169 Carbamidomethylation
K.IQDKE(+14.02)GIPPDQQR.L N 28.37 1536.7896 13 -14.0 513.2633 3 43.09 4 20592 VEV_1_3_RA4_01_1235.d 1.4E6 2 2 75 87 Methylation(others)
R.L(+108.00)IFAGKQLEDGR.T N 26.64 1453.7329 12 -20.6 485.5749 3 65.04 6 34170 VEV_3_3_RA6_01_1237.d 4.89E5 2 2 88 99 O-Ethylphosphorylation
R.LIFAGK(+14.02).Q N 26.06 661.4163 6 -20.9 331.7085 2 58.65 6 29475 VEV_3_3_RA6_01_1237.d 8.4E5 5 5 88 93 Methylation(KR)
K.TITLEVESSDTIDNVKSK(+14.02).I N 25.84 1992.0262 18 6.0 665.0200 3 70.39 5 39276 VEV_2_3_RA5_01_1236.d 0 1 1 57 74 Methylation(KR)
K.SKIQD(-18.01)K(+14.02)EGIPPDQQR.L N 24.63 1733.9060 15 8.1 434.4873 4 30.43 4 13088 VEV_1_3_RA4_01_1235.d 0 1 1 73 87 Dehydration; Methylation(KR)
R.TLSD(+37.03)YNIQKESTLHLVLR.L N 23.66 2166.1797 18 9.8 542.5575 4 74.51 5 42259 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 100 117 Propargylamine
K.TITLE(+14.02)VESSDTIDNVK.S N 22.92 1776.8993 16 -11.7 593.3001 3 76.06 6 42319 VEV_3_3_RA6_01_1237.d 1.76E5 1 1 57 72 Methylation(others)
K.TITLEVESSDTIDNVK(+14.02)SK.I N 21.55 1992.0262 18 -14.1 665.0067 3 71.01 6 38615 VEV_3_3_RA6_01_1237.d 9.51E4 1 1 57 74 Methylation(KR)
K.Q(-17.03)LEDGRTLSDYNIQ(+.98)K.E N 21.37 1762.8373 15 -13.7 882.4138 2 73.11 6 40171 VEV_3_3_RA6_01_1237.d 0 1 1 94 108 Pyro-glu from Q; Deamidation (NQ)
K.Q(-17.03)LEDGR.T N 21.10 699.3187 6 -17.4 700.3138 1 31.50 6 13696 VEV_3_3_RA6_01_1237.d 1.08E6 2 2 94 99 Pyro-glu from Q
K.SKIQDK(-1.03)EGIPPDQQR.L N 20.63 1736.8693 15 -34.0 435.2098 4 29.93 5 13221 VEV_2_3_RA5_01_1236.d 0 1 1 73 87 Lysine oxidation to aminoadipic semialdehyde
R.L(+41.03)IFAGK.Q N 19.93 688.4272 6 -34.3 345.2091 2 49.95 5 25113 VEV_2_3_RA5_01_1236.d 0 1 1 88 93 Amidination of lysines or N-terminal amines with methyl acetimidate
R.T(-18.01)LSDYNIQK(+14.02)ESTLHLVLR.L N 19.72 2125.1531 18 -24.8 532.2823 4 74.54 4 42776 VEV_1_3_RA4_01_1235.d 0 1 1 100 117 Dehydration; Methylation(KR)
R.GGIIEPSLR.A Y 19.43 940.5341 9 -3.4 471.2727 2 67.54 5 37179 VEV_2_3_RA5_01_1236.d 0 1 1 120 128
K.QLEDGR.T N 18.77 716.3453 6 43.4 717.3837 1 45.77 5 22589 VEV_2_3_RA5_01_1236.d 8.79E4 1 1 94 99
K.IQDK(+164.06)EGIPPDQQR.L N 18.75 1686.8341 13 -7.0 563.2814 3 32.26 5 14630 VEV_2_3_RA5_01_1236.d 0 1 1 75 87 O-Diisopropylphosphorylation
R.ALASK(+21.98).Y Y 18.72 510.2778 5 -13.1 511.2784 1 70.80 5 39579 VEV_2_3_RA5_01_1236.d 0 1 1 129 133 Sodium adduct
K.EGIPPDQQR(+14.02).L N 18.59 1052.5250 9 1.0 527.2703 2 34.20 6 15197 VEV_3_3_RA6_01_1237.d 0 2 2 79 87 Methylation(KR)
K.IQDKEGIPPDQQ(+.98)R(+14.02).L N 18.22 1537.7736 13 -68.3 769.8416 2 37.73 5 17783 VEV_2_3_RA5_01_1236.d 7.79E4 1 1 75 87 Deamidation (NQ); Methylation(KR)
R.GGIIEPSLRALAS(+79.97)K(+42.01).Y Y 18.16 1532.7963 14 -5.4 384.2043 4 53.57 4 27167 VEV_1_3_RA4_01_1235.d 2.3E4 1 1 120 133 Phosphorylation (STY); Acetylation (K)
R.LPPRATNC(+57.02)R.K Y 18.16 1083.5607 9 -16.3 362.1883 3 16.64 4 5644 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 148 156 Carbamidomethylation
K.IQDK(+210.20)EGIPPDQQR.L N 17.58 1732.9723 13 -63.9 434.2227 4 30.13 5 13335 VEV_2_3_RA5_01_1236.d 0 1 1 75 87 Myristoylation
R.GGIIEPSLRALASK(+226.08).Y Y 17.25 1636.8970 14 -33.9 819.4280 2 93.85 4 55744 VEV_1_3_RA4_01_1235.d 0 1 1 120 133 Biotinylation
K.T(+43.01)ITLEVESSDTIDNVK.S N 16.26 1805.8894 16 4.1 362.1866 5 44.85 6 21323 VEV_3_3_RA6_01_1237.d 0 1 1 57 72 Carbamylation
R.G(+42.01)GIIEPSLR.A Y 15.80 982.5447 9 -51.7 328.5052 3 25.28 6 10351 VEV_3_3_RA6_01_1237.d 4.81E4 1 1 120 128 Acetylation (N-term)
MPTTHALSESSK.L Y 15.45 1287.6129 12 59.6 430.2372 3 59.82 4 31350 VEV_1_3_RA4_01_1235.d 0 1 1 1 12
K.IQDK(+43.01)EGIPPDQQR.L N 15.42 1565.7798 13 27.0 314.1717 5 11.16 6 2993 VEV_3_3_RA6_01_1237.d 0 1 1 75 87 Carbamylation
total 80 peptides
C1G5V6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VVDALGNPIDGKGPIKTTEK.R Y 123.17 2051.1262 20 -14.1 513.7816 4 63.89 6 33287 VEV_3_3_RA6_01_1237.d 7.74E5 7 7 153 172
R.HALIIYDDLSKQAVAYR.Q Y 117.35 1975.0526 17 -7.0 494.7670 4 74.34 4 42614 VEV_1_3_RA4_01_1235.d 5.2E5 4 4 309 325
R.IRGVQEEAGLAETGR.V Y 116.83 1584.8219 15 -9.7 529.2761 3 55.71 6 27556 VEV_3_3_RA6_01_1237.d 4.33E5 8 8 62 76
R.VVDALGNPIDGKGPIK.T Y 113.84 1591.8933 16 -16.2 531.6298 3 67.22 6 35786 VEV_3_3_RA6_01_1237.d 5.18E5 2 2 153 168
K.AAPTEVSSILEQR.I Y 111.50 1399.7307 13 -8.8 700.8665 2 71.27 4 40217 VEV_1_3_RA4_01_1235.d 9.07E5 7 7 49 61
R.TGEIVDVPVGPELLGR.V Y 107.56 1649.8988 16 -8.6 825.9496 2 82.29 5 47547 VEV_2_3_RA5_01_1236.d 1E6 5 5 137 152
K.ILQWESDFLAHLK.S Y 105.43 1598.8456 13 -8.3 533.9514 3 84.01 4 49993 VEV_1_3_RA4_01_1235.d 5.66E5 4 4 507 519
K.GIRPAINVGLSVSR.V Y 101.65 1437.8416 14 -12.6 480.2817 3 68.66 4 38181 VEV_1_3_RA4_01_1235.d 2.57E5 3 3 406 419
K.DLEAQLKDVIVAFNK.S Y 96.62 1701.9301 15 -15.2 568.3087 3 87.62 6 50010 VEV_3_3_RA6_01_1237.d 4.4E4 1 1 538 552
R.EAYPGDVFYLHSR.L Y 96.22 1552.7310 13 -19.0 518.5744 3 71.22 6 38810 VEV_3_3_RA6_01_1237.d 1.13E6 5 5 338 350
R.RSVNQPVQTGLK.S Y 94.63 1325.7416 12 -8.7 442.9173 3 34.08 4 15227 VEV_1_3_RA4_01_1235.d 2.61E6 10 10 186 197
R.AQLKAPGILPR.R Y 91.50 1162.7186 11 -14.2 388.5746 3 62.34 4 33246 VEV_1_3_RA4_01_1235.d 1.13E6 6 6 175 185
R.GVQEEAGLAETGR.V Y 88.57 1315.6367 13 -9.3 658.8195 2 51.95 4 26133 VEV_1_3_RA4_01_1235.d 1.05E6 10 10 64 76
R.SVNQPVQTGLK.S Y 87.52 1169.6404 11 -14.0 585.8193 2 43.04 5 20983 VEV_2_3_RA5_01_1236.d 1.38E6 7 7 187 197
R.HALIIYDDLSK.Q Y 86.76 1286.6870 11 -11.5 644.3434 2 69.13 4 38541 VEV_1_3_RA4_01_1235.d 5.96E5 4 4 309 319
K.EGQLSKDLEAQLKDVIVAFNKSFSA Y 80.38 2736.4333 25 -10.4 685.1085 4 93.41 5 53533 VEV_2_3_RA5_01_1236.d 1.96E5 1 1 532 556
K.TAVALDAMLNQKR.W Y 79.63 1429.7711 13 -10.4 477.5927 3 67.21 4 37073 VEV_1_3_RA4_01_1235.d 7.61E5 4 4 222 234
K.SVDSMVPIGR.G Y 77.09 1059.5382 10 -12.1 530.7700 2 65.53 5 35686 VEV_2_3_RA5_01_1236.d 6.3E5 3 3 198 207
K.EGQLSKDLEAQLKDVIVAFNK.S Y 76.18 2344.2637 21 -11.8 587.0663 4 86.73 6 49511 VEV_3_3_RA6_01_1237.d 6.67E5 3 3 532 552
R.VVDALGNPIDGKGPIKTTEKR.R Y 74.94 2207.2273 21 -24.0 552.8008 4 61.01 4 32241 VEV_1_3_RA4_01_1235.d 1.96E5 2 2 153 173
K.SVDSM(+15.99)VPIGR.G Y 69.82 1075.5332 10 -9.7 538.7687 2 52.51 4 26487 VEV_1_3_RA4_01_1235.d 8.57E5 8 8 198 207 Oxidation (M)
R.VLSVGDGIAR.V Y 66.65 985.5556 10 -14.2 493.7781 2 60.71 6 30998 VEV_3_3_RA6_01_1237.d 1.88E6 6 6 77 86
K.SNEPEVLEK.I Y 64.34 1043.5134 9 -11.1 522.7582 2 37.80 4 17394 VEV_1_3_RA4_01_1235.d 3.48E5 4 4 520 528
R.GVQEEAGLAETGRVLSVGDGIAR.V Y 64.24 2283.1819 23 -21.4 762.0516 3 76.46 6 42599 VEV_3_3_RA6_01_1237.d 6.74E4 3 3 64 86
K.EGQLS(-18.01)K(+14.02)DLEAQLKDVIVAFNK.S Y 63.47 2340.2688 21 -10.5 586.0684 4 87.01 4 51888 VEV_1_3_RA4_01_1235.d 0 1 1 532 552 Dehydration; Methylation(KR)
R.TGEIVDVPVGPELLGRVVDALGNPIDGKGPIK.T Y 61.92 3223.7815 32 -2.7 806.9504 4 90.16 5 51962 VEV_2_3_RA5_01_1236.d 6.67E4 2 2 137 168
K.Q(-17.03)VAGSLKLFLAQYREVAAFAQFGSDLDASTK.Q Y 60.92 3313.6982 31 -8.5 1105.5640 3 94.93 4 56263 VEV_1_3_RA4_01_1235.d 8.6E4 1 1 431 461 Pyro-glu from Q
R.GVQE(+14.02)EAGLAETGR.V Y 56.15 1329.6525 13 -6.9 665.8289 2 57.47 5 29749 VEV_2_3_RA5_01_1236.d 1.01E5 3 3 64 76 Methylation(others)
R.GVQEEAGLAETGR(+14.02).V Y 56.13 1329.6525 13 -9.6 665.8271 2 59.78 5 31391 VEV_2_3_RA5_01_1236.d 1.58E5 3 3 64 76 Methylation(KR)
R.GVQ(+.98)EEAGLAETGR.V Y 56.10 1316.6207 13 -14.6 659.3080 2 56.58 6 28097 VEV_3_3_RA6_01_1237.d 1.03E5 4 4 64 76 Deamidation (NQ)
K.IEKEGQLSKDLEAQLKDVIVAFNK.S Y 54.39 2714.4854 24 0.2 543.9045 5 84.43 6 48101 VEV_3_3_RA6_01_1237.d 1.64E5 2 2 529 552
K.Q(-17.03)YQPMAVNEMVPLIYAGVNGHLDSIPVAK.I Y 52.81 3136.5725 29 -10.9 1046.5200 3 93.14 5 53412 VEV_2_3_RA5_01_1236.d 3.18E5 2 2 478 506 Pyro-glu from Q
K.TAVALDAM(+15.99)LNQKR.W Y 51.59 1445.7660 13 -12.8 482.9231 3 54.02 4 27451 VEV_1_3_RA4_01_1235.d 3.72E5 2 2 222 234 Oxidation (M)
R.VGSAAQLK.A Y 51.27 772.4443 8 -19.1 387.2220 2 18.49 6 6764 VEV_3_3_RA6_01_1237.d 2.7E5 2 2 420 427
R.ELIIGDRQTGK.T Y 51.19 1228.6775 11 -4.7 615.3431 2 42.54 4 20248 VEV_1_3_RA4_01_1235.d 1.6E6 11 11 211 221
R.EAYPGDVFYLHSR(+14.02).L Y 51.04 1566.7466 13 -8.0 523.2520 3 71.46 4 40370 VEV_1_3_RA4_01_1235.d 2.04E5 3 3 338 350 Methylation(KR)
R.IRGVQEEAGLAETGRVLSVGDGIAR.V Y 50.41 2552.3669 25 -37.1 639.0753 4 75.17 5 42712 VEV_2_3_RA5_01_1236.d 0 1 1 62 86
R.AQ(+.98)LKAPGILPR.R Y 49.66 1163.7026 11 -14.7 388.9025 3 63.82 6 33232 VEV_3_3_RA6_01_1237.d 4.79E4 1 1 175 185 Deamidation (NQ)
R.SVNQ(+.98)PVQTGLK.S Y 47.13 1170.6244 11 -29.8 586.3020 2 47.45 6 22882 VEV_3_3_RA6_01_1237.d 3.94E4 2 2 187 197 Deamidation (NQ)
R.STVAQLVK.T Y 46.05 844.5018 8 -11.7 423.2532 2 45.63 4 22157 VEV_1_3_RA4_01_1235.d 1.4E6 9 9 257 264
K.SNEPEVLEKIEK.E Y 45.13 1413.7351 12 -13.5 472.2459 3 62.40 4 33291 VEV_1_3_RA4_01_1235.d 3.11E5 2 2 520 531
R.R(-43.05)PPGREAYPGDVFYLHSR.L Y 44.69 2073.0068 18 -29.0 519.2440 4 71.38 6 38896 VEV_3_3_RA6_01_1237.d 2.32E5 1 1 333 350 Arginine oxidation to glutamic semialdehyde
R.VVDALGNPIDGK.G Y 42.79 1196.6400 12 -91.2 599.2727 2 64.92 5 35213 VEV_2_3_RA5_01_1236.d 3.61E4 4 4 153 164
R.E(+14.02)AYPGDVFYLHSR.L Y 42.37 1566.7466 13 -12.2 784.3710 2 73.26 6 40278 VEV_3_3_RA6_01_1237.d 4.69E5 5 5 338 350 Methylation(others)
K.APGILPR.R Y 41.66 722.4438 7 -26.0 362.2198 2 49.11 6 23776 VEV_3_3_RA6_01_1237.d 3.5E5 3 3 179 185
R.TGEIVDVPVGPELLGR(+14.02).V Y 40.47 1663.9144 16 -32.3 832.9376 2 82.96 6 47164 VEV_3_3_RA6_01_1237.d 9.07E4 2 2 137 152 Methylation(KR)
R.IRGVQEEAGLAETGRVLSVGDGIAR(-.98).V Y 39.41 2551.3831 25 -18.8 638.8411 4 75.00 6 41543 VEV_3_3_RA6_01_1237.d 0 1 1 62 86 Amidation
R.HALIIY(-2.02)DDLSKQAVAYR.Q Y 39.04 1973.0370 17 -33.9 494.2498 4 74.43 6 41127 VEV_3_3_RA6_01_1237.d 3.26E4 1 1 309 325 2-amino-3-oxo-butanoic_acid
R.RSVNQ(+.98)PVQTGLK.S Y 38.54 1326.7256 12 -34.8 443.2338 3 37.88 4 17437 VEV_1_3_RA4_01_1235.d 6.19E4 3 3 186 197 Deamidation (NQ)
R.T(+14.02)GEIVDVPVGPELLGR.V Y 36.21 1663.9144 16 -15.4 832.9517 2 83.56 6 47549 VEV_3_3_RA6_01_1237.d 1.08E5 1 1 137 152 Methylation(others)
R.IRGVQEE(+14.02)AGLAETGR.V Y 35.98 1598.8375 15 22.5 533.9651 3 62.97 4 33739 VEV_1_3_RA4_01_1235.d 0 1 1 62 76 Methylation(others)
R.ELIIGDRQTGK(+14.02).T Y 35.91 1242.6931 11 -13.6 622.3454 2 47.65 5 23727 VEV_2_3_RA5_01_1236.d 1.37E4 1 1 211 221 Methylation(KR)
R.LTELLK.Q Y 35.86 715.4480 6 -18.9 358.7245 2 52.38 5 26612 VEV_2_3_RA5_01_1236.d 1.15E6 11 11 470 475
R.RAQLKAPGILPR.R Y 35.81 1318.8197 12 -17.1 330.7066 4 56.55 5 29119 VEV_2_3_RA5_01_1236.d 7.37E4 2 2 174 185
R.ELIIGDR.Q Y 34.77 814.4548 7 -23.3 408.2252 2 54.30 6 26885 VEV_3_3_RA6_01_1237.d 5.22E5 7 7 211 217
K.AAPTEVSSILEQR(+14.02).I Y 33.16 1413.7463 13 -17.6 472.2477 3 73.94 6 40770 VEV_3_3_RA6_01_1237.d 1.84E5 2 2 49 61 Methylation(KR)
R.RSVNQPVQ(+.98)TGLK.S Y 32.32 1326.7256 12 -23.7 664.3544 2 36.18 5 16880 VEV_2_3_RA5_01_1236.d 0 1 1 186 197 Deamidation (NQ)
K.LFLAQYR.E Y 31.05 909.5072 7 -13.7 455.7547 2 68.34 4 37908 VEV_1_3_RA4_01_1235.d 2.73E5 2 2 438 444
R.LVKEGETVKR.T Y 29.88 1157.6768 10 -17.8 579.8353 2 15.50 6 5205 VEV_3_3_RA6_01_1237.d 3.31E4 2 2 127 136
K.TLEENDAMK.Y Y 29.36 1049.4700 9 -7.4 525.7384 2 29.77 4 12726 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 265 273
R.DNGRHALIIYDDLSK.Q Y 29.17 1728.8794 15 -21.8 577.2878 3 69.71 5 38779 VEV_2_3_RA5_01_1236.d 1.85E5 1 1 305 319
R.RSVN(+.98)QPVQTGLK.S Y 28.68 1326.7256 12 -20.4 664.3566 2 37.86 4 17427 VEV_1_3_RA4_01_1235.d 5.18E4 1 1 186 197 Deamidation (NQ)
K.GIRPAIN(+.98)VGLSVSR(+14.02).V Y 28.33 1452.8412 14 -44.5 485.2661 3 69.44 6 37442 VEV_3_3_RA6_01_1237.d 0 1 1 406 419 Deamidation (NQ); Methylation(KR)
K.QTLN(-17.03)RGER.L Y 27.98 955.4835 8 -8.5 478.7450 2 20.71 4 7772 VEV_1_3_RA4_01_1235.d 4.49E5 3 3 462 469 Ammonia-loss (N)
R.GVQEE(+14.02)AGLAETGR.V Y 27.18 1329.6525 13 -9.1 665.8275 2 61.44 5 32609 VEV_2_3_RA5_01_1236.d 6.15E4 1 1 64 76 Methylation(others)
K.LFLAQYREVAAFAQFGSDLDASTK.Q Y 26.78 2647.3281 24 -10.0 883.4412 3 87.24 5 50439 VEV_2_3_RA5_01_1236.d 0 1 1 438 461
R.SVNQPVQ(+.98)TGLK.S Y 26.45 1170.6244 11 -13.4 586.3116 2 45.50 6 21696 VEV_3_3_RA6_01_1237.d 3.89E5 3 3 187 197 Deamidation (NQ)
K.ILQWESDFLAHLKSNEPEVLEK.I Y 25.85 2624.3486 22 -52.5 875.7442 3 83.94 5 48526 VEV_2_3_RA5_01_1236.d 0 1 1 507 528
K.TAVALDAMLNQK(+42.01)R.W Y 25.65 1471.7817 13 -14.3 368.9474 4 33.41 4 14814 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 222 234 Acetylation (K)
R.VVDALGNPIDGK(+226.08).G Y 25.51 1422.7177 12 6.5 475.2496 3 76.16 6 42389 VEV_3_3_RA6_01_1237.d 2.33E5 1 1 153 164 Biotinylation
K.AAPTE(+14.02)VSSILEQR.I Y 25.07 1413.7463 13 -11.7 472.2505 3 74.17 5 42004 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 49 61 Methylation(others)
MFRNALRQSSR.S Y 24.59 1364.7095 11 5.6 683.3658 2 41.29 6 19239 VEV_3_3_RA6_01_1237.d 1.21E5 2 2 1 11
R.IRGVQ(+.98)EEAGLAETGR.V Y 24.51 1585.8059 15 -14.2 529.6017 3 55.90 6 27671 VEV_3_3_RA6_01_1237.d 1.95E5 1 1 62 76 Deamidation (NQ)
K.R(+42.01)STVAQLVK(+42.01).T Y 23.97 1084.6240 9 -5.3 543.3164 2 67.63 5 37247 VEV_2_3_RA5_01_1236.d 5.82E3 1 1 256 264 Acetylation (N-term); Acetylation (K)
R.WNDTGDETKK.L Y 23.70 1192.5360 10 -14.7 597.2665 2 15.16 6 5030 VEV_3_3_RA6_01_1237.d 1.42E4 1 1 235 244
R.IAGVR.G N 22.86 514.3227 5 -26.7 515.3162 1 13.74 5 4357 VEV_2_3_RA5_01_1236.d 5.8E4 1 1 22 26
R.IAGVRGAT(+79.97)PGPLAVASK(+42.01)QAR.T Y 22.78 2041.0833 20 -17.2 409.2169 5 72.13 4 40898 VEV_1_3_RA4_01_1235.d 9.47E4 1 1 22 41 Phosphorylation (STY); Acetylation (K)
R.VGSAAQ(+.98)LK(+27.99).A Y 22.32 801.4232 8 -23.8 802.4114 1 90.01 4 53663 VEV_1_3_RA4_01_1235.d 6.05E4 1 1 420 427 Deamidation (NQ); Formylation
R.EAY(+15.01)PGDVFYLHSR.L Y 22.18 1567.7419 13 -8.5 523.5835 3 73.36 6 40347 VEV_3_3_RA6_01_1237.d 5.64E4 1 1 338 350 Tyrosine oxidation to 2-aminotyrosine
R.E(+41.03)AYPGDVFYLHSR.L Y 22.12 1593.7576 13 9.6 532.2649 3 71.59 4 40472 VEV_1_3_RA4_01_1235.d 8.05E4 1 1 338 350 Amidination of lysines or N-terminal amines with methyl acetimidate
K.SN(+.98)EPEVLEK.I Y 21.34 1044.4974 9 8.0 523.2602 2 38.23 4 17657 VEV_1_3_RA4_01_1235.d 0 1 1 520 528 Deamidation (NQ)
R.SVTAVC(+57.02)ASGRIAGVR.G Y 20.78 1502.7987 15 -29.5 376.6959 4 42.77 5 20782 VEV_2_3_RA5_01_1236.d 2.43E5 1 1 12 26 Carbamidomethylation
K.LNDKHK.G Y 20.60 753.4133 6 -7.7 754.4148 1 95.16 4 56361 VEV_1_3_RA4_01_1235.d 1.97E4 2 2 358 363
R.STVAQLVK(+14.02).T Y 20.42 858.5175 8 -48.4 430.2452 2 58.08 5 30166 VEV_2_3_RA5_01_1236.d 0 1 1 257 264 Methylation(KR)
K.AAPTEVSSILEQ(+.98)R.I Y 19.99 1400.7147 13 56.5 351.2057 4 60.33 4 31733 VEV_1_3_RA4_01_1235.d 0 1 1 49 61 Deamidation (NQ)
R.T(+42.01)GEIVDVPVGPE(+21.98)LLGR.V Y 19.98 1713.8912 16 -19.6 572.2932 3 70.88 5 39639 VEV_2_3_RA5_01_1236.d 9.81E4 1 1 137 152 Acetylation (N-term); Sodium adduct
R.AAK(+43.99)LNDK.H Y 19.94 802.4185 7 -14.0 803.4145 1 87.64 4 52280 VEV_1_3_RA4_01_1235.d 7E5 4 4 355 361 Carboxylation (DKW)
R.VVDALGNPIDGK(+14.02).G Y 19.89 1210.6558 12 -52.6 606.3033 2 67.49 6 36007 VEV_3_3_RA6_01_1237.d 0 1 1 153 164 Methylation(KR)
R.ELIIGDR(+14.02)QTGK.T Y 19.61 1242.6931 11 -31.9 622.3340 2 48.06 4 23667 VEV_1_3_RA4_01_1235.d 1.28E4 1 1 211 221 Methylation(KR)
R.VVDALGN(+.98)PID(+43.99)GK.G Y 19.33 1241.6139 12 39.7 414.8950 3 41.02 5 19727 VEV_2_3_RA5_01_1236.d 5.32E4 1 1 153 164 Deamidation (NQ); Carboxylation (DKW)
R.SVTAVC(+57.02)ASGR.I Y 19.01 1006.4866 10 -2.7 504.2492 2 17.48 6 6235 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 12 21 Carbamidomethylation
K.TAVALDAMLN(+.98)QK(+31.99).R Y 18.97 1306.6438 12 -0.6 436.5550 3 35.54 5 16492 VEV_2_3_RA5_01_1236.d 5.73E4 1 1 222 233 Deamidation (NQ); Dihydroxy
R.V(+42.01)LS(+79.97)VGDGIAR(+14.02).V Y 18.87 1121.5482 10 2.5 374.8576 3 18.09 4 6408 VEV_1_3_RA4_01_1235.d 7.12E4 1 1 77 86 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.GATPGPLAVASK(+27.99).Q Y 18.83 1095.5924 12 0.2 366.2048 3 65.53 6 34522 VEV_3_3_RA6_01_1237.d 0 1 1 27 38 Formylation
K.TAVALDAMLNQK(+43.01).R Y 18.81 1316.6758 12 -12.8 330.1720 4 26.11 5 11103 VEV_2_3_RA5_01_1236.d 0 1 1 222 233 Carbamylation
R.SVNQ(+.98)PVQTGLK(+14.02).S Y 18.46 1184.6401 11 -42.4 593.3022 2 53.90 5 27528 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 187 197 Deamidation (NQ); Methylation(KR)
R.L(+43.01)TELLK.Q Y 18.22 758.4538 6 -18.3 380.2272 2 53.10 4 26861 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 470 475 Carbamylation
R.QTGKTAVALD(-18.01)AMLNQKR.W Y 18.08 1825.9833 17 21.6 366.2118 5 12.15 5 3524 VEV_2_3_RA5_01_1236.d 0 1 1 218 234 Dehydration
K.TAVALDAMLNQ(+.98)K(+14.02).R Y 18.03 1288.6697 12 -8.5 645.3366 2 60.60 4 31933 VEV_1_3_RA4_01_1235.d 6.11E4 1 1 222 233 Deamidation (NQ); Methylation(KR)
K.QVAGS(-18.01)LK.L Y 17.98 683.3966 7 -19.9 684.3903 1 51.49 5 26070 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 431 437 Dehydration
K.D(+27.99)VIVAFN(+.98)K.S Y 17.85 933.4807 8 -8.7 934.4799 1 90.99 6 51826 VEV_3_3_RA6_01_1237.d 0 1 1 545 552 Formylation; Deamidation (NQ)
R.AQLK(+42.01)APGILPR.R Y 17.67 1204.7291 11 17.5 302.1948 4 23.80 5 9786 VEV_2_3_RA5_01_1236.d 0 1 1 175 185 Acetylation (K)
K.RSTVAQLVK(+27.99).T Y 17.62 1028.5978 9 -28.7 515.2914 2 48.28 5 24097 VEV_2_3_RA5_01_1236.d 0 1 1 256 264 Formylation
K.TAVALDAMLN(+.98)QKR.W Y 17.50 1430.7551 13 -3.1 477.9242 3 67.53 6 36028 VEV_3_3_RA6_01_1237.d 8.85E4 1 1 222 234 Deamidation (NQ)
R.QTGK(+43.99)TAVALDAMLNQK.R Y 17.44 1731.8826 16 4.6 578.3041 3 76.82 4 44550 VEV_1_3_RA4_01_1235.d 4.47E4 1 1 218 233 Carboxylation (DKW)
R.GVQEEAGLAETGR(-.98).V Y 17.42 1314.6527 13 25.0 658.3500 2 51.81 5 26274 VEV_2_3_RA5_01_1236.d 0 1 1 64 76 Amidation
R.GQRELIIGDR.Q Y 17.28 1155.6360 10 -30.4 386.2076 3 45.89 6 21917 VEV_3_3_RA6_01_1237.d 0 1 1 208 217
R.VLSVGD(-18.01)GIAR(+14.02).V Y 17.24 981.5607 10 -5.3 328.1924 3 50.30 6 24459 VEV_3_3_RA6_01_1237.d 0 1 1 77 86 Dehydration; Methylation(KR)
K.Q(+164.06)ARTYAAEAK.A Y 16.84 1271.6274 10 -10.9 636.8141 2 64.32 4 34752 VEV_1_3_RA4_01_1235.d 7.1E5 1 1 39 48 O-Diisopropylphosphorylation
R.QTGK(+109.05)TAVALDAMLNQKR.W Y 16.80 1953.0465 17 -25.5 489.2565 4 66.96 6 35598 VEV_3_3_RA6_01_1237.d 0 1 1 218 234 Methylpyrroline
R.GERLT(+79.96)ELLK.Q Y 16.79 1137.5699 9 48.0 380.2155 3 52.71 4 26620 VEV_1_3_RA4_01_1235.d 1.04E5 2 2 467 475 Sulfation
R.SVN(+.98)QPVQTGLK.S Y 16.64 1170.6244 11 -56.7 586.2863 2 48.49 4 23924 VEV_1_3_RA4_01_1235.d 1.99E5 1 1 187 197 Deamidation (NQ)
K.SVDSM(-48.00)VPIGR.G Y 16.50 1011.5349 10 -19.3 338.1791 3 34.74 6 15503 VEV_3_3_RA6_01_1237.d 4.79E5 1 1 198 207 Dethiomethyl
R.R(+42.01)SVNQPVQTGLK(+27.99).S Y 16.44 1395.7469 12 0.8 349.9443 4 32.64 5 14784 VEV_2_3_RA5_01_1236.d 7.96E4 1 1 186 197 Acetylation (N-term); Formylation
K.TAVALDAMLNQ(+.98)KR.W Y 16.35 1430.7551 13 -45.8 716.3521 2 71.43 6 38969 VEV_3_3_RA6_01_1237.d 0 1 1 222 234 Deamidation (NQ)
K.D(+21.98)LEAQLK.D Y 16.29 837.4208 7 39.9 838.4614 1 107.00 4 60318 VEV_1_3_RA4_01_1235.d 0 1 1 538 544 Sodium adduct
K.LNDKHK(+21.98).G Y 16.20 775.3953 6 -44.4 776.3681 1 77.39 5 44294 VEV_2_3_RA5_01_1236.d 2.61E4 1 1 358 363 Sodium adduct
K.Q(+27.99)AVAYRQ(+.98)MSLLLR.R Y 16.18 1576.8395 13 -4.2 395.2155 4 41.35 4 19520 VEV_1_3_RA4_01_1235.d 0 1 1 320 332 Formylation; Deamidation (NQ)
K.TAVALDAMLN(+.98)QK(+42.01)R.W Y 16.14 1472.7657 13 -8.6 369.1956 4 25.72 5 10888 VEV_2_3_RA5_01_1236.d 0 1 1 222 234 Deamidation (NQ); Acetylation (K)
K.TAVALDAM(+15.99)LNQ(+.98)K.R Y 16.12 1290.6489 12 -22.8 646.3170 2 33.60 6 14846 VEV_3_3_RA6_01_1237.d 0 1 1 222 233 Oxidation (M); Deamidation (NQ)
R.E(+43.04)AYPGDVFYLHSR.L Y 16.10 1595.7732 13 23.6 532.9442 3 71.44 5 40052 VEV_2_3_RA5_01_1236.d 0 1 1 338 350 Carboxyl modification with ethanolamine
R.RSVNQPVQ(+.98)TGLK(+226.08).S Y 16.04 1552.8031 12 -32.7 389.1954 4 59.86 6 30393 VEV_3_3_RA6_01_1237.d 1.93E5 1 1 186 197 Deamidation (NQ); Biotinylation
K.Q(+.98)VAGSLK(+21.98).L Y 15.98 724.3731 7 -1.5 725.3793 1 83.09 4 49286 VEV_1_3_RA4_01_1235.d 2.44E4 1 1 431 437 Deamidation (NQ); Sodium adduct
K.Q(+42.01)AVAY(+31.99)R.Q Y 15.96 780.3766 6 -5.5 781.3796 1 62.68 4 33515 VEV_1_3_RA4_01_1235.d 2.86E4 1 1 320 325 Acetylation (N-term); Dihydroxy
R.VGSAAQLK(+21.98)(+42.01).A Y 15.94 836.4368 8 -21.6 419.2166 2 37.91 4 17462 VEV_1_3_RA4_01_1235.d 0 1 1 420 427 Sodium adduct; Acetylation (K)
K.L(+42.01)YC(+57.02)VYVAVGQK.R Y 15.91 1340.6798 11 -23.7 447.8900 3 51.87 5 26307 VEV_2_3_RA5_01_1236.d 2.47E4 1 1 245 255 Acetylation (N-term); Carbamidomethylation
R.IRGVQEE(+516.17)AGLAETGR.V Y 15.77 2100.9922 15 13.0 526.2621 4 55.73 5 28592 VEV_2_3_RA5_01_1236.d 0 1 1 62 76 Tetraglutamyl
R.ST(+79.97)VAQ(+.98)LVK(+42.01).T Y 15.51 967.4627 8 14.5 323.4995 3 10.60 4 2688 VEV_1_3_RA4_01_1235.d 0 1 1 257 264 Phosphorylation (STY); Deamidation (NQ); Acetylation (K)
K.EGQLSK(+43.01)DLEAQLK.D Y 15.35 1500.7783 13 -23.6 751.3787 2 87.92 4 52457 VEV_1_3_RA4_01_1235.d 2.87E4 1 1 532 544 Carbamylation
R.G(+27.99)ATPGPLAVASK(+42.01).Q Y 15.32 1137.6029 12 -18.5 380.2012 3 35.70 5 16592 VEV_2_3_RA5_01_1236.d 2.02E5 1 1 27 38 Formylation; Acetylation (K)
K.DVIVAFNKSFSA Y 15.18 1296.6714 12 2.8 433.2323 3 13.00 6 3919 VEV_3_3_RA6_01_1237.d 0 1 1 545 556
R.R(+282.05)AQLKAPGILPR.R Y 15.13 1600.8726 12 -30.2 401.2133 4 62.26 5 33231 VEV_2_3_RA5_01_1236.d 0 1 1 174 185 Bis(hydroxphenylglyoxal) arginine
R.VGS(+79.97)AAQ(+.98)LKAMK(+14.02).Q Y 15.10 1197.5829 11 -13.8 300.3989 4 18.24 6 6659 VEV_3_3_RA6_01_1237.d 3.22E5 1 1 420 430 Phosphorylation (STY); Deamidation (NQ); Methylation(KR)
R.R(+42.01)(+28.03)PPGR.E Y 15.06 651.3816 5 -28.0 326.6890 2 26.13 4 10757 VEV_1_3_RA4_01_1235.d 6.74E4 1 1 333 337 Acetylation (N-term); Dimethylation(KR)
R.VLS(+75.98)VGDGIAR.V Y 15.05 1061.5361 10 0.9 531.7758 2 48.60 4 23992 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 77 86 EDT
total 135 peptides
C1GAM9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TTGFALIYDSTEALKKFEPR.Y Y 132.36 2286.1895 20 -13.8 572.5468 4 84.33 6 48071 VEV_3_3_RA6_01_1237.d 3.77E6 14 14 161 180
R.THYGGGKTTGFALIYDSTEALKKFEPR.Y Y 128.35 2986.5188 27 -9.9 598.3051 5 80.05 5 46084 VEV_2_3_RA5_01_1236.d 6.37E5 3 3 154 180
K.SNKEQVSVFGLR.T Y 124.89 1362.7256 12 -19.3 455.2404 3 63.18 6 32804 VEV_3_3_RA6_01_1237.d 6.51E6 12 12 142 153
K.TTGFALIYDSTEALKK.F Y 120.17 1756.9247 16 -19.4 586.6375 3 78.83 6 44325 VEV_3_3_RA6_01_1237.d 1.4E6 4 4 161 176
R.KQIVVDILHPNR.A Y 118.33 1430.8357 12 -5.7 477.9498 3 63.26 4 33981 VEV_1_3_RA4_01_1235.d 4.3E6 13 13 113 124
K.TTGFALIYDSTEALK.K Y 116.59 1628.8297 15 -12.1 815.4123 2 82.97 6 47168 VEV_3_3_RA6_01_1237.d 2.13E6 9 9 161 175
K.LSELYKSNKEQVSVFGLR.T Y 111.64 2096.1265 18 -9.6 1049.0604 2 70.88 5 39640 VEV_2_3_RA5_01_1236.d 1.17E6 7 7 136 153
R.THYGGGKTTGFALIYDSTEALKK.F Y 111.16 2457.2539 23 -11.0 615.3140 4 72.68 5 40952 VEV_2_3_RA5_01_1236.d 1.2E6 5 5 154 176
R.KQIVVDILHPNRANISKDELR.G Y 105.89 2457.3816 21 -11.9 492.4777 5 66.80 5 36627 VEV_2_3_RA5_01_1236.d 1.04E6 7 7 113 133
R.THYGGGKTTGFALIYDSTEALK.K Y 105.34 2329.1589 22 13.4 583.3048 4 76.29 4 44186 VEV_1_3_RA4_01_1235.d 8.57E5 5 5 154 175
R.GKLSELYKSNKEQVSVFGLR.T Y 102.17 2281.2429 20 -11.8 571.3113 4 71.88 5 40370 VEV_2_3_RA5_01_1236.d 1.01E6 4 4 134 153
R.IGAAEKVEKASR.Q Y 100.02 1257.7041 12 -14.9 629.8500 2 20.51 5 8027 VEV_2_3_RA5_01_1236.d 1.5E6 9 9 186 197
K.QIVVDILHPNR.A Y 96.58 1302.7408 11 -10.4 435.2497 3 70.36 4 39524 VEV_1_3_RA4_01_1235.d 8.93E5 5 5 114 124
K.TTGFALIYDSTEALKKFEPR(+14.02).Y Y 90.74 2300.2051 20 -6.9 576.0546 4 86.59 4 51620 VEV_1_3_RA4_01_1235.d 1.12E6 6 6 161 180 Methylation(KR)
K.Q(-17.03)IVVDILHPNR.A Y 87.19 1285.7142 11 -8.4 643.8590 2 81.49 4 48176 VEV_1_3_RA4_01_1235.d 1.44E6 6 6 114 124 Pyro-glu from Q
K.FIRNPLLAR.K Y 84.29 1098.6661 9 -21.1 367.2216 3 65.48 6 34526 VEV_3_3_RA6_01_1237.d 5.55E6 10 10 104 112
R.GKLSELYK.S Y 83.35 936.5280 8 -10.8 469.2662 2 41.92 4 19889 VEV_1_3_RA4_01_1235.d 3.92E6 9 9 134 141
K.Q(-17.03)IVVDILHPNRANISKDELR.G Y 75.43 2312.2600 20 -15.9 579.0631 4 77.95 5 44711 VEV_2_3_RA5_01_1236.d 4.35E5 4 4 114 133 Pyro-glu from Q
K.TTGFALIYDSTEALKK(+14.02)FEPR.Y Y 72.79 2300.2051 20 -18.6 576.0479 4 86.35 5 49962 VEV_2_3_RA5_01_1236.d 3.56E5 3 3 161 180 Methylation(KR)
K.QIVVDILHPNRANISKDELR.G Y 71.88 2329.2866 20 -14.0 583.3208 4 71.21 5 39882 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 114 133
K.TTGFALIYDSTE(+14.02)ALKKFEPR.Y Y 69.74 2300.2051 20 -9.6 576.0530 4 84.55 4 50280 VEV_1_3_RA4_01_1235.d 2.42E5 3 3 161 180 Methylation(others)
K.SNKEQ(+.98)VSVFGLR.T Y 68.24 1363.7096 12 -10.9 682.8546 2 65.14 5 35378 VEV_2_3_RA5_01_1236.d 4.29E5 4 4 142 153 Deamidation (NQ)
R.ANISKDELR.G Y 67.58 1044.5564 9 -10.3 523.2801 2 25.92 4 10607 VEV_1_3_RA4_01_1235.d 5.72E6 18 18 125 133
K.SNK(+14.02)EQVSVFGLR.T Y 66.85 1376.7412 12 -14.3 459.9145 3 66.94 5 36731 VEV_2_3_RA5_01_1236.d 1E6 3 3 142 153 Methylation(KR)
K.TTGFALIYDSTEALKK(+14.02).F Y 66.49 1770.9403 16 -9.5 591.3151 3 79.84 4 46896 VEV_1_3_RA4_01_1235.d 2.93E5 1 1 161 176 Methylation(KR)
R.KFIRNPLLAR.K Y 65.01 1226.7611 10 -9.3 409.9239 3 62.19 4 33140 VEV_1_3_RA4_01_1235.d 3.2E6 11 11 103 112
K.FIRNPLLAR(+14.02).K Y 60.73 1112.6818 9 -8.8 371.8979 3 66.76 5 36628 VEV_2_3_RA5_01_1236.d 2.15E5 2 2 104 112 Methylation(KR)
R.KQIVVDILHPNR(+14.02).A Y 60.71 1444.8514 12 -15.0 362.2147 4 63.77 5 34364 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 113 124 Methylation(KR)
K.EQVSVFGLR.T Y 60.43 1033.5557 9 -16.2 517.7767 2 71.54 6 39021 VEV_3_3_RA6_01_1237.d 4.37E5 2 2 145 153
K.T(-2.02)TGFALIYDSTEALKKFEPR.Y Y 60.36 2284.1738 20 -19.1 762.3840 3 84.42 4 50202 VEV_1_3_RA4_01_1235.d 8.64E4 1 1 161 180 2-amino-3-oxo-butanoic_acid
K.TTGFALIYDSTEALK(+14.02)K.F Y 59.88 1770.9403 16 -23.4 591.3069 3 79.69 6 44963 VEV_3_3_RA6_01_1237.d 1.86E5 2 2 161 176 Methylation(KR)
R.ANISKDELRGK.L Y 59.74 1229.6727 11 -12.1 615.8362 2 21.22 4 8059 VEV_1_3_RA4_01_1235.d 1.67E6 10 10 125 135
R.IGAAEKVEK.A Y 58.82 943.5338 9 -20.2 472.7646 2 15.81 5 5505 VEV_2_3_RA5_01_1236.d 5.92E6 11 11 186 194
K.Q(-17.03)IVVDILHPNR(+14.02).A Y 58.24 1299.7299 11 -10.1 650.8657 2 80.91 5 46647 VEV_2_3_RA5_01_1236.d 4.53E4 1 1 114 124 Pyro-glu from Q; Methylation(KR)
R.THYGGGKTTGFALIYD(+6.01)STEALK.K Y 57.39 2335.1672 22 -3.6 584.7970 4 76.40 4 44223 VEV_1_3_RA4_01_1235.d 1E5 1 1 154 175 Replacement of proton by lithium
K.TTGFALIYDSTEALK(+14.02).K Y 57.21 1642.8453 15 -8.9 822.4226 2 84.91 4 50530 VEV_1_3_RA4_01_1235.d 6.37E5 7 7 161 175 Methylation(KR)
R.GK(+14.02)LS(-18.01)ELYKSNKEQVSVFGLR.T Y 56.97 2277.2480 20 -58.2 570.2861 4 71.96 5 40429 VEV_2_3_RA5_01_1236.d 3.89E4 1 1 134 153 Methylation(KR); Dehydration
R.NPLLAR.K Y 56.85 682.4126 6 -16.3 342.2080 2 35.73 5 16613 VEV_2_3_RA5_01_1236.d 2.16E6 9 9 107 112
R.KQ(+.98)IVVDILHPNRANISKDELR.G Y 56.36 2458.3655 21 -3.3 492.6787 5 67.12 6 35720 VEV_3_3_RA6_01_1237.d 2.42E4 1 1 113 133 Deamidation (NQ)
K.LSELYK(+14.02).S Y 56.19 765.4272 6 -11.7 766.4256 1 48.29 5 24104 VEV_2_3_RA5_01_1236.d 4.65E5 5 5 136 141 Methylation(KR)
K.SNKE(+14.02)QVSVFGLR.T Y 54.56 1376.7412 12 -8.2 459.9172 3 67.07 4 36900 VEV_1_3_RA4_01_1235.d 5.02E5 1 1 142 153 Methylation(others)
K.FIRNPLLARK.Q Y 54.45 1226.7611 10 -5.8 409.9253 3 58.13 5 30201 VEV_2_3_RA5_01_1236.d 9.19E5 6 6 104 113
R.KQ(+.98)IVVDILHPNR.A Y 51.10 1431.8197 12 -12.8 358.9576 4 65.23 4 35457 VEV_1_3_RA4_01_1235.d 0 2 2 113 124 Deamidation (NQ)
K.LSELYK.S Y 45.18 751.4116 6 -10.1 376.7093 2 38.12 4 17579 VEV_1_3_RA4_01_1235.d 3.09E6 11 11 136 141
R.IGAAEKVEK(+14.02).A Y 44.92 957.5494 9 -14.9 479.7748 2 22.64 5 9179 VEV_2_3_RA5_01_1236.d 4.8E5 4 4 186 194 Methylation(KR)
R.I(+41.03)GAAEKVEK.A Y 42.57 984.5604 9 -23.5 329.1863 3 15.83 5 5494 VEV_2_3_RA5_01_1236.d 0 2 2 186 194 Amidination of lysines or N-terminal amines with methyl acetimidate
R.KQ(+.98)IVVDILHPNR(+14.02).A Y 41.40 1445.8354 12 1.7 362.4667 4 63.80 4 34360 VEV_1_3_RA4_01_1235.d 6.8E4 1 1 113 124 Deamidation (NQ); Methylation(KR)
R.TRKFIRNPLLAR.K Y 40.94 1483.9099 12 -16.2 371.9787 4 60.09 5 31616 VEV_2_3_RA5_01_1236.d 1.8E5 1 1 101 112
K.SN(-17.03)KEQVSVFGLR.T Y 38.86 1345.6990 12 -10.6 673.8496 2 71.60 4 40480 VEV_1_3_RA4_01_1235.d 6.86E4 1 1 142 153 Ammonia-loss (N)
R.AN(+.98)ISKDELR.G Y 36.80 1045.5404 9 2.5 349.5216 3 25.60 5 10828 VEV_2_3_RA5_01_1236.d 7.71E5 4 4 125 133 Deamidation (NQ)
R.IGAAE(+14.02)KVEK.A Y 34.96 957.5494 9 -9.7 479.7773 2 23.75 4 9414 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 186 194 Methylation(others)
K.FIRNPLLAR(+14.02)K.Q Y 34.83 1240.7767 10 -15.0 311.1968 4 60.16 5 31667 VEV_2_3_RA5_01_1236.d 2.02E4 1 1 104 113 Methylation(KR)
K.Q(+.98)IVVDILHPNR.A Y 34.59 1303.7249 11 -2.6 435.5811 3 72.06 5 40507 VEV_2_3_RA5_01_1236.d 4.83E4 1 1 114 124 Deamidation (NQ)
R.THYGGGKTTGFALIYDSTEALK(+56.06).K Y 34.39 2385.2217 22 21.3 597.3254 4 79.99 5 46047 VEV_2_3_RA5_01_1236.d 0 1 1 154 175 Diethylation
K.SNK(+14.02)EQVSVFGLR(+14.02).T Y 33.83 1390.7568 12 -18.2 464.5845 3 70.86 4 39894 VEV_1_3_RA4_01_1235.d 2.22E5 3 3 142 153 Methylation(KR)
K.LSELY(+44.99)KSNKEQVSVFGLR.T Y 31.93 2141.1116 18 -28.5 536.2699 4 71.10 4 40077 VEV_1_3_RA4_01_1235.d 6.38E4 1 1 136 153 Oxidation to nitro
K.SN(+.98)KEQVSVFGLR.T Y 31.64 1363.7096 12 -4.5 455.5751 3 65.78 4 35894 VEV_1_3_RA4_01_1235.d 2.82E5 1 1 142 153 Deamidation (NQ)
R.ANISKDE(+14.02)LR.G Y 29.98 1058.5720 9 -19.4 353.8578 3 36.01 6 16236 VEV_3_3_RA6_01_1237.d 7.67E5 2 2 125 133 Methylation(others)
R.GTEKTTGPK.K Y 29.80 917.4818 9 -8.5 459.7443 2 47.60 4 23383 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 212 220
R.K(+27.99)(+42.01)QIVVDILHPNR.A Y 28.73 1500.8412 12 -8.0 376.2146 4 63.14 5 33887 VEV_2_3_RA5_01_1236.d 3.73E4 1 1 113 124 Formylation; Acetylation (K)
K.F(+43.01)IR(+14.02)NPLLAR.K Y 28.58 1155.6876 9 -11.3 386.2321 3 72.25 5 40648 VEV_2_3_RA5_01_1236.d 6.32E4 2 2 104 112 Carbamylation; Methylation(KR)
R.THYGGGKTTGFALIYDSTEALK(+14.02).K Y 28.09 2343.1746 22 -16.5 782.0526 3 77.46 5 44347 VEV_2_3_RA5_01_1236.d 0 1 1 154 175 Methylation(KR)
R.L(+43.01)VR(+14.02)IGAAEKVEK.A Y 27.67 1368.8088 12 -30.0 343.1992 4 16.17 4 5399 VEV_1_3_RA4_01_1235.d 0 1 1 183 194 Carbamylation; Methylation(KR)
R.ANISKDELR(+14.02).G Y 27.60 1058.5720 9 -10.0 353.8611 3 36.71 4 16761 VEV_1_3_RA4_01_1235.d 1.56E6 7 7 125 133 Methylation(KR)
R.GT(-18.01)EKTTGPK.K Y 27.60 899.4713 9 0.5 300.8312 3 16.75 4 5699 VEV_1_3_RA4_01_1235.d 3.2E4 1 1 212 220 Dehydration
R.YRLVR.I Y 27.41 705.4286 5 -17.0 353.7156 2 24.64 5 10271 VEV_2_3_RA5_01_1236.d 1.93E6 4 4 181 185
R.IGAAEK(+14.02)VEK.A Y 27.27 957.5494 9 -16.7 479.7740 2 22.78 6 9019 VEV_3_3_RA6_01_1237.d 3.74E5 3 3 186 194 Methylation(KR)
R.IGAAEKVEK(+164.06).A Y 26.92 1107.5940 9 -18.9 554.7938 2 15.16 6 5027 VEV_3_3_RA6_01_1237.d 6.89E4 2 2 186 194 O-Diisopropylphosphorylation
R.K(+42.01)(+43.99)QIVVDILHPNR.A Y 26.68 1516.8362 12 -80.8 380.1857 4 63.35 4 34018 VEV_1_3_RA4_01_1235.d 0 1 1 113 124 Acetylation (N-term); Carboxylation (DKW)
K.TTGFALIYD(+14.02)STEALKKFEPR.Y Y 26.66 2300.2051 20 13.5 576.0663 4 85.36 4 50835 VEV_1_3_RA4_01_1235.d 1.75E5 2 2 161 180 Methylation(others)
K.Q(+43.01)(+.98)IVVDILHPNR.A Y 26.16 1346.7306 11 -45.5 449.8971 3 70.42 4 39542 VEV_1_3_RA4_01_1235.d 4.51E4 1 1 114 124 Carbamylation; Deamidation (NQ)
R.GK(+14.02)LSELYKSNKEQVSVFGLR.T Y 25.46 2295.2585 20 -9.4 574.8165 4 71.62 5 40184 VEV_2_3_RA5_01_1236.d 0 1 1 134 153 Methylation(KR)
R.AN(+.98)IS(+79.96)KDELR.G Y 25.08 1125.4972 9 87.8 376.2060 3 25.49 4 10392 VEV_1_3_RA4_01_1235.d 0 1 1 125 133 Deamidation (NQ); Sulfation
R.ANISK(+14.02)DELR.G Y 24.54 1058.5720 9 -10.5 530.2877 2 34.65 6 15454 VEV_3_3_RA6_01_1237.d 6.16E5 3 3 125 133 Methylation(KR)
K.LSELYK(+43.01).S Y 24.51 794.4174 6 -31.5 398.2035 2 38.13 4 17592 VEV_1_3_RA4_01_1235.d 3.61E5 1 1 136 141 Carbamylation
R.KQIVVD(+14.02)ILHPNR.A Y 24.47 1444.8514 12 -8.6 362.2170 4 63.09 4 33826 VEV_1_3_RA4_01_1235.d 7.57E4 1 1 113 124 Methylation(others)
R.K(+78.05)QIVVDILHPNR.A Y 23.91 1508.8827 12 -71.0 378.2012 4 63.27 6 32842 VEV_3_3_RA6_01_1237.d 0 2 2 113 124 2,5-dimethypyrrole
K.TTGPK.K Y 23.73 502.2751 5 -23.6 503.2705 1 40.05 6 18515 VEV_3_3_RA6_01_1237.d 0 2 2 216 220
K.FRGTEKTTGPK.K Y 23.33 1220.6512 11 -38.4 407.8754 3 40.42 5 19369 VEV_2_3_RA5_01_1236.d 1.34E4 2 2 210 220
R.GKLSE(+14.02)LYK.S Y 23.28 950.5436 8 -12.7 476.2731 2 47.17 4 23107 VEV_1_3_RA4_01_1235.d 9.65E4 1 1 134 141 Methylation(others)
K.LSE(+14.02)LYK.S Y 22.24 765.4272 6 -14.5 383.7153 2 51.63 4 25918 VEV_1_3_RA4_01_1235.d 8.17E5 4 4 136 141 Methylation(others)
K.Q(+.98)IVVDILHPNR(+14.02).A Y 21.88 1317.7405 11 -11.1 440.2492 3 70.22 6 38021 VEV_3_3_RA6_01_1237.d 1.68E4 1 1 114 124 Deamidation (NQ); Methylation(KR)
K.VEKASR(+21.98).Q Y 21.01 710.3687 6 -14.5 711.3657 1 82.84 4 49114 VEV_1_3_RA4_01_1235.d 0 1 1 192 197 Sodium adduct
MVKNGSK(+14.02).K Y 20.89 776.4214 7 -38.5 389.2031 2 48.55 5 24286 VEV_2_3_RA5_01_1236.d 0 1 1 1 7 Methylation(KR)
K.KFEPR.Y Y 20.56 675.3704 5 -20.9 338.6854 2 12.15 6 3467 VEV_3_3_RA6_01_1237.d 3.44E5 3 3 176 180
K.SNK(+43.99)EQ(+.98)VSVFGLR.T Y 20.17 1407.6993 12 10.7 470.2454 3 63.59 4 34197 VEV_1_3_RA4_01_1235.d 0 1 1 142 153 Carboxylation (DKW); Deamidation (NQ)
R.EPTSK.H Y 20.01 560.2806 5 -18.2 561.2776 1 23.94 5 9865 VEV_2_3_RA5_01_1236.d 8.49E3 1 1 40 44
R.TTATTDKPSSQPSSS(+162.05)R.F Y 19.58 1811.8384 16 -19.0 906.9092 2 71.61 6 39078 VEV_3_3_RA6_01_1237.d 1.62E6 1 1 57 72 Hexose (NSY)
R.GKLSELYK(+14.02).S Y 19.24 950.5436 8 -13.4 476.2727 2 51.35 5 26003 VEV_2_3_RA5_01_1236.d 1.53E5 1 1 134 141 Methylation(KR)
K.LSELYKSNKEQVSVFGLR(+14.02).T Y 19.14 2110.1421 18 -5.7 528.5398 4 73.41 5 41464 VEV_2_3_RA5_01_1236.d 1.81E5 1 1 136 153 Methylation(KR)
K.E(+21.98)QVSVFGLR.T Y 18.91 1055.5376 9 12.9 528.7829 2 72.75 6 39934 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 145 153 Sodium adduct
K.SNK(+41.03)EQVSVFGLR.T Y 18.67 1403.7521 12 0.0 468.9247 3 63.64 5 34267 VEV_2_3_RA5_01_1236.d 2.24E4 1 1 142 153 Amidination of lysines or N-terminal amines with methyl acetimidate
K.TT(+14.02)GPK.K Y 18.57 516.2908 5 -64.7 517.2646 1 62.87 6 32542 VEV_3_3_RA6_01_1237.d 4.88E4 1 1 216 220 Methylation(others)
K.Q(-17.03)IVVDILHPNRANIS(+79.97)KDELRGK.L Y 17.94 2577.3428 22 -45.4 645.3137 4 81.30 6 46068 VEV_3_3_RA6_01_1237.d 0 1 1 114 135 Pyro-glu from Q; Phosphorylation (STY)
R.KFIRNPLLAR(+14.02).K Y 17.92 1240.7767 10 -15.8 311.1966 4 63.79 4 34350 VEV_1_3_RA4_01_1235.d 4.59E4 2 2 103 112 Methylation(KR)
K.TTGFALIYDSTE(+129.04)ALK.K Y 17.91 1757.8723 15 23.1 586.9783 3 78.88 5 45305 VEV_2_3_RA5_01_1236.d 1.2E5 1 1 161 175 Monoglutamyl
R.G(+43.01)TEKTTGPK.K Y 17.66 960.4876 9 -16.9 321.1644 3 13.99 4 4290 VEV_1_3_RA4_01_1235.d 6.73E4 1 1 212 220 Carbamylation
R.I(+42.01)GAAEK.V Y 17.64 629.3384 6 55.9 630.3809 1 35.20 5 16290 VEV_2_3_RA5_01_1236.d 4.75E4 1 1 186 191 Acetylation (N-term)
K.T(+42.01)TGP(+31.99)K.K Y 17.24 576.2755 5 4.5 577.2854 1 60.67 5 32042 VEV_2_3_RA5_01_1236.d 0 1 1 216 220 Acetylation (N-term); Dihydroxy
R.K(+42.01)(+14.02)Q(+.98)IVVDILHPNR.A Y 17.11 1487.8459 12 -51.8 496.9302 3 63.98 5 34514 VEV_2_3_RA5_01_1236.d 0 1 1 113 124 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
K.LSELY(-18.01)KSNK.E Y 16.75 1062.5709 9 -32.1 1063.5441 1 90.99 5 52393 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 136 144 Dehydration
K.FR(+.98)GTEKTTGPK.K Y 15.69 1221.6353 11 2.2 408.2199 3 41.29 5 19901 VEV_2_3_RA5_01_1236.d 3.79E4 1 1 210 220 Deamidation (R)
R.THYGGGKT(+114.04)TGFALIYDSTEALK.K Y 15.57 2443.2019 22 4.0 815.4111 3 83.40 6 47446 VEV_3_3_RA6_01_1237.d 0 1 1 154 175 Ubiquitin
R.THYGGGK(+27.99).T Y 15.57 746.3347 7 -8.9 747.3353 1 52.05 5 26418 VEV_2_3_RA5_01_1236.d 5.6E4 1 1 154 160 Formylation
R.N(+42.01)AVVGPSR(+21.98).E Y 15.20 862.4273 8 4.1 863.4381 1 97.33 4 57255 VEV_1_3_RA4_01_1235.d 0 1 1 32 39 Acetylation (N-term); Sodium adduct
R.I(+134.05)GAAEKVEK.A Y 15.13 1077.5818 9 -12.7 360.1967 3 32.44 6 14221 VEV_3_3_RA6_01_1237.d 6.06E4 1 1 186 194 3-methyl-2-pyridyl isocyanate
total 106 peptides
C1GLV8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KAPIHAEAPEFVEQSTTAEVLVTGIKVVDLLAPYAR.G Y 142.05 3862.0879 36 -8.6 773.4182 5 91.69 4 54604 VEV_1_3_RA4_01_1235.d 1.62E5 2 2 147 182
R.GATVTDTGAPIMIPVGPGTLGR.I Y 139.43 2080.0986 22 -7.9 1041.0483 2 81.82 4 48428 VEV_1_3_RA4_01_1235.d 6.61E5 4 4 106 127
K.GSITSVQAVYVPADDLTDPAPATTFAHLDATTVLSR.G Y 118.79 3699.8630 36 -8.8 1234.2841 3 86.22 6 49206 VEV_3_3_RA6_01_1237.d 3.04E5 3 3 335 370
K.AHGGYSVFTGVGER.T Y 110.44 1435.6843 14 -13.1 718.8400 2 61.66 4 32727 VEV_1_3_RA4_01_1235.d 1.1E6 7 7 210 223
K.SLQDIIAILGMDELSEADKLTVER.A Y 109.22 2658.3784 24 -8.9 887.1255 3 95.46 5 54413 VEV_2_3_RA5_01_1236.d 3.36E5 4 4 416 439
R.FTQAGSEVSALLGR.I Y 108.29 1434.7467 14 -9.0 718.3741 2 76.83 4 44606 VEV_1_3_RA4_01_1235.d 3.18E5 3 3 294 307
K.KAPIHAEAPEFVEQSTTAEVLVTGIK.V Y 106.65 2764.4646 26 -11.7 692.1154 4 78.16 4 45652 VEV_1_3_RA4_01_1235.d 1.32E5 3 3 147 172
R.GISELGIYPAVDPLDSK.S Y 103.73 1772.9196 17 -12.0 887.4564 2 82.84 6 47084 VEV_3_3_RA6_01_1237.d 5.15E5 3 3 371 387
R.IVGEEHYEVATR.V Y 103.12 1401.6888 12 -12.7 701.8428 2 48.27 6 23296 VEV_3_3_RA6_01_1237.d 1.92E6 7 7 395 406
K.TVFIQELINNIAK.A Y 102.39 1501.8503 13 1.4 751.9335 2 88.93 4 53092 VEV_1_3_RA4_01_1235.d 4.93E5 5 5 197 209
R.FLSQPFTVAQVFTGIEGKLVDLKDTIR.S Y 92.78 3021.6538 27 -10.0 756.4132 4 92.85 5 53279 VEV_2_3_RA5_01_1236.d 1.73E5 2 2 446 472
K.VVDLLAPYAR.G Y 85.44 1115.6338 10 -17.7 558.8143 2 76.09 6 42338 VEV_3_3_RA6_01_1237.d 5.02E5 3 3 173 182
R.GATVTDTGAPIM(+15.99)IPVGPGTLGR.I Y 85.40 2096.0935 22 -6.8 1049.0469 2 79.86 4 46913 VEV_1_3_RA4_01_1235.d 7.75E4 2 2 106 127 Oxidation (M)
K.LVLEVAQHLGENVVR.T Y 80.37 1674.9417 15 -12.2 559.3143 3 77.50 4 45091 VEV_1_3_RA4_01_1235.d 6.64E4 2 2 79 93
K.APIHAEAPEFVEQSTTAEVLVTGIKVVDLLAPYAR.G Y 76.80 3733.9929 35 -42.4 934.4659 4 94.46 5 54000 VEV_2_3_RA5_01_1236.d 0 2 2 148 182
R.TREGNDLYHEMQETR.V Y 74.74 1877.8326 15 -14.1 626.9427 3 54.54 5 27922 VEV_2_3_RA5_01_1236.d 5.41E4 1 1 224 238
R.FLSQPFTVAQVFTGIEGK.L Y 68.53 1968.0356 18 11.7 657.0269 3 88.28 6 50393 VEV_3_3_RA6_01_1237.d 1.26E5 2 2 446 463
R.TIAMDGTEGLVR.G Y 65.60 1261.6337 12 -9.5 631.8181 2 67.95 4 37595 VEV_1_3_RA4_01_1235.d 6.16E5 3 3 94 105
K.IGLFGGAGVGK.T Y 64.59 974.5549 11 -13.0 488.2784 2 70.28 5 39194 VEV_2_3_RA5_01_1236.d 7.28E5 8 8 186 196
K.AHGGYSVFTGVGER(+14.02).T Y 62.33 1449.7001 14 -5.4 484.2380 3 64.82 6 33984 VEV_3_3_RA6_01_1237.d 1.54E5 2 2 210 223 Methylation(KR)
K.VALVFGQMNEPPGAR.A Y 59.62 1584.8082 15 -11.5 793.4023 2 76.17 4 44041 VEV_1_3_RA4_01_1235.d 2.1E5 3 3 248 262
R.VQQMLQEYKSLQDIIAILGMDELSEADKLTVER.A Y 59.30 3805.9480 33 -3.7 952.4907 4 95.56 4 56543 VEV_1_3_RA4_01_1235.d 1.11E5 2 2 407 439
R.TIAM(+15.99)DGTEGLVR.G Y 54.90 1277.6285 12 -13.6 639.8129 2 59.92 6 30394 VEV_3_3_RA6_01_1237.d 2.48E5 3 3 94 105 Oxidation (M)
R.IMNVTGDPIDER.G Y 50.49 1358.6500 12 2.0 680.3337 2 66.72 6 35434 VEV_3_3_RA6_01_1237.d 3.35E5 2 2 128 139
R.EGNDLYHEMQETR.V Y 50.28 1620.6838 13 35.0 541.2542 3 60.54 4 31883 VEV_1_3_RA4_01_1235.d 0 2 2 226 238
K.LVDLKDTIR.S Y 50.18 1071.6288 9 -20.8 358.2094 3 61.72 6 31692 VEV_3_3_RA6_01_1237.d 5.94E5 4 4 464 472
K.ILAELEKS Y 49.86 901.5120 8 -13.1 451.7574 2 57.30 4 29510 VEV_1_3_RA4_01_1235.d 7.93E5 4 4 506 513
R.IMNVTGDPIDERGPIKHSK.K Y 48.15 2106.0891 19 -10.6 422.2206 5 59.49 4 31105 VEV_1_3_RA4_01_1235.d 3.22E5 2 2 128 146
R.GISELGIYPAVDPLDSK(+14.02).S Y 47.67 1786.9352 17 -14.5 894.4619 2 83.11 6 47266 VEV_3_3_RA6_01_1237.d 1.09E5 2 2 371 387 Methylation(KR)
R.FLSQPFTVAQVFTGIEGK(+14.02).L Y 45.91 1982.0513 18 -42.0 991.9913 2 90.44 6 51537 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 446 463 Methylation(KR)
K.S(-2.02)LQDIIAILGMDELSEADKLTVER.A Y 45.28 2656.3628 24 -17.2 886.4464 3 95.68 4 56603 VEV_1_3_RA4_01_1235.d 4.78E3 1 1 416 439 2-amino-3-oxo-butanoic_acid
R.FTQAGSE(+14.02)VSALLGR.I Y 43.38 1448.7623 14 -20.7 725.3735 2 79.94 6 45117 VEV_3_3_RA6_01_1237.d 3.22E4 1 1 294 307 Methylation(others)
R.GISE(+14.02)LGIYPAVDPLDSK.S Y 42.23 1786.9352 17 -12.6 894.4636 2 84.46 6 48119 VEV_3_3_RA6_01_1237.d 9.12E4 1 1 371 387 Methylation(others)
R.GGKIGLFGGAGVGK.T Y 35.40 1216.6927 14 -2.1 406.5707 3 62.60 5 33502 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 183 196
R.SLASRYASTSS(+79.97)GQVGK(-.98).I Y 28.61 1676.7883 16 -6.1 420.2018 4 22.75 5 9213 VEV_2_3_RA5_01_1236.d 4.29E4 1 1 30 45 Phosphorylation (STY); Amidation
R.TIAMDGTEGLVR(+14.02).G Y 28.22 1275.6493 12 -7.5 638.8271 2 71.03 6 38630 VEV_3_3_RA6_01_1237.d 4.45E4 1 1 94 105 Methylation(KR)
K.KAPIHAEAPEFVEQ(+.98)STTAEVLVTGIK.V Y 27.49 2765.4487 26 -25.4 692.3519 4 78.13 5 44802 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 147 172 Deamidation (NQ)
K.TVFIQELINNIAK(+14.02).A Y 26.95 1515.8661 13 -11.9 758.9313 2 90.17 6 51398 VEV_3_3_RA6_01_1237.d 2.1E4 1 1 197 209 Methylation(KR)
R.GGKIGLFGGAGVGKT(+291.10)VFIQELINNIAK.A Y 26.91 2991.6279 27 -15.6 748.9026 4 88.85 6 50708 VEV_3_3_RA6_01_1237.d 5.15E4 2 2 183 209 N-acetyl neuraminic acid
R.GGK(+43.99)IGLFGGAGVGK.T Y 25.03 1260.6826 14 -6.3 421.2322 3 74.82 6 41411 VEV_3_3_RA6_01_1237.d 2.75E4 1 1 183 196 Carboxylation (DKW)
K.IGLFGGAGVGK(+43.01).T Y 24.94 1017.5607 11 30.9 340.2047 3 63.66 5 34286 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 186 196 Carbamylation
K.T(+175.04)VFIQELINNIAKAHGGYSVFTGVGER.T Y 23.45 3094.5664 27 2.0 774.6504 4 92.17 5 52968 VEV_2_3_RA5_01_1236.d 7.96E4 1 1 197 223 Naphthalene-2,3-dicarboxaldehyde
K.AHGGYS(+79.97)VFTGVGER.T Y 22.40 1515.6508 14 56.6 506.2528 3 62.01 6 31910 VEV_3_3_RA6_01_1237.d 0 1 1 210 223 Phosphorylation (STY)
R.VIQLDGESK(+14.02).V Y 22.31 1001.5393 9 -17.5 501.7682 2 53.85 6 26560 VEV_3_3_RA6_01_1237.d 8.66E4 1 1 239 247 Methylation(KR)
K.AHGGYSVFTGVGER(-.98).T Y 22.01 1434.7003 14 42.1 479.2609 3 61.43 6 31468 VEV_3_3_RA6_01_1237.d 0 1 1 210 223 Amidation
K.I(+42.01)GLFGGAGVGK.T Y 21.82 1016.5654 11 -7.4 339.8599 3 45.17 5 22234 VEV_2_3_RA5_01_1236.d 2.86E4 1 1 186 196 Acetylation (N-term)
R.IPSAVGYQPT(-2.02)LAVDMGGMQER.I Y 21.57 2217.0559 21 -1.4 740.0249 3 80.05 4 47056 VEV_1_3_RA4_01_1235.d 6.25E4 1 1 308 328 2-amino-3-oxo-butanoic_acid
K.SGVAR(+14.02).T Y 21.28 502.2863 5 9.6 503.2984 1 72.33 5 40702 VEV_2_3_RA5_01_1236.d 5.35E5 1 1 4 8 Methylation(KR)
R.VQ(+.98)QM(+15.99)LQEYK.S Y 20.65 1182.5591 9 5.2 592.2899 2 35.78 4 16206 VEV_1_3_RA4_01_1235.d 0 1 1 407 415 Deamidation (NQ); Oxidation (M)
R.IVGEEHYE(+14.02)VATR.V Y 20.61 1415.7045 12 -17.9 472.9003 3 53.49 5 27292 VEV_2_3_RA5_01_1236.d 1.1E5 2 2 395 406 Methylation(others)
R.MLDPR.I Y 20.13 630.3159 5 -3.9 631.3207 1 33.44 5 15246 VEV_2_3_RA5_01_1236.d 2.19E4 1 1 390 394
K.S(-17.03)GVAR.T Y 19.66 471.2441 5 -17.6 472.2431 1 20.39 4 7597 VEV_1_3_RA4_01_1235.d 5.65E4 2 2 4 8 Ammonia-loss (Protein N-term)
R.VIQ(+.98)LDGES(+79.97)K.V Y 19.50 1068.4740 9 11.5 535.2504 2 55.85 6 27644 VEV_3_3_RA6_01_1237.d 0 1 1 239 247 Deamidation (NQ); Phosphorylation (STY)
K.L(+226.08)VLEVAQHLGENVVR.T Y 19.06 1901.0193 15 -7.4 476.2586 4 68.90 4 38356 VEV_1_3_RA4_01_1235.d 0 1 1 79 93 Biotinylation
K.LQRFLSQPFTVAQVFT(-18.01)GIEGK(+14.02).L Y 18.41 2361.2844 21 -6.7 473.2610 5 78.61 5 45124 VEV_2_3_RA5_01_1236.d 0 1 1 443 463 Dehydration; Methylation(KR)
R.MLDPR(+28.03).I Y 18.38 658.3472 5 -15.0 659.3446 1 83.48 6 47499 VEV_3_3_RA6_01_1237.d 1.44E5 2 2 390 394 Dimethylation(KR)
K.I(+42.01)GLFGGAGVGK(+43.99).T Y 18.35 1060.5553 11 1.7 531.2858 2 23.53 6 9420 VEV_3_3_RA6_01_1237.d 2.39E4 1 1 186 196 Acetylation (N-term); Carboxylation (DKW)
R.YASTSSGQVGK(-.98)(+14.02).I Y 18.05 1096.5513 11 -14.7 549.2748 2 33.91 5 15516 VEV_2_3_RA5_01_1236.d 1.58E5 1 1 35 45 Amidation; Methylation(KR)
R.I(+42.01)TTTTK.G Y 17.38 705.3909 6 -48.6 706.3639 1 110.26 6 58163 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 329 334 Acetylation (N-term)
K.L(+226.08)TVER.A Y 16.83 842.4320 5 -33.6 843.4110 1 103.09 6 56243 VEV_3_3_RA6_01_1237.d 9.96E4 1 1 435 439 Biotinylation
R.YASTSSGQVGK.I Y 16.63 1083.5197 11 55.1 362.2004 3 49.52 6 24030 VEV_3_3_RA6_01_1237.d 0 1 1 35 45
R.GIS(+79.97)ELGIYPAVDPLDSK.S Y 16.25 1852.8859 17 20.5 464.2383 4 71.50 4 40402 VEV_1_3_RA4_01_1235.d 0 1 1 371 387 Phosphorylation (STY)
R.VALT(+79.96)GLTIAEYFR.D Y 16.23 1532.7544 13 50.0 384.2150 4 66.80 4 36681 VEV_1_3_RA4_01_1235.d 0 1 1 265 277 Sulfation
R.YASTSS(+14.02)GQVGK.I Y 16.19 1097.5353 11 24.3 366.8613 3 48.64 5 24317 VEV_2_3_RA5_01_1236.d 9.55E4 1 1 35 45 Methylation(others)
R.GISE(+6.01)LGIYPAVDPLDSK.S Y 16.12 1778.9277 17 -40.3 890.4353 2 82.87 5 47872 VEV_2_3_RA5_01_1236.d 3.42E4 1 1 371 387 Replacement of proton by lithium
R.IVGE(+14.02)EHYEVATR.V Y 15.85 1415.7045 12 -10.2 472.9039 3 57.26 4 29489 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 395 406 Methylation(others)
R.VIQ(+.98)LDGESK(+21.98).V Y 15.85 1010.4896 9 2.6 506.2534 2 53.06 5 27024 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 239 247 Deamidation (NQ); Sodium adduct
R.SLAS(-18.01)R.Y Y 15.79 514.2863 5 -52.6 515.2665 1 35.26 6 15800 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 30 34 Dehydration
R.VIQ(+.98)LDGES(-18.01)K.V Y 15.47 970.4971 9 -5.4 486.2532 2 36.37 5 17019 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 239 247 Deamidation (NQ); Dehydration
R.IMN(+.98)VT(+79.97)GDPIDER.G Y 15.25 1439.6003 12 2.6 480.8753 3 43.93 6 20773 VEV_3_3_RA6_01_1237.d 2E5 1 1 128 139 Deamidation (NQ); Phosphorylation (STY)
R.SLAS(+79.97)R.Y Y 15.05 612.2632 5 9.2 613.2761 1 57.60 5 29841 VEV_2_3_RA5_01_1236.d 0 1 1 30 34 Phosphorylation (STY)
total 71 peptides
A0A0A0HWY2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YVYAHFPINVNIETNKDTGVSEVEIR.N Y 163.68 3006.5085 26 -4.4 752.6311 4 79.84 4 46895 VEV_1_3_RA4_01_1235.d 7.27E5 4 4 91 116
R.RVVC(+57.02)QPDVEITVSPNVKDEIQLTGNSLEGVSQSAADIQQIC(+57.02)R.V Y 149.74 4652.3174 42 -11.5 931.4601 5 83.54 6 47536 VEV_3_3_RA6_01_1237.d 7.28E5 3 3 126 167 Carbamidomethylation
K.DLSHLAVSFSLPK.K Y 114.60 1412.7664 13 -18.2 471.9208 3 80.98 6 45866 VEV_3_3_RA6_01_1237.d 1.85E6 7 7 36 48
K.DEIQLTGNSLEGVSQSAADIQQIC(+57.02)R.V Y 112.61 2731.3083 25 -6.5 911.4375 3 82.45 4 48856 VEV_1_3_RA4_01_1235.d 2.78E4 1 1 143 167 Carbamidomethylation
K.FLDGIYVSERGNIIEE Y 106.23 1852.9207 16 -8.6 927.4596 2 81.49 5 47043 VEV_2_3_RA5_01_1236.d 2.87E5 4 4 176 191
K.KNVLAIEIHHGSR.K Y 105.54 1472.8212 13 -9.0 491.9433 3 42.38 4 20144 VEV_1_3_RA4_01_1235.d 2.04E6 9 9 49 61
R.VVC(+57.02)QPDVEITVSPNVKDEIQLTGNSLEGVSQSAADIQQIC(+57.02)R.V Y 104.83 4496.2163 41 -4.1 1499.7399 3 85.60 4 50978 VEV_1_3_RA4_01_1235.d 2E5 2 2 127 167 Carbamidomethylation
R.RVVC(+57.02)QPDVEITVSPNVKDEIQLTGNSLEGVSQ(+.98)SAADIQQIC(+57.02)R.V Y 99.70 4653.3013 42 -3.1 1164.3290 4 84.42 4 50204 VEV_1_3_RA4_01_1235.d 8.64E4 1 1 126 167 Carbamidomethylation; Deamidation (NQ)
K.DLSHLAVSFSLPKK.N Y 91.30 1540.8613 14 -14.4 386.2171 4 75.98 4 43917 VEV_1_3_RA4_01_1235.d 2.76E5 3 3 36 49
K.DTGVSEVEIR.N Y 88.23 1103.5459 10 -14.5 552.7722 2 58.65 6 29508 VEV_3_3_RA6_01_1237.d 1.01E6 6 6 107 116
R.KFLDGIYVSERGNIIEE Y 86.02 1981.0156 17 -13.0 991.5023 2 78.22 5 44866 VEV_2_3_RA5_01_1236.d 3.11E5 4 4 175 191
K.LVKDLSHLAVSFSLPK.K Y 85.79 1753.0138 16 -12.5 439.2552 4 78.80 4 46122 VEV_1_3_RA4_01_1235.d 2.18E5 3 3 33 48
R.VVC(+57.02)QPDVEITVSPNVK(-1.03)DEIQLTGNSLEGVSQSAADIQQIC(+57.02)R.V Y 81.17 4495.1846 41 3.6 1499.4075 3 85.47 6 48753 VEV_3_3_RA6_01_1237.d 3.59E4 1 1 127 167 Carbamidomethylation; Lysine oxidation to aminoadipic semialdehyde
R.YVYAHFPINVNIETNK.D Y 80.46 1920.9734 16 -8.8 481.2464 4 77.18 4 44840 VEV_1_3_RA4_01_1235.d 6.21E4 1 1 91 106
R.TLINNLIIGVTR.G Y 80.10 1325.8031 12 -18.6 663.8965 2 83.38 4 49478 VEV_1_3_RA4_01_1235.d 1.49E6 4 4 72 83
K.DLSHLAVSFSLPK(+14.02).K Y 76.84 1426.7820 13 -13.1 476.5950 3 82.68 4 49003 VEV_1_3_RA4_01_1235.d 1.79E5 3 3 36 48 Methylation(KR)
K.FLDGIYVSER.G Y 76.24 1197.6029 10 -10.4 599.8025 2 74.57 6 41247 VEV_3_3_RA6_01_1237.d 8.82E5 6 6 176 185
R.KFLDGIYVSER.G Y 70.54 1325.6979 11 -9.3 442.9025 3 69.19 4 38600 VEV_1_3_RA4_01_1235.d 3.84E5 2 2 175 185
R.GNIIEE Y 66.67 673.3282 6 -11.0 674.3281 1 46.44 6 22229 VEV_3_3_RA6_01_1237.d 4.85E5 2 2 186 191
R.YVYAHFPINVNIETNK(-1.03)DTGVSEVEIR.N Y 63.19 3005.4771 26 -6.5 1002.8265 3 79.79 5 45912 VEV_2_3_RA5_01_1236.d 3.21E4 2 2 91 116 Lysine oxidation to aminoadipic semialdehyde
R.RVVC(+57.02)QPDVEITVSPNVKDEIQLT(-2.02)GNSLEGVSQSAADIQQIC(+57.02)R.V Y 59.92 4650.3018 42 1.1 1163.5840 4 84.39 5 48800 VEV_2_3_RA5_01_1236.d 0 1 1 126 167 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.TLINN(+.98)LIIGVTR.G Y 57.03 1326.7871 12 -4.0 664.3982 2 86.33 4 51453 VEV_1_3_RA4_01_1235.d 5.28E4 1 1 72 83 Deamidation (NQ)
K.NVLAIEIHHGSR.K Y 54.57 1344.7262 12 -15.8 337.1835 4 52.08 4 26214 VEV_1_3_RA4_01_1235.d 2.8E5 6 6 50 61
R.TLIN(+.98)NLIIGVTR.G Y 47.67 1326.7871 12 -40.6 664.3739 2 86.09 6 49123 VEV_3_3_RA6_01_1237.d 0 1 1 72 83 Deamidation (NQ)
R.VVC(+57.02)QPDVEITVSPNVK.D Y 46.45 1782.9186 16 -49.8 892.4222 2 71.25 6 38806 VEV_3_3_RA6_01_1237.d 1.06E5 3 3 127 142 Carbamidomethylation
R.YVYAHFPINVNIETNKDTGVSEVEIR(+14.02).N Y 44.35 3020.5242 26 -43.7 756.1053 4 80.24 6 45322 VEV_3_3_RA6_01_1237.d 0 1 1 91 116 Methylation(KR)
K.DTGVSE(+14.02)VEIR.N Y 40.61 1117.5615 10 -5.8 559.7848 2 64.49 6 33730 VEV_3_3_RA6_01_1237.d 1.76E4 1 1 107 116 Methylation(others)
K.FLDGIYVSER(+14.02)GNIIEE Y 39.54 1866.9363 16 -8.8 934.4672 2 83.55 5 48314 VEV_2_3_RA5_01_1236.d 2.61E4 1 1 176 191 Methylation(KR)
R.NFLGEKR.V Y 38.88 862.4661 7 -20.7 432.2314 2 25.65 4 10476 VEV_1_3_RA4_01_1235.d 1.73E5 2 2 117 123
R.GNIIE(+14.02)E Y 36.63 687.3439 6 -21.1 688.3367 1 56.18 6 27841 VEV_3_3_RA6_01_1237.d 3.57E4 1 1 186 191 Methylation(others)
R.KGIASLRTVRTLINNLIIGVTR.G Y 34.79 2407.4751 22 -9.8 482.4976 5 90.57 5 52176 VEV_2_3_RA5_01_1236.d 1.31E5 2 2 62 83
K.LVKDLSHLAVSFSLPKK.N Y 29.16 1881.1086 17 -22.3 377.2206 5 74.82 4 42986 VEV_1_3_RA4_01_1235.d 4.1E4 1 1 33 49
R.NFLGEK.R Y 28.50 706.3650 6 -11.5 707.3641 1 36.42 4 16596 VEV_1_3_RA4_01_1235.d 6.66E5 2 2 117 122
R.KFLDGIYVSER(+14.02).G Y 27.98 1339.7135 11 -23.8 447.5678 3 73.19 6 40233 VEV_3_3_RA6_01_1237.d 2.69E4 2 2 175 185 Methylation(KR)
K.DTGVSEVEIR(+14.02).N Y 26.17 1117.5615 10 -7.8 559.7837 2 62.91 4 33688 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 107 116 Methylation(KR)
R.KGIASLR.T Y 26.06 743.4653 7 -37.6 372.7260 2 23.28 6 9326 VEV_3_3_RA6_01_1237.d 3.7E5 3 3 62 68
R.RVVC(+57.02)QPDVEITVSPNVK(+387.13).D Y 25.90 2326.1475 17 -5.9 1164.0741 2 83.53 6 47529 VEV_3_3_RA6_01_1237.d 5.72E3 1 1 126 142 Carbamidomethylation; Triglutamyl
R.KFLDGIYVSERGN(+.98)IIEE Y 23.45 1981.9996 17 -5.2 661.6704 3 78.38 4 45776 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 175 191 Deamidation (NQ)
R.RVVC(+57.02)QPDVEITVSPN(+.98)VK.D Y 22.01 1940.0037 17 -41.9 647.6481 3 67.31 6 35862 VEV_3_3_RA6_01_1237.d 0 1 1 126 142 Carbamidomethylation; Deamidation (NQ)
K.GIASLR.T Y 21.21 615.3704 6 -20.9 308.6860 2 32.45 6 14247 VEV_3_3_RA6_01_1237.d 5.22E5 3 3 63 68
K.D(+42.01)LSHLAVSFSLPK(+14.02).K Y 20.84 1468.7925 13 -4.0 368.2039 4 58.07 6 29076 VEV_3_3_RA6_01_1237.d 0 1 1 36 48 Acetylation (N-term); Methylation(KR)
R.KFLDGIYVSER(+31.99).G Y 19.31 1357.6877 11 -7.2 340.4268 4 27.94 4 11713 VEV_1_3_RA4_01_1235.d 9.83E4 1 1 175 185 Dihydroxy
K.KNVLAIEIHHGSRK.G Y 18.91 1600.9161 14 -26.1 401.2259 4 36.69 6 16595 VEV_3_3_RA6_01_1237.d 0 1 1 49 62
K.DTGVSEVEIR(+28.03).N Y 18.86 1131.5771 10 -15.8 566.7869 2 67.39 6 35931 VEV_3_3_RA6_01_1237.d 5.6E4 1 1 107 116 Dimethylation(KR)
K.D(+226.08)LSHLAVSFSLPK.K Y 17.10 1638.8439 13 -5.1 547.2858 3 69.45 5 38598 VEV_2_3_RA5_01_1236.d 2.95E4 1 1 36 48 Biotinylation
R.GNIIEE(-.98) Y 16.52 672.3442 6 -42.8 673.3228 1 48.00 4 23652 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 186 191 Amidation
R.NFLGEKR(+14.02).V Y 16.19 876.4817 7 -7.1 439.2450 2 68.20 4 37795 VEV_1_3_RA4_01_1235.d 3.68E4 1 1 117 123 Methylation(KR)
K.GIAS(-18.01)LR(+14.02).T Y 15.45 611.3755 6 -35.1 612.3613 1 101.13 4 58565 VEV_1_3_RA4_01_1235.d 3.27E5 1 1 63 68 Dehydration; Methylation(KR)
total 48 peptides
C1GA13
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AFEHTADYDEAISDFFR.K Y 124.82 2032.8802 17 -5.0 1017.4423 2 82.68 4 49004 VEV_1_3_RA4_01_1235.d 2.97E5 3 3 206 222
K.YLVLQMDETYAPPTEETR.T Y 123.38 2155.0144 18 -7.1 1078.5068 2 79.59 4 46710 VEV_1_3_RA4_01_1235.d 9.92E4 1 1 391 408
R.VTILSDPKDYPEFLQELEAGDVSEK.K Y 120.33 2821.3909 25 -5.7 941.4656 3 86.72 4 51725 VEV_1_3_RA4_01_1235.d 2.74E5 2 2 173 197
K.VYMVDDVAGIDESGLAQAYAR.A Y 118.57 2242.0576 21 -6.9 1122.0283 2 82.33 5 47554 VEV_2_3_RA5_01_1236.d 2.15E5 2 2 314 334
R.MSSFGDLIALSDIVDVPTAK.I Y 114.65 2078.0605 20 -7.9 1040.0293 2 91.34 4 54434 VEV_1_3_RA4_01_1235.d 6.93E5 5 5 341 360
K.WLAQLGEVAVSSDAFFPFTDNVFR.A Y 108.13 2715.3333 24 -6.0 1358.6658 2 96.50 4 56964 VEV_1_3_RA4_01_1235.d 1.49E5 2 2 562 585
K.HVSPAGAAIGVPLNEK.E Y 105.71 1558.8467 16 -9.9 520.6177 3 63.56 4 34172 VEV_1_3_RA4_01_1235.d 2.95E5 2 2 295 310
K.YATDTQYIPLR.Y Y 105.03 1339.6772 11 -9.4 670.8396 2 69.57 4 38875 VEV_1_3_RA4_01_1235.d 7.49E5 3 3 225 235
K.SNAIDLLC(+57.02)SGQVPR.D Y 104.46 1528.7667 14 -9.6 765.3833 2 75.94 4 43894 VEV_1_3_RA4_01_1235.d 4.34E5 3 3 520 533 Carbamidomethylation
K.FTTELPASAQR.D Y 102.13 1219.6196 11 -14.1 610.8085 2 59.68 6 30244 VEV_3_3_RA6_01_1237.d 6.37E5 4 4 438 448
R.YGANPHQKPAC(+57.02)AFTR.Q Y 100.08 1716.8154 15 -2.4 430.2101 4 36.99 4 16979 VEV_1_3_RA4_01_1235.d 1.09E6 7 7 236 250 Carbamidomethylation
R.M(+15.99)SSFGDLIALSDIVDVPTAK.I Y 99.28 2094.0554 20 -23.9 1048.0100 2 89.88 5 51820 VEV_2_3_RA5_01_1236.d 7.97E4 2 2 341 360 Oxidation (M)
K.VLC(+57.02)GAPGYINLLDALNAWPLVK.E Y 95.73 2396.2925 22 -7.7 799.7653 3 96.37 4 56912 VEV_1_3_RA4_01_1235.d 1.84E5 3 3 258 279 Carbamidomethylation
K.YTQSNSVC(+57.02)YALNGQVIGLGAGQQSR.I Y 92.44 2670.2820 25 -3.6 891.0980 3 77.97 4 45459 VEV_1_3_RA4_01_1235.d 1.96E5 2 2 459 483 Carbamidomethylation
K.SAILSVYDKTGLLDLAK.G Y 91.59 1806.0138 17 -0.7 904.0135 2 81.37 4 48068 VEV_1_3_RA4_01_1235.d 7.91E4 3 3 37 53
R.EAGFPVEDVSAITHAPEMLGGR.V Y 86.11 2282.1001 22 2.4 761.7092 3 82.65 5 47740 VEV_2_3_RA5_01_1236.d 5.55E4 2 2 74 95
R.EVSDGVIAPGYC(+57.02)PDAIALLSK.K Y 85.80 2174.0928 21 -6.5 1088.0466 2 84.35 4 50174 VEV_1_3_RA4_01_1235.d 2.31E5 3 3 365 385 Carbamidomethylation
K.HVSPAGAAIGVPLNEKEK.K Y 84.99 1815.9843 18 -12.1 606.3281 3 58.89 4 30649 VEV_1_3_RA4_01_1235.d 1.86E5 4 4 295 312
K.KYATDTQYIPLR.Y Y 84.01 1467.7721 12 -9.9 490.2598 3 63.89 4 34426 VEV_1_3_RA4_01_1235.d 1.84E5 1 1 224 235
R.NIESDEQDLAAQK.I Y 80.22 1459.6791 13 -7.2 730.8416 2 58.09 4 30078 VEV_1_3_RA4_01_1235.d 3.27E5 3 3 111 123
K.KVYMVDDVAGIDESGLAQAYAR.A Y 79.69 2370.1526 22 -3.6 791.0553 3 78.92 6 44381 VEV_3_3_RA6_01_1237.d 1.01E5 2 2 313 334
K.AFEHTADYDE(+14.02)AISDFFR.K Y 77.74 2046.8959 17 -8.9 683.2998 3 83.03 4 49241 VEV_1_3_RA4_01_1235.d 2.54E4 1 1 206 222 Methylation(others)
R.TVYGIQLSQR.H Y 75.07 1163.6299 10 -10.4 582.8162 2 65.12 4 35367 VEV_1_3_RA4_01_1235.d 6.19E5 6 6 409 418
R.MSSFGDLIALSDIVDVPTAK(+14.02).I Y 71.31 2092.0762 20 -14.2 1047.0305 2 91.66 4 54585 VEV_1_3_RA4_01_1235.d 3.42E4 1 1 341 360 Methylation(KR)
K.QALGYPAAASFK.H Y 67.37 1222.6345 12 -1.5 612.3236 2 67.22 4 37094 VEV_1_3_RA4_01_1235.d 6.5E4 2 2 283 294
K.TLHPAVHGGILAR.N Y 65.69 1340.7677 13 -14.1 336.1945 4 52.28 5 26551 VEV_2_3_RA5_01_1236.d 7.37E5 8 8 98 110
R.GADRMSSFGDLIALSDIVDVPTAK.I Y 64.52 2477.2471 24 -11.9 826.7465 3 88.22 5 50965 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 337 360
K.Q(-17.03)ALGYPAAASFK.H Y 63.38 1205.6080 12 -8.6 603.8061 2 78.23 4 45659 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 283 294 Pyro-glu from Q
K.YIAAPTGSQNDMPVFETAEK.L Y 55.78 2168.0095 20 14.1 1085.0273 2 76.13 4 44014 VEV_1_3_RA4_01_1235.d 3.44E4 1 1 593 612
R.HNDILIKPHESFNK.I Y 55.71 1690.8790 14 -13.9 423.7212 4 51.44 6 25141 VEV_3_3_RA6_01_1237.d 3.74E5 2 2 419 432
K.YIAAPTGSQNDMPVFETAEKLGIVFVEQGIR.L Y 54.90 3379.7122 31 -8.0 1127.5690 3 93.42 4 55518 VEV_1_3_RA4_01_1235.d 9.49E4 1 1 593 623
R.YGANPHQ(+.98)KPAC(+57.02)AFTR.Q Y 49.44 1717.7994 15 -25.5 573.5925 3 37.12 4 17003 VEV_1_3_RA4_01_1235.d 3.47E4 1 1 236 250 Deamidation (NQ); Carbamidomethylation
K.LGIVFVEQGIR.L Y 48.86 1229.7131 11 -8.7 615.8585 2 79.14 4 46355 VEV_1_3_RA4_01_1235.d 3.41E4 1 1 613 623
K.SNAIDLLC(+57.02)SGQ(+.98)VPR.D Y 43.22 1529.7507 14 -12.3 765.8732 2 77.01 4 44706 VEV_1_3_RA4_01_1235.d 7.26E4 2 2 520 533 Carbamidomethylation; Deamidation (NQ)
R.NIESDEQDLAAQKISK.V Y 41.11 1787.8900 16 -5.8 596.9672 3 61.99 5 33033 VEV_2_3_RA5_01_1236.d 8.88E4 1 1 111 126
K.IISREVSDGVIAPGYC(+57.02)PDAIALLSK.K Y 38.03 2643.3940 25 -5.8 882.1335 3 81.87 5 47266 VEV_2_3_RA5_01_1236.d 6.99E4 2 2 361 385 Carbamidomethylation
R.LAGDKADNWWMR.F Y 32.77 1461.6823 12 25.3 488.2470 3 69.84 4 39087 VEV_1_3_RA4_01_1235.d 0 1 1 489 500
K.QALGY(-18.01)PAAASFK.H Y 30.40 1204.6240 12 -19.0 603.3079 2 78.20 4 45631 VEV_1_3_RA4_01_1235.d 0 1 1 283 294 Dehydration
K.IITPK.F N 30.23 570.3741 5 -18.4 571.3708 1 20.42 4 7613 VEV_1_3_RA4_01_1235.d 2.18E4 2 2 433 437
K.Q(+.98)ALGYPAAASFK.H Y 29.56 1223.6185 12 -17.0 612.8062 2 68.61 6 36848 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 283 294 Deamidation (NQ)
K.S(+42.01)N(+.98)AIDLLC(+57.02)SGQVPR.D Y 25.24 1571.7614 14 36.4 524.9468 3 75.89 6 42202 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 520 533 Acetylation (N-term); Deamidation (NQ); Carbamidomethylation
K.YATDTQ(+.98)YIPLR.Y Y 25.12 1340.6613 11 -9.9 671.3312 2 70.53 6 38251 VEV_3_3_RA6_01_1237.d 5.71E4 1 1 225 235 Deamidation (NQ)
R.LLASGGTAK.L Y 24.68 816.4705 9 -69.6 409.2141 2 19.11 6 7102 VEV_3_3_RA6_01_1237.d 1.09E5 3 3 62 70
K.VFEEGGVPAPFTTEER.E Y 23.38 1763.8365 16 -18.7 353.7680 5 10.51 5 2733 VEV_2_3_RA5_01_1236.d 1.7E5 1 1 544 559
R.DGVERVEFEK.V Y 22.70 1206.5880 10 -27.3 604.2848 2 48.67 6 23569 VEV_3_3_RA6_01_1237.d 3.94E4 1 1 534 543
R.Y(-2.02)GANPHQKPAC(+57.02)AFTR.Q Y 21.75 1714.7998 15 -48.7 572.5793 3 36.77 5 17225 VEV_2_3_RA5_01_1236.d 1.82E5 1 1 236 250 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.KVYMVDDVAGIDESGLAQ(+.98)AYAR.A Y 21.52 2371.1365 22 2.0 791.3877 3 78.99 4 46235 VEV_1_3_RA4_01_1235.d 2.51E4 1 1 313 334 Deamidation (NQ)
K.SAILSVY(-18.01)DK.T Y 21.38 976.5229 9 4.8 326.5165 3 29.98 6 12857 VEV_3_3_RA6_01_1237.d 7.8E5 1 1 37 45 Dehydration
K.Q(+42.01)ALGYPAAASFK(+28.03).H Y 21.19 1292.6764 12 -1.1 431.8989 3 69.87 6 37756 VEV_3_3_RA6_01_1237.d 9.85E4 1 1 283 294 Acetylation (N-term); Dimethylation(KR)
K.S(+42.01)LNAK(+21.98).E Y 20.30 595.2941 5 23.6 596.3154 1 55.79 4 28496 VEV_1_3_RA4_01_1235.d 0 1 1 14 18 Acetylation (Protein N-term); Sodium adduct
R.L(+42.01)AGD(+21.98)K.A Y 19.95 566.2676 5 -34.4 567.2554 1 23.69 6 9508 VEV_3_3_RA6_01_1237.d 5.8E4 1 1 489 493 Acetylation (N-term); Sodium adduct
K.H(+42.01)VSPAGAAIGVPLNEK.E Y 19.58 1600.8573 16 22.8 401.2307 4 64.84 6 33989 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 295 310 Acetylation (N-term)
R.MSSFGDLIALSD(+14.02)IVDVPTAK.I Y 19.47 2092.0762 20 -17.8 1047.0267 2 92.50 4 55035 VEV_1_3_RA4_01_1235.d 9.12E4 1 1 341 360 Methylation(others)
R.L(+27.99)LASGGTAK.L Y 19.32 844.4654 9 24.2 845.4931 1 100.38 5 56138 VEV_2_3_RA5_01_1236.d 0 1 1 62 70 Formylation
R.WKANTKRPEK.S Y 19.14 1256.6990 10 -41.2 315.1691 4 18.78 4 6766 VEV_1_3_RA4_01_1235.d 2.83E4 1 1 510 519
K.SAILSVYDK.T Y 19.11 994.5334 9 -6.3 498.2709 2 63.25 4 33940 VEV_1_3_RA4_01_1235.d 8.08E4 1 1 37 45
K.I(+27.99)ITPK.F N 18.95 598.3690 5 3.4 300.1928 2 39.54 6 18273 VEV_3_3_RA6_01_1237.d 5.66E5 1 1 433 437 Formylation
R.A(+42.01)AAK(+14.02)NHSR.V Y 18.79 909.4780 8 -5.8 304.1649 3 21.60 6 8394 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 165 172 Acetylation (N-term); Methylation(KR)
R.KK(+411.26)YATDTQYIPLR.Y Y 18.25 2007.1265 13 -81.5 669.9949 3 69.93 4 39157 VEV_1_3_RA4_01_1235.d 6.12E4 1 1 223 235 LeudimethylArgGlyGly
K.QALGYPAAASFK(+21.98).H Y 18.02 1244.6165 12 -2.0 312.1608 4 31.41 5 14084 VEV_2_3_RA5_01_1236.d 3.16E4 1 1 283 294 Sodium adduct
R.I(+43.01)HC(+57.02)TRLAGDK.A Y 17.82 1212.6033 10 -25.6 304.1503 4 8.97 4 2132 VEV_1_3_RA4_01_1235.d 0 1 1 484 493 Carbamylation; Carbamidomethylation
R.LLASGGTAK(+226.08).L Y 17.34 1042.5481 9 -48.8 522.2559 2 65.52 4 35686 VEV_1_3_RA4_01_1235.d 0 1 1 62 70 Biotinylation
K.GLVK(+42.01)HNVR.L Y 16.93 963.5614 8 -12.6 322.1904 3 51.17 6 24967 VEV_3_3_RA6_01_1237.d 0 1 1 54 61 Acetylation (K)
K.SAILSVY(-18.01)DK(+14.02).T Y 16.86 990.5386 9 19.3 331.1932 3 28.79 6 12211 VEV_3_3_RA6_01_1237.d 3E4 1 1 37 45 Dehydration; Methylation(KR)
R.T(+79.96)VYGIQLSQR.H Y 16.68 1243.5867 10 23.3 311.9112 4 20.83 5 8194 VEV_2_3_RA5_01_1236.d 0 1 1 409 418 Sulfation
R.A(+43.01)LNLR.W N 16.28 628.3657 5 -3.8 315.1889 2 27.77 4 11615 VEV_1_3_RA4_01_1235.d 0 1 1 505 509 Carbamylation
R.HNDILIKPHES(+79.97)FNK.I Y 16.19 1770.8453 14 0.5 591.2894 3 60.27 5 31748 VEV_2_3_RA5_01_1236.d 1.57E4 1 1 419 432 Phosphorylation (STY)
K.HVS(+79.97)PAGAAIGVPLNEK(+14.02).E Y 16.12 1652.8286 16 31.6 414.2275 4 60.44 5 31873 VEV_2_3_RA5_01_1236.d 0 1 1 295 310 Phosphorylation (STY); Methylation(KR)
K.Q(+.98)ALGYPAAASFK(+27.99).H Y 16.09 1251.6135 12 -8.2 418.2084 3 24.95 4 10091 VEV_1_3_RA4_01_1235.d 0 1 1 283 294 Deamidation (NQ); Formylation
K.F(+42.01)TTELPASAQ(+.98)R.D Y 15.83 1262.6143 11 -28.9 632.2961 2 49.98 6 24291 VEV_3_3_RA6_01_1237.d 2.23E5 2 2 438 448 Acetylation (N-term); Deamidation (NQ)
K.SNAIDLLC(+57.02)SGQVPR(-.98).D Y 15.69 1527.7827 14 -9.9 764.8911 2 75.85 5 43208 VEV_2_3_RA5_01_1236.d 2.16E4 1 1 520 533 Carbamidomethylation; Amidation
K.SLNAK(+43.01).E Y 15.67 574.3074 5 -22.0 575.3021 1 50.87 5 25676 VEV_2_3_RA5_01_1236.d 1.21E4 1 1 14 18 Carbamylation
K.VF(+17.99)EEGGVPAPFTTEEREK.W Y 15.58 2038.9647 18 0.2 510.7485 4 56.51 4 28961 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 544 561 Fluorination
K.FTTELPASAQ(+.98)R.D Y 15.27 1220.6036 11 19.2 306.1640 4 13.56 4 4078 VEV_1_3_RA4_01_1235.d 5.24E4 1 1 438 448 Deamidation (NQ)
K.QALGYPAAASF(+31.99)K.H Y 15.19 1254.6244 12 -28.9 419.2033 3 20.07 6 7591 VEV_3_3_RA6_01_1237.d 8.97E4 1 1 283 294 Dihydroxy
K.K(+42.01)SLNAKEFDR(+14.02)PAALRYFFEK.M Y 15.18 2485.3118 20 -9.8 622.3291 4 73.58 4 42033 VEV_1_3_RA4_01_1235.d 4.16E4 1 1 13 32 Acetylation (Protein N-term); Methylation(KR)
K.SAILSVYD(-18.01)K.T Y 15.17 976.5229 9 -53.0 977.4785 1 94.38 4 56004 VEV_1_3_RA4_01_1235.d 3.35E5 2 2 37 45 Dehydration
R.LLASGGT(+79.96)AKLIR(+14.02).E Y 15.14 1292.7122 12 17.5 324.1910 4 46.66 4 22798 VEV_1_3_RA4_01_1235.d 7.35E4 1 1 62 73 Sulfation; Methylation(KR)
R.LAGDK(+42.01).A Y 15.06 544.2856 5 -37.0 545.2728 1 18.35 6 6692 VEV_3_3_RA6_01_1237.d 8.23E4 1 1 489 493 Acetylation (K)
total 79 peptides
C1G942
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KKANVDEFPLC(+57.02)VHMVSNEYEQLSSEALEAAR.I Y 135.99 3563.7024 31 -12.7 713.7387 5 82.88 6 47107 VEV_3_3_RA6_01_1237.d 3.03E5 4 4 39 69 Carbamidomethylation
K.ANVDEFPLC(+57.02)VHMVSNEYEQLSSEALEAAR.I Y 132.19 3307.5125 29 -5.5 1103.5054 3 87.97 4 52502 VEV_1_3_RA4_01_1235.d 5.31E5 5 5 41 69 Carbamidomethylation
R.VNIGQILLSVR.T Y 109.30 1210.7397 11 -14.8 606.3682 2 84.15 6 47945 VEV_3_3_RA6_01_1237.d 5.91E6 8 8 129 139
R.VKIDGAYVQFLR.N Y 109.03 1407.7874 12 -9.6 704.8942 2 75.84 5 43221 VEV_2_3_RA5_01_1236.d 4.06E6 11 11 190 201
K.KANVDEFPLC(+57.02)VHMVSNEYEQLSSEALEAAR.I Y 107.31 3435.6074 30 -2.7 1146.2067 3 85.12 4 50663 VEV_1_3_RA4_01_1235.d 2.99E5 4 4 40 69 Carbamidomethylation
K.MLSC(+57.02)AGADRLQTGMR.G Y 102.38 1665.7749 15 -9.3 556.2604 3 61.04 4 32280 VEV_1_3_RA4_01_1235.d 1.67E6 7 7 102 116 Carbamidomethylation
R.AHPYHVVR.I Y 99.26 977.5195 8 -12.3 489.7610 2 16.60 5 5882 VEV_2_3_RA5_01_1236.d 3.85E6 12 12 91 98
R.NKGNIEENMK.R Y 98.34 1175.5604 10 -8.1 588.7827 2 17.61 4 6178 VEV_1_3_RA4_01_1235.d 9.62E5 7 7 202 211
K.M(+15.99)LSC(+57.02)AGADRLQTGMR.G Y 89.98 1681.7698 15 -9.4 561.5919 3 56.99 4 29344 VEV_1_3_RA4_01_1235.d 1.12E6 6 6 102 116 Oxidation (M); Carbamidomethylation
R.FPEAYENLS(+79.97)QV Y 86.39 1375.5697 11 -2.0 688.7908 2 83.17 4 49338 VEV_1_3_RA4_01_1235.d 9.9E5 7 7 213 223 Phosphorylation (STY)
K.RFPEAYENLS(+79.97)QV Y 85.50 1531.6708 12 -10.7 766.8345 2 78.47 4 45845 VEV_1_3_RA4_01_1235.d 2.02E6 5 5 212 223 Phosphorylation (STY)
K.IDGAYVQFLR.N Y 85.16 1180.6240 10 13.5 591.3273 2 77.32 6 43241 VEV_3_3_RA6_01_1237.d 0 2 2 192 201
R.GAFGKPNGTVAR.V Y 84.72 1173.6254 12 -16.3 392.2094 3 30.08 5 13337 VEV_2_3_RA5_01_1236.d 4.22E6 14 14 117 128
R.VRAHPYHVVR.I Y 84.14 1232.6890 10 -18.4 411.8960 3 24.42 6 9895 VEV_3_3_RA6_01_1237.d 3.24E6 15 15 89 98
R.GAFGKPN(+.98)GTVAR.V Y 82.57 1174.6094 12 -9.8 392.5399 3 34.99 4 15828 VEV_1_3_RA4_01_1235.d 7.55E6 31 31 117 128 Deamidation (NQ)
R.DAHRATAVEALRR.S Y 79.60 1464.7909 13 -15.3 489.2634 3 30.75 6 13275 VEV_3_3_RA6_01_1237.d 2.67E6 8 8 142 154
R.SMYKFPGR.Q Y 78.21 984.4851 8 -6.5 493.2466 2 50.58 4 25223 VEV_1_3_RA4_01_1235.d 2.92E6 13 13 155 162
R.VNIGQILLSVR(+14.02).T Y 73.93 1224.7554 11 -15.5 613.3755 2 87.20 6 49772 VEV_3_3_RA6_01_1237.d 7.71E5 5 5 129 139 Methylation(KR)
R.IC(+57.02)ANKYLVK.I Y 73.54 1107.6111 9 -13.6 554.8053 2 45.68 5 22536 VEV_2_3_RA5_01_1236.d 5.06E6 15 15 70 78 Carbamidomethylation
R.VKIDGAYVQFLR(+14.02).N Y 73.01 1421.8030 12 -6.7 474.9384 3 77.80 4 45321 VEV_1_3_RA4_01_1235.d 7.06E5 4 4 190 201 Methylation(KR)
K.IAGKEGFHLR.V Y 71.91 1126.6246 10 -10.9 376.5447 3 40.52 4 19008 VEV_1_3_RA4_01_1235.d 4.98E6 18 18 79 88
R.VNIGQ(+.98)ILLSVR.T Y 71.29 1211.7238 11 -11.4 606.8622 2 85.35 5 49411 VEV_2_3_RA5_01_1236.d 4.97E5 3 3 129 139 Deamidation (NQ)
R.VKIDGAYVQ(+.98)FLR.N Y 70.11 1408.7714 12 2.1 470.5987 3 76.01 4 43921 VEV_1_3_RA4_01_1235.d 9.73E5 2 2 190 201 Deamidation (NQ)
K.M(+15.99)LSC(+57.02)AGADR.L Y 67.34 995.4164 9 -6.7 498.7122 2 18.58 4 6707 VEV_1_3_RA4_01_1235.d 8.12E5 17 17 102 110 Oxidation (M); Carbamidomethylation
K.MLSC(+57.02)AGADR.L Y 65.05 979.4215 9 -9.0 490.7136 2 27.25 4 11322 VEV_1_3_RA4_01_1235.d 6.62E5 6 6 102 110 Carbamidomethylation
K.ANVDEFPLC(+57.02)VHM(+15.99)VSNEYEQLSSEALEAAR.I Y 63.94 3323.5073 29 -12.2 1108.8296 3 86.02 4 51260 VEV_1_3_RA4_01_1235.d 7.15E4 1 1 41 69 Carbamidomethylation; Oxidation (M)
R.VNIGQILLSVRTR.D Y 63.11 1467.8885 13 -14.5 490.2964 3 80.27 5 46226 VEV_2_3_RA5_01_1236.d 4.48E4 1 1 129 141
R.NKGNIEENM(+15.99)KR.F Y 62.18 1347.6565 11 -11.1 450.2211 3 9.79 5 2434 VEV_2_3_RA5_01_1236.d 8.46E4 3 3 202 212 Oxidation (M)
R.VN(+.98)IGQILLSVR.T Y 60.87 1211.7238 11 -12.2 606.8618 2 85.81 5 49626 VEV_2_3_RA5_01_1236.d 2.7E4 3 3 129 139 Deamidation (NQ)
R.NKGNIEENMKR.F Y 60.82 1331.6616 11 -13.9 444.8883 3 16.67 5 5926 VEV_2_3_RA5_01_1236.d 9.34E5 9 9 202 212
K.IRIFDLGR.K Y 60.00 988.5818 8 -12.8 330.5303 3 71.64 4 40532 VEV_1_3_RA4_01_1235.d 1.86E6 10 10 31 38
R.NKGNIEENM(+15.99)K.R Y 59.43 1191.5554 10 -12.4 596.7776 2 10.00 5 2518 VEV_2_3_RA5_01_1236.d 1.66E5 5 5 202 211 Oxidation (M)
R.ATAVEALRR.S Y 59.36 985.5668 9 -16.3 493.7827 2 30.39 6 13066 VEV_3_3_RA6_01_1237.d 6.26E6 11 11 146 154
K.MLSC(+57.02)AGADRLQTGM(+15.99)R.G Y 53.38 1681.7698 15 -10.2 561.5915 3 52.73 4 26634 VEV_1_3_RA4_01_1235.d 2.39E5 1 1 102 116 Carbamidomethylation; Oxidation (M)
K.ANVDEFPLC(+57.02)VHMVSNEYE(+14.02)QLSSEALEAAR.I Y 52.91 3321.5281 29 -8.0 1108.1744 3 88.72 4 52945 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 41 69 Carbamidomethylation; Methylation(others)
R.YC(+57.02)KNKPYPK.S Y 52.87 1196.6012 9 -11.2 599.3011 2 12.39 5 3649 VEV_2_3_RA5_01_1236.d 2.79E4 1 1 11 19 Carbamidomethylation
K.NWGFTPLRREEYVR.L Y 51.86 1821.9274 14 -11.3 456.4840 4 69.64 5 38728 VEV_2_3_RA5_01_1236.d 1.87E6 4 4 170 183
K.RFPEAYENLSQV Y 51.62 1451.7045 12 -7.9 726.8538 2 74.62 4 42888 VEV_1_3_RA4_01_1235.d 6.39E5 2 2 212 223
R.V(+43.01)K(+14.02)IDGAYVQFLR.N Y 51.39 1464.8088 12 -9.5 489.2722 3 76.81 4 44548 VEV_1_3_RA4_01_1235.d 2.61E5 3 3 190 201 Carbamylation; Methylation(KR)
K.NWGFTPLR.R Y 49.42 989.5083 8 -16.9 495.7531 2 74.68 6 41309 VEV_3_3_RA6_01_1237.d 9.05E5 4 4 170 177
K.R(+14.02)FPEAYENLS(+79.97)QV Y 49.29 1545.6864 12 -5.3 773.8464 2 80.45 4 47362 VEV_1_3_RA4_01_1235.d 3.36E5 4 4 212 223 Methylation(KR); Phosphorylation (STY)
R.SM(+15.99)YKFPGR.Q Y 48.67 1000.4800 8 2.2 501.2484 2 39.06 4 18133 VEV_1_3_RA4_01_1235.d 2.9E6 14 14 155 162 Oxidation (M)
K.MLSC(+57.02)AGADR(+.98)LQTGMR.G Y 48.38 1666.7589 15 0.3 556.5938 3 61.21 4 32394 VEV_1_3_RA4_01_1235.d 3.51E5 1 1 102 116 Carbamidomethylation; Deamidation (R)
R.VKID(-18.01)GAYVQFLR.N Y 48.08 1389.7769 12 -13.2 464.2601 3 78.10 4 45554 VEV_1_3_RA4_01_1235.d 1.17E5 3 3 190 201 Dehydration
K.IRIFDLGR(+14.02).K Y 47.53 1002.5974 8 -30.3 335.1963 3 71.86 5 40355 VEV_2_3_RA5_01_1236.d 1.71E5 3 3 31 38 Methylation(KR)
R.VRAHPY(+79.96)HVVR.I Y 47.44 1312.6459 10 14.7 329.1736 4 23.51 5 9630 VEV_2_3_RA5_01_1236.d 0 1 1 89 98 Sulfation
R.ATAVEALR.R Y 45.88 829.4658 8 -16.9 415.7332 2 36.62 5 17140 VEV_2_3_RA5_01_1236.d 9.52E5 6 6 146 153
R.Q(-17.03)KIIVSK.N Y 45.34 797.5010 7 -8.5 399.7544 2 37.26 4 17076 VEV_1_3_RA4_01_1235.d 1.45E6 5 5 163 169 Pyro-glu from Q
R.GAFGKPN(+.98)GTVAR(+14.02).V Y 42.24 1188.6251 12 -36.6 595.2981 2 43.44 4 20807 VEV_1_3_RA4_01_1235.d 4.55E5 9 9 117 128 Deamidation (NQ); Methylation(KR)
K.RFPEAYENLSQ(+.98)V Y 42.16 1452.6885 12 6.5 727.3563 2 74.93 4 43075 VEV_1_3_RA4_01_1235.d 4.92E5 4 4 212 223 Deamidation (NQ)
R.IFDLGR.K Y 41.44 719.3966 6 -20.9 360.6981 2 64.35 6 33624 VEV_3_3_RA6_01_1237.d 3.55E6 9 9 33 38
K.GNIEENMK.R Y 41.01 933.4225 8 -6.3 467.7156 2 24.55 4 9877 VEV_1_3_RA4_01_1235.d 7.28E4 2 2 204 211
R.SMYKFPGR(+14.02).Q Y 39.83 998.5007 8 -17.7 500.2488 2 53.14 4 26892 VEV_1_3_RA4_01_1235.d 3.12E5 5 5 155 162 Methylation(KR)
K.ANVDEFPLC(+57.02)VHMVSNE(+55.92)YEQLSSEALEAAR.I Y 39.64 3363.4321 29 2.8 841.8677 4 81.61 6 46283 VEV_3_3_RA6_01_1237.d 0 1 1 41 69 Carbamidomethylation; Replacement of 2 protons by nickel
R.DAHRATAVEALR.R Y 39.55 1308.6898 12 -6.1 437.2346 3 33.73 4 15017 VEV_1_3_RA4_01_1235.d 3.17E5 4 4 142 153
K.NWGFTPLRR.E Y 39.46 1145.6094 9 -12.3 382.8724 3 67.05 4 36899 VEV_1_3_RA4_01_1235.d 1.1E6 4 4 170 178
R.I(+42.01)C(+57.02)ANKYLVK.I Y 38.70 1149.6216 9 -18.9 384.2072 3 45.67 4 22186 VEV_1_3_RA4_01_1235.d 0 1 1 70 78 Acetylation (N-term); Carbamidomethylation
K.MLSC(+57.02)AGADR(+14.02).L Y 37.32 993.4372 9 16.7 497.7342 2 35.77 4 16196 VEV_1_3_RA4_01_1235.d 0 1 1 102 110 Carbamidomethylation; Methylation(KR)
K.NKPYPK.S Y 36.01 745.4122 6 -17.1 373.7070 2 9.75 6 2396 VEV_3_3_RA6_01_1237.d 9.88E4 2 2 14 19
R.IFDLGRK.K Y 35.67 847.4916 7 -15.9 424.7463 2 48.95 5 24511 VEV_2_3_RA5_01_1236.d 5.27E5 3 3 33 39
R.D(-18.01)AHR(+14.02)ATAVEALRR.S Y 34.92 1460.7960 13 -3.0 366.2052 4 30.75 5 13697 VEV_2_3_RA5_01_1236.d 1.52E5 1 1 142 154 Dehydration; Methylation(KR)
R.FNRGVPDAK.I Y 34.58 1002.5247 9 -12.4 502.2634 2 24.42 5 10146 VEV_2_3_RA5_01_1236.d 1.69E5 2 2 22 30
R.NKGNIEENMKRFPEAYENLS(+79.97)QV Y 33.77 2689.2207 22 -1.4 897.4130 3 76.17 5 43420 VEV_2_3_RA5_01_1236.d 1.13E5 2 2 202 223 Phosphorylation (STY)
R.ATAVEALR(+14.02)R.S Y 33.70 999.5825 9 -17.5 500.7898 2 36.69 5 17184 VEV_2_3_RA5_01_1236.d 2.05E5 2 2 146 154 Methylation(KR)
R.DAHR(+14.02)ATAVEALRR.S Y 33.56 1478.8065 13 -50.6 370.6902 4 30.69 4 13276 VEV_1_3_RA4_01_1235.d 8.68E5 1 1 142 154 Methylation(KR)
R.V(+42.01)KIDGAYVQFLR.N Y 32.06 1449.7980 12 -36.0 484.2559 3 76.06 4 43966 VEV_1_3_RA4_01_1235.d 0 2 2 190 201 Acetylation (N-term)
K.IAGKE(+14.02)GFHLR.V Y 31.73 1140.6404 10 -17.9 571.3173 2 49.05 4 24281 VEV_1_3_RA4_01_1235.d 4.73E5 3 3 79 88 Methylation(others)
K.ANVDEFPLC(+57.02)VHMVSNEYEQLSSEALEAAR(+14.02).I Y 31.61 3321.5281 29 -1.9 1108.1812 3 89.29 4 53265 VEV_1_3_RA4_01_1235.d 1.94E4 2 2 41 69 Carbamidomethylation; Methylation(KR)
K.ANVDEFPLC(+57.02)VHMVSNEYEQLSSE(+14.02)ALEAAR.I Y 31.40 3321.5281 29 -6.8 1108.1758 3 89.21 6 50902 VEV_3_3_RA6_01_1237.d 2.48E4 1 1 41 69 Carbamidomethylation; Methylation(others)
K.EGFHLR.V Y 31.38 757.3871 6 -17.0 379.6944 2 34.30 6 15251 VEV_3_3_RA6_01_1237.d 1.38E6 7 7 83 88
R.FPEAYENLS(+79.97)Q(+.98)V Y 31.20 1376.5537 11 44.3 689.3146 2 84.10 4 49979 VEV_1_3_RA4_01_1235.d 0 1 1 213 223 Phosphorylation (STY); Deamidation (NQ)
R.IC(+57.02)AN(+.98)KYLVK.I Y 31.00 1108.5951 9 1.9 370.5397 3 45.37 5 22359 VEV_2_3_RA5_01_1236.d 5.21E5 2 2 70 78 Carbamidomethylation; Deamidation (NQ)
R.GVPDAKIR.I Y 30.79 854.4974 8 -20.5 428.2472 2 26.44 6 10966 VEV_3_3_RA6_01_1237.d 6.21E5 4 4 25 32
R.DAHR(+.98)ATAVEALRR.S Y 30.60 1465.7749 13 1.1 489.5994 3 30.94 5 13791 VEV_2_3_RA5_01_1236.d 3.24E4 1 1 142 154 Deamidation (R)
K.IIVSKNWGFTPLRREEYVR.L Y 30.57 2362.2910 19 -15.9 473.4579 5 72.77 6 39917 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 165 183
K.I(+43.01)R(+14.02)IFDLGR.K Y 29.62 1045.6033 8 -15.5 349.5363 3 72.97 4 41558 VEV_1_3_RA4_01_1235.d 4.2E4 1 1 31 38 Carbamylation; Methylation(KR)
R.FPEAYENLSQV Y 29.35 1295.6034 11 6.0 648.8129 2 78.96 4 46218 VEV_1_3_RA4_01_1235.d 9.77E4 1 1 213 223
R.KK(+14.02)ANVDEFPLC(+57.02)VHMVSNEYEQLSSEALEAAR.I Y 28.60 3577.7180 31 -14.6 716.5405 5 83.40 5 48191 VEV_2_3_RA5_01_1236.d 1.41E5 1 1 39 69 Methylation(KR); Carbamidomethylation
K.ANVDEFPLC(+57.02)VHMVSN(+15.00)EYEQLSSEALEAAR.I Y 27.93 3322.5122 29 -1.4 1108.5098 3 88.59 5 51163 VEV_2_3_RA5_01_1236.d 2.01E4 1 1 41 69 Carbamidomethylation; Deamidation followed by a methylation
R.NKGNIEE(+14.02)NMK.R Y 27.66 1189.5760 10 -15.0 595.7864 2 24.20 4 9674 VEV_1_3_RA4_01_1235.d 1.59E4 1 1 202 211 Methylation(others)
R.SMYKFPGRQK.I Y 27.44 1240.6387 10 -10.7 311.1636 4 35.61 5 16534 VEV_2_3_RA5_01_1236.d 7.67E4 2 2 155 164
R.GAFGK(+14.02)PN(+.98)GTVAR.V Y 27.15 1188.6251 12 -28.6 397.2043 3 35.12 4 15823 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 117 128 Methylation(KR); Deamidation (NQ)
R.TR(+54.01)DAHRATAVEALRR.S Y 27.10 1775.9503 15 7.7 356.2001 5 30.55 4 13154 VEV_1_3_RA4_01_1235.d 0 1 1 140 154 Methylglyoxal-derived hydroimidazolone
R.FNRGVPDAKIR.I Y 26.64 1271.7098 11 -9.4 318.9318 4 40.61 5 19477 VEV_2_3_RA5_01_1236.d 8.64E4 1 1 22 32
R.NKGNIEENM(-48.00)K.R Y 26.57 1127.5571 10 -13.2 564.7784 2 8.41 6 1978 VEV_3_3_RA6_01_1237.d 1.45E4 1 1 202 211 Dethiomethyl
R.IFDLGR(+14.02).K Y 25.32 733.4122 6 -14.5 367.7081 2 66.39 5 36313 VEV_2_3_RA5_01_1236.d 6.67E5 3 3 33 38 Methylation(KR)
K.NKPYPK(+14.02).S Y 25.18 759.4279 6 -59.8 760.3898 1 13.17 5 4064 VEV_2_3_RA5_01_1236.d 0 1 1 14 19 Methylation(KR)
R.QKIIVSK.N Y 24.45 814.5276 7 -35.9 408.2564 2 17.01 6 5989 VEV_3_3_RA6_01_1237.d 1.42E4 3 3 163 169
K.IIVSK(+14.02).N Y 24.34 572.3897 5 -27.5 573.3812 1 26.94 5 11565 VEV_2_3_RA5_01_1236.d 9.06E3 2 2 165 169 Methylation(KR)
R.D(+88.00)AHRATAVEALRR.S Y 24.24 1552.7892 13 16.5 389.2110 4 30.76 4 13281 VEV_1_3_RA4_01_1235.d 1.99E5 1 1 142 154 3-sulfanylpropanoyl
R.AHPYHVVR(+14.02).I Y 24.12 991.5352 8 -17.2 331.5133 3 24.25 6 9807 VEV_3_3_RA6_01_1237.d 1.82E5 2 2 91 98 Methylation(KR)
R.G(+42.01)AFGK(+42.01)PNGTVAR.V Y 23.52 1257.6465 12 6.9 420.2257 3 48.51 6 23443 VEV_3_3_RA6_01_1237.d 6.12E4 1 1 117 128 Acetylation (N-term); Acetylation (K)
R.LQTGM(+15.99)R.G Y 23.48 720.3589 6 -0.4 721.3659 1 112.77 5 59593 VEV_2_3_RA5_01_1236.d 1.48E4 1 1 111 116 Oxidation (M)
R.REEYVR.L Y 23.22 850.4297 6 -15.7 426.2154 2 13.42 6 4140 VEV_3_3_RA6_01_1237.d 5.8E4 1 1 178 183
K.S(-18.01)RFNRGVPDAK(+42.01).I Y 23.19 1269.6577 11 0.3 424.2266 3 73.91 4 42290 VEV_1_3_RA4_01_1235.d 8.74E4 1 1 20 30 Dehydration; Acetylation (K)
R.ATAVEALRR(+14.02).S Y 23.12 999.5825 9 -10.6 500.7932 2 36.79 4 16808 VEV_1_3_RA4_01_1235.d 8.32E4 1 1 146 154 Methylation(KR)
K.IDGAYVQFLR(+14.02)NKGN(+.98)IEENMK.R Y 22.93 2353.1736 20 -22.5 589.2874 4 66.71 5 36557 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 192 211 Methylation(KR); Deamidation (NQ)
K.N(+.98)WGFTPLR.R Y 22.85 990.4923 8 -4.6 496.2512 2 74.96 6 41509 VEV_3_3_RA6_01_1237.d 7.77E4 2 2 170 177 Deamidation (NQ)
K.IRIFDLGRK.K Y 22.81 1116.6768 9 -13.5 373.2278 3 63.92 4 34452 VEV_1_3_RA4_01_1235.d 3.98E4 1 1 31 39
R.QK(+14.02)IIVS(+79.97)K(+42.01).N Y 22.62 950.5201 7 -27.1 476.2545 2 68.04 5 37568 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 163 169 Methylation(KR); Phosphorylation (STY); Acetylation (K)
K.IAGKEGFHLR(+14.02).V Y 22.49 1140.6404 10 -20.2 381.2131 3 49.18 5 24658 VEV_2_3_RA5_01_1236.d 2.8E5 1 1 79 88 Methylation(KR)
R.NKGN(+.98)IEENMK.R Y 22.13 1176.5444 10 5.7 589.2828 2 17.56 6 6277 VEV_3_3_RA6_01_1237.d 2.68E4 1 1 202 211 Deamidation (NQ)
K.IAGKEGFH(+14.02)LR.V Y 21.29 1140.6404 10 -12.8 571.3202 2 48.95 5 24514 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 79 88 Methylation(others)
R.IFDLGR(+21.98).K Y 21.16 741.3785 6 -12.0 742.3770 1 79.14 5 45482 VEV_2_3_RA5_01_1236.d 0 1 1 33 38 Sodium adduct
R.GAFGKPNGTVAR(+14.02).V Y 21.09 1187.6411 12 -17.4 396.8808 3 37.54 6 17079 VEV_3_3_RA6_01_1237.d 9.61E4 1 1 117 128 Methylation(KR)
R.TRDAHR(+54.01)ATAVEALRR.S Y 21.01 1775.9503 15 -26.8 356.1878 5 31.16 4 13517 VEV_1_3_RA4_01_1235.d 0 1 1 140 154 Methylglyoxal-derived hydroimidazolone
R.ICANK(+14.02).Y Y 20.55 561.2944 5 -19.5 562.2908 1 84.15 4 50017 VEV_1_3_RA4_01_1235.d 0 1 1 70 74 Methylation(KR)
R.A(+42.01)T(+79.96)AVEALRR.S Y 20.29 1107.5342 9 75.2 370.2131 3 30.25 5 13405 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 146 154 Acetylation (N-term); Sulfation
R.FN(+.98)RGVPDAK(+14.02).I Y 20.08 1017.5243 9 -7.5 340.1795 3 23.93 6 9634 VEV_3_3_RA6_01_1237.d 0 1 1 22 30 Deamidation (NQ); Methylation(KR)
K.IRIFD(+79.97)LGR.K Y 19.56 1068.5481 8 4.6 357.1916 3 71.45 6 38954 VEV_3_3_RA6_01_1237.d 4.69E4 1 1 31 38 Phosphorylation (HCDR)
R.INKM(+15.99)LSC(+57.02)AGADR.L Y 19.52 1350.6384 12 -9.2 451.2159 3 25.26 4 10260 VEV_1_3_RA4_01_1235.d 7.52E4 1 1 99 110 Oxidation (M); Carbamidomethylation
K.GN(+.98)IEENMKR.F Y 19.22 1090.5077 9 1.2 546.2618 2 21.70 5 8652 VEV_2_3_RA5_01_1236.d 1.93E4 1 1 204 212 Deamidation (NQ)
R.RSMYKFPGR.Q Y 18.96 1140.5862 9 -34.1 571.2809 2 74.93 6 41492 VEV_3_3_RA6_01_1237.d 0 1 1 154 162
K.N(+.98)K(+14.02)PY(+79.97)PK.S Y 18.67 840.3782 6 5.8 841.3904 1 77.22 5 44181 VEV_2_3_RA5_01_1236.d 2.7E4 1 1 14 19 Deamidation (NQ); Methylation(KR); Phosphorylation (STY)
R.INKMLSC(+57.02)AGADR(+14.02).L Y 18.61 1348.6592 12 9.8 338.1754 4 16.99 6 5974 VEV_3_3_RA6_01_1237.d 7.01E5 1 1 99 110 Carbamidomethylation; Methylation(KR)
R.ATAVEALR(+14.02).R Y 18.55 843.4814 8 -12.4 422.7427 2 44.47 4 21434 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 146 153 Methylation(KR)
K.E(-18.01)GFHLR.V Y 18.44 739.3765 6 -13.2 370.6907 2 34.61 4 15523 VEV_1_3_RA4_01_1235.d 3.07E5 1 1 83 88 Pyro-glu from E
R.IFD(+14.02)LGR.K Y 18.03 733.4122 6 -21.0 367.7057 2 67.52 5 37165 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 33 38 Methylation(others)
R.LQTGMR.G Y 17.68 704.3640 6 -22.5 705.3553 1 106.61 6 57198 VEV_3_3_RA6_01_1237.d 2.11E5 3 3 111 116
R.GVPD(-18.01)AK.I Y 17.22 567.3016 6 -40.6 568.2859 1 50.12 5 25213 VEV_2_3_RA5_01_1236.d 0 1 1 25 30 Dehydration
R.L(+42.01)QT(+79.97)GMRGAFGKPNGTVAR.V Y 16.91 1981.9557 18 3.8 991.9889 2 90.87 5 52334 VEV_2_3_RA5_01_1236.d 4.51E4 1 1 111 128 Acetylation (N-term); Phosphorylation (STY)
K.SRFNRGVPDAK.I Y 16.90 1245.6577 11 -6.3 416.2239 3 67.12 5 36865 VEV_2_3_RA5_01_1236.d 0 1 1 20 30
R.LQTGMRGAFGK(+71.04)PNGTVAR.V Y 16.84 1931.0159 18 -10.8 387.2063 5 64.08 4 34574 VEV_1_3_RA4_01_1235.d 0 1 1 111 128 Propionamide (K, X@N-term)
R.NKGNIEEN(+.98)MK.R Y 16.16 1176.5444 10 4.9 589.2823 2 22.09 4 8513 VEV_1_3_RA4_01_1235.d 3.13E4 1 1 202 211 Deamidation (NQ)
K.EGFHLR(+14.02).V Y 16.10 771.4028 6 -8.2 386.7055 2 45.37 4 21983 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 83 88 Methylation(KR)
K.SRFNRGVPDAK(-.98).I Y 15.90 1244.6737 11 -22.6 312.1687 4 21.15 5 8369 VEV_2_3_RA5_01_1236.d 1.43E5 1 1 20 30 Amidation
K.IDGAYVQFLR(+14.02).N Y 15.70 1194.6396 10 -41.4 598.3024 2 79.87 4 46920 VEV_1_3_RA4_01_1235.d 0 1 1 192 201 Methylation(KR)
K.N(+.98)W(+43.99)GFTPLRR.E Y 15.59 1190.5833 9 42.0 397.8850 3 66.87 6 35529 VEV_3_3_RA6_01_1237.d 5.42E4 1 1 170 178 Deamidation (NQ); Carboxylation (DKW)
R.FNRGVP(+31.99)DAK.I Y 15.42 1034.5144 9 -33.7 518.2471 2 51.92 4 26112 VEV_1_3_RA4_01_1235.d 0 1 1 22 30 Dihydroxy
K.S(+79.97)RFNRGVPDAK(+42.01).I Y 15.32 1367.6346 11 -10.1 456.8809 3 35.31 5 16356 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 20 30 Phosphorylation (STY); Acetylation (K)
K.S(+79.97)R(+14.02)FNR(+14.02)GVPDAK.I Y 15.22 1353.6554 11 -7.2 339.4187 4 52.33 5 26584 VEV_2_3_RA5_01_1236.d 2.13E4 1 1 20 30 Phosphorylation (STY); Methylation(KR)
R.VK(+54.01)IDGAYVQFLR.N Y 15.19 1461.7980 12 -5.2 488.2708 3 76.87 4 44593 VEV_1_3_RA4_01_1235.d 0 1 1 190 201 MDA adduct +54
R.GVPDAK.I Y 15.09 585.3122 6 -68.0 586.2797 1 34.52 6 15388 VEV_3_3_RA6_01_1237.d 4.29E4 1 1 25 30
total 133 peptides
C1G2V1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NIAAHVSPAFRVEEGDQVTVGQC(+57.02)RPLSK.T Y 137.24 3064.5513 28 -12.6 767.1354 4 68.92 6 37069 VEV_3_3_RA6_01_1237.d 3.41E6 9 9 111 138 Carbamidomethylation
R.AFQKQPHIFLNSK.Q Y 122.44 1556.8463 13 -11.5 519.9501 3 57.86 5 30053 VEV_2_3_RA5_01_1236.d 3.04E6 18 18 12 24
R.VEEGDQVTVGQC(+57.02)RPLSK.T Y 121.86 1900.9313 17 -13.6 634.6424 3 53.83 6 26614 VEV_3_3_RA6_01_1237.d 3.93E6 18 18 122 138 Carbamidomethylation
R.HKNIAAHVSPAFRVEEGDQVTVGQC(+57.02)RPLSK.T Y 121.14 3329.7051 30 -10.4 833.4249 4 64.06 5 34579 VEV_2_3_RA5_01_1236.d 1.93E5 2 2 109 138 Carbamidomethylation
K.TAIEGSYIDKKC(+57.02)PFTGQVSIR.G Y 106.24 2369.2048 21 -11.7 790.7330 3 69.29 5 38481 VEV_2_3_RA5_01_1236.d 6.66E5 6 6 52 72 Carbamidomethylation
R.GRILTGTVVSTK.M Y 102.89 1230.7296 12 -13.6 411.2449 3 51.63 4 25917 VEV_1_3_RA4_01_1235.d 8.96E5 6 6 73 84
R.WYKDVGLGFR.T Y 101.21 1239.6400 10 -16.1 414.2140 3 70.22 5 39188 VEV_2_3_RA5_01_1236.d 5.3E6 11 11 39 48
K.TAIEGSYIDKK.C Y 95.89 1223.6398 11 -7.3 612.8227 2 39.22 4 18231 VEV_1_3_RA4_01_1235.d 1.25E7 21 21 52 62
R.HKNIAAHVSPAFR.V Y 93.72 1446.7844 13 -13.6 483.2622 3 41.50 5 20019 VEV_2_3_RA5_01_1236.d 2.29E6 10 10 109 121
K.C(+57.02)PFTGQVSIR.G Y 92.16 1163.5757 10 -11.7 582.7883 2 63.91 4 34442 VEV_1_3_RA4_01_1235.d 1.61E6 4 4 63 72 Carbamidomethylation
R.WYKDVGLGFRTPK.T Y 88.95 1565.8354 13 -9.8 783.9173 2 67.20 5 36999 VEV_2_3_RA5_01_1236.d 1.84E6 6 6 39 51
K.NIAAHVSPAFRVEEGDQ(+.98)VTVGQC(+57.02)RPLSK.T Y 88.10 3065.5352 28 -8.4 767.3846 4 69.85 4 39098 VEV_1_3_RA4_01_1235.d 8.39E4 2 2 111 138 Deamidation (NQ); Carbamidomethylation
K.NIAAHVSPAFR.V Y 87.98 1181.6305 11 -15.1 591.8136 2 56.91 5 29405 VEV_2_3_RA5_01_1236.d 2.12E6 11 11 111 121
K.KC(+57.02)PFTGQVSIR.G Y 85.47 1291.6707 11 -15.2 431.5576 3 56.99 6 28407 VEV_3_3_RA6_01_1237.d 5.91E5 7 7 62 72 Carbamidomethylation
K.C(+58.01)PFTGQVSIR.G Y 79.49 1164.5597 10 -13.2 583.2794 2 68.00 6 36416 VEV_3_3_RA6_01_1237.d 8.13E5 4 4 63 72 Carboxymethyl
R.TGKGVKQFGKF Y 78.33 1195.6713 11 -10.8 598.8364 2 36.76 5 17251 VEV_2_3_RA5_01_1236.d 1.24E6 8 8 151 161
K.Q(-17.03)PHIFLNSK.Q Y 78.33 1065.5607 9 -18.2 533.7779 2 67.37 6 35913 VEV_3_3_RA6_01_1237.d 2.14E6 7 7 16 24 Pyro-glu from Q
R.VEEGDQVTVGQC(+57.02)R(+.98)PLSK.T Y 77.64 1901.9153 17 -6.6 634.9749 3 58.66 4 30476 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 122 138 Carbamidomethylation; Deamidation (R)
R.EYLHYIPK.Y Y 75.43 1061.5546 8 -12.7 531.7778 2 59.12 4 30852 VEV_1_3_RA4_01_1235.d 3.49E6 10 10 94 101
R.ILTGTVVSTK.M Y 72.76 1017.6070 10 -13.7 509.8038 2 54.25 5 27743 VEV_2_3_RA5_01_1236.d 5.55E6 12 12 75 84
R.VE(+14.02)EGDQVTVGQC(+57.02)RPLSK.T Y 71.94 1914.9469 17 -8.6 639.3174 3 57.89 4 29935 VEV_1_3_RA4_01_1235.d 4.43E5 3 3 122 138 Methylation(others); Carbamidomethylation
K.TAIEGSYIDK.K Y 70.12 1095.5448 10 -13.1 548.7725 2 52.04 4 26189 VEV_1_3_RA4_01_1235.d 1.54E6 10 10 52 61
K.NIAAHVSPAFRVEEGDQVTVGQC(+57.02)RPLSK(+14.02).T Y 70.12 3078.5669 28 -19.4 616.7087 5 69.49 4 38814 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 111 138 Carbamidomethylation; Methylation(KR)
K.NIAAHVSPAFR(+14.02)VEEGDQVTVGQC(+57.02)RPLSK.T Y 68.03 3078.5669 28 -1.2 770.6481 4 70.85 5 39618 VEV_2_3_RA5_01_1236.d 2.18E5 2 2 111 138 Methylation(KR); Carbamidomethylation
K.QPHIFLNSK.Q Y 67.56 1082.5873 9 -10.2 542.2954 2 49.51 4 24576 VEV_1_3_RA4_01_1235.d 1.6E6 7 7 16 24
R.AFQKQPHIFLN(+.98)SK.Q Y 64.71 1557.8303 13 -9.1 390.4613 4 60.21 4 31632 VEV_1_3_RA4_01_1235.d 1.83E6 4 4 12 24 Deamidation (NQ)
K.C(+57.02)PFTGQVSIRGR.I Y 62.59 1376.6982 12 -11.3 459.9015 3 57.37 5 29676 VEV_2_3_RA5_01_1236.d 4.07E5 2 2 63 74 Carbamidomethylation
K.DVGLGFRTPK.T Y 61.92 1088.5978 10 -12.1 545.2996 2 61.47 5 32637 VEV_2_3_RA5_01_1236.d 7.1E5 4 4 42 51
M.A(+42.01)TELTVQSERAFQKQPHIFLNSK.Q Y 61.86 2713.4187 23 -9.6 679.3555 4 77.42 4 45026 VEV_1_3_RA4_01_1235.d 6.01E5 3 3 2 24 Acetylation (Protein N-term)
R.VEE(+14.02)GDQVTVGQC(+57.02)RPLSK.T Y 61.66 1914.9469 17 -8.2 639.3177 3 59.91 4 31425 VEV_1_3_RA4_01_1235.d 5.26E5 2 2 122 138 Methylation(others); Carbamidomethylation
K.C(+57.02)PFTGQ(+.98)VSIR.G Y 61.29 1164.5597 10 -7.8 583.2826 2 65.81 4 35917 VEV_1_3_RA4_01_1235.d 6.64E5 3 3 63 72 Carbamidomethylation; Deamidation (NQ)
R.VEEGDQVTVGQ(+.98)C(+57.02)RPLSK.T Y 61.24 1901.9153 17 29.1 634.9975 3 58.44 6 29329 VEV_3_3_RA6_01_1237.d 6.94E5 5 5 122 138 Deamidation (NQ); Carbamidomethylation
R.AFQKQPHIFLNSK(+14.02).Q Y 60.85 1570.8619 13 -14.8 393.7169 4 59.85 5 31441 VEV_2_3_RA5_01_1236.d 9.72E5 5 5 12 24 Methylation(KR)
K.TAIEGSYIDKK(+14.02).C Y 59.92 1237.6554 11 -9.9 619.8289 2 46.09 6 22032 VEV_3_3_RA6_01_1237.d 9.71E5 3 3 52 62 Methylation(KR)
K.Q(-17.03)PHIFLNSK(+14.02).Q Y 59.23 1079.5763 9 -14.0 540.7878 2 68.63 6 36861 VEV_3_3_RA6_01_1237.d 1.31E5 2 2 16 24 Pyro-glu from Q; Methylation(KR)
R.RWYKDVGLGFR.T Y 59.10 1395.7411 11 -12.1 466.2487 3 67.43 5 37096 VEV_2_3_RA5_01_1236.d 5.16E5 4 4 38 48
K.TAIE(+14.02)GSYIDKK.C Y 58.94 1237.6554 11 -10.5 619.8285 2 47.67 5 23736 VEV_2_3_RA5_01_1236.d 2.68E6 11 11 52 62 Methylation(others)
R.AFQKQ(+.98)PHIFLNSK.Q Y 58.22 1557.8303 13 -18.7 390.4576 4 60.63 6 30894 VEV_3_3_RA6_01_1237.d 2.11E6 6 6 12 24 Deamidation (NQ)
R.WYKDVGLGFR(+14.02).T Y 57.43 1253.6556 10 -15.0 418.8862 3 72.96 5 41145 VEV_2_3_RA5_01_1236.d 3.41E5 3 3 39 48 Methylation(KR)
K.C(+57.02)PFTGQVSIR(+14.02).G Y 57.36 1177.5913 10 -8.6 589.7979 2 68.58 4 38099 VEV_1_3_RA4_01_1235.d 2.48E5 3 3 63 72 Carbamidomethylation; Methylation(KR)
K.C(+58.01)PFTGQVSIRGR.I Y 53.77 1377.6823 12 7.9 460.2383 3 61.93 5 33014 VEV_2_3_RA5_01_1236.d 4.41E4 1 1 63 74 Carboxymethyl
K.GVKQFGKF Y 53.10 909.5072 8 -13.6 455.7547 2 44.19 5 21632 VEV_2_3_RA5_01_1236.d 1.21E6 7 7 154 161
K.TAIEGSYIDK(+14.02)K.C Y 50.74 1237.6554 11 -20.5 619.8223 2 46.60 4 22808 VEV_1_3_RA4_01_1235.d 3.74E5 3 3 52 62 Methylation(KR)
R.WY(-18.01)K(+14.02)DVGLGFRTPK.T Y 50.11 1561.8405 13 -49.5 521.5950 3 67.15 5 36880 VEV_2_3_RA5_01_1236.d 8.25E4 1 1 39 51 Dehydration; Methylation(KR)
K.TAIEGSYIDKKC(+57.02)PFTGQVSIRGR.I Y 49.96 2582.3274 23 2.1 646.5905 4 66.02 5 36048 VEV_2_3_RA5_01_1236.d 4.04E4 1 1 52 74 Carbamidomethylation
K.N(+.98)IAAHVSPAFR.V Y 49.52 1182.6145 11 -1.3 395.2116 3 57.30 5 29629 VEV_2_3_RA5_01_1236.d 9.34E5 4 4 111 121 Deamidation (NQ)
R.AFQKQPHIFLNS(+79.96)K.Q Y 49.36 1636.8031 13 23.9 410.2178 4 57.80 5 29975 VEV_2_3_RA5_01_1236.d 0 1 1 12 24 Sulfation
M.A(+42.01)TELTVQSER.A Y 49.13 1174.5830 10 -10.7 588.2925 2 64.19 4 34673 VEV_1_3_RA4_01_1235.d 4.49E6 12 12 2 11 Acetylation (Protein N-term)
K.TVRFNVLR.V Y 48.97 1003.5927 8 -18.1 335.5321 3 59.43 5 31125 VEV_2_3_RA5_01_1236.d 1.66E6 4 4 139 146
R.VEEGDQVTVGQC(+57.02)RPLSK(+14.02).T Y 48.63 1914.9469 17 -9.6 639.3168 3 56.94 5 29389 VEV_2_3_RA5_01_1236.d 1.85E5 2 2 122 138 Carbamidomethylation; Methylation(KR)
M.A(+42.01)TELTVQSER(+14.02).A Y 46.40 1188.5986 10 -0.1 595.3065 2 67.59 5 37258 VEV_2_3_RA5_01_1236.d 2.72E6 10 10 2 11 Acetylation (Protein N-term); Methylation(KR)
K.DVGLGFRT(+79.96)PK.T Y 46.05 1168.5546 10 6.9 390.5281 3 67.11 6 35712 VEV_3_3_RA6_01_1237.d 2.4E5 1 1 42 51 Sulfation
K.T(+41.03)AIEGSYIDKK.C Y 46.05 1264.6663 11 -13.8 422.5569 3 39.03 5 18539 VEV_2_3_RA5_01_1236.d 3.64E5 2 2 52 62 Amidination of lysines or N-terminal amines with methyl acetimidate
R.VEEGDQVTVGQC(+57.02)R(+14.02)PLSK.T Y 44.95 1914.9469 17 -19.0 639.3108 3 57.19 6 28491 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 122 138 Carbamidomethylation; Methylation(KR)
R.VEEGDQ(+.98)VTVGQ(+.98)C(+57.02)RPLSK.T Y 44.77 1902.8993 17 -9.0 635.3013 3 58.60 6 29441 VEV_3_3_RA6_01_1237.d 0 1 1 122 138 Deamidation (NQ); Carbamidomethylation
R.W(+42.01)YKDVGLGFR.T Y 43.91 1281.6505 10 -8.6 428.2205 3 70.41 6 38188 VEV_3_3_RA6_01_1237.d 1.62E6 2 2 39 48 Acetylation (N-term)
R.VEEGD(+14.02)QVTVGQC(+57.02)RPLSK.T Y 43.90 1914.9469 17 -1.4 639.3220 3 58.88 5 30732 VEV_2_3_RA5_01_1236.d 1.3E4 1 1 122 138 Methylation(others); Carbamidomethylation
K.NIAAHVSPAFR(+14.02).V Y 43.20 1195.6461 11 -8.8 399.5525 3 61.63 6 31630 VEV_3_3_RA6_01_1237.d 8.23E4 2 2 111 121 Methylation(KR)
R.REYLHYIPK.Y Y 42.78 1217.6556 9 -17.4 406.8854 3 51.87 6 25447 VEV_3_3_RA6_01_1237.d 1.2E5 2 2 93 101
K.DVGLGFR.T Y 42.12 762.4024 7 -11.9 382.2039 2 64.28 4 34715 VEV_1_3_RA4_01_1235.d 1.13E6 8 8 42 48
R.FNVLR.V Y 41.93 647.3755 5 -19.9 324.6886 2 49.34 6 23921 VEV_3_3_RA6_01_1237.d 1.47E7 9 9 142 146
K.G(+43.01)GRRWYKDVGLGFR.T Y 41.28 1708.8910 14 -2.8 428.2288 4 70.46 5 39330 VEV_2_3_RA5_01_1236.d 0 1 1 35 48 Carbamylation
M.A(+42.01)TELTVQSERAFQK.Q Y 40.31 1648.8420 14 -8.5 825.4213 2 72.13 5 40561 VEV_2_3_RA5_01_1236.d 4.31E4 1 1 2 15 Acetylation (Protein N-term)
M.ATELTVQSER.A Y 39.15 1132.5724 10 0.4 567.2937 2 36.79 4 16807 VEV_1_3_RA4_01_1235.d 1.45E5 3 3 2 11
K.Q(+.98)FGKF Y 38.71 626.3064 5 -12.8 627.3057 1 48.60 5 24285 VEV_2_3_RA5_01_1236.d 1.61E5 1 1 157 161 Deamidation (NQ)
K.Q(-17.03)PHIFLN(+.98)SK.Q Y 38.58 1066.5447 9 -17.4 534.2703 2 69.84 6 37727 VEV_3_3_RA6_01_1237.d 7.4E4 1 1 16 24 Pyro-glu from Q; Deamidation (NQ)
R.WYKD(+14.02)VGLGFR.T Y 35.07 1253.6556 10 -1.2 418.8920 3 72.34 6 39614 VEV_3_3_RA6_01_1237.d 3.43E4 2 2 39 48 Methylation(others)
K.C(+44.03)PFTGQVSIR.G Y 34.56 1150.5804 10 -22.1 576.2848 2 79.10 4 46325 VEV_1_3_RA4_01_1235.d 2.42E5 1 1 63 72 Ethanolation (C)
K.QFGKF Y 34.28 625.3224 5 -8.3 626.3245 1 44.69 4 21575 VEV_1_3_RA4_01_1235.d 1.97E6 4 4 157 161
R.GRILTGTVVSTK(+42.01)MHR.T Y 34.15 1696.9407 15 -49.1 425.2216 4 51.71 4 25970 VEV_1_3_RA4_01_1235.d 0 1 1 73 87 Acetylation (K)
R.WYKDVGLGFR(+.98)TPK.T Y 33.20 1566.8195 13 1.4 392.7127 4 67.38 4 37144 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 39 51 Deamidation (R)
R.W(+43.01)YKDVGLGFR.T Y 32.78 1282.6458 10 36.4 428.5714 3 70.46 5 39329 VEV_2_3_RA5_01_1236.d 0 1 1 39 48 Carbamylation
K.QPHIFLNS(+79.96)K.Q Y 32.76 1162.5441 9 18.3 388.5291 3 58.52 4 30375 VEV_1_3_RA4_01_1235.d 9.48E4 1 1 16 24 Sulfation
K.G(+183.98)GRRWYKDVGLGFR.T Y 32.41 1849.8682 14 -15.2 617.6206 3 70.28 5 39202 VEV_2_3_RA5_01_1236.d 0 1 1 35 48 3-Sulfobenzoic succinimidyl ester
R.A(+42.01)FQK(+42.01)QPHIFLNSK.Q Y 31.98 1640.8674 13 4.1 411.2258 4 58.02 4 30030 VEV_1_3_RA4_01_1235.d 0 2 2 12 24 Acetylation (Protein N-term); Acetylation (K)
K.T(+79.96)VRFNVLR.V Y 31.35 1083.5494 8 68.0 362.2150 3 59.57 5 31238 VEV_2_3_RA5_01_1236.d 0 1 1 139 146 Sulfation
M.A(+42.01)TELTVQ(+.98)SER.A Y 30.51 1175.5670 10 -14.6 588.7822 2 66.49 6 35318 VEV_3_3_RA6_01_1237.d 2.79E5 3 3 2 11 Acetylation (Protein N-term); Deamidation (NQ)
R.AFQKQPHIFLNSKQK.S Y 29.90 1812.9999 15 -15.9 454.2501 4 49.22 5 24680 VEV_2_3_RA5_01_1236.d 1.79E5 1 1 12 26
K.TAIE(+14.02)GSYIDKKC(+57.02)PFTGQVSIR.G Y 29.82 2383.2205 21 -15.6 795.4017 3 71.20 5 39877 VEV_2_3_RA5_01_1236.d 5.44E4 1 1 52 72 Methylation(others); Carbamidomethylation
K.TVRFNVLR(+14.02).V Y 29.50 1017.6083 8 -16.9 340.2043 3 63.24 5 33965 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 139 146 Methylation(KR)
R.WYKDVGLGFRTPK(+14.02).T Y 29.19 1579.8511 13 -22.5 527.6124 3 69.16 5 38378 VEV_2_3_RA5_01_1236.d 4.38E4 1 1 39 51 Methylation(KR)
R.VEEGDQ(+.98)VTVGQC(+57.02)RPLSK.T Y 28.91 1901.9153 17 6.2 634.9830 3 56.85 6 28266 VEV_3_3_RA6_01_1237.d 0 1 1 122 138 Deamidation (NQ); Carbamidomethylation
R.E(+14.02)YLHYIPK.Y Y 28.83 1075.5702 8 -11.4 538.7863 2 59.67 5 31301 VEV_2_3_RA5_01_1236.d 1.26E5 2 2 94 101 Methylation(others)
R.WY(-2.02)KDVGLGFRTPK.T Y 28.74 1563.8197 13 -20.1 522.2700 3 67.34 4 37115 VEV_1_3_RA4_01_1235.d 5.98E4 1 1 39 51 2-amino-3-oxo-butanoic_acid
R.TIIIR.R N 28.71 614.4115 5 -12.1 308.2093 2 38.89 4 18033 VEV_1_3_RA4_01_1235.d 3.65E5 3 3 88 92
R.AFQKQPHIFLNSK(+14.02)Q(+.98)KSK.S Y 27.79 2043.1265 17 -59.3 409.6083 5 58.12 4 30091 VEV_1_3_RA4_01_1235.d 6.9E5 1 1 12 28 Methylation(KR); Deamidation (NQ)
R.AFQ(+.98)KQPHIFLN(+.98)SK.Q Y 25.82 1558.8143 13 -4.9 390.7090 4 60.41 6 30738 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 12 24 Deamidation (NQ)
K.Q(-17.03)FGKF Y 25.29 608.2958 5 -14.4 609.2944 1 74.24 6 41028 VEV_3_3_RA6_01_1237.d 7.84E5 2 2 157 161 Pyro-glu from Q
K.C(+45.99)PFTGQVSIR.G Y 24.84 1152.5420 10 40.8 577.3018 2 63.71 6 33159 VEV_3_3_RA6_01_1237.d 3.92E4 1 1 63 72 Beta-methylthiolation
K.N(+.98)IAAHVSPAFRVEEGDQ(+.98)VTVGQC(+57.02)RPLSK.T Y 24.77 3066.5193 28 4.9 614.3141 5 69.22 4 38606 VEV_1_3_RA4_01_1235.d 0 1 1 111 138 Deamidation (NQ); Carbamidomethylation
R.EYLHYIPKYSR(+37.96).Y Y 24.59 1505.7069 11 -8.4 753.8544 2 86.27 4 51431 VEV_1_3_RA4_01_1235.d 3.98E5 3 3 94 104 Replacement of proton by potassium
R.FN(+.98)VLR.V Y 24.49 648.3595 5 -3.1 325.1860 2 55.80 4 28505 VEV_1_3_RA4_01_1235.d 7.79E4 2 2 142 146 Deamidation (NQ)
R.FNVLR(+14.02).V Y 24.26 661.3911 5 -9.5 331.6997 2 59.32 5 31044 VEV_2_3_RA5_01_1236.d 3.93E5 3 3 142 146 Methylation(KR)
R.HKNIAAHVSPAFR(+.98).V Y 23.83 1447.7684 13 2.1 483.5977 3 40.97 4 19276 VEV_1_3_RA4_01_1235.d 9.38E2 1 1 109 121 Deamidation (R)
R.GRILTGTVVST(-18.01)K(+14.02).M Y 22.88 1226.7346 12 -61.3 409.8937 3 51.83 4 26050 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 73 84 Dehydration; Methylation(KR)
K.QPHIFLN(+.98)S(+79.97)K.Q Y 22.82 1163.5376 9 61.3 388.8769 3 58.09 4 30077 VEV_1_3_RA4_01_1235.d 7.91E4 1 1 16 24 Deamidation (NQ); Phosphorylation (STY)
R.A(+42.01)FQKQPHIFLNSK(+14.02).Q Y 22.57 1612.8726 13 -25.2 404.2152 4 60.21 6 30590 VEV_3_3_RA6_01_1237.d 0 1 1 12 24 Acetylation (Protein N-term); Methylation(KR)
K.N(+42.01)(+.98)IAAHVSPAFR.V Y 22.19 1224.6251 11 -34.4 409.2016 3 57.40 6 28629 VEV_3_3_RA6_01_1237.d 0 1 1 111 121 Acetylation (N-term); Deamidation (NQ)
K.D(+356.19)VGLGFRTPK.T Y 21.84 1444.7860 10 39.8 362.2181 4 61.55 5 32720 VEV_2_3_RA5_01_1236.d 2.44E5 1 1 42 51 Biotin polyethyleneoxide amine
R.W(+42.01)(+31.99)YKDVGLGFR.T Y 21.59 1313.6404 10 29.7 438.9004 3 70.37 5 39264 VEV_2_3_RA5_01_1236.d 1.6E5 1 1 39 48 Acetylation (N-term); Dihydroxy
K.QPHIFLN(+.98)SK(-.98).Q Y 21.21 1082.5873 9 -13.1 361.8650 3 49.12 4 24322 VEV_1_3_RA4_01_1235.d 7.19E5 1 1 16 24 Deamidation (NQ); Amidation
R.WYK(+14.02)DVGLGFRTPK.T Y 21.20 1579.8511 13 -2.0 395.9692 4 68.61 5 37986 VEV_2_3_RA5_01_1236.d 3.04E4 1 1 39 51 Methylation(KR)
K.QPHIFLNSK(-.98).Q Y 21.03 1081.6033 9 -16.6 361.5357 3 65.26 5 35474 VEV_2_3_RA5_01_1236.d 7.6E4 1 1 16 24 Amidation
R.I(+42.01)LTGTVVSTK(+42.01).M Y 20.64 1101.6282 10 -15.1 368.2111 3 53.15 4 26896 VEV_1_3_RA4_01_1235.d 6.18E4 1 1 75 84 Acetylation (N-term); Acetylation (K)
R.ILTGTVVST(+79.97)K.M Y 20.59 1097.5734 10 -18.2 549.7840 2 77.15 6 43119 VEV_3_3_RA6_01_1237.d 2.63E4 1 1 75 84 Phosphorylation (STY)
K.QPHIFLNS(+162.05)K.Q Y 20.23 1244.6400 9 -1.9 623.3261 2 74.58 5 42309 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 16 24 Hexose (NSY)
R.A(+42.01)FQK(+14.02)Q(+.98)PHIFLNSK.Q Y 20.21 1613.8566 13 -5.9 404.4690 4 58.39 5 30375 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 12 24 Acetylation (Protein N-term); Methylation(KR); Deamidation (NQ)
K.TAIEGSYID(+21.98)K.K Y 19.99 1117.5267 10 5.4 559.7737 2 25.06 5 10514 VEV_2_3_RA5_01_1236.d 0 1 1 52 61 Sodium adduct
R.GRILTGTVVSTKM(+15.99)HR(+28.03).T Y 19.59 1698.9563 15 -93.4 425.7067 4 51.80 4 26034 VEV_1_3_RA4_01_1235.d 1.2E6 1 1 73 87 Oxidation (M); Dimethylation(KR)
K.TAIEGS(-18.01)YIDK.K Y 19.55 1077.5342 10 11.8 360.1896 3 56.17 4 28746 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 52 61 Dehydration
R.EYLHYIPK(-.98).Y Y 19.31 1060.5706 8 -30.1 531.2766 2 59.30 6 29932 VEV_3_3_RA6_01_1237.d 4.75E4 1 1 94 101 Amidation
K.C(+57.02)PFT(-18.01)GQ(+.98)VSIRGR.I Y 19.11 1359.6718 12 -11.9 680.8351 2 71.18 5 39861 VEV_2_3_RA5_01_1236.d 1.79E5 1 1 63 74 Carbamidomethylation; Dehydration; Deamidation (NQ)
K.DVGLGFRT(-18.01)PK.T Y 18.64 1070.5873 10 -21.0 536.2897 2 74.38 5 42151 VEV_2_3_RA5_01_1236.d 1.54E5 1 1 42 51 Dehydration
K.TAIEGSYIDK(+14.02).K Y 18.43 1109.5604 10 -15.0 555.7792 2 60.04 5 31577 VEV_2_3_RA5_01_1236.d 3.5E4 1 1 52 61 Methylation(KR)
R.GRILTGTVVST(+79.97)K.M Y 18.39 1310.6959 12 6.4 328.6833 4 27.96 4 11720 VEV_1_3_RA4_01_1235.d 0 1 1 73 84 Phosphorylation (STY)
K.C(+57.02)PFTGQ(+.98)VSIR(+14.02).G Y 18.24 1178.5753 10 6.0 590.2985 2 68.55 4 38078 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 63 72 Carbamidomethylation; Deamidation (NQ); Methylation(KR)
MATELT(+79.97)VQS(+79.97)ER.A Y 18.21 1423.5455 11 42.6 475.5427 3 40.40 6 18716 VEV_3_3_RA6_01_1237.d 5.86E4 1 1 1 11 Phosphorylation (STY)
K.YSRYEKR.H Y 17.86 1000.5090 7 -12.5 501.2555 2 9.81 5 2443 VEV_2_3_RA5_01_1236.d 5.25E4 2 2 102 108
MAT(-18.01)ELTVQSER(+14.02).A Y 17.83 1259.6179 11 -24.2 630.8010 2 68.19 5 37680 VEV_2_3_RA5_01_1236.d 7.75E4 1 1 1 11 Dehydration; Methylation(KR)
R.TIIIRR.E Y 17.68 770.5126 6 -27.6 386.2530 2 27.90 6 11762 VEV_3_3_RA6_01_1237.d 7.32E5 1 1 88 93
R.TPKTAIEGSYID(+21.98)K.K Y 17.01 1443.7222 13 7.5 482.2516 3 61.66 5 32781 VEV_2_3_RA5_01_1236.d 0 1 1 49 61 Sodium adduct
R.AFQ(+.98)KQ(+.98)PHIFLNSK.Q Y 16.73 1558.8143 13 0.8 390.7112 4 60.55 4 31891 VEV_1_3_RA4_01_1235.d 9.06E4 1 1 12 24 Deamidation (NQ)
K.DVGLGFR(+14.02).T Y 16.55 776.4180 7 -14.1 389.2108 2 69.85 4 39095 VEV_1_3_RA4_01_1235.d 8.59E4 1 1 42 48 Methylation(KR)
M(+42.01)ATELTVQSERAFQ(+.98)K.Q Y 16.27 1780.8666 15 12.4 446.2294 4 58.56 6 29431 VEV_3_3_RA6_01_1237.d 0 1 1 1 15 Acetylation (Protein N-term); Deamidation (NQ)
K.Y(+42.01)SRYEKR.H Y 16.07 1042.5195 7 5.3 348.5156 3 10.07 4 2495 VEV_1_3_RA4_01_1235.d 7.7E3 1 1 102 108 Acetylation (N-term)
R.I(+119.04)LTGTVVSTKMHR.T Y 15.45 1560.8446 13 -32.0 391.2059 4 50.29 6 24449 VEV_3_3_RA6_01_1237.d 2.15E5 1 1 75 87 Pyridylacetyl
total 126 peptides
C1G2J3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LRLNIVDTPGYGDQVNNDR.C Y 129.27 2158.0767 19 -8.8 720.3599 3 72.11 4 40875 VEV_1_3_RA4_01_1235.d 3.22E5 3 3 97 115
R.THLQDLIETTSQIHYETFR.A Y 128.88 2331.1494 19 -11.9 583.7877 4 79.68 4 46769 VEV_1_3_RA4_01_1235.d 4.25E5 4 4 284 302
K.LSDVVNVVPVIAK.S Y 122.42 1351.8075 13 -8.8 676.9051 2 77.94 5 44669 VEV_2_3_RA5_01_1236.d 6.18E5 3 3 174 186
K.STLINTIFASHLIDSK.G Y 118.31 1758.9515 16 -16.2 587.3149 3 82.35 6 46790 VEV_3_3_RA6_01_1237.d 8.63E5 7 7 53 68
R.AVNAQIKDIIPFAVVGSEK.S Y 112.58 1998.1149 19 -15.0 1000.0497 2 81.04 5 46749 VEV_2_3_RA5_01_1236.d 6.27E5 8 8 227 245
R.SHVGFDSITSQIERK.L Y 108.57 1702.8638 15 -19.8 568.6173 3 66.40 5 36316 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 18 32
R.LNIVDTPGYGDQVNNDR.C Y 103.46 1888.8915 17 -7.6 945.4458 2 69.45 4 38782 VEV_1_3_RA4_01_1235.d 1.9E5 3 3 99 115
K.KLSDVVNVVPVIAK.S Y 101.65 1479.9025 14 -27.2 494.2947 3 76.95 4 44652 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 173 186
R.SHVGFDSITSQIER.K Y 99.60 1574.7688 14 -12.9 525.9235 3 70.15 5 39104 VEV_2_3_RA5_01_1236.d 5.09E5 5 5 18 31
K.ESSATGHSSGSRPISPSTNR.E Y 99.04 2013.9464 20 -7.2 504.4902 4 20.18 4 7482 VEV_1_3_RA4_01_1235.d 6.61E5 7 7 311 330
R.IHC(+57.02)C(+57.02)LFFIQPSGHALKPIDIVVLK.K Y 97.62 2804.5232 24 -0.1 561.9119 5 82.62 4 48958 VEV_1_3_RA4_01_1235.d 2.36E5 2 2 149 172 Carbamidomethylation
R.LNIVDTPGYGDQVNNDRC(+57.02)WDPIVK.Y Y 94.75 2787.3286 24 -5.3 930.1119 3 78.84 4 46127 VEV_1_3_RA4_01_1235.d 3.51E5 5 5 99 122 Carbamidomethylation
R.GFQFNVIC(+57.02)VGQTGLGK.S Y 93.41 1723.8716 16 -11.1 862.9335 2 82.02 5 47358 VEV_2_3_RA5_01_1236.d 2.8E5 3 3 37 52 Carbamidomethylation
R.STTEIQAVSHIIEENGVR.L Y 91.16 1982.0068 18 -7.6 661.6712 3 77.24 4 44883 VEV_1_3_RA4_01_1235.d 1.64E5 1 1 79 96
K.MYPYDNDELDNEER.A Y 84.11 1801.7101 14 -7.1 901.8560 2 67.51 4 37249 VEV_1_3_RA4_01_1235.d 2.87E5 3 3 213 226
K.M(+15.99)YPYDNDELDNEER.A Y 81.11 1817.7050 14 -11.2 909.8496 2 63.22 6 32802 VEV_3_3_RA6_01_1237.d 2.2E5 3 3 213 226 Oxidation (M)
M.A(+42.01)SPLSPVSAQSTVFPR.S Y 78.28 1684.8784 16 -8.3 843.4395 2 82.59 4 48932 VEV_1_3_RA4_01_1235.d 1.58E6 7 7 2 17 Acetylation (Protein N-term)
K.RGFQFNVIC(+57.02)VGQTGLGK.S Y 74.86 1879.9727 17 -17.3 627.6540 3 78.26 4 45681 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 36 52 Carbamidomethylation
R.LRPDEPVR.S Y 72.12 980.5403 8 -16.4 491.2694 2 26.31 5 11293 VEV_2_3_RA5_01_1236.d 6.79E5 6 6 71 78
K.SDSLTLEER.M Y 71.05 1048.5037 9 -13.6 525.2520 2 47.18 6 22661 VEV_3_3_RA6_01_1237.d 1.75E6 10 10 187 195
R.THLQDLIET(-2.02)TSQIHYETFR.A Y 69.36 2329.1338 19 20.6 583.3027 4 79.79 4 46859 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 284 302 2-amino-3-oxo-butanoic_acid
K.STLINTIFASHLIDSKGR.L Y 67.96 1972.0741 18 -21.6 658.3511 3 79.20 5 45521 VEV_2_3_RA5_01_1236.d 4.46E5 4 4 53 70
R.WGVINVEDESHC(+57.02)EFVYLR.N Y 67.09 2251.0369 18 -7.4 751.3474 3 81.77 6 46426 VEV_3_3_RA6_01_1237.d 7.08E4 3 3 261 278 Carbamidomethylation
K.YIKDQHSAYLRK.E Y 62.91 1520.8099 12 1.4 507.9446 3 26.60 5 11393 VEV_2_3_RA5_01_1236.d 8.98E5 8 8 123 134
R.IKEEFAFHNLK.M Y 51.38 1374.7295 11 -21.9 344.6821 4 60.58 6 30852 VEV_3_3_RA6_01_1237.d 1.17E6 4 4 202 212
K.SDSLTLEER(+14.02).M Y 50.38 1062.5193 9 -6.0 532.2637 2 57.24 6 28524 VEV_3_3_RA6_01_1237.d 7.08E5 5 5 187 195 Methylation(KR)
R.WGVIN(+.98)VEDESHC(+57.02)EFVYLR.N Y 46.96 2252.0208 18 -0.4 751.6805 3 81.87 4 48439 VEV_1_3_RA4_01_1235.d 6.27E4 2 2 261 278 Deamidation (NQ); Carbamidomethylation
R.THLQDLIETTSQIHYETFR(+14.02).A Y 45.74 2345.1650 19 -2.8 587.2969 4 81.02 4 47806 VEV_1_3_RA4_01_1235.d 9.85E4 3 3 284 302 Methylation(KR)
R.THLQDLIE(+14.02)TTSQIHYETFR.A Y 42.78 2345.1650 19 -9.5 782.7215 3 79.97 5 46028 VEV_2_3_RA5_01_1236.d 2.38E5 1 1 284 302 Methylation(others)
M.A(+42.01)SPLSPVSAQSTVFPR(+14.02).S Y 42.73 1698.8940 16 -14.6 850.4419 2 84.05 5 48628 VEV_2_3_RA5_01_1236.d 4.52E4 1 1 2 17 Acetylation (Protein N-term); Methylation(KR)
K.SIIVAGK.Q Y 40.88 686.4326 7 -8.0 687.4344 1 31.95 4 13980 VEV_1_3_RA4_01_1235.d 4.71E5 6 6 246 252
K.ESSATGHSSGSRPIS(+79.97)PSTNR.E Y 36.66 2093.9126 20 -11.1 698.9704 3 23.97 6 9653 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 311 330 Phosphorylation (STY)
K.ELTAQRER.Y Y 36.16 1001.5254 8 -11.4 501.7643 2 12.85 5 3889 VEV_2_3_RA5_01_1236.d 8.08E4 2 2 135 142
K.Q(-17.03)LLALKESSATGHSSGSRPISPSTNR.E Y 32.29 2663.3625 26 -12.0 888.7842 3 64.58 5 34960 VEV_2_3_RA5_01_1236.d 2.1E5 3 3 305 330 Pyro-glu from Q
K.SIIVAGKQVR.G Y 29.58 1069.6608 10 -8.9 357.5577 3 41.70 5 20137 VEV_2_3_RA5_01_1236.d 8.87E4 2 2 246 255
R.THLQDLIETT(-2.02)SQIHYETFR.A Y 27.53 2329.1338 19 9.4 777.3925 3 79.68 6 44933 VEV_3_3_RA6_01_1237.d 0 2 2 284 302 2-amino-3-oxo-butanoic_acid
R.AVNAQ(+.98)IKDIIPFAVVGSEK.S Y 26.72 1999.0989 19 1.2 667.3744 3 81.08 4 47844 VEV_1_3_RA4_01_1235.d 7.88E4 1 1 227 245 Deamidation (NQ)
R.AVNAQIK(+14.02)D(-18.01)IIPFAVVGSEK.S Y 25.34 1994.1200 19 -67.6 665.6690 3 81.02 5 46718 VEV_2_3_RA5_01_1236.d 0 1 1 227 245 Methylation(KR); Dehydration
R.NFLTR.T N 25.19 649.3547 5 -10.9 325.6811 2 39.89 4 18633 VEV_1_3_RA4_01_1235.d 2.79E5 2 2 279 283
R.LRLNIVDTPGYGDQVN(+.98)NDR.C Y 24.79 2159.0605 19 -22.6 720.6779 3 73.13 4 41683 VEV_1_3_RA4_01_1235.d 0 1 1 97 115 Deamidation (NQ)
R.S(-2.02)TTEIQAVSHIIEENGVRLR.L Y 24.73 2249.1763 20 -22.7 563.2886 4 78.69 6 44212 VEV_3_3_RA6_01_1237.d 0 1 1 79 98 2-amino-3-oxo-butanoic_acid
R.AVN(+.98)AQIKDIIPFAVVGSEK.S Y 23.45 1999.0989 19 -61.4 667.3326 3 82.43 6 46819 VEV_3_3_RA6_01_1237.d 1.56E5 2 2 227 245 Deamidation (NQ)
K.YIKDQHSAYLR.K Y 23.37 1392.7150 11 -10.6 349.1823 4 34.02 6 15086 VEV_3_3_RA6_01_1237.d 1E5 2 2 123 133
K.SD(+14.02)SLTLEER.M Y 23.31 1062.5193 9 -6.7 532.2634 2 58.07 4 30064 VEV_1_3_RA4_01_1235.d 2.26E5 1 1 187 195 Methylation(others)
K.LS(-2.02)DVVNVVPVIAK.S Y 23.31 1349.7919 13 -70.7 675.8555 2 78.20 4 45630 VEV_1_3_RA4_01_1235.d 0 1 1 174 186 2-amino-3-oxo-butanoic_acid
K.ELTAQ(+.98)R.E Y 22.07 717.3657 6 -11.9 718.3644 1 67.12 4 36938 VEV_1_3_RA4_01_1235.d 4.97E4 1 1 135 140 Deamidation (NQ)
K.QLLALK.E Y 21.61 684.4534 6 -54.3 343.2154 2 43.81 5 21391 VEV_2_3_RA5_01_1236.d 5.02E4 1 1 305 310
R.T(+162.08)HLQDLIETTSQIHYETFR.A Y 20.60 2493.2305 19 19.8 624.3272 4 88.79 5 51274 VEV_2_3_RA5_01_1236.d 5.73E4 1 1 284 302 O-Pinacolylmethylphosphonylation
K.DQHSAYLRK.E Y 20.18 1116.5676 9 -16.9 559.2817 2 15.47 6 5186 VEV_3_3_RA6_01_1237.d 1.94E4 1 1 126 134
K.ELTAQR(+14.02).E Y 19.97 730.3973 6 -26.0 731.3856 1 76.25 4 44104 VEV_1_3_RA4_01_1235.d 0 1 1 135 140 Methylation(KR)
K.DQH(+26.02)SAYLRK.E Y 19.68 1142.5833 9 -4.4 381.8667 3 26.69 5 11448 VEV_2_3_RA5_01_1236.d 3.99E5 1 1 126 134 Acetaldehyde +26
R.K(+14.02)ELT(+79.97)AQRER.Y Y 19.14 1223.6023 9 33.9 306.9182 4 31.01 4 13416 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 134 142 Methylation(KR); Phosphorylation (STY)
R.A(+42.01)VNAQIK(+21.98).D Y 18.56 806.4262 7 -22.1 807.4156 1 81.21 4 47948 VEV_1_3_RA4_01_1235.d 0 1 1 227 233 Acetylation (N-term); Sodium adduct
R.ERYIQDTR(+31.99).I Y 18.23 1111.5258 8 2.5 556.7715 2 49.28 4 24433 VEV_1_3_RA4_01_1235.d 1.31E5 1 1 141 148 Dihydroxy
K.SDSLT(+14.02)LEER.M Y 18.01 1062.5193 9 -8.4 532.2625 2 57.53 6 28715 VEV_3_3_RA6_01_1237.d 1.96E5 2 2 187 195 Methylation(others)
K.RGFQFNVIC(+57.02)VGQTGLGK(-.98).S Y 17.59 1878.9886 17 -29.9 627.3181 3 78.23 6 43905 VEV_3_3_RA6_01_1237.d 4.65E4 1 1 36 52 Carbamidomethylation; Amidation
R.AVNAQ(+.98)IK(+31.99)DIIPFAVVGSEK.S Y 17.46 2031.0887 19 -18.7 508.7700 4 75.09 6 41611 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 227 245 Deamidation (NQ); Dihydroxy
R.STT(+14.02)EIQAVSHIIEENGVR.L Y 17.09 1996.0225 18 -9.3 666.3419 3 80.73 4 47580 VEV_1_3_RA4_01_1235.d 0 1 1 79 96 Methylation(others)
R.SHVGFDSITSQIERK(-.98).L Y 16.63 1701.8798 15 -20.2 568.2891 3 66.28 6 35091 VEV_3_3_RA6_01_1237.d 2.9E4 1 1 18 32 Amidation
R.AVNAQIK.D Y 16.17 742.4337 7 -31.1 372.2126 2 65.87 5 35934 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 227 233
R.A(+42.01)KQ(+.98)LLALK.E Y 15.91 926.5800 8 -15.5 309.8625 3 43.44 5 21181 VEV_2_3_RA5_01_1236.d 2.34E5 1 1 303 310 Acetylation (N-term); Deamidation (NQ)
R.STTEIQAVSHIIEENGVRLR.L Y 15.89 2251.1919 20 -9.1 563.8001 4 78.72 4 46031 VEV_1_3_RA4_01_1235.d 0 1 1 79 98
MASPLS(+79.97)PVS(+79.97)AQSTVFPR.S Y 15.87 1933.8409 17 -6.2 967.9218 2 32.51 4 14294 VEV_1_3_RA4_01_1235.d 2.04E4 1 1 1 17 Phosphorylation (STY)
K.KLSDVVNVVPVIAK(-1.03).S Y 15.51 1478.8707 14 -30.2 493.9493 3 76.83 5 43896 VEV_2_3_RA5_01_1236.d 1.94E3 1 1 173 186 Lysine oxidation to aminoadipic semialdehyde
K.E(-18.01)LTAQR.E Y 15.30 698.3711 6 -11.0 350.1890 2 15.19 5 5137 VEV_2_3_RA5_01_1236.d 0 1 1 135 140 Pyro-glu from E
R.T(-2.02)HLQDLIETTSQIHYETFR.A Y 15.20 2329.1338 19 16.4 777.3979 3 79.66 4 46756 VEV_1_3_RA4_01_1235.d 0 1 1 284 302 2-amino-3-oxo-butanoic_acid
total 66 peptides
C1GMZ1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSGGFGGSPKPTAR.R Y 126.68 1274.6367 14 -8.3 638.3204 2 25.09 5 10569 VEV_2_3_RA5_01_1236.d 1.24E6 5 5 754 767
R.IVNTTSTSGIYGNFGQANYAAAK.L Y 125.07 2347.1443 23 -8.9 783.3817 3 73.60 4 42068 VEV_1_3_RA4_01_1235.d 6.02E5 5 5 439 461
R.GANVVVNDLGGSHTGVGASSK.A Y 121.79 1924.9602 21 -17.5 642.6495 3 60.32 6 30685 VEV_3_3_RA6_01_1237.d 5.45E5 3 3 32 52
R.VINTSSSAGLFGNFGQTNYSAAK.L Y 107.00 2333.1287 23 -15.4 778.7048 3 78.70 4 46016 VEV_1_3_RA4_01_1235.d 1.52E5 3 3 145 167
K.YNIFVNTIAPNAGTQLTR.T Y 104.94 1992.0428 18 -7.9 997.0209 2 81.14 4 47896 VEV_1_3_RA4_01_1235.d 3.47E5 5 5 478 495
K.YNILANVIAPIAASR.M Y 96.51 1584.8987 15 -15.0 793.4448 2 85.79 6 48954 VEV_3_3_RA6_01_1237.d 8.44E4 2 2 184 198
R.SDHPEDGQAGMK.S Y 95.78 1270.5248 12 -1.1 636.2690 2 14.32 4 4450 VEV_1_3_RA4_01_1235.d 1.21E4 1 1 576 587
K.LIDVIDKGNAAIVVVGYTTK.D Y 92.39 2088.1831 20 -6.4 697.0638 3 80.20 4 47174 VEV_1_3_RA4_01_1235.d 4.1E4 1 1 716 735
K.LGAAVVVNDLVDPESVVQEIRK.A Y 90.85 2349.2903 22 -5.6 784.0997 3 84.87 4 50499 VEV_1_3_RA4_01_1235.d 6.95E4 2 2 336 357
R.FDNQTVVITGAGGGLGK.A Y 87.31 1632.8470 17 -7.6 817.4246 2 70.83 4 39868 VEV_1_3_RA4_01_1235.d 1.48E5 3 3 6 22
R.LN(+.98)GD(-18.01)YNPLHIDPEFSK.I Y 85.46 1840.8632 16 -4.2 921.4350 2 83.34 4 49493 VEV_1_3_RA4_01_1235.d 1.31E5 1 1 801 816 Deamidation (NQ); Dehydration
K.AVANYDSVEFGER.I Y 84.83 1455.6630 13 18.3 728.8521 2 66.30 4 36336 VEV_1_3_RA4_01_1235.d 8.39E4 2 2 68 80
R.IDILINNAGILR.D Y 84.62 1323.7874 12 -38.5 662.8755 2 81.39 4 48080 VEV_1_3_RA4_01_1235.d 0 1 1 92 103
K.LAIAGAGAELVSTGSKL Y 83.08 1556.8773 17 -29.6 779.4229 2 79.53 4 46654 VEV_1_3_RA4_01_1235.d 0 1 1 885 901
K.TSEDQAVLYR.L Y 82.29 1180.5724 10 -14.3 591.2850 2 49.53 6 24080 VEV_3_3_RA6_01_1237.d 6.03E5 7 7 791 800
K.AATAAYKPLQR.K Y 80.45 1188.6615 11 -30.6 595.3198 2 32.46 4 14274 VEV_1_3_RA4_01_1235.d 8.99E5 7 7 771 781
R.LN(-17.03)GDYNPLHIDPEFSK.I Y 75.73 1840.8632 16 -5.7 921.4337 2 83.16 5 48053 VEV_2_3_RA5_01_1236.d 7.59E4 2 2 801 816 Ammonia-loss (N)
R.SGGHGFPVDTK.L Y 75.59 1100.5250 11 22.8 551.2823 2 30.56 5 13577 VEV_2_3_RA5_01_1236.d 0 2 2 546 556
K.TGDDLFYNESTIFIR.G Y 74.39 1789.8523 15 -5.7 895.9283 2 84.32 4 50139 VEV_1_3_RA4_01_1235.d 3.37E5 3 3 739 753
R.FAGVVLPGQTLK.T Y 71.11 1228.7179 12 -45.6 615.3382 2 75.39 6 41827 VEV_3_3_RA6_01_1237.d 1.04E5 3 3 852 863
K.AADVVVDEIKAAGGK.A Y 67.92 1441.7776 15 -12.3 721.8872 2 66.61 5 36475 VEV_2_3_RA5_01_1236.d 2.45E5 5 5 53 67
K.AADVVVDEIK.A Y 59.96 1057.5656 10 -7.4 529.7861 2 62.07 4 33043 VEV_1_3_RA4_01_1235.d 1.47E5 2 2 53 62
K.LGAAVVVNDLVDPESVVQEIR.K Y 58.70 2221.1953 21 -26.4 741.3862 3 88.18 5 50939 VEV_2_3_RA5_01_1236.d 0 1 1 336 356
K.VALITGAGAGLGR.A Y 58.19 1154.6771 13 -42.1 578.3215 2 69.18 4 38579 VEV_1_3_RA4_01_1235.d 4.45E4 4 4 315 327
R.KPDTVVEEK.T Y 56.30 1043.5498 9 -16.0 522.7738 2 15.65 5 5389 VEV_2_3_RA5_01_1236.d 9.8E4 4 4 782 790
R.VIN(+.98)TSSSAGLFGNFGQTNYSAAK.L Y 47.35 2334.1128 23 6.7 779.0500 3 78.66 4 45985 VEV_1_3_RA4_01_1235.d 2.26E5 2 2 145 167 Deamidation (NQ)
K.AYALFFGQR.G Y 47.12 1071.5502 9 -16.7 536.7734 2 76.65 6 42744 VEV_3_3_RA6_01_1237.d 6.88E4 1 1 23 31
K.LGILGFSR.A Y 46.32 861.5072 8 -19.4 431.7525 2 75.96 6 42254 VEV_3_3_RA6_01_1237.d 2.61E5 3 3 462 469
K.SIMANMSNVSGGK.E Y 45.24 1294.6010 13 -2.8 648.3060 2 60.90 4 32166 VEV_1_3_RA4_01_1235.d 1.57E5 2 2 588 600
R.DVILYNVSLGAK.R Y 44.51 1290.7183 12 -29.5 646.3474 2 78.11 5 44839 VEV_2_3_RA5_01_1236.d 2.56E4 2 2 633 644
K.AEGTPLDYVSR.D Y 39.82 1206.5880 11 -17.0 604.2910 2 66.61 4 36535 VEV_1_3_RA4_01_1235.d 9.5E4 1 1 622 632
R.AYALLFSK.L Y 39.06 911.5116 8 -34.4 456.7474 2 72.37 5 40785 VEV_2_3_RA5_01_1236.d 7.62E4 2 2 328 335
K.LSMVGFTETLAK.E Y 39.02 1295.6794 12 -43.5 648.8188 2 78.95 6 44402 VEV_3_3_RA6_01_1237.d 4.68E4 2 2 168 179
K.GLYEC(+57.02)GSGWFTK.T Y 37.33 1403.6179 12 -5.1 702.8126 2 75.61 4 43609 VEV_1_3_RA4_01_1235.d 5.03E4 1 1 529 540 Carbamidomethylation
K.WNDVKDFSEPSYPTGPANFLELLEQAQNVPSAPAAQSLDFTGK.V Y 32.78 4678.2500 43 -5.2 1170.5637 4 93.45 4 55533 VEV_1_3_RA4_01_1235.d 0 1 1 272 314
K.DLDWDLINKVHVFGSYK.C Y 32.56 2048.0366 17 42.8 513.0383 4 84.03 4 49934 VEV_1_3_RA4_01_1235.d 0 1 1 112 128
K.AEGTPLDYVSRDVILYNVSLGAK.R Y 32.48 2479.2959 23 -8.0 827.4326 3 85.69 4 51038 VEV_1_3_RA4_01_1235.d 1.59E5 2 2 622 644
K.ILAAIETAK.N Y 31.32 928.5593 9 -12.5 465.2812 2 58.01 4 30015 VEV_1_3_RA4_01_1235.d 1.7E5 3 3 610 618
R.A(+42.01)VGSK(+31.99).A Y 30.70 534.2649 5 25.1 535.2856 1 55.97 5 28745 VEV_2_3_RA5_01_1236.d 0 1 1 362 366 Acetylation (N-term); Dihydroxy
R.GS(-2.02)GGFGGSPKPTAR.R Y 30.47 1272.6211 14 -28.7 425.2021 3 25.03 5 10493 VEV_2_3_RA5_01_1236.d 0 1 1 754 767 2-amino-3-oxo-butanoic_acid
K.TSEDQAVLYR(+14.02).L Y 30.22 1194.5880 10 -9.9 598.2953 2 58.63 4 30461 VEV_1_3_RA4_01_1235.d 7.16E4 2 2 791 800 Methylation(KR)
K.YN(+.98)IFVN(+.98)TIAPNAGTQLTR.T Y 29.74 1994.0109 18 -5.6 665.6738 3 80.96 6 45832 VEV_3_3_RA6_01_1237.d 2.69E4 1 1 478 495 Deamidation (NQ)
R.DISFK.N Y 27.08 608.3170 5 -15.0 609.3151 1 38.92 4 18054 VEV_1_3_RA4_01_1235.d 2.78E4 3 3 104 108
K.AAGGK(+21.98).A Y 26.81 424.2046 5 -3.3 425.2105 1 19.09 5 7262 VEV_2_3_RA5_01_1236.d 0 1 1 63 67 Sodium adduct
R.ALALEGAK.Y Y 26.12 771.4490 8 -19.2 772.4415 1 37.06 4 16965 VEV_1_3_RA4_01_1235.d 1.67E5 2 2 470 477
R.LNGDYNPLHIDPEFSK.I Y 25.27 1857.8896 16 -3.3 620.3018 3 76.95 4 44656 VEV_1_3_RA4_01_1235.d 3.11E5 2 2 801 816
K.VHVFGSYK.C Y 24.55 935.4865 8 -15.2 468.7434 2 64.39 6 33654 VEV_3_3_RA6_01_1237.d 6.57E4 1 1 121 128
K.AAGGK.A Y 24.53 402.2227 5 -1.4 403.2294 1 74.97 4 43103 VEV_1_3_RA4_01_1235.d 1.66E4 2 2 63 67
K.IVTFDAR.S Y 23.47 820.4443 7 -17.6 411.2222 2 50.50 6 24578 VEV_3_3_RA6_01_1237.d 8.73E4 2 2 569 575
K.TSE(+14.02)DQAVLYR.L Y 22.71 1194.5880 10 -18.0 598.2905 2 59.84 4 31369 VEV_1_3_RA4_01_1235.d 8.53E4 1 1 791 800 Methylation(others)
R.AVGSK(-.98).A Y 21.82 459.2805 5 11.3 460.2930 1 100.68 6 55537 VEV_3_3_RA6_01_1237.d 0 1 1 362 366 Amidation
K.ENGAVVFQ(+.98)TTVVETGK(+226.08).L Y 21.30 1904.9189 16 -2.7 635.9785 3 56.78 4 29157 VEV_1_3_RA4_01_1235.d 8.53E4 1 1 869 884 Deamidation (NQ); Biotinylation
K.L(+42.01)T(+79.97)PEAVK.S Y 20.81 878.4150 7 28.7 440.2274 2 68.67 6 36897 VEV_3_3_RA6_01_1237.d 9.97E4 1 1 557 563 Acetylation (N-term); Phosphorylation (STY)
K.AAGGK(+27.99).A Y 20.41 430.2176 5 -37.0 431.2089 1 34.86 6 15567 VEV_3_3_RA6_01_1237.d 2.3E5 1 1 63 67 Formylation
K.YPIPTAAKT(+79.97)VSIP(+31.99)K.L Y 20.35 1596.8164 14 -21.9 400.2026 4 52.06 5 26425 VEV_2_3_RA5_01_1236.d 0 1 1 702 715 Phosphorylation (STY); Dihydroxy
K.TEM(+15.99)WKENGAVVFQTTVVETGK.L Y 20.29 2369.1572 21 -10.3 593.2905 4 69.93 5 38943 VEV_2_3_RA5_01_1236.d 0 1 1 864 884 Oxidation (M)
R.K(+14.02)PDTVVEEKTSEDQAVLYR.L Y 19.89 2220.1274 19 -12.7 556.0321 4 62.97 4 33735 VEV_1_3_RA4_01_1235.d 8.6E4 1 1 782 800 Methylation(KR)
K.AAGGK(+43.01).A Y 19.64 445.2285 5 -7.1 446.2326 1 34.73 4 15599 VEV_1_3_RA4_01_1235.d 0 1 1 63 67 Carbamylation
R.WQR(+14.02)SGGHGFPVDTKLTPEAVK(+42.01)SEWK.K Y 19.51 2895.4668 25 11.0 724.8820 4 66.60 4 36534 VEV_1_3_RA4_01_1235.d 7.28E4 1 1 543 567 Methylation(KR); Acetylation (K)
K.IVT(+79.97)FDAR.S Y 18.69 900.4106 7 30.7 451.2264 2 28.86 6 12254 VEV_3_3_RA6_01_1237.d 0 1 1 569 575 Phosphorylation (STY)
K.YPIPTAAKT(+79.97)VSIPK(+42.01).L Y 18.62 1606.8372 14 37.6 402.7317 4 68.60 4 38115 VEV_1_3_RA4_01_1235.d 0 1 1 702 715 Phosphorylation (STY); Acetylation (K)
K.LTPEAVK.S Y 18.40 756.4381 7 -49.1 379.2078 2 36.32 4 16560 VEV_1_3_RA4_01_1235.d 0 1 1 557 563
K.G(+43.01)NAAIVVVGYTTK.D Y 18.37 1334.7194 13 -55.4 668.3300 2 63.14 5 33883 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 723 735 Carbamylation
R.FD(-18.01)NQTVVITGAGGGLGK.A Y 17.96 1614.8365 17 -23.4 808.4066 2 79.44 4 46590 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 6 22 Dehydration
K.AAGGK(-.98)(+42.01).A Y 17.88 443.2492 5 -21.8 444.2468 1 63.10 4 33837 VEV_1_3_RA4_01_1235.d 1.7E5 1 1 63 67 Amidation; Acetylation (K)
R.A(+42.01)VGSK.A Y 17.78 502.2751 5 15.8 503.2903 1 85.32 4 50809 VEV_1_3_RA4_01_1235.d 1.94E4 1 1 362 366 Acetylation (N-term)
R.IIETAIN(+.98)AFGR(+21.98).I Y 17.75 1226.6271 11 -18.2 614.3096 2 73.04 4 41617 VEV_1_3_RA4_01_1235.d 0 1 1 81 91 Deamidation (NQ); Sodium adduct
K.SIMANMSNVSGGK(+14.02)EGGSTGDK(+43.01)K.I Y 17.61 2211.0259 22 17.0 738.0284 3 77.58 4 45152 VEV_1_3_RA4_01_1235.d 4.88E5 1 1 588 609 Methylation(KR); Carbamylation
K.T(+79.97)DASLTPQAILAK.W Y 17.58 1407.7010 13 14.4 470.2477 3 56.27 5 28979 VEV_2_3_RA5_01_1236.d 0 1 1 259 271 Phosphorylation (STY)
K.AAWPYFLK(+21.98).Q Y 17.25 1016.5095 8 -5.3 509.2593 2 28.88 4 12230 VEV_1_3_RA4_01_1235.d 0 1 1 426 433 Sodium adduct
K.ASVEDGEAVVKPAIDAFGR.I Y 17.22 1929.9795 19 -28.4 644.3155 3 76.28 6 42469 VEV_3_3_RA6_01_1237.d 1.03E5 1 1 367 385
K.AADVVVDEIK(+31.99).A Y 16.58 1089.5553 10 12.2 364.1968 3 47.71 5 23784 VEV_2_3_RA5_01_1236.d 1.85E5 1 1 53 62 Dihydroxy
K.LTPEAVKSEWK.K Y 16.55 1286.6870 11 -8.8 644.3451 2 74.67 4 42875 VEV_1_3_RA4_01_1235.d 1.16E4 1 1 557 567
R.GANVVVNDLGGSHTGVGASSK(+43.01).A Y 16.41 1967.9661 21 9.5 493.0034 4 55.22 6 27290 VEV_3_3_RA6_01_1237.d 4.07E4 1 1 32 52 Carbamylation
R.WQR(+14.02)SGGHGFPVDTK.L Y 16.10 1584.7797 14 -9.4 793.3896 2 88.15 6 50316 VEV_3_3_RA6_01_1237.d 5.42E4 1 1 543 556 Methylation(KR)
K.AY(-18.01)ALFFGQR.G Y 16.02 1053.5396 9 13.0 352.1917 3 29.70 5 13093 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 23 31 Dehydration
K.K(+42.01)IVT(+79.97)FDAR.S Y 16.01 1070.5161 8 -7.0 536.2616 2 58.31 5 30322 VEV_2_3_RA5_01_1236.d 0 1 1 568 575 Acetylation (N-term); Phosphorylation (STY)
R.GAN(+.98)VVVNDLGGSHTGVGASSK(+21.98).A Y 15.99 1947.9261 21 -16.5 650.3053 3 73.98 5 41859 VEV_2_3_RA5_01_1236.d 0 1 1 32 52 Deamidation (NQ); Sodium adduct
K.GN(+.98)AAIVVVGYTTKD(+21.98)AK.T Y 15.89 1628.8385 16 -12.5 408.2118 4 19.20 5 7319 VEV_2_3_RA5_01_1236.d 1.9E4 1 1 723 738 Deamidation (NQ); Sodium adduct
R.AVGS(-18.01)K(+42.01).A Y 15.88 484.2645 5 -22.9 485.2607 1 15.88 5 5523 VEV_2_3_RA5_01_1236.d 2.32E4 1 1 362 366 Dehydration; Acetylation (K)
K.LT(+79.97)PEAVK(+42.01).S Y 15.85 878.4150 7 48.5 440.2361 2 62.12 5 33131 VEV_2_3_RA5_01_1236.d 1.7E4 1 1 557 563 Phosphorylation (STY); Acetylation (K)
K.T(+42.01)YGPFKS(+79.97)LK(+42.01)VR.F Y 15.67 1458.7272 11 -18.1 487.2409 3 47.16 4 23149 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 841 851 Acetylation (N-term); Phosphorylation (STY); Acetylation (K)
K.YNIFVNTIAPNAGTQLT(+79.97)R.T Y 15.58 2072.0093 18 18.1 519.0190 4 75.86 6 42176 VEV_3_3_RA6_01_1237.d 2.26E4 1 1 478 495 Phosphorylation (STY)
K.DLDWDLINK(+42.01)VHVFGSYKC(+57.02)TR.A Y 15.54 2507.2268 20 -0.1 627.8139 4 64.68 4 35028 VEV_1_3_RA4_01_1235.d 0 1 1 112 131 Acetylation (K); Carbamidomethylation
K.S(+42.01)IMANMSNVSGGK(+42.01).E Y 15.50 1378.6221 13 -2.6 690.3165 2 46.30 5 22906 VEV_2_3_RA5_01_1236.d 0 1 1 588 600 Acetylation (N-term); Acetylation (K)
K.LTPEAVKSEWK(+21.98).K Y 15.48 1308.6689 11 9.7 328.1777 4 19.62 4 7217 VEV_1_3_RA4_01_1235.d 1.86E5 1 1 557 567 Sodium adduct
K.SIMAN(+.98)MSN(+.98)VSGGK.E Y 15.47 1296.5690 13 18.5 649.3038 2 78.86 6 44343 VEV_3_3_RA6_01_1237.d 4.62E4 2 2 588 600 Deamidation (NQ)
K.DLDWDLINK.V Y 15.44 1130.5608 9 0.7 566.2881 2 61.97 4 32964 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 112 120
K.VPEPTK.G Y 15.44 669.3697 6 -13.4 335.6877 2 63.80 6 33222 VEV_3_3_RA6_01_1237.d 0 1 1 523 528
K.AAGGK(+42.01).A Y 15.41 444.2332 5 -43.1 445.2213 1 41.31 5 19916 VEV_2_3_RA5_01_1236.d 0 1 1 63 67 Acetylation (K)
R.AAWPYFRK.Q Y 15.32 1037.5447 8 -31.5 346.8446 3 61.97 6 31878 VEV_3_3_RA6_01_1237.d 3.52E4 2 2 132 139
K.L(+42.01)SMVGFTET(+79.97)LAK(+14.02)EGAK.Y Y 15.28 1816.8682 16 14.4 455.2309 4 57.44 6 28653 VEV_3_3_RA6_01_1237.d 2.52E5 1 1 168 183 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.IIETAINAFGR.I Y 15.28 1203.6611 11 -21.5 402.2190 3 61.82 6 31764 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 81 91
R.KAGGRAVGS(-18.01)K.A Y 15.22 911.5300 10 -24.4 456.7612 2 26.60 5 11387 VEV_2_3_RA5_01_1236.d 6.57E5 1 1 357 366 Dehydration
R.GS(+126.10)GGFGGSPKPTAR.R Y 15.17 1400.7412 14 -4.0 351.1912 4 57.09 6 28424 VEV_3_3_RA6_01_1237.d 0 1 1 754 767 Octanoyl
K.L(+42.01)GAAVVVNDLVDPES(-18.01)VVQEIR.K Y 15.04 2245.1953 21 -31.9 749.3818 3 77.90 5 44646 VEV_2_3_RA5_01_1236.d 6.2E4 1 1 336 356 Acetylation (N-term); Dehydration
total 96 peptides
C1G4N0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.QLTTLGDIYINDAFGTAHR.A Y 133.82 2105.0542 19 -14.6 702.6818 3 80.95 6 45825 VEV_3_3_RA6_01_1237.d 8.66E5 8 8 153 171
K.ALENPTRPFLAILGGSK.V Y 127.88 1782.9991 17 -16.8 595.3303 3 81.13 6 45971 VEV_3_3_RA6_01_1237.d 1.09E6 7 7 200 216
R.AHSSMVGINLPQK.A Y 121.15 1380.7184 13 -11.9 461.2413 3 61.04 4 32258 VEV_1_3_RA4_01_1235.d 2.09E5 6 6 172 184
K.ASGGQVILLENLR.F Y 105.08 1368.7725 13 -10.3 685.3865 2 76.94 5 43978 VEV_2_3_RA5_01_1236.d 5.59E5 5 5 111 123
K.Q(-17.03)LTTLGDIYINDAFGTAHR.A Y 104.37 2088.0276 19 -10.4 1045.0103 2 88.28 6 50402 VEV_3_3_RA6_01_1237.d 1.03E6 10 10 153 171 Pyro-glu from Q
R.AHSSM(+15.99)VGINLPQK.A Y 102.28 1396.7133 13 -12.0 466.5728 3 50.68 4 25295 VEV_1_3_RA4_01_1235.d 6.06E5 5 5 172 184 Oxidation (M)
K.VSDKIQLIDNLLDKVNTLIIC(+57.02)GAMAYTFKK.V Y 102.02 3423.8508 30 -21.6 685.7626 5 96.44 4 56934 VEV_1_3_RA4_01_1235.d 3.31E5 3 3 217 246 Carbamidomethylation
K.FSLKPVVPELEKLLGGSVVFTDDC(+57.02)VGK.Q Y 100.64 2932.5620 27 -6.8 734.1428 4 90.06 4 53683 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 76 102 Carbamidomethylation
R.KQLTTLGDIYINDAFGTAHR.A Y 100.36 2233.1492 20 -8.1 559.2900 4 77.10 4 44776 VEV_1_3_RA4_01_1235.d 9.82E4 3 3 152 171
K.FSLKPVVPELEK.L Y 86.04 1384.7965 12 -13.2 462.6000 3 74.77 4 42989 VEV_1_3_RA4_01_1235.d 7.53E5 3 3 76 87
K.IGSSLFDEAGSK.I Y 83.85 1209.5876 12 -0.3 605.8009 2 65.65 4 35792 VEV_1_3_RA4_01_1235.d 2.76E5 2 2 253 264
K.IGSSLFDEAGSKIVLDIVTK.A Y 82.55 2091.1462 20 -15.9 698.0449 3 86.08 6 49121 VEV_3_3_RA6_01_1237.d 2.52E5 4 4 253 272
K.AVVLMSHLGRPDGKPNPK.F Y 81.42 1915.0461 18 -13.7 479.7623 4 56.53 5 29125 VEV_2_3_RA5_01_1236.d 4.81E5 5 5 58 75
K.LLGGSVVFTDDC(+57.02)VGK.Q Y 78.16 1565.7759 15 -20.4 783.8793 2 76.42 6 42585 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 88 102 Carbamidomethylation
M.S(+42.01)LSNKLSIADVDLKDKR.V Y 75.34 1943.0687 17 -10.1 648.6903 3 70.62 5 39443 VEV_2_3_RA5_01_1236.d 1.36E6 7 7 2 18 Acetylation (Protein N-term)
R.IVGAVPTIK.Y Y 75.25 896.5695 9 -25.8 449.2804 2 60.96 5 32300 VEV_2_3_RA5_01_1236.d 8.4E5 6 6 41 49
K.LSIADVDLKDKR.V Y 74.63 1371.7721 12 -17.3 343.9444 4 62.03 6 31967 VEV_3_3_RA6_01_1237.d 3.75E5 3 3 7 18
K.LLGGSVVFTDDC(+57.02)VGKQVEETVNK.A Y 70.27 2493.2419 23 -8.0 624.3128 4 78.87 4 46148 VEV_1_3_RA4_01_1235.d 3.85E4 2 2 88 110 Carbamidomethylation
R.VDFNVPLDGDKK.V Y 69.22 1345.6877 12 -18.1 449.5617 3 65.49 6 34548 VEV_3_3_RA6_01_1237.d 4.96E5 3 3 23 34
K.IVIIGGGDTATVAAK.Y Y 68.97 1384.7925 15 -41.0 693.3751 2 68.15 6 36504 VEV_3_3_RA6_01_1237.d 0 3 3 368 382
K.ELEYFAK.A Y 67.44 898.4436 7 -9.3 899.4425 1 59.70 4 31266 VEV_1_3_RA4_01_1235.d 9.42E5 4 4 193 199
R.FHPEEEGSYKDENGKK.V Y 64.16 1892.8540 16 -9.9 631.9524 3 22.19 6 8707 VEV_3_3_RA6_01_1237.d 5.32E5 7 7 124 139
R.IVGAVPTIKYAIDHGAK.A Y 61.47 1751.9934 17 -21.0 438.9964 4 69.37 5 38541 VEV_2_3_RA5_01_1236.d 1.17E5 2 2 41 57
K.VLDNVKIGSSLFDEAGSKIVLDIVTK.A Y 58.89 2759.5320 26 -13.3 690.8811 4 87.03 5 50326 VEV_2_3_RA5_01_1236.d 1.09E5 2 2 247 272
R.VLIRVDFNVPLDGDKK.V Y 56.39 1827.0254 16 -17.1 610.0053 3 76.26 5 43488 VEV_2_3_RA5_01_1236.d 3.28E5 2 2 19 34
K.YHAEDKLSHVSTGGGASLELLEGKDLPGVSALSSK Y 56.11 3551.8105 35 -38.0 711.3424 5 77.51 6 43380 VEV_3_3_RA6_01_1237.d 4.77E4 1 1 383 417
K.ALE(+14.02)NPTRPFLAILGGSK.V Y 53.89 1797.0148 17 -12.8 600.0045 3 82.22 4 48682 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 200 216 Methylation(others)
R.AHSSMVGINLPQ(+.98)K.A Y 53.79 1381.7024 13 -1.9 461.5739 3 61.13 4 32332 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 172 184 Deamidation (NQ)
K.ADKAKVEEFRK.Q Y 53.33 1319.7197 11 -11.7 440.9087 3 16.76 5 5967 VEV_2_3_RA5_01_1236.d 4.88E5 4 4 142 152
K.IVLDIVTK.A Y 48.90 899.5692 8 -14.4 450.7854 2 70.27 5 39193 VEV_2_3_RA5_01_1236.d 7.54E5 6 6 265 272
K.ALENPTRPFLAILGGSK(+14.02).V Y 47.55 1797.0148 17 -10.4 600.0060 3 81.36 6 46107 VEV_3_3_RA6_01_1237.d 3.73E4 1 1 200 216 Methylation(KR)
R.FHPEEEGSYKDEN(+.98)GKK.V Y 46.53 1893.8380 16 -6.1 474.4639 4 24.37 4 9769 VEV_1_3_RA4_01_1235.d 3.14E5 4 4 124 139 Deamidation (NQ)
K.AAGFLVK.K Y 46.48 704.4221 7 -20.1 353.2112 2 48.75 6 23585 VEV_3_3_RA6_01_1237.d 7.76E5 4 4 185 191
K.LFEGAIAEAK.T Y 44.91 1047.5601 10 -8.6 524.7828 2 65.58 4 35798 VEV_1_3_RA4_01_1235.d 3.96E5 3 3 323 332
K.AAGFLVKKELEYFAK.A Y 44.89 1712.9501 15 -15.1 429.2383 4 77.44 4 45037 VEV_1_3_RA4_01_1235.d 1.6E5 3 3 185 199
R.VLIRVDFNVPLDGDKKVANNQR.I Y 43.26 2509.3765 22 41.8 502.9035 5 72.98 4 41565 VEV_1_3_RA4_01_1235.d 0 1 1 19 40
K.Q(+.98)LTTLGDIYINDAFGTAHR.A Y 43.16 2106.0381 19 4.2 703.0229 3 82.03 5 47365 VEV_2_3_RA5_01_1236.d 5.8E4 1 1 153 171 Deamidation (NQ)
K.AAGFLVKK.E Y 40.86 832.5170 8 -19.5 417.2577 2 30.72 6 13254 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 185 192
K.ASGGQVILLE(+14.02)NLR.F Y 40.76 1382.7881 13 -12.7 461.9308 3 79.37 4 46527 VEV_1_3_RA4_01_1235.d 3.79E4 1 1 111 123 Methylation(others)
K.FSLKPVVPELEKLLGGSVVFTDDC(+57.02)VGKQVEETVNK.A Y 37.45 3860.0281 35 12.7 773.0227 5 89.37 4 53311 VEV_1_3_RA4_01_1235.d 0 1 1 76 110 Carbamidomethylation
K.AKVEEFRK.Q Y 37.10 1005.5607 8 -13.2 503.7810 2 15.12 6 5007 VEV_3_3_RA6_01_1237.d 4.47E4 2 2 145 152
K.LLGGSVVFTDDC(+57.02)VGKQVEETVNKASGGQVILLENLR.F Y 35.13 3844.0039 36 -4.8 962.0037 4 88.04 4 52534 VEV_1_3_RA4_01_1235.d 6.06E4 1 1 88 123 Carbamidomethylation
K.KELEYFAK.A Y 35.01 1026.5386 8 -21.4 514.2656 2 44.38 6 21052 VEV_3_3_RA6_01_1237.d 1.52E5 3 3 192 199
K.DLPGVSALSSK(+21.98) Y 32.98 1094.5583 11 -4.9 548.2838 2 61.74 4 32791 VEV_1_3_RA4_01_1235.d 2.56E4 1 1 407 417 Sodium adduct
K.Q(-17.03)LTTLGDIYIN(+.98)DAFGTAHR.A Y 32.05 2089.0117 19 -1.0 1045.5121 2 88.69 6 50626 VEV_3_3_RA6_01_1237.d 8.86E4 1 1 153 171 Pyro-glu from Q; Deamidation (NQ)
K.DLPGVSALSSK Y 30.85 1072.5764 11 -41.1 537.2734 2 69.02 6 37137 VEV_3_3_RA6_01_1237.d 1.54E4 1 1 407 417
K.ASGGQ(+.98)VILLENLR.F Y 26.97 1369.7565 13 -29.4 685.8654 2 76.99 4 44687 VEV_1_3_RA4_01_1235.d 0 1 1 111 123 Deamidation (NQ)
R.AHSSM(-48.00)VGINLPQK.A Y 25.98 1332.7150 13 -16.7 445.2382 3 37.88 6 17327 VEV_3_3_RA6_01_1237.d 5.12E5 1 1 172 184 Dethiomethyl
K.YAIDHGAK.A Y 25.42 873.4344 8 -11.2 437.7196 2 16.66 6 5804 VEV_3_3_RA6_01_1237.d 1.71E5 2 2 50 57
K.LSIADVDLK.D Y 24.25 972.5491 9 2.6 325.1912 3 44.10 4 21208 VEV_1_3_RA4_01_1235.d 5.28E4 2 2 7 15
K.ALEN(+.98)PTRPFLAILGGSK(+14.02).V Y 23.60 1797.9988 17 1.4 600.3411 3 81.45 4 48123 VEV_1_3_RA4_01_1235.d 3E3 1 1 200 216 Deamidation (NQ); Methylation(KR)
K.IGSSLFDEAGSK(-.98).I Y 23.45 1208.6036 12 3.3 605.3111 2 78.65 4 45980 VEV_1_3_RA4_01_1235.d 0 3 3 253 264 Amidation
K.VEEFRK.Q Y 23.07 806.4286 6 -17.7 404.2144 2 14.27 6 4560 VEV_3_3_RA6_01_1237.d 8.92E4 1 1 147 152
M(+15.99)SLSNK.L Y 21.45 694.3320 6 4.7 695.3425 1 112.02 5 59385 VEV_2_3_RA5_01_1236.d 0 1 1 1 6 Oxidation (M)
K.NNINIVFPVDHLIADK.F Y 21.23 1820.9784 16 -7.9 456.2483 4 70.20 5 39141 VEV_2_3_RA5_01_1236.d 7.35E4 1 1 276 291
K.S(+43.01)IKLFEGAIAEAK.T Y 20.89 1418.7769 13 -16.4 355.6957 4 46.32 5 22914 VEV_2_3_RA5_01_1236.d 1.35E6 1 1 320 332 Carbamylation
M.SLSNK(+40.03)LSIADVDLKDKR.V Y 19.60 1941.0895 17 -63.2 486.2490 4 70.87 4 39898 VEV_1_3_RA4_01_1235.d 9.52E4 1 1 2 18 Propionaldehyde +40
K.IVIIGGGDTAT(+79.97)VAAK.Y Y 19.17 1464.7589 15 -2.3 367.1962 4 43.79 5 21373 VEV_2_3_RA5_01_1236.d 0 1 1 368 382 Phosphorylation (STY)
MS(-18.01)LSNK.L Y 18.81 660.3265 6 -20.8 661.3200 1 22.39 5 9009 VEV_2_3_RA5_01_1236.d 7.42E3 1 1 1 6 Dehydration
K.IVLDIVTK(+21.98).A Y 18.52 921.5511 8 30.0 308.2002 3 49.75 4 24726 VEV_1_3_RA4_01_1235.d 0 1 1 265 272 Sodium adduct
K.V(+42.01)N(+.98)TLIIC(+57.02)GAMAYTFK.K Y 18.24 1743.8575 15 -12.7 582.2858 3 41.67 4 19704 VEV_1_3_RA4_01_1235.d 0 1 1 231 245 Acetylation (N-term); Deamidation (NQ); Carbamidomethylation
K.VSDKIQLIDNLLDKVNTLIIC(+57.02)GAM(+15.99)AYTFKK.V Y 18.12 3439.8457 30 20.9 688.9908 5 94.28 4 55953 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 217 246 Carbamidomethylation; Oxidation (M)
K.A(+42.01)AGFLVK.K Y 17.97 746.4326 7 -17.9 374.2169 2 49.15 5 24638 VEV_2_3_RA5_01_1236.d 4.98E5 2 2 185 191 Acetylation (N-term)
K.K(+42.01)NNINIVFPVDHLIADK.F Y 17.83 1991.0840 17 -80.6 399.1920 5 37.25 5 17505 VEV_2_3_RA5_01_1236.d 0 1 1 275 291 Acetylation (N-term)
K.FAGSTK(+175.04).A Y 17.80 784.3544 6 -8.4 393.1812 2 51.10 5 25817 VEV_2_3_RA5_01_1236.d 0 1 1 348 353 Naphthalene-2,3-dicarboxaldehyde
K.VN(+.98)TLIIC(+57.02)GAMAYTFK.K Y 17.62 1701.8470 15 -17.2 568.2798 3 58.81 5 30677 VEV_2_3_RA5_01_1236.d 3.16E4 1 1 231 245 Deamidation (NQ); Carbamidomethylation
K.ELEYFAK(+43.01).A Y 16.94 941.4494 7 -16.5 942.4412 1 85.47 5 49447 VEV_2_3_RA5_01_1236.d 6.54E4 1 1 193 199 Carbamylation
R.AHSSMVGIN(+.98)LPQK(+42.01).A Y 16.88 1423.7129 13 0.9 356.9358 4 58.95 5 30783 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 172 184 Deamidation (NQ); Acetylation (K)
K.VANNQR.I Y 16.87 700.3616 6 3.9 351.1895 2 24.13 5 9977 VEV_2_3_RA5_01_1236.d 0 1 1 35 40
K.AMLNAC(+57.02)IEAVKK.G Y 16.62 1346.7050 12 -4.7 449.9068 3 60.53 6 30819 VEV_3_3_RA6_01_1237.d 2.12E5 1 1 354 365 Carbamidomethylation
MS(+79.97)LSNKLSIADVDLK.D Y 16.59 1712.8419 15 50.7 429.2395 4 34.37 4 15371 VEV_1_3_RA4_01_1235.d 0 1 1 1 15 Phosphorylation (STY)
K.V(+42.01)EEFRK.Q Y 15.62 848.4392 6 -35.9 425.2116 2 14.31 6 4590 VEV_3_3_RA6_01_1237.d 6.76E4 1 1 147 152 Acetylation (N-term)
K.A(+42.01)VVLMS(+79.97)HLGRPDGKPNPK(+42.01).F Y 15.26 2079.0337 18 -16.8 520.7570 4 69.58 6 37554 VEV_3_3_RA6_01_1237.d 5.57E4 1 1 58 75 Acetylation (N-term); Phosphorylation (STY); Acetylation (K)
total 73 peptides
C1GDK2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGGETLTLDQLALRAPTGANTLLLR.G Y 141.77 2564.4285 25 -8.8 855.8093 3 84.18 5 48702 VEV_2_3_RA5_01_1236.d 1.63E6 11 11 124 148
K.AGGETLTLDQLALRAPTGANTLLLRGPK.N Y 120.95 2846.5977 28 -11.4 712.6486 4 81.49 5 47021 VEV_2_3_RA5_01_1236.d 5.25E5 2 2 124 151
R.APTGANTLLLRGPK.N Y 116.05 1407.8197 14 -10.7 470.2755 3 61.75 5 32868 VEV_2_3_RA5_01_1236.d 1.65E6 8 8 138 151
K.AGGETLTLDQLALR.A Y 113.54 1456.7886 14 -15.5 729.3903 2 78.39 6 44019 VEV_3_3_RA6_01_1237.d 1.27E6 7 7 124 137
R.IVSAIGTKETAEANKGK.T Y 112.84 1715.9417 17 -10.7 572.9817 3 33.09 5 15102 VEV_2_3_RA5_01_1236.d 4.69E6 18 18 70 86
K.TIVIVGTVTDDNRLLNVPK.I Y 108.67 2066.1736 19 -16.3 689.7206 3 78.76 6 44291 VEV_3_3_RA6_01_1237.d 9.04E5 5 5 87 105
K.TIVIVGTVTDDNR.L Y 103.47 1401.7463 13 -14.2 701.8705 2 69.10 6 37210 VEV_3_3_RA6_01_1237.d 3.8E5 3 3 87 99
R.APTGANTLLLR.G Y 95.73 1125.6506 11 -11.3 563.8262 2 65.70 4 35850 VEV_1_3_RA4_01_1235.d 2.75E6 6 6 138 148
K.SDNVYLLLLVKLYRFLSR.R Y 95.49 2211.2778 18 -14.8 553.8185 4 97.47 6 54476 VEV_3_3_RA6_01_1237.d 2.19E5 3 3 24 41
R.IEKAGGETLTLDQLALR.A Y 92.32 1827.0101 17 -11.6 610.0036 3 75.03 6 41562 VEV_3_3_RA6_01_1237.d 1.94E5 3 3 121 137
R.EAVKHFGFGPHSGK.K Y 91.39 1496.7524 14 -7.5 499.9210 3 36.39 4 16573 VEV_1_3_RA4_01_1235.d 2.9E6 12 12 155 168
R.EAVKHFGFGPHSGKKPYVQSK.G Y 87.06 2327.2173 21 -3.8 776.7434 3 46.53 5 23036 VEV_2_3_RA5_01_1236.d 2.03E6 12 12 155 175
K.SDNVYLLLLVK.L Y 82.07 1275.7438 11 -8.9 638.8735 2 85.49 4 50908 VEV_1_3_RA4_01_1235.d 7.71E4 1 1 24 34
R.INRPPVSLSR.I Y 80.56 1137.6619 10 -15.0 380.2222 3 48.24 5 24068 VEV_2_3_RA5_01_1236.d 8.39E6 22 22 60 69
K.SDNVYLLLLVKLYRFLSRR.T Y 74.93 2367.3789 19 -6.6 474.4799 5 94.79 4 56219 VEV_1_3_RA4_01_1235.d 8.66E5 7 7 24 42
K.SDNVYLLLLVKLYR.F Y 74.26 1707.9923 14 -9.5 570.3326 3 88.04 4 52530 VEV_1_3_RA4_01_1235.d 1.79E4 1 1 24 37
K.HFGFGPHSGK.K Y 73.75 1069.5093 10 -9.4 535.7569 2 31.19 5 13984 VEV_2_3_RA5_01_1236.d 6.18E5 10 10 159 168
K.HFGFGPHSGKKPYVQSK.G Y 70.66 1899.9744 17 -19.7 475.9915 4 46.60 6 22328 VEV_3_3_RA6_01_1237.d 2.02E6 8 8 159 175
R.RTDSSFNKVVLR.R Y 65.37 1420.7786 12 -10.5 474.5952 3 47.00 4 23006 VEV_1_3_RA4_01_1235.d 5.98E4 2 2 42 53
R.INRPPVSLSR(+14.02).I Y 61.84 1151.6775 10 -8.7 384.8964 3 52.13 4 26298 VEV_1_3_RA4_01_1235.d 6.62E5 6 6 60 69 Methylation(KR)
R.IVSAIGTK.E Y 61.52 787.4803 8 -12.1 788.4781 1 32.03 6 13995 VEV_3_3_RA6_01_1237.d 2.07E6 9 9 70 77
R.APTGANTLLLR(+14.02)GPK.N Y 54.32 1421.8354 14 -6.6 474.9493 3 64.43 5 34845 VEV_2_3_RA5_01_1236.d 4.68E4 1 1 138 151 Methylation(KR)
R.IVSAIGTKETAE(+14.02)ANKGK.T Y 51.40 1729.9574 17 -13.7 577.6519 3 39.19 4 18218 VEV_1_3_RA4_01_1235.d 2.24E5 2 2 70 86 Methylation(others)
R.ARIEKAGGETLTLDQLALR.A Y 51.15 2054.1484 19 -7.3 514.5406 4 71.50 5 40096 VEV_2_3_RA5_01_1236.d 5.95E4 1 1 119 137
R.IVSAIGTKETAEANK.G Y 49.88 1530.8253 15 -37.6 766.3912 2 39.50 6 18204 VEV_3_3_RA6_01_1237.d 0 1 1 70 84
K.AGGE(+14.02)TLTLDQLALR.A Y 48.04 1470.8042 14 -16.6 736.3972 2 80.38 6 45427 VEV_3_3_RA6_01_1237.d 3.6E5 3 3 124 137 Methylation(others)
R.IN(+.98)RPPVSLSR.I Y 43.68 1138.6459 10 3.2 380.5571 3 48.47 4 23917 VEV_1_3_RA4_01_1235.d 5.71E5 2 2 60 69 Deamidation (NQ)
K.ISVAALR.F Y 43.40 728.4545 7 -19.8 365.2273 2 55.52 6 27450 VEV_3_3_RA6_01_1237.d 4.42E6 12 12 106 112
R.IVS(-2.02)AIGTKETAEANKGK.T Y 41.14 1713.9260 17 1.0 572.3165 3 33.33 5 15190 VEV_2_3_RA5_01_1236.d 0 3 3 70 86 2-amino-3-oxo-butanoic_acid
K.KPYVQSK.G Y 39.53 848.4756 7 -21.8 425.2358 2 10.02 6 2511 VEV_3_3_RA6_01_1237.d 1.18E4 1 1 169 175
R.IVSAIGTKE(+14.02)TAEANKGK.T Y 34.19 1729.9574 17 -6.7 433.4937 4 43.39 4 20772 VEV_1_3_RA4_01_1235.d 2.46E5 1 1 70 86 Methylation(others)
K.AGGETLT(+14.02)LDQLALR.A Y 33.76 1470.8042 14 -13.5 736.3995 2 80.53 5 46437 VEV_2_3_RA5_01_1236.d 9.3E4 1 1 124 137 Methylation(others)
R.APTGAN(+.98)TLLLR.G Y 30.59 1126.6346 11 -20.4 564.3131 2 68.59 6 36834 VEV_3_3_RA6_01_1237.d 2.95E4 1 1 138 148 Deamidation (NQ)
K.AGGETLTLDQLALR(+14.02).A Y 30.54 1470.8042 14 -20.0 736.3947 2 80.63 6 45608 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 124 137 Methylation(KR)
K.AGGETLTLDQLALR(+14.02)APTGANTLLLR.G Y 30.31 2578.4441 25 -28.0 860.4646 3 85.32 4 50824 VEV_1_3_RA4_01_1235.d 0 1 1 124 148 Methylation(KR)
K.AGGE(+14.02)TLTLDQLALRAPTGANTLLLR.G Y 30.31 2578.4441 25 -13.1 860.4774 3 85.18 6 48578 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 124 148 Methylation(others)
K.ISVAALR(+14.02).F Y 30.26 742.4701 7 -17.9 372.2357 2 63.48 5 34150 VEV_2_3_RA5_01_1236.d 2.68E5 4 4 106 112 Methylation(KR)
K.ETAEANK.G Y 29.01 761.3555 7 25.9 762.3825 1 82.45 5 47617 VEV_2_3_RA5_01_1236.d 2.01E5 3 3 78 84
K.TIVIVGTVTDDNRLLN(+.98)VPK.I Y 26.56 2067.1575 19 -12.0 690.0515 3 79.57 6 44847 VEV_3_3_RA6_01_1237.d 0 1 1 87 105 Deamidation (NQ)
R.T(+41.03)DSSFNKVVLR.R Y 25.54 1305.7041 11 -40.7 436.2242 3 57.07 4 29356 VEV_1_3_RA4_01_1235.d 6.52E4 1 1 43 53 Amidination of lysines or N-terminal amines with methyl acetimidate
K.AGGE(+14.02)TLTLDQLALRAPTGANTLLLRGPK.N Y 23.91 2860.6133 28 -2.3 716.1589 4 82.57 5 47696 VEV_2_3_RA5_01_1236.d 5.06E4 1 1 124 151 Methylation(others)
R.LFM(+15.99)SR.I Y 23.56 668.3315 5 -15.8 335.1678 2 24.70 6 10040 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 55 59 Oxidation (M)
R.IVSAIGTKETAEANKGK(+14.02).T Y 22.48 1729.9574 17 -17.3 577.6498 3 38.78 6 17797 VEV_3_3_RA6_01_1237.d 9.07E4 1 1 70 86 Methylation(KR)
R.RLFMSR.I Y 21.99 808.4377 6 -15.7 405.2198 2 39.30 6 18090 VEV_3_3_RA6_01_1237.d 2.73E5 2 2 54 59
K.GRKFER.A Y 21.76 791.4402 6 -18.5 396.7200 2 10.21 6 2585 VEV_3_3_RA6_01_1237.d 1.91E5 2 2 176 181
R.LFMSR.I Y 21.10 652.3367 5 -8.8 327.1727 2 44.66 4 21551 VEV_1_3_RA4_01_1235.d 4.36E5 2 2 55 59
R.IVSAIGTK(+226.08).E Y 20.67 1013.5579 8 15.4 338.8651 3 30.25 5 13407 VEV_2_3_RA5_01_1236.d 1.81E5 1 1 70 77 Biotinylation
K.HFGFGPHS(-18.01)GK(+14.02)KPYVQSK.G Y 20.29 1895.9794 17 19.4 380.2105 5 45.24 5 22272 VEV_2_3_RA5_01_1236.d 0 1 1 159 175 Dehydration; Methylation(KR)
K.ETAEANK(+14.02)GK(+42.01).T Y 19.34 1002.4982 9 8.4 502.2606 2 51.77 4 26014 VEV_1_3_RA4_01_1235.d 2.49E5 1 1 78 86 Methylation(KR); Acetylation (K)
K.KPYVQS(+79.97)K(+14.02)GR.K Y 18.79 1155.5801 9 -10.6 386.1965 3 37.95 6 17308 VEV_3_3_RA6_01_1237.d 1.98E5 1 1 169 177 Phosphorylation (STY); Methylation(KR)
K.ETAEANKGK(+42.01).T Y 18.44 988.4825 9 15.1 495.2560 2 14.79 5 4914 VEV_2_3_RA5_01_1236.d 0 1 1 78 86 Acetylation (K)
K.I(+42.01)SVAALR.F Y 18.15 770.4650 7 -48.5 771.4349 1 35.72 5 16611 VEV_2_3_RA5_01_1236.d 7.59E4 1 1 106 112 Acetylation (N-term)
K.ETAEANK(+42.01)GK(+14.02).T Y 17.98 1002.4982 9 82.4 335.2009 3 15.41 5 5253 VEV_2_3_RA5_01_1236.d 1E5 1 1 78 86 Acetylation (K); Methylation(KR)
R.I(+42.01)VS(+79.97)AIGTK.E Y 17.97 909.4572 8 -5.5 304.1580 3 49.45 5 24818 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 70 77 Acetylation (N-term); Phosphorylation (STY)
R.HHVRGSHR.K Y 17.61 984.5114 8 26.4 329.1864 3 12.34 4 3459 VEV_1_3_RA4_01_1235.d 6.1E4 2 2 12 19
R.RTDSSFNK.V Y 17.57 953.4567 8 -34.9 477.7190 2 28.62 4 12086 VEV_1_3_RA4_01_1235.d 4.62E4 1 1 42 49
K.ETAEANK(-.98).G Y 17.31 760.3715 7 1.0 761.3796 1 64.98 5 35258 VEV_2_3_RA5_01_1236.d 6.32E3 1 1 78 84 Amidation
K.KPY(-18.01)VQSKGR.K Y 16.85 1043.5875 9 -44.0 522.7781 2 58.74 5 30631 VEV_2_3_RA5_01_1236.d 5E4 1 1 169 177 Dehydration
M(+42.01)GK(+14.02)PPC(+57.02)IDLDR.H Y 16.81 1356.6530 11 10.3 453.2296 3 27.89 5 12073 VEV_2_3_RA5_01_1236.d 0 1 1 1 11 Acetylation (Protein N-term); Methylation(KR); Carbamidomethylation
MGKPPC(+57.02)IDLDR.H Y 16.57 1300.6267 11 17.0 651.3317 2 74.84 4 43001 VEV_1_3_RA4_01_1235.d 4.1E4 1 1 1 11 Carbamidomethylation
R.SRGFK.V Y 16.41 593.3285 5 -49.6 594.3063 1 74.64 5 42343 VEV_2_3_RA5_01_1236.d 0 1 1 188 192
K.KPY(+79.97)VQ(+.98)SKGRK.F Y 15.73 1270.6434 10 -10.1 636.3226 2 58.11 6 29104 VEV_3_3_RA6_01_1237.d 9.49E4 1 1 169 178 Phosphorylation (STY); Deamidation (NQ)
K.HFGFGPHSGK(+14.02).K Y 15.57 1083.5250 10 -17.4 542.7604 2 18.01 5 6657 VEV_2_3_RA5_01_1236.d 0 1 1 159 168 Methylation(KR)
K.ETAEANK(+14.02)GKT(+79.97)IVIVGTVTDDNR.L Y 15.38 2424.1897 22 16.7 607.0648 4 78.95 5 45352 VEV_2_3_RA5_01_1236.d 5.62E4 1 1 78 99 Methylation(KR); Phosphorylation (STY)
R.FTSTAR.A Y 15.24 681.3446 6 -19.2 341.6730 2 12.04 6 3412 VEV_3_3_RA6_01_1237.d 6.1E4 1 1 113 118
total 65 peptides
C1G371
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ATQEMLTIVNPYITYGYPNLK.T Y 136.32 2428.2349 21 -10.3 1215.1122 2 86.18 6 49186 VEV_3_3_RA6_01_1237.d 1.68E6 7 7 127 147
K.FGIVC(+57.02)MEDLIHEIYTVGPNFK.Q Y 122.08 2481.2073 21 -3.7 1241.6063 2 93.19 4 55401 VEV_1_3_RA4_01_1235.d 7.8E5 6 6 181 201 Carbamidomethylation
K.FKHFVEGGDLGNREENINALVK.Q Y 118.26 2485.2712 22 -8.3 622.3199 4 69.70 5 38768 VEV_2_3_RA5_01_1236.d 2.19E6 7 7 224 245
R.VALSDNQIIEENLGKFGIVC(+57.02)MEDLIHEIYTVGPNFK.Q Y 116.84 4105.0542 36 9.0 1027.2800 4 97.03 4 57164 VEV_1_3_RA4_01_1235.d 5.02E5 5 5 166 201 Carbamidomethylation
R.VALSDNQIIEENLGK.F Y 112.54 1641.8573 15 -15.3 821.9234 2 74.26 6 41017 VEV_3_3_RA6_01_1237.d 1.48E6 6 6 166 180
K.QQGNFEVPAEPK.L Y 106.41 1342.6517 12 -12.2 672.3250 2 59.46 6 30117 VEV_3_3_RA6_01_1237.d 1.01E6 5 5 76 87
K.QASNFLWPFKLSNPTGGFR.T Y 106.20 2166.1011 19 -7.6 723.0355 3 84.61 4 50319 VEV_1_3_RA4_01_1235.d 3.43E5 2 2 202 220
R.AESYVKEYRDAEREK.I Y 92.24 1871.9012 15 -11.7 468.9771 4 36.69 5 17180 VEV_2_3_RA5_01_1236.d 2.44E6 12 12 53 67
R.LLQINNGVFIR.L Y 89.58 1285.7506 11 -14.1 429.5848 3 78.05 4 45516 VEV_1_3_RA4_01_1235.d 5.82E5 4 4 113 123
K.Q(-17.03)QGNFEVPAEPKLVFVIR.I Y 87.69 2053.0996 18 -6.4 1027.5505 2 85.21 6 48599 VEV_3_3_RA6_01_1237.d 9.24E4 2 2 76 93 Pyro-glu from Q
K.Q(-17.03)ASNFLWPFKLSNPTGGFR.T Y 86.85 2149.0745 19 -7.0 717.3604 3 90.19 5 51979 VEV_2_3_RA5_01_1236.d 1.17E6 9 9 202 220 Pyro-glu from Q
R.KILQLLRLLQINNGVFIR.L Y 86.74 2150.3416 18 -14.9 538.5847 4 90.01 6 51320 VEV_3_3_RA6_01_1237.d 1.87E5 2 2 106 123
K.Q(-17.03)QGN(+.98)FEVPAEPK.L Y 82.40 1326.6091 12 -6.0 664.3079 2 71.46 4 40367 VEV_1_3_RA4_01_1235.d 1.23E5 2 2 76 87 Pyro-glu from Q; Deamidation (NQ)
K.HFVEGGDLGNREENINALVK.Q Y 81.88 2210.1079 20 -11.8 553.5277 4 69.28 6 37324 VEV_3_3_RA6_01_1237.d 4.38E5 4 4 226 245
R.LAKQQGNFEVPAEPK.L Y 77.70 1654.8678 15 -8.1 828.4345 2 56.84 5 29314 VEV_2_3_RA5_01_1236.d 4.87E5 4 4 73 87
K.ATQ(+.98)EMLTIVNPYITYGYPNLK.T Y 76.80 2429.2188 21 -6.6 1215.6086 2 87.14 4 51968 VEV_1_3_RA4_01_1235.d 5.22E4 1 1 127 147 Deamidation (NQ)
K.RAESYVKEYR.D Y 75.63 1299.6571 10 -9.2 434.2223 3 27.09 4 11240 VEV_1_3_RA4_01_1235.d 6.95E5 6 6 52 61
K.QASNFLWPFK.L Y 74.91 1236.6292 10 -6.0 619.3181 2 83.22 4 49394 VEV_1_3_RA4_01_1235.d 1.15E6 5 5 202 211
K.FKHFVEGGDLGNR(+14.02)EENINALVK.Q Y 74.72 2499.2869 22 3.5 625.8312 4 72.13 5 40557 VEV_2_3_RA5_01_1236.d 6.9E4 2 2 224 245 Methylation(KR)
R.AAANAELLKR.K Y 73.72 1055.6086 10 -8.7 528.8070 2 33.27 4 14724 VEV_1_3_RA4_01_1235.d 2.83E6 13 13 29 38
K.Q(-17.03)ASNFLWPFK.L Y 71.30 1219.6025 10 -8.0 610.8036 2 91.45 4 54497 VEV_1_3_RA4_01_1235.d 1.93E6 9 9 202 211 Pyro-glu from Q
K.Q(+.98)QGNFEVPAEPK.L Y 70.78 1343.6357 12 -8.8 672.8192 2 60.88 5 32268 VEV_2_3_RA5_01_1236.d 3.22E5 2 2 76 87 Deamidation (NQ)
K.Q(-17.03)QGNFEVPAEPK(+14.02).L Y 70.17 1339.6407 12 -9.8 670.8211 2 74.89 4 43097 VEV_1_3_RA4_01_1235.d 3.63E5 3 3 76 87 Pyro-glu from Q; Methylation(KR)
K.Q(-17.03)QGNFEVPAEPK.L Y 69.50 1325.6251 12 -8.4 663.8143 2 70.17 4 39340 VEV_1_3_RA4_01_1235.d 1.59E6 3 3 76 87 Pyro-glu from Q
K.QQ(+.98)GNFEVPAEPK.L Y 66.81 1343.6357 12 -9.2 672.8190 2 60.97 4 32261 VEV_1_3_RA4_01_1235.d 4.93E5 5 5 76 87 Deamidation (NQ)
K.LSNPTGGFR.T Y 66.68 947.4824 9 -12.8 474.7424 2 47.35 5 23543 VEV_2_3_RA5_01_1236.d 6.35E6 8 8 212 220
R.VALSDNQIIEE(+14.02)NLGK.F Y 64.62 1655.8729 15 -13.1 828.9329 2 76.97 4 44695 VEV_1_3_RA4_01_1235.d 5.32E4 1 1 166 180 Methylation(others)
R.AESYVKEYR.D Y 64.50 1143.5560 9 -7.7 382.1897 3 30.38 4 13065 VEV_1_3_RA4_01_1235.d 1.05E6 6 6 53 61
M.A(+42.01)TSVPTQDQVLVPETLLK.K Y 62.24 1980.0779 18 -11.7 991.0346 2 86.67 6 49478 VEV_3_3_RA6_01_1237.d 2.17E6 5 5 2 19 Acetylation (Protein N-term)
R.AAANAELLK.R Y 61.46 899.5076 9 -9.5 450.7568 2 39.49 4 18398 VEV_1_3_RA4_01_1235.d 2.13E6 7 7 29 37
R.AESYVKEYRDAER.E Y 61.34 1614.7637 13 -7.5 539.2578 3 37.23 4 17065 VEV_1_3_RA4_01_1235.d 2.53E5 3 3 53 65
M.A(+42.01)TSVPTQDQVLVPETLLKK.R Y 61.01 2108.1729 19 -11.1 703.7238 3 81.50 4 48177 VEV_1_3_RA4_01_1235.d 7.22E5 6 6 2 20 Acetylation (Protein N-term)
K.LVFVIR.I Y 60.64 745.4850 6 -17.1 373.7434 2 71.59 5 40176 VEV_2_3_RA5_01_1236.d 1.75E6 6 6 88 93
R.KFKHFVEGGDLGNREENINALVK.Q Y 60.22 2613.3662 23 -24.5 523.6677 5 68.29 4 37869 VEV_1_3_RA4_01_1235.d 4.71E4 3 3 223 245
R.VALSDNQIIE(+14.02)ENLGK.F Y 54.33 1655.8729 15 -9.9 828.9355 2 76.41 4 44228 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 166 180 Methylation(others)
K.LSNPTGGFR(+14.02).T Y 54.30 961.4981 9 -9.7 481.7516 2 58.80 4 30621 VEV_1_3_RA4_01_1235.d 6.35E5 4 4 212 220 Methylation(KR)
K.Q(-17.03)ASN(+.98)FLWPFK.L Y 53.76 1220.5865 10 5.7 611.3040 2 91.60 4 54548 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 202 211 Pyro-glu from Q; Deamidation (NQ)
K.Q(+.98)ASNFLWPFK.L Y 52.15 1237.6132 10 -14.0 619.8052 2 84.29 4 50118 VEV_1_3_RA4_01_1235.d 7.17E4 1 1 202 211 Deamidation (NQ)
R.VALSDN(+.98)QIIEENLGK.F Y 52.11 1642.8413 15 -11.5 822.4185 2 75.66 4 43652 VEV_1_3_RA4_01_1235.d 6.83E4 1 1 166 180 Deamidation (NQ)
K.QQGNFEVPAEPKLVFVIR.I Y 51.87 2070.1262 18 -10.0 691.0424 3 80.80 5 46582 VEV_2_3_RA5_01_1236.d 7.35E4 1 1 76 93
R.LLQINNGVFIRLTKATQEMLTIVNPYITYGYPNLK.T Y 49.45 4038.2017 35 4.9 1010.5626 4 97.47 5 55155 VEV_2_3_RA5_01_1236.d 0 1 1 113 147
K.FGIVC(+57.02)MEDLIHE(+14.02)IYTVGPNFK.Q Y 48.52 2495.2229 21 -6.8 832.7426 3 94.65 4 56136 VEV_1_3_RA4_01_1235.d 7.92E4 2 2 181 201 Carbamidomethylation; Methylation(others)
R.VALSDNQ(+.98)IIEENLGK.F Y 46.61 1642.8413 15 -14.4 822.4161 2 75.50 6 41910 VEV_3_3_RA6_01_1237.d 4.98E4 1 1 166 180 Deamidation (NQ)
K.HFVEGGD(+14.02)LGNREENINALVK.Q Y 44.83 2224.1235 20 -13.1 557.0309 4 71.56 4 40450 VEV_1_3_RA4_01_1235.d 2.1E5 1 1 226 245 Methylation(others)
K.ATQEMLTIVNPYITYGYPNLK(+14.02).T Y 42.92 2442.2505 21 -5.9 815.0860 3 87.33 4 52082 VEV_1_3_RA4_01_1235.d 1.87E5 2 2 127 147 Methylation(KR)
K.QAS(-18.01)NFLWPFKLSNPTGGFR.T Y 42.13 2148.0903 19 -23.5 1075.0272 2 90.40 5 52090 VEV_2_3_RA5_01_1236.d 1.69E5 1 1 202 220 Dehydration
K.LSN(+.98)PTGGFR.T Y 40.40 948.4665 9 6.7 475.2437 2 47.52 5 23646 VEV_2_3_RA5_01_1236.d 7.31E5 2 2 212 220 Deamidation (NQ)
K.FKHFVEGGD(-18.01)LGNR(+14.02)EENINALVK.Q Y 39.71 2481.2764 22 -20.8 621.3135 4 69.88 4 39123 VEV_1_3_RA4_01_1235.d 4.98E4 2 2 224 245 Dehydration; Methylation(KR)
K.Q(-17.03)ASNFLWPFK(+14.02).L Y 38.01 1233.6182 10 -35.6 1234.5815 1 92.38 6 52476 VEV_3_3_RA6_01_1237.d 1.77E5 3 3 202 211 Pyro-glu from Q; Methylation(KR)
M.A(+42.01)TSVPTQ(+.98)DQVLVPETLLK.K Y 37.14 1981.0619 18 -6.2 991.5321 2 87.77 4 52356 VEV_1_3_RA4_01_1235.d 2.73E5 2 2 2 19 Acetylation (Protein N-term); Deamidation (NQ)
K.LVFVIR(+14.02).I Y 37.01 759.5007 6 -7.7 380.7547 2 76.43 6 42575 VEV_3_3_RA6_01_1237.d 1.08E5 3 3 88 93 Methylation(KR)
K.IAPKPR.K Y 36.19 680.4333 6 -33.1 341.2126 2 10.71 4 2732 VEV_1_3_RA4_01_1235.d 6.48E4 2 2 100 105
M.A(+42.01)TSVPTQDQVLVPETLLK(+14.02).K Y 35.86 1994.0935 18 -6.6 998.0475 2 88.75 4 52964 VEV_1_3_RA4_01_1235.d 6.39E5 2 2 2 19 Acetylation (Protein N-term); Methylation(KR)
R.AAANAELLK(+14.02).R Y 35.64 913.5233 9 -17.1 457.7611 2 52.60 4 26552 VEV_1_3_RA4_01_1235.d 3.41E5 3 3 29 37 Methylation(KR)
R.LLQINN(+.98)GVFIR.L Y 35.60 1286.7346 11 -49.6 644.3427 2 79.53 6 44825 VEV_3_3_RA6_01_1237.d 1.29E5 3 3 113 123 Deamidation (NQ)
R.VALSDNQIIEENLGK(+14.02).F Y 35.51 1655.8729 15 -16.7 828.9299 2 76.82 6 42872 VEV_3_3_RA6_01_1237.d 2.64E4 2 2 166 180 Methylation(KR)
K.IAPKPRKILQLLRLLQINNGVFIR.L Y 34.53 2812.7642 24 -19.4 563.5492 5 92.54 6 52553 VEV_3_3_RA6_01_1237.d 1.76E5 2 2 100 123
R.AVIFK.R Y 32.64 576.3635 5 -28.9 577.3541 1 36.80 6 16658 VEV_3_3_RA6_01_1237.d 1.76E5 4 4 47 51
K.QQ(+.98)GN(+.98)FEVPAEPK.L Y 31.30 1344.6198 12 18.5 673.3296 2 59.87 4 31392 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 76 87 Deamidation (NQ)
R.AAANAE(+14.02)LLKR.K Y 30.47 1069.6244 10 -50.6 535.7924 2 38.15 6 17465 VEV_3_3_RA6_01_1237.d 0 1 1 29 38 Methylation(others)
R.ELIYKR.G Y 28.43 820.4807 6 -15.7 411.2411 2 26.02 5 11048 VEV_2_3_RA5_01_1236.d 4.63E5 3 3 151 156
K.EYRD(-18.01)AEREKIR.L Y 27.22 1445.7374 11 -5.4 362.4397 4 19.92 4 7352 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 59 69 Dehydration
K.Q(+42.01)ASNFLWPFKLSNPT(-18.01)GGFR.T Y 26.72 2190.1011 19 -21.1 548.5210 4 50.75 5 25603 VEV_2_3_RA5_01_1236.d 6.04E5 1 1 202 220 Acetylation (N-term); Dehydration
R.AVIFKR.A Y 26.09 732.4646 6 -14.2 367.2344 2 28.17 5 12224 VEV_2_3_RA5_01_1236.d 2.27E5 3 3 47 52
R.DAEREKIR.L Y 26.00 1015.5410 8 -17.4 508.7690 2 11.51 6 3160 VEV_3_3_RA6_01_1237.d 1.12E5 2 2 62 69
K.HFVEGGDLGNR(+14.02)EENINALVK.Q Y 25.70 2224.1235 20 -15.9 557.0293 4 72.36 4 41081 VEV_1_3_RA4_01_1235.d 2.65E5 1 1 226 245 Methylation(KR)
R.AAAN(+.98)AELLKR.K Y 24.99 1056.5927 10 -8.4 353.2019 3 40.22 4 18824 VEV_1_3_RA4_01_1235.d 6.34E5 1 1 29 38 Deamidation (NQ)
K.Q(-17.03)QGN(+.98)FEVPAEPKLVFVIR.I Y 22.77 2054.0835 18 -3.7 685.6992 3 85.21 5 49292 VEV_2_3_RA5_01_1236.d 3.97E4 1 1 76 93 Pyro-glu from Q; Deamidation (NQ)
R.LLQ(+.98)INN(+.98)GVFIR.L Y 21.18 1287.7186 11 -48.5 644.8354 2 80.25 6 45330 VEV_3_3_RA6_01_1237.d 0 1 1 113 123 Deamidation (NQ)
R.IKGINK.I Y 21.10 671.4330 6 -18.2 336.7177 2 12.34 6 3572 VEV_3_3_RA6_01_1237.d 1E5 2 2 94 99
R.KILQLLR.L Y 20.85 882.6014 7 -38.4 442.2910 2 64.33 5 34806 VEV_2_3_RA5_01_1236.d 0 2 2 106 112
K.ILQLLR.L Y 20.66 754.5065 6 -51.8 378.2410 2 68.58 6 36822 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 107 112
K.Q(-17.03)Q(+.98)GNFEVPAEPK.L Y 20.65 1326.6091 12 8.3 664.3173 2 71.89 4 40709 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 76 87 Pyro-glu from Q; Deamidation (NQ)
R.VALS(+79.97)DN(+.98)QIIEENLGK.F Y 19.48 1722.8076 15 -11.9 431.7040 4 9.55 6 2328 VEV_3_3_RA6_01_1237.d 0 1 1 166 180 Phosphorylation (STY); Deamidation (NQ)
K.EY(-18.01)RDAEREK.I Y 18.79 1176.5522 9 -20.0 393.1835 3 10.21 6 2589 VEV_3_3_RA6_01_1237.d 3.21E4 1 1 59 67 Dehydration
R.AAANAE(+14.02)LLK.R Y 18.73 913.5233 9 -11.0 457.7639 2 47.88 4 23553 VEV_1_3_RA4_01_1235.d 3.22E4 1 1 29 37 Methylation(others)
K.RAESYVK.E Y 18.56 851.4501 7 -18.8 426.7243 2 12.44 6 3620 VEV_3_3_RA6_01_1237.d 3.21E4 1 1 52 58
R.A(+43.01)VIFKR(+14.02)AESYVKEYR.D Y 17.58 1915.0315 15 -105.5 383.9732 5 30.10 4 12908 VEV_1_3_RA4_01_1235.d 0 1 1 47 61 Carbamylation; Methylation(KR)
R.GYGKVNK(-.98).Q Y 17.17 763.4340 7 -14.5 382.7188 2 63.71 4 34286 VEV_1_3_RA4_01_1235.d 4.86E3 1 1 157 163 Amidation
R.AES(-2.02)YVKEYRDAEREK.I Y 16.90 1869.8856 15 1.7 624.3035 3 36.78 5 17233 VEV_2_3_RA5_01_1236.d 4.33E4 1 1 53 67 2-amino-3-oxo-butanoic_acid
K.Q(-15.01)QGNFEVPAEPK.L Y 16.90 1327.6407 12 51.0 664.8615 2 69.56 5 38665 VEV_2_3_RA5_01_1236.d 0 1 1 76 87 ISD (z+2)-series
K.RGYGK(+21.98).V Y 16.53 601.2948 5 8.8 602.3074 1 59.70 4 31265 VEV_1_3_RA4_01_1235.d 0 1 1 156 160 Sodium adduct
K.HFVEGGDLGNR(+14.02)EENINALVK(-.98).Q Y 16.23 2223.1396 20 -19.7 556.7812 4 71.97 4 40764 VEV_1_3_RA4_01_1235.d 0 1 1 226 245 Methylation(KR); Amidation
R.E(-18.01)LIYKR.G Y 15.65 802.4701 6 -9.6 402.2385 2 26.17 4 10754 VEV_1_3_RA4_01_1235.d 2.85E5 1 1 151 156 Pyro-glu from E
K.T(+79.97)VRELIYKR.G Y 15.62 1256.6642 9 -35.9 315.1620 4 26.65 4 11011 VEV_1_3_RA4_01_1235.d 0 1 1 148 156 Phosphorylation (STY)
K.RAE(+21.98)SYVKEYR.D Y 15.13 1321.6390 10 -10.6 1322.6323 1 76.78 4 44519 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 52 61 Sodium adduct
K.L(+27.99)SNPTGGFR.T Y 15.10 975.4774 9 41.3 326.1798 3 33.07 6 14566 VEV_3_3_RA6_01_1237.d 7.53E4 1 1 212 220 Formylation
total 87 peptides
C1FZT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNPEATDIGEAGSFETFFTETGSGKYVPR.S Y 132.16 3119.4722 29 -7.1 1040.8240 3 84.28 4 50110 VEV_1_3_RA4_01_1235.d 3.94E5 3 3 37 65
R.LNPEATDIGEAGSFETFFTETGSGK.Y Y 131.28 2604.1868 25 -8.7 1303.0894 2 85.40 6 48705 VEV_3_3_RA6_01_1237.d 1.57E5 3 3 37 61
R.IHYPLISYAPVVSSNR.S Y 121.69 1814.9679 16 -15.1 605.9874 3 76.25 6 42443 VEV_3_3_RA6_01_1237.d 1.87E6 9 9 266 281
R.FDGALNVDLNEFQTNLVPYPR.I Y 116.45 2421.1963 21 -4.3 1211.6002 2 87.98 4 52492 VEV_1_3_RA4_01_1235.d 5.81E4 1 1 245 265
R.SSHESFKVHDLTFQC(+57.02)FEPNNQMVVC(+57.02)DPR.N Y 113.38 3407.5122 28 3.1 682.5118 5 76.54 4 44337 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 282 309 Carbamidomethylation
K.IGINYQKPMRVPGGELAPVDR.S Y 106.43 2309.2314 21 -13.0 578.3076 4 71.04 4 40030 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 354 374
R.SIFVDLDPSPIDEIR.T Y 101.40 1714.8777 15 -7.9 858.4393 2 85.24 4 50780 VEV_1_3_RA4_01_1235.d 8.5E5 4 4 66 80
R.GHYTIGKELVDSVIDR.I Y 101.10 1800.9370 16 -8.6 451.2377 4 75.79 4 43749 VEV_1_3_RA4_01_1235.d 4.94E5 4 4 107 122
R.DC(+57.02)NAAVASLK.A Y 99.78 1047.5018 10 -8.9 524.7535 2 44.48 4 21465 VEV_1_3_RA4_01_1235.d 1.47E6 10 10 328 337 Carbamidomethylation
R.NLDIPRPGYEHLNSLIAQVVSSITSSLR.F Y 97.26 3078.6462 28 6.8 770.6741 4 96.44 4 56936 VEV_1_3_RA4_01_1235.d 3.3E5 3 3 217 244
R.VPGGELAPVDR.S Y 87.87 1108.5876 11 -15.1 555.2927 2 57.40 6 28627 VEV_3_3_RA6_01_1237.d 5.53E5 6 6 364 374
K.TSFNLVEWC(+57.02)PTGFK.I Y 85.25 1684.7919 14 -2.9 843.4008 2 83.70 4 49754 VEV_1_3_RA4_01_1235.d 2.66E5 3 3 340 353 Carbamidomethylation
K.YMAVALLYR.G Y 83.06 1098.5896 9 -10.4 550.2964 2 77.98 4 45470 VEV_1_3_RA4_01_1235.d 2.57E5 2 2 313 321
R.GHYTIGKELVDSVIDRIR.R Y 74.31 2070.1221 18 -36.7 415.0165 5 80.31 5 46254 VEV_2_3_RA5_01_1236.d 1.38E5 3 3 107 124
R.VSTAVVEPYNAVLSTHSTIENSDC(+57.02)TFLVDNEAVYDIC(+57.02)HR.N Y 73.12 4425.0527 39 -10.7 1107.2587 4 83.69 5 48373 VEV_2_3_RA5_01_1236.d 5.1E4 3 3 178 216 Carbamidomethylation
R.Q(-17.03)LFHPEMLISGKEDAANNYAR.G Y 71.59 2386.1375 21 -13.2 796.3759 3 79.88 6 45071 VEV_3_3_RA6_01_1237.d 1.69E5 3 3 86 106 Pyro-glu from Q
R.DC(+57.02)NAAVASLKAK.T Y 70.21 1246.6339 12 -6.0 624.3205 2 38.34 5 18141 VEV_2_3_RA5_01_1236.d 2.33E5 6 6 328 339 Carbamidomethylation
R.VADNC(+57.02)SSLQGFLIFHSFGGGTGSGFGALLLER.L Y 69.68 3313.6189 32 -6.4 1105.5398 3 91.74 4 54624 VEV_1_3_RA4_01_1235.d 5.61E4 2 2 126 157 Carbamidomethylation
K.SKLEFAVYPAPR.V Y 64.14 1376.7451 12 -12.3 689.3713 2 68.16 4 37764 VEV_1_3_RA4_01_1235.d 1.63E6 5 5 166 177
K.LEFAVYPAPR.V Y 62.72 1161.6182 10 -8.3 581.8115 2 74.08 5 41939 VEV_2_3_RA5_01_1236.d 2.29E5 2 2 168 177
R.DC(+57.02)N(+.98)AAVASLK.A Y 55.10 1048.4858 10 9.8 525.2553 2 44.70 4 21582 VEV_1_3_RA4_01_1235.d 2.92E5 2 2 328 337 Carbamidomethylation; Deamidation (NQ)
K.AKTSFNLVEWC(+57.02)PTGFK.I Y 52.02 1883.9240 16 12.6 628.9899 3 79.09 5 45448 VEV_2_3_RA5_01_1236.d 0 2 2 338 353 Carbamidomethylation
R.DC(+57.02)NAAVASLK(+14.02).A Y 49.97 1061.5176 10 -7.6 531.7620 2 58.86 4 30628 VEV_1_3_RA4_01_1235.d 9.05E4 3 3 328 337 Carbamidomethylation; Methylation(KR)
R.Q(-17.03)LFHPEM(+15.99)LISGKEDAANNYAR.G Y 48.19 2402.1323 21 -19.8 601.5284 4 74.09 4 42423 VEV_1_3_RA4_01_1235.d 0 1 1 86 106 Pyro-glu from Q; Oxidation (M)
R.SIFVDLDPSPIDEIRTGPYR.Q Y 46.01 2289.1641 20 2.9 764.0642 3 83.53 5 48275 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 66 85
R.IHYPLISY(-2.02)APVVSSNR.S Y 43.65 1812.9523 16 -37.0 605.3024 3 76.28 5 43500 VEV_2_3_RA5_01_1236.d 2.96E4 2 2 266 281 2-amino-3-oxo-butanoic_acid
K.ELVDSVIDRIR.R Y 43.40 1313.7302 11 -6.7 438.9144 3 75.87 4 43814 VEV_1_3_RA4_01_1235.d 9.03E4 1 1 114 124
R.LSTDYGKK.S Y 40.41 910.4760 8 -16.0 456.2379 2 15.12 6 5006 VEV_3_3_RA6_01_1237.d 4.51E4 1 1 158 165
K.IGINYQKPMR.V Y 37.45 1218.6543 10 16.1 407.2319 3 53.59 4 27185 VEV_1_3_RA4_01_1235.d 1.76E5 3 3 354 363
R.SIFVDLDPSPIDEIR(+14.02).T Y 36.33 1728.8933 15 -35.0 865.4237 2 86.75 5 50165 VEV_2_3_RA5_01_1236.d 0 1 1 66 80 Methylation(KR)
R.LDHKFDLMYSKR.A Y 36.11 1551.7867 12 2.3 311.3653 5 57.73 4 29816 VEV_1_3_RA4_01_1235.d 9.46E4 1 1 392 403
K.KSKLEFAVYPAPR.V Y 30.15 1504.8401 13 -16.7 377.2110 4 62.76 4 33568 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 165 177
K.IGINY(-18.01)QK(+14.02)PMRVPGGELAPVDR.S Y 27.84 2305.2363 21 -6.9 577.3124 4 70.91 5 39669 VEV_2_3_RA5_01_1236.d 0 1 1 354 374 Dehydration; Methylation(KR)
R.DC(+57.02)N(+.98)AAVASLKAK.T Y 26.47 1247.6179 12 -13.4 624.8079 2 38.41 4 17755 VEV_1_3_RA4_01_1235.d 0 1 1 328 339 Carbamidomethylation; Deamidation (NQ)
K.S(+42.01)KLEFAVYPAPR.V Y 24.69 1418.7557 12 1.2 355.6966 4 49.02 6 23737 VEV_3_3_RA6_01_1237.d 1.16E6 1 1 166 177 Acetylation (N-term)
R.IHYPLISYAPVVS(-18.01)SNR(+14.02).S Y 24.40 1810.9729 16 -50.0 604.6347 3 76.26 4 44109 VEV_1_3_RA4_01_1235.d 2.65E4 1 1 266 281 Dehydration; Methylation(KR)
R.GDVVPRDC(+57.02)NAAVASLK(+28.03).A Y 23.40 1698.8723 16 -18.7 425.7174 4 40.40 6 18739 VEV_3_3_RA6_01_1237.d 1.77E5 1 1 322 337 Carbamidomethylation; Dimethylation(KR)
K.ELVDSVIDR.I Y 23.27 1044.5452 9 -37.5 523.2603 2 38.01 5 17941 VEV_2_3_RA5_01_1236.d 1.29E5 1 1 114 122
R.QLFHPEMLIS(-18.01)GKEDAANNYAR.G Y 21.66 2385.1536 21 -19.7 796.0428 3 80.05 5 46088 VEV_2_3_RA5_01_1236.d 0 1 1 86 106 Dehydration
R.Q(-17.03)LFHPEMLISGKEDAAN(+.98)NYAR.G Y 21.33 2387.1216 21 -1.0 796.7137 3 80.03 5 46074 VEV_2_3_RA5_01_1236.d 4.64E4 1 1 86 106 Pyro-glu from Q; Deamidation (NQ)
R.GHYTIGK(+14.02)ELVD(-18.01)SVIDRIR.R Y 20.83 2066.1272 18 -8.7 414.2291 5 80.57 6 45565 VEV_3_3_RA6_01_1237.d 0 1 1 107 124 Methylation(KR); Dehydration
R.TGPYR.Q Y 19.56 592.2969 5 -3.4 593.3021 1 77.48 6 43369 VEV_3_3_RA6_01_1237.d 0 2 2 81 85
R.IHYPLIS(+79.97)YAPVVS(+79.97)SNR(+14.02).S Y 19.54 1988.9161 16 16.5 498.2445 4 71.76 5 40289 VEV_2_3_RA5_01_1236.d 2.52E4 1 1 266 281 Phosphorylation (STY); Methylation(KR)
K.IGINYQKPMR(+14.02).V Y 18.44 1232.6699 10 0.1 309.1748 4 23.30 5 9527 VEV_2_3_RA5_01_1236.d 6.93E5 1 1 354 363 Methylation(KR)
R.IHY(+31.99)PLISYAPVVS(+79.97)SNR.S Y 18.36 1926.9241 16 30.0 643.3346 3 80.38 5 46301 VEV_2_3_RA5_01_1236.d 0 1 1 266 281 Dihydroxy; Phosphorylation (STY)
K.FDLMY(-18.01)SK.R Y 18.01 884.4102 7 -7.4 885.4109 1 87.62 6 50008 VEV_3_3_RA6_01_1237.d 7.91E4 1 1 396 402 Dehydration
K.ELVDSVIDR(+.98)IR.R Y 16.99 1314.7142 11 -5.2 439.2431 3 66.10 5 36106 VEV_2_3_RA5_01_1236.d 0 1 1 114 124 Deamidation (R)
R.G(+27.99)DVVPR.D Y 16.34 669.3445 6 -20.6 670.3380 1 43.28 5 21083 VEV_2_3_RA5_01_1236.d 3.95E4 1 1 322 327 Formylation
K.ELVDSVID(-18.01)R.I Y 16.15 1026.5345 9 16.0 343.1909 3 39.57 4 18450 VEV_1_3_RA4_01_1235.d 0 1 1 114 122 Dehydration
K.L(+71.04)EFAVYPAPR.V Y 16.08 1232.6553 10 -27.3 309.1627 4 17.81 5 6583 VEV_2_3_RA5_01_1236.d 6.62E5 1 1 168 177 Propionamide (K, X@N-term)
K.Y(-18.01)MAVALLYRGDVVPR.D Y 15.61 1703.9181 15 -34.8 426.9720 4 61.32 5 32522 VEV_2_3_RA5_01_1236.d 3.77E4 1 1 313 327 Dehydration
K.I(+42.01)GINYQKPMR.V Y 15.03 1260.6648 10 -42.0 316.1602 4 51.16 6 24963 VEV_3_3_RA6_01_1237.d 4.59E4 1 1 354 363 Acetylation (N-term)
total 52 peptides
C1FYX6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AADAVGEGPSQYGQSIETDTDGFQQAMK.A Y 151.46 2900.2771 28 -7.1 967.7595 3 78.09 4 45552 VEV_1_3_RA4_01_1235.d 6.17E5 5 5 326 353
K.VIFLPAINQTVQDQLR.A Y 140.23 1854.0363 16 -12.2 619.0118 3 84.23 6 48008 VEV_3_3_RA6_01_1237.d 1.24E6 7 7 310 325
R.AADAVGEGPSQYGQSIETDTDGFQQAMKAHIVEDI Y 119.16 3677.6790 35 -3.3 1226.8962 3 84.30 5 48753 VEV_2_3_RA5_01_1236.d 1.29E5 2 2 326 360
K.DNVTLNLTSVIYYHITSPHK.A Y 115.04 2314.1958 20 -7.4 579.5519 4 83.07 4 49270 VEV_1_3_RA4_01_1235.d 5.58E5 4 4 156 175
K.APTQSGPLSTDVGFRPSNNGIVK.V Y 114.43 2341.2026 23 -7.3 781.4025 3 70.77 4 39821 VEV_1_3_RA4_01_1235.d 3.53E5 3 3 21 43
K.APTQSGPLSTDVGFRPSNN(+.98)GIVK.V Y 100.74 2342.1865 23 -15.0 781.7244 3 72.18 6 39524 VEV_3_3_RA6_01_1237.d 7.21E5 4 4 21 43 Deamidation (NQ)
K.TANSKVIFLPAINQTVQDQLR.A Y 97.92 2355.2910 21 -15.4 786.0922 3 80.01 5 46060 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 305 325
R.LEDLQPSYAQVLR.H Y 91.13 1530.8042 13 -12.5 766.3998 2 75.14 6 41645 VEV_3_3_RA6_01_1237.d 8.62E5 5 5 49 61
M.S(+42.01)ASTNLLDTPSTSTATN(+.98)GKAPTQSGPLSTDVGFRPSNNGIVK.V Y 86.83 4231.0879 42 -3.1 1058.7760 4 79.69 5 45847 VEV_2_3_RA5_01_1236.d 3.1E5 2 2 2 43 Acetylation (Protein N-term); Deamidation (NQ)
K.VNPLSEHLTTVDVK.I Y 85.68 1550.8304 14 -18.8 517.9410 3 67.29 6 35851 VEV_3_3_RA6_01_1237.d 9.46E5 6 6 128 141
R.TAANILSSAPAMQIR.Y Y 84.73 1542.8188 15 -9.0 772.4098 2 76.06 5 43346 VEV_2_3_RA5_01_1236.d 2.31E5 4 4 280 294
M.S(+42.01)ASTNLLDTPSTSTATNGK.A Y 77.78 1906.9120 19 -12.0 954.4518 2 71.63 6 39150 VEV_3_3_RA6_01_1237.d 4.25E5 3 3 2 20 Acetylation (Protein N-term)
R.AADAVGEGPSQYGQSIETDTDGFQQAM(+15.99)K.A Y 76.18 2916.2720 28 -23.1 973.0755 3 73.93 6 40761 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 326 353 Oxidation (M)
K.VQPARLEDLQPSYAQVLR.H Y 75.82 2082.1221 18 -7.4 695.0428 3 75.73 5 43115 VEV_2_3_RA5_01_1236.d 7.32E5 4 4 44 61
R.YLETMQAMAK.T Y 68.65 1184.5570 10 -9.0 593.2805 2 63.88 5 34445 VEV_2_3_RA5_01_1236.d 1.38E5 2 2 295 304
M.S(+42.01)ASTNLLDTPSTSTATN(+.98)GK.A Y 66.50 1907.8960 19 -11.0 954.9448 2 73.21 6 40245 VEV_3_3_RA6_01_1237.d 6.45E5 6 6 2 20 Acetylation (Protein N-term); Deamidation (NQ)
K.AAFGITNIR.Q Y 64.45 961.5345 9 -13.0 481.7682 2 67.19 5 36941 VEV_2_3_RA5_01_1236.d 8.17E5 6 6 176 184
K.VIFLPAINQ(+.98)TVQDQLR.A Y 64.15 1855.0203 16 -12.6 619.3396 3 84.92 6 48408 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 310 325 Deamidation (NQ)
R.AVDPGLVK.V Y 63.71 797.4647 8 -15.9 399.7333 2 41.06 6 19091 VEV_3_3_RA6_01_1237.d 1.71E6 6 6 120 127
K.VIFLPAINQTVQ(+.98)DQLR.A Y 62.06 1855.0203 16 -16.7 619.3370 3 85.25 5 49316 VEV_2_3_RA5_01_1236.d 8.21E4 2 2 310 325 Deamidation (NQ)
R.AADAVGEGPSQYGQ(+.98)SIETDTDGFQQAMK.A Y 59.95 2901.2610 28 12.6 968.1064 3 78.58 4 45926 VEV_1_3_RA4_01_1235.d 6.49E4 1 1 326 353 Deamidation (NQ)
K.AHIVEDI Y 59.82 795.4127 7 -19.1 398.7060 2 53.46 6 26337 VEV_3_3_RA6_01_1237.d 1.29E6 7 7 354 360
K.VIFLPAIN(+.98)QTVQDQLR.A Y 57.56 1855.0203 16 -13.3 619.3391 3 84.13 6 47916 VEV_3_3_RA6_01_1237.d 1.59E5 3 3 310 325 Deamidation (NQ)
R.VLQDVIER.R Y 56.84 970.5447 8 -16.8 486.2715 2 59.22 6 29865 VEV_3_3_RA6_01_1237.d 4.85E5 3 3 203 210
K.IQIVEVPR.Q Y 54.38 952.5706 8 -20.1 477.2830 2 65.92 6 34822 VEV_3_3_RA6_01_1237.d 3.05E5 3 3 142 149
K.APTQ(+.98)SGPLSTDVGFRPSNNGIVK.V Y 53.73 2342.1865 23 -5.2 781.7321 3 70.59 5 39425 VEV_2_3_RA5_01_1236.d 4.1E4 1 1 21 43 Deamidation (NQ)
R.LEDLQPSYAQ(+.98)VLR.H Y 48.15 1531.7882 13 -16.8 766.8885 2 76.38 6 42541 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 49 61 Deamidation (NQ)
R.TAANILSSAPAM(+15.99)QIR.Y Y 42.89 1558.8137 15 -17.2 520.6029 3 68.18 6 36524 VEV_3_3_RA6_01_1237.d 0 2 2 280 294 Oxidation (M)
K.VQPAR(+14.02)LEDLQPSYAQVLR.H Y 41.57 2096.1377 18 -13.6 699.7103 3 77.15 6 43120 VEV_3_3_RA6_01_1237.d 6.54E4 1 1 44 61 Methylation(KR)
R.AVDPGLVKVNPLSEHLTTVDVK.I Y 41.36 2330.2844 22 -4.7 777.7651 3 76.21 5 43449 VEV_2_3_RA5_01_1236.d 3.35E3 1 1 120 141
R.TAANILSSAPAMQ(+.98)IR.Y Y 41.21 1543.8029 15 -11.6 772.8997 2 76.84 5 43903 VEV_2_3_RA5_01_1236.d 1.22E5 2 2 280 294 Deamidation (NQ)
K.APTQSGPLSTDVGFRPSN(+.98)NGIVK.V Y 37.01 2342.1865 23 -17.5 781.7225 3 72.32 4 41052 VEV_1_3_RA4_01_1235.d 2.26E5 1 1 21 43 Deamidation (NQ)
R.VLQDVIERR.E Y 31.66 1126.6459 9 -15.4 564.3215 2 53.19 6 26173 VEV_3_3_RA6_01_1237.d 6.45E4 1 1 203 211
K.TAN(+.98)SK.V Y 28.21 520.2493 5 8.1 521.2607 1 37.13 4 17005 VEV_1_3_RA4_01_1235.d 2.45E4 1 1 305 309 Deamidation (NQ)
K.VNPLSE(+14.02)HLTTVDVK.I Y 27.73 1564.8461 14 -15.8 522.6144 3 70.44 6 38187 VEV_3_3_RA6_01_1237.d 3.54E4 1 1 128 141 Methylation(others)
K.VQ(+.98)PARLEDLQPSYAQVLR.H Y 23.96 2083.1062 18 -12.4 695.3674 3 76.59 6 42696 VEV_3_3_RA6_01_1237.d 5.25E4 1 1 44 61 Deamidation (NQ)
K.VQ(+.98)PAR.L Y 23.43 570.3126 5 -31.5 571.3019 1 76.23 6 42430 VEV_3_3_RA6_01_1237.d 1.54E4 1 1 44 48 Deamidation (NQ)
R.FGRFER.A Y 23.23 810.4136 6 -15.5 406.2078 2 29.54 5 13001 VEV_2_3_RA5_01_1236.d 1.28E6 3 3 114 119
R.AEVESAKLM(+15.99)R.T Y 22.61 1148.5859 10 10.2 575.3061 2 25.17 6 10287 VEV_3_3_RA6_01_1237.d 0 1 1 270 279 Oxidation (M)
R.IGESK(+31.99).V Y 22.28 564.2755 5 -15.2 565.2742 1 38.74 5 18386 VEV_2_3_RA5_01_1236.d 0 1 1 260 264 Dihydroxy
R.IGESK.V Y 20.98 532.2856 5 -79.7 533.2505 1 54.50 6 26941 VEV_3_3_RA6_01_1237.d 0 1 1 260 264
K.IQIVEVPRQVC(+57.02)MTK(-.98)(+42.01).D Y 20.87 1740.9379 14 -54.8 581.2881 3 70.93 6 38554 VEV_3_3_RA6_01_1237.d 0 1 1 142 155 Carbamidomethylation; Amidation; Acetylation (K)
K.IQIVE(+14.02)VPR.Q Y 20.80 966.5862 8 -56.2 484.2732 2 68.44 6 36716 VEV_3_3_RA6_01_1237.d 0 2 2 142 149 Methylation(others)
R.AEVESAKLMR.T Y 20.64 1132.5911 10 -19.4 378.5303 3 36.89 5 17288 VEV_2_3_RA5_01_1236.d 2.25E5 1 1 270 279
K.TANSK.V Y 19.74 519.2653 5 -17.8 520.2633 1 62.11 5 33124 VEV_2_3_RA5_01_1236.d 9.34E4 1 1 305 309
K.VQPARLEDLQ(+.98)PSYAQVLR.H Y 19.67 2083.1062 18 -10.1 695.3690 3 76.59 5 43727 VEV_2_3_RA5_01_1236.d 8.37E4 1 1 44 61 Deamidation (NQ)
R.YLETMQAM(+15.99)AK.T Y 19.02 1200.5519 10 13.6 601.2914 2 48.94 4 24207 VEV_1_3_RA4_01_1235.d 0 1 1 295 304 Oxidation (M)
R.I(+42.01)GESK.V Y 18.68 574.2962 5 -32.1 575.2850 1 80.41 6 45451 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 260 264 Acetylation (N-term)
K.AHIVEDI(+14.02) Y 17.91 809.4283 7 -20.6 405.7131 2 61.44 5 32607 VEV_2_3_RA5_01_1236.d 7.9E4 1 1 354 360 Methylation(C-term)
K.AHIVEDI(-.98) Y 17.55 794.4286 7 -53.9 795.3931 1 53.91 6 26596 VEV_3_3_RA6_01_1237.d 6.72E4 1 1 354 360 Amidation
K.APTQSGPLSTDVGFRPSNNGIVK(+183.04).V Y 17.14 2524.2380 23 -3.4 842.4171 3 85.36 4 50836 VEV_1_3_RA4_01_1235.d 9.95E4 1 1 21 43 Aminoethylbenzenesulfonylation
K.T(+42.01)ANSK.V Y 16.88 561.2758 5 -15.9 562.2742 1 56.51 4 28964 VEV_1_3_RA4_01_1235.d 0 1 1 305 309 Acetylation (N-term)
K.RIGESK(-.98).V Y 16.36 687.4028 6 4.9 344.7104 2 64.59 4 34956 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 259 264 Amidation
R.T(+42.01)(-18.01)AANILSSAPAMQIR.Y Y 16.08 1566.8188 15 18.4 784.4312 2 88.16 4 52603 VEV_1_3_RA4_01_1235.d 0 1 1 280 294 Acetylation (N-term); Dehydration
R.T(+14.02)AANILSSAPAMQIR.Y Y 15.49 1556.8345 15 -22.5 390.2072 4 35.63 4 16113 VEV_1_3_RA4_01_1235.d 0 1 1 280 294 Methylation(others)
R.QALVERTQT(-18.01)T(+79.97)LR.H Y 15.30 1476.7450 12 -1.5 370.1930 4 21.59 6 8383 VEV_3_3_RA6_01_1237.d 1.89E5 1 1 185 196 Dehydration; Phosphorylation (STY)
K.VQPAR.L Y 15.24 569.3285 5 -30.6 570.3184 1 90.79 4 54101 VEV_1_3_RA4_01_1235.d 0 1 1 44 48
R.F(+27.99)ERAVDPGLVK.V Y 15.02 1257.6716 11 -40.9 420.2140 3 40.74 6 18912 VEV_3_3_RA6_01_1237.d 0 1 1 117 127 Formylation
total 58 peptides
C1G0X4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TANVDQKTKDQLAEYGY Y 131.23 1942.9272 17 -16.8 648.6388 3 64.73 6 33959 VEV_3_3_RA6_01_1237.d 2.53E6 5 5 186 202
R.LSHEVGWKYQDVVAR.L Y 129.68 1785.9161 15 -10.6 447.4816 4 63.68 4 34295 VEV_1_3_RA4_01_1235.d 2.34E6 8 8 143 157
R.LSHEVGWKYQDVVARLEER.R Y 116.71 2313.1865 19 -11.7 579.2971 4 75.13 5 42686 VEV_2_3_RA5_01_1236.d 1.01E6 4 4 143 161
R.C(+57.02)EALNISGEFFR.A Y 111.42 1441.6660 12 -9.4 721.8335 2 79.80 4 46874 VEV_1_3_RA4_01_1235.d 7.02E5 5 5 39 50 Carbamidomethylation
R.LKVFEGVPPPYDK.K Y 97.54 1487.8024 13 -12.5 744.8992 2 69.24 5 38439 VEV_2_3_RA5_01_1236.d 1.04E6 9 9 104 116
K.TKDQLAEYGY Y 92.91 1186.5505 10 -13.3 594.2747 2 62.36 6 32195 VEV_3_3_RA6_01_1237.d 4.44E6 11 11 193 202
M.S(+42.01)TFEPVVVIDGKGHLLGR.L Y 87.17 1965.0684 18 -8.6 983.5330 2 80.96 4 47778 VEV_1_3_RA4_01_1235.d 4.61E6 12 12 2 19 Acetylation (Protein N-term)
K.RVVVPQALR.I Y 84.59 1036.6505 9 -14.7 346.5524 3 50.84 4 25435 VEV_1_3_RA4_01_1235.d 2.15E6 16 16 119 127
K.VFEGVPPPYDKK.K Y 84.56 1374.7183 12 -12.0 459.2412 3 59.32 4 30977 VEV_1_3_RA4_01_1235.d 2.1E6 11 11 106 117
R.C(+58.01)EALNISGEFFR.A Y 80.20 1442.6500 12 -0.4 722.3320 2 82.69 4 49063 VEV_1_3_RA4_01_1235.d 2.25E5 3 3 39 50 Carboxymethyl
R.QLAQAQKTANVDQK.T Y 76.19 1541.8162 14 -20.2 771.8998 2 23.72 5 9744 VEV_2_3_RA5_01_1236.d 2.31E4 1 1 179 192
R.VVVPQALR.I Y 74.64 880.5494 8 -13.8 441.2759 2 60.00 4 31523 VEV_1_3_RA4_01_1235.d 7.03E6 7 7 120 127
K.VKGSAYYER.K Y 73.40 1071.5349 9 -17.2 536.7655 2 19.86 6 7499 VEV_3_3_RA6_01_1237.d 1.73E6 10 10 164 172
K.KRVVVPQALR.I Y 72.61 1164.7455 10 -15.3 389.2498 3 40.39 5 19346 VEV_2_3_RA5_01_1236.d 2.2E5 3 3 118 127
R.Q(-17.03)LAQAQKTANVDQK.T Y 71.84 1524.7896 14 -10.9 763.3937 2 52.05 6 25512 VEV_3_3_RA6_01_1237.d 3.02E5 6 6 179 192 Pyro-glu from Q
R.LKVFEGVPPPYDKK.K Y 69.77 1615.8973 14 -13.9 404.9760 4 64.11 4 34662 VEV_1_3_RA4_01_1235.d 3.75E6 14 14 104 117
K.VFEGVPPPYDK.K Y 69.32 1246.6233 11 -9.1 624.3132 2 66.38 4 36356 VEV_1_3_RA4_01_1235.d 1.52E6 5 5 106 116
R.LSHEVGWK.Y Y 68.83 954.4923 8 -16.2 478.2457 2 34.26 6 15273 VEV_3_3_RA6_01_1237.d 1.53E6 9 9 143 150
M.S(+42.01)TFEPVVVIDGKGHLLGR(+14.02).L Y 65.95 1979.0840 18 -8.6 990.5407 2 80.40 4 47328 VEV_1_3_RA4_01_1235.d 5.63E5 5 5 2 19 Acetylation (Protein N-term); Methylation(KR)
K.YQDVVAR.L Y 65.38 849.4344 7 -11.0 425.7198 2 28.92 4 12245 VEV_1_3_RA4_01_1235.d 2.4E6 10 10 151 157
R.GGPFHFR.A Y 62.83 816.4031 7 -13.5 409.2033 2 48.95 4 24215 VEV_1_3_RA4_01_1235.d 5.02E6 16 16 70 76
R.RQLAQAQKTANVDQK.T Y 62.45 1697.9172 15 -10.4 425.4822 4 21.79 5 8700 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 178 192
K.YQDVVARLEER.R Y 62.27 1376.7048 11 -12.7 459.9031 3 63.91 4 34446 VEV_1_3_RA4_01_1235.d 6.15E5 4 4 151 161
K.TKDQLAE(+14.02)YGY Y 58.34 1200.5663 10 -10.5 601.2841 2 65.67 4 35808 VEV_1_3_RA4_01_1235.d 5.8E5 2 2 193 202 Methylation(others)
R.GGPFHFRAPSR.I Y 58.31 1227.6261 11 -15.3 410.2097 3 52.17 5 26483 VEV_2_3_RA5_01_1236.d 1.13E6 5 5 70 80
K.TKDQ(+.98)LAEYGY Y 57.23 1187.5345 10 -9.9 594.7687 2 65.16 5 35440 VEV_2_3_RA5_01_1236.d 4.04E5 3 3 193 202 Deamidation (NQ)
R.C(+57.02)EALN(-17.03)ISGEFFR.A Y 55.39 1424.6394 12 -7.3 713.3218 2 88.58 4 52880 VEV_1_3_RA4_01_1235.d 5.95E5 4 4 39 50 Carbamidomethylation; Ammonia-loss (N)
M.S(+42.01)TFEPVVVIDGK.G Y 51.92 1331.6973 12 -15.1 666.8458 2 83.07 6 47234 VEV_3_3_RA6_01_1237.d 4.12E5 3 3 2 13 Acetylation (Protein N-term)
K.TANVDQKTKDQLAEYGY(+14.02) Y 51.19 1956.9429 17 -5.3 653.3181 3 67.97 4 37614 VEV_1_3_RA4_01_1235.d 4.93E5 4 4 186 202 Methylation(C-term)
K.VKGSAYYERK.K Y 50.74 1199.6299 10 -21.8 600.8091 2 15.05 5 5059 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 164 173
R.LSHEVGWKYQDVVAR(+14.02).L Y 50.10 1799.9319 15 -24.4 450.9792 4 65.63 6 34594 VEV_3_3_RA6_01_1237.d 1.28E5 2 2 143 157 Methylation(KR)
R.LSHEVGWKYQDVVARLEER(+14.02).R Y 49.26 2327.2021 19 -3.7 466.4460 5 77.85 4 45367 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 143 161 Methylation(KR)
K.TK(+14.02)DQLAEYGY Y 47.74 1200.5663 10 -3.1 601.2886 2 65.15 5 35416 VEV_2_3_RA5_01_1236.d 2.68E5 2 2 193 202 Methylation(KR)
R.RQLAQAQK.T Y 47.45 941.5406 8 -11.2 471.7723 2 10.43 5 2691 VEV_2_3_RA5_01_1236.d 8.72E4 3 3 178 185
R.KVKGSAYYER.K Y 47.37 1199.6299 10 -12.1 600.8149 2 16.06 5 5604 VEV_2_3_RA5_01_1236.d 2.99E4 1 1 163 172
K.GSAYYER.K Y 46.72 844.3715 7 -12.6 423.1877 2 20.47 5 7984 VEV_2_3_RA5_01_1236.d 6.28E5 3 3 166 172
K.YHAYLR.K Y 45.31 821.4184 6 -18.4 411.7089 2 26.31 6 10882 VEV_3_3_RA6_01_1237.d 3.54E5 3 3 55 60
R.APSRIFYK.A Y 44.67 980.5443 8 -8.3 491.2754 2 38.74 5 18381 VEV_2_3_RA5_01_1236.d 2.23E5 2 2 77 84
M.S(+56.06)TFEPVVVIDGKGHLLGR.L Y 44.05 1979.1204 18 -26.9 990.5408 2 82.46 4 48870 VEV_1_3_RA4_01_1235.d 2.11E5 3 3 2 19 Diethylation
R.GMIPHKSSR.G Y 43.33 1011.5284 9 -10.8 506.7660 2 15.39 5 5274 VEV_2_3_RA5_01_1236.d 4.75E5 3 3 88 96
R.GMIPHK.S Y 41.87 681.3632 6 -8.4 341.6860 2 19.52 4 7163 VEV_1_3_RA4_01_1235.d 9.86E5 4 4 88 93
K.YQ(+.98)DVVAR.L Y 41.70 850.4185 7 -1.9 426.2157 2 31.82 4 13905 VEV_1_3_RA4_01_1235.d 5.36E5 3 3 151 157 Deamidation (NQ)
K.YC(+57.02)TVGR.L Y 41.43 754.3432 6 -15.6 378.1730 2 17.13 6 6050 VEV_3_3_RA6_01_1237.d 4.1E5 4 4 137 142 Carbamidomethylation
R.GAAAMER.L Y 41.09 704.3275 7 20.2 353.1781 2 12.09 5 3492 VEV_2_3_RA5_01_1236.d 0 1 1 97 103
R.KYC(+57.02)TVGR.L Y 40.37 882.4382 7 -17.8 442.2185 2 13.36 6 4102 VEV_3_3_RA6_01_1237.d 2.19E5 3 3 136 142 Carbamidomethylation
K.GSAYYER(+14.02).K Y 40.07 858.3871 7 -12.0 430.1957 2 28.53 5 12421 VEV_2_3_RA5_01_1236.d 1.28E6 5 5 166 172 Methylation(KR)
R.VVVPQ(+.98)ALR.I Y 38.93 881.5334 8 -9.7 441.7697 2 62.27 4 33204 VEV_1_3_RA4_01_1235.d 3.04E5 1 1 120 127 Deamidation (NQ)
K.TKDQLAEYGY(+14.02) Y 38.58 1200.5663 10 -12.4 601.2830 2 67.08 6 35688 VEV_3_3_RA6_01_1237.d 7.06E5 6 6 193 202 Methylation(C-term)
R.LSHE(+14.02)VGWKYQDVVAR.L Y 38.14 1799.9319 15 -11.6 450.9850 4 65.37 5 35557 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 143 157 Methylation(others)
R.GM(-48.00)IPHKSSR.G Y 36.72 963.5250 9 -16.5 482.7618 2 9.12 5 2187 VEV_2_3_RA5_01_1236.d 3.89E4 2 2 88 96 Dethiomethyl
K.RVVVPQ(+.98)ALR.I Y 35.43 1037.6345 9 4.6 346.8871 3 54.34 6 26868 VEV_3_3_RA6_01_1237.d 0 1 1 119 127 Deamidation (NQ)
R.Q(+.98)LAQAQK.T Y 35.38 786.4235 7 -21.1 787.4142 1 94.25 5 53911 VEV_2_3_RA5_01_1236.d 0 1 1 179 185 Deamidation (NQ)
R.LS(-2.02)HEVGWKYQDVVARLEER.R Y 34.89 2311.1709 19 12.1 463.2471 5 75.27 4 43338 VEV_1_3_RA4_01_1235.d 0 2 2 143 161 2-amino-3-oxo-butanoic_acid
R.LASIVAK.Q Y 34.19 700.4483 7 -27.7 351.2217 2 34.85 6 15563 VEV_3_3_RA6_01_1237.d 3.68E6 8 8 20 26
R.LSHEVGWK(+14.02).Y Y 33.51 968.5079 8 -7.2 485.2578 2 42.69 4 20346 VEV_1_3_RA4_01_1235.d 8.75E4 1 1 143 150 Methylation(KR)
K.Q(-17.03)LLNGQ(+.98)K.I Y 32.93 783.4127 7 -6.1 784.4152 1 55.98 4 28616 VEV_1_3_RA4_01_1235.d 3.71E4 1 1 27 33 Pyro-glu from Q; Deamidation (NQ)
K.TANVDQ(+.98)KTKDQLAEYGY Y 32.63 1943.9113 17 -8.9 972.9543 2 65.77 5 35865 VEV_2_3_RA5_01_1236.d 2.27E4 1 1 186 202 Deamidation (NQ)
R.FNPTR.G Y 32.60 633.3234 5 -8.3 317.6664 2 16.67 4 5654 VEV_1_3_RA4_01_1235.d 1.09E6 5 5 65 69
R.LKVFE(+14.02)GVPPPYDK.K Y 32.58 1501.8180 13 -9.4 751.9092 2 71.46 5 40068 VEV_2_3_RA5_01_1236.d 4.64E4 1 1 104 116 Methylation(others)
R.FNPTRGGPFHFRAPS(-18.01)R.I Y 32.48 1824.9283 16 -6.3 457.2365 4 42.79 5 20796 VEV_2_3_RA5_01_1236.d 0 1 1 65 80 Dehydration
K.SSRGAAAM(+15.99)ER.L Y 32.41 1050.4877 10 -5.0 351.1681 3 14.50 6 4695 VEV_3_3_RA6_01_1237.d 6.2E4 1 1 94 103 Oxidation (M)
R.Q(-17.03)LAQAQKTANVDQKTKDQLAEYGY Y 32.11 2693.3296 24 -10.2 898.7747 3 73.42 4 41915 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 179 202 Pyro-glu from Q
R.VVVPQALR(+14.02).I Y 31.93 894.5651 8 -30.7 448.2761 2 64.71 5 35051 VEV_2_3_RA5_01_1236.d 0 3 3 120 127 Methylation(KR)
K.QLLNGQK(+43.99)IVVVRC(+57.02)EALNISGEFFR.A Y 31.78 2833.4907 24 -0.5 709.3796 4 88.66 4 52912 VEV_1_3_RA4_01_1235.d 6.89E4 1 1 27 50 Carboxylation (DKW); Carbamidomethylation
R.FNPT(+79.96)RGGPFHFR.A Y 31.67 1511.6727 12 38.5 378.9400 4 63.80 5 34391 VEV_2_3_RA5_01_1236.d 0 1 1 65 76 Sulfation
R.C(+57.02)EALN(+.98)ISGEFFR.A Y 31.65 1442.6500 12 48.0 722.3669 2 81.37 4 48066 VEV_1_3_RA4_01_1235.d 6.56E4 1 1 39 50 Carbamidomethylation; Deamidation (NQ)
K.YC(+57.02)TVGR(+14.02).L Y 31.09 768.3588 6 -11.0 385.1825 2 22.14 4 8529 VEV_1_3_RA4_01_1235.d 2.19E5 2 2 137 142 Carbamidomethylation; Methylation(KR)
R.FNPTRGGPFHFR.A Y 30.93 1431.7159 12 -9.9 478.2412 3 63.91 5 34469 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 65 76
K.VKGSAYYER(+14.02).K Y 30.28 1085.5505 9 -12.7 543.7756 2 26.25 6 10860 VEV_3_3_RA6_01_1237.d 3.85E5 3 3 164 172 Methylation(KR)
K.ITRFNPTR.G Y 29.70 1003.5563 8 -22.5 335.5185 3 30.68 6 13251 VEV_3_3_RA6_01_1237.d 4.47E5 3 3 62 69
K.YQD(+14.02)VVAR.L Y 29.38 863.4501 7 -8.6 432.7286 2 40.77 4 19149 VEV_1_3_RA4_01_1235.d 2.58E5 2 2 151 157 Methylation(others)
K.GSAYYERK.K Y 28.88 972.4664 8 3.2 487.2421 2 13.62 5 4331 VEV_2_3_RA5_01_1236.d 9.52E4 2 2 166 173
R.AKLKYHAYLR.K Y 28.30 1261.7295 10 -7.2 316.4374 4 36.82 5 17252 VEV_2_3_RA5_01_1236.d 4.32E5 3 3 51 60
K.YQDVVAR(+14.02).L Y 27.60 863.4501 7 -7.7 432.7290 2 37.38 4 17206 VEV_1_3_RA4_01_1235.d 7.17E5 3 3 151 157 Methylation(KR)
K.LKYHAYLR.K Y 26.66 1062.5974 8 19.0 355.2131 3 51.01 5 25765 VEV_2_3_RA5_01_1236.d 1.04E6 6 6 53 60
R.LK(+14.02)VFEGVPPPYDKK.K Y 26.19 1629.9130 14 -18.8 408.4778 4 65.76 6 34698 VEV_3_3_RA6_01_1237.d 8.22E5 3 3 104 117 Methylation(KR)
K.Q(-17.03)LLNGQK.I Y 26.07 782.4286 7 -16.9 783.4227 1 50.87 4 25426 VEV_1_3_RA4_01_1235.d 0 1 1 27 33 Pyro-glu from Q
R.LASIVAK(+14.02).Q Y 25.36 714.4639 7 -17.0 358.2332 2 46.07 5 22767 VEV_2_3_RA5_01_1236.d 5.24E5 3 3 20 26 Methylation(KR)
R.C(+44.03)EALNISGEFFR.A Y 25.20 1428.6707 12 22.9 715.3589 2 88.71 6 50635 VEV_3_3_RA6_01_1237.d 1.79E5 1 1 39 50 Ethanolation (C)
R.RQLAQAQK(+14.02).T Y 25.18 955.5563 8 -14.2 478.7786 2 13.69 4 4153 VEV_1_3_RA4_01_1235.d 2.04E4 1 1 178 185 Methylation(KR)
M.S(+42.01)TFEPVVVIDGK(+14.02)GHLLGR.L Y 23.52 1979.0840 18 -7.6 660.6969 3 82.83 4 49105 VEV_1_3_RA4_01_1235.d 4.07E5 1 1 2 19 Acetylation (Protein N-term); Methylation(KR)
K.Q(+.98)LLNGQK(+42.01)IVVVR(+14.02)C(+57.02)EALNISGEFFR.A Y 23.24 2846.5112 24 -17.8 712.6224 4 89.01 4 53116 VEV_1_3_RA4_01_1235.d 0 1 1 27 50 Deamidation (NQ); Acetylation (K); Methylation(KR); Carbamidomethylation
K.GHLLGR.L Y 23.13 651.3816 6 -17.1 326.6925 2 19.43 5 7441 VEV_2_3_RA5_01_1236.d 9.14E4 1 1 14 19
K.AVRGM(+15.99)IPHKSSRGAAAM(+15.99)ER.L Y 22.37 2056.0417 19 -0.8 412.2153 5 11.65 4 3144 VEV_1_3_RA4_01_1235.d 3E4 2 2 85 103 Oxidation (M)
R.RQ(+.98)LAQAQK.T Y 22.09 942.5247 8 -29.2 472.2559 2 11.07 6 2952 VEV_3_3_RA6_01_1237.d 0 1 1 178 185 Deamidation (NQ)
K.YHAYLR(-.98).K Y 21.43 820.4344 6 48.9 821.4818 1 26.48 4 10920 VEV_1_3_RA4_01_1235.d 2.32E4 1 1 55 60 Amidation
K.Q(+42.01)LLNGQKIVVVR(+14.02)C(+57.02)EALNISGEFFR.A Y 21.26 2845.5271 24 -26.7 712.3701 4 89.03 4 53126 VEV_1_3_RA4_01_1235.d 0 1 1 27 50 Acetylation (N-term); Methylation(KR); Carbamidomethylation
R.G(+42.01)MIPHKSSRGAAAMERLK.V Y 20.99 1981.0349 18 -9.9 496.2611 4 75.85 4 43802 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 88 105 Acetylation (N-term)
R.GM(+15.99)IPHK.S Y 20.99 697.3581 6 11.1 698.3731 1 41.33 5 19926 VEV_2_3_RA5_01_1236.d 1.61E5 2 2 88 93 Oxidation (M)
K.SSRGAAAMER.L Y 20.85 1034.4927 10 -64.1 345.8161 3 22.26 6 8741 VEV_3_3_RA6_01_1237.d 1.94E5 1 1 94 103
R.QLAQ(+.98)AQ(+.98)K.T Y 20.70 787.4075 7 7.9 394.7141 2 30.66 6 13222 VEV_3_3_RA6_01_1237.d 2.25E5 1 1 179 185 Deamidation (NQ)
R.FNPTR(+14.02).G Y 20.45 647.3391 5 -14.7 324.6721 2 23.41 5 9565 VEV_2_3_RA5_01_1236.d 5.63E4 1 1 65 69 Methylation(KR)
R.RQLAQ(+.98)AQK.T Y 20.17 942.5247 8 -20.0 472.2602 2 11.50 4 3080 VEV_1_3_RA4_01_1235.d 1.73E4 1 1 178 185 Deamidation (NQ)
R.GAAAMER(+14.02).L Y 20.01 718.3432 7 22.5 360.1870 2 17.96 5 6670 VEV_2_3_RA5_01_1236.d 0 1 1 97 103 Methylation(KR)
R.LS(-18.01)HEVGWK(+14.02)YQDVVARLEER.R Y 19.96 2309.1917 19 31.5 578.3234 4 75.14 5 42696 VEV_2_3_RA5_01_1236.d 0 1 1 143 161 Dehydration; Methylation(KR)
K.YQ(+.98)DVVARLEER.R Y 19.75 1377.6888 11 -9.4 460.2326 3 66.17 6 35015 VEV_3_3_RA6_01_1237.d 6.69E4 1 1 151 161 Deamidation (NQ)
K.VFEGVPPPYDKKK.R Y 19.05 1502.8132 13 0.0 376.7106 4 48.72 6 23574 VEV_3_3_RA6_01_1237.d 0 1 1 106 118
R.LSHEVGW(+15.99)K.Y Y 18.95 970.4872 8 44.8 486.2726 2 29.73 6 12724 VEV_3_3_RA6_01_1237.d 0 1 1 143 150 Oxidation (HW)
R.LKVFEGVPPPYDK(+14.02).K Y 18.87 1501.8180 13 3.2 501.6149 3 71.43 4 40345 VEV_1_3_RA4_01_1235.d 0 1 1 104 116 Methylation(KR)
R.QLAQ(+.98)AQKTANVDQK.T Y 18.62 1542.8002 14 -31.5 772.3831 2 86.05 4 51278 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 179 192 Deamidation (NQ)
R.L(+42.01)K(+42.01)VFEGVPPPYDKK.K Y 18.06 1699.9185 14 -26.2 425.9758 4 64.19 6 33504 VEV_3_3_RA6_01_1237.d 3.16E5 1 1 104 117 Acetylation (N-term); Acetylation (K)
K.Y(+41.03)QDVVAR.L Y 17.86 890.4610 7 -31.4 446.2238 2 28.72 4 12135 VEV_1_3_RA4_01_1235.d 1.57E5 1 1 151 157 Amidination of lysines or N-terminal amines with methyl acetimidate
K.R(+226.08)VVVPQALR(+14.02).I Y 17.35 1276.7438 9 -25.5 1277.7185 1 99.03 4 57884 VEV_1_3_RA4_01_1235.d 5.42E4 1 1 119 127 Biotinylation; Methylation(KR)
R.G(+42.01)MIPHK(+42.01).S Y 17.25 765.3843 6 31.7 766.4159 1 99.10 5 55707 VEV_2_3_RA5_01_1236.d 0 1 1 88 93 Acetylation (N-term); Acetylation (K)
R.LSHEVGW(+31.99)KYQDVVAR.L Y 17.08 1817.9060 15 15.3 606.9852 3 57.06 5 29474 VEV_2_3_RA5_01_1236.d 0 1 1 143 157 Dihydroxy
R.GM(-48.00)IPHK.S Y 17.01 633.3599 6 -15.3 317.6824 2 8.91 5 2123 VEV_2_3_RA5_01_1236.d 8.27E4 1 1 88 93 Dethiomethyl
R.LASIVAK(+226.08).Q Y 16.85 926.5259 7 -28.9 464.2568 2 46.82 6 22452 VEV_3_3_RA6_01_1237.d 1.98E5 1 1 20 26 Biotinylation
K.YC(+57.02)TVGRLSHEVGWK(+43.99).Y Y 16.65 1734.8148 14 36.5 579.3000 3 34.39 4 15387 VEV_1_3_RA4_01_1235.d 0 1 1 137 150 Carbamidomethylation; Carboxylation (DKW)
R.QLAQAQ(+.98)KTANVDQK(+42.01).T Y 16.47 1584.8107 14 -9.7 397.2061 4 19.35 4 7067 VEV_1_3_RA4_01_1235.d 0 1 1 179 192 Deamidation (NQ); Acetylation (K)
K.V(+43.01)KGSAYYERK(+42.01).K Y 16.38 1284.6462 10 -10.5 643.3237 2 75.61 4 43605 VEV_1_3_RA4_01_1235.d 3.98E4 1 1 164 173 Carbamylation; Acetylation (K)
K.IVVVR.C N 16.35 584.4009 5 -11.1 585.4017 1 29.57 4 12610 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 34 38
R.C(+57.02)E(+17.03)ALNISGEFFR.A Y 16.26 1458.6925 12 -5.2 730.3497 2 81.15 6 45965 VEV_3_3_RA6_01_1237.d 5.83E4 1 1 39 50 Carbamidomethylation; Replacement of proton with ammonium ion
K.QLLNGQ(+.98)K.I Y 16.19 800.4392 7 -24.0 401.2173 2 23.74 4 9412 VEV_1_3_RA4_01_1235.d 5.43E5 1 1 27 33 Deamidation (NQ)
R.GMIPHKSSRGAAAMER(-.98).L Y 15.95 1696.8613 16 -7.2 425.2196 4 60.23 4 31651 VEV_1_3_RA4_01_1235.d 0 1 1 88 103 Amidation
K.IVVVR(+14.02).C N 15.70 598.4166 5 -21.7 300.2091 2 42.38 6 19883 VEV_3_3_RA6_01_1237.d 1.71E4 1 1 34 38 Methylation(KR)
R.RQLAQAQK(-.98).T Y 15.48 940.5566 8 -17.0 471.2776 2 10.90 4 2813 VEV_1_3_RA4_01_1235.d 0 1 1 178 185 Amidation
total 116 peptides
C1GB47
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KASLVLIPNDVDPIELVVFLPALC(+57.02)RK.M Y 135.30 2918.6667 26 -2.7 730.6720 4 92.01 6 52314 VEV_3_3_RA6_01_1237.d 4.94E5 3 3 138 163 Carbamidomethylation
K.ASLVLIPNDVDPIELVVFLPALC(+57.02)R.K Y 131.65 2662.4768 24 -7.1 888.4933 3 97.68 5 55256 VEV_2_3_RA5_01_1236.d 2.53E5 5 5 139 162 Carbamidomethylation
K.KASLVLIPNDVDPIELVVFLPALC(+57.02)R.K Y 120.75 2790.5718 25 -3.7 931.1944 3 95.38 4 56471 VEV_1_3_RA4_01_1235.d 1.96E6 10 10 138 162 Carbamidomethylation
K.YGLNHVVGLIENK.K Y 110.30 1454.7881 13 -6.9 485.9333 3 73.60 5 41624 VEV_2_3_RA5_01_1236.d 1.72E6 9 9 125 137
K.YGLNHVVGLIENKK.A Y 97.11 1582.8831 14 -14.0 792.4377 2 68.89 5 38196 VEV_2_3_RA5_01_1236.d 2.22E6 7 7 125 138
R.NFGIGQDIQPKR.N Y 94.94 1371.7258 12 -12.3 458.2436 3 60.42 5 31860 VEV_2_3_RA5_01_1236.d 2.33E6 10 10 39 50
K.TAAVLALTEVRSEDKTELSK.L Y 89.02 2160.1638 20 -13.8 541.0408 4 69.04 6 37152 VEV_3_3_RA6_01_1237.d 4.06E5 5 5 185 204
K.KKEDVSKKPYAVK.Y Y 88.48 1518.8770 13 -9.4 760.4386 2 14.11 5 4552 VEV_2_3_RA5_01_1236.d 7.35E5 6 6 112 124
K.LISAIKEGYSDKYEESKR.H Y 87.04 2115.0847 18 -19.9 529.7679 4 55.83 4 28523 VEV_1_3_RA4_01_1235.d 9.16E5 7 7 205 222
K.EGYSDKYEESKR.H Y 86.08 1489.6685 12 -14.0 745.8311 2 19.34 6 7223 VEV_3_3_RA6_01_1237.d 6E5 9 9 211 222
R.NFGIGQDIQPK.R Y 83.50 1215.6248 11 -9.8 608.8137 2 66.34 4 36354 VEV_1_3_RA4_01_1235.d 2.41E6 6 6 39 49
R.LLKEASAIEAGK.K Y 80.57 1228.7026 12 -16.8 410.5679 3 51.94 6 25475 VEV_3_3_RA6_01_1237.d 2.47E6 10 10 100 111
K.LISAIKEGYSDKYEESK.R Y 80.52 1958.9836 17 -12.8 653.9935 3 59.08 6 29776 VEV_3_3_RA6_01_1237.d 3.3E5 5 5 205 221
K.TAAVLALTEVR.S Y 71.48 1142.6659 11 -16.3 572.3309 2 73.18 6 40220 VEV_3_3_RA6_01_1237.d 1.33E6 5 5 185 195
R.NFGIGQ(+.98)DIQPK.R Y 66.27 1216.6088 11 -11.6 609.3046 2 67.79 5 37364 VEV_2_3_RA5_01_1236.d 6.27E5 3 3 39 49 Deamidation (NQ)
R.KMGVPYAIIK.G Y 64.61 1118.6521 10 -9.5 373.8878 3 65.99 4 36080 VEV_1_3_RA4_01_1235.d 3.22E5 2 2 163 172
K.MGVPYAIIK.G Y 64.37 990.5572 9 -11.7 496.2801 2 73.33 4 41877 VEV_1_3_RA4_01_1235.d 9.67E5 5 5 164 172
K.YGLNHVVGLIENKKASLVLIPNDVDPIELVVFLPALC(+57.02)R.K Y 63.67 4227.3491 38 -9.4 846.4691 5 95.14 4 56354 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 125 162 Carbamidomethylation
K.ASLVLIPNDVDPIELVVFLPALC(+57.02)RK.M Y 63.34 2790.5718 25 -6.8 931.1915 3 95.90 4 56748 VEV_1_3_RA4_01_1235.d 1.07E6 3 3 139 163 Carbamidomethylation
K.TAAVLALTEVR(+14.02).S Y 62.62 1156.6815 11 -13.2 579.3404 2 76.36 4 44190 VEV_1_3_RA4_01_1235.d 1.78E5 3 3 185 195 Methylation(KR)
R.NTAAQAFK.L Y 60.76 849.4344 8 -9.9 425.7203 2 20.90 4 7919 VEV_1_3_RA4_01_1235.d 2.84E6 6 6 76 83
K.ASENAIKL Y 59.17 844.4654 8 -17.4 423.2326 2 47.71 6 22976 VEV_3_3_RA6_01_1237.d 2.23E6 8 8 243 250
R.LGTVVHKK.T Y 58.78 880.5494 8 -14.3 441.2757 2 12.10 4 3363 VEV_1_3_RA4_01_1235.d 3.33E5 3 3 177 184
K.EASAIEAGK.K Y 57.10 874.4396 9 -14.1 438.2209 2 16.20 5 5673 VEV_2_3_RA5_01_1236.d 4.3E5 6 6 103 111
K.YGLNHVVGLIENK(+14.02).K Y 55.56 1468.8038 13 -5.4 490.6059 3 76.94 4 44649 VEV_1_3_RA4_01_1235.d 1.62E5 2 2 125 137 Methylation(KR)
R.NFGIGQDIQPK(+14.02).R Y 50.51 1229.6404 11 -9.6 615.8215 2 69.30 4 38665 VEV_1_3_RA4_01_1235.d 3.57E5 3 3 39 49 Methylation(KR)
K.YGLNHVVGLIENK(+14.02)K.A Y 49.60 1596.8987 14 -20.4 400.2238 4 70.99 5 39717 VEV_2_3_RA5_01_1236.d 0 1 1 125 138 Methylation(KR)
R.NFGIGQDIQ(+.98)PKR.N Y 48.63 1372.7098 12 2.3 458.5783 3 60.56 4 31902 VEV_1_3_RA4_01_1235.d 3.43E5 2 2 39 50 Deamidation (NQ)
R.HWGGGIMGAK.A Y 47.22 1012.4913 10 -13.3 507.2462 2 50.40 4 25125 VEV_1_3_RA4_01_1235.d 2.17E5 6 6 223 232
R.LLKEASAIEAGKK.K Y 46.73 1356.7976 13 -22.1 340.1992 4 42.58 6 20050 VEV_3_3_RA6_01_1237.d 3.59E5 5 5 100 112
R.NFGIGQDIQ(+.98)PK.R Y 46.50 1216.6088 11 -7.4 609.3071 2 68.41 4 38056 VEV_1_3_RA4_01_1235.d 3.19E5 3 3 39 49 Deamidation (NQ)
K.EASAIEAGK(+14.02).K Y 46.32 888.4552 9 -15.5 445.2280 2 24.64 5 10278 VEV_2_3_RA5_01_1236.d 1.47E5 2 2 103 111 Methylation(KR)
R.NTAAQ(+.98)AFK.L Y 45.60 850.4185 8 -25.0 426.2059 2 24.34 6 9856 VEV_3_3_RA6_01_1237.d 4.63E5 3 3 76 83 Deamidation (NQ)
R.LLK(+14.02)EASAIEAGK.K Y 44.06 1242.7183 12 -16.7 415.2398 3 59.40 5 31105 VEV_2_3_RA5_01_1236.d 1.52E5 2 2 100 111 Methylation(KR)
R.NFGIGQDIQPKR(+14.02).N Y 43.16 1385.7415 12 -9.3 462.9168 3 61.48 5 32640 VEV_2_3_RA5_01_1236.d 9.95E4 1 1 39 50 Methylation(KR)
K.TAAVLALT(+14.02)EVR.S Y 41.76 1156.6815 11 -14.0 579.3400 2 76.27 5 43494 VEV_2_3_RA5_01_1236.d 4.49E4 1 1 185 195 Methylation(others)
R.SEDKTELSKLISAIK.E Y 41.48 1660.9247 15 -11.1 416.2338 4 75.66 4 43651 VEV_1_3_RA4_01_1235.d 8.38E4 1 1 196 210
R.KASENAIKL Y 39.66 972.5604 9 -8.1 487.2835 2 33.00 4 14578 VEV_1_3_RA4_01_1235.d 3.66E5 3 3 242 250
K.LISAIKE(+14.02)GYSDKYEESKR.H Y 38.94 2129.1003 18 -13.5 426.8216 5 59.02 4 30749 VEV_1_3_RA4_01_1235.d 2.07E5 1 1 205 222 Methylation(others)
K.YGLNHVVGLIENKK(+14.02).A Y 35.24 1596.8987 14 -19.1 400.2243 4 72.58 4 41252 VEV_1_3_RA4_01_1235.d 2.72E5 2 2 125 138 Methylation(KR)
R.HWGGGIM(+15.99)GAK.A Y 34.46 1028.4862 10 -6.0 515.2473 2 31.01 4 13465 VEV_1_3_RA4_01_1235.d 3.12E5 2 2 223 232 Oxidation (M)
K.YGLN(+.98)HVVGLIENKK.A Y 33.79 1583.8671 14 -37.4 396.9592 4 68.81 6 36991 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 125 138 Deamidation (NQ)
K.LISAIK.E N 32.75 643.4268 6 -14.1 644.4250 1 38.50 6 17631 VEV_3_3_RA6_01_1237.d 5.55E5 6 6 205 210
R.LLKEASAIEAGK(+14.02).K Y 32.53 1242.7183 12 -36.1 622.3440 2 59.67 4 31240 VEV_1_3_RA4_01_1235.d 0 1 1 100 111 Methylation(KR)
K.LIS(+14.02)AIKEGYSDKYEESKR.H Y 31.23 2129.1003 18 -24.2 426.8170 5 59.01 6 29721 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 205 222 Methylation(others)
K.K(+54.01)ERLLKEASAIEAGK.K Y 30.30 1695.9519 15 -11.7 424.9903 4 52.01 4 26169 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 97 111 MDA adduct +54
K.LLNKYRPESK.A Y 29.15 1246.7034 10 -12.9 416.5697 3 31.47 5 14114 VEV_2_3_RA5_01_1236.d 1.89E6 7 7 84 93
K.KEDVSKKPYAVK.Y Y 28.45 1390.7820 12 -14.5 464.5945 3 16.51 6 5724 VEV_3_3_RA6_01_1237.d 2.79E5 2 2 113 124
R.LLKEASAIE(+14.02)AGK.K Y 26.67 1242.7183 12 -18.1 415.2392 3 61.43 5 32600 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 100 111 Methylation(others)
R.RKASENAIKL Y 26.14 1128.6615 10 -15.7 565.3292 2 27.80 5 12028 VEV_2_3_RA5_01_1236.d 2.53E5 2 2 241 250
K.EASAIEAGKKKEDVSK.K Y 25.36 1688.8944 16 -20.0 563.9608 3 16.86 5 6024 VEV_2_3_RA5_01_1236.d 0 1 1 103 118
K.YRPESK.A Y 24.96 778.3973 6 -18.9 390.1986 2 9.26 5 2236 VEV_2_3_RA5_01_1236.d 1.42E4 1 1 88 93
K.A(+42.01)S(+79.97)LVLIPN(+.98)DVDPIELVVFLPALC(+57.02)R.K Y 24.28 2785.4377 24 -31.9 697.3445 4 95.38 5 54379 VEV_2_3_RA5_01_1236.d 2.2E4 1 1 139 162 Acetylation (N-term); Phosphorylation (STY); Deamidation (NQ); Carbamidomethylation
R.NFGIGQ(+.98)DIQ(+.98)PK.R Y 24.14 1217.5928 11 17.3 1218.6211 1 87.83 5 50750 VEV_2_3_RA5_01_1236.d 1.23E5 2 2 39 49 Deamidation (NQ)
K.KEDVSKK(+43.99)PYAVK.Y Y 23.75 1434.7717 12 -14.3 479.2577 3 54.10 4 27501 VEV_1_3_RA4_01_1235.d 0 1 1 113 124 Carboxylation (DKW)
K.EASAIEAGKK.K Y 23.06 1002.5345 10 -29.2 502.2599 2 11.83 6 3316 VEV_3_3_RA6_01_1237.d 2.08E4 1 1 103 112
K.ASLVLIPNDVDPIE(+129.04)LVVFLPALC(+57.02)R.K Y 23.03 2791.5193 24 6.0 931.5193 3 96.60 4 57019 VEV_1_3_RA4_01_1235.d 1.88E5 1 1 139 162 Monoglutamyl; Carbamidomethylation
K.LISAIK(+14.02)EGYSDKYEESKR.H Y 22.99 2129.1003 18 -15.2 533.2743 4 59.03 4 30757 VEV_1_3_RA4_01_1235.d 8.98E4 1 1 205 222 Methylation(KR)
K.R(+27.99)HWGGGIMGAKANAR.Q Y 22.38 1608.8055 15 -6.8 805.4045 2 85.85 6 48988 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 222 236 Formylation
R.HWGGGIM(+15.99)GAKANAR.Q Y 22.29 1440.7045 14 -33.0 481.2263 3 21.30 6 8242 VEV_3_3_RA6_01_1237.d 5.33E4 1 1 223 236 Oxidation (M)
K.KKEDVSK(+42.01)KPYAVK.Y Y 22.11 1560.8875 13 -18.8 391.2218 4 67.24 5 36955 VEV_2_3_RA5_01_1236.d 0 1 1 112 124 Acetylation (K)
R.KM(+15.99)GVPYAIIK.G Y 21.91 1134.6471 10 -22.1 379.2146 3 58.71 4 30517 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 163 172 Oxidation (M)
K.ARLGTVVHK.K Y 21.88 979.5927 9 -62.6 980.5386 1 103.29 5 57031 VEV_2_3_RA5_01_1236.d 0 1 1 175 183
R.NFGIGQDIQPKRNLSR.M Y 21.80 1841.9860 16 -4.0 615.0001 3 61.53 5 32686 VEV_2_3_RA5_01_1236.d 4.08E4 1 1 39 54
K.TAAVLALTEVR(+14.02)SEDKTELSK.L Y 21.68 2174.1794 20 -2.5 544.5508 4 71.73 5 40266 VEV_2_3_RA5_01_1236.d 2.45E4 1 1 185 204 Methylation(KR)
K.LISAIKEGYSDKYEESK(+14.02)R.H Y 21.55 2129.1003 18 -15.4 426.8208 5 58.59 6 29430 VEV_3_3_RA6_01_1237.d 6.2E4 1 1 205 222 Methylation(KR)
K.YGLNHVVGLIE(+14.02)NKK.A Y 21.37 1596.8987 14 -14.1 400.2263 4 72.85 6 39978 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 125 138 Methylation(others)
K.K(+42.01)(+42.01)EDVSK(+42.01)KPYAVK.Y Y 21.25 1516.8136 12 -42.3 380.1946 4 14.14 5 4568 VEV_2_3_RA5_01_1236.d 0 1 1 113 124 Acetylation (N-term); Acetylation (K)
K.AS(+79.97)LVLIPNDVD(+43.99)PIELVVFLPALC(+57.02)R.K Y 21.16 2786.4329 24 0.6 929.8188 3 95.88 4 56698 VEV_1_3_RA4_01_1235.d 3.91E4 2 2 139 162 Phosphorylation (STY); Carboxylation (DKW); Carbamidomethylation
R.HWGGGIMGAK(+114.04).A Y 20.87 1126.5342 10 32.6 1127.5781 1 90.00 4 53648 VEV_1_3_RA4_01_1235.d 2.22E5 1 1 223 232 Ubiquitin
R.NTAAQAFKLLNK.Y Y 20.80 1317.7405 12 -23.7 440.2437 3 65.78 5 35897 VEV_2_3_RA5_01_1236.d 0 1 1 76 87
K.EASAIEAGK(-.98).K Y 20.00 873.4556 9 -10.4 437.7305 2 45.25 5 22288 VEV_2_3_RA5_01_1236.d 3.09E5 1 1 103 111 Amidation
K.MGVPYAIIKGK.A Y 19.69 1175.6736 11 -11.5 392.8940 3 66.19 5 36167 VEV_2_3_RA5_01_1236.d 7.87E4 1 1 164 174
K.KPYAVK.Y Y 19.02 704.4221 6 -39.0 705.4019 1 48.59 6 23493 VEV_3_3_RA6_01_1237.d 0 1 1 119 124
R.LLKEASAIEAGK(+42.01)K(+42.01).K Y 19.02 1440.8187 13 -54.3 361.1924 4 50.95 6 24841 VEV_3_3_RA6_01_1237.d 0 1 1 100 112 Acetylation (K)
R.LGT(+79.96)VVHK.K Y 18.62 832.4113 7 26.8 833.4409 1 103.10 4 59193 VEV_1_3_RA4_01_1235.d 1.31E4 1 1 177 183 Sulfation
R.LLK(+40.03)EASAIEAGK.K Y 18.45 1268.7339 12 -51.1 423.8970 3 52.29 6 25649 VEV_3_3_RA6_01_1237.d 0 1 1 100 111 Propionaldehyde +40
MSISSSFPLSQSK(+21.98).V Y 18.26 1419.6680 13 18.7 474.2388 3 12.48 5 3689 VEV_2_3_RA5_01_1236.d 3E4 1 1 1 13 Sodium adduct
K.RHWGGGIM(+15.99)GAK.A Y 18.11 1184.5873 11 -26.5 593.2852 2 47.69 6 22966 VEV_3_3_RA6_01_1237.d 0 1 1 222 232 Oxidation (M)
K.NLQNPLIEK.R Y 16.94 1067.5975 9 -27.6 356.8633 3 37.55 6 17086 VEV_3_3_RA6_01_1237.d 0 1 1 27 35
R.L(+42.01)GTVVHK(+14.02).K Y 16.90 808.4807 7 -8.6 809.4810 1 99.60 4 58077 VEV_1_3_RA4_01_1235.d 0 1 1 177 183 Acetylation (N-term); Methylation(KR)
K.MGVPYAIIK(+226.08).G Y 16.90 1216.6348 9 -6.5 305.1640 4 28.52 5 12455 VEV_2_3_RA5_01_1236.d 7.79E5 1 1 164 172 Biotinylation
K.YGLNH(+40.03)VVGLIENK.K Y 16.82 1494.8195 13 -53.8 499.2536 3 73.78 6 40656 VEV_3_3_RA6_01_1237.d 4.25E4 1 1 125 137 Propionaldehyde +40
K.KEDVSKKPYAVK(+42.01).Y Y 16.76 1432.7925 12 -1.1 359.2050 4 56.16 6 27825 VEV_3_3_RA6_01_1237.d 7.8E4 1 1 113 124 Acetylation (K)
K.KEDVSK.K Y 16.57 704.3704 6 -46.5 705.3449 1 77.55 6 43402 VEV_3_3_RA6_01_1237.d 0 1 1 113 118
R.N(+.98)TAAQAFK(+14.02).L Y 16.36 864.4341 8 -6.1 433.2217 2 33.38 4 14791 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 76 83 Deamidation (NQ); Methylation(KR)
K.E(+43.01)ASAIEAGK.K Y 16.07 917.4454 9 4.4 459.7320 2 38.81 6 17812 VEV_3_3_RA6_01_1237.d 2.51E5 1 1 103 111 Carbamylation
K.R(+226.08)HWGGGIM(+15.99)GAK.A Y 16.07 1410.6649 11 -8.5 706.3337 2 55.27 5 28325 VEV_2_3_RA5_01_1236.d 0 1 1 222 232 Biotinylation; Oxidation (M)
R.RKASEN(+.98)AIKL Y 16.06 1129.6455 10 -19.1 377.5486 3 61.86 5 32969 VEV_2_3_RA5_01_1236.d 4.91E4 1 1 241 250 Deamidation (NQ)
K.M(+15.99)GVPYAIIKGKAR.L Y 15.96 1418.8068 13 -37.9 355.6955 4 46.92 6 22549 VEV_3_3_RA6_01_1237.d 1.16E6 1 1 164 176 Oxidation (M)
K.E(+27.99)ASAIEAGK.K Y 15.79 902.4345 9 -6.6 452.2216 2 19.53 4 7175 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 103 111 Formylation
R.LGT(+79.96)VVHKK.T Y 15.64 960.5062 8 -23.1 321.1686 3 12.19 6 3497 VEV_3_3_RA6_01_1237.d 0 1 1 177 184 Sulfation
K.Y(+120.03)GLNHVVGLIENKK.A Y 15.57 1702.9171 14 -9.4 426.7325 4 69.11 4 38529 VEV_1_3_RA4_01_1235.d 0 1 1 125 138 O-Isopropylmethylphosphonylation
R.NFGIGQ(+.98)DIQPKR.N Y 15.56 1372.7098 12 -8.8 687.3561 2 62.07 5 33096 VEV_2_3_RA5_01_1236.d 4.62E4 1 1 39 50 Deamidation (NQ)
K.E(+17.03)RLLKEASAIEAGKK.K Y 15.40 1658.9679 15 -30.1 415.7368 4 58.83 5 30693 VEV_2_3_RA5_01_1236.d 0 1 1 98 112 Replacement of proton with ammonium ion
K.EASAIEAGKKKEDVSK(-.98).K Y 15.38 1687.9104 16 -9.4 422.9809 4 60.74 5 32097 VEV_2_3_RA5_01_1236.d 0 1 1 103 118 Amidation
total 96 peptides
C1GA20
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLEQLSGQTPVYSK.A Y 135.53 1547.8195 14 -15.4 774.9051 2 66.66 6 35408 VEV_3_3_RA6_01_1237.d 5.29E6 12 12 37 50
R.AAKVLEQLSGQTPVYSK.A Y 127.58 1817.9886 17 -10.2 606.9973 3 67.08 5 36857 VEV_2_3_RA5_01_1236.d 5.06E5 4 4 34 50
K.YDPGIGIYGMDFYC(+57.02)C(+57.02)MTRPGER.V Y 127.08 2657.1172 22 -4.5 886.7090 3 83.50 4 49562 VEV_1_3_RA4_01_1235.d 1.95E5 1 1 117 138 Carbamidomethylation
K.LVLNISVGESGDRLTR.A Y 120.54 1727.9530 16 -12.3 576.9845 3 73.56 6 40511 VEV_3_3_RA6_01_1237.d 3.18E6 9 9 18 33
R.IQKLVLNISVGESGDR.L Y 115.64 1726.9578 16 -11.6 576.6532 3 72.02 4 40809 VEV_1_3_RA4_01_1235.d 2.62E5 2 2 15 30
K.LVLNISVGESGDR.L Y 102.59 1357.7201 13 -8.6 679.8615 2 73.75 4 42193 VEV_1_3_RA4_01_1235.d 8.93E5 7 7 18 30
R.GPKAEEILER.G Y 100.59 1140.6138 10 -6.8 571.3103 2 47.09 4 23060 VEV_1_3_RA4_01_1235.d 2.07E6 16 16 74 83
K.VLEQ(+.98)LSGQTPVYSK.A Y 93.53 1548.8035 14 -14.2 775.3980 2 68.11 6 36500 VEV_3_3_RA6_01_1237.d 9.61E5 3 3 37 50 Deamidation (NQ)
R.IQKLVLNISVGESGDRLTR.A Y 91.58 2097.1904 19 -11.4 525.2989 4 72.23 4 40973 VEV_1_3_RA4_01_1235.d 1.29E6 5 5 15 33
K.VLE(+14.02)QLSGQTPVYSK.A Y 90.89 1561.8351 14 -12.8 781.9148 2 68.84 6 37004 VEV_3_3_RA6_01_1237.d 7.13E5 3 3 37 50 Methylation(others)
K.INQTETIKWFK.S Y 90.66 1406.7557 11 -9.2 704.3787 2 67.92 4 37573 VEV_1_3_RA4_01_1235.d 1.87E6 7 7 155 165
K.VLEQLSGQTPVYSKAR.Y Y 83.24 1774.9578 16 -10.6 592.6536 3 63.09 5 33843 VEV_2_3_RA5_01_1236.d 1.46E5 3 3 37 52
K.IGSSHKINQTETIK.W Y 81.42 1554.8365 14 -8.7 778.4188 2 29.01 6 12343 VEV_3_3_RA6_01_1237.d 7.43E5 9 9 149 162
K.VLEQLSGQTPVYSK(+14.02).A Y 77.62 1561.8351 14 -12.5 781.9150 2 68.66 4 38184 VEV_1_3_RA4_01_1235.d 4.96E5 4 4 37 50 Methylation(KR)
R.GLKVKEYELR.K Y 72.51 1233.7080 10 -16.4 412.2365 3 48.21 5 24089 VEV_2_3_RA5_01_1236.d 1.58E6 8 8 84 93
K.IGSSHKINQTETIKWFK.S Y 69.27 2016.0792 17 -14.1 505.0200 4 62.48 5 33394 VEV_2_3_RA5_01_1236.d 1.48E6 5 5 149 165
R.KQNFSETGNFGFGISEHIDLGIK.Y Y 68.76 2537.2549 23 -13.7 635.3123 4 111.69 4 61577 VEV_1_3_RA4_01_1235.d 4.03E5 3 3 94 116
K.INQTETIKWFKSRFEGIVR Y 67.00 2351.2749 19 -11.8 471.2567 5 79.50 5 45725 VEV_2_3_RA5_01_1236.d 1.94E5 2 2 155 173
R.NEKIAVHVTVR.G Y 66.16 1264.7251 11 -10.2 422.5780 3 41.39 4 19585 VEV_1_3_RA4_01_1235.d 4.07E4 1 1 63 73
K.IAVHVTVRGPK.A Y 63.78 1175.7139 11 -15.0 392.9060 3 43.44 4 20856 VEV_1_3_RA4_01_1235.d 9.29E5 6 6 66 76
K.SRFEGIVR Y 62.60 962.5297 8 -10.5 482.2671 2 44.21 4 21296 VEV_1_3_RA4_01_1235.d 6.63E6 17 17 166 173
K.IAVHVTVRGPKAEEILER.G Y 61.90 2016.1479 18 -10.1 404.2328 5 65.93 4 36003 VEV_1_3_RA4_01_1235.d 4.87E5 4 4 66 83
K.VLEQ(+.98)LSGQ(+.98)TPVYSK.A Y 57.22 1549.7875 14 -17.2 775.8877 2 69.67 6 37611 VEV_3_3_RA6_01_1237.d 4.74E4 1 1 37 50 Deamidation (NQ)
K.LVLNISVGESGDRLTR(+14.02).A Y 52.09 1741.9686 16 -12.5 581.6562 3 74.52 5 42278 VEV_2_3_RA5_01_1236.d 3.45E5 3 3 18 33 Methylation(KR)
K.VLEQLSGQ(+.98)TPVYSK.A Y 51.87 1548.8035 14 -16.1 775.3965 2 68.54 6 36797 VEV_3_3_RA6_01_1237.d 1.17E6 3 3 37 50 Deamidation (NQ)
K.INQTETIK.W Y 50.91 945.5131 8 -2.2 473.7628 2 22.78 4 8886 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 155 162
K.LVLNISVGESGDR(+14.02)LTR.A Y 49.61 1741.9686 16 -8.6 581.6585 3 76.18 4 44052 VEV_1_3_RA4_01_1235.d 1.7E5 1 1 18 33 Methylation(KR)
K.SRFEGIVR(+14.02) Y 49.56 976.5453 8 -16.5 326.5170 3 54.67 6 27019 VEV_3_3_RA6_01_1237.d 4.94E5 5 5 166 173 Methylation(KR)
K.VKEYELR.K Y 45.31 935.5076 7 -9.6 468.7566 2 27.68 4 11573 VEV_1_3_RA4_01_1235.d 2.72E6 10 10 87 93
K.LVLNISVGESGDR(+14.02).L Y 44.75 1371.7357 13 -14.0 686.8655 2 74.26 6 41010 VEV_3_3_RA6_01_1237.d 8.39E4 2 2 18 30 Methylation(KR)
R.GPKAEEILER(+14.02).G Y 44.47 1154.6295 10 -8.9 385.8804 3 53.89 4 27366 VEV_1_3_RA4_01_1235.d 1.67E5 1 1 74 83 Methylation(KR)
K.VKEYELRK.Q Y 41.43 1063.6025 8 -16.0 355.5358 3 19.34 4 7059 VEV_1_3_RA4_01_1235.d 6.46E5 5 5 87 94
R.GLKVKEYELRK.Q Y 41.12 1361.8030 11 -4.9 454.9394 3 38.50 5 18233 VEV_2_3_RA5_01_1236.d 9.34E5 6 6 84 94
K.VLEQ(+15.00)LSGQTPVYSK.A Y 40.32 1562.8192 14 -12.9 782.4068 2 70.52 4 39622 VEV_1_3_RA4_01_1235.d 5.37E4 1 1 37 50 Deamidation followed by a methylation
K.IAVHVTVR.G Y 39.15 893.5447 8 -8.4 894.5444 1 42.99 4 20535 VEV_1_3_RA4_01_1235.d 7.23E4 2 2 66 73
K.I(+43.01)AVHVTVR.G Y 38.54 936.5505 8 -38.9 313.1786 3 43.26 4 20695 VEV_1_3_RA4_01_1235.d 1.96E6 2 2 66 73 Carbamylation
K.AEEILER.G Y 37.40 858.4446 7 -20.2 430.2209 2 37.29 6 16929 VEV_3_3_RA6_01_1237.d 7.88E5 2 2 77 83
K.SRFE(+14.02)GIVR Y 37.35 976.5453 8 -12.9 326.5182 3 52.57 4 26609 VEV_1_3_RA4_01_1235.d 1.09E6 5 5 166 173 Methylation(others)
K.SNPMRELR.I Y 36.06 1001.5076 8 -11.8 501.7552 2 31.65 5 14220 VEV_2_3_RA5_01_1236.d 7.72E5 4 4 7 14
R.GPK(+14.02)AEEILER.G Y 34.13 1154.6295 10 -15.7 385.8777 3 56.07 6 27774 VEV_3_3_RA6_01_1237.d 1.73E5 1 1 74 83 Methylation(KR)
K.AEEILER(+14.02).G Y 33.75 872.4603 7 -10.7 437.2328 2 47.07 4 23041 VEV_1_3_RA4_01_1235.d 1.42E6 6 6 77 83 Methylation(KR)
K.VLEQLSGQ(+.98)TPVYSK(+42.01).A Y 32.86 1590.8141 14 -35.1 796.3864 2 87.80 5 50731 VEV_2_3_RA5_01_1236.d 0 1 1 37 50 Deamidation (NQ); Acetylation (K)
K.IAVHVTVRGPKAEEILER(+14.02).G Y 31.44 2030.1636 18 -13.4 407.0345 5 67.44 4 37197 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 66 83 Methylation(KR)
K.IGS(-18.01)SHK.I Y 31.29 609.3234 6 -4.2 610.3281 1 99.29 5 55774 VEV_2_3_RA5_01_1236.d 1.28E4 2 2 149 154 Dehydration
K.INQ(+.98)TETIKWFK.S Y 29.92 1407.7397 11 -5.4 470.2513 3 70.30 4 39445 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 155 165 Deamidation (NQ)
K.I(+42.01)AVHVTVRGPK.A Y 28.75 1217.7244 11 -57.0 406.8923 3 43.40 5 21155 VEV_2_3_RA5_01_1236.d 2.9E5 1 1 66 76 Acetylation (N-term)
K.AEE(+14.02)ILER.G Y 27.95 872.4603 7 -11.2 437.2326 2 47.47 4 23295 VEV_1_3_RA4_01_1235.d 1.07E6 2 2 77 83 Methylation(others)
K.INQTETIKW(+15.99)FK.S Y 27.45 1422.7507 11 -9.5 475.2530 3 67.00 4 36840 VEV_1_3_RA4_01_1235.d 0 1 1 155 165 Oxidation (HW)
R.FEGIVR Y 27.31 719.3966 6 -20.1 360.6983 2 46.23 6 22116 VEV_3_3_RA6_01_1237.d 6.21E5 3 3 168 173
R.NEK(+31.99)IAVHVTVR.G Y 26.04 1296.7150 11 -52.1 325.1691 4 42.58 6 19989 VEV_3_3_RA6_01_1237.d 0 1 1 63 73 Dihydroxy
R.GLKVKE(+14.02)YELR.K Y 24.42 1247.7238 10 -21.7 416.9062 3 56.82 5 29300 VEV_2_3_RA5_01_1236.d 9.85E4 1 1 84 93 Methylation(others)
K.INQT(-2.02)ETIKWFK.S Y 24.03 1404.7401 11 -24.9 469.2423 3 67.49 6 36002 VEV_3_3_RA6_01_1237.d 8.09E4 1 1 155 165 2-amino-3-oxo-butanoic_acid
K.ARYTVR.T Y 23.84 764.4293 6 -18.1 383.2150 2 13.88 6 4370 VEV_3_3_RA6_01_1237.d 1.28E5 2 2 51 56
K.A(+42.01)EEILER.G Y 23.81 900.4552 7 -23.8 451.2242 2 37.05 6 16829 VEV_3_3_RA6_01_1237.d 1.08E6 3 3 77 83 Acetylation (N-term)
K.AE(+14.02)EILER.G Y 23.66 872.4603 7 -17.2 437.2299 2 46.87 6 22478 VEV_3_3_RA6_01_1237.d 3.53E5 1 1 77 83 Methylation(others)
K.INQTETIK(+14.02).W Y 23.64 959.5287 8 -7.4 480.7681 2 36.32 4 16523 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 155 162 Methylation(KR)
K.VKE(+14.02)YELR.K Y 23.56 949.5233 7 -13.0 317.5109 3 39.97 4 18672 VEV_1_3_RA4_01_1235.d 2.58E5 1 1 87 93 Methylation(others)
K.EYELR.K N 23.46 708.3442 5 -7.1 709.3465 1 29.10 4 12347 VEV_1_3_RA4_01_1235.d 2.8E4 1 1 89 93
K.IGSSH(+15.99)K(+14.02).I Y 22.38 657.3445 6 -17.8 658.3401 1 80.96 6 45829 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 149 154 Oxidation (HW); Methylation(KR)
K.IGSSHK.I Y 22.15 627.3340 6 11.2 628.3483 1 41.01 6 19100 VEV_3_3_RA6_01_1237.d 0 2 2 149 154
R.TFGIR(+14.02).R Y 21.29 606.3489 5 10.5 304.1849 2 51.91 4 26107 VEV_1_3_RA4_01_1235.d 4.62E4 1 1 57 61 Methylation(KR)
K.SK(+27.99)IGSSHK.I Y 21.14 870.4559 8 -39.1 871.4292 1 92.14 6 52368 VEV_3_3_RA6_01_1237.d 0 1 1 147 154 Formylation
K.VLEQ(+.98)LSGQTPVYSK(+14.02).A Y 21.10 1562.8192 14 -14.5 782.4056 2 69.97 5 38974 VEV_2_3_RA5_01_1236.d 8.96E4 1 1 37 50 Deamidation (NQ); Methylation(KR)
MAEGK.K Y 20.35 534.2472 5 -63.3 535.2206 1 8.70 4 2056 VEV_1_3_RA4_01_1235.d 3.48E4 2 2 1 5
MAEGK(+14.02).K Y 19.87 548.2628 5 61.4 549.3038 1 30.66 6 13226 VEV_3_3_RA6_01_1237.d 2.6E5 1 1 1 5 Methylation(KR)
R.ELRIQKLVLNISVGESGDRLTR.A Y 19.85 2495.4182 22 -37.8 500.0721 5 78.09 5 44777 VEV_2_3_RA5_01_1236.d 0 1 1 12 33
K.IGSS(-18.01)HK(+14.02)INQTETIKWFK.S Y 18.66 2012.0844 17 -27.0 504.0148 4 62.60 4 33452 VEV_1_3_RA4_01_1235.d 2.54E4 1 1 149 165 Dehydration; Methylation(KR)
K.VKEYELR(+14.02).K Y 18.60 949.5233 7 -21.7 475.7586 2 33.69 4 14999 VEV_1_3_RA4_01_1235.d 4.92E4 1 1 87 93 Methylation(KR)
K.SRFEGIVR(+37.96) Y 18.41 1000.4856 8 5.6 334.5043 3 44.30 4 21329 VEV_1_3_RA4_01_1235.d 0 2 2 166 173 Replacement of proton by potassium
K.S(+42.01)K(+27.99)IGSSHK.I Y 18.24 912.4665 8 -27.7 457.2279 2 25.78 4 10537 VEV_1_3_RA4_01_1235.d 8.55E4 1 1 147 154 Acetylation (N-term); Formylation
K.VLEQLSGQTPVY(+31.99)SK(+42.01)AR.Y Y 17.44 1848.9581 16 -27.6 463.2341 4 50.65 5 25544 VEV_2_3_RA5_01_1236.d 0 1 1 37 52 Dihydroxy; Acetylation (K)
K.SK(+42.01)IGSSHKINQTETIK(+21.98).W Y 16.90 1833.9561 16 -19.2 612.3142 3 80.46 5 46358 VEV_2_3_RA5_01_1236.d 7.27E4 1 1 147 162 Acetylation (K); Sodium adduct
K.SKIGSSHK.I Y 16.82 842.4610 8 -33.9 422.2235 2 13.01 6 3965 VEV_3_3_RA6_01_1237.d 0 1 1 147 154
K.S(+27.99)NPMR.E Y 16.55 631.2748 5 20.0 632.2947 1 25.49 6 10457 VEV_3_3_RA6_01_1237.d 0 1 1 7 11 Formylation (Protein N-term)
R.TFGIRR.N Y 16.37 748.4344 6 -9.1 375.2211 2 28.15 4 11826 VEV_1_3_RA4_01_1235.d 1.59E6 2 2 57 62
K.IAVHVTVRGPK(+27.99).A Y 16.20 1203.7087 11 14.2 402.2492 3 66.22 4 36229 VEV_1_3_RA4_01_1235.d 9.05E4 1 1 66 76 Formylation
R.G(+42.01)PKAEEILER.G Y 16.18 1182.6244 10 12.4 395.2203 3 47.03 4 23025 VEV_1_3_RA4_01_1235.d 0 1 1 74 83 Acetylation (N-term)
K.SNPMR.E Y 15.64 603.2799 5 -11.0 604.2805 1 19.81 4 7304 VEV_1_3_RA4_01_1235.d 5.09E4 1 1 7 11
K.IGSSHK(+14.02)INQT(-18.01)ETIK.W Y 15.13 1550.8417 14 -5.9 388.7154 4 29.19 6 12436 VEV_3_3_RA6_01_1237.d 5.86E4 1 1 149 162 Methylation(KR); Dehydration
total 79 peptides
C1G283
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NAALTVGNILPLGSVPEGTVVTNVEEK.I Y 147.95 2720.4595 27 -6.6 1361.2280 2 85.96 5 49730 VEV_2_3_RA5_01_1236.d 3.1E6 11 11 93 119
R.TSGNYVTVIGHNPEEGKTR.V Y 147.64 2058.0129 19 -14.3 515.5032 4 53.41 6 26336 VEV_3_3_RA6_01_1237.d 9.34E6 28 28 129 147
K.YKDVIETFIANEGMYTGQFIYAGK.N Y 140.42 2757.3359 24 -8.0 920.1119 3 88.64 5 51201 VEV_2_3_RA5_01_1236.d 1.09E6 5 5 69 92
R.TSGNYVTVIGHNPEEGK.T Y 106.49 1800.8643 17 -9.5 601.2897 3 59.48 5 31168 VEV_2_3_RA5_01_1236.d 1.13E6 9 9 129 145
R.GMVGIVAGGGRTDKPLLK.A Y 96.08 1768.0029 18 -10.0 590.3357 3 65.34 5 35537 VEV_2_3_RA5_01_1236.d 3.2E5 3 3 164 181
K.NAALTVGNILPLGSVPEGTVVTNVEEK(+14.02).I Y 90.16 2734.4753 27 -7.2 912.4925 3 87.36 4 52104 VEV_1_3_RA4_01_1235.d 1.73E6 16 16 93 119 Methylation(KR)
K.NAALTVGNILPLGSVPEGTVVTNVEEKIGDRGALGR.T Y 85.17 3615.9583 36 -13.4 724.1892 5 86.03 5 49754 VEV_2_3_RA5_01_1236.d 9.68E4 2 2 93 128
R.TSGNYVTVIGHNPEEGK(+14.02)TR.V Y 84.88 2072.0286 19 -22.2 519.0029 4 60.20 4 31650 VEV_1_3_RA4_01_1235.d 1.25E6 7 7 129 147 Methylation(KR)
K.YKDVIETFIANE(+14.02)GMYTGQFIYAGK.N Y 79.81 2771.3516 24 -8.3 924.7835 3 93.03 4 55309 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 69 92 Methylation(others)
R.TSGNYVTVIGHNPE(+14.02)EGKTR.V Y 78.23 2072.0286 19 -22.6 519.0027 4 60.05 6 30473 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 129 147 Methylation(others)
K.Q(-17.03)IVHDPGRGAPLAK.V Y 74.99 1440.7837 14 -12.9 481.2623 3 57.16 5 29571 VEV_2_3_RA5_01_1236.d 1.53E6 7 7 47 60 Pyro-glu from Q
R.TLDYAERHGYIR.G Y 69.08 1492.7422 12 -13.8 498.5811 3 50.76 5 25607 VEV_2_3_RA5_01_1236.d 1.85E6 10 10 31 42
R.GM(+15.99)VGIVAGGGR.T Y 67.38 988.5124 11 -2.5 495.2622 2 37.84 4 17411 VEV_1_3_RA4_01_1235.d 7.89E5 7 7 164 174 Oxidation (M)
K.QIVHDPGR.G Y 66.25 920.4828 8 -11.4 461.2434 2 18.62 4 6682 VEV_1_3_RA4_01_1235.d 8.03E5 4 4 47 54
K.NAALTVGN(+.98)ILPLGSVPEGTVVTNVEEK.I Y 66.00 2721.4436 27 -5.7 1361.7213 2 87.03 4 51902 VEV_1_3_RA4_01_1235.d 2.71E4 1 1 93 119 Deamidation (NQ)
R.TSGN(+.98)YVTVIGHNPEEGKTR.V Y 64.76 2058.9971 19 -7.0 515.7529 4 57.21 4 29450 VEV_1_3_RA4_01_1235.d 1.12E6 3 3 129 147 Deamidation (NQ)
R.TSGN(+.98)YVTVIGHN(+.98)PEEGKTR.V Y 62.34 2059.9810 19 10.2 687.6746 3 53.71 4 27257 VEV_1_3_RA4_01_1235.d 8.99E4 1 1 129 147 Deamidation (NQ)
K.N(+.98)AALTVGN(+.98)ILPLGSVPEGTVVTNVEEK.I Y 62.20 2722.4275 27 -9.5 908.4745 3 86.11 5 49797 VEV_2_3_RA5_01_1236.d 7.43E4 1 1 93 119 Deamidation (NQ)
K.NAALTVGNILPLGSVPEGTVVTNVEEKIGDR.G Y 61.81 3161.6931 31 -18.9 1054.8850 3 87.02 4 51897 VEV_1_3_RA4_01_1235.d 7.58E4 2 2 93 123
R.GMVGIVAGGGR.T Y 61.65 972.5175 11 -14.3 487.2590 2 59.49 4 31104 VEV_1_3_RA4_01_1235.d 1.33E6 8 8 164 174
R.ARGMVGIVAGGGR.T Y 57.38 1199.6556 13 -16.7 400.8858 3 52.41 5 26635 VEV_2_3_RA5_01_1236.d 2.24E5 1 1 162 174
R.T(-2.02)SGNYVTVIGHNPEEGKTR.V Y 56.82 2055.9973 19 -30.3 686.3190 3 54.46 4 27734 VEV_1_3_RA4_01_1235.d 1.66E5 2 2 129 147 2-amino-3-oxo-butanoic_acid
R.LNKAPAQFR.T Y 56.53 1043.5875 9 -16.4 348.8641 3 29.62 5 13044 VEV_2_3_RA5_01_1236.d 4.07E6 11 11 22 30
K.APAQFR.T Y 56.31 688.3656 6 -8.3 345.1872 2 18.79 5 7081 VEV_2_3_RA5_01_1236.d 1.04E6 4 4 25 30
R.GVAMNPVDHPHGGGNHQHIGK.A Y 56.29 2158.0239 21 -6.8 720.3437 3 35.27 5 16331 VEV_2_3_RA5_01_1236.d 9.22E5 7 7 201 221
R.ARGMVGIVAGGGRTDKPLLK.A Y 55.61 1995.1411 20 -5.2 499.7900 4 62.62 4 33464 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 162 181
R.TDKPLLK.A Y 54.63 813.4960 7 -17.9 407.7480 2 17.89 6 6491 VEV_3_3_RA6_01_1237.d 6.28E5 3 3 175 181
R.TLDYAER.H Y 52.25 866.4134 7 5.3 434.2162 2 32.19 4 14135 VEV_1_3_RA4_01_1235.d 2.06E6 6 6 31 37
K.Q(-17.03)IVHDPGR.G Y 49.11 903.4562 8 -9.1 452.7313 2 38.87 4 18021 VEV_1_3_RA4_01_1235.d 2.38E6 7 7 47 54 Pyro-glu from Q
R.GVAM(+15.99)NPVDHPHGGGNHQHIGK.A Y 47.83 2174.0188 21 -22.9 435.8011 5 27.28 4 11348 VEV_1_3_RA4_01_1235.d 3.21E5 2 2 201 221 Oxidation (M)
R.VKLPSGAKK.V Y 46.72 926.5912 9 -12.4 464.2971 2 15.72 5 5424 VEV_2_3_RA5_01_1236.d 1.09E6 8 8 148 156
K.VSFRHPYK.Y Y 46.64 1032.5504 8 -16.8 517.2738 2 29.41 6 12545 VEV_3_3_RA6_01_1237.d 1.11E6 4 4 61 68
R.TSGNYVTVIGHNPEEGK(+14.02).T Y 45.60 1814.8799 17 -3.1 605.9653 3 62.10 4 33069 VEV_1_3_RA4_01_1235.d 7.28E4 2 2 129 145 Methylation(KR)
R.VKLPSGAK.K Y 43.09 798.4963 8 -31.1 400.2430 2 21.60 5 8636 VEV_2_3_RA5_01_1236.d 7.25E5 6 6 148 155
K.IGDRGALGR.T Y 42.44 913.5093 9 -18.4 457.7535 2 23.49 6 9390 VEV_3_3_RA6_01_1237.d 4.29E6 9 9 120 128
R.NSWPK.T Y 40.70 630.3126 5 -11.3 631.3127 1 19.70 5 7570 VEV_2_3_RA5_01_1236.d 7.56E4 2 2 194 198
R.TGLLRGTQK.T Y 37.37 972.5716 9 -17.3 487.2846 2 22.19 5 8910 VEV_2_3_RA5_01_1236.d 3.48E5 2 2 243 251
R.GVVKQIVHDPGR.G Y 34.70 1303.7361 12 -9.1 435.5820 3 44.83 4 21663 VEV_1_3_RA4_01_1235.d 1.3E5 2 2 43 54
R.GMVGIVAGGGR(+14.02).T Y 34.01 986.5331 11 -4.9 494.2714 2 62.40 4 33292 VEV_1_3_RA4_01_1235.d 8.52E4 1 1 164 174 Methylation(KR)
K.NAALTVGNILPLGSVPE(+14.02)GTVVTNVEEK.I Y 33.56 2734.4753 27 -8.5 912.4913 3 87.81 4 52409 VEV_1_3_RA4_01_1235.d 3.55E5 1 1 93 119 Methylation(others)
R.LNKAPAQ(+.98)FR.T Y 31.51 1044.5715 9 -41.7 523.2712 2 32.37 4 14215 VEV_1_3_RA4_01_1235.d 6.35E5 5 5 22 30 Deamidation (NQ)
K.YKDVIETFIANEGM(+15.99)YTGQFIYAGK.N Y 31.04 2773.3308 24 -9.7 925.4419 3 87.33 6 49850 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 69 92 Oxidation (M)
R.TSGNYVTVIGHN(+.98)PEEGKTR.V Y 30.73 2058.9971 19 -7.4 687.3345 3 55.89 5 28699 VEV_2_3_RA5_01_1236.d 6.3E4 1 1 129 147 Deamidation (NQ)
K.AGLIAAR.R Y 30.12 670.4126 7 -12.1 336.2095 2 32.65 4 14366 VEV_1_3_RA4_01_1235.d 1.44E6 7 7 235 241
R.HGYIR.G Y 28.77 644.3394 5 -10.5 323.1736 2 13.33 4 3971 VEV_1_3_RA4_01_1235.d 2.11E5 1 1 38 42
R.GAPLAK(+14.02).V Y 28.39 569.3536 6 -25.6 570.3463 1 17.66 5 6464 VEV_2_3_RA5_01_1236.d 2.1E4 1 1 55 60 Methylation(KR)
K.Q(-17.03)IVHDPGR(+14.02).G Y 26.53 917.4719 8 -15.1 459.7363 2 43.89 5 21448 VEV_2_3_RA5_01_1236.d 3.9E5 3 3 47 54 Pyro-glu from Q; Methylation(KR)
K.NAALTVGNILPLGSVPE(+28.03)GTVVTNVEEK.I Y 26.28 2748.4910 27 3.2 917.1738 3 89.05 4 53139 VEV_1_3_RA4_01_1235.d 1.67E4 1 1 93 119 Ethylation
K.YKDVIETFIANEGMYTGQFIYAGK(-.98).N Y 25.48 2756.3518 24 -16.6 919.7760 3 88.69 4 52930 VEV_1_3_RA4_01_1235.d 0 2 2 69 92 Amidation
K.NAALTVGNILPLGSVPEGTVVTN(+.98)VEEK.I Y 24.69 2721.4436 27 1.0 908.1560 3 86.87 5 50239 VEV_2_3_RA5_01_1236.d 1.22E5 2 2 93 119 Deamidation (NQ)
K.NAALTVGNILPLGS(-2.02)VPEGTVVTNVEEK.I Y 24.66 2718.4438 27 -24.7 907.1328 3 86.43 4 51516 VEV_1_3_RA4_01_1235.d 9.18E4 1 1 93 119 2-amino-3-oxo-butanoic_acid
R.TSGNYVTVIGHNPEEGKT(+164.06)R.V Y 24.38 2222.0732 19 10.9 556.5316 4 50.43 5 25402 VEV_2_3_RA5_01_1236.d 2.02E5 2 2 129 147 O-Diisopropylphosphorylation
R.GVAMN(+.98)PVDHPHGGGNHQHIGK.A Y 24.31 2159.0078 21 -2.3 432.8078 5 35.46 5 16440 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 201 221 Deamidation (NQ)
R.RTGLLR.G Y 24.14 714.4500 6 -22.3 358.2243 2 22.11 6 8656 VEV_3_3_RA6_01_1237.d 5.47E5 2 2 242 247
R.GAPLAK(+21.98).V Y 23.88 577.3199 6 -19.7 578.3159 1 62.91 5 33719 VEV_2_3_RA5_01_1236.d 1E4 1 1 55 60 Sodium adduct
K.AGLIAARR.T Y 23.23 826.5137 8 -19.2 414.2562 2 24.06 5 9935 VEV_2_3_RA5_01_1236.d 4.98E5 2 2 235 242
R.Q(+42.01)ITAAN(+.98)TR.L Y 23.16 916.4614 8 -27.4 917.4436 1 90.63 6 51678 VEV_3_3_RA6_01_1237.d 3.48E5 1 1 14 21 Acetylation (Protein N-term); Deamidation (NQ)
K.NAALTVGNILPLGSVPEGTVVTNVEEKIGDR(+453.21).G Y 22.26 3614.9055 31 -3.0 904.7310 4 86.14 4 51327 VEV_1_3_RA4_01_1235.d 0 1 1 93 123 Puromycin
R.QITAANT(+79.97)R.L Y 21.30 953.4332 8 25.4 477.7360 2 36.07 4 16374 VEV_1_3_RA4_01_1235.d 4.33E4 1 1 14 21 Phosphorylation (STY)
R.TLDYAER(+14.02).H Y 21.29 880.4290 7 -14.1 441.2156 2 44.07 6 20859 VEV_3_3_RA6_01_1237.d 7.74E5 2 2 31 37 Methylation(KR)
K.A(+42.01)GLIAAR.R Y 21.26 712.4232 7 -4.7 357.2172 2 51.80 5 26270 VEV_2_3_RA5_01_1236.d 1.48E5 3 3 235 241 Acetylation (N-term)
K.L(+42.01)PSGAK(+21.98).K Y 21.16 635.3254 6 -12.5 636.3248 1 64.86 5 35171 VEV_2_3_RA5_01_1236.d 0 1 1 150 155 Acetylation (N-term); Sodium adduct
R.AKHKFAVK.R Y 21.06 927.5654 8 -61.5 310.1767 3 28.85 5 12653 VEV_2_3_RA5_01_1236.d 4.33E5 4 4 185 192
R.NSWPKTR.G Y 20.89 887.4613 7 -15.1 444.7312 2 18.40 5 6857 VEV_2_3_RA5_01_1236.d 1.54E5 1 1 194 200
R.QITAAN(+.98)T(+79.97)R.L Y 20.02 954.4172 8 64.7 319.1669 3 17.03 6 6001 VEV_3_3_RA6_01_1237.d 0 1 1 14 21 Deamidation (NQ); Phosphorylation (STY)
K.RNSWPK.T Y 19.01 786.4136 6 -7.0 787.4154 1 29.77 6 12744 VEV_3_3_RA6_01_1237.d 5.22E4 1 1 193 198
R.G(+42.01)M(+15.99)VGIVAGGGR.T Y 18.64 1030.5229 11 5.5 516.2716 2 33.49 6 14796 VEV_3_3_RA6_01_1237.d 0 2 2 164 174 Acetylation (N-term); Oxidation (M)
K.LPSGAK(+43.01).K Y 18.40 614.3387 6 -15.4 615.3365 1 37.60 5 17702 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 150 155 Carbamylation
K.LPSGAK(+42.01).K Y 18.20 613.3435 6 -12.7 614.3430 1 83.44 4 49522 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 150 155 Acetylation (K)
K.L(+42.01)PSGAK.K Y 18.18 613.3435 6 35.2 307.6898 2 21.76 6 8477 VEV_3_3_RA6_01_1237.d 1.76E4 1 1 150 155 Acetylation (N-term)
R.QIT(+14.02)AANTR.L Y 18.17 887.4825 8 -49.1 888.4462 1 92.46 4 55018 VEV_1_3_RA4_01_1235.d 0 1 1 14 21 Methylation(others)
R.NS(-18.01)WPK.T Y 17.37 612.3020 5 -25.3 613.2938 1 31.64 4 13794 VEV_1_3_RA4_01_1235.d 2.25E4 1 1 194 198 Dehydration
K.I(+41.03)GDRGALGR.T Y 17.36 954.5359 9 -48.5 319.1705 3 23.28 4 9147 VEV_1_3_RA4_01_1235.d 8.66E4 1 1 120 128 Amidination of lysines or N-terminal amines with methyl acetimidate
R.YASAGQK(+54.01).A Y 17.16 777.3657 7 -12.3 389.6854 2 43.10 6 20293 VEV_3_3_RA6_01_1237.d 1.15E5 1 1 228 234 MDA adduct +54
K.R(+43.01)QITAAN(+.98)TRLNK.A Y 17.05 1428.7797 12 -2.6 477.2659 3 66.66 4 36580 VEV_1_3_RA4_01_1235.d 0 1 1 13 24 Carbamylation; Deamidation (NQ)
R.Q(+.98)ITAANTR.L Y 17.00 874.4508 8 16.2 875.4723 1 102.48 4 59003 VEV_1_3_RA4_01_1235.d 0 1 1 14 21 Deamidation (NQ)
K.QIVHDPGRGAPLAKVSFRHPYK.Y Y 16.97 2472.3501 22 -47.2 619.0656 4 87.00 5 50309 VEV_2_3_RA5_01_1236.d 3.98E4 1 1 47 68
K.R(+31.99)Q(+.98)ITAANTR.L Y 16.93 1062.5417 9 -25.2 532.2648 2 49.20 4 24372 VEV_1_3_RA4_01_1235.d 2.57E5 2 2 13 21 Dihydroxy; Deamidation (NQ)
R.ARGM(+15.99)VGIVAGGGRTDKPLLK.A Y 16.86 2011.1360 20 -17.7 403.2274 5 53.90 4 27373 VEV_1_3_RA4_01_1235.d 8.59E4 1 1 162 181 Oxidation (M)
R.YASAGQK.A Y 16.82 723.3551 7 5.9 724.3666 1 97.34 5 55103 VEV_2_3_RA5_01_1236.d 8.93E4 1 1 228 234
R.YASAGQK(+68.03).A Y 16.67 791.3813 7 -0.6 792.3882 1 78.63 5 45136 VEV_2_3_RA5_01_1236.d 3.71E4 1 1 228 234 Crotonylation
R.GAPLAK(+43.99).V Y 16.39 599.3278 6 -44.8 600.3082 1 37.89 6 17279 VEV_3_3_RA6_01_1237.d 0 1 1 55 60 Carboxylation (DKW)
R.Q(+71.04)ITAANTR.L Y 16.37 944.5039 8 6.1 315.8438 3 44.73 4 21600 VEV_1_3_RA4_01_1235.d 1.96E5 1 1 14 21 Propionamide (K, X@N-term)
K.LPSGAK(+71.04).K Y 16.30 642.3701 6 8.2 322.1949 2 53.05 6 26082 VEV_3_3_RA6_01_1237.d 0 1 1 150 155 Propionamide (K, X@N-term)
K.S(+79.97)RARGM(+15.99)VGIVAGGGR.T Y 16.20 1538.7500 15 -3.3 513.9222 3 49.70 4 24695 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 160 174 Phosphorylation (STY); Oxidation (M)
K.FAVKR.N Y 15.90 619.3806 5 -16.1 310.6926 2 14.88 5 4979 VEV_2_3_RA5_01_1236.d 4.5E5 2 2 189 193
R.G(+42.01)APLAKVSFR.H Y 15.68 1086.6185 10 5.0 363.2153 3 66.28 4 36274 VEV_1_3_RA4_01_1235.d 0 1 1 55 64 Acetylation (N-term)
K.QIVHDP(+31.99)GR.G Y 15.67 952.4726 8 -8.4 477.2396 2 12.80 4 3694 VEV_1_3_RA4_01_1235.d 0 1 1 47 54 Dihydroxy
R.A(+42.01)RGMVGIVAGGGR.T Y 15.45 1241.6663 13 -26.6 414.8850 3 56.44 6 27996 VEV_3_3_RA6_01_1237.d 1.69E5 1 1 162 174 Acetylation (N-term)
R.TSGNY(+125.90)VTVIGHNPEEGKTR.V Y 15.45 2183.9097 19 -3.8 546.9826 4 62.43 4 33318 VEV_1_3_RA4_01_1235.d 1.9E4 1 1 129 147 Iodination
R.TGLLRGTQK(+42.01)T(+79.97)K(+14.02)D Y 15.44 1452.7338 12 -1.8 364.1901 4 59.83 5 31426 VEV_2_3_RA5_01_1236.d 0 1 1 243 254 Acetylation (K); Phosphorylation (STY); Methylation(KR)
R.QITAANTR(+14.02).L Y 15.21 887.4825 8 -7.3 888.4833 1 100.75 5 56259 VEV_2_3_RA5_01_1236.d 0 1 1 14 21 Methylation(KR)
R.V(+42.01)KLPS(+79.97)GAK.K Y 15.11 920.4732 8 -7.0 307.8295 3 18.34 6 6683 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 148 155 Acetylation (N-term); Phosphorylation (STY)
R.GMVGIVAGGGR(+21.98).T Y 15.03 994.4994 11 -3.6 498.2552 2 42.34 5 20526 VEV_2_3_RA5_01_1236.d 5.07E4 1 1 164 174 Sodium adduct
total 94 peptides
C1G0N2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAPANSLGEPAAATDEPKKA Y 145.41 1937.9694 20 -11.7 646.9895 3 49.21 6 23839 VEV_3_3_RA6_01_1237.d 2.72E6 12 12 242 261
K.ITSLSISPSSGEPDAPQSATVTFEKEAAAK.T Y 138.64 3018.5032 30 -10.4 1007.1646 3 76.22 6 42445 VEV_3_3_RA6_01_1237.d 3.19E5 3 3 31 60
R.GIDSSYGITDKAASGLR.G Y 117.72 1709.8584 17 -15.2 570.9514 3 65.34 6 34379 VEV_3_3_RA6_01_1237.d 7.85E5 6 6 166 182
R.TAPANSLGEPAAATDEPK.K Y 116.83 1738.8373 18 -11.7 870.4157 2 57.05 6 28437 VEV_3_3_RA6_01_1237.d 7.5E5 5 5 242 259
K.ITSLSISPSSGEPDAPQSATVTFEK.E Y 115.91 2548.2544 25 -10.3 1275.1213 2 77.19 6 43148 VEV_3_3_RA6_01_1237.d 2.13E4 1 1 31 55
K.TALLLDNTQLGQSSVK.V Y 106.89 1686.9152 16 -16.7 563.3029 3 74.21 6 40999 VEV_3_3_RA6_01_1237.d 7.25E5 7 7 61 76
K.VTGAANIDDLAGGR.S Y 105.96 1328.6685 14 -14.4 665.3320 2 63.83 6 33266 VEV_3_3_RA6_01_1237.d 1.12E6 6 6 77 90
R.STDASEAKDENNHLLEQEDKPR.S Y 94.08 2525.1628 22 -7.6 506.0360 5 42.21 4 20094 VEV_1_3_RA4_01_1235.d 8.77E5 5 5 91 112
R.IIAEYLAQGYR.I Y 92.81 1295.6874 11 -10.2 648.8444 2 73.21 5 41366 VEV_2_3_RA5_01_1236.d 5.79E5 3 3 115 125
M.S(+42.01)SHTTVHVSDISPK.T Y 89.89 1535.7579 14 -10.8 512.9211 3 50.31 4 25118 VEV_1_3_RA4_01_1235.d 2.52E6 11 11 2 15 Acetylation (Protein N-term)
K.AHKEHADVTQPER.T Y 74.73 1516.7382 13 -15.7 506.5787 3 13.00 6 3915 VEV_3_3_RA6_01_1237.d 1.04E5 4 4 229 241
R.GIDSSYGITDK.A Y 72.92 1154.5455 11 -13.4 578.2723 2 56.13 5 28836 VEV_2_3_RA5_01_1236.d 9.05E5 3 3 166 176
K.EHADVTQPER.T Y 71.61 1180.5472 10 1.8 591.2820 2 17.11 4 5891 VEV_1_3_RA4_01_1235.d 9.14E4 3 3 232 241
K.ALDTPTGHK.I Y 58.08 938.4821 9 6.4 470.2513 2 15.40 4 5026 VEV_1_3_RA4_01_1235.d 1.89E5 6 6 191 199
R.IIAEYLAQGYRISDTAIQK.A Y 55.12 2152.1528 19 -15.6 718.3804 3 78.74 5 45213 VEV_2_3_RA5_01_1236.d 0 1 1 115 133
K.IRDFYLQSDK.Q Y 51.83 1283.6510 10 -10.0 428.8867 3 57.83 4 29887 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 200 209
K.ITSLSISPSSGEPDAPQSATVTFEK(+14.02)EAAAK.T Y 50.96 3032.5188 30 -5.8 1011.8410 3 78.32 5 44936 VEV_2_3_RA5_01_1236.d 3.23E4 1 1 31 60 Methylation(KR)
R.TAPANSLGEPAAATDEPKK(+14.02)A Y 47.07 1951.9850 20 -13.3 651.6603 3 55.26 4 28197 VEV_1_3_RA4_01_1235.d 6.74E4 1 1 242 261 Methylation(KR)
R.TAPANSLGEPAAATDEPK(+14.02).K Y 46.46 1752.8529 18 -9.3 877.4256 2 62.26 4 33197 VEV_1_3_RA4_01_1235.d 7.04E4 2 2 242 259 Methylation(KR)
R.TAPAN(+.98)SLGEPAAATDEPKKA Y 44.07 1938.9534 20 -14.0 647.3160 3 50.86 5 25672 VEV_2_3_RA5_01_1236.d 0 2 2 242 261 Deamidation (NQ)
K.AISLDQKHGFSAK.F Y 42.72 1400.7412 13 -7.0 467.9177 3 46.18 5 22832 VEV_2_3_RA5_01_1236.d 4.44E5 4 4 134 146
R.GLSSYFEK.A Y 42.34 929.4494 8 -19.4 465.7230 2 64.66 6 33854 VEV_3_3_RA6_01_1237.d 7.48E5 4 4 183 190
M.S(+42.01)SHTTVHVSDISPK(+14.02).T Y 31.63 1549.7737 14 -9.0 517.5939 3 56.96 6 28337 VEV_3_3_RA6_01_1237.d 4.01E5 2 2 2 15 Acetylation (Protein N-term); Methylation(KR)
R.TAPANSLGEPAAATDEPK(+14.02)KA Y 28.89 1951.9850 20 -14.4 651.6595 3 54.71 5 28026 VEV_2_3_RA5_01_1236.d 8E4 1 1 242 261 Methylation(KR)
R.IIAE(+14.02)YLAQGYR.I Y 27.66 1309.7030 11 -16.5 655.8480 2 74.78 6 41380 VEV_3_3_RA6_01_1237.d 1.34E4 1 1 115 125 Methylation(others)
R.LADLQNGK.A Y 26.38 857.4606 8 -4.6 858.4640 1 95.96 6 53977 VEV_3_3_RA6_01_1237.d 0 1 1 221 228
K.EAAAK.T N 26.36 488.2594 5 -17.3 489.2582 1 29.04 6 12362 VEV_3_3_RA6_01_1237.d 3.95E4 3 3 56 60
R.SRIIAEYLAQGYR.I Y 24.95 1538.8204 13 -23.4 513.9354 3 71.84 4 40667 VEV_1_3_RA4_01_1235.d 0 1 1 113 125
R.GID(+6.01)SSYGITDKAASGLR.G Y 24.83 1715.8666 17 16.9 572.9725 3 65.39 6 34413 VEV_3_3_RA6_01_1237.d 0 1 1 166 182 Replacement of proton by lithium
K.TTEKEVRDFFSFC(+57.02)GK.I Y 24.75 1849.8668 15 -14.2 463.4674 4 72.24 5 40639 VEV_2_3_RA5_01_1236.d 7.79E4 2 2 16 30 Carbamidomethylation
R.GLSSYFEK(+14.02).A Y 23.57 943.4651 8 -9.0 472.7356 2 68.93 4 38380 VEV_1_3_RA4_01_1235.d 8.16E4 1 1 183 190 Methylation(KR)
K.A(+42.01)ASGLR.G Y 22.76 615.3340 6 8.2 616.3463 1 28.35 4 11947 VEV_1_3_RA4_01_1235.d 0 1 1 177 182 Acetylation (N-term)
K.AASGLR(+21.98).G Y 21.16 595.3054 6 -20.3 596.3005 1 19.12 4 6950 VEV_1_3_RA4_01_1235.d 0 1 1 177 182 Sodium adduct
R.TAPANS(-18.01)LGEPAAATDEPK(+42.01)K.A Y 21.08 1890.9323 19 14.3 946.4869 2 88.75 5 51251 VEV_2_3_RA5_01_1236.d 3.07E4 1 1 242 260 Dehydration; Acetylation (K)
K.HGFSAK(+14.02).F Y 21.04 659.3391 6 -0.5 330.6767 2 15.23 6 5068 VEV_3_3_RA6_01_1237.d 0 1 1 141 146 Methylation(KR)
K.HGFSAKFHQILSDFDSKFHATDKAR.G Y 20.93 2889.4309 25 9.5 723.3719 4 74.09 5 41945 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 141 165
K.EAAAK(+27.99).T N 19.90 516.2543 5 27.9 517.2760 1 29.71 4 12680 VEV_1_3_RA4_01_1235.d 0 1 1 56 60 Formylation
K.DENNHLLEQEDKPRSR.I Y 19.84 1978.9457 16 -9.2 660.6498 3 73.86 6 40714 VEV_3_3_RA6_01_1237.d 5.61E4 2 2 99 114
K.AAS(+42.01)GLR.G Y 19.48 615.3340 6 -0.7 616.3408 1 34.16 5 15666 VEV_2_3_RA5_01_1236.d 0 1 1 177 182 Acetylation (TSCYH)
K.ALDT(-18.01)PTGHK.I Y 18.70 920.4716 9 25.0 921.5018 1 97.55 6 54511 VEV_3_3_RA6_01_1237.d 0 1 1 191 199 Dehydration
K.F(-15.01)HATDK.A Y 18.54 702.3337 6 -21.6 703.3258 1 112.56 5 59539 VEV_2_3_RA5_01_1236.d 1.03E4 1 1 158 163 ISD (z+2)-series
R.TAPAN(+.98)SLGEPAAATDEPK(+14.02)KA Y 18.21 1952.9690 20 0.9 651.9976 3 57.06 4 29351 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 242 261 Deamidation (NQ); Methylation(KR)
R.ISDTAIQK(+42.01).A Y 18.03 916.4866 8 -5.9 459.2479 2 42.69 6 20062 VEV_3_3_RA6_01_1237.d 5.19E3 1 1 126 133 Acetylation (K)
R.LADLQ(+.98)NGK(+21.98).A Y 17.36 880.4266 8 20.4 881.4518 1 93.32 4 55463 VEV_1_3_RA4_01_1235.d 0 1 1 221 228 Deamidation (NQ); Sodium adduct
K.IRDFYLQ(+.98)SDK.Q Y 17.28 1284.6350 10 23.6 429.2290 3 57.66 5 29875 VEV_2_3_RA5_01_1236.d 0 1 1 200 209 Deamidation (NQ)
K.FHQILSDFDSKFHATDK.A Y 17.25 2034.9799 17 -9.0 679.3278 3 69.14 5 38362 VEV_2_3_RA5_01_1236.d 5.43E4 1 1 147 163
K.VTGAAN(+.98)IDDLAGGR.S Y 16.78 1329.6525 14 3.0 665.8355 2 64.62 4 34981 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 77 90 Deamidation (NQ)
R.RLAD(+43.99)LQNGK.A Y 16.78 1057.5516 9 -49.7 1058.5063 1 112.44 5 59506 VEV_2_3_RA5_01_1236.d 3.46E3 1 1 220 228 Carboxylation (DKW)
MSSHTTVHVSD(+14.02)ISPK.T Y 16.70 1638.8036 15 -7.5 820.4029 2 84.23 5 48709 VEV_2_3_RA5_01_1236.d 2.83E4 1 1 1 15 Methylation(others)
K.ALDTPTGHK(+31.99).I Y 16.31 970.4719 9 -0.1 971.4791 1 85.98 4 51234 VEV_1_3_RA4_01_1235.d 5.67E4 1 1 191 199 Dihydroxy
R.TAPANSLGEPAAATD(-18.01)EPK(+42.01)K.A Y 16.10 1890.9323 19 31.1 379.2055 5 24.79 4 10005 VEV_1_3_RA4_01_1235.d 0 1 1 242 260 Dehydration; Acetylation (K)
K.AISLDQK.H Y 15.88 773.4283 7 -21.4 387.7131 2 29.67 6 12686 VEV_3_3_RA6_01_1237.d 9.97E4 1 1 134 140
K.A(+42.01)LDTPTGHK.I Y 15.84 980.4927 9 9.8 327.8414 3 11.42 4 3041 VEV_1_3_RA4_01_1235.d 0 1 1 191 199 Acetylation (N-term)
R.ISDTAIQK(+28.03).A Y 15.56 902.5073 8 8.2 452.2646 2 67.69 4 37394 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 126 133 Dimethylation(KR)
R.TAPANSLGEPAAATD(-18.01)EPK.K Y 15.53 1720.8268 18 29.2 861.4458 2 93.92 5 53759 VEV_2_3_RA5_01_1236.d 3.38E5 1 1 242 259 Dehydration
R.GIDSSYGIT(+79.97)DK(+42.01).A Y 15.39 1276.5225 11 53.8 426.5377 3 10.76 4 2758 VEV_1_3_RA4_01_1235.d 3.78E4 1 1 166 176 Phosphorylation (STY); Acetylation (K)
K.H(+42.01)GFSAK(+14.02).F Y 15.17 701.3497 6 8.8 702.3631 1 21.96 5 8790 VEV_2_3_RA5_01_1236.d 5.84E4 1 1 141 146 Acetylation (N-term); Methylation(KR)
total 57 peptides
C1GK98
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVPTGTAIVSPAPIDSGASNAPNEGETHR.A Y 172.26 2831.3684 29 -11.7 708.8411 4 67.56 6 36080 VEV_3_3_RA6_01_1237.d 4.34E6 16 16 258 286
K.RSVPTGTAIVSPAPIDSGASNAPNEGETHR.A Y 144.70 2987.4697 30 -12.5 747.8654 4 63.69 6 33147 VEV_3_3_RA6_01_1237.d 2.37E5 3 3 257 286
R.EVEENSAHLTNIPEER.Q Y 138.57 1865.8755 16 -10.7 933.9351 2 58.84 6 29607 VEV_3_3_RA6_01_1237.d 1.15E6 7 7 233 248
R.RGNKDPQREVEENSAHLTNIPEER.Q Y 131.16 2817.3752 24 -10.1 564.4766 5 58.73 5 30642 VEV_2_3_RA5_01_1236.d 2.73E5 2 2 225 248
R.SVPTGTAIVSPAPIDSGASNAPNEGETHR(+14.02).A Y 88.29 2845.3843 29 -5.9 949.4631 3 69.30 4 38661 VEV_1_3_RA4_01_1235.d 4.51E5 5 5 258 286 Methylation(KR)
M.PLQALFSAWR.L Y 86.17 1187.6451 10 -14.3 594.8214 2 82.73 5 47798 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 2 11
R.EYVVEPGWVSPR.D Y 79.73 1416.7037 12 -2.4 709.3574 2 74.14 6 40913 VEV_3_3_RA6_01_1237.d 1.73E5 3 3 356 367
R.GNKDPQREVEENSAHLTNIPEER.Q Y 77.99 2661.2742 23 -8.1 888.0915 3 61.28 5 32495 VEV_2_3_RA5_01_1236.d 4.43E5 4 4 226 248
R.TWHLGFTAFGGPPVHFR.I Y 77.54 1925.9689 17 -11.9 482.4938 4 80.72 6 45668 VEV_3_3_RA6_01_1237.d 5.31E4 3 3 39 55
R.APYEANNEKLLNR.F Y 76.83 1530.7791 13 -13.7 511.2599 3 52.27 4 26337 VEV_1_3_RA4_01_1235.d 2.42E5 3 3 19 31
R.SVPTGTAIVSPAPIDSGASNAPNE(+14.02)GETHR.A Y 71.76 2845.3843 29 -6.1 949.4630 3 69.72 5 38787 VEV_2_3_RA5_01_1236.d 2.78E5 2 2 258 286 Methylation(others)
R.EVEENSAHLTNIPEER(+14.02).Q Y 70.96 1879.8911 16 -13.5 627.6292 3 62.23 6 32083 VEV_3_3_RA6_01_1237.d 3.86E5 5 5 233 248 Methylation(KR)
R.SVPTGTAIVSPAPIDSGASN(+.98)APNEGETHR.A Y 69.31 2832.3525 29 -6.6 945.1185 3 68.81 4 38281 VEV_1_3_RA4_01_1235.d 6.65E5 4 4 258 286 Deamidation (NQ)
R.LQSHDTRAPYEANNEK.L Y 68.86 1871.8762 16 -7.1 624.9616 3 24.69 5 10306 VEV_2_3_RA5_01_1236.d 1.8E5 4 4 12 27
R.SVPTGTAIVSPAPIDSGASNAPNEGE(+14.02)THR.A Y 61.38 2845.3843 29 -12.1 949.4572 3 69.00 6 37128 VEV_3_3_RA6_01_1237.d 4.51E4 1 1 258 286 Methylation(others)
R.APYEANNEK.L Y 53.67 1034.4668 9 -14.5 518.2332 2 14.31 6 4583 VEV_3_3_RA6_01_1237.d 8.97E4 2 2 19 27
R.TIPLTTSFLR.G Y 51.81 1147.6600 10 -12.1 574.8303 2 78.37 4 45765 VEV_1_3_RA4_01_1235.d 5.49E4 2 2 433 442
R.SVPTGTAIVSPAPIDSGASNAPNEGETHR(+.98).A Y 51.74 2832.3525 29 -4.9 945.1202 3 68.57 5 37960 VEV_2_3_RA5_01_1236.d 9.58E4 1 1 258 286 Deamidation (R)
R.EVEENS(+14.02)AHLTNIPEER.Q Y 47.87 1879.8911 16 -13.9 627.6289 3 61.45 6 31529 VEV_3_3_RA6_01_1237.d 2.54E4 1 1 233 248 Methylation(others)
R.E(+14.02)VEENSAHLTNIPEER.Q Y 35.62 1879.8911 16 -27.6 627.6204 3 60.01 5 31553 VEV_2_3_RA5_01_1236.d 7.36E4 2 2 233 248 Methylation(others)
R.Q(-17.03)STGGMQKR(+14.02).S Y 34.37 988.4760 9 -11.6 495.2395 2 18.78 5 7074 VEV_2_3_RA5_01_1236.d 4.28E4 1 1 249 257 Pyro-glu from Q; Methylation(KR)
R.FLDVIQR.T Y 32.94 889.5021 7 -15.9 445.7513 2 68.22 6 36628 VEV_3_3_RA6_01_1237.d 5.08E5 4 4 32 38
R.EVEE(+14.02)NSAHLTNIPEER.Q Y 30.14 1879.8911 16 -15.0 627.6282 3 62.66 5 33531 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 233 248 Methylation(others)
K.FVEGQGGK(+42.01).T Y 27.92 862.4185 8 8.0 432.2200 2 11.00 5 2960 VEV_2_3_RA5_01_1236.d 0 1 1 61 68 Acetylation (K)
K.FVEGQGGK.T Y 26.32 820.4079 8 11.3 411.2159 2 34.56 4 15497 VEV_1_3_RA4_01_1235.d 0 2 2 61 68
R.KFVEGQ(+.98)GGK(+42.01).T Y 26.07 991.4974 9 -46.4 496.7330 2 35.26 5 16321 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 60 68 Deamidation (NQ); Acetylation (K)
R.APYEANNEK(+14.02).L Y 25.37 1048.4825 9 1.0 525.2491 2 21.92 4 8428 VEV_1_3_RA4_01_1235.d 0 2 2 19 27 Methylation(KR)
R.SVPTGTAIVS(-18.01)PAPIDSGASNAPNEGETHR(+14.02).A Y 24.15 2827.3735 29 -0.5 707.8503 4 67.61 6 36093 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 258 286 Dehydration; Methylation(KR)
R.F(+226.08)LDVIQR.T Y 22.61 1115.5797 7 10.7 372.8712 3 52.71 5 26816 VEV_2_3_RA5_01_1236.d 0 1 1 32 38 Biotinylation
R.TIPLT(+79.97)TS(-18.01)FLR.G Y 22.46 1209.6158 10 5.1 303.4128 4 37.71 4 17344 VEV_1_3_RA4_01_1235.d 6.82E4 1 1 433 442 Phosphorylation (STY); Dehydration
R.A(+27.99)ASVDAR.S Y 22.15 716.3453 7 -12.6 717.3435 1 42.31 4 20095 VEV_1_3_RA4_01_1235.d 0 1 1 287 293 Formylation
R.APYEANN(+28.03)EK.L Y 21.79 1062.4982 9 -16.1 532.2478 2 41.45 5 19992 VEV_2_3_RA5_01_1236.d 0 1 1 19 27 Dimethylation(NP)
R.APYEANNEK(+42.01)LLNR.F Y 21.70 1572.7896 13 -5.9 394.2023 4 56.32 6 27919 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 19 31 Acetylation (K)
R.AASVDARSH(+15.99)K.I Y 21.60 1056.5311 10 -18.1 1057.5193 1 95.39 4 56469 VEV_1_3_RA4_01_1235.d 4.55E4 1 1 287 296 Oxidation (HW)
R.AASVDARSHK(+27.99).I Y 20.81 1068.5311 10 -33.2 535.2551 2 20.50 4 7657 VEV_1_3_RA4_01_1235.d 0 1 1 287 296 Formylation
K.FVEGQGGK(+14.02).T Y 20.43 834.4235 8 -5.2 418.2169 2 25.96 4 10634 VEV_1_3_RA4_01_1235.d 0 1 1 61 68 Methylation(KR)
R.LWEIGYLSANSVAGQSLGK.E Y 19.79 1992.0316 19 -24.4 665.0016 3 93.39 4 55502 VEV_1_3_RA4_01_1235.d 0 1 1 459 477
R.SVPTGTAIVSPAPIDSGASNAPNEGETHRAAS(+79.97)VDAR.S Y 19.76 3581.6746 36 -16.6 896.4110 4 68.65 6 36875 VEV_3_3_RA6_01_1237.d 3.43E4 1 1 258 293 Phosphorylation (STY)
K.D(+42.01)PLTR.I Y 19.22 642.3337 5 19.1 322.1802 2 28.30 5 12291 VEV_2_3_RA5_01_1236.d 0 1 1 171 175 Acetylation (N-term)
R.APYEANNEK(+28.03).L Y 19.09 1062.4982 9 -16.3 532.2477 2 41.63 4 19688 VEV_1_3_RA4_01_1235.d 6.42E5 1 1 19 27 Dimethylation(KR)
M.PLQALFSAWRLQSHDTR.A Y 18.38 2025.0544 17 -23.5 507.2590 4 78.51 6 44094 VEV_3_3_RA6_01_1237.d 5.3E4 1 1 2 18
R.AASVDARSHK.I Y 18.29 1040.5363 10 -27.5 521.2611 2 44.42 4 21405 VEV_1_3_RA4_01_1235.d 0 1 1 287 296
R.AASVD(+21.98)ARSHK.I Y 16.64 1062.5182 10 8.1 355.1829 3 9.83 6 2434 VEV_3_3_RA6_01_1237.d 0 1 1 287 296 Sodium adduct
K.F(+42.01)VEGQGGK(+42.01).T Y 16.61 904.4290 8 -5.8 453.2192 2 18.42 4 6584 VEV_1_3_RA4_01_1235.d 0 1 1 61 68 Acetylation (N-term); Acetylation (K)
R.KFVEGQGGK.T Y 16.41 948.5028 9 -40.4 475.2395 2 13.16 4 3883 VEV_1_3_RA4_01_1235.d 0 1 1 60 68
R.LWEIGYLSANS(-18.01)VAGQSLGK(+42.01).E Y 15.76 2016.0316 19 19.6 404.2215 5 62.80 5 33634 VEV_2_3_RA5_01_1236.d 3.54E5 1 1 459 477 Dehydration; Acetylation (K)
R.KFVEGQ(+.98)GGK(-.98).T Y 15.72 948.5028 9 -16.2 475.2510 2 43.64 6 20599 VEV_3_3_RA6_01_1237.d 0 1 1 60 68 Deamidation (NQ); Amidation
K.TPWIDEQTYQELFALC(+57.02)QALPGPGSTK.M Y 15.23 2949.4219 26 24.5 738.3808 4 91.86 4 54700 VEV_1_3_RA4_01_1235.d 0 1 1 69 94 Carbamidomethylation
total 48 peptides
C1GKG3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSYPVAEPATLLNYDAFLFGIPTR.Y Y 172.82 2641.3428 24 -9.9 1321.6655 2 93.55 6 53006 VEV_3_3_RA6_01_1237.d 2.41E6 15 15 62 85
K.GIEAAGGTADIYQIAETLPQEVLDK.M Y 147.12 2601.3174 25 -15.3 1301.6461 2 90.02 6 51324 VEV_3_3_RA6_01_1237.d 6.47E5 6 6 31 55
R.GGSPWGAGTYAGADGSR.Q Y 139.92 1565.6858 17 -12.2 783.8406 2 62.33 6 32158 VEV_3_3_RA6_01_1237.d 5.88E5 4 4 165 181
K.GIEAAGGTADIYQIAETLPQEVLDKMHAPGK.S Y 108.49 3222.6230 31 -2.5 645.5303 5 88.78 5 51282 VEV_2_3_RA5_01_1236.d 6.02E5 5 5 31 61
R.Q(-17.03)PSALELQLAEEQGKAFYGAVSK.V Y 100.14 2446.2380 23 -5.2 1224.1199 2 86.22 4 51378 VEV_1_3_RA4_01_1235.d 1.56E5 4 4 182 204 Pyro-glu from Q
K.TTFPILANLDEVR.G Y 99.67 1487.7983 13 -12.4 744.8972 2 83.67 6 47612 VEV_3_3_RA6_01_1237.d 7.93E5 5 5 152 164
R.Q(-17.03)PSALELQLAEEQGKAFYGAVSKVNFE Y 88.69 2935.4602 27 -11.8 979.4825 3 90.85 6 51769 VEV_3_3_RA6_01_1237.d 3.91E5 3 3 182 208 Pyro-glu from Q
K.SSYPVAEPATLLNYDAFLFGIPTRYGNFPGQWK.A Y 87.38 3718.8459 33 -8.3 1240.6123 3 92.92 5 53304 VEV_2_3_RA5_01_1236.d 3.11E5 3 3 62 94
R.YGNFPGQWK.A Y 87.18 1095.5138 9 -10.9 548.7582 2 66.21 6 35182 VEV_3_3_RA6_01_1237.d 7.36E5 5 5 86 94
K.SSYPVAEPATLLNYD(+37.95)AFLFGIPTR.Y Y 86.40 2679.2896 24 -14.5 670.8199 4 93.65 6 53054 VEV_3_3_RA6_01_1237.d 7.68E4 1 1 62 85 Replacement of 2 protons by calcium
K.SSYPVAE(+14.02)PATLLNYDAFLFGIPTR.Y Y 86.03 2655.3584 24 -5.5 1328.6792 2 94.82 4 56220 VEV_1_3_RA4_01_1235.d 7.23E5 5 5 62 85 Methylation(others)
K.SSYPVAEPATLLNYDAFLFGIPTR(+14.02).Y Y 83.22 2655.3584 24 -7.7 1328.6763 2 93.63 6 53032 VEV_3_3_RA6_01_1237.d 1.46E5 4 4 62 85 Methylation(KR)
R.QPSALELQLAEEQGK.A Y 78.49 1639.8417 15 -16.8 820.9144 2 70.20 6 38010 VEV_3_3_RA6_01_1237.d 1.43E5 3 3 182 196
K.SSYPVAEPATLLN(+.98)YDAFLFGIPTR.Y Y 62.06 2642.3267 24 -7.4 1322.1609 2 94.58 6 53428 VEV_3_3_RA6_01_1237.d 6.24E5 2 2 62 85 Deamidation (NQ)
K.AFYGAVSK.V Y 52.70 841.4333 8 -12.4 421.7187 2 43.37 5 21130 VEV_2_3_RA5_01_1236.d 1.08E6 6 6 197 204
K.TTFPILANLDEVRGGSPWGAGTYAGADGSR.Q Y 49.56 3035.4736 30 -11.1 1012.8206 3 84.93 6 48418 VEV_3_3_RA6_01_1237.d 3.52E5 3 3 152 181
R.GGSPWGAGTYAGADGSR(+14.02).Q Y 48.97 1579.7015 17 -5.3 790.8538 2 64.35 4 34772 VEV_1_3_RA4_01_1235.d 3.01E4 2 2 165 181 Methylation(KR)
K.S(+14.02)SYPVAEPATLLNYDAFLFGIPTR.Y Y 46.29 2655.3584 24 -1.7 886.1252 3 94.71 5 54098 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 62 85 Methylation(others)
K.AFWDK.T Y 39.44 665.3173 5 -12.1 666.3165 1 54.13 6 26726 VEV_3_3_RA6_01_1237.d 1.25E5 2 2 95 99
K.KGIEAAGGTADIYQIAETLPQEVLDK.M Y 30.65 2729.4124 26 -5.2 910.8067 3 86.42 4 51510 VEV_1_3_RA4_01_1235.d 5.81E4 1 1 30 55
R.QPSALELQLAEEQGKAFYGAVSKVNFE Y 27.19 2952.4868 27 -10.5 739.1212 4 85.85 5 49652 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 182 208
R.GGSPW(+3.99)GAGTYAGADGSR.Q Y 26.94 1569.6808 17 58.6 785.8937 2 62.45 5 33376 VEV_2_3_RA5_01_1236.d 4.55E3 1 1 165 181 Tryptophan oxidation to kynurenin
R.QPSALELQLAEEQGKAFYGAVSK.V Y 26.12 2463.2644 23 -11.8 822.0858 3 80.61 6 45588 VEV_3_3_RA6_01_1237.d 3.33E4 1 1 182 204
K.SSYPVAE(+6.01)PATLLNYDAFLFGIPTR.Y Y 24.65 2647.3508 24 -29.8 883.4313 3 94.94 5 54192 VEV_2_3_RA5_01_1236.d 8.99E4 2 2 62 85 Replacement of proton by lithium
R.QPS(-18.01)ALELQLAEEQGKAFYGAVSK.V Y 23.00 2445.2539 23 5.0 816.0959 3 86.08 5 49782 VEV_2_3_RA5_01_1236.d 0 1 1 182 204 Dehydration
K.T(+42.01)TFPILAN(+.98)LDEVR(+14.02).G Y 22.06 1544.8086 13 -0.3 387.2093 4 51.74 5 26228 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 152 164 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
K.GIE(+14.02)AAGGTADIYQIAETLPQEVLDK.M Y 21.91 2615.3330 25 26.1 1308.7079 2 90.67 4 54033 VEV_1_3_RA4_01_1235.d 0 1 1 31 55 Methylation(others)
R.QPSALELQLAEEQGK(-.98)(+42.01).A Y 21.31 1680.8682 15 2.7 421.2254 4 68.86 4 38322 VEV_1_3_RA4_01_1235.d 0 1 1 182 196 Amidation; Acetylation (K)
K.SSYPVAEPATLLNYDAFLFGIPTR(-.98).Y Y 19.99 2640.3586 24 -18.2 1321.1626 2 93.66 4 55641 VEV_1_3_RA4_01_1235.d 0 1 1 62 85 Amidation
K.TGGIWSTGGFW(+31.99)GK.Y Y 18.03 1384.6411 13 55.9 347.1869 4 33.86 6 14991 VEV_3_3_RA6_01_1237.d 0 1 1 100 112 Dihydroxy
R.Y(+226.08)GNFPGQWK(+42.01).A Y 17.90 1363.6019 9 20.5 341.9147 4 18.46 5 6897 VEV_2_3_RA5_01_1236.d 0 1 1 86 94 Biotinylation; Acetylation (K)
K.TTFPILANLDEVR(+14.02).G Y 17.52 1501.8140 13 -10.1 751.9067 2 85.34 4 50820 VEV_1_3_RA4_01_1235.d 9.99E4 1 1 152 164 Methylation(KR)
K.SS(-18.01)YPVAEPATLLNYDAFLFGIPTR.Y Y 17.22 2623.3323 24 -6.2 875.4460 3 93.60 6 53020 VEV_3_3_RA6_01_1237.d 6.85E4 1 1 62 85 Dehydration
K.MHAPGK.S Y 16.97 639.3163 6 -3.5 640.3214 1 37.92 5 17890 VEV_2_3_RA5_01_1236.d 2.38E4 1 1 56 61
total 34 peptides
C1GE52
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LGFAGNDSPSFVFPTAIATK.S Y 140.68 2039.0364 20 -8.3 1020.5170 2 85.47 4 50906 VEV_1_3_RA4_01_1235.d 6.4E5 5 5 19 38
K.SAGGVGGGSGAGRPAVANKPSFLSGGAASAGSQLSAK.R Y 123.52 3185.6177 37 -9.2 797.4044 4 66.12 4 36148 VEV_1_3_RA4_01_1235.d 5.68E5 4 4 39 75
K.RGTEDLDFFIGDEAINASGGPGYGISYPIR.H Y 117.54 3186.5256 30 -19.2 1063.1621 3 86.40 4 51499 VEV_1_3_RA4_01_1235.d 0 1 1 76 105
R.FLAPEIFFNPEIYSSDFLTPLPTVVDGVIQSSPIDVR.R Y 115.94 4122.1240 37 -6.5 1375.0397 3 97.75 4 57461 VEV_1_3_RA4_01_1235.d 6.05E4 2 2 297 333
R.GTEDLDFFIGDEAINASGGPGYGISYPIR.H Y 115.01 3030.4246 29 -0.7 1516.2185 2 89.87 4 53583 VEV_1_3_RA4_01_1235.d 6.93E4 1 1 77 105
R.FLAPEIFFNPEIYSSDFLTPLPTVVDGVIQSSPIDVRR.G Y 112.83 4278.2251 38 -2.6 1427.0786 3 97.61 4 57386 VEV_1_3_RA4_01_1235.d 1.29E4 1 1 297 334
R.SLTGTVIDSGDGVTHVIPVAEGYVIGSSIK.S Y 110.77 2970.5549 30 -10.7 991.1816 3 84.98 6 48450 VEV_3_3_RA6_01_1237.d 4.38E5 4 4 188 217
R.DITHFVQNLLR.E Y 106.06 1354.7357 11 -14.5 452.5793 3 85.63 4 51013 VEV_1_3_RA4_01_1235.d 4.39E5 4 4 225 235
R.FALLGGPGST Y 90.50 918.4811 10 -16.4 919.4733 1 79.03 6 44467 VEV_3_3_RA6_01_1237.d 2.41E5 4 4 431 440
R.HGPWFGGSLLGQTPEFR.S Y 89.90 1884.9270 17 -7.0 629.3119 3 80.94 5 46666 VEV_2_3_RA5_01_1236.d 5.72E4 4 4 395 411
R.GLYKNIVLSGGSTLYKDFGR.R Y 85.25 2187.1687 20 -1.5 547.7986 4 79.41 5 45662 VEV_2_3_RA5_01_1236.d 1.01E5 2 2 335 354
K.VKEEYC(+57.02)YVC(+57.02)PDIVKEFAR.Y Y 83.23 2304.0918 18 -3.0 577.0285 4 76.92 4 44631 VEV_1_3_RA4_01_1235.d 1.57E5 1 1 250 267 Carbamidomethylation
K.SIPIAGRDITHFVQNLLR.E Y 82.68 2049.1482 18 -10.3 513.2891 4 85.59 4 50971 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 218 235
K.RGTEDLDFFIGDE(+6.01)AINASGGPGYGISYPIR.H Y 72.87 3192.5339 30 13.1 1065.1992 3 86.49 4 51555 VEV_1_3_RA4_01_1235.d 2.87E4 1 1 76 105 Replacement of proton by lithium
R.TVTIDVGYER.F Y 72.37 1151.5823 10 -13.7 576.7905 2 64.19 6 33502 VEV_3_3_RA6_01_1237.d 2.34E5 4 4 287 296
R.SYC(+57.02)HTKAEYDEIGPSIVR.R Y 64.57 2123.9946 18 -4.6 709.0022 3 63.39 4 34048 VEV_1_3_RA4_01_1235.d 6.51E4 1 1 412 429 Carbamidomethylation
R.SGGLEVQVITHKR.Q Y 58.87 1422.7943 13 -21.9 475.2617 3 48.93 4 24197 VEV_1_3_RA4_01_1235.d 2.07E5 2 2 380 392
R.SYC(+57.02)HTKAEYDEIGPSIVRR.F Y 57.70 2280.0957 19 -17.5 571.0212 4 60.45 5 31881 VEV_2_3_RA5_01_1236.d 2.18E5 2 2 412 430 Carbamidomethylation
K.NIVLSGGSTLYKDFGR.R Y 47.55 1725.9049 16 -24.4 576.2949 3 76.33 5 43537 VEV_2_3_RA5_01_1236.d 8.64E4 1 1 339 354
K.N(+.98)IVLSGGSTLYKDFGR.R Y 45.48 1726.8889 16 -16.5 576.6274 3 76.21 6 42418 VEV_3_3_RA6_01_1237.d 8.88E4 1 1 339 354 Deamidation (NQ)
R.DIKHLVDAR.I Y 39.67 1065.5930 9 -16.1 356.1992 3 44.81 4 21643 VEV_1_3_RA4_01_1235.d 3.11E5 4 4 359 367
R.S(-2.02)LTGTVIDSGDGVTHVIPVAEGYVIGSSIK.S Y 36.35 2968.5393 30 -4.9 990.5156 3 85.26 4 50768 VEV_1_3_RA4_01_1235.d 5.32E3 1 1 188 217 2-amino-3-oxo-butanoic_acid
K.AEYDEIGPSIVR.R Y 31.56 1347.6670 12 -19.9 674.8273 2 70.60 6 38302 VEV_3_3_RA6_01_1237.d 6.7E4 1 1 418 429
K.RGTEDLDFFIGDEAINASGGPGYGISYPIR(-.98).H Y 28.82 3185.5417 30 -14.1 1062.8396 3 86.27 6 49231 VEV_3_3_RA6_01_1237.d 2.11E4 1 1 76 105 Amidation
K.NIVLSGGSTLYK(+43.01).D Y 23.40 1293.6929 12 -28.5 432.2259 3 45.60 6 21754 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 339 350 Carbamylation
R.T(+42.01)VTIDVGYER.F Y 22.93 1193.5928 10 -18.4 398.8642 3 48.96 6 23703 VEV_3_3_RA6_01_1237.d 0 1 1 287 296 Acetylation (N-term)
K.SIPIAGR.D Y 21.94 712.4232 7 -16.7 357.2129 2 66.39 5 36314 VEV_2_3_RA5_01_1236.d 3.25E5 2 2 218 224
R.ASEARSGGAR(+14.02).S Y 20.85 974.4893 10 -7.3 488.2484 2 34.17 4 15258 VEV_1_3_RA4_01_1235.d 6.98E4 1 1 370 379 Methylation(KR)
R.ASEAR(+28.03).S Y 20.77 560.2918 5 -36.4 561.2787 1 25.65 4 10478 VEV_1_3_RA4_01_1235.d 0 1 1 370 374 Dimethylation(KR)
K.NIVLSGGSTLYK.D Y 20.72 1250.6870 12 26.1 313.6872 4 63.36 5 34128 VEV_2_3_RA5_01_1236.d 1.66E5 2 2 339 350
R.A(+42.01)SEAR(+14.02)SGGAR.S Y 20.51 1016.4999 10 0.2 509.2573 2 29.12 5 12760 VEV_2_3_RA5_01_1236.d 0 1 1 370 379 Acetylation (N-term); Methylation(KR)
K.AEYDEIGPSIVRR.F Y 19.72 1503.7681 13 8.5 502.2676 3 65.59 5 35738 VEV_2_3_RA5_01_1236.d 0 1 1 418 430
R.TVT(-2.02)IDVGYER.F Y 19.66 1149.5665 10 6.2 384.1985 3 24.35 6 9864 VEV_3_3_RA6_01_1237.d 8.59E4 1 1 287 296 2-amino-3-oxo-butanoic_acid
K.HTVTSPN(+.98)GR(+14.02).T Y 19.57 982.4832 9 7.6 492.2526 2 49.14 5 24633 VEV_2_3_RA5_01_1236.d 5.24E4 1 1 278 286 Deamidation (NQ); Methylation(KR)
K.NIVLSGGSTLYK(+43.01)DFGR.R Y 18.97 1768.9108 16 8.7 443.2388 4 70.97 4 39976 VEV_1_3_RA4_01_1235.d 0 1 1 339 354 Carbamylation
R.ASEARSGGAR.S Y 18.95 960.4736 10 -21.1 481.2339 2 34.36 6 15284 VEV_3_3_RA6_01_1237.d 0 1 1 370 379
R.ASEAR(+14.02).S Y 18.86 546.2761 5 -15.4 547.2750 1 38.06 6 17377 VEV_3_3_RA6_01_1237.d 0 1 1 370 374 Methylation(KR)
R.S(-18.01)GGAR.S N 18.75 428.2132 5 11.6 429.2254 1 63.46 5 34136 VEV_2_3_RA5_01_1236.d 8.15E4 1 1 375 379 Dehydration
R.S(+43.01)GGARSGGLEVQVITHKR.Q Y 18.09 1894.0133 18 -82.7 474.4714 4 49.07 6 23758 VEV_3_3_RA6_01_1237.d 2.58E5 1 1 375 392 Carbamylation
K.HLVDAR.I Y 17.96 709.3871 6 -19.1 355.6940 2 24.76 4 9989 VEV_1_3_RA4_01_1235.d 0 1 1 362 367
R.QEADS(+79.97)SM(+15.99)K.T Y 17.46 990.3365 8 -24.2 991.3198 1 1.87 5 434 VEV_2_3_RA5_01_1236.d 3.39E5 1 1 238 245 Phosphorylation (STY); Oxidation (M)
R.SGGAR.S N 17.33 446.2237 5 -47.7 447.2097 1 103.86 6 56466 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 375 379
K.N(+42.01)IVLSGGSTLYK.D Y 17.32 1292.6976 12 -10.2 324.1784 4 10.05 4 2484 VEV_1_3_RA4_01_1235.d 6.05E4 1 1 339 350 Acetylation (N-term)
R.SGGARSGGLEVQVIT(+79.97)HKRQR.H Y 16.68 2215.1335 20 -22.6 444.0240 5 69.36 5 38529 VEV_2_3_RA5_01_1236.d 0 1 1 375 394 Phosphorylation (STY)
R.A(+42.01)SEARSGGAR(+14.02).S Y 16.66 1016.4999 10 -2.3 509.2560 2 40.50 4 18991 VEV_1_3_RA4_01_1235.d 2.12E5 1 1 370 379 Acetylation (N-term); Methylation(KR)
R.SGGLEVQVITHK.R Y 15.97 1266.6931 12 11.4 317.6842 4 23.86 5 9825 VEV_2_3_RA5_01_1236.d 2.04E4 1 1 380 391
R.S(+42.01)GGAR.S N 15.66 488.2343 5 -2.9 489.2401 1 50.00 5 25150 VEV_2_3_RA5_01_1236.d 1.82E3 1 1 375 379 Acetylation (N-term)
K.N(+.98)IVLSGGSTLY(+162.05)K.D Y 15.63 1413.7239 12 4.2 472.2505 3 69.46 6 37463 VEV_3_3_RA6_01_1237.d 0 1 1 339 350 Deamidation (NQ); Hexose (NSY)
K.H(+42.01)LVDARIR(+14.02)AS(+79.97)EAR.S Y 15.58 1628.8147 13 -17.6 408.2038 4 47.79 5 23808 VEV_2_3_RA5_01_1236.d 0 1 1 362 374 Acetylation (N-term); Methylation(KR); Phosphorylation (STY)
K.SAGGVGGGSGAGRPAVANK(+14.02)PSFLS(-18.01)GGAASAGSQLSAK.R Y 15.55 3181.6228 37 -35.4 637.3093 5 65.99 6 34877 VEV_3_3_RA6_01_1237.d 0 1 1 39 75 Methylation(KR); Dehydration
K.NIVLS(+14.02)GGSTLYK.D Y 15.37 1264.7026 12 20.4 317.1894 4 67.32 6 35872 VEV_3_3_RA6_01_1237.d 6.39E5 1 1 339 350 Methylation(others)
R.AS(+162.05)EARSGGAR.S Y 15.37 1122.5265 10 -8.4 375.1796 3 51.81 6 25361 VEV_3_3_RA6_01_1237.d 0 1 1 370 379 Hexose (NSY)
R.SGGLEVQ(+.98)VITHK(+43.01).R Y 15.11 1310.6830 12 -13.7 437.8956 3 60.77 6 31004 VEV_3_3_RA6_01_1237.d 3.94E3 1 1 380 391 Deamidation (NQ); Carbamylation
total 53 peptides
A0A0A0HV62
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KIWLDPNEVNEISTANSR.Q Y 126.32 2085.0491 18 -7.8 1043.5237 2 75.67 4 43682 VEV_1_3_RA4_01_1235.d 2.26E6 8 8 2703 2720
R.KLLSDGLIIHKPVTMHSR.S Y 121.76 2044.1615 18 -10.3 1023.0775 2 64.31 5 34754 VEV_2_3_RA5_01_1236.d 1.87E6 9 9 2725 2742
K.LLSDGLIIHKPVTMHSR.S Y 121.53 1916.0665 17 -7.4 959.0334 2 65.87 5 35937 VEV_2_3_RA5_01_1236.d 2.62E6 11 11 2726 2742
K.IWLDPNEVNEISTANSR.Q Y 114.56 1956.9541 17 -8.9 979.4756 2 79.62 5 45804 VEV_2_3_RA5_01_1236.d 1.18E6 5 5 2704 2720
K.RLAASVVGC(+57.02)GQR.K Y 105.37 1272.6721 12 -8.8 425.2276 3 38.65 4 17895 VEV_1_3_RA4_01_1235.d 2.22E6 15 15 2691 2702 Carbamidomethylation
R.LAASVVGC(+57.02)GQR.K Y 84.64 1116.5709 11 -11.0 559.2866 2 42.03 5 20373 VEV_2_3_RA5_01_1236.d 6.16E6 18 18 2692 2702 Carbamidomethylation
R.KIWLDPNEVNEISTANSR(+14.02).Q Y 81.23 2099.0647 18 -13.3 700.6862 3 76.28 6 42466 VEV_3_3_RA6_01_1237.d 3.73E5 3 3 2703 2720 Methylation(KR)
K.RNAHLAEVEEE Y 80.90 1295.6106 11 -8.9 648.8068 2 33.47 4 14874 VEV_1_3_RA4_01_1235.d 1.29E6 8 8 2863 2873
R.LAASVVGC(+57.02)GQRK.I Y 79.58 1244.6659 12 -15.7 415.8894 3 30.18 5 13400 VEV_2_3_RA5_01_1236.d 2.56E6 11 11 2692 2703 Carbamidomethylation
R.TIKEEMDAKR.A Y 79.26 1219.6230 10 -9.8 407.5443 3 21.43 4 8241 VEV_1_3_RA4_01_1235.d 5.26E6 18 18 2836 2845
R.MPSQVLWMR.R Y 78.19 1146.5679 9 -13.5 574.2834 2 75.68 4 43662 VEV_1_3_RA4_01_1235.d 4.7E5 2 2 2771 2779
R.KIWLDPNEVNE(+14.02)ISTANSR.Q Y 75.21 2099.0647 18 -4.5 700.6924 3 76.92 5 43956 VEV_2_3_RA5_01_1236.d 5.39E5 3 3 2703 2720 Methylation(others)
R.ALVEHIHKAK.A Y 75.05 1144.6716 10 -11.5 573.3365 2 19.09 5 7257 VEV_2_3_RA5_01_1236.d 5.8E4 4 4 2819 2828
R.ALVEHIHK.A Y 74.89 945.5396 8 -16.0 473.7695 2 22.99 6 9117 VEV_3_3_RA6_01_1237.d 2.78E6 14 14 2819 2826
R.KIWLDPNE(+14.02)VNEISTANSR.Q Y 73.35 2099.0647 18 -8.5 700.6896 3 77.87 4 45426 VEV_1_3_RA4_01_1235.d 3.37E5 3 3 2703 2720 Methylation(others)
K.IWLDPNEVNEISTANSR(+14.02).Q Y 73.23 1970.9697 17 -6.8 986.4855 2 79.98 4 47005 VEV_1_3_RA4_01_1235.d 7.41E4 3 3 2704 2720 Methylation(KR)
R.KIW(+15.99)LDPNEVNEISTANSR.Q Y 72.89 2101.0439 18 -10.3 701.3480 3 73.17 4 41716 VEV_1_3_RA4_01_1235.d 2.77E5 2 2 2703 2720 Oxidation (HW)
R.LAASVVGC(+57.02)GQ(+.98)R.K Y 70.20 1117.5549 11 -13.5 559.7772 2 44.79 6 21338 VEV_3_3_RA6_01_1237.d 1.7E6 13 13 2692 2702 Carbamidomethylation; Deamidation (NQ)
R.KIW(+31.99)LDPNEVNEISTANSR.Q Y 69.70 2117.0388 18 -4.5 706.6837 3 71.58 4 40466 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 2703 2720 Dihydroxy
R.KIWLDPNEVN(+.98)EISTANSR.Q Y 66.30 2086.0330 18 -7.3 696.3465 3 76.49 4 44293 VEV_1_3_RA4_01_1235.d 5.8E5 2 2 2703 2720 Deamidation (NQ)
R.KIWLDPN(+.98)EVNEISTAN(+.98)SR.Q Y 65.89 2087.0171 18 -0.3 696.6794 3 76.52 4 44321 VEV_1_3_RA4_01_1235.d 2.71E5 1 1 2703 2720 Deamidation (NQ)
R.TIKEEMDAK.R Y 65.86 1063.5220 9 3.5 532.7701 2 22.47 4 8722 VEV_1_3_RA4_01_1235.d 1.85E6 9 9 2836 2844
R.NAHLAEVEEE Y 65.59 1139.5094 10 -11.1 570.7557 2 42.73 6 20087 VEV_3_3_RA6_01_1237.d 6.2E6 16 16 2864 2873
K.IWLDPNEVNE(+14.02)ISTANSR.Q Y 63.04 1970.9697 17 -8.5 986.4838 2 80.77 5 46569 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 2704 2720 Methylation(others)
R.NAHLAEVEEE(+14.02) Y 61.84 1153.5251 10 -10.7 577.7637 2 54.84 5 28142 VEV_2_3_RA5_01_1236.d 4.04E6 12 12 2864 2873 Methylation(others)
R.KIWLDPNEVNEISTAN(+.98)SR.Q Y 61.50 2086.0330 18 -9.0 696.3453 3 76.50 5 43690 VEV_2_3_RA5_01_1236.d 0 1 1 2703 2720 Deamidation (NQ)
K.HLYHELYHLTK.G Y 59.66 1452.7513 11 -12.0 364.1908 4 58.85 4 30620 VEV_1_3_RA4_01_1235.d 6.96E5 2 2 2800 2810
R.TIKEEM(+15.99)DAK.R Y 58.10 1079.5168 9 -11.9 540.7593 2 10.99 5 2956 VEV_2_3_RA5_01_1236.d 1.02E5 3 3 2836 2844 Oxidation (M)
K.LLSDGLIIHKPVTM(+15.99)HSR.S Y 57.94 1932.0615 17 -6.9 387.4169 5 62.01 4 32997 VEV_1_3_RA4_01_1235.d 5.3E5 2 2 2726 2742 Oxidation (M)
R.TIKEEMDAKRAK.V Y 57.52 1418.7551 12 -7.1 473.9223 3 18.90 5 7147 VEV_2_3_RA5_01_1236.d 2.89E5 3 3 2836 2847
R.KIWLDPNEVNEIS(-2.02)TANSR.Q Y 57.29 2083.0334 18 -13.6 695.3423 3 75.64 5 43056 VEV_2_3_RA5_01_1236.d 4.97E3 2 2 2703 2720 2-amino-3-oxo-butanoic_acid
R.NAHLAEVEE(+14.02)E Y 55.78 1153.5251 10 -11.2 577.7634 2 53.08 5 27029 VEV_2_3_RA5_01_1236.d 3.25E6 5 5 2864 2873 Methylation(others)
R.TIKEEM(+15.99)DAKR.A Y 55.47 1235.6179 10 -17.4 618.8055 2 10.87 6 2856 VEV_3_3_RA6_01_1237.d 2.63E5 4 4 2836 2845 Oxidation (M)
R.K(+31.99)IWLDPNEVNEISTANSR.Q Y 54.91 2117.0388 18 -19.7 706.6730 3 71.39 6 38903 VEV_3_3_RA6_01_1237.d 1.68E4 1 1 2703 2720 Dihydroxy
R.N(+.98)AHLAEVEEE Y 54.05 1140.4934 10 7.1 571.2581 2 52.26 4 26353 VEV_1_3_RA4_01_1235.d 1.05E6 6 6 2864 2873 Deamidation (NQ)
K.RLAASVVGC(+57.02)GQRK.I Y 53.50 1400.7670 13 -11.9 351.1949 4 30.45 5 13524 VEV_2_3_RA5_01_1236.d 6.56E5 6 6 2691 2703 Carbamidomethylation
R.NAHLAEVEEE(+28.03) Y 51.23 1167.5408 10 -9.7 584.7720 2 61.71 4 32826 VEV_1_3_RA4_01_1235.d 5.95E5 3 3 2864 2873 Ethylation
R.LAASVVGC(+57.02)GQR(+14.02).K Y 50.88 1130.5865 11 -12.1 566.2937 2 49.18 5 24659 VEV_2_3_RA5_01_1236.d 3.92E5 5 5 2692 2702 Carbamidomethylation; Methylation(KR)
K.RNAHLAEVEE(+14.02)E Y 50.31 1309.6262 11 -3.6 655.8181 2 43.09 5 20978 VEV_2_3_RA5_01_1236.d 1.54E5 2 2 2863 2873 Methylation(others)
R.HRGFGKR.K Y 47.04 856.4780 7 -14.9 429.2399 2 10.60 5 2796 VEV_2_3_RA5_01_1236.d 2.52E5 3 3 2757 2763
R.NAHLAEVE(+14.02)EE Y 46.96 1153.5251 10 -9.1 577.7646 2 54.23 4 27576 VEV_1_3_RA4_01_1235.d 2.45E6 5 5 2864 2873 Methylation(others)
R.NAHLAEVEE(+28.03)E Y 46.92 1167.5408 10 -13.6 584.7697 2 61.58 6 31601 VEV_3_3_RA6_01_1237.d 1.16E6 7 7 2864 2873 Ethylation
K.IWLDPNEVN(+.98)EISTANSR.Q Y 46.22 1957.9381 17 -9.4 979.9672 2 80.45 6 45474 VEV_3_3_RA6_01_1237.d 4.18E4 2 2 2704 2720 Deamidation (NQ)
K.GNTFK(+14.02).H Y 46.06 579.3016 5 -9.5 580.3034 1 17.47 4 6077 VEV_1_3_RA4_01_1235.d 6.64E4 3 3 2811 2815 Methylation(KR)
K.RLAASVVGC(+57.02)GQR(+14.02).K Y 46.00 1286.6877 12 -8.2 429.8997 3 45.92 4 22337 VEV_1_3_RA4_01_1235.d 5.42E4 1 1 2691 2702 Carbamidomethylation; Methylation(KR)
R.ASGKIDKHLYHELYHLTK.G Y 45.98 2152.1428 18 -15.5 539.0347 4 62.09 5 33106 VEV_2_3_RA5_01_1236.d 1.26E5 1 1 2793 2810
K.LLSDGLIIHKPVTMHSR(+14.02).S Y 45.36 1930.0822 17 -2.8 387.0226 5 66.59 4 36519 VEV_1_3_RA4_01_1235.d 1.28E5 3 3 2726 2742 Methylation(KR)
R.NAHLAE(+14.02)VEEE Y 44.96 1153.5251 10 -12.0 577.7629 2 51.16 5 25856 VEV_2_3_RA5_01_1236.d 1.24E6 9 9 2864 2873 Methylation(others)
R.KIWLDPNEVN(+15.00)EISTANSR.Q Y 44.71 2100.0488 18 -14.4 701.0135 3 77.78 6 43575 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 2703 2720 Deamidation followed by a methylation
K.RLAASVVGC(+57.02)GQ(+.98)R.K Y 44.04 1273.6561 12 -16.4 425.5523 3 41.66 5 20147 VEV_2_3_RA5_01_1236.d 7.51E4 1 1 2691 2702 Carbamidomethylation; Deamidation (NQ)
K.GNTFKHKR.A Y 43.69 986.5410 8 -12.2 494.2717 2 9.26 5 2237 VEV_2_3_RA5_01_1236.d 1.42E4 2 2 2811 2818
R.ARELAEAR.K Y 42.38 914.4933 8 -15.0 458.2471 2 14.22 6 4538 VEV_3_3_RA6_01_1237.d 4.48E5 1 1 2745 2752
K.RNAHLAEVE(+14.02)EE Y 42.14 1309.6262 11 -7.4 655.8156 2 44.76 4 21619 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 2863 2873 Methylation(others)
R.ERTIKEEMDAK.R Y 41.88 1348.6656 11 -11.9 450.5571 3 25.58 4 10442 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 2834 2844
R.KLLSDGLIIHKPVTM(-48.00)HSR.S Y 40.61 1996.1582 18 -21.0 400.2305 5 58.88 6 29635 VEV_3_3_RA6_01_1237.d 1.83E5 1 1 2725 2742 Dethiomethyl
R.ERTIKEEMDAKR.A Y 39.29 1504.7667 12 -27.7 377.1885 4 24.83 6 10104 VEV_3_3_RA6_01_1237.d 3.85E5 3 3 2834 2845
R.TIKEEM(-48.00)DAKR.A Y 36.13 1171.6196 10 -17.1 391.5405 3 8.92 6 2123 VEV_3_3_RA6_01_1237.d 3.99E5 6 6 2836 2845 Dethiomethyl
R.TISMLTSDGASGSR.N Y 35.67 1381.6508 14 23.7 691.8490 2 60.13 4 31584 VEV_1_3_RA4_01_1235.d 0 1 1 187 200
R.NAHLAEVE(+28.03)EE Y 35.46 1167.5408 10 -10.0 584.7719 2 61.37 4 32516 VEV_1_3_RA4_01_1235.d 1.17E6 4 4 2864 2873 Ethylation
R.TQK(+114.04)RLAASVVGC(+57.02)GQRK.I Y 35.22 1872.0111 16 -57.0 624.9754 3 30.07 5 13306 VEV_2_3_RA5_01_1236.d 1.47E4 1 1 2688 2703 Ubiquitin; Carbamidomethylation
R.TIKEEMDAK(+14.02).R Y 34.43 1077.5376 9 -4.1 539.7739 2 33.74 5 15422 VEV_2_3_RA5_01_1236.d 2.23E5 3 3 2836 2844 Methylation(KR)
K.RNAHLAEVEEE(-.98) Y 33.69 1294.6266 11 -18.1 648.3088 2 34.43 6 15328 VEV_3_3_RA6_01_1237.d 2.16E3 1 1 2863 2873 Amidation
R.ARELAE(+14.02)AR.K Y 33.58 928.5090 8 -14.4 465.2551 2 20.37 4 7584 VEV_1_3_RA4_01_1235.d 9.28E4 1 1 2745 2752 Methylation(others)
R.K(+72.02)IWLDPNEVNEISTANSR.Q Y 33.50 2157.0701 18 -3.4 720.0282 3 74.50 6 41189 VEV_3_3_RA6_01_1237.d 3.28E5 2 2 2703 2720 Carboxyethyl
K.RNAHLAE(+14.02)VEEE Y 32.58 1309.6262 11 -6.4 655.8162 2 41.52 4 19629 VEV_1_3_RA4_01_1235.d 4.48E4 2 2 2863 2873 Methylation(others)
R.LAASVVGC(+57.02)GQ(+.98)RK.I Y 32.48 1245.6499 12 -5.0 623.8291 2 33.13 4 14652 VEV_1_3_RA4_01_1235.d 6.75E5 7 7 2692 2703 Carbamidomethylation; Deamidation (NQ)
K.RNAHLAEVEEE(+14.02) Y 31.78 1309.6262 11 -7.9 655.8152 2 45.39 4 22004 VEV_1_3_RA4_01_1235.d 6.43E4 1 1 2863 2873 Methylation(others)
R.KLLSDGLIIHKPVTM(+15.99)HSR.S Y 31.64 2060.1565 18 -18.8 413.0308 5 60.45 4 31825 VEV_1_3_RA4_01_1235.d 1.92E5 1 1 2725 2742 Oxidation (M)
R.T(+42.01)IKEEMDAKR.A Y 31.36 1261.6335 10 7.0 421.5547 3 21.46 6 8330 VEV_3_3_RA6_01_1237.d 1.27E4 1 1 2836 2845 Acetylation (N-term)
R.TIKEEMDAKR(+14.02).A Y 30.95 1233.6387 10 -14.9 412.2141 3 29.10 5 12773 VEV_2_3_RA5_01_1236.d 9.46E4 1 1 2836 2845 Methylation(KR)
R.T(-18.01)IK(+14.02)EEMDAKR.A Y 30.95 1215.6282 10 -29.5 406.2047 3 21.57 4 8237 VEV_1_3_RA4_01_1235.d 2.85E4 2 2 2836 2845 Dehydration; Methylation(KR)
K.SEQGLLK.V Y 30.94 773.4283 7 -17.2 774.4222 1 29.61 6 12655 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 342 348
R.ARELAEAR(+14.02).K Y 30.56 928.5090 8 -10.9 465.2567 2 21.35 4 8134 VEV_1_3_RA4_01_1235.d 1.26E5 3 3 2745 2752 Methylation(KR)
R.ETS(-18.01)LR.A N 30.17 586.3074 5 -8.3 587.3098 1 77.00 4 44692 VEV_1_3_RA4_01_1235.d 3.81E4 1 1 1775 1779 Dehydration
R.TIKEEMDAK(+14.02)R.A Y 29.43 1233.6387 10 -15.2 412.2139 3 29.12 4 12352 VEV_1_3_RA4_01_1235.d 8.55E5 1 1 2836 2845 Methylation(KR)
R.MPSQVLWM(+15.99)R.R Y 29.10 1162.5627 9 -2.3 582.2873 2 69.14 4 38546 VEV_1_3_RA4_01_1235.d 7.14E5 1 1 2771 2779 Oxidation (M)
R.TFARGLADT(+79.97)SSDVLR.K Y 28.87 1687.7930 15 -11.8 563.5983 3 75.34 5 42836 VEV_2_3_RA5_01_1236.d 2.07E5 1 1 2327 2341 Phosphorylation (STY)
K.LLSDGLIIHKPVTM(-48.00)HSR.S Y 28.62 1868.0632 17 -21.0 374.6121 5 59.07 6 29801 VEV_3_3_RA6_01_1237.d 3.86E5 1 1 2726 2742 Dethiomethyl
R.ALVE(+14.02)HIHK.A Y 28.52 959.5552 8 -20.9 480.7749 2 29.13 6 12397 VEV_3_3_RA6_01_1237.d 1.23E5 1 1 2819 2826 Methylation(others)
R.ARELAEARK.I Y 27.42 1042.5883 9 -11.7 348.5326 3 12.00 4 3329 VEV_1_3_RA4_01_1235.d 7.41E4 1 1 2745 2753
R.TIKEEM(-48.00)DAK.R Y 27.27 1015.5186 9 -8.6 508.7622 2 8.62 4 2041 VEV_1_3_RA4_01_1235.d 1.87E4 2 2 2836 2844 Dethiomethyl
K.AAWDALTQLTTHMR.K Y 27.03 1613.7985 14 -5.7 538.9370 3 63.57 4 34183 VEV_1_3_RA4_01_1235.d 9.27E4 1 1 2191 2204
K.TGIDPGELVSEK.Y Y 26.93 1243.6295 12 11.4 311.9182 4 26.48 5 11321 VEV_2_3_RA5_01_1236.d 3.92E5 2 2 711 722
K.HLYHELYHLTK(+31.99).G Y 26.59 1484.7412 11 -18.6 743.3641 2 77.72 4 45265 VEV_1_3_RA4_01_1235.d 2.99E4 1 1 2800 2810 Dihydroxy
R.KIWLDPNE(+21.98)VNEISTANSR.Q Y 26.43 2107.0310 18 -21.0 703.3362 3 74.87 4 43028 VEV_1_3_RA4_01_1235.d 0 1 1 2703 2720 Sodium adduct
R.NAHLAEVEEE(+17.03) Y 26.36 1156.5360 10 5.2 579.2783 2 55.22 4 28178 VEV_1_3_RA4_01_1235.d 3.86E4 1 1 2864 2873 Replacement of proton with ammonium ion
K.FPSETPSIIC(+57.02)NGIS(+79.97)NK.D Y 26.32 1842.8223 16 35.1 615.3029 3 64.72 6 33906 VEV_3_3_RA6_01_1237.d 6.99E4 1 1 2473 2488 Carbamidomethylation; Phosphorylation (STY)
R.LSSADAATYIK.E Y 26.23 1138.5869 11 -41.5 570.2771 2 62.29 5 33253 VEV_2_3_RA5_01_1236.d 0 2 2 1352 1362
K.T(-18.01)GIDPGELVSEK.Y Y 26.07 1225.6190 12 -4.0 409.5453 3 42.73 5 20758 VEV_2_3_RA5_01_1236.d 0 1 1 711 722 Dehydration
R.VT(+79.97)ALQT(-18.01)LISSMQR.Y Y 25.36 1508.7422 13 9.4 378.1964 4 60.07 4 31539 VEV_1_3_RA4_01_1235.d 0 1 1 1034 1046 Phosphorylation (STY); Dehydration
R.AR(+14.02)ELAEAR.K Y 25.30 928.5090 8 -11.6 465.2564 2 19.47 4 7168 VEV_1_3_RA4_01_1235.d 8.07E4 2 2 2745 2752 Methylation(KR)
R.ERTIKEEM(-48.00)DAKR.A Y 24.69 1456.7633 12 -14.0 365.1930 4 10.31 5 2653 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 2834 2845 Dethiomethyl
R.ALVEHIHK(+14.02).A Y 24.62 959.5552 8 -18.9 320.8530 3 29.12 6 12393 VEV_3_3_RA6_01_1237.d 5.28E5 2 2 2819 2826 Methylation(KR)
R.E(-18.01)LAEARK.I Y 24.01 797.4395 7 -17.9 399.7199 2 10.62 6 2754 VEV_3_3_RA6_01_1237.d 3.81E4 1 1 2747 2753 Pyro-glu from E
R.ALSTVSRSAVFQTGDLLAQK.Y Y 23.54 2091.1323 20 -44.2 419.2153 5 58.47 5 30435 VEV_2_3_RA5_01_1236.d 4.3E4 1 1 567 586
R.SVDIK(+42.01)C(+57.02)AVFLALNR(+14.02).L Y 23.53 1660.8970 14 -14.5 416.2255 4 41.44 5 19986 VEV_2_3_RA5_01_1236.d 0 1 1 2295 2308 Acetylation (K); Carbamidomethylation; Methylation(KR)
R.LLVK(+27.99)NFAT(+79.97)KSIDLLLPELERGLADDNYR.I Y 23.24 3323.7166 28 -10.7 831.9276 4 84.69 6 48261 VEV_3_3_RA6_01_1237.d 3.66E5 1 1 1783 1810 Formylation; Phosphorylation (STY)
R.L(+42.01)GSAQALSEVLAGLGTS(+79.97)R.L Y 23.13 1850.9138 18 -20.3 617.9660 3 62.31 4 33233 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 1696 1713 Acetylation (N-term); Phosphorylation (STY)
K.IWLDPN(+.98)EVNEISTANSR(+14.02).Q Y 23.04 1971.9537 17 2.2 986.9863 2 80.82 4 47655 VEV_1_3_RA4_01_1235.d 4.66E4 1 1 2704 2720 Deamidation (NQ); Methylation(KR)
R.T(+79.96)IKEEMDAK.R Y 22.47 1143.4788 9 69.2 382.1932 3 22.49 6 8874 VEV_3_3_RA6_01_1237.d 0 1 1 2836 2844 Sulfation
K.DKN(+203.08)GAT(+79.97)LLAYDK.V Y 22.36 1590.7178 12 5.6 1591.7340 1 88.95 5 51359 VEV_2_3_RA5_01_1236.d 2.18E4 1 1 520 531 HexNAcylation (N); Phosphorylation (STY)
K.VIAGN(+.98)ALGELIK(+43.01).K Y 22.31 1240.7026 12 -19.9 311.1768 4 26.61 5 11400 VEV_2_3_RA5_01_1236.d 6.24E4 1 1 1917 1928 Deamidation (NQ); Carbamylation
K.TQKITNAEQ(+.98)R.G Y 22.04 1188.6099 10 -19.0 595.3009 2 69.13 4 38538 VEV_1_3_RA4_01_1235.d 4.12E5 1 1 359 368 Deamidation (NQ)
MDAIEWNK.V Y 21.93 1005.4590 8 35.0 1006.5014 1 86.44 4 51529 VEV_1_3_RA4_01_1235.d 5.8E4 1 1 1 8
R.VLKFEPTDIAIAR.T Y 21.85 1471.8398 13 -13.2 491.6141 3 84.52 6 48159 VEV_3_3_RA6_01_1237.d 2.43E4 1 1 781 793
K.TQKITN(+.98)AEQR.G Y 21.81 1188.6099 10 -20.0 595.3003 2 68.94 5 38246 VEV_2_3_RA5_01_1236.d 2.93E5 2 2 359 368 Deamidation (NQ)
R.ENGAIR(+14.02).L Y 21.44 672.3555 6 2.0 673.3641 1 46.42 5 22979 VEV_2_3_RA5_01_1236.d 0 1 1 2149 2154 Methylation(KR)
R.ELAEAR.K Y 21.40 687.3551 6 -10.2 344.6813 2 13.90 4 4244 VEV_1_3_RA4_01_1235.d 2.93E5 2 2 2747 2752
R.KIWLDPNEVNE(+6.01)ISTANSR.Q Y 21.18 2091.0571 18 -4.1 698.0234 3 76.93 4 44640 VEV_1_3_RA4_01_1235.d 0 1 1 2703 2720 Replacement of proton by lithium
R.GAGIVESLAR(+80.99).G Y 21.09 1052.5250 10 -10.9 527.2640 2 19.86 5 7659 VEV_2_3_RA5_01_1236.d 0 1 1 874 883 Arginine replacement by Nitropyrimidyl ornithine
K.DGIQESKDSK.G Y 21.06 1105.5251 10 -14.3 1106.5166 1 89.10 4 53166 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 999 1008
R.MPSQVLWMRR.L Y 21.01 1302.6689 10 -9.5 435.2261 3 68.12 5 37631 VEV_2_3_RA5_01_1236.d 1.64E5 2 2 2771 2780
R.SRARELAEAR.K Y 20.98 1157.6265 10 -19.1 579.8094 2 19.71 5 7575 VEV_2_3_RA5_01_1236.d 5.06E4 1 1 2743 2752
R.ELAEAR(+14.02).K Y 20.96 701.3708 6 -81.1 702.3212 1 112.14 5 59422 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 2747 2752 Methylation(KR)
R.TELDISR(+14.02)YHPDLIR.V Y 20.92 1740.9159 14 -5.5 349.1885 5 60.05 5 31583 VEV_2_3_RA5_01_1236.d 0 1 1 2162 2175 Methylation(KR)
K.A(+42.01)LGS(+79.97)LIEK.L Y 20.61 951.4678 8 -1.5 318.1627 3 20.07 5 7763 VEV_2_3_RA5_01_1236.d 5.43E3 1 1 1662 1669 Acetylation (N-term); Phosphorylation (STY)
K.VEQLMQLFENTLETSDK(-.98).A Y 20.54 2022.9932 17 -6.4 506.7523 4 53.57 6 26410 VEV_3_3_RA6_01_1237.d 5.79E4 1 1 1274 1290 Amidation
R.AHNHIISS(+79.97)EILK.A Y 20.52 1440.7126 12 -9.9 721.3564 2 90.94 5 52369 VEV_2_3_RA5_01_1236.d 0 1 1 673 684 Phosphorylation (STY)
R.SQ(+.98)IS(-18.01)KGR.A Y 20.50 757.4082 7 -35.4 758.3887 1 101.72 5 56568 VEV_2_3_RA5_01_1236.d 3.39E4 1 1 740 746 Deamidation (NQ); Dehydration
R.HRGFGK.R Y 20.42 700.3768 6 15.7 351.2012 2 24.58 6 9981 VEV_3_3_RA6_01_1237.d 3.07E5 2 2 2757 2762
R.ELAEAR(+14.02)K.I Y 20.26 829.4657 7 -14.2 415.7342 2 13.99 5 4487 VEV_2_3_RA5_01_1236.d 2.71E4 1 1 2747 2753 Methylation(KR)
R.IM(+15.99)AHLTDALENKNDPNQR.Q Y 20.10 2095.0117 18 -17.4 524.7511 4 24.43 5 10156 VEV_2_3_RA5_01_1236.d 0 1 1 1401 1418 Oxidation (M)
K.EILDQLFHSK.Q Y 19.90 1228.6451 10 -8.2 615.3248 2 43.14 4 20723 VEV_1_3_RA4_01_1235.d 0 1 1 1363 1372
R.TELDISR(+14.02).Y Y 19.80 846.4447 7 -30.8 424.2166 2 29.36 5 12955 VEV_2_3_RA5_01_1236.d 7.95E4 1 1 2162 2168 Methylation(KR)
K.EILDAATK(+21.98).G Y 19.77 881.4470 8 -24.7 882.4326 1 83.51 5 48266 VEV_2_3_RA5_01_1236.d 9.97E4 1 1 429 436 Sodium adduct
K.LLS(+14.02)DGLIIHKPVTMHSR.S Y 19.64 1930.0822 17 -16.0 387.0175 5 67.87 4 37537 VEV_1_3_RA4_01_1235.d 6.88E4 1 1 2726 2742 Methylation(others)
K.QYAAR.R Y 19.62 607.3078 5 7.1 608.3194 1 71.69 6 39132 VEV_3_3_RA6_01_1237.d 8.3E4 3 3 1373 1377
R.LAAS(+14.02)VVGC(+57.02)GQRK.I Y 19.62 1258.6815 12 -9.2 315.6748 4 17.76 5 6522 VEV_2_3_RA5_01_1236.d 6.56E3 1 1 2692 2703 Methylation(others); Carbamidomethylation
K.STPVISK.G Y 19.59 730.4225 7 8.5 731.4360 1 23.91 6 9618 VEV_3_3_RA6_01_1237.d 1.76E4 1 1 808 814
R.E(+71.04)RTIKEEMDAKR.A Y 19.59 1575.8038 12 30.4 316.1776 5 21.76 4 8341 VEV_1_3_RA4_01_1235.d 0 1 1 2834 2845 Propionamide (K, X@N-term)
R.VVSER(+28.03).S Y 19.52 616.3544 5 -0.5 309.1843 2 32.14 4 14080 VEV_1_3_RA4_01_1235.d 0 1 1 2290 2294 Dimethylation(KR)
K.C(+44.03)LTDLAR.A Y 19.50 834.4269 7 -25.9 418.2100 2 23.74 5 9755 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 899 905 Ethanolation (C)
K.SANASIR(+.98).N Y 19.43 718.3610 7 -31.7 719.3455 1 83.69 6 47631 VEV_3_3_RA6_01_1237.d 9.68E4 1 1 320 326 Deamidation (R)
R.K(+14.02)IWLDPNEVNEISTANSR.Q Y 19.39 2099.0647 18 -9.5 700.6888 3 74.05 4 42399 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 2703 2720 Methylation(KR)
R.I(+42.01)MAHLTDALENK(+42.01).N Y 19.37 1438.7126 12 19.8 480.5876 3 71.12 6 38697 VEV_3_3_RA6_01_1237.d 0 1 1 1401 1412 Acetylation (N-term); Acetylation (K)
K.YINGPGAELPS(+79.97)ATK.R Y 19.37 1496.6912 14 58.8 499.9337 3 73.18 6 40223 VEV_3_3_RA6_01_1237.d 9.25E4 1 1 2601 2614 Phosphorylation (STY)
R.Q(+.98)AAQK.C Y 19.30 545.2809 5 -27.7 546.2731 1 22.01 5 8813 VEV_2_3_RA5_01_1236.d 7.54E4 1 1 71 75 Deamidation (NQ)
R.AVDDLTRSQISK.G Y 19.19 1331.7045 12 -26.4 333.9246 4 10.49 5 2730 VEV_2_3_RA5_01_1236.d 5.02E4 1 1 733 744
R.NAMLQALYEVVSK.A Y 18.97 1464.7646 13 -9.9 733.3823 2 87.08 4 51928 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 2378 2390
R.DAGVVK(+42.01)AAWDALTQLTTHMR.K Y 18.89 2225.1262 20 -37.3 557.2681 4 67.14 6 35737 VEV_3_3_RA6_01_1237.d 6.02E4 1 1 2185 2204 Acetylation (K)
R.LGSAQALSEVLAGLGTS(-20.03)R.L Y 18.89 1708.9108 18 1.4 428.2356 4 22.28 5 8955 VEV_2_3_RA5_01_1236.d 0 1 1 1696 1713 Formation of five membered aromatic heterocycle
R.AVDDLTRSQIS(-18.01)K(+14.02)GR.A Y 18.84 1540.8322 14 -28.5 771.4014 2 93.62 4 55623 VEV_1_3_RA4_01_1235.d 0 1 1 733 746 Dehydration; Methylation(KR)
R.FGEVISN(+.98)PE(+43.99)VK.S Y 18.77 1262.6030 11 26.8 632.3257 2 83.84 5 48462 VEV_2_3_RA5_01_1236.d 9.58E4 1 1 1548 1558 Deamidation (NQ); Carboxylation (E)
K.A(+27.99)LASLAQ(+.98)VASSSMTR.R Y 18.74 1520.7505 15 46.0 381.2124 4 14.96 6 4922 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 2073 2087 Formylation; Deamidation (NQ)
R.TIKEE(+14.02)MDAKR.A Y 18.72 1233.6387 10 -12.8 412.2149 3 30.96 5 13803 VEV_2_3_RA5_01_1236.d 3.35E5 1 1 2836 2845 Methylation(others)
R.IM(+15.99)AHLTD(-18.01)ALENK.N Y 18.67 1352.6758 12 3.0 677.3472 2 82.80 4 49086 VEV_1_3_RA4_01_1235.d 1.91E4 1 1 1401 1412 Oxidation (M); Dehydration
R.EY(-18.01)RIMAHLTDALENK.N Y 18.65 1784.8879 15 -6.7 447.2263 4 26.99 5 11589 VEV_2_3_RA5_01_1236.d 0 1 1 1398 1412 Dehydration
R.SAAIAVW(+15.99)K.A Y 18.33 860.4756 8 -27.8 431.2331 2 74.84 6 41421 VEV_3_3_RA6_01_1237.d 6.52E4 1 1 1877 1884 Oxidation (HW)
R.QVGVPGSNLPGFSLPK.G Y 18.27 1595.8671 16 14.8 320.1854 5 12.85 4 3726 VEV_1_3_RA4_01_1235.d 3.96E4 1 1 2221 2236
R.SAVFQTGDLLAQK(+43.99).Y Y 18.23 1420.7197 13 -14.5 474.5737 3 47.02 5 23339 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 574 586 Carboxylation (DKW)
R.T(+27.99)FARGLADTSSDVLR.K Y 18.15 1635.8217 15 35.5 546.3005 3 77.36 5 44274 VEV_2_3_RA5_01_1236.d 2.89E4 1 1 2327 2341 Formylation
K.VNAQLAK(+43.99).E Y 18.12 786.4235 7 45.4 787.4665 1 101.36 5 56453 VEV_2_3_RA5_01_1236.d 5.87E4 1 1 850 856 Carboxylation (DKW)
K.DSASVN(+.98)AGTGNER.L Y 18.07 1277.5483 13 20.5 639.7946 2 55.80 6 27615 VEV_3_3_RA6_01_1237.d 7.32E4 1 1 645 657 Deamidation (NQ)
R.LANQAR(+14.02).E Y 17.93 685.3871 6 -18.9 343.6943 2 44.44 6 21078 VEV_3_3_RA6_01_1237.d 0 1 1 2628 2633 Methylation(KR)
R.GLGSR(+21.98).S Y 17.92 510.2526 5 -11.6 511.2540 1 48.90 4 24184 VEV_1_3_RA4_01_1235.d 0 1 1 1606 1610 Sodium adduct
R.S(+42.01)QISK(+42.01).G N 17.88 645.3334 5 -41.6 646.3138 1 46.00 6 21982 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 740 744 Acetylation (N-term); Acetylation (K)
R.S(+86.00)GIALAFGAMAK.G Y 17.87 1221.6063 12 -11.0 408.2049 3 56.14 5 28847 VEV_2_3_RA5_01_1236.d 9.83E4 1 1 1216 1227 Malonylation
R.AVDDLTRSQISK(+145.02).G Y 17.83 1476.7242 12 -17.2 493.2402 3 38.10 5 17994 VEV_2_3_RA5_01_1236.d 5.89E4 1 1 733 744 3-(carbamidomethylthio)propanoyl
R.ATAS(-18.01)K.A Y 17.77 458.2489 5 -42.8 459.2365 1 58.15 4 30114 VEV_1_3_RA4_01_1235.d 9.02E4 1 1 1657 1661 Dehydration
K.RLAASVVGC(+57.02)GQR(+6.01).K Y 17.70 1278.6803 12 -36.3 427.2186 3 38.92 5 18480 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 2691 2702 Carbamidomethylation; Replacement of proton by lithium
K.ALASLAQ(+.98)VASSSMTR(+28.03).R Y 17.70 1520.7869 15 -7.1 381.2013 4 58.07 4 30057 VEV_1_3_RA4_01_1235.d 0 1 1 2073 2087 Deamidation (NQ); Dimethylation(KR)
R.VTALQTLISSM(+15.99)QR.Y Y 17.68 1462.7814 13 -20.1 366.6953 4 12.96 4 3783 VEV_1_3_RA4_01_1235.d 0 1 1 1034 1046 Oxidation (M)
R.TISMLTSDGASGSR(+44.03).N Y 17.67 1425.6770 14 9.0 476.2372 3 50.85 5 25666 VEV_2_3_RA5_01_1236.d 8.95E4 1 1 187 200 Ethanolation (KR)
R.SAVFQTGDLLAQK(+21.98)(+42.01).Y Y 17.67 1440.7224 13 7.1 361.1904 4 42.90 4 20467 VEV_1_3_RA4_01_1235.d 8.07E4 1 1 574 586 Sodium adduct; Acetylation (K)
R.KIGRHR.G Y 17.66 765.4722 6 -20.5 766.4637 1 109.07 4 60881 VEV_1_3_RA4_01_1235.d 1.96E6 1 1 2753 2758
R.E(-18.01)NGAIR.L Y 17.61 640.3292 6 10.0 321.1751 2 42.79 6 20115 VEV_3_3_RA6_01_1237.d 0 1 1 2149 2154 Pyro-glu from E
K.GTKDAR.M Y 17.61 646.3398 6 8.0 324.1798 2 44.42 5 21776 VEV_2_3_RA5_01_1236.d 2.8E1 1 1 2765 2770
R.FGEVISNPEVK.S Y 17.59 1217.6292 11 -32.1 609.8023 2 72.39 4 41104 VEV_1_3_RA4_01_1235.d 4.85E4 2 2 1548 1558
K.D(+42.01)SASVNAGTGNER(+14.02).L Y 17.53 1332.5906 13 1.8 667.3038 2 35.28 6 15809 VEV_3_3_RA6_01_1237.d 3.23E4 1 1 645 657 Acetylation (N-term); Methylation(KR)
K.RNAHLAEVEE(+28.03)E Y 17.47 1323.6418 11 -6.9 662.8236 2 53.72 4 27258 VEV_1_3_RA4_01_1235.d 7.67E4 1 1 2863 2873 Ethylation
R.L(+42.01)AASVVGC(+57.02)GQR.K Y 17.44 1158.5815 11 33.6 387.2141 3 41.92 6 19607 VEV_3_3_RA6_01_1237.d 0 1 1 2692 2702 Acetylation (N-term); Carbamidomethylation
R.NAHLAEVEEE(-.98) Y 17.39 1138.5254 10 5.3 570.2730 2 43.94 5 21481 VEV_2_3_RA5_01_1236.d 1.59E5 2 2 2864 2873 Amidation
R.GAAS(-18.01)R.A Y 17.38 442.2288 5 -5.3 443.2338 1 37.88 4 17436 VEV_1_3_RA4_01_1235.d 0 1 1 1158 1162 Dehydration
R.EAAAEAFDSLQQVLDK.R Y 17.19 1733.8472 16 -32.9 578.9373 3 66.11 5 36135 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 1998 2013
K.DSASVNAGTGNER.L Y 17.17 1276.5643 13 13.8 639.2982 2 45.89 4 22317 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 645 657
R.ALSTVS(+79.97)R(+31.99).S Y 17.14 844.3691 7 62.1 423.2181 2 36.17 4 16434 VEV_1_3_RA4_01_1235.d 0 1 1 567 573 Phosphorylation (STY); Dihydroxy
R.LASPNMEQK(+114.04).V Y 17.13 1130.5389 9 -6.3 566.2732 2 56.61 5 29163 VEV_2_3_RA5_01_1236.d 1.32E5 1 1 1908 1916 Ubiquitin
R.GQPQK(+21.98)(+42.01).K Y 17.10 620.2894 5 -10.4 621.2903 1 65.19 6 34263 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 836 840 Sodium adduct; Acetylation (K)
R.S(+79.97)AVFQTGDLLAQ(+.98)K(+14.02).Y Y 17.08 1471.6959 13 -36.6 368.9178 4 19.33 6 7211 VEV_3_3_RA6_01_1237.d 9.01E4 1 1 574 586 Phosphorylation (STY); Deamidation (NQ); Methylation(KR)
R.G(+27.99)AASR.A Y 16.96 488.2343 5 12.0 489.2474 1 61.24 4 32416 VEV_1_3_RA4_01_1235.d 1.06E5 2 2 1158 1162 Formylation
K.EIIGS(-18.01)R.T Y 16.95 655.3653 6 3.0 656.3745 1 27.94 5 12093 VEV_2_3_RA5_01_1236.d 0 2 2 236 241 Dehydration
R.T(-18.01)IK(+14.02)EEMDAK.R Y 16.95 1059.5270 9 -20.9 530.7597 2 22.63 4 8791 VEV_1_3_RA4_01_1235.d 4.23E4 1 1 2836 2844 Dehydration; Methylation(KR)
R.LSSADAATY(-94.04)IK.E Y 16.91 1044.5452 11 0.6 523.2802 2 44.20 4 21261 VEV_1_3_RA4_01_1235.d 5.01E6 1 1 1352 1362 Dehydroalanine (Y)
R.LEEILPTILQN(+.98)VAS(+79.97)AK.A Y 16.90 1818.9380 16 -22.2 607.3065 3 82.60 6 46934 VEV_3_3_RA6_01_1237.d 5.41E4 1 1 1714 1729 Deamidation (NQ); Phosphorylation (STY)
R.EEVMPKAPEK(+42.01)DAYGMPKK.V Y 16.86 2089.0222 18 -14.3 523.2554 4 24.03 4 9576 VEV_1_3_RA4_01_1235.d 0 1 1 1188 1205 Acetylation (K)
R.G(+43.01)LGSR.S Y 16.82 531.2765 5 15.3 532.2919 1 63.65 5 34277 VEV_2_3_RA5_01_1236.d 5.93E4 1 1 1606 1610 Carbamylation
R.F(+27.99)GEVISNPEVK.S Y 16.78 1245.6240 11 -4.7 623.8163 2 58.71 5 30610 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 1548 1558 Formylation
K.GNTFK.H Y 16.77 565.2860 5 -31.9 566.2753 1 98.98 4 57865 VEV_1_3_RA4_01_1235.d 0 1 1 2811 2815
R.EYR(+14.02)IMAHLTDALENK.N Y 16.74 1816.9142 15 -11.2 909.4542 2 82.04 4 48581 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 1398 1412 Methylation(KR)
R.NSANR.S N 16.74 560.2667 5 -12.9 561.2667 1 18.42 4 6587 VEV_1_3_RA4_01_1235.d 0 1 1 1539 1543
R.ATASK.A Y 16.73 476.2595 5 -70.8 477.2330 1 42.94 4 20496 VEV_1_3_RA4_01_1235.d 4.22E4 1 1 1657 1661
R.N(+42.01)GAVK.A Y 16.70 529.2860 5 -7.6 530.2892 1 31.37 4 13645 VEV_1_3_RA4_01_1235.d 0 1 1 327 331 Acetylation (N-term)
R.TFAR(+28.03)GLADTSSDVLR.K Y 16.66 1635.8580 15 12.4 546.3000 3 77.53 4 45114 VEV_1_3_RA4_01_1235.d 1.84E4 1 1 2327 2341 Dimethylation(KR)
K.EILDAATK(+14.02)GC(+57.02)SEK.R Y 16.65 1434.7024 13 -8.7 1435.6971 1 97.70 6 54579 VEV_3_3_RA6_01_1237.d 1.96E4 1 1 429 441 Methylation(KR); Carbamidomethylation
K.G(+42.01)NTFK.H Y 16.64 607.2966 5 90.0 608.3585 1 98.83 5 55612 VEV_2_3_RA5_01_1236.d 8.46E3 1 1 2811 2815 Acetylation (N-term)
K.VLIS(+79.97)IVR(+31.99).T Y 16.54 910.4888 7 -12.4 456.2460 2 30.98 4 13466 VEV_1_3_RA4_01_1235.d 0 1 1 1980 1986 Phosphorylation (STY); Dihydroxy
R.SQISK(+43.01).G N 16.48 604.3180 5 -58.3 605.2900 1 62.30 6 32120 VEV_3_3_RA6_01_1237.d 0 1 1 740 744 Carbamylation
R.GLGSRSATK(+21.98).K Y 16.45 897.4644 9 5.3 898.4764 1 97.43 4 57298 VEV_1_3_RA4_01_1235.d 4.47E4 1 1 1606 1614 Sodium adduct
R.ATASK(+21.98)(+14.02).A Y 16.40 512.2570 5 -2.5 513.2630 1 36.40 6 16449 VEV_3_3_RA6_01_1237.d 1.96E5 1 1 1657 1661 Sodium adduct; Methylation(KR)
R.G(+42.01)AAYGLGGIVSGK(+43.99)GVSAFREYR.I Y 16.35 2300.1548 22 3.0 576.0477 4 80.62 6 45597 VEV_3_3_RA6_01_1237.d 2.18E5 1 1 1379 1400 Acetylation (N-term); Carboxylation (DKW)
R.L(+43.01)AASVVGC(+57.02)GQR.K Y 16.33 1159.5768 11 -17.9 580.7853 2 47.28 6 22719 VEV_3_3_RA6_01_1237.d 0 1 1 2692 2702 Carbamylation; Carbamidomethylation
K.VYTK(+14.02)LNSTEDFLWK.T Y 16.32 1756.9036 14 -5.2 440.2309 4 72.85 6 40022 VEV_3_3_RA6_01_1237.d 1.48E5 1 1 551 564 Methylation(KR)
R.M(+42.01)PSQVLWMR.R Y 16.31 1188.5784 9 -9.7 595.2907 2 40.26 6 18637 VEV_3_3_RA6_01_1237.d 4.25E4 1 1 2771 2779 Acetylation (N-term)
R.NSANRSLQR.F Y 16.30 1044.5425 9 -9.7 523.2734 2 16.75 5 5962 VEV_2_3_RA5_01_1236.d 2.79E6 2 2 1539 1547
K.NGATLLAYDK(+21.98).V Y 16.28 1086.5321 10 -29.5 544.2573 2 65.58 6 34597 VEV_3_3_RA6_01_1237.d 0 1 1 522 531 Sodium adduct
K.A(+43.01)GILQFYAK.E Y 16.28 1052.5654 9 -18.0 527.2805 2 25.87 5 10969 VEV_2_3_RA5_01_1236.d 0 1 1 227 235 Carbamylation
K.QLHEDLD(-18.01)PK.R Y 16.25 1075.5298 9 -12.1 538.7657 2 40.63 5 19487 VEV_2_3_RA5_01_1236.d 0 1 1 771 779 Dehydration
R.VVSERSVDIK.C Y 16.23 1130.6295 10 -18.4 377.8768 3 49.65 4 24662 VEV_1_3_RA4_01_1235.d 0 1 1 2290 2299
K.C(+57.02)LTDLAR.A Y 16.22 847.4222 7 40.8 424.7357 2 20.99 5 8280 VEV_2_3_RA5_01_1236.d 2.23E4 1 1 899 905 Carbamidomethylation
K.FPSETPSIIC(+57.02)NGIS(+79.97)N(+.98)K.D Y 16.19 1843.8063 16 -10.2 461.9541 4 32.47 6 14230 VEV_3_3_RA6_01_1237.d 2.47E4 1 1 2473 2488 Carbamidomethylation; Phosphorylation (STY); Deamidation (NQ)
R.ARE(+14.02)LAEAR.K Y 16.16 928.5090 8 -14.6 465.2550 2 19.17 5 7292 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 2745 2752 Methylation(others)
K.GTK(+14.02)DAR(+14.02).M Y 16.15 674.3711 6 -27.1 338.1837 2 33.42 4 14821 VEV_1_3_RA4_01_1235.d 9.82E4 1 1 2765 2770 Methylation(KR)
K.D(+42.01)PFISDNSVLAAGK(+42.01).Y Y 16.08 1516.7408 14 6.8 380.1951 4 59.84 5 31478 VEV_2_3_RA5_01_1236.d 0 1 1 2489 2502 Acetylation (N-term); Acetylation (K)
K.ITNAEQR.G Y 16.03 830.4246 7 -27.7 416.2081 2 20.62 6 7885 VEV_3_3_RA6_01_1237.d 0 1 1 362 368
R.TISMLTSDGASGSR(+14.02).N Y 15.98 1395.6664 14 12.3 466.2351 3 27.54 4 11500 VEV_1_3_RA4_01_1235.d 0 1 1 187 200 Methylation(KR)
K.LTTDEQAK(+42.01)VNAQLAK(+42.01)EALIR.Q Y 15.95 2295.2434 20 -17.1 574.8083 4 54.14 5 27676 VEV_2_3_RA5_01_1236.d 0 1 1 842 861 Acetylation (K)
R.T(+79.97)FARGLADTSSDVLRK.R Y 15.95 1815.8879 16 -2.2 364.1841 5 23.99 4 9547 VEV_1_3_RA4_01_1235.d 0 1 1 2327 2342 Phosphorylation (STY)
K.I(+149.03)WLDPNEVNEISTANSR.Q Y 15.84 2105.9839 17 7.6 703.0073 3 74.26 5 42071 VEV_2_3_RA5_01_1236.d 9.75E4 1 1 2704 2720 Benzyl isothiocyanate
R.IPAANQDR(+14.02)Q(+.98)YFIQELSK.E Y 15.75 2035.0374 17 24.1 408.0245 5 30.06 4 12881 VEV_1_3_RA4_01_1235.d 3.12E4 1 1 83 99 Methylation(KR); Deamidation (NQ)
R.NSPFLGIVAGVSAR(+31.99).I Y 15.69 1418.7517 14 -1.9 355.6945 4 45.31 5 22321 VEV_2_3_RA5_01_1236.d 1.35E6 1 1 201 214 Dihydroxy
R.M(+43.01)PSQVLWMR(+14.02).R Y 15.68 1203.5892 9 -29.7 602.7840 2 83.05 4 49257 VEV_1_3_RA4_01_1235.d 0 1 1 2771 2779 Carbamylation; Methylation(KR)
K.STPVIS(+79.97)K(+43.99)GR.D Y 15.63 1067.5012 9 -23.9 534.7451 2 52.24 5 26568 VEV_2_3_RA5_01_1236.d 4.73E5 1 1 808 816 Phosphorylation (STY); Carboxylation (DKW)
K.A(+42.01)IS(+79.97)ISPPER(+14.02).A Y 15.61 1104.5216 9 -4.0 369.1797 3 11.16 6 2992 VEV_3_3_RA6_01_1237.d 3.33E4 1 1 664 672 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.LAN(+.98)QAR(+14.02).E Y 15.55 686.3711 6 -64.1 687.3344 1 67.75 4 37442 VEV_1_3_RA4_01_1235.d 1.57E4 1 1 2628 2633 Deamidation (NQ); Methylation(KR)
R.LGSAQ(+.98)ALSEVLAGLGT(+79.97)SR.L Y 15.51 1809.8873 18 4.2 905.9548 2 84.74 5 49008 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 1696 1713 Deamidation (NQ); Phosphorylation (STY)
K.AISIS(+42.01)PPER.A Y 15.45 1010.5396 9 -42.5 337.8395 3 25.62 6 10524 VEV_3_3_RA6_01_1237.d 2.35E3 1 1 664 672 Acetylation (TSCYH)
R.VTALQTLIS(+162.05)SMQR.Y Y 15.44 1608.8392 13 -7.6 403.2140 4 35.74 4 16178 VEV_1_3_RA4_01_1235.d 0 1 1 1034 1046 Hexose (NSY)
K.AAQIIGS(+59.02)LAHLTER.K Y 15.40 1537.8398 14 -26.7 385.4570 4 53.37 4 27043 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 1617 1630 Aminoethylcysteine
K.YLES(-18.01)TDSQLR.G Y 15.39 1192.5724 10 -0.4 597.2932 2 17.88 6 6443 VEV_3_3_RA6_01_1237.d 2.49E4 1 1 1148 1157 Dehydration
R.LGSAQALSEVLAGLGTSR.L Y 15.29 1728.9370 18 -42.9 346.7798 5 50.25 5 25284 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 1696 1713
K.EIIGS(+162.05)R(+14.02).T Y 15.29 849.4443 6 -18.5 850.4359 1 99.38 4 57994 VEV_1_3_RA4_01_1235.d 7.73E4 1 1 236 241 Hexose (NSY); Methylation(KR)
K.AGILQF(+31.99)YAK.E Y 15.25 1041.5494 9 -26.9 348.1811 3 31.68 5 14246 VEV_2_3_RA5_01_1236.d 1.69E5 1 1 227 235 Dihydroxy
R.L(+43.01)ANQAR.E Y 15.22 714.3773 6 -29.1 715.3638 1 83.87 5 48482 VEV_2_3_RA5_01_1236.d 2.36E4 1 1 2628 2633 Carbamylation
R.TFAR(+31.99)GLADTSS(+79.97)DVLR.K Y 15.17 1719.7828 15 -5.6 574.2650 3 65.23 6 34295 VEV_3_3_RA6_01_1237.d 3.55E5 1 1 2327 2341 Dihydroxy; Phosphorylation (STY)
K.EILDQ(+.98)LFHSKQYAAR.R Y 15.14 1818.9264 15 -11.3 607.3092 3 58.78 5 30657 VEV_2_3_RA5_01_1236.d 0 1 1 1363 1377 Deamidation (NQ)
K.GTK(+42.01)DAR(+14.02).M Y 15.10 702.3660 6 -13.7 703.3636 1 95.34 4 56445 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 2765 2770 Acetylation (K); Methylation(KR)
K.K(+43.99)AGDGVLSSLLPSLEAGLNASTDVDSR(+14.02).Q Y 15.10 2729.3718 27 -4.9 683.3469 4 79.70 5 45855 VEV_2_3_RA5_01_1236.d 5.36E4 1 1 1929 1955 Carboxylation (DKW); Methylation(KR)
K.IWLDPN(+15.00)EVNEISTANSR.Q Y 15.09 1971.9537 17 2.9 658.3271 3 81.84 4 48420 VEV_1_3_RA4_01_1235.d 9.17E4 1 1 2704 2720 Deamidation followed by a methylation
K.ASKESDWLNEAVIVLY(+79.97)GSLAR.H Y 15.08 2400.1726 21 2.2 481.0428 5 69.84 6 37733 VEV_3_3_RA6_01_1237.d 0 1 1 1291 1311 Phosphorylation (STY)
R.G(-15.01)AASR.A Y 15.07 445.2285 5 -16.3 446.2285 1 13.75 5 4361 VEV_2_3_RA5_01_1236.d 1.32E4 1 1 1158 1162 ISD (z+2)-series
R.LAASVVGC(+57.02)GQR(+14.02)K.I Y 15.03 1258.6815 12 -21.8 420.5587 3 36.07 6 16279 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 2692 2703 Carbamidomethylation; Methylation(KR)
total 241 peptides
C1GHV2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SIAEC(+57.02)LAEELINAAK.G Y 125.29 1630.8236 15 -13.3 816.4082 2 89.46 6 51053 VEV_3_3_RA6_01_1237.d 2.03E6 13 13 178 192 Carbamidomethylation
K.SIAEC(+57.02)LAEELINAAKGSSNSYAIK.K Y 124.94 2538.2634 24 -6.7 1270.1305 2 88.76 5 51257 VEV_2_3_RA5_01_1236.d 8.74E5 7 7 178 201 Carbamidomethylation
R.NVKSIAEC(+57.02)LAEELINAAKGSSNSYAIK.K Y 117.61 2879.4697 27 -13.7 720.8649 4 89.70 5 51726 VEV_2_3_RA5_01_1236.d 1.49E5 2 2 175 201 Carbamidomethylation
R.RVNQAIALLTIGAR.E Y 108.48 1494.8994 14 -11.5 499.3014 3 75.97 4 43892 VEV_1_3_RA4_01_1235.d 6.27E5 3 3 156 169
R.IVAHTFEIIHIMTDQNPIQ(+.98)VAVDAIVNC(+57.02)GPR.E Y 106.56 3471.7642 31 -1.5 868.9470 4 94.06 4 55847 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 102 132 Deamidation (NQ); Carbamidomethylation
R.IVAHTFEIIHIMTDQNPIQVAVDAIVNC(+57.02)GPR.E Y 105.33 3470.7803 31 -9.2 868.6943 4 94.02 4 55821 VEV_1_3_RA4_01_1235.d 7.03E5 6 6 102 132 Carbamidomethylation
R.VNQAIALLTIGAR.E Y 104.73 1338.7983 13 -23.0 670.3911 2 79.95 6 45131 VEV_3_3_RA6_01_1237.d 2.08E6 8 8 157 169
R.DMSLTDYIQIR.Q Y 92.22 1353.6598 11 -2.4 677.8356 2 83.11 4 49295 VEV_1_3_RA4_01_1235.d 2.23E5 2 2 44 54
R.NVKSIAEC(+57.02)LAEELINAAK.G Y 91.28 1972.0299 18 -9.6 658.3443 3 90.11 5 51937 VEV_2_3_RA5_01_1236.d 7.92E5 6 6 175 192 Carbamidomethylation
K.EVAAEIGAIKLFNK.W Y 90.16 1501.8503 14 -17.0 501.6155 3 77.01 6 43013 VEV_3_3_RA6_01_1237.d 2.34E5 3 3 21 34
R.IVAHTFEIIHIMTDQNPIQVAVDAIVNC(+57.02)GPREDSTR.I Y 87.24 4059.0305 36 -5.0 812.8093 5 91.69 5 52740 VEV_2_3_RA5_01_1236.d 1.88E5 1 1 102 137 Carbamidomethylation
R.Q(-17.03)PVYISHSAGR.Y Y 85.38 1196.5938 11 -13.8 599.2959 2 55.18 6 27303 VEV_3_3_RA6_01_1237.d 3.86E6 12 12 55 65 Pyro-glu from Q
R.QPVYISHSAGR.Y Y 80.78 1213.6204 11 -10.6 607.8110 2 28.96 5 12665 VEV_2_3_RA5_01_1236.d 1.21E6 10 10 55 65
R.RQAVDVSPLR.R Y 77.86 1139.6411 10 -9.8 380.8839 3 46.44 4 22663 VEV_1_3_RA4_01_1235.d 2.2E6 11 11 146 155
R.RQAVDVSPLRR.V Y 77.54 1295.7422 11 -15.1 432.9148 3 38.59 5 18340 VEV_2_3_RA5_01_1236.d 5.4E5 8 8 146 156
K.AQC(+57.02)PIIER.L Y 72.07 985.5015 8 -15.0 493.7506 2 39.35 6 18125 VEV_3_3_RA6_01_1237.d 2.4E6 10 10 74 81 Carbamidomethylation
R.IGYPVLPK.E Y 71.79 885.5323 8 -18.9 443.7651 2 66.68 6 35410 VEV_3_3_RA6_01_1237.d 3.82E6 6 6 13 20
R.LTNSLMMN(+.98)GR.N Y 71.51 1136.5319 10 -6.3 569.2697 2 61.96 4 32957 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 82 91 Deamidation (NQ)
K.SIAEC(+57.02)LAEELINAAK(+14.02).G Y 71.09 1644.8392 15 -10.6 549.2812 3 91.28 4 54375 VEV_1_3_RA4_01_1235.d 2.8E5 3 3 178 192 Carbamidomethylation; Methylation(KR)
K.SIAEC(+57.02)LAE(+14.02)ELINAAK.G Y 69.95 1644.8392 15 -14.3 823.4151 2 89.85 6 51242 VEV_3_3_RA6_01_1237.d 5.47E5 4 4 178 192 Carbamidomethylation; Methylation(others)
R.Q(-17.03)PVYISHSAGR(+14.02).Y Y 69.84 1210.6095 11 -13.9 606.3036 2 57.76 6 28864 VEV_3_3_RA6_01_1237.d 5.49E5 3 3 55 65 Pyro-glu from Q; Methylation(KR)
K.SIAEC(+57.02)LAEE(+14.02)LINAAK.G Y 69.22 1644.8392 15 -11.0 823.4178 2 92.62 4 55108 VEV_1_3_RA4_01_1235.d 1.03E6 7 7 178 192 Carbamidomethylation; Methylation(others)
K.GSSNSYAIK.K Y 66.88 925.4505 9 -8.4 463.7286 2 21.82 4 8386 VEV_1_3_RA4_01_1235.d 4.09E5 4 4 193 201
R.Q(-17.03)AVDVSPLRR.V Y 66.01 1122.6145 10 -11.9 562.3079 2 63.43 5 34129 VEV_2_3_RA5_01_1236.d 2.11E6 4 4 147 156 Pyro-glu from Q
R.KAQC(+57.02)PIIER.L Y 65.31 1113.5964 9 -9.2 557.8004 2 28.46 4 12037 VEV_1_3_RA4_01_1235.d 6.02E5 5 5 73 81 Carbamidomethylation
K.GSSNSYAIKKKDELER.V Y 64.53 1823.9376 16 -19.4 456.9828 4 28.17 5 12226 VEV_2_3_RA5_01_1236.d 4.28E5 3 3 193 208
R.LTNSLMM(+15.99)NGR.N Y 64.07 1151.5427 10 -6.5 576.7749 2 46.32 4 22592 VEV_1_3_RA4_01_1235.d 5.74E5 6 6 82 91 Oxidation (M)
K.EVAAEIGAIK.L Y 63.64 999.5600 10 -10.6 500.7820 2 60.79 4 32111 VEV_1_3_RA4_01_1235.d 1.06E6 4 4 21 30
R.QAVDVSPLR.R Y 60.14 983.5400 9 -13.2 492.7708 2 56.89 4 29215 VEV_1_3_RA4_01_1235.d 1.25E6 7 7 147 155
R.LTNSLM(+15.99)MNGR.N Y 57.53 1151.5427 10 -19.5 576.7674 2 47.08 4 23113 VEV_1_3_RA4_01_1235.d 0 3 3 82 91 Oxidation (M)
K.LFNKWSYEDIEIR.D Y 54.96 1711.8569 13 -20.4 571.6146 3 77.97 6 43706 VEV_3_3_RA6_01_1237.d 2.42E4 1 1 31 43
K.SIAE(+14.02)C(+57.02)LAEELINAAK.G Y 52.27 1644.8392 15 -5.8 823.4221 2 90.31 4 53828 VEV_1_3_RA4_01_1235.d 4.5E5 4 4 178 192 Methylation(others); Carbamidomethylation
R.LTNSLMMNGR.N Y 52.00 1135.5479 10 -6.5 568.7775 2 58.36 5 30376 VEV_2_3_RA5_01_1236.d 1.22E6 4 4 82 91
R.FRKAQC(+57.02)PIIER.L Y 51.78 1416.7660 11 -7.2 473.2592 3 40.85 4 19189 VEV_1_3_RA4_01_1235.d 3.41E5 3 3 71 81 Carbamidomethylation
R.Q(+.98)PVYISHSAGR.Y Y 51.26 1214.6044 11 -14.6 608.3006 2 32.45 5 14696 VEV_2_3_RA5_01_1236.d 5.37E4 3 3 55 65 Deamidation (NQ)
R.Q(-17.03)AVDVSPLR.R Y 49.16 966.5134 9 -20.0 967.5014 1 71.35 6 38875 VEV_3_3_RA6_01_1237.d 5.84E5 3 3 147 155 Pyro-glu from Q
R.IGSAGTVR.R Y 48.83 759.4239 8 -17.6 380.7125 2 16.75 6 5884 VEV_3_3_RA6_01_1237.d 7.19E5 4 4 138 145
R.IVAHTFEIIHIM(+15.99)TD(-18.01)QNPIQVAVDAIVNC(+57.02)GPR.E Y 47.59 3468.7646 31 -38.9 868.1647 4 94.16 5 53872 VEV_2_3_RA5_01_1236.d 6.36E4 2 2 102 132 Oxidation (M); Dehydration; Carbamidomethylation
K.AQC(+57.02)PIIER(+14.02).L Y 46.98 999.5172 8 -11.4 500.7601 2 48.46 4 23922 VEV_1_3_RA4_01_1235.d 1.07E6 4 4 74 81 Carbamidomethylation; Methylation(KR)
K.LMAVRIVAHTFEIIHIMTDQNPIQVAVDAIVNC(+57.02)GPR.E Y 44.97 4041.1113 36 -21.4 809.2123 5 97.92 4 57534 VEV_1_3_RA4_01_1235.d 5.37E4 1 1 97 132 Carbamidomethylation
R.VNQAIALLTIGAR(+14.02).E Y 44.67 1352.8140 13 -54.9 677.3771 2 80.99 6 45851 VEV_3_3_RA6_01_1237.d 0 1 1 157 169 Methylation(KR)
K.GSSNSYAIKK.K Y 44.30 1053.5454 10 -10.3 527.7745 2 14.68 4 4631 VEV_1_3_RA4_01_1235.d 0 1 1 193 202
K.EVAAE(+14.02)IGAIK.L Y 40.65 1013.5757 10 -9.4 507.7903 2 65.76 4 35875 VEV_1_3_RA4_01_1235.d 1.66E5 2 2 21 30 Methylation(others)
R.Q(+42.01)AVDVS(+162.05)PLRRVNQAIALLTIGAR.E Y 40.30 2664.4922 23 -22.5 667.1154 4 80.21 6 45305 VEV_3_3_RA6_01_1237.d 0 1 1 147 169 Acetylation (N-term); Hexose (NSY)
R.QAVDVSPLRR.V Y 39.72 1139.6411 10 -28.0 570.8119 2 46.23 5 22859 VEV_2_3_RA5_01_1236.d 5.01E5 3 3 147 156
R.IGSAGTVRR.Q Y 38.36 915.5250 9 -18.2 458.7614 2 14.13 5 4559 VEV_2_3_RA5_01_1236.d 4.39E5 2 2 138 146
R.Q(+43.01)PVYISHSAGR.Y Y 38.05 1256.6261 11 7.7 419.8859 3 28.94 4 12258 VEV_1_3_RA4_01_1235.d 6.33E4 1 1 55 65 Carbamylation
K.S(-2.02)IAEC(+57.02)LAEELINAAK.G Y 37.61 1628.8080 15 -1.9 815.4097 2 90.89 6 51774 VEV_3_3_RA6_01_1237.d 1.9E5 1 1 178 192 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
M.S(+42.01)DTGGVEVESR.I Y 36.82 1176.5259 11 -5.2 589.2672 2 48.21 6 23272 VEV_3_3_RA6_01_1237.d 2.37E5 3 3 2 12 Acetylation (Protein N-term)
R.EAAFRNVK.S Y 35.91 933.5032 8 -48.1 467.7364 2 19.51 5 7480 VEV_2_3_RA5_01_1236.d 0 2 2 170 177
R.DM(+15.99)SLTDYIQIR.Q Y 35.57 1369.6548 11 -7.1 685.8298 2 79.69 6 44938 VEV_3_3_RA6_01_1237.d 3.72E4 1 1 44 54 Oxidation (M)
R.Q(+.98)AVDVSPLR.R Y 33.07 984.5240 9 -10.6 493.2640 2 56.10 5 28823 VEV_2_3_RA5_01_1236.d 3.09E5 3 3 147 155 Deamidation (NQ)
R.VN(+162.05)QAIALLTIGAR.E Y 33.04 1500.8511 13 -26.7 501.2776 3 76.19 6 42404 VEV_3_3_RA6_01_1237.d 0 2 2 157 169 Hexose (NSY)
R.LTNSLM(+15.99)MN(+.98)GR.N Y 31.77 1152.5267 10 0.8 577.2711 2 52.93 4 26770 VEV_1_3_RA4_01_1235.d 1.81E5 3 3 82 91 Oxidation (M); Deamidation (NQ)
R.LTNSLM(+15.99)M(+15.99)NGR.N Y 31.02 1167.5376 10 6.8 584.7800 2 29.59 6 12649 VEV_3_3_RA6_01_1237.d 1.25E5 1 1 82 91 Oxidation (M)
R.Q(+.98)AVDVSPLRR.V Y 30.86 1140.6251 10 -12.4 571.3127 2 48.90 6 23672 VEV_3_3_RA6_01_1237.d 3.16E5 5 5 147 156 Deamidation (NQ)
R.N(+.98)VKSIAEC(+57.02)LAEELINAAK.G Y 30.32 1973.0139 18 -3.5 658.6763 3 90.18 4 53754 VEV_1_3_RA4_01_1235.d 1.33E3 1 1 175 192 Deamidation (NQ); Carbamidomethylation
R.I(+42.01)GSAGTVR.R Y 30.01 801.4344 8 -30.2 802.4175 1 94.44 4 56028 VEV_1_3_RA4_01_1235.d 0 1 1 138 145 Acetylation (N-term)
R.KAQC(+57.02)PIIER(+14.02).L Y 29.28 1127.6121 9 -9.3 376.8745 3 35.71 4 16155 VEV_1_3_RA4_01_1235.d 2.79E5 2 2 73 81 Carbamidomethylation; Methylation(KR)
R.LTNS(+79.97)LMMNGRNNGK(+14.02).K Y 28.27 1642.7321 14 55.1 822.4186 2 87.55 5 50604 VEV_2_3_RA5_01_1236.d 1.48E5 2 2 82 95 Phosphorylation (STY); Methylation(KR)
K.AQ(+.98)C(+57.02)PIIER.L Y 27.91 986.4855 8 -15.3 494.2425 2 43.27 6 20396 VEV_3_3_RA6_01_1237.d 8.94E5 5 5 74 81 Deamidation (NQ); Carbamidomethylation
R.LTNSLMMN(+162.05)GR(+14.02).N Y 27.37 1311.6162 10 -30.6 438.1993 3 54.39 5 27832 VEV_2_3_RA5_01_1236.d 0 1 1 82 91 Hexose (NSY); Methylation(KR)
K.KKDELER.V Y 26.70 916.4977 7 -9.3 306.5037 3 9.95 4 2438 VEV_1_3_RA4_01_1235.d 2.01E5 4 4 202 208
K.GSSN(+.98)SYAIKK.K Y 26.22 1054.5294 10 -35.2 528.2534 2 14.37 6 4626 VEV_3_3_RA6_01_1237.d 0 1 1 193 202 Deamidation (NQ)
R.IGSAGTVR(+14.02).R Y 25.92 773.4395 8 -39.0 387.7119 2 27.70 6 11615 VEV_3_3_RA6_01_1237.d 2.09E6 1 1 138 145 Methylation(KR)
R.K(+42.01)AQ(+.98)C(+57.02)PIIERLTNSLMMN(+.98)GR.N Y 25.47 2275.1123 19 -34.4 569.7658 4 61.76 6 31723 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 73 91 Acetylation (N-term); Deamidation (NQ); Carbamidomethylation
K.SIAEC(+57.02)LAE(+28.03)ELINAAK.G Y 24.46 1658.8549 15 -9.0 830.4272 2 92.62 4 55106 VEV_1_3_RA4_01_1235.d 9.64E4 1 1 178 192 Carbamidomethylation; Ethylation
R.IGYPVLPK(+14.02).E Y 22.62 899.5480 8 -63.9 450.7525 2 71.11 5 39806 VEV_2_3_RA5_01_1236.d 0 2 2 13 20 Methylation(KR)
R.Q(-17.03)AVDVSPLRR(+14.02).V Y 22.45 1136.6301 10 -12.2 569.3154 2 64.54 5 34928 VEV_2_3_RA5_01_1236.d 0 1 1 147 156 Pyro-glu from Q; Methylation(KR)
R.R(+43.01)QAVDVSPLR.R Y 22.07 1182.6469 10 8.5 395.2263 3 46.21 4 22517 VEV_1_3_RA4_01_1235.d 0 1 1 146 155 Carbamylation
K.SIAEC(+57.02)LAE(+14.02)ELINAAKGSSNSYAIK.K Y 21.99 2552.2791 24 -35.1 851.7371 3 89.04 4 53133 VEV_1_3_RA4_01_1235.d 0 2 2 178 201 Carbamidomethylation; Methylation(others)
R.KAQC(+57.02)PIIE(+14.02)R.L Y 21.85 1127.6121 9 -10.5 564.8074 2 35.61 5 16537 VEV_2_3_RA5_01_1236.d 7.08E4 1 1 73 81 Carbamidomethylation; Methylation(others)
R.EAAFR.N N 21.44 592.2969 5 -17.2 593.2939 1 71.95 4 40750 VEV_1_3_RA4_01_1235.d 0 1 1 170 174
R.IVAHTFEIIHIMTDQNPIQVAVDAIVNC(+57.02)GPR(-.98).E Y 20.95 3469.7961 31 -4.9 694.9631 5 94.06 4 55843 VEV_1_3_RA4_01_1235.d 0 1 1 102 132 Carbamidomethylation; Amidation
R.FR(+14.02)K(+43.99)AQC(+57.02)PIIER.L Y 20.94 1474.7714 11 -4.1 369.6986 4 11.29 4 2982 VEV_1_3_RA4_01_1235.d 0 1 1 71 81 Methylation(KR); Carboxylation (DKW); Carbamidomethylation
R.EAAFRNVKSIAE(+21.98)C(+57.02)LAEELIN(+.98)AAK.G Y 20.88 2569.2822 23 -18.9 643.3157 4 51.82 5 26282 VEV_2_3_RA5_01_1236.d 0 1 1 170 192 Sodium adduct; Carbamidomethylation; Deamidation (NQ)
K.E(+42.01)VAAEIGAIK(+42.01).L Y 20.72 1083.5812 10 6.1 542.8011 2 67.66 6 36122 VEV_3_3_RA6_01_1237.d 1.46E5 1 1 21 30 Acetylation (Protein N-term); Acetylation (K)
K.SIAEC(+57.02)LAEELIN(+.98)AAK.G Y 20.64 1631.8076 15 -7.3 816.9051 2 91.15 4 54342 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 178 192 Carbamidomethylation; Deamidation (NQ)
K.E(+27.99)VAAEIGAIK.L Y 20.56 1027.5549 10 -7.3 514.7810 2 9.98 5 2510 VEV_2_3_RA5_01_1236.d 0 1 1 21 30 Formylation (Protein N-term)
K.SIAEC(+57.02)LAEELIN(+.98)AAK(+42.01).G Y 20.33 1673.8181 15 -7.2 558.9426 3 47.25 4 23160 VEV_1_3_RA4_01_1235.d 0 1 1 178 192 Carbamidomethylation; Deamidation (NQ); Acetylation (K)
R.VNQ(+.98)AIALLT(+79.97)IGAR.E Y 20.24 1419.7487 13 -24.1 710.8645 2 55.85 5 28678 VEV_2_3_RA5_01_1236.d 2.48E4 1 1 157 169 Deamidation (NQ); Phosphorylation (STY)
R.IGY(+125.90)PVLPK.E Y 19.84 1011.4290 8 -11.7 506.7159 2 75.41 6 41835 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 13 20 Iodination
R.LTNSLMMN(+.98)GR(+28.03).N Y 19.33 1164.5631 10 -6.1 583.2853 2 52.00 6 25534 VEV_3_3_RA6_01_1237.d 7.81E4 1 1 82 91 Deamidation (NQ); Dimethylation(KR)
R.Q(+.98)PVYISHS(+162.05)AGR.Y Y 18.86 1376.6571 11 14.4 345.1765 4 12.23 6 3515 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 55 65 Deamidation (NQ); Hexose (NSY)
K.WSYEDIEIR.D Y 18.47 1209.5665 9 6.2 605.7943 2 77.51 6 43392 VEV_3_3_RA6_01_1237.d 0 1 1 35 43
R.NNGKKLM(+15.99)AVR.I Y 18.41 1145.6339 10 9.2 382.8888 3 64.86 4 35165 VEV_1_3_RA4_01_1235.d 5.47E4 1 1 92 101 Oxidation (M)
R.R(+39.99)QAVDVSPLR.R Y 18.32 1179.6360 10 -54.1 394.1980 3 46.35 4 22607 VEV_1_3_RA4_01_1235.d 5.53E4 1 1 146 155 Glyoxal-derived hydroimiadazolone
K.EVAAEIGAIK(+114.04).L Y 17.98 1113.6029 10 12.9 372.2130 3 52.55 5 26720 VEV_2_3_RA5_01_1236.d 4.12E4 1 1 21 30 Ubiquitin
R.Q(-17.03)AVDVSPLR(+14.02)R.V Y 17.75 1136.6301 10 -16.2 569.3131 2 64.52 6 33750 VEV_3_3_RA6_01_1237.d 8.41E4 1 1 147 156 Pyro-glu from Q; Methylation(KR)
R.KAQ(+.98)C(+57.02)PIIER.L Y 17.47 1114.5804 9 -6.6 558.2938 2 31.84 5 14338 VEV_2_3_RA5_01_1236.d 2.66E4 1 1 73 81 Deamidation (NQ); Carbamidomethylation
K.L(+42.01)MAVR(+14.02).I Y 17.34 644.3680 5 -16.2 323.1860 2 34.77 5 16042 VEV_2_3_RA5_01_1236.d 0 1 1 97 101 Acetylation (N-term); Methylation(KR)
R.LTNSLMM(+15.99)N(+.98)GR.N Y 17.19 1152.5267 10 -2.0 577.2695 2 57.86 4 29917 VEV_1_3_RA4_01_1235.d 2.61E5 1 1 82 91 Oxidation (M); Deamidation (NQ)
R.IGSAGTVRRQAVDVSPLR.R Y 17.04 1881.0544 18 -36.4 377.2045 5 50.32 5 25325 VEV_2_3_RA5_01_1236.d 8.06E4 1 1 138 155
R.RQ(+.98)AVDVSPLR.R Y 16.92 1140.6251 10 -8.1 381.2126 3 49.27 6 23880 VEV_3_3_RA6_01_1237.d 3.06E5 1 1 146 155 Deamidation (NQ)
K.LFNK(-1.03)WSYEDIEIR.D Y 16.79 1710.8253 13 6.7 571.2862 3 78.02 6 43743 VEV_3_3_RA6_01_1237.d 6.19E4 1 1 31 43 Lysine oxidation to aminoadipic semialdehyde
R.QAVDVSP(+31.99)LR.R Y 16.43 1015.5298 9 2.7 339.5181 3 11.68 4 3156 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 147 155 Dihydroxy
R.VNQAIALLT(+79.97)IGAR.E Y 15.95 1418.7646 13 -1.1 355.6981 4 48.93 4 24199 VEV_1_3_RA4_01_1235.d 2.2E6 1 1 157 169 Phosphorylation (STY)
R.IGSAGTVR(-.98).R Y 15.89 758.4399 8 -15.7 380.2213 2 21.49 6 8341 VEV_3_3_RA6_01_1237.d 0 1 1 138 145 Amidation
R.LTN(+.98)SLMMNGRNN(+.98)GK.K Y 15.89 1550.7181 14 -1.4 517.9126 3 26.40 5 11270 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 82 95 Deamidation (NQ)
R.LTNSLMMNGRNNGK(+27.99).K Y 15.81 1576.7450 14 -2.7 395.1925 4 20.84 6 8007 VEV_3_3_RA6_01_1237.d 2.61E4 1 1 82 95 Formylation
R.EDST(+79.97)RIGSAGTVR(+14.02).R Y 15.74 1441.6562 13 51.7 481.5842 3 47.40 4 23259 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 133 145 Phosphorylation (STY); Methylation(KR)
K.S(+79.97)IAEC(+57.02)LAEELINAAK(+42.01).G Y 15.60 1752.8004 15 24.8 877.4293 2 83.74 4 49727 VEV_1_3_RA4_01_1235.d 2.92E4 1 1 178 192 Phosphorylation (STY); Carbamidomethylation; Acetylation (K)
R.Q(+43.01)AVDVSPLRR.V Y 15.29 1182.6469 10 -12.5 395.2180 3 46.56 4 22770 VEV_1_3_RA4_01_1235.d 0 1 1 147 156 Carbamylation
K.DELERVAKSNR Y 15.02 1315.6843 11 -39.1 439.5516 3 64.78 4 35109 VEV_1_3_RA4_01_1235.d 0 1 1 204 214
total 104 peptides
C1GCI0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LWNDVFNLAQDYVGMPR.G Y 132.81 2036.9778 17 -7.7 1019.4883 2 90.52 5 52195 VEV_2_3_RA5_01_1236.d 6.16E5 6 6 226 242
R.AGHDGTWVAHPALAK.I Y 123.25 1529.7739 15 -29.1 765.8719 2 49.38 5 24801 VEV_2_3_RA5_01_1236.d 1.62E6 11 11 362 376
K.IATDIFDQYMPTPNQLFVR.R Y 103.15 2268.1248 19 -8.1 757.0427 3 89.51 4 53385 VEV_1_3_RA4_01_1235.d 4.94E5 6 6 377 395
K.ILTKEATAFLALLHR.T Y 102.51 1696.0035 15 -13.3 425.0025 4 82.06 5 47393 VEV_2_3_RA5_01_1236.d 1E5 3 3 24 38
K.LLQEQTDELASK.A Y 100.08 1373.7037 12 -11.0 687.8516 2 59.47 4 31083 VEV_1_3_RA4_01_1235.d 5.3E5 3 3 484 495
K.EATAFLALLHR.T Y 98.72 1240.6927 11 -19.5 414.5634 3 78.59 6 44217 VEV_3_3_RA6_01_1237.d 4.75E5 4 4 28 38
R.LWNDVFNLAQDYVGM(+15.99)PR.G Y 97.46 2052.9727 17 -1.7 685.3303 3 88.42 4 52771 VEV_1_3_RA4_01_1235.d 2.71E5 4 4 226 242 Oxidation (M)
R.YFAGQVTGEDYADFLTSLLYNEISAPGSAAKL Y 93.23 3410.6558 32 11.4 1137.9055 3 97.65 4 57407 VEV_1_3_RA4_01_1235.d 3.64E4 2 2 508 539
M.A(+42.01)YVDTLLKDVAILGPLNDQTRK.I Y 84.72 2484.3586 22 -11.3 829.1175 3 91.67 6 52160 VEV_3_3_RA6_01_1237.d 4.8E5 5 5 2 23 Acetylation (Protein N-term)
M.A(+42.01)YVDTLLKDVAILGPLNDQTR.K Y 84.36 2356.2637 21 -7.7 786.4224 3 95.86 5 54581 VEV_2_3_RA5_01_1236.d 1.24E6 10 10 2 22 Acetylation (Protein N-term)
R.ENDAWKGAPPAPGLVDR.R Y 83.10 1791.8904 17 -7.3 598.2997 3 67.29 4 37074 VEV_1_3_RA4_01_1235.d 2.99E5 3 3 75 91
R.REDVHITANDLLNTNVPGR.I Y 81.85 2133.0925 19 -7.6 534.2764 4 70.80 4 39844 VEV_1_3_RA4_01_1235.d 3.79E5 2 2 396 414
R.SDRQAELDRGSLLDFLPETK.H Y 77.49 2289.1599 20 -10.3 573.2914 4 79.08 4 46307 VEV_1_3_RA4_01_1235.d 4.93E5 4 4 52 71
R.RVEITGPTDR.K Y 75.46 1142.6044 10 -8.9 381.8720 3 32.86 5 14918 VEV_2_3_RA5_01_1236.d 1.08E6 8 8 92 101
R.GVGC(+57.02)IPINYLMEDAATAEVSR.S Y 75.25 2265.0769 21 -6.7 1133.5381 2 85.83 6 48980 VEV_3_3_RA6_01_1237.d 6.08E4 2 2 437 457 Carbamidomethylation
K.RGAGPYFYLPK.M Y 70.58 1267.6713 11 -9.0 423.5605 3 67.71 4 37405 VEV_1_3_RA4_01_1235.d 2.81E5 2 2 207 217
M.AYVDTLLKDVAILGPLNDQTR.K Y 70.05 2314.2532 21 -11.7 772.4160 3 88.54 4 52842 VEV_1_3_RA4_01_1235.d 2.64E5 4 4 2 22
K.ANEAAMASVR.A Y 65.38 1018.4866 10 -11.2 510.2449 2 32.64 6 14331 VEV_3_3_RA6_01_1237.d 7.04E5 6 6 344 353
K.NLNIGLSYMEGWLR.G Y 65.32 1664.8345 14 -3.8 833.4214 2 88.72 4 52947 VEV_1_3_RA4_01_1235.d 3.98E5 2 2 423 436
K.LLQEQTDELASKAPK.G Y 63.64 1669.8887 15 -15.7 557.6281 3 62.15 5 33150 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 484 498
K.EATAFLALLHR(+14.02).T Y 62.86 1254.7084 11 -8.7 419.2397 3 78.61 4 45948 VEV_1_3_RA4_01_1235.d 1.79E4 1 1 28 38 Methylation(KR)
R.SDVTMTVPFMDAYVK.L Y 60.85 1702.7947 15 -7.7 852.3981 2 83.83 4 49797 VEV_1_3_RA4_01_1235.d 1.07E5 3 3 301 315
R.RVEITGPTDRK.M Y 59.41 1270.6993 11 -9.9 424.5695 3 24.11 4 9622 VEV_1_3_RA4_01_1235.d 9.54E4 1 1 92 102
M.A(+42.01)YVDTLLKDVAILGPLNDQ(+.98)TR.K Y 57.86 2357.2478 21 -3.2 1179.6274 2 96.49 4 56961 VEV_1_3_RA4_01_1235.d 6.14E4 1 1 2 22 Acetylation (Protein N-term); Deamidation (NQ)
K.DVAILGPLNDQTR.K Y 56.47 1410.7467 13 -16.2 706.3692 2 77.17 4 44831 VEV_1_3_RA4_01_1235.d 5.25E4 1 1 10 22
R.GAGPYFYLPK.M Y 53.01 1111.5702 10 -12.1 556.7856 2 74.51 5 42254 VEV_2_3_RA5_01_1236.d 1.21E6 4 4 208 217
K.ANEAAM(+15.99)ASVR.A Y 51.30 1034.4814 10 -13.6 518.2410 2 17.25 6 6123 VEV_3_3_RA6_01_1237.d 2.7E5 4 4 344 353 Oxidation (M)
R.WDYIFSFIKK.F Y 49.33 1345.7070 10 -11.0 449.5714 3 82.34 4 48777 VEV_1_3_RA4_01_1235.d 3.67E4 1 1 279 288
K.GAPPAPGLVDR.R Y 49.28 1048.5665 11 -12.0 525.2842 2 52.76 4 26651 VEV_1_3_RA4_01_1235.d 6.46E5 3 3 81 91
R.TFNPTR.K Y 43.81 734.3711 6 -10.5 368.1890 2 22.99 4 8995 VEV_1_3_RA4_01_1235.d 3.02E5 4 4 39 44
R.KLPTLIAR.A Y 43.58 910.5964 8 -18.5 304.5338 3 58.20 5 30245 VEV_2_3_RA5_01_1236.d 7.67E5 6 6 161 168
R.TDRKLPTLIAR.A Y 43.56 1282.7721 11 -15.1 428.5915 3 56.09 5 28818 VEV_2_3_RA5_01_1236.d 1.85E5 4 4 158 168
K.GSKYQLAAR.Y Y 43.49 992.5403 9 -2.3 497.2763 2 23.26 4 9135 VEV_1_3_RA4_01_1235.d 6.04E4 3 3 499 507
R.VEITGPTDRK.M Y 42.25 1114.5981 10 -15.0 558.2980 2 28.00 5 12131 VEV_2_3_RA5_01_1236.d 2.3E5 2 2 93 102
R.GVGC(+57.02)IPIN(+.98)YLMEDAATAEVSR.S Y 40.15 2266.0610 21 -3.8 1134.0334 2 85.88 5 49668 VEV_2_3_RA5_01_1236.d 3.39E5 2 2 437 457 Carbamidomethylation; Deamidation (NQ)
R.Q(-17.03)AELDRGSLLDFLPETK.H Y 38.22 1913.9734 17 -13.7 957.9808 2 86.62 6 49436 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 55 71 Pyro-glu from Q
R.LWN(+.98)DVFN(+.98)LAQDYVGMPR.G Y 35.04 2038.9458 17 19.6 1020.5002 2 90.60 6 51628 VEV_3_3_RA6_01_1237.d 5.44E4 1 1 226 242 Deamidation (NQ)
R.SQLWQWVK.H Y 33.13 1073.5658 8 -11.6 537.7839 2 77.35 4 44967 VEV_1_3_RA4_01_1235.d 1E5 1 1 458 465
K.M(+15.99)ESHLEAR.L Y 28.33 987.4443 8 -2.1 494.7284 2 14.44 4 4509 VEV_1_3_RA4_01_1235.d 4.72E4 2 2 218 225 Oxidation (M)
K.Q(-17.03)GGKDYKLR.T Y 28.18 1046.5509 9 -14.6 524.2751 2 25.06 5 10513 VEV_2_3_RA5_01_1236.d 2.44E4 1 1 149 157 Pyro-glu from Q
R.LWNDVFNLAQDYVGMPR(-.98).G Y 27.51 2035.9938 17 -23.7 679.6558 3 90.47 5 52125 VEV_2_3_RA5_01_1236.d 0 1 1 226 242 Amidation
R.Q(-17.03)AELDR(+14.02)GSLLDFLPETK.H Y 27.37 1927.9890 17 -0.5 965.0013 2 87.96 4 52479 VEV_1_3_RA4_01_1235.d 1.69E4 1 1 55 71 Pyro-glu from Q; Methylation(KR)
R.ITEDGIRK.N Y 26.77 930.5134 8 -5.5 466.2614 2 18.40 4 6578 VEV_1_3_RA4_01_1235.d 3.82E4 2 2 415 422
K.ANEAAM(-48.00)ASVR.A Y 26.37 970.4832 10 -23.1 324.4942 3 10.93 6 2885 VEV_3_3_RA6_01_1237.d 2.41E4 1 1 344 353 Dethiomethyl
R.TFNPTRK.A Y 26.00 862.4661 7 -7.8 432.2369 2 15.99 4 5297 VEV_1_3_RA4_01_1235.d 7.06E4 1 1 39 45
R.EDVHITANDLLN(+.98)TNVPGR.I Y 25.80 1977.9756 18 -2.8 660.3306 3 74.86 4 43017 VEV_1_3_RA4_01_1235.d 0 1 1 397 414 Deamidation (NQ)
K.D(+119.04)VAILGPLNDQTRK.I Y 25.71 1657.8788 14 -45.4 829.9091 2 91.72 6 52178 VEV_3_3_RA6_01_1237.d 2.3E4 1 1 10 23 Pyridylacetyl
R.RSDRQAELD(+21.98)R.G Y 25.34 1266.6040 10 5.7 423.2110 3 66.13 6 34979 VEV_3_3_RA6_01_1237.d 0 1 1 51 60 Sodium adduct
M.A(+42.01)YVDTLLKDVAILGPLN(+.98)DQTR.K Y 24.78 2357.2478 21 1.4 786.7576 3 96.38 6 54120 VEV_3_3_RA6_01_1237.d 6.68E4 1 1 2 22 Acetylation (Protein N-term); Deamidation (NQ)
R.QAELD(-18.01)RGSLLDFLPETK.H Y 24.13 1912.9894 17 -50.4 957.4537 2 86.89 4 51881 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 55 71 Dehydration
R.VEITGPTDR.K Y 24.02 986.5032 9 -7.4 494.2552 2 39.80 4 18582 VEV_1_3_RA4_01_1235.d 5.16E5 1 1 93 101
R.LWNDVFN(+.98)LAQDYVGM(+15.99)PR.G Y 22.77 2053.9568 17 0.5 685.6599 3 88.30 5 51006 VEV_2_3_RA5_01_1236.d 6.55E4 1 1 226 242 Deamidation (NQ); Oxidation (M)
R.LWN(+.98)DVFNLAQDYVGMPR.G Y 21.88 2037.9618 17 13.4 680.3370 3 90.66 6 51658 VEV_3_3_RA6_01_1237.d 0 1 1 226 242 Deamidation (NQ)
K.DVAILGPLNDQT(+79.97)R.K Y 20.79 1490.7130 13 -33.2 497.8951 3 70.40 6 38170 VEV_3_3_RA6_01_1237.d 5.21E4 2 2 10 22 Phosphorylation (STY)
R.VDKAYALK.L Y 20.68 906.5175 8 -10.3 303.1766 3 26.11 5 11101 VEV_2_3_RA5_01_1236.d 0 1 1 476 483
R.QAELDRGSLLDFLPETK(+14.02).H Y 20.48 1945.0156 17 -10.6 649.3389 3 83.22 5 48087 VEV_2_3_RA5_01_1236.d 1.62E5 1 1 55 71 Methylation(KR)
R.V(+42.01)EITGPTD(+21.98)R.K Y 20.43 1050.4957 9 -12.6 526.2485 2 32.59 6 14295 VEV_3_3_RA6_01_1237.d 0 1 1 93 101 Acetylation (N-term); Sodium adduct
R.SQLWQWVKHNVMTAEGK.R Y 20.35 2041.0204 17 6.5 409.2140 5 72.05 5 40501 VEV_2_3_RA5_01_1236.d 2.82E4 1 1 458 474
R.LWNDVFNLAQDY(-2.02)VGMPR.G Y 20.02 2034.9622 17 34.7 679.3515 3 90.78 4 54094 VEV_1_3_RA4_01_1235.d 3.75E4 1 1 226 242 2-amino-3-oxo-butanoic_acid
K.QGGKDYK.L Y 19.98 794.3922 7 8.9 795.4066 1 90.74 5 52269 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 149 155
K.ANEAAM(+15.99)ASVRADK.L Y 19.41 1348.6405 13 -17.8 675.3155 2 48.12 5 23995 VEV_2_3_RA5_01_1236.d 1.65E5 4 4 344 356 Oxidation (M)
K.EATAFLALLH(+15.99)RTFNPTR.K Y 19.38 1973.0482 17 1.8 494.2702 4 58.65 5 30560 VEV_2_3_RA5_01_1236.d 0 1 1 28 44 Oxidation (HW)
R.S(+42.01)DVTMTVPFMDAYVK.L Y 19.06 1744.8052 15 -1.8 873.4083 2 71.00 5 39729 VEV_2_3_RA5_01_1236.d 5.35E4 1 1 301 315 Acetylation (N-term)
M.AYVDTLLK(+40.03)DVAILGPLNDQTRK.I Y 18.64 2482.3794 22 -69.1 828.4099 3 91.83 4 54681 VEV_1_3_RA4_01_1235.d 5.18E3 1 1 2 23 Propionaldehyde +40
R.QVDFK.Q Y 18.60 635.3279 5 -29.6 636.3163 1 75.75 5 43133 VEV_2_3_RA5_01_1236.d 8.49E3 1 1 144 148
R.KNLN(+162.05)IGLS(+79.97)YMEGWLR.G Y 18.10 2034.9485 15 12.7 679.3320 3 75.46 5 42917 VEV_2_3_RA5_01_1236.d 4.35E4 1 1 422 436 Hexose (NSY); Phosphorylation (STY)
R.R(+42.01)QVDFKQGGKD(+21.98)YK.L Y 17.96 1631.8031 13 -3.9 408.9565 4 18.39 5 6853 VEV_2_3_RA5_01_1236.d 7.47E4 1 1 143 155 Acetylation (N-term); Sodium adduct
R.Q(-17.03)AELDRGSLLDFLPETK(+14.02).H Y 17.64 1927.9890 17 -7.2 964.9948 2 87.07 5 50346 VEV_2_3_RA5_01_1236.d 1E5 2 2 55 71 Pyro-glu from Q; Methylation(KR)
K.LLQEQT(+79.97)DELASKAPKGS(+79.97)K(+14.02).Y Y 17.56 2115.9854 18 24.3 706.3528 3 63.70 5 34313 VEV_2_3_RA5_01_1236.d 4.42E4 1 1 484 501 Phosphorylation (STY); Methylation(KR)
R.RVEIT(-2.02)GPTDR.K Y 17.25 1140.5887 10 -12.4 381.1988 3 32.92 6 14483 VEV_3_3_RA6_01_1237.d 8.41E4 1 1 92 101 2-amino-3-oxo-butanoic_acid
K.EAT(-18.01)AFLALLHR.T Y 17.15 1222.6823 11 -14.8 408.5620 3 78.65 4 45981 VEV_1_3_RA4_01_1235.d 5.1E4 1 1 28 38 Dehydration
R.VEIT(-18.01)GPTDR.K Y 17.05 968.4927 9 -52.7 485.2281 2 30.88 5 13764 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 93 101 Dehydration
R.R(+42.01)(+14.02)VEIT(+79.97)GPTDR.K Y 17.03 1278.5969 10 16.6 320.6618 4 50.75 6 24716 VEV_3_3_RA6_01_1237.d 6.08E4 1 1 92 101 Acetylation (N-term); Methylation(KR); Phosphorylation (STY)
K.Q(+42.01)GGK(+14.02)DYK.L Y 16.99 850.4185 7 -18.5 426.2086 2 27.22 6 11372 VEV_3_3_RA6_01_1237.d 0 1 1 149 155 Acetylation (N-term); Methylation(KR)
K.ME(+14.02)SHLEAR.L Y 16.94 985.4651 8 -9.3 493.7353 2 13.42 4 4010 VEV_1_3_RA4_01_1235.d 0 1 1 218 225 Methylation(others)
R.HNPSFVLPDR.S Y 16.82 1180.5989 10 -11.7 591.2998 2 70.73 4 39785 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 291 300
R.GSLLDFLPETK(+226.08).H Y 16.76 1444.7272 11 -15.7 723.3595 2 85.23 6 48610 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 61 71 Biotinylation
R.RSDRQAELDRGSLLDFLPETK.H Y 16.17 2445.2612 21 -1.5 490.0588 5 76.39 5 43582 VEV_2_3_RA5_01_1236.d 8.81E4 1 1 51 71
K.HLTVDGEPMSGSLFDFGLYFFHNAEELVKR(-.98).G Y 16.16 3453.6814 30 -2.2 691.7421 5 93.98 4 55801 VEV_1_3_RA4_01_1235.d 0 1 1 178 207 Amidation
K.YQLAAR.Y Y 16.07 720.3918 6 -9.8 361.1997 2 29.76 4 12711 VEV_1_3_RA4_01_1235.d 2.19E5 1 1 502 507
R.VEIT(+79.96)GPTDRK.M Y 15.83 1194.5551 10 7.8 598.2895 2 38.38 5 18163 VEV_2_3_RA5_01_1236.d 5.56E4 1 1 93 102 Sulfation
R.VEITGPTDR(-.98).K Y 15.82 985.5192 9 -13.7 493.7601 2 22.40 5 9018 VEV_2_3_RA5_01_1236.d 0 1 1 93 101 Amidation
R.VE(+43.99)ITGPTDRK.M Y 15.75 1158.5880 10 2.1 580.3025 2 81.67 4 48299 VEV_1_3_RA4_01_1235.d 6.12E4 1 1 93 102 Carboxylation (E)
K.DVAILGPLNDQT(-18.01)R.K Y 15.57 1392.7361 13 -8.5 349.1884 4 63.22 6 32799 VEV_3_3_RA6_01_1237.d 2.54E4 1 1 10 22 Dehydration
R.EDVHITAND(-18.01)LLNTNVPGR.I Y 15.45 1958.9810 18 -15.8 980.4823 2 83.15 4 49328 VEV_1_3_RA4_01_1235.d 0 1 1 397 414 Dehydration
R.ITED(-18.01)GIR.K Y 15.43 784.4079 7 11.4 785.4241 1 85.76 4 51084 VEV_1_3_RA4_01_1235.d 6.35E3 1 1 415 421 Dehydration
K.D(+226.08)VAILGPLNDQT(+79.97)RK.I Y 15.34 1844.8855 14 -1.6 462.2279 4 45.87 4 22310 VEV_1_3_RA4_01_1235.d 0 1 1 10 23 Biotinylation; Phosphorylation (STY)
K.MESHLEAR(-.98).L Y 15.28 970.4655 8 -11.7 486.2343 2 18.90 6 6993 VEV_3_3_RA6_01_1237.d 0 1 1 218 225 Amidation
total 88 peptides
C1GBZ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.S(+42.01)HLAVEPEFEQAYRELASTLENSTLFDQHPEYRR.A Y 128.70 4103.9614 34 -9.5 821.7917 5 90.35 5 52063 VEV_2_3_RA5_01_1236.d 1.04E6 3 3 2 35 Acetylation (Protein N-term)
K.AANAGGVAVSGLEMAQNAQR.L Y 126.90 1913.9377 20 -8.0 638.9814 3 71.61 5 40177 VEV_2_3_RA5_01_1236.d 8.87E5 6 6 376 395
R.VAISGSGNVAQYAALK.A Y 116.05 1547.8307 16 -14.1 774.9117 2 70.07 6 37929 VEV_3_3_RA6_01_1237.d 4.57E5 4 4 224 239
R.VQFNSALGPYKGGLR.F Y 98.08 1605.8627 15 -7.4 536.2909 3 68.47 4 38013 VEV_1_3_RA4_01_1235.d 1.72E5 2 2 68 82
R.ALAVAAVPER.T Y 94.76 995.5764 10 -15.7 498.7877 2 58.66 6 29507 VEV_3_3_RA6_01_1237.d 1.29E6 4 4 36 45
K.FC(+57.02)SAFMMELSK.H Y 92.64 1349.5818 11 -11.3 675.7905 2 79.36 4 46523 VEV_1_3_RA4_01_1235.d 4.37E4 2 2 132 142 Carbamidomethylation
K.AANAGGVAVSGLEM(+15.99)AQNAQR.L Y 89.69 1929.9326 20 -7.4 644.3134 3 65.94 4 36010 VEV_1_3_RA4_01_1235.d 9.16E4 2 2 376 395 Oxidation (M)
R.EHGGSITPEEIYLIQQIKVER.K Y 89.04 2438.2805 21 -14.0 813.7561 3 79.08 5 45444 VEV_2_3_RA5_01_1236.d 4E4 1 1 261 281
K.HIGADIDVPAGDIGVSGR.E Y 88.28 1747.8853 18 -5.5 874.9451 2 70.81 4 39856 VEV_1_3_RA4_01_1235.d 1.66E5 3 3 143 160
R.VTWENDKGGLEVNR.G Y 87.92 1615.7954 14 -10.8 539.5999 3 60.43 6 30746 VEV_3_3_RA6_01_1237.d 6.9E5 6 6 51 64
K.AIEFGGTVC(+57.02)SLSDSK.G Y 87.48 1569.7345 15 -9.1 785.8674 2 72.12 4 40889 VEV_1_3_RA4_01_1235.d 2.63E5 2 2 240 254 Carbamidomethylation
R.DC(+57.02)FVTGVETAK.K Y 81.77 1225.5648 11 -11.7 613.7825 2 62.45 4 33333 VEV_1_3_RA4_01_1235.d 1.96E5 1 1 413 423 Carbamidomethylation
K.NALTGLNM(+15.99)GGGK.G Y 81.37 1147.5656 12 -5.1 574.7871 2 42.89 4 20506 VEV_1_3_RA4_01_1235.d 1.78E5 4 4 103 114 Oxidation (M)
R.YIAEGSNMGC(+57.02)TLAAIEHFEASRR.F Y 78.04 2582.2004 23 -15.4 646.5474 4 79.35 5 45622 VEV_2_3_RA5_01_1236.d 7.24E4 1 1 339 361 Carbamidomethylation
M.SHLAVE(+43.99)PEFEQAYRELASTLENSTLFDQHPEYRR.A Y 77.57 4105.9404 34 -0.5 822.1949 5 90.48 4 53918 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 2 35 Carboxylation (E)
R.VQFNSALGPYK.G Y 75.61 1222.6345 11 -9.5 612.3187 2 67.71 4 37403 VEV_1_3_RA4_01_1235.d 4.28E5 2 2 68 78
K.FLGFEQIFK.N Y 74.95 1127.6014 9 -13.2 564.8005 2 85.41 4 50888 VEV_1_3_RA4_01_1235.d 4E5 3 3 94 102
M.S(+42.01)HLAVEPEFEQAYR.E Y 72.89 1716.8107 14 -7.7 859.4060 2 75.09 4 43221 VEV_1_3_RA4_01_1235.d 4.76E5 3 3 2 15 Acetylation (Protein N-term)
R.HLWEGVLTGK.G Y 72.46 1138.6135 10 -10.8 380.5410 3 69.17 4 38573 VEV_1_3_RA4_01_1235.d 1.8E5 2 2 174 183
K.Q(-17.03)LSTLASTDALRER.C Y 71.32 1542.8002 14 -14.4 772.3962 2 75.19 6 41708 VEV_3_3_RA6_01_1237.d 4.93E5 3 3 283 296 Pyro-glu from Q
R.DC(+57.02)FVTGVETAKK.Y Y 66.05 1353.6598 12 -8.9 677.8312 2 52.28 4 26347 VEV_1_3_RA4_01_1235.d 2.83E5 3 3 413 424 Carbamidomethylation
R.EIGFLFGAYKR.Q Y 64.60 1299.6975 11 -10.6 434.2352 3 76.79 4 44527 VEV_1_3_RA4_01_1235.d 2.88E5 3 3 161 171
K.SVWYGPGK.A Y 62.54 892.4443 8 -11.3 447.2244 2 52.80 4 26673 VEV_1_3_RA4_01_1235.d 1.12E6 8 8 368 375
K.NALTGLNMGGGK.G Y 60.11 1131.5707 12 -12.1 566.7858 2 61.84 4 32869 VEV_1_3_RA4_01_1235.d 3.17E5 5 5 103 114
K.RVAISGSGNVAQYAALK.A Y 59.39 1703.9318 17 -13.6 568.9768 3 65.70 6 34646 VEV_3_3_RA6_01_1237.d 2.8E4 1 1 223 239
K.YTHPDEGKLPSLVTGSNIAGFMK.V Y 58.26 2461.2312 23 -5.2 821.4134 3 78.29 5 44917 VEV_2_3_RA5_01_1236.d 2.8E4 1 1 425 447
R.VAISGSGNVAQYAALK(+14.02).A Y 55.71 1561.8463 16 -17.8 781.9166 2 73.58 6 40506 VEV_3_3_RA6_01_1237.d 2.08E4 1 1 224 239 Methylation(KR)
K.GKSVWYGPGK.A Y 52.78 1077.5607 10 -14.8 539.7797 2 37.49 6 17047 VEV_3_3_RA6_01_1237.d 2.26E4 1 1 366 375
K.AIEFGGTVC(+57.02)SLSDSKGSLIAR.E Y 51.67 2167.0942 21 -8.6 723.3658 3 76.68 4 44448 VEV_1_3_RA4_01_1235.d 7.03E5 3 3 240 260 Carbamidomethylation
R.Q(-17.03)RHLWEGVLTGK.G Y 51.38 1405.7466 12 -12.7 469.5835 3 72.39 4 41101 VEV_1_3_RA4_01_1235.d 1.38E5 2 2 172 183 Pyro-glu from Q
K.GGADFDPK.G Y 48.23 805.3606 8 -9.0 403.6840 2 25.91 4 10596 VEV_1_3_RA4_01_1235.d 3.87E5 2 2 115 122
R.KQLSTLASTDALRER.C Y 45.93 1687.9216 15 -23.1 422.9779 4 57.33 6 28581 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 282 296
K.AANAGGVAVS(-2.02)GLEMAQNAQR.L Y 45.58 1911.9221 20 2.8 638.3164 3 71.59 5 40167 VEV_2_3_RA5_01_1236.d 1.18E5 2 2 376 395 2-amino-3-oxo-butanoic_acid
R.KQ(+.98)LSTLASTDALRER.C Y 44.12 1688.9056 15 12.3 423.2389 4 57.21 4 29456 VEV_1_3_RA4_01_1235.d 0 1 1 282 296 Deamidation (NQ)
K.YTHPD(-18.01)EGK(+14.02)LPSLVTGSNIAGFMK.V Y 43.69 2457.2361 23 23.0 615.3304 4 78.37 4 45773 VEV_1_3_RA4_01_1235.d 8.24E4 1 1 425 447 Dehydration; Methylation(KR)
R.QRHLWEGVLTGK.G Y 43.14 1422.7732 12 -5.4 356.6987 4 65.69 4 35822 VEV_1_3_RA4_01_1235.d 0 1 1 172 183
K.VAEAMKDQGDWW Y 42.31 1434.6238 12 27.8 718.3391 2 75.04 5 42626 VEV_2_3_RA5_01_1236.d 0 2 2 448 459
K.AANAGGVAVSGLEMAQNAQR(+14.02).L Y 41.93 1927.9534 20 -6.1 964.9781 2 73.13 5 41262 VEV_2_3_RA5_01_1236.d 1.48E4 1 1 376 395 Methylation(KR)
K.AIEFGGT(+14.02)VC(+57.02)SLSDSK.G Y 40.22 1583.7501 15 -9.7 792.8747 2 73.91 4 42291 VEV_1_3_RA4_01_1235.d 1.59E5 2 2 240 254 Methylation(others); Carbamidomethylation
K.HIGADID(+6.01)VPAGDIGVSGR.E Y 39.15 1753.8934 18 -16.4 585.6288 3 70.82 6 38461 VEV_3_3_RA6_01_1237.d 6.21E4 1 1 143 160 Replacement of proton by lithium
K.QLSTLASTDALR.E Y 35.64 1274.6830 12 -50.6 638.3165 2 66.23 5 36200 VEV_2_3_RA5_01_1236.d 3.74E4 2 2 283 294
R.EHGGSITPEEIYLIQ(+.98)Q(+.98)IKVER.K Y 32.21 2440.2485 21 -2.5 814.4214 3 79.07 5 45440 VEV_2_3_RA5_01_1236.d 1.3E3 1 1 261 281 Deamidation (NQ)
R.ELASTLENSTLFDQHPEYR.R Y 30.62 2249.0601 19 -17.3 750.6810 3 76.80 6 42853 VEV_3_3_RA6_01_1237.d 2.74E4 1 1 16 34
K.QLSTLAS(+79.97)TDALR.E Y 30.39 1354.6493 12 9.0 339.6726 4 16.02 4 5319 VEV_1_3_RA4_01_1235.d 3.24E5 1 1 283 294 Phosphorylation (STY)
K.AANAGGVAVSGLEM(-4.99)AQNAQR.L Y 30.03 1908.9514 20 -16.8 637.3137 3 71.59 6 39059 VEV_3_3_RA6_01_1237.d 2.89E4 1 1 376 395 Methionine replacement by azido homoalanine
R.FHPTVNMSILK.F Y 27.29 1285.6853 11 -15.2 429.5625 3 70.26 6 38049 VEV_3_3_RA6_01_1237.d 7.41E4 1 1 83 93
K.FLGFE(+14.02)QIFK.N Y 26.24 1141.6172 9 -10.5 571.8099 2 86.27 4 51414 VEV_1_3_RA4_01_1235.d 4.15E4 1 1 94 102 Methylation(others)
R.VAISGSGNVAQYAALK(+226.08).A Y 26.22 1773.9083 16 -13.2 887.9497 2 84.63 6 48229 VEV_3_3_RA6_01_1237.d 9.48E4 1 1 224 239 Biotinylation
R.L(+71.04)TWTAAEVDEK.L Y 25.47 1332.6561 11 -16.4 667.3244 2 32.99 6 14521 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 396 406 Propionamide (K, X@N-term)
R.VQFNSALGPYK(+42.01).G Y 24.42 1264.6451 11 1.0 317.1689 4 14.23 5 4613 VEV_2_3_RA5_01_1236.d 0 1 1 68 78 Acetylation (K)
R.VTWENDKGGLEVNR(+14.02).G Y 23.84 1629.8110 14 1.0 544.2781 3 62.20 6 32051 VEV_3_3_RA6_01_1237.d 1.29E5 2 2 51 64 Methylation(KR)
R.FHS(+79.96)KGKSVWYGPGK.A Y 23.69 1656.7719 14 25.2 829.4141 2 90.32 4 53833 VEV_1_3_RA4_01_1235.d 0 1 1 362 375 Sulfation
K.Q(+127.06)LSTLASTDALRER.C Y 22.55 1686.8900 14 -10.4 422.7254 4 57.18 5 29547 VEV_2_3_RA5_01_1236.d 1.86E5 1 1 283 296 N-Succinimidyl-2-morpholine acetate
K.N(+203.08)ALTGLN(+.98)MGGGK.G Y 21.75 1335.6340 12 18.7 446.2270 3 41.86 5 20230 VEV_2_3_RA5_01_1236.d 0 1 1 103 114 HexNAcylation (N); Deamidation (NQ)
K.N(+.98)ALTGLNMGGGK.G Y 21.28 1132.5547 12 13.3 567.2922 2 46.86 4 22942 VEV_1_3_RA4_01_1235.d 1.26E5 3 3 103 114 Deamidation (NQ)
K.QLS(+79.96)TLASTDALR.E Y 20.89 1354.6398 12 7.0 678.3319 2 69.53 5 38650 VEV_2_3_RA5_01_1236.d 5.49E4 1 1 283 294 Sulfation
K.A(+226.08)ANAGGVAVSGLEMAQN(+.98)AQR.L Y 20.42 2140.9993 20 0.5 714.6741 3 64.61 5 34976 VEV_2_3_RA5_01_1236.d 5.55E4 1 1 376 395 Biotinylation; Deamidation (NQ)
K.N(+42.01)ALTGLNMGGGKGGADFD(-18.01)PKGK.S Y 20.30 2128.0371 22 0.1 533.0166 4 75.84 4 43787 VEV_1_3_RA4_01_1235.d 4.08E4 1 1 103 124 Acetylation (N-term); Dehydration
K.L(+42.01)PSLVTGSN(+.98)IAGFM(+15.99)K.V Y 19.77 1592.8120 15 3.5 399.2117 4 57.13 5 29560 VEV_2_3_RA5_01_1236.d 4.93E4 1 1 433 447 Acetylation (N-term); Deamidation (NQ); Oxidation (M)
K.QLSTLASTDALR(+21.98).E Y 19.36 1296.6649 12 -3.9 325.1722 4 10.34 4 2594 VEV_1_3_RA4_01_1235.d 0 1 1 283 294 Sodium adduct
R.VQ(+.98)FN(+.98)SALGPYK.G Y 19.00 1224.6027 11 -30.9 613.2897 2 48.97 6 23709 VEV_3_3_RA6_01_1237.d 3.15E4 1 1 68 78 Deamidation (NQ)
K.QLSTLASTD(+21.98)ALR.E Y 18.90 1296.6649 12 3.2 325.1745 4 13.19 4 3901 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 283 294 Sodium adduct
K.N(+42.01)ALTGLNMGGGK(+42.01).G Y 18.76 1215.5918 12 -19.8 406.1965 3 25.93 4 10616 VEV_1_3_RA4_01_1235.d 0 1 1 103 114 Acetylation (N-term); Acetylation (K)
R.TIQFR.V N 18.58 663.3704 5 -29.5 664.3581 1 84.51 5 48871 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 46 50
K.AIEFGGTVC(+57.02)SLSDSK(+31.99).G Y 18.53 1601.7242 15 -2.4 534.9141 3 17.07 5 6147 VEV_2_3_RA5_01_1236.d 2.38E4 1 1 240 254 Carbamidomethylation; Dihydroxy
K.N(+42.01)ALTGLNMGGGKGGADFDPK.G Y 18.42 1960.9313 20 14.7 491.2473 4 29.06 5 12725 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 103 122 Acetylation (N-term)
K.QLSTLASTD(+43.99)ALR(+14.02).E Y 18.36 1332.6885 12 -13.9 334.1748 4 49.69 6 24127 VEV_3_3_RA6_01_1237.d 0 1 1 283 294 Carboxylation (DKW); Methylation(KR)
R.VAISGSGNVAQ(+.98)YAALK(+21.98).A Y 18.12 1570.7966 16 17.8 393.7134 4 56.63 5 29178 VEV_2_3_RA5_01_1236.d 0 1 1 224 239 Deamidation (NQ); Sodium adduct
K.GGADFDPKGK.S Y 17.98 990.4770 10 -9.5 496.2411 2 19.15 6 7131 VEV_3_3_RA6_01_1237.d 4.89E4 1 1 115 124
R.VAISGSGNVAQY(+79.97)AALK(+42.01).A Y 17.43 1669.8076 16 6.1 835.9161 2 81.35 5 46931 VEV_2_3_RA5_01_1236.d 3.77E4 1 1 224 239 Phosphorylation (STY); Acetylation (K)
K.LPS(+79.97)LVTGSNIAGFM(+15.99)K.V Y 17.34 1629.7837 15 -5.1 544.2657 3 69.33 4 38690 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 433 447 Phosphorylation (STY); Oxidation (M)
R.VQFN(+.98)SALGPY(+79.97)KGGLR.F Y 17.03 1686.8130 15 23.9 563.2917 3 45.67 6 21798 VEV_3_3_RA6_01_1237.d 9.54E3 1 1 68 82 Deamidation (NQ); Phosphorylation (STY)
K.QLSTLAS(+79.97)TD(+21.98)ALR.E Y 17.00 1376.6312 12 39.2 345.1786 4 11.81 6 3302 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 283 294 Phosphorylation (STY); Sodium adduct
K.N(-15.01)ALTGLNMGGGK.G Y 16.42 1116.5597 12 -29.4 559.2707 2 44.77 5 21999 VEV_2_3_RA5_01_1236.d 4.43E4 1 1 103 114 ISD (z+2)-series
K.G(+42.01)SLIAR(+14.02).E Y 16.42 671.3966 6 -25.3 672.3869 1 34.41 6 15320 VEV_3_3_RA6_01_1237.d 2.2E5 1 1 255 260 Acetylation (N-term); Methylation(KR)
K.N(+.98)ALTGLNM(+15.99)GGGK.G Y 16.41 1148.5496 12 -12.7 575.2748 2 62.85 4 33640 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 103 114 Deamidation (NQ); Oxidation (M)
R.GYRVQFNS(+79.97)ALGPYK(+14.02).G Y 16.35 1692.8025 14 15.0 424.2142 4 33.47 5 15323 VEV_2_3_RA5_01_1236.d 0 1 1 65 78 Phosphorylation (STY); Methylation(KR)
K.R(+31.99)VAISGSGNVAQYAALK(+42.01).A Y 16.34 1777.9323 17 -14.1 445.4841 4 64.73 4 35065 VEV_1_3_RA4_01_1235.d 6.39E5 1 1 223 239 Dihydroxy; Acetylation (K)
R.KQLST(+79.97)LASTDALR.E Y 16.04 1482.7443 13 -2.1 495.2543 3 64.26 4 34703 VEV_1_3_RA4_01_1235.d 1.85E4 1 1 282 294 Phosphorylation (STY)
R.ALAVAAVPERT(+79.97)IQFR.V Y 15.93 1720.9025 15 24.8 345.1963 5 51.56 4 25869 VEV_1_3_RA4_01_1235.d 0 1 1 36 50 Phosphorylation (STY)
K.HIGADIDVPAGDIGVS(+79.96)GR.E Y 15.84 1827.8420 18 17.3 457.9757 4 12.06 5 3474 VEV_2_3_RA5_01_1236.d 3.51E5 1 1 143 160 Sulfation
R.LTWTAAEVDEK(+14.02)LK(+226.08).Q Y 15.43 1742.8912 13 4.0 436.7318 4 55.88 4 28551 VEV_1_3_RA4_01_1235.d 0 1 1 396 408 Methylation(KR); Biotinylation
R.VQFNS(+79.97)ALGPYK(+28.03).G Y 15.30 1330.6322 11 16.6 333.6708 4 27.59 6 11553 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 68 78 Phosphorylation (STY); Dimethylation(KR)
K.G(+42.01)GLEVNR(+14.02).G Y 15.28 799.4188 7 11.5 400.7213 2 30.58 4 13167 VEV_1_3_RA4_01_1235.d 3.14E5 1 1 58 64 Acetylation (N-term); Methylation(KR)
K.FLGFEQIFK(+21.98).N Y 15.03 1149.5834 9 -46.4 575.7723 2 47.09 6 22616 VEV_3_3_RA6_01_1237.d 0 1 1 94 102 Sodium adduct
total 85 peptides
C1G989
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLFDENYNLANTQQR.K Y 120.91 1811.8438 15 -8.8 906.9211 2 75.02 4 43161 VEV_1_3_RA4_01_1235.d 6.21E5 4 4 633 647
K.AIYQEIIINAVAR.S Y 105.75 1472.8351 13 -15.8 737.4131 2 81.76 6 46378 VEV_3_3_RA6_01_1237.d 1.89E5 3 3 295 307
R.VLSEEGPGYVAAK.F Y 103.26 1318.6769 13 -9.8 660.3392 2 57.20 4 29486 VEV_1_3_RA4_01_1235.d 4.75E5 7 7 102 114
R.SLFDENYNLANTQQRK.N Y 103.14 1939.9387 16 -8.1 647.6483 3 69.16 4 38562 VEV_1_3_RA4_01_1235.d 2.01E5 2 2 633 648
R.SASSLPDNHEQQLR.C Y 101.26 1580.7543 14 -5.8 527.9223 3 37.96 4 17516 VEV_1_3_RA4_01_1235.d 2.05E6 11 11 243 256
K.YC(+57.02)AIVDGSGVIVDPQGLDHDELVR.L Y 98.55 2626.2698 24 -8.2 876.4233 3 80.23 4 47194 VEV_1_3_RA4_01_1235.d 2.5E5 2 2 803 826 Carbamidomethylation
K.EGSGTGTPTTGFQRPPLINK.Q Y 98.45 2057.0542 20 -9.9 686.6852 3 65.22 4 35519 VEV_1_3_RA4_01_1235.d 4.85E5 3 3 54 73
R.SFDMFVPC(+57.02)GGRPESIDLSNVSR.L Y 90.98 2469.1416 22 -16.5 824.0409 3 80.71 6 45659 VEV_3_3_RA6_01_1237.d 3.97E5 4 4 881 902 Carbamidomethylation
R.TPGRQPSPQPTHLGIPGGTHR.V Y 87.80 2190.1406 21 -12.7 439.0298 5 49.89 4 24870 VEV_1_3_RA4_01_1235.d 1.4E6 5 5 81 101
R.EDGTIPNFYVEYVREVQEIIQR.N Y 83.57 2696.3445 22 -35.0 675.0698 4 92.48 4 55028 VEV_1_3_RA4_01_1235.d 0 1 1 974 995
R.KMQTGGPDGDLGSNEILLGNEK.Y Y 80.73 2272.1006 22 -13.2 758.3641 3 69.72 4 38997 VEV_1_3_RA4_01_1235.d 9.71E4 2 2 781 802
K.IGLETILERVPISYLR.S Y 79.06 1871.0880 16 -12.4 624.6956 3 87.80 4 52381 VEV_1_3_RA4_01_1235.d 1.75E5 3 3 1061 1076
R.VLSEEGPGYVAAKFEGK.K Y 76.92 1779.9043 17 -12.3 594.3014 3 70.10 5 39067 VEV_2_3_RA5_01_1236.d 6.7E5 5 5 102 118
K.TNFYTPTK.V Y 75.83 970.4760 8 -9.8 486.2405 2 44.53 4 21464 VEV_1_3_RA4_01_1235.d 1.38E6 9 9 562 569
R.VLVDESNVVLPSGEVVHNGTVFR.N Y 74.79 2465.2915 23 -13.5 822.7600 3 78.61 4 45956 VEV_1_3_RA4_01_1235.d 1.94E5 3 3 849 871
K.TVVSENDEMVMNSFR.I Y 72.74 1756.7760 15 -6.3 879.3898 2 75.46 5 42918 VEV_2_3_RA5_01_1236.d 1.73E5 3 3 539 553
K.GVILLDVNHQNK.A Y 70.48 1348.7463 12 -19.4 450.5807 3 62.61 4 33458 VEV_1_3_RA4_01_1235.d 3.06E5 3 3 659 670
R.LQVDEPLDQEGLDK.L Y 67.19 1597.7834 14 -9.4 799.8915 2 70.60 4 39687 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 521 534
K.AGC(+57.02)VIFKDASVNK.G Y 67.15 1407.7180 13 -3.9 704.8635 2 56.10 5 28825 VEV_2_3_RA5_01_1236.d 9.44E4 3 3 933 945 Carbamidomethylation
K.NAYRVETFR.S Y 61.89 1154.5833 9 -9.2 385.8648 3 45.68 4 22222 VEV_1_3_RA4_01_1235.d 1.49E6 8 8 234 242
K.SRDKEAYAINAR.S Y 61.62 1392.7109 12 -11.8 465.2388 3 24.44 5 10158 VEV_2_3_RA5_01_1236.d 5.42E4 4 4 621 632
R.SASSLPDNHEQQLR(+14.02).C Y 61.56 1594.7699 14 -8.2 532.5929 3 48.34 4 23846 VEV_1_3_RA4_01_1235.d 3.61E5 4 4 243 256 Methylation(KR)
R.KNKDIPEGGAK.G Y 61.11 1155.6248 11 -17.1 578.8098 2 11.04 5 2981 VEV_2_3_RA5_01_1236.d 3.15E4 2 2 648 658
K.NKDIPEGGAK.G Y 59.31 1027.5298 10 -11.8 514.7661 2 13.00 5 3993 VEV_2_3_RA5_01_1236.d 9.38E4 4 4 649 658
K.GVILLDVNHQNKAR.V Y 57.87 1575.8845 14 -23.3 526.2899 3 57.03 6 28389 VEV_3_3_RA6_01_1237.d 1.76E5 3 3 659 672
R.Q(-17.03)GSAMGMFSALSDLYHYYR.L Y 57.53 2178.9502 19 7.3 1090.4904 2 92.96 6 52742 VEV_3_3_RA6_01_1237.d 1.4E5 2 2 331 349 Pyro-glu from Q
R.AMIVEFDKSKLSPEGYR.V Y 56.96 1968.9978 17 2.1 493.2578 4 71.58 4 40465 VEV_1_3_RA4_01_1235.d 2.35E5 3 3 832 848
R.SIFGSYLASR.F Y 55.24 1099.5662 10 2.8 550.7919 2 75.35 5 42844 VEV_2_3_RA5_01_1236.d 2.94E5 3 3 1077 1086
R.EDGTIPNFYVEYVR.E Y 52.31 1700.8046 14 -6.0 851.4044 2 81.67 4 48296 VEV_1_3_RA4_01_1235.d 2.53E4 1 1 974 987
K.YIN(+.98)GC(+57.02)TPK.N Y 46.83 952.4324 8 -11.9 477.2178 2 27.13 4 11265 VEV_1_3_RA4_01_1235.d 2.79E5 2 2 226 233 Deamidation (NQ); Carbamidomethylation
R.SGPVIEMFEIEGSR.E Y 44.55 1549.7446 14 -20.4 775.8638 2 81.47 5 47005 VEV_2_3_RA5_01_1236.d 1.29E5 2 2 308 321
K.LVAN(+.98)GLSSTHFSMSTRPGLSPFSSK.E Y 44.21 2608.2954 25 -28.1 653.0628 4 76.84 4 44568 VEV_1_3_RA4_01_1235.d 0 1 1 29 53 Deamidation (NQ)
R.DKEAYAINAR.S Y 44.21 1149.5778 10 -10.0 384.1960 3 31.95 5 14390 VEV_2_3_RA5_01_1236.d 5.86E5 2 2 623 632
R.VLVDESNVVLPSGEVVHN(+.98)GTVFR.N Y 43.56 2466.2754 23 -7.1 823.0932 3 80.77 4 47618 VEV_1_3_RA4_01_1235.d 8.86E4 2 2 849 871 Deamidation (NQ)
K.IGLETILER.V Y 42.83 1042.6022 9 -9.6 522.3033 2 78.31 4 45723 VEV_1_3_RA4_01_1235.d 2.91E4 1 1 1061 1069
K.SFFTGK.S Y 41.99 685.3435 6 -11.3 343.6752 2 43.46 4 20814 VEV_1_3_RA4_01_1235.d 2.3E5 1 1 737 742
R.EVQEIIQR.N Y 39.96 1013.5505 8 -36.4 507.7641 2 48.03 4 23655 VEV_1_3_RA4_01_1235.d 5.19E4 4 4 988 995
K.LLLEK.I N 39.50 614.4003 5 -20.4 615.3950 1 41.73 6 19496 VEV_3_3_RA6_01_1237.d 4.61E4 1 1 1056 1060
K.VALSFR.L N 38.68 691.4017 6 -9.6 346.7048 2 57.73 4 29811 VEV_1_3_RA4_01_1235.d 5.7E5 5 5 570 575
K.EAPDHAVYIDTSKPGISAFDGPR.Y Y 37.65 2442.1814 23 15.0 611.5618 4 71.01 6 38610 VEV_3_3_RA6_01_1237.d 0 1 1 195 217
R.NTFHLR.E Y 36.93 786.4136 6 -14.6 394.2083 2 29.82 5 13149 VEV_2_3_RA5_01_1236.d 6.21E5 4 4 872 877
R.SMLSDKLSIAITKLDEELQK.T Y 36.52 2261.2188 20 -11.5 566.3055 4 86.44 4 51525 VEV_1_3_RA4_01_1235.d 5.32E4 2 2 1016 1035
K.AGC(+57.02)VIFK.D Y 36.46 793.4156 7 -11.1 397.7107 2 46.98 5 23314 VEV_2_3_RA5_01_1236.d 5.27E5 4 4 933 939 Carbamidomethylation
K.EAPDHAVYIDT(-2.02)SKPGISAFDGPR.Y Y 36.16 2440.1658 23 5.6 611.0521 4 71.17 4 40139 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 195 217 2-amino-3-oxo-butanoic_acid
K.Q(+.98)LEMVIR.T Y 32.88 888.4739 7 -30.3 445.2308 2 63.48 4 34115 VEV_1_3_RA4_01_1235.d 0 1 1 74 80 Deamidation (NQ)
K.S(+79.97)RDKEAYAIN(+.98)AR.S Y 32.33 1473.6613 12 8.6 492.2319 3 40.90 5 19650 VEV_2_3_RA5_01_1236.d 0 1 1 621 632 Phosphorylation (STY); Deamidation (NQ)
R.VLSE(+14.02)EGPGYVAAK.F Y 29.38 1332.6925 13 -10.5 667.3466 2 63.48 4 34118 VEV_1_3_RA4_01_1235.d 1.6E4 1 1 102 114 Methylation(others)
K.LGGIPHDR.Y Y 28.55 863.4613 8 -14.0 432.7319 2 27.46 5 11838 VEV_2_3_RA5_01_1236.d 1.5E5 2 2 746 753
K.LGIDPSTVR.K Y 28.55 956.5291 9 -13.1 479.2655 2 61.46 4 32574 VEV_1_3_RA4_01_1235.d 2.25E5 3 3 772 780
K.TT(-2.02)IPYIVEGANLFLTQDSK.L Y 28.27 2107.0837 19 -11.9 703.3602 3 87.95 6 50198 VEV_3_3_RA6_01_1237.d 0 1 1 909 927 2-amino-3-oxo-butanoic_acid
K.LSPEGYR.V Y 28.24 820.4079 7 -2.3 411.2103 2 32.32 5 14623 VEV_2_3_RA5_01_1236.d 3.97E5 1 1 842 848
R.YGMTTLSVR.Q Y 28.11 1026.5168 9 -11.1 514.2600 2 63.77 5 34370 VEV_2_3_RA5_01_1236.d 0 1 1 754 762
R.S(+79.96)AKLLEEKQK(+14.02).Q Y 26.97 1266.6489 10 8.9 423.2274 3 32.56 4 14318 VEV_1_3_RA4_01_1235.d 0 1 1 1108 1117 Sulfation; Methylation(KR)
R.LYGM(+15.99)FLVISSEFR.G Y 24.77 1576.7959 13 7.4 395.2092 4 53.94 5 27559 VEV_2_3_RA5_01_1236.d 1.6E5 2 2 590 602 Oxidation (M)
K.ATANTK(+156.12)AIYQEIIINAVAR.S Y 24.64 2215.2576 19 -63.2 739.3798 3 81.89 5 47280 VEV_2_3_RA5_01_1236.d 6.92E4 1 1 289 307 4-hydroxynonenal (HNE)
K.LGID(+21.98)PSTVRK.M Y 23.83 1106.6060 10 57.8 369.8972 3 60.46 5 31882 VEV_2_3_RA5_01_1236.d 1.85E5 1 1 772 781 Sodium adduct
R.T(-18.01)PGR(+14.02)QPSPQPTHLGIPGGTHR.V Y 23.77 2186.1458 21 -40.2 438.2188 5 49.68 4 24682 VEV_1_3_RA4_01_1235.d 0 1 1 81 101 Dehydration; Methylation(KR)
R.SMLSDK.L Y 23.14 679.3210 6 -10.2 680.3214 1 72.70 6 39875 VEV_3_3_RA6_01_1237.d 1.58E4 2 2 1016 1021
K.DASVNK.G Y 22.98 632.3129 6 -38.6 633.2958 1 34.36 6 15287 VEV_3_3_RA6_01_1237.d 0 1 1 940 945
R.LVIAYR.Q Y 22.71 733.4486 6 -15.0 367.7261 2 56.70 5 29214 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 325 330
R.IFNN(+.98)AVLK(+31.99).T Y 22.54 950.5073 8 -22.1 476.2504 2 46.76 4 22861 VEV_1_3_RA4_01_1235.d 0 1 1 554 561 Deamidation (NQ); Dihydroxy
R.N(+.98)TFHLR.E Y 21.03 787.3976 6 27.3 394.7169 2 30.14 5 13339 VEV_2_3_RA5_01_1236.d 2.86E5 2 2 872 877 Deamidation (NQ)
K.ATANTK(+14.02).A Y 20.24 618.3337 6 -27.7 619.3239 1 81.67 4 48329 VEV_1_3_RA4_01_1235.d 0 1 1 289 294 Methylation(KR)
K.RAM(+15.99)IVEFDK.S Y 20.08 1123.5696 9 -5.1 1124.5712 1 87.37 5 50504 VEV_2_3_RA5_01_1236.d 2.3E4 1 1 831 839 Oxidation (M)
K.LDEELQK(+14.02)T(+79.96)QLWEDRELR.K Y 19.84 2294.0847 17 -6.8 574.5245 4 73.76 6 40642 VEV_3_3_RA6_01_1237.d 4.7E4 1 1 1029 1045 Methylation(KR); Sulfation
R.KLGIDP(+31.99)S(+79.97)TVRK.M Y 19.72 1324.6752 11 -27.3 332.1670 4 56.80 4 29166 VEV_1_3_RA4_01_1235.d 0 1 1 771 781 Dihydroxy; Phosphorylation (STY)
R.KN(+.98)K(+14.02)DIPEGGAK.G Y 19.58 1170.6244 11 -14.7 391.2097 3 53.06 6 26090 VEV_3_3_RA6_01_1237.d 4.35E5 1 1 648 658 Deamidation (NQ); Methylation(KR)
R.YGM(+15.99)TTLSVR.Q Y 18.96 1042.5117 9 -11.4 522.2572 2 48.80 4 24120 VEV_1_3_RA4_01_1235.d 8E4 1 1 754 762 Oxidation (M)
K.DASVN(-17.03)K.G Y 18.55 615.2864 6 -7.1 616.2893 1 41.81 4 19790 VEV_1_3_RA4_01_1235.d 2.53E5 1 1 940 945 Ammonia-loss (N)
K.S(+79.97)PKLGGIPHDR(+14.02).Y Y 17.62 1269.6230 11 36.1 424.2302 3 42.86 6 20165 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 743 753 Phosphorylation (STY); Methylation(KR)
R.SGPVIEMFEIEGSR(+14.02).E Y 17.61 1563.7603 14 -2.0 782.8858 2 83.06 4 49266 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 308 321 Methylation(KR)
K.LGGIPHD(-18.01)R.Y Y 17.56 845.4507 8 -15.8 423.7260 2 38.05 5 17960 VEV_2_3_RA5_01_1236.d 2.85E5 1 1 746 753 Dehydration
K.L(+42.01)GIDPS(+79.97)TVRK.M Y 17.56 1206.6010 10 -3.5 403.2062 3 41.43 5 19977 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 772 781 Acetylation (N-term); Phosphorylation (STY)
K.SKLSPEGYR(+14.02).V Y 17.01 1049.5505 9 -12.0 350.8532 3 33.27 5 15149 VEV_2_3_RA5_01_1236.d 3.51E5 1 1 840 848 Methylation(KR)
R.LAADFLPEHEYPQR(+28.03).L Y 16.93 1712.8522 14 9.7 429.2245 4 48.83 6 23631 VEV_3_3_RA6_01_1237.d 0 1 1 576 589 Dimethylation(KR)
K.EIS(+79.97)LLYC(+57.02)IPQNK(+28.03).F Y 16.90 1584.7622 12 15.3 397.2039 4 35.98 4 16330 VEV_1_3_RA4_01_1235.d 0 1 1 396 407 Phosphorylation (STY); Carbamidomethylation; Dimethylation(KR)
K.EAYAINAR(+28.03).S Y 16.89 934.4872 8 -23.9 468.2397 2 62.63 5 33506 VEV_2_3_RA5_01_1236.d 1.99E5 1 1 625 632 Dimethylation(KR)
R.QYVLGIYRK.L Y 16.83 1138.6499 9 -10.8 380.5532 3 60.77 4 32061 VEV_1_3_RA4_01_1235.d 9.09E4 1 1 763 771
K.KKQ(+.98)MEAVMDELEEK.G Y 16.73 1707.8059 14 27.6 570.2916 3 33.20 4 14679 VEV_1_3_RA4_01_1235.d 0 1 1 119 132 Deamidation (NQ)
K.HPPIEAAIHQ(+.98)IMK.E Y 16.56 1484.7809 13 34.0 743.4230 2 70.57 4 39660 VEV_1_3_RA4_01_1235.d 4E4 1 1 383 395 Deamidation (NQ)
R.D(+42.01)K(+42.01)EAYAINAR.S Y 16.50 1233.5989 10 -0.1 412.2068 3 12.75 5 3836 VEV_2_3_RA5_01_1236.d 1.55E4 1 1 623 632 Acetylation (N-term); Acetylation (K)
K.E(+21.98)AYAINAR.S Y 16.46 928.4379 8 21.6 465.2362 2 24.31 6 9844 VEV_3_3_RA6_01_1237.d 0 1 1 625 632 Sodium adduct
R.FLQKAT(+79.97)ANTK(+42.01).A Y 16.37 1242.6010 10 -9.3 622.3020 2 64.05 6 33408 VEV_3_3_RA6_01_1237.d 0 1 1 285 294 Phosphorylation (STY); Acetylation (K)
R.LYGMFLVIS(+79.97)SEFR.G Y 16.26 1640.7673 13 21.8 821.4088 2 97.94 6 54652 VEV_3_3_RA6_01_1237.d 0 1 1 590 602 Phosphorylation (STY)
K.YINGC(+57.02)TPKNAY(-18.01)R.V Y 16.18 1437.6823 12 26.9 719.8677 2 74.93 6 41494 VEV_3_3_RA6_01_1237.d 6.86E4 1 1 226 237 Carbamidomethylation; Dehydration
K.LSPEGYR(+14.02).V Y 16.05 834.4235 7 8.1 835.4376 1 97.33 4 57280 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 842 848 Methylation(KR)
K.LS(-18.01)PEGYR(+14.02).V Y 15.84 816.4130 7 -1.3 409.2132 2 31.78 5 14287 VEV_2_3_RA5_01_1236.d 4E5 1 1 842 848 Dehydration; Methylation(KR)
K.LGGIPHDR(+21.98).Y Y 15.67 885.4432 8 -19.4 886.4333 1 107.64 6 57471 VEV_3_3_RA6_01_1237.d 0 1 1 746 753 Sodium adduct
R.LTS(+79.97)SR(+14.02).K Y 15.66 656.2894 5 59.7 657.3359 1 82.06 5 47395 VEV_2_3_RA5_01_1236.d 2.3E4 1 1 350 354 Phosphorylation (STY); Methylation(KR)
K.HPPIEAAIHQIMK.E Y 15.57 1483.7969 13 12.0 371.9609 4 47.53 4 23341 VEV_1_3_RA4_01_1235.d 0 1 1 383 395
K.SFFTGKSPK.L Y 15.39 997.5233 9 -12.7 333.5108 3 37.94 4 17478 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 737 745
K.VAAYAR.D Y 15.33 649.3547 6 -11.5 325.6809 2 34.41 4 15396 VEV_1_3_RA4_01_1235.d 1.2E6 1 1 178 183
K.TTIPYIVE(+21.98)GANLFLTQDSK.L Y 15.17 2131.0813 19 -30.4 533.7614 4 64.58 5 34961 VEV_2_3_RA5_01_1236.d 0 1 1 909 927 Sodium adduct
R.LYGMFLVISSEFR.G Y 15.16 1560.8010 13 5.3 391.2096 4 64.22 4 34682 VEV_1_3_RA4_01_1235.d 9.76E4 1 1 590 602
total 94 peptides
C1GLM2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAHEGPISGSLESK.Y Y 141.80 1397.6786 14 -13.9 699.8369 2 37.94 6 17349 VEV_3_3_RA6_01_1237.d 3.79E6 15 15 48 61
K.AANDLLNKDFYHTC(+57.02)AANLEVK.S Y 135.65 2406.1638 21 -8.4 803.0552 3 73.76 5 41709 VEV_2_3_RA5_01_1236.d 1.17E6 4 4 13 33 Carbamidomethylation
R.GIAALAYNVLLRPGVTLGLGASFDTQK.L Y 113.88 2744.5225 27 -8.4 915.8405 3 91.42 4 54459 VEV_1_3_RA4_01_1235.d 7.37E5 7 7 256 282
R.AFFDLLKGPTANIDAVLGHEGFLVGAEGGYDVQK.A Y 108.79 3547.7986 34 -1.0 887.9561 4 91.18 5 52481 VEV_2_3_RA5_01_1236.d 9.46E5 8 8 141 174
K.VGNTVGLEVSSK.Y Y 99.95 1188.6350 12 -14.5 595.3162 2 52.17 6 25602 VEV_3_3_RA6_01_1237.d 1.67E6 12 12 228 239
K.GLKAEILTQYLPSSQSK.G Y 99.59 1862.0149 17 -15.7 621.6692 3 76.53 6 42674 VEV_3_3_RA6_01_1237.d 8.66E5 3 3 108 124
K.LNLYFKQPNIHAR.A Y 94.36 1612.8838 13 -16.4 404.2216 4 65.78 6 34716 VEV_3_3_RA6_01_1237.d 1.19E6 4 4 128 140
K.SKAPNGVTFNVK.G Y 93.22 1260.6826 12 -9.5 631.3426 2 46.93 4 23018 VEV_1_3_RA4_01_1235.d 1.05E6 6 6 34 45
K.INDRGIAALAYNVLLRPGVTLGLGASFDTQK.L Y 80.61 3242.7773 31 -17.0 811.6879 4 90.50 4 53933 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 252 282
K.AEILTQYLPSSQSK.G Y 76.71 1563.8145 14 -8.7 782.9077 2 74.63 4 42923 VEV_1_3_RA4_01_1235.d 3.38E5 5 5 111 124
K.VGASFTFEG Y 76.17 913.4181 9 -6.0 914.4199 1 75.03 5 42615 VEV_2_3_RA5_01_1236.d 7.54E5 2 2 290 298
K.GLK(+14.02)AEILTQYLPSSQSK.G Y 73.78 1876.0305 17 -12.4 626.3430 3 77.69 4 45238 VEV_1_3_RA4_01_1235.d 1.44E5 2 2 108 124 Methylation(KR)
R.VNAQVEAGAK.A Y 71.88 985.5192 10 -7.3 493.7633 2 20.41 4 7610 VEV_1_3_RA4_01_1235.d 3.1E5 6 6 212 221
K.YSAAVAYSVSEYTAAITASNNLSLFSASYYHR.V Y 70.33 3476.6523 32 -9.3 1159.8806 3 88.97 6 50776 VEV_3_3_RA6_01_1237.d 4.46E4 1 1 180 211
K.SKAPN(+.98)GVTFNVK.G Y 67.82 1261.6666 12 -11.3 421.5581 3 49.08 4 24301 VEV_1_3_RA4_01_1235.d 1.63E6 11 11 34 45 Deamidation (NQ)
K.APNGVTFNVK.G Y 66.76 1045.5557 10 -12.0 523.7788 2 57.76 5 29953 VEV_2_3_RA5_01_1236.d 3.52E5 2 2 36 45
M.PSPPAFSDIAK.A Y 64.53 1128.5814 11 -18.0 565.2878 2 65.58 6 34568 VEV_3_3_RA6_01_1237.d 1.75E6 5 5 2 12
R.SAHE(+14.02)GPISGSLESK.Y Y 63.49 1411.6943 14 -9.3 706.8479 2 47.60 4 23386 VEV_1_3_RA4_01_1235.d 4.32E5 3 3 48 61 Methylation(others)
R.SAHEGPISGSLESK(+14.02).Y Y 63.03 1411.6943 14 -16.3 706.8430 2 46.73 6 22407 VEV_3_3_RA6_01_1237.d 7.58E5 7 7 48 61 Methylation(KR)
K.YRLDPSSFAK.A Y 62.40 1182.6033 10 -17.9 395.2013 3 63.96 6 33334 VEV_3_3_RA6_01_1237.d 7.21E5 3 3 240 249
K.AANDLLNKDFYHTC(+57.02)AANLEVK(+14.02).S Y 58.23 2420.1794 21 -16.8 606.0420 4 75.58 4 43579 VEV_1_3_RA4_01_1235.d 2.55E5 2 2 13 33 Carbamidomethylation; Methylation(KR)
K.GRSAHEGPISGSLESK.Y Y 57.75 1610.8011 16 0.3 537.9412 3 32.13 4 14070 VEV_1_3_RA4_01_1235.d 3.69E4 1 1 46 61
K.APN(+.98)GVTFNVK.G Y 56.85 1046.5397 10 -17.2 524.2681 2 61.15 6 31273 VEV_3_3_RA6_01_1237.d 3.11E5 4 4 36 45 Deamidation (NQ)
K.ATWDSKVGNTVGLEVSSK.Y Y 56.77 1876.9530 18 -16.5 626.6479 3 68.52 6 36803 VEV_3_3_RA6_01_1237.d 2.37E5 2 2 222 239
K.GLKAEILTQYLPSSQSK(+14.02).G Y 56.32 1876.0305 17 -13.0 626.3427 3 76.78 4 44555 VEV_1_3_RA4_01_1235.d 1.13E5 2 2 108 124 Methylation(KR)
R.AFFDLLK.G Y 54.56 852.4745 7 -11.6 427.2396 2 82.07 4 48596 VEV_1_3_RA4_01_1235.d 4.23E5 3 3 141 147
K.Q(-17.03)PNIHAR.A Y 53.13 817.4195 7 -8.0 409.7137 2 27.98 4 11765 VEV_1_3_RA4_01_1235.d 9.4E5 4 4 134 140 Pyro-glu from Q
R.AFFDLLKGPT(-2.02)ANIDAVLGHEGFLVGAEGGYDVQK.A Y 50.82 3545.7830 34 -3.5 887.4500 4 91.34 4 54416 VEV_1_3_RA4_01_1235.d 0 1 1 141 174 2-amino-3-oxo-butanoic_acid
K.GAKLNLYFKQPNIHAR.A Y 50.80 1869.0372 16 -24.2 374.8057 5 63.35 5 34044 VEV_2_3_RA5_01_1236.d 1.66E5 2 2 125 140
R.LDPSSFAK.A Y 50.09 863.4388 8 -10.8 432.7220 2 58.36 4 30265 VEV_1_3_RA4_01_1235.d 1.52E6 9 9 242 249
K.AAN(+.98)DLLN(+.98)KDFYHTC(+57.02)AANLEVK.S Y 46.87 2408.1318 21 5.5 603.0435 4 73.82 5 41753 VEV_2_3_RA5_01_1236.d 6.65E4 1 1 13 33 Deamidation (NQ); Carbamidomethylation
R.S(+14.02)AHEGPISGSLESK.Y Y 44.19 1411.6943 14 -10.3 471.5672 3 47.67 4 23424 VEV_1_3_RA4_01_1235.d 4.62E5 1 1 48 61 Methylation(others)
K.VGNTVGLE(+14.02)VSSK.Y Y 40.43 1202.6506 12 -28.9 602.3152 2 58.71 4 30516 VEV_1_3_RA4_01_1235.d 0 1 1 228 239 Methylation(others)
K.LNLYFK.Q Y 40.31 796.4483 6 -10.1 399.2274 2 68.97 4 38435 VEV_1_3_RA4_01_1235.d 4.58E5 2 2 128 133
R.KPSPTRLT(+79.97)M(+15.99)IQ(+.98)TWTTANSLDTKLELDNTIVK.G Y 37.62 3611.8157 31 -9.9 903.9523 4 91.01 4 54210 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 77 107 Phosphorylation (STY); Oxidation (M); Deamidation (NQ)
R.SAHEGPISGSLES(-18.01)K(+14.02).Y Y 36.98 1393.6837 14 -10.6 697.8417 2 38.03 5 17950 VEV_2_3_RA5_01_1236.d 5.29E3 1 1 48 61 Dehydration; Methylation(KR)
K.AANDLLNK(-1.03)DFYHTC(+57.02)AANLEVK.S Y 36.39 2405.1321 21 29.9 1203.6093 2 73.77 5 41718 VEV_2_3_RA5_01_1236.d 2.23E5 2 2 13 33 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
K.AAN(+.98)DLLNKDFYHTC(+57.02)AANLEVK.S Y 36.20 2407.1477 21 -6.8 602.7901 4 73.91 6 40751 VEV_3_3_RA6_01_1237.d 2.4E5 1 1 13 33 Deamidation (NQ); Carbamidomethylation
K.LNLYFKQPNIHAR(+14.02).A Y 26.56 1626.8994 13 -11.6 407.7274 4 67.06 6 35670 VEV_3_3_RA6_01_1237.d 4.77E4 1 1 128 140 Methylation(KR)
R.AFFDLLK(+14.02).G Y 26.34 866.4902 7 -11.2 434.2475 2 83.86 5 48470 VEV_2_3_RA5_01_1236.d 3.63E4 1 1 141 147 Methylation(KR)
K.GLKAEILTQ(+.98)YLPSSQSK(+14.02).G Y 25.16 1877.0145 17 -40.3 626.6536 3 76.65 6 42745 VEV_3_3_RA6_01_1237.d 1.97E4 1 1 108 124 Deamidation (NQ); Methylation(KR)
R.LDPSSFAK(+14.02).A Y 24.89 877.4545 8 -22.9 439.7245 2 64.16 6 33479 VEV_3_3_RA6_01_1237.d 9.36E4 1 1 242 249 Methylation(KR)
R.VNAQ(+.98)VEAGAK(+14.02).A Y 23.82 1000.5189 10 -30.1 501.2517 2 27.76 6 11743 VEV_3_3_RA6_01_1237.d 0 2 2 212 221 Deamidation (NQ); Methylation(KR)
K.LN(+.98)LYFKQ(+.98)PNIHAR.A Y 23.19 1614.8518 13 -0.6 404.7200 4 65.96 5 36003 VEV_2_3_RA5_01_1236.d 1.84E5 2 2 128 140 Deamidation (NQ)
R.LTMIQ(+.98)TWTTANS(-18.01)LDTK.L Y 23.12 1805.8870 16 1.2 362.1851 5 23.15 5 9424 VEV_2_3_RA5_01_1236.d 0 1 1 83 98 Deamidation (NQ); Dehydration
K.AANDLLNK.D Y 22.83 857.4606 8 -22.2 429.7281 2 15.14 5 5126 VEV_2_3_RA5_01_1236.d 2.51E5 1 1 13 20
R.VN(+.98)AQVEAGAK(+42.01).A Y 22.35 1028.5138 10 -0.7 515.2638 2 14.65 5 4882 VEV_2_3_RA5_01_1236.d 0 1 1 212 221 Deamidation (NQ); Acetylation (K)
K.VGNTVGLEVSSK(+14.02).Y Y 22.10 1202.6506 12 -36.7 602.3105 2 58.76 6 29546 VEV_3_3_RA6_01_1237.d 0 1 1 228 239 Methylation(KR)
R.SAHEGPISGS(-2.02)LESK.Y Y 21.99 1395.6630 14 23.6 466.2393 3 38.99 4 18099 VEV_1_3_RA4_01_1235.d 4.81E4 1 1 48 61 2-amino-3-oxo-butanoic_acid
K.GRSAHEGPISGSLES(-18.01)K.Y Y 21.36 1592.7906 16 -2.5 797.4006 2 85.75 5 49595 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 46 61 Dehydration
K.LHQSAH(+15.99)K.V Y 20.38 835.4301 7 -16.9 418.7152 2 31.58 6 13760 VEV_3_3_RA6_01_1237.d 0 1 1 283 289 Oxidation (HW)
K.ASPDTPR.K Y 20.29 742.3610 7 -1.5 743.3671 1 79.74 5 45881 VEV_2_3_RA5_01_1236.d 2.2E5 2 2 70 76
K.SKAPNGVTF(+31.99)NVK(+14.02).G Y 20.26 1306.6881 12 -18.1 654.3395 2 77.18 5 44151 VEV_2_3_RA5_01_1236.d 0 1 1 34 45 Dihydroxy; Methylation(KR)
K.QPN(+.98)IH(+15.99)AR.A Y 19.93 851.4249 7 -41.5 852.3969 1 79.92 6 45107 VEV_3_3_RA6_01_1237.d 2.24E4 1 1 134 140 Deamidation (NQ); Oxidation (HW)
K.A(+42.01)EILTQ(+.98)YLPSSQSKGAK(+42.01).L Y 19.72 1904.9730 17 -6.7 953.4874 2 90.49 4 53927 VEV_1_3_RA4_01_1235.d 5.08E4 1 1 111 127 Acetylation (N-term); Deamidation (NQ); Acetylation (K)
R.LDPSS(-18.01)FAK.A Y 18.98 845.4283 8 -2.6 846.4333 1 85.97 5 49719 VEV_2_3_RA5_01_1236.d 8.75E4 1 1 242 249 Dehydration
K.S(+79.97)KAPNGVTFNVK.G Y 18.93 1340.6489 12 -1.1 336.1691 4 19.35 4 7065 VEV_1_3_RA4_01_1235.d 2.18E5 1 1 34 45 Phosphorylation (STY)
K.VGN(+.98)TVGLEVSSK.Y Y 18.85 1189.6190 12 -36.6 595.7950 2 57.65 4 29757 VEV_1_3_RA4_01_1235.d 4.08E4 1 1 228 239 Deamidation (NQ)
K.LHQ(+.98)SAHK.V Y 18.22 820.4191 7 -8.7 411.2133 2 52.92 4 26752 VEV_1_3_RA4_01_1235.d 6.41E4 1 1 283 289 Deamidation (NQ)
R.LDPSSFAK(+27.99).A Y 17.90 891.4338 8 -12.5 892.4299 1 87.55 6 49971 VEV_3_3_RA6_01_1237.d 3.83E4 1 1 242 249 Formylation
K.LNLYFKQ(+.98)PN(+.98)IHAR.A Y 17.61 1614.8518 13 7.2 539.2951 3 73.35 6 40341 VEV_3_3_RA6_01_1237.d 1.65E4 1 1 128 140 Deamidation (NQ)
R.LTMIQT(-18.01)WTTANSLDTK.L Y 17.37 1804.9030 16 23.0 452.2434 4 62.33 6 32141 VEV_3_3_RA6_01_1237.d 0 1 1 83 98 Dehydration
R.LTMIQTWTTANSLDTK(+380.15).L Y 17.29 2203.0605 16 -10.3 441.6148 5 68.19 5 37686 VEV_2_3_RA5_01_1236.d 0 1 1 83 98 Nucleophilic addition to cytopiloyne+H2O
R.SAHEGPISGSLESK(-.98).Y Y 17.13 1396.6946 14 -16.4 699.3431 2 37.77 6 17217 VEV_3_3_RA6_01_1237.d 0 1 1 48 61 Amidation
K.GLKAEILTQY(-2.02)LPSSQSK.G Y 16.98 1859.9993 17 -26.3 620.9907 3 76.77 5 43854 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 108 124 2-amino-3-oxo-butanoic_acid
R.SAHEGP(+13.98)ISGSLESK.Y Y 16.70 1411.6578 14 16.0 706.8475 2 47.72 5 23771 VEV_2_3_RA5_01_1236.d 1.58E5 1 1 48 61 Proline oxidation to pyroglutamic acid
K.APNGVTFN(+.98)VK(+31.99).G Y 16.65 1078.5294 10 -28.5 540.2566 2 44.01 6 20822 VEV_3_3_RA6_01_1237.d 4.5E4 1 1 36 45 Deamidation (NQ); Dihydroxy
K.LHQS(-18.01)AHK.V Y 16.58 801.4246 7 -26.2 802.4108 1 101.60 4 58714 VEV_1_3_RA4_01_1235.d 0 1 1 283 289 Dehydration
K.AANDLLNKDFYHTC(+57.02)AANLEVK(-2.02).S Y 16.48 2404.1482 21 14.2 802.4014 3 73.82 5 41751 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 13 33 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.LTMIQTWTTANSLDTK.L Y 16.46 1822.9136 16 12.3 608.6526 3 82.69 5 47772 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 83 98
MPS(+79.97)PPAFSDIAK(+21.98).A Y 16.38 1361.5702 12 70.6 454.8961 3 40.62 6 18855 VEV_3_3_RA6_01_1237.d 5.92E4 1 1 1 12 Phosphorylation (STY); Sodium adduct
R.VNAQVEAGAKATWDSK(-.98).V Y 15.98 1672.8533 16 -44.3 837.3969 2 82.58 4 48929 VEV_1_3_RA4_01_1235.d 4.29E4 1 1 212 227 Amidation
K.QPNIHAR(+14.02).A Y 15.68 848.4617 7 -71.7 425.2077 2 16.92 5 6064 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 134 140 Methylation(KR)
K.SKAPNGVTFN(+45.99)VK.G Y 15.62 1306.6703 12 -17.6 654.3309 2 77.14 6 43108 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 34 45 Beta-methylthiolation (ND)
K.S(+42.01)KAPNGVTFNVK(+42.01).G Y 15.52 1344.7037 12 -6.3 337.1811 4 21.79 6 8498 VEV_3_3_RA6_01_1237.d 0 1 1 34 45 Acetylation (N-term); Acetylation (K)
R.V(+43.01)NAQVEAGAK(+42.01).A Y 15.11 1070.5356 10 -1.2 536.2745 2 30.19 5 13373 VEV_2_3_RA5_01_1236.d 3.93E4 1 1 212 221 Carbamylation; Acetylation (K)
total 76 peptides
C1FZR2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RENILTSVADIFRYPTLSELALTLK.H Y 135.36 2862.5854 25 -10.3 716.6462 4 93.49 4 55553 VEV_1_3_RA4_01_1235.d 8.02E4 1 1 903 927
K.FSGNIIDIISGESDHISKPLESIR.A Y 104.03 2626.3601 24 -12.3 657.5892 4 84.11 4 49985 VEV_1_3_RA4_01_1235.d 2.63E5 3 3 179 202
R.VLESDILPSLEVLGLGGESVSAR.D Y 103.56 2339.2583 23 -11.4 1170.6230 2 90.28 6 51454 VEV_3_3_RA6_01_1237.d 1.02E5 3 3 562 584
K.SSTVFIKDPTWLVSGGGGIPGR.H Y 101.06 2230.1746 22 -17.2 744.3860 3 80.63 6 45600 VEV_3_3_RA6_01_1237.d 6.48E4 2 2 669 690
R.LLPFGAIGELLIEGQFK.S Y 98.11 1844.0447 17 -11.9 615.6815 3 95.82 4 56663 VEV_1_3_RA4_01_1235.d 2.78E5 5 5 1428 1444
R.NASVVGVDKIEGPMITTVPVR.V Y 92.90 2181.1826 21 -15.7 728.0568 3 77.25 6 43189 VEV_3_3_RA6_01_1237.d 4.29E4 1 1 1216 1236
R.GQGEIAAFSTELQHVLNIMDKELAASLPR.Y Y 88.53 3137.6179 29 -9.0 785.4047 4 97.52 5 55175 VEV_2_3_RA5_01_1236.d 2.06E4 1 1 777 805
K.IIIAYGPSEC(+57.02)TVGC(+57.02)TINNDVHIDR.S Y 86.85 2716.2949 24 -7.7 906.4319 3 78.08 4 45541 VEV_1_3_RA4_01_1235.d 7.61E4 1 1 595 618 Carbamidomethylation
R.YMVPAAYIPLFEMPLLVSC(+57.02)K.T Y 86.50 2341.1924 20 -9.3 1171.5925 2 96.60 4 57003 VEV_1_3_RA4_01_1235.d 6.53E4 1 1 806 825 Carbamidomethylation
R.TSTEQAREPQSEMER.K Y 85.78 1777.7900 15 -4.8 593.6011 3 30.48 4 13112 VEV_1_3_RA4_01_1235.d 6.35E4 1 1 848 862
R.AFETAVADSAILR.T Y 85.67 1362.7142 13 -11.3 682.3567 2 75.44 4 43474 VEV_1_3_RA4_01_1235.d 3.18E5 5 5 1012 1024
R.SLPSALPFSSFVHHVVR.E Y 76.35 1879.0104 17 -44.9 470.7388 4 79.83 6 45039 VEV_3_3_RA6_01_1237.d 5.34E4 2 2 1780 1796
K.DITIATLPSAAWALC(+57.02)LAR.R Y 72.42 1942.0345 18 -10.3 648.3455 3 91.62 6 52130 VEV_3_3_RA6_01_1237.d 1.92E5 3 3 1844 1861 Carbamidomethylation
K.YLSGLNSNESK.S Y 68.03 1210.5830 11 -8.7 606.2935 2 42.34 4 20170 VEV_1_3_RA4_01_1235.d 4.07E5 6 6 1128 1138
R.AEAVGYGPHSR.V Y 67.95 1142.5469 11 6.8 572.2846 2 21.84 6 8522 VEV_3_3_RA6_01_1237.d 0 2 2 493 503
R.LAVRDVTFGEVVSGR.N Y 64.99 1603.8682 15 -25.6 535.6163 3 73.14 4 41692 VEV_1_3_RA4_01_1235.d 6.39E4 1 1 1863 1877
K.ISEAYVAQR.V Y 62.45 1035.5349 9 -16.2 518.7664 2 40.39 6 18715 VEV_3_3_RA6_01_1237.d 3.02E5 4 4 988 996
R.N(+.98)ASVVGVDKIEGPMITTVPVR.V Y 61.48 2182.1667 21 -6.1 728.3917 3 77.36 4 44979 VEV_1_3_RA4_01_1235.d 2.26E4 1 1 1216 1236 Deamidation (NQ)
R.LSDMADIVKDSLSLSTPAK.A Y 60.32 1990.0292 19 -10.4 664.3434 3 82.95 4 49187 VEV_1_3_RA4_01_1235.d 8.78E4 1 1 1577 1595
R.DVTFGEVVSGR.N Y 54.93 1164.5775 11 -9.6 583.2905 2 70.99 4 39990 VEV_1_3_RA4_01_1235.d 3.64E5 4 4 1867 1877
K.TFDISSRPK.D Y 54.07 1049.5505 9 -57.6 525.7523 2 40.42 4 18939 VEV_1_3_RA4_01_1235.d 5.89E5 4 4 1835 1843
K.SATSTSIQSTNWLAAGC(+57.02)R.D Y 53.51 1909.8953 18 -7.0 637.6346 3 72.34 6 39616 VEV_3_3_RA6_01_1237.d 1.9E4 1 1 1445 1462 Carbamidomethylation
R.YELFYLDAAVDRPHLFK.S Y 52.70 2096.0730 17 16.6 525.0342 4 82.06 5 47388 VEV_2_3_RA5_01_1236.d 0 2 2 1654 1670
R.TSTEQAREPQSEM(+15.99)ER.K Y 51.26 1793.7850 15 12.1 598.9429 3 18.34 4 6530 VEV_1_3_RA4_01_1235.d 0 1 1 848 862 Oxidation (M)
K.YNSDGSLVFKGQK.S Y 46.86 1441.7201 13 -11.3 721.8592 2 50.66 4 25280 VEV_1_3_RA4_01_1235.d 2.32E5 2 2 1480 1492
R.VELGEVEHHLR.M Y 40.80 1316.6837 11 -9.0 330.1752 4 56.50 4 28957 VEV_1_3_RA4_01_1235.d 7.7E4 2 2 728 738
R.LFDDSGELVSNLQLMSEEDLAEVWHFSNTSK.Y Y 38.72 3539.6401 31 -14.0 1180.8708 3 95.86 4 56687 VEV_1_3_RA4_01_1235.d 6.13E4 1 1 1370 1400
R.IDR(+14.02)NS(+79.97)R(+14.02)VSEYLR.K Y 38.60 1614.7878 12 11.8 404.7090 4 58.55 6 29404 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 1239 1250 Methylation(KR); Phosphorylation (STY)
R.YGPDGSGSIVFVGR.G Y 35.99 1409.6938 14 -13.5 705.8447 2 72.86 6 39983 VEV_3_3_RA6_01_1237.d 8.55E4 1 1 703 716
R.VVELKDIQTAER.L Y 34.97 1399.7671 12 -7.5 467.5928 3 59.64 4 31215 VEV_1_3_RA4_01_1235.d 7.57E4 3 3 997 1008
K.IQAFPK.G Y 34.24 702.4064 6 -44.2 703.3826 1 38.86 4 18018 VEV_1_3_RA4_01_1235.d 0 1 1 1984 1989
R.RENILTSVADIFR.Y Y 34.14 1532.8311 13 -6.9 384.2124 4 54.07 5 27633 VEV_2_3_RA5_01_1236.d 1.66E4 1 1 903 915
R.NYNMLEK.I Y 30.82 910.4219 7 18.5 456.2266 2 51.49 4 25821 VEV_1_3_RA4_01_1235.d 0 1 1 2057 2063
K.TSSNPRPRC(+57.02)SGAYFDASR.D Y 26.35 2027.9231 18 -13.1 507.9814 4 23.22 5 9461 VEV_2_3_RA5_01_1236.d 0 1 1 2035 2052 Carbamidomethylation
R.N(+42.01)ASVVGVDK.I Y 24.91 929.4818 9 -19.4 930.4711 1 91.23 5 52507 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 1216 1224 Acetylation (N-term)
R.ENILTS(+79.97)VADIFR(+21.98).Y Y 24.82 1478.6782 12 -5.0 740.3427 2 48.35 4 23835 VEV_1_3_RA4_01_1235.d 0 1 1 904 915 Phosphorylation (STY); Sodium adduct
K.ELAASLPR.Y Y 24.71 855.4814 8 -96.5 856.4061 1 112.21 5 59441 VEV_2_3_RA5_01_1236.d 3.11E5 3 3 798 805
R.ISHAQYDEIC(+57.02)LPILLRQLSALYER.R Y 23.75 2900.5217 24 2.0 581.1128 5 107.05 4 60330 VEV_1_3_RA4_01_1235.d 0 1 1 1755 1778 Carbamidomethylation
R.NRPAQTLC(+57.02)IPWDDKVITYSSNSK.K Y 23.71 2692.3279 23 43.0 674.1182 4 83.78 4 49759 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 48 70 Carbamidomethylation
K.L(+27.99)RAIGSAMSR(+14.02)K.E Y 23.52 1230.6866 11 1.8 308.6795 4 29.42 4 12527 VEV_1_3_RA4_01_1235.d 0 1 1 831 841 Formylation; Methylation(KR)
K.KSVFIC(+57.02)K(+42.01).T Y 23.10 922.4946 7 -32.1 462.2398 2 50.28 4 25047 VEV_1_3_RA4_01_1235.d 2.23E5 1 1 1828 1834 Carbamidomethylation; Acetylation (K)
R.AIGSAM(+15.99)SR.K Y 22.84 807.3909 8 41.5 808.4316 1 110.13 5 58877 VEV_2_3_RA5_01_1236.d 2.19E3 2 2 833 840 Oxidation (M)
K.DS(+79.97)LSLSTPAK(+42.01).A Y 22.76 1139.5111 10 22.8 570.7758 2 61.99 5 33031 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 1586 1595 Phosphorylation (STY); Acetylation (K)
K.IGTAVPLC(+57.02)FEK.S Y 22.62 1233.6427 11 -22.4 412.2123 3 30.90 6 13361 VEV_3_3_RA6_01_1237.d 3.23E5 3 3 363 373 Carbamidomethylation
K.LQHIMIDLFGK(+43.01).E Y 22.37 1356.7224 11 -21.5 340.1806 4 40.56 5 19445 VEV_2_3_RA5_01_1236.d 0 1 1 864 874 Carbamylation
K.DYSIFFTN(-17.03)VAHTAEK.Y Y 22.18 1724.8046 15 12.2 432.2137 4 33.48 5 15279 VEV_2_3_RA5_01_1236.d 0 1 1 218 232 Ammonia-loss (N)
K.LQELWSR.I Y 21.76 930.4923 7 -1.7 931.4980 1 96.46 5 54817 VEV_2_3_RA5_01_1236.d 0 1 1 1521 1527
R.NASVVGVD(-18.01)K.I Y 21.47 869.4606 9 -31.7 435.7238 2 52.40 4 26425 VEV_1_3_RA4_01_1235.d 7.51E4 2 2 1216 1224 Dehydration
R.FYKTGDLVR.Y Y 21.25 1097.5869 9 -11.3 366.8654 3 52.74 4 26645 VEV_1_3_RA4_01_1235.d 3.01E5 2 2 694 702
K.VNMAHM(+15.99)TPSVAR.V Y 20.69 1328.6329 12 -21.4 333.1584 4 12.70 6 3763 VEV_3_3_RA6_01_1237.d 0 1 1 550 561 Oxidation (M)
K.I(+42.01)SSRQVSSSVAEGER(+31.99)LWSAENR.F Y 20.37 2521.2156 22 6.1 841.4176 3 85.58 4 50966 VEV_1_3_RA4_01_1235.d 0 1 1 2064 2085 Acetylation (N-term); Dihydroxy
R.L(+27.99)SPDAR.E Y 20.27 685.3395 6 -18.0 686.3344 1 23.80 4 9448 VEV_1_3_RA4_01_1235.d 3.17E4 1 1 1273 1278 Formylation
R.G(+226.08)DQQVK.L Y 20.07 899.4171 6 -12.0 900.4136 1 81.44 6 46168 VEV_3_3_RA6_01_1237.d 2.76E4 1 1 717 722 Biotinylation
R.DMPGR.R Y 20.01 574.2533 5 33.5 575.2798 1 52.06 5 26424 VEV_2_3_RA5_01_1236.d 8.67E4 2 2 1463 1467
K.LQELWSR(+21.98)(+14.02).I Y 19.90 966.4899 7 -29.1 484.2382 2 43.63 5 21290 VEV_2_3_RA5_01_1236.d 5.33E4 1 1 1521 1527 Sodium adduct; Methylation(KR)
K.E(+43.99)LAASLPR.Y Y 19.76 899.4712 8 -8.9 900.4705 1 70.01 5 38995 VEV_2_3_RA5_01_1236.d 0 1 1 798 805 Carboxylation (E)
K.GVGGVTWVVDPADHN(+.98)R(+28.03).L Y 19.65 1706.8376 16 1.4 569.9540 3 83.09 5 48010 VEV_2_3_RA5_01_1236.d 0 1 1 626 641 Deamidation (NQ); Dimethylation(KR)
K.Q(+71.04)EELGHRLLPR.G Y 19.61 1417.7789 11 -8.5 473.5962 3 72.08 4 40857 VEV_1_3_RA4_01_1235.d 6.12E4 1 1 421 431 Propionamide (K, X@N-term)
K.FNTYALM(+15.99)LVC(+57.02)SLDPK.G Y 19.27 1786.8634 15 -9.5 447.7189 4 28.74 6 12179 VEV_3_3_RA6_01_1237.d 0 1 1 1324 1338 Oxidation (M); Carbamidomethylation
R.N(+.98)ASVVGVDK.I Y 18.91 888.4553 9 -13.1 445.2291 2 24.65 6 10055 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 1216 1224 Deamidation (NQ)
K.SC(+57.02)QELISR.N Y 18.73 991.4756 8 -14.1 496.7381 2 35.22 4 15926 VEV_1_3_RA4_01_1235.d 2.77E5 2 2 1671 1678 Carbamidomethylation
R.N(+42.01)(+.98)ASVVGVDK.I Y 18.58 930.4658 9 -5.5 931.4680 1 93.18 4 55408 VEV_1_3_RA4_01_1235.d 9.4E4 1 1 1216 1224 Acetylation (N-term); Deamidation (NQ)
R.DVT(+27.05)FGEVVSGR.N Y 18.30 1191.6248 11 -1.8 398.2148 3 48.47 4 23911 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 1867 1877 Ethyl amino
R.AIGS(-18.01)AMSRK.E Y 18.30 901.4803 9 11.8 451.7527 2 21.03 5 8300 VEV_2_3_RA5_01_1236.d 4.94E4 1 1 833 841 Dehydration
K.YLSGLNSN(+.98)ESK.S Y 18.16 1211.5670 11 -3.2 606.7888 2 42.85 4 20453 VEV_1_3_RA4_01_1235.d 9.17E4 1 1 1128 1138 Deamidation (NQ)
R.FAVLPNKK.T Y 18.14 915.5541 8 -12.3 306.1882 3 41.30 4 19479 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 1073 1080
R.VSEYLR.K Y 18.12 765.4021 6 -17.9 383.7015 2 32.72 6 14374 VEV_3_3_RA6_01_1237.d 2.51E5 1 1 1245 1250
R.GKLHET(+79.97)SQLVK.Y Y 17.88 1318.6646 11 3.7 330.6746 4 56.07 4 28681 VEV_1_3_RA4_01_1235.d 5.7E4 1 1 1469 1479 Phosphorylation (STY)
R.NSALFWTDK.T Y 17.86 1080.5239 9 -16.6 541.2603 2 38.72 4 17945 VEV_1_3_RA4_01_1235.d 3.82E5 2 2 2026 2034
K.FLFVR.C Y 17.79 680.4009 5 -14.1 341.2029 2 70.61 4 39690 VEV_1_3_RA4_01_1235.d 3.19E4 1 1 1739 1743
R.L(+43.01)SPDAR.E Y 17.64 700.3503 6 -11.7 701.3494 1 77.18 5 44155 VEV_2_3_RA5_01_1236.d 4.23E4 1 1 1273 1278 Carbamylation
R.GKLHET(-18.01)SQLVK.Y Y 17.61 1220.6877 11 -13.6 306.1750 4 14.71 5 4877 VEV_2_3_RA5_01_1236.d 2.12E5 1 1 1469 1479 Dehydration
K.DPTWLVS(+60.00)GGGGIPGR.H Y 17.52 1527.7504 15 -15.0 510.2498 3 75.81 6 42137 VEV_3_3_RA6_01_1237.d 0 1 1 676 690 2-OH-ethyl thio-Ser
K.GVGGVTWVVDPADHNR.L Y 17.26 1677.8223 16 -20.1 560.2701 3 70.56 6 38267 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 626 641
K.LVAAAR.R Y 17.25 599.3755 6 18.1 300.7004 2 22.90 6 9076 VEV_3_3_RA6_01_1237.d 0 1 1 897 902
K.E(-18.01)LAASLPR.Y Y 17.22 837.4708 8 -0.3 419.7426 2 34.63 5 15969 VEV_2_3_RA5_01_1236.d 1.6E5 1 1 798 805 Pyro-glu from E
R.R(+42.01)LSPDAREAC(+57.02)ELR.T Y 17.16 1613.7943 13 -5.2 404.4538 4 61.67 4 32735 VEV_1_3_RA4_01_1235.d 4.43E4 1 1 1272 1284 Acetylation (N-term); Carbamidomethylation
R.QVS(-18.01)SSVAEGER.L Y 17.14 1129.5364 11 30.6 565.7927 2 47.01 5 23331 VEV_2_3_RA5_01_1236.d 0 1 1 2068 2078 Dehydration
R.VDAISIE(+21.98)QPLFLNR.N Y 17.02 1635.8596 14 -4.3 328.1778 5 20.80 5 8176 VEV_2_3_RA5_01_1236.d 1.58E5 1 1 118 131 Sodium adduct
K.TFDISSR(+14.02)PK(+43.99).D Y 17.01 1107.5560 9 31.6 370.2043 3 61.74 6 31709 VEV_3_3_RA6_01_1237.d 0 1 1 1835 1843 Methylation(KR); Carboxylation (DKW)
K.QEELGHR.L Y 16.92 867.4199 7 4.1 868.4307 1 90.10 4 53712 VEV_1_3_RA4_01_1235.d 8.86E4 2 2 421 427
K.LHETSQLVK.Y Y 16.84 1053.5818 9 -33.0 352.1896 3 16.09 6 5509 VEV_3_3_RA6_01_1237.d 0 1 1 1471 1479
R.VNN(+.98)LSGAIR.N Y 16.82 943.5087 9 -16.0 472.7541 2 32.80 6 14422 VEV_3_3_RA6_01_1237.d 1.79E5 1 1 538 546 Deamidation (NQ)
R.RPSISNDER.K Y 16.72 1072.5261 9 -20.2 537.2595 2 16.24 6 5640 VEV_3_3_RA6_01_1237.d 3.38E4 1 1 205 213
R.QLSALYER.R Y 16.68 978.5134 8 -19.0 490.2547 2 53.83 4 27337 VEV_1_3_RA4_01_1235.d 0 1 1 1771 1778
R.NM(+15.99)KVNMAHMTPSVAR.V Y 16.59 1701.8113 15 9.6 568.2831 3 68.45 6 36727 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 547 561 Oxidation (M)
R.MEGLELTVMQVFQHRR(-.98).L Y 16.57 1972.0135 16 -24.7 658.3289 3 85.93 5 49697 VEV_2_3_RA5_01_1236.d 0 1 1 1561 1576 Amidation
K.VITY(+31.99)SSNSKK(+42.01).A Y 16.44 1199.6034 10 -31.8 300.8986 4 16.70 6 5826 VEV_3_3_RA6_01_1237.d 2.44E4 1 1 62 71 Dihydroxy; Acetylation (K)
K.DYSIFFTNVAHTAEK(+14.02).Y Y 16.21 1755.8468 15 8.5 586.2945 3 79.41 4 46568 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 218 232 Methylation(KR)
R.DVTFGEVVS(-18.01)GR.N Y 16.19 1146.5669 11 -11.3 574.2842 2 59.01 4 30744 VEV_1_3_RA4_01_1235.d 0 1 1 1867 1877 Dehydration
K.TNGGVHLNGDAD(-18.01)GR.V Y 16.14 1363.6229 14 11.9 455.5537 3 42.98 5 20912 VEV_2_3_RA5_01_1236.d 4.67E4 1 1 104 117 Dehydration
R.AYNGK.E Y 16.14 551.2703 5 -39.7 552.2557 1 18.24 6 6635 VEV_3_3_RA6_01_1237.d 2.26E4 1 1 1110 1114
R.FAVLPN(+.98)K.K Y 16.09 788.4432 7 -30.2 395.2169 2 37.33 4 17125 VEV_1_3_RA4_01_1235.d 0 1 1 1073 1079 Deamidation (NQ)
R.QLSALYERR.S Y 16.08 1134.6145 9 3.7 379.2135 3 58.56 5 30503 VEV_2_3_RA5_01_1236.d 1.83E4 1 1 1771 1779
K.T(-18.01)FDISSRPK.D Y 15.95 1031.5399 9 8.0 516.7814 2 55.70 5 28569 VEV_2_3_RA5_01_1236.d 2.06E4 1 1 1835 1843 Dehydration
K.LRTSTEQAREPQSEMER.K Y 15.79 2046.9752 17 12.4 512.7574 4 57.26 5 29600 VEV_2_3_RA5_01_1236.d 1.14E5 1 1 846 862
R.C(-18.01)SDGR.S Y 15.70 518.1907 5 -54.0 519.1700 1 7.59 4 1787 VEV_1_3_RA4_01_1235.d 3.43E3 1 1 1744 1748 Dehydration (C@N-term)
R.EWKIQAFPK.G Y 15.69 1145.6233 9 -26.1 382.8717 3 31.11 5 13912 VEV_2_3_RA5_01_1236.d 0 1 1 1981 1989
K.VITYSS(+14.02)NSK.K Y 15.66 1011.5237 9 -5.7 338.1799 3 45.03 6 21420 VEV_3_3_RA6_01_1237.d 0 1 1 62 70 Methylation(others)
R.LSPDAR(+14.02).E Y 15.64 671.3602 6 -13.2 672.3586 1 41.36 4 19526 VEV_1_3_RA4_01_1235.d 4.14E4 1 1 1273 1278 Methylation(KR)
K.LVAAAR(+79.97).R Y 15.56 679.3418 6 -8.4 680.3434 1 26.79 4 11085 VEV_1_3_RA4_01_1235.d 0 1 1 897 902 Phosphorylation (HCDR)
R.VNNLSGAIR.N Y 15.50 942.5247 9 -28.8 315.1731 3 17.24 4 5954 VEV_1_3_RA4_01_1235.d 9.26E4 1 1 538 546
K.ELIKLR(+31.99)TSTEQAR.E Y 15.26 1575.8580 13 -13.3 788.9258 2 70.63 4 39732 VEV_1_3_RA4_01_1235.d 2.28E4 1 1 842 854 Dihydroxy
R.EALKFNT(+79.97)YALMLVCSLDPK.G Y 15.15 2235.0720 19 0.5 559.7756 4 78.00 6 43728 VEV_3_3_RA6_01_1237.d 0 1 1 1320 1338 Phosphorylation (STY)
K.IEGPM(+15.99)ITTVPVR.V Y 15.12 1327.7169 12 -13.3 332.9321 4 30.68 5 13654 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 1225 1236 Oxidation (M)
total 105 peptides
A0A0A0HV09
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALQEGPQVVVGTPGR.V Y 142.45 1506.8154 15 -15.5 754.4033 2 64.68 6 33918 VEV_3_3_RA6_01_1237.d 1.73E6 10 10 140 154
R.GIDVQQVSLVINYDLPANRENYIHR.I Y 134.67 2925.5098 25 -15.5 732.3734 4 80.68 6 45637 VEV_3_3_RA6_01_1237.d 1.65E6 13 13 328 352
R.GIDVQQVSLVINYDLPANR.E Y 119.98 2113.1167 19 -6.1 705.3752 3 84.51 4 50255 VEV_1_3_RA4_01_1235.d 7.18E5 7 7 328 346
R.KGVAINFVTADDVR.M Y 108.99 1503.8044 14 -12.9 752.8998 2 68.82 5 38140 VEV_2_3_RA5_01_1236.d 1.11E6 7 7 362 375
R.DFTVSAMHGDMEQSQR.D Y 108.07 1837.7723 16 -9.4 919.8848 2 65.29 4 35505 VEV_1_3_RA4_01_1235.d 1.72E5 2 2 289 304
K.TATFSISALQKVDTNLK.A Y 102.95 1835.9993 17 -8.7 613.0017 3 77.16 4 44818 VEV_1_3_RA4_01_1235.d 1.28E5 2 2 77 93
K.GVAINFVTADDVR.M Y 93.06 1375.7096 13 -15.8 688.8512 2 75.43 6 41856 VEV_3_3_RA6_01_1237.d 6.21E5 4 4 363 375
R.VLIATDLLAR.G Y 83.19 1083.6652 10 -15.9 542.8312 2 78.28 6 43934 VEV_3_3_RA6_01_1237.d 1.94E6 5 5 318 327
K.TATFSISALQK.V Y 77.99 1165.6343 11 -10.7 583.8182 2 70.66 5 39478 VEV_2_3_RA5_01_1236.d 1.18E6 7 7 77 87
R.GVYAYGFERPSAIQQR.A Y 77.71 1840.9220 16 -9.9 614.6418 3 67.29 4 37070 VEV_1_3_RA4_01_1235.d 6.92E5 5 5 39 54
K.AC(+57.02)QALILAPTR.E Y 74.13 1212.6648 11 -14.7 607.3307 2 66.09 6 34950 VEV_3_3_RA6_01_1237.d 3.1E5 4 4 94 104 Carbamidomethylation
K.ALQ(+.98)EGPQVVVGTPGR.V Y 74.00 1507.7994 15 -7.8 754.9011 2 66.65 4 36571 VEV_1_3_RA4_01_1235.d 1.75E5 2 2 140 154 Deamidation (NQ)
K.ALQE(+14.02)GPQVVVGTPGR.V Y 73.73 1520.8311 15 -17.3 761.4097 2 68.86 6 37021 VEV_3_3_RA6_01_1237.d 1.12E5 4 4 140 154 Methylation(others)
K.ALQEGPQVVVGTPGR(+14.02).V Y 72.41 1520.8311 15 -11.7 761.4139 2 65.57 6 34553 VEV_3_3_RA6_01_1237.d 8.05E4 3 3 140 154 Methylation(KR)
R.RKVDWLTDKLTAR.D Y 66.87 1600.9049 13 -4.1 401.2319 4 64.23 5 34700 VEV_2_3_RA5_01_1236.d 6.98E5 4 4 276 288
K.AC(+57.02)QALILAPTRELAQQIQK.V Y 63.45 2151.1833 19 42.3 718.0988 3 77.45 5 44340 VEV_2_3_RA5_01_1236.d 4.16E4 2 2 94 112 Carbamidomethylation
K.ALQEGPQ(+.98)VVVGTPGR.V Y 61.09 1507.7994 15 -15.9 754.8950 2 65.98 6 34866 VEV_3_3_RA6_01_1237.d 1.75E5 2 2 140 154 Deamidation (NQ)
K.VDTNLKAC(+57.02)QALILAPTR.E Y 51.77 1883.0298 17 -35.3 628.6617 3 72.88 6 40002 VEV_3_3_RA6_01_1237.d 0 1 1 88 104 Carbamidomethylation
R.ELAQQIQK.V Y 49.29 956.5291 8 -16.6 479.2639 2 30.27 4 13006 VEV_1_3_RA4_01_1235.d 7.66E5 7 7 105 112
R.VLIATDLLAR(+14.02).G Y 49.02 1097.6808 10 -11.6 549.8413 2 80.01 4 47022 VEV_1_3_RA4_01_1235.d 2.95E5 3 3 318 327 Methylation(KR)
R.GIDVQQVS(-2.02)LVINYDLPANRENYIHR.I Y 45.44 2923.4939 25 -33.4 585.6865 5 80.88 4 47704 VEV_1_3_RA4_01_1235.d 0 1 1 328 352 2-amino-3-oxo-butanoic_acid
R.DVIMKEFR.S Y 44.74 1036.5375 8 -12.5 346.5154 3 60.89 5 32211 VEV_2_3_RA5_01_1236.d 4.27E5 4 4 305 312
R.AIMPVIK.G Y 43.32 770.4724 7 -18.3 386.2365 2 62.86 6 32533 VEV_3_3_RA6_01_1237.d 9.11E5 5 5 55 61
K.TATFSISALQ(+.98)K.V Y 42.43 1166.6183 11 -26.8 584.3008 2 73.39 5 41449 VEV_2_3_RA5_01_1236.d 9.81E4 1 1 77 87 Deamidation (NQ)
R.GVYAYGFER(+14.02)PSAIQQR.A Y 42.30 1854.9376 16 -6.4 619.3159 3 69.68 5 38756 VEV_2_3_RA5_01_1236.d 2.3E5 3 3 39 54 Methylation(KR)
R.KGVAINFVTADDVR(+14.02).M Y 42.19 1517.8202 14 -29.1 506.9326 3 72.52 4 41219 VEV_1_3_RA4_01_1235.d 0 1 1 362 375 Methylation(KR)
K.AC(+57.02)QALILAPTR(+14.02).E Y 41.75 1226.6805 11 -17.6 614.3367 2 68.43 4 37977 VEV_1_3_RA4_01_1235.d 8.92E4 3 3 94 104 Carbamidomethylation; Methylation(KR)
K.ALQEGPQVVVGTPGRVHDMIQRR.V Y 41.34 2542.3550 23 3.3 509.4799 5 68.36 6 36660 VEV_3_3_RA6_01_1237.d 2.34E5 3 3 140 162
R.VLKTDHMK.M Y 40.94 970.5270 8 -14.1 486.2639 2 13.01 5 3976 VEV_2_3_RA5_01_1236.d 7.71E4 1 1 163 170
R.KVDWLTDKLTAR.D Y 39.86 1444.8038 12 -14.7 362.2029 4 67.96 4 37606 VEV_1_3_RA4_01_1235.d 1.91E5 2 2 277 288
R.GIDVQQVSLVINYDLPANR(+14.02)ENY(-18.01)IHR.I Y 39.37 2921.5146 25 -38.0 731.3582 4 80.80 5 46578 VEV_2_3_RA5_01_1236.d 9.16E4 1 1 328 352 Methylation(KR); Dehydration
R.DVIM(+15.99)KEFR.S Y 38.63 1052.5325 8 -12.2 527.2671 2 46.51 4 22710 VEV_1_3_RA4_01_1235.d 9.36E4 1 1 305 312 Oxidation (M)
R.ENYIHR.I N 35.49 830.4035 6 -6.3 416.2064 2 18.27 4 6496 VEV_1_3_RA4_01_1235.d 4.42E5 2 2 347 352
R.VHDMIQRR.V Y 32.05 1053.5502 8 -8.6 527.7778 2 18.00 4 6360 VEV_1_3_RA4_01_1235.d 4.05E4 1 1 155 162
K.LDTLSDLYETVTITQAVIFC(+57.02)NTRR.K Y 29.04 2828.4377 24 -15.0 943.8057 3 94.14 5 53863 VEV_2_3_RA5_01_1236.d 8.27E4 1 1 253 276 Carbamidomethylation
R.DVIMK(+42.01).E Y 28.76 646.3360 5 -20.3 647.3301 1 78.33 4 45737 VEV_1_3_RA4_01_1235.d 0 1 1 305 309 Acetylation (K)
K.VDWLTDKLTAR.D Y 28.57 1316.7089 11 -11.0 439.9054 3 72.82 4 41438 VEV_1_3_RA4_01_1235.d 6.55E4 1 1 278 288
R.VHDMIQR.R Y 27.25 897.4491 7 -6.5 300.1550 3 22.71 4 8844 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 155 161
R.RKVDWLT(-18.01)DKLTAR.D Y 26.88 1582.8943 13 -33.3 317.5756 5 64.51 6 33775 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 276 288 Dehydration
K.EFRS(+164.06)GSSRVLIATDLLAR.G Y 26.73 2154.1562 18 -87.4 539.4993 4 78.55 4 45905 VEV_1_3_RA4_01_1235.d 0 1 1 310 327 O-Diisopropylphosphorylation
K.VDTN(+.98)LK(+42.01).A Y 25.43 731.3701 6 -20.0 732.3628 1 74.29 6 41031 VEV_3_3_RA6_01_1237.d 0 1 1 88 93 Deamidation (NQ); Acetylation (K)
R.S(-18.01)GS(+79.97)SRVLIATDLLAR.G Y 25.41 1619.8396 15 21.0 540.9651 3 78.71 4 46027 VEV_1_3_RA4_01_1235.d 0 1 1 313 327 Dehydration; Phosphorylation (STY)
R.S(+60.00)GSSRVLIATDLLAR.G Y 23.02 1617.8872 15 -50.4 540.2758 3 78.38 6 43993 VEV_3_3_RA6_01_1237.d 7.11E4 1 1 313 327 2-OH-ethyl thio-Ser
R.RKVDWLTDKLTAR(+14.02).D Y 21.43 1614.9205 13 -73.3 323.9677 5 66.63 6 35359 VEV_3_3_RA6_01_1237.d 0 1 1 276 288 Methylation(KR)
K.FMRDPVR.I Y 20.91 919.4698 7 -7.4 307.4949 3 35.11 4 15816 VEV_1_3_RA4_01_1235.d 2.45E5 1 1 220 226
R.DVIMKEFR(+14.02).S Y 20.64 1050.5532 8 -23.3 351.1835 3 66.69 4 36603 VEV_1_3_RA4_01_1235.d 4.84E4 1 1 305 312 Methylation(KR)
R.ELAQQ(+.98)IQK(+28.03).V Y 20.56 985.5444 8 -8.3 493.7754 2 41.20 6 19180 VEV_3_3_RA6_01_1237.d 1.61E4 1 1 105 112 Deamidation (NQ); Dimethylation(KR)
K.VDTNLK(+226.08).A Y 19.77 914.4531 6 -2.6 458.2327 2 16.70 6 5831 VEV_3_3_RA6_01_1237.d 0 1 1 88 93 Biotinylation
R.ELAQQIQ(+.98)K(+21.98).V Y 19.39 979.4951 8 -21.0 980.4818 1 104.57 4 59639 VEV_1_3_RA4_01_1235.d 2.64E4 1 1 105 112 Deamidation (NQ); Sodium adduct
K.ALQEGPQVVVGTPGR(+28.03).V Y 19.16 1534.8467 15 -37.4 384.7046 4 52.99 6 26051 VEV_3_3_RA6_01_1237.d 7.63E4 1 1 140 154 Dimethylation(KR)
K.ALQEGPQVVVGTPGRVHDMIQR.R Y 19.11 2386.2539 22 -30.6 796.4009 3 74.12 5 41971 VEV_2_3_RA5_01_1236.d 3.69E4 1 1 140 161
R.GIDVQ(+.98)QVSLVINYDLPANR(+14.02).E Y 18.78 2128.1165 19 -5.4 710.3756 3 84.81 4 50458 VEV_1_3_RA4_01_1235.d 7.37E4 1 1 328 346 Deamidation (NQ); Methylation(KR)
K.GAP(-27.99)MSSPQAQSGTGK.T Y 18.49 1374.6561 15 -22.8 688.3196 2 40.19 5 19227 VEV_2_3_RA5_01_1236.d 0 1 1 62 76 Pyrrolidone from Proline
R.FGRK(+145.02)GVAINFVTADDVR.M Y 18.37 2009.0153 17 -22.3 503.2499 4 69.09 5 38331 VEV_2_3_RA5_01_1236.d 2.59E5 2 2 359 375 3-(carbamidomethylthio)propanoyl
R.S(+79.97)GS(-18.01)SRVLIATDLLAR.G Y 18.37 1619.8396 15 -14.2 540.9462 3 78.75 6 44261 VEV_3_3_RA6_01_1237.d 4.12E4 1 1 313 327 Phosphorylation (STY); Dehydration
K.VDT(-2.02)NLKAC(+57.02)QALILAPTR.E Y 18.31 1881.0142 17 -21.2 627.9987 3 72.82 6 39954 VEV_3_3_RA6_01_1237.d 0 1 1 88 104 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.ELAQ(+.98)QIQ(+.98)K.V Y 18.23 958.4971 8 -18.2 480.2471 2 31.68 6 13845 VEV_3_3_RA6_01_1237.d 0 1 1 105 112 Deamidation (NQ)
K.FM(+15.99)RDPVR.I Y 18.13 935.4647 7 -12.0 468.7340 2 20.69 6 7924 VEV_3_3_RA6_01_1237.d 3.4E4 2 2 220 226 Oxidation (M)
R.KVD(+356.19)WLTDKLTAR.D Y 18.00 1800.9919 12 9.0 361.2089 5 67.98 4 37620 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 277 288 Biotin polyethyleneoxide amine
R.S(-18.01)GSSR(+14.02).V Y 17.89 488.2343 5 17.1 489.2499 1 47.36 5 23551 VEV_2_3_RA5_01_1236.d 0 1 1 313 317 Dehydration; Methylation(KR)
R.VLKTDHM(-48.00)K.M Y 17.31 922.5236 8 -30.8 462.2549 2 8.64 4 2039 VEV_1_3_RA4_01_1235.d 0 1 1 163 170 Dethiomethyl
R.DVIMK(+21.98).E Y 17.13 626.3074 5 2.8 627.3164 1 42.24 4 20052 VEV_1_3_RA4_01_1235.d 0 1 1 305 309 Sodium adduct
R.ELAQ(+.98)Q(+.98)IQK(+42.01).V Y 17.01 1000.5077 8 -16.7 501.2528 2 61.32 6 31384 VEV_3_3_RA6_01_1237.d 7.86E4 1 1 105 112 Deamidation (NQ); Acetylation (K)
R.KGVAIN(+.98)FVTADDVR(+14.02).M Y 16.45 1518.8042 14 -24.5 507.2629 3 77.13 5 44110 VEV_2_3_RA5_01_1236.d 8.72E4 1 1 362 375 Deamidation (NQ); Methylation(KR)
K.AELTLE(+21.98)GIK.Q Y 16.24 994.5311 9 -23.9 498.2609 2 19.61 5 7524 VEV_2_3_RA5_01_1236.d 3.39E4 1 1 232 240 Sodium adduct
K.TATFSIS(+79.97)ALQ(+.98)K(+14.02).V Y 16.18 1260.6002 11 -10.0 421.2032 3 101.31 5 56440 VEV_2_3_RA5_01_1236.d 0 1 1 77 87 Phosphorylation (STY); Deamidation (NQ); Methylation(KR)
R.AELLR.G N 16.06 600.3595 5 0.0 301.1870 2 44.30 5 21737 VEV_2_3_RA5_01_1236.d 4.39E5 1 1 34 38
K.TATFSISALQK(+43.99).V Y 15.87 1209.6241 11 5.3 404.2175 3 51.49 4 25825 VEV_1_3_RA4_01_1235.d 0 1 1 77 87 Carboxylation (DKW)
R.A(+42.01)IM(+15.99)PVIKGAPMSSPQAQSGT(+79.97)GK.T Y 15.70 2293.0847 22 -8.2 574.2737 4 66.75 6 35445 VEV_3_3_RA6_01_1237.d 0 1 1 55 76 Acetylation (N-term); Oxidation (M); Phosphorylation (STY)
R.A(+42.01)ELLR.G N 15.36 642.3701 5 -4.3 322.1909 2 52.62 6 25829 VEV_3_3_RA6_01_1237.d 0 1 1 34 38 Acetylation (N-term)
R.A(+42.01)IMPVIK.G Y 15.15 812.4830 7 -34.7 407.2347 2 63.24 4 33930 VEV_1_3_RA4_01_1235.d 0 1 1 55 61 Acetylation (N-term)
K.VDTNLK(+42.01)ACQALILAPTR.E Y 15.03 1868.0189 17 -66.0 467.9812 4 64.50 5 34901 VEV_2_3_RA5_01_1236.d 0 1 1 88 104 Acetylation (K)
total 72 peptides
C1G3T6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAAEFDAMTDKELDALPSLPLVIAR.C Y 131.39 2686.3887 25 -13.5 1344.1835 2 88.23 5 50966 VEV_2_3_RA5_01_1236.d 7.73E5 6 6 701 725
R.NGHETTIPSGEVVPGDIVQIK.M Y 118.91 2189.1328 21 -10.0 730.7109 3 75.01 5 42593 VEV_2_3_RA5_01_1236.d 7.43E5 5 5 134 154
K.DIDFSPSGSELDTGVGDRLNMAYSSSTVTK.G Y 107.02 3148.4507 30 -12.7 1050.4775 3 80.72 6 45664 VEV_3_3_RA6_01_1237.d 1.83E5 3 3 188 217
R.TGWFSEGEDYEGVTPATGFR.R Y 100.83 2204.9651 20 -9.6 1103.4792 2 81.58 6 46263 VEV_3_3_RA6_01_1237.d 3.11E5 3 3 1050 1069
K.DIDFSPSGSELDTGVGDR.L Y 99.91 1865.8279 18 -7.0 933.9147 2 76.88 4 44599 VEV_1_3_RA4_01_1235.d 8.61E4 2 2 188 205
R.ILEQMNFLAEQGLR.V Y 88.41 1660.8606 14 -9.5 831.4297 2 82.36 5 47569 VEV_2_3_RA5_01_1236.d 3.51E5 4 4 606 619
R.IIDLC(+57.02)TSVGTGDHQEAMTPETK.E Y 86.94 2402.1094 22 -8.2 801.7039 3 69.80 4 39058 VEV_1_3_RA4_01_1235.d 9.31E4 1 1 582 603 Carbamidomethylation
R.IIDLC(+57.02)TSVGTGDHQEAMTPETKER.I Y 86.46 2687.2532 24 -6.3 672.8163 4 66.42 4 36389 VEV_1_3_RA4_01_1235.d 5.56E4 1 1 582 605 Carbamidomethylation
R.NPGTLSAEEAK.S Y 84.04 1115.5458 11 -12.7 558.7731 2 29.56 5 13045 VEV_2_3_RA5_01_1236.d 8.65E5 9 9 686 696
K.AWIPGVGIYSLHQSDDANNPTR.G Y 77.60 2410.1665 22 -7.3 804.3903 3 78.43 6 44034 VEV_3_3_RA6_01_1237.d 1.66E5 3 3 391 412
K.QISEYPFDSSVKR.M Y 77.36 1554.7678 13 -13.3 519.2563 3 62.53 6 32285 VEV_3_3_RA6_01_1237.d 1.83E5 2 2 546 558
K.MGDTVPADLR.L Y 76.51 1073.5176 10 -13.6 537.7588 2 58.76 6 29549 VEV_3_3_RA6_01_1237.d 5.95E5 4 4 155 164
K.M(+15.99)GDTVPADLR.L Y 70.55 1089.5125 10 -12.2 545.7568 2 47.95 5 23927 VEV_2_3_RA5_01_1236.d 2.32E5 2 2 155 164 Oxidation (M)
R.VHMLTGDHPSTATAIAK.E Y 70.14 1748.8879 17 -8.7 583.9648 3 55.73 5 28642 VEV_2_3_RA5_01_1236.d 3.11E5 2 2 662 678
K.YGNFQPIKGGALR.V Y 66.64 1419.7622 13 -10.3 474.2565 3 62.75 4 33564 VEV_1_3_RA4_01_1235.d 2.26E5 3 3 257 269
R.GTIVLGQPPASKQEAEQER.E Y 66.56 2037.0491 19 -16.5 680.0125 3 57.17 6 28476 VEV_3_3_RA6_01_1237.d 1.43E5 2 2 413 431
R.GRTDHSLGSR.R Y 64.09 1084.5374 10 -5.3 543.2731 2 10.88 5 2906 VEV_2_3_RA5_01_1236.d 2.56E4 3 3 1119 1128
K.ELAEVLHTNIETGLLDANIPK.L Y 61.43 2289.2217 21 -2.3 573.3114 4 83.15 4 49327 VEV_1_3_RA4_01_1235.d 9.03E4 1 1 23 43
K.TGTLTQGQMVTR.K Y 57.51 1291.6554 12 -9.7 646.8287 2 48.04 4 23662 VEV_1_3_RA4_01_1235.d 2.81E5 4 4 378 389
R.GTIVLGQPPASKQEAEQERER.K Y 56.26 2322.1926 21 1.5 581.5563 4 52.93 5 26947 VEV_2_3_RA5_01_1236.d 3.75E5 2 2 413 433
R.GTIVLGQPPASK.Q Y 54.25 1166.6659 12 -33.9 584.3204 2 57.98 5 30102 VEV_2_3_RA5_01_1236.d 1.26E4 4 4 413 424
R.LFDAMNLEC(+57.02)DEKILTGEAVPVAK.D Y 53.62 2562.2710 23 7.6 855.1041 3 86.79 5 50195 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 165 187 Carbamidomethylation
K.ERILEQMNFLAEQGLR.V Y 53.53 1946.0044 16 -14.9 649.6657 3 81.42 5 46974 VEV_2_3_RA5_01_1236.d 6.49E4 1 1 604 619
R.KAWIPGVGIYSLHQSDDANNPTR.G Y 52.10 2538.2615 23 -9.5 847.0864 3 74.21 5 42035 VEV_2_3_RA5_01_1236.d 5.08E4 1 1 390 412
R.QGFFSFAR.T Y 51.33 958.4661 8 -5.0 480.2379 2 75.50 6 41951 VEV_3_3_RA6_01_1237.d 9.03E5 7 7 1081 1088
R.SLSSPSATVIR.N Y 51.15 1116.6139 11 -12.8 559.3071 2 57.66 5 29927 VEV_2_3_RA5_01_1236.d 6.13E5 6 6 123 133
K.Q(-17.03)ISEYPFDSSVKR.M Y 49.99 1537.7412 13 -14.1 769.8670 2 73.27 6 40283 VEV_3_3_RA6_01_1237.d 3.96E5 4 4 546 558 Pyro-glu from Q
K.SAADIVLTDDNFASIVNAIEEGRR.M Y 46.86 2575.2878 24 -5.9 859.4315 3 89.06 4 53144 VEV_1_3_RA4_01_1235.d 0 1 1 777 800
R.MSVIYIRETDGETR.V Y 44.67 1668.8141 14 10.5 557.2845 3 64.38 6 33647 VEV_3_3_RA6_01_1237.d 0 1 1 559 572
R.SAAGLKFDIPAEKEERDQR.R Y 42.72 2159.0969 19 -47.2 432.8063 5 60.50 4 31861 VEV_1_3_RA4_01_1235.d 0 1 1 443 461
R.SAAGLKFDIPAEKEER.D Y 41.74 1759.9104 16 -6.3 440.9821 4 63.37 4 34032 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 443 458
K.LQEEYGANR.L Y 40.91 1078.5043 9 -13.2 540.2523 2 27.27 6 11391 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 44 52
R.N(+.98)GHETTIPSGEVVPGDIVQIK.M Y 40.26 2190.1167 21 -25.3 731.0277 3 78.32 6 43953 VEV_3_3_RA6_01_1237.d 1.68E5 2 2 134 154 Deamidation (NQ)
R.NPGTLSAE(+14.02)EAK.S Y 39.17 1129.5615 11 -9.0 565.7830 2 40.04 4 18726 VEV_1_3_RA4_01_1235.d 1.49E5 2 2 686 696 Methylation(others)
R.LNMAYSSSTVTK.G Y 38.17 1300.6333 12 -18.7 651.3118 2 57.30 6 28559 VEV_3_3_RA6_01_1237.d 5.77E4 2 2 206 217
R.VLETQYGWK.Q Y 37.77 1122.5709 9 11.7 562.2993 2 63.87 6 33309 VEV_3_3_RA6_01_1237.d 1.27E6 2 2 537 545
K.EVGILPR.N Y 36.11 782.4650 7 -15.5 392.2337 2 58.04 5 30140 VEV_2_3_RA5_01_1236.d 2.07E5 2 2 679 685
R.NPGTLSAEEAK(+14.02).S Y 33.37 1129.5615 11 -9.0 565.7830 2 39.89 6 18432 VEV_3_3_RA6_01_1237.d 1.69E5 2 2 686 696 Methylation(KR)
R.SSISGRDNTSSRPR.G Y 33.03 1518.7499 14 -11.8 507.2513 3 13.13 5 4037 VEV_2_3_RA5_01_1236.d 6.31E4 1 1 1105 1118
R.GTIVLGQPPASKQ(+.98)EAEQER.E Y 31.99 2038.0331 19 -15.7 680.3410 3 59.12 6 29798 VEV_3_3_RA6_01_1237.d 4.07E4 1 1 413 431 Deamidation (NQ)
R.ILEQ(+.98)MNFLAEQGLR(+14.02).V Y 30.58 1675.8604 14 -9.8 838.9292 2 84.06 6 47872 VEV_3_3_RA6_01_1237.d 0 1 1 606 619 Deamidation (NQ); Methylation(KR)
K.YGN(+.98)FQPIKGGALR.V Y 30.54 1420.7462 13 7.1 474.5927 3 62.82 4 33620 VEV_1_3_RA4_01_1235.d 3.3E4 1 1 257 269 Deamidation (NQ)
K.YGNFQPIK.G Y 25.38 965.4970 8 -6.8 483.7525 2 57.69 4 29785 VEV_1_3_RA4_01_1235.d 0 1 1 257 264
M(+15.99)GPPK.T Y 24.99 544.2679 5 4.0 545.2773 1 18.44 5 6882 VEV_2_3_RA5_01_1236.d 1.31E5 3 3 1 5 Oxidation (M)
K.TRMIAALHRR.H Y 24.56 1223.7034 10 -59.3 306.9150 4 30.80 5 13744 VEV_2_3_RA5_01_1236.d 1.33E5 1 1 732 741
K.FLGLTEGT(+79.97)PLQIK.L Y 24.26 1495.7687 13 7.8 499.6007 3 60.95 6 31130 VEV_3_3_RA6_01_1237.d 7.88E4 1 1 277 289 Phosphorylation (STY)
R.ILEQMNFLAEQGLR(+14.02).V Y 23.32 1674.8763 14 -20.7 838.4281 2 84.17 4 50030 VEV_1_3_RA4_01_1235.d 3.7E4 1 1 606 619 Methylation(KR)
R.NSMFNLDPLRDR.S Y 21.08 1476.7144 12 -5.0 493.2429 3 75.67 6 42031 VEV_3_3_RA6_01_1237.d 7.26E4 1 1 961 972
R.GRTDHSLGSRRVK.E Y 20.69 1467.8018 13 -44.1 490.2529 3 76.41 6 42564 VEV_3_3_RA6_01_1237.d 0 1 1 1119 1131
R.SSISGR(+14.02)DNTSS(+79.97)RPR.G Y 20.02 1612.7318 14 42.0 404.2072 4 44.25 6 20969 VEV_3_3_RA6_01_1237.d 0 1 1 1105 1118 Methylation(KR); Phosphorylation (STY)
R.LDGDGGVK(+43.01).W Y 19.74 802.3821 8 9.3 803.3968 1 73.52 4 41993 VEV_1_3_RA4_01_1235.d 0 1 1 53 60 Carbamylation
R.EKYGNFQPIKGGALR.V Y 18.98 1676.8998 15 -20.6 420.2236 4 60.12 6 30516 VEV_3_3_RA6_01_1237.d 0 1 1 255 269
R.K(+43.99)R(+14.02)AEQDRLR.S Y 18.96 1228.6636 9 -12.9 308.1692 4 16.31 6 5619 VEV_3_3_RA6_01_1237.d 0 1 1 434 442 Carboxylation (DKW); Methylation(KR)
R.EEIEK(+14.02).D N 18.64 660.3330 5 -10.0 331.1705 2 46.28 6 22140 VEV_3_3_RA6_01_1237.d 0 1 1 641 645 Methylation(KR)
R.LRSAAGLK(+172.05)FDIPAEKEER.D Y 18.47 2201.1479 18 -11.3 441.2319 5 63.17 5 33902 VEV_2_3_RA5_01_1236.d 0 1 1 441 458 Menadione hydroquinone derivative
R.TDHSLGSR.R Y 18.23 871.4148 8 10.8 436.7194 2 40.12 5 19187 VEV_2_3_RA5_01_1236.d 1.76E5 1 1 1121 1128
K.T(+43.01)AAEFDAMTDK(+14.02)ELDALPSLPLVIAR.C Y 18.02 2743.4102 25 -8.5 686.8540 4 82.58 6 46917 VEV_3_3_RA6_01_1237.d 1.59E5 1 1 701 725 Carbamylation; Methylation(KR)
R.RPPHDTK(+68.03).K Y 18.01 917.4719 7 -13.5 918.4667 1 91.86 4 54698 VEV_1_3_RA4_01_1235.d 0 1 1 872 878 Crotonylation
R.S(+27.99)SISGR.D Y 17.88 633.3082 6 -17.2 634.3046 1 27.73 5 11989 VEV_2_3_RA5_01_1236.d 0 1 1 1105 1110 Formylation
K.TGTLTQ(+.98)GQM(+15.99)VTR.K Y 17.87 1308.6344 12 20.8 655.3381 2 33.54 4 14897 VEV_1_3_RA4_01_1235.d 9.67E3 1 1 378 389 Deamidation (NQ); Oxidation (M)
K.FLGLTEGTPLQIK(+226.08).L Y 17.84 1641.8800 13 -7.5 411.4742 4 64.42 4 34827 VEV_1_3_RA4_01_1235.d 0 1 1 277 289 Biotinylation
R.SSISGRDN(+203.08)TSSRPR.G Y 17.61 1721.8292 14 1.0 574.9509 3 40.61 6 18883 VEV_3_3_RA6_01_1237.d 2.74E5 1 1 1105 1118 HexNAcylation (N)
R.TDHSLGSRR.V Y 17.46 1027.5159 9 -8.0 514.7611 2 10.24 5 2616 VEV_2_3_RA5_01_1236.d 1.35E4 1 1 1121 1129
R.GT(+79.97)IVLGQP(+31.99)PASK.Q Y 17.20 1278.6221 12 -7.0 640.3138 2 75.46 6 41883 VEV_3_3_RA6_01_1237.d 1.81E4 1 1 413 424 Phosphorylation (STY); Dihydroxy
R.VLGIAQK(+42.01)AGPPDVHSHS(+79.97)EIPR.E Y 17.17 2329.1580 21 9.0 583.3020 4 78.85 5 45288 VEV_2_3_RA5_01_1236.d 0 1 1 620 640 Acetylation (K); Phosphorylation (STY)
R.MSVIYIR(+37.96).E Y 17.14 918.4399 7 9.1 919.4556 1 89.38 5 51570 VEV_2_3_RA5_01_1236.d 7.85E4 1 1 559 565 Replacement of proton by potassium
R.SLSSPSAT(+79.97)VIR.N Y 16.91 1196.5802 11 5.0 300.1538 4 12.34 5 3615 VEV_2_3_RA5_01_1236.d 6.54E4 1 1 123 133 Phosphorylation (STY)
R.Q(-17.03)GFFSFAR.T Y 16.87 941.4395 8 -11.8 942.4357 1 85.42 6 48731 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 1081 1088 Pyro-glu from Q
R.VWDGVGK(+42.01).F Y 16.61 801.4021 7 3.1 802.4119 1 91.53 4 54513 VEV_1_3_RA4_01_1235.d 0 1 1 270 276 Acetylation (K)
K.ILTGEAVPVAK(+27.99).D Y 16.47 1124.6440 11 -15.3 375.8829 3 35.51 5 16476 VEV_2_3_RA5_01_1236.d 2E5 1 1 177 187 Formylation
R.GTIVLGQPPAS(+79.97)K(+42.01).Q Y 16.43 1288.6428 12 22.4 323.1752 4 38.26 4 17671 VEV_1_3_RA4_01_1235.d 0 1 1 413 424 Phosphorylation (STY); Acetylation (K)
R.RWPSHELGLRQGFFSFARTLT(+79.97)R.G Y 16.35 2741.3704 22 8.2 686.3555 4 79.77 5 45901 VEV_2_3_RA5_01_1236.d 6.09E4 1 1 1071 1092 Phosphorylation (STY)
R.LDGDGGVK.W Y 16.18 759.3762 8 -27.5 760.3626 1 79.88 6 45075 VEV_3_3_RA6_01_1237.d 7.02E4 1 1 53 60
R.VLETQY(-18.01)GWK.Q Y 16.14 1104.5604 9 -4.2 553.2852 2 68.77 5 38107 VEV_2_3_RA5_01_1236.d 0 1 1 537 545 Dehydration
K.AGPPD(-18.01)VHS(+79.97)HSEIPR.E Y 16.13 1559.6881 14 3.5 390.9307 4 68.86 6 37022 VEV_3_3_RA6_01_1237.d 0 1 1 627 640 Dehydration; Phosphorylation (STY)
R.NDSSPEK.S Y 16.01 775.3348 7 22.4 388.6833 2 43.56 5 21247 VEV_2_3_RA5_01_1236.d 0 1 1 467 473
MGPPK.T Y 15.93 528.2730 5 28.4 529.2953 1 39.75 5 18978 VEV_2_3_RA5_01_1236.d 0 1 1 1 5
K.TDAKQEYTK.H Y 15.84 1082.5244 9 -22.2 542.2574 2 47.55 5 23664 VEV_2_3_RA5_01_1236.d 3.37E4 1 1 6 14
R.VWDGVGK(+31.99).F Y 15.63 791.3813 7 -2.9 792.3864 1 78.60 4 45943 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 270 276 Dihydroxy
K.TGTLTQGQM(+15.99)VTRK.A Y 15.33 1435.7454 13 -4.7 479.5868 3 49.79 6 24182 VEV_3_3_RA6_01_1237.d 8.92E4 1 1 378 390 Oxidation (M)
K.A(+42.01)SAASMR(-.98).R Y 15.19 733.3541 7 -28.3 734.3406 1 32.55 5 14740 VEV_2_3_RA5_01_1236.d 5.05E4 1 1 865 871 Acetylation (N-term); Amidation
R.TLTR(+14.02)GSEK(+42.01).S Y 15.18 946.5084 8 -1.3 474.2609 2 72.59 4 41261 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 1089 1096 Methylation(KR); Acetylation (K)
K.LQEEYGANR(+21.98).L Y 15.08 1100.4862 9 6.6 551.2540 2 16.20 4 5413 VEV_1_3_RA4_01_1235.d 0 1 1 44 52 Sodium adduct
K.FDIPAEK(+28.03).E Y 15.05 846.4487 7 -14.7 424.2254 2 34.55 6 15399 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 449 455 Dimethylation(KR)
total 84 peptides
C1GAG4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HLTPLPLKLQTPVPSDIAISR.A Y 115.51 2295.3313 21 -18.3 574.8296 4 79.25 4 46438 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 398 418
K.TNPDDLTPEEINR.F Y 111.82 1512.7056 13 -9.1 757.3531 2 62.60 6 32363 VEV_3_3_RA6_01_1237.d 5.29E5 5 5 599 611
K.DVDGFGAVNIGELAK.R Y 105.79 1503.7568 15 -8.7 752.8792 2 82.05 4 48563 VEV_1_3_RA4_01_1235.d 3.33E5 2 2 219 233
K.LAGTEPDEDHEAK.T Y 105.22 1410.6262 13 -5.7 706.3163 2 20.97 4 7922 VEV_1_3_RA4_01_1235.d 3.31E5 6 6 752 764
R.SDIVGSPVSYLLK.S Y 102.92 1376.7551 13 -11.1 689.3772 2 81.43 5 46979 VEV_2_3_RA5_01_1236.d 5.26E5 3 3 270 282
K.AAQEANIQC(+57.02)QLTK.F Y 99.65 1473.7246 13 -10.1 737.8621 2 53.43 5 27265 VEV_2_3_RA5_01_1236.d 3.09E5 4 4 157 169 Carbamidomethylation
R.YILVC(+57.02)GITPTPLGEGK.S Y 93.36 1716.9120 16 -15.9 859.4496 2 80.08 6 45215 VEV_3_3_RA6_01_1237.d 2.38E5 3 3 465 480 Carbamidomethylation
R.SSGLVPDTVVIVATVR.A Y 91.13 1611.9196 16 -11.0 538.3079 3 82.28 4 48731 VEV_1_3_RA4_01_1235.d 1.36E5 3 3 790 805
R.AQRPKPITTVAAEIGIAPQELEPYGHTK.A Y 89.02 3014.6189 28 -9.7 754.6547 4 76.88 4 44595 VEV_1_3_RA4_01_1235.d 3.44E4 1 1 419 446
K.TKDLENIIKQADILVAAIGKPEFVK.G Y 88.24 2752.5737 25 -12.2 551.5153 5 88.72 4 52946 VEV_1_3_RA4_01_1235.d 8.69E4 1 1 295 319
K.Q(-17.03)ADILVAAIGKPEFVK.G Y 87.95 1680.9449 16 -8.4 841.4727 2 85.86 4 51162 VEV_1_3_RA4_01_1235.d 4.91E4 3 3 304 319 Pyro-glu from Q
R.IAFANVRQPSQGPTFGIK.G Y 86.57 1930.0425 18 -9.0 644.3490 3 73.00 4 41583 VEV_1_3_RA4_01_1235.d 2.75E5 3 3 498 515
K.GSWLKPGVVVIDVGTNYIDDPTKK.S Y 82.03 2600.3850 24 -17.7 651.0920 4 81.14 4 47891 VEV_1_3_RA4_01_1235.d 9.47E4 1 1 320 343
K.STTTM(+15.99)GLTQALGAHLNR.I Y 81.26 1786.8995 17 -10.0 596.6345 3 68.25 4 37834 VEV_1_3_RA4_01_1235.d 1.82E5 3 3 481 497 Oxidation (M)
K.TQYSLSHDPNLK.G Y 76.49 1401.6888 12 -13.8 701.8420 2 47.99 6 23134 VEV_3_3_RA6_01_1237.d 1.47E6 5 5 970 981
R.GITIGQAATER.G Y 69.03 1115.5935 11 -13.9 558.7963 2 52.41 6 25706 VEV_3_3_RA6_01_1237.d 1.21E6 6 6 637 647
K.LLYDLEGTVQER.I Y 68.00 1434.7355 12 -9.2 718.3684 2 74.60 4 42824 VEV_1_3_RA4_01_1235.d 2.07E5 3 3 917 928
R.MFHESTQSDAALYKR.L Y 67.13 1782.8359 15 -12.0 446.7109 4 51.23 5 25900 VEV_2_3_RA5_01_1236.d 2.42E5 2 2 558 572
R.EFQPIFFR.R Y 64.74 1082.5548 8 -8.8 542.2799 2 80.02 4 47068 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 582 589
K.LQTPVPSDIAISR.A Y 64.39 1395.7721 13 -5.6 698.8894 2 72.31 4 41043 VEV_1_3_RA4_01_1235.d 4.2E5 4 4 406 418
K.STTTMGLTQALGAHLNR.I Y 63.35 1770.9047 17 3.8 591.3111 3 71.92 6 39299 VEV_3_3_RA6_01_1237.d 2.72E5 3 3 481 497
R.LDIDPETITWRR.V Y 60.17 1513.7888 12 -13.4 505.5968 3 75.59 4 43601 VEV_1_3_RA4_01_1235.d 2.76E5 2 2 615 626
R.IGKDMYGAEKVEFSELAQK.K Y 60.12 2142.0667 19 -9.9 536.5186 4 70.31 4 39455 VEV_1_3_RA4_01_1235.d 9.83E4 1 1 932 950
R.LNAEIQKSQQTNPR.F Y 59.49 1625.8485 14 -12.3 542.9501 3 31.15 5 13932 VEV_2_3_RA5_01_1236.d 8.24E4 1 1 118 131
K.RGDPVTC(+57.02)DDIGC(+57.02)GGALTALMK.D Y 57.77 2206.0181 21 5.5 736.3507 3 77.44 4 45042 VEV_1_3_RA4_01_1235.d 8.04E4 1 1 690 710 Carbamidomethylation
R.FKPSLVIFQIGDR.S Y 56.39 1518.8558 13 -22.7 507.2811 3 80.48 6 45497 VEV_3_3_RA6_01_1237.d 5.45E4 1 1 132 144
R.QPSQGPTFGIK.G Y 56.22 1158.6033 11 -10.8 580.3027 2 57.80 4 29868 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 505 515
K.GGAAGGGYSQVIPMDEFNLHLTGDIHAITAANNLLAAAIETR.M Y 51.18 4249.1226 42 -12.6 1063.2745 4 92.46 6 52518 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 516 557
R.AQRPKPITTVAAEIGIAPQ(+.98)ELEPYGHTK.A Y 49.99 3015.6028 28 -8.2 604.1229 5 76.93 6 42952 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 419 446 Deamidation (NQ)
K.GAPTGYTVPIRDVR.L Y 49.77 1500.8048 14 -15.4 501.2678 3 62.98 6 32617 VEV_3_3_RA6_01_1237.d 1.33E5 2 2 982 995
K.AKVTLDLLDR.L Y 46.11 1142.6659 10 -6.3 381.8935 3 68.64 4 38146 VEV_1_3_RA4_01_1235.d 8.3E4 2 2 447 456
R.NGRYILVC(+57.02)GITPTPLGEGK.S Y 42.13 2044.0775 19 -13.8 682.3571 3 76.33 5 43540 VEV_2_3_RA5_01_1236.d 3.02E4 2 2 462 480 Carbamidomethylation
R.EFQPIFFRR.L Y 40.77 1238.6560 9 -19.6 413.8845 3 73.10 6 40158 VEV_3_3_RA6_01_1237.d 5.26E5 3 3 582 590
R.IAFANVR.Q Y 37.20 789.4497 7 -13.6 395.7267 2 55.67 4 28438 VEV_1_3_RA4_01_1235.d 4.95E5 3 3 498 504
K.GAPTGYTVPIR.D Y 36.50 1130.6084 11 -20.1 566.3001 2 62.84 4 33632 VEV_1_3_RA4_01_1235.d 7.18E4 1 1 982 992
K.Q(-17.03)GFGNLPIC(+57.02)IAK.T Y 36.34 1299.6646 12 -15.0 650.8298 2 85.08 6 48558 VEV_3_3_RA6_01_1237.d 2.7E5 2 2 958 969 Pyro-glu from Q; Carbamidomethylation
K.DLENIIKQADILVAAIGKPEFVK.G Y 34.94 2523.4312 23 9.4 631.8710 4 94.16 4 55892 VEV_1_3_RA4_01_1235.d 0 1 1 297 319
R.LNAEIQK.S Y 34.89 814.4548 7 -10.2 408.2305 2 26.38 4 10861 VEV_1_3_RA4_01_1235.d 2.67E5 3 3 118 124
R.QPS(-18.01)Q(+.98)GPTFGIK.G Y 33.82 1141.5768 11 -15.4 571.7869 2 71.02 6 38623 VEV_3_3_RA6_01_1237.d 5.44E4 1 1 505 515 Dehydration; Deamidation (NQ)
K.LLYDLEGTVQERIER.I Y 31.94 1832.9631 15 -13.7 611.9866 3 77.19 4 44846 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 917 931
K.SADATVTVC(+57.02)HSK.T Y 31.58 1274.5925 12 -9.7 425.8673 3 20.18 4 7479 VEV_1_3_RA4_01_1235.d 2.29E5 2 2 283 294 Carbamidomethylation
R.QPSQGPTF(+31.99)GIK.G Y 31.33 1190.5931 11 -35.3 596.2828 2 53.41 5 27257 VEV_2_3_RA5_01_1236.d 4.76E4 2 2 505 515 Dihydroxy
R.HLTPLPLK(+14.02)LQT(-18.01)PVPSDIAISR.A Y 29.43 2291.3364 21 -89.2 573.7903 4 79.28 5 45581 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 398 418 Methylation(KR); Dehydration
K.VSGIELAGK.N Y 28.43 872.4967 9 -20.8 437.2466 2 48.91 5 24489 VEV_2_3_RA5_01_1236.d 4.37E5 5 5 254 262
K.RGDPVTC(+57.02)DDIGC(+57.02)GGALTALM(+15.99)K.D Y 28.24 2222.0129 21 -11.1 741.6700 3 71.55 4 40444 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 690 710 Carbamidomethylation; Oxidation (M)
K.QGFGNLPIC(+57.02)IAK.T Y 27.63 1316.6910 12 -15.3 659.3427 2 78.16 5 44825 VEV_2_3_RA5_01_1236.d 1.56E5 2 2 958 969 Carbamidomethylation
R.FAR(+306.17)LDIDPETITWR.R Y 27.36 2038.0663 14 -21.5 680.3481 3 80.47 4 47380 VEV_1_3_RA4_01_1235.d 8.94E4 1 1 612 625 Levuglandinyl - arginine hydroxylactam adduct
M(+15.99)PVPAATGFAC(+57.02)R.A Y 24.29 1292.6006 12 30.8 324.1674 4 11.17 5 3049 VEV_2_3_RA5_01_1236.d 2.07E5 1 1 1 12 Oxidation (M); Carbamidomethylation
R.QPS(-18.01)QGPTFGIK.G Y 24.26 1140.5928 11 -12.4 571.2966 2 43.18 6 20370 VEV_3_3_RA6_01_1237.d 2.2E4 2 2 505 515 Dehydration
R.VLDVNDRHLR.G Y 24.20 1235.6735 10 -26.5 618.8276 2 39.53 5 18845 VEV_2_3_RA5_01_1236.d 0 1 1 627 636
K.STTTM(-4.99)GLTQALGAHLNR.I Y 23.26 1765.9183 17 -37.6 589.6246 3 72.16 4 40916 VEV_1_3_RA4_01_1235.d 8.48E4 1 1 481 497 Methionine replacement by azido homoalanine
K.GVIIASSKPK(+27.99).D Y 22.94 1026.6073 10 -3.5 343.2085 3 29.27 4 12440 VEV_1_3_RA4_01_1235.d 5.27E5 2 2 904 913 Formylation
R.FK(-1.03)PSLVIFQIGDRSDSSTYVR.M Y 22.31 2413.2278 21 33.6 604.3345 4 79.31 4 46481 VEV_1_3_RA4_01_1235.d 0 1 1 132 152 Lysine oxidation to aminoadipic semialdehyde
R.YILVCGITPTPLGEGK(+42.01).S Y 22.17 1701.9011 16 -13.0 568.3003 3 79.32 5 45603 VEV_2_3_RA5_01_1236.d 7.23E4 1 1 465 480 Acetylation (K)
K.D(+42.01)FKLLY(-18.01)DLEGTVQER.I Y 20.64 1848.9258 15 -3.7 617.3136 3 66.63 5 36497 VEV_2_3_RA5_01_1236.d 6.54E4 1 1 914 928 Acetylation (N-term); Dehydration
K.SQQTNPR.F Y 20.07 829.4042 7 25.3 415.7199 2 60.83 5 32162 VEV_2_3_RA5_01_1236.d 1.62E5 1 1 125 131
R.RFSSFPIR.S Y 19.86 1008.5505 8 -11.7 337.1868 3 42.18 4 20021 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 53 60
K.IDGLF Y 19.77 563.2955 5 -39.7 564.2804 1 31.35 5 14047 VEV_2_3_RA5_01_1236.d 0 2 2 1034 1038
K.L(+42.01)LYDLEGT(-18.01)VQER.I Y 19.64 1458.7355 12 -18.3 487.2435 3 51.23 6 25005 VEV_3_3_RA6_01_1237.d 7.81E5 1 1 917 928 Acetylation (N-term); Dehydration
R.GITIGQ(+.98)AATERGHTR.E Y 19.62 1567.8066 15 14.2 392.9645 4 22.52 5 9078 VEV_2_3_RA5_01_1236.d 0 1 1 637 651 Deamidation (NQ)
R.GITIGQ(+.98)AAT(+79.97)ER.G Y 19.34 1196.5438 11 31.2 599.2979 2 73.38 4 41885 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 637 647 Deamidation (NQ); Phosphorylation (STY)
K.VSGIELAGK(+21.98).N Y 19.06 894.4786 9 -55.4 895.4364 1 106.40 6 57140 VEV_3_3_RA6_01_1237.d 3.42E3 1 1 254 262 Sodium adduct
K.S(-15.99)ADATVTVC(+57.02)HSK.T Y 18.82 1258.5975 12 -27.0 630.2891 2 36.88 5 17282 VEV_2_3_RA5_01_1236.d 3.06E4 1 1 283 294 Deoxy; Carbamidomethylation
K.GVIIASSKPK.D Y 18.79 998.6124 10 -74.5 500.2762 2 26.70 6 11097 VEV_3_3_RA6_01_1237.d 0 1 1 904 913
R.FSSFPIR.S Y 18.62 852.4493 7 -34.0 853.4276 1 99.81 5 55956 VEV_2_3_RA5_01_1236.d 3.92E4 2 2 54 60
R.LVPAKNGK.R Y 18.59 825.5072 8 -4.8 413.7589 2 60.65 6 30910 VEV_3_3_RA6_01_1237.d 0 1 1 573 580
K.GVIIASSK(+27.99)PK.D Y 18.26 1026.6073 10 -10.3 343.2062 3 28.57 6 12079 VEV_3_3_RA6_01_1237.d 0 1 1 904 913 Formylation
R.LN(+.98)AEIQKSQQTNPR(+14.02).F Y 17.46 1640.8481 14 22.1 329.1841 5 61.13 4 32331 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 118 131 Deamidation (NQ); Methylation(KR)
K.T(+42.01)QYSLSHDPNLK(+28.03).G Y 17.08 1471.7307 12 -7.0 368.9374 4 33.99 6 15065 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 970 981 Acetylation (N-term); Dimethylation(KR)
K.LKAAQEANIQC(+57.02)QLTK(+226.08).F Y 17.03 1940.9812 15 -19.5 486.2431 4 51.19 5 25875 VEV_2_3_RA5_01_1236.d 1.38E5 1 1 155 169 Carbamidomethylation; Biotinylation
K.GVMELLK.V Y 16.94 788.4466 7 -16.6 395.2240 2 70.59 5 39420 VEV_2_3_RA5_01_1236.d 1.53E5 2 2 247 253
R.GITIGQ(+.98)AATER(+14.02).G Y 16.61 1130.5931 11 -9.6 377.8680 3 57.51 4 29666 VEV_1_3_RA4_01_1235.d 6.99E4 1 1 637 647 Deamidation (NQ); Methylation(KR)
K.Q(+.98)ADILVAAIGKPEFVK(+43.99).G Y 16.48 1742.9454 16 4.9 436.7458 4 78.14 5 44809 VEV_2_3_RA5_01_1236.d 7.54E4 1 1 304 319 Deamidation (NQ); Carboxylation (DKW)
R.HLRGIT(+79.97)IGQ(+.98)AATER(+14.02).G Y 16.39 1616.8036 14 54.1 405.2300 4 64.86 6 34006 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 634 647 Phosphorylation (STY); Deamidation (NQ); Methylation(KR)
K.Q(+27.99)YGIPVIVAINK.F Y 16.36 1341.7656 12 -54.7 448.2380 3 61.76 6 31721 VEV_3_3_RA6_01_1237.d 7.58E4 1 1 850 861 Formylation
R.SYFEKQKDR.H Y 16.28 1199.5934 9 -8.2 300.9032 4 16.95 4 5805 VEV_1_3_RA4_01_1235.d 6.56E4 1 1 389 397
R.GITIGQAATERGHTR.E Y 16.13 1566.8226 15 -8.5 392.7096 4 42.21 6 19780 VEV_3_3_RA6_01_1237.d 4.96E4 1 1 637 651
K.S(+42.01)ADATVTVC(+57.02)HSK(+28.03).T Y 16.05 1344.6344 12 19.6 673.3376 2 67.14 4 36955 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 283 294 Acetylation (N-term); Carbamidomethylation; Dimethylation(KR)
K.Q(+27.99)(+.98)YGIPVIVAINK.F Y 15.94 1342.7496 12 -62.7 448.5624 3 61.85 6 31787 VEV_3_3_RA6_01_1237.d 2.68E5 1 1 850 861 Formylation; Deamidation (NQ)
R.E(+27.99)RLNAEIQKSQ(+.98)QTNPR.F Y 15.93 1939.9711 16 3.6 970.9963 2 89.52 6 51066 VEV_3_3_RA6_01_1237.d 1.85E5 1 1 116 131 Formylation; Deamidation (NQ)
R.HHQPN(+.98)S(+79.97)LSRPHPIAQ(+.98)FHAHHGTR.L Y 15.91 2743.2629 23 6.1 686.8272 4 74.69 6 41320 VEV_3_3_RA6_01_1237.d 5.62E4 1 1 26 48 Deamidation (NQ); Phosphorylation (STY)
R.GITIGQ(+.98)AATER.G Y 15.91 1116.5775 11 -34.9 559.2766 2 56.48 6 28089 VEV_3_3_RA6_01_1237.d 0 1 1 637 647 Deamidation (NQ)
K.GVIIASSKPKDFK.L Y 15.81 1388.8027 13 -10.4 348.2043 4 46.50 4 22704 VEV_1_3_RA4_01_1235.d 1.83E5 1 1 904 916
K.SADATVTVC(+57.02)HS(-18.01)K(+14.02).T Y 15.71 1270.5975 12 27.0 1271.6392 1 87.91 4 52452 VEV_1_3_RA4_01_1235.d 5.1E4 1 1 283 294 Carbamidomethylation; Dehydration; Methylation(KR)
K.S(+42.01)ADATVTVC(+57.02)HSK(+42.01).T Y 15.03 1358.6136 12 5.7 680.3180 2 79.11 4 46333 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 283 294 Acetylation (N-term); Carbamidomethylation; Acetylation (K)
total 85 peptides
C1GCK9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HAISLSHVSLTPFTIPKLPR.S Y 147.23 2213.2683 20 -15.6 443.6541 5 78.91 6 44396 VEV_3_3_RA6_01_1237.d 2.66E6 12 12 59 78
R.HAISLSHVSLTPFTIPK.L Y 131.11 1847.0305 17 -11.1 616.6773 3 77.15 5 44145 VEV_2_3_RA5_01_1236.d 4.77E6 13 13 59 75
R.SGSYTGKLAVIVEIIDHKR.V Y 122.26 2085.1582 19 -12.3 418.0338 5 79.11 4 46366 VEV_1_3_RA4_01_1235.d 4E5 4 4 24 42
R.VLVDGPAGHENKVVPR.H Y 119.82 1685.9213 16 -11.8 422.4826 4 52.83 4 26693 VEV_1_3_RA4_01_1235.d 3.1E6 15 15 43 58
K.LWEKEEIDSKWASSLFAK.K Y 109.65 2166.0996 18 -9.8 542.5269 4 79.43 4 46580 VEV_1_3_RA4_01_1235.d 1.17E6 5 5 88 105
R.VLVDGPAGHENK.V Y 104.99 1234.6306 12 -6.1 618.3188 2 29.28 4 12497 VEV_1_3_RA4_01_1235.d 2.7E6 13 13 43 54
R.YEVQKAHAK.I Y 98.38 1072.5665 9 -13.8 537.2831 2 10.85 6 2846 VEV_3_3_RA6_01_1237.d 4.17E5 6 6 133 141
R.NLTDFERFKVMR.L Y 94.66 1554.7976 12 -14.5 389.7010 4 71.60 5 40196 VEV_2_3_RA5_01_1236.d 2.52E5 3 3 115 126
K.LAVIVEIIDHKR.V Y 87.79 1404.8452 12 -26.5 352.2093 4 72.68 6 39881 VEV_3_3_RA6_01_1237.d 3.13E5 6 6 31 42
R.VLVDGPAGHE(+14.02)NKVVPR.H Y 73.51 1699.9369 16 -22.7 425.9818 4 58.86 6 29616 VEV_3_3_RA6_01_1237.d 1.54E5 1 1 43 58 Methylation(others)
R.VLVDGPAGHENKVVPR(+14.02).H Y 71.85 1699.9369 16 -21.6 425.9823 4 58.46 6 29343 VEV_3_3_RA6_01_1237.d 6.79E4 1 1 43 58 Methylation(KR)
R.HAISLSHVSLTPFTIPKLPR(+14.02).S Y 64.51 2227.2839 20 4.1 446.4659 5 79.69 4 46780 VEV_1_3_RA4_01_1235.d 6.91E4 1 1 59 78 Methylation(KR)
K.LWEKEEIDSK.W Y 64.19 1275.6346 10 -13.6 638.8159 2 47.96 6 23111 VEV_3_3_RA6_01_1237.d 1.89E6 9 9 88 97
K.LWEKEE(+14.02)IDSKWASSLFAK.K Y 62.77 2180.1152 18 -7.3 546.0321 4 80.58 4 47467 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 88 105 Methylation(others)
R.NLTDFERFK.V Y 61.36 1168.5876 9 -19.7 390.5288 3 66.70 6 35411 VEV_3_3_RA6_01_1237.d 8.25E5 3 3 115 123
R.SAGTGPVKK.L Y 60.26 843.4814 9 -15.6 422.7414 2 9.34 6 2251 VEV_3_3_RA6_01_1237.d 4.04E4 2 2 79 87
R.NLTDFER.F Y 59.39 893.4243 7 -17.9 447.7114 2 55.28 6 27365 VEV_3_3_RA6_01_1237.d 4.34E6 11 11 115 121
R.VLVD(+43.99)GPAGHENKVVPR.H Y 58.81 1729.9111 16 -38.8 433.4683 4 52.71 5 26814 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 43 58 Carboxylation (DKW)
R.HAISLSHVSLTPFTIPK(+14.02).L Y 58.22 1861.0461 17 -22.6 466.2583 4 78.78 6 44280 VEV_3_3_RA6_01_1237.d 1.77E5 3 3 59 75 Methylation(KR)
R.HAISLSHVSLT(-2.02)PFTIPK.L Y 54.01 1845.0148 17 -34.1 462.2452 4 77.62 6 43459 VEV_3_3_RA6_01_1237.d 8.27E4 1 1 59 75 2-amino-3-oxo-butanoic_acid
R.HAISLSHVSLTPFTIPK(+43.01)LPR(+14.02).S Y 49.12 2270.2898 20 -12.6 455.0595 5 78.76 5 45229 VEV_2_3_RA5_01_1236.d 5.4E4 2 2 59 78 Carbamylation; Methylation(KR)
K.LWEK(+14.02)EEIDSKWASSLFAK.K Y 48.22 2180.1152 18 -3.9 546.0339 4 81.38 4 48076 VEV_1_3_RA4_01_1235.d 1.85E5 2 2 88 105 Methylation(KR)
R.IVLIR.S N 47.59 612.4323 5 -24.7 307.2159 2 54.08 5 27686 VEV_2_3_RA5_01_1236.d 8.42E5 7 7 19 23
R.VLVDGPAGHENK(+14.02).V Y 47.15 1248.6462 12 -1.0 417.2223 3 38.46 4 17775 VEV_1_3_RA4_01_1235.d 8.89E5 6 6 43 54 Methylation(KR)
R.YEVQKAHAK(+14.02).I Y 45.66 1086.5822 9 -18.4 544.2883 2 13.94 5 4463 VEV_2_3_RA5_01_1236.d 3.95E4 2 2 133 141 Methylation(KR)
R.HAISLSHVSLTPFT(-18.01)IPK(+14.02).L Y 44.24 1843.0355 17 -54.8 615.3188 3 77.15 5 44131 VEV_2_3_RA5_01_1236.d 0 1 1 59 75 Dehydration; Methylation(KR)
R.HAISLSHVS(-18.01)LTPFTIPKLPR.S Y 42.06 2195.2578 20 -35.6 440.0432 5 78.81 5 45261 VEV_2_3_RA5_01_1236.d 0 1 1 59 78 Dehydration
R.VLVD(+14.02)GPAGHENKVVPR.H Y 39.50 1699.9369 16 -42.0 425.9736 4 55.54 4 28360 VEV_1_3_RA4_01_1235.d 0 1 1 43 58 Methylation(others)
K.WASSLFAK.K Y 38.88 908.4756 8 -17.7 455.2370 2 68.63 6 36858 VEV_3_3_RA6_01_1237.d 6.93E5 2 2 98 105
R.VLVDGPAGHENK(+14.02)VVPR.H Y 37.45 1699.9369 16 -16.3 425.9846 4 58.87 4 30633 VEV_1_3_RA4_01_1235.d 2.55E5 1 1 43 58 Methylation(KR)
R.HAISLSHVSLTPFTIPKLPR(-.98)(+14.02).S Y 36.79 2226.3000 20 -19.1 446.2588 5 79.66 5 45830 VEV_2_3_RA5_01_1236.d 6.72E4 1 1 59 78 Amidation; Methylation(KR)
R.V(+42.01)LVDGPAGHEN(+.98)KVVPR.H Y 35.76 1728.9158 16 -27.1 433.2245 4 56.53 4 28980 VEV_1_3_RA4_01_1235.d 0 1 1 43 58 Acetylation (N-term); Deamidation (NQ)
K.LVEVGR.I Y 35.20 671.3966 6 -18.8 336.6993 2 27.50 6 11513 VEV_3_3_RA6_01_1237.d 5.58E5 4 4 13 18
M.A(+42.01)QVDIKTSSWK.L Y 33.61 1303.6772 11 -13.2 652.8373 2 66.54 4 36547 VEV_1_3_RA4_01_1235.d 3.01E5 3 3 2 12 Acetylation (Protein N-term)
K.KLWEKEEIDSKWASSLFAK.K Y 31.88 2294.1946 19 -10.6 459.8413 5 77.32 4 44947 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 87 105
K.TSSWKLVEVGR.I Y 31.02 1260.6826 11 -12.4 421.2296 3 64.39 4 34804 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 8 18
K.KLWEKEEIDSK.W Y 29.36 1403.7296 11 -5.4 468.9146 3 44.12 4 21217 VEV_1_3_RA4_01_1235.d 8.43E4 1 1 87 97
R.RNLTDFER.F Y 27.20 1049.5254 8 -11.4 525.7640 2 45.55 4 22109 VEV_1_3_RA4_01_1235.d 2.28E5 2 2 114 121
R.NLTDFERFK(+14.02).V Y 25.66 1182.6033 9 -17.3 395.2015 3 71.50 5 40095 VEV_2_3_RA5_01_1236.d 8.41E4 2 2 115 123 Methylation(KR)
M(+42.01)AQVDIK(+14.02).T Y 25.42 859.4473 7 -16.4 860.4405 1 112.16 5 59427 VEV_2_3_RA5_01_1236.d 1.56E4 1 1 1 7 Acetylation (Protein N-term); Methylation(KR)
R.NLTDFER(+14.02).F Y 25.26 907.4399 7 -9.0 454.7231 2 56.82 4 29178 VEV_1_3_RA4_01_1235.d 2.51E5 4 4 115 121 Methylation(KR)
R.HAISLSHVSLTPFTIPK(+362.14).L Y 23.23 2209.1670 17 -27.8 553.2837 4 78.80 4 46092 VEV_1_3_RA4_01_1235.d 7.38E4 1 1 59 75 Nucleophilic addtion to cytopiloyne
K.K(+42.01)QARYEVQK(+42.01).A Y 22.92 1232.6512 9 -4.0 309.1689 4 19.42 4 7105 VEV_1_3_RA4_01_1235.d 0 1 1 129 137 Acetylation (N-term); Acetylation (K)
K.L(+42.01)PRSAGT(+79.97)GPVK(+14.02).K Y 22.54 1217.6169 11 -22.5 305.4047 4 15.27 5 5176 VEV_2_3_RA5_01_1236.d 8.58E4 1 1 76 86 Acetylation (N-term); Phosphorylation (STY); Methylation(KR)
R.NLTDFERFK(+31.99).V Y 22.44 1200.5775 9 -14.3 601.2875 2 63.06 4 33808 VEV_1_3_RA4_01_1235.d 5.8E4 1 1 115 123 Dihydroxy
R.HAISLSHVS(-18.01)LTPFTIPK(+14.02).L Y 22.21 1843.0355 17 -29.7 615.3342 3 77.53 4 45116 VEV_1_3_RA4_01_1235.d 0 1 1 59 75 Dehydration; Methylation(KR)
K.L(+27.99)VEVGR.I Y 21.86 699.3915 6 -35.8 700.3738 1 27.20 6 11361 VEV_3_3_RA6_01_1237.d 0 1 1 13 18 Formylation (Protein N-term)
R.FKVMR.L Y 20.75 679.3839 5 -15.6 340.6939 2 26.49 4 10924 VEV_1_3_RA4_01_1235.d 3.21E5 2 2 122 126
R.SAGTGPVKK(+14.02).L Y 20.54 857.4970 9 -10.2 429.7514 2 11.77 4 3201 VEV_1_3_RA4_01_1235.d 2.97E4 1 1 79 87 Methylation(KR)
K.KEQTDR.R Y 19.63 775.3824 6 -5.4 776.3854 1 64.52 5 34920 VEV_2_3_RA5_01_1236.d 0 1 1 107 112
R.N(+.98)LTDFER.F Y 18.77 894.4083 7 10.1 448.2159 2 55.56 5 28491 VEV_2_3_RA5_01_1236.d 3.18E5 1 1 115 121 Deamidation (NQ)
K.IRASSS Y 18.21 619.3289 6 -11.3 620.3292 1 74.00 4 42356 VEV_1_3_RA4_01_1235.d 0 1 1 142 147
R.NLTDFER(+14.02)FK.V Y 17.86 1182.6033 9 -20.3 395.2004 3 71.37 6 38891 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 115 123 Methylation(KR)
R.HAISLSHVSLTPFTIPKLPR(+80.99).S Y 17.25 2294.2534 20 -35.2 459.8418 5 77.24 5 44193 VEV_2_3_RA5_01_1236.d 8.15E4 1 1 59 78 Arginine replacement by Nitropyrimidyl ornithine
M(+42.01)AQVDIK.T Y 16.99 845.4317 7 -11.9 423.7181 2 60.39 6 30719 VEV_3_3_RA6_01_1237.d 0 1 1 1 7 Acetylation (Protein N-term)
R.SAGTGPVK.K Y 16.74 715.3864 8 -46.0 716.3608 1 78.07 6 43772 VEV_3_3_RA6_01_1237.d 6.18E4 1 1 79 86
R.N(+.98)LTDFER(+14.02).F Y 16.70 908.4240 7 15.8 455.2264 2 56.64 5 29190 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 115 121 Deamidation (NQ); Methylation(KR)
MAQVDIKTSSWK.L Y 16.48 1392.7072 12 -18.1 349.1778 4 32.76 6 14395 VEV_3_3_RA6_01_1237.d 8.91E4 1 1 1 12
R.HAISLSHVSLTPFTIPK(-.98).L Y 16.45 1846.0465 17 -71.4 616.3122 3 77.67 4 45222 VEV_1_3_RA4_01_1235.d 0 1 1 59 75 Amidation
K.LWEK(+14.02)EEIDSK.W Y 15.82 1289.6503 10 -8.7 430.8870 3 57.02 4 29366 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 88 97 Methylation(KR)
R.S(+27.99)AGTGPVK.K Y 15.76 743.3813 8 -31.0 744.3656 1 85.29 4 50788 VEV_1_3_RA4_01_1235.d 7.17E4 1 1 79 86 Formylation
K.L(+42.01)AVIVEIID(+43.99)HK.R Y 15.73 1334.7445 11 -3.3 668.3773 2 102.63 5 56841 VEV_2_3_RA5_01_1236.d 0 1 1 31 41 Acetylation (N-term); Carboxylation (DKW)
K.LVEVGR(+14.02).I Y 15.64 685.4122 6 -40.0 686.3921 1 105.91 5 57750 VEV_2_3_RA5_01_1236.d 0 1 1 13 18 Methylation(KR)
R.VLVDGPAGHENK(+68.03).V Y 15.45 1302.6567 12 33.2 652.3573 2 43.12 5 20998 VEV_2_3_RA5_01_1236.d 0 1 1 43 54 Crotonylation
MAQVD(+43.99)IK(+14.02).T Y 15.37 861.4266 7 -5.5 862.4291 1 87.83 5 50748 VEV_2_3_RA5_01_1236.d 7.52E4 1 1 1 7 Carboxylation (DKW); Methylation(KR)
R.V(+42.01)LVDGPAGHE(+21.98)NK.V Y 15.31 1298.6230 12 -46.7 433.8614 3 49.15 5 24642 VEV_2_3_RA5_01_1236.d 0 1 1 43 54 Acetylation (N-term); Sodium adduct
K.LPRS(+79.97)AGTGPVK(+42.01).K Y 15.00 1203.6012 11 9.1 402.2113 3 51.14 6 24953 VEV_3_3_RA6_01_1237.d 0 1 1 76 86 Phosphorylation (STY); Acetylation (K)
total 67 peptides
C1GFG5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YVHNNNKITVTSQSAFDAQFNR.A Y 138.22 2553.2361 22 -12.1 639.3086 4 65.15 6 34235 VEV_3_3_RA6_01_1237.d 1.25E6 6 6 45 66
R.KTPTAPAVVEPTKVLGK.T Y 131.48 1735.0243 17 -11.4 434.7584 4 61.92 4 32995 VEV_1_3_RA4_01_1235.d 2.38E6 10 10 149 165
K.AAGSKPSGTATHASYR.D Y 115.10 1560.7644 16 -18.3 521.2526 3 14.18 6 4520 VEV_3_3_RA6_01_1237.d 1.04E6 9 9 6 21
K.EATKPAAKPAAK.K Y 113.64 1181.6768 12 -10.7 591.8394 2 9.39 5 2293 VEV_2_3_RA5_01_1236.d 3.3E5 6 6 93 104
R.KTPTAPAVVEPTK.V Y 108.82 1337.7554 13 -7.5 669.8799 2 42.38 4 20146 VEV_1_3_RA4_01_1235.d 5.55E5 8 8 149 161
K.ITVTSQSAFDAQFNR.A Y 92.77 1683.8217 15 -3.6 562.2791 3 72.03 4 40815 VEV_1_3_RA4_01_1235.d 7.03E5 6 6 52 66
K.KAAGSKPSGTATHASYR.D Y 88.65 1688.8594 17 -9.4 423.2182 4 12.68 4 3635 VEV_1_3_RA4_01_1235.d 1.33E5 3 3 5 21
R.AVKSGVEKGEFTQPK.G Y 83.52 1603.8569 15 -9.8 802.9279 2 31.94 5 14385 VEV_2_3_RA5_01_1236.d 1E5 3 3 67 81
K.KEATKPAAKPAAK.K Y 81.04 1309.7717 13 -5.9 655.8893 2 9.10 4 2171 VEV_1_3_RA4_01_1235.d 3.82E5 6 6 92 104
K.E(-18.01)ATKPAAKPAAK.K Y 80.73 1163.6661 12 -14.7 388.8903 3 9.31 5 2291 VEV_2_3_RA5_01_1236.d 2.56E5 3 3 93 104 Pyro-glu from E
K.TPTAPAVVEPTK.V Y 77.87 1209.6605 12 -11.3 605.8307 2 53.75 4 27287 VEV_1_3_RA4_01_1235.d 5.6E4 2 2 150 161
R.DMIKDAIINLKER.N Y 77.85 1557.8549 13 -9.7 390.4672 4 73.86 4 42275 VEV_1_3_RA4_01_1235.d 2.58E5 2 2 22 34
K.SGVEKGEFTQPK.G Y 76.85 1305.6565 12 -13.2 653.8269 2 30.98 6 13443 VEV_3_3_RA6_01_1237.d 3.37E6 12 12 70 81
K.SGVEKGEFTQPKGPSGPLK.L Y 68.50 1942.0159 19 -8.1 486.5073 4 55.25 5 28310 VEV_2_3_RA5_01_1236.d 5.64E5 3 3 70 88
K.KAAGSKPSGT(-18.01)ATHASYR.D Y 65.95 1670.8489 17 -8.5 335.1742 5 12.76 4 3704 VEV_1_3_RA4_01_1235.d 2.22E5 1 1 5 21 Dehydration
K.YVHN(+.98)NN(+.98)KITVTSQSAFDAQFNR.A Y 63.90 2555.2041 22 6.3 639.8123 4 65.37 4 35566 VEV_1_3_RA4_01_1235.d 8.36E4 1 1 45 66 Deamidation (NQ)
K.EATKPAAKPAAKK.A Y 59.95 1309.7717 13 -13.3 655.8844 2 8.96 5 2132 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 93 105
K.KEATKPAAKPAAKK.A Y 59.24 1437.8667 14 -26.7 480.2834 3 8.89 5 2109 VEV_2_3_RA5_01_1236.d 2.5E4 2 2 92 105
R.DMIKDAIINLKER(+14.02).N Y 58.01 1571.8705 13 -15.2 393.9689 4 76.34 4 44180 VEV_1_3_RA4_01_1235.d 4.9E4 1 1 22 34 Methylation(KR)
K.GPSGPLK.L Y 55.26 654.3701 7 -17.6 328.1866 2 16.41 5 5819 VEV_2_3_RA5_01_1236.d 1.28E6 7 7 82 88
R.K(+14.02)TPT(-18.01)APAVVEPTKVLGK.T Y 38.39 1731.0294 17 -49.2 433.7433 4 61.93 4 32940 VEV_1_3_RA4_01_1235.d 0 1 1 149 165 Methylation(KR); Dehydration
K.ANVAKPR.K Y 34.73 754.4449 7 -29.3 378.2187 2 9.51 6 2314 VEV_3_3_RA6_01_1237.d 2.31E4 1 1 142 148
K.AAGS(-18.01)K(+14.02)PSGTATHASYR.D Y 32.79 1556.7695 16 12.0 390.2043 4 14.17 6 4509 VEV_3_3_RA6_01_1237.d 0 1 1 6 21 Dehydration; Methylation(KR)
R.KTPTAPAVVE(+14.02)PTKVLGK.T Y 32.32 1749.0399 17 -22.4 438.2575 4 63.97 4 34494 VEV_1_3_RA4_01_1235.d 1.59E5 2 2 149 165 Methylation(others)
MPPK(+111.03)KAAGSKPSGTATHASYR.D Y 31.92 2253.1323 21 -8.7 564.2855 4 12.69 4 3648 VEV_1_3_RA4_01_1235.d 7.03E3 1 1 1 21 Nmethylmaleimide
K.KEATK(+164.06)PAAKPAAK.K Y 31.85 1473.8319 13 -16.0 369.4594 4 9.01 5 2154 VEV_2_3_RA5_01_1236.d 8.97E3 1 1 92 104 O-Diisopropylphosphorylation
K.GEFTQPK.G Y 30.88 805.3970 7 9.6 403.7096 2 22.79 4 8930 VEV_1_3_RA4_01_1235.d 0 2 2 75 81
K.YVHNNNK(-1.03)ITVTSQSAFDAQFNR.A Y 27.44 2552.2043 22 18.5 639.0702 4 111.69 5 59288 VEV_2_3_RA5_01_1236.d 3.73E4 1 1 45 66 Lysine oxidation to aminoadipic semialdehyde
K.TP(+31.99)TAPAVVEPT(+79.97)K.V Y 27.16 1321.6166 12 37.0 331.4236 4 11.46 6 3138 VEV_3_3_RA6_01_1237.d 8.09E4 1 1 150 161 Dihydroxy; Phosphorylation (STY)
K.ITVTSQSAFDAQFNR(+14.02).A Y 26.87 1697.8373 15 12.6 566.9601 3 72.98 4 41567 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 52 66 Methylation(KR)
R.K(+42.01)TPTAPAVVEPTKVLGK.T Y 26.46 1777.0349 17 -70.6 445.2346 4 61.97 4 32966 VEV_1_3_RA4_01_1235.d 0 1 1 149 165 Acetylation (N-term)
K.DAIINLK.E Y 26.37 785.4647 7 -23.1 393.7305 2 62.67 4 33506 VEV_1_3_RA4_01_1235.d 9.29E4 1 1 26 32
K.DAIINLKER.N Y 26.29 1070.6084 9 7.8 357.8795 3 55.96 5 28739 VEV_2_3_RA5_01_1236.d 1.85E5 2 2 26 34
K.YVHNNNK.I Y 26.20 887.4249 7 -10.9 888.4225 1 88.32 4 52704 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 45 51
K.EATK(+14.02)PAAKPAAK.K Y 25.21 1195.6924 12 -17.1 399.5646 3 11.16 4 2925 VEV_1_3_RA4_01_1235.d 1.91E4 1 1 93 104 Methylation(KR)
K.AAK(+42.01)PAATK.K Y 23.62 798.4599 8 -29.8 400.2253 2 39.52 6 18213 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 106 113 Acetylation (K)
K.SGVEKGEFTQPK(+14.02).G Y 23.27 1319.6721 12 -18.0 440.8901 3 40.26 5 19269 VEV_2_3_RA5_01_1236.d 2.13E6 2 2 70 81 Methylation(KR)
K.T(+42.01)TTTTK.K Y 23.25 693.3545 6 -13.9 347.6797 2 31.19 4 13532 VEV_1_3_RA4_01_1235.d 3.93E5 2 2 189 194 Acetylation (N-term)
K.QATTKAATTK(+42.01).K Y 22.51 1061.5717 10 14.7 354.8697 3 42.38 5 20548 VEV_2_3_RA5_01_1236.d 0 1 1 119 128 Acetylation (K)
K.K(+226.08)AAKPAAT(+79.97)K.K Y 21.11 1190.5883 9 37.5 397.8849 3 57.02 6 28382 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 105 113 Biotinylation; Phosphorylation (STY)
K.ANVAKPR(+14.02).K Y 21.07 768.4606 7 -14.7 385.2319 2 11.98 5 3428 VEV_2_3_RA5_01_1236.d 2.55E4 1 1 142 148 Methylation(KR)
K.T(+119.04)PTAPAVVEPTKVLGK.T Y 21.00 1725.9664 16 -9.6 432.4947 4 61.61 6 31616 VEV_3_3_RA6_01_1237.d 0 1 1 150 165 Pyridylacetyl
K.AATTK.K N 20.70 490.2751 5 -49.6 491.2581 1 73.39 4 41895 VEV_1_3_RA4_01_1235.d 0 1 1 124 128
K.T(+42.01)PT(+79.96)APAVVEPTK.V Y 20.65 1331.6278 12 24.4 666.8374 2 42.49 4 20218 VEV_1_3_RA4_01_1235.d 9.79E4 1 1 150 161 Acetylation (N-term); Sulfation
R.VTK(+27.99)TTAKS(+79.97)SPK.K Y 20.39 1254.6221 11 -10.1 419.2104 3 57.59 6 28754 VEV_3_3_RA6_01_1237.d 2.5E5 1 1 171 181 Formylation; Phosphorylation (STY)
K.SGVEK.G Y 20.10 518.2700 5 -9.6 519.2723 1 64.66 5 35017 VEV_2_3_RA5_01_1236.d 0 1 1 70 74
K.A(+42.01)GATK.K Y 20.07 488.2595 5 -37.5 489.2484 1 48.19 4 23745 VEV_1_3_RA4_01_1235.d 0 1 1 183 187 Acetylation (N-term)
K.GPSGPLKLAK.K Y 20.05 966.5862 10 -76.9 484.2632 2 38.54 5 18255 VEV_2_3_RA5_01_1236.d 0 2 2 82 91
K.AAGS(+79.97)KPSGTATHAS(-18.01)YR.D Y 19.79 1622.7202 16 -10.8 406.6830 4 20.31 6 7712 VEV_3_3_RA6_01_1237.d 6.57E4 1 1 6 21 Phosphorylation (STY); Dehydration
K.A(+27.99)ATTK.K N 19.30 518.2700 5 -11.0 519.2716 1 10.85 5 2891 VEV_2_3_RA5_01_1236.d 4.76E3 1 1 124 128 Formylation
R.AVKS(+162.05)GVEK.G Y 19.18 978.5233 8 -32.3 490.2531 2 61.69 6 31677 VEV_3_3_RA6_01_1237.d 2.04E5 1 1 67 74 Hexose (NSY)
K.EAT(-18.01)KPAAKPAAK.K Y 18.77 1163.6661 12 -15.4 388.8900 3 9.24 4 2212 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 93 104 Dehydration
K.AGATK.K Y 18.74 446.2489 5 -10.8 447.2513 1 16.68 4 5669 VEV_1_3_RA4_01_1235.d 1.93E4 1 1 183 187
K.ITVTSQSAFD(+21.98)AQ(+.98)FNRAVK.S Y 18.73 2004.9880 18 -2.9 502.2528 4 61.18 5 32482 VEV_2_3_RA5_01_1236.d 3.26E5 1 1 52 69 Sodium adduct; Deamidation (NQ)
K.AAK(+43.01)PAATKK.A Y 18.27 927.5501 9 8.1 928.5649 1 100.25 4 58273 VEV_1_3_RA4_01_1235.d 1.2E4 1 1 106 114 Carbamylation
K.AAT(-18.01)TKK.A Y 18.15 600.3595 6 -24.5 601.3521 1 99.94 6 55320 VEV_3_3_RA6_01_1237.d 0 1 1 124 129 Dehydration
K.SGVE(+14.02)KGEFTQPK.G Y 18.02 1319.6721 12 -15.1 660.8334 2 38.31 6 17530 VEV_3_3_RA6_01_1237.d 4.65E4 1 1 70 81 Methylation(others)
K.KAT(+79.96)PK.K Y 17.55 623.2949 5 12.9 624.3102 1 16.21 4 5416 VEV_1_3_RA4_01_1235.d 9.71E3 1 1 195 199 Sulfation
K.AATTK(+43.99).K N 17.48 534.2650 5 -21.5 535.2607 1 44.89 6 21336 VEV_3_3_RA6_01_1237.d 0 1 1 124 128 Carboxylation (DKW)
K.AATTK(+21.98).K N 17.20 512.2570 5 -6.2 513.2611 1 33.98 4 15137 VEV_1_3_RA4_01_1235.d 2.79E4 2 2 124 128 Sodium adduct
K.AATTK(+27.99).K N 16.96 518.2700 5 -35.6 519.2589 1 47.90 4 23571 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 124 128 Formylation
K.AATTK(+31.99).K N 16.91 522.2650 5 -2.4 523.2710 1 70.09 5 39060 VEV_2_3_RA5_01_1236.d 0 1 1 124 128 Dihydroxy
K.SGVEKGEFTQ(+.98)PK.G Y 16.47 1306.6405 12 -9.5 436.5500 3 35.43 4 16001 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 70 81 Deamidation (NQ)
K.K(+42.01)TAAAKPK.A Y 16.40 855.5178 8 -16.9 428.7589 2 62.39 6 32237 VEV_3_3_RA6_01_1237.d 2.37E6 1 1 134 141 Acetylation (N-term)
K.Q(+42.01)(+.98)ATTK.A Y 16.34 590.2911 5 -13.3 591.2906 1 67.80 4 37483 VEV_1_3_RA4_01_1235.d 5.01E4 1 1 119 123 Acetylation (N-term); Deamidation (NQ)
K.SSPKKAGATKK.T Y 16.07 1101.6505 11 -80.6 368.1945 3 33.85 6 14984 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 178 188
K.A(+43.01)APKQATTK.A Y 15.93 957.5243 9 -22.0 479.7589 2 25.98 4 10650 VEV_1_3_RA4_01_1235.d 3.94E5 1 1 115 123 Carbamylation
R.VTK(+42.01)TT(+79.97)AK(+42.01).S Y 15.89 911.4365 7 17.7 912.4599 1 94.53 5 54026 VEV_2_3_RA5_01_1236.d 0 1 1 171 177 Acetylation (K); Phosphorylation (STY)
K.GEFTQPKGPSGPLK(+27.99).L Y 15.71 1469.7513 14 -37.1 490.9062 3 60.18 6 30570 VEV_3_3_RA6_01_1237.d 4.34E4 1 1 75 88 Formylation
K.K(+42.01)AT(+79.97)PK(+42.01).K Y 15.63 707.3255 5 2.7 708.3347 1 112.53 4 61829 VEV_1_3_RA4_01_1235.d 0 1 1 195 199 Acetylation (N-term); Phosphorylation (STY); Acetylation (K)
K.TTAKSSPKKAGATK(+226.08).K Y 15.36 1600.8606 14 14.2 401.2281 4 36.91 6 16720 VEV_3_3_RA6_01_1237.d 0 1 1 174 187 Biotinylation
R.VTKTTAK(+58.01)SSPK.K Y 15.30 1204.6663 11 -48.6 603.3112 2 36.07 4 16375 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 171 181 Carboxymethyl (KW, X@N-term)
K.K(+42.01)AGAT(+79.97)KK.T Y 15.21 824.4157 7 -7.1 413.2122 2 29.33 6 12513 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 182 188 Acetylation (N-term); Phosphorylation (STY)
K.T(+79.97)AAAK(+43.01)PK.A Y 15.17 808.3844 7 45.6 809.4285 1 97.91 5 55329 VEV_2_3_RA5_01_1236.d 0 1 1 135 141 Phosphorylation (STY); Carbamylation
K.VLGKTK(+42.01)SGRVT(+79.97)K.T Y 15.15 1394.7646 12 -8.0 349.6956 4 69.00 6 37124 VEV_3_3_RA6_01_1237.d 8.39E4 1 1 162 173 Acetylation (K); Phosphorylation (STY)
R.NGSSR.Q Y 15.14 519.2401 5 5.1 520.2501 1 46.30 4 22574 VEV_1_3_RA4_01_1235.d 3.48E4 1 1 35 39
K.K(+14.02)AGAT(+79.97)KKTTTTTK(+42.01).K Y 15.05 1471.7648 13 -47.7 491.5721 3 67.41 5 37076 VEV_2_3_RA5_01_1236.d 0 1 1 182 194 Methylation(KR); Phosphorylation (STY); Acetylation (K)
total 77 peptides
C1GJS2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KDEPAPAPAPAPAPAPETK.T Y 133.20 1853.9523 19 -7.7 927.9763 2 45.83 6 21891 VEV_3_3_RA6_01_1237.d 3.52E5 5 5 84 102
R.TVTLKEDTPAPTLAPPAAETNGTAAK.D Y 112.55 2564.3333 26 -11.2 855.7755 3 67.57 6 36063 VEV_3_3_RA6_01_1237.d 3.78E5 3 3 379 404
K.DEPAPAPAPAPAPAPETK.T Y 109.48 1725.8573 18 -10.3 863.9270 2 57.84 6 28925 VEV_3_3_RA6_01_1237.d 2.79E5 4 4 85 102
R.ANEGNVKLAEEQLTK.A Y 102.80 1642.8525 15 -12.1 548.6182 3 59.37 5 31083 VEV_2_3_RA5_01_1236.d 6.63E5 3 3 163 177
K.DSDDVPTVNVLIK.F Y 101.23 1413.7351 13 -8.3 707.8690 2 77.85 4 45362 VEV_1_3_RA4_01_1235.d 6.05E5 7 7 147 159
K.TPEAPIDNRPEYLSK.N Y 101.05 1728.8682 15 -6.2 865.4360 2 61.16 4 32352 VEV_1_3_RA4_01_1235.d 1.76E6 9 9 103 117
R.EFTFADELPKSYGGK.A Y 99.78 1687.8093 15 -7.7 563.6061 3 74.88 5 42509 VEV_2_3_RA5_01_1236.d 5.43E5 4 4 355 369
K.SYGGKAAELQESAR.T Y 98.97 1465.7161 14 -13.6 489.5726 3 41.28 5 19891 VEV_2_3_RA5_01_1236.d 3.11E5 5 5 365 378
K.TPEAPIDNRPEYLSKNPALSQFFEK.L Y 89.73 2890.4500 25 -2.6 723.6179 4 78.50 4 45868 VEV_1_3_RA4_01_1235.d 2.6E5 2 2 103 127
K.VETARPTEDAKPAETAAAPAPAPAPVEATAPAVVEKPAASALTTAATSTA Y 83.60 4737.4346 50 -8.6 1185.3557 4 76.36 6 42524 VEV_3_3_RA6_01_1237.d 4.6E5 4 4 412 461
K.NPALSQFFEKLASILNK.T Y 83.47 1919.0516 17 -17.4 640.6801 3 92.63 4 55109 VEV_1_3_RA4_01_1235.d 2.56E5 3 3 118 134
K.FQGLGYVANYKDPK.G Y 83.35 1598.8092 14 -14.3 533.9360 3 66.69 5 36542 VEV_2_3_RA5_01_1236.d 4.78E5 6 6 201 214
R.EFTFADELPK.S Y 82.67 1195.5760 10 -11.3 598.7886 2 77.69 5 44543 VEV_2_3_RA5_01_1236.d 1.15E6 4 4 355 364
R.TVTLKEDTPAPTLAPPAAETN(+.98)GTAAK.D Y 78.83 2565.3174 26 -8.6 856.1057 3 69.22 4 38601 VEV_1_3_RA4_01_1235.d 8.04E5 6 6 379 404 Deamidation (NQ)
K.NPALSQFFEK.L Y 71.21 1179.5924 10 -8.6 590.7984 2 75.10 4 43201 VEV_1_3_RA4_01_1235.d 8.97E5 4 4 118 127
M.S(+42.01)EAEKPTQPVAAAAADAPVAAEATPEKPHEQQPADDKPSQNER.V Y 69.21 4518.1533 43 -8.5 904.6302 5 63.70 6 33152 VEV_3_3_RA6_01_1237.d 7.9E4 1 1 2 44 Acetylation (Protein N-term)
K.QTIEVFSTAYPELLK.E Y 67.99 1737.9188 15 -7.9 869.9598 2 83.20 4 49360 VEV_1_3_RA4_01_1235.d 7.91E4 2 2 299 313
K.LAEEQLTK.A Y 66.63 930.5022 8 -14.1 466.2518 2 34.78 5 16046 VEV_2_3_RA5_01_1236.d 6.14E5 6 6 170 177
K.QTIEVFSTAYPELLKEK.F Y 57.14 1995.0564 17 -5.7 666.0223 3 79.49 4 46651 VEV_1_3_RA4_01_1235.d 7.87E4 2 2 299 315
K.TGHNEMWGVTLKDSDDVPTVNVLIK.F Y 52.37 2767.3850 25 -9.5 923.4602 3 80.41 4 47334 VEV_1_3_RA4_01_1235.d 6.02E4 1 1 135 159
K.Q(-17.03)TIEVFSTAYPELLKEK.F Y 52.04 1978.0299 17 -0.1 990.0221 2 85.17 5 49269 VEV_2_3_RA5_01_1236.d 6.48E4 1 1 299 315 Pyro-glu from Q
R.VALMELAVR.D Y 51.38 1000.5739 9 -13.6 501.2874 2 75.68 4 43665 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 246 254
K.TPEAPIDNRPEYLSK(+14.02).N Y 46.63 1742.8839 15 -7.9 581.9640 3 63.43 4 34071 VEV_1_3_RA4_01_1235.d 2.34E5 1 1 103 117 Methylation(KR)
K.Q(-17.03)TIEVFSTAYPELLK.E Y 46.35 1720.8923 15 -7.6 861.4469 2 90.37 6 51504 VEV_3_3_RA6_01_1237.d 1.08E5 2 2 299 313 Pyro-glu from Q
K.LASILNK.T Y 45.73 757.4698 7 -11.5 758.4683 1 47.81 6 23032 VEV_3_3_RA6_01_1237.d 7.41E4 2 2 128 134
K.FLRANEGNVKLAEEQLTK.A Y 45.29 2059.1062 18 -12.4 515.7775 4 67.01 5 36780 VEV_2_3_RA5_01_1236.d 2.18E5 2 2 160 177
R.TVTLKEDTPAPTLAPPAAETNGTAAKDATQTAK.V Y 43.35 3279.6833 33 -13.6 820.9170 4 66.25 6 35068 VEV_3_3_RA6_01_1237.d 3.74E4 1 1 379 411
K.FHPITN(+.98)GANLAR.E Y 42.40 1310.6731 12 -14.1 437.8922 3 60.37 6 30707 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 343 354 Deamidation (NQ)
K.AAE(+14.02)LQESAR.T Y 42.36 987.4985 9 -7.5 494.7528 2 27.67 4 11599 VEV_1_3_RA4_01_1235.d 2.93E5 3 3 370 378 Methylation(others)
K.FHPITNGANLAR.E Y 42.23 1309.6891 12 -6.3 655.8477 2 56.96 5 29398 VEV_2_3_RA5_01_1236.d 2.88E4 1 1 343 354
R.KFHPITNGAN(+.98)LAR.E Y 39.99 1438.7681 13 -15.1 360.6938 4 53.53 5 27328 VEV_2_3_RA5_01_1236.d 9.42E4 1 1 342 354 Deamidation (NQ)
K.AAELQ(+.98)ESAR.T Y 39.74 974.4669 9 -1.8 488.2398 2 23.30 4 9156 VEV_1_3_RA4_01_1235.d 3.28E5 4 4 370 378 Deamidation (NQ)
K.KMDPLALADKATYSASK.F Y 38.87 1808.9342 17 -21.6 603.9723 3 68.02 5 37584 VEV_2_3_RA5_01_1236.d 4.23E4 1 1 184 200
K.TPEAPIDN(+.98)RPEYLSK.N Y 36.64 1729.8522 15 7.4 577.6289 3 61.07 4 32290 VEV_1_3_RA4_01_1235.d 4.39E5 2 2 103 117 Deamidation (NQ)
R.VEKSETPSTQTPAAAAPSVTPTAAAPAQSSGADAIEAQKKDEPAPAPAPAPAPAPETK.T Y 35.95 5571.7856 58 -8.1 1115.3553 5 67.49 6 36006 VEV_3_3_RA6_01_1237.d 6.85E4 1 1 45 102
K.LAE(+14.02)EQLTK.A Y 33.75 944.5178 8 -17.7 473.2578 2 50.05 4 24931 VEV_1_3_RA4_01_1235.d 1.91E5 2 2 170 177 Methylation(others)
R.EFTFADE(+14.02)LPKSYGGK.A Y 33.22 1701.8250 15 -9.4 568.2769 3 75.94 5 43296 VEV_2_3_RA5_01_1236.d 7.21E4 1 1 355 369 Methylation(others)
R.EFTFADELPK(+14.02).S Y 32.06 1209.5917 10 -8.1 605.7982 2 80.41 5 46315 VEV_2_3_RA5_01_1236.d 8.97E4 1 1 355 364 Methylation(KR)
K.MDPLALADK.A Y 31.81 972.4950 9 -4.2 487.2527 2 70.39 4 39515 VEV_1_3_RA4_01_1235.d 0 1 1 185 193
K.AAELQESAR(+14.02).T Y 30.88 987.4985 9 -8.7 494.7522 2 32.67 4 14384 VEV_1_3_RA4_01_1235.d 5.26E5 4 4 370 378 Methylation(KR)
R.EFTFADE(+14.02)LPK.S Y 28.76 1209.5917 10 -22.8 605.7893 2 81.44 6 46162 VEV_3_3_RA6_01_1237.d 7.48E4 1 1 355 364 Methylation(others)
R.LNPTIR.A Y 26.49 712.4232 6 -18.5 357.2122 2 30.02 5 13277 VEV_2_3_RA5_01_1236.d 6.74E5 4 4 289 294
K.TGHNEM(+15.99)WGVTLK.D Y 26.06 1387.6554 12 -20.3 694.8209 2 52.82 5 26870 VEV_2_3_RA5_01_1236.d 9.53E4 1 1 135 146 Oxidation (M)
K.AAELQE(+14.02)SAR.T Y 24.88 987.4985 9 -11.3 494.7509 2 32.33 5 14647 VEV_2_3_RA5_01_1236.d 2.05E5 1 1 370 378 Methylation(others)
K.LAEEQLTK(+14.02).A Y 24.38 944.5178 8 -12.6 473.2602 2 44.42 4 21408 VEV_1_3_RA4_01_1235.d 2.97E5 4 4 170 177 Methylation(KR)
K.SYGGKAAELQ(+.98)ESAR.T Y 24.19 1466.7001 14 -8.0 489.9034 3 22.98 6 9112 VEV_3_3_RA6_01_1237.d 6.73E4 1 1 365 378 Deamidation (NQ)
K.FQGLGYVANY(+31.99)KDPK.G Y 23.58 1630.7991 14 8.7 816.4139 2 86.53 6 49390 VEV_3_3_RA6_01_1237.d 0 1 1 201 214 Dihydroxy
R.KFHPITNGANLAR.E Y 23.53 1437.7841 13 -44.7 480.2472 3 51.03 5 25773 VEV_2_3_RA5_01_1236.d 0 1 1 342 354
K.SY(-18.01)GGK(+14.02)AAELQESAR.T Y 23.16 1461.7212 14 -36.2 488.2300 3 41.39 5 19959 VEV_2_3_RA5_01_1236.d 1.89E5 1 1 365 378 Dehydration; Methylation(KR)
R.TVTLKEDTPAPTLAPPAAETN(+15.00)GTAAK.D Y 23.01 2579.3330 26 -0.6 860.7844 3 71.23 4 40184 VEV_1_3_RA4_01_1235.d 4.07E4 1 1 379 404 Deamidation followed by a methylation
K.ALEWR.K Y 22.95 673.3547 5 -17.1 337.6789 2 45.33 5 22330 VEV_2_3_RA5_01_1236.d 5E5 4 4 178 182
K.FQGLGYVANYKDPKGGNVVFTWNVYGAVKDVNNTFGDVDEFIK.W Y 20.91 4784.3550 43 -18.5 957.8606 5 90.36 5 52071 VEV_2_3_RA5_01_1236.d 0 1 1 201 243
K.MDPLALADK(-.98).A Y 18.37 971.5110 9 5.1 486.7653 2 56.88 5 29381 VEV_2_3_RA5_01_1236.d 3.09E5 1 1 185 193 Amidation
R.KFHPITN(+.98)GANLAR.E Y 17.71 1438.7681 13 -28.6 720.3707 2 53.43 5 27262 VEV_2_3_RA5_01_1236.d 3.86E4 1 1 342 354 Deamidation (NQ)
K.FQGLGYVANYKDPK(+42.01).G Y 17.61 1640.8198 14 -4.5 821.4135 2 94.00 5 53797 VEV_2_3_RA5_01_1236.d 5.8E4 1 1 201 214 Acetylation (K)
K.FLRANEGNVK(+14.02).L Y 17.61 1160.6301 10 3.3 387.8853 3 47.07 6 22606 VEV_3_3_RA6_01_1237.d 0 1 1 160 169 Methylation(KR)
K.LAEE(+14.02)QLTK.A Y 16.99 944.5178 8 -13.9 473.2596 2 46.54 4 22731 VEV_1_3_RA4_01_1235.d 5.35E4 1 1 170 177 Methylation(others)
K.MDP(+31.99)LALADK.A Y 16.91 1004.4848 9 -14.2 1005.4778 1 91.32 4 54405 VEV_1_3_RA4_01_1235.d 5.23E4 1 1 185 193 Dihydroxy
R.A(+43.01)NEGNVK.L Y 16.19 773.3668 7 -5.1 774.3701 1 112.53 5 59528 VEV_2_3_RA5_01_1236.d 0 1 1 163 169 Carbamylation
K.MDPLALADKATYSASK.F Y 15.89 1680.8392 16 -26.0 841.4050 2 90.10 6 51365 VEV_3_3_RA6_01_1237.d 0 1 1 185 200
K.LAEEQLTK(+27.99).A Y 15.88 958.4971 8 -7.5 480.2522 2 32.32 4 14186 VEV_1_3_RA4_01_1235.d 3.49E5 1 1 170 177 Formylation
K.FHPIT(+121.04)NGANLAR.E Y 15.87 1430.7241 12 -31.0 716.3472 2 43.86 4 21054 VEV_1_3_RA4_01_1235.d 7.01E4 1 1 343 354 Phosphorylation to pyridyl thiol
K.L(+43.01)AEEQLTK(+14.02).A Y 15.82 987.5236 8 -8.1 330.1791 3 16.38 4 5519 VEV_1_3_RA4_01_1235.d 0 1 1 170 177 Carbamylation; Methylation(KR)
R.TVTLK(+42.01).E Y 15.78 602.3639 5 3.2 302.1902 2 50.41 4 25130 VEV_1_3_RA4_01_1235.d 5.78E4 1 1 379 383 Acetylation (K)
K.Q(+71.04)TIEVFSTAYPELLK.E Y 15.61 1808.9559 15 -14.5 362.7932 5 63.29 4 34043 VEV_1_3_RA4_01_1235.d 2.94E5 1 1 299 313 Propionamide (K, X@N-term)
R.K(+111.03)FHPITNGANLAR.E Y 15.41 1548.8160 13 -3.1 388.2101 4 44.62 6 21196 VEV_3_3_RA6_01_1237.d 0 1 1 342 354 Nmethylmaleimide
R.KFHPIT(+79.97)NGANLAREFTFADELPK.S Y 15.15 2695.3159 23 18.8 674.8489 4 85.26 6 48627 VEV_3_3_RA6_01_1237.d 0 1 1 342 364 Phosphorylation (STY)
K.KMDPLALADK(+59.05).A Y 15.12 1159.6396 10 1.8 387.5545 3 72.68 6 39857 VEV_3_3_RA6_01_1237.d 6.54E4 1 1 184 193 5-hydroxy-N6,N6,N6-trimethyl
K.VFLSK(+27.99).N Y 15.08 620.3533 5 -20.8 311.1775 2 49.22 4 24390 VEV_1_3_RA4_01_1235.d 1.28E4 1 1 333 337 Formylation
total 69 peptides
C1GEX7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ELAHMNAGLVEMERIEASQSPNAPATK.A Y 158.95 2893.4062 27 -7.8 724.3532 4 75.55 4 43558 VEV_1_3_RA4_01_1235.d 8.08E5 3 3 350 376
R.HC(+57.02)C(+57.02)SGGADVYTSSR.S Y 157.40 1555.6144 14 -12.9 519.5387 3 23.00 6 9154 VEV_3_3_RA6_01_1237.d 1.8E6 13 13 288 301 Carbamidomethylation
K.Q(-17.03)SATSANWDATKQESNVTTDASMRR.D Y 137.47 2737.2361 25 -5.4 913.4144 3 65.07 4 35347 VEV_1_3_RA4_01_1235.d 4.1E5 3 3 312 336 Pyro-glu from Q
R.DHPLVGNSNSMGR.E Y 119.08 1382.6361 13 -12.7 461.8801 3 37.03 5 17370 VEV_2_3_RA5_01_1236.d 1.25E6 14 14 337 349
R.IEASQSPNAPATK.A Y 114.38 1312.6622 13 -11.7 657.3307 2 28.28 5 12309 VEV_2_3_RA5_01_1236.d 1.01E6 9 9 364 376
K.AIVDEQSSDGQVSEDGNSIK.L Y 107.94 2076.9446 20 -7.5 1039.4718 2 59.97 4 31474 VEV_1_3_RA4_01_1235.d 4.07E5 4 4 377 396
K.QSATSANWDATKQESNVTTDASMRR.D Y 98.92 2754.2627 25 -6.2 689.5687 4 59.96 4 31463 VEV_1_3_RA4_01_1235.d 2.03E5 3 3 312 336
R.DHPLVGNSNSM(+15.99)GR.E Y 95.43 1398.6310 13 -5.7 467.2149 3 23.01 4 9012 VEV_1_3_RA4_01_1235.d 1.79E6 16 16 337 349 Oxidation (M)
K.QSATSANWDATKQESNVTTDASMR.R Y 83.99 2598.1616 24 -4.6 867.0572 3 62.86 6 32529 VEV_3_3_RA6_01_1237.d 1.38E5 3 3 312 335
R.HC(+57.02)C(+57.02)SGGADVYTSSR(+14.02).S Y 82.10 1569.6300 14 -15.1 785.8104 2 30.31 5 13440 VEV_2_3_RA5_01_1236.d 8.74E4 3 3 288 301 Carbamidomethylation; Methylation(KR)
K.Q(-17.03)SATSANWDATKQESNVTTDASMR.R Y 81.46 2581.1350 24 -3.7 1291.5701 2 68.89 4 38343 VEV_1_3_RA4_01_1235.d 3.7E4 1 1 312 335 Pyro-glu from Q
R.DHPLVGNSNSM(-48.00)GR.E Y 72.63 1334.6327 13 -12.7 445.8792 3 13.98 5 4476 VEV_2_3_RA5_01_1236.d 6.71E5 3 3 337 349 Dethiomethyl
R.IE(+14.02)ASQSPNAPATK.A Y 69.13 1326.6779 13 -8.3 664.3407 2 31.96 6 13958 VEV_3_3_RA6_01_1237.d 3.7E4 1 1 364 376 Methylation(others)
R.ELAHMNAGLVEMERIEASQSPNAPAT(-18.01)K(+14.02).A Y 62.14 2889.4114 27 10.0 723.3674 4 75.59 4 43595 VEV_1_3_RA4_01_1235.d 0 1 1 350 376 Dehydration; Methylation(KR)
R.IEASQ(+.98)SPNAPATK.A Y 61.76 1313.6462 13 -15.0 657.8206 2 31.73 6 13834 VEV_3_3_RA6_01_1237.d 1.73E5 4 4 364 376 Deamidation (NQ)
K.Q(-17.03)SATSANWDATKQESNVTTDASM(+15.99)RR.D Y 61.56 2753.2312 25 -7.5 918.7441 3 62.26 5 33237 VEV_2_3_RA5_01_1236.d 2.48E5 3 3 312 336 Pyro-glu from Q; Oxidation (M)
K.QSATSANWDATK.Q Y 61.29 1278.5840 12 -16.2 640.2889 2 36.06 6 16272 VEV_3_3_RA6_01_1237.d 2.28E5 4 4 312 323
K.QSATSANWDATKQESNVTTDASM(+15.99)RR.D Y 54.73 2770.2576 25 3.0 693.5737 4 56.43 5 29037 VEV_2_3_RA5_01_1236.d 8.05E4 2 2 312 336 Oxidation (M)
K.QSATSANWDATKQE(+14.02)SNVTTDASMRR.D Y 46.44 2768.2783 25 -10.1 693.0699 4 63.95 4 34477 VEV_1_3_RA4_01_1235.d 7.8E4 1 1 312 336 Methylation(others)
K.Q(+.98)SATSANWDATKQESNVTTDASMRR.D Y 44.31 2755.2468 25 -5.4 689.8152 4 60.93 4 32185 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 312 336 Deamidation (NQ)
R.E(+14.02)LAHMNAGLVEMERIEASQSPNAPATK.A Y 42.04 2907.4219 27 -15.9 727.8512 4 75.51 5 42961 VEV_2_3_RA5_01_1236.d 0 1 1 350 376 Methylation(others)
R.GTC(+57.02)SNDPSGAGSDYNTPLHVGALVIILAVSSLAC(+57.02)SFPLMAVK.V Y 40.71 4289.1172 42 -28.0 1073.2566 4 97.96 5 55344 VEV_2_3_RA5_01_1236.d 0 1 1 169 210 Carbamidomethylation
R.ELAHMNAGLVE(+55.92)MERIEASQSPNAPATK.A Y 37.77 2949.3259 27 22.6 738.3554 4 63.32 5 34032 VEV_2_3_RA5_01_1236.d 4.2E4 1 1 350 376 Replacement of 2 protons by nickel
R.IAVINWGK.N Y 37.70 899.5229 8 -13.0 450.7629 2 69.21 5 38418 VEV_2_3_RA5_01_1236.d 5.18E5 3 3 458 465
K.Q(-17.03)ESNVTTDASMRR.D Y 37.27 1476.6627 13 -7.2 739.3333 2 45.99 4 22385 VEV_1_3_RA4_01_1235.d 1.86E5 3 3 324 336 Pyro-glu from Q
R.DHPLVGNSN(+.98)SM(+15.99)GR.E Y 35.29 1399.6150 13 -12.1 700.8063 2 25.80 6 10622 VEV_3_3_RA6_01_1237.d 3.12E4 1 1 337 349 Deamidation (NQ); Oxidation (M)
K.QS(-20.03)ATSANWDATK.Q Y 32.04 1258.5579 12 23.7 630.3011 2 59.35 4 31008 VEV_1_3_RA4_01_1235.d 9.01E4 1 1 312 323 Formation of five membered aromatic heterocycle
R.RDHPLVGNSNSM(+15.99)GR.E Y 31.55 1554.7321 14 -11.2 519.2455 3 19.36 6 7270 VEV_3_3_RA6_01_1237.d 2.61E5 1 1 336 349 Oxidation (M)
K.LTPQQHLK.K Y 31.33 963.5502 8 -15.4 482.7749 2 19.27 5 7359 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 397 404
R.DHPLVGNSNSMGR(-.98)(+14.02).E Y 29.84 1395.6677 13 18.3 466.2383 3 22.79 4 8894 VEV_1_3_RA4_01_1235.d 0 1 1 337 349 Amidation; Methylation(KR)
R.RDH(+15.99)PLVGNSNSMGR.E Y 29.32 1554.7321 14 -14.7 519.2437 3 22.07 5 8849 VEV_2_3_RA5_01_1236.d 0 1 1 336 349 Oxidation (HW)
R.EDLNGTVN(+.98)SR.S Y 26.29 1104.5048 10 -6.0 1105.5054 1 85.82 5 49636 VEV_2_3_RA5_01_1236.d 1.73E4 1 1 32 41 Deamidation (NQ)
R.ELAHMNAGLVEMER(+14.02)IEASQ(+.98)SPNAPATK.A Y 26.23 2908.4058 27 -13.4 728.0989 4 67.88 4 37547 VEV_1_3_RA4_01_1235.d 1.08E5 2 2 350 376 Methylation(KR); Deamidation (NQ)
K.NLDSSLEK(+42.01).L Y 25.13 946.4607 8 1.7 474.2384 2 41.18 5 19833 VEV_2_3_RA5_01_1236.d 0 1 1 60 67 Acetylation (K)
R.EDLN(+.98)GTVN(+.98)SR.S Y 24.10 1105.4888 10 10.3 1106.5074 1 88.50 6 50513 VEV_3_3_RA6_01_1237.d 1.23E4 1 1 32 41 Deamidation (NQ)
R.E(+42.01)LAHMNAGLVEMER(+14.02)IEASQ(+.98)SPNAPATK.A Y 22.24 2950.4165 27 -2.5 591.0891 5 63.38 5 34069 VEV_2_3_RA5_01_1236.d 1.42E5 2 2 350 376 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
R.ELAHMNAGLVEMER(+14.02).I Y 21.44 1612.7701 14 7.1 404.2027 4 32.70 6 14362 VEV_3_3_RA6_01_1237.d 0 1 1 350 363 Methylation(KR)
K.LTPQQHLKK.A Y 20.94 1091.6451 9 -33.0 364.8770 3 15.14 5 5108 VEV_2_3_RA5_01_1236.d 7.7E4 1 1 397 405
R.SKDHENTAVK(+14.02).Q Y 19.10 1141.5728 10 -15.4 571.7849 2 10.82 6 2830 VEV_3_3_RA6_01_1237.d 3.26E3 1 1 302 311 Methylation(KR)
K.NLDSSLEK.L Y 19.05 904.4501 8 -26.3 905.4337 1 78.13 4 45578 VEV_1_3_RA4_01_1235.d 1.13E5 2 2 60 67
R.DHPLVGN(+.98)SN(+.98)SM(+15.99)GR.E Y 18.23 1400.5990 13 6.2 467.8765 3 27.50 4 11475 VEV_1_3_RA4_01_1235.d 2.74E5 1 1 337 349 Deamidation (NQ); Oxidation (M)
R.IEASQSPNAPATK(+14.02).A Y 17.43 1326.6779 13 35.3 332.6884 4 54.68 4 27858 VEV_1_3_RA4_01_1235.d 1.4E5 2 2 364 376 Methylation(KR)
K.LPPYLSLTHTSGADAGR.Q Y 16.18 1754.8951 17 -31.5 439.7172 4 35.86 6 16158 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 68 84
K.VPWLR.I Y 15.80 669.3962 5 -11.9 335.7014 2 63.35 4 34019 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 211 215
K.LTPQQHLK(+42.01)K(+27.99).A Y 15.33 1161.6506 9 -15.2 388.2183 3 62.52 5 33424 VEV_2_3_RA5_01_1236.d 0 1 1 397 405 Acetylation (K); Formylation
R.ALAPVSHS(+79.97)TIC(+57.02)PNGVYR(+28.03).K Y 15.12 1948.9230 17 28.5 488.2519 4 69.80 6 37704 VEV_3_3_RA6_01_1237.d 0 1 1 100 116 Phosphorylation (STY); Carbamidomethylation; Dimethylation(KR)
total 46 peptides
C1FZI7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DTYSSPSAIGVMLGTGNVGEYLTLK.S Y 151.74 2572.2729 25 -0.6 1287.1429 2 90.38 4 53862 VEV_1_3_RA4_01_1235.d 2.1E5 3 3 1076 1100
R.GC(+57.02)NWAVSTPIFGDGLNLSK.E Y 104.20 2034.9833 19 -6.6 1018.4922 2 84.60 4 50316 VEV_1_3_RA4_01_1235.d 5.16E5 3 3 175 193 Carbamidomethylation
R.DTYSSPSAIGVMLGTGNVGEYLTLKSDADTFITR.D Y 99.95 3578.7449 34 -5.8 1193.9153 3 90.43 4 53892 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 1076 1109
R.ELQHLDSIGDIC(+57.02)EC(+57.02)TR.S Y 97.99 1944.8669 16 -7.1 649.2916 3 69.31 6 37346 VEV_3_3_RA6_01_1237.d 1.21E5 2 2 1262 1277 Carbamidomethylation
R.SDYEC(+57.02)DYNYEPQIDGTC(+57.02)APVPGLKPLDPK.L Y 94.15 3340.4902 29 -1.4 1114.5024 3 79.51 4 46638 VEV_1_3_RA4_01_1235.d 6.06E4 1 1 1278 1306 Carbamidomethylation
R.IFC(+57.02)IVPGLQSPWSDYNR.L Y 80.14 2050.9934 17 -31.2 684.6504 3 86.90 4 51819 VEV_1_3_RA4_01_1235.d 0 1 1 199 215 Carbamidomethylation
R.STEGKSC(+57.02)VPAR.S Y 75.21 1190.5713 11 -13.5 596.2849 2 13.77 4 4198 VEV_1_3_RA4_01_1235.d 5.31E4 2 2 613 623 Carbamidomethylation
R.TSELALYVTDDGSQWHR.A Y 74.27 1976.9229 17 -9.6 659.9752 3 75.10 6 41616 VEV_3_3_RA6_01_1237.d 1.16E5 2 2 261 277
R.DISTVPSDTSR.N Y 70.66 1176.5623 11 -1.6 589.2875 2 43.01 6 20264 VEV_3_3_RA6_01_1237.d 4.59E5 9 9 1170 1180
K.LIC(+57.02)TEDPKAVEWYEPTGYR.R Y 69.52 2326.0940 19 0.2 776.3721 3 75.72 6 42068 VEV_3_3_RA6_01_1237.d 9.04E4 2 2 1307 1325 Carbamidomethylation
K.SDADTFITR.D Y 66.44 1024.4825 9 -15.5 513.2406 2 54.08 6 26698 VEV_3_3_RA6_01_1237.d 9.78E5 4 4 1101 1109
R.LLYSDRFFKQDSGTEAPLDSGR.A Y 66.28 2501.2185 22 -14.3 626.3030 4 73.88 6 40727 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 216 237
R.DAGVKWDMVNLDGLKGQALSLWSHPTDR.T Y 65.45 3108.5452 28 -35.9 622.6940 5 85.05 4 50622 VEV_1_3_RA4_01_1235.d 0 1 1 65 92
R.AYTVLESR.T Y 64.77 937.4869 8 -11.9 469.7451 2 49.02 4 24258 VEV_1_3_RA4_01_1235.d 4.19E5 3 3 937 944
R.SLPVPEGAC(+57.02)K.K Y 62.65 1056.5273 10 -11.6 529.2648 2 50.70 4 25307 VEV_1_3_RA4_01_1235.d 1.05E6 7 7 624 633 Carbamidomethylation
K.FQEPVPQFEPC(+57.02)KC(+57.02)TVEDFEC(+57.02)DFNFIR.S Y 59.46 3337.4517 26 1.1 1113.4924 3 87.11 4 51950 VEV_1_3_RA4_01_1235.d 2.87E4 1 1 587 612 Carbamidomethylation
R.VC(+57.02)TDTLTVPVSGEIVVQK.T Y 58.74 1944.0238 18 -10.9 649.0082 3 77.31 6 43232 VEV_3_3_RA6_01_1237.d 2.38E5 2 2 668 685 Carbamidomethylation
K.KPGVAAVNIDFSNLKER.H Y 54.29 1857.0107 17 -11.1 465.2548 4 68.71 4 38203 VEV_1_3_RA4_01_1235.d 2.08E5 2 2 1194 1210
R.DGGITWQEVR.K Y 54.21 1159.5621 10 -6.2 580.7847 2 67.89 4 37556 VEV_1_3_RA4_01_1235.d 4.67E4 1 1 1110 1119
K.KPNDKYMGSSGFR.L Y 52.46 1485.7034 13 -4.4 496.2396 3 34.03 4 15170 VEV_1_3_RA4_01_1235.d 9.25E4 1 1 634 646
R.EGGVELDKQIER.V Y 51.35 1371.6993 12 -5.5 686.8531 2 51.61 4 25898 VEV_1_3_RA4_01_1235.d 6.01E5 5 5 656 667
R.DTYSS(-2.02)PSAIGVMLGTGNVGEYLTLKSDADTFITR.D Y 50.28 3576.7292 34 -24.5 1193.2212 3 90.33 5 52054 VEV_2_3_RA5_01_1236.d 0 1 1 1076 1109 2-amino-3-oxo-butanoic_acid
R.DYSC(+57.02)STEGGKPTDK.C Y 48.52 1543.6460 14 -10.9 772.8219 2 20.03 4 7412 VEV_1_3_RA4_01_1235.d 4.25E4 1 1 1047 1060 Carbamidomethylation
K.LIC(+57.02)TEDPK.A Y 40.18 974.4742 8 -5.9 488.2415 2 31.24 6 13592 VEV_3_3_RA6_01_1237.d 3.92E5 2 2 1307 1314 Carbamidomethylation
K.YLLAAAK.S Y 36.49 748.4483 7 -52.3 749.4164 1 47.07 6 22607 VEV_3_3_RA6_01_1237.d 2.79E5 3 3 251 257
K.FLLVGSSKR.D Y 34.80 1005.5970 9 -13.4 336.2018 3 54.38 4 27684 VEV_1_3_RA4_01_1235.d 6.51E4 3 3 515 523
K.TVDILIENAR.G Y 32.68 1142.6295 10 -34.3 572.3024 2 69.38 4 38729 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 165 174
K.C(+57.02)ALHLHSYTER.A Y 29.60 1385.6510 11 -7.8 462.8874 3 42.08 4 19961 VEV_1_3_RA4_01_1235.d 1.87E5 2 2 1061 1071 Carbamidomethylation
K.EIFPGETITR.I Y 27.54 1161.6029 10 -8.1 388.2051 3 31.25 5 13993 VEV_2_3_RA5_01_1236.d 1.18E5 3 3 733 742
K.HDLHLHSVTHLSNSGR.V Y 27.37 1808.9031 16 -27.0 453.2208 4 43.97 5 21524 VEV_2_3_RA5_01_1236.d 0 1 1 394 409
R.THAAFLHVTVNNVEDHEYGSIIK.S Y 26.78 2593.2925 23 -36.0 519.6471 5 73.20 4 41741 VEV_1_3_RA4_01_1235.d 0 2 2 945 967
R.VPGGSSSQR.V Y 26.77 873.4304 9 8.5 437.7262 2 19.65 4 7234 VEV_1_3_RA4_01_1235.d 9.63E4 1 1 1446 1454
K.GQALSLWSHPTDRTK.A Y 26.48 1695.8693 15 18.2 566.3073 3 78.20 5 44852 VEV_2_3_RA5_01_1236.d 3.75E4 1 1 80 94
K.SCVPAR.S Y 25.78 631.3112 6 -2.0 632.3172 1 79.69 5 45854 VEV_2_3_RA5_01_1236.d 4.29E4 1 1 618 623
K.APIPP(+31.99)NQDK.L Y 25.61 1010.5032 9 -7.1 506.2553 2 22.13 6 8668 VEV_3_3_RA6_01_1237.d 0 1 1 777 785 Dihydroxy
R.AVSGVVR(+14.02)TASVK(+42.01).K Y 24.92 1228.7139 12 -41.9 308.1729 4 24.66 5 10289 VEV_2_3_RA5_01_1236.d 0 1 1 238 249 Methylation(KR); Acetylation (K)
R.GYAR(+31.99)VPGGSSSQR.V Y 24.56 1352.6432 13 -28.0 677.3099 2 70.39 6 38147 VEV_3_3_RA6_01_1237.d 4.12E4 1 1 1442 1454 Dihydroxy
K.KPNDKYMGSSGFRLIPGNAC(+57.02)IR.E Y 23.33 2480.2417 22 -16.4 621.0576 4 107.16 6 57343 VEV_3_3_RA6_01_1237.d 0 1 1 634 655 Carbamidomethylation
R.DAGVK(+31.99).W Y 23.17 520.2493 5 -10.7 521.2510 1 38.16 5 18073 VEV_2_3_RA5_01_1236.d 0 1 1 65 69 Dihydroxy
R.AVSGVVR(+14.02).T Y 22.53 700.4232 7 -19.2 351.2121 2 46.13 4 22469 VEV_1_3_RA4_01_1235.d 0 1 1 238 244 Methylation(KR)
R.DIST(-2.02)VPSDTSR.N Y 21.23 1174.5466 11 2.1 588.2818 2 62.82 4 33619 VEV_1_3_RA4_01_1235.d 0 1 1 1170 1180 2-amino-3-oxo-butanoic_acid
R.TGKISYS(+79.97)LNHGK(+42.01).D Y 20.84 1425.6653 12 32.2 476.2444 3 29.92 4 12804 VEV_1_3_RA4_01_1235.d 0 1 1 475 486 Phosphorylation (STY); Acetylation (K)
K.IISQ(+.98)ISFDDGR.T Y 20.82 1250.6143 11 1.1 626.3151 2 69.23 4 38611 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 374 384 Deamidation (NQ)
K.LIC(+57.02)TED(-18.01)PK.A Y 20.66 956.4637 8 -21.0 479.2291 2 11.18 5 3050 VEV_2_3_RA5_01_1236.d 6.06E4 1 1 1307 1314 Carbamidomethylation; Dehydration
R.DISTVPSDT(-18.01)SR(+14.02).N Y 20.59 1172.5673 11 -27.1 391.8524 3 29.77 4 12724 VEV_1_3_RA4_01_1235.d 0 1 1 1170 1180 Dehydration; Methylation(KR)
R.I(+43.01)LTTM(+15.99)PDSTGLK.F Y 20.36 1334.6752 12 4.0 334.6774 4 32.65 5 14797 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 503 514 Carbamylation; Oxidation (M)
R.ILTTMPDSTGLK(+27.99).F Y 20.26 1303.6693 12 -30.4 652.8221 2 48.55 5 24254 VEV_2_3_RA5_01_1236.d 2.62E4 1 1 503 514 Formylation
R.GYARVPGGSSSQR.V Y 19.88 1320.6534 13 -25.2 661.3174 2 71.87 6 39264 VEV_3_3_RA6_01_1237.d 2.8E4 1 1 1442 1454
R.A(+42.01)VSGVVR.T Y 19.79 728.4181 7 -19.0 365.2094 2 39.64 6 18280 VEV_3_3_RA6_01_1237.d 0 1 1 238 244 Acetylation (N-term)
R.LLYSD(-18.01)R.F Y 19.64 747.3915 6 -22.5 748.3820 1 91.19 5 52490 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 216 221 Dehydration
K.S(-18.01)C(+57.02)VPARSLPVPEGAC(+57.02)K.K Y 19.31 1708.8389 16 -2.9 855.4242 2 88.50 4 52814 VEV_1_3_RA4_01_1235.d 2.36E5 1 1 618 633 Dehydration; Carbamidomethylation
R.DAGVKWDM(+15.99)VNLDGLK.G Y 19.26 1675.8240 15 -4.0 559.6130 3 73.11 6 40172 VEV_3_3_RA6_01_1237.d 0 1 1 65 79 Oxidation (M)
K.C(+57.02)EGGK.Q Y 19.24 549.2217 5 51.7 550.2573 1 59.59 4 31176 VEV_1_3_RA4_01_1235.d 7.04E4 1 1 1332 1336 Carbamidomethylation
K.A(+43.01)DSPIIMATR.F Y 18.69 1116.5597 10 22.7 373.2023 3 31.33 4 13614 VEV_1_3_RA4_01_1235.d 0 1 1 24 33 Carbamylation
R.AVSGVVR(+.98).T Y 18.68 687.3915 7 -63.9 688.3549 1 31.46 4 13692 VEV_1_3_RA4_01_1235.d 1.18E4 1 1 238 244 Deamidation (R)
R.STEGK.S N 18.65 520.2493 5 22.9 521.2684 1 72.08 6 39425 VEV_3_3_RA6_01_1237.d 0 1 1 613 617
K.KPND(-18.01)K(+14.02).Y Y 18.58 596.3282 5 -11.9 597.3284 1 66.73 4 36635 VEV_1_3_RA4_01_1235.d 0 1 1 634 638 Dehydration; Methylation(KR)
R.NFLLWGNE(+14.02)VGNGK.K Y 18.29 1460.7412 13 -13.7 366.1876 4 19.57 5 7505 VEV_2_3_RA5_01_1236.d 0 1 1 1181 1193 Methylation(others)
R.STEGKSC(+57.02)VPARSLPVPEGAC(+57.02)K.K Y 18.05 2229.0881 21 -1.8 558.2783 4 27.31 5 11759 VEV_2_3_RA5_01_1236.d 0 1 1 613 633 Carbamidomethylation
K.A(+27.99)PIPPNQDK.L Y 17.78 1006.5083 9 -17.0 504.2529 2 57.25 5 29599 VEV_2_3_RA5_01_1236.d 1.53E5 1 1 777 785 Formylation
K.S(+79.97)CVPAR.S Y 17.74 711.2775 6 10.5 712.2922 1 112.73 4 61878 VEV_1_3_RA4_01_1235.d 1.22E4 1 1 618 623 Phosphorylation (STY)
R.STEGKSC(+57.02)VPAR(+14.02)SLPVPEGAC(+57.02)KKPNDK(+14.02).Y Y 17.50 2839.4319 26 -28.7 947.4574 3 83.34 6 47406 VEV_3_3_RA6_01_1237.d 0 1 1 613 638 Carbamidomethylation; Methylation(KR)
K.ALDEAHK.Y Y 17.42 782.3922 7 1.9 783.4009 1 76.31 5 43523 VEV_2_3_RA5_01_1236.d 2.92E4 1 1 450 456
K.YLLAAAKSAR.T Y 17.01 1062.6185 10 -14.2 355.2084 3 61.02 6 31177 VEV_3_3_RA6_01_1237.d 0 1 1 251 260
K.E(+42.01)IFPGETITR.I Y 16.94 1203.6135 10 -11.3 402.2072 3 45.12 6 21511 VEV_3_3_RA6_01_1237.d 7.82E4 1 1 733 742 Acetylation (N-term)
R.DAGVK(+14.02).W Y 16.76 502.2751 5 26.2 503.2955 1 72.42 6 39695 VEV_3_3_RA6_01_1237.d 7.7E5 1 1 65 69 Methylation(KR)
K.KADSPIIMATR.F Y 16.70 1201.6489 11 -35.6 401.5427 3 30.97 5 13812 VEV_2_3_RA5_01_1236.d 0 1 1 23 33
R.TASVK(+43.99).K Y 16.64 548.2806 5 -18.7 549.2776 1 35.69 6 16056 VEV_3_3_RA6_01_1237.d 0 1 1 245 249 Carboxylation (DKW)
K.EASLPDGIK(+42.01).I Y 16.62 970.4971 9 -6.7 486.2526 2 56.13 4 28717 VEV_1_3_RA4_01_1235.d 1.45E6 1 1 490 498 Acetylation (K)
R.E(+27.99)GGVELDK(+14.02).Q Y 16.45 887.4236 8 -5.8 888.4257 1 88.73 4 52954 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 656 663 Formylation; Methylation(KR)
K.ADVDC(+57.02)FIK.K Y 16.43 966.4481 8 4.0 484.2332 2 35.18 4 15862 VEV_1_3_RA4_01_1235.d 3.95E5 2 2 577 584 Carbamidomethylation
R.NGLGFVDFEK.I Y 16.14 1124.5502 10 -4.6 563.2798 2 30.62 5 13620 VEV_2_3_RA5_01_1236.d 4.9E5 2 2 336 345
R.KDSSK.G Y 16.01 563.2914 5 -1.0 564.2982 1 43.53 4 20862 VEV_1_3_RA4_01_1235.d 0 1 1 702 706
R.A(+42.01)AFAAQR(+14.02).A Y 15.99 789.4133 7 32.4 395.7267 2 56.09 4 28692 VEV_1_3_RA4_01_1235.d 2.29E5 1 1 1460 1466 Acetylation (N-term); Methylation(KR)
K.TVDILIEN(+162.05)AR.G Y 15.85 1304.6823 10 -24.3 653.3325 2 85.73 5 49581 VEV_2_3_RA5_01_1236.d 9.71E4 1 1 165 174 Hexose (NSY)
R.AVSGVVR(+21.98)(+14.02).T Y 15.52 722.4051 7 -22.6 362.2017 2 56.29 6 27901 VEV_3_3_RA6_01_1237.d 8.62E4 1 1 238 244 Sodium adduct; Methylation(KR)
K.K(+42.01)PND(-18.01)K.Y Y 15.44 624.3231 5 -15.0 625.3210 1 19.60 5 7517 VEV_2_3_RA5_01_1236.d 0 1 1 634 638 Acetylation (N-term); Dehydration
R.GYARVPGGS(+79.97)SSQR(+28.03).V Y 15.43 1428.6510 13 40.9 477.2438 3 41.18 6 19183 VEV_3_3_RA6_01_1237.d 7.78E4 1 1 1442 1454 Phosphorylation (STY); Dimethylation(KR)
R.EGGVELDK.Q Y 15.40 845.4130 8 1.3 423.7144 2 26.82 4 11105 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 656 663
R.EGGVELD(-18.01)K(+14.02).Q Y 15.25 841.4181 8 0.8 842.4260 1 80.20 4 47178 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 656 663 Dehydration; Methylation(KR)
R.GYARVPGGSSS(+79.97)QR.V Y 15.20 1400.6198 13 -16.0 467.8730 3 16.75 4 5701 VEV_1_3_RA4_01_1235.d 3.01E5 1 1 1442 1454 Phosphorylation (STY)
R.ARILTTMPDSTGLK.F Y 15.20 1502.8126 14 -46.4 501.9216 3 63.50 6 33001 VEV_3_3_RA6_01_1237.d 0 1 1 501 514
R.VPGGSSSQ(+.98)RVYSSR(+21.98).A Y 15.19 1488.6932 14 -9.8 497.2335 3 38.74 4 17963 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 1446 1459 Deamidation (NQ); Sodium adduct
K.F(+27.99)KAPIPPNQDK.L Y 15.04 1281.6716 11 -3.7 428.2296 3 12.92 5 3921 VEV_2_3_RA5_01_1236.d 0 1 1 775 785 Formylation
total 84 peptides
C1GAG3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AKDTVIPGPGTLELVYTPK.G Y 143.54 1998.1036 19 -11.3 667.0343 3 78.67 5 45194 VEV_2_3_RA5_01_1236.d 1.21E6 5 5 219 237
K.NPVVELDGDEMTR.I Y 112.61 1473.6769 13 -7.5 737.8402 2 68.47 4 38034 VEV_1_3_RA4_01_1235.d 1.67E5 2 2 101 113
R.NILGGTVFREPIVINRVPR.L Y 98.74 2149.2483 19 -8.3 538.3149 4 77.91 4 45405 VEV_1_3_RA4_01_1235.d 1.37E6 6 6 179 197
R.DKTNDQVTIDSAEAIKK.Y Y 96.82 1874.9585 17 -8.6 625.9880 3 53.00 4 26803 VEV_1_3_RA4_01_1235.d 1.26E6 7 7 128 144
R.RGQLDNTPDVVVWAEQLEQAC(+57.02)IDVVDEEGIMTK.D Y 96.13 3756.7974 33 -4.3 1253.2677 3 95.25 4 56401 VEV_1_3_RA4_01_1235.d 7.96E4 1 1 419 451 Carbamidomethylation
K.TNDQVTIDSAEAIKK.Y Y 94.54 1631.8365 15 -7.9 544.9485 3 56.67 4 29130 VEV_1_3_RA4_01_1235.d 6.24E5 4 4 130 144
R.HAFGDQYR.A Y 90.00 992.4464 8 -0.4 497.2303 2 27.52 4 11532 VEV_1_3_RA4_01_1235.d 1.51E6 13 13 211 218
K.GRETSTNPIASIFAWTR.G Y 85.38 1905.9697 17 -14.9 636.3210 3 83.77 6 47675 VEV_3_3_RA6_01_1237.d 2.09E5 3 3 398 414
R.ETSTNPIASIFAWTR.G Y 82.71 1692.8472 15 -7.9 847.4242 2 88.78 4 53035 VEV_1_3_RA4_01_1235.d 4.52E5 4 4 400 414
R.FKDIFQSIYESTYKK.S Y 82.31 1895.9668 15 -13.7 474.9925 4 77.36 4 45005 VEV_1_3_RA4_01_1235.d 8.27E5 3 3 299 313
K.NYDGDVQSDIVAQGFGSLGLMTSTLTTPDGTAFESEAAHGTVTR.H Y 80.29 4516.0977 44 -1.6 1506.3707 3 90.25 4 53793 VEV_1_3_RA4_01_1235.d 4.34E4 1 1 347 390
R.NILGGTVFREPIVINR.V Y 77.62 1797.0260 16 -22.8 450.2535 4 79.05 6 44482 VEV_3_3_RA6_01_1237.d 1.52E5 4 4 179 194
K.NPVVELDGDEM(+15.99)TR.I Y 71.64 1489.6719 13 -10.5 745.8354 2 61.30 6 31370 VEV_3_3_RA6_01_1237.d 9.68E4 2 2 101 113 Oxidation (M)
K.DTVIPGPGTLELVYTPK.G Y 66.80 1798.9717 17 -9.4 900.4846 2 84.28 4 50108 VEV_1_3_RA4_01_1235.d 3.49E5 4 4 221 237
R.VYLEAVER.R Y 64.18 977.5182 8 -11.5 489.7607 2 58.80 5 30722 VEV_2_3_RA5_01_1236.d 5.41E5 3 3 470 477
R.LVPGWKKPIIIGR.H Y 60.17 1475.9340 13 -16.2 492.9773 3 67.92 5 37469 VEV_2_3_RA5_01_1236.d 9.08E5 6 6 198 210
K.GMPLYMSTK.N Y 59.06 1026.4878 9 -9.1 514.2465 2 63.23 4 33920 VEV_1_3_RA4_01_1235.d 2.88E5 2 2 280 288
K.C(+58.01)ATITPDEER.V Y 56.80 1191.5077 10 -6.4 596.7573 2 41.51 4 19621 VEV_1_3_RA4_01_1235.d 1.29E5 6 6 151 160 Carboxymethyl
R.LIDDMVAQMIK.S Y 56.27 1275.6566 11 -6.5 638.8314 2 82.26 4 48718 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 326 336
R.FKDIFQSIYESTYK.K Y 54.67 1767.8719 14 -11.5 884.9330 2 80.89 4 47709 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 299 312
K.DLALAC(+57.02)GR.K Y 51.08 874.4330 8 -10.7 438.2191 2 49.20 4 24376 VEV_1_3_RA4_01_1235.d 4.83E5 4 4 452 459 Carbamidomethylation
R.AKDT(-2.02)VIPGPGTLELVYTPK.G Y 44.31 1996.0880 19 -39.7 666.3435 3 78.63 5 45133 VEV_2_3_RA5_01_1236.d 1.28E5 2 2 219 237 2-amino-3-oxo-butanoic_acid
K.YDGRFKDIFQSIYESTYKK.S Y 43.65 2387.1797 19 -8.5 478.4391 5 80.61 4 47488 VEV_1_3_RA4_01_1235.d 1.65E5 4 4 295 313
K.NLANAKL Y 42.10 742.4337 7 -17.9 743.4277 1 41.80 5 20202 VEV_2_3_RA5_01_1236.d 2.98E5 4 4 482 488
K.Q(-17.03)MWLSPNGTIR.N Y 41.15 1284.6285 11 -3.8 643.3191 2 83.23 4 49377 VEV_1_3_RA4_01_1235.d 4.89E4 1 1 168 178 Pyro-glu from Q
R.E(+14.02)TSTNPIASIFAWTR.G Y 35.65 1706.8628 15 -7.0 854.4327 2 88.58 4 52866 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 400 414 Methylation(others)
K.T(-2.02)NDQVTIDSAEAIKK.Y Y 35.53 1629.8209 15 -8.3 544.2764 3 56.61 4 29038 VEV_1_3_RA4_01_1235.d 0 1 1 130 144 2-amino-3-oxo-butanoic_acid
R.AAWVTTR.V Y 32.29 803.4290 7 -8.9 402.7182 2 38.67 4 17959 VEV_1_3_RA4_01_1235.d 3.21E5 1 1 463 469
K.DLALAC(+57.02)GRK.D Y 30.97 1002.5280 9 15.9 502.2792 2 32.83 4 14476 VEV_1_3_RA4_01_1235.d 2.68E5 1 1 452 460 Carbamidomethylation
K.QM(+15.99)WLSPNGTIR.N Y 30.25 1317.6499 11 -10.2 659.8255 2 42.36 5 20536 VEV_2_3_RA5_01_1236.d 1.06E4 1 1 168 178 Oxidation (M)
K.LAILK.G N 29.52 556.3948 5 -13.1 557.3948 1 47.33 5 23535 VEV_2_3_RA5_01_1236.d 3.65E5 3 3 275 279
R.NTPER.T N 26.42 615.2976 5 7.9 616.3098 1 65.48 4 35817 VEV_1_3_RA4_01_1235.d 3.13E5 3 3 72 76
K.GIWYEHR.L Y 25.12 959.4613 7 -10.9 320.8242 3 43.73 4 21025 VEV_1_3_RA4_01_1235.d 2.14E5 2 2 319 325
K.QMWLSPN(+.98)GTIR.N Y 24.81 1302.6390 11 -9.0 652.3209 2 75.12 4 43222 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 168 178 Deamidation (NQ)
R.S(+43.01)LS(+79.97)AFSK.K Y 24.60 861.3633 7 1.3 862.3717 1 95.32 6 53723 VEV_3_3_RA6_01_1237.d 2.69E4 1 1 32 38 Carbamylation; Phosphorylation (STY)
R.AKDTVIPGPGTLELVYTPK(+42.01)GGQ(+.98)PER.I Y 24.04 2665.3962 25 -24.2 667.3402 4 78.87 6 44345 VEV_3_3_RA6_01_1237.d 0 1 1 219 243 Acetylation (K); Deamidation (NQ)
R.VKEFNLK.Q Y 22.64 876.5068 7 -17.3 439.2531 2 34.23 4 15290 VEV_1_3_RA4_01_1235.d 9.13E4 1 1 161 167
R.N(+43.01)(+.98)ILGGTVFR.E Y 22.13 1019.5400 9 -3.7 340.8527 3 52.94 5 26950 VEV_2_3_RA5_01_1236.d 8.24E4 1 1 179 187 Carbamylation; Deamidation (NQ)
K.NLANAK(+43.01).L Y 21.87 672.3555 6 -27.1 673.3445 1 51.92 4 26117 VEV_1_3_RA4_01_1235.d 1.19E4 1 1 482 487 Carbamylation
R.HAFGDQYRAK.D Y 21.42 1191.5785 10 -18.8 596.7853 2 48.56 5 24259 VEV_2_3_RA5_01_1236.d 4.42E5 2 2 211 220
R.SLS(-18.01)AFSK.K Y 21.01 720.3806 7 -37.9 721.3606 1 74.18 6 40944 VEV_3_3_RA6_01_1237.d 4.05E4 1 1 32 38 Dehydration
K.GR(+14.02)ETSTNPIASIFAWTR.G Y 20.05 1919.9854 17 41.9 641.0292 3 83.70 5 48382 VEV_2_3_RA5_01_1236.d 0 1 1 398 414 Methylation(KR)
R.S(+42.01)LSAFSK.K Y 19.62 780.4017 7 -3.3 781.4064 1 94.93 5 54191 VEV_2_3_RA5_01_1236.d 1.91E5 1 1 32 38 Acetylation (N-term)
R.N(+42.01)MAAS(-18.01)R.R Y 19.47 672.3013 6 -14.0 673.2992 1 52.36 5 26602 VEV_2_3_RA5_01_1236.d 2.89E4 1 1 89 94 Acetylation (N-term); Dehydration
K.GGQP(+31.99)ERIK.V Y 19.37 915.4774 8 -18.6 458.7374 2 18.80 6 6928 VEV_3_3_RA6_01_1237.d 0 1 1 238 245 Dihydroxy
K.DRAAWVTTR.V Y 19.31 1074.5570 9 -7.0 359.1904 3 14.40 5 4699 VEV_2_3_RA5_01_1236.d 0 1 1 461 469
R.WASIPTT(-18.01)QTR.N Y 19.30 1141.5880 10 -3.1 571.7995 2 15.09 5 5078 VEV_2_3_RA5_01_1236.d 1.98E4 1 1 79 88 Dehydration
R.TRWASIPTTQTR.N Y 18.86 1416.7473 12 -11.6 473.2509 3 59.34 5 31063 VEV_2_3_RA5_01_1236.d 2.23E5 1 1 77 88
R.NILGGTVFR.E Y 18.57 975.5502 9 -15.9 488.7746 2 72.25 6 39552 VEV_3_3_RA6_01_1237.d 7.1E4 1 1 179 187
R.ETSTNPIASIFAW(+43.99)TR.G Y 18.24 1736.8369 15 1.4 435.2171 4 34.72 4 15592 VEV_1_3_RA4_01_1235.d 0 1 1 400 414 Carboxylation (DKW)
R.LVPGWK.K Y 18.21 698.4115 6 -15.8 350.2075 2 58.03 4 30036 VEV_1_3_RA4_01_1235.d 1.64E5 1 1 198 203
R.N(+42.01)ILGGTVFR.E Y 18.04 1017.5607 9 -3.8 340.1929 3 33.12 4 14643 VEV_1_3_RA4_01_1235.d 6.44E4 2 2 179 187 Acetylation (N-term)
R.IIWKDIK.D Y 18.03 914.5589 7 -16.3 305.8553 3 35.75 4 16189 VEV_1_3_RA4_01_1235.d 5.66E4 1 1 114 120
R.NTPER(-42.02).T N 17.69 573.2758 5 16.6 574.2926 1 49.06 4 24292 VEV_1_3_RA4_01_1235.d 1.49E4 1 1 72 76 Ornithine from Arginine
K.DKGLEYRD(-18.01)K.T Y 17.50 1104.5563 9 -3.8 369.1913 3 13.63 4 4128 VEV_1_3_RA4_01_1235.d 0 1 1 121 129 Dehydration
K.IVVK(-1.03)NPVVELDGDEMTR.I Y 17.31 1911.9612 17 -5.7 638.3240 3 73.71 4 42132 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 97 113 Lysine oxidation to aminoadipic semialdehyde
R.HAFGDQYRAK(+43.01).D Y 17.29 1234.5842 10 1.9 412.5361 3 50.55 6 24611 VEV_3_3_RA6_01_1237.d 2.39E5 1 1 211 220 Carbamylation
K.DKGLEYRDK.T Y 17.18 1122.5669 9 -16.8 1123.5553 1 90.17 4 53746 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 121 129
R.WASIP(+31.99)TTQTR.N Y 17.14 1191.5884 10 10.5 398.2076 3 70.86 4 39889 VEV_1_3_RA4_01_1235.d 0 1 1 79 88 Dihydroxy
K.SFDAK(+14.02).G Y 16.66 580.2856 5 0.5 581.2932 1 78.48 4 45856 VEV_1_3_RA4_01_1235.d 1.9E4 1 1 314 318 Methylation(KR)
R.WAS(+162.05)IPTTQTRNMAASR.R Y 16.45 1951.9421 16 -7.6 651.6497 3 75.12 6 41629 VEV_3_3_RA6_01_1237.d 5.12E4 1 1 79 94 Hexose (NSY)
R.VKEFNLK(+145.02)QMWLSPNGTIR.N Y 16.39 2305.1711 18 47.1 769.4338 3 90.62 6 51635 VEV_3_3_RA6_01_1237.d 0 1 1 161 178 3-(carbamidomethylthio)propanoyl
K.DKGLEYRD(-18.01)K(+42.01).T Y 16.15 1146.5669 9 -2.4 383.1953 3 59.20 4 30885 VEV_1_3_RA4_01_1235.d 5.74E4 1 1 121 129 Dehydration; Acetylation (K)
R.DKTNDQVTID(+43.99)SAEAIK(+14.02).K Y 16.02 1804.8690 16 2.3 903.4438 2 93.00 5 53340 VEV_2_3_RA5_01_1236.d 1.72E5 1 1 128 143 Carboxylation (DKW); Methylation(KR)
R.AAW(+43.99)VTTRVY(+79.97)LEAVER.R Y 15.92 1886.8927 15 18.4 629.9831 3 38.00 5 17938 VEV_2_3_RA5_01_1236.d 2.16E5 1 1 463 477 Carboxylation (DKW); Phosphorylation (STY)
R.N(+.98)MAASR.R Y 15.80 649.2853 6 4.1 650.2953 1 25.79 4 10541 VEV_1_3_RA4_01_1235.d 0 1 1 89 94 Deamidation (NQ)
R.NILGGT(-18.01)VFR(+14.02)EPIVINRVPR.L Y 15.54 2145.2534 19 -80.6 537.2774 4 78.03 4 45500 VEV_1_3_RA4_01_1235.d 0 1 1 179 197 Dehydration; Methylation(KR)
K.C(+210.20)ATITPDEER.V Y 15.29 1343.7007 10 -16.2 448.9003 3 68.36 6 36652 VEV_3_3_RA6_01_1237.d 0 1 1 151 160 Myristoylation
R.LIDDM(+15.99)VAQM(+15.99)IKSEGGFIIAM(+15.99)K.N Y 15.26 2357.1680 21 8.2 590.3041 4 79.86 5 45959 VEV_2_3_RA5_01_1236.d 0 1 1 326 346 Oxidation (M)
R.VP(+31.99)RLVPGWK(+42.01).K Y 15.11 1124.6342 9 -1.6 375.8847 3 35.04 6 15675 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 195 203 Dihydroxy; Acetylation (K)
R.LQ(+.98)KN(+.98)LANAKL Y 15.10 1113.6393 10 -7.1 372.2177 3 41.06 6 19093 VEV_3_3_RA6_01_1237.d 0 1 1 479 488 Deamidation (NQ)
total 71 peptides
C1GB65
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EQGEGKEGGAPGDFAPSFR.G Y 154.71 1934.8757 19 -13.2 645.9573 3 63.78 6 33203 VEV_3_3_RA6_01_1237.d 3.65E6 10 10 220 238
R.RREQGEGKEGGAPGDFAPSFR.G Y 133.31 2247.0779 21 -11.1 562.7705 4 53.89 5 27575 VEV_2_3_RA5_01_1236.d 4.59E6 17 17 218 238
K.HGDIDTKNLYVIK.A Y 105.13 1514.8092 13 -15.3 505.9360 3 61.18 6 31293 VEV_3_3_RA6_01_1237.d 2E6 10 10 119 131
R.REQGEGKEGGAPGDFAPSFR.G Y 102.38 2090.9768 20 15.0 523.7593 4 59.09 4 30798 VEV_1_3_RA4_01_1235.d 1.07E6 7 7 219 238
K.EGGAPGDFAPSFR.G Y 101.46 1306.5941 13 -10.9 654.2972 2 69.22 5 38474 VEV_2_3_RA5_01_1236.d 2.25E6 6 6 226 238
R.EQ(+.98)GEGKEGGAPGDFAPSFR.G Y 78.52 1935.8597 19 -8.8 646.2882 3 64.58 6 33802 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 220 238 Deamidation (NQ)
R.EGVLVAKKDFNLPK.H Y 75.18 1556.8926 14 -5.4 779.4493 2 64.23 5 34701 VEV_2_3_RA5_01_1236.d 4.46E5 4 4 105 118
R.FSWQYYYYTLTPEGLDFLREWLHLPAEIVPATHVK.Q Y 73.05 4282.1567 35 -4.5 857.4348 5 96.87 4 57101 VEV_1_3_RA4_01_1235.d 6.4E5 2 2 146 180
R.EQGEGKEGGAPGDFAPSFR(+14.02).G Y 72.51 1948.8915 19 -8.6 650.6322 3 67.19 4 36992 VEV_1_3_RA4_01_1235.d 2.31E5 3 3 220 238 Methylation(KR)
R.EWLHLPAEIVPATHVK.Q Y 71.25 1839.0043 16 -23.2 460.7477 4 77.85 4 45432 VEV_1_3_RA4_01_1235.d 2.03E5 1 1 165 180
R.EQGEGK(+14.02)EGGAPGDFAPSFR.G Y 71.23 1948.8915 19 -12.2 650.6298 3 66.36 4 36335 VEV_1_3_RA4_01_1235.d 4.57E5 4 4 220 238 Methylation(KR)
R.EQGE(+14.02)GKEGGAPGDFAPSFR.G Y 69.41 1948.8915 19 -9.6 650.6315 3 65.82 4 35970 VEV_1_3_RA4_01_1235.d 1.81E5 1 1 220 238 Methylation(others)
R.GDRGEGGYR.R Y 69.20 965.4315 9 -12.5 483.7170 2 10.30 6 2631 VEV_3_3_RA6_01_1237.d 1.52E5 6 6 209 217
K.AC(+57.02)QSLTSR.G Y 64.25 921.4338 8 -12.2 461.7186 2 16.42 6 5693 VEV_3_3_RA6_01_1237.d 9.26E5 5 5 132 139 Carbamidomethylation
K.IHEYLFR.E Y 63.64 976.5130 7 -24.4 326.5037 3 59.73 6 30264 VEV_3_3_RA6_01_1237.d 1.75E6 7 7 98 104
R.RREQGEGKEGGAPGDFAPS(-18.01)FR(+14.02).G Y 62.10 2243.0830 21 21.5 561.7901 4 53.88 5 27521 VEV_2_3_RA5_01_1236.d 5.76E4 3 3 218 238 Dehydration; Methylation(KR)
R.E(+14.02)QGEGKEGGAPGDFAPSFR.G Y 60.29 1948.8915 19 -11.1 650.6306 3 64.46 4 34852 VEV_1_3_RA4_01_1235.d 1.79E5 2 2 220 238 Methylation(others)
K.E(+14.02)GGAPGDFAPSFR.G Y 58.14 1320.6097 13 -11.5 661.3046 2 70.90 5 39654 VEV_2_3_RA5_01_1236.d 2.78E5 2 2 226 238 Methylation(others)
K.AC(+57.02)QSLTSR(+14.02).G Y 56.70 935.4495 8 -7.1 468.7287 2 23.64 4 9350 VEV_1_3_RA4_01_1235.d 4.29E5 3 3 132 139 Carbamidomethylation; Methylation(KR)
K.IHEYLFREGVLVAK.K Y 53.21 1672.9301 14 -12.6 558.6436 3 70.45 5 39321 VEV_2_3_RA5_01_1236.d 2.38E5 2 2 98 111
R.KKIHEYLFR.E Y 50.86 1232.7029 9 -15.5 411.9019 3 49.71 6 24136 VEV_3_3_RA6_01_1237.d 1.53E5 2 2 96 104
R.EGVLVAKK.D Y 49.87 842.5225 8 -24.7 422.2581 2 18.47 6 6746 VEV_3_3_RA6_01_1237.d 2.32E5 2 2 105 112
R.SHAPPR(+14.02).G Y 48.79 677.3609 6 -15.9 339.6823 2 10.88 5 2901 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 184 189 Methylation(KR)
K.DFNLPK.H Y 47.29 732.3806 6 3.9 367.1990 2 60.74 5 32132 VEV_2_3_RA5_01_1236.d 0 4 4 113 118
R.RPGGR(+14.02)GGPRGDRGEGGYR.R Y 45.67 1869.9418 18 -17.0 374.9893 5 18.60 5 6974 VEV_2_3_RA5_01_1236.d 8.05E5 2 2 200 217 Methylation(KR)
K.EGGAPGDFAPSFR(+.98).G Y 44.76 1307.5781 13 2.4 654.7979 2 69.34 6 37370 VEV_3_3_RA6_01_1237.d 1.7E5 2 2 226 238 Deamidation (R)
R.GDRGE(+14.02)GGYR.R Y 43.61 979.4471 9 -10.3 490.7258 2 14.29 4 4436 VEV_1_3_RA4_01_1235.d 2.18E5 3 3 209 217 Methylation(others)
K.NLYVIK.A Y 43.13 748.4483 6 -13.7 749.4453 1 55.79 6 27607 VEV_3_3_RA6_01_1237.d 2.7E6 9 9 126 131
K.IHE(+14.02)YLFR.E Y 42.81 990.5287 7 -8.1 331.1808 3 66.61 4 36563 VEV_1_3_RA4_01_1235.d 2.76E5 3 3 98 104 Methylation(others)
R.RREQGEGK(+14.02)EGGAPGDFAPSFR.G Y 42.41 2261.0938 21 -6.9 453.2229 5 58.72 4 30523 VEV_1_3_RA4_01_1235.d 3.58E5 2 2 218 238 Methylation(KR)
K.KIHEYLFR.E Y 42.01 1104.6079 8 -11.8 553.3047 2 54.23 4 27583 VEV_1_3_RA4_01_1235.d 5.49E5 3 3 97 104
K.AC(+57.02)Q(+.98)SLTSR.G Y 40.37 922.4178 8 -16.1 462.2088 2 19.90 6 7502 VEV_3_3_RA6_01_1237.d 1.41E5 5 5 132 139 Carbamidomethylation; Deamidation (NQ)
R.E(-18.01)QGEGK(+14.02)EGGAPGDFAPSFR.G Y 39.62 1930.8809 19 15.8 644.6444 3 64.84 4 35154 VEV_1_3_RA4_01_1235.d 3.47E4 1 1 220 238 Pyro-glu from E; Methylation(KR)
R.GMMGGEERER.R Y 39.16 1150.4860 10 -7.7 576.2458 2 19.95 5 7731 VEV_2_3_RA5_01_1236.d 3.58E5 6 6 190 199
R.GDRGEGGYRRR.E Y 38.86 1277.6337 11 -5.9 639.8203 2 9.75 5 2414 VEV_2_3_RA5_01_1236.d 1.06E4 1 1 209 219
R.G(+42.01)GFGRGRGAPPPSS Y 36.57 1340.6584 14 18.6 671.3489 2 31.83 5 14324 VEV_2_3_RA5_01_1236.d 4.58E6 6 6 239 252 Acetylation (N-term)
R.ERRPGGR(+14.02)GGPR.G Y 35.74 1207.6646 11 -9.4 302.9206 4 10.91 4 2844 VEV_1_3_RA4_01_1235.d 9.61E5 2 2 198 208 Methylation(KR)
R.RREQGEGK(+164.06)EGGAPGDFAPSFR.G Y 35.52 2411.1382 21 4.9 603.7948 4 51.66 5 26177 VEV_2_3_RA5_01_1236.d 8.29E4 1 1 218 238 O-Diisopropylphosphorylation
R.EGVLVAK.K Y 33.35 714.4276 7 -10.1 358.2174 2 30.09 4 12897 VEV_1_3_RA4_01_1235.d 1.73E6 6 6 105 111
R.GM(+15.99)MGGEERER.R Y 33.20 1166.4808 10 -5.3 584.2446 2 12.33 4 3472 VEV_1_3_RA4_01_1235.d 4.83E5 4 4 190 199 Oxidation (M)
K.KDFNLPK.H Y 33.02 860.4756 7 -11.9 431.2400 2 37.94 4 17475 VEV_1_3_RA4_01_1235.d 2.32E6 7 7 112 118
R.REQGEGKEGGAPGDFAPS(-2.02)FR.G Y 32.23 2088.9612 20 32.3 523.2645 4 59.30 4 30964 VEV_1_3_RA4_01_1235.d 0 1 1 219 238 2-amino-3-oxo-butanoic_acid
R.RPGGR(+14.02)GGPR.G Y 32.03 922.5209 9 -19.5 308.5082 3 9.75 6 2417 VEV_3_3_RA6_01_1237.d 2.94E5 3 3 200 208 Methylation(KR)
R.GGFGR(+14.02)GR(+28.03)GAPPPSS Y 31.11 1340.6948 14 -12.8 447.8998 3 32.05 5 14450 VEV_2_3_RA5_01_1236.d 2.66E6 2 2 239 252 Methylation(KR); Dimethylation(KR)
R.G(+42.01)GFGRGR(+14.02)GAPPPSS Y 30.23 1354.6742 14 17.5 678.3562 2 34.29 5 15753 VEV_2_3_RA5_01_1236.d 8.05E6 10 10 239 252 Acetylation (N-term); Methylation(KR)
R.REQGEGKEGGAPGDFAPS(-18.01)FR(+14.02).G Y 29.31 2086.9819 20 40.3 522.7738 4 59.20 5 30961 VEV_2_3_RA5_01_1236.d 0 1 1 219 238 Dehydration; Methylation(KR)
R.GMMGGEER.E Y 28.94 865.3422 8 -9.0 433.6745 2 21.68 4 8301 VEV_1_3_RA4_01_1235.d 3.83E4 1 1 190 197
R.ERRPGGR(+28.03)GGPR.G Y 28.45 1221.6802 11 -8.0 306.4249 4 11.44 4 3068 VEV_1_3_RA4_01_1235.d 1.14E6 3 3 198 208 Dimethylation(KR)
R.GMM(+15.99)GGEERER.R Y 27.84 1166.4808 10 -13.3 389.8290 3 11.77 4 3195 VEV_1_3_RA4_01_1235.d 5.48E4 1 1 190 199 Oxidation (M)
R.GMM(-48.00)GGEERER.R Y 27.76 1102.4825 10 -17.2 368.4951 3 9.28 6 2228 VEV_3_3_RA6_01_1237.d 2.36E5 2 2 190 199 Dethiomethyl
R.RREQGEGKEGGAPGDFAPSFR(+14.02).G Y 27.42 2261.0938 21 0.6 453.2263 5 59.21 4 30895 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 218 238 Methylation(KR)
K.EGGAPGDFAPSFR(+14.02).G Y 25.99 1320.6097 13 29.5 661.3316 2 72.67 5 40975 VEV_2_3_RA5_01_1236.d 0 1 1 226 238 Methylation(KR)
R.SHAPPR.G Y 25.61 663.3452 6 -10.9 332.6763 2 29.49 4 12561 VEV_1_3_RA4_01_1235.d 2.22E5 1 1 184 189
K.K(+42.01)IHEYLFR.E Y 25.15 1146.6185 8 0.1 383.2135 3 53.69 5 27404 VEV_2_3_RA5_01_1236.d 0 1 1 97 104 Acetylation (N-term)
R.EQGEGKEGGAPGDFAPS(-2.02)FR.G Y 24.92 1932.8601 19 57.1 645.3307 3 64.24 4 34691 VEV_1_3_RA4_01_1235.d 0 2 2 220 238 2-amino-3-oxo-butanoic_acid
R.REQGEGK(+154.10)EGGAPGDFAPSFR.G Y 24.84 2245.0762 20 28.3 562.2922 4 54.82 4 27947 VEV_1_3_RA4_01_1235.d 5.68E4 2 2 219 238 4-Oxononenal (ONE)
R.GM(-48.00)MGGEERER.R Y 24.32 1102.4825 10 -13.3 368.4966 3 9.60 5 2354 VEV_2_3_RA5_01_1236.d 3.09E5 2 2 190 199 Dethiomethyl
R.SHAPPRGM(+15.99)M(+15.99)GGEERER.R Y 22.41 1827.8104 16 -16.2 457.9525 4 11.74 4 3186 VEV_1_3_RA4_01_1235.d 5.23E4 1 1 184 199 Oxidation (M)
R.GDRGEGGYR(+14.02).R Y 22.25 979.4471 9 -14.1 327.4850 3 14.47 4 4518 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 209 217 Methylation(KR)
R.EGVLVAK(+14.02).K Y 21.65 728.4432 7 -12.4 365.2244 2 42.41 4 20165 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 105 111 Methylation(KR)
R.EQGE(+6.01)GKEGGAPGDFAPSFR.G Y 21.44 1940.8839 19 39.9 647.9944 3 64.33 4 34755 VEV_1_3_RA4_01_1235.d 1.36E4 1 1 220 238 Replacement of proton by lithium
K.IHEYLFR(+14.02)EGVLVAK.K Y 21.39 1686.9457 14 -5.9 422.7412 4 74.30 5 42095 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 98 111 Methylation(KR)
K.DFNLPK(+14.02).H Y 21.09 746.3962 6 -25.1 374.1960 2 68.81 6 36989 VEV_3_3_RA6_01_1237.d 6.58E4 1 1 113 118 Methylation(KR)
R.G(+28.03)EGGYR.R Y 21.06 665.3132 6 27.6 666.3389 1 49.53 4 24589 VEV_1_3_RA4_01_1235.d 1.69E4 1 1 212 217 Ethylation
R.RPGGR(+28.03)GGPR.G Y 21.04 936.5366 9 -15.6 469.2682 2 10.31 4 2588 VEV_1_3_RA4_01_1235.d 8.14E4 1 1 200 208 Dimethylation(KR)
R.RP(+31.99)GGRGGPRGDR.G Y 20.91 1268.6445 12 0.9 318.1687 4 11.59 5 3249 VEV_2_3_RA5_01_1236.d 2.72E5 1 1 200 211 Dihydroxy
K.EGGAPGD(+43.99)FAPSFR.G Y 20.75 1350.5840 13 46.0 451.2227 3 54.11 5 27657 VEV_2_3_RA5_01_1236.d 1.99E5 1 1 226 238 Carboxylation (DKW)
R.EQGEGKE(+17.03)GGAPGDFAPSFR.G Y 20.69 1951.9023 19 13.1 651.6499 3 65.62 6 34583 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 220 238 Replacement of proton with ammonium ion
R.GGPRGDRGEGGYR.R Y 20.51 1332.6283 13 -9.9 445.2123 3 12.25 5 3580 VEV_2_3_RA5_01_1236.d 1.43E4 1 1 205 217
R.ERRPGGRGGPR(+14.02).G Y 19.84 1207.6646 11 -10.9 403.5577 3 10.70 5 2818 VEV_2_3_RA5_01_1236.d 7.82E4 1 1 198 208 Methylation(KR)
R.GGFGR(+14.02)GR(+14.02)GAPPPSS Y 19.80 1326.6792 14 -8.2 443.2300 3 29.78 4 12730 VEV_1_3_RA4_01_1235.d 3.86E5 1 1 239 252 Methylation(KR)
R.RPGGRGGPR(+.98).G Y 19.72 909.4893 9 -35.4 304.1596 3 31.56 5 14175 VEV_2_3_RA5_01_1236.d 0 1 1 200 208 Deamidation (R)
R.RREQGEGKEGGAPGDFAPSFR(+28.03).G Y 19.50 2275.1094 21 -5.5 569.7815 4 75.21 6 41693 VEV_3_3_RA6_01_1237.d 1.78E5 1 1 218 238 Dimethylation(KR)
R.RREQ(+.98)GEGKEGGAPGDFAPSFR.G Y 19.32 2248.0620 21 -35.6 450.6037 5 56.22 5 28901 VEV_2_3_RA5_01_1236.d 0 1 1 218 238 Deamidation (NQ)
R.GAPPPSS Y 19.27 611.2914 7 36.9 612.3213 1 29.96 4 12829 VEV_1_3_RA4_01_1235.d 5.96E3 1 1 246 252
K.EGGAPGDFAPSFR(+28.03)GGFGR(+14.02)GRGAPPPSS Y 18.86 2629.2786 27 -7.9 658.3217 4 73.66 5 41638 VEV_2_3_RA5_01_1236.d 9.53E4 1 1 226 252 Dimethylation(KR); Methylation(KR)
K.EGGAP(+15.99)GDFAPSFR.G Y 18.79 1322.5891 13 -30.3 662.2818 2 71.32 4 40272 VEV_1_3_RA4_01_1235.d 0 1 1 226 238 Oxidation or Hydroxylation
R.GYLKTR.F Y 18.39 736.4232 6 -51.9 369.1997 2 16.73 5 5947 VEV_2_3_RA5_01_1236.d 0 1 1 140 145
R.GGFGR(+28.03)GR(+14.02)GAPPPSS Y 18.26 1340.6948 14 17.5 671.3664 2 32.24 5 14556 VEV_2_3_RA5_01_1236.d 6.08E5 2 2 239 252 Dimethylation(KR); Methylation(KR)
R.GRGAPPPSS Y 17.96 824.4140 9 -10.4 413.2100 2 36.60 4 16702 VEV_1_3_RA4_01_1235.d 0 1 1 244 252
R.RPGGR(+14.02)GGPRGDR(+14.02)GEGGYR.R Y 17.91 1883.9574 18 -5.7 377.7966 5 19.76 4 7271 VEV_1_3_RA4_01_1235.d 3.61E5 1 1 200 217 Methylation(KR)
K.AC(+57.02)QSLTSRGYLK.T Y 17.84 1382.6976 12 -20.2 692.3421 2 44.69 5 21954 VEV_2_3_RA5_01_1236.d 9.58E4 1 1 132 143 Carbamidomethylation
R.G(+298.19)GPRGDRGEGGYR.R Y 17.81 1630.8215 13 -19.2 408.7048 4 14.92 4 4753 VEV_1_3_RA4_01_1235.d 8.19E4 1 1 205 217 Levuglandinyl-lysine anhyropyrrole adduct
R.EQGEGK(+164.06)EGGAPGDFAPSFR.G Y 17.71 2098.9360 19 7.3 700.6577 3 62.44 5 33365 VEV_2_3_RA5_01_1236.d 7.62E4 1 1 220 238 O-Diisopropylphosphorylation
R.E(+14.02)GVLVAK.K Y 17.32 728.4432 7 -10.8 365.2250 2 40.46 4 18965 VEV_1_3_RA4_01_1235.d 2.65E5 1 1 105 111 Methylation(others)
R.R(+42.01)PGGR(+28.03)GGPR.G Y 17.21 978.5471 9 -3.2 327.1886 3 10.22 5 2607 VEV_2_3_RA5_01_1236.d 0 1 1 200 208 Acetylation (N-term); Dimethylation(KR)
R.G(+42.01)RGAPPPSS Y 17.09 866.4246 9 -12.1 434.2143 2 15.99 6 5467 VEV_3_3_RA6_01_1237.d 0 1 1 244 252 Acetylation (N-term)
K.QQRSHAP(-27.99)PR.G Y 16.82 1047.5686 9 1.1 350.1972 3 37.40 6 16996 VEV_3_3_RA6_01_1237.d 1.87E5 1 1 181 189 Pyrrolidone from Proline
K.A(+42.01)C(+57.02)QSLTSRGYLK(+42.01).T Y 16.12 1466.7188 12 -10.8 489.9083 3 73.21 6 40249 VEV_3_3_RA6_01_1237.d 8.4E4 1 1 132 143 Acetylation (N-term); Carbamidomethylation; Acetylation (K)
R.EQGEGK.E Y 16.04 646.2922 6 29.6 647.3186 1 54.10 5 27650 VEV_2_3_RA5_01_1236.d 5.54E4 1 1 220 225
K.E(+6.01)GGAPGDFAPSFR.G Y 15.86 1312.6023 13 14.1 657.3177 2 70.82 6 38464 VEV_3_3_RA6_01_1237.d 6.06E4 1 1 226 238 Replacement of proton by lithium
K.EGGAPGDFAPSFR(+21.98).G Y 15.51 1328.5760 13 -36.8 665.2709 2 40.70 6 18894 VEV_3_3_RA6_01_1237.d 1.46E5 1 1 226 238 Sodium adduct
R.GGFGR(+14.02).G N 15.48 506.2601 5 -1.2 507.2668 1 27.29 4 11354 VEV_1_3_RA4_01_1235.d 5.27E4 2 2 239 243 Methylation(KR)
K.E(+17.03)GGAPGDFAPSFR.G Y 15.47 1323.6207 13 15.7 662.8280 2 70.95 6 38568 VEV_3_3_RA6_01_1237.d 1.51E5 1 1 226 238 Replacement of proton with ammonium ion
total 94 peptides
C1G6F6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLSNATQTTIEIDSLFDGEDFNSQITR.A Y 127.29 3015.4309 27 -7.6 1508.7113 2 88.31 6 50411 VEV_3_3_RA6_01_1237.d 4.6E5 5 5 278 304
R.IINEPTAAAIAYGLGSGRSEKER.N Y 124.32 2402.2554 23 -8.6 601.5660 4 71.61 5 40180 VEV_2_3_RA5_01_1236.d 7.13E5 4 4 176 198
K.AFSGTLEPVQQVLK.D Y 124.09 1515.8296 14 -14.8 758.9108 2 77.24 6 43182 VEV_3_3_RA6_01_1237.d 2.09E5 3 3 314 327
R.IINEPTAAAIAYGLGSGR.S Y 121.93 1772.9420 18 -4.0 591.9856 3 79.51 4 46666 VEV_1_3_RA4_01_1235.d 4.47E5 6 6 176 193
R.TFTTVVDNQQTVQFPVYQGER.T Y 117.16 2456.1973 21 -12.9 819.7291 3 79.49 4 46628 VEV_1_3_RA4_01_1235.d 2.85E5 3 3 433 453
K.ATAGDTHLGGQDFDTNLLEHFKR.E Y 97.61 2542.2200 23 -12.6 509.4449 5 74.47 6 41162 VEV_3_3_RA6_01_1237.d 5.72E5 2 2 226 248
K.AVITVPAYFNDNQR.Q Y 97.58 1606.8103 14 -17.1 536.6016 3 76.66 4 44460 VEV_1_3_RA4_01_1235.d 8.63E5 6 6 146 159
K.VVDQGGNPVVQVQYLGETK.T Y 86.94 2029.0480 19 -15.4 677.3462 3 74.55 4 42783 VEV_1_3_RA4_01_1235.d 2.47E5 2 2 98 116
K.DAGAIAGLNVLR.I Y 81.14 1168.6564 12 -17.9 585.3250 2 77.65 6 43475 VEV_3_3_RA6_01_1237.d 4.03E5 3 3 164 175
R.NVLIYDLGGGTFDVSLLNIQGGVFTVK.A Y 74.33 2838.5166 27 -8.5 947.1714 3 95.37 6 53742 VEV_3_3_RA6_01_1237.d 1.66E5 2 2 199 225
R.Q(-17.03)ATKDAGAIAGLNVLR.I Y 68.15 1579.8682 16 -8.4 790.9347 2 77.33 5 44254 VEV_2_3_RA5_01_1236.d 4.73E4 2 2 160 175 Pyro-glu from Q
R.SANITISNAVGKLSSTEIENMINDAAK.F Y 65.76 2790.4070 27 30.5 931.1713 3 85.22 5 49302 VEV_2_3_RA5_01_1236.d 0 2 2 504 530
K.NQAAMNPQNTVFDIKR.L Y 62.78 1845.9155 16 -7.3 616.3080 3 67.05 4 36883 VEV_1_3_RA4_01_1235.d 9.69E4 1 1 61 76
R.QATKDAGAIAGLNVLR.I Y 62.36 1596.8947 16 -10.7 533.2998 3 69.25 4 38629 VEV_1_3_RA4_01_1235.d 1.35E5 2 2 160 175
K.TFSPQEISSMVLMK.M Y 53.47 1596.7892 14 -17.8 799.3876 2 83.74 6 47665 VEV_3_3_RA6_01_1237.d 7.11E4 2 2 117 130
R.TLSNATQTTIEIDSLFDGEDFNSQITR(-.98).A Y 50.37 3014.4468 27 -9.9 1508.2157 2 88.38 5 51047 VEV_2_3_RA5_01_1236.d 3.71E3 1 1 278 304 Amidation
R.LRTAC(+57.02)ER.A N 49.83 904.4549 7 -20.3 453.2255 2 11.20 6 3026 VEV_3_3_RA6_01_1237.d 2.07E5 4 4 268 274 Carbamidomethylation
R.Q(-17.03)QLESYISRVEEIISDPTMSLK.I Y 48.52 2548.2729 22 -6.3 1275.1357 2 96.90 4 57115 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 546 567 Pyro-glu from Q
R.SANITISNAVGK.L Y 44.38 1173.6354 12 -8.1 587.8202 2 57.23 6 28518 VEV_3_3_RA6_01_1237.d 1.42E5 2 2 504 515
R.ARFEDLNAK.A Y 44.03 1062.5458 9 -7.4 532.2762 2 35.40 5 16418 VEV_2_3_RA5_01_1236.d 1.53E6 9 9 305 313
K.MKEVAETK.L Y 38.44 934.4794 8 -12.3 468.2412 2 12.15 6 3465 VEV_3_3_RA6_01_1237.d 2.76E4 1 1 131 138
K.DLSGDPRALR.R Y 35.50 1098.5781 10 -8.3 367.1969 3 34.04 6 15143 VEV_3_3_RA6_01_1237.d 6.25E5 2 2 257 266
R.LRT(+79.96)AC(+57.02)ER.A N 35.00 984.4117 7 94.2 329.1754 3 11.20 6 3010 VEV_3_3_RA6_01_1237.d 0 1 1 268 274 Sulfation; Carbamidomethylation
K.DANIDKSKVDEIVLVGGSTR.I Y 31.54 2115.1172 20 22.1 529.7983 4 70.62 4 39694 VEV_1_3_RA4_01_1235.d 0 1 1 328 347
K.LLSDFFN(+.98)GKKLEK.S Y 29.90 1538.8344 13 -3.8 385.7144 4 73.10 4 41660 VEV_1_3_RA4_01_1235.d 5.39E4 1 1 354 366 Deamidation (NQ)
R.LRTAC(+57.02)ER(+14.02).A N 24.98 918.4705 7 -17.9 307.1586 3 15.11 6 5002 VEV_3_3_RA6_01_1237.d 3.31E5 2 2 268 274 Carbamidomethylation; Methylation(KR)
K.LSSTEIENMINDAAK(+226.08).F Y 24.47 1860.8597 15 10.1 931.4465 2 92.71 5 53222 VEV_2_3_RA5_01_1236.d 1.78E4 1 1 516 530 Biotinylation
K.LSST(+79.97)EIENMIN(+.98)DAAKFK.S Y 24.39 1990.8959 17 36.3 498.7493 4 60.49 5 31905 VEV_2_3_RA5_01_1236.d 0 1 1 516 532 Phosphorylation (STY); Deamidation (NQ)
K.KDLSGDPR.A Y 23.74 886.4508 8 -13.5 444.2267 2 38.89 5 18455 VEV_2_3_RA5_01_1236.d 5.89E5 4 4 256 263
R.SANITIS(-2.02)NAVGKLSSTEIENMINDAAK.F Y 23.67 2788.3914 27 21.5 930.4911 3 85.19 6 48584 VEV_3_3_RA6_01_1237.d 0 1 1 504 530 2-amino-3-oxo-butanoic_acid
R.LIGEAAK(+14.02).N Y 23.62 714.4276 7 -21.1 358.2135 2 14.30 6 4582 VEV_3_3_RA6_01_1237.d 3.5E4 1 1 54 60 Methylation(KR)
R.S(+79.97)ANITISNAVGK(+14.02).L Y 23.45 1267.6173 12 21.3 423.5554 3 62.43 6 32224 VEV_3_3_RA6_01_1237.d 9.64E4 1 1 504 515 Phosphorylation (STY); Methylation(KR)
R.QATKDAGAIAGLN(+.98)VLR.I Y 23.42 1597.8787 16 -33.1 533.6158 3 68.96 6 37093 VEV_3_3_RA6_01_1237.d 0 1 1 160 175 Deamidation (NQ)
K.DANIDKSKVDEIVLVGGSTRIPR.I Y 23.14 2481.3550 23 -20.4 497.2682 5 73.23 4 41764 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 328 350
R.IQKLLSDFFNGK.K Y 23.12 1408.7714 12 -14.0 470.5912 3 77.13 6 43101 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 351 362
R.TLSNATQTTIEIDSLFDGE(+14.02)DFNSQITR.A Y 22.75 3029.4465 27 -7.6 1010.8151 3 89.67 6 51140 VEV_3_3_RA6_01_1237.d 1.99E5 1 1 278 304 Methylation(others)
K.TFSPQEISSMVLM(+15.99)K.M Y 21.66 1612.7841 14 -56.8 538.5714 3 70.91 6 38534 VEV_3_3_RA6_01_1237.d 0 1 1 117 130 Oxidation (M)
K.EVAET(-18.01)K.L Y 21.40 657.3333 6 -12.3 658.3325 1 86.82 6 49567 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 133 138 Dehydration
R.Q(+.98)ATK(+14.02)DAGAIAGLNVLR.I Y 21.34 1611.8944 16 -30.0 538.2893 3 76.80 5 43879 VEV_2_3_RA5_01_1236.d 2.6E3 1 1 160 175 Deamidation (NQ); Methylation(KR)
K.D(+42.01)LSGDPR.A Y 21.32 800.3664 7 -5.7 801.3691 1 112.71 6 58831 VEV_3_3_RA6_01_1237.d 0 1 1 257 263 Acetylation (N-term)
K.ATAGDTHLGGQDFDTNLLEHFK.R Y 20.80 2386.1189 22 -11.6 796.3710 3 84.52 5 48888 VEV_2_3_RA5_01_1236.d 5.9E4 1 1 226 247
K.T(+79.97)KKDLSGDPR(+14.02).A Y 19.70 1209.5754 10 21.2 404.2076 3 56.44 6 28000 VEV_3_3_RA6_01_1237.d 5.32E4 1 1 254 263 Phosphorylation (STY); Methylation(KR)
K.AVITVPAYFNDNQR(+14.02).Q Y 19.37 1620.8259 14 -1.0 541.2820 3 77.01 4 44701 VEV_1_3_RA4_01_1235.d 1.84E5 1 1 146 159 Methylation(KR)
R.QATKD(+43.99)AGAIAGLNVLR.I Y 19.29 1640.8845 16 -23.3 411.2188 4 54.94 4 28023 VEV_1_3_RA4_01_1235.d 0 1 1 160 175 Carboxylation (DKW)
K.EVAETK(+31.99)LAK.K Y 19.19 1019.5499 9 -63.8 510.7497 2 57.76 4 29839 VEV_1_3_RA4_01_1235.d 1.62E4 1 1 133 141 Dihydroxy
K.RLIGR.R N 19.03 613.4023 5 -22.7 307.7015 2 17.13 6 6051 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 76 80
R.QQLESYIS(+79.97)R(+14.02).V Y 18.85 1216.5490 9 3.8 609.2841 2 52.20 6 25593 VEV_3_3_RA6_01_1237.d 0 1 1 546 554 Phosphorylation (STY); Methylation(KR)
K.KDVESWPFK.V Y 18.57 1134.5709 9 -28.3 1135.5461 1 86.44 4 51528 VEV_1_3_RA4_01_1235.d 7.42E4 1 1 89 97
K.A(+42.01)MAT(-18.01)R Y 18.40 572.2740 5 -1.0 573.2808 1 52.63 4 26576 VEV_1_3_RA4_01_1235.d 0 1 1 611 615 Acetylation (N-term); Dehydration
K.DLSGDPR.A Y 17.86 758.3558 7 -1.8 759.3618 1 107.74 6 57496 VEV_3_3_RA6_01_1237.d 7.29E4 1 1 257 263
K.L(+42.01)LSDFFNGK(+14.02).K Y 17.81 1095.5601 9 24.6 366.2029 3 38.36 4 17732 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 354 362 Acetylation (N-term); Methylation(KR)
K.V(+27.99)TATEK.S Y 17.67 675.3439 6 -29.4 676.3314 1 80.14 5 46139 VEV_2_3_RA5_01_1236.d 2.23E4 1 1 494 499 Formylation
K.AVIT(+79.97)VPAYFNDNQRQATK.D Y 17.50 2115.0149 18 -13.9 529.7537 4 58.35 6 29264 VEV_3_3_RA6_01_1237.d 5.36E4 1 1 146 163 Phosphorylation (STY)
K.VVDQGGNPVVQVQYLGETK(+43.01).T Y 17.35 2072.0537 19 4.7 415.4200 5 66.52 5 36410 VEV_2_3_RA5_01_1236.d 1.77E4 1 1 98 116 Carbamylation
R.IINE(+43.99)PTAAAIAYGLGSGR.S Y 17.17 1816.9319 18 -10.5 455.2355 4 52.81 4 26681 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 176 193 Carboxylation (E)
K.DLSGD(+43.99)PR.A Y 17.13 802.3457 7 69.6 803.4088 1 93.48 6 52969 VEV_3_3_RA6_01_1237.d 3.11E5 1 1 257 263 Carboxylation (DKW)
R.QQLESYISR.V Y 16.62 1122.5669 9 -10.8 562.2847 2 19.21 6 7157 VEV_3_3_RA6_01_1237.d 0 1 1 546 554
K.LSSTEIENMIND(-18.01)AAK(+14.02).F Y 16.59 1630.7872 15 -11.5 816.3915 2 81.07 4 47836 VEV_1_3_RA4_01_1235.d 9.47E4 1 1 516 530 Dehydration; Methylation(KR)
K.K(+42.01)VSK(+42.01)AVITVPAYFNDNQR.Q Y 16.58 2133.1218 18 -18.1 534.2781 4 76.96 4 44663 VEV_1_3_RA4_01_1235.d 8.87E4 1 1 142 159 Acetylation (N-term); Acetylation (K)
K.AVIT(+79.97)VPAYFNDNQR.Q Y 16.49 1686.7766 14 -6.6 563.2625 3 39.86 5 19037 VEV_2_3_RA5_01_1236.d 0 1 1 146 159 Phosphorylation (STY)
R.RFDDPVVKK.D Y 16.20 1102.6134 9 -25.6 552.2999 2 28.83 6 12237 VEV_3_3_RA6_01_1237.d 3.03E4 1 1 81 89
K.SKVDEIVLVGGSTR(+14.02).I Y 16.20 1472.8198 14 -30.8 491.9321 3 75.55 5 42987 VEV_2_3_RA5_01_1236.d 0 1 1 334 347 Methylation(KR)
R.LIGEAAK(+27.99).N Y 16.18 728.4068 7 -13.0 365.2059 2 54.22 5 27725 VEV_2_3_RA5_01_1236.d 3.5E5 2 2 54 60 Formylation
K.D(+42.01)LSGDPR(+28.03).A Y 15.84 828.3977 7 -21.7 415.1971 2 8.87 6 2098 VEV_3_3_RA6_01_1237.d 4.32E3 1 1 257 263 Acetylation (N-term); Dimethylation(KR)
K.D(+14.02)LSGDPR.A Y 15.71 772.3715 7 -21.8 387.1846 2 106.77 4 60256 VEV_1_3_RA4_01_1235.d 0 1 1 257 263 Methylation(others)
K.K(+72.02)DLSGDPR.A Y 15.54 958.4719 8 -14.6 959.4652 1 84.67 4 50362 VEV_1_3_RA4_01_1235.d 0 1 1 256 263 Carboxyethyl
total 66 peptides
C1G9C0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GATYGKPTNHGINQLKYQR.S Y 133.86 2145.1079 19 -9.0 537.2794 4 45.12 4 21845 VEV_1_3_RA4_01_1235.d 2.84E6 11 11 78 96
K.GATYGKPTNHGINQLK.Y Y 133.42 1697.8849 16 -11.4 849.9400 2 36.94 6 16742 VEV_3_3_RA6_01_1237.d 5.9E6 14 14 78 93
R.VLNSYWINQDSTYKYYEVILVDPQHK.A Y 127.86 3214.5974 26 -5.0 1072.5344 3 83.57 4 49608 VEV_1_3_RA4_01_1235.d 9.79E5 7 7 115 140
R.VLNSYWINQDSTYK.Y Y 116.55 1729.8312 14 1.6 865.9243 2 73.98 4 42340 VEV_1_3_RA4_01_1235.d 2.94E5 3 3 115 128
R.INWIVNPVHK.H Y 94.48 1218.6873 10 -12.6 407.2313 3 69.61 4 38936 VEV_1_3_RA4_01_1235.d 2.56E6 6 6 148 157
K.YYEVILVDPQHK.A Y 88.55 1502.7769 12 -11.5 501.9271 3 70.35 4 39482 VEV_1_3_RA4_01_1235.d 8.52E5 3 3 129 140
K.GATYGKPTNHGINQ(+.98)LK.Y Y 85.89 1698.8689 16 -7.7 567.2925 3 40.33 4 18889 VEV_1_3_RA4_01_1235.d 9.09E5 8 8 78 93 Deamidation (NQ)
K.GATYGKPTNHGINQLKYQ(+.98)R.S Y 83.77 2146.0918 19 -7.6 537.5261 4 46.72 5 23156 VEV_2_3_RA5_01_1236.d 1.88E5 2 2 78 96 Deamidation (NQ)
R.INWIVNPVHKHR.E Y 80.11 1511.8473 12 -12.7 378.9643 4 59.32 5 31045 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 148 159
K.QGYVIYR.I Y 74.00 897.4708 7 -17.5 449.7348 2 52.80 6 25937 VEV_3_3_RA6_01_1237.d 2.1E6 7 7 57 63
R.LNTQSYWR.Y Y 71.09 1066.5195 8 -11.0 534.2612 2 59.73 5 31398 VEV_2_3_RA5_01_1236.d 1.86E6 12 12 194 201
K.GAT(-2.02)YGKPTNHGINQLK.Y Y 67.78 1695.8693 16 28.8 566.3133 3 36.94 4 16900 VEV_1_3_RA4_01_1235.d 0 2 2 78 93 2-amino-3-oxo-butanoic_acid
K.AKQGYVIYR.I Y 66.34 1096.6029 9 -26.6 549.2941 2 37.62 4 17328 VEV_1_3_RA4_01_1235.d 5.94E5 5 5 55 63
K.YVEELQK.K Y 65.71 907.4651 7 -9.3 454.7356 2 33.78 4 15059 VEV_1_3_RA4_01_1235.d 1.37E6 7 7 6 12
K.GAT(-18.01)YGK(+14.02)PTNHGINQLKYQR.S Y 65.25 2141.1130 19 -2.1 429.2290 5 45.11 5 22203 VEV_2_3_RA5_01_1236.d 0 3 3 78 96 Dehydration; Methylation(KR)
R.ASRPSRPDKAR.R Y 64.04 1239.6796 11 -14.8 414.2277 3 10.17 6 2568 VEV_3_3_RA6_01_1237.d 7.12E5 6 6 39 49
K.GAT(+79.96)YGKPTNHGINQLK.Y Y 61.94 1777.8417 16 41.6 445.4862 4 37.15 4 17014 VEV_1_3_RA4_01_1235.d 2.87E5 1 1 78 93 Sulfation
R.Q(-17.03)LNVIHR.A Y 60.72 861.4821 7 -13.2 431.7426 2 60.73 4 32028 VEV_1_3_RA4_01_1235.d 1.62E6 3 3 32 38 Pyro-glu from Q
K.GATYGKPTN(+.98)HGINQLK.Y Y 60.44 1698.8689 16 -11.0 425.7198 4 42.00 4 19913 VEV_1_3_RA4_01_1235.d 6.99E5 5 5 78 93 Deamidation (NQ)
M.GALKYVEELQK.K Y 60.17 1276.7026 11 -11.2 426.5700 3 66.40 4 36396 VEV_1_3_RA4_01_1235.d 8.5E5 3 3 2 12
R.VLNSYWINQDSTYK(-1.03)YYEVILVDPQHK.A Y 58.09 3213.5659 26 9.2 1072.2058 3 83.52 4 49580 VEV_1_3_RA4_01_1235.d 0 1 1 115 140 Lysine oxidation to aminoadipic semialdehyde
K.G(+41.03)ATYGKPTNHGINQLK.Y Y 56.91 1738.9114 16 3.6 435.7367 4 36.90 4 16876 VEV_1_3_RA4_01_1235.d 0 1 1 78 93 Amidination of lysines or N-terminal amines with methyl acetimidate
R.QLNVIHR.A Y 55.48 878.5086 7 -21.6 440.2521 2 31.04 6 13484 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 32 38
K.RLNTQSYWR.Y Y 55.34 1222.6207 9 -25.1 408.5373 3 50.88 6 24799 VEV_3_3_RA6_01_1237.d 1.62E6 4 4 193 201
K.GATYGKPTNHGINQ(+.98)LKYQR.S Y 52.09 2146.0918 19 -2.6 537.5288 4 48.02 5 23938 VEV_2_3_RA5_01_1236.d 8.36E4 1 1 78 96 Deamidation (NQ)
R.ASRPSRPDK.A Y 51.30 1012.5413 9 -10.6 338.5175 3 9.41 4 2270 VEV_1_3_RA4_01_1235.d 8.99E5 5 5 39 47
K.GATYGK(+40.03)PTNHGINQLK.Y Y 44.71 1737.9161 16 43.2 435.5051 4 36.96 5 17334 VEV_2_3_RA5_01_1236.d 0 1 1 78 93 Propionaldehyde +40
K.GATY(-18.01)GK(+14.02)PTNHGINQLKYQR.S Y 44.40 2141.1130 19 -10.5 429.2254 5 45.28 6 21570 VEV_3_3_RA6_01_1237.d 0 1 1 78 96 Dehydration; Methylation(KR)
R.LNTQSYW(+15.99)R.Y Y 43.03 1082.5145 8 -8.7 542.2598 2 57.57 4 29699 VEV_1_3_RA4_01_1235.d 1.63E5 4 4 194 201 Oxidation (HW)
K.YVEELQKKK.Q Y 41.60 1163.6550 9 -31.3 582.8166 2 17.31 5 6279 VEV_2_3_RA5_01_1236.d 0 1 1 6 14
K.GATY(-2.02)GKPTNHGINQLK.Y Y 40.87 1695.8693 16 -6.2 566.2935 3 36.83 6 16673 VEV_3_3_RA6_01_1237.d 0 1 1 78 93 2-amino-3-oxo-butanoic_acid
K.GATYGKPTNHGIN(+.98)QLK.Y Y 40.15 1698.8689 16 -18.8 567.2863 3 41.70 6 19482 VEV_3_3_RA6_01_1237.d 3.08E5 2 2 78 93 Deamidation (NQ)
K.G(+42.01)ATYGKPTNHGINQ(+.98)LK.Y Y 38.37 1740.8795 16 -20.7 436.2181 4 40.29 4 18870 VEV_1_3_RA4_01_1235.d 0 1 1 78 93 Acetylation (N-term); Deamidation (NQ)
R.GLGRGHKYNK.T Y 36.68 1128.6152 10 -11.2 565.3086 2 11.70 5 3297 VEV_2_3_RA5_01_1236.d 1.09E4 1 1 173 182
K.YVEELQKK.K Y 36.38 1035.5601 8 -30.6 518.7715 2 23.78 4 9434 VEV_1_3_RA4_01_1235.d 5.85E4 1 1 6 13
R.D(+42.01)(+43.99)PRINWIVNPVHK.H Y 36.10 1672.8685 13 -5.1 419.2223 4 69.82 4 39079 VEV_1_3_RA4_01_1235.d 0 1 1 145 157 Acetylation (N-term); Carboxylation (DKW)
K.QGYVIYR(+14.02).I Y 36.06 911.4865 7 -9.3 456.7463 2 59.96 4 31465 VEV_1_3_RA4_01_1235.d 1.68E5 2 2 57 63 Methylation(KR)
R.LNTQSY(+31.99)WR.Y Y 35.76 1098.5094 8 -5.1 550.2592 2 36.47 4 16662 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 194 201 Dihydroxy
R.GLTATGKK(+14.02).S Y 34.31 788.4756 8 -58.5 395.2220 2 12.79 5 3853 VEV_2_3_RA5_01_1236.d 0 1 1 163 170 Methylation(KR)
R.SLRSTAEER.V Y 34.26 1047.5309 9 -11.9 524.7665 2 17.78 5 6534 VEV_2_3_RA5_01_1236.d 4.13E5 3 3 97 105
K.YVEE(+14.02)LQK.K Y 33.75 921.4807 7 -8.8 461.7436 2 43.19 4 20672 VEV_1_3_RA4_01_1235.d 6E5 2 2 6 12 Methylation(others)
R.INWIVNPVHK(+14.02).H Y 32.17 1232.7030 10 -12.1 411.9033 3 68.07 6 36443 VEV_3_3_RA6_01_1237.d 2.31E5 3 3 148 157 Methylation(KR)
K.Q(+.98)GYVIYR.I Y 31.94 898.4548 7 11.9 450.2401 2 56.39 5 29008 VEV_2_3_RA5_01_1236.d 0 1 1 57 63 Deamidation (NQ)
R.VRC(+57.02)WELR.Q Y 31.44 1017.5178 7 -15.6 340.1746 3 47.25 6 22703 VEV_3_3_RA6_01_1237.d 8.11E5 8 8 25 31 Carbamidomethylation
K.YVEELQK(+14.02).K Y 30.60 921.4807 7 -9.2 461.7434 2 43.63 4 20919 VEV_1_3_RA4_01_1235.d 5.42E5 2 2 6 12 Methylation(KR)
R.LNTQSYWR(+31.99).Y Y 29.32 1098.5094 8 -10.7 550.2561 2 36.44 6 16504 VEV_3_3_RA6_01_1237.d 5.42E4 1 1 194 201 Dihydroxy
K.GATYGKPTNHGIN(+.98)Q(+.98)LK.Y Y 29.01 1699.8529 16 14.8 567.6333 3 37.05 4 16961 VEV_1_3_RA4_01_1235.d 8.25E4 1 1 78 93 Deamidation (NQ)
R.INWIVN(+.98)PVHK.H Y 24.55 1219.6713 10 -6.3 407.5618 3 71.50 5 40097 VEV_2_3_RA5_01_1236.d 5.1E4 1 1 148 157 Deamidation (NQ)
R.ASR(+14.02)PSRPDK.A Y 23.20 1026.5570 9 -17.4 514.2769 2 75.77 6 42111 VEV_3_3_RA6_01_1237.d 8.39E4 1 1 39 47 Methylation(KR)
R.ESRGLTATGK(+108.02).K Y 23.13 1126.5618 10 9.1 1127.5793 1 89.66 5 51707 VEV_2_3_RA5_01_1236.d 1.98E5 1 1 160 169 HydroxymethylOP
R.INWIVNPVH(+15.99)K.H Y 22.98 1234.6823 10 10.3 309.6810 4 48.78 4 24106 VEV_1_3_RA4_01_1235.d 3.85E4 1 1 148 157 Oxidation (HW)
R.LNTQSYW(+31.99)R.Y Y 22.43 1098.5094 8 -8.0 550.2576 2 36.25 5 16925 VEV_2_3_RA5_01_1236.d 9.98E4 2 2 194 201 Dihydroxy
R.GLTATGKKS(-18.01)R.G Y 20.49 999.5825 10 -22.3 500.7874 2 34.51 6 15379 VEV_3_3_RA6_01_1237.d 8.46E4 1 1 163 172 Dehydration
R.GLGRGHK.Y Y 20.46 723.4140 7 -33.1 724.3973 1 88.61 5 51174 VEV_2_3_RA5_01_1236.d 0 1 1 173 179
R.GLTAT(-18.01)GK(+14.02).K Y 20.02 642.3701 7 -17.6 322.1866 2 37.92 5 17892 VEV_2_3_RA5_01_1236.d 0 1 1 163 169 Dehydration; Methylation(KR)
R.G(+42.01)LTATGK(+21.98).K Y 19.33 710.3575 7 -10.0 711.3577 1 83.84 4 49798 VEV_1_3_RA4_01_1235.d 0 1 1 163 169 Acetylation (N-term); Sodium adduct
R.INW(+31.99)IVNPVHK.H Y 19.23 1250.6771 10 -12.6 417.8944 3 61.74 4 32792 VEV_1_3_RA4_01_1235.d 9.72E4 1 1 148 157 Dihydroxy
K.GATYGKPTNHGINQLK(+14.02).Y Y 19.08 1711.9005 16 -7.7 571.6364 3 45.62 4 22147 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 78 93 Methylation(KR)
K.G(+43.01)ATYGKPTNHGINQLK.Y Y 18.62 1740.8907 16 -5.4 436.2276 4 37.29 5 17525 VEV_2_3_RA5_01_1236.d 0 1 1 78 93 Carbamylation
R.E(+27.99)SRGLTATGK.K Y 18.54 1046.5356 10 5.5 524.2780 2 35.30 4 15920 VEV_1_3_RA4_01_1235.d 6.36E5 1 1 160 169 Formylation
K.YQR(-43.05)SLRSTAEER.V Y 17.95 1451.7004 12 -11.6 363.9282 4 17.86 5 6576 VEV_2_3_RA5_01_1236.d 9.65E4 1 1 94 105 Arginine oxidation to glutamic semialdehyde
R.ASR(+31.99)PSRPDK.A Y 17.93 1044.5311 9 2.1 523.2739 2 65.45 5 35622 VEV_2_3_RA5_01_1236.d 0 1 1 39 47 Dihydroxy
R.V(+42.01)GRRC(+57.02)ANLR(+14.02).V Y 17.81 1156.6248 9 -20.0 386.5411 3 59.94 4 31444 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 106 114 Acetylation (N-term); Carbamidomethylation; Methylation(KR)
R.VLNSYWIN(+.98)Q(+.98)DSTYKYYEVILVDPQHK.A Y 17.77 3216.5654 26 7.2 805.1544 4 84.32 4 50142 VEV_1_3_RA4_01_1235.d 0 1 1 115 140 Deamidation (NQ)
M.GALKYVEELQKK.K Y 17.51 1404.7976 12 -14.5 352.2016 4 62.75 4 33562 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 2 13
K.KKQS(+42.01)DVIR.F Y 17.26 1014.5822 8 -49.2 339.1847 3 41.24 4 19444 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 13 20 Acetylation (TSCYH)
K.K(+42.01)(+14.02)QSDVIR.F Y 16.08 900.5029 7 -24.1 451.2479 2 60.60 4 31932 VEV_1_3_RA4_01_1235.d 0 1 1 14 20 Acetylation (Protein N-term); Methylation(KR)
R.INWIVNPVHKHRESR.G Y 16.06 1884.0231 15 -81.1 471.9748 4 57.66 5 29874 VEV_2_3_RA5_01_1236.d 0 1 1 148 162
K.RPAPK.G N 16.06 567.3492 5 -58.7 568.3232 1 94.80 5 54137 VEV_2_3_RA5_01_1236.d 0 1 1 73 77
MGALK(+43.99).Y Y 16.00 562.2784 5 13.8 563.2935 1 31.52 4 13726 VEV_1_3_RA4_01_1235.d 0 1 1 1 5 Carboxylation (DKW)
M.GALKYVE(+14.02)ELQK.K Y 15.78 1290.7183 11 -11.3 431.2418 3 68.90 4 38349 VEV_1_3_RA4_01_1235.d 1.86E5 1 1 2 12 Methylation(others)
R.A(+42.01)SRPSR(+14.02)PDK.A Y 15.53 1068.5675 9 -15.3 357.1910 3 62.10 4 33070 VEV_1_3_RA4_01_1235.d 7.03E4 1 1 39 47 Acetylation (N-term); Methylation(KR)
R.C(+57.02)(+42.01)WELRQLNVIHRAS(-18.01)RPSRPDK.A Y 15.35 2641.3772 21 -35.9 881.4347 3 95.20 5 54304 VEV_2_3_RA5_01_1236.d 0 1 1 27 47 Carbamidomethylation; Acetylation (N-term); Dehydration
R.G(+42.01)LTATGKKS(+79.97)R.G Y 15.34 1139.5699 10 0.1 380.8640 3 10.39 5 2677 VEV_2_3_RA5_01_1236.d 3.12E4 1 1 163 172 Acetylation (N-term); Phosphorylation (STY)
R.GLGR(-43.05)GHK.Y Y 15.30 680.3605 7 -15.9 341.1821 2 11.99 5 3436 VEV_2_3_RA5_01_1236.d 1.19E4 1 1 173 179 Arginine oxidation to glutamic semialdehyde
R.GLTAT(-18.01)GK.K Y 15.27 628.3544 7 -49.7 629.3305 1 36.14 4 16416 VEV_1_3_RA4_01_1235.d 0 1 1 163 169 Dehydration
R.A(+42.01)SRPSRPDK(+31.99).A Y 15.26 1086.5417 9 -7.7 363.1851 3 16.43 4 5534 VEV_1_3_RA4_01_1235.d 0 1 1 39 47 Acetylation (N-term); Dihydroxy
total 77 peptides
C1GC65
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SEDQRPEATQPSQPSQL Y 127.65 1896.8813 17 -10.2 949.4382 2 55.41 6 27407 VEV_3_3_RA6_01_1237.d 4.55E6 18 18 186 202
R.HAIEKEIHKAEGQPAEQEPTPEVPTVK.S Y 126.07 2991.5300 27 -8.3 599.3083 5 61.44 5 32714 VEV_2_3_RA5_01_1236.d 7.5E5 4 4 159 185
K.GLESLYTSLSTTYPGK.F Y 120.00 1715.8617 16 -16.3 858.9241 2 80.89 6 45803 VEV_3_3_RA6_01_1237.d 5.74E5 4 4 47 62
K.AEGQPAEQEPTPEVPTVK.S Y 112.67 1905.9319 18 -10.2 953.9635 2 63.51 6 33010 VEV_3_3_RA6_01_1237.d 1.54E5 3 3 168 185
K.FTIIGFPC(+57.02)NQFGSQEPGTNDEIQSFC(+57.02)SANYGVTFPVLSK.V Y 110.55 4356.0142 39 -5.9 1453.0034 3 92.55 5 53142 VEV_2_3_RA5_01_1236.d 8.65E5 5 5 63 101 Carbamidomethylation
K.VDVNGENAAPLWK.W Y 110.50 1411.7096 13 -13.9 706.8523 2 69.71 6 37656 VEV_3_3_RA6_01_1237.d 8.07E5 5 5 102 114
K.EIHKAEGQPAEQEPTPEVPTVK.S Y 105.12 2413.2124 22 -14.9 604.3014 4 58.11 5 30183 VEV_2_3_RA5_01_1236.d 1.34E6 10 10 164 185
R.WASFTKPESLR.H Y 87.72 1320.6826 11 -16.9 441.2274 3 64.29 6 33602 VEV_3_3_RA6_01_1237.d 2.63E6 10 10 148 158
K.SEDQRPEATQ(+.98)PSQPSQL Y 78.51 1897.8654 17 -7.7 949.9326 2 58.13 5 30223 VEV_2_3_RA5_01_1236.d 1.12E6 5 5 186 202 Deamidation (NQ)
K.C(+57.02)GFT(-18.01)PQ(+.98)FKGLESLYTSLSTTYPGK.F Y 76.29 2664.2781 24 -12.9 1333.1292 2 91.53 5 52654 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 39 62 Carbamidomethylation; Dehydration; Deamidation (NQ)
K.SEDQRPEATQPSQ(+.98)PSQL Y 75.58 1897.8654 17 -11.6 633.6217 3 58.35 5 30347 VEV_2_3_RA5_01_1236.d 1.79E6 8 8 186 202 Deamidation (NQ)
M.S(+42.01)SATSFYEFQPLDK.K Y 73.34 1660.7620 14 -10.0 831.3799 2 83.64 5 48366 VEV_2_3_RA5_01_1236.d 8.94E5 4 4 2 15 Acetylation (Protein N-term)
M.S(+42.01)SATSFYEFQPLDKK.G Y 73.08 1788.8569 15 -14.3 895.4230 2 78.42 6 44021 VEV_3_3_RA6_01_1237.d 4.82E5 4 4 2 16 Acetylation (Protein N-term)
K.GKVVLIVNTASK.C Y 72.38 1227.7550 12 -13.1 614.8767 2 54.06 5 27628 VEV_2_3_RA5_01_1236.d 9.69E4 5 5 27 38
K.SEDQ(+.98)RPEATQPSQPSQL Y 68.58 1897.8654 17 -10.4 949.9301 2 57.35 6 28607 VEV_3_3_RA6_01_1237.d 2.9E5 2 2 186 202 Deamidation (NQ)
K.VVLIVNTASK.C Y 64.34 1042.6387 10 -23.9 522.3141 2 61.36 6 31418 VEV_3_3_RA6_01_1237.d 9.03E5 5 5 29 38
K.SEDQR(+14.02)PEATQPSQPSQL Y 62.74 1910.8970 17 -8.3 956.4478 2 57.51 5 29775 VEV_2_3_RA5_01_1236.d 1.26E6 13 13 186 202 Methylation(KR)
K.C(+57.02)GFTPQFK.G Y 62.67 983.4535 8 -18.6 492.7249 2 61.49 6 31513 VEV_3_3_RA6_01_1237.d 2.3E5 2 2 39 46 Carbamidomethylation
K.SEDQRPEATQPSQPSQ(+.98)L Y 62.67 1897.8654 17 -10.7 633.6223 3 57.43 5 29719 VEV_2_3_RA5_01_1236.d 1.83E5 1 1 186 202 Deamidation (NQ)
K.VDVN(+.98)GENAAPLWK.W Y 62.17 1412.6936 13 -10.8 707.3464 2 71.53 5 40120 VEV_2_3_RA5_01_1236.d 9.6E4 1 1 102 114 Deamidation (NQ)
R.VKWNFEKFLVSADGK.V Y 58.30 1766.9355 15 -3.7 442.7395 4 78.03 4 45503 VEV_1_3_RA4_01_1235.d 1.24E5 3 3 129 143
K.GLESLYTSLSTTYPGKFTIIGFPC(+57.02)NQFGSQEPGTNDEIQSFC(+57.02)SANYGVTFPVLSK.V Y 57.15 6053.8652 55 2.1 1514.4768 4 94.40 4 56014 VEV_1_3_RA4_01_1235.d 0 1 1 47 101 Carbamidomethylation
K.FLVSADGK.V Y 56.78 835.4439 8 -11.7 418.7243 2 50.44 5 25456 VEV_2_3_RA5_01_1236.d 1.56E6 8 8 136 143
K.C(+58.01)GFTPQFK.G Y 56.27 984.4375 8 -16.6 493.2179 2 66.27 6 35076 VEV_3_3_RA6_01_1237.d 3.28E5 3 3 39 46 Carboxymethyl
M.S(+42.01)SATSFYEFQPLDKKGEPFLMTGLK.G Y 54.67 2862.4148 25 11.0 955.1560 3 85.29 4 50782 VEV_1_3_RA4_01_1235.d 0 1 1 2 26 Acetylation (Protein N-term)
M.S(+42.01)SATSFYEFQPLDKKGEPFLMTGLKGK.V Y 54.14 3047.5312 27 -7.8 762.8842 4 81.99 5 47337 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 2 28 Acetylation (Protein N-term)
K.SEDQRPEATQ(+.98)PSQ(+.98)PSQL Y 52.12 1898.8494 17 12.3 950.4436 2 58.46 4 30330 VEV_1_3_RA4_01_1235.d 4.62E4 1 1 186 202 Deamidation (NQ)
K.SEDQRPEATQPSQPSQL(+14.02) Y 51.80 1910.8970 17 -4.8 956.4512 2 61.60 5 32738 VEV_2_3_RA5_01_1236.d 1.94E5 3 3 186 202 Methylation(C-term)
K.SEDQ(+.98)RPEATQPSQ(+.98)PSQL Y 51.76 1898.8494 17 -11.1 950.4214 2 59.58 5 31247 VEV_2_3_RA5_01_1236.d 1.54E5 2 2 186 202 Deamidation (NQ)
K.FLVSADGKVVHR.W Y 51.54 1326.7407 12 -15.3 332.6874 4 54.34 6 26867 VEV_3_3_RA6_01_1237.d 2.54E5 4 4 136 147
K.EIHK(+14.02)AEGQPAEQEPTPEVPTVK.S Y 50.39 2427.2280 22 -4.6 607.8115 4 60.33 4 31729 VEV_1_3_RA4_01_1235.d 2.07E5 2 2 164 185 Methylation(KR)
K.SEDQR(+14.02)PEATQ(+.98)PSQPSQL Y 46.96 1911.8810 17 -7.7 956.9404 2 60.67 5 32046 VEV_2_3_RA5_01_1236.d 1.27E5 2 2 186 202 Methylation(KR); Deamidation (NQ)
K.VDVNGE(+14.02)NAAPLWK.W Y 43.85 1425.7252 13 -12.9 713.8607 2 73.71 6 40604 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 102 114 Methylation(others)
K.GLESLYTSLSTTYPGK(+14.02).F Y 39.36 1729.8774 16 -3.9 865.9426 2 81.47 5 47014 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 47 62 Methylation(KR)
R.WASFTK(+14.02)PESLR.H Y 37.23 1334.6982 11 -15.9 445.8996 3 67.40 5 37072 VEV_2_3_RA5_01_1236.d 9.46E4 1 1 148 158 Methylation(KR)
R.W(+43.01)ASFTKPESLR.H Y 34.26 1363.6884 11 31.0 455.5842 3 64.39 5 34816 VEV_2_3_RA5_01_1236.d 0 1 1 148 158 Carbamylation
R.VKWNFEK.F Y 33.66 949.5021 7 -12.4 475.7524 2 50.20 4 24999 VEV_1_3_RA4_01_1235.d 2E5 3 3 129 135
K.EIHKAEGQPAEQ(+.98)EPTPEVPTVK.S Y 29.04 2414.1965 22 6.6 604.5604 4 59.25 5 30994 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 164 185 Deamidation (NQ)
K.GLE(+14.02)SLYTSLSTTYPGK.F Y 28.26 1729.8774 16 -13.8 865.9341 2 81.81 6 46418 VEV_3_3_RA6_01_1237.d 7.08E4 1 1 47 62 Methylation(others)
M.S(+42.01)SATSFYEFQPLDKK(+14.02).G Y 26.70 1802.8727 15 -6.1 902.4381 2 80.22 5 46192 VEV_2_3_RA5_01_1236.d 5.75E4 1 1 2 16 Acetylation (Protein N-term); Methylation(KR)
K.WLKSEMPGIMGMK(+42.02).R Y 24.73 1548.7615 13 34.1 517.2787 3 72.54 5 40864 VEV_2_3_RA5_01_1236.d 0 1 1 115 127 Guanidination
M.S(+42.01)SATSFYEFQPLDK(+14.02).K Y 23.94 1674.7777 14 -9.6 838.3881 2 84.52 6 48158 VEV_3_3_RA6_01_1237.d 8.96E4 4 4 2 15 Acetylation (Protein N-term); Methylation(KR)
R.HAIEK.E Y 22.91 596.3282 5 -42.6 597.3101 1 68.37 5 37818 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 159 163
R.WASFTKPESLR(+14.02).H Y 22.38 1334.6982 11 -17.8 668.3445 2 67.34 5 37029 VEV_2_3_RA5_01_1236.d 0 1 1 148 158 Methylation(KR)
K.F(+42.01)LVSADGK(+31.99).V Y 21.21 909.4443 8 38.8 304.1671 3 45.62 4 22153 VEV_1_3_RA4_01_1235.d 0 1 1 136 143 Acetylation (N-term); Dihydroxy
K.WLKSEM(+15.99)PGIM(+15.99)GM(+15.99)KR.V Y 20.80 1710.8256 14 13.9 343.1772 5 33.19 5 15114 VEV_2_3_RA5_01_1236.d 2.21E4 1 1 115 128 Oxidation (M)
K.FLVSADGK(+226.08).V Y 20.16 1061.5215 8 -3.1 354.8467 3 27.03 6 11274 VEV_3_3_RA6_01_1237.d 0 1 1 136 143 Biotinylation
K.SEDQRPE(+14.02)ATQPSQPSQL Y 18.59 1910.8970 17 -11.3 637.9658 3 59.12 5 30897 VEV_2_3_RA5_01_1236.d 2.16E5 1 1 186 202 Methylation(others)
K.KGEPFLMTGLK.G Y 18.13 1219.6635 11 -12.4 407.5567 3 68.27 6 36593 VEV_3_3_RA6_01_1237.d 2.81E4 1 1 16 26
K.VDVNGENAAPLWK(+43.01).W Y 17.46 1454.7153 13 -11.0 728.3569 2 85.96 5 49714 VEV_2_3_RA5_01_1236.d 0 1 1 102 114 Carbamylation
K.K(+31.99)GEPFLM(+15.99)TGLKGK.V Y 16.53 1452.7646 13 -23.4 364.1899 4 60.29 6 30650 VEV_3_3_RA6_01_1237.d 2.86E5 1 1 16 28 Dihydroxy; Oxidation (M)
K.SEMPGIMGMK(-.98).R Y 15.98 1078.4973 10 -2.9 540.2544 2 46.10 6 22045 VEV_3_3_RA6_01_1237.d 0 1 1 118 127 Amidation
K.GLES(+291.10)LYTSLSTTYPGK.F Y 15.31 2006.9572 16 -16.3 669.9821 3 64.37 5 34801 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 47 62 N-acetyl neuraminic acid
total 53 peptides
C1GML7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SFHPDYVIYNAGSFPANR.W Y 131.21 2053.9646 18 -17.6 685.6501 3 75.69 6 42089 VEV_3_3_RA6_01_1237.d 5.18E5 3 3 252 269
R.VVDYDDSTLTENTR.C Y 124.85 1626.7373 14 -12.2 814.3660 2 61.89 6 31841 VEV_3_3_RA6_01_1237.d 5.84E5 5 5 411 424
K.YSSEATKEVLAAAPVVTSK.G Y 115.26 1950.0309 19 -13.4 651.0089 3 69.36 6 37383 VEV_3_3_RA6_01_1237.d 2.13E5 2 2 620 638
R.FGSVLENVVFDPTTR.V Y 108.17 1679.8518 15 -10.3 840.9246 2 83.14 5 48034 VEV_2_3_RA5_01_1236.d 5.63E5 4 4 396 410
R.VSIIANPAVASLYEDALVYETGTAITSSGALTAYSGAK.T Y 106.82 3773.9250 38 -5.5 1258.9753 3 95.54 4 56536 VEV_1_3_RA4_01_1235.d 2.47E5 3 3 120 157
K.ANYEVYDVFNLYVPTSC(+57.02)PGVPSELLNPK.K Y 99.27 3184.5427 28 -9.9 1062.5110 3 91.33 5 52561 VEV_2_3_RA5_01_1236.d 1.58E5 3 3 566 593 Carbamidomethylation
K.LNTEQTMFHFISGYTSK.M Y 87.56 2002.9458 17 -12.4 668.6476 3 80.75 5 46541 VEV_2_3_RA5_01_1236.d 2E5 2 2 465 481
K.GVGAAPAKVN(+.98)GTPTPA Y 80.49 1407.7357 16 -11.5 704.8671 2 54.03 5 27645 VEV_2_3_RA5_01_1236.d 4.47E5 5 5 642 657 Deamidation (NQ)
R.IYVIDGFAGWDERYR.I Y 76.03 1858.9001 15 -8.3 620.6355 3 81.05 4 47822 VEV_1_3_RA4_01_1235.d 1.65E5 2 2 208 222
R.AILDAIHSGELAK.A Y 74.83 1336.7350 13 -19.0 446.5771 3 68.75 6 36943 VEV_3_3_RA6_01_1237.d 4.51E5 3 3 553 565
K.GVFTVLFYEMPVK.H Y 63.62 1528.7999 13 -9.1 765.4003 2 89.55 4 53410 VEV_1_3_RA4_01_1235.d 3.97E5 2 2 303 315
K.TTLSADPKR.A Y 63.11 987.5349 9 -13.7 494.7679 2 17.86 5 6578 VEV_2_3_RA5_01_1236.d 1.57E5 3 3 345 353
R.NIILLTC(+57.02)DAR.G Y 62.88 1187.6332 10 -9.8 594.8181 2 71.78 4 40622 VEV_1_3_RA4_01_1235.d 5.28E5 3 3 447 456 Carbamidomethylation
K.C(+58.01)IGLSAEKEPDIFNAIR.F Y 59.56 1932.9614 17 -14.0 645.3187 3 80.78 6 45704 VEV_3_3_RA6_01_1237.d 1.58E5 3 3 379 395 Carboxymethyl
M(+42.01)DSGSASGGPLPTVTR.A Y 57.91 1573.7406 16 -6.8 787.8723 2 74.79 4 42965 VEV_1_3_RA4_01_1235.d 9.39E4 1 1 1 16 Acetylation (Protein N-term)
K.IPC(+57.02)LADQHPR.N Y 49.37 1205.5975 10 -13.9 402.8675 3 43.86 6 20733 VEV_3_3_RA6_01_1237.d 8.81E5 4 4 437 446 Carbamidomethylation
K.MAGTEDGVTEPQATFSSC(+57.02)FAQPFLALHPMR.Y Y 47.09 3295.5100 30 -6.5 1099.5034 3 85.76 4 51087 VEV_1_3_RA4_01_1235.d 2.64E4 1 1 482 511 Carbamidomethylation
R.AVDYLNTR.N Y 45.61 950.4821 8 -11.6 476.2428 2 48.52 4 23943 VEV_1_3_RA4_01_1235.d 1.47E6 8 8 198 205
R.GVFNIEGGC(+57.02)YAK.C Y 43.61 1313.6074 12 -4.4 657.8081 2 69.79 4 39053 VEV_1_3_RA4_01_1235.d 1.31E5 2 2 367 378 Carbamidomethylation
R.FGSVLE(+14.02)NVVFDPTTR.V Y 42.41 1693.8676 15 8.2 847.9480 2 84.79 6 48332 VEV_3_3_RA6_01_1237.d 1.17E5 2 2 396 410 Methylation(others)
K.LNTEQTM(+15.99)FHFISGYTSK.M Y 40.95 2018.9408 17 -36.1 673.9633 3 72.21 4 40963 VEV_1_3_RA4_01_1235.d 0 1 1 465 481 Oxidation (M)
R.VVDYDDSTLTENTR(+14.02).C Y 40.72 1640.7529 14 -7.8 821.3773 2 65.38 4 35574 VEV_1_3_RA4_01_1235.d 3.11E5 3 3 411 424 Methylation(KR)
K.ANAWLLNTGWVGAGATTGGKR.C Y 31.99 2100.0864 21 -14.6 701.0259 3 78.74 4 46044 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 525 545
R.AYHALFMR.N Y 28.40 1007.5011 8 7.4 336.8434 3 60.24 4 31661 VEV_1_3_RA4_01_1235.d 0 1 1 232 239
K.GVGAAPAKVNGTPTPA Y 28.20 1406.7517 16 -12.3 704.3745 2 50.78 5 25626 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 642 657
R.SPLDKR.I Y 26.31 714.4024 6 -11.7 358.2043 2 12.54 5 3719 VEV_2_3_RA5_01_1236.d 1.84E5 2 2 161 166
K.Y(-2.02)SSEATKEVLAAAPVVTSK.G Y 25.96 1948.0153 19 -47.9 650.3146 3 69.49 6 37485 VEV_3_3_RA6_01_1237.d 2.59E4 1 1 620 638 2-amino-3-oxo-butanoic_acid
K.TTLSADPK.R Y 24.80 831.4338 8 -19.8 416.7159 2 21.09 5 8335 VEV_2_3_RA5_01_1236.d 5.95E5 4 4 345 352
K.SFHPDYVIYNAGS(+79.97)FPAN(+.98)R(+14.02).W Y 23.93 2148.9307 18 -6.7 538.2363 4 12.63 4 3621 VEV_1_3_RA4_01_1235.d 3.77E3 1 1 252 269 Phosphorylation (STY); Deamidation (NQ); Methylation(KR)
K.GVGAAPAK(+42.01)VNGTPTPA Y 23.80 1448.7623 16 -34.4 725.3635 2 92.59 5 53160 VEV_2_3_RA5_01_1236.d 8.8E4 1 1 642 657 Acetylation (K)
R.Q(-17.03)QAAK.Q Y 23.41 527.2703 5 -10.6 528.2720 1 46.01 5 22739 VEV_2_3_RA5_01_1236.d 0 1 1 59 63 Pyro-glu from Q
K.G(+58.01)VGAAPAKVNGTPTPA Y 23.19 1464.7572 16 21.4 367.2044 4 58.60 5 30530 VEV_2_3_RA5_01_1236.d 0 1 1 642 657 Carboxymethyl (KW, X@N-term)
R.QQAAK.Q Y 22.92 544.2969 5 -3.5 545.3022 1 22.27 6 8751 VEV_3_3_RA6_01_1237.d 0 1 1 59 63
K.GTK(+43.99)GVGAAPAK.V Y 22.78 999.5349 11 -59.3 334.1658 3 22.05 6 8619 VEV_3_3_RA6_01_1237.d 0 1 1 639 649 Carboxylation (DKW)
K.TGRSPLDKR.I Y 22.77 1028.5726 9 -17.1 343.8589 3 13.12 5 4078 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 158 166
R.QQAAK(+21.98).Q Y 21.97 566.2788 5 -4.2 567.2837 1 33.61 5 15354 VEV_2_3_RA5_01_1236.d 0 1 1 59 63 Sodium adduct
K.SWTASTSFEGEVNKLAVLFNENFKK.Y Y 21.92 2845.4287 25 -17.3 712.3522 4 87.97 4 52485 VEV_1_3_RA4_01_1235.d 0 1 1 595 619
R.GVLPPISK.L Y 21.85 809.5010 8 55.4 810.5532 1 105.35 6 56874 VEV_3_3_RA6_01_1237.d 0 1 1 457 464
K.VN(+.98)GTPTPA Y 21.79 756.3654 8 19.3 379.1973 2 35.88 6 16169 VEV_3_3_RA6_01_1237.d 2.42E5 3 3 650 657 Deamidation (NQ)
K.SFHPDYVIYN(+.98)AGSFPANR.W Y 21.27 2054.9485 18 32.6 686.0125 3 76.23 4 44088 VEV_1_3_RA4_01_1235.d 9.92E4 1 1 252 269 Deamidation (NQ)
K.C(+58.01)IGLSAEK.E Y 20.96 877.4215 8 46.4 439.7384 2 63.74 5 34343 VEV_2_3_RA5_01_1236.d 4.7E4 1 1 379 386 Carboxymethyl
R.ALIGDDEHC(+57.02)WTDR.G Y 20.57 1586.6783 13 -14.6 529.8923 3 64.87 6 34019 VEV_3_3_RA6_01_1237.d 2.02E4 1 1 354 366 Carbamidomethylation
K.C(+57.02)IGLSAEK(+28.03).E Y 20.51 904.4688 8 -0.6 453.2414 2 60.18 5 31681 VEV_2_3_RA5_01_1236.d 0 1 1 379 386 Carbamidomethylation; Dimethylation(KR)
R.IYVIDGFAGWDER.Y Y 20.49 1539.7357 13 -7.2 385.9384 4 57.32 6 28574 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 208 220
R.M(+15.99)LADKIAE(+21.98)HK.A Y 20.27 1192.5886 10 -54.4 398.5152 3 43.36 4 20752 VEV_1_3_RA4_01_1235.d 0 1 1 515 524 Oxidation (M); Sodium adduct
K.CIGLSAEK(+14.02)EPDIFNAIR.F Y 20.09 1888.9717 17 -14.5 473.2433 4 64.28 5 34732 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 379 395 Methylation(KR)
K.GTKGVGAAPAK.V Y 19.85 955.5450 11 -7.5 319.5199 3 39.37 5 18750 VEV_2_3_RA5_01_1236.d 0 1 1 639 649
K.TTLSADPK(+42.01).R Y 19.62 873.4443 8 -19.0 874.4350 1 90.77 5 52284 VEV_2_3_RA5_01_1236.d 3.09E4 1 1 345 352 Acetylation (K)
K.T(+42.01)TLSADPK.R Y 19.51 873.4443 8 -9.4 874.4434 1 93.86 5 53737 VEV_2_3_RA5_01_1236.d 0 1 1 345 352 Acetylation (N-term)
R.NM(+15.99)LIRPSREELK.S Y 19.42 1500.8082 12 -7.8 501.2728 3 37.01 4 16944 VEV_1_3_RA4_01_1235.d 0 1 1 240 251 Oxidation (M)
K.GVGAAPAK.V Y 18.95 669.3809 8 -31.7 335.6871 2 9.83 4 2397 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 642 649
K.C(+57.02)IGLSAEK.E Y 18.86 876.4375 8 -4.9 439.2239 2 18.57 5 6963 VEV_2_3_RA5_01_1236.d 3.62E4 1 1 379 386 Carbamidomethylation
K.EPDIFNAIRFGSVLENVVFDPTTRVVDYDDSTLTENTR.C Y 18.80 4344.1187 38 -29.3 1087.0051 4 119.75 5 61242 VEV_2_3_RA5_01_1236.d 4.37E3 1 1 387 424
K.GTKGVGAAPAK(+43.01).V Y 18.23 998.5508 11 -26.2 999.5320 1 106.28 5 57852 VEV_2_3_RA5_01_1236.d 0 1 1 639 649 Carbamylation
K.GTK(+26.02)GVGAAPAK.V Y 17.99 981.5607 11 -13.1 328.1899 3 9.57 4 2318 VEV_1_3_RA4_01_1235.d 0 1 1 639 649 Acetaldehyde +26
K.T(+79.97)TLSADPK(+14.02).R Y 17.87 925.4158 8 -1.1 926.4221 1 84.63 5 48942 VEV_2_3_RA5_01_1236.d 1.27E4 1 1 345 352 Phosphorylation (STY); Methylation(KR)
R.FGSVLENVVFDPTTR(-.98).V Y 17.49 1678.8678 15 -24.9 840.4203 2 83.08 5 48006 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 396 410 Amidation
R.Q(+42.01)QAAK(+21.98).Q Y 17.47 608.2894 5 -21.0 609.2839 1 33.57 4 14907 VEV_1_3_RA4_01_1235.d 0 1 1 59 63 Acetylation (N-term); Sodium adduct
R.AVDYLNTR(+14.02)NR(+14.02).I Y 17.20 1248.6575 10 -25.4 313.1637 4 11.67 6 3243 VEV_3_3_RA6_01_1237.d 0 1 1 198 207 Methylation(KR)
K.TTLSADPK(-.98).R Y 17.17 830.4498 8 5.3 416.2344 2 26.35 6 10913 VEV_3_3_RA6_01_1237.d 0 1 1 345 352 Amidation
R.A(+42.01)ILDAIHSGELAK(+14.02).A Y 17.04 1392.7612 13 -47.8 465.2388 3 72.19 4 40949 VEV_1_3_RA4_01_1235.d 3.16E4 1 1 553 565 Acetylation (N-term); Methylation(KR)
K.GTKGVGAAPAKVNGTPT(-2.02)PA Y 16.99 1690.9001 19 -22.5 846.4384 2 96.02 5 54653 VEV_2_3_RA5_01_1236.d 7.9E4 1 1 639 657 2-amino-3-oxo-butanoic_acid
K.TMLATSVNR(+44.03).T Y 16.89 1035.5383 9 -11.0 346.1829 3 37.12 6 16836 VEV_3_3_RA6_01_1237.d 6.27E4 1 1 80 88 Ethanolation (KR)
R.S(+162.05)PLDK.R Y 16.75 720.3541 5 19.9 361.1915 2 53.15 4 26900 VEV_1_3_RA4_01_1235.d 0 1 1 161 165 Hexose (NSY)
K.KSWTASTSFEGEVNKLAVLFNENFKK.Y Y 16.73 2973.5234 26 -49.0 595.6828 5 84.84 4 50478 VEV_1_3_RA4_01_1235.d 0 1 1 594 619
R.S(+42.01)PLDK.R Y 16.66 600.3119 5 -29.1 601.3017 1 53.48 4 27109 VEV_1_3_RA4_01_1235.d 0 1 1 161 165 Acetylation (N-term)
K.GTK(+42.01)GVGAAPAK(+14.02)VNGTPTPA Y 16.19 1748.9420 19 -36.8 438.2267 4 55.88 5 28692 VEV_2_3_RA5_01_1236.d 8.14E4 1 1 639 657 Acetylation (K); Methylation(KR)
K.TM(-4.99)LATSVNR.T Y 16.13 986.5258 9 -13.0 494.2637 2 33.86 6 14989 VEV_3_3_RA6_01_1237.d 2.38E4 1 1 80 88 Methionine replacement by azido homoalanine
R.SPLDK.R Y 16.06 558.3013 5 5.2 559.3115 1 27.72 4 11612 VEV_1_3_RA4_01_1235.d 0 1 1 161 165
R.AILDAIHSGELAK(+14.02).A Y 16.04 1350.7506 13 3.1 451.2589 3 72.10 4 40873 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 553 565 Methylation(KR)
K.L(+27.99)AVLFNENFK.K Y 15.78 1221.6393 10 -14.3 408.2145 3 61.46 6 31497 VEV_3_3_RA6_01_1237.d 1.18E5 1 1 609 618 Formylation
K.IPC(+57.02)LADQHPR(+.98).N Y 15.73 1206.5815 10 -26.0 604.2823 2 52.13 6 25556 VEV_3_3_RA6_01_1237.d 0 1 1 437 446 Carbamidomethylation; Deamidation (R)
R.C(+57.02)AYPIEY(-18.01)IEN(+.98)AKIPC(+57.02)LADQHPR.N Y 15.70 2640.2463 22 -1.1 881.0884 3 84.68 5 48974 VEV_2_3_RA5_01_1236.d 2.96E4 1 1 425 446 Carbamidomethylation; Dehydration; Deamidation (NQ)
K.TMLATSVNR.T Y 15.65 991.5121 9 -4.9 496.7609 2 63.25 6 32821 VEV_3_3_RA6_01_1237.d 6.64E4 1 1 80 88
K.E(+42.01)VLAAAPVVTSK(+42.01).G Y 15.50 1267.7024 12 -28.5 423.5627 3 35.30 4 15921 VEV_1_3_RA4_01_1235.d 9.22E5 1 1 627 638 Acetylation (N-term); Acetylation (K)
K.GVGAAPAK(+78.05).V Y 15.35 747.4279 8 -16.5 374.7150 2 62.93 5 33729 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 642 649 2,5-dimethypyrrole
R.C(+57.02)AY(-18.01)PIEYIEN(+.98)AKIPC(+57.02)LADQHPR.N Y 15.35 2640.2463 22 1.5 881.0907 3 84.77 4 50427 VEV_1_3_RA4_01_1235.d 4.88E4 1 1 425 446 Carbamidomethylation; Dehydration; Deamidation (NQ)
K.Y(+79.97)TRAILDAIHSGELAK(+14.02).A Y 15.32 1850.9291 16 -24.2 617.9687 3 62.10 5 33116 VEV_2_3_RA5_01_1236.d 0 1 1 550 565 Phosphorylation (STY); Methylation(KR)
K.TTLSAD(-18.01)PK.R Y 15.17 813.4232 8 -48.2 814.3913 1 82.19 6 46671 VEV_3_3_RA6_01_1237.d 9.33E4 1 1 345 352 Dehydration
total 79 peptides
C1G1C8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VFAIPAINVTSSSAVVAALEAAR.D Y 137.13 2256.2478 23 -12.1 753.0808 3 91.26 6 51958 VEV_3_3_RA6_01_1237.d 9.37E5 8 8 30 52
K.TLSAISPYFSIAAGFGNVHGVYKPGNVR.L Y 125.15 2921.5188 28 -7.9 974.8392 3 82.52 4 48894 VEV_1_3_RA4_01_1235.d 6.94E5 4 4 209 236
R.DKNSPIILQVSQGGAAFFAGK.G Y 121.85 2147.1375 21 -9.8 716.7128 3 82.92 5 47903 VEV_2_3_RA5_01_1236.d 7.48E5 7 7 53 73
K.INLDTDLQYAYLSGVRDFVLK.K Y 119.54 2442.2793 21 -8.1 815.0938 3 88.46 6 50507 VEV_3_3_RA6_01_1237.d 5.17E5 3 3 287 307
K.GVPNGNQEASVAGAIAAAHYIR.S Y 115.46 2165.0977 22 -20.2 722.6919 3 75.90 6 42235 VEV_3_3_RA6_01_1237.d 1.19E6 5 5 74 95
R.SIAPSYGIPVVLHTDHC(+57.02)AK.K Y 112.44 2064.0461 19 -13.7 517.0117 4 70.24 6 38036 VEV_3_3_RA6_01_1237.d 1.69E6 7 7 96 114 Carbamidomethylation
R.KTGVIVGDDVLR.L Y 81.62 1270.7245 12 -19.3 424.5739 3 61.95 6 31862 VEV_3_3_RA6_01_1237.d 1.57E5 4 4 10 21
K.NKPVYLVFHGGSGSTK.A Y 80.40 1689.8838 16 -13.5 564.2943 3 55.99 6 27724 VEV_3_3_RA6_01_1237.d 5.11E5 2 2 258 273
R.LHPELLSK.H Y 78.47 935.5440 8 -16.8 468.7714 2 45.04 6 21485 VEV_3_3_RA6_01_1237.d 3.37E6 14 14 237 244
K.LLPWLDGMLDADER.Y Y 75.44 1642.8025 14 -9.5 822.4007 2 89.55 4 53412 VEV_1_3_RA4_01_1235.d 3.97E4 1 1 116 129
K.AEFKEAISYGVVK.I Y 74.58 1439.7660 13 -11.2 480.9239 3 65.81 6 34737 VEV_3_3_RA6_01_1237.d 4.15E5 3 3 274 286
K.GVPN(+.98)GNQEASVAGAIAAAHYIR.S Y 73.51 2166.0818 22 -3.6 723.0319 3 77.75 4 45280 VEV_1_3_RA4_01_1235.d 8.3E5 4 4 74 95 Deamidation (NQ)
R.LFQHAQEK.V Y 71.75 999.5137 8 -15.0 500.7567 2 19.30 6 7227 VEV_3_3_RA6_01_1237.d 5.73E5 5 5 22 29
K.INLDTDLQYAYLSGVR.D Y 66.96 1839.9366 16 -9.8 614.3135 3 82.78 6 47049 VEV_3_3_RA6_01_1237.d 0 2 2 287 302
K.GVPNGN(+.98)QEASVAGAIAAAHYIR.S Y 64.68 2166.0818 22 -3.8 1084.0441 2 77.71 5 44518 VEV_2_3_RA5_01_1236.d 3.47E5 2 2 74 95 Deamidation (NQ)
R.DKNSPIILQVSQGGAAFFAGK(+14.02).G Y 51.31 2161.1531 21 -17.0 721.3794 3 83.93 6 47781 VEV_3_3_RA6_01_1237.d 8.52E4 1 1 53 73 Methylation(KR)
K.GVPNGNQ(+.98)EASVAGAIAAAHYIR.S Y 49.68 2166.0818 22 -5.7 723.0304 3 77.04 5 44054 VEV_2_3_RA5_01_1236.d 0 2 2 74 95 Deamidation (NQ)
K.NS(+236.21)PIILQVSQGGAAFFAGK.G Y 44.00 2140.2295 19 -93.2 714.3506 3 82.90 5 47889 VEV_2_3_RA5_01_1236.d 7.34E4 1 1 55 73 Palmitoleyl
K.VFAIPAINVTSSSAVVAALEAAR(+14.02).D Y 42.69 2270.2634 23 -25.0 1136.1106 2 93.17 4 55389 VEV_1_3_RA4_01_1235.d 5.78E4 3 3 30 52 Methylation(KR)
R.DKNSPIILQ(+.98)VSQGGAAFFAGK.G Y 41.78 2148.1213 21 -20.3 717.0332 3 83.74 6 47663 VEV_3_3_RA6_01_1237.d 1.16E5 2 2 53 73 Deamidation (NQ)
K.TLSAISPYFSIAAGFGNVHGVYKPGNVR(+14.02).L Y 41.13 2935.5344 28 -11.2 734.8827 4 82.68 6 46993 VEV_3_3_RA6_01_1237.d 4.57E4 1 1 209 236 Methylation(KR)
R.VQEAFDDFNTSNQL Y 41.06 1626.7162 14 -14.4 814.3536 2 79.41 6 44755 VEV_3_3_RA6_01_1237.d 3.51E5 2 2 347 360
K.N(+162.05)S(+79.97)PIILQVSQGGAAFFAGK.G Y 41.05 2146.0347 19 39.3 716.3802 3 83.14 4 49318 VEV_1_3_RA4_01_1235.d 1.83E4 2 2 55 73 Hexose (NSY); Phosphorylation (STY)
K.VFAIPAINVTSSSAVVAALEAARDK.N Y 36.96 2499.3696 25 3.1 834.1331 3 88.04 4 52528 VEV_1_3_RA4_01_1235.d 8.24E4 1 1 30 54
K.TLSAISPYFSIAAGFGNVH(+14.02)GVYKPGNVR.L Y 35.69 2935.5344 28 -7.1 734.8857 4 82.77 4 49071 VEV_1_3_RA4_01_1235.d 6.53E4 1 1 209 236 Methylation(others)
K.GVPNGNQE(+14.02)ASVAGAIAAAHYIR.S Y 34.93 2179.1133 22 -5.4 727.3745 3 78.48 4 45854 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 74 95 Methylation(others)
K.TGVIVGDDVLR.L Y 34.81 1142.6295 11 -43.4 572.2972 2 69.79 6 37694 VEV_3_3_RA6_01_1237.d 1.94E4 1 1 11 21
R.AAPM(+15.99)K.Q Y 31.77 532.2679 5 -49.3 533.2489 1 54.31 5 27777 VEV_2_3_RA5_01_1236.d 0 2 2 165 169 Oxidation (M)
R.D(+6.01)KNSPIILQVSQGGAAFFAGK.G Y 31.09 2153.1455 21 -54.8 718.6831 3 82.96 6 47162 VEV_3_3_RA6_01_1237.d 0 1 1 53 73 Replacement of proton by lithium
K.DILSR(+31.99).K Y 29.46 634.3286 5 8.0 635.3409 1 79.35 4 46512 VEV_1_3_RA4_01_1235.d 0 1 1 5 9 Dihydroxy
R.DKNSPIILQ(+.98)VSQ(+.98)GGAAFFAGK.G Y 26.22 2149.1055 21 -15.6 717.3646 3 84.19 6 47957 VEV_3_3_RA6_01_1237.d 2.49E4 1 1 53 73 Deamidation (NQ)
M.GVKDILSR.K Y 24.55 886.5236 8 -9.0 444.2651 2 47.13 6 22641 VEV_3_3_RA6_01_1237.d 4.68E5 3 3 2 9
K.NKPVYLVFHGGSGSTKAEFK.E Y 24.14 2165.1270 20 -11.5 542.2828 4 62.21 5 33199 VEV_2_3_RA5_01_1236.d 5.97E4 1 1 258 277
K.DILS(+79.97)R.K Y 24.00 682.3051 5 4.3 683.3152 1 39.35 6 18123 VEV_3_3_RA6_01_1237.d 3.28E4 1 1 5 9 Phosphorylation (STY)
R.AAPM(+31.99)K(+14.02).Q Y 21.36 562.2784 5 -1.5 563.2849 1 41.95 6 19639 VEV_3_3_RA6_01_1237.d 3.02E5 1 1 165 169 Sulphone; Methylation(KR)
R.LFQ(+.98)HAQEK.V Y 20.29 1000.4977 8 -17.0 501.2477 2 19.46 4 7135 VEV_1_3_RA4_01_1235.d 0 1 1 22 29 Deamidation (NQ)
R.AAPMK.Q Y 19.21 516.2730 5 -33.6 517.2629 1 16.78 6 5872 VEV_3_3_RA6_01_1237.d 5.99E4 2 2 165 169
R.LHPE(+14.02)LLSK.H Y 18.61 949.5596 8 -15.0 317.5224 3 51.00 5 25758 VEV_2_3_RA5_01_1236.d 4.57E4 1 1 237 244 Methylation(others)
K.TGS(+79.97)SK(+14.02)NK(+14.02)PVYLVFHGGSGSTK.A Y 18.07 2258.1096 21 -62.9 565.4991 4 56.10 6 27791 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 253 273 Phosphorylation (STY); Methylation(KR)
R.K(+43.99)TGVIVGDDVLR.L Y 16.86 1314.7144 12 31.3 329.6962 4 49.61 5 24926 VEV_2_3_RA5_01_1236.d 0 1 1 10 21 Carboxylation (DKW)
R.LFQHAQEK(+14.02).V Y 16.75 1013.5294 8 -25.3 507.7592 2 28.73 6 12174 VEV_3_3_RA6_01_1237.d 5.94E4 1 1 22 29 Methylation(KR)
K.YFDPR.V Y 16.67 696.3231 5 -12.0 349.1647 2 36.20 5 16888 VEV_2_3_RA5_01_1236.d 1.1E6 3 3 329 333
R.K(+42.01)TGVIVGDDVLR.L Y 16.08 1312.7350 12 -17.1 329.1854 4 56.29 5 28938 VEV_2_3_RA5_01_1236.d 0 2 2 10 21 Acetylation (Protein N-term)
K.EAIS(+79.97)YGVVK(+43.01).I Y 15.37 1087.4951 9 41.1 544.7772 2 42.27 5 20483 VEV_2_3_RA5_01_1236.d 0 1 1 278 286 Phosphorylation (STY); Carbamylation
R.K(+14.02)TGVIVGDDVLR.L Y 15.13 1284.7401 12 22.5 322.1995 4 15.15 6 5024 VEV_3_3_RA6_01_1237.d 0 1 1 10 21 Methylation(KR)
K.D(-18.01)ILSR(+14.02).K Y 15.06 598.3438 5 0.0 300.1792 2 36.90 6 16758 VEV_3_3_RA6_01_1237.d 0 1 1 5 9 Dehydration; Methylation(KR)
total 46 peptides
C1GAT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TYDVSVPFVLMNSFNTDEDTQSIIK.K Y 114.72 2862.3633 25 -10.3 1432.1742 2 91.19 6 51924 VEV_3_3_RA6_01_1237.d 6.92E5 6 6 153 177
R.KGEADISIIQLETAVGAAIR.H Y 112.18 2054.1372 20 -16.8 685.7082 3 85.85 5 49646 VEV_2_3_RA5_01_1236.d 4.45E5 7 7 358 377
K.KYEGHNIDILTFNQSR.Y Y 109.75 1933.9646 16 -11.7 645.6546 3 67.68 5 37291 VEV_2_3_RA5_01_1236.d 1.65E5 3 3 178 193
K.GNVLSWDSIAPPQPGQVVEYSNLGNSASVNFLK.K Y 105.07 3486.7419 33 -5.0 1163.2488 3 89.34 4 53292 VEV_1_3_RA4_01_1235.d 1.59E5 3 3 75 107
K.LNGGLGTSMGC(+57.02)VGPK.S Y 98.79 1446.6959 15 -8.2 724.3493 2 64.69 4 35034 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 114 128 Carbamidomethylation
K.RFEAEMDNFFSLFR.R Y 96.71 1807.8351 14 6.1 603.6226 3 87.98 4 52494 VEV_1_3_RA4_01_1235.d 0 1 1 53 66
K.RFEAEMDNFFSLFRR.Y Y 96.13 1963.9363 15 7.1 491.9948 4 84.56 4 50289 VEV_1_3_RA4_01_1235.d 0 2 2 53 67
R.VVENNELEMEIIPNEK.S Y 90.35 1898.9294 16 -10.5 950.4620 2 76.80 6 42854 VEV_3_3_RA6_01_1237.d 1.82E5 3 3 336 351
R.ILELDHLTISGVVNLGR.G Y 85.26 1848.0469 17 -7.7 617.0181 3 84.39 6 48074 VEV_3_3_RA6_01_1237.d 5.71E4 1 1 451 467
K.FKYFNTNNIWMDLR.A Y 83.34 1860.8981 14 -3.1 621.3047 3 82.57 4 48980 VEV_1_3_RA4_01_1235.d 2.34E5 3 3 318 331
K.ADVKGGTIIDYEGR.A Y 77.76 1492.7521 14 -8.8 747.3767 2 59.38 5 31091 VEV_2_3_RA5_01_1236.d 6.92E4 2 2 282 295
R.DGMSFLDLAVR.Q Y 77.61 1222.6016 11 -14.3 612.2993 2 85.08 6 48513 VEV_3_3_RA6_01_1237.d 4.85E5 5 5 135 145
R.ILRDSLLPAPK.T Y 75.15 1221.7445 11 -20.8 611.8668 2 64.94 5 35224 VEV_2_3_RA5_01_1236.d 4.49E5 4 4 197 207
K.YEGHNIDILTFNQSR.Y Y 70.43 1805.8696 15 -29.5 602.9460 3 72.84 4 41457 VEV_1_3_RA4_01_1235.d 0 1 1 179 193
R.KGEADISIIQLETAVGAAIRHFK.N Y 67.15 2466.3594 23 -4.2 494.2771 5 86.90 4 51823 VEV_1_3_RA4_01_1235.d 6.64E4 2 2 358 380
K.HGQLVIDPNRFGGTPLIK.L Y 65.84 1961.0846 18 -16.3 491.2704 4 74.55 4 42821 VEV_1_3_RA4_01_1235.d 8.47E5 5 5 413 430
K.KRFEAEMDNFFSLFRR.Y Y 62.94 2092.0312 16 -1.2 419.4130 5 81.99 4 48524 VEV_1_3_RA4_01_1235.d 3.62E4 2 2 52 67
K.SDLYTLK.H Y 62.24 838.4436 7 -15.8 839.4376 1 53.63 6 26432 VEV_3_3_RA6_01_1237.d 3.24E4 1 1 406 412
K.NAHGVNVPR.R Y 61.85 962.5046 9 -14.5 482.2526 2 20.42 6 7774 VEV_3_3_RA6_01_1237.d 7.25E5 5 5 381 389
K.GGTIIDYEGR.A Y 58.40 1079.5247 10 -9.9 540.7643 2 59.16 4 30914 VEV_1_3_RA4_01_1235.d 8.36E5 6 6 286 295
R.DSLLPAPK.T Y 55.79 839.4752 8 -16.3 420.7380 2 59.77 5 31456 VEV_2_3_RA5_01_1236.d 7.81E5 5 5 200 207
R.K(+14.02)GEADISIIQLETAVGAAIR.H Y 52.80 2068.1528 20 -21.0 690.3771 3 86.50 5 50022 VEV_2_3_RA5_01_1236.d 6.59E4 1 1 358 377 Methylation(KR)
K.LN(+.98)GGLGTSMGC(+57.02)VGPK.S Y 49.56 1447.6799 15 -8.4 724.8412 2 67.51 4 37250 VEV_1_3_RA4_01_1235.d 6.14E4 1 1 114 128 Deamidation (NQ); Carbamidomethylation
K.TC(+57.02)SDLMLVK.S Y 48.24 1065.5199 9 -7.6 533.7632 2 64.28 4 34719 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 397 405 Carbamidomethylation
K.YFNTNNIWMDLR.A Y 45.64 1585.7347 12 5.7 793.8792 2 83.24 5 48097 VEV_2_3_RA5_01_1236.d 0 1 1 320 331
R.LLEIAQVPK.E Y 42.90 1009.6171 9 -18.6 505.8065 2 69.62 4 38917 VEV_1_3_RA4_01_1235.d 1.57E5 2 2 298 306
R.FGGTPLIK.L Y 42.85 831.4854 8 -7.9 416.7467 2 61.52 4 32616 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 423 430
R.LLEIAQVPKEHVNEFK.S Y 40.45 1893.0359 16 -20.7 474.2564 4 69.23 5 38429 VEV_2_3_RA5_01_1236.d 2.89E5 3 3 298 313
R.ILRDSLLPAPK(+14.02).T Y 39.02 1235.7601 11 -5.2 412.9252 3 67.32 5 37014 VEV_2_3_RA5_01_1236.d 2.67E4 1 1 197 207 Methylation(KR)
K.GNVLSWDSIAPPQPGQVVEYSNLGNSASVNFLKK.L Y 36.69 3614.8369 34 -9.2 1205.9418 3 86.07 5 49775 VEV_2_3_RA5_01_1236.d 2.45E4 1 1 75 108
R.IPSIPR.I N 35.11 681.4174 6 -14.8 341.7109 2 52.38 4 26441 VEV_1_3_RA4_01_1235.d 8.85E5 6 6 445 450
K.LAVIK.L N 32.66 542.3792 5 -15.6 543.3780 1 34.38 6 15303 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 109 113
K.S(+60.00)IPADRKGEADISIIQLETAVGAAIR.H Y 31.08 2753.4744 26 -26.7 689.3575 4 86.62 4 51637 VEV_1_3_RA4_01_1235.d 0 1 1 352 377 2-OH-ethyl thio-Ser
R.KGEADISIIQLETAVGAAIR(-.98).H Y 28.71 2053.1531 20 -41.3 514.2744 4 85.91 4 51189 VEV_1_3_RA4_01_1235.d 7.55E4 1 1 358 377 Amidation
R.FLPVK.T Y 25.78 602.3792 5 -39.8 603.3624 1 41.61 6 19417 VEV_3_3_RA6_01_1237.d 0 1 1 392 396
R.VVENNELE(+14.02)MEIIPNEK.S Y 25.42 1912.9452 16 -5.4 957.4747 2 79.13 4 46347 VEV_1_3_RA4_01_1235.d 6.84E4 1 1 336 351 Methylation(others)
K.YEGHNIDILTFN(+.98)QSR.Y Y 24.12 1806.8536 15 -1.0 603.2912 3 72.82 6 39952 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 179 193 Deamidation (NQ)
K.SDLYTLKHGQLVIDPNR.F Y 23.43 1968.0428 17 -36.6 656.9976 3 83.85 6 47733 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 406 422
R.D(+14.02)GMSFLDLAVR.Q Y 22.07 1236.6172 11 11.6 619.3231 2 80.65 4 47541 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 135 145 Methylation(others)
K.KVSDFQK.R Y 21.34 850.4548 7 -20.1 426.2261 2 14.39 5 4695 VEV_2_3_RA5_01_1236.d 0 1 1 437 443
R.QIEYLNR.T Y 21.34 934.4872 7 -29.3 468.2372 2 49.20 4 24371 VEV_1_3_RA4_01_1235.d 0 1 1 146 152
R.DGMSFLDLAVRQIEYLNR.T Y 21.23 2139.0781 18 15.0 714.0440 3 93.61 5 53624 VEV_2_3_RA5_01_1236.d 0 1 1 135 152
K.RIPSIPR.I Y 21.14 837.5184 7 -51.3 419.7450 2 43.79 6 20723 VEV_3_3_RA6_01_1237.d 0 1 1 444 450
K.GGTIIDYEGR(-.98).A Y 20.35 1078.5406 10 8.6 540.2822 2 60.04 4 31519 VEV_1_3_RA4_01_1235.d 0 1 1 286 295 Amidation
K.GGTIIDYEGR(+14.02).A Y 20.21 1093.5404 10 -10.1 547.7720 2 65.93 5 35982 VEV_2_3_RA5_01_1236.d 7.5E4 1 1 286 295 Methylation(KR)
R.FLPVKTC(+57.02)SDLMLVK.S Y 19.85 1649.8884 14 -16.0 550.9613 3 76.07 5 43358 VEV_2_3_RA5_01_1236.d 4.76E4 1 1 392 405 Carbamidomethylation
R.HFKNAHGVN(+162.05)VPR.R Y 19.53 1536.7797 12 6.1 513.2703 3 71.70 5 40244 VEV_2_3_RA5_01_1236.d 7.38E4 1 1 378 389 Hexose (NSY)
K.G(+42.01)GTIIDYEGR(+28.03)AR.L Y 19.12 1376.7048 12 1.9 345.1841 4 55.56 5 28490 VEV_2_3_RA5_01_1236.d 0 1 1 286 297 Acetylation (N-term); Dimethylation(KR)
R.HFKNAHGVNVPR.R Y 17.94 1374.7268 12 35.8 459.2659 3 66.60 5 36470 VEV_2_3_RA5_01_1236.d 4.58E4 1 1 378 389
K.HGQLVIDPN(+.98)RFGGT(+79.97)PLIK(+14.02).L Y 17.19 2056.0505 18 14.6 412.2234 5 60.86 6 31066 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 413 430 Deamidation (NQ); Phosphorylation (STY); Methylation(KR)
R.AIKRVVEN(+162.05)NELEMEIIPNEK.S Y 17.10 2529.2996 20 1.0 633.3328 4 76.90 4 44617 VEV_1_3_RA4_01_1235.d 9.05E4 1 1 332 351 Hexose (NSY)
K.NKAEYIMELTDKT(+79.97)K(+42.01).A Y 16.94 1804.8318 14 24.6 452.2263 4 43.84 5 21414 VEV_2_3_RA5_01_1236.d 1.99E5 1 1 268 281 Phosphorylation (STY); Acetylation (K)
K.GEADISIIQLETAVGAAIR.H Y 16.61 1926.0421 19 -59.9 642.9828 3 97.42 6 54460 VEV_3_3_RA6_01_1237.d 2.1E4 2 2 359 377
K.NKAEYIMELTD(-18.01)K.T Y 16.55 1435.7017 12 -35.7 718.8325 2 59.42 6 30029 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 268 279 Dehydration
K.FKYFNTNNIWM(+15.99)DLRAIK.R Y 16.27 2189.1091 17 -7.4 548.2805 4 31.33 5 14038 VEV_2_3_RA5_01_1236.d 8.16E2 1 1 318 334 Oxidation (M)
K.SIPAD(-18.01)R.K Y 16.20 639.3340 6 -13.5 640.3326 1 101.20 6 55683 VEV_3_3_RA6_01_1237.d 0 1 1 352 357 Dehydration
K.YEGHN(+.98)IDILTFNQSR.Y Y 15.80 1806.8536 15 7.8 603.2965 3 72.69 5 40959 VEV_2_3_RA5_01_1236.d 7.01E4 1 1 179 193 Deamidation (NQ)
K.G(+43.01)GTIIDYEGR.A Y 15.50 1122.5305 10 -17.2 562.2629 2 59.48 6 30071 VEV_3_3_RA6_01_1237.d 1.69E5 1 1 286 295 Carbamylation
R.VVENNELEM(+15.99)EIIPNEKSIPADRKGEADISIIQLETAVGAAIR.H Y 15.42 4590.3848 42 -19.5 919.0663 5 96.84 4 57091 VEV_1_3_RA4_01_1235.d 0 1 1 336 377 Oxidation (M)
K.HGQLVIDPNR(+14.02).F Y 15.31 1161.6255 10 -11.2 388.2114 3 50.39 5 25377 VEV_2_3_RA5_01_1236.d 0 1 1 413 422 Methylation(KR)
K.ADVK(+28.03)GGTIIDYEGR.A Y 15.24 1520.7834 14 0.6 381.2034 4 59.42 4 31055 VEV_1_3_RA4_01_1235.d 0 1 1 282 295 Dimethylation(KR)
K.G(+127.06)EADISIIQLETAVGAAIR.H Y 15.03 2053.1055 19 -51.1 1027.5076 2 85.91 4 51188 VEV_1_3_RA4_01_1235.d 0 1 1 359 377 N-Succinimidyl-2-morpholine acetate
total 62 peptides
C1G6U5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GHYTEGAELVDQVIDVVRR.E Y 124.86 2155.1021 19 -4.7 539.7803 4 81.50 4 48159 VEV_1_3_RA4_01_1235.d 6.53E5 4 4 124 142
K.MSSTFVGNSTSIQELFKR.V Y 123.73 2031.0095 18 -10.9 678.0031 3 79.19 5 45509 VEV_2_3_RA5_01_1236.d 7.58E5 4 4 383 400
K.M(+15.99)SSTFVGNSTSIQELFKR.V Y 114.36 2047.0044 18 -8.3 683.3364 3 77.80 4 45326 VEV_1_3_RA4_01_1235.d 4.96E5 3 3 383 400 Oxidation (M)
R.LHFFMVGFAPLTSR.G Y 110.69 1621.8439 14 -11.2 541.6158 3 84.89 4 50529 VEV_1_3_RA4_01_1235.d 4.17E5 4 4 283 296
K.LAVNMVPFPRLHFFMVGFAPLTSR.G Y 105.43 2746.4602 24 15.5 687.6330 4 91.30 4 54392 VEV_1_3_RA4_01_1235.d 1.4E5 2 2 273 296
K.MSSTFVGNSTSIQELFK.R Y 105.20 1874.9084 17 -7.8 938.4542 2 82.54 5 47683 VEV_2_3_RA5_01_1236.d 3.43E5 3 3 383 399
K.M(+15.99)SSTFVGNSTSIQELFK.R Y 98.36 1890.9033 17 -5.3 946.4539 2 81.16 4 47911 VEV_1_3_RA4_01_1235.d 1.66E5 3 3 383 399 Oxidation (M)
R.YLTC(+57.02)SAIFR.G Y 96.46 1129.5590 9 -15.6 565.7780 2 70.39 6 38180 VEV_3_3_RA6_01_1237.d 8.94E5 5 5 330 338 Carbamidomethylation
K.LSEPSYGDLNHLVSAVMSGVTTC(+57.02)LR.F Y 92.16 2705.3152 25 -9.2 902.7707 3 91.99 4 54771 VEV_1_3_RA4_01_1235.d 4.27E5 3 3 237 261 Carbamidomethylation
R.AGPFGELFRPDNFVFGQSGAGNNWAK.G Y 90.77 2782.3252 26 -6.2 928.4432 3 86.50 4 51560 VEV_1_3_RA4_01_1235.d 7.46E5 4 4 98 123
R.EAEGC(+57.02)DC(+57.02)LQGFQITHSLGGGTGAGMGTLLISK.I Y 87.62 3264.5212 32 -5.6 1089.1749 3 83.07 4 49273 VEV_1_3_RA4_01_1235.d 6.77E4 1 1 143 174 Carbamidomethylation
R.AVLVDLEPGTMDAVR.A Y 86.82 1584.8181 15 -12.4 793.4065 2 78.98 5 45365 VEV_2_3_RA5_01_1236.d 3.46E5 5 5 83 97
R.AVTVPELSQQMFDPK.N Y 83.05 1688.8444 15 -9.0 845.4218 2 80.25 4 47214 VEV_1_3_RA4_01_1235.d 7.08E5 5 5 303 317
R.MNVYFNEASGK.K Y 81.97 1258.5652 11 -7.5 630.2852 2 62.82 5 33648 VEV_2_3_RA5_01_1236.d 2.18E5 3 3 67 77
R.LHFFM(+15.99)VGFAPLTSR.G Y 77.96 1637.8387 14 11.8 546.9600 3 82.26 4 48715 VEV_1_3_RA4_01_1235.d 0 2 2 283 296 Oxidation (M)
R.VGDQFTAMFR.R Y 74.69 1170.5492 10 7.0 586.2859 2 76.63 4 44438 VEV_1_3_RA4_01_1235.d 2.61E5 4 4 401 410
R.MMATFSVVPSPK.V Y 69.48 1293.6461 12 -4.4 647.8275 2 74.80 4 42975 VEV_1_3_RA4_01_1235.d 3.52E5 2 2 183 194
R.MNVYFNEASGKK.Y Y 63.20 1386.6602 12 -0.3 694.3372 2 52.85 4 26706 VEV_1_3_RA4_01_1235.d 4.22E5 5 5 67 78
R.M(+15.99)NVYFNEASGK.K Y 59.22 1274.5601 11 0.1 638.2874 2 51.40 6 25112 VEV_3_3_RA6_01_1237.d 8.76E4 2 2 67 77 Oxidation (M)
R.VGDQFTAMFRR.K Y 57.99 1326.6503 11 -12.2 443.2187 3 71.06 4 40050 VEV_1_3_RA4_01_1235.d 2.9E5 2 2 401 411
K.LAVNMVPFPR.L Y 57.13 1142.6270 10 -8.7 572.3158 2 78.04 4 45510 VEV_1_3_RA4_01_1235.d 2.57E5 2 2 273 282
R.AVLVDLEPGTM(+15.99)DAVR.A Y 56.03 1600.8130 15 -9.4 801.4062 2 74.47 5 42224 VEV_2_3_RA5_01_1236.d 2.23E5 4 4 83 97 Oxidation (M)
R.FPGQLNSDLRK.L Y 54.57 1273.6779 11 -21.1 425.5576 3 57.53 6 28713 VEV_3_3_RA6_01_1237.d 1.72E5 1 1 262 272
K.RVGDQFTAMFR.R Y 52.00 1326.6503 11 -11.4 443.2190 3 73.09 4 41650 VEV_1_3_RA4_01_1235.d 5.42E4 1 1 400 410
K.GHYTE(+14.02)GAELVDQVIDVVRR.E Y 50.66 2169.1177 19 -8.5 543.2821 4 82.74 6 47030 VEV_3_3_RA6_01_1237.d 7.17E4 1 1 124 142 Methylation(others)
K.MSSTFVGNSTSIQELFK(+14.02)R.V Y 47.00 2045.0251 18 -26.8 682.6641 3 79.53 4 46656 VEV_1_3_RA4_01_1235.d 0 1 1 383 400 Methylation(KR)
K.M(+15.99)S(-18.01)STFVGNSTSIQELFKR.V Y 43.83 2028.9939 18 -9.3 677.3323 3 79.24 6 44618 VEV_3_3_RA6_01_1237.d 4.23E4 2 2 383 400 Oxidation (M); Dehydration
K.IREEFPDR.M Y 39.04 1060.5302 8 -17.4 354.5112 3 37.95 6 17310 VEV_3_3_RA6_01_1237.d 2.34E5 2 2 175 182
R.GAYSFR.A Y 33.63 699.3340 6 -11.3 350.6703 2 33.92 4 15103 VEV_1_3_RA4_01_1235.d 5.85E5 5 5 297 302
K.LSEPSYGDLNHLVSAVMSGVTTC(+57.02)LRFPGQLNSDLR.K Y 31.90 3832.8877 35 -13.7 767.5743 5 93.79 6 53100 VEV_3_3_RA6_01_1237.d 5.75E4 1 1 237 271 Carbamidomethylation
K.GH(+14.02)YTEGAELVDQVIDVVRR.E Y 30.59 2169.1177 19 -1.7 543.2858 4 82.83 4 49112 VEV_1_3_RA4_01_1235.d 9.13E4 1 1 124 142 Methylation(others)
R.VGDQFTAMFR(+14.02).R Y 29.74 1184.5648 10 0.8 593.2902 2 78.93 4 46189 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 401 410 Methylation(KR)
R.AVTVPELSQQM(+15.99)FDPK.N Y 25.13 1704.8392 15 -10.2 853.4182 2 74.98 4 43113 VEV_1_3_RA4_01_1235.d 9.5E4 1 1 303 317 Oxidation (M)
R.AVTVPELSQQMFDPK(+14.02).N Y 24.88 1702.8600 15 -12.1 852.4270 2 80.86 4 47690 VEV_1_3_RA4_01_1235.d 4.62E4 1 1 303 317 Methylation(KR)
K.LAVNM(+15.99)VPFPR.L Y 24.76 1158.6219 10 -18.7 580.3074 2 72.00 5 40458 VEV_2_3_RA5_01_1236.d 0 2 2 273 282 Oxidation (M)
R.MN(+.98)VYFNEASGKK.Y Y 20.24 1387.6442 12 -8.0 694.8238 2 53.11 4 26865 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 67 78 Deamidation (NQ)
R.N(+42.01)(+.98)VQNK.N Y 18.96 644.3129 5 -26.1 645.3034 1 44.58 6 21168 VEV_3_3_RA6_01_1237.d 0 1 1 352 356 Acetylation (N-term); Deamidation (NQ)
K.VSM(+15.99)KEVEDQM(+15.99)R.N Y 18.33 1382.6169 11 17.5 692.3278 2 62.33 4 33240 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 341 351 Oxidation (M)
R.KLAVNMVPFP(+31.99)R(+14.02).L Y 18.07 1316.7274 11 -20.6 330.1823 4 15.45 5 5281 VEV_2_3_RA5_01_1236.d 0 1 1 272 282 Dihydroxy; Methylation(KR)
R.LH(+14.02)FFMVGFAPLTSR.G Y 17.75 1635.8595 14 -1.0 546.2932 3 82.35 4 48781 VEV_1_3_RA4_01_1235.d 0 1 1 283 296 Methylation(others)
K.L(+42.01)AVNM(+31.99)VPFPR.L Y 17.20 1216.6274 10 -7.0 305.1620 4 12.95 5 3934 VEV_2_3_RA5_01_1236.d 7.07E4 1 1 273 282 Acetylation (N-term); Sulphone
R.NVQ(+.98)NK(+14.02).N Y 16.83 616.3181 5 -11.5 617.3182 1 52.00 6 25473 VEV_3_3_RA6_01_1237.d 1.62E3 1 1 352 356 Deamidation (NQ); Methylation(KR)
K.NMM(-48.00)AASDFR.N Y 16.67 993.4338 9 -9.5 497.7195 2 26.43 4 10891 VEV_1_3_RA4_01_1235.d 8.06E4 1 1 318 326 Dethiomethyl
R.NVQN(+.98)K(+14.02).N Y 15.85 616.3181 5 -7.9 617.3204 1 28.59 5 12451 VEV_2_3_RA5_01_1236.d 0 1 1 352 356 Deamidation (NQ); Methylation(KR)
R.NVQ(+.98)NK.N Y 15.68 602.3024 5 3.3 603.3116 1 60.90 6 31098 VEV_3_3_RA6_01_1237.d 0 1 1 352 356 Deamidation (NQ)
K.IREEFPD(-18.01)R(+14.02).M Y 15.62 1056.5352 8 0.1 529.2749 2 24.99 6 10185 VEV_3_3_RA6_01_1237.d 0 1 1 175 182 Dehydration; Methylation(KR)
R.L(+42.01)HFFMVGFAPLTSR.G Y 15.11 1663.8545 14 -7.2 555.6215 3 49.46 4 24540 VEV_1_3_RA4_01_1235.d 5.7E5 1 1 283 296 Acetylation (N-term)
total 47 peptides
C1GHD6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGHNDEPIGISTVDLLKDNDC(+57.02)LVK.F Y 124.78 2622.2959 24 -7.7 656.5762 4 78.36 6 43979 VEV_3_3_RA6_01_1237.d 2.13E5 2 2 433 456 Carbamidomethylation
R.LVEAVNFETDEALLTGESLPVHK.D Y 97.99 2510.2903 23 -8.1 837.7639 3 83.12 4 49308 VEV_1_3_RA4_01_1235.d 1.06E5 2 2 175 197
K.FTDSPLENEEYNRDDVER.D Y 96.89 2226.9666 18 8.2 743.3355 3 64.93 5 35230 VEV_2_3_RA5_01_1236.d 1.5E5 3 3 596 613
R.GEPTEIAIQVFASR.F Y 92.68 1516.7885 14 -13.2 759.3915 2 80.66 5 46501 VEV_2_3_RA5_01_1236.d 1.98E5 2 2 481 494
R.ELRTDPEDGLTAEEAK.R Y 90.95 1772.8428 16 -11.0 591.9484 3 59.33 6 29953 VEV_3_3_RA6_01_1237.d 8.14E4 1 1 37 52
K.HADVGIAMGESGSDVAK.D Y 88.55 1642.7621 17 -7.7 822.3820 2 57.55 5 29808 VEV_2_3_RA5_01_1236.d 6.77E4 1 1 743 759
R.ELRTDPEDGLTAEEAKR.R Y 86.52 1928.9438 17 -12.8 483.2371 4 55.35 6 27352 VEV_3_3_RA6_01_1237.d 4.03E5 4 4 37 53
R.NGNTTTIASIDIVPGDMVELR.T Y 85.64 2215.1155 21 -10.3 1108.5536 2 84.62 5 48939 VEV_2_3_RA5_01_1236.d 6.8E4 2 2 144 164
K.KAWIPSGGTFSVGTSTEPFNPEMGAVGFER.A Y 85.48 3155.5022 30 -11.6 1052.8291 3 83.72 4 49719 VEV_1_3_RA4_01_1235.d 4.89E4 1 1 398 427
R.KLDSLEALGAVTNIC(+57.02)SDK.T Y 78.50 1932.9825 18 -11.1 645.3276 3 77.91 4 45411 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 368 385 Carbamidomethylation
R.TGDTVPADLR.L Y 76.30 1043.5247 10 -12.9 522.7629 2 47.26 5 23482 VEV_2_3_RA5_01_1236.d 7.42E5 6 6 165 174
R.GLIGLYDPPRPETAGAIEEC(+57.02)FR.A Y 73.45 2460.2107 22 -12.0 821.0676 3 81.11 5 46773 VEV_2_3_RA5_01_1236.d 3.23E5 3 3 619 640 Carbamidomethylation
K.SLLSLPAHC(+57.02)LPYDDVIR.E Y 72.62 1968.0138 17 8.2 657.0173 3 81.04 5 46734 VEV_2_3_RA5_01_1236.d 0 1 1 20 36 Carbamidomethylation
R.SLSSPTGNVSR.N Y 70.24 1103.5571 11 -10.6 552.7800 2 34.47 5 15879 VEV_2_3_RA5_01_1236.d 1.08E6 7 7 133 143
K.GQDAIWHQVAEFPFDSSIK.K Y 69.86 2174.0432 19 -24.4 725.6707 3 83.55 4 49597 VEV_1_3_RA4_01_1235.d 2.05E1 3 3 505 523
K.TEIGSIAAALR.A Y 69.85 1100.6189 11 -14.8 551.3086 2 74.51 5 42255 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 238 248
K.DASDIILTDDNFASILNAIEEGRR.I Y 67.31 2647.3088 24 -14.6 883.4307 3 92.46 6 52520 VEV_3_3_RA6_01_1237.d 7.89E3 2 2 760 783
K.FLDIASMANLAHVYK.T Y 66.49 1691.8705 15 -27.5 564.9486 3 83.40 5 48195 VEV_2_3_RA5_01_1236.d 4.18E4 2 2 457 471
R.FLGVNVGTPLQR.K Y 66.45 1299.7299 12 -12.9 650.8638 2 77.48 5 44363 VEV_2_3_RA5_01_1236.d 3.28E4 1 1 285 296
K.GQDAIWHQVAEFPFDSSIKK.M Y 65.84 2302.1382 20 -7.8 576.5374 4 79.88 5 45972 VEV_2_3_RA5_01_1236.d 2.37E5 2 2 505 524
K.MSVIFENPTQK.D Y 60.33 1292.6434 11 -5.7 647.3253 2 69.57 5 38711 VEV_2_3_RA5_01_1236.d 2.39E5 3 3 525 535
R.AGISVHMVTGDHPGTAR.A Y 58.49 1704.8365 17 15.5 427.2230 4 56.78 4 29152 VEV_1_3_RA4_01_1235.d 1.12E5 2 2 641 657
R.TDPEDGLTAEEAKR.R Y 55.43 1530.7161 14 -0.3 766.3651 2 45.92 5 22679 VEV_2_3_RA5_01_1236.d 0 1 1 40 53
R.TGDTVPADLRLVEAVNFETDEALLTGESLPVHK.D Y 54.11 3535.8044 33 22.0 884.9778 4 89.05 4 53136 VEV_1_3_RA4_01_1235.d 0 1 1 165 197
K.HADVGIAM(+15.99)GESGSDVAK.D Y 41.29 1658.7570 17 0.9 553.9268 3 42.45 6 19927 VEV_3_3_RA6_01_1237.d 6.12E4 1 1 743 759 Oxidation (M)
K.DAEQ(+.98)AFHQDTGPGDRLNIAYSSSTVTR.G Y 40.41 2936.3535 27 -22.1 735.0794 4 70.53 6 38250 VEV_3_3_RA6_01_1237.d 9.06E4 1 1 198 224 Deamidation (NQ)
R.LNIAYSSSTVTR.G Y 38.58 1310.6830 12 -42.2 656.3211 2 62.85 6 32527 VEV_3_3_RA6_01_1237.d 2.19E4 2 2 213 224
K.HADVGIAMGE(+14.02)SGSDVAK.D Y 36.86 1656.7777 17 8.3 553.2711 3 62.02 5 33052 VEV_2_3_RA5_01_1236.d 4.78E4 2 2 743 759 Methylation(others)
R.LQIYGPNVLEGGER.V Y 32.93 1543.7994 14 -4.6 515.6047 3 76.01 6 42283 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 55 68
K.AWALTGTDAVGR.F Y 32.73 1216.6200 12 -0.6 305.1621 4 22.20 5 8919 VEV_2_3_RA5_01_1236.d 0 2 2 273 284
K.M(+15.99)VFTKGAVER.V Y 30.07 1152.5961 10 0.7 577.3057 2 78.96 4 46217 VEV_1_3_RA4_01_1235.d 0 1 1 538 547 Oxidation (M)
K.AGHNDEPIGIS(-2.02)TVDLLKDNDC(+57.02)LVK.F Y 29.48 2620.2803 24 -2.5 874.4319 3 78.39 5 44982 VEV_2_3_RA5_01_1236.d 8.99E4 1 1 433 456 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.LNIAYSSSTVTR(+14.02).G Y 29.08 1324.6986 12 -14.8 663.3468 2 92.17 6 52385 VEV_3_3_RA6_01_1237.d 2.9E5 1 1 213 224 Methylation(KR)
R.GEPT(-2.02)EIAIQVFASR.F Y 27.80 1514.7728 14 -18.5 758.3797 2 80.56 6 45557 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 481 494 2-amino-3-oxo-butanoic_acid
R.LVEAVNFET(-2.02)DEALLTGESLPVHK.D Y 27.14 2508.2747 23 -7.0 837.0930 3 82.97 5 47938 VEV_2_3_RA5_01_1236.d 0 1 1 175 197 2-amino-3-oxo-butanoic_acid
K.M(+42.01)VFTKGAVER.V Y 26.96 1178.6118 10 -39.4 590.2900 2 70.37 5 39268 VEV_2_3_RA5_01_1236.d 0 2 2 538 547 Acetylation (N-term)
K.FLDIASM(+15.99)ANLAHVYK.T Y 24.90 1707.8654 15 44.8 570.3212 3 32.14 5 14497 VEV_2_3_RA5_01_1236.d 3.71E5 2 2 457 471 Oxidation (M)
R.C(+44.03)APNTK.V Y 23.36 676.3214 6 -10.1 677.3218 1 79.07 6 44495 VEV_3_3_RA6_01_1237.d 4.15E4 1 1 709 714 Ethanolation (C)
R.LNIAYSSSTVT(+79.97)R(+14.02).G Y 22.35 1404.6650 12 29.2 469.2426 3 55.51 6 27445 VEV_3_3_RA6_01_1237.d 0 2 2 213 224 Phosphorylation (STY); Methylation(KR)
K.AWALTGT(-18.01)DAVGR.F Y 22.06 1198.6095 12 9.8 600.3179 2 57.93 4 29965 VEV_1_3_RA4_01_1235.d 0 1 1 273 284 Dehydration
R.FLGVN(+.98)VGT(+79.97)PLQRK.L Y 21.66 1508.7751 13 -5.7 378.1989 4 61.38 5 32565 VEV_2_3_RA5_01_1236.d 6.81E4 1 1 285 297 Deamidation (NQ); Phosphorylation (STY)
R.AR(+14.02)GVVVATGMK(+14.02)TEIGSIAAALR.A Y 20.99 2198.2568 22 -59.2 550.5389 4 74.58 4 42802 VEV_1_3_RA4_01_1235.d 1.79E5 1 1 227 248 Methylation(KR)
K.AK(+42.01)ASSGD(+21.98)LR.I Y 19.99 967.4698 9 -16.0 968.4617 1 84.25 6 47994 VEV_3_3_RA6_01_1237.d 2.09E4 1 1 1033 1041 Acetylation (K); Sodium adduct
K.AWALT(-18.01)GTDAVGR(+14.02).F Y 19.47 1212.6251 12 0.7 405.2159 3 37.76 5 17796 VEV_2_3_RA5_01_1236.d 3.78E4 1 1 273 284 Dehydration; Methylation(KR)
R.IFDN(+.98)IQ(+.98)K.F Y 19.22 878.4385 7 -9.2 879.4377 1 111.93 4 61650 VEV_1_3_RA4_01_1235.d 1.72E4 1 1 784 790 Deamidation (NQ)
R.VLALAGR.K Y 19.20 698.4438 7 -7.4 350.2266 2 44.09 4 21192 VEV_1_3_RA4_01_1235.d 0 4 4 588 594
R.R(+14.02)GAEAASTAGDEK(+31.99).S Y 19.11 1307.5953 13 16.1 654.8155 2 49.06 5 24585 VEV_2_3_RA5_01_1236.d 4.85E4 1 1 7 19 Methylation(KR); Dihydroxy
R.KFTDSPLENEEYNRDDVERDLTFR.G Y 18.76 2987.3896 24 9.7 747.8619 4 74.90 5 42524 VEV_2_3_RA5_01_1236.d 0 1 1 595 618
K.AWALTGTD(-18.01)AVGR.F Y 18.08 1198.6095 12 24.1 600.3265 2 52.47 5 26672 VEV_2_3_RA5_01_1236.d 3.97E5 1 1 273 284 Dehydration
K.TEIGSIAAALRASDS(-18.01)K.V Y 18.03 1570.8314 16 -5.7 393.7129 4 56.82 4 29177 VEV_1_3_RA4_01_1235.d 0 1 1 238 253 Dehydration
K.AWALTGTDAVGR(-.98).F Y 17.81 1215.6360 12 21.8 406.2281 3 43.77 5 21361 VEV_2_3_RA5_01_1236.d 4.05E4 1 1 273 284 Amidation
K.AWALTGT(+79.97)DAVGR.F Y 17.77 1296.5863 12 60.6 325.1735 4 11.02 5 2968 VEV_2_3_RA5_01_1236.d 1.58E5 1 1 273 284 Phosphorylation (STY)
R.TDPEDGLTAEEAK.R Y 17.71 1374.6150 13 -4.3 688.3118 2 51.46 6 25153 VEV_3_3_RA6_01_1237.d 4.67E4 1 1 40 52
K.DK(+14.02)MVFTK(+43.01)GAVER.V Y 17.57 1436.7445 12 -1.1 360.1930 4 54.59 5 27949 VEV_2_3_RA5_01_1236.d 5.86E4 1 1 536 547 Methylation(KR); Carbamylation
K.AK(+43.01)ASSGDLR.I Y 17.26 946.4832 9 -28.9 474.2352 2 33.39 6 14738 VEV_3_3_RA6_01_1237.d 0 1 1 1033 1041 Carbamylation
K.AWALT(+79.97)GTDAVGR.F Y 17.24 1296.5863 12 68.8 325.1761 4 42.60 4 20292 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 273 284 Phosphorylation (STY)
R.GAEAASTAGDEK(-.98).S Y 16.91 1104.5046 12 18.1 1105.5319 1 91.84 4 54688 VEV_1_3_RA4_01_1235.d 4.13E3 1 1 8 19 Amidation
K.AGHNDEPIGISTVDLLK(-1.03)DNDC(+57.02)LVK.F Y 16.84 2621.2642 24 15.6 656.3336 4 78.37 5 44967 VEV_2_3_RA5_01_1236.d 7.55E4 1 1 433 456 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
K.TEIGSIAAALRAS(+79.97)DSK(+28.03).V Y 16.56 1696.8396 16 -8.7 425.2135 4 58.26 4 30189 VEV_1_3_RA4_01_1235.d 0 1 1 238 253 Phosphorylation (STY); Dimethylation(KR)
R.M(+15.99)QPNSK.K Y 16.31 719.3272 6 48.0 720.3690 1 75.05 4 43169 VEV_1_3_RA4_01_1235.d 6.3E4 1 1 946 951 Oxidation (M)
K.QGIFTR.E Y 16.30 720.3918 6 -21.9 361.1953 2 41.68 4 19711 VEV_1_3_RA4_01_1235.d 0 1 1 861 866
K.MVFTKGAVE(+21.98)R.V Y 16.07 1158.5831 10 -17.8 387.1948 3 17.50 5 6421 VEV_2_3_RA5_01_1236.d 1.29E5 1 1 538 547 Sodium adduct
R.GVVVATGM(+15.99)K.T Y 15.90 876.4739 9 -41.5 439.2260 2 39.11 5 18590 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 229 237 Oxidation (M)
K.AWALTGTDAVGR(+31.99).F Y 15.67 1248.6099 12 -26.8 625.2955 2 35.30 6 15813 VEV_3_3_RA6_01_1237.d 0 1 1 273 284 Dihydroxy
R.A(+42.01)GIS(-18.01)VHMVTGDHPGTAR.A Y 15.36 1728.8365 17 -11.4 577.2795 3 43.91 6 20763 VEV_3_3_RA6_01_1237.d 0 1 1 641 657 Acetylation (N-term); Dehydration
R.IADVEQ(-18.01) Y 15.18 655.3177 6 16.7 656.3359 1 32.72 5 14844 VEV_2_3_RA5_01_1236.d 0 1 1 1042 1047 Dehydration
K.D(+43.01)KMVFTKGAVER.V Y 15.14 1422.7289 12 -4.2 475.2482 3 27.14 5 11673 VEV_2_3_RA5_01_1236.d 0 1 1 536 547 Carbamylation
R.L(+42.01)QIYGPNVLEGGE(+21.98)R.V Y 15.14 1607.7919 14 -18.9 536.9278 3 30.15 5 13351 VEV_2_3_RA5_01_1236.d 3.49E4 1 1 55 68 Acetylation (N-term); Sodium adduct
total 68 peptides
C1GBT4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IC(+57.02)GTINNTSEYGLTGSVFSVQR.D Y 131.65 2402.1536 22 -4.1 1202.0791 2 79.67 5 45840 VEV_2_3_RA5_01_1236.d 5.15E4 1 1 475 496 Carbamidomethylation
K.NAWQAEIDAAAELADFLR.F Y 119.23 2002.9747 18 -4.2 668.6627 3 95.85 4 56683 VEV_1_3_RA4_01_1235.d 3.52E5 4 4 156 173
R.YAEEALRNTAGNFYINC(+57.02)K.S Y 104.48 2132.9949 18 3.7 712.0082 3 71.03 5 39750 VEV_2_3_RA5_01_1236.d 1.43E5 2 2 501 518 Carbamidomethylation
R.NTAGNFYINC(+57.02)K.S Y 96.52 1300.5870 11 -11.8 651.2931 2 57.91 6 29005 VEV_3_3_RA6_01_1237.d 3.28E5 5 5 508 518 Carbamidomethylation
K.Q(-17.03)KFPLEVPAVIGGK.N Y 91.77 1464.8340 14 -11.0 733.4162 2 82.05 5 47382 VEV_2_3_RA5_01_1236.d 3.05E5 3 3 60 73 Pyro-glu from Q
R.SIKEEFSALSQTTYPSNEV Y 88.52 2129.0164 19 -9.1 1065.5057 2 79.31 4 46482 VEV_1_3_RA4_01_1235.d 2.04E5 4 4 555 573
R.Q(-17.03)SGTNDKAGSATILSR.F Y 88.29 1587.7853 16 -9.2 794.8926 2 54.25 4 27598 VEV_1_3_RA4_01_1235.d 6.47E5 5 5 534 549 Pyro-glu from Q
K.IGQC(+57.02)IANGVYR.S Y 87.93 1249.6238 11 -12.5 625.8113 2 60.59 4 31924 VEV_1_3_RA4_01_1235.d 3.84E5 3 3 301 311 Carbamidomethylation
K.STGAVVGQQPFGGAR.Q Y 85.19 1430.7266 15 -9.9 716.3635 2 59.88 5 31461 VEV_2_3_RA5_01_1236.d 3.41E5 1 1 519 533
R.GYFIQPTIYLAK.D Y 81.85 1412.7704 12 -17.4 707.3802 2 80.98 6 45845 VEV_3_3_RA6_01_1237.d 2.06E5 2 2 430 441
R.FNVQYAEELYAQQPQHHSPGVWNR.V Y 77.43 2897.3633 24 0.5 725.3484 4 76.17 6 42390 VEV_3_3_RA6_01_1237.d 7.15E4 1 1 174 197
K.LMSTELFGPILVIYVYDDTKSPVEAFQK.I Y 68.53 3202.6511 28 -5.3 1068.5520 3 94.33 4 55980 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 447 474
R.QSGTNDKAGSATILSR.F Y 68.36 1604.8118 16 -8.6 535.9399 3 36.58 4 16687 VEV_1_3_RA4_01_1235.d 5.45E5 6 6 534 549
K.SGPPEDFGSFIGPVIHEVSFK.K Y 67.72 2245.1055 21 -14.1 749.3652 3 86.27 6 49232 VEV_3_3_RA6_01_1237.d 3.73E5 2 2 382 402
K.IGQC(+57.02)IAN(+.98)GVYR.S Y 67.64 1250.6078 11 -9.0 626.3055 2 59.37 5 31085 VEV_2_3_RA5_01_1236.d 3.87E5 3 3 301 311 Carbamidomethylation; Deamidation (NQ)
K.SKLEWELLSFADR.A Y 66.48 1592.8198 13 -5.2 531.9445 3 82.63 6 46955 VEV_3_3_RA6_01_1237.d 4.22E4 1 1 114 126
R.GAFEYQGQK.C Y 66.43 1026.4771 9 1.3 514.2465 2 36.90 4 16870 VEV_1_3_RA4_01_1235.d 3.79E5 6 6 344 352
K.STGAVVGQ(+.98)QPFGGAR.Q Y 65.60 1431.7106 15 -8.5 716.8564 2 61.95 5 32999 VEV_2_3_RA5_01_1236.d 9.84E4 2 2 519 533 Deamidation (NQ)
K.SLKQKFPLEVPAVIGGK.N Y 57.38 1810.0715 17 -5.0 453.5229 4 74.41 5 42182 VEV_2_3_RA5_01_1236.d 1.19E5 2 2 57 73
K.NFHLVHPSADITNAAINT(-18.01)VR(+14.02).G Y 51.79 2185.1392 20 1.8 547.2930 4 74.64 4 42853 VEV_1_3_RA4_01_1235.d 0 1 1 324 343 Dehydration; Methylation(KR)
R.YAEEALR.N Y 49.31 850.4185 7 -15.8 426.2098 2 32.79 6 14415 VEV_3_3_RA6_01_1237.d 2.61E5 4 4 501 507
K.KLTGVMDAANKDSELELIVGGK.Y Y 43.49 2287.2092 22 0.0 572.8096 4 77.14 4 44804 VEV_1_3_RA4_01_1235.d 2.08E4 1 1 403 424
K.NFHLVHPSADITNAAINTVR.G Y 41.99 2189.1340 20 -15.9 730.7070 3 74.86 6 41440 VEV_3_3_RA6_01_1237.d 2.49E5 1 1 324 343
K.YRYDIM(+15.99)AATMLGQGK.N Y 27.87 1732.8276 15 19.1 434.2225 4 56.60 4 29032 VEV_1_3_RA4_01_1235.d 0 1 1 141 155 Oxidation (M)
K.LTGVMDAANK.D Y 27.60 1018.5117 10 -33.2 510.2462 2 29.57 4 12607 VEV_1_3_RA4_01_1235.d 0 1 1 404 413
R.YDIMAATM(+15.99)LGQGK.N Y 27.38 1413.6632 13 42.1 707.8687 2 78.95 4 46210 VEV_1_3_RA4_01_1235.d 0 1 1 143 155 Oxidation (M)
K.LTGVM(+15.99)DAANK.D Y 25.10 1034.5066 10 -11.0 518.2549 2 34.85 6 15581 VEV_3_3_RA6_01_1237.d 2.91E5 6 6 404 413 Oxidation (M)
R.QSGT(-18.01)NDK(+14.02)AGSATILSR.F Y 23.74 1600.8169 16 -8.9 534.6082 3 36.62 6 16557 VEV_3_3_RA6_01_1237.d 5.3E4 1 1 534 549 Dehydration; Methylation(KR)
R.DAIRYAEEALR.N Y 22.48 1305.6676 11 -4.7 436.2278 3 71.68 4 40540 VEV_1_3_RA4_01_1235.d 6.31E4 2 2 497 507
R.FVSMR.S Y 21.74 638.3210 5 1.2 320.1682 2 30.90 6 13366 VEV_3_3_RA6_01_1237.d 2.91E4 1 1 550 554
K.LTGVMD(-18.01)AANK.D Y 21.30 1000.5012 10 -8.4 501.2536 2 52.17 4 26282 VEV_1_3_RA4_01_1235.d 0 1 1 404 413 Dehydration
K.AGSATILSRFVSMR.S Y 20.62 1494.7976 14 -15.5 499.2654 3 74.26 4 42588 VEV_1_3_RA4_01_1235.d 7.44E4 1 1 541 554
K.NIKSPNLSR.Q Y 20.09 1027.5774 9 -19.2 343.5265 3 28.14 6 11850 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 74 82
R.AAVFLK.A Y 19.45 647.4006 6 -22.9 324.7002 2 51.89 4 26088 VEV_1_3_RA4_01_1235.d 2.9E6 1 1 127 132
K.C(+57.02)SATSRAYVPQSRWEEFK.S Y 19.26 2201.0322 18 -24.6 734.6666 3 26.42 4 10885 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 353 370 Carbamidomethylation
R.QSGTNDK.A Y 18.31 748.3351 7 28.9 749.3640 1 53.27 4 26963 VEV_1_3_RA4_01_1235.d 0 1 1 534 540
R.SYPRVVGETGGK.N Y 17.69 1248.6462 12 -1.8 313.1683 4 52.40 6 25704 VEV_3_3_RA6_01_1237.d 0 1 1 312 323
R.FARSFGSFAGFK.Q Y 16.12 1320.6614 12 25.7 441.2390 3 57.38 5 29680 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 27 38
R.QSGTNDKAGSATILSRFVSM(+15.99)R.S Y 15.58 2241.1172 21 6.1 561.2900 4 79.53 4 46655 VEV_1_3_RA4_01_1235.d 6.99E4 1 1 534 554 Oxidation (M)
K.S(-18.01)K(+42.01)LEWELLSFADR.A Y 15.47 1616.8198 13 -6.4 405.2097 4 40.95 5 19679 VEV_2_3_RA5_01_1236.d 6.47E4 1 1 114 126 Dehydration; Acetylation (K)
K.YRYDIM(+15.99)AATM(+15.99)LGQGK.N Y 15.35 1748.8225 15 29.0 438.2256 4 35.30 5 16351 VEV_2_3_RA5_01_1236.d 0 1 1 141 155 Oxidation (M)
total 41 peptides
A0A0A0HVP8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GRDYVDQLNQILHYLGTPNEETLSR.I Y 133.62 2930.4521 25 -12.4 733.6112 4 87.35 6 49858 VEV_3_3_RA6_01_1237.d 5.35E5 4 4 235 259
R.DYVDQLNQILHYLGTPNEETLSR.I Y 128.02 2717.3296 23 -7.1 906.7774 3 92.51 4 55043 VEV_1_3_RA4_01_1235.d 1.2E5 2 2 237 259
R.GFSIDPDENAGYMTEYVATR.W Y 122.51 2234.9790 20 -3.0 1118.4934 2 81.66 4 48289 VEV_1_3_RA4_01_1235.d 2.07E5 3 3 177 196
R.APEIMLSFPSYTK.A Y 106.48 1482.7428 13 -10.1 742.3712 2 80.93 4 47738 VEV_1_3_RA4_01_1235.d 2.49E5 2 2 200 212
R.DLKPGNLLVNADC(+57.02)ELK.I Y 80.39 1797.9294 16 -14.2 600.3086 3 76.64 6 42738 VEV_3_3_RA6_01_1237.d 2.85E5 2 2 153 168 Carbamidomethylation
R.LFPSANPDALDLLDRMLAFDPSSR.I Y 76.77 2660.3267 24 -13.1 887.7712 3 93.39 5 53576 VEV_2_3_RA5_01_1236.d 3.29E5 4 4 283 306
K.VFNQEFVVDER.Y Y 74.60 1380.6674 11 -16.7 691.3294 2 70.10 6 37931 VEV_3_3_RA6_01_1237.d 1.57E5 2 2 12 22
R.LFPSANPDALDLLDR.M Y 70.31 1655.8518 15 -9.2 828.9255 2 83.94 5 48535 VEV_2_3_RA5_01_1236.d 4.45E5 4 4 283 297
R.DLKPGNLLVNADC(+57.02)ELKIC(+57.02)DFGLAR.G Y 68.25 2730.3833 24 -7.7 911.1281 3 84.39 4 50186 VEV_1_3_RA4_01_1235.d 3.7E4 1 1 153 176 Carbamidomethylation
R.SGQPLTDAHFQSFIYQILC(+57.02)GLK.Y Y 67.69 2522.2627 22 -10.5 841.7527 3 93.16 4 55382 VEV_1_3_RA4_01_1235.d 1.61E5 1 1 121 142 Carbamidomethylation
R.ISVEEALEHR.Y Y 67.08 1181.6040 10 -12.9 394.8702 3 63.91 5 34468 VEV_2_3_RA5_01_1236.d 3.22E5 3 3 307 316
R.NPNDLEASLQR.G Y 66.01 1255.6156 11 -12.9 628.8070 2 59.97 5 31541 VEV_2_3_RA5_01_1236.d 5.74E4 2 2 412 422
R.NLPFMHKIPFQR.L Y 64.87 1526.8180 12 -8.4 382.7086 4 72.65 4 41352 VEV_1_3_RA4_01_1235.d 4.51E5 3 3 271 282
R.GFSIDPDENAGYMTE(+14.02)YVATR.W Y 64.08 2248.9946 20 -4.1 1125.5000 2 82.86 4 49134 VEV_1_3_RA4_01_1235.d 4.42E4 1 1 177 196 Methylation(others)
K.YIHSANVLHR.D Y 57.29 1208.6414 10 -16.4 403.8811 3 36.17 4 16432 VEV_1_3_RA4_01_1235.d 2.5E5 4 4 143 152
K.IC(+57.02)DFGLAR.G N 56.39 950.4644 8 -11.7 476.2339 2 65.17 4 35435 VEV_1_3_RA4_01_1235.d 5.05E5 5 5 169 176 Carbamidomethylation
R.WYRAPEIMLSFPSYTK.A Y 54.98 1987.9866 16 -46.5 663.6387 3 82.15 4 48632 VEV_1_3_RA4_01_1235.d 0 1 1 197 212
R.MILDEVVR.F Y 53.62 973.5266 8 -10.2 487.7656 2 72.42 5 40774 VEV_2_3_RA5_01_1236.d 4.13E5 3 3 350 357
R.APE(+14.02)IMLSFPSYTK.A Y 53.09 1496.7584 13 -8.7 749.3800 2 82.21 4 48684 VEV_1_3_RA4_01_1235.d 2.18E4 1 1 200 212 Methylation(others)
K.VTNVFSK.K Y 50.36 793.4334 7 -19.4 397.7163 2 36.07 6 16277 VEV_3_3_RA6_01_1237.d 3.8E5 4 4 54 60
R.SGQPLTDAHFQSFIYQILC(+57.02)GLKYIHSANVLHR.D Y 48.01 3712.8936 32 -30.7 743.5632 5 91.43 4 54464 VEV_1_3_RA4_01_1235.d 0 1 1 121 152 Carbamidomethylation
R.DLK(-1.03)PGNLLVNADC(+57.02)ELKIC(+57.02)DFGLAR.G Y 42.95 2729.3516 24 10.4 683.3523 4 84.38 4 50179 VEV_1_3_RA4_01_1235.d 0 1 1 153 176 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
R.MLAFDPSSR.I Y 41.56 1022.4855 9 0.6 512.2503 2 65.95 4 36021 VEV_1_3_RA4_01_1235.d 5.45E5 5 5 298 306
R.DYVDQLNQILHYLGTPNEETLSR(+14.02).I Y 39.11 2731.3452 23 0.5 911.4561 3 93.57 4 55595 VEV_1_3_RA4_01_1235.d 3.27E4 1 1 237 259 Methylation(KR)
K.VFNQEFVVDERYNVTK.E Y 33.92 1985.9846 16 7.6 663.0072 3 72.29 4 41022 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 12 27
K.YIHSAN(+.98)VLHR.D Y 32.42 1209.6255 10 -28.5 404.2043 3 60.45 4 31820 VEV_1_3_RA4_01_1235.d 6.31E5 4 4 143 152 Deamidation (NQ)
R.NLPFMHK(+42.01)IPFQR.L Y 30.09 1568.8286 12 -23.7 393.2051 4 42.42 5 20573 VEV_2_3_RA5_01_1236.d 7.29E4 1 1 271 282 Acetylation (K)
K.GRDYVDQLNQILHY(-2.02)LGTPNEETLSR.I Y 29.01 2928.4365 25 -2.2 977.1506 3 87.34 6 49851 VEV_3_3_RA6_01_1237.d 0 1 1 235 259 2-amino-3-oxo-butanoic_acid
K.GRDYVDQLNQILHYLGTPNEETLSR(-.98).I Y 24.68 2929.4683 25 -5.7 977.4911 3 87.40 5 50526 VEV_2_3_RA5_01_1236.d 0 1 1 235 259 Amidation
K.LLQHFR.G Y 22.85 812.4657 6 -19.3 407.2323 2 38.61 5 18302 VEV_2_3_RA5_01_1236.d 1.65E5 1 1 73 78
R.AQEYVRNLPFMHK(+43.01).I Y 19.85 1674.8300 13 -42.1 838.3870 2 85.56 6 48811 VEV_3_3_RA6_01_1237.d 6.4E4 1 1 265 277 Carbamylation
K.QEDPRPQEAVLDSSR.N Y 18.75 1725.8281 15 -6.8 576.2794 3 47.95 5 23894 VEV_2_3_RA5_01_1236.d 0 1 1 397 411
R.MLAFDPSS(-18.01)R(+14.02).I Y 18.36 1018.4906 9 -10.5 510.2472 2 16.60 6 5770 VEV_3_3_RA6_01_1237.d 4.95E4 1 1 298 306 Dehydration; Methylation(KR)
K.YIHSANVLHR(+21.98).D Y 18.10 1230.6234 10 -8.8 411.2115 3 38.48 6 17616 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 143 152 Sodium adduct
R.APEIM(+15.99)LSFPSYTK(+14.02).A Y 17.37 1512.7534 13 -4.3 757.3807 2 81.68 4 48304 VEV_1_3_RA4_01_1235.d 5.02E4 1 1 200 212 Oxidation (M); Methylation(KR)
R.F(+226.08)RQQVR.Q Y 17.32 1058.5443 6 -31.4 530.2628 2 10.08 5 2554 VEV_2_3_RA5_01_1236.d 4.34E4 1 1 358 363 Biotinylation
K.IPFQR.L N 17.11 659.3755 5 -9.0 330.6920 2 37.51 4 17227 VEV_1_3_RA4_01_1235.d 3E5 2 2 278 282
R.MILDEVVRFR.Q Y 16.89 1276.6962 10 10.7 1277.7170 1 98.99 5 55682 VEV_2_3_RA5_01_1236.d 4.36E4 1 1 350 359
R.DLKPGNLLVNADCELK(+42.01).I Y 16.60 1782.9186 16 -42.6 892.4286 2 82.66 5 47748 VEV_2_3_RA5_01_1236.d 6.08E3 1 1 153 168 Acetylation (K)
R.NLPFMHK(+43.01).I Y 16.58 928.4589 7 -18.2 465.2283 2 62.79 4 33592 VEV_1_3_RA4_01_1235.d 0 1 1 271 277 Carbamylation
MTDLPGRK.V Y 16.43 916.4800 8 -24.2 306.4932 3 10.61 4 2695 VEV_1_3_RA4_01_1235.d 1.85E4 1 1 1 8
K.V(+42.01)TNVFSK.K Y 16.28 835.4440 7 -8.2 836.4444 1 92.30 6 52442 VEV_3_3_RA6_01_1237.d 0 1 1 54 60 Acetylation (N-term)
K.V(+42.01)FNQ(+.98)EFVVDER.Y Y 16.24 1423.6619 11 19.6 712.8522 2 47.72 6 22986 VEV_3_3_RA6_01_1237.d 1.83E5 1 1 12 22 Acetylation (Protein N-term); Deamidation (NQ)
K.VFK(+43.99)VFNQEFVVDER(+14.02).Y Y 15.90 1812.9045 14 -7.0 454.2302 4 22.72 5 9198 VEV_2_3_RA5_01_1236.d 0 1 1 9 22 Carboxylation (DKW); Methylation(KR)
K.VTN(+.98)VFSK(+14.02).K Y 15.24 808.4330 7 -16.3 405.2172 2 21.83 6 8518 VEV_3_3_RA6_01_1237.d 0 1 1 54 60 Deamidation (NQ); Methylation(KR)
total 45 peptides
C1G411
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ILSGEEDSLGDISTLSDPSVVAK.I Y 116.95 2331.1692 23 -11.4 1166.5786 2 81.15 6 45959 VEV_3_3_RA6_01_1237.d 1.45E5 3 3 626 648
R.YGTFEMGNIAWFLGGR.L Y 106.68 1817.8558 16 -2.2 909.9332 2 90.78 4 54100 VEV_1_3_RA4_01_1235.d 2.74E5 4 4 69 84
R.KILSGEEDSLGDISTLSDPSVVAK.I Y 100.76 2459.2642 24 -10.7 820.7532 3 78.31 6 43949 VEV_3_3_RA6_01_1237.d 4.69E4 1 1 625 648
R.NITYGELLKEVSR.L Y 97.94 1520.8198 13 -4.4 507.9450 3 76.92 4 44630 VEV_1_3_RA4_01_1235.d 3E5 2 2 117 129
K.GLMHTTGGYLVGAAATGK.Y Y 97.40 1703.8665 18 -9.9 568.9572 3 68.13 4 37739 VEV_1_3_RA4_01_1235.d 2.04E5 1 1 281 298
R.LNASYNC(+57.02)VDR.H Y 93.40 1210.5400 10 -6.2 606.2736 2 43.89 4 21108 VEV_1_3_RA4_01_1235.d 8.69E5 7 7 85 94 Carbamidomethylation
K.LYEESIRDPDTFWSR.L Y 88.55 1912.8955 15 -13.9 638.6302 3 76.03 4 43936 VEV_1_3_RA4_01_1235.d 1.42E5 2 2 38 52
K.GLYFTGDGAGR.D Y 88.24 1112.5250 11 -8.0 557.2653 2 62.57 4 33427 VEV_1_3_RA4_01_1235.d 4.07E5 3 3 503 513
R.GRVDDVVNVSGHR.L Y 85.59 1408.7170 13 -6.8 353.1841 4 41.25 4 19449 VEV_1_3_RA4_01_1235.d 9.9E5 9 9 523 535
R.VDDVVNVSGHR.L Y 84.47 1195.5945 11 1.9 598.8057 2 37.50 4 17257 VEV_1_3_RA4_01_1235.d 3.55E4 3 3 525 535
R.YMDTYFNVYK.G Y 78.75 1342.5903 10 -8.1 672.2970 2 75.68 4 43666 VEV_1_3_RA4_01_1235.d 3.52E5 4 4 493 502
R.TGADVPWTK.G Y 75.33 973.4869 9 -10.6 487.7455 2 55.70 4 28481 VEV_1_3_RA4_01_1235.d 5.56E5 4 4 231 239
K.AVFVVEDLPK.T Y 72.88 1115.6226 10 -11.2 558.8123 2 75.74 4 43705 VEV_1_3_RA4_01_1235.d 2.49E5 4 4 603 612
K.GLM(+15.99)HTTGGYLVGAAATGK.Y Y 69.08 1719.8613 18 -6.3 574.2908 3 61.32 4 32479 VEV_1_3_RA4_01_1235.d 2.23E5 2 2 281 298 Oxidation (M)
R.ELLTWERDFDTAR.Y Y 68.05 1650.8002 13 -9.2 551.2689 3 76.33 4 44166 VEV_1_3_RA4_01_1235.d 4.6E5 5 5 56 68
R.SRVVITTDEGKR.G Y 67.58 1359.7469 12 -6.8 340.9417 4 24.55 4 9876 VEV_1_3_RA4_01_1235.d 1.19E5 3 3 190 201
K.LALIYEADDPGEGR.N Y 64.75 1517.7361 14 -9.3 759.8683 2 73.05 4 41649 VEV_1_3_RA4_01_1235.d 3.17E5 4 4 103 116
R.VVITTDEGKR.G Y 58.90 1116.6139 10 2.8 559.3158 2 25.63 4 10467 VEV_1_3_RA4_01_1235.d 4.82E5 7 7 192 201
K.IVDEALKQC(+57.02)PDVNHC(+57.02)IVYKR.T Y 58.51 2456.2305 20 -8.5 615.0597 4 62.71 5 33567 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 211 230 Carbamidomethylation
R.YWDVIEKHEVTQFYVAPTALR.L Y 56.76 2564.3064 21 -13.0 855.7650 3 80.46 4 47374 VEV_1_3_RA4_01_1235.d 2.63E4 1 1 350 370
R.AGNQYIHHKLETLR.I Y 56.75 1678.8903 14 -10.6 420.7254 4 48.43 4 23886 VEV_1_3_RA4_01_1235.d 5.1E5 2 2 375 388
R.HAIKDPNKLALIYEADDPGEGR.N Y 52.93 2421.2288 22 1.8 485.2539 5 66.73 4 36631 VEV_1_3_RA4_01_1235.d 1.9E5 1 1 95 116
K.GLMHTTGGY(-2.02)LVGAAATGK.Y Y 51.34 1701.8508 18 15.3 568.2996 3 68.22 4 37809 VEV_1_3_RA4_01_1235.d 0 1 1 281 298 2-amino-3-oxo-butanoic_acid
K.IIDVYQATK.S Y 49.86 1049.5757 9 -11.2 525.7892 2 60.36 4 31755 VEV_1_3_RA4_01_1235.d 4.71E5 1 1 649 657
R.YGTFEM(+15.99)GNIAWFLGGR.L Y 48.08 1833.8508 16 4.0 917.9363 2 86.58 4 51648 VEV_1_3_RA4_01_1235.d 1.4E4 1 1 69 84 Oxidation (M)
R.VVITTDEGK.R Y 46.74 960.5128 9 -15.6 481.2562 2 31.66 4 13812 VEV_1_3_RA4_01_1235.d 7.33E4 3 3 192 200
R.NITYGELLKEVSR(+14.02).L Y 39.37 1534.8354 13 -7.5 512.6152 3 79.56 4 46679 VEV_1_3_RA4_01_1235.d 4.98E4 1 1 117 129 Methylation(KR)
R.VVITTDEGKRGGK.L Y 38.94 1358.7517 13 -16.9 340.6895 4 19.57 5 7504 VEV_2_3_RA5_01_1236.d 5.6E4 1 1 192 204
K.YVFDIHPTDR.F Y 37.86 1261.6091 10 -19.5 421.5355 3 66.27 4 36272 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 299 308
R.YWDVIEKHEVTQFYVAPTALR(-.98).L Y 37.83 2563.3223 21 -17.3 641.8268 4 80.44 4 47360 VEV_1_3_RA4_01_1235.d 0 1 1 350 370 Amidation
R.AGN(+.98)QYIHHKLETLR.I Y 34.97 1679.8743 14 -5.7 336.9802 5 48.54 4 23958 VEV_1_3_RA4_01_1235.d 5.07E4 1 1 375 388 Deamidation (NQ)
R.LNASYNC(+57.02)VDR(+14.02).H Y 33.47 1224.5557 10 2.5 613.2866 2 53.29 4 26981 VEV_1_3_RA4_01_1235.d 1.05E5 3 3 85 94 Carbamidomethylation; Methylation(KR)
R.LNASYN(+.98)C(+57.02)VDR.H Y 28.02 1211.5240 10 -5.0 606.7663 2 50.41 4 25131 VEV_1_3_RA4_01_1235.d 2.84E4 1 1 85 94 Deamidation (NQ); Carbamidomethylation
R.LAWVLK.Q Y 26.27 728.4585 6 -11.5 365.2323 2 70.94 4 39950 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 130 135
R.NITYGELLKEVSRLAWVLKQAGVK.K Y 26.04 2714.5483 24 -7.1 543.9131 5 91.39 4 54444 VEV_1_3_RA4_01_1235.d 5.74E4 1 1 117 140
K.LYEES(-18.01)IR.D Y 23.24 890.4498 7 -8.8 891.4492 1 109.11 5 58607 VEV_2_3_RA5_01_1236.d 0 1 1 38 44 Dehydration
R.T(+42.01)VWGAHK.R Y 22.92 839.4290 7 5.1 840.4406 1 98.64 6 54864 VEV_3_3_RA6_01_1237.d 0 1 1 485 491 Acetylation (N-term)
K.IVDEALK.Q Y 22.76 786.4487 7 -14.1 394.2261 2 35.59 4 16095 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 211 217
R.QVIEAHEVDTFHVPQAFLDKHPTR.T Y 21.44 2813.4248 24 -12.5 704.3547 4 84.39 4 50182 VEV_1_3_RA4_01_1235.d 4.99E4 1 1 3 26
R.SRVVITTDEGK.R Y 20.23 1203.6459 11 -20.8 402.2142 3 35.38 4 15968 VEV_1_3_RA4_01_1235.d 2.72E6 1 1 190 200
K.SIGPFAAPK(+43.99).A Y 20.16 930.4810 9 -4.8 311.1661 3 54.49 6 26937 VEV_3_3_RA6_01_1237.d 0 1 1 594 602 Carboxylation (DKW)
K.EVSRLAWVLKQAGVK.K Y 19.85 1682.9832 15 30.7 421.7660 4 37.61 6 17118 VEV_3_3_RA6_01_1237.d 0 1 1 126 140
K.L(+43.01)ETLR.I Y 19.53 673.3759 5 -4.2 337.6938 2 10.38 6 2648 VEV_3_3_RA6_01_1237.d 2.15E4 1 1 384 388 Carbamylation
K.GLMHTTGGYLVGAAATGK(-.98).Y Y 19.25 1702.8824 18 22.8 852.4679 2 68.19 4 37789 VEV_1_3_RA4_01_1235.d 0 1 1 281 298 Amidation
K.HPWPS(-18.01)MAR.T Y 18.84 962.4545 8 -5.9 482.2317 2 17.99 6 6505 VEV_3_3_RA6_01_1237.d 2.11E4 1 1 477 484 Dehydration
R.AGNQYIHHK.L Y 18.67 1066.5308 9 -41.8 534.2504 2 43.91 4 21119 VEV_1_3_RA4_01_1235.d 0 1 1 375 383
K.HPTRTHLKDLDEY(+31.99)KK.L Y 18.40 1911.9802 15 -16.5 956.9816 2 95.36 6 53739 VEV_3_3_RA6_01_1237.d 1.9E5 1 1 23 37 Dihydroxy
K.QAGVK(+21.98).K Y 18.04 523.2730 5 -50.6 524.2538 1 45.00 6 21408 VEV_3_3_RA6_01_1237.d 3.56E4 1 1 136 140 Sodium adduct
R.TGADVPWTK(-.98).G Y 17.61 972.5029 9 -11.3 487.2532 2 55.40 4 28274 VEV_1_3_RA4_01_1235.d 0 1 1 231 239 Amidation
K.LALIYE(+14.02)ADDPGEGR.N Y 17.57 1531.7518 14 -7.7 766.8773 2 76.39 4 44217 VEV_1_3_RA4_01_1235.d 0 1 1 103 116 Methylation(others)
R.DRVLDARSRVVITTDEGK.R Y 17.55 2029.0916 18 -12.8 508.2737 4 76.57 6 42681 VEV_3_3_RA6_01_1237.d 5.41E4 1 1 183 200
R.ELLTWER.D Y 17.43 945.4919 7 -19.1 473.7442 2 68.57 6 36818 VEV_3_3_RA6_01_1237.d 7.49E4 1 1 56 62
R.NIT(-2.02)YGELLKEVSR.L Y 17.38 1518.8042 13 11.2 507.2810 3 76.83 5 43895 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 117 129 2-amino-3-oxo-butanoic_acid
K.HEVTQFY(-94.04)VAPTALR.L Y 17.07 1536.8048 14 -17.1 385.2019 4 24.95 5 10455 VEV_2_3_RA5_01_1236.d 9.23E4 1 1 357 370 Dehydroalanine (Y)
R.T(+43.01)VWGAHKR.Y Y 16.94 996.5253 8 -21.2 333.1754 3 11.85 5 3368 VEV_2_3_RA5_01_1236.d 4.44E4 1 1 485 492 Carbamylation
K.GNDVEGVLAIK.H Y 16.87 1113.6029 11 -20.0 372.2008 3 43.15 6 20328 VEV_3_3_RA6_01_1237.d 1.25E4 1 1 466 476
K.SIGPFAAPK.A Y 16.59 886.4912 9 -31.4 887.4706 1 103.30 5 57057 VEV_2_3_RA5_01_1236.d 2.78E3 2 2 594 602
R.NIT(+79.97)YGE(+21.98)LLK.E Y 16.52 1151.5239 9 14.6 384.8542 3 66.77 6 35458 VEV_3_3_RA6_01_1237.d 1.81E4 1 1 117 125 Phosphorylation (STY); Sodium adduct
K.RT(-18.01)GADVPWTK.G Y 16.43 1111.5774 10 -44.3 556.7714 2 67.62 6 36097 VEV_3_3_RA6_01_1237.d 3.11E4 1 1 230 239 Dehydration
K.QAGVK.K Y 16.42 501.2911 5 -0.4 502.2982 1 33.65 4 14960 VEV_1_3_RA4_01_1235.d 0 1 1 136 140
K.LYEESIR.D Y 16.06 908.4603 7 29.5 455.2509 2 38.60 6 17692 VEV_3_3_RA6_01_1237.d 0 1 1 38 44
K.S(+42.01)IGPFAAPK(+14.02).A Y 15.71 942.5174 9 -51.7 315.1635 3 10.28 5 2628 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 594 602 Acetylation (N-term); Methylation(KR)
R.YM(+15.99)DTYFNVYK.G Y 15.66 1358.5853 10 -11.2 680.2923 2 70.13 6 37957 VEV_3_3_RA6_01_1237.d 1.01E4 1 1 493 502 Oxidation (M)
K.Q(+42.01)AGVK(+42.01).K Y 15.61 585.3122 5 -41.3 586.2953 1 72.51 4 41195 VEV_1_3_RA4_01_1235.d 0 1 1 136 140 Acetylation (N-term); Acetylation (K)
R.L(+42.01)LK(+31.99)RAGNQYIHHK.L Y 15.50 1650.8954 13 19.6 413.7392 4 65.94 4 36012 VEV_1_3_RA4_01_1235.d 0 1 1 371 383 Acetylation (N-term); Dihydroxy
R.D(+42.01)(-18.01)RVLDARSR.V Y 15.33 1110.5894 9 8.4 371.2068 3 75.72 4 43693 VEV_1_3_RA4_01_1235.d 3.13E4 1 1 183 191 Acetylation (N-term); Dehydration
R.VDDVVNVSGHR(-.98).L Y 15.27 1194.6105 11 -3.2 399.2095 3 17.57 5 6416 VEV_2_3_RA5_01_1236.d 5.44E4 1 1 525 535 Amidation
R.AGNQYIHHK(+226.08).L Y 15.20 1292.6084 9 -18.1 647.2998 2 40.83 4 19173 VEV_1_3_RA4_01_1235.d 4.82E4 1 1 375 383 Biotinylation
K.Q(+.98)AGVK(+42.01).K Y 15.02 544.2856 5 -22.6 545.2806 1 34.78 4 15622 VEV_1_3_RA4_01_1235.d 2.3E4 1 1 136 140 Deamidation (NQ); Acetylation (K)
total 69 peptides
C1G1D9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGSSDQHPDDAERGEQEKINLHSNLTAR.I Y 116.79 3090.4351 28 -10.9 619.0875 5 53.60 5 27356 VEV_2_3_RA5_01_1236.d 3.74E5 1 1 26 53
K.LGQDENSINEIR.R Y 113.86 1386.6738 12 -13.0 694.3351 2 58.26 6 29234 VEV_3_3_RA6_01_1237.d 1.23E6 6 6 624 635
R.TLEELDYIFAVPTR.R Y 101.38 1665.8613 14 -9.2 833.9303 2 86.70 5 50131 VEV_2_3_RA5_01_1236.d 1.79E5 3 3 576 589
R.DVKEFAQRFGLEDIIPTLQR.G Y 100.61 2374.2644 20 -7.8 792.4225 3 86.54 5 50045 VEV_2_3_RA5_01_1236.d 1.14E6 6 6 69 88
R.FGLEDIIPTLQR.G Y 99.91 1400.7664 12 -14.7 701.3801 2 87.53 5 50612 VEV_2_3_RA5_01_1236.d 2.43E6 12 12 77 88
R.TLEELDYIFAVPTRR.H Y 96.35 1821.9624 15 -12.8 608.3203 3 82.58 5 47714 VEV_2_3_RA5_01_1236.d 1.08E6 6 6 576 590
R.LQLGSAFIPAVPLAFGVYFC(+57.02)PESPR.W Y 94.78 2735.4146 25 -12.8 912.8004 3 95.90 6 53953 VEV_3_3_RA6_01_1237.d 3.26E5 4 4 297 321 Carbamidomethylation
R.IKNPLADIPKSTLMR.D Y 79.44 1695.9705 15 -14.2 566.3228 3 72.52 5 40880 VEV_2_3_RA5_01_1236.d 2.66E5 3 3 54 68
R.INKAYESLLSLR.N Y 79.33 1405.7928 12 -7.2 469.6015 3 73.43 5 41478 VEV_2_3_RA5_01_1236.d 3.49E5 4 4 329 340
K.DC(+57.02)VADAVVPEPQESEVMHK.S Y 79.03 2138.9612 19 -11.7 713.9860 3 69.14 6 37229 VEV_3_3_RA6_01_1237.d 2.36E5 3 3 7 25 Carbamidomethylation
K.DPSNFENVEGITEDEVEAIRNEVLHK.W Y 77.67 2982.4207 26 -13.4 746.6024 4 87.92 6 50175 VEV_3_3_RA6_01_1237.d 1.5E5 4 4 95 120
K.EFAQRFGLEDIIPTLQR.G Y 74.73 2032.0741 17 -17.2 678.3536 3 84.87 5 49105 VEV_2_3_RA5_01_1236.d 1.65E5 2 2 72 88
R.HMSYQLFTAVPYWFKR.Y Y 73.17 2073.0295 16 -0.5 519.2644 4 82.59 4 48940 VEV_1_3_RA4_01_1235.d 8.52E4 2 2 591 606
R.FFQLFTIPR.V Y 71.03 1167.6440 9 -14.4 584.8209 2 85.18 6 48576 VEV_3_3_RA6_01_1237.d 2.19E5 2 2 373 381
K.LGQDENS(+79.97)INEIR.R Y 68.00 1466.6403 12 -10.8 734.3195 2 61.66 6 31651 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 624 635 Phosphorylation (STY)
R.IKNPLADIPK.S Y 66.97 1107.6652 10 -16.3 370.2230 3 66.16 5 36207 VEV_2_3_RA5_01_1236.d 1.47E6 7 7 54 63
K.INLHSNLTAR.I Y 66.41 1137.6255 10 -11.3 569.8136 2 47.05 5 23359 VEV_2_3_RA5_01_1236.d 7.68E5 5 5 44 53
K.GKEKDDINRVLTQ Y 63.83 1514.8052 13 -9.2 758.4029 2 45.50 5 22428 VEV_2_3_RA5_01_1236.d 3.71E5 3 3 654 666
K.SGSSDQHPDDAERGEQEK.I Y 63.39 1970.8202 18 -12.7 657.9390 3 12.04 6 3414 VEV_3_3_RA6_01_1237.d 3.2E4 2 2 26 43
K.LGQDEN(+.98)SINEIR.R Y 63.26 1387.6580 12 -5.4 694.8325 2 60.67 5 32043 VEV_2_3_RA5_01_1236.d 2.56E5 4 4 624 635 Deamidation (NQ)
R.FGLEDIIPTLQ(+.98)R.G Y 61.55 1401.7504 12 -12.4 701.8738 2 88.63 5 51184 VEV_2_3_RA5_01_1236.d 2.7E5 3 3 77 88 Deamidation (NQ)
K.ASTVPIFC(+57.02)AENTPASVR.G Y 61.39 1818.8934 17 -9.5 910.4453 2 73.77 4 42179 VEV_1_3_RA4_01_1235.d 1.94E5 3 3 246 262 Carbamidomethylation
R.FGLEDIIPTLQR(+14.02).G Y 61.30 1414.7820 12 -14.9 472.5942 3 87.92 6 50181 VEV_3_3_RA6_01_1237.d 1.82E5 5 5 77 88 Methylation(KR)
R.FGLE(+14.02)DIIPTLQR.G Y 60.97 1414.7820 12 -13.6 708.3887 2 88.34 6 50426 VEV_3_3_RA6_01_1237.d 1.89E5 4 4 77 88 Methylation(others)
K.LGQDENSINEIR(+14.02).R Y 57.29 1400.6896 12 -9.7 701.3453 2 64.83 5 35146 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 624 635 Methylation(KR)
K.SGSS(+79.97)DQHPDDAERGEQEKINLHSNLTAR.I Y 57.27 3170.4014 28 -7.6 793.6016 4 57.61 5 29847 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 26 53 Phosphorylation (STY)
K.AYESLLSLR.N Y 56.09 1050.5709 9 -15.1 526.2848 2 74.70 5 42381 VEV_2_3_RA5_01_1236.d 8.18E5 5 5 332 340
K.LGQDENSIN(+.98)EIR.R Y 55.04 1387.6580 12 -11.0 694.8286 2 61.10 5 32377 VEV_2_3_RA5_01_1236.d 2.64E4 1 1 624 635 Deamidation (NQ)
R.MNVQLEPLYHFEK.L Y 51.95 1646.8126 13 -11.0 549.9388 3 76.20 4 44064 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 611 623
R.DVKEFAQR.F Y 51.74 991.5087 8 -10.6 496.7563 2 30.96 5 13800 VEV_2_3_RA5_01_1236.d 1.28E6 9 9 69 76
R.NHPIQAAR.D Y 49.61 905.4832 8 -12.9 453.7430 2 11.76 6 3280 VEV_3_3_RA6_01_1237.d 9.11E4 2 2 341 348
K.GKEKDDINRVLT(+79.97)Q Y 48.92 1594.7716 13 -15.1 532.5898 3 44.47 6 21099 VEV_3_3_RA6_01_1237.d 1.01E6 6 6 654 666 Phosphorylation (STY)
R.DLYYMHSQIQIEESVAGK.S Y 45.21 2110.0042 18 -6.4 704.3375 3 77.19 5 44162 VEV_2_3_RA5_01_1236.d 6.44E4 1 1 349 366
R.DVKEFAQRFGLE(+14.02)DIIPTLQR.G Y 37.29 2388.2800 20 -11.7 598.0703 4 86.91 5 50257 VEV_2_3_RA5_01_1236.d 2.69E5 1 1 69 88 Methylation(others)
K.LGQDE(+14.02)NSINEIR.R Y 35.75 1400.6896 12 -2.2 701.3505 2 63.48 4 34114 VEV_1_3_RA4_01_1235.d 9.2E4 1 1 624 635 Methylation(others)
R.NANVLKEK.G Y 35.62 914.5185 8 -13.2 458.2605 2 14.53 5 4771 VEV_2_3_RA5_01_1236.d 2.36E5 1 1 646 653
K.LGQ(+.98)DENSIN(+.98)EIR.R Y 32.16 1388.6420 12 2.2 695.3298 2 61.09 6 31224 VEV_3_3_RA6_01_1237.d 0 1 1 624 635 Deamidation (NQ)
R.IKN(+.98)PLADIPK.S Y 31.34 1108.6492 10 -7.2 370.5543 3 66.21 6 35041 VEV_3_3_RA6_01_1237.d 5.66E4 1 1 54 63 Deamidation (NQ)
R.RRS(+79.97)GEIAQSR.N Y 30.13 1238.5880 10 -8.5 413.8665 3 11.49 4 3072 VEV_1_3_RA4_01_1235.d 7.77E4 1 1 636 645 Phosphorylation (STY)
R.NANVLKEK(+14.02).G Y 25.98 928.5342 8 -16.3 465.2668 2 23.10 5 9392 VEV_2_3_RA5_01_1236.d 9.94E4 2 2 646 653 Methylation(KR)
R.IKNPLADIPK(+14.02).S Y 24.43 1121.6808 10 -12.2 374.8963 3 70.84 4 39877 VEV_1_3_RA4_01_1235.d 3.99E4 1 1 54 63 Methylation(KR)
K.AYESLLSLRNHPIQAAR.D Y 23.72 1938.0435 17 0.0 485.5181 4 68.48 5 37893 VEV_2_3_RA5_01_1236.d 2.74E4 1 1 332 348
R.DVKEFAQRFGLEDIIPTLQ(+.98)R.G Y 23.15 2375.2485 20 -13.0 594.8117 4 87.26 6 49808 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 69 88 Deamidation (NQ)
R.DVK(+14.02)EFAQRFGLEDIIPTLQR.G Y 22.85 2388.2800 20 -20.5 598.0651 4 86.30 5 49906 VEV_2_3_RA5_01_1236.d 6.46E4 1 1 69 88 Methylation(KR)
K.DC(+57.02)VADAVVPEPQ(+.98)ESEVMHK.S Y 22.45 2139.9453 19 25.4 714.3405 3 69.18 6 37252 VEV_3_3_RA6_01_1237.d 0 1 1 7 25 Carbamidomethylation; Deamidation (NQ)
R.LLMGIGMGAK.A Y 19.46 989.5402 10 -22.5 495.7662 2 72.35 5 40725 VEV_2_3_RA5_01_1236.d 0 1 1 236 245
R.DVKEFAQR(+14.02)FGLEDIIPTLQR.G Y 16.93 2388.2800 20 -25.6 598.0620 4 86.91 6 49609 VEV_3_3_RA6_01_1237.d 0 1 1 69 88 Methylation(KR)
M.ANGKKDC(+57.02)VADAVVPEPQESEVMHK.S Y 16.47 2637.2527 24 -14.1 660.3112 4 60.16 4 31602 VEV_1_3_RA4_01_1235.d 6.7E4 1 1 2 25 Carbamidomethylation
R.FGLEDIIPTLQ(+.98)R(+14.02).G Y 16.47 1415.7660 12 12.8 708.8994 2 88.05 5 50867 VEV_2_3_RA5_01_1236.d 0 1 1 77 88 Deamidation (NQ); Methylation(KR)
K.EK(+14.02)DDINRVLTQ(+.98) Y 16.11 1344.6885 11 -7.5 337.1769 4 17.69 5 6481 VEV_2_3_RA5_01_1236.d 0 1 1 656 666 Methylation(KR); Deamidation (NQ)
R.GEQEKINLHSNLTAR.I Y 15.99 1708.8856 15 44.1 428.2475 4 48.79 5 24411 VEV_2_3_RA5_01_1236.d 9.56E4 1 1 39 53
total 51 peptides
C1GCX5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YYGGNQHIDAIELTC(+57.02)QR.R Y 124.69 2036.9374 17 -4.4 679.9834 3 67.98 4 37619 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 74 90 Carbamidomethylation
R.AVFDALGSPMSNKYSEGYPGAR.Y Y 123.86 2316.0845 22 -7.6 773.0295 3 76.06 4 43959 VEV_1_3_RA4_01_1235.d 2.74E5 2 2 52 73
K.ISAVSTYFETFPYQVDLQTGIIDYDTLAK.N Y 120.60 3297.6333 29 -11.5 1100.2057 3 93.37 4 55484 VEV_1_3_RA4_01_1235.d 4.24E5 5 5 152 180
K.C(+57.02)LVAGTSAYC(+57.02)R.L Y 89.81 1256.5642 11 -10.0 629.2831 2 55.74 4 28502 VEV_1_3_RA4_01_1235.d 4.49E5 5 5 189 199 Carbamidomethylation
R.MREIADSVGAYLIVDMAHISGLIAAGVIPSPFEYADVVTTTTHK.S Y 88.89 4658.3765 44 -33.1 932.6517 5 97.55 4 57359 VEV_1_3_RA4_01_1235.d 9.72E3 1 1 206 249
K.KISAVSTYFETFPYQVDLQTGIIDYDTLAK.N Y 87.57 3425.7283 30 -6.5 1142.9093 3 89.86 4 53576 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 151 180
R.IANFIDKAINIC(+57.02)K.S Y 82.56 1518.8228 13 -11.2 507.2758 3 75.01 5 42594 VEV_2_3_RA5_01_1236.d 1.87E5 1 1 413 425 Carbamidomethylation
K.Q(-17.03)ANTPEFKQYQEQVLK.N Y 81.49 1932.9581 16 -7.4 967.4792 2 73.20 4 41746 VEV_1_3_RA4_01_1235.d 4.25E4 1 1 310 325 Pyro-glu from Q
K.DIAEWASTFPLPV Y 81.24 1444.7238 13 -4.9 723.3656 2 97.64 4 57401 VEV_1_3_RA4_01_1235.d 4.29E4 4 4 459 471
R.AVFDALGSPM(+15.99)SNKYSEGYPGAR.Y Y 70.58 2332.0793 22 -1.1 778.3662 3 71.79 4 40632 VEV_1_3_RA4_01_1235.d 3.39E4 1 1 52 73 Oxidation (M)
K.NSIPGDKSALSPGGIR.I Y 68.51 1567.8318 16 -16.0 523.6095 3 59.62 6 30167 VEV_3_3_RA6_01_1237.d 6.63E4 1 1 379 394
K.YSEGYPGAR.Y N 67.60 998.4457 9 -9.3 500.2255 2 32.68 4 14391 VEV_1_3_RA4_01_1235.d 3.12E5 6 6 65 73
K.VASETVPEILTLRK.D Y 58.41 1554.8981 14 -11.8 519.3005 3 72.33 4 41057 VEV_1_3_RA4_01_1235.d 2.84E5 2 2 445 458
K.C(+58.01)LVAGTSAYC(+57.02)R.L Y 55.19 1257.5482 11 14.0 629.7902 2 61.56 4 32651 VEV_1_3_RA4_01_1235.d 0 1 1 189 199 Carboxymethyl; Carbamidomethylation
R.YYGGNQHIDAIELTC(+57.02)QRR.A Y 54.88 2193.0386 18 1.4 732.0212 3 63.96 5 34513 VEV_2_3_RA5_01_1236.d 3.87E4 2 2 74 91 Carbamidomethylation
R.ALEAFKLDSSK.W Y 54.27 1207.6448 11 -14.7 403.5496 3 61.40 4 32534 VEV_1_3_RA4_01_1235.d 2.96E5 2 2 92 102
K.ALEHEFKK.L Y 53.79 1000.5341 8 -26.4 501.2611 2 18.62 6 6838 VEV_3_3_RA6_01_1237.d 1.23E5 3 3 329 336
R.IGAPAMTSR.G Y 53.10 902.4644 9 -12.4 452.2339 2 40.22 5 19239 VEV_2_3_RA5_01_1236.d 1.39E6 6 6 395 403
K.SVQSELPK.N Y 41.83 886.4760 8 -27.3 444.2332 2 38.46 4 17772 VEV_1_3_RA4_01_1235.d 0 4 4 426 433
K.QYQEQVLK.N Y 41.35 1034.5397 8 -10.3 518.2718 2 39.26 4 18253 VEV_1_3_RA4_01_1235.d 1.54E5 2 2 318 325
R.IANFIDK.A Y 40.46 819.4490 7 -18.2 410.7243 2 54.67 6 27013 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 413 419
R.GAMIFFR.K N 39.85 840.4316 7 -10.6 421.2186 2 74.69 4 42887 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 256 262
K.LVSDGTDSHMVLLDLTPK.A Y 37.48 1939.9924 18 -40.3 647.6454 3 79.25 4 46433 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 341 358
M.A(+42.01)TYALSLAHREQLEK.S Y 37.05 1770.9264 15 -15.8 591.3068 3 74.39 4 42711 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 2 16 Acetylation (Protein N-term)
K.SALSPGGIR.I Y 34.91 856.4766 9 -10.6 429.2411 2 42.71 4 20355 VEV_1_3_RA4_01_1235.d 1.13E6 8 8 386 394
K.C(+57.02)LVAGTSAYC(+57.02)RLIDYK.R Y 34.84 1888.9175 16 19.2 473.2457 4 67.08 4 36908 VEV_1_3_RA4_01_1235.d 2.16E5 1 1 189 204 Carbamidomethylation
R.AVFDALGSPMSNK.Y Y 33.86 1335.6493 13 -8.8 668.8260 2 73.32 4 41838 VEV_1_3_RA4_01_1235.d 1.46E6 3 3 52 64
R.A(+42.01)VFDALGSPMSN(+.98)K(+14.02)YSEGYPGAR.Y Y 32.75 2373.0947 22 -8.3 594.2761 4 66.57 6 35304 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 52 73 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
R.VEAVLEQINIAC(+57.02)NK.N Y 27.23 1599.8290 14 -9.2 534.2787 3 75.26 4 43328 VEV_1_3_RA4_01_1235.d 9.37E4 2 2 365 378 Carbamidomethylation
R.AVFDALGS(-2.02)PMSNKYSEGYPGAR.Y Y 25.14 2314.0688 22 53.9 772.4052 3 75.96 6 42255 VEV_3_3_RA6_01_1237.d 1.05E4 1 1 52 73 2-amino-3-oxo-butanoic_acid
K.SLVESDPEVAEIMR.K Y 21.99 1573.7657 14 -48.8 787.8517 2 77.13 6 43102 VEV_3_3_RA6_01_1237.d 5.92E4 1 1 17 30
K.SLRGPRGAMIFFR.K Y 20.97 1506.8241 13 -26.9 377.7032 4 58.36 5 30358 VEV_2_3_RA5_01_1236.d 5.44E4 1 1 250 262
R.ES(-2.02)VVLIASENFTSR.A Y 20.88 1548.7783 14 -19.1 775.3817 2 77.99 5 44706 VEV_2_3_RA5_01_1236.d 3.49E4 1 1 38 51 2-amino-3-oxo-butanoic_acid
R.GM(+15.99)GEEDFKR.I Y 20.09 1083.4655 9 23.3 542.7526 2 18.07 6 6552 VEV_3_3_RA6_01_1237.d 0 1 1 404 412 Oxidation (M)
R.LIDYKR.M Y 19.85 806.4650 6 -16.7 404.2331 2 25.47 4 10382 VEV_1_3_RA4_01_1235.d 2.49E5 3 3 200 205
K.AIN(+.98)IC(+57.02)KS(+79.97)VQSELPK(+14.02)NANK.L Y 19.66 2108.0337 18 -37.3 527.9960 4 66.95 5 36738 VEV_2_3_RA5_01_1236.d 0 1 1 420 437 Deamidation (NQ); Carbamidomethylation; Phosphorylation (STY); Methylation(KR)
R.GMGEEDFKR.I Y 19.05 1067.4706 9 -3.7 534.7406 2 31.77 4 13875 VEV_1_3_RA4_01_1235.d 0 1 1 404 412
R.KDIAEWASTFPLPV Y 18.44 1572.8187 14 1.8 394.2126 4 56.22 5 28903 VEV_2_3_RA5_01_1236.d 2.39E5 1 1 458 471
R.ALEAFK.L Y 15.41 677.3748 6 35.5 678.4061 1 99.76 6 55242 VEV_3_3_RA6_01_1237.d 4.95E3 1 1 92 97
R.EQLEK.S N 15.17 645.3333 5 33.1 646.3619 1 14.82 6 4847 VEV_3_3_RA6_01_1237.d 1.95E4 1 1 12 16
total 40 peptides
C1GF71
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AMSILNSFVNDIFERVATEASKLAAYNKK.S Y 130.91 3229.6804 29 -6.2 646.9393 5 95.44 5 54434 VEV_2_3_RA5_01_1236.d 1.01E6 7 7 73 101
R.AMSILNSFVNDIFER.V Y 120.68 1754.8661 15 -12.3 878.4296 2 92.21 6 52418 VEV_3_3_RA6_01_1237.d 1.46E6 8 8 73 87
R.AMSILNSFVNDIFERVATEASK.L Y 110.74 2441.2261 22 -35.4 814.7205 3 94.43 5 53994 VEV_2_3_RA5_01_1236.d 2.3E5 2 2 73 94
K.APVGGKAPAEKK.E Y 102.82 1151.6661 12 -13.0 576.8329 2 10.85 6 2845 VEV_3_3_RA6_01_1237.d 4.91E5 6 6 16 27
R.AM(+15.99)SILNSFVNDIFER.V Y 98.85 1770.8611 15 -5.9 886.4326 2 90.32 4 53898 VEV_1_3_RA4_01_1235.d 5.14E5 6 6 73 87 Oxidation (M)
R.KETYSSYIYK.V Y 94.61 1280.6288 10 -9.4 641.3157 2 51.82 4 26085 VEV_1_3_RA4_01_1235.d 1.76E6 11 11 49 58
K.KPSTAGKAPVGGK.A Y 94.37 1196.6876 13 -11.2 599.3444 2 11.33 5 3128 VEV_2_3_RA5_01_1236.d 3.63E5 8 8 9 21
K.HAVSEGTKAVTK.Y Y 88.71 1226.6619 12 -9.7 614.3323 2 13.86 5 4423 VEV_2_3_RA5_01_1236.d 2.2E4 1 1 124 135
K.QVHPDTGISNR.A Y 87.38 1222.6055 11 -16.4 408.5358 3 23.25 6 9305 VEV_3_3_RA6_01_1237.d 2.15E6 10 10 62 72
K.VLKQVHPDTGISNR.A Y 85.02 1562.8529 14 -9.0 521.9536 3 38.66 4 17906 VEV_1_3_RA4_01_1235.d 6.14E5 9 9 59 72
R.AMSILNSFVNDIFER(+14.02).V Y 84.70 1768.8817 15 -8.2 885.4409 2 93.18 4 55442 VEV_1_3_RA4_01_1235.d 5.75E5 3 3 73 87 Methylation(KR)
K.Q(-17.03)VHPDTGISNR.A Y 83.13 1205.5789 11 -11.6 603.7897 2 42.83 5 20855 VEV_2_3_RA5_01_1236.d 2.37E6 6 6 62 72 Pyro-glu from Q
R.VATEASKLAAYNKK.S Y 81.10 1492.8250 14 -9.9 498.6107 3 35.84 5 16679 VEV_2_3_RA5_01_1236.d 5.38E5 5 5 88 101
K.ETYSSYIYK.V Y 78.45 1152.5339 9 -11.7 577.2675 2 62.40 6 32201 VEV_3_3_RA6_01_1237.d 1.11E6 6 6 50 58
K.TRKETYSSYIYK.V Y 75.88 1537.7776 12 -7.0 513.5962 3 44.20 4 21319 VEV_1_3_RA4_01_1235.d 2.29E6 7 7 47 58
K.KPSTAGK(+42.01)APVGGK.A Y 72.74 1238.6982 13 -23.0 620.3422 2 20.61 5 8064 VEV_2_3_RA5_01_1236.d 1.95E4 1 1 9 21 Acetylation (K)
R.AM(+15.99)SILNSFVNDIFER(+14.02).V Y 70.11 1784.8767 15 -7.4 893.4390 2 91.23 4 54353 VEV_1_3_RA4_01_1235.d 6.93E4 1 1 73 87 Oxidation (M); Methylation(KR)
K.AAEKKPSTAGKAPVGGK.A Y 61.44 1595.8994 17 -11.0 532.9679 3 12.80 5 3860 VEV_2_3_RA5_01_1236.d 1.6E4 1 1 5 21
K.Q(-17.03)VHPDTGISN(+.98)R.A Y 49.93 1206.5629 11 -14.2 604.2802 2 46.70 6 22404 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 62 72 Pyro-glu from Q; Deamidation (NQ)
R.LILPGELAK.H Y 47.31 952.5957 9 -15.4 477.2978 2 71.79 5 40302 VEV_2_3_RA5_01_1236.d 1.16E6 4 4 115 123
R.AMSILNSFVNDIFER(+14.02)VATEASK.L Y 44.58 2455.2417 22 -6.5 819.4158 3 94.64 5 54073 VEV_2_3_RA5_01_1236.d 0 1 1 73 94 Methylation(KR)
K.KPSTAGKAPVGGKAPAEKK.E Y 43.89 1821.0471 19 -12.3 608.0155 3 13.78 5 4382 VEV_2_3_RA5_01_1236.d 7.02E4 3 3 9 27
R.AM(+15.99)SILNSFVNDIFERVATEASKLAAYNKK.S Y 37.73 3245.6753 29 -16.9 650.1313 5 93.98 4 55804 VEV_1_3_RA4_01_1235.d 0 1 1 73 101 Oxidation (M)
K.KPSTAGKAPVGGKAPAEK.K Y 35.38 1692.9521 18 91.4 424.2840 4 16.48 4 5556 VEV_1_3_RA4_01_1235.d 0 2 2 9 26
K.TRKETYSSYIYKVLK.Q Y 34.91 1878.0250 15 -6.5 470.5105 4 66.11 5 36109 VEV_2_3_RA5_01_1236.d 6.87E4 1 1 47 61
K.APVGGKAPAEK.K Y 29.23 1023.5712 11 -33.5 512.7758 2 13.41 6 4137 VEV_3_3_RA6_01_1237.d 1.29E5 2 2 16 26
K.AVTKYSSSAK Y 29.07 1040.5502 10 -30.8 521.2664 2 11.91 5 3397 VEV_2_3_RA5_01_1236.d 0 1 1 132 141
K.T(+42.01)AAAAGGDK.K Y 24.81 802.3821 9 18.6 803.4043 1 88.47 6 50497 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 33 41 Acetylation (N-term)
K.APAEK.K Y 24.36 514.2751 5 -29.6 515.2672 1 29.74 4 12703 VEV_1_3_RA4_01_1235.d 0 1 1 22 26
R.AM(+15.99)SILN(+.98)SFVNDIFER.V Y 23.86 1771.8451 15 16.2 886.9442 2 90.25 6 51438 VEV_3_3_RA6_01_1237.d 0 1 1 73 87 Oxidation (M); Deamidation (NQ)
K.KTAAAAGGDK.K Y 20.48 888.4664 10 -21.9 445.2307 2 14.81 5 4927 VEV_2_3_RA5_01_1236.d 0 1 1 32 41
K.STISSREIQTSVR.L Y 19.74 1462.7739 13 -12.6 488.5924 3 46.18 5 22834 VEV_2_3_RA5_01_1236.d 5.05E4 1 1 102 114
K.TAAAAGGDK.K Y 19.72 760.3715 9 5.4 761.3829 1 83.24 4 49386 VEV_1_3_RA4_01_1235.d 2.3E4 2 2 33 41
R.VATEASKLAAYNK.K Y 19.13 1364.7300 13 -35.1 342.1778 4 22.47 6 8861 VEV_3_3_RA6_01_1237.d 5.87E4 1 1 88 100
R.EIQ(+.98)TSVR.L Y 17.51 832.4290 7 -31.1 417.2088 2 22.69 6 8972 VEV_3_3_RA6_01_1237.d 3.89E4 1 1 108 114 Deamidation (NQ)
R.A(+56.06)MSILNSFVNDIFER.V Y 16.23 1810.9287 15 -18.5 906.4549 2 84.77 4 50426 VEV_1_3_RA4_01_1235.d 2.31E4 1 1 73 87 Diethylation
R.AMS(+14.02)ILNSFVNDIFER.V Y 16.09 1768.8817 15 -22.3 885.4284 2 90.12 4 53718 VEV_1_3_RA4_01_1235.d 6.73E4 1 1 73 87 Methylation(others)
K.APVGGK(+14.02)APAEK(+27.99)K.E Y 15.40 1193.6768 12 -49.6 597.8160 2 18.99 5 7198 VEV_2_3_RA5_01_1236.d 0 1 1 16 27 Methylation(KR); Formylation
R.LILPGELAK(+14.02).H Y 15.38 966.6113 9 -34.5 484.2963 2 74.54 6 41206 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 115 123 Methylation(KR)
K.APAEKKEAGK.K Y 15.00 1027.5662 10 -15.0 514.7827 2 64.61 6 33818 VEV_3_3_RA6_01_1237.d 2.51E4 1 1 22 31
total 40 peptides
C1GL73
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SNHTANNSTSTITATANDAR.Q Y 107.10 2045.9363 20 -8.9 682.9800 3 39.13 4 18211 VEV_1_3_RA4_01_1235.d 4.89E5 5 5 1923 1942
R.RYAGSTTSAGSLEDSFSAVDSK.T Y 105.38 2235.0291 22 -4.7 746.0134 3 68.17 4 37775 VEV_1_3_RA4_01_1235.d 1.89E5 3 3 108 129
R.GYLVAPPSLLAGLTSVK.G Y 100.00 1684.9763 17 -13.4 843.4841 2 87.30 6 49844 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 49 65
K.STGGVVISSISNAAAK.M Y 99.44 1460.7834 16 -12.4 731.3900 2 68.27 5 37740 VEV_2_3_RA5_01_1236.d 1.32E5 2 2 2054 2069
K.NHIYEDNSVINSSSITASR.A Y 95.08 2105.9978 19 2.3 703.0082 3 65.20 6 34271 VEV_3_3_RA6_01_1237.d 9.43E4 2 2 2124 2142
R.NNPTSLHNVAQTKR.I Y 91.19 1578.8226 14 -12.9 527.2747 3 25.45 5 10740 VEV_2_3_RA5_01_1236.d 4.15E5 5 5 589 602
R.TVGVGALEIGSLLK.Q Y 86.75 1355.8024 14 -11.1 678.9009 2 83.62 5 48328 VEV_2_3_RA5_01_1236.d 4.9E4 1 1 506 519
R.TVSGGTHGNN(+.98)GNNNVTSASNAHPVTSER.L Y 78.12 2779.2505 28 -0.8 695.8193 4 35.62 5 16544 VEV_2_3_RA5_01_1236.d 1.86E5 2 2 2076 2103 Deamidation (NQ)
K.TDGADAVSVTPSR.A Y 77.53 1274.6102 13 -9.6 638.3063 2 44.30 5 21743 VEV_2_3_RA5_01_1236.d 3.1E5 4 4 1962 1974
R.TVSGGTHGNNGNNNVTSASNAHPVTSER.L Y 74.99 2778.2666 28 -6.8 695.5692 4 32.20 5 14531 VEV_2_3_RA5_01_1236.d 4.28E4 1 1 2076 2103
K.NSSPISAPATSTEDIR.T Y 73.99 1644.7954 16 -13.9 823.3936 2 62.45 6 32235 VEV_3_3_RA6_01_1237.d 9.81E4 2 2 2006 2021
R.NENNVSSPYNTEK.S Y 72.28 1494.6587 13 -2.2 748.3350 2 32.71 4 14406 VEV_1_3_RA4_01_1235.d 7.5E4 2 2 2041 2053
R.C(+57.02)LALYSRPAYQATQAELTR.R Y 69.93 2211.1106 19 5.8 738.0484 3 71.98 5 40442 VEV_2_3_RA5_01_1236.d 1.99E5 2 2 1815 1833 Carbamidomethylation
R.NNPTSLHNVAQTK.R Y 67.37 1422.7216 13 -9.5 712.3613 2 29.91 5 13208 VEV_2_3_RA5_01_1236.d 1.5E5 3 3 589 601
R.LLTGDDSATELTK.L Y 65.58 1362.6879 13 -8.4 682.3455 2 63.63 6 33102 VEV_3_3_RA6_01_1237.d 7.45E4 1 1 293 305
R.LLQATPDSQQSR.N Y 64.94 1342.6841 12 -9.0 672.3433 2 39.08 5 18576 VEV_2_3_RA5_01_1236.d 2.76E5 3 3 907 918
R.SLSQSSDSVTAKPNKPDTPGKEPTVIR.T Y 64.28 2838.4722 27 -7.2 947.1579 3 56.01 5 28767 VEV_2_3_RA5_01_1236.d 2.55E5 3 3 479 505
K.TIYTTAEPFPNILR.R Y 61.30 1634.8668 14 -12.0 818.4309 2 81.45 5 47028 VEV_2_3_RA5_01_1236.d 4.37E4 2 2 1685 1698
R.GAYLSLPWSALGK.N Y 59.97 1361.7343 13 -4.3 681.8715 2 83.97 6 47809 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 759 771
R.GSGLEVGKEPSR.S Y 56.78 1214.6255 12 -9.6 608.3142 2 31.03 4 13470 VEV_1_3_RA4_01_1235.d 5.97E5 7 7 467 478
K.NSSPISAPATSTEDIRTTQQR.I Y 52.08 2259.1091 21 -2.9 754.0415 3 59.90 5 31476 VEV_2_3_RA5_01_1236.d 6E4 3 3 2006 2026
K.IYDQIVKDTNPPQR.Y Y 51.22 1685.8737 14 5.3 562.9681 3 60.18 5 31678 VEV_2_3_RA5_01_1236.d 4.24E4 3 3 1554 1567
K.Q(-17.03)FNFPFATSC(+57.02)LIR.S Y 49.16 1582.7603 13 -9.7 792.3798 2 92.92 5 53303 VEV_2_3_RA5_01_1236.d 1E5 2 2 890 902 Pyro-glu from Q; Carbamidomethylation
R.APVDGSANANTGGGGGGVRDSVMKR.L Y 48.54 2329.1191 25 -19.7 777.3650 3 45.79 5 22596 VEV_2_3_RA5_01_1236.d 3.23E4 1 1 2143 2167
K.GLGFPTSLRDKQYIFEGSPTDR.M Y 46.36 2483.2444 22 9.8 621.8245 4 76.98 5 44002 VEV_2_3_RA5_01_1236.d 0 1 1 1575 1596
R.IGFTGAPTKPR.S Y 46.22 1143.6400 11 15.3 572.8361 2 46.62 5 23135 VEV_2_3_RA5_01_1236.d 1.35E5 4 4 603 613
R.VFSGIFPK.N Y 44.49 893.5010 8 -13.2 447.7519 2 71.62 5 40238 VEV_2_3_RA5_01_1236.d 1.15E5 2 2 73 80
R.SDIYITINR.A Y 43.27 1093.5768 9 -16.8 547.7865 2 66.84 5 36657 VEV_2_3_RA5_01_1236.d 3.36E5 2 2 614 622
K.IPNPTPLLLKDEDLALFLTQSLQTHK.S Y 42.07 2944.6272 26 9.5 737.1711 4 89.89 5 51822 VEV_2_3_RA5_01_1236.d 3.53E4 2 2 1157 1182
R.TSDANDQYRDQVR.L Y 41.68 1566.7023 13 -7.3 523.2375 3 24.68 4 9941 VEV_1_3_RA4_01_1235.d 1.36E5 3 3 1065 1077
R.ISLNPFKR.S Y 40.92 973.5709 8 -19.1 325.5247 3 65.33 5 35556 VEV_2_3_RA5_01_1236.d 1.55E5 2 2 1915 1922
R.DGSFSNKVSSSLNSAGK.G Y 38.96 1683.8064 17 -13.5 562.2685 3 59.30 4 30961 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 434 450
R.NAAGVRLEHC(+57.02)IYPSSNGPGQTAWR.T Y 38.05 2640.2615 24 -14.3 661.0632 4 68.13 6 36493 VEV_3_3_RA6_01_1237.d 2.88E4 1 1 658 681 Carbamidomethylation
R.QQDNPSHTK.H Y 34.39 1053.4839 9 -18.9 527.7393 2 9.73 5 2408 VEV_2_3_RA5_01_1236.d 2.1E4 1 1 1895 1903
R.GSPWNQSIR.L Y 33.68 1043.5148 9 -9.7 522.7596 2 55.47 5 28444 VEV_2_3_RA5_01_1236.d 2.95E5 2 2 688 696
K.MLSGEVVVRDPK.Q Y 26.66 1328.7122 12 -23.9 333.1774 4 53.78 6 26522 VEV_3_3_RA6_01_1237.d 0 1 1 277 288
K.TDGADAVSVTPSR(+14.02).A Y 25.26 1288.6259 13 -30.7 645.3004 2 50.79 5 25673 VEV_2_3_RA5_01_1236.d 4.97E3 1 1 1962 1974 Methylation(KR)
K.G(+43.01)LGFPTSLR.D Y 23.01 989.5294 9 -10.8 330.8469 3 40.87 4 19201 VEV_1_3_RA4_01_1235.d 4.15E5 2 2 1575 1583 Carbamylation
R.IDAPPK.T Y 22.92 639.3591 6 -77.1 640.3171 1 73.97 4 42332 VEV_1_3_RA4_01_1235.d 6.54E4 3 3 421 426
R.NEN(+.98)NVSSPYNT(-18.01)EKSTGGVVISSISNAAAK.M Y 22.89 2920.4050 29 38.1 731.1364 4 68.20 5 37691 VEV_2_3_RA5_01_1236.d 0 1 1 2041 2069 Deamidation (NQ); Dehydration
R.TLEAR.V Y 22.67 588.3231 5 -40.0 589.3069 1 69.57 5 38675 VEV_2_3_RA5_01_1236.d 0 1 1 68 72
R.SMM(+15.99)WGHKSRGSGLEVGK.E Y 22.33 1861.8927 17 49.0 466.5033 4 60.17 5 31674 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 458 474 Oxidation (M)
K.VQSTFNRDLHFIFQSVESLMQNPSPILVGSK.T Y 21.96 3517.8027 31 -10.1 880.4490 4 95.80 4 56657 VEV_1_3_RA4_01_1235.d 1.69E5 1 1 953 983
K.GLGFPTSLR.D Y 21.92 946.5236 9 -21.3 474.2590 2 72.13 6 39458 VEV_3_3_RA6_01_1237.d 7.82E4 1 1 1575 1583
R.IDAPPKTR.S Y 21.87 896.5079 8 -22.2 449.2513 2 51.52 4 25844 VEV_1_3_RA4_01_1235.d 0 1 1 421 428
K.TAMGGTATSSQNNHGK.N Y 21.43 1560.6951 16 16.0 521.2473 3 12.30 4 3438 VEV_1_3_RA4_01_1235.d 0 1 1 2108 2123
R.RSRTRGGDTPSK.R Y 20.70 1316.6909 12 4.4 330.1815 4 17.10 4 5882 VEV_1_3_RA4_01_1235.d 9.31E4 2 2 1979 1990
R.GNKMLSGEVVVRDPK.Q Y 20.39 1627.8716 15 15.1 407.9813 4 58.86 4 30624 VEV_1_3_RA4_01_1235.d 2.05E5 1 1 274 288
K.DEDLALFLTQSLQTHK.S Y 20.20 1857.9473 16 -11.4 929.9703 2 87.74 6 50081 VEV_3_3_RA6_01_1237.d 0 1 1 1167 1182
K.VSSSLNSAGK.G Y 20.15 948.4876 10 9.6 475.2556 2 12.27 6 3538 VEV_3_3_RA6_01_1237.d 4.97E4 3 3 441 450
R.T(-2.02)VGVGALEIGSLLK.Q Y 19.83 1353.7867 14 -87.4 677.8415 2 83.71 6 47641 VEV_3_3_RA6_01_1237.d 8.7E4 1 1 506 519 2-amino-3-oxo-butanoic_acid
R.GRLLTGDDSATELTK.L Y 19.79 1575.8104 15 12.6 526.2841 3 60.96 5 32263 VEV_2_3_RA5_01_1236.d 0 1 1 291 305
K.QANGDTR.Q Y 19.40 760.3464 7 -50.5 761.3152 1 46.87 5 23245 VEV_2_3_RA5_01_1236.d 5.76E4 2 2 354 360
K.NESAK.D N 19.28 547.2602 5 -0.5 548.2672 1 50.46 5 25417 VEV_2_3_RA5_01_1236.d 0 1 1 772 776
R.M(+15.99)ATFTDR.M Y 18.82 856.3749 7 -1.6 429.1940 2 22.82 5 9250 VEV_2_3_RA5_01_1236.d 2.97E4 1 1 1597 1603 Oxidation (M)
K.SFPFQLK.Q Y 18.78 865.4697 7 -14.0 433.7361 2 74.03 6 40837 VEV_3_3_RA6_01_1237.d 8.27E4 1 1 1126 1132
K.QYIFEGSPTDRMATFTDR.M Y 17.75 2133.9790 18 32.9 712.3570 3 67.12 4 36936 VEV_1_3_RA4_01_1235.d 5.86E4 1 1 1586 1603
K.VQSTFNR.D Y 17.29 850.4297 7 -53.3 851.3916 1 99.90 5 56002 VEV_2_3_RA5_01_1236.d 4.39E4 1 1 953 959
K.ASMAK.I Y 16.97 506.2523 5 1.7 507.2604 1 25.41 4 10346 VEV_1_3_RA4_01_1235.d 0 1 1 1549 1553
K.IAGDVR.E Y 16.81 629.3497 6 -57.0 630.3210 1 45.61 6 21765 VEV_3_3_RA6_01_1237.d 0 1 1 1267 1272
K.M(+15.99)SQITIIKLEEDGTRRR.S Y 16.46 2061.1001 17 2.7 516.2837 4 78.05 5 44746 VEV_2_3_RA5_01_1236.d 2.59E4 1 1 145 161 Oxidation (M)
R.LSTEPVPR.R Y 16.31 897.4919 8 0.4 449.7534 2 38.74 4 17960 VEV_1_3_RA4_01_1235.d 0 1 1 100 107
R.IDAPPKTR(+.98).S Y 15.72 897.4919 8 -18.9 449.7448 2 71.10 6 38685 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 421 428 Deamidation (R)
R.SRTRGGDTPSK.R Y 15.69 1160.5897 11 -24.0 581.2882 2 42.28 6 19821 VEV_3_3_RA6_01_1237.d 0 1 1 1980 1990
total 64 peptides
C1GHE4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HGYIGEFEEVDDHR.S Y 138.29 1701.7383 14 -9.6 568.2479 3 62.72 4 33541 VEV_1_3_RA4_01_1235.d 7.1E5 4 4 44 57
M.VKTSVLNDALNAINNAEK.S Y 122.20 1913.0217 18 -8.8 957.5097 2 78.73 5 45200 VEV_2_3_RA5_01_1236.d 2.13E6 8 8 2 19
K.TSVLNDALNAINNAEK.S Y 121.21 1685.8584 16 -10.4 843.9277 2 82.29 5 47525 VEV_2_3_RA5_01_1236.d 5.35E5 6 6 4 19
K.LLPSRQFGYIVLTTSAGIMDHEEAR.R Y 98.91 2803.4326 25 -1.0 701.8647 4 84.17 5 48673 VEV_2_3_RA5_01_1236.d 3.24E5 3 3 93 117
M.VKTSVLNDALNAINNAEKSGKR.Q Y 87.43 2341.2712 22 -14.1 469.2549 5 75.38 5 42863 VEV_2_3_RA5_01_1236.d 7.2E5 3 3 2 23
R.QFGYIVLTTSAGIMDHEEAR.R Y 84.84 2237.0786 20 -16.8 746.6876 3 83.34 4 49489 VEV_1_3_RA4_01_1235.d 2.01E5 2 2 98 117
K.TSVLNDALNAINNAEK(+14.02).S Y 82.96 1699.8740 16 -14.4 850.9321 2 86.11 6 49157 VEV_3_3_RA6_01_1237.d 3.32E5 3 3 4 19 Methylation(KR)
K.HGYIGEFEEVDDHRSGK.I Y 77.43 1973.8867 17 -30.2 395.7727 5 58.34 6 29258 VEV_3_3_RA6_01_1237.d 3.23E5 5 5 44 60
R.Q(-17.03)FGYIVLTTSAGIMDHEEAR.R Y 75.62 2220.0520 20 -9.1 1111.0232 2 90.15 5 51959 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 98 117 Pyro-glu from Q
R.YNVQLRDLEK.W Y 73.68 1276.6775 10 -13.1 426.5609 3 61.71 4 32763 VEV_1_3_RA4_01_1235.d 1.05E6 5 5 79 88
K.VIGFFY Y 73.25 744.3846 6 -18.1 745.3784 1 86.13 6 49147 VEV_3_3_RA6_01_1237.d 8.53E5 1 1 125 130
M.VKTSVLNDALNAINNAEK(+14.02).S Y 71.23 1927.0375 18 -24.3 964.5026 2 82.47 4 48869 VEV_1_3_RA4_01_1235.d 8E5 5 5 2 19 Methylation(KR)
R.Q(-17.03)VLIRPSSK.V Y 71.07 1009.5920 9 -11.1 505.7976 2 56.12 4 28710 VEV_1_3_RA4_01_1235.d 2.34E6 4 4 24 32 Pyro-glu from Q
R.YNVQLRDLEKWVVK.L Y 62.32 1788.9886 14 -15.6 597.3275 3 78.60 5 45115 VEV_2_3_RA5_01_1236.d 7.7E5 5 5 79 92
R.LNKTGVISPR.Y Y 62.27 1083.6400 10 -26.0 542.8132 2 30.75 5 13700 VEV_2_3_RA5_01_1236.d 1.85E5 5 5 69 78
R.Q(-17.03)VLIRPSSK(+14.02).V Y 61.27 1023.6077 9 -19.5 512.8011 2 59.83 4 31361 VEV_1_3_RA4_01_1235.d 6.84E4 1 1 24 32 Pyro-glu from Q; Methylation(KR)
R.QVLIRPSSK.V Y 57.80 1026.6185 9 -21.0 514.3058 2 28.78 4 12204 VEV_1_3_RA4_01_1235.d 7.43E5 6 6 24 32
R.Q(-17.03)FGYIVLTTSAGIMDHEEAR(+14.02).R Y 57.50 2234.0676 20 -0.5 1118.0405 2 92.82 4 55203 VEV_1_3_RA4_01_1235.d 3.52E5 4 4 98 117 Pyro-glu from Q; Methylation(KR)
K.HVAGKVIGFFY Y 55.08 1236.6655 11 -14.0 413.2233 3 76.23 5 43465 VEV_2_3_RA5_01_1236.d 1.78E5 2 2 120 130
M.VKTSVLNDALNAIN(+.98)NAEK.S Y 54.36 1914.0057 18 -6.7 639.0049 3 79.62 4 46729 VEV_1_3_RA4_01_1235.d 4.5E5 1 1 2 19 Deamidation (NQ)
K.IVIQLNGR.L Y 53.97 911.5552 8 -9.6 456.7805 2 61.70 5 32806 VEV_2_3_RA5_01_1236.d 7.69E5 4 4 61 68
R.YNVQLR.D Y 46.19 791.4290 6 -10.8 396.7175 2 43.99 4 21130 VEV_1_3_RA4_01_1235.d 1.51E6 8 8 79 84
K.TGVISPR.Y Y 46.09 728.4181 7 -11.6 365.2121 2 25.36 4 10313 VEV_1_3_RA4_01_1235.d 3.7E6 11 11 72 78
K.RQVLIRPSSK.V Y 45.58 1182.7196 10 -12.2 395.2423 3 25.28 4 10273 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 23 32
K.VIGFFY(+14.02) Y 44.35 758.4003 6 -10.2 759.3998 1 90.02 4 53659 VEV_1_3_RA4_01_1235.d 2.5E5 2 2 125 130 Methylation(C-term)
K.FLSVM(+15.99)QK.H Y 41.20 867.4524 7 -9.2 434.7295 2 43.25 4 20708 VEV_1_3_RA4_01_1235.d 4.78E5 3 3 37 43 Oxidation (M)
R.SGKIVIQLNGR.L Y 38.64 1183.7036 11 -39.9 592.8354 2 53.95 4 27412 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 58 68
M.VKTSVLN(+.98)DALNAINNAEK(+14.02).S Y 36.53 1928.0215 18 -3.9 643.6786 3 82.53 5 47667 VEV_2_3_RA5_01_1236.d 2.2E5 1 1 2 19 Deamidation (NQ); Methylation(KR)
K.TS(-2.02)VLNDALNAINNAEK.S Y 35.38 1683.8428 16 -48.2 842.8881 2 82.23 5 47491 VEV_2_3_RA5_01_1236.d 0 1 1 4 19 2-amino-3-oxo-butanoic_acid
K.IVIQLN(+.98)GR.L Y 34.33 912.5392 8 -13.2 457.2709 2 65.23 5 35452 VEV_2_3_RA5_01_1236.d 2.39E5 3 3 61 68 Deamidation (NQ)
K.IVIQLNGRLNK.T Y 33.22 1266.7772 11 -23.4 423.2565 3 63.76 4 34358 VEV_1_3_RA4_01_1235.d 3.73E5 2 2 61 71
K.TGVISPR(+14.02).Y Y 31.04 742.4337 7 -20.4 372.2166 2 33.18 6 14621 VEV_3_3_RA6_01_1237.d 2.27E5 1 1 72 78 Methylation(KR)
M.VKTSVLNDALNAINNAEK(+28.03).S Y 30.85 1941.0531 18 14.9 648.0346 3 83.57 4 49617 VEV_1_3_RA4_01_1235.d 0 1 1 2 19 Dimethylation(KR)
K.IVIQLN(+.98)GRLNK.T Y 30.26 1267.7612 11 -14.4 423.5883 3 68.54 5 37930 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 61 71 Deamidation (NQ)
M.V(+43.01)K(+14.02)TSVLNDALNAINNAEK.S Y 30.00 1970.0432 18 -14.4 657.6789 3 79.47 6 44778 VEV_3_3_RA6_01_1237.d 2.31E4 1 1 2 19 Carbamylation; Methylation(KR)
R.YNVQLRDLEKWVVKLLPSR.Q Y 23.30 2355.3425 19 8.7 472.0799 5 87.35 4 52101 VEV_1_3_RA4_01_1235.d 3.56E4 1 1 79 97
R.QFGY(-18.01)IVLTTSAGIMDHEEAR(+14.02).R Y 22.76 2233.0837 20 -15.2 1117.5322 2 91.54 5 52662 VEV_2_3_RA5_01_1236.d 2.84E4 1 1 98 117 Dehydration; Methylation(KR)
R.DLEKWVVK.L Y 18.12 1015.5702 8 -15.1 339.5256 3 64.92 4 35243 VEV_1_3_RA4_01_1235.d 1.87E5 1 1 85 92
R.L(+42.01)NKTGVISPR.Y Y 16.55 1125.6506 10 -45.3 376.2072 3 30.93 4 13373 VEV_1_3_RA4_01_1235.d 5.18E5 1 1 69 78 Acetylation (N-term)
total 39 peptides
C1GEM8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IYQPPVEEDDEHAAQHAR.S Y 138.42 2103.9609 18 -16.2 526.9890 4 49.90 6 24239 VEV_3_3_RA6_01_1237.d 2.82E6 19 19 205 222
R.LTVIDTPGFGDYVNNR.D Y 114.27 1779.8792 16 -6.2 594.2966 3 79.14 4 46350 VEV_1_3_RA4_01_1235.d 3.02E5 4 4 92 107
M.APPTSETASPIGIANLPNQR.H Y 94.36 2033.0541 20 -9.6 1017.5245 2 73.19 5 41307 VEV_2_3_RA5_01_1236.d 1.22E5 3 3 2 21
K.TTFINTLFSTTIK.N Y 89.61 1485.8079 13 -13.1 743.9015 2 84.73 6 48283 VEV_3_3_RA6_01_1237.d 1.5E5 2 2 45 57
R.THMLDLIHTTEESHYEAYR.A Y 89.60 2345.0747 19 -9.3 470.0179 5 71.38 4 40302 VEV_1_3_RA4_01_1235.d 2.98E5 2 2 277 295
K.TTFINTLFSTTIKNYADHK.R Y 88.23 2214.1321 19 -15.6 554.5317 4 81.94 6 46500 VEV_3_3_RA6_01_1237.d 4.92E5 3 3 45 63
R.VNLIPVVAK.A Y 86.42 951.6117 9 -20.4 476.8034 2 71.29 6 38873 VEV_3_3_RA6_01_1237.d 1.31E6 4 4 170 178
K.ADTLSPSDLAR.F Y 85.45 1144.5724 11 -16.2 573.2842 2 61.97 6 31922 VEV_3_3_RA6_01_1237.d 2.52E6 9 9 179 189
K.IYQPPVE(+14.02)EDDEHAAQHAR.S Y 83.27 2117.9766 18 -9.4 530.4965 4 56.67 4 29073 VEV_1_3_RA4_01_1235.d 5.81E5 2 2 205 222 Methylation(others)
R.FTEQVKIEEQR.F Y 80.76 1405.7201 11 -20.0 469.5713 3 49.94 6 24299 VEV_3_3_RA6_01_1237.d 1.17E6 10 10 328 338
R.IRGVIEAQGIK.I Y 77.57 1182.7084 11 -17.4 395.2365 3 53.28 4 26966 VEV_1_3_RA4_01_1235.d 1.57E5 8 8 194 204
R.LSSRVNLIPVVAK.A Y 70.41 1394.8608 13 -12.7 465.9550 3 69.35 5 38519 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 166 178
R.SLMAAMPFSVIGSEKDVK.T Y 64.43 1908.9689 18 -17.4 955.4751 2 80.50 4 47401 VEV_1_3_RA4_01_1235.d 6.38E5 3 3 223 240
K.Q(-17.03)VDKTVEIEITKAELEEKFFK.V Y 60.84 2506.3206 21 -10.6 627.5807 4 83.04 4 49252 VEV_1_3_RA4_01_1235.d 3.26E4 1 1 69 89 Pyro-glu from Q
K.Q(-17.03)LEQELETMQGSAVR.S Y 57.73 1700.8040 15 -6.6 851.4036 2 83.17 5 48058 VEV_2_3_RA5_01_1236.d 1.97E4 1 1 366 380 Pyro-glu from Q
K.ADTLSPSDLAR(+14.02).F Y 48.22 1158.5880 11 -7.8 580.2968 2 66.54 4 36484 VEV_1_3_RA4_01_1235.d 2.37E5 2 2 179 189 Methylation(KR)
R.GVIEAQGIK.I Y 44.62 913.5233 9 -11.4 457.7637 2 46.65 4 22790 VEV_1_3_RA4_01_1235.d 1.02E6 5 5 196 204
K.FGEARPR.K Y 44.35 831.4351 7 -13.4 416.7192 2 16.26 5 5695 VEV_2_3_RA5_01_1236.d 3E5 3 3 304 310
K.TTFINTLFSTTIKNYADHKR.R Y 43.38 2370.2332 20 -35.4 475.0371 5 79.67 4 46764 VEV_1_3_RA4_01_1235.d 0 2 2 45 64
K.FKEEEENLR.K Y 41.93 1192.5724 9 -8.7 597.2883 2 31.98 5 14411 VEV_2_3_RA5_01_1236.d 4.63E5 2 2 317 325
K.I(+41.03)YQPPVEEDDEHAAQHAR.S Y 41.59 2144.9875 18 19.0 537.2643 4 50.09 4 24941 VEV_1_3_RA4_01_1235.d 0 1 1 205 222 Amidination of lysines or N-terminal amines with methyl acetimidate
R.SLMAAMPFSVIGSEK.D Y 41.54 1566.7786 15 -13.0 523.2600 3 56.48 5 29068 VEV_2_3_RA5_01_1236.d 7.29E5 2 2 223 237
K.DLESTHAAIK.Q Y 34.51 1083.5560 10 -17.6 542.7758 2 33.07 6 14569 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 356 365
R.IRGVIEAQGIK(+43.01).I Y 30.01 1225.7142 11 -6.5 409.5760 3 52.98 5 26975 VEV_2_3_RA5_01_1236.d 6.61E4 1 1 194 204 Carbamylation
R.ALQMETRK.F Y 27.88 975.5172 8 -14.7 488.7587 2 18.03 5 6674 VEV_2_3_RA5_01_1236.d 2.77E4 1 1 296 303
R.KFGEARPR.K Y 27.55 959.5300 8 -12.8 480.7661 2 14.15 5 4574 VEV_2_3_RA5_01_1236.d 8.65E4 1 1 303 310
R.RVDKIDLR.V Y 25.92 1013.5981 8 -17.3 338.8675 3 29.94 4 12813 VEV_1_3_RA4_01_1235.d 4.14E5 2 2 133 140
K.LDNPK.F N 24.88 585.3122 5 -41.4 586.2952 1 75.87 4 43818 VEV_1_3_RA4_01_1235.d 4.79E4 4 4 312 316
R.LNKDLESTHAAIKQLEQELETMQGSAVR.S Y 24.08 3138.5979 28 -44.6 628.6989 5 82.97 4 49201 VEV_1_3_RA4_01_1235.d 0 1 1 353 380
R.SILIR.T N 23.63 600.3959 5 -15.3 301.2006 2 43.37 5 21131 VEV_2_3_RA5_01_1236.d 3.69E5 6 6 272 276
R.FRQWEQK.L Y 23.34 1020.5141 7 -18.4 511.2549 2 28.39 5 12341 VEV_2_3_RA5_01_1236.d 2E5 2 2 339 345
K.IYQPPVEEDDEHAAQHAR(+14.02).S Y 22.05 2117.9766 18 -3.5 706.9970 3 56.46 5 29056 VEV_2_3_RA5_01_1236.d 1.7E5 1 1 205 222 Methylation(KR)
K.QVDKTVEIEITKAELEEKFFK.V Y 21.98 2523.3472 21 -45.2 505.6539 5 78.76 6 44267 VEV_3_3_RA6_01_1237.d 0 2 2 69 89
K.RGAAFTIMVAGESGLGK.T Y 20.32 1663.8716 17 -27.3 416.9638 4 49.36 4 24472 VEV_1_3_RA4_01_1235.d 9.32E5 1 1 28 44
R.FTEQVK.I Y 19.68 750.3912 6 0.0 376.2029 2 18.92 5 7158 VEV_2_3_RA5_01_1236.d 0 1 1 328 333
K.QLEQELETMQGSAVRSHGR.R Y 19.02 2155.0439 19 -12.3 539.7617 4 78.79 6 44305 VEV_3_3_RA6_01_1237.d 5.4E4 1 1 366 384
K.TVEIEITKAELEEKFFK.V Y 17.20 2053.0981 17 -45.2 685.3424 3 82.83 6 47081 VEV_3_3_RA6_01_1237.d 5.34E4 1 1 73 89
K.QLEQELETM(+15.99)QGSAVRSHGR.R Y 15.72 2171.0388 19 1.4 724.6879 3 73.16 6 40204 VEV_3_3_RA6_01_1237.d 1.43E4 1 1 366 384 Oxidation (M)
total 38 peptides
C1GE03
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SC(+57.02)LTIQLIQSHFVDEYDPTIEDSYR.K Y 127.20 3028.4124 25 -9.0 1010.4690 3 85.36 5 49380 VEV_2_3_RA5_01_1236.d 2.37E5 3 3 53 77 Carbamidomethylation
R.YNKEM(+15.99)SSYSSGGGGFGSR.A Y 125.17 1885.7900 18 -15.4 629.5943 3 37.55 6 17089 VEV_3_3_RA6_01_1237.d 2.36E5 4 4 203 220 Oxidation (M)
R.INVDNAFYDIVR.E Y 111.70 1437.7252 12 -16.7 719.8579 2 81.56 6 46244 VEV_3_3_RA6_01_1237.d 1.12E6 9 9 187 198
R.TGEGFLLVYSITSR.Q Y 109.46 1541.8090 14 -9.9 771.9041 2 84.89 5 49100 VEV_2_3_RA5_01_1236.d 5.39E5 6 6 110 123
R.YNKEMSSYSSGGGGFGSR.A Y 106.80 1869.7952 18 -7.1 935.8982 2 51.14 5 25846 VEV_2_3_RA5_01_1236.d 1.03E6 8 8 203 220
K.SRINVDNAFYDIVR.E Y 101.22 1680.8583 14 -13.2 561.2859 3 77.45 4 45048 VEV_1_3_RA4_01_1235.d 8.09E5 5 5 185 198
K.SC(+57.02)LTIQLIQSHFVDEYDPTIEDSYRK.Q Y 91.89 3156.5073 26 -4.0 790.1309 4 82.71 4 49019 VEV_1_3_RA4_01_1235.d 1.99E5 1 1 53 78 Carbamidomethylation
R.VVSQQEGEALAR.D Y 89.13 1285.6626 12 -12.8 643.8303 2 42.36 6 19914 VEV_3_3_RA6_01_1237.d 1.91E6 9 9 161 172
R.Q(-17.03)SFEEIMTYQQQILR.V Y 84.03 1895.9087 15 5.8 632.9805 3 90.39 5 52085 VEV_2_3_RA5_01_1236.d 3.77E5 6 6 124 138 Pyro-glu from Q
R.VVSQQEGEALARDFGC(+57.02)K.F Y 78.82 1892.9050 17 -39.0 631.9510 3 68.54 5 37934 VEV_2_3_RA5_01_1236.d 8.43E4 4 4 161 177 Carbamidomethylation
R.QSFEEIMTYQQQILR.V Y 77.84 1912.9353 15 -6.5 957.4688 2 82.49 5 47643 VEV_2_3_RA5_01_1236.d 6.03E4 2 2 124 138
K.LVVVGGGGVGK.S Y 77.45 940.5706 11 -30.0 471.2784 2 52.76 6 25916 VEV_3_3_RA6_01_1237.d 2.31E5 5 5 42 52
K.MDVEDREDGSTC(+57.02)C(+57.02)R.K Y 73.88 1728.6501 14 2.8 577.2256 3 31.46 5 14110 VEV_2_3_RA5_01_1236.d 5.31E4 1 1 225 238 Carbamidomethylation
R.INVDNAFYDIVREIR.R Y 64.48 1835.9529 15 -14.2 612.9828 3 85.99 5 49731 VEV_2_3_RA5_01_1236.d 6.63E4 1 1 187 201
K.EMSSYSSGGGGFGSR.A Y 61.07 1464.5939 15 3.3 733.3066 2 50.94 6 24839 VEV_3_3_RA6_01_1237.d 2.12E5 4 4 206 220
R.VKDKDYFPIIVVGNKC(+57.02)DLEK.E Y 57.71 2379.2507 20 -12.8 476.8513 5 71.47 4 40379 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 139 158 Carbamidomethylation
R.VVSQQ(+.98)EGEALAR.D Y 52.42 1286.6466 12 -5.3 644.3271 2 46.32 6 22163 VEV_3_3_RA6_01_1237.d 1.37E5 2 2 161 172 Deamidation (NQ)
R.VKDKDYFPIIVVGNK.C Y 51.73 1733.9716 15 -13.1 578.9902 3 71.33 5 39974 VEV_2_3_RA5_01_1236.d 3.51E4 1 1 139 153
R.APEKMDVEDREDGSTC(+57.02)C(+57.02)R.K Y 48.60 2153.8777 18 -6.9 718.9615 3 34.67 4 15559 VEV_1_3_RA4_01_1235.d 1.57E5 4 4 221 238 Carbamidomethylation
R.YN(+.98)KEM(+15.99)SSYSSGGGGFGSR.A Y 45.74 1886.7740 18 62.4 629.9712 3 37.69 4 17329 VEV_1_3_RA4_01_1235.d 0 2 2 203 220 Deamidation (NQ); Oxidation (M)
R.DFGC(+57.02)KFIETSAK.S Y 45.74 1401.6598 12 -20.1 468.2178 3 66.02 5 36053 VEV_2_3_RA5_01_1236.d 1.54E5 2 2 173 184 Carbamidomethylation
R.VVSQ(+.98)QEGEALAR.D Y 45.73 1286.6466 12 -15.8 644.3204 2 48.30 6 23319 VEV_3_3_RA6_01_1237.d 1.43E5 2 2 161 172 Deamidation (NQ)
K.FIETSAK.S Y 43.95 794.4174 7 -15.4 398.2098 2 25.11 5 10546 VEV_2_3_RA5_01_1236.d 1.2E6 7 7 178 184
R.Y(+43.01)NK(+14.02)EMSSYSSGGGGFGSR.A Y 39.58 1926.8167 18 -10.8 482.7062 4 25.54 6 10530 VEV_3_3_RA6_01_1237.d 2.54E5 5 5 203 220 Carbamylation; Methylation(KR)
R.VVS(-2.02)QQEGEALARDFGC(+57.02)K.F Y 34.65 1890.8894 17 15.2 631.3134 3 68.62 5 37996 VEV_2_3_RA5_01_1236.d 0 1 1 161 177 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.INVDNAFYDIVR(+14.02).E Y 30.64 1451.7408 12 -13.6 726.8679 2 83.74 6 47658 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 187 198 Methylation(KR)
R.VVSQQE(+14.02)GEALAR.D Y 29.42 1299.6782 12 -10.1 650.8398 2 53.98 5 27581 VEV_2_3_RA5_01_1236.d 1.18E5 1 1 161 172 Methylation(others)
R.YNK(+14.02)EMSSYSSGGGGFGSR.A Y 28.52 1883.8108 18 -12.0 628.9366 3 57.24 4 29479 VEV_1_3_RA4_01_1235.d 6.98E4 1 1 203 220 Methylation(KR)
R.YNKEMSSYSSGGGGFGSRAPEK.M Y 22.69 2295.0225 22 -6.4 574.7592 4 49.65 5 24945 VEV_2_3_RA5_01_1236.d 4.15E4 1 1 203 224
R.Y(+17.99)NKEMSSYSSGGGGFGSR.A Y 22.33 1887.7858 18 37.1 630.2925 3 37.64 4 17298 VEV_1_3_RA4_01_1235.d 0 1 1 203 220 Fluorination
K.DYFPIIVVGNKC(+57.02)DLEK.E Y 20.92 1908.9655 16 -18.6 637.3173 3 82.30 6 46740 VEV_3_3_RA6_01_1237.d 0 1 1 143 158 Carbamidomethylation
R.RYNKEMSSYSSGGGGFGSR.A Y 20.38 2025.8962 19 5.9 507.4843 4 46.06 6 22022 VEV_3_3_RA6_01_1237.d 5.95E4 1 1 202 220
R.INVDNAFYDIVREIRR.Y Y 17.05 1992.0541 16 -8.5 499.0166 4 83.42 6 47460 VEV_3_3_RA6_01_1237.d 9.28E4 1 1 187 202
total 33 peptides
C1GAF5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ERPASAVYQNQLFYITK.E Y 112.40 2027.0476 17 -31.5 676.6685 3 74.69 6 41356 VEV_3_3_RA6_01_1237.d 1.21E5 2 2 288 304
R.NSPLAADHVAAGSFDTAMQLLNR.Q Y 98.35 2398.1699 23 -6.6 800.3920 3 83.02 4 49231 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 868 890
R.AILVTSPTDGGTYELIHIPR.D Y 97.47 2152.1528 20 -18.1 718.3785 3 80.69 5 46500 VEV_2_3_RA5_01_1236.d 1.27E5 3 3 346 365
R.LFDKLSFLYLATGDKEK.L Y 95.48 1987.0665 17 -5.0 497.7714 4 82.17 4 48648 VEV_1_3_RA4_01_1235.d 2.34E5 2 2 667 683
R.GVNWVSFHPTLPLIVSAGDDR.L Y 95.36 2279.1699 21 -16.0 760.7184 3 85.82 4 51152 VEV_1_3_RA4_01_1235.d 1.05E5 2 2 173 193
R.VSQVTEVGAPASGLR.L Y 90.99 1469.7838 15 -11.3 735.8909 2 62.33 4 33250 VEV_1_3_RA4_01_1235.d 3.49E5 4 4 1149 1163
R.DLEYVANVHLQEGYAAMK.S Y 84.00 2049.9829 18 -5.7 684.3310 3 77.59 4 45179 VEV_1_3_RA4_01_1235.d 9.08E4 2 2 947 964
K.TYLPATAGLPPLVNYVR.R Y 80.50 1844.0195 17 -8.0 923.0096 2 84.66 6 48240 VEV_3_3_RA6_01_1237.d 4.93E4 1 1 913 929
R.Q(-17.03)VGAVNFEPLKPR.F Y 79.12 1436.7776 13 -10.5 719.3885 2 77.05 4 44738 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 891 903 Pyro-glu from Q
R.ANANQADMFGNTDAVVK.F Y 76.81 1764.8101 17 -7.5 883.4057 2 67.90 4 37564 VEV_1_3_RA4_01_1235.d 6.75E4 1 1 148 164
R.GDFTSQFQNALYLGDVESR.V Y 76.27 2145.9966 19 -18.0 1073.9862 2 84.49 4 50245 VEV_1_3_RA4_01_1235.d 2.48E4 1 1 695 713
R.FAVFNQSTQQIDIKDLSNSTTK.T Y 74.78 2484.2495 22 -5.3 829.0861 3 78.02 4 45493 VEV_1_3_RA4_01_1235.d 1.4E5 2 2 392 413
R.SLELSAYFTIPK.L Y 72.62 1367.7336 12 -15.6 684.8634 2 83.75 6 47667 VEV_3_3_RA6_01_1237.d 4.56E4 2 2 1030 1041
K.EIDLLPLAYLTAK.S Y 71.34 1458.8334 13 -11.4 730.4156 2 89.83 4 53556 VEV_1_3_RA4_01_1235.d 6.84E4 2 2 719 731
R.DSTGAMEPTNIKR.G Y 70.37 1418.6824 13 -18.5 710.3353 2 40.81 5 19588 VEV_2_3_RA5_01_1236.d 1.44E5 2 2 366 378
R.TVSYNPAER.A Y 65.74 1035.4985 9 -8.2 518.7523 2 35.67 4 16131 VEV_1_3_RA4_01_1235.d 1.09E6 9 9 337 345
R.VQMFKEIDLLPLAYLTAK.S Y 65.61 2092.1641 18 -7.9 698.3898 3 89.43 4 53345 VEV_1_3_RA4_01_1235.d 2.08E5 3 3 714 731
K.YHEQYKGSVC(+57.02)R.V Y 62.31 1425.6459 11 -15.1 476.2154 3 18.90 5 7148 VEV_2_3_RA5_01_1236.d 7.16E4 1 1 1138 1148 Carbamidomethylation
R.FLEIYQATK.T Y 61.60 1111.5913 9 -7.2 556.7990 2 69.52 5 38642 VEV_2_3_RA5_01_1236.d 2.7E5 3 3 904 912
R.DSTGAMEPTNIK.R Y 60.45 1262.5813 12 -17.5 632.2869 2 49.87 5 25069 VEV_2_3_RA5_01_1236.d 2.38E5 2 2 366 377
K.VASHSSFER.A Y 60.30 1018.4832 9 -15.6 510.2409 2 15.35 6 5151 VEV_3_3_RA6_01_1237.d 1.77E5 3 3 780 788
K.TSSLVGQSIISYLQK.K Y 57.84 1622.8879 15 -0.5 541.9697 3 82.49 4 48876 VEV_1_3_RA4_01_1235.d 5.73E4 1 1 585 599
R.LGTEALSHGNHQTLEMTYQK.Q Y 53.90 2257.0798 20 -10.3 753.3594 3 62.50 4 33367 VEV_1_3_RA4_01_1235.d 0 1 1 645 664
R.AILVTSPTDGGT(+14.02)YELIHIPR.D Y 52.02 2166.1685 20 -8.6 723.0573 3 81.49 5 47054 VEV_2_3_RA5_01_1236.d 3.25E4 1 1 346 365 Methylation(others)
R.LFVSGKP Y 49.03 746.4326 7 -56.0 747.3981 1 48.73 6 23578 VEV_3_3_RA6_01_1237.d 0 2 2 1164 1170
R.TSVQSFKR.D Y 48.89 951.5137 8 -17.6 476.7558 2 20.31 6 7714 VEV_3_3_RA6_01_1237.d 1.22E5 3 3 248 255
K.TLEHVSTLHETIR.I Y 47.78 1534.8103 13 -7.2 384.7071 4 53.01 4 26813 VEV_1_3_RA4_01_1235.d 2.14E5 2 2 485 497
K.FVLEGHDR.G Y 46.47 971.4824 8 -4.4 486.7463 2 36.65 4 16732 VEV_1_3_RA4_01_1235.d 2.52E5 3 3 165 172
K.ISEHRGDFTSQFQNALYLGDVESR.V Y 41.04 2768.3154 24 -8.6 693.0802 4 78.60 6 44152 VEV_3_3_RA6_01_1237.d 6.22E4 1 1 690 713
R.GHGTSAVFVAR.N Y 40.34 1100.5726 11 -6.7 367.8624 3 35.72 4 16193 VEV_1_3_RA4_01_1235.d 9.17E4 3 3 379 389
R.AILVTSPTDGGTYE(+14.02)LIHIPR.D Y 36.01 2166.1685 20 28.6 723.0841 3 81.47 6 46183 VEV_3_3_RA6_01_1237.d 0 1 1 346 365 Methylation(others)
R.MIANGGVAK.F Y 32.12 859.4586 9 -6.8 860.4600 1 98.70 4 57771 VEV_1_3_RA4_01_1235.d 0 1 1 1074 1082
K.LALIK.R N 29.52 556.3948 5 -13.1 557.3948 1 47.33 5 23535 VEV_2_3_RA5_01_1236.d 3.65E5 3 3 569 573
R.VWDLNKR.T Y 26.46 929.5083 7 -5.7 310.8416 3 39.88 5 19044 VEV_2_3_RA5_01_1236.d 1.89E6 3 3 241 247
R.SYDFSKNVESLPMLSLK.K Y 26.19 1956.9866 17 -1.2 653.3353 3 81.99 5 47342 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 310 326
R.DSTGAM(+15.99)EPTNIK.R Y 26.15 1278.5762 12 20.7 427.2082 3 10.85 5 2892 VEV_2_3_RA5_01_1236.d 3.34E3 1 1 366 377 Oxidation (M)
R.GIDFHK.T Y 22.85 715.3653 6 -36.5 716.3464 1 87.30 4 52070 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 17 22
R.SPQDK.I Y 22.60 573.2758 5 18.4 574.2936 1 22.88 5 9275 VEV_2_3_RA5_01_1236.d 1.23E4 1 1 1097 1101
R.TLDSTVYLVRVRAR.N Y 20.52 1647.9420 14 -5.9 330.5937 5 64.22 5 34691 VEV_2_3_RA5_01_1236.d 7.03E4 1 1 531 544
K.FLDEAR.K Y 18.83 749.3708 6 -8.7 375.6894 2 37.29 5 17522 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 1083 1088
K.ISEHR.G Y 18.54 640.3292 5 30.6 641.3561 1 70.40 5 39286 VEV_2_3_RA5_01_1236.d 0 1 1 690 694
R.AIGTDTPEK.L Y 17.24 930.4658 9 22.1 466.2505 2 35.80 6 16120 VEV_3_3_RA6_01_1237.d 0 1 1 1018 1026
MGTLIDR.F Y 17.15 804.4164 7 -15.7 403.2091 2 13.13 5 4044 VEV_2_3_RA5_01_1236.d 2.08E5 1 1 1 7
R.VIVPTFKSNWPVK.V Y 16.59 1513.8656 13 -23.6 757.9222 2 84.59 6 48201 VEV_3_3_RA6_01_1237.d 2.22E4 1 1 767 779
K.VWSYQTR.R Y 16.55 938.4610 7 8.4 939.4761 1 86.35 6 49286 VEV_3_3_RA6_01_1237.d 1.93E4 2 2 38 44
R.TVEESDLRNVLPIIPR.D Y 16.50 1850.0261 16 -25.6 617.6669 3 80.18 5 46166 VEV_2_3_RA5_01_1236.d 0 1 1 931 946
R.C(+57.02)LFTLNGHLDYVR.T Y 16.19 1606.7926 13 2.6 804.4057 2 91.89 4 54714 VEV_1_3_RA4_01_1235.d 0 1 1 46 58 Carbamidomethylation
K.TQPLFVSGGDDYK.I Y 15.91 1425.6776 13 -9.4 476.2287 3 10.11 4 2508 VEV_1_3_RA4_01_1235.d 1.61E4 1 1 23 35
K.LWSRLGTEALSHGNHQTLEM(+15.99)TYQKQR.L Y 15.62 3099.5308 26 8.3 620.9186 5 81.61 4 48254 VEV_1_3_RA4_01_1235.d 6.06E4 1 1 641 666 Oxidation (M)
K.RSLELSAYFTIPK.L Y 15.46 1523.8347 13 -11.2 381.9617 4 66.73 5 36573 VEV_2_3_RA5_01_1236.d 9.78E4 1 1 1029 1041
total 50 peptides
A0A0A0HYV6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YIDDDIDAGDLEEIYAEAHK.A Y 163.58 2294.0225 20 -11.8 765.6724 3 81.26 6 46055 VEV_3_3_RA6_01_1237.d 6.13E5 5 5 468 487
R.YGITHGLTNWAAAYATGLLLAR.R Y 125.73 2332.2327 22 -5.8 1167.1168 2 89.32 4 53284 VEV_1_3_RA4_01_1235.d 6.7E5 7 7 325 346
K.KLGLDEDFVGVEEPEGQYNLTEAAETDEGTRRPFK.A Y 110.20 3938.8809 35 -6.5 788.7783 5 78.29 4 45700 VEV_1_3_RA4_01_1235.d 9.35E4 1 1 351 385
K.LGLDEDFVGVEEPEGQYNLTEAAETDEGTRRPFK.A Y 90.55 3810.7859 34 4.2 953.7078 4 80.43 4 47345 VEV_1_3_RA4_01_1235.d 8.78E4 1 1 352 385
R.ADPFKKDEDAGSKK.T Y 74.98 1534.7627 14 -6.1 768.3839 2 16.43 5 5796 VEV_2_3_RA5_01_1236.d 5.28E5 8 8 491 504
R.YIFGGHVAEYMETLADDDEERYKSQFQK.Y Y 74.74 3368.5295 28 -17.3 674.7015 5 83.27 6 47362 VEV_3_3_RA6_01_1237.d 1.02E5 2 2 440 467
K.YIDDDIDAGDLEEIYAEAHKAIR.A Y 65.94 2634.2449 23 -5.9 879.0837 3 82.79 5 47831 VEV_2_3_RA5_01_1236.d 1.22E4 1 1 468 490
K.AVLDVGLAR.T Y 59.62 912.5392 9 -12.0 457.2714 2 67.22 4 37046 VEV_1_3_RA4_01_1235.d 1.56E6 8 8 386 394
K.GASDGGILIPHSENRFPGYDIESK.E Y 55.40 2558.2400 24 -10.1 640.5608 4 74.36 6 41081 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 407 430
K.YIDDDIDAGDLEEIYAEAHK(+14.02).A Y 50.44 2308.0383 20 -6.2 770.3486 3 81.65 6 46312 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 468 487 Methylation(KR)
R.Q(-17.03)GKTDYYAR.K Y 45.25 1083.4985 9 -6.7 542.7529 2 31.47 4 13702 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 264 272 Pyro-glu from Q
K.NKYNAPK.Y Y 41.43 833.4395 7 -16.6 417.7201 2 10.44 6 2674 VEV_3_3_RA6_01_1237.d 2.47E4 1 1 281 287
K.YIDDDIDAGDLE(+14.02)EIYAEAHK.A Y 37.91 2308.0383 20 -3.0 770.3511 3 82.72 5 47787 VEV_2_3_RA5_01_1236.d 5.76E4 1 1 468 487 Methylation(others)
R.ADPFKKDEDAGSK.K Y 37.36 1406.6677 13 -6.8 469.8933 3 20.72 4 7783 VEV_1_3_RA4_01_1235.d 2.98E5 3 3 491 503
K.ELDAETLRR.Y Y 34.54 1101.5778 9 -13.0 368.1951 3 41.52 6 19364 VEV_3_3_RA6_01_1237.d 9.2E5 6 6 431 439
K.L(+127.06)GLDEDFVGVEEPEGQYNLTEAAETDEGTRRPFK.A Y 34.51 3937.8494 34 -17.0 788.5637 5 78.16 6 43842 VEV_3_3_RA6_01_1237.d 0 1 1 352 385 N-Succinimidyl-2-morpholine acetate
R.LITQAK.N Y 28.57 672.4170 6 -12.4 337.2116 2 16.49 4 5591 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 275 280
K.LVKNSAYYSR.F Y 26.11 1199.6299 10 -14.6 600.8135 2 28.11 5 12196 VEV_2_3_RA5_01_1236.d 6.09E4 1 1 245 254
R.QGKTDYYAR.K Y 24.88 1100.5250 9 -3.5 551.2679 2 16.22 5 5680 VEV_2_3_RA5_01_1236.d 8.9E4 2 2 264 272
K.ELDAETLR.R Y 23.55 945.4767 8 1.0 473.7461 2 50.90 4 25444 VEV_1_3_RA4_01_1235.d 1.29E5 2 2 431 438
R.TSTGAR.V Y 23.28 591.2976 6 -6.9 592.3008 1 72.34 6 39615 VEV_3_3_RA6_01_1237.d 7.88E4 1 1 395 400
K.AESLK(+27.99).Y Y 19.03 574.2962 5 -48.5 575.2756 1 79.97 6 45137 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 511 515 Formylation
R.K(+42.01)(+43.99)PDPK.I Y 18.80 669.3333 5 11.2 670.3481 1 87.68 6 50042 VEV_3_3_RA6_01_1237.d 0 1 1 179 183 Acetylation (N-term); Carboxylation (DKW)
K.IDAEYLFWEMM(+15.99)RVAR.S Y 18.57 1944.9226 15 7.9 649.3199 3 74.84 5 42480 VEV_2_3_RA5_01_1236.d 0 1 1 106 120 Oxidation (M)
K.TKDAPFTK.L Y 18.00 906.4811 8 0.3 303.1677 3 15.48 6 5194 VEV_3_3_RA6_01_1237.d 0 1 1 237 244
R.ADPFK.K Y 17.86 576.2907 5 -14.6 577.2896 1 37.16 5 17448 VEV_2_3_RA5_01_1236.d 0 1 1 491 495
M(+15.99)AGNK.R Y 17.32 535.2424 5 -83.6 536.2050 1 10.09 6 2540 VEV_3_3_RA6_01_1237.d 0 1 1 1 5 Oxidation (M)
K.VDLGK.T N 17.30 530.3064 5 -36.7 531.2942 1 27.22 4 11311 VEV_1_3_RA4_01_1235.d 0 1 1 232 236
R.RQGKTDYYAR.K Y 17.16 1256.6261 10 -22.1 629.3065 2 13.70 6 4283 VEV_3_3_RA6_01_1237.d 7.73E3 1 1 263 272
K.YNAPK.Y Y 16.86 591.3016 5 -7.6 592.3044 1 45.06 5 22169 VEV_2_3_RA5_01_1236.d 5.22E4 2 2 283 287
R.KPDPK.I Y 15.46 583.3329 5 -26.7 584.3246 1 41.20 5 19841 VEV_2_3_RA5_01_1236.d 0 1 1 179 183
R.YGITHGLTNWAAAYATGLLLARR.T Y 15.45 2488.3340 23 -63.4 623.0513 4 86.62 6 49440 VEV_3_3_RA6_01_1237.d 0 1 1 325 347
total 32 peptides
C1GK99
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TTPEQVVDQIC(+57.02)K.L Y 118.98 1416.6919 12 -13.5 709.3437 2 70.24 6 38034 VEV_3_3_RA6_01_1237.d 5.99E6 12 12 28 39 Carbamidomethylation
K.ANGLAPEIPEDLYMLIKK.A Y 108.81 2014.0808 18 -8.1 672.3621 3 85.22 4 50738 VEV_1_3_RA4_01_1235.d 1.28E6 5 5 77 94
K.GKGIASSAIPYSR.N Y 107.82 1305.7041 13 -12.8 653.8510 2 53.42 6 26357 VEV_3_3_RA6_01_1237.d 6.15E6 21 21 8 20
K.KGATPSQIGVILRDSHGIAQVK.V Y 101.60 2274.2808 22 -1.8 569.5764 4 69.02 4 38455 VEV_1_3_RA4_01_1235.d 2.5E5 3 3 43 64
K.KGATPSQIGVILR.D Y 100.10 1338.7983 13 -12.6 447.2678 3 63.91 5 34464 VEV_2_3_RA5_01_1236.d 2.55E6 10 10 43 55
K.GATPSQIGVILR.D Y 98.30 1210.7034 12 -15.4 606.3496 2 70.93 6 38579 VEV_3_3_RA6_01_1237.d 1.47E6 5 5 44 55
K.ANGLAPEIPEDLYMLIK.K Y 95.45 1885.9858 17 -10.2 943.9906 2 89.38 5 51580 VEV_2_3_RA5_01_1236.d 6.79E5 5 5 77 93
R.DSHGIAQVK.V Y 90.19 953.4930 9 -16.2 477.7461 2 19.27 6 7185 VEV_3_3_RA6_01_1237.d 3.08E6 12 12 56 64
K.GIASSAIPYSR.N Y 88.06 1120.5876 11 -11.9 561.2944 2 62.60 5 33476 VEV_2_3_RA5_01_1236.d 6.13E6 8 8 10 20
R.ILKANGLAPEIPEDLYMLIK.K Y 86.74 2240.2490 20 -10.0 747.7495 3 87.19 5 50403 VEV_2_3_RA5_01_1236.d 1.7E5 2 2 74 93
R.ILKANGLAPEIPEDLYMLIKK.A Y 85.38 2368.3440 21 -7.3 593.0889 4 84.05 4 50008 VEV_1_3_RA4_01_1235.d 3.96E5 4 4 74 94
R.NPPSWLKTTPEQVVDQIC(+57.02)K.L Y 85.17 2239.1306 19 -11.2 747.3758 3 79.63 5 45808 VEV_2_3_RA5_01_1236.d 2.74E5 1 1 21 39 Carbamidomethylation
K.TTPEQVVDQIC(+57.02)KLAK.K Y 78.88 1728.9080 15 -7.6 577.3055 3 79.47 5 45701 VEV_2_3_RA5_01_1236.d 5.54E5 4 4 28 42 Carbamidomethylation
K.GIASSAIPYSRNPPSWLK.T Y 76.52 1943.0265 18 -9.6 972.5112 2 75.52 5 42964 VEV_2_3_RA5_01_1236.d 2.55E5 3 3 10 27
K.AN(-17.03)GLAPEIPEDLYMLIK.K Y 76.01 1868.9594 17 -6.5 935.4808 2 96.53 4 56975 VEV_1_3_RA4_01_1235.d 7.29E5 3 3 77 93 Ammonia-loss (N)
K.AN(+.98)GLAPEIPEDLYMLIKK.A Y 73.26 2015.0648 18 -9.6 672.6891 3 86.83 4 51771 VEV_1_3_RA4_01_1235.d 3.53E5 2 2 77 94 Deamidation (NQ)
K.SVGVLPPTWR.Y Y 69.80 1110.6185 10 -12.2 556.3098 2 73.79 4 42192 VEV_1_3_RA4_01_1235.d 3.52E6 15 15 131 140
K.GKGIASSAIPYSR(+14.02).N Y 65.39 1319.7197 13 -2.8 660.8653 2 56.77 4 29147 VEV_1_3_RA4_01_1235.d 2.44E4 1 1 8 20 Methylation(KR)
K.FRLILIESR.I Y 65.30 1145.6920 9 -13.0 382.8997 3 75.39 5 42873 VEV_2_3_RA5_01_1236.d 3.06E5 4 4 113 121
K.KGATPSQ(+.98)IGVILR.D Y 64.55 1339.7823 13 -13.2 447.5955 3 66.61 4 36586 VEV_1_3_RA4_01_1235.d 1.67E5 1 1 43 55 Deamidation (NQ)
R.YESATASTLVA Y 58.56 1111.5397 11 -10.2 556.7714 2 65.44 4 35619 VEV_1_3_RA4_01_1235.d 6.72E5 3 3 141 151
K.TTPEQVVDQ(+.98)IC(+57.02)K.L Y 58.22 1417.6759 12 -8.8 709.8390 2 72.50 4 41185 VEV_1_3_RA4_01_1235.d 1.42E6 7 7 28 39 Deamidation (NQ); Carbamidomethylation
K.AN(-17.03)GLAPEIPEDLYMLIKK.A Y 56.40 1997.0543 18 -10.0 999.5244 2 90.40 6 51536 VEV_3_3_RA6_01_1237.d 5.91E5 4 4 77 94 Ammonia-loss (N)
K.AN(+.98)GLAPEIPEDLYMLIK.K Y 54.74 1886.9698 17 -14.4 944.4786 2 91.43 5 52608 VEV_2_3_RA5_01_1236.d 1.17E5 2 2 77 93 Deamidation (NQ)
R.NPPSWLK.T Y 51.77 840.4493 7 -10.2 421.2277 2 57.76 4 29869 VEV_1_3_RA4_01_1235.d 6.34E6 9 9 21 27
K.ANGLAPEIPE(+14.02)DLYMLIK.K Y 51.61 1900.0016 17 -14.9 950.9940 2 90.26 6 51473 VEV_3_3_RA6_01_1237.d 2.58E4 1 1 77 93 Methylation(others)
K.ANGLAPE(+14.02)IPEDLYMLIKK.A Y 51.42 2028.0964 18 -9.6 677.0330 3 86.00 4 51242 VEV_1_3_RA4_01_1235.d 2.63E5 1 1 77 94 Methylation(others)
K.VVTGNKILR.I Y 51.08 998.6237 9 -20.5 500.3089 2 34.15 5 15691 VEV_2_3_RA5_01_1236.d 2.4E6 11 11 65 73
R.ILKAN(+.98)GLAPEIPEDLYMLIKK.A Y 50.71 2369.3279 21 -18.2 593.3285 4 84.92 6 48409 VEV_3_3_RA6_01_1237.d 8.78E4 2 2 74 94 Deamidation (NQ)
K.SVGVLPPTWRYESATASTLVA Y 47.36 2204.1477 21 -6.9 1103.0735 2 82.88 4 49142 VEV_1_3_RA4_01_1235.d 2.94E5 3 3 131 151
K.ANGLAPEIPEDLYM(+15.99)LIK.K Y 46.60 1901.9808 17 -15.5 951.9829 2 87.95 6 50218 VEV_3_3_RA6_01_1237.d 2.07E5 3 3 77 93 Oxidation (M)
K.G(+43.01)K(+14.02)GIASSAIPYSR.N Y 43.04 1362.7255 13 -12.9 682.3612 2 53.73 5 27424 VEV_2_3_RA5_01_1236.d 8.21E4 2 2 8 20 Carbamylation; Methylation(KR)
K.TTPEQVVDQIC(+57.02)K(+14.02).L Y 42.44 1430.7075 12 -9.9 716.3539 2 72.41 4 41121 VEV_1_3_RA4_01_1235.d 7.58E5 1 1 28 39 Carbamidomethylation; Methylation(KR)
K.V(+43.01)VTGNKILR.I Y 39.81 1041.6294 9 -72.9 348.1918 3 34.28 5 15747 VEV_2_3_RA5_01_1236.d 2.88E5 2 2 65 73 Carbamylation
R.LILIESR.I Y 39.23 842.5225 7 -14.0 422.2626 2 64.77 4 35114 VEV_1_3_RA4_01_1235.d 2.72E6 6 6 115 121
K.TTPEQ(+.98)VVDQ(+.98)IC(+57.02)K.L Y 37.84 1418.6599 12 11.2 710.3452 2 70.00 6 37854 VEV_3_3_RA6_01_1237.d 3.88E5 2 2 28 39 Deamidation (NQ); Carbamidomethylation
K.VVTGN(+.98)KILR.I Y 31.20 999.6077 9 -19.0 334.2035 3 39.90 5 19061 VEV_2_3_RA5_01_1236.d 6.83E4 1 1 65 73 Deamidation (NQ)
K.VVTGNKILR(+14.02).I Y 29.24 1012.6393 9 -17.3 338.5479 3 43.59 5 21259 VEV_2_3_RA5_01_1236.d 1.45E5 2 2 65 73 Methylation(KR)
R.LILIESR(+14.02).I Y 26.14 856.5381 7 -46.9 429.2563 2 69.48 6 37474 VEV_3_3_RA6_01_1237.d 1.72E5 2 2 115 121 Methylation(KR)
K.GK(-1.03)GIASSAIPYSR.N Y 25.81 1304.6724 13 -14.6 653.3339 2 63.08 6 32693 VEV_3_3_RA6_01_1237.d 6.07E4 2 2 8 20 Lysine oxidation to aminoadipic semialdehyde
K.TTPEQVVD(+14.02)QIC(+57.02)K.L Y 20.26 1430.7075 12 -5.7 716.3569 2 71.62 4 40493 VEV_1_3_RA4_01_1235.d 7.58E5 1 1 28 39 Methylation(others); Carbamidomethylation
K.G(+56.06)IASSAIPYSR.N Y 20.11 1176.6503 11 -36.6 589.3109 2 62.43 5 33355 VEV_2_3_RA5_01_1236.d 0 1 1 10 20 Diethylation
K.GK(+14.02)GIAS(-18.01)SAIPYSR.N Y 17.23 1301.7091 13 -22.4 434.9006 3 53.88 6 26579 VEV_3_3_RA6_01_1237.d 6.25E4 1 1 8 20 Methylation(KR); Dehydration
K.TTPEQ(+.98)VVDQIC(+57.02)K.L Y 17.08 1417.6759 12 -4.0 709.8424 2 72.94 5 41131 VEV_2_3_RA5_01_1236.d 2.09E5 1 1 28 39 Deamidation (NQ); Carbamidomethylation
total 44 peptides
C1G9D7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TDAVQSLYQDM(+15.99)AAR.H Y 121.87 1583.7250 14 -8.5 792.8630 2 65.02 4 35351 VEV_1_3_RA4_01_1235.d 4.33E5 3 3 104 117 Oxidation (M)
R.TDAVQSLYQDMAAR.H Y 118.00 1567.7300 14 -6.1 784.8675 2 77.75 4 45320 VEV_1_3_RA4_01_1235.d 1.82E6 5 5 104 117
R.EMSRTDAVQSLYQDMAAR.H Y 117.00 2070.9463 18 -9.1 691.3164 3 75.83 4 43851 VEV_1_3_RA4_01_1235.d 6.9E5 5 5 100 117
R.HLPTEANPTPK.L Y 116.22 1203.6248 11 -11.4 602.8128 2 32.26 5 14576 VEV_2_3_RA5_01_1236.d 8.4E6 42 42 17 27
R.EMSRTDAVQSLYQDM(+15.99)AAR.H Y 107.60 2086.9412 18 -9.2 696.6479 3 65.18 4 35415 VEV_1_3_RA4_01_1235.d 6.85E4 1 1 100 117 Oxidation (M)
R.SGTHNMYKEYR.E Y 103.67 1384.6194 11 -19.2 462.5382 3 21.66 6 8423 VEV_3_3_RA6_01_1237.d 9.52E5 9 9 89 99
R.HLPTEANPTPKLYR.M Y 89.08 1635.8733 14 -12.6 546.2915 3 57.59 5 29824 VEV_2_3_RA5_01_1236.d 2.76E5 2 2 17 30
K.ANGEIVSLNVIHEK.H Y 81.63 1521.8151 14 -3.1 761.9125 2 67.84 4 37519 VEV_1_3_RA4_01_1235.d 4.62E5 4 4 58 71
K.SRFWYFLMKLR.K Y 81.40 1545.8279 11 -2.8 387.4632 4 83.15 6 47288 VEV_3_3_RA6_01_1237.d 1.29E5 3 3 43 53
R.TDAVQSLYQ(+.98)DMAAR.H Y 79.42 1568.7140 14 3.8 785.3672 2 77.84 4 45358 VEV_1_3_RA4_01_1235.d 2.91E5 3 3 104 117 Deamidation (NQ)
K.NLKFPLPHRVPK.A Y 78.59 1444.8666 12 -12.4 482.6235 3 60.29 5 31902 VEV_2_3_RA5_01_1236.d 3.82E6 15 15 151 162
R.SGTHNM(+15.99)YKEYR.E Y 77.75 1400.6143 11 -8.2 467.8749 3 13.76 4 4203 VEV_1_3_RA4_01_1235.d 1.32E6 11 11 89 99 Oxidation (M)
R.IFAPNTVVAK.S Y 75.56 1058.6124 10 -12.7 530.3068 2 62.77 5 33644 VEV_2_3_RA5_01_1236.d 2.82E6 4 4 33 42
R.VVEIEKKDLVR.R Y 71.57 1326.7871 11 -19.2 443.2612 3 45.78 6 21864 VEV_3_3_RA6_01_1237.d 2.32E6 13 13 130 140
R.TDAVQSLYQDMAAR(+14.02).H Y 69.72 1581.7457 14 -6.4 791.8751 2 79.65 4 46751 VEV_1_3_RA4_01_1235.d 2.52E5 4 4 104 117 Methylation(KR)
R.LTEYQVIGR.H Y 69.27 1077.5818 9 -10.9 539.7923 2 61.75 6 31715 VEV_3_3_RA6_01_1237.d 6.37E5 5 5 8 16
K.AN(-17.03)GEIVSLNVIHEK.H Y 69.26 1504.7886 14 -11.3 753.3931 2 76.33 4 44169 VEV_1_3_RA4_01_1235.d 1.98E5 3 3 58 71 Ammonia-loss (N)
R.HLPTE(+14.02)ANPTPK.L Y 64.17 1217.6404 11 -4.5 406.8856 3 42.21 4 20037 VEV_1_3_RA4_01_1235.d 1.12E6 6 6 17 27 Methylation(others)
R.FRSIHILR.V Y 62.32 1040.6243 8 -8.0 347.8793 3 58.50 5 30454 VEV_2_3_RA5_01_1236.d 4.16E5 4 4 122 129
K.KANGEIVSLNVIHEK.H Y 62.29 1649.9100 15 -16.7 413.4779 4 62.03 6 31929 VEV_3_3_RA6_01_1237.d 2.1E5 3 3 57 71
R.IFAPNTVVAK(+14.02).S Y 59.78 1072.6281 10 -26.2 537.3073 2 66.43 4 36397 VEV_1_3_RA4_01_1235.d 2.07E5 2 2 33 42 Methylation(KR)
K.SRFWYFLMKLRK.V Y 58.61 1673.9227 12 -22.6 335.7842 5 79.81 6 45022 VEV_3_3_RA6_01_1237.d 8.02E4 2 2 43 54
R.RPSTFA Y 57.68 677.3497 6 -20.9 339.6750 2 19.79 6 7478 VEV_3_3_RA6_01_1237.d 1.49E6 6 6 173 178
R.HLPTEAN(+.98)PTPK.L Y 57.63 1204.6088 11 -3.5 402.5421 3 31.85 6 13895 VEV_3_3_RA6_01_1237.d 2.12E6 4 4 17 27 Deamidation (NQ)
K.SRFWYFLMK.L Y 54.34 1276.6427 9 -13.3 426.5492 3 80.96 4 47779 VEV_1_3_RA4_01_1235.d 2.17E5 3 3 43 51
R.HLP(+31.99)TEANPTPK.L Y 52.63 1235.6146 11 21.0 412.8875 3 32.00 4 14005 VEV_1_3_RA4_01_1235.d 5.67E5 1 1 17 27 Dihydroxy
R.M(+15.99)RIFAPNTVVAK.S Y 51.79 1361.7489 12 -22.6 454.9133 3 60.05 4 31528 VEV_1_3_RA4_01_1235.d 1.54E5 4 4 31 42 Oxidation (M)
R.IFAPNTVVAKSRFWYFLMKLR.K Y 49.91 2586.4297 21 -22.2 518.2817 5 86.17 4 51351 VEV_1_3_RA4_01_1235.d 7.82E4 1 1 33 53
K.VKNFGIWIR.Y Y 47.70 1131.6553 9 -18.9 378.2186 3 70.44 6 38181 VEV_3_3_RA6_01_1237.d 4.3E5 3 3 76 84
R.EM(+15.99)SRTDAVQSLYQDMAAR.H Y 46.54 2086.9412 18 3.1 696.6565 3 73.48 5 41512 VEV_2_3_RA5_01_1236.d 5.06E4 2 2 100 117 Oxidation (M)
R.MRIFAPNTVVAK.S Y 45.01 1345.7540 12 -21.1 449.5825 3 66.51 4 36460 VEV_1_3_RA4_01_1235.d 2.89E5 2 2 31 42
K.SRFWYFLM(+15.99)K.L Y 44.83 1292.6376 9 7.7 431.8898 3 77.62 4 45180 VEV_1_3_RA4_01_1235.d 1.31E4 1 1 43 51 Oxidation (M)
R.VVEIEKK.D Y 40.90 843.5065 7 -13.3 422.7549 2 14.99 5 5022 VEV_2_3_RA5_01_1236.d 4.7E5 3 3 130 136
K.NFGIWIR.Y Y 40.29 904.4919 7 -19.1 453.2446 2 77.48 6 43388 VEV_3_3_RA6_01_1237.d 1.47E6 4 4 78 84
R.SGTHNM(-48.00)YKEYR.E Y 39.51 1336.6160 11 -8.2 446.5423 3 11.78 4 3228 VEV_1_3_RA4_01_1235.d 3.71E5 3 3 89 99 Dethiomethyl
R.H(+43.01)LPTEANPTPK.L Y 39.39 1246.6306 11 47.3 416.5705 3 31.96 5 14395 VEV_2_3_RA5_01_1236.d 3.3E5 1 1 17 27 Carbamylation
R.SIHILR.V Y 38.58 737.4548 6 -11.3 369.7305 2 40.57 4 19030 VEV_1_3_RA4_01_1235.d 2.93E6 9 9 124 129
R.H(+41.03)LPTEANPTPK.L Y 35.54 1244.6514 11 9.5 415.8950 3 32.20 4 14118 VEV_1_3_RA4_01_1235.d 3.29E5 1 1 17 27 Amidination of lysines or N-terminal amines with methyl acetimidate
K.FPLPHRVPK.A Y 33.55 1089.6447 9 -27.3 364.2122 3 51.33 5 25961 VEV_2_3_RA5_01_1236.d 2.74E5 2 2 154 162
K.ANGEIVSLNVIHEKHPLK.V Y 32.33 1997.1057 18 -1.1 400.4280 5 64.11 4 34595 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 58 75
K.NLKFPLPHR.V Y 27.98 1120.6505 9 -10.5 374.5535 3 60.00 4 31489 VEV_1_3_RA4_01_1235.d 2.92E5 2 2 151 159
R.SGTHNMYKEYREMSR.T Y 26.19 1887.8356 15 -26.9 472.9535 4 41.61 5 20082 VEV_2_3_RA5_01_1236.d 0 1 1 89 103
R.HLPTE(+37.96)ANPTPK.L Y 25.00 1241.5807 11 11.1 414.8721 3 31.72 6 13833 VEV_3_3_RA6_01_1237.d 5.13E4 2 2 17 27 Replacement of proton by potassium
R.RPYIK.Q Y 22.94 675.4067 5 -12.2 338.7065 2 13.68 4 4139 VEV_1_3_RA4_01_1235.d 4.67E5 1 1 141 145
K.EYREMSRTDAVQSLYQDMAAR.H Y 21.72 2519.1533 21 31.1 630.8152 4 74.46 4 42712 VEV_1_3_RA4_01_1235.d 0 1 1 97 117
K.KLFAAR.R Y 21.33 704.4333 6 -20.3 353.2168 2 26.06 6 10754 VEV_3_3_RA6_01_1237.d 2.9E6 9 9 167 172
R.TDAVQ(+.98)SLYQDMAAR(+14.02).H Y 20.46 1582.7297 14 -0.2 792.3719 2 80.51 6 45519 VEV_3_3_RA6_01_1237.d 9.34E4 1 1 104 117 Deamidation (NQ); Methylation(KR)
total 47 peptides
C1GN52
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FGYGPLAQVSTTAERLPAFGGEFQPGLYR.S Y 172.26 3128.5718 29 -10.1 1043.8540 3 86.94 6 49688 VEV_3_3_RA6_01_1237.d 2.38E6 10 10 40 68
R.FGYGPLAQVSTTAER.L Y 119.38 1595.7943 15 -11.7 798.8951 2 75.12 6 41667 VEV_3_3_RA6_01_1237.d 8.48E5 4 4 40 54
K.FANPAPMGLASFALTTFLLSLINLQTR.G Y 112.22 2906.5728 27 -11.5 1454.2770 2 98.08 4 57571 VEV_1_3_RA4_01_1235.d 2.13E4 1 1 75 101
R.LPAFGGEFQPGLYR.S Y 109.43 1550.7881 14 -13.3 776.3910 2 80.21 5 46202 VEV_2_3_RA5_01_1236.d 7.82E5 7 7 55 68
R.TMTHEEREVAQAAAR.F Y 105.98 1698.8108 15 -5.5 567.2744 3 41.19 4 19407 VEV_1_3_RA4_01_1235.d 2.49E6 11 11 25 39
M.S(+42.01)EPTDKDFADNGKVSSTGTEPGR.T Y 75.15 2436.1040 23 -5.7 813.0374 3 58.37 4 30285 VEV_1_3_RA4_01_1235.d 9.37E5 5 5 2 24 Acetylation (Protein N-term)
R.FGYGPLAQVSTTAER(+14.02)LPAFGGEFQPGLYR.S Y 74.44 3142.5874 29 -2.4 1048.5339 3 88.29 4 52698 VEV_1_3_RA4_01_1235.d 5.49E5 3 3 40 68 Methylation(KR)
R.KFANPAPMGLASFALTTFLLSLINLQTR.G Y 74.36 3034.6677 28 -4.2 1012.5590 3 97.88 4 57508 VEV_1_3_RA4_01_1235.d 2.05E4 1 1 74 101
M.S(+42.01)EPTDKDFADNGK.V Y 69.30 1464.6368 13 -8.5 733.3195 2 44.57 5 21911 VEV_2_3_RA5_01_1236.d 1.17E6 6 6 2 14 Acetylation (Protein N-term)
M.S(+42.01)EPTDKDFADN(+.98)GKVSSTGTEPGR.T Y 66.97 2437.0881 23 -5.2 813.3657 3 60.03 4 31520 VEV_1_3_RA4_01_1235.d 1.98E5 2 2 2 24 Acetylation (Protein N-term); Deamidation (NQ)
R.LPAFGGEFQ(+.98)PGLYR.S Y 61.03 1551.7721 14 -16.2 776.8807 2 80.98 6 45881 VEV_3_3_RA6_01_1237.d 4.34E2 2 2 55 68 Deamidation (NQ)
R.LPAFGGE(+14.02)FQPGLYR.S Y 58.27 1564.8037 14 -9.8 783.4015 2 82.36 4 48790 VEV_1_3_RA4_01_1235.d 2.6E5 3 3 55 68 Methylation(others)
R.FGYGPLAQVSTTAERLPAFGGEFQ(+.98)PGLYR.S Y 57.43 3129.5559 29 -9.1 1044.1831 3 87.46 6 49922 VEV_3_3_RA6_01_1237.d 2.31E5 1 1 40 68 Deamidation (NQ)
K.VSSTGTEPGR.T Y 54.73 989.4778 10 -13.2 495.7396 2 13.47 6 4169 VEV_3_3_RA6_01_1237.d 2.11E5 2 2 15 24
M.S(+42.01)EPTDKDFADN(+.98)GK.V Y 52.72 1465.6208 13 -10.9 733.8097 2 47.32 5 23529 VEV_2_3_RA5_01_1236.d 4.65E5 7 7 2 14 Acetylation (Protein N-term); Deamidation (NQ)
M.S(+42.01)EPTDKDFADNGK(+14.02).V Y 46.29 1478.6525 13 -9.4 740.3265 2 52.29 6 25648 VEV_3_3_RA6_01_1237.d 2.95E5 2 2 2 14 Acetylation (Protein N-term); Methylation(KR)
R.LPAFGGEFQPGLYR(+14.02).S Y 44.70 1564.8037 14 -10.7 783.4008 2 81.24 5 46861 VEV_2_3_RA5_01_1236.d 7.28E4 1 1 55 68 Methylation(KR)
R.FGYGPLAQVSTTAER(+14.02).L Y 36.74 1609.8099 15 -12.7 805.9020 2 77.46 6 43344 VEV_3_3_RA6_01_1237.d 9.09E4 1 1 40 54 Methylation(KR)
R.LPAFGGEFQPGLYRSVEQR.K Y 26.77 2150.0908 19 -28.2 431.0133 5 56.11 4 28715 VEV_1_3_RA4_01_1235.d 0 1 1 55 73
K.FANPAPM(+15.99)GLASFALTTFLLSLINLQTR.G Y 25.89 2922.5676 27 2.3 975.1987 3 97.97 4 57538 VEV_1_3_RA4_01_1235.d 4.06E4 1 1 75 101 Oxidation (M)
R.EVAQ(+.98)AAAR(+14.02)FGYGPLAQVSTTAER(+14.02).L Y 22.30 2421.2288 23 -31.0 808.0585 3 76.32 6 42504 VEV_3_3_RA6_01_1237.d 7.75E4 1 1 32 54 Deamidation (NQ); Methylation(KR)
K.DFADNGK.V Y 21.43 765.3293 7 36.4 766.3644 1 112.76 4 61884 VEV_1_3_RA4_01_1235.d 0 1 1 8 14
R.FGYGPLAQVSTTAERLPAFGGE(+14.02)FQPGLYR.S Y 20.32 3142.5874 29 -14.4 1048.5214 3 87.48 5 50568 VEV_2_3_RA5_01_1236.d 2.74E5 1 1 40 68 Methylation(others)
R.FGYGPLAQVSTTAERLPAFGGEFQPGLYR(-.98).S Y 20.22 3127.5879 29 -9.8 1043.5264 3 87.00 5 50308 VEV_2_3_RA5_01_1236.d 3.96E5 1 1 40 68 Amidation
M.SEPTDK(+42.01)DFADNGK(+14.02)VSSTGTEPGR.T Y 16.93 2450.1196 23 -12.7 817.7034 3 60.61 4 31941 VEV_1_3_RA4_01_1235.d 3.66E4 1 1 2 24 Acetylation (K); Methylation(KR)
total 25 peptides
A0A0A0HWS3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYSPNVLTLTLVDLPGLTK.V Y 139.30 2056.1819 19 -8.6 1029.0894 2 92.16 6 52376 VEV_3_3_RA6_01_1237.d 5.68E5 5 5 156 174
K.SNAIILAVTAANQDLANSDGLK.L Y 122.52 2198.1543 22 -15.7 733.7139 3 85.91 6 49019 VEV_3_3_RA6_01_1237.d 2.84E5 3 3 199 220
R.TVLDGNNQELSSVELSGGAR.I Y 109.14 2045.0024 20 -6.9 1023.5014 2 73.52 4 41995 VEV_1_3_RA4_01_1235.d 1.37E5 2 2 371 390
K.VDLMDTGTDVVDILAGR.I Y 95.78 1788.8927 17 -9.7 895.4449 2 90.17 4 53764 VEV_1_3_RA4_01_1235.d 4.35E5 2 2 239 255
R.NAGISPVPINLR.I Y 85.74 1249.7142 12 -8.8 625.8589 2 73.35 4 41856 VEV_1_3_RA4_01_1235.d 6.11E5 3 3 144 155
K.SSVLENIVGRDFLPR.G N 82.21 1700.9209 15 -8.5 567.9761 3 82.25 5 47506 VEV_2_3_RA5_01_1236.d 7.19E5 5 5 53 67
K.AVDPFDQVKDIDIR.T Y 80.12 1629.8362 14 -8.7 544.2812 3 77.34 4 44964 VEV_1_3_RA4_01_1235.d 1.89E5 3 3 405 418
R.SAS(+79.97)PSLDPMSDANGGFFGSFFASK.N Y 78.91 2503.0403 24 -2.9 1252.5238 2 93.45 4 55531 VEV_1_3_RA4_01_1235.d 3.43E4 2 2 563 586 Phosphorylation (STY)
K.TGKPLPPSAVPPR.S Y 70.67 1315.7611 13 -24.6 439.5835 3 43.72 5 21340 VEV_2_3_RA5_01_1236.d 7.76E5 5 5 550 562
K.MAAMEPPPPTLK.A Y 66.32 1281.6461 12 -8.3 641.8250 2 65.84 4 35940 VEV_1_3_RA4_01_1235.d 0 1 1 591 602
R.HAASRPTQVDPK.T Y 61.01 1305.6790 12 -10.6 653.8398 2 14.16 4 4377 VEV_1_3_RA4_01_1235.d 2.13E5 4 4 538 549
R.LGYVPVVNR.G Y 58.50 1015.5814 9 -12.9 508.7914 2 65.14 4 35387 VEV_1_3_RA4_01_1235.d 3.24E5 2 2 261 269
K.M(+15.99)AAMEPPPPTLK.A Y 39.98 1297.6410 12 -14.9 649.8181 2 60.93 4 32184 VEV_1_3_RA4_01_1235.d 2.62E4 1 1 591 602 Oxidation (M)
K.SSVLENIVGR.D N 37.60 1072.5876 10 -20.6 537.2900 2 71.76 6 39176 VEV_3_3_RA6_01_1237.d 5.11E4 1 1 53 62
R.AMAIVNER.H Y 36.84 902.4644 8 -18.2 452.2313 2 41.43 5 19983 VEV_2_3_RA5_01_1236.d 1.39E6 6 6 530 537
R.EVDPEGQR.T Y 34.92 928.4250 8 -10.3 465.2150 2 16.05 6 5490 VEV_3_3_RA6_01_1237.d 1.97E5 4 4 224 231
K.LLINSYYNIVKR.T Y 33.55 1494.8558 12 -19.3 499.2830 3 74.63 6 41277 VEV_3_3_RA6_01_1237.d 1.69E4 1 1 620 631
K.LQDVFTTVGVQNPIDLPQIVVVGSQSSGK.S Y 31.89 3024.6130 29 -3.5 1009.2081 3 89.75 4 53517 VEV_1_3_RA4_01_1235.d 2.75E4 1 1 24 52
K.AVDPFDQVK.D Y 31.09 1017.5131 9 -8.1 509.7597 2 64.31 4 34739 VEV_1_3_RA4_01_1235.d 9.65E4 2 2 405 413
R.IIPLR.L N 30.10 610.4166 5 -20.7 306.2093 2 45.20 4 21893 VEV_1_3_RA4_01_1235.d 1.78E5 3 3 256 260
K.ASGTLSERENSEVEVIKLLINSYYNIVKR.T Y 24.97 3323.7725 29 0.7 665.7622 5 90.17 5 51969 VEV_2_3_RA5_01_1236.d 7.59E4 1 1 603 631
R.LGYVPVVNRGQR.D Y 22.24 1356.7626 12 -36.6 453.2449 3 57.76 4 29841 VEV_1_3_RA4_01_1235.d 0 1 1 261 272
R.ENSEVEVIKLLINSYYNIVKR.T Y 21.46 2522.3743 21 0.2 631.6010 4 92.82 4 55205 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 611 631
K.DIDIR.T N 21.18 630.3337 5 3.9 316.1754 2 49.24 6 23862 VEV_3_3_RA6_01_1237.d 2.09E5 1 1 414 418
K.AVM(+15.99)LNLVQHTK.D Y 20.24 1268.6910 11 -3.2 318.1790 4 21.66 4 8286 VEV_1_3_RA4_01_1235.d 0 1 1 640 650 Oxidation (M)
K.LETTDK.E Y 20.06 705.3545 6 26.3 706.3803 1 110.63 4 61293 VEV_1_3_RA4_01_1235.d 0 1 1 100 105
R.TILYNSSGSSPALFVGTTAFELIVK.Q Y 19.80 2614.3894 25 -14.9 872.4574 3 93.69 4 55708 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 419 443
K.MAAM(+15.99)EPPPPTLK.A Y 19.41 1297.6410 12 -17.9 649.8162 2 60.72 5 32083 VEV_2_3_RA5_01_1236.d 2.15E4 1 1 591 602 Oxidation (M)
R.H(+42.01)AASRPT(+79.97)QVDPK.T Y 17.97 1427.6558 12 17.5 476.9008 3 52.08 5 26435 VEV_2_3_RA5_01_1236.d 3.98E4 1 1 538 549 Acetylation (N-term); Phosphorylation (STY)
R.AM(+15.99)AIVNER.H Y 17.46 918.4593 8 -22.0 460.2268 2 23.42 6 9357 VEV_3_3_RA6_01_1237.d 6.33E5 3 3 530 537 Oxidation (M)
K.SSVLENIVGRDFLPR(+.98).G N 17.36 1701.9049 15 -8.1 568.3043 3 84.27 4 50104 VEV_1_3_RA4_01_1235.d 0 1 1 53 67 Deamidation (R)
R.LEDPSLK.C Y 16.88 800.4280 7 -7.4 401.2183 2 15.95 6 5450 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 449 455
R.TM(+15.99)IDM(+15.99)VPK.A Y 16.26 965.4562 8 -14.3 483.7285 2 22.49 5 9058 VEV_2_3_RA5_01_1236.d 1.92E5 1 1 632 639 Oxidation (M)
R.GQRDIENKRPISYALEHEKNFFENHK.A Y 15.29 3198.5957 26 -7.0 800.6506 4 112.10 4 61703 VEV_1_3_RA4_01_1235.d 0 1 1 270 295
K.VPVGDQPK.D Y 15.13 838.4548 8 -13.5 420.2290 2 37.62 4 17289 VEV_1_3_RA4_01_1235.d 1.5E5 1 1 175 182
total 35 peptides
C1GMI6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.AGPDQDSSADAAAGNLANLHLDEVTGER.V Y 144.60 2793.2800 28 -20.4 932.0817 3 76.99 6 43012 VEV_3_3_RA6_01_1237.d 4.25E5 3 3 2 29
K.KASAEEEESNLTPNQYFEIR.S Y 115.14 2354.1025 20 -9.2 785.7009 3 72.94 4 41562 VEV_1_3_RA4_01_1235.d 3.5E5 3 3 62 81
K.ASAEEEESNLTPNQYFEIR.S Y 111.65 2226.0076 19 7.2 1114.0190 2 77.78 4 45309 VEV_1_3_RA4_01_1235.d 1.76E5 3 3 63 81
K.IQVAC(+57.02)QSQNAEGDVSFEAQHEHLR.R Y 102.89 2752.2622 24 -20.3 689.0588 4 64.24 6 33534 VEV_3_3_RA6_01_1237.d 1.78E5 3 3 156 179 Carbamidomethylation
R.RGDIIGVVGWPGR.T Y 91.69 1380.7626 13 -11.9 461.2560 3 75.39 4 43430 VEV_1_3_RA4_01_1235.d 2.47E5 2 2 180 192
K.VNVQC(+57.02)SPPETNAR.M Y 80.42 1470.6885 13 -7.3 736.3461 2 41.74 4 19745 VEV_1_3_RA4_01_1235.d 7.56E5 7 7 435 447 Carbamidomethylation
M.AGPDQDSSADAAAGNLANLHLDEVTGERVSK.S Y 74.51 3107.4756 31 -4.8 777.8724 4 74.86 4 43022 VEV_1_3_RA4_01_1235.d 2.31E5 2 2 2 32
K.AAVAPPKAEK.K Y 67.49 980.5654 10 -21.3 491.2795 2 17.41 6 6222 VEV_3_3_RA6_01_1237.d 2.54E5 4 4 52 61
K.AAVAPPKAEKK.A Y 61.92 1108.6604 11 -13.6 555.3300 2 12.59 6 3705 VEV_3_3_RA6_01_1237.d 1.35E5 6 6 52 62
K.EIVNAYTELNDPFDQR.L Y 56.65 1922.9010 16 6.7 641.9786 3 80.21 6 45303 VEV_3_3_RA6_01_1237.d 3.12E4 2 2 499 514
R.SPNPYPHK.F Y 52.33 938.4610 8 -7.8 470.2341 2 15.86 4 5234 VEV_1_3_RA4_01_1235.d 3.32E5 4 4 93 100
K.EVILLAPC(+57.02)LHQIPSEHYGLR.D Y 51.29 2344.2361 20 -17.8 587.0558 4 78.48 4 45851 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 209 228 Carbamidomethylation
K.VNVQ(+.98)C(+57.02)SPPETNAR.M Y 47.85 1471.6725 13 -10.9 736.8355 2 44.48 4 21440 VEV_1_3_RA4_01_1235.d 5.1E4 1 1 435 447 Deamidation (NQ); Carbamidomethylation
K.VNVQC(+57.02)SPPETNAR(+14.02).M Y 39.85 1484.7041 13 -12.0 743.3504 2 49.32 4 24456 VEV_1_3_RA4_01_1235.d 5.73E4 1 1 435 447 Carbamidomethylation; Methylation(KR)
K.EVILLAPC(+57.02)LHQIPSEHYGLRDQEQR.Y Y 29.72 3000.5239 25 -9.9 601.1061 5 75.77 6 42110 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 209 233 Carbamidomethylation
K.FQVTDDAR.E Y 28.57 950.4457 8 -7.7 476.2265 2 21.23 6 8206 VEV_3_3_RA6_01_1237.d 1.12E5 2 2 101 108
R.IEMIPALEEATGEK.F Y 26.76 1529.7646 14 22.6 510.9404 3 78.40 6 44009 VEV_3_3_RA6_01_1237.d 0 1 1 399 412
R.NVFITR.S Y 26.62 748.4232 6 -18.0 375.2121 2 46.16 6 22078 VEV_3_3_RA6_01_1237.d 8.26E5 3 3 249 254
K.FQVTDDAREIIK.K Y 26.04 1433.7513 12 -7.4 478.9208 3 69.08 4 38505 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 101 112
K.SAAAK.E N 25.46 446.2489 5 -66.8 447.2263 1 24.87 5 10406 VEV_2_3_RA5_01_1236.d 5.41E4 1 1 583 587
R.LRFEEQASQK.A Y 24.58 1234.6306 10 -8.8 618.3171 2 32.50 5 14718 VEV_2_3_RA5_01_1236.d 8.36E4 2 2 515 524
R.VYELGR.Q Y 24.09 735.3915 6 -18.1 368.6964 2 36.67 6 16585 VEV_3_3_RA6_01_1237.d 1.47E5 2 2 322 327
K.SAAAK(+27.99).E N 23.50 474.2438 5 -11.4 475.2456 1 61.26 5 32481 VEV_2_3_RA5_01_1236.d 0 1 1 583 587 Formylation
K.EVLAFPFMK.E Y 22.03 1080.5677 9 -21.5 541.2795 2 77.19 6 43147 VEV_3_3_RA6_01_1237.d 1.58E6 4 4 571 579
R.SPNPYPHKFQVTDDAR.E Y 21.41 1870.8961 16 -8.4 468.7274 4 55.10 6 27233 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 93 108
R.GDIIGVVGWPGR.T Y 20.79 1224.6615 12 -39.9 409.2115 3 43.99 5 21511 VEV_2_3_RA5_01_1236.d 3.41E5 3 3 181 192
K.SRNVFITRSK.M Y 19.85 1206.6832 10 -62.3 604.3113 2 77.06 5 44087 VEV_2_3_RA5_01_1236.d 0 2 2 247 256
K.RSAGAK(+43.01).L Y 19.17 631.3401 6 8.2 632.3526 1 93.32 4 55466 VEV_1_3_RA4_01_1235.d 4.35E3 1 1 138 143 Carbamylation
R.NNVGLC(+57.02)ER.F Y 18.35 960.4447 8 12.0 481.2354 2 26.68 4 11074 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 483 490 Carbamidomethylation
R.SAGAK(+97.02).L Y 17.54 529.2496 5 19.6 530.2673 1 73.97 6 40795 VEV_3_3_RA6_01_1237.d 6.25E3 1 1 139 143 Maleimide
K.YESLQKGDQIKEKEVR.I Y 16.61 1949.0217 16 -10.6 488.2575 4 68.40 4 37952 VEV_1_3_RA4_01_1235.d 0 1 1 114 129
K.YHRNNVGLC(+57.02)ER.F Y 15.86 1416.6681 11 30.6 473.2444 3 33.40 5 15232 VEV_2_3_RA5_01_1236.d 0 1 1 480 490 Carbamidomethylation
K.MLIVGGLER.V Y 15.80 986.5583 9 14.1 329.8647 3 31.33 5 14036 VEV_2_3_RA5_01_1236.d 0 1 1 313 321
R.YLDLIMNDK.S Y 15.69 1123.5583 9 4.2 1124.5703 1 87.39 6 49878 VEV_3_3_RA6_01_1237.d 4.33E3 1 1 238 246
K.YESLQKGDQIK.E Y 15.64 1307.6721 11 -23.9 327.9175 4 18.97 5 7184 VEV_2_3_RA5_01_1236.d 6.37E5 1 1 114 124
R.AEGVK.I Y 15.54 502.2751 5 -95.7 503.2343 1 14.12 5 4555 VEV_2_3_RA5_01_1236.d 2.24E4 1 1 151 155
total 36 peptides
C1GL34
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DSGYVVGAEIDDPDAGLSEEER.A Y 138.16 2322.0134 22 -10.6 1162.0017 2 77.27 6 43204 VEV_3_3_RA6_01_1237.d 2.04E5 3 3 28 49
K.DSGYVVGAEIDDPDAGLSEEERAENDRK.L Y 135.46 3035.3591 28 -9.7 759.8397 4 70.78 6 38435 VEV_3_3_RA6_01_1237.d 3.6E5 4 4 28 55
K.DSGYVVGAEIDDPDAGLSEEERAENDRKLLR.K Y 127.03 3417.6284 31 -9.6 684.5264 5 74.52 4 42763 VEV_1_3_RA4_01_1235.d 2.39E5 3 3 28 58
R.AQLLSVPPYAVAAVLTITVGYIADRTR.Q Y 106.57 2857.6064 27 -23.6 953.5203 3 97.62 5 55218 VEV_2_3_RA5_01_1236.d 4.74E4 3 3 330 356
M(+42.01)DTKDQEVRDPSTNSK.G Y 98.68 1891.8582 16 -11.8 631.6192 3 41.46 5 20076 VEV_2_3_RA5_01_1236.d 1.18E6 5 5 1 16 Acetylation (Protein N-term)
R.GDMRPDFIYTL Y 92.06 1326.6278 11 -11.6 664.3135 2 82.22 5 47485 VEV_2_3_RA5_01_1236.d 6.87E5 5 5 501 511
R.AQLLSVPPYAVAAVLTITVGYIADR.T Y 79.14 2600.4578 25 -2.5 1301.2329 2 97.79 6 54609 VEV_3_3_RA6_01_1237.d 1E4 1 1 330 354
K.GAWSEENVGAK.D Y 78.55 1146.5305 11 -9.5 574.2671 2 44.39 4 21422 VEV_1_3_RA4_01_1235.d 1.19E6 8 8 17 27
K.DSGYVVGAEIDDPDAGLSEEERAENDR.K Y 74.81 2907.2642 27 -9.3 970.0863 3 74.94 4 43085 VEV_1_3_RA4_01_1235.d 6.27E4 1 1 28 54
M(+42.01)(+15.99)DTKDQEVRDPSTNSK.G Y 70.36 1907.8530 16 -7.3 636.9536 3 27.35 4 11428 VEV_1_3_RA4_01_1235.d 2.5E5 2 2 1 16 Acetylation (Protein N-term); Oxidation (M)
K.DQEVRDPSTNSK.G Y 69.62 1374.6375 12 -11.2 688.3183 2 15.77 6 5354 VEV_3_3_RA6_01_1237.d 5.14E4 1 1 5 16
K.IDGLQDDLR.L Y 59.80 1043.5247 9 -12.2 522.7632 2 62.88 6 32573 VEV_3_3_RA6_01_1237.d 1.25E6 6 6 87 95
R.LAADK.Q Y 23.43 516.2907 5 -76.0 517.2587 1 44.99 6 21402 VEV_3_3_RA6_01_1237.d 4.57E5 1 1 267 271
R.YSASR.A Y 20.22 582.2761 5 0.6 583.2838 1 67.34 5 37033 VEV_2_3_RA5_01_1236.d 0 1 1 325 329
R.TN(+.98)IGNAK.I Y 19.42 717.3657 7 19.7 359.6972 2 41.36 6 19276 VEV_3_3_RA6_01_1237.d 4.74E4 1 1 80 86 Deamidation (NQ)
R.C(+57.02)GERD(-18.01)HWIQ(+.98)GLDAK.Q Y 19.00 1666.7522 14 -10.2 556.5857 3 68.23 4 37850 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 482 495 Carbamidomethylation; Dehydration; Deamidation (NQ)
total 16 peptides
C1GBM4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SNGQSVPIGIHPSKVVITK.L Y 109.25 1960.1105 19 -12.8 654.3691 3 63.40 5 34086 VEV_2_3_RA5_01_1236.d 4.73E5 3 3 90 108
R.DKSNGQSVPIGIHPSK.V Y 106.95 1662.8689 16 -13.4 555.2895 3 43.68 6 20624 VEV_3_3_RA6_01_1237.d 1.41E6 14 14 88 103
R.SIPIRKDDEVTIIR.G Y 96.48 1653.9413 14 -8.5 827.9709 2 62.46 5 33393 VEV_2_3_RA5_01_1236.d 7.97E6 17 17 47 60
K.AHFSAPSSERR.V Y 92.61 1243.6057 11 -13.2 622.8019 2 18.82 6 6936 VEV_3_3_RA6_01_1237.d 2.48E6 12 12 18 28
K.AHFSAPSSER.R Y 89.49 1087.5046 10 -11.6 544.7533 2 23.33 5 9536 VEV_2_3_RA5_01_1236.d 1.79E6 10 10 18 27
R.DKSNGQSVPIGIHPSKVVITK.L Y 88.46 2203.2324 21 -17.1 441.6462 5 61.89 5 33006 VEV_2_3_RA5_01_1236.d 5.82E5 4 4 88 108
R.KAHFSAPSSERR.V Y 88.36 1371.7007 12 -8.0 458.2372 3 15.67 5 5442 VEV_2_3_RA5_01_1236.d 5.02E6 17 17 17 28
R.KAHFSAPSSER.R Y 85.18 1215.5996 11 -13.0 608.7992 2 18.25 6 6638 VEV_3_3_RA6_01_1237.d 3.25E6 15 15 17 27
K.LKIDKDRESILER.M Y 84.87 1613.9100 13 -11.1 538.9713 3 54.70 5 28023 VEV_2_3_RA5_01_1236.d 7.09E6 24 24 109 121
K.SNGQSVPIGIHPSK.V Y 84.84 1419.7469 14 -15.4 710.8698 2 47.69 6 22970 VEV_3_3_RA6_01_1237.d 2.46E6 5 5 90 103
R.DKSN(+.98)GQSVPIGIHPSK.V Y 83.85 1663.8529 16 -9.7 832.9257 2 48.25 5 24078 VEV_2_3_RA5_01_1236.d 2.39E6 9 9 88 103 Deamidation (NQ)
R.RVIMSAPLSK.E Y 83.56 1100.6376 10 -16.1 367.8806 3 51.50 6 25223 VEV_3_3_RA6_01_1237.d 2.78E6 12 12 28 37
K.S(-18.01)N(+.98)GQSVPIGIHPSK.V Y 80.34 1402.7205 14 -12.5 702.3588 2 61.42 6 31463 VEV_3_3_RA6_01_1237.d 1.12E6 3 3 90 103 Dehydration; Deamidation (NQ)
R.DKSN(+.98)GQSVPIGIHPSKVVITK.L Y 79.72 2204.2163 21 0.3 441.8507 5 63.91 4 34511 VEV_1_3_RA4_01_1235.d 4.97E5 2 2 88 108 Deamidation (NQ)
K.DDEVTIIR.G Y 79.33 959.4924 8 -11.7 480.7479 2 60.81 4 32092 VEV_1_3_RA4_01_1235.d 1.46E6 5 5 53 60
R.EGKITSVYR.L Y 78.29 1051.5662 9 -18.4 526.7807 2 31.02 5 13846 VEV_2_3_RA5_01_1236.d 3.39E6 19 19 67 75
K.SN(-17.03)GQSVPIGIHPSK.V Y 77.08 1402.7205 14 -13.1 702.3583 2 61.47 5 32658 VEV_2_3_RA5_01_1236.d 9.9E5 3 3 90 103 Ammonia-loss (N)
K.IDKDRESILER.M Y 76.76 1372.7310 11 -9.9 458.5797 3 38.19 5 18044 VEV_2_3_RA5_01_1236.d 3.5E6 11 11 111 121
M.AKINSDLASSR.R Y 75.29 1160.6149 11 -9.5 387.8752 3 26.62 4 11048 VEV_1_3_RA4_01_1235.d 7.81E6 15 15 2 12
K.SN(+.98)GQSVPIGIHPSK.V Y 71.75 1420.7310 14 -11.6 711.3645 2 55.17 4 28148 VEV_1_3_RA4_01_1235.d 4.81E5 3 3 90 103 Deamidation (NQ)
R.KAHFSAPSSER(+14.02).R Y 69.57 1229.6152 11 -12.6 410.8738 3 25.40 5 10738 VEV_2_3_RA5_01_1236.d 9.29E5 8 8 17 27 Methylation(KR)
R.VIMSAPLSK.E Y 68.77 944.5365 9 -11.7 473.2700 2 59.23 5 30978 VEV_2_3_RA5_01_1236.d 3.3E6 6 6 29 37
R.LKYVVHVER.V Y 67.91 1141.6608 9 -22.0 571.8251 2 42.33 6 19850 VEV_3_3_RA6_01_1237.d 2.86E6 12 12 76 84
K.S(-18.01)N(+.98)GQSVPIGIHPSKVVITK.L Y 67.81 1943.0840 19 -20.4 972.5294 2 68.80 4 38277 VEV_1_3_RA4_01_1235.d 4.3E4 2 2 90 108 Dehydration; Deamidation (NQ)
R.KDDEVTIIR.G Y 66.18 1087.5873 9 -12.1 544.7943 2 42.74 5 20793 VEV_2_3_RA5_01_1236.d 1.04E6 7 7 52 60
K.S(-18.01)NGQ(+.98)SVPIGIHPSKVVITK.L Y 65.20 1943.0840 19 -34.9 648.6793 3 68.51 6 36773 VEV_3_3_RA6_01_1237.d 0 1 1 90 108 Dehydration; Deamidation (NQ)
M.AKINSDLASSRR.K Y 64.94 1316.7161 12 -8.1 439.9091 3 22.30 4 8648 VEV_1_3_RA4_01_1235.d 1.85E6 6 6 2 13
K.INSDLASSR.R Y 64.74 961.4828 9 -15.2 481.7414 2 28.60 6 12098 VEV_3_3_RA6_01_1237.d 9.73E5 8 8 4 12
K.ELREKHNVR.S Y 62.72 1179.6472 9 -11.5 590.8241 2 11.46 5 3203 VEV_2_3_RA5_01_1236.d 1.87E5 3 3 38 46
K.YVVHVER.V Y 62.61 900.4818 7 -17.5 451.2403 2 31.39 6 13634 VEV_3_3_RA6_01_1237.d 2.85E6 9 9 78 84
R.VIMSAPLSK(+14.02).E Y 60.88 958.5521 9 -13.7 480.2768 2 62.40 4 33288 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 29 37 Methylation(KR)
R.VIMSAPLSKELR.E Y 60.14 1342.7642 12 -35.9 672.3652 2 65.61 5 35748 VEV_2_3_RA5_01_1236.d 1.62E5 2 2 29 40
R.VIM(+15.99)SAPLSK.E Y 58.16 960.5314 9 -16.9 481.2649 2 38.69 6 17747 VEV_3_3_RA6_01_1237.d 2.41E6 18 18 29 37 Oxidation (M)
R.SIPIRKDD(+14.02)EVTIIR.G Y 53.76 1667.9569 14 -17.4 417.9893 4 65.57 4 35724 VEV_1_3_RA4_01_1235.d 1.19E6 2 2 47 60 Methylation(others)
R.SIPIRK(+14.02)DDEVTIIR.G Y 52.63 1667.9569 14 -12.0 417.9915 4 65.45 5 35620 VEV_2_3_RA5_01_1236.d 6.75E5 2 2 47 60 Methylation(KR)
R.VIMSAPLSKELREK.H Y 48.86 1599.9017 14 -16.3 400.9762 4 61.95 5 33003 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 29 42
K.AHFSAPSSER(+14.02).R Y 48.00 1101.5203 10 -5.8 551.7642 2 32.27 4 14154 VEV_1_3_RA4_01_1235.d 1.5E5 1 1 18 27 Methylation(KR)
R.SIPIR(+.98)KDDEVTIIR.G Y 46.69 1654.9253 14 1.3 552.6498 3 62.85 4 33639 VEV_1_3_RA4_01_1235.d 2.84E5 2 2 47 60 Deamidation (R)
R.RVIM(+15.99)SAPLSK.E Y 45.88 1116.6324 10 -20.4 559.3121 2 35.71 6 16098 VEV_3_3_RA6_01_1237.d 6.76E5 8 8 28 37 Oxidation (M)
K.ITSVYR.L Y 43.69 737.4072 6 -10.6 369.7069 2 27.85 4 11658 VEV_1_3_RA4_01_1235.d 1.66E6 8 8 70 75
K.VVITK.L N 42.35 558.3741 5 -21.4 559.3694 1 17.00 4 5829 VEV_1_3_RA4_01_1235.d 4.58E4 1 1 104 108
R.VIMSAPLSK(+14.02)ELR.E Y 40.18 1356.7799 12 -28.3 453.2545 3 69.90 5 38922 VEV_2_3_RA5_01_1236.d 1.79E4 1 1 29 40 Methylation(KR)
R.EGKIT(+79.96)SVYR.L Y 39.01 1131.5229 9 43.5 378.1980 3 31.18 6 13520 VEV_3_3_RA6_01_1237.d 6.8E4 2 2 67 75 Sulfation
R.VIM(-48.00)SAPLSK.E Y 38.70 896.5331 9 -18.3 449.2656 2 23.56 6 9431 VEV_3_3_RA6_01_1237.d 1.34E6 3 3 29 37 Dethiomethyl
R.DKSNGQS(-2.02)VPIGIHPSKVVITK.L Y 34.19 2201.2168 21 -33.3 441.2360 5 63.91 4 34447 VEV_1_3_RA4_01_1235.d 0 1 1 88 108 2-amino-3-oxo-butanoic_acid
K.ITSVYRLKYVVHVER.V Y 33.37 1861.0574 15 -0.4 373.2186 5 65.26 4 35479 VEV_1_3_RA4_01_1235.d 3.25E4 2 2 70 84
K.AHFSAPSSER(+14.02)R.V Y 31.62 1257.6213 11 -10.6 420.2099 3 24.27 5 10062 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 18 28 Methylation(KR)
R.LKYVVHVER(+14.02).V Y 31.31 1155.6764 9 -14.0 386.2274 3 49.54 4 24593 VEV_1_3_RA4_01_1235.d 6.27E5 4 4 76 84 Methylation(KR)
R.KAHFSAPS(-18.01)SERR.V Y 30.99 1353.6902 12 -11.6 452.2321 3 16.15 4 5387 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 17 28 Dehydration
R.KAHFSAPSSER(+14.02)R.V Y 30.39 1385.7163 12 2.7 462.9139 3 20.99 5 8283 VEV_2_3_RA5_01_1236.d 0 1 1 17 28 Methylation(KR)
M.AKINSDLASSR(+14.02).R Y 28.47 1174.6306 11 -14.5 588.3141 2 35.64 5 16551 VEV_2_3_RA5_01_1236.d 6.68E5 2 2 2 12 Methylation(KR)
R.EGK(+14.02)ITSVYR.L Y 28.41 1065.5818 9 -14.2 533.7906 2 38.16 6 17443 VEV_3_3_RA6_01_1237.d 8.54E4 1 1 67 75 Methylation(KR)
R.ESILER.M Y 25.46 745.3970 6 -25.0 746.3856 1 34.90 6 15600 VEV_3_3_RA6_01_1237.d 6.48E5 4 4 116 121
R.E(+43.99)GKITSVYR.L Y 25.38 1095.5560 9 23.0 366.2010 3 30.88 4 13339 VEV_1_3_RA4_01_1235.d 0 1 1 67 75 Carboxylation (E)
M.AKIN(+.98)SDLASSR.R Y 24.34 1161.5989 11 -10.0 581.8009 2 31.37 5 14054 VEV_2_3_RA5_01_1236.d 1.13E5 1 1 2 12 Deamidation (NQ)
K.LKIDKDRESILER(+14.02).M Y 24.06 1627.9257 13 -13.0 407.9834 4 58.86 5 30713 VEV_2_3_RA5_01_1236.d 2.12E5 1 1 109 121 Methylation(KR)
R.E(-18.01)GK(+14.02)ITSVYR.L Y 23.29 1047.5713 9 -56.4 350.1780 3 30.97 5 13813 VEV_2_3_RA5_01_1236.d 0 1 1 67 75 Pyro-glu from E; Methylation(KR)
R.R(+43.01)(+14.02)VIMSAPLSK.E Y 23.15 1157.6591 10 -11.9 579.8299 2 26.25 5 11186 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 28 37 Carbamylation; Methylation(KR)
R.EGK(+78.05)ITSVYR.L Y 22.42 1129.6132 9 -18.8 377.5379 3 30.77 6 13287 VEV_3_3_RA6_01_1237.d 4.45E4 1 1 67 75 2,5-dimethypyrrole
R.K(+43.01)(+14.02)AHFSAPSSER.R Y 22.36 1272.6211 11 -16.2 637.3075 2 19.13 5 7278 VEV_2_3_RA5_01_1236.d 2.46E4 1 1 17 27 Carbamylation; Methylation(KR)
K.LKIDKDR(+14.02)ESILER.M Y 21.22 1627.9257 13 -11.1 543.6431 3 58.27 5 30295 VEV_2_3_RA5_01_1236.d 8.78E4 1 1 109 121 Methylation(KR)
R.K(+26.02)SRKAHFSAPSSER.R Y 20.68 1612.8434 14 -43.5 404.2006 4 18.41 4 6581 VEV_1_3_RA4_01_1235.d 6.67E4 1 1 14 27 Acetaldehyde +26
R.DKSNGQS(-2.02)VPIGIHPSK.V Y 19.05 1660.8533 16 38.3 416.2365 4 48.25 5 24081 VEV_2_3_RA5_01_1236.d 0 1 1 88 103 2-amino-3-oxo-butanoic_acid
R.E(+21.98)GK(+14.02)ITSVYR.L Y 17.93 1087.5637 9 -37.6 363.5149 3 30.77 4 13289 VEV_1_3_RA4_01_1235.d 0 1 1 67 75 Sodium adduct; Methylation(KR)
R.KSRK(+14.02)AH(+15.99)FSAPSSER.R Y 15.54 1616.8383 14 -37.0 405.2019 4 18.75 4 6749 VEV_1_3_RA4_01_1235.d 3.13E5 1 1 14 27 Methylation(KR); Oxidation (HW)
R.K(+14.02)AHFS(-18.01)APSSER.R Y 15.42 1211.6046 11 -1.9 404.8747 3 18.36 5 6828 VEV_2_3_RA5_01_1236.d 9.69E4 1 1 17 27 Methylation(KR); Dehydration
total 66 peptides
C1GJ83
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVEGGASTNHDSSMNPEDLASQSVR.L Y 130.70 2574.1252 25 -7.8 859.0424 3 65.34 4 35539 VEV_1_3_RA4_01_1235.d 4.16E5 3 3 299 323
K.DADDAQNAHLEEGVR.I Y 113.19 1638.7234 15 -9.5 820.3612 2 42.81 5 20807 VEV_2_3_RA5_01_1236.d 8.44E5 6 6 54 68
R.VNVIPVIGKADSLTPAELAESK.K Y 113.12 2250.2471 22 -7.1 751.0843 3 79.98 5 46034 VEV_2_3_RA5_01_1236.d 1.22E5 2 2 166 187
R.VHALLYFITPTGHGLR.E Y 106.51 1793.9940 16 -4.3 449.5038 4 78.22 6 43885 VEV_3_3_RA6_01_1237.d 1.21E5 2 2 137 152
R.QYDDILAEESR.I Y 97.13 1337.6099 11 -13.2 669.8034 2 66.27 6 35080 VEV_3_3_RA6_01_1237.d 2.34E5 3 3 115 125
K.ADSLTPAELAESK.K Y 83.40 1330.6616 13 -13.2 666.3293 2 63.98 6 33350 VEV_3_3_RA6_01_1237.d 3.95E5 3 3 175 187
R.VNVIPVIGK.A Y 80.18 937.5960 9 -12.7 938.5914 1 70.56 5 39405 VEV_2_3_RA5_01_1236.d 9.82E5 4 4 166 174
R.TTFVNTLC(+57.02)GKK.V Y 75.85 1267.6594 11 -12.4 634.8291 2 51.10 5 25816 VEV_2_3_RA5_01_1236.d 1.31E6 8 8 38 48 Carbamidomethylation
R.TTFVNTLC(+57.02)GK.K Y 73.92 1139.5645 10 -12.2 570.7825 2 62.65 4 33551 VEV_1_3_RA4_01_1235.d 5.62E5 3 3 38 47 Carbamidomethylation
K.SVEGGASTNHDSSM(+15.99)NPEDLASQSVR.L Y 71.84 2590.1201 25 -10.0 864.3720 3 59.31 6 29942 VEV_3_3_RA6_01_1237.d 1.6E5 2 2 299 323 Oxidation (M)
R.IEREHNSHLHHQDELNGEVNA Y 70.28 2477.1431 21 -10.4 496.4308 5 41.51 6 19391 VEV_3_3_RA6_01_1237.d 5.97E5 3 3 368 388
R.ISLTIVDT(-2.02)PGFGDQIDNEQSFSEIVGYLER.Q Y 64.50 3339.6145 30 -8.6 1114.2025 3 94.85 4 56216 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 85 114 2-amino-3-oxo-butanoic_acid
R.Q(-17.03)YPWGVVEVDNPR.H Y 62.25 1540.7310 13 -7.2 771.3672 2 84.49 4 50243 VEV_1_3_RA4_01_1235.d 1.6E5 3 3 248 260 Pyro-glu from Q
R.QYPWGVVEVDNPRHSDFLAIR.S Y 53.98 2497.2502 21 -1.6 625.3188 4 80.05 5 46094 VEV_2_3_RA5_01_1236.d 1.91E5 3 3 248 268
R.VNVIPVIGKADSLTPAELAESKK.L Y 53.02 2378.3420 23 -9.3 595.5873 4 76.72 5 43819 VEV_2_3_RA5_01_1236.d 5.1E4 1 1 166 188
R.HSDFLAIR.S Y 51.26 957.5032 8 -17.5 320.1694 3 59.16 6 29825 VEV_3_3_RA6_01_1237.d 3.4E5 2 2 261 268
R.ESQLKEIEAR.I Y 49.40 1201.6302 10 -14.3 601.8138 2 38.69 6 17752 VEV_3_3_RA6_01_1237.d 6.9E5 3 3 358 367
K.VLQGKDADDAQNAHLEEGVR.I Y 46.80 2164.0508 20 -20.8 722.3425 3 49.63 5 24937 VEV_2_3_RA5_01_1236.d 2.52E4 2 2 49 68
R.Q(-17.03)YPWGVVEVDNPRHSDFLAIR.S Y 42.43 2480.2236 21 -14.7 827.7363 3 84.47 5 48848 VEV_2_3_RA5_01_1236.d 4.89E4 1 1 248 268 Pyro-glu from Q
R.ISLTIVDTPGFGDQIDNEQSFSEIVGYLER.Q Y 38.88 3341.6304 30 -3.9 1114.8798 3 94.97 4 56271 VEV_1_3_RA4_01_1235.d 3.96E4 2 2 85 114
K.KVLQGKDADDAQNAHLEEGVR.I Y 35.03 2292.1458 21 -5.4 765.0518 3 45.67 5 22531 VEV_2_3_RA5_01_1236.d 1.71E4 1 1 48 68
R.VN(+.98)VIPVIGK.A Y 28.76 938.5800 9 -48.8 470.2744 2 70.83 4 39869 VEV_1_3_RA4_01_1235.d 0 1 1 166 174 Deamidation (NQ)
R.IK(-1.03)PITVELELDEEGTR.I Y 27.44 1839.9465 16 -13.4 614.3146 3 75.12 4 43224 VEV_1_3_RA4_01_1235.d 2.94E5 1 1 69 84 Lysine oxidation to aminoadipic semialdehyde
K.A(+42.01)DSLTPAELAESK(+27.99).K Y 25.33 1400.6671 13 -16.8 701.3291 2 61.34 6 31416 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 175 187 Acetylation (N-term); Formylation
R.QYPWGVVEVDNPR.H Y 23.95 1557.7576 13 -11.2 779.8773 2 76.71 6 42794 VEV_3_3_RA6_01_1237.d 1.4E5 2 2 248 260
K.EIEAR.I Y 19.20 616.3180 5 -8.2 309.1638 2 18.65 5 7001 VEV_2_3_RA5_01_1236.d 0 1 1 363 367
K.KLVMEDIEHYR.I Y 18.76 1431.7180 11 -14.7 358.9315 4 63.06 4 33807 VEV_1_3_RA4_01_1235.d 2.03E4 1 1 188 198
R.QYDDILAEESRIK.R Y 17.75 1578.7889 13 -9.4 527.2653 3 59.80 5 31405 VEV_2_3_RA5_01_1236.d 8.05E4 1 1 115 127
K.EEQLR.R Y 16.85 673.3395 5 29.7 337.6870 2 21.92 6 8572 VEV_3_3_RA6_01_1237.d 2.43E5 1 1 326 330
R.LSPRVNVIPVIGK.A Y 16.13 1390.8660 13 -100.6 464.5826 3 69.50 5 38628 VEV_2_3_RA5_01_1236.d 7.13E4 1 1 162 174
R.R(+87.03)YDQIK.I Y 15.90 908.4716 6 -16.2 455.2357 2 38.99 6 17909 VEV_3_3_RA6_01_1237.d 0 1 1 7 12 Glycidamide adduct
total 31 peptides
C1GB13
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNRLPAAGVGDMVMATVK.K Y 146.66 1841.9856 18 -4.0 615.0000 3 77.80 4 45425 VEV_1_3_RA4_01_1235.d 4.56E5 4 4 24 41
R.LNRLPAAGVGDMVMATVKK.G Y 131.08 1970.0804 19 -7.2 493.5239 4 74.49 4 42737 VEV_1_3_RA4_01_1235.d 1.69E6 9 9 24 42
R.RADGIYLYFEDNAGVIVNAK.G Y 103.85 2227.1272 20 -10.2 743.3754 3 82.63 6 46966 VEV_3_3_RA6_01_1237.d 3.96E5 10 10 65 84
R.LNRLPAAGVGDM(+15.99)VM(+15.99)ATVK.K Y 100.86 1873.9753 18 -5.6 625.6622 3 65.36 4 35564 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 24 41 Oxidation (M)
K.GSAITGPIGKEATDLWPR.I Y 96.89 1867.9791 18 -16.5 623.6567 3 77.44 4 45063 VEV_1_3_RA4_01_1235.d 3.04E5 3 3 89 106
K.GSAITGPIGK.E Y 85.26 899.5076 10 -10.3 450.7564 2 42.89 4 20456 VEV_1_3_RA4_01_1235.d 2.76E6 14 14 89 98
R.NIYIISVK.G Y 73.70 948.5644 8 -13.9 475.2829 2 70.59 4 39692 VEV_1_3_RA4_01_1235.d 3.47E6 7 7 11 18
R.NIYIISVKGIGAR.L Y 66.67 1402.8296 13 -20.6 468.6075 3 73.41 5 41459 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 11 23
K.EATDLWPR.I Y 65.52 986.4821 8 -10.3 494.2433 2 65.65 4 35786 VEV_1_3_RA4_01_1235.d 2.13E6 9 9 99 106
K.VMPAVVVR.Q Y 61.32 869.5157 8 -8.7 435.7613 2 59.05 5 30851 VEV_2_3_RA5_01_1236.d 8.3E6 6 6 51 58
K.VM(+15.99)PAVVVR.Q Y 54.92 885.5106 8 -8.7 443.7587 2 42.29 4 20082 VEV_1_3_RA4_01_1235.d 5.52E5 5 5 51 58 Oxidation (M)
K.GEMKGSAITGPIGK.E Y 54.05 1344.7072 14 -29.2 673.3412 2 48.29 5 24103 VEV_2_3_RA5_01_1236.d 4.69E5 4 4 85 98
R.LPAAGVGDMVMATVKK.G Y 51.38 1586.8524 16 4.0 529.9602 3 74.58 4 42804 VEV_1_3_RA4_01_1235.d 3.01E5 2 2 27 42
R.KKVMPAVVVR.Q Y 49.30 1125.7056 10 -24.6 563.8462 2 38.65 5 18329 VEV_2_3_RA5_01_1236.d 1.12E5 2 2 49 58
K.KVMPAVVVR.Q Y 47.09 997.6107 9 -11.8 333.5402 3 49.06 4 24324 VEV_1_3_RA4_01_1235.d 2.36E5 3 3 50 58
K.GSAITGPIGK(+14.02).E Y 44.45 913.5233 10 -19.9 457.7598 2 49.18 4 24427 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 89 98 Methylation(KR)
K.GEM(+15.99)KGSAITGPIGK.E Y 42.42 1360.7020 14 -13.3 454.5686 3 35.93 4 16324 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 85 98 Oxidation (M)
K.KGKPELR.K Y 40.52 826.5024 7 -13.4 414.2530 2 10.42 5 2690 VEV_2_3_RA5_01_1236.d 6.55E4 1 1 42 48
R.LNRLPAAGVGDMVM(+15.99)ATVK.K Y 40.23 1857.9805 18 -10.2 620.3278 3 73.31 6 40313 VEV_3_3_RA6_01_1237.d 9.88E4 1 1 24 41 Oxidation (M)
R.QSKPWR.R Y 39.35 800.4293 6 -12.4 401.2170 2 14.25 4 4434 VEV_1_3_RA4_01_1235.d 2.21E5 3 3 59 64
R.IAANSGVVV Y 38.19 828.4705 9 -49.7 415.2220 2 18.17 6 6599 VEV_3_3_RA6_01_1237.d 6.1E5 3 3 107 115
K.E(+14.02)ATDLWPR.I Y 33.53 1000.4977 8 -4.5 501.2539 2 68.40 4 38025 VEV_1_3_RA4_01_1235.d 3.5E5 1 1 99 106 Methylation(others)
K.GKPELR.K Y 31.46 698.4075 6 -17.1 350.2050 2 11.72 4 3174 VEV_1_3_RA4_01_1235.d 4.52E5 4 4 43 48
R.LPAAGVGDMVMATVK.K Y 31.15 1458.7574 15 16.3 487.2677 3 79.02 4 46263 VEV_1_3_RA4_01_1235.d 0 1 1 27 41
R.LPAAGVGDM(+15.99)VM(+15.99)ATVK.K Y 29.48 1490.7473 15 16.1 497.9311 3 77.28 6 43211 VEV_3_3_RA6_01_1237.d 3.69E4 1 1 27 41 Oxidation (M)
R.Q(-17.03)SKPWR.R Y 28.01 783.4028 6 -11.3 392.7042 2 28.55 4 12036 VEV_1_3_RA4_01_1235.d 9.33E5 1 1 59 64 Pyro-glu from Q
R.RADGIYLYFEDNAGVIVNAKGEMK.G Y 22.25 2672.3267 24 -8.5 669.0833 4 107.58 4 60476 VEV_1_3_RA4_01_1235.d 0 1 1 65 88
R.N(+.98)IYIISVKGIGAR.L Y 21.82 1403.8136 13 -48.4 468.9225 3 73.66 4 42095 VEV_1_3_RA4_01_1235.d 0 1 1 11 23 Deamidation (NQ)
K.KGKPELRK.K Y 20.84 954.5974 8 -38.0 478.2878 2 9.83 5 2448 VEV_2_3_RA5_01_1236.d 0 2 2 42 49
K.GIGAR.L N 18.00 472.2758 5 -41.5 473.2634 1 27.66 5 11983 VEV_2_3_RA5_01_1236.d 4.42E4 1 1 19 23
R.LPAAGVGDMVM(+15.99)ATVK.K Y 17.14 1474.7523 15 -3.1 738.3812 2 71.76 4 40606 VEV_1_3_RA4_01_1235.d 0 1 1 27 41 Oxidation (M)
R.RADGIYLYFEDNAGVIVNAK(-.98).G Y 16.10 2226.1433 20 35.6 743.0815 3 82.68 5 47762 VEV_2_3_RA5_01_1236.d 0 1 1 65 84 Amidation
total 32 peptides
C1GGI0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IPDSKPHVHGDAELEPNSEVQSK.I Y 143.58 2512.2192 23 -10.8 838.4047 3 50.79 5 25685 VEV_2_3_RA5_01_1236.d 1.16E7 30 30 289 311
R.GLNYEATTAAIVMAGIFLSFLVEYIGNR.I Y 128.28 3032.5681 28 -7.0 1011.8562 3 98.37 4 57668 VEV_1_3_RA4_01_1235.d 6.55E4 1 1 256 283
R.GLNYEATTAAIVMAGIFLSFLVEYIGNRIILAR.I Y 126.22 3598.9585 33 -2.8 900.7444 4 98.32 4 57648 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 256 288
K.MPSC(+57.02)HFHGGVEHC(+57.02)SGDADNSAPVSC(+57.02)ERR.D Y 123.65 3155.2815 28 -11.1 632.0566 5 47.62 5 23711 VEV_2_3_RA5_01_1236.d 1.93E6 7 7 152 179 Carbamidomethylation
K.MPSC(+57.02)HFHGGVEHC(+57.02)SGDADNSAPVSC(+57.02)ER.R Y 116.54 2999.1804 27 -10.3 600.8372 5 51.83 5 26325 VEV_2_3_RA5_01_1236.d 4.37E6 13 13 152 178 Carbamidomethylation
K.M(+15.99)PSC(+57.02)HFHGGVEHC(+57.02)SGDADNSAPVSC(+57.02)ERR.D Y 106.74 3171.2764 28 -13.0 635.2543 5 40.61 6 18841 VEV_3_3_RA6_01_1237.d 6.13E5 11 11 152 179 Oxidation (M); Carbamidomethylation
R.NYNVPLRIGSLFAILATSGIAVFGPILWAR.F Y 102.58 3228.8174 30 -21.1 1077.2571 3 97.87 4 57505 VEV_1_3_RA4_01_1235.d 0 1 1 182 211
K.M(+15.99)PSC(+57.02)HFHGGVEHC(+57.02)SGDADNSAPVSC(+57.02)ER.R Y 102.32 3015.1753 27 -7.4 754.7955 4 44.54 4 21468 VEV_1_3_RA4_01_1235.d 3.56E6 15 15 152 178 Oxidation (M); Carbamidomethylation
R.IPDSKPHVHGDAELEPNSEVQSKIPQAK.S Y 88.96 3049.5469 28 -17.4 610.9061 5 60.65 5 32030 VEV_2_3_RA5_01_1236.d 5.79E5 2 2 289 316
R.IPDSKPHVHGDAELEPN(+.98)SEVQSK.I Y 72.71 2513.2034 23 -7.7 629.3033 4 53.47 4 27099 VEV_1_3_RA4_01_1235.d 1.16E6 4 4 289 311 Deamidation (NQ)
R.IPDSKPHVHGDAELEPNSEVQSK(+14.02).I Y 70.95 2526.2349 23 -7.4 632.5613 4 55.41 4 28277 VEV_1_3_RA4_01_1235.d 4.11E5 1 1 289 311 Methylation(KR)
R.GLNYEATTAAIVM(+15.99)AGIFLSFLVEYIGNRIILAR.I Y 67.70 3614.9534 33 -7.5 1205.9827 3 98.14 4 57587 VEV_1_3_RA4_01_1235.d 2.45E4 1 1 256 288 Oxidation (M)
R.IPDSKPHVHGDAELEPNS(-18.01)EVQSK.I Y 67.00 2494.2087 23 -11.0 499.8435 5 51.32 6 25119 VEV_3_3_RA6_01_1237.d 1.03E6 2 2 289 311 Dehydration
R.DRNYNVPLR.I Y 64.16 1145.5941 9 -14.6 382.8664 3 46.32 5 22913 VEV_2_3_RA5_01_1236.d 1.01E6 8 8 180 188
R.IPDSKPHVHGDAELEPNSEVQ(+.98)SK.I Y 61.74 2513.2034 23 -10.6 503.6426 5 53.30 4 26988 VEV_1_3_RA4_01_1235.d 6.97E5 1 1 289 311 Deamidation (NQ)
R.IPDSKPHVHGDAE(+14.02)LEPNSEVQSK.I Y 59.79 2526.2349 23 -8.1 506.2502 5 55.77 4 28521 VEV_1_3_RA4_01_1235.d 1.01E6 1 1 289 311 Methylation(others)
R.NYNVPLR.I Y 58.18 874.4661 7 -12.5 438.2349 2 51.76 6 25328 VEV_3_3_RA6_01_1237.d 2.03E6 2 2 182 188
R.IPDS(-18.01)K(+14.02)PHVHGDAELEPNSEVQSK.I Y 55.74 2508.2244 23 -19.1 628.0514 4 51.44 4 25788 VEV_1_3_RA4_01_1235.d 0 1 1 289 311 Dehydration; Methylation(KR)
R.FC(+57.02)VGES(+162.05)GHEVK.V Y 48.88 1409.6133 11 -10.3 705.8066 2 34.24 6 15233 VEV_3_3_RA6_01_1237.d 8.68E5 3 3 122 132 Carbamidomethylation; Hexose (NSY)
R.FC(+57.02)VGESGHEVK.V Y 45.62 1247.5604 11 -0.6 624.7871 2 36.98 4 16925 VEV_1_3_RA4_01_1235.d 5.6E4 1 1 122 132 Carbamidomethylation
R.IPDSKPHVHGDAELEPNS(+14.02)EVQSK.I Y 44.43 2526.2349 23 -4.6 632.5631 4 56.75 4 29136 VEV_1_3_RA4_01_1235.d 0 1 1 289 311 Methylation(others)
R.IPDSKPHVHGDAELEPN(-17.03)SEVQSK.I Y 37.29 2495.1929 23 8.7 500.0502 5 51.64 6 25261 VEV_3_3_RA6_01_1237.d 0 1 1 289 311 Ammonia-loss (N)
R.IPDSKPHVHGDAELEPNS(+164.06)EVQSK.I Y 37.20 2676.2795 23 -11.2 536.2572 5 48.92 5 24497 VEV_2_3_RA5_01_1236.d 2.36E5 1 1 289 311 O-Diisopropylphosphorylation
R.I(+42.01)PDS(+79.97)K(+42.01)PHVHGDAELEPNSEVQSK.I Y 34.97 2676.2068 23 11.2 536.2546 5 48.96 6 23715 VEV_3_3_RA6_01_1237.d 2.66E5 1 1 289 311 Acetylation (N-term); Phosphorylation (STY); Acetylation (K)
R.IGSLFAILATSGIAVFGPILWAR.F Y 33.07 2372.3621 23 -10.9 791.7860 3 98.00 4 57549 VEV_1_3_RA4_01_1235.d 0 1 1 189 211
R.GLN(+.98)YEATTAAIVMAGIFLSFLVEYIGNR.I Y 28.25 3033.5520 28 -0.3 1012.1910 3 98.41 5 55471 VEV_2_3_RA5_01_1236.d 3.14E4 1 1 256 283 Deamidation (NQ)
total 26 peptides
C1GCJ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LVATDYTDGSEAATSELVESLR.K Y 135.91 2326.1177 22 -8.6 1164.0562 2 83.13 6 47279 VEV_3_3_RA6_01_1237.d 1.24E5 2 2 432 453
R.TIPNALTVTLNDGTVLKEVEVAAPLGHR.L Y 127.91 2927.6079 28 -3.9 732.9064 4 84.71 4 50382 VEV_1_3_RA4_01_1235.d 2.1E5 5 5 475 502
K.VSYPAEFHSQTAIEAAK.N Y 106.79 1847.9053 17 -14.9 616.9665 3 64.63 6 33833 VEV_3_3_RA6_01_1237.d 9.89E5 5 5 355 371
R.EYDSEIAAMANYIHNYNINSDLAFDTAR.W Y 105.94 3220.4407 28 -3.5 1074.4838 3 88.33 4 52709 VEV_1_3_RA4_01_1235.d 1.42E5 3 3 77 104
R.KSWAAGDAC(+57.02)QR.A Y 91.60 1248.5669 11 -6.4 625.2867 2 23.04 4 9027 VEV_1_3_RA4_01_1235.d 7.05E5 6 6 291 301 Carbamidomethylation
K.Q(-17.03)TADAITQAWVDGQSLR.T Y 88.86 1841.8907 17 -6.4 921.9468 2 85.94 6 49074 VEV_3_3_RA6_01_1237.d 1.49E5 2 2 263 279 Pyro-glu from Q
R.T(-2.02)IPNALTVTLNDGTVLKEVEVAAPLGHR.L Y 80.13 2925.5923 28 -21.1 732.3899 4 84.72 4 50399 VEV_1_3_RA4_01_1235.d 6.06E4 1 1 475 502 2-amino-3-oxo-butanoic_acid
R.WVFLDTLGC(+57.02)GLEALK.F Y 75.55 1720.8857 15 -12.1 861.4397 2 91.31 4 54394 VEV_1_3_RA4_01_1235.d 4.8E5 3 3 105 119 Carbamidomethylation
K.FQRPYGSYVMENVLFK.V Y 73.99 1976.9818 16 -9.6 659.9949 3 80.17 6 45280 VEV_3_3_RA6_01_1237.d 6.43E4 2 2 339 354
K.EVEVAAPLGHR.L Y 62.80 1176.6251 11 -13.7 589.3118 2 50.23 5 25276 VEV_2_3_RA5_01_1236.d 1.07E5 2 2 492 502
K.VPGTPYQLDPVNGAFNIGAMIR.W Y 54.31 2329.1887 22 -7.7 777.3975 3 87.78 4 52367 VEV_1_3_RA4_01_1235.d 2.21E4 1 1 142 163
K.TLESTDVDKYVDLYVK.K Y 49.08 1886.9513 16 -9.7 629.9849 3 78.73 5 45204 VEV_2_3_RA5_01_1236.d 5.95E4 1 1 541 556
R.TIPNALTVTLNDGT(-18.01)VLK(+14.02)EVEVAAPLGHR.L Y 44.37 2923.6130 28 -36.6 731.8838 4 84.59 5 48922 VEV_2_3_RA5_01_1236.d 3.87E4 1 1 475 502 Dehydration; Methylation(KR)
K.SWAAGDAC(+57.02)QR.A Y 41.47 1120.4719 10 41.3 561.2664 2 32.93 5 14952 VEV_2_3_RA5_01_1236.d 0 4 4 292 301 Carbamidomethylation
K.DIKDVTIR.T Y 30.41 958.5447 8 -10.6 320.5188 3 46.14 4 22475 VEV_1_3_RA4_01_1235.d 4.3E4 1 1 386 393
R.LRREEAKPEILAK.Y Y 29.81 1551.9095 13 -17.3 388.9780 4 37.08 6 16806 VEV_3_3_RA6_01_1237.d 3.88E5 2 2 503 515
R.AVNLALK.V Y 26.97 727.4592 7 -15.4 728.4553 1 48.35 6 23346 VEV_3_3_RA6_01_1237.d 4.74E4 2 2 302 308
K.TLESTDVDKYVDLYVKK.K Y 26.64 2015.0463 17 6.1 504.7719 4 75.29 5 42818 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 541 557
K.VMKGEPGVPTVLSAPVWGFYDVLFNGNK.F Y 25.00 3020.5469 28 -9.2 756.1370 4 101.93 6 55902 VEV_3_3_RA6_01_1237.d 0 1 1 309 336
R.TNRAGGSLGNGK.V Y 23.86 1130.5792 12 -27.0 377.8568 3 11.91 5 3396 VEV_2_3_RA5_01_1236.d 0 1 1 196 207
K.TLAGM(+15.99)GKSAK.D Y 22.98 978.5168 10 -35.1 490.2485 2 56.03 5 28781 VEV_2_3_RA5_01_1236.d 1.02E6 7 7 376 385 Oxidation (M)
MSVAR.Q Y 22.57 562.2897 5 -46.0 563.2711 1 33.32 4 14759 VEV_1_3_RA4_01_1235.d 0 1 1 1 5
R.AGGSLGNGK.V Y 22.54 759.3875 9 -54.3 760.3536 1 98.58 4 57733 VEV_1_3_RA4_01_1235.d 1.17E4 1 1 199 207
K.NINKTLAGMGKSAK.D Y 20.84 1431.7867 14 -41.8 478.2496 3 52.42 4 26437 VEV_1_3_RA4_01_1235.d 0 1 1 372 385
K.STVSR.S Y 20.18 548.2918 5 -10.7 549.2932 1 31.04 4 13437 VEV_1_3_RA4_01_1235.d 0 1 1 52 56
K.TLAGMGK.S Y 19.52 676.3578 7 -42.6 677.3362 1 76.70 4 44465 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 376 382
K.VATTAVVSK.M Y 18.14 874.5124 9 -31.3 438.2498 2 23.37 5 9541 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 247 255
K.AHEIQGVLALENSYNK.V Y 18.05 1784.9056 16 -11.3 595.9691 3 65.94 4 36015 VEV_1_3_RA4_01_1235.d 0 1 1 221 236
K.MLGLNEKQTADAITQAWVDGQSLR.T Y 17.68 2644.3279 24 -9.8 882.4413 3 84.90 6 48402 VEV_3_3_RA6_01_1237.d 4.69E4 1 1 256 279
K.MLGLNEK(-1.03)QTADAITQAWVDGQSLR.T Y 17.46 2643.2961 24 -0.9 882.1052 3 84.82 6 48346 VEV_3_3_RA6_01_1237.d 0 1 1 256 279 Lysine oxidation to aminoadipic semialdehyde
K.LGLDQK.T Y 17.35 672.3806 6 -42.4 673.3594 1 16.69 5 5920 VEV_2_3_RA5_01_1236.d 1.56E4 2 2 535 540
K.TLAGMGKSAK.D Y 17.22 962.5219 10 -13.7 321.8435 3 32.83 5 14905 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 376 385
R.QLASSSVAASSLR.S Y 16.28 1275.6782 13 -27.9 426.2215 3 15.65 6 5288 VEV_3_3_RA6_01_1237.d 1.71E4 1 1 23 35
R.AGGSLGN(+162.05)GK(+42.01).V Y 15.10 963.4509 9 -3.4 482.7311 2 35.63 5 16546 VEV_2_3_RA5_01_1236.d 3.02E4 1 1 199 207 Hexose (NSY); Acetylation (K)
R.EEAKPEILAK.Y Y 15.05 1126.6233 10 -56.3 564.2872 2 36.10 5 16832 VEV_2_3_RA5_01_1236.d 0 1 1 506 515
total 35 peptides
C1G7L4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGPGHSEVATGR.G Y 112.01 1153.5476 12 -10.5 577.7750 2 13.45 5 4225 VEV_2_3_RA5_01_1236.d 5.56E5 6 6 1730 1741
R.MTGSSSYVQQGDLDWHDAK.S Y 105.75 2123.9219 19 -17.3 708.9690 3 66.38 6 35164 VEV_3_3_RA6_01_1237.d 8.41E4 2 2 930 948
R.Q(-17.03)AQEWAGLDQNPDADLLVFVGR.W Y 95.69 2424.1709 22 -10.2 1213.0803 2 94.79 6 53520 VEV_3_3_RA6_01_1237.d 1.53E5 3 3 1440 1461 Pyro-glu from Q
K.NLFYPYEELTLIPGPK.K Y 94.85 1892.9923 16 -14.6 631.9955 3 88.27 6 50388 VEV_3_3_RA6_01_1237.d 7.48E5 8 8 665 680
K.QNFFLPGEITGGNTLGSIYLGR.G Y 94.22 2353.2065 22 -7.3 1177.6019 2 88.34 4 52718 VEV_1_3_RA4_01_1235.d 2.17E5 3 3 336 357
R.HGGDIQGLVDSLDYLQGMGIK.G Y 91.36 2215.0942 21 4.0 739.3749 3 87.59 4 52307 VEV_1_3_RA4_01_1235.d 3.37E4 1 1 97 117
K.GVDLIADVFPAVLEAR.K Y 88.38 1683.9196 16 -12.4 842.9566 2 91.68 6 52166 VEV_3_3_RA6_01_1237.d 2.26E5 3 3 1467 1482
R.YVQFGEVFNLLHAGASYLR.L Y 88.22 2183.1162 19 -11.8 728.7041 3 89.71 6 51162 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 1350 1368
K.Q(-17.03)NFFLPGEITGGNTLGSIYLGR.G Y 86.75 2336.1799 22 -13.3 779.7236 3 94.93 6 53573 VEV_3_3_RA6_01_1237.d 5.73E5 6 6 336 357 Pyro-glu from Q
R.M(+15.99)TGSSSYVQQGDLDWHDAK.S Y 85.71 2139.9167 19 -9.2 714.3063 3 64.83 4 35147 VEV_1_3_RA4_01_1235.d 5.41E4 2 2 930 948 Oxidation (M)
R.NTASVDHFLFR.I Y 79.14 1305.6466 11 -7.1 436.2197 3 69.70 4 39002 VEV_1_3_RA4_01_1235.d 3.06E5 2 2 830 840
K.GVDLIADVFPAVLEARK.N Y 77.80 1812.0144 17 5.3 605.0153 3 86.86 5 50237 VEV_2_3_RA5_01_1236.d 3.79E4 2 2 1467 1483
R.LHQQGFGAVGVSK.K Y 76.90 1326.7043 13 -8.6 443.2383 3 48.07 4 23674 VEV_1_3_RA4_01_1235.d 8.79E4 4 4 1369 1381
R.DVSPGPDIENEITPQGLGSK.V Y 75.92 2052.0010 20 -13.8 1026.9937 2 77.66 6 43487 VEV_3_3_RA6_01_1237.d 5.51E4 3 3 1704 1723
R.SSEQYFIREEGK.V Y 66.22 1471.6942 12 -8.9 736.8478 2 51.20 4 25635 VEV_1_3_RA4_01_1235.d 1.01E6 6 6 378 389
R.SRNPSYSSPQR.M Y 65.73 1277.6112 11 -14.8 426.8714 3 16.72 6 5845 VEV_3_3_RA6_01_1237.d 5.98E5 7 7 1677 1687
R.IGQHDNPMVFTR.S Y 64.52 1413.6823 12 -9.5 472.2302 3 60.65 4 31966 VEV_1_3_RA4_01_1235.d 2.9E5 4 4 841 852
K.VDPFFTDSNGEFYR.A Y 62.35 1692.7419 14 4.7 847.3823 2 79.69 5 45853 VEV_2_3_RA5_01_1236.d 7.61E4 2 2 1870 1883
R.SFIPLSIR.Q Y 57.23 931.5491 8 -14.8 466.7749 2 76.98 6 42993 VEV_3_3_RA6_01_1237.d 1.7E5 3 3 1111 1118
K.FASVQDR.L Y 53.19 821.4031 7 -1.6 411.7082 2 24.83 6 10106 VEV_3_3_RA6_01_1237.d 0 2 2 272 278
R.M(+15.99)T(-18.01)GSSSYVQQGDLDWHDAK.S Y 51.47 2121.9062 19 50.3 708.3450 3 66.77 4 36665 VEV_1_3_RA4_01_1235.d 0 1 1 930 948 Oxidation (M); Dehydration
K.ALQVTVDALADMSEHYREC(+57.02)AR.K Y 46.61 2434.1370 21 2.2 609.5428 4 78.53 4 45892 VEV_1_3_RA4_01_1235.d 4.25E4 1 1 311 331 Carbamidomethylation
R.KQDKPSSIFR.V Y 43.83 1204.6564 10 -41.7 603.3104 2 28.27 5 12278 VEV_2_3_RA5_01_1236.d 0 1 1 1926 1935
R.NPSYSSPQR.M Y 43.64 1034.4781 9 1.3 518.2470 2 20.74 5 8143 VEV_2_3_RA5_01_1236.d 1.4E5 3 3 1679 1687
R.RFPHLFWNGPYNQYGFDAGLR.N Y 42.53 2554.2295 21 -24.0 639.5493 4 83.54 6 47540 VEV_3_3_RA6_01_1237.d 8.37E4 2 2 951 971
R.LSSVSSLSLGSVVGGKTDFK.L Y 37.82 1967.0575 20 1.2 656.6939 3 76.88 6 42914 VEV_3_3_RA6_01_1237.d 2.97E4 1 1 1847 1866
R.FVRPRPMVTQFMPGHDAR.L Y 36.84 2141.0774 18 -18.7 536.2666 4 67.82 5 37390 VEV_2_3_RA5_01_1236.d 1.45E5 1 1 713 730
K.GVDLIADVFPAVLEAR(+14.02).K Y 34.71 1697.9352 16 1.0 849.9757 2 92.76 6 52657 VEV_3_3_RA6_01_1237.d 0 1 1 1467 1482 Methylation(KR)
K.AYVPVDR.F Y 31.92 818.4286 7 -15.0 410.2154 2 37.62 6 17123 VEV_3_3_RA6_01_1237.d 2.56E5 2 2 706 712
R.SFTRFPIFWGLK.K Y 30.09 1497.8132 12 -5.7 500.2755 3 84.00 6 47826 VEV_3_3_RA6_01_1237.d 7.29E4 1 1 1387 1398
R.Q(-17.03)AQ(+.98)EWAGLDQNPDADLLVFVGR.W Y 26.91 2425.1550 22 10.7 809.4009 3 94.77 6 53508 VEV_3_3_RA6_01_1237.d 1.82E4 1 1 1440 1461 Pyro-glu from Q; Deamidation (NQ)
K.AEPYPGR.M Y 26.52 788.3817 7 -12.3 395.1932 2 21.25 6 8217 VEV_3_3_RA6_01_1237.d 1.12E4 2 2 1256 1262
R.LREWVPSVR.D Y 25.40 1140.6404 9 -1.1 381.2203 3 63.50 6 33003 VEV_3_3_RA6_01_1237.d 4.13E4 1 1 279 287
K.VSLGVR.S Y 25.31 629.3860 6 -19.3 315.6942 2 35.00 6 15649 VEV_3_3_RA6_01_1237.d 1.79E5 2 2 1724 1729
K.GALGIGAR.V Y 25.16 713.4184 8 -5.4 357.7145 2 13.81 4 4207 VEV_1_3_RA4_01_1235.d 0 1 1 1556 1563
R.HSC(+57.02)M(+15.99)VIAQLDIDGFRYDK.A Y 21.65 2183.0139 18 -11.4 728.6703 3 78.83 6 44317 VEV_3_3_RA6_01_1237.d 0 1 1 293 310 Carbamidomethylation; Oxidation (M)
R.TFSPNK.I Y 20.36 692.3493 6 13.6 693.3660 1 87.49 6 49934 VEV_3_3_RA6_01_1237.d 0 1 1 2360 2365
R.QAQEWAGLD(-18.01)QNPDADLLVFVGR.W Y 19.88 2423.1870 22 -22.5 1212.5735 2 94.88 5 54168 VEV_2_3_RA5_01_1236.d 3.92E4 1 1 1440 1461 Dehydration
K.LYPGR.V N 19.76 604.3333 5 -40.5 605.3160 1 21.14 6 8165 VEV_3_3_RA6_01_1237.d 0 1 1 1511 1515
R.HGGDIQGLVDSLDYLQGM(+15.99)GIK(+42.01).G Y 19.17 2273.0999 21 -1.7 569.2812 4 80.91 6 45798 VEV_3_3_RA6_01_1237.d 3E4 1 1 97 117 Oxidation (M); Acetylation (K)
R.DAITEIHR.R Y 18.44 953.4930 8 -17.9 954.4832 1 86.35 4 51470 VEV_1_3_RA4_01_1235.d 3.37E4 1 1 156 163
R.FLQSTSNLVGESGHR.R Y 17.14 1630.8063 15 2.7 816.4126 2 82.41 5 47599 VEV_2_3_RA5_01_1236.d 8.02E4 1 1 1144 1158
R.DEPFGLVAVEFGR.K Y 16.42 1434.7142 13 -20.7 479.2355 3 62.38 6 32182 VEV_3_3_RA6_01_1237.d 5.32E4 1 1 1542 1554
R.QPNM(+15.99)RPETLEIAVK.L Y 16.39 1640.8556 14 -15.7 547.9506 3 34.11 5 15642 VEV_2_3_RA5_01_1236.d 0 2 2 360 373 Oxidation (M)
R.MSVVGLQSK.N Y 15.24 947.5110 9 -13.6 316.8400 3 20.49 5 7998 VEV_2_3_RA5_01_1236.d 0 1 1 1688 1696
R.QLAKFASVQDR.L Y 15.05 1261.6779 11 -39.2 421.5501 3 51.91 4 26105 VEV_1_3_RA4_01_1235.d 0 1 1 268 278
K.VPSFYK.S Y 15.01 739.3904 6 -45.4 740.3641 1 103.55 6 56376 VEV_3_3_RA6_01_1237.d 0 1 1 2191 2196
total 47 peptides
C1G1P4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IIAAIDNPADIC(+57.02)VISARPYGQR.A Y 127.11 2412.2583 22 -28.1 604.0549 4 78.71 6 44232 VEV_3_3_RA6_01_1237.d 6.56E5 5 5 66 87 Carbamidomethylation
K.TRPDGINVINIGKTWEK.I Y 113.35 1940.0480 17 -8.3 486.0153 4 71.92 4 40792 VEV_1_3_RA4_01_1235.d 3.3E5 2 2 43 59
K.EASYVNIPVIALC(+57.02)DTDSPTEFVDVAIPTNNKGR.H Y 113.14 3604.7720 33 -6.5 1202.5901 3 88.10 4 52566 VEV_1_3_RA4_01_1235.d 4.18E5 3 3 138 170 Carbamidomethylation
K.EASYVNIPVIALC(+57.02)DTDSPTEFVDVAIPTNNK.G Y 112.17 3391.6492 31 -6.0 1131.5502 3 90.94 6 51822 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 138 168 Carbamidomethylation
K.FAAHTGAVAIAGR.F Y 111.00 1240.6676 13 -15.0 621.3318 2 50.42 6 24553 VEV_3_3_RA6_01_1237.d 2.88E6 16 16 92 104
M.APSNLPPVFNATSQDIEMLLAAQC(+57.02)HLGSK.N Y 101.26 3108.5371 29 -9.6 1037.1764 3 90.47 4 53910 VEV_1_3_RA4_01_1235.d 1.72E6 10 10 2 30 Carbamidomethylation
R.FTPGNFTNYITR.S Y 99.05 1429.6990 12 -14.1 715.8467 2 76.95 6 42990 VEV_3_3_RA6_01_1237.d 1.81E6 3 3 105 116
K.TRPDGINVINIGK.T Y 84.34 1395.7833 13 -10.8 466.2634 3 65.49 4 35661 VEV_1_3_RA4_01_1235.d 4.16E5 3 3 43 55
K.NLQVHMEPYLWK.T Y 73.47 1556.7810 12 -9.7 779.3903 2 76.12 4 44002 VEV_1_3_RA4_01_1235.d 5.48E4 2 2 31 42
K.TRPDGINVINIGKTWEKIVLAAR.I Y 70.33 2563.4597 23 31.7 513.7155 5 84.74 4 50407 VEV_1_3_RA4_01_1235.d 0 2 2 43 65
R.LIIVTDPRTDSQAIK.E Y 67.85 1668.9410 15 -10.5 835.4690 2 68.30 5 37770 VEV_2_3_RA5_01_1236.d 2.93E5 3 3 123 137
R.IIAAIDN(+.98)PADIC(+57.02)VISARPYGQR.A Y 65.49 2413.2424 22 0.3 604.3181 4 78.84 4 46126 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 66 87 Deamidation (NQ); Carbamidomethylation
R.FTPGN(+.98)FTNYITR.S Y 62.03 1430.6830 12 -1.3 716.3478 2 77.08 6 43062 VEV_3_3_RA6_01_1237.d 4.98E5 2 2 105 116 Deamidation (NQ)
R.LIIVTDPR.T Y 55.78 925.5596 8 -13.3 463.7809 2 64.34 5 34821 VEV_2_3_RA5_01_1236.d 1.76E6 6 6 123 130
M.APSNLPPVFNATSQ(+.98)DIEMLLAAQC(+57.02)HLGSK.N Y 52.84 3109.5212 29 -8.3 1037.5057 3 90.78 5 52286 VEV_2_3_RA5_01_1236.d 2.32E5 1 1 2 30 Deamidation (NQ); Carbamidomethylation
R.TDSQAIKEASYVNIPVIALC(+57.02)DTDSPTEFVDVAIPTNNKGR.H Y 50.57 4348.1533 40 1.4 1088.0471 4 86.24 6 49215 VEV_3_3_RA6_01_1237.d 7.88E4 1 1 131 170 Carbamidomethylation
R.FTPGNFTNYITR(+14.02).S Y 43.72 1443.7146 12 -8.4 722.8585 2 78.40 5 44992 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 105 116 Methylation(KR)
K.TWEKIVLAAR.I Y 36.52 1185.6870 10 -27.9 396.2253 3 68.67 6 36891 VEV_3_3_RA6_01_1237.d 4.8E4 1 1 56 65
R.SFKEPR.L Y 32.86 762.4024 6 -16.8 382.2021 2 14.63 4 4622 VEV_1_3_RA4_01_1235.d 1.05E6 3 3 117 122
R.IIAAIDNPADIC(+57.02)VISARPYGQ(+.98)R.A Y 31.18 2413.2424 22 -12.9 805.4111 3 79.28 4 46464 VEV_1_3_RA4_01_1235.d 7.3E4 1 1 66 87 Carbamidomethylation; Deamidation (NQ)
K.NLQVHM(+15.99)EPYLWK.T Y 28.06 1572.7759 12 -6.1 525.2627 3 68.55 4 38077 VEV_1_3_RA4_01_1235.d 0 1 1 31 42 Oxidation (M)
R.LIIVTDPR(+14.02).T Y 26.89 939.5753 8 -9.6 470.7904 2 67.57 5 37198 VEV_2_3_RA5_01_1236.d 1.54E5 1 1 123 130 Methylation(KR)
R.HAIGLIWWMLAR.E Y 24.92 1465.8016 12 -54.4 489.5812 3 48.18 6 23260 VEV_3_3_RA6_01_1237.d 8.27E4 1 1 171 182
K.IVLAAR.I Y 24.14 641.4224 6 -12.3 321.7145 2 35.42 4 15987 VEV_1_3_RA4_01_1235.d 4.76E5 2 2 60 65
M.APSNLPPVFNATSQDIEM(+15.99)LLAAQC(+57.02)HLGSK.N Y 23.79 3124.5322 29 -25.3 782.1205 4 89.27 6 50931 VEV_3_3_RA6_01_1237.d 0 1 1 2 30 Oxidation (M); Carbamidomethylation
K.FAAHTGAVAIAGRFTPGNFTNYITRSFKEPR.L Y 18.13 3396.7478 31 20.4 680.3707 5 88.40 4 52750 VEV_1_3_RA4_01_1235.d 0 1 1 92 122
R.FTPGNFTN(+.98)YITR.S Y 16.54 1430.6830 12 -7.7 716.3433 2 78.56 6 44120 VEV_3_3_RA6_01_1237.d 5.49E4 1 1 105 116 Deamidation (NQ)
R.G(+27.99)TLANR.E Y 15.36 658.3398 6 1.8 330.1778 2 38.40 6 17577 VEV_3_3_RA6_01_1237.d 0 1 1 189 194 Formylation
total 28 peptides
C1GB62
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YTDEDGEPDEPPAPTQETKEDLTR.F Y 117.44 2732.1936 24 -9.6 911.7297 3 62.51 6 32273 VEV_3_3_RA6_01_1237.d 1.24E5 2 2 148 171
R.TGPAEAFFDKLFDNELNVLAR.E Y 114.52 2366.1907 21 -3.8 789.7345 3 93.53 4 55617 VEV_1_3_RA4_01_1235.d 4.62E5 3 3 830 850
R.YTDEDGEPDEPPAPTQETK.E Y 95.59 2117.8911 19 -2.7 1059.9500 2 55.82 4 28518 VEV_1_3_RA4_01_1235.d 5.18E4 1 1 148 166
K.GTGVVTSVPSDSPDDYATVVDLSK.K Y 95.49 2408.1594 24 -8.0 1205.0774 2 79.39 6 44729 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 430 453
K.SGDAFPFADPAGK.V Y 91.66 1278.5880 13 -11.3 640.2941 2 72.28 6 39570 VEV_3_3_RA6_01_1237.d 5.04E5 4 4 542 554
R.LFTLKEWIEEVAKDDSLR.T Y 91.08 2191.1523 18 -19.2 548.7849 4 87.68 4 52305 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 812 829
K.SGDAFPFADPAGKVVSR.S Y 87.77 1719.8579 17 -11.0 574.2869 3 72.91 5 41108 VEV_2_3_RA5_01_1236.d 2.29E5 3 3 542 558
R.DQSELEPVVEAPGSAFVGTLVNAPLSVHTEGVR.I Y 82.56 3403.7258 33 -12.9 1135.5679 3 87.88 4 52433 VEV_1_3_RA4_01_1235.d 1.42E5 1 1 386 418
R.TTASNITSSEATFVR.K Y 81.84 1583.7791 15 -8.8 792.8898 2 65.70 4 35832 VEV_1_3_RA4_01_1235.d 1.76E5 2 2 952 966
R.IAFADAGDAIEDANFEESVANSNILR.L Y 69.35 2751.2986 26 -6.4 918.1010 3 86.77 5 50180 VEV_2_3_RA5_01_1236.d 7.72E4 1 1 786 811
K.STGNFLTLKDAVDKYGADATR.I Y 68.91 2242.1228 21 -29.2 561.5216 4 75.75 6 42096 VEV_3_3_RA6_01_1237.d 9.31E4 2 2 765 785
R.REFEYWYPLDVR.V Y 62.38 1671.8044 12 -0.5 558.2751 3 79.73 4 46865 VEV_1_3_RA4_01_1235.d 5.65E4 3 3 707 718
K.SALYDFTSAR.D Y 60.77 1129.5404 10 -9.3 565.7722 2 68.42 6 36704 VEV_3_3_RA6_01_1237.d 1.95E5 2 2 867 876
R.QFVTTDANPYYDAFTR.W Y 59.17 1907.8689 16 -2.8 954.9390 2 79.15 4 46365 VEV_1_3_RA4_01_1235.d 1.22E4 1 1 236 251
K.VSDKEYYVVTKR.A Y 53.16 1485.7827 12 -22.9 496.2568 3 40.71 4 19113 VEV_1_3_RA4_01_1235.d 1.11E5 2 2 355 366
R.RQFVTTDANPYYDAFTR.W Y 51.67 2063.9700 17 -0.7 688.9968 3 74.43 4 42688 VEV_1_3_RA4_01_1235.d 2.26E4 1 1 235 251
K.FGNFFER.Y Y 48.51 915.4238 7 -17.6 458.7111 2 70.67 4 39738 VEV_1_3_RA4_01_1235.d 6.27E4 1 1 141 147
R.EFEYWYPLDVR.V Y 41.22 1515.7034 11 34.1 758.8848 2 84.66 4 50357 VEV_1_3_RA4_01_1235.d 9.5E3 1 1 708 718
M.A(+42.01)AAAAAAAALDASNSAK.N Y 37.83 1485.7423 17 -6.8 743.8734 2 81.02 5 46719 VEV_2_3_RA5_01_1236.d 6.37E4 1 1 2 18 Acetylation (Protein N-term)
MAAAAAAAAALDASNSAK.N Y 30.85 1574.7722 18 -13.5 394.6950 4 17.14 6 6056 VEV_3_3_RA6_01_1237.d 9.26E4 1 1 1 18
K.VEFM(+15.99)AGTAR.M Y 25.69 996.4698 9 9.1 499.2467 2 35.47 6 15927 VEV_3_3_RA6_01_1237.d 4.02E3 1 1 100 108 Oxidation (M)
K.LGEM(+15.99)K.K Y 24.37 592.2891 5 3.7 593.2985 1 20.83 5 8197 VEV_2_3_RA5_01_1236.d 3.65E4 1 1 1026 1030 Oxidation (M)
K.VKEWSPAVR.E Y 23.85 1070.5873 9 -31.3 536.2842 2 42.52 4 20239 VEV_1_3_RA4_01_1235.d 0 1 1 303 311
K.DALLTM(+15.99)R.R Y 23.83 834.4269 7 -13.1 835.4233 1 95.25 4 56404 VEV_1_3_RA4_01_1235.d 6.59E3 1 1 700 706 Oxidation (M)
K.AMPFVQGLK.K Y 21.85 989.5368 9 -3.5 495.7739 2 71.49 4 40390 VEV_1_3_RA4_01_1235.d 8.54E4 1 1 1032 1040
R.LGIKPEQM(+15.99)TDEIWDFVFTR.R Y 21.56 2340.1460 19 -6.2 586.0402 4 78.19 5 44844 VEV_2_3_RA5_01_1236.d 8.43E4 1 1 666 684 Oxidation (M)
R.DFYRESTTAAGIGMHR.D Y 21.23 1810.8420 16 -5.5 363.1737 5 37.78 4 17382 VEV_1_3_RA4_01_1235.d 0 1 1 877 892
R.YGKEPGR.L Y 20.32 805.4082 7 -30.6 806.3909 1 111.51 4 61527 VEV_1_3_RA4_01_1235.d 9.44E2 1 1 659 665
R.IDWRRQFVTTDANPYYDAFTRWQM(+15.99)NR.L Y 19.52 3365.5789 26 28.2 842.4257 4 107.92 5 58291 VEV_2_3_RA5_01_1236.d 7.85E4 1 1 231 256 Oxidation (M)
M(+15.99)AAAAAAAAALDASNSAK.N Y 19.12 1590.7671 18 9.3 531.2679 3 68.73 5 38069 VEV_2_3_RA5_01_1236.d 3.25E4 1 1 1 18 Oxidation (M)
K.GTM(+15.99)LHGEYKGQPVQEAK.E Y 18.95 1887.9149 17 12.0 630.3198 3 75.19 6 41676 VEV_3_3_RA6_01_1237.d 2.7E5 1 1 516 532 Oxidation (M)
K.DALLTM(+15.99)RR.E Y 18.79 990.5280 8 61.4 331.2036 3 45.23 4 21909 VEV_1_3_RA4_01_1235.d 0 1 1 700 707 Oxidation (M)
R.TGPAEAFFDK.L Y 17.83 1081.5079 10 -8.8 541.7565 2 48.16 4 23727 VEV_1_3_RA4_01_1235.d 3.54E4 1 1 830 839
K.AKELAYSEGFYK.G Y 17.74 1404.6925 12 -9.5 352.1771 4 16.99 5 6106 VEV_2_3_RA5_01_1236.d 0 1 1 504 515
K.EYYVVTK.R Y 17.65 900.4592 7 -26.7 451.2249 2 21.22 4 8058 VEV_1_3_RA4_01_1235.d 0 1 1 359 365
K.YIDLVREAFDAVSLSINDK.E Y 17.06 2167.1160 19 -4.9 723.3757 3 81.09 6 45925 VEV_3_3_RA6_01_1237.d 1.89E4 1 1 999 1017
K.GQPVQEAK.E Y 16.89 855.4450 8 -2.0 428.7289 2 21.47 5 8531 VEV_2_3_RA5_01_1236.d 6.49E4 1 1 525 532
K.LENTDKR.D Y 16.81 874.4508 7 0.0 438.2327 2 14.81 5 4925 VEV_2_3_RA5_01_1236.d 4.42E4 1 1 23 29
K.GPLNMYSEEAR.H Y 16.35 1265.5710 11 14.0 633.8016 2 62.80 5 33639 VEV_2_3_RA5_01_1236.d 0 1 1 592 602
R.TTGC(+57.02)K.I Y 16.33 565.2530 5 11.5 566.2668 1 20.33 6 7725 VEV_3_3_RA6_01_1237.d 2.16E4 1 1 1076 1080 Carbamidomethylation
K.LVDDIK.K Y 15.39 701.3959 6 -11.9 702.3949 1 77.29 6 43217 VEV_3_3_RA6_01_1237.d 0 1 1 134 139
total 41 peptides
C1G0G4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLGFDTLKVNVVPVTQQQSDNRPR.R Y 137.55 2697.4197 24 -12.3 675.3539 4 75.80 6 42133 VEV_3_3_RA6_01_1237.d 1.1E6 6 6 113 136
R.KDQYVPEISALDVSQTESGQLDVDADTKDLLK.S Y 120.74 3519.7468 32 -14.1 880.9316 4 81.69 6 46333 VEV_3_3_RA6_01_1237.d 2.43E5 2 2 81 112
R.IC(+57.02)DEIAIIASK.R Y 105.24 1231.6482 11 -15.7 616.8217 2 72.33 6 39608 VEV_3_3_RA6_01_1237.d 1.6E6 6 6 34 44 Carbamidomethylation
R.IC(+57.02)DEIAIIASKR.L Y 103.49 1387.7493 12 -17.0 463.5825 3 67.48 6 36038 VEV_3_3_RA6_01_1237.d 1.82E6 3 3 34 45 Carbamidomethylation
K.VNVVPVTQQQSDNRPR.R Y 97.14 1835.9602 16 -11.4 612.9871 3 48.07 6 23229 VEV_3_3_RA6_01_1237.d 1.39E6 12 12 121 136
R.YYPKLTLDFETNKR.I Y 85.94 1786.9253 14 -10.0 447.7341 4 70.50 5 39356 VEV_2_3_RA5_01_1236.d 6.28E5 3 3 20 33
K.LTLDFETNKR.I Y 77.45 1235.6510 10 -19.7 412.8828 3 62.30 6 32154 VEV_3_3_RA6_01_1237.d 3.03E6 7 7 24 33
K.VIIERYYPK.L Y 69.85 1179.6652 9 -12.1 590.8327 2 60.45 5 31920 VEV_2_3_RA5_01_1236.d 4.03E5 4 4 15 23
R.NKIAGYTTHLMK.R Y 67.39 1375.7281 12 -17.9 688.8590 2 52.85 4 26705 VEV_1_3_RA4_01_1235.d 8.53E5 7 7 48 59
R.IC(+57.02)DEIAIIASK(+14.02)R.L Y 61.87 1401.7649 12 -13.4 468.2560 3 70.10 5 39064 VEV_2_3_RA5_01_1236.d 2.26E5 2 2 34 45 Carbamidomethylation; Methylation(KR)
K.IAGYTTHLMKR.I Y 55.49 1289.6914 11 -12.8 645.8447 2 47.19 5 23506 VEV_2_3_RA5_01_1236.d 9.85E5 7 7 50 60
K.RIC(+57.02)DEIAIIASK.R Y 54.32 1387.7493 12 -2.8 463.5891 3 71.89 4 40706 VEV_1_3_RA4_01_1235.d 9.61E4 1 1 33 44 Carbamidomethylation
R.IC(+57.02)DE(+14.02)IAIIASK.R Y 49.66 1245.6638 11 -10.7 623.8325 2 76.99 5 44067 VEV_2_3_RA5_01_1236.d 4.85E4 1 1 34 44 Carbamidomethylation; Methylation(others)
R.NKIAGYTTHLMKR.I Y 49.16 1531.8293 13 -9.4 383.9610 4 49.48 4 24557 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 48 60
K.SLGFDTLK.V Y 43.29 879.4702 8 -11.8 440.7372 2 67.21 4 37047 VEV_1_3_RA4_01_1235.d 1.12E6 3 3 113 120
R.IC(+57.02)DE(+14.02)IAIIASKR.L Y 42.34 1401.7649 12 -14.8 468.2553 3 72.12 4 40890 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 34 45 Carbamidomethylation; Methylation(others)
K.SLGFDTLKVNVVPVTQQQSDN(+.98)RPR.R Y 40.62 2698.4038 24 24.6 540.7013 5 76.34 5 43546 VEV_2_3_RA5_01_1236.d 0 1 1 113 136 Deamidation (NQ)
K.LTLDFE(+14.02)TNKR.I Y 38.77 1249.6666 10 -10.8 417.5583 3 66.91 4 36776 VEV_1_3_RA4_01_1235.d 2.43E5 1 1 24 33 Methylation(others)
R.IQRGPVR.G Y 35.23 824.4980 7 -20.9 413.2477 2 13.28 5 4139 VEV_2_3_RA5_01_1236.d 4.48E5 3 3 61 67
K.LTLDFETNKRIC(+57.02)DEIAIIASK.R Y 33.97 2449.2886 21 -13.2 613.3214 4 82.61 5 47718 VEV_2_3_RA5_01_1236.d 2.08E5 1 1 24 44 Carbamidomethylation
K.LTLDFETNKR(+14.02).I Y 32.57 1249.6666 10 -9.6 417.5588 3 63.81 4 34369 VEV_1_3_RA4_01_1235.d 9.85E4 1 1 24 33 Methylation(KR)
K.VNVVPVTQQQ(+.98)SDNRPR.R Y 29.94 1836.9442 16 -21.5 613.3088 3 51.19 6 24979 VEV_3_3_RA6_01_1237.d 7.35E4 1 1 121 136 Deamidation (NQ)
K.VNVVPVTQQQSDN(+.98)RPR.R Y 29.39 1836.9442 16 -9.3 613.3163 3 52.24 4 26322 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 121 136 Deamidation (NQ)
K.LTLDFETNK(+14.02)R.I Y 28.68 1249.6666 10 -16.1 417.5561 3 63.55 6 33038 VEV_3_3_RA6_01_1237.d 0 1 1 24 33 Methylation(KR)
K.IAGYTTHLM(+15.99)K.R Y 27.83 1149.5852 10 -11.2 575.7935 2 40.18 6 18595 VEV_3_3_RA6_01_1237.d 9.56E4 1 1 50 59 Oxidation (M)
R.RFGGAR Y 27.59 662.3612 6 -10.4 332.1844 2 11.20 4 2942 VEV_1_3_RA4_01_1235.d 2.71E5 3 3 137 142
R.GISFK.L N 26.40 550.3115 5 -46.6 551.2931 1 30.57 6 13175 VEV_3_3_RA6_01_1237.d 0 1 1 68 72
R.FGGAR N 25.15 506.2601 5 -21.1 507.2567 1 58.57 4 30415 VEV_1_3_RA4_01_1235.d 2.36E5 5 5 138 142
K.VNVVPVTQ(+.98)QQSDNRPR.R Y 24.73 1836.9442 16 -10.3 613.3157 3 51.83 4 26052 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 121 136 Deamidation (NQ)
K.IAGYTTHLMK.R Y 23.65 1133.5903 10 7.5 378.8735 3 50.30 5 25312 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 50 59
K.VIIERYYPKLTLDFETNKR.I Y 22.71 2397.3057 19 -15.6 600.3243 4 76.30 5 43521 VEV_2_3_RA5_01_1236.d 5.48E4 1 1 15 33
K.LQEEERER.K Y 21.80 1087.5258 8 23.5 544.7830 2 11.67 5 3276 VEV_2_3_RA5_01_1236.d 5.94E4 3 3 73 80
K.VIIER.Y N 21.52 628.3908 5 -72.7 315.1798 2 26.72 5 11510 VEV_2_3_RA5_01_1236.d 1.15E6 7 7 15 19
total 33 peptides
C1G9T0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPAPTNSSPAPEAR.D Y 126.33 1380.6633 14 -6.6 691.3344 2 30.68 5 13695 VEV_2_3_RA5_01_1236.d 6.46E5 9 9 1030 1043
R.AGAGGRDFSTNIPGER.M Y 115.36 1603.7703 16 -15.6 535.5891 3 56.53 5 29110 VEV_2_3_RA5_01_1236.d 7.44E5 5 5 988 1003
R.DGSTPTASGTPAVWRPK.F Y 103.26 1726.8638 17 -10.6 576.6224 3 61.84 4 32882 VEV_1_3_RA4_01_1235.d 4.19E5 5 5 1044 1060
K.TASFVLLSALSIPVISTSR.S Y 98.25 1961.1196 19 -26.1 981.5415 2 92.36 6 52470 VEV_3_3_RA6_01_1237.d 1.5E5 4 4 342 360
K.GIDVSEINLEELDSNSLR.T Y 92.55 2001.9855 18 -11.6 1001.9884 2 83.24 6 47343 VEV_3_3_RA6_01_1237.d 2.43E5 2 2 685 702
R.SAESEVGSVQR.L Y 88.66 1147.5469 11 -8.1 574.7761 2 31.87 5 14352 VEV_2_3_RA5_01_1236.d 9.83E4 1 1 537 547
R.TTGGYVYPQRR.A Y 70.40 1296.6575 11 -18.4 649.3241 2 30.98 6 13415 VEV_3_3_RA6_01_1237.d 9.94E5 6 6 977 987
R.LVPYFNEFRK.N Y 68.75 1311.6975 10 -12.4 438.2344 3 70.75 4 39798 VEV_1_3_RA4_01_1235.d 4.54E5 5 5 785 794
R.SPAPTNSSPAPEAR(+14.02).D Y 65.82 1394.6790 14 -8.1 698.3411 2 37.59 6 17110 VEV_3_3_RA6_01_1237.d 1.16E5 2 2 1030 1043 Methylation(KR)
K.YLPADYDAQR.K Y 61.46 1210.5618 10 7.9 606.2930 2 55.24 4 28186 VEV_1_3_RA4_01_1235.d 6.14E5 8 8 741 750
R.LQSTPAEIAR.S Y 61.20 1084.5876 10 -14.1 543.2935 2 45.19 5 22242 VEV_2_3_RA5_01_1236.d 8E5 6 6 548 557
R.AAEKEFENKKR.Q Y 58.76 1348.7098 11 -13.1 450.5713 3 10.97 6 2902 VEV_3_3_RA6_01_1237.d 3.05E5 7 7 810 820
R.QAAKEAEAAAAAAGAGTATPPAEATASSTREELSLPR.T Y 47.91 3522.7549 37 1.8 881.6976 4 71.62 5 40191 VEV_2_3_RA5_01_1236.d 5.38E4 1 1 940 976
K.EAEAAAAAAGAGT(-2.02)ATPPAEATASSTREELSLPR.T Y 46.65 3122.5115 33 -19.5 1041.8241 3 71.96 4 40761 VEV_1_3_RA4_01_1235.d 1.85E4 1 1 944 976 2-amino-3-oxo-butanoic_acid
R.ELYNILEVDFHPLSIC(+57.02)K.K Y 43.01 2089.0554 17 -7.3 697.3540 3 86.24 4 51391 VEV_1_3_RA4_01_1235.d 5.59E4 1 1 413 429 Carbamidomethylation
R.Q(+.98)SAAAIAAGQSTK.K Y 39.78 1203.6095 13 3.5 602.8141 2 28.55 6 12071 VEV_3_3_RA6_01_1237.d 2.62E4 1 1 316 328 Deamidation (NQ)
R.Q(-17.03)SAAAIAAGQSTK.K Y 35.00 1185.5989 13 9.9 593.8126 2 55.08 4 28098 VEV_1_3_RA4_01_1235.d 0 1 1 316 328 Pyro-glu from Q
K.EAALESLQK.K Y 33.22 987.5236 9 -12.3 494.7630 2 45.92 4 22339 VEV_1_3_RA4_01_1235.d 6.3E4 2 2 616 624
R.TQELQEAER.R Y 32.61 1102.5254 9 -15.2 552.2616 2 25.02 6 10213 VEV_3_3_RA6_01_1237.d 2.56E5 2 2 637 645
R.LTNLLGMPQAPTR.A Y 31.65 1410.7653 13 -56.6 706.3500 2 75.53 4 43542 VEV_1_3_RA4_01_1235.d 0 1 1 379 391
R.S(-2.02)PAPTNSSPAPEAR.D Y 30.69 1378.6477 14 105.3 690.4037 2 30.77 6 13288 VEV_3_3_RA6_01_1237.d 0 1 1 1030 1043 2-amino-3-oxo-butanoic_acid
K.AMHPGSAAR.S Y 30.07 896.4286 9 14.7 449.2282 2 11.70 4 3207 VEV_1_3_RA4_01_1235.d 2.49E4 2 2 528 536
R.EAVPPPKTLSR.S Y 29.40 1193.6768 11 -62.7 398.8746 3 35.50 5 16473 VEV_2_3_RA5_01_1236.d 0 3 3 1019 1029
R.EELSLPRTTGGYVYPQR.R Y 28.04 1964.9955 17 13.9 656.0149 3 74.92 4 43066 VEV_1_3_RA4_01_1235.d 5.88E4 2 2 970 986
K.NIAQNSNVGTIEMVLKK.F Y 27.57 1857.9982 17 -15.3 620.3305 3 73.55 4 42017 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 78 94
R.LHDEHLER.E Y 26.08 1047.5098 8 -6.3 524.7589 2 15.92 6 5434 VEV_3_3_RA6_01_1237.d 1.95E4 1 1 648 655
R.RLHDEHLERER.K Y 26.05 1488.7545 11 15.0 373.2015 4 48.56 5 24265 VEV_2_3_RA5_01_1236.d 1.53E4 1 1 647 657
K.EAALESLQKKQQEEER.R Y 25.19 1914.9646 16 -17.1 958.4732 2 86.17 4 51419 VEV_1_3_RA4_01_1235.d 2.37E5 3 3 616 631
R.QSAAAIAAGQSTK.K Y 25.05 1202.6255 13 -26.0 602.3044 2 28.69 5 12505 VEV_2_3_RA5_01_1236.d 7.09E4 1 1 316 328
K.AM(+15.99)HPGSAAR.S Y 22.82 912.4236 9 -19.7 457.2101 2 14.89 6 4874 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 528 536 Oxidation (M)
R.LC(+57.02)ELLR.N Y 22.32 802.4371 6 -25.6 402.2155 2 56.59 6 28105 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 208 213 Carbamidomethylation
R.LNLAGR.T Y 21.41 642.3813 6 -14.6 322.1932 2 53.89 4 27369 VEV_1_3_RA4_01_1235.d 2.23E5 4 4 926 931
R.LVPYFNEFR.K Y 21.34 1183.6025 9 -9.0 395.5379 3 18.98 4 6880 VEV_1_3_RA4_01_1235.d 3.42E4 1 1 785 793
R.NHVQNAAK.Y Y 20.82 880.4515 8 -13.5 441.2271 2 50.91 6 24822 VEV_3_3_RA6_01_1237.d 3.71E4 1 1 214 221
R.SRGALVDVDEVRKNK.N Y 20.68 1684.9220 15 -3.9 422.2361 4 70.10 6 37934 VEV_3_3_RA6_01_1237.d 0 1 1 361 375
R.HVEFEKNR.R Y 20.66 1057.5305 8 -12.7 353.5130 3 14.34 5 4692 VEV_2_3_RA5_01_1236.d 1.59E4 1 1 801 808
R.AGAGGR.D Y 19.64 487.2503 6 -35.2 488.2404 1 29.16 4 12385 VEV_1_3_RA4_01_1235.d 1.41E5 4 4 988 993
K.LAQLEK.E Y 19.43 700.4119 6 19.9 351.2202 2 35.54 5 16509 VEV_2_3_RA5_01_1236.d 0 3 3 706 711
K.RIDHLER.A Y 19.31 937.5093 7 -25.6 469.7499 2 17.02 5 6118 VEV_2_3_RA5_01_1236.d 7.56E4 1 1 726 732
R.QREEQERIEK.E Y 18.57 1343.6793 10 -6.2 672.8428 2 71.64 6 39093 VEV_3_3_RA6_01_1237.d 7.14E4 1 1 844 853
R.IEKEEQERAARDAER.R Y 17.94 1828.9027 15 1.7 915.4602 2 90.53 5 52159 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 851 865
R.EELSLPR.T Y 17.76 842.4498 7 -10.7 843.4480 1 103.30 5 57035 VEV_2_3_RA5_01_1236.d 1.24E5 2 2 970 976
K.SAKEGLYQYK.N Y 16.09 1185.6029 10 -25.8 396.1980 3 20.81 5 8180 VEV_2_3_RA5_01_1236.d 0 1 1 68 77
R.SRGALVDVDEVRK.N Y 15.98 1442.7841 13 -31.5 481.9202 3 68.97 5 38252 VEV_2_3_RA5_01_1236.d 7.47E4 1 1 361 373
R.EEQER.I N 15.90 689.2980 5 36.6 345.6689 2 9.94 4 2436 VEV_1_3_RA4_01_1235.d 6.47E3 1 1 846 850
K.YLPADYDAQRKRDIEIYEK.N Y 15.59 2385.1963 19 -10.7 597.3000 4 84.07 5 48603 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 741 759
K.AKAGAAKEHEETLAR.R Y 15.46 1580.8270 15 -9.7 396.2102 4 14.70 6 4793 VEV_3_3_RA6_01_1237.d 6.54E4 1 1 593 607
R.LFQQLSQVYESVEVK.F Y 15.27 1795.9355 15 -4.4 599.6498 3 67.93 4 37587 VEV_1_3_RA4_01_1235.d 4.56E4 1 1 459 473
R.DFSTNIPGERMSERM(+15.99)SER.G Y 15.17 2156.9578 18 -9.5 540.2416 4 56.49 4 28949 VEV_1_3_RA4_01_1235.d 0 1 1 994 1011 Oxidation (M)
total 49 peptides
C1FZ57
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TYAAEIGHAVSSGK.R Y 136.13 1389.6888 14 -9.2 695.8453 2 56.79 4 29213 VEV_1_3_RA4_01_1235.d 4E6 13 13 168 181
K.VFLVQNPKDVELLLMHNR.T Y 131.80 2164.1826 18 -8.7 542.0482 4 81.10 4 47882 VEV_1_3_RA4_01_1235.d 6.95E5 4 4 150 167
R.TYAAE(+14.02)IGHAVSSGK.R Y 91.35 1403.7045 14 -10.8 702.8519 2 60.14 5 31653 VEV_2_3_RA5_01_1236.d 4.63E5 4 4 168 181 Methylation(others)
R.HLTPSGHKVFLVQNPK.D Y 88.27 1800.9999 16 -7.6 451.2538 4 56.57 4 29007 VEV_1_3_RA4_01_1235.d 8.93E5 6 6 142 157
R.TYAAEIGHAVSSGKR.I Y 88.21 1545.7899 15 -11.8 516.2645 3 50.29 4 25055 VEV_1_3_RA4_01_1235.d 2.54E6 11 11 168 182
R.HLTPSGHK.V Y 87.54 875.4613 8 -11.5 438.7329 2 9.86 5 2459 VEV_2_3_RA5_01_1236.d 1.75E5 4 4 142 149
K.DVELLLMHNR.T Y 77.25 1238.6442 10 -13.6 620.3209 2 72.44 4 41145 VEV_1_3_RA4_01_1235.d 6.3E5 7 7 158 167
K.ALGVKVTNPK.G Y 76.20 1025.6233 10 -20.6 513.8083 2 35.47 5 16448 VEV_2_3_RA5_01_1236.d 9.38E5 7 7 191 200
R.FNRHQSDRYK.C Y 71.18 1349.6588 10 -12.8 450.8878 3 13.16 5 4056 VEV_2_3_RA5_01_1236.d 3.83E5 5 5 94 103
R.FSGQASM(+15.99)PK.I Y 68.23 967.4433 9 0.8 484.7293 2 17.62 4 6197 VEV_1_3_RA4_01_1235.d 5.84E5 13 13 123 131 Oxidation (M)
R.FSGQASMPK.I Y 66.57 951.4484 9 -7.6 476.7278 2 37.28 5 17537 VEV_2_3_RA5_01_1236.d 3.22E6 6 6 123 131
K.IGYGSNKK.T Y 61.80 865.4658 8 -26.5 433.7287 2 11.44 6 3162 VEV_3_3_RA6_01_1237.d 1.65E5 3 3 132 139
R.TYAAEIGHAVSSGK(+14.02).R Y 59.59 1403.7045 14 -11.2 468.9035 3 62.22 5 33206 VEV_2_3_RA5_01_1236.d 5.38E5 3 3 168 181 Methylation(KR)
K.IGYGSNKKTR.H Y 54.24 1122.6145 10 -26.7 562.2996 2 11.37 5 3144 VEV_2_3_RA5_01_1236.d 2.91E4 2 2 132 141
R.FSGQ(+.98)ASMPK.I Y 46.07 952.4324 9 -5.1 477.2210 2 41.90 4 19849 VEV_1_3_RA4_01_1235.d 8.63E4 1 1 123 131 Deamidation (NQ)
K.HITIVKK.H Y 45.31 837.5436 7 -18.6 419.7713 2 18.04 6 6536 VEV_3_3_RA6_01_1237.d 4.85E5 4 4 83 89
R.FSGQASMPK(+14.02).I Y 43.98 965.4641 9 -8.0 483.7354 2 50.68 4 25291 VEV_1_3_RA4_01_1235.d 0 1 1 123 131 Methylation(KR)
R.RFSGQASMPK.I Y 42.68 1107.5494 10 -8.7 554.7772 2 30.93 4 13368 VEV_1_3_RA4_01_1235.d 2.87E5 5 5 122 131
K.C(+57.02)VDPSWRKPK.G Y 34.89 1271.6444 10 -15.8 424.8820 3 27.79 5 12018 VEV_2_3_RA5_01_1236.d 6.66E5 4 4 104 113 Carbamidomethylation
R.RFSGQASM(+15.99)PK.I Y 34.59 1123.5444 10 -11.4 562.7731 2 15.13 6 5013 VEV_3_3_RA6_01_1237.d 1.03E5 5 5 122 131 Oxidation (M)
K.C(+58.01)VDPSWR.K Y 33.06 919.3858 7 -1.8 460.6993 2 52.88 6 25981 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 104 110 Carboxymethyl
R.RFSGQASM(-48.00)PK.I Y 32.77 1059.5461 10 -11.0 354.1854 3 10.85 4 2795 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 122 131 Dethiomethyl
K.M(+15.99)VAAK.K Y 30.68 534.2836 5 -40.3 535.2693 1 64.07 5 34582 VEV_2_3_RA5_01_1236.d 0 1 1 77 81 Oxidation (M)
K.KHITIVKK.H Y 29.99 965.6385 8 -17.6 483.8181 2 15.06 5 5063 VEV_2_3_RA5_01_1236.d 1.58E5 2 2 82 89
R.IDIIAK.A Y 29.70 671.4218 6 -21.6 336.7109 2 47.11 6 22621 VEV_3_3_RA6_01_1237.d 9.27E5 4 4 183 188
K.RIDIIAK.A Y 29.54 827.5228 7 -19.3 414.7607 2 39.70 6 18314 VEV_3_3_RA6_01_1237.d 1.28E6 5 5 182 188
K.GRLTTES Y 28.40 762.3871 7 3.9 382.2023 2 35.02 4 15762 VEV_1_3_RA4_01_1235.d 5.08E5 1 1 201 207
R.RRFSGQASMPK.I Y 27.95 1263.6506 11 -13.0 422.2187 3 28.45 5 12374 VEV_2_3_RA5_01_1236.d 4.77E5 2 2 121 131
K.C(+57.02)VDPSWR.K Y 27.82 918.4018 7 5.1 460.2105 2 44.56 4 21487 VEV_1_3_RA4_01_1235.d 0 4 4 104 110 Carbamidomethylation
K.AKALGVK.V Y 27.64 685.4486 7 -26.4 343.7225 2 13.68 5 4329 VEV_2_3_RA5_01_1236.d 6.32E4 1 1 189 195
K.VFLVQNPK.D Y 26.38 943.5491 8 -47.8 472.7593 2 59.86 6 30351 VEV_3_3_RA6_01_1237.d 8.4E4 1 1 150 157
K.MVAAK.K Y 26.35 518.2886 5 -3.3 519.2942 1 30.24 6 12998 VEV_3_3_RA6_01_1237.d 0 1 1 77 81
K.HITIVK.K Y 25.87 709.4487 6 -52.8 355.7129 2 24.60 6 9998 VEV_3_3_RA6_01_1237.d 0 3 3 83 88
R.T(+14.02)YAAEIGHAVSSGKR.I Y 25.06 1559.8055 15 -34.1 390.9454 4 56.06 4 28671 VEV_1_3_RA4_01_1235.d 0 1 1 168 182 Methylation(others)
R.T(+43.01)YAAEIGHAVSSGKR.I Y 24.92 1588.7958 15 63.4 398.2314 4 50.16 6 24388 VEV_3_3_RA6_01_1237.d 0 1 1 168 182 Carbamylation
K.GIDNRVR.R Y 22.90 828.4565 7 -15.4 415.2292 2 14.60 5 4812 VEV_2_3_RA5_01_1236.d 4.44E5 2 2 114 120
R.TYAAE(+14.02)IGHAVSSGKR.I Y 21.98 1559.8055 15 -69.6 390.9315 4 55.86 6 27663 VEV_3_3_RA6_01_1237.d 0 1 1 168 182 Methylation(others)
K.VFLVQNPKDVELLLM(+15.99)HNR.T Y 21.78 2180.1775 18 -3.6 546.0497 4 79.19 4 46394 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 150 167 Oxidation (M)
R.FSGQASM(-48.00)PK.I Y 20.35 903.4450 9 -20.0 452.7207 2 10.20 6 2587 VEV_3_3_RA6_01_1237.d 7.92E4 1 1 123 131 Dethiomethyl
R.LTTES Y 20.34 549.2646 5 -5.4 550.2689 1 48.17 6 23255 VEV_3_3_RA6_01_1237.d 0 1 1 203 207
R.FNRHQSDR.Y Y 19.66 1058.5006 8 -6.7 530.2540 2 9.54 4 2308 VEV_1_3_RA4_01_1235.d 7.41E3 1 1 94 101
R.R(+160.04)RFSGQASMPK.I Y 17.85 1423.6877 11 6.1 475.5728 3 37.64 5 17728 VEV_2_3_RA5_01_1236.d 0 1 1 121 131 Condensation product of glucosone
K.G(+42.01)IDNR.V Y 16.67 615.2976 5 -8.0 616.3000 1 46.31 5 22910 VEV_2_3_RA5_01_1236.d 0 1 1 114 118 Acetylation (N-term)
K.MVAAK(+27.99).K Y 16.34 546.2836 5 -93.7 547.2397 1 11.56 5 3231 VEV_2_3_RA5_01_1236.d 0 1 1 77 81 Formylation
K.IGYGSNK.K Y 16.14 737.3708 7 10.1 738.3855 1 105.17 6 56815 VEV_3_3_RA6_01_1237.d 0 1 1 132 138
total 45 peptides
C1G8H6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LYGSGAGGAPGGDDDEPSGHDEL Y 107.77 2171.8879 23 -7.7 1086.9429 2 65.50 4 35684 VEV_1_3_RA4_01_1235.d 6.27E5 3 3 655 677
K.TVTNAVVTVPAYFNDNQR.Q Y 103.52 2008.0013 18 -10.2 670.3342 3 77.35 4 44966 VEV_1_3_RA4_01_1235.d 4.63E5 4 4 184 201
R.VVNEPTAAAIAYGLDK.T Y 101.24 1630.8566 16 -10.6 816.4269 2 75.77 5 43151 VEV_2_3_RA5_01_1236.d 1.13E5 3 3 218 233
R.VVNEPTAAAIAYGLDKTGDER.Q Y 99.24 2189.0964 21 -9.2 730.6993 3 73.97 4 42360 VEV_1_3_RA4_01_1235.d 3.94E5 3 3 218 238
K.DNNLLGKFELTGIPPAPR.G N 92.55 1951.0526 18 -15.0 651.3484 3 82.62 4 48975 VEV_1_3_RA4_01_1235.d 4.19E5 8 8 495 512
K.VQALLEEFFGGKK.A Y 86.94 1464.7976 13 -7.3 489.2696 3 80.42 4 47338 VEV_1_3_RA4_01_1235.d 2.96E5 3 3 391 403
K.LSNVAYPITSK.L Y 85.51 1191.6499 11 -10.4 596.8260 2 61.24 4 32415 VEV_1_3_RA4_01_1235.d 4.93E5 4 4 644 654
R.NTLENYAFSLK.N Y 83.78 1298.6506 11 -9.8 650.3262 2 76.41 4 44230 VEV_1_3_RA4_01_1235.d 3.1E5 3 3 583 593
R.ITPSYVAFTDDERLVGDAAK.N Y 82.27 2167.0796 20 -7.2 723.3619 3 77.18 5 44150 VEV_2_3_RA5_01_1236.d 6.55E4 1 1 83 102
K.DAGTIAGLNVLR.V Y 81.12 1198.6670 12 -11.7 600.3337 2 77.36 5 44273 VEV_2_3_RA5_01_1236.d 2.66E5 3 3 206 217
R.KSQIFSTAADNQPVVLIQVYEGERPLTK.D Y 78.45 3130.6663 28 12.8 783.6838 4 80.32 4 47267 VEV_1_3_RA4_01_1235.d 0 1 1 467 494
R.Q(-17.03)ATKDAGTIAGLNVLR.V Y 78.40 1609.8788 16 -11.1 805.9377 2 76.82 5 43902 VEV_2_3_RA5_01_1236.d 3.83E4 1 1 202 217 Pyro-glu from Q
K.SQIFSTAADNQPVVLIQVYEGERPLTK.D Y 75.14 3002.5713 27 -12.1 751.6410 4 83.44 4 49524 VEV_1_3_RA4_01_1235.d 2.9E4 2 2 468 494
K.ATTEDFEEQKEK.L Y 74.56 1453.6572 12 -9.2 485.5552 3 25.09 4 10178 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 632 643
K.MKEVAENYLGK.T Y 63.62 1280.6434 11 -6.2 641.3250 2 51.21 4 25639 VEV_1_3_RA4_01_1235.d 3.12E5 1 1 173 183
R.IPKVQALLEEFFGGKK.A Y 60.77 1803.0294 16 -12.4 451.7590 4 86.00 5 49734 VEV_2_3_RA5_01_1236.d 7.16E4 2 2 388 403
K.LYGSGAGGAPGGDDDEPSGHDE(+14.02)L Y 53.24 2185.9036 23 -6.9 1093.9515 2 68.38 4 37941 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 655 677 Methylation(others)
R.IEIEAFHDGKDFSETLTR.A Y 50.69 2107.0222 18 -9.3 527.7579 4 74.55 4 42786 VEV_1_3_RA4_01_1235.d 1.42E5 2 2 327 344
R.ITPSYVAFTDDER.L Y 48.92 1512.7096 13 -16.2 757.3499 2 71.17 6 38738 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 83 95
K.NQYAANPQR.T Y 43.64 1060.5050 9 -2.8 531.2583 2 17.82 6 6414 VEV_3_3_RA6_01_1237.d 2.95E5 4 4 103 111
R.LSQEEIDRMVAEAAEFAEEDKAMK.A Y 38.69 2739.2729 24 53.8 685.8624 4 86.16 4 51343 VEV_1_3_RA4_01_1235.d 0 1 1 553 576
R.VVNKDGKPQVK.V Y 37.62 1210.7034 11 -34.2 606.3383 2 12.12 4 3356 VEV_1_3_RA4_01_1235.d 0 1 1 140 150
R.QATKDAGTIAGLNVLR.V Y 37.00 1626.9053 16 -25.8 543.2950 3 82.19 4 48661 VEV_1_3_RA4_01_1235.d 1.04E4 1 1 202 217
R.AKFEELNMDLFKK.T Y 32.23 1611.8330 13 -7.2 403.9626 4 73.19 4 41732 VEV_1_3_RA4_01_1235.d 2.51E5 2 2 345 357
R.NTVIPTR.K Y 31.82 799.4552 7 -7.4 400.7319 2 33.45 4 14837 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 460 466
K.TLRPVEQVLKDAK.V Y 30.54 1495.8722 13 -14.6 374.9699 4 63.17 5 33910 VEV_2_3_RA5_01_1236.d 7.36E4 1 1 358 370
K.VTAGDK.G Y 29.07 589.3071 6 -27.1 590.2985 1 62.58 5 33483 VEV_2_3_RA5_01_1236.d 1.39E5 4 4 531 536
R.NTVIPTRK.S Y 27.83 927.5502 8 -15.7 464.7751 2 20.84 5 8217 VEV_2_3_RA5_01_1236.d 1.22E5 3 3 460 467
K.VTAGDKGTGK.A Y 27.21 932.4927 10 -5.7 467.2510 2 58.82 6 29602 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 531 540
R.LVGDAAK.N Y 26.51 672.3806 7 -51.7 673.3531 1 87.17 4 51986 VEV_1_3_RA4_01_1235.d 6.68E4 1 1 96 102
K.DNNLLGK(+226.08)FELTGIPPAPR.G N 24.58 2177.1301 18 -6.5 545.2863 4 77.62 4 45183 VEV_1_3_RA4_01_1235.d 3.24E4 1 1 495 512 Biotinylation
K.FELTGIPPAPR.G N 23.40 1196.6553 11 -22.5 300.1644 4 12.44 4 3520 VEV_1_3_RA4_01_1235.d 0 2 2 502 512
R.KFDDQDAQKDIK.H Y 21.85 1449.7100 12 -17.7 484.2354 3 29.14 6 12409 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 123 134
R.ITPSYVAFTDDERLVGDAAKNQYAANPQR.T Y 21.43 3209.5740 29 -14.9 803.3888 4 76.85 5 43910 VEV_2_3_RA5_01_1236.d 0 1 1 83 111
R.TLSSQMSTR.I Y 20.10 1009.4863 9 -21.2 505.7397 2 29.47 5 12998 VEV_2_3_RA5_01_1236.d 6.7E4 1 1 318 326
K.VQALLEEFFGGK.K Y 19.69 1336.7026 12 -34.4 669.3356 2 74.77 5 42433 VEV_2_3_RA5_01_1236.d 0 1 1 391 402
K.RLIGR.K N 19.03 613.4023 5 -22.7 307.7015 2 17.13 6 6051 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 118 122
K.VEVNGK.D Y 17.89 644.3493 6 -29.5 323.1724 2 23.00 4 8999 VEV_1_3_RA4_01_1235.d 2.89E5 1 1 151 156
R.TIFDIKR.L Y 17.59 891.5178 7 -69.8 446.7350 2 58.13 6 29112 VEV_3_3_RA6_01_1237.d 1.03E5 1 1 112 118
R.LSQEEIDR(+14.02).M Y 17.35 1002.4982 8 -44.3 502.2342 2 22.76 5 9217 VEV_2_3_RA5_01_1236.d 9.76E4 1 1 553 560 Methylation(KR)
R.VINHFVK.Q Y 16.87 855.4966 7 -11.5 428.7507 2 29.28 5 12859 VEV_2_3_RA5_01_1236.d 8.56E4 1 1 282 288
K.A(+58.01)ESITITNDKGR.L Y 16.08 1361.6786 12 -23.9 454.8893 3 20.96 5 8264 VEV_2_3_RA5_01_1236.d 6.72E4 1 1 541 552 Carboxymethyl (KW, X@N-term)
R.LSQEEIDR.M Y 15.98 988.4825 8 4.1 495.2505 2 32.00 6 13980 VEV_3_3_RA6_01_1237.d 2.02E4 1 1 553 560
K.SEIHDIVLVGGSTR.I Y 15.98 1481.7838 14 -38.4 494.9162 3 60.30 6 30660 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 374 387
total 44 peptides
C1GN84
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ITSFDDGDGGIVTR.L Y 118.43 1451.6892 14 -13.1 726.8423 2 66.58 6 35345 VEV_3_3_RA6_01_1237.d 1.16E6 6 6 352 365
R.AAVAAANDSGQVWK.G Y 113.04 1386.6891 14 -9.5 694.3452 2 57.30 4 29549 VEV_1_3_RA4_01_1235.d 7.6E5 7 7 620 633
R.VQVVASGPAEMGHDLR.A Y 110.36 1664.8304 16 -8.8 555.9459 3 63.29 5 34003 VEV_2_3_RA5_01_1236.d 1.29E6 7 7 604 619
R.NILAIAGGTGISFALPLAAAAAASGNK.E Y 103.71 2439.3484 27 -13.0 814.1129 3 92.62 6 52588 VEV_3_3_RA6_01_1237.d 2.51E5 3 3 455 481
K.Q(-17.03)LQNNSQHAYVIR.C Y 98.13 1552.7747 13 -12.8 777.3847 2 63.37 6 32932 VEV_3_3_RA6_01_1237.d 4.54E5 3 3 402 414 Pyro-glu from Q
R.LPLLASNSSGDITIPVILTGPYGTHVLDK.S Y 91.93 2990.6328 29 -9.8 997.8751 3 88.31 5 51033 VEV_2_3_RA5_01_1236.d 2E5 2 2 423 451
K.QLQNNSQHAYVIR.C Y 79.42 1569.8011 13 -5.6 785.9034 2 43.00 4 20538 VEV_1_3_RA4_01_1235.d 1.73E5 3 3 402 414
R.LPLLASNSSGDITIPVILTGPYGTHVLDKSTR.N Y 74.28 3334.8135 32 20.3 834.7275 4 85.67 6 48876 VEV_3_3_RA6_01_1237.d 0 1 1 423 454
R.AAVAAANDSGQ(+.98)VWK.G Y 73.79 1387.6731 14 0.7 694.8443 2 57.10 6 28431 VEV_3_3_RA6_01_1237.d 1.12E5 2 2 620 633 Deamidation (NQ)
R.NIEWVQDELTVLLHSHPK.N Y 71.92 2157.1218 18 2.2 720.0494 3 85.59 4 50974 VEV_1_3_RA4_01_1235.d 2.94E5 3 3 499 516
R.VQVVASGPAEM(+15.99)GHDLR.A Y 70.77 1680.8253 16 -8.9 841.4125 2 53.67 4 27237 VEV_1_3_RA4_01_1235.d 6.37E5 6 6 604 619 Oxidation (M)
K.GKEEFDVSLYWDNR Y 70.25 1756.8057 14 -9.2 440.2047 4 77.25 4 44895 VEV_1_3_RA4_01_1235.d 6.43E4 2 2 634 647
R.AENLSLSDEK.T Y 68.03 1104.5298 10 -13.8 553.2645 2 41.65 6 19448 VEV_3_3_RA6_01_1237.d 6.47E5 7 7 538 547
R.IFVSREPSMELTNTHR.A Y 67.25 1915.9574 16 -22.9 639.6451 3 63.30 5 34017 VEV_2_3_RA5_01_1236.d 3.95E5 4 4 522 537
K.GIGFKPAEGK.I Y 63.19 1002.5498 10 -12.9 502.2757 2 35.67 5 16572 VEV_2_3_RA5_01_1236.d 7.92E5 7 7 342 351
R.HIQGQESKIPHWGYSSR.L Y 61.16 2008.9867 17 -25.0 402.7946 5 56.70 5 29215 VEV_2_3_RA5_01_1236.d 2.72E5 4 4 10 26
R.TTLGPLANR.I Y 59.65 941.5294 9 -16.1 471.7644 2 52.52 6 25771 VEV_3_3_RA6_01_1237.d 1.06E6 7 7 168 176
K.Q(-17.03)LQNNSQ(+.98)HAYVIR.C Y 59.35 1553.7587 13 -12.4 777.8770 2 64.92 6 34057 VEV_3_3_RA6_01_1237.d 3.63E4 1 1 402 414 Pyro-glu from Q; Deamidation (NQ)
R.AWNALSAGAR.H Y 59.11 1015.5199 10 -5.7 508.7643 2 58.65 6 29487 VEV_3_3_RA6_01_1237.d 3.11E5 3 3 102 111
R.NILAIAGGTGIS(-2.02)FALPLAAAAAASGNK.E Y 50.94 2437.3328 27 -60.8 813.4021 3 92.66 6 52605 VEV_3_3_RA6_01_1237.d 0 1 1 455 481 2-amino-3-oxo-butanoic_acid
R.LYQPQPK.V Y 49.91 872.4756 7 -15.2 437.2384 2 27.43 4 11431 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 238 244
R.C(+57.02)LSGETSRLPLLASNSSGDITIPVILTGPYGTHVLDK.S Y 49.29 3881.0244 37 2.6 971.2659 4 86.74 4 51715 VEV_1_3_RA4_01_1235.d 4.13E4 1 1 415 451 Carbamidomethylation
R.ENILSLITGIPYR.H Y 43.12 1487.8347 13 21.0 744.9402 2 90.62 4 54005 VEV_1_3_RA4_01_1235.d 0 1 1 195 207
K.Q(-17.03)LQNN(+.98)SQHAYVIR.C Y 41.61 1553.7587 13 -7.2 777.8810 2 64.95 5 35234 VEV_2_3_RA5_01_1236.d 3.23E4 1 1 402 414 Pyro-glu from Q; Deamidation (NQ)
K.IPHWGYSSR.L Y 41.29 1101.5355 9 -12.9 368.1810 3 54.16 4 27534 VEV_1_3_RA4_01_1235.d 2.04E5 3 3 18 26
R.ELEGQTLVK.A Y 39.84 1015.5549 9 -7.3 508.7810 2 51.51 4 25833 VEV_1_3_RA4_01_1235.d 6.44E5 6 6 87 95
R.AAVAAANDSGQVWK(+31.99).G Y 34.48 1418.6790 14 -4.8 710.3434 2 36.44 6 16462 VEV_3_3_RA6_01_1237.d 5.57E4 1 1 620 633 Dihydroxy
R.TRNIEWVQDELTVLLHSHPK.N Y 29.42 2414.2705 20 1.0 483.8619 5 82.81 4 49098 VEV_1_3_RA4_01_1235.d 3.95E4 1 1 497 516
R.KPGSR.R Y 26.37 543.3129 5 -12.6 544.3133 1 27.93 4 11711 VEV_1_3_RA4_01_1235.d 2.72E4 1 1 81 85
R.IFVSREPSM(+15.99)ELTNTHR.A Y 23.06 1931.9523 16 -13.0 483.9890 4 57.81 6 28909 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 522 537 Oxidation (M)
R.HYLLPESLVNFFGHVTR.L Y 22.46 2028.0581 17 -7.4 508.0181 4 80.43 4 47354 VEV_1_3_RA4_01_1235.d 0 1 1 112 128
R.AAVAAANDSGQVW(+15.99)K.G Y 20.65 1402.6841 14 -39.5 702.3216 2 49.95 5 25116 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 620 633 Oxidation (HW)
R.HDQPPWEAGQHFFLC(+57.02)FPDITIWQSHPFTPFPK.Q Y 20.51 3906.8406 32 3.6 782.3782 5 90.40 5 52094 VEV_2_3_RA5_01_1236.d 0 1 1 370 401 Carbamidomethylation
K.ITSFDDGDGGIVTR(+14.02).L Y 19.38 1465.7048 14 -5.8 733.8555 2 70.31 4 39457 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 352 365 Methylation(KR)
R.Y(+162.05)KGIGFKPAEGK.I Y 19.22 1455.7609 12 -5.0 728.8841 2 59.36 4 31023 VEV_1_3_RA4_01_1235.d 1.83E5 2 2 340 351 Hexose (NSY)
R.VVRWTGYEFFRK.S Y 17.33 1586.8357 12 -25.8 794.4047 2 73.51 5 41532 VEV_2_3_RA5_01_1236.d 9.07E4 1 1 276 287
K.NSSSFSTR.T Y 16.93 884.3988 8 24.3 443.2174 2 15.00 6 4946 VEV_3_3_RA6_01_1237.d 0 1 1 160 167
R.C(+57.02)LS(-18.01)GETSRLPLLASN(+.98)SSGDITIPVILTGPYGTHVLDK.S Y 15.73 3863.9978 37 -5.6 967.0013 4 91.18 5 52482 VEV_2_3_RA5_01_1236.d 6.18E4 1 1 415 451 Carbamidomethylation; Dehydration; Deamidation (NQ)
total 38 peptides
A0A0A0HU84
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGTGGGGGGGGAAAAAAAVAAR.E Y 133.20 1627.8026 22 -16.2 543.5994 3 59.22 6 29867 VEV_3_3_RA6_01_1237.d 1.44E6 9 9 270 291
K.ALSSSQSSTSNSKDKPAPATR.S Y 110.53 2119.0505 21 -5.3 530.7671 4 18.13 4 6428 VEV_1_3_RA4_01_1235.d 4.44E5 7 7 22 42
R.GASFSSNLVNLLR.T Y 106.91 1376.7412 13 -11.5 689.3699 2 82.70 4 49016 VEV_1_3_RA4_01_1235.d 2.18E5 3 3 318 330
R.AIHPYFILVQAVSIGDLDGFVNTVQK.H Y 100.28 2843.5220 26 -2.5 948.8456 3 93.79 4 55719 VEV_1_3_RA4_01_1235.d 5.39E5 4 4 481 506
R.LSGDPDQNRTDVAMNR.A Y 92.54 1787.8220 16 -8.2 596.9431 3 45.27 4 21930 VEV_1_3_RA4_01_1235.d 3.5E5 4 4 144 159
K.AIRDGVIEASLDHER.G Y 77.00 1679.8590 15 -17.3 420.9648 4 61.98 6 31886 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 566 580
R.LGLDSEESAEYIVAK.A Y 74.79 1622.8038 15 -10.7 812.4005 2 75.00 4 43126 VEV_1_3_RA4_01_1235.d 2.48E5 3 3 551 565
R.DKALSDIKSNFSLLER.A Y 73.58 1834.9788 16 -10.3 459.7472 4 75.49 6 41901 VEV_3_3_RA6_01_1237.d 1.76E5 2 2 177 192
K.GSAEQQQQQQQQQQQQQQQQQAATR.D Y 69.04 2938.3625 25 -3.3 980.4583 3 25.35 4 10310 VEV_1_3_RA4_01_1235.d 2.38E4 1 1 99 123
R.DGGDGDEEMTVVVPPSK.S Y 66.14 1730.7668 17 -6.6 866.3849 2 68.28 4 37860 VEV_1_3_RA4_01_1235.d 1.39E5 2 2 124 140
K.DVGDVYATAEPGEVFHER.I Y 64.95 1989.9067 18 -12.2 664.3015 3 73.54 6 40477 VEV_3_3_RA6_01_1237.d 2.45E5 3 3 587 604
R.SIFRQPALER.A Y 64.77 1215.6724 10 -19.7 406.2234 3 61.01 6 31169 VEV_3_3_RA6_01_1237.d 4.62E5 3 3 471 480
K.SNFSLLER.A Y 61.55 964.4977 8 -17.7 483.2476 2 66.99 6 35618 VEV_3_3_RA6_01_1237.d 9.38E5 3 3 185 192
K.ALSSSQ(+.98)SSTSNSKDKPAPATR.S Y 57.79 2120.0344 21 -4.9 531.0133 4 20.21 4 7503 VEV_1_3_RA4_01_1235.d 5.83E4 1 1 22 42 Deamidation (NQ)
K.SPSTHTAGGFYQASTK.L Y 41.76 1638.7638 16 8.2 547.2664 3 39.67 4 18509 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 440 455
R.DK(-1.03)ALSDIKSNFSLLER.A Y 39.94 1833.9471 16 -20.0 612.3108 3 75.50 5 42982 VEV_2_3_RA5_01_1236.d 2.92E4 1 1 177 192 Lysine oxidation to aminoadipic semialdehyde
K.ALSDIKSNFSLLER.A Y 36.89 1591.8569 14 -8.7 531.6216 3 76.79 5 43867 VEV_2_3_RA5_01_1236.d 4.71E4 1 1 179 192
R.AVSQFDPR.F Y 31.41 918.4559 8 -7.9 460.2316 2 41.67 4 19703 VEV_1_3_RA4_01_1235.d 4.34E5 2 2 193 200
K.DKPAPATR.S Y 29.26 854.4610 8 -6.2 428.2351 2 28.72 4 12133 VEV_1_3_RA4_01_1235.d 7.77E4 3 3 35 42
R.RTLD(+21.98)SLAAR.V Y 28.13 1023.5437 9 86.7 342.2181 3 34.67 6 15469 VEV_3_3_RA6_01_1237.d 0 1 1 335 343 Sodium adduct
R.ISLRDIC(+57.02)LR.L Y 26.04 1144.6387 9 -11.5 382.5491 3 70.62 4 39701 VEV_1_3_RA4_01_1235.d 7.43E4 1 1 542 550 Carbamidomethylation
MPAER.R Y 25.60 602.2846 5 -0.6 603.2915 1 24.77 4 9994 VEV_1_3_RA4_01_1235.d 4.16E4 1 1 1 5
R.AEDGGDASEIEMQIDPR(-.98).D Y 23.12 1830.8053 17 -1.7 916.4084 2 71.90 4 40719 VEV_1_3_RA4_01_1235.d 4.44E4 1 1 160 176 Amidation
R.DK(+42.01)ALSDIKSNFSLLER.A Y 20.79 1876.9894 16 -40.9 626.6448 3 78.46 5 45031 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 177 192 Acetylation (K)
R.TLDSLAAR.V Y 19.92 845.4606 8 -27.2 423.7261 2 43.44 4 20804 VEV_1_3_RA4_01_1235.d 0 1 1 336 343
K.ALSSSQSSTSN(+.98)SKDKPAPATR.S Y 18.87 2120.0344 21 -4.0 707.6826 3 20.30 4 7555 VEV_1_3_RA4_01_1235.d 1.37E4 1 1 22 42 Deamidation (NQ)
K.GQGQVQGDGNILPSQRR.L Y 18.83 1808.9241 17 -2.6 362.7911 5 63.35 5 34045 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 858 874
K.GQGQVQGDGNILPSQR.R Y 17.38 1652.8230 16 -5.1 414.2109 4 39.14 4 18184 VEV_1_3_RA4_01_1235.d 0 1 1 858 873
K.TVAGK.K Y 17.03 474.2802 5 9.8 475.2921 1 110.09 4 61149 VEV_1_3_RA4_01_1235.d 0 1 1 49 53
R.GAS(-2.02)FSSNLVNLLR.T Y 16.87 1374.7256 13 -18.5 688.3574 2 82.89 4 49152 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 318 330 2-amino-3-oxo-butanoic_acid
R.QNVIKTGIR.M Y 16.57 1027.6138 9 -35.4 343.5331 3 65.90 5 35959 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 525 533
K.SSRLSGDPDQNR.T Y 16.38 1330.6226 12 24.8 333.6712 4 27.57 5 11906 VEV_2_3_RA5_01_1236.d 9.9E4 1 1 141 152
R.SIFRQ(+.98)PALER.A Y 15.97 1216.6564 10 -7.8 305.1690 4 17.24 6 6116 VEV_3_3_RA6_01_1237.d 0 1 1 471 480 Deamidation (NQ)
R.FC(+57.02)LNLHDESVKAM(+15.99)R.F Y 15.17 1734.8181 14 -16.5 434.7047 4 20.11 5 7787 VEV_2_3_RA5_01_1236.d 7.37E4 1 1 607 620 Carbamidomethylation; Oxidation (M)
total 34 peptides
C1G0P4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LVDFPEAGYFSHNNPPQGEVWIR.G Y 137.33 2671.2817 23 -19.7 668.8146 4 82.06 6 46614 VEV_3_3_RA6_01_1237.d 6.32E5 6 6 487 509
R.ISKKPPFSVEVPGAEKVEGESIPR.R Y 101.84 2579.3958 24 -10.1 645.8497 4 69.60 5 38750 VEV_2_3_RA5_01_1236.d 3.92E5 3 3 13 36
K.Q(-17.03)ADVDSLKASFPDLNVISFEDLR.K Y 99.67 2561.2649 23 -5.3 1281.6329 2 91.82 4 54673 VEV_1_3_RA4_01_1235.d 2.06E5 3 3 222 244 Pyro-glu from Q
K.HVIIDTATEVK.Q Y 87.74 1224.6714 11 -15.7 409.2247 3 56.07 6 27771 VEV_3_3_RA6_01_1237.d 1.44E5 3 3 211 221
K.NFLMSTGLPGSGILDAVVFKK.V Y 81.82 2193.1868 21 3.7 732.0723 3 89.16 4 53195 VEV_1_3_RA4_01_1235.d 1.12E5 2 2 396 416
K.ASFPDLNVISFEDLRK.L Y 79.01 1849.9574 16 -6.8 617.6555 3 83.04 4 49250 VEV_1_3_RA4_01_1235.d 5.04E5 3 3 230 245
K.ASFPDLNVISFEDLR.K Y 78.47 1721.8624 15 -5.0 861.9342 2 87.63 6 50016 VEV_3_3_RA6_01_1237.d 4.14E5 5 5 230 244
K.QADVDSLKASFPDLNVISFEDLR.K Y 75.78 2578.2915 23 -9.0 860.4301 3 87.35 6 49860 VEV_3_3_RA6_01_1237.d 1.47E5 1 1 222 244
K.KPPFSVEVPGAEKVEGESIPR.R Y 69.36 2251.1848 21 7.8 563.8079 4 72.59 4 41334 VEV_1_3_RA4_01_1235.d 1.72E5 2 2 16 36
R.IVNTHVENKK.V Y 67.87 1180.6564 10 -24.2 591.3212 2 12.57 5 3736 VEV_2_3_RA5_01_1236.d 2.1E4 2 2 78 87
R.ELKPTVLVGVPAVWETVK.K Y 58.28 1964.1346 18 -13.0 655.7103 3 83.04 6 47216 VEV_3_3_RA6_01_1237.d 3.93E4 1 1 353 370
K.DGLLTKPRPEISTLYEN(+.98)LQWSVK.Q Y 56.32 2687.4170 23 -2.3 672.8600 4 82.65 4 48983 VEV_1_3_RA4_01_1235.d 5.61E4 1 1 43 65 Deamidation (NQ)
K.GIFWGGLAAK.N Y 54.44 1018.5599 10 -9.1 510.2826 2 78.31 4 45725 VEV_1_3_RA4_01_1235.d 7.35E4 2 2 386 395
R.GASVMEGYYDNEAETK.S Y 54.29 1762.7356 16 -3.3 882.3722 2 64.51 4 34891 VEV_1_3_RA4_01_1235.d 7.37E4 1 1 510 525
K.SAITEDGWFMTGDIGEFDKYGHLK.I Y 52.04 2716.2478 24 -32.0 680.0475 4 82.95 4 49190 VEV_1_3_RA4_01_1235.d 0 1 1 526 549
K.N(+.98)FLMSTGLPGSGILDAVVFKK.V Y 49.94 2194.1707 21 -8.1 732.3915 3 89.01 5 51386 VEV_2_3_RA5_01_1236.d 3.47E4 1 1 396 416 Deamidation (NQ)
R.SAAVVANIMVHAAEDQTKPVAVIIPAEPALVALAK.A Y 49.68 3506.9534 35 -7.7 877.7389 4 88.13 5 50912 VEV_2_3_RA5_01_1236.d 1.04E5 2 2 577 611
K.QADVDSLKAS(-2.02)FPDLNVISFEDLR.K Y 48.81 2576.2759 23 0.0 859.7659 3 87.56 5 50608 VEV_2_3_RA5_01_1236.d 1.76E5 1 1 222 244 2-amino-3-oxo-butanoic_acid
K.TLSDTSVR.N Y 44.59 877.4505 8 -16.0 439.7255 2 25.24 6 10323 VEV_3_3_RA6_01_1237.d 7.03E5 6 6 338 345
R.IVNTHVENK.K Y 43.02 1052.5614 9 -24.0 527.2753 2 15.63 6 5309 VEV_3_3_RA6_01_1237.d 3.79E4 1 1 78 86
R.DGLLLQPR.I Y 42.61 910.5236 8 -20.7 456.2596 2 66.30 5 36251 VEV_2_3_RA5_01_1236.d 3.95E5 3 3 5 12
K.IASQFHKEIER.A Y 42.50 1356.7150 11 -16.1 340.1806 4 37.26 6 16913 VEV_3_3_RA6_01_1237.d 3.64E5 4 4 680 690
K.QADVD(-18.01)SLK(+14.02)ASFPDLNVISFEDLR.K Y 39.69 2574.2964 23 -5.5 859.1013 3 87.36 5 50502 VEV_2_3_RA5_01_1236.d 4.71E2 1 1 222 244 Dehydration; Methylation(KR)
K.VKEATGGHLR.I Y 39.42 1066.5883 10 -3.8 356.5353 3 12.70 5 3808 VEV_2_3_RA5_01_1236.d 3.43E4 2 2 417 426
K.ASFPDLN(+.98)VISFEDLR.K Y 33.37 1722.8464 15 1.5 862.4318 2 87.36 5 50514 VEV_2_3_RA5_01_1236.d 8.61E4 1 1 230 244 Deamidation (NQ)
K.DGLLTKPRPEISTLYENLQWSVK(-.98).Q Y 28.99 2685.4490 23 -54.5 672.3329 4 82.53 6 46890 VEV_3_3_RA6_01_1237.d 0 1 1 43 65 Amidation
M.AKRDGLLLQPR.I Y 26.98 1265.7567 11 -8.2 422.9227 3 43.69 5 21319 VEV_2_3_RA5_01_1236.d 1.27E5 1 1 2 12
K.KPPFS(-2.02)VEVPGAEKVEGESIPR.R Y 26.56 2249.1692 21 -14.7 563.2913 4 72.28 6 39571 VEV_3_3_RA6_01_1237.d 7.34E3 1 1 16 36 2-amino-3-oxo-butanoic_acid
K.NSLTQTHSTAIFLEPVLLPTLEHVLK.D Y 25.28 2900.6011 26 -41.5 726.1274 4 88.15 4 52597 VEV_1_3_RA4_01_1235.d 0 1 1 179 204
R.RIVNTHVENK.K Y 25.02 1208.6626 10 -4.2 403.8931 3 19.77 4 7280 VEV_1_3_RA4_01_1235.d 4.77E4 1 1 77 86
K.ASFPDLNVIS(+14.02)FEDLR.K Y 23.76 1735.8781 15 6.0 868.9515 2 89.59 4 53433 VEV_1_3_RA4_01_1235.d 0 1 1 230 244 Methylation(others)
R.IMLTGGGPISKDTQR.F Y 23.26 1572.8293 15 -20.9 525.2728 3 37.57 5 17688 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 427 441
K.ELQNAGR.A Y 22.68 786.3984 7 -12.4 787.3959 1 88.34 5 51027 VEV_2_3_RA5_01_1236.d 4E5 1 1 636 642
R.IMLTGGGPISK.D Y 22.23 1072.5951 11 -28.4 537.2896 2 46.67 4 22806 VEV_1_3_RA4_01_1235.d 1.32E5 2 2 427 437
R.AGGLKPFEIIEGVVLSDEEWTPQNGFITAAQK.L Y 21.61 3443.7612 32 -11.4 861.9377 4 93.33 6 52904 VEV_3_3_RA6_01_1237.d 0 1 1 643 674
K.VEGESIPR.R Y 19.86 885.4556 8 -0.4 886.4625 1 76.00 5 43312 VEV_2_3_RA5_01_1236.d 1.25E5 2 2 29 36
K.E(+27.99)IERAYGK Y 19.32 992.4927 8 -17.9 497.2448 2 16.97 6 5962 VEV_3_3_RA6_01_1237.d 2.24E4 1 1 687 694 Formylation
K.GIINNVNKGGALIK.G Y 19.29 1409.8354 14 -17.0 470.9445 3 63.82 6 33236 VEV_3_3_RA6_01_1237.d 2.94E4 1 1 372 385
K.EIERAYGK Y 18.29 964.4977 8 -56.9 965.4501 1 91.16 6 51909 VEV_3_3_RA6_01_1237.d 2.1E4 1 1 687 694
R.KIASQFHK.E Y 16.99 957.5396 8 -15.6 320.1822 3 21.30 4 8106 VEV_1_3_RA4_01_1235.d 0 1 1 679 686
K.M(+15.99)VDGVEQEVDK.A Y 15.95 1263.5653 11 8.3 632.7952 2 74.32 5 42112 VEV_2_3_RA5_01_1236.d 8.17E4 1 1 91 101 Oxidation (M)
K.GGALIK(+43.01).G Y 15.48 600.3595 6 -39.9 301.1750 2 25.92 6 10689 VEV_3_3_RA6_01_1237.d 3.19E4 1 1 380 385 Carbamylation
total 42 peptides
C1G9D5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GPLKEDEGTGADNFR.V Y 135.12 1604.7430 15 -13.7 535.9143 3 50.79 6 24785 VEV_3_3_RA6_01_1237.d 1.47E6 12 12 600 614
R.VPQTSIMFVSQASK.S Y 126.74 1521.7861 14 -15.0 761.8889 2 71.65 6 39129 VEV_3_3_RA6_01_1237.d 3.13E5 4 4 696 709
K.NIREDVAFAESR.I Y 94.73 1405.6949 12 -17.8 469.5639 3 63.57 6 33057 VEV_3_3_RA6_01_1237.d 4.56E5 3 3 539 550
K.MVVGAC(+57.02)TDVISGEGK.I Y 79.20 1521.7167 15 15.5 761.8774 2 66.15 4 36173 VEV_1_3_RA4_01_1235.d 5.78E4 2 2 324 338 Carbamidomethylation
K.M(+15.99)VVGAC(+57.02)TDVISGEGK.I Y 75.33 1537.7117 15 -10.7 769.8549 2 60.98 6 31149 VEV_3_3_RA6_01_1237.d 2.08E5 3 3 324 338 Oxidation (M); Carbamidomethylation
R.EAYEHMFGPTTGDLVR.L Y 74.96 1821.8356 16 -6.3 608.2820 3 73.11 4 41667 VEV_1_3_RA4_01_1235.d 2.42E5 4 4 218 233
K.AYGYRLDIPAGTSIR.F Y 74.67 1651.8682 15 -13.7 551.6224 3 72.42 6 39719 VEV_3_3_RA6_01_1237.d 4.44E5 3 3 135 149
K.AGNPDIMDGVHPK.M Y 72.64 1349.6398 13 -8.2 675.8217 2 52.69 5 26796 VEV_2_3_RA5_01_1236.d 3.76E5 3 3 311 323
K.VEKDMTSYGDEC(+57.02)SFGGGK.T Y 72.29 1965.8083 18 23.3 656.2920 3 58.58 4 30444 VEV_1_3_RA4_01_1235.d 0 1 1 243 260 Carbamidomethylation
R.GPLKEDEGTGADNFRVK.R Y 66.43 1831.9064 17 -9.7 611.6368 3 55.46 5 28434 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 600 616
K.AYGYRLDIPAGTSIRFEPGDSK.T Y 62.71 2412.2073 22 -40.5 604.0347 4 76.54 6 42656 VEV_3_3_RA6_01_1237.d 0 1 1 135 156
K.ALYGSFLPVPSNDIFPDPVPEDYHPLK.M Y 55.66 3026.5063 27 0.8 1009.8436 3 88.29 4 52684 VEV_1_3_RA4_01_1235.d 2.13E5 1 1 53 79
K.SLGIIDSYGIK.K Y 53.79 1164.6390 11 -20.3 583.3150 2 76.10 6 42361 VEV_3_3_RA6_01_1237.d 7.64E4 1 1 710 720
K.SLGIIDSYGIKK.R Y 52.28 1292.7340 12 -18.2 431.9108 3 68.09 6 36459 VEV_3_3_RA6_01_1237.d 2.61E5 3 3 710 721
K.DMTSYGDEC(+57.02)SFGGGK.T Y 50.88 1609.6024 15 -12.8 805.7982 2 64.57 4 34942 VEV_1_3_RA4_01_1235.d 3.47E4 1 1 246 260 Carbamidomethylation
R.LHLTQQYFVY Y 49.75 1310.6659 10 -12.5 656.3320 2 78.22 5 44873 VEV_2_3_RA5_01_1236.d 5.33E4 3 3 770 779
K.TVTLVEIAGEK.I Y 37.41 1158.6495 11 -12.2 580.3250 2 70.22 4 39382 VEV_1_3_RA4_01_1235.d 1.36E5 2 2 157 167
K.GGDIVAIGK.A Y 35.69 828.4705 9 -23.1 415.2329 2 47.39 6 22788 VEV_3_3_RA6_01_1237.d 3.29E5 2 2 302 310
K.GLREQC(+57.02)R.A Y 33.65 917.4501 7 -16.8 459.7246 2 11.30 6 3057 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 418 424 Carbamidomethylation
R.ADEIIER.L Y 33.36 844.4290 7 17.5 423.2292 2 32.95 4 14544 VEV_1_3_RA4_01_1235.d 6.62E5 3 3 185 191
K.YNDVMPK.M Y 31.14 865.4004 7 -7.8 433.7041 2 36.32 4 16524 VEV_1_3_RA4_01_1235.d 7.26E4 2 2 739 745
R.VEAVR.N Y 25.18 572.3282 5 -50.5 573.3066 1 74.14 5 41986 VEV_2_3_RA5_01_1236.d 2.75E4 1 1 723 727
K.VDLGRADEIIER.L Y 20.36 1384.7310 12 -4.6 347.1884 4 33.39 4 14797 VEV_1_3_RA4_01_1235.d 6.28E4 2 2 180 191
K.GNDSGPK.G Y 20.05 673.3031 7 4.6 674.3135 1 51.82 4 26080 VEV_1_3_RA4_01_1235.d 3.44E4 1 1 411 417
R.AGAAGLK.L Y 19.53 586.3438 7 -42.7 587.3260 1 24.81 4 10013 VEV_1_3_RA4_01_1235.d 2.91E4 1 1 425 431
K.SGMIAAAMVGDPNASIPTIEPIVMR.Y Y 18.43 2540.2800 25 6.2 847.7725 3 87.91 4 52450 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 665 689
K.IVLNGGR.K Y 18.27 727.4341 7 -39.0 364.7101 2 28.18 6 11869 VEV_3_3_RA6_01_1237.d 0 1 1 92 98
K.TLREGM(+15.99)GQASGR.G Y 17.27 1277.6146 12 -24.4 426.8684 3 18.84 4 6798 VEV_1_3_RA4_01_1235.d 0 1 1 261 272 Oxidation (M)
K.IVLNGGRKR.L Y 17.20 1011.6301 9 -3.0 506.8208 2 56.90 4 29226 VEV_1_3_RA4_01_1235.d 0 1 1 92 100
K.RVEAVR(+14.02)NC(+57.02)RGIGK.K Y 16.94 1527.8416 13 -14.0 764.9174 2 19.12 6 7115 VEV_3_3_RA6_01_1237.d 4.65E4 1 1 722 734 Methylation(KR); Carbamidomethylation
K.VDLGR.A N 15.38 558.3126 5 -72.0 559.2797 1 73.85 6 40710 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 180 184
total 31 peptides
C1GN83
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASHDAIDLITALLEYTPTQR.L Y 130.40 2227.1484 20 -10.1 557.7888 4 92.52 4 55064 VEV_1_3_RA4_01_1235.d 1.19E6 8 8 287 306
R.KASHDAIDLITALLEYTPTQR.L Y 114.88 2355.2434 21 -12.5 589.8108 4 89.17 4 53218 VEV_1_3_RA4_01_1235.d 6.68E5 6 6 286 306
R.SPELIFGATNYTTK.I Y 109.99 1540.7773 14 -16.5 771.3832 2 75.41 6 41839 VEV_3_3_RA6_01_1237.d 1.92E5 3 3 203 216
R.GLDIDNFTPLTKDEMMAHLD Y 96.46 2275.0500 20 -6.1 759.3527 3 83.99 4 49901 VEV_1_3_RA4_01_1235.d 2.95E5 6 6 375 394
R.DIKPQNLLLDPNTGILK.L Y 96.01 1891.0778 17 -16.2 631.3563 3 81.32 6 46077 VEV_3_3_RA6_01_1237.d 2.77E5 4 4 160 176
K.ILVENEPNVSY(+79.97)IC(+57.02)SR.Y Y 93.67 1871.8489 15 -4.0 936.9280 2 75.34 4 43433 VEV_1_3_RA4_01_1235.d 6.36E5 4 4 185 199 Phosphorylation (STY); Carbamidomethylation
R.LSAIEAMC(+57.02)HPFFDELRDPNTRLPDSR.H Y 84.71 3086.4702 26 -5.3 618.2980 5 80.22 4 47191 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 307 332 Carbamidomethylation
R.EKVQDGLTGETR.D Y 69.60 1331.6681 12 -15.5 666.8310 2 31.60 4 13773 VEV_1_3_RA4_01_1235.d 1.18E5 3 3 20 31
K.ISPSGEDAAIKR.V Y 64.72 1242.6567 12 -12.0 622.3282 2 33.86 6 15018 VEV_3_3_RA6_01_1237.d 1.77E6 9 9 54 65
K.LC(+57.02)DFGSAK.I Y 61.17 896.4062 8 -11.1 449.2054 2 35.44 5 16426 VEV_2_3_RA5_01_1236.d 8.97E5 5 5 177 184 Carbamidomethylation
R.HELSINPTLNHR.L Y 53.52 1429.7426 12 -16.2 477.5804 3 49.40 5 24788 VEV_2_3_RA5_01_1236.d 2.96E5 2 2 350 361
R.YYRSPELIFGATNYTTK.I Y 48.16 2023.0050 17 -10.0 675.3355 3 74.58 5 42303 VEV_2_3_RA5_01_1236.d 2.72E4 1 1 200 216
K.VQDGLTGETR.D Y 48.13 1074.5305 10 -6.7 538.2689 2 30.43 4 13087 VEV_1_3_RA4_01_1235.d 3.27E5 5 5 22 31
R.SLAYIHSQGIC(+57.02)HR.D Y 42.31 1540.7568 13 -11.9 386.1919 4 48.83 4 24198 VEV_1_3_RA4_01_1235.d 2.82E5 2 2 147 159 Carbamidomethylation
R.IVRHPNIVELK.A Y 41.74 1316.7928 11 -18.4 330.1994 4 53.40 4 27065 VEV_1_3_RA4_01_1235.d 8.65E4 2 2 82 92
K.ISPSGEDAAIK.R Y 31.09 1086.5557 11 -10.5 544.2794 2 63.24 4 33935 VEV_1_3_RA4_01_1235.d 8.59E4 3 3 54 64
R.VLQDK.R Y 30.44 601.3435 5 -5.2 602.3477 1 38.67 5 18341 VEV_2_3_RA5_01_1236.d 2.62E5 2 2 66 70
R.M(+15.99)GEVVREK.V Y 27.82 962.4855 8 -4.7 482.2477 2 11.88 5 3379 VEV_2_3_RA5_01_1236.d 1.91E4 1 1 14 21 Oxidation (M)
R.HPNIVELK.A Y 25.17 948.5392 8 -53.0 475.2518 2 44.09 4 21193 VEV_1_3_RA4_01_1235.d 4.27E4 3 3 85 92
K.VLGTPTRDQIR.T Y 23.89 1254.7043 11 -22.7 419.2325 3 43.99 4 21132 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 251 261
K.TTMPMLEVK.L Y 21.92 1048.5297 9 -2.6 525.2708 2 82.42 6 46815 VEV_3_3_RA6_01_1237.d 0 1 1 130 138
R.ADLLSR.G Y 21.11 673.3759 6 -9.4 337.6920 2 34.70 4 15576 VEV_1_3_RA4_01_1235.d 4.56E5 2 2 369 374
K.VLGTPTR.D Y 18.32 742.4337 7 5.6 372.2262 2 27.26 4 11413 VEV_1_3_RA4_01_1235.d 9.6E4 3 3 251 257
M(+15.99)SQTRPGVFSSLRMGEVVR.E Y 18.21 2152.0881 19 -56.1 538.9991 4 12.93 6 3868 VEV_3_3_RA6_01_1237.d 4.61E5 1 1 1 19 Oxidation (M)
K.IS(-2.02)PSGEDAAIKR.V Y 17.62 1240.6411 12 -42.0 621.3018 2 33.72 6 14909 VEV_3_3_RA6_01_1237.d 1.61E4 1 1 54 65 2-amino-3-oxo-butanoic_acid
K.ISPSGEDAAIK(+226.08).R Y 15.87 1312.6333 11 5.8 657.3278 2 55.95 4 28599 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 54 64 Biotinylation
total 26 peptides
C1G4M5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KC(+57.02)PFGAIHIINLPTNLETQVTHR.Y Y 110.83 2658.4065 23 -16.5 532.6798 5 78.73 4 46035 VEV_1_3_RA4_01_1235.d 1.85E5 1 1 64 86 Carbamidomethylation
R.EGINIFLDGHIPTENLR.F Y 110.54 1937.0006 17 -17.2 646.6630 3 81.35 6 46099 VEV_3_3_RA6_01_1237.d 6.27E5 6 6 310 326
K.AVVKPQYVDQIPR.A Y 97.66 1511.8459 13 -15.0 504.9484 3 63.10 6 32701 VEV_3_3_RA6_01_1237.d 4.95E5 3 3 166 178
R.VAIVLALGIPADIYLIDEPSAYLDSEQR.I Y 96.67 3043.6116 28 -6.1 1522.8037 2 96.61 4 57006 VEV_1_3_RA4_01_1235.d 4.22E4 2 2 473 500
R.IAEAGDEFLVDKGR.A Y 94.30 1518.7677 14 -9.3 507.2585 3 63.83 4 34381 VEV_1_3_RA4_01_1235.d 1.32E6 6 6 336 349
K.VLEDDLKAVVKPQYVDQIPR.A Y 86.00 2324.2739 20 -25.5 582.0609 4 77.18 4 44841 VEV_1_3_RA4_01_1235.d 0 1 1 159 178
R.ANTPESLLTGC(+57.02)NKFLK.N Y 83.50 1791.9189 16 -10.4 598.3074 3 73.98 4 42338 VEV_1_3_RA4_01_1235.d 6.24E5 6 6 548 563 Carbamidomethylation
K.LLAGAEKPDGR.T Y 79.04 1125.6141 11 -35.6 563.7943 2 29.89 6 12813 VEV_3_3_RA6_01_1237.d 1.25E6 12 12 394 404
R.TGKLC(+57.02)IEVTPESK.I Y 78.51 1460.7544 13 -6.6 487.9222 3 57.57 4 29696 VEV_1_3_RA4_01_1235.d 2.93E5 3 3 34 46 Carbamidomethylation
R.IAIVNSDKC(+57.02)KPK.K Y 73.18 1371.7544 12 -7.6 686.8793 2 26.51 5 11339 VEV_2_3_RA5_01_1236.d 1.81E5 3 3 8 19 Carbamidomethylation
R.INKHQSQLDQEQK.L Y 71.28 1594.8063 13 -15.7 532.6010 3 14.46 6 4674 VEV_3_3_RA6_01_1237.d 2.49E5 3 3 580 592
R.GSELQNYFTK.V Y 66.12 1185.5665 10 -8.5 593.7855 2 67.39 4 37194 VEV_1_3_RA4_01_1235.d 6.83E5 5 5 149 158
K.LC(+57.02)IEVTPESK.I Y 62.26 1174.5903 10 2.0 588.3036 2 63.31 4 34006 VEV_1_3_RA4_01_1235.d 9.93E5 3 3 37 46 Carbamidomethylation
R.FREESLTFR.I Y 58.41 1183.5985 9 -14.0 395.5346 3 60.71 5 32073 VEV_2_3_RA5_01_1236.d 6.42E5 7 7 327 335
R.ANTPESLLTGC(+57.02)NK.F Y 57.65 1403.6715 13 -1.9 702.8417 2 64.10 6 33441 VEV_3_3_RA6_01_1237.d 6.67E4 1 1 548 560 Carbamidomethylation
R.IAE(+14.02)AGDEFLVDKGR.A Y 54.77 1532.7834 14 -8.9 511.9305 3 67.58 4 37304 VEV_1_3_RA4_01_1235.d 2.65E5 2 2 336 349 Methylation(others)
K.IAFISER.L Y 52.51 834.4599 7 -20.6 418.2286 2 61.78 5 32869 VEV_2_3_RA5_01_1236.d 6.68E5 3 3 47 53
R.YSANSFKLHR.L Y 51.62 1221.6254 10 -6.7 408.2130 3 42.69 4 20339 VEV_1_3_RA4_01_1235.d 6.34E5 4 4 87 96
R.YDNPPDWEEILK.Y Y 51.05 1517.7037 12 -5.3 759.8551 2 81.37 4 48065 VEV_1_3_RA4_01_1235.d 2.19E5 3 3 134 145
K.NLDVTFR.R Y 50.28 863.4501 7 -4.3 432.7305 2 63.23 4 33980 VEV_1_3_RA4_01_1235.d 1.22E6 4 4 564 570
R.IAIVNSDK.C Y 44.83 858.4811 8 -4.7 430.2458 2 34.87 4 15674 VEV_1_3_RA4_01_1235.d 8.95E4 4 4 8 15
R.AVKGPTKEVELLIK.A Y 42.98 1523.9286 14 -2.9 508.9820 3 64.40 5 34827 VEV_2_3_RA5_01_1236.d 4.98E4 1 1 179 192
R.YDNPPDWEEILKYFR.G Y 42.12 1983.9366 15 -7.2 662.3147 3 88.51 6 50518 VEV_3_3_RA6_01_1237.d 1.97E5 3 3 134 148
R.AFSYPK.M Y 40.91 711.3591 6 -17.4 712.3540 1 39.09 6 17971 VEV_3_3_RA6_01_1237.d 4.13E5 5 5 350 355
R.IAEAGDE(+14.02)FLVDKGR.A Y 40.47 1532.7834 14 -8.1 511.9310 3 67.19 4 36994 VEV_1_3_RA4_01_1235.d 2.35E4 1 1 336 349 Methylation(others)
R.FR(+14.02)EESLTFR.I Y 40.40 1197.6141 9 -11.2 400.2075 3 67.21 4 37007 VEV_1_3_RA4_01_1235.d 1.18E5 2 2 327 335 Methylation(KR)
K.LSGNYK.R Y 35.60 680.3493 6 -30.4 681.3359 1 65.20 6 34272 VEV_3_3_RA6_01_1237.d 9.98E4 1 1 593 598
R.DVGLLSGGELQR.F Y 33.75 1242.6567 12 -19.9 622.3233 2 72.43 6 39684 VEV_3_3_RA6_01_1237.d 0 3 3 216 227
K.VLEDDLK.A Y 29.83 830.4385 7 -12.5 416.2214 2 42.81 4 20419 VEV_1_3_RA4_01_1235.d 0 1 1 159 165
K.SC(+57.02)PVVRTGKLC(+57.02)IEVTPESK.I Y 25.53 2159.1079 19 -27.0 540.7697 4 68.04 5 37561 VEV_2_3_RA5_01_1236.d 2.57E4 1 1 28 46 Carbamidomethylation
R.DPNSYRPR.I Y 21.16 1003.4835 8 -5.0 502.7465 2 19.15 4 7003 VEV_1_3_RA4_01_1235.d 1.59E5 2 2 572 579
K.GRAFSYPKM(+15.99)EK.T Y 20.93 1328.6547 11 -5.9 333.1690 4 13.86 4 4230 VEV_1_3_RA4_01_1235.d 2.28E4 1 1 348 358 Oxidation (M)
R.LC(+57.02)IGC(+57.02)GIC(+57.02)PK.K Y 19.78 1176.5454 10 -1.2 589.2793 2 64.82 4 35138 VEV_1_3_RA4_01_1235.d 3.78E5 2 2 54 63 Carbamidomethylation
MSDKLTRIAIVNSDK.C Y 16.97 1689.9083 15 -40.3 564.2874 3 64.95 5 35235 VEV_2_3_RA5_01_1236.d 0 1 1 1 15
K.FQGTVR.Q Y 16.54 706.3762 6 -17.3 354.1893 2 18.73 4 6727 VEV_1_3_RA4_01_1235.d 8.65E4 1 1 423 428
total 35 peptides
C1G2S7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SYDATSHFETTTDDVKDIYR.R Y 132.56 2363.0554 20 -8.3 788.6859 3 68.98 5 38259 VEV_2_3_RA5_01_1236.d 4.33E5 5 5 427 446
K.SPYIYPLFGLGELPQGFAR.L Y 120.27 2124.1042 19 -14.8 709.0316 3 90.93 6 51792 VEV_3_3_RA6_01_1237.d 8.49E5 8 8 233 251
R.YGKSPYIYPLFGLGELPQGFAR.L Y 115.34 2472.2842 22 -14.0 825.0905 3 86.98 5 50297 VEV_2_3_RA5_01_1236.d 1.09E5 2 2 230 251
K.LLMSNGELTNILVSTDVTR.Y Y 107.67 2075.0933 19 -14.3 1038.5391 2 85.62 6 48846 VEV_3_3_RA6_01_1237.d 4.81E4 2 2 85 103
R.QIAGSYVQQGC(+57.02)GSK.A Y 87.96 1481.6932 14 -6.3 741.8492 2 41.21 4 19422 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 109 122 Carbamidomethylation
R.Q(-17.03)IAGSYVQQGC(+57.02)GSK.A Y 81.51 1464.6667 14 -11.4 733.3323 2 63.51 6 33012 VEV_3_3_RA6_01_1237.d 1.85E5 2 2 109 122 Pyro-glu from Q; Carbamidomethylation
R.VNDWNVDLVPK.L Y 73.17 1297.6666 11 -6.4 649.8364 2 75.97 4 43897 VEV_1_3_RA4_01_1235.d 3.66E5 4 4 74 84
R.LSAIYGGTYMLNTNVDEILYDGEKVSGIK.A Y 72.55 3162.5793 29 -1.2 1055.1991 3 88.83 4 53015 VEV_1_3_RA4_01_1235.d 5.7E4 1 1 252 280
K.DFIGHSMALYQSDDYITEAGK.A Y 61.67 2360.0630 21 -26.7 787.6740 3 80.04 6 45189 VEV_3_3_RA6_01_1237.d 6.27E4 3 3 192 212
K.VPSDAGEALR.S Y 60.99 1013.5142 10 -5.9 507.7614 2 40.57 4 19035 VEV_1_3_RA4_01_1235.d 7.4E5 7 7 128 137
K.IIGDPTYFPGK.V Y 56.09 1206.6284 11 -12.9 604.3137 2 70.54 4 39632 VEV_1_3_RA4_01_1235.d 4.76E5 3 3 302 312
K.ATVAKVPSDAGEALR.S Y 53.96 1483.7994 15 -11.0 742.8989 2 56.74 5 29251 VEV_2_3_RA5_01_1236.d 2.28E4 1 1 123 137
R.RAEGHELVVEGLRDGANLVQEE Y 42.35 2419.2090 22 -13.6 807.3993 3 76.14 5 43399 VEV_2_3_RA5_01_1236.d 7.77E4 1 1 447 468
K.IIGDPTYFPGKVR.V Y 42.27 1461.7980 13 -24.4 488.2614 3 68.04 6 36421 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 302 314
R.SEPGEGMTFTTK.T Y 41.96 1283.5703 12 -7.4 642.7877 2 58.31 4 30232 VEV_1_3_RA4_01_1235.d 1.8E5 3 3 287 298
R.SSLMGLFEK.R Y 41.88 1010.5106 9 -9.4 506.2578 2 78.23 4 45658 VEV_1_3_RA4_01_1235.d 0 2 2 138 146
K.SPYIYPLFGLGELPQGFAR(+14.02).L Y 39.15 2138.1199 19 -13.2 1070.0531 2 92.12 6 52360 VEV_3_3_RA6_01_1237.d 4.28E4 1 1 233 251 Methylation(KR)
R.VTGYLLK.A Y 29.60 792.4745 7 -22.0 397.2358 2 54.69 6 27072 VEV_3_3_RA6_01_1237.d 7.44E4 2 2 315 321
K.LLM(+15.99)S(-18.01)NGELTNILVSTDVTR.Y Y 25.09 2073.0776 19 -10.0 1037.5358 2 85.72 4 51060 VEV_1_3_RA4_01_1235.d 2.23E4 1 1 85 103 Oxidation (M); Dehydration
K.VSGIKATM(+15.99)K.D Y 23.90 949.5266 9 -10.1 317.5129 3 45.23 6 21543 VEV_3_3_RA6_01_1237.d 2.85E5 2 2 276 284 Oxidation (M)
R.LYVNSMAR.Y Y 23.38 952.4800 8 -1.8 477.2465 2 49.54 4 24595 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 222 229
R.YLEFR.Q Y 20.82 726.3701 5 -0.1 364.1923 2 20.77 5 8158 VEV_2_3_RA5_01_1236.d 0 1 1 104 108
K.KIIGDPTYFPGK.V Y 18.47 1334.7234 12 -44.2 445.8954 3 57.62 5 29855 VEV_2_3_RA5_01_1236.d 1.13E5 1 1 301 312
K.AKETIDRIR.L Y 17.99 1100.6301 9 -16.3 551.3134 2 21.00 5 8285 VEV_2_3_RA5_01_1236.d 2.57E4 1 1 213 221
K.VSGIKATM(+15.99)KDR.S Y 17.14 1220.6547 11 5.6 306.1726 4 14.70 6 4790 VEV_3_3_RA6_01_1237.d 7.31E4 1 1 276 286 Oxidation (M)
R.SSLM(+15.99)GLFEKR.R Y 16.38 1182.6067 10 -35.9 395.1953 3 11.32 6 3071 VEV_3_3_RA6_01_1237.d 3.61E4 1 1 138 147 Oxidation (M)
K.ETIDR.I N 15.97 632.3129 5 -15.6 633.3104 1 28.40 4 11968 VEV_1_3_RA4_01_1235.d 0 1 1 215 219
K.AT(-2.02)VAKVPSDAGEALR.S Y 15.59 1481.7837 15 -58.8 494.9061 3 57.01 4 29302 VEV_1_3_RA4_01_1235.d 2.09E5 1 1 123 137 2-amino-3-oxo-butanoic_acid
total 28 peptides
C1GJI0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GGSAAAQVDFVVSR.V Y 110.84 1362.6891 14 -18.7 682.3391 2 67.30 6 35889 VEV_3_3_RA6_01_1237.d 4.52E5 6 6 297 310
R.TPQDYSESVQK.A Y 105.21 1280.5884 11 -8.7 641.2959 2 33.37 5 15210 VEV_2_3_RA5_01_1236.d 4.46E5 6 6 447 457
K.IQQIGAGTTALIEMMNAFR.A Y 102.25 2064.0496 19 -14.2 689.0140 3 91.93 6 52272 VEV_3_3_RA6_01_1237.d 2.48E5 3 3 632 650
K.KSDVVYIDYGNSETVPWTR.L Y 102.12 2228.0750 19 -6.5 743.6941 3 76.38 6 42538 VEV_3_3_RA6_01_1237.d 9.37E4 1 1 696 714
K.VKPQASDAVLSFLQFPVSAEYLQDAVEYLGER.S Y 99.52 3568.8088 32 -5.4 1190.6038 3 96.49 4 56959 VEV_1_3_RA4_01_1235.d 4.44E5 4 4 728 759
R.NPGETSEPFGQEAHDFAYRR.C Y 93.45 2307.0303 20 -7.4 577.7606 4 65.63 4 35769 VEV_1_3_RA4_01_1235.d 5.81E5 6 6 490 509
K.ANDTPLSGPPK.A Y 83.75 1095.5560 11 -7.5 548.7812 2 40.22 4 18822 VEV_1_3_RA4_01_1235.d 2.88E5 6 6 657 667
R.TLSLAYASAPR.L Y 83.54 1148.6189 11 -14.6 575.3083 2 66.01 5 36039 VEV_2_3_RA5_01_1236.d 1.55E5 3 3 30 40
R.VFSADTIFVR.S Y 83.06 1153.6132 10 -17.4 577.8038 2 77.01 6 43011 VEV_3_3_RA6_01_1237.d 3.65E5 3 3 311 320
R.LRPLTQPQFSTQK.V Y 82.18 1542.8518 13 -12.7 515.2847 3 59.94 5 31503 VEV_2_3_RA5_01_1236.d 1.45E5 3 3 715 727
K.LPNNQELPDISLAEGWVK.L Y 70.92 2022.0421 18 -8.4 1012.0198 2 84.77 4 50428 VEV_1_3_RA4_01_1235.d 1.13E5 2 2 86 103
K.SARNPGETSEPFGQEAHDFAYRR.C Y 63.57 2621.2007 23 -7.2 656.3027 4 62.50 4 33368 VEV_1_3_RA4_01_1235.d 7.54E4 1 1 487 509
R.KGLFTGFAAPK.G Y 61.84 1135.6389 11 -27.3 379.5432 3 67.06 6 35672 VEV_3_3_RA6_01_1237.d 1.58E5 3 3 286 296
R.VKSILSGDTLILTHVTNR.S Y 60.64 1966.1211 18 -2.5 492.5363 4 75.12 4 43223 VEV_1_3_RA4_01_1235.d 3.9E4 2 2 8 25
R.SAGETLAYLEKLQEEAKEGR.K Y 56.62 2221.1226 20 -9.7 556.2825 4 77.51 4 45095 VEV_1_3_RA4_01_1235.d 0 2 2 817 836
K.LTLVLAGIRAPK.S Y 51.73 1250.8074 12 -1.2 417.9426 3 73.99 6 40809 VEV_3_3_RA6_01_1237.d 1.52E5 3 3 475 486
K.Q(-17.03)APFIAEAKEFLR.K Y 49.64 1501.7928 13 -23.3 751.8862 2 87.01 6 49668 VEV_3_3_RA6_01_1237.d 9.92E4 1 1 345 357 Pyro-glu from Q
K.AN(+.98)DTPLSGPPK.A Y 45.58 1096.5400 11 -16.6 549.2682 2 40.50 4 18995 VEV_1_3_RA4_01_1235.d 1.94E4 2 2 657 667 Deamidation (NQ)
R.TPQDYSESVQ(+.98)K.A Y 35.81 1281.5724 11 -2.6 641.7918 2 36.69 4 16753 VEV_1_3_RA4_01_1235.d 3.32E4 1 1 447 457 Deamidation (NQ)
R.TNADGTEIPGEPLGEQAQQFVELR.L Y 35.15 2598.2561 24 7.2 867.0989 3 82.57 4 48926 VEV_1_3_RA4_01_1235.d 7.98E4 1 1 194 217
R.S(+42.01)QER(+31.99)TLSLAYASAPR.L Y 33.33 1722.8536 15 29.4 575.3087 3 66.17 4 36192 VEV_1_3_RA4_01_1235.d 1.35E5 2 2 26 40 Acetylation (N-term); Dihydroxy
R.TPQDYS(+14.02)ESVQK.A Y 29.91 1294.6041 11 -7.9 648.3042 2 42.07 4 20008 VEV_1_3_RA4_01_1235.d 5.89E4 1 1 447 457 Methylation(others)
R.SAGETLAYLEK.L Y 29.26 1180.5975 11 -13.9 591.2979 2 66.07 4 36114 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 817 827
R.EGLAMVPR.K Y 28.40 871.4586 8 13.6 436.7425 2 60.40 4 31781 VEV_1_3_RA4_01_1235.d 6.79E4 1 1 802 809
R.EGLAM(+15.99)VPR.K Y 23.17 887.4535 8 13.1 444.7398 2 50.52 4 25195 VEV_1_3_RA4_01_1235.d 3.32E5 1 1 802 809 Oxidation (M)
K.ISLSSVRQPK.L Y 21.75 1113.6506 10 -16.2 372.2181 3 45.73 5 22563 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 330 339
K.LTLVLAGIR.A Y 21.64 954.6226 9 -108.4 478.2668 2 78.11 4 45562 VEV_1_3_RA4_01_1235.d 0 1 1 475 483
MPLLEAR.V Y 21.53 828.4528 7 7.6 415.2368 2 17.82 4 6272 VEV_1_3_RA4_01_1235.d 0 2 2 1 7
K.IQAFC(+57.02)DAK.T Y 21.04 951.4484 8 1.5 952.4570 1 79.32 4 46491 VEV_1_3_RA4_01_1235.d 3.3E4 1 1 460 467 Carbamidomethylation
K.LQEEAKEGR.K Y 20.32 1058.5356 9 -4.2 1059.5385 1 79.36 4 46520 VEV_1_3_RA4_01_1235.d 7E4 1 1 828 836
K.LSDPK.Q Y 19.79 558.3013 5 -23.5 559.2954 1 28.40 4 11970 VEV_1_3_RA4_01_1235.d 0 2 2 340 344
K.ALVESEKGK.Q Y 19.27 959.5287 9 13.2 480.7780 2 29.25 5 12835 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 157 165
K.L(+43.01)RGLESR.A Y 18.60 872.4828 7 -33.9 437.2339 2 40.22 4 18828 VEV_1_3_RA4_01_1235.d 0 1 1 124 130 Carbamylation
K.KISLSSVRQPK.L Y 18.53 1241.7455 11 -18.5 414.9148 3 37.45 5 17623 VEV_2_3_RA5_01_1236.d 3.09E4 1 1 329 339
K.GMWSSKPPTTR.T Y 17.90 1246.6128 11 -37.2 624.2905 2 71.25 6 38801 VEV_3_3_RA6_01_1237.d 0 1 1 436 446
R.EYGIVK.L Y 15.79 707.3854 6 -36.3 708.3669 1 32.06 6 14005 VEV_3_3_RA6_01_1237.d 0 1 1 80 85
K.SWERSAGETLAYLEKLQEEAKEGR.K Y 15.75 2779.3777 24 6.3 927.4724 3 86.85 4 51785 VEV_1_3_RA4_01_1235.d 6.33E5 1 1 813 836
K.QIDAVVEK.R Y 15.58 900.4916 8 23.5 301.1782 3 49.41 4 24507 VEV_1_3_RA4_01_1235.d 0 1 1 166 173
total 38 peptides
C1GEW2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.STSTGRELVTYSVATSYGPKEDR.Q Y 145.83 2503.2190 23 -10.7 626.8054 4 65.44 6 34500 VEV_3_3_RA6_01_1237.d 5.06E5 4 4 45 67
R.INLVGNLGGQPELR.S Y 127.77 1478.8204 14 -15.9 740.4058 2 76.30 6 42485 VEV_3_3_RA6_01_1237.d 1.59E6 4 4 31 44
R.ELVTYSVATSYGPKEDR.Q Y 119.10 1913.9370 17 -13.7 638.9775 3 67.51 6 36017 VEV_3_3_RA6_01_1237.d 6.97E5 5 5 51 67
R.SYEDSDGKKNSALNITQR.H Y 98.79 2024.9763 18 -10.5 675.9923 3 44.24 6 21005 VEV_3_3_RA6_01_1237.d 8.3E5 8 8 106 123
R.ITSFAPEGPAR.E Y 88.33 1144.5876 11 -9.1 573.2959 2 58.27 4 30243 VEV_1_3_RA4_01_1235.d 1.11E6 7 7 74 84
R.STSTGRELVTYSVATSYGPK.E Y 85.51 2103.0483 20 -8.3 702.0176 3 68.41 4 37961 VEV_1_3_RA4_01_1235.d 2.91E4 2 2 45 64
K.GTLLYVEGDASMR.S Y 74.53 1410.6813 13 -2.6 706.3461 2 72.31 4 41044 VEV_1_3_RA4_01_1235.d 5.19E5 7 7 93 105
R.ITSFAPEGPAREHLLSLPK.G Y 71.67 2062.1211 19 -11.5 688.3730 3 73.33 5 41438 VEV_2_3_RA5_01_1236.d 9.78E5 5 5 74 92
K.NSALNITQR.H Y 66.26 1015.5410 9 -10.1 508.7727 2 42.89 4 20458 VEV_1_3_RA4_01_1235.d 5.94E5 5 5 115 123
K.GTLLYVEGDASM(+15.99)R.S Y 44.05 1426.6761 13 -13.0 714.3361 2 66.68 4 36599 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 93 105 Oxidation (M)
R.SYEDSDGK(+14.02)KNSALNITQR.H Y 34.80 2038.9919 18 -5.5 510.7524 4 51.85 4 26066 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 106 123 Methylation(KR)
R.EHLLSLPK.G Y 34.42 935.5440 8 -23.9 312.8478 3 60.13 6 30529 VEV_3_3_RA6_01_1237.d 9.99E5 3 3 85 92
R.ELVTYSVATSYGPK.E Y 20.80 1513.7664 14 -62.1 757.8434 2 71.66 4 40524 VEV_1_3_RA4_01_1235.d 0 1 1 51 64
R.APIATRAFSTTRPNAVAR.I Y 20.03 1899.0438 18 -22.6 475.7575 4 68.48 4 38019 VEV_1_3_RA4_01_1235.d 3.01E5 1 1 13 30
R.RGSSE Y 18.09 534.2397 5 26.5 535.2612 1 42.04 5 20343 VEV_2_3_RA5_01_1236.d 0 1 1 130 134
R.QTSWWRITSFAPEGPAR.E Y 15.17 1988.9856 17 6.8 498.2571 4 62.04 6 31933 VEV_3_3_RA6_01_1237.d 0 1 1 68 84
total 16 peptides
C1G8S5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DGGYGAASSPFVLGIK.H Y 124.95 1537.7776 16 -15.1 769.8845 2 80.41 6 45446 VEV_3_3_RA6_01_1237.d 3.21E5 4 4 315 330
R.IHIGDEGKGTSPAPEKGDVNR.D Y 118.84 2176.0872 21 -8.7 545.0244 4 39.63 6 18318 VEV_3_3_RA6_01_1237.d 6.53E5 7 7 7 27
R.IHIGDEGKGTSPAPEKGDVNRDAIR.A Y 107.39 2631.3364 25 -4.9 527.2720 5 50.38 5 25370 VEV_2_3_RA5_01_1236.d 1.66E6 6 6 7 31
R.IHIGDEGKGTSPAPEK.G Y 99.60 1634.8263 16 -13.9 545.9418 3 35.31 6 15825 VEV_3_3_RA6_01_1237.d 1.97E5 3 3 7 22
R.NEPWLYSPYDVDLQTGLEEITEAEITPK.M Y 88.08 3249.5605 28 -0.9 1084.1931 3 94.37 4 55997 VEV_1_3_RA4_01_1235.d 2.76E5 2 2 511 538
R.SLYSLAVAGNAPSIFK.T Y 86.20 1636.8824 16 -9.6 819.4406 2 83.24 5 48100 VEV_2_3_RA5_01_1236.d 9.35E4 4 4 363 378
R.ALVEAELLDKR.Y Y 75.47 1255.7135 11 -11.2 628.8570 2 66.46 5 36395 VEV_2_3_RA5_01_1236.d 2.08E6 8 8 32 42
K.GTSPAPEKGDVNR.D Y 68.84 1326.6527 13 -15.4 664.3234 2 16.60 6 5771 VEV_3_3_RA6_01_1237.d 7.84E4 4 4 15 27
R.D(+21.98)AIRALVEAELLDKR.Y Y 59.96 1732.9447 15 -6.4 434.2407 4 66.55 5 36431 VEV_2_3_RA5_01_1236.d 0 1 1 28 42 Sodium adduct
R.ALVEAELLDKRYAR.T Y 58.45 1645.9150 14 -11.8 412.4812 4 66.78 5 36613 VEV_2_3_RA5_01_1236.d 4.94E4 1 1 32 45
K.AVDAQGVERPYK.S Y 54.76 1331.6833 12 -12.0 666.8409 2 37.64 5 17732 VEV_2_3_RA5_01_1236.d 1.13E5 2 2 440 451
R.IHIGDEGK.G Y 53.76 867.4450 8 -16.5 434.7226 2 21.25 6 8214 VEV_3_3_RA6_01_1237.d 1.91E5 2 2 7 14
K.GTSPAPEKGDVNRDAIR.A Y 47.56 1781.9020 17 -9.3 594.9691 3 32.83 5 14899 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 15 31
M.G(+42.01)DAERIHIGDEGKGTSPAPEKGDVNR.D Y 45.60 2746.3269 26 -7.9 550.2683 5 55.45 5 28432 VEV_2_3_RA5_01_1236.d 0 1 1 2 27 Acetylation (Protein N-term)
K.SVMQPWGAR.A Y 42.96 1030.5018 9 -9.5 516.2533 2 62.77 5 33608 VEV_2_3_RA5_01_1236.d 4.78E5 3 3 452 460
K.DLKDGGYGAASSPFVLGIK.H Y 40.20 1893.9835 19 -13.9 632.3264 3 79.28 4 46463 VEV_1_3_RA4_01_1235.d 1.18E5 2 2 312 330
R.ALVE(+14.02)AELLDKR.Y Y 37.23 1269.7292 11 -13.0 424.2448 3 71.32 5 39967 VEV_2_3_RA5_01_1236.d 2.18E5 2 2 32 42 Methylation(others)
R.IHIGDEGK(+14.02)GT(-18.01)SPAPEKGDVNR.D Y 37.08 2172.0923 21 -15.4 544.0220 4 39.88 5 19046 VEV_2_3_RA5_01_1236.d 1.86E4 1 1 7 27 Methylation(KR); Dehydration
R.LGFHYWR.D Y 34.62 977.4871 7 -14.6 326.8315 3 65.82 5 35904 VEV_2_3_RA5_01_1236.d 8.86E4 3 3 222 228
R.IHIGDEGK(-1.03)GTSPAPEKGDVNRDAIR.A Y 34.24 2630.3047 25 -25.5 527.0548 5 50.89 5 25752 VEV_2_3_RA5_01_1236.d 8.41E4 1 1 7 31 Lysine oxidation to aminoadipic semialdehyde
R.ALVEAE(+14.02)LLDKR.Y Y 29.55 1269.7292 11 -16.3 424.2435 3 69.28 5 38495 VEV_2_3_RA5_01_1236.d 2.67E5 2 2 32 42 Methylation(others)
K.GDVNRDAIR.A Y 25.98 1014.5206 9 -16.0 508.2595 2 17.63 5 6458 VEV_2_3_RA5_01_1236.d 5.92E4 1 1 23 31
R.DPGAAK.E Y 22.15 557.2809 6 11.5 558.2946 1 29.05 4 12321 VEV_1_3_RA4_01_1235.d 8.01E4 1 1 229 234
R.DPGAAK(+43.01).E Y 20.58 600.2867 6 -11.4 601.2871 1 67.16 5 36891 VEV_2_3_RA5_01_1236.d 0 1 1 229 234 Carbamylation
R.ALVE(+37.96)AELLDKR.Y Y 19.76 1293.6694 11 2.1 432.2313 3 66.36 6 35154 VEV_3_3_RA6_01_1237.d 0 2 2 32 42 Replacement of proton by potassium
R.NIPQASR.R Y 19.18 784.4191 7 8.9 785.4333 1 36.91 5 17300 VEV_2_3_RA5_01_1236.d 3.15E5 1 1 279 285
R.A(+43.01)LVEAELLDKR.Y Y 19.13 1298.7194 11 -73.2 433.8820 3 66.61 4 36537 VEV_1_3_RA4_01_1235.d 5.69E4 1 1 32 42 Carbamylation
K.GDVNR.D Y 18.45 559.2714 5 5.8 560.2819 1 21.54 6 8367 VEV_3_3_RA6_01_1237.d 3.43E4 1 1 23 27
R.ALVEAELLDK(+42.01).R Y 18.12 1141.6230 10 -16.9 381.5419 3 46.71 6 22398 VEV_3_3_RA6_01_1237.d 8.65E4 1 1 32 41 Acetylation (K)
K.GWIGYITVLWE Y 17.54 1335.6863 11 -13.3 446.2301 3 34.49 6 15421 VEV_3_3_RA6_01_1237.d 1.11E6 1 1 542 552
K.SVM(+15.99)QPWGAR.A Y 17.45 1046.4967 9 -11.3 524.2497 2 48.46 4 23903 VEV_1_3_RA4_01_1235.d 6.35E4 1 1 452 460 Oxidation (M)
M.GDAER.I N 15.80 546.2397 5 10.3 547.2526 1 56.15 5 28853 VEV_2_3_RA5_01_1236.d 0 1 1 2 6
total 32 peptides
C1GDJ1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NSAVPNITATSPSSPLKPATPSRR.D Y 107.98 2448.3083 24 -13.7 613.0760 4 64.05 4 34549 VEV_1_3_RA4_01_1235.d 2.44E5 5 5 2186 2209
K.GVIIPVNYLDDAEEMLSR.A Y 98.53 2033.0139 18 -5.8 1017.5083 2 91.05 4 54283 VEV_1_3_RA4_01_1235.d 4.32E5 3 3 1187 1204
R.ALADGGLLVLLDGR.S Y 98.34 1381.7928 14 -11.9 691.8954 2 87.33 5 50488 VEV_2_3_RA5_01_1236.d 1.7E5 2 2 652 665
K.Q(-17.03)PGSTLEAGDILGILALDNPSR.V Y 93.52 2219.1433 22 -14.8 1110.5625 2 96.57 5 54893 VEV_2_3_RA5_01_1236.d 2.6E5 3 3 748 769 Pyro-glu from Q
R.FIDDNVTPADADILR.T Y 89.36 1673.8260 15 -9.3 837.9125 2 78.62 4 45955 VEV_1_3_RA4_01_1235.d 3.5E5 2 2 883 897
R.LGGIPIGVIAVETR.S Y 88.90 1393.8292 14 -12.5 697.9132 2 81.69 4 48332 VEV_1_3_RA4_01_1235.d 5.6E4 1 1 1920 1933
R.HSEPALAFQLELGR.L Y 78.53 1566.8154 14 -13.2 523.2722 3 76.51 5 43673 VEV_2_3_RA5_01_1236.d 2.54E5 3 3 1314 1327
K.TAQALKDFNFGEQLPVMILANWR.G Y 74.49 2661.3738 23 -9.0 666.3447 4 91.18 4 54314 VEV_1_3_RA4_01_1235.d 2.46E5 1 1 1968 1990
R.MPQKLDSLLAQVVDR.A Y 64.09 1711.9291 15 -33.4 571.6312 3 81.45 4 48122 VEV_1_3_RA4_01_1235.d 0 2 2 849 863
K.TC(+57.02)LLEEENDPTQLR.T Y 62.93 1716.7988 14 -3.4 859.4038 2 69.96 4 39185 VEV_1_3_RA4_01_1235.d 4.03E4 2 2 686 699 Carbamidomethylation
R.AHLSSEAC(+57.02)IAEYR.K Y 61.85 1505.6932 13 -22.3 502.8938 3 57.11 5 29500 VEV_2_3_RA5_01_1236.d 4.94E4 2 2 584 596 Carbamidomethylation
M.GVTDTPATATN(+.98)GFGSSFAAK.H Y 58.54 1899.8850 20 -6.2 950.9438 2 71.63 4 40500 VEV_1_3_RA4_01_1235.d 3.77E4 1 1 2 21 Deamidation (NQ)
R.MAAAAPSTTSR.N Y 52.80 1062.5128 11 -10.6 532.2581 2 25.27 5 10639 VEV_2_3_RA5_01_1236.d 2.37E5 3 3 2175 2185
K.IVQWMSFIPDKK.N Y 50.31 1490.7955 12 -10.8 497.9337 3 79.39 4 46541 VEV_1_3_RA4_01_1235.d 3.26E4 1 1 1839 1850
K.AGGQSDFGMVAGSSHPSTPTTPTMESNPFKK.I Y 48.02 3150.4387 31 4.5 788.6205 4 71.99 4 40782 VEV_1_3_RA4_01_1235.d 3.29E4 1 1 1135 1165
R.M(+15.99)AAAAPSTTSR.N Y 43.51 1078.5077 11 -9.8 540.2559 2 20.06 4 7465 VEV_1_3_RA4_01_1235.d 3.66E5 3 3 2175 2185 Oxidation (M)
R.GSGLIAGATSK.A Y 41.70 960.5240 11 -8.4 481.2653 2 36.67 4 16741 VEV_1_3_RA4_01_1235.d 8.83E4 1 1 1743 1753
R.TSLQPLVDVIRR.Y Y 40.60 1395.8198 12 -60.2 466.2526 3 74.49 4 42742 VEV_1_3_RA4_01_1235.d 0 1 1 898 909
K.ALNDKFLPADQLSK.I Y 39.18 1558.8354 14 -19.4 520.6090 3 68.47 5 37890 VEV_2_3_RA5_01_1236.d 6.25E5 2 2 2093 2106
R.LDPEYGELRK.A Y 36.08 1218.6244 10 -19.2 610.3078 2 48.81 6 23624 VEV_3_3_RA6_01_1237.d 8.41E4 2 2 2083 2092
K.YTVENGEHVK.A Y 34.51 1174.5618 10 -0.9 588.2877 2 23.55 4 9299 VEV_1_3_RA4_01_1235.d 3.27E4 1 1 709 718
K.YLYLTPEVK.K Y 33.45 1124.6117 9 -2.4 563.3118 2 71.67 4 40537 VEV_1_3_RA4_01_1235.d 9.37E4 1 1 1692 1700
K.TVFPVDFIYEGFR.Y Y 31.56 1588.7925 13 -2.2 795.4018 2 89.27 5 51520 VEV_2_3_RA5_01_1236.d 1.64E5 1 1 612 624
R.LSVDGKTC(+57.02)LLEEENDPTQLR.T Y 31.36 2316.1267 20 3.4 773.0521 3 72.76 4 41391 VEV_1_3_RA4_01_1235.d 4.56E4 1 1 680 699 Carbamidomethylation
M.GVTDTPATATNGFGSSFAAK.H Y 30.47 1898.9010 20 3.8 950.4614 2 71.37 4 40294 VEV_1_3_RA4_01_1235.d 5.07E4 1 1 2 21
R.TPEYPR.G Y 30.04 761.3708 6 43.7 381.7093 2 22.99 6 9119 VEV_3_3_RA6_01_1237.d 3.74E5 1 1 1610 1615
R.SVGIGAYLVR.L Y 28.39 1033.5920 10 -11.5 517.7974 2 73.35 5 41418 VEV_2_3_RA5_01_1236.d 0 1 1 1768 1777
K.DGGLR.G N 28.04 516.2656 5 -46.4 517.2489 1 48.32 6 23331 VEV_3_3_RA6_01_1237.d 0 1 1 2270 2274
R.GVQQVLSM(+15.99)LPVEER.E Y 26.80 1599.8290 14 -53.3 534.2552 3 57.31 5 29637 VEV_2_3_RA5_01_1236.d 4.96E4 1 1 2275 2288 Oxidation (M)
R.GVQQVLSMLPVEER.E Y 26.62 1583.8341 14 7.1 528.9557 3 71.80 4 40640 VEV_1_3_RA4_01_1235.d 0 1 1 2275 2288
K.YLGSP Y 25.59 535.2642 5 14.3 536.2791 1 39.81 4 18584 VEV_1_3_RA4_01_1235.d 0 2 2 2294 2298
R.LLYGVDPNTSSEIDFHFENEESTKTQR.R Y 25.49 3155.4683 27 -3.6 789.8715 4 77.73 4 45269 VEV_1_3_RA4_01_1235.d 3.95E4 1 1 415 441
R.SHNVYWK.E Y 23.89 932.4504 7 4.0 467.2344 2 57.79 6 28888 VEV_3_3_RA6_01_1237.d 8.61E4 1 1 666 672
K.ISSISDMSYLVNK.G Y 23.62 1455.7279 13 -14.4 728.8608 2 76.34 4 44177 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 1166 1178
R.HMITTVIGAEDGLGVEC(+57.02)LR.G Y 22.49 2070.0237 19 -28.2 690.9957 3 79.13 6 44536 VEV_3_3_RA6_01_1237.d 0 1 1 1724 1742 Carbamidomethylation
K.GPESDKAVDK.R Y 22.17 1044.5087 10 -5.5 523.2587 2 37.39 4 17168 VEV_1_3_RA4_01_1235.d 5.74E4 1 1 1352 1361
R.HQKIIEEAPVTIAKPETFRAM(+15.99)ER.A Y 22.03 2709.4272 23 -54.6 678.3271 4 76.04 6 42327 VEV_3_3_RA6_01_1237.d 9.6E4 1 1 320 342 Oxidation (M)
R.K(+43.99)PTPR.V Y 21.96 641.3497 5 -43.3 642.3292 1 82.04 6 46571 VEV_3_3_RA6_01_1237.d 0 1 1 1231 1235 Carboxylation (DKW)
K.RM(+15.99)AAAAPSTTSR.N Y 20.44 1234.6088 12 -12.4 618.3040 2 38.14 5 18017 VEV_2_3_RA5_01_1236.d 7.41E4 1 1 2174 2185 Oxidation (M)
R.AIQFTVMATPEDLR.A Y 20.25 1590.8075 14 -11.7 796.4017 2 77.07 4 44749 VEV_1_3_RA4_01_1235.d 2.84E5 3 3 87 100
K.WAYNTFGDER.A Y 20.16 1257.5414 10 34.0 629.7993 2 68.33 4 37900 VEV_1_3_RA4_01_1235.d 0 1 1 77 86
K.IIFIGPPGSAM(+15.99)R.S Y 19.99 1273.6852 12 10.4 425.5734 3 70.32 5 39225 VEV_2_3_RA5_01_1236.d 6.57E4 1 1 166 177 Oxidation (M)
R.AESQK.S N 19.22 561.2758 5 -37.1 562.2623 1 47.37 6 22781 VEV_3_3_RA6_01_1237.d 4.31E5 2 2 1212 1216
K.AVDKRYFTR.A Y 19.16 1154.6196 9 -11.8 578.3103 2 20.43 4 7617 VEV_1_3_RA4_01_1235.d 3.49E4 1 1 1358 1366
K.VALWYEENK.K Y 18.88 1150.5658 9 6.9 576.2941 2 45.36 4 21979 VEV_1_3_RA4_01_1235.d 0 1 1 2234 2242
R.GGVLEPEGIVNIK.Y Y 18.22 1323.7397 13 -39.6 662.8510 2 75.83 4 43785 VEV_1_3_RA4_01_1235.d 0 1 1 2058 2070
R.MGVHAVWAGWGHASENPK.L Y 17.89 1932.9053 18 -27.0 387.5779 5 12.61 4 3607 VEV_1_3_RA4_01_1235.d 0 1 1 137 154
K.YLYLTPEVKKR.L Y 17.76 1408.8077 11 -13.1 353.2046 4 61.77 6 31728 VEV_3_3_RA6_01_1237.d 2.62E4 1 1 1692 1702
K.QLDTMAR.L Y 17.65 833.4066 7 -47.4 834.3743 1 97.22 5 55065 VEV_2_3_RA5_01_1236.d 0 1 1 2076 2082
K.TRKAEFPANQLM(+15.99)K.T Y 17.43 1548.8082 13 -2.6 388.2083 4 45.03 4 21784 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 866 878 Oxidation (M)
K.C(+57.02)TELAR.K Y 17.20 748.3538 6 -0.1 749.3610 1 52.48 5 26679 VEV_2_3_RA5_01_1236.d 0 1 1 1644 1649 Carbamidomethylation
K.LPESLAASPK.K Y 16.97 1011.5600 10 -44.0 338.1791 3 11.33 5 3129 VEV_2_3_RA5_01_1236.d 3.46E5 3 3 155 164
R.AIQFTVM(+15.99)ATPEDLR.A Y 16.96 1606.8025 14 16.8 402.7147 4 18.10 5 6709 VEV_2_3_RA5_01_1236.d 0 1 1 87 100 Oxidation (M)
K.EEAAATR.L Y 16.88 746.3558 7 -19.2 747.3488 1 39.27 5 18682 VEV_2_3_RA5_01_1236.d 3.57E4 1 1 673 679
R.ILC(+57.02)TEPTTGMAYPLR.V Y 16.84 1721.8480 15 -17.6 574.9465 3 38.10 6 17403 VEV_3_3_RA6_01_1237.d 2.75E5 2 2 1454 1468 Carbamidomethylation
R.SLGDK.I Y 15.95 518.2700 5 -31.7 519.2609 1 37.55 5 17678 VEV_2_3_RA5_01_1236.d 0 1 1 178 182
R.K(+42.01)GVIIPVNY(+79.97)LDDAEEMLSRALEVFPR.A Y 15.91 3095.5403 26 -14.4 774.8812 4 86.92 4 51854 VEV_1_3_RA4_01_1235.d 2.79E5 1 1 1186 1211 Acetylation (N-term); Phosphorylation (STY)
R.SSVVESK.Y Y 15.89 734.3810 7 -23.7 735.3708 1 107.25 4 60387 VEV_1_3_RA4_01_1235.d 9.97E4 1 1 1046 1052
K.C(+57.02)SVGVR.A Y 15.89 676.3326 6 -7.3 339.1711 2 25.54 6 10525 VEV_3_3_RA6_01_1237.d 0 1 1 646 651 Carbamidomethylation
K.YGETGWDHR.E Y 15.59 1119.4734 9 -96.0 1120.3732 1 7.07 5 1662 VEV_2_3_RA5_01_1236.d 4.13E3 1 1 1053 1061
K.IIEEAPVTIAKPETFR.A Y 15.56 1812.9985 16 -66.0 605.3002 3 71.32 6 38850 VEV_3_3_RA6_01_1237.d 0 1 1 323 338
R.EPGTNTHGM(+15.99)VGWM(+15.99)ITAR.T Y 15.56 1888.8560 17 41.2 1889.9410 1 6.43 5 1510 VEV_2_3_RA5_01_1236.d 1.54E3 1 1 1593 1609 Oxidation (M)
K.LVGYVSAGTVEYLYSHADDK.F Y 15.47 2186.0532 20 -54.1 438.1943 5 105.25 6 56837 VEV_3_3_RA6_01_1237.d 0 1 1 350 369
K.EVVDSK.Y Y 15.43 675.3439 6 -7.7 676.3459 1 87.45 6 49948 VEV_3_3_RA6_01_1237.d 6.86E4 1 1 1070 1075
K.FLPADQLSK.I Y 15.39 1017.5494 9 -8.3 340.1876 3 45.87 4 22307 VEV_1_3_RA4_01_1235.d 1.67E5 1 1 2098 2106
R.IYLSANSGAR.I Y 15.38 1050.5458 10 -38.1 526.2601 2 58.82 4 30606 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 1656 1665
R.VTGAEIR.I Y 15.25 744.4130 7 -48.1 373.1959 2 18.50 6 6774 VEV_3_3_RA6_01_1237.d 0 1 1 1447 1453
K.FTATR.S Y 15.10 594.3126 5 -17.8 595.3093 1 73.14 4 41695 VEV_1_3_RA4_01_1235.d 4.61E4 1 1 627 631
total 68 peptides
C1GCG8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GENLDSLQDKTDNLAVSAQGFR.R Y 132.87 2377.1509 22 -7.3 793.3851 3 75.12 4 43244 VEV_1_3_RA4_01_1235.d 2.99E5 3 3 54 75
M.A(+42.01)DHEQPYDPYIPSGSSQPATTGNGNQR.T Y 130.93 2928.2910 27 -11.8 977.0928 3 69.29 6 37366 VEV_3_3_RA6_01_1237.d 4.38E5 3 3 2 28 Acetylation (Protein N-term)
M.A(+42.01)DHEQPYDPYIPSGSSQPATTGN(+.98)GNQR.T Y 130.05 2929.2749 27 -8.2 977.4242 3 71.05 6 38642 VEV_3_3_RA6_01_1237.d 1.41E6 8 8 2 28 Acetylation (Protein N-term); Deamidation (NQ)
K.VSQRGENLDSLQDKTDNLAVSAQGFRR.G Y 122.53 3003.5122 27 -16.5 601.6998 5 68.37 4 37929 VEV_1_3_RA4_01_1235.d 4.69E5 4 4 50 76
K.VSQRGENLDSLQDKTDNLAVSAQGFR.R Y 120.89 2847.4111 26 -4.9 712.8566 4 71.33 4 40263 VEV_1_3_RA4_01_1235.d 4.33E5 3 3 50 75
R.TAALQAQIDDTVGVMRENINK.V Y 114.02 2286.1638 21 -8.2 763.0557 3 79.05 6 44503 VEV_3_3_RA6_01_1237.d 4.35E5 3 3 29 49
R.GENLDSLQDKTDNLAVSAQGFRR.G Y 113.85 2533.2520 23 -10.7 634.3135 4 71.33 4 40260 VEV_1_3_RA4_01_1235.d 4.89E5 5 5 54 76
R.TAALQAQIDDTVGVMR.E Y 82.00 1687.8563 16 -8.8 844.9280 2 77.21 4 44866 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 29 44
R.T(-2.02)AALQAQIDDTVGVMRENINK.V Y 71.44 2284.1482 21 -5.0 762.3862 3 79.10 5 45455 VEV_2_3_RA5_01_1236.d 6.73E4 3 3 29 49 2-amino-3-oxo-butanoic_acid
R.TAALQAQIDDTVGVM(+15.99)RENINK.V Y 70.73 2302.1587 21 -6.6 768.3884 3 69.69 4 38975 VEV_1_3_RA4_01_1235.d 4.77E4 1 1 29 49 Oxidation (M)
M.A(+42.01)DHEQPYDPYIPSGSSQ(+.98)PATTGN(+.98)GNQR.T Y 61.34 2930.2590 27 -10.4 977.7501 3 71.47 6 38967 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 2 28 Acetylation (Protein N-term); Deamidation (NQ)
K.TDNLAVSAQGFR.R Y 52.15 1277.6364 12 -20.1 639.8126 2 64.64 6 33843 VEV_3_3_RA6_01_1237.d 1.69E5 2 2 64 75
K.VSQRGENLDS(-2.02)LQDKTDNLAVSAQGFRR.G Y 37.49 3001.4966 27 -15.2 601.2975 5 68.27 6 36590 VEV_3_3_RA6_01_1237.d 7.56E4 1 1 50 76 2-amino-3-oxo-butanoic_acid
R.TAALQ(+.98)AQIDDTVGVMRENINK.V Y 34.54 2287.1477 21 -0.6 763.3894 3 79.12 4 46337 VEV_1_3_RA4_01_1235.d 1.75E5 1 1 29 49 Deamidation (NQ)
R.ENINK.V Y 26.27 616.3180 5 -0.4 617.3250 1 38.34 4 17720 VEV_1_3_RA4_01_1235.d 9.43E4 3 3 45 49
R.ENINKVSQR.G Y 24.39 1086.5781 9 4.0 544.2985 2 14.62 5 4828 VEV_2_3_RA5_01_1236.d 1.29E4 1 1 45 53
R.GENLDSLQDK.T Y 23.99 1117.5251 10 -4.9 559.7671 2 43.93 5 21473 VEV_2_3_RA5_01_1236.d 1.93E5 2 2 54 63
R.ENINK(+114.04).V Y 23.14 730.3610 5 -10.1 731.3608 1 79.41 4 46562 VEV_1_3_RA4_01_1235.d 0 1 1 45 49 Ubiquitin
total 18 peptides
C1G0T1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IPNISQDFVVSAVPQYVR.G Y 125.91 2031.0789 18 -9.4 1016.5371 2 83.98 6 47828 VEV_3_3_RA6_01_1237.d 4.7E4 1 1 383 400
R.VFLDEEAGTGIVAVSHEK.L Y 114.95 1899.9578 18 -10.2 950.9765 2 72.82 5 41048 VEV_2_3_RA5_01_1236.d 3.63E5 6 6 560 577
K.ASTIDELKTIYDDVVPINR.I Y 113.96 2161.1267 19 -16.1 721.3713 3 86.16 6 49163 VEV_3_3_RA6_01_1237.d 1.1E6 8 8 49 67
R.LAHIFPWEAYAPKPTR.V Y 113.55 1896.0045 16 -11.2 475.0031 4 76.79 4 44525 VEV_1_3_RA4_01_1235.d 9.28E5 4 4 544 559
K.HGLGQLHAAGIVHEPTKPPER.M Y 95.48 2243.1924 21 -24.0 449.6350 5 58.43 6 29347 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 266 286
R.IVNHC(+57.02)PANLYLMDRPDLASTFSK.I Y 86.99 2661.3042 23 -14.5 666.3237 4 77.07 6 43060 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 68 90 Carbamidomethylation
R.AAPEPSFSSPR.M Y 74.99 1144.5513 11 -12.1 573.2760 2 51.28 6 25035 VEV_3_3_RA6_01_1237.d 4.82E5 5 5 472 482
R.GEEHVTAYR.H Y 69.23 1060.4938 9 -16.6 531.2454 2 19.67 6 7378 VEV_3_3_RA6_01_1237.d 1.41E5 2 2 401 409
K.TIYDDVVPINR.I Y 64.17 1303.6772 11 -10.3 652.8392 2 72.91 5 41107 VEV_2_3_RA5_01_1236.d 4.81E4 1 1 57 67
R.SSTTGGDFETDITGR.K Y 63.53 1542.6798 15 -11.9 772.3380 2 64.81 6 33973 VEV_3_3_RA6_01_1237.d 3.35E4 1 1 648 662
M.A(+42.01)DPGEAVYC(+57.02)TMLLTDNYLPGAMVLAHSLRDNGC(+57.02)K.A Y 44.13 3793.7571 34 -6.2 1265.5851 3 94.32 5 53941 VEV_2_3_RA5_01_1236.d 1.62E5 2 2 2 35 Acetylation (Protein N-term); Carbamidomethylation
K.LLSEVPNKR.D Y 42.07 1054.6134 9 -24.0 528.3013 2 35.09 5 16239 VEV_2_3_RA5_01_1236.d 3.75E4 4 4 578 586
K.HGLGQLHAAGIVHEPT(-2.02)KPPER.M Y 41.84 2241.1765 21 -18.4 449.2343 5 58.53 6 29392 VEV_3_3_RA6_01_1237.d 0 1 1 266 286 2-amino-3-oxo-butanoic_acid
K.LSSRADIAK.H Y 33.33 959.5400 9 -37.2 480.7594 2 56.54 6 28067 VEV_3_3_RA6_01_1237.d 2.41E5 2 2 257 265
R.Q(-17.03)LFPSGSPYNQLLGR.W Y 32.09 1658.8416 15 -2.1 830.4263 2 88.58 4 52865 VEV_1_3_RA4_01_1235.d 8.44E4 1 1 224 238 Pyro-glu from Q
R.WWATYYR.H Y 26.29 1044.4817 7 -11.9 523.2419 2 72.40 6 39663 VEV_3_3_RA6_01_1237.d 6.43E4 1 1 239 245
K.V(+42.01)QVLKS(+79.97)GLAR.S Y 23.32 1191.6377 10 -46.3 398.2014 3 41.07 6 19106 VEV_3_3_RA6_01_1237.d 0 1 1 638 647 Acetylation (N-term); Phosphorylation (STY)
R.RPFDSPSISK.E Y 19.57 1132.5876 10 23.5 378.5454 3 47.91 4 23572 VEV_1_3_RA4_01_1235.d 0 1 1 414 423
K.VPPKQPNTQR.L Y 18.19 1163.6411 10 -13.6 388.8824 3 13.28 6 4064 VEV_3_3_RA6_01_1237.d 8.18E4 1 1 534 543
K.SGLAR.S N 17.68 502.2863 5 12.0 503.2996 1 72.10 4 40868 VEV_1_3_RA4_01_1235.d 4.96E5 3 3 643 647
K.RDTALGAPR.E Y 17.18 955.5199 9 3.9 319.5151 3 33.21 4 14687 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 586 594
K.SYPEAPK.D Y 16.61 790.3861 7 -5.7 396.1981 2 24.49 6 9939 VEV_3_3_RA6_01_1237.d 7.78E5 1 1 522 528
total 22 peptides
A0A0A0HT22
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVEPFIQTASPTSTTAALAGAVPLEITR.A Y 149.19 2827.4966 28 -9.3 1414.7424 2 86.73 6 49507 VEV_3_3_RA6_01_1237.d 4.92E5 6 6 285 312
K.AHKEPEAAGDSGC(+57.02)VAEKAEVER.Q Y 124.92 2339.0811 22 -8.1 585.7728 4 38.20 5 18081 VEV_2_3_RA5_01_1236.d 3.67E5 5 5 340 361 Carbamidomethylation
R.SIDLAHADPEATAVPEAVVEKEEVER.Q Y 95.41 2803.3875 26 -8.4 701.8483 4 76.06 5 43350 VEV_2_3_RA5_01_1236.d 5.89E4 1 1 383 408
R.EVKHDDSAGEPAPVITAETSPTVPGGTPLAAKEYQEQSISPK.S Y 91.67 4331.1445 42 -18.6 867.2201 5 73.52 4 41994 VEV_1_3_RA4_01_1235.d 2.83E5 3 3 413 454
K.NTIASTATTDKAGYEK.D Y 87.73 1669.8159 16 -6.2 835.9100 2 37.75 4 17362 VEV_1_3_RA4_01_1235.d 1.17E5 3 3 241 256
K.EYQEQSISPK.S Y 76.40 1207.5720 10 -7.5 604.7888 2 35.69 5 16636 VEV_2_3_RA5_01_1236.d 4.68E5 6 6 445 454
K.SREPAPAPAPADK.D Y 75.51 1305.6676 13 -14.2 653.8318 2 21.08 6 8139 VEV_3_3_RA6_01_1237.d 9.03E4 3 3 455 467
R.EVKHDDSAGEPAPVITAETSPTVPGGTPLAAK.E Y 68.62 3141.5830 32 -11.9 786.3937 4 71.48 4 40381 VEV_1_3_RA4_01_1235.d 2.34E3 1 1 413 444
R.TEDGFRKDVEVPAISTK.M Y 40.17 1890.9686 17 -8.5 631.3248 3 64.22 5 34690 VEV_2_3_RA5_01_1236.d 3.63E5 3 3 57 73
K.AHK(+14.02)EPEAAGD(-18.01)SGC(+57.02)VAEKAEVER.Q Y 36.82 2335.0862 22 -2.6 584.7773 4 38.22 5 18068 VEV_2_3_RA5_01_1236.d 0 1 1 340 361 Methylation(KR); Dehydration; Carbamidomethylation
K.EVPEVVKESMSK.A Y 31.90 1360.6908 12 -10.5 454.5661 3 58.74 4 30541 VEV_1_3_RA4_01_1235.d 3.27E5 3 3 328 339
R.KDVEVPAISTKM(+15.99)LYK.F Y 30.59 1736.9382 15 -19.3 435.2335 4 31.60 6 13762 VEV_3_3_RA6_01_1237.d 0 1 1 63 77 Oxidation (M)
K.DVEVPAISTKM(+15.99)LYK.F Y 23.11 1608.8433 14 8.3 403.2214 4 37.19 6 16876 VEV_3_3_RA6_01_1237.d 0 1 1 64 77 Oxidation (M)
K.EVPEVVK.E Y 21.82 798.4487 7 -41.1 400.2152 2 20.36 6 7743 VEV_3_3_RA6_01_1237.d 0 1 1 328 334
K.GPESSAK.E Y 20.03 674.3235 7 10.8 675.3380 1 79.75 6 44976 VEV_3_3_RA6_01_1237.d 4.93E3 1 1 321 327
R.EPAPAPAPADK.D Y 18.95 1062.5345 11 -5.8 532.2715 2 31.43 5 14094 VEV_2_3_RA5_01_1236.d 3.59E5 4 4 457 467
R.APNGSVSKGPESSAK.E Y 17.52 1414.7052 15 -9.0 708.3535 2 84.07 6 47880 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 313 327
K.QLPPPSK.D Y 16.68 765.4385 7 -21.9 766.4290 1 99.24 6 55060 VEV_3_3_RA6_01_1237.d 0 1 1 111 117
K.DVEVPAISTKMLYK.F Y 16.11 1592.8484 14 6.6 399.2220 4 59.56 4 31153 VEV_1_3_RA4_01_1235.d 0 1 1 64 77
K.ESMSK.A N 15.17 580.2527 5 48.4 581.2880 1 26.36 5 11247 VEV_2_3_RA5_01_1236.d 0 1 1 335 339
total 20 peptides
C1G0C5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IDPSSAFGISLGDAHVIR.N Y 124.74 1853.9635 18 -8.7 927.9810 2 80.81 4 47673 VEV_1_3_RA4_01_1235.d 2.13E6 11 11 43 60
R.NAGYANTFNQSHLAIPPVEK.Y Y 123.13 2170.0806 20 -13.9 724.3574 3 71.99 6 39399 VEV_3_3_RA6_01_1237.d 1.42E6 11 11 13 32
R.WLSEQVLVTPGIPISGWVYEIETGKVR.K Y 109.80 3055.6382 27 -12.1 1019.5410 3 92.14 6 52379 VEV_3_3_RA6_01_1237.d 3.7E5 3 3 156 182
K.LVESHRQNGTGAADGGC(+57.02)R.V Y 95.57 1883.8656 18 -9.3 628.9567 3 17.16 5 6193 VEV_2_3_RA5_01_1236.d 1.8E5 4 4 111 128 Carbamidomethylation
R.WLSEQVLVTPGIPISGWVYEIETGK.V Y 90.67 2800.4688 25 -16.4 934.4816 3 95.32 6 53744 VEV_3_3_RA6_01_1237.d 2.9E5 4 4 156 180
R.DIPDFQPFPLLEEAVREDVR.W Y 90.40 2384.2012 20 -8.5 795.7343 3 91.50 4 54539 VEV_1_3_RA4_01_1235.d 2.05E6 10 10 136 155
K.YLVLTC(+57.02)MDAR.I Y 82.18 1240.5944 10 -14.8 621.2953 2 72.60 6 39799 VEV_3_3_RA6_01_1237.d 9.47E5 6 6 33 42 Carbamidomethylation
K.LVESHRQN(+.98)GTGAADGGC(+57.02)R.V Y 79.65 1884.8496 18 -5.4 629.2871 3 19.56 4 7191 VEV_1_3_RA4_01_1235.d 2.24E5 3 3 111 128 Deamidation (NQ); Carbamidomethylation
R.SIVISQQLLGTR.E Y 79.01 1313.7667 12 -11.4 657.8831 2 74.86 6 41437 VEV_3_3_RA6_01_1237.d 3.46E5 3 3 72 83
R.DIPDFQPFPLLEEAVR.E Y 75.71 1884.9620 16 -10.5 943.4784 2 92.80 4 55196 VEV_1_3_RA4_01_1235.d 3.12E5 4 4 136 151
R.IDPSSAFGISLGDAHVIRNAGASAR.D Y 56.86 2481.2725 25 -12.9 621.3174 4 77.64 5 44464 VEV_2_3_RA5_01_1236.d 1.15E5 1 1 43 67
R.IDPS(-2.02)SAFGISLGDAHVIR.N Y 53.82 1851.9479 18 -7.7 618.3185 3 80.78 4 47622 VEV_1_3_RA4_01_1235.d 2.23E5 2 2 43 60 2-amino-3-oxo-butanoic_acid
R.DIPDFQPFPLLEEAVREDVR(+14.02).W Y 52.70 2398.2168 20 -10.9 800.4042 3 92.39 6 52524 VEV_3_3_RA6_01_1237.d 3.04E5 2 2 136 155 Methylation(KR)
R.DIPDFQPFPLLEEAVR(+14.02)EDVR.W Y 52.31 2398.2168 20 -7.5 800.4069 3 92.61 5 53202 VEV_2_3_RA5_01_1236.d 5.75E5 3 3 136 155 Methylation(KR)
R.N(+.98)AGYANTFNQSHLAIPPVEK.Y Y 50.46 2171.0647 20 -3.9 724.6927 3 72.26 5 40655 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 13 32 Deamidation (NQ)
M.A(+42.01)TQIQQKLQDR.N Y 39.63 1369.7313 11 -5.6 685.8691 2 64.05 5 34569 VEV_2_3_RA5_01_1236.d 6.88E4 1 1 2 12 Acetylation (Protein N-term)
R.I(+43.01)DPSSAFGISLGDAHVIR.N Y 36.85 1896.9694 18 -19.9 633.3178 3 80.79 6 45716 VEV_3_3_RA6_01_1237.d 0 1 1 43 60 Carbamylation
K.KLVESHRQ(+.98)NGTGAADGGC(+57.02)R.V Y 34.50 2012.9446 19 -1.8 504.2425 4 21.11 5 8348 VEV_2_3_RA5_01_1236.d 2.86E4 1 1 110 128 Deamidation (NQ); Carbamidomethylation
R.VLEALKR.D Y 34.01 827.5228 7 -18.0 414.7612 2 33.64 6 14870 VEV_3_3_RA6_01_1237.d 2.99E5 3 3 129 135
R.NAGYANTFNQSHLAIPPVEKYLVLTC(+57.02)MDAR.I Y 33.27 3392.6646 30 -11.0 849.1641 4 83.88 6 47752 VEV_3_3_RA6_01_1237.d 3.94E4 2 2 13 42 Carbamidomethylation
R.N(+.98)AGYANTFNQSHLAIPPVEKYLVLTC(+57.02)MDAR.I Y 32.75 3393.6484 30 -0.7 849.4188 4 83.82 5 48454 VEV_2_3_RA5_01_1236.d 9.27E4 1 1 13 42 Deamidation (NQ); Carbamidomethylation
K.KLVESHRQNGTGAADGGC(+57.02)R.V Y 29.84 2011.9606 19 -24.7 503.9850 4 19.14 6 7125 VEV_3_3_RA6_01_1237.d 5.74E4 1 1 110 128 Carbamidomethylation
K.LQDRNAGYANTFNQSHLAIPPVEK.Y Y 28.84 2682.3513 24 38.7 671.6210 4 70.59 6 38296 VEV_3_3_RA6_01_1237.d 0 1 1 9 32
R.NAGASAR.D Y 26.93 645.3194 7 -7.9 646.3216 1 44.13 4 21227 VEV_1_3_RA4_01_1235.d 0 1 1 61 67
R.SIVISQ(+.98)QLLGTR.E Y 24.43 1314.7507 12 -49.3 658.3502 2 74.95 5 42560 VEV_2_3_RA5_01_1236.d 8.62E4 1 1 72 83 Deamidation (NQ)
R.EILLIK.H N 22.82 727.4844 6 -19.7 364.7423 2 66.54 6 35284 VEV_3_3_RA6_01_1237.d 1.87E5 3 3 84 89
K.YLVLTC(+57.02)MDAR(+14.02).I Y 22.13 1254.6101 10 1.9 628.3135 2 75.68 5 43087 VEV_2_3_RA5_01_1236.d 2.69E4 1 1 33 42 Carbamidomethylation; Methylation(KR)
R.S(-2.02)IVISQQLLGTR.E Y 19.62 1311.7510 12 -83.4 656.8281 2 74.84 6 41425 VEV_3_3_RA6_01_1237.d 0 1 1 72 83 2-amino-3-oxo-butanoic_acid
M.A(+42.01)TQIQQK.L Y 19.30 857.4607 7 -18.7 429.7296 2 29.57 6 12632 VEV_3_3_RA6_01_1237.d 9.65E4 1 1 2 8 Acetylation (Protein N-term)
K.LVESHR.Q Y 18.92 739.3976 6 22.9 740.4219 1 100.26 5 56100 VEV_2_3_RA5_01_1236.d 0 1 1 111 116
R.DIPDFQ(+.98)PFPLLEEAVR(+14.02)EDVR.W Y 16.76 2399.2007 20 -6.2 800.7359 3 92.54 6 52556 VEV_3_3_RA6_01_1237.d 9.53E4 1 1 136 155 Deamidation (NQ); Methylation(KR)
total 31 peptides
C1GKR7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FQNGKTESLFLQR.K Y 110.27 1566.8154 13 -12.7 523.2725 3 64.58 5 34988 VEV_2_3_RA5_01_1236.d 1.89E6 13 13 16 28
R.AIVGASLDVIKER.R Y 104.71 1369.7928 13 -12.9 685.8948 2 69.23 5 38453 VEV_2_3_RA5_01_1236.d 3.58E6 9 9 66 78
R.AIVGASLDVIKERR.S Y 97.40 1525.8939 14 -10.9 763.9459 2 65.07 5 35327 VEV_2_3_RA5_01_1236.d 2.34E6 9 9 66 79
K.IFRFQNGKTESLFLQR.K Y 96.87 1983.0690 16 -4.1 496.7725 4 73.74 4 42200 VEV_1_3_RA4_01_1235.d 7.93E5 4 4 13 28
R.FQN(+.98)GKTESLFLQR.K Y 86.52 1567.7994 13 -14.7 523.5994 3 69.21 5 38433 VEV_2_3_RA5_01_1236.d 3.1E6 14 14 16 28 Deamidation (NQ)
K.IFRFQN(+.98)GKTESLFLQR.K Y 81.38 1984.0530 16 -11.7 497.0147 4 76.79 4 44526 VEV_1_3_RA4_01_1235.d 6.74E5 2 2 13 28 Deamidation (NQ)
R.RISWTVLYR.R Y 78.42 1192.6716 9 -8.4 398.5612 3 72.31 4 41037 VEV_1_3_RA4_01_1235.d 1.96E6 5 5 33 41
R.ISWTVLYR.R Y 74.28 1036.5706 8 -9.3 519.2877 2 77.93 4 45446 VEV_1_3_RA4_01_1235.d 1.09E6 5 5 34 41
R.Q(-17.03)QAIKEGKEK.K Y 73.10 1140.6139 10 -13.6 571.3065 2 13.26 5 4120 VEV_2_3_RA5_01_1236.d 3.35E5 4 4 91 100 Pyro-glu from Q
K.TESLFLQR.K Y 72.56 992.5291 8 -17.4 497.2632 2 64.40 6 33686 VEV_3_3_RA6_01_1237.d 2E6 9 9 21 28
R.AIVGASLDVIK.E Y 72.28 1084.6492 11 -9.7 1085.6459 1 73.30 5 41390 VEV_2_3_RA5_01_1236.d 2.27E6 7 7 66 76
R.RISWTVLYRR.Q Y 68.00 1348.7727 10 -14.1 450.5918 3 67.15 5 36884 VEV_2_3_RA5_01_1236.d 1.26E6 7 7 33 42
R.Q(-17.03)QAIKEGKEKK.S Y 67.41 1268.7087 11 -10.7 423.9057 3 11.40 4 3028 VEV_1_3_RA4_01_1235.d 1.63E5 2 2 91 101 Pyro-glu from Q
K.LYVRGDGKIFR.F Y 63.04 1322.7458 11 -13.9 441.9164 3 57.66 5 29907 VEV_2_3_RA5_01_1236.d 1.26E6 7 7 5 15
R.AIVGASLDVIK(+14.02)ER.R Y 62.98 1383.8085 13 -11.6 692.9035 2 72.72 5 40976 VEV_2_3_RA5_01_1236.d 3.27E5 3 3 66 78 Methylation(KR)
R.AIVGASLDVIKER(+14.02).R Y 61.98 1383.8085 13 -12.1 462.2712 3 71.75 4 40596 VEV_1_3_RA4_01_1235.d 1.1E6 6 6 66 78 Methylation(KR)
R.Q(-17.03)QAIKEGK.E Y 61.90 883.4763 8 -10.0 442.7410 2 16.54 4 5609 VEV_1_3_RA4_01_1235.d 5.41E5 2 2 91 98 Pyro-glu from Q
R.FQN(+.98)GKTESLFLQR(+14.02).K Y 61.21 1581.8151 13 -7.5 528.2750 3 71.57 4 40451 VEV_1_3_RA4_01_1235.d 2.2E5 1 1 16 28 Deamidation (NQ); Methylation(KR)
K.GAPPKVAAK.S Y 59.30 837.5072 9 -12.4 419.7557 2 12.13 5 3533 VEV_2_3_RA5_01_1236.d 6.03E5 7 7 135 143
K.GISEEVAK.K Y 58.39 831.4338 8 -15.9 416.7176 2 28.13 5 12203 VEV_2_3_RA5_01_1236.d 2.52E6 8 8 47 54
K.LYVRGDGK.I Y 56.50 906.4923 8 -8.0 454.2498 2 16.51 4 5589 VEV_1_3_RA4_01_1235.d 6.21E5 4 4 5 12
K.KGISEEVAK.K Y 55.88 959.5287 9 -12.1 480.7658 2 19.22 5 7326 VEV_2_3_RA5_01_1236.d 7.15E5 4 4 46 54
R.QQAIKEGKEK.K Y 53.30 1157.6404 10 -17.8 579.8171 2 9.11 5 2181 VEV_2_3_RA5_01_1236.d 5.71E4 5 5 91 100
R.FQ(+.98)NGKTESLFLQR.K Y 49.77 1567.7994 13 -22.0 523.5956 3 66.06 6 34928 VEV_3_3_RA6_01_1237.d 2.96E5 1 1 16 28 Deamidation (NQ)
R.GDGKIFRFQN(+.98)GKTESLFLQR.K Y 47.34 2341.2178 20 -10.6 586.3055 4 75.18 5 42717 VEV_2_3_RA5_01_1236.d 4.16E4 1 1 9 28 Deamidation (NQ)
R.ISWTVLYRR.Q Y 46.05 1192.6716 9 -14.2 398.5588 3 71.76 5 40301 VEV_2_3_RA5_01_1236.d 1.8E6 4 4 34 42
R.LAARQQAIKEGKEK.K Y 45.35 1568.8998 14 -8.4 523.9695 3 16.42 5 5793 VEV_2_3_RA5_01_1236.d 1.6E5 3 3 87 100
R.GDGKIFR.F Y 43.74 791.4290 7 -10.4 396.7176 2 21.43 4 8172 VEV_1_3_RA4_01_1235.d 8.8E5 6 6 9 15
R.AIVGASLDVIKER(+14.02)R.S Y 42.03 1539.9097 14 -17.6 385.9779 4 67.83 5 37424 VEV_2_3_RA5_01_1236.d 3.35E5 3 3 66 79 Methylation(KR)
K.GISEEVAKKR.T Y 41.66 1115.6299 10 -30.4 558.8052 2 20.38 4 7594 VEV_1_3_RA4_01_1235.d 4.86E5 5 5 47 56
R.FQN(+.98)GK(+14.02)TESLFLQR.K Y 41.66 1581.8151 13 -10.1 528.2736 3 74.66 4 42865 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 16 28 Deamidation (NQ); Methylation(KR)
R.QQAIKEGKEKK.S Y 41.17 1285.7354 11 -12.2 429.5805 3 8.72 4 2064 VEV_1_3_RA4_01_1235.d 5.35E3 1 1 91 101
K.TESLFLQ(+.98)R.K Y 41.04 993.5131 8 -10.0 497.7589 2 66.52 4 36526 VEV_1_3_RA4_01_1235.d 2.17E5 2 2 21 28 Deamidation (NQ)
R.LAARQQAIKEGK.E Y 38.46 1311.7622 12 -10.3 656.8816 2 17.41 5 6336 VEV_2_3_RA5_01_1236.d 1.41E5 2 2 87 98
R.Q(-17.03)Q(+.98)AIKEGKEK.K Y 37.95 1141.5979 10 -5.7 571.8030 2 15.37 4 4976 VEV_1_3_RA4_01_1235.d 1.17E4 1 1 91 100 Pyro-glu from Q; Deamidation (NQ)
R.Q(-17.03)QAIKEGK(+14.02).E Y 37.48 897.4919 8 -8.6 449.7494 2 23.13 4 9074 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 91 98 Pyro-glu from Q; Methylation(KR)
K.SAAGAARGQASR.I Y 37.20 1101.5638 12 -10.3 551.7835 2 10.18 5 2590 VEV_2_3_RA5_01_1236.d 1.03E5 2 2 115 126
R.FQNGKTE(+14.02)SLFLQR.K Y 33.25 1580.8311 13 -11.2 791.4139 2 68.51 5 37917 VEV_2_3_RA5_01_1236.d 1.44E4 1 1 16 28 Methylation(others)
R.SMRPEAR.L Y 31.07 845.4177 7 -9.7 423.7120 2 12.30 4 3448 VEV_1_3_RA4_01_1235.d 4.33E5 3 3 80 86
R.RSM(+15.99)RPEAR.L Y 30.48 1017.5138 8 -12.9 340.1742 3 9.08 5 2167 VEV_2_3_RA5_01_1236.d 2.68E5 3 3 79 86 Oxidation (M)
R.SM(+15.99)RPEAR.L Y 28.57 861.4127 7 -9.3 431.7096 2 8.95 4 2127 VEV_1_3_RA4_01_1235.d 2.51E5 5 5 80 86 Oxidation (M)
R.RSMRPEAR.L Y 27.67 1001.5189 8 -14.8 334.8419 3 11.84 5 3362 VEV_2_3_RA5_01_1236.d 6.89E5 4 4 79 86
K.GISEEVAKK.R Y 25.59 959.5287 9 -18.1 480.7629 2 20.36 6 7745 VEV_3_3_RA6_01_1237.d 3.37E4 1 1 47 55
R.FQNGK.T Y 23.61 592.2969 5 -6.6 593.3002 1 34.46 5 15853 VEV_2_3_RA5_01_1236.d 0 1 1 16 20
R.AIVGASLDVIKERR(+14.02).S Y 23.32 1539.9097 14 -14.1 514.3033 3 67.01 5 36777 VEV_2_3_RA5_01_1236.d 4.88E4 1 1 66 79 Methylation(KR)
K.SQRAIVGASLDVIKER.R Y 22.95 1740.9846 16 -39.6 436.2362 4 54.38 6 26890 VEV_3_3_RA6_01_1237.d 0 1 1 63 78
K.TESLFLQR(+14.02).K Y 21.36 1006.5447 8 -23.6 504.2678 2 67.03 6 35668 VEV_3_3_RA6_01_1237.d 2.29E5 1 1 21 28 Methylation(KR)
R.RSM(+15.99)RPEARLAARQQAIK.E Y 20.26 1997.1064 17 2.2 500.2850 4 76.15 4 44026 VEV_1_3_RA4_01_1235.d 0 1 1 79 95 Oxidation (M)
R.IQSKQGAKGAPPK.V Y 17.10 1308.7513 13 -56.9 437.2329 3 29.34 4 12480 VEV_1_3_RA4_01_1235.d 2.77E4 1 1 127 139
K.SAAGAAR.G Y 16.98 602.3136 7 -35.7 603.2994 1 74.27 5 42077 VEV_2_3_RA5_01_1236.d 5.54E4 3 3 115 121
total 50 peptides
C1GBT0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ILVEEGIYDTFLER.F Y 117.51 1695.8719 14 -7.9 848.9365 2 85.11 4 50655 VEV_1_3_RA4_01_1235.d 3.15E5 3 3 303 316
K.VGDPFHQDTFQGPQVSQLQFDR.I Y 115.15 2545.1985 22 -13.6 849.3953 3 79.10 6 44512 VEV_3_3_RA6_01_1237.d 1.17E5 2 2 326 347
K.LVVEAGFPPGVINIISGFGR.V Y 114.61 2041.1360 20 -10.7 681.3787 3 92.73 4 55155 VEV_1_3_RA4_01_1235.d 4.71E5 5 5 202 221
K.VIDTDTDSFNYTR.H Y 96.26 1545.6947 13 -8.8 773.8478 2 65.90 4 35975 VEV_1_3_RA4_01_1235.d 4.71E5 4 4 138 150
K.SAEQTPLSALYAAK.L Y 92.98 1448.7511 14 -18.5 725.3694 2 74.05 6 40912 VEV_3_3_RA6_01_1237.d 7.15E5 6 6 188 201
K.IGPVVATGNTVVLK.S Y 88.00 1366.8184 14 -20.7 684.4023 2 71.13 6 38709 VEV_3_3_RA6_01_1237.d 8.63E4 1 1 174 187
R.IDVANAAGC(+57.02)IR.Y Y 84.77 1158.5815 11 -13.0 580.2905 2 62.78 6 32469 VEV_3_3_RA6_01_1237.d 1.03E6 7 7 115 125 Carbamidomethylation
K.LADLMEQHVDTLAAIEALDNGKAYSIAR.I Y 73.06 3027.5334 28 13.6 1010.1989 3 83.91 4 49849 VEV_1_3_RA4_01_1235.d 2.24E5 4 4 87 114
R.ELGEYALDNYTQVK.A Y 61.99 1641.7886 14 -9.0 821.8942 2 74.69 6 41313 VEV_3_3_RA6_01_1237.d 4.69E5 3 3 449 462
R.TFESINPHNEK(-1.03)PIVAVYEATEKDVDIAVAAAR.A Y 55.92 3495.7520 32 -2.7 874.9429 4 83.76 4 49742 VEV_1_3_RA4_01_1235.d 0 1 1 34 65 Lysine oxidation to aminoadipic semialdehyde
R.ILVEEGIYDTFLER(+14.02).F Y 55.89 1709.8876 14 -3.4 855.9481 2 86.44 4 51544 VEV_1_3_RA4_01_1235.d 5.68E5 3 3 303 316 Methylation(KR)
K.AAGAKVEIGGER.L Y 55.30 1156.6200 12 -20.3 579.3055 2 27.79 6 11665 VEV_3_3_RA6_01_1237.d 1.1E4 1 1 357 368
M.A(+42.01)LFQQITTPTITYEQPLGLFINNEFVK.G Y 54.03 3166.6589 27 -9.4 1056.5503 3 97.80 4 57479 VEV_1_3_RA4_01_1235.d 1.76E5 4 4 2 28 Acetylation (Protein N-term)
R.Q(-17.03)ILQAAAK.S Y 51.54 824.4756 8 -20.4 825.4661 1 63.35 6 32886 VEV_3_3_RA6_01_1237.d 8.67E4 2 2 247 254 Pyro-glu from Q
K.LADLMEQHVDTLAAIEALDNGK.A Y 49.26 2366.1787 22 -39.5 789.7024 3 83.79 4 49769 VEV_1_3_RA4_01_1235.d 0 1 1 87 108
K.HVTPTNR.G Y 48.90 823.4301 7 -14.2 412.7165 2 9.94 6 2481 VEV_3_3_RA6_01_1237.d 2.34E4 3 3 74 80
R.YYGGWADKIHGK.V Y 35.21 1393.6779 12 -11.2 349.4229 4 56.77 4 29173 VEV_1_3_RA4_01_1235.d 2.37E5 1 1 126 137
R.QILQAAAK.S Y 28.54 841.5021 8 -38.2 421.7423 2 31.19 4 13531 VEV_1_3_RA4_01_1235.d 2.21E5 1 1 247 254
K.VIDTDTDSFNYTR(+14.02).H Y 27.54 1559.7103 13 -14.2 780.8514 2 67.86 6 36279 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 138 150 Methylation(KR)
R.VSNELK.A Y 24.46 688.3755 6 45.2 689.4139 1 28.09 4 11797 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 415 420
K.AAGAK.V N 21.64 416.2383 5 -20.3 417.2372 1 28.56 4 12050 VEV_1_3_RA4_01_1235.d 2.18E5 1 1 357 361
R.LGDALFG Y 16.70 691.3541 7 -30.7 692.3401 1 76.08 6 42330 VEV_3_3_RA6_01_1237.d 2.61E4 1 1 468 474
R.IMGYIR.E Y 16.61 751.4051 6 10.0 376.7136 2 35.95 5 16740 VEV_2_3_RA5_01_1236.d 7.22E4 1 1 348 353
K.GVEGR.T N 16.15 516.2656 5 -6.4 517.2695 1 38.54 6 17655 VEV_3_3_RA6_01_1237.d 0 1 1 29 33
R.EGKAAGAKVEIGGER.L Y 15.94 1470.7789 15 -40.1 368.6873 4 41.47 5 20004 VEV_2_3_RA5_01_1236.d 2.45E4 1 1 354 368
total 25 peptides
C1G820
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KGVIPLSTFLR.V Y 98.57 1229.7495 11 -18.3 410.9163 3 76.92 5 43976 VEV_2_3_RA5_01_1236.d 1.05E6 8 8 22 32
R.VGDIVDIKVNGAVQQGMPFK.I Y 97.54 2114.1194 20 -14.7 705.7034 3 78.39 4 45788 VEV_1_3_RA4_01_1235.d 3.37E5 2 2 36 55
R.VGDIVDIKVN(+.98)GAVQQGMPFK.I Y 95.07 2115.1033 20 -7.2 706.0366 3 79.41 4 46560 VEV_1_3_RA4_01_1235.d 3.39E5 2 2 36 55 Deamidation (NQ)
K.VNGAVQQGMPFK.I Y 92.90 1274.6442 12 -16.7 638.3187 2 61.83 4 32888 VEV_1_3_RA4_01_1235.d 4.3E5 4 4 44 55
R.TVSTEGNLPETITPVPYETTI Y 90.86 2261.1313 21 -10.4 1131.5612 2 85.21 4 50759 VEV_1_3_RA4_01_1235.d 1.26E6 4 4 140 160
K.AKEEGIHVHLKR.Q Y 88.52 1415.7997 12 -11.6 708.8989 2 25.26 5 10665 VEV_2_3_RA5_01_1236.d 2.2E6 11 11 119 130
R.KAKEEGIHVHLK.R Y 85.60 1387.7936 12 -15.2 463.5981 3 22.93 6 9124 VEV_3_3_RA6_01_1237.d 2.79E5 4 4 118 129
R.VNVRIEHVSHSR.S Y 85.42 1431.7695 12 -30.5 478.2492 3 26.36 6 10923 VEV_3_3_RA6_01_1237.d 1.11E6 7 7 89 100
K.GVIPLSTFLR.V Y 80.24 1101.6545 10 -9.8 551.8292 2 82.64 4 48995 VEV_1_3_RA4_01_1235.d 2.9E6 5 5 23 32
K.TGVVYNVTK.S Y 75.00 979.5338 9 -10.4 490.7691 2 44.39 4 21380 VEV_1_3_RA4_01_1235.d 3.82E6 9 9 61 69
K.VN(+.98)GAVQQGMPFK.I Y 74.03 1275.6282 12 -10.1 638.8149 2 65.13 4 35399 VEV_1_3_RA4_01_1235.d 1.43E5 1 1 44 55 Deamidation (NQ)
R.YAFSRDYK.K Y 73.95 1048.4978 8 -3.6 525.2543 2 40.00 4 18755 VEV_1_3_RA4_01_1235.d 8.15E5 9 9 13 20
K.KKGVIPLSTFLR.V Y 73.88 1357.8445 12 -9.1 453.6180 3 70.62 5 39441 VEV_2_3_RA5_01_1236.d 3.99E5 4 4 21 32
K.SAVGVIIYKR.V Y 73.28 1104.6655 10 -17.9 369.2225 3 57.75 6 28857 VEV_3_3_RA6_01_1237.d 2.06E6 9 9 70 79
R.IEHVSHSR.S Y 72.69 963.4886 8 -13.9 482.7449 2 9.88 6 2460 VEV_3_3_RA6_01_1237.d 1.79E5 4 4 93 100
K.VN(-17.03)GAVQQGMPFK.I Y 67.33 1257.6176 12 -7.8 629.8112 2 75.82 4 43770 VEV_1_3_RA4_01_1235.d 8.19E4 1 1 44 55 Ammonia-loss (N)
R.VYRVGDIVDIKVNGAVQQGMPFK.I Y 67.17 2532.3523 23 -7.7 634.0905 4 79.20 5 45518 VEV_2_3_RA5_01_1236.d 5.19E4 1 1 33 55
K.RQPVGPR.E Y 58.68 808.4667 7 -14.4 405.2348 2 11.58 5 3236 VEV_2_3_RA5_01_1236.d 7.77E5 4 4 130 136
R.VGDIVDIK.V Y 57.95 857.4858 8 -13.0 858.4819 1 60.52 6 30807 VEV_3_3_RA6_01_1237.d 2.23E6 8 8 36 43
R.VYRVGDIVDIK.V Y 56.41 1275.7186 11 -6.7 638.8623 2 69.56 5 38667 VEV_2_3_RA5_01_1236.d 4.03E5 4 4 33 43
R.SGTRYAFSR.D Y 56.05 1043.5148 9 -11.7 522.7585 2 28.50 5 12418 VEV_2_3_RA5_01_1236.d 5.63E5 3 3 9 17
K.VNGAVQQGM(+15.99)PFK.I Y 52.66 1290.6390 12 -10.8 646.3198 2 44.07 5 21563 VEV_2_3_RA5_01_1236.d 1.66E5 6 6 44 55 Oxidation (M)
K.SAVGVIIYK.R Y 50.61 948.5644 9 -12.3 475.2837 2 64.96 4 35241 VEV_1_3_RA4_01_1235.d 2.88E5 4 4 70 78
R.KAKEEGIHVHLKR.Q Y 48.81 1543.8947 13 -8.3 386.9777 4 22.41 4 8677 VEV_1_3_RA4_01_1235.d 1.84E6 6 6 118 130
M.GHSHGLR.S Y 48.47 762.3885 7 -11.6 382.1971 2 9.27 4 2229 VEV_1_3_RA4_01_1235.d 2.49E5 3 3 2 8
R.SREEFLR.R Y 46.24 935.4824 7 -8.9 468.7443 2 31.56 4 13799 VEV_1_3_RA4_01_1235.d 3.59E6 15 15 101 107
K.VNGAVQQGMPFKIYHGK.T Y 41.86 1872.9668 17 -3.6 469.2473 4 64.11 4 34663 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 44 60
K.GVIPLSTFLR(+14.02).V Y 41.51 1115.6703 10 -8.8 558.8375 2 84.25 4 50089 VEV_1_3_RA4_01_1235.d 3.08E5 3 3 23 32 Methylation(KR)
R.SREEFLRR.V Y 40.34 1091.5835 8 -13.8 364.8634 3 26.93 5 11594 VEV_2_3_RA5_01_1236.d 3.1E6 7 7 101 108
K.TGVVYNVTK(+14.02).S Y 38.08 993.5495 9 -15.9 497.7741 2 52.44 5 26655 VEV_2_3_RA5_01_1236.d 3.67E5 3 3 61 69 Methylation(KR)
K.S(+42.01)AVGVIIYKR.V Y 35.47 1146.6760 10 -53.3 383.2122 3 57.99 4 30007 VEV_1_3_RA4_01_1235.d 2.38E4 1 1 70 79 Acetylation (N-term)
R.QPVGPR.E Y 35.20 652.3656 6 -7.7 327.1876 2 12.96 4 3785 VEV_1_3_RA4_01_1235.d 1.11E5 2 2 131 136
K.AKEEGIHVHLK.R Y 34.41 1259.6986 11 -8.3 420.9033 3 27.26 6 11388 VEV_3_3_RA6_01_1237.d 2.44E5 1 1 119 129
K.RQPVGPR(+14.02).E Y 30.45 822.4824 7 -8.3 412.2451 2 15.11 4 4838 VEV_1_3_RA4_01_1235.d 5.94E4 1 1 130 136 Methylation(KR)
R.VKENAVKK.R Y 29.24 914.5549 8 -27.9 458.2719 2 8.65 4 2042 VEV_1_3_RA4_01_1235.d 7.77E3 2 2 109 116
R.YAFSRDYKK.K Y 26.96 1176.5927 9 -22.2 589.2905 2 29.44 5 12953 VEV_2_3_RA5_01_1236.d 3.09E4 1 1 13 21
R.YAFSR.D Y 26.82 642.3125 5 -21.1 322.1567 2 31.47 6 13675 VEV_3_3_RA6_01_1237.d 4.21E6 10 10 13 17
R.VGDIVDIK(+14.02).V Y 25.99 871.5015 8 -16.1 436.7510 2 67.96 6 36397 VEV_3_3_RA6_01_1237.d 7.02E4 1 1 36 43 Methylation(KR)
R.VGNRYIEKR.V Y 25.32 1133.6305 9 -14.2 567.8145 2 18.14 4 6435 VEV_1_3_RA4_01_1235.d 1.69E5 2 2 80 88
K.TGVVYN(+.98)VTK.S Y 25.00 980.5178 9 -18.2 491.2573 2 49.71 6 24139 VEV_3_3_RA6_01_1237.d 1.76E5 1 1 61 69 Deamidation (NQ)
R.VGNRYIEK.R Y 22.84 977.5294 8 -16.4 489.7640 2 20.62 6 7881 VEV_3_3_RA6_01_1237.d 1.28E5 2 2 80 87
R.IEHVSHSRSR.E Y 21.26 1206.6217 10 -15.5 302.6580 4 11.23 5 3077 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 93 102
R.SRE(+14.02)EFLR.R Y 20.65 949.4981 7 -11.9 317.5029 3 44.12 4 21214 VEV_1_3_RA4_01_1235.d 2.17E5 1 1 101 107 Methylation(others)
K.SAVGVIIYK(+14.02)R.V Y 18.36 1118.6812 10 -20.8 373.8932 3 60.10 6 30507 VEV_3_3_RA6_01_1237.d 4.08E4 1 1 70 79 Methylation(KR)
K.EEGIHVHLK.R Y 17.62 1060.5665 9 -11.6 531.2844 2 34.74 5 16021 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 121 129
K.RVNVRIEHVSHSR.S Y 15.34 1587.8706 13 -16.6 397.9684 4 26.42 5 11281 VEV_2_3_RA5_01_1236.d 1.32E5 1 1 88 100
R.RVKENAVK.K Y 15.20 942.5610 8 -21.3 472.2778 2 9.53 5 2336 VEV_2_3_RA5_01_1236.d 9.34E3 1 1 108 115
total 47 peptides
C1GHN2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISVESNQPTTSGETPAATKVEYR.V Y 126.40 2464.2080 23 -8.9 822.4026 3 61.79 4 32848 VEV_1_3_RA4_01_1235.d 4.4E5 3 3 105 127
K.VLYLGAASGTSVSHVADLVGPTGTVYAVEFSHR.S Y 99.03 3359.7148 33 -7.7 1120.9036 3 83.58 4 49620 VEV_1_3_RA4_01_1235.d 5.55E4 2 2 155 187
K.ANC(+57.02)IDSTAKPEVVFAR.E Y 98.44 1776.8828 16 -6.9 593.2975 3 65.26 4 35475 VEV_1_3_RA4_01_1235.d 6.68E5 3 3 258 273 Carbamidomethylation
R.ISVESNQPTTSGETPAATK.V Y 88.24 1916.9327 19 -11.7 959.4624 2 52.94 4 26768 VEV_1_3_RA4_01_1235.d 4.32E5 5 5 105 123
K.NLTPGESVYGEKR.I Y 85.01 1448.7260 13 -9.4 483.9114 3 47.07 4 23040 VEV_1_3_RA4_01_1235.d 1.01E6 7 7 92 104
K.LAAGILGGLDDIYMRPGSK.V Y 81.89 1946.0294 19 -14.7 649.6742 3 81.75 4 48357 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 136 154
R.TNVIPIVEDARHPLR.Y Y 79.92 1728.9635 15 -12.2 433.2429 4 68.45 4 38035 VEV_1_3_RA4_01_1235.d 2.25E5 3 3 200 214
R.MLVGMVDVIFADVAQPDQAR.I Y 75.72 2174.0864 20 -22.1 725.6868 3 91.97 5 52874 VEV_2_3_RA5_01_1236.d 5.58E4 3 3 217 236
K.NLTPGESVYGEK.R Y 65.75 1292.6248 12 -8.2 647.3143 2 56.81 4 29174 VEV_1_3_RA4_01_1235.d 3.24E5 3 3 92 103
R.TNVIPIVEDAR.H Y 63.53 1225.6666 11 -6.2 613.8368 2 70.68 4 39771 VEV_1_3_RA4_01_1235.d 6.88E4 1 1 200 210
K.RISVESNQPTTSGETPAATKVEYR.V Y 61.14 2620.3093 24 -14.0 656.0754 4 58.90 6 29648 VEV_3_3_RA6_01_1237.d 6.13E4 1 1 104 127
R.GGKEDLLVTK.N Y 50.44 1058.5972 10 -17.6 530.2966 2 35.58 6 15991 VEV_3_3_RA6_01_1237.d 0 4 4 82 91
R.ISVESNQPTTSGETPAATKVEYR(+14.02).V Y 49.68 2478.2239 23 -7.8 827.0754 3 63.46 4 34101 VEV_1_3_RA4_01_1235.d 3.71E4 1 1 105 127 Methylation(KR)
R.IVGLNAHLFLK.A Y 47.98 1223.7390 11 -12.0 408.9154 3 76.61 5 43775 VEV_2_3_RA5_01_1236.d 1.25E5 3 3 237 247
K.EQLTLEPFER.D Y 45.87 1260.6350 10 -11.3 631.3177 2 74.86 4 43019 VEV_1_3_RA4_01_1235.d 5.33E5 3 3 287 296
K.VEYRVWNPFR.S Y 44.15 1364.6990 10 -19.1 455.8982 3 75.67 4 43655 VEV_1_3_RA4_01_1235.d 0 1 1 124 133
R.VWNPFR.S Y 33.22 817.4235 6 -14.4 409.7131 2 71.72 4 40576 VEV_1_3_RA4_01_1235.d 3.58E5 3 3 128 133
K.EQLTLEPFERDHC(+57.02)IVAGIYRES Y 31.33 2661.2856 22 29.6 666.3484 4 91.16 6 51906 VEV_3_3_RA6_01_1237.d 0 2 2 287 308 Carbamidomethylation
R.SGRDLIGMATHR.T Y 28.90 1312.6670 12 -11.8 329.1701 4 54.35 5 27802 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 188 199
R.GGGGR.G N 27.39 402.1975 5 -0.6 403.2046 1 14.26 4 4423 VEV_1_3_RA4_01_1235.d 0 1 1 34 38
R.DLIGM(+15.99)ATHR.T Y 26.63 1028.5073 9 -2.7 1029.5118 1 93.72 5 53676 VEV_2_3_RA5_01_1236.d 5.21E4 1 1 191 199 Oxidation (M)
R.GGGRGGAAGAKGGAK.V Y 26.55 1170.6217 15 -6.7 391.2119 3 48.00 4 23635 VEV_1_3_RA4_01_1235.d 0 1 1 52 66
R.GGAAGAKGGAK.V Y 22.69 843.4562 11 -8.6 422.7318 2 21.76 6 8476 VEV_3_3_RA6_01_1237.d 0 2 2 56 66
R.G(+42.01)GRGGGRGGAAGAKGGAK(+14.02).V Y 22.55 1496.7920 18 36.2 375.2188 4 27.45 5 11831 VEV_2_3_RA5_01_1236.d 0 1 1 49 66 Acetylation (N-term); Methylation(KR)
R.D(+27.99)HC(+57.02)IVAGIYR.E Y 21.31 1230.5815 10 29.9 616.3165 2 73.23 5 41334 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 297 306 Formylation; Carbamidomethylation
R.GGGGRGGGR.G N 19.53 729.3630 9 7.0 730.3754 1 83.05 4 49259 VEV_1_3_RA4_01_1235.d 0 1 1 34 42
K.LAAGILGGLDDIYM(+15.99)RPGSK.V Y 18.61 1962.0244 19 -16.0 655.0049 3 79.89 6 45080 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 136 154 Oxidation (M)
R.SKLAAGILGGLDDIYMRPGSK.V Y 15.73 2161.1565 21 -4.0 541.2943 4 79.56 5 45765 VEV_2_3_RA5_01_1236.d 0 1 1 134 154
R.GGAAGAK.G Y 15.34 530.2812 7 -46.2 531.2640 1 69.16 5 38376 VEV_2_3_RA5_01_1236.d 3.06E4 1 1 56 62
total 29 peptides
C1GI70
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLAEDYLDINGSPINPYSR.V Y 132.78 2135.0535 19 -8.9 1068.5245 2 82.51 4 48886 VEV_1_3_RA4_01_1235.d 2.46E5 5 5 117 135
R.VYPEEMISTGISAIDTMNSIAR.G Y 105.06 2397.1555 22 -13.4 1199.5690 2 90.53 5 52164 VEV_2_3_RA5_01_1236.d 1.66E5 4 4 136 157
R.YNEIVSLTLPDGTER.S Y 104.32 1705.8523 15 -9.0 853.9258 2 78.91 4 46179 VEV_1_3_RA4_01_1235.d 1.04E5 3 3 40 54
R.DHSDVSNQLYAK.Y Y 100.95 1375.6367 12 -7.2 688.8207 2 38.69 5 18354 VEV_2_3_RA5_01_1236.d 5.28E4 1 1 387 398
R.TFISQSPYESR.T Y 90.09 1313.6251 11 -9.5 657.8136 2 61.64 4 32707 VEV_1_3_RA4_01_1235.d 2.28E5 4 4 434 444
R.GYPGYMYTDLSTIYER.A Y 81.88 1927.8662 16 -41.1 964.9008 2 82.03 4 48552 VEV_1_3_RA4_01_1235.d 0 1 1 295 310
K.VLAEDYLDIN(+.98)GSPINPYSR.V Y 74.29 2136.0374 19 -6.2 1069.0193 2 82.87 5 47871 VEV_2_3_RA5_01_1236.d 6.68E4 3 3 117 135 Deamidation (NQ)
R.VTLFLNLANDPTIER.I Y 71.28 1714.9253 15 -27.7 858.4462 2 83.38 4 49535 VEV_1_3_RA4_01_1235.d 6.56E4 1 1 230 244
R.GQKIPIFSAAGLPHNEIAAQIC(+57.02)R.Q Y 59.51 2490.3164 23 -14.3 831.1009 3 77.46 5 44345 VEV_2_3_RA5_01_1236.d 2.84E4 1 1 158 180 Carbamidomethylation
K.GVYPPINVLPSLSR.L Y 59.50 1510.8507 14 -34.8 756.4064 2 82.31 4 48755 VEV_1_3_RA4_01_1235.d 0 2 2 360 373
R.Q(-17.03)AGLVNKPSK.D Y 59.45 1023.5713 10 -22.1 512.7816 2 36.31 4 16514 VEV_1_3_RA4_01_1235.d 0 1 1 181 190 Pyro-glu from Q
K.LGVSEDMLGR.V Y 40.48 1075.5332 10 -7.4 538.7699 2 67.82 4 37502 VEV_1_3_RA4_01_1235.d 8.65E4 1 1 93 102
R.AKGNKDTRDNTAGESNLIDV Y 37.41 2117.0349 20 -12.9 706.6765 3 52.12 5 26456 VEV_2_3_RA5_01_1236.d 6.98E4 1 1 485 504
R.LM(+15.99)KSAIGEGR.T Y 32.30 1076.5648 10 -32.4 359.8506 3 23.00 4 9006 VEV_1_3_RA4_01_1235.d 7.22E5 2 2 374 383 Oxidation (M)
K.AVVGEEALSAEDKLSLEFLDKFER.T Y 31.47 2694.3750 24 -8.4 674.5953 4 85.29 6 48642 VEV_3_3_RA6_01_1237.d 3.29E4 1 1 410 433
R.DNTAGESNLIDV Y 28.23 1246.5677 12 36.6 624.3140 2 56.25 6 27882 VEV_3_3_RA6_01_1237.d 0 2 2 493 504
K.IIDEYYQR.S Y 27.21 1098.5345 8 -9.8 550.2692 2 54.99 5 28172 VEV_2_3_RA5_01_1236.d 2.11E5 2 2 472 479
K.VEFTGHSLK.L Y 22.36 1016.5291 9 -28.1 509.2575 2 40.50 6 18785 VEV_3_3_RA6_01_1237.d 5.12E4 1 1 84 92
R.SGQVLEAR.G Y 20.52 858.4559 8 0.2 430.2353 2 23.50 6 9397 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 55 62
K.AVVGEEALSAEDK.L Y 18.88 1316.6459 13 -23.2 659.3149 2 30.87 5 13755 VEV_2_3_RA5_01_1236.d 0 1 1 410 422
MGPGINDPR.M Y 18.74 955.4545 9 12.6 478.7406 2 20.80 6 7986 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 1 9
R.AVVQVFEGTPGIDVK.K Y 18.61 1557.8402 15 -29.7 520.2719 3 60.72 4 32075 VEV_1_3_RA4_01_1235.d 3.45E5 1 1 66 80
R.IITPR.L N 18.18 598.3802 5 -11.0 300.1941 2 39.30 5 18692 VEV_2_3_RA5_01_1236.d 2.01E6 4 4 245 249
M.GPGINDPR.M Y 17.85 824.4141 8 -6.2 413.2117 2 25.34 5 10677 VEV_2_3_RA5_01_1236.d 1.43E5 1 1 2 9
K.Y(-18.01)AIGRDASDMK.A Y 15.70 1207.5656 11 0.0 604.7900 2 46.14 6 22067 VEV_3_3_RA6_01_1237.d 0 1 1 399 409 Dehydration
total 25 peptides
C1G9R9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AC(+57.02)C(+57.02)RPQSSSGGFFDGASK.A Y 136.01 1917.8097 18 -8.9 640.2715 3 50.68 4 25297 VEV_1_3_RA4_01_1235.d 4.45E5 6 6 66 83 Carbamidomethylation
R.VTATAPGC(+57.02)GVIDVLPNSISR.D Y 101.95 2026.0516 20 -13.6 1014.0193 2 79.16 6 44558 VEV_3_3_RA6_01_1237.d 7.2E4 3 3 1773 1792 Carbamidomethylation
R.SFALELGSSIPSSDQR.L Y 94.18 1692.8318 16 -6.8 847.4174 2 77.68 5 44495 VEV_2_3_RA5_01_1236.d 4.21E5 4 4 1015 1030
K.AEDKVLKDIESLLESTAR.I Y 82.62 2016.0739 18 -5.9 505.0228 4 86.53 4 51584 VEV_1_3_RA4_01_1235.d 4.6E5 4 4 1336 1353
K.VDLTSPNYVNTVK.K Y 80.59 1448.7511 13 -8.9 725.3763 2 67.87 5 37430 VEV_2_3_RA5_01_1236.d 1.86E4 2 2 1081 1093
K.TYQLMADGIVTNPR.S Y 78.04 1577.7871 14 -15.9 789.8883 2 73.96 5 41848 VEV_2_3_RA5_01_1236.d 0 1 1 505 518
R.TISEIDLLDEYISR.A Y 60.29 1665.8461 14 -9.7 833.9222 2 86.42 4 51541 VEV_1_3_RA4_01_1235.d 3.41E4 1 1 320 333
R.SEIAQQYYQELR.I Y 59.89 1526.7365 12 -17.0 764.3625 2 69.97 6 37831 VEV_3_3_RA6_01_1237.d 1.23E5 1 1 733 744
K.ILSTELPNSESDIR.R Y 57.70 1572.7994 14 -14.1 787.3959 2 68.78 4 38261 VEV_1_3_RA4_01_1235.d 8.84E4 1 1 787 800
R.ILQFFESHFNATR.Q Y 50.80 1608.8048 13 -8.5 537.2710 3 77.55 5 44407 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 1236 1248
K.AQNIISPHFR.I Y 40.19 1181.6305 10 -14.0 591.8143 2 57.88 5 30029 VEV_2_3_RA5_01_1236.d 0 1 1 1226 1235
R.KILSTELPNSESDIRR.L Y 38.86 1856.9955 16 -13.1 465.2501 4 61.20 5 32438 VEV_2_3_RA5_01_1236.d 3.75E4 1 1 786 801
K.TYQLM(+15.99)ADGIVTNPR.S Y 36.59 1593.7821 14 -12.8 532.2612 3 65.47 4 35645 VEV_1_3_RA4_01_1235.d 3.35E5 1 1 505 518 Oxidation (M)
K.VQQVAATNANK.I Y 33.90 1142.6044 11 -9.4 572.3041 2 82.40 4 48815 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 893 903
R.SIFTTVGLDAFVYPYR.V Y 29.37 1847.9457 16 7.1 616.9935 3 89.70 5 51730 VEV_2_3_RA5_01_1236.d 0 1 1 1757 1772
K.MGIFNPDFQYVDPFMLK.T Y 29.06 2060.9739 17 -3.6 1031.4905 2 92.09 4 54846 VEV_1_3_RA4_01_1235.d 3.31E4 1 1 1192 1208
K.AQPPLSSTPLTIRELDVLLALC(+57.02)K.A Y 26.31 2534.4141 23 -7.1 634.6063 4 88.98 5 51374 VEV_2_3_RA5_01_1236.d 6.44E4 1 1 84 106 Carbamidomethylation
K.GYDQFQLLTNNIPY Y 24.91 1684.8097 14 -28.8 562.5944 3 88.89 5 51324 VEV_2_3_RA5_01_1236.d 8.28E4 2 2 1999 2012
R.AAFDKLAQLASR.Y Y 23.91 1289.7091 12 -28.6 430.8980 3 71.71 5 40251 VEV_2_3_RA5_01_1236.d 6.04E4 1 1 37 48
R.IATDASSTR.R Y 23.83 920.4563 9 -1.5 461.2347 2 40.53 6 18818 VEV_3_3_RA6_01_1237.d 2.46E5 2 2 1354 1362
K.KKEENGNGNGVTMPK.A Y 23.43 1601.7831 15 -2.6 534.9336 3 48.09 5 23978 VEV_2_3_RA5_01_1236.d 0 1 1 1684 1698
K.M(+15.99)GISLWLGVIHENPHTEPR.I Y 23.18 2201.1052 19 65.0 551.3193 4 107.11 5 58074 VEV_2_3_RA5_01_1236.d 0 1 1 1157 1175 Oxidation (M)
K.SLSGR.L N 21.77 518.2812 5 -9.1 519.2838 1 30.43 4 13092 VEV_1_3_RA4_01_1235.d 0 2 2 862 866
R.TWVSTVM(+15.99)NIAPLDVK.G Y 20.94 1688.8807 15 -22.9 423.2178 4 61.91 6 31830 VEV_3_3_RA6_01_1237.d 0 2 2 977 991 Oxidation (M)
K.LFSSM(+15.99)ALNTTR.C Y 18.79 1255.6230 11 -27.7 1256.5956 1 91.27 5 52532 VEV_2_3_RA5_01_1236.d 2.81E4 1 1 440 450 Oxidation (M)
R.QGSVHIER.I Y 18.07 924.4777 8 -2.4 309.1658 3 11.00 4 2853 VEV_1_3_RA4_01_1235.d 0 1 1 1249 1256
K.SGK(+43.01)PLQSHAK.A Y 17.90 1094.5833 10 -22.8 548.2864 2 69.36 5 38533 VEV_2_3_RA5_01_1236.d 2.82E5 1 1 1661 1670 Carbamylation
R.ELDVLLALC(+57.02)K.A Y 17.84 1172.6475 10 -21.0 587.3187 2 82.86 5 47867 VEV_2_3_RA5_01_1236.d 1.23E4 2 2 97 106 Carbamidomethylation
R.FPFPK.L Y 17.80 634.3478 5 -15.7 318.1762 2 62.78 5 33619 VEV_2_3_RA5_01_1236.d 3.84E4 1 1 1432 1436
R.LEIIR.Q N 17.55 642.4064 5 -26.4 322.2020 2 53.85 6 26558 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 242 246
K.IEEELR.Q Y 16.96 787.4075 6 -23.3 394.7019 2 67.43 4 37185 VEV_1_3_RA4_01_1235.d 9.78E4 1 1 1631 1636
R.NSELPDR.V Y 16.82 829.3929 7 62.5 830.4520 1 101.09 4 58548 VEV_1_3_RA4_01_1235.d 5.57E4 1 1 269 275
R.VWLSPLEHEK.R Y 16.58 1236.6503 10 -25.5 413.2135 3 38.36 4 17731 VEV_1_3_RA4_01_1235.d 7.77E4 1 1 1385 1394
K.TKKKEENGNGNGVTMPK.A Y 16.35 1830.9258 17 0.1 611.3159 3 85.50 6 48776 VEV_3_3_RA6_01_1237.d 7.79E4 1 1 1682 1698
R.AAFDK.L Y 16.23 550.2751 5 -30.9 551.2654 1 25.73 5 10894 VEV_2_3_RA5_01_1236.d 0 1 1 37 41
R.ILTEVAQAWER.T Y 15.54 1314.6931 11 -21.5 658.3397 2 75.80 4 43757 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 1176 1186
R.FQEARSNFVK.S Y 15.35 1224.6251 10 -17.6 409.2085 3 40.41 4 18924 VEV_1_3_RA4_01_1235.d 1.3E6 1 1 1819 1828
R.TFTTFYQLARTWVSTVM(+15.99)NIAPLDVK.G Y 15.22 2917.5049 25 -9.3 584.5028 5 109.21 4 60918 VEV_1_3_RA4_01_1235.d 0 1 1 967 991 Oxidation (M)
R.FIRASTSPAR.A Y 15.21 1104.6040 10 4.0 369.2101 3 44.71 4 21586 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 306 315
total 39 peptides
C1G8F8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FSPEQLPLSELPLLLNK.Q Y 132.38 1937.0873 17 -10.4 646.6963 3 90.83 4 54121 VEV_1_3_RA4_01_1235.d 3.99E5 5 5 125 141
R.DRDGQGGNAGTWQASNR.G Y 99.67 1788.7888 17 -8.5 597.2651 3 28.94 4 12261 VEV_1_3_RA4_01_1235.d 1.92E5 2 2 638 654
R.AGKPSTSSAPITQQPVAMSGLPGGPGASGAAPSAPSGAQPR.S Y 93.16 3697.8481 41 -7.9 925.4620 4 71.53 4 40424 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 413 453
K.HVVQYSPLLPEAIKR.S Y 89.16 1748.9937 15 -11.5 438.2507 4 68.45 5 37875 VEV_2_3_RA5_01_1236.d 2.38E5 4 4 96 110
K.ASFNDVWDTVKGEVETAINANEAQR.T Y 78.48 2763.3101 25 -7.1 691.8299 4 90.47 4 53916 VEV_1_3_RA4_01_1235.d 8.34E4 1 1 308 332
R.SAGGVSQFGQAPVPNR.T Y 74.18 1570.7852 16 -9.7 786.3922 2 62.65 4 33487 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 454 469
R.TGGYGGAGGPGKGAAGGAGTDSPASSTSTPVPAGENKGGAGGE Y 72.49 3573.6204 43 -5.0 1192.2081 3 58.29 4 30214 VEV_1_3_RA4_01_1235.d 2.59E5 4 4 712 754
K.GAAGGAGTDSPASSTSTPVPAGENKGGAGGE Y 70.69 2614.1743 31 -2.4 872.3966 3 53.85 4 27353 VEV_1_3_RA4_01_1235.d 9.2E4 2 2 724 754
R.EGMLNQLSVTLK.A Y 59.96 1331.7119 12 -19.2 666.8505 2 77.95 4 45440 VEV_1_3_RA4_01_1235.d 7.31E4 1 1 259 270
R.TGGYGGAGGPGK.G Y 59.68 977.4566 12 5.5 489.7383 2 16.32 4 5474 VEV_1_3_RA4_01_1235.d 4.36E4 1 1 712 723
R.SAGGVSQ(+.98)FGQAPVPNR.T Y 59.62 1571.7692 16 -8.2 786.8854 2 64.23 4 34687 VEV_1_3_RA4_01_1235.d 3.51E4 1 1 454 469 Deamidation (NQ)
R.VFVTHASPAR.E Y 59.25 1083.5825 10 -24.2 542.7854 2 32.11 4 14057 VEV_1_3_RA4_01_1235.d 3.35E5 2 2 249 258
R.ADHIIHTGDFGFYDDSSLER.I Y 57.93 2294.0239 20 6.2 765.6866 3 74.69 5 42373 VEV_2_3_RA5_01_1236.d 7.25E4 1 1 69 88
R.LLDIGGVKLR.L Y 51.46 1082.6812 10 -16.7 361.8950 3 71.72 6 39154 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 185 194
R.GGPAGGIGQR.S Y 44.42 868.4515 10 -0.8 435.2327 2 20.65 5 8091 VEV_2_3_RA5_01_1236.d 1.98E5 3 3 655 664
R.VIQTGGVR.V Y 35.64 828.4818 8 -12.2 415.2431 2 22.92 4 8955 VEV_1_3_RA4_01_1235.d 4.09E4 2 2 39 46
R.Q(+42.01)PPEHK(+28.03).K Y 34.87 804.4130 6 -0.5 403.2136 2 11.86 4 3242 VEV_1_3_RA4_01_1235.d 0 1 1 609 614 Acetylation (N-term); Dimethylation(KR)
R.ADHIIHTGDFGFYDDSSLER(-.98).I Y 27.75 2293.0398 20 1.7 574.2682 4 74.80 4 42970 VEV_1_3_RA4_01_1235.d 3.64E4 1 1 69 88 Amidation
R.GGRGGDRGGRGGSGGGR.G Y 25.87 1471.7100 17 -43.3 491.5560 3 61.59 5 32726 VEV_2_3_RA5_01_1236.d 0 1 1 692 708
K.SLNELAR.H Y 24.94 801.4344 7 -3.4 802.4390 1 68.07 4 37693 VEV_1_3_RA4_01_1235.d 5.69E4 2 2 59 65
K.GEVETAINANEAQR.T Y 24.72 1500.7168 14 -18.5 501.2370 3 42.64 6 20032 VEV_3_3_RA6_01_1237.d 9.05E4 2 2 319 332
R.IGTEM(+15.99)R.A Y 24.22 721.3429 6 -8.9 722.3438 1 112.54 6 58785 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 398 403 Oxidation (M)
K.ADFSISAGLHFR.Y Y 24.03 1319.6622 12 -7.4 440.8914 3 75.43 4 43464 VEV_1_3_RA4_01_1235.d 4.86E4 1 1 271 282
K.ASFNDVWDTVK(-1.03)GEVETAINANEAQR.T Y 22.90 2762.2783 25 -5.7 691.5729 4 90.37 6 51505 VEV_3_3_RA6_01_1237.d 0 1 1 308 332 Lysine oxidation to aminoadipic semialdehyde
K.LFDNGEGK.T Y 19.27 878.4133 8 4.6 440.2159 2 29.28 4 12450 VEV_1_3_RA4_01_1235.d 1.65E5 1 1 207 214
R.RDRDGQGGNAGTWQASNR.G Y 17.97 1944.8899 18 44.3 487.2513 4 24.80 4 10007 VEV_1_3_RA4_01_1235.d 1.96E5 2 2 637 654
R.GGRGGSGGGRGAR.T Y 17.52 1100.5547 13 -18.0 551.2747 2 42.53 4 20243 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 699 711
R.A(+42.01)GK(+14.02)PSTSSAPITQ(+.98)QPVAMSGLPGGPGASGAAPSAPSGAQPR.S Y 16.17 3754.8584 41 -2.2 939.7198 4 63.49 4 34121 VEV_1_3_RA4_01_1235.d 5.29E4 1 1 413 453 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
R.A(+42.01)GK(+14.02)PSTSSAPITQQ(+.98)PVAMSGLPGGPGASGAAPSAPSGAQPR.S Y 15.96 3754.8584 41 -20.2 751.9638 5 63.21 6 32789 VEV_3_3_RA6_01_1237.d 4.15E4 1 1 413 453 Acetylation (N-term); Methylation(KR); Deamidation (NQ)
R.IGTEM(+15.99)RAQGF(+31.99)NFAHR.A Y 15.53 1781.8267 15 -32.7 594.9301 3 46.88 6 22489 VEV_3_3_RA6_01_1237.d 1.83E5 1 1 398 412 Oxidation (M); Dihydroxy
R.SIAQVPPQQSIK.Q Y 15.34 1294.7245 12 -52.3 648.3356 2 57.82 5 29988 VEV_2_3_RA5_01_1236.d 0 1 1 111 122
total 31 peptides
C1GBE8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AKPADKTTEDAANPDAPSTSSNEPGPGR.A Y 116.82 2780.2849 28 -7.1 696.0735 4 38.10 4 17569 VEV_1_3_RA4_01_1235.d 9.91E5 9 9 593 620
K.TTEDAANPDAPSTSSNEPGPGR.A Y 108.96 2169.9409 22 -9.4 1085.9675 2 44.51 6 21126 VEV_3_3_RA6_01_1237.d 2.31E5 3 3 599 620
R.IADFGVLHRNEASGALHGLTR.V Y 107.68 2233.1716 21 -11.2 559.2939 4 70.32 4 39473 VEV_1_3_RA4_01_1235.d 2.41E5 4 4 442 462
K.SKKPESTAEEPLPDFIVER.N Y 102.65 2171.1108 19 -13.1 543.7779 4 69.71 6 37658 VEV_3_3_RA6_01_1237.d 1.87E5 3 3 44 62
K.LDDKELWDLDRPLER.D Y 73.49 1911.9690 15 -6.2 478.9966 4 76.62 4 44398 VEV_1_3_RA4_01_1235.d 1.71E5 2 2 128 142
R.NEASGALHGLTR.V Y 73.45 1224.6211 12 -13.2 613.3098 2 44.70 4 21579 VEV_1_3_RA4_01_1235.d 9.78E5 10 10 451 462
K.GSLVPLEEAR.V Y 71.36 1069.5768 10 -11.1 535.7897 2 65.20 4 35433 VEV_1_3_RA4_01_1235.d 1.89E5 3 3 736 745
K.IINALQSLLR.A Y 68.05 1139.7026 10 -20.9 570.8467 2 81.53 6 46225 VEV_3_3_RA6_01_1237.d 7.43E4 1 1 360 369
R.SVYGLFGFSFK.L Y 64.20 1250.6335 11 -8.9 626.3185 2 86.49 4 51559 VEV_1_3_RA4_01_1235.d 1.58E5 2 2 493 503
K.AKPADKTTEDAANPDAPSTSSNE(+14.02)PGPGR.A Y 58.62 2794.3005 28 2.4 699.5841 4 44.90 4 21706 VEV_1_3_RA4_01_1235.d 3.96E4 1 1 593 620 Methylation(others)
K.IDITIQDALKR.E Y 54.64 1284.7401 11 -13.4 429.2482 3 71.74 4 40621 VEV_1_3_RA4_01_1235.d 4.31E5 4 4 553 563
R.IADFGVLHR.N Y 50.61 1026.5610 9 -19.8 343.1875 3 63.87 6 33270 VEV_3_3_RA6_01_1237.d 1.38E5 1 1 442 450
K.KPESTAEEPLPDFIVER.N Y 50.23 1955.9839 17 -2.5 653.0002 3 74.81 6 41400 VEV_3_3_RA6_01_1237.d 2.3E5 1 1 46 62
K.LEYMTGETGAK.A Y 49.01 1198.5540 11 -14.1 600.2758 2 49.84 4 24777 VEV_1_3_RA4_01_1235.d 6.75E4 1 1 582 592
R.NRDDPSSQVK.G Y 47.56 1144.5472 10 -8.1 573.2762 2 12.81 5 3863 VEV_2_3_RA5_01_1236.d 5.25E4 3 3 726 735
R.GPHIQNTGK.I Y 41.96 950.4933 9 -15.2 476.2467 2 11.20 6 3016 VEV_3_3_RA6_01_1237.d 2.59E4 1 1 271 279
R.AWETTPGSFLR.D Y 40.99 1263.6248 11 6.0 632.8234 2 75.50 5 42948 VEV_2_3_RA5_01_1236.d 1.55E5 3 3 103 113
R.FDIN(+.98)ITVDVGDSHPSTVIGR.A Y 36.36 2142.0593 20 -0.5 715.0267 3 80.01 4 47026 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 83 102 Deamidation (NQ)
R.FDINITVDVGDSHPSTVIGR.A Y 30.95 2141.0752 20 -51.0 714.6626 3 79.93 5 46004 VEV_2_3_RA5_01_1236.d 0 1 1 83 102
R.SYRELPLR.I Y 30.07 1032.5715 8 -34.9 517.2750 2 49.20 4 24370 VEV_1_3_RA4_01_1235.d 3.88E5 4 4 434 441
R.GVAFPDKK.Q Y 27.89 860.4756 8 -10.5 431.2405 2 26.18 5 11136 VEV_2_3_RA5_01_1236.d 2.78E5 1 1 307 314
R.VSFLPFDSSEGR.E Y 24.39 1339.6407 12 -10.8 447.5494 3 25.11 6 10264 VEV_3_3_RA6_01_1237.d 5.08E4 1 1 146 157
K.EISSTVVVAKLDDK.E Y 23.31 1502.8191 14 4.6 376.7138 4 29.46 4 12542 VEV_1_3_RA4_01_1235.d 6.87E5 1 1 118 131
K.LDVEK.R N 22.41 602.3275 5 -21.1 603.3221 1 62.01 6 31917 VEV_3_3_RA6_01_1237.d 0 1 1 407 411
R.ARPVVIHR.A Y 22.33 946.5825 8 -44.1 474.2776 2 19.49 4 7149 VEV_1_3_RA4_01_1235.d 0 1 1 621 628
R.NKLFEELKR.K Y 22.19 1175.6663 9 -6.8 392.8934 3 55.19 5 28277 VEV_2_3_RA5_01_1236.d 6.39E4 1 1 63 71
R.IGKEQDLFFFDEVSPGC(+57.02)PFLLPNGTK.I Y 19.50 2954.4524 26 -7.0 985.8178 3 88.34 4 52715 VEV_1_3_RA4_01_1235.d 6.9E4 1 1 334 359 Carbamidomethylation
R.GVAFPDKKQMQEHLK.F Y 17.16 1754.9137 15 19.8 585.9901 3 82.24 4 48696 VEV_1_3_RA4_01_1235.d 2.59E4 1 1 307 321
R.DIPKEISSTVVVAKLDDK.E Y 16.11 1956.0779 18 -27.9 490.0131 4 84.44 6 48105 VEV_3_3_RA6_01_1237.d 6.13E4 1 1 114 131
K.QPFDRLEVSK.E Y 15.72 1217.6404 10 -13.1 406.8821 3 27.51 6 11517 VEV_3_3_RA6_01_1237.d 1.72E5 1 1 222 231
K.GSLVPLEEARVK.L Y 15.54 1296.7401 12 -61.8 433.2273 3 70.94 4 39958 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 736 747
total 31 peptides
C1GGQ1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVALVGLKDDEAALKDLVEASR.L Y 124.91 2282.2480 22 -18.5 571.5587 4 82.61 6 46937 VEV_3_3_RA6_01_1237.d 2.12E5 2 2 317 338
K.VVDC(+57.02)GQLSGDSYEAAK.E Y 110.98 1697.7566 16 -10.6 849.8766 2 58.98 6 29702 VEV_3_3_RA6_01_1237.d 3.5E5 3 3 170 185 Carbamidomethylation
R.LAPGDAAVVSETAR.V Y 100.19 1355.7045 14 -11.5 678.8517 2 61.53 6 31549 VEV_3_3_RA6_01_1237.d 9.85E5 6 6 339 352
R.IVFELFDDVVPK.T Y 97.75 1419.7649 12 -11.5 710.8816 2 87.53 5 50591 VEV_2_3_RA5_01_1236.d 5.03E5 3 3 24 35
R.VFFDIEIGNKPEGR.I Y 95.74 1619.8307 14 -13.4 540.9436 3 76.59 4 44376 VEV_1_3_RA4_01_1235.d 5.58E5 5 5 10 23
K.EVSVDETGDKYEDYPEDAGETLSGAEYYK.I Y 87.97 3258.3887 29 -8.9 1087.1272 3 76.65 6 42749 VEV_3_3_RA6_01_1237.d 6.74E4 2 2 186 214
K.RFDDAQSWAGFALETATAAQAK.D Y 76.10 2354.1292 22 -32.3 785.6917 3 84.47 4 50232 VEV_1_3_RA4_01_1235.d 0 1 1 284 305
K.SGNLDLGLEKYQK.A Y 74.40 1463.7620 13 -13.1 488.9215 3 64.26 5 34716 VEV_2_3_RA5_01_1236.d 3.21E5 3 3 229 241
R.IVFELFDDVVPKTAENFR.A Y 70.63 2138.1047 18 -5.3 713.7051 3 86.04 5 49760 VEV_2_3_RA5_01_1236.d 9.39E4 1 1 24 41
K.HVVFGEVITGK.G Y 70.42 1184.6553 11 -18.2 395.8852 3 64.67 4 35019 VEV_1_3_RA4_01_1235.d 1.1E5 4 4 137 147
R.FTLHSNSALLANK.L Y 62.04 1414.7568 13 -12.9 708.3766 2 63.24 5 33976 VEV_2_3_RA5_01_1236.d 1.35E5 2 2 269 281
R.FTLHSNSALLANKLK.R Y 50.73 1655.9358 15 5.9 552.9891 3 65.79 5 35875 VEV_2_3_RA5_01_1236.d 1.17E5 3 3 269 283
R.ALC(+57.02)TGEKGEGK.S Y 45.61 1148.5496 11 -2.3 575.2808 2 12.13 4 3358 VEV_1_3_RA4_01_1235.d 2.39E4 3 3 42 52 Carbamidomethylation
R.LAPGDAAVVSETAR(+14.02).V Y 42.21 1369.7201 14 -10.5 685.8601 2 66.01 4 36064 VEV_1_3_RA4_01_1235.d 2.86E4 1 1 339 352 Methylation(KR)
R.LAPGDAAVVS(+14.02)ETAR.V Y 37.20 1369.7201 14 -8.0 685.8618 2 65.87 5 35935 VEV_2_3_RA5_01_1236.d 3.81E4 1 1 339 352 Methylation(others)
K.S(-2.02)GNLDLGLEKYQK.A Y 32.70 1461.7463 13 -9.3 488.2515 3 64.18 6 33493 VEV_3_3_RA6_01_1237.d 6.99E4 1 1 229 241 2-amino-3-oxo-butanoic_acid
K.SPTDTSDKPHK.E Y 23.40 1211.5782 11 -0.4 404.8665 3 21.35 6 8273 VEV_3_3_RA6_01_1237.d 8.79E4 1 1 156 166
K.TAENFR.A N 22.68 736.3504 6 -11.0 369.1784 2 16.37 6 5651 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 36 41
K.DLVEASR.L Y 18.06 788.4028 7 -8.5 789.4034 1 83.29 4 49427 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 332 338
K.SIAEQQR.K Y 17.17 830.4246 7 4.5 416.2215 2 20.66 5 8097 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 356 362
total 20 peptides
C1G496
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IGDVLGNVPENFTVHR.N Y 114.67 1765.9111 16 -8.4 589.6394 3 75.91 4 43887 VEV_1_3_RA4_01_1235.d 3.94E5 2 2 660 675
R.VILC(+57.02)SGQVYAALHK.H Y 105.31 1557.8337 14 -9.2 520.2804 3 70.64 4 39714 VEV_1_3_RA4_01_1235.d 4.43E5 2 2 943 956 Carbamidomethylation
K.KIGDVLGNVPENFTVHR.N Y 92.97 1894.0061 17 -6.7 474.5056 4 73.98 4 42344 VEV_1_3_RA4_01_1235.d 1.31E5 2 2 659 675
R.SGLVMSLPHGYDGQGPEHSSAR.I Y 86.41 2281.0544 22 -6.7 571.2671 4 66.48 4 36439 VEV_1_3_RA4_01_1235.d 3.22E5 2 2 815 836
R.AANESLKNTAITR.I Y 85.28 1387.7419 13 -10.4 463.5831 3 34.87 4 15673 VEV_1_3_RA4_01_1235.d 5.54E5 5 5 959 971
R.YLQLC(+57.02)NEDPR.V Y 79.34 1306.5975 10 -9.9 654.2996 2 61.07 4 32282 VEV_1_3_RA4_01_1235.d 2.63E5 2 2 840 849 Carbamidomethylation
R.HAVLHDQENETTYTSLQHISPDQGK.F Y 77.26 2847.3423 25 -0.7 712.8423 4 62.00 4 32989 VEV_1_3_RA4_01_1235.d 3.57E4 2 2 730 754
K.ELATEVLPHPPTGVPADTLKK.I Y 70.85 2212.2102 21 -14.1 554.0520 4 72.52 4 41207 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 639 659
K.ELATEVLPHPPTGVPADTLK.K Y 66.92 2084.1152 20 -8.0 695.7068 3 76.90 4 44616 VEV_1_3_RA4_01_1235.d 1.84E5 2 2 639 658
R.KPLIIFFSK.S Y 56.91 1091.6742 9 -10.9 364.8947 3 75.23 4 43312 VEV_1_3_RA4_01_1235.d 4.01E4 1 1 891 899
R.VSGQDVERGTFSQR.H Y 54.02 1564.7594 14 -10.6 522.5882 3 45.91 4 22367 VEV_1_3_RA4_01_1235.d 4.82E5 4 4 716 729
R.STPYC(+57.02)SDIAK.A Y 50.89 1140.5121 10 -8.6 571.2584 2 40.99 4 19286 VEV_1_3_RA4_01_1235.d 5.1E5 6 6 500 509 Carbamidomethylation
R.LNVLSNVVR.K Y 48.40 1012.6029 9 -10.5 507.3034 2 69.73 4 39003 VEV_1_3_RA4_01_1235.d 6.84E4 1 1 358 366
R.SVDYGVKDIVIGMPHR.G Y 47.14 1784.9243 16 -14.1 447.2321 4 72.56 4 41235 VEV_1_3_RA4_01_1235.d 2.47E5 2 2 340 355
R.DVVIDIVC(+57.02)YRK.Q Y 40.64 1378.7278 11 -5.8 460.5805 3 73.19 4 41734 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 543 553 Carbamidomethylation
R.DRVEIPQPYK.Y Y 40.38 1243.6560 10 -4.9 415.5573 3 60.42 4 31801 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 279 288
R.Q(-17.03)FRKPLIIFFSK.S Y 40.06 1505.8757 12 1.0 502.9664 3 81.87 5 47262 VEV_2_3_RA5_01_1236.d 2.63E4 1 1 888 899 Pyro-glu from Q
R.FGLEGC(+57.02)ETLVPGMK.A Y 38.05 1536.7316 14 -7.9 769.3670 2 79.33 4 46499 VEV_1_3_RA4_01_1235.d 1.79E5 1 1 321 334 Carbamidomethylation
R.GEAEAFGYNKPR.E Y 34.64 1337.6364 12 -41.8 446.8674 3 40.65 4 19073 VEV_1_3_RA4_01_1235.d 0 1 1 197 208
R.VSGQDVER.G Y 34.18 888.4301 8 -13.1 445.2165 2 15.37 6 5138 VEV_3_3_RA6_01_1237.d 1.91E5 4 4 716 723
K.YSVDEK.R Y 33.16 739.3388 6 -23.4 370.6680 2 29.54 5 13005 VEV_2_3_RA5_01_1236.d 2.14E5 1 1 289 294
K.ENLDGYPNAK.N Y 31.01 1119.5197 10 -8.9 560.7621 2 40.65 4 19075 VEV_1_3_RA4_01_1235.d 5.39E4 1 1 985 994
R.IETLLNETK.H Y 27.89 1059.5812 9 -13.6 530.7906 2 61.21 4 32437 VEV_1_3_RA4_01_1235.d 7.3E4 1 1 1016 1024
R.YLQLC(+57.02)NEDPRVFPPPDRIDR.Q Y 26.78 2499.2329 20 -22.6 625.8014 4 74.52 5 42267 VEV_2_3_RA5_01_1236.d 0 1 1 840 859 Carbamidomethylation
R.HVLYAGRNPSASVATGNK.G Y 25.06 1840.9543 18 -14.6 461.2391 4 45.46 4 22046 VEV_1_3_RA4_01_1235.d 0 1 1 1030 1047
R.ELQLSHYGFTEADLDEEFALGPGILPR.F Y 21.67 3016.4817 27 44.9 755.1616 4 88.62 5 51177 VEV_2_3_RA5_01_1236.d 0 1 1 209 235
K.YHLGMNFERPTPSGK.R Y 21.32 1732.8354 15 28.0 434.2283 4 35.88 4 16262 VEV_1_3_RA4_01_1235.d 0 1 1 392 406
R.IAEQTNQLDK.Y Y 20.84 1158.5880 10 24.4 387.2127 3 20.98 6 8090 VEV_3_3_RA6_01_1237.d 1.08E5 3 3 573 582
K.NTAITR.I Y 19.77 674.3712 6 -46.7 338.1771 2 17.26 4 5969 VEV_1_3_RA4_01_1235.d 0 1 1 966 971
R.RILDR.L N 19.51 671.4078 5 9.7 672.4216 1 48.59 5 24282 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 296 300
R.VFPPPDRIDR.Q Y 19.05 1210.6458 10 -18.0 404.5486 3 54.10 6 26709 VEV_3_3_RA6_01_1237.d 1.84E5 2 2 850 859
R.NPSASVATGNKGSHLK.E Y 17.06 1566.8114 16 -36.6 784.3843 2 91.96 5 52872 VEV_2_3_RA5_01_1236.d 0 1 1 1037 1052
R.VFPPPDR.I Y 16.97 826.4337 7 -14.0 414.2184 2 37.30 4 17106 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 850 856
R.NPSASVATGNK.G Y 16.60 1044.5200 11 7.6 523.2712 2 71.89 4 40713 VEV_1_3_RA4_01_1235.d 0 1 1 1037 1047
R.AYQAR.G Y 15.27 607.3078 5 -26.9 608.2988 1 29.97 6 12851 VEV_3_3_RA6_01_1237.d 0 1 1 179 183
K.DIVIGMPHR.G Y 15.02 1036.5488 9 -28.1 346.5139 3 44.65 6 21206 VEV_3_3_RA6_01_1237.d 6.08E4 1 1 347 355
total 36 peptides
C1G4K1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.Q(-17.03)FGGATEAYKNLSPAERESLNQTAQLNR.A Y 125.90 3075.5010 28 -7.3 769.8769 4 77.02 4 44712 VEV_1_3_RA4_01_1235.d 5.68E5 5 5 172 199 Pyro-glu from Q
K.AVALVPPKGLPETPIMLLQK.Q Y 96.88 2114.2537 20 -2.8 705.7565 3 83.34 5 48156 VEV_2_3_RA5_01_1236.d 2.79E5 2 2 149 168
R.ESLNQTAQLNR.A Y 96.27 1272.6422 11 -8.7 637.3229 2 45.00 4 21800 VEV_1_3_RA4_01_1235.d 8.12E5 5 5 189 199
K.SIYGMEAPSQSK.S Y 91.02 1296.6019 12 0.2 649.3083 2 58.88 4 30685 VEV_1_3_RA4_01_1235.d 3.08E5 3 3 312 323
K.SIYGMEAPSQSKSPSPA Y 88.78 1735.8086 17 -6.8 868.9056 2 64.40 4 34810 VEV_1_3_RA4_01_1235.d 1.88E5 3 3 312 328
K.SIYGM(+15.99)EAPSQSKSPSPA Y 83.90 1751.8036 17 -9.4 876.9008 2 55.49 4 28325 VEV_1_3_RA4_01_1235.d 1.51E5 3 3 312 328 Oxidation (M)
K.SHTPLQIK.Q Y 79.12 922.5236 8 -6.1 462.2663 2 30.10 4 12901 VEV_1_3_RA4_01_1235.d 1.52E6 10 10 212 219
K.RPVNAYLFFLK.E Y 78.68 1366.7761 11 -20.9 456.5898 3 79.80 6 45012 VEV_3_3_RA6_01_1237.d 1.62E5 3 3 249 259
K.Q(-17.03)FGGATEAYKNLSPAER.E Y 73.87 1820.8693 17 -12.3 911.4307 2 74.82 5 42467 VEV_2_3_RA5_01_1236.d 2.01E5 2 2 172 188 Pyro-glu from Q
K.GLPETPIMLLQK.Q Y 70.78 1338.7581 12 -11.1 447.2550 3 81.46 5 47003 VEV_2_3_RA5_01_1236.d 1.71E5 3 3 157 168
R.ESLNQTAQ(+.98)LNR.A Y 67.96 1273.6262 11 -9.1 637.8146 2 48.22 4 23768 VEV_1_3_RA4_01_1235.d 5.9E4 1 1 189 199 Deamidation (NQ)
K.NLSPAERESLNQTAQLNR.A Y 67.29 2040.0348 18 16.6 511.0244 4 61.09 4 32300 VEV_1_3_RA4_01_1235.d 0 2 2 182 199
K.AVALVPPK.G Y 62.94 793.5061 8 -13.3 794.5028 1 50.72 4 25321 VEV_1_3_RA4_01_1235.d 1.15E6 8 8 149 156
K.SIYGM(+15.99)EAPSQSK.S Y 59.17 1312.5969 12 0.4 657.3060 2 39.06 4 18141 VEV_1_3_RA4_01_1235.d 2.6E5 5 5 312 323 Oxidation (M)
R.ASNKTMFQDWVK.S Y 57.70 1453.7024 12 -12.5 485.5687 3 68.19 4 37786 VEV_1_3_RA4_01_1235.d 2.48E5 2 2 200 211
K.QFGGATEAYKNLSPAER.E Y 56.86 1837.8958 17 -36.1 613.6171 3 64.47 6 33722 VEV_3_3_RA6_01_1237.d 0 1 1 172 188
R.SRKPNKQLTEK.Q Y 49.76 1327.7572 11 -14.9 664.8760 2 10.73 5 2834 VEV_2_3_RA5_01_1236.d 5.26E5 4 4 120 130
R.ESLNQTAQLNR(+14.02).A Y 45.13 1286.6578 11 -12.1 644.3284 2 51.28 5 25946 VEV_2_3_RA5_01_1236.d 1.07E5 2 2 189 199 Methylation(KR)
K.QFGGATEAYK.N Y 43.58 1070.5032 10 7.3 536.2628 2 42.21 4 20088 VEV_1_3_RA4_01_1235.d 1.24E5 3 3 172 181
K.TMFQDWVK.S Y 33.88 1053.4954 8 -6.9 527.7513 2 75.48 6 41897 VEV_3_3_RA6_01_1237.d 3.24E5 4 4 204 211
R.KPNKQLTEK.Q Y 28.33 1084.6240 9 -56.4 543.2887 2 9.80 5 2436 VEV_2_3_RA5_01_1236.d 0 2 2 122 130
R.E(+14.02)SLNQTAQLNR.A Y 26.38 1286.6578 11 -20.1 644.3232 2 55.57 4 28422 VEV_1_3_RA4_01_1235.d 2.66E4 1 1 189 199 Methylation(others)
K.SPSPA Y 23.68 457.2172 5 -8.3 458.2207 1 17.12 6 6045 VEV_3_3_RA6_01_1237.d 8.24E4 4 4 324 328
K.N(+.98)LK(+42.01)AVALVPPK.G Y 22.96 1191.7227 11 -60.7 398.2241 3 50.46 5 25418 VEV_2_3_RA5_01_1236.d 0 2 2 146 156 Deamidation (NQ); Acetylation (K)
K.LFKKPR.R Y 20.64 787.5068 6 -24.8 394.7509 2 15.82 4 5218 VEV_1_3_RA4_01_1235.d 2.61E4 1 1 231 236
K.QFGGATEAYKNLSPAERESLNQTAQLNR.A Y 19.00 3092.5273 28 -27.1 774.1182 4 70.67 6 38356 VEV_3_3_RA6_01_1237.d 8.13E4 1 1 172 199
K.AATAK.N N 17.21 460.2645 5 -89.0 461.2308 1 32.16 5 14509 VEV_2_3_RA5_01_1236.d 0 1 1 92 96
K.SHTPLQIKQANMAR.Q Y 16.06 1593.8409 14 -32.8 532.2701 3 44.36 5 21772 VEV_2_3_RA5_01_1236.d 0 1 1 212 225
K.YLQQHK.S Y 15.92 815.4290 6 -20.8 408.7133 2 10.34 6 2637 VEV_3_3_RA6_01_1237.d 2E4 1 1 306 311
K.TAAAWR.G Y 15.90 674.3500 6 -26.2 338.1734 2 21.60 6 8393 VEV_3_3_RA6_01_1237.d 0 1 1 276 281
K.TAAAWRGM(+15.99)TAGEK.E Y 15.50 1364.6506 13 -2.0 342.1693 4 25.39 5 10705 VEV_2_3_RA5_01_1236.d 8.64E4 1 1 276 288 Oxidation (M)
K.ADTAASK.A Y 15.39 662.3235 7 -11.4 663.3232 1 86.44 5 49991 VEV_2_3_RA5_01_1236.d 0 1 1 76 82
K.ESMSK.T N 15.17 580.2527 5 48.4 581.2880 1 26.36 5 11247 VEV_2_3_RA5_01_1236.d 0 1 1 271 275
total 33 peptides
C1G766
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSYAGDYTWTGDAESGAR.Q Y 124.72 1906.7969 18 -8.8 954.3973 2 67.70 6 36157 VEV_3_3_RA6_01_1237.d 1.73E5 4 4 1045 1062
K.DMVLATNPLLESFGNAK.T Y 94.88 1818.9186 17 -4.1 910.4628 2 86.76 4 51742 VEV_1_3_RA4_01_1235.d 1.18E5 3 3 545 561
K.SGTIHTSQGEPPNSVSRPTPRPK.Q Y 79.07 2429.2410 23 -6.5 608.3136 4 36.04 5 16794 VEV_2_3_RA5_01_1236.d 9.26E4 1 1 1335 1357
K.YLELQFNSVGEPVGATITNYLLEK.S Y 76.07 2697.3901 24 -15.5 900.1234 3 90.74 6 51697 VEV_3_3_RA6_01_1237.d 1.33E5 2 2 574 597
R.LNFLSQNPNFESR.Q Y 74.46 1564.7634 13 -0.3 783.3888 2 75.39 4 43473 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 888 900
K.AAPQAYRDNFGIQQPQSYVYTSR.S Y 74.24 2659.2778 23 -8.1 887.4260 3 72.72 4 41365 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 619 641
R.DSAVSMNSQDSPGGSGR.A Y 73.91 1650.6903 17 -2.2 826.3506 2 39.59 4 18459 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 1584 1600
R.APPPPPPPPPAAPPAAK.K Y 72.13 1568.8713 17 -11.1 785.4343 2 59.26 4 30933 VEV_1_3_RA4_01_1235.d 1.98E5 5 5 1434 1450
K.HYAGDVGYTVK.G Y 70.52 1208.5825 11 -15.3 605.2893 2 40.76 5 19566 VEV_2_3_RA5_01_1236.d 1.6E5 3 3 908 918
K.ASANDLVATLMK.A Y 69.51 1232.6434 12 -11.1 617.3221 2 79.17 4 46377 VEV_1_3_RA4_01_1235.d 5.07E5 5 5 969 980
K.VSNEAINENLK.K Y 65.54 1229.6251 11 -8.6 615.8146 2 45.06 4 21818 VEV_1_3_RA4_01_1235.d 1.27E5 2 2 430 440
K.LLRPGGPGGGPSK.L Y 58.15 1191.6724 13 -46.4 398.2130 3 32.36 4 14245 VEV_1_3_RA4_01_1235.d 0 1 1 1369 1381
K.YLELQ(+.98)FNSVGEPVGATITNYLLEK.S Y 51.12 2698.3740 24 0.3 900.4655 3 90.95 4 54187 VEV_1_3_RA4_01_1235.d 5.39E4 1 1 574 597 Deamidation (NQ)
R.AATISNSNNNNNNPVNPITTN(+.98)GASR.A Y 49.94 2555.1960 25 -10.6 852.7303 3 62.38 4 33275 VEV_1_3_RA4_01_1235.d 2.37E5 3 3 1529 1553 Deamidation (NQ)
R.NFHIFYQFTK.A Y 41.52 1343.6663 10 12.3 448.9016 3 76.45 4 44262 VEV_1_3_RA4_01_1235.d 0 1 1 609 618
R.FLGDYLGVGNTGGPGEMIR.D Y 37.61 1951.9462 19 12.9 976.9929 2 82.91 4 49161 VEV_1_3_RA4_01_1235.d 0 1 1 1167 1185
R.KPAAPATPR.D Y 37.18 907.5239 9 -25.9 454.7575 2 14.98 5 5014 VEV_2_3_RA5_01_1236.d 3.59E4 2 2 1575 1583
R.DNFGIQQPQSYVYTSR.S Y 35.83 1901.8907 16 6.2 634.9748 3 75.27 4 43337 VEV_1_3_RA4_01_1235.d 7.73E4 1 1 626 641
K.ILGGM(+15.99)K.E Y 33.03 633.3520 6 -5.0 317.6817 2 8.96 6 2124 VEV_3_3_RA6_01_1237.d 1.97E5 2 2 1149 1154 Oxidation (M)
K.YLGLQENVR.I Y 32.23 1090.5770 9 -12.2 546.2891 2 63.28 4 33967 VEV_1_3_RA4_01_1235.d 5.62E4 1 1 1011 1019
R.FYLLSPK.T Y 31.83 866.4902 7 -13.6 434.2465 2 71.34 4 40270 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 1038 1044
K.VSNEAINENLKK.R Y 28.51 1357.7201 12 -7.2 453.5774 3 33.47 4 14854 VEV_1_3_RA4_01_1235.d 7.3E4 1 1 430 441
K.TPETIFALEHMR.D Y 28.03 1443.7180 12 -5.8 482.2438 3 73.96 4 42329 VEV_1_3_RA4_01_1235.d 8.75E4 1 1 1086 1097
K.VLYDFNSER.T Y 24.21 1141.5404 9 5.9 571.7808 2 64.54 4 34915 VEV_1_3_RA4_01_1235.d 0 1 1 1456 1464
R.TNSAQAR.A Y 24.08 746.3671 7 4.0 374.1923 2 10.04 6 2518 VEV_3_3_RA6_01_1237.d 5.9E4 2 2 1427 1433
R.TALAWAAGTSNLTR.N Y 23.41 1431.7471 14 2.5 358.9449 4 15.34 5 5217 VEV_2_3_RA5_01_1236.d 0 1 1 58 71
K.LRDQGHKILGGM(+15.99)K.E Y 22.96 1467.7980 13 0.7 490.2736 3 75.77 4 43734 VEV_1_3_RA4_01_1235.d 2.87E4 1 1 1142 1154 Oxidation (M)
K.DTLEAMR.I Y 22.93 834.3906 7 -9.6 418.1985 2 13.15 6 4001 VEV_3_3_RA6_01_1237.d 0 1 1 658 664
R.DQGHK.I Y 21.46 583.2714 5 10.3 584.2847 1 29.81 6 12764 VEV_3_3_RA6_01_1237.d 1.7E5 4 4 1144 1148
R.RPPTAGDK.I Y 21.37 840.4453 8 -31.8 421.2166 2 31.90 5 14371 VEV_2_3_RA5_01_1236.d 8.38E4 1 1 959 966
K.ASANDLVATLM(+15.99)K.A Y 20.74 1248.6384 12 -16.6 625.3161 2 70.41 4 39534 VEV_1_3_RA4_01_1235.d 1.65E5 1 1 969 980 Oxidation (M)
R.NNNSSR.F N 20.63 690.3045 6 -4.8 691.3085 1 53.52 6 26372 VEV_3_3_RA6_01_1237.d 1.43E4 1 1 565 570
K.RRPPTAGDK.I Y 18.96 996.5464 9 -19.0 499.2710 2 60.88 5 32202 VEV_2_3_RA5_01_1236.d 0 1 1 958 966
R.VGEIVQIMAK.E Y 18.50 1086.6107 10 -26.6 363.2012 3 52.78 6 25930 VEV_3_3_RA6_01_1237.d 0 1 1 1472 1481
R.IQRAWRNYLR.Y Y 17.58 1374.7633 10 -44.5 459.2413 3 61.59 5 32723 VEV_2_3_RA5_01_1236.d 0 1 1 1108 1117
K.TEQEEYAR.E Y 17.49 1024.4462 8 41.2 513.2515 2 16.28 6 5605 VEV_3_3_RA6_01_1237.d 0 1 1 827 834
R.DALAK.A Y 16.94 516.2907 5 -19.2 517.2881 1 34.42 6 15345 VEV_3_3_RA6_01_1237.d 0 1 1 756 760
R.EDVADRLAELEESEQAAR.R Y 16.91 2029.9552 18 -36.0 508.4778 4 63.80 4 34361 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 274 291
K.LEEINDIHAR.G Y 16.77 1208.6149 10 -41.2 605.2898 2 67.47 6 35993 VEV_3_3_RA6_01_1237.d 6.91E4 1 1 352 361
K.LEKQSPKNM(+15.99)QR.I Y 16.62 1373.7085 11 -26.6 687.8433 2 74.73 6 41346 VEV_3_3_RA6_01_1237.d 2.24E5 1 1 308 318 Oxidation (M)
R.SSNSPLGLIDGM(+15.99)ELK.G Y 16.37 1575.7814 15 -8.0 526.2635 3 59.78 4 31324 VEV_1_3_RA4_01_1235.d 0 1 1 17 31 Oxidation (M)
K.TEAAK.R N 16.09 518.2700 5 -35.6 519.2589 1 23.80 6 9566 VEV_3_3_RA6_01_1237.d 0 1 1 519 523
K.TEAQIKLEESLAAK.E Y 15.64 1529.8301 14 -22.4 510.9392 3 66.83 6 35504 VEV_3_3_RA6_01_1237.d 1.29E5 1 1 199 212
R.DRYWHNM(+15.99)AIR.I Y 15.26 1376.6407 10 40.0 459.9059 3 42.06 5 20356 VEV_2_3_RA5_01_1236.d 2.01E5 1 1 1098 1107 Oxidation (M)
total 44 peptides
C1GE98
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.A(+42.01)DVDPHTNTGFTSAMDEAAAASQQEGLGSAKTER.S Y 126.06 3504.5698 34 -8.3 1169.1875 3 78.35 5 44955 VEV_2_3_RA5_01_1236.d 2.4E5 4 4 2 35 Acetylation (Protein N-term)
R.TASTELSPVATSPSPQQSPIDRR.M Y 118.76 2424.2244 23 -11.7 607.0563 4 64.40 5 34823 VEV_2_3_RA5_01_1236.d 1.1E6 5 5 57 79
R.SQSTGDPFASQRTPDNDPFAR.T Y 109.07 2293.0359 21 -13.5 765.3423 3 68.36 6 36672 VEV_3_3_RA6_01_1237.d 8.32E5 3 3 36 56
M.A(+42.01)DVDPHTNTGFTSAMDEAAAASQQEGLGSAK.T Y 101.33 3118.3784 31 -3.0 1040.4636 3 80.75 6 45684 VEV_3_3_RA6_01_1237.d 5.63E4 1 1 2 32 Acetylation (Protein N-term)
R.TASTELSPVATSPSPQQSPIDR.R Y 91.38 2268.1233 22 -10.9 757.0401 3 68.22 6 36559 VEV_3_3_RA6_01_1237.d 1.58E5 3 3 57 78
R.SQSTGDPFASQR.T Y 85.10 1279.5792 12 -9.0 640.7911 2 42.57 5 20709 VEV_2_3_RA5_01_1236.d 1.25E6 9 9 36 47
R.TPDNDPFAR.T Y 80.98 1031.4672 9 -12.8 516.7343 2 48.05 6 23169 VEV_3_3_RA6_01_1237.d 1.59E6 8 8 48 56
R.EGSIFSTSSSR.D Y 77.09 1156.5360 11 -12.1 579.2683 2 48.45 5 24237 VEV_2_3_RA5_01_1236.d 1.41E6 12 12 126 136
R.REGSIFSTSSSR.D Y 70.85 1312.6371 12 -17.7 438.5452 3 37.32 6 16950 VEV_3_3_RA6_01_1237.d 3.72E5 5 5 125 136
R.TASTELSPVATSPSPQ(+.98)QSPIDRR.M Y 61.79 2425.2085 23 -9.8 809.4022 3 65.64 4 35780 VEV_1_3_RA4_01_1235.d 2.49E5 3 3 57 79 Deamidation (NQ)
R.KDRDSAFHAK.L Y 53.86 1173.5890 10 -11.6 587.7950 2 10.91 5 2916 VEV_2_3_RA5_01_1236.d 1.4E5 4 4 143 152
R.SQSTGDPFASQ(+.98)R.T Y 52.60 1280.5632 12 -13.3 641.2804 2 46.28 6 22141 VEV_3_3_RA6_01_1237.d 3.8E5 4 4 36 47 Deamidation (NQ)
R.EGSIFSTSSSRDSHLSR.K Y 51.47 1851.8711 17 -10.6 618.2911 3 50.77 5 25614 VEV_2_3_RA5_01_1236.d 1.57E5 2 2 126 142
R.SQ(+.98)STGDPFASQR.T Y 46.61 1280.5632 12 9.3 641.2949 2 42.40 5 20557 VEV_2_3_RA5_01_1236.d 2.51E5 2 2 36 47 Deamidation (NQ)
R.TASTE(+14.02)LSPVATSPSPQQSPIDRR.M Y 38.61 2438.2400 23 -18.3 813.7391 3 66.52 5 36412 VEV_2_3_RA5_01_1236.d 2.79E4 1 1 57 79 Methylation(others)
R.EGSIFSTSSSRDSHLSRK.D Y 29.07 1979.9661 18 -2.9 660.9941 3 41.35 5 19941 VEV_2_3_RA5_01_1236.d 2.57E4 1 1 126 143
R.EGSIFSTSSSR(+14.02).D Y 26.11 1170.5516 11 -13.5 586.2752 2 55.96 5 28742 VEV_2_3_RA5_01_1236.d 6.82E4 1 1 126 136 Methylation(KR)
K.EKVSC(+57.02) Y 20.13 621.2792 5 16.4 622.2966 1 57.47 5 29750 VEV_2_3_RA5_01_1236.d 1.88E4 2 2 155 159 Carbamidomethylation
M.ADVDPH(+40.03)TNTGFTSAMDEAAAASQQEGLGSAK.T Y 17.24 3116.3992 31 10.5 1039.8179 3 80.86 4 47685 VEV_1_3_RA4_01_1235.d 5.57E4 1 1 2 32 Propionaldehyde +40
total 19 peptides
C1FZ06
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GISHPTTVSPSSFVTPYTPLVSDAEEAATTLK.A Y 133.73 3302.6558 32 -12.8 1101.8784 3 86.30 6 49247 VEV_3_3_RA6_01_1237.d 1.35E5 2 2 63 94
R.KADLLLATYYANELLLR.L Y 131.27 1979.1091 17 -15.5 660.7001 3 87.24 6 49793 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 131 147
R.QYEPAGEADGSPVSR.L Y 97.09 1561.7008 15 -11.2 781.8489 2 48.30 6 23317 VEV_3_3_RA6_01_1237.d 3.14E5 5 5 311 325
K.AYGC(+57.02)SLVENTTSWLFEHNEIEGK.K Y 81.66 2683.2224 23 -7.5 895.4081 3 85.22 6 48602 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 187 209 Carbamidomethylation
R.Q(-17.03)YEPAGEADGSPVSR.L Y 74.58 1544.6743 15 -12.7 773.3346 2 64.31 6 33587 VEV_3_3_RA6_01_1237.d 2.74E5 4 4 311 325 Pyro-glu from Q
R.FGTFPFSLR.Q Y 65.28 1070.5549 9 -11.8 536.2784 2 82.14 4 48621 VEV_1_3_RA4_01_1235.d 5.52E5 3 3 280 288
K.VGVVEC(+57.02)VR.G Y 62.17 916.4800 8 -14.4 459.2407 2 42.90 6 20183 VEV_3_3_RA6_01_1237.d 6.92E5 5 5 298 305 Carbamidomethylation
K.IIIAPGAGVK.G Y 60.58 937.5960 10 -33.0 469.7898 2 61.31 6 31379 VEV_3_3_RA6_01_1237.d 6.55E4 2 2 212 221
R.LLTTVVITK.N Y 59.10 986.6376 9 -31.7 494.3104 2 67.33 6 35876 VEV_3_3_RA6_01_1237.d 1.42E5 3 3 326 334
K.ITDEEILKILERPLAR.S Y 57.62 1908.1044 16 -16.1 478.0257 4 83.84 6 47723 VEV_3_3_RA6_01_1237.d 3.97E4 1 1 357 372
R.RFGTFPFSLR.Q Y 55.58 1226.6560 10 -13.7 409.8870 3 77.85 6 43621 VEV_3_3_RA6_01_1237.d 1.15E5 2 2 279 288
R.VAAPPPLDLSK.V Y 54.68 1106.6335 11 -22.0 554.3119 2 66.35 6 35136 VEV_3_3_RA6_01_1237.d 3.49E5 3 3 340 350
R.Q(+.98)YEPAGEADGSPVSR.L Y 51.47 1562.6848 15 -11.4 782.3408 2 50.59 6 24630 VEV_3_3_RA6_01_1237.d 6.9E4 1 1 311 325 Deamidation (NQ)
R.TTTTYILK.R Y 45.97 939.5277 8 -13.0 470.7650 2 51.29 4 25688 VEV_1_3_RA4_01_1235.d 5.23E5 5 5 258 265
K.A(+43.01)DLLLAT(+79.97)YYANELLLR.L Y 37.91 1973.9863 16 -1.2 659.0020 3 87.22 6 49783 VEV_3_3_RA6_01_1237.d 5.43E4 1 1 132 147 Carbamylation; Phosphorylation (STY)
K.ILERPLAR.S Y 33.91 966.5974 8 -13.4 323.2021 3 41.65 5 20111 VEV_2_3_RA5_01_1236.d 5.63E4 3 3 365 372
R.LMVPPGLLASGSEEEK.K Y 30.64 1655.8440 16 -3.2 828.9266 2 84.81 4 50460 VEV_1_3_RA4_01_1235.d 9.59E4 1 1 148 163
K.RPSSRQTLSEIVR.R Y 25.58 1527.8481 13 -32.3 510.2736 3 19.36 4 7101 VEV_1_3_RA4_01_1235.d 1.25E6 4 4 266 278
R.STGTK.K Y 16.76 492.2544 5 -26.6 493.2485 1 18.89 4 6823 VEV_1_3_RA4_01_1235.d 0 1 1 373 377
total 19 peptides
C1GBG9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RQVNAVQNAQGQPKPSPLAAPR.R Y 133.89 2326.2617 22 -12.6 582.5654 4 51.27 4 25680 VEV_1_3_RA4_01_1235.d 4.59E5 5 5 322 343
K.NAQAIAQASGNQGADEEEKPR.R Y 128.16 2183.0203 21 -6.8 728.6758 3 39.43 4 18386 VEV_1_3_RA4_01_1235.d 2.83E5 3 3 301 321
K.LAERVPSGTVDTPDTNR.A Y 96.29 1826.9122 17 0.0 609.9780 3 55.86 5 28682 VEV_2_3_RA5_01_1236.d 2.11E5 5 5 346 362
R.GFPNEFSVYLNYTR.S Y 87.56 1705.8099 14 -10.6 853.9032 2 83.48 6 47498 VEV_3_3_RA6_01_1237.d 4.48E4 1 1 246 259
R.SASKGANANTGYSGVAYHR.S Y 79.82 1909.9031 19 -6.0 478.4802 4 31.32 5 14032 VEV_2_3_RA5_01_1236.d 7.57E4 1 1 373 391
R.QVNAVQNAQGQPKPSPLAAPR.R Y 78.30 2170.1606 21 -10.9 724.3863 3 58.10 4 30084 VEV_1_3_RA4_01_1235.d 5.79E4 2 2 323 343
R.YASINTHLGVEQSR.R Y 77.18 1573.7848 14 -17.6 525.5930 3 59.10 5 30886 VEV_2_3_RA5_01_1236.d 6.25E5 5 5 182 195
R.GNQVNVIDFGLAK.K Y 74.98 1373.7302 13 -15.5 687.8618 2 77.04 5 44051 VEV_2_3_RA5_01_1236.d 9.5E4 3 3 145 157
K.GANANTGYSGVAYHR.S Y 58.59 1536.7069 15 -5.6 769.3564 2 38.31 5 18122 VEV_2_3_RA5_01_1236.d 4.39E4 2 2 377 391
R.GSLPWQGLK.A Y 32.55 984.5392 9 -10.8 493.2716 2 71.17 4 40140 VEV_1_3_RA4_01_1235.d 1.72E5 3 3 212 220
K.NAQAIAQASGNQGADEEEKPRR.Q Y 32.50 2339.1213 22 -13.1 585.7800 4 34.53 5 15897 VEV_2_3_RA5_01_1236.d 7.73E4 1 1 301 322
K.LAERVPSGT(-2.02)VDTPDTNR.A Y 28.48 1824.8966 17 -50.0 609.2758 3 56.38 4 28873 VEV_1_3_RA4_01_1235.d 1.79E4 1 1 346 362 2-amino-3-oxo-butanoic_acid
R.AVGGSDRMLRSASK.G Y 27.48 1433.7408 14 -15.3 478.9136 3 62.79 6 32484 VEV_3_3_RA6_01_1237.d 6.57E4 2 2 363 376
K.M(+15.99)TTPTEVLC(+57.02)R.G Y 24.25 1222.5686 10 1.5 612.2925 2 47.58 4 23371 VEV_1_3_RA4_01_1235.d 8.77E4 1 1 236 245 Oxidation (M); Carbamidomethylation
K.KM(+15.99)TTPTEVLC(+57.02)R.G Y 22.25 1350.6636 11 -41.5 676.3110 2 26.07 5 11086 VEV_2_3_RA5_01_1236.d 2.57E5 2 2 235 245 Oxidation (M); Carbamidomethylation
K.MTTPTEVLC(+57.02)R.G Y 21.02 1206.5737 10 -7.0 604.2899 2 64.91 4 35205 VEV_1_3_RA4_01_1235.d 1.58E5 4 4 236 245 Carbamidomethylation
K.HPQLEYEAR.V Y 18.30 1141.5516 9 -0.3 571.7829 2 35.13 5 16250 VEV_2_3_RA5_01_1236.d 2.22E4 1 1 49 57
K.NLTGTAR.Y Y 15.04 731.3926 7 -5.4 366.7016 2 11.73 4 3183 VEV_1_3_RA4_01_1235.d 2.62E4 1 1 175 181
total 18 peptides
C1G8F9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPTDESC(+57.02)PLGGLAPYSNALVLDSK.S Y 172.26 2490.1948 24 -9.1 1246.0934 2 83.82 6 47710 VEV_3_3_RA6_01_1237.d 1.34E5 2 2 988 1011 Carbamidomethylation
K.TGNVC(+57.02)C(+57.02)EDPQIDALSSHLK.I Y 102.99 2142.9673 19 18.8 715.3431 3 69.52 6 37514 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 79 97 Carbamidomethylation
K.AFFDENFGPFYR.A Y 78.34 1508.6724 12 -8.6 755.3370 2 84.43 4 50207 VEV_1_3_RA4_01_1235.d 1.47E5 3 3 398 409
K.LLGSPFQINFMTQPK.G Y 73.47 1719.9017 15 -5.3 574.3048 3 85.14 4 50677 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 198 212
K.GLALEDVC(+57.02)FKPTGR.A Y 57.89 1561.7922 14 -37.4 521.5852 3 72.21 5 40626 VEV_2_3_RA5_01_1236.d 0 1 1 452 465 Carbamidomethylation
K.LSFFGGQLPC(+57.02)PDNGLAK.A Y 57.30 1819.8927 17 -5.5 910.9486 2 82.04 4 48559 VEV_1_3_RA4_01_1235.d 1.38E5 2 2 43 59 Carbamidomethylation
K.SPTDESC(+57.02)PLGGLAPYSNALVLDSK(-.98).S Y 51.63 2489.2107 24 -10.1 1245.6001 2 83.88 5 48484 VEV_2_3_RA5_01_1236.d 0 1 1 988 1011 Carbamidomethylation; Amidation
K.LWVSPTSAAAQEK.A Y 37.27 1386.7144 13 -35.2 694.3400 2 64.87 6 34020 VEV_3_3_RA6_01_1237.d 0 1 1 385 397
K.VVTELDNLWSEVYQVGFYDSC(+57.02)KDVK.N Y 36.72 2992.4165 25 32.0 998.5114 3 89.50 4 53382 VEV_1_3_RA4_01_1235.d 3.96E4 2 2 143 167 Carbamidomethylation
R.TSHTPLR.S Y 31.84 810.4348 7 -22.2 406.2157 2 12.66 6 3744 VEV_3_3_RA6_01_1237.d 0 1 1 1022 1028
R.HHQQQLC(+57.02)GR.F Y 23.81 1162.5414 9 -14.5 388.5154 3 10.97 4 2845 VEV_1_3_RA4_01_1235.d 1.35E4 1 1 895 903 Carbamidomethylation
R.AM(+15.99)DFIGGGAR.N Y 22.88 1009.4651 10 26.3 505.7531 2 18.32 6 6673 VEV_3_3_RA6_01_1237.d 7.96E4 1 1 175 184 Oxidation (M)
R.NFTQFLK.F Y 22.29 896.4756 7 -41.4 449.2265 2 40.50 4 18998 VEV_1_3_RA4_01_1235.d 0 1 1 185 191
R.AC(+57.02)VVQSLTGYFGGSFSNVDPNNWK.S Y 21.91 2646.2173 24 -3.1 883.0770 3 87.38 4 52122 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 466 489 Carbamidomethylation
K.TYASR.L Y 21.34 596.2918 5 -3.5 597.2970 1 31.19 5 13962 VEV_2_3_RA5_01_1236.d 0 1 1 817 821
K.FLGDKK.L Y 19.88 706.4014 6 -16.5 354.2021 2 15.22 5 5150 VEV_2_3_RA5_01_1236.d 5.59E4 1 1 192 197
R.AFMFPSSPLLEQAR.G Y 19.83 1592.8020 14 -9.3 797.4009 2 86.88 6 49595 VEV_3_3_RA6_01_1237.d 0 1 1 1150 1163
R.RVESLR.A Y 18.74 758.4399 6 -49.2 380.2086 2 35.12 5 16244 VEV_2_3_RA5_01_1236.d 0 1 1 774 779
K.DFINAYASARRIANDISETHK.I Y 17.28 2391.1931 21 -6.9 798.0662 3 76.07 4 43967 VEV_1_3_RA4_01_1235.d 0 1 1 1032 1052
K.DVKNGASGGRAM(+15.99)DFIGGGAR.N Y 16.23 1950.9330 20 -6.5 651.3140 3 51.59 5 26133 VEV_2_3_RA5_01_1236.d 6.17E4 1 1 165 184 Oxidation (M)
R.IANDISETHK.I Y 15.93 1126.5618 10 3.7 564.2902 2 42.39 6 19889 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 1043 1052
total 21 peptides
C1G5M9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAYPEYNQAFDDVAAETAYELILATSK.T Y 140.88 2963.4075 27 -2.4 1482.7075 2 95.69 4 56608 VEV_1_3_RA4_01_1235.d 2.88E5 4 4 874 900
K.SGSAAAPAAPKNSEK.K Y 83.55 1384.6946 15 -9.5 693.3480 2 14.17 5 4587 VEV_2_3_RA5_01_1236.d 1.66E5 5 5 65 79
K.SGSAAAPAAPK.N Y 82.09 926.4821 11 -17.2 464.2404 2 17.33 6 6207 VEV_3_3_RA6_01_1237.d 5.37E5 7 7 65 75
K.NADAYDPPTIEAGKYEWWEK.Q Y 76.75 2382.0803 20 -9.9 795.0262 3 78.76 4 46059 VEV_1_3_RA4_01_1235.d 3.4E4 1 1 89 108
K.ITPAHDFNDFIR.G Y 73.78 1444.7098 12 -25.4 482.5650 3 70.15 6 37996 VEV_3_3_RA6_01_1237.d 4.73E5 3 3 381 392
K.LGDDFKPQASPTK.T Y 72.00 1402.7092 13 -13.4 468.5707 3 47.72 4 23459 VEV_1_3_RA4_01_1235.d 6.7E5 9 9 748 760
R.TLLEVPGYQR.K Y 69.37 1174.6346 10 -12.6 392.5472 3 71.50 4 40404 VEV_1_3_RA4_01_1235.d 4.75E5 5 5 290 299
K.GIPEC(+57.02)GTDALR.F Y 67.76 1187.5604 11 -9.3 594.7820 2 59.12 4 30841 VEV_1_3_RA4_01_1235.d 2.96E5 4 4 697 707 Carbamidomethylation
K.AKSGSAAAPAAPK.N Y 54.11 1125.6141 13 -11.1 563.8081 2 13.28 4 3948 VEV_1_3_RA4_01_1235.d 8.63E3 1 1 63 75
K.GLAEPAIK.A Y 51.13 797.4647 8 -11.6 399.7350 2 45.55 4 22108 VEV_1_3_RA4_01_1235.d 3.54E5 2 2 473 480
R.FC(+57.02)NKIYQATR.Y Y 48.64 1299.6394 10 -5.2 434.2181 3 43.35 6 20437 VEV_3_3_RA6_01_1237.d 9.88E4 1 1 733 742 Carbamidomethylation
R.LGGSFDWTR.E Y 45.85 1037.4930 9 -8.3 519.7495 2 69.84 4 39090 VEV_1_3_RA4_01_1235.d 8.99E4 1 1 225 233
K.IQTYDSTSFR.T Y 42.45 1216.5724 10 -4.8 609.2905 2 58.20 4 30149 VEV_1_3_RA4_01_1235.d 0 2 2 919 928
K.SNDVIEPILKPQWWMSMK.G Y 41.73 2201.1013 18 -26.2 734.6885 3 85.66 4 51021 VEV_1_3_RA4_01_1235.d 0 1 1 455 472
R.YQVIEALKEK.G Y 39.77 1219.6812 10 -19.1 407.5599 3 60.64 6 30897 VEV_3_3_RA6_01_1237.d 1.99E5 2 2 427 436
R.LHEEGIIYRENR.L Y 36.48 1527.7793 12 -11.8 382.9476 4 45.06 4 21803 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 253 264
K.SLGNVINPIDVIEGIKLQDLHEKLK.H Y 26.57 2784.5750 25 -10.3 557.9165 5 84.73 6 48288 VEV_3_3_RA6_01_1237.d 6.93E4 1 1 650 674
K.S(-2.02)GSAAAPAAPKNSEK.K Y 23.54 1382.6790 15 -58.9 461.8731 3 14.21 6 4535 VEV_3_3_RA6_01_1237.d 2.22E4 1 1 65 79 2-amino-3-oxo-butanoic_acid
MASNK.A Y 21.74 549.2581 5 6.6 550.2690 1 55.40 5 28399 VEV_2_3_RA5_01_1236.d 2.09E5 3 3 1 5
K.NTPDFEK.L Y 21.71 849.3868 7 -20.6 425.6920 2 23.80 6 9564 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 590 596
R.RPGDKTPSIM(+15.99)K.A Y 20.71 1244.6547 11 -21.1 312.1644 4 30.03 4 12866 VEV_1_3_RA4_01_1235.d 0 1 1 863 873 Oxidation (M)
K.FAEKK(+14.02)AKSGSAAAPAAPK.N Y 19.03 1742.9678 18 -22.3 436.7395 4 52.49 6 25754 VEV_3_3_RA6_01_1237.d 7.82E4 1 1 58 75 Methylation(KR)
M(+15.99)ASNK.A Y 18.96 565.2530 5 0.5 566.2606 1 20.50 5 8001 VEV_2_3_RA5_01_1236.d 1.62E4 1 1 1 5 Oxidation (M)
K.SGSAAAPAAPKNSEKK.V Y 17.40 1512.7896 16 1.3 379.2051 4 62.93 4 33703 VEV_1_3_RA4_01_1235.d 0 1 1 65 80
R.LHEEGIIYR.E Y 17.22 1128.5928 9 -49.7 377.1862 3 61.30 6 31371 VEV_3_3_RA6_01_1237.d 7.25E4 1 1 253 261
K.SGSAAAP(-30.01)AAPK.N Y 16.70 896.4716 11 -39.0 449.2256 2 29.18 5 12799 VEV_2_3_RA5_01_1236.d 1.86E5 1 1 65 75 Proline oxidation to pyrrolidinone
K.AKSGSAAAPAAPK(+42.01)NSEK(+43.01).K Y 16.65 1668.8430 17 -4.6 835.4249 2 93.14 6 52824 VEV_3_3_RA6_01_1237.d 0 1 1 63 79 Acetylation (K); Carbamylation
K.S(-2.02)LGNVINPIDVIEGIKLQDLHEK.L Y 16.49 2541.3801 23 -36.8 636.3289 4 86.24 4 51395 VEV_1_3_RA4_01_1235.d 1.13E4 1 1 650 672 2-amino-3-oxo-butanoic_acid
R.LVNWC(+57.02)VALNTSLSNLEVENKDLEGR.T Y 16.16 2872.4390 25 0.5 958.4874 3 97.96 6 54656 VEV_3_3_RA6_01_1237.d 0 1 1 265 289 Carbamidomethylation
R.SIFSEYEIK.T Y 16.07 1114.5546 9 2.8 558.2861 2 59.87 6 30358 VEV_3_3_RA6_01_1237.d 4.81E4 1 1 904 912
K.AKSGSAAAPAAPKNSEK.K Y 15.76 1583.8267 17 -2.4 528.9482 3 70.30 5 39213 VEV_2_3_RA5_01_1236.d 0 1 1 63 79
K.DLEGRTLLEVPGYQR.K Y 15.67 1744.9108 15 3.3 437.2364 4 56.32 6 27924 VEV_3_3_RA6_01_1237.d 1.65E5 1 1 285 299
R.LHEEGIIYRENRLVNWC(+57.02)VALNTSLSNLEVENK.D Y 15.48 3811.9314 32 -25.8 953.9656 4 87.81 6 50117 VEV_3_3_RA6_01_1237.d 6.33E4 1 1 253 284 Carbamidomethylation
R.MIMLGIKMTGK.V Y 15.37 1221.6648 11 -11.2 408.2243 3 23.94 4 9516 VEV_1_3_RA4_01_1235.d 0 1 1 617 627
total 34 peptides
C1GN78
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SNVSDDLVWEITR.S Y 114.83 1532.7471 13 -15.9 767.3687 2 80.86 6 45782 VEV_3_3_RA6_01_1237.d 9.47E5 6 6 7 19
K.AIGIQPTEEGTIAVTTK.K Y 110.76 1727.9305 17 -7.4 864.9661 2 72.12 4 40931 VEV_1_3_RA4_01_1235.d 1.38E6 6 6 56 72
K.KPATIHKPASSTTTNTYSSTATNR.K Y 106.71 2534.2725 24 -9.2 845.7570 3 32.35 5 14637 VEV_2_3_RA5_01_1236.d 2.31E5 4 4 73 96
R.KYAGFVNC(+57.02)K.A Y 96.18 1085.5327 9 -7.7 543.7695 2 33.33 4 14810 VEV_1_3_RA4_01_1235.d 1.34E6 7 7 47 55 Carbamidomethylation
K.KPATIHKPASSTTTNTYSSTATNRK.I Y 84.82 2662.3674 25 -15.7 666.5887 4 28.42 5 12363 VEV_2_3_RA5_01_1236.d 5.59E5 6 6 73 97
M.S(+42.01)YVGKSNVSDDLVWEITR.S Y 69.10 2109.0378 18 -10.7 1055.5149 2 83.43 5 48213 VEV_2_3_RA5_01_1236.d 6.6E4 2 2 2 19 Acetylation (Protein N-term)
K.AIGIQ(+.98)PTEEGTIAVTTK.K Y 67.75 1728.9146 17 -5.6 865.4597 2 73.73 4 42145 VEV_1_3_RA4_01_1235.d 2.51E4 2 2 56 72 Deamidation (NQ)
K.YAGFVNC(+57.02)K.A Y 66.35 957.4378 8 -10.4 479.7212 2 43.81 5 21382 VEV_2_3_RA5_01_1236.d 0 2 2 48 55 Carbamidomethylation
R.KIYKGIANTAAK.S Y 65.46 1276.7502 12 -12.9 639.3741 2 28.84 6 12241 VEV_3_3_RA6_01_1237.d 3.46E4 3 3 97 108
R.ADLRAEAVGR.A Y 64.25 1056.5675 10 -14.3 353.1914 3 34.00 5 15563 VEV_2_3_RA5_01_1236.d 1.37E6 8 8 113 122
R.SQNSFLVK.C Y 58.21 921.4919 8 -9.0 461.7491 2 46.33 4 22640 VEV_1_3_RA4_01_1235.d 2.27E6 8 8 20 27
K.SNVSDDLVWEITR(+14.02).S Y 55.83 1546.7627 13 -8.5 774.3821 2 83.39 6 47465 VEV_3_3_RA6_01_1237.d 3.42E5 5 5 7 19 Methylation(KR)
K.C(+57.02)AGAQ(+.98)FS(-18.01)RDPLNLVNKHSR.K Y 55.46 2152.0596 19 -9.9 718.3533 3 70.53 5 39381 VEV_2_3_RA5_01_1236.d 4.06E5 3 3 28 46 Carbamidomethylation; Deamidation (NQ); Dehydration
K.KEVPEKKPR.G Y 52.27 1109.6556 9 -12.8 555.8280 2 9.30 5 2254 VEV_2_3_RA5_01_1236.d 2.1E5 6 6 134 142
K.IYKGIANTAAK.S Y 50.68 1148.6553 11 -8.5 575.3300 2 30.70 4 13245 VEV_1_3_RA4_01_1235.d 9.21E5 6 6 98 108
K.SGYRADLRAEAVGR.A Y 46.80 1519.7855 14 -11.3 507.5967 3 47.46 5 23606 VEV_2_3_RA5_01_1236.d 6.9E5 3 3 109 122
K.C(+57.02)AGAQFSRDPLNLVNK.H Y 46.15 1788.8940 16 -7.8 597.3007 3 70.32 4 39466 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 28 43 Carbamidomethylation
K.EVPEKKPR.G Y 45.30 981.5607 8 -17.0 491.7793 2 9.77 6 2406 VEV_3_3_RA6_01_1237.d 8.4E3 1 1 135 142
K.C(+57.02)AGAQ(+.98)FSRD(-18.01)PLNLVNKHSR.K Y 36.12 2152.0596 19 -10.1 539.0167 4 70.47 5 39337 VEV_2_3_RA5_01_1236.d 2.18E5 1 1 28 46 Carbamidomethylation; Deamidation (NQ); Dehydration
R.SQ(+.98)NSFLVK.C Y 31.75 922.4760 8 -15.1 462.2383 2 50.69 4 25299 VEV_1_3_RA4_01_1235.d 2.23E5 1 1 20 27 Deamidation (NQ)
R.ASAIRM(+15.99)SQRPK.K Y 26.14 1259.6768 11 -8.6 420.8959 3 52.34 4 26382 VEV_1_3_RA4_01_1235.d 0 1 1 123 133 Oxidation (M)
K.GIANTAAK.S Y 21.96 744.4130 8 -19.7 373.2064 2 13.63 6 4247 VEV_3_3_RA6_01_1237.d 2.34E4 2 2 101 108
R.DPLNLVNKHSR.K Y 19.52 1291.6997 11 -26.3 323.9237 4 45.85 4 22290 VEV_1_3_RA4_01_1235.d 6.3E4 1 1 36 46
K.EVPEK.K Y 15.10 600.3119 5 -54.9 601.2862 1 34.32 6 15265 VEV_3_3_RA6_01_1237.d 0 1 1 135 139
total 24 peptides
C1GHB9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LADSGTQHTIVEQDNVR.F Y 116.39 1881.9181 17 -9.7 628.3073 3 50.66 4 25331 VEV_1_3_RA4_01_1235.d 6.34E5 5 5 40 56
K.VRGDLGPESEEIPLVSTATAPAHSDAVAQSR.A Y 104.36 3159.5796 31 -8.3 790.8956 4 73.46 4 41947 VEV_1_3_RA4_01_1235.d 2.17E5 2 2 240 270
R.GDLGPESEEIPLVSTATAPAHSDAVAQSR.A Y 102.86 2904.4099 29 -3.8 969.1403 3 76.66 4 44434 VEV_1_3_RA4_01_1235.d 8.34E4 1 1 242 270
R.VTGTDSPDVLPITFTVWVNR.G Y 92.70 2216.1477 20 -31.7 739.6998 3 89.15 4 53199 VEV_1_3_RA4_01_1235.d 0 1 1 372 391
R.APSYPVYSPPTRPTPTEAINSYEAEKKK.T Y 88.59 3120.5767 28 -24.1 625.1075 5 68.18 4 37788 VEV_1_3_RA4_01_1235.d 5.54E4 3 3 185 212
R.APSYPVYSPPTRPTPTEAINSYEAEK.K Y 86.35 2864.3867 26 -5.2 955.7979 3 73.67 4 42101 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 185 210
R.FVYQPLDELYIVLITNK.Q Y 85.33 2067.1292 17 -10.6 690.0430 3 94.78 6 53512 VEV_3_3_RA6_01_1237.d 1.53E5 3 3 57 73
K.LGLTANPTHEAVFR.T Y 73.30 1524.8048 14 -9.7 509.2706 3 67.65 4 37415 VEV_1_3_RA4_01_1235.d 5.46E5 4 4 321 334
R.SRIEALLASFPK.L Y 70.36 1330.7609 12 -8.7 444.5904 3 79.58 5 45776 VEV_2_3_RA5_01_1236.d 1.8E5 3 3 28 39
R.NKELEATEER.K Y 63.82 1217.5887 10 -8.2 609.7966 2 19.26 4 7023 VEV_1_3_RA4_01_1235.d 2.73E5 4 4 151 160
R.ITDDTFAK.V Y 63.36 909.4443 8 -10.8 455.7245 2 36.59 4 16697 VEV_1_3_RA4_01_1235.d 3.85E5 5 5 311 318
R.DGTVKSYEIKGDLQLR.I Y 46.05 1820.9631 16 -14.4 456.2415 4 64.97 6 34091 VEV_3_3_RA6_01_1237.d 0 1 1 295 310
R.KEAARSGRGVTPR.A Y 32.78 1383.7694 13 -36.0 346.9372 4 22.70 5 9190 VEV_2_3_RA5_01_1236.d 1.37E5 2 2 172 184
K.DFKTIADGYVVE Y 26.52 1355.6609 12 -10.3 452.8896 3 39.47 6 18186 VEV_3_3_RA6_01_1237.d 0 1 1 506 517
R.THPNVDR.A Y 21.94 837.4093 7 -17.4 419.7047 2 10.39 6 2655 VEV_3_3_RA6_01_1237.d 2.2E4 1 1 335 341
K.ATPF(+31.99)VDVDVQTVSLLEMDGQTVNFSK.D Y 20.82 2871.3848 26 -2.3 958.1333 3 84.93 4 50545 VEV_1_3_RA4_01_1235.d 3.56E4 1 1 480 505 Dihydroxy
K.SFPHNISIGVLR.W Y 20.81 1338.7407 12 -35.0 447.2386 3 74.21 4 42514 VEV_1_3_RA4_01_1235.d 0 1 1 358 369
K.SLDER.E Y 20.35 618.2973 5 -17.0 619.2941 1 56.90 6 28307 VEV_3_3_RA6_01_1237.d 1.84E5 1 1 97 101
R.FVYQPLDELY(-2.02)IVLITNK.Q Y 19.01 2065.1135 17 -49.2 689.3446 3 94.87 4 56225 VEV_1_3_RA4_01_1235.d 0 1 1 57 73 2-amino-3-oxo-butanoic_acid
R.ASVSADR.E Y 18.60 704.3453 7 0.7 705.3530 1 54.41 5 27843 VEV_2_3_RA5_01_1236.d 0 1 1 271 277
M(+15.99)QVILAASIC(+57.02)TR.G Y 15.04 1377.7108 12 23.2 460.2549 3 65.61 5 35749 VEV_2_3_RA5_01_1236.d 2.88E4 1 1 1 12 Oxidation (M); Carbamidomethylation
total 21 peptides
C1G9F5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPSSFSFGSGSGSGSGSKPYPAR.E Y 123.59 2189.9978 23 -13.1 730.9969 3 61.69 6 31671 VEV_3_3_RA6_01_1237.d 7.45E5 4 4 254 276
R.HTSHANSVQDASTQADRPR.R Y 95.13 2076.9685 19 -15.0 520.2416 4 20.17 6 7642 VEV_3_3_RA6_01_1237.d 1.96E5 3 3 41 59
R.SNVPDAVNTPSKTK.T Y 90.42 1456.7522 14 -14.7 486.5842 3 31.11 5 13906 VEV_2_3_RA5_01_1236.d 3.12E5 3 3 113 126
K.NILSTEPSIDEGPVER.H Y 89.84 1754.8687 16 -8.6 878.4341 2 73.05 5 41206 VEV_2_3_RA5_01_1236.d 4.1E5 3 3 25 40
K.THPGEGSNLPVLTK.S Y 89.62 1448.7623 14 -12.2 725.3796 2 56.37 5 29000 VEV_2_3_RA5_01_1236.d 5.52E5 3 3 240 253
K.GSGSNSATPLPNDAPTKK.N Y 80.89 1740.8643 18 -3.8 581.2932 3 34.06 5 15605 VEV_2_3_RA5_01_1236.d 6.02E5 3 3 7 24
K.S(-2.02)PSSFSFGSGSGSGSGSKPYPAR.E Y 78.92 2187.9819 23 58.3 730.3771 3 62.01 4 32999 VEV_1_3_RA4_01_1235.d 6.62E4 2 2 254 276 2-amino-3-oxo-butanoic_acid
K.SAVSNAASTWAEK.N Y 71.82 1320.6310 13 -13.7 661.3137 2 59.97 6 30425 VEV_3_3_RA6_01_1237.d 1.44E5 1 1 292 304
R.SNVPDAVNTPSK.T Y 68.71 1227.6095 12 -10.4 614.8057 2 39.66 5 18917 VEV_2_3_RA5_01_1236.d 8.62E5 5 5 113 124
M.T(+42.01)TLPKGSGSNSATPLPNDAPTKK.N Y 59.40 2323.2019 23 -9.9 775.4003 3 60.05 5 31579 VEV_2_3_RA5_01_1236.d 1.02E5 2 2 2 24 Acetylation (Protein N-term)
R.ATELPPPPPLDR.N Y 58.26 1301.6979 12 -15.9 651.8459 2 67.60 6 36086 VEV_3_3_RA6_01_1237.d 1.7E5 1 1 350 361
K.SPSSFSFGSGSGSGSGSKPYPARESESR.S Y 54.20 2778.2480 28 -5.0 927.0853 3 58.40 5 30384 VEV_2_3_RA5_01_1236.d 7.04E4 1 1 254 281
K.YASPVPAIPQDK.Q Y 43.46 1284.6714 12 -19.1 643.3307 2 65.43 5 35605 VEV_2_3_RA5_01_1236.d 5.9E4 3 3 369 380
K.RSNVPDAVNTPSKTK.T Y 41.23 1612.8533 15 -19.9 404.2126 4 25.12 5 10553 VEV_2_3_RA5_01_1236.d 0 1 1 112 126
R.SVKPLSSHGR.Q Y 35.15 1066.5883 10 -13.2 534.2944 2 13.10 6 3977 VEV_3_3_RA6_01_1237.d 1.08E5 3 3 169 178
R.SFLHIPSR.S Y 31.34 955.5239 8 -15.6 319.5103 3 62.83 5 33662 VEV_2_3_RA5_01_1236.d 1.63E5 3 3 63 70
R.GQPTAPDK.R Y 29.34 812.4028 8 -10.1 813.4019 1 87.78 5 50726 VEV_2_3_RA5_01_1236.d 2.24E5 2 2 79 86
K.RSNVPDAVNTPSK.T Y 27.45 1383.7106 13 -13.4 462.2379 3 51.57 5 26120 VEV_2_3_RA5_01_1236.d 8.2E4 1 1 112 124
R.ATELPPPPPLDRNTEPINK.Y Y 26.72 2098.1057 19 -10.5 700.3685 3 67.58 5 37208 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 350 368
R.EDVAENNAGSK.K Y 25.36 1132.4996 11 0.6 567.2574 2 24.92 5 10437 VEV_2_3_RA5_01_1236.d 9.32E4 1 1 88 98
R.DSC(+57.02)YNHQGNYVK.D Y 22.03 1483.6150 12 -14.5 495.5385 3 27.21 4 11308 VEV_1_3_RA4_01_1235.d 3.14E4 1 1 484 495 Carbamidomethylation
R.SKRSNVPDAVNTPSK.T Y 20.28 1598.8376 15 -48.0 400.6975 4 70.54 6 38258 VEV_3_3_RA6_01_1237.d 0 1 1 110 124
R.SLPTIAASEK.S Y 17.51 1015.5549 10 -60.5 508.7540 2 55.82 5 28652 VEV_2_3_RA5_01_1236.d 5.06E4 1 1 282 291
M(+15.99)TT(-18.01)LPK.G Y 17.05 687.3625 6 -30.4 688.3489 1 73.38 6 40362 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 1 6 Oxidation (M); Dehydration
K.LRGQPTAPDK.R Y 16.76 1081.5880 10 27.2 361.5464 3 33.07 5 15040 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 77 86
R.SSSSIK.L N 15.83 607.3177 6 -12.5 608.3174 1 51.83 6 25368 VEV_3_3_RA6_01_1237.d 0 1 1 71 76
K.KRANSMGSSKR.S Y 15.41 1220.6407 11 -33.9 306.1571 4 13.23 6 4039 VEV_3_3_RA6_01_1237.d 1.45E4 1 1 99 109
total 27 peptides
C1G570
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GIQGGTSHGLGQNFSK.M Y 121.46 1586.7800 16 -5.0 794.3933 2 47.21 5 23504 VEV_2_3_RA5_01_1236.d 1.62E6 11 11 314 329
K.FAGGLYTTTVEGYIPATGR.G Y 112.67 1972.9894 19 -8.2 987.4939 2 80.49 4 47399 VEV_1_3_RA4_01_1235.d 4.96E5 3 3 295 313
R.VADVQTVIIPVGITAK.T Y 108.54 1622.9607 16 -17.5 812.4734 2 80.04 5 46083 VEV_2_3_RA5_01_1236.d 2.31E5 3 3 382 397
K.KKPDGPALIGIDVLK.N Y 80.69 1562.9395 15 -10.6 391.7380 4 71.85 4 40677 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 85 99
R.TMDPATGENHPAGEVSK.N Y 72.85 1739.7784 17 2.8 580.9351 3 36.78 4 16830 VEV_1_3_RA4_01_1235.d 7.68E4 1 1 28 44
K.IAIRPTSETVMYPYYAK.W Y 64.41 2002.0233 17 -19.3 668.3355 3 72.88 6 40000 VEV_3_3_RA6_01_1237.d 4.29E4 2 2 195 211
R.DLPLRLNQWNSVVR.W Y 62.00 1708.9373 14 -9.9 570.6474 3 79.96 4 46987 VEV_1_3_RA4_01_1235.d 5.4E4 1 1 218 231
R.ASLYAEIDALAAVIEDAGVRVEVDKR.D Y 60.52 2772.4656 26 -14.5 694.1136 4 93.82 6 53113 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 404 429
K.SLC(+57.02)IPFEQPPGIEK.G Y 55.13 1613.8123 14 -15.7 807.9007 2 79.24 6 44621 VEV_3_3_RA6_01_1237.d 8.23E4 2 2 569 582 Carbamidomethylation
R.WEFKNPQPFLR.T Y 53.65 1460.7565 11 -12.9 487.9198 3 74.93 4 43073 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 232 242
K.STIPISELKTQVPALLETIQADLYKR.A Y 51.02 2926.6379 26 -2.9 732.6647 4 89.97 6 51303 VEV_3_3_RA6_01_1237.d 2.91E4 2 2 475 500
K.SLC(+57.02)IPFEQPPGIEKGVTK.C Y 50.90 1999.0448 18 -14.4 667.3459 3 76.28 5 43503 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 569 586 Carbamidomethylation
K.STIPISELK.T Y 50.58 986.5648 9 -12.8 494.2834 2 64.50 4 34884 VEV_1_3_RA4_01_1235.d 2.81E5 3 3 475 483
K.SANKGIGKSEAK.N Y 42.32 1188.6462 12 -17.2 397.2159 3 9.21 5 2217 VEV_2_3_RA5_01_1236.d 1.02E4 1 1 64 75
R.LNQWNSVVR.W Y 39.93 1114.5884 9 -13.7 558.2938 2 61.83 4 32899 VEV_1_3_RA4_01_1235.d 9.42E4 1 1 223 231
R.FAENWC(+57.02)LFGR.K Y 30.76 1298.5865 10 -2.1 650.2992 2 80.70 4 47558 VEV_1_3_RA4_01_1235.d 1.78E4 1 1 595 604 Carbamidomethylation
K.SEKSANK.G Y 30.71 762.3871 7 -2.1 763.3928 1 109.12 4 60898 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 61 67
K.NPQPFLR.T Y 22.17 870.4711 7 -24.9 436.2320 2 19.48 6 7295 VEV_3_3_RA6_01_1237.d 3.56E4 3 3 236 242
K.EKDHIEGFAAEVAWVTHAGNSK.L Y 17.45 2395.1555 22 -12.9 599.7885 4 73.34 6 40336 VEV_3_3_RA6_01_1237.d 8.96E4 1 1 169 190
K.HITNWDDFSPALNEK.N Y 16.60 1785.8322 15 36.5 596.3064 3 74.52 4 42762 VEV_1_3_RA4_01_1235.d 0 1 1 511 525
R.DLPLR.L N 15.35 612.3595 5 -0.3 307.1869 2 56.56 4 29001 VEV_1_3_RA4_01_1235.d 7.79E4 1 1 218 222
total 21 peptides
C1G3V5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SNLDKEYAGITGVPAFTK.A Y 119.41 1909.9785 18 -7.9 955.9890 2 74.61 4 42831 VEV_1_3_RA4_01_1235.d 8.37E5 5 5 89 106
R.YYNKDTIGLDFEGLIADLK.L Y 113.21 2187.1099 19 -0.4 730.0436 3 88.38 4 52736 VEV_1_3_RA4_01_1235.d 3.36E5 2 2 180 198
K.AAAELAFGSFSPAIKEDR.I Y 103.88 1878.9475 18 -23.8 627.3082 3 76.36 4 44189 VEV_1_3_RA4_01_1235.d 7.81E4 5 5 107 124
R.IAITQSISGTGALR.I Y 91.21 1386.7831 14 -11.3 694.3910 2 70.57 4 39673 VEV_1_3_RA4_01_1235.d 2.05E5 3 3 125 138
R.VGAFSVVC(+57.02)ESAEEKKR.V Y 83.39 1794.8934 16 -11.1 449.7256 4 57.63 4 29741 VEV_1_3_RA4_01_1235.d 7.55E4 1 1 287 302 Carbamidomethylation
K.ILVRPLYSNPPVHGVR.I Y 82.33 1816.0471 16 -28.2 606.3392 3 66.09 5 36126 VEV_2_3_RA5_01_1236.d 5.19E5 6 6 309 324
R.VGAFSVVC(+57.02)ESAEEK.K Y 77.97 1510.6973 14 -7.5 756.3503 2 67.93 4 37583 VEV_1_3_RA4_01_1235.d 9.01E4 1 1 287 300 Carbamidomethylation
R.VSVAGITTGNVKR.L Y 63.01 1300.7463 13 -18.3 434.5815 3 54.18 6 26756 VEV_3_3_RA6_01_1237.d 2.22E5 5 5 407 419
R.IAAAFLER.F Y 48.71 889.5021 8 -10.0 445.7539 2 65.52 4 35683 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 139 146
K.SKGHFAFFDMAYQGFASGDTDRDAFALR.H Y 37.92 3127.4246 28 -18.7 626.4805 5 83.32 4 49447 VEV_1_3_RA4_01_1235.d 0 1 1 234 261
K.NM(-48.00)GLYGER.V Y 35.53 890.4246 8 -4.8 446.2174 2 16.40 4 5510 VEV_1_3_RA4_01_1235.d 3.82E3 1 1 279 286 Dethiomethyl
R.LAEC(+57.02)IYKVTG Y 30.63 1152.5848 10 -10.0 577.2939 2 64.99 5 35333 VEV_2_3_RA5_01_1236.d 2.75E5 3 3 420 429 Carbamidomethylation
K.SKGHFAFFDMAYQ(+.98)GFASGDTDRDAFALR.H Y 30.15 3128.4084 28 9.2 626.6947 5 83.29 6 47374 VEV_3_3_RA6_01_1237.d 0 1 1 234 261 Deamidation (NQ)
R.IASTILNDPALNK.Q Y 28.41 1368.7612 13 -32.6 343.1864 4 16.36 5 5758 VEV_2_3_RA5_01_1236.d 9.18E4 1 1 325 337
K.NMGLYGER.V Y 26.22 938.4280 8 -3.4 470.2197 2 46.89 4 22941 VEV_1_3_RA4_01_1235.d 3.27E5 3 3 279 286
R.VS(-2.02)VAGITTGNVKR.L Y 24.65 1298.7306 13 -49.1 433.8962 3 54.36 6 26878 VEV_3_3_RA6_01_1237.d 7.36E4 1 1 407 419 2-amino-3-oxo-butanoic_acid
R.AAEEK.V N 23.26 546.2649 5 -2.1 547.2710 1 54.72 5 28027 VEV_2_3_RA5_01_1236.d 1.24E5 2 2 81 85
R.IAITQSIS(-18.01)GTGALR.I Y 19.86 1368.7725 14 -4.7 343.1988 4 57.67 4 29771 VEV_1_3_RA4_01_1235.d 0 1 1 125 138 Dehydration
K.INLGVGAYR.D Y 19.81 961.5345 9 -38.4 321.5065 3 14.46 6 4675 VEV_3_3_RA6_01_1237.d 5.66E4 1 1 59 67
K.DAGLQVEK.Y Y 18.96 858.4446 8 13.0 430.2352 2 31.18 6 13514 VEV_3_3_RA6_01_1237.d 0 2 2 170 177
R.QISDVMK.S Y 18.61 819.4160 7 -45.5 820.3860 1 88.10 5 50898 VEV_2_3_RA5_01_1236.d 4.24E4 1 1 227 233
K.AAAELAFGSFSPAIK.E Y 18.05 1478.7769 15 -10.6 493.9277 3 49.71 5 24975 VEV_2_3_RA5_01_1236.d 0 1 1 107 121
K.DGRVSVAGITTGNVKR.L Y 17.55 1628.8958 16 -28.0 408.2198 4 53.73 6 26516 VEV_3_3_RA6_01_1237.d 0 1 1 404 419
K.EHSVYATKDGR.V Y 16.82 1261.6051 11 -14.3 631.8008 2 49.38 5 24778 VEV_2_3_RA5_01_1236.d 1.29E5 1 1 396 406
R.HFLQEGHGIVLSQSFAK.N Y 16.72 1896.9846 17 31.1 475.2682 4 71.41 4 40327 VEV_1_3_RA4_01_1235.d 0 1 1 262 278
K.QWLC(+57.02)EVKGM(+15.99)ADR.I Y 15.97 1507.6912 12 -19.7 754.8380 2 39.93 4 18659 VEV_1_3_RA4_01_1235.d 8.19E4 1 1 338 349 Carbamidomethylation; Oxidation (M)
K.E(+42.01)YAGITGVPAFTK.A Y 15.96 1394.7081 13 -15.2 698.3507 2 79.76 6 45040 VEV_3_3_RA6_01_1237.d 9.01E4 1 1 94 106 Acetylation (N-term)
K.VIKSNLDKEYAGITGVPAFTK.A Y 15.94 2250.2258 21 -15.4 563.5551 4 72.69 6 39868 VEV_3_3_RA6_01_1237.d 2.84E4 1 1 86 106
R.RAAAR.D N 15.57 543.3241 5 8.2 544.3358 1 38.81 6 17814 VEV_3_3_RA6_01_1237.d 6.79E4 1 1 11 15
K.ENLEALGSK.H Y 15.29 959.4923 9 -44.4 960.4570 1 87.50 5 50577 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 359 367
total 30 peptides
C1G5J0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GIDLDQLLDLSSEQLRDVVHAR.A Y 129.83 2491.3030 22 -13.1 623.8249 4 88.67 6 50639 VEV_3_3_RA6_01_1237.d 3.78E6 15 15 27 48
R.GIDLDQLLDLSSEQLR.D Y 109.74 1813.9421 16 -5.7 907.9731 2 89.74 4 53510 VEV_1_3_RA4_01_1235.d 4.35E5 5 5 27 42
K.HGRPGIGATHSSR.F Y 97.54 1331.6807 13 -9.3 444.8967 3 13.43 4 4017 VEV_1_3_RA4_01_1235.d 1.74E6 10 10 136 148
R.DMIVVPEMIGSVIGIYSGK.E Y 85.61 2007.0420 19 -11.0 1004.5173 2 95.71 5 54523 VEV_2_3_RA5_01_1236.d 3.85E5 4 4 90 108
K.QEAKPNEKPDLVK.T Y 83.17 1494.8042 13 -39.7 748.3797 2 26.07 6 10761 VEV_3_3_RA6_01_1237.d 2.64E5 6 6 73 85
R.GIDLDQLLDLSSEQLRDVVHAR(+14.02).A Y 82.63 2505.3186 22 -8.2 627.3318 4 88.76 4 52986 VEV_1_3_RA4_01_1235.d 1.82E6 5 5 27 48 Methylation(KR)
K.Q(-17.03)EAKPNEKPDLVK.T Y 81.37 1477.7776 13 -14.6 493.5926 3 40.49 6 18777 VEV_3_3_RA6_01_1237.d 1.34E6 7 7 73 85 Pyro-glu from Q
R.GIDLDQLLDLSSEQLR(+14.02)DVVHAR.A Y 80.24 2505.3186 22 -19.7 627.3246 4 88.60 6 50591 VEV_3_3_RA6_01_1237.d 1.58E6 6 6 27 48 Methylation(KR)
R.GIDLDQ(+.98)LLDLSSEQLRDVVHAR.A Y 79.08 2492.2871 22 -11.8 624.0717 4 89.51 6 51057 VEV_3_3_RA6_01_1237.d 4.61E5 4 4 27 48 Deamidation (NQ)
K.THLRDMIVVPEMIGSVIGIYSGK.E Y 78.13 2514.3337 23 -9.3 629.5848 4 90.51 4 53935 VEV_1_3_RA4_01_1235.d 5.13E4 2 2 86 108
R.GIDLDQLLDLSSEQ(+.98)LRDVVHAR.A Y 69.82 2492.2871 22 -12.6 624.0712 4 91.13 4 54311 VEV_1_3_RA4_01_1235.d 2.32E5 1 1 27 48 Deamidation (NQ)
M.A(+42.01)DIEYNADEAAEIKKKR.A Y 68.86 2005.0116 17 -9.4 1003.5036 2 60.73 5 32094 VEV_2_3_RA5_01_1236.d 6.93E5 3 3 2 18 Acetylation (Protein N-term)
R.GIDLDQLLDLSSEQLR(+14.02).D Y 66.53 1827.9578 16 -18.8 610.3151 3 90.86 6 51757 VEV_3_3_RA6_01_1237.d 7.75E4 3 3 27 42 Methylation(KR)
R.GIDLDQLLDLS(+14.02)SEQLRDVVHAR.A Y 66.04 2505.3186 22 -2.3 836.1116 3 89.02 5 51438 VEV_2_3_RA5_01_1236.d 2.31E5 1 1 27 48 Methylation(others)
M.A(+42.01)DIEYNADEAAEIKKK.R Y 65.07 1848.9104 16 -8.9 925.4543 2 63.99 5 34523 VEV_2_3_RA5_01_1236.d 7.57E5 5 5 2 17 Acetylation (Protein N-term)
R.AKQEAKPNEKPDLVK.T Y 64.29 1693.9362 15 -6.9 424.4884 4 21.14 4 8005 VEV_1_3_RA4_01_1235.d 1.63E6 6 6 71 85
R.GIDLD(+14.02)QLLDLSSEQLRDVVHAR.A Y 58.20 2505.3186 22 -5.9 627.3333 4 89.63 4 53451 VEV_1_3_RA4_01_1235.d 9.3E5 2 2 27 48 Methylation(others)
M.A(+42.01)DIEYNADEAAEIKK.K Y 57.28 1720.8154 15 -6.4 861.4095 2 69.34 4 38710 VEV_1_3_RA4_01_1235.d 9.46E5 5 5 2 16 Acetylation (Protein N-term)
R.GIDLDQLLDLSSEQLRDVVHAR(+28.03).A Y 48.96 2519.3342 22 -3.5 630.8386 4 88.95 6 50769 VEV_3_3_RA6_01_1237.d 1.83E5 1 1 27 48 Dimethylation(KR)
K.FSYRGIDLDQLLDLSSEQLRDVVHAR.A Y 48.37 3044.5679 26 -14.8 609.9119 5 88.27 6 50389 VEV_3_3_RA6_01_1237.d 9.55E4 1 1 23 48
R.RAKQEAKPNEKPDLVK.T Y 46.80 1850.0374 16 -16.8 617.6760 3 20.72 6 7937 VEV_3_3_RA6_01_1237.d 8.72E5 5 5 70 85
M.AD(+37.96)IEYNADEAAEIKKK.R Y 34.69 1844.8557 16 50.1 615.9900 3 64.24 4 34692 VEV_1_3_RA4_01_1235.d 0 1 1 2 17 Replacement of proton by potassium
M.A(+42.01)DIEYNADEAAEIK(+14.02)K.K Y 31.91 1734.8312 15 -12.9 868.4117 2 71.27 6 38814 VEV_3_3_RA6_01_1237.d 3.37E5 4 4 2 16 Acetylation (Protein N-term); Methylation(KR)
R.FIPLK Y 20.87 616.3948 5 -21.6 309.1980 2 50.53 6 24598 VEV_3_3_RA6_01_1237.d 1.53E5 2 2 149 153
R.GIDLDQLLDLS(-2.02)SEQLRDVVHAR.A Y 20.01 2489.2874 22 32.4 623.3493 4 89.05 4 53138 VEV_1_3_RA4_01_1235.d 0 1 1 27 48 2-amino-3-oxo-butanoic_acid
R.DVVHARAR.R Y 19.79 922.5096 8 3.0 462.2635 2 33.52 5 15299 VEV_2_3_RA5_01_1236.d 2.74E4 1 1 43 50
R.DVVHAR.A Y 16.63 695.3715 6 -27.8 696.3594 1 18.30 5 6803 VEV_2_3_RA5_01_1236.d 2.51E4 1 1 43 48
total 27 peptides
C1G653
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GIAAHTPDRPGYWIHTSGTGILTFEDLGNSTFGDLR.T Y 122.18 3871.8916 36 -5.4 775.3814 5 84.25 4 50091 VEV_1_3_RA4_01_1235.d 2.04E5 3 3 100 135
R.DVDKIVLGVGENAADRVK.T Y 99.97 1897.0269 18 -12.4 475.2581 4 73.80 4 42202 VEV_1_3_RA4_01_1235.d 1.84E5 2 2 159 176
K.LVYGDLDTAEILEEEAK.K Y 95.99 1906.9410 17 -13.6 954.4648 2 82.20 6 46680 VEV_3_3_RA6_01_1237.d 5.6E4 1 1 61 77
K.GENIWHEVHVHDLSDLFLLLGEAAAAGSGK.A Y 88.80 3184.5940 30 2.6 637.9277 5 92.36 4 54969 VEV_1_3_RA4_01_1235.d 6.61E4 1 1 219 248
K.ELFSSGPFSWGTNSR.A Y 87.96 1670.7688 15 -6.9 836.3859 2 82.25 4 48746 VEV_1_3_RA4_01_1235.d 4.14E5 3 3 298 312
K.GLIPTPEVDILDGKQAK.E Y 81.94 1792.9934 17 -11.0 598.6652 3 78.70 4 46017 VEV_1_3_RA4_01_1235.d 4.37E4 1 1 281 297
R.ELLPEIVDLEAKALNLER.S Y 76.76 2064.1465 18 -6.7 689.0515 3 89.44 5 51600 VEV_2_3_RA5_01_1236.d 7.05E4 1 1 333 350
R.ELLPEIVDLEAK.A Y 66.40 1367.7548 12 -8.5 684.8788 2 83.19 4 49401 VEV_1_3_RA4_01_1235.d 3.83E5 4 4 333 344
R.SNQIYNLTK.Y Y 64.06 1079.5612 9 -9.6 540.7827 2 54.55 4 27788 VEV_1_3_RA4_01_1235.d 1.33E6 7 7 197 205
K.TAIVC(+57.02)PPTIYGPGR.G Y 59.49 1500.7759 14 -17.6 751.3820 2 72.11 6 39448 VEV_3_3_RA6_01_1237.d 3.77E5 6 6 177 190 Carbamidomethylation
K.GLIPTPEVDILDGK.Q Y 55.82 1465.8027 14 -7.9 733.9028 2 83.32 4 49439 VEV_1_3_RA4_01_1235.d 9.58E4 1 1 281 294
K.TAIVC(+57.02)PPTIYGPGRGPGNTR.S Y 53.46 2083.0632 20 -2.9 695.3597 3 67.81 4 37492 VEV_1_3_RA4_01_1235.d 4.04E4 4 4 177 196 Carbamidomethylation
R.ELLPEIVDLEAK(+14.02).A Y 53.29 1381.7704 12 -7.9 691.8870 2 86.33 4 51456 VEV_1_3_RA4_01_1235.d 1.25E5 2 2 333 344 Methylation(KR)
R.NKQKGELVTSKYPNTK.L Y 28.70 1833.9949 16 -6.4 459.5031 4 24.71 5 10319 VEV_2_3_RA5_01_1236.d 0 1 1 45 60
R.E(+14.02)LLPEIVDLEAK.A Y 25.55 1381.7704 12 -13.9 691.8829 2 83.70 6 47638 VEV_3_3_RA6_01_1237.d 4.07E4 1 1 333 344 Methylation(others)
K.YPNTK.L Y 22.09 621.3122 5 -11.4 622.3124 1 75.99 5 43307 VEV_2_3_RA5_01_1236.d 6.56E4 1 1 56 60
K.ALNLER.S Y 21.35 714.4024 6 -9.3 358.2051 2 34.10 4 15210 VEV_1_3_RA4_01_1235.d 4.55E5 1 1 345 350
K.LLGWNPHRPAAR.E Y 21.11 1386.7632 12 -21.8 347.6905 4 58.83 6 29593 VEV_3_3_RA6_01_1237.d 0 1 1 321 332
K.VFVGALTKPR.T Y 19.64 1086.6549 10 -25.9 1087.6340 1 103.18 6 56269 VEV_3_3_RA6_01_1237.d 0 1 1 6 15
K.AMAQIAFEK.G Y 19.46 1007.5110 9 -21.5 336.8370 3 11.24 5 3086 VEV_2_3_RA5_01_1236.d 0 1 1 272 280
M(+15.99)GSPK.V Y 17.75 534.2472 5 -1.1 535.2539 1 64.70 6 33885 VEV_3_3_RA6_01_1237.d 1.27E4 1 1 1 5 Oxidation (M)
R.GPGNTR.S Y 16.44 600.2980 6 22.2 601.3186 1 25.86 4 10575 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 191 196
total 22 peptides
C1G388
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EANHFPFFDTAYQGFASGDPK.H Y 126.51 2345.0388 21 -8.0 782.6807 3 81.87 6 46457 VEV_3_3_RA6_01_1237.d 1.43E5 3 3 260 280
R.TASYPYYSPATK.G Y 108.03 1347.6346 12 -12.8 674.8160 2 58.74 6 29591 VEV_3_3_RA6_01_1237.d 1.49E6 6 6 201 212
R.AGAFHFVTAPGPQAVESAAHIASQLAILQR.S Y 100.85 3057.6147 30 14.1 612.5388 5 86.94 4 51849 VEV_1_3_RA4_01_1235.d 0 1 1 313 342
R.ISMAGLNTHNIDYFAEAVDSVVR.E Y 97.94 2521.2271 23 -8.5 841.4092 3 87.61 4 52258 VEV_1_3_RA4_01_1235.d 7.95E4 2 2 437 459
R.SEISNPPAYGAR.I Y 79.20 1260.6099 12 -12.2 631.3045 2 47.45 6 22829 VEV_3_3_RA6_01_1237.d 4.61E5 5 5 343 354
R.KDPDLNHEYLPIAGLAEFTSAAQK.L Y 63.21 2627.3230 24 -9.9 657.8315 4 82.07 6 46585 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 111 134
K.GLDIDGMLN(+.98)GLR.S Y 58.22 1273.6337 12 -5.8 637.8204 2 81.08 4 47846 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 213 224 Deamidation (NQ)
K.GLDIDGMLNGLR.S Y 57.10 1272.6497 12 -14.6 637.3228 2 83.59 6 47570 VEV_3_3_RA6_01_1237.d 5.77E5 3 3 213 224
R.SAPHGSIVLLHAC(+57.02)AHNPTGVDPTR.A Y 55.62 2506.2500 24 -11.5 502.2515 5 63.89 6 33289 VEV_3_3_RA6_01_1237.d 1.88E5 1 1 225 248 Carbamidomethylation
R.AVTFQTISGTGAVHLGGLFLSK.F Y 52.96 2203.2000 22 -57.6 735.3650 3 83.62 6 47621 VEV_3_3_RA6_01_1237.d 0 2 2 149 170
K.LVLGADSPAIR.E Y 49.94 1110.6396 11 -16.4 556.3180 2 66.89 6 35539 VEV_3_3_RA6_01_1237.d 5.03E5 4 4 135 145
R.ISMAGLNTHNIDYFAEAVDSVVREIA Y 49.33 2834.3909 26 -11.0 945.7939 3 95.52 5 54439 VEV_2_3_RA5_01_1236.d 8.82E4 1 1 437 462
R.TASYPYYSPATK(+14.02).G Y 45.32 1361.6503 12 -7.5 681.8273 2 61.77 4 32815 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 201 212 Methylation(KR)
K.APEDPLFGLKR.A Y 43.32 1241.6768 11 -4.5 414.8977 3 67.56 4 37284 VEV_1_3_RA4_01_1235.d 2.75E5 3 3 61 71
K.NFGLYGER.A Y 41.18 954.4559 8 -15.3 478.2279 2 61.53 6 31546 VEV_3_3_RA6_01_1237.d 1.85E5 1 1 305 312
R.IASLVLNDPVLYKEWEENLREMSGR.I Y 38.77 2960.5066 25 -4.3 741.1307 4 86.26 5 49886 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 355 379
R.SE(+14.02)ISNPPAYGAR.I Y 38.40 1274.6255 12 -14.9 638.3105 2 56.79 6 28233 VEV_3_3_RA6_01_1237.d 9.75E4 1 1 343 354 Methylation(others)
K.Q(+.98)IAAVMR.E Y 24.12 788.4214 7 -10.1 395.2140 2 39.23 4 18236 VEV_1_3_RA4_01_1235.d 0 1 1 253 259 Deamidation (NQ)
K.LVLGADSPAIREK.R Y 21.41 1367.7772 13 -62.5 456.9045 3 61.04 4 32267 VEV_1_3_RA4_01_1235.d 3.02E4 1 1 135 147
R.KDPDLNHEYLPIAGLAEFTSAAQKLVLGADSPAIR.E Y 17.42 3719.9521 35 47.1 745.0327 5 91.79 6 52209 VEV_3_3_RA6_01_1237.d 0 1 1 111 145
MAHPLDSPR.F Y 15.06 1022.4967 9 -26.6 512.2420 2 14.08 6 4469 VEV_3_3_RA6_01_1237.d 4.63E4 1 1 1 9
total 21 peptides
C1G5Y7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VAGDSASQYLLQQVLSNPSAAASSR.L Y 142.16 2519.2615 25 -5.6 1260.6310 2 83.80 4 49774 VEV_1_3_RA4_01_1235.d 1.26E5 3 3 454 478
K.TFDDYNQIADGK.M Y 131.83 1385.6099 12 -8.7 693.8062 2 64.32 4 34750 VEV_1_3_RA4_01_1235.d 1.57E5 4 4 357 368
R.LGGSSLLGC(+57.02)VVYGR.V Y 96.62 1436.7445 14 -11.6 719.3712 2 78.46 5 45032 VEV_2_3_RA5_01_1236.d 2.91E5 4 4 440 453 Carbamidomethylation
K.SIQAAPVPTAAAGK.S Y 75.34 1280.7087 14 -12.6 641.3536 2 54.57 5 27938 VEV_2_3_RA5_01_1236.d 3.93E5 7 7 510 523
R.LGGHSFPR.T Y 47.65 869.4507 8 -12.8 435.7271 2 32.02 5 14432 VEV_2_3_RA5_01_1236.d 7.86E5 4 4 113 120
K.ASNVLDFHTR.H Y 47.10 1158.5781 10 -10.2 387.1960 3 55.98 5 28753 VEV_2_3_RA5_01_1236.d 8.08E5 5 5 318 327
K.ATSGINGALTR.T Y 46.85 1059.5673 11 -10.4 530.7854 2 42.62 5 20719 VEV_2_3_RA5_01_1236.d 2.51E5 2 2 44 54
K.WRPDTYNLPSTNGVHATGDGQK.M Y 46.56 2413.1411 22 3.9 604.2949 4 64.30 5 34751 VEV_2_3_RA5_01_1236.d 4.09E4 1 1 209 230
K.EIGC(+57.02)GEAALKK.T Y 40.82 1174.6016 11 -18.0 588.2975 2 32.12 6 14044 VEV_3_3_RA6_01_1237.d 4.6E4 2 2 346 356 Carbamidomethylation
K.ATSGIN(+.98)GALTR.T Y 35.78 1060.5513 11 -16.0 531.2744 2 43.31 6 20417 VEV_3_3_RA6_01_1237.d 2.88E5 2 2 44 54 Deamidation (NQ)
K.WKFLAAEALR.G Y 32.91 1203.6764 10 -10.0 402.2287 3 72.28 5 40700 VEV_2_3_RA5_01_1236.d 3.3E5 2 2 262 271
R.LILNSK.A Y 32.07 686.4327 6 -26.1 344.2147 2 32.72 6 14372 VEV_3_3_RA6_01_1237.d 1.52E5 1 1 312 317
R.L(+226.08)GGHSFPR.T Y 24.03 1095.5283 8 -14.9 366.1779 3 22.41 5 9022 VEV_2_3_RA5_01_1236.d 9.9E4 1 1 113 120 Biotinylation
K.ARVTAVNK.E Y 21.16 857.5083 8 -11.4 429.7565 2 13.94 4 4267 VEV_1_3_RA4_01_1235.d 4.12E4 1 1 159 166
R.TQTELGIADSVK.Q Y 20.99 1260.6561 12 5.1 421.2281 3 47.11 5 23400 VEV_2_3_RA5_01_1236.d 3.36E5 4 4 55 66
K.MLMAIGANGIDMDK.V Y 20.89 1478.6931 14 1.8 740.3552 2 73.01 5 41181 VEV_2_3_RA5_01_1236.d 8.86E4 1 1 231 244
K.EIGC(+57.02)GEAALK.K Y 19.31 1046.5066 10 3.4 524.2623 2 18.56 4 6657 VEV_1_3_RA4_01_1235.d 0 1 1 346 355 Carbamidomethylation
R.G(+42.01)EGGLLLNSDGQR.F Y 18.80 1356.6633 13 -15.8 453.2213 3 21.06 6 8132 VEV_3_3_RA6_01_1237.d 0 1 1 272 284 Acetylation (N-term)
K.SAAPAK.A Y 18.10 543.3016 6 -87.3 544.2615 1 41.07 5 19757 VEV_2_3_RA5_01_1236.d 2.36E5 2 2 524 529
K.YAAGIVIGR.V Y 17.11 918.5287 9 -13.9 307.1793 3 23.90 4 9499 VEV_1_3_RA4_01_1235.d 0 1 1 610 618
K.TFDDYNQIADGKM(+15.99)QDPFGK.K Y 16.53 2204.9685 19 12.3 1103.5051 2 90.75 4 54077 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 357 375 Oxidation (M)
total 21 peptides
C1G0S7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AHVNDNLGDSQGK.S Y 126.26 1353.6273 13 -7.1 677.8161 2 18.43 5 6886 VEV_2_3_RA5_01_1236.d 8.25E4 3 3 741 753
R.TLFPEYC(+57.02)PEFEEEDFVINDPIAK.I Y 104.61 2801.2781 23 -12.3 1401.6290 2 88.70 6 50630 VEV_3_3_RA6_01_1237.d 5.22E4 1 1 308 330 Carbamidomethylation
R.LGTDSNNQNTTTNSHDATVDIPLTTVSSR.G Y 101.60 3058.4438 29 -5.2 1020.4833 3 70.71 5 39513 VEV_2_3_RA5_01_1236.d 4.05E5 3 3 19 47
K.GGAGSPKQNVNSSIQR.V Y 79.06 1598.8125 16 -11.4 533.9387 3 24.10 5 9989 VEV_2_3_RA5_01_1236.d 1.38E5 2 2 825 840
R.VGDKITAAFGNVAQEITGK.Q Y 75.09 1918.0160 19 -8.0 640.3408 3 81.35 4 48052 VEV_1_3_RA4_01_1235.d 1.81E5 2 2 353 371
K.VGSKGGAGSPKQNVNSSIQR.V Y 64.96 1970.0293 20 -13.1 657.6751 3 24.15 5 9991 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 821 840
R.LVPTDEVDEYLR.A Y 64.16 1447.7195 12 -12.5 724.8580 2 77.36 6 43270 VEV_3_3_RA6_01_1237.d 1.65E5 2 2 729 740
R.HLESAEDGTITR.M Y 58.98 1327.6367 12 -32.1 664.8043 2 33.35 4 14778 VEV_1_3_RA4_01_1235.d 0 3 3 101 112
R.VDESEIFREDFTTSPINHPSVK.V Y 53.74 2546.2288 22 -19.4 637.5521 4 76.13 6 42364 VEV_3_3_RA6_01_1237.d 1.66E5 2 2 799 820
R.VGDKITAAFGN(+.98)VAQEITGK.Q Y 53.45 1919.0000 19 -0.7 640.6735 3 81.33 4 48038 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 353 371 Deamidation (NQ)
R.AHVNDNLGDSQGKSSAVQAK.T Y 50.11 2024.9875 20 -17.3 507.2454 4 28.97 5 12671 VEV_2_3_RA5_01_1236.d 1E5 2 2 741 760
K.TPGGTTVYR.G Y 47.20 950.4821 9 -17.8 476.2399 2 28.32 5 12357 VEV_2_3_RA5_01_1236.d 3.66E5 2 2 761 769
K.ITAAFGNVAQEITGK.Q Y 41.44 1518.8042 15 -27.2 760.3887 2 77.90 4 45402 VEV_1_3_RA4_01_1235.d 3.21E4 2 2 357 371
K.G(+42.01)GAGSPK.Q Y 37.98 614.3024 7 16.7 615.3199 1 67.40 6 35937 VEV_3_3_RA6_01_1237.d 0 1 1 825 831 Acetylation (N-term)
K.GGAGSPK.Q Y 29.04 572.2918 7 12.1 573.3060 1 53.32 6 26261 VEV_3_3_RA6_01_1237.d 0 1 1 825 831
R.DKENSR.D Y 26.90 747.3511 6 21.1 748.3741 1 91.33 4 54409 VEV_1_3_RA4_01_1235.d 0 1 1 624 629
K.SSAVQ(+.98)AK(+42.01).T Y 22.85 732.3654 7 -3.8 733.3699 1 78.28 6 43929 VEV_3_3_RA6_01_1237.d 0 1 1 754 760 Deamidation (NQ); Acetylation (K)
K.VGSKGGAGSPK(+143.06).Q Y 21.61 1086.5669 11 -18.7 544.2806 2 71.03 6 38624 VEV_3_3_RA6_01_1237.d 8.7E4 1 1 821 831 Nethylmaleimidehydrolysis
R.RTGGASSGTPAR.F Y 20.28 1116.5636 12 -7.6 559.2849 2 53.79 6 26523 VEV_3_3_RA6_01_1237.d 1.48E5 2 2 847 858
R.VISTGRRTGGASSGTPAR.F Y 18.32 1729.9183 18 2.6 577.6482 3 43.62 4 20912 VEV_1_3_RA4_01_1235.d 9.85E4 1 1 841 858
K.QNVNSSIQR.V Y 17.77 1044.5312 9 -67.3 523.2377 2 39.43 6 18163 VEV_3_3_RA6_01_1237.d 3.35E4 4 4 832 840
R.VDIGDR.Q Y 17.39 673.3395 6 -23.1 674.3312 1 74.31 4 42592 VEV_1_3_RA4_01_1235.d 7E4 1 1 545 550
R.LIHGVGR.V Y 17.25 750.4500 7 -19.9 376.2248 2 22.38 6 8805 VEV_3_3_RA6_01_1237.d 1.65E5 2 2 346 352
R.KSSEALAR.R Y 16.71 860.4716 8 -72.0 431.2121 2 23.78 4 9436 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 391 398
R.DQKTFQAPNIILNTQWIENVTRSK.A Y 15.45 2843.4929 24 -13.1 711.8712 4 93.66 4 55642 VEV_1_3_RA4_01_1235.d 0 1 1 569 592
K.QGGHR.M Y 15.29 553.2721 5 -17.1 554.2699 1 36.19 5 16883 VEV_2_3_RA5_01_1236.d 6.08E4 1 1 89 93
R.TGGASSGTPAR.F Y 15.22 960.4625 11 10.5 481.2435 2 58.48 5 30440 VEV_2_3_RA5_01_1236.d 8.06E4 1 1 848 858
R.R(+14.02)T(+79.97)GGAS(+79.97)SGTPAR.F Y 15.07 1290.5118 12 101.0 323.6678 4 17.08 4 5865 VEV_1_3_RA4_01_1235.d 1.76E5 1 1 847 858 Methylation(KR); Phosphorylation (STY)
total 28 peptides
C1GB79
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSDLALDLLEKLLAFNPVKR.I Y 135.01 2255.2888 20 -8.2 564.8248 4 94.27 4 55969 VEV_1_3_RA4_01_1235.d 5.86E5 4 4 274 293
R.SAASTDDNSGFMTEYVATR.W Y 124.46 2021.8636 19 -6.4 1011.9326 2 72.58 4 41258 VEV_1_3_RA4_01_1235.d 2.14E5 3 3 165 183
R.TQDLSDDHC(+57.02)QYFIYQTLR.A Y 111.53 2302.0325 18 -5.1 768.3475 3 76.84 4 44570 VEV_1_3_RA4_01_1235.d 1.96E5 3 3 110 127 Carbamidomethylation
R.DLKPSNLLLNANC(+57.02)DLK.V Y 79.27 1826.9561 16 -16.1 609.9828 3 76.85 6 42887 VEV_3_3_RA6_01_1237.d 9E4 1 1 141 156 Carbamidomethylation
K.TSDLALDLLE(+14.02)KLLAFNPVKR.I Y 73.48 2269.3044 20 -8.7 568.3284 4 94.82 4 56204 VEV_1_3_RA4_01_1235.d 7.99E4 1 1 274 293 Methylation(others)
K.TSDLALDLLEK.L Y 63.27 1216.6550 11 -12.9 609.3270 2 79.59 4 46708 VEV_1_3_RA4_01_1235.d 7.12E4 1 1 274 284
R.NYESFTEVYLIQELMETDMHR.V Y 62.49 2647.1934 21 -7.8 883.3982 3 90.25 4 53795 VEV_1_3_RA4_01_1235.d 3.76E4 1 1 86 106
K.VLIFEEIMR Y 54.44 1148.6263 9 -13.6 575.3126 2 83.90 4 49840 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 341 349
K.VC(+57.02)DFGLAR.S Y 44.41 936.4487 8 -11.3 469.2263 2 61.02 5 32303 VEV_2_3_RA5_01_1236.d 1.68E5 2 2 157 164 Carbamidomethylation
K.ITPFDHSMFC(+57.02)LR.T Y 39.03 1522.7061 12 -3.1 508.5744 3 78.75 6 44260 VEV_3_3_RA6_01_1237.d 2.09E4 1 1 48 59 Carbamidomethylation
K.LLAFNPVKR.I Y 35.80 1056.6444 9 -16.0 353.2164 3 63.36 4 34029 VEV_1_3_RA4_01_1235.d 6.73E4 1 1 285 293
MALGGSR.K Y 34.05 690.3483 7 7.9 691.3610 1 91.19 4 54323 VEV_1_3_RA4_01_1235.d 2.44E5 4 4 1 7
R.APEIMLTFKEYTK.A Y 33.44 1569.8113 13 -5.4 524.2749 3 76.06 4 43962 VEV_1_3_RA4_01_1235.d 4.36E4 1 1 187 199
K.DSLS(+120.03)KEQLKVLIFEEIMR Y 18.91 2297.2104 18 8.5 575.3148 4 83.84 5 48480 VEV_2_3_RA5_01_1236.d 1.26E5 2 2 332 349 O-Isopropylmethylphosphonylation
R.ISVEDALR.H Y 18.16 901.4869 8 0.6 451.7510 2 62.80 5 33635 VEV_2_3_RA5_01_1236.d 6.53E4 1 1 294 301
total 15 peptides
C1GLJ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NMVESAAIRDISDASVFPDYAVPK.M Y 126.91 2594.2686 24 -6.5 865.7578 3 83.16 4 49352 VEV_1_3_RA4_01_1235.d 1.21E6 8 8 43 66
R.DISDASVFPDYAVPK.M Y 107.27 1622.7827 15 -14.8 812.3866 2 80.17 6 45278 VEV_3_3_RA6_01_1237.d 2.8E6 6 6 52 66
R.NM(+15.99)VESAAIRDISDASVFPDYAVPK.M Y 104.44 2610.2634 24 -6.4 871.0895 3 81.47 4 48157 VEV_1_3_RA4_01_1235.d 5.6E5 3 3 43 66 Oxidation (M)
K.LQYC(+57.02)VSC(+57.02)AIHGK.I Y 99.11 1434.6748 12 -10.2 479.2274 3 57.98 4 30032 VEV_1_3_RA4_01_1235.d 4.8E6 13 13 71 82 Carbamidomethylation
K.MYLKLQYC(+57.02)VSC(+57.02)AIHGK.I Y 93.73 1969.9576 16 -10.1 657.6532 3 71.95 5 40444 VEV_2_3_RA5_01_1236.d 3.9E5 4 4 67 82 Carbamidomethylation
K.SNPTQAAKAAQA Y 67.95 1156.5836 12 -9.9 579.2933 2 22.39 5 9011 VEV_2_3_RA5_01_1236.d 1.28E5 3 3 110 121
R.GHVKPIR.C Y 66.40 805.4922 7 -9.5 403.7496 2 11.49 4 3069 VEV_1_3_RA4_01_1235.d 1E6 3 3 16 22
R.DISDASVFPDYAVPK(+14.02).M Y 60.61 1636.7983 15 -13.3 819.3956 2 81.84 6 46433 VEV_3_3_RA6_01_1237.d 3.84E5 2 2 52 66 Methylation(KR)
K.LQYC(+57.02)VSC(+57.02)AIHGK(+14.02).I Y 59.63 1448.6904 12 2.8 483.9055 3 60.89 4 32153 VEV_1_3_RA4_01_1235.d 1.04E6 6 6 71 82 Carbamidomethylation; Methylation(KR)
K.LQ(+.98)YC(+57.02)VSC(+57.02)AIHGK.I Y 58.56 1435.6588 12 0.8 479.5606 3 58.21 4 30153 VEV_1_3_RA4_01_1235.d 1.04E6 3 3 71 82 Deamidation (NQ); Carbamidomethylation
K.KSNPTQAAKAAQA Y 57.23 1284.6786 13 -9.6 643.3404 2 14.99 5 5072 VEV_2_3_RA5_01_1236.d 4.26E4 1 1 109 121
R.FTIRNMVESAAIR.D Y 54.30 1506.7976 13 -16.0 503.2651 3 75.42 5 42885 VEV_2_3_RA5_01_1236.d 0 1 1 39 51
K.GRGHVKPIR.C Y 51.47 1018.6148 9 -17.9 510.3055 2 12.61 4 3609 VEV_1_3_RA4_01_1235.d 9.31E5 7 7 14 22
R.NM(+15.99)VESAAIR.D Y 50.52 1005.4913 9 -14.9 503.7455 2 30.30 6 13027 VEV_3_3_RA6_01_1237.d 2.19E6 20 20 43 51 Oxidation (M)
R.NRAPPPR.I Y 50.02 806.4510 7 -19.0 404.2252 2 9.13 6 2186 VEV_3_3_RA6_01_1237.d 3.45E5 5 5 94 100
R.NMVESAAIRDISDASVFPDYAVPK(+14.02).M Y 49.62 2608.2842 24 -10.6 870.4261 3 83.94 6 47856 VEV_3_3_RA6_01_1237.d 9.15E4 1 1 43 66 Methylation(KR)
R.NMVESAAIR.D Y 47.88 989.4964 9 -11.2 495.7499 2 49.51 4 24573 VEV_1_3_RA4_01_1235.d 3.02E6 7 7 43 51
K.KSNPTQAAK.A Y 42.81 943.5087 9 -11.2 472.7563 2 8.22 5 1934 VEV_2_3_RA5_01_1236.d 5.61E3 2 2 109 117
K.KSNPTQAAK(+14.02).A Y 36.79 957.5243 9 -13.9 479.7628 2 10.17 6 2571 VEV_3_3_RA6_01_1237.d 2.03E4 1 1 109 117 Methylation(KR)
R.N(+.98)MVESAAIR.D Y 36.23 990.4804 9 6.2 496.2505 2 49.49 4 24566 VEV_1_3_RA4_01_1235.d 9E4 1 1 43 51 Deamidation (NQ)
R.NM(-48.00)VESAAIR.D Y 34.71 941.4930 9 -9.0 471.7496 2 17.52 4 6092 VEV_1_3_RA4_01_1235.d 9.15E5 2 2 43 51 Dethiomethyl
R.YNRDAKKSNPTQAAK.A Y 30.53 1690.8750 15 -6.2 564.6288 3 11.27 5 3098 VEV_2_3_RA5_01_1236.d 1.6E4 1 1 103 117
R.RNRAPPPR.I Y 30.07 962.5522 8 -14.8 321.8532 3 9.38 5 2283 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 93 100
R.DAKKSNPTQAAK.A Y 25.09 1257.6677 12 -24.1 420.2197 3 8.87 5 2103 VEV_2_3_RA5_01_1236.d 1.83E4 1 1 106 117
R.DISDASVFPDYAVPKM(+15.99)YLK.L Y 22.35 2174.0605 19 -52.9 725.6558 3 80.60 6 45586 VEV_3_3_RA6_01_1237.d 0 1 1 52 70 Oxidation (M)
R.C(+58.01)TPKDKAIKR.F Y 18.49 1216.6598 10 -12.8 406.5554 3 11.33 5 3122 VEV_2_3_RA5_01_1236.d 2.43E4 1 1 29 38 Carboxymethyl
R.N(+15.00)MVESAAIR.D Y 17.87 1004.4961 9 -3.8 503.2534 2 41.32 4 19501 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 43 51 Deamidation followed by a methylation
K.K(+43.01)GR(+14.02)GHVKPIR.C Y 17.23 1203.7312 10 -89.1 402.2152 3 11.36 5 3141 VEV_2_3_RA5_01_1236.d 3.79E4 1 1 13 22 Carbamylation; Methylation(KR)
R.GHVKPIR(+14.02).C Y 16.89 819.5079 7 -81.0 410.7280 2 15.76 6 5350 VEV_3_3_RA6_01_1237.d 0 1 1 16 22 Methylation(KR)
R.DISDAS(-18.01)VFPDYAVPK(+14.02).M Y 16.86 1618.7878 15 -4.5 810.3976 2 80.15 6 45270 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 52 66 Dehydration; Methylation(KR)
R.N(+.98)M(+15.99)VESAAIR.D Y 16.65 1006.4753 9 -5.5 504.2422 2 39.07 6 17963 VEV_3_3_RA6_01_1237.d 0 1 1 43 51 Deamidation (NQ); Oxidation (M)
R.N(+42.01)(+.98)MVESAAIR(+14.02)DISDASVFPDYAVPK.M Y 16.43 2651.2788 24 -4.2 663.8242 4 77.87 5 44688 VEV_2_3_RA5_01_1236.d 2.64E5 1 1 43 66 Acetylation (N-term); Deamidation (NQ); Methylation(KR)
R.C(+57.02)T(-18.01)PKDKAIKR.F Y 15.97 1197.6652 10 -29.9 400.2171 3 19.48 5 7502 VEV_2_3_RA5_01_1236.d 0 1 1 29 38 Carbamidomethylation; Dehydration
total 33 peptides
A0A0A0HQN9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DVDAQKFIAAYSAFLKR.Q Y 123.93 1942.0311 17 -11.0 648.3439 3 84.11 4 50061 VEV_1_3_RA4_01_1235.d 1.08E6 7 7 8 24
R.GSRPSHHVEGSGSVDRK.V Y 91.37 1790.8772 17 -8.3 448.7228 4 12.40 4 3495 VEV_1_3_RA4_01_1235.d 8.74E5 10 10 86 102
R.DVDAQKFIAAYSAFLK.R Y 87.76 1785.9301 16 -5.5 596.3140 3 87.20 4 52002 VEV_1_3_RA4_01_1235.d 4.01E4 2 2 8 23
R.IAKTTVEEEEEE Y 86.94 1405.6460 12 -7.8 703.8248 2 35.74 5 16630 VEV_2_3_RA5_01_1236.d 2.89E5 3 3 135 146
R.GSRPSHHVEGSGSVDR.K Y 86.76 1662.7822 16 -15.9 555.2592 3 13.32 6 4083 VEV_3_3_RA6_01_1237.d 3.97E5 9 9 86 101
R.ANELPPQSIDWYYIR.A Y 86.40 1863.9155 15 -13.2 932.9528 2 81.58 6 46262 VEV_3_3_RA6_01_1237.d 7.73E5 9 9 42 56
M.GGVTVRDVDAQKFIAAYSAFLKR.Q Y 84.22 2511.3596 23 -12.7 628.8392 4 82.06 5 47385 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 2 24
R.Q(-17.03)GKLPIPGWVDTVK.T Y 78.35 1519.8398 14 -5.7 760.9229 2 81.83 4 48412 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 25 38 Pyro-glu from Q
R.QGKLPIPGWVDTVK.T Y 71.90 1536.8663 14 -12.7 513.2896 3 76.14 4 44021 VEV_1_3_RA4_01_1235.d 3.46E5 2 2 25 38
K.IGVLELDEEKGGRR.I Y 59.65 1569.8474 14 -15.9 393.4629 4 57.97 6 29003 VEV_3_3_RA6_01_1237.d 5.52E5 2 2 110 123
K.IGVLELDEEKGGR.R Y 54.16 1413.7463 13 -16.3 472.2484 3 63.72 6 33161 VEV_3_3_RA6_01_1237.d 7.22E5 3 3 110 122
K.LPIPGWVDTVK.T Y 49.32 1223.6914 11 -18.3 612.8418 2 80.14 6 45262 VEV_3_3_RA6_01_1237.d 2.42E4 1 1 28 38
K.IGVLELDEEKGGR(+14.02)R.I Y 45.61 1583.8630 14 -34.1 396.9595 4 62.64 4 33478 VEV_1_3_RA4_01_1235.d 0 1 1 110 123 Methylation(KR)
K.VIQSLEK.I Y 39.90 815.4752 7 -19.9 408.7368 2 29.41 6 12543 VEV_3_3_RA6_01_1237.d 5.3E5 3 3 103 109
M.GGVTVR(+72.02)DVDAQKFIAAYSAFLKR.Q Y 30.60 2583.3809 23 -22.5 646.8380 4 83.89 6 47760 VEV_3_3_RA6_01_1237.d 0 2 2 2 24 Dihydroxy methylglyoxal adduct
R.AASIAR.H N 26.02 587.3391 6 -15.5 588.3373 1 18.47 4 6611 VEV_1_3_RA4_01_1235.d 0 1 1 57 62
R.ITQSGQRDLDR.I Y 23.94 1287.6531 11 -12.1 644.8260 2 18.87 5 7128 VEV_2_3_RA5_01_1236.d 3.41E4 1 1 124 134
K.IGVLELDEEKGGR(+14.02).R Y 23.47 1427.7620 13 -7.0 476.9246 3 67.60 6 36085 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 110 122 Methylation(KR)
R.GSRPSHHVEGS(-2.02)GSVDR.K Y 22.61 1660.7666 16 74.1 416.2297 4 13.35 4 3984 VEV_1_3_RA4_01_1235.d 0 1 1 86 101 2-amino-3-oxo-butanoic_acid
K.NRGSRPSHHVEGSGSVDR.K Y 20.79 1932.9263 18 0.7 484.2392 4 14.92 6 4905 VEV_3_3_RA6_01_1237.d 9.2E4 1 1 84 101
R.HIYLRK.T Y 20.33 828.4969 6 -41.9 415.2384 2 17.35 4 6012 VEV_1_3_RA4_01_1235.d 0 2 2 63 68
MGGVTVR.D Y 19.98 718.3796 7 -0.5 360.1969 2 30.60 4 13186 VEV_1_3_RA4_01_1235.d 0 1 1 1 7
K.FIAAYSAFLK.R Y 18.20 1129.6172 10 -22.5 565.8032 2 64.64 5 35007 VEV_2_3_RA5_01_1236.d 6.44E4 1 1 14 23
R.ITQSGQR.D Y 15.87 788.4141 7 0.0 395.2143 2 10.46 5 2706 VEV_2_3_RA5_01_1236.d 0 1 1 124 130
K.AHGSQKNR.G Y 15.68 896.4576 8 -36.8 449.2196 2 28.97 5 12674 VEV_2_3_RA5_01_1236.d 0 1 1 78 85
R.HIYLR.K Y 15.16 700.4020 5 -9.4 351.2050 2 24.44 4 9811 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 63 67
total 26 peptides
C1G561
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KQTAAPAPAPAPAPAPAPLLSPSLIDLR.V Y 139.92 2730.5432 28 -21.1 911.1691 3 81.58 6 46261 VEV_3_3_RA6_01_1237.d 1.61E5 3 3 228 255
R.SDDAHAGPVELVSPPADAHAGER.V Y 105.82 2297.0671 23 -3.0 575.2723 4 62.82 6 32546 VEV_3_3_RA6_01_1237.d 3.45E5 2 2 345 367
K.EKKPTGQGGGNVSAEK.N Y 101.45 1585.8059 16 -4.4 529.6069 3 11.21 4 2950 VEV_1_3_RA4_01_1235.d 8.45E4 4 4 179 194
R.AVPSTSIDLDLQTISPK.V Y 96.52 1783.9567 17 -8.8 892.9778 2 79.93 4 46964 VEV_1_3_RA4_01_1235.d 1.57E5 3 3 22 38
R.GKDVAAGVVDPAAR.E Y 77.26 1324.7098 14 -65.3 663.3190 2 46.28 5 22896 VEV_2_3_RA5_01_1236.d 3.37E5 7 7 201 214
M.A(+42.01)TNSAPMASLLSLLYR.S Y 48.38 1748.9131 16 -6.4 875.4583 2 97.71 5 55274 VEV_2_3_RA5_01_1236.d 1.49E5 2 2 2 17 Acetylation (Protein N-term)
K.AVEPPRDEKEK.K Y 41.47 1296.6674 11 -10.3 649.3343 2 12.93 5 3924 VEV_2_3_RA5_01_1236.d 1.39E4 1 1 165 175
R.YIDFVQNAPLFGLK.I Y 37.48 1623.8660 14 -11.0 812.9313 2 86.53 4 51580 VEV_1_3_RA4_01_1235.d 4.54E4 2 2 132 145
K.QTQPK.Q Y 35.62 600.3231 5 -13.7 601.3221 1 21.65 6 8420 VEV_3_3_RA6_01_1237.d 0 1 1 221 225
K.SAAMVLAASPR.S Y 31.29 1072.5698 11 -16.4 537.2834 2 72.67 6 39846 VEV_3_3_RA6_01_1237.d 9.61E4 1 1 334 344
K.EGEVSATPATPAVGK.L Y 22.77 1412.7147 15 -1.8 354.1853 4 9.87 5 2466 VEV_2_3_RA5_01_1236.d 1.4E4 2 2 418 432
K.SAAM(+15.99)VLAASPR.S Y 20.52 1088.5648 11 33.7 363.8745 3 54.31 6 26850 VEV_3_3_RA6_01_1237.d 5.13E4 1 1 334 344 Oxidation (M)
K.DVAAGVVDPAAR.E Y 19.15 1139.5934 12 7.3 380.8745 3 36.31 4 16519 VEV_1_3_RA4_01_1235.d 4.98E4 1 1 203 214
K.AVEPPRDEK.E Y 19.10 1039.5298 9 -2.3 520.7710 2 33.75 5 15427 VEV_2_3_RA5_01_1236.d 0 1 1 165 173
K.KPTGQGGGNVSAEK.N Y 18.78 1328.6685 14 3.3 333.1755 4 33.70 4 14987 VEV_1_3_RA4_01_1235.d 0 2 2 181 194
K.AVEPPR.D Y 18.42 667.3653 6 -29.9 334.6799 2 33.55 6 14825 VEV_3_3_RA6_01_1237.d 2.04E5 4 4 165 170
R.GIKSAAM(+15.99)VLAASPR.S Y 18.12 1386.7653 14 -3.0 463.2610 3 72.69 4 41343 VEV_1_3_RA4_01_1235.d 3.52E4 1 1 331 344 Oxidation (M)
K.LVTKSGGVC(+57.02)TVK.S Y 18.04 1247.6908 12 71.8 416.9341 3 66.18 6 35022 VEV_3_3_RA6_01_1237.d 0 1 1 433 444 Carbamidomethylation
R.GIKSAAMVLAASPR.S Y 15.15 1370.7704 14 -7.5 457.9273 3 62.51 5 33420 VEV_2_3_RA5_01_1236.d 0 1 1 331 344
total 19 peptides
C1GEU2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVFHPEFLNSSNPVLPLDYDDFVR.G Y 111.54 2818.3965 24 -8.3 940.4650 3 87.78 5 50741 VEV_2_3_RA5_01_1236.d 4.67E5 5 5 465 488
R.AYPSSFDPAEDFSDIIGGTEQK.I Y 111.32 2373.0647 22 -5.5 1187.5331 2 86.28 5 49895 VEV_2_3_RA5_01_1236.d 3.74E5 5 5 606 627
R.AAAHSADVFTTVSHITAFESEHLLK.R Y 86.17 2681.3450 25 -17.1 537.2671 5 81.23 6 46017 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 233 257
K.APVTTAEYGER.Y Y 76.05 1192.5724 11 -17.8 597.2828 2 38.32 6 17533 VEV_3_3_RA6_01_1237.d 1.94E5 5 5 38 48
R.VQLFNHPSDR.V Y 73.85 1211.6047 10 -14.8 606.8007 2 46.51 6 22276 VEV_3_3_RA6_01_1237.d 2.54E5 2 2 453 462
R.YTLIGPLNR.S Y 72.64 1045.5920 9 -16.7 523.7946 2 71.55 6 39048 VEV_3_3_RA6_01_1237.d 3.51E5 3 3 49 57
R.VVLIDTGAGYK.Y Y 71.82 1134.6284 11 -18.5 568.3110 2 65.87 6 34780 VEV_3_3_RA6_01_1237.d 3.33E5 3 3 101 111
K.SKAPVTTAEYGER.Y Y 69.01 1407.6993 13 -15.5 704.8461 2 31.55 6 13733 VEV_3_3_RA6_01_1237.d 8.84E5 7 7 36 48
R.WLIEGAPR.V Y 56.65 940.5130 8 -19.8 471.2545 2 68.80 6 36983 VEV_3_3_RA6_01_1237.d 4.19E5 4 4 93 100
R.NKGVDMFIESLAR.L Y 56.55 1478.7551 13 -17.7 493.9169 3 78.37 4 45772 VEV_1_3_RA4_01_1235.d 6.01E4 1 1 322 334
K.GVDMFIESLAR.L Y 44.36 1236.6172 11 -9.0 619.3103 2 82.50 6 46864 VEV_3_3_RA6_01_1237.d 1E5 1 1 324 334
R.HMDVTTIFTTHATLLGR.Y Y 39.43 1912.9829 17 -15.2 479.2457 4 79.51 5 45731 VEV_2_3_RA5_01_1236.d 9.25E4 1 1 181 197
K.ISRPFSVPGSPR.D Y 35.34 1298.7095 12 -6.9 433.9074 3 60.67 6 30925 VEV_3_3_RA6_01_1237.d 5.5E4 2 2 628 639
R.VGGIYSVLK.S Y 34.00 934.5487 9 -17.1 312.5182 3 33.96 6 15045 VEV_3_3_RA6_01_1237.d 1.94E5 1 1 27 35
R.YC(+57.02)IER.A N 32.09 739.3323 5 -17.7 370.6669 2 28.92 6 12287 VEV_3_3_RA6_01_1237.d 7.48E5 4 4 228 232 Carbamidomethylation
R.GVDMIYGR.W Y 30.63 909.4378 8 -14.1 455.7198 2 59.29 5 31022 VEV_2_3_RA5_01_1236.d 9.04E4 1 1 85 92
K.ERGVDM(+15.99)IYGR.W Y 28.75 1210.5764 10 -21.6 1211.5575 1 94.37 6 53347 VEV_3_3_RA6_01_1237.d 5.94E4 1 1 83 92 Oxidation (M)
R.NKGVDM(+15.99)FIESLAR.L Y 26.92 1494.7500 13 -13.2 748.3724 2 71.15 4 40122 VEV_1_3_RA4_01_1235.d 4.92E5 3 3 322 334 Oxidation (M)
R.TERLSDLLDWKR.M Y 26.81 1530.8154 12 -25.4 511.2661 3 19.47 4 7136 VEV_1_3_RA4_01_1235.d 0 2 2 579 590
R.LSDLLDWKR.M Y 25.21 1144.6240 9 13.5 382.5538 3 70.99 5 39757 VEV_2_3_RA5_01_1236.d 1.82E5 3 3 582 590
R.GIYHRYC(+57.02)IER.A Y 24.73 1365.6611 10 -3.6 456.2260 3 43.84 5 21415 VEV_2_3_RA5_01_1236.d 3.49E4 1 1 223 232 Carbamidomethylation
R.DTLEMVEQGIGK.R Y 23.49 1318.6438 12 6.6 660.3335 2 63.38 5 34076 VEV_2_3_RA5_01_1236.d 7.26E4 1 1 377 388
R.AVVAHFHEWLAGIALPLTK.K Y 20.92 2072.1570 19 -25.9 519.0331 4 84.01 4 49914 VEV_1_3_RA4_01_1235.d 5.07E4 1 1 160 178
R.NRTERLSDLLDWK.R Y 20.24 1644.8583 13 -10.0 412.2177 4 43.58 6 20564 VEV_3_3_RA6_01_1237.d 0 1 1 577 589
R.VQLFNHPSDRVK.V Y 19.77 1438.7681 12 -10.6 360.6955 4 48.79 5 24410 VEV_2_3_RA5_01_1236.d 5.6E5 2 2 453 464
K.GVDM(+15.99)FIESLAR.L Y 16.63 1252.6122 11 0.6 418.5449 3 28.41 6 11991 VEV_3_3_RA6_01_1237.d 7.29E4 1 1 324 334 Oxidation (M)
R.NRTERLSDLLDWKR.M Y 16.63 1800.9595 14 -6.0 451.2444 4 66.11 5 36108 VEV_2_3_RA5_01_1236.d 0 1 1 577 590
R.LSDLLDWK.R Y 16.18 988.5229 8 -27.9 495.2550 2 60.03 4 31537 VEV_1_3_RA4_01_1235.d 0 1 1 582 589
total 28 peptides
C1G3D9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASVGGAPINNSLGSGGSSGGYGGR.S Y 135.82 2077.9775 24 -17.5 693.6544 3 63.29 6 32851 VEV_3_3_RA6_01_1237.d 5.19E5 5 5 218 241
R.SYNRTGNGADFSDQTGGYSR.R Y 114.21 2151.9207 20 -10.8 718.3064 3 50.94 6 24838 VEV_3_3_RA6_01_1237.d 3.43E4 3 3 242 261
R.SYNRTGN(+.98)GADFSDQTGGYSR.R Y 93.12 2152.9045 20 2.5 718.6439 3 55.97 5 28748 VEV_2_3_RA5_01_1236.d 2.11E5 3 3 242 261 Deamidation (NQ)
R.TGNGADFSDQTGGYSR.R Y 90.56 1631.6812 16 -8.2 816.8411 2 50.41 4 25133 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 246 261
R.IVEVQGTPEGIEK.A Y 85.90 1397.7401 13 -12.9 699.8683 2 61.48 6 31510 VEV_3_3_RA6_01_1237.d 1.19E5 1 1 178 190
R.VLTVTGPLQGAAK.A Y 77.02 1253.7343 13 -24.0 627.8594 2 66.85 6 35515 VEV_3_3_RA6_01_1237.d 1.94E5 2 2 91 103
R.TGN(+.98)GADFSDQTGGYSR.R Y 73.30 1632.6652 16 2.4 817.3418 2 55.57 4 28370 VEV_1_3_RA4_01_1235.d 1.61E5 2 2 246 261 Deamidation (NQ)
R.GTGTVLYNPAVR.A Y 67.55 1246.6670 12 -10.5 624.3342 2 63.34 4 34007 VEV_1_3_RA4_01_1235.d 2.8E5 3 3 206 217
K.YIQDASGVR.M Y 54.87 1007.5036 9 -16.7 504.7507 2 33.35 6 14710 VEV_3_3_RA6_01_1237.d 1.9E5 1 1 155 163
K.SLLEGAPQLGMGGVVSNNGTHPVR.L Y 39.35 2389.2173 24 -14.4 797.4016 3 76.18 4 44051 VEV_1_3_RA4_01_1235.d 2.94E4 1 1 111 134
K.ALYLLYENLEAEK.M Y 32.36 1567.8134 13 -14.0 784.9030 2 81.45 6 46172 VEV_3_3_RA6_01_1237.d 1.77E4 1 1 343 355
K.N(+.98)VADLR.D Y 27.59 687.3551 6 -6.5 344.6826 2 34.29 4 15328 VEV_1_3_RA4_01_1235.d 2.54E5 1 1 66 71 Deamidation (NQ)
K.AGKNVADLR.D Y 26.24 942.5247 9 -29.0 315.1731 3 22.69 4 8828 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 63 71
K.AYAIVAK.S Y 24.39 734.4326 7 -42.8 368.2079 2 35.86 6 16155 VEV_3_3_RA6_01_1237.d 7.29E4 1 1 104 110
R.IVEVQGTPEGIEK(+14.02).A Y 22.07 1411.7559 13 -15.8 706.8741 2 65.86 4 35951 VEV_1_3_RA4_01_1235.d 3.95E4 1 1 178 190 Methylation(KR)
K.AYAIVAKSLLEGAPQLGM(+15.99)GGVVSNNGTHPVR.L Y 21.64 3121.6343 31 -9.5 781.4084 4 83.88 4 49828 VEV_1_3_RA4_01_1235.d 0 1 1 104 134 Oxidation (M)
R.MVAQK.E Y 18.95 575.3101 5 -18.0 576.3071 1 66.71 5 36554 VEV_2_3_RA5_01_1236.d 5.82E4 1 1 164 168
K.C(+57.02)LIDDWQR.G Y 17.42 1104.5022 8 -14.8 553.2502 2 50.27 6 24442 VEV_3_3_RA6_01_1237.d 5.78E4 1 1 198 205 Carbamidomethylation
R.ISIAKAPHDETGERM(+15.99)FTIM(+15.99)GSAAANEK.A Y 16.15 2906.3901 27 -15.4 582.2764 5 20.09 5 7770 VEV_2_3_RA5_01_1236.d 0 1 1 316 342 Oxidation (M)
total 19 peptides
C1GGR5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LIDLHAPTETVK.Q Y 102.40 1335.7397 12 -14.0 668.8678 2 64.88 6 34050 VEV_3_3_RA6_01_1237.d 1.55E6 7 7 87 98
K.SLNVKGPVRLPTK.T Y 101.03 1407.8562 13 -23.1 704.9191 2 58.06 5 30203 VEV_2_3_RA5_01_1236.d 4.31E6 12 12 46 58
K.VASLEKVC(+57.02)QELIDR.A Y 92.33 1658.8661 14 -15.0 553.9543 3 74.91 6 41499 VEV_3_3_RA6_01_1237.d 5.37E5 4 4 28 41 Carbamidomethylation
R.KVASLEKVC(+57.02)QELIDR.A Y 88.54 1786.9611 15 -2.7 447.7463 4 70.10 5 39065 VEV_2_3_RA5_01_1236.d 8.88E5 5 5 27 41 Carbamidomethylation
K.DFSEGPKIHK.I Y 81.48 1156.5876 10 -9.6 579.2955 2 32.59 5 14766 VEV_2_3_RA5_01_1236.d 9.15E5 3 3 9 18
M.S(+42.01)FQKPEKDFSEGPK.I Y 77.97 1664.8046 14 -13.7 555.9345 3 58.80 6 29613 VEV_3_3_RA6_01_1237.d 1.97E6 7 7 2 15 Acetylation (Protein N-term)
M.S(+42.01)FQKPEKDFSEGPKIHK.I Y 72.09 2043.0425 17 -11.6 511.7620 4 57.70 6 28835 VEV_3_3_RA6_01_1237.d 3.08E5 2 2 2 18 Acetylation (Protein N-term)
R.KVASLEKVC(+57.02)QELIDRAR.S Y 69.57 2014.0992 17 -2.2 504.5310 4 70.50 5 39357 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 27 43 Carbamidomethylation
K.VC(+57.02)QELIDR.A Y 66.80 1031.5070 8 -14.2 516.7534 2 44.84 6 21361 VEV_3_3_RA6_01_1237.d 3.12E6 10 10 34 41 Carbamidomethylation
K.GPVRLPTK.T Y 65.57 866.5338 8 -45.2 434.2546 2 32.56 5 14744 VEV_2_3_RA5_01_1236.d 0 7 7 51 58
K.VC(+57.02)QELIDRAR.S Y 61.43 1258.6451 10 -15.7 630.3199 2 44.50 5 21864 VEV_2_3_RA5_01_1236.d 8.82E5 5 5 34 43 Carbamidomethylation
K.VC(+57.02)Q(+.98)ELIDR.A Y 57.25 1032.4910 8 -5.2 517.2501 2 52.01 4 26171 VEV_1_3_RA4_01_1235.d 6.51E5 4 4 34 41 Carbamidomethylation; Deamidation (NQ)
K.IRITLTSR.K Y 55.65 958.5923 8 -14.6 480.2964 2 51.42 5 26022 VEV_2_3_RA5_01_1236.d 6.55E5 7 7 19 26
K.SLNVKGPVRLPTK(+14.02).T Y 48.65 1421.8718 13 -16.3 356.4694 4 60.64 6 30900 VEV_3_3_RA6_01_1237.d 7.02E4 1 1 46 58 Methylation(KR)
K.DFSEGPK.I Y 48.29 778.3497 7 0.7 390.1824 2 25.11 4 10262 VEV_1_3_RA4_01_1235.d 4.24E5 4 4 9 15
R.SKSLNVKGPVRLPTK.T Y 48.19 1622.9832 15 -24.6 406.7431 4 49.15 5 24639 VEV_2_3_RA5_01_1236.d 3.57E5 2 2 44 58
K.TLKISTR.K Y 43.75 817.5021 7 -5.7 409.7560 2 22.06 5 8865 VEV_2_3_RA5_01_1236.d 6.46E4 2 2 59 65
R.ITLTSR.K Y 39.24 689.4072 6 -12.4 345.7066 2 30.52 4 13127 VEV_1_3_RA4_01_1235.d 1.98E6 5 5 21 26
R.KVASLEK.V Y 33.01 773.4647 7 -18.6 387.7324 2 13.09 6 3971 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 27 33
R.KTPNGEGSKTWDMYEMR.I Y 30.09 2028.9033 17 -4.7 677.3052 3 61.13 4 32336 VEV_1_3_RA4_01_1235.d 8.88E4 2 2 66 82
M.S(+42.01)FQKPEK.D Y 29.58 904.4654 7 -10.0 453.2354 2 26.42 4 10880 VEV_1_3_RA4_01_1235.d 4.81E6 9 9 2 8 Acetylation (Protein N-term)
M.S(+42.01)FQ(+.98)KPEK.D Y 29.20 905.4494 7 -13.3 453.7260 2 29.10 5 12751 VEV_2_3_RA5_01_1236.d 1.32E6 3 3 2 8 Acetylation (Protein N-term); Deamidation (NQ)
R.ITLTSRK.V Y 28.96 817.5021 7 -17.7 409.7511 2 18.12 6 6575 VEV_3_3_RA6_01_1237.d 1.42E5 3 3 21 27
K.SLNVKGPVR.L Y 28.58 968.5767 9 -51.6 485.2706 2 31.79 5 14298 VEV_2_3_RA5_01_1236.d 1.06E5 3 3 46 54
R.L(+41.03)IDLHAPTETVK.Q Y 23.48 1376.7664 12 -60.8 459.9015 3 65.34 4 35541 VEV_1_3_RA4_01_1235.d 1.96E5 1 1 87 98 Amidination of lysines or N-terminal amines with methyl acetimidate
R.KVASLEK(+14.02)VC(+57.02)QELIDR.A Y 22.14 1800.9767 15 -20.6 451.2422 4 73.18 6 40224 VEV_3_3_RA6_01_1237.d 5.62E4 1 1 27 41 Methylation(KR); Carbamidomethylation
K.DFSEGPKIHKIR.I Y 21.14 1425.7728 12 -17.6 357.4442 4 43.62 5 21280 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 9 20
M.S(+42.01)FQKPEK(+14.02).D Y 20.29 918.4810 7 -12.1 460.2422 2 33.81 5 15458 VEV_2_3_RA5_01_1236.d 7.15E5 3 3 2 8 Acetylation (Protein N-term); Methylation(KR)
M.SFQK(+40.03)PEKDFSEGPKIHK.I Y 20.06 2041.0632 17 -25.1 409.2097 5 57.81 6 28908 VEV_3_3_RA6_01_1237.d 8.59E4 1 1 2 18 Propionaldehyde +40
M.SFQKPE(+37.96)KDFSEGPKIHK.I Y 18.78 2038.9878 17 18.1 510.7635 4 57.84 6 28926 VEV_3_3_RA6_01_1237.d 0 1 1 2 18 Replacement of proton by potassium
R.ITLTSR(+14.02).K Y 16.04 703.4229 6 -17.1 352.7127 2 38.70 5 18361 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 21 26 Methylation(KR)
total 31 peptides
C1FYN4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGSAALQAGVPVQDSSHSER.T Y 116.42 1951.9347 20 -11.4 651.6448 3 52.01 4 26172 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 169 188
R.SDSRGGSAALQAGVPVQDSSHSER.T Y 99.38 2397.1270 24 -7.9 600.2843 4 49.05 4 24286 VEV_1_3_RA4_01_1235.d 2.59E5 3 3 165 188
R.TLGEGSYSTVVAATDR.Q Y 97.95 1625.7897 16 -11.4 813.8928 2 68.36 4 37924 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 273 288
R.LRTESSPLPTSESQSR.S Y 97.90 1773.8856 16 -8.2 592.2976 3 45.76 4 22286 VEV_1_3_RA4_01_1235.d 6.71E5 8 8 149 164
M(+42.01)DGDLSLSQSFGGLR.I Y 77.27 1623.7562 15 -5.1 812.8813 2 86.74 5 50159 VEV_2_3_RA5_01_1236.d 3.79E4 1 1 1 15 Acetylation (Protein N-term)
R.TESSPLPTSESQSR.S Y 73.55 1504.7004 14 -7.5 753.3519 2 42.02 4 19928 VEV_1_3_RA4_01_1235.d 2.11E5 3 3 151 164
K.MGLGSSGNSGSTR.N Y 72.76 1209.5408 13 -8.1 605.7728 2 25.93 4 10618 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 587 599
K.GANEYQTFQK.I Y 60.42 1184.5461 10 23.5 593.2943 2 39.67 5 18989 VEV_2_3_RA5_01_1236.d 0 5 5 489 498
R.VIIAPAGGEEK.K Y 55.98 1082.5972 11 -10.7 542.3000 2 45.87 4 22304 VEV_1_3_RA4_01_1235.d 7.27E4 2 2 686 696
K.M(+15.99)GLGSSGNSGSTR.N Y 50.41 1225.5358 13 -10.0 613.7690 2 15.09 4 4829 VEV_1_3_RA4_01_1235.d 5.37E4 1 1 587 599 Oxidation (M)
K.YVNIEKDTLNR.L Y 49.09 1363.7096 11 -20.3 455.5679 3 54.68 6 27025 VEV_3_3_RA6_01_1237.d 2.26E5 3 3 312 322
K.IVGLDYEFPPGFPAVAR.D Y 43.82 1846.9617 17 -19.5 924.4701 2 86.66 5 50147 VEV_2_3_RA5_01_1236.d 2.42E5 4 4 499 515
K.ITDFGTAK.M Y 35.74 851.4388 8 -11.1 426.7220 2 33.93 4 15105 VEV_1_3_RA4_01_1235.d 3.85E5 3 3 408 415
K.MDISLLAPGAQYR.S Y 29.34 1433.7336 13 -32.1 478.9032 3 79.26 6 44629 VEV_3_3_RA6_01_1237.d 0 2 2 700 712
R.LTDHPGVVR.L Y 26.64 992.5403 9 -70.5 497.2424 2 27.06 6 11289 VEV_3_3_RA6_01_1237.d 3.56E4 1 1 323 331
R.LLVLDPSR(-.98).R Y 24.93 910.5600 8 5.9 456.2900 2 75.13 5 42688 VEV_2_3_RA5_01_1236.d 0 1 1 521 528 Amidation
R.GVIHR.D N 22.48 580.3445 5 -52.2 581.3215 1 88.60 5 51169 VEV_2_3_RA5_01_1236.d 2.19E5 2 2 387 391
K.MGNLLVLSSPAPHNQHGK.G Y 19.64 1898.9785 18 2.9 475.7533 4 78.37 6 43992 VEV_3_3_RA6_01_1237.d 0 1 1 632 649
K.AKM(+15.99)DISLLAPGAQYR.S Y 18.64 1648.8606 15 -17.4 825.4232 2 95.39 5 54384 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 698 712 Oxidation (M)
R.DFSFGR.T Y 16.89 727.3289 6 1.5 728.3373 1 34.97 6 15638 VEV_3_3_RA6_01_1237.d 7.67E4 1 1 267 272
R.GAAVGVR.Q Y 15.96 628.3656 7 -16.0 315.1851 2 29.79 4 12733 VEV_1_3_RA4_01_1235.d 0 1 1 241 247
total 21 peptides
C1FYE5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AALLNDYFAHEQNKGTLIC(+57.02)R.F Y 113.72 2333.1587 20 -9.3 584.2915 4 73.30 4 41891 VEV_1_3_RA4_01_1235.d 1.77E5 3 3 222 241 Carbamidomethylation
K.IYPTYDFC(+57.02)VPILDSLEGVTHALR.T Y 91.58 2678.3413 23 -13.9 893.7753 3 92.43 6 52502 VEV_3_3_RA6_01_1237.d 8.1E5 7 7 379 401 Carbamidomethylation
R.NVVNLDWTLFWATNR.K Y 82.35 1847.9319 15 -6.5 616.9806 3 90.41 4 53879 VEV_1_3_RA4_01_1235.d 8.44E4 2 2 489 503
K.ANGSFLLPTLLAINYVK.Q Y 79.83 1833.0399 17 -15.4 612.0112 3 90.93 6 51790 VEV_3_3_RA6_01_1237.d 1.66E5 2 2 10 26
R.NVVNLDWTLFWATNRK.Y Y 79.57 1976.0269 16 -0.4 659.6826 3 85.71 4 51055 VEV_1_3_RA4_01_1235.d 0 1 1 489 504
K.GIEGVQTADKPK.H Y 79.28 1241.6615 12 -15.6 621.8284 2 28.41 6 12021 VEV_3_3_RA6_01_1237.d 6.83E5 6 6 528 539
R.HTAIDKQDVVR.V Y 77.35 1280.6837 11 -25.3 641.3329 2 26.79 6 11166 VEV_3_3_RA6_01_1237.d 3.04E4 1 1 513 523
K.YIDPVAPR.H Y 68.84 929.4970 8 -16.1 465.7483 2 55.34 6 27351 VEV_3_3_RA6_01_1237.d 9.16E5 5 5 505 512
R.RNESIEDNLAR.F Y 61.33 1315.6479 11 -6.2 439.5539 3 40.24 4 18841 VEV_1_3_RA4_01_1235.d 1.67E5 2 2 318 328
K.ALRDPVIYR.C Y 60.00 1101.6294 9 -16.3 368.2111 3 54.60 4 27812 VEV_1_3_RA4_01_1235.d 4.22E5 4 4 356 364
K.AN(+.98)GSFLLPTLLAINYVK.Q Y 50.00 1834.0239 17 -14.3 612.3398 3 93.80 5 53713 VEV_2_3_RA5_01_1236.d 2.87E4 1 1 10 26 Deamidation (NQ)
R.NESIEDNLAR.F Y 49.45 1159.5469 10 -8.1 580.7760 2 51.23 4 25652 VEV_1_3_RA4_01_1235.d 2.79E5 3 3 319 328
K.RRNESIEDNLAR.F Y 35.67 1471.7491 12 -9.8 491.5855 3 33.68 5 15388 VEV_2_3_RA5_01_1236.d 2.43E5 2 2 317 328
R.TGTTWKIYPTYDFC(+57.02)VPILDSLEGVTHALR.T Y 34.57 3352.6802 29 -29.5 839.1526 4 91.24 5 52515 VEV_2_3_RA5_01_1236.d 0 1 1 373 401 Carbamidomethylation
K.RSTALRPLDFK.S Y 31.63 1302.7407 11 -13.3 326.6881 4 57.19 4 29439 VEV_1_3_RA4_01_1235.d 4.19E4 1 1 91 101
K.QGPSR.N Y 24.17 543.2765 5 -7.9 544.2795 1 44.38 5 21750 VEV_2_3_RA5_01_1236.d 8.59E3 1 1 484 488
K.AALLNDYFAHEQNK.G Y 22.83 1632.7896 14 -40.0 817.3694 2 89.28 6 50935 VEV_3_3_RA6_01_1237.d 9.53E3 1 1 222 235
R.VNFIR.A Y 22.59 647.3755 5 -12.9 324.6909 2 43.90 4 21075 VEV_1_3_RA4_01_1235.d 1.22E5 4 4 432 436
R.AKISIDDLNK.A Y 21.01 1115.6187 10 -14.5 372.8748 3 31.02 5 13850 VEV_2_3_RA5_01_1236.d 0 1 1 346 355
K.VTWLAEKGQK.L Y 19.94 1158.6396 10 -35.1 580.3068 2 42.02 4 19929 VEV_1_3_RA4_01_1235.d 4.06E4 1 1 616 625
R.KYIDPVAPR.H Y 19.91 1057.5920 9 -33.2 529.7858 2 44.67 4 21555 VEV_1_3_RA4_01_1235.d 0 1 1 504 512
R.GMTVPALREFILK.Q Y 19.71 1473.8378 13 -13.6 492.2798 3 80.73 4 47581 VEV_1_3_RA4_01_1235.d 7.97E4 1 1 471 483
K.ISIDDLNK.A Y 18.98 916.4865 8 -22.2 459.2404 2 62.29 6 32114 VEV_3_3_RA6_01_1237.d 0 1 1 348 355
K.ITSDPMSGGR.I Y 18.76 1019.4706 10 6.0 510.7456 2 37.74 5 17787 VEV_2_3_RA5_01_1236.d 8.97E4 1 1 586 595
R.MPTIRGIR.R Y 18.70 942.5433 8 4.6 315.1898 3 32.68 5 14821 VEV_2_3_RA5_01_1236.d 0 1 1 461 468
R.KVHIWDFSR.V Y 18.44 1186.6248 9 -15.1 396.5429 3 65.13 4 35381 VEV_1_3_RA4_01_1235.d 5.15E4 1 1 423 431
K.ISIDDLNKALR.D Y 17.49 1256.7089 11 5.1 315.1861 4 37.44 6 17021 VEV_3_3_RA6_01_1237.d 0 1 1 348 358
K.GTLIC(+57.02)R.F Y 17.39 718.3796 6 -1.6 719.3857 1 76.91 5 43951 VEV_2_3_RA5_01_1236.d 0 1 1 236 241 Carbamidomethylation
R.VTVKGIEGVQTADKPK.H Y 17.23 1668.9410 16 -26.2 557.3064 3 78.32 4 45734 VEV_1_3_RA4_01_1235.d 6.45E4 1 1 524 539
R.LDRPYK.E Y 16.71 790.4337 6 -57.2 396.2015 2 23.68 6 9502 VEV_3_3_RA6_01_1237.d 7.78E5 1 1 688 693
R.WC(+57.02)IRAKISIDDLNK.A Y 16.40 1730.9137 14 -43.7 577.9533 3 73.50 4 41973 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 342 355 Carbamidomethylation
R.FN(+.98)GIESK.R Y 16.15 794.3810 7 12.0 398.2025 2 26.49 6 10989 VEV_3_3_RA6_01_1237.d 0 1 1 310 316 Deamidation (NQ)
K.SDDGK.A N 15.98 520.2129 5 -13.8 521.2130 1 8.34 6 1959 VEV_3_3_RA6_01_1237.d 2.41E3 1 1 55 59
R.G(+43.01)N(+.98)RIAISAIR.K Y 15.94 1113.6254 10 -2.4 372.2148 3 56.90 5 29376 VEV_2_3_RA5_01_1236.d 0 1 1 138 147 Carbamylation; Deamidation (NQ)
K.VIYSPK.I Y 15.92 705.4061 6 10.8 706.4210 1 110.64 5 59010 VEV_2_3_RA5_01_1236.d 0 1 1 551 556
K.GIEGVQTADK(+226.08)PK.H Y 15.74 1467.7391 12 -38.9 734.8483 2 112.24 6 58704 VEV_3_3_RA6_01_1237.d 1.77E4 1 1 528 539 Biotinylation
R.IAISAIR.K Y 15.31 742.4701 7 -41.8 372.2268 2 22.15 5 8887 VEV_2_3_RA5_01_1236.d 0 1 1 141 147
total 37 peptides
C1GC66
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGNLGDSIQISQVGDGKIEVVTHIPFSGR.Y Y 130.41 3021.5884 29 -20.8 756.3887 4 81.37 6 46119 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 48 76
K.YIINASQPANDKIFDVSAFEK.F Y 122.19 2369.1902 21 -20.5 790.7211 3 80.32 6 45383 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 16 36
R.VGNLGDSIQISQVGDGK.I Y 118.20 1685.8584 17 -10.4 843.9277 2 70.82 6 38476 VEV_3_3_RA6_01_1237.d 1.44E5 1 1 48 64
K.KYIINASQPANDKIFDVSAFEK.F Y 100.21 2497.2852 22 -15.2 625.3191 4 77.12 6 43095 VEV_3_3_RA6_01_1237.d 2.19E5 1 1 15 36
K.YIINASQPANDK.I Y 65.82 1332.6674 12 -13.1 667.3322 2 53.09 6 26112 VEV_3_3_RA6_01_1237.d 8.22E4 1 1 16 27
K.IFDVSAFEK.F Y 58.57 1054.5334 9 -19.1 528.2639 2 76.03 6 42341 VEV_3_3_RA6_01_1237.d 2.88E5 2 2 28 36
K.FLHDKIKVEGR.V Y 51.36 1340.7565 11 -15.9 447.9190 3 44.67 6 21214 VEV_3_3_RA6_01_1237.d 5.05E5 4 4 37 47
R.FYNVVNDEADEDED Y 40.05 1672.6376 14 1.6 837.3274 2 71.43 6 38937 VEV_3_3_RA6_01_1237.d 0 2 2 109 122
K.GVYELR.F Y 27.40 735.3915 6 -16.2 368.6971 2 41.97 6 19646 VEV_3_3_RA6_01_1237.d 2.27E5 1 1 103 108
R.VGNLGDSIQ(+.98)ISQVGDGK.I Y 26.66 1686.8424 17 -12.0 844.4183 2 71.81 6 39223 VEV_3_3_RA6_01_1237.d 8.42E4 1 1 48 64 Deamidation (NQ)
K.IEVVTHIPFSGR.Y Y 21.89 1353.7405 12 -14.1 452.2477 3 71.16 6 38735 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 65 76
R.DWLRVVSTSKGVYELR.F Y 15.76 1907.0265 16 -13.7 954.5074 2 97.78 5 55289 VEV_2_3_RA5_01_1236.d 0 1 1 93 108
total 12 peptides
C1G172
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AHPFPYALVAGIERYPSK.V Y 118.80 2015.0627 18 -15.5 504.7651 4 77.60 5 44462 VEV_2_3_RA5_01_1236.d 1.36E6 10 10 43 60
K.AHPFPYALVAGIER.Y Y 114.67 1539.8197 14 -8.3 514.2762 3 78.58 4 45929 VEV_1_3_RA4_01_1235.d 1.49E6 11 11 43 56
R.YTLELEGLR.G Y 91.13 1092.5815 9 8.4 547.3026 2 75.17 4 43265 VEV_1_3_RA4_01_1235.d 6.7E5 6 6 93 101
R.GAITNDTFKEVSQREEAK.K Y 77.40 2022.0017 18 -13.3 506.5010 4 59.83 6 30329 VEV_3_3_RA6_01_1237.d 1.62E5 1 1 102 119
K.TINYNHLMPTR.Y Y 77.40 1358.6765 11 -12.0 680.3374 2 62.97 4 33792 VEV_1_3_RA4_01_1235.d 1.51E6 9 9 82 92
K.TINYNHLMPTRYTLELEGLR.G Y 69.43 2433.2476 20 -6.7 609.3151 4 79.17 4 46379 VEV_1_3_RA4_01_1235.d 1.59E5 2 2 82 101
K.AHPFPYALVAGIERYPSKVTR.R Y 66.39 2371.2800 21 -23.9 475.2520 5 76.59 6 42697 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 43 63
K.TINYNHLM(+15.99)PTR.Y Y 62.29 1374.6714 11 -6.7 688.3384 2 49.56 4 24606 VEV_1_3_RA4_01_1235.d 9.73E5 6 6 82 92 Oxidation (M)
K.SLEERYNSGK.N Y 60.93 1181.5676 10 -14.8 591.7823 2 20.38 6 7758 VEV_3_3_RA6_01_1237.d 3.69E5 3 3 125 134
K.AHPFPYALVAGIER(+14.02).Y Y 57.10 1553.8353 14 -4.5 518.9501 3 81.17 6 45977 VEV_3_3_RA6_01_1237.d 2.44E5 2 2 43 56 Methylation(KR)
K.AHPFPYALVAGIER(+14.02)YPSK.V Y 49.43 2029.0785 18 -23.2 508.2651 4 80.12 6 45247 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 43 60 Methylation(KR)
R.GAITNDTFKEVSQREEAKK.T Y 48.07 2150.0967 19 -12.6 717.6971 3 55.56 5 28492 VEV_2_3_RA5_01_1236.d 7.61E5 4 4 102 120
K.AHPFPY(-2.02)ALVAGIERYPSK.V Y 44.66 2013.0471 18 19.3 504.2787 4 77.52 5 44384 VEV_2_3_RA5_01_1236.d 2.63E4 1 1 43 60 2-amino-3-oxo-butanoic_acid
R.GAITNDTFK.E Y 43.35 965.4818 9 -7.9 483.7444 2 43.34 4 20753 VEV_1_3_RA4_01_1235.d 2.66E5 2 2 102 110
R.SKVKPFIK.T Y 40.48 945.6011 8 -47.0 473.7856 2 23.42 6 9351 VEV_3_3_RA6_01_1237.d 0 1 1 74 81
R.YTLELEGLRGAITNDTFK.E Y 40.23 2040.0527 18 0.1 681.0249 3 80.72 6 45661 VEV_3_3_RA6_01_1237.d 0 1 1 93 110
R.YTLELEGLR(+14.02).G Y 39.60 1106.5972 9 -17.3 554.2963 2 78.00 6 43726 VEV_3_3_RA6_01_1237.d 2.02E5 1 1 93 101 Methylation(KR)
K.SLEERYNSGKNR.W Y 37.52 1451.7117 12 -12.3 363.9307 4 18.19 4 6454 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 125 136
R.YTLELE(+14.02)GLR.G Y 35.43 1106.5972 9 -19.4 554.2951 2 77.59 6 43434 VEV_3_3_RA6_01_1237.d 2.02E5 1 1 93 101 Methylation(others)
R.YPSKVTR.R Y 32.70 849.4708 7 -15.3 425.7362 2 14.51 6 4702 VEV_3_3_RA6_01_1237.d 1.49E5 2 2 57 63
K.AHPFPYALVAGIER(+.98).Y Y 30.07 1540.8037 14 -7.6 514.6046 3 78.22 6 43884 VEV_3_3_RA6_01_1237.d 7.65E4 1 1 43 56 Deamidation (R)
K.VKPFIK.T Y 26.53 730.4741 6 -23.0 366.2359 2 27.37 5 11785 VEV_2_3_RA5_01_1236.d 9.29E5 5 5 76 81
K.AATPQLT(+77.99)C(+57.02)VFFLPYYQVVIIQPYDTGSK.A Y 22.49 3296.6233 28 38.2 660.3571 5 66.56 5 36438 VEV_2_3_RA5_01_1236.d 0 1 1 15 42 Methylphosphonylation; Carbamidomethylation
R.GAITNDTFKEVSQR.E Y 22.39 1564.7845 14 -4.6 522.5997 3 70.39 5 39282 VEV_2_3_RA5_01_1236.d 4.28E4 1 1 102 115
K.T(-2.02)INYNHLMPTR.Y Y 19.64 1356.6609 11 31.7 453.2419 3 63.28 4 33962 VEV_1_3_RA4_01_1235.d 2.31E5 1 1 82 92 2-amino-3-oxo-butanoic_acid
K.AHPFPY(+31.99)ALVAGIERYPSK.V Y 19.18 2047.0526 18 -0.8 512.7700 4 77.58 6 43428 VEV_3_3_RA6_01_1237.d 6.86E4 1 1 43 60 Dihydroxy
K.EVSQR.E Y 15.70 617.3133 5 22.0 618.3342 1 64.47 4 34863 VEV_1_3_RA4_01_1235.d 0 1 1 111 115
total 27 peptides
C1G9U8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVIC(+57.02)PGC(+57.02)EGIGGKPGSVK.Q Y 124.22 1800.8862 18 -9.5 601.2970 3 59.04 4 30788 VEV_1_3_RA4_01_1235.d 8.15E5 6 6 142 159 Carbamidomethylation
R.FVVEC(+57.02)TDC(+57.02)DR.T Y 96.17 1299.5223 10 -1.7 650.7673 2 51.29 4 25728 VEV_1_3_RA4_01_1235.d 5.42E5 6 6 183 192 Carbamidomethylation
R.TIVHPLKVTLEDIYR.G Y 94.64 1796.0195 15 -10.6 450.0074 4 77.34 4 44965 VEV_1_3_RA4_01_1235.d 2.93E5 2 2 117 131
K.IDFRGEGDQAPGVITGDVQFEIDQQPHPR.F Y 87.14 3220.5537 29 -15.2 806.1335 4 78.71 4 46022 VEV_1_3_RA4_01_1235.d 8.69E4 2 2 232 260
R.FVVEC(+57.02)TDC(+57.02)DRTGQVINER.D Y 73.65 2196.9893 18 -7.7 733.3314 3 64.09 4 34581 VEV_1_3_RA4_01_1235.d 5.42E4 1 1 183 200 Carbamidomethylation
R.FVVEC(+57.02)TDC(+57.02)DRTGQVINERDR.C Y 68.63 2468.1172 20 -10.7 618.0300 4 61.46 4 32577 VEV_1_3_RA4_01_1235.d 2E5 3 3 183 202 Carbamidomethylation
K.ALSHAYEVLSDPQKR.Q Y 67.37 1712.8845 15 -9.9 429.2242 4 59.25 4 30935 VEV_1_3_RA4_01_1235.d 4.69E5 3 3 50 64
K.YYDVLGVSPSASEAELK.T Y 66.08 1826.8938 17 -5.6 914.4491 2 78.16 5 44827 VEV_2_3_RA5_01_1236.d 1.27E5 3 3 7 23
K.KSVIC(+57.02)PGC(+57.02)EGIGGKPGSVK.Q Y 57.00 1928.9812 19 -7.2 643.9964 3 50.01 5 25155 VEV_2_3_RA5_01_1236.d 5.25E4 1 1 141 159 Carbamidomethylation
K.Q(-17.03)C(+57.02)VAC(+57.02)GGTGKR.T Y 49.31 1175.5176 11 -7.5 588.7617 2 20.54 5 8026 VEV_2_3_RA5_01_1236.d 7.87E4 1 1 160 170 Pyro-glu from Q; Carbamidomethylation
R.TIVHPLKVTLEDIYRGK.V Y 48.29 1981.1360 17 -16.7 397.2278 5 76.30 6 42483 VEV_3_3_RA6_01_1237.d 5.23E4 2 2 117 133
R.EQGPK.K Y 35.03 557.2809 5 -15.6 558.2795 1 27.18 4 11294 VEV_1_3_RA4_01_1235.d 1.73E5 9 9 109 113
K.GQGMPSYR.H Y 29.89 894.4018 8 -2.3 448.2071 2 34.01 4 15150 VEV_1_3_RA4_01_1235.d 9.02E4 2 2 315 322
R.KVLHVHIDR.G Y 26.09 1115.6564 9 -10.1 372.8890 3 32.37 5 14644 VEV_2_3_RA5_01_1236.d 6.62E4 1 1 216 224
R.TGQVINERDR.C Y 25.83 1186.6055 10 -16.2 594.3004 2 18.06 6 6547 VEV_3_3_RA6_01_1237.d 2.45E4 1 1 193 202
K.RTMMRQMGPM(+15.99)IQR.F Y 25.11 1650.7939 13 -7.1 413.7029 4 20.49 6 7857 VEV_3_3_RA6_01_1237.d 1.25E5 1 1 170 182 Oxidation (M)
K.VIIER.K N 21.52 628.3908 5 -72.7 315.1798 2 26.72 5 11510 VEV_2_3_RA5_01_1236.d 1.15E6 7 7 211 215
K.ALS(-2.02)HAYEVLSDPQKR.Q Y 16.24 1710.8689 15 17.6 571.3069 3 59.23 4 30910 VEV_1_3_RA4_01_1235.d 0 1 1 50 64 2-amino-3-oxo-butanoic_acid
total 18 peptides
C1G6M8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HYFQNTQGIIFVVDSNDRDR.V Y 144.35 2423.1619 20 -11.7 606.7906 4 75.68 6 42042 VEV_3_3_RA6_01_1237.d 5.9E5 3 3 80 99
R.MLNEDELRDALLLVFANKQDLPNAMSPAEITQQLGLQSLTR.R Y 109.97 4595.3726 41 -3.8 1149.8461 4 96.00 4 56751 VEV_1_3_RA4_01_1235.d 3.88E5 3 3 110 150
R.RAWYIQSTC(+57.02)ATTGDGLYEGLEWLANALKK.A Y 84.08 3314.6394 29 -5.5 829.6626 4 91.38 4 54438 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 151 179 Carbamidomethylation
K.LGEIVTTIPTIGFNVETVEYK.N Y 70.39 2322.2358 21 -13.1 1162.1100 2 87.54 6 49965 VEV_3_3_RA6_01_1237.d 2.04E5 3 3 39 59
R.ILMVGLDAAGK.T Y 64.07 1086.6107 11 -19.0 544.3023 2 72.95 6 40050 VEV_3_3_RA6_01_1237.d 8.3E4 2 2 20 30
K.NIQFTVWDVGGQDK.I Y 61.83 1605.7787 14 -15.3 803.8843 2 80.27 6 45347 VEV_3_3_RA6_01_1237.d 1.98E5 2 2 60 73
K.TTILYK.L N 43.78 737.4323 6 -33.6 738.4148 1 38.71 6 17761 VEV_3_3_RA6_01_1237.d 2.84E5 3 3 31 36
R.VVEAREELQR.M Y 41.94 1227.6571 10 -7.7 410.2231 3 32.31 4 14179 VEV_1_3_RA4_01_1235.d 4.16E5 3 3 100 109
R.AWYIQSTC(+57.02)ATTGDGLYEGLEWLANALKK.A Y 41.07 3158.5383 28 -2.2 1053.8511 3 94.75 4 56173 VEV_1_3_RA4_01_1235.d 7.58E4 1 1 152 179 Carbamidomethylation
K.NIQFTVWDVGGQDKIRPLWR.H Y 37.06 2427.2810 20 -3.0 607.8257 4 82.32 6 46754 VEV_3_3_RA6_01_1237.d 1.67E5 2 2 60 79
R.RAWYIQSTC(+57.02)ATTGDGLYEGLEWLANALK.K Y 29.92 3186.5444 28 -36.8 1063.1497 3 94.94 5 54195 VEV_2_3_RA5_01_1236.d 0 1 1 151 178 Carbamidomethylation
R.M(+15.99)LNEDELRDALLLVFANKQDLPNAMSPAEITQQLGLQSLTR.R Y 29.89 4611.3677 41 8.0 1153.8584 4 94.97 5 54206 VEV_2_3_RA5_01_1236.d 3.14E4 1 1 110 150 Oxidation (M)
R.HYFQNTQGIIFVVDSNDR.D Y 22.67 2152.0337 18 13.9 718.3618 3 78.29 4 45709 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 80 97
R.M(+15.99)LNEDELRDALLLVFANK.Q Y 21.13 2119.0984 18 -11.6 707.3652 3 90.20 6 51416 VEV_3_3_RA6_01_1237.d 9.99E4 1 1 110 127 Oxidation (M)
R.ILMVGLDAAGKTTILYK.L Y 17.32 1806.0325 17 2.7 362.2148 5 68.96 4 38409 VEV_1_3_RA4_01_1235.d 2.28E4 1 1 20 36
R.DRVVEAR.E Y 17.19 843.4562 7 -40.1 844.4297 1 84.63 6 48224 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 98 104
total 16 peptides
C1G6U8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DYLALSSLSEER.S Y 100.36 1381.6725 12 -12.9 691.8346 2 77.30 6 43226 VEV_3_3_RA6_01_1237.d 5.05E4 2 2 714 725
R.SPGGPSLSPVDLHPVPPLEGKENR.G Y 94.39 2478.2866 24 -2.2 620.5776 4 72.33 4 41060 VEV_1_3_RA4_01_1235.d 7.25E4 1 1 65 88
K.LGETVAVTGDGTNDAPALK.A Y 92.54 1827.9214 19 -7.6 914.9611 2 68.22 5 37705 VEV_2_3_RA5_01_1236.d 5.54E5 4 4 941 959
R.IVLDPAAELSETPLTDR.N Y 92.10 1838.9625 17 -12.5 920.4771 2 82.32 6 46756 VEV_3_3_RA6_01_1237.d 8.83E4 3 3 772 788
R.SDPHTGLVHQK.G Y 77.48 1217.6152 11 -13.9 609.8065 2 15.23 5 5157 VEV_2_3_RA5_01_1236.d 3.79E5 4 4 1367 1377
K.TETALLSFARDYLALSSLSEER.S Y 76.25 2471.2544 22 -36.2 824.7289 3 89.45 6 51026 VEV_3_3_RA6_01_1237.d 0 1 1 704 725
K.SLSAFYALGGLAGLEK.G Y 67.83 1595.8558 16 12.9 532.9661 3 86.57 5 50060 VEV_2_3_RA5_01_1236.d 0 4 4 201 216
R.STLDDIIESYASR.S Y 66.47 1468.7045 13 -11.9 735.3508 2 83.26 6 47357 VEV_3_3_RA6_01_1237.d 1.45E5 2 2 791 803
R.GSRPTSPHNVSSPASK.W Y 57.59 1607.8015 16 -4.2 536.9388 3 17.92 5 6606 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 89 104
R.GSRPTSPHNVSSPASKWPEGPSQTFLSVPGTR.S Y 53.88 3347.6646 32 -34.2 670.5173 5 70.74 5 39533 VEV_2_3_RA5_01_1236.d 0 1 1 89 120
R.AIENHENLAK.I Y 53.47 1137.5778 10 -10.9 569.7900 2 20.70 6 7929 VEV_3_3_RA6_01_1237.d 1.01E5 3 3 446 455
R.SSSNVPPNQTTPPS Y 48.85 1411.6580 14 -10.8 706.8286 2 42.29 5 20491 VEV_2_3_RA5_01_1236.d 2.33E5 1 1 1439 1452
R.ISTEHLGAGSR.S Y 47.66 1126.5730 11 -9.6 564.2884 2 26.75 5 11479 VEV_2_3_RA5_01_1236.d 1.42E5 3 3 54 64
K.M(+15.99)TVVAGTFGTASR.F Y 41.25 1312.6445 13 -10.8 657.3224 2 58.38 5 30366 VEV_2_3_RA5_01_1236.d 2.75E4 1 1 616 628 Oxidation (M)
R.MVTGDNLTTAK.A Y 37.80 1149.5699 11 -11.6 575.7856 2 44.09 4 21199 VEV_1_3_RA4_01_1235.d 7.71E4 1 1 874 884
R.LIPDDFAR.K Y 37.64 945.4919 8 -19.3 473.7441 2 66.11 5 36107 VEV_2_3_RA5_01_1236.d 9.31E4 1 1 1214 1221
R.KVSGTEAYR.A Y 28.65 1009.5192 9 -14.9 505.7594 2 14.08 6 4468 VEV_3_3_RA6_01_1237.d 1.35E4 1 1 437 445
R.SNKETVQLVPFDSGRK.C Y 28.54 1803.9479 16 -12.3 451.9887 4 60.07 5 31594 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 726 741
K.VENNK.F Y 25.42 602.3024 5 -3.0 603.3079 1 64.89 5 35190 VEV_2_3_RA5_01_1236.d 0 1 1 181 185
K.M(+15.99)LNPK.S N 23.89 617.3207 5 -39.8 618.3034 1 37.98 4 17506 VEV_1_3_RA4_01_1235.d 4.38E4 1 1 196 200 Oxidation (M)
R.VMSMKSHGSK.H Y 23.67 1090.5264 10 4.3 546.2728 2 34.46 5 15852 VEV_2_3_RA5_01_1236.d 3.48E4 2 2 260 269
R.VFSDNHLPAK.K Y 23.42 1126.5770 10 -54.4 564.2651 2 47.80 4 23510 VEV_1_3_RA4_01_1235.d 1.96E6 7 7 282 291
R.KVSGTEAYRAIENHENLAK.I Y 22.89 2129.0864 19 -15.5 533.2706 4 58.56 6 29412 VEV_3_3_RA6_01_1237.d 2.82E4 1 1 437 455
K.ETVQLVPFDSGR.K Y 22.24 1346.6830 12 -3.0 449.9003 3 68.22 5 37711 VEV_2_3_RA5_01_1236.d 2.02E4 1 1 729 740
R.SSPEDK.R N 21.66 661.2919 6 -10.6 662.2921 1 112.70 4 61868 VEV_1_3_RA4_01_1235.d 0 1 1 926 931
R.GPGEADSLK.F Y 21.31 872.4240 9 -2.8 437.2180 2 27.89 5 12072 VEV_2_3_RA5_01_1236.d 1.86E5 2 2 1355 1363
R.TIGLVYRDFEQWPPR.G Y 21.04 1875.9631 15 -12.3 626.3206 3 80.07 4 47074 VEV_1_3_RA4_01_1235.d 2.04E5 1 1 807 821
K.SHGSK.H N 20.76 514.2499 5 74.6 515.2956 1 108.59 6 57725 VEV_3_3_RA6_01_1237.d 1.69E3 1 1 265 269
R.I(+71.04)STEHLGAGSR.S Y 20.62 1197.6102 11 -31.8 300.4003 4 18.10 5 6753 VEV_2_3_RA5_01_1236.d 4.51E5 1 1 54 64 Propionamide (K, X@N-term)
K.GASEILIAK.C Y 20.15 900.5280 9 -64.5 451.2422 2 56.14 6 27817 VEV_3_3_RA6_01_1237.d 0 1 1 760 768
R.LQVLAR.S Y 19.96 698.4439 6 -29.3 350.2190 2 42.32 4 20103 VEV_1_3_RA4_01_1235.d 0 1 1 920 925
K.MTVVAGTFGTASR.F Y 19.76 1296.6497 13 -33.6 433.2093 3 23.76 6 9543 VEV_3_3_RA6_01_1237.d 5.14E5 1 1 616 628
R.VMSM(+15.99)KSHGSK.H Y 17.87 1106.5212 10 4.8 554.2706 2 54.86 5 28098 VEV_2_3_RA5_01_1236.d 5.5E4 1 1 260 269 Oxidation (M)
K.VSGTEAYR.A Y 17.40 881.4243 8 24.1 882.4528 1 105.51 5 57644 VEV_2_3_RA5_01_1236.d 1.33E5 1 1 438 445
R.DQLAFLK.T Y 17.18 833.4647 7 -48.1 834.4319 1 92.10 4 54827 VEV_1_3_RA4_01_1235.d 9.85E4 1 1 1256 1262
K.MLNPK.S N 16.23 601.3257 5 -1.6 602.3320 1 22.36 6 8794 VEV_3_3_RA6_01_1237.d 0 1 1 196 200
R.FEWNPALEEIR.D Y 15.73 1402.6881 11 -27.9 468.5569 3 22.52 5 9081 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 1245 1255
K.FLASLSSIQGPAAK.G Y 15.52 1388.7664 14 -37.1 348.1860 4 53.94 4 27404 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 530 543
total 38 peptides
C1GGG3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GGAEHTTTATLASK.Q Y 128.98 1343.6681 14 -11.3 672.8337 2 20.91 6 8048 VEV_3_3_RA6_01_1237.d 4.42E6 12 12 317 330
K.NVDSPSPSSIEKGGAEHTTTATLASK.Q Y 124.09 2584.2617 26 -11.5 647.0653 4 59.59 5 31251 VEV_2_3_RA5_01_1236.d 7.77E5 6 6 305 330
K.SSHVSSTQAPPTSPPNDQLNPDAIKPSLDGK.A Y 110.96 3184.5635 31 -17.6 797.1342 4 67.30 6 35854 VEV_3_3_RA6_01_1237.d 5.09E5 2 2 272 302
R.DC(+57.02)VSHDSESLAK.T Y 97.66 1346.5773 12 -13.3 674.2869 2 28.02 6 11792 VEV_3_3_RA6_01_1237.d 5.55E5 8 8 369 380 Carbamidomethylation
K.NVDSPSPSSIEK.G Y 62.73 1258.6041 12 -8.4 630.3041 2 45.08 5 22178 VEV_2_3_RA5_01_1236.d 1.43E6 9 9 305 316
K.QFLEPEER.F Y 46.29 1046.5032 8 -5.2 524.2562 2 53.90 6 26589 VEV_3_3_RA6_01_1237.d 9.94E5 4 4 331 338
K.NVDSPSPSSIEK(+14.02).G Y 41.62 1272.6198 12 -11.6 637.3098 2 53.37 5 27228 VEV_2_3_RA5_01_1236.d 2.67E5 3 3 305 316 Methylation(KR)
R.FLAPTK.H Y 37.08 675.3955 6 -13.0 338.7007 2 33.93 4 15104 VEV_1_3_RA4_01_1235.d 8.66E5 6 6 339 344
K.HLPFYNPSRVWSY(-2.02)VKFFFLQGVSR.D Y 34.05 2971.5286 24 -10.5 595.3068 5 93.66 4 55643 VEV_1_3_RA4_01_1235.d 0 1 1 345 368 2-amino-3-oxo-butanoic_acid
K.ITQLSPTR.G Y 32.22 914.5185 8 -24.4 458.2554 2 34.76 5 16032 VEV_2_3_RA5_01_1236.d 1.15E5 3 3 472 479
K.HLPFYNPSRVWSYVKFFFLQGVSR.D Y 27.16 2973.5442 24 -15.2 595.7071 5 95.80 6 53913 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 345 368
K.HLPFYNPSR.V Y 25.30 1129.5669 9 -32.3 377.5174 3 59.99 5 31539 VEV_2_3_RA5_01_1236.d 2.31E4 1 1 345 353
R.DPLKWAMR.L Y 23.57 1015.5273 8 -2.0 508.7699 2 67.32 4 37099 VEV_1_3_RA4_01_1235.d 2.53E4 1 1 161 168
R.ALGNK.I N 23.40 501.2911 5 -78.7 502.2589 1 52.65 6 25847 VEV_3_3_RA6_01_1237.d 2.74E4 1 1 467 471
K.YSVLER.R Y 21.57 765.4021 6 -11.2 383.7040 2 41.69 5 20131 VEV_2_3_RA5_01_1236.d 5.57E4 1 1 154 159
K.SGIIDITK.F Y 21.45 845.4858 8 -11.4 423.7454 2 62.01 4 32998 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 73 80
total 16 peptides
C1G248
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LAQQYPSEFQNLR.G Y 104.92 1592.7947 13 -8.6 531.9343 3 69.97 4 39188 VEV_1_3_RA4_01_1235.d 1.07E6 7 7 426 438
K.GLNQVFTAMAGSDANETAYK.A Y 97.64 2086.9629 20 -15.5 696.6508 3 79.72 4 46838 VEV_1_3_RA4_01_1235.d 1.4E5 2 2 158 177
K.AQAAGYFYGDPQLC(+57.02)PNK.A Y 89.26 1898.8621 17 -7.1 950.4316 2 72.03 4 40819 VEV_1_3_RA4_01_1235.d 5.03E4 1 1 362 378 Carbamidomethylation
K.NTASTGEYLYAGLER.L Y 89.07 1643.7791 15 -8.9 822.8895 2 72.23 4 40976 VEV_1_3_RA4_01_1235.d 3.27E5 2 2 411 425
R.GKGQGTFIAWDSPQR.D Y 76.82 1646.8164 15 -3.8 549.9440 3 65.09 4 35346 VEV_1_3_RA4_01_1235.d 4.64E5 3 3 439 453
K.VDIPAFDWPQASFPR.L Y 74.70 1744.8572 15 -4.6 873.4318 2 86.53 4 51581 VEV_1_3_RA4_01_1235.d 7.13E5 3 3 242 256
K.Q(-17.03)NNVLLIVDEVQTGIGATGK.F Y 72.43 2051.0898 20 -17.9 1026.5338 2 93.74 6 53078 VEV_3_3_RA6_01_1237.d 7.83E4 2 2 321 340 Pyro-glu from Q
R.LKYPLEQFAAENAQEEKR.C Y 68.39 2163.0959 18 -11.0 541.7753 4 68.26 4 37845 VEV_1_3_RA4_01_1235.d 8.15E5 6 6 257 274
K.N(+.98)TASTGEYLYAGLER.L Y 68.15 1644.7631 15 3.0 823.3913 2 72.35 4 41072 VEV_1_3_RA4_01_1235.d 9.49E4 1 1 411 425 Deamidation (NQ)
R.SKPIHKVDIPAFDWPQASFPR.L Y 67.56 2435.2749 21 -15.7 488.0546 5 77.41 6 43309 VEV_3_3_RA6_01_1237.d 1E5 3 3 236 256
K.GQGTFIAWDSPQR.D Y 65.62 1461.7001 13 -15.2 731.8462 2 72.13 4 40912 VEV_1_3_RA4_01_1235.d 2.24E5 2 2 441 453
K.SVGINIGGSGER.A Y 62.39 1144.5836 12 -13.7 573.2913 2 56.53 5 29108 VEV_2_3_RA5_01_1236.d 1.05E6 6 6 462 473
R.NPVAAVVVEPIQSEGGDNHASPAFFQGLR.E Y 62.06 3005.4995 29 -20.8 752.3665 4 81.80 4 48387 VEV_1_3_RA4_01_1235.d 0 1 1 288 316
R.LFGSLSTTR.S Y 57.54 980.5291 9 -15.0 491.2645 2 62.83 6 32510 VEV_3_3_RA6_01_1237.d 4.51E5 3 3 227 235
K.NTASTGEYLYAGLER(+14.02).L Y 54.24 1657.7947 15 -7.1 829.8987 2 75.91 4 43845 VEV_1_3_RA4_01_1235.d 2.06E4 2 2 411 425 Methylation(KR)
K.GKSVGINIGGSGER.A Y 52.52 1329.7001 14 -5.5 444.2382 3 41.87 4 19820 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 460 473
K.FWAHDHWNLQTPPDIVTFSK.K Y 47.97 2438.1807 20 -22.4 610.5388 4 80.88 4 47705 VEV_1_3_RA4_01_1235.d 1.12E5 2 2 341 360
R.LAQQY(-2.02)PSEFQNLR.G Y 41.00 1590.7791 13 7.5 531.2709 3 70.09 4 39279 VEV_1_3_RA4_01_1235.d 3.37E4 1 1 426 438 2-amino-3-oxo-butanoic_acid
R.LAQQYPSEFQN(+.98)LR.G Y 39.28 1593.7787 13 -8.6 797.8898 2 71.55 4 40439 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 426 438 Deamidation (NQ)
K.GQ(+.98)GTFIAWDSPQR.D Y 31.06 1462.6841 13 4.7 732.3527 2 71.89 5 40382 VEV_2_3_RA5_01_1236.d 8.42E4 1 1 441 453 Deamidation (NQ)
K.AAFIC(+57.02)YR.Q Y 29.72 899.4323 7 -9.1 450.7193 2 59.43 5 31128 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 178 184 Carbamidomethylation
R.C(+57.02)LAEVER.I Y 27.98 875.4171 7 -15.6 438.7090 2 32.12 6 14046 VEV_3_3_RA6_01_1237.d 9.08E4 1 1 275 281 Carbamidomethylation
R.ALIFR.A Y 26.63 618.3853 5 -13.5 310.1958 2 58.48 4 30394 VEV_1_3_RA4_01_1235.d 1.77E5 2 2 393 397
K.NTASTGE(+14.02)YLYAGLER.L Y 21.65 1657.7947 15 -4.3 829.9011 2 74.51 4 42754 VEV_1_3_RA4_01_1235.d 9.75E4 1 1 411 425 Methylation(others)
R.LAQQYPSEFQ(+.98)NLR.G Y 19.59 1593.7787 13 -5.8 797.8920 2 71.43 5 40047 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 426 438 Deamidation (NQ)
R.LK(+14.02)Y(-18.01)PLEQFAAENAQEEKR.C Y 18.50 2159.1011 18 -29.5 540.7666 4 68.30 4 37879 VEV_1_3_RA4_01_1235.d 8.08E4 1 1 257 274 Methylation(KR); Dehydration
K.SVGINIGGSGERAVR.L Y 17.32 1470.7903 15 -22.8 368.6965 4 46.42 5 22978 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 462 476
MAAAISR.S Y 16.30 718.3796 7 -28.6 360.1868 2 44.87 4 21688 VEV_1_3_RA4_01_1235.d 0 1 1 1 7
total 28 peptides
A0A0A0HV38
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGTLAPHLVVGFGEAC(+57.02)R.I Y 122.18 1769.8883 17 -9.1 590.9647 3 73.93 4 42300 VEV_1_3_RA4_01_1235.d 3.74E5 3 3 816 832 Carbamidomethylation
R.ALGNSDESAHSSIR.F Y 119.86 1442.6749 14 -6.9 722.3398 2 27.51 4 11518 VEV_1_3_RA4_01_1235.d 4.41E5 6 6 916 929
R.HLQDEGFEVTYLPVQNNGLINLDDLK.A Y 100.00 2983.4927 26 -2.0 995.5029 3 86.78 4 51755 VEV_1_3_RA4_01_1235.d 8.9E4 2 2 688 713
R.VRLDPIITGGGQER.G Y 89.73 1509.8263 14 -14.4 504.2755 3 64.25 4 34695 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 799 812
R.VLDAMLPFLTGLYGNPHSR.T Y 59.50 2100.0825 19 7.6 1051.0565 2 87.79 4 52372 VEV_1_3_RA4_01_1235.d 0 1 1 594 612
R.IATEEMEYDAK.R Y 49.30 1298.5699 11 -5.5 650.2887 2 54.43 4 27715 VEV_1_3_RA4_01_1235.d 6.41E4 1 1 833 843
K.IYGPK.G Y 47.03 576.3271 5 -55.2 577.3026 1 16.41 6 5669 VEV_3_3_RA6_01_1237.d 8.69E4 3 3 782 786
R.LDPIITGGGQER.G Y 45.38 1254.6567 12 -43.3 628.3085 2 60.95 5 32254 VEV_2_3_RA5_01_1236.d 4.19E4 3 3 801 812
K.GIGAC(+57.02)YVR.R Y 45.17 894.4382 8 -9.3 448.2222 2 44.80 4 21637 VEV_1_3_RA4_01_1235.d 5.39E5 4 4 787 794 Carbamidomethylation
K.LIGADAK.E Y 37.39 686.3962 7 -6.8 687.3989 1 22.16 4 8543 VEV_1_3_RA4_01_1235.d 4.52E4 1 1 634 640
K.TLTSAGGPSATAWPR.T Y 32.81 1471.7419 15 -24.9 491.5757 3 65.54 5 35692 VEV_2_3_RA5_01_1236.d 1.43E5 2 2 367 381
K.AVSQGVSDFASR.Y Y 30.47 1222.5942 12 -17.1 612.2939 2 52.95 6 26030 VEV_3_3_RA6_01_1237.d 3.04E5 3 3 225 236
R.THAYGWETEK.A Y 28.28 1220.5461 10 5.5 611.2837 2 35.22 4 15875 VEV_1_3_RA4_01_1235.d 2.86E4 1 1 613 622
R.VSFLR.E N 21.97 620.3646 5 -20.4 311.1832 2 50.48 4 25171 VEV_1_3_RA4_01_1235.d 7.43E4 2 2 952 956
K.VFLHTDAAQAVGK.I Y 18.14 1355.7197 13 5.6 452.9164 3 73.47 4 41952 VEV_1_3_RA4_01_1235.d 5.65E4 2 2 750 762
R.YTDPK.I Y 16.84 622.2962 5 7.7 312.1578 2 19.07 4 6926 VEV_1_3_RA4_01_1235.d 4.88E4 1 1 237 241
K.IYGPKGIGAC(+57.02)YVR.R Y 16.68 1452.7548 13 -28.3 485.2452 3 43.24 5 21063 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 782 794 Carbamidomethylation
R.EVNELTASLR.F Y 15.95 1130.5931 10 39.7 377.8866 3 25.59 5 10819 VEV_2_3_RA5_01_1236.d 5.62E4 1 1 304 313
K.EIGAIC(+57.02)RANK.V Y 15.73 1130.5865 10 3.6 377.8708 3 57.04 5 29461 VEV_2_3_RA5_01_1236.d 5.11E4 1 1 740 749 Carbamidomethylation
M(+15.99)ALLPEHKAAVR.S Y 15.28 1350.7441 12 -20.6 451.2460 3 66.92 6 35563 VEV_3_3_RA6_01_1237.d 3.23E4 1 1 1 12 Oxidation (M)
R.TVETNPAFR.A Y 15.04 1033.5193 9 -11.6 1034.5145 1 112.50 6 58774 VEV_3_3_RA6_01_1237.d 0 1 1 345 353
total 21 peptides
C1GFB1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.APTIAQAIPAAVAAAR.A Y 126.90 1490.8568 16 -16.2 746.4236 2 77.67 6 43556 VEV_3_3_RA6_01_1237.d 1.37E6 8 8 195 210
R.AVGGFSTKVEVEC(+57.02)R.T Y 100.45 1537.7559 14 -10.4 769.8772 2 59.98 5 31535 VEV_2_3_RA5_01_1236.d 9.82E5 6 6 211 224 Carbamidomethylation
R.SHNWNGIIAGTR.K Y 98.43 1324.6636 12 -3.3 663.3369 2 59.72 5 31341 VEV_2_3_RA5_01_1236.d 4.26E5 4 4 128 139
R.SHNWNGIIAGTRK.T Y 91.20 1452.7585 13 -14.9 727.3757 2 49.15 6 23809 VEV_3_3_RA6_01_1237.d 7.49E5 6 6 128 140
K.TANLVNIIR.S Y 81.56 1012.6029 9 -31.2 507.2929 2 69.88 6 37823 VEV_3_3_RA6_01_1237.d 1.33E6 8 8 119 127
K.SQPQGSSTQSTKAPTIAQAIPAAVAAAR.A Y 77.56 2707.4253 28 -12.7 903.4709 3 73.28 6 40294 VEV_3_3_RA6_01_1237.d 1.92E5 2 2 183 210
R.TIDEAHAAIAAGANVIMLDNFSAAEVAGAAKK.L Y 67.08 3139.5972 32 0.4 785.9069 4 83.42 6 47458 VEV_3_3_RA6_01_1237.d 5.53E4 1 1 225 256
R.VALNLLAR.C Y 48.09 868.5494 8 -14.2 435.2758 2 70.80 4 39840 VEV_1_3_RA4_01_1235.d 1.46E6 3 3 104 111
R.QILLGER.V Y 37.60 827.4865 7 -18.3 414.7429 2 52.15 6 25567 VEV_3_3_RA6_01_1237.d 9.41E5 6 6 97 103
R.VALNLLAR(+14.02).C Y 33.79 882.5651 8 -20.8 442.2806 2 72.47 6 39713 VEV_3_3_RA6_01_1237.d 1E5 3 3 104 111 Methylation(KR)
R.KTTPGFR.L Y 29.65 805.4446 7 -16.3 403.7230 2 15.53 5 5316 VEV_2_3_RA5_01_1236.d 2.83E5 3 3 140 146
R.Q(+42.01)ILLGE(+21.98)RVALNLLAR.C Y 26.29 1742.0178 15 -16.8 436.5044 4 70.79 5 39567 VEV_2_3_RA5_01_1236.d 1.87E5 1 1 97 111 Acetylation (N-term); Sodium adduct
K.VEVEC(+57.02)R.T Y 25.77 790.3643 6 8.4 791.3782 1 79.03 6 44469 VEV_3_3_RA6_01_1237.d 2.83E4 1 1 219 224 Carbamidomethylation
K.APTIAQAIPAAVAAARAVGGFSTK.V Y 22.92 2238.2483 24 -92.2 747.0212 3 77.91 6 43662 VEV_3_3_RA6_01_1237.d 0 1 1 195 218
K.TTPGFR.L Y 17.17 677.3497 6 -10.9 339.6784 2 23.64 4 9370 VEV_1_3_RA4_01_1235.d 1.86E5 1 1 141 146
R.AVGGFSTK.V Y 15.76 765.4021 8 -47.5 766.3730 1 46.38 5 22953 VEV_2_3_RA5_01_1236.d 3.39E4 1 1 211 218
K.SQPQGSSTQSTK.A Y 15.33 1234.5790 12 -0.3 412.5335 3 12.17 5 3539 VEV_2_3_RA5_01_1236.d 4.22E4 1 1 183 194
total 17 peptides
C1G9X9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FVRDIIKEVAGLAPYER.R Y 111.13 1975.0890 17 -10.2 494.7745 4 82.11 4 48618 VEV_1_3_RA4_01_1235.d 1.29E6 6 6 40 56
R.DIIKEVAGLAPYER.R Y 109.53 1572.8511 14 -20.6 525.2802 3 79.14 6 44564 VEV_3_3_RA6_01_1237.d 1.86E6 9 9 43 56
R.DIIKEVAGLAPYERR.V Y 98.08 1728.9521 15 -11.9 433.2402 4 76.17 4 44039 VEV_1_3_RA4_01_1235.d 5.86E5 4 4 43 57
K.FVRDIIKEVAGLAPYERR.V Y 94.26 2131.1902 18 -26.5 427.2340 5 80.08 6 45220 VEV_3_3_RA6_01_1237.d 2.64E5 3 3 40 57
K.EVAGLAPYER.R Y 82.21 1103.5610 10 -10.6 552.7819 2 60.20 4 31628 VEV_1_3_RA4_01_1235.d 1.57E6 6 6 47 56
R.TKFVRDIIKEVAGLAPYER.R Y 80.78 2204.2317 19 -13.5 441.8477 5 82.44 5 47609 VEV_2_3_RA5_01_1236.d 6.03E5 6 6 38 56
R.SGIILGLNKGHK.T Y 80.27 1235.7350 12 -11.2 618.8679 2 46.85 5 23229 VEV_2_3_RA5_01_1236.d 7.36E6 22 22 6 17
R.DIIKEVAGLAPYER(+14.02).R Y 76.96 1586.8667 14 -21.9 529.9512 3 81.56 6 46246 VEV_3_3_RA6_01_1237.d 1.74E5 3 3 43 56 Methylation(KR)
R.DIIKE(+14.02)VAGLAPYER.R Y 66.89 1586.8667 14 0.1 529.9629 3 81.19 4 47929 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 43 56 Methylation(others)
R.DIIK(+14.02)EVAGLAPYER.R Y 66.57 1586.8667 14 -13.9 529.9555 3 81.11 5 46774 VEV_2_3_RA5_01_1236.d 2.22E5 3 3 43 56 Methylation(KR)
R.SGIILGLNK.G Y 66.30 913.5596 9 -11.4 914.5565 1 67.55 5 37186 VEV_2_3_RA5_01_1236.d 1.61E6 6 6 6 14
K.TTANTTKPR.I Y 57.75 988.5302 9 -44.1 495.2505 2 8.50 5 2003 VEV_2_3_RA5_01_1236.d 1.22E4 3 3 18 26
K.TTANTTKPR(+14.02).I Y 52.63 1002.5458 9 -7.3 502.2765 2 10.91 4 2820 VEV_1_3_RA4_01_1235.d 1.08E5 3 3 18 26 Methylation(KR)
R.DIIK(+14.02)EVAGLAPYERR.V Y 45.96 1742.9679 15 -17.0 436.7418 4 78.08 6 43783 VEV_3_3_RA6_01_1237.d 4.61E4 1 1 43 57 Methylation(KR)
R.VVELLR.N N 36.13 727.4592 6 -16.5 364.7309 2 57.12 5 29507 VEV_2_3_RA5_01_1236.d 1.84E6 7 7 58 63
R.RVVELLR.N Y 35.00 883.5603 7 -17.6 442.7796 2 51.87 5 26336 VEV_2_3_RA5_01_1236.d 2.56E6 6 6 57 63
R.DIIKE(+14.02)VAGLAPYERR.V Y 34.94 1742.9679 15 7.0 436.7523 4 78.17 4 45607 VEV_1_3_RA4_01_1235.d 0 1 1 43 57 Methylation(others)
R.TKGHLSR.R Y 33.60 797.4507 7 -12.2 399.7278 2 8.72 5 2061 VEV_2_3_RA5_01_1236.d 1.63E4 2 2 30 36
K.EVAGLAPYERR.V Y 30.23 1259.6622 11 -13.4 630.8300 2 50.44 5 25406 VEV_2_3_RA5_01_1236.d 1.31E5 3 3 47 57
R.SGIILGLNKGHKTTANTTKPR.I Y 29.67 2206.2546 21 -44.0 442.2388 5 44.60 5 21892 VEV_2_3_RA5_01_1236.d 0 1 1 6 26
K.EVAGLAPYER(+14.02).R Y 23.65 1117.5768 10 -15.9 559.7868 2 65.87 6 34782 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 47 56 Methylation(KR)
K.FVRDIIKE(+43.99)VAGLAPYER.R Y 23.47 2019.0789 17 -45.1 505.7542 4 82.16 6 46646 VEV_3_3_RA6_01_1237.d 5.41E4 1 1 40 56 Carboxylation (E)
R.TKFVR.D Y 22.59 649.3911 5 -16.2 325.6976 2 13.48 5 4224 VEV_2_3_RA5_01_1236.d 2.5E5 2 2 38 42
R.TKFVRDIIKEVAGLAPYER(-.98).R Y 19.55 2203.2476 19 -19.0 441.6484 5 82.34 5 47555 VEV_2_3_RA5_01_1236.d 0 1 1 38 56 Amidation
total 24 peptides
C1GAY4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVC(+57.02)SGTTGHAEALR.I Y 128.80 1444.6729 14 -11.2 723.3356 2 31.12 5 13950 VEV_2_3_RA5_01_1236.d 1.21E6 6 6 80 93 Carbamidomethylation
R.LFSTTPSLSLTPEVLAAR.G Y 99.47 1902.0461 18 -22.2 952.0093 2 84.41 4 50192 VEV_1_3_RA4_01_1235.d 3.99E5 3 3 11 28
R.SAIFTHSEEQQK.I Y 91.24 1403.6681 12 -8.9 702.8351 2 29.97 5 13247 VEV_2_3_RA5_01_1236.d 9.62E5 10 10 132 143
R.SAIFTHSEEQQKIAK.L Y 76.56 1715.8842 15 -15.7 858.9359 2 42.43 5 20578 VEV_2_3_RA5_01_1236.d 5.44E5 3 3 132 146
R.Q(-17.03)GQDVGTQYR.S Y 73.97 1133.5101 10 -11.0 567.7561 2 47.24 6 22754 VEV_3_3_RA6_01_1237.d 5.64E5 4 4 122 131 Pyro-glu from Q
R.VGYC(+57.02)GGESR.S Y 71.27 983.4131 9 -13.2 492.7073 2 19.40 6 7251 VEV_3_3_RA6_01_1237.d 2.47E5 4 4 66 74 Carbamidomethylation
R.M(+15.99)HDPTTLNR.Q Y 68.18 1099.5081 9 -10.3 550.7556 2 19.01 6 7052 VEV_3_3_RA6_01_1237.d 1.15E5 2 2 113 121 Oxidation (M)
R.IIFDPSIVTYR.Q Y 66.59 1322.7234 11 -13.9 662.3598 2 80.68 6 45636 VEV_3_3_RA6_01_1237.d 4.77E4 1 1 94 104
R.QGQD(-18.01)VGTQYR.S Y 55.74 1132.5261 10 14.3 567.2784 2 47.12 5 23406 VEV_2_3_RA5_01_1236.d 0 1 1 122 131 Dehydration
R.GFPENAQEATFAAGC(+57.02)FWGVEHLFR.K Y 53.43 2740.2493 24 0.5 914.4242 3 88.70 4 52983 VEV_1_3_RA4_01_1235.d 1.2E5 2 2 29 52 Carbamidomethylation
R.LFSTTPSLSLTPEVLAAR(+14.02).G Y 52.11 1916.0619 18 -2.2 959.0361 2 85.55 5 49484 VEV_2_3_RA5_01_1236.d 3.05E4 1 1 11 28 Methylation(KR)
R.MHDPTTLNR.Q Y 52.01 1083.5132 9 -5.9 542.7607 2 28.51 4 12021 VEV_1_3_RA4_01_1235.d 1.23E5 2 2 113 121
R.Q(-17.03)LVEFFYR.M Y 44.79 1083.5389 8 -4.8 542.7742 2 89.76 6 51187 VEV_3_3_RA6_01_1237.d 2.67E4 1 1 105 112 Pyro-glu from Q
R.QGQDVGTQYR.S Y 41.46 1150.5366 10 -8.4 576.2708 2 25.38 4 10331 VEV_1_3_RA4_01_1235.d 2.69E5 6 6 122 131
R.GFPEN(+.98)AQEATFAAGC(+57.02)FWGVEHLFR.K Y 33.35 2741.2332 24 -2.3 914.7496 3 88.46 5 51091 VEV_2_3_RA5_01_1236.d 3.15E4 1 1 29 52 Deamidation (NQ); Carbamidomethylation
R.SPSYR.S Y 24.90 608.2918 5 -26.3 609.2831 1 62.74 6 32444 VEV_3_3_RA6_01_1237.d 0 1 1 75 79
R.SVC(+57.02)SGTTGHAEALR(+14.02).I Y 24.11 1458.6885 14 21.0 730.3668 2 38.76 5 18392 VEV_2_3_RA5_01_1236.d 0 1 1 80 93 Carbamidomethylation; Methylation(KR)
R.IIFDPSIVTYRQLVEFFYRMHDPTTLNR.Q Y 23.85 3470.7808 28 2.7 695.1653 5 91.52 4 54504 VEV_1_3_RA4_01_1235.d 9.3E4 1 1 94 121
K.FGGGK.G Y 18.74 464.2383 5 -15.9 465.2382 1 36.06 4 16371 VEV_1_3_RA4_01_1235.d 6.54E4 1 1 55 59
K.GLLDAR.V Y 17.77 643.3653 6 -14.5 322.6853 2 43.70 5 21329 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 60 65
K.G(+42.01)LLDAR.V Y 16.85 685.3759 6 -33.0 343.6839 2 43.22 6 20366 VEV_3_3_RA6_01_1237.d 0 1 1 60 65 Acetylation (N-term)
K.VATEWWK.R Y 15.72 918.4600 7 -16.1 460.2299 2 41.85 6 19567 VEV_3_3_RA6_01_1237.d 0 1 1 152 158
R.QLVEFFYR.M Y 15.39 1100.5654 8 -3.7 551.2880 2 78.48 6 44064 VEV_3_3_RA6_01_1237.d 3.77E4 1 1 105 112
M(+15.99)PPFMSR.I Y 15.33 880.3935 7 25.9 881.4236 1 104.93 5 57489 VEV_2_3_RA5_01_1236.d 1.31E3 1 1 1 7 Oxidation (M)
total 24 peptides
C1G5E8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AC(+57.02)SETPERC(+57.02)DGGSDESDGTAR.A Y 113.80 2255.8655 21 -9.3 752.9554 3 23.70 5 9774 VEV_2_3_RA5_01_1236.d 6.59E5 7 7 409 429 Carbamidomethylation
K.SAIAFLQALYPPVGGVAK.S Y 110.36 1801.0137 18 -9.4 901.5056 2 88.59 5 51185 VEV_2_3_RA5_01_1236.d 6.98E5 7 7 107 124
K.STPPTELTTLGYEQVFTTGAYYHNR.Y Y 92.52 2845.3560 25 -6.7 949.4529 3 81.34 5 46920 VEV_2_3_RA5_01_1236.d 3.23E5 3 3 47 71
K.TKEVVASAPEDEVLQK.S Y 84.22 1741.9098 16 -9.8 581.6382 3 59.66 4 31233 VEV_1_3_RA4_01_1235.d 1.5E5 2 2 91 106
K.EVVASAPEDEVLQK.S Y 83.83 1512.7671 14 -9.0 757.3840 2 64.78 4 35104 VEV_1_3_RA4_01_1235.d 2.5E5 3 3 93 106
R.YISPTSDFR.I Y 78.29 1084.5189 9 -14.2 543.2590 2 61.49 6 31593 VEV_3_3_RA6_01_1237.d 8.63E5 4 4 72 80
R.AVSGSTLAGEVLSGLREVITTGGSK.T Y 76.54 2388.2859 25 -11.2 797.0937 3 89.89 6 51268 VEV_3_3_RA6_01_1237.d 1.52E5 3 3 268 292
K.AC(+57.02)SETPERC(+57.02)DGGSDESDGTAR(+14.02).A Y 71.72 2269.8811 21 -10.4 757.6265 3 30.09 5 13311 VEV_2_3_RA5_01_1236.d 3.72E4 1 1 409 429 Carbamidomethylation; Methylation(KR)
R.SGSIIPGAPETVPVAYPLFGQSDTLMPWSEFESNMEK.I Y 65.79 4010.8958 37 -6.5 1337.9639 3 95.45 4 56500 VEV_1_3_RA4_01_1235.d 3.38E4 1 1 361 397
R.ILNISPDIVK.T Y 61.70 1110.6648 10 -12.9 556.3325 2 75.12 5 42680 VEV_2_3_RA5_01_1236.d 5.37E5 4 4 81 90
K.AC(+57.02)SETPER(+14.02)C(+57.02)DGGSDESDGTAR.A Y 45.01 2269.8811 21 -10.0 757.6268 3 30.47 5 13533 VEV_2_3_RA5_01_1236.d 8.92E4 2 2 409 429 Carbamidomethylation; Methylation(KR)
K.SIAPMVER.T Y 37.59 901.4691 8 -14.4 451.7353 2 51.17 5 25861 VEV_2_3_RA5_01_1236.d 2.96E4 2 2 195 202
K.TKEVVASAPEDEVLQKSAIAFLQALYPPVGGVAK.S Y 35.00 3524.9128 34 -11.5 882.2253 4 90.61 5 52198 VEV_2_3_RA5_01_1236.d 5.34E4 1 1 91 124
R.AVSGSTLAGEVLSGLR.E Y 26.48 1515.8257 16 -39.4 304.1605 5 13.01 4 3813 VEV_1_3_RA4_01_1235.d 5.41E4 2 2 268 283
R.EVITTGGSK.T Y 21.40 890.4709 9 -11.7 891.4678 1 93.47 4 55540 VEV_1_3_RA4_01_1235.d 1.17E5 3 3 284 292
K.RDGMSK.A Y 19.29 692.3275 6 -25.1 693.3174 1 21.81 4 8372 VEV_1_3_RA4_01_1235.d 1.75E5 2 2 437 442
R.DGM(+15.99)SK.A Y 17.29 552.2214 5 64.0 553.2640 1 38.02 5 17946 VEV_2_3_RA5_01_1236.d 1.81E4 1 1 438 442 Oxidation (M)
K.EVVASAPEDEVLQ(+.98)K.S Y 16.44 1513.7511 14 -20.4 757.8674 2 64.58 5 34956 VEV_2_3_RA5_01_1236.d 0 1 1 93 106 Deamidation (NQ)
total 18 peptides
C1GIP8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DNIQGITKPAIR.R N 113.70 1324.7462 12 -13.8 663.3712 2 58.12 6 29110 VEV_3_3_RA6_01_1237.d 2.38E6 12 12 70 81
R.TLYGFGG Y 103.75 713.3384 7 -11.0 714.3379 1 73.43 4 41926 VEV_1_3_RA4_01_1235.d 1.88E6 3 3 142 148
K.TVTSLDVVYALKR.Q N 86.02 1463.8347 13 -7.8 488.9484 3 74.08 5 41960 VEV_2_3_RA5_01_1236.d 2.22E6 10 10 126 138
K.SFLESVIRDAVTYTEHAK.R Y 80.92 2065.0479 18 -5.1 689.3530 3 87.07 4 51951 VEV_1_3_RA4_01_1235.d 5.13E5 7 7 106 123
R.ISAMIYEETRGVLK.S N 77.61 1608.8545 14 -13.8 805.4234 2 72.69 5 40961 VEV_2_3_RA5_01_1236.d 4.9E5 5 5 92 105
K.ILRDNIQGITKPAIR.R N 74.85 1707.0155 15 -9.4 427.7571 4 63.80 4 34359 VEV_1_3_RA4_01_1235.d 1.45E5 3 3 67 81
R.ISAMIYEETR.G N 68.59 1211.5856 10 -11.4 606.7932 2 64.91 4 35200 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 92 101
K.TVTSLDVVYALK.R N 67.24 1307.7336 12 -8.9 654.8683 2 78.93 4 46197 VEV_1_3_RA4_01_1235.d 4.78E4 1 1 126 137
R.DNIQGITKPAIRR.L N 60.89 1480.8474 13 -21.0 741.4154 2 50.03 4 24901 VEV_1_3_RA4_01_1235.d 2.34E6 10 10 70 82
K.RISAMIYEETRGVLK.S N 60.55 1764.9556 15 -12.8 442.2405 4 73.18 5 41303 VEV_2_3_RA5_01_1236.d 3.55E4 1 1 91 105
R.ISAM(+15.99)IYEETRGVLK.S N 55.19 1624.8494 14 -19.7 542.6130 3 69.07 4 38500 VEV_1_3_RA4_01_1235.d 2.98E5 2 2 92 105 Oxidation (M)
R.DAVTYTEHAK.R N 45.96 1133.5353 10 -13.1 567.7675 2 24.03 6 9705 VEV_3_3_RA6_01_1237.d 3.94E5 3 3 114 123
K.SFLESVIR.D Y 45.60 949.5233 8 -10.8 475.7638 2 75.82 4 43773 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 106 113
R.KTVTSLDVVYALKR.Q N 44.96 1591.9297 14 -17.4 398.9828 4 68.18 6 36531 VEV_3_3_RA6_01_1237.d 2.96E5 3 3 125 138
R.DNIQ(+.98)GITKPAIR.R N 44.06 1325.7302 12 -22.8 442.9073 3 60.87 4 32136 VEV_1_3_RA4_01_1235.d 2.69E5 2 2 70 81 Deamidation (NQ)
R.ISAM(+15.99)IYEETR.G N 37.51 1227.5806 10 -16.7 614.7873 2 58.75 6 29538 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 92 101 Oxidation (M)
K.RKTVTSLDVVYALKR.Q N 30.41 1748.0308 15 -67.6 437.9854 4 65.00 4 35275 VEV_1_3_RA4_01_1235.d 1.13E4 1 1 124 138
R.KILRDNIQGITKPAIR.R N 23.98 1835.1105 16 -55.3 368.0091 5 62.38 5 33321 VEV_2_3_RA5_01_1236.d 0 1 1 66 81
K.TVTSLDVVYALKR(+14.02).Q N 19.23 1477.8503 13 -27.8 493.6104 3 75.05 6 41582 VEV_3_3_RA6_01_1237.d 7.37E4 1 1 126 138 Methylation(KR)
R.VIHHAAFGEPC(+57.02)GKGGK.G Y 15.19 1663.8252 16 11.3 416.9683 4 47.84 6 23052 VEV_3_3_RA6_01_1237.d 1.57E5 1 1 39 54 Carbamidomethylation
total 20 peptides
C1G6S0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLSDGTYATESALTSQSSAAAK.L Y 103.55 2157.0437 22 -7.1 1079.5215 2 68.31 4 37883 VEV_1_3_RA4_01_1235.d 5.58E4 1 1 521 542
R.VLSDGTYATESALTSQSSAAAKLETVK.A Y 101.77 2727.3813 27 -10.9 910.1245 3 75.33 6 41777 VEV_3_3_RA6_01_1237.d 9.08E4 2 2 521 547
R.QLILDGDYYLATVLSSTLTK.L Y 94.80 2213.1831 20 -9.0 1107.5889 2 94.12 4 55873 VEV_1_3_RA4_01_1235.d 2.54E4 1 1 556 575
K.ATGGDSIYGDLPSK.L Y 93.46 1379.6569 14 -12.1 690.8274 2 64.02 6 33388 VEV_3_3_RA6_01_1237.d 2.25E5 2 2 707 720
K.LREPELLEPLLSSAR.S Y 89.67 1721.9675 15 -4.3 574.9940 3 80.33 4 47274 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 127 141
K.ATGGDSIYGDLPSKLSR.V Y 84.76 1735.8740 17 -14.1 579.6238 3 68.92 5 38254 VEV_2_3_RA5_01_1236.d 3.18E5 3 3 707 723
R.SVFGEDALANLSIEK.Q Y 76.67 1591.8093 15 -16.5 796.8988 2 81.69 6 46331 VEV_3_3_RA6_01_1237.d 8.53E4 1 1 906 920
K.SAEEGADEIELDLAK.A Y 67.86 1588.7467 15 -4.6 795.3770 2 73.77 6 40647 VEV_3_3_RA6_01_1237.d 9.64E4 1 1 692 706
R.Q(-17.03)LILDGDYYLATVLSSTLTK.L Y 66.42 2196.1565 20 -9.6 1099.0750 2 97.94 4 57528 VEV_1_3_RA4_01_1235.d 7.23E4 1 1 556 575 Pyro-glu from Q
R.NDLQHPNEYIR.G Y 57.21 1397.6687 11 -11.1 699.8339 2 52.46 4 26458 VEV_1_3_RA4_01_1235.d 3.79E5 6 6 107 117
K.ELETTFLEDTR.Q Y 38.58 1352.6460 11 -18.4 677.3178 2 68.44 6 36722 VEV_3_3_RA6_01_1237.d 2.71E5 1 1 640 650
R.NAFAALVTISHQK.A Y 30.30 1398.7620 13 -16.0 467.2538 3 72.42 5 40768 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 192 204
K.KSAEEGADEIELDLAKATGGDSIYGDLPSK.L Y 26.69 3078.4880 30 -17.8 770.6156 4 81.18 6 45981 VEV_3_3_RA6_01_1237.d 5.19E4 1 1 691 720
R.GNTLRFLC(+57.02)KLR.E Y 23.72 1376.7710 11 -27.3 345.1906 4 35.19 6 15768 VEV_3_3_RA6_01_1237.d 0 1 1 118 128 Carbamidomethylation
K.TQLEK.G N 21.83 617.3384 5 -17.2 618.3351 1 70.00 4 39214 VEV_1_3_RA4_01_1235.d 0 1 1 28 32
K.AT(-2.02)GGDSIYGDLPSK.L Y 20.21 1377.6412 14 -0.9 689.8273 2 63.88 6 33280 VEV_3_3_RA6_01_1237.d 0 1 1 707 720 2-amino-3-oxo-butanoic_acid
R.FVM(+15.99)PSK.S Y 19.70 723.3625 6 -21.2 724.3545 1 81.15 5 46807 VEV_2_3_RA5_01_1236.d 7.88E4 1 1 65 70 Oxidation (M)
R.GVLWVVGEYSLEANDIREAWK.R Y 19.70 2433.2329 21 -13.5 609.3073 4 77.41 4 45018 VEV_1_3_RA4_01_1235.d 0 1 1 454 474
K.AAASK(+28.03).L N 19.37 474.2802 5 7.5 475.2910 1 106.69 4 60234 VEV_1_3_RA4_01_1235.d 0 1 1 280 284 Dimethylation(KR)
K.TVDEQYEKNNEYR.Q Y 18.77 1686.7485 13 19.0 563.2675 3 35.05 4 15783 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 365 377
K.I(+43.01)DTM(+15.99)R.R Y 17.87 693.3116 5 -0.7 694.3184 1 73.92 5 41820 VEV_2_3_RA5_01_1236.d 3.12E4 1 1 39 43 Carbamylation; Oxidation (M)
K.TAVQVDDTIPIR.Q Y 17.45 1326.7144 12 -22.8 664.3493 2 69.16 5 38375 VEV_2_3_RA5_01_1236.d 7.65E4 1 1 675 686
R.IMSC(+57.02)VR.S Y 16.53 764.3673 6 -3.9 765.3716 1 44.58 6 21166 VEV_3_3_RA6_01_1237.d 0 1 1 625 630 Carbamidomethylation
K.TQLEKGTDESK.I Y 16.42 1234.6041 11 -12.1 618.3019 2 61.65 5 32774 VEV_2_3_RA5_01_1236.d 5.21E4 1 1 28 38
K.IDTMR.R Y 15.79 634.3109 5 -7.5 635.3134 1 52.57 6 25805 VEV_3_3_RA6_01_1237.d 0 1 1 39 43
R.QAFRAMVQVE(+43.99)EKK.R Y 15.55 1606.8137 13 -18.9 536.6017 3 62.88 5 33694 VEV_2_3_RA5_01_1236.d 1.52E5 1 1 651 663 Carboxylation (E)
R.QAFRAMVQVEEK.K Y 15.01 1434.7289 12 -3.2 479.2487 3 49.41 4 24506 VEV_1_3_RA4_01_1235.d 3.77E4 1 1 651 662
total 27 peptides
C1GBU2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AANVIHVVDFGMAK.Q Y 110.85 1470.7653 14 -13.0 736.3804 2 72.89 5 41093 VEV_2_3_RA5_01_1236.d 2.35E5 3 3 147 160
R.RDDLEALGHVFMYFLR.G Y 106.31 1980.9879 16 -10.6 496.2490 4 90.28 4 53811 VEV_1_3_RA4_01_1235.d 8.58E4 2 2 199 214
K.Q(-17.03)TTAVKDLC(+57.02)EGYPEEFNKYLTYVR.N Y 102.59 2906.3796 24 -9.5 969.7913 3 83.23 5 48095 VEV_2_3_RA5_01_1236.d 3.61E4 1 1 239 262 Pyro-glu from Q; Carbamidomethylation
M.T(+42.01)SSSSNVVGVHYR.V Y 85.47 1433.6899 13 -9.6 717.8454 2 58.50 5 30453 VEV_2_3_RA5_01_1236.d 6.04E5 6 6 2 14 Acetylation (Protein N-term)
K.Q(-17.03)YPTQHHLHTSNVPNTSTR.D Y 79.84 2200.0410 19 -12.4 734.3452 3 48.72 5 24367 VEV_2_3_RA5_01_1236.d 4.85E5 3 3 310 328 Pyro-glu from Q
R.DIKPDNFLIGRPNSK.A Y 69.28 1712.9209 15 -10.6 429.2330 4 66.95 5 36734 VEV_2_3_RA5_01_1236.d 2.91E5 3 3 132 146
K.DLC(+57.02)EGYPEEFNKYLTYVR.N Y 63.58 2295.0518 18 -3.7 766.0217 3 82.71 4 49020 VEV_1_3_RA4_01_1235.d 1.36E5 3 3 245 262 Carbamidomethylation
K.RQNGAAGVLETTPAASTQAQFQNSNTHLPGR.I Y 62.66 3221.5925 31 -6.5 806.4002 4 70.01 4 39220 VEV_1_3_RA4_01_1235.d 4.27E5 3 3 362 392
R.DIHGASVPR.G Y 55.84 950.4933 9 -23.1 476.2430 2 28.96 6 12312 VEV_3_3_RA6_01_1237.d 1.56E6 8 8 329 337
K.IGEGSFGVIFEGTNLLNSQQVAIKFEPR.K Y 41.71 3049.5872 28 -9.1 763.3972 4 88.58 4 52867 VEV_1_3_RA4_01_1235.d 0 1 1 19 46
K.QTTAVK(+145.02)DLC(+57.02)EGYPEEFNKYLTYVR.N Y 37.99 3068.4258 24 -43.6 768.0803 4 82.59 6 46932 VEV_3_3_RA6_01_1237.d 0 1 1 239 262 3-(carbamidomethylthio)propanoyl; Carbamidomethylation
R.NLGFEDTPDYDYLRDLFTQALK.N Y 35.32 2633.2649 22 -12.6 1317.6232 2 92.77 6 52660 VEV_3_3_RA6_01_1237.d 3.71E4 1 1 263 284
R.YM(+15.99)SINTHLGR.E Y 34.65 1206.5815 10 0.4 403.2013 3 45.67 4 22183 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 185 194 Oxidation (M)
R.KSDAPQLRDEYR.T Y 32.55 1476.7321 12 -14.8 370.1848 4 32.45 6 14255 VEV_3_3_RA6_01_1237.d 3.79E5 4 4 47 58
M.TSSSSNVVGVHYR.V Y 28.02 1391.6793 13 -16.9 696.8352 2 37.88 6 17273 VEV_3_3_RA6_01_1237.d 1.46E4 1 1 2 14
R.YMSINTHLGR.E Y 27.39 1190.5867 10 -13.3 596.2927 2 58.95 5 30781 VEV_2_3_RA5_01_1236.d 8.27E4 1 1 185 194
K.SLSGTAR(-.98).Y Y 24.37 689.3820 7 21.6 345.7057 2 43.48 6 20505 VEV_3_3_RA6_01_1237.d 3.37E4 1 1 178 184 Amidation
K.SLSGTAR.Y Y 21.09 690.3660 7 6.6 346.1926 2 32.42 4 14252 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 178 184
R.KSLSGTARYMSINTHLGR.E Y 17.51 1991.0371 18 -20.5 399.2065 5 58.72 5 30617 VEV_2_3_RA5_01_1236.d 0 1 1 177 194
R.GPHRPGELGK.R Y 16.98 1046.5621 10 -0.3 349.8612 3 33.03 5 15015 VEV_2_3_RA5_01_1236.d 0 1 1 338 347
K.AATNK.Q N 16.25 503.2704 5 -49.3 504.2528 1 32.93 6 14488 VEV_3_3_RA6_01_1237.d 1.81E5 2 2 224 228
K.QMLSRVQTIHEK.N Y 15.48 1468.7820 12 -20.7 368.1952 4 44.44 5 21784 VEV_2_3_RA5_01_1236.d 0 1 1 115 126
total 22 peptides
C1GM11
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SFPSDFEGVSQFGHTIPAYK.L Y 130.43 2213.0430 20 -13.9 738.6780 3 79.60 6 44922 VEV_3_3_RA6_01_1237.d 1.11E6 8 8 72 91
K.ITADNLTTQLLK.S Y 89.43 1329.7504 12 -14.5 665.8728 2 75.85 6 42170 VEV_3_3_RA6_01_1237.d 7.51E5 3 3 60 71
K.VKLFSPEWILR.E Y 82.74 1386.8022 11 -12.4 463.2690 3 81.75 4 48351 VEV_1_3_RA4_01_1235.d 1.92E5 3 3 135 145
K.SFPSDFEGVSQFGHTIPAYKLR.R Y 79.22 2482.2280 22 2.0 621.5656 4 79.66 5 45835 VEV_2_3_RA5_01_1236.d 2.54E5 2 2 72 93
R.KITADNLTTQLLK.S Y 74.41 1457.8453 13 -12.3 486.9498 3 70.41 6 38160 VEV_3_3_RA6_01_1237.d 2.58E5 4 4 59 71
K.LFSPEWILR.E Y 63.13 1159.6389 9 -17.0 580.8169 2 83.43 6 47463 VEV_3_3_RA6_01_1237.d 4.84E5 4 4 137 145
K.VKLFSPEWILREK.I Y 51.85 1643.9398 13 -9.5 411.9883 4 77.93 5 44666 VEV_2_3_RA5_01_1236.d 8.8E4 2 2 135 147
K.LFSPEWILREK.I Y 51.66 1416.7765 11 -12.6 473.2602 3 78.70 5 45175 VEV_2_3_RA5_01_1236.d 4.94E5 3 3 137 147
R.TTLNINGQK.V Y 48.66 987.5349 9 -18.7 494.7655 2 33.32 6 14756 VEV_3_3_RA6_01_1237.d 1.84E5 2 2 126 134
K.ILSQYQR.Q Y 46.94 906.4923 7 -7.5 454.2500 2 35.08 4 15796 VEV_1_3_RA4_01_1235.d 1.36E6 8 8 148 154
K.IKC(+57.02)SAVFHN Y 40.05 1074.5281 9 -8.2 538.2669 2 34.45 6 15340 VEV_3_3_RA6_01_1237.d 3.79E5 2 2 211 219 Carbamidomethylation
K.RPDLSSALK.A Y 32.62 985.5556 9 -27.2 493.7717 2 45.49 6 21683 VEV_3_3_RA6_01_1237.d 2.8E5 3 3 200 208
K.EGTDIRDIISMIPLAVPGKPELNFNQSQELQTALANLVQK.R Y 32.53 4390.3203 40 34.6 879.1017 5 95.54 6 53809 VEV_3_3_RA6_01_1237.d 0 1 1 160 199
R.TTLNINGQKVK.L Y 29.27 1214.6982 11 -26.7 405.8959 3 36.07 6 16280 VEV_3_3_RA6_01_1237.d 9.72E4 1 1 126 136
R.EKILSQYQR.Q Y 27.70 1163.6299 9 -11.2 388.8796 3 38.66 6 17731 VEV_3_3_RA6_01_1237.d 8.96E4 1 1 146 154
M.APLSSDELK.T Y 25.47 958.4971 9 -14.3 480.2490 2 43.35 6 20435 VEV_3_3_RA6_01_1237.d 4.49E5 2 2 2 10
K.LFSPE(+21.98)WILREKILSQYQR.Q Y 23.14 2327.2402 18 -27.6 582.8013 4 38.58 5 18283 VEV_2_3_RA5_01_1236.d 0 1 1 137 154 Sodium adduct
M.APLSSDELKTVVSVLAQK.L Y 16.35 1884.0568 18 -17.0 629.0155 3 82.98 6 47180 VEV_3_3_RA6_01_1237.d 3.16E4 1 1 2 19
total 18 peptides
C1GC48
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IALPTVDGDVVIKLISELVK.L Y 123.39 2121.2661 20 -7.8 708.0905 3 97.56 5 55194 VEV_2_3_RA5_01_1236.d 1.27E5 3 3 154 173
R.IALPTVDGDVVIKLISELVKLDSRFIPQAR.G Y 95.34 3304.9121 30 -7.6 661.9847 5 97.57 5 55197 VEV_2_3_RA5_01_1236.d 6.02E4 1 1 154 183
R.SDGLPGIDFSKLSITK.T Y 93.79 1676.8984 16 -9.4 559.9681 3 80.94 5 46665 VEV_2_3_RA5_01_1236.d 3.52E5 3 3 40 55
K.RIALPTVDGDVVIKLISELVK.L Y 89.67 2277.3672 21 -14.5 570.3408 4 94.54 4 56078 VEV_1_3_RA4_01_1235.d 5.65E4 1 1 153 173
K.M(+15.99)SEIAQASNEGR.M Y 86.58 1307.5775 12 -6.0 654.7921 2 27.23 4 11314 VEV_1_3_RA4_01_1235.d 5.64E4 1 1 342 353 Oxidation (M)
K.AISLEATNYAVR.A Y 72.01 1306.6881 12 -16.4 654.3406 2 68.89 6 37047 VEV_3_3_RA6_01_1237.d 1.48E5 3 3 227 238
R.SDGLPGIDFSK.L Y 71.21 1134.5557 11 -9.9 568.2795 2 73.82 4 42213 VEV_1_3_RA4_01_1235.d 4.48E5 3 3 40 50
K.NKETGQNELVTAPLDGTILEGVTR.D Y 54.95 2554.3237 24 -36.5 852.4175 3 80.28 4 47239 VEV_1_3_RA4_01_1235.d 8.98E4 1 1 294 317
R.IALPTVDGDVVIK.L Y 53.23 1338.7759 13 -42.2 670.3669 2 79.19 4 46395 VEV_1_3_RA4_01_1235.d 0 2 2 154 166
K.MSEIAQASNEGR.M Y 51.82 1291.5826 12 -2.6 646.7969 2 36.89 6 16710 VEV_3_3_RA6_01_1237.d 4.17E5 3 3 342 353
R.MIEVFGAGTAAIVSPVR.T Y 44.07 1716.9232 17 -55.9 859.4209 2 82.58 4 48930 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 354 370
R.DSVLTLAR.E Y 30.39 873.4919 8 -18.2 437.7453 2 64.31 6 33589 VEV_3_3_RA6_01_1237.d 1.81E5 2 2 318 325
R.AWPGGVGDK.K Y 20.24 885.4344 9 -22.8 886.4216 1 91.48 5 52630 VEV_2_3_RA5_01_1236.d 0 1 1 239 247
R.LFRPDKNM(+15.99)ER.L Y 15.91 1320.6608 10 -19.1 331.1662 4 10.57 5 2760 VEV_2_3_RA5_01_1236.d 0 1 1 137 146 Oxidation (M)
R.GVTALSGC(+57.02)SSAWR.H Y 15.47 1350.6350 13 -7.1 338.6636 4 26.35 6 10914 VEV_3_3_RA6_01_1237.d 0 1 1 11 23 Carbamidomethylation
total 15 peptides
C1FZ00
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TVAGGAWTVSTPAAATTR.S Y 132.31 1716.8795 18 -14.0 859.4351 2 68.63 6 36878 VEV_3_3_RA6_01_1237.d 2.28E6 6 6 35 52
K.KTVAGGAWTVSTPAAATTR.S Y 121.71 1844.9745 19 -17.9 923.4780 2 63.04 5 33807 VEV_2_3_RA5_01_1236.d 5.96E5 5 5 34 52
R.YVC(+57.02)TFC(+57.02)GK.N Y 85.48 1033.4362 8 -10.9 517.7197 2 42.46 5 20645 VEV_2_3_RA5_01_1236.d 4.03E6 10 10 9 16 Carbamidomethylation
K.TVAGGAW(+31.99)TVSTPAAATTR.S Y 85.19 1748.8693 18 -11.6 875.4318 2 61.28 5 32498 VEV_2_3_RA5_01_1236.d 3.62E5 5 5 35 52 Dihydroxy
K.TVAGGAW(+15.99)TVSTPAAATTR.S Y 72.16 1732.8744 18 -14.0 867.4324 2 66.15 6 35001 VEV_3_3_RA6_01_1237.d 2.46E5 5 5 35 52 Oxidation (HW)
R.KAVGIWEC(+57.02)R.S Y 66.18 1117.5702 9 -13.3 373.5257 3 50.64 4 25308 VEV_1_3_RA4_01_1235.d 7.1E5 3 3 22 30 Carbamidomethylation
K.TVAGGAWTVSTPAAATTR(+14.02).S Y 65.19 1730.8951 18 -9.1 866.4470 2 70.70 4 39765 VEV_1_3_RA4_01_1235.d 8.42E4 1 1 35 52 Methylation(KR)
MEISQHAR.Y Y 63.96 970.4655 8 -10.5 486.2349 2 18.02 6 6518 VEV_3_3_RA6_01_1237.d 1.32E5 3 3 1 8
M(+15.99)EISQHAR.Y Y 59.71 986.4603 8 -4.8 494.2351 2 11.51 4 3084 VEV_1_3_RA4_01_1235.d 4.67E4 2 2 1 8 Oxidation (M)
R.YVC(+57.02)TFC(+57.02)GKNSVK.R Y 59.10 1461.6744 12 -8.9 731.8380 2 41.02 5 19728 VEV_2_3_RA5_01_1236.d 4.34E5 4 4 9 20 Carbamidomethylation
K.AVGIWEC(+57.02)R.S Y 59.00 989.4753 8 -10.4 495.7397 2 62.86 4 33666 VEV_1_3_RA4_01_1235.d 1.17E6 6 6 23 30 Carbamidomethylation
R.LREIAEV Y 54.82 828.4705 7 -16.1 415.2358 2 54.45 5 27891 VEV_2_3_RA5_01_1236.d 3.04E6 9 9 58 64
R.YVC(+57.02)TFC(+57.02)GK(+14.02).N Y 46.93 1047.4518 8 -11.1 524.7274 2 52.17 4 26275 VEV_1_3_RA4_01_1235.d 5.07E5 3 3 9 16 Carbamidomethylation; Methylation(KR)
R.EIAEV Y 39.44 559.2853 5 -33.9 560.2737 1 40.96 5 19687 VEV_2_3_RA5_01_1236.d 0 2 2 60 64
K.RKAVGIWEC(+57.02)R.S Y 34.86 1273.6714 10 -10.4 425.5600 3 43.62 5 21282 VEV_2_3_RA5_01_1236.d 2.09E5 2 2 21 30 Carbamidomethylation
K.T(+79.97)VAGGAW(+43.99)TVSTPAAATTR.S Y 34.14 1840.8357 18 11.1 614.6260 3 63.11 6 32714 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 35 52 Phosphorylation (STY); Carboxylation (DKW)
R.YVC(+57.02)TFC(+57.02)GKNSVKR.K Y 25.91 1617.7755 13 -23.2 540.2533 3 34.57 5 15916 VEV_2_3_RA5_01_1236.d 0 1 1 9 21 Carbamidomethylation
R.KAVGIWEC(+57.02)R(+14.02).S Y 22.35 1131.5858 9 -17.6 566.7902 2 57.78 4 29855 VEV_1_3_RA4_01_1235.d 0 1 1 22 30 Carbamidomethylation; Methylation(KR)
R.SC(+57.02)K(+233.05)KTVAGGAWTVSTPAAATTR.S Y 21.41 2453.1831 22 -17.7 614.2922 4 62.99 6 32629 VEV_3_3_RA6_01_1237.d 0 1 1 31 52 Carbamidomethylation; 5-dimethylaminonaphthalene-1-sulfonyl
M(+42.01)EIS(+79.96)QHAR.Y Y 18.75 1092.4329 8 80.5 365.1809 3 9.60 6 2347 VEV_3_3_RA6_01_1237.d 0 1 1 1 8 Acetylation (Protein N-term); Sulfation
MEIS(+79.97)QHAR.Y Y 18.03 1050.4318 8 54.4 351.1703 3 9.39 6 2312 VEV_3_3_RA6_01_1237.d 3.13E3 1 1 1 8 Phosphorylation (STY)
total 21 peptides
C1GKE7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASGDHDFGYITFVLFPR.H Y 119.18 1940.9420 17 -9.5 647.9818 3 87.01 6 49667 VEV_3_3_RA6_01_1237.d 4.99E5 5 5 231 247
MLLLDYQNVLIQSLLTER.F Y 112.75 2161.1816 18 -6.4 1081.5912 2 95.71 4 56616 VEV_1_3_RA4_01_1235.d 1.25E5 4 4 1 18
R.AIQNAPQVLFRHDPPLEIQGIPGVK.A Y 97.44 2736.5073 25 -9.6 685.1276 4 80.27 5 46227 VEV_2_3_RA5_01_1236.d 5.38E4 1 1 206 230
R.FTSESAPQGVK.E Y 80.96 1149.5665 11 -10.9 575.7843 2 35.46 6 15922 VEV_3_3_RA6_01_1237.d 5.05E5 5 5 140 150
R.FSGTPPVSIDQVVSDFDGVTFHLSTPETK.S Y 79.66 3106.5134 29 -6.6 1036.5049 3 90.10 4 53725 VEV_1_3_RA4_01_1235.d 3.13E5 3 3 19 47
R.TADFLQVLNR.A Y 73.54 1175.6299 10 -9.9 392.8800 3 78.99 4 46240 VEV_1_3_RA4_01_1235.d 1.05E5 2 2 287 296
R.AIQNAPQVLFR.H Y 54.51 1255.7036 11 20.5 628.8719 2 71.27 6 38813 VEV_3_3_RA6_01_1237.d 0 1 1 206 216
R.EYGPFIVSPEPGYDFSILVDLENLPAEPEAK.E Y 45.78 3434.6809 31 -22.8 1145.8748 3 96.71 4 57047 VEV_1_3_RA4_01_1235.d 0 2 2 74 104
R.HDPPLEIQGIPGVK.A Y 41.96 1498.8143 14 -17.0 500.6036 3 72.69 4 41340 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 217 230
R.ARPENEERER.K Y 33.85 1284.6171 10 -4.7 429.2109 3 9.45 4 2276 VEV_1_3_RA4_01_1235.d 4.92E4 2 2 297 306
K.AFDEFAR.L Y 32.30 854.3922 7 10.7 428.2079 2 57.78 6 28884 VEV_3_3_RA6_01_1237.d 2.83E5 4 4 126 132
R.EYGPFIVSPEPGYDFSILVDLENLPAEPEAKEDLVNR.I Y 28.94 4161.0469 37 -4.1 1041.2648 4 94.17 4 55896 VEV_1_3_RA4_01_1235.d 1.85E5 1 1 74 110
R.GENISHIQTFR.D Y 22.54 1300.6523 11 15.5 326.1754 4 22.07 4 8501 VEV_1_3_RA4_01_1235.d 0 1 1 255 265
M(+15.99)LLLDYQNVLIQSLLTER.F Y 20.15 2177.1765 18 5.5 726.7368 3 93.28 5 53479 VEV_2_3_RA5_01_1236.d 4.9E4 1 1 1 18 Oxidation (M)
R.RGENISHIQTFRDYFHYHIK.A Y 17.48 2560.2722 20 -10.0 854.4229 3 90.35 6 51492 VEV_3_3_RA6_01_1237.d 7.74E4 1 1 254 273
K.RNVMAAPFEK.A Y 15.55 1161.5964 10 -10.6 581.7993 2 32.91 4 14523 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 116 125
total 16 peptides
C1GFM6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LADGNVFSIPVTLDVSAKEIQDLGVSPGAR.I Y 120.96 3067.6189 30 -13.9 1023.5327 3 89.08 6 50870 VEV_3_3_RA6_01_1237.d 2.28E5 3 3 73 102
R.AIVHEIILMLESQGFLDRS Y 97.24 2170.1455 19 -6.2 724.3846 3 95.32 4 56484 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 555 573
R.Q(-17.03)ANVLIHPVVGLTKPGDIDHFTR.V Y 90.63 2509.3440 23 -10.6 628.3366 4 79.49 4 46626 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 218 240 Pyro-glu from Q
R.LADGNVFSIPVTLDVSAK.E Y 72.19 1844.9883 18 -8.6 923.4935 2 85.38 4 50844 VEV_1_3_RA4_01_1235.d 6.27E4 2 2 73 90
R.LRTGASIPEWFSYPEVVK.V Y 67.90 2078.0835 18 -23.3 693.6857 3 81.22 6 46023 VEV_3_3_RA6_01_1237.d 1.88E5 1 1 366 383
R.ALQVTLNQQGGR.S Y 62.99 1283.6946 12 -15.2 642.8448 2 56.89 6 28293 VEV_3_3_RA6_01_1237.d 2.12E5 3 3 415 426
K.GFTGVDDPYETPK.S Y 62.63 1424.6459 13 -7.7 713.3247 2 66.09 4 36131 VEV_1_3_RA4_01_1235.d 2.42E5 2 2 528 540
R.DTISSVGSFFLVHVATSLEYAEKTDKR.G Y 61.69 2999.5239 27 -15.4 600.9028 5 89.12 6 50858 VEV_3_3_RA6_01_1237.d 2.32E5 3 3 489 515
R.TGASIPEWFSYPEVVK.V Y 60.60 1808.8984 16 -11.6 905.4460 2 84.03 6 47867 VEV_3_3_RA6_01_1237.d 3.31E5 3 3 368 383
K.TLDISGTDLR.K Y 54.38 1089.5665 10 -18.8 545.7803 2 65.87 5 35936 VEV_2_3_RA5_01_1236.d 6.34E5 3 3 354 363
R.QANVLIHPVVGLTKPGDIDHFTR.V Y 52.82 2526.3706 23 -10.4 506.2762 5 75.04 4 43163 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 218 240
K.EIQDLGVSPGAR.I Y 47.42 1240.6411 12 -10.6 621.3212 2 61.02 4 32242 VEV_1_3_RA4_01_1235.d 1.49E5 2 2 91 102
K.GVDFYGPYDAQHAVEK.Y Y 36.83 1794.8213 16 -1.9 599.2799 3 68.61 4 38127 VEV_1_3_RA4_01_1235.d 1.38E5 3 3 303 318
R.AYQAILSR.Y Y 32.35 920.5079 8 -38.7 461.2434 2 53.18 6 26169 VEV_3_3_RA6_01_1237.d 1.54E5 4 4 243 250
R.DTISSVGSFFLVHVATSLEYAEK.T Y 26.48 2499.2532 23 -23.7 834.0719 3 93.92 6 53174 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 489 511
K.SADLTVDVEKQTVR.A Y 26.11 1559.8154 14 -5.0 520.9432 3 61.66 4 32728 VEV_1_3_RA4_01_1235.d 1.84E5 1 1 541 554
R.HELSFELGFSREDR.H Y 18.10 1720.8169 14 7.6 431.2148 4 29.28 4 12445 VEV_1_3_RA4_01_1235.d 0 1 1 438 451
R.FTPAELR.S Y 15.93 832.4443 7 -20.3 417.2210 2 53.36 6 26281 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 176 182
total 18 peptides
C1G233
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NKQAVVDASGGPDQEASKPHLGDLNPSYR.Y Y 124.92 3049.4854 29 -7.0 763.3733 4 62.66 5 33525 VEV_2_3_RA5_01_1236.d 6.72E4 1 1 467 495
K.QAVVDASGGPDQEASKPHLGDLNPSYR.Y Y 121.04 2807.3474 27 -13.4 702.8347 4 66.08 5 36094 VEV_2_3_RA5_01_1236.d 2.31E5 3 3 469 495
K.Q(-17.03)AVVDASGGPDQEASKPHLGDLNPSYR.Y Y 104.22 2790.3208 27 -4.4 931.1101 3 71.86 4 40689 VEV_1_3_RA4_01_1235.d 4.21E5 3 3 469 495 Pyro-glu from Q
K.IVDDVALENFLVSTTEK.K Y 95.23 1891.9778 17 -10.1 946.9866 2 86.26 5 49881 VEV_2_3_RA5_01_1236.d 3.03E5 3 3 24 40
MHEVSLGPVGER.K Y 88.67 1309.6449 12 -9.2 655.8237 2 58.47 5 30434 VEV_2_3_RA5_01_1236.d 1.63E4 1 1 1 12
M(+15.99)HEVSLGPVGER.K Y 87.99 1325.6398 12 -6.2 442.8845 3 50.62 5 25522 VEV_2_3_RA5_01_1236.d 6.42E5 7 7 1 12 Oxidation (M)
M(+15.99)HEVSLGPVGERKEDAASR.G Y 86.87 2083.0115 19 -7.8 521.7561 4 41.36 4 19525 VEV_1_3_RA4_01_1235.d 9.32E4 1 1 1 19 Oxidation (M)
K.IVDDVALENFLVSTTEKK.L Y 62.88 2020.0728 18 -16.8 674.3536 3 82.66 6 46976 VEV_3_3_RA6_01_1237.d 8.87E4 1 1 24 41
R.IFVQTK.L Y 39.98 734.4327 6 -8.8 368.2204 2 32.87 4 14495 VEV_1_3_RA4_01_1235.d 3.35E5 2 2 248 253
K.QAVVDAS(-2.02)GGPDQEASKPHLGDLNPSYR.Y Y 39.58 2805.3318 27 10.6 702.3477 4 66.21 4 36223 VEV_1_3_RA4_01_1235.d 4.71E4 1 1 469 495 2-amino-3-oxo-butanoic_acid
R.NEAQK.R Y 23.11 588.2867 5 -10.5 589.2878 1 98.92 5 55645 VEV_2_3_RA5_01_1236.d 3.58E4 1 1 171 175
K.LDGVRGFLGWR.W Y 21.84 1274.6884 11 -35.2 425.8885 3 28.86 5 12606 VEV_2_3_RA5_01_1236.d 7.09E4 1 1 201 211
R.FLLGLFETGM(+15.99)FPGSFYLLGMWYK.R Y 21.68 2732.3423 23 -29.2 684.0729 4 80.12 6 45252 VEV_3_3_RA6_01_1237.d 0 1 1 147 169 Oxidation (M)
K.EDAASR.G Y 21.06 647.2874 6 -8.0 648.2895 1 112.78 4 61889 VEV_1_3_RA4_01_1235.d 0 1 1 14 19
K.WLSEEER.I Y 20.86 947.4348 7 -3.1 474.7232 2 43.26 4 20699 VEV_1_3_RA4_01_1235.d 8.08E4 1 1 241 247
K.LDGVR.G Y 17.86 558.3126 5 -49.7 559.2921 1 29.20 5 12809 VEV_2_3_RA5_01_1236.d 0 1 1 201 205
total 16 peptides
C1G631
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AQASASHATSGDLESLDRNADER.S Y 111.69 2400.0901 23 -6.3 601.0260 4 53.00 4 26801 VEV_1_3_RA4_01_1235.d 5.44E5 5 5 95 117
K.AQASASHATSGDLESLDR.N Y 107.82 1814.8395 18 -9.6 908.4183 2 50.71 4 25320 VEV_1_3_RA4_01_1235.d 6.05E5 7 7 95 112
K.AVANQTSATFLR.I Y 90.02 1277.6727 12 -10.0 639.8373 2 61.28 4 32450 VEV_1_3_RA4_01_1235.d 3.89E5 4 4 259 270
K.SVSVVGVLTDDADPLVSVMK.L Y 89.39 2030.0605 20 -15.0 1016.0223 2 88.54 6 50539 VEV_3_3_RA6_01_1237.d 6.15E4 1 1 177 196
R.TMLELLNQLDGFDDRGDVK.V Y 76.97 2178.0627 19 -2.9 727.0261 3 86.63 4 51643 VEV_1_3_RA4_01_1235.d 1.82E5 1 1 329 347
K.Q(-17.03)KYEPPPQPTTR.I Y 65.70 1423.7096 12 -10.0 712.8550 2 48.72 4 24070 VEV_1_3_RA4_01_1235.d 7.79E5 6 6 26 37 Pyro-glu from Q
K.MSLGDDVDLDEFINQKDDLSGADIK.A Y 60.00 2752.2749 25 -2.9 918.4296 3 84.14 4 50013 VEV_1_3_RA4_01_1235.d 2.7E4 1 1 393 417
K.ILFENPDQNTK.K Y 58.60 1317.6565 11 -10.8 659.8284 2 63.25 4 33944 VEV_1_3_RA4_01_1235.d 1.46E5 2 2 372 382
K.Q(-17.03)KYEPPPQ(+.98)PTTR.I Y 47.09 1424.6936 12 -17.2 713.3419 2 52.35 6 25677 VEV_3_3_RA6_01_1237.d 1.25E5 2 2 26 37 Pyro-glu from Q; Deamidation (NQ)
K.TKAQASASHATSGDLESLDRNADER.S Y 46.75 2629.2327 25 -4.5 658.3125 4 47.78 4 23498 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 93 117
K.LPAVYPTSR.C Y 39.63 1002.5498 9 -15.4 502.2745 2 59.02 5 30834 VEV_2_3_RA5_01_1236.d 1.5E5 2 2 54 62
R.IHDHLLLEEEYVENQER.I Y 37.13 2165.0388 17 -4.0 542.2648 4 70.03 4 39236 VEV_1_3_RA4_01_1235.d 2.3E5 1 1 73 89
K.LPAVYPTSRC(+57.02)K.L Y 28.10 1290.6754 11 -18.1 323.6703 4 45.62 6 21767 VEV_3_3_RA6_01_1237.d 0 1 1 54 64 Carbamidomethylation
K.YLGDGPR.L Y 27.34 776.3817 7 2.9 389.1992 2 25.91 4 10597 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 280 286
K.IFTLHTSK.M Y 23.48 945.5283 8 -25.8 473.7592 2 43.08 5 20970 VEV_2_3_RA5_01_1236.d 6.63E4 1 1 385 392
K.RYESTSGGEREVQR.T Y 21.85 1652.7866 14 -4.0 551.9340 3 17.39 4 6036 VEV_1_3_RA4_01_1235.d 3.72E4 1 1 315 328
K.AQAS(-2.02)ASHATSGDLESLDR.N Y 20.72 1812.8237 18 18.8 605.2932 3 50.28 5 25300 VEV_2_3_RA5_01_1236.d 6.42E4 1 1 95 112 2-amino-3-oxo-butanoic_acid
K.YEPPPQPTTR.I Y 20.27 1184.5825 10 4.2 593.3010 2 79.89 5 46006 VEV_2_3_RA5_01_1236.d 0 1 1 28 37
R.MRVQMADFR.A Y 16.45 1152.5532 9 3.3 577.2858 2 43.19 4 20657 VEV_1_3_RA4_01_1235.d 0 1 1 433 441
R.MRVQM(+15.99)ADFRAAR.E Y 16.37 1466.7234 12 -11.0 734.3609 2 22.05 4 8484 VEV_1_3_RA4_01_1235.d 1.95E4 1 1 433 444 Oxidation (M)
K.RKQAGPNASAK.L Y 15.49 1126.6206 11 -28.3 564.3016 2 64.37 4 34791 VEV_1_3_RA4_01_1235.d 5.14E4 1 1 43 53
K.TLLAK(+114.04)AVANQTSATFLR.I Y 15.10 1918.0636 17 -41.8 640.3351 3 60.99 5 32285 VEV_2_3_RA5_01_1236.d 5.66E4 1 1 254 270 Ubiquitin
total 22 peptides
C1G0P0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SEDGQQQQSQQSNEGQQSGEGEKKP Y 105.99 2717.1760 25 -5.8 680.2974 4 18.15 5 6737 VEV_2_3_RA5_01_1236.d 3.52E5 6 6 656 680
K.ARSEDGQQQQSQQSNEGQQSGEGEKKP Y 95.83 2944.3142 27 -4.6 737.0825 4 15.91 4 5263 VEV_1_3_RA4_01_1235.d 1.16E5 4 4 654 680
R.SQLEALVDPLISR.T Y 89.84 1439.7983 13 -9.3 720.8997 2 83.31 4 49437 VEV_1_3_RA4_01_1235.d 3.34E5 3 3 345 357
K.SQSGEGSITADELK.A Y 76.30 1420.6681 14 -15.7 711.3301 2 53.12 6 26124 VEV_3_3_RA6_01_1237.d 1.74E5 5 5 621 634
R.QAVVNPENTLFATKR.L Y 67.50 1686.9053 15 -15.3 563.3004 3 67.36 4 37126 VEV_1_3_RA4_01_1235.d 5.02E4 1 1 104 118
K.DAGQIAGLNVLR.V Y 66.39 1225.6779 12 -8.3 613.8411 2 76.40 5 43591 VEV_2_3_RA5_01_1236.d 1.74E5 2 2 203 214
R.IIENAEGAR.T Y 64.12 971.5035 9 -9.7 486.7543 2 25.80 4 10546 VEV_1_3_RA4_01_1235.d 6.61E5 5 5 73 81
K.IVQHANGDAWVEAQGQK.Y Y 62.87 1849.9071 17 -9.7 617.6370 3 52.44 4 26449 VEV_1_3_RA4_01_1235.d 6.82E4 1 1 140 156
R.TTPSVVAFTK.D Y 62.73 1049.5757 10 -13.5 525.7880 2 63.14 4 33859 VEV_1_3_RA4_01_1235.d 2.86E5 5 5 82 91
K.DIQEVILVGGMTR.M Y 57.71 1429.7599 13 -8.2 715.8813 2 81.39 4 48078 VEV_1_3_RA4_01_1235.d 2.73E4 1 1 375 387
K.NGVVTVPAYFNDSQR.Q Y 50.41 1665.8110 15 -6.2 833.9076 2 73.81 6 40676 VEV_3_3_RA6_01_1237.d 1.58E5 2 2 184 198
R.NTTIPTKK.S N 48.40 901.5233 8 -13.2 451.7630 2 12.90 5 3909 VEV_2_3_RA5_01_1236.d 5.22E4 1 1 457 464
K.YSPSQIGGFVLQK.M Y 48.09 1422.7507 13 -12.5 475.2516 3 76.36 4 44191 VEV_1_3_RA4_01_1235.d 2.11E5 1 1 157 169
R.SQ(+.98)LEALVDPLISR.T Y 42.86 1440.7823 13 -14.6 721.3879 2 84.86 6 48374 VEV_3_3_RA6_01_1237.d 2.84E4 1 1 345 357 Deamidation (NQ)
R.QATKDAGQIAGLNVLR.V Y 40.43 1653.9161 16 -19.8 552.3018 3 67.33 6 35877 VEV_3_3_RA6_01_1237.d 4.56E4 1 1 199 214
R.IIENAE(+14.02)GAR.T Y 28.28 985.5192 9 -12.7 493.7607 2 36.07 5 16811 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 73 81 Methylation(others)
R.SSAYKLPATPFRR.W Y 27.21 1492.8149 13 -17.7 374.2044 4 41.91 4 19854 VEV_1_3_RA4_01_1235.d 6.08E5 3 3 24 36
R.MAIQRIREAC(+57.02)EK.A Y 26.38 1503.7650 12 -12.9 502.2558 3 62.21 6 32058 VEV_3_3_RA6_01_1237.d 0 1 1 299 310 Carbamidomethylation
R.SQ(+.98)LEALVDPLISR(+14.02).T Y 24.72 1454.7980 13 -56.8 728.3649 2 83.98 5 48548 VEV_2_3_RA5_01_1236.d 0 1 1 345 357 Deamidation (NQ); Methylation(KR)
K.EVPYK.I Y 24.51 634.3326 5 -1.2 635.3391 1 98.68 5 55560 VEV_2_3_RA5_01_1236.d 0 2 2 135 139
K.LDKTEADQIK.E Y 22.00 1159.6084 10 8.3 387.5466 3 48.03 6 23158 VEV_3_3_RA6_01_1237.d 0 1 1 599 608
R.TTPSVVAFTKDGER.L Y 20.16 1506.7678 14 -18.2 503.2541 3 60.03 6 30460 VEV_3_3_RA6_01_1237.d 2.49E5 1 1 82 95
R.ADSVLNDTEK.A Y 19.43 1090.5142 10 -1.4 546.2636 2 32.90 4 14518 VEV_1_3_RA4_01_1235.d 2.57E4 1 1 581 590
K.RLIGR.K N 19.03 613.4023 5 -22.7 307.7015 2 17.13 6 6051 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 118 122
K.LLGNFQLVGIPPAHR.G Y 16.22 1630.9307 15 -18.4 544.6408 3 79.01 4 46254 VEV_1_3_RA4_01_1235.d 1.48E5 1 1 495 509
K.VDELQNASLTLFDK.M Y 15.82 1591.8093 14 2.8 398.9607 4 57.61 4 29725 VEV_1_3_RA4_01_1235.d 0 1 1 637 650
total 26 peptides
C1G945
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSVHHFSGNNIELGTAC(+57.02)GK.L Y 127.86 2027.9484 19 -6.4 1014.9750 2 55.14 5 28254 VEV_2_3_RA5_01_1236.d 1.52E6 9 9 68 86 Carbamidomethylation
K.SELEYYSMLSK.T Y 99.37 1348.6221 11 -12.5 675.3099 2 74.91 6 41478 VEV_3_3_RA6_01_1237.d 5.3E5 5 5 57 67
K.LVIIAGNTPPLRK.S Y 92.37 1390.8660 13 -35.1 464.6130 3 65.97 6 34885 VEV_3_3_RA6_01_1237.d 0 3 3 44 56
R.KSELEYYSMLSK.T Y 85.95 1476.7170 12 -8.0 493.2423 3 68.84 4 38309 VEV_1_3_RA4_01_1235.d 2.84E5 2 2 56 67
K.LVIIAGNTPPLR.K Y 83.52 1262.7710 12 -42.3 632.3661 2 73.88 6 40726 VEV_3_3_RA6_01_1237.d 0 3 3 44 55
K.SGKVTLGYK.S Y 66.90 951.5389 9 -20.6 476.7669 2 27.58 5 11913 VEV_2_3_RA5_01_1236.d 3.12E5 3 3 23 31
K.SELEYYSM(+15.99)LSK.T Y 66.74 1364.6169 11 -13.2 683.3068 2 67.81 6 36281 VEV_3_3_RA6_01_1237.d 1.46E5 3 3 57 67 Oxidation (M)
R.C(+57.02)STMAILDAGDSDILSGTAA Y 45.17 1967.8816 20 -16.4 984.9319 2 86.08 6 49119 VEV_3_3_RA6_01_1237.d 1.05E4 1 1 90 109 Carbamidomethylation
K.KSAENINSR.L Y 44.05 1017.5203 9 -17.8 509.7584 2 10.11 6 2547 VEV_3_3_RA6_01_1237.d 4.39E4 2 2 8 16
K.SAENINSR.L Y 42.70 889.4254 8 -11.7 445.7148 2 12.59 5 3750 VEV_2_3_RA5_01_1236.d 6.11E4 2 2 9 16
R.LALVMK.S Y 41.23 673.4197 6 -18.4 337.7109 2 58.20 5 30285 VEV_2_3_RA5_01_1236.d 3.77E5 3 3 17 22
K.VTLGYK.S Y 30.45 679.3904 6 -24.7 340.6941 2 36.24 6 16366 VEV_3_3_RA6_01_1237.d 3.41E5 5 5 26 31
K.K(-1.03)SAENINSR.L Y 20.49 1016.4886 9 -11.7 509.2456 2 10.01 5 2541 VEV_2_3_RA5_01_1236.d 9.29E3 1 1 8 16 Lysine oxidation to aminoadipic semialdehyde
K.ALRSGK.A Y 19.15 630.3813 6 -1.9 631.3874 1 102.85 5 56904 VEV_2_3_RA5_01_1236.d 8.68E3 1 1 36 41
total 14 peptides
C1GF12
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLDFNQQSMPFASASIGK.S Y 106.97 1952.9666 18 -5.4 977.4853 2 82.98 4 49207 VEV_1_3_RA4_01_1235.d 1.43E5 4 4 232 249
K.AVEAAVNALSQDLLAK.L Y 100.54 1611.8832 16 -6.5 806.9436 2 81.62 4 48261 VEV_1_3_RA4_01_1235.d 5.26E4 1 1 437 452
K.VLLVPLSNNPSFQPLVHR.L Y 92.11 2029.1472 18 -7.3 677.3848 3 81.54 4 48198 VEV_1_3_RA4_01_1235.d 9.59E4 1 1 542 559
R.LGVSNRVDDSSASIGKR.Y Y 86.37 1759.9176 17 -11.4 587.6398 3 46.56 5 23063 VEV_2_3_RA5_01_1236.d 3.27E5 5 5 567 583
K.RLPEFVSQDAE Y 74.86 1289.6251 11 -16.2 645.8094 2 67.25 6 35840 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 646 656
R.EYTPNVIEPSFGIGR.I Y 61.53 1677.8362 15 -14.9 839.9128 2 79.04 6 44472 VEV_3_3_RA6_01_1237.d 9.58E4 2 2 495 509
R.IQLFLLK.I Y 60.37 873.5687 7 -13.7 437.7857 2 80.42 4 47341 VEV_1_3_RA4_01_1235.d 7.07E4 2 2 336 342
K.SFRNEISPR.S Y 55.66 1104.5676 9 -7.3 369.1938 3 39.71 4 18527 VEV_1_3_RA4_01_1235.d 7.69E5 4 4 250 258
R.FHEVQDLELSFLDREVQLSGSTK.V Y 47.53 2676.3394 23 -43.3 670.0631 4 82.32 4 48757 VEV_1_3_RA4_01_1235.d 0 1 1 287 309
R.SAYDLTVHK.N Y 42.35 1032.5239 9 -8.3 517.2650 2 40.15 4 18788 VEV_1_3_RA4_01_1235.d 1.19E5 3 3 388 396
R.SGKVELEKDIINIEKR.T Y 39.01 1870.0522 16 -40.5 375.0026 5 64.67 6 33858 VEV_3_3_RA6_01_1237.d 0 1 1 472 487
R.ASEEEIC(+57.02)KAVK.S Y 35.65 1262.6176 11 -9.7 632.3099 2 35.33 5 16369 VEV_2_3_RA5_01_1236.d 5.64E4 1 1 621 631 Carbamidomethylation
K.TGAPLFVR.E Y 33.29 859.4916 8 -17.8 430.7454 2 61.26 6 31345 VEV_3_3_RA6_01_1237.d 3.63E5 3 3 399 406
R.ASEEEIC(+57.02)K.A Y 30.17 964.4171 8 2.4 483.2170 2 18.32 4 6524 VEV_1_3_RA4_01_1235.d 3.3E4 1 1 621 628 Carbamidomethylation
K.NKTGAPLFVR.E Y 26.49 1101.6294 10 -16.6 368.2110 3 48.45 6 23410 VEV_3_3_RA6_01_1237.d 4.8E5 3 3 397 406
K.LDDALVK.E Y 20.95 772.4330 7 -35.0 387.2103 2 44.92 5 22118 VEV_2_3_RA5_01_1236.d 1.18E5 1 1 152 158
R.MTIGKAVADK.I Y 20.14 1032.5637 10 -7.5 345.1926 3 41.76 5 20221 VEV_2_3_RA5_01_1236.d 2.32E5 2 2 313 322
K.SLVEGEETWDDIKK.R Y 19.95 1647.7991 14 -2.2 550.2724 3 67.86 4 37532 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 632 645
K.IGIDESKIR.M Y 19.38 1029.5818 9 14.8 344.2063 3 48.72 6 23572 VEV_3_3_RA6_01_1237.d 0 1 1 343 351
R.NEISPR.S Y 18.42 714.3660 6 0.4 715.3736 1 92.23 5 52998 VEV_2_3_RA5_01_1236.d 2.89E5 2 2 253 258
R.SEPLRIEEWQIDLDKKK.F Y 17.95 2126.1372 17 -13.3 426.2291 5 70.76 6 38414 VEV_3_3_RA6_01_1237.d 1.08E5 1 1 410 426
K.TSGHVDK.F Y 17.66 742.3610 7 -11.6 743.3596 1 112.43 5 59502 VEV_2_3_RA5_01_1236.d 0 1 1 84 90
R.GVLSFPPIVAPTK.V Y 17.58 1324.7754 13 -29.1 332.1915 4 50.86 4 25422 VEV_1_3_RA4_01_1235.d 0 1 1 529 541
K.LSLDLTENGK.I Y 16.79 1088.5713 10 -36.0 545.2733 2 52.55 4 26520 VEV_1_3_RA4_01_1235.d 2.2E4 1 1 453 462
total 24 peptides
C1GK89
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AWSSIDGATGVIPGPVTALGLAR.E Y 105.38 2208.1902 23 -3.5 1105.0985 2 86.96 5 50286 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 1020 1042
K.AGQQNIHVVASR.V Y 104.10 1278.6792 12 -10.6 640.3401 2 28.52 6 12060 VEV_3_3_RA6_01_1237.d 4.76E5 4 4 534 545
R.IPFGSSSSATGSWQVTPSR.H Y 101.65 1950.9435 19 -8.1 976.4711 2 74.97 4 43105 VEV_1_3_RA4_01_1235.d 2.51E5 3 3 410 428
R.ISAGSSTTNTDYSNPR.N Y 96.89 1669.7544 16 -8.9 835.8771 2 41.33 5 19956 VEV_2_3_RA5_01_1236.d 5.03E5 5 5 247 262
K.GLGLQPLPVNIQSIEASSSLQKPLAALQDVPIVTTGLFYNR.S Y 67.77 4347.3843 41 -10.7 1087.8417 4 95.17 6 53664 VEV_3_3_RA6_01_1237.d 1.08E5 2 2 792 832
R.IPPEHLLDSLR.R Y 67.56 1288.7139 11 -13.5 430.5728 3 72.82 6 39949 VEV_3_3_RA6_01_1237.d 3.64E5 7 7 1217 1227
R.TSDYLIAQVASTDQTPTSVTFMPDIK.Q Y 66.41 2828.3789 26 -33.4 943.7688 3 86.28 4 51420 VEV_1_3_RA4_01_1235.d 0 2 2 431 456
R.LYNTHLDGRGTK.T Y 57.73 1373.7051 12 -19.3 687.8466 2 28.44 5 12368 VEV_2_3_RA5_01_1236.d 1.87E4 1 1 303 314
R.LYNTHLDGR.G Y 40.82 1087.5410 9 -12.7 363.5163 3 36.33 5 16988 VEV_2_3_RA5_01_1236.d 1.26E5 2 2 303 311
K.SSDGSPFLVFYDGSK.F Y 33.97 1604.7358 15 -0.2 803.3751 2 81.90 4 48462 VEV_1_3_RA4_01_1235.d 4.96E4 1 1 1054 1068
R.GAVALTDNK.G Y 30.32 887.4712 9 -16.9 888.4634 1 85.33 5 49358 VEV_2_3_RA5_01_1236.d 2.17E4 4 4 783 791
R.GTDRRPDLQR.I Y 30.22 1212.6323 10 -10.0 607.3174 2 16.95 5 6082 VEV_2_3_RA5_01_1236.d 1.78E5 3 3 1207 1216
R.LYN(+.98)THLDGR.G Y 26.38 1088.5250 9 2.7 363.8499 3 36.39 4 16572 VEV_1_3_RA4_01_1235.d 8.17E4 1 1 303 311 Deamidation (NQ)
K.FGYQPTKLR.L Y 25.75 1108.6029 9 -25.8 370.5320 3 52.64 6 25843 VEV_3_3_RA6_01_1237.d 3.22E5 2 2 294 302
R.ISAGSSTTNTDYSNPR(+14.02).N Y 25.19 1683.7700 16 -14.4 842.8802 2 49.06 5 24583 VEV_2_3_RA5_01_1236.d 7.09E4 1 1 247 262 Methylation(KR)
K.GENDATVNNLLFMDGSR.N Y 21.99 1851.8420 17 35.8 618.3101 3 78.78 4 46088 VEV_1_3_RA4_01_1235.d 1.42E5 1 1 848 864
K.DQQVINLDTSRISAGSSTTNTDYSNPR.N Y 21.52 2939.3857 27 16.3 735.8657 4 84.37 5 48786 VEV_2_3_RA5_01_1236.d 4.75E4 1 1 236 262
K.QSTIYGIQVLGVR.K Y 20.37 1432.8038 13 20.3 359.2155 4 47.40 4 23255 VEV_1_3_RA4_01_1235.d 0 1 1 1079 1091
K.WANKDK.L Y 18.90 760.3868 6 -12.9 761.3843 1 79.67 5 45838 VEV_2_3_RA5_01_1236.d 7.74E4 1 1 990 995
K.AWGPLGAGVDGR.V Y 18.89 1154.5833 12 -21.5 578.2865 2 29.66 4 12655 VEV_1_3_RA4_01_1235.d 0 1 1 678 689
K.ETSVDFSK.S Y 18.14 911.4236 8 -22.5 456.7088 2 33.35 6 14709 VEV_3_3_RA6_01_1237.d 3.56E5 1 1 569 576
K.KAWGPLGAGVDGR.V Y 18.04 1282.6782 13 -23.7 642.3312 2 75.66 4 43648 VEV_1_3_RA4_01_1235.d 1.28E5 2 2 677 689
K.SLSNVAAYSLSK.K Y 15.34 1238.6506 12 -30.6 620.3137 2 66.28 5 36235 VEV_2_3_RA5_01_1236.d 9.13E4 1 1 665 676
total 23 peptides
C1FZC6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AATTRPSPPASTASTSSLTGLTHQER.V Y 113.45 2624.3154 26 -19.3 657.0735 4 61.14 5 32394 VEV_2_3_RA5_01_1236.d 7.85E4 1 1 913 938
R.AAELAGRPPPSTGDDDAAAAR.R Y 92.69 2007.9609 21 -8.5 670.3219 3 48.03 5 23943 VEV_2_3_RA5_01_1236.d 5.24E5 7 7 787 807
K.AHPNSASTIVGTGPGGAVTESDRIK.A Y 82.73 2421.2249 25 -0.6 808.0817 3 60.83 5 32166 VEV_2_3_RA5_01_1236.d 4.89E4 1 1 752 776
K.Q(-17.03)SAAADTESKNPYFGK.F Y 78.73 1695.7739 16 -6.0 848.8892 2 61.30 4 32466 VEV_1_3_RA4_01_1235.d 3.08E4 1 1 1226 1241 Pyro-glu from Q
R.SLRDEQQAQEAESR.R Y 74.86 1645.7655 14 -14.1 823.8784 2 28.01 6 11781 VEV_3_3_RA6_01_1237.d 8.02E4 3 3 1058 1071
K.DATVFKNNDDAIGYR.S Y 61.50 1697.8009 15 -12.5 566.9338 3 64.30 4 34748 VEV_1_3_RA4_01_1235.d 8.85E4 3 3 596 610
K.VGGGAVGGDVR.G Y 54.97 942.4883 11 -12.3 472.2456 2 26.46 4 10932 VEV_1_3_RA4_01_1235.d 5.78E5 9 9 1485 1495
R.KSSGAFLQPQQTGVSYLK.N Y 45.93 1938.0210 18 -4.4 647.0114 3 68.71 4 38208 VEV_1_3_RA4_01_1235.d 3.77E4 1 1 562 579
K.SAFTATPLPGSLGRKSR.A Y 39.19 1744.9584 17 -13.2 349.9944 5 60.49 5 31908 VEV_2_3_RA5_01_1236.d 0 2 2 1298 1314
K.SAVGNNQSLDGETAKDLLQR.S Y 37.92 2115.0557 20 -15.4 706.0150 3 68.08 6 36451 VEV_3_3_RA6_01_1237.d 3.03E5 3 3 182 201
R.NLDDSIGTVK.S Y 32.92 1060.5400 10 -25.0 531.2640 2 56.45 6 28006 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 542 551
K.SLLSQDAESR.K Y 27.64 1104.5411 10 -11.3 553.2716 2 45.02 5 22153 VEV_2_3_RA5_01_1236.d 0 3 3 552 561
R.VQDDIDTDSKAPFR.N Y 27.59 1605.7634 14 -4.9 536.2592 3 58.51 5 30461 VEV_2_3_RA5_01_1236.d 1.75E5 1 1 688 701
R.LEAEAR(+14.02).E Y 27.37 701.3708 6 -9.2 351.6895 2 21.87 4 8404 VEV_1_3_RA4_01_1235.d 1.76E5 1 1 1073 1078 Methylation(KR)
R.AEIEAAHAR.E Y 27.19 966.4883 9 26.4 967.5211 1 91.03 5 52414 VEV_2_3_RA5_01_1236.d 0 1 1 1135 1143
K.EFTRSLEDGLK.E Y 24.83 1293.6565 11 -7.2 432.2230 3 54.89 6 27130 VEV_3_3_RA6_01_1237.d 0 1 1 836 846
R.VQDDIDTDSK.A Y 23.61 1134.5040 10 4.9 568.2621 2 26.12 5 11107 VEV_2_3_RA5_01_1236.d 0 1 1 688 697
R.LEEEASSVK.A Y 22.11 990.4869 9 4.0 331.1709 3 18.50 5 6921 VEV_2_3_RA5_01_1236.d 1.64E5 1 1 809 817
R.LM(+15.99)PQSGR.E Y 21.90 803.3959 7 -29.9 804.3792 1 108.93 6 57813 VEV_3_3_RA6_01_1237.d 0 1 1 424 430 Oxidation (M)
K.FEQLFK.S Y 21.06 810.4276 6 -17.9 406.2138 2 10.68 4 2722 VEV_1_3_RA4_01_1235.d 0 1 1 176 181
R.SKLPGSDLSR.I Y 20.83 1058.5720 10 -25.9 530.2796 2 35.48 5 16489 VEV_2_3_RA5_01_1236.d 6.4E4 1 1 202 211
K.KPPPPPSR.K Y 19.50 874.5024 8 -87.4 438.2203 2 11.56 4 3104 VEV_1_3_RA4_01_1235.d 0 2 2 1017 1024
R.I(+27.99)WTLSDPSNR.G Y 18.80 1215.5884 10 2.8 406.2045 3 23.65 4 9355 VEV_1_3_RA4_01_1235.d 2.18E5 1 1 494 503 Formylation
R.NTDSGAERR.A Y 17.80 1004.4635 9 14.7 503.2464 2 27.05 4 11214 VEV_1_3_RA4_01_1235.d 0 1 1 702 710
R.MAAAGLKPSTDGGETLLER.Q Y 17.45 1915.9673 19 -36.4 384.1868 5 28.46 5 12381 VEV_2_3_RA5_01_1236.d 0 1 1 954 972
K.QSAAADTESK.N Y 17.43 1006.4567 10 19.0 504.2451 2 52.88 5 26915 VEV_2_3_RA5_01_1236.d 0 1 1 1226 1235
R.GALLASIQAGK.G Y 17.11 1027.6025 11 -20.3 514.7981 2 65.87 5 35996 VEV_2_3_RA5_01_1236.d 3.73E5 1 1 1496 1506
R.AEIEAAHARER.E Y 16.51 1251.6320 11 -19.9 418.2096 3 19.44 6 7273 VEV_3_3_RA6_01_1237.d 7.87E4 1 1 1135 1145
R.KEENASAAR.S Y 16.22 974.4781 9 4.3 488.2484 2 45.76 4 22234 VEV_1_3_RA4_01_1235.d 8.53E4 1 1 889 897
K.ELPSTLPER.I Y 15.99 1040.5502 9 28.4 347.8672 3 34.69 5 15996 VEV_2_3_RA5_01_1236.d 0 1 1 244 252
R.NEAM(+15.99)TK.D Y 15.73 708.3112 6 -11.8 709.3101 1 112.58 4 61837 VEV_1_3_RA4_01_1235.d 0 1 1 823 828 Oxidation (M)
K.DRSAAAVSGR.V Y 15.59 988.5049 10 2.4 495.2609 2 36.53 4 16660 VEV_1_3_RA4_01_1235.d 9.93E4 1 1 1515 1524
R.NLDDSIGTVKSLLSQDAESRK.S Y 15.40 2275.1655 21 -15.0 1138.5730 2 86.57 4 51604 VEV_1_3_RA4_01_1235.d 9.18E4 1 1 542 562
K.AEQER.N N 15.23 631.2925 5 -25.6 632.2836 1 29.01 4 12303 VEV_1_3_RA4_01_1235.d 0 1 1 818 822
R.ALRRQLQSYQDQLPEIASSVRK.V Y 15.11 2585.4038 22 -23.7 647.3429 4 110.80 5 59051 VEV_2_3_RA5_01_1236.d 0 1 1 711 732
total 35 peptides
C1GBT3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.STTSSC(+57.02)ESPTEASVLQPQPQVRPTLLQHTAR.S Y 175.87 3405.6946 31 -13.3 852.4196 4 70.09 6 37928 VEV_3_3_RA6_01_1237.d 4.19E6 12 12 104 134 Carbamidomethylation
K.STTSSC(+57.02)ESPTEASVLQ(+.98)PQPQVRPTLLQHTAR.S Y 131.18 3406.6787 31 -7.8 852.6703 4 70.94 6 38582 VEV_3_3_RA6_01_1237.d 1.67E6 4 4 104 134 Carbamidomethylation; Deamidation (NQ)
K.S(+79.97)TTSSC(+57.02)ESPTEASVLQPQPQVRPTLLQHTAR.S Y 112.97 3485.6609 31 2.0 872.4243 4 72.90 5 41173 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 104 134 Phosphorylation (STY); Carbamidomethylation
K.STTSSC(+57.02)ESPTEASVLQPQPQ(+.98)VRPTLLQHTAR.S Y 79.82 3406.6787 31 -7.0 852.6710 4 71.57 4 40455 VEV_1_3_RA4_01_1235.d 4.48E5 1 1 104 134 Carbamidomethylation; Deamidation (NQ)
R.VGSEFDRYLAGK.R Y 70.12 1340.6724 12 -11.5 671.3358 2 65.42 5 35599 VEV_2_3_RA5_01_1236.d 1.04E6 6 6 76 87
R.VGSEFDRYLAGKR.L Y 67.47 1496.7736 13 24.5 375.2098 4 60.95 4 32195 VEV_1_3_RA4_01_1235.d 3.72E5 5 5 76 88
R.VGSEFDR.Y Y 56.44 808.3715 7 -17.6 405.1859 2 26.25 6 10859 VEV_3_3_RA6_01_1237.d 9.24E5 5 5 76 82
R.LSVPTR.L Y 42.31 671.3966 6 -15.9 336.7002 2 36.62 5 17138 VEV_2_3_RA5_01_1236.d 8.6E6 10 10 89 94
R.LSVPTRLQR.T Y 37.35 1068.6404 9 -15.2 535.3193 2 53.70 5 27407 VEV_2_3_RA5_01_1236.d 6.15E6 11 11 89 97
K.RLSVPTRLQR.T Y 35.69 1224.7415 10 -42.8 409.2369 3 45.99 5 22809 VEV_2_3_RA5_01_1236.d 6.43E5 3 3 88 97
R.VGSEFDRYLAGK(+14.02).R Y 34.36 1354.6881 12 -24.0 452.5591 3 68.77 4 38247 VEV_1_3_RA4_01_1235.d 6.76E4 1 1 76 87 Methylation(KR)
K.RLSVPTR.L Y 33.43 827.4977 7 -22.7 414.7467 2 28.31 5 12350 VEV_2_3_RA5_01_1236.d 1.99E6 5 5 88 94
R.LSVPTR(+14.02).L Y 27.77 685.4122 6 -18.9 343.7069 2 45.04 6 21425 VEV_3_3_RA6_01_1237.d 8.4E5 4 4 89 94 Methylation(KR)
R.RVGSEFDRYLAGKR.L Y 25.07 1652.8746 14 -12.4 414.2208 4 59.44 6 30066 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 75 88
R.YLAGKR.L Y 23.28 706.4126 6 -16.8 354.2076 2 11.32 5 3115 VEV_2_3_RA5_01_1236.d 3.66E4 1 1 83 88
R.LQRTNVNPK.S Y 20.91 1068.6040 9 -49.5 535.2828 2 14.56 6 4724 VEV_3_3_RA6_01_1237.d 0 1 1 95 103
R.TNVNPK.S Y 19.52 671.3602 6 -19.8 672.3542 1 53.95 6 26624 VEV_3_3_RA6_01_1237.d 3.23E5 3 3 98 103
total 17 peptides
C1G349
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EILPGKFVVLGILSR.L Y 103.40 1640.0024 15 -9.5 547.6696 3 85.41 4 50866 VEV_1_3_RA4_01_1235.d 1.32E5 2 2 484 498
R.TSILDTITQVISPSSK.L Y 99.73 1688.9196 16 -12.7 845.4563 2 88.44 6 50487 VEV_3_3_RA6_01_1237.d 3.34E5 6 6 624 639
K.HYSPYC(+57.02)PYC(+57.02)LDIAPTWQTLYEFYYTSNPLSTSTSK.Q Y 97.90 4252.9072 35 -16.8 1418.6193 3 92.82 4 55206 VEV_1_3_RA4_01_1235.d 3.65E4 1 1 84 118 Carbamidomethylation
R.YWDTTTSGAYIMPSR.T Y 89.48 1747.7876 15 -9.6 874.8927 2 75.70 4 43721 VEV_1_3_RA4_01_1235.d 2.03E4 1 1 609 623
R.VSSYPTIYFFR.G Y 72.41 1378.6921 11 -8.6 690.3474 2 81.85 4 48431 VEV_1_3_RA4_01_1235.d 4.48E5 2 2 328 338
K.GILNVGEVNC(+57.02)ETER.R Y 69.53 1588.7515 14 -8.4 795.3763 2 69.19 4 38585 VEV_1_3_RA4_01_1235.d 1.7E5 3 3 307 320 Carbamidomethylation
R.DGKPSYYNALAPK.D Y 67.20 1422.7142 13 -6.2 475.2424 3 59.81 4 31347 VEV_1_3_RA4_01_1235.d 3.28E5 2 2 442 454
R.GLGDLVSYAR.K Y 59.46 1049.5505 10 -16.7 525.7738 2 74.24 6 41022 VEV_3_3_RA6_01_1237.d 3.28E5 3 3 350 359
K.TDSEILATR.F Y 55.74 1004.5138 9 -8.2 503.2600 2 44.62 4 21556 VEV_1_3_RA4_01_1235.d 3.9E5 4 4 420 428
R.TSILDTITQ(+.98)VISPSSK.L Y 55.65 1689.9036 16 -11.2 845.9496 2 88.43 6 50475 VEV_3_3_RA6_01_1237.d 2.5E4 1 1 624 639 Deamidation (NQ)
K.VDSTPLSDTSGSK.L Y 46.28 1292.6096 13 -16.3 647.3016 2 36.39 5 17005 VEV_2_3_RA5_01_1236.d 9.37E4 2 2 213 225
K.KPSAPQANLQADK.S Y 44.33 1366.7205 13 -6.6 456.5778 3 29.22 4 12419 VEV_1_3_RA4_01_1235.d 1.08E5 3 3 34 46
K.SETSTSVSTTSGKPQPARPVPN(+162.05)PQGTSIPLTAESFQK.L Y 43.14 3973.9756 37 -13.3 994.4879 4 68.51 4 38041 VEV_1_3_RA4_01_1235.d 6.28E4 1 1 234 270 Hexose (NSY)
K.VDSTPLSDTSGSKLESKPEGK.S Y 37.90 2161.0750 21 -12.4 721.3567 3 50.09 5 25196 VEV_2_3_RA5_01_1236.d 9.44E4 2 2 213 233
R.KAAEVVGNGVQYVDAAAFK.E Y 30.51 1936.0054 19 -29.4 646.3234 3 72.77 4 41399 VEV_1_3_RA4_01_1235.d 1.64E5 1 1 360 378
K.GILNVGEVNC(+57.02)ETER(+14.02).R Y 22.11 1602.7671 14 -1.5 802.3896 2 71.82 4 40655 VEV_1_3_RA4_01_1235.d 8.05E4 1 1 307 320 Carbamidomethylation; Methylation(KR)
K.LFQLER.Q Y 19.25 804.4493 6 -18.5 403.2245 2 62.47 6 32245 VEV_3_3_RA6_01_1237.d 0 1 1 525 530
R.LLVSRDGKPSYYNALAPK.D Y 18.27 1991.0840 18 12.5 399.2291 5 64.20 4 34668 VEV_1_3_RA4_01_1235.d 0 1 1 437 454
K.LESFIGK.K Y 17.18 792.4381 7 -57.4 793.3999 1 87.74 4 52343 VEV_1_3_RA4_01_1235.d 2.12E4 1 1 170 176
total 19 peptides
A0A0A0HRG7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M(+42.01)EEEVAALVIDNGSGMC(+57.02)K.A Y 109.35 1993.8795 18 -16.8 997.9303 2 91.28 5 52545 VEV_2_3_RA5_01_1236.d 5.59E5 5 5 1 18 Acetylation (Protein N-term); Carbamidomethylation
R.HHGIMIGMGQKDSYVGDEAQSKR.G Y 107.44 2543.2009 23 -9.7 509.6425 5 58.51 5 30459 VEV_2_3_RA5_01_1236.d 1.68E5 2 2 40 62
K.DSYVGDEAQSKR.G N 101.44 1353.6160 12 -11.0 677.8078 2 24.53 5 10211 VEV_2_3_RA5_01_1236.d 2.12E6 13 13 51 62
R.AVFPSIVGRPR.H Y 94.65 1197.6981 11 -12.0 599.8491 2 65.80 5 35912 VEV_2_3_RA5_01_1236.d 2.98E6 12 12 29 39
M(+42.01)EEEVAALVIDN(+.98)GSGMC(+57.02)K.A Y 90.83 1994.8635 18 -4.8 998.4343 2 90.82 5 52310 VEV_2_3_RA5_01_1236.d 2.82E4 1 1 1 18 Acetylation (Protein N-term); Deamidation (NQ); Carbamidomethylation
K.DSYVGDEAQSK.R N 87.47 1197.5149 11 -8.5 599.7596 2 28.42 6 12036 VEV_3_3_RA6_01_1237.d 4.69E5 10 10 51 61
M(+42.01)EEEVAALVIDNGSGMC(+57.02)K(+14.02).A Y 79.04 2007.8951 18 -9.3 1004.9456 2 91.79 4 54655 VEV_1_3_RA4_01_1235.d 4.05E4 1 1 1 18 Acetylation (Protein N-term); Carbamidomethylation; Methylation(KR)
K.AGFAGDDAPRAVFPSIVGRPR.H Y 77.57 2155.1287 21 -6.8 539.7858 4 73.85 5 41774 VEV_2_3_RA5_01_1236.d 1.93E5 1 1 19 39
K.AGFAGDDAPR.A Y 77.47 975.4410 10 -12.3 488.7218 2 34.94 5 16130 VEV_2_3_RA5_01_1236.d 6E6 14 14 19 28
M(+56.06)EEEVAALVIDNGSGMC(+57.02)K.A Y 76.88 2007.9315 18 -35.4 1004.9375 2 95.36 4 56476 VEV_1_3_RA4_01_1235.d 4.09E5 6 6 1 18 Diethylation; Carbamidomethylation
K.DSYVGDEAQ(+.98)SKR.G N 50.44 1354.6001 12 -9.8 678.3007 2 28.08 5 12176 VEV_2_3_RA5_01_1236.d 1.39E5 3 3 51 62 Deamidation (NQ)
K.DSYVGDEAQSK(+14.02)R.G N 48.46 1367.6317 12 -9.2 684.8168 2 32.19 5 14527 VEV_2_3_RA5_01_1236.d 8.87E4 2 2 51 62 Methylation(KR)
R.AVFPSIVGRPR(+14.02).H Y 46.96 1211.7139 11 -14.7 404.9060 3 67.18 5 36905 VEV_2_3_RA5_01_1236.d 1.43E5 1 1 29 39 Methylation(KR)
K.AGFAGDDAPR(+14.02).A Y 41.09 989.4566 10 -8.3 495.7315 2 47.49 4 23315 VEV_1_3_RA4_01_1235.d 8.01E5 4 4 19 28 Methylation(KR)
K.RGILTLR.Y N 40.48 827.5341 7 -15.4 414.7680 2 53.39 5 27241 VEV_2_3_RA5_01_1236.d 5.23E5 4 4 62 68
R.A(+42.01)VFPSIVGRPR.H Y 40.18 1239.7087 11 -14.3 414.2376 3 66.07 6 34934 VEV_3_3_RA6_01_1237.d 0 1 1 29 39 Acetylation (N-term)
R.VT(+14.02)EAPLNPK.I Y 31.97 981.5494 9 -14.5 491.7749 2 42.76 5 20772 VEV_2_3_RA5_01_1236.d 3.12E5 2 2 105 113 Methylation(others)
R.GILTLR.Y N 28.40 671.4330 6 -18.6 336.7175 2 62.91 5 33713 VEV_2_3_RA5_01_1236.d 5.59E5 5 5 63 68
R.YPIEHGVVTNWDDMEKIWHHTFYNELR.V N 27.30 3428.6035 27 -40.2 686.7004 5 83.41 6 47450 VEV_3_3_RA6_01_1237.d 0 1 1 69 95
K.AGFAGDDAPR(+.98).A Y 25.69 976.4250 10 12.2 489.2257 2 34.95 4 15725 VEV_1_3_RA4_01_1235.d 6.74E5 5 5 19 28 Deamidation (R)
R.NPSIGLDSGDGGTPR.C Y 22.00 1441.6797 15 -41.3 481.5473 3 11.52 6 3176 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 148 162
R.NP(+31.99)SIGLDSGDGGTPR.C Y 19.66 1473.6696 15 -12.6 492.2243 3 48.81 4 24124 VEV_1_3_RA4_01_1235.d 0 1 1 148 162 Dihydroxy
total 22 peptides
C1GK66
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.MLDDPTEVLTTMAGSFGYAAPEVMLK.Q Y 127.21 2786.3215 26 -11.4 1394.1522 2 96.14 4 56809 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 167 192
R.DLKPENLLYLTPAPDSPLVIADFGIAK.M Y 117.49 2909.5789 27 -24.4 970.8433 3 92.33 5 53048 VEV_2_3_RA5_01_1236.d 2.89E5 4 4 140 166
R.SENLQDLIDEC(+57.02)LSGR.V Y 92.36 1747.8047 15 -10.7 874.9003 2 84.25 6 48006 VEV_3_3_RA6_01_1237.d 7.69E4 2 2 220 234 Carbamidomethylation
K.Q(-17.03)ILGAVNYLHER.N Y 80.18 1394.7306 12 -13.7 698.3630 2 79.68 4 46771 VEV_1_3_RA4_01_1235.d 7.24E4 1 1 123 134 Pyro-glu from Q
R.TLGAGTYGIVR.E Y 69.92 1106.6084 11 -11.6 554.3051 2 65.38 4 35576 VEV_1_3_RA4_01_1235.d 3.97E5 5 5 26 36
K.FTEKDASQTIK.Q Y 49.38 1266.6455 11 -6.5 634.3259 2 36.02 4 16410 VEV_1_3_RA4_01_1235.d 0 2 2 112 122
K.FTEKDASQTIKQILGAVNYLHER.N Y 35.17 2660.3921 23 -57.4 533.0552 5 85.03 6 48482 VEV_3_3_RA6_01_1237.d 0 1 1 112 134
K.QILGAVNYLHER.N Y 29.65 1411.7572 12 -1.4 471.5923 3 68.86 4 38320 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 123 134
R.LHHPNIVR.F Y 29.22 984.5617 8 -41.6 493.2677 2 27.59 4 11539 VEV_1_3_RA4_01_1235.d 1.57E5 4 4 72 79
K.FTEKDASQTIK(-1.03)QILGAVNYLHER.N Y 26.50 2659.3606 23 16.8 532.8883 5 85.08 5 49213 VEV_2_3_RA5_01_1236.d 0 1 1 112 134 Lysine oxidation to aminoadipic semialdehyde
K.EQIER.E N 24.83 673.3395 5 -6.1 674.3427 1 80.21 6 45310 VEV_3_3_RA6_01_1237.d 4.53E4 1 1 443 447
R.TLGAGTYGIVREADGPSGK.V Y 24.63 1847.9377 19 -10.7 462.9868 4 28.36 5 12348 VEV_2_3_RA5_01_1236.d 5.8E4 1 1 26 44
R.FHDWFESR.D Y 21.48 1122.4883 8 64.8 375.1943 3 66.44 4 36405 VEV_1_3_RA4_01_1235.d 0 1 1 80 87
R.DLK(-1.03)PENLLYLTPAPDSPLVIADFGIAK.M Y 19.58 2908.5474 27 -68.0 970.4571 3 92.23 6 52409 VEV_3_3_RA6_01_1237.d 0 1 1 140 166 Lysine oxidation to aminoadipic semialdehyde
K.AYMAK.A Y 18.11 582.2836 5 -6.0 583.2874 1 21.55 4 8229 VEV_1_3_RA4_01_1235.d 4.88E4 3 3 292 296
K.AYM(+15.99)AK.A Y 17.71 598.2784 5 26.4 599.3015 1 71.09 5 39835 VEV_2_3_RA5_01_1236.d 1.38E5 1 1 292 296 Oxidation (M)
K.DASQTIK.Q Y 16.17 761.3919 7 -27.9 762.3779 1 111.85 4 61628 VEV_1_3_RA4_01_1235.d 6.38E4 1 1 116 122
total 17 peptides
C1FYJ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DNIQGITKPAIR.R N 113.70 1324.7462 12 -13.8 663.3712 2 58.12 6 29110 VEV_3_3_RA6_01_1237.d 2.38E6 12 12 25 36
K.TFLEGVIRDAVTYTEHAK.R Y 98.71 2049.0530 18 -12.4 513.2642 4 84.08 6 47904 VEV_3_3_RA6_01_1237.d 9.13E5 6 6 61 78
K.TVTSLDVVYALKR.Q N 86.02 1463.8347 13 -7.8 488.9484 3 74.08 5 41960 VEV_2_3_RA5_01_1236.d 2.22E6 10 10 81 93
R.ISAMIYEETRGVLK.T N 77.61 1608.8545 14 -13.8 805.4234 2 72.69 5 40961 VEV_2_3_RA5_01_1236.d 4.9E5 5 5 47 60
K.ILRDNIQGITKPAIR.R N 74.85 1707.0155 15 -9.4 427.7571 4 63.80 4 34359 VEV_1_3_RA4_01_1235.d 1.45E5 3 3 22 36
R.ISAMIYEETR.G N 68.59 1211.5856 10 -11.4 606.7932 2 64.91 4 35200 VEV_1_3_RA4_01_1235.d 2.7E5 2 2 47 56
K.TVTSLDVVYALK.R N 67.24 1307.7336 12 -8.9 654.8683 2 78.93 4 46197 VEV_1_3_RA4_01_1235.d 4.78E4 1 1 81 92
R.DNIQGITKPAIRR.L N 60.89 1480.8474 13 -21.0 741.4154 2 50.03 4 24901 VEV_1_3_RA4_01_1235.d 2.34E6 10 10 25 37
K.RISAMIYEETRGVLK.T N 60.55 1764.9556 15 -12.8 442.2405 4 73.18 5 41303 VEV_2_3_RA5_01_1236.d 3.55E4 1 1 46 60
R.ISAM(+15.99)IYEETRGVLK.T N 55.19 1624.8494 14 -19.7 542.6130 3 69.07 4 38500 VEV_1_3_RA4_01_1235.d 2.98E5 2 2 47 60 Oxidation (M)
K.TFLEGVIRDAVTYTEHAK(+14.02).R Y 46.52 2063.0686 18 -15.9 516.7662 4 85.75 4 51080 VEV_1_3_RA4_01_1235.d 9.75E4 1 1 61 78 Methylation(KR)
R.DAVTYTEHAK.R N 45.96 1133.5353 10 -13.1 567.7675 2 24.03 6 9705 VEV_3_3_RA6_01_1237.d 3.94E5 3 3 69 78
R.KTVTSLDVVYALKR.Q N 44.96 1591.9297 14 -17.4 398.9828 4 68.18 6 36531 VEV_3_3_RA6_01_1237.d 2.96E5 3 3 80 93
R.DNIQ(+.98)GITKPAIR.R N 44.06 1325.7302 12 -22.8 442.9073 3 60.87 4 32136 VEV_1_3_RA4_01_1235.d 2.69E5 2 2 25 36 Deamidation (NQ)
K.TFLEGVIR.D Y 40.12 933.5283 8 -19.5 467.7623 2 73.70 6 40596 VEV_3_3_RA6_01_1237.d 4.48E5 2 2 61 68
R.ISAM(+15.99)IYEETR.G N 37.51 1227.5806 10 -16.7 614.7873 2 58.75 6 29538 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 47 56 Oxidation (M)
K.RKTVTSLDVVYALKR.Q N 30.41 1748.0308 15 -67.6 437.9854 4 65.00 4 35275 VEV_1_3_RA4_01_1235.d 1.13E4 1 1 79 93
R.KILRDNIQGITKPAIR.R N 23.98 1835.1105 16 -55.3 368.0091 5 62.38 5 33321 VEV_2_3_RA5_01_1236.d 0 1 1 21 36
K.TVTSLDVVYALKR(+14.02).Q N 19.23 1477.8503 13 -27.8 493.6104 3 75.05 6 41582 VEV_3_3_RA6_01_1237.d 7.37E4 1 1 81 93 Methylation(KR)
total 19 peptides
A0A0A0HS42
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FGTSVVSESDTR.S Y 100.81 1283.5994 12 -11.3 642.7997 2 54.15 5 27703 VEV_2_3_RA5_01_1236.d 6.52E5 4 4 806 817
R.LIGHAQAGQAPTEELALQPGPLPK.F Y 95.44 2435.3171 24 -11.3 812.7705 3 74.20 5 42026 VEV_2_3_RA5_01_1236.d 4.75E4 1 1 79 102
R.GALDATEFIIAMHLLSAYR.N Y 91.34 2091.0823 19 -11.1 698.0270 3 93.36 5 53510 VEV_2_3_RA5_01_1236.d 2.87E5 2 2 190 208
R.SNLPAETLGLIWQIADTQNR.G Y 89.70 2239.1597 20 -6.9 747.3887 3 93.10 6 52810 VEV_3_3_RA6_01_1237.d 1.31E5 3 3 46 65
K.SAATDFEAAFAGLDLAPAR.E Y 80.26 1892.9268 19 -7.4 631.9782 3 88.12 4 52580 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 1031 1049
R.LVPQNTAQR.S Y 61.49 1025.5618 9 -13.7 513.7811 2 23.48 5 9602 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 362 370
K.SGSSGSGIPESSGSK.S Y 60.11 1322.5950 15 -5.2 662.3013 2 19.26 4 7022 VEV_1_3_RA4_01_1235.d 1.52E5 4 4 909 923
R.ILPQSLPPGFYDAAAR.H Y 58.78 1714.9042 16 -10.7 858.4502 2 79.17 5 45497 VEV_2_3_RA5_01_1236.d 5.94E4 1 1 214 229
R.DIVAPKPFSPASESSFLSK.T Y 52.07 2006.0360 19 -35.6 669.6621 3 77.64 5 44470 VEV_2_3_RA5_01_1236.d 0 2 2 971 989
R.AVAEQDLNKTSQQKKDFESR.L Y 45.39 2321.1611 20 -7.4 465.2361 5 39.10 5 18589 VEV_2_3_RA5_01_1236.d 1.1E5 2 2 501 520
R.GLLTPSGFGVVMR.L Y 44.12 1332.7224 13 -23.0 667.3531 2 81.56 5 47066 VEV_2_3_RA5_01_1236.d 6.67E4 1 1 66 78
K.SSSPSPFSQK.L Y 44.12 1050.4982 10 -13.6 526.2492 2 33.46 6 14775 VEV_3_3_RA6_01_1237.d 5.99E5 8 8 1118 1127
R.FGTSVVSESDTR(+14.02).S Y 42.16 1297.6150 12 -9.9 649.8083 2 61.79 5 32885 VEV_2_3_RA5_01_1236.d 6.14E4 1 1 806 817 Methylation(KR)
K.QFSGSGLPQR.A Y 40.67 1075.5410 10 -15.1 538.7697 2 45.83 5 22630 VEV_2_3_RA5_01_1236.d 3.01E5 3 3 254 263
K.DVSFDELFGGVAHAR.S Y 39.14 1618.7739 15 -7.8 540.5944 3 82.20 4 48668 VEV_1_3_RA4_01_1235.d 7.06E4 2 2 875 889
R.DESLAALEK.F Y 34.77 974.4920 9 -39.9 488.2339 2 57.44 6 28647 VEV_3_3_RA6_01_1237.d 6.91E5 1 1 1220 1228
K.KLQQDFALIDASR.Q Y 26.88 1503.8044 13 -7.8 376.9554 4 58.40 6 29302 VEV_3_3_RA6_01_1237.d 2.44E5 1 1 551 563
K.LFQAADKTNLGVITGEVAVSFFER.S Y 25.29 2611.3645 24 -7.4 871.4556 3 89.17 4 53203 VEV_1_3_RA4_01_1235.d 0 1 1 22 45
R.MQGEIDSTIR.E Y 23.94 1148.5496 10 15.4 575.2909 2 59.04 6 29747 VEV_3_3_RA6_01_1237.d 6.13E4 1 1 636 645
R.SDVQNGLLSGENAK.Q Y 23.91 1430.7001 14 -10.2 716.3500 2 64.09 5 34598 VEV_2_3_RA5_01_1236.d 7.45E4 2 2 151 164
K.VSSVSDGGSSQAR.H Y 18.04 1235.5742 13 63.4 309.9204 4 39.74 6 18343 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 838 850
R.ILPQ(+.98)SLPPGFYDAAAR.H Y 17.93 1715.8882 16 -30.2 858.9255 2 79.08 5 45441 VEV_2_3_RA5_01_1236.d 0 1 1 214 229 Deamidation (NQ)
R.LT(+27.05)GMGYPR.D Y 15.68 920.4902 8 -8.9 461.2483 2 32.97 5 14982 VEV_2_3_RA5_01_1236.d 0 1 1 1212 1219 Ethyl amino
total 23 peptides
C1GDA8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.Q(-17.03)SGYGGQTK(+14.02)PVFR.K Y 88.09 1420.7098 13 -19.5 711.3483 2 59.38 6 30032 VEV_3_3_RA6_01_1237.d 4.47E6 6 6 73 85 Pyro-glu from Q; Methylation(KR)
K.KVVLRLEC(+57.02)TVC(+57.02)K.T Y 86.46 1503.8265 12 -9.0 752.9138 2 57.71 5 29912 VEV_2_3_RA5_01_1236.d 5.36E5 4 4 93 104 Carbamidomethylation
K.HTQHKVTQYK.A Y 83.72 1268.6626 10 -15.1 635.3290 2 11.63 6 3227 VEV_3_3_RA6_01_1237.d 2.63E5 4 4 46 55
R.KQSGYGGQTK(+14.02)PVFR.K Y 81.43 1565.8314 14 -13.4 522.9441 3 32.81 6 14472 VEV_3_3_RA6_01_1237.d 3.94E6 12 12 72 85 Methylation(KR)
K.VVLRLEC(+57.02)TVC(+57.02)K.T Y 77.16 1375.7316 11 -6.9 688.8683 2 62.43 5 33357 VEV_2_3_RA5_01_1236.d 1.61E6 6 6 94 104 Carbamidomethylation
K.AGKASLFAQGK.R Y 75.79 1076.5978 11 -20.5 539.2951 2 30.11 5 13320 VEV_2_3_RA5_01_1236.d 1.74E5 2 2 56 66
R.C(+57.02)KHFELGGDKK.T Y 75.61 1317.6499 11 -16.4 440.2167 3 19.03 6 7082 VEV_3_3_RA6_01_1237.d 1.95E6 6 6 114 124 Carbamidomethylation
K.KHTQHKVTQYK.A Y 73.70 1396.7576 11 4.3 699.3890 2 11.73 5 3314 VEV_2_3_RA5_01_1236.d 9.37E4 3 3 45 55
K.Q(+.98)SGYGGQTK(+14.02)PVFR.K Y 73.64 1438.7205 13 -6.8 720.3626 2 45.50 4 22078 VEV_1_3_RA4_01_1235.d 9.68E4 1 1 73 85 Deamidation (NQ); Methylation(KR)
K.QSGYGGQTK(+14.02)PVFR.K Y 71.56 1437.7365 13 -7.1 719.8704 2 43.08 4 20586 VEV_1_3_RA4_01_1235.d 3.94E6 12 12 73 85 Methylation(KR)
K.Q(-17.03)SGYGGQTK(+14.02)PVFRK.K Y 70.95 1548.8048 14 -12.2 775.4003 2 47.13 4 23105 VEV_1_3_RA4_01_1235.d 8.76E5 4 4 73 86 Pyro-glu from Q; Methylation(KR)
K.HFELGGDKKTK.G Y 70.20 1258.6670 11 -37.1 630.3174 2 17.36 5 6312 VEV_2_3_RA5_01_1236.d 1.12E5 2 2 116 126
K.HFELGGDKK.T Y 69.03 1029.5243 9 -12.5 515.7630 2 20.65 5 8089 VEV_2_3_RA5_01_1236.d 5.37E5 6 6 116 124
K.AGKASLFAQGKR.R Y 64.62 1232.6989 12 -9.7 617.3507 2 24.68 5 10302 VEV_2_3_RA5_01_1236.d 1.79E5 2 2 56 67
R.LEC(+57.02)TVC(+57.02)K.T Y 63.89 908.4095 7 -8.2 455.2083 2 21.43 4 8171 VEV_1_3_RA4_01_1235.d 7.88E5 6 6 98 104 Carbamidomethylation
K.GAALVF Y 57.42 576.3271 6 -14.4 577.3261 1 74.67 5 42361 VEV_2_3_RA5_01_1236.d 2.14E5 1 1 127 132
K.ASLFAQGK(+14.02).R Y 56.38 834.4599 8 -11.8 835.4573 1 49.77 5 25010 VEV_2_3_RA5_01_1236.d 1.3E6 6 6 59 66 Methylation(KR)
K.QSGYGGQTK(+14.02)PVFRK.K Y 56.30 1565.8314 14 -17.9 783.9089 2 31.94 6 13944 VEV_3_3_RA6_01_1237.d 3.52E5 5 5 73 86 Methylation(KR)
K.ASLFAQGKR.R Y 56.24 976.5453 9 -16.4 489.2719 2 29.20 6 12476 VEV_3_3_RA6_01_1237.d 3.99E6 15 15 59 67
K.ASLFAQGK.R Y 53.31 820.4443 8 -18.0 411.2220 2 39.30 6 18126 VEV_3_3_RA6_01_1237.d 6.85E6 16 16 59 66
R.C(+58.01)KHFELGGDKK.T Y 49.09 1318.6339 11 -10.9 660.3170 2 22.42 6 8831 VEV_3_3_RA6_01_1237.d 2.37E5 3 3 114 124 Carboxymethyl
K.TKAQLALKR.C Y 42.95 1027.6501 9 -13.4 514.8254 2 20.21 4 7500 VEV_1_3_RA4_01_1235.d 3.47E5 3 3 105 113
K.A(+42.01)SLFAQGKR.R Y 34.66 1018.5559 9 9.4 340.5291 3 29.65 5 13064 VEV_2_3_RA5_01_1236.d 7.35E5 4 4 59 67 Acetylation (N-term)
K.ASLFAQ(+.98)GK.R Y 30.52 821.4283 8 -19.9 411.7133 2 44.41 6 21065 VEV_3_3_RA6_01_1237.d 1.01E6 6 6 59 66 Deamidation (NQ)
K.AQLALKR.C Y 27.42 798.5076 7 -19.9 400.2531 2 22.46 6 8885 VEV_3_3_RA6_01_1237.d 1.54E6 4 4 107 113
K.ASLFAQ(+.98)GKR.R Y 26.45 977.5294 9 -15.8 489.7643 2 33.25 6 14661 VEV_3_3_RA6_01_1237.d 9.24E4 1 1 59 67 Deamidation (NQ)
K.AQLALK.R Y 21.50 642.4064 6 -24.3 643.3981 1 29.21 5 12810 VEV_2_3_RA5_01_1236.d 1.2E5 3 3 107 112
R.LE(+14.02)C(+57.02)TVC(+57.02)K.T Y 17.76 922.4252 7 -6.7 462.2168 2 27.73 4 11596 VEV_1_3_RA4_01_1235.d 3.57E5 1 1 98 104 Methylation(others); Carbamidomethylation
K.QSGYGGQTK(+71.04)PVFR.K Y 17.11 1494.7579 13 -3.3 499.2583 3 41.74 4 19743 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 73 85 Propionamide (K, X@N-term)
K.A(+42.01)SLFAQGK.R Y 17.01 862.4548 8 -19.8 432.2262 2 39.69 5 18932 VEV_2_3_RA5_01_1236.d 1.53E5 1 1 59 66 Acetylation (N-term)
K.HTQHKVTQYKAGK.A Y 17.00 1524.8160 13 -17.5 509.2704 3 11.83 5 3359 VEV_2_3_RA5_01_1236.d 1.69E4 1 1 46 58
total 31 peptides
C1GKQ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TLADKDQSLAVLDGYVYDLTNYIIGGRR.I Y 97.99 3128.6143 28 -18.0 783.1468 4 93.61 4 55611 VEV_1_3_RA4_01_1235.d 4.94E5 3 3 1108 1135
K.ALAAQEENDDDDISGSGGSASGSKR.Q Y 92.91 2436.0637 25 -10.8 813.0197 3 41.99 5 20316 VEV_2_3_RA5_01_1236.d 1.42E5 3 3 625 649
K.TLADKDQSLAVLDGYVYDLTNYIIGGR.R Y 87.30 2972.5129 27 -5.9 991.8391 3 96.75 5 54918 VEV_2_3_RA5_01_1236.d 1.2E5 3 3 1108 1134
R.DNDPNAQYHDFR.A Y 78.98 1490.6174 12 14.2 746.3265 2 44.14 4 21231 VEV_1_3_RA4_01_1235.d 8.7E4 3 3 1061 1072
R.AC(+57.02)LTNLFQVGKLDTR.S Y 66.75 1734.9087 15 -13.7 579.3022 3 78.41 5 44996 VEV_2_3_RA5_01_1236.d 2.14E5 3 3 1187 1201 Carbamidomethylation
R.VGSTGVFLSER.C Y 64.51 1150.5981 11 -11.2 576.2999 2 63.86 4 34403 VEV_1_3_RA4_01_1235.d 2.34E5 3 3 771 781
K.VGINDAEGFQQFK.N Y 64.24 1451.7045 13 -5.7 726.8553 2 72.57 4 41244 VEV_1_3_RA4_01_1235.d 8.28E4 1 1 253 265
K.VYSGLYEVQGHIVPFLVVVK.V Y 57.48 2245.2510 20 -15.5 749.4127 3 85.68 6 48886 VEV_3_3_RA6_01_1237.d 1.81E4 1 1 1333 1352
K.LSLAAFVFDTLTTTK.S Y 49.10 1626.8868 15 -16.7 814.4371 2 93.72 6 53094 VEV_3_3_RA6_01_1237.d 1.18E4 1 1 131 145
R.IASVPTGER.S Y 47.17 928.4977 9 -25.7 465.2442 2 33.95 6 15059 VEV_3_3_RA6_01_1237.d 4.63E5 3 3 188 196
R.IANQFDSK.C Y 41.58 921.4556 8 -20.2 461.7258 2 27.04 6 11282 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 698 705
R.GEVFDLGAYIPSHYPK.I Y 40.69 1791.8831 16 -13.5 598.2936 3 80.70 6 45709 VEV_3_3_RA6_01_1237.d 0 2 2 990 1005
R.NTDFTVFLPFSEFIGLSDTESVIVGSDKEK.C Y 38.53 3320.6340 30 -23.9 1107.8589 3 95.53 5 54447 VEV_2_3_RA5_01_1236.d 4.79E4 1 1 725 754
R.FYVSLPTAR.L Y 37.96 1052.5654 9 -43.3 527.2672 2 73.71 5 41672 VEV_2_3_RA5_01_1236.d 3.89E5 4 4 39 47
K.APPGEDLPENVNVNFMDPLVVDLFQQRPGQDISELFR.R Y 36.43 4195.0684 37 26.1 1049.8018 4 96.16 4 56816 VEV_1_3_RA4_01_1235.d 0 1 1 1138 1174
K.RFENKNPAISVGSATATLPGSNFASK.N Y 33.26 2663.3667 26 -10.7 666.8419 4 71.41 4 40328 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 505 530
R.TADLM(+15.99)TVTKK.S Y 23.10 1122.5955 10 61.5 1123.6718 1 99.69 5 55919 VEV_2_3_RA5_01_1236.d 1.09E4 1 1 1819 1828 Oxidation (M)
R.M(+15.99)PSM(+15.99)ARRKM(+15.99)DGPAR.L Y 21.69 1650.7753 14 -6.3 551.2622 3 65.61 4 35758 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 609 622 Oxidation (M)
K.GSPVFGPNQGAAAQFLASLNIINK.S Y 20.94 2413.2754 24 -13.7 805.4214 3 90.66 4 54029 VEV_1_3_RA4_01_1235.d 0 1 1 653 676
K.SITTPIASK.A Y 20.63 916.5229 9 -38.0 459.2513 2 43.03 4 20564 VEV_1_3_RA4_01_1235.d 5.36E4 1 1 146 154
K.NLAATFTVR.H Y 19.52 991.5450 9 -7.8 992.5446 1 98.60 4 57739 VEV_1_3_RA4_01_1235.d 0 2 2 531 539
K.TLADK.D N 19.11 546.3013 5 -50.1 547.2812 1 80.78 4 47628 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 1108 1112
K.TIHRER.V Y 18.74 810.4460 6 -23.2 406.2209 2 17.65 6 6324 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 353 358
K.C(+57.02)QLVVDERRWPANEAR.V Y 18.47 1997.9854 16 -17.5 666.9907 3 79.80 6 45011 VEV_3_3_RA6_01_1237.d 1.42E4 1 1 755 770 Carbamidomethylation
K.GNERKMEEVDDVVVSGSR.K Y 17.95 2004.9534 18 15.9 669.3357 3 70.06 4 39257 VEV_1_3_RA4_01_1235.d 2.92E4 1 1 882 899
K.SAIM(+15.99)QAQVMSKPLRMPSM(+15.99)AR.R Y 17.77 2264.1262 20 0.1 755.7161 3 85.71 5 49570 VEV_2_3_RA5_01_1236.d 0 1 1 595 614 Oxidation (M)
R.RKMDGPAR.L Y 17.69 929.4865 8 -15.7 930.4792 1 88.48 4 52841 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 615 622
R.M(+15.99)PSMAR.R Y 16.83 707.3094 6 4.1 708.3196 1 19.24 6 7182 VEV_3_3_RA6_01_1237.d 3.68E4 1 1 609 614 Oxidation (M)
K.MNMLR.M Y 16.71 663.3196 5 -4.3 664.3241 1 38.82 4 17997 VEV_1_3_RA4_01_1235.d 0 1 1 1087 1091
R.SFHVLYYLLAGTTAAEK.A Y 16.69 1882.9829 17 -17.1 471.7450 4 77.34 5 44261 VEV_2_3_RA5_01_1236.d 0 1 1 197 213
R.KM(+15.99)DGPAR.L Y 16.46 789.3803 7 3.6 790.3904 1 82.11 4 48612 VEV_1_3_RA4_01_1235.d 1.68E5 1 1 616 622 Oxidation (M)
R.TADLMTVTK.K Y 16.11 978.5056 9 -7.4 490.2564 2 44.78 6 21276 VEV_3_3_RA6_01_1237.d 5.19E5 1 1 1819 1827
K.ILDYRLER.S Y 15.89 1076.5978 8 -15.7 359.8676 3 60.23 4 31654 VEV_1_3_RA4_01_1235.d 7.3E4 1 1 178 185
R.HPQEK.S Y 15.66 637.3184 5 -11.2 638.3185 1 69.25 5 38448 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 590 594
R.FNINLDAK.R Y 15.58 933.4919 8 -6.1 312.1694 3 19.61 5 7522 VEV_2_3_RA5_01_1236.d 1.12E5 1 1 1838 1845
R.E(+42.01)RVTVM(+15.99)LDPK.G Y 15.21 1244.6434 10 12.4 312.1720 4 36.42 4 16597 VEV_1_3_RA4_01_1235.d 8.41E4 1 1 357 366 Acetylation (N-term); Oxidation (M)
total 36 peptides
C1GLV1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SASNVEQAFLTMAR.Q Y 113.55 1523.7402 14 -9.4 762.8702 2 79.85 5 45950 VEV_2_3_RA5_01_1236.d 3.02E5 4 4 144 157
K.EFADSLGIPFLETSAK.S Y 100.68 1723.8668 16 -7.7 862.9341 2 87.10 4 51937 VEV_1_3_RA4_01_1235.d 2.6E5 4 4 128 143
R.FADDTYTESYISTIGVDFK.I Y 95.54 2170.9946 19 -7.6 1086.4963 2 84.89 4 50513 VEV_1_3_RA4_01_1235.d 7.4E4 3 3 18 36
K.VVEYTVAKEFADSLGIPFLETSAK.S Y 80.66 2613.3577 24 -6.3 872.1210 3 90.09 4 53702 VEV_1_3_RA4_01_1235.d 3.38E5 3 3 120 143
LLLIGDSGVGK.S N 68.81 1070.6335 11 -10.1 536.3187 2 73.22 4 41752 VEV_1_3_RA4_01_1235.d 6.62E5 3 3 1 11
K.SASNVEQAFLTM(+15.99)AR.Q Y 61.19 1539.7351 14 -14.3 770.8638 2 72.24 6 39598 VEV_3_3_RA6_01_1237.d 2.39E5 3 3 144 157 Oxidation (M)
R.TITSSYYR.G Y 60.39 989.4818 8 -13.7 495.7414 2 42.51 6 19955 VEV_3_3_RA6_01_1237.d 1.16E6 8 8 62 69
K.LQIWDTAGQER.F N 59.71 1315.6521 11 -15.7 658.8230 2 68.52 6 36774 VEV_3_3_RA6_01_1237.d 3.33E5 2 2 49 59
K.LQIWDTAGQERFR.T N 48.94 1618.8215 13 -31.6 540.5974 3 71.60 4 40475 VEV_1_3_RA4_01_1235.d 1.87E5 3 3 49 61
K.SC(+57.02)LLLR.F Y 47.27 760.4265 6 -20.5 381.2127 2 55.59 6 27492 VEV_3_3_RA6_01_1237.d 1.01E6 5 5 12 17 Carbamidomethylation
R.FADDTYTESYISTIGVDFKIR.T Y 46.96 2440.1797 21 -11.4 814.3912 3 84.50 6 48147 VEV_3_3_RA6_01_1237.d 1.62E5 1 1 18 38
K.KVVEYTVAKEFADSLGIPFLETSAK.S Y 36.15 2741.4526 25 -7.4 686.3654 4 86.88 4 51818 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 119 143
R.TIELDGKTVK.L Y 32.00 1102.6234 10 -53.7 552.2894 2 43.34 6 20432 VEV_3_3_RA6_01_1237.d 0 1 1 39 48
R.TIELDGK.T N 29.64 774.4123 7 -38.1 775.3901 1 33.29 6 14677 VEV_3_3_RA6_01_1237.d 3.83E5 2 2 39 45
R.YATEGVNK.L Y 19.49 880.4290 8 20.2 881.4540 1 107.48 4 60447 VEV_1_3_RA4_01_1235.d 0 1 1 99 106
K.LLVGNK.S N 19.30 642.4064 6 -44.0 322.1964 2 36.69 5 17186 VEV_2_3_RA5_01_1236.d 0 1 1 107 112
K.SASNVEQAFLTMAR(-.98).Q Y 17.77 1522.7562 14 -16.4 762.3729 2 79.92 5 45994 VEV_2_3_RA5_01_1236.d 8.19E4 1 1 144 157 Amidation
total 17 peptides
A0A0A0HVT2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NDPLSGAVIAAIMQEAGLR.A Y 110.54 1925.0040 19 -7.9 642.6702 3 94.94 6 53575 VEV_3_3_RA6_01_1237.d 3.14E5 4 4 369 387
R.ENSPAIIFIDEIDAIATK.R Y 87.30 1959.0200 18 -23.5 980.4943 2 95.04 4 56305 VEV_1_3_RA4_01_1235.d 5.99E4 4 4 257 274
K.STPADAIPNIDSLEGIGNDDGDDYATLKR.L Y 85.16 3032.4209 29 -6.9 1011.8073 3 81.54 6 46232 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 19 47
K.AVANSTTANFIR.V Y 83.46 1263.6571 12 -5.7 632.8322 2 59.96 4 31488 VEV_1_3_RA4_01_1235.d 3.32E5 4 4 219 230
K.MSLSPEVDLDSLIVR.N Y 77.68 1672.8705 15 -6.1 837.4374 2 86.40 4 51498 VEV_1_3_RA4_01_1235.d 2.11E5 2 2 354 368
R.GVLLYGPPGTGK.T N 76.00 1157.6444 12 -12.4 579.8223 2 68.08 5 37595 VEV_2_3_RA5_01_1236.d 4.84E5 3 3 202 213
R.EAVELPLTQFDLYK.Q Y 65.27 1664.8661 14 -6.2 833.4351 2 85.20 5 49287 VEV_2_3_RA5_01_1236.d 1.41E5 3 3 180 193
M.G(+42.01)DVVVENPASPVPPYRK.S Y 54.70 1864.9683 17 -8.4 933.4836 2 71.55 4 40440 VEV_1_3_RA4_01_1235.d 7.36E4 1 1 2 18 Acetylation (Protein N-term)
R.IQSVPLVIGQFMEAIDQNTGIVQSSTGSNYVVR.I Y 46.81 3549.8137 33 -13.0 1184.2632 3 96.59 4 56999 VEV_1_3_RA4_01_1235.d 2.75E5 3 3 83 115
R.VVGSEFVQK.Y Y 41.31 991.5338 9 -18.9 496.7648 2 50.22 6 24426 VEV_3_3_RA6_01_1237.d 6.4E5 3 3 231 239
R.KIEFPSLR.D Y 41.29 988.5705 8 -15.8 330.5256 3 66.02 6 34897 VEV_3_3_RA6_01_1237.d 7.58E4 2 2 331 338
K.GAQDADKFDFYR Y 31.78 1431.6418 12 -2.2 478.2202 3 64.54 4 34916 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 411 422
K.YLGEGPR.M Y 30.71 790.3973 7 -32.0 396.1933 2 40.00 5 19121 VEV_2_3_RA5_01_1236.d 2.97E5 4 4 240 246
K.VIMATNR.A N 28.28 803.4324 7 -43.2 804.4049 1 111.91 5 59353 VEV_2_3_RA5_01_1236.d 2.14E4 1 1 308 314
K.TM(+15.99)LVK.A Y 23.35 606.3411 5 -19.6 607.3364 1 34.38 5 15807 VEV_2_3_RA5_01_1236.d 2.7E5 5 5 214 218 Oxidation (M)
M.G(+42.01)DVVVENPAS(+79.97)PVPPYRK.S Y 22.82 1944.9346 17 -3.9 649.3163 3 74.18 4 42497 VEV_1_3_RA4_01_1235.d 8.09E4 1 1 2 18 Acetylation (Protein N-term); Phosphorylation (STY)
K.QIGIDPPR.G Y 21.58 894.4923 8 -70.2 895.4368 1 86.00 5 49732 VEV_2_3_RA5_01_1236.d 0 1 1 194 201
R.EN(+.98)SPAIIFIDEIDAIATKR.F Y 20.72 2116.1052 19 -1.9 706.3743 3 91.38 5 52587 VEV_2_3_RA5_01_1236.d 9.84E4 1 1 257 275 Deamidation (NQ)
R.FDAQTGADREVQR.I Y 20.18 1491.7065 13 -10.2 498.2377 3 37.53 6 17069 VEV_3_3_RA6_01_1237.d 9.99E4 1 1 276 288
R.HLEYINLQEEYIK.D Y 17.67 1690.8566 13 -8.6 846.4283 2 85.62 6 48844 VEV_3_3_RA6_01_1237.d 0 1 1 51 63
K.TM(+15.99)LVKAVANSTTANFIR.V Y 17.01 1851.9877 17 -17.9 618.3254 3 81.16 4 47908 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 214 230 Oxidation (M)
total 21 peptides
C1G9U4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGAIAPLDVYVPAGNTGMEPGK.T Y 108.10 2127.0669 22 -9.6 1064.5305 2 80.16 4 47143 VEV_1_3_RA4_01_1235.d 3.73E4 1 1 111 132
K.TSFFQALGVPTK.I Y 95.36 1294.6921 12 -19.7 648.3406 2 80.54 6 45554 VEV_3_3_RA6_01_1237.d 2.05E5 2 2 133 144
K.GNVGFIFTNADLNEVR.Q Y 92.51 1764.8794 16 -11.7 883.4366 2 81.50 6 46207 VEV_3_3_RA6_01_1237.d 5.55E5 6 6 82 97
R.IANPEAYAAAAPAAAAAETK.A Y 91.05 1870.9424 20 -8.1 936.4709 2 71.24 4 40193 VEV_1_3_RA4_01_1235.d 6.04E4 1 1 267 286
R.SILIVNVDNVSSQQMHEIR.H Y 86.22 2181.1211 19 1.0 728.0483 3 76.82 4 44549 VEV_1_3_RA4_01_1235.d 6.1E4 1 1 24 42
R.AIKGFVADNPEYER.L Y 80.70 1607.7943 14 -11.6 536.9325 3 61.25 6 31336 VEV_3_3_RA6_01_1237.d 4.27E5 3 3 62 75
K.GFVADNPEYER.L Y 75.91 1295.5781 11 -8.2 648.7910 2 59.32 4 30978 VEV_1_3_RA4_01_1235.d 4.93E5 3 3 65 75
R.AGAIAPLDVYVPAGNTGMEPGKTSFFQALGVPTK.I Y 74.63 3403.7485 34 -9.8 1135.5790 3 87.23 4 52024 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 111 144
K.GFVADN(+.98)PEYER.L Y 37.54 1296.5621 11 7.9 649.2935 2 59.31 4 30975 VEV_1_3_RA4_01_1235.d 1.89E4 1 1 65 75 Deamidation (NQ)
R.LLPHVK.G Y 37.25 705.4537 6 -16.5 706.4493 1 32.81 4 14467 VEV_1_3_RA4_01_1235.d 1.8E4 2 2 76 81
K.GFVADNPEYER(+14.02).L Y 32.31 1309.5939 11 -7.0 655.7996 2 63.30 6 32861 VEV_3_3_RA6_01_1237.d 9.49E4 1 1 65 75 Methylation(KR)
R.GEAVVLM(+15.99)GK.N Y 26.53 918.4844 9 0.9 919.4926 1 93.67 4 55646 VEV_1_3_RA4_01_1235.d 1.1E5 3 3 47 55 Oxidation (M)
K.GLLDEHR.S Y 23.71 838.4297 7 20.3 420.2306 2 32.81 6 14425 VEV_3_3_RA6_01_1237.d 9.58E4 1 1 17 23
R.IAAPAR.A Y 23.00 597.3598 6 -61.9 299.6687 2 17.09 5 6187 VEV_2_3_RA5_01_1236.d 0 2 2 105 110
R.I(+27.99)AAPAR.A Y 22.10 625.3547 6 -19.0 626.3502 1 63.44 4 34082 VEV_1_3_RA4_01_1235.d 0 1 1 105 110 Formylation
K.LQSAIR.T Y 18.83 686.4075 6 -7.5 344.2084 2 34.02 5 15582 VEV_2_3_RA5_01_1236.d 0 1 1 213 218
R.GEAVVLM(+15.99)GKNTM(+15.99)VR.R Y 16.85 1535.7800 14 -4.0 512.9319 3 61.05 5 32326 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 47 60 Oxidation (M)
K.LVEAGSK.V Y 15.52 702.3912 7 42.2 703.4281 1 99.22 6 55054 VEV_3_3_RA6_01_1237.d 0 1 1 158 164
total 18 peptides
C1GKW0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AQSPDEAALVATAR.D Y 99.14 1398.7102 14 -9.5 700.3557 2 62.11 5 33123 VEV_2_3_RA5_01_1236.d 3.6E5 6 6 756 769
R.SYTVLNTLEFNSSR.K Y 91.09 1629.7998 14 -12.2 815.8972 2 78.57 6 44130 VEV_3_3_RA6_01_1237.d 2.03E5 3 3 793 806
R.FNSQQEGQSLAVPR.S Y 90.85 1559.7692 14 -10.0 780.8840 2 61.25 5 32479 VEV_2_3_RA5_01_1236.d 2.34E5 3 3 295 308
K.SAASSPPHSDGSTVDEGSVDSSNLR.R Y 90.68 2458.0845 25 -8.6 820.3617 3 54.02 5 27606 VEV_2_3_RA5_01_1236.d 1.63E5 3 3 57 81
R.DC(+57.02)GFTVLGR.S Y 58.06 1023.4808 9 -12.8 512.7411 2 69.09 5 38330 VEV_2_3_RA5_01_1236.d 9.21E4 1 1 770 778 Carbamidomethylation
K.GADSIIYSR.L Y 56.14 980.4927 9 -12.0 491.2477 2 53.80 6 26531 VEV_3_3_RA6_01_1237.d 0 2 2 826 834
K.YTPLSFVPK.N Y 51.65 1050.5750 9 -18.3 526.2852 2 75.23 4 43305 VEV_1_3_RA4_01_1235.d 3.05E5 2 2 114 122
K.THDLAAQSLTDR.E Y 47.90 1326.6528 12 -15.9 664.3231 2 44.39 6 21057 VEV_3_3_RA6_01_1237.d 2.32E5 3 3 880 891
R.DFWKNVQVGDFVR.I Y 47.35 1608.8048 13 -7.7 537.2714 3 81.05 5 46737 VEV_2_3_RA5_01_1236.d 5.57E4 1 1 350 362
K.SAASSPPHSDGSTVDEGSVDSSNLRR.V Y 42.15 2614.1855 26 -5.7 654.5499 4 48.15 5 24012 VEV_2_3_RA5_01_1236.d 9.37E4 1 1 57 82
R.WATQRHAGAGGSR.K Y 38.23 1353.6650 13 50.0 452.2515 3 62.73 6 32433 VEV_3_3_RA6_01_1237.d 0 1 1 23 35
R.DYGSVLNK.A Y 37.84 894.4447 8 -12.9 448.2238 2 48.88 6 23656 VEV_3_3_RA6_01_1237.d 5.28E4 2 2 330 337
K.FKYLDEYEAYVPPAAADLSPASTDVDKPIDLSTK.R Y 35.85 3728.8347 34 -8.4 933.2081 4 83.39 6 47439 VEV_3_3_RA6_01_1237.d 8.26E4 1 1 1361 1394
M.AVVQFGAEDEAHISKPVRR.M Y 34.32 2108.1125 19 -5.5 528.0325 4 58.99 5 30813 VEV_2_3_RA5_01_1236.d 5.35E4 1 1 2 20
K.NVQVGDFVR.I Y 34.13 1032.5352 9 -11.5 517.2689 2 65.15 5 35387 VEV_2_3_RA5_01_1236.d 3.08E5 2 2 354 362
K.NLDGETNLKVR.Q Y 33.16 1257.6677 11 -11.4 629.8340 2 46.53 5 23064 VEV_2_3_RA5_01_1236.d 5.7E4 1 1 391 401
R.SIHNNPYLHDDKLTFVSPDFVSDLAGNAGEK.Q Y 29.53 3399.6370 31 -4.7 850.9125 4 80.56 5 46419 VEV_2_3_RA5_01_1236.d 3.78E4 1 1 692 722
R.TVLDNELNNSPIHR.L Y 29.01 1620.8220 14 -14.9 811.4062 2 85.67 5 49548 VEV_2_3_RA5_01_1236.d 0 1 1 179 192
K.VSLAVPQLYK.T Y 26.06 1116.6543 10 -6.8 373.2228 3 34.52 6 15384 VEV_3_3_RA6_01_1237.d 0 1 1 1189 1198
R.LQDGVPDTISLLAR.A Y 25.09 1496.8198 14 -20.5 749.4019 2 80.35 6 45409 VEV_3_3_RA6_01_1237.d 5.01E4 1 1 918 931
K.FLLLC(+57.02)K.Q Y 24.26 792.4568 6 -16.4 397.2292 2 70.65 5 39467 VEV_2_3_RA5_01_1236.d 3.73E4 1 1 1031 1036 Carbamidomethylation
R.TPGDPPK.I Y 22.40 710.3599 7 13.3 711.3766 1 110.28 4 61201 VEV_1_3_RA4_01_1235.d 1.25E5 3 3 745 751
R.EGINVEEVSK.K Y 21.97 1102.5505 10 -12.6 552.2756 2 53.62 5 27367 VEV_2_3_RA5_01_1236.d 1.79E5 1 1 664 673
K.YSRNK.I Y 21.67 666.3449 5 25.4 667.3691 1 98.29 4 57639 VEV_1_3_RA4_01_1235.d 0 1 1 104 108
R.MESTQTKP Y 21.29 920.4273 8 34.3 461.2367 2 31.14 5 13931 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 1484 1491
R.LNVMGEERSYTVLNTLEFNSSR.K Y 19.36 2558.2434 22 -3.6 853.7520 3 91.51 6 52074 VEV_3_3_RA6_01_1237.d 0 1 1 785 806
K.SRVMMLQQLR.S Y 18.65 1260.6794 10 5.8 316.1790 4 37.23 5 17489 VEV_2_3_RA5_01_1236.d 1.51E5 1 1 682 691
K.IM(+15.99)LNSGATPTK.R Y 18.59 1147.5907 11 -0.3 574.8024 2 43.18 5 21034 VEV_2_3_RA5_01_1236.d 3.16E4 1 1 491 501 Oxidation (M)
R.M(+15.99)ESTQTKP Y 18.10 936.4222 8 -0.3 469.2183 2 48.95 6 23697 VEV_3_3_RA6_01_1237.d 0 1 1 1484 1491 Oxidation (M)
K.HLEM(+15.99)FAR.E Y 17.43 918.4382 7 20.9 460.2360 2 15.21 6 5049 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 850 856 Oxidation (M)
K.RDFWKNVQVGDFVR.I Y 17.26 1764.9059 14 -7.8 442.2303 4 73.85 6 40703 VEV_3_3_RA6_01_1237.d 2.12E5 2 2 349 362
K.SRVM(+15.99)M(+15.99)LQQLR.S Y 16.69 1292.6693 10 47.0 324.1898 4 42.22 4 20045 VEV_1_3_RA4_01_1235.d 0 1 1 682 691 Oxidation (M)
R.WATQR.H Y 16.52 660.3344 5 0.4 661.3419 1 64.30 5 34746 VEV_2_3_RA5_01_1236.d 0 1 1 23 27
R.SILDRLHHGTGLKEEK.R Y 16.36 1831.9904 16 -34.5 458.9891 4 72.27 4 41011 VEV_1_3_RA4_01_1235.d 0 1 1 39 54
K.LEYPC(+57.02)TPK.S Y 15.72 1006.4794 8 20.7 504.2574 2 16.56 6 5753 VEV_3_3_RA6_01_1237.d 0 1 1 603 610 Carbamidomethylation
R.M(+15.99)PDGK.I Y 15.69 562.2421 5 30.0 563.2662 1 20.00 5 7727 VEV_2_3_RA5_01_1236.d 0 1 1 815 819 Oxidation (M)
K.NLDGETNLK.V Y 15.46 1002.4982 9 -1.5 502.2556 2 58.17 4 30124 VEV_1_3_RA4_01_1235.d 1.02E5 1 1 391 399
R.HAGAGGSRKR.R Y 15.19 995.5373 10 -57.8 498.7471 2 16.97 4 5813 VEV_1_3_RA4_01_1235.d 0 1 1 28 37
total 38 peptides
C1FYR1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GVGAGAGAGNSGGLGGGR.S Y 116.28 1370.6650 18 -9.7 686.3331 2 34.58 5 15966 VEV_2_3_RA5_01_1236.d 5.79E5 8 8 251 268
R.NAQAALVVYDLTKPSSLTK.A Y 111.29 2018.1047 19 -15.6 673.6984 3 77.88 4 45383 VEV_1_3_RA4_01_1235.d 2.73E5 3 3 86 104
K.TGVNVAEVFTAIANAIPETSLK.G Y 88.70 2244.2002 22 -11.5 1123.0945 2 95.44 6 53770 VEV_3_3_RA6_01_1237.d 3.95E5 6 6 226 247
R.GVGAGAGAGNSGGLGGGRSGEDAR.I Y 78.34 1985.9263 24 -4.7 662.9796 3 34.90 4 15703 VEV_1_3_RA4_01_1235.d 4.02E4 1 1 251 274
M.T(+42.01)DAGAAGPKPSSSVK.L Y 68.17 1413.7100 15 -13.0 707.8531 2 34.51 6 15395 VEV_3_3_RA6_01_1237.d 2.95E5 3 3 2 16 Acetylation (Protein N-term)
R.FASLAPMYYR.N Y 65.05 1217.5903 10 -8.9 609.7970 2 74.83 4 42998 VEV_1_3_RA4_01_1235.d 3.02E5 3 3 76 85
R.GVGAGAGAGN(+.98)SGGLGGGR.S Y 63.47 1371.6490 18 -5.1 686.8283 2 39.20 4 18222 VEV_1_3_RA4_01_1235.d 4.53E4 1 1 251 268 Deamidation (NQ)
R.TIKFEIWDTAGQER.F Y 58.08 1692.8470 14 -14.0 565.2817 3 75.54 6 41940 VEV_3_3_RA6_01_1237.d 3.51E5 2 2 62 75
R.GVGAGAGAGNSGGLGGGR(+14.02).S Y 55.97 1384.6807 18 -14.7 693.3374 2 41.32 6 19253 VEV_3_3_RA6_01_1237.d 7.41E4 2 2 251 268 Methylation(KR)
R.RPAPSASSGSR.G Y 50.09 1071.5421 11 -13.0 536.7714 2 10.09 5 2556 VEV_2_3_RA5_01_1236.d 6.96E4 3 3 146 156
R.DAATAK(+42.01).E Y 29.75 617.3020 6 13.3 618.3175 1 29.18 5 12796 VEV_2_3_RA5_01_1236.d 0 1 1 281 286 Acetylation (K)
K.LVLLGEAAVGK.S Y 27.86 1068.6543 11 -85.8 535.2886 2 72.58 4 41251 VEV_1_3_RA4_01_1235.d 0 2 2 17 27
R.FVNNDFQENKEPTIGAAFLTQK.C Y 24.52 2510.2441 22 -16.0 837.7419 3 77.57 5 44424 VEV_2_3_RA5_01_1236.d 1.45E5 1 1 34 55
K.AKHWVAELQR.Q Y 21.35 1236.6727 10 -31.6 413.2185 3 45.94 6 21950 VEV_3_3_RA6_01_1237.d 5.15E4 2 2 105 114
K.FEIWDTAGQER.F N 19.30 1350.6204 11 -18.8 338.6560 4 26.35 5 11243 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 65 75
R.TIKFE(+212.01)IWDTAGQER.F Y 17.38 1904.8557 14 27.2 635.9764 3 60.04 6 30468 VEV_3_3_RA6_01_1237.d 1.56E5 1 1 62 75 phosphate-ribosylation
K.EPTIGAAFLTQKC(+57.02)SLPTR.T Y 16.62 1989.0353 18 -8.4 498.2619 4 67.78 6 36218 VEV_3_3_RA6_01_1237.d 0 1 1 44 61 Carbamidomethylation
R.DAATAKEGC(+57.02)AC(+57.02) Y 15.85 1152.4540 11 -98.4 1153.3479 1 113.01 5 59652 VEV_2_3_RA5_01_1236.d 0 1 1 281 291 Carbamidomethylation
total 18 peptides
C1GDQ2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.A(+42.01)ASSAILVHIDEDVGKDDQTATGGESAPYK.T Y 135.46 3086.4680 30 -6.0 1029.8237 3 79.60 4 46712 VEV_1_3_RA4_01_1235.d 1.51E5 3 3 2 31 Acetylation (Protein N-term)
R.FGDDIAEAAER.K Y 85.94 1192.5360 11 -8.1 597.2704 2 63.07 4 33816 VEV_1_3_RA4_01_1235.d 5.14E5 4 4 447 457
K.SVTGPVSEGEDPSVR.L Y 78.35 1514.7212 15 -8.0 758.3618 2 56.36 4 28868 VEV_1_3_RA4_01_1235.d 5.79E4 1 1 54 68
K.LRPSDGDTPGTR.V Y 73.61 1270.6266 12 -12.8 636.3124 2 22.50 5 9068 VEV_2_3_RA5_01_1236.d 3.91E5 6 6 146 157
R.AAGDKEAITTR.V Y 72.17 1131.5884 11 -12.8 566.7943 2 16.34 6 5637 VEV_3_3_RA6_01_1237.d 3.93E5 7 7 240 250
K.SVTGPVSEGEDPSVRLEWK.A Y 57.40 2071.0222 19 -5.6 691.3441 3 72.38 4 41094 VEV_1_3_RA4_01_1235.d 6.68E4 1 1 54 72
R.MDDWDELMAAYKR.E Y 46.32 1642.7119 13 -32.7 548.5600 3 79.52 4 46653 VEV_1_3_RA4_01_1235.d 0 1 1 511 523
M.A(+42.01)ASSAILVHIDEDVGKDDQ(+.98)TATGGESAPYK.T Y 41.04 3087.4519 30 -0.9 1030.1570 3 79.69 4 46783 VEV_1_3_RA4_01_1235.d 2.92E4 1 1 2 31 Acetylation (Protein N-term); Deamidation (NQ)
K.ATNLYEQR.K Y 33.10 993.4879 8 -11.2 497.7457 2 30.02 6 12883 VEV_3_3_RA6_01_1237.d 1.54E5 4 4 82 89
R.EC(+57.02)C(+57.02)LYPR.F Y 29.64 996.4157 7 11.2 499.2207 2 43.60 4 20902 VEV_1_3_RA4_01_1235.d 0 1 1 567 573 Carbamidomethylation
K.TLVHAFLQQPPSTPDIQYLTR.K Y 23.70 2424.2800 21 -47.6 607.0485 4 81.34 4 48041 VEV_1_3_RA4_01_1235.d 0 1 1 32 52
K.VIIKEDESLPKPLK.I Y 20.17 1607.9497 14 -17.8 402.9875 4 63.20 4 33904 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 120 133
R.LNEKDPEKIK.L Y 19.37 1212.6714 10 -64.6 607.3038 2 20.91 5 8267 VEV_2_3_RA5_01_1236.d 0 1 1 136 145
K.DPEKIK.L Y 18.10 728.4068 6 -7.2 365.2081 2 51.19 4 25655 VEV_1_3_RA4_01_1235.d 8.83E4 1 1 140 145
K.AAKEQELVIR.E Y 18.02 1155.6611 10 -76.5 578.7936 2 38.05 6 17367 VEV_3_3_RA6_01_1237.d 6.44E4 1 1 93 102
K.KAAKEQELVIR.E Y 17.79 1283.7561 11 28.9 321.9556 4 63.19 4 33894 VEV_1_3_RA4_01_1235.d 0 1 1 92 102
R.LEWKAATK.S Y 17.58 945.5283 8 -15.6 473.7640 2 68.19 4 37791 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 69 76
R.VTESVDVLMPGVGEIVGGSM(+15.99)R.M Y 16.98 2147.0603 21 -2.8 537.7709 4 48.30 4 23811 VEV_1_3_RA4_01_1235.d 5.62E4 1 1 490 510 Oxidation (M)
R.FGDDIAEAAERK.M Y 15.62 1320.6310 12 1.1 441.2181 3 32.46 4 14275 VEV_1_3_RA4_01_1235.d 0 1 1 447 458
total 19 peptides
C1GAC4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YIVEYVTC(+57.02)K.T Y 90.80 1173.5740 9 -8.8 587.7891 2 66.17 4 36189 VEV_1_3_RA4_01_1235.d 2.7E5 4 4 251 259 Carbamidomethylation
R.SEDHVMQFLFAELVTSGSVDGSRR.L Y 89.61 2666.2759 24 -4.6 667.5732 4 87.54 4 52215 VEV_1_3_RA4_01_1235.d 5.01E4 2 2 209 232
R.LYFVTC(+57.02)NSC(+57.02)GSR.R Y 88.52 1462.6333 12 -10.3 732.3164 2 65.28 4 35495 VEV_1_3_RA4_01_1235.d 2.1E5 2 2 275 286 Carbamidomethylation
R.SEDHVMQFLFAELVTSGSVDGSR.R Y 88.49 2510.1748 23 -10.7 837.7233 3 90.78 4 54132 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 209 231
R.TIFANITDIC(+57.02)KR.M Y 77.93 1450.7603 12 -22.2 484.5833 3 72.95 6 40052 VEV_3_3_RA6_01_1237.d 5.65E5 5 5 194 205 Carbamidomethylation
K.SYKIPPPQC(+57.02)LR.E Y 77.63 1357.7177 11 -7.5 453.5764 3 59.25 5 30998 VEV_2_3_RA5_01_1236.d 8.96E5 4 4 178 188 Carbamidomethylation
K.LAEAGLTTEEAAPEDKPSTEEIVSDIEHGR.G Y 76.57 3193.5261 30 -7.5 799.3828 4 77.67 4 45225 VEV_1_3_RA4_01_1235.d 1.36E5 1 1 111 140
R.SPDTELNKGENR.L Y 74.72 1358.6426 12 -13.2 453.8821 3 20.42 5 7963 VEV_2_3_RA5_01_1236.d 5.46E5 7 7 263 274
R.SPDTELNKGENRLYFVTC(+57.02)NSC(+57.02)GSR.R Y 71.32 2803.2654 24 -7.3 701.8185 4 67.45 4 37205 VEV_1_3_RA4_01_1235.d 1.13E5 3 3 263 286 Carbamidomethylation
K.KAADGDFEAK.L Y 66.61 1050.4982 10 -0.6 526.2560 2 16.05 4 5342 VEV_1_3_RA4_01_1235.d 5.37E4 2 2 101 110
M.A(+42.01)DTEAPVVQRK.H Y 50.91 1254.6567 11 0.5 628.3359 2 42.90 4 20524 VEV_1_3_RA4_01_1235.d 6.12E5 5 5 2 12 Acetylation (Protein N-term)
K.LAEAGLTTEEAAPEDK(-1.03)PSTEEIVSDIEHGR.G Y 43.38 3192.4946 30 -1.5 799.1297 4 77.39 6 43292 VEV_3_3_RA6_01_1237.d 0 1 1 111 140 Lysine oxidation to aminoadipic semialdehyde
R.LYFVTC(+57.02)NSC(+57.02)GSRR.S Y 42.13 1618.7344 13 -19.0 540.5751 3 57.78 5 29961 VEV_2_3_RA5_01_1236.d 6.66E4 1 1 275 287 Carbamidomethylation
M.A(+42.01)DTEAPVVQR.K Y 40.95 1126.5618 10 -18.8 564.2776 2 57.56 6 28732 VEV_3_3_RA6_01_1237.d 1.73E5 2 2 2 11 Acetylation (Protein N-term)
R.FFTLIHSHHPDILSSGSK.S Y 38.84 2022.0322 18 -5.0 506.5128 4 70.79 5 39571 VEV_2_3_RA5_01_1236.d 1.56E5 1 1 160 177
K.IPPPQC(+57.02)LR.E Y 36.38 979.5273 8 -9.6 490.7662 2 46.00 5 22729 VEV_2_3_RA5_01_1236.d 2.72E5 2 2 181 188 Carbamidomethylation
R.SEDHVMQFLFAELVTSGSVDGSR(-.98).R Y 32.07 2509.1907 23 -31.1 837.3782 3 90.74 6 51694 VEV_3_3_RA6_01_1237.d 0 1 1 209 231 Amidation
K.HTATSPDKEVDEVTELFK.G Y 22.98 2044.9952 18 3.9 512.2581 4 75.40 4 43446 VEV_1_3_RA4_01_1235.d 1.31E5 2 2 46 63
K.TGFRGQVGR.R Y 21.01 976.5203 9 -18.5 489.2584 2 22.22 6 8725 VEV_3_3_RA6_01_1237.d 7.07E4 1 1 294 302
R.TIFANITDIC(+57.02)K.R Y 20.62 1294.6591 11 -12.1 648.3290 2 77.76 5 44552 VEV_2_3_RA5_01_1236.d 5.84E4 2 2 194 204 Carbamidomethylation
K.TTAEK.H Y 17.33 548.2806 5 -53.5 549.2585 1 26.19 6 10834 VEV_3_3_RA6_01_1237.d 4.94E4 1 1 41 45
K.SSKKAADGDFEAK.L Y 16.96 1352.6571 13 -23.1 677.3202 2 67.56 5 37191 VEV_2_3_RA5_01_1236.d 1.81E5 1 1 98 110
R.GQVGR.R Y 16.60 515.2816 5 4.5 516.2911 1 20.36 6 7747 VEV_3_3_RA6_01_1237.d 0 1 1 298 302
R.SEDHVM(-4.99)QFLFAELVTSGSVDGSRR.L Y 16.41 2661.2896 24 39.4 666.3559 4 87.58 4 52242 VEV_1_3_RA4_01_1235.d 0 1 1 209 232 Methionine replacement by azido homoalanine
total 24 peptides
C1GHF5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VISEPQEIEAWSGFSFPGR.G Y 116.13 2135.0322 19 -7.7 1068.5151 2 85.65 5 49535 VEV_2_3_RA5_01_1236.d 1.64E5 3 3 124 142
R.VISEPQEIEAWSGFSFPGRGNQYSK.M Y 104.53 2812.3455 25 -7.8 938.4484 3 81.57 5 47076 VEV_2_3_RA5_01_1236.d 8.52E4 1 1 124 148
K.SHAGSVWTEVYGTC(+57.02)R.S Y 85.06 1708.7627 15 -38.3 570.5730 3 65.85 5 35921 VEV_2_3_RA5_01_1236.d 9.56E4 2 2 441 455 Carbamidomethylation
R.DSFGKFDSDIYSSSC(+57.02) Y 79.23 1713.6827 15 -4.8 857.8445 2 75.77 5 43146 VEV_2_3_RA5_01_1236.d 1.34E5 3 3 487 501 Carbamidomethylation
R.NC(+57.02)IGFVR.M Y 66.10 864.4276 7 -15.1 433.2146 2 53.18 5 27093 VEV_2_3_RA5_01_1236.d 9.14E5 4 4 406 412 Carbamidomethylation
K.ILGPQNKDWAR.D Y 64.78 1296.6938 11 -17.2 433.2311 3 55.02 5 28185 VEV_2_3_RA5_01_1236.d 5.13E5 7 7 173 183
K.AIGVTSIWLPPGC(+57.02)K.A Y 64.15 1497.8014 14 12.0 749.9170 2 80.43 5 46331 VEV_2_3_RA5_01_1236.d 1.09E5 3 3 28 41 Carbamidomethylation
R.LQAALPSLK.A Y 51.27 939.5753 9 -24.9 470.7832 2 67.03 6 35646 VEV_3_3_RA6_01_1237.d 4.25E5 3 3 19 27
K.WGTKEELVSLVTR.A Y 45.01 1516.8250 13 -3.6 506.6138 3 76.17 5 43418 VEV_2_3_RA5_01_1236.d 7.19E4 2 2 71 83
R.VFEGSLVK.Y Y 28.52 877.4909 8 -9.3 439.7487 2 57.25 5 29593 VEV_2_3_RA5_01_1236.d 7.9E5 2 2 305 312
R.RLQAALPSLK.A Y 26.33 1095.6764 10 -4.4 366.2311 3 62.61 5 33484 VEV_2_3_RA5_01_1236.d 0 1 1 18 27
K.HYSAGFLR.D Y 23.72 949.4770 8 26.7 317.5081 3 39.74 6 18342 VEV_3_3_RA6_01_1237.d 4.46E5 5 5 234 241
R.KLYAYGQQR.D Y 21.62 1125.5930 9 -0.6 376.2047 3 35.98 4 16325 VEV_1_3_RA4_01_1235.d 5.52E4 1 1 391 399
R.M(+15.99)NVGK.S Y 18.80 563.2737 5 1.3 564.2817 1 72.66 6 39845 VEV_3_3_RA6_01_1237.d 4.68E4 2 2 436 440 Oxidation (M)
R.M(+15.99)GDSAHPHGLAC(+57.02)VLSNGPADK.K Y 18.79 2148.9680 21 -13.4 538.2421 4 12.42 6 3612 VEV_3_3_RA6_01_1237.d 2.49E4 2 2 413 433 Oxidation (M); Carbamidomethylation
total 15 peptides
C1G9A5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YEQLAQLYADNPEFAAK.V Y 103.24 1969.9421 17 -6.5 985.9720 2 78.71 4 46023 VEV_1_3_RA4_01_1235.d 1.86E5 3 3 403 419
K.IDATANDVPEEIQGFPTVK.L Y 98.38 2043.0160 19 -8.9 1022.5062 2 79.01 4 46256 VEV_1_3_RA4_01_1235.d 2.18E5 4 4 425 443
R.YIQAGIPLAYIFAETPEEREEFSK.M Y 97.19 2800.3958 24 -6.1 934.4669 3 87.06 5 50340 VEV_2_3_RA5_01_1236.d 4.06E5 2 2 249 272
K.ALAPKYEQLAQLYADNPEFAAK.V Y 93.37 2450.2480 22 -13.6 817.7455 3 80.02 5 46064 VEV_2_3_RA5_01_1236.d 2.03E5 2 2 398 419
K.LFAAGSKDKPFDYQGSR.T Y 85.07 1885.9321 17 -13.6 472.4839 4 61.69 6 31673 VEV_3_3_RA6_01_1237.d 3.39E5 2 2 444 460
R.TIQGLAEFVR.D Y 71.39 1132.6240 10 -11.7 567.3127 2 76.30 5 43514 VEV_2_3_RA5_01_1236.d 3.32E5 4 4 461 470
K.ALAPEYETAATQLK.E Y 68.16 1504.7772 14 -10.2 753.3882 2 68.30 4 37877 VEV_1_3_RA4_01_1235.d 2.62E5 4 4 63 76
R.GLEQVKPYSGPR.K Y 49.32 1329.7041 12 -12.2 665.8512 2 50.97 5 25779 VEV_2_3_RA5_01_1236.d 5.56E5 8 8 110 121
K.VEPSIK.S Y 38.68 671.3854 6 -2.0 672.3913 1 55.66 5 28541 VEV_2_3_RA5_01_1236.d 9.63E5 2 2 348 353
K.LSSTPLIGELGPHTYAR.Y Y 35.84 1810.9578 17 -11.0 604.6532 3 73.88 5 41795 VEV_2_3_RA5_01_1236.d 1.65E5 1 1 232 248
R.GSINIATIDAK.T Y 28.69 1101.6029 11 -7.8 368.2054 3 59.79 4 31329 VEV_1_3_RA4_01_1235.d 6.8E4 1 1 283 293
K.DKPFDYQGSR.T Y 28.46 1211.5570 10 -8.3 606.7808 2 38.51 4 17808 VEV_1_3_RA4_01_1235.d 2.65E5 3 3 451 460
K.VDAYDESK.V Y 26.97 925.4028 8 -11.8 926.3992 1 67.88 5 37437 VEV_2_3_RA5_01_1236.d 9.76E2 1 1 477 484
K.QPSIVM(+15.99)YK.D Y 19.35 980.5001 8 -4.4 491.2551 2 16.28 4 5456 VEV_1_3_RA4_01_1235.d 0 2 2 201 208 Oxidation (M)
K.KETKTTSSAAPK.D Y 18.93 1247.6721 12 6.1 312.9272 4 57.27 4 29496 VEV_1_3_RA4_01_1235.d 0 1 1 510 521
K.K(+42.01)ETK(+27.99)TTSSAAPK.D Y 16.65 1317.6776 12 2.8 659.8479 2 77.04 4 44723 VEV_1_3_RA4_01_1235.d 3.03E4 1 1 510 521 Acetylation (N-term); Formylation
R.DEFLFGATDDAK.L Y 16.58 1327.5931 12 -9.2 664.7977 2 20.17 6 7643 VEV_3_3_RA6_01_1237.d 6.23E3 1 1 181 192
K.SEPIPEK.Q Y 15.77 798.4123 7 -15.0 799.4076 1 91.40 5 52597 VEV_2_3_RA5_01_1236.d 2.49E5 1 1 354 360
total 18 peptides
C1FYL2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NAPDAPEDFTLSFEK.G Y 98.07 1679.7678 15 -19.8 840.8746 2 78.42 6 44040 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 214 228
K.TVTDSVEIFTALNELGR.K Y 94.19 1863.9578 17 -3.2 932.9832 2 87.86 4 52430 VEV_1_3_RA4_01_1235.d 1.22E5 3 3 240 256
R.LAHIDLEGLVLDREVR.L Y 93.17 1847.0265 16 -9.7 462.7594 4 78.91 6 44377 VEV_3_3_RA6_01_1237.d 4.81E5 4 4 289 304
K.SILASQDDVNGQVR.L Y 87.33 1500.7532 14 -9.1 751.3770 2 60.53 6 30812 VEV_3_3_RA6_01_1237.d 8.2E4 1 1 335 348
R.LAHIDLEGLVLDR.E Y 82.78 1462.8143 13 -14.9 488.6048 3 80.73 6 45674 VEV_3_3_RA6_01_1237.d 3.9E4 1 1 289 301
K.LLYNGLYFSPER.K Y 81.79 1470.7506 12 -18.9 736.3687 2 79.54 6 44831 VEV_3_3_RA6_01_1237.d 9.09E4 1 1 318 329
R.EFVEDLC(+57.02)YR.A Y 73.56 1229.5387 9 -17.9 615.7656 2 70.16 6 37975 VEV_3_3_RA6_01_1237.d 1.03E5 2 2 67 75 Carbamidomethylation
R.FELAFYAIQPSIR.V Y 63.08 1553.8241 13 -16.9 777.9062 2 85.14 6 48552 VEV_3_3_RA6_01_1237.d 2.33E4 2 2 125 137
R.GC(+57.02)YDSPAMTILR.L Y 60.40 1382.6322 12 1.3 692.3243 2 74.17 4 42510 VEV_1_3_RA4_01_1235.d 5.25E4 1 1 277 288 Carbamidomethylation
K.GIPSALTLGGK.T Y 59.48 1012.5917 11 -40.3 507.2827 2 68.60 6 36836 VEV_3_3_RA6_01_1237.d 1.27E5 1 1 229 239
R.LLRDQFVTVTWSK.L Y 52.71 1591.8722 13 -22.8 531.6193 3 75.16 6 41656 VEV_3_3_RA6_01_1237.d 5.87E4 1 1 305 317
K.SILASQDDVNGQ(+.98)VR.L Y 43.69 1501.7372 14 -12.0 751.8669 2 61.38 6 31436 VEV_3_3_RA6_01_1237.d 4.44E4 1 1 335 348 Deamidation (NQ)
R.NAPDAPEDFTLSFEK(+14.02).G Y 42.80 1693.7834 15 -15.7 847.8857 2 80.85 6 45756 VEV_3_3_RA6_01_1237.d 4.84E4 1 1 214 228 Methylation(KR)
K.AYGLAEAEK.R Y 32.54 950.4709 9 -36.2 476.2255 2 20.02 4 7407 VEV_1_3_RA4_01_1235.d 1.05E6 9 9 400 408
R.VIAPWR.L Y 22.59 740.4333 6 -17.3 371.2175 2 59.40 6 30012 VEV_3_3_RA6_01_1237.d 0 1 1 138 143
R.SSQTSK.L Y 17.54 636.3079 6 -33.4 637.2939 1 106.57 6 57188 VEV_3_3_RA6_01_1237.d 0 2 2 362 367
R.IDIVENR.Y Y 16.74 857.4606 7 -9.8 429.7334 2 35.84 5 16677 VEV_2_3_RA5_01_1236.d 1.22E5 1 1 263 269
K.GLASVLGR.S Y 16.13 771.4603 8 -63.0 772.4189 1 37.04 6 16793 VEV_3_3_RA6_01_1237.d 2.84E4 1 1 354 361
R.N(+.98)APDAPEDFTLSFEK(+14.02).G Y 15.40 1694.7675 15 10.6 848.4000 2 79.48 4 46613 VEV_1_3_RA4_01_1235.d 4.62E4 1 1 214 228 Deamidation (NQ); Methylation(KR)
total 19 peptides
C1GM08
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.A(+42.01)NDEYDFLFKVVLIGDSGVGKSNLLSR.F Y 92.70 2997.5447 27 -9.0 1000.1799 3 92.70 5 53216 VEV_2_3_RA5_01_1236.d 2.04E5 2 2 2 28 Acetylation (Protein N-term)
R.GAVGALLVYDTTKK.Q Y 87.27 1434.8082 14 -24.7 479.2649 3 68.90 6 37051 VEV_3_3_RA6_01_1237.d 1.44E5 2 2 81 94
K.ALEN(+.98)GSSSQNPLGDR.K Y 87.05 1544.7067 15 -5.9 773.3560 2 56.71 4 29153 VEV_1_3_RA4_01_1235.d 3.22E5 3 3 178 192 Deamidation (NQ)
K.ALEN(+.98)GSSSQNPLGDRK.V Y 83.64 1672.8016 16 -8.8 558.6029 3 44.42 4 21402 VEV_1_3_RA4_01_1235.d 5.74E5 7 7 178 193 Deamidation (NQ)
K.ALENGSSSQNPLGDRK.V Y 83.32 1671.8176 16 -7.2 836.9100 2 39.76 4 18558 VEV_1_3_RA4_01_1235.d 2.85E5 8 8 178 193
R.GAVGALLVYDTTK.K Y 75.65 1306.7133 13 -17.4 654.3525 2 75.63 4 43627 VEV_1_3_RA4_01_1235.d 1.48E5 3 3 81 93
K.AQIWDTAGQER.Y Y 75.01 1273.6051 11 -7.0 637.8054 2 60.34 4 31806 VEV_1_3_RA4_01_1235.d 2.62E5 3 3 60 70
K.VVLIGDSGVGKSNLLSR.F Y 71.60 1712.9784 17 2.7 572.0016 3 72.34 6 39612 VEV_3_3_RA6_01_1237.d 0 1 1 12 28
M.A(+42.01)NDEYDFLFKVVLIGDSGVGK.S Y 65.92 2327.1685 21 -5.4 1164.5852 2 94.70 6 53482 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 2 22 Acetylation (Protein N-term)
K.STIGVEFATR.S Y 62.32 1079.5610 10 -17.1 540.7786 2 64.96 6 34086 VEV_3_3_RA6_01_1237.d 6.38E5 3 3 40 49
R.FTRNEFNLDSK.S Y 60.39 1369.6626 11 7.2 457.5648 3 57.21 6 28501 VEV_3_3_RA6_01_1237.d 5.14E5 5 5 29 39
K.KQTFANC(+57.02)ER.W Y 58.83 1152.5345 9 -7.4 577.2703 2 15.45 4 5017 VEV_1_3_RA4_01_1235.d 1E5 3 3 94 102 Carbamidomethylation
R.AITSAYYR.G Y 53.82 943.4763 8 -11.7 472.7399 2 45.75 4 22221 VEV_1_3_RA4_01_1235.d 5.37E5 3 3 73 80
K.AQIWDTAGQERYR.A Y 52.66 1592.7695 13 -18.7 531.9205 3 61.72 6 31696 VEV_3_3_RA6_01_1237.d 3.52E5 3 3 60 72
M.A(+42.01)NDEYDFLFK.V Y 49.09 1302.5768 10 -9.4 652.2896 2 86.60 4 51641 VEV_1_3_RA4_01_1235.d 2.1E5 2 2 2 11 Acetylation (Protein N-term)
K.QTFANC(+57.02)ER.W Y 48.60 1024.4396 8 -5.3 513.2244 2 22.00 4 8465 VEV_1_3_RA4_01_1235.d 1.03E5 3 3 95 102 Carbamidomethylation
K.VVLIGDSGVGK.S Y 43.21 1042.6022 11 -13.3 522.3015 2 63.33 4 34004 VEV_1_3_RA4_01_1235.d 1.42E5 3 3 12 22
R.SIQVDGKTIK.A Y 17.66 1087.6237 10 11.8 1088.6438 1 103.19 6 56273 VEV_3_3_RA6_01_1237.d 7.06E2 1 1 50 59
K.NIVIM(+15.99)LVGNK.I Y 16.10 1115.6372 10 -6.7 372.8839 3 35.09 4 15803 VEV_1_3_RA4_01_1235.d 0 1 1 114 123 Oxidation (M)
R.EHADK.N N 15.56 598.2711 5 29.0 599.2957 1 59.63 5 31280 VEV_2_3_RA5_01_1236.d 8.14E4 1 1 109 113
total 20 peptides
C1G1M5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGLSNPNSPPSFLFSGPSGTGK.T Y 105.49 2134.0330 22 -12.7 1068.0103 2 78.74 6 44256 VEV_3_3_RA6_01_1237.d 1.62E5 3 3 622 643
R.RLPDSAVDLIDEAAAAVR.V Y 98.14 1880.9955 18 -15.9 627.9958 3 85.87 6 48998 VEV_3_3_RA6_01_1237.d 2.69E5 2 2 407 424
R.IVNADVPANLANC(+57.02)K.L Y 77.38 1497.7610 14 -12.4 749.8785 2 64.73 6 33910 VEV_3_3_RA6_01_1237.d 2.49E4 1 1 244 257 Carbamidomethylation
R.LASQDPPPETISPSPAFAK.V Y 75.39 1951.9890 19 0.2 977.0020 2 70.02 4 39228 VEV_1_3_RA4_01_1235.d 5.24E4 1 1 90 108
K.TQKDTYVAIDHLIAALAQDPTIQR.A Y 65.66 2680.4185 24 -5.3 537.0881 5 86.02 6 49084 VEV_3_3_RA6_01_1237.d 2.1E5 3 3 119 142
R.ALADANIPNVK.M Y 55.44 1124.6189 11 -17.4 563.3069 2 62.92 6 32577 VEV_3_3_RA6_01_1237.d 1.58E5 3 3 143 153
R.ESQPEALDTLER.R Y 53.59 1386.6626 12 -14.5 694.3285 2 63.94 5 34499 VEV_2_3_RA5_01_1236.d 7.01E4 3 3 428 439
R.MIGAPPGYVGHDAGGQLTESLR.R Y 53.44 2225.0898 22 -10.3 742.6962 3 73.50 4 41978 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 678 699
R.LAVLILR.G Y 41.38 796.5534 7 -28.8 399.2725 2 74.94 4 43080 VEV_1_3_RA4_01_1235.d 4.09E4 3 3 865 871
K.M(+15.99)IDSAIQQIR.G Y 37.43 1189.6125 10 -16.2 595.8039 2 61.35 6 31407 VEV_3_3_RA6_01_1237.d 8.33E4 2 2 154 163 Oxidation (M)
R.IEQLEAER.A Y 32.68 986.5032 8 -1.1 494.2584 2 36.09 6 16323 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 535 542
K.TTVVEGLAR.R Y 30.99 944.5291 9 -16.8 473.2639 2 51.63 5 26156 VEV_2_3_RA5_01_1236.d 6.67E4 2 2 234 242
K.TTVVEGLARR.I Y 27.59 1100.6301 10 -24.2 367.8751 3 70.98 6 38588 VEV_3_3_RA6_01_1237.d 5.04E4 1 1 234 243
K.LDLLK.V N 26.09 600.3846 5 -24.1 601.3774 1 35.69 6 16060 VEV_3_3_RA6_01_1237.d 2.93E4 1 1 501 505
R.LPDSAVDLIDEAAAAVR.V Y 24.76 1724.8944 17 -7.5 432.2277 4 62.67 5 33574 VEV_2_3_RA5_01_1236.d 0 2 2 408 424
K.EAVQSVSNAIR.L Y 22.99 1172.6149 11 -56.2 587.2817 2 52.27 6 25640 VEV_3_3_RA6_01_1237.d 0 1 1 608 618
R.GQLHC(+57.02)IGATTLGEYRK.Y Y 22.44 1802.9097 16 -9.2 451.7305 4 60.17 6 30562 VEV_3_3_RA6_01_1237.d 5.52E4 1 1 328 343 Carbamidomethylation
R.GAIKDGETARVVM(+15.99)QEGR.I Y 22.39 1831.9210 17 4.7 458.9897 4 48.68 4 24050 VEV_1_3_RA4_01_1235.d 0 1 1 872 888 Oxidation (M)
R.SKDIQDAR.I Y 21.98 931.4723 8 2.0 932.4814 1 92.02 6 52315 VEV_3_3_RA6_01_1237.d 4.88E5 2 2 491 498
K.ELVMGALR.N Y 21.16 887.4899 8 -63.1 888.4412 1 83.60 5 48320 VEV_2_3_RA5_01_1236.d 9.33E4 2 2 773 780
R.NYFLPEFLNR.I Y 20.93 1311.6611 10 -12.8 656.8295 2 79.36 5 45631 VEV_2_3_RA5_01_1236.d 2.59E5 1 1 781 790
K.E(+226.08)LVMGALR.N Y 19.67 1113.5674 8 -2.4 372.1955 3 53.15 4 26901 VEV_1_3_RA4_01_1235.d 2.85E4 1 1 773 780 Biotinylation
R.HSLSR.M Y 19.01 598.3187 5 61.1 599.3625 1 62.98 6 32619 VEV_3_3_RA6_01_1237.d 1.44E5 2 2 673 677
R.QLQIEIHALAR.E Y 18.45 1290.7407 11 -33.6 431.2397 3 68.71 5 38055 VEV_2_3_RA5_01_1236.d 2.42E5 2 2 443 453
K.IVVGQK.E Y 17.30 642.4064 6 -26.2 322.2021 2 53.43 6 26321 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 602 607
R.AASNLSK.T Y 17.24 689.3708 7 -60.0 690.3367 1 112.58 5 59559 VEV_2_3_RA5_01_1236.d 3.63E4 1 1 112 118
R.TTEKDRLLHM(+15.99)ESHLSK.I Y 17.23 1939.9785 16 -3.4 486.0002 4 75.74 5 43132 VEV_2_3_RA5_01_1236.d 6.16E4 1 1 586 601 Oxidation (M)
K.IVVGQKEAVQSVSNAIR.L Y 16.90 1797.0107 17 -20.8 599.9984 3 83.00 6 47190 VEV_3_3_RA6_01_1237.d 0 1 1 602 618
R.RIVNADVPANLANC(+57.02)K.L Y 16.55 1653.8621 15 -5.4 552.2916 3 83.70 5 48380 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 243 257 Carbamidomethylation
R.YLTAR.R N 16.48 622.3439 5 -37.8 623.3276 1 74.56 5 42293 VEV_2_3_RA5_01_1236.d 0 1 1 402 406
K.KFTVDMTAMAR.E Y 15.86 1269.6210 11 18.6 424.2221 3 14.66 5 4848 VEV_2_3_RA5_01_1236.d 1.15E4 1 1 184 194
K.DQQVTTHPSHQASSGSLFK.R Y 15.85 2053.9817 19 -26.4 514.4891 4 15.42 5 5265 VEV_2_3_RA5_01_1236.d 7.02E4 1 1 48 66
K.MIDSAIQQIRGM(+15.99)K.R Y 15.57 1505.7694 13 -53.0 753.8521 2 86.74 4 51713 VEV_1_3_RA4_01_1235.d 2.34E5 1 1 154 166 Oxidation (M)
R.LLHM(+15.99)ESHLSK.I Y 15.21 1209.6176 10 -28.7 404.2016 3 8.91 4 2115 VEV_1_3_RA4_01_1235.d 4.54E3 1 1 592 601 Oxidation (M)
R.IEQLEAERAR.Q Y 15.11 1213.6415 10 -5.3 607.8248 2 72.78 4 41412 VEV_1_3_RA4_01_1235.d 1.7E4 1 1 535 544
total 35 peptides
C1FYM2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPDNSYTYGNLVAVSPR.D Y 115.60 1838.8799 17 -13.2 920.4351 2 73.63 5 41615 VEV_2_3_RA5_01_1236.d 2.87E5 3 3 119 135
R.NFENQILAPGQK.I Y 87.11 1357.6990 12 -10.0 679.8500 2 66.88 5 36692 VEV_2_3_RA5_01_1236.d 5.78E4 2 2 234 245
R.YNSPNQPPSGYGPDRR.M Y 85.29 1803.8289 16 -10.9 602.2770 3 43.77 5 21364 VEV_2_3_RA5_01_1236.d 7.71E5 6 6 34 49
R.GILTSFTLINFFKDAK.T Y 83.01 1813.9978 16 -7.6 605.6686 3 89.52 6 51068 VEV_3_3_RA6_01_1237.d 2.71E4 2 2 287 302
K.SSSAPTTSDPHAR.G Y 79.26 1312.6007 13 -9.7 657.3013 2 13.34 5 4147 VEV_2_3_RA5_01_1236.d 4.84E4 3 3 274 286
K.TGINVKPSNR.R Y 53.93 1084.5989 10 -60.1 543.2741 2 22.40 5 9021 VEV_2_3_RA5_01_1236.d 0 3 3 303 312
K.IAIDSGFPFVK.L Y 44.27 1192.6492 11 -6.7 597.3279 2 80.87 5 46624 VEV_2_3_RA5_01_1236.d 3.81E4 2 2 667 677
R.TWAQVALTDMVTVRR.Y Y 31.66 1745.9247 15 30.2 437.5016 4 75.71 4 43688 VEV_1_3_RA4_01_1235.d 0 1 1 177 191
K.SPTSVIVMDNIER.I Y 30.41 1459.7340 13 9.6 365.9443 4 12.96 5 3943 VEV_2_3_RA5_01_1236.d 0 1 1 706 718
R.DPQSTTSLFSVLLHGPPGSGK.T Y 29.96 2124.0850 21 -12.9 709.0265 3 85.12 4 50664 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 640 660
R.GPPPPPQPVNLGWGQNR.V Y 27.65 1809.9274 17 18.2 604.3274 3 75.18 4 43268 VEV_1_3_RA4_01_1235.d 4.3E4 2 2 85 101
R.FASVIAR.A Y 25.38 762.4388 7 -16.0 382.2206 2 49.22 6 23850 VEV_3_3_RA6_01_1237.d 4.12E4 1 1 842 848
R.DIPPSR.D Y 23.12 683.3602 6 16.5 684.3788 1 51.74 6 25321 VEV_3_3_RA6_01_1237.d 0 1 1 136 141
K.QRGSGAGGGTGVGDSVVNQLLSK.L Y 22.91 2143.0981 23 -15.7 715.3621 3 86.11 4 51309 VEV_1_3_RA4_01_1235.d 0 1 1 447 469
K.TVQLGNLASEK.S Y 22.57 1158.6244 11 -21.1 387.2073 3 53.98 5 27585 VEV_2_3_RA5_01_1236.d 7.4E4 2 2 261 271
R.IGVGIKK.V Y 22.48 713.4799 7 -10.7 714.4796 1 15.05 6 4971 VEV_3_3_RA6_01_1237.d 1.38E4 1 1 818 824
R.M(+15.99)DMIDDALLRPGRLEVHM(+15.99)EISLPDEHGR.A Y 20.66 3276.5688 28 -8.6 1093.1875 3 0.58 4 133 VEV_1_3_RA4_01_1235.d 0 1 1 488 515 Oxidation (M)
K.VLHM(+15.99)SKVFMDAYK.S Y 19.61 1583.7839 13 17.7 528.9446 3 65.32 4 35524 VEV_1_3_RA4_01_1235.d 9.66E4 1 1 693 705 Oxidation (M)
R.AGR(+.98)FASVIAR.A Y 19.24 1047.5825 10 64.8 350.2241 3 42.34 5 20522 VEV_2_3_RA5_01_1236.d 0 1 1 839 848 Deamidation (R)
R.AFASR.I N 18.69 550.2863 5 -31.2 551.2764 1 57.65 6 28799 VEV_3_3_RA6_01_1237.d 7.09E4 1 1 345 349
R.DVDLLELAQLTK.N Y 17.60 1356.7500 12 -32.5 340.1837 4 28.00 4 11749 VEV_1_3_RA4_01_1235.d 0 1 1 535 546
R.RAFASR.I Y 16.14 706.3875 6 -45.0 354.1851 2 36.02 5 16781 VEV_2_3_RA5_01_1236.d 4.55E5 1 1 344 349
K.SASSFAFNR.H Y 15.93 985.4617 9 31.1 493.7535 2 54.01 4 27482 VEV_1_3_RA4_01_1235.d 0 1 1 559 567
K.LFADAEK.E Y 15.88 792.4017 7 -29.1 793.3859 1 82.89 4 49148 VEV_1_3_RA4_01_1235.d 8.82E4 1 1 416 422
R.LLILATTTERSILK.Q Y 15.82 1570.9658 14 -14.9 315.1958 5 58.08 4 30071 VEV_1_3_RA4_01_1235.d 0 1 1 751 764
K.YVGQSEENIR.K Y 15.82 1193.5676 10 10.8 299.4024 4 25.15 4 10196 VEV_1_3_RA4_01_1235.d 2.28E5 1 1 405 414
total 26 peptides
C1GGQ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NIIVATGSEPTPFPGLTIDEER.I Y 118.10 2355.1958 22 -6.8 1178.5972 2 83.94 4 49874 VEV_1_3_RA4_01_1235.d 1.04E5 2 2 185 206
R.AKTNLDTEGLVK.F Y 80.45 1287.7034 12 -13.4 644.8503 2 48.21 6 23271 VEV_3_3_RA6_01_1237.d 1.93E5 4 4 435 446
R.VGTFPFSANSR.A Y 72.30 1181.5829 11 -13.0 591.7910 2 67.99 5 37594 VEV_2_3_RA5_01_1236.d 6.67E5 4 4 424 434
K.SLLNNSHLYHQILHDTK.K Y 65.57 2032.0490 17 -14.4 407.4112 5 68.46 6 36732 VEV_3_3_RA6_01_1237.d 3.52E5 4 4 98 114
R.GIEVGDVKLNLEQMMK.A Y 51.92 1802.9270 16 25.8 601.9985 3 81.18 4 47928 VEV_1_3_RA4_01_1235.d 0 2 2 117 132
K.GTGSFIDQNSVKVDLLEGGER.T Y 51.74 2220.1023 21 -19.3 741.0271 3 77.70 6 43514 VEV_3_3_RA6_01_1237.d 1.73E5 1 1 159 179
R.LGAEVTIVEFLNQIGGPGMDAEISK.Q Y 51.61 2587.3203 25 -10.5 863.4383 3 94.36 4 55995 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 242 266
K.GGKEQKLDADVVLVAIGR.R Y 49.85 1867.0526 18 -15.3 467.7633 4 74.30 6 41037 VEV_3_3_RA6_01_1237.d 0 2 2 304 321
K.FIADAETDR.I Y 49.42 1036.4825 9 -4.4 519.2463 2 43.89 4 21070 VEV_1_3_RA4_01_1235.d 5.31E5 5 5 447 455
K.GTGSFIDQNSVK.V Y 46.04 1251.6095 12 -13.3 626.8037 2 56.08 6 27777 VEV_3_3_RA6_01_1237.d 9.99E4 1 1 159 170
K.AKESSVDSLTK.G Y 44.88 1163.6034 11 -9.9 582.8032 2 22.17 5 8901 VEV_2_3_RA5_01_1236.d 4.94E4 2 2 133 143
R.VVIDQEYR.T Y 38.30 1020.5240 8 -18.6 511.2598 2 49.32 6 23913 VEV_3_3_RA6_01_1237.d 2.05E5 2 2 343 350
K.ESSVDSLTK.G Y 33.28 964.4713 9 -21.4 483.2326 2 30.57 6 13179 VEV_3_3_RA6_01_1237.d 1.99E4 1 1 135 143
R.VVIDQEYRTK.S Y 29.48 1249.6666 10 -16.0 625.8306 2 39.73 5 18960 VEV_2_3_RA5_01_1236.d 7.33E4 2 2 343 352
K.YRVGTFPFSANSR.A Y 29.05 1500.7473 13 -9.7 501.2515 3 68.94 5 38227 VEV_2_3_RA5_01_1236.d 3.04E5 2 2 422 434
K.AAGIKYR.V Y 27.70 777.4497 7 -41.1 389.7162 2 16.58 6 5760 VEV_3_3_RA6_01_1237.d 0 1 1 417 423
K.GIEFLLK.K Y 27.69 818.4902 7 -16.4 410.2457 2 76.54 6 42658 VEV_3_3_RA6_01_1237.d 2.99E4 1 1 144 150
R.GIEVGDVKLNLEQM(+15.99)MK.A Y 26.53 1818.9219 16 -17.2 910.4526 2 95.44 6 53771 VEV_3_3_RA6_01_1237.d 0 1 1 117 132 Oxidation (M)
K.FLVGTK.V Y 24.10 663.3955 6 -19.4 332.6986 2 42.17 6 19749 VEV_3_3_RA6_01_1237.d 1.4E5 1 1 279 284
K.TNLDTEGLVK.F Y 23.24 1088.5713 10 -28.8 545.2772 2 59.67 6 30265 VEV_3_3_RA6_01_1237.d 2.23E5 3 3 437 446
K.TVC(+57.02)IEKR.G Y 22.12 904.4800 7 -23.4 453.2367 2 15.61 6 5269 VEV_3_3_RA6_01_1237.d 3.72E4 1 1 75 81 Carbamidomethylation
K.EAAMATYSKAIHF Y 21.38 1438.6914 13 -7.2 720.3478 2 79.83 5 45939 VEV_2_3_RA5_01_1236.d 0 1 1 502 514
K.RGIEVGDVK.L Y 20.32 971.5400 9 -18.6 324.8479 3 25.56 4 10421 VEV_1_3_RA4_01_1235.d 2.56E5 1 1 116 124
K.NSVEYVKGTGSFIDQNSVK.V Y 19.47 2071.0222 19 -13.5 691.3387 3 76.47 6 42609 VEV_3_3_RA6_01_1237.d 6.48E4 3 3 152 170
K.NVVLNVESAK.G Y 19.05 1071.5924 10 -8.0 536.7992 2 57.60 4 29720 VEV_1_3_RA4_01_1235.d 0 1 1 294 303
K.TVC(+57.02)IEK.R Y 18.77 748.3789 6 -6.8 749.3811 1 98.68 5 55562 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 75 80 Carbamidomethylation
R.G(+42.01)IEVGDVK.L Y 17.45 857.4494 8 51.8 429.7542 2 13.67 6 4266 VEV_3_3_RA6_01_1237.d 5.96E4 1 1 117 124 Acetylation (N-term)
K.NSVEYVK.G Y 16.16 837.4232 7 -23.0 838.4113 1 46.44 5 22991 VEV_2_3_RA5_01_1236.d 2.44E5 1 1 152 158
K.R(+164.06)GIEVGDVK.L Y 16.11 1135.6002 9 -54.0 379.5202 3 12.41 5 3659 VEV_2_3_RA5_01_1236.d 1.91E4 1 1 116 124 O-Diisopropylphosphorylation
R.VGTFPFSANSRAK.T Y 15.53 1380.7150 13 0.8 346.1863 4 42.20 4 20032 VEV_1_3_RA4_01_1235.d 0 1 1 424 436
K.GIEFLLKK.N Y 15.43 946.5851 8 -11.5 316.5320 3 67.47 4 37218 VEV_1_3_RA4_01_1235.d 3.56E4 1 1 144 151
total 31 peptides
C1G1G2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQDDFLSNDETISETAR.L Y 102.16 1952.8962 17 -10.3 977.4453 2 75.12 6 41628 VEV_3_3_RA6_01_1237.d 1.12E5 3 3 705 721
R.NYANFVSTESTTPSR.T Y 99.40 1672.7693 15 -13.7 837.3805 2 64.39 6 33657 VEV_3_3_RA6_01_1237.d 2.69E5 3 3 150 164
K.QLNIVVPVILDNLYSTEDLLPLQEK.A Y 87.00 2865.5740 25 -7.7 956.1913 3 96.65 5 54887 VEV_2_3_RA5_01_1236.d 4.75E4 1 1 199 223
K.SPNTSPTNFSGR.V Y 80.81 1263.5844 12 -7.2 632.7949 2 38.82 5 18465 VEV_2_3_RA5_01_1236.d 4.62E5 6 6 821 832
R.VFSIPVLSQGHVSLAPGR.V Y 69.51 1863.0366 18 8.0 622.0245 3 80.38 5 46300 VEV_2_3_RA5_01_1236.d 0 1 1 833 850
R.TAAYN(+.98)GSSVPKQSTAPDDDTAR.A Y 62.50 2252.0193 22 -6.1 751.6758 3 47.55 5 23663 VEV_2_3_RA5_01_1236.d 6.82E4 1 1 1151 1172 Deamidation (NQ)
R.KPETAAGVDTR.N Y 54.22 1143.5884 11 -13.8 572.7936 2 15.61 6 5268 VEV_3_3_RA6_01_1237.d 4.17E4 5 5 553 563
R.Q(-17.03)ATKGQPTVSTTPR.Q Y 46.38 1453.7524 14 -19.6 727.8693 2 38.24 6 17507 VEV_3_3_RA6_01_1237.d 3.39E4 1 1 1126 1139 Pyro-glu from Q
R.SIYTSFTDLPELVAQIENAYNTIVK.S Y 38.94 2828.4482 25 -5.1 943.8185 3 97.74 5 55276 VEV_2_3_RA5_01_1236.d 1.87E4 1 1 796 820
K.IFATGSNR.S Y 34.07 864.4453 8 -18.9 433.2218 2 26.63 5 11411 VEV_2_3_RA5_01_1236.d 1.69E5 2 2 284 291
K.GQPTVSTTPR.Q Y 32.74 1042.5408 10 -42.1 522.2557 2 26.46 5 11303 VEV_2_3_RA5_01_1236.d 1.8E5 3 3 1130 1139
R.QATKGQPTVSTTPRQSR.S Y 30.57 1841.9707 17 7.6 615.0022 3 86.50 5 50019 VEV_2_3_RA5_01_1236.d 0 1 1 1126 1142
R.QAT(-18.01)KGQPTVSTTPR.Q Y 28.05 1452.7684 14 -31.3 727.3688 2 38.22 5 18069 VEV_2_3_RA5_01_1236.d 7.01E3 1 1 1126 1139 Dehydration
R.QIM(+15.99)PR.G Y 27.47 659.3425 5 -2.2 660.3483 1 62.19 4 33156 VEV_1_3_RA4_01_1235.d 0 1 1 998 1002 Oxidation (M)
R.TAAYNGSSVPK.Q Y 26.02 1093.5404 11 -9.0 547.7726 2 30.63 5 13624 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 1151 1161
R.VPPEEQLPTTVR.E Y 25.29 1364.7300 12 -22.1 342.1822 4 28.08 6 11823 VEV_3_3_RA6_01_1237.d 9.05E4 1 1 851 862
R.QATKGQPTVSTTPR.Q Y 24.21 1470.7791 14 -12.5 491.2608 3 22.40 5 9016 VEV_2_3_RA5_01_1236.d 8.5E4 1 1 1126 1139
K.IFATGSNRSQIR.I Y 23.71 1348.7211 12 -11.0 338.1838 4 34.34 5 15785 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 284 295
R.TAAYN(+.98)GSSVPK.Q Y 22.84 1094.5244 11 -6.4 548.2660 2 34.88 6 15587 VEV_3_3_RA6_01_1237.d 1.62E5 1 1 1151 1161 Deamidation (NQ)
R.AISSSISGSR.A Y 21.71 963.4985 10 -14.2 482.7497 2 28.42 6 11998 VEV_3_3_RA6_01_1237.d 3.07E4 1 1 883 892
R.IVSTISQR.D Y 20.07 902.5185 8 -13.4 452.2605 2 30.55 4 13157 VEV_1_3_RA4_01_1235.d 5.34E4 1 1 636 643
R.RVDVDKLLK.G Y 19.95 1084.6604 9 -13.0 362.5560 3 54.94 5 28144 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 1195 1203
K.YGLPMLMR.L Y 18.97 979.4983 8 76.6 980.5806 1 100.90 6 55587 VEV_3_3_RA6_01_1237.d 1.95E5 1 1 697 704
R.TSLALPLRLR.W Y 18.94 1138.7186 10 -4.7 380.5784 3 73.13 5 41263 VEV_2_3_RA5_01_1236.d 2.11E4 1 1 165 174
R.SVRGMGSGVR.G Y 18.25 1004.5186 10 0.6 503.2669 2 26.61 4 10993 VEV_1_3_RA4_01_1235.d 8.34E4 1 1 1261 1270
R.ATSTGNGR.A Y 17.74 762.3620 8 -28.4 763.3477 1 73.78 4 42188 VEV_1_3_RA4_01_1235.d 4.27E4 1 1 1173 1180
K.VGAFLEKRAARDVWR.G Y 16.70 1772.9797 15 -27.2 444.2401 4 50.68 6 24681 VEV_3_3_RA6_01_1237.d 0 1 1 54 68
K.NILLANVR.K Y 15.95 911.5552 8 55.2 912.6128 1 102.75 5 56877 VEV_2_3_RA5_01_1236.d 7.98E4 1 1 545 552
R.TSTATVQTADTTDGDPTTASGTTADSDR.V Y 15.46 2743.1904 28 -20.0 549.6344 5 12.76 4 3673 VEV_1_3_RA4_01_1235.d 6.35E4 1 1 240 267
total 29 peptides
C1FZL1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FDDGAGGDNEVQR.T Y 106.99 1378.5750 13 -10.4 690.2876 2 37.43 6 17017 VEV_3_3_RA6_01_1237.d 4.35E5 7 7 291 303
R.MQEEQPLQVAR.C Y 92.96 1327.6554 11 -10.6 664.8279 2 57.12 4 29391 VEV_1_3_RA4_01_1235.d 1.74E5 3 3 91 101
R.M(+15.99)QEEQPLQVAR.C Y 77.18 1343.6503 11 -13.5 672.8234 2 47.53 6 22905 VEV_3_3_RA6_01_1237.d 7.29E4 1 1 91 101 Oxidation (M)
K.KITPLTDEDIQVLK.T Y 77.07 1611.9083 14 -40.2 538.2885 3 72.25 6 39553 VEV_3_3_RA6_01_1237.d 1.4E5 2 2 25 38
K.TYGAAPYAAALK.K Y 70.50 1195.6237 12 -17.3 598.8088 2 64.55 6 33774 VEV_3_3_RA6_01_1237.d 2.87E5 3 3 39 50
R.LC(+57.02)PNSTGAELR.S Y 67.28 1216.5870 11 -11.0 609.2941 2 45.04 5 22158 VEV_2_3_RA5_01_1236.d 7.13E5 9 9 382 392 Carbamidomethylation
R.KIEFSLPDLEGR.A Y 65.36 1402.7456 12 -3.4 468.5876 3 77.71 4 45262 VEV_1_3_RA4_01_1235.d 2.79E5 3 3 346 357
R.FVSLGIDPPKGALLYGPPGTGK.T Y 58.75 2183.1990 22 -17.2 728.7277 3 80.48 6 45500 VEV_3_3_RA6_01_1237.d 4.55E4 2 2 207 228
K.NFADDEQEEKKITPLTDEDIQVLK.T Y 57.80 2817.3918 24 -9.0 705.3489 4 76.37 4 44197 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 15 38
R.DIRWELISR.L Y 47.56 1186.6459 9 -27.3 396.5451 3 74.79 4 42966 VEV_1_3_RA4_01_1235.d 2.45E4 2 2 373 381
R.FDDGAGGD(+14.02)NEVQR.T Y 43.03 1392.5906 13 -7.3 697.2975 2 46.87 4 22930 VEV_1_3_RA4_01_1235.d 3.84E4 1 1 291 303 Methylation(others)
R.TMLELITQLDGFDSR.G Y 40.53 1737.8607 15 -30.6 869.9110 2 90.56 4 53966 VEV_1_3_RA4_01_1235.d 0 1 1 304 318
K.IIQDEKDPEKSKYVINVK.Q Y 34.45 2145.1680 18 -10.9 430.0362 5 56.39 4 28881 VEV_1_3_RA4_01_1235.d 1.52E5 1 1 105 122
K.NFADDEQEEK.K Y 31.18 1223.4941 10 -3.8 612.7520 2 28.81 4 12195 VEV_1_3_RA4_01_1235.d 6.02E4 1 1 15 24
K.FVVNLGER.V Y 30.36 932.5079 8 -21.3 467.2513 2 66.80 6 35473 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 127 134
R.FVSLGIDPPK.G Y 29.46 1071.5964 10 -18.7 358.1994 3 12.25 4 3415 VEV_1_3_RA4_01_1235.d 0 1 1 207 216
R.VIGSELVQK.Y Y 28.29 971.5651 9 0.5 324.8625 3 20.65 5 8087 VEV_2_3_RA5_01_1236.d 1.1E6 1 1 246 254
R.VSPTDIEEGMR.V Y 23.47 1232.5707 11 2.5 1233.5811 1 96.67 5 54891 VEV_2_3_RA5_01_1236.d 0 1 1 135 145
K.QTSVNEK.I Y 23.31 804.3977 7 6.3 805.4100 1 87.77 6 50095 VEV_3_3_RA6_01_1237.d 3.55E5 1 1 60 66
K.VATEK.D Y 23.18 546.3013 5 -15.2 547.3003 1 98.81 4 57809 VEV_1_3_RA4_01_1235.d 0 1 1 409 413
K.YVGEGAR.M Y 22.03 750.3660 7 -7.7 751.3675 1 74.99 5 42586 VEV_2_3_RA5_01_1236.d 5.47E4 1 1 255 261
K.VMFATNRPSTLDPALMRPGR.I Y 20.97 2229.1511 20 -6.6 558.2914 4 72.39 4 41102 VEV_1_3_RA4_01_1235.d 1.63E5 1 1 323 342
R.EVVEMPLLSPER.F Y 20.59 1397.7224 12 -35.0 699.8440 2 80.22 5 46195 VEV_2_3_RA5_01_1236.d 4.23E4 1 1 195 206
K.IIQDEKDPEK.S Y 17.72 1213.6190 10 0.4 607.8170 2 46.06 5 22763 VEV_2_3_RA5_01_1236.d 5.14E3 1 1 105 114
K.EKQTSVNEK.I Y 15.80 1061.5353 9 5.0 531.7776 2 21.33 4 8126 VEV_1_3_RA4_01_1235.d 0 1 1 58 66
K.EQIEK.L N 15.17 645.3333 5 33.1 646.3619 1 14.82 6 4847 VEV_3_3_RA6_01_1237.d 1.95E4 1 1 188 192
total 26 peptides
C1GJT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TILGATNPADSAPGTIRGDYAIDVGR.N Y 131.20 2600.3193 26 -16.0 867.7665 3 76.90 6 42948 VEV_3_3_RA6_01_1237.d 5.33E5 3 3 89 114
R.NVC(+57.02)HGSDSVESAKK.E Y 111.01 1516.6940 14 -10.6 759.3462 2 12.65 6 3738 VEV_3_3_RA6_01_1237.d 1.2E5 4 4 115 128 Carbamidomethylation
R.TILGATNPADSAPGTIR.G Y 107.22 1653.8685 17 -10.6 827.9328 2 68.98 6 37114 VEV_3_3_RA6_01_1237.d 3.63E5 3 3 89 105
M.S(+42.01)ASEQTFIAIKPDGVQR.G Y 63.90 1887.9690 17 -9.6 944.9827 2 75.09 5 42655 VEV_2_3_RA5_01_1236.d 9.37E5 6 6 2 18 Acetylation (Protein N-term)
K.EIALWFKPEELVK.Y Y 63.20 1600.8865 13 -5.9 534.6329 3 82.63 4 48971 VEV_1_3_RA4_01_1235.d 1.73E5 2 2 129 141
R.GDYAIDVGR.N Y 53.47 964.4614 9 -8.3 483.2339 2 56.73 5 29237 VEV_2_3_RA5_01_1236.d 1.26E5 1 1 106 114
M.S(+43.01)ASEQTFIAIKPDGVQR.G Y 50.05 1888.9642 17 -5.5 630.6586 3 75.00 4 43130 VEV_1_3_RA4_01_1235.d 1E5 1 1 2 18 Carbamylation
R.GLVGPIISRFENR.G Y 28.66 1456.8149 13 -7.3 486.6087 3 76.94 6 42963 VEV_3_3_RA6_01_1237.d 2.37E5 3 3 19 31
K.EHLEK.H N 15.19 654.3337 5 6.1 655.3450 1 35.94 4 16296 VEV_1_3_RA4_01_1235.d 5.49E3 1 1 46 50
total 9 peptides
C1GH49
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HPFPGPGIAIR.I Y 91.19 1160.6454 11 -14.0 387.8837 3 65.45 4 35691 VEV_1_3_RA4_01_1235.d 8.59E4 3 3 419 429
K.VIGNTFIEVFQEEAKK.I Y 88.40 1850.9778 16 -7.7 617.9951 3 81.23 4 47964 VEV_1_3_RA4_01_1235.d 7.36E4 2 2 319 334
R.HLGVNLTVVDASER.F Y 77.97 1508.7947 14 -18.1 503.9297 3 68.50 4 38037 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 288 301
R.AVETTDFMTADWYPFDGEFLK.T Y 77.64 2482.1038 21 -9.9 1242.0469 2 91.70 4 54605 VEV_1_3_RA4_01_1235.d 6.08E4 1 1 492 512
K.LVGEKGQVIGAVSGGVDSTVAAK.L Y 65.74 2141.1692 23 -45.1 714.6981 3 69.50 4 38821 VEV_1_3_RA4_01_1235.d 0 1 1 231 253
K.ISQAFAALLPVK.A Y 62.30 1256.7493 12 -9.2 629.3762 2 81.37 5 46938 VEV_2_3_RA5_01_1236.d 2.12E4 2 2 462 473
R.LNEAAIVKETLTR.H Y 60.48 1456.8250 13 -15.1 486.6083 3 70.02 6 37869 VEV_3_3_RA6_01_1237.d 1.64E5 2 2 275 287
K.GQVIGAVSGGVDSTVAAK.L Y 59.32 1614.8577 18 -13.2 808.4254 2 66.08 6 34943 VEV_3_3_RA6_01_1237.d 6.96E4 2 2 236 253
K.AQQNWTMGEFVSQEIER.I Y 59.10 2051.9370 17 -15.5 684.9757 3 81.46 6 46177 VEV_3_3_RA6_01_1237.d 8.59E4 2 2 211 227
R.EADHIFIEEIKAAGLYR.K Y 58.86 1974.0210 17 -4.6 494.5103 4 79.82 4 46879 VEV_1_3_RA4_01_1235.d 1.86E5 2 2 444 460
K.LIEPLRELFKDEVR.E Y 57.98 1755.9883 14 -34.9 439.9890 4 80.09 6 45227 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 390 403
K.VIGNTFIEVFQEEAKKIAAAAK.G Y 52.04 2376.3052 22 -13.1 595.0758 4 88.51 4 52823 VEV_1_3_RA4_01_1235.d 1.38E5 2 2 319 340
R.KLVGEKGQVIGAVSGGVDSTVAAK.L Y 51.37 2269.2642 24 -19.1 568.3125 4 66.68 6 35394 VEV_3_3_RA6_01_1237.d 5.29E4 2 2 230 253
K.EAIGDRFHAVLVDNGVLR.L Y 49.55 1980.0541 18 16.0 496.0287 4 78.24 4 45660 VEV_1_3_RA4_01_1235.d 0 1 1 257 274
R.EADHIFIEEIKAAGLYRK.I Y 49.15 2102.1160 18 -5.3 421.4282 5 76.17 4 44044 VEV_1_3_RA4_01_1235.d 5.13E4 1 1 444 461
R.ELGVQLGIPEELVWR.H Y 48.90 1736.9460 15 -8.2 869.4731 2 87.97 4 52489 VEV_1_3_RA4_01_1235.d 1.94E4 2 2 404 418
K.FVTIASTPNAPFAGIAHVEELFYGIQFHPELTHTPR.G Y 37.25 4007.0369 36 -12.9 802.4043 5 89.93 5 51845 VEV_2_3_RA5_01_1236.d 0 1 1 161 196
K.IADLSWKPK.G Y 27.69 1056.5967 9 -11.9 353.2020 3 60.29 4 31695 VEV_1_3_RA4_01_1235.d 2E5 1 1 52 60
K.THHNVGGLLEGMHLK.L Y 27.60 1641.8409 15 -2.6 411.4664 4 64.13 5 34625 VEV_2_3_RA5_01_1236.d 7.15E4 1 1 375 389
R.ILGEVTPEQVR.I Y 27.31 1239.6823 11 -76.7 620.8008 2 64.36 5 34794 VEV_2_3_RA5_01_1236.d 0 1 1 430 440
K.GQ(+.98)VIGAVSGGVDSTVAAK.L Y 26.27 1615.8417 18 -10.4 808.9197 2 66.17 5 36156 VEV_2_3_RA5_01_1236.d 0 1 1 236 253 Deamidation (NQ)
R.IVNEVKGVC(+57.02)R.V Y 22.82 1172.6335 10 -29.2 587.3069 2 33.98 4 15135 VEV_1_3_RA4_01_1235.d 1.46E4 2 2 518 527 Carbamidomethylation
R.HLGVNLT(-2.02)VVDASER.F Y 19.16 1506.7791 14 -30.9 503.2514 3 68.49 4 38028 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 288 301 2-amino-3-oxo-butanoic_acid
R.NFAVR.I Y 16.54 605.3285 5 -18.4 606.3246 1 24.98 6 10180 VEV_3_3_RA6_01_1237.d 2.26E4 1 1 203 207
K.AVGVM(+15.99)GDQR.V Y 15.47 947.4495 9 -5.6 474.7294 2 24.77 4 10009 VEV_1_3_RA4_01_1235.d 0 1 1 474 482 Oxidation (M)
K.ISQAFAALLPVKAVGVM(+15.99)GDQR.V Y 15.27 2186.1880 21 -23.3 547.5416 4 74.41 5 42177 VEV_2_3_RA5_01_1236.d 0 1 1 462 482 Oxidation (M)
total 26 peptides
C1G373
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AIRPEDLLGDEDEGFAIVGR.G Y 127.19 2171.0857 20 -6.7 724.6976 3 82.78 4 49089 VEV_1_3_RA4_01_1235.d 1.21E5 2 2 218 237
R.LSDEQSLYTSIVR.S Y 97.02 1509.7675 13 -3.7 755.8882 2 74.85 4 43008 VEV_1_3_RA4_01_1235.d 1.89E5 3 3 394 406
K.AIADLEDFMNETITEQK.S Y 66.25 1966.9193 17 1.2 984.4681 2 85.84 4 51196 VEV_1_3_RA4_01_1235.d 1.2E5 3 3 141 157
R.YSSVSPEQEKLER.Q Y 65.45 1550.7576 13 -13.9 776.3752 2 44.12 6 20895 VEV_3_3_RA6_01_1237.d 7.39E5 7 7 585 597
K.VPGSVVSFVERLDDELTR.S Y 51.87 2017.0480 18 -9.7 673.3501 3 88.45 4 52781 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 361 378
R.TQGMANAFQR.D Y 50.66 1122.5240 10 -7.3 562.2652 2 47.08 4 23052 VEV_1_3_RA4_01_1235.d 1.35E5 3 3 807 816
K.TLC(+57.02)NYLFELSDGIIR.A Y 40.23 1812.9080 15 -7.6 907.4543 2 90.33 6 51480 VEV_3_3_RA6_01_1237.d 1.75E5 1 1 481 495 Carbamidomethylation
K.VPGSVVSFVER.L Y 40.04 1174.6345 11 -26.8 588.3088 2 71.76 6 39179 VEV_3_3_RA6_01_1237.d 0 1 1 361 371
R.RPGGQQFGGGALGGAIKA Y 37.13 1640.8746 18 -39.0 821.4126 2 64.07 5 34584 VEV_2_3_RA5_01_1236.d 0 1 1 847 864
R.TLQYTPESILK.H Y 34.21 1291.7024 11 -11.4 646.8511 2 74.00 5 41878 VEV_2_3_RA5_01_1236.d 2.32E5 3 3 241 251
R.QVFNGPPENTR.D Y 32.05 1257.6101 11 -8.9 629.8068 2 47.42 4 23284 VEV_1_3_RA4_01_1235.d 6.69E4 1 1 656 666
R.SLQHIDPHTAEYIER.L Y 24.15 1807.8853 15 -48.4 452.9567 4 61.79 6 31736 VEV_3_3_RA6_01_1237.d 0 1 1 379 393
R.GGGGGGLPR.R Y 24.00 726.3773 9 -44.4 727.3523 1 80.53 6 45535 VEV_3_3_RA6_01_1237.d 0 2 2 838 846
R.DPGHGGR.G Y 21.31 694.3146 7 -12.5 695.3132 1 37.98 4 17504 VEV_1_3_RA4_01_1235.d 3.49E3 1 1 817 823
K.GVELSR.L N 21.12 659.3602 6 -18.5 330.6813 2 23.15 6 9243 VEV_3_3_RA6_01_1237.d 0 1 1 775 780
K.LDSGITPR.K Y 18.77 857.4606 8 -8.6 429.7339 2 23.98 4 9543 VEV_1_3_RA4_01_1235.d 2.4E5 3 3 461 468
K.AMLGEQIQEEGLR.T Y 18.52 1472.7292 13 -25.1 737.3534 2 70.55 4 39642 VEV_1_3_RA4_01_1235.d 9.38E4 2 2 705 717
K.KMNASNAK.G Y 17.91 862.4331 8 23.3 432.2339 2 15.94 5 5552 VEV_2_3_RA5_01_1236.d 8.1E4 1 1 162 169
K.IWDLMAQPDK.I Y 16.28 1215.5958 10 -17.0 406.1990 3 20.70 5 8121 VEV_2_3_RA5_01_1236.d 3.78E4 1 1 693 702
R.GGRGGGRGGGGGGLPR.R Y 15.98 1323.6868 16 -27.0 442.2243 3 41.10 6 19125 VEV_3_3_RA6_01_1237.d 6.49E4 1 1 831 846
total 20 peptides
C1GAW6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EYSQVSRPKK.S Y 104.53 1220.6512 10 -12.0 611.3256 2 13.51 5 4250 VEV_2_3_RA5_01_1236.d 4.82E5 6 6 62 71
R.EYSQVSRPK.K Y 88.34 1092.5564 9 -8.3 547.2809 2 18.32 4 6554 VEV_1_3_RA4_01_1235.d 1.76E6 13 13 62 70
K.LQGIPALRPR.E Y 81.17 1119.6876 10 -13.7 374.2314 3 62.48 4 33350 VEV_1_3_RA4_01_1235.d 1.96E6 9 9 52 61
R.AFLIEEQKIVK.K Y 80.05 1316.7704 11 -26.3 659.3752 2 68.08 5 37597 VEV_2_3_RA5_01_1236.d 8.68E5 6 6 93 103
K.C(+57.02)GDC(+57.02)GIKLQGIPALRPR.E Y 72.31 1909.9978 17 -1.9 478.5058 4 69.58 5 38685 VEV_2_3_RA5_01_1236.d 1.43E5 2 2 45 61 Carbamidomethylation
R.AFLIEEQK.I Y 62.67 976.5229 8 -20.3 489.2588 2 61.25 6 31334 VEV_3_3_RA6_01_1237.d 9.64E5 4 4 93 100
K.VLKESQEKTAAASK.K Y 61.74 1488.8147 14 -25.2 497.2663 3 14.16 5 4605 VEV_2_3_RA5_01_1236.d 1.27E5 4 4 105 118
K.C(+58.01)GDC(+57.02)GIKLQGIPALRPR.E Y 58.52 1910.9818 17 -8.5 478.7487 4 72.40 5 40789 VEV_2_3_RA5_01_1236.d 2.1E5 1 1 45 61 Carboxymethyl; Carbamidomethylation
R.IIKTPGGKLR.Y Y 56.07 1081.6971 10 -16.7 541.8468 2 31.54 5 14159 VEV_2_3_RA5_01_1236.d 4.27E5 2 2 23 32
R.EYSQ(+.98)VSRPK.K Y 53.74 1093.5404 9 -8.6 547.7728 2 20.72 4 7785 VEV_1_3_RA4_01_1235.d 3.18E4 1 1 62 70 Deamidation (NQ)
R.EYSQVSR(+14.02)PK.K Y 49.28 1106.5720 9 -41.8 554.2701 2 25.09 5 10531 VEV_2_3_RA5_01_1236.d 0 1 1 62 70 Methylation(KR)
R.RRNPYNTR.S Y 48.14 1075.5635 8 -13.8 359.5235 3 11.19 5 3078 VEV_2_3_RA5_01_1236.d 6.17E5 3 3 10 17
R.RNPYNTR.S Y 47.49 919.4624 7 -12.1 460.7329 2 11.05 5 2986 VEV_2_3_RA5_01_1236.d 1.67E5 3 3 11 17
K.KVLKESQEKTAAASK.K Y 45.62 1616.9097 15 -19.2 539.9668 3 14.78 5 4911 VEV_2_3_RA5_01_1236.d 1.83E4 1 1 104 118
R.AFLIEEQKIVKK.V Y 44.17 1444.8652 12 -11.8 482.6234 3 61.76 4 32851 VEV_1_3_RA4_01_1235.d 2.26E5 2 2 93 104
R.EY(-18.01)SQVSRPK.K Y 41.77 1074.5458 9 -13.9 538.2727 2 34.71 4 15590 VEV_1_3_RA4_01_1235.d 1.87E5 1 1 62 70 Dehydration
K.KVLKESQEK.T Y 35.46 1087.6237 9 -9.2 544.8141 2 10.84 4 2793 VEV_1_3_RA4_01_1235.d 3.58E4 3 3 104 112
R.EYSQVSRPK(+14.02).K Y 32.57 1106.5720 9 -42.6 554.2697 2 25.15 4 10199 VEV_1_3_RA4_01_1235.d 0 1 1 62 70 Methylation(KR)
K.TPGGKLR.Y Y 28.77 727.4340 7 -13.4 364.7194 2 12.58 5 3740 VEV_2_3_RA5_01_1236.d 1.64E5 3 3 26 32
R.IIKTPGGK.L Y 27.91 812.5120 8 -36.2 407.2485 2 16.44 5 5800 VEV_2_3_RA5_01_1236.d 5.56E5 4 4 23 30
R.YLHIK.K Y 22.30 672.3959 5 -19.2 673.3903 1 24.43 6 9903 VEV_3_3_RA6_01_1237.d 1.17E5 2 2 33 37
R.YLHIKK.K Y 21.55 800.4908 6 -13.9 401.2471 2 17.19 5 6239 VEV_2_3_RA5_01_1236.d 4.66E5 3 3 33 38
R.E(+14.02)YSQVSRPK.K Y 17.80 1106.5720 9 -12.6 369.8600 3 21.99 4 8458 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 62 70 Methylation(others)
R.IVRAFLIEEQK.I Y 17.32 1344.7765 11 -24.6 449.2551 3 60.82 5 32159 VEV_2_3_RA5_01_1236.d 0 1 1 90 100
total 24 peptides
C1G6E6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AIKPAFIPDTGTVTAPNSSPLNDGAAAVVLVSEAK.L Y 121.42 3420.8140 35 -5.2 1141.2727 3 84.98 4 50571 VEV_1_3_RA4_01_1235.d 1.56E5 3 3 235 269
R.TPVGSFLGSLSSLTAPQLGSHAIK.A Y 120.22 2367.2798 24 -11.9 790.0912 3 85.25 6 48620 VEV_3_3_RA6_01_1237.d 4.23E5 4 4 15 38
R.VPQIKPGDVEEVFFGNVLSANVGQNPAR.Q Y 81.62 2980.5405 28 -10.1 994.5107 3 86.81 4 51762 VEV_1_3_RA4_01_1235.d 1.41E5 3 3 44 71
K.AGLLDAEIAPIELPGSR.G Y 65.09 1720.9359 17 -54.1 861.4287 2 84.91 4 50594 VEV_1_3_RA4_01_1235.d 1.34E5 3 3 196 212
K.FTTAPSLAIPK.A Y 57.69 1144.6492 11 -9.1 573.3267 2 71.14 4 40112 VEV_1_3_RA4_01_1235.d 4.05E5 4 4 294 304
K.ATSKFTTAPSLAIPK.A Y 52.92 1531.8610 15 -10.6 511.6222 3 66.96 4 36813 VEV_1_3_RA4_01_1235.d 9.76E4 1 1 290 304
K.AGLLDAEIAPIELPGSR(+14.02).G Y 46.98 1734.9515 17 -10.8 868.4737 2 86.00 4 51246 VEV_1_3_RA4_01_1235.d 2.36E4 1 1 196 212 Methylation(KR)
K.ILGWGDAAK.A Y 44.84 929.4970 9 -1.3 465.7552 2 67.63 4 37345 VEV_1_3_RA4_01_1235.d 1.57E5 1 1 281 289
R.EQQDSYAIR.S Y 41.13 1108.5149 9 -11.7 555.2582 2 33.68 6 14894 VEV_3_3_RA6_01_1237.d 3.39E5 3 3 177 185
K.VNLHGGAVALGHPLGASGAR.I Y 20.54 1853.0020 20 -18.7 464.2491 4 72.48 4 41175 VEV_1_3_RA4_01_1235.d 0 1 1 343 362
R.AQAAQK.A Y 19.97 615.3340 6 -18.1 616.3301 1 22.35 6 8793 VEV_3_3_RA6_01_1237.d 0 1 1 190 195
K.AAVQR.V N 16.74 543.3129 5 -3.3 544.3184 1 38.78 5 18402 VEV_2_3_RA5_01_1236.d 0 1 1 39 43
K.NLHPEK.L Y 16.22 736.3868 6 -13.7 369.1956 2 40.96 6 19041 VEV_3_3_RA6_01_1237.d 0 1 1 227 232
total 13 peptides
C1G5P1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NEAAAADAEAAPSR.G Y 115.31 1342.6112 14 2.1 672.3143 2 29.99 4 12879 VEV_1_3_RA4_01_1235.d 3.74E5 5 5 184 197
K.ATAAAAVGEDAAGASSAAAGGSGSGGISEAVKDVVR.R Y 106.38 3087.5068 36 -7.3 1030.1687 3 76.27 4 44117 VEV_1_3_RA4_01_1235.d 3.23E4 1 1 363 398
R.ALKEVEAYSLFSPNR.Y Y 71.97 1722.8940 15 -18.3 575.2948 3 74.38 6 41097 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 75 89
R.NEAAAADAEAAPSRGR.S Y 66.12 1555.7339 16 -9.5 778.8668 2 26.26 4 10806 VEV_1_3_RA4_01_1235.d 5.28E4 2 2 184 199
K.TVYILLPYYQR.G Y 63.98 1427.7812 11 -9.3 476.9299 3 82.26 4 48716 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 118 128
R.DIKPGNIMIDDDGITPVVMDLGSLAPSPIAITSR.S Y 60.67 3520.8157 34 -13.2 1174.5970 3 93.31 5 53491 VEV_2_3_RA5_01_1236.d 2.39E5 2 2 241 274
R.GNLQDAINANLVNHTR.F Y 56.45 1748.8917 16 -5.4 583.9680 3 69.81 4 39068 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 129 144
R.SLALAVQDIAAEHSTMPYRAPELFDVK.T Y 55.38 2971.5112 27 -12.3 743.8759 4 83.51 4 49569 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 275 301
R.C(+57.02)PFGQESVSR.A Y 46.13 1165.5186 10 -21.7 583.7539 2 45.03 4 21785 VEV_1_3_RA4_01_1235.d 7.4E4 1 1 65 74 Carbamidomethylation
K.ATAAAAVGEDAAGAS(-2.02)SAAAGGSGSGGISEAVKDVVRR.C Y 32.14 3241.5923 37 -7.9 811.3989 4 74.10 4 42437 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 363 399 2-amino-3-oxo-butanoic_acid
R.NEAAAADAEAAPSR(+14.02).G Y 26.84 1356.6270 14 -0.8 679.3202 2 40.07 4 18744 VEV_1_3_RA4_01_1235.d 7.32E4 1 1 184 197 Methylation(KR)
K.MVRNEAAAADAEAAPSR.G Y 20.19 1728.8213 17 -2.4 346.7707 5 48.80 6 23617 VEV_3_3_RA6_01_1237.d 0 1 1 181 197
K.GSGQK.G Y 19.90 475.2390 5 -1.4 476.2457 1 11.47 5 3188 VEV_2_3_RA5_01_1236.d 1.52E4 2 2 356 360
K.SMHQYR.I Y 19.67 820.3650 6 60.5 821.4219 1 66.41 5 36328 VEV_2_3_RA5_01_1236.d 7.06E3 1 1 163 168
R.ADGGDAGSKTVYILLPYYQR.G Y 18.66 2186.1008 20 -2.7 729.7056 3 79.76 5 45894 VEV_2_3_RA5_01_1236.d 8.87E4 1 1 109 128
R.GGPGAVKK.A Y 16.68 712.4232 8 -0.2 357.2188 2 10.52 5 2741 VEV_2_3_RA5_01_1236.d 0 1 1 171 178
K.GSGQKGK(+72.02).A Y 16.01 732.3766 7 -10.6 367.1917 2 18.65 5 7007 VEV_2_3_RA5_01_1236.d 8.14E4 1 1 356 362 Carboxyethyl
total 17 peptides
A0A0A0HT57
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HTC(+57.02)SSC(+57.02)GYPSAK.T Y 161.43 1353.5442 12 -13.4 677.7703 2 14.91 6 4938 VEV_3_3_RA6_01_1237.d 1.43E6 12 12 77 88 Carbamidomethylation
R.SLHIQKHTC(+57.02)SSC(+57.02)GYPSAK.T Y 77.87 2059.9568 18 -7.6 687.6543 3 33.90 5 15544 VEV_2_3_RA5_01_1236.d 9.03E5 6 6 71 88 Carbamidomethylation
K.HTC(+57.02)SSC(+57.02)GYPSAK(+14.02).T Y 75.65 1367.5598 12 -4.1 684.7844 2 20.76 4 7807 VEV_1_3_RA4_01_1235.d 7.58E4 2 2 77 88 Carbamidomethylation; Methylation(KR)
K.FKN(+.98)GFQTGTPK.G Y 68.60 1224.6139 11 -8.8 613.3088 2 40.19 5 19261 VEV_2_3_RA5_01_1236.d 2.26E6 6 6 119 129 Deamidation (NQ)
K.NGFQTGTPK.G Y 60.82 948.4665 9 -11.2 475.2352 2 25.79 5 10922 VEV_2_3_RA5_01_1236.d 1.17E6 10 10 121 129
K.FKNGFQTGTPK.G Y 56.31 1223.6299 11 -11.2 612.8154 2 36.08 5 16846 VEV_2_3_RA5_01_1236.d 1.17E6 6 6 119 129
K.N(+.98)GFQTGTPK.G Y 54.90 949.4505 9 -9.3 475.7281 2 35.77 5 16634 VEV_2_3_RA5_01_1236.d 1.61E6 7 7 121 129 Deamidation (NQ)
K.YNWGEK.A Y 49.24 795.3551 6 -4.8 796.3586 1 34.92 4 15708 VEV_1_3_RA4_01_1235.d 1.2E6 7 7 92 97
R.HNKTHTLC(+57.02)R.R Y 31.68 1165.5775 9 -8.9 389.5297 3 10.83 4 2805 VEV_1_3_RA4_01_1235.d 6.16E4 1 1 57 65 Carbamidomethylation
R.KYNWGEK.A Y 29.25 923.4501 7 -15.8 462.7250 2 22.28 5 8950 VEV_2_3_RA5_01_1236.d 3.83E5 3 3 91 97
R.RSLHIQKHTC(+57.02)SSC(+57.02)GYPSAK.T Y 28.12 2216.0579 19 -14.3 555.0138 4 33.00 5 14994 VEV_2_3_RA5_01_1236.d 4.56E4 1 1 70 88 Carbamidomethylation
R.SLHIQK.H Y 19.20 724.4232 6 -44.7 363.2027 2 15.37 5 5231 VEV_2_3_RA5_01_1236.d 0 3 3 71 76
total 12 peptides
C1GED5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVQTFSGHESDINAIQFFPDGNAFGTGSDDTTC(+57.02)R.L Y 102.71 3677.5964 34 -5.6 920.4012 4 82.77 5 47820 VEV_2_3_RA5_01_1236.d 2.55E5 5 5 230 263 Carbamidomethylation
R.ELSGHTGYLSC(+57.02)C(+57.02)R.F Y 97.68 1538.6606 13 3.2 770.3401 2 47.04 5 23351 VEV_2_3_RA5_01_1236.d 1.02E6 11 11 149 161 Carbamidomethylation
R.RKDELADTSLRQVAQNNTDPLPR.I Y 95.09 2636.3630 23 -18.4 660.0859 4 66.16 5 36146 VEV_2_3_RA5_01_1236.d 1.33E5 3 3 31 53
R.ELNTYQSDQVLC(+57.02)GITSVAFSVSGR.L Y 78.04 2630.2646 24 -16.9 877.7474 3 88.55 6 50545 VEV_3_3_RA6_01_1237.d 1.61E5 2 2 272 295 Carbamidomethylation
R.HLVSASQDGK.L Y 71.74 1040.5250 10 -7.6 521.2658 2 15.59 4 5096 VEV_1_3_RA4_01_1235.d 8.5E4 3 3 80 89
R.LLFAGYDDYEC(+57.02)KVWDVLRGEK.V Y 70.97 2575.2417 21 -4.0 644.8151 4 85.85 5 49650 VEV_2_3_RA5_01_1236.d 1.51E5 3 3 296 316 Carbamidomethylation
R.QVAQNNTDPLPR.I Y 60.32 1351.6844 12 -9.5 676.8431 2 46.57 6 22312 VEV_3_3_RA6_01_1237.d 1.55E5 2 2 42 53
R.Q(-17.03)VAQNNTDPLPR.I Y 59.08 1334.6578 12 -23.4 668.3206 2 65.44 6 34510 VEV_3_3_RA6_01_1237.d 3.78E5 3 3 42 53 Pyro-glu from Q
M.A(+42.01)ADLSGEQMQAK.I Y 58.67 1289.5922 12 -26.5 645.7863 2 63.16 5 33970 VEV_2_3_RA5_01_1236.d 0 3 3 2 13 Acetylation (Protein N-term)
K.VGSLSGHENR.V Y 56.46 1054.5155 10 -6.3 528.2617 2 14.21 4 4398 VEV_1_3_RA4_01_1235.d 3.97E5 5 5 317 326
R.QVAQN(-17.03)NTDPLPR.I Y 56.06 1334.6578 12 -7.2 668.3314 2 65.58 5 35724 VEV_2_3_RA5_01_1236.d 1.97E5 1 1 42 53 Ammonia-loss (N)
K.LIIWDAYTTNKVHAIPLR.S Y 44.72 2123.1892 18 -10.8 531.7988 4 78.69 6 44216 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 90 107
K.SVQTFSGHESDINAIQFFPDGNAFGTGSDDTTC(+57.02)R(-.98).L Y 24.28 3676.6123 34 -14.6 920.1470 4 82.76 6 47038 VEV_3_3_RA6_01_1237.d 0 1 1 230 263 Carbamidomethylation; Amidation
M.A(+42.01)ADLSGEQM(+15.99)QAK.I Y 23.17 1305.5870 12 -5.3 653.7974 2 50.37 5 25362 VEV_2_3_RA5_01_1236.d 2.85E5 2 2 2 13 Acetylation (Protein N-term); Oxidation (M)
R.RKDELADTSLR.Q Y 22.41 1302.6891 11 -7.5 652.3469 2 32.37 5 14650 VEV_2_3_RA5_01_1236.d 2.08E5 3 3 31 41
K.LWDIR.A N 22.15 701.3860 5 -16.6 351.6945 2 64.77 4 35095 VEV_1_3_RA4_01_1235.d 2.66E5 2 2 222 226
R.LFDIR.A N 21.04 662.3751 5 -19.6 332.1884 2 63.82 5 34404 VEV_2_3_RA5_01_1236.d 4.81E5 5 5 264 268
R.EAEGLKDRIK.R Y 18.50 1157.6404 10 -0.4 579.8272 2 25.77 5 10956 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 20 29
M.A(+42.01)ADLSGEQMQAK(+14.02).I Y 16.82 1303.6078 12 4.3 652.8140 2 68.81 5 38134 VEV_2_3_RA5_01_1236.d 3.3E4 1 1 2 13 Acetylation (Protein N-term); Methylation(KR)
total 19 peptides
C1GG81
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IDSGVGGTGDSHHDAQR.V Y 115.55 1707.7561 17 -9.1 570.2542 3 18.14 5 6732 VEV_2_3_RA5_01_1236.d 1.35E5 4 4 73 89
R.SAMASTTQPAPIAR.E Y 98.38 1400.7081 14 -20.4 701.3470 2 50.66 6 24668 VEV_3_3_RA6_01_1237.d 2.75E5 5 5 196 209
K.TASSYIHGGPTAPSQVIRPTK.V Y 86.87 2167.1384 21 -9.3 542.7869 4 60.65 5 32031 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 117 137
R.SAM(+15.99)ASTTQPAPIAR.E Y 71.18 1416.7031 14 -5.2 709.3552 2 37.89 4 17451 VEV_1_3_RA4_01_1235.d 2.42E5 2 2 196 209 Oxidation (M)
R.RDSTTLGSLMGTTATYTTATSR.S Y 67.04 2291.1064 22 -26.5 764.6892 3 74.46 6 41155 VEV_3_3_RA6_01_1237.d 2.36E5 2 2 174 195
K.AAISDFITREPGPR.L Y 54.44 1528.7997 14 -9.7 510.6022 3 69.79 5 38837 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 325 338
R.LSNMEDVQQAR.N Y 50.05 1289.6034 11 -20.8 645.7955 2 44.63 6 21198 VEV_3_3_RA6_01_1237.d 2.02E5 3 3 490 500
K.VGKAEAVHEAAGRPTIR.R Y 44.85 1760.9645 17 -17.4 441.2407 4 35.70 5 16594 VEV_2_3_RA5_01_1236.d 1.23E5 2 2 287 303
R.TDAIISGQGSHLANIRSSWASDRVPPR.Y Y 30.29 2890.4797 27 -25.9 964.4756 3 85.60 6 48872 VEV_3_3_RA6_01_1237.d 5.21E5 1 1 26 52
K.GRESRPLAHDPLAGIPR.R Y 23.63 1841.0020 17 12.0 461.2633 4 72.56 6 39774 VEV_3_3_RA6_01_1237.d 0 1 1 157 173
R.ATGPEK.S Y 23.03 601.3071 6 -35.0 602.2933 1 76.99 6 42995 VEV_3_3_RA6_01_1237.d 0 1 1 12 17
K.AEAVHEAAGRPTIR.R Y 22.81 1476.7797 14 -3.0 370.2011 4 53.98 6 26637 VEV_3_3_RA6_01_1237.d 0 1 1 290 303
R.FNGEK.K Y 22.16 593.2809 5 -8.9 594.2829 1 28.98 5 12680 VEV_2_3_RA5_01_1236.d 1.63E4 1 1 433 437
R.EPGPR.L N 21.85 554.2812 5 -21.9 555.2764 1 51.12 6 24938 VEV_3_3_RA6_01_1237.d 7.38E4 2 2 334 338
R.WGERLSNMEDVQQARNGK.G Y 18.69 2117.0073 18 7.9 530.2633 4 68.76 6 36955 VEV_3_3_RA6_01_1237.d 0 1 1 486 503
R.YPDEM(+15.99)GAVVAGTSPDLK.H Y 17.77 1764.8240 17 54.8 442.2374 4 74.32 4 42606 VEV_1_3_RA4_01_1235.d 0 1 1 53 69 Oxidation (M)
R.QKGYGINR.A Y 17.45 934.4984 8 -9.1 468.2522 2 70.12 4 39303 VEV_1_3_RA4_01_1235.d 0 1 1 521 528
R.KEEKGTQRWGER.L Y 17.37 1502.7589 12 1.4 501.9276 3 69.74 4 39010 VEV_1_3_RA4_01_1235.d 5.48E5 1 1 478 489
R.SSWASDR.V Y 17.02 807.3511 7 7.2 808.3643 1 99.87 6 55276 VEV_3_3_RA6_01_1237.d 7.46E3 1 1 42 48
R.GTSIAKPGHP Y 16.98 963.5137 10 18.8 322.1846 3 41.89 6 19590 VEV_3_3_RA6_01_1237.d 0 1 1 533 542
R.RVPVEKPDVMR.A Y 16.77 1324.7285 11 -21.0 332.1825 4 43.00 5 20926 VEV_2_3_RA5_01_1236.d 0 1 1 304 314
R.QGRQARDTKDMQK.Q Y 16.08 1560.7791 13 -10.7 781.3885 2 69.82 6 37714 VEV_3_3_RA6_01_1237.d 9.82E4 1 1 451 463
K.IMGLQR.Q Y 15.73 716.4003 6 4.1 359.2089 2 64.83 4 35142 VEV_1_3_RA4_01_1235.d 0 1 1 515 520
K.EEKGTQR.W Y 15.45 846.4195 7 -13.9 424.2112 2 12.36 6 3586 VEV_3_3_RA6_01_1237.d 8.22E4 1 1 479 485
R.R(+226.08)R(+14.02)TDAIISGQGSHLANIR.S Y 15.27 2204.1597 18 -11.9 552.0406 4 63.66 6 33126 VEV_3_3_RA6_01_1237.d 0 1 1 24 41 Biotinylation; Methylation(KR)
total 25 peptides
C1FYJ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FQSSAIGALQESVEAYLVSLFEDTNLC(+57.02)AIHAK.R Y 121.40 3510.7339 32 -5.5 1171.2455 3 97.64 6 54552 VEV_3_3_RA6_01_1237.d 3.7E5 3 3 85 116 Carbamidomethylation
K.RVTIQSKDIQLAR.R Y 82.58 1526.8893 13 -10.1 509.9652 3 53.27 5 27159 VEV_2_3_RA5_01_1236.d 3.4E5 5 5 117 129
R.VTIQSKDIQLAR.R Y 64.00 1370.7881 12 -6.3 457.9338 3 59.37 5 31082 VEV_2_3_RA5_01_1236.d 3.98E5 5 5 118 129
R.EIAQDFKSDLR.F Y 59.65 1320.6674 11 35.8 441.2455 3 60.86 4 32133 VEV_1_3_RA4_01_1235.d 0 5 5 74 84
R.EIAQDFK(+14.02)SDLR.F Y 58.17 1334.6830 11 -6.0 445.8989 3 61.68 4 32742 VEV_1_3_RA4_01_1235.d 8.32E5 2 2 74 84 Methylation(KR)
K.AAPSTGGVKK(+14.02)PHR.Y Y 56.54 1318.7469 13 -12.3 440.5842 3 12.77 5 3849 VEV_2_3_RA5_01_1236.d 4.72E4 1 1 29 41 Methylation(KR)
R.YQK(+42.01)STELLIR.K Y 54.95 1291.7136 10 -16.9 646.8531 2 70.13 4 39368 VEV_1_3_RA4_01_1235.d 1.58E5 3 3 55 64 Acetylation (K)
R.YKPGTVALR.E Y 50.07 1003.5814 9 -11.3 335.5306 3 38.62 4 17915 VEV_1_3_RA4_01_1235.d 4.72E6 14 14 42 50
R.K(+42.01)AAPSTGGVK.K Y 44.91 956.5291 10 -14.9 479.2647 2 24.00 6 9671 VEV_3_3_RA6_01_1237.d 8.05E4 1 1 28 37 Acetylation (N-term)
K.STELLIR.K Y 44.26 830.4861 7 -19.0 416.2425 2 57.13 6 28449 VEV_3_3_RA6_01_1237.d 0 3 3 58 64
R.YKPGTVALREIR.R Y 43.28 1401.8092 12 -17.2 468.2690 3 56.06 5 28797 VEV_2_3_RA5_01_1236.d 7.68E5 4 4 42 53
K.AAPSTGGVKKPHR.Y Y 42.51 1304.7313 13 -51.3 435.8954 3 12.60 6 3711 VEV_3_3_RA6_01_1237.d 1.58E4 1 1 29 41
K.AAPSTGGVK(+14.02)KPHR.Y Y 41.79 1318.7469 13 -17.8 660.3690 2 12.75 5 3835 VEV_2_3_RA5_01_1236.d 1.11E5 4 4 29 41 Methylation(KR)
R.KSTGGKVPR.K Y 38.35 928.5454 9 -12.8 465.2740 2 9.36 6 2262 VEV_3_3_RA6_01_1237.d 4.46E4 3 3 10 18
K.AAPSTGGVKK(+28.03)PHR.Y Y 36.92 1332.7626 13 -15.2 445.2547 3 12.84 6 3829 VEV_3_3_RA6_01_1237.d 4.01E4 1 1 29 41 Dimethylation(KR)
R.KSTGGK(+42.01)VPR.K Y 36.58 970.5560 9 -12.0 486.2794 2 14.02 6 4436 VEV_3_3_RA6_01_1237.d 2.92E5 3 3 10 18 Acetylation (K)
R.EIAQDFK.S Y 35.77 849.4232 7 -25.8 425.7079 2 38.13 4 17609 VEV_1_3_RA4_01_1235.d 1.46E6 2 2 74 80
R.KAAPSTGGVK(+42.01)KPHR.Y Y 32.73 1474.8368 14 2.4 369.7173 4 11.76 6 3283 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 28 41 Acetylation (K)
K.AAPSTGGVK(+27.99)KPHR.Y Y 32.29 1332.7262 13 -2.8 445.2481 3 12.86 5 3891 VEV_2_3_RA5_01_1236.d 0 1 1 29 41 Formylation
R.K(+42.01)QLASK(+42.01)VAR.K Y 29.11 1083.6400 9 -18.9 542.8170 2 51.60 4 25895 VEV_1_3_RA4_01_1235.d 3.81E5 3 3 19 27 Acetylation (Protein N-term); Acetylation (K)
R.K(+43.99)AAPSTGGVK.K Y 27.29 958.5083 10 -17.8 480.2529 2 24.36 5 10116 VEV_2_3_RA5_01_1236.d 0 1 1 28 37 Carboxylation (DKW)
R.YKPGTVALREIRR.Y Y 26.70 1557.9103 13 -12.1 390.4801 4 52.20 5 26505 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 42 54
K.DIQLAR.R Y 25.75 714.4024 6 -19.2 358.2016 2 39.13 6 18045 VEV_3_3_RA6_01_1237.d 1.45E6 6 6 124 129
R.K(+42.01)STGGK(+42.01)VPR.K Y 24.40 1012.5665 9 -32.6 507.2740 2 30.06 6 12901 VEV_3_3_RA6_01_1237.d 0 1 1 10 18 Acetylation (Protein N-term); Acetylation (K)
R.LVREIAQDFKSDLR.F Y 23.49 1688.9209 14 -12.0 423.2324 4 71.56 5 40142 VEV_2_3_RA5_01_1236.d 4.18E4 1 1 71 84
K.AAPST(+42.01)GGVKKPHR.Y Y 22.86 1346.7418 13 15.7 449.9283 3 12.62 5 3765 VEV_2_3_RA5_01_1236.d 1.42E5 1 1 29 41 Acetylation (TSCYH)
R.KLPFQR.L Y 21.52 787.4704 6 -16.1 394.7361 2 42.83 5 20813 VEV_2_3_RA5_01_1236.d 2.23E6 5 5 65 70
R.KQLASK(+42.01)VAR.K Y 20.06 1041.6294 9 -18.5 521.8123 2 27.28 5 11745 VEV_2_3_RA5_01_1236.d 1.33E5 1 1 19 27 Acetylation (K)
R.YQKSTELLIR.K Y 18.02 1249.7030 10 -15.9 417.5683 3 54.05 5 27620 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 55 64
K.LPFQR.L N 17.11 659.3755 5 -9.0 330.6920 2 37.51 4 17227 VEV_1_3_RA4_01_1235.d 3E5 2 2 66 70
K.AAPSTGGVK(+42.01)KPHR.Y Y 16.55 1346.7418 13 11.1 449.9262 3 12.66 6 3741 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 29 41 Acetylation (K)
R.K(+42.02)STGGKVPR.K Y 16.49 970.5672 9 -29.5 324.5201 3 14.41 6 4645 VEV_3_3_RA6_01_1237.d 1.76E5 1 1 10 18 Guanidination
R.Y(+41.03)KPGTVALR.E Y 15.38 1044.6080 9 11.7 349.2140 3 38.62 5 18306 VEV_2_3_RA5_01_1236.d 5.64E4 1 1 42 50 Amidination of lysines or N-terminal amines with methyl acetimidate
total 33 peptides
C1GKM7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYGQTSNAVFENAETKPLENKK.T Y 148.31 2454.2026 22 -7.6 614.5533 4 61.79 4 32849 VEV_1_3_RA4_01_1235.d 5.71E5 6 6 72 93
K.TLYVVASSDKGLC(+57.02)GGIHSGLSK.A Y 98.50 2248.1521 22 -9.4 563.0400 4 68.11 4 37721 VEV_1_3_RA4_01_1235.d 5.24E5 6 6 94 115 Carbamidomethylation
R.MVLEQPDADIVVLGEK.A Y 58.83 1754.9124 16 -9.3 878.4553 2 80.34 4 47276 VEV_1_3_RA4_01_1235.d 8.88E4 3 3 120 135
K.TLYVVASSDK.G Y 51.51 1081.5656 10 -14.0 541.7825 2 52.13 6 25554 VEV_3_3_RA6_01_1237.d 6.86E4 2 2 94 103
K.NLVLSFANVGK.D Y 46.45 1160.6553 11 -47.2 581.3075 2 77.96 6 43695 VEV_3_3_RA6_01_1237.d 0 1 1 147 157
R.FQILYNR.Q Y 46.27 952.5130 7 -11.9 477.2581 2 66.89 4 36755 VEV_1_3_RA4_01_1235.d 2.95E5 2 2 269 275
R.RM(+15.99)VLEQPDADIVVLGEK.A Y 25.56 1927.0084 17 -13.1 643.3350 3 73.44 4 41935 VEV_1_3_RA4_01_1235.d 2.9E4 1 1 119 135 Oxidation (M)
K.GLC(+57.02)GGIHSGLSK.A Y 23.69 1184.5972 12 -16.0 395.8667 3 41.70 6 19495 VEV_3_3_RA6_01_1237.d 2.72E5 2 2 104 115 Carbamidomethylation
K.NAGDMIQR.F Y 18.92 903.4232 8 4.7 452.7210 2 30.07 4 12888 VEV_1_3_RA4_01_1235.d 3.81E4 1 1 261 268
R.EIEGR.L N 17.39 602.3024 5 -11.7 603.3026 1 58.34 5 30339 VEV_2_3_RA5_01_1236.d 8.73E3 1 1 34 38
R.RNAPANAANFATLR.E Y 16.34 1485.7800 14 -20.0 496.2574 3 14.19 4 4388 VEV_1_3_RA4_01_1235.d 0 1 1 20 33
total 11 peptides
C1G7C1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FGGALALGIIDAGGR.N Y 99.65 1386.7618 15 -16.7 694.3766 2 84.03 6 47854 VEV_3_3_RA6_01_1237.d 1.61E5 2 2 828 842
K.VILC(+57.02)ASEDEKQQEASSR.S Y 87.27 1948.9160 17 -11.3 650.6386 3 43.78 6 20685 VEV_3_3_RA6_01_1237.d 1.35E5 2 2 238 254 Carbamidomethylation
R.ETKQPAGGETIQDR.I Y 78.50 1528.7480 14 -7.6 510.5861 3 23.75 4 9421 VEV_1_3_RA4_01_1235.d 2.38E5 2 2 1066 1079
R.ESMDIDQTPTTPK.V Y 71.46 1461.6658 13 -11.3 731.8319 2 58.84 4 30616 VEV_1_3_RA4_01_1235.d 7.06E4 1 1 953 965
K.ETDSLFQNQESR.S Y 68.17 1452.6481 12 -18.7 727.3177 2 56.64 5 29221 VEV_2_3_RA5_01_1236.d 4.3E5 5 5 378 389
R.MVELLSESYNPHVR.Y Y 67.79 1672.8242 14 -13.2 558.6080 3 70.80 4 39843 VEV_1_3_RA4_01_1235.d 1.71E5 2 2 736 749
R.YGAAMALGISC(+57.02)AGTGLDEAVDLLEPMLKDPTDFVR.Q Y 65.31 3695.7883 35 -3.5 1232.9324 3 96.63 4 57014 VEV_1_3_RA4_01_1235.d 5.4E4 1 1 750 784 Carbamidomethylation
K.VGC(+57.02)ELQNMSR.V Y 59.76 1192.5328 10 -8.0 597.2689 2 47.88 4 23552 VEV_1_3_RA4_01_1235.d 3.09E5 3 3 1009 1018 Carbamidomethylation
K.TAVLSTTAQAK.R Y 58.86 1089.6030 11 -11.0 545.8028 2 33.68 5 15470 VEV_2_3_RA5_01_1236.d 4.13E5 4 4 930 940
R.FHSNTRPSLFDYPPEIQVK.A Y 49.94 2274.1433 19 -49.8 569.5148 4 74.61 5 42329 VEV_2_3_RA5_01_1236.d 9.57E4 2 2 902 920
K.TAVLSTTAQAKR.R Y 49.39 1245.7041 12 -17.7 623.8483 2 28.02 4 11757 VEV_1_3_RA4_01_1235.d 1.7E4 1 1 930 941
R.LLAPYLPK.D Y 35.99 913.5637 8 -19.1 457.7804 2 71.24 6 38791 VEV_3_3_RA6_01_1237.d 2.67E5 2 2 517 524
K.FTATAALGVIHR.G Y 30.53 1255.7036 12 -24.8 419.5648 3 69.25 6 37301 VEV_3_3_RA6_01_1237.d 6.05E4 2 2 497 508
K.LEVPVFR.F Y 30.00 858.4963 7 -12.5 430.2501 2 72.50 4 41187 VEV_1_3_RA4_01_1235.d 9.78E4 1 1 895 901
R.M(+15.99)VELLSESYNPHVR.Y Y 28.05 1688.8192 14 -5.5 563.9439 3 67.33 4 37101 VEV_1_3_RA4_01_1235.d 9.31E4 1 1 736 749 Oxidation (M)
R.VLPAQLK.Y Y 26.39 767.4905 7 -8.0 768.4916 1 44.87 4 21691 VEV_1_3_RA4_01_1235.d 1.86E5 2 2 1019 1025
K.YLTFPDPR.Y Y 22.62 1007.5076 8 -4.4 504.7589 2 70.16 5 39110 VEV_2_3_RA5_01_1236.d 3.75E5 2 2 1026 1033
K.VGC(+57.02)ELQNM(+15.99)SR.V Y 18.76 1208.5278 10 10.0 605.2772 2 27.89 5 12087 VEV_2_3_RA5_01_1236.d 1.95E4 1 1 1009 1018 Carbamidomethylation; Oxidation (M)
R.YRQVVGIAVEAK.N Y 16.99 1331.7561 12 -8.1 444.9224 3 59.53 4 31132 VEV_1_3_RA4_01_1235.d 3.63E4 1 1 219 230
K.NPSEPR.E Y 16.22 698.3347 6 41.8 699.3712 1 107.44 5 58162 VEV_2_3_RA5_01_1236.d 0 1 1 1051 1056
K.NLDVLR.K N 16.02 728.4181 6 -31.4 365.2049 2 52.84 6 25959 VEV_3_3_RA6_01_1237.d 1.23E6 2 2 231 236
total 21 peptides
C1G2F3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DGHAPLHAGEEDAGTTHR.A Y 125.70 1869.8353 18 -4.6 624.2828 3 24.96 5 10458 VEV_2_3_RA5_01_1236.d 5.17E5 6 6 712 729
R.LAWLENIISSPLMAPIR.L Y 91.90 1923.0652 17 -7.8 962.5323 2 93.57 4 55613 VEV_1_3_RA4_01_1235.d 1.06E5 3 3 513 529
R.Q(-17.03)LEHTYVYKEPVEDPSFITGGRPGPYVEER.S Y 87.79 3474.6731 30 5.4 869.6802 4 77.92 6 43673 VEV_3_3_RA6_01_1237.d 7.88E4 1 1 416 445 Pyro-glu from Q
R.TC(+57.02)DEKSREEI Y 58.48 1265.5558 10 -9.8 633.7790 2 18.29 5 6798 VEV_2_3_RA5_01_1236.d 1.49E5 3 3 848 857 Carbamidomethylation
K.LLEDPIKAFWR.F Y 47.00 1386.7659 11 -17.9 463.2543 3 81.36 4 48056 VEV_1_3_RA4_01_1235.d 1.76E5 3 3 181 191
R.NFNIPIEHDFR.F Y 43.23 1400.6836 11 -5.7 467.8991 3 73.62 6 40550 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 606 616
K.AVANLLAR.R Y 35.87 826.5024 8 -45.3 414.2398 2 58.77 4 30564 VEV_1_3_RA4_01_1235.d 1.72E5 4 4 634 641
R.FHFPR.H Y 29.46 702.3602 5 -6.2 352.1852 2 46.48 5 23013 VEV_2_3_RA5_01_1236.d 2.68E5 1 1 789 793
K.LLEDPIK.A Y 27.23 826.4800 7 3.1 414.2486 2 57.72 4 29803 VEV_1_3_RA4_01_1235.d 1.45E6 7 7 181 187
K.VTMPSR.N Y 26.75 689.3530 6 -8.6 690.3544 1 39.58 5 18874 VEV_2_3_RA5_01_1236.d 9.16E4 1 1 676 681
K.C(+57.02)AASNKVTM(+15.99)PSR.N Y 22.35 1336.6228 12 -39.2 669.2925 2 66.26 6 35069 VEV_3_3_RA6_01_1237.d 1.12E4 1 1 670 681 Carbamidomethylation; Oxidation (M)
K.LFNLPPGGK.E Y 22.23 941.5334 9 -40.1 314.8391 3 9.47 4 2291 VEV_1_3_RA4_01_1235.d 7.42E4 2 2 659 667
R.AADGVSNVSGM(+15.99)IGGLDVSIR.V Y 20.61 1932.9574 20 -43.0 484.2258 4 32.55 6 14277 VEV_3_3_RA6_01_1237.d 0 2 2 730 749 Oxidation (M)
R.TC(+57.02)DEK.S Y 17.40 651.2534 5 9.6 652.2669 1 27.80 4 11632 VEV_1_3_RA4_01_1235.d 1.54E3 1 1 848 852 Carbamidomethylation
R.FYSNR.N Y 15.98 685.3184 5 -0.3 686.3254 1 112.64 4 61853 VEV_1_3_RA4_01_1235.d 2.59E4 1 1 601 605
R.ASNQSSR.S Y 15.86 748.3464 7 29.7 749.3759 1 98.64 6 54862 VEV_3_3_RA6_01_1237.d 4.79E4 1 1 779 785
R.QLEHT(-15.99)YVYKEPVEDPSFITGGRPGPYVEER.S Y 15.78 3475.7048 30 -12.7 869.9225 4 77.95 5 44679 VEV_2_3_RA5_01_1236.d 8.96E4 1 1 416 445 Deoxy
K.SREEI Y 15.38 632.3129 5 -24.9 633.3044 1 31.86 6 13900 VEV_3_3_RA6_01_1237.d 0 1 1 853 857
R.LGRRM(+15.99)SFVGIDAR.T Y 15.37 1492.7932 13 -13.0 374.2007 4 48.81 4 24123 VEV_1_3_RA4_01_1235.d 0 1 1 453 465 Oxidation (M)
R.GIGGVAFK.Y Y 15.29 747.4279 8 -68.1 748.3842 1 111.73 4 61590 VEV_1_3_RA4_01_1235.d 2.56E4 1 1 372 379
total 20 peptides
C1GKL8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FLLPVQQADFQITNVLEQLQR.D Y 124.90 2499.3484 21 -23.1 1250.6526 2 95.87 4 56692 VEV_1_3_RA4_01_1235.d 3.95E5 5 5 233 253
R.AVLNPFANVDIR.A Y 86.61 1327.7249 12 -22.7 664.8546 2 80.29 6 45363 VEV_3_3_RA6_01_1237.d 2.35E5 3 3 69 80
R.LVVPIGAIYTPLK.E Y 86.14 1382.8536 13 -48.8 692.4003 2 83.47 4 49543 VEV_1_3_RA4_01_1235.d 0 1 1 36 48
R.FIIC(+57.02)DAGGSQAR.F Y 75.22 1293.6135 12 -9.3 647.8080 2 61.29 4 32542 VEV_1_3_RA4_01_1235.d 3.05E5 6 6 711 722 Carbamidomethylation
K.NFTLYPQFMFHLRR.S Y 62.86 1868.9508 14 -9.0 468.2408 4 81.04 4 47817 VEV_1_3_RA4_01_1235.d 6.54E4 1 1 578 591
R.LSWNTFPSTR.M Y 57.16 1207.5985 10 -9.6 604.8007 2 73.45 4 41970 VEV_1_3_RA4_01_1235.d 2.17E5 2 2 21 30
R.TFSSPAGDSALAQ(+.98)SFDQEAAAVLMSR.I Y 43.81 2657.2278 26 -32.1 886.7214 3 89.17 5 51469 VEV_2_3_RA5_01_1236.d 0 1 1 508 533 Deamidation (NQ)
R.IMLFTSGPATEGPGHVVGPQLKEPMR.S Y 43.15 2748.4092 26 -42.6 688.0803 4 76.87 4 44590 VEV_1_3_RA4_01_1235.d 0 1 1 290 315
R.FLLPVQQADFQIT(-2.02)NVLEQLQR.D Y 31.97 2497.3328 21 -19.2 833.4355 3 95.72 6 53880 VEV_3_3_RA6_01_1237.d 0 1 1 233 253 2-amino-3-oxo-butanoic_acid
K.AILDQPKEDAR.E Y 26.01 1254.6567 11 -18.8 419.2183 3 38.07 5 17971 VEV_2_3_RA5_01_1236.d 2.72E5 1 1 689 699
K.ALKFYESLAKR.V Y 18.43 1324.7502 11 -7.4 332.1924 4 61.58 4 32667 VEV_1_3_RA4_01_1235.d 6.18E4 1 1 331 341
K.GLANSTGGHM(+15.99)ILTDSFTSSQFK.Q Y 18.34 2314.0898 22 -26.1 579.5146 4 12.26 6 3535 VEV_3_3_RA6_01_1237.d 8.22E4 1 1 366 387 Oxidation (M)
R.FPLPR.F Y 15.27 628.3696 5 17.4 315.1976 2 45.16 5 22221 VEV_2_3_RA5_01_1236.d 6.38E5 1 1 706 710
total 13 peptides
C1GCF0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.INLAINYDLPADADSYLHR.V Y 116.91 2173.0803 19 -2.3 725.3657 3 81.95 4 48495 VEV_1_3_RA4_01_1235.d 1.41E5 2 2 373 391
R.EC(+57.02)NFPSIAVHSGVSQEER.I Y 90.23 2044.9272 18 -11.7 682.6417 3 66.22 4 36233 VEV_1_3_RA4_01_1235.d 7.79E4 1 1 326 343 Carbamidomethylation
R.ELAYQIKNEYAR.F Y 82.10 1496.7623 12 -4.1 749.3854 2 61.10 5 32366 VEV_2_3_RA5_01_1236.d 1.21E6 6 6 139 150
K.DIELLSSKDNYPNIVVGTPGRLNALVR.D Y 74.35 2952.6033 27 -8.9 739.1515 4 82.68 4 49006 VEV_1_3_RA4_01_1235.d 3.28E4 1 1 172 198
R.IC(+57.02)VATDVFGR.G Y 69.38 1136.5648 10 -7.6 569.2853 2 71.86 4 40682 VEV_1_3_RA4_01_1235.d 3.94E5 3 3 357 366 Carbamidomethylation
K.TAVFYGGTPMQK.D Y 68.13 1298.6329 12 -10.8 650.3167 2 64.09 4 34578 VEV_1_3_RA4_01_1235.d 6.14E4 2 2 160 171
K.DNYPNIVVGTPGR.L Y 45.36 1400.7048 13 -9.9 701.3528 2 69.77 5 38827 VEV_2_3_RA5_01_1236.d 1.44E4 1 1 180 192
R.DVQEIFR.A Y 42.54 905.4606 7 -12.2 453.7321 2 65.65 5 35786 VEV_2_3_RA5_01_1236.d 4.04E5 4 4 227 233
R.ATELDKLLR.E Y 38.65 1057.6132 9 -22.6 353.5370 3 65.98 4 36084 VEV_1_3_RA4_01_1235.d 8.91E4 1 1 317 325
K.EGDLTVSGVR.A Y 29.30 1031.5247 10 -12.6 516.7631 2 49.62 4 24641 VEV_1_3_RA4_01_1235.d 9.39E5 3 3 38 47
K.TAVFYGGTPM(+15.99)QK.D Y 23.30 1314.6278 12 -4.8 658.3180 2 54.82 5 28089 VEV_2_3_RA5_01_1236.d 5.07E5 4 4 160 171 Oxidation (M)
R.LNALVR.D Y 19.06 684.4282 6 -21.9 343.2139 2 37.52 6 17061 VEV_3_3_RA6_01_1237.d 1.36E5 1 1 193 198
R.EC(+57.02)NFPSIAVHSGVSQEER(-.98).I Y 18.66 2043.9432 18 -15.3 682.3113 3 65.96 6 34858 VEV_3_3_RA6_01_1237.d 7.08E4 1 1 326 343 Carbamidomethylation; Amidation
K.LSESEKN(+.98)R.K Y 17.21 962.4669 8 7.7 482.2444 2 34.96 5 16146 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 286 293 Deamidation (NQ)
K.EFKEFNKR(+54.01)IC(+57.02)VATDVFGR.G Y 16.25 2269.1313 18 -21.1 568.2781 4 71.74 5 40272 VEV_2_3_RA5_01_1236.d 0 1 1 349 366 Methylglyoxal-derived hydroimidazolone; Carbamidomethylation
total 15 peptides
C1G035
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGIVSTYAGADASLYDAIVALEGFPGPK.S Y 119.90 2752.3958 28 2.1 1377.2080 2 95.28 5 54338 VEV_2_3_RA5_01_1236.d 3.09E5 4 4 621 648
R.GIDFSEDPLLQGR.V Y 95.93 1445.7150 13 -9.1 723.8582 2 79.65 5 45859 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 382 394
R.FSTVAGSRGSADTAR.D Y 73.55 1481.7222 15 -13.9 741.8580 2 34.53 4 15474 VEV_1_3_RA4_01_1235.d 5.6E5 5 5 149 163
K.AGGSRGPTLLEDFIFR.Q Y 57.98 1734.9053 16 -13.2 579.3014 3 83.49 5 48251 VEV_2_3_RA5_01_1236.d 2.27E5 2 2 79 94
K.TVGVVGSNGDQIVK.S Y 54.91 1371.7357 14 -10.0 686.8683 2 60.42 6 30779 VEV_3_3_RA6_01_1237.d 6.23E4 1 1 670 683
R.VFSYLDTQLNR.H Y 48.15 1354.6881 11 -26.6 678.3333 2 68.55 5 37993 VEV_2_3_RA5_01_1236.d 1.62E5 3 3 395 405
K.TVGVVGSN(+.98)GDQIVK.S Y 47.54 1372.7197 14 -14.8 687.3570 2 63.77 6 33197 VEV_3_3_RA6_01_1237.d 2.29E4 1 1 670 683 Deamidation (NQ)
R.FSTVAGSR.G Y 46.85 823.4188 8 -15.3 412.7104 2 25.48 5 10755 VEV_2_3_RA5_01_1236.d 9.29E4 1 1 149 156
R.GIDFSEDPLLQ(+.98)GR.V Y 38.56 1446.6990 13 -5.3 724.3529 2 80.06 6 45208 VEV_3_3_RA6_01_1237.d 9.03E4 1 1 382 394 Deamidation (NQ)
K.SGLYPPGRPQQLLIDAYR.Y Y 36.18 2043.0901 18 -12.5 682.0288 3 77.71 6 43521 VEV_3_3_RA6_01_1237.d 6.91E4 1 1 649 666
R.FS(-2.02)TVAGSRGSADTAR.D Y 28.60 1479.7065 15 32.9 494.2590 3 34.35 5 15791 VEV_2_3_RA5_01_1236.d 1.41E4 1 1 149 163 2-amino-3-oxo-butanoic_acid
K.AGIVSTYAGADASLY(-2.02)DAIVALEGFPGPK.S Y 28.39 2750.3801 28 5.6 917.8058 3 95.24 5 54322 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 621 648 2-amino-3-oxo-butanoic_acid
R.QNVIFHLNLIDHDLAVK.V Y 25.82 1988.0844 17 -20.8 498.0180 4 41.13 4 19383 VEV_1_3_RA4_01_1235.d 0 1 1 524 540
R.TVNGPLVR.E Y 25.79 854.4974 8 -5.9 428.2534 2 36.73 5 17203 VEV_2_3_RA5_01_1236.d 1.71E5 2 2 471 478
K.TPVFVR.F Y 24.47 717.4174 6 -19.1 359.7091 2 43.96 5 21492 VEV_2_3_RA5_01_1236.d 1.14E5 2 2 143 148
K.MTLNRNPINYFAETEQVGFQPGHVVR.G Y 21.11 3016.4978 26 -4.3 755.1285 4 80.23 5 46199 VEV_2_3_RA5_01_1236.d 9.69E4 1 1 356 381
K.QANQTVGK.G Y 20.67 844.4402 8 -6.7 845.4419 1 26.30 6 10878 VEV_3_3_RA6_01_1237.d 1.71E4 2 2 455 462
R.YGKTVGVVGSNGDQIVK.S Y 20.58 1719.9155 17 -13.0 574.3050 3 77.51 6 43377 VEV_3_3_RA6_01_1237.d 4.01E4 1 1 667 683
R.ISEQISLK.A Y 20.12 916.5229 8 -33.3 459.2535 2 55.38 5 28439 VEV_2_3_RA5_01_1236.d 3.83E5 2 2 71 78
R.DGTGQM(+15.99)FIHK.N Y 19.36 1148.5284 10 19.9 575.2829 2 48.55 5 24316 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 429 438 Oxidation (M)
R.DVHGFATR.F Y 18.18 901.4406 8 72.6 301.5093 3 30.23 6 12994 VEV_3_3_RA6_01_1237.d 2.82E5 1 1 164 171
R.LGTFGTNLNK.L Y 17.00 1063.5662 10 -16.2 532.7817 2 61.69 4 32751 VEV_1_3_RA4_01_1235.d 0 1 1 565 574
R.KDLWDSISAGR.F Y 15.89 1246.6306 11 40.1 416.5675 3 31.40 6 13636 VEV_3_3_RA6_01_1237.d 2.35E5 1 1 303 313
K.AALVWEEAQAIAGK.N Y 15.61 1455.7721 14 -9.0 486.2603 3 69.20 5 38444 VEV_2_3_RA5_01_1236.d 8.8E4 1 1 283 296
R.FHVSPM(+15.99)IKY Y 15.14 1136.5688 9 -15.0 569.2832 2 62.96 5 33755 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 728 736 Oxidation (M)
total 25 peptides
A0A0A0HVH2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LYSFVQAVNVKDAK.G Y 85.91 1580.8562 14 -7.5 791.4294 2 70.28 4 39436 VEV_1_3_RA4_01_1235.d 8.05E5 6 6 100 113
R.SAISDVVSREYTIHLHR.R Y 85.12 1982.0333 17 -7.6 496.5118 4 70.96 5 39734 VEV_2_3_RA5_01_1236.d 8.63E5 8 8 13 29
R.EYTIHLHR.R Y 75.68 1067.5513 8 -8.4 534.7784 2 40.10 4 18756 VEV_1_3_RA4_01_1235.d 1.15E6 8 8 22 29
K.VWEAGIKGVPFR.L Y 75.41 1357.7506 12 -18.1 453.5826 3 71.65 6 39130 VEV_3_3_RA6_01_1237.d 4.81E5 4 4 70 81
K.LYSFVQAVNVK.D Y 70.14 1266.6971 11 -16.9 634.3452 2 75.52 6 41986 VEV_3_3_RA6_01_1237.d 2.58E5 4 4 100 110
K.DVRLDPQLNKK.V Y 61.92 1324.7462 11 -21.5 442.5798 3 41.87 4 19821 VEV_1_3_RA4_01_1235.d 1.28E6 7 7 59 69
R.VHGVSFKK.R Y 59.20 900.5181 8 -15.0 451.2596 2 18.14 5 6727 VEV_2_3_RA5_01_1236.d 4.5E5 4 4 31 38
R.VHGVSFK.K Y 54.83 772.4232 7 -4.4 387.2172 2 25.10 6 10250 VEV_3_3_RA6_01_1237.d 6.98E5 5 5 31 37
R.SAISDVVSR.E Y 54.31 932.4927 9 -14.7 467.2468 2 54.22 5 27722 VEV_2_3_RA5_01_1236.d 4.9E6 14 14 13 21
R.LDPQLNKK.V Y 50.13 954.5498 8 -17.6 478.2738 2 20.12 6 7609 VEV_3_3_RA6_01_1237.d 1.32E6 7 7 62 69
R.LDPQLNK.K Y 48.40 826.4548 7 -19.8 414.2265 2 30.44 6 13107 VEV_3_3_RA6_01_1237.d 1.25E6 7 7 62 68
R.RVHGVSFK.K Y 47.00 928.5242 8 -16.9 465.2615 2 21.86 5 8740 VEV_2_3_RA5_01_1236.d 1.16E6 4 4 30 37
R.EYTIHLHRR.V Y 42.64 1223.6523 9 -10.7 612.8269 2 30.80 5 13725 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 22 30
R.SAISDVVSR(+.98)EYTIHLHR.R Y 41.64 1983.0173 17 -0.5 496.7614 4 70.94 5 39685 VEV_2_3_RA5_01_1236.d 2.17E5 1 1 13 29 Deamidation (R)
R.SAISDVVSREYTIHLHRR.V Y 41.23 2138.1345 18 -22.4 428.6246 5 67.37 5 37046 VEV_2_3_RA5_01_1236.d 3.37E5 2 2 13 30
K.KVWEAGIK.G Y 40.38 929.5334 8 -8.6 465.7700 2 40.76 4 19136 VEV_1_3_RA4_01_1235.d 1.35E5 3 3 69 76
K.LY(-2.02)SFVQAVNVKDAK.G Y 40.03 1578.8406 14 -47.8 527.2623 3 69.94 6 37806 VEV_3_3_RA6_01_1237.d 1.41E5 2 2 100 113 2-amino-3-oxo-butanoic_acid
K.DVRLDPQLNK.K Y 38.98 1196.6512 10 -12.9 399.8859 3 55.68 4 28439 VEV_1_3_RA4_01_1235.d 4.01E5 3 3 59 68
R.LDPQLNKKVWEAGIK.G Y 38.57 1737.9777 15 2.0 435.5026 4 66.25 5 36215 VEV_2_3_RA5_01_1236.d 4.99E4 1 1 62 76
K.VWEAGIK.G Y 35.94 801.4385 7 -20.5 401.7183 2 49.34 6 23922 VEV_3_3_RA6_01_1237.d 1.91E6 6 6 70 76
R.LDPQLNKKVWEAGIKGVPFR.L Y 35.13 2294.2898 20 -9.2 459.8610 5 75.21 5 42743 VEV_2_3_RA5_01_1236.d 6.95E4 1 1 62 81
R.AFTEK.A Y 34.59 594.3013 5 -9.2 595.3031 1 12.07 5 3482 VEV_2_3_RA5_01_1236.d 3.3E4 2 2 49 53
R.AFTEKAMGTK.D Y 31.19 1082.5430 10 -8.9 542.2739 2 26.68 5 11444 VEV_2_3_RA5_01_1236.d 2.3E4 1 1 49 58
R.N(+.98)DEEGAKEK(+43.99)LYSFVQAVNVKDAK.G Y 23.60 2626.2761 23 -7.5 526.2585 5 70.08 5 39045 VEV_2_3_RA5_01_1236.d 1.63E5 1 1 91 113 Deamidation (NQ); Carboxylation (DKW)
R.RVHGVSFKK.R Y 23.01 1056.6193 9 -14.1 529.3094 2 17.97 5 6634 VEV_2_3_RA5_01_1236.d 7.09E4 1 1 30 38
R.R(+14.02)VH(+15.99)GVSFK.K Y 22.54 958.5348 8 -2.8 480.2733 2 16.74 6 5855 VEV_3_3_RA6_01_1237.d 2.75E4 1 1 30 37 Methylation(KR); Oxidation (HW)
R.SAISDVVSR(+14.02).E Y 22.20 946.5084 9 -17.4 474.2532 2 61.50 6 31523 VEV_3_3_RA6_01_1237.d 3.47E5 3 3 13 21 Methylation(KR)
R.SAISDVVSR(+14.02)EYTIHLHR.R Y 21.08 1996.0490 17 -14.1 400.2114 5 75.95 5 43279 VEV_2_3_RA5_01_1236.d 5.83E4 1 1 13 29 Methylation(KR)
R.AIKEIR.A Y 20.19 728.4545 6 -24.0 365.2258 2 14.72 5 4896 VEV_2_3_RA5_01_1236.d 6.72E5 3 3 43 48
K.GLQTSVIEDA Y 15.08 1031.5134 10 -8.9 516.7594 2 70.17 4 39372 VEV_1_3_RA4_01_1235.d 1.53E5 1 1 114 123
total 30 peptides
C1FZL2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGANSLLDLIVFGR.A Y 115.44 1486.8507 14 -6.0 744.4282 2 93.49 4 55548 VEV_1_3_RA4_01_1235.d 1.39E5 2 2 477 490
R.FC(+57.02)AHNTVLATGGYGR.A Y 97.91 1622.7623 15 -22.3 541.9160 3 60.03 6 30464 VEV_3_3_RA6_01_1237.d 0 1 1 271 285 Carbamidomethylation
R.EAPQSVIELEGYGC(+57.02)PFSR.T Y 91.58 2037.9465 18 -12.7 1019.9676 2 80.67 6 45632 VEV_3_3_RA6_01_1237.d 1.06E5 2 2 169 186 Carbamidomethylation
R.AAFGLAEAGFNTAC(+57.02)ISK.L Y 79.59 1726.8348 17 -8.0 864.4178 2 78.84 4 46129 VEV_1_3_RA4_01_1235.d 1.43E5 3 3 100 116 Carbamidomethylation
K.NYPVIDHEYDAVVVGAGGAGLR.A Y 51.26 2271.1284 22 5.8 758.0544 3 78.30 4 45715 VEV_1_3_RA4_01_1235.d 1.25E5 2 2 78 99
R.YTGEVLTIDEK.G Y 38.51 1266.6343 11 -16.0 634.3143 2 64.84 6 33993 VEV_3_3_RA6_01_1237.d 7.09E4 1 1 441 451
R.AKEASPFVSK.N Y 38.25 1062.5709 10 -26.2 532.2788 2 24.87 4 10054 VEV_1_3_RA4_01_1235.d 2.45E3 1 1 68 77
K.TMQTDVSVFR.T Y 29.94 1182.5703 10 -1.0 592.2919 2 66.57 5 36446 VEV_2_3_RA5_01_1236.d 3.35E4 1 1 543 552
R.TQESLDEGVRK.I Y 22.84 1260.6310 11 2.9 631.3246 2 24.51 6 9950 VEV_3_3_RA6_01_1237.d 0 1 1 553 563
K.ESRGAHAR.E Y 21.46 882.4420 8 -11.6 883.4390 1 95.18 4 56368 VEV_1_3_RA4_01_1235.d 7.34E4 1 1 612 619
R.DVVSRSMTLEIREGR.G Y 20.92 1746.9047 15 -8.0 874.4526 2 98.74 5 55581 VEV_2_3_RA5_01_1236.d 1.41E4 1 1 365 379
K.ASPGQPHK.E Y 20.82 820.4191 8 -23.8 411.2071 2 19.61 5 7525 VEV_2_3_RA5_01_1236.d 0 1 1 500 507
R.NAM(+15.99)QKTMQTDVSVFR.T Y 20.75 1770.8392 15 6.7 591.2910 3 66.24 6 35060 VEV_3_3_RA6_01_1237.d 0 1 1 538 552 Oxidation (M)
K.GGQAYR.C Y 19.48 650.3136 6 -20.9 326.1573 2 24.20 6 9783 VEV_3_3_RA6_01_1237.d 8.74E4 1 1 207 212
R.DVVSR.S Y 17.04 574.3074 5 -25.5 575.3000 1 70.13 5 39092 VEV_2_3_RA5_01_1236.d 0 1 1 365 369
R.SM(+15.99)TLEIR.E Y 15.60 864.4375 7 -17.0 433.2187 2 40.86 5 19643 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 370 376 Oxidation (M)
K.EPHGK.V Y 15.34 566.2812 5 27.8 567.3043 1 11.14 5 3024 VEV_2_3_RA5_01_1236.d 7.35E3 1 1 640 644
total 17 peptides
C1GLB8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EVGLDFFSIPVELGASGAEK.A Y 110.33 2064.0415 20 -6.9 1033.0209 2 90.63 6 51662 VEV_3_3_RA6_01_1237.d 4.14E5 3 3 302 321
K.GYLPDNDGLKNALTGADIIVIPAGIPR.K Y 103.64 2762.4966 27 -12.4 921.8281 3 87.36 4 52105 VEV_1_3_RA4_01_1235.d 1.91E5 2 2 87 113
K.AFILVISNPVNSTVPIAAEVLK.A Y 94.05 2294.3250 22 -8.2 1148.1604 2 91.07 4 54248 VEV_1_3_RA4_01_1235.d 1.57E5 3 3 144 165
K.ASPLVDELALYDVVNTPGVAADLSHISTVATIK.G Y 92.31 3378.7922 33 -14.9 845.6927 4 91.68 5 52734 VEV_2_3_RA5_01_1236.d 5.36E5 5 5 54 86
R.EVGLDFFSIPVE(+14.02)LGASGAEK.A Y 52.12 2078.0571 20 -8.2 1040.0273 2 92.06 6 52340 VEV_3_3_RA6_01_1237.d 1.43E5 1 1 302 321 Methylation(others)
K.N(+.98)ALTGADIIVIPAGIPR.K Y 45.45 1690.9617 17 -32.9 846.4603 2 84.13 6 47917 VEV_3_3_RA6_01_1237.d 0 1 1 97 113 Deamidation (NQ)
R.VQFGGDEVVK.A Y 39.92 1076.5502 10 -13.4 539.2751 2 59.03 4 30800 VEV_1_3_RA4_01_1235.d 2.83E5 3 3 240 249
R.AETFTQEFTGQKDPSK.T Y 30.08 1812.8529 16 -16.6 605.2816 3 61.33 6 31392 VEV_3_3_RA6_01_1237.d 7.02E4 1 1 186 201
K.GYLPDNDGLK.N Y 29.14 1090.5294 10 26.2 546.2863 2 62.81 6 32496 VEV_3_3_RA6_01_1237.d 2.34E6 9 9 87 96
R.LFGVTTLDVVR.A Y 28.05 1218.6971 11 -35.1 610.3345 2 81.39 4 48084 VEV_1_3_RA4_01_1235.d 0 1 1 175 185
R.FAESVIK.A Y 26.66 792.4381 7 -21.9 397.2177 2 49.79 6 24177 VEV_3_3_RA6_01_1237.d 2.58E5 2 2 268 274
MVKAVVLGASGGIGQVR.G Y 25.09 1640.9396 17 -32.5 411.2288 4 67.72 5 37314 VEV_2_3_RA5_01_1236.d 6.34E4 3 3 1 17
K.ASPLVDELALY(-2.02)DVVNTPGVAADLSHISTVATIK.G Y 21.31 3376.7766 33 -29.7 1126.5660 3 91.63 6 52135 VEV_3_3_RA6_01_1237.d 1.57E4 1 1 54 86 2-amino-3-oxo-butanoic_acid
K.AHNILGGITEQEK.K Y 20.63 1408.7310 13 -11.6 353.1859 4 19.38 4 7084 VEV_1_3_RA4_01_1235.d 1.99E5 1 1 322 334
K.GIEFAKNPPPK Y 20.58 1196.6553 11 -52.6 300.1554 4 12.36 6 3585 VEV_3_3_RA6_01_1237.d 0 1 1 351 361
R.KPGMTR.D N 17.23 688.3690 6 -17.8 345.1857 2 31.90 4 13951 VEV_1_3_RA4_01_1235.d 1.85E5 1 1 114 119
K.VNAGIVQTLVK.G Y 16.68 1140.6866 11 -86.2 571.3015 2 71.62 4 40496 VEV_1_3_RA4_01_1235.d 0 1 1 125 135
K.AAGVFDPKR.L Y 16.60 959.5188 9 -15.3 320.8420 3 30.66 5 13640 VEV_2_3_RA5_01_1236.d 2.75E5 2 2 166 174
total 18 peptides
C1GFT4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LTGTGDLGDIVDRELTNAANAIEAAAQR.L Y 101.49 2854.4419 28 -8.0 714.6121 4 93.33 4 55491 VEV_1_3_RA4_01_1235.d 7.22E5 5 5 861 888
K.AVASSTNTLIETADGVISGR.N Y 89.40 1961.0065 20 -6.5 981.5042 2 81.76 4 48402 VEV_1_3_RA4_01_1235.d 5.99E4 2 2 966 985
R.LAELEQENLNAR.A Y 87.09 1398.7102 12 -8.1 700.3567 2 61.70 5 32810 VEV_2_3_RA5_01_1236.d 9.79E4 2 2 431 442
K.AATASQQEIVR.E Y 59.06 1172.6149 11 -11.8 587.3078 2 31.62 4 13790 VEV_1_3_RA4_01_1235.d 1.79E5 5 5 928 938
K.VQPVLADEVQTFK.A Y 49.28 1472.7875 13 -15.6 737.3895 2 73.95 6 40777 VEV_3_3_RA6_01_1237.d 6.53E4 2 2 109 121
K.VLQEGHPITVR.E Y 47.12 1247.6986 11 -29.4 624.8383 2 45.52 4 22088 VEV_1_3_RA4_01_1235.d 0 1 1 129 139
R.LAIEKAENAER.S Y 45.52 1242.6567 11 -6.3 415.2236 3 35.77 5 16638 VEV_2_3_RA5_01_1236.d 2.17E5 2 2 584 594
K.AASAQEAIDRR.E Y 36.41 1186.6053 11 -11.1 594.3033 2 23.51 5 9629 VEV_2_3_RA5_01_1236.d 1.38E5 3 3 526 536
R.IAGGNREEVEK.L Y 35.13 1200.6099 11 -19.8 601.3003 2 16.00 6 5472 VEV_3_3_RA6_01_1237.d 9.63E4 3 3 567 577
R.FATDDKKADQLLGAAR.Q Y 34.34 1718.8950 16 -16.0 573.9631 3 61.81 5 32893 VEV_2_3_RA5_01_1236.d 8.2E4 2 2 788 803
K.SSEISSLLSK.Y Y 33.90 1049.5604 10 -10.0 525.7822 2 67.22 6 35793 VEV_3_3_RA6_01_1237.d 1.87E5 1 1 597 606
R.LAELEQENLNAR(+14.02).A Y 30.44 1412.7260 12 -8.9 707.3640 2 67.38 5 37057 VEV_2_3_RA5_01_1236.d 5.15E4 1 1 431 442 Methylation(KR)
R.NSPEQLIVASNEVAASTAQLVASSR.V Y 30.34 2541.3035 25 6.9 848.1143 3 88.21 5 50958 VEV_2_3_RA5_01_1236.d 0 1 1 986 1010
K.SSKLTGTGDLGDIVDR.E Y 27.33 1632.8318 16 -19.4 409.2073 4 50.33 5 25336 VEV_2_3_RA5_01_1236.d 0 1 1 858 873
K.INDIIDSVLQSGIQR.V Y 26.32 1669.8999 15 -22.5 835.9385 2 84.45 4 50221 VEV_1_3_RA4_01_1235.d 7.03E4 1 1 693 707
K.ATSIEETAPK.R Y 25.36 1045.5292 10 14.5 523.7794 2 30.19 6 12985 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 74 83
K.LIFSHFR.H Y 23.72 918.5076 7 -30.5 460.2471 2 64.80 5 35122 VEV_2_3_RA5_01_1236.d 0 1 1 228 234
K.TRALDEIR.A Y 23.70 972.5352 8 -14.2 325.1811 3 27.82 4 11641 VEV_1_3_RA4_01_1235.d 0 1 1 622 629
K.IVDTFSSK.S Y 23.55 895.4651 8 -12.6 448.7342 2 39.18 5 18633 VEV_2_3_RA5_01_1236.d 3.64E4 1 1 850 857
K.TKNLELADM(+15.99)IR.E Y 22.25 1318.6914 11 -22.7 330.6726 4 10.28 4 2569 VEV_1_3_RA4_01_1235.d 0 1 1 545 555 Oxidation (M)
K.SGMEQALMELEELKLNQGDADR.A Y 21.58 2476.1572 22 -41.3 620.0210 4 11.96 6 3374 VEV_3_3_RA6_01_1237.d 9.25E4 1 1 655 676
R.HEQVVFPAQFVASFK.A Y 20.64 1732.8937 15 -14.3 434.2245 4 62.84 6 32520 VEV_3_3_RA6_01_1237.d 0 1 1 33 47
K.IVDTFSSKSSK.L Y 19.80 1197.6240 11 -19.0 400.2077 3 65.43 6 34449 VEV_3_3_RA6_01_1237.d 8.11E4 2 2 850 860
R.GLQSFR.L Y 19.51 706.3762 6 -39.7 707.3555 1 109.26 5 58646 VEV_2_3_RA5_01_1236.d 1.44E4 1 1 815 820
R.ELRLAIEKAENAER.S Y 19.05 1640.8845 14 -12.8 411.2231 4 65.35 6 34387 VEV_3_3_RA6_01_1237.d 0 1 1 581 594
K.NLELADM(+15.99)IRER.D Y 18.64 1374.6925 11 -0.2 459.2380 3 47.18 5 23448 VEV_2_3_RA5_01_1236.d 6.2E4 2 2 547 557 Oxidation (M)
R.ANNGEK.D Y 17.80 631.2925 6 7.2 632.3044 1 70.20 4 39367 VEV_1_3_RA4_01_1235.d 1.24E5 1 1 630 635
R.DPSPPPK.A Y 17.66 736.3755 7 -29.0 369.1844 2 16.00 4 5310 VEV_1_3_RA4_01_1235.d 1.39E5 1 1 341 347
K.LNQGDADR(+.98)ALDTQIDDVLHNSVAK.I Y 17.33 2608.2729 24 9.0 870.4394 3 75.71 5 43110 VEV_2_3_RA5_01_1236.d 1.17E4 1 1 669 692 Deamidation (R)
K.RQQEEFENEQLR.L Y 16.71 1604.7543 12 -0.5 535.9251 3 43.42 4 20790 VEV_1_3_RA4_01_1235.d 8.9E4 1 1 366 377
R.LAELEQENLNARAQYER.D Y 16.32 2046.0129 17 -6.2 683.0074 3 81.49 6 46200 VEV_3_3_RA6_01_1237.d 5.08E1 1 1 431 447
K.LNQGDADRALDTQIDDVLHNSVAK.I Y 16.29 2607.2888 24 25.2 652.8459 4 110.64 5 59009 VEV_2_3_RA5_01_1236.d 0 1 1 669 692
R.EM(+15.99)KTKNLELADM(+15.99)IR.E Y 16.22 1722.8644 14 -14.2 862.4272 2 86.34 4 51462 VEV_1_3_RA4_01_1235.d 2.44E4 1 1 542 555 Oxidation (M)
R.EYVHFLASK.L Y 15.98 1092.5603 9 -12.5 547.2806 2 70.64 5 39456 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 169 177
R.VKATFMSK.T Y 15.95 910.4946 8 1.2 456.2551 2 72.93 5 41129 VEV_2_3_RA5_01_1236.d 4.63E4 1 1 1011 1018
K.LNQGDADR.A Y 15.94 887.4097 8 1.8 888.4186 1 89.92 6 51274 VEV_3_3_RA6_01_1237.d 2.15E5 1 1 669 676
K.NLELADMIRER.D Y 15.71 1358.6976 11 0.5 680.3564 2 58.51 5 30464 VEV_2_3_RA5_01_1236.d 0 1 1 547 557
R.GLQSFRLEGLEPLQK.T Y 15.49 1713.9413 15 -38.2 572.2992 3 77.64 4 45200 VEV_1_3_RA4_01_1235.d 4.44E3 1 1 815 829
K.LTGTGDLGDIVDR.E Y 15.48 1330.6729 13 -7.6 666.3386 2 29.06 6 12368 VEV_3_3_RA6_01_1237.d 0 1 1 861 873
K.DRIAGGNR.E Y 15.32 857.4467 8 -3.2 429.7292 2 29.99 5 13259 VEV_2_3_RA5_01_1236.d 2.74E5 1 1 565 572
K.FITSM(+15.99)LR.A Y 15.11 882.4633 7 -10.7 442.2342 2 73.83 5 41764 VEV_2_3_RA5_01_1236.d 7.56E4 1 1 259 265 Oxidation (M)
total 41 peptides
C1G092
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVSTEQGQQLANELGIPFLEVSAK.N Y 123.43 2528.3123 24 -9.1 1265.1519 2 87.98 6 50219 VEV_3_3_RA6_01_1237.d 9E4 3 3 132 155
R.FSEDSFTPSFITTIGIDFK.I Y 108.67 2151.0410 19 -1.0 1076.5267 2 90.95 4 54195 VEV_1_3_RA4_01_1235.d 2.52E5 3 3 30 48
K.LLLIGDSGVGK.S N 68.81 1070.6335 11 -10.1 536.3187 2 73.22 4 41752 VEV_1_3_RA4_01_1235.d 6.62E5 3 3 13 23
K.LQIWDTAGQER.F N 59.71 1315.6521 11 -15.7 658.8230 2 68.52 6 36774 VEV_3_3_RA6_01_1237.d 3.33E5 2 2 61 71
K.AFYTLASDIKR.V Y 59.64 1283.6874 11 -20.9 428.8941 3 66.54 5 36419 VEV_2_3_RA5_01_1236.d 3.82E5 3 3 163 173
K.LQIWDTAGQERFR.T N 48.94 1618.8215 13 -31.6 540.5974 3 71.60 4 40475 VEV_1_3_RA4_01_1235.d 1.87E5 3 3 61 73
R.NYDFLIK.L Y 31.65 911.4752 7 -11.1 456.7398 2 72.28 4 41020 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 6 12
K.SC(+57.02)C(+57.02)LLR.F Y 30.24 807.3731 6 -13.8 404.6883 2 34.86 5 16089 VEV_2_3_RA5_01_1236.d 2.55E5 3 3 24 29 Carbamidomethylation
R.TIELDGK.R N 29.64 774.4123 7 -38.1 775.3901 1 33.29 6 14677 VEV_3_3_RA6_01_1237.d 3.83E5 2 2 51 57
K.NN(+.98)INVEK(+28.03).A Y 24.94 858.4447 7 -0.5 430.2294 2 43.57 6 20550 VEV_3_3_RA6_01_1237.d 2.38E5 1 1 156 162 Deamidation (NQ); Dimethylation(KR)
K.AFYTLASDIK.R Y 20.42 1127.5862 10 -9.0 564.7953 2 56.35 5 28978 VEV_2_3_RA5_01_1236.d 0 1 1 163 172
M(+15.99)AGTR.N N 20.08 550.2534 5 -17.4 551.2510 1 15.76 5 5454 VEV_2_3_RA5_01_1236.d 3.49E4 2 2 1 5 Oxidation (M)
MAGTR.N N 18.32 534.2584 5 12.0 535.2721 1 62.95 6 32601 VEV_3_3_RA6_01_1237.d 9.31E4 1 1 1 5
R.TIELDGKRVKLQIWDTAGQER.F Y 15.58 2455.3184 21 -54.5 492.0442 5 78.86 5 45290 VEV_2_3_RA5_01_1236.d 0 1 1 51 71
total 14 peptides
C1GGQ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NGGGFLDEFYPNAAK.A Y 113.46 1598.7365 15 -13.9 800.3644 2 80.37 6 45511 VEV_3_3_RA6_01_1237.d 3.19E5 4 4 88 102
K.SPIFHPGPVEPQFSPGR.Y Y 105.76 1847.9318 17 -37.0 616.9617 3 71.38 6 38894 VEV_3_3_RA6_01_1237.d 0 3 3 267 283
R.EGDLLSANAGSVK.V Y 90.94 1259.6357 13 -13.1 630.8169 2 60.24 5 31756 VEV_2_3_RA5_01_1236.d 5.84E5 5 5 147 159
K.AIWDFEGIFC(+57.02)SSR.H Y 87.98 1586.7188 13 5.9 794.3713 2 88.12 6 50302 VEV_3_3_RA6_01_1237.d 6.46E4 2 2 103 115 Carbamidomethylation
K.VVAKPPEPINVHAGSASDAIK.A Y 80.23 2099.1375 21 -21.3 525.7805 4 62.18 6 32028 VEV_3_3_RA6_01_1237.d 3.04E5 1 1 160 180
K.N(+.98)GGGFLDEFYPNAAK.A Y 69.57 1599.7205 15 -15.4 800.8552 2 84.76 6 48309 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 88 102 Deamidation (NQ)
R.FAGLIHPGILGC(+57.02)APSAEVLAEWNR.R Y 54.01 2577.3162 24 -22.4 860.0934 3 85.81 6 48972 VEV_3_3_RA6_01_1237.d 3.27E4 1 1 122 145 Carbamidomethylation
R.TIPGRPEHGGNC(+57.02)DIKNLSR.G Y 21.72 2120.0544 19 -60.8 424.9924 5 45.38 6 21632 VEV_3_3_RA6_01_1237.d 0 1 1 190 208 Carbamidomethylation
K.NNDSADDM(+15.99)RDIDLTR.V Y 20.84 1765.7537 15 -19.3 589.5804 3 46.97 6 22550 VEV_3_3_RA6_01_1237.d 5.83E4 1 1 30 44 Oxidation (M)
R.REGDLLSANAGSVK.V Y 18.43 1415.7368 14 2.6 472.9208 3 73.80 4 42203 VEV_1_3_RA4_01_1235.d 0 1 1 146 159
K.QHFLDATVAYR.E Y 15.68 1319.6622 11 24.0 660.8542 2 65.40 4 35592 VEV_1_3_RA4_01_1235.d 0 1 1 298 308
R.ETC(+57.02)MR.V Y 15.04 695.2731 5 32.0 696.3026 1 37.65 4 17301 VEV_1_3_RA4_01_1235.d 0 1 1 309 313 Carbamidomethylation
total 12 peptides
A0A0A0HYY2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.AITLEGEEVHSEYDGQQQR.D Y 122.87 2188.0032 19 -10.5 730.3340 3 62.63 6 32384 VEV_3_3_RA6_01_1237.d 1.92E6 10 10 2 20
K.HVDPFGNEDSADVKYK.T Y 118.94 1819.8376 16 -12.8 607.6121 3 59.07 6 29763 VEV_3_3_RA6_01_1237.d 2.78E5 5 5 51 66
K.HVDPFGNEDSADVK.Y Y 113.03 1528.6793 14 -15.8 510.5590 3 56.56 6 28079 VEV_3_3_RA6_01_1237.d 5.98E5 6 6 51 64
R.DALDKVEDEEK.V Y 90.80 1289.5986 11 -13.9 645.7976 2 47.85 6 23058 VEV_3_3_RA6_01_1237.d 5.1E5 8 8 21 31
M.AITLEGEEVHS(+14.02)EYDGQQQR.D Y 64.20 2202.0188 19 -8.9 735.0070 3 65.54 5 35691 VEV_2_3_RA5_01_1236.d 2.56E5 1 1 2 20 Methylation(others)
M.AITLEGEE(+14.02)VHSEYDGQQQR.D Y 64.04 2202.0188 19 -11.9 735.0048 3 65.43 6 34445 VEV_3_3_RA6_01_1237.d 2.64E5 2 2 2 20 Methylation(others)
M.AITLEGEEVHSEYDGQQQ(+.98)R.D Y 55.30 2188.9873 19 -9.8 730.6625 3 63.62 4 34221 VEV_1_3_RA4_01_1235.d 3.21E5 2 2 2 20 Deamidation (NQ)
M.AITLE(+14.02)GEEVHSEYDGQQQR.D Y 52.76 2202.0188 19 -17.3 735.0009 3 65.85 6 34765 VEV_3_3_RA6_01_1237.d 4.65E5 3 3 2 20 Methylation(others)
M.AITLEGEEVHSEYDGQQQR(+14.02).D Y 52.04 2202.0188 19 -3.6 735.0109 3 63.76 4 34326 VEV_1_3_RA4_01_1235.d 9.84E4 1 1 2 20 Methylation(KR)
M.AITLEGEEVH(+14.02)SEYDGQQQR.D Y 51.65 2202.0188 19 -8.9 1102.0068 2 65.56 5 35714 VEV_2_3_RA5_01_1236.d 1.42E4 1 1 2 20 Methylation(others)
M.AITLEGE(+14.02)EVHSEYDGQQQR.D Y 50.39 2202.0188 19 5.6 735.0176 3 66.65 4 36567 VEV_1_3_RA4_01_1235.d 2.46E5 2 2 2 20 Methylation(others)
K.VHLENSNSLPPYEK.N Y 41.38 1625.8049 14 -6.5 542.9387 3 58.36 5 30356 VEV_2_3_RA5_01_1236.d 1.58E5 2 2 32 45
K.VHLENSNSLPPYEKNTESK.H Y 19.12 2185.0652 19 -30.4 547.2570 4 54.98 6 27172 VEV_3_3_RA6_01_1237.d 0 1 1 32 50
M.AITLEGEE(+28.03)VHSEYDGQQQR.D Y 16.04 2216.0344 19 -17.3 739.6727 3 69.36 5 38535 VEV_2_3_RA5_01_1236.d 7.95E4 1 1 2 20 Ethylation
total 14 peptides
C1GIR0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EATVVASQLGQGIHGVNK.T Y 114.66 1806.9587 18 -11.0 603.3203 3 64.59 4 34952 VEV_1_3_RA4_01_1235.d 1.94E5 4 4 316 333
R.GTAGMVQSGEHPALIR.E Y 89.70 1622.8198 16 -8.5 541.9426 3 60.34 4 31735 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 269 284
K.ALDGFSMPLTVVQNENVK.A Y 86.49 1960.9928 18 -8.7 981.4951 2 82.68 4 49007 VEV_1_3_RA4_01_1235.d 4.18E5 5 5 90 107
R.AEAQMMAAQVMR.G Y 69.55 1335.6097 12 -7.1 668.8074 2 66.52 4 36462 VEV_1_3_RA4_01_1235.d 6.2E4 1 1 257 268
R.SVREATVVASQLGQGIHGVNK.T Y 68.49 2149.1604 21 -16.8 538.2883 4 67.64 4 37350 VEV_1_3_RA4_01_1235.d 0 1 1 313 333
R.NINIDSVNLAQK.S Y 59.63 1327.7096 12 -15.2 664.8520 2 68.88 6 37038 VEV_3_3_RA6_01_1237.d 1.04E5 3 3 7 18
K.VSTPGGC(+57.02)TIGGLLVLEEGRVR.G Y 45.02 2169.1575 21 -8.0 724.0540 3 80.42 4 47343 VEV_1_3_RA4_01_1235.d 4.41E4 1 1 287 307 Carbamidomethylation
R.AMPNTAALVR.E Y 44.13 1042.5593 10 -12.6 522.2804 2 60.96 5 32264 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 176 185
R.N(+.98)INIDSVNLAQK.S Y 41.94 1328.6936 12 -22.3 665.3392 2 68.97 5 38257 VEV_2_3_RA5_01_1236.d 0 1 1 7 18 Deamidation (NQ)
K.IPSKFIAC(+57.02)VR.R Y 29.48 1189.6641 10 -12.6 397.5570 3 61.32 4 32478 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 70 79 Carbamidomethylation
K.FIAC(+57.02)VR.R Y 26.39 764.4003 6 -14.5 383.2019 2 45.11 5 22200 VEV_2_3_RA5_01_1236.d 2.35E5 2 2 74 79 Carbamidomethylation
R.VVRAM(+15.99)PNTAALVR.E Y 23.23 1412.7922 13 -29.0 354.1951 4 40.90 5 19653 VEV_2_3_RA5_01_1236.d 8.6E4 1 1 173 185 Oxidation (M)
R.A(+42.01)M(+15.99)PNTAALVR.E Y 20.58 1100.5648 10 -52.9 551.2606 2 25.76 4 10561 VEV_1_3_RA4_01_1235.d 0 1 1 176 185 Acetylation (N-term); Oxidation (M)
K.AVEQAEVVILGC(+57.02)KPYM(+15.99)LR.D Y 19.74 2091.0857 18 -10.9 523.7730 4 9.75 4 2370 VEV_1_3_RA4_01_1235.d 0 1 1 108 125 Carbamidomethylation; Oxidation (M)
R.VVRAMPNTAALVR.E Y 19.10 1396.7972 13 -37.1 350.1936 4 45.85 6 21898 VEV_3_3_RA6_01_1237.d 0 1 1 173 185
R.DVLDEPGM(+15.99)C(+57.02)K.A Y 17.10 1178.4948 10 1.1 590.2553 2 46.46 4 22678 VEV_1_3_RA4_01_1235.d 5.49E4 1 1 126 135 Oxidation (M); Carbamidomethylation
MSVAHR.N Y 15.77 699.3486 6 44.4 700.3870 1 64.34 6 33613 VEV_3_3_RA6_01_1237.d 2.09E4 1 1 1 6
total 17 peptides
C1GEJ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IAVLPIADTVEGLTGSLFDVFLAPYFR.E Y 96.08 2923.5735 27 -11.3 1462.7775 2 98.07 4 57569 VEV_1_3_RA4_01_1235.d 2.32E4 1 1 130 156
R.AVANETGAFFFLINGPEIMSK.M Y 86.17 2255.1296 21 -21.1 752.7013 3 91.19 4 54325 VEV_1_3_RA4_01_1235.d 0 1 1 273 293
R.FALGVSNPSALR.E Y 72.19 1230.6720 12 -11.7 616.3361 2 72.33 5 40705 VEV_2_3_RA5_01_1236.d 1.33E5 3 3 470 481
R.AAAPC(+57.02)VVFLDELDSIAK.S Y 68.57 1817.9232 17 -10.4 909.9594 2 90.40 5 52092 VEV_2_3_RA5_01_1236.d 5.39E4 2 2 585 601 Carbamidomethylation
K.THGFSGADLGFVTQR.A Y 65.42 1591.7743 15 -13.7 531.5914 3 70.80 4 39846 VEV_1_3_RA4_01_1235.d 5.49E4 2 2 696 710
K.AVANEC(+57.02)AANFISVK.G Y 64.27 1492.7344 14 -7.9 747.3685 2 69.19 5 38404 VEV_2_3_RA5_01_1236.d 2.81E5 3 3 547 560 Carbamidomethylation
R.VVSQLLTLMDGMK.A Y 63.43 1433.7622 13 -0.8 717.8878 2 85.50 4 50916 VEV_1_3_RA4_01_1235.d 1.7E5 1 1 340 352
R.DTVLIVLADDDLDDGSAR.I Y 59.99 1901.9218 18 -12.9 951.9559 2 84.81 4 50470 VEV_1_3_RA4_01_1235.d 8.62E4 1 1 82 99
R.EVDIGIPDPTGRLEILQIHTK.N Y 55.29 2343.2798 21 3.1 586.8290 4 82.01 4 48539 VEV_1_3_RA4_01_1235.d 4.68E4 1 1 382 402
K.GVLFYGPPGTGK.T Y 54.47 1191.6288 12 -8.6 596.8165 2 71.14 4 40114 VEV_1_3_RA4_01_1235.d 5.66E5 3 3 530 541
R.ELVELPLRHPQLFK.S Y 51.66 1717.9879 14 -12.5 430.4989 4 76.60 4 44383 VEV_1_3_RA4_01_1235.d 1.31E5 2 2 234 247
K.M(+15.99)AGESESNLRK.A Y 42.62 1236.5768 11 -27.7 619.2786 2 13.88 5 4431 VEV_2_3_RA5_01_1236.d 0 1 1 294 304 Oxidation (M)
R.ELIESVQYPVDHPEK.F Y 38.53 1781.8835 15 -22.6 594.9550 3 74.87 6 41448 VEV_3_3_RA6_01_1237.d 2.91E4 1 1 505 519
R.AAAPC(+57.02)VVFLDELDSIAK(+14.02).S Y 36.25 1831.9390 17 -9.1 916.9684 2 93.56 5 53606 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 585 601 Carbamidomethylation; Methylation(KR)
K.MAGESESNLR.K Y 28.31 1092.4869 10 -5.6 547.2477 2 28.75 4 12156 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 294 303
R.AAAPC(+57.02)VVFLD(+14.02)ELDSIAK.S Y 26.86 1831.9390 17 3.8 916.9802 2 93.48 6 52967 VEV_3_3_RA6_01_1237.d 5.71E4 1 1 585 601 Carbamidomethylation; Methylation(others)
R.DIFDK.A Y 20.93 636.3119 5 26.9 637.3363 1 81.27 5 46876 VEV_2_3_RA5_01_1236.d 9.07E4 1 1 578 582
R.VVSQLLTLM(+15.99)DGMK.A Y 20.36 1449.7571 13 -28.9 725.8649 2 38.86 5 18438 VEV_2_3_RA5_01_1236.d 2.39E4 1 1 340 352 Oxidation (M)
K.AFEEAEKNSPAIIFIDEIDSIAPK.R Y 20.14 2646.3428 24 38.5 883.1555 3 91.08 4 54258 VEV_1_3_RA4_01_1235.d 0 1 1 305 328
R.SNVVVMAATNRPNSVDPALR.R Y 17.91 2110.0952 20 -43.3 423.0080 5 25.47 6 10442 VEV_3_3_RA6_01_1237.d 6.38E5 1 1 355 374
K.HGDVITVHPC(+57.02)PDIK.Y Y 16.88 1586.7875 14 -9.9 397.7002 4 57.30 5 29628 VEV_2_3_RA5_01_1236.d 5.48E4 1 1 112 125 Carbamidomethylation
K.FLKFGLSPSK.G Y 16.33 1122.6437 10 79.3 1123.7400 1 102.56 5 56823 VEV_2_3_RA5_01_1236.d 6.44E4 1 1 520 529
R.EAYRPVRQGDLFTVR.A Y 16.24 1805.9536 15 -21.0 362.1904 5 37.58 5 17694 VEV_2_3_RA5_01_1236.d 0 1 1 157 171
R.KTPVAADVDLK.F Y 16.02 1155.6499 11 -57.8 386.2017 3 30.31 6 13030 VEV_3_3_RA6_01_1237.d 2.03E5 1 1 680 690
K.FGLSPSK.G Y 15.13 734.3962 7 -0.5 368.2052 2 48.88 6 23653 VEV_3_3_RA6_01_1237.d 0 1 1 523 529
total 25 peptides
C1GIE3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TC(+57.02)GVIVEPIQGEGGVHSATPEFLSALR.T Y 111.62 2823.4224 27 -12.0 942.1368 3 81.51 6 46216 VEV_3_3_RA6_01_1237.d 1.21E5 1 1 248 274 Carbamidomethylation
R.TRC(+57.02)DDVGAVLIFDEIQC(+57.02)GLSR.T Y 101.97 2423.1572 21 -16.4 808.7131 3 87.74 4 52342 VEV_1_3_RA4_01_1235.d 5.46E4 2 2 275 295 Carbamidomethylation
K.YGTYNDVAQLPSLITSK.T Y 95.94 1868.9519 17 -21.2 935.4634 2 80.96 6 45831 VEV_3_3_RA6_01_1237.d 8.18E4 2 2 231 247
R.TFGALSATPNPK.Y Y 80.26 1202.6295 12 -22.8 602.3083 2 61.45 6 31486 VEV_3_3_RA6_01_1237.d 4.21E5 3 3 206 217
K.YQAPFAPMVPGFK.Y Y 63.11 1451.7271 13 -7.7 726.8652 2 81.52 4 48182 VEV_1_3_RA4_01_1235.d 8.71E4 1 1 218 230
R.GLIMGLQLAEPYQGLIGDVVTEAR.H Y 50.36 2542.3464 24 -24.2 848.4355 3 93.19 4 55425 VEV_1_3_RA4_01_1235.d 0 1 1 411 434
K.DAHSLPAHPDILTTAK.A Y 48.47 1685.8737 16 -7.3 422.4726 4 62.94 4 33714 VEV_1_3_RA4_01_1235.d 2.35E5 1 1 311 326
K.YQ(+.98)APFAPMVPGFK.Y Y 37.44 1452.7111 13 3.2 727.3651 2 81.50 4 48161 VEV_1_3_RA4_01_1235.d 8.27E4 1 1 218 230 Deamidation (NQ)
R.C(+57.02)VSTKSGAER.V Y 18.89 1093.5186 10 12.1 547.7732 2 63.13 6 32728 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 31 40 Carbamidomethylation
R.VQGVERTPSHK.D Y 17.83 1236.6575 11 23.4 310.1789 4 52.68 5 26792 VEV_2_3_RA5_01_1236.d 2.22E4 1 1 41 51
R.FPDAVADIR.G Y 17.21 1002.5134 9 -36.4 502.2457 2 60.44 5 31872 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 400 408
K.RFPDAVADIR.G Y 16.75 1158.6145 10 33.6 387.2251 3 64.34 6 33616 VEV_3_3_RA6_01_1237.d 0 1 1 399 408
MAFGTATRR.I Y 16.21 1009.5127 9 -8.7 505.7592 2 41.39 4 19543 VEV_1_3_RA4_01_1235.d 3.11E4 1 1 1 9
K.WTGALSQLLVTYTLDSGAMR.T Y 15.56 2182.1091 20 -18.4 728.3636 3 78.79 5 45248 VEV_2_3_RA5_01_1236.d 4.92E4 1 1 138 157
total 14 peptides
C1GCK7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TLANIETARPFEDLTVDDISK.A Y 121.15 2347.1907 21 -15.7 783.3919 3 80.42 6 45521 VEV_3_3_RA6_01_1237.d 4.25E5 3 3 121 141
K.VQVLSDQPQTVDFAHYR.S Y 103.97 2001.9908 17 -15.4 668.3273 3 72.04 6 39390 VEV_3_3_RA6_01_1237.d 3.59E5 3 3 44 60
R.FGDISFM Y 79.01 815.3524 7 -11.4 816.3503 1 84.00 5 48563 VEV_2_3_RA5_01_1236.d 3.04E4 2 2 168 174
K.SFTPSTFDVNR.Q Y 72.87 1269.5989 11 -6.6 635.8026 2 68.27 4 37887 VEV_1_3_RA4_01_1235.d 4.36E5 6 6 78 88
R.GQTAASLAAFK.K Y 51.23 1063.5662 11 -16.0 532.7819 2 61.10 6 31235 VEV_3_3_RA6_01_1237.d 0 1 1 24 34
K.ARPDIIEK.T Y 40.46 940.5341 8 -12.4 471.2685 2 27.56 4 11513 VEV_1_3_RA4_01_1235.d 1.73E5 3 3 142 149
R.SVLKNQAIVDEIEKHFK.S Y 30.58 1997.0945 17 -19.0 400.4186 5 75.98 4 43899 VEV_1_3_RA4_01_1235.d 4.63E4 1 1 61 77
K.AIEAFEAQAMK.G Y 30.29 1207.5907 11 29.2 604.8203 2 61.49 4 32601 VEV_1_3_RA4_01_1235.d 2.69E4 1 1 92 102
K.NQAIVDEIEKHFK.S Y 26.71 1569.8151 13 -16.5 393.4546 4 73.97 4 42333 VEV_1_3_RA4_01_1235.d 3.1E5 2 2 65 77
K.TSQLVS(+60.00)K.G Y 25.81 821.4317 7 -1.0 411.7227 2 62.93 6 32580 VEV_3_3_RA6_01_1237.d 2.7E5 2 2 150 156 2-OH-ethyl thio-Ser
K.WMPPGYKER.F Y 25.18 1162.5593 9 9.4 582.2924 2 60.51 6 30854 VEV_3_3_RA6_01_1237.d 2.64E4 1 1 159 167
K.GAEETK.D Y 18.31 633.2969 6 29.5 634.3229 1 78.58 4 45927 VEV_1_3_RA4_01_1235.d 4.26E4 1 1 103 108
total 12 peptides
C1G6B0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TTDMNHTTAAAFDGSVGSPK.A Y 133.55 2006.9004 20 -10.0 669.9674 3 60.88 5 32196 VEV_2_3_RA5_01_1236.d 1.93E5 4 4 14 33
K.ASDAIRGGNDEEGQEGPR.A Y 99.40 1856.8248 18 -13.1 619.9408 3 28.85 5 12596 VEV_2_3_RA5_01_1236.d 1.63E5 3 3 34 51
M.T(+42.01)EAVDSIHVQTK.T Y 84.66 1368.6885 12 -12.6 685.3429 2 64.05 6 33435 VEV_3_3_RA6_01_1237.d 8.01E5 4 4 2 13 Acetylation (Protein N-term)
R.GGNDEEGQEGPR.A Y 82.77 1243.5065 12 -10.8 622.7538 2 13.46 5 4215 VEV_2_3_RA5_01_1236.d 8.15E4 3 3 40 51
R.GGNDEEGQEGPRAPATK.K Y 67.26 1711.7761 17 -4.0 571.5970 3 22.44 4 8703 VEV_1_3_RA4_01_1235.d 4.71E4 1 1 40 56
M.T(+56.06)EAVDSIHVQTK.T Y 36.98 1382.7405 12 -36.6 692.3522 2 67.06 4 36890 VEV_1_3_RA4_01_1235.d 1.3E5 3 3 2 13 Diethylation
K.T(-18.01)TDM(+15.99)NHTTAAAFDGSVGSPK.A Y 29.94 2004.8846 20 52.1 669.3370 3 61.11 5 32376 VEV_2_3_RA5_01_1236.d 1.79E5 1 1 14 33 Dehydration; Oxidation (M)
K.KPWLGVNQEK.G Y 22.64 1197.6506 10 -2.7 400.2231 3 45.06 6 21441 VEV_3_3_RA6_01_1237.d 9.08E4 3 3 381 390
K.GVSGVGTAK.R Y 16.45 774.4235 9 -35.4 388.2053 2 43.76 6 20671 VEV_3_3_RA6_01_1237.d 2.56E5 1 1 391 399
total 9 peptides
C1GA89
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SNRGDISLANTTSEQSSDWVDSK.Q Y 116.40 2496.1365 23 -12.9 833.0421 3 67.46 6 35984 VEV_3_3_RA6_01_1237.d 2.04E5 3 3 410 432
K.DGQPVSPFHDIPLYANEQQTILNMVVEIPR.W Y 91.51 3419.7183 30 -21.0 1140.8894 3 92.90 4 55244 VEV_1_3_RA4_01_1235.d 0 2 2 198 227
R.TWEDPNVVHPETK.A Y 83.57 1550.7365 13 -5.9 517.9164 3 59.19 4 30881 VEV_1_3_RA4_01_1235.d 4.14E5 4 4 275 287
K.VGQPQTLDFR.A Y 64.79 1159.5985 10 -9.5 580.8010 2 62.75 4 33588 VEV_1_3_RA4_01_1235.d 2.33E5 3 3 183 192
R.KVGQPQTLDFR.A Y 57.35 1287.6935 11 -17.0 430.2311 3 54.85 6 27114 VEV_3_3_RA6_01_1237.d 4.42E5 3 3 182 192
K.SPSEYTVRK.V Y 44.47 1065.5454 9 -9.1 533.7751 2 18.39 5 6855 VEV_2_3_RA5_01_1236.d 2.66E4 1 1 174 182
R.ATNEWFR.I Y 37.12 922.4297 7 18.0 462.2304 2 58.94 4 30687 VEV_1_3_RA4_01_1235.d 2.33E5 3 3 360 366
K.LNDIEDVER.H Y 35.38 1101.5302 9 16.2 551.7812 2 53.62 4 27201 VEV_1_3_RA4_01_1235.d 0 3 3 344 352
R.HSSPVNR.A Y 30.34 795.3987 7 -27.0 796.3845 1 111.87 6 58595 VEV_3_3_RA6_01_1237.d 3E4 1 1 141 147
K.LNDIEDVERHLPGLLR.A Y 27.52 1888.0166 16 -32.6 472.9960 4 79.32 6 44676 VEV_3_3_RA6_01_1237.d 5.76E4 1 1 344 359
K.SPSEYTVR.K Y 26.89 937.4505 8 -14.3 469.7258 2 27.84 6 11693 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 174 181
K.WFFISGAAV Y 26.55 996.5068 9 16.5 499.2689 2 49.07 5 24589 VEV_2_3_RA5_01_1236.d 1E5 2 2 454 462
K.LRYVR.N Y 19.94 705.4286 5 -17.2 353.7155 2 15.62 6 5273 VEV_3_3_RA6_01_1237.d 2.14E5 1 1 253 257
R.SC(+57.02)LVPPSSTK.L Y 19.68 1074.5380 10 1.3 359.1871 3 14.64 4 4610 VEV_1_3_RA4_01_1235.d 0 1 1 62 71 Carbamidomethylation
total 14 peptides
C1GHF6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSINLGSGLIAGLAAAVVSQPADTMLSK.I Y 105.04 2684.4419 28 -20.3 895.8031 3 94.61 5 54059 VEV_2_3_RA5_01_1236.d 3.6E5 3 3 228 255
K.ILKNEGIGAFYSGFGPILLK.Q Y 89.88 2136.1982 20 -10.9 713.0656 3 85.32 4 50805 VEV_1_3_RA4_01_1235.d 1.28E5 3 3 175 194
K.INKTEGLPGEGTVSR.L Y 81.19 1556.8158 15 -8.6 519.9414 3 48.32 4 23820 VEV_1_3_RA4_01_1235.d 4.1E5 5 5 256 270
K.SAPVLPQGPQLSGLNLYSR.F Y 77.96 1996.0741 19 -7.4 999.0369 2 81.26 4 47992 VEV_1_3_RA4_01_1235.d 1.05E5 2 2 16 34
R.VLNATQGVELK Y 73.25 1170.6608 11 -32.7 586.3185 2 61.11 4 32345 VEV_1_3_RA4_01_1235.d 7.74E4 4 4 311 321
K.QSIDYLGYETAAK.N Y 58.61 1457.7037 13 -3.5 729.8566 2 69.33 4 38696 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 115 127
M.A(+42.01)ATASAPQLDGLKK.S Y 54.51 1411.7671 14 -8.8 706.8846 2 64.57 5 34948 VEV_2_3_RA5_01_1236.d 6.36E5 3 3 2 15 Acetylation (Protein N-term)
R.LVSQPGFANGLIGGFGK.I Y 49.43 1660.8937 17 -18.9 831.4384 2 81.07 6 45909 VEV_3_3_RA6_01_1237.d 1.42E5 3 3 158 174
K.GSFSGIGAR.L Y 39.71 850.4297 9 -16.2 426.2152 2 40.77 6 18935 VEV_3_3_RA6_01_1237.d 0 1 1 282 290
K.TSINLGSGLIAGLAAAVVSQPADTMLSK(-.98).I Y 33.44 2683.4578 28 -13.2 1342.7185 2 94.68 4 56140 VEV_1_3_RA4_01_1235.d 0 1 1 228 255 Amidation
K.FVVFER.V Y 31.94 795.4279 6 -20.1 398.7132 2 64.78 6 33947 VEV_3_3_RA6_01_1237.d 6.72E4 1 1 203 208
M.A(+42.01)ATASAPQ(+.98)LDGLKK.S Y 31.11 1412.7511 14 -9.2 707.3763 2 66.41 4 36382 VEV_1_3_RA4_01_1235.d 1.08E4 1 1 2 15 Acetylation (Protein N-term); Deamidation (NQ)
K.INKT(-2.02)EGLPGEGTVSR.L Y 21.52 1554.8002 15 -30.9 519.2580 3 47.88 6 23073 VEV_3_3_RA6_01_1237.d 0 1 1 256 270 2-amino-3-oxo-butanoic_acid
R.FAFAGAVC(+57.02)C(+57.02)SVTHGLLTPVDVVK.T Y 21.06 2447.2341 23 -35.2 816.7233 3 83.86 5 48475 VEV_2_3_RA5_01_1236.d 0 1 1 35 57 Carbamidomethylation
K.QVPYTMAK.F Y 18.15 936.4739 8 0.4 469.2444 2 25.42 5 10724 VEV_2_3_RA5_01_1236.d 2.3E5 1 1 195 202
K.FGGYEFFKK.Q Y 17.52 1121.5546 9 -8.9 374.8555 3 68.03 4 37664 VEV_1_3_RA4_01_1235.d 4.16E4 1 1 106 114
R.VSEAIYGQLDK.E Y 15.87 1221.6240 11 4.2 408.2170 3 44.39 6 21056 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 209 219
total 17 peptides
C1G9X0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NATDVAQTELTPTHPIR.L Y 100.84 1862.9486 17 -15.0 621.9808 3 63.23 6 32807 VEV_3_3_RA6_01_1237.d 4.22E5 6 6 177 193
R.VC(+57.02)QDVLDVLDQSLIPK.A Y 86.59 1840.9604 16 -16.8 921.4720 2 87.92 6 50176 VEV_3_3_RA6_01_1237.d 3.74E5 2 2 119 134 Carbamidomethylation
K.VAATAAHEAYK.N Y 83.39 1130.5720 11 -14.2 566.2853 2 19.27 4 7042 VEV_1_3_RA4_01_1235.d 6.76E5 12 12 166 176
R.NLLSVAYK.N N 65.97 906.5175 8 -23.3 454.2555 2 66.68 6 35390 VEV_3_3_RA6_01_1237.d 3.03E5 2 2 66 73
K.AESGESKVFYHK.M Y 65.53 1380.6674 12 -14.8 691.3307 2 25.09 6 10246 VEV_3_3_RA6_01_1237.d 1.77E5 4 4 135 146
R.YLAEFASGNKRK.V Y 65.04 1382.7306 12 -11.6 692.3646 2 35.76 5 16629 VEV_2_3_RA5_01_1236.d 1.46E5 2 2 154 165
K.HVAIISEYR.Q Y 63.87 1086.5822 9 -21.0 363.1937 3 53.51 6 26361 VEV_3_3_RA6_01_1237.d 1.18E5 2 2 101 109
R.YLAEFASGNK.R Y 56.38 1098.5345 10 -14.2 550.2667 2 57.76 6 28868 VEV_3_3_RA6_01_1237.d 5.22E5 6 6 154 163
K.Q(-17.03)AFDDAIAELDSLSEESYR.D Y 54.49 2140.9436 19 8.1 1071.4878 2 94.82 6 53529 VEV_3_3_RA6_01_1237.d 0 1 1 220 238 Pyro-glu from Q
K.NAT(-2.02)DVAQTELTPTHPIR.L Y 52.80 1860.9330 17 -20.1 621.3058 3 63.35 6 32885 VEV_3_3_RA6_01_1237.d 0 1 1 177 193 2-amino-3-oxo-butanoic_acid
R.YLAEFASGNKR.K Y 49.58 1254.6356 11 -10.1 628.3187 2 47.28 4 23182 VEV_1_3_RA4_01_1235.d 1.71E5 4 4 154 164
K.EVANLGGELTVDER.N Y 30.95 1500.7419 14 -11.5 751.3696 2 69.74 5 38804 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 52 65
K.IETELER.V Y 27.32 888.4552 7 -48.7 445.2132 2 36.37 6 16432 VEV_3_3_RA6_01_1237.d 1.19E5 1 1 112 118
K.VFYHK.M N 22.35 692.3646 5 -26.9 693.3532 1 16.44 6 5687 VEV_3_3_RA6_01_1237.d 2.42E4 1 1 142 146
R.IISSIEQK.E Y 21.88 916.5229 8 -24.5 459.2575 2 37.21 6 16917 VEV_3_3_RA6_01_1237.d 5.07E4 2 2 85 92
K.EVANLGGE(+14.02)LTVDER.N Y 19.38 1514.7576 14 -10.6 758.3781 2 74.00 6 40819 VEV_3_3_RA6_01_1237.d 9.51E4 1 1 52 65 Methylation(others)
total 16 peptides
C1G4K3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.APLPHQVNSQANAGR.T Y 131.30 1558.7964 15 -11.0 520.6003 3 33.22 4 14744 VEV_1_3_RA4_01_1235.d 1.59E6 10 10 34 48
R.VLGTNPNPSQAPR.A Y 122.81 1349.7051 13 -11.9 675.8518 2 45.89 5 22703 VEV_2_3_RA5_01_1236.d 1.42E6 9 9 21 33
K.AYNPTEPFAHPGR.V Y 99.14 1455.6895 13 -11.6 728.8436 2 59.69 5 31322 VEV_2_3_RA5_01_1236.d 3.68E5 6 6 8 20
R.VLGTNPNPSQ(+.98)APR.A Y 76.63 1350.6891 13 -21.0 676.3376 2 49.47 4 24549 VEV_1_3_RA4_01_1235.d 3.38E5 6 6 21 33 Deamidation (NQ)
R.APLPHQVNSQ(+.98)ANAGR.T Y 76.01 1559.7804 15 -12.9 520.9274 3 37.05 5 17423 VEV_2_3_RA5_01_1236.d 2.83E5 2 2 34 48 Deamidation (NQ)
R.VLGTNPN(+.98)PSQAPR.A Y 59.44 1350.6891 13 -17.4 676.3401 2 50.21 5 25262 VEV_2_3_RA5_01_1236.d 6.32E4 2 2 21 33 Deamidation (NQ)
R.VLGTNPNPSQAPR(+14.02).A Y 54.23 1363.7208 13 -15.7 682.8570 2 55.22 6 27292 VEV_3_3_RA6_01_1237.d 7.17E4 2 2 21 33 Methylation(KR)
R.APLPHQ(+.98)VNSQANAGR.T Y 46.79 1559.7804 15 -7.3 780.8918 2 36.87 5 17278 VEV_2_3_RA5_01_1236.d 7.03E4 1 1 34 48 Deamidation (NQ)
R.TLGGSQGSSRGNDDPRNAAAR.A Y 41.15 2085.9900 21 -9.4 522.4999 4 28.07 5 12198 VEV_2_3_RA5_01_1236.d 3.57E5 3 3 49 69
K.QASAAK.K Y 18.26 574.3074 6 -63.6 575.2782 1 23.69 4 9385 VEV_1_3_RA4_01_1235.d 6.57E4 1 1 78 83
R.TLGGSQGSSR.G Y 17.96 948.4625 10 -18.3 475.2298 2 32.80 5 14882 VEV_2_3_RA5_01_1236.d 4.44E4 1 1 49 58
R.NETLG Y 17.22 532.2493 5 77.8 533.2980 1 71.64 5 40198 VEV_2_3_RA5_01_1236.d 8.26E4 1 1 100 104
R.NAAAR.A N 16.80 501.2659 5 -34.2 502.2560 1 58.49 6 29365 VEV_3_3_RA6_01_1237.d 0 1 1 65 69
total 13 peptides
C1G647
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KPEPAEHKGDAVSGGEGTSGGESR.K Y 100.19 2338.0784 24 -13.3 780.3564 3 17.81 5 6549 VEV_2_3_RA5_01_1236.d 3E5 6 6 118 141
K.AYTIENTSIPVNPR.T Y 93.51 1573.8099 14 -5.8 787.9077 2 70.19 4 39363 VEV_1_3_RA4_01_1235.d 1.69E5 3 3 63 76
R.LYIGNLAYATTEGELKDFFK.A Y 87.44 2292.1677 20 -13.5 765.0529 3 87.43 6 49900 VEV_3_3_RA6_01_1237.d 6.89E4 1 1 43 62
K.VAIDSPGKEDDASFEER.S Y 80.62 1863.8486 17 -9.5 622.2842 3 59.88 6 30365 VEV_3_3_RA6_01_1237.d 1.63E5 3 3 304 320
K.IALRPIPR.F Y 54.95 934.6075 8 16.0 312.5481 3 53.01 6 26105 VEV_3_3_RA6_01_1237.d 1.38E5 4 4 247 254
R.LYIGNLAYATTEGELKDFFKAYTIENTSIPVNPR.T Y 47.54 3847.9670 34 -9.9 962.9895 4 90.08 5 51924 VEV_2_3_RA5_01_1236.d 9.05E4 1 1 43 76
R.GFGFVTLGSEALQAK.A Y 43.65 1523.7983 15 12.2 508.9462 3 82.23 6 46699 VEV_3_3_RA6_01_1237.d 8.26E4 2 2 271 285
K.VMVANLPYDLSEEKLKELFAAYEPVSSK.I Y 40.50 3169.6255 28 -5.8 793.4091 4 88.38 4 52737 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 219 246
R.GPPEDGIPSKTK.V Y 40.14 1224.6350 12 -64.9 613.2850 2 26.86 5 11525 VEV_2_3_RA5_01_1236.d 0 2 2 207 218
K.ELFAAYEPVSSK.I Y 37.12 1339.6659 12 -10.0 447.5581 3 40.88 4 19214 VEV_1_3_RA4_01_1235.d 7.43E4 1 1 235 246
R.GPPEDGIPSK.T Y 36.54 995.4923 10 -9.7 498.7486 2 36.29 6 16395 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 207 216
R.LYIGN(+.98)LAYATTEGELKDFFK.A Y 35.00 2293.1519 20 -6.4 765.3864 3 87.59 5 50625 VEV_2_3_RA5_01_1236.d 0 1 1 43 62 Deamidation (NQ)
R.STSEPGANAPVAA Y 27.36 1170.5516 13 8.1 391.1943 3 15.45 5 5282 VEV_2_3_RA5_01_1236.d 6.36E4 1 1 321 333
R.LY(-2.02)IGNLAYATTEGELKDFFK.A Y 27.21 2290.1521 20 17.7 764.4048 3 87.64 4 52273 VEV_1_3_RA4_01_1235.d 2.1E2 2 2 43 62 2-amino-3-oxo-butanoic_acid
R.KPEPAEHK.G Y 18.89 934.4872 8 -27.9 468.2378 2 35.81 6 16127 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 118 125
R.GSGRGRGRGR.G Y 18.33 1014.5543 10 -37.1 508.2656 2 14.48 6 4682 VEV_3_3_RA6_01_1237.d 1.11E4 1 1 144 153
K.EIEGR.E N 17.39 602.3024 5 -11.7 603.3026 1 58.34 5 30339 VEV_2_3_RA5_01_1236.d 8.73E3 1 1 294 298
R.GGRSGR.G Y 16.41 588.3092 6 -9.3 589.3110 1 24.49 4 9846 VEV_1_3_RA4_01_1235.d 0 1 1 156 161
K.VSVQLAR.K Y 15.98 771.4603 7 -43.8 386.7205 2 41.51 4 19619 VEV_1_3_RA4_01_1235.d 2.42E5 2 2 111 117
total 19 peptides
C1GLM4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IVDSAFTIAFDPVYDNLLAAVKDATNTGIK.Q Y 104.54 3181.6545 30 -8.0 1061.5503 3 95.61 4 56579 VEV_1_3_RA4_01_1235.d 1.68E5 2 2 224 253
K.AIKPGQTLTEIAEGIEESVR.A Y 98.27 2140.1375 20 -12.1 714.3778 3 85.56 5 49488 VEV_2_3_RA5_01_1236.d 4.4E4 2 2 144 163
R.IVDSAFTIAFDPVYDNLLAAVK.D Y 89.47 2381.2517 22 -5.6 1191.6265 2 94.63 4 56122 VEV_1_3_RA4_01_1235.d 4.02E4 1 1 224 245
M.A(+42.01)AQVASGVGNLNLNSEDGAAAK.N Y 79.31 2098.0291 22 -3.6 1050.0181 2 78.54 5 45080 VEV_2_3_RA5_01_1236.d 1.72E5 3 3 2 23 Acetylation (Protein N-term)
R.ALTGYPGLEEGDNLR.G Y 66.89 1603.7842 15 -9.5 802.8918 2 72.28 4 41018 VEV_1_3_RA4_01_1235.d 1.93E5 4 4 164 178
K.IPDAPNVPLR.L Y 45.76 1090.6134 10 -41.9 546.2911 2 66.84 5 36658 VEV_2_3_RA5_01_1236.d 0 2 2 353 362
K.NLLNVITK.N Y 39.54 913.5596 8 -15.1 457.7802 2 71.75 6 39173 VEV_3_3_RA6_01_1237.d 1.49E5 2 2 368 375
K.SVPIVK.G Y 24.38 641.4112 6 -48.7 642.3872 1 30.37 6 13059 VEV_3_3_RA6_01_1237.d 0 1 1 310 315
K.EVISRGDDY Y 23.20 1052.4774 9 -2.8 527.2445 2 40.34 6 18745 VEV_3_3_RA6_01_1237.d 5.58E4 1 1 437 445
K.Q(+43.01)AGIDVR.M Y 21.46 800.4141 7 10.3 801.4296 1 90.25 5 52013 VEV_2_3_RA5_01_1236.d 0 1 1 254 260 Carbamylation
K.GGDQTK.M Y 21.18 604.2816 6 -3.6 605.2867 1 50.24 4 25025 VEV_1_3_RA4_01_1235.d 7.74E4 1 1 316 321
R.LGQDK.Y N 20.27 559.2966 5 -53.6 560.2739 1 49.63 5 24936 VEV_2_3_RA5_01_1236.d 0 1 1 390 394
R.HLDRMNNDFLAEYR.Y Y 17.73 1792.8314 14 25.6 449.2266 4 63.61 6 33086 VEV_3_3_RA6_01_1237.d 0 1 1 115 128
K.M(+15.99)VLQYEDVMK.V Y 16.97 1270.5938 10 -12.4 424.5333 3 25.19 6 10300 VEV_3_3_RA6_01_1237.d 0 1 1 204 213 Oxidation (M)
R.NLNGHTIGR.Y Y 16.63 980.5151 9 -32.5 491.2489 2 25.20 5 10602 VEV_2_3_RA5_01_1236.d 0 1 1 291 299
K.VQTEPPR.V Y 15.39 825.4344 7 -14.7 413.7184 2 50.00 6 24296 VEV_3_3_RA6_01_1237.d 0 1 1 74 80
total 16 peptides
C1GGZ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISNYNAVPVENVEK.L Y 106.85 1574.7939 14 -8.8 788.3973 2 63.95 4 34491 VEV_1_3_RA4_01_1235.d 1.68E5 3 3 421 434
R.RLEVGSLPGPTVLDYGAIAK.N Y 89.96 2055.1365 20 -2.2 686.0513 3 80.40 5 46312 VEV_2_3_RA5_01_1236.d 1.32E5 3 3 293 312
R.SPTANQILADTK.A Y 75.98 1257.6565 12 -13.6 629.8270 2 60.92 6 31107 VEV_3_3_RA6_01_1237.d 2.74E5 2 2 46 57
R.YLEDYANGRG Y 59.24 1156.5149 10 -7.3 579.2605 2 50.47 4 25163 VEV_1_3_RA4_01_1235.d 3.91E5 3 3 438 447
K.GSAPAFVYYC(+57.02)DNETVDGVEFPGFPAVLEAR.D Y 57.99 3276.5073 30 -5.0 1093.1709 3 91.25 4 54362 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 197 226 Carbamidomethylation
K.VGGQEEVANHK.A Y 50.80 1166.5680 11 -54.4 584.2595 2 14.17 4 4408 VEV_1_3_RA4_01_1235.d 1.16E5 2 2 344 354
K.AALLYGALDKYPQIYGIVPQR.N Y 50.62 2348.2891 21 -20.3 588.0676 4 83.62 5 48332 VEV_2_3_RA5_01_1236.d 4.17E4 1 1 355 375
R.FVNVAADAR.Q Y 49.53 961.4981 9 -9.8 481.7516 2 49.41 6 23985 VEV_3_3_RA6_01_1237.d 4.32E5 6 6 161 169
R.VSGGDAEKEKGFLAGAER.K Y 38.00 1819.9064 18 -32.0 455.9693 4 52.98 5 26973 VEV_2_3_RA5_01_1236.d 1.37E5 3 3 387 404
K.FGTIPDEKEWR.L Y 37.51 1376.6724 11 -5.4 459.8956 3 65.91 4 35992 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 176 186
R.YLEDYANGR(+.98)G Y 34.57 1157.4989 10 -9.2 579.7514 2 51.37 5 25995 VEV_2_3_RA5_01_1236.d 6.21E4 1 1 438 447 Deamidation (R)
K.GHRSVGGIR.I Y 26.70 937.5206 9 -17.3 313.5087 3 16.97 5 6095 VEV_2_3_RA5_01_1236.d 7.2E4 1 1 412 420
R.YLEDYAN(+.98)GRG Y 25.05 1157.4989 10 10.5 579.7628 2 51.43 6 25136 VEV_3_3_RA6_01_1237.d 0 1 1 438 447 Deamidation (NQ)
K.RRGIAAAAAAAAAAEGK.D Y 22.86 1524.8484 17 -23.4 382.2104 4 64.86 6 34012 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 100 116
R.REGGK.G N 22.42 545.2921 5 -14.2 546.2916 1 70.70 6 38376 VEV_3_3_RA6_01_1237.d 0 1 1 192 196
R.VSGGDAEK.E Y 21.52 761.3555 8 52.3 381.7050 2 48.33 5 24128 VEV_2_3_RA5_01_1236.d 1.06E5 2 2 387 394
K.FGTIPDEK.E Y 19.34 905.4494 8 -4.9 906.4522 1 93.68 5 53660 VEV_2_3_RA5_01_1236.d 0 1 1 176 183
R.QENGGKFGTIPDEK.E Y 17.05 1518.7314 14 9.7 760.3804 2 112.29 5 59464 VEV_2_3_RA5_01_1236.d 5.65E4 1 1 170 183
K.AM(+15.99)QEAK.R Y 17.04 692.3163 6 -9.4 693.3171 1 59.97 4 31472 VEV_1_3_RA4_01_1235.d 0 1 1 149 154 Oxidation (M)
R.S(+43.01)VGGIR.I Y 15.22 630.3449 6 -12.5 316.1758 2 49.50 5 24848 VEV_2_3_RA5_01_1236.d 2.33E5 1 1 415 420 Carbamylation
total 20 peptides
C1G1Y1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VQDYIEYLSSYQIDADPNTPIDPK.V Y 115.61 2783.3176 24 -5.1 1392.6589 2 85.44 5 49417 VEV_2_3_RA5_01_1236.d 1.99E5 3 3 103 126
R.ITAPDYIPNEADVLR.A Y 100.58 1685.8624 15 -15.2 843.9257 2 78.66 6 44210 VEV_3_3_RA6_01_1237.d 4.48E5 4 4 166 180
K.IIHQNGYSVEELTLC(+57.02)R.S Y 80.40 1930.9570 16 9.8 644.6660 3 70.84 4 39876 VEV_1_3_RA4_01_1235.d 0 1 1 58 73 Carbamidomethylation
M.G(+210.20)GC(+57.02)C(+57.02)SSASGENAEQR.K Y 53.30 1778.7927 15 -4.3 890.3998 2 97.94 5 55339 VEV_2_3_RA5_01_1236.d 1.7E4 1 1 2 16 Myristoylation; Carbamidomethylation
K.ILLLGSGESGK.S Y 52.90 1072.6128 11 -32.1 537.2964 2 66.56 6 35350 VEV_3_3_RA6_01_1237.d 5.13E4 1 1 39 49
K.YFPDYSGGNDVNR.A Y 46.46 1502.6426 13 -9.8 752.3212 2 63.65 6 33116 VEV_3_3_RA6_01_1237.d 9.22E4 2 2 290 302
K.DLIGALHHFDLQPSSPK.V Y 39.73 1873.9686 17 -18.3 469.4908 4 78.77 6 44278 VEV_3_3_RA6_01_1237.d 5.39E4 1 1 86 102
R.ITAPDYIPNEADVLR(+14.02).A Y 38.00 1699.8781 15 -10.4 850.9374 2 81.96 5 47322 VEV_2_3_RA5_01_1236.d 2.93E3 1 1 166 180 Methylation(KR)
K.TTGIYETR.F Y 36.76 939.4661 8 -16.4 470.7326 2 29.92 6 12827 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 185 192
R.SQMIDKGLEDDSKR.L Y 30.52 1620.7777 14 -10.2 541.2610 3 37.00 5 17358 VEV_2_3_RA5_01_1236.d 0 3 3 19 32
R.ITAPDYIPNEADVLRAR.T Y 24.40 1913.0006 17 -22.1 638.6600 3 76.31 6 42489 VEV_3_3_RA6_01_1237.d 5.88E4 1 1 166 182
R.TKTTGIYETR.F Y 20.90 1168.6088 10 -9.4 585.3062 2 23.17 6 9218 VEV_3_3_RA6_01_1237.d 7.43E4 2 2 183 192
R.AHLNLYPHLTQATDTSNIR.L Y 16.87 2164.1025 19 -21.8 542.0211 4 68.47 6 36736 VEV_3_3_RA6_01_1237.d 1.74E5 1 1 317 335
R.SPLNK.Y Y 16.05 557.3173 5 -53.4 558.2948 1 22.21 5 8922 VEV_2_3_RA5_01_1236.d 0 1 1 285 289
total 14 peptides
C1GCI8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VGTQELDPTQDWAYNFAELLGK.G Y 95.64 2494.2017 22 -7.9 832.4012 3 92.42 6 52508 VEV_3_3_RA6_01_1237.d 3.31E5 6 6 226 247
K.NSEIAPGVLAEHGK.T Y 93.82 1420.7310 14 -9.7 474.5797 3 54.16 5 27688 VEV_2_3_RA5_01_1236.d 1.3E6 7 7 386 399
K.SGQVVPGYGHGVLR.K Y 91.34 1424.7524 14 -16.0 475.9171 3 60.09 6 30497 VEV_3_3_RA6_01_1237.d 6.16E5 3 3 342 355
R.AIGPLAQLIWSR.A Y 83.27 1323.7662 12 -19.9 662.8772 2 85.43 6 48725 VEV_3_3_RA6_01_1237.d 1.87E5 2 2 435 446
K.ASYWEPTFDDSISLLAK.I Y 78.66 1941.9359 17 -6.6 971.9688 2 86.82 4 51770 VEV_1_3_RA4_01_1235.d 5.81E5 3 3 193 209
K.SVNLQGLLDLSRK Y 64.16 1441.8252 13 -17.8 481.6071 3 78.69 6 44231 VEV_3_3_RA6_01_1237.d 1.25E5 2 2 457 469
R.HILDLFK.S Y 49.46 884.5120 7 -21.5 443.2538 2 74.52 5 42260 VEV_2_3_RA5_01_1236.d 2.24E5 4 4 151 157
R.ALSSELAQK.S Y 48.95 945.5131 9 -8.2 473.7599 2 37.51 4 17225 VEV_1_3_RA4_01_1235.d 6.77E5 4 4 137 145
R.IAALVFRPDEIEK.V Y 39.99 1499.8347 13 -9.4 750.9176 2 74.54 4 42777 VEV_1_3_RA4_01_1235.d 1.46E4 1 1 213 225
R.GEDVIGEVTVASTIGGMR.G Y 22.43 1789.8879 18 -41.1 895.9144 2 78.05 6 43761 VEV_3_3_RA6_01_1237.d 1.61E4 1 1 57 74
R.ALGLPIERPK.S Y 18.15 1092.6655 10 -14.1 365.2240 3 62.93 5 33777 VEV_2_3_RA5_01_1236.d 1.99E5 2 2 447 456
K.RGEDVIGEVTVASTIGGMR.G Y 16.45 1945.9891 19 -18.3 649.6584 3 77.84 6 43616 VEV_3_3_RA6_01_1237.d 6.73E4 1 1 56 74
total 12 peptides
C1G5T0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.C(+57.02)VSAC(+57.02)DGGDSRC(+57.02)QSNC(+57.02)R.E Y 113.00 1987.7354 17 -6.6 663.5814 3 17.33 4 6038 VEV_1_3_RA4_01_1235.d 1.02E6 6 6 100 116 Carbamidomethylation
R.EKNPC(+57.02)GAQNPTR.V Y 108.66 1370.6361 12 -12.7 457.8802 3 13.38 5 4160 VEV_2_3_RA5_01_1236.d 1.04E6 7 7 117 128 Carbamidomethylation
R.C(+57.02)VSAC(+57.02)DGGDSR.C Y 89.61 1182.4393 11 3.4 592.2289 2 13.82 5 4424 VEV_2_3_RA5_01_1236.d 8.36E4 3 3 100 110 Carbamidomethylation
K.NPC(+57.02)GAQNPTR.V Y 82.61 1113.4985 10 -5.1 557.7537 2 14.65 4 4647 VEV_1_3_RA4_01_1235.d 2.48E5 3 3 119 128 Carbamidomethylation
R.C(+57.02)VSAC(+57.02)DGGDSRC(+57.02)QSNC(+57.02)REK.N Y 71.93 2244.8728 19 4.1 562.2278 4 14.78 4 4691 VEV_1_3_RA4_01_1235.d 1.45E5 5 5 100 118 Carbamidomethylation
R.C(+58.01)VSAC(+57.02)DGGDSR.C Y 64.42 1183.4233 11 -2.4 592.7175 2 17.78 6 6394 VEV_3_3_RA6_01_1237.d 5.76E5 8 8 100 110 Carboxymethyl; Carbamidomethylation
R.EKNPC(+57.02)GAQ(+.98)NPTR.V Y 52.92 1371.6201 12 -12.7 686.8086 2 15.24 5 5164 VEV_2_3_RA5_01_1236.d 1.36E4 1 1 117 128 Carbamidomethylation; Deamidation (NQ)
R.C(+57.02)VSAC(+57.02)DGGDSR(+14.02)C(+57.02)QSNC(+57.02)R.E Y 50.53 2001.7510 17 -3.9 668.2550 3 23.49 5 9638 VEV_2_3_RA5_01_1236.d 3.9E4 1 1 100 116 Carbamidomethylation; Methylation(KR)
R.C(+57.02)VSAC(+57.02)DGGDS(-18.01)RC(+57.02)Q(+.98)SNC(+57.02)R.E Y 37.59 1970.7087 17 -8.1 986.3536 2 40.80 5 19600 VEV_2_3_RA5_01_1236.d 5.69E5 2 2 100 116 Carbamidomethylation; Dehydration; Deamidation (NQ)
R.DIWC(+57.02)R.N Y 27.02 748.3326 5 -4.1 375.1721 2 50.45 5 25412 VEV_2_3_RA5_01_1236.d 1.36E6 8 8 33 37 Carbamidomethylation
R.C(+57.02)VSAC(+57.02)DGGDSRC(+57.02)QSNC(+57.02)REKNPC(+57.02)GAQNPTR.V Y 26.13 3340.3608 29 -10.7 669.0723 5 29.14 5 12767 VEV_2_3_RA5_01_1236.d 2.7E4 1 1 100 128 Carbamidomethylation
R.C(+57.02)VSAC(+57.02)D(+14.02)GGDSRC(+57.02)QSNC(+57.02)R.E Y 25.99 2001.7510 17 9.5 668.2639 3 22.10 5 8859 VEV_2_3_RA5_01_1236.d 0 1 1 100 116 Carbamidomethylation; Methylation(others)
R.C(+57.02)VS(-15.99)AC(+57.02)DGGDSRC(+57.02)QSNC(+57.02)R.E Y 22.58 1971.7404 17 0.5 658.2544 3 41.54 5 20047 VEV_2_3_RA5_01_1236.d 0 1 1 100 116 Carbamidomethylation; Deoxy
R.C(+57.02)VS(-18.01)AC(+57.02)DGGDSR.C Y 22.31 1164.4288 11 102.7 583.2815 2 45.69 6 21813 VEV_3_3_RA6_01_1237.d 3.93E4 1 1 100 110 Carbamidomethylation; Dehydration
R.NGAVR.G N 18.87 515.2816 5 -15.4 516.2809 1 37.80 4 17397 VEV_1_3_RA4_01_1235.d 0 3 3 166 170
total 15 peptides
C1GEV1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLPPATQVVVVSATLPYDVLDMTTK.F Y 111.94 2720.4346 25 -25.5 1361.1898 2 94.19 6 53275 VEV_3_3_RA6_01_1237.d 0 1 1 194 218
K.GRDTIAQAQSGTGK.T Y 85.12 1388.7008 14 -7.9 695.3522 2 18.68 4 6709 VEV_1_3_RA4_01_1235.d 6.57E4 6 6 62 75
K.MLVLDEADELLNR.G Y 66.43 1529.7759 13 -1.9 510.9316 3 85.07 4 50631 VEV_1_3_RA4_01_1235.d 1.53E5 2 2 170 182
R.GFREQIYDVYR.Y Y 66.16 1444.7098 11 -13.0 482.5710 3 68.61 4 38121 VEV_1_3_RA4_01_1235.d 8.68E4 1 1 183 193
R.KGVAINFVTSEDVR.I Y 62.35 1533.8151 14 -22.7 512.2673 3 67.97 4 37616 VEV_1_3_RA4_01_1235.d 1.45E5 3 3 361 374
K.LDHGQHVVSGTPGR.V Y 55.91 1458.7328 14 -11.4 487.2460 3 27.29 4 11351 VEV_1_3_RA4_01_1235.d 3.32E5 4 4 140 153
R.VLISTDVWAR.G Y 47.64 1158.6396 10 -26.7 580.3116 2 75.81 6 42135 VEV_3_3_RA6_01_1237.d 3.67E4 1 1 317 326
R.ENYIHR.I N 35.49 830.4035 6 -6.3 416.2064 2 18.27 4 6496 VEV_1_3_RA4_01_1235.d 4.42E5 2 2 346 351
R.KLDHGQHVVSGTPGR.V Y 32.89 1586.8278 15 -35.6 397.7001 4 65.46 5 35626 VEV_2_3_RA5_01_1236.d 0 1 1 139 153
R.AIVQIC(+57.02)K.G Y 25.00 830.4684 7 -45.5 416.2226 2 45.61 6 21758 VEV_3_3_RA6_01_1237.d 2.01E5 2 2 55 61 Carbamidomethylation
R.NIKM(+15.99)LVLDEADELLNR.G Y 22.00 1900.9928 16 -33.9 476.2394 4 40.55 5 19440 VEV_2_3_RA5_01_1236.d 5.18E5 1 1 167 182 Oxidation (M)
K.EVTVAPTFEDMHLK.E Y 21.32 1615.7915 14 -30.4 404.9429 4 36.96 5 17331 VEV_2_3_RA5_01_1236.d 8.11E4 1 1 20 33
R.GIDVQQVSLVINYD(-18.01)LPSNREN(+.98)YIHR.I Y 20.21 2924.4780 25 3.3 732.1292 4 80.72 5 46521 VEV_2_3_RA5_01_1236.d 1.16E5 1 1 327 351 Dehydration; Deamidation (NQ)
R.D(+27.99)ELTLEGLK.Q Y 19.38 1044.5338 9 10.7 349.1889 3 53.90 4 27374 VEV_1_3_RA4_01_1235.d 7.98E4 1 1 231 239 Formylation
R.ETQALVLSPTR.E Y 16.52 1213.6666 11 -63.0 607.8024 2 62.38 4 33280 VEV_1_3_RA4_01_1235.d 0 1 1 93 103
K.FGVGRQSFLQPIP Y 16.36 1444.7826 13 -32.1 362.1913 4 36.63 5 17147 VEV_2_3_RA5_01_1236.d 0 1 1 423 435
K.FM(+15.99)TDPVR.I Y 15.53 880.4113 7 45.3 441.2328 2 28.58 6 12091 VEV_3_3_RA6_01_1237.d 7.35E4 1 1 219 225 Oxidation (M)
total 17 peptides
C1GBN3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IIVSGLPSDVNEANIKEYFHK.S Y 107.43 2372.2375 21 -11.1 594.0601 4 78.34 4 45742 VEV_1_3_RA4_01_1235.d 6.43E5 3 3 70 90
R.VAQPKPQPKPVSATK.G Y 95.84 1574.9143 15 -15.5 525.9706 3 21.82 6 8509 VEV_3_3_RA6_01_1237.d 3.47E5 8 8 163 177
R.SSRPAHAAPVGGVR.K Y 85.56 1360.7323 14 -8.1 454.5810 3 20.25 4 7529 VEV_1_3_RA4_01_1235.d 3.11E5 4 4 31 44
R.GIAAITFVRPDTAAK.A Y 79.98 1529.8566 15 -3.5 765.9329 2 70.34 5 39239 VEV_2_3_RA5_01_1236.d 5.61E5 5 5 110 124
K.SIPTGPALGLGESK.I Y 73.96 1325.7190 14 -8.4 663.8612 2 69.49 5 38622 VEV_2_3_RA5_01_1236.d 3.76E4 3 3 56 69
M.A(+42.01)DKLDKSLDDILSSR.R Y 57.19 1716.8893 15 -8.7 573.2987 3 80.66 4 47528 VEV_1_3_RA4_01_1235.d 2.87E5 2 2 2 16 Acetylation (Protein N-term)
K.SLDDILSSR.R Y 37.26 1004.5138 9 -9.5 503.2594 2 70.79 5 39573 VEV_2_3_RA5_01_1236.d 3.02E5 2 2 8 16
K.LDKSLDDILSSR.R Y 28.82 1360.7197 12 -22.3 341.1796 4 13.33 5 4143 VEV_2_3_RA5_01_1236.d 0 1 1 5 16
K.VMLTYNQNGTSR.G Y 15.74 1382.6613 12 -25.6 692.3202 2 73.36 4 41872 VEV_1_3_RA4_01_1235.d 9.36E4 1 1 98 109
K.SAGPVKK(-.98).V Y 15.36 684.4282 7 16.9 685.4471 1 105.58 6 56924 VEV_3_3_RA6_01_1237.d 0 1 1 91 97 Amidation
total 10 peptides
C1G506
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TRNEAEDFLANREDTAAGGTSWER.I Y 139.02 2695.2222 24 -6.4 674.8085 4 69.53 6 37513 VEV_3_3_RA6_01_1237.d 1.09E5 2 2 182 205
K.LVDVSGKGSKGGASGSGKER.F Y 87.87 1874.9810 20 -12.3 469.7468 4 16.61 5 5888 VEV_2_3_RA5_01_1236.d 2.15E5 2 2 209 228
R.ALLGEDADQFATPNDQR.L Y 75.92 1859.8649 17 -13.3 930.9274 2 72.17 6 39490 VEV_3_3_RA6_01_1237.d 5.21E4 1 1 37 53
K.AQQDIDDYYESYNKRTDR.A Y 75.51 2279.0090 18 -11.4 570.7531 4 60.88 5 32200 VEV_2_3_RA5_01_1236.d 2.49E5 3 3 160 177
K.LVDVSGKGSK.G Y 36.65 988.5553 10 -55.0 495.2578 2 17.76 4 6232 VEV_1_3_RA4_01_1235.d 0 3 3 209 218
R.FRELLIELKKDEGAPGAAGV Y 31.54 2112.1577 20 2.4 529.0480 4 75.94 5 43269 VEV_2_3_RA5_01_1236.d 7.81E4 1 1 229 248
total 6 peptides
C1G9M3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GSTKNDTQLQTVHQNTISTLR.V Y 101.24 2341.1985 21 -6.5 586.3031 4 56.69 4 29088 VEV_1_3_RA4_01_1235.d 2.3E5 3 3 360 380
R.STITTLAWHPNSVLLAAGSTDSHAR.V Y 101.24 2605.3250 25 -7.3 652.3337 4 77.75 4 45348 VEV_1_3_RA4_01_1235.d 6.87E5 3 3 188 212
K.AQSGAGSAREESALNKFR.Q Y 81.40 1877.9343 18 -9.4 470.4865 4 47.17 4 23171 VEV_1_3_RA4_01_1235.d 7.91E5 4 4 337 354
K.TVTGVDIAPISGK.I Y 58.99 1256.6976 13 -8.7 629.3506 2 68.11 4 37719 VEV_1_3_RA4_01_1235.d 2.05E5 3 3 99 111
R.VYEEDGGKVR.K Y 44.64 1150.5618 10 -13.8 576.2802 2 18.79 4 6772 VEV_1_3_RA4_01_1235.d 7.98E4 2 2 381 390
K.FAVGSGAR.V Y 41.83 763.3976 8 -19.5 382.6987 2 28.82 6 12230 VEV_3_3_RA6_01_1237.d 5.93E5 4 4 156 163
R.VFSSFIK.G Y 40.60 826.4589 7 -15.7 414.2302 2 66.57 5 36444 VEV_2_3_RA5_01_1236.d 6.45E5 5 5 213 219
R.WSPSEQKFAVGSGAR.V Y 34.22 1605.7899 15 31.1 536.2872 3 61.25 5 32472 VEV_2_3_RA5_01_1236.d 0 1 1 149 163
K.YALSDELKGHDK.T Y 34.20 1374.6779 12 -4.3 459.2313 3 48.79 5 24414 VEV_2_3_RA5_01_1236.d 2.29E5 1 1 87 98
K.IVTC(+57.02)SQDRNAYVWER.T Y 33.33 1895.8948 15 -6.8 632.9679 3 63.31 4 34054 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 112 126 Carbamidomethylation
K.IVTC(+57.02)SQDR.N Y 25.93 977.4600 8 -10.6 489.7321 2 15.39 4 4986 VEV_1_3_RA4_01_1235.d 3.45E4 1 1 112 119 Carbamidomethylation
R.TATGWKPTLVLLR.I Y 25.47 1454.8610 13 8.2 485.9649 3 76.62 6 42727 VEV_3_3_RA6_01_1237.d 0 1 1 127 139
K.GSTK(-1.03)NDTQLQTVHQNTISTLR.V Y 22.23 2340.1670 21 -26.8 586.0333 4 56.54 6 28063 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 360 380 Lysine oxidation to aminoadipic semialdehyde
R.GSENGWQLVGSIDAK.A Y 20.91 1559.7579 15 22.4 520.9382 3 66.77 5 36601 VEV_2_3_RA5_01_1236.d 0 1 1 322 336
R.EESALNKFR.Q Y 20.73 1092.5563 9 -13.4 547.2781 2 40.07 4 18741 VEV_1_3_RA4_01_1235.d 4.2E4 1 1 346 354
K.FRQMDIK.G Y 19.21 936.4851 7 -12.9 469.2438 2 61.56 4 32648 VEV_1_3_RA4_01_1235.d 0 1 1 353 359
R.NAYVWER.T Y 17.77 936.4453 7 -8.5 469.2260 2 57.84 5 30008 VEV_2_3_RA5_01_1236.d 7.17E4 1 1 120 126
R.FRGSENGWQLVGSIDAK.A Y 16.18 1862.9275 17 4.0 932.4747 2 92.87 6 52700 VEV_3_3_RA6_01_1237.d 0 1 1 320 336
total 18 peptides
C1GA97
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HNLPPKTFGATVR.V Y 95.53 1436.7888 13 -13.7 360.1996 4 47.48 4 23336 VEV_1_3_RA4_01_1235.d 1.05E7 80 80 164 176
K.VTRTHGNSGVVR.A Y 90.63 1281.6902 12 -15.2 428.2308 3 12.06 5 3473 VEV_2_3_RA5_01_1236.d 1.48E5 4 4 148 159
R.THGNSGVVR.A Y 71.68 925.4730 9 -8.9 463.7397 2 10.17 4 2524 VEV_1_3_RA4_01_1235.d 2E5 5 5 151 159
R.VM(+15.99)LYPSSI Y 71.46 924.4626 8 -10.3 925.4604 1 76.79 5 43866 VEV_2_3_RA5_01_1236.d 2.3E5 3 3 177 184 Oxidation (M)
K.AANFYLGKK.V Y 63.89 1010.5549 9 -7.0 1011.5551 1 38.42 4 17757 VEV_1_3_RA4_01_1235.d 3.35E6 11 11 117 125
R.VMLYPSSI Y 55.78 908.4677 8 -11.5 455.2359 2 79.59 4 46706 VEV_1_3_RA4_01_1235.d 1.42E5 3 3 177 184
R.AQFRHNLPPKTFGATVR.V Y 55.29 1939.0540 17 -18.0 485.7621 4 58.22 5 30257 VEV_2_3_RA5_01_1236.d 0 1 1 160 176
K.AANFYLGK.K Y 52.49 882.4599 8 2.1 442.2382 2 56.35 4 28856 VEV_1_3_RA4_01_1235.d 1.01E6 7 7 117 124
K.VAFVYR.A Y 47.87 753.4174 6 -15.9 377.7100 2 55.26 5 28352 VEV_2_3_RA5_01_1236.d 4.2E6 12 12 126 131
K.REVQGSKIR.V Y 46.07 1071.6149 9 -19.9 358.2051 3 11.73 5 3312 VEV_2_3_RA5_01_1236.d 6.32E4 2 2 134 142
K.KVAFVYR.A Y 45.05 881.5123 7 -16.6 441.7561 2 42.36 6 19868 VEV_3_3_RA6_01_1237.d 1.79E6 7 7 125 131
K.TFGATVR.V Y 45.00 750.4024 7 -19.4 376.2012 2 31.61 6 13799 VEV_3_3_RA6_01_1237.d 3.22E6 9 9 170 176
R.HNLPPK(+43.99)TFGATVR.V Y 42.60 1480.7786 13 21.1 371.2097 4 47.34 4 23219 VEV_1_3_RA4_01_1235.d 0 1 1 164 176 Carboxylation (DKW)
R.HNLPPK(+14.02)T(-18.01)FGATVR.V Y 42.24 1432.7938 13 -35.3 359.1931 4 48.41 6 23387 VEV_3_3_RA6_01_1237.d 3.78E5 3 3 164 176 Methylation(KR); Dehydration
R.VIWGKVTR.T Y 36.69 957.5760 8 -18.9 320.1932 3 49.15 5 24636 VEV_2_3_RA5_01_1236.d 6.34E5 5 5 143 150
R.VIWGK.V Y 22.42 601.3588 5 -9.9 301.6837 2 38.61 4 17936 VEV_1_3_RA4_01_1235.d 1.09E6 2 2 143 147
R.THGNS(+14.02)GVVR.A Y 17.61 939.4886 9 -15.7 470.7442 2 13.52 6 4211 VEV_3_3_RA6_01_1237.d 7.87E4 1 1 151 159 Methylation(others)
K.A(+42.01)ANFYLGK.K Y 16.27 924.4705 8 23.2 463.2532 2 56.08 5 28812 VEV_2_3_RA5_01_1236.d 0 1 1 117 124 Acetylation (N-term)
R.HNLPPK.T Y 15.44 704.3969 6 -21.2 353.1983 2 10.45 6 2680 VEV_3_3_RA6_01_1237.d 0 1 1 164 169
total 19 peptides
C1G3P9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LHAEEFSNASPYVIMFGPDK.C Y 101.32 2251.0620 20 -0.3 751.3610 3 81.08 4 47895 VEV_1_3_RA4_01_1235.d 3.59E4 1 1 157 176
K.SVPEVAGGLGALVFTLALVIVGAIGLSSPAPAPAAAK.K Y 93.89 3383.9431 37 -1.1 1128.9871 3 98.46 4 57691 VEV_1_3_RA4_01_1235.d 2.36E5 3 3 491 527
K.AAEAVSTTADNVKGAATR.R Y 82.99 1731.8751 18 -27.4 866.9211 2 46.48 5 23015 VEV_2_3_RA5_01_1236.d 1.54E5 3 3 543 560
K.NAAAHHAISAK.F Y 69.01 1089.5679 11 -18.7 545.7810 2 10.91 6 2877 VEV_3_3_RA6_01_1237.d 7.75E4 2 2 107 117
K.EKAAEAVSTTADNVK.G Y 46.32 1532.7682 15 -17.9 511.9208 3 37.95 6 17315 VEV_3_3_RA6_01_1237.d 4.07E4 1 1 541 555
K.AAE(+14.02)AVSTTADNVK.G Y 44.56 1289.6462 13 -18.4 645.8185 2 41.41 6 19298 VEV_3_3_RA6_01_1237.d 1.9E5 3 3 543 555 Methylation(others)
R.EKINLFISIAR.K Y 40.02 1302.7659 11 -15.2 435.2560 3 76.63 5 43757 VEV_2_3_RA5_01_1236.d 1.4E4 1 1 472 482
K.EAPVQFVR.E Y 39.88 944.5079 8 -18.5 473.2525 2 58.34 6 29257 VEV_3_3_RA6_01_1237.d 3.87E5 3 3 464 471
K.NAAAHHAISAKFPK.K Y 39.47 1461.7841 14 -13.5 488.2621 3 32.44 5 14689 VEV_2_3_RA5_01_1236.d 6.35E4 1 1 107 120
K.AAEAVSTTADNVKGAATRR.S Y 38.21 1887.9762 19 -13.8 472.9948 4 44.59 6 21174 VEV_3_3_RA6_01_1237.d 7.32E4 1 1 543 561
K.HLKNPPAAR.V Y 35.50 1002.5723 9 -16.0 502.2854 2 12.40 6 3602 VEV_3_3_RA6_01_1237.d 2.99E4 4 4 201 209
K.TGEYEEKHLKNPPAAR.V Y 34.12 1838.9275 16 -14.5 460.7325 4 28.99 5 12694 VEV_2_3_RA5_01_1236.d 0 1 1 194 209
K.GAATR.R Y 20.18 474.2550 5 -23.0 475.2514 1 43.71 4 20966 VEV_1_3_RA4_01_1235.d 0 1 1 556 560
K.LQNGLNC(+57.02)GGAYMK.L Y 16.68 1424.6541 13 -8.6 713.3282 2 59.36 4 31011 VEV_1_3_RA4_01_1235.d 4.8E4 1 1 137 149 Carbamidomethylation
total 14 peptides
A0A0A0HU09
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNASDSC(+57.02)LPLSTER.T Y 109.21 1561.7406 14 -18.5 781.8632 2 66.39 4 36368 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 253 266 Carbamidomethylation
R.TLNNEPLEAPSTAQSK.T Y 91.89 1698.8424 16 -9.9 850.4200 2 58.20 6 29166 VEV_3_3_RA6_01_1237.d 8.05E4 2 2 203 218
R.FGGPAASAYATR.S Y 81.71 1167.5673 12 -19.3 584.7797 2 55.38 6 27375 VEV_3_3_RA6_01_1237.d 9.22E4 1 1 296 307
K.GTAAQILETQPIQSTASQNDR.A Y 60.73 2228.1033 21 -15.5 743.6968 3 70.14 6 37963 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 99 119
K.AFGLIIR.T Y 47.03 788.4908 7 -19.5 395.2450 2 73.65 6 40558 VEV_3_3_RA6_01_1237.d 7.78E4 2 2 196 202
R.AVISSAEAATC(+57.02)IGK.G Y 45.30 1376.6969 14 -16.6 689.3443 2 63.42 6 32939 VEV_3_3_RA6_01_1237.d 3.53E4 1 1 141 154 Carbamidomethylation
R.IREIQEASGAR.L Y 34.74 1228.6523 11 2.8 410.5592 3 28.68 6 12140 VEV_3_3_RA6_01_1237.d 7.53E5 1 1 242 252
R.EIQEASGAR.L Y 33.42 959.4672 9 -19.0 960.4562 1 87.91 5 50794 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 244 252
K.GGENVSQIR.R Y 27.56 958.4832 9 -15.2 480.2416 2 17.54 6 6271 VEV_3_3_RA6_01_1237.d 9.72E3 1 1 155 163
R.LSGAK.C N 19.71 474.2802 5 8.5 475.2915 1 110.97 5 59098 VEV_2_3_RA5_01_1236.d 0 1 1 165 169
K.TYPLR.L Y 18.81 648.3595 5 -20.0 325.1805 2 28.77 5 12548 VEV_2_3_RA5_01_1236.d 6.94E4 1 1 219 223
K.TYPLRLLIPHLLIGSIIGK.S Y 18.63 2116.3135 19 -11.7 530.0795 4 91.03 6 51846 VEV_3_3_RA6_01_1237.d 1.27E4 1 1 219 237
K.AGYAPEDIR.F Y 18.25 990.4770 9 12.2 496.2518 2 18.38 4 6563 VEV_1_3_RA4_01_1235.d 5.73E4 1 1 869 877
R.AVIS(-2.02)SAEAATC(+57.02)IGK.G Y 18.16 1374.6813 14 -13.2 688.3389 2 63.45 6 32962 VEV_3_3_RA6_01_1237.d 5.56E4 1 1 141 154 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
R.A(+42.01)GIIVAK.W Y 17.15 712.4483 7 -19.7 357.2244 2 32.69 6 14351 VEV_3_3_RA6_01_1237.d 0 1 1 929 935 Acetylation (N-term)
R.WLAGGDVLR.A Y 15.55 985.5345 9 -61.7 986.4810 1 103.87 4 59428 VEV_1_3_RA4_01_1235.d 0 1 1 920 928
R.SRKDGDGAPTR.K Y 15.31 1158.5741 11 10.2 580.3002 2 26.28 4 10814 VEV_1_3_RA4_01_1235.d 0 1 1 609 619
R.RLSGAKC(+57.02)TVSDYSR.G Y 15.20 1598.7834 14 -3.2 800.3964 2 78.17 5 44831 VEV_2_3_RA5_01_1236.d 4.74E4 1 1 164 177 Carbamidomethylation
total 18 peptides
C1G159
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TMLELLNQLDGFASDDRVK.V Y 105.37 2164.0835 19 -13.0 722.3591 3 87.69 6 50050 VEV_3_3_RA6_01_1237.d 3.86E5 3 3 331 349
R.AC(+57.02)AAQTNATFLK.L Y 99.54 1294.6339 12 -3.6 648.3219 2 55.58 4 28377 VEV_1_3_RA4_01_1235.d 3.38E5 7 7 261 272 Carbamidomethylation
K.LAGPQLVQMFIGDGAK.L Y 90.28 1643.8705 16 -10.4 822.9340 2 86.53 4 51582 VEV_1_3_RA4_01_1235.d 1.06E5 2 2 273 288
K.VLAATNRVDVLDPALLR.S Y 75.99 1835.0629 17 -8.4 612.6898 3 78.45 4 45829 VEV_1_3_RA4_01_1235.d 9.85E4 1 1 350 366
R.Q(-17.03)TIFLPLIGLVDHEK.L Y 61.19 1704.9451 15 -8.7 853.4724 2 94.33 4 56012 VEV_1_3_RA4_01_1235.d 9.12E4 2 2 152 166 Pyro-glu from Q
R.KMAVDDGVNWAELAR.S Y 54.21 1673.8195 15 -5.4 558.9441 3 75.18 4 43270 VEV_1_3_RA4_01_1235.d 6.39E4 1 1 394 408
K.AVC(+57.02)VEAGMIALR.K Y 36.48 1288.6631 12 -22.1 645.3246 2 75.56 4 43565 VEV_1_3_RA4_01_1235.d 2.48E5 1 1 420 431 Carbamidomethylation
R.KIEFPLPNEEAR.A Y 25.75 1441.7565 12 -13.3 481.5864 3 68.43 5 37857 VEV_2_3_RA5_01_1236.d 9.09E4 1 1 373 384
K.VLAATNR.V Y 15.81 743.4290 7 -16.1 372.7158 2 13.93 5 4457 VEV_2_3_RA5_01_1236.d 2.32E4 1 1 350 356
K.YTDVGGLDK.Q Y 15.02 966.4658 9 -1.8 484.2393 2 55.32 6 27338 VEV_3_3_RA6_01_1237.d 6.68E4 1 1 207 215
total 10 peptides
C1GBG1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLDPNDEGFEDYIGAFR.Q Y 94.25 1913.8431 17 -3.1 957.9259 2 84.47 5 48850 VEV_2_3_RA5_01_1236.d 9.21E4 3 3 484 500
K.DAERPPPESATDEVDSEGVPC(+57.02)VTLK.T Y 91.38 2697.2439 25 -15.5 900.0746 3 72.91 6 40026 VEV_3_3_RA6_01_1237.d 4.61E5 5 5 202 226 Carbamidomethylation
R.INDAKELEAAMVSK.G Y 88.64 1517.7759 14 -7.1 506.9290 3 66.17 4 36188 VEV_1_3_RA4_01_1235.d 1E5 1 1 470 483
K.AAVQVTQAADFSK.H Y 86.52 1334.6830 13 -8.1 668.3434 2 61.63 4 32721 VEV_1_3_RA4_01_1235.d 6.64E5 5 5 61 73
R.Q(-17.03)GC(+57.02)PPHAGGGLGLNR.I Y 85.67 1472.6942 15 -8.0 737.3485 2 59.92 4 31436 VEV_1_3_RA4_01_1235.d 5.78E4 1 1 501 515 Pyro-glu from Q; Carbamidomethylation
K.HLYGPIPDDADVVQITNIADLSEELFEKEVTVVAR.A Y 63.07 3894.9890 35 -10.5 974.7443 4 96.26 6 54082 VEV_3_3_RA6_01_1237.d 3.62E4 1 1 74 108
K.AYLAQSPQLYK.Q Y 52.52 1280.6764 11 -9.9 641.3391 2 65.13 6 34217 VEV_3_3_RA6_01_1237.d 1.36E5 3 3 293 303
K.EVTVVAR.A Y 32.37 772.4443 7 -10.8 387.2253 2 45.58 4 22121 VEV_1_3_RA4_01_1235.d 2.06E5 2 2 102 108
R.LATLFPRDPQR.L Y 23.91 1312.7251 11 -10.7 438.5776 3 63.46 4 34099 VEV_1_3_RA4_01_1235.d 1.24E5 2 2 528 538
K.EVTVVARADNARVQSAK.L Y 21.66 1812.9806 17 -7.1 605.3298 3 89.67 4 53476 VEV_1_3_RA4_01_1235.d 3.03E4 1 1 102 118
K.YMDGVALLK.E Y 21.62 1008.5314 9 -3.8 505.2711 2 72.60 4 41269 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 382 390
total 11 peptides
A0A0A0HX63
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HIFGYPGGAILPVFDAIFNSPHLDFVLPR.H Y 99.76 3208.6860 29 -8.2 803.1722 4 96.87 4 57104 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 86 114
R.TMITSGGLGTMGYGLPSAIGAK.V Y 95.03 2082.0488 22 -3.2 1042.0283 2 82.22 4 48688 VEV_1_3_RA4_01_1235.d 3.04E4 1 1 495 516
K.KPVLYVGQGILARPEGPQLLK.Q Y 87.07 2275.3416 21 -43.2 569.8181 4 77.22 6 43161 VEV_3_3_RA6_01_1237.d 0 1 1 280 300
R.TIITTGVGQHQMWAAQHFR.W Y 84.22 2181.0901 19 -8.1 546.2754 4 70.57 4 39661 VEV_1_3_RA4_01_1235.d 1.04E5 2 2 471 489
R.YLEANIGR.A Y 53.94 934.4872 8 -13.2 468.2447 2 51.55 5 26107 VEV_2_3_RA5_01_1236.d 4.21E5 6 6 263 270
R.FDDRVTGSIPK.F Y 36.99 1233.6353 11 -16.6 617.8146 2 59.13 5 30908 VEV_2_3_RA5_01_1236.d 2.56E5 2 2 356 366
K.EAFEIATGGRPGPVLVDLPK.D Y 36.01 2065.1206 20 -40.3 689.3531 3 79.47 6 44781 VEV_3_3_RA6_01_1237.d 0 1 1 209 228
K.LSEAMGVQAR.R Y 31.22 1060.5334 10 -5.3 531.2712 2 44.38 4 21437 VEV_1_3_RA4_01_1235.d 1.49E6 8 8 588 597
R.FPLSSYEK.Q Y 28.82 969.4807 8 -12.7 485.7415 2 61.14 6 31269 VEV_3_3_RA6_01_1237.d 7.04E4 1 1 437 444
R.AESAAWAHTK.R Y 22.02 1070.5145 10 10.1 536.2700 2 29.91 6 12822 VEV_3_3_RA6_01_1237.d 4.32E4 2 2 22 31
R.VTGSIPK.F Y 20.00 700.4119 7 -4.0 351.2119 2 20.70 5 8122 VEV_2_3_RA5_01_1236.d 1.66E5 1 1 360 366
K.LSEAM(+15.99)GVQAR.R Y 19.11 1076.5284 10 -29.3 539.2557 2 41.52 5 20032 VEV_2_3_RA5_01_1236.d 2.87E4 1 1 588 597 Oxidation (M)
K.SVAELPR.R Y 16.97 770.4286 7 -22.8 386.2128 2 19.67 6 7380 VEV_3_3_RA6_01_1237.d 3.09E4 1 1 199 205
K.VPVLPM(+15.99)VPTGK.G Y 16.53 1152.6576 11 -71.3 385.1991 3 49.65 6 24108 VEV_3_3_RA6_01_1237.d 0 1 1 629 639 Oxidation (M)
K.FAPQAK.A Y 16.03 660.3595 6 -52.2 331.1698 2 9.74 5 2411 VEV_2_3_RA5_01_1236.d 0 1 1 367 372
R.C(+57.02)TKPSEVEASLK.W Y 15.95 1347.6704 12 -26.2 674.8248 2 73.42 5 41469 VEV_2_3_RA5_01_1236.d 1.93E5 1 1 599 610 Carbamidomethylation
R.RC(+57.02)TKPSEVEASLK.W Y 15.91 1503.7715 13 4.7 502.2668 3 46.32 4 22586 VEV_1_3_RA4_01_1235.d 0 1 1 598 610 Carbamidomethylation
total 17 peptides
C1GB04
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NATEVAQTDLAPTHPIR.L Y 100.85 1832.9380 17 -20.5 611.9741 3 61.83 6 31766 VEV_3_3_RA6_01_1237.d 3E5 2 2 132 148
K.IC(+57.02)EDILDVLDKHLIASAETGESK.V Y 77.56 2555.2788 23 4.6 639.8299 4 83.81 4 49779 VEV_1_3_RA4_01_1235.d 1.78E5 2 2 74 96 Carbamidomethylation
K.DSADKSLEAYK.N Y 70.11 1225.5826 11 -9.7 613.7927 2 37.86 4 17429 VEV_1_3_RA4_01_1235.d 1.15E5 2 2 121 131
K.DEAPAATSEDAPK.A Y 69.49 1300.5782 13 -15.2 651.2865 2 30.85 4 13328 VEV_1_3_RA4_01_1235.d 5.58E4 2 2 229 241
R.NLLSVAYK.N N 65.97 906.5175 8 -23.3 454.2555 2 66.68 6 35390 VEV_3_3_RA6_01_1237.d 3.03E5 2 2 21 28
K.IVASADKELSVEER.N Y 65.50 1544.8046 14 -36.7 773.3812 2 55.86 6 27650 VEV_3_3_RA6_01_1237.d 0 4 4 7 20
R.YLAEFALGDK.R Y 58.49 1125.5706 10 -8.6 563.7877 2 73.83 4 42322 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 109 118
R.YLAEFALGDKRK.D Y 56.76 1409.7666 12 -12.6 353.4445 4 61.18 4 32372 VEV_1_3_RA4_01_1235.d 3.87E5 5 5 109 120
R.YLAEFALGDKR.K Y 35.83 1281.6716 11 -23.5 428.2211 3 67.08 6 35689 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 109 119
M(+15.99)VENM(+15.99)KIVASADK.E Y 22.90 1466.7109 13 -25.6 489.8984 3 41.60 4 19670 VEV_1_3_RA4_01_1235.d 0 2 2 1 13 Oxidation (M)
K.VFYHK.M N 22.35 692.3646 5 -26.9 693.3532 1 16.44 6 5687 VEV_3_3_RA6_01_1237.d 2.42E4 1 1 97 101
K.NAT(-2.02)EVAQTDLAPTHPIR.L Y 19.99 1830.9224 17 -19.9 611.3026 3 62.00 5 33039 VEV_2_3_RA5_01_1236.d 0 1 1 132 148 2-amino-3-oxo-butanoic_acid
R.IVTSIEQK.E Y 19.34 916.5229 8 -76.3 459.2338 2 36.75 6 16631 VEV_3_3_RA6_01_1237.d 0 1 1 40 47
K.RKDSADKSLEAYK.N Y 19.08 1509.7787 13 -17.4 504.2581 3 75.11 4 43217 VEV_1_3_RA4_01_1235.d 6.95E4 1 1 119 131
K.NVIGAR.R Y 17.69 628.3657 6 -31.8 315.1801 2 26.25 6 10862 VEV_3_3_RA6_01_1237.d 5.54E5 3 3 29 34
K.GNEAQVALIK.E Y 16.78 1041.5818 10 -42.8 348.1863 3 61.75 4 32802 VEV_1_3_RA4_01_1235.d 0 1 1 52 61
K.ELSVEER.N Y 15.04 860.4240 7 18.3 431.2271 2 55.69 4 28447 VEV_1_3_RA4_01_1235.d 0 1 1 14 20
MVENM(+15.99)KIVASADKELSVEER.N Y 15.02 2293.1294 20 4.1 765.3869 3 81.64 4 48273 VEV_1_3_RA4_01_1235.d 1.64E3 1 1 1 20 Oxidation (M)
total 18 peptides
C1G675
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FNDQC(+57.02)RPSEASSTYSITR.V Y 115.96 2117.9436 18 -0.1 706.9884 3 59.01 5 30826 VEV_2_3_RA5_01_1236.d 3.02E5 3 3 707 724 Carbamidomethylation
R.YSTTVSQTSTPNISR.F Y 87.10 1640.8005 15 -7.8 821.4012 2 58.04 4 30042 VEV_1_3_RA4_01_1235.d 3.53E5 4 4 692 706
R.TGRPDLSSNTR.H Y 50.45 1202.6003 11 16.7 602.3175 2 21.54 5 8564 VEV_2_3_RA5_01_1236.d 3.95E4 2 2 1253 1263
R.RVETHAPSSANKR.Q Y 48.47 1451.7593 13 -52.0 363.9282 4 11.06 5 2989 VEV_2_3_RA5_01_1236.d 1.34E5 2 2 437 449
R.LNTFLSSAR.S Y 39.85 1007.5400 9 -16.8 504.7688 2 62.35 5 33292 VEV_2_3_RA5_01_1236.d 1.77E5 2 2 499 507
R.LN(+.98)TFLSSAR.S Y 29.00 1008.5240 9 -8.7 505.2649 2 62.30 6 32118 VEV_3_3_RA6_01_1237.d 3.63E4 1 1 499 507 Deamidation (NQ)
K.LFDAETSSK.R Y 28.95 996.4764 9 -18.1 499.2365 2 40.70 5 19529 VEV_2_3_RA5_01_1236.d 1.41E5 3 3 941 949
R.TAAPSVEAGTDGK.Q Y 26.96 1202.5779 13 -16.0 602.2866 2 30.53 6 13158 VEV_3_3_RA6_01_1237.d 2.76E4 2 2 1061 1073
K.ELSDK.L N 26.61 590.2911 5 -27.8 591.2820 1 22.47 6 8862 VEV_3_3_RA6_01_1237.d 3.64E4 2 2 74 78
K.QVNEK.L Y 25.67 616.3180 5 -32.2 617.3054 1 42.31 4 20096 VEV_1_3_RA4_01_1235.d 7.71E3 1 1 287 291
R.M(+15.99)IQAITQTM(+15.99)IGEFLWK.Y Y 25.22 1940.9740 16 -0.6 389.2018 5 51.46 4 25800 VEV_1_3_RA4_01_1235.d 0 1 1 1233 1248 Oxidation (M)
K.NGVTPR.A Y 23.79 642.3449 6 5.1 322.1814 2 34.61 5 15948 VEV_2_3_RA5_01_1236.d 0 2 2 1185 1190
K.SVAIEAVR.V Y 22.32 843.4814 8 -15.7 422.7414 2 44.52 5 21837 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 1296 1303
K.M(+15.99)ELKRMLQEAR.D Y 21.88 1419.7327 11 -30.3 474.2372 3 61.41 6 31453 VEV_3_3_RA6_01_1237.d 0 1 1 420 430 Oxidation (M)
K.SSLYHAHRMIQNLK.N Y 21.01 1696.8832 14 0.3 425.2282 4 65.67 5 35797 VEV_2_3_RA5_01_1236.d 9.95E4 1 1 396 409
R.ALEAHLAETER.R Y 20.94 1238.6255 11 -5.9 413.8800 3 42.26 5 20475 VEV_2_3_RA5_01_1236.d 1.84E5 2 2 46 56
R.SKKPTGQSMTKPGDR.T Y 19.30 1616.8304 15 -10.0 405.2108 4 41.12 6 19135 VEV_3_3_RA6_01_1237.d 2.86E5 1 1 575 589
R.M(+15.99)LQEAR.D Y 19.02 762.3694 6 -9.1 763.3698 1 79.83 4 46892 VEV_1_3_RA4_01_1235.d 1.01E5 2 2 425 430 Oxidation (M)
R.RTAAPSVEAGTDGK.Q Y 18.76 1358.6790 14 -23.8 680.3306 2 34.29 6 15245 VEV_3_3_RA6_01_1237.d 0 1 1 1060 1073
R.RSRYDR.A Y 18.26 851.4362 6 -36.8 852.4121 1 46.69 6 22381 VEV_3_3_RA6_01_1237.d 1.26E4 1 1 1462 1467
R.TSVISGTLSSR.R Y 18.22 1106.5931 11 -26.2 554.2894 2 55.13 5 28250 VEV_2_3_RA5_01_1236.d 1.04E5 2 2 1451 1461
R.LLPSTLQK.D Y 17.85 898.5488 8 -60.9 450.2543 2 53.91 6 26600 VEV_3_3_RA6_01_1237.d 0 1 1 1093 1100
K.TIWDVPVTEK.Q Y 17.50 1186.6234 10 -32.1 594.2999 2 75.62 4 43617 VEV_1_3_RA4_01_1235.d 0 1 1 801 810
K.QAIAAASQRR.S Y 17.49 1070.5945 10 -0.1 536.3044 2 40.75 6 18919 VEV_3_3_RA6_01_1237.d 0 2 2 1136 1145
R.LTTNLNAATAENATAQR.K Y 17.38 1758.8860 17 -7.8 880.4434 2 62.47 4 33347 VEV_1_3_RA4_01_1235.d 6.99E5 3 3 264 280
K.ATPRHGHLESETLK.S Y 16.45 1574.8164 14 -0.5 394.7112 4 57.03 4 29322 VEV_1_3_RA4_01_1235.d 0 1 1 382 395
R.MSIASR.T N 16.32 663.3374 6 34.9 664.3678 1 85.59 6 48828 VEV_3_3_RA6_01_1237.d 0 1 1 1388 1393
K.NGVTPRAHTR.R Y 15.96 1107.5897 10 -26.9 370.1939 3 49.26 6 23872 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 1185 1194
K.RMLQEAR.D Y 15.68 902.4756 7 -6.7 452.2421 2 20.34 4 7571 VEV_1_3_RA4_01_1235.d 5.3E4 1 1 424 430
K.SLEIITPGR.I Y 15.61 984.5604 9 -103.2 985.4661 1 104.03 6 56511 VEV_3_3_RA6_01_1237.d 0 2 2 1319 1327
K.VDELTNQNQELAK.A Y 15.54 1500.7419 13 11.5 751.3869 2 76.34 4 44179 VEV_1_3_RA4_01_1235.d 4.39E4 1 1 328 340
R.ASPALSSGR.N Y 15.50 844.4402 9 -19.0 423.2194 2 28.23 4 11875 VEV_1_3_RA4_01_1235.d 0 1 1 1421 1429
R.RGSITSYPPLPPDHKQAIAAASQRR.S Y 15.18 2716.4521 25 23.1 544.3102 5 85.64 4 51006 VEV_1_3_RA4_01_1235.d 0 1 1 1121 1145
total 33 peptides
C1GKG2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLHDIPLAILVNNVGGTGGQIR.S Y 117.89 2257.2542 22 -13.7 753.4150 3 83.63 6 47610 VEV_3_3_RA6_01_1237.d 4.57E5 4 4 123 144
R.GSYALVTGSTEGTGTEFAR.E Y 105.87 1902.8959 19 -11.6 952.4442 2 71.12 6 38700 VEV_3_3_RA6_01_1237.d 3.02E5 3 3 49 67
K.Q(-17.03)IDVMSMVLASVQTAGNPLGR.G Y 62.22 2169.0923 21 -4.6 1085.5485 2 97.94 6 54651 VEV_3_3_RA6_01_1237.d 0 1 1 229 249 Pyro-glu from Q
R.GFFVPTPDKIAR.S Y 55.44 1346.7346 12 -18.5 449.9105 3 72.33 5 40711 VEV_2_3_RA5_01_1236.d 4.44E5 4 4 250 261
K.GLKAEADEQER.R Y 53.76 1244.5996 11 -12.1 415.8688 3 20.60 4 7714 VEV_1_3_RA4_01_1235.d 1.27E5 3 3 305 315
K.QIDVMSMVLASVQTAGNPLGR.G Y 53.62 2186.1187 21 -69.8 729.6626 3 93.74 4 55684 VEV_1_3_RA4_01_1235.d 0 1 1 229 249
K.QID(-18.01)VMSMVLASVQTAGNPLGR.G Y 39.65 2168.1082 21 -7.4 1085.0533 2 97.90 5 55325 VEV_2_3_RA5_01_1236.d 8.12E3 1 1 229 249 Dehydration
R.VIFAPR Y 34.99 701.4224 6 -16.0 351.7129 2 51.35 5 25980 VEV_2_3_RA5_01_1236.d 4E5 2 2 324 329
R.FMTQLTR.V Y 30.60 895.4586 7 -13.5 448.7305 2 57.06 5 29469 VEV_2_3_RA5_01_1236.d 4.63E4 1 1 168 174
K.Q(-17.03)IDVMSM(+15.99)VLASVQTAGNPLGR.G Y 29.21 2185.0872 21 0.0 729.3697 3 93.64 6 53039 VEV_3_3_RA6_01_1237.d 8.21E4 1 1 229 249 Pyro-glu from Q; Oxidation (M)
R.EFPLAK.F Y 26.06 703.3904 6 -22.4 352.6946 2 48.83 5 24442 VEV_2_3_RA5_01_1236.d 1.04E5 2 2 96 101
K.ATNPAR.V Y 18.56 628.3292 6 -17.8 629.3253 1 71.39 6 38905 VEV_3_3_RA6_01_1237.d 8.61E4 2 2 318 323
R.RLVVYNIK.G Y 16.85 1003.6178 8 -16.7 502.8078 2 55.97 5 28746 VEV_2_3_RA5_01_1236.d 1.95E4 1 1 297 304
R.NPEKLSHVEASLR.R Y 15.27 1478.7841 13 -16.8 493.9270 3 49.64 6 24094 VEV_3_3_RA6_01_1237.d 0 1 1 82 94
total 14 peptides
C1GMI8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSNEAATNFGC(+57.02)IVSDSHSK.R Y 132.27 2021.9113 19 -10.0 674.9709 3 64.83 6 33985 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 156 174 Carbamidomethylation
R.VSNEAATNFGC(+57.02)IVSDSHSKR.V Y 71.85 2178.0125 20 -13.4 545.5031 4 61.07 6 31211 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 156 175 Carbamidomethylation
K.AVILVGGPSR.G Y 69.55 967.5814 10 -14.3 484.7911 2 60.39 4 31842 VEV_1_3_RA4_01_1235.d 3.73E5 3 3 16 25
R.EYQALGTAGGLYHFR.D Y 65.60 1681.8212 15 -17.3 561.6046 3 72.50 4 41254 VEV_1_3_RA4_01_1235.d 4.48E4 2 2 97 111
K.LGPNVSIGAR.A Y 47.82 982.5560 10 -43.8 492.2637 2 60.53 6 30811 VEV_3_3_RA6_01_1237.d 0 2 2 325 334
K.LFEEKDAEAVILGTR.V Y 39.07 1689.8937 15 -17.3 564.2954 3 77.75 4 45286 VEV_1_3_RA4_01_1235.d 0 1 1 141 155
K.AVILVGGPSRGTR.F Y 20.11 1281.7517 13 -26.5 428.2465 3 50.42 5 25393 VEV_2_3_RA5_01_1236.d 4.69E4 1 1 16 28
R.VQNC(+57.02)VC(+57.02)LPYK.E Y 19.33 1279.6053 10 -7.9 640.8049 2 62.43 4 33322 VEV_1_3_RA4_01_1235.d 1.92E5 1 1 416 425 Carbamidomethylation
R.AVIGPGVR.I Y 17.94 767.4653 8 71.3 384.7673 2 39.31 4 18273 VEV_1_3_RA4_01_1235.d 3.88E6 2 2 335 342
K.VQSITILGKEC(+57.02)AVGDEVR.V Y 15.91 1973.0251 18 -12.0 494.2577 4 110.02 6 58102 VEV_3_3_RA6_01_1237.d 0 1 1 398 415 Carbamidomethylation
R.VGAWAR.V Y 15.45 658.3551 6 -14.4 330.1801 2 18.10 5 6707 VEV_2_3_RA5_01_1236.d 4.95E5 1 1 371 376
total 11 peptides
C1G5X0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AFVPNPFDTAPGSVMYR.T Y 82.62 1867.8927 17 -7.5 934.9467 2 83.07 5 48003 VEV_2_3_RA5_01_1236.d 5.05E4 2 2 372 388
R.VAVVTGASSGIGAAVAAALAR.E Y 77.62 1811.0265 21 -35.7 906.4882 2 84.45 6 48111 VEV_3_3_RA6_01_1237.d 0 1 1 1037 1057
R.GSGHIVAISSDAGR.K Y 77.03 1325.6687 14 -5.5 663.8380 2 41.12 4 19375 VEV_1_3_RA4_01_1235.d 2.96E5 3 3 1162 1175
R.GGDGAFTVDILR.S Y 75.43 1219.6196 12 -16.0 610.8073 2 77.80 6 43586 VEV_3_3_RA6_01_1237.d 1.39E5 2 2 950 961
K.YGEPSGAQILYPEDVANSIVYALR.Q Y 71.09 2624.3123 24 -0.9 875.7772 3 91.25 4 54403 VEV_1_3_RA4_01_1235.d 2.14E5 2 2 1234 1257
R.FNDPSGEDGPSGVAR.I Y 65.28 1503.6589 15 -10.2 752.8290 2 51.88 6 25402 VEV_3_3_RA6_01_1237.d 2.2E5 2 2 679 693
R.IVVLNNVETR.F Y 60.97 1155.6611 10 -11.5 578.8312 2 63.53 4 34156 VEV_1_3_RA4_01_1235.d 2.89E4 1 1 973 982
R.VTSVQPGNTATDLLEMSTDAEAVKK.Y Y 55.56 2604.2952 25 -3.3 869.1028 3 78.44 4 45822 VEV_1_3_RA4_01_1235.d 1.24E5 3 3 1209 1233
R.ADSTLEENLRPSGAK.I Y 51.45 1586.7899 15 -8.6 794.3954 2 51.78 4 26017 VEV_1_3_RA4_01_1235.d 5.22E4 1 1 624 638
R.AEMTPVDFVSR.A Y 47.22 1250.5964 11 -2.9 626.3036 2 72.68 4 41336 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 879 889
R.LLPSGLLEISGR.V Y 40.88 1253.7343 12 -14.0 627.8656 2 80.18 5 46171 VEV_2_3_RA5_01_1236.d 9.92E3 1 1 395 406
K.WVAEQLVLEAGRR.G Y 33.07 1525.8364 13 9.7 509.6244 3 75.92 4 43859 VEV_1_3_RA4_01_1235.d 0 1 1 819 831
R.GATVVAVPDDVSYDPAALVDLLSTKR.I Y 30.73 2671.4067 26 -12.3 891.4652 3 87.89 6 50211 VEV_3_3_RA6_01_1237.d 8.34E4 2 2 214 239
R.AIIHLSNQTHANR.V Y 25.89 1473.7800 13 -3.2 369.4511 4 36.48 4 16628 VEV_1_3_RA4_01_1235.d 1.96E5 1 1 890 902
R.VIFHLGDPNPVDAR.T Y 24.42 1548.8048 14 -11.9 517.2694 3 72.55 4 41233 VEV_1_3_RA4_01_1235.d 2.85E5 1 1 903 916
R.APVLSYNLR.F Y 22.69 1031.5763 9 -14.7 516.7878 2 66.53 4 36488 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 177 185
R.ITETLMTPTLLAAVLSR.H Y 20.75 1829.0332 17 -12.9 915.5121 2 90.73 6 51693 VEV_3_3_RA6_01_1237.d 8.28E3 1 1 240 256
K.VFPGLSVYSASK.F Y 17.33 1253.6655 12 -5.8 418.8933 3 72.45 4 41148 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 1177 1188
K.WVAEQLVLEAGR.R Y 17.27 1369.7354 12 7.3 457.5891 3 78.98 4 46229 VEV_1_3_RA4_01_1235.d 6.37E4 1 1 819 830
total 19 peptides
C1GMC5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQTTTQYSSALDC(+57.02)ATK.I Y 102.14 1786.8407 16 -11.4 894.4174 2 64.53 6 33759 VEV_3_3_RA6_01_1237.d 2.25E5 3 3 42 57 Carbamidomethylation
R.TIKDLTAGAAGGIAQVLLGQPFDIVK.V Y 99.46 2595.4636 26 -4.9 866.1576 3 91.57 6 52106 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 14 39
K.VATYGGLAGEALWLGSYPLDVVK.S Y 84.09 2378.2522 23 -4.4 1190.1282 2 91.31 4 54401 VEV_1_3_RA4_01_1235.d 1.71E5 3 3 216 238
R.LQTQPHGAQR.I Y 70.82 1134.5894 10 -3.0 379.2026 3 13.13 4 3866 VEV_1_3_RA4_01_1235.d 3.75E5 7 7 140 149
M.A(+42.01)SNEIESQGALR.T Y 62.17 1315.6367 12 -10.5 658.8187 2 64.95 6 34111 VEV_3_3_RA6_01_1237.d 4.12E5 3 3 2 13 Acetylation (Protein N-term)
R.IYNGPLDC(+57.02)IR.K Y 50.27 1219.6019 10 -6.3 610.8044 2 68.62 4 38134 VEV_1_3_RA4_01_1235.d 4.87E5 4 4 150 159 Carbamidomethylation
K.KTFAAEGLGGFWK.G Y 22.05 1410.7295 13 -3.6 706.3695 2 63.86 5 34432 VEV_2_3_RA5_01_1236.d 0 1 1 261 273
K.FSGMTDC(+57.02)FKK.T Y 18.25 1219.5365 10 -4.9 610.7725 2 53.15 5 27081 VEV_2_3_RA5_01_1236.d 2.92E4 1 1 252 261 Carbamidomethylation
R.FEELNAK.K Y 17.87 849.4232 7 -8.1 850.4236 1 88.10 5 50892 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 96 102
K.LSSHEGVLKGLYR.G Y 17.00 1457.7991 13 3.6 365.4583 4 38.78 4 17981 VEV_1_3_RA4_01_1235.d 3.48E5 1 1 161 173
K.GTLTPLIGIGAC(+57.02)VSVQFGAFHEAR.R Y 16.84 2500.2896 24 -51.9 626.0472 4 24.58 5 10239 VEV_2_3_RA5_01_1236.d 0 1 1 70 93 Carbamidomethylation
K.RNNIK(+28.03).R Y 15.99 671.4078 5 7.4 336.7137 2 48.07 4 23675 VEV_1_3_RA4_01_1235.d 5.17E5 1 1 203 207 Dimethylation(KR)
R.EAQAYGVWFLSFEYLMNWEAK.R Y 15.84 2581.1987 21 -30.8 646.2871 4 12.77 6 3796 VEV_3_3_RA6_01_1237.d 2.19E5 1 1 182 202
K.SKMQSDGIGAQQK.F Y 15.11 1376.6718 13 -1.9 459.8970 3 37.20 4 17044 VEV_1_3_RA4_01_1235.d 3.16E4 1 1 239 251
K.MQSDGIGAQQK.F Y 15.05 1161.5448 11 -21.8 388.1805 3 9.60 5 2352 VEV_2_3_RA5_01_1236.d 0 1 1 241 251
total 15 peptides
C1GG28
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTLADIFAASLSSR.G Y 90.49 1463.7983 14 -12.8 732.8971 2 91.20 4 54329 VEV_1_3_RA4_01_1235.d 3.16E5 4 4 154 167
R.GNDAAPAFDVAPDWESYTFTK.L Y 90.03 2301.0225 21 -11.6 1151.5051 2 84.76 6 48311 VEV_3_3_RA6_01_1237.d 7.15E4 2 2 349 369
K.APELEEEEPKPASKPK.H Y 76.86 1777.9097 16 -16.1 593.6343 3 37.14 5 17440 VEV_2_3_RA5_01_1236.d 1.92E5 3 3 232 247
K.LIEQSTVPEAEYAK.Y Y 75.15 1576.7983 14 -7.8 789.4003 2 63.88 5 34446 VEV_2_3_RA5_01_1236.d 3.4E4 1 1 31 44
K.HPLDSLSKPSLILDDWKR.K Y 57.92 2119.1426 18 -32.9 424.8218 5 76.19 6 42405 VEV_3_3_RA6_01_1237.d 0 1 1 248 265
K.IYGM(+15.99)ADNPR.T Y 54.98 1051.4757 9 -11.3 526.7392 2 29.18 6 12429 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 6 14 Oxidation (M)
R.GFEFVLSR.S Y 53.65 953.4970 8 -8.0 477.7520 2 76.51 4 44313 VEV_1_3_RA4_01_1235.d 1.06E5 1 1 168 175
K.IYGMADNPR.T Y 50.53 1035.4807 9 -10.4 518.7422 2 49.99 4 24876 VEV_1_3_RA4_01_1235.d 2.49E5 4 4 6 14
R.SWRLDNPAVTR.W Y 35.80 1313.6840 11 -13.3 438.8961 3 62.40 4 33290 VEV_1_3_RA4_01_1235.d 2.83E5 1 1 176 186
R.KFIFGAASVFGK.T Y 33.03 1270.7073 12 -1.8 424.5756 3 77.20 4 44855 VEV_1_3_RA4_01_1235.d 2.67E4 1 1 324 335
R.ALAVLEK.H Y 28.92 742.4589 7 -14.3 372.2314 2 48.46 4 23906 VEV_1_3_RA4_01_1235.d 8.14E4 2 2 135 141
R.DPYNKASVDASSK.A Y 24.19 1380.6521 13 12.1 346.1745 4 36.17 4 16436 VEV_1_3_RA4_01_1235.d 7.91E4 1 1 118 130
K.ASVDASSK.A Y 22.37 763.3712 8 23.5 764.3964 1 112.76 5 59591 VEV_2_3_RA5_01_1236.d 0 1 1 123 130
K.TGDSIIQGAFVIR.G Y 21.71 1375.7460 13 -8.1 459.5855 3 79.39 6 44727 VEV_3_3_RA6_01_1237.d 5.5E4 1 1 336 348
M(+15.99)SFGKIYGMADNPR.T Y 21.62 1601.7330 14 2.3 801.8757 2 76.50 4 44354 VEV_1_3_RA4_01_1235.d 8.92E4 1 1 1 14 Oxidation (M)
K.AIVPNPIFTEEGLK.N Y 20.22 1526.8344 14 -38.4 764.3951 2 80.09 6 45222 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 199 212
K.YNDELKM(+15.99)VFMSNNLIGGFFAR.L Y 18.69 2481.1821 21 55.5 497.2712 5 69.86 4 39105 VEV_1_3_RA4_01_1235.d 0 1 1 298 318 Oxidation (M)
K.MVFMSNNLIGGFFAR.L Y 17.93 1702.8323 15 -7.6 426.7121 4 53.24 5 27139 VEV_2_3_RA5_01_1236.d 0 1 1 304 318
K.TKQDYASILR.W Y 17.71 1193.6404 10 -14.9 398.8815 3 55.10 6 27230 VEV_3_3_RA6_01_1237.d 1.07E5 1 1 85 94
K.AIVPNPIFTEEGLK(+14.02)NVAPK.K Y 16.19 2050.1462 19 -33.5 684.3665 3 80.83 4 47666 VEV_1_3_RA4_01_1235.d 0 1 1 199 217 Methylation(KR)
K.LDASKPEDR.K Y 15.98 1029.5090 9 13.0 344.1814 3 31.02 4 13426 VEV_1_3_RA4_01_1235.d 0 1 1 370 378
K.FIENQWAQDVSTTVDGK.E Y 15.05 1936.9166 17 12.3 485.2424 4 64.27 5 34727 VEV_2_3_RA5_01_1236.d 0 1 1 380 396
total 22 peptides
C1G635
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ILDKMEADGFIQPVVPDKIFTFR.F Y 87.79 2678.4141 23 -0.3 670.6106 4 85.11 4 50657 VEV_1_3_RA4_01_1235.d 1.46E5 2 2 372 394
K.LIYYGGNYDVYHK.V Y 86.31 1603.7671 13 -13.5 535.5891 3 67.72 4 37417 VEV_1_3_RA4_01_1235.d 1.64E5 1 1 314 326
R.AALILTGLGFNK.S Y 85.73 1216.7179 12 -12.3 609.3588 2 81.22 4 48013 VEV_1_3_RA4_01_1235.d 2.13E5 4 4 219 230
R.YGLTGEAQTALMGTLSEGQKSR.I Y 66.31 2297.1321 22 -17.7 766.7044 3 77.90 4 45400 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 515 536
K.KFIASAGTYANLVR.Q Y 55.86 1509.8303 14 -18.9 504.2745 3 69.74 4 39012 VEV_1_3_RA4_01_1235.d 9.19E4 1 1 351 364
R.VTTGVLASLPASR.D Y 53.03 1270.7245 13 -9.1 636.3637 2 69.69 4 38974 VEV_1_3_RA4_01_1235.d 5.45E4 1 1 81 93
K.FGLSDRVTTGVLASLPASR.D Y 51.66 1946.0585 19 0.8 649.6940 3 79.97 4 46998 VEV_1_3_RA4_01_1235.d 4.26E4 1 1 75 93
R.YGLLGENGC(+57.02)GK.S Y 51.39 1166.5389 11 0.6 584.2771 2 57.77 4 29843 VEV_1_3_RA4_01_1235.d 2.18E5 3 3 123 133 Carbamidomethylation
R.TALVGPNGVGK.S Y 50.98 1011.5713 11 -10.8 506.7874 2 49.20 4 24373 VEV_1_3_RA4_01_1235.d 6.48E5 6 6 437 447
K.SQDYQYWR.Q Y 44.64 1144.4938 8 28.7 573.2706 2 60.04 4 31534 VEV_1_3_RA4_01_1235.d 0 1 1 502 509
K.LTSQVDKFGLSDRVTTGVLASLPASR.D Y 40.40 2717.4712 26 -23.1 680.3594 4 79.55 4 46676 VEV_1_3_RA4_01_1235.d 5.01E4 1 1 68 93
R.TALVGPN(+.98)GVGK.S Y 30.31 1012.5553 11 -13.7 507.2780 2 53.73 4 27269 VEV_1_3_RA4_01_1235.d 0 3 3 437 447 Deamidation (NQ)
R.RWDGSIGEYKAHLR.K Y 22.29 1686.8590 14 35.9 422.7372 4 60.30 5 31768 VEV_2_3_RA5_01_1236.d 0 1 1 605 618
K.INSVSLVFHGR.V Y 22.15 1227.6724 11 -12.9 410.2261 3 65.18 6 34262 VEV_3_3_RA6_01_1237.d 0 1 1 97 107
K.LTSQVDKFGLSDR.V Y 21.05 1464.7572 13 -10.9 489.2543 3 62.52 4 33382 VEV_1_3_RA4_01_1235.d 0 1 1 68 80
K.VRSDQEVNQMK.A Y 20.44 1332.6456 11 2.4 667.3317 2 33.17 5 15098 VEV_2_3_RA5_01_1236.d 0 1 1 327 337
R.DKYPEKSQDYQYWR.Q Y 18.67 1904.8693 14 -0.5 477.2244 4 58.72 4 30525 VEV_1_3_RA4_01_1235.d 9.63E4 1 1 496 509
R.RYGLLGENGC(+57.02)GK.S Y 15.74 1322.6401 12 -51.1 662.2935 2 29.67 4 12659 VEV_1_3_RA4_01_1235.d 2.72E4 1 1 122 133 Carbamidomethylation
R.RWDGSIGEYK.A Y 15.01 1209.5778 10 16.1 404.2064 3 56.26 4 28800 VEV_1_3_RA4_01_1235.d 0 1 1 605 614
total 19 peptides
C1G6I0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLLDAAGIAGLTC(+57.02)LR.L Y 91.38 1529.8235 15 -12.6 765.9094 2 85.75 6 48932 VEV_3_3_RA6_01_1237.d 3.42E5 5 5 131 145 Carbamidomethylation
R.GC(+57.02)AFSC(+57.02)AILSPVFR.V Y 88.38 1583.7588 14 -7.7 792.8806 2 82.83 4 49103 VEV_1_3_RA4_01_1235.d 2.61E5 3 3 350 363 Carbamidomethylation
K.VSEFFGKPLSFTLNQDEAVAR.G Y 82.54 2354.1907 21 -20.6 785.7213 3 80.84 6 45745 VEV_3_3_RA6_01_1237.d 1.58E5 2 2 329 349
R.KGDLPVSGGTAGLDAESKER.L Y 81.78 1986.0017 20 -9.1 497.5032 4 55.33 5 28356 VEV_2_3_RA5_01_1236.d 2.46E5 2 2 518 537
K.ILSANAAAPMSIESLMDDIDVR.T Y 71.07 2331.1450 22 -3.7 1166.5754 2 90.56 4 53965 VEV_1_3_RA4_01_1235.d 0 1 1 252 273
R.RSLLDAAGIAGLTC(+57.02)LR.L Y 43.37 1685.9247 16 12.3 562.9891 3 81.78 5 47205 VEV_2_3_RA5_01_1236.d 0 1 1 130 145 Carbamidomethylation
K.GITESSDGDFTTVK.L Y 41.03 1455.6729 14 -7.7 728.8381 2 61.44 4 32557 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 444 457
K.TQEISNLKNTVGTLR.R Y 39.07 1672.9108 15 -16.9 558.6348 3 65.33 6 34368 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 31 45
R.YGDIDRLPGKTNPWIGHFSVK.G Y 31.39 2399.2385 21 -4.3 480.8529 5 74.36 4 42635 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 423 443
K.ILTFYR.K Y 31.16 811.4592 6 -13.6 406.7314 2 66.37 5 36295 VEV_2_3_RA5_01_1236.d 7.86E4 1 1 408 413
R.KQPFDVEAR.Y Y 26.28 1088.5614 9 -12.0 545.2814 2 41.54 5 20041 VEV_2_3_RA5_01_1236.d 1.84E5 2 2 414 422
R.VRDFSVHDIVNYPIEFTWER.A Y 25.80 2521.2390 20 0.2 631.3171 4 83.80 5 48443 VEV_2_3_RA5_01_1236.d 0 1 1 364 383
K.ATTYDRHFGGR.N Y 22.58 1279.6057 11 -14.0 640.8011 2 24.13 6 9742 VEV_3_3_RA6_01_1237.d 3.76E4 1 1 200 210
K.FNIDIK.T Y 21.20 748.4119 6 -10.5 375.2093 2 64.55 4 34971 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 228 233
R.LINDSTAIALGWGITKFDLPTAEEKPR.R Y 20.90 2955.5706 27 -6.3 739.8953 4 84.34 5 48774 VEV_2_3_RA5_01_1236.d 0 1 1 146 172
K.G(+42.01)DLPVSGGT(+79.97)AGLDAESKER.L Y 16.30 1979.8837 19 85.3 496.0204 4 55.30 5 28340 VEV_2_3_RA5_01_1236.d 0 1 1 519 537 Acetylation (N-term); Phosphorylation (STY)
total 16 peptides
C1GLT7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.EAGITTRPVLLGPVSFLALAK.A Y 105.80 2152.2620 21 -8.4 718.4219 3 87.26 4 52040 VEV_1_3_RA4_01_1235.d 2.52E5 2 2 157 177
K.YGLHPVDEYFAMGR.G Y 76.74 1653.7609 14 -4.6 552.2584 3 77.01 4 44702 VEV_1_3_RA4_01_1235.d 6.42E4 1 1 86 99
R.GQTVDPISLIGKLVPLYVELLAR.L Y 68.23 2493.4570 23 -8.9 832.1522 3 97.68 5 55249 VEV_2_3_RA5_01_1236.d 2.55E4 2 2 181 203
K.AAFKPTYEMLGALGDKAPR.L Y 66.75 2035.0560 19 -8.8 509.7668 4 74.38 5 42152 VEV_2_3_RA5_01_1236.d 2.64E5 2 2 229 247
R.HIGPGVYDIHSPR.V Y 65.36 1446.7368 13 -7.0 362.6889 4 58.20 4 30151 VEV_1_3_RA4_01_1235.d 2.12E5 2 2 703 715
K.AVTEGPASVREEIEANSK.S Y 50.96 1885.9381 18 -11.1 629.6464 3 64.00 6 33382 VEV_3_3_RA6_01_1237.d 2.7E4 1 1 376 393
K.VFVDEAYPR.H Y 44.33 1094.5396 9 -4.8 548.2744 2 63.70 4 34343 VEV_1_3_RA4_01_1235.d 3.36E5 4 4 694 702
K.QILSAGVVDGR.N Y 37.60 1113.6141 11 -8.9 557.8094 2 63.17 4 33945 VEV_1_3_RA4_01_1235.d 6.62E4 1 1 295 305
R.NSPFPVR.I Y 34.60 815.4290 7 -12.4 408.7167 2 47.59 4 23379 VEV_1_3_RA4_01_1235.d 6.49E5 2 2 424 430
R.NPEQLDTVINALGPK.Q Y 32.67 1607.8518 15 -6.6 536.9543 3 80.24 4 47206 VEV_1_3_RA4_01_1235.d 3.12E4 1 1 280 294
K.LNLPLFPTTTIGSFPQTK.H Y 30.60 1974.0825 18 -11.3 988.0374 2 87.13 6 49732 VEV_3_3_RA6_01_1237.d 5.26E4 1 1 438 455
K.YAVSISK.K Y 26.64 766.4225 7 -13.3 384.2134 2 40.83 6 18968 VEV_3_3_RA6_01_1237.d 1.72E5 2 2 556 562
K.AGVDLIPSNDFAFYDQVLDHIQLFGAIPER.Y Y 22.78 3359.6826 30 -30.6 1120.8672 3 96.01 4 56756 VEV_1_3_RA4_01_1235.d 0 1 1 53 82
K.AALTNMVNAAK.F Y 19.64 1102.5804 11 -14.4 552.2896 2 60.74 4 32043 VEV_1_3_RA4_01_1235.d 9.53E4 1 1 756 766
total 14 peptides
C1GJB5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RPPTAQDTSYPR.L Y 113.46 1387.6843 12 -16.9 463.5609 3 29.43 5 12944 VEV_2_3_RA5_01_1236.d 7.07E5 9 9 98 109
R.SGGGGGGNTADQDLAR.N Y 100.44 1431.6338 16 -10.0 716.8170 2 24.95 6 10169 VEV_3_3_RA6_01_1237.d 3.62E5 6 6 400 415
M.A(+42.01)NNVSGYNASHDEPIGR.S Y 65.97 1841.8292 17 -8.6 921.9140 2 61.75 4 32801 VEV_1_3_RA4_01_1235.d 1.67E5 3 3 2 18 Acetylation (Protein N-term)
R.NSSHNSLPAGAAPAAPGGAILKGNLGR.V Y 65.47 2497.3149 27 -19.2 625.3240 4 67.12 5 36861 VEV_2_3_RA5_01_1236.d 5.05E4 1 1 307 333
R.SGGGGGGNTADQDLAR(+14.02).N Y 56.73 1445.6494 16 -15.4 723.8209 2 33.71 6 14905 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 400 415 Methylation(KR)
K.WGLMDPGR.N Y 30.51 930.4382 8 1.2 931.4465 1 92.74 5 53232 VEV_2_3_RA5_01_1236.d 0 1 1 722 729
K.AGLKIPDC(+57.02)GGKTAS Y 30.14 1373.6973 14 -26.2 687.8379 2 48.20 5 24041 VEV_2_3_RA5_01_1236.d 0 1 1 733 746 Carbamidomethylation
K.AGLKIPDC(+57.02)GGK.T Y 26.02 1114.5804 11 -15.4 372.5284 3 44.54 5 21849 VEV_2_3_RA5_01_1236.d 1.44E5 1 1 733 743 Carbamidomethylation
K.GVIVGNEVLFR.G Y 24.98 1201.6819 11 -12.4 401.5629 3 66.73 6 35431 VEV_3_3_RA6_01_1237.d 4.95E4 1 1 540 550
K.WGLM(+15.99)DPGR.N Y 20.39 946.4330 8 31.1 474.2385 2 8.59 5 2024 VEV_2_3_RA5_01_1236.d 2.4E4 2 2 722 729 Oxidation (M)
R.TIPSLK.K Y 19.77 657.4061 6 -15.6 658.4031 1 36.97 6 16754 VEV_3_3_RA6_01_1237.d 3.99E5 1 1 560 565
R.SILSLGR.N Y 19.31 744.4493 7 -13.2 373.2271 2 64.72 4 35055 VEV_1_3_RA4_01_1235.d 1.49E5 2 2 300 306
R.TTVTATSGR.D Y 19.13 892.4614 9 -29.6 447.2248 2 17.58 5 6424 VEV_2_3_RA5_01_1236.d 6.14E4 2 2 113 121
K.SVFKGVIVGNEVLFR.G Y 19.12 1662.9457 15 -66.5 555.2856 3 79.72 6 44959 VEV_3_3_RA6_01_1237.d 6.53E4 1 1 536 550
K.LTNTVR.L Y 17.58 702.4025 6 -27.2 352.1989 2 22.26 4 8594 VEV_1_3_RA4_01_1235.d 1.75E5 1 1 474 479
K.IPDC(+57.02)GGKTAS Y 17.36 1004.4597 10 -12.1 503.2310 2 13.84 6 4359 VEV_3_3_RA6_01_1237.d 6.59E4 1 1 737 746 Carbamidomethylation
K.YIESVK.S Y 16.90 737.3959 6 -7.9 369.7023 2 28.18 5 12231 VEV_2_3_RA5_01_1236.d 3.21E5 1 1 567 572
total 17 peptides
C1GEX6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AWHAVC(+57.02)MADGILVPGGFGHR.G Y 103.87 2150.0303 20 -3.5 538.5129 4 78.87 4 46145 VEV_1_3_RA4_01_1235.d 4.43E4 1 1 344 363 Carbamidomethylation
K.TVQIVPHLTDAIQDWIER.V Y 87.99 2133.1218 18 -1.4 712.0469 3 86.95 4 51857 VEV_1_3_RA4_01_1235.d 2.16E5 2 2 110 127
K.MDLNLIPGR Y 84.51 1027.5485 9 -10.8 514.7759 2 76.00 4 43916 VEV_1_3_RA4_01_1235.d 1.12E5 2 2 557 565
R.SAGLSPDLIAC(+57.02)R.C Y 61.49 1258.6339 12 -9.2 630.3184 2 69.61 6 37573 VEV_3_3_RA6_01_1237.d 6.99E5 4 4 207 218 Carbamidomethylation
K.LYGGTPAIWER.H Y 54.81 1261.6455 11 -13.3 631.8217 2 72.82 5 41049 VEV_2_3_RA5_01_1236.d 1.97E5 5 5 455 465
K.AGLTFIGKDDKGER.M Y 48.75 1505.7837 14 -17.9 377.4465 4 48.98 6 23716 VEV_3_3_RA6_01_1237.d 2.3E5 2 2 483 496
R.YEVNPQMVETLEK.A Y 44.56 1578.7599 13 -21.0 790.3706 2 75.14 6 41641 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 470 482
K.RPTIFQPGTDWSR.L Y 44.17 1559.7844 13 -7.5 520.9315 3 69.08 4 38502 VEV_1_3_RA4_01_1235.d 1.48E5 1 1 439 451
MKYILVSGGVISGVGK.G Y 35.57 1606.9116 16 -11.6 536.6382 3 75.03 6 41566 VEV_3_3_RA6_01_1237.d 4.19E4 1 1 1 16
K.LYGGTPAIWERHR.H Y 32.66 1554.8055 13 8.0 311.9709 5 53.52 6 26369 VEV_3_3_RA6_01_1237.d 4.47E4 2 2 455 467
total 10 peptides
C1GI58
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLQSEYVDTSRKELAR.L Y 82.19 1956.9905 16 -8.0 490.2510 4 60.81 4 32095 VEV_1_3_RA4_01_1235.d 2.25E5 3 3 62 77
R.GC(+57.02)AVFHVPAR.N Y 80.05 1112.5549 10 0.2 557.2849 2 53.18 5 27097 VEV_2_3_RA5_01_1236.d 4.86E5 5 5 236 245 Carbamidomethylation
R.TTMPTSHGFEPK.I Y 75.23 1331.6179 12 -13.8 666.8071 2 45.56 5 22467 VEV_2_3_RA5_01_1236.d 1.05E5 3 3 252 263
R.AGKGEAYSELGISDISK.N Y 70.98 1723.8628 17 -7.0 575.6242 3 65.83 6 34749 VEV_3_3_RA6_01_1237.d 1.37E5 2 2 447 463
R.NLNHGSYGAFPR.A Y 69.58 1331.6371 12 -10.3 444.8817 3 52.74 4 26641 VEV_1_3_RA4_01_1235.d 8.18E5 6 6 28 39
R.VALFDIIVSNPGVR.F Y 69.57 1498.8507 14 -41.6 750.4015 2 85.59 4 51016 VEV_1_3_RA4_01_1235.d 0 1 1 170 183
K.NATTGVNTVLR.N Y 56.53 1144.6200 11 -15.3 573.3085 2 52.91 6 26001 VEV_3_3_RA6_01_1237.d 3.62E5 4 4 91 101
R.KFQDELESKPDLFIR.Y Y 56.11 1863.9730 15 -15.6 466.9933 4 73.01 6 40097 VEV_3_3_RA6_01_1237.d 2.06E5 2 2 47 61
R.LPLAVDDGSGR.H Y 50.79 1098.5669 11 -22.8 550.2782 2 59.75 6 30268 VEV_3_3_RA6_01_1237.d 2.12E4 1 1 364 374
R.YLQSEYVDTSRK.E Y 48.03 1487.7256 12 -9.8 744.8628 2 46.72 4 22827 VEV_1_3_RA4_01_1235.d 5.61E4 1 1 62 73
M.GFVEALEQTPFGHSMAK.H Y 43.00 1847.8876 17 0.3 616.9700 3 80.74 4 47593 VEV_1_3_RA4_01_1235.d 3.05E4 1 1 2 18
R.LLKVPVNEVVFTK.N Y 40.85 1484.8966 13 -9.3 495.9682 3 74.51 6 41186 VEV_3_3_RA6_01_1237.d 7.26E4 1 1 78 90
K.VADASKLR.Q Y 24.86 858.4923 8 -15.7 430.2467 2 16.41 5 5788 VEV_2_3_RA5_01_1236.d 1.22E4 1 1 348 355
R.NQPLIR.T Y 21.41 739.4341 6 -17.5 370.7179 2 26.63 5 11407 VEV_2_3_RA5_01_1236.d 1.19E5 1 1 246 251
R.TTM(+15.99)PTSHGFEPK.I Y 20.68 1347.6129 12 -2.5 450.2104 3 29.57 4 12606 VEV_1_3_RA4_01_1235.d 6.32E4 1 1 252 263 Oxidation (M)
K.VADASK.L Y 19.87 589.3071 6 -22.2 590.3013 1 49.96 6 24275 VEV_3_3_RA6_01_1237.d 0 1 1 348 353
total 16 peptides
C1GAA3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DAFSTFIPLSVESDAR.T Y 89.39 1753.8522 16 -8.2 877.9262 2 86.14 5 49818 VEV_2_3_RA5_01_1236.d 4.54E5 3 3 153 168
K.NFEYRDSDLALQQFSNFDDPVR.A Y 73.04 2675.2251 22 -12.1 892.7382 3 82.06 4 48573 VEV_1_3_RA4_01_1235.d 1.99E4 1 1 301 322
R.GLEIPFLLLPFRPNSDPSSAR.T Y 67.76 2325.2480 21 -10.0 776.0822 3 90.07 5 51915 VEV_2_3_RA5_01_1236.d 4.75E5 4 4 63 83
K.TSIGPDQHAR.I Y 66.16 1080.5312 10 -14.5 361.1791 3 17.48 5 6365 VEV_2_3_RA5_01_1236.d 8.78E5 6 6 580 589
K.VGEQDSQFAR.D Y 56.48 1135.5258 10 -9.9 568.7645 2 34.54 5 15906 VEV_2_3_RA5_01_1236.d 3.22E5 3 3 143 152
K.WANNYDKNAVR.A Y 54.90 1349.6476 11 6.0 450.8925 3 38.15 5 18020 VEV_2_3_RA5_01_1236.d 4.24E5 2 2 646 656
K.KTEKVEQPPVKPTGAETSAVAAAR.A Y 53.61 2464.3284 24 -11.7 617.0822 4 51.02 6 24885 VEV_3_3_RA6_01_1237.d 4.8E4 1 1 781 804
K.VEQPPVKPTGAETSAVAAAR.A Y 52.53 1978.0483 20 -25.2 660.3401 3 59.25 5 30995 VEV_2_3_RA5_01_1236.d 8.58E4 3 3 785 804
R.TAQVAQPSTLAPSKLPTAHR.L Y 51.01 2073.1331 20 -10.9 692.0441 3 60.38 5 31834 VEV_2_3_RA5_01_1236.d 3.98E4 1 1 811 830
R.IQAAAAALQR.K Y 49.55 1011.5825 10 -14.8 506.7910 2 45.65 6 21782 VEV_3_3_RA6_01_1237.d 3.16E5 3 3 590 599
R.AAYLGNNMAGTGAPAESLQISTNR.L Y 43.41 2406.1597 24 -4.0 803.0573 3 75.52 6 41929 VEV_3_3_RA6_01_1237.d 6.94E4 1 1 657 680
K.ISTIEEPYQR.A Y 35.15 1234.6194 10 -10.9 618.3102 2 57.32 6 28571 VEV_3_3_RA6_01_1237.d 2.05E5 4 4 561 570
R.C(+57.02)ISSTNQSNVSAAAQESAALR.D Y 34.52 2164.0178 21 -4.6 722.3432 3 64.78 5 35107 VEV_2_3_RA5_01_1236.d 6.34E4 1 1 334 354 Carbamidomethylation
K.GAAPEPEVGAYIAEKK.G Y 30.43 1628.8409 16 14.4 543.9621 3 62.66 5 33523 VEV_2_3_RA5_01_1236.d 0 2 2 524 539
R.IQAAAAALQRK.H Y 21.83 1139.6775 11 -38.3 380.8852 3 57.44 6 28651 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 590 600
R.TEVSPEEVQELLHGC(+57.02)TIELK.S Y 21.32 2310.1414 20 3.1 771.0568 3 82.49 5 47639 VEV_2_3_RA5_01_1236.d 4.99E4 1 1 41 60 Carbamidomethylation
K.GFFGFR.S Y 20.24 729.3598 6 -9.4 365.6837 2 75.06 6 41591 VEV_3_3_RA6_01_1237.d 2.61E4 1 1 540 545
R.SLSPDSIR.G Y 18.96 873.4556 8 -28.0 437.7228 2 44.85 6 21319 VEV_3_3_RA6_01_1237.d 0 1 1 238 245
R.AAEHR.N Y 16.85 582.2874 5 -17.9 583.2842 1 75.36 6 41802 VEV_3_3_RA6_01_1237.d 0 1 1 611 615
total 19 peptides
C1G7F7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALPNAPDGYNPTYVSC(+57.02)SDKRPTVR.S Y 137.26 2677.2917 24 -8.0 670.3248 4 65.06 5 35345 VEV_2_3_RA5_01_1236.d 1.18E6 5 5 36 59 Carbamidomethylation
K.FDAGSLPQSESC(+57.02)VR.G Y 80.87 1551.6987 14 -8.7 776.8499 2 64.63 4 34989 VEV_1_3_RA4_01_1235.d 6.93E4 1 1 324 337 Carbamidomethylation
R.SFDRTNTEVPEAC(+57.02)RK.C Y 65.86 1808.8475 15 -11.8 603.9493 3 38.68 6 17754 VEV_3_3_RA6_01_1237.d 6.62E5 3 3 570 584 Carbamidomethylation
R.SAAALSPNEK.S Y 42.00 986.5032 10 -11.3 494.2533 2 22.24 5 8939 VEV_2_3_RA5_01_1236.d 2.35E5 3 3 60 69
K.GSKPLNTMDYYQQINDAVQGKK.D Y 41.17 2497.2271 22 -14.9 833.4039 3 73.39 5 41450 VEV_2_3_RA5_01_1236.d 1.61E5 1 1 206 227
R.SAAALSPNEKSWLEER.R Y 23.23 1786.8849 16 -6.6 596.6317 3 66.92 6 35569 VEV_3_3_RA6_01_1237.d 5.38E4 1 1 60 75
K.GSKPLNTM(+15.99)DYYQQINDAVQGKK.D Y 22.15 2513.2219 22 16.7 629.3232 4 69.84 6 37736 VEV_3_3_RA6_01_1237.d 0 1 1 206 227 Oxidation (M)
K.TIAAMK.D Y 19.26 633.3520 6 -46.9 634.3296 1 67.28 5 36981 VEV_2_3_RA5_01_1236.d 0 1 1 79 84
R.DVAVR.A Y 15.17 558.3126 5 -63.6 559.2843 1 39.73 4 18540 VEV_1_3_RA4_01_1235.d 0 1 1 31 35
total 9 peptides
C1GCV9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAFPFVDC(+57.02)ETGDTSDVVQDMLR.G Y 111.54 2472.0938 22 -20.1 1237.0293 2 88.30 4 52687 VEV_1_3_RA4_01_1235.d 7.93E4 3 3 108 129 Carbamidomethylation
K.YGLLYHSSFIGR.A Y 71.43 1411.7249 12 -10.0 471.5775 3 73.18 4 41754 VEV_1_3_RA4_01_1235.d 5.05E5 3 3 355 366
K.VVHQADTVGNR.L Y 67.69 1194.6105 11 -10.0 598.3065 2 15.33 4 4956 VEV_1_3_RA4_01_1235.d 4.77E5 4 4 18 28
K.YPASTVQILGAEK.A Y 66.51 1375.7347 13 -10.0 688.8677 2 69.07 4 38510 VEV_1_3_RA4_01_1235.d 7.13E4 1 1 328 340
R.KSDSAAEVETPK.K Y 56.37 1260.6198 12 -10.2 631.3107 2 19.17 6 7138 VEV_3_3_RA6_01_1237.d 5.83E5 2 2 493 504
K.MVELTSFLPFENNK.Q Y 39.79 1667.8229 14 9.3 834.9265 2 86.65 4 51656 VEV_1_3_RA4_01_1235.d 2.46E4 1 1 45 58
M.A(+42.01)DYLLFEGPMGYSLFK.V Y 37.59 1891.9066 16 -4.7 946.9561 2 97.74 5 55277 VEV_2_3_RA5_01_1236.d 0 1 1 2 17 Acetylation (Protein N-term)
R.LEFYATGAAP(+31.99)TK.N Y 22.81 1299.6346 12 3.7 434.2204 3 11.22 4 2955 VEV_1_3_RA4_01_1235.d 5.96E3 1 1 412 423 Dihydroxy
R.SIIDAAK.H Y 22.65 716.4068 7 -34.3 717.3895 1 36.44 6 16463 VEV_3_3_RA6_01_1237.d 0 1 1 250 256
K.NEVAM(+15.99)K.N Y 21.55 706.3320 6 34.5 707.3636 1 80.95 4 47759 VEV_1_3_RA4_01_1235.d 5.45E4 3 3 424 429 Oxidation (M)
K.EVQENLK.D Y 20.36 858.4447 7 -31.4 859.4250 1 95.09 5 54263 VEV_2_3_RA5_01_1236.d 0 1 1 31 37
K.M(+15.99)VELTSFLPFENNK.Q Y 19.78 1683.8177 14 -23.2 562.2668 3 58.17 4 30128 VEV_1_3_RA4_01_1235.d 1.89E5 1 1 45 58 Oxidation (M)
K.ALAGSIK.A Y 19.33 658.4014 7 -29.9 659.3890 1 24.07 5 9950 VEV_2_3_RA5_01_1236.d 5.25E4 2 2 101 107
M(+15.99)ADYLLFEGPMGYSLFK.V Y 18.85 1996.9314 17 16.6 666.6621 3 81.44 6 46166 VEV_3_3_RA6_01_1237.d 0 1 1 1 17 Oxidation (M)
K.GNTPK.Y Y 18.85 515.2703 5 -14.0 516.2704 1 36.28 5 16944 VEV_2_3_RA5_01_1236.d 0 1 1 350 354
R.VVSLSTYRK.N Y 17.56 1051.6025 9 -30.7 351.5307 3 37.44 6 17020 VEV_3_3_RA6_01_1237.d 5.09E4 1 1 278 286
K.C(+57.02)SIASR.I Y 15.54 692.3276 6 -28.5 693.3151 1 22.30 5 8965 VEV_2_3_RA5_01_1236.d 0 1 1 383 388 Carbamidomethylation
K.VVLGVSDKALAGSIK.A Y 15.54 1455.8660 15 -16.5 486.2879 3 68.75 5 38091 VEV_2_3_RA5_01_1236.d 1.41E4 1 1 93 107
total 18 peptides
C1GKF2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ADTEAWAAVHEGNTVDGPEMGAAETR.L Y 126.82 2684.1772 26 -12.4 895.7219 3 70.38 6 38134 VEV_3_3_RA6_01_1237.d 1.61E5 3 3 256 281
K.ADTEAWAAVHEGNTVDGPEM(+15.99)GAAETR.L Y 110.53 2700.1721 26 -15.3 901.0509 3 66.15 6 34998 VEV_3_3_RA6_01_1237.d 9.21E4 2 2 256 281 Oxidation (M)
K.ADTEAWAAVHEGNTVDGPEMGAAETRLDEAK Y 105.98 3240.4629 31 -3.8 1081.1575 3 73.72 5 41685 VEV_2_3_RA5_01_1236.d 3.35E4 1 1 256 286
R.ATQGFFVYPFLNPDSSGR.G Y 97.40 2001.9584 18 -13.3 1001.9731 2 86.33 6 49269 VEV_3_3_RA6_01_1237.d 3.97E5 3 3 195 212
R.SLM(+15.99)GVDPAHDK.F Y 38.47 1184.5496 11 -1.8 593.2810 2 30.34 6 13049 VEV_3_3_RA6_01_1237.d 3.03E4 1 1 6 16 Oxidation (M)
K.ADTEAWAAVHEGNTVDGPEM(+15.99)GAAETRLDEAK Y 37.69 3256.4578 31 -15.3 815.1093 4 69.11 6 37206 VEV_3_3_RA6_01_1237.d 5.1E4 1 1 256 286 Oxidation (M)
R.LDEAK N 15.89 574.2962 5 39.5 575.3262 1 30.61 5 13613 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 282 286
R.SLMGVDPAHDK.F Y 15.07 1168.5547 11 12.6 585.2920 2 67.91 6 36318 VEV_3_3_RA6_01_1237.d 0 1 1 6 16
total 8 peptides
C1G547
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NFVDGQVAEAEKMPFPEATPR.I Y 90.97 2332.1157 21 -7.1 778.3737 3 77.97 4 45519 VEV_1_3_RA4_01_1235.d 1.64E5 3 3 358 378
R.GPLVFEYVTYR.Y Y 71.26 1342.6921 11 -9.7 672.3468 2 80.34 6 45449 VEV_3_3_RA6_01_1237.d 2.22E5 3 3 292 302
K.SIIGELLGRR.E Y 66.37 1112.6665 10 -12.1 371.8916 3 78.26 4 45684 VEV_1_3_RA4_01_1235.d 1.4E5 3 3 147 156
R.STNDPIAGLKQK.L Y 55.72 1270.6881 12 -18.6 424.5621 3 42.97 5 20948 VEV_2_3_RA5_01_1236.d 3.27E5 3 3 326 337
R.GRTVDETFYY Y 55.36 1249.5615 10 -9.3 625.7822 2 67.60 5 37223 VEV_2_3_RA5_01_1236.d 4.41E4 1 1 396 405
R.ILFEDTYVR.G Y 53.05 1154.5972 9 -9.2 578.3005 2 74.23 4 42528 VEV_1_3_RA4_01_1235.d 2.3E5 1 1 379 387
R.NFVDGQVAEAEK.M Y 48.81 1305.6200 12 -9.5 653.8111 2 60.16 4 31604 VEV_1_3_RA4_01_1235.d 8.79E4 1 1 358 369
R.YGGHS(+79.97)MSDPGTTYR.T Y 48.65 1607.6075 14 -7.3 536.8726 3 49.09 4 24305 VEV_1_3_RA4_01_1235.d 6.72E4 1 1 303 316 Phosphorylation (STY)
R.SSALTDYYKR.G Y 43.94 1202.5931 10 -11.6 602.2969 2 48.06 6 23175 VEV_3_3_RA6_01_1237.d 1.14E6 7 7 250 259
K.LSDESFETYELDPPPYTLQTTKK.E Y 43.71 2701.3010 23 -8.8 901.4330 3 78.59 6 44142 VEV_3_3_RA6_01_1237.d 1.27E5 2 2 51 73
R.GSEPVWTR.G Y 43.23 930.4559 8 -9.6 466.2308 2 43.89 4 21068 VEV_1_3_RA4_01_1235.d 6.58E5 6 6 388 395
K.LLDWGVTSEEELKGIDKDAR.N Y 40.92 2273.1538 20 -30.6 758.7020 3 77.27 4 44915 VEV_1_3_RA4_01_1235.d 0 1 1 338 357
K.SIIGELLGR.R Y 38.53 956.5654 9 -11.3 479.2846 2 82.46 5 47623 VEV_2_3_RA5_01_1236.d 3.54E4 2 2 147 155
R.GQYIPGLK.I Y 29.95 874.4912 8 -12.1 438.2476 2 61.48 6 31507 VEV_3_3_RA6_01_1237.d 3.46E5 3 3 260 267
R.TREEIQR.M Y 29.27 930.4883 7 -14.5 466.2447 2 11.82 6 3310 VEV_3_3_RA6_01_1237.d 3.17E4 2 2 317 323
R.ARQLPPLGRKGFVPAVR.R Y 19.61 1861.1162 17 -11.4 373.2263 5 62.87 5 33693 VEV_2_3_RA5_01_1236.d 0 1 1 8 24
K.MPFPEATPR.I Y 17.85 1044.5062 9 -25.4 523.2471 2 13.13 5 4041 VEV_2_3_RA5_01_1236.d 1.25E5 2 2 370 378
R.RMEMAADRLYKEK.K Y 17.59 1639.8174 13 -21.7 547.6012 3 62.17 5 33172 VEV_2_3_RA5_01_1236.d 3.84E4 1 1 87 99
R.EGIAYGK.G Y 16.01 736.3755 7 -11.0 737.3746 1 102.20 6 55985 VEV_3_3_RA6_01_1237.d 0 1 1 157 163
total 19 peptides
C1GLJ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KVETPPVPQSATSDVGSSSALSTSR.Q Y 126.98 2487.2451 25 -10.9 830.0800 3 65.00 6 34113 VEV_3_3_RA6_01_1237.d 1.93E5 2 2 31 55
R.VIAPGLDPNTC(+57.02)SVVR.V Y 74.87 1596.8293 15 -10.2 799.4138 2 71.08 5 39795 VEV_2_3_RA5_01_1236.d 1.76E5 3 3 317 331 Carbamidomethylation
R.TVGR(+14.02)GQIPFDGSPSGIPR.K Y 72.08 1853.9747 18 -12.8 618.9910 3 68.85 4 38312 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 13 30 Methylation(KR)
R.GQIPFDGSPSGIPR.K Y 50.37 1426.7205 14 -7.6 714.3621 2 71.54 4 40432 VEV_1_3_RA4_01_1235.d 3.1E5 3 3 17 30
K.APSGR.V Y 28.95 486.2550 5 -19.6 487.2527 1 23.37 5 9543 VEV_2_3_RA5_01_1236.d 1.93E5 3 3 483 487
K.DLAFRVVGAGIR.A Y 25.22 1272.7302 12 -8.5 319.1871 4 35.97 5 16755 VEV_2_3_RA5_01_1236.d 1.17E4 2 2 143 154
R.EAAALM(+15.99)K.E Y 21.10 748.3789 7 -1.8 749.3848 1 82.75 5 47810 VEV_2_3_RA5_01_1236.d 5.98E4 1 1 283 289 Oxidation (M)
R.ARDVTIAEIMTKNPLC(+57.02)AR.T Y 21.04 2058.0713 18 -29.2 687.0110 3 85.12 4 50668 VEV_1_3_RA4_01_1235.d 0 1 1 155 172 Carbamidomethylation
R.VVGAGIR.A Y 18.69 670.4126 7 -21.7 336.2063 2 38.23 4 17655 VEV_1_3_RA4_01_1235.d 0 1 1 148 154
K.VDLYVHDPEK.Q Y 15.60 1213.5979 10 -6.6 607.8022 2 59.50 6 30089 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 568 577
R.DVTIAEIM(+15.99)TKNPLC(+57.02)ARTDTSATDALDLMVR.K Y 15.59 3336.6362 30 9.1 835.1740 4 83.66 5 48354 VEV_2_3_RA5_01_1236.d 2.11E5 1 1 157 186 Oxidation (M); Carbamidomethylation
R.THVER.E Y 15.48 640.3293 5 -28.4 641.3184 1 63.16 6 32755 VEV_3_3_RA6_01_1237.d 4.38E4 1 1 439 443
total 12 peptides
C1GA81
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAQGAFSNILTAILHR.L Y 123.45 1711.9369 16 -16.4 571.6436 3 86.82 6 49563 VEV_3_3_RA6_01_1237.d 5.97E5 5 5 397 412
R.LSVLPAETSASAK.A Y 70.37 1272.6925 13 -22.8 637.3390 2 63.07 4 33815 VEV_1_3_RA4_01_1235.d 1.37E5 2 2 413 425
R.IPTLAIHLER.Q Y 61.54 1161.6870 10 -12.9 388.2313 3 71.22 4 40177 VEV_1_3_RA4_01_1235.d 2.28E5 3 3 225 234
R.NGSTIIAFAIGQK.W Y 56.14 1318.7245 13 -21.7 440.5726 3 78.27 4 45689 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 131 143
R.LVALFDDEEIGSR.T Y 53.91 1462.7303 13 -9.9 732.3652 2 78.84 4 46124 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 384 396
R.LVDAGFKEVKER.D Y 35.57 1389.7616 12 -16.4 464.2535 3 46.92 5 23313 VEV_2_3_RA5_01_1236.d 1.1E5 2 2 102 113
K.LVHINRPILR.I Y 24.92 1229.7720 10 -9.2 308.4474 4 57.94 4 29972 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 215 224
R.VMVRNADESIEAK.L Y 19.57 1460.7292 13 -38.4 731.3439 2 79.60 6 44870 VEV_3_3_RA6_01_1237.d 5.8E4 1 1 202 214
R.LVDAGFKEVK.E Y 18.66 1104.6179 10 -13.7 369.2082 3 49.40 4 24504 VEV_1_3_RA4_01_1235.d 0 1 1 102 111
K.AC(+57.02)LGGLLDEFIFSAR.L Y 18.29 1667.8341 15 -4.1 834.9209 2 92.18 5 52974 VEV_2_3_RA5_01_1236.d 4.63E4 1 1 338 352 Carbamidomethylation
R.LDNLNMSFC(+57.02)AIM(+15.99)GLINSLAQPGALDK.E Y 17.68 2821.3813 26 -11.5 706.3445 4 74.56 5 42294 VEV_2_3_RA5_01_1236.d 6.16E4 1 1 353 378 Carbamidomethylation; Oxidation (M)
K.AKEYLEIR.S Y 16.31 1020.5604 8 -33.9 511.2701 2 45.74 5 22570 VEV_2_3_RA5_01_1236.d 0 1 1 266 273
total 12 peptides
C1G8E5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DLAPWFDGPSLLDFLHNMR.M Y 98.90 2243.0833 19 -12.0 748.6927 3 96.19 4 56828 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 503 521
K.TTGNTPDGPVER.H Y 75.01 1242.5840 12 -12.2 622.2917 2 26.70 6 11092 VEV_3_3_RA6_01_1237.d 6.13E5 7 7 369 380
R.LETIGGAGAVC(+57.02)VER.F Y 72.66 1430.7188 14 -11.0 716.3588 2 65.59 4 35742 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 687 700 Carbamidomethylation
K.MTATAEPPKAK.V Y 63.85 1143.5957 11 -16.1 572.7959 2 20.65 5 8101 VEV_2_3_RA5_01_1236.d 8.23E4 3 3 166 176
K.TIGVSAPVPK.D Y 59.10 967.5702 10 -15.0 484.7851 2 58.74 4 30537 VEV_1_3_RA4_01_1235.d 1.58E6 3 3 493 502
R.KINAPFMMPISAK.Y Y 46.65 1446.7727 13 -11.7 483.2592 3 73.93 4 42303 VEV_1_3_RA4_01_1235.d 4.74E4 1 1 526 538
R.HYTILDAPGHK.S Y 44.62 1250.6407 11 -6.6 626.3235 2 45.10 4 21832 VEV_1_3_RA4_01_1235.d 5.31E5 3 3 381 391
K.TTGNTPDGPVER(+14.02).H Y 38.63 1256.5997 12 16.5 629.3175 2 33.71 6 14907 VEV_3_3_RA6_01_1237.d 0 1 1 369 380 Methylation(KR)
K.M(+15.99)TATAEPPKAK.V Y 36.53 1159.5907 11 -37.9 580.7806 2 14.11 4 4347 VEV_1_3_RA4_01_1235.d 0 2 2 166 176 Oxidation (M)
R.KGEYETGFER.G Y 35.65 1214.5568 10 -8.6 608.2805 2 35.49 4 16032 VEV_1_3_RA4_01_1235.d 1.25E5 3 3 415 424
K.INAPFMMPISAK.Y Y 30.89 1318.6777 12 -19.4 660.3334 2 79.28 5 45580 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 527 538
K.TTGNTPD(+14.02)GPVER.H Y 26.56 1256.5997 12 -3.3 629.3051 2 33.82 4 15091 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 369 380 Methylation(others)
K.VLSIGGDAMK.S Y 26.20 989.5215 10 -12.8 495.7617 2 61.64 5 32770 VEV_2_3_RA5_01_1236.d 8.41E4 1 1 177 186
R.SSPARGGEAK.T Y 22.70 958.4832 10 -14.5 480.2419 2 18.60 5 6972 VEV_2_3_RA5_01_1236.d 0 1 1 253 262
R.FEDYNQLGR.F Y 20.43 1140.5199 9 -8.6 571.2623 2 58.38 6 29287 VEV_3_3_RA6_01_1237.d 2.14E5 3 3 701 709
K.SKKPPPFASK.G Y 19.16 1085.6233 10 -40.6 543.7969 2 15.15 5 5116 VEV_2_3_RA5_01_1236.d 0 1 1 670 679
R.DQGQTIAIGM(+15.99)ITK.L Y 17.97 1390.7126 13 -19.7 348.6786 4 32.69 4 14395 VEV_1_3_RA4_01_1235.d 0 1 1 714 726 Oxidation (M)
K.EQAADVDEATLKEIYGEK.R Y 17.51 2007.9636 18 -10.7 670.3213 3 47.63 5 23719 VEV_2_3_RA5_01_1236.d 1.61E5 1 1 274 291
K.QAPEASK(+14.02)PK(+43.99).M Y 15.80 1012.5189 9 -50.1 507.2413 2 22.05 6 8626 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 157 165 Methylation(KR); Carboxylation (DKW)
total 19 peptides
C1FZG1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RNPDNPVVFFDITLGGQELGR.I Y 135.39 2343.1970 21 -8.8 782.0661 3 86.07 5 49772 VEV_2_3_RA5_01_1236.d 1.01E6 9 9 7 27
R.TAENFRQFC(+57.02)TGEAK.N Y 86.29 1657.7518 14 -11.5 553.5848 3 53.74 5 27431 VEV_2_3_RA5_01_1236.d 6.16E5 5 5 40 53 Carbamidomethylation
R.DKPNQDVVIAQC(+57.02)GQI Y 53.52 1683.8250 15 34.1 842.9485 2 68.65 4 38182 VEV_1_3_RA4_01_1235.d 7.21E5 3 3 166 180 Carbamidomethylation
R.R(+14.02)NPD(-18.01)NPVVFFDITLGGQELGR.I Y 51.17 2339.2021 21 -11.8 780.7321 3 86.09 4 51299 VEV_1_3_RA4_01_1235.d 1.29E5 1 1 7 27 Methylation(KR); Dehydration
K.FADENFK.I Y 39.03 869.3919 7 14.4 435.7095 2 41.76 6 19511 VEV_3_3_RA6_01_1237.d 0 6 6 98 104
R.RIENTNTKR.D Y 37.30 1130.6156 9 -21.6 566.3029 2 9.32 6 2243 VEV_3_3_RA6_01_1237.d 7.24E3 1 1 157 165
R.RNPDNPVVFFDIT(-2.02)LGGQELGR.I Y 28.21 2341.1814 21 -10.7 781.3927 3 86.17 6 49173 VEV_3_3_RA6_01_1237.d 3.96E4 1 1 7 27 2-amino-3-oxo-butanoic_acid
R.TAENFR.Q N 22.68 736.3504 6 -11.0 369.1784 2 16.37 6 5651 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 40 45
R.IKMELFADVTPR.T Y 15.45 1418.7592 12 -0.1 355.6970 4 47.08 5 23424 VEV_2_3_RA5_01_1236.d 1.35E6 1 1 28 39
R.IKM(+15.99)ELFADVTPR.T Y 15.21 1434.7540 12 -11.9 479.2529 3 67.22 6 35791 VEV_3_3_RA6_01_1237.d 0 1 1 28 39 Oxidation (M)
R.GKSQGYK.G Y 15.01 766.3973 7 -14.7 384.2003 2 59.44 6 30040 VEV_3_3_RA6_01_1237.d 0 1 1 57 63
total 11 peptides
C1G9D6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VSPKDQGELTGMLQDLGYTKDQVYKF Y 89.79 2959.4636 26 -8.1 740.8672 4 82.98 4 49206 VEV_1_3_RA4_01_1235.d 3.43E5 4 4 298 323
K.LRFEFEDPESVSGVHVSSAVLTK.Y Y 88.24 2532.2859 23 -7.3 634.0742 4 78.59 4 45933 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 92 114
R.AFYTLDKPPKDWPQGTGFITK.E Y 80.06 2409.2368 21 -16.8 603.3063 4 77.59 4 45161 VEV_1_3_RA4_01_1235.d 3E5 1 1 244 264
K.YKGPKDEKPTIRPYTPISDEDQPGYLELLVK.K Y 62.89 3588.8713 31 -28.3 718.7612 5 77.30 5 44236 VEV_2_3_RA5_01_1236.d 0 1 1 115 145
K.VTLVFGNVTEDDILLKK.E Y 55.87 1903.0665 17 -13.8 635.3540 3 81.58 4 48227 VEV_1_3_RA4_01_1235.d 3.41E4 1 1 213 229
K.DQGELTGMLQDLGYTKDQVYKF Y 55.40 2548.2156 22 -3.4 850.4095 3 86.86 4 51791 VEV_1_3_RA4_01_1235.d 2E5 3 3 302 323
K.TENIKIFVC(+57.02)GPPGMYK.A Y 55.13 1852.9215 16 -12.4 618.6401 3 75.70 5 43099 VEV_2_3_RA5_01_1236.d 4.67E4 1 1 276 291 Carbamidomethylation
K.ELEKLENTYPR.R Y 40.00 1390.7092 11 -25.9 464.5650 3 56.58 6 28092 VEV_3_3_RA6_01_1237.d 5.53E5 2 2 230 240
R.NAVLKGGDQGWVGLR.L Y 32.05 1568.8423 15 -3.5 523.9529 3 67.89 4 37551 VEV_1_3_RA4_01_1235.d 0 1 1 64 78
K.IFVC(+57.02)GPPGMYK.A Y 29.58 1267.6093 11 -0.4 634.8116 2 71.35 5 39990 VEV_2_3_RA5_01_1236.d 4.95E4 1 1 281 291 Carbamidomethylation
K.VTLVFGNVTEDDILLKKELEKLENTYPR.R Y 26.51 3275.7651 28 -0.9 656.1597 5 87.06 5 50342 VEV_2_3_RA5_01_1236.d 9.25E4 2 2 213 240
K.TVLPEPK.T Y 23.27 782.4538 7 -19.0 392.2267 2 41.80 6 19540 VEV_3_3_RA6_01_1237.d 2.27E5 2 2 269 275
total 12 peptides
C1G606
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)QIKGDLC(+57.02)TFEIC(+57.02)SIEK.S Y 105.79 2050.9702 17 -7.8 1026.4844 2 80.31 5 46266 VEV_2_3_RA5_01_1236.d 3.49E5 3 3 13 29 Pyro-glu from Q; Carbamidomethylation
K.ETPDVIDEEGK.T Y 88.01 1230.5615 11 -10.2 616.2817 2 50.20 4 24997 VEV_1_3_RA4_01_1235.d 6.09E5 6 6 295 305
K.ETPDVIDEEGKTISR Y 76.69 1687.8264 15 -10.4 563.6102 3 61.33 5 32548 VEV_2_3_RA5_01_1236.d 6E4 1 1 295 309
R.IFIPC(+57.02)DILALALQGTGGGLASTAETGSNQADVGK.N Y 73.61 3344.6921 34 -33.6 1115.8672 3 94.89 5 54172 VEV_2_3_RA5_01_1236.d 0 1 1 143 176 Carbamidomethylation
K.GDLC(+57.02)TFEIC(+57.02)SIEK.S Y 71.30 1570.7007 13 -4.4 786.3541 2 77.18 5 44153 VEV_2_3_RA5_01_1236.d 1.43E5 3 3 17 29 Carbamidomethylation
R.C(+57.02)FKETPDVIDEEGK.T Y 39.48 1665.7555 14 17.9 556.2690 3 60.28 6 30654 VEV_3_3_RA6_01_1237.d 1.53E5 1 1 292 305 Carbamidomethylation
R.IVTTFGTSNSR.I Y 35.47 1181.6040 11 -15.6 591.8000 2 48.85 6 23641 VEV_3_3_RA6_01_1237.d 6.84E4 1 1 124 134
total 7 peptides
C1GJJ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FRIDNTSPPSASSGILALFSLK.G Y 115.08 2320.2427 22 -13.5 774.4111 3 87.95 6 50203 VEV_3_3_RA6_01_1237.d 8.43E4 1 1 10 31
K.VVTTDIDGVFYSAR.A Y 85.03 1541.7726 14 -13.6 771.8831 2 76.99 6 42994 VEV_3_3_RA6_01_1237.d 1.61E5 3 3 139 152
K.FRIDNTSPPSASSGILALFSLKGK.T Y 62.79 2505.3591 24 -21.4 627.3337 4 83.74 6 47662 VEV_3_3_RA6_01_1237.d 5.59E4 1 1 10 33
R.AAEIENKYGVK.C Y 58.73 1220.6400 11 -10.8 611.3207 2 33.99 6 15070 VEV_3_3_RA6_01_1237.d 1.04E6 9 9 73 83
R.Q(-17.03)KEEGTDINGK.K Y 54.56 1200.5623 11 9.3 601.2940 2 21.85 6 8525 VEV_3_3_RA6_01_1237.d 0 1 1 161 171 Pyro-glu from Q
M.S(+42.01)GPIVDGK.F Y 33.50 813.4232 8 -19.1 814.4149 1 44.87 6 21328 VEV_3_3_RA6_01_1237.d 2.31E5 1 1 2 9 Acetylation (Protein N-term)
M.S(+42.01)GPIVDGKFR.I Y 25.75 1116.5928 10 -15.7 559.2949 2 63.96 6 33335 VEV_3_3_RA6_01_1237.d 3.62E5 3 3 2 11 Acetylation (Protein N-term)
R.IDNTSPPSASSGILALFSLKGK.T Y 25.48 2202.1895 22 -7.2 735.0651 3 84.16 6 47934 VEV_3_3_RA6_01_1237.d 4.54E4 1 1 12 33
R.IDNTSPPSASSGILALFSLK.G Y 23.93 2017.0731 20 -5.8 1009.5380 2 89.80 4 53545 VEV_1_3_RA4_01_1235.d 2.37E4 1 1 12 31
total 9 peptides
C1G7K8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FAPESNHAANAGLK.A Y 104.90 1425.7001 14 -13.7 713.8475 2 37.03 6 16827 VEV_3_3_RA6_01_1237.d 3.66E5 5 5 155 168
R.MGFDDREIVALC(+57.02)GAHSLGR.A Y 86.21 2102.9990 19 -12.4 526.7505 4 76.23 4 44154 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 243 261 Carbamidomethylation
R.SGYDGPWDFSPTVFTNEFFR.M Y 61.40 2368.0437 20 10.2 1185.0413 2 93.54 6 52992 VEV_3_3_RA6_01_1237.d 6.82E4 2 2 267 286
K.ASTKPSGPFTPTKDDYQKVYDEIAR.L Y 58.60 2813.3872 25 -8.6 563.6799 5 72.91 4 41508 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 87 111
R.LLVENDDYDDGSYGPVLIR.L Y 57.36 2152.0325 19 -0.1 1077.0234 2 81.36 4 48060 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 112 130
R.LAWHASGTYDKETGTGGSN(+.98)GATMR.F Y 38.00 2468.1025 24 -20.9 618.0200 4 60.25 4 31668 VEV_1_3_RA4_01_1235.d 0 1 1 131 154 Deamidation (NQ)
K.ASTKPSGPFTPTKDDYQK.V Y 35.11 1966.9636 18 8.8 492.7525 4 43.20 4 20694 VEV_1_3_RA4_01_1235.d 0 1 1 87 104
R.FAPESN(+.98)HAANAGLK.A Y 23.66 1426.6841 14 10.2 714.3566 2 37.58 4 17270 VEV_1_3_RA4_01_1235.d 2.33E4 1 1 155 168 Deamidation (NQ)
K.VYDEIAR.L Y 22.22 864.4341 7 -11.5 433.2194 2 37.31 6 16944 VEV_3_3_RA6_01_1237.d 1.79E5 1 1 105 111
K.ADDRFVFK.T Y 22.19 996.5028 8 -15.5 499.2510 2 52.94 6 26024 VEV_3_3_RA6_01_1237.d 8.07E4 1 1 363 370
R.DIFGR.M N 21.90 606.3125 5 -8.7 304.1609 2 49.22 4 24388 VEV_1_3_RA4_01_1235.d 0 1 1 238 242
R.KWNGPAQFTDK.T Y 20.47 1290.6356 11 -3.0 646.3231 2 61.47 5 32633 VEV_2_3_RA5_01_1236.d 2.87E5 1 1 297 307
M(+15.99)ASVARTFTRGFTR.A Y 17.02 1615.8253 14 -7.0 808.9143 2 80.76 6 45691 VEV_3_3_RA6_01_1237.d 1.45E4 1 1 1 14 Oxidation (M)
R.E(+37.03)IVALC(+57.02)GAHSLGR.A Y 16.81 1418.7452 13 11.1 355.6975 4 49.42 6 23972 VEV_3_3_RA6_01_1237.d 1.16E6 1 1 249 261 Propargylamine; Carbamidomethylation
R.M(+15.99)LVNEK.W Y 15.28 748.3789 6 -16.5 375.1906 2 14.04 4 4321 VEV_1_3_RA4_01_1235.d 0 1 1 287 292 Oxidation (M)
total 15 peptides
C1G4P8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NKEELTKQLDELKTELGQLR.V Y 80.04 2384.2910 20 -6.7 477.8623 5 79.58 4 46696 VEV_1_3_RA4_01_1235.d 3.7E5 3 3 15 34
K.Q(-17.03)LDELKTELGQLR.V Y 75.73 1524.8147 13 -14.3 763.4037 2 83.24 6 47340 VEV_3_3_RA6_01_1237.d 4.83E5 3 3 22 34 Pyro-glu from Q
R.LTKHEASLKTER.Q Y 72.78 1411.7783 12 -10.1 706.8893 2 15.57 5 5348 VEV_2_3_RA5_01_1236.d 1.62E5 3 3 97 108
K.Q(-17.03)LDELKTELGQLRVQK.I Y 67.70 1880.0366 16 -9.2 627.6804 3 81.17 5 46814 VEV_2_3_RA5_01_1236.d 7E4 1 1 22 37 Pyro-glu from Q
K.QLDELKTELGQLR.V Y 66.11 1541.8413 13 -6.7 514.9509 3 73.71 4 42128 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 22 34
K.YLPLDLRPK.Q Y 64.67 1113.6545 9 -12.2 557.8278 2 67.64 5 37256 VEV_2_3_RA5_01_1236.d 2.2E6 8 8 80 88
K.VLTIINANQR.S Y 64.53 1140.6615 10 -10.8 571.3318 2 62.97 5 33775 VEV_2_3_RA5_01_1236.d 1.27E6 5 5 59 68
R.IHDLRKSIAKVLTIINANQR.S Y 56.89 2302.3596 20 -14.7 461.4724 5 80.50 5 46382 VEV_2_3_RA5_01_1236.d 5.53E4 1 1 49 68
K.HEASLKTER.Q Y 47.94 1069.5516 9 -11.1 357.5205 3 11.59 4 3111 VEV_1_3_RA4_01_1235.d 4.39E5 6 6 100 108
K.QLDELKTELGQLRVQK.I Y 42.67 1897.0632 16 -15.6 475.2657 4 72.74 4 41382 VEV_1_3_RA4_01_1235.d 8.88E4 2 2 22 37
K.TGQLWGK.N Y 40.39 788.4181 7 -9.0 395.2128 2 40.03 4 18718 VEV_1_3_RA4_01_1235.d 8.44E5 2 2 8 14
K.KYLPLDLRPK.Q Y 37.03 1241.7495 10 -13.7 311.4404 4 63.45 6 32960 VEV_3_3_RA6_01_1237.d 1.54E5 3 3 79 88
K.IAGGAASKLTR.I Y 34.69 1043.6086 11 -33.7 348.8651 3 29.21 5 12812 VEV_2_3_RA5_01_1236.d 8.95E5 1 1 38 48
K.YLPLDLRPKQTR.A Y 32.24 1498.8619 12 -17.1 375.7163 4 62.74 5 33588 VEV_2_3_RA5_01_1236.d 6.07E4 1 1 80 91
K.MVHFPQR.K Y 32.22 913.4592 7 -16.1 305.4888 3 39.96 6 18472 VEV_3_3_RA6_01_1237.d 3.35E5 4 4 113 119
R.RLTKHEASLKTER.Q Y 30.55 1567.8794 13 -19.3 314.5771 5 20.20 5 7836 VEV_2_3_RA5_01_1236.d 1.62E6 5 5 96 108
K.YLPLDLRPK(+14.02).Q Y 28.40 1127.6703 9 -13.1 376.8925 3 69.36 4 38714 VEV_1_3_RA4_01_1235.d 7.12E4 1 1 80 88 Methylation(KR)
K.YLPLDLR(+14.02)PK.Q Y 26.64 1127.6703 9 -17.1 376.8909 3 68.97 6 37105 VEV_3_3_RA6_01_1237.d 5.86E4 1 1 80 88 Methylation(KR)
K.IAGGAASK.L Y 23.30 673.3759 8 -56.4 337.6762 2 45.14 6 21488 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 38 45
K.MVHFPQRK.Y Y 20.74 1041.5542 8 -15.4 348.1867 3 28.33 5 12310 VEV_2_3_RA5_01_1236.d 2.1E5 1 1 113 120
K.VLTIINANQR(+14.02).S Y 20.44 1154.6771 10 -41.7 578.3218 2 66.04 4 36090 VEV_1_3_RA4_01_1235.d 0 1 1 59 68 Methylation(KR)
K.QLD(-18.01)ELKTELGQLR.V Y 19.89 1523.8307 13 -8.0 508.9468 3 83.44 4 49527 VEV_1_3_RA4_01_1235.d 4.06E3 1 1 22 34 Dehydration
K.VLTIINAN(+.98)QR.S Y 16.34 1141.6455 10 -40.8 571.8068 2 64.46 5 34872 VEV_2_3_RA5_01_1236.d 0 1 1 59 68 Deamidation (NQ)
total 23 peptides
C1GM22
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TIYC(+57.02)DLEPNVVDEVR.S Y 121.86 1820.8615 15 -11.1 911.4279 2 77.71 6 43519 VEV_3_3_RA6_01_1237.d 1.63E5 3 3 65 79 Carbamidomethylation
R.IHFPLVAYAPVVSAAK.A N 97.01 1681.9554 16 -10.5 561.6532 3 80.25 5 46214 VEV_2_3_RA5_01_1236.d 9.62E4 1 1 265 280
R.TIQFVDWC(+57.02)PTGFK.I Y 73.97 1597.7599 13 -13.8 799.8762 2 82.64 6 46964 VEV_3_3_RA6_01_1237.d 2E5 2 2 340 352 Carbamidomethylation
K.DVHAAVATLK.T Y 52.90 1023.5713 10 -13.3 512.7861 2 45.07 6 21448 VEV_3_3_RA6_01_1237.d 2.01E5 2 2 327 336
R.NLGIERPSFENLNR.L Y 19.82 1657.8535 14 -22.9 829.9150 2 81.18 5 46822 VEV_2_3_RA5_01_1236.d 9.71E4 1 1 216 229
R.IHFPLVAYAPVVSAAK(-.98).A N 18.52 1680.9714 16 -71.1 561.2913 3 80.46 4 47372 VEV_1_3_RA4_01_1235.d 6.64E4 1 1 265 280 Amidation
R.EDLAALER.D Y 17.79 915.4661 8 3.8 458.7421 2 76.09 4 43979 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 423 430
K.IGIC(+57.02)YQPPHMVPNGDLAK.V Y 15.18 2008.9862 18 1.5 503.2546 4 46.26 4 22547 VEV_1_3_RA4_01_1235.d 0 1 1 353 370 Carbamidomethylation
total 8 peptides
C1G3M0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GGFPGAQGPYYC(+57.02)GVGTGK.V Y 106.62 1771.7987 18 -9.2 886.8984 2 69.88 4 39168 VEV_1_3_RA4_01_1235.d 3.93E5 5 5 226 243 Carbamidomethylation
K.SVEELPEWNFDGSSTGQAPGENSDVYLRPVAMFPDPFR.R Y 89.67 4239.9482 38 -8.4 1414.3115 3 90.88 4 54153 VEV_1_3_RA4_01_1235.d 4.5E4 1 1 127 164
K.GYFEDRRPASNADPYQITGIIVETLC(+57.02)GAS Y 84.61 3199.5244 29 -3.9 1067.5112 3 89.90 4 53623 VEV_1_3_RA4_01_1235.d 4.19E5 3 3 405 433 Carbamidomethylation
R.GHVLAEYVWIDASSGVR.S Y 69.05 1857.9373 17 -11.4 620.3126 3 79.43 4 46624 VEV_1_3_RA4_01_1235.d 2.12E5 2 2 99 115
R.HSEHIAVYGEGNEDRLTGR.H Y 48.30 2139.0093 19 -27.7 428.7973 5 53.46 4 27094 VEV_1_3_RA4_01_1235.d 0 1 1 355 373
R.FTYGVADR.G Y 34.60 927.4450 8 5.2 464.7322 2 50.82 6 24765 VEV_3_3_RA6_01_1237.d 0 1 1 382 389
R.FLLSR.V N 17.84 634.3802 5 -14.5 318.1928 2 57.03 5 29452 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 297 301
K.ISGINAEVMPAQWEYQVGPC(+57.02)EGITLGDQLWM(+15.99)SR.F Y 17.63 3750.7480 33 1.6 751.1581 5 97.49 6 54486 VEV_3_3_RA6_01_1237.d 0 1 1 264 296 Carbamidomethylation; Oxidation (M)
total 8 peptides
C1G1R3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
MRSNQFGNFYELC(+57.02)R.D Y 108.07 1820.8086 14 -11.0 607.9368 3 71.32 5 39968 VEV_2_3_RA5_01_1236.d 1.39E5 2 2 1 14 Carbamidomethylation
M(+15.99)RSNQFGNFYELC(+57.02)R.D Y 104.15 1836.8036 14 -9.6 613.2693 3 69.21 6 37298 VEV_3_3_RA6_01_1237.d 2.12E5 2 2 1 14 Oxidation (M); Carbamidomethylation
R.DATIPVC(+57.02)NLLVADNQPPNAK.Y Y 98.97 2149.0837 20 -17.6 717.3559 3 80.60 6 45596 VEV_3_3_RA6_01_1237.d 3.06E5 7 7 15 34 Carbamidomethylation
K.YGGC(+57.02)ALTGISLSGDR.N Y 94.50 1525.7195 15 -9.1 763.8600 2 72.45 4 41155 VEV_1_3_RA4_01_1235.d 2.65E5 3 3 35 49 Carbamidomethylation
R.SNQFGNFYELC(+57.02)R.D Y 78.50 1533.6670 12 -16.3 767.8282 2 75.44 6 41860 VEV_3_3_RA6_01_1237.d 4.02E5 3 3 3 14 Carbamidomethylation
R.SNQFGNFYELC(+57.02)RDATIPVC(+57.02)NLLVADNQPPNAK.Y Y 23.71 3664.7402 32 -7.5 917.1854 4 86.29 5 49903 VEV_2_3_RA5_01_1236.d 1.4E5 1 1 3 34 Carbamidomethylation
M.RSNQFGNFYELC(+57.02)R.D Y 19.83 1689.7682 13 30.8 564.2807 3 69.15 6 37230 VEV_3_3_RA6_01_1237.d 9.03E4 1 1 2 14 Carbamidomethylation
total 7 peptides
A0A0A0HRM2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGKPLSVELGPGLMETIYDGIQRPLK.A Y 83.29 2811.5203 26 -14.7 703.8770 4 85.59 5 49507 VEV_2_3_RA5_01_1236.d 0 1 1 257 282
R.TC(+57.02)LIANTSNMPVAAR.E Y 78.94 1617.7968 15 -7.3 809.8997 2 68.57 5 37962 VEV_2_3_RA5_01_1236.d 2.01E5 2 2 484 498 Carbamidomethylation
K.LASDSPFIVGQR.V Y 75.27 1288.6775 12 -11.3 645.3387 2 68.60 5 38017 VEV_2_3_RA5_01_1236.d 1.19E5 2 2 396 407
R.IAGPGSYTVDEK.L Y 72.94 1235.6034 12 -15.1 618.7996 2 54.26 6 26808 VEV_3_3_RA6_01_1237.d 1.74E5 4 4 354 365
K.AISDASGSIYIPR.G Y 68.08 1348.6986 13 -16.3 675.3456 2 69.94 6 37807 VEV_3_3_RA6_01_1237.d 4.24E5 5 5 283 295
R.VLDALFPSVQGGTVC(+57.02)IPGAFGC(+57.02)GK.T Y 65.98 2449.2134 24 -6.6 817.4064 3 87.66 4 52298 VEV_1_3_RA4_01_1235.d 7.96E4 2 2 408 431 Carbamidomethylation
R.EATAEIQNMLR.G Y 53.88 1274.6289 11 -11.0 638.3147 2 70.89 6 38521 VEV_3_3_RA6_01_1237.d 2.38E5 3 3 741 751
K.LASFYER.A Y 40.32 884.4392 7 -4.2 443.2250 2 53.66 6 26447 VEV_3_3_RA6_01_1237.d 4.31E5 3 3 557 563
R.LGEMPADQGFPAYLGAK.L Y 38.53 1763.8552 17 -3.6 882.9317 2 79.26 4 46448 VEV_1_3_RA4_01_1235.d 9.99E4 1 1 540 556
R.GMKFEIPDDEEAVTK.K Y 25.58 1707.8025 15 14.4 570.2830 3 70.53 4 39662 VEV_1_3_RA4_01_1235.d 8.25E4 1 1 752 766
R.GISIPALDREK.K Y 24.12 1197.6716 11 -23.0 400.2220 3 64.91 6 34046 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 296 306
K.SALGDPDK.I Y 19.15 801.3868 8 5.7 802.3987 1 111.87 4 61633 VEV_1_3_RA4_01_1235.d 0 1 1 674 681
R.EISGR.L N 16.02 560.2918 5 -12.9 561.2919 1 70.72 4 39776 VEV_1_3_RA4_01_1235.d 9.47E4 1 1 535 539
R.TGLSKDPPLTPQPNLR.Q Y 15.31 1732.9471 16 3.2 434.2455 4 71.54 4 40435 VEV_1_3_RA4_01_1235.d 0 1 1 102 117
total 14 peptides
C1G479
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.INAGIYILNPSVLK.R Y 85.83 1513.8867 14 -9.9 757.9431 2 82.77 6 47044 VEV_3_3_RA6_01_1237.d 1.38E5 3 3 172 185
R.IELRPTSIEQETFPAIC(+57.02)K.D Y 72.61 2131.0984 18 -12.8 711.3643 3 77.89 4 45391 VEV_1_3_RA4_01_1235.d 1.66E5 1 1 187 204 Carbamidomethylation
K.DFLTGTC(+57.02)LYLSSLTK.R Y 69.70 1717.8596 15 -4.8 859.9329 2 88.65 4 52905 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 225 239 Carbamidomethylation
K.HGDEGTIVVTKVEEPSK.Y Y 67.58 1823.9265 17 0.9 608.9833 3 53.25 4 26952 VEV_1_3_RA4_01_1235.d 1.96E5 2 2 127 143
R.INAGIYILNPSVLKR.I Y 63.78 1669.9879 15 -15.7 557.6612 3 78.72 6 44236 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 172 186
K.ALILVGGFGTR.L Y 55.83 1102.6499 11 -11.0 552.3262 2 78.62 4 45954 VEV_1_3_RA4_01_1235.d 1.07E5 2 2 3 13
R.IGPNVVIGPNVVVGDGVR.L Y 50.08 1759.9944 18 -12.8 587.6646 3 79.31 6 44663 VEV_3_3_RA6_01_1237.d 4.03E4 1 1 271 288
K.SDSLC(+57.02)TSEPYVYKGNVMVDPSAK.I Y 48.10 2546.1667 23 -5.6 849.7247 3 72.22 4 40970 VEV_1_3_RA4_01_1235.d 6.26E4 1 1 242 264 Carbamidomethylation
K.HGDEGTIVVTK.V Y 45.07 1154.5931 11 -8.2 578.2991 2 28.14 4 11820 VEV_1_3_RA4_01_1235.d 1.59E5 3 3 127 137
K.SDSLC(+57.02)TSEPYVYK.G Y 44.00 1547.6814 13 -8.3 774.8416 2 64.75 4 35081 VEV_1_3_RA4_01_1235.d 5.34E4 1 1 242 254 Carbamidomethylation
R.FVEKPVEFVGNR.I Y 41.22 1419.7510 12 -14.8 474.2506 3 63.00 5 33779 VEV_2_3_RA5_01_1236.d 2.11E5 2 2 160 171
K.STIVGWNSTVGR.W Y 39.23 1275.6571 12 -20.5 638.8228 2 67.40 6 35949 VEV_3_3_RA6_01_1237.d 3.36E5 2 2 308 319
MKALILVGGFGTR.L Y 17.91 1361.7853 13 70.0 454.9675 3 76.65 4 44426 VEV_1_3_RA4_01_1235.d 0 1 1 1 13
total 13 peptides
C1G6F9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LAPEKFWPFSAALFAR.Q Y 93.07 1849.9878 16 -16.5 617.6597 3 86.62 6 49437 VEV_3_3_RA6_01_1237.d 4.34E5 4 4 99 114
R.LIGVHFTPTVYFDGVEER.T Y 89.97 2078.0471 18 -16.3 693.6783 3 81.60 6 46274 VEV_3_3_RA6_01_1237.d 1.88E5 1 1 184 201
K.IAAGVGVDEAALLK.M Y 88.74 1325.7554 14 -15.2 663.8749 2 74.62 6 41268 VEV_3_3_RA6_01_1237.d 2.66E5 3 3 138 151
R.Q(-17.03)TEFFDANVVNETRNETYAR.L Y 74.02 2386.0825 20 -13.7 1194.0322 2 80.33 6 45395 VEV_3_3_RA6_01_1237.d 6.75E4 1 1 115 134 Pyro-glu from Q
R.LIGVHFTPTVYFDGVEER(+14.02).T Y 61.79 2092.0630 18 -17.4 698.3495 3 82.61 6 46942 VEV_3_3_RA6_01_1237.d 0 1 1 184 201 Methylation(KR)
K.LSLSGGTETK.H Y 56.24 991.5186 10 -17.5 496.7579 2 36.76 6 16640 VEV_3_3_RA6_01_1237.d 5.85E5 4 4 12 21
R.QTEFFDANVVNETRNETYAR.L Y 52.22 2403.1091 20 -16.7 802.0303 3 74.23 5 42048 VEV_2_3_RA5_01_1236.d 3.92E4 1 1 115 134
R.DNLQVIFR.Q Y 42.36 1003.5450 8 -20.2 502.7697 2 73.91 4 42301 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 69 76
R.FTAEQWEKWLEKNVV Y 33.67 1905.9624 15 -9.4 636.3221 3 86.11 5 49794 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 207 221
M.T(+42.01)LNPQFAGQK.L Y 28.44 1144.5876 10 -16.9 573.2914 2 67.29 6 35850 VEV_3_3_RA6_01_1237.d 6.3E5 3 3 2 11 Acetylation (Protein N-term)
R.Q(+.98)TEFFDANVVNETRNETYAR.L Y 22.63 2404.0930 20 26.3 802.3927 3 74.23 6 40982 VEV_3_3_RA6_01_1237.d 0 1 1 115 134 Deamidation (NQ)
K.NAHYRDNLQVIFR.Q Y 17.60 1644.8484 13 -10.5 412.2151 4 65.99 5 36027 VEV_2_3_RA5_01_1236.d 7.66E4 1 1 64 76
total 12 peptides
C1GJY9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGVNTDKELVWPQDIDLDKGIANYDR.E Y 104.56 2972.4878 26 -20.3 744.1141 4 80.11 6 45239 VEV_3_3_RA6_01_1237.d 3E5 3 3 49 74
K.FSYQVPAIFNAGSFFGR.W Y 98.18 1906.9365 17 -7.1 636.6483 3 89.79 5 51770 VEV_2_3_RA5_01_1236.d 4.54E5 5 5 364 380
R.ATGIATTGGSLGGVLYPLMLQDLFPK.L Y 72.67 2619.3982 26 -25.3 1310.6732 2 95.17 5 54295 VEV_2_3_RA5_01_1236.d 2.26E5 5 5 254 279
K.Q(-17.03)IENQTSEKTR.V Y 70.63 1315.6368 11 -13.8 658.8167 2 27.73 6 11657 VEV_3_3_RA6_01_1237.d 7.5E5 3 3 38 48 Pyro-glu from Q
K.QIENQTSEKTR.V Y 60.48 1332.6633 11 -20.3 667.3254 2 12.33 6 3569 VEV_3_3_RA6_01_1237.d 2.06E5 6 6 38 48
K.ENILPDFR.I Y 51.92 1002.5134 8 -18.0 502.2549 2 73.30 6 40303 VEV_3_3_RA6_01_1237.d 6.39E5 5 5 316 323
K.Q(-17.03)IENQTSEKTR(+14.02).V Y 40.40 1329.6525 11 -9.4 665.8273 2 35.99 5 16767 VEV_2_3_RA5_01_1236.d 1.67E5 1 1 38 48 Pyro-glu from Q; Methylation(KR)
K.Q(-17.03)IEN(+.98)QTSEKTR.V Y 23.23 1316.6208 11 -8.9 659.3118 2 31.26 5 14002 VEV_2_3_RA5_01_1236.d 4.96E4 1 1 38 48 Pyro-glu from Q; Deamidation (NQ)
K.ELVWPQDIDLDK.G Y 19.66 1469.7401 12 14.2 490.9276 3 70.41 5 39296 VEV_2_3_RA5_01_1236.d 5.93E4 2 2 56 67
K.Q(+42.01)ATK(+27.99)ENILPDFR.I Y 19.03 1500.7572 12 -13.7 501.2528 3 73.90 4 42283 VEV_1_3_RA4_01_1235.d 5.1E4 1 1 312 323 Acetylation (N-term); Formylation
K.Q(+.98)IEN(+.98)Q(+.98)TSEKTR.V Y 18.80 1335.6154 11 -14.0 446.2062 3 12.36 6 3583 VEV_3_3_RA6_01_1237.d 0 1 1 38 48 Deamidation (NQ)
R.V(+225.09)GVNTDK.E Y 15.33 956.4749 7 -1.9 479.2438 2 60.16 6 30550 VEV_3_3_RA6_01_1237.d 0 1 1 49 55 Iminobiotinylation
total 12 peptides
A0A0A0HUI8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAVYVTAVLEYLTAEVLELAGNAAK.D Y 134.72 2578.3894 25 -4.6 1290.1960 2 97.99 4 57544 VEV_1_3_RA4_01_1235.d 5.98E4 2 2 323 347
R.ATIAFGGVLPR.I Y 60.84 1100.6342 11 -12.2 551.3176 2 75.89 4 43831 VEV_1_3_RA4_01_1235.d 2.8E5 3 3 375 385
K.AGLQFPC(+57.02)GR.V Y 56.61 1004.4861 9 -13.2 503.2437 2 61.86 5 32931 VEV_2_3_RA5_01_1236.d 8.19E5 6 6 296 304 Carbamidomethylation
R.FLKNNTQNK.M Y 29.68 1105.5880 9 -15.1 369.5311 3 13.58 6 4223 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 308 316
R.IGNSAFLADALFSDIFK.V Y 25.01 1827.9407 17 -36.1 610.2988 3 74.41 5 42183 VEV_2_3_RA5_01_1236.d 3.98E5 1 1 198 214
R.HLQLAIRGDEELDTLIR.A Y 24.63 1991.0800 17 -31.8 498.7614 4 78.22 5 44867 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 358 374
K.SHSAK.A Y 23.56 528.2656 5 1.0 529.2734 1 15.36 5 5227 VEV_2_3_RA5_01_1236.d 7.78E3 3 3 291 295
K.SVGGK.G Y 23.18 446.2489 5 -40.3 447.2382 1 72.19 4 40944 VEV_1_3_RA4_01_1235.d 0 2 2 274 278
K.TQK(+44.03)SHSAK.A Y 21.14 929.4930 8 -16.9 310.8331 3 25.47 6 10443 VEV_3_3_RA6_01_1237.d 9.07E5 1 1 288 295 Ethanolation (KR)
R.LDLPHLFDMPGGK.G Y 20.55 1438.7278 13 29.8 360.7000 4 48.33 5 24129 VEV_2_3_RA5_01_1236.d 2.73E5 1 1 259 271
R.ALLLK.V N 19.26 556.3948 5 -13.4 557.3946 1 61.07 5 32346 VEV_2_3_RA5_01_1236.d 3.65E5 2 2 389 393
total 11 peptides
C1G9U1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SIDGGDDAAEGHKER.L Y 93.93 1555.6863 15 -14.4 778.8392 2 14.88 6 4871 VEV_3_3_RA6_01_1237.d 1.78E5 5 5 352 366
R.FGPQLSDEISSR.W Y 86.18 1334.6466 12 -9.3 668.3244 2 68.99 4 38478 VEV_1_3_RA4_01_1235.d 5.33E5 4 4 255 266
R.LAPESEGGHVIDTTALVLHTQTDAAK.H Y 73.83 2673.3608 26 -8.3 669.3419 4 74.47 4 42718 VEV_1_3_RA4_01_1235.d 3.31E5 3 3 108 133
K.VVSTSYLPLGWSPEFSSSVHETTLGNTPLGK.Q Y 64.15 3289.6506 31 -7.3 1097.5494 3 84.89 4 50520 VEV_1_3_RA4_01_1235.d 8.39E4 1 1 298 328
R.VNKVVGNFHIAPGR.S Y 61.00 1506.8419 14 -18.9 377.7106 4 58.81 6 29576 VEV_3_3_RA6_01_1237.d 3.47E5 3 3 209 222
K.NLDAQRNEGC(+57.02)RIEGVLR.V Y 51.63 1999.0017 17 -16.1 500.7496 4 62.04 4 33023 VEV_1_3_RA4_01_1235.d 1.58E5 2 2 192 208 Carbamidomethylation
R.YNFMYFVK.V Y 44.09 1110.5208 8 -8.3 556.2631 2 80.12 4 47114 VEV_1_3_RA4_01_1235.d 3.92E4 1 1 290 297
R.FGPQLSDEISSR(+14.02).W Y 35.24 1348.6622 12 3.1 675.3405 2 71.10 4 40078 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 255 266 Methylation(KR)
R.GENVEQC(+57.02)EREGYSK.N Y 21.28 1683.7158 14 19.5 562.2568 3 27.59 4 11528 VEV_1_3_RA4_01_1235.d 0 1 1 178 191 Carbamidomethylation
R.ALYEGVAR.V Y 18.40 877.4657 8 -15.1 439.7335 2 44.57 5 21870 VEV_2_3_RA5_01_1236.d 1.5E5 1 1 421 428
R.NEGC(+57.02)RIEGVLR.V Y 18.37 1301.6510 11 -6.7 434.8880 3 60.39 4 31777 VEV_1_3_RA4_01_1235.d 2.26E4 1 1 198 208 Carbamidomethylation
R.IEGVLR.V Y 16.92 685.4122 6 -10.7 343.7097 2 45.36 4 21975 VEV_1_3_RA4_01_1235.d 3.41E5 1 1 203 208
total 12 peptides
C1GLX7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLEAKDEDGNHPGPR.Y Y 117.60 1646.8011 15 -8.7 824.4007 2 32.99 5 14991 VEV_2_3_RA5_01_1236.d 1.61E6 12 12 76 90
R.YGVFSGEFDLGSDGKR.N Y 111.21 1732.8055 16 -10.1 578.6033 3 75.62 4 43647 VEV_1_3_RA4_01_1235.d 9.13E5 6 6 91 106
K.IALISWVPEGC(+57.02)HVFYSMLYGSALSDFKK.L Y 64.73 3217.5979 28 4.8 805.4106 4 91.63 4 54607 VEV_1_3_RA4_01_1235.d 7.34E4 1 1 109 136 Carbamidomethylation
K.FVIFR.I Y 32.96 680.4009 5 -12.1 341.2036 2 69.01 4 38444 VEV_1_3_RA4_01_1235.d 1.9E5 3 3 43 47
R.GIDPK.D Y 17.33 528.2907 5 -4.4 529.2957 1 66.63 6 35360 VEV_3_3_RA6_01_1237.d 1.41E4 1 1 34 38
K.TSPSLPLDAASTK.A Y 16.65 1286.6718 13 -6.4 322.6732 4 23.21 5 9457 VEV_2_3_RA5_01_1236.d 1.2E5 1 1 15 27
MGFC(+57.02)QEAMRAIGDK.T Y 15.41 1612.7159 14 93.8 404.2241 4 50.78 5 25627 VEV_2_3_RA5_01_1236.d 0 1 1 1 14 Carbamidomethylation
total 7 peptides
C1FYH3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.INLAQPNNQDSPAAKR.Q Y 92.24 1735.8965 16 -12.7 579.6321 3 45.43 5 22445 VEV_2_3_RA5_01_1236.d 2.19E5 2 2 50 65
K.INLAQPNNQDSPAAK.R Y 89.63 1579.7954 15 -9.8 790.8972 2 52.53 6 25784 VEV_3_3_RA6_01_1237.d 2.31E5 4 4 50 64
R.RAYKEYEDEVFR.I Y 70.17 1603.7629 12 -1.9 535.5939 3 58.92 5 30761 VEV_2_3_RA5_01_1236.d 7.58E4 2 2 251 262
M.AGAGKAPAPAEHQK.R Y 66.67 1331.6946 14 -12.1 444.9001 3 10.45 5 2718 VEV_2_3_RA5_01_1236.d 4.38E4 2 2 2 15
R.AYKEYEDEVFR.I Y 60.92 1447.6619 11 -11.7 483.5556 3 62.67 4 33500 VEV_1_3_RA4_01_1235.d 4.57E4 2 2 252 262
K.SQSGGYRAEVGR.T Y 30.69 1265.6112 12 -8.1 422.8743 3 22.06 4 8494 VEV_1_3_RA4_01_1235.d 8.63E4 1 1 327 338
K.TLDNPEAK.A Y 28.21 886.4396 8 -7.8 444.2236 2 20.81 5 8184 VEV_2_3_RA5_01_1236.d 7.44E5 3 3 184 191
MAGAGK.A Y 28.03 533.2632 6 9.2 534.2754 1 18.36 6 6696 VEV_3_3_RA6_01_1237.d 9.51E2 1 1 1 6
K.AQEEIDRLNEEDANTKEK.H Y 27.56 2131.0029 18 -5.3 533.7552 4 42.99 4 20536 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 440 457
K.ALSDR.Y N 20.21 560.2918 5 -31.0 561.2817 1 12.04 4 3317 VEV_1_3_RA4_01_1235.d 0 1 1 192 196
K.QVDSGTM(+15.99)K.L Y 15.90 880.3961 8 38.4 881.4371 1 99.37 6 55104 VEV_3_3_RA6_01_1237.d 1.74E4 1 1 133 140 Oxidation (M)
K.GFSGFDEAQKVIDDLKSQLSDLKK.T Y 15.58 2667.3755 24 -8.3 667.8456 4 87.93 4 52462 VEV_1_3_RA4_01_1235.d 3.03E4 1 1 160 183
K.TSLEA Y 15.18 519.2540 5 -10.3 520.2560 1 73.83 6 40694 VEV_3_3_RA6_01_1237.d 7.44E4 1 1 501 505
total 13 peptides
C1GHN0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MVLVSAGGIPHDQLVR.L Y 89.13 1690.9188 16 -16.3 564.6377 3 72.98 6 40139 VEV_3_3_RA6_01_1237.d 2.68E5 3 3 222 237
R.LSFSVTEAEVER.A Y 82.48 1365.6776 12 -5.3 683.8425 2 73.04 4 41616 VEV_1_3_RA4_01_1235.d 2.75E5 3 3 378 389
R.TPDFIGSEVR.L Y 77.21 1119.5560 10 -11.7 560.7787 2 65.70 5 35808 VEV_2_3_RA5_01_1236.d 4.53E5 6 6 265 274
R.TILGPKENIQTIKR.E Y 64.73 1609.9515 14 -33.6 537.6398 3 56.96 5 29399 VEV_2_3_RA5_01_1236.d 0 1 1 193 206
K.AVDILSDILQNSK.L Y 63.03 1414.7667 13 -17.4 708.3784 2 84.50 4 50250 VEV_1_3_RA4_01_1235.d 8.92E3 1 1 136 148
R.ENLVDYIK.T Y 48.18 992.5178 8 -17.9 497.2573 2 71.44 6 38984 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 207 214
R.TPDFIGSEVR(+14.02).L Y 34.03 1133.5717 10 -11.2 567.7867 2 70.76 6 38413 VEV_3_3_RA6_01_1237.d 2.05E5 2 2 265 274 Methylation(KR)
K.ITEKDVMSFAQR.K Y 33.24 1423.7129 12 13.1 475.5845 3 69.31 5 38491 VEV_2_3_RA5_01_1236.d 0 1 1 435 446
R.SQNQLELEIENMGAHLNAYTSR.E Y 27.43 2517.1919 22 1.5 840.0725 3 83.87 6 47747 VEV_3_3_RA6_01_1237.d 1.33E4 1 1 98 119
K.RTPDFIGSEVR.L Y 22.52 1275.6571 11 -6.7 426.2234 3 59.84 6 30339 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 264 274
K.SFNGDVPKAVDILSDILQNSKLEPAAIER.E Y 21.88 3138.6560 29 33.2 785.6973 4 90.57 6 51610 VEV_3_3_RA6_01_1237.d 0 1 1 128 156
K.SFNGDVPK.A Y 19.18 862.4185 8 4.9 432.2186 2 52.49 4 26480 VEV_1_3_RA4_01_1235.d 0 1 1 128 135
R.SM(-48.00)GNSPYLGSK.L Y 19.07 1091.5247 11 -12.1 546.7630 2 17.02 6 5992 VEV_3_3_RA6_01_1237.d 4.03E4 1 1 315 325 Dethiomethyl
R.ENTVYYAK.S Y 17.02 986.4709 8 31.6 494.2583 2 29.27 4 12484 VEV_1_3_RA4_01_1235.d 0 1 1 120 127
total 14 peptides
C1G1M0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSGENKILGAIPIAGNYVQSSGR.T Y 110.99 2317.2026 23 -8.9 773.4012 3 78.28 4 45722 VEV_1_3_RA4_01_1235.d 5.15E5 4 4 88 110
K.ILGAIPIAGNYVQSSGR.T Y 89.61 1714.9365 17 -9.0 858.4678 2 78.54 4 45896 VEV_1_3_RA4_01_1235.d 5.25E4 2 2 94 110
R.KVVSTVQGPGSR.G Y 80.75 1213.6779 12 -8.5 405.5631 3 24.41 4 9789 VEV_1_3_RA4_01_1235.d 3E5 6 6 291 302
K.SYAQVDEMFVLR.L Y 57.01 1456.7020 12 -5.1 729.3546 2 80.88 4 47703 VEV_1_3_RA4_01_1235.d 1.49E5 1 1 201 212
K.VVSTVQGPGSR.G Y 48.46 1085.5829 11 -9.4 543.7936 2 28.33 4 11932 VEV_1_3_RA4_01_1235.d 2.29E5 3 3 292 302
R.TLDPK.I N 17.91 572.3170 5 -17.5 573.3142 1 71.07 4 40054 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 111 115
total 6 peptides
C1G0B0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VEGSSGGDSEVQR.T Y 92.11 1305.5796 13 -8.7 653.7914 2 17.30 6 6151 VEV_3_3_RA6_01_1237.d 7.17E4 2 2 242 254
K.YVVDVADNVDISK.L Y 84.18 1435.7195 13 1.1 718.8678 2 71.68 4 40539 VEV_1_3_RA4_01_1235.d 9.65E4 2 2 78 90
R.EHAPSIIFMDEIDSIGSSR.V Y 77.79 2102.9941 19 40.2 702.0335 3 82.98 4 49209 VEV_1_3_RA4_01_1235.d 0 1 1 223 241
K.GVLLYGPPGTGK.T N 76.00 1157.6444 12 -12.4 579.8223 2 68.08 5 37595 VEV_2_3_RA5_01_1236.d 4.84E5 3 3 168 179
R.VSLLSDSYKLEK.M Y 37.81 1380.7500 12 -42.0 691.3533 2 67.46 5 37118 VEV_2_3_RA5_01_1236.d 2.1E5 3 3 97 108
R.TMLELLNQLDGFEPT(+121.04)K.N Y 32.43 1968.9689 16 4.9 985.4966 2 96.14 4 56808 VEV_1_3_RA4_01_1235.d 8.67E4 2 2 255 270 Phosphorylation to pyridyl thiol
K.IEFPPPTVEAR.A Y 30.64 1254.6608 11 -13.7 419.2218 3 36.00 5 16773 VEV_2_3_RA5_01_1236.d 0 1 1 298 308
K.VIMATNR.L N 28.28 803.4324 7 -43.2 804.4049 1 111.91 5 59353 VEV_2_3_RA5_01_1236.d 2.14E4 1 1 274 280
K.VMGTK.K Y 25.00 534.2836 5 -19.8 535.2803 1 62.86 4 33663 VEV_1_3_RA4_01_1235.d 5.62E4 2 2 62 66
R.VSLLSDSYK.L Y 24.87 1010.5284 9 6.1 506.2745 2 71.24 5 39906 VEV_2_3_RA5_01_1236.d 0 1 1 97 105
R.ELFIMAR.E Y 21.29 878.4684 7 -8.8 440.2376 2 71.94 4 40749 VEV_1_3_RA4_01_1235.d 9.97E3 1 1 216 222
R.TMLELLNQLDGFEPTK.N Y 16.38 1847.9338 16 -0.3 924.9739 2 89.70 4 53490 VEV_1_3_RA4_01_1235.d 3.04E4 1 1 255 270
K.MLPSSVDPLVSLMM(+15.99)VEK.V Y 15.11 1890.9504 17 17.1 379.2038 5 22.34 5 8984 VEV_2_3_RA5_01_1236.d 0 1 1 109 125 Oxidation (M)
total 13 peptides
C1GKL7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TTGGEVGAQSALAPK.I Y 127.65 1385.7150 15 -13.1 693.8557 2 48.78 6 23629 VEV_3_3_RA6_01_1237.d 1.14E6 9 9 17 31
K.SIPLDEIIEIAR.V Y 69.36 1367.7660 12 -15.2 684.8799 2 85.67 6 48873 VEV_3_3_RA6_01_1237.d 3.58E5 3 3 103 114
K.ELKGTVLEILGTAFSVGC(+57.02)QVDGR.S Y 65.37 2448.2683 23 -4.9 817.0927 3 91.54 4 54520 VEV_1_3_RA4_01_1235.d 3.59E4 1 1 124 146 Carbamidomethylation
R.TTGGE(+14.02)VGAQSALAPK.I Y 63.31 1399.7307 15 -12.1 700.8642 2 56.85 5 29335 VEV_2_3_RA5_01_1236.d 1.42E5 2 2 17 31 Methylation(others)
R.TTGGEVGAQ(+.98)SALAPK.I Y 53.93 1386.6990 15 -10.7 694.3494 2 55.60 5 28511 VEV_2_3_RA5_01_1236.d 1.66E5 3 3 17 31 Deamidation (NQ)
R.TTGGEVGAQSALAPK(+14.02).I Y 52.94 1399.7307 15 -8.5 700.8667 2 57.28 4 29504 VEV_1_3_RA4_01_1235.d 7.25E4 1 1 17 31 Methylation(KR)
K.IGPLGLSPK(+28.03)K.I Y 42.64 1036.6644 10 -13.5 346.5574 3 56.96 4 29303 VEV_1_3_RA4_01_1235.d 4.01E5 3 3 32 41 Dimethylation(KR)
R.SPKDISDEVK.A Y 27.74 1116.5662 10 -34.5 559.2711 2 28.87 6 12259 VEV_3_3_RA6_01_1237.d 0 1 1 147 156
K.ALKEPPRDR.K Y 20.82 1080.6039 9 -14.4 541.3015 2 13.17 5 4062 VEV_2_3_RA5_01_1236.d 6.15E4 1 1 84 92
K.IIHLR.T N 17.63 650.4227 5 -50.1 326.2024 2 28.61 4 12079 VEV_1_3_RA4_01_1235.d 0 1 1 12 16
M(+15.99)PPKFDPNEVK.I Y 15.73 1316.6434 11 -11.1 330.1645 4 67.17 4 36976 VEV_1_3_RA4_01_1235.d 0 1 1 1 11 Oxidation (M)
MPPKFDPNEVK.I Y 15.50 1300.6486 11 7.6 651.3365 2 48.36 6 23352 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 1 11
total 12 peptides
C1G1P0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SDNSANYTFESTPPTPHAGK.A Y 95.38 2119.9446 20 -11.9 707.6471 3 61.05 4 32273 VEV_1_3_RA4_01_1235.d 7.23E4 1 1 118 137
R.TTILIDDLADTSNTITR.A Y 88.91 1861.9633 17 -9.2 931.9803 2 81.04 4 47820 VEV_1_3_RA4_01_1235.d 1.44E5 3 3 353 369
R.VYALVTHGILSGDAIER.I Y 69.82 1812.9734 17 -24.6 605.3169 3 76.50 5 43665 VEV_2_3_RA5_01_1236.d 2.27E5 2 2 382 398
R.TATAVPATNGTATNDDVMSVASNSSK.L Y 63.37 2509.1602 26 1.8 837.3955 3 67.38 4 37143 VEV_1_3_RA4_01_1235.d 9.13E4 1 1 200 225
R.INASALDKVVVTNTVAQDVHK.V Y 60.20 2221.2065 21 -14.2 556.3010 4 71.15 4 40117 VEV_1_3_RA4_01_1235.d 4.73E4 1 1 399 419
K.AESIGLTSDGLQK.G Y 38.25 1317.6776 13 -2.6 659.8444 2 63.65 4 34246 VEV_1_3_RA4_01_1235.d 8.84E4 2 2 138 150
R.QSDIPYNK.I Y 30.16 963.4661 8 1.4 482.7410 2 30.72 4 13258 VEV_1_3_RA4_01_1235.d 6.62E4 1 1 98 105
R.ESIIVSPDAGGAKR.A Y 22.58 1398.7466 14 -30.2 467.2421 3 56.40 4 28885 VEV_1_3_RA4_01_1235.d 0 1 1 298 311
K.DVYIIQSGGGK.V Y 18.71 1135.5873 11 -40.7 1136.5483 1 92.85 6 52691 VEV_3_3_RA6_01_1237.d 2.5E5 2 2 53 63
K.VVVTNTVAQDVHK.V Y 16.92 1408.7675 13 -40.5 353.1849 4 33.01 4 14583 VEV_1_3_RA4_01_1235.d 0 1 1 407 419
R.INAS(-2.02)ALDKVVVTNTVAQDVHK.V Y 16.04 2219.1909 21 -44.4 555.7804 4 70.91 6 38535 VEV_3_3_RA6_01_1237.d 5.5E4 1 1 399 419 2-amino-3-oxo-butanoic_acid
total 11 peptides
C1G4I0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ETQNSLYSSVDTAPR.Q Y 96.90 1666.7798 15 -9.8 834.3890 2 62.71 4 33532 VEV_1_3_RA4_01_1235.d 1.28E5 2 2 502 516
R.IVSDTSGSPQNTR.S Y 77.91 1360.6582 13 -6.4 681.3320 2 25.18 4 10218 VEV_1_3_RA4_01_1235.d 1.95E5 3 3 446 458
R.ASGIPETASDAAGSR.K Y 66.06 1388.6531 15 -1.4 695.3328 2 46.24 5 22868 VEV_2_3_RA5_01_1236.d 5.56E5 7 7 251 265
R.FDSGPR.S Y 40.26 677.3132 6 -24.9 678.3036 1 63.76 5 34356 VEV_2_3_RA5_01_1236.d 0 1 1 565 570
R.LSVQGDSHAGPR.F Y 38.27 1222.6055 12 -11.3 612.3031 2 27.03 4 11206 VEV_1_3_RA4_01_1235.d 2.21E5 3 3 545 556
R.VNQTNIDSQIDLQPR.G Y 26.21 1739.8802 15 -9.8 580.9617 3 67.83 6 36253 VEV_3_3_RA6_01_1237.d 8.99E4 1 1 988 1002
R.LENLK.G N 24.14 615.3591 5 -8.6 616.3611 1 56.03 4 28655 VEV_1_3_RA4_01_1235.d 0 1 1 240 244
K.QSQSSGAVEK.S Y 21.72 1019.4883 10 -13.7 340.8321 3 16.09 4 5362 VEV_1_3_RA4_01_1235.d 7.5E4 1 1 150 159
K.NSTTGLDSIVR.F Y 20.80 1161.5990 11 23.5 388.2160 3 24.94 5 10449 VEV_2_3_RA5_01_1236.d 9.6E4 1 1 1101 1111
R.EPGIR.G Y 20.78 570.3125 5 -37.6 571.2983 1 79.53 6 44826 VEV_3_3_RA6_01_1237.d 0 1 1 401 405
K.KPNDGGK.G Y 20.40 714.3660 7 13.1 715.3826 1 94.82 6 53528 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 267 273
K.NAASGISSPSAR.T Y 20.36 1116.5524 12 1.3 559.2842 2 37.46 4 17205 VEV_1_3_RA4_01_1235.d 0 1 1 111 122
K.C(+57.02)PITPPLAKPAAAKSSPLGENR.L Y 20.01 2274.2153 22 -29.3 569.5444 4 83.51 4 49567 VEV_1_3_RA4_01_1235.d 7.67E4 1 1 218 239 Carbamidomethylation
K.ATSKENGWEKHTTAVK.E Y 19.27 1785.9009 16 4.4 596.3102 3 76.48 5 43652 VEV_2_3_RA5_01_1236.d 7.61E4 1 1 171 186
R.REAQEAKAKASAALK.C Y 18.88 1570.8790 15 -17.8 315.1775 5 57.68 5 29894 VEV_2_3_RA5_01_1236.d 0 1 1 203 217
R.AQDFANVSSHR.G Y 18.71 1230.5741 11 -5.2 411.1965 3 31.13 4 13489 VEV_1_3_RA4_01_1235.d 6.85E4 1 1 527 537
K.ATSKENGWEK.H Y 18.52 1148.5461 10 -1.3 575.2796 2 49.43 4 24524 VEV_1_3_RA4_01_1235.d 1.56E5 2 2 171 180
K.DLFLR.K N 18.44 662.3751 5 -10.7 332.1913 2 39.40 6 18149 VEV_3_3_RA6_01_1237.d 2.96E5 2 2 749 753
K.SSPLGENRLENLK.G Y 18.14 1455.7681 13 -22.1 486.2526 3 45.41 5 22385 VEV_2_3_RA5_01_1236.d 0 1 1 232 244
R.VM(+15.99)PDAVAR.D Y 18.03 873.4378 8 -27.8 874.4208 1 81.63 4 48267 VEV_1_3_RA4_01_1235.d 2.7E4 1 1 1122 1129 Oxidation (M)
R.NFNSK.M Y 17.79 608.2918 5 5.4 609.3024 1 67.99 6 36383 VEV_3_3_RA6_01_1237.d 0 1 1 1080 1084
R.NGAFNFK.S Y 17.60 796.3868 7 0.8 797.3947 1 99.09 5 55705 VEV_2_3_RA5_01_1236.d 4.15E4 1 1 1158 1164
R.GGRPAR.G N 17.31 612.3456 6 -53.2 613.3203 1 74.73 6 41345 VEV_3_3_RA6_01_1237.d 0 1 1 392 397
K.SSPLGENR.L Y 16.23 858.4195 8 56.8 430.2414 2 21.22 4 8056 VEV_1_3_RA4_01_1235.d 0 1 1 232 239
R.GLSM(+15.99)R.S Y 15.80 578.2846 5 -9.5 579.2864 1 75.09 6 41612 VEV_3_3_RA6_01_1237.d 5.51E4 1 1 676 680 Oxidation (M)
K.RDKWEQWIIAM(+15.99)ESR.D Y 15.70 1862.9097 14 20.0 466.7440 4 34.01 5 15571 VEV_2_3_RA5_01_1236.d 0 1 1 808 821 Oxidation (M)
R.GRSPSLSK.I Y 15.37 830.4610 8 -18.3 416.2302 2 22.26 6 8750 VEV_3_3_RA6_01_1237.d 0 1 1 1003 1010
total 27 peptides
C1G7V1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSSMLLGGGKDGEGAGAGAGAGAGTR.T Y 110.76 2205.0444 26 -4.5 736.0188 3 57.70 4 29792 VEV_1_3_RA4_01_1235.d 5.58E4 1 1 589 614
R.TDVSPASLGGQDVIAEVLGEK.S Y 88.39 2084.0637 21 0.2 695.6953 3 87.06 5 50345 VEV_2_3_RA5_01_1236.d 3.55E4 1 1 615 635
R.VAFVTQYDVAEAAR.E Y 66.00 1538.7728 14 -13.3 770.3835 2 73.99 4 42349 VEV_1_3_RA4_01_1235.d 1.22E5 3 3 20 33
R.TDVSPASLGGQDVIAEVLGEKSG Y 59.90 2228.1172 23 0.5 1115.0664 2 86.88 5 50246 VEV_2_3_RA5_01_1236.d 6.33E4 1 1 615 637
K.TDPLAPVAYYFR.N Y 58.95 1411.7135 12 -21.8 706.8486 2 83.28 6 47369 VEV_3_3_RA6_01_1237.d 9.1E4 1 1 44 55
K.HLSLWER.M Y 24.77 939.4926 7 -10.2 314.1683 3 13.55 5 4255 VEV_2_3_RA5_01_1236.d 9.85E4 1 1 522 528
total 6 peptides
C1GDK8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASTLGC(+57.02)TTQAC(+57.02)LFR.D Y 91.55 1584.7389 14 -13.3 793.3662 2 69.38 6 37396 VEV_3_3_RA6_01_1237.d 2.76E5 3 3 107 120 Carbamidomethylation
K.TPIESDITASTASAPTR.E Y 86.45 1716.8530 17 -9.5 859.4257 2 64.97 4 35257 VEV_1_3_RA4_01_1235.d 7.59E4 2 2 29 45
K.VGDTINLDEIGVNISTHDGTPTTLK.S Y 76.39 2609.3184 25 -23.5 870.7596 3 80.21 6 45307 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 65 89
K.KTPIESDITASTASAPTR.E Y 73.21 1844.9479 18 1.5 615.9908 3 60.87 6 31075 VEV_3_3_RA6_01_1237.d 0 2 2 28 45
R.DRYDNLTSTGLSIFGLSTDSPK.A Y 72.74 2386.1653 22 -18.5 796.3810 3 84.65 4 50376 VEV_1_3_RA4_01_1235.d 1.25E5 1 1 121 142
K.TETTAETPSLR.K Y 53.24 1204.5935 11 8.4 603.3091 2 42.75 4 20382 VEV_1_3_RA4_01_1235.d 1.52E5 3 3 50 60
R.ELTKTETTAETPSLR.K Y 25.38 1675.8628 15 -11.4 559.6218 3 53.06 6 26093 VEV_3_3_RA6_01_1237.d 7.47E4 1 1 46 60
MVELR.K Y 15.73 646.3472 5 14.2 324.1855 2 54.76 5 28051 VEV_2_3_RA5_01_1236.d 6.2E4 1 1 1 5
total 8 peptides
C1GAA6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSQTAVAFTGGYLAGILC(+57.02)AIVSHPADVMVSK.L Y 98.59 3149.5889 31 -12.0 1050.8577 3 95.50 5 54436 VEV_2_3_RA5_01_1236.d 2.98E5 2 2 293 323 Carbamidomethylation
K.FASFETIVEMIYNRLPGQK.S Y 64.25 2242.1455 19 -5.9 748.3847 3 92.73 4 55157 VEV_1_3_RA4_01_1235.d 2.71E5 2 2 269 287
R.LPGEAFGGAMSR.I Y 63.35 1191.5706 12 -5.5 596.7893 2 66.20 4 36212 VEV_1_3_RA4_01_1235.d 6.09E4 2 2 329 340
K.TGQIELYSPK.Y Y 59.68 1134.5920 10 -20.1 568.2919 2 61.04 6 31232 VEV_3_3_RA6_01_1237.d 2.25E5 2 2 77 86
K.FYGDLVGEEK.A Y 57.21 1155.5448 10 -14.4 578.7714 2 65.87 6 34792 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 180 189
R.GIFTGWSPTFFGYSAQGAFK.Y Y 50.19 2168.0366 20 -6.6 1085.0184 2 90.15 6 51390 VEV_3_3_RA6_01_1237.d 1.46E5 2 2 151 170
K.EGIAGLYK.G Y 45.70 849.4596 8 -19.5 425.7288 2 59.61 6 30161 VEV_3_3_RA6_01_1237.d 5.86E5 1 1 245 252
K.LN(+.98)ANRLPGEAFGGAMSR.I Y 44.34 1760.8628 17 0.2 587.9617 3 68.17 4 37769 VEV_1_3_RA4_01_1235.d 7.99E4 1 1 324 340 Deamidation (NQ)
K.SATHELEKASAK.I Y 40.89 1270.6517 12 -40.9 636.3071 2 16.32 5 5732 VEV_2_3_RA5_01_1236.d 0 1 1 61 72
K.TGQ(+.98)IELYSPK.Y Y 21.88 1135.5760 10 6.2 568.7988 2 61.46 5 32631 VEV_2_3_RA5_01_1236.d 2.25E4 1 1 77 86 Deamidation (NQ)
R.Q(+.98)VDAK.M N 21.33 560.2806 5 -22.4 561.2753 1 8.59 4 2028 VEV_1_3_RA4_01_1235.d 3.96E3 1 1 127 131 Deamidation (NQ)
K.SSQTAVAFT(-2.02)GGYLAGILC(+57.02)AIVSHPADVMVSK.L Y 19.43 3147.5732 31 -7.8 1050.1902 3 95.51 4 56523 VEV_1_3_RA4_01_1235.d 0 1 1 293 323 2-amino-3-oxo-butanoic_acid; Carbamidomethylation
K.T(-2.02)GQIELYSPK.Y Y 17.91 1132.5764 10 -21.0 567.2836 2 61.34 4 32554 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 77 86 2-amino-3-oxo-butanoic_acid
R.AEGIR.G N 15.15 544.2969 5 -53.1 545.2753 1 75.01 6 41547 VEV_3_3_RA6_01_1237.d 5.78E4 1 1 146 150
total 14 peptides
C1G7W6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGNSDVVELATHDSVPIDTPK.A Y 127.06 2192.0959 21 -12.8 731.6966 3 75.21 6 41690 VEV_3_3_RA6_01_1237.d 3.36E5 3 3 4 24
K.ASNATMPESEIFDNAK.S Y 91.53 1723.7722 16 -11.8 862.8832 2 70.61 5 39434 VEV_2_3_RA5_01_1236.d 5.22E4 1 1 25 40
R.SFAELDVLFEHR.I Y 58.26 1461.7252 12 -19.7 488.2394 3 81.87 6 46459 VEV_3_3_RA6_01_1237.d 5.8E4 1 1 514 525
R.MTLLQGLR.L Y 31.72 930.5320 8 -21.5 466.2633 2 72.54 6 39759 VEV_3_3_RA6_01_1237.d 1.36E4 2 2 49 56
R.IDEAK.R N 15.89 574.2962 5 39.5 575.3262 1 30.61 5 13613 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 264 268
R.TKVNVFEEEVK.D Y 15.70 1320.6925 11 -36.5 441.2220 3 33.51 5 15296 VEV_2_3_RA5_01_1236.d 2.51E5 1 1 534 544
total 6 peptides
C1G4D1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GYLEEPELMMLALR Y 77.82 1663.8313 14 -11.7 832.9132 2 88.67 5 51224 VEV_2_3_RA5_01_1236.d 3.15E5 2 2 482 495
K.GLNVDILNVTGTGKDGR.V Y 72.92 1727.9166 17 -8.5 576.9746 3 75.15 4 43241 VEV_1_3_RA4_01_1235.d 8.2E5 3 3 203 219
K.YATLATPAVR.G Y 65.69 1061.5869 10 -13.7 531.7935 2 60.24 5 31729 VEV_2_3_RA5_01_1236.d 2.53E5 3 3 189 198
R.SILDIATELVR.L Y 63.47 1228.7026 11 -8.7 615.3533 2 88.25 4 52649 VEV_1_3_RA4_01_1235.d 4.65E5 4 4 379 389
K.EGSAISLNTAEAPPKPVEQPATLK.S Y 56.85 2447.2908 24 -12.6 816.7606 3 69.71 4 38991 VEV_1_3_RA4_01_1235.d 2.62E5 3 3 163 186
K.AVSLSLNTFPLLNAR.V Y 56.65 1614.9093 15 -16.6 808.4485 2 85.73 6 48916 VEV_3_3_RA6_01_1237.d 6.27E4 3 3 324 338
R.VDTTNPNKPSLIMR.S Y 51.08 1584.8293 14 -12.0 793.4125 2 58.64 5 30553 VEV_2_3_RA5_01_1236.d 2.86E5 4 4 339 352
K.LTPADLNGGTITVSNIGNIGGTYVGPVIVPNEVAILGIGR.A Y 50.94 3931.1418 40 -9.6 1311.3754 3 94.27 6 53305 VEV_3_3_RA6_01_1237.d 2.95E4 1 1 399 438
K.LSYLPFIIK.A Y 49.91 1092.6583 9 -9.5 547.3312 2 84.05 4 49946 VEV_1_3_RA4_01_1235.d 5.89E4 2 2 315 323
R.SLSIPHFLYADELNIASLSSIR.K Y 47.36 2445.2903 22 22.0 816.1219 3 88.90 4 53052 VEV_1_3_RA4_01_1235.d 0 1 1 281 302
K.SKYATLATPAVR.G Y 45.35 1276.7139 12 -35.3 639.3417 2 53.53 5 27320 VEV_2_3_RA5_01_1236.d 0 1 1 187 198
K.LASHPTHPQK.L Y 38.64 1114.5884 10 -19.4 558.2906 2 10.95 4 2833 VEV_1_3_RA4_01_1235.d 9.77E3 1 1 305 314
R.SILDIATELVR(+14.02).L Y 26.71 1242.7183 11 -7.2 622.3619 2 89.78 4 53534 VEV_1_3_RA4_01_1235.d 1.06E5 3 3 379 389 Methylation(KR)
R.VIKEDVLR.Y Y 23.34 970.5811 8 -14.4 324.5297 3 40.98 6 19053 VEV_3_3_RA6_01_1237.d 9.26E4 1 1 220 227
K.GLN(+.98)VDILNVTGTGKDGR.V Y 20.27 1728.9006 17 22.7 577.3206 3 75.06 6 41583 VEV_3_3_RA6_01_1237.d 0 1 1 203 219 Deamidation (NQ)
R.SLSIPHFLY(-2.02)ADELNIASLSSIR.K Y 16.56 2443.2747 22 -22.1 815.4142 3 89.06 4 53141 VEV_1_3_RA4_01_1235.d 0 1 1 281 302 2-amino-3-oxo-butanoic_acid
total 16 peptides
C1G9J2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EGPLQDPTSTSQMSPDRPEK.T Y 109.88 2199.0112 20 -8.2 734.0050 3 60.12 5 31638 VEV_2_3_RA5_01_1236.d 2.85E5 3 3 43 62
R.AAPTVSPSTVLQEGATSLQK.V Y 84.15 1984.0476 20 -9.3 993.0219 2 77.59 5 44435 VEV_2_3_RA5_01_1236.d 1.66E5 2 2 522 541
R.DPKPTTDANHASASTSISALSK.L Y 71.25 2198.0815 22 -10.7 733.6933 3 54.46 5 27864 VEV_2_3_RA5_01_1236.d 1.78E5 3 3 11 32
K.TALETLDPQAEK.T Y 70.45 1314.6666 12 -12.0 658.3327 2 62.35 6 32159 VEV_3_3_RA6_01_1237.d 2.27E5 4 4 63 74
R.EGPLQDPTSTSQM(+15.99)SPDRPEK.T Y 42.82 2215.0063 20 -9.4 739.3358 3 50.91 6 24821 VEV_3_3_RA6_01_1237.d 1.15E5 2 2 43 62 Oxidation (M)
K.GVSATK.S Y 23.48 561.3122 6 -48.3 562.2924 1 39.12 6 17993 VEV_3_3_RA6_01_1237.d 6.16E4 2 2 390 395
K.KLDSVAAAS Y 21.77 860.4603 9 -19.6 431.2290 2 55.85 5 28676 VEV_2_3_RA5_01_1236.d 5.88E4 2 2 589 597
K.WGGTK.Y Y 15.86 547.2755 5 20.3 548.2938 1 67.21 4 37010 VEV_1_3_RA4_01_1235.d 0 1 1 311 315
K.LDSVAAAS Y 15.37 732.3654 8 5.1 367.1918 2 26.39 4 10866 VEV_1_3_RA4_01_1235.d 7.98E4 1 1 590 597
total 9 peptides
C1G736
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALKPAGPQGSELLQR.E Y 93.58 1563.8733 15 -9.7 522.2933 3 59.91 4 31424 VEV_1_3_RA4_01_1235.d 1.77E5 3 3 10 24
R.AVFAGQAPDNDTC(+57.02)R.I Y 86.78 1520.6677 14 -2.8 761.3390 2 50.25 6 24475 VEV_3_3_RA6_01_1237.d 3.32E5 4 4 464 477 Carbamidomethylation
K.AAGENQVLDYK.M Y 68.65 1206.5880 11 4.5 604.3040 2 53.00 4 26810 VEV_1_3_RA4_01_1235.d 4.17E5 3 3 333 343
R.TAFLTFEALK.H Y 68.09 1139.6226 10 -11.4 570.8121 2 80.39 4 47317 VEV_1_3_RA4_01_1235.d 7.1E4 1 1 509 518
R.LVDAWKFPDWQLDSSLGR.S Y 46.86 2132.0691 18 -17.1 711.6848 3 84.84 4 50482 VEV_1_3_RA4_01_1235.d 7.54E4 1 1 623 640
K.THEPLEGVHVGDIGPK.F Y 32.89 1683.8580 16 -12.6 421.9665 4 63.78 4 34345 VEV_1_3_RA4_01_1235.d 1.45E5 2 2 227 242
R.YGPHPFVVPIRDLK.T Y 20.81 1636.9089 14 -28.8 410.2227 4 71.24 6 38794 VEV_3_3_RA6_01_1237.d 8.23E4 2 2 213 226
R.KDTGAAFDILDSDAEIVDAFAWR.T Y 20.23 2525.2073 23 -8.4 842.7360 3 91.45 6 52051 VEV_3_3_RA6_01_1237.d 1.18E4 1 1 486 508
K.AAGENQVLDYKMVQIR.I Y 20.21 1833.9407 16 -37.8 612.2977 3 85.03 6 48483 VEV_3_3_RA6_01_1237.d 0 1 1 333 348
K.TFVMHSPTLTASK.W Y 18.24 1418.7228 13 -32.8 473.8994 3 14.31 5 4652 VEV_2_3_RA5_01_1236.d 4.01E4 1 1 175 187
M.APIPEWVK.A Y 17.88 938.5225 8 -19.0 470.2596 2 68.63 4 38142 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 2 9
R.QFQDRDAK.D Y 16.99 1006.4832 8 5.1 504.2514 2 33.66 6 14886 VEV_3_3_RA6_01_1237.d 0 1 1 323 330
K.ALGSTIAAEGLEVC(+57.02)RR.A Y 15.02 1701.8832 16 -16.0 568.2926 3 50.04 4 24906 VEV_1_3_RA4_01_1235.d 0 1 1 402 417 Carbamidomethylation
total 13 peptides
C1G3N7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPTGTVSYLSTTR.K Y 105.00 1368.6885 13 -10.3 685.3445 2 61.40 6 31444 VEV_3_3_RA6_01_1237.d 3.12E5 3 3 559 571
R.DAIHTTDVGLNSC(+57.02)TTK.H Y 94.69 1731.8098 16 -12.6 578.2700 3 56.73 6 28184 VEV_3_3_RA6_01_1237.d 0 2 2 397 412 Carbamidomethylation
R.NDVC(+57.02)GVGVAYDSSVAGIR.I Y 68.36 1837.8628 18 -6.1 919.9331 2 73.47 4 41954 VEV_1_3_RA4_01_1235.d 1.54E4 1 1 258 275 Carbamidomethylation
R.C(+57.02)AGEVAGVRN(-17.03)DVC(+57.02)GVGVAYDSSVAGIR.I Y 56.51 2720.2646 27 -18.4 907.7455 3 81.53 4 48191 VEV_1_3_RA4_01_1235.d 3.11E4 1 1 249 275 Carbamidomethylation; Ammonia-loss (N)
R.LYDDKHGTR.C Y 34.09 1103.5359 9 -17.8 368.8460 3 11.60 6 3204 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 240 248
R.RTQVWIYGFLTLILIFC(+57.02)STLGTYFLIQR.R Y 23.35 3421.8623 28 -1.2 856.4719 4 98.50 4 57706 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 727 754 Carbamidomethylation
R.RGDLSVELR.S Y 22.13 1043.5723 9 -2.5 348.8638 3 49.43 4 24523 VEV_1_3_RA4_01_1235.d 6.09E4 1 1 550 558
K.GLASSFEVTK.E Y 18.10 1037.5393 10 -57.2 346.8339 3 25.30 5 10659 VEV_2_3_RA5_01_1236.d 1.65E5 1 1 516 525
total 8 peptides
C1G5A0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YGQSGVADGGYSHGYGAQPQQGYR.T Y 104.22 2502.0947 24 -6.0 835.0338 3 59.02 5 30835 VEV_2_3_RA5_01_1236.d 3.4E5 4 4 274 297
R.AIGSNTGGVGTVGGGGVSAGFTK.Y Y 96.77 1949.9806 23 -9.0 975.9888 2 68.30 4 37882 VEV_1_3_RA4_01_1235.d 1.52E5 3 3 249 271
R.TAQFPESPRNF Y 78.37 1292.6149 11 -8.0 647.3096 2 66.81 5 36634 VEV_2_3_RA5_01_1236.d 8.9E4 2 2 298 308
R.TAQFPESPR.N Y 63.63 1031.5035 9 -10.4 516.7537 2 43.92 5 21471 VEV_2_3_RA5_01_1236.d 3.09E5 3 3 298 306
R.AIGS(-2.02)NTGGVGTVGGGGVSAGFTK.Y Y 44.05 1947.9650 23 -11.5 974.9785 2 68.09 5 37604 VEV_2_3_RA5_01_1236.d 1.55E4 1 1 249 271 2-amino-3-oxo-butanoic_acid
K.SLAGPGTGNNDK.L Y 28.26 1129.5364 12 -3.9 377.5179 3 21.28 4 8096 VEV_1_3_RA4_01_1235.d 2.55E5 1 1 122 133
K.WFGPSPGNNYTEGLSRNSK.R Y 16.31 2109.9868 19 17.6 704.3486 3 52.75 5 26833 VEV_2_3_RA5_01_1236.d 1.28E4 1 1 180 198
K.WFGPSPGNNYTEGLSR.N Y 15.27 1780.8169 16 -4.8 446.2094 4 15.30 4 4945 VEV_1_3_RA4_01_1235.d 0 1 1 180 195
total 8 peptides
C1GF47
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTPDVDALDIAATK.L Y 79.42 1441.7664 14 -11.9 721.8819 2 76.94 6 42960 VEV_3_3_RA6_01_1237.d 2.1E5 3 3 136 149
K.TLYDVDTVKINTLIRPDGSK.K Y 77.87 2247.2109 20 -10.0 562.8044 4 76.58 6 42698 VEV_3_3_RA6_01_1237.d 1.64E5 2 2 111 130
R.TSTTFHRPK.T Y 76.44 1073.5618 9 -12.1 537.7817 2 14.67 5 4864 VEV_2_3_RA5_01_1236.d 1.54E6 9 9 38 46
K.IIIHPLNTESAMK.K Y 71.87 1465.7963 13 -19.9 733.8908 2 65.14 5 35385 VEV_2_3_RA5_01_1236.d 5.33E5 5 5 72 84
K.TLYDVDTVK.I Y 67.08 1052.5389 9 -11.0 527.2709 2 60.73 4 32030 VEV_1_3_RA4_01_1235.d 9.58E5 7 7 111 119
K.INTLIRPDGSK.K Y 49.70 1212.6826 11 -16.5 405.2281 3 45.04 6 21427 VEV_3_3_RA6_01_1237.d 8.1E5 8 8 120 130
R.TS(+162.05)TTFHRPK.T Y 37.70 1235.6146 9 -19.7 309.9048 4 15.01 4 4797 VEV_1_3_RA4_01_1235.d 0 1 1 38 46 Hexose (NSY)
K.INTLIRPDGSKK.A Y 36.53 1340.7776 12 -30.5 671.3756 2 34.25 6 15224 VEV_3_3_RA6_01_1237.d 0 1 1 120 131
K.TLQLSR.S Y 30.52 716.4181 6 -12.0 359.2120 2 32.02 5 14431 VEV_2_3_RA5_01_1236.d 1.74E6 8 8 47 52
R.SPKYPR.K Y 28.67 746.4075 6 -23.4 374.2023 2 12.25 5 3584 VEV_2_3_RA5_01_1236.d 2.46E5 3 3 53 58
R.KSIPHETRLDQHK.I Y 27.72 1587.8481 13 -15.0 530.2820 3 18.38 5 6846 VEV_2_3_RA5_01_1236.d 8.75E4 2 2 59 71
R.KSIPHETR.L Y 25.78 966.5247 8 -36.3 484.2521 2 10.67 5 2832 VEV_2_3_RA5_01_1236.d 1.2E5 3 3 59 66
K.TLYDVDTVKINTLIRPDGSKK.A Y 21.71 2375.3059 21 -23.9 476.0571 5 72.84 6 39969 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 111 131
K.T(+42.01)LQLSR.S Y 20.14 758.4286 6 -19.1 380.2144 2 31.69 4 13825 VEV_1_3_RA4_01_1235.d 1.98E4 1 1 47 52 Acetylation (N-term)
R.SPKYPRK.S Y 16.63 874.5024 7 -32.8 438.2441 2 9.81 5 2441 VEV_2_3_RA5_01_1236.d 1.47E4 1 1 53 59
K.TLQLSRSPKYPR.K Y 15.14 1444.8149 12 -12.7 362.2064 4 66.42 4 36388 VEV_1_3_RA4_01_1235.d 0 1 1 47 58
total 16 peptides
C1GAG5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YIIAGHEDGSVSQYDAK.T Y 125.76 1851.8639 17 -10.5 618.2888 3 60.43 6 30749 VEV_3_3_RA6_01_1237.d 2.05E5 2 2 166 182
K.GHFGPLNTIAAHPLGTAYASGGEDGYVR.V Y 95.63 2827.3677 28 -4.6 707.8459 4 76.31 4 44149 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 291 318
K.TYVADTPLNTAALTVKK.E Y 41.74 1804.9934 17 -15.5 602.6624 3 70.19 5 39135 VEV_2_3_RA5_01_1236.d 2.28E4 1 1 233 249
R.LWNTKTGEC(+57.02)VK.V Y 29.77 1334.6653 11 -1.4 668.3390 2 85.23 6 48609 VEV_3_3_RA6_01_1237.d 7.54E4 1 1 78 88 Carbamidomethylation
K.EFVILGGGQAAM(+15.99)DVTTTDAR.Q Y 18.68 2066.9941 20 1.3 690.0062 3 81.62 5 47108 VEV_2_3_RA5_01_1236.d 8.92E3 1 1 250 269 Oxidation (M)
MRPILLQGHER.S Y 16.00 1348.7397 11 -16.1 338.1868 4 49.50 5 24852 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 1 11
R.SINQIKFNR.D Y 15.38 1118.6196 9 -29.3 373.8696 3 47.89 5 23863 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 12 20
total 7 peptides
C1GF70
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGAGAPVYLAAVLEYLAAEILELAGNAAR.D Y 134.20 2884.5698 29 -7.2 962.5236 3 98.26 4 57626 VEV_1_3_RA4_01_1235.d 1.3E5 2 2 45 73
K.AGLAFPVGR.V Y 76.33 886.5024 9 -11.5 444.2534 2 68.15 4 37781 VEV_1_3_RA4_01_1235.d 9.21E5 5 5 23 31
K.SGKNTSSLEL Y 35.34 1034.5244 10 -9.7 518.2645 2 45.00 4 21764 VEV_1_3_RA4_01_1235.d 0 1 1 125 134
MTGGK.S Y 29.63 492.2366 5 28.2 493.2578 1 60.79 4 32078 VEV_1_3_RA4_01_1235.d 1.81E5 2 2 1 5
K.NTSSLEL Y 21.86 762.3759 7 -23.8 382.1862 2 13.48 6 4182 VEV_3_3_RA6_01_1237.d 4.43E4 1 1 128 134
K.ASGSK.T N 16.97 448.2281 5 -21.1 449.2260 1 25.02 5 10489 VEV_2_3_RA5_01_1236.d 9.18E4 1 1 10 14
K.A(+27.99)SGSK.T N 16.57 476.2231 5 17.4 477.2386 1 56.59 6 28104 VEV_3_3_RA6_01_1237.d 5.71E4 1 1 10 14 Formylation (Protein N-term)
M(+15.99)TGGK.S Y 16.20 508.2315 5 9.5 509.2437 1 16.30 4 5463 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 1 5 Oxidation (M)
K.SGGKASGSK.T Y 16.00 777.3981 9 -20.1 778.3897 1 85.05 4 50624 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 6 14
MTGGKSGGK.A Y 15.61 821.4065 9 -21.5 822.3961 1 90.98 6 51819 VEV_3_3_RA6_01_1237.d 0 1 1 1 9
total 10 peptides
C1GIR8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NIINPPLNDEVAASPQPVGDGLHAAQQR.M Y 100.24 2920.4790 28 -9.8 974.4908 3 75.75 4 43718 VEV_1_3_RA4_01_1235.d 2.77E5 3 3 197 224
K.GKYSLDDFTLQR.T Y 73.57 1441.7201 12 -20.7 481.5707 3 70.75 4 39820 VEV_1_3_RA4_01_1235.d 1.88E5 3 3 263 274
R.DLKPENLLLDR.Y Y 60.44 1324.7350 11 -22.8 442.5755 3 74.21 6 40965 VEV_3_3_RA6_01_1237.d 8.21E4 1 1 393 403
R.TLGTGSFGR.V Y 52.44 894.4559 9 -17.3 448.2275 2 47.23 6 22686 VEV_3_3_RA6_01_1237.d 1.05E6 9 9 275 283
K.YSLDDFTLQR.T Y 49.50 1256.6036 10 -2.9 629.3073 2 77.54 5 44401 VEV_2_3_RA5_01_1236.d 4.25E4 1 1 265 274
R.MHSQHPQQQQHQQQQQQQQQQQQQQVQQSVPSVSR.Q Y 48.88 4244.9980 35 -6.0 850.0018 5 41.65 4 19693 VEV_1_3_RA4_01_1235.d 4.12E4 1 1 225 259
R.VHLVQSR.H Y 43.48 837.4821 7 -13.9 419.7425 2 19.20 5 7311 VEV_2_3_RA5_01_1236.d 1.25E5 3 3 284 290
R.VKYPSYMHPDAQDLLSQLITPDLTVR.L Y 26.88 2999.5425 26 -2.9 750.8907 4 87.21 4 52011 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 483 508
K.IYENIIK.C Y 25.86 891.5065 7 -5.7 446.7580 2 60.34 4 31740 VEV_1_3_RA4_01_1235.d 8.17E4 1 1 474 480
K.ITDFGFAK.E Y 15.87 897.4596 8 25.1 898.4894 1 71.62 5 40188 VEV_2_3_RA5_01_1236.d 2.68E5 1 1 409 416
total 10 peptides
C1GAQ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GFEGDATPFTDVTVDSISGLLR.E Y 86.72 2296.1223 22 -4.1 1149.0637 2 90.83 4 54128 VEV_1_3_RA4_01_1235.d 1.37E5 1 1 1071 1092
K.TAPLAPDAEELGQR.T Y 82.36 1466.7365 14 -8.9 734.3690 2 65.44 4 35621 VEV_1_3_RA4_01_1235.d 9.56E4 2 2 947 960
R.STLPYIKTDIPIVVVFR.A Y 71.28 1960.1396 17 -60.6 654.3476 3 85.66 5 49539 VEV_2_3_RA5_01_1236.d 2.6E4 3 3 292 308
K.ALNEDEPEEENVFIGR.M Y 53.60 1859.8536 16 -5.6 930.9289 2 73.20 4 41740 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 171 186
R.LISERDDADQDEQDNDEDRR.N Y 52.27 2433.0276 20 6.3 609.2680 4 33.71 4 14992 VEV_1_3_RA4_01_1235.d 7.99E4 3 3 140 159
R.EGITPDIIINPHAIPSR.M Y 42.00 1841.9999 17 -4.6 615.0044 3 77.55 5 44406 VEV_2_3_RA5_01_1236.d 3.1E5 1 1 1036 1052
K.SENC(+57.02)GSLVLSK.E Y 36.80 1192.5758 11 -31.0 597.2767 2 48.29 4 23803 VEV_1_3_RA4_01_1235.d 5.25E3 1 1 668 678 Carbamidomethylation
R.DGGLR.F N 28.04 516.2656 5 -46.4 517.2489 1 48.32 6 23331 VEV_3_3_RA6_01_1237.d 0 1 1 1157 1161
K.APPSPTPYVAEIR.S Y 26.23 1396.7350 13 -38.5 699.3479 2 68.50 6 36765 VEV_3_3_RA6_01_1237.d 7.38E4 2 2 246 258
K.ASTLSGGLK.Y Y 24.87 832.4654 9 -9.8 417.2359 2 29.54 4 12588 VEV_1_3_RA4_01_1235.d 0 1 1 472 480
R.YTYASTLSHLR.R Y 23.88 1310.6619 11 -16.0 437.8876 3 63.22 4 33931 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 508 518
K.AGVSQVLNR.Y Y 21.63 942.5247 9 -16.2 472.2620 2 46.19 4 22496 VEV_1_3_RA4_01_1235.d 0 2 2 499 507
R.ILSQLSIK.L Y 15.33 900.5644 8 -80.9 451.2531 2 65.36 4 35559 VEV_1_3_RA4_01_1235.d 0 1 1 267 274
total 13 peptides
C1GFL2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLAVDLLNPTPQAEAR.K Y 121.62 1705.9363 16 -14.8 853.9628 2 79.11 6 44543 VEV_3_3_RA6_01_1237.d 1.11E6 4 4 64 79
R.VLAVDLLNPTPQAEAR(+14.02).K Y 82.81 1719.9519 16 -7.9 860.9764 2 80.53 4 47426 VEV_1_3_RA4_01_1235.d 2.02E5 4 4 64 79 Methylation(KR)
R.VLAVDLLNPTPQ(+.98)AEAR.K Y 76.97 1706.9203 16 -15.8 854.4539 2 79.94 6 45115 VEV_3_3_RA6_01_1237.d 6.93E4 3 3 64 79 Deamidation (NQ)
R.LTEGC(+57.02)SFR.R Y 67.49 968.4385 8 -11.2 485.2211 2 36.86 5 17348 VEV_2_3_RA5_01_1236.d 2.59E6 10 10 135 142 Carbamidomethylation
K.M(+15.99)LVPAPR.S Y 59.16 798.4422 7 -10.3 400.2243 2 42.18 4 20015 VEV_1_3_RA4_01_1235.d 1.33E6 14 14 85 91 Oxidation (M)
R.VLAVDLLNPTPQAEARK.H Y 51.87 1834.0312 17 -0.4 459.5149 4 73.79 6 40666 VEV_3_3_RA6_01_1237.d 0 1 1 64 80
K.MLVPAPR.S Y 46.82 782.4473 7 -19.1 392.2234 2 53.94 5 27558 VEV_2_3_RA5_01_1236.d 2.75E5 2 2 85 91
R.LTEGC(+57.02)SFR(+14.02).R Y 28.63 982.4542 8 -11.3 492.2289 2 49.37 5 24765 VEV_2_3_RA5_01_1236.d 1.11E5 2 2 135 142 Carbamidomethylation; Methylation(KR)
R.SFFMDVK.C Y 25.59 872.4102 7 -10.7 437.2077 2 71.12 4 40092 VEV_1_3_RA4_01_1235.d 1.82E5 3 3 92 98
K.M(+15.99)LVPAPRSFFM(+15.99)DVK.C Y 21.61 1668.8367 14 18.4 418.2241 4 53.26 5 27211 VEV_2_3_RA5_01_1236.d 0 1 1 85 98 Oxidation (M)
K.LKMLVPAPR.S Y 19.89 1023.6263 9 -20.8 342.2089 3 61.35 5 32549 VEV_2_3_RA5_01_1236.d 2.92E4 1 1 83 91
K.HK(+43.99)LKMLVPAPR.S Y 16.61 1332.7700 11 -11.6 334.1959 4 37.47 5 17635 VEV_2_3_RA5_01_1236.d 0 2 2 81 91 Carboxylation (DKW)
K.H(+42.01)KLKMLVPAPR.S Y 15.61 1330.7908 11 24.5 333.7131 4 37.37 5 17564 VEV_2_3_RA5_01_1236.d 0 1 1 81 91 Acetylation (N-term)
total 13 peptides
C1GD55
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSVNSIDPVMLSIFGHR.F Y 89.59 1869.9771 17 -7.8 624.3281 3 85.23 4 50747 VEV_1_3_RA4_01_1235.d 1.39E5 2 2 772 788
R.KGGPLTVTDANLYLGR.L Y 85.52 1673.9100 16 16.4 558.9865 3 72.93 4 41523 VEV_1_3_RA4_01_1235.d 0 1 1 418 433
R.IPVQVSILSER.R Y 40.40 1239.7186 11 -29.4 620.8484 2 86.32 5 49919 VEV_2_3_RA5_01_1236.d 9.62E5 3 3 1237 1247
R.AQLQALYDEGFR.S Y 40.22 1409.6938 12 -13.0 705.8450 2 75.29 6 41748 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 195 206
R.NPRHAWKGGSLASR.T Y 32.83 1535.8069 14 -10.5 384.9550 4 31.08 4 13463 VEV_1_3_RA4_01_1235.d 2.54E5 1 1 1327 1340
K.IANESMTRPIR.S Y 32.43 1286.6765 11 8.2 644.3508 2 41.10 4 19362 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 489 499
R.ITDSEVFER.R Y 32.32 1094.5244 9 -9.4 548.2643 2 58.11 5 30187 VEV_2_3_RA5_01_1236.d 2.2E5 4 4 1194 1202
R.NGLFVVGPESAGAHPGPAC(+57.02)YR.K Y 29.33 2155.0269 21 -4.2 719.3466 3 72.27 4 41013 VEV_1_3_RA4_01_1235.d 3.26E4 2 2 397 417 Carbamidomethylation
K.IFDLAIC(+57.02)KPDVLHEK.V Y 28.71 1796.9495 15 -13.6 450.2385 4 75.07 6 41593 VEV_3_3_RA6_01_1237.d 1.48E5 1 1 123 137 Carbamidomethylation
K.IFGPNENEALDRNASAK.L Y 27.10 1844.9016 17 -16.2 615.9645 3 60.10 4 31560 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 442 458
R.C(+57.02)LADNLNDLK.A Y 22.76 1174.5652 10 4.9 588.2927 2 67.76 4 37449 VEV_1_3_RA4_01_1235.d 1.61E3 1 1 958 967 Carbamidomethylation
K.ISIDAEK.G Y 21.53 774.4123 7 -39.3 775.3892 1 59.06 5 30861 VEV_2_3_RA5_01_1236.d 0 1 1 1039 1045
R.LARETGFTHISLSHELM(+15.99)PMIK.L Y 21.35 2426.2449 21 -30.6 486.2414 5 52.55 6 25793 VEV_3_3_RA6_01_1237.d 3.2E4 1 1 228 248 Oxidation (M)
K.TVDQQLEEAKPR.D Y 21.13 1412.7260 12 -25.3 707.3524 2 83.73 4 49723 VEV_1_3_RA4_01_1235.d 0 1 1 683 694
R.MGTTVATNALLER.K Y 20.32 1375.7129 13 -22.1 344.9279 4 53.25 4 26954 VEV_1_3_RA4_01_1235.d 0 1 1 84 96
R.AHHADIGGVLPGSM(+15.99)PPSSR.E Y 19.53 1900.9214 19 12.8 476.2437 4 57.35 5 29658 VEV_2_3_RA5_01_1236.d 0 1 1 896 914 Oxidation (M)
R.VSVNSIDPVM(+15.99)LSIFGHR.F Y 19.33 1885.9720 17 -31.0 472.4857 4 44.83 4 21658 VEV_1_3_RA4_01_1235.d 2.11E5 1 1 772 788 Oxidation (M)
R.SLTEAKGHDTSK.H Y 18.59 1272.6310 12 61.1 425.2435 3 43.90 5 21455 VEV_2_3_RA5_01_1236.d 0 1 1 500 511
R.THVVINIGTSESR.D Y 18.06 1411.7419 13 20.2 353.9499 4 67.62 4 37335 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 756 768
R.GTESALM(+15.99)IINPKFQTTADMPDGGEDWAFGK.A Y 18.06 3242.4900 30 0.9 649.5059 5 71.24 5 39904 VEV_2_3_RA5_01_1236.d 1.72E5 1 1 615 644 Oxidation (M)
K.AQVAANQK.G Y 17.94 828.4453 8 11.8 415.2348 2 60.21 5 31701 VEV_2_3_RA5_01_1236.d 0 2 2 968 975
K.KGSDTKGAR.C Y 17.06 918.4883 9 -29.3 460.2380 2 57.42 4 29598 VEV_1_3_RA4_01_1235.d 1.79E5 1 1 288 296
K.TSVSTNVKER.L Y 16.93 1119.5884 10 -14.0 374.1982 3 34.27 6 15231 VEV_3_3_RA6_01_1237.d 1.47E6 1 1 803 812
K.IANESMTRPIRSLTEAKGHDTSK.H Y 16.21 2541.2969 23 -11.5 636.3242 4 70.29 5 39207 VEV_2_3_RA5_01_1236.d 9.64E4 1 1 489 511
K.DC(+57.02)LEIGNQTRPK.I Y 16.15 1429.6984 12 32.4 477.5888 3 67.69 5 37296 VEV_2_3_RA5_01_1236.d 1.45E5 1 1 111 122 Carbamidomethylation
R.ILQRPSESTVRAQLQALYDEGFR.S Y 15.50 2676.3982 23 -43.2 670.0779 4 65.53 4 35693 VEV_1_3_RA4_01_1235.d 0 1 1 184 206
R.G(+42.01)VSSEAVR.I Y 15.38 845.4243 8 -14.8 423.7132 2 28.87 5 12615 VEV_2_3_RA5_01_1236.d 6.32E4 1 1 176 183 Acetylation (N-term)
R.VETPIYK.L Y 15.16 848.4644 7 -54.0 425.2166 2 34.48 6 15358 VEV_3_3_RA6_01_1237.d 0 1 1 714 720
total 28 peptides
C1GB82
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYINPFVTFLDHGHR.W Y 90.02 1801.8900 15 -11.7 451.4745 4 80.28 4 47235 VEV_1_3_RA4_01_1235.d 5.04E4 1 1 270 284
R.YTGGQTYFYPGWNAGR.S Y 85.75 1836.8219 16 -6.7 919.4120 2 76.38 4 44211 VEV_1_3_RA4_01_1235.d 8.04E4 2 2 548 563
R.VITLALPTTQSLADVYSSADQSAIITYFSHK.A Y 69.00 3339.7239 31 -11.4 835.9287 4 91.01 4 54213 VEV_1_3_RA4_01_1235.d 4.17E4 2 2 658 688
R.MSTFYGNFFNR.S Y 56.27 1382.6078 11 -4.3 692.3082 2 79.76 4 46839 VEV_1_3_RA4_01_1235.d 3.93E4 1 1 598 608
R.SSDLC(+57.02)AFPAFPR.D Y 53.19 1366.6339 12 -10.2 684.3173 2 77.89 6 43647 VEV_3_3_RA6_01_1237.d 4.1E4 1 1 609 620 Carbamidomethylation
K.ESSLLQTGNSFYK.S Y 39.92 1472.7147 13 -13.6 737.3546 2 71.36 6 38880 VEV_3_3_RA6_01_1237.d 7.5E4 1 1 502 514
R.TLGSGLEPAR.D Y 32.23 999.5349 10 -14.1 1000.5281 1 95.04 5 54237 VEV_2_3_RA5_01_1236.d 2.82E4 2 2 693 702
K.LISPVGGK.M Y 25.96 769.4697 8 -11.5 385.7377 2 40.81 4 19180 VEV_1_3_RA4_01_1235.d 3.35E5 3 3 465 472
K.Q(-15.01)FLPELENDFNER.V Y 19.25 1634.7576 13 16.3 818.3994 2 89.29 6 50941 VEV_3_3_RA6_01_1237.d 0 1 1 863 875 ISD (z+2)-series
R.STLNAVPTTHSLLK.K Y 17.58 1480.8250 14 -19.0 371.2065 4 13.43 5 4198 VEV_2_3_RA5_01_1236.d 3.63E4 2 2 218 231
total 10 peptides
C1G596
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EVANAVHSTGAGK.F Y 92.35 1239.6207 13 -12.0 620.8102 2 16.18 6 5555 VEV_3_3_RA6_01_1237.d 2.09E5 4 4 148 160
R.ESETIITSLPEPR.H Y 88.06 1470.7566 13 -20.9 736.3702 2 73.07 6 40197 VEV_3_3_RA6_01_1237.d 2.56E4 2 2 98 110
K.VTQQFVQEAAR.G Y 74.61 1275.6571 11 -13.5 638.8272 2 52.53 6 25782 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 72 82
K.TLGQMINSSTGR.S Y 55.72 1263.6241 12 -19.4 632.8071 2 61.28 6 31363 VEV_3_3_RA6_01_1237.d 1.02E5 2 2 249 260
R.LFIDC(+57.02)STIDPASSR.E Y 55.36 1580.7504 14 -9.1 791.3753 2 75.98 5 43299 VEV_2_3_RA5_01_1236.d 2.88E5 1 1 134 147 Carbamidomethylation
R.AENTLLFMGK.K Y 46.46 1122.5743 10 -15.6 562.2857 2 72.66 6 39863 VEV_3_3_RA6_01_1237.d 0 1 1 195 204
R.ESE(+14.02)TIITSLPEPR.H Y 30.36 1484.7722 13 -27.1 743.3733 2 76.11 6 42349 VEV_3_3_RA6_01_1237.d 8.26E3 1 1 98 110 Methylation(others)
R.SWSSEVNNPVPGVVETAPASR.E Y 19.27 2182.0654 21 -14.3 728.3521 3 75.72 6 42072 VEV_3_3_RA6_01_1237.d 1.08E5 1 1 261 281
R.L(+226.08)AVEAAR.E Y 15.57 954.4957 7 -12.6 478.2491 2 17.95 6 6485 VEV_3_3_RA6_01_1237.d 0 1 1 298 304 Biotinylation
total 9 peptides
C1G7E0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SHYDWINDINEVTGSDLQFPIIADADRK.I Y 90.76 3231.5471 28 -10.9 808.8853 4 87.31 6 49835 VEV_3_3_RA6_01_1237.d 2.51E5 2 2 82 109
K.SHYDWINDINEVTGSDLQFPIIADADR.K Y 71.82 3103.4521 27 -5.4 1035.4857 3 90.40 6 51520 VEV_3_3_RA6_01_1237.d 7.69E4 2 2 82 108
R.LTISYPASTGR.N Y 68.72 1164.6139 11 -21.6 583.3016 2 63.48 6 33056 VEV_3_3_RA6_01_1237.d 6.45E5 3 3 148 158
R.LGSTAPNFK.A Y 51.96 933.4919 9 -9.3 467.7489 2 43.43 4 20794 VEV_1_3_RA4_01_1235.d 1.28E6 9 9 11 19
K.LIGLSANTLK.S Y 47.55 1028.6229 10 -25.4 515.3057 2 68.82 6 37026 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 72 81
K.SHYDWINDINEVT(-2.02)GSDLQFPIIADADRK.I Y 47.23 3229.5315 28 -14.4 1077.5023 3 87.35 5 50496 VEV_2_3_RA5_01_1236.d 6.69E3 1 1 82 109 2-amino-3-oxo-butanoic_acid
K.LEPEFTAR.G Y 46.40 961.4869 8 -14.9 481.7435 2 54.25 6 26798 VEV_3_3_RA6_01_1237.d 1.2E6 6 6 61 68
R.LTISYPASTGR(+14.02).N Y 36.49 1178.6295 11 -15.1 590.3131 2 64.72 5 35056 VEV_2_3_RA5_01_1236.d 1.29E5 2 2 148 158 Methylation(KR)
R.SVFIIDPNKKIR.L Y 33.05 1428.8452 12 -42.2 477.2689 3 64.43 5 34844 VEV_2_3_RA5_01_1236.d 1.02E5 2 2 136 147
R.VIDALQTTDK.N Y 31.67 1102.5870 10 -43.8 552.2767 2 49.71 6 24137 VEV_3_3_RA6_01_1237.d 0 1 1 166 175
R.IVKPYLR.Y Y 30.11 887.5592 7 -17.2 444.7792 2 38.49 6 17621 VEV_3_3_RA6_01_1237.d 2.23E5 1 1 210 216
M.A(+42.01)EEHRAPLR.L Y 29.17 1119.5785 9 -12.2 560.7897 2 24.54 5 10250 VEV_2_3_RA5_01_1236.d 2.38E5 1 1 2 10 Acetylation (Protein N-term)
R.SVFIIDPNKK.I Y 23.97 1159.6600 10 -34.5 580.8173 2 62.68 5 33540 VEV_2_3_RA5_01_1236.d 4E5 3 3 136 145
R.VIDALQTTDKNGVNTPINWNVGDDVIIPPAVK.T Y 18.76 3415.7986 32 -5.2 854.9525 4 84.58 6 48193 VEV_3_3_RA6_01_1237.d 8.44E4 1 1 166 197
total 14 peptides
C1GC82
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALPNIMVWRPADGNETSAAYYSALTSR.H Y 96.94 2953.4392 27 -6.5 985.4806 3 83.82 5 48453 VEV_2_3_RA5_01_1236.d 7.1E4 2 2 535 561
M.GGYNDVDQLAINTIR.V Y 82.46 1647.8217 15 -9.9 824.9100 2 77.21 5 44175 VEV_2_3_RA5_01_1236.d 5.28E4 2 2 2 16
R.YSPTDPAIASR.K Y 65.51 1176.5775 11 -12.9 589.2885 2 52.56 6 25800 VEV_3_3_RA6_01_1237.d 1E6 4 4 393 403
R.AVATIEFYKGSPVLSPINR.A Y 64.53 2061.1257 19 -42.3 688.0201 3 78.13 4 45576 VEV_1_3_RA4_01_1235.d 0 2 2 704 722
R.HTPSILALTR.Q Y 51.27 1107.6400 10 -19.9 370.2133 3 64.83 5 35144 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 562 571
R.VVSIPC(+57.02)FEVFDVQDKEYR.L Y 31.07 2229.0776 18 -16.2 744.0211 3 82.23 5 47492 VEV_2_3_RA5_01_1236.d 8.05E4 2 2 629 646 Carbamidomethylation
R.YSPTDPAIASR(+14.02).K Y 20.93 1190.5931 11 -16.2 596.2942 2 57.86 6 28935 VEV_3_3_RA6_01_1237.d 4.72E4 1 1 393 403 Methylation(KR)
K.Y(+27.99)PAEHADFTR.R Y 18.95 1233.5414 10 2.2 412.1887 3 21.43 6 8315 VEV_3_3_RA6_01_1237.d 1.74E5 1 1 367 376 Formylation
R.LSALSQVR.V Y 17.70 872.5079 8 -69.5 437.2309 2 47.29 6 22726 VEV_3_3_RA6_01_1237.d 3.53E5 1 1 498 505
R.YSHEQFGLNR.F Y 15.12 1249.5840 10 17.1 625.8099 2 44.68 6 21227 VEV_3_3_RA6_01_1237.d 0 1 1 670 679
total 10 peptides
C1FYE8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SEEKGAEANVAEADAEPEER.V Y 90.06 2129.9348 20 -11.3 710.9775 3 45.10 6 21467 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 173 192
K.GAEANVAEADAEPEER.V Y 81.35 1656.7227 16 -9.4 829.3608 2 48.90 4 24183 VEV_1_3_RA4_01_1235.d 7.06E4 2 2 177 192
R.VKSYDEYLAEQAEQR.R Y 62.38 1827.8639 15 -16.7 610.2850 3 64.51 4 34897 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 193 207
R.VNPTGPSVR.V Y 59.07 925.4981 9 -13.9 463.7499 2 27.28 5 11743 VEV_2_3_RA5_01_1236.d 4.49E5 3 3 316 324
R.YGGNEQAFR.D Y 39.71 1040.4675 9 12.1 521.2473 2 34.87 4 15675 VEV_1_3_RA4_01_1235.d 9.53E4 2 2 87 95
R.VNPTGPSVRVDEK.N Y 38.50 1396.7310 13 -24.9 699.3553 2 39.77 4 18561 VEV_1_3_RA4_01_1235.d 1.38E5 4 4 316 328
R.ASNQTFAR.S Y 36.11 893.4355 8 -16.1 447.7178 2 17.05 6 6013 VEV_3_3_RA6_01_1237.d 1.67E5 3 3 69 76
K.NFPALGGGK Y 29.95 859.4551 9 -2.5 430.7338 2 54.48 6 26980 VEV_3_3_RA6_01_1237.d 5.41E4 1 1 329 337
R.DGLSQPPR.A Y 23.97 868.4402 8 -13.5 435.2215 2 28.02 6 11788 VEV_3_3_RA6_01_1237.d 0 1 1 61 68
R.GRGGEFRGGTPR.G Y 21.15 1245.6326 12 -32.5 623.8033 2 45.49 5 22423 VEV_2_3_RA5_01_1236.d 8.58E4 1 1 299 310
R.GGASRVNPTGPSVR.V Y 19.00 1353.7113 14 -31.0 677.8419 2 90.07 4 53694 VEV_1_3_RA4_01_1235.d 3.94E4 1 1 311 324
R.GGEFRGGTPR.G Y 16.79 1032.5100 10 18.8 517.2720 2 51.25 6 25022 VEV_3_3_RA6_01_1237.d 0 1 1 301 310
K.S(-2.02)EEKGAEANVAEADAEPEER.V Y 15.96 2127.9192 20 -8.0 710.3080 3 45.21 5 22257 VEV_2_3_RA5_01_1236.d 5.98E4 1 1 173 192 2-amino-3-oxo-butanoic_acid
total 13 peptides
C1GJD4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IGVMGSEQLSSVMEAVGR.T Y 85.49 1848.9073 18 -5.9 925.4555 2 83.86 4 49811 VEV_1_3_RA4_01_1235.d 9.35E4 1 1 503 520
K.AATGEVVSAEDLGGGR.L Y 81.20 1487.7216 16 -12.2 744.8590 2 62.33 4 33242 VEV_1_3_RA4_01_1235.d 1.23E5 2 2 277 292
R.DYGSTLVTGFAR.I Y 76.98 1285.6302 12 -7.1 643.8178 2 76.42 4 44234 VEV_1_3_RA4_01_1235.d 6.31E4 1 1 383 394
R.IDAESESIFSSAR.L Y 70.10 1410.6626 13 -4.8 706.3352 2 69.37 4 38718 VEV_1_3_RA4_01_1235.d 1.89E5 2 2 530 542
R.NIPLIFLQNISGFMVGADAEK.G Y 39.80 2276.1875 21 -8.5 1139.0913 2 95.72 4 56623 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 428 448
R.SISNLNWPK.T Y 27.00 1057.5557 9 17.5 353.5320 3 44.36 4 21364 VEV_1_3_RA4_01_1235.d 9.04E4 1 1 318 326
K.VLGM(+15.99)SLAAALGGR.V Y 26.63 1230.6754 13 -28.4 411.2208 3 38.72 4 17947 VEV_1_3_RA4_01_1235.d 0 1 1 557 569 Oxidation (M)
R.KVLGMSLAAALGGRVEEVK.T Y 22.39 1927.0924 19 -44.9 643.3426 3 79.23 6 44612 VEV_3_3_RA6_01_1237.d 1.07E5 2 2 556 574
R.AYSPR.F Y 21.28 592.2969 5 7.9 593.3088 1 73.39 4 41888 VEV_1_3_RA4_01_1235.d 0 1 1 489 493
K.VLGMSLAAALGGRVEEVK.T Y 19.23 1798.9974 18 -83.2 600.6232 3 41.66 5 20114 VEV_2_3_RA5_01_1236.d 7.04E4 1 1 557 574
K.GGPPK.A Y 17.76 454.2540 5 -25.2 455.2498 1 37.47 4 17207 VEV_1_3_RA4_01_1235.d 0 2 2 94 98
K.IGVM(+15.99)GSEQLSSVMEAVGR.T Y 17.37 1864.9022 18 13.1 467.2390 4 61.72 4 32775 VEV_1_3_RA4_01_1235.d 2.65E5 2 2 503 520 Oxidation (M)
R.VEEVK.T N 15.95 602.3275 5 -65.9 603.2951 1 73.87 4 42256 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 570 574
R.TADPALK.A Y 15.31 714.3912 7 -14.5 715.3881 1 50.83 4 25403 VEV_1_3_RA4_01_1235.d 5.49E5 1 1 521 527
total 14 peptides
C1G584
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YDGGAEGTVAAELR.A Y 108.95 1407.6630 14 -10.0 704.8317 2 65.49 6 34492 VEV_3_3_RA6_01_1237.d 2.82E5 3 3 503 516
K.VLALENPPAPVVVADKLSR.K Y 69.89 1987.1465 19 -12.2 663.3813 3 78.29 6 43935 VEV_3_3_RA6_01_1237.d 5.69E5 5 5 17 35
R.IGTWFFF Y 57.63 916.4483 7 -12.4 917.4442 1 96.19 6 54058 VEV_3_3_RA6_01_1237.d 3.52E5 3 3 533 539
R.AKKPFKELTLQEK.A Y 54.52 1558.9082 13 -13.3 520.6364 3 44.66 5 21933 VEV_2_3_RA5_01_1236.d 7.39E4 1 1 517 529
M(+42.01)EFVPPTSDRNHDVEK.V Y 52.35 1941.8890 16 -11.3 971.9409 2 68.44 5 37863 VEV_2_3_RA5_01_1236.d 1.37E5 2 2 1 16 Acetylation (Protein N-term)
R.NVFWR.I Y 21.66 720.3707 5 11.4 361.1967 2 9.51 5 2324 VEV_2_3_RA5_01_1236.d 0 2 2 264 268
K.RIGTWFFF Y 20.70 1072.5494 8 -12.5 537.2753 2 89.32 4 53283 VEV_1_3_RA4_01_1235.d 1.42E5 2 2 532 539
K.YIGGK.N Y 17.79 536.2958 5 -2.2 537.3019 1 66.45 5 36358 VEV_2_3_RA5_01_1236.d 0 1 1 207 211
total 8 peptides
C1G5Z8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IYTGFYDYGPQSIVPLEK.Q Y 90.83 2089.0408 18 -8.3 1045.5190 2 83.81 6 47705 VEV_3_3_RA6_01_1237.d 2.19E5 3 3 776 793
R.TEQSNISPSYPDR.G Y 75.28 1492.6793 13 -8.1 747.3409 2 47.95 5 23893 VEV_2_3_RA5_01_1236.d 3.85E5 6 6 142 154
R.AAPTTMVSQSASSR.F Y 57.49 1392.6667 14 -13.9 697.3310 2 42.42 5 20571 VEV_2_3_RA5_01_1236.d 1.46E5 2 2 592 605
R.RRTDLESGGYLDNPSTPVSGGR.R Y 46.81 2333.1360 22 -14.5 584.2828 4 62.33 6 32142 VEV_3_3_RA6_01_1237.d 0 1 1 28 49
R.AAPTTM(+15.99)VSQSASSR.F Y 46.55 1408.6616 14 -8.2 705.3323 2 27.53 4 11487 VEV_1_3_RA4_01_1235.d 5.21E4 1 1 592 605 Oxidation (M)
R.GIDATHIFQSPADKR.L Y 45.02 1654.8427 15 -24.4 552.6080 3 63.53 5 34188 VEV_2_3_RA5_01_1236.d 5.13E4 1 1 452 466
R.FTSPYVLDR.G Y 42.82 1096.5553 9 -10.4 549.2792 2 68.11 4 37724 VEV_1_3_RA4_01_1235.d 9.8E4 1 1 577 585
R.LADLAGPDRGGK.R Y 42.09 1168.6200 12 31.5 585.3357 2 34.15 5 15663 VEV_2_3_RA5_01_1236.d 0 1 1 554 565
R.FAAQTNIDPSSK.E Y 30.33 1277.6251 12 -33.5 639.7985 2 51.10 6 24927 VEV_3_3_RA6_01_1237.d 0 1 1 523 534
R.LADLAGPDR.G Y 29.23 926.4821 9 -15.3 464.2412 2 45.66 6 21789 VEV_3_3_RA6_01_1237.d 0 1 1 554 562
R.FNALNSMYK.M Y 28.28 1086.5168 9 -7.1 544.2618 2 65.71 5 35819 VEV_2_3_RA5_01_1236.d 6.75E4 1 1 606 614
R.SQVFVPPQFDALR.T Y 26.44 1502.7881 13 -20.7 752.3857 2 80.67 4 47532 VEV_1_3_RA4_01_1235.d 7.72E4 2 2 433 445
R.GSGIFPTTSR.F Y 24.82 1021.5192 10 -13.0 511.7603 2 56.60 5 29159 VEV_2_3_RA5_01_1236.d 6.42E4 1 1 567 576
total 13 peptides
C1FZF8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LVGNVGNTFANSSR.M Y 90.28 1434.7216 14 -13.7 718.3582 2 62.08 6 31962 VEV_3_3_RA6_01_1237.d 7.33E4 1 1 272 285
R.LNNIATLDAIITHFTR.L Y 79.51 1811.9894 16 3.5 605.0059 3 87.47 4 52172 VEV_1_3_RA4_01_1235.d 6.91E4 2 2 598 613
R.TVYTTASEAPAEGR.M Y 64.56 1451.6892 14 -8.8 726.8455 2 45.52 6 21709 VEV_3_3_RA6_01_1237.d 2.13E5 2 2 572 585
K.LYLLELPDSLVSSQVYEIVR.T Y 64.42 2335.2673 20 -9.5 1168.6299 2 93.96 4 55794 VEV_1_3_RA4_01_1235.d 2.9E4 2 2 552 571
R.Q(-17.03)SSTLGNLGPGGPRPR.A Y 44.53 1575.8118 16 -9.2 788.9059 2 64.64 4 34994 VEV_1_3_RA4_01_1235.d 4.73E4 1 1 673 688 Pyro-glu from Q
K.C(+57.02)RLVEDLEEENK.L Y 31.97 1532.7140 12 27.0 767.3849 2 43.68 5 21315 VEV_2_3_RA5_01_1236.d 1.91E5 3 3 150 161 Carbamidomethylation
R.T(-2.02)VYTTASEAPAEGR.M Y 28.56 1449.6736 14 -1.4 725.8430 2 45.71 5 22552 VEV_2_3_RA5_01_1236.d 4.49E4 1 1 572 585 2-amino-3-oxo-butanoic_acid
K.LAFQSPEK.E Y 26.12 918.4810 8 -15.9 460.2405 2 34.78 6 15525 VEV_3_3_RA6_01_1237.d 5.71E5 4 4 162 169
R.ELVINPFGR.W Y 22.32 1043.5763 9 -43.4 348.8510 3 59.12 4 30851 VEV_1_3_RA4_01_1235.d 1.02E6 2 2 101 109
R.QSSTLGNLGPGGPRPR.A Y 18.94 1592.8383 16 -11.5 531.9473 3 53.63 4 27211 VEV_1_3_RA4_01_1235.d 7.48E4 1 1 673 688
R.LVGNVGNTFANSSRMNYQWR.S Y 18.88 2313.1072 20 15.1 579.2928 4 78.83 6 44321 VEV_3_3_RA6_01_1237.d 1.8E5 1 1 272 291
R.SEMIEATKNHQK.I Y 18.53 1414.6875 12 -5.3 708.3473 2 63.86 6 33262 VEV_3_3_RA6_01_1237.d 0 1 1 83 94
K.LGEIAPAIDR.M Y 17.55 1053.5818 10 -18.9 352.1946 3 24.72 5 10323 VEV_2_3_RA5_01_1236.d 8.29E4 1 1 52 61
R.TVYTTASEAPAEGRMK.V Y 16.85 1710.8247 16 -10.3 428.7090 4 13.51 5 4235 VEV_2_3_RA5_01_1236.d 8.55E3 1 1 572 587
total 14 peptides
C1GEG2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGFYC(+57.02)VSTYGFSGDDYKGVVTFR.N Y 91.06 2625.1846 23 -8.9 876.0610 3 81.59 4 48237 VEV_1_3_RA4_01_1235.d 8.06E4 2 2 110 132 Carbamidomethylation
R.NSYGELSAPQIPK.L Y 84.25 1402.7092 13 -9.2 702.3554 2 68.96 4 38400 VEV_1_3_RA4_01_1235.d 3.74E5 3 3 133 145
K.EPIC(+57.02)DQENIAAK.L Y 75.84 1386.6449 12 -11.6 694.3217 2 48.97 4 24229 VEV_1_3_RA4_01_1235.d 1.77E5 4 4 55 66 Carbamidomethylation
K.NPKPINYPVVR.T Y 58.48 1295.7350 11 -25.4 432.9080 3 54.35 4 27661 VEV_1_3_RA4_01_1235.d 6.21E5 2 2 99 109
K.SPIVTMAINLKNPKPINYPVVR.T Y 57.42 2463.4036 22 -5.0 616.8551 4 78.07 4 45531 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 88 109
R.FAMSDEIAQDDDGFEIR.S Y 33.84 1957.8363 17 29.9 979.9547 2 80.56 4 47454 VEV_1_3_RA4_01_1235.d 0 1 1 398 414
K.SPIVTM(+15.99)AINLK.N Y 33.26 1201.6741 11 0.4 601.8445 2 69.53 4 38847 VEV_1_3_RA4_01_1235.d 3.06E4 1 1 88 98 Oxidation (M)
total 7 peptides
C1GEE2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAEAQGVNSYPTIK.F Y 101.89 1477.7412 14 -6.4 739.8732 2 58.05 4 30104 VEV_1_3_RA4_01_1235.d 3.27E5 5 5 211 224
R.YVNGGKQDLAGSLYEAK.V Y 72.44 1811.9053 17 -13.1 604.9678 3 61.72 6 31697 VEV_3_3_RA6_01_1237.d 1.93E5 3 3 280 296
R.LVGGGLDKEAGTIDILDMIVVR.Y Y 68.09 2283.2507 22 3.5 762.0935 3 88.86 5 51310 VEV_2_3_RA5_01_1236.d 2.88E4 2 2 258 279
K.NLAPIWEKLADDFKR.E Y 62.40 1814.9679 15 -7.1 454.7460 4 81.94 5 47313 VEV_2_3_RA5_01_1236.d 5.94E4 1 1 178 192
K.FGVQGFPTLK.W Y 41.24 1092.5967 10 -15.8 547.2970 2 76.79 5 43924 VEV_2_3_RA5_01_1236.d 1.41E5 2 2 94 103
R.NLAPIYDQLADVFANENVHISK.V Y 37.15 2470.2493 22 -10.7 824.4149 3 86.73 5 50164 VEV_2_3_RA5_01_1236.d 0 2 2 60 81
K.NLAPIWEK.L Y 27.90 969.5283 8 -15.4 485.7640 2 68.59 4 38108 VEV_1_3_RA4_01_1235.d 5.64E4 1 1 178 185
total 7 peptides
C1G1L3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YFLTVPAIWNDAGK.A Y 86.44 1593.8191 14 -8.5 797.9100 2 85.78 4 51095 VEV_1_3_RA4_01_1235.d 7.91E4 1 1 300 313
R.AHNTGELDATGR.S Y 77.09 1240.5796 12 -15.2 621.2877 2 19.91 6 7506 VEV_3_3_RA6_01_1237.d 1.63E5 4 4 141 152
K.EVVTLTSDLSR.K Y 65.96 1218.6455 11 -12.0 610.3227 2 67.43 4 37184 VEV_1_3_RA4_01_1235.d 1.11E5 2 2 659 669
K.VVRPMDSVSAIVK.G Y 56.05 1399.7856 13 -5.1 467.6001 3 67.95 4 37596 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 539 551
K.GAVTAGITER.V Y 45.92 973.5192 10 -10.1 487.7620 2 39.37 4 18315 VEV_1_3_RA4_01_1235.d 2.77E5 1 1 552 561
K.TLGEVFNREER.N Y 44.86 1348.6735 11 -11.3 450.5600 3 57.74 4 29822 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 286 296
R.NFSNILR.A Y 31.97 862.4661 7 -18.1 432.2325 2 63.60 5 34238 VEV_2_3_RA5_01_1236.d 5.53E5 3 3 405 411
R.Q(-17.03)IFVQKGER.I Y 29.65 1086.5822 9 -6.5 544.2948 2 58.34 4 30249 VEV_1_3_RA4_01_1235.d 1.19E5 1 1 605 613 Pyro-glu from Q
R.MDTPQGTFYR.V Y 28.86 1214.5389 10 10.1 608.2829 2 61.77 6 31726 VEV_3_3_RA6_01_1237.d 2.99E4 1 1 679 688
K.NLEKDFER.M Y 21.86 1049.5142 8 -11.3 525.7584 2 41.33 6 19277 VEV_3_3_RA6_01_1237.d 1.29E5 1 1 671 678
R.VP(+31.99)SLDGK.D Y 20.79 746.3810 7 -8.5 374.1946 2 19.48 5 7466 VEV_2_3_RA5_01_1236.d 0 1 1 591 597 Dihydroxy
K.SEIDVAADYLFK.L Y 16.59 1369.6765 12 28.6 685.8651 2 57.14 5 29564 VEV_2_3_RA5_01_1236.d 0 1 1 263 274
total 12 peptides
C1G620
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FDFTQYLSAIER.C Y 95.60 1488.7249 12 2.5 745.3716 2 88.25 4 52656 VEV_1_3_RA4_01_1235.d 1.75E5 2 2 292 303
R.LLSPDGEEITGYDQPGELVVR.S Y 82.10 2286.1379 21 -5.0 1144.0706 2 80.52 4 47418 VEV_1_3_RA4_01_1235.d 3.51E4 1 1 398 418
K.SPSAGSDDAATIR.S Y 63.68 1246.5789 13 -7.1 624.2923 2 31.92 6 13937 VEV_3_3_RA6_01_1237.d 1.2E5 2 2 516 528
K.QTAFLC(+57.02)YSSGTSGLPK.G Y 52.06 1715.8188 16 -8.6 858.9094 2 73.83 4 42226 VEV_1_3_RA4_01_1235.d 4.71E4 1 1 205 220 Carbamidomethylation
R.IYLLDLPSQFPGGGK.A Y 45.22 1603.8610 15 8.4 802.9445 2 84.66 4 50356 VEV_1_3_RA4_01_1235.d 0 1 1 157 171
K.KSYSALEVAERVDVLAR.S Y 30.03 1905.0319 17 -27.3 477.2523 4 75.81 6 42139 VEV_3_3_RA6_01_1237.d 0 1 1 49 65
K.SLFTC(+57.02)ATNLPIALEAAANVGIPK.S Y 28.01 2370.2617 23 1.5 791.0957 3 91.18 6 51917 VEV_3_3_RA6_01_1237.d 8.62E4 1 1 132 154 Carbamidomethylation
K.SPSGK.I Y 17.71 474.2438 5 -9.1 475.2467 1 15.75 4 5177 VEV_1_3_RA4_01_1235.d 0 1 1 557 561
K.LNWQPGQGTK.Q Y 16.73 1127.5724 10 -15.7 564.7846 2 51.83 4 26053 VEV_1_3_RA4_01_1235.d 3.79E4 1 1 195 204
K.S(-2.02)PSAGSDDAATIR.S Y 16.66 1244.5632 13 26.8 623.3055 2 32.03 5 14444 VEV_2_3_RA5_01_1236.d 4.2E5 1 1 516 528 2-amino-3-oxo-butanoic_acid
total 10 peptides
C1G7B3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLGISSLLSGSVAKPSR.D Y 101.77 1669.9727 17 -19.6 557.6539 3 77.97 6 43704 VEV_3_3_RA6_01_1237.d 7.57E5 5 5 41 57
R.FDPSLGLVIPFAVGPNLIAYSR.M Y 82.83 2345.2783 22 -6.3 782.7618 3 95.85 4 56684 VEV_1_3_RA4_01_1235.d 1.85E5 4 4 238 259
R.FQLPTATVADIDWR.F Y 79.47 1631.8307 14 -7.3 816.9166 2 84.25 6 47991 VEV_3_3_RA6_01_1237.d 1.21E5 3 3 279 292
K.GKKPPTLAER.F Y 59.91 1095.6400 10 -17.8 366.2141 3 15.86 6 5402 VEV_3_3_RA6_01_1237.d 1.14E5 4 4 269 278
R.FQ(+.98)LPTATVADIDWR.F Y 27.68 1632.8147 14 8.7 817.4218 2 84.54 4 50274 VEV_1_3_RA4_01_1235.d 5.51E4 1 1 279 292 Deamidation (NQ)
MPDHVPDHR.K Y 21.98 1102.4978 9 19.8 552.2671 2 44.95 6 21385 VEV_3_3_RA6_01_1237.d 1.64E5 1 1 1 9
K.VLGFFSVFDWSR.F Y 21.07 1458.7295 12 37.6 365.7034 4 67.13 6 35728 VEV_3_3_RA6_01_1237.d 1.34E4 1 1 226 237
total 7 peptides
C1G532
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAYGTILFFEDPAHVR.G Y 107.29 1805.9100 16 -0.1 602.9772 3 81.02 4 47819 VEV_1_3_RA4_01_1235.d 3.16E5 3 3 111 126
R.SVYQLSASSPVPDSK.I Y 104.09 1563.7780 15 -7.0 782.8908 2 66.81 4 36695 VEV_1_3_RA4_01_1235.d 4.06E5 4 4 27 41
K.TFKPVEER.V Y 42.56 1004.5291 8 -8.8 503.2674 2 26.02 5 11053 VEV_2_3_RA5_01_1236.d 5.93E5 5 5 207 214
K.AAY(-2.02)GTILFFEDPAHVR.G Y 34.89 1803.8944 16 11.5 602.3123 3 80.95 5 46678 VEV_2_3_RA5_01_1236.d 8.15E4 1 1 111 126 2-amino-3-oxo-butanoic_acid
K.IFEEGLVPDGK.V Y 25.14 1202.6183 11 5.6 301.6635 4 13.57 5 4266 VEV_2_3_RA5_01_1236.d 1.07E5 2 2 82 92
K.LGLFK.A Y 24.91 576.3635 5 -45.5 577.3446 1 36.41 6 16452 VEV_3_3_RA6_01_1237.d 0 1 1 106 110
K.VFGSK.A N 17.97 536.2958 5 9.3 537.3081 1 66.84 4 36713 VEV_1_3_RA4_01_1235.d 0 1 1 217 221
K.DISHDAPPASYEAFLALAQDR.R Y 17.70 2286.0916 21 -6.2 763.0331 3 75.70 4 43680 VEV_1_3_RA4_01_1235.d 2.16E4 1 1 5 25
M(+15.99)TVKDISHDAPPASYEAFLALAQDR.R Y 17.16 2761.3381 25 -1.3 691.3409 4 78.08 5 44769 VEV_2_3_RA5_01_1236.d 4.73E4 1 1 1 25 Oxidation (M)
total 9 peptides
C1GEA4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.MGRDDGQSPSEQPGSPTSPR.G Y 92.55 2084.9182 20 -3.2 695.9778 3 36.16 5 16874 VEV_2_3_RA5_01_1236.d 4.53E4 1 1 67 86
R.LGSGPTDAQEIMSHAFFR.N Y 78.07 1962.9258 18 -6.5 655.3116 3 80.34 5 46271 VEV_2_3_RA5_01_1236.d 5.07E4 1 1 1035 1052
K.ESHSGPVVTQQPQPQQPKPK.V Y 64.34 2196.1287 20 -6.9 550.0356 4 35.27 4 15909 VEV_1_3_RA4_01_1235.d 4.73E4 1 1 767 786
K.SGDRPTPIGMLWIR.I Y 49.28 1597.8398 14 6.1 533.6238 3 79.26 4 46445 VEV_1_3_RA4_01_1235.d 0 1 1 340 353
R.VPYGDSRPDDTVPK.A Y 48.74 1544.7471 14 -11.3 773.3721 2 48.48 5 24212 VEV_2_3_RA5_01_1236.d 3.66E5 6 6 135 148
K.SVSAGGTGMSSR.S Y 44.75 1095.4978 12 -2.8 548.7546 2 21.43 5 8515 VEV_2_3_RA5_01_1236.d 7.55E4 2 2 582 593
K.VGLDHFNFLAVLGK.G Y 42.53 1528.8401 14 -10.5 510.6153 3 85.97 4 51223 VEV_1_3_RA4_01_1235.d 1.12E5 1 1 787 800
K.YAAAK.R N 16.17 522.2802 5 -14.4 523.2799 1 60.22 5 31712 VEV_2_3_RA5_01_1236.d 2.27E5 1 1 497 501
K.IESEFNASGWVSADK.M Y 15.88 1638.7526 15 22.2 410.7045 4 63.75 5 34350 VEV_2_3_RA5_01_1236.d 0 1 1 366 380
total 9 peptides
C1GCI7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGSAEDALFNEQVK.A Y 102.33 1477.7048 14 -9.9 739.8524 2 67.74 4 37433 VEV_1_3_RA4_01_1235.d 2.66E5 2 2 66 79
K.SPVFWSWDIPR.T Y 68.99 1388.6877 11 -8.0 695.3456 2 85.07 4 50634 VEV_1_3_RA4_01_1235.d 2.88E5 4 4 416 426
R.GSLQQTYPSSIMAR.K Y 68.22 1537.7559 14 -12.7 769.8754 2 67.98 4 37624 VEV_1_3_RA4_01_1235.d 1.75E5 2 2 107 120
K.AVTEWWNTPR.Y Y 49.76 1258.6095 10 -15.0 630.3026 2 72.35 6 39627 VEV_3_3_RA6_01_1237.d 1.2E5 2 2 80 89
K.LVTFDEAVEQHLK.S Y 37.41 1527.7932 13 -16.1 510.2635 3 73.39 6 40367 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 367 379
K.LSPEER.K Y 21.17 729.3657 6 -20.2 730.3582 1 50.89 6 24810 VEV_3_3_RA6_01_1237.d 0 1 1 211 216
K.S(-2.02)EGATQSSIDAYKK.Q Y 19.22 1481.6997 14 -30.1 741.8348 2 32.03 6 13994 VEV_3_3_RA6_01_1237.d 2.58E4 1 1 380 393 2-amino-3-oxo-butanoic_acid
K.VLVPIGEHINR.L Y 15.85 1245.7194 11 -18.6 416.2393 3 63.32 5 34027 VEV_2_3_RA5_01_1236.d 4.81E4 1 1 276 286
M(+15.99)IRNPARWLPR.Q Y 15.54 1424.7822 11 39.8 357.2170 4 43.41 5 21158 VEV_2_3_RA5_01_1236.d 0 1 1 1 11 Oxidation (M)
K.LLSSTIDVR.D Y 15.05 1002.5709 9 -38.4 502.2735 2 10.65 5 2800 VEV_2_3_RA5_01_1236.d 2.87E4 1 1 314 322
total 10 peptides
C1G2H4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AC(+57.02)GRPTLFVC(+57.02)GTDEYGTATETK.A Y 107.41 2433.0940 22 -7.4 812.0326 3 68.86 4 38321 VEV_1_3_RA4_01_1235.d 1.42E5 3 3 47 68 Carbamidomethylation
R.TPTAQHTQISQNIFKR.L Y 82.49 1868.9857 16 -13.2 468.2475 4 57.36 4 29553 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 104 119
R.SFVDANNGELLAK.L Y 44.47 1376.6936 13 -21.4 689.3394 2 69.56 4 38870 VEV_1_3_RA4_01_1235.d 2.49E5 4 4 384 396
K.ALEEGVTPEELC(+57.02)AK.Y Y 37.32 1544.7391 14 -14.9 773.3654 2 67.14 6 35736 VEV_3_3_RA6_01_1237.d 2.99E5 3 3 69 82 Carbamidomethylation
K.GGAEGGAEGAKDGGGEAAK.V Y 33.94 1587.7124 19 -3.3 530.2430 3 12.64 4 3625 VEV_1_3_RA4_01_1235.d 5.59E3 1 1 607 625
K.LDGATPVR.R Y 25.66 827.4501 8 -53.7 828.4129 1 79.95 6 45125 VEV_3_3_RA6_01_1237.d 3.55E4 1 1 184 191
R.YVEGEC(+57.02)PR.C Y 22.46 1008.4335 8 -11.4 505.2183 2 23.39 4 9206 VEV_1_3_RA4_01_1235.d 2.65E4 1 1 147 154 Carbamidomethylation
K.LIASPK.A N 16.57 627.3955 6 0.6 314.7052 2 47.97 5 23900 VEV_2_3_RA5_01_1236.d 6.95E5 1 1 407 412
R.ATISSS Y 16.12 564.2755 6 -39.6 565.2604 1 37.69 6 17171 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 648 653
total 9 peptides
C1G1C6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTDEINVTPSVPR.T Y 103.51 1439.7620 13 -9.9 720.8811 2 70.01 5 39038 VEV_2_3_RA5_01_1236.d 2.52E5 3 3 231 243
R.LIASDVESLGPGK.S Y 71.96 1284.6925 13 -18.2 643.3419 2 67.75 6 36187 VEV_3_3_RA6_01_1237.d 4.29E5 3 3 711 723
R.TPDSNTM(+15.99)PVVPR.M Y 69.53 1328.6394 12 -12.1 665.3190 2 44.58 4 21499 VEV_1_3_RA4_01_1235.d 9.83E4 3 3 891 902 Oxidation (M)
R.TPDSNTMPVVPR.M Y 59.76 1312.6445 12 -15.1 657.3196 2 60.82 5 32160 VEV_2_3_RA5_01_1236.d 6.2E4 2 2 891 902
R.LSIGGGEVPEDGTNPHGHAR.T Y 57.46 1998.9507 20 -7.3 667.3193 3 52.24 5 26528 VEV_2_3_RA5_01_1236.d 4.83E5 3 3 871 890
R.SFFN(+.98)DLDTPASSR.S Y 32.17 1456.6470 13 22.9 729.3474 2 74.61 5 42330 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 849 861 Deamidation (NQ)
K.DRPDFR.D Y 19.11 804.3878 6 1.2 403.2017 2 12.10 6 3442 VEV_3_3_RA6_01_1237.d 0 1 1 820 825
R.LS(-2.02)IGGGEVPEDGTNPHGHAR.T Y 19.09 1996.9351 20 22.3 500.2522 4 52.31 5 26575 VEV_2_3_RA5_01_1236.d 0 1 1 871 890 2-amino-3-oxo-butanoic_acid
R.LTDEINVTPSVPRTSTGRNM(+15.99)K.H Y 16.71 2331.1853 21 -15.6 583.7945 4 72.83 4 41450 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 231 251 Oxidation (M)
total 9 peptides
C1GDL1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ATTVDTAGTEDDITTSKPK.K Y 85.32 1949.9429 19 -11.3 650.9809 3 49.38 4 24490 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 194 212
R.SAQGYYNDQSNLR.G Y 73.85 1514.6749 13 -6.0 758.3402 2 47.35 4 23223 VEV_1_3_RA4_01_1235.d 1.27E5 3 3 131 143
K.Q(-17.03)AIPETADLVSPSQLSR.L Y 51.01 1793.9159 17 -9.7 897.9565 2 82.53 6 46889 VEV_3_3_RA6_01_1237.d 8.47E4 2 2 401 417 Pyro-glu from Q
K.GADTVILER.L Y 40.32 972.5240 9 -42.7 487.2485 2 55.25 6 27387 VEV_3_3_RA6_01_1237.d 2.9E5 1 1 776 784
R.VVNAYDTTR.S Y 35.08 1037.5142 9 -14.8 519.7567 2 28.82 6 12227 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 1342 1350
K.YNVQDYRPR.M Y 33.39 1209.5890 9 -6.1 605.7981 2 46.61 4 22802 VEV_1_3_RA4_01_1235.d 8.98E4 1 1 1298 1306
R.DRNSIMSLGGSLVGR.A Y 33.19 1560.8042 15 -5.9 521.2723 3 76.21 4 44071 VEV_1_3_RA4_01_1235.d 9.91E3 1 1 155 169
R.TAIHHFLTLLATC(+57.02)HTVIPER.K Y 27.93 2329.2366 20 -29.0 466.8411 5 79.80 4 46870 VEV_1_3_RA4_01_1235.d 8.25E4 1 1 675 694 Carbamidomethylation
K.IDPSTLGPR.I Y 26.03 954.5134 9 -2.0 478.2630 2 72.62 5 40914 VEV_2_3_RA5_01_1236.d 8.2E5 5 5 229 237
R.NATATPIKR.T Y 25.21 970.5560 9 -18.4 486.2763 2 15.09 5 5079 VEV_2_3_RA5_01_1236.d 1.1E4 2 2 485 493
R.AGDFK.F Y 22.15 536.2594 5 -3.6 537.2648 1 29.09 6 12382 VEV_3_3_RA6_01_1237.d 1.63E4 2 2 217 221
M.T(+42.01)SARPPGHHPSPGSDDDFVHIER.T Y 21.40 2552.1792 23 -38.1 511.4236 5 60.38 5 31828 VEV_2_3_RA5_01_1236.d 0 1 1 2 24 Acetylation (Protein N-term)
R.YPQLYQLGQK.G Y 21.12 1236.6503 10 -14.3 413.2181 3 46.33 4 22596 VEV_1_3_RA4_01_1235.d 4.35E4 1 1 1129 1138
R.YGEMASSRPVV Y 20.37 1194.5703 11 -1.1 598.2917 2 59.37 4 31015 VEV_1_3_RA4_01_1235.d 4.56E4 1 1 1355 1365
R.KDEKPDDIK.Y Y 17.66 1086.5557 9 2.4 544.2864 2 18.12 4 6425 VEV_1_3_RA4_01_1235.d 0 1 1 695 703
R.G(+27.99)AVPLR.D Y 17.32 639.3704 6 -8.9 640.3719 1 98.08 6 54687 VEV_3_3_RA6_01_1237.d 0 1 1 144 149 Formylation
K.DFYLLGATAIEDR.L Y 17.10 1482.7354 13 8.4 495.2565 3 64.01 5 34539 VEV_2_3_RA5_01_1236.d 5.12E4 1 1 854 866
R.IYC(+57.02)KGADTVILER.L Y 16.50 1536.7970 13 -1.1 385.2061 4 57.47 6 28670 VEV_3_3_RA6_01_1237.d 0 1 1 772 784 Carbamidomethylation
R.AGDFKFGFGR.R Y 15.90 1100.5403 10 -4.8 551.2748 2 52.66 5 26784 VEV_2_3_RA5_01_1236.d 0 1 1 217 226
R.MYFPQAYHHVQEIQKYNVQDYRPR.M Y 15.44 3109.4980 24 -20.5 1037.4854 3 91.57 4 54533 VEV_1_3_RA4_01_1235.d 0 1 1 1283 1306
total 20 peptides
C1GLD2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IDIDDYFPVNVYGGTK.S Y 102.47 1814.8727 16 -8.8 908.4357 2 85.41 6 48720 VEV_3_3_RA6_01_1237.d 1.11E5 3 3 319 334
R.AGNYRIDIDDYFPVNVYGGTK.S Y 62.16 2376.1387 21 -7.8 1189.0674 2 82.92 5 47901 VEV_2_3_RA5_01_1236.d 6.38E4 2 2 314 334
K.SRRPANTAFR.Q Y 56.79 1174.6318 10 -13.0 392.5461 3 17.10 5 6205 VEV_2_3_RA5_01_1236.d 1.4E5 3 3 25 34
R.TAGLPTFSK.L Y 56.13 920.4967 9 -19.1 461.2468 2 61.13 6 31250 VEV_3_3_RA6_01_1237.d 1.51E6 6 6 294 302
R.RPANTAFR.Q Y 33.03 931.4988 8 -12.0 466.7511 2 16.62 6 5779 VEV_3_3_RA6_01_1237.d 1.25E5 2 2 27 34
K.YHSSFR.S Y 32.92 795.3663 6 -16.0 398.6841 2 15.44 6 5168 VEV_3_3_RA6_01_1237.d 2.25E5 3 3 102 107
K.GISWSSDKELYKK.T Y 27.80 1539.7932 13 -8.2 514.2675 3 57.60 4 29721 VEV_1_3_RA4_01_1235.d 7.53E4 2 2 239 251
R.SREINTPTWK.R Y 25.59 1230.6356 10 -14.5 411.2132 3 47.97 5 23905 VEV_2_3_RA5_01_1236.d 0 2 2 108 117
R.KLGDHTYLTWNNEQSSTATATGR(-.98).A Y 15.70 2549.2258 23 -6.0 638.3099 4 65.73 6 34675 VEV_3_3_RA6_01_1237.d 8.51E4 1 1 379 401 Amidation
total 9 peptides
C1G6K0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DVSKDFPDIEFDEELLDNTC(+57.02)LK.I Y 104.04 2641.2104 22 -9.0 881.4028 3 87.38 6 49879 VEV_3_3_RA6_01_1237.d 1.54E5 3 3 237 258 Carbamidomethylation
K.TSEYAGAIISKL Y 66.53 1251.6710 12 -9.5 626.8369 2 77.13 4 44798 VEV_1_3_RA4_01_1235.d 9.15E4 1 1 372 383
R.NFVALKGPLATPVGK.G Y 48.98 1510.8871 15 -7.7 504.6324 3 71.63 4 40507 VEV_1_3_RA4_01_1235.d 5.93E4 2 2 111 125
K.TAIPDDAIASVRR.N Y 46.68 1383.7469 13 -23.6 462.2454 3 62.53 6 32284 VEV_3_3_RA6_01_1237.d 6.87E5 3 3 98 110
K.GPLATPVGK.G Y 44.45 838.4912 9 -15.9 420.2462 2 41.29 4 19473 VEV_1_3_RA4_01_1235.d 8.68E4 1 1 117 125
R.TFNLFANVRPC(+57.02)R.S Y 40.11 1493.7561 12 -15.1 498.9185 3 74.29 5 42093 VEV_2_3_RA5_01_1236.d 1.89E5 2 2 137 148 Carbamidomethylation
K.TAIPDDAIASVR.R Y 31.56 1227.6459 12 -14.1 614.8215 2 67.70 4 37410 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 98 109
R.RTFNLFANVRPC(+57.02)R.S Y 16.29 1649.8572 13 -41.4 413.4545 4 68.46 4 38005 VEV_1_3_RA4_01_1235.d 0 1 1 136 148 Carbamidomethylation
total 8 peptides
C1GKU6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IISNFMIQGGDPTGTGR.G Y 90.78 1762.8672 17 -9.8 882.4322 2 75.47 5 42927 VEV_2_3_RA5_01_1236.d 5.4E5 3 3 37 53
R.GYYNNVIFHR.I Y 84.31 1281.6255 10 -13.3 641.8115 2 64.91 5 35202 VEV_2_3_RA5_01_1236.d 4.16E5 5 5 27 36
R.IISNFM(+15.99)IQGGDPTGTGR.G Y 65.87 1778.8621 17 -11.3 890.4283 2 70.46 6 38199 VEV_3_3_RA6_01_1237.d 4.74E4 1 1 37 53 Oxidation (M)
K.TGAEDRPIDEVK.I Y 65.27 1328.6571 12 -11.2 665.3284 2 35.16 5 16262 VEV_2_3_RA5_01_1236.d 9.07E5 4 4 128 139
K.TGAEDRPIDEVKILSAK.V Y 62.64 1840.9894 17 -17.4 461.2466 4 66.52 6 35262 VEV_3_3_RA6_01_1237.d 6.41E5 3 3 128 144
K.NFASLAQR.G Y 45.76 905.4719 8 -15.1 453.7364 2 52.37 5 26611 VEV_2_3_RA5_01_1236.d 9.89E5 7 7 19 26
R.VKDGMGVVQR.M Y 37.46 1087.5808 10 -16.7 544.7886 2 30.13 6 12954 VEV_3_3_RA6_01_1237.d 2.56E5 4 4 113 122
R.VK(+42.01)DGM(+15.99)GVVQR.M Y 20.29 1145.5863 10 -6.2 382.8670 3 11.60 6 3206 VEV_3_3_RA6_01_1237.d 2.71E4 1 1 113 122 Acetylation (K); Oxidation (M)
total 8 peptides
C1G4R2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TVYHIQPSGLFIIGGPQGDAGLTGR.K Y 89.25 2553.3340 25 -7.5 852.1122 3 81.73 6 46362 VEV_3_3_RA6_01_1237.d 6.16E4 1 1 237 261
K.YGHFTNQSFSWEKPK.T Y 78.98 1854.8689 15 -7.6 619.2922 3 63.78 4 34347 VEV_1_3_RA4_01_1235.d 5.27E4 3 3 374 388
R.TVYHIQPSGLFIIGGPQGDAGLTGRK.I Y 65.85 2681.4290 26 -21.2 671.3503 4 78.68 4 46000 VEV_1_3_RA4_01_1235.d 3.54E4 2 2 237 262
K.SQSELVQIIR.N Y 62.32 1171.6560 10 -16.6 586.8256 2 69.83 6 37724 VEV_3_3_RA6_01_1237.d 1.67E5 2 2 338 347
K.ELDLAKPIYFQTAK.Y Y 48.07 1635.8872 14 -25.6 546.2891 3 75.62 4 43664 VEV_1_3_RA4_01_1235.d 3.48E5 2 2 360 373
R.VDGTLPWLRPDTK.T Y 41.60 1496.7987 13 -13.9 499.9332 3 73.30 4 41816 VEV_1_3_RA4_01_1235.d 3.46E5 2 2 166 178
R.TVYHIQ(+.98)PSGLFIIGGPQGDAGLTGR.K Y 31.65 2554.3179 25 -11.6 852.4367 3 81.77 5 47204 VEV_2_3_RA5_01_1236.d 1.68E4 1 1 237 261 Deamidation (NQ)
K.E(-18.01)LDLAK(+14.02)PIYFQTAK.Y Y 22.54 1631.8922 14 -51.1 544.9435 3 75.62 4 43616 VEV_1_3_RA4_01_1235.d 1.28E4 1 1 360 373 Pyro-glu from E; Methylation(KR)
K.TQVTIEYAHDNGAVKPFR.V Y 20.26 2045.0330 18 -4.9 512.2630 4 63.90 4 34434 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 179 196
total 9 peptides
C1GI69
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FGEFGGQYVPESLMDSLAELEAGFKK.A Y 107.38 2848.3628 26 1.7 950.4632 3 93.82 6 53143 VEV_3_3_RA6_01_1237.d 2.49E5 4 4 330 355
R.VHAYSGNIPTALGFGISTR.E Y 75.68 1960.0166 19 -10.6 654.3392 3 77.35 4 44974 VEV_1_3_RA4_01_1235.d 8.86E4 1 1 200 218
R.IIAETGAGQHGVATATVC(+57.02)AK.F Y 48.03 1953.9941 20 -9.5 652.3325 3 57.16 4 29423 VEV_1_3_RA4_01_1235.d 6.99E4 1 1 427 446 Carbamidomethylation
R.ATFIAATDAQALQGFR.L Y 39.32 1679.8630 16 -64.7 560.9254 3 79.36 5 45628 VEV_2_3_RA5_01_1236.d 0 1 1 643 658
K.LSEGLPELLAR.V Y 31.13 1196.6764 11 -68.6 599.3044 2 77.96 6 43694 VEV_3_3_RA6_01_1237.d 0 2 2 189 199
K.VVAVESGSR.T Y 20.71 902.4821 9 -24.3 452.2374 2 19.95 6 7525 VEV_3_3_RA6_01_1237.d 3.78E4 1 1 477 485
K.EGLSYVPLIAPATSDSR.M Y 17.40 1774.9100 17 -22.0 888.4428 2 80.35 6 45411 VEV_3_3_RA6_01_1237.d 7.27E4 1 1 146 162
K.AKDDPTFWEEFR.S Y 16.19 1539.6993 12 67.0 514.2748 3 75.56 4 43567 VEV_1_3_RA4_01_1235.d 0 1 1 356 367
total 8 peptides
C1G437
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSALDEDNEDGHLSGNVR.E Y 81.86 1925.8715 18 -11.5 642.9570 3 57.45 6 28663 VEV_3_3_RA6_01_1237.d 2.29E5 2 2 688 705
K.TLLEEEPVD Y 81.61 1043.5022 9 -5.9 1044.5033 1 70.50 4 39605 VEV_1_3_RA4_01_1235.d 4.73E4 2 2 849 857
R.DLNTDTTAFQR.T Y 52.62 1280.5997 11 -12.2 641.2993 2 61.88 6 31812 VEV_3_3_RA6_01_1237.d 2.53E5 3 3 43 53
R.AGLSVPTIVNQIR.T Y 44.63 1366.7932 13 -39.3 684.3770 2 78.80 6 44294 VEV_3_3_RA6_01_1237.d 0 3 3 369 381
R.DQVYDVNTR.L Y 42.34 1108.5149 9 -6.3 555.2612 2 43.83 4 21029 VEV_1_3_RA4_01_1235.d 3.47E5 4 4 281 289
R.VASLNESYETLK.K Y 36.97 1352.6824 12 -13.2 677.3395 2 64.42 4 34825 VEV_1_3_RA4_01_1235.d 2.03E5 2 2 115 126
K.TTLQDVNDR.A Y 36.79 1060.5149 9 -9.6 531.2596 2 33.11 4 14665 VEV_1_3_RA4_01_1235.d 1.33E5 1 1 360 368
R.LADVGSVLR.N Y 29.35 928.5342 9 -18.2 465.2659 2 65.20 6 34275 VEV_3_3_RA6_01_1237.d 3.22E5 2 2 290 298
R.NTKNTLDAELAQIAR.S Y 29.11 1656.8795 15 -27.0 553.2855 3 71.89 6 39279 VEV_3_3_RA6_01_1237.d 0 1 1 299 313
R.YFHSQMEK.A Y 27.02 1068.4698 8 -3.7 535.2402 2 25.52 5 10784 VEV_2_3_RA5_01_1236.d 6.87E4 2 2 71 78
R.TFTNEIR.R Y 26.05 879.4450 7 -18.8 440.7215 2 41.57 5 20057 VEV_2_3_RA5_01_1236.d 2.81E5 1 1 54 60
K.ISESLGADLYSVDENSELRR.D Y 21.65 2252.0920 20 11.8 751.7135 3 75.41 4 43449 VEV_1_3_RA4_01_1235.d 0 1 1 261 280
total 12 peptides
C1GJ45
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IAASDYLPSDQDVLR.S Y 85.33 1661.8260 15 -9.4 831.9125 2 76.98 5 44019 VEV_2_3_RA5_01_1236.d 4.94E5 3 3 162 176
R.SREYQLNDSAR.Y Y 76.51 1337.6323 11 -15.6 446.8777 3 28.09 6 11826 VEV_3_3_RA6_01_1237.d 6.19E5 7 7 143 153
R.NEEIENQLKR.D Y 50.79 1271.6470 10 -13.1 636.8224 2 37.98 6 17330 VEV_3_3_RA6_01_1237.d 5.36E4 1 1 16 25
K.ARNEEIENQLKR.D Y 47.16 1498.7852 12 -14.2 500.5952 3 33.99 6 15072 VEV_3_3_RA6_01_1237.d 1.15E5 1 1 14 25
R.EYQLNDSAR.Y Y 43.80 1094.4993 9 -9.9 548.2515 2 36.58 6 16543 VEV_3_3_RA6_01_1237.d 3.73E5 5 5 145 153
R.YYFDSIKR.I Y 31.71 1090.5447 8 -30.3 364.5112 3 59.18 6 29866 VEV_3_3_RA6_01_1237.d 2.14E5 3 3 154 161
K.MLLLGAGESGK.S Y 26.98 1074.5743 11 -21.9 538.2827 2 67.35 4 37117 VEV_1_3_RA4_01_1235.d 1.63E5 2 2 36 46
R.VILEAMEGLDIPLDDQR.A Y 26.57 1925.9768 17 -17.6 642.9882 3 85.91 6 49024 VEV_3_3_RA6_01_1237.d 0 1 1 83 99
R.FVSLNQAEQK.Q Y 25.51 1162.5981 10 -16.2 582.2969 2 53.33 5 27204 VEV_2_3_RA5_01_1236.d 9.41E4 1 1 307 316
R.LC(+57.02)GLI Y 25.33 574.3149 5 -36.6 575.3011 1 71.44 5 40055 VEV_2_3_RA5_01_1236.d 9.7E3 1 1 349 353 Carbamidomethylation
K.TTGITETTFIIGDLTYR.M Y 23.22 1900.9781 17 -27.6 951.4701 2 84.80 6 48378 VEV_3_3_RA6_01_1237.d 8.83E4 1 1 181 197
R.MFDVGGQR.S Y 20.22 908.4174 8 -1.4 455.2153 2 52.17 4 26280 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 198 205
K.R(+14.02)IAASD(-18.01)YLPSDQDVLR.S Y 16.88 1813.9323 16 14.0 363.7988 5 52.82 5 26871 VEV_2_3_RA5_01_1236.d 2.23E5 1 1 161 176 Methylation(KR); Dehydration
total 13 peptides
C1GHM0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLVTPTQLTTLTGEQAVPSSR.L Y 73.58 2197.1953 21 -5.8 1099.5985 2 80.02 4 47037 VEV_1_3_RA4_01_1235.d 1.4E4 1 1 81 101
R.IVTATESQDTLEEALQRPSQK.S Y 70.50 2343.1917 21 -2.6 782.0692 3 71.55 4 40437 VEV_1_3_RA4_01_1235.d 1.06E5 2 2 434 454
R.GFVKDVYLSYDGAEAVTK.A Y 69.77 1960.9781 18 -16.6 654.6558 3 76.55 4 44343 VEV_1_3_RA4_01_1235.d 7.3E4 1 1 149 166
K.SNDAIVALVKPIIEDIRK.N Y 68.15 1993.1571 18 -9.4 499.2919 4 84.41 4 50195 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 455 472
R.KENAPSGSYTGR.L Y 62.76 1265.6000 12 -6.9 633.8029 2 16.35 4 5488 VEV_1_3_RA4_01_1235.d 2.3E5 4 4 314 325
R.GAIDHSVTFVVKDIDEAIALSNR.Y Y 37.21 2469.2864 23 -10.8 618.3222 4 87.15 5 50385 VEV_2_3_RA5_01_1236.d 0 1 1 735 757
K.YTHKFEK.A Y 36.47 951.4814 7 -16.3 476.7402 2 12.45 6 3630 VEV_3_3_RA6_01_1237.d 4.06E4 1 1 481 487
K.VGLESTKEEQK.N Y 21.66 1246.6405 11 -50.8 624.2958 2 21.00 4 7932 VEV_1_3_RA4_01_1235.d 2.43E4 2 2 404 414
K.VEPTNANDVNR.K Y 19.69 1227.5844 11 -0.3 410.2019 3 10.79 6 2819 VEV_3_3_RA6_01_1237.d 3.67E4 1 1 417 427
K.HITSSNLTAEGLR.N Y 18.14 1397.7263 13 1.1 466.9166 3 55.67 5 28548 VEV_2_3_RA5_01_1236.d 8.39E4 1 1 824 836
K.ATSLTSPVIK.A Y 16.08 1015.5913 10 -9.2 508.7983 2 58.14 4 30102 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 488 497
R.SDGSISPEIVYIAHK.V Y 16.05 1614.8253 15 0.2 539.2825 3 70.40 4 39528 VEV_1_3_RA4_01_1235.d 7.7E4 1 1 593 607
R.VGLYVPGGTAVLPSTAMMLGVPAMVAGC(+57.02)K.K Y 16.03 2846.4565 29 3.4 949.8293 3 92.33 4 54953 VEV_1_3_RA4_01_1235.d 2.24E5 1 1 555 583 Carbamidomethylation
total 13 peptides
C1FYQ2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ATGATIVNRVDDLQESDVGTR.C Y 100.99 2216.1033 21 -11.6 739.6998 3 69.10 4 38519 VEV_1_3_RA4_01_1235.d 2.09E5 2 2 326 346
R.TLIQNAGASPIR.V Y 68.44 1239.6935 12 -11.6 620.8468 2 62.67 5 33536 VEV_2_3_RA5_01_1236.d 3.64E4 1 1 450 461
R.NIHPVVIISAFKR.A Y 63.47 1492.8878 13 -8.5 374.2261 4 71.07 4 40059 VEV_1_3_RA4_01_1235.d 4.98E4 2 2 115 127
R.LSPGGGATEMAVSVK.L Y 44.64 1402.7126 15 -13.0 702.3545 2 64.34 4 34762 VEV_1_3_RA4_01_1235.d 3.14E4 1 1 407 421
R.IILLDC(+57.02)PLEYK.K Y 31.73 1375.7421 11 -21.7 688.8634 2 80.41 5 46318 VEV_2_3_RA5_01_1236.d 1.13E4 1 1 238 248 Carbamidomethylation
R.TLIQ(+.98)NAGASPIR.V Y 30.44 1240.6775 12 -37.5 621.3228 2 62.63 6 32360 VEV_3_3_RA6_01_1237.d 0 1 1 450 461 Deamidation (NQ)
R.ATGATIVNR.V Y 19.50 901.4981 9 -23.1 451.7459 2 25.85 5 10986 VEV_2_3_RA5_01_1236.d 0 1 1 326 334
R.TVSYDAGGGKKEVDIKR.Y Y 17.48 1821.9584 17 -16.4 608.3168 3 109.43 6 57945 VEV_3_3_RA6_01_1237.d 4.72E4 1 1 181 197
K.LSQM(+15.99)AK.S Y 17.00 692.3527 6 -1.7 347.1830 2 48.79 4 24107 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 422 427 Oxidation (M)
K.LQSIKTAVESAC(+57.02)MLLR.V Y 17.00 1818.9696 16 -27.0 607.3141 3 83.77 5 48420 VEV_2_3_RA5_01_1236.d 3.82E4 1 1 502 517 Carbamidomethylation
total 10 peptides
A0A0A0HV89
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYEDLIALHEIGEYPLGR.M Y 93.18 2074.0371 18 -13.3 692.3438 3 82.67 6 46982 VEV_3_3_RA6_01_1237.d 8.44E4 2 2 211 228
R.NLIFMVSDGMGPASLSLTR.N Y 79.16 2008.0122 19 -3.8 1005.0096 2 88.33 4 52710 VEV_1_3_RA4_01_1235.d 6.66E4 1 1 91 109
K.ATEDSDKGFFIMIEGSR.I Y 52.95 1901.8828 17 -35.3 634.9459 3 78.82 4 46110 VEV_1_3_RA4_01_1235.d 0 1 1 327 343
R.NTLNAYLDGTGK.G Y 44.31 1265.6251 12 -15.5 633.8100 2 65.25 6 34310 VEV_3_3_RA6_01_1237.d 8.61E4 1 1 427 438
R.SSSSLITDSAAGATAFSC(+57.02)AK.K Y 38.66 1930.8942 20 -4.9 644.6355 3 73.36 5 41427 VEV_2_3_RA5_01_1236.d 9.19E4 1 1 138 157 Carbamidomethylation
R.TGEADALLTGER.T Y 25.13 1231.6044 12 -34.6 616.7881 2 62.87 4 33657 VEV_1_3_RA4_01_1235.d 0 1 1 19 30
K.GSC(+57.02)RADDIDVVK.L Y 24.42 1333.6296 12 -9.1 667.8160 2 40.63 6 18858 VEV_3_3_RA6_01_1237.d 1.32E5 2 2 248 259 Carbamidomethylation
K.DIPYEIDRR.L Y 20.56 1175.5934 9 1.6 392.8723 3 59.41 5 31114 VEV_2_3_RA5_01_1236.d 6.3E4 1 1 296 304
K.LGPGEKPTGK.R Y 18.11 982.5447 10 -50.8 492.2546 2 16.26 6 5597 VEV_3_3_RA6_01_1237.d 0 1 1 80 89
K.MGENVDLPLLGLLAPK.D Y 15.84 1678.9327 16 -16.8 840.4595 2 91.52 4 54505 VEV_1_3_RA4_01_1235.d 3.47E4 1 1 280 295
total 10 peptides
C1G645
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GAYGAGHGSQASGSYQDGHPGR Y 132.26 2115.9106 22 -7.3 706.3057 3 25.63 4 10477 VEV_1_3_RA4_01_1235.d 2.37E5 6 6 291 312
R.NGC(+57.02)DAFAFGSPAK.C Y 61.13 1340.5819 13 -2.8 671.2964 2 65.78 6 34712 VEV_3_3_RA6_01_1237.d 2.02E4 2 2 117 129 Carbamidomethylation
K.AAFSSNPAQDFDDEDDRDAEFR.S Y 45.24 2517.0315 22 -2.2 840.0159 3 72.85 4 41462 VEV_1_3_RA4_01_1235.d 3.12E5 3 3 182 203
R.NLIEYR.R Y 18.55 806.4286 6 -11.4 807.4267 1 70.68 4 39750 VEV_1_3_RA4_01_1235.d 1.38E4 1 1 157 162
total 4 peptides
C1G0A1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAQAAVNVGISAISATASTAPKPK.T Y 114.75 2223.2222 24 -23.8 742.0637 3 74.04 4 42387 VEV_1_3_RA4_01_1235.d 0 1 1 48 71
K.TVSAAPAAPVASK.K Y 60.77 1168.6451 13 -8.6 585.3248 2 40.02 4 18709 VEV_1_3_RA4_01_1235.d 1.7E5 4 4 30 42
R.GNDGILGFDSNTK.V Y 44.11 1336.6259 13 9.4 669.3265 2 68.78 4 38262 VEV_1_3_RA4_01_1235.d 6.67E4 1 1 294 306
K.ILTWGVNDQGALGR.D Y 24.12 1498.7892 14 -11.6 375.7002 4 27.38 5 11790 VEV_2_3_RA5_01_1236.d 2.27E5 1 1 205 218
K.GECLAFGR(+14.02)LDGFQTGLK.I Y 23.81 1824.9192 17 -26.8 457.2249 4 34.24 4 15297 VEV_1_3_RA4_01_1235.d 0 1 1 448 464 Methylation(KR)
K.VVINQPPSQR.L Y 22.24 1136.6301 10 -69.6 569.2828 2 38.27 4 17675 VEV_1_3_RA4_01_1235.d 0 1 1 136 145
K.L(+42.01)N(+162.05)GLQPR.E Y 17.79 1000.5189 7 -36.5 501.2484 2 28.38 5 12337 VEV_2_3_RA5_01_1236.d 0 1 1 360 366 Acetylation (N-term); Hexose (NSY)
K.TDSVK.L Y 17.16 548.2806 5 -10.2 549.2823 1 64.29 4 34726 VEV_1_3_RA4_01_1235.d 0 1 1 85 89
R.LNPHLR.A Y 15.34 748.4344 6 -3.5 375.2231 2 60.14 6 30557 VEV_3_3_RA6_01_1237.d 0 1 1 175 180
R.DDRNKPR.I Y 15.03 899.4573 7 19.4 900.4820 1 84.15 6 47926 VEV_3_3_RA6_01_1237.d 2.69E4 1 1 476 482
total 10 peptides
C1FZD4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALLSAFTSPSVFDFTPLTASDAIQSLR.T Y 119.61 2854.4751 27 -5.4 1428.2372 2 95.81 6 53918 VEV_3_3_RA6_01_1237.d 5.05E5 6 6 244 270
R.Q(-17.03)QQQQEHQPR.E Y 66.40 1288.5908 10 16.7 645.3135 2 13.40 4 4004 VEV_1_3_RA4_01_1235.d 1.53E4 2 2 474 483 Pyro-glu from Q
R.EKEQLEEEPSPAQK.Q Y 52.45 1640.7893 14 -12.0 547.9305 3 32.00 6 13982 VEV_3_3_RA6_01_1237.d 1.52E5 2 2 48 61
K.ATPLSSIHNLAASADILQTK.M Y 32.24 2050.1057 20 -19.8 684.3623 3 80.35 4 47287 VEV_1_3_RA4_01_1235.d 3.88E4 1 1 297 316
R.VFGEK.Q Y 16.71 578.3064 5 4.9 579.3165 1 40.37 6 18704 VEV_3_3_RA6_01_1237.d 0 1 1 383 387
total 5 peptides
A0A0A0HR72
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLSDSSAPSTPESGPAEGAR.A Y 88.13 1901.8602 20 -6.8 951.9309 2 53.41 4 27069 VEV_1_3_RA4_01_1235.d 2.76E5 5 5 461 480
R.TGSSTTPATFKR.S Y 62.07 1252.6411 12 -26.4 627.3113 2 24.91 5 10436 VEV_2_3_RA5_01_1236.d 1.8E4 3 3 449 460
R.YAHSEQNQGYPR.N Y 60.48 1448.6433 12 -11.2 725.3208 2 21.09 6 8144 VEV_3_3_RA6_01_1237.d 7.21E4 2 2 72 83
K.RM(+15.99)LAVFLNR.C Y 36.53 1134.6332 9 11.7 379.2227 3 62.87 6 32539 VEV_3_3_RA6_01_1237.d 0 1 1 185 193 Oxidation (M)
R.ASSPAVGPVTR.G Y 33.79 1040.5614 11 -23.7 521.2756 2 36.24 4 16480 VEV_1_3_RA4_01_1235.d 1.39E5 2 2 1340 1350
R.TAEPPTATPPSHR.K Y 32.93 1360.6735 13 -26.1 681.3262 2 28.04 6 11800 VEV_3_3_RA6_01_1237.d 1.74E5 4 4 514 526
R.STDAVPTGFSSVDEIKDFTSMASR.L Y 25.78 2547.1799 24 -9.5 850.0592 3 82.69 4 49010 VEV_1_3_RA4_01_1235.d 2.34E4 1 1 1831 1854
R.AATAR.G Y 21.02 488.2707 5 -18.5 489.2689 1 71.42 4 40337 VEV_1_3_RA4_01_1235.d 2.36E4 1 1 661 665
R.ELLEMKDQTANPK.Y Y 20.68 1515.7603 13 15.3 506.2684 3 53.22 5 27124 VEV_2_3_RA5_01_1236.d 0 1 1 1260 1272
R.TLTHLSSLSADLMELGAR.Y Y 20.46 1913.9880 18 -29.5 638.9845 3 85.03 4 50605 VEV_1_3_RA4_01_1235.d 2.28E4 2 2 328 345
R.TAEPPTATPPSHRK.T Y 19.24 1488.7684 14 -12.0 497.2575 3 19.46 4 7133 VEV_1_3_RA4_01_1235.d 1.58E4 1 1 514 527
K.SQGAR.I Y 18.70 517.2609 5 1.6 518.2690 1 74.11 6 40891 VEV_3_3_RA6_01_1237.d 4.36E4 1 1 1689 1693
K.GYVVSANWLGR.V Y 18.64 1220.6301 11 -15.6 611.3128 2 75.98 6 42268 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 1027 1037
K.GVYQSR.I Y 17.60 708.3555 6 -18.7 709.3495 1 78.93 5 45336 VEV_2_3_RA5_01_1236.d 0 1 1 86 91
R.VNSAHSK.D Y 17.55 741.3770 7 20.1 742.3991 1 56.09 5 28819 VEV_2_3_RA5_01_1236.d 4.2E4 1 1 1890 1896
K.IM(+15.99)RSTDAVPTGFSSVDEIKDFTSMASR.L Y 16.21 2963.4004 27 2.1 741.8589 4 81.39 5 46954 VEV_2_3_RA5_01_1236.d 0 1 1 1828 1854 Oxidation (M)
K.AGSQNK.A Y 16.01 603.2976 6 10.5 604.3112 1 22.35 4 8646 VEV_1_3_RA4_01_1235.d 0 1 1 1323 1328
R.GNSPISSEDELSGPAR.R Y 16.00 1614.7485 16 21.7 539.2685 3 40.78 6 18940 VEV_3_3_RA6_01_1237.d 8.47E4 1 1 1873 1888
total 18 peptides
C1GF83
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPVSSHGFSASPSTSASPSTK.E Y 98.59 2004.9388 21 -7.8 669.3150 3 50.24 4 25061 VEV_1_3_RA4_01_1235.d 3.59E5 4 4 306 326
R.LC(+57.02)AHSPPPGTFGGELNVETMR.Q Y 63.67 2269.0620 21 4.1 757.3644 3 72.40 5 40761 VEV_2_3_RA5_01_1236.d 7.06E4 1 1 344 364 Carbamidomethylation
R.EAQGPAADTTTNKK.E Y 51.39 1430.7001 14 -7.7 477.9036 3 11.86 6 3330 VEV_3_3_RA6_01_1237.d 3.57E4 2 2 50 63
K.ELDTSPNQGGRLPGSPR.L Y 43.58 1779.8864 17 -10.3 594.2966 3 55.95 5 28733 VEV_2_3_RA5_01_1236.d 5.27E5 2 2 327 343
R.M(+15.99)HSPASSQIFER.S Y 39.36 1404.6456 12 24.6 469.2340 3 45.83 5 22625 VEV_2_3_RA5_01_1236.d 6.84E4 2 2 139 150 Oxidation (M)
R.S(+43.01)PSPVRSPVSSHGFSASPSTSASPSTK.E Y 38.92 2671.2837 27 -25.7 668.8110 4 49.80 5 25032 VEV_2_3_RA5_01_1236.d 0 1 1 300 326 Carbamylation
R.TGSGDIGGVR.S Y 25.34 917.4567 10 -17.6 459.7275 2 24.78 5 10360 VEV_2_3_RA5_01_1236.d 2.06E5 2 2 370 379
R.NPYIC(+57.02)PSPNR.A Y 25.13 1216.5659 10 35.3 609.3117 2 46.84 5 23275 VEV_2_3_RA5_01_1236.d 6.75E4 3 3 121 130 Carbamidomethylation
R.LPGSPR.L Y 16.05 625.3547 6 -32.3 626.3418 1 84.50 4 50251 VEV_1_3_RA4_01_1235.d 0 1 1 338 343
total 9 peptides
C1GKU3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DGSGVGAALGALVAGR.T Y 114.25 1369.7313 16 -12.0 685.8647 2 82.23 5 47490 VEV_2_3_RA5_01_1236.d 8E4 2 2 489 504
R.IAAQFEYPAEELNR.G Y 80.35 1649.8049 14 -16.1 825.8965 2 74.55 6 41218 VEV_3_3_RA6_01_1237.d 1.07E5 2 2 17 30
M.S(+42.01)SSSSSSPVLDEARR.I Y 34.47 1605.7594 15 -9.0 803.8798 2 54.94 4 28020 VEV_1_3_RA4_01_1235.d 5.59E5 5 5 2 16 Acetylation (Protein N-term)
K.LLQDAIDER.K Y 28.54 1071.5560 9 -10.5 536.7797 2 60.77 4 32064 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 196 204
R.QIPTYVTAVPEGTEK.G Y 16.54 1631.8406 15 1.3 544.9548 3 44.02 5 21534 VEV_2_3_RA5_01_1236.d 1.21E5 1 1 52 66
R.EIEGIGENGEAR.I Y 15.98 1272.5946 12 6.3 637.3086 2 65.95 6 34913 VEV_3_3_RA6_01_1237.d 1.95E5 1 1 470 481
K.KNGNSADAKYDR.A Y 15.20 1337.6323 12 12.9 669.8321 2 63.22 4 33915 VEV_1_3_RA4_01_1235.d 4.45E4 1 1 261 272
total 7 peptides
C1G7G9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGKDNPSDGLER.R Y 81.11 1273.5898 12 -16.9 425.5301 3 19.78 6 7439 VEV_3_3_RA6_01_1237.d 9.46E5 8 8 10 21
R.FGEPKPSGDGYFFSNVR.A Y 77.66 1902.8900 17 0.2 635.3041 3 73.22 4 41758 VEV_1_3_RA4_01_1235.d 0 1 1 80 96
K.TVKDQPWYEIFIAPR.M Y 73.18 1861.9727 15 -22.0 621.6512 3 83.70 6 47633 VEV_3_3_RA6_01_1237.d 2.14E5 3 3 288 302
K.SGKDNPSDGLERR.T Y 41.69 1429.6909 13 -12.4 477.5650 3 17.15 5 6190 VEV_2_3_RA5_01_1236.d 2.61E5 3 3 10 22
K.ESFSHNNDVAK.T Y 40.36 1246.5579 11 -1.5 624.2853 2 19.25 5 7347 VEV_2_3_RA5_01_1236.d 4.73E4 2 2 535 545
K.ESFSHNNDVAKTEGDDC(+57.02)GRNN Y 32.89 2364.9624 21 -6.5 592.2440 4 31.47 5 14121 VEV_2_3_RA5_01_1236.d 1.36E5 2 2 535 555 Carbamidomethylation
K.DQPWYEIFIAPR.M Y 28.64 1533.7616 12 -24.2 767.8695 2 89.96 4 53624 VEV_1_3_RA4_01_1235.d 0 1 1 291 302
K.SENFVLPPLEGQQDR.H Y 26.97 1727.8478 15 3.1 576.9583 3 77.57 4 45144 VEV_1_3_RA4_01_1235.d 0 1 1 517 531
R.QLHLELEEIR.L Y 26.46 1278.6931 10 -14.0 427.2324 3 70.25 6 38045 VEV_3_3_RA6_01_1237.d 5E4 1 1 271 280
R.FFKSGKDNPSDGLER.R Y 20.64 1695.8215 15 -29.3 424.9503 4 48.61 6 23506 VEV_3_3_RA6_01_1237.d 0 1 1 7 21
total 10 peptides
C1GBC4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSSSDDSSQGKPDIQSK.I Y 88.77 1751.7809 17 -10.0 876.8889 2 17.47 5 6360 VEV_2_3_RA5_01_1236.d 2.93E5 4 4 470 486
R.YYDVLDPFAAYR.R Y 67.55 1491.7034 12 -11.2 746.8506 2 85.26 4 50789 VEV_1_3_RA4_01_1235.d 1.46E5 2 2 651 662
R.YYDVLDPFAAYRR.A Y 55.99 1647.8044 13 -11.4 550.2692 3 80.62 6 45598 VEV_3_3_RA6_01_1237.d 6.64E4 1 1 651 663
K.TQLPGLWPTLIDASGC(+57.02)K.M Y 52.44 1855.9502 17 -4.8 928.9779 2 85.94 4 51204 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 389 405 Carbamidomethylation
R.ALAWGHDELRPVYGR.Y Y 44.66 1738.8903 15 -17.5 435.7222 4 68.12 6 36485 VEV_3_3_RA6_01_1237.d 7.56E4 1 1 215 229
K.SSSSDDSSQ(+.98)GKPDIQSK.I Y 38.94 1752.7649 17 -3.6 585.2601 3 19.41 4 7098 VEV_1_3_RA4_01_1235.d 4.18E4 1 1 470 486 Deamidation (NQ)
K.EPPAK.K Y 27.96 540.2907 5 -67.9 541.2613 1 58.60 6 29440 VEV_3_3_RA6_01_1237.d 6.76E4 1 1 569 573
K.SSS(-2.02)SDDSSQGKPDIQSK.I Y 27.37 1749.7653 17 -6.8 584.2584 3 17.37 6 6182 VEV_3_3_RA6_01_1237.d 0 1 1 470 486 2-amino-3-oxo-butanoic_acid
K.S(-2.02)SSSDDSSQGKPDIQSK.I Y 24.90 1749.7653 17 -0.9 584.2618 3 17.53 4 6102 VEV_1_3_RA4_01_1235.d 2.73E4 1 1 470 486 2-amino-3-oxo-butanoic_acid
K.SS(-2.02)SSDDSSQGKPDIQSK.I Y 22.46 1749.7653 17 -2.0 584.2612 3 17.33 5 6292 VEV_2_3_RA5_01_1236.d 9.39E4 1 1 470 486 2-amino-3-oxo-butanoic_acid
K.SLSHK.E Y 19.96 570.3126 5 -10.3 571.3140 1 90.85 6 51753 VEV_3_3_RA6_01_1237.d 8.03E4 1 1 745 749
K.YQVLVDKAIELAEILMGAFDTPNR.M Y 19.04 2705.4097 24 -22.3 677.3446 4 92.05 5 52912 VEV_2_3_RA5_01_1236.d 0 1 1 301 324
R.M(+15.99)PVTYYYWAPEYASQPHR.A Y 18.21 2274.0203 18 30.5 759.0372 3 75.67 4 43659 VEV_1_3_RA4_01_1235.d 1.75E5 1 1 325 342 Oxidation (M)
K.LFGIQ(+.98)SDIEIASK.L Y 18.08 1420.7449 13 -27.4 711.3602 2 79.95 6 45126 VEV_3_3_RA6_01_1237.d 0 1 1 600 612 Deamidation (NQ)
K.IDFATSTR.D Y 16.73 909.4556 8 -4.6 304.1577 3 15.79 6 5364 VEV_3_3_RA6_01_1237.d 5.52E4 1 1 267 274
K.EYALLGGANNQYR.T Y 15.07 1467.7106 13 -21.6 734.8467 2 72.57 6 39786 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 521 533
total 16 peptides
C1FYF6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGSGPFPTEQNNAVGEK.L Y 74.98 1729.8270 17 -9.0 865.9130 2 60.74 4 32041 VEV_1_3_RA4_01_1235.d 1.75E5 3 3 268 284
R.VGSGPFPTEQNNAVGEKLQR.A Y 72.09 2127.0708 20 1.0 710.0316 3 64.27 4 34711 VEV_1_3_RA4_01_1235.d 2.76E4 1 1 268 287
R.Q(-17.03)FGELKYDLEDEVKR.F Y 59.53 1850.9050 15 -24.4 617.9606 3 78.80 6 44293 VEV_3_3_RA6_01_1237.d 2.95E4 1 1 171 185 Pyro-glu from Q
R.AGREFGVTTGR.R Y 57.38 1149.5890 11 -7.7 384.2007 3 33.44 4 14833 VEV_1_3_RA4_01_1235.d 3.21E5 2 2 288 298
K.ITDLLSQSATLC(+57.02)C(+57.02)R.A Y 44.39 1636.7913 14 -9.2 819.3954 2 74.36 4 42690 VEV_1_3_RA4_01_1235.d 2.1E5 2 2 18 31 Carbamidomethylation
R.SSPSVLVEGANALLLDIDHGTYPYVTSSC(+57.02)TGLGGAIQGLTLNPTSIK.S Y 38.75 4786.4375 47 -5.6 1596.4775 3 94.88 4 56233 VEV_1_3_RA4_01_1235.d 5.05E4 1 1 209 255 Carbamidomethylation
R.WIGTGPAR.N Y 38.73 856.4555 8 -12.8 429.2296 2 44.23 5 21658 VEV_2_3_RA5_01_1236.d 5.28E5 3 3 407 414
K.GIGPC(+57.02)YSDK.A Y 32.33 995.4382 9 -9.2 498.7218 2 36.91 4 16883 VEV_1_3_RA4_01_1235.d 7.93E4 2 2 132 140 Carbamidomethylation
R.IGEVLEK.G Y 29.24 786.4487 7 -13.8 394.2262 2 40.51 4 19037 VEV_1_3_RA4_01_1235.d 2.47E5 2 2 148 154
R.WIGTGPARNHMIER.I Y 17.64 1636.8256 14 13.0 410.2190 4 47.15 4 23096 VEV_1_3_RA4_01_1235.d 0 1 1 407 420
R.EFGVTTGR.R Y 17.10 865.4294 8 7.4 866.4431 1 97.41 5 55129 VEV_2_3_RA5_01_1236.d 0 1 1 291 298
K.LDILDDFDEIKVAVAYQLDGK.L Y 17.06 2379.2209 21 -39.2 595.7892 4 72.27 5 40662 VEV_2_3_RA5_01_1236.d 4.16E5 1 1 327 347
K.LQPYVVDQMAFMHKHR.S Y 15.22 1998.9921 16 -17.3 667.3264 3 75.59 5 43022 VEV_2_3_RA5_01_1236.d 5.01E4 1 1 193 208
total 13 peptides
C1GB53
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YTSNIGQAGYEAHVR.K Y 105.08 1664.7906 15 -8.4 833.3956 2 54.73 4 27951 VEV_1_3_RA4_01_1235.d 3.45E5 4 4 254 268
R.VIIQPSIEVVKDVLAQSK.D Y 67.83 1965.1510 18 -6.0 656.0537 3 83.58 4 49623 VEV_1_3_RA4_01_1235.d 2.29E4 2 2 5 22
R.LARPTSLHPFNLYR.H Y 53.70 1683.9209 14 -17.0 562.3047 3 68.82 5 38142 VEV_2_3_RA5_01_1236.d 4.79E5 2 2 288 301
R.SIFPAGTVSGAPK.V Y 38.74 1230.6608 13 -12.7 616.3298 2 67.67 4 37374 VEV_1_3_RA4_01_1235.d 8.06E4 1 1 430 442
K.GDIFQTVPSQR.L Y 35.16 1246.6306 11 -16.3 624.3124 2 65.89 4 35972 VEV_1_3_RA4_01_1235.d 6.81E5 1 1 277 287
K.LGANIQC(+57.02)IK.S Y 20.00 1015.5485 9 -25.7 508.7685 2 52.02 4 26180 VEV_1_3_RA4_01_1235.d 0 1 1 525 533 Carbamidomethylation
R.YFEPK.T Y 15.85 682.3326 5 -9.8 683.3332 1 29.06 4 12324 VEV_1_3_RA4_01_1235.d 1.48E4 1 1 166 170
total 7 peptides
C1G785
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NANC(+57.02)AVVVYDITQASSLDKAK.S Y 86.79 2266.1262 21 -11.7 756.3738 3 77.10 4 44778 VEV_1_3_RA4_01_1235.d 2.82E5 2 2 90 110 Carbamidomethylation
R.AIQTADAEAYAR.E Y 71.17 1278.6204 12 -12.9 640.3092 2 54.41 6 26907 VEV_3_3_RA6_01_1237.d 7.44E5 6 6 144 155
R.EAGLLFFETSAK.S Y 59.36 1311.6710 12 -16.5 656.8320 2 80.71 6 45657 VEV_3_3_RA6_01_1237.d 1.78E5 2 2 156 167
K.LVLLGESAVGK.S Y 52.45 1084.6492 11 -35.0 543.3129 2 70.64 6 38331 VEV_3_3_RA6_01_1237.d 0 2 2 20 30
R.AIQ(+.98)TADAEAYAR.E Y 45.78 1279.6044 12 -10.5 640.8027 2 57.32 6 28601 VEV_3_3_RA6_01_1237.d 1.38E5 1 1 144 155 Deamidation (NQ)
K.KLPLDQAGPR.N Y 40.01 1093.6244 10 -35.0 547.8004 2 43.51 5 21218 VEV_2_3_RA5_01_1236.d 1.68E5 5 5 182 191
R.AIQTADAEAYAR(+14.02).E Y 34.35 1292.6360 12 -17.1 647.3142 2 60.37 6 30709 VEV_3_3_RA6_01_1237.d 5.49E4 1 1 144 155 Methylation(KR)
R.NANC(+57.02)AVVVYDITQASSLDK.A Y 33.93 2066.9941 19 -11.2 1034.4928 2 80.09 5 46114 VEV_2_3_RA5_01_1236.d 0 1 1 90 108 Carbamidomethylation
R.AIQTADAEAYAREAGLLFFETSAK.S Y 33.67 2572.2808 24 -12.4 858.4236 3 86.99 5 50301 VEV_2_3_RA5_01_1236.d 6.8E4 2 2 144 167
R.ELFTAIAK.K Y 19.36 891.5065 8 -14.7 446.7540 2 66.83 6 35499 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 174 181
K.FEIWDTAGQER.Y N 19.30 1350.6204 11 -18.8 338.6560 4 26.35 5 11243 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 69 79
R.AIQ(+.98)TADAEAYAREAGLLFFETSAK.S Y 15.62 2573.2649 24 -1.0 858.7614 3 86.98 5 50295 VEV_2_3_RA5_01_1236.d 2.9E4 1 1 144 167 Deamidation (NQ)
total 12 peptides
C1G1V9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VGYAAQNFPEHQFPSIVGRPILR.S Y 79.09 2595.3708 23 -12.2 649.8420 4 77.88 5 44632 VEV_2_3_RA5_01_1236.d 1.64E5 2 2 18 40
R.LSEDTTVLVESYTLPDGR.V Y 73.53 1993.9844 18 -9.6 997.9899 2 80.22 4 47187 VEV_1_3_RA4_01_1235.d 1.13E5 2 2 230 247
R.NLIALLLR.R Y 50.88 924.6120 8 -33.5 463.2978 2 86.13 6 49146 VEV_3_3_RA6_01_1237.d 7.68E4 2 2 189 196
R.SEEQAGDIIVKDIMC(+57.02)GDEAAAAR.S Y 47.97 2448.1260 23 -13.7 817.0381 3 80.82 4 47660 VEV_1_3_RA4_01_1235.d 6.66E4 2 2 41 63 Carbamidomethylation
K.ILLTEPPMNPLK.N Y 45.46 1364.7737 12 -34.5 683.3706 2 78.68 4 45998 VEV_1_3_RA4_01_1235.d 0 1 1 104 115
R.VLQGNPER.L Y 43.51 911.4824 8 -16.0 456.7412 2 19.82 6 7459 VEV_3_3_RA6_01_1237.d 2.8E5 5 5 326 333
K.AIVLSGGSSMYPGLPSR.L Y 33.48 1690.8712 17 -10.2 846.4343 2 77.51 4 45108 VEV_1_3_RA4_01_1235.d 5.81E4 1 1 297 313
M.A(+42.01)DQPPIVLDGGTGFLK.V Y 28.59 1668.8722 16 -10.9 835.4343 2 86.74 5 50154 VEV_2_3_RA5_01_1236.d 2.61E5 2 2 2 17 Acetylation (Protein N-term)
R.VGSERFEAPEC(+57.02)LFQPHLVDVEQPGIAEFLFNT(-2.02)IQAADVDVR.S Y 27.57 4640.2646 41 7.5 1161.0822 4 94.96 4 56266 VEV_1_3_RA4_01_1235.d 8.96E4 1 1 251 291 Carbamidomethylation; 2-amino-3-oxo-butanoic_acid
R.NLIALLLRR.G Y 23.90 1080.7131 9 -17.9 361.2385 3 81.64 4 48277 VEV_1_3_RA4_01_1235.d 2.34E4 2 2 189 197
R.TADFETVR.Q Y 18.99 937.4505 8 33.1 469.7480 2 42.65 4 20317 VEV_1_3_RA4_01_1235.d 0 1 1 204 211
K.VRIEDPPR.R Y 16.60 980.5403 8 -39.1 491.2583 2 30.23 4 12987 VEV_1_3_RA4_01_1235.d 0 1 1 339 346
total 12 peptides
C1GDE1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TYQQNVLENAK.A Y 85.58 1306.6517 11 -12.1 654.3253 2 51.35 4 25731 VEV_1_3_RA4_01_1235.d 2.43E5 4 4 362 372
R.YYGGNQFIDQAEILC(+57.02)QQR.A Y 75.70 2202.0164 18 -11.7 735.0042 3 79.91 6 45094 VEV_3_3_RA6_01_1237.d 4.81E4 2 2 119 136 Carbamidomethylation
K.YSEGYPGAR.Y N 67.60 998.4457 9 -9.3 500.2255 2 32.68 4 14391 VEV_1_3_RA4_01_1235.d 3.12E5 6 6 110 118
K.LLIAGTSAYSR.L Y 49.86 1150.6346 11 -37.8 576.3029 2 65.05 5 35310 VEV_2_3_RA5_01_1236.d 9.21E4 3 3 234 244
R.GFLPEDFVR.V Y 44.36 1078.5447 9 -10.0 540.2742 2 79.07 5 45481 VEV_2_3_RA5_01_1236.d 2.04E5 2 2 454 462
R.GAMIFFR.K N 39.85 840.4316 7 -10.6 421.2186 2 74.69 4 42887 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 301 307
R.RAAAR.L N 15.57 543.3241 5 8.2 544.3358 1 38.81 6 17814 VEV_3_3_RA6_01_1237.d 6.79E4 1 1 9 13
K.NTVPGDK.S Y 15.22 729.3657 7 -4.0 730.3701 1 84.04 4 49936 VEV_1_3_RA4_01_1235.d 0 1 1 429 435
total 8 peptides
C1GG77
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SC(+57.02)YDIESTFTC(+57.02)LPASIYC(+57.02)NNALIGPYQK.T Y 93.52 3284.4827 28 -6.0 1095.8282 3 88.73 4 52951 VEV_1_3_RA4_01_1235.d 2.35E5 3 3 349 376 Carbamidomethylation
K.AVDPSDLGIDKVK.Q Y 75.28 1355.7296 13 -15.3 452.9102 3 64.19 6 33497 VEV_3_3_RA6_01_1237.d 3.89E5 3 3 132 144
R.IPVLIYAGDADFIC(+57.02)NWLGNK.A Y 66.43 2278.1455 20 -10.2 760.3813 3 93.00 6 52784 VEV_3_3_RA6_01_1237.d 1.17E5 1 1 453 472 Carbamidomethylation
K.TGRNPYDVR.T Y 36.89 1076.5363 9 -17.6 539.2659 2 24.59 6 9996 VEV_3_3_RA6_01_1237.d 7.86E5 8 8 377 385
R.LVPSLLAR.I Y 29.88 867.5541 8 -15.7 434.7775 2 68.46 6 36731 VEV_3_3_RA6_01_1237.d 1.27E5 2 2 445 452
K.AWTEALEYPGHAK.F Y 28.76 1471.7095 13 -14.3 491.5701 3 66.28 6 35085 VEV_3_3_RA6_01_1237.d 1.6E5 2 2 473 485
K.AVDPSDLGIDK.V Y 15.27 1128.5662 11 -10.1 565.2847 2 78.35 4 45757 VEV_1_3_RA4_01_1235.d 0 1 1 132 142
K.NEVFGEVK.S Y 15.23 920.4603 8 -5.6 461.2349 2 48.04 6 23163 VEV_3_3_RA6_01_1237.d 0 1 1 503 510
total 8 peptides
C1GBG4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.WQSETQEAASSAK.Q Y 71.82 1421.6422 13 -8.7 711.8222 2 34.69 6 15475 VEV_3_3_RA6_01_1237.d 1.55E5 3 3 173 185
R.SIATFAITTLLK.T Y 64.53 1277.7595 12 -15.2 639.8773 2 87.28 6 49815 VEV_3_3_RA6_01_1237.d 1.08E5 2 2 356 367
R.AALAAAATQK.Y Y 60.97 914.5185 10 -9.5 458.2622 2 24.34 4 9750 VEV_1_3_RA4_01_1235.d 2.63E5 2 2 644 653
K.DTSVGSDVLYR.A Y 60.42 1210.5830 11 -7.0 606.2946 2 64.50 4 34888 VEV_1_3_RA4_01_1235.d 2.15E5 2 2 107 117
R.SVVESMFDLIK.F Y 35.01 1266.6530 11 -10.9 634.3268 2 86.42 5 49989 VEV_2_3_RA5_01_1236.d 3.26E5 2 2 433 443
R.TSVFQDAR.L Y 33.89 922.4508 8 -6.9 462.2295 2 39.43 4 18360 VEV_1_3_RA4_01_1235.d 4.45E5 3 3 20 27
R.IIDATTVQAIER.L Y 33.15 1328.7300 12 -47.1 665.3409 2 69.32 4 38713 VEV_1_3_RA4_01_1235.d 0 1 1 127 138
K.FGVGQKDPELKR.S Y 32.74 1372.7462 12 -10.4 344.1902 4 40.86 4 19196 VEV_1_3_RA4_01_1235.d 1.99E5 2 2 515 526
R.C(+57.02)LDDTDDEVRDR.A Y 26.69 1507.6208 12 -6.3 754.8130 2 37.07 4 16968 VEV_1_3_RA4_01_1235.d 2.57E4 1 1 535 546 Carbamidomethylation
R.LLSNDPGIVYVAFKK.L Y 25.81 1662.9344 15 -20.8 555.3073 3 76.57 4 44359 VEV_1_3_RA4_01_1235.d 4.54E4 1 1 741 755
R.AALNLR.L Y 25.13 656.3969 6 -23.1 329.1982 2 34.17 6 15180 VEV_3_3_RA6_01_1237.d 1.2E5 4 4 547 552
R.IIDATTVQAIERLIK.T Y 24.85 1682.9930 15 -4.3 421.7537 4 36.45 6 16471 VEV_3_3_RA6_01_1237.d 0 2 2 127 141
R.LFNSSPISPR.R Y 22.41 1116.5928 10 -18.4 559.2934 2 64.78 5 35119 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 28 37
K.AISSSGAER.A Y 20.79 876.4301 9 10.3 439.2268 2 30.73 6 13266 VEV_3_3_RA6_01_1237.d 4.44E4 1 1 635 643
R.AAAVTALAK.F Y 19.57 814.4912 9 -57.8 408.2293 2 34.80 6 15536 VEV_3_3_RA6_01_1237.d 0 2 2 506 514
K.LTTATPTLK.A Y 16.61 944.5543 9 -22.4 473.2738 2 47.72 6 22983 VEV_3_3_RA6_01_1237.d 2.07E4 1 1 618 626
total 16 peptides
C1GLJ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VC(+57.02)QATGASTQSTC(+57.02)TDIQDR.H Y 99.55 2097.9055 19 -5.5 1049.9542 2 46.57 4 22743 VEV_1_3_RA4_01_1235.d 5.39E4 2 2 329 347 Carbamidomethylation
K.TFSYAGFEQQPK.F Y 65.64 1401.6565 12 -9.2 701.8291 2 68.23 4 37818 VEV_1_3_RA4_01_1235.d 9.06E4 1 1 226 237
R.GGAEQFIAEAER.S Y 43.82 1276.6047 12 4.9 639.3127 2 68.62 4 38174 VEV_1_3_RA4_01_1235.d 3.56E5 2 2 383 394
K.LLDIVHPAAR.I Y 25.54 1103.6451 10 1.1 368.8894 3 63.11 4 33840 VEV_1_3_RA4_01_1235.d 9.02E4 1 1 72 81
R.LAGTAM(+15.99)NSK.L Y 23.79 907.4433 9 -5.9 908.4452 1 93.51 4 55563 VEV_1_3_RA4_01_1235.d 2.97E4 1 1 164 172 Oxidation (M)
R.QIGGER.F Y 21.03 658.3398 6 -1.7 330.1766 2 55.07 4 28094 VEV_1_3_RA4_01_1235.d 0 1 1 359 364
R.ILTDIAR.S Y 20.06 800.4756 7 -5.9 401.2427 2 54.79 5 28069 VEV_2_3_RA5_01_1236.d 8.66E4 4 4 82 88
K.MEALC(+57.02)K.T Y 19.51 750.3405 6 38.1 376.1918 2 10.92 4 2822 VEV_1_3_RA4_01_1235.d 0 1 1 285 290 Carbamidomethylation
K.VQTLR.R Y 18.66 615.3704 5 -38.9 308.6805 2 16.09 6 5507 VEV_3_3_RA6_01_1237.d 3.11E4 1 1 158 162
R.FNIFSDC(+57.02)PAAK.T Y 18.34 1268.5859 11 1.4 635.3011 2 47.22 6 22680 VEV_3_3_RA6_01_1237.d 3.14E3 1 1 365 375 Carbamidomethylation
K.GTLGPYGGDLLMVDANGK.Q Y 17.27 1776.8716 18 -20.1 593.2859 3 64.29 5 34763 VEV_2_3_RA5_01_1236.d 0 1 1 42 59
R.IKEIAVDLR.S Y 16.17 1055.6338 9 -10.1 352.8817 3 40.45 6 18750 VEV_3_3_RA6_01_1237.d 0 1 1 140 148
R.VLGGGRGRGM(+15.99)PRR Y 15.11 1383.7629 13 -7.3 346.9455 4 39.83 5 19022 VEV_2_3_RA5_01_1236.d 2.64E5 1 1 551 563 Oxidation (M)
total 13 peptides
C1GJD0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYAENPDQGFIPDSGR.L Y 95.14 1777.8270 16 -6.5 889.9150 2 71.23 6 38785 VEV_3_3_RA6_01_1237.d 7.97E4 1 1 384 399
R.VTTLYTDPDAR.A Y 73.55 1250.6143 11 -13.4 626.3060 2 57.10 4 29379 VEV_1_3_RA4_01_1235.d 2.75E5 3 3 71 81
K.AGTALVEFADASSR.A Y 40.99 1393.6837 14 -1.6 697.8480 2 71.32 4 40254 VEV_1_3_RA4_01_1235.d 8.85E4 1 1 708 721
K.ILEESPAPHLPEATR.K Y 25.40 1658.8627 15 10.5 415.7273 4 65.02 4 35288 VEV_1_3_RA4_01_1235.d 9.55E4 1 1 278 292
R.IASSKETFRD(+43.99)QLISAK.S Y 20.58 1836.9581 16 -10.0 460.2422 4 66.68 5 36529 VEV_2_3_RA5_01_1236.d 3.62E4 1 1 210 225 Carboxylation (DKW)
K.AVKGGGGKGM(+15.99)RIASSK.E Y 20.24 1518.8300 16 -50.8 760.3837 2 78.95 6 44404 VEV_3_3_RA6_01_1237.d 0 1 1 199 214 Oxidation (M)
K.M(+15.99)ETVIRSPHDGTIEK.I Y 18.79 1727.8512 15 -17.8 346.5714 5 33.85 5 15492 VEV_2_3_RA5_01_1236.d 3.05E5 1 1 683 697 Oxidation (M)
K.GHAIEAR.I Y 18.79 752.3929 7 -20.5 753.3847 1 106.06 4 60058 VEV_1_3_RA4_01_1235.d 1.36E3 1 1 377 383
R.VEVAEGATVVK.D Y 17.93 1100.6077 11 -53.8 551.2815 2 27.25 6 11381 VEV_3_3_RA6_01_1237.d 0 1 1 661 671
K.AGDIC(+57.02)K.A Y 17.31 662.3057 6 19.2 663.3257 1 72.68 4 41333 VEV_1_3_RA4_01_1235.d 3.99E4 1 1 702 707 Carbamidomethylation
K.VAGPAGATVGFSPAYQER.Q Y 17.25 1776.8794 18 23.7 445.2376 4 63.58 6 33066 VEV_3_3_RA6_01_1237.d 6.87E4 1 1 522 539
K.AVKGGGGK.G Y 16.98 672.3918 8 -72.0 673.3507 1 79.79 4 46861 VEV_1_3_RA4_01_1235.d 4.07E4 1 1 199 206
K.DTANSVLAPMPC(+57.02)K.I Y 16.12 1402.6584 13 16.4 702.3480 2 74.34 4 42620 VEV_1_3_RA4_01_1235.d 8.61E4 1 1 645 657 Carbamidomethylation
K.DQPLVVIESMKM(+15.99)ETVIRSPHDGTIEK.I Y 15.88 2967.5044 26 -10.1 742.8759 4 100.91 5 56313 VEV_2_3_RA5_01_1236.d 0 1 1 672 697 Oxidation (M)
total 14 peptides
C1GCV8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AATAQDDITGDGTTSVVLLVGELLK.Q Y 98.54 2486.3115 25 -9.2 1244.1516 2 95.48 5 54424 VEV_2_3_RA5_01_1236.d 4.99E5 6 6 80 104
K.GIDPLSLDVLVK.N Y 60.90 1267.7388 12 -16.6 634.8661 2 84.49 6 48134 VEV_3_3_RA6_01_1237.d 1.58E5 2 2 297 308
R.DIDRELLLSVAR.T Y 49.44 1398.7831 12 -12.0 467.2627 3 78.08 4 45540 VEV_1_3_RA4_01_1235.d 6.77E4 1 1 142 153
K.SNLGPSGTLK.M Y 35.40 972.5240 10 -10.8 487.2640 2 38.36 4 17727 VEV_1_3_RA4_01_1235.d 3.78E5 4 4 36 45
R.HLSEGLHPR.V Y 31.58 1044.5464 9 -32.0 523.2637 2 21.88 6 8543 VEV_3_3_RA6_01_1237.d 5.39E4 1 1 109 117
R.TASDTQLIR.G Y 30.77 1003.5298 9 39.7 502.7921 2 38.87 5 18442 VEV_2_3_RA5_01_1236.d 3.83E5 1 1 200 208
K.GIDPLSLDVLVKNGILALRR.A Y 26.61 2161.2947 20 -9.3 541.3259 4 88.48 5 51099 VEV_2_3_RA5_01_1236.d 6.33E4 2 2 297 316
R.HPDMPK.R Y 15.91 723.3374 6 29.9 724.3663 1 66.95 4 36803 VEV_1_3_RA4_01_1235.d 1.26E4 1 1 218 223
R.EM(+15.99)QIQNPTAVM(+15.99)IAR.A Y 15.28 1632.7964 14 -4.4 409.2046 4 50.04 6 24325 VEV_3_3_RA6_01_1237.d 0 1 1 66 79 Oxidation (M)
total 9 peptides
C1FYF5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFRGPGDEDDLMNAGTAVGTSSLETSGTSSSPFK.S Y 121.80 3404.5312 34 -6.1 1135.8441 3 79.18 4 46385 VEV_1_3_RA4_01_1235.d 5.17E4 1 1 226 259
K.STLDQYHHPGGLNASSNF Y 90.91 1943.8762 18 -7.9 648.9609 3 66.35 4 36333 VEV_1_3_RA4_01_1235.d 1.2E6 4 4 260 277
R.TTPPSSTSR.T Y 17.20 932.4563 9 -7.0 467.2321 2 44.29 5 21703 VEV_2_3_RA5_01_1236.d 0 1 1 93 101
total 3 peptides
C1GAW5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SDDPNLPAFYFDPVINPISSR.S Y 113.03 2363.1433 21 -6.8 1182.5709 2 89.04 5 51403 VEV_2_3_RA5_01_1236.d 1.8E5 3 3 351 371
R.VAFPYLYNSLPR.S Y 50.44 1438.7609 12 -17.6 720.3751 2 82.14 4 48622 VEV_1_3_RA4_01_1235.d 3.75E5 2 2 323 334
K.GLLDPLEVHLLDFPNISIR.A Y 45.78 2160.1943 19 -15.8 721.0607 3 92.20 4 54880 VEV_1_3_RA4_01_1235.d 1.03E5 2 2 2458 2476
K.Q(-17.03)TDTGVTHYR.A Y 31.73 1159.5258 10 -14.1 580.7620 2 38.79 6 17805 VEV_3_3_RA6_01_1237.d 0 1 1 1363 1372 Pyro-glu from Q
R.STLSFDKGFR.T Y 27.06 1156.5876 10 -25.6 386.5266 3 61.90 4 32915 VEV_1_3_RA4_01_1235.d 5.73E4 1 1 1446 1455
R.KGLLDPLEVHLLDFPNISIR.A Y 23.44 2288.2891 20 -27.2 573.0640 4 88.21 4 52633 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 2457 2476
K.AEQER.Q N 15.23 631.2925 5 -25.6 632.2836 1 29.01 4 12303 VEV_1_3_RA4_01_1235.d 0 1 1 804 808
total 7 peptides
C1GC92
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IYQSLGQDYDER.V Y 93.70 1485.6736 12 -11.3 743.8357 2 60.81 6 31094 VEV_3_3_RA6_01_1237.d 2.31E5 3 3 105 116
R.AEGEAESAEIISK.A Y 64.38 1332.6409 13 -13.0 667.3190 2 50.62 6 24645 VEV_3_3_RA6_01_1237.d 8E4 2 2 213 225
K.SIVAQFDAAELITQR.E Y 60.84 1660.8784 15 -9.8 554.6280 3 82.60 4 48941 VEV_1_3_RA4_01_1235.d 6.3E4 2 2 128 142
R.NISTTTGSKDLQMVSLTLR.V Y 45.06 2064.0884 19 3.6 689.0392 3 76.45 5 43625 VEV_2_3_RA5_01_1236.d 9.67E4 2 2 74 92
K.DLQMVSLTLR.V Y 24.73 1174.6379 10 -31.7 588.3076 2 80.12 6 45248 VEV_3_3_RA6_01_1237.d 2.01E4 1 1 83 92
K.STSLLLGLR.S Y 23.13 958.5811 9 -9.4 320.5313 3 38.27 4 17672 VEV_1_3_RA4_01_1235.d 1.69E4 1 1 271 279
K.AEQERQANVIR.A Y 18.92 1312.6847 11 -2.5 329.1776 4 13.90 4 4251 VEV_1_3_RA4_01_1235.d 0 1 1 202 212
K.STSLLLGLRS Y 17.54 1045.6132 10 -18.8 523.8040 2 74.11 5 41964 VEV_2_3_RA5_01_1236.d 4.7E4 1 1 271 280
R.NIS(-2.02)TTTGSKDLQMVSLTLR.V Y 17.30 2062.0728 19 -34.4 688.3412 3 76.47 4 44281 VEV_1_3_RA4_01_1235.d 0 1 1 74 92 2-amino-3-oxo-butanoic_acid
K.AEQER.Q N 15.23 631.2925 5 -25.6 632.2836 1 29.01 4 12303 VEV_1_3_RA4_01_1235.d 0 1 1 202 206
total 10 peptides
C1G9P1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YTVTLIPGDGIGAEVAESVK.T Y 75.06 2018.0571 20 -3.4 1010.0324 2 83.17 6 47302 VEV_3_3_RA6_01_1237.d 1.15E5 3 3 52 71
K.AVYDVIGEGVVR.T Y 66.59 1275.6823 12 -14.7 638.8391 2 74.79 5 42446 VEV_2_3_RA5_01_1236.d 5.97E5 5 5 352 363
R.EVAVFEPGC(+57.02)R.H Y 60.08 1162.5441 10 -8.6 582.2743 2 61.48 6 31511 VEV_3_3_RA6_01_1237.d 6.73E5 2 2 303 312 Carbamidomethylation
R.DM(+15.99)GGQATTNEFTR.A Y 59.47 1442.6096 13 24.3 722.3296 2 43.81 6 20702 VEV_3_3_RA6_01_1237.d 0 2 2 366 378 Oxidation (M)
R.TRDMGGQATTNEFTR.A Y 48.15 1683.7634 15 -1.7 562.2608 3 44.99 5 22132 VEV_2_3_RA5_01_1236.d 1.41E5 2 2 364 378
R.HLGLDEHANR.I Y 36.00 1160.5686 10 -2.8 581.2900 2 25.33 4 10304 VEV_1_3_RA4_01_1235.d 5.63E4 2 2 339 348
R.HDNVDLC(+57.02)IIR.E Y 35.82 1253.6187 10 49.7 418.9009 3 64.37 6 33638 VEV_3_3_RA6_01_1237.d 0 1 1 159 168 Carbamidomethylation
K.LADGLFR.S Y 30.04 790.4337 7 -20.9 396.2159 2 65.43 6 34473 VEV_3_3_RA6_01_1237.d 6.84E5 3 3 228 234
R.AVLDKMEAAL Y 24.29 1059.5634 10 -9.8 530.7838 2 75.81 5 43181 VEV_2_3_RA5_01_1236.d 8.8E4 1 1 379 388
R.IS(+79.97)K(+226.08)AVYDVIGEGVVR.T Y 23.04 1909.9373 15 -1.2 637.6523 3 75.21 4 43298 VEV_1_3_RA4_01_1235.d 3.71E5 1 1 349 363 Phosphorylation (STY); Biotinylation
total 10 peptides
C1GF14
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGDTPNHHGSLR.S Y 97.04 1276.5908 12 -7.3 639.2980 2 11.97 5 3421 VEV_2_3_RA5_01_1236.d 5.81E4 2 2 435 446
R.SPGDRSQSSSPAHSQR.N Y 93.72 1682.7720 16 -6.3 561.9277 3 10.45 5 2703 VEV_2_3_RA5_01_1236.d 6.36E4 2 2 292 307
R.QDGSRPQPSSNTAR.Y Y 49.92 1499.7076 14 -7.7 500.9060 3 12.79 4 3690 VEV_1_3_RA4_01_1235.d 4.49E4 2 2 451 464
R.AAPSPPNGTQPSSQ(+.98)R.S Y 29.56 1494.7063 15 -6.1 748.3559 2 31.96 4 13982 VEV_1_3_RA4_01_1235.d 4.33E4 1 1 420 434 Deamidation (NQ)
R.AAPSPPN(+.98)GTQPSSQR.S Y 25.66 1494.7063 15 -11.9 748.3516 2 32.07 5 14463 VEV_2_3_RA5_01_1236.d 4.16E4 1 1 420 434 Deamidation (NQ)
K.ENALSRVAREIYR.T Y 15.40 1575.8481 13 -36.6 526.2708 3 66.37 6 35159 VEV_3_3_RA6_01_1237.d 0 1 1 586 598
total 6 peptides
C1G8X1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.RLDYIYVGDGAFGQFSSPK.K Y 112.93 2119.0374 19 -6.6 707.3484 3 79.89 5 45974 VEV_2_3_RA5_01_1236.d 4.02E5 3 3 285 303
R.EGNIVVDGELPDPLAK.R Y 70.55 1664.8621 16 -7.8 833.4318 2 79.89 5 45977 VEV_2_3_RA5_01_1236.d 1.8E5 2 2 269 284
R.IGPASTDIADVFC(+57.02)THLHAPYER.E Y 31.67 2469.1746 22 40.5 618.3259 4 79.63 4 46739 VEV_1_3_RA4_01_1235.d 0 1 1 131 152 Carbamidomethylation
R.NSDELPEKISILTLNC(+57.02)WGLK.F Y 28.81 2329.1987 20 -19.4 777.3918 3 85.46 5 49427 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 5 24 Carbamidomethylation
R.ETQEILPYGK.F Y 23.54 1176.6027 10 -11.0 589.3021 2 61.52 4 32621 VEV_1_3_RA4_01_1235.d 5.61E4 1 1 68 77
total 5 peptides
C1GI20
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LDPTTEVVIAPPAIYLVLAR.Q Y 87.12 2150.2351 20 1.1 1076.1260 2 93.71 4 55667 VEV_1_3_RA4_01_1235.d 2.22E5 4 4 32 51
K.SITHIITNLNSAK.L Y 63.74 1410.7831 13 -12.1 471.2626 3 65.21 4 35442 VEV_1_3_RA4_01_1235.d 2.21E5 3 3 19 31
K.VATTEQAQEVHASIRK.W Y 55.70 1766.9275 16 -12.4 589.9758 3 36.35 5 16983 VEV_2_3_RA5_01_1236.d 8.05E4 2 2 176 191
K.ISPEAAENTR.V Y 53.22 1086.5305 10 -12.3 544.2659 2 30.79 6 13307 VEV_3_3_RA6_01_1237.d 3.77E5 5 5 197 206
R.VIYGGSVTESNC(+57.02)R.D Y 50.34 1440.6667 13 -14.2 721.3304 2 49.25 6 23865 VEV_3_3_RA6_01_1237.d 2.37E5 5 5 207 219 Carbamidomethylation
K.VVIAYEPIWAIGTGK.V Y 30.98 1615.8973 15 -15.0 808.9438 2 84.32 6 48033 VEV_3_3_RA6_01_1237.d 1.42E4 1 1 161 175
R.TIDVVTR.Q Y 17.34 802.4548 7 -32.9 402.2215 2 38.53 6 17669 VEV_3_3_RA6_01_1237.d 0 1 1 138 144
R.KFFVGGNFK.M Y 16.50 1042.5599 9 -12.0 522.2810 2 21.27 6 8226 VEV_3_3_RA6_01_1237.d 0 1 1 4 12
total 8 peptides
C1G6E7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LYSTPDASKFNAFGR.V Y 71.66 1672.8208 15 -16.0 558.6053 3 70.08 4 39276 VEV_1_3_RA4_01_1235.d 3.23E5 3 3 498 512
R.GGGQIIPTAR.R N 64.56 968.5403 10 -10.2 485.2725 2 46.16 5 22871 VEV_2_3_RA5_01_1236.d 1.63E6 10 10 823 832
R.EFMTDLLNFPDQTR.N Y 53.70 1725.8032 14 10.9 863.9183 2 86.28 4 51421 VEV_1_3_RA4_01_1235.d 5.52E4 1 1 125 138
K.FKLTDISLAEQAIFR.G Y 53.66 1750.9617 15 -0.9 584.6606 3 85.93 4 51203 VEV_1_3_RA4_01_1235.d 5.84E4 1 1 808 822
K.FAVQEADLPPVFYSR.E Y 42.91 1737.8726 15 -15.2 869.9304 2 82.56 5 47685 VEV_2_3_RA5_01_1236.d 0 1 1 110 124
R.GGGQIIPTARR.A N 37.02 1124.6414 11 -10.7 563.3220 2 35.26 5 16323 VEV_2_3_RA5_01_1236.d 3.57E5 4 4 823 833
K.KFAVQEADLPPVFYSR.E Y 32.19 1865.9675 16 5.5 622.9999 3 78.82 4 46112 VEV_1_3_RA4_01_1235.d 2.79E4 1 1 109 124
K.SHLFNIIDTPGHVNFVDEVAAAFR.L Y 31.12 2668.3396 24 10.8 668.0994 4 88.49 4 52808 VEV_1_3_RA4_01_1235.d 1.92E5 1 1 212 235
K.LRPLDMASAMATAR.D Y 30.36 1502.7698 14 -25.7 501.9177 3 74.28 4 42572 VEV_1_3_RA4_01_1235.d 0 2 2 937 950
K.YYTGPLDTK.V Y 25.25 1056.5127 9 -8.2 529.2593 2 58.20 4 30181 VEV_1_3_RA4_01_1235.d 1.98E5 2 2 469 477
K.GLRESGVLGEG Y 22.07 1072.5513 11 -2.4 537.2816 2 35.68 4 16142 VEV_1_3_RA4_01_1235.d 1.58E5 2 2 979 989
R.VMSGIARPGQQVR.V Y 20.17 1397.7561 13 -2.4 466.9249 3 45.03 4 21781 VEV_1_3_RA4_01_1235.d 6.8E4 1 1 513 525
R.AVYSSFLMASPR.L Y 17.20 1327.6594 12 4.7 664.8401 2 76.75 5 43844 VEV_2_3_RA5_01_1236.d 0 1 1 834 845
K.WSVVPGDPLDR.D Y 16.71 1239.6248 11 -14.7 414.2095 3 42.48 6 19942 VEV_3_3_RA6_01_1237.d 9.25E4 1 1 923 933
total 14 peptides
C1GDK4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGTTLYVTGFGHGTR.A Y 85.18 1522.7528 15 -12.8 508.5851 3 63.32 4 34015 VEV_1_3_RA4_01_1235.d 1.14E6 6 6 4 18
R.LFAFVEYESRR.D Y 67.38 1415.7197 11 -11.2 472.9086 3 73.46 4 41996 VEV_1_3_RA4_01_1235.d 6.19E5 3 3 47 57
R.IGRDDLLKIEWAR.T Y 54.33 1583.8783 13 -21.6 396.9683 4 74.86 6 41439 VEV_3_3_RA6_01_1237.d 2.21E5 3 3 71 83
R.TPPSASWR.F Y 44.93 900.4453 8 -17.1 451.2222 2 36.57 6 16531 VEV_3_3_RA6_01_1237.d 7.68E5 3 3 84 91
R.DADDAYHEMHNKR.I Y 31.56 1600.6688 13 -21.0 534.5524 3 20.70 6 7931 VEV_3_3_RA6_01_1237.d 1.62E4 1 1 58 70
R.ARELAYEFER.Y Y 28.36 1282.6305 10 -6.9 642.3181 2 59.20 6 29875 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 19 28
R.ELAYEFER.Y Y 26.11 1055.4923 8 -4.1 528.7513 2 64.85 4 35159 VEV_1_3_RA4_01_1235.d 1.45E5 1 1 21 28
R.RPRSPSPRR.A Y 17.60 1107.6373 9 -70.0 370.1939 3 49.89 6 24232 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 107 115
R.SPSPR.R N 16.92 542.2812 5 -11.6 543.2822 1 17.13 4 5899 VEV_1_3_RA4_01_1235.d 6.26E4 2 2 110 114
R.C(+57.02)DIPAPR.T Y 16.88 827.3959 7 30.6 414.7179 2 35.36 6 15859 VEV_3_3_RA6_01_1237.d 0 1 1 35 41 Carbamidomethylation
total 10 peptides
A0A0A0HSK3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KPVGVVASAQAAAAAPAAAPER.K Y 97.30 2002.0958 22 -38.7 668.3467 3 63.04 4 33795 VEV_1_3_RA4_01_1235.d 3.59E4 2 2 376 397
R.NDASGAGGPGLNVGSSVMR.K Y 66.63 1744.8162 19 -5.1 873.4109 2 67.14 5 36873 VEV_2_3_RA5_01_1236.d 7.23E4 2 2 357 375
R.RSSYFGDRGTAAGGPSHQNR.G Y 41.18 2119.9895 20 -6.9 531.0010 4 29.89 5 13197 VEV_2_3_RA5_01_1236.d 5.46E4 1 1 141 160
R.SFEAAIDGSYMNRR.A Y 29.00 1615.7412 14 -19.1 539.5774 3 67.19 5 36912 VEV_2_3_RA5_01_1236.d 4.31E4 1 1 111 124
R.SRVLSFTSNK.S Y 26.74 1137.6143 10 -18.2 380.2051 3 51.17 5 25885 VEV_2_3_RA5_01_1236.d 0 1 1 11 20
R.SSYFGDRGTAAGGPSHQNR.G Y 26.70 1963.8884 19 -27.5 491.9659 4 34.27 5 15744 VEV_2_3_RA5_01_1236.d 0 1 1 142 160
R.SIQHKDIYGNLITDPDLSNPTR.H Y 21.61 2496.2607 22 -8.9 833.0868 3 71.66 5 40212 VEV_2_3_RA5_01_1236.d 2.45E4 1 1 78 99
R.VLSFTSNK.S Y 17.46 894.4811 8 -20.6 448.2386 2 14.29 5 4641 VEV_2_3_RA5_01_1236.d 0 1 1 13 20
K.SGRTHK.S Y 16.96 684.3667 6 4.1 343.1920 2 48.14 6 23228 VEV_3_3_RA6_01_1237.d 2.93E6 1 1 21 26
total 9 peptides
C1GGK1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LVQGSVLSVDYPVPSAIQNAVQAK.Y Y 74.59 2482.3430 24 -1.8 1242.1765 2 84.04 4 49937 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 139 162
M.A(+42.01)YQGPHPSGGGYGEAHR.L Y 67.32 1781.7870 17 -9.5 594.9306 3 47.60 4 23382 VEV_1_3_RA4_01_1235.d 2.76E5 2 2 2 18 Acetylation (Protein N-term)
K.LINPLVAAQNFEYK.I N 59.97 1618.8718 14 -13.1 810.4326 2 83.26 4 49404 VEV_1_3_RA4_01_1235.d 7.38E4 2 2 406 419
K.ISNILDKPLESSFGYVSVLPGAFSAYR.F Y 55.82 2929.5225 27 -12.6 977.5025 3 88.71 5 51230 VEV_2_3_RA5_01_1236.d 7.29E4 1 1 420 446
R.SETSSTEAWR.Q Y 47.85 1152.5048 10 -6.8 577.2557 2 34.18 4 15293 VEV_1_3_RA4_01_1235.d 1.82E5 4 4 112 121
R.WLFNAFGR.I Y 30.96 1009.5134 8 -4.3 505.7618 2 82.31 4 48749 VEV_1_3_RA4_01_1235.d 6.97E4 1 1 347 354
R.ALTPFVEPK.V Y 29.37 1000.5593 9 -15.3 501.2793 2 66.40 6 35179 VEV_3_3_RA6_01_1237.d 2.01E5 2 2 810 818
R.QGPGN(-17.03)LRR.Y Y 23.47 879.4675 8 -21.3 440.7317 2 28.06 6 11811 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 124 131 Ammonia-loss (N)
K.MLTSR.T Y 18.89 606.3159 5 -10.4 607.3169 1 22.52 4 8733 VEV_1_3_RA4_01_1235.d 3.53E4 1 1 220 224
R.IPSPYTR.S Y 16.20 832.4443 7 -17.4 417.2222 2 41.72 4 19746 VEV_1_3_RA4_01_1235.d 9.23E4 1 1 105 111
total 10 peptides
C1GA32
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.PSEVSDIKQFIEIC(+57.02)R.R Y 111.95 1819.9138 15 -24.5 607.6304 3 77.78 6 43590 VEV_3_3_RA6_01_1237.d 9.14E5 5 5 2 16 Carbamidomethylation
R.FIYTLVLKDSDKADK.L Y 58.30 1754.9454 15 -26.8 439.7319 4 70.06 4 39253 VEV_1_3_RA4_01_1235.d 0 2 2 43 57
K.IADVSKGR.K Y 38.42 844.4766 8 -16.4 423.2387 2 12.70 5 3804 VEV_2_3_RA5_01_1236.d 4.78E4 1 1 68 75
K.Q(-17.03)SLPPSLK.I Y 36.85 851.4752 8 -14.6 852.4701 1 68.91 4 38363 VEV_1_3_RA4_01_1235.d 0 2 2 60 67 Pyro-glu from Q
K.QSLPPSLK.I Y 28.26 868.5018 8 -16.2 435.2511 2 48.09 4 23694 VEV_1_3_RA4_01_1235.d 2E5 8 8 60 67
R.FIYTLVLK.D Y 22.14 995.6055 8 -48.9 498.7857 2 79.51 4 46643 VEV_1_3_RA4_01_1235.d 0 1 1 43 50
total 6 peptides
C1GD34
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RNTRIENPSVFPQQGNAGISQNF Y 98.76 2573.2734 23 -12.0 858.7548 3 72.79 5 41038 VEV_2_3_RA5_01_1236.d 3.14E5 3 3 357 379
R.NTRIENPSVFPQQGNAGISQNF Y 83.66 2417.1724 22 -7.7 1209.5841 2 77.14 5 44118 VEV_2_3_RA5_01_1236.d 2.41E5 4 4 358 379
R.IENPSVFPQQGNAGISQNF Y 47.57 2045.9806 19 -12.3 682.9924 3 81.14 6 45955 VEV_3_3_RA6_01_1237.d 1.23E5 1 1 361 379
R.FNPNHDPTLPSVGLAGGNYDDSAGMK.D Y 44.14 2673.2129 26 -6.6 892.0724 3 75.30 4 43361 VEV_1_3_RA4_01_1235.d 6.75E4 1 1 222 247
total 4 peptides
C1GE74
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGQAVDVVGQAGKPK.T Y 105.37 1451.8096 15 -14.2 726.9017 2 46.76 4 22855 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 841 855
R.LDADPAMALLSESVGPEAK.S Y 69.94 1912.9451 19 -8.1 957.4720 2 84.50 4 50253 VEV_1_3_RA4_01_1235.d 2.74E4 1 1 466 484
R.GAGLTNVDSAR.H Y 42.81 1059.5309 11 -7.7 530.7686 2 36.97 4 16915 VEV_1_3_RA4_01_1235.d 6.08E5 8 8 366 376
K.VYDTLSR.Y Y 22.77 852.4341 7 -7.1 427.2213 2 35.14 4 15840 VEV_1_3_RA4_01_1235.d 0 3 3 701 707
K.EEETK.E N 18.85 634.2809 5 12.3 635.2960 1 27.01 4 11193 VEV_1_3_RA4_01_1235.d 6.64E4 1 1 42 46
K.GPWVWK.T Y 15.44 771.4068 6 -23.2 386.7017 2 8.90 4 2112 VEV_1_3_RA4_01_1235.d 5.83E3 1 1 405 410
total 6 peptides
C1GKQ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DSQILLLSFLNR.V Y 73.42 1417.7928 12 -11.7 473.5994 3 90.36 4 53853 VEV_1_3_RA4_01_1235.d 1.47E5 3 3 1194 1205
R.VIAVEDEAFDPR.S Y 63.21 1359.6670 12 -2.9 680.8388 2 70.76 5 39549 VEV_2_3_RA5_01_1236.d 2.37E4 1 1 1531 1542
R.DVNWYGGVFLPR.I Y 61.38 1421.7091 12 -12.6 711.8529 2 85.02 6 48472 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 912 923
R.YTDQPLGSR.S Y 54.55 1035.4985 9 -9.7 518.7515 2 34.41 5 15823 VEV_2_3_RA5_01_1236.d 9.43E4 2 2 1641 1649
K.SVGAGSDQLNYGK.V Y 46.30 1294.6154 13 1.1 648.3157 2 46.76 4 22859 VEV_1_3_RA4_01_1235.d 3.5E5 5 5 1143 1155
R.LVASC(+57.02)ANDAK.I Y 31.12 1047.5018 10 -2.1 524.7571 2 19.88 5 7671 VEV_2_3_RA5_01_1236.d 7.47E4 2 2 1254 1263 Carbamidomethylation
R.NQFYVGR.T Y 26.32 882.4348 7 -6.9 442.2216 2 45.43 5 22392 VEV_2_3_RA5_01_1236.d 0 2 2 1014 1020
K.EGVLEK.V Y 20.84 673.3646 6 0.0 337.6896 2 22.04 5 8826 VEV_2_3_RA5_01_1236.d 3.13E5 1 1 447 452
R.SSHFSSFTR.Y Y 20.63 1054.4832 9 14.9 528.2567 2 34.41 5 15822 VEV_2_3_RA5_01_1236.d 0 1 1 1632 1640
R.GQNLDVYFPVPLNVAC(+57.02)R.G Y 19.96 1960.9829 17 -0.3 491.2529 4 86.86 6 49587 VEV_3_3_RA6_01_1237.d 3.28E4 1 1 856 872 Carbamidomethylation
R.RAWEHAR.R Y 16.23 924.4678 7 -8.3 463.2373 2 58.12 5 30195 VEV_2_3_RA5_01_1236.d 4.85E4 1 1 83 89
total 11 peptides
C1G5P0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALVQEQVGNFGER.L Y 77.79 1445.7262 13 -14.5 723.8599 2 66.56 6 35299 VEV_3_3_RA6_01_1237.d 1.22E5 2 2 609 621
R.YIDYPISEILQMFGK.A Y 64.36 1815.9116 15 21.2 908.9823 2 95.49 4 56513 VEV_1_3_RA4_01_1235.d 0 2 2 1743 1757
R.LISISDLPDWARPSFK.N Y 58.09 1843.9832 16 -7.7 615.6636 3 83.96 4 49884 VEV_1_3_RA4_01_1235.d 1.51E5 2 2 523 538
K.AVYIAPFQELIDHR.L Y 39.82 1670.8779 14 -13.4 557.9591 3 81.78 6 46395 VEV_3_3_RA6_01_1237.d 9.41E4 1 1 1442 1455
K.LTGETTADLK.I Y 35.51 1047.5448 10 -6.9 524.7761 2 38.66 4 17908 VEV_1_3_RA4_01_1235.d 1.32E5 3 3 1475 1484
R.TVC(+57.02)DLISKFPR.L Y 31.78 1334.7017 11 -23.7 445.8973 3 74.37 4 42639 VEV_1_3_RA4_01_1235.d 3.11E5 2 2 1237 1247 Carbamidomethylation
R.LGNLDSGKNIAK.L Y 25.91 1228.6775 12 -11.0 615.3392 2 37.81 4 17404 VEV_1_3_RA4_01_1235.d 2.01E4 1 1 1463 1474
K.EEGDGTTSFIVGDGKR.E Y 25.42 1666.7798 16 -30.5 556.5836 3 68.02 5 37582 VEV_2_3_RA5_01_1236.d 1.34E5 1 1 2293 2308
K.LILPERFPAHTPLLDMQR.V Y 18.34 2146.1721 18 6.0 537.5535 4 79.24 4 46429 VEV_1_3_RA4_01_1235.d 0 1 1 1356 1373
K.KEIDDLLGSSMGPK.E Y 18.25 1488.7494 14 10.1 497.2621 3 77.26 6 43195 VEV_3_3_RA6_01_1237.d 1.32E4 1 1 170 183
K.AFILLQAHFSR.M Y 17.88 1301.7244 11 22.7 434.9253 3 76.48 4 44287 VEV_1_3_RA4_01_1235.d 0 1 1 1959 1969
K.GTQVYSPEK.G Y 17.69 1007.4924 9 -22.7 504.7420 2 26.70 4 11043 VEV_1_3_RA4_01_1235.d 7.46E4 2 2 895 903
total 12 peptides
C1GB99
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IGFFLHTPFPSSEIYR.I Y 97.54 1909.9727 16 -14.6 637.6555 3 83.17 4 49339 VEV_1_3_RA4_01_1235.d 2.24E5 2 2 174 189
R.LLLVSNRLPITIKR.S Y 49.46 1635.0559 14 -19.1 409.7634 4 74.63 4 42846 VEV_1_3_RA4_01_1235.d 9.47E4 2 2 14 27
R.SDDGKYEFSMSSGGLVSGLSGLSK.S Y 49.05 2407.1213 24 -3.3 803.3784 3 80.96 4 47760 VEV_1_3_RA4_01_1235.d 7.44E4 1 1 28 51
K.VIAVGAFPIGIDPDKFSEGLKK.E Y 43.89 2300.2778 22 -3.7 576.0746 4 82.14 4 48629 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 241 262
R.ILGLSTTPNGVEFQGK.V Y 24.11 1659.8832 16 -21.7 830.9308 2 77.78 4 45311 VEV_1_3_RA4_01_1235.d 5.75E4 1 1 225 240
R.AVVNELVGR.I Y 22.67 955.5450 9 -15.7 478.7723 2 60.67 6 30924 VEV_3_3_RA6_01_1237.d 3.29E4 1 1 336 344
R.HFLSSC(+57.02)SR.I Y 21.53 992.4498 8 -12.8 497.2258 2 26.15 5 11123 VEV_2_3_RA5_01_1236.d 7.46E4 2 2 217 224 Carbamidomethylation
R.SDDGK.Y N 15.98 520.2129 5 -13.8 521.2130 1 8.34 6 1959 VEV_3_3_RA6_01_1237.d 2.41E3 1 1 28 32
R.NTSAIPSDLSHGK.E Y 15.62 1325.6575 13 5.9 332.4236 4 12.61 4 3614 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 489 501
total 9 peptides
C1GN32
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YDTWSRPPPPEAAAGQVK.F Y 87.53 1968.9694 18 -3.7 657.3279 3 63.28 5 33997 VEV_2_3_RA5_01_1236.d 5.83E4 1 1 396 413
K.IVIDAGGPNDGSASR.I Y 55.24 1427.7004 15 -15.3 714.8466 2 54.07 5 27631 VEV_2_3_RA5_01_1236.d 7.42E4 1 1 1037 1051
R.Q(-17.03)GAVVQGIHDR.T Y 37.38 1161.5890 11 -5.9 581.7983 2 53.78 4 27341 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 293 303 Pyro-glu from Q
K.FSPDPDRHIQISGER.S Y 36.36 1752.8542 15 -10.9 439.2161 4 57.95 5 30081 VEV_2_3_RA5_01_1236.d 5.96E4 1 1 414 428
R.LEGNAAIVER.I Y 31.89 1070.5720 10 -3.8 536.2913 2 46.61 4 22820 VEV_1_3_RA4_01_1235.d 1.37E4 2 2 1067 1076
R.ALTSYLQQR.Q Y 31.73 1078.5771 9 -21.9 540.2841 2 62.94 6 32590 VEV_3_3_RA6_01_1237.d 3.99E4 1 1 542 550
R.AEELQGQITLR.Q Y 30.77 1256.6725 11 -10.8 629.3367 2 64.80 4 35124 VEV_1_3_RA4_01_1235.d 2.44E4 1 1 442 452
R.NLHHSVADNGR.L Y 28.67 1218.5853 11 -12.4 407.1974 3 12.45 5 3677 VEV_2_3_RA5_01_1236.d 9.01E4 1 1 1170 1180
R.TPAAAPMAWGVR.T Y 21.18 1226.6230 12 -13.6 614.3105 2 69.38 5 38548 VEV_2_3_RA5_01_1236.d 0 1 1 123 134
R.GGETR.R N 20.73 518.2449 5 -3.2 519.2505 1 14.26 6 4557 VEV_3_3_RA6_01_1237.d 1.5E4 2 2 1110 1114
K.ALIGGGGATIR.K Y 19.55 984.5716 11 -10.5 493.2879 2 58.66 4 30478 VEV_1_3_RA4_01_1235.d 4.9E4 1 1 1025 1035
R.NARPSQAPDEVVVRGPR.K Y 17.76 1846.9761 17 -12.2 462.7457 4 45.65 6 21784 VEV_3_3_RA6_01_1237.d 7.41E4 1 1 897 913
total 12 peptides
C1GJ98
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQSGPLVVFSPVALTAK.A Y 78.33 1726.0028 17 -9.7 864.0003 2 84.69 6 48263 VEV_3_3_RA6_01_1237.d 1.09E5 3 3 47 63
K.EAYPNAQIIAPQGLK.E Y 70.52 1611.8621 15 -5.9 806.9335 2 73.01 4 41591 VEV_1_3_RA4_01_1235.d 1E5 3 3 94 108
R.GLQQYDHVFTK.A Y 67.79 1334.6619 11 -11.2 668.3307 2 62.85 5 33672 VEV_2_3_RA5_01_1236.d 6.16E5 5 5 119 129
R.KVHDDIITLNVPFYR.F Y 59.29 1828.9835 15 -18.9 610.6569 3 77.52 5 44389 VEV_2_3_RA5_01_1236.d 2.4E4 1 1 18 32
R.LQ(+.98)SGPLVVFSPVALTAK.A Y 44.87 1726.9868 17 -29.3 864.4754 2 84.74 5 49007 VEV_2_3_RA5_01_1236.d 0 1 1 47 63 Deamidation (NQ)
R.FIWYVLSAPDRK.S Y 22.05 1493.8030 12 18.7 498.9509 3 79.36 4 46524 VEV_1_3_RA4_01_1235.d 0 1 1 215 226
R.FGHAR.I Y 20.96 586.2975 5 -4.1 587.3024 1 28.83 4 12201 VEV_1_3_RA4_01_1235.d 0 1 1 33 37
K.YIVAPDMEHHIFLTPWK.E Y 17.83 2096.0554 17 -36.4 525.0021 4 80.64 4 47511 VEV_1_3_RA4_01_1235.d 0 1 1 77 93
M(+15.99)PSM(+15.99)LVPSRPNDVMVVR.K Y 15.23 1958.9740 17 7.2 654.0033 3 82.96 6 47163 VEV_3_3_RA6_01_1237.d 7.56E4 1 1 1 17 Oxidation (M)
total 9 peptides
C1GAM5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.Q(-17.03)C(+57.02)YHC(+57.02)QGLGHVQADC(+57.02)PTLR.L Y 78.93 2281.9780 19 -8.4 761.6602 3 65.04 4 35382 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 76 94 Pyro-glu from Q; Carbamidomethylation
R.C(+57.02)YN(-17.03)C(+57.02)NILGHLAR.N Y 70.62 1472.6653 12 -8.2 737.3339 2 78.21 5 44860 VEV_2_3_RA5_01_1236.d 9.38E4 2 2 104 115 Carbamidomethylation; Ammonia-loss (N)
R.C(+57.02)YNC(+57.02)NILGHLAR.N Y 52.04 1489.6919 12 -8.2 745.8471 2 66.69 5 36538 VEV_2_3_RA5_01_1236.d 4.72E4 1 1 104 115 Carbamidomethylation
R.NC(+57.02)PSTGMQGAGR(+28.03)GVPSAR.G Y 46.63 1829.8624 18 -8.4 610.9563 3 45.32 4 21957 VEV_1_3_RA4_01_1235.d 2.15E5 1 1 116 133 Carbamidomethylation; Dimethylation(KR)
R.GVFNSPFR.G Y 42.20 922.4661 8 -15.0 462.2334 2 69.32 5 38497 VEV_2_3_RA5_01_1236.d 6.51E5 3 3 134 141
R.DC(+57.02)TAPNGGPLSSVGK.V Y 34.58 1458.6772 15 -8.3 730.3398 2 60.32 4 31728 VEV_1_3_RA4_01_1235.d 8.58E4 2 2 185 199 Carbamidomethylation
K.C(+57.02)S(-18.01)Q(+.98)AGHISR.D Y 33.92 997.4399 9 -7.7 499.7234 2 28.19 4 11849 VEV_1_3_RA4_01_1235.d 2.63E5 2 2 204 212 Carbamidomethylation; Dehydration; Deamidation (NQ)
R.C(+58.01)YNC(+57.02)NILGHLAR.N Y 31.24 1490.6759 12 -7.1 746.3400 2 70.43 5 39309 VEV_2_3_RA5_01_1236.d 1.86E4 1 1 104 115 Carboxymethyl; Carbamidomethylation
K.C(+57.02)GGPN(-17.03)HFAR.D Y 31.02 997.4188 9 -7.6 499.7129 2 36.98 4 16919 VEV_1_3_RA4_01_1235.d 5.21E5 3 3 156 164 Carbamidomethylation; Ammonia-loss (N)
R.TTETKQC(+57.02)YHC(+57.02)QGLGHVQADC(+57.02)PTLR.L Y 26.27 2859.2852 24 -6.8 715.8237 4 56.63 4 29052 VEV_1_3_RA4_01_1235.d 1.84E5 2 2 71 94 Carbamidomethylation
K.QC(+57.02)YHC(+57.02)QGLGHVQADC(+57.02)PTLR.L Y 25.37 2299.0044 19 -5.0 575.7555 4 58.95 5 30782 VEV_2_3_RA5_01_1236.d 4.41E4 1 1 76 94 Carbamidomethylation
K.C(+57.02)GGPNHFAR.D Y 23.48 1014.4454 9 -7.9 339.1530 3 16.69 4 5672 VEV_1_3_RA4_01_1235.d 7.28E4 2 2 156 164 Carbamidomethylation
K.C(+57.02)SQAGHISR.D Y 16.57 1014.4665 9 1.7 508.2414 2 13.06 4 3836 VEV_1_3_RA4_01_1235.d 0 1 1 204 212 Carbamidomethylation
K.LGHISR.D Y 16.02 681.3922 6 -19.7 341.6967 2 13.72 6 4289 VEV_3_3_RA6_01_1237.d 6.22E4 1 1 179 184
total 14 peptides
C1G452
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSTLC(+57.02)DYGDPNGYSSMAR.L Y 68.52 1993.8146 18 -9.2 997.9054 2 69.19 4 38588 VEV_1_3_RA4_01_1235.d 4.35E4 1 1 381 398 Carbamidomethylation
R.GNPLDTLC(+57.02)ATLEAK.M Y 65.45 1501.7446 14 16.1 751.8917 2 82.13 6 46625 VEV_3_3_RA6_01_1237.d 0 3 3 338 351 Carbamidomethylation
R.YQGFPEMIR.T Y 54.60 1139.5433 9 -8.3 570.7742 2 72.77 4 41398 VEV_1_3_RA4_01_1235.d 2.12E5 2 2 252 260
R.WIGIFSDEKIIPR.G Y 50.19 1572.8663 13 -11.2 525.2902 3 81.08 4 47847 VEV_1_3_RA4_01_1235.d 2.85E5 3 3 325 337
K.ILAATSSSER.D Y 46.71 1033.5404 10 -10.3 517.7722 2 27.07 4 11230 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 289 298
R.YNIPEAQTVIR.G Y 38.50 1302.6931 11 -12.3 652.3458 2 69.87 4 39148 VEV_1_3_RA4_01_1235.d 4.81E5 4 4 237 247
R.LVGIPC(+57.02)GVAVK.Q Y 33.92 1111.6423 11 -13.2 556.8211 2 70.02 6 37868 VEV_3_3_RA6_01_1237.d 2.09E5 3 3 399 409 Carbamidomethylation
K.ILAATSSSERDLEWAISSR.T Y 31.18 2091.0596 19 -12.7 698.0182 3 76.90 5 43946 VEV_2_3_RA5_01_1236.d 6.85E4 1 1 289 307
K.AISLDVTNNAALDAELSKVDLVVSLIPYTHHATVIK.G Y 22.79 3830.0828 36 -6.2 767.0191 5 89.85 4 53573 VEV_1_3_RA4_01_1235.d 1.42E5 1 1 55 90
MLQPIEGRK.V Y 17.03 1070.5906 9 -30.6 536.2862 2 36.22 4 16461 VEV_1_3_RA4_01_1235.d 0 1 1 1 9
M(+15.99)LQPIEGR.K Y 15.00 958.4906 8 -52.2 959.4479 1 81.89 6 46468 VEV_3_3_RA6_01_1237.d 1.41E5 1 1 1 8 Oxidation (M)
total 11 peptides
C1G5Y3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVAENNLSHDLTPAGAVVGGGMPR.A Y 90.00 2360.1907 24 -10.2 787.7295 3 74.23 4 42532 VEV_1_3_RA4_01_1235.d 2.21E5 2 2 118 141
R.LTHHDTVVAAVPR.R Y 65.97 1414.7681 13 -8.8 472.5925 3 43.27 4 20709 VEV_1_3_RA4_01_1235.d 4.1E5 9 9 158 170
R.SFFSEIISSISDVR.F Y 54.08 1585.7987 14 -7.6 793.9006 2 93.87 6 53135 VEV_3_3_RA6_01_1237.d 8.85E4 1 1 280 293
R.APLISFR.D Y 52.65 802.4701 7 -16.9 402.2355 2 67.73 5 37320 VEV_2_3_RA5_01_1236.d 2.37E5 2 2 142 148
K.KVGIPTPINNSVSSK.K Y 22.55 1539.8621 15 -18.2 514.2853 3 60.74 4 32042 VEV_1_3_RA4_01_1235.d 7.96E4 1 1 393 407
R.ETDADQTDFNRK.I Y 19.12 1438.6324 12 -1.2 720.3226 2 23.24 6 9261 VEV_3_3_RA6_01_1237.d 9.71E4 1 1 426 437
total 6 peptides
C1FYK9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPGLTASSIPVSPSYAPK.A Y 85.25 1757.9199 18 2.1 879.9691 2 72.89 5 41096 VEV_2_3_RA5_01_1236.d 3.26E4 1 1 545 562
R.LGISAQTSTGGGQER.E Y 68.21 1460.7219 15 -7.9 731.3625 2 45.08 4 21819 VEV_1_3_RA4_01_1235.d 1.94E5 3 3 856 870
K.VAANPVFVTEAGHTLK.G Y 48.53 1652.8885 16 -7.4 551.9661 3 67.31 5 37006 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 659 674
R.EVSDPFADESLGTR.N Y 46.98 1521.6947 14 -8.1 761.8484 2 72.18 6 39499 VEV_3_3_RA6_01_1237.d 3.18E4 2 2 871 884
R.FSTSVSGPR.K Y 41.13 936.4665 9 -10.7 469.2355 2 40.57 5 19449 VEV_2_3_RA5_01_1236.d 1.77E6 8 8 829 837
R.LNNFQILEK.V Y 20.60 1117.6132 9 -19.2 559.8031 2 68.94 5 38230 VEV_2_3_RA5_01_1236.d 7.7E4 1 1 650 658
R.FS(+79.97)T(-18.01)SVSGPR.K Y 20.28 998.4222 9 -38.1 333.8020 3 45.51 5 22431 VEV_2_3_RA5_01_1236.d 3.92E5 1 1 829 837 Phosphorylation (STY); Dehydration
K.FDLLNANGGER.L Y 19.45 1204.5836 11 -15.2 603.2899 2 54.85 4 27966 VEV_1_3_RA4_01_1235.d 0 1 1 845 855
total 8 peptides
C1G255
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TEYHVAEFLNSRPGTATISSGSR.E Y 73.31 2479.2092 23 -0.5 620.8093 4 70.59 6 38292 VEV_3_3_RA6_01_1237.d 0 1 1 51 73
R.Q(-17.03)HVEGDSPTSR.N Y 52.16 1194.5265 11 -9.8 598.2646 2 25.07 5 10518 VEV_2_3_RA5_01_1236.d 2.66E5 3 3 851 861 Pyro-glu from Q
R.VPSISPAAVPADPDAPKIQVTDEDRR.V Y 51.84 2743.4141 26 -2.2 686.8593 4 71.09 6 38679 VEV_3_3_RA6_01_1237.d 5.07E4 1 1 773 798
K.Q(-17.03)GDEASTALGTAPTNSVSR.A Y 48.35 1843.8547 19 6.9 922.9410 2 67.70 6 36156 VEV_3_3_RA6_01_1237.d 0 1 1 240 258 Pyro-glu from Q
R.LDGPSSTPKR.S Y 34.99 1056.5564 10 -14.0 529.2781 2 17.58 6 6286 VEV_3_3_RA6_01_1237.d 3.35E5 6 6 870 879
R.DRAYGLLSTLTK.L Y 34.59 1336.7350 12 -6.0 446.5829 3 74.54 6 41210 VEV_3_3_RA6_01_1237.d 2.2E5 2 2 1116 1127
R.SPSDAIGDSSR.N Y 33.50 1090.4890 11 -3.0 546.2501 2 25.82 4 10563 VEV_1_3_RA4_01_1235.d 1.08E5 6 6 804 814
R.YLEALDAAR.C Y 31.33 1020.5240 9 -12.0 511.2632 2 64.09 5 34592 VEV_2_3_RA5_01_1236.d 8.39E4 2 2 12 20
K.LGSAWDSSEAWFALSR.A Y 29.96 1781.8373 16 -10.0 891.9170 2 85.47 6 48757 VEV_3_3_RA6_01_1237.d 4.6E4 2 2 1128 1143
K.TNPQPQHNDDTNVTSDSSSPHDITPEALDR.L Y 29.59 3287.4563 30 -13.6 822.8602 4 62.01 6 31912 VEV_3_3_RA6_01_1237.d 5.13E4 1 1 1082 1111
K.SSQSQC(+57.02)QEPGEKSVR.W Y 25.59 1705.7689 15 -11.2 569.5906 3 16.79 5 5983 VEV_2_3_RA5_01_1236.d 6.23E3 1 1 639 653 Carbamidomethylation
R.VSTERSPSDAIGDSSR.N Y 15.90 1662.7809 16 -5.7 555.2644 3 36.37 6 16435 VEV_3_3_RA6_01_1237.d 5.98E4 1 1 799 814
R.TDIQAEALEAFEK.S Y 15.10 1463.7144 13 -19.4 732.8503 2 79.34 4 46504 VEV_1_3_RA4_01_1235.d 0 1 1 520 532
total 13 peptides
C1G9Y1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IFNYAPSTYLGLTGLATDVSTVSDVLR.F Y 120.45 2872.4858 27 -4.7 1437.2434 2 94.54 4 56076 VEV_1_3_RA4_01_1235.d 1.25E5 4 4 91 117
R.Q(-17.03)ISPQTLANLVSSSLYEK.R Y 49.93 1960.0153 18 -10.3 981.0048 2 95.87 6 53942 VEV_3_3_RA6_01_1237.d 2.94E4 1 1 130 147 Pyro-glu from Q
R.Q(-17.03)ISPQTLANLVSSSLYEKR.F Y 30.54 2116.1165 19 -14.3 1059.0504 2 91.03 6 51845 VEV_3_3_RA6_01_1237.d 3.76E4 1 1 130 148 Pyro-glu from Q
K.VNMYRLREERQISPQTLANLVSSSLYEK.R Y 20.34 3323.7295 28 -4.6 831.9358 4 84.83 4 50469 VEV_1_3_RA4_01_1235.d 1.81E5 1 1 120 147
total 4 peptides
C1G2Y7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGSVEDGSKFSESVMNQLIKDVFGDPAIFLDC(+57.02)R.S Y 85.35 3616.7178 33 -8.7 905.1788 4 95.97 5 54652 VEV_2_3_RA5_01_1236.d 2.34E5 2 2 265 297 Carbamidomethylation
K.NALDLSEFLKDQIKGPATFTSLSTR.G Y 85.02 2751.4443 25 -10.2 688.8613 4 85.49 6 48765 VEV_3_3_RA6_01_1237.d 1.3E5 2 2 240 264
K.IVDMLGAQKPEVTFSC(+57.02)K.A Y 38.02 1921.9641 17 -17.4 641.6508 3 73.25 4 41776 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 165 181 Carbamidomethylation
K.TTFLDILAR.K Y 37.14 1048.5917 9 -18.3 525.2935 2 83.43 6 47467 VEV_3_3_RA6_01_1237.d 9.97E4 2 2 415 423
R.IQQPSTVSLR.I Y 35.46 1127.6299 10 -15.3 564.8136 2 55.51 6 27444 VEV_3_3_RA6_01_1237.d 6.43E4 1 1 740 749
R.GGSVEDGSKFSESVM(-4.99)NQLIKDVFGDPAIFLDC(+57.02)R.S Y 23.74 3611.7314 33 6.4 903.9459 4 96.12 6 54032 VEV_3_3_RA6_01_1237.d 0 1 1 265 297 Methionine replacement by azido homoalanine; Carbamidomethylation
K.TTFLDILARK.N Y 20.19 1176.6866 10 -20.1 393.2283 3 78.59 6 44140 VEV_3_3_RA6_01_1237.d 1.58E4 1 1 415 424
total 7 peptides
C1GAK7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVVVDDIIATGGSAAAAGALVK.K Y 94.82 1996.1204 22 -11.6 999.0559 2 83.44 5 48223 VEV_2_3_RA5_01_1236.d 6.04E4 3 3 158 179
R.GFLFGPSLALR.L Y 80.41 1176.6655 11 -8.3 589.3351 2 84.22 4 50068 VEV_1_3_RA4_01_1235.d 2.27E5 3 3 103 113
R.LGAAFVPVR.K Y 45.17 928.5494 9 -22.9 465.2713 2 66.89 6 35541 VEV_3_3_RA6_01_1237.d 1.01E5 3 3 114 122
K.KLGGNLLGFVFVLNLDSC(+57.02)KGC(+57.02)EK.L Y 38.47 2567.3240 23 -12.3 642.8304 4 86.65 6 49455 VEV_3_3_RA6_01_1237.d 9.17E4 1 1 180 202 Carbamidomethylation
total 4 peptides
C1FZL0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAAANQTVSIVAR.G Y 77.25 1286.6942 13 -28.5 644.3361 2 54.25 4 27644 VEV_1_3_RA4_01_1235.d 1.78E5 4 4 374 386
R.ALIAGGGAPEIEIAQALAK.Q Y 67.89 1792.0094 19 0.8 897.0127 2 83.81 5 48447 VEV_2_3_RA5_01_1236.d 2.54E4 1 1 415 433
R.DAVNDISLYFLSR.V Y 61.14 1511.7620 13 1.7 756.8895 2 87.33 4 52087 VEV_1_3_RA4_01_1235.d 2.58E5 3 3 301 313
R.SLHDALC(+57.02)VIR.C Y 31.36 1182.6179 10 1.1 395.2137 3 66.06 4 36106 VEV_1_3_RA4_01_1235.d 5.68E4 1 1 399 408 Carbamidomethylation
K.SAGGPVRVEK.A Y 27.08 998.5508 10 -39.7 500.2629 2 16.74 6 5856 VEV_3_3_RA6_01_1237.d 3.19E4 1 1 228 237
K.IVSQYSNLLGPIAVDSVLK.T Y 25.58 2015.1302 19 -12.0 672.7093 3 86.57 4 51609 VEV_1_3_RA4_01_1235.d 7.71E3 1 1 167 185
R.ATLLQ(+.98)AASTSLSSK.I Y 21.24 1377.7351 14 -0.6 689.8744 2 72.20 4 40950 VEV_1_3_RA4_01_1235.d 1.73E5 1 1 153 166 Deamidation (NQ)
K.SILRDAVNDISLYFLSR.V Y 19.13 1981.0632 17 -13.9 661.3525 3 93.31 6 52894 VEV_3_3_RA6_01_1237.d 4.64E4 1 1 297 313
K.TIDPK.T N 17.91 572.3170 5 -17.5 573.3142 1 71.07 4 40054 VEV_1_3_RA4_01_1235.d 2.41E5 2 2 186 190
R.ALTGTEAIC(+57.02)WK.A Y 15.60 1248.6172 11 -4.7 625.3129 2 69.45 6 37451 VEV_3_3_RA6_01_1237.d 2.34E5 1 1 437 447 Carbamidomethylation
R.M(+15.99)YLLNMVKK.I Y 15.53 1154.6191 9 -28.7 578.3003 2 18.87 6 6970 VEV_3_3_RA6_01_1237.d 0 1 1 275 283 Oxidation (M)
total 11 peptides
C1GE86
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SAMNPDSLVNVTLKR.T Y 75.02 1643.8665 15 -11.8 548.9563 3 72.24 5 40638 VEV_2_3_RA5_01_1236.d 1.59E5 2 2 161 175
R.C(+57.02)QVEGSIISPER.E Y 67.09 1373.6609 12 -10.6 687.8304 2 60.34 4 31743 VEV_1_3_RA4_01_1235.d 2.33E5 3 3 209 220 Carbamidomethylation
R.DGTSYFGTDPK.N Y 63.64 1186.5142 11 -9.0 594.2590 2 57.80 4 29866 VEV_1_3_RA4_01_1235.d 3.37E5 6 6 185 195
R.TAPGFAAGR.D Y 59.35 846.4348 9 -18.6 424.2168 2 30.76 6 13295 VEV_3_3_RA6_01_1237.d 1.77E6 11 11 176 184
K.IYATDGKSEHR.W Y 47.16 1275.6207 11 -21.7 426.2050 3 13.00 6 3914 VEV_3_3_RA6_01_1237.d 9.52E4 3 3 113 123
K.S(-18.01)AM(+15.99)NPDSLVNVTLKR.T Y 33.29 1641.8508 15 0.7 548.2913 3 72.61 4 41277 VEV_1_3_RA4_01_1235.d 4.83E4 1 1 161 175 Dehydration; Oxidation (M)
R.EIDFKGR.G Y 20.76 863.4501 7 -17.3 432.7249 2 28.08 6 11825 VEV_3_3_RA6_01_1237.d 1.09E5 1 1 221 227
K.SAM(-4.99)NPDSLVNVTLKR.T Y 18.97 1638.8801 15 -23.0 547.2881 3 72.40 5 40758 VEV_2_3_RA5_01_1236.d 0 1 1 161 175 Methionine replacement by azido homoalanine
R.TAPGFAAGR(+14.02).D Y 17.95 860.4504 9 -8.8 431.2287 2 39.05 5 18556 VEV_2_3_RA5_01_1236.d 1.25E5 1 1 176 184 Methylation(KR)
total 9 peptides
C1GLA6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGKPADSTPFLSSQGGGGSSSHR.R Y 103.59 2217.0410 23 -12.2 740.0119 3 43.66 6 20617 VEV_3_3_RA6_01_1237.d 2.82E5 4 4 40 62
R.TGKPADSTPFLSSQGGGGSSSHRR.D Y 87.53 2373.1421 24 -3.9 475.6339 5 36.64 4 16720 VEV_1_3_RA4_01_1235.d 1.42E6 12 12 40 63
R.T(-18.01)GK(+14.02)PADSTPFLSSQGGGGSSSHRR.D Y 26.21 2369.1472 24 13.9 593.3023 4 36.78 4 16800 VEV_1_3_RA4_01_1235.d 0 1 1 40 63 Dehydration; Methylation(KR)
K.ILFFAHGSPVSEKGKDK.G Y 17.57 1858.9940 17 -26.6 465.7434 4 68.71 4 38206 VEV_1_3_RA4_01_1235.d 4.18E5 1 1 293 309
R.C(+57.02)TATLYPR.T Y 15.30 980.4749 8 -21.2 491.2343 2 42.63 6 20026 VEV_3_3_RA6_01_1237.d 5.01E4 1 1 97 104 Carbamidomethylation
total 5 peptides
C1GAE3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EASPPELAPDPNTHGK.R Y 73.05 1658.7899 16 -8.8 553.9324 3 48.94 4 24209 VEV_1_3_RA4_01_1235.d 4.23E5 5 5 279 294
K.HSPC(+57.02)DIIDILPGAGLFSAK.L Y 70.57 2010.0244 19 -8.5 1006.0109 2 87.04 4 51908 VEV_1_3_RA4_01_1235.d 2.43E5 2 2 64 82 Carbamidomethylation
R.SMSDLIQSIPSLAPFSRPK.V Y 59.16 2073.0928 19 -13.3 692.0290 3 85.53 6 48794 VEV_3_3_RA6_01_1237.d 8.2E4 1 1 535 553
K.SLTEDPNSC(+57.02)YK.H Y 47.44 1312.5605 11 -3.6 657.2852 2 41.49 4 19608 VEV_1_3_RA4_01_1235.d 5.57E4 1 1 108 118 Carbamidomethylation
R.LVSLSSADNAK.K Y 35.53 1103.5823 11 -15.8 552.7897 2 47.83 4 23526 VEV_1_3_RA4_01_1235.d 1.63E5 2 2 567 577
R.TIDDIFEQGHLPEQTQR.A Y 30.55 2025.9756 17 -12.6 676.3240 3 74.06 6 40862 VEV_3_3_RA6_01_1237.d 2.48E5 2 2 129 145
K.RAENNGVVTPGGR.E Y 15.80 1325.6799 13 -8.7 442.8967 3 20.55 6 7849 VEV_3_3_RA6_01_1237.d 6.15E4 1 1 266 278
R.GRPSSK.T Y 15.35 630.3449 6 -10.4 316.1765 2 50.30 4 25060 VEV_1_3_RA4_01_1235.d 3.46E5 1 1 329 334
total 8 peptides
C1G241
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LRAQLLEPTAGAGSGGGSGFDVSK.S Y 88.48 2274.1604 24 -4.6 759.0573 3 71.42 4 40340 VEV_1_3_RA4_01_1235.d 5.06E4 1 1 33 56
R.VGLGHVVADEDVVSIATK Y 82.56 1807.9679 18 -33.5 603.6431 3 74.74 4 42963 VEV_1_3_RA4_01_1235.d 0 1 1 346 363
K.GVDPDFSEALIVR.N Y 38.27 1416.7249 13 -22.2 709.3539 2 79.53 6 44819 VEV_3_3_RA6_01_1237.d 2.35E6 1 1 297 309
K.AGGMK(+14.02)ITFQSPPK.K Y 35.98 1374.7329 13 -53.2 459.2272 3 49.48 4 24552 VEV_1_3_RA4_01_1235.d 3.91E5 1 1 181 193 Methylation(KR)
R.ISLVGFPSVGK.S Y 19.24 1102.6385 11 -17.5 552.3169 2 78.11 6 43806 VEV_3_3_RA6_01_1237.d 4.26E4 1 1 62 72
total 5 peptides
C1GDN3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YVEC(+57.02)SALTQYK.L Y 110.95 1360.6333 11 -12.1 681.3157 2 61.92 6 31843 VEV_3_3_RA6_01_1237.d 7.08E5 3 3 156 166 Carbamidomethylation
K.LKDVFDEAIVAALEPAPSK.K Y 61.39 2012.0829 19 5.4 671.7052 3 84.26 4 50096 VEV_1_3_RA4_01_1235.d 7.53E4 2 2 167 185
K.DLGAVKYVEC(+57.02)SALTQYK.L Y 40.26 1943.9662 17 0.5 648.9963 3 77.88 4 45387 VEV_1_3_RA4_01_1235.d 4.81E4 1 1 150 166 Carbamidomethylation
total 3 peptides
C1G194
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YGSGSLSGFVSQDVVR.I Y 85.69 1656.8107 16 -13.0 829.4019 2 76.16 6 42401 VEV_3_3_RA6_01_1237.d 7.4E5 4 4 147 162
R.WYSVYDLGNHQIGLAK.A Y 76.19 1862.9315 16 -4.5 621.9816 3 78.34 4 45815 VEV_1_3_RA4_01_1235.d 4.01E5 3 3 382 397
K.SFNGQYTVDC(+57.02)TKR.S Y 49.94 1574.7147 13 10.5 788.3729 2 45.24 6 21544 VEV_3_3_RA6_01_1237.d 0 4 4 313 325 Carbamidomethylation
R.IGDMTVNNQDFAEATSEPGLAFAFGR.F Y 41.41 2757.2703 26 -2.3 920.0952 3 86.59 6 49418 VEV_3_3_RA6_01_1237.d 3.07E4 2 2 163 188
K.KSFNGQYTVDC(+57.02)TKR.S Y 20.18 1702.8097 14 -9.4 426.7057 4 34.64 6 15449 VEV_3_3_RA6_01_1237.d 4.57E4 1 1 312 325 Carbamidomethylation
total 5 peptides
C1G0F2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGPEALPLFEELFR.S Y 85.68 1573.8140 14 -8.4 787.9077 2 91.75 4 54641 VEV_1_3_RA4_01_1235.d 6.02E5 3 3 330 343
R.TGSNEEEAQLLR.E Y 69.80 1345.6473 12 -13.7 673.8217 2 56.23 6 27871 VEV_3_3_RA6_01_1237.d 4.11E5 4 4 132 143
R.NEDPTDVAGEYGNRPLYR.M Y 60.36 2064.9500 18 -4.7 689.3207 3 66.39 4 36363 VEV_1_3_RA4_01_1235.d 2.37E5 2 2 177 194
R.NTLYNPTVK.S Y 28.86 1048.5553 9 -25.3 525.2717 2 48.99 5 24537 VEV_2_3_RA5_01_1236.d 1.35E5 2 2 380 388
K.GSNSYDAIAK.K Y 18.61 1024.4825 10 -1.7 513.2477 2 21.00 6 8104 VEV_3_3_RA6_01_1237.d 0 1 1 279 288
K.LAGFLDVEPEQLR.A Y 15.60 1485.7827 13 -32.6 743.8745 2 69.88 4 39120 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 402 414
total 6 peptides
C1GEX3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ADVYILDDVLSAVDQHVGR.H Y 104.42 2084.0537 19 -20.1 695.6779 3 88.92 6 50751 VEV_3_3_RA6_01_1237.d 1.27E5 3 3 768 786
R.NDLELNTLR.K Y 28.66 1086.5669 9 -20.4 544.2797 2 64.80 5 35118 VEV_2_3_RA5_01_1236.d 0 1 1 514 522
R.RM(+15.99)STSSLRRASTTSWHGPR.N Y 28.21 2189.0872 19 -5.6 548.2760 4 67.42 4 37178 VEV_1_3_RA4_01_1235.d 1.76E5 1 1 909 927 Oxidation (M)
R.TIITIAHR.I N 25.57 923.5552 8 -14.9 308.8544 3 49.05 5 24581 VEV_2_3_RA5_01_1236.d 5.69E4 2 2 1477 1484
R.LSNEGRASK.T Y 21.89 960.4988 9 -6.2 481.2537 2 43.26 4 20698 VEV_1_3_RA4_01_1235.d 1.3E5 1 1 391 399
K.TTGDIVNHM(+15.99)AVDQQR.L Y 20.13 1699.7948 15 4.5 567.6081 3 80.77 5 46556 VEV_2_3_RA5_01_1236.d 2.23E4 1 1 400 414 Oxidation (M)
R.A(+42.01)ST(+79.97)TSWHGPR.N Y 19.06 1220.4976 10 24.1 611.2708 2 35.85 6 16148 VEV_3_3_RA6_01_1237.d 0 1 1 918 927 Acetylation (N-term); Phosphorylation (STY)
K.LHGEVVVR.G Y 18.96 907.5239 8 46.4 908.5733 1 103.05 6 56231 VEV_3_3_RA6_01_1237.d 0 1 1 680 687
R.LDSVSK.S Y 16.80 647.3490 6 16.4 648.3669 1 109.51 4 61000 VEV_1_3_RA4_01_1235.d 0 1 1 1136 1141
R.TFNM(+15.99)LFVNVAR.A Y 16.28 1326.6754 11 -40.4 664.3182 2 52.98 5 27000 VEV_2_3_RA5_01_1236.d 5.21E4 1 1 1083 1093 Oxidation (M)
R.ENIVFGHR.W Y 15.73 970.4984 8 -4.0 486.2545 2 63.17 5 33905 VEV_2_3_RA5_01_1236.d 0 1 1 706 713
K.TTGDIVNHMAVDQQR.L Y 15.66 1683.7998 15 31.5 562.2916 3 58.01 5 30125 VEV_2_3_RA5_01_1236.d 8.44E4 1 1 400 414
R.M(+15.99)STSSLRRASTTSWHGPRNFVDEEGALK.S Y 15.27 3135.5156 28 -13.3 1046.1653 3 85.29 6 48643 VEV_3_3_RA6_01_1237.d 3.51E4 1 1 910 937 Oxidation (M)
total 13 peptides
C1GMY9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLAEPAETADRER.Q Y 79.24 1443.6953 13 -10.8 482.2339 3 35.92 5 16721 VEV_2_3_RA5_01_1236.d 7.84E5 6 6 272 284
R.SLAEPAETADRERQPLLSEE Y 64.54 2240.0920 20 -6.7 747.6996 3 66.97 5 36753 VEV_2_3_RA5_01_1236.d 3.1E5 3 3 272 291
M.A(+42.01)DIVHHYNPFAK.R Y 64.07 1452.7150 12 -15.9 485.2379 3 74.80 6 41456 VEV_3_3_RA6_01_1237.d 2.01E6 4 4 2 13 Acetylation (Protein N-term)
R.NALNAYR.V Y 46.44 820.4191 7 -11.1 411.2123 2 31.78 5 14285 VEV_2_3_RA5_01_1236.d 1.52E6 3 3 20 26
R.SLAEPAETADR.E Y 27.67 1158.5516 11 -13.2 580.2755 2 37.61 6 17122 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 272 282
M.ADIVHHYNPFAK.R Y 27.59 1410.7043 12 -10.8 471.2370 3 62.32 5 33271 VEV_2_3_RA5_01_1236.d 1.98E5 2 2 2 13
R.DFFFR.S Y 18.65 730.3438 5 -35.6 366.1662 2 75.49 5 42940 VEV_2_3_RA5_01_1236.d 3.83E4 3 3 267 271
total 7 peptides
C1G750
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FNVNC(+57.02)TIIQQGVASPEAAESIEK.A Y 101.89 2504.2217 23 -16.4 835.7341 3 78.95 6 44407 VEV_3_3_RA6_01_1237.d 6.69E4 2 2 75 97 Carbamidomethylation
MFGEAATGNLPVPIADLTK.I Y 101.40 1944.0026 19 -9.3 972.9995 2 85.08 5 49216 VEV_2_3_RA5_01_1236.d 1.81E5 3 3 1 19
M(+15.99)FGEAATGNLPVPIADLTK.I Y 38.78 1959.9976 19 -16.8 980.9896 2 82.91 6 47133 VEV_3_3_RA6_01_1237.d 4.84E4 1 1 1 19 Oxidation (M)
total 3 peptides
C1G760
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPNTC(+57.02)EAQNILEAC(+57.02)LQSTQALLK.T Y 111.69 2588.2573 23 -12.5 863.7490 3 88.23 5 50986 VEV_2_3_RA5_01_1236.d 1.56E5 4 4 25 47 Carbamidomethylation
K.TC(+57.02)VPNDWQC(+57.02)LC(+57.02)TQYTNVLTC(+57.02)YNNC(+57.02)PNDSGR.H Y 80.43 3709.5112 30 3.5 1237.5154 3 84.03 4 49928 VEV_1_3_RA4_01_1235.d 1.34E4 1 1 48 77 Carbamidomethylation
total 2 peptides
C1GBS0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLTTLFFEPSTR.T Y 64.55 1409.7554 12 -1.5 705.8839 2 81.47 4 48142 VEV_1_3_RA4_01_1235.d 5.18E4 1 1 2034 2045
R.EIVPSTPQPESSLAR.R Y 63.93 1609.8311 15 -8.9 805.9156 2 67.00 4 36847 VEV_1_3_RA4_01_1235.d 4.43E4 1 1 1920 1934
R.IMPVGVDSFVTDSQALR.T Y 59.58 1833.9294 17 -7.4 917.9652 2 82.23 4 48691 VEV_1_3_RA4_01_1235.d 7.85E4 1 1 1614 1630
R.IGSSVEFDWC(+57.02)SVR.T Y 40.15 1540.6980 13 -0.4 771.3560 2 77.93 4 45423 VEV_1_3_RA4_01_1235.d 4.53E4 1 1 1061 1073 Carbamidomethylation
R.SVTLPGLINIAAFVPGLANPDSPDFQEVTK.A Y 33.12 3109.6335 30 -9.6 1037.5419 3 96.49 4 56960 VEV_1_3_RA4_01_1235.d 8.18E4 1 1 1573 1602
R.LFSPPKDLALSHPSGR.T Y 25.77 1720.9260 16 -16.4 431.2317 4 66.07 4 36110 VEV_1_3_RA4_01_1235.d 2.02E5 2 2 276 291
R.IFELHDQPDTSVEVEFDRPYVVQGR.G Y 24.61 2974.4460 25 9.3 744.6257 4 78.91 4 46176 VEV_1_3_RA4_01_1235.d 4.88E4 1 1 1838 1862
R.SDVLYC(+57.02)TR.V Y 23.16 1012.4648 8 -5.5 507.2369 2 42.72 4 20368 VEV_1_3_RA4_01_1235.d 5.24E4 1 1 2210 2217 Carbamidomethylation
R.VSTQLGSSM(+15.99)K.S Y 20.02 1052.5172 10 -51.1 527.2390 2 12.80 6 3811 VEV_3_3_RA6_01_1237.d 4.37E4 1 1 866 875 Oxidation (M)
R.ELFARSMESIGEKC(+57.02)AK.S Y 17.20 1854.8967 16 -7.1 619.3018 3 56.01 4 28634 VEV_1_3_RA4_01_1235.d 2.34E5 1 1 630 645 Carbamidomethylation
R.VEAGIMPVVK.Q Y 16.53 1041.5892 10 -52.3 1042.5420 1 94.34 5 53948 VEV_2_3_RA5_01_1236.d 0 1 1 1008 1017
R.LTVDDVTSR.L Y 16.33 1004.5138 9 -15.9 503.2562 2 55.43 4 28296 VEV_1_3_RA4_01_1235.d 0 1 1 1822 1830
R.EQGHK.T Y 16.17 597.2870 5 -21.2 598.2817 1 58.18 4 30135 VEV_1_3_RA4_01_1235.d 2.06E4 1 1 1080 1084
total 13 peptides
C1G3J3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLEDDNLSGNSYGR.R Y 89.61 1525.6644 14 6.5 763.8444 2 59.33 4 31038 VEV_1_3_RA4_01_1235.d 2.01E5 3 3 634 647
R.APSANSNPGQYR.M Y 72.06 1260.5847 12 -10.1 631.2933 2 27.53 5 11882 VEV_2_3_RA5_01_1236.d 0 4 4 718 729
R.SFNTSPLPR.A Y 37.60 1017.5243 9 -9.9 509.7644 2 59.06 6 29760 VEV_3_3_RA6_01_1237.d 2.11E5 1 1 709 717
K.NPDTR.Y Y 22.78 601.2820 5 34.8 602.3102 1 26.09 6 10767 VEV_3_3_RA6_01_1237.d 0 1 1 595 599
R.RPDSPPTILQR.Q Y 22.33 1278.7043 11 -61.3 427.2159 3 51.92 6 25426 VEV_3_3_RA6_01_1237.d 0 1 1 648 658
K.RTNNDNTIGETVR.N Y 15.65 1488.7280 13 -7.3 497.2463 3 68.30 6 36614 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 299 311
total 6 peptides
C1G0L9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TIDEEATNQVNANPVGR.A Y 118.23 1826.8759 17 -10.4 914.4357 2 61.46 5 32630 VEV_2_3_RA5_01_1236.d 1.78E5 3 3 16 32
K.DTVNLAEDIK.F Y 33.68 1116.5663 10 -19.3 559.2797 2 18.46 4 6604 VEV_1_3_RA4_01_1235.d 1.75E5 3 3 471 480
R.EQTAPK.D Y 23.92 672.3442 6 -31.2 673.3305 1 66.73 4 36636 VEV_1_3_RA4_01_1235.d 5.98E4 1 1 363 368
R.ATGVVKEV Y 18.08 801.4596 8 -14.3 401.7313 2 30.43 5 13527 VEV_2_3_RA5_01_1236.d 2.45E5 1 1 505 512
R.GYTR(+14.02)EQTAPKDSPR.I Y 16.16 1618.8063 14 16.4 405.7155 4 63.21 4 33910 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 359 372 Methylation(KR)
total 5 peptides
C1GH63
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ANHAVVLDK.A Y 66.74 965.5294 9 -15.6 483.7644 2 20.83 6 8004 VEV_3_3_RA6_01_1237.d 8.71E4 1 1 70 78
R.LITVATLVDR.L Y 66.54 1099.6600 10 -16.9 550.8280 2 77.03 6 43032 VEV_3_3_RA6_01_1237.d 2.79E5 2 2 93 102
K.LYKDVQSYR.L Y 56.15 1170.6033 9 -9.4 586.3034 2 38.63 6 17710 VEV_3_3_RA6_01_1237.d 4.06E5 2 2 84 92
R.LITVATLVDRLK.I Y 50.98 1340.8391 12 -9.6 447.9493 3 80.72 4 47571 VEV_1_3_RA4_01_1235.d 1.96E5 3 3 93 104
K.L(+42.01)YKDVQSYR.L Y 43.68 1212.6139 9 -10.9 405.2075 3 38.81 4 17994 VEV_1_3_RA4_01_1235.d 0 1 1 84 92 Acetylation (N-term)
R.LITVATLVDRLKINGSLAR.K Y 38.14 2052.2419 19 -5.0 514.0652 4 82.68 5 47764 VEV_2_3_RA5_01_1236.d 2.83E4 2 2 93 111
K.ATSEKLYKDVQSYR.L Y 35.04 1686.8577 14 -8.1 422.7183 4 54.60 4 27820 VEV_1_3_RA4_01_1235.d 1.13E5 1 1 79 92
R.LITVATLVDR(+14.02)LK.I Y 31.37 1354.8547 12 -12.8 452.6198 3 82.52 6 46878 VEV_3_3_RA6_01_1237.d 2.63E4 1 1 93 104 Methylation(KR)
R.KALSDLEEKGQIK.K Y 25.30 1457.8088 13 -6.5 486.9404 3 45.88 5 22708 VEV_2_3_RA5_01_1236.d 2.52E5 3 3 112 124
K.MNIYTR.A Y 17.21 796.3901 6 9.5 399.2061 2 39.13 4 18172 VEV_1_3_RA4_01_1235.d 0 2 2 132 137
R.LITVATLVDRLK(+14.02).I Y 15.07 1354.8547 12 -10.4 452.6208 3 82.65 4 48982 VEV_1_3_RA4_01_1235.d 1.99E4 1 1 93 104 Methylation(KR)
total 11 peptides
A0A0A0HU99
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DASATPGATSAATPATLVDTPTGK.G Y 84.99 2200.0859 24 -6.6 1101.0430 2 70.68 4 39749 VEV_1_3_RA4_01_1235.d 3.86E4 1 1 257 280
R.FSSTSGIAPELSR.Q Y 73.58 1350.6779 13 19.2 676.3592 2 66.57 5 36445 VEV_2_3_RA5_01_1236.d 7.91E4 3 3 430 442
R.SLSPLGGR.S Y 29.59 785.4395 8 -17.7 393.7201 2 58.55 6 29406 VEV_3_3_RA6_01_1237.d 0 1 1 485 492
R.SLSPLGGRSGTPGR.G Y 28.00 1340.7161 14 10.4 336.1898 4 44.16 4 21243 VEV_1_3_RA4_01_1235.d 9.16E4 1 1 485 498
R.ETARFSSTSGIAPELSR.Q Y 22.45 1807.9064 17 -20.1 603.6306 3 65.43 5 35612 VEV_2_3_RA5_01_1236.d 1.06E5 1 1 426 442
R.GPAGEK.I N 17.60 557.2809 6 1.0 558.2887 1 71.57 5 40149 VEV_2_3_RA5_01_1236.d 0 1 1 83 88
K.RRFRSLSPLGGR.S Y 17.32 1400.8113 12 -45.0 351.1943 4 16.42 6 5679 VEV_3_3_RA6_01_1237.d 0 1 1 481 492
R.KPDPAPPYR.I Y 16.99 1039.5450 9 -5.1 347.5205 3 25.35 5 10680 VEV_2_3_RA5_01_1236.d 0 1 1 168 176
total 8 peptides
C1FZ44
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.STSSDPISPENQC(+57.02)TLSELC(+57.02)GFSKR.H Y 122.31 2699.2166 24 -14.7 900.7329 3 75.62 6 41996 VEV_3_3_RA6_01_1237.d 2.6E5 3 3 229 252 Carbamidomethylation
K.YLSC(+57.02)LPIQGK.N Y 25.46 1177.6165 10 -25.4 589.8005 2 67.77 4 37454 VEV_1_3_RA4_01_1235.d 3.45E4 1 1 501 510 Carbamidomethylation
K.NKFM(+15.99)ATKPVKFFTGR.K Y 21.48 1786.9552 15 -25.6 447.7346 4 66.18 6 35019 VEV_3_3_RA6_01_1237.d 5.76E4 1 1 446 460 Oxidation (M)
R.NEEGVQNNK.N Y 18.22 1030.4679 9 30.0 1031.5061 1 88.96 5 51364 VEV_2_3_RA5_01_1236.d 2.18E5 2 2 207 215
R.VPLNPNPMSDHPR.G Y 17.45 1472.7194 13 0.7 737.3675 2 68.27 4 37852 VEV_1_3_RA4_01_1235.d 3.01E4 1 1 123 135
total 5 peptides
C1GEC6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ETVKDTANEAPLPDEILQTQPGDK.G Y 89.36 2608.2866 24 -8.8 870.4285 3 73.74 4 42160 VEV_1_3_RA4_01_1235.d 7.83E4 1 1 206 229
R.WGDAPIHSLAAGILLAPK.D Y 79.32 1829.0199 18 -12.7 610.6729 3 83.30 4 49443 VEV_1_3_RA4_01_1235.d 6.04E4 2 2 284 301
R.NRELEGVIQSIK.S Y 35.13 1384.7673 12 -41.7 462.5771 3 68.11 5 37615 VEV_2_3_RA5_01_1236.d 1.46E5 1 1 18 29
R.ANAAFVVLAR.N Y 30.33 1030.5923 10 -16.5 516.2949 2 69.58 6 37552 VEV_3_3_RA6_01_1237.d 5.46E4 1 1 8 17
total 4 peptides
A0A0A0HUB3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AILGSAAGQGNPLR.S Y 97.42 1323.7258 14 -9.6 662.8638 2 65.38 5 35572 VEV_2_3_RA5_01_1236.d 6.54E4 2 2 322 335
R.LLTYPVTIASVLHELSPYHIR.K Y 51.70 2421.3420 21 -13.1 606.3348 4 88.59 4 52872 VEV_1_3_RA4_01_1235.d 1.2E5 2 2 1461 1481
R.SGVGEAGVGGKDAR.E Y 42.83 1258.6265 14 -18.1 420.5418 3 19.53 6 7319 VEV_3_3_RA6_01_1237.d 1.65E5 3 3 336 349
K.SSGGNAGSTIASHDQPPSGAREEVLTR.S Y 24.58 2680.2800 27 -1.1 671.0765 4 58.23 6 29187 VEV_3_3_RA6_01_1237.d 3.4E4 1 1 43 69
R.GAINMRIATLHMDAQDKTR.F Y 20.74 2141.0833 19 2.5 429.2250 5 19.94 5 7697 VEV_2_3_RA5_01_1236.d 0 1 1 392 410
total 5 peptides
C1G4J8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTAHPNFPQDPSTTEPTHLR.N Y 96.29 2258.1079 20 -6.1 565.5308 4 63.25 4 33949 VEV_1_3_RA4_01_1235.d 2.01E5 2 2 91 110
R.NAAHPDHLNDVQR.A Y 58.66 1485.7073 13 -17.7 496.2343 3 23.43 5 9581 VEV_2_3_RA5_01_1236.d 2.13E5 2 2 111 123
R.SVAAFASINYR.L Y 43.55 1197.6141 11 -21.7 599.8013 2 70.39 5 39283 VEV_2_3_RA5_01_1236.d 1.52E4 1 1 80 90
K.YGPGTLR.S Y 30.67 762.4024 7 -11.6 382.2041 2 35.51 5 16470 VEV_2_3_RA5_01_1236.d 7.82E5 4 4 73 79
total 4 peptides
C1GA10
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGNTGLSTAFFSR.I Y 61.11 1327.6520 13 -7.2 664.8285 2 73.20 4 41738 VEV_1_3_RA4_01_1235.d 2.31E5 1 1 550 562
K.TGGFLFPILSK.S Y 60.17 1178.6699 11 -15.6 590.3331 2 84.59 6 48199 VEV_3_3_RA6_01_1237.d 1.48E5 3 3 249 259
R.ELVSQIYDEAR.K Y 53.45 1321.6514 11 -7.6 661.8279 2 70.72 4 39781 VEV_1_3_RA4_01_1235.d 3.88E4 2 2 292 302
R.VGSTSENITQR.V Y 49.13 1190.5891 11 -5.7 596.2985 2 28.41 6 11995 VEV_3_3_RA6_01_1237.d 2.38E5 6 6 423 433
R.SMVDLLKDANQEVPDFLEK.L Y 46.29 2190.0879 19 5.7 731.0407 3 86.89 4 51814 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 571 589
K.AYPTALILGPTR.E Y 41.10 1271.7238 12 -24.6 636.8535 2 76.65 5 43772 VEV_2_3_RA5_01_1236.d 1.39E4 1 1 280 291
R.GLDIPNVTHVINYDLPNEIDDYVHR.I Y 33.15 2920.4355 25 2.3 974.4880 3 85.40 4 50860 VEV_1_3_RA4_01_1235.d 2.27E5 1 1 519 543
R.HFNPNEYGKPGGGANSYR.G Y 28.82 1963.8925 18 -8.5 655.6325 3 48.74 4 24081 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 108 125
R.VVYGGAEM(+15.99)GNQLR.Q Y 17.36 1408.6769 13 -12.0 705.3373 2 50.32 4 25073 VEV_1_3_RA4_01_1235.d 7.98E4 1 1 314 326 Oxidation (M)
total 9 peptides
C1G413
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLVVNADEGEPGTC(+57.02)KDR.E Y 87.91 1921.8839 17 -15.2 641.6255 3 58.65 6 29477 VEV_3_3_RA6_01_1237.d 1.21E5 2 2 145 161 Carbamidomethylation
R.AIQEAYGAGLIGK.N Y 51.72 1289.6979 13 -13.6 645.8474 2 68.52 6 36782 VEV_3_3_RA6_01_1237.d 6.8E4 2 2 205 217
R.GGAGFPSGLK.W Y 34.83 889.4657 10 -20.2 445.7311 2 54.34 4 27651 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 119 128
R.QQQQRGLATVQDAAATTPPR.S Y 30.39 2136.1035 20 -3.6 428.2264 5 61.71 5 32882 VEV_2_3_RA5_01_1236.d 1.37E5 2 2 41 60
R.FERGQAR.E Y 23.32 862.4409 7 12.9 432.2333 2 20.63 6 7889 VEV_3_3_RA6_01_1237.d 0 1 1 432 438
R.LK(-1.03)PPFPAAVGLFGC(+57.02)PSTVTNVETVAVAPTIC(+57.02)R.R Y 18.54 3367.7307 32 -22.6 1123.5588 3 86.83 4 51778 VEV_1_3_RA4_01_1235.d 0 1 1 258 289 Lysine oxidation to aminoadipic semialdehyde; Carbamidomethylation
K.ASGLRGRGGAGFPSGLKWSFM(+15.99)NFK.D Y 17.91 2543.2854 24 6.4 636.8327 4 81.75 5 47192 VEV_2_3_RA5_01_1236.d 0 1 1 112 135 Oxidation (M)
K.LIAPGQ Y 17.06 597.3486 6 -35.1 598.3349 1 39.06 4 18158 VEV_1_3_RA4_01_1235.d 0 1 1 510 515
R.SYGGLKDQDR.I Y 15.44 1137.5414 10 29.9 380.1991 3 25.16 5 10578 VEV_2_3_RA5_01_1236.d 0 1 1 61 70
total 9 peptides
C1G2I2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.WSGGTGFELSPGVWAPR.Q Y 95.46 1802.8740 17 -2.5 902.4420 2 82.98 4 49230 VEV_1_3_RA4_01_1235.d 2.46E5 3 3 398 414
R.NSKPAVELLPGLLEEGLPILLFSGQK.D Y 83.54 2761.5630 26 -12.9 921.5164 3 95.09 6 53632 VEV_3_3_RA6_01_1237.d 7.54E3 2 2 355 380
R.IDGEK.G Y 17.18 560.2806 5 -6.2 561.2844 1 23.44 5 9586 VEV_2_3_RA5_01_1236.d 0 1 1 477 481
R.HIADKPR.T Y 15.42 835.4664 7 -24.0 418.7305 2 10.30 4 2577 VEV_1_3_RA4_01_1235.d 0 1 1 73 79
total 4 peptides
C1G5A5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HYFSGTQGLIFVIDSNDR.S Y 64.26 2068.0015 18 -8.3 690.3354 3 81.59 6 46272 VEV_3_3_RA6_01_1237.d 1.76E5 2 2 80 97
K.LNQDVTTIPTVGFNVESVTYK.N Y 60.83 2324.1899 21 -6.7 1163.0945 2 82.52 4 48895 VEV_1_3_RA4_01_1235.d 9.92E4 3 3 39 59
K.LKLNQDVTTIPTVGFNVESVTYK.N Y 56.41 2565.3689 23 -11.8 856.1201 3 81.34 6 46090 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 37 59
K.IWYVVPSC(+57.02)ATTGEGLFEGLGWLSSNVK.A Y 47.91 2969.4634 27 -1.9 990.8265 3 94.64 4 56125 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 152 178 Carbamidomethylation
K.TTILYK.L N 43.78 737.4323 6 -33.6 738.4148 1 38.71 6 17761 VEV_3_3_RA6_01_1237.d 2.84E5 3 3 31 36
K.DKIWYVVPSC(+57.02)ATTGEGLFEGLGWLSSNVK.A Y 27.97 3212.5852 29 7.2 1071.8767 3 92.37 4 54974 VEV_1_3_RA4_01_1235.d 1.83E5 2 2 150 178 Carbamidomethylation
R.IEEARQELHR.I Y 25.36 1279.6632 10 -12.3 427.5564 3 23.66 5 9714 VEV_2_3_RA5_01_1236.d 7.51E4 2 2 100 109
R.LLMLGLDAAGK.T Y 17.43 1100.6263 11 -17.3 551.3109 2 78.40 4 45789 VEV_1_3_RA4_01_1235.d 5.05E4 1 1 20 30
K.FNVWDVGGQDK.I Y 15.91 1263.5884 11 29.1 632.8198 2 74.58 4 42808 VEV_1_3_RA4_01_1235.d 0 1 1 63 73
total 9 peptides
C1GEM3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TPDAEDYDDEKAEIGGYGGGGSK.K Y 107.16 2329.9822 23 -6.5 777.6630 3 62.90 4 33682 VEV_1_3_RA4_01_1235.d 9.22E4 2 2 97 119
K.GEVNK.A Y 28.19 545.2809 5 -6.9 546.2844 1 71.89 6 39284 VEV_3_3_RA6_01_1237.d 5.14E4 1 1 137 141
R.AAAVSKDEHK.D Y 27.62 1054.5406 10 -6.3 528.2743 2 35.75 4 16185 VEV_1_3_RA4_01_1235.d 0 3 3 275 284
K.V(+43.01)SDAIVGK.D Y 26.15 830.4498 8 -20.3 416.2237 2 51.29 5 25939 VEV_2_3_RA5_01_1236.d 0 1 1 415 422 Carbamylation
K.ETVLATGSADK.S Y 21.25 1090.5505 11 -18.0 546.2727 2 32.28 6 14132 VEV_3_3_RA6_01_1237.d 0 2 2 297 307
K.IDHKGEVNK.A Y 16.65 1038.5458 9 -1.0 520.2797 2 71.67 6 39114 VEV_3_3_RA6_01_1237.d 0 1 1 133 141
K.QAVPDK.C Y 15.61 656.3493 6 -4.5 657.3536 1 81.66 5 47135 VEV_2_3_RA5_01_1236.d 0 1 1 59 64
total 7 peptides
C1G025
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SRDDIFEVFTKPAFGLTVVR.I Y 90.79 2296.2214 20 -16.7 575.0530 4 85.53 4 50932 VEV_1_3_RA4_01_1235.d 2.12E4 1 1 414 433
R.NTSDLTNSLDIAPAYLR.N Y 73.05 1862.9374 17 -13.2 932.4636 2 81.34 6 46094 VEV_3_3_RA6_01_1237.d 4.64E4 2 2 338 354
R.LVALASDQGHSC(+57.02)TAK.G Y 38.91 1556.7617 15 -15.6 779.3760 2 37.94 6 17304 VEV_3_3_RA6_01_1237.d 3.09E4 2 2 196 210 Carbamidomethylation
R.IAGVR.Y N 22.86 514.3227 5 -26.7 515.3162 1 13.74 5 4357 VEV_2_3_RA5_01_1236.d 5.8E4 1 1 214 218
total 4 peptides
C1GHK4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HGINPATGNPNPEVPVSTPADVDK.A Y 76.47 2425.1873 24 -8.5 809.3961 3 66.24 4 36246 VEV_1_3_RA4_01_1235.d 3.97E4 1 1 26 49
R.IVVEEPFGPIVPLIPWNDEAAVIEAANNTK.M Y 65.66 3244.7019 30 -5.5 1082.5686 3 95.10 5 54267 VEV_2_3_RA5_01_1236.d 2.26E5 2 2 375 404
R.HGINPATGNPNPEVPVSTPADVDKAVEAGK.A Y 65.18 2980.4890 30 -23.6 746.1119 4 69.57 6 37544 VEV_3_3_RA6_01_1237.d 8.96E4 1 1 26 55
M.G(+42.01)SVIDFTTFQNVIGGK.L Y 37.27 1723.8781 16 -12.8 862.9352 2 91.93 6 52273 VEV_3_3_RA6_01_1237.d 3.45E4 1 1 2 17 Acetylation (Protein N-term)
K.ESGIGYEGGIGGLK.S Y 27.54 1335.6670 14 -15.4 668.8305 2 68.53 6 36791 VEV_3_3_RA6_01_1237.d 4.17E4 1 1 450 463
total 5 peptides
C1GLU1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LC(+57.02)FTPDTGSGGWLAGSPAVK.L Y 87.41 2019.9724 20 -7.3 1010.9861 2 81.00 4 47790 VEV_1_3_RA4_01_1235.d 7.4E4 1 1 111 130 Carbamidomethylation
R.FTFSAADAGQHK.L Y 71.72 1278.5992 12 -11.9 640.2993 2 52.32 5 26578 VEV_2_3_RA5_01_1236.d 6.89E4 2 2 99 110
R.EALFRDQSEATNAR.V Y 53.54 1606.7699 14 -11.9 536.5909 3 48.50 4 23934 VEV_1_3_RA4_01_1235.d 6.55E4 1 1 179 192
R.GGNAGR.F Y 17.52 530.2561 6 30.2 531.2794 1 50.95 5 25725 VEV_2_3_RA5_01_1236.d 3.32E4 2 2 93 98
total 4 peptides
A0A0A0HT52
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLFENTGGSYPELITR.G Y 91.47 1782.8788 16 -13.7 892.4344 2 79.60 6 44875 VEV_3_3_RA6_01_1237.d 4.27E5 5 5 10 25
K.LFLPPIGGLTVYC(+57.02)FGDPAK.M Y 49.55 2064.0754 19 -16.2 689.0213 3 90.72 6 51686 VEV_3_3_RA6_01_1237.d 8.31E4 1 1 30 48 Carbamidomethylation
R.FQALMPDILHWLGITK.I Y 40.77 1882.0175 16 -10.5 628.3398 3 95.01 4 56288 VEV_1_3_RA4_01_1235.d 7.36E4 1 1 147 162
R.GDIKLFLPPIGGLTVYC(+57.02)FGDPAK.M Y 30.15 2477.3027 23 -16.3 826.7614 3 89.86 4 53610 VEV_1_3_RA4_01_1235.d 7.26E4 1 1 26 48 Carbamidomethylation
K.YLVYNAR.K Y 23.79 897.4708 7 -21.0 449.7332 2 50.37 4 25108 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 116 122
K.RTENIAGVKDMR.F Y 15.22 1388.7194 12 -9.4 463.9094 3 61.16 6 31276 VEV_3_3_RA6_01_1237.d 2.15E4 1 1 135 146
total 6 peptides
C1GFA5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.THPEATAQSGPPGNSGVAGSTLGK.V Y 99.07 2220.0771 24 -11.9 741.0242 3 50.44 4 25149 VEV_1_3_RA4_01_1235.d 3.56E5 3 3 1640 1663
K.AFAASPSFPTHNR.T Y 37.09 1401.6790 13 -20.1 701.8326 2 57.98 4 30001 VEV_1_3_RA4_01_1235.d 0 2 2 203 215
R.GSFTPGDSFR.G Y 23.69 1069.4828 10 10.0 535.7540 2 60.60 6 30888 VEV_3_3_RA6_01_1237.d 0 1 1 307 316
K.FSLLDLHPNIFVQR.S Y 20.39 1697.9253 14 -12.9 566.9751 3 85.10 4 50651 VEV_1_3_RA4_01_1235.d 1E5 1 1 932 945
R.GLSYSGPSRPEGR.G Y 20.19 1361.6687 13 -11.5 454.8916 3 41.01 5 19718 VEV_2_3_RA5_01_1236.d 9.7E4 2 2 364 376
R.IQDEFLAR.S Y 19.53 990.5134 8 -17.3 496.2554 2 62.21 6 32055 VEV_3_3_RA6_01_1237.d 2.06E5 3 3 1395 1402
R.NPSGR.S Y 17.40 529.2609 5 17.7 530.2775 1 99.43 5 55830 VEV_2_3_RA5_01_1236.d 0 1 1 124 128
K.VHITD(-18.01)SK(+42.01).F Y 16.19 822.4236 7 -15.0 412.2129 2 27.81 5 12029 VEV_2_3_RA5_01_1236.d 1.57E5 1 1 488 494 Dehydration; Acetylation (K)
R.IGDALVER.I Y 15.25 871.4763 8 -9.8 436.7411 2 52.86 5 26904 VEV_2_3_RA5_01_1236.d 2.9E5 1 1 1166 1173
total 9 peptides
C1GMC8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GIGGAITGGLAGGFVGSK.A Y 92.76 1517.8202 18 -11.8 759.9084 2 78.56 5 45111 VEV_2_3_RA5_01_1236.d 3.55E5 4 4 118 135
K.ANHGILGTIGGAIIGSIAEDKLK.N Y 77.37 2247.2585 23 -19.4 562.8110 4 85.22 6 48604 VEV_3_3_RA6_01_1237.d 1.34E5 3 3 136 158
R.QDVAPGGAQEGER.G Y 34.79 1312.6007 13 -10.1 657.3010 2 25.17 6 10286 VEV_3_3_RA6_01_1237.d 3.31E4 1 1 105 117
total 3 peptides
C1GL49
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.APQQAPQQSAQR.S Y 82.35 1308.6534 12 -12.7 655.3257 2 15.38 4 4977 VEV_1_3_RA4_01_1235.d 7.75E4 5 5 146 157
R.YQVSSVSPIDYTTESVR.L Y 60.73 1929.9320 17 -7.5 965.9661 2 74.90 4 43049 VEV_1_3_RA4_01_1235.d 3.71E4 1 1 576 592
M.A(+42.01)DPASEITMGALSAIFDDSKPK.V Y 55.83 2305.1147 22 -1.4 1153.5630 2 94.62 4 56116 VEV_1_3_RA4_01_1235.d 8.92E4 2 2 2 23 Acetylation (Protein N-term)
R.LFSVNLLDDSGEIR.A Y 30.21 1576.8097 14 -15.3 789.4000 2 83.30 4 49473 VEV_1_3_RA4_01_1235.d 1.22E5 3 3 205 218
M.A(+43.01)DPASEITMGALSAIFDDSKPK.V Y 25.79 2306.1099 22 -4.8 1154.0566 2 94.57 5 54043 VEV_2_3_RA5_01_1236.d 6.37E3 1 1 2 23 Carbamylation
R.VQIAK.K Y 20.54 557.3537 5 -28.7 558.3450 1 19.37 6 7237 VEV_3_3_RA6_01_1237.d 5.61E3 1 1 247 251
total 6 peptides
C1GF62
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FVDGVFVESYYPTIENTFSSTIK.Y Y 107.93 2642.2791 23 -10.2 1322.1333 2 89.36 6 50979 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 27 49
K.AFDLMIAEVEK.S Y 38.46 1264.6373 11 -16.0 633.3158 2 80.39 6 45439 VEV_3_3_RA6_01_1237.d 2.5E5 1 1 161 171
MPPPPK.Q Y 27.82 665.3571 6 -19.7 666.3512 1 87.36 6 49866 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 1 6
K.SDLRPDVR.Q Y 26.04 956.5039 8 -25.9 479.2469 2 27.63 6 11575 VEV_3_3_RA6_01_1237.d 2.56E5 2 2 122 129
M(+42.01)(+15.99)PPPPK.Q Y 15.57 723.3625 6 -19.3 724.3559 1 90.16 6 51396 VEV_3_3_RA6_01_1237.d 0 1 1 1 6 Acetylation (Protein N-term); Oxidation (M)
total 5 peptides
C1GDU8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SIDFSQYVDLAPLTVHPR.L Y 91.83 2057.0581 18 -10.8 686.6859 3 84.76 4 50425 VEV_1_3_RA4_01_1235.d 4.9E4 1 1 753 770
R.FTTAPSATSHR.H Y 57.67 1174.5731 11 -13.1 588.2861 2 23.31 5 9504 VEV_2_3_RA5_01_1236.d 5.55E4 2 2 680 690
R.TFDDITTSTSIR.S Y 52.75 1355.6569 12 -9.7 678.8291 2 67.80 4 37479 VEV_1_3_RA4_01_1235.d 6.13E4 1 1 741 752
R.LPLETVM(+15.99)EVFKKM(+15.99)GPR.V Y 17.97 1906.0056 16 -21.7 636.3287 3 77.34 6 43257 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 771 786 Oxidation (M)
total 4 peptides
C1GIR6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AYTLTQPYLDSDSDNRWFDFGGDTVVR.A Y 100.82 3137.4365 27 -6.3 1046.8129 3 85.42 4 50874 VEV_1_3_RA4_01_1235.d 7.05E4 2 2 43 69
R.LTPALQSR.Q Y 28.07 884.5079 8 -8.8 885.5074 1 36.47 5 17047 VEV_2_3_RA5_01_1236.d 2.64E4 1 1 76 83
K.GPVFGSTDKFQGLGIFFDMYK.N Y 27.12 2353.1453 21 2.3 785.3909 3 89.16 4 53196 VEV_1_3_RA4_01_1235.d 1.23E5 1 1 129 149
K.AYTLTQPYLDSDSDNRWFDFGGDTVVRADQYIR.L Y 24.30 3883.8076 33 -8.1 971.9514 4 85.68 5 49554 VEV_2_3_RA5_01_1236.d 1.83E4 1 1 43 75
K.EKVLSETGKGPAYYR.Q Y 23.72 1696.8784 15 1.0 425.2273 4 47.55 6 22886 VEV_3_3_RA6_01_1237.d 9.63E4 1 1 284 298
K.KEKVLSETGKGPAYYR.Q Y 20.73 1824.9734 16 -7.8 457.2471 4 12.16 4 3376 VEV_1_3_RA4_01_1235.d 0 1 1 283 298
R.ADQYIRLTPALQSR.Q Y 17.59 1630.8790 14 -23.1 408.7176 4 48.07 4 23679 VEV_1_3_RA4_01_1235.d 0 1 1 70 83
R.QGWLFSR.V Y 16.31 892.4555 7 -7.1 447.2319 2 53.95 4 27409 VEV_1_3_RA4_01_1235.d 0 1 1 84 90
total 8 peptides
C1GI12
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGGGANGYDNSGGYGDGRR.G Y 84.82 1799.7571 19 -2.3 600.9249 3 26.89 4 11141 VEV_1_3_RA4_01_1235.d 6.58E4 1 1 291 309
R.LSYDVVEADLEREFGR.F Y 68.69 1896.9216 16 -7.8 633.3096 3 83.32 4 49440 VEV_1_3_RA4_01_1235.d 1.11E5 1 1 109 124
R.GVTGSNREPVRPR.D Y 37.64 1423.7644 13 -7.3 475.5919 3 21.70 4 8322 VEV_1_3_RA4_01_1235.d 3.12E5 3 3 331 343
R.GYAFIVYER.E Y 31.16 1116.5603 9 -10.7 559.2814 2 74.15 4 42469 VEV_1_3_RA4_01_1235.d 2.33E5 1 1 150 158
R.FGPIER.I Y 15.82 717.3809 6 -9.0 359.6945 2 43.67 4 20943 VEV_1_3_RA4_01_1235.d 2.82E5 1 1 125 130
total 5 peptides
C1GL26
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFVNHDVPAASGPEGEAVK.K Y 82.13 1909.9170 19 -9.3 637.6404 3 61.03 5 32310 VEV_2_3_RA5_01_1236.d 1.3E5 1 1 286 304
R.SFVNHDVPAASGPEGEAVKK.K Y 60.30 2038.0118 20 -17.8 680.3325 3 55.93 6 27691 VEV_3_3_RA6_01_1237.d 1.52E5 3 3 286 305
R.MLPGQSISVYELPR.M Y 42.77 1588.8282 14 -19.5 795.4059 2 78.57 6 44131 VEV_3_3_RA6_01_1237.d 3.23E4 1 1 324 337
K.LTDIDRYGR.E Y 22.96 1107.5673 9 -16.4 554.7818 2 41.21 6 19189 VEV_3_3_RA6_01_1237.d 2.72E4 1 1 123 131
K.KSLATNLEIFR.V Y 17.27 1290.7295 11 -21.5 431.2412 3 70.70 6 38373 VEV_3_3_RA6_01_1237.d 7.84E4 1 1 432 442
K.TTDHYGVTDIDWDPTGR.Y Y 16.34 1947.8599 17 9.9 650.3003 3 74.05 6 40874 VEV_3_3_RA6_01_1237.d 5.78E4 1 1 571 587
R.SWLGDPNAR.D Y 15.88 1014.4883 9 40.6 508.2720 2 58.95 6 29681 VEV_3_3_RA6_01_1237.d 0 1 1 155 163
K.TSNGIYWSPK.G Y 15.04 1151.5612 10 -5.2 576.7849 2 63.02 4 33781 VEV_1_3_RA4_01_1235.d 8.18E4 1 1 518 527
total 8 peptides
C1G1H4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLISPVDVAEYLFTRLHQVGIR.S Y 68.62 2482.3696 22 2.4 621.6012 4 94.08 5 53835 VEV_2_3_RA5_01_1236.d 7.07E4 1 1 9 30
K.GLISPVDVAEYLFTR.L Y 65.99 1678.8929 15 -8.6 840.4465 2 94.25 4 55952 VEV_1_3_RA4_01_1235.d 3.72E5 3 3 9 23
R.SIHGLPGDYNLVALDYLPHC(+57.02)K.L Y 44.11 2381.1838 21 -4.9 596.3003 4 80.88 4 47707 VEV_1_3_RA4_01_1235.d 5.86E4 3 3 31 51 Carbamidomethylation
M(+15.99)ATDIASKGLISPVDVAEYLFTR.L Y 43.30 2512.2883 23 -16.5 838.4229 3 94.08 6 53230 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 1 23 Oxidation (M)
K.SPVILVDAC(+57.02)AIR.H Y 42.70 1312.7173 12 -41.6 657.3386 2 75.74 4 43710 VEV_1_3_RA4_01_1235.d 2.39E4 2 2 222 233 Carbamidomethylation
K.IANQVPTNER.L Y 38.58 1140.5887 10 -28.2 571.2856 2 31.21 4 13551 VEV_1_3_RA4_01_1235.d 0 2 2 357 366
K.IANQVPTNER(+14.02).L Y 21.40 1154.6044 10 -20.8 578.2974 2 41.45 6 19320 VEV_3_3_RA6_01_1237.d 3.86E4 1 1 357 366 Methylation(KR)
K.IANQVP(+13.98)TNER.L Y 16.92 1154.5680 10 -32.8 578.2723 2 41.62 5 20095 VEV_2_3_RA5_01_1236.d 0 1 1 357 366 Proline oxidation to pyroglutamic acid
total 8 peptides
A0A0A0HVY3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ATALSPEVLEPNLGILVK.A Y 94.99 1863.0717 18 -9.7 932.5341 2 85.73 4 51074 VEV_1_3_RA4_01_1235.d 9.89E4 3 3 626 643
K.AISSPSTPSSQGAHR.G Y 74.37 1481.7223 15 -11.3 494.9091 3 26.43 5 11287 VEV_2_3_RA5_01_1236.d 3.73E5 5 5 57 71
R.DEFQVLLDTEREDDLAR.M Y 17.94 2062.9807 17 -3.5 516.7507 4 57.50 4 29656 VEV_1_3_RA4_01_1235.d 1.62E5 1 1 295 311
K.AISS(-2.02)PSTPSSQGAHR.G Y 16.57 1479.7065 15 32.1 494.2586 3 26.62 4 10998 VEV_1_3_RA4_01_1235.d 1.53E4 1 1 57 71 2-amino-3-oxo-butanoic_acid
R.YTDSLLK.K Y 15.47 838.4436 7 -18.9 420.2212 2 49.32 5 24742 VEV_2_3_RA5_01_1236.d 1.91E5 1 1 414 420
total 5 peptides
Q1XA91
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FVVSAADVIHSFAC(+57.02)PSLGIK.C Y 103.84 2117.0979 20 -1.4 706.7056 3 86.32 5 49917 VEV_2_3_RA5_01_1236.d 2.38E5 3 3 177 196 Carbamidomethylation
R.LNQSSIYLQR.Q Y 53.73 1220.6514 10 -15.8 611.3233 2 60.24 6 30688 VEV_3_3_RA6_01_1237.d 8.39E4 2 2 204 213
R.EQMNN Y 20.87 634.2381 5 -0.6 635.2450 1 8.67 4 2048 VEV_1_3_RA4_01_1235.d 2.9E3 2 2 250 254
K.TFSASK.S Y 15.27 639.3228 6 -41.9 640.3032 1 49.77 6 24169 VEV_3_3_RA6_01_1237.d 2.96E4 1 1 62 67
total 4 peptides
A0A0A0HVP9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FVNVTLTGGK.R Y 65.71 1034.5760 10 -18.1 518.2859 2 63.66 6 33121 VEV_3_3_RA6_01_1237.d 1.03E5 1 1 44 53
K.SQTPKVEPQEK.K Y 62.04 1269.6565 11 -16.4 635.8251 2 18.53 6 6792 VEV_3_3_RA6_01_1237.d 6.83E5 6 6 16 26
K.VKSQTPKVEPQEK.K Y 51.07 1496.8198 13 -14.1 499.9402 3 18.47 5 6901 VEV_2_3_RA5_01_1236.d 3.06E4 1 1 14 26
R.RFVNVTLTGGK.R Y 41.85 1190.6771 11 -10.6 397.8954 3 60.80 6 31030 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 43 53
K.SQ(+.98)TPKVEPQEK.K Y 41.16 1270.6405 11 -11.1 636.3205 2 18.96 4 6867 VEV_1_3_RA4_01_1235.d 0 1 1 16 26 Deamidation (NQ)
M.GKVHGSLAR.A Y 35.78 923.5301 9 -9.8 462.7678 2 11.73 4 3177 VEV_1_3_RA4_01_1235.d 3E5 4 4 2 10
K.SQTPKVEPQEKK.K Y 35.34 1397.7513 12 -10.1 466.9197 3 13.75 5 4365 VEV_2_3_RA5_01_1236.d 5.9E4 2 2 16 27
R.FVNVTLTGGKR.K Y 25.60 1190.6771 11 -11.9 397.8949 3 55.53 6 27456 VEV_3_3_RA6_01_1237.d 2.31E5 2 2 44 54
total 8 peptides
C1G9Z7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ADRLLGFVLGHR.G Y 58.89 1352.7677 12 -14.0 339.1945 4 75.06 4 43175 VEV_1_3_RA4_01_1235.d 7.96E4 2 2 401 412
R.VVSLLAEQNDLKFAVPGGLIGVGTR.V Y 57.94 2552.4326 25 -8.4 851.8110 3 85.83 4 51130 VEV_1_3_RA4_01_1235.d 3.96E4 1 1 369 393
K.LSLTSPAC(+57.02)TEIGEK.I Y 51.81 1504.7443 14 -9.4 753.3723 2 68.80 4 38279 VEV_1_3_RA4_01_1235.d 1.17E5 3 3 477 490 Carbamidomethylation
K.KPELPEQPDPQTLDLSILTALTPEIIAR.Q Y 45.14 3097.6909 28 -38.2 1033.5315 3 92.21 6 52402 VEV_3_3_RA6_01_1237.d 3.91E4 1 1 62 89
R.LLGFVLGHR.G Y 42.82 1010.6025 9 -25.4 337.8662 3 73.11 6 40168 VEV_3_3_RA6_01_1237.d 6.47E4 2 2 404 412
K.AISGVQTVR.F Y 37.74 929.5294 9 -16.9 465.7641 2 35.74 4 16249 VEV_1_3_RA4_01_1235.d 8.83E4 1 1 111 119
R.LIGWANIVAGNTLEPIVD Y 36.26 1894.0200 18 -11.0 948.0068 2 93.85 6 53161 VEV_3_3_RA6_01_1237.d 6.69E4 1 1 503 520
K.LGDEIEIRPGIVTK.D Y 28.37 1538.8667 14 -9.8 513.9578 3 69.79 4 39047 VEV_1_3_RA4_01_1235.d 8.3E4 2 2 341 354
total 8 peptides
C1G673
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGSSVLIPPLLAQADGVVLDIGPGTGSQTPFFNNPNLIR.M Y 79.57 3973.1311 39 -0.5 994.2896 4 96.64 5 54879 VEV_2_3_RA5_01_1236.d 2.25E5 4 4 78 116
R.EGLLAETETDVVSGK.V Y 56.29 1546.7726 15 -4.3 774.3903 2 74.45 4 42710 VEV_1_3_RA4_01_1235.d 6.54E4 1 1 162 176
R.GIFDTIVC(+57.02)VR.V Y 55.60 1178.6118 10 -9.9 590.3074 2 82.15 4 48669 VEV_1_3_RA4_01_1235.d 3.66E5 3 3 185 194 Carbamidomethylation
K.VESC(+57.02)GLGGKYQILPC(+57.02)GAER.T Y 39.56 2093.0034 19 -7.0 698.6702 3 68.48 5 37899 VEV_2_3_RA5_01_1236.d 8.13E4 1 1 134 152 Carbamidomethylation
K.YQILPC(+57.02)GAER.T Y 17.22 1205.5863 10 15.2 603.8096 2 63.90 5 34460 VEV_2_3_RA5_01_1236.d 0 1 1 143 152 Carbamidomethylation
total 5 peptides
C1GEZ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AANIYDFIISLPDGFSTIVGSK.G Y 85.03 2327.2048 22 -3.7 1164.6053 2 96.83 5 54943 VEV_2_3_RA5_01_1236.d 3.8E4 2 2 1249 1270
R.YAGAGDEEELQR.T Y 46.33 1336.5895 12 -14.1 669.2926 2 44.42 6 21079 VEV_3_3_RA6_01_1237.d 2.34E4 1 1 754 765
K.TTALVGPSGSGK.S Y 39.33 1073.5717 12 -17.8 537.7836 2 31.62 6 13773 VEV_3_3_RA6_01_1237.d 1.02E5 2 2 493 504
K.LARQYDAHLAEARK.W Y 24.85 1640.8746 14 -14.5 411.2200 4 63.63 4 34228 VEV_1_3_RA4_01_1235.d 0 1 1 344 357
K.STVIGLM(+15.99)ER.F Y 19.80 1020.5273 9 -28.9 341.1732 3 42.01 5 20327 VEV_2_3_RA5_01_1236.d 2.51E5 2 2 505 513 Oxidation (M)
K.SEGVVQAALDAAAVGR.T Y 19.76 1512.7896 16 -13.1 379.1997 4 33.22 4 14693 VEV_1_3_RA4_01_1235.d 3.06E5 2 2 645 660
R.NATAFGTQEK.L Y 18.66 1065.5090 10 -19.4 533.7515 2 25.82 5 10937 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 334 343
K.ADVIYVIDQGR.V Y 15.58 1247.6510 11 46.4 312.9345 4 57.03 6 28387 VEV_3_3_RA6_01_1237.d 9.23E4 1 1 1338 1348
total 8 peptides
C1G696
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LFADADLIPLGR.L Y 74.19 1299.7186 12 -5.3 650.8632 2 83.04 4 49249 VEV_1_3_RA4_01_1235.d 9.86E4 3 3 81 92
R.YAAPLTEEMYER.L Y 55.72 1471.6653 12 -3.1 736.8376 2 69.83 4 39080 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 155 166
R.LQSYLGPLISR.R Y 50.84 1245.7081 11 -9.0 623.8557 2 76.92 4 44673 VEV_1_3_RA4_01_1235.d 6.44E4 2 2 93 103
K.ILDKISPETAPHKPYVAFR.Y Y 37.91 2181.1946 19 -20.2 437.2374 5 67.24 4 37032 VEV_1_3_RA4_01_1235.d 0 1 1 136 154
R.LLNDGFGR.G Y 25.50 890.4610 8 -12.1 446.2324 2 59.11 4 30815 VEV_1_3_RA4_01_1235.d 0 1 1 167 174
K.QYAAIGGGSPIRK.W Y 21.21 1316.7200 13 -9.4 439.9098 3 47.84 4 23527 VEV_1_3_RA4_01_1235.d 3.28E4 1 1 112 124
K.SLASYGEHQR.C Y 15.28 1146.5417 10 16.3 1147.5677 1 92.46 6 52516 VEV_3_3_RA6_01_1237.d 7.35E4 1 1 28 37
total 7 peptides
C1G885
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TPGPTVIEVPVDTSLVGSVIAEDVYASEAVPAYR.A Y 84.07 3500.7925 34 -3.4 1167.9341 3 94.40 4 56013 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 258 291
R.Q(-17.03)LGGTIHFGR.V Y 47.93 1067.5511 10 -6.9 534.7792 2 72.66 4 41314 VEV_1_3_RA4_01_1235.d 1E5 1 1 532 541 Pyro-glu from Q
R.ADGSLLATSTGLGGPGAGVGQR.S Y 41.54 1940.9915 22 8.3 648.0098 3 73.96 4 42326 VEV_1_3_RA4_01_1235.d 0 1 1 651 672
R.ASIVDGYAVIASPHKADGTGSTK.G Y 37.51 2244.1387 23 -11.2 562.0356 4 65.74 4 35857 VEV_1_3_RA4_01_1235.d 1.74E5 1 1 292 314
K.DNTPEAVLPLIHR.H Y 24.73 1473.7939 13 -9.6 492.2672 3 75.34 4 43397 VEV_1_3_RA4_01_1235.d 1.01E5 1 1 86 98
K.SLMITLPGSPK.G Y 17.79 1142.6370 11 -15.5 572.3169 2 76.32 4 44171 VEV_1_3_RA4_01_1235.d 3.99E4 1 1 131 141
total 6 peptides
C1GLF9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSANAPVNGTEQSQTENTEVAR.A Y 65.44 2289.0469 22 -13.0 764.0130 3 46.81 4 22889 VEV_1_3_RA4_01_1235.d 5.79E4 1 1 251 272
R.TVSVAPLVLLSVADHYGR.S Y 63.35 1896.0469 18 -3.4 633.0208 3 85.39 6 48703 VEV_3_3_RA6_01_1237.d 9.15E4 2 2 15 32
K.EVGVPTDAYFAVEEIKDDGTTTSK.T Y 49.67 2571.2227 24 -6.1 858.0763 3 80.10 4 47098 VEV_1_3_RA4_01_1235.d 4.37E4 1 1 136 159
R.YTPNPLLVIIDVQPK.E Y 42.15 1708.9763 15 -33.9 570.6467 3 88.09 6 50280 VEV_3_3_RA6_01_1237.d 0 1 1 121 135
M.PATTADTLSLVTR.T Y 41.22 1344.7249 13 -20.4 673.3560 2 69.24 6 37295 VEV_3_3_RA6_01_1237.d 1.67E5 3 3 2 14
K.VLDGDLPVNHAILGNLQDVFNLLPNLSTPK.S Y 25.64 3225.7397 30 15.9 1076.2710 3 95.79 4 56652 VEV_1_3_RA4_01_1235.d 0 1 1 221 250
R.DVAVGTLSTR.I Y 16.48 1017.5455 10 -27.7 340.1797 3 40.30 6 18658 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 187 196
total 7 peptides
C1GFR7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALQDLISEGDSGLGLQMQK.F Y 65.25 2002.0040 19 4.9 668.3452 3 82.90 5 47934 VEV_2_3_RA5_01_1236.d 0 1 1 261 279
R.DALHALINNLPDPNYATLR.A Y 60.29 2120.1013 19 -12.2 707.6991 3 85.18 4 50750 VEV_1_3_RA4_01_1235.d 2.14E5 3 3 593 611
K.SAAQHEQDLLR.K Y 53.09 1266.6316 11 -17.7 634.3119 2 36.78 6 16648 VEV_3_3_RA6_01_1237.d 1.72E5 5 5 217 227
K.AKYNSLAEQYDR.A Y 37.98 1456.6946 12 -8.1 729.3486 2 48.06 5 23956 VEV_2_3_RA5_01_1236.d 8.2E4 1 1 188 199
R.KVQNADADYAAK.V Y 31.56 1292.6360 12 -11.2 647.3181 2 17.74 5 6508 VEV_2_3_RA5_01_1236.d 2.09E4 2 2 228 239
K.SLRDVAYEVDNEGDFKSYVLSHASK.I Y 27.27 2828.3616 25 3.1 708.0999 4 77.28 5 44222 VEV_2_3_RA5_01_1236.d 0 1 1 311 335
K.ALFDNDSSQVDFTNPENFFHDVNSVAGLLK.Q Y 20.09 3339.5684 30 -8.0 1114.1879 3 93.72 6 53070 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 531 560
K.FATFTEK.L Y 18.56 842.4174 7 -7.8 422.2127 2 46.96 4 22987 VEV_1_3_RA4_01_1235.d 1.79E5 1 1 280 286
total 8 peptides
C1GHZ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.Q(-17.03)LGGGSGGGGNTVGLGR.R Y 83.98 1425.6960 17 -11.4 713.8472 2 68.18 5 37673 VEV_2_3_RA5_01_1236.d 9.23E4 2 2 131 147 Pyro-glu from Q
K.QLGGGSGGGGNTVGLGR.R Y 82.70 1442.7225 17 -19.5 722.3545 2 50.74 5 25595 VEV_2_3_RA5_01_1236.d 1.35E5 3 3 131 147
K.LAISAVDPSC(+57.02)PESK.A Y 52.60 1472.7180 14 -8.2 737.3602 2 64.87 6 34018 VEV_3_3_RA6_01_1237.d 1.87E4 1 1 277 290 Carbamidomethylation
K.ITVADQVIANSAAQK.V Y 31.47 1527.8257 15 -19.0 510.2728 3 67.10 4 36924 VEV_1_3_RA4_01_1235.d 5.6E5 2 2 307 321
K.AKETLC(+57.02)NFIDAFIR.E Y 29.77 1696.8606 14 1.2 566.6282 3 85.64 4 51009 VEV_1_3_RA4_01_1235.d 1.94E4 1 1 291 304 Carbamidomethylation
R.VGTAIVAMTAK.E Y 21.13 1060.5951 11 -43.8 531.2816 2 61.67 4 32733 VEV_1_3_RA4_01_1235.d 0 1 1 413 423
K.TISPADSTQK.I Y 20.60 1046.5244 10 -11.7 524.2634 2 20.27 4 7538 VEV_1_3_RA4_01_1235.d 4.61E4 1 1 55 64
K.REEDLM(+15.99)AADKAVAVFSHLSLQKR.R Y 16.56 2629.3645 23 -27.2 658.3305 4 83.07 5 48001 VEV_2_3_RA5_01_1236.d 3E4 1 1 165 187 Oxidation (M)
total 8 peptides
C1GI49
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AC(+57.02)LIPNLSYVSEAAAYVLDTR.L Y 92.26 2325.1675 21 -6.5 1163.5835 2 94.54 4 56090 VEV_1_3_RA4_01_1235.d 9.33E4 1 1 231 251 Carbamidomethylation
K.MISQGSSGSYFAR.N Y 70.86 1389.6346 13 -7.8 695.8192 2 61.00 5 32293 VEV_2_3_RA5_01_1236.d 1.67E5 3 3 178 190
R.AWGNK.K Y 18.39 574.2863 5 -14.7 575.2852 1 79.87 4 46922 VEV_1_3_RA4_01_1235.d 1.63E5 2 2 280 284
R.DLAASWASVPAR.S Y 16.31 1242.6356 12 -11.6 415.2144 3 39.14 5 18612 VEV_2_3_RA5_01_1236.d 4.33E4 2 2 701 712
total 4 peptides
C1G2D0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AADSAAFIPVPYEIR.Y Y 71.00 1618.8354 15 -7.9 810.4186 2 81.63 4 48305 VEV_1_3_RA4_01_1235.d 1.58E5 3 3 172 186
R.TYISAPVGVTEER.A Y 68.04 1420.7197 13 -11.7 711.3588 2 66.70 4 36612 VEV_1_3_RA4_01_1235.d 3.38E5 3 3 159 171
R.YGDAERNGLEAIAAAR.D Y 65.43 1675.8278 16 -19.4 559.6057 3 67.36 6 35907 VEV_3_3_RA6_01_1237.d 3.35E5 2 2 187 202
K.VDAADIENDFNNHIQDVLVVSYLANTIR.T Y 43.48 3157.5679 28 -8.0 1053.5215 3 93.31 4 55460 VEV_1_3_RA4_01_1235.d 0 1 1 264 291
total 4 peptides
C1G0H6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LAADEYFTVMAR.K Y 92.65 1385.6649 12 -10.9 693.8322 2 78.29 6 43932 VEV_3_3_RA6_01_1237.d 1.34E5 3 3 161 172
R.VKPNYIVWAAGAGGK.G Y 44.38 1529.8354 15 -8.6 510.9481 3 68.32 4 37894 VEV_1_3_RA4_01_1235.d 7.41E4 1 1 77 91
K.HFITAAFNDPAITK.F Y 31.07 1544.7987 14 -5.0 515.9376 3 72.40 4 41108 VEV_1_3_RA4_01_1235.d 9.92E4 1 1 107 120
R.SWDVTSAIRNPEQTR.D Y 28.65 1758.8649 15 -6.3 587.2919 3 69.37 6 37388 VEV_3_3_RA6_01_1237.d 0 1 1 27 41
K.FLLISHIGSR.R Y 24.96 1141.6608 10 -19.3 381.5535 3 70.93 6 38549 VEV_3_3_RA6_01_1237.d 5.68E4 1 1 121 130
total 5 peptides
A0A0A0HWJ2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VWNFLDYSALTFPAGEVC(+57.02)AK.R Y 70.76 2287.0984 20 -6.5 1144.5491 2 90.70 4 54049 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 367 386 Carbamidomethylation
R.GFDTTLGYVGR.S Y 63.45 1184.5825 11 -8.0 593.2938 2 71.54 4 40431 VEV_1_3_RA4_01_1235.d 5.97E5 3 3 41 51
K.GSPISVYEYWQLNR.R Y 38.10 1710.8365 14 41.4 571.3098 3 81.90 4 48466 VEV_1_3_RA4_01_1235.d 0 1 1 303 316
R.SFSPAAEDATLVQILK.S Y 37.15 1688.8984 16 -10.9 845.4473 2 83.70 4 49704 VEV_1_3_RA4_01_1235.d 1.4E4 2 2 52 67
R.AAGEPFIPHVEK.L Y 31.36 1293.6716 12 -12.1 432.2259 3 62.51 4 33374 VEV_1_3_RA4_01_1235.d 7.2E4 1 1 287 298
R.DLSSLIYISK.H Y 26.20 1137.6281 10 -4.0 569.8190 2 81.66 4 48285 VEV_1_3_RA4_01_1235.d 7.6E4 1 1 178 187
K.VKGPLHGIPVSLKDQFNVR.G Y 15.35 2103.1953 19 -13.1 421.6408 5 71.92 6 39300 VEV_3_3_RA6_01_1237.d 3.79E4 1 1 22 40
total 7 peptides
A0A0A0HST0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SFNAEDILPLLR.N Y 102.98 1386.7506 12 -10.3 694.3754 2 86.92 4 51835 VEV_1_3_RA4_01_1235.d 1.77E5 2 2 145 156
K.MTLPSLATFQGYYQPLLR.N Y 44.94 2098.0920 18 4.6 1050.0581 2 89.52 4 53394 VEV_1_3_RA4_01_1235.d 0 1 1 113 130
K.FIAIVDSLIPPTIYYSR.V Y 34.10 1967.0768 17 -37.8 984.5085 2 91.44 4 54472 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 82 98
total 3 peptides
C1GAW1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGGDEQYAGC(+57.02)TGFPADSHTVIWLTVSR.K Y 72.89 2910.3242 27 -15.2 971.1006 3 81.43 4 48107 VEV_1_3_RA4_01_1235.d 8.64E4 1 1 161 187 Carbamidomethylation
R.LGTLDNPIIVK.S Y 63.48 1181.7019 11 -8.9 591.8530 2 73.00 4 41582 VEV_1_3_RA4_01_1235.d 4.12E5 2 2 150 160
K.AGSIPTDYEQATGLERLELLGK.M Y 56.59 2360.2222 22 -17.8 787.7340 3 80.93 6 45807 VEV_3_3_RA6_01_1237.d 8.72E4 1 1 112 133
K.AGSIPTDYEQATGLER.L Y 52.27 1706.8110 16 -7.7 854.4062 2 69.87 4 39115 VEV_1_3_RA4_01_1235.d 2.32E5 3 3 112 127
R.LGTLDN(+.98)PIIVK.S Y 20.84 1182.6859 11 -25.6 592.3351 2 72.98 6 40074 VEV_3_3_RA6_01_1237.d 0 1 1 150 160 Deamidation (NQ)
total 5 peptides
A0A0A0HQS4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IDAGNATAASGAQATATATGVSASK.S Y 81.46 2191.0715 25 -8.8 1096.5334 2 62.47 4 33346 VEV_1_3_RA4_01_1235.d 2.03E4 1 1 680 704
R.LFGHSGPVYAVAFAPSIASPDEQEVK.T Y 76.83 2715.3542 26 -22.2 906.1052 3 81.67 6 46323 VEV_3_3_RA6_01_1237.d 7.69E4 2 2 443 468
K.QKEGGMVMLAILSSYC(+57.02)TIVTK.E Y 25.25 2328.1892 21 0.5 583.0549 4 80.59 6 45579 VEV_3_3_RA6_01_1237.d 0 1 1 209 229 Carbamidomethylation
R.VIGEGGAGTK.I Y 18.89 887.4712 10 14.4 888.4913 1 101.54 4 58692 VEV_1_3_RA4_01_1235.d 0 1 1 670 679
R.FTGMNLVVAGGAYMP Y 16.55 1526.7262 15 -14.0 764.3597 2 72.73 6 39892 VEV_3_3_RA6_01_1237.d 9.27E4 1 1 741 755
total 5 peptides
C1GE91
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SEATTAAQAPTSTSQAK.V Y 85.52 1648.7904 17 -13.5 825.3914 2 30.01 4 12851 VEV_1_3_RA4_01_1235.d 2.05E5 3 3 968 984
R.GTVGTAGEDADELEK.A Y 39.56 1490.6736 15 -7.1 746.3388 2 53.33 6 26267 VEV_3_3_RA6_01_1237.d 8.84E4 2 2 819 833
K.WLGEFLLR.N Y 35.50 1032.5756 8 -18.5 517.2855 2 84.89 6 48391 VEV_3_3_RA6_01_1237.d 1.31E5 3 3 838 845
R.LNAPDSIDAQR.I Y 32.08 1198.5942 11 32.4 600.3238 2 51.70 6 25295 VEV_3_3_RA6_01_1237.d 8.34E5 4 4 582 592
R.GTVGTAGEDADELEKAAPK.W Y 27.88 1857.8955 19 -5.3 620.3025 3 63.63 5 34261 VEV_2_3_RA5_01_1236.d 1.36E5 1 1 819 837
R.TLEERSKEATGTSR.L Y 18.69 1563.7853 14 -13.1 522.2622 3 45.79 4 22257 VEV_1_3_RA4_01_1235.d 1.14E5 1 1 568 581
R.TGNDMVLFYK.A Y 15.07 1186.5692 10 -13.1 594.2841 2 53.98 6 26641 VEV_3_3_RA6_01_1237.d 1.03E5 1 1 947 956
total 7 peptides
C1GBY7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.EALNSFSTSC(+57.02)AEAGHK.V Y 97.66 1707.7522 16 -9.6 570.2526 3 51.64 4 25923 VEV_1_3_RA4_01_1235.d 3.74E5 4 4 64 79 Carbamidomethylation
R.LC(+57.02)PDNQVKEALNSFSTSC(+57.02)AEAGHK.V Y 39.63 2662.2114 24 -11.1 666.5527 4 73.02 5 41188 VEV_2_3_RA5_01_1236.d 4.97E4 1 1 56 79 Carbamidomethylation
K.NVQMEILR.L Y 37.83 1001.5328 8 -19.2 501.7640 2 65.12 6 34216 VEV_3_3_RA6_01_1237.d 4.37E4 1 1 48 55
R.LC(+57.02)PDNQVK.E Y 23.09 972.4698 8 26.8 487.2552 2 21.12 6 8153 VEV_3_3_RA6_01_1237.d 0 1 1 56 63 Carbamidomethylation
total 4 peptides
C1GA36
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YC(+57.02)YQSFEAGERDPGAV Y 86.91 1847.7784 16 -12.6 924.8849 2 69.41 6 37422 VEV_3_3_RA6_01_1237.d 1.2E5 3 3 483 498 Carbamidomethylation
K.SGARDEEEGGQETNTRGELR.I Y 86.34 2189.9897 20 -4.1 548.5024 4 27.32 4 11372 VEV_1_3_RA4_01_1235.d 6.23E4 1 1 383 402
R.DPGAV Y 16.57 457.2172 5 60.7 458.2523 1 34.74 6 15507 VEV_3_3_RA6_01_1237.d 0 1 1 494 498
total 3 peptides
C1GF18
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AANILLGAYYLYDSSR.H Y 71.90 1788.9045 16 -10.0 895.4506 2 85.76 4 51107 VEV_1_3_RA4_01_1235.d 5.76E4 1 1 289 304
R.VVDEEEEEEEEGGER.A Y 65.97 1762.7017 15 -5.9 882.3529 2 38.86 4 18016 VEV_1_3_RA4_01_1235.d 3.95E4 1 1 1180 1194
K.GLDEAISTFTQISK.A Y 47.78 1508.7722 14 -34.7 755.3672 2 81.91 6 46480 VEV_3_3_RA6_01_1237.d 2.12E5 3 3 908 921
R.VTNIAEDHEQR.H Y 45.52 1310.6215 11 -2.6 437.8800 3 22.71 4 8849 VEV_1_3_RA4_01_1235.d 9.27E4 1 1 688 698
R.YAEALEGYQEVLM(+15.99)KMPNM(+15.99)R.D Y 16.76 2304.0588 19 1.9 577.0231 4 59.35 5 31065 VEV_2_3_RA5_01_1236.d 1.47E5 1 1 234 252 Oxidation (M)
total 5 peptides
C1G7G3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYQSLDPTVPIIVADADNNNSPIFSITR.E Y 72.51 3072.5767 28 -4.3 1025.1951 3 89.86 4 53577 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 230 257
R.GGIPLVFPVFGPPPK.G Y 58.35 1520.8755 15 -54.0 761.4039 2 87.87 6 50152 VEV_3_3_RA6_01_1237.d 0 2 2 75 89
K.GHATSALPQHGFAR.N Y 53.43 1448.7273 14 -12.9 483.9102 3 38.16 6 17439 VEV_3_3_RA6_01_1237.d 1.88E5 1 1 90 103
R.IYQSLDPT(-2.02)VPIIVADADNNNSPIFSITR.E Y 38.93 3070.5610 28 2.4 1024.5300 3 89.67 6 51143 VEV_3_3_RA6_01_1237.d 6.15E3 1 1 230 257 2-amino-3-oxo-butanoic_acid
K.GSLITSLQVQNK.G Y 29.69 1286.7194 12 -34.6 644.3447 2 68.26 6 36588 VEV_3_3_RA6_01_1237.d 2.28E5 2 2 160 171
R.ESLNDVVVWNPWIEK.A Y 23.36 1826.9203 15 -6.8 914.4612 2 86.89 4 51817 VEV_1_3_RA4_01_1235.d 9.09E4 1 1 258 272
R.NVHWEFLGK.S Y 23.17 1128.5717 9 -19.4 377.1905 3 69.37 6 37386 VEV_3_3_RA6_01_1237.d 7.74E4 1 1 104 112
total 7 peptides
C1G6V7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLLDDSYSYLAGNAFSR.D Y 103.71 1877.8795 17 -12.8 939.9351 2 85.08 6 48516 VEV_3_3_RA6_01_1237.d 7.2E4 2 2 338 354
K.S(-2.02)LLDDSYSYLAGNAFSR.D Y 51.95 1875.8639 17 33.5 938.9706 2 85.21 5 49295 VEV_2_3_RA5_01_1236.d 9.87E4 1 1 338 354 2-amino-3-oxo-butanoic_acid
R.LETLC(+57.02)QGVVGK.V Y 26.37 1202.6329 11 -9.8 401.8810 3 35.65 6 16064 VEV_3_3_RA6_01_1237.d 3.37E5 4 4 66 76 Carbamidomethylation
K.SLASIVDPR.L Y 21.30 956.5291 9 -44.1 479.2507 2 69.69 5 38764 VEV_2_3_RA5_01_1236.d 6.83E4 2 2 170 178
K.MKMANDKPVEQYLR.T Y 18.12 1721.8593 14 -11.4 574.9538 3 40.85 5 19616 VEV_2_3_RA5_01_1236.d 2.59E5 1 1 95 108
R.RDLDQASADAKR.L Y 17.66 1344.6746 12 44.5 337.1909 4 14.19 6 4523 VEV_3_3_RA6_01_1237.d 4.31E4 1 1 268 279
R.TFQWNK.V Y 16.07 822.4024 6 26.5 412.2194 2 27.38 4 11458 VEV_1_3_RA4_01_1235.d 0 1 1 109 114
total 7 peptides
C1G8V5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FSFLQSSDRFDVVGGLPTYGPDGALLAVVK.Q Y 84.81 3154.6338 30 -17.1 1052.5339 3 90.07 6 51359 VEV_3_3_RA6_01_1237.d 2.83E4 1 1 49 78
K.SITVTDYSTGSEYR.Y Y 59.51 1577.7209 14 -13.2 789.8573 2 64.41 6 33673 VEV_3_3_RA6_01_1237.d 1.54E5 3 3 239 252
K.NQQGTFNR.G Y 37.67 963.4522 8 -11.5 482.7278 2 15.45 6 5178 VEV_3_3_RA6_01_1237.d 5.25E4 1 1 142 149
K.SC(+57.02)PANPAFGGTGK.F Y 29.88 1262.5713 13 2.1 632.2943 2 39.80 4 18578 VEV_1_3_RA4_01_1235.d 3.39E5 3 3 36 48 Carbamidomethylation
total 4 peptides
C1G351
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DINTFASAC(+57.02)LDR.T Y 70.05 1381.6296 12 -14.8 691.8119 2 73.07 6 40141 VEV_3_3_RA6_01_1237.d 9.61E4 2 2 134 145 Carbamidomethylation
R.LNYLVGDQTYTISHFDQPMYLLGYLTR.D Y 66.78 3220.5903 27 -6.9 1074.5300 3 91.97 4 54772 VEV_1_3_RA4_01_1235.d 4E5 3 3 525 551
R.KNWIVC(+57.02)GSDDFQLR.V Y 38.49 1736.8304 14 -1.4 579.9500 3 74.98 6 41525 VEV_3_3_RA6_01_1237.d 9.35E4 1 1 49 62 Carbamidomethylation
K.GGDATLKDGAPLTLPTK.E Y 35.87 1653.8937 17 -60.4 552.2719 3 66.14 4 36168 VEV_1_3_RA4_01_1235.d 1.18E5 2 2 310 326
K.ITSFEAHPDYIR.S Y 31.21 1447.7095 12 -6.8 724.8571 2 63.46 4 34102 VEV_1_3_RA4_01_1235.d 4.83E4 1 1 72 83
R.EEPAVSMDGSGKLVWAR.H Y 16.68 1830.8934 17 8.8 611.3105 3 75.17 6 41664 VEV_3_3_RA6_01_1237.d 0 1 1 283 299
total 6 peptides
C1G957
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGADPELQGSIYTYGPYK.T Y 96.38 1958.9261 18 -8.4 980.4622 2 75.25 4 43322 VEV_1_3_RA4_01_1235.d 5.88E4 1 1 208 225
K.LVILR.K N 47.59 612.4323 5 -24.7 307.2159 2 54.08 5 27686 VEV_2_3_RA5_01_1236.d 8.42E5 7 7 471 475
K.VGGLEVR.D Y 20.35 728.4181 7 -34.1 729.4005 1 37.70 6 17175 VEV_3_3_RA6_01_1237.d 0 1 1 96 102
R.DIEVSHWGGNLATEER.L Y 16.44 1811.8438 16 -4.2 604.9526 3 63.08 4 33824 VEV_1_3_RA4_01_1235.d 4.24E4 1 1 257 272
R.EALLELKLR.Y Y 15.96 1083.6652 9 -35.6 542.8206 2 67.34 5 37025 VEV_2_3_RA5_01_1236.d 8.3E4 1 1 340 348
total 5 peptides
C1GJI6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AITVAASTLADER.A Y 79.01 1316.6936 13 -13.8 659.3450 2 65.40 6 34423 VEV_3_3_RA6_01_1237.d 4.97E5 3 3 333 345
K.VLTSSGSGTISDVIKGVEYVATSHTK.N Y 55.77 2635.3704 26 -1.5 659.8489 4 83.27 6 47359 VEV_3_3_RA6_01_1237.d 5.02E4 1 1 240 265
K.GSVANMSLGGSK.S Y 47.26 1106.5389 12 -9.7 554.2714 2 47.05 4 23054 VEV_1_3_RA4_01_1235.d 3.91E5 3 3 282 293
K.GVEYVAT(+114.04)SHTK.N Y 32.93 1304.6361 11 -25.3 653.3088 2 26.10 6 10771 VEV_3_3_RA6_01_1237.d 0 1 1 255 265 Ubiquitin
K.AITVAASTLADER(+14.02).A Y 28.53 1330.7092 13 -9.7 666.3555 2 70.63 4 39709 VEV_1_3_RA4_01_1235.d 4.93E4 1 1 333 345 Methylation(KR)
K.GSVANM(+15.99)SLGGSK(+27.99).S Y 16.25 1150.5288 12 -0.1 576.2716 2 19.56 5 7497 VEV_2_3_RA5_01_1236.d 0 1 1 282 293 Oxidation (M); Formylation
R.TLKDEVNDVIDK.F Y 16.19 1387.7195 12 40.9 463.5994 3 62.03 5 33066 VEV_2_3_RA5_01_1236.d 0 1 1 463 474
total 7 peptides
C1GBH1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASIAQAPAGPPPPGQAPTPTSRGPNTGGTHGSR.N Y 62.97 3089.5391 33 -9.3 773.3849 4 57.88 5 30030 VEV_2_3_RA5_01_1236.d 1.23E4 1 1 519 551
R.ESAASGRPDASSPAPGPGGPNSR.L Y 56.34 2120.9834 23 -5.5 707.9979 3 36.50 4 16643 VEV_1_3_RA4_01_1235.d 1.01E5 2 2 493 515
R.ASIAQAPAGPPPPGQAPTPTSR.G Y 55.31 2068.0701 22 -59.9 690.3227 3 63.27 5 33987 VEV_2_3_RA5_01_1236.d 0 2 2 519 540
R.RTPIQQSSTR.L Y 39.95 1172.6262 10 -26.5 587.3049 2 14.07 5 4535 VEV_2_3_RA5_01_1236.d 1.31E4 1 1 604 613
R.TPIQQSSTR.L Y 31.13 1016.5251 9 -2.5 509.2685 2 16.08 5 5614 VEV_2_3_RA5_01_1236.d 7.52E3 1 1 605 613
K.TSTSVANLETQLAK.L Y 29.09 1461.7675 14 -2.4 731.8893 2 68.60 5 37980 VEV_2_3_RA5_01_1236.d 6.49E4 2 2 1280 1293
R.DRADSEPQGPR.T Y 21.01 1226.5640 11 -10.9 614.2826 2 15.05 5 5057 VEV_2_3_RA5_01_1236.d 2.57E4 1 1 78 88
total 7 peptides
C1G6J5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.STSM(+15.99)GSVTSPTSR.G Y 65.06 1312.5929 13 -6.5 657.2994 2 22.31 4 8630 VEV_1_3_RA4_01_1235.d 1.57E5 4 4 339 351 Oxidation (M)
R.NASTEINNIR.E Y 58.38 1130.5680 10 -14.9 566.2828 2 41.87 6 19580 VEV_3_3_RA6_01_1237.d 1.38E5 1 1 137 146
R.STSMGSVTSPTSR.G Y 51.93 1296.5980 13 -8.5 649.3008 2 39.46 5 18806 VEV_2_3_RA5_01_1236.d 4.5E5 7 7 339 351
K.TVLQAFEAER.T Y 46.92 1162.5981 10 -14.2 582.2981 2 70.21 6 38015 VEV_3_3_RA6_01_1237.d 2.46E5 2 2 103 112
R.ESIAGAEFYGNR.V Y 42.69 1312.6047 12 -2.9 657.3077 2 64.61 6 33821 VEV_3_3_RA6_01_1237.d 6.41E4 2 2 182 193
R.AGSIVPER.S Y 39.96 827.4501 8 -11.0 414.7278 2 33.24 4 14705 VEV_1_3_RA4_01_1235.d 4.24E5 3 3 331 338
K.RLEAATSRLEDMASSLESSNPSSPAAGGSITK.I Y 29.23 3219.5676 32 -3.7 805.8962 4 77.43 5 44328 VEV_2_3_RA5_01_1236.d 6.31E4 1 1 15 46
K.RLEAATSRLEDMASSLES(-2.02)SNPSSPAAGGSITK.I Y 26.00 3217.5520 32 0.4 805.3956 4 77.49 4 45080 VEV_1_3_RA4_01_1235.d 7.31E4 1 1 15 46 2-amino-3-oxo-butanoic_acid
total 8 peptides
C1GBJ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLIPVNLANYPSNDEIASALLSK.I Y 82.02 2454.3369 23 -2.5 1228.1726 2 90.33 4 53838 VEV_1_3_RA4_01_1235.d 4.04E4 2 2 171 193
R.AGPNYQEGLK.N Y 45.39 1075.5298 10 -10.2 538.7667 2 39.67 6 18301 VEV_3_3_RA6_01_1237.d 2.63E5 4 4 434 443
R.AGPNYQEGLKNIK.A Y 37.83 1430.7517 13 -8.5 716.3770 2 54.89 5 28112 VEV_2_3_RA5_01_1236.d 2.96E5 4 4 434 446
K.VLFIGGGIANFTNVASTFK.G Y 31.18 1955.0516 19 -16.6 978.5168 2 89.04 4 53130 VEV_1_3_RA4_01_1235.d 2.33E4 2 2 391 409
R.SPAALGIR.K Y 27.42 783.4603 8 -13.7 392.7321 2 44.34 6 21024 VEV_3_3_RA6_01_1237.d 7.43E5 4 4 265 272
K.LTVLNPNGR.I Y 15.13 982.5560 9 -54.4 492.2585 2 53.50 4 27120 VEV_1_3_RA4_01_1235.d 0 1 1 319 327
total 6 peptides
C1GLZ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VIGEVTLGQVYGGAR.G Y 92.63 1517.8202 15 -15.4 759.9057 2 74.87 6 41442 VEV_3_3_RA6_01_1237.d 2.16E5 3 3 68 82
K.I(+43.01)APGVLTEHGK.T Y 33.74 1163.6299 11 -32.6 388.8712 3 41.55 4 19646 VEV_1_3_RA4_01_1235.d 0 1 1 392 402 Carbamylation
K.SFSTEDYAKLVGVQL Y 32.62 1655.8406 15 -10.1 828.9192 2 84.73 5 48999 VEV_2_3_RA5_01_1236.d 2.43E4 1 1 460 474
K.IAPGVLTEHGK.T Y 30.06 1120.6240 11 -8.3 374.5455 3 41.50 5 20020 VEV_2_3_RA5_01_1236.d 3.45E5 2 2 392 402
R.SDVPKFVEELIDR.C Y 25.27 1545.8038 13 -18.4 516.2657 3 83.49 4 49557 VEV_1_3_RA4_01_1235.d 4.33E4 1 1 154 166
K.SLVWEGSVLDSEEGIRFR.G Y 19.44 2078.0432 18 -24.7 693.6712 3 81.50 4 48165 VEV_1_3_RA4_01_1235.d 2.01E5 1 1 86 103
R.ALSAEWAAR.S Y 15.09 973.4981 9 -5.5 487.7536 2 59.35 4 31067 VEV_1_3_RA4_01_1235.d 2.25E5 1 1 145 153
total 7 peptides
C1GJD3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSNTGELIFDDVFVPQENVLGEVNR.G Y 64.55 2747.3401 25 -3.6 687.8398 4 89.33 4 53287 VEV_1_3_RA4_01_1235.d 1.49E5 4 4 247 271
K.MWITNGPDADYIVVYAK.T Y 57.34 1954.9498 17 -7.5 978.4749 2 83.68 4 49702 VEV_1_3_RA4_01_1235.d 6.45E4 2 2 196 212
R.QIDDAAASDSAR.S Y 47.87 1218.5476 12 -1.9 610.2799 2 26.44 4 10898 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 346 357
R.KQFDAPIAHNQLIQGK.L Y 36.08 1806.9740 16 -15.7 603.3225 3 61.45 4 32569 VEV_1_3_RA4_01_1235.d 6.25E4 1 1 310 325
K.AVDGGYLLNGTK.M Y 25.21 1206.6244 12 -2.5 604.3179 2 64.03 4 34533 VEV_1_3_RA4_01_1235.d 1.23E5 3 3 184 195
R.EIPEEVAAR.T Y 24.80 1012.5189 9 -10.3 507.2615 2 47.20 4 23125 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 63 71
K.LYEIGAGTSEIRR.M Y 18.17 1463.7732 13 -0.8 488.9313 3 62.04 4 33017 VEV_1_3_RA4_01_1235.d 0 1 1 409 421
K.TFKGFSC(+57.02)SR.K Y 16.19 1088.5073 9 2.2 545.2621 2 35.91 4 16286 VEV_1_3_RA4_01_1235.d 3.63E4 1 1 230 238 Carbamidomethylation
total 8 peptides
C1G0C7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DLGFSEQC(+57.02)IEDAKDTIQKLYK.V Y 68.32 2500.2156 21 -25.8 626.0450 4 84.07 5 48605 VEV_2_3_RA5_01_1236.d 0 1 1 225 245 Carbamidomethylation
R.LC(+57.02)NAVYIC(+57.02)ER.K Y 50.86 1296.5955 10 -14.6 649.2955 2 61.11 6 31239 VEV_3_3_RA6_01_1237.d 5.11E4 1 1 151 160 Carbamidomethylation
R.TAEEAEAVAK.Q Y 45.35 1017.4978 10 -15.9 509.7481 2 22.08 6 8641 VEV_3_3_RA6_01_1237.d 2.95E5 3 3 79 88
K.FGFDDNAEFR.Q Y 35.49 1216.5149 10 13.3 609.2728 2 73.07 6 40137 VEV_3_3_RA6_01_1237.d 0 2 2 275 284
R.VIYSPTEAK.M Y 29.92 1006.5334 9 -16.6 504.2656 2 41.76 6 19512 VEV_3_3_RA6_01_1237.d 2.43E5 1 1 121 129
K.LNGGS(+79.97)PAN(+.98)FLDVGGGATPQAIR.S Y 21.39 2192.0264 22 2.8 439.4138 5 59.80 5 31402 VEV_2_3_RA5_01_1236.d 3.25E5 1 1 337 358 Phosphorylation (STY); Deamidation (NQ)
K.VTAIFVNIFGGIVR.C Y 16.76 1504.8766 14 -50.0 377.2076 4 61.59 6 31600 VEV_3_3_RA6_01_1237.d 0 1 1 370 383
K.LN(+.98)GGSPANFLDVGGGAT(+79.97)PQAIR.S Y 15.11 2192.0264 22 -0.6 439.4123 5 59.96 6 30411 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 337 358 Deamidation (NQ); Phosphorylation (STY)
K.LINDSGLK.I Y 15.01 858.4811 8 -17.2 430.2404 2 40.17 4 18799 VEV_1_3_RA4_01_1235.d 0 1 1 419 426
total 9 peptides
C1G114
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KYLEC(+57.02)SSLTGEGVDDVFEAATR.A Y 81.71 2446.1321 22 -6.5 816.3793 3 79.43 5 45694 VEV_2_3_RA5_01_1236.d 1.03E5 2 2 176 197 Carbamidomethylation
K.EGHDTAAQVGAR.K Y 52.53 1210.5691 12 -14.3 606.2831 2 14.69 6 4788 VEV_3_3_RA6_01_1237.d 5.34E4 2 2 164 175
R.FVSSKEGHDTAAQVGAR.K Y 43.31 1758.8649 17 -12.8 587.2881 3 32.37 5 14651 VEV_2_3_RA5_01_1236.d 8.41E4 1 1 159 175
K.TSLLSVFTLGYFPTHYVPTVFENYVTDC(+57.02)R.V Y 35.39 3425.6641 29 6.6 1142.9028 3 95.36 4 56457 VEV_1_3_RA4_01_1235.d 9.05E4 2 2 40 68 Carbamidomethylation
total 4 peptides
C1GEC2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GADC(+57.02)C(+57.02)VLVYDVNNSK.S Y 81.37 1712.7498 15 -7.9 857.3754 2 68.56 4 38088 VEV_1_3_RA4_01_1235.d 4.59E4 1 1 55 69 Carbamidomethylation
R.FQSLGVAFYR.G Y 48.15 1186.6134 10 -10.2 594.3079 2 76.41 4 44233 VEV_1_3_RA4_01_1235.d 3.34E5 2 2 45 54
K.EAINVEQAFEEIAK.S Y 44.19 1589.7937 14 -19.4 795.8887 2 83.96 6 47803 VEV_3_3_RA6_01_1237.d 1.22E5 1 1 135 148
K.GNIPYFETSAK.E Y 30.27 1225.5979 11 -7.7 613.8015 2 67.05 4 36886 VEV_1_3_RA4_01_1235.d 4.5E5 3 3 124 134
R.MISPK.R Y 17.52 574.3149 5 -30.2 575.3048 1 16.82 4 5731 VEV_1_3_RA4_01_1235.d 0 1 1 110 114
total 5 peptides
A0A0A0HTQ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASQFLSEELPIR.L Y 81.81 1388.7300 12 -8.5 695.3664 2 77.61 4 45175 VEV_1_3_RA4_01_1235.d 1.81E5 1 1 43 54
R.FGERPSTGTLFR.A Y 67.69 1366.6993 12 -4.3 456.5718 3 64.19 4 34657 VEV_1_3_RA4_01_1235.d 2.87E5 2 2 31 42
R.AVVETHGAEKEAFPVTK.V Y 31.44 1811.9417 17 -2.8 604.9861 3 53.57 4 27173 VEV_1_3_RA4_01_1235.d 3.81E4 1 1 331 347
K.ISDEGGGIPR.S Y 20.26 999.4985 10 8.0 500.7605 2 40.17 4 18801 VEV_1_3_RA4_01_1235.d 8.07E4 1 1 361 370
total 4 peptides
C1GHV0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGTLTSHNYAFNPADKPSYGEPR.T Y 70.59 2508.1670 23 -5.3 837.0585 3 63.70 5 34314 VEV_2_3_RA5_01_1236.d 8.98E4 1 1 178 200
K.KREDIPALVVPDLAYIEFSR.A Y 54.54 2330.2634 20 -32.3 583.5543 4 84.74 5 49011 VEV_2_3_RA5_01_1236.d 0 1 1 457 476
R.FQGGSPTPVIVEPEFLR.T Y 35.52 1871.9780 17 -10.6 936.9863 2 82.21 4 48675 VEV_1_3_RA4_01_1235.d 2.43E4 1 1 822 838
K.TNEFGSYHPK.K Y 33.98 1178.5356 10 -4.9 590.2722 2 32.92 5 14948 VEV_2_3_RA5_01_1236.d 3E5 2 2 447 456
K.TGFGSSLIGGTAVPTPK.Q Y 31.75 1588.8461 17 -49.3 795.3911 2 76.47 4 44280 VEV_1_3_RA4_01_1235.d 0 1 1 700 716
R.LSEDAPAFLHLIADFRVR.A Y 24.73 2069.1057 18 -7.3 518.2799 4 86.08 5 49780 VEV_2_3_RA5_01_1236.d 5.03E4 1 1 1157 1174
M.A(+42.01)EDNPELQVALR.Q Y 17.44 1395.6993 12 -13.2 698.8477 2 77.49 6 43362 VEV_3_3_RA6_01_1237.d 7.01E4 1 1 2 13 Acetylation (Protein N-term)
total 7 peptides
C1G1J4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AYVDGDQIINVAK.Q Y 76.79 1404.7249 13 -11.4 703.3617 2 70.53 6 38247 VEV_3_3_RA6_01_1237.d 1.01E5 2 2 61 73
K.IC(+57.02)GPPTNLEFLASILTDAR.F Y 51.60 2087.0720 19 -11.2 1044.5316 2 93.06 6 52788 VEV_3_3_RA6_01_1237.d 1.34E5 1 1 426 444 Carbamidomethylation
R.VYAENPAR.N Y 27.73 918.4559 8 -17.2 460.2273 2 23.58 5 9712 VEV_2_3_RA5_01_1236.d 2.49E5 2 2 353 360
K.ANAIIPGYGFLSENTDFAR.M Y 25.57 2055.0061 19 13.0 686.0182 3 84.72 4 50398 VEV_1_3_RA4_01_1235.d 8.36E4 2 2 77 95
R.WAAEK.E N 23.07 603.3016 5 16.2 604.3187 1 29.83 4 12758 VEV_1_3_RA4_01_1235.d 1.05E5 4 4 1143 1147
K.FRRVTLDDALALR.R Y 22.89 1544.8787 13 -5.6 387.2248 4 32.22 5 14547 VEV_2_3_RA5_01_1236.d 0 2 2 759 771
K.GLDAAYLEK.L Y 17.05 978.5022 9 -4.0 490.2564 2 61.97 4 32967 VEV_1_3_RA4_01_1235.d 2.2E5 1 1 330 338
K.EAGIAFAGPSPESIEAFGLK.H Y 15.44 1990.0046 20 -32.9 498.4921 4 12.41 5 3658 VEV_2_3_RA5_01_1236.d 2.84E5 1 1 99 118
total 8 peptides
C1G6Q5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSDELTQVKNEQQYIVVR.E Y 97.20 2161.1379 18 -12.4 721.3776 3 73.52 4 41992 VEV_1_3_RA4_01_1235.d 4.48E4 2 2 139 156
K.EVSFNVHGLVYVPESEAPIDPLEAEVR.K Y 56.94 2994.4973 27 -5.3 999.1678 3 85.72 4 51059 VEV_1_3_RA4_01_1235.d 6.18E4 1 1 111 137
R.THRNTAESTNAR.V Y 15.55 1356.6494 12 -27.6 679.3132 2 56.45 4 28917 VEV_1_3_RA4_01_1235.d 6.41E4 1 1 159 170
total 3 peptides
C1G5X3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLDSWVQYEGQVK.V Y 89.83 1549.7776 13 -15.1 775.8843 2 75.47 6 41886 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 189 201
K.AQSIIDALPGNSLVSK.T Y 54.68 1611.8832 16 -15.9 806.9360 2 78.97 6 44421 VEV_3_3_RA6_01_1237.d 8.56E4 2 2 51 66
R.TALAAEAKR.V Y 18.47 929.5294 9 -10.0 310.8473 3 16.84 6 5966 VEV_3_3_RA6_01_1237.d 2.73E4 1 1 180 188
R.TALAAEAK.R Y 17.19 773.4283 8 -27.3 387.7109 2 49.29 6 23901 VEV_3_3_RA6_01_1237.d 0 1 1 180 187
R.LEAQAYELEQR.T Y 15.44 1348.6622 11 -38.8 675.3122 2 52.40 6 25753 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 169 179
total 5 peptides
C1GG11
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.MVSVGDSSATGSSTAK.M Y 72.45 1483.6824 16 -5.5 742.8444 2 39.22 4 18228 VEV_1_3_RA4_01_1235.d 4.8E4 1 1 14 29
M(+42.01)DVVSAVSGYVSK.M Y 54.64 1382.6752 13 -3.4 692.3425 2 88.03 5 50859 VEV_2_3_RA5_01_1236.d 1.31E5 1 1 1 13 Acetylation (Protein N-term)
R.LIQSPTVTADNKVR.L Y 40.15 1540.8573 14 -45.7 514.6029 3 52.64 5 26772 VEV_2_3_RA5_01_1236.d 0 3 3 386 399
K.LLAYHHSLQAPPVAGGFSDLFESASFLSGAR.D Y 27.81 3244.6304 31 -8.0 812.1584 4 86.93 4 51839 VEV_1_3_RA4_01_1235.d 2.46E4 1 1 440 470
K.ELQYPFLEGGGHTR.D Y 24.47 1602.7791 14 0.1 535.2670 3 77.23 6 43175 VEV_3_3_RA6_01_1237.d 6.03E4 1 1 504 517
K.NSLIAK(+27.99).K Y 15.63 672.3806 6 -12.2 337.1935 2 62.21 4 33157 VEV_1_3_RA4_01_1235.d 3.54E4 1 1 194 199 Formylation
R.FVEDYPEFR.K Y 15.41 1200.5450 9 7.9 601.2845 2 69.92 6 37793 VEV_3_3_RA6_01_1237.d 0 1 1 327 335
total 7 peptides
C1G6S1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGSLYYPVSSENR.S Y 67.11 1483.7307 13 -9.7 742.8654 2 68.94 5 38234 VEV_2_3_RA5_01_1236.d 2.45E5 2 2 115 127
K.SGYKYEAEGVK Y 54.63 1229.5928 11 -11.8 615.7964 2 30.33 5 13455 VEV_2_3_RA5_01_1236.d 1.52E5 1 1 505 515
K.GSSAQTGLPALR.Y Y 43.50 1156.6200 12 -39.4 579.2945 2 59.44 6 30039 VEV_3_3_RA6_01_1237.d 1.6E5 4 4 367 378
M.TFGNFVDAGPSGGK.A Y 42.83 1352.6360 14 -8.5 677.3195 2 67.04 5 36870 VEV_2_3_RA5_01_1236.d 4.52E5 2 2 2 15
R.TPLDLVSITQGNRR.T Y 22.83 1568.8634 14 -14.8 523.9540 3 71.70 5 40240 VEV_2_3_RA5_01_1236.d 7.51E4 1 1 274 287
R.DKGSSAQTGLPALR.Y Y 19.57 1399.7419 14 -13.7 467.5815 3 54.74 5 28044 VEV_2_3_RA5_01_1236.d 1.14E5 1 1 365 378
total 6 peptides
C1G2H2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.RIDLHFPLGLEVTAR.N Y 85.22 1735.9733 15 -3.2 434.9992 4 80.47 5 46364 VEV_2_3_RA5_01_1236.d 9.59E4 2 2 89 103
R.IDLHFPLGLEVTAR.N Y 55.72 1579.8722 14 -11.7 527.6252 3 83.16 5 48051 VEV_2_3_RA5_01_1236.d 1.18E5 2 2 90 103
K.LNTSPTTLDDKEALKK.F Y 27.49 1772.9519 16 -8.1 444.2417 4 50.92 4 25456 VEV_1_3_RA4_01_1235.d 1.8E5 2 2 65 80
K.FLTTPPVK.R Y 20.27 901.5273 8 -8.1 451.7673 2 60.69 6 30940 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 81 88
total 4 peptides
C1GIX4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAADASPNANILVIANPVNSTVPIVAEVFK.S Y 77.66 3004.6233 30 -3.6 1503.3135 2 93.22 4 55415 VEV_1_3_RA4_01_1235.d 4.58E5 4 4 127 156
R.GGPGVAADLSHINTNSTVTGYDPTPSGLR.D Y 52.02 2853.3892 29 -5.6 952.1317 3 76.66 4 44431 VEV_1_3_RA4_01_1235.d 5.28E4 1 1 59 87
K.DGAGSATLSMAMAGAR.F Y 37.98 1465.6653 16 -9.8 733.8327 2 71.68 4 40542 VEV_1_3_RA4_01_1235.d 3.59E4 1 1 241 256
R.FAESLLK.A Y 29.11 806.4537 7 -15.1 404.2281 2 63.19 5 33923 VEV_2_3_RA5_01_1236.d 1.86E5 2 2 257 263
R.KPGMTR.D N 17.23 688.3690 6 -17.8 345.1857 2 31.90 4 13951 VEV_1_3_RA4_01_1235.d 1.85E5 1 1 105 110
total 5 peptides
C1G445
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LGAALITEHGKDIQHAPESNPSSGFATPAHLPK.T Y 72.05 3390.7319 33 -11.0 679.1462 5 69.45 5 38595 VEV_2_3_RA5_01_1236.d 8.3E4 2 2 136 168
K.AGGKFSIFDGNVEGEYVKIEPSTNIVQK.W Y 53.82 3025.5396 28 -10.3 757.3844 4 79.23 4 46419 VEV_1_3_RA4_01_1235.d 0 1 1 233 260
R.VISMDGDVDVSQR.K Y 53.28 1419.6664 13 -13.3 710.8310 2 64.14 6 33472 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 45 57
K.FSIFDGNVEGEYVKIEPSTNIVQK.W Y 23.47 2712.3645 24 -5.6 905.1237 3 82.32 4 48761 VEV_1_3_RA4_01_1235.d 7.82E4 1 1 237 260
R.NWEGYYVR.S Y 21.35 1085.4930 8 -14.4 543.7460 2 65.23 6 34296 VEV_3_3_RA6_01_1237.d 2.12E5 2 2 307 314
total 5 peptides
C1GE31
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASLGLGTGSSISDPNDPRK.C Y 77.14 1870.9385 19 -12.7 624.6455 3 62.32 5 33270 VEV_2_3_RA5_01_1236.d 3.13E5 4 4 43 61
K.KFNAEEAPSGMIAR.G Y 48.10 1519.7452 14 -15.2 507.5813 3 60.66 4 31976 VEV_1_3_RA4_01_1235.d 9.76E5 2 2 155 168
K.FNAEEAPSGMIAR.G Y 47.91 1391.6503 13 -2.6 696.8306 2 66.23 4 36240 VEV_1_3_RA4_01_1235.d 5.85E4 1 1 156 168
R.GHYNALSR.F Y 38.51 916.4515 8 -12.5 459.2273 2 18.86 5 7121 VEV_2_3_RA5_01_1236.d 3.12E5 2 2 169 176
total 4 peptides
C1GKV7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLVLEGLYALNER.K Y 69.19 1445.7878 13 -18.6 482.9276 3 83.51 6 47521 VEV_3_3_RA6_01_1237.d 6.11E4 1 1 214 226
R.Q(-17.03)ELLDELFEQAR.V Y 59.00 1472.7147 12 -13.5 737.3547 2 93.38 6 52923 VEV_3_3_RA6_01_1237.d 4.6E4 1 1 175 186 Pyro-glu from Q
R.LLEIDALPAVR.E Y 48.18 1208.7128 11 -43.4 605.3374 2 79.96 4 46983 VEV_1_3_RA4_01_1235.d 0 1 1 298 308
K.KGGGGYQTTLK.G Y 21.05 1108.5876 11 -35.1 555.2816 2 18.78 6 6923 VEV_3_3_RA6_01_1237.d 0 1 1 203 213
K.AIGEAEAEFKEK.V Y 19.21 1320.6561 12 -9.8 441.2216 3 48.21 4 23757 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 243 254
R.KAIGEAEAEFK.E Y 16.84 1191.6135 11 -14.5 398.2060 3 35.34 6 15843 VEV_3_3_RA6_01_1237.d 0 2 2 242 252
total 6 peptides
C1G3U9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NPYGHNAGVTDFVSNVSR.F Y 87.46 1932.9078 18 -13.9 645.3009 3 67.78 6 36216 VEV_3_3_RA6_01_1237.d 9.56E4 2 2 14 31
R.VGIADTVGC(+57.02)ASPR.Q Y 78.33 1301.6398 13 -11.6 651.8196 2 61.28 6 31356 VEV_3_3_RA6_01_1237.d 3.47E5 3 3 189 201 Carbamidomethylation
total 2 peptides
C1GLA9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AETAKPVAEEKPQAPAAAPPAAETGGK.K Y 80.52 2586.3289 27 -9.4 863.1088 3 50.25 4 25030 VEV_1_3_RA4_01_1235.d 1.22E5 3 3 194 220
K.TAAPAAAPAPK.A Y 64.76 964.5341 11 -7.7 483.2706 2 24.58 4 9896 VEV_1_3_RA4_01_1235.d 1.28E5 4 4 183 193
K.IAANDLEHAIAGSR.L Y 26.77 1436.7372 14 -2.7 479.9184 3 67.68 6 36141 VEV_3_3_RA6_01_1237.d 9.12E4 1 1 786 799
K.NNPVTGVKEIINLGR.V Y 19.07 1622.9104 15 -20.1 541.9666 3 75.31 6 41765 VEV_3_3_RA6_01_1237.d 2.49E4 1 1 981 995
total 4 peptides
C1GL71
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SAASANDNPGVAPSK.T Y 91.06 1384.6582 15 -10.3 693.3292 2 25.34 4 10306 VEV_1_3_RA4_01_1235.d 6.1E4 2 2 598 612
K.EKSGAEPDNVTGVISAPLSR.T Y 31.14 2026.0331 20 -21.4 676.3372 3 69.42 5 38575 VEV_2_3_RA5_01_1236.d 1.56E3 1 1 517 536
R.FVEEQIR.A Y 24.01 919.4763 7 -14.7 307.4949 3 22.29 5 8962 VEV_2_3_RA5_01_1236.d 0 1 1 1140 1146
K.QTKDVASSLR.R Y 20.89 1103.5935 10 -5.8 368.8697 3 57.07 5 29477 VEV_2_3_RA5_01_1236.d 0 1 1 484 493
R.LRPQFPPSNHPQPR.G Y 18.98 1669.8800 14 -4.4 835.9436 2 76.61 5 43743 VEV_2_3_RA5_01_1236.d 5.29E4 1 1 302 315
K.QYMSLAFRIAEQK.M Y 17.39 1583.8130 13 -17.8 396.9535 4 35.43 6 15908 VEV_3_3_RA6_01_1237.d 0 1 1 858 870
total 6 peptides
C1GCX3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YEKGENDEFLKPIIVGGQER.R Y 69.19 2320.1699 20 -22.0 581.0370 4 70.44 6 38182 VEV_3_3_RA6_01_1237.d 3.38E5 2 2 235 254
R.EITQLLGNVDR.S Y 61.86 1256.6725 11 -14.7 629.3343 2 73.12 6 40175 VEV_3_3_RA6_01_1237.d 2.83E5 2 2 274 284
K.ELGVGEVATVVGR.Y Y 39.78 1284.7037 13 -13.8 643.3503 2 74.42 4 42680 VEV_1_3_RA4_01_1235.d 2.03E4 3 3 183 195
K.SAAGYMQQLLDKTKELGVGEVATVVGR.Y Y 24.85 2819.4851 27 4.5 705.8817 4 86.80 4 51752 VEV_1_3_RA4_01_1235.d 2.06E5 1 1 169 195
K.M(+15.99)SAAPVAEK.L Y 17.88 918.4481 9 4.1 919.4591 1 91.45 5 52619 VEV_2_3_RA5_01_1236.d 2.71E4 1 1 380 388 Oxidation (M)
R.IQDNDTLFFFNYR.S Y 17.27 1691.7943 13 -11.7 564.9321 3 84.60 6 48210 VEV_3_3_RA6_01_1237.d 2.63E4 1 1 256 268
total 6 peptides
C1GF52
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GTVIYPDSIAELDETTPGHNPK.L Y 77.67 2353.1438 22 -9.5 785.3811 3 74.97 4 43104 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 327 348
R.YGTVDIIPQMAILSLVGR.H Y 54.98 1945.0707 18 -8.3 973.5345 2 93.53 4 55596 VEV_1_3_RA4_01_1235.d 6.16E4 2 2 454 471
R.LLPAITPAEAAELTFYGSEVIHPFTMEQVIR.A Y 35.39 3442.7847 31 -3.8 1148.5978 3 94.56 4 56088 VEV_1_3_RA4_01_1235.d 1E5 2 2 280 310
R.QEGPK.R Y 20.78 557.2809 5 -31.0 558.2709 1 51.86 4 26069 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 362 366
R.VAVVC(+57.02)SAWSSSSK.A Y 18.23 1366.6550 13 -11.5 684.3270 2 62.05 4 33031 VEV_1_3_RA4_01_1235.d 5.59E4 1 1 59 71 Carbamidomethylation
total 5 peptides
C1G0R1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TFTTAETITNANTAK.A Y 88.28 1582.7838 15 -14.7 792.3876 2 60.58 5 31982 VEV_2_3_RA5_01_1236.d 2.39E5 3 3 217 231
R.YSTGPIVFGEPATNAQHSFYQLLHQGTK.L Y 25.29 3090.5198 28 -12.2 1031.1680 3 82.01 5 47354 VEV_2_3_RA5_01_1236.d 2.94E4 1 1 378 405
K.A(+27.99)KDTAHIAK.H Y 19.16 981.5243 9 11.3 328.1857 3 9.63 5 2368 VEV_2_3_RA5_01_1236.d 2.05E4 1 1 238 246 Formylation
K.FGIDK.K Y 18.83 578.3064 5 -49.5 579.2850 1 57.15 5 29525 VEV_2_3_RA5_01_1236.d 1.77E3 1 1 261 265
K.EAGVEK.L Y 18.61 631.3177 6 -35.3 632.3027 1 68.68 5 38035 VEV_2_3_RA5_01_1236.d 2.22E4 1 1 79 84
K.TFLGNRPTTSILAQK.I Y 17.90 1645.9152 15 -16.6 549.6365 3 67.74 5 37331 VEV_2_3_RA5_01_1236.d 5.03E4 1 1 464 478
K.IEKELETEGEGGGHDGSTSGLIAAYK.K Y 15.64 2647.2612 26 -22.6 662.8076 4 83.56 6 47552 VEV_3_3_RA6_01_1237.d 0 1 1 522 547
K.A(+43.01)SLLR.E Y 15.44 601.3547 5 -32.1 301.6750 2 55.86 6 27651 VEV_3_3_RA6_01_1237.d 0 1 1 550 554 Carbamylation
K.SVVEEVNSVLNHM(+15.99)K.E Y 15.33 1599.7926 14 12.5 534.2781 3 70.66 5 39475 VEV_2_3_RA5_01_1236.d 2.89E5 1 1 122 135 Oxidation (M)
K.SVVEEVNSVLNHMK.E Y 15.32 1583.7977 14 21.3 396.9651 4 70.27 6 38060 VEV_3_3_RA6_01_1237.d 5.88E4 1 1 122 135
total 10 peptides
C1GDK5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LINDSVPDTIDER.V Y 71.19 1485.7311 13 -11.3 743.8644 2 67.71 4 37412 VEV_1_3_RA4_01_1235.d 8.71E4 1 1 183 195
R.APLQTHDLLQR.A Y 40.02 1290.7043 11 -10.1 431.2377 3 58.97 4 30729 VEV_1_3_RA4_01_1235.d 9.16E4 3 3 337 347
K.FLTPTSLVAGNPK.L Y 37.26 1343.7449 13 -12.0 672.8716 2 75.08 4 43190 VEV_1_3_RA4_01_1235.d 3.06E4 1 1 363 375
K.SSYVDYDLVTPGR.T Y 37.18 1470.6990 13 -10.1 736.3494 2 72.74 6 39897 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 581 593
K.SSYVDYDLVTPGRTDEDAYANAK.L Y 36.14 2549.1558 23 -7.9 850.7191 3 72.83 4 41453 VEV_1_3_RA4_01_1235.d 5.83E4 1 1 581 603
R.ANQVLDNADLLEC(+57.02)RK.F Y 25.92 1757.8730 15 -11.1 586.9584 3 67.10 5 36844 VEV_2_3_RA5_01_1236.d 2.06E4 1 1 348 362 Carbamidomethylation
K.S(-2.02)SYVDYDLVTPGR.T Y 15.25 1468.6833 13 5.6 735.3530 2 72.75 4 41411 VEV_1_3_RA4_01_1235.d 9.89E4 1 1 581 593 2-amino-3-oxo-butanoic_acid
total 7 peptides
C1G3V2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)LGQPKPATPIHVVR.L Y 61.66 1622.9257 15 -8.3 541.9780 3 64.85 4 35157 VEV_1_3_RA4_01_1235.d 1.6E5 2 2 164 178 Pyro-glu from Q
K.AWEDSIPLLSADASSPSLAK.V Y 59.30 2057.0317 20 -6.6 1029.5164 2 84.62 4 50330 VEV_1_3_RA4_01_1235.d 8.04E4 2 2 116 135
K.ANKAWEDSIPLLSADASSPSLAK.V Y 50.21 2370.2065 23 -30.0 791.0524 3 80.24 5 46207 VEV_2_3_RA5_01_1236.d 1.71E5 2 2 113 135
K.S(+162.05)AAVTADTAAGSK.A Y 39.63 1310.6201 13 -11.2 656.3100 2 19.22 6 7222 VEV_3_3_RA6_01_1237.d 1.63E5 2 2 50 62 Hexose (NSY)
R.QLGQPKPATPIHVVR.L Y 37.86 1639.9521 15 -11.5 410.9906 4 56.03 4 28650 VEV_1_3_RA4_01_1235.d 6.78E4 1 1 164 178
R.MGPPRPQVAPPAGAAR Y 31.10 1571.8354 16 -0.3 524.9523 3 57.33 4 29539 VEV_1_3_RA4_01_1235.d 5.55E4 1 1 255 270
K.S(+162.05)AAVTADTAAGSK(+14.02).A Y 25.29 1324.6357 13 -6.7 663.3207 2 26.74 4 11064 VEV_1_3_RA4_01_1235.d 3.13E4 1 1 50 62 Hexose (NSY); Methylation(KR)
R.M(+15.99)GPPRPQVAPPAGAAR Y 16.04 1587.8303 16 -16.5 530.2753 3 48.72 4 24072 VEV_1_3_RA4_01_1235.d 1.56E5 1 1 255 270 Oxidation (M)
total 8 peptides
C1GAU3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGETEEQTAER.I Y 64.00 1219.5316 11 -11.3 610.7662 2 14.36 6 4614 VEV_3_3_RA6_01_1237.d 6.83E4 3 3 508 518
K.ALEAQFSAR.A Y 60.07 991.5087 9 -12.6 496.7554 2 52.28 5 26548 VEV_2_3_RA5_01_1236.d 6.33E5 6 6 499 507
K.FSEAIAIEPENHVLYSNR.S Y 40.79 2088.0276 18 -8.2 697.0107 3 73.51 6 40456 VEV_3_3_RA6_01_1237.d 4.37E4 1 1 25 42
R.EIDQQQQKALEAQFSAR.A Y 39.53 1988.9915 17 -24.9 663.9879 3 66.58 5 36451 VEV_2_3_RA5_01_1236.d 0 1 1 491 507
K.TTELKPDWVK.G Y 17.96 1215.6499 10 -11.7 304.9162 4 12.35 4 3467 VEV_1_3_RA4_01_1235.d 1.88E5 1 1 62 71
K.TSSLLADPDFMAK.L Y 17.78 1394.6752 13 -3.1 698.3427 2 77.11 6 43085 VEV_3_3_RA6_01_1237.d 0 1 1 153 165
total 6 peptides
A0A0A0HVC6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GVTQEVPNDDELQELAR.C Y 89.37 1911.9174 17 -12.9 956.9536 2 75.37 6 41810 VEV_3_3_RA6_01_1237.d 1.19E5 2 2 35 51
R.ADHNPPNNDGPR.E Y 55.91 1302.5701 12 -7.5 435.1941 3 12.62 4 3616 VEV_1_3_RA4_01_1235.d 2.99E5 5 5 14 25
K.LGAGAR.K Y 18.97 543.3129 6 -24.7 544.3067 1 66.03 6 34906 VEV_3_3_RA6_01_1237.d 0 2 2 269 274
total 3 peptides
C1G0X9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DLFPEVESLISTANPYIR.R Y 60.53 2063.0574 18 -4.8 1032.5310 2 94.38 4 56003 VEV_1_3_RA4_01_1235.d 2.38E5 2 2 136 153
R.ASFREESADSTIR.R Y 43.90 1467.6953 13 -13.8 490.2323 3 42.48 5 20608 VEV_2_3_RA5_01_1236.d 7.13E4 1 1 33 45
R.VLGEATNKR.Q Y 29.12 986.5508 9 -49.6 494.2582 2 15.50 6 5207 VEV_3_3_RA6_01_1237.d 2.09E4 2 2 602 610
R.SSAGAQILAR.F Y 25.60 972.5352 10 -20.3 487.2650 2 42.55 4 20256 VEV_1_3_RA4_01_1235.d 0 2 2 751 760
R.LIATTPELQTYSVQK.L Y 21.65 1690.9141 15 -29.2 423.7234 4 51.99 5 26382 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 448 462
R.EEQRVLGEATNKR.Q Y 21.28 1528.7958 13 -10.3 383.2023 4 27.94 4 11712 VEV_1_3_RA4_01_1235.d 0 1 1 598 610
K.EQILSSFVR.L Y 21.23 1077.5818 9 -42.8 360.1858 3 10.75 6 2803 VEV_3_3_RA6_01_1237.d 1.88E5 4 4 439 447
R.NVRASK.T Y 20.36 673.3871 6 -24.2 674.3781 1 74.35 5 42131 VEV_2_3_RA5_01_1236.d 3.06E4 1 1 10 15
R.SADLSVEIQQR.A Y 20.16 1244.6360 11 0.4 415.8861 3 46.43 6 22225 VEV_3_3_RA6_01_1237.d 2.76E5 2 2 560 570
K.TIADERSVIQK.E Y 18.94 1258.6881 11 -17.9 630.3401 2 72.22 4 40967 VEV_1_3_RA4_01_1235.d 6.5E3 1 1 16 26
R.FSPNK.R Y 18.44 591.3016 5 -52.0 592.2781 1 60.98 6 31154 VEV_3_3_RA6_01_1237.d 8.09E3 1 1 415 419
R.ITEPAQIER.I Y 18.02 1055.5610 9 -9.2 528.7830 2 46.66 4 22800 VEV_1_3_RA4_01_1235.d 9.88E4 1 1 543 551
R.GVLEKM(+15.99)PPPEIR.E Y 16.56 1380.7435 12 -1.0 346.1928 4 54.18 4 27546 VEV_1_3_RA4_01_1235.d 0 1 1 586 597 Oxidation (M)
R.WHVDTM(+15.99)LR.V Y 15.79 1072.5125 8 1.7 537.2644 2 35.01 6 15657 VEV_3_3_RA6_01_1237.d 5.99E4 1 1 421 428 Oxidation (M)
K.ESAAIR.A Y 15.54 645.3445 6 -20.4 646.3386 1 86.38 4 51488 VEV_1_3_RA4_01_1235.d 6.62E2 1 1 27 32
total 15 peptides
C1GMG0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TDTHPPANIFFSTLATTR.A Y 67.62 1988.9956 18 -12.4 663.9976 3 79.87 5 45964 VEV_2_3_RA5_01_1236.d 5.43E5 3 3 68 85
K.LKGDIEESILALGFER.T Y 65.23 1788.9620 16 -11.3 597.3212 3 83.87 4 49824 VEV_1_3_RA4_01_1235.d 6.86E4 2 2 136 151
R.AIEHDANVELAR.A Y 39.70 1336.6735 12 -6.9 669.3394 2 46.00 5 22779 VEV_2_3_RA5_01_1236.d 0 1 1 96 107
M.A(+42.01)SVALVGGTGLVGSHILTTLLPHSSIAHIEFLAR.R Y 22.50 3478.9299 34 -3.2 870.7369 4 93.13 6 52820 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 2 35 Acetylation (Protein N-term)
R.AN(+.98)AGGLAAQR.A Y 16.65 928.4726 10 19.2 465.2525 2 20.41 5 7952 VEV_2_3_RA5_01_1236.d 9.75E4 1 1 86 95 Deamidation (NQ)
R.ANAGGLAAQR.A Y 15.22 927.4886 10 -20.6 464.7420 2 20.34 6 7735 VEV_3_3_RA6_01_1237.d 6.48E4 1 1 86 95
total 6 peptides
C1GMS3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HHLTDAVSK.K Y 59.71 1006.5196 9 -11.1 504.2615 2 19.74 5 7588 VEV_2_3_RA5_01_1236.d 8.54E4 2 2 211 219
K.NC(+57.02)HSFVGK.T Y 58.18 947.4283 8 -13.8 474.7149 2 16.26 5 5696 VEV_2_3_RA5_01_1236.d 3.52E5 3 3 221 228 Carbamidomethylation
R.HHLTDAVSKK.N Y 50.45 1134.6145 10 -18.3 568.3041 2 17.25 6 6124 VEV_3_3_RA6_01_1237.d 2.78E4 1 1 211 220
R.FGEADIAK.E Y 39.89 849.4232 8 -11.6 850.4207 1 46.29 6 22149 VEV_3_3_RA6_01_1237.d 7.54E5 5 5 145 152
K.KNC(+57.02)HSFVGK.T Y 33.18 1075.5233 9 -10.0 538.7635 2 12.94 5 3931 VEV_2_3_RA5_01_1236.d 6.51E4 1 1 220 228 Carbamidomethylation
total 5 peptides
C1GGE5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IVSSADAALDPVDFPVAPAK.A Y 92.29 1982.0360 20 -12.2 992.0132 2 80.31 6 45376 VEV_3_3_RA6_01_1237.d 4.38E4 2 2 319 338
R.EQQDEYAIQSYKR.A Y 41.63 1656.7743 13 -12.6 553.2584 3 49.50 4 24570 VEV_1_3_RA4_01_1235.d 3.86E4 1 1 214 226
R.VPYYVAR.A Y 27.12 866.4650 7 -19.7 434.2313 2 47.61 6 22919 VEV_3_3_RA6_01_1237.d 3.9E5 1 1 162 168
total 3 peptides
C1G1Y7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IQDPQMTGYVSTR.Y Y 58.53 1494.7136 13 -13.8 748.3538 2 63.31 6 32863 VEV_3_3_RA6_01_1237.d 3.57E5 3 3 165 177
K.IC(+57.02)DFGLAR.I N 56.39 950.4644 8 -11.7 476.2339 2 65.17 4 35435 VEV_1_3_RA4_01_1235.d 5.05E5 5 5 157 164 Carbamidomethylation
R.DLKPSNILINENC(+57.02)DLK.I Y 55.83 1884.9614 16 0.4 629.3280 3 73.47 5 41500 VEV_2_3_RA5_01_1236.d 0 1 1 141 156 Carbamidomethylation
R.IQDPQM(+15.99)TGYVSTR.Y Y 50.13 1510.7086 13 -13.4 756.3514 2 51.47 4 25808 VEV_1_3_RA4_01_1235.d 7.6E4 1 1 165 177 Oxidation (M)
R.AQIFGTTFEITNR.Y Y 44.69 1496.7623 13 -24.9 499.9156 3 78.72 6 44241 VEV_3_3_RA6_01_1237.d 7.41E4 2 2 7 19
R.YADLQPVGMGAFGLVC(+57.02)SAK.D Y 27.78 1982.9594 19 -4.6 992.4824 2 83.55 4 49598 VEV_1_3_RA4_01_1235.d 7.47E4 1 1 20 38 Carbamidomethylation
R.IQ(+.98)DPQMTGYVSTR.Y Y 24.52 1495.6976 13 -8.9 748.8494 2 64.71 4 35047 VEV_1_3_RA4_01_1235.d 6.03E4 1 1 165 177 Deamidation (NQ)
total 7 peptides
C1GHV7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AINITLNSFGTELSK.A Y 80.76 1606.8566 15 -12.4 804.4256 2 80.88 4 47701 VEV_1_3_RA4_01_1235.d 4.59E4 2 2 220 234
R.FVNSEPGLR.G Y 41.27 1017.5243 9 -15.0 509.7618 2 48.82 6 23628 VEV_3_3_RA6_01_1237.d 8.71E5 4 4 192 200
R.YLQAQATGSIAK.F Y 40.00 1249.6666 12 -15.5 625.8309 2 50.02 6 24308 VEV_3_3_RA6_01_1237.d 2.67E4 1 1 80 91
R.AINITLNSFGTELSKAER.K Y 28.94 1963.0374 18 -10.9 655.3459 3 79.09 4 46312 VEV_1_3_RA4_01_1235.d 6.39E4 1 1 220 237
total 4 peptides
C1GA06
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ITNKVYFDITHGDKPLGR.I Y 70.52 2073.1006 18 -25.2 415.6169 5 66.66 4 36608 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 33 50
K.VYFDITHGDKPLGR.I Y 34.84 1616.8311 14 -15.6 405.2087 4 67.14 4 36952 VEV_1_3_RA4_01_1235.d 1.01E5 2 2 37 50
R.VIKDFMIQGGDFTNGDGTGGR.S Y 34.44 2184.0269 21 4.0 729.0192 3 74.24 4 42544 VEV_1_3_RA4_01_1235.d 6.79E4 1 1 87 107
K.SGELAM(+15.99)EPEEGDGKHSEL Y 30.81 1929.8262 18 -5.3 644.2792 3 53.71 6 26475 VEV_3_3_RA6_01_1237.d 2.12E4 1 1 193 210 Oxidation (M)
K.SGELAMEPEEGDGKHSEL Y 27.86 1913.8312 18 -8.5 638.9456 3 62.51 5 33418 VEV_2_3_RA5_01_1236.d 5.99E4 1 1 193 210
R.SIYGEKFADESFKLR.H Y 24.48 1788.9045 15 -5.2 597.3057 3 70.83 5 39604 VEV_2_3_RA5_01_1236.d 6.81E4 1 1 108 122
R.ALATGEKGFGYEGSTFHR.V Y 23.24 1926.9224 18 -13.0 643.3064 3 61.57 5 32715 VEV_2_3_RA5_01_1236.d 9.34E4 1 1 69 86
K.TAENFR.A N 22.68 736.3504 6 -11.0 369.1784 2 16.37 6 5651 VEV_3_3_RA6_01_1237.d 1.13E5 1 1 63 68
K.FADESFKLR.H Y 21.22 1111.5662 9 -20.2 371.5219 3 61.64 6 31675 VEV_3_3_RA6_01_1237.d 8.01E4 1 1 114 122
total 9 peptides
C1G4C0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AIDTLSEPLPPNVSEVIAADFDPLLPK.S Y 77.55 2860.5110 27 -7.2 1431.2524 2 95.21 6 53679 VEV_3_3_RA6_01_1237.d 6.93E4 2 2 724 750
R.VNGTAEGEADSAER.K Y 64.05 1404.6117 14 -2.8 703.3112 2 23.85 4 9468 VEV_1_3_RA4_01_1235.d 5.08E4 1 1 591 604
K.TALKYDSTSQAIQR.D Y 35.78 1580.8158 14 5.5 527.9488 3 49.55 4 24605 VEV_1_3_RA4_01_1235.d 7.89E4 1 1 106 119
total 3 peptides
C1GAM1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALTLSGTPIPNTSR.T Y 71.97 1426.7780 14 -26.7 714.3772 2 69.47 6 37467 VEV_3_3_RA6_01_1237.d 2.91E5 3 3 122 135
R.DKFSGSNAGYC(+57.02)FVDFSSPAAAAK.A Y 52.02 2396.0742 23 -9.3 799.6913 3 77.38 4 44996 VEV_1_3_RA4_01_1235.d 3.94E4 1 1 99 121 Carbamidomethylation
R.FSDETDQQR.A Y 40.76 1124.4734 9 28.7 563.2601 2 20.03 5 7746 VEV_2_3_RA5_01_1236.d 0 2 2 208 216
K.IMTDPISGMSR.G Y 22.93 1206.5737 11 -8.6 604.2889 2 67.85 4 37525 VEV_1_3_RA4_01_1235.d 0 1 1 191 201
K.LNWASGGGLADR.S Y 19.97 1215.5996 12 -19.0 608.7955 2 67.53 4 37285 VEV_1_3_RA4_01_1235.d 0 1 1 139 150
total 5 peptides
C1G887
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQLWDTAGQER.F N 59.71 1315.6521 11 -15.7 658.8230 2 68.52 6 36774 VEV_3_3_RA6_01_1237.d 3.33E5 2 2 91 101
R.IAQALPGMDDEAGR.G Y 59.07 1442.6824 14 -10.1 722.3412 2 64.91 4 35206 VEV_1_3_RA4_01_1235.d 1.58E5 2 2 197 210
M.A(+42.01)SESATGSYSNPLKK.F Y 50.28 1580.7682 15 -6.8 791.3860 2 59.91 4 31429 VEV_1_3_RA4_01_1235.d 2.31E5 3 3 2 16 Acetylation (Protein N-term)
R.LQLWDTAGQERFR.S N 48.94 1618.8215 13 -31.6 540.5974 3 71.60 4 40475 VEV_1_3_RA4_01_1235.d 1.87E5 3 3 91 103
R.FRSLIPSYIR.D Y 15.01 1250.7135 10 -37.3 417.8962 3 32.33 5 14628 VEV_2_3_RA5_01_1236.d 0 1 1 102 111
total 5 peptides
C1G3N9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSTSASDGGGGPTGIFDNFADTFVNAFTK.V Y 71.28 2881.3042 29 -5.3 961.4370 3 95.14 5 54285 VEV_2_3_RA5_01_1236.d 2.17E5 4 4 201 229
R.AVFDRDSLTNNPASYYSPNPLTSNPASFIR.S Y 62.73 3313.6003 30 -3.8 1105.5365 3 83.85 4 49810 VEV_1_3_RA4_01_1235.d 3.75E4 1 1 356 385
R.NGPDSDLSRPTTSGTDAER.S Y 41.44 1974.8878 19 -3.3 659.3010 3 41.74 4 19747 VEV_1_3_RA4_01_1235.d 1.17E5 2 2 13 31
R.HKSKKGGLEDALVGLGHS Y 16.56 1831.9904 18 18.6 367.4122 5 63.98 4 34496 VEV_1_3_RA4_01_1235.d 0 1 1 495 512
total 4 peptides
C1GF68
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HNPSKPEPAQTSQPAPGNREER.R Y 70.81 2426.1687 22 -3.0 607.5476 4 21.77 4 8351 VEV_1_3_RA4_01_1235.d 3.46E5 4 4 214 235
R.NAESLELIGIEK.A Y 63.43 1314.7030 12 -19.0 658.3463 2 75.26 6 41732 VEV_3_3_RA6_01_1237.d 2.15E5 3 3 348 359
K.QVPSPPPKPEQATQNPARPK.H Y 26.59 2166.1545 20 13.1 542.5530 4 42.96 6 20217 VEV_3_3_RA6_01_1237.d 0 3 3 194 213
K.IEIRPMMYLALTYDHR.L Y 22.66 2021.0227 16 14.8 506.2704 4 81.69 6 46332 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 424 439
K.HNPSK(-1.03)PEPAQTSQPAPGNREER.R Y 21.56 2425.1370 22 9.2 607.2971 4 21.68 6 8436 VEV_3_3_RA6_01_1237.d 3.84E4 1 1 214 235 Lysine oxidation to aminoadipic semialdehyde
R.HPPPSHPK.Q Y 17.64 895.4664 8 -3.7 448.7388 2 8.40 4 1979 VEV_1_3_RA4_01_1235.d 4.73E3 1 1 186 193
total 6 peptides
C1G347
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KLSSKPTDDDLLELYALFK.Q Y 70.37 2195.1724 19 -3.8 549.7983 4 84.23 6 47983 VEV_3_3_RA6_01_1237.d 8.24E4 1 1 18 36
K.SSNFEAAIEASR.K Y 60.71 1280.5996 12 -10.2 641.3005 2 64.77 5 35097 VEV_2_3_RA5_01_1236.d 1.82E5 3 3 6 17
K.LSSKPTDDDLLELYALFK.Q Y 38.46 2067.0776 18 22.0 690.0483 3 87.46 6 49923 VEV_3_3_RA6_01_1237.d 0 1 1 19 36
K.YGYDALKAPEQVGGS Y 28.08 1553.7361 15 -5.4 777.8711 2 69.10 4 38520 VEV_1_3_RA4_01_1235.d 1.4E5 1 1 92 106
total 4 peptides
C1G9A3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAVDAGQPAQATYR.T Y 78.30 1447.7056 14 -8.7 724.8538 2 44.51 5 21865 VEV_2_3_RA5_01_1236.d 3.11E5 4 4 252 265
R.GVQHSPLGGDFISSQIR.A Y 50.51 1796.9169 17 22.0 599.9927 3 71.66 6 39105 VEV_3_3_RA6_01_1237.d 0 1 1 213 229
R.ITAAGNTAER.K Y 25.00 1002.5094 10 26.9 502.2755 2 17.15 6 6069 VEV_3_3_RA6_01_1237.d 0 1 1 423 432
K.TAVDAGQPAQ(+.98)ATYR.T Y 22.48 1448.6896 14 -13.8 725.3420 2 48.24 6 23283 VEV_3_3_RA6_01_1237.d 4.54E4 1 1 252 265 Deamidation (NQ)
R.AGFAGEDTPK.S Y 20.54 991.4611 10 0.8 496.7382 2 35.71 4 16161 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 31 40
R.TVTPDQAPDPSFRR.L Y 17.36 1585.7848 14 -1.1 793.8988 2 56.11 4 28704 VEV_1_3_RA4_01_1235.d 3.83E3 1 1 266 279
total 6 peptides
C1GF88
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ELALQTSQVC(+57.02)K.T Y 62.15 1275.6493 11 -4.0 638.8293 2 58.29 4 30213 VEV_1_3_RA4_01_1235.d 1.64E5 2 2 126 136 Carbamidomethylation
R.NLVC(+57.02)SDLLTR.G Y 51.11 1189.6125 10 -10.4 595.8074 2 70.96 4 39968 VEV_1_3_RA4_01_1235.d 9.32E4 2 2 337 346 Carbamidomethylation
K.TAAFVIPTLER.T Y 48.87 1216.6815 11 -37.4 609.3253 2 78.58 6 44172 VEV_3_3_RA6_01_1237.d 9.33E4 3 3 98 108
K.KITELGYSC(+57.02)FYSHAK.M Y 45.43 1802.8661 15 -3.5 451.7222 4 65.21 4 35444 VEV_1_3_RA4_01_1235.d 3.48E4 1 1 303 317 Carbamidomethylation
R.GITQYYAFVEEK.Q Y 23.39 1446.7030 12 -1.9 724.3574 2 77.17 4 44830 VEV_1_3_RA4_01_1235.d 1.48E5 1 1 258 269
total 5 peptides
C1G0I9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NALSAEESSLSTAR.S Y 70.00 1434.6951 14 -7.1 718.3497 2 62.93 4 33702 VEV_1_3_RA4_01_1235.d 3.11E5 3 3 403 416
R.FTTITVDEQNFSGR.V Y 58.58 1613.7686 14 -11.2 807.8825 2 71.95 6 39346 VEV_3_3_RA6_01_1237.d 3.1E5 3 3 480 493
R.GLGPEFAK.Y Y 38.71 817.4333 8 -12.0 409.7191 2 53.41 5 27261 VEV_2_3_RA5_01_1236.d 1.48E5 1 1 32 39
R.S(+27.99)QLDDHK.A Y 16.64 869.3879 7 -16.2 870.3811 1 97.00 5 54997 VEV_2_3_RA5_01_1236.d 0 1 1 417 423 Formylation
K.AARNALSAEESSLSTAR.S Y 16.53 1732.8704 17 -13.6 434.2190 4 56.11 6 27798 VEV_3_3_RA6_01_1237.d 2.62E5 1 1 400 416
total 5 peptides
C1FYW7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KGVVTPDGEEPTDLEKR.T Y 79.00 1868.9479 17 -5.7 623.9863 3 52.42 5 26643 VEV_2_3_RA5_01_1236.d 6.86E5 4 4 49 65
K.GVVTPDGEEPTDLEKR.T Y 44.23 1740.8529 16 -5.0 581.2887 3 60.39 4 31778 VEV_1_3_RA4_01_1235.d 7.13E5 3 3 50 65
K.SSFQVEQGMGR.S Y 38.24 1224.5557 11 -10.5 613.2787 2 55.51 5 28466 VEV_2_3_RA5_01_1236.d 1.07E5 1 1 323 333
K.SSFQVEQGM(+15.99)GR.S Y 36.46 1240.5507 11 -7.4 621.2780 2 37.23 6 16893 VEV_3_3_RA6_01_1237.d 3.05E5 4 4 323 333 Oxidation (M)
R.SFPWNDHFVDELKR.A Y 22.21 1788.8583 14 -18.1 448.2137 4 76.77 6 42830 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 334 347
total 5 peptides
A0A0A0HQC4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVPSFQQTMLTGSPAGGSRPNNPFR.Q Y 88.25 2632.2815 25 -8.3 878.4272 3 76.53 5 43688 VEV_2_3_RA5_01_1236.d 1.5E5 2 2 463 487
K.FGSSSVEKEK.G Y 25.51 1096.5400 10 -11.5 549.2710 2 18.59 5 6971 VEV_2_3_RA5_01_1236.d 3.16E4 1 1 277 286
K.YLSQNPK.R Y 21.43 848.4392 7 -30.2 849.4209 1 99.36 5 55795 VEV_2_3_RA5_01_1236.d 0 2 2 80 86
R.TLQFR.I N 18.58 663.3704 5 -29.5 664.3581 1 84.51 5 48871 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 45 49
R.FSAQTEEVVR(+14.02).F Y 18.06 1178.5931 10 -14.3 590.2954 2 59.98 4 31478 VEV_1_3_RA4_01_1235.d 6.44E4 1 1 217 226 Methylation(KR)
K.N(+.98)AAPK.S Y 17.33 500.2594 5 -2.8 501.2653 1 62.25 5 33226 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 18 22 Deamidation (NQ)
K.N(+42.01)AAPK.S Y 15.71 541.2860 5 -4.3 542.2910 1 18.12 5 6717 VEV_2_3_RA5_01_1236.d 2.27E4 1 1 18 22 Acetylation (Protein N-term)
total 7 peptides
C1G390
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ADVLHQADIMEDVAIAYGFNELPR.Y Y 66.04 2686.3062 24 -2.1 896.4408 3 90.63 4 54007 VEV_1_3_RA4_01_1235.d 0 1 1 352 375
R.TSLLPGLLK.T Y 62.43 940.5957 9 -19.8 471.2958 2 78.18 4 45616 VEV_1_3_RA4_01_1235.d 2.54E5 4 4 449 457
K.SGTIAQPLPVNK.L Y 32.28 1223.6874 12 -56.3 612.8165 2 58.91 4 30667 VEV_1_3_RA4_01_1235.d 0 1 1 381 392
K.TVEFQVVR.T Y 25.88 976.5342 8 -15.7 489.2667 2 62.71 5 33564 VEV_2_3_RA5_01_1236.d 1.24E5 1 1 441 448
R.ETPNLNPR.H Y 23.52 939.4774 8 -10.7 470.7409 2 33.62 4 14936 VEV_1_3_RA4_01_1235.d 2.9E5 2 2 293 300
total 5 peptides
C1GM91
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASTASSASSFQPVSR.Q Y 89.55 1481.7109 15 -11.0 741.8546 2 48.85 5 24460 VEV_2_3_RA5_01_1236.d 1.34E5 3 3 16 30
R.SLPHNSSVTR.R Y 26.89 1096.5625 10 -23.6 549.2756 2 19.31 6 7202 VEV_3_3_RA6_01_1237.d 1.68E4 1 1 556 565
K.YGNLLFLLQSEPR.H Y 26.31 1548.8300 13 -27.5 775.4009 2 85.84 6 48981 VEV_3_3_RA6_01_1237.d 4.48E3 1 1 146 158
K.DVRYLDSR.I Y 15.29 1022.5145 8 -17.5 512.2556 2 51.03 6 24894 VEV_3_3_RA6_01_1237.d 0 1 1 98 105
R.GPGQAYLK.Q Y 15.02 832.4443 8 -0.7 833.4509 1 93.76 5 53695 VEV_2_3_RA5_01_1236.d 0 1 1 235 242
total 5 peptides
C1GJK4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SKVDVSSTESQTKNEFPEQYR.T Y 95.02 2458.1611 21 -12.0 615.5402 4 60.31 5 31776 VEV_2_3_RA5_01_1236.d 2.14E5 3 3 7 27
R.TTSEAQGVIDNAEEDGYELHR.G Y 47.14 2333.0408 21 -11.0 778.6790 3 71.04 6 38638 VEV_3_3_RA6_01_1237.d 5.61E4 1 1 28 48
total 2 peptides
C1GIC8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NLNEPDDAANVLTEAFKVYR.K Y 63.89 2278.1228 20 -11.8 760.3726 3 83.73 6 47656 VEV_3_3_RA6_01_1237.d 2.76E4 1 1 70 89
R.VKNNIEEPGEDFS Y 53.71 1476.6732 13 -7.8 739.3381 2 60.67 4 31983 VEV_1_3_RA4_01_1235.d 2.4E5 3 3 280 292
K.NLNEPDDAANVLTEAFK.V Y 41.03 1859.8900 17 -11.8 930.9413 2 82.11 6 46613 VEV_3_3_RA6_01_1237.d 5.3E4 1 1 70 86
K.VADLAALKGDYYK.A Y 26.74 1425.7504 13 -16.4 476.2496 3 67.05 6 35667 VEV_3_3_RA6_01_1237.d 0 1 1 164 176
R.ELDNSFATTR.E Y 23.54 1152.5411 10 -16.1 577.2686 2 52.85 6 25962 VEV_3_3_RA6_01_1237.d 1.38E5 1 1 227 236
K.AGIC(+57.02)HLASKDLVATNR.A Y 16.30 1724.8992 16 -16.9 432.2248 4 57.38 5 29685 VEV_2_3_RA5_01_1236.d 1.04E5 1 1 205 220 Carbamidomethylation
total 6 peptides
C1GMV5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.VADTAYYDVLGVPTDATEIQIK.K Y 70.03 2381.2002 22 -7.1 1191.5989 2 84.69 4 50373 VEV_1_3_RA4_01_1235.d 1.19E5 3 3 2 23
M.VADTAYYDVLGVPTDATEIQIKK.A Y 52.98 2509.2952 23 -13.4 837.4278 3 80.50 4 47407 VEV_1_3_RA4_01_1235.d 2.13E5 3 3 2 24
R.TKAESTGEGTWTSEQNS Y 46.09 1811.7810 17 -5.6 906.8927 2 40.08 4 18748 VEV_1_3_RA4_01_1235.d 5.25E4 1 1 472 488
K.FLGISGFWSR.L Y 25.68 1168.6029 10 -15.3 585.2998 2 84.69 6 48264 VEV_3_3_RA6_01_1237.d 2.56E5 2 2 321 330
total 4 peptides
C1FYK2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SYWIPSFVK.D Y 55.12 1125.5858 9 -16.5 563.7909 2 80.99 4 47785 VEV_1_3_RA4_01_1235.d 7.16E4 1 1 429 437
M.A(+42.01)VDFPKEEEAVLKR.W Y 48.58 1671.8831 14 -17.4 558.2919 3 73.73 6 40619 VEV_3_3_RA6_01_1237.d 3.14E5 2 2 2 15 Acetylation (Protein N-term)
R.LVVDGQVTHSYPFC(+57.02)WR.S Y 42.75 1962.9410 16 5.5 655.3246 3 77.86 5 44621 VEV_2_3_RA5_01_1236.d 6.36E4 1 1 383 398 Carbamidomethylation
K.NYPDPTLIMDR.Y Y 33.79 1333.6337 11 -2.3 667.8226 2 75.40 4 43442 VEV_1_3_RA4_01_1235.d 1.93E4 1 1 605 615
R.FASWITNAR.D Y 22.56 1064.5403 9 -18.9 533.2673 2 69.43 6 37437 VEV_3_3_RA6_01_1237.d 1.61E5 1 1 441 449
R.SDTPLIYR.A Y 18.89 963.5025 8 6.8 322.1770 3 25.24 6 10325 VEV_3_3_RA6_01_1237.d 0 1 1 399 406
K.MVVDGIELVDGDLVIKR.G Y 18.30 1870.0233 17 -30.0 935.9908 2 82.24 5 47499 VEV_2_3_RA5_01_1236.d 0 1 1 930 946
R.AVPSWFVK.I Y 18.20 932.5120 8 -10.8 467.2582 2 72.50 4 41189 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 407 414
K.ALGMSGSEAVEK.L Y 16.56 1177.5648 12 -16.2 589.7802 2 63.65 6 33117 VEV_3_3_RA6_01_1237.d 5.05E4 1 1 93 104
K.EIGAFEK.Q Y 15.04 792.4017 7 -14.0 793.3979 1 91.27 5 52548 VEV_2_3_RA5_01_1236.d 7.96E4 1 1 18 24
total 10 peptides
C1G4F7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TNQPLAVLTGATAGATESFVVVPFELVK.I Y 95.54 2858.5430 28 -14.1 1430.2585 2 94.93 4 56255 VEV_1_3_RA4_01_1235.d 2.65E5 4 4 126 153
K.FAANDSWGSFYR.S Y 44.90 1419.6207 12 -4.8 710.8142 2 76.36 4 44193 VEV_1_3_RA4_01_1235.d 5.74E4 1 1 107 118
K.TNQPLAVLTGAT(-2.02)AGATESFVVVPFELVK.I Y 16.85 2856.5273 28 -20.5 953.1635 3 94.91 5 54183 VEV_2_3_RA5_01_1236.d 2.15E4 1 1 126 153 2-amino-3-oxo-butanoic_acid
total 3 peptides
C1FZK1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TIKLDDIFTGR.L Y 58.77 1277.6979 11 -18.1 426.8989 3 75.82 6 42144 VEV_3_3_RA6_01_1237.d 1.3E5 3 3 125 135
R.SNPEIKYEIPPLETIIC(+57.02)GR.N Y 54.12 2228.1511 19 -17.0 743.7117 3 83.00 5 47953 VEV_2_3_RA5_01_1236.d 1.09E5 1 1 219 237 Carbamidomethylation
R.YIANALTELSESK.L Y 50.51 1437.7351 13 -8.5 719.8687 2 74.92 5 42536 VEV_2_3_RA5_01_1236.d 1.59E5 2 2 202 214
K.SDDIFTEIHLGGNSYSPDTC(+57.02)R.K Y 43.64 2383.0386 21 -2.6 795.3514 3 79.29 4 46472 VEV_1_3_RA4_01_1235.d 4.25E4 1 1 91 111 Carbamidomethylation
R.GVGALLHVAR.K Y 20.69 991.5927 10 -17.8 331.5323 3 63.14 4 33864 VEV_1_3_RA4_01_1235.d 4.18E4 2 2 360 369
total 5 peptides
C1G6F7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYSYPFTPTAVPR.L Y 71.94 1484.7300 13 -10.0 743.3648 2 74.32 4 42603 VEV_1_3_RA4_01_1235.d 5.05E4 3 3 550 562
R.VGPASSSVVGAGGGGGGGGTR.A Y 51.08 1642.8022 21 -15.0 822.3961 2 44.52 4 21462 VEV_1_3_RA4_01_1235.d 6.61E4 2 2 697 717
K.APPNARNRTVSGPAELSSK.M Y 28.61 1951.0234 19 -5.4 391.2098 5 53.71 5 27413 VEV_2_3_RA5_01_1236.d 0 1 1 506 524
R.GTVAGSPEGPAK.G Y 18.23 1069.5403 12 -12.5 535.7708 2 42.70 6 20068 VEV_3_3_RA6_01_1237.d 4.07E4 1 1 7 18
R.RGTVAGSPEGPAKGQK.R Y 16.89 1538.8164 16 -14.9 385.7056 4 59.10 4 30804 VEV_1_3_RA4_01_1235.d 0 1 1 6 21
K.VEGTGVSTPTLR.S Y 16.09 1215.6459 12 -22.5 406.2134 3 24.84 6 10111 VEV_3_3_RA6_01_1237.d 0 1 1 485 496
total 6 peptides
A0A0A0HYM8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AIETLNNSQLTR.I Y 80.96 1358.7153 12 -12.7 680.3563 2 60.29 4 31737 VEV_1_3_RA4_01_1235.d 1.58E5 3 3 227 238
R.ITAVIPNFPYAR.Q Y 44.30 1360.7502 12 -13.8 681.3730 2 79.42 4 46567 VEV_1_3_RA4_01_1235.d 6.22E4 2 2 56 67
R.RITAVIPNFPYAR.Q Y 30.97 1516.8513 13 -25.0 506.6117 3 75.95 5 43277 VEV_2_3_RA5_01_1236.d 2.2E4 1 1 55 67
R.ATAIADRLDLQFALIHKER.A Y 16.56 2180.2065 19 -11.2 437.0437 5 75.16 5 42710 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 148 166
total 4 peptides
C1G6M3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)NVQQLLDFSLNEK.K Y 63.37 1657.8312 14 -4.1 829.9194 2 90.15 4 53747 VEV_1_3_RA4_01_1235.d 1.29E5 2 2 11 24 Pyro-glu from Q
R.NFLETVELQIGLK.N Y 61.74 1502.8344 13 -15.9 752.4125 2 88.35 6 50432 VEV_3_3_RA6_01_1237.d 8.94E4 1 1 27 39
R.KYDAFIASDSIIK.M Y 52.99 1469.7765 13 -10.9 735.8875 2 71.98 4 40774 VEV_1_3_RA4_01_1235.d 2.21E4 1 1 106 118
R.QNVQQLLDFSLNEK.K Y 31.03 1674.8577 14 -7.2 838.4301 2 81.80 4 48394 VEV_1_3_RA4_01_1235.d 3.38E4 1 1 11 24
R.LLGPGLSK.A Y 21.42 783.4854 8 -12.1 392.7452 2 53.28 4 26968 VEV_1_3_RA4_01_1235.d 2.74E5 1 1 123 130
total 5 peptides
C1G9X5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TC(+57.02)WATYLATATGLAPEITYFQLDSPSR.M Y 63.63 3032.4590 27 -13.3 1011.8135 3 94.41 4 56017 VEV_1_3_RA4_01_1235.d 1.84E5 2 2 474 500 Carbamidomethylation
K.MDHLVC(+57.02)FMPGTIALGATGGIPISQAR.K Y 62.23 2712.3550 26 2.6 905.1279 3 85.51 4 50920 VEV_1_3_RA4_01_1235.d 1.78E4 1 1 427 452 Carbamidomethylation
R.MVFNTEAHVFPR.F Y 54.53 1446.7078 12 -18.5 483.2343 3 70.33 4 39516 VEV_1_3_RA4_01_1235.d 2.27E4 2 2 665 676
R.SFTSLENVDVIPAVK.R Y 16.10 1617.8613 15 -8.7 809.9309 2 81.00 4 47795 VEV_1_3_RA4_01_1235.d 1.16E4 1 1 620 634
total 4 peptides
C1GBM3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALLQTYNTAPPADSLASAR.K Y 82.89 1959.0061 19 -6.9 980.5036 2 74.22 4 42523 VEV_1_3_RA4_01_1235.d 9.59E4 3 3 150 168
R.STILAEHSSPGTSSTSASSLASIILPK.I Y 67.85 2641.3811 27 -19.6 881.4504 3 80.34 6 45398 VEV_3_3_RA6_01_1237.d 3.17E4 1 1 30 56
total 2 peptides
C1GJI4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NTGEITELAGC(+57.02)DYLTISPNLLEELYNSTAHIPK.K Y 60.74 3675.7979 33 -5.7 1226.2662 3 92.83 4 55209 VEV_1_3_RA4_01_1235.d 1.07E5 3 3 230 262 Carbamidomethylation
K.LIDSAIEYGK.I Y 48.73 1107.5812 10 -17.2 554.7883 2 63.49 6 32994 VEV_3_3_RA6_01_1237.d 1.45E5 1 1 52 61
K.DFTPEEDPGVK.S Y 44.53 1232.5560 11 -11.9 617.2780 2 58.89 6 29638 VEV_3_3_RA6_01_1237.d 3.72E5 4 4 195 205
K.LIDSAIEYGKIQGK.T Y 25.58 1533.8402 14 -45.1 512.2643 3 65.23 6 34297 VEV_3_3_RA6_01_1237.d 0 1 1 52 65
K.ALHIIELYK.S Y 25.46 1098.6437 9 -12.1 367.2174 3 70.41 5 39295 VEV_2_3_RA5_01_1236.d 1.1E5 2 2 113 121
K.AATLDIPKR.S Y 18.25 983.5764 9 -14.4 328.8613 3 41.63 6 19429 VEV_3_3_RA6_01_1237.d 8.83E4 1 1 269 277
K.KDFTPEEDPGVK.S Y 16.03 1360.6510 12 -29.7 681.3126 2 42.96 6 20221 VEV_3_3_RA6_01_1237.d 6.13E4 1 1 194 205
total 7 peptides
C1GA71
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KLYDPVAENTGQ Y 71.90 1333.6514 12 -12.5 667.8246 2 60.56 6 30885 VEV_3_3_RA6_01_1237.d 2.08E5 2 2 460 471
K.LVSQSQMGGSDLR.V Y 61.85 1376.6718 13 -10.3 689.3361 2 52.46 6 25742 VEV_3_3_RA6_01_1237.d 1.11E5 2 2 118 130
K.LVSQSQM(+15.99)GGSDLR.V Y 44.67 1392.6667 13 -20.8 697.3262 2 34.66 4 15554 VEV_1_3_RA4_01_1235.d 3.68E4 1 1 118 130 Oxidation (M)
R.SVSTTTDPPSLPPLR.V Y 41.21 1566.8253 15 -31.6 784.3951 2 70.79 4 39837 VEV_1_3_RA4_01_1235.d 9E4 2 2 213 227
total 4 peptides
C1GIB2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.WLERPVSVSFGFGGR.V Y 61.54 1692.8735 15 -14.5 565.2903 3 78.87 4 46147 VEV_1_3_RA4_01_1235.d 2.24E5 3 3 377 391
R.SHIPANAQPIFEILSADMQR.V Y 47.46 2237.1262 20 -39.3 746.6867 3 84.79 6 48329 VEV_3_3_RA6_01_1237.d 2.09E5 2 2 1166 1185
K.SIQEASDDTSFSIHVR.A Y 44.90 1790.8435 16 -3.9 597.9528 3 66.89 4 36762 VEV_1_3_RA4_01_1235.d 2.17E4 1 1 714 729
R.TNDPFQIYTGSESEADRGITR.A Y 38.87 2356.0930 21 -12.6 786.3618 3 73.40 6 40379 VEV_3_3_RA6_01_1237.d 9.43E4 2 2 547 567
R.TSMAAPPPPKGPAPPQR.M Y 25.35 1698.8875 17 -51.3 567.2740 3 51.42 6 25123 VEV_3_3_RA6_01_1237.d 2.11E5 1 1 988 1004
total 5 peptides
C1GF61
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VVDIVSGALNNAASR.K Y 69.16 1484.7947 15 -10.0 743.3972 2 72.92 4 41517 VEV_1_3_RA4_01_1235.d 5.12E4 2 2 335 349
R.GAPVEAVDEVVALFK.I Y 66.01 1542.8293 15 -15.3 772.4102 2 89.66 4 53471 VEV_1_3_RA4_01_1235.d 8.02E4 1 1 31 45
K.NSEEFYQSLGLPYRVVDIVSGALNNAASR.K Y 24.97 3168.5840 29 28.9 1057.2324 3 93.27 4 55438 VEV_1_3_RA4_01_1235.d 0 1 1 321 349
R.KNDLEAWFPSQGTYK.E Y 17.54 1782.8577 15 -39.4 595.2698 3 65.33 6 34376 VEV_3_3_RA6_01_1237.d 0 1 1 350 364
total 4 peptides
C1FYR9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TVNVDSLDPESSVNFPLETLLPGNLPAPTTSSEAASVGSQIR.Q Y 97.50 4309.1602 42 -5.2 1078.2917 4 91.86 5 52822 VEV_2_3_RA5_01_1236.d 5.55E5 5 5 8 49
K.KLSLSPQSTGFSQIQAR.N Y 24.14 1846.9901 17 -83.3 616.6194 3 68.79 6 36976 VEV_3_3_RA6_01_1237.d 0 1 1 137 153
R.SGDSENALR.H Y 15.17 947.4308 9 -14.1 474.7160 2 16.51 6 5727 VEV_3_3_RA6_01_1237.d 9.73E4 1 1 54 62
total 3 peptides
C1GGA8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HVIAAVAGIDSLVGR.E Y 70.44 1476.8412 15 -16.4 493.2796 3 77.46 5 44344 VEV_2_3_RA5_01_1236.d 4.55E4 1 1 288 302
K.LLARPEEGINTVYDIVR.R Y 63.90 1957.0632 17 -11.8 653.3540 3 78.96 4 46213 VEV_1_3_RA4_01_1235.d 5.25E4 1 1 49 65
K.LLGDAQSITVVIYNNTR.L Y 21.69 1876.0054 17 -18.2 626.3310 3 82.56 4 48918 VEV_1_3_RA4_01_1235.d 0 1 1 206 222
R.ELLDVHVETR.K Y 16.64 1209.6354 10 -6.2 404.2166 3 63.76 4 34333 VEV_1_3_RA4_01_1235.d 3.25E4 1 1 81 90
total 4 peptides
C1G6V8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LFADSNTIAITSFISPYRK.D Y 72.37 2143.1313 19 -9.9 715.3773 3 83.58 4 49618 VEV_1_3_RA4_01_1235.d 2E5 2 2 93 111
K.GLTIWLTGLSASGK.S Y 40.85 1402.7820 14 -17.8 702.3858 2 83.84 6 47722 VEV_3_3_RA6_01_1237.d 0 1 1 25 38
K.EFTGISAPYEAPK.K Y 30.79 1408.6874 13 -11.4 705.3430 2 69.61 4 38913 VEV_1_3_RA4_01_1235.d 6.68E4 2 2 166 178
R.EGAVKEFTGISAPYEAPK.K Y 24.43 1892.9519 18 -12.4 631.9834 3 69.84 6 37729 VEV_3_3_RA6_01_1237.d 1.44E4 1 1 161 178
K.DLGFSETDRNENIR.R Y 20.26 1664.7754 14 0.2 555.9325 3 61.98 4 32977 VEV_1_3_RA4_01_1235.d 2.31E5 2 2 72 85
total 5 peptides
C1FZH6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSVLENIVGRDFLPR.G N 82.21 1700.9209 15 -8.5 567.9761 3 82.25 5 47506 VEV_2_3_RA5_01_1236.d 7.19E5 5 5 44 58
K.SSVLENIVGR.D N 37.60 1072.5876 10 -20.6 537.2900 2 71.76 6 39176 VEV_3_3_RA6_01_1237.d 5.11E4 1 1 44 53
R.TIGILTK.L Y 34.72 744.4745 7 -22.4 373.2362 2 67.32 6 35871 VEV_3_3_RA6_01_1237.d 5.91E5 2 2 216 222
K.SSVLENIVGRDFLPR(+.98).G N 17.36 1701.9049 15 -8.1 568.3043 3 84.27 4 50104 VEV_1_3_RA4_01_1235.d 0 1 1 44 58 Deamidation (R)
total 4 peptides
C1G054
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALVYGNYGEPKDVLSLHSYSISAPHNTQVNVR.L Y 87.53 3527.7798 32 -9.4 706.5566 5 76.57 4 44361 VEV_1_3_RA4_01_1235.d 6.97E4 1 1 53 84
R.THAQFDESSLLK.I Y 35.34 1374.6779 12 1.0 459.2337 3 63.02 4 33776 VEV_1_3_RA4_01_1235.d 0 1 1 157 168
K.IDDRTNLTPLQVGT(-2.02)VGVNPVTAYR.M Y 20.83 2596.3608 24 -30.8 866.4342 3 79.73 4 46827 VEV_1_3_RA4_01_1235.d 0 1 1 169 192 2-amino-3-oxo-butanoic_acid
total 3 peptides
C1G1D6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DKVVSTEAAPSTITKEPSSEASPQK.S Y 86.65 2586.3025 25 -0.7 647.5825 4 56.39 4 28883 VEV_1_3_RA4_01_1235.d 1.09E5 2 2 205 229
R.ITDGNVSQWGEVK.K Y 50.82 1431.6993 13 -14.9 716.8463 2 64.97 4 35253 VEV_1_3_RA4_01_1235.d 1.73E5 2 2 97 109
total 2 peptides
C1GJH8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KNPNDPPKPVATGPK.R Y 78.11 1558.8467 15 -9.1 520.6181 3 22.23 4 8584 VEV_1_3_RA4_01_1235.d 5.65E4 3 3 45 59
R.LSTDASAPPAKR.G Y 46.52 1212.6462 12 -25.6 607.3149 2 22.50 5 9069 VEV_2_3_RA5_01_1236.d 1.65E5 3 3 79 90
R.AAPVRGEDDAAK.S Y 31.68 1198.5941 12 -12.0 600.2971 2 13.16 6 4006 VEV_3_3_RA6_01_1237.d 2.98E4 2 2 191 202
total 3 peptides
C1G3F2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IHFPLVAYAPVVSAAK.A N 97.01 1681.9554 16 -10.5 561.6532 3 80.25 5 46214 VEV_2_3_RA5_01_1236.d 9.62E4 1 1 35 50
M(+15.99)DVVVSSITASLR.F Y 19.08 1392.7283 13 -26.9 349.1800 4 32.52 5 14726 VEV_2_3_RA5_01_1236.d 1.17E5 3 3 1 13 Oxidation (M)
R.IHFPLVAYAPVVSAAK(-.98).A N 18.52 1680.9714 16 -71.1 561.2913 3 80.46 4 47372 VEV_1_3_RA4_01_1235.d 6.64E4 1 1 35 50 Amidation
R.M(+15.99)RLQFTVYR.L Y 15.79 1228.6387 9 -16.4 615.3165 2 62.84 4 33634 VEV_1_3_RA4_01_1235.d 0 1 1 96 104 Oxidation (M)
total 4 peptides
C1GHR9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASSTC(+57.02)VLNFDDVEIPKENLIGVEGQGYK.Y Y 56.89 3081.4963 28 -3.0 1028.1697 3 82.77 4 49069 VEV_1_3_RA4_01_1235.d 7.5E4 1 1 261 288 Carbamidomethylation
K.YAINLLNEGR.I Y 51.19 1161.6141 10 -4.9 581.8115 2 72.71 4 41353 VEV_1_3_RA4_01_1235.d 1.26E5 1 1 289 298
K.LYASQVAGR.V Y 41.72 963.5137 9 -18.9 482.7550 2 37.40 6 16993 VEV_3_3_RA6_01_1237.d 2.05E5 2 2 377 385
R.VDPSVSVLC(+57.02)DVHNTLVNTAILR.F Y 35.62 2421.2686 22 -38.9 808.0654 3 86.18 4 51355 VEV_1_3_RA4_01_1235.d 1.04E5 2 2 135 156 Carbamidomethylation
R.ALVFNAAR.K Y 32.41 860.4868 8 -23.0 431.2408 2 57.92 5 30060 VEV_2_3_RA5_01_1236.d 2.73E5 3 3 353 360
total 5 peptides
C1G6S5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IPAPEAAHTNQNAYEIPGDKETGGR.S Y 81.58 2635.2627 25 -13.9 659.8138 4 60.86 6 31067 VEV_3_3_RA6_01_1237.d 8.64E4 1 1 606 630
K.NLETGEQVAVK.I Y 25.59 1186.6194 11 -19.1 594.3057 2 46.88 5 23276 VEV_2_3_RA5_01_1236.d 1.26E5 2 2 209 219
K.SRQQQSDHVATQDSKPTTR.T Y 25.17 2169.0522 19 4.3 434.8196 5 13.77 5 4375 VEV_2_3_RA5_01_1236.d 0 1 1 815 833
K.VLESEDYQNIVR.L Y 22.71 1463.7256 12 -15.3 732.8589 2 67.86 6 36277 VEV_3_3_RA6_01_1237.d 2.44E4 1 1 501 512
K.TIGAGSMGK.V Y 16.64 820.4113 9 3.0 821.4210 1 98.33 4 57652 VEV_1_3_RA4_01_1235.d 0 1 1 195 203
total 5 peptides
C1G2P3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALNALC(+57.02)SPLFR.E Y 64.91 1260.6648 11 -18.3 631.3281 2 78.42 6 44028 VEV_3_3_RA6_01_1237.d 5.99E5 3 3 57 67 Carbamidomethylation
K.VIDGGKDELVAAAVETASTIASYSR.V Y 55.89 2522.2864 25 -10.6 841.7605 3 88.88 5 51316 VEV_2_3_RA5_01_1236.d 2.54E4 1 1 213 237
K.LGVGLITLNRPK.A Y 34.65 1279.7976 12 -22.0 427.5971 3 71.16 6 38784 VEV_3_3_RA6_01_1237.d 6.76E4 1 1 45 56
K.LGT(+79.97)IPGAGGSQR(-.98).L Y 28.20 1191.5760 12 -4.6 398.1974 3 37.61 6 17121 VEV_3_3_RA6_01_1237.d 3.15E5 1 1 168 179 Phosphorylation (STY); Amidation
K.LGTIPGAGGSQR.L Y 20.58 1112.5938 12 -27.9 371.8615 3 19.86 6 7480 VEV_3_3_RA6_01_1237.d 1.47E5 2 2 168 179
total 5 peptides
C1GH26
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ADSASPTC(+57.02)DSPTC(+57.02)R.S Y 63.14 1523.5980 14 -4.7 762.8027 2 27.33 4 11377 VEV_1_3_RA4_01_1235.d 8.55E4 2 2 151 164 Carbamidomethylation
R.SVHGSLGSLDGHSETTSAGTATR.G Y 42.43 2227.0464 23 -9.8 557.7634 4 48.89 5 24479 VEV_2_3_RA5_01_1236.d 0 1 1 88 110
K.SPLYVPAVLRPTER.T Y 40.85 1596.8987 14 -9.5 533.3018 3 73.79 5 41733 VEV_2_3_RA5_01_1236.d 5.82E4 1 1 63 76
R.GSTHESESLKTSVSK.R Y 38.34 1575.7740 15 1.8 526.2662 3 19.66 5 7553 VEV_2_3_RA5_01_1236.d 3.94E4 1 1 111 125
R.TSKPSPLTPPR.S Y 19.31 1179.6611 11 -23.4 394.2184 3 40.98 6 19052 VEV_3_3_RA6_01_1237.d 0 1 1 77 87
total 5 peptides
C1GIJ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GLQPFQPAPNTIVTPGKPHPSTER.A Y 71.17 2568.3447 24 -8.5 643.0880 4 67.22 4 37012 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 258 281
R.STVGDKQSSRPSIASIGLGTAAAR.A Y 45.06 2329.2349 24 -22.3 583.3030 4 64.56 6 33782 VEV_3_3_RA6_01_1237.d 0 1 1 579 602
K.SLPEFFNSR.N Y 33.96 1095.5349 9 -6.4 548.7712 2 73.76 4 42170 VEV_1_3_RA4_01_1235.d 1.58E5 2 2 163 171
R.ITADTPR.G Y 23.95 772.4079 7 -18.4 387.2041 2 19.74 6 7420 VEV_3_3_RA6_01_1237.d 7.81E4 1 1 251 257
total 4 peptides
C1G4T3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DTDKPFLMSIEEVFSISGR.G Y 68.22 2170.0615 19 -3.3 724.3587 3 91.92 4 54732 VEV_1_3_RA4_01_1235.d 1.54E5 1 1 248 266
K.SHRPVAAEAGQR.F Y 50.36 1277.6588 12 -15.3 426.8870 3 13.59 6 4226 VEV_3_3_RA6_01_1237.d 1.13E5 3 3 409 420
R.GITISTSHIEYSTDKR.H Y 23.73 1806.9111 16 -12.1 603.3037 3 59.90 6 30377 VEV_3_3_RA6_01_1237.d 1.97E5 2 2 100 115
K.GLANFLEYGAIDKAPEER.K Y 20.94 1991.9951 18 -11.3 664.9982 3 79.40 5 45660 VEV_2_3_RA5_01_1236.d 0 1 1 80 97
K.TTLTAAITKR.Q Y 20.92 1074.6396 10 -15.0 538.3190 2 44.32 6 21010 VEV_3_3_RA6_01_1237.d 4.39E4 1 1 66 75
total 5 peptides
C1G240
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSGSGPTSPGFEER.F Y 82.94 1405.6473 14 -8.4 703.8251 2 47.73 4 23519 VEV_1_3_RA4_01_1235.d 1.74E5 2 2 312 325
R.DGDDLTTVIEIPLKEALTGWSR.T Y 27.12 2428.2485 22 -3.8 810.4204 3 94.59 4 56099 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 279 300
K.ILEFDVKPGLK.A Y 25.18 1257.7332 11 -39.4 420.2351 3 71.28 4 40226 VEV_1_3_RA4_01_1235.d 0 1 1 233 243
R.VSGSGPTSPGFEERFPSLGMPK.S Y 19.84 2263.0942 22 -4.8 755.3684 3 76.54 4 44339 VEV_1_3_RA4_01_1235.d 1.16E5 1 1 312 333
total 4 peptides
C1G6G2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TC(+57.02)TEATNSC(+57.02)SGHGSC(+57.02)YR.K Y 76.02 1946.7306 17 -4.3 649.9147 3 19.89 4 7340 VEV_1_3_RA4_01_1235.d 9.64E4 3 3 302 318 Carbamidomethylation
R.TC(+57.02)TEATNSC(+57.02)SGHGSC(+57.02)YRK.F Y 52.03 2074.8254 18 -7.9 519.7095 4 14.47 5 4745 VEV_2_3_RA5_01_1236.d 1.19E5 4 4 302 319 Carbamidomethylation
K.TVQWGGPAC(+57.02)QK.K Y 23.25 1230.5815 11 41.5 616.3236 2 47.73 6 23012 VEV_3_3_RA6_01_1237.d 5.79E4 1 1 350 360 Carbamidomethylation
total 3 peptides
C1GJD9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAGQTLGTASPLLVPILR.A Y 78.42 1777.0461 18 -37.2 889.4973 2 84.54 6 48181 VEV_3_3_RA6_01_1237.d 0 2 2 184 201
R.APATAYSYDTK.E Y 46.70 1186.5505 11 10.2 594.2886 2 38.74 6 17780 VEV_3_3_RA6_01_1237.d 0 3 3 202 212
K.AAGQ(+.98)TLGTASPLLVPILR.A Y 23.56 1778.0302 18 4.7 890.0266 2 84.65 4 50354 VEV_1_3_RA4_01_1235.d 2.81E3 1 1 184 201 Deamidation (NQ)
K.SFFSGEGVVAFPK.A Y 23.25 1370.6870 13 -21.8 686.3358 2 80.50 6 45512 VEV_3_3_RA6_01_1237.d 4E4 1 1 171 183
total 4 peptides
C1GJ85
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DAAFSEIFGGNPSGR.S Y 66.75 1523.7004 15 -7.6 762.8517 2 79.53 5 45743 VEV_2_3_RA5_01_1236.d 9.27E4 3 3 26 40
K.DLEYLR.D N 35.15 807.4127 6 -9.7 404.7097 2 58.88 4 30642 VEV_1_3_RA4_01_1235.d 4.62E5 4 4 545 550
R.NYRPNPYGHSSSFQR.D Y 27.27 1808.8342 15 20.5 453.2251 4 42.24 6 19799 VEV_3_3_RA6_01_1237.d 0 1 1 11 25
R.GRRPSEASQNSR.T Y 26.85 1343.6654 12 -12.6 448.8901 3 9.37 6 2264 VEV_3_3_RA6_01_1237.d 8.36E3 1 1 288 299
R.IVPERHDNER.S Y 18.18 1263.6320 10 -7.7 632.8184 2 13.19 5 4070 VEV_2_3_RA5_01_1236.d 1.86E4 1 1 213 222
R.ERISVGER.L Y 17.68 944.5039 8 -19.7 315.8357 3 21.82 6 8510 VEV_3_3_RA6_01_1237.d 1.05E5 1 1 360 367
R.AQSM(+15.99)SSHNAEPFMHPR.A Y 16.43 1841.7937 16 25.0 614.9539 3 50.88 4 25430 VEV_1_3_RA4_01_1235.d 3.65E5 1 1 56 71 Oxidation (M)
total 7 peptides
C1FZ53
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TVEAEPASPTATTGDSK.A Y 69.91 1660.7792 17 -8.5 831.3898 2 40.12 4 18769 VEV_1_3_RA4_01_1235.d 1.52E5 3 3 336 352
R.GYAIR.E Y 25.84 578.3176 5 -12.1 579.3179 1 40.54 5 19434 VEV_2_3_RA5_01_1236.d 5.94E4 1 1 66 70
R.GNQAR.G N 22.38 544.2717 5 7.8 545.2833 1 45.60 5 22489 VEV_2_3_RA5_01_1236.d 0 1 1 570 574
R.REFHERPAPER.T Y 20.66 1422.7115 11 -27.8 475.2313 3 41.16 5 19818 VEV_2_3_RA5_01_1236.d 1.56E5 1 1 275 285
R.VSVAEPPKER.Q Y 19.15 1110.6033 10 -5.5 371.2063 3 9.70 4 2359 VEV_1_3_RA4_01_1235.d 0 1 1 152 161
R.GFVQGHAKAQQNR.G Y 18.34 1439.7382 13 23.7 480.9314 3 71.42 4 40341 VEV_1_3_RA4_01_1235.d 0 1 1 521 533
K.GGSAVTTANGAK.E Y 17.63 1032.5200 12 -30.2 517.2517 2 51.85 5 26351 VEV_2_3_RA5_01_1236.d 2.86E5 2 2 415 426
R.NGPAR.T Y 16.79 513.2659 5 -36.4 514.2545 1 25.02 6 10210 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 504 508
R.VSVAEPPK.E Y 16.01 825.4596 8 -63.7 826.4143 1 83.02 6 47201 VEV_3_3_RA6_01_1237.d 3.07E4 1 1 152 159
total 9 peptides
C1GEE9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSDTRPVASLPAGVR.T Y 58.42 1511.8055 15 -1.4 504.9417 3 57.73 4 29813 VEV_1_3_RA4_01_1235.d 5.18E4 1 1 302 316
K.SGNSGSDVQALPIGR.S Y 54.74 1456.7269 15 -10.2 729.3633 2 62.31 6 32130 VEV_3_3_RA6_01_1237.d 1.1E5 3 3 774 788
R.SNSPSYTPSPTSPKER.S Y 36.06 1733.8220 16 0.7 578.9484 3 36.27 4 16495 VEV_1_3_RA4_01_1235.d 9.1E4 2 2 874 889
R.SYHLVFPQQES Y 31.30 1333.6302 11 -10.9 667.8151 2 70.50 6 38231 VEV_3_3_RA6_01_1237.d 0 1 1 1188 1198
R.SNS(-2.02)PSYTPSPTSPKER.S Y 15.66 1731.8064 16 9.8 578.2817 3 36.17 5 16877 VEV_2_3_RA5_01_1236.d 0 1 1 874 889 2-amino-3-oxo-butanoic_acid
R.LSNSSSIGSGR.A Y 15.09 1063.5258 11 33.1 355.5276 3 13.97 6 4418 VEV_3_3_RA6_01_1237.d 7.8E4 1 1 972 982
total 6 peptides
C1FZ84
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSGQPKTETEQASVTGAER.S Y 77.29 1961.9290 19 -11.0 654.9764 3 31.07 5 13881 VEV_2_3_RA5_01_1236.d 1.05E5 2 2 219 237
K.TETEQASVTGAER.S Y 62.16 1377.6372 13 -9.2 689.8195 2 29.31 4 12470 VEV_1_3_RA4_01_1235.d 7.15E4 2 2 225 237
total 2 peptides
C1GB68
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LTDIPDQDLSELLPVAK.K Y 93.10 1865.9985 17 -0.1 934.0064 2 85.28 4 50778 VEV_1_3_RA4_01_1235.d 1.36E5 3 3 54 70
R.VLAFLDIQPLSK.G Y 29.46 1342.7860 12 -42.6 672.3717 2 84.73 4 50405 VEV_1_3_RA4_01_1235.d 0 1 1 29 40
total 2 peptides
C1G1H9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LATPPSAEVVDFVLIPR.S Y 59.23 1823.0192 17 -6.3 912.5111 2 87.11 5 50367 VEV_2_3_RA5_01_1236.d 4.74E4 2 2 417 433
R.FENRDIVQTAHADGIIR.M Y 56.16 1954.0021 17 31.3 489.5231 4 66.66 5 36514 VEV_2_3_RA5_01_1236.d 0 1 1 524 540
R.G(+27.99)NIAT(+79.97)FKILPSAETYTASFAGSR.N Y 40.61 2509.1890 23 -3.7 837.4005 3 73.92 6 40756 VEV_3_3_RA6_01_1237.d 1.04E5 1 1 737 759 Formylation; Phosphorylation (STY)
K.SLIPSQSMAHFLR.G Y 26.41 1485.7762 13 -6.4 496.2628 3 41.81 5 20205 VEV_2_3_RA5_01_1236.d 2.26E5 1 1 47 59
total 4 peptides
C1GIL9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AHIAELVAEALGVDSQTVYPR.L Y 79.59 2238.1643 21 -7.7 747.0563 3 87.49 6 49952 VEV_3_3_RA6_01_1237.d 1.45E5 2 2 114 134
K.TLEPTTILTYLFR.M Y 32.32 1566.8657 13 -18.8 784.4254 2 92.75 6 52650 VEV_3_3_RA6_01_1237.d 3.45E4 2 2 658 670
R.AHIAELVAEALGVDSQ(+.98)TVYPR.L Y 25.77 2239.1484 21 -11.1 747.3818 3 87.56 4 52230 VEV_1_3_RA4_01_1235.d 4.13E4 1 1 114 134 Deamidation (NQ)
R.AHIAELVAEALGVDS(-2.02)QTVYPR.L Y 21.27 2236.1487 21 -15.1 746.3789 3 87.48 4 52184 VEV_1_3_RA4_01_1235.d 0 1 1 114 134 2-amino-3-oxo-butanoic_acid
R.LNIGFDC(+57.02)YSGESQVKPESLAK.A Y 20.44 2341.1260 21 -12.4 781.3729 3 74.89 6 41463 VEV_3_3_RA6_01_1237.d 8.02E4 1 1 397 417 Carbamidomethylation
K.YGNEEELVKDPINHLFDVYVK.I Y 19.27 2520.2537 21 -5.6 631.0671 4 82.55 6 46899 VEV_3_3_RA6_01_1237.d 5.67E4 1 1 293 313
total 6 peptides
C1GG29
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGGVTGQAEAMTVALGK.A Y 71.30 1545.7821 17 -7.0 773.8929 2 72.26 4 41002 VEV_1_3_RA4_01_1235.d 3.29E5 2 2 267 283
R.ILPTSPAYFTGTPK.F Y 46.19 1491.7972 14 -14.5 746.8951 2 74.62 4 42837 VEV_1_3_RA4_01_1235.d 2.11E4 1 1 90 103
K.ALLVHEPAIKPILR.R Y 27.54 1568.9766 14 -16.4 393.2450 4 70.52 4 39619 VEV_1_3_RA4_01_1235.d 1.75E4 1 1 284 297
K.FIDDVLK.L Y 15.06 848.4644 7 -37.3 425.2236 2 29.88 4 12777 VEV_1_3_RA4_01_1235.d 2.4E5 1 1 104 110
total 4 peptides
C1G4I1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AIGVQGSHDQSGAGEEVSGRPR.A Y 73.28 2193.0522 22 -8.4 549.2657 4 39.43 4 18406 VEV_1_3_RA4_01_1235.d 1.54E5 3 3 393 414
R.AGELTPQEFGDASSPAAGTGQQR.G Y 48.49 2274.0513 23 -3.1 759.0220 3 67.99 5 37527 VEV_2_3_RA5_01_1236.d 1.13E5 3 3 415 437
R.SEIGQLTLDHVLKER.A Y 28.72 1736.9420 15 -6.9 435.2398 4 72.53 4 41216 VEV_1_3_RA4_01_1235.d 6.91E4 1 1 196 210
total 3 peptides
C1GKI5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALLASSDGTDDDTPR.F Y 77.23 1532.6954 15 -6.1 767.3503 2 57.10 4 29375 VEV_1_3_RA4_01_1235.d 1.55E5 2 2 55 69
K.DSVKLPVFDLLLLGC(+57.02)GPDGHTC(+57.02)SLFPGHELLR.E Y 36.55 3561.8110 32 -5.9 713.3653 5 90.70 5 52244 VEV_2_3_RA5_01_1236.d 6.88E4 1 1 144 175 Carbamidomethylation
R.SLPC(+57.02)ALVNAGGAEK.V Y 34.12 1385.6973 14 2.4 693.8575 2 66.11 5 36110 VEV_2_3_RA5_01_1236.d 2.31E4 2 2 232 245 Carbamidomethylation
total 3 peptides
C1GE23
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KAAEEQGETGTPAAR.F Y 69.43 1514.7324 15 -1.3 505.9174 3 16.06 4 5345 VEV_1_3_RA4_01_1235.d 3.34E4 1 1 153 167
R.SDLEGMDTVTALR.S Y 43.86 1406.6711 13 18.1 704.3556 2 73.54 4 42009 VEV_1_3_RA4_01_1235.d 0 2 2 187 199
K.AAEEQGETGTPAAR.F Y 27.33 1386.6375 14 -6.1 694.3218 2 21.10 6 8146 VEV_3_3_RA6_01_1237.d 0 1 1 154 167
R.IAAFGSGFVR.D Y 23.47 1023.5501 10 -63.3 512.7499 2 70.65 6 38337 VEV_3_3_RA6_01_1237.d 0 1 1 124 133
total 4 peptides
C1GHL1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)ITPQMALNIFR.N Y 53.88 1413.7439 12 -5.8 707.8751 2 92.20 4 54882 VEV_1_3_RA4_01_1235.d 2.7E5 3 3 215 226 Pyro-glu from Q
R.TVITGDPNLSLDEVGVPISIAQTLTYPEVVTPFNIAK.L Y 46.36 3911.0818 37 -5.6 1304.6938 3 96.57 5 54856 VEV_2_3_RA5_01_1236.d 2.83E5 3 3 368 404
K.LGELVDNGPDIHPGAR.Y Y 44.85 1658.8375 16 -8.4 553.9485 3 64.86 6 34008 VEV_3_3_RA6_01_1237.d 1.37E5 1 1 405 420
K.GGGGR.N N 27.39 402.1975 5 -0.6 403.2046 1 14.26 4 4423 VEV_1_3_RA4_01_1235.d 0 1 1 437 441
K.NVTLGVPR.L Y 23.15 854.4974 8 -5.5 428.2536 2 22.41 4 8678 VEV_1_3_RA4_01_1235.d 7.68E4 2 2 1116 1123
R.LVVVR.G N 16.35 584.4009 5 -11.1 585.4017 1 29.57 4 12610 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 1020 1024
total 6 peptides
C1GA79
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ATDTANEALPASQLTSR.S Y 63.10 1744.8591 17 -7.6 873.4302 2 64.22 5 34692 VEV_2_3_RA5_01_1236.d 2.06E5 3 3 263 279
K.ATATATNPPTSR.G Y 54.08 1186.5942 12 -7.5 594.2999 2 20.66 4 7748 VEV_1_3_RA4_01_1235.d 1.09E5 3 3 298 309
R.SQSADALFDEIIGIAPTK.A Y 47.82 1874.9625 18 -15.4 938.4741 2 88.64 6 50595 VEV_3_3_RA6_01_1237.d 3.3E4 2 2 280 297
total 3 peptides
C1GGE1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.PSSASTISTPVPTELESPK.Q Y 59.90 1926.9785 19 -9.6 964.4873 2 71.36 4 40288 VEV_1_3_RA4_01_1235.d 1.04E5 3 3 2 20
K.Q(-17.03)ASTASTASTAPNATVAHIK.S Y 55.56 1908.9541 20 -12.7 955.4722 2 60.84 6 31059 VEV_3_3_RA6_01_1237.d 5.54E4 2 2 21 40 Pyro-glu from Q
R.DGPGSAAYFAAYEYIKR.S Y 42.07 1877.8948 17 -10.2 626.9658 3 78.96 4 46212 VEV_1_3_RA4_01_1235.d 4.21E4 1 1 214 230
K.QASTASTASTAPNATVAHIK.S Y 40.01 1925.9806 20 -7.3 642.9961 3 48.25 4 23785 VEV_1_3_RA4_01_1235.d 1.2E5 2 2 21 40
K.YSGGIDVVR.Q Y 17.37 964.4977 9 -6.9 483.2528 2 56.06 5 28802 VEV_2_3_RA5_01_1236.d 6.01E4 1 1 184 192
total 5 peptides
C1G022
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GHAAIVPGGC(+57.02)NIDGTR.I Y 71.72 1593.7682 16 -8.7 532.2587 3 54.08 4 27481 VEV_1_3_RA4_01_1235.d 1.44E5 2 2 124 139 Carbamidomethylation
R.IADIDPASIEAQAEIIHSK.N Y 68.05 2020.0476 19 -9.7 674.3500 3 78.68 4 45997 VEV_1_3_RA4_01_1235.d 1.08E5 1 1 140 158
total 2 peptides
C1GMH9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EYLQAIFREDTPYPELLK.S Y 63.00 2224.1416 18 -11.8 742.3790 3 84.20 4 50056 VEV_1_3_RA4_01_1235.d 0 1 1 88 105
R.RDVTNHLPLSIGDYTDFYAGLNHAYNVGVLFR.G Y 41.88 3636.8113 32 -3.9 728.3667 5 87.70 6 50054 VEV_3_3_RA6_01_1237.d 1.16E5 3 3 119 150
R.VFLQDGDEVILR.G Y 35.63 1402.7456 12 -15.2 702.3694 2 77.85 6 43626 VEV_3_3_RA6_01_1237.d 5.46E3 1 1 392 403
R.DIQAWEYVPLGPFNAK.N Y 22.91 1846.9253 16 0.4 924.4703 2 88.39 4 52744 VEV_1_3_RA4_01_1235.d 3.83E5 1 1 249 264
R.GPDNALQPNYK.H Y 18.25 1215.5884 11 -4.7 608.7986 2 46.54 4 22768 VEV_1_3_RA4_01_1235.d 7.78E4 1 1 151 161
total 5 peptides
C1GDG5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AVIAGAGTGGTITGVAR.G Y 76.75 1470.8154 17 -34.5 736.3896 2 64.94 4 35274 VEV_1_3_RA4_01_1235.d 0 3 3 187 203
R.DKGFDQLPVLAPTGR.R Y 36.37 1612.8573 15 -11.3 538.6203 3 75.59 4 43593 VEV_1_3_RA4_01_1235.d 6.74E4 1 1 392 406
K.T(+79.97)IIALPEK(+28.03).M Y 17.53 991.5355 8 -12.3 331.5150 3 32.91 4 14526 VEV_1_3_RA4_01_1235.d 0 1 1 102 109 Phosphorylation (STY); Dimethylation(KR)
R.VPKDPFLGAK.A Y 16.70 1070.6124 10 -9.0 357.8749 3 56.96 6 28336 VEV_3_3_RA6_01_1237.d 7.28E4 2 2 356 365
total 4 peptides
C1G9G6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KVNNDDEKPNTTELSTNMK.V Y 76.68 2177.0271 19 -9.3 545.2590 4 43.21 5 21046 VEV_2_3_RA5_01_1236.d 5.63E5 6 6 309 327
K.VGELLPVR.M Y 33.72 881.5334 8 -19.1 441.7656 2 65.22 6 34337 VEV_3_3_RA6_01_1237.d 3.85E5 1 1 328 335
K.GLKPHISSR.K Y 33.51 993.5719 9 -17.9 332.1920 3 20.36 5 7924 VEV_2_3_RA5_01_1236.d 5.63E5 4 4 300 308
R.KVNNDDEKPNTTELSTNM(+15.99)K.V Y 22.77 2193.0220 19 -11.5 732.0062 3 31.22 6 13543 VEV_3_3_RA6_01_1237.d 4.27E4 1 1 309 327 Oxidation (M)
total 4 peptides
C1G7A3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYGDTIPSSVPGNR.I Y 76.86 1474.7416 14 -16.3 738.3660 2 66.07 6 34932 VEV_3_3_RA6_01_1237.d 1.23E5 2 2 130 143
R.ALDLGSNFFRPTVLK.G Y 32.18 1676.9249 15 6.2 559.9857 3 80.33 6 45392 VEV_3_3_RA6_01_1237.d 0 1 1 368 382
K.AIDAAVAAFPTFRK.T Y 20.73 1476.8088 14 -37.2 370.1957 4 21.65 4 8279 VEV_1_3_RA4_01_1235.d 1.91E5 1 1 57 70
K.IGPALAAGC(+57.02)TVVAK.S Y 17.48 1326.7329 14 -63.4 664.3317 2 66.39 6 35174 VEV_3_3_RA6_01_1237.d 0 1 1 171 184 Carbamidomethylation
total 4 peptides
A0A0A0HT88
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.WGVSDDLNIISSLTR.A Y 75.69 1674.8577 15 -14.4 838.4240 2 89.25 6 50924 VEV_3_3_RA6_01_1237.d 0 1 1 26 40
M.A(+42.01)VAAIPLSLAVPAAVASAAYLNAR.W Y 44.88 2321.3105 24 -11.4 1161.6493 2 97.84 6 54624 VEV_3_3_RA6_01_1237.d 2.94E4 2 2 2 25 Acetylation (Protein N-term)
R.VAVVELDYETEQPIRDPK.T Y 17.94 2100.0737 18 9.8 701.0387 3 71.80 6 39212 VEV_3_3_RA6_01_1237.d 0 1 1 411 428
total 3 peptides
C1G421
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GGFKDTAASDLLAGVFK.S Y 61.80 1695.8831 17 8.7 566.3065 3 82.03 5 47363 VEV_2_3_RA5_01_1236.d 0 2 2 48 64
R.AEQDAFAASSYQK.A Y 53.61 1414.6365 13 -4.9 708.3220 2 52.66 4 26594 VEV_1_3_RA4_01_1235.d 9.66E4 2 2 192 204
K.GGAIAFGHPLGC(+57.02)TGAR.Q Y 27.94 1540.7568 16 -3.3 514.5912 3 62.85 5 33673 VEV_2_3_RA5_01_1236.d 8.89E4 1 1 366 381 Carbamidomethylation
K.GGVAAITTKNPDDIVVTC(+57.02)ALR.S Y 23.75 2170.1416 21 -19.0 724.3741 3 74.94 5 42556 VEV_2_3_RA5_01_1236.d 2.57E4 1 1 19 39 Carbamidomethylation
total 4 peptides
C1FYD8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RIEAGPGGYEQNDNYSGER.Q Y 103.52 2110.9304 19 -10.4 704.6434 3 52.29 4 26352 VEV_1_3_RA4_01_1235.d 1.03E5 2 2 396 414
total 1 peptides
C1G080
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGGGTEYGGGYAHDEIWDSR.M Y 72.08 2126.8928 20 -13.4 709.9620 3 67.17 4 36974 VEV_1_3_RA4_01_1235.d 1.01E5 2 2 101 120
R.GAYEEPLHPGISR.G Y 62.65 1424.7048 13 -7.6 475.9053 3 58.09 4 30076 VEV_1_3_RA4_01_1235.d 6.38E5 4 4 84 96
total 2 peptides
C1FZU0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.EGGPDPIVC(+57.02)DIAYYAR.R Y 52.57 1794.8246 16 -6.8 898.4135 2 81.81 5 47228 VEV_2_3_RA5_01_1236.d 1.39E5 3 3 206 221 Carbamidomethylation
R.DMAALDLPALVTR.V Y 43.82 1384.7384 13 -9.0 693.3702 2 85.33 5 49360 VEV_2_3_RA5_01_1236.d 1.18E5 1 1 350 362
R.ISIFC(+57.02)ALSPAAYAGPLVNTPYLK.F Y 41.24 2465.3027 23 -13.5 1233.6420 2 91.59 6 52117 VEV_3_3_RA6_01_1237.d 4.82E4 1 1 400 422 Carbamidomethylation
K.EYSPLSPTDRDC(+57.02)IGPPSSLQVPK.V Y 26.86 2542.2373 23 -5.5 848.4150 3 76.08 6 42333 VEV_3_3_RA6_01_1237.d 3.29E4 1 1 250 272 Carbamidomethylation
R.RVGLDSETYR.V Y 22.99 1194.5992 10 -18.2 399.1998 3 40.74 5 19556 VEV_2_3_RA5_01_1236.d 1.69E5 1 1 222 231
K.HIQPSLGSR.I Y 17.91 993.5355 9 -16.1 497.7670 2 29.30 5 12869 VEV_2_3_RA5_01_1236.d 3.99E4 1 1 391 399
total 6 peptides
C1GJ63
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GYLDHSGGAGNEHHSYR.N Y 60.20 1855.7986 17 -16.6 464.9492 4 30.23 6 12990 VEV_3_3_RA6_01_1237.d 3.85E5 4 4 133 149
K.KATGETGIAPSNYLILL Y 58.67 1759.9719 17 -13.1 880.9817 2 85.52 6 48785 VEV_3_3_RA6_01_1237.d 3.54E5 3 3 293 309
K.ATGETGIAPSNYLILL Y 38.00 1631.8770 16 -12.5 816.9355 2 91.55 6 52104 VEV_3_3_RA6_01_1237.d 2.1E5 2 2 294 309
R.GY(-2.02)LDHSGGAGNEHHSYR.N Y 18.29 1853.7830 17 27.8 618.9521 3 30.14 4 12934 VEV_1_3_RA4_01_1235.d 0 1 1 133 149 2-amino-3-oxo-butanoic_acid
total 4 peptides
C1GEJ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GLQTHIYAPTGLDIR.N Y 84.91 1653.8838 15 -10.2 552.2963 3 72.98 5 41164 VEV_2_3_RA5_01_1236.d 3.76E5 4 4 91 105
K.AC(+57.02)FHDLPR.G Y 33.82 1014.4705 8 -5.9 508.2396 2 41.96 5 20300 VEV_2_3_RA5_01_1236.d 4.71E4 1 1 83 90 Carbamidomethylation
total 2 peptides
C1GJN5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AATSDDFSQIAPFVSGK.R Y 83.25 1739.8365 17 -14.6 870.9128 2 79.42 6 44744 VEV_3_3_RA6_01_1237.d 2.31E5 3 3 255 271
K.AIVNASEEDTQLLLR.R Y 36.82 1670.8839 15 -28.9 836.4251 2 76.86 4 44581 VEV_1_3_RA4_01_1235.d 0 1 1 218 232
total 2 peptides
C1G2M4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGGIGAAERGEATGFGNGR.G Y 85.18 1732.8241 19 -8.6 578.6104 3 53.16 4 26926 VEV_1_3_RA4_01_1235.d 2.2E5 2 2 133 151
R.APLTGNIGSNSSSSARPNITSSYLTSSIPGEDRR.A Y 22.75 3491.7241 34 -13.2 873.9268 4 74.16 4 42478 VEV_1_3_RA4_01_1235.d 5.87E4 1 1 58 91
R.GEATGFGNGR.G Y 15.00 964.4362 10 -4.2 483.2234 2 21.79 6 8494 VEV_3_3_RA6_01_1237.d 4.52E4 1 1 142 151
total 3 peptides
C1G0U1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TYSIGQQQSSLVFR.G Y 66.04 1612.8209 14 -3.6 807.4148 2 73.19 4 41735 VEV_1_3_RA4_01_1235.d 3.37E5 3 3 119 132
R.LDGKTYSIGQQQSSLVFR.G Y 59.95 2026.0483 18 -10.2 676.3499 3 71.94 4 40755 VEV_1_3_RA4_01_1235.d 1.69E5 1 1 115 132
R.LDGKTYSIGQ(+.98)QQSSLVFR.G Y 50.31 2027.0323 18 -4.6 676.6816 3 71.60 5 40172 VEV_2_3_RA5_01_1236.d 1E5 1 1 115 132 Deamidation (NQ)
R.LDGKTYSIGQQQSS(-18.01)LVFR(+14.02).G Y 17.12 2022.0533 18 -17.3 675.0134 3 71.74 4 40591 VEV_1_3_RA4_01_1235.d 0 1 1 115 132 Dehydration; Methylation(KR)
K.GGDSTQK.T Y 15.42 691.3137 7 4.0 692.3237 1 112.56 4 61833 VEV_1_3_RA4_01_1235.d 0 1 1 179 185
total 5 peptides
A0A0A0HWQ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NLDSELSGNVIDLC(+57.02)PVGALTSKPYAFR.A Y 64.23 2935.4749 27 -9.6 979.4895 3 85.54 4 50938 VEV_1_3_RA4_01_1235.d 1.72E5 1 1 226 252 Carbamidomethylation
R.FANDIAGAPELGTTGR.G Y 52.17 1588.7844 16 -8.6 795.3926 2 70.25 4 39409 VEV_1_3_RA4_01_1235.d 1.65E5 2 2 198 213
R.FAC(+57.02)DGLR.T Y 19.10 837.3803 7 5.1 419.6996 2 40.89 4 19217 VEV_1_3_RA4_01_1235.d 8.34E4 1 1 305 311 Carbamidomethylation
K.AALAGAFGK.T Y 17.03 804.4493 9 -43.0 403.2147 2 50.09 6 24347 VEV_3_3_RA6_01_1237.d 0 1 1 470 478
total 4 peptides
C1GC10
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSIYSYAGAASGER.S Y 67.77 1387.6367 14 -7.1 694.8207 2 61.98 5 33020 VEV_2_3_RA5_01_1236.d 1.43E5 1 1 320 333
R.SSYQPGRLQLGDTGSVR.S Y 66.04 1819.9176 17 -9.2 607.6409 3 62.74 5 33592 VEV_2_3_RA5_01_1236.d 7.05E4 1 1 334 350
total 2 peptides
A0A0A0HYS7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLNYGFVEYDDPGAAER.A Y 92.51 1871.8325 17 -6.5 936.9175 2 76.95 4 44657 VEV_1_3_RA4_01_1235.d 1.16E5 2 2 123 139
K.ALSSMDGEWLGSR.A Y 16.41 1407.6453 13 16.8 470.2302 3 29.30 5 12910 VEV_2_3_RA5_01_1236.d 3.13E5 1 1 231 243
total 2 peptides
C1GE59
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALEELNYLAC(+57.02)LDDDGNLTPLGR.L Y 72.04 2461.1794 22 -4.6 1231.5913 2 88.22 4 52639 VEV_1_3_RA4_01_1235.d 6.24E4 1 1 499 520 Carbamidomethylation
R.THPVEIFYTPEPEQDYVEAAIR.T Y 57.26 2603.2544 22 -7.6 868.7521 3 81.11 6 45939 VEV_3_3_RA6_01_1237.d 1.01E4 2 2 274 295
total 2 peptides
C1GJW2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TPGAFELNNSK.S Y 71.55 1176.5775 11 -10.6 589.2898 2 54.88 4 27981 VEV_1_3_RA4_01_1235.d 3.89E5 2 2 95 105
K.LSLSTSGSDNKDNSGRQDSSR.S Y 35.15 2210.0159 21 -3.8 553.5092 4 27.96 4 11722 VEV_1_3_RA4_01_1235.d 5.9E4 1 1 16 36
R.IDGGR.N N 22.01 516.2656 5 -12.8 517.2662 1 98.88 4 57834 VEV_1_3_RA4_01_1235.d 0 1 1 276 280
R.SAIDQARQDK.A Y 16.74 1130.5680 10 -40.4 566.2684 2 17.38 5 6318 VEV_2_3_RA5_01_1236.d 0 1 1 313 322
total 4 peptides
C1GB27
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGFPSC(+57.02)YPISTQTYTR.K Y 49.72 1847.8512 16 -8.1 924.9254 2 74.08 4 42418 VEV_1_3_RA4_01_1235.d 1.37E5 2 2 226 241 Carbamidomethylation
K.NQGGANDLIER.I Y 49.07 1185.5737 11 -6.7 593.7902 2 43.01 4 20550 VEV_1_3_RA4_01_1235.d 2.12E5 2 2 412 422
K.NAGDTYAQQWFER.T Y 44.41 1584.6957 13 -7.9 793.3489 2 74.49 6 41174 VEV_3_3_RA6_01_1237.d 2.8E4 1 1 313 325
K.VSELSV Y 19.06 632.3381 6 -71.3 633.3003 1 33.93 6 15028 VEV_3_3_RA6_01_1237.d 0 1 1 479 484
K.FC(+57.02)GPNGEVQK.A Y 18.89 1134.5128 10 -16.1 568.2546 2 34.14 5 15660 VEV_2_3_RA5_01_1236.d 1.94E4 1 1 456 465 Carbamidomethylation
R.VANALSAFGTTVQR.I Y 17.70 1433.7627 14 -24.2 717.8713 2 71.64 6 39095 VEV_3_3_RA6_01_1237.d 1.69E4 1 1 247 260
total 6 peptides
C1GBN1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSLTPTSISFLGHSDTK.K Y 60.22 1802.9414 17 -21.2 601.9750 3 78.34 4 45743 VEV_1_3_RA4_01_1235.d 2.23E5 2 2 41 57
M.A(+42.01)ATQTPEVLWAQR.S Y 52.94 1511.7732 13 -13.6 756.8836 2 80.53 6 45533 VEV_3_3_RA6_01_1237.d 2.62E5 2 2 2 14 Acetylation (Protein N-term)
R.GVDLVLR.K Y 27.17 770.4650 7 -14.6 386.2342 2 64.12 5 34613 VEV_2_3_RA5_01_1236.d 2.26E5 3 3 84 90
R.SSSTDPEKNILYIHLSVPDVPPFSAK.L Y 18.21 2840.4595 26 -19.9 947.8082 3 83.32 5 48149 VEV_2_3_RA5_01_1236.d 6.55E4 1 1 15 40
total 4 peptides
C1G9M7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGGSSQEVGSVR.E Y 67.48 1162.5579 12 -10.9 582.2798 2 20.51 6 7824 VEV_3_3_RA6_01_1237.d 8.1E4 2 2 174 185
R.LPAGDFTPLFR.L Y 46.47 1232.6553 11 -11.6 617.3278 2 80.46 5 46355 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 61 71
K.T(-2.02)GGSSQEVGSVR.E Y 26.25 1160.5421 12 -23.2 581.2649 2 20.56 5 8041 VEV_2_3_RA5_01_1236.d 0 1 1 174 185 2-amino-3-oxo-butanoic_acid
R.LLDDYESHR.S Y 24.88 1146.5305 9 25.6 574.2872 2 41.58 6 19424 VEV_3_3_RA6_01_1237.d 3.19E4 1 1 72 80
total 4 peptides
C1GA21
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GTHVVSC(+57.02)SVDGPPPADPAAR.L Y 81.34 1988.9374 20 -6.4 663.9822 3 56.83 4 29189 VEV_1_3_RA4_01_1235.d 2.53E5 3 3 79 98 Carbamidomethylation
K.TTQAPGSSTPSLVEVEEKR.T Y 34.98 2015.0171 19 -14.1 672.6702 3 62.28 6 32103 VEV_3_3_RA6_01_1237.d 1.04E5 2 2 52 70
total 2 peptides
C1GL11
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQALPSEYPPIDHR.L Y 73.22 1634.8416 14 -17.2 545.9451 3 68.17 4 37772 VEV_1_3_RA4_01_1235.d 1.6E5 1 1 237 250
K.YLPNITLPSNIR.A Y 31.10 1399.7823 12 -0.9 700.8978 2 78.99 5 45375 VEV_2_3_RA5_01_1236.d 5.05E4 2 2 88 99
R.ANPSLEEAVK.G Y 15.95 1056.5450 10 -7.9 529.2756 2 48.32 4 23822 VEV_1_3_RA4_01_1235.d 2.17E5 1 1 100 109
K.VTVIGSGN(+.98)W(+31.99)GSVISK.M Y 15.50 1535.7831 15 7.2 512.9387 3 30.81 6 13358 VEV_3_3_RA6_01_1237.d 1.26E5 1 1 13 27 Deamidation (NQ); Dihydroxy
total 4 peptides
C1GA42
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGSSHSLAAQGGQC(+57.02)GTAR.Q Y 80.21 1742.8118 18 -7.7 581.9401 3 25.59 4 10446 VEV_1_3_RA4_01_1235.d 2.1E5 3 3 484 501 Carbamidomethylation
K.GSVENGVSNPAR.K Y 22.70 1185.5737 12 -18.0 593.7834 2 28.66 6 12134 VEV_3_3_RA6_01_1237.d 1.97E4 1 1 199 210
K.STEGK.K N 18.65 520.2493 5 22.9 521.2684 1 72.08 6 39425 VEV_3_3_RA6_01_1237.d 0 1 1 312 316
total 3 peptides
C1GGZ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DIPLVVAGSFGNIFSR.N Y 84.29 1690.9042 16 -14.5 846.4471 2 90.64 6 51652 VEV_3_3_RA6_01_1237.d 1.06E5 3 3 754 769
K.EAAAK.N N 26.36 488.2594 5 -17.3 489.2582 1 29.04 6 12362 VEV_3_3_RA6_01_1237.d 3.95E4 3 3 476 480
total 2 peptides
C1GHZ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TVSEWTTVPTTSAK.N Y 68.56 1506.7566 14 -6.9 754.3804 2 65.56 5 35712 VEV_2_3_RA5_01_1236.d 2.75E5 3 3 88 101
R.ALVVNMPFLILGFFKLISPFIDPTSK.A Y 39.20 2906.6382 26 -25.1 969.8623 3 98.00 4 57548 VEV_1_3_RA4_01_1235.d 0 1 1 256 281
K.NAPTGPITDDDR.M Y 27.49 1270.5790 12 8.8 636.3024 2 40.40 6 18721 VEV_3_3_RA6_01_1237.d 0 2 2 102 113
total 3 peptides
C1GC74
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.PTDLC(+57.02)PVYAPFFGALGC(+57.02)TSAIVFTC(+57.02)LGAAYGTAK.A Y 69.41 3595.7190 34 1.5 1199.5820 3 97.64 6 54553 VEV_3_3_RA6_01_1237.d 3.01E4 2 2 2 35 Carbamidomethylation
K.AGVGIC(+57.02)ATSVLRPDLIVK.N Y 55.47 1868.0553 18 -20.3 623.6797 3 79.28 5 45574 VEV_2_3_RA5_01_1236.d 1.74E5 3 3 36 53 Carbamidomethylation
total 2 peptides
C1GDE6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVSSQEGSALAK.E Y 65.87 1146.5880 12 -4.3 574.2988 2 27.48 4 11453 VEV_1_3_RA4_01_1235.d 3.54E5 6 6 151 162
R.QQQGTRQTLNRSPGTQK.D Y 36.95 1926.9984 17 1.9 643.3413 3 82.55 6 46904 VEV_3_3_RA6_01_1237.d 4.4E5 3 3 195 211
K.AFYDVVR.L Y 36.19 868.4443 7 -13.5 435.2235 2 65.75 6 34758 VEV_3_3_RA6_01_1237.d 1.51E5 3 3 182 188
total 3 peptides
C1G7L5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GTGADPAPC(+57.02)PAGPR.Q Y 53.65 1322.6036 14 -5.5 662.3055 2 36.37 4 16558 VEV_1_3_RA4_01_1235.d 1.91E5 3 3 353 366 Carbamidomethylation
K.ELELIDFPEEADFHPLGVNIFR.S Y 52.62 2599.2957 22 -6.4 867.4337 3 91.14 4 54290 VEV_1_3_RA4_01_1235.d 2.08E5 2 2 112 133
R.TGSTVEVFDVNYDLHQAK.Y Y 32.86 2021.9694 18 -10.1 674.9902 3 74.80 4 42973 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 150 167
K.GSLVIFDYASTGK.T Y 21.50 1356.6925 13 -16.2 679.3425 2 78.70 6 44222 VEV_3_3_RA6_01_1237.d 1.41E5 2 2 97 109
total 4 peptides
C1FZN1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GPEVLVTLTADIGKILDGLHR.T Y 55.25 2216.2529 21 10.0 555.0760 4 95.03 4 56297 VEV_1_3_RA4_01_1235.d 8.81E4 2 2 58 78
R.IIVFTC(+57.02)SPIAEDEK.I Y 53.67 1620.8069 14 -8.0 811.4042 2 76.94 4 44645 VEV_1_3_RA4_01_1235.d 6.55E4 1 1 110 123 Carbamidomethylation
R.IIVFTC(+57.02)SPIAEDEKILIK.L Y 40.02 2088.1541 18 -12.7 697.0498 3 81.91 6 46479 VEV_3_3_RA6_01_1237.d 4.57E4 2 2 110 127 Carbamidomethylation
total 3 peptides
C1GDU4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ESPISQSKPDQR.T Y 77.78 1370.6790 12 -11.7 686.3387 2 21.29 5 8469 VEV_2_3_RA5_01_1236.d 9.14E5 6 6 27 38
R.LISFGK.L Y 24.14 663.3955 6 -17.2 332.6993 2 53.27 5 27162 VEV_2_3_RA5_01_1236.d 1E5 1 1 261 266
R.ERGDFVEK.R Y 15.57 978.4770 8 -10.3 327.1629 3 25.92 5 10997 VEV_2_3_RA5_01_1236.d 0 1 1 18 25
total 3 peptides
C1G017
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AASGDADENDSFFK.C Y 46.93 1472.6055 14 -8.0 737.3041 2 60.81 6 31034 VEV_3_3_RA6_01_1237.d 3.36E4 1 1 137 150
R.GGDASAAQVDGVLNDVDLIISK.I Y 45.85 2156.0959 22 -21.8 719.6902 3 88.56 4 52854 VEV_1_3_RA4_01_1235.d 0 1 1 374 395
R.NVEPVGPHFLAHAR.R Y 39.51 1542.8055 14 -21.5 386.7004 4 60.64 6 30902 VEV_3_3_RA6_01_1237.d 1.71E5 1 1 37 50
R.LVDDALAADER.I Y 27.00 1186.5829 11 -11.3 594.2920 2 59.40 6 30079 VEV_3_3_RA6_01_1237.d 1.03E5 2 2 278 288
K.ISNEELAELAAK.L Y 25.91 1286.6718 12 -11.4 644.3358 2 69.54 4 38855 VEV_1_3_RA4_01_1235.d 2.82E5 2 2 396 407
total 5 peptides
C1GAU7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KLESGEVEPAPESNSGIAR.F Y 62.55 1968.9752 19 -7.6 657.3274 3 54.31 5 27816 VEV_2_3_RA5_01_1236.d 7.73E4 1 1 559 577
K.SVESDTQPSTSTK.T Y 29.18 1365.6260 13 -4.6 683.8171 2 22.36 4 8649 VEV_1_3_RA4_01_1235.d 3.8E4 1 1 875 887
R.SGGAKGDTGTANFTIVSASGYPSGTNVR.V Y 27.37 2671.2837 28 -1.4 891.4340 3 69.73 6 37652 VEV_3_3_RA6_01_1237.d 3.42E4 1 1 1315 1342
R.ASILFDGATAPLTPTTSTPQTPHSR.S Y 19.35 2566.3027 25 -5.4 856.4369 3 76.12 5 43392 VEV_2_3_RA5_01_1236.d 5.83E3 1 1 1276 1300
K.GIDVIVQDFAFSSLMR.V Y 18.62 1796.9131 16 -23.8 450.2249 4 56.00 6 27733 VEV_3_3_RA6_01_1237.d 1.56E5 1 1 329 344
total 5 peptides
C1G9I8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISKPANFADIQSR.V Y 65.47 1445.7626 13 -5.2 482.9256 3 57.98 5 30099 VEV_2_3_RA5_01_1236.d 2.91E5 2 2 48 60
R.FSNLKPLSEFFDIKR.I Y 57.86 1839.9883 15 -15.3 460.9973 4 79.84 4 46897 VEV_1_3_RA4_01_1235.d 6.14E5 4 4 33 47
R.FS(-18.01)NLK(+14.02)PLSEFFDIKR.I Y 29.77 1835.9933 15 -6.7 460.0025 4 79.98 4 47003 VEV_1_3_RA4_01_1235.d 1.88E4 1 1 33 47 Dehydration; Methylation(KR)
total 3 peptides
C1GLY2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLAAAQQTDTEAAVASK Y 80.88 1660.8268 17 -12.1 831.4106 2 53.68 6 26460 VEV_3_3_RA6_01_1237.d 2.57E5 4 4 52 68
K.WQNGKQGDVK.S Y 16.19 1158.5781 10 -16.8 580.2866 2 62.46 5 33384 VEV_2_3_RA5_01_1236.d 5.22E4 1 1 42 51
K.EEPRLQAER.R Y 15.10 1126.5730 9 -7.2 564.2897 2 55.34 5 28416 VEV_2_3_RA5_01_1236.d 4.17E4 1 1 23 31
total 3 peptides
C1GB89
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TPLSAASPDAR.F Y 64.77 1084.5513 11 -2.2 543.2817 2 40.49 4 18986 VEV_1_3_RA4_01_1235.d 4.3E5 6 6 55 65
K.AGEQFITHPSNVVAYTITAPSPRPYK.F Y 36.95 2843.4604 26 -10.6 711.8649 4 75.59 4 43596 VEV_1_3_RA4_01_1235.d 3.31E4 1 1 214 239
K.ISSASPITALIATR.S Y 31.92 1399.8035 14 -14.2 700.8990 2 79.21 5 45526 VEV_2_3_RA5_01_1236.d 2.83E4 1 1 127 140
total 3 peptides
C1G3R8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ILYTYLLPGSER.E Y 85.90 1423.7711 12 -11.5 712.8846 2 79.76 6 44985 VEV_3_3_RA6_01_1237.d 3.98E4 1 1 184 195
R.SDGYTSGHSLK.S Y 15.84 1150.5254 11 -37.9 576.2482 2 20.40 6 7769 VEV_3_3_RA6_01_1237.d 4.42E4 1 1 122 132
total 2 peptides
C1GJN2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.STANNVDILVPVPEDADSPR.F Y 54.88 2108.0386 20 -7.3 1055.0189 2 78.17 4 45612 VEV_1_3_RA4_01_1235.d 3.27E4 1 1 305 324
R.TNIGSVHYAPEK.S Y 34.54 1314.6567 12 -17.2 658.3243 2 43.19 4 20653 VEV_1_3_RA4_01_1235.d 2.1E5 2 2 327 338
K.FEIPYFTTSGIQVR.Y Y 31.11 1656.8511 14 -9.2 553.2859 3 85.16 6 48566 VEV_3_3_RA6_01_1237.d 0 1 1 400 413
R.YITQSGDIAVR.L Y 28.52 1221.6354 11 -16.0 611.8152 2 58.80 4 30587 VEV_1_3_RA4_01_1235.d 6.63E4 1 1 432 442
R.YITQSGDIAVRLPDVQ Y 20.59 1773.9260 16 -19.4 887.9531 2 78.34 5 44976 VEV_2_3_RA5_01_1236.d 5.26E4 1 1 432 447
total 5 peptides
C1GJM4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IPSLAVHFGPQSR.G Y 61.03 1407.7622 13 5.6 470.2640 3 70.91 4 39926 VEV_1_3_RA4_01_1235.d 0 2 2 203 215
K.MVGMFDSEEIGSLLR.Q Y 37.89 1682.8008 15 2.2 842.4095 2 86.90 4 51822 VEV_1_3_RA4_01_1235.d 5.86E4 1 1 333 347
R.DLDTGTIESK.L Y 29.20 1077.5189 10 -15.4 539.7584 2 47.52 6 22908 VEV_3_3_RA6_01_1237.d 3.86E5 3 3 183 192
R.DLGIGGR(+28.03).V Y 15.06 714.4024 7 13.6 358.2133 2 53.37 4 27039 VEV_1_3_RA4_01_1235.d 0 1 1 172 178 Dimethylation(KR)
total 4 peptides
C1G2W2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MNFSHGDYEYHQSVIDNAR.K Y 60.53 2281.9810 19 -3.2 571.5007 4 64.22 4 34678 VEV_1_3_RA4_01_1235.d 4.85E4 1 1 70 88
K.NKVDMVFASFIR.R Y 32.49 1425.7438 12 -18.8 476.2463 3 79.99 4 47009 VEV_1_3_RA4_01_1235.d 0 1 1 225 236
K.KGVNLPGTDIDLPALSEKDKADLR.F Y 23.47 2564.3809 24 40.9 513.9044 5 75.31 5 42813 VEV_2_3_RA5_01_1236.d 0 1 1 197 220
R.GDLGIEIPAAK.V Y 22.01 1082.5972 11 -14.2 542.2982 2 71.16 5 39890 VEV_2_3_RA5_01_1236.d 1.6E5 2 2 285 295
K.VFIAQK.M Y 15.23 704.4221 6 -63.1 705.3849 1 30.86 4 13333 VEV_1_3_RA4_01_1235.d 0 1 1 296 301
total 5 peptides
C1GEQ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AKDDAYAPDNPNSAR.I Y 73.29 1603.7227 15 -5.6 802.8641 2 28.09 4 11796 VEV_1_3_RA4_01_1235.d 2.69E4 1 1 62 76
R.DIGYQHVPYFNC(+57.02)PNSPK.C Y 39.32 2034.9258 17 -8.2 679.3103 3 72.05 4 40833 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 348 364 Carbamidomethylation
total 2 peptides
C1GDK6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TNPFD Y 60.50 592.2493 5 -6.8 593.2525 1 41.62 6 19423 VEV_3_3_RA6_01_1237.d 1.14E5 6 6 1077 1081
R.AQAANSKEEFFK.S Y 49.20 1368.6674 12 -14.9 457.2229 3 39.30 6 18086 VEV_3_3_RA6_01_1237.d 5.9E5 7 7 971 982
R.SLGLSEGSKPQQTAGGHQK.S Y 22.56 1908.9653 19 -0.2 478.2485 4 76.55 6 42670 VEV_3_3_RA6_01_1237.d 4.92E4 1 1 779 797
total 3 peptides
C1G7X8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGTNFNALNSQK.E Y 52.69 1263.6207 12 -12.0 632.8101 2 47.28 4 23179 VEV_1_3_RA4_01_1235.d 7.06E4 1 1 490 501
K.VLITTNVLAR.G Y 48.61 1098.6760 10 -34.9 550.3261 2 71.27 6 38812 VEV_3_3_RA6_01_1237.d 0 1 1 384 393
R.IADAQTYLHR.I Y 30.55 1186.6095 10 -24.5 396.5341 3 52.26 6 25629 VEV_3_3_RA6_01_1237.d 1.58E5 1 1 420 429
K.VATAVPMESNR.N Y 19.23 1173.5812 11 -5.5 587.7946 2 45.24 4 21916 VEV_1_3_RA4_01_1235.d 6.75E4 1 1 194 204
total 4 peptides
C1GMW4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SAASENAQHGTQNESLQR.R Y 91.71 1926.8779 18 -8.4 643.2946 3 23.69 5 9733 VEV_2_3_RA5_01_1236.d 1.78E5 3 3 62 79
total 1 peptides
C1GAS0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISVGDGYHGSHGVIDIQTR.L Y 60.95 2009.9918 19 2.6 503.5066 4 65.23 4 35453 VEV_1_3_RA4_01_1235.d 9.87E4 1 1 124 142
R.YSDNLEDLIPWSDSTLANLPATNHIYSR.H Y 37.54 3204.5364 28 -8.7 1069.1768 3 88.18 6 50337 VEV_3_3_RA6_01_1237.d 3.25E4 1 1 54 81
K.YLGGHSDILC(+57.02)GVLVTK.S Y 35.90 1730.9025 16 -4.3 577.9723 3 76.62 6 42720 VEV_3_3_RA6_01_1237.d 8.23E4 1 1 222 237 Carbamidomethylation
total 3 peptides
C1GFI8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SDHQTPSNAPPTGSASQNR.S Y 91.43 1950.8779 19 -5.7 651.2962 3 22.32 4 8631 VEV_1_3_RA4_01_1235.d 1.31E5 4 4 624 642
total 1 peptides
C1G0Y7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TRNNTLGSGDDDNIAYAK.T Y 71.37 1923.8922 18 -3.4 642.3025 3 50.17 5 25241 VEV_2_3_RA5_01_1236.d 1.18E5 2 2 302 319
K.ATASSSNNNSFSSSQRPSTR.S Y 39.74 2084.9470 20 -8.9 695.9834 3 26.44 5 11295 VEV_2_3_RA5_01_1236.d 8.42E4 2 2 412 431
total 2 peptides
C1GGW8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ADASLSEQGVDYAR.K Y 62.82 1480.6793 14 -2.8 741.3448 2 60.02 4 31510 VEV_1_3_RA4_01_1235.d 5.53E4 1 1 272 285
R.SQMSQLNPGVC(+57.02)EK.L Y 43.74 1476.6700 13 -7.1 739.3370 2 56.62 4 29042 VEV_1_3_RA4_01_1235.d 5.28E4 1 1 343 355 Carbamidomethylation
R.NDLLIIAHESVLR.V Y 19.49 1491.8409 13 -69.1 498.2532 3 76.34 6 42512 VEV_3_3_RA6_01_1237.d 2.8E4 1 1 406 418
total 3 peptides
C1G6P0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VKFSSPTTIELDLPTSDNKR.F Y 62.51 2247.1746 20 -6.1 562.7975 4 73.74 4 42152 VEV_1_3_RA4_01_1235.d 7.06E4 1 1 236 255
K.FSSPTTIELDLPTSDNKR.F Y 56.92 2020.0112 18 -11.7 674.3365 3 75.45 4 43479 VEV_1_3_RA4_01_1235.d 8.98E4 1 1 238 255
total 2 peptides
C1GD04
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAGASVAGTAAPK.Q Y 73.71 1086.5669 13 -14.1 544.2831 2 26.86 5 11519 VEV_2_3_RA5_01_1236.d 4.84E5 12 12 218 230
R.IPGAQLVSR.W Y 22.32 939.5501 9 -25.6 470.7703 2 60.13 6 30528 VEV_3_3_RA6_01_1237.d 5.55E4 1 1 51 59
R.TWFLQADTSR.I Y 17.24 1223.5935 10 -39.5 612.7798 2 55.81 4 28514 VEV_1_3_RA4_01_1235.d 0 1 1 41 50
total 3 peptides
C1G4X7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LIDELQITHFGTSAK.Y Y 60.72 1671.8832 15 -14.8 558.2934 3 75.01 4 43137 VEV_1_3_RA4_01_1235.d 2.39E5 1 1 380 394
R.SDGVLKPAGVR.F Y 46.66 1097.6193 11 -26.5 549.8024 2 36.07 4 16377 VEV_1_3_RA4_01_1235.d 0 2 2 560 570
K.WAAEH Y 19.08 612.2656 5 14.0 613.2815 1 19.93 6 7513 VEV_3_3_RA6_01_1237.d 1.32E4 1 1 723 727
total 3 peptides
C1GDV0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KGPAPLNLEIPTYSFPTESTLLIG Y 63.82 2557.3679 24 -5.4 1279.6843 2 90.59 5 52191 VEV_2_3_RA5_01_1236.d 2.4E5 3 3 228 251
K.GPAPLNLEIPTYSFPTESTLLIG Y 42.94 2429.2729 23 -7.8 1215.6343 2 95.89 4 56738 VEV_1_3_RA4_01_1235.d 1.1E5 2 2 229 251
R.TPSEIQEAESTK.W Y 15.10 1318.6252 12 -4.2 660.3171 2 43.33 4 20726 VEV_1_3_RA4_01_1235.d 7.69E4 1 1 157 168
total 3 peptides
C1GL70
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FSSPSALKNPPSSTSTSNAK.S Y 64.24 2006.9908 20 16.7 670.0154 3 51.08 5 25804 VEV_2_3_RA5_01_1236.d 0 1 1 393 412
K.SATAADVAAIAAK.I Y 40.18 1158.6244 13 -14.1 580.3113 2 61.19 5 32433 VEV_2_3_RA5_01_1236.d 6.76E4 1 1 287 299
R.GSYRGGPIDIGPGK.S Y 16.95 1372.7098 14 -47.2 687.3298 2 74.04 4 42389 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 483 496
total 3 peptides
C1GFE3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MIADGKDVAAFVELVER.R Y 62.93 1861.9607 17 -24.9 621.6454 3 84.93 4 50544 VEV_1_3_RA4_01_1235.d 0 1 1 765 781
R.SLFAPHQTVQGK.I Y 37.87 1311.6935 12 -16.1 438.2314 3 48.13 4 23712 VEV_1_3_RA4_01_1235.d 0 1 1 1159 1170
K.EYASLGR.D Y 23.38 794.3922 7 -19.1 795.3843 1 98.95 6 54964 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 875 881
total 3 peptides
C1GBB1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VFVVSVNDPFVTGAWSR.M Y 48.93 1878.9628 17 -12.4 940.4771 2 86.07 5 49776 VEV_2_3_RA5_01_1236.d 1.03E4 1 1 94 110
R.MIDPQQTSGIR.F Y 42.08 1244.6183 11 -11.1 623.3095 2 57.03 4 29323 VEV_1_3_RA4_01_1235.d 1.65E5 2 2 111 121
K.ALDLGFDAK.A Y 40.90 948.4916 9 -12.4 475.2472 2 70.07 5 39043 VEV_2_3_RA5_01_1236.d 2.48E5 2 2 133 141
R.M(+15.99)IDPQQTSGIR.F Y 24.34 1260.6133 11 -12.5 631.3060 2 46.35 4 22611 VEV_1_3_RA4_01_1235.d 1.94E5 1 1 111 121 Oxidation (M)
K.GLIIGTPGAFSPAC(+57.02)SASHVPGFIK.H Y 23.19 2383.2358 24 -17.1 795.4056 3 81.63 6 46302 VEV_3_3_RA6_01_1237.d 7.99E4 2 2 61 84 Carbamidomethylation
R.VFVVSVN(+.98)DPFVTGAWSR.M Y 18.48 1879.9468 17 0.6 940.9813 2 86.17 4 51349 VEV_1_3_RA4_01_1235.d 4.41E4 1 1 94 110 Deamidation (NQ)
R.VFVVS(-2.02)VNDPFVTGAWSR.M Y 16.59 1876.9471 17 -24.6 939.4578 2 86.23 4 51387 VEV_1_3_RA4_01_1235.d 2.76E4 1 1 94 110 2-amino-3-oxo-butanoic_acid
total 7 peptides
C1G4I6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KDYPTAISFYTQALSIAPSNPIYLSNR.A Y 80.44 3029.5498 27 -13.8 1010.8433 3 87.09 5 50358 VEV_2_3_RA5_01_1236.d 3.98E4 1 1 124 150
R.NLM(+15.99)GGGAGRGAGRGS Y 17.25 1332.6316 15 1.7 667.3242 2 32.49 6 14236 VEV_3_3_RA6_01_1237.d 2.28E4 1 1 353 367 Oxidation (M)
total 2 peptides
C1G763
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GYAYVEFTEPSLVAQALVLNESVFR.G Y 88.89 2801.4275 25 -3.5 1401.7161 2 95.29 4 56424 VEV_1_3_RA4_01_1235.d 4.01E4 1 1 108 132
K.GYAYVEFTEPS(-2.02)LVAQALVLNESVFR.G Y 26.17 2799.4119 25 -10.1 934.1351 3 95.14 6 53651 VEV_3_3_RA6_01_1237.d 0 1 1 108 132 2-amino-3-oxo-butanoic_acid
total 2 peptides
C1G6Y4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)IIAAGGAAGAEGVDGKR.H Y 61.69 1622.8375 18 -13.1 812.4154 2 65.84 4 35939 VEV_1_3_RA4_01_1235.d 3.98E4 2 2 768 785 Pyro-glu from Q
R.QIIAAGGAAGAEGVDGKR.H Y 48.46 1639.8641 18 -20.9 820.9222 2 51.17 4 25619 VEV_1_3_RA4_01_1235.d 1.56E4 1 1 768 785
R.TVSNESVEFVR.T Y 33.32 1265.6251 11 -18.6 633.8080 2 61.02 6 31180 VEV_3_3_RA6_01_1237.d 2.1E5 3 3 529 539
K.ATEKHTAM(+15.99)TR.I Y 18.23 1160.5608 10 12.5 387.8657 3 13.61 5 4295 VEV_2_3_RA5_01_1236.d 5.11E4 1 1 557 566 Oxidation (M)
R.LFGTAR.V Y 17.48 663.3704 6 -11.0 332.6888 2 39.64 4 18492 VEV_1_3_RA4_01_1235.d 1.58E5 1 1 208 213
total 5 peptides
C1FZG2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SSNYDTDVFTPLFEK.I Y 63.24 1761.8097 15 8.0 881.9192 2 82.31 6 46746 VEV_3_3_RA6_01_1237.d 0 1 1 351 365
R.AVFGETYPDPVR.V Y 37.23 1349.6615 12 -14.3 675.8284 2 70.90 6 38529 VEV_3_3_RA6_01_1237.d 7.68E4 1 1 774 785
K.SAVSDSDLEEIER.I Y 20.78 1448.6631 13 -13.8 725.3289 2 65.83 6 34754 VEV_3_3_RA6_01_1237.d 3.64E4 1 1 732 744
total 3 peptides
C1GAK2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SC(+57.02)VAVHQLPK.G Y 54.43 1137.5964 10 -14.7 569.7971 2 35.59 6 16000 VEV_3_3_RA6_01_1237.d 7.72E4 1 1 104 113 Carbamidomethylation
R.ANGQVFLSGAIPADEKGNVIEGTVGEK.T Y 39.36 2699.3765 27 -8.8 900.7915 3 76.86 6 42898 VEV_3_3_RA6_01_1237.d 3.45E4 1 1 25 51
K.DAC(+57.02)PPAGPYSHAIR.A Y 31.62 1510.6986 14 -9.7 504.5686 3 54.67 6 27017 VEV_3_3_RA6_01_1237.d 5.91E5 5 5 11 24 Carbamidomethylation
M.A(+42.01)DIVHVFAK.D Y 16.53 1040.5654 9 -36.2 521.2712 2 78.18 6 43894 VEV_3_3_RA6_01_1237.d 0 2 2 2 10 Acetylation (Protein N-term)
total 4 peptides
C1GFJ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ILIPMPWSPVG Y 49.97 1208.6627 11 -8.1 1209.6602 1 92.84 4 55213 VEV_1_3_RA4_01_1235.d 2.82E4 1 1 399 409
R.DITPDTAASFNAR.Q Y 39.42 1377.6525 13 -3.9 689.8308 2 66.01 4 36070 VEV_1_3_RA4_01_1235.d 7.71E4 1 1 35 47
R.KLGGLFELR.S Y 27.53 1031.6127 9 -15.1 344.8730 3 71.49 4 40395 VEV_1_3_RA4_01_1235.d 4.17E4 1 1 305 313
R.APSIRDITPDTAASFNAR.Q Y 24.89 1901.9595 18 -12.2 634.9860 3 70.79 6 38444 VEV_3_3_RA6_01_1237.d 1.32E4 1 1 30 47
R.SFSEVLAR.G Y 18.37 907.4763 8 -12.7 454.7397 2 61.26 4 32476 VEV_1_3_RA4_01_1235.d 2.5E5 1 1 186 193
total 5 peptides
C1FYX3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NC(+57.02)GGGEGYVSVGK.A Y 53.60 1282.5612 13 -10.7 642.2810 2 40.41 6 18728 VEV_3_3_RA6_01_1237.d 1.04E5 2 2 131 143 Carbamidomethylation
K.ADSLSSQGLK.R Y 40.61 1004.5138 10 -15.7 503.2563 2 34.81 6 15545 VEV_3_3_RA6_01_1237.d 6.41E5 4 4 74 83
K.ADSLSSQGLKR.V Y 27.11 1160.6149 11 -11.2 581.3082 2 28.43 4 12028 VEV_1_3_RA4_01_1235.d 1.8E6 2 2 74 84
K.SLQLADK.S Y 23.08 773.4283 7 -22.2 387.7128 2 30.74 6 13300 VEV_3_3_RA6_01_1237.d 0 1 1 41 47
total 4 peptides
C1G0X3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.Q(-17.03)GYGFLTSLPVR.V Y 47.91 1319.6874 12 -20.9 660.8372 2 87.64 4 52275 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 390 401 Pyro-glu from Q
R.SC(+57.02)YLATLANIIESGLNYNR.G Y 44.48 2171.0681 19 -4.6 1086.5364 2 94.76 5 54122 VEV_2_3_RA5_01_1236.d 4.63E4 1 1 235 253 Carbamidomethylation
R.HALSPTFFLPR.A Y 35.40 1284.6979 11 -14.8 429.2336 3 76.28 5 43504 VEV_2_3_RA5_01_1236.d 1.61E5 2 2 37 47
K.SQGAEAQGDQFSHNFNR.H Y 26.55 1891.8197 17 -12.9 631.6057 3 51.55 4 25864 VEV_1_3_RA4_01_1235.d 6.7E4 1 1 20 36
R.QGYGFLTSLPVR.V Y 18.38 1336.7139 12 -23.1 669.3488 2 80.47 6 45494 VEV_3_3_RA6_01_1237.d 1.14E5 1 1 390 401
total 5 peptides
C1GJI2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TVVVHAGTDDLGKGGNEESKK.T Y 72.00 2140.0759 21 -13.7 536.0189 4 34.61 6 15426 VEV_3_3_RA6_01_1237.d 1.61E5 2 2 117 137
K.LIGEHSVLGR.T Y 32.98 1079.6088 10 -15.9 360.8712 3 56.98 6 28353 VEV_3_3_RA6_01_1237.d 1.47E5 1 1 107 116
total 2 peptides
C1GC24
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AYFSQFGPITR.L Y 55.24 1285.6455 11 -14.5 643.8207 2 75.49 6 41903 VEV_3_3_RA6_01_1237.d 1.12E5 1 1 268 278
K.AAVTSAPTPADPPSKK.S Y 39.94 1536.8147 16 -16.1 513.2706 3 34.37 5 15802 VEV_2_3_RA5_01_1236.d 1.38E5 2 2 12 27
K.TGTETQEPGTIYVGR.V Y 38.71 1607.7791 15 -17.7 804.8826 2 59.97 6 30426 VEV_3_3_RA6_01_1237.d 0 1 1 242 256
total 3 peptides
C1GMJ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFADALDAVPMALAENSGLRPIETLAALK.S Y 73.40 2983.5688 29 -13.5 995.5168 3 94.22 4 55928 VEV_1_3_RA4_01_1235.d 2.24E5 2 2 455 483
R.SLHDALC(+57.02)VVR.N Y 29.04 1168.6023 10 -24.7 390.5317 3 61.85 6 31789 VEV_3_3_RA6_01_1237.d 2.59E4 1 1 406 415 Carbamidomethylation
total 2 peptides
C1G0Q6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AIDIGADLIC(+57.02)AQGGEGGGHTGDVPTSVLIPTVSK.I Y 52.80 3304.6609 34 11.3 1102.5734 3 84.15 4 50015 VEV_1_3_RA4_01_1235.d 0 1 1 163 196 Carbamidomethylation
K.AIVDELVGDAVKWLQQGSK.M Y 39.40 2055.1001 19 -6.2 686.0364 3 94.18 4 55901 VEV_1_3_RA4_01_1235.d 1.52E5 2 2 345 363
K.GKLDELIDIIIESGAR.L Y 33.63 1740.9622 16 -17.0 581.3181 3 91.46 4 54479 VEV_1_3_RA4_01_1235.d 0 1 1 111 126
R.TVTTDLLGINHPVILAGMNVAAGPK.L Y 16.21 2501.3674 25 -29.1 626.3309 4 83.91 5 48506 VEV_2_3_RA5_01_1236.d 7.1E4 1 1 22 46
total 4 peptides
C1G0Q2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.RPSNSPSQSATPPVVSR.T Y 72.39 1765.9071 17 -9.9 589.6371 3 38.78 5 18405 VEV_2_3_RA5_01_1236.d 5.11E4 1 1 170 186
K.AESQK.I N 19.22 561.2758 5 -37.1 562.2623 1 47.37 6 22781 VEV_3_3_RA6_01_1237.d 4.31E5 2 2 6 10
R.IASPAPVSPAR.G Y 17.21 1064.5978 11 -73.6 533.2670 2 46.55 5 23056 VEV_2_3_RA5_01_1236.d 0 1 1 306 316
total 3 peptides
C1GHB7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LAGKTDEEDGVPTDGIASIQTR.R Y 66.37 2272.1182 22 -17.2 758.3670 3 67.11 6 35718 VEV_3_3_RA6_01_1237.d 7.31E4 2 2 285 306
R.SSSSLDYYGGPSDR.Q Y 42.58 1489.6321 14 -6.2 745.8187 2 57.81 4 29874 VEV_1_3_RA4_01_1235.d 4.45E4 1 1 321 334
total 2 peptides
C1G6C1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLGAEVYPVPAVAFDNPANYNHQAR.Q Y 67.27 2725.3611 25 -16.4 909.4460 3 81.22 6 46011 VEV_3_3_RA6_01_1237.d 3.61E4 1 1 144 168
R.AALYVVQDAVER.G Y 29.62 1332.7037 12 -18.4 667.3469 2 71.02 4 40015 VEV_1_3_RA4_01_1235.d 6.74E4 1 1 83 94
R.TGSSITEGIGQGR.V Y 16.70 1261.6262 13 -16.7 631.8099 2 47.23 6 22692 VEV_3_3_RA6_01_1237.d 1.28E5 1 1 262 274
total 3 peptides
C1GF00
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NRPIPQWIR.L Y 70.94 1178.6672 9 -8.6 393.8930 3 62.96 4 33783 VEV_1_3_RA4_01_1235.d 1.58E6 5 5 20 28
K.RNRPIPQWIR.L Y 22.24 1334.7683 10 -21.0 334.6924 4 58.68 6 29495 VEV_3_3_RA6_01_1237.d 3.05E4 1 1 19 28
R.LRTGNTIR Y 16.64 929.5406 8 -16.2 465.7701 2 16.96 6 5967 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 29 36
total 3 peptides
C1FZM8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISPSGELQTPQR.S Y 75.15 1311.6782 12 -12.6 656.8381 2 53.22 5 27121 VEV_2_3_RA5_01_1236.d 2.13E5 3 3 611 622
R.HAGTSLVGTGGRPAK.L Y 24.69 1407.7582 15 -68.7 470.2278 3 24.26 6 9812 VEV_3_3_RA6_01_1237.d 5.14E5 2 2 749 763
total 2 peptides
C1GCH9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VALEDRPC(+57.02)PTIQSSTDAIVK.L Y 69.88 2199.1206 20 -1.2 734.0466 3 69.39 4 38739 VEV_1_3_RA4_01_1235.d 7.27E4 2 2 83 102 Carbamidomethylation
R.IPHAASSLYK.L Y 23.56 1085.5869 10 -17.9 543.7910 2 44.05 6 20848 VEV_3_3_RA6_01_1237.d 4.05E4 1 1 196 205
K.ALVYQSQGK.V Y 17.29 992.5291 9 -14.8 497.2645 2 29.75 5 13115 VEV_2_3_RA5_01_1236.d 7.38E4 1 1 74 82
total 3 peptides
C1GD94
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSEDALNVFLPTLIR.S Y 70.64 1685.9352 15 -33.0 843.9470 2 88.97 5 51369 VEV_2_3_RA5_01_1236.d 4.89E4 5 5 449 463
R.GYDDDTVLQR.Q Y 21.39 1180.5360 10 -9.5 591.2697 2 56.17 5 28867 VEV_2_3_RA5_01_1236.d 4.39E4 1 1 25 34
K.VLLDTESLASR.T Y 18.17 1202.6506 11 -15.1 602.3235 2 68.84 5 38155 VEV_2_3_RA5_01_1236.d 0 1 1 123 133
total 3 peptides
C1GG56
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSADSFSYSGSR.V Y 75.11 1275.5731 12 -9.4 638.7878 2 62.88 4 33680 VEV_1_3_RA4_01_1235.d 2.04E5 2 2 85 96
R.FSKPQWLSSATAR.T Y 24.52 1477.7677 13 0.7 493.5969 3 66.68 5 36528 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 11 23
total 2 peptides
C1GJR5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.QQQQLSQHQQYQQQHQQR.M Y 67.34 2348.1118 18 -8.4 588.0303 4 19.87 4 7326 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 81 98
R.Q(-17.03)QQQLSQHQQYQQQHQQR.M Y 57.21 2331.0852 18 -8.2 778.0293 3 34.53 5 15895 VEV_2_3_RA5_01_1236.d 1E5 2 2 81 98 Pyro-glu from Q
R.AALEVHGGGGR.S Y 40.01 1022.5257 11 1.3 512.2708 2 18.91 4 6840 VEV_1_3_RA4_01_1235.d 1.37E5 2 2 184 194
total 3 peptides
C1G389
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ISATGLYSAPYSHASPALQQGLR.Q Y 69.20 2387.2234 23 -20.5 796.7321 3 74.04 6 40845 VEV_3_3_RA6_01_1237.d 9.31E4 2 2 145 167
K.SGQTGTPGPR.N Y 35.74 956.4675 10 6.2 479.2440 2 12.91 5 3919 VEV_2_3_RA5_01_1236.d 3.1E4 3 3 564 573
total 2 peptides
C1GLD3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SDEGEYAYLR.I Y 47.93 1201.5251 10 -6.4 601.7660 2 60.58 4 31919 VEV_1_3_RA4_01_1235.d 8.89E4 1 1 573 582
R.VGESGPYIFTK.D Y 41.04 1196.6077 11 -10.4 599.3049 2 67.07 4 36901 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 417 427
R.VPGEVEIHQNGLR.Y Y 24.61 1446.7579 13 -4.7 724.3828 2 99.22 5 55749 VEV_2_3_RA5_01_1236.d 1.18E4 1 1 679 691
K.NASKSDEGEYAYLR.I Y 22.72 1601.7321 14 -0.6 534.9177 3 48.53 4 23957 VEV_1_3_RA4_01_1235.d 8.12E4 1 1 569 582
R.SKDNDRLAQVAQDISELRK.N Y 21.51 2185.1450 19 -17.7 438.0286 5 72.03 6 39384 VEV_3_3_RA6_01_1237.d 7.37E4 1 1 615 633
total 5 peptides
C1GBX3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GYLNNPAANDSSFTK.S Y 65.18 1597.7372 15 -6.9 799.8704 2 65.49 4 35658 VEV_1_3_RA4_01_1235.d 6.13E4 1 1 364 378
K.GSLENDVSAVR.A Y 31.04 1145.5676 11 -1.4 573.7903 2 57.93 5 30064 VEV_2_3_RA5_01_1236.d 1.15E5 2 2 106 116
M.S(+42.01)TLANSFPDNK.S Y 16.30 1234.5830 11 -1.3 618.2980 2 70.30 4 39449 VEV_1_3_RA4_01_1235.d 6.44E4 1 1 2 12 Acetylation (Protein N-term)
total 3 peptides
C1G5Z2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FYDNWETYYDKLLLR.S Y 50.04 2037.9835 15 -3.5 680.3328 3 85.54 4 50943 VEV_1_3_RA4_01_1235.d 1.35E5 3 3 337 351
K.KVPAALADYVENNNLQGK.L Y 47.38 1943.0112 18 -26.0 648.6608 3 71.67 6 39113 VEV_3_3_RA6_01_1237.d 2.27E5 1 1 49 66
R.SQQVSNSPELIRR.L Y 36.70 1512.8008 13 -9.9 505.2692 3 44.45 4 21424 VEV_1_3_RA4_01_1235.d 9.1E4 1 1 352 364
total 3 peptides
C1FZ18
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TFVSPAVEQVIEEVTSR.M Y 59.23 1889.9734 17 -9.7 945.9848 2 89.68 6 51166 VEV_3_3_RA6_01_1237.d 1.38E5 2 2 586 602
R.DSANQLTQYQSLAK.K Y 52.88 1565.7686 14 -6.2 783.8867 2 68.07 4 37695 VEV_1_3_RA4_01_1235.d 1.19E5 3 3 678 691
total 2 peptides
A0A0A0HX82
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TFFTRYDYENVDSAGASK.V Y 53.69 2069.9331 18 -6.4 690.9805 3 70.04 4 39244 VEV_1_3_RA4_01_1235.d 1.24E5 2 2 420 437
R.LSGTGSSGATIR.L Y 38.83 1105.5728 12 -30.4 553.7769 2 29.36 5 12911 VEV_2_3_RA5_01_1236.d 6.17E4 2 2 498 509
K.TVSITPFTDQKAGTSGLR.K Y 35.26 1877.9846 18 -5.0 626.9990 3 68.51 5 37915 VEV_2_3_RA5_01_1236.d 1.05E5 1 1 5 22
total 3 peptides
C1G188
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SQHGGDDGVVEEPPSTSYR.R Y 62.02 2015.8821 19 -8.8 672.9620 3 52.77 4 26659 VEV_1_3_RA4_01_1235.d 6.48E4 1 1 545 563
R.AADADVHGYGSITSR.G Y 45.61 1518.7063 15 -9.1 760.3535 2 49.73 4 24716 VEV_1_3_RA4_01_1235.d 5.3E4 1 1 1015 1029
total 2 peptides
C1GDR6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VASPTGIGAAQDAAR.M Y 49.74 1383.7106 15 -16.1 692.8514 2 53.74 6 26491 VEV_3_3_RA6_01_1237.d 5.5E4 1 1 17 31
R.GPAPEIKPTGLLGR.Y Y 43.56 1404.8088 14 -27.8 469.2639 3 67.08 6 35686 VEV_3_3_RA6_01_1237.d 1.3E5 2 2 45 58
R.IVGFYEKLPR.G Y 39.64 1220.6917 10 -9.4 407.9007 3 67.65 5 37262 VEV_2_3_RA5_01_1236.d 1.35E5 2 2 35 44
total 3 peptides
C1GM45
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALTTEIGGGKPTQQNVER.Y Y 58.86 1897.9857 18 -10.8 633.6624 3 52.91 5 26929 VEV_2_3_RA5_01_1236.d 2.36E5 3 3 419 436
R.LRPDFQHISGGDPNAR.L Y 50.60 1778.8812 16 -7.8 445.7241 4 57.43 5 29723 VEV_2_3_RA5_01_1236.d 1.63E5 2 2 401 416
total 2 peptides
C1GGB6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ESLGSIIFGDR.I Y 50.87 1192.6088 11 -3.9 597.3093 2 81.20 4 47937 VEV_1_3_RA4_01_1235.d 1.21E5 1 1 85 95
R.LTPTISELDEHLHSVIPFDYYYAAFHFC(+57.02)QPK.D Y 42.47 3737.7864 31 1.0 748.5653 5 88.00 4 52503 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 47 77 Carbamidomethylation
R.VVGVLVLPESR.K Y 35.94 1166.7023 11 -36.5 584.3371 2 74.93 4 43076 VEV_1_3_RA4_01_1235.d 0 1 1 202 212
total 3 peptides
C1G5N0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAAAQSLQNSGTASHS Y 64.54 1499.6964 16 -8.2 750.8494 2 26.68 4 11037 VEV_1_3_RA4_01_1235.d 1.13E5 2 2 322 337
R.FVSNEAIDFLDKLLR.Y Y 37.46 1778.9567 15 -5.2 593.9897 3 90.47 5 52126 VEV_2_3_RA5_01_1236.d 8.39E4 2 2 285 299
total 2 peptides
C1GBD3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GSGIVAFESADDAR.N Y 64.48 1393.6473 14 -16.1 697.8197 2 66.33 6 35124 VEV_3_3_RA6_01_1237.d 1.13E5 3 3 256 269
R.ADVHVDPSGRPK.G Y 22.81 1276.6523 12 -23.0 426.5482 3 22.16 5 8896 VEV_2_3_RA5_01_1236.d 1.23E5 1 1 244 255
R.SAIIFVR.N Y 20.95 804.4857 7 -51.3 403.2295 2 66.31 5 36254 VEV_2_3_RA5_01_1236.d 0 1 1 375 381
total 3 peptides
C1G2Z9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AC(+57.02)EYLALTTLPTDDLLR.T Y 73.37 1963.9924 17 -6.4 982.9972 2 86.51 4 51574 VEV_1_3_RA4_01_1235.d 1.51E5 2 2 565 581 Carbamidomethylation
R.IYSQSPDSELQQR.A Y 18.82 1549.7372 13 -15.8 775.8636 2 54.85 5 28096 VEV_2_3_RA5_01_1236.d 8.83E4 1 1 552 564
total 2 peptides
C1GH68
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPAEETLYPNESNC(+57.02)HR.F Y 50.61 1902.8167 16 -9.5 635.2734 3 48.71 4 24078 VEV_1_3_RA4_01_1235.d 7.99E4 2 2 213 228 Carbamidomethylation
R.AAVSDLPSSPLQK.H Y 35.44 1311.7034 13 -10.0 656.8524 2 65.61 4 35763 VEV_1_3_RA4_01_1235.d 2.81E4 1 1 461 473
R.NHLPGNDTFC(+57.02)TLEAFKK.I Y 25.94 1990.9570 17 15.9 498.7545 4 70.28 5 39201 VEV_2_3_RA5_01_1236.d 0 1 1 496 512 Carbamidomethylation
R.YLYVDQLGFMPK.V Y 22.71 1472.7373 12 2.2 737.3776 2 82.78 4 49075 VEV_1_3_RA4_01_1235.d 4.41E4 2 2 154 165
total 4 peptides
C1GDX9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AASQAGGITEAGSSPGR.I Y 82.65 1515.7277 17 -6.5 758.8662 2 36.17 5 16878 VEV_2_3_RA5_01_1236.d 4.4E4 1 1 111 127
total 1 peptides
C1GKB8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LILPQIDQLGLDLLSR.M Y 64.78 1806.0614 16 -13.9 904.0254 2 93.37 5 53516 VEV_2_3_RA5_01_1236.d 2.54E5 2 2 343 358
K.LGDFGLAR.A Y 24.58 847.4551 8 -9.0 424.7310 2 65.27 5 35480 VEV_2_3_RA5_01_1236.d 1.76E5 1 1 236 243
R.APDVLLGSR.T Y 15.05 926.5185 9 -31.6 464.2519 2 59.41 6 30018 VEV_3_3_RA6_01_1237.d 2.67E4 1 1 263 271
total 3 peptides
C1GBD6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPIEETVAQLGEGR.G Y 57.14 1484.7471 14 -5.1 743.3770 2 74.54 6 41255 VEV_3_3_RA6_01_1237.d 1.53E5 2 2 154 167
K.NYRSPIEETVAQLGEGR.G Y 29.92 1917.9543 17 -12.7 640.3173 3 75.56 5 42996 VEV_2_3_RA5_01_1236.d 1.11E5 1 1 151 167
R.IKEHYGIDVPAAPQPAGP Y 29.54 1858.9576 18 -12.8 620.6519 3 68.83 5 38146 VEV_2_3_RA5_01_1236.d 8.7E4 1 1 182 199
total 3 peptides
A0A0A0HXV1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLSNTTDPNAAK.N Y 50.15 1243.6409 12 -9.5 622.8218 2 37.70 4 17331 VEV_1_3_RA4_01_1235.d 1.76E5 3 3 529 540
K.VLQAATAENDNPDIRDR.A Y 38.59 1896.9290 17 -8.5 633.3115 3 54.21 4 27621 VEV_1_3_RA4_01_1235.d 4.09E5 3 3 506 522
K.AAIEEQLQNAR.E Y 36.64 1241.6364 11 18.3 621.8368 2 56.24 5 28916 VEV_2_3_RA5_01_1236.d 0 1 1 597 607
total 3 peptides
C1GL06
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAESPIHTTSQTPK.L Y 67.21 1496.7471 14 -13.2 749.3709 2 30.42 5 13501 VEV_2_3_RA5_01_1236.d 1.1E5 3 3 36 49
R.IPTDTSKESR.I Y 28.56 1132.5724 10 -16.6 567.2841 2 14.26 6 4556 VEV_3_3_RA6_01_1237.d 3.28E4 2 2 128 137
total 2 peptides
C1GHR8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.STIVQTSVTASR.L Y 66.66 1248.6674 12 -8.6 625.3356 2 50.48 6 24566 VEV_3_3_RA6_01_1237.d 1.94E5 3 3 248 259
R.INTISTSAAGLSSK.T Y 29.52 1348.7197 14 -51.2 675.3326 2 59.70 5 31331 VEV_2_3_RA5_01_1236.d 7.79E4 1 1 303 316
total 2 peptides
C1GFK5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NRGVNEAFTEAAR.V Y 47.42 1433.7010 13 -8.4 478.9036 3 47.02 4 23020 VEV_1_3_RA4_01_1235.d 3.39E4 1 1 116 128
R.GVNEAFTEAAR.V Y 35.54 1163.5570 11 -13.8 582.7778 2 55.75 6 27579 VEV_3_3_RA6_01_1237.d 7.03E5 4 4 118 128
R.VALTVKPAR.S Y 29.87 953.6022 9 -7.4 318.8723 3 35.67 4 16133 VEV_1_3_RA4_01_1235.d 3.67E5 4 4 129 137
R.YLEC(+57.02)SAMR.N Y 24.51 1028.4419 8 0.6 515.2285 2 43.79 4 21012 VEV_1_3_RA4_01_1235.d 1.77E5 1 1 108 115 Carbamidomethylation
total 4 peptides
C1GGC0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VKDILNC(+57.02)FPFEDPVVVLR.I Y 72.76 2159.1448 18 7.8 720.7278 3 86.73 4 51706 VEV_1_3_RA4_01_1235.d 1.59E5 3 3 367 384 Carbamidomethylation
R.QKAGLDADR.V Y 16.62 972.4988 9 -31.2 487.2415 2 10.67 6 2771 VEV_3_3_RA6_01_1237.d 0 1 1 629 637
total 2 peptides
C1G0J6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVNSVADQLR.S Y 45.47 1099.5985 10 -19.3 550.7959 2 53.30 5 27182 VEV_2_3_RA5_01_1236.d 2.63E5 3 3 288 297
K.STNYDPESIQAAR.Q Y 38.58 1450.6688 13 -15.2 726.3307 2 57.66 4 29768 VEV_1_3_RA4_01_1235.d 2.38E5 4 4 245 257
R.EQVVEIIEQR.D Y 35.29 1241.6615 10 -12.3 621.8304 2 60.30 6 30684 VEV_3_3_RA6_01_1237.d 3.78E5 2 2 47 56
R.ELASGLSFPIGYK.N Y 17.23 1380.7289 13 -13.8 691.3622 2 80.29 4 47319 VEV_1_3_RA4_01_1235.d 0 1 1 180 192
total 4 peptides
A0A0A0HRT0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLLKQDGIFSGLR.K Y 50.55 1444.8401 13 -10.7 482.6155 3 75.44 4 43476 VEV_1_3_RA4_01_1235.d 1.2E4 1 1 371 383
R.AGEPNKAVIC(+57.02)SLALAK.L Y 48.77 1640.8920 16 -10.6 547.9655 3 68.02 6 36405 VEV_3_3_RA6_01_1237.d 0 1 1 414 429 Carbamidomethylation
R.AGEPNK.A Y 16.66 614.3024 6 -7.9 615.3048 1 29.35 6 12520 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 414 419
total 3 peptides
A0A0A0HW80
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LAANGDPEAQDFTR.Y Y 66.24 1503.6953 14 -11.5 752.8463 2 60.06 6 30481 VEV_3_3_RA6_01_1237.d 4.33E4 1 1 111 124
R.YQTLPC(+57.02)AR.T Y 27.98 1007.4858 8 -11.0 504.7447 2 42.90 5 20857 VEV_2_3_RA5_01_1236.d 2.31E5 2 2 125 132 Carbamidomethylation
total 2 peptides
C1GMY3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSHGSQQSSIQDPSRPESGHSSR.G Y 61.89 2463.1487 23 -14.1 493.6301 5 24.97 4 10108 VEV_1_3_RA4_01_1235.d 1.3E5 3 3 460 482
R.SSQQATAYGHGR.S Y 24.27 1261.5800 12 -4.9 421.5319 3 12.71 5 3815 VEV_2_3_RA5_01_1236.d 1.1E5 2 2 124 135
R.GLVPVSFFEVIGKNER.N Y 18.44 1789.9727 16 -15.4 597.6556 3 83.80 5 48437 VEV_2_3_RA5_01_1236.d 8.36E4 1 1 84 99
total 3 peptides
A0A0A0HYT2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAASSLLASGDPSDLAFAGEIFSK.L Y 55.68 2324.1536 24 -3.7 1163.0797 2 87.72 4 52328 VEV_1_3_RA4_01_1235.d 7.96E3 1 1 449 472
K.SIVDKLSPIQDLISDIDVSSLEAAGIPSITNTAATK.M Y 26.61 3681.9563 36 -22.6 1228.2983 3 95.69 5 54512 VEV_2_3_RA5_01_1236.d 3.29E4 1 1 501 536
K.FHEIPTSTDSDKLFSFQTR.A Y 21.55 2255.0857 19 27.5 564.7942 4 74.64 4 42850 VEV_1_3_RA4_01_1235.d 0 1 1 269 287
K.IDEAK.S N 15.89 574.2962 5 39.5 575.3262 1 30.61 5 13613 VEV_2_3_RA5_01_1236.d 1.28E5 1 1 224 228
total 4 peptides
C1GFX9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HNISNPADELSASFR.V Y 80.12 1656.7855 15 -11.2 553.2629 3 69.96 4 39180 VEV_1_3_RA4_01_1235.d 5.11E4 1 1 119 133
total 1 peptides
C1GIW6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TTSPDYIGQDPELAALDFR.S Y 62.99 2108.0061 19 -5.3 1055.0048 2 82.95 4 49194 VEV_1_3_RA4_01_1235.d 3.57E4 2 2 141 159
R.HGESEFNLLGR.I Y 21.62 1257.6101 11 -12.4 420.2054 3 65.28 6 34335 VEV_3_3_RA6_01_1237.d 3.51E4 1 1 223 233
K.GSSAK.H N 18.84 448.2281 5 -24.9 449.2242 1 33.97 6 15057 VEV_3_3_RA6_01_1237.d 1.97E5 1 1 422 426
total 3 peptides
C1GB60
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSQTSASAGPAHSAPPQQQQR.Q Y 79.76 2119.9995 21 -9.4 707.6671 3 22.71 5 9195 VEV_2_3_RA5_01_1236.d 1.56E5 2 2 327 347
R.SSQTSASAGPAHSAPPQQQQ(+.98)R.Q Y 40.07 2120.9834 21 -3.8 707.9990 3 24.59 5 10244 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 327 347 Deamidation (NQ)
R.SSQTSASAGPAHSAPPQ(+.98)QQQR.Q Y 34.00 2120.9834 21 -2.4 708.0001 3 24.40 4 9784 VEV_1_3_RA4_01_1235.d 8.06E4 1 1 327 347 Deamidation (NQ)
total 3 peptides
C1G021
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSLQDSTGAFSLVK.C Y 79.58 1438.7303 14 -11.5 720.3642 2 74.20 5 42023 VEV_2_3_RA5_01_1236.d 2.58E5 3 3 31 44
total 1 peptides
C1GCW3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TPEDNADLLIADFGLSR.I Y 68.76 1845.9108 17 4.9 923.9672 2 86.87 5 50241 VEV_2_3_RA5_01_1236.d 2.39E4 1 1 151 167
R.DLKPENLLFRTPEDNADLLIADFGLSR.I Y 21.60 3071.5928 27 -12.3 768.8960 4 90.52 4 53944 VEV_1_3_RA4_01_1235.d 0 1 1 141 167
total 2 peptides
C1GD03
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IHDTASEEPSTVTVSEIATR.H Y 79.43 2142.0439 20 -3.7 715.0193 3 65.85 4 35947 VEV_1_3_RA4_01_1235.d 8.72E4 2 2 115 134
total 1 peptides
C1GLZ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LWHELDIVPLVLHGK.G Y 61.90 1768.0035 15 -1.1 443.0077 4 82.45 4 48844 VEV_1_3_RA4_01_1235.d 7.68E4 2 2 160 174
K.TLDEQAESVAR.K Y 34.75 1217.5887 11 11.2 609.8085 2 48.47 4 23910 VEV_1_3_RA4_01_1235.d 7.45E3 1 1 191 201
total 2 peptides
C1G9V0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALVSAGFGYPTPSPGGNIR.W Y 69.37 1859.9529 19 -16.9 930.9680 2 76.78 5 43861 VEV_2_3_RA5_01_1236.d 2.5E4 2 2 697 715
R.GFQHAAVPQVDAK.I Y 19.52 1366.6993 13 -36.5 684.3320 2 52.81 4 26731 VEV_1_3_RA4_01_1235.d 6.39E4 1 1 328 340
total 2 peptides
C1G8R5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IRFVGSGVSGGEEGAR.Y Y 45.96 1576.7957 16 0.1 526.6059 3 57.22 5 29603 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 141 156
K.AALWGIPTPAFSTALSFYDGYR.T Y 43.39 2403.1899 22 -8.0 1202.5927 2 93.54 4 55579 VEV_1_3_RA4_01_1235.d 1.14E5 2 2 431 452
K.SIVGAHSIEEFC(+57.02)AK.L Y 32.07 1546.7450 14 -17.0 516.5802 3 66.87 4 36741 VEV_1_3_RA4_01_1235.d 5.03E4 1 1 71 84 Carbamidomethylation
total 3 peptides
C1G6I9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VTNQPSPAPELNNNTPSR.F Y 64.66 1934.9446 18 -9.9 645.9824 3 55.20 5 28286 VEV_2_3_RA5_01_1236.d 7.99E4 1 1 444 461
R.ILGSHDSQNQESLLKR.V Y 27.10 1823.9490 16 -10.8 608.9837 3 54.27 5 27757 VEV_2_3_RA5_01_1236.d 3.6E4 1 1 629 644
total 2 peptides
C1G106
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGNDEAEKYPDIPLRR.G Y 43.43 1842.9224 16 -17.1 615.3042 3 59.92 5 31497 VEV_2_3_RA5_01_1236.d 2.39E5 2 2 245 260
K.VAIITGAGQGVGAEAAR.L Y 34.21 1539.8369 17 -28.8 770.9036 2 65.45 4 35629 VEV_1_3_RA4_01_1235.d 4.8E4 2 2 25 41
R.LFANEGAK.V Y 32.41 848.4392 8 -16.5 425.2199 2 30.65 5 13635 VEV_2_3_RA5_01_1236.d 5.83E5 3 3 42 49
K.LVQAASPYFR.V Y 26.73 1150.6134 10 -28.6 576.2975 2 65.33 6 34429 VEV_3_3_RA6_01_1237.d 7.22E4 2 2 140 149
total 4 peptides
C1G8P5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TYTFSDLVHQDDLYGRPLGGDNATIQETPESR.L Y 61.12 3594.6863 32 6.8 899.6849 4 79.89 4 46932 VEV_1_3_RA4_01_1235.d 4.01E4 1 1 232 263
R.TLYTALLAFEDQIKSR.G Y 22.67 1868.0043 16 -6.8 623.6711 3 86.97 6 49644 VEV_3_3_RA6_01_1237.d 9.1E4 1 1 82 97
K.TGTTAGIEAR.S Y 16.05 975.4985 10 3.6 488.7583 2 45.80 6 21876 VEV_3_3_RA6_01_1237.d 0 1 1 304 313
total 3 peptides
C1GF57
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSGYVESLPASIR.R Y 56.30 1364.6936 13 -10.3 683.3470 2 69.38 5 38545 VEV_2_3_RA5_01_1236.d 2.01E5 5 5 75 87
R.ATIVNGNSEPTEDEVK.A Y 42.94 1701.8057 16 -6.6 851.9045 2 55.14 4 28134 VEV_1_3_RA4_01_1235.d 9.74E4 2 2 130 145
total 2 peptides
C1G6X9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.EAVTPAEEEQSEGSAR.R Y 50.92 1688.7489 16 -8.3 845.3748 2 38.43 6 17590 VEV_3_3_RA6_01_1237.d 6.59E4 1 1 23 38
R.EGILPFSR.L Y 24.57 917.4970 8 -18.0 459.7475 2 73.38 6 40393 VEV_3_3_RA6_01_1237.d 4.13E4 1 1 350 357
M.A(+42.01)TEANHWLSGIWR.S Y 24.41 1581.7688 13 -5.6 791.8873 2 84.19 6 47953 VEV_3_3_RA6_01_1237.d 2.92E5 2 2 2 14 Acetylation (Protein N-term)
R.VLAASFFR.N Y 24.24 909.5072 8 -21.1 455.7513 2 73.34 6 40333 VEV_3_3_RA6_01_1237.d 8.16E4 1 1 303 310
total 4 peptides
C1GD67
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NNAATEAISSGAGSSSADGKIR.A Y 68.22 2062.9878 22 -18.7 688.6570 3 55.17 5 28266 VEV_2_3_RA5_01_1236.d 4.72E4 1 1 62 83
K.NLPYYFNPITK.E Y 17.87 1368.7078 11 -15.0 685.3509 2 78.73 5 45205 VEV_2_3_RA5_01_1236.d 5.2E4 1 1 22 32
total 2 peptides
C1GFU1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NTIFTNQYAVTSR.S Y 50.99 1513.7524 13 -9.5 757.8763 2 68.01 5 37538 VEV_2_3_RA5_01_1236.d 9.75E4 1 1 302 314
R.KNTIFTNQYAVTSR.S Y 29.62 1641.8474 14 -7.4 548.2857 3 61.56 5 32706 VEV_2_3_RA5_01_1236.d 2.81E4 1 1 301 314
R.AGTVDPYSQVLPDPSTISPSQRK.N Y 22.03 2442.2390 23 -10.7 815.0782 3 74.35 4 42629 VEV_1_3_RA4_01_1235.d 3.37E4 1 1 279 301
R.ELNVALSGGGR.E Y 16.03 1071.5673 11 -3.7 536.7889 2 57.21 4 29455 VEV_1_3_RA4_01_1235.d 8.84E4 1 1 131 141
total 4 peptides
C1G162
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ISYTFETEDGIR.A Y 60.24 1429.6725 12 -23.9 715.8264 2 71.22 4 40179 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 330 341
K.DVALTEPLVDTVELK.A Y 22.04 1640.8872 15 -29.8 821.4264 2 83.47 4 49546 VEV_1_3_RA4_01_1235.d 1.54E4 1 1 208 222
R.FSTGPHAK.Y Y 17.61 843.4239 8 -15.4 422.7127 2 13.52 4 4064 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 280 287
total 3 peptides
C1GGW7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EALGLSNPGTVENVAR.E Y 60.99 1625.8373 16 -11.1 813.9169 2 69.38 6 37395 VEV_3_3_RA6_01_1237.d 2.1E4 1 1 32 47
K.EGLATVGAKYEFR.A Y 20.50 1439.7408 13 18.2 480.9296 3 66.20 5 36179 VEV_2_3_RA5_01_1236.d 1.13E5 1 1 270 282
R.KEGLATVGAKYEFR.A Y 16.79 1567.8358 14 28.2 392.9773 4 20.78 6 7970 VEV_3_3_RA6_01_1237.d 0 1 1 269 282
total 3 peptides
A0A0A0HVN3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NVPRPVETFDEAGFPQYVMTEVK.A Y 55.62 2652.2893 23 -8.4 885.0963 3 81.92 6 46488 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 123 145
R.VTYLVLDEADR.M Y 25.20 1292.6611 11 -35.6 647.3148 2 72.93 6 40038 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 277 287
R.DVVGIAETGSGK.T Y 24.63 1131.5771 12 -11.5 566.7894 2 56.51 6 28046 VEV_3_3_RA6_01_1237.d 9.63E4 1 1 168 179
total 3 peptides
C1FYP5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GAVASDVPEVPASAPAPAAK.A Y 76.05 1803.9366 20 -6.6 902.9696 2 66.57 6 35305 VEV_3_3_RA6_01_1237.d 2.27E5 3 3 195 214
total 1 peptides
A0A0A0HRQ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KLADATTDAAYGTLAAIQVSR.L Y 56.46 2135.1221 21 -62.5 712.6702 3 77.90 6 43658 VEV_3_3_RA6_01_1237.d 0 1 1 328 348
R.Q(-17.03)YC(+57.02)QEQLAPR.I Y 39.13 1274.5713 10 4.0 638.2955 2 64.54 5 34935 VEV_2_3_RA5_01_1236.d 7.4E4 1 1 60 69 Pyro-glu from Q; Carbamidomethylation
total 2 peptides
C1FYE6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YESGTSATLR.K Y 42.01 1083.5197 10 -5.9 542.7639 2 30.56 4 13162 VEV_1_3_RA4_01_1235.d 5.01E4 2 2 239 248
K.GASAVSADPIHITLSFLSPITPTSTLR.Q Y 41.90 2751.4807 27 -12.2 918.1563 3 90.24 6 51435 VEV_3_3_RA6_01_1237.d 5.98E4 1 1 124 150
R.Q(-17.03)VLGATSFAGTAENPILFLK.E Y 26.77 2059.0989 20 -10.0 1030.5464 2 93.88 6 53136 VEV_3_3_RA6_01_1237.d 4.84E4 1 1 379 398 Pyro-glu from Q
R.QVLGAT(-18.01)SFAGTAENPILFLK.E Y 20.81 2058.1150 20 -10.3 1030.0542 2 94.11 4 55871 VEV_1_3_RA4_01_1235.d 0 1 1 379 398 Dehydration
R.IVWQFDHIVPEDKIRPR.L Y 16.37 2147.1638 17 -8.6 430.4363 5 75.04 6 41571 VEV_3_3_RA6_01_1237.d 8.14E4 1 1 187 203
total 5 peptides
C1GMH1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLQDALAAEGPR.I Y 75.86 1238.6619 12 -10.4 620.3318 2 63.26 4 33952 VEV_1_3_RA4_01_1235.d 3.41E4 2 2 40 51
total 1 peptides
C1G833
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGKPLGFDQSAPPTSK.S Y 62.52 1615.8206 16 -10.9 539.6083 3 50.74 4 25338 VEV_1_3_RA4_01_1235.d 3.82E5 6 6 225 240
K.ELSDK.Q N 26.61 590.2911 5 -27.8 591.2820 1 22.47 6 8862 VEV_3_3_RA6_01_1237.d 3.64E4 2 2 96 100
total 2 peptides
C1GEQ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLATSPTNPELQQAR.S Y 56.87 1611.8217 15 -10.2 806.9099 2 59.26 6 29900 VEV_3_3_RA6_01_1237.d 1.27E5 3 3 36 50
R.YGLELDEVGR.R Y 25.80 1149.5665 10 -7.5 575.7863 2 71.28 6 38826 VEV_3_3_RA6_01_1237.d 8.54E3 1 1 81 90
K.LQGGVR.R N 17.93 628.3657 6 0.8 315.1904 2 11.59 5 3247 VEV_2_3_RA5_01_1236.d 0 1 1 215 220
total 3 peptides
C1GMH8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VDVDFSPYPTVK.A Y 61.03 1365.6816 12 -12.8 683.8394 2 75.44 6 41866 VEV_3_3_RA6_01_1237.d 1.08E5 1 1 205 216
R.TLVNIIAC(+57.02)DIQPVTNLR.I Y 29.02 1939.0560 17 -26.2 647.3423 3 86.14 6 49154 VEV_3_3_RA6_01_1237.d 7.07E4 1 1 128 144 Carbamidomethylation
total 2 peptides
C1GJA6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GPQYAESQATAESSK.G Y 61.84 1552.7004 15 -7.5 777.3517 2 33.14 4 14657 VEV_1_3_RA4_01_1235.d 8.31E4 2 2 88 102
R.LRSEAGFDPPVDEM(+15.99)KK.H Y 16.53 1833.8931 16 -6.3 612.3011 3 33.24 5 15134 VEV_2_3_RA5_01_1236.d 1.01E5 1 1 403 418 Oxidation (M)
R.LAPTFPIVSFSTAFGSSLPMESTANSR.N Y 16.12 2814.3896 27 -1.6 939.1357 3 91.49 4 54490 VEV_1_3_RA4_01_1235.d 8.9E3 1 1 308 334
total 3 peptides
C1G136
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HKETFSGPPDR.S Y 40.32 1269.6101 11 -12.7 635.8043 2 21.99 6 8597 VEV_3_3_RA6_01_1237.d 2.03E5 2 2 81 91
R.VLC(+57.02)TQDIQSQEDRQPR.E Y 38.01 1971.9432 16 -10.0 658.3151 3 53.21 4 26931 VEV_1_3_RA4_01_1235.d 0 1 1 166 181 Carbamidomethylation
R.HYDDPYAPR.Q Y 29.10 1132.4938 9 1.6 567.2551 2 35.54 4 16069 VEV_1_3_RA4_01_1235.d 8.64E5 3 3 272 280
R.VLC(+57.02)TQDIQSQEDRQPREPYR.S Y 23.74 2517.2029 20 -14.1 630.2991 4 59.23 6 29879 VEV_3_3_RA6_01_1237.d 1.54E5 2 2 166 185 Carbamidomethylation
total 4 peptides
C1G5G4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KADRGELVIEGSPSFR.Y Y 43.05 1759.9216 16 20.6 440.9968 4 62.77 5 33610 VEV_2_3_RA5_01_1236.d 0 1 1 465 480
R.FLTKEEC(+57.02)AFVIR.R Y 40.34 1511.7806 12 2.3 504.9353 3 71.20 4 40159 VEV_1_3_RA4_01_1235.d 1.44E5 1 1 242 253 Carbamidomethylation
K.ADRGELVIEGSPSFR.Y Y 35.17 1631.8267 15 0.7 544.9499 3 67.49 5 37137 VEV_2_3_RA5_01_1236.d 1.03E5 1 1 466 480
total 3 peptides
C1G764
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GDFDVDSPNLPLSK.V Y 63.02 1502.7252 14 -2.5 752.3680 2 75.78 6 42119 VEV_3_3_RA6_01_1237.d 2.82E5 2 2 158 171
K.VVTHGSLR.I Y 23.49 867.4926 8 -15.3 434.7469 2 15.63 6 5279 VEV_3_3_RA6_01_1237.d 1.71E4 1 1 172 179
total 2 peptides
C1GK52
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGSIPSIAAGLSVGALYALSC(+57.02)FR.L Y 74.21 2310.2041 23 -12.2 771.0659 3 95.90 6 53956 VEV_3_3_RA6_01_1237.d 3E5 3 3 32 54 Carbamidomethylation
total 1 peptides
C1GLD8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SGVKGFGATGGAGGGPR.R Y 54.33 1431.7218 17 -9.1 716.8616 2 36.73 5 17199 VEV_2_3_RA5_01_1236.d 1.78E5 3 3 292 308
K.GFGATGGAGGGPR.R Y 39.49 1060.5050 13 -6.8 531.2562 2 31.55 4 13743 VEV_1_3_RA4_01_1235.d 1.83E5 2 2 296 308
total 2 peptides
C1G801
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EGNAATSALQSAIK.I Y 53.73 1359.6993 14 -6.6 680.8525 2 66.62 5 36486 VEV_2_3_RA5_01_1236.d 7.46E4 1 1 133 146
K.ITQSGPLGGR.F Y 40.06 984.5352 10 -16.5 493.2668 2 33.74 6 14916 VEV_3_3_RA6_01_1237.d 1.97E5 3 3 147 156
total 2 peptides
C1FYX7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ESGQTSSGAPTAGR.Y Y 62.89 1304.5957 14 -4.8 653.3020 2 14.97 4 4778 VEV_1_3_RA4_01_1235.d 7.07E4 3 3 141 154
R.QVANLDDQLALIIQAITHSK.A Y 21.67 2190.2007 20 -24.3 731.0564 3 93.43 4 55521 VEV_1_3_RA4_01_1235.d 0 1 1 416 435
total 2 peptides
C1G3R7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLSLPNHAALESLVTQAIYSSLITAR.I Y 65.28 2754.4915 26 -1.4 919.1698 3 93.13 4 55364 VEV_1_3_RA4_01_1235.d 5.91E4 1 1 123 148
R.VPGLRPQFSGTSSSGASGNKR.D Y 15.45 2089.0664 21 -13.9 523.2666 4 49.80 4 24755 VEV_1_3_RA4_01_1235.d 4.91E4 1 1 266 286
total 2 peptides
A0A0A0HVE7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EKQIYANYSGPQY Y 40.76 1559.7256 13 -7.9 780.8639 2 65.13 4 35383 VEV_1_3_RA4_01_1235.d 8.89E4 1 1 148 160
K.EIGATSAPLMSASFFIGDR.C Y 39.83 1968.9614 19 -10.1 985.4780 2 86.32 4 51447 VEV_1_3_RA4_01_1235.d 7.52E4 1 1 29 47
R.RPEVALNAC(+57.02)VFEK.L Y 36.59 1531.7816 13 -10.2 511.5959 3 67.55 5 37187 VEV_2_3_RA5_01_1236.d 4.95E3 1 1 115 127 Carbamidomethylation
total 3 peptides
C1G6U1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYVVGYTPTQADVVTFK.A Y 72.84 1873.9462 17 -7.6 937.9732 2 78.02 5 44726 VEV_2_3_RA5_01_1236.d 1.55E5 3 3 3 19
total 1 peptides
C1G5K1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DAAGVFDDLVR.V Y 43.35 1176.5774 11 -12.9 589.2884 2 80.41 6 45469 VEV_3_3_RA6_01_1237.d 1.41E5 2 2 379 389
K.VVVDNTFLSPYIQNPLDLGADIVMHSVTK.Y Y 35.45 3184.6477 29 -12.5 1062.5432 3 94.29 6 53315 VEV_3_3_RA6_01_1237.d 4.41E4 1 1 196 224
K.YINGHSDVLMGVAAFNSPSLHER.L Y 19.19 2513.2122 23 3.2 629.3123 4 76.22 4 44076 VEV_1_3_RA4_01_1235.d 7.86E4 1 1 225 247
R.IKGGVTAAER.F Y 18.67 1000.5665 10 -13.3 501.2839 2 17.03 6 5999 VEV_3_3_RA6_01_1237.d 3.77E4 1 1 332 341
total 4 peptides
A0A0A0HU35
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LINPLVAAQNFEYK.M N 59.97 1618.8718 14 -13.1 810.4326 2 83.26 4 49404 VEV_1_3_RA4_01_1235.d 7.38E4 2 2 19 32
K.MSNILDKPLESAFGFISVLPGAFSAYR.Y Y 24.18 2929.5046 27 -8.2 977.5009 3 95.83 4 56672 VEV_1_3_RA4_01_1235.d 4.2E4 1 1 33 59
total 2 peptides
C1GJX3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ISGQLSTISR.N Y 48.65 1060.5876 10 -20.1 531.2905 2 50.09 6 24349 VEV_3_3_RA6_01_1237.d 3.59E5 4 4 146 155
K.AC(+57.02)FYTYVESPPAK.V Y 46.71 1531.7017 13 -0.9 766.8574 2 70.45 6 38194 VEV_3_3_RA6_01_1237.d 1.53E5 2 2 35 47 Carbamidomethylation
total 2 peptides
C1GK68
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LIPTDPDFAPGGPK.H Y 71.96 1423.7346 14 -12.2 712.8659 2 71.75 4 40602 VEV_1_3_RA4_01_1235.d 1.98E5 3 3 54 67
total 1 peptides
C1G164
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YLPNAQAGGVDIK.V Y 43.20 1344.7037 13 -11.4 673.3515 2 64.05 4 34560 VEV_1_3_RA4_01_1235.d 1.32E5 2 2 275 287
R.IDGLQSQYNR.G Y 34.66 1192.5836 10 -15.2 597.2900 2 48.98 5 24534 VEV_2_3_RA5_01_1236.d 6.22E5 3 3 536 545
R.VYAEAATRSEADDLATR.V Y 34.18 1837.8806 17 -7.9 613.6293 3 59.14 4 30844 VEV_1_3_RA4_01_1235.d 9.85E4 1 1 561 577
total 3 peptides
C1FZ88
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DFVLGAGALRPLLALIGDGRK.L Y 71.93 2151.2527 21 -17.5 538.8110 4 91.24 4 54357 VEV_1_3_RA4_01_1235.d 1.53E5 3 3 205 225
total 1 peptides
C1G312
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLVDQASTLTLSSR.A Y 54.83 1488.8147 14 -11.2 745.4062 2 71.71 4 40571 VEV_1_3_RA4_01_1235.d 1.79E4 1 1 103 116
R.SKTAQTANALSGQATPLDR.S Y 34.15 1928.9916 19 1.3 644.0053 3 57.21 5 29566 VEV_2_3_RA5_01_1236.d 3.24E4 1 1 17 35
total 2 peptides
C1GLP7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSNQISLLGTKR.D Y 41.66 1328.7776 12 7.4 443.9364 3 61.87 5 32940 VEV_2_3_RA5_01_1236.d 0 2 2 49 60
R.LFTLTSNISR.L Y 33.76 1150.6346 10 -13.7 576.3167 2 72.18 4 40936 VEV_1_3_RA4_01_1235.d 1.02E5 2 2 39 48
R.LSALEAQPTR.R Y 25.46 1084.5876 10 -37.3 543.2809 2 47.44 4 23282 VEV_1_3_RA4_01_1235.d 0 1 1 6 15
R.NIEQSVGELNELFRDVAHIVHEQGGQLDLISENVER.T Y 19.37 4086.0405 36 -9.3 818.2078 5 94.46 4 56041 VEV_1_3_RA4_01_1235.d 0 1 1 188 223
total 4 peptides
C1FYT2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.VSNNIMESSGPTK.Q Y 58.13 1362.6449 13 -12.0 682.3215 2 43.57 6 20558 VEV_3_3_RA6_01_1237.d 2.63E5 5 5 2 14
M.VSNNIM(+15.99)ESSGPTK.Q Y 19.76 1378.6399 13 2.3 690.3288 2 26.34 4 10845 VEV_1_3_RA4_01_1235.d 6.88E4 1 1 2 14 Oxidation (M)
R.DTILEVVDGGKGDIPNGDTDR.T Y 16.54 2185.0498 21 13.7 547.2772 4 71.76 5 40312 VEV_2_3_RA5_01_1236.d 0 1 1 458 478
R.ISGLGEDIDLSGR.R Y 16.01 1330.6729 13 10.7 333.6790 4 26.67 4 11025 VEV_1_3_RA4_01_1235.d 0 1 1 70 82
total 4 peptides
C1G970
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VYSLSDGYSHPAVQNGR.L Y 51.08 1848.8755 17 -9.5 617.2933 3 60.37 5 31842 VEV_2_3_RA5_01_1236.d 1.89E5 3 3 85 101
R.SFSEASTGGSR.S Y 30.46 1084.4785 11 -12.3 543.2399 2 21.95 5 8786 VEV_2_3_RA5_01_1236.d 5.01E4 2 2 70 80
R.SLRLETQTSLSSIQR.S Y 16.04 1717.9323 15 -66.9 573.6130 3 66.28 6 35086 VEV_3_3_RA6_01_1237.d 5.4E3 1 1 55 69
total 3 peptides
C1GE87
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAHIETGIPIPTLVTIRPDR.S Y 60.65 2199.2375 20 -19.9 550.8057 4 78.89 6 44364 VEV_3_3_RA6_01_1237.d 3.14E4 1 1 49 68
R.SFTFDIR.S Y 21.82 884.4392 7 -9.3 443.2227 2 72.69 4 41344 VEV_1_3_RA4_01_1235.d 0 1 1 69 75
total 2 peptides
C1GBQ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YTNEILPK.A Y 42.71 976.5229 8 -11.2 489.2633 2 54.47 5 27870 VEV_2_3_RA5_01_1236.d 7.84E5 4 4 121 128
R.YQSPDEYPFFPDALEELIIQPIDYPK.I Y 26.42 3126.5112 26 -22.1 1043.1547 3 97.53 4 57346 VEV_1_3_RA4_01_1235.d 0 1 1 79 104
K.IVEVEYLMQR.L Y 21.73 1278.6642 10 -17.6 640.3281 2 76.17 5 43419 VEV_2_3_RA5_01_1236.d 1.02E5 2 2 253 262
K.AGDREGIHEAITNVAVEKK.V Y 19.68 2036.0649 19 -15.6 408.2139 5 55.73 6 27627 VEV_3_3_RA6_01_1237.d 2.36E5 2 2 187 205
K.AGDREGIHEAITNVAVEK.K Y 17.16 1907.9701 18 -1.9 636.9961 3 60.24 5 31723 VEV_2_3_RA5_01_1236.d 0 1 1 187 204
total 5 peptides
C1G6D0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALSVFSPDGHVFQVEYALEAVKR.G Y 46.49 2561.3276 23 -7.2 641.3346 4 83.44 6 47474 VEV_3_3_RA6_01_1237.d 0 1 1 8 30
K.SIEAEKQEEAAK.K Y 33.97 1331.6569 12 -16.2 666.8250 2 17.73 6 6363 VEV_3_3_RA6_01_1237.d 1.61E4 1 1 233 244
R.LYQTEPSGIYSAWK.A Y 24.00 1641.8038 14 -19.4 821.8932 2 75.10 6 41618 VEV_3_3_RA6_01_1237.d 1.16E5 1 1 148 161
total 3 peptides
C1G4I7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAYEAASGAATSK.T Y 62.19 1196.5673 13 -19.4 599.2793 2 26.00 4 10662 VEV_1_3_RA4_01_1235.d 2.15E5 4 4 191 203
R.EYM(+15.99)LPEVLDAYVK.G Y 16.60 1584.7745 13 3.1 793.3970 2 87.24 5 50492 VEV_2_3_RA5_01_1236.d 4.3E4 1 1 399 411 Oxidation (M)
total 2 peptides
C1GH64
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYGAGGGYNSLAGVDATR.A Y 55.36 1740.8430 18 -6.6 871.4230 2 70.07 4 39270 VEV_1_3_RA4_01_1235.d 1.48E5 2 2 158 175
R.VLGGPGVEGKGLEM(+15.99)R.E Y 18.45 1513.7922 15 -12.4 505.5984 3 74.56 4 42795 VEV_1_3_RA4_01_1235.d 0 1 1 255 269 Oxidation (M)
R.AISILDIFR.L Y 16.56 1046.6124 9 47.1 349.8945 3 57.74 5 29930 VEV_2_3_RA5_01_1236.d 0 1 1 71 79
total 3 peptides
C1FZB5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVVHQAFDAPTQTPSTPAGSILR.S Y 69.93 2379.2183 23 1.3 794.0811 3 73.01 4 41592 VEV_1_3_RA4_01_1235.d 1.79E5 2 2 284 306
R.SVVHQAFDAPTQT(-2.02)PSTPAGSILR.S Y 22.58 2377.2026 23 -19.6 793.3926 3 72.87 6 39997 VEV_3_3_RA6_01_1237.d 0 1 1 284 306 2-amino-3-oxo-butanoic_acid
total 2 peptides
C1G0S4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RLPQGFVATATVQLAGR.G Y 51.34 1784.0056 17 -18.2 595.6650 3 75.31 4 43371 VEV_1_3_RA4_01_1235.d 2.58E5 1 1 469 485
R.VNQDSSTVPSLSR.L Y 25.00 1388.6896 13 -12.9 695.3431 2 51.94 4 26123 VEV_1_3_RA4_01_1235.d 5.54E4 2 2 311 323
R.IC(+57.02)QFVQRGGAYLGLC(+57.02)AGGYYASKR.C Y 17.00 2694.3159 24 -19.8 899.0948 3 82.20 5 47476 VEV_2_3_RA5_01_1236.d 6.12E4 1 1 105 128 Carbamidomethylation
total 3 peptides
C1G589
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GPPGGQQGDKPVAGTAPAVGGGGGSTFAGR.V Y 69.39 2607.2788 30 -1.9 870.0986 3 60.94 4 32192 VEV_1_3_RA4_01_1235.d 4.09E4 1 1 224 253
total 1 peptides
A0A0A0HWP2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FTTGTSTTSDTEANAK.H Y 69.23 1630.7322 16 -0.2 816.3732 2 35.16 4 15853 VEV_1_3_RA4_01_1235.d 8.14E4 2 2 65 80
total 1 peptides
C1G790
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTGVNPQPGDANSAR.A Y 56.54 1495.7379 15 -10.6 748.8683 2 43.99 6 20810 VEV_3_3_RA6_01_1237.d 1.6E5 3 3 292 306
K.LLAEDPNAR.V Y 24.59 997.5192 9 -8.6 499.7626 2 38.36 4 17730 VEV_1_3_RA4_01_1235.d 1.59E5 1 1 115 123
total 2 peptides
C1GHH0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KLQGFYTLQNQNIER.L Y 49.96 1850.9639 15 -1.6 617.9943 3 67.99 5 37520 VEV_2_3_RA5_01_1236.d 1.1E5 1 1 105 119
R.YTPESDPFQLASK.L Y 35.38 1481.7037 13 -7.4 741.8536 2 72.47 4 41168 VEV_1_3_RA4_01_1235.d 1.88E5 1 1 62 74
total 2 peptides
C1GL41
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GATEQLLDEAER.S Y 43.80 1330.6365 12 -5.4 666.3219 2 67.05 4 36892 VEV_1_3_RA4_01_1235.d 3.21E4 1 1 375 386
K.VTLGGGNAEMVMAK.A Y 24.14 1376.6792 14 -9.0 689.3407 2 67.06 4 36894 VEV_1_3_RA4_01_1235.d 3.44E4 1 1 404 417
R.LAC(+57.02)DAVLR.L Y 22.05 916.4800 8 -20.5 459.2379 2 50.16 5 25230 VEV_2_3_RA5_01_1236.d 1.37E5 1 1 180 187 Carbamidomethylation
K.AIALDNAAAK.V Y 17.51 956.5291 10 -28.4 479.2582 2 15.95 6 5446 VEV_3_3_RA6_01_1237.d 6.92E4 1 1 71 80
total 4 peptides
C1GCK8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GILFVINQPDVYR.S Y 53.84 1532.8351 13 -17.1 767.4117 2 82.59 5 47709 VEV_2_3_RA5_01_1236.d 0 1 1 80 92
R.IEELPDDDVTPK.T Y 26.83 1369.6613 12 -11.2 685.8303 2 64.04 4 34545 VEV_1_3_RA4_01_1235.d 8.5E4 1 1 6 17
total 2 peptides
C1G3B6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAYDLEPSTTGNPK.W Y 55.18 1462.6940 14 -9.4 732.3474 2 57.82 4 29883 VEV_1_3_RA4_01_1235.d 1.28E5 2 2 95 108
K.GGVKPANSINVR.H Y 23.86 1210.6782 12 -34.0 606.3258 2 33.22 5 15128 VEV_2_3_RA5_01_1236.d 0 1 1 28 39
total 2 peptides
C1GI75
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTQSADASPPHHDVSPTSPISTR.S Y 67.07 2400.1670 23 -16.9 601.0389 4 56.34 5 28971 VEV_2_3_RA5_01_1236.d 1.95E5 2 2 95 117
total 1 peptides
A0A0A0HTR8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVDNQVYVALC(+57.02)SPAR.D Y 43.33 1661.8195 15 -10.1 831.9086 2 71.71 5 40252 VEV_2_3_RA5_01_1236.d 2.24E5 3 3 212 226 Carbamidomethylation
K.YAETLSPSPPSK.E Y 35.77 1275.6346 12 -9.3 638.8187 2 53.40 6 26308 VEV_3_3_RA6_01_1237.d 2E5 2 2 62 73
K.A(+43.01)LNLR.H N 16.28 628.3657 5 -3.8 315.1889 2 27.77 4 11615 VEV_1_3_RA4_01_1235.d 0 1 1 23 27 Carbamylation
total 3 peptides
C1GMM3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLYPDSYINSPAVK.N Y 66.45 1566.7930 14 -18.5 784.3893 2 71.80 5 40318 VEV_2_3_RA5_01_1236.d 2.81E5 4 4 78 91
total 1 peptides
C1G9H9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSTASSLTPSNASYR.G Y 41.70 1527.7166 15 -10.6 764.8574 2 50.78 4 25364 VEV_1_3_RA4_01_1235.d 1.12E5 3 3 578 592
R.VADDPTTPESTSLSHSK.A Y 30.46 1770.8271 17 -8.8 591.2778 3 41.46 6 19330 VEV_3_3_RA6_01_1237.d 1.06E5 1 1 940 956
R.LSAAS(-18.01)SR.L Y 16.59 672.3555 7 -5.6 673.3589 1 26.72 6 11103 VEV_3_3_RA6_01_1237.d 0 1 1 374 380 Dehydration
R.KSTSSSVSSIR.S Y 15.62 1137.5990 11 41.1 380.2225 3 52.99 6 26048 VEV_3_3_RA6_01_1237.d 0 1 1 642 652
total 4 peptides
C1G798
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SATPSTTFYYTR.D Y 53.75 1393.6514 12 -9.9 697.8260 2 63.80 4 34431 VEV_1_3_RA4_01_1235.d 1.33E5 2 2 56 67
K.NFITR.T N 25.19 649.3547 5 -10.9 325.6811 2 39.89 4 18633 VEV_1_3_RA4_01_1235.d 2.79E5 2 2 15 19
total 2 peptides
C1G4X6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FSALQPAEVNR.A Y 58.59 1230.6356 11 -13.1 616.3170 2 62.47 6 32247 VEV_3_3_RA6_01_1237.d 1.5E5 1 1 470 480
K.QVFGGHVHNK.G Y 15.35 1121.5730 10 -17.6 1122.5605 1 80.92 4 47732 VEV_1_3_RA4_01_1235.d 7E4 1 1 537 546
total 2 peptides
C1G654
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LAGSNVDDGASAAGSSR.I Y 57.70 1533.7019 17 -11.2 767.8496 2 36.55 4 16671 VEV_1_3_RA4_01_1235.d 3.26E4 1 1 2544 2560
MPSAAGGK.R Y 17.06 717.3480 8 -14.0 718.3452 1 112.20 6 58693 VEV_3_3_RA6_01_1237.d 0 1 1 1 8
total 2 peptides
C1G1W8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLALQTAGDEAVALK.G Y 66.13 1497.8402 15 -14.4 749.9166 2 75.19 4 43302 VEV_1_3_RA4_01_1235.d 4.9E4 2 2 76 90
total 1 peptides
C1FYT6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVLTK.Q N 42.35 558.3741 5 -21.4 559.3694 1 17.00 4 5829 VEV_1_3_RA4_01_1235.d 4.58E4 1 1 536 540
R.SIEEINSC(+57.02)LLDTR.C Y 36.90 1548.7454 13 -15.1 775.3682 2 74.97 6 41529 VEV_3_3_RA6_01_1237.d 1.36E5 2 2 305 317 Carbamidomethylation
R.ATAVGQEADDGARR.C Y 15.32 1415.6753 14 -6.8 472.8958 3 18.91 5 7149 VEV_2_3_RA5_01_1236.d 1.02E5 1 1 434 447
total 3 peptides
C1GDM0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGNTVSELSPYLDPSTNPNVR.A Y 48.56 2272.1335 21 -13.7 758.3748 3 79.42 5 45670 VEV_2_3_RA5_01_1236.d 1.99E5 2 2 102 122
R.VYVVADAVSSINPEER.G Y 34.50 1746.8788 16 -26.8 874.4232 2 76.42 4 44267 VEV_1_3_RA4_01_1235.d 2.92E4 1 1 173 188
total 2 peptides
C1GLB3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TTTGTVQDIPQTITWR.S Y 43.94 1816.9319 16 -11.2 909.4630 2 76.72 4 44478 VEV_1_3_RA4_01_1235.d 1.99E4 1 1 245 260
K.NALALFSR.A Y 30.87 890.4974 8 -21.6 446.2463 2 71.99 5 40454 VEV_2_3_RA5_01_1236.d 1.01E5 2 2 462 469
R.TAVNYALIGWR.V Y 19.17 1262.6771 11 -36.6 632.3228 2 78.27 6 43925 VEV_3_3_RA6_01_1237.d 1.42E5 1 1 347 357
total 3 peptides
C1GLE5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NC(+57.02)SQGYGSGGYGGGAGGYGGGYGGNR.Q Y 65.48 2385.9417 26 -12.1 796.3115 3 59.55 6 30114 VEV_3_3_RA6_01_1237.d 2.82E4 1 1 104 129 Carbamidomethylation
total 1 peptides
C1GIQ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HSQGTYNAAASASSPAHPK.I Y 56.92 1880.8765 19 -4.2 471.2244 4 24.76 4 9988 VEV_1_3_RA4_01_1235.d 3.41E4 1 1 82 100
R.RRSSPTTSQDEHPQR.R Y 16.56 1780.8564 15 -25.1 446.2102 4 23.80 6 9614 VEV_3_3_RA6_01_1237.d 0 1 1 17 31
total 2 peptides
C1G1E5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GAARPTGGAGC(+57.02)IAMLIGPDAPIVFEPGLR.G Y 53.53 2863.4836 29 -5.7 955.4963 3 86.22 4 51380 VEV_1_3_RA4_01_1235.d 0 1 1 157 185 Carbamidomethylation
R.C(+57.02)YTQAVDSC(+57.02)YK.A Y 23.27 1393.5642 11 17.1 697.8013 2 49.76 4 24732 VEV_1_3_RA4_01_1235.d 0 1 1 215 225 Carbamidomethylation
total 2 peptides
C1GI54
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DANNPQTDVDPFAHLEDVLGQFTR.E Y 64.99 2698.2622 24 8.1 900.4353 3 92.30 6 52453 VEV_3_3_RA6_01_1237.d 2.92E3 2 2 180 203
total 1 peptides
C1GD28
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYIASASQDKTVR.I Y 38.24 1424.7260 13 -17.2 713.3580 2 36.32 5 16966 VEV_2_3_RA5_01_1236.d 5.02E4 2 2 232 244
K.FGTILASSSYDGK.V Y 37.57 1344.6561 13 -2.7 673.3335 2 68.25 6 36577 VEV_3_3_RA6_01_1237.d 4.31E4 1 1 68 80
R.FVTGGSDNLVK.I Y 23.73 1135.5873 11 -17.9 568.7908 2 57.96 6 29000 VEV_3_3_RA6_01_1237.d 3.73E4 1 1 185 195
total 3 peptides
C1G3P2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YDLTVPFAR.W Y 42.60 1080.5603 9 -9.4 541.2823 2 77.40 4 45009 VEV_1_3_RA4_01_1235.d 0 1 1 83 91
R.TISSAVDKLDKLPWADIRK.E Y 33.13 2155.2000 19 -8.3 432.0437 5 76.76 4 44510 VEV_1_3_RA4_01_1235.d 5.78E4 1 1 190 208
K.GLDGAVADK.I Y 16.43 844.4290 9 -19.5 845.4198 1 92.61 5 53171 VEV_2_3_RA5_01_1236.d 3.63E4 1 1 215 223
total 3 peptides
C1G560
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YYDLSNFQGTAR.G Y 64.24 1433.6575 12 -6.8 717.8311 2 70.33 4 39470 VEV_1_3_RA4_01_1235.d 8.19E4 3 3 91 102
total 1 peptides
C1G0Q3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GFIGNITGIQTPSER.L Y 47.29 1588.8209 15 -16.0 795.4050 2 77.57 4 45149 VEV_1_3_RA4_01_1235.d 1.77E4 1 1 564 578
R.GAFEELSYFPWLVGTSLK.G Y 33.83 2043.0353 18 -6.2 1022.5186 2 93.91 4 55770 VEV_1_3_RA4_01_1235.d 0 1 1 546 563
total 2 peptides
C1G4D4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LFLGGFDLTPTFR.D Y 49.64 1482.7871 13 -17.2 742.3881 2 88.27 6 50387 VEV_3_3_RA6_01_1237.d 3.32E5 2 2 247 259
R.MPPETNSPIK.M Y 29.06 1112.5536 10 20.4 557.2954 2 47.85 6 23094 VEV_3_3_RA6_01_1237.d 0 1 1 153 162
total 2 peptides
C1G3B1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IALIHDGLAR.G Y 42.84 1077.6294 10 -14.9 360.2117 3 62.59 4 33437 VEV_1_3_RA4_01_1235.d 4.75E5 4 4 48 57
R.SVLLNYFQTGQ Y 42.36 1268.6401 11 -13.7 635.3187 2 83.43 6 47464 VEV_3_3_RA6_01_1237.d 1.66E5 1 1 146 156
total 2 peptides
C1G8S4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TPTSPSPPDAR.F Y 63.68 1124.5461 11 -8.4 563.2756 2 33.17 5 15119 VEV_2_3_RA5_01_1236.d 5.6E5 5 5 263 273
total 1 peptides
A0A0A0HVZ1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IIIEK.E N 39.50 614.4003 5 -20.4 615.3950 1 41.73 6 19496 VEV_3_3_RA6_01_1237.d 4.61E4 1 1 1299 1303
R.NNNSSR.F N 20.63 690.3045 6 -4.8 691.3085 1 53.52 6 26372 VEV_3_3_RA6_01_1237.d 1.43E4 1 1 321 326
K.M(+42.01)NEQLSDDISK.S Y 18.84 1320.5867 11 48.9 441.2244 3 25.06 5 10517 VEV_2_3_RA5_01_1236.d 0 1 1 2296 2306 Acetylation (N-term)
R.LDAEAAIEK.K Y 17.89 958.4971 9 -17.1 480.2476 2 59.87 6 30355 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 1348 1356
R.TLALDKEEIFKR.L Y 15.21 1461.8191 12 -26.1 488.2676 3 75.97 5 43291 VEV_2_3_RA5_01_1236.d 7.52E4 1 1 980 991
total 5 peptides
C1G650
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NASLFNTNLNLSER.A Y 39.34 1591.7954 14 -8.5 796.8982 2 77.11 4 44787 VEV_1_3_RA4_01_1235.d 4.58E4 1 1 455 468
R.TGDTLLSYPGNK.A Y 30.01 1264.6299 12 -13.4 633.3137 2 65.16 4 35467 VEV_1_3_RA4_01_1235.d 9.45E4 1 1 502 513
R.NIGVQPLLDQVLNLLPSPNERPDPEIR.I Y 27.65 3035.6404 27 26.7 1012.9144 3 93.24 4 55426 VEV_1_3_RA4_01_1235.d 0 1 1 348 374
total 3 peptides
C1GM32
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFHLFLDPLR.S Y 46.79 1243.6713 10 -6.2 415.5618 3 81.20 4 47942 VEV_1_3_RA4_01_1235.d 3.6E4 1 1 427 436
R.YASNIIATSK.L Y 33.37 1066.5658 10 -17.5 534.2808 2 46.68 6 22375 VEV_3_3_RA6_01_1237.d 1.01E5 1 1 399 408
total 2 peptides
C1GC97
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FSVHGGTQSENLALQNIQAR.S Y 46.41 2169.0925 20 -9.7 724.0311 3 69.14 6 37228 VEV_3_3_RA6_01_1237.d 7.82E4 2 2 478 497
K.AAGAK.L N 21.64 416.2383 5 -20.3 417.2372 1 28.56 4 12050 VEV_1_3_RA4_01_1235.d 2.18E5 1 1 35 39
R.IELIR.H N 17.55 642.4064 5 -26.4 322.2020 2 53.85 6 26558 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 218 222
total 3 peptides
C1G0X0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGGDDGVTEYTAEDEHVR.E Y 62.86 1949.8239 18 -10.0 650.9421 3 56.69 5 29210 VEV_2_3_RA5_01_1236.d 8.7E4 3 3 634 651
total 1 peptides
C1GD88
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPAAYKFNC(+57.02)AQR.A Y 62.82 1411.6666 12 -9.7 706.8337 2 39.85 4 18605 VEV_1_3_RA4_01_1235.d 3.2E5 4 4 56 67 Carbamidomethylation
total 1 peptides
C1GLR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LISPFGILESTR.T Y 51.33 1331.7449 12 -16.0 666.8691 2 84.67 6 48249 VEV_3_3_RA6_01_1237.d 0 2 2 292 303
R.RQLDDLVPVWAVLDYTDSALVQR.E Y 22.93 2671.3970 23 -10.9 668.8492 4 84.30 4 50125 VEV_1_3_RA4_01_1235.d 9.63E4 1 1 152 174
total 2 peptides
C1GMF6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ATSVGANNASAQSLLK.Q Y 62.45 1530.8002 16 -12.9 766.3975 2 61.68 5 32794 VEV_2_3_RA5_01_1236.d 7.46E4 3 3 161 176
total 1 peptides
C1GBW5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VIENFRDQNDSIGGTVSC(+57.02)VIR.N Y 52.87 2378.1648 21 -4.6 793.7252 3 74.48 4 42731 VEV_1_3_RA4_01_1235.d 8.68E4 2 2 213 233 Carbamidomethylation
R.AVPIVEAMAALVITDALMAQNAR.E Y 19.15 2367.2654 23 -2.9 790.0934 3 97.83 5 55305 VEV_2_3_RA5_01_1236.d 1.07E4 1 1 363 385
total 2 peptides
C1GIF6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALAILSDVFKK.D Y 62.12 1203.7227 11 -11.1 402.2437 3 78.13 5 44806 VEV_2_3_RA5_01_1236.d 1.18E5 3 3 73 83
total 1 peptides
C1GCD3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LYPDITAVSVHPGVIDTNLYSSSK.T Y 36.44 2575.3169 24 -15.4 859.4330 3 80.78 6 45711 VEV_3_3_RA6_01_1237.d 6.52E4 1 1 296 319
R.FLPLDLSSFQSIR.A Y 30.01 1521.8191 13 -11.6 761.9080 2 86.71 5 50137 VEV_2_3_RA5_01_1236.d 2.58E4 1 1 157 169
K.MPLSPQQQTADVR.V Y 18.79 1469.7296 13 -28.3 735.8513 2 59.48 4 31099 VEV_1_3_RA4_01_1235.d 2.67E4 1 1 231 243
K.ALSAIADIK.S Y 17.62 900.5280 9 -27.2 451.2590 2 64.15 5 34636 VEV_2_3_RA5_01_1236.d 1.47E4 1 1 134 142
total 4 peptides
C1GF19
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFNSPPSFVVYSDR.F Y 48.33 1600.7521 14 -10.4 801.3750 2 75.86 6 42179 VEV_3_3_RA6_01_1237.d 5.98E4 1 1 32 45
K.VLYC(+57.02)AQGDIGR.T Y 26.31 1250.6078 11 -14.7 626.3020 2 59.02 6 29730 VEV_3_3_RA6_01_1237.d 3.51E5 2 2 134 144 Carbamidomethylation
total 2 peptides
C1GJZ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGTVTGGPSNSNVNLPDHEEYWNNVR.A Y 61.48 2826.2957 26 -9.1 943.0972 3 71.18 4 40151 VEV_1_3_RA4_01_1235.d 1.51E5 2 2 307 332
total 1 peptides
C1G4S4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NQGISVQATAAEAR.A Y 61.06 1414.7164 14 -10.2 708.3583 2 55.16 4 28139 VEV_1_3_RA4_01_1235.d 4.42E4 1 1 340 353
total 1 peptides
A0A0A0HTY8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KYNPDADGLAGDEGAAASSSK.K Y 60.85 2022.9130 21 -9.1 675.3055 3 51.00 4 25511 VEV_1_3_RA4_01_1235.d 0 2 2 445 465
total 1 peptides
C1GJ38
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLISFSTC(+57.02)APAQAR.K Y 40.39 1477.7347 14 -12.8 739.8652 2 71.92 6 39306 VEV_3_3_RA6_01_1237.d 5.8E4 1 1 320 333 Carbamidomethylation
R.YFDYSSQLLR.H Y 19.22 1290.6244 10 8.1 646.3247 2 76.39 4 44236 VEV_1_3_RA4_01_1235.d 1.41E5 1 1 604 613
R.LMDLVPDSTIVC(+57.02)ALSGISRPGDVK.T Y 19.11 2542.3135 24 -14.4 848.4329 3 87.30 6 49831 VEV_3_3_RA6_01_1237.d 9.98E4 1 1 465 488 Carbamidomethylation
R.ASPSKGLISFSTC(+57.02)APAQAR.K Y 17.63 1947.9836 19 -14.4 650.3258 3 66.80 4 36686 VEV_1_3_RA4_01_1235.d 1.42E4 1 1 315 333 Carbamidomethylation
total 4 peptides
C1GIY1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TVQVFSGSSHPALTEAIC(+57.02)ER.L Y 49.91 2188.0583 20 -12.0 730.3513 3 72.18 6 39496 VEV_3_3_RA6_01_1237.d 1.32E5 1 1 45 64 Carbamidomethylation
R.WNEAVVVTK.N Y 21.61 1044.5604 9 -11.6 523.2814 2 60.26 4 31670 VEV_1_3_RA4_01_1235.d 0 1 1 202 210
total 2 peptides
C1GMP5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LAGQGPSQADKAR.V Y 51.36 1297.6738 13 -10.6 433.5606 3 17.67 4 6186 VEV_1_3_RA4_01_1235.d 1.43E5 2 2 158 170
R.LAGQGPSQADK.A Y 18.63 1070.5356 11 4.7 536.2776 2 16.54 5 5855 VEV_2_3_RA5_01_1236.d 0 1 1 158 168
total 2 peptides
A0A0A0HWU6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLNTIQTGAYR.N Y 51.20 1234.6670 11 -14.2 618.3320 2 59.52 5 31195 VEV_2_3_RA5_01_1236.d 5.61E4 3 3 425 435
R.FLITSYTPFTSDNVEQAK.T Y 18.57 2060.0103 18 -5.2 1031.0071 2 82.11 4 48602 VEV_1_3_RA4_01_1235.d 0 1 1 619 636
total 2 peptides
C1G356
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FYEWVVEQTPFGDVGHPDIK.A Y 33.05 2362.1270 20 -8.4 788.3763 3 83.88 6 47751 VEV_3_3_RA6_01_1237.d 0 1 1 179 198
R.ISNPYLEDVVQR.V Y 28.91 1431.7357 12 -16.0 716.8637 2 73.85 6 40709 VEV_3_3_RA6_01_1237.d 1.82E5 1 1 282 293
K.AVHFGGGNIGR.G Y 22.42 1083.5574 11 -20.8 542.7747 2 42.07 6 19691 VEV_3_3_RA6_01_1237.d 4.72E4 1 1 5 15
K.LTDLEADHPLYPR.V Y 21.66 1538.7728 13 -5.8 513.9286 3 66.22 5 36189 VEV_2_3_RA5_01_1236.d 1.9E5 2 2 363 375
total 4 peptides
C1G5J3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFLDLIGEPEGPKL Y 60.27 1513.8027 14 -17.4 757.8955 2 86.93 6 49621 VEV_3_3_RA6_01_1237.d 2.51E4 1 1 433 446
total 1 peptides
C1FYS5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RGGTTPVNSTGGR.G Y 44.29 1258.6378 13 -3.0 420.5519 3 13.36 4 3997 VEV_1_3_RA4_01_1235.d 6.56E4 4 4 169 181
R.RKGAGPPAPASSR.G Y 19.00 1250.6843 13 -42.8 417.8842 3 12.39 5 3646 VEV_2_3_RA5_01_1236.d 2.73E4 1 1 145 157
K.GAGPPAPASSRGPGTTSATGAR.R Y 17.96 1922.9558 22 -12.9 641.9843 3 35.43 5 16422 VEV_2_3_RA5_01_1236.d 5.27E4 1 1 147 168
total 3 peptides
C1G792
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GVIAC(+57.02)SAGNHAQGVAYSAR.T Y 45.71 1887.9010 19 7.7 630.3124 3 55.03 5 28193 VEV_2_3_RA5_01_1236.d 1.28E5 3 3 123 141 Carbamidomethylation
R.LNSLALTEGSAK.T Y 27.81 1202.6506 12 -16.4 602.3228 2 60.09 4 31555 VEV_1_3_RA4_01_1235.d 4.19E4 1 1 18 29
total 2 peptides
C1GER4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NLNNAFAYDLVPSVSVMTAALK.A Y 59.54 2337.2039 22 -8.4 1169.5994 2 90.86 4 54147 VEV_1_3_RA4_01_1235.d 1.63E5 3 3 93 114
total 1 peptides
C1G0Y9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KAELPALLR.A Y 40.69 1009.6284 9 -15.9 337.5447 3 64.19 5 34663 VEV_2_3_RA5_01_1236.d 4.19E4 1 1 89 97
K.HIGGNSDLQAR.K Y 36.53 1166.5792 11 -10.8 584.2906 2 23.65 5 9710 VEV_2_3_RA5_01_1236.d 7.96E4 2 2 78 88
total 2 peptides
C1G953
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VEALPQIYR.T Y 39.69 1087.6025 9 -6.0 544.8053 2 68.56 4 38084 VEV_1_3_RA4_01_1235.d 8.75E4 1 1 131 139
R.LQQSLQQQR.F Y 37.54 1127.6047 9 -17.5 564.7998 2 25.10 4 10172 VEV_1_3_RA4_01_1235.d 9.64E4 2 2 12 20
total 2 peptides
C1GBE6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSAAPSPAGSDAPSNDTNSKDR.V Y 58.45 2130.9414 22 -5.5 711.3171 3 26.92 4 11150 VEV_1_3_RA4_01_1235.d 9.23E4 2 2 5 26
total 1 peptides
C1GDI1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VTPSSQVSQPSEPK.R Y 50.02 1469.7362 14 -18.6 735.8617 2 39.11 4 18163 VEV_1_3_RA4_01_1235.d 7.95E4 3 3 289 302
R.LSTTSVGSSGALR.A Y 16.58 1234.6517 13 -14.4 618.3243 2 51.87 5 26310 VEV_2_3_RA5_01_1236.d 5.14E4 1 1 216 228
total 2 peptides
C1G2M7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GSSPGSDITSGTAESR.S Y 58.02 1507.6750 16 -8.8 754.8381 2 39.53 5 18892 VEV_2_3_RA5_01_1236.d 2.24E5 3 3 206 221
total 1 peptides
C1G8M6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAEPAPAENAQSAKADAEPTDATK.T Y 57.94 2383.1138 24 -2.4 795.3766 3 46.80 4 22885 VEV_1_3_RA4_01_1235.d 1.16E5 2 2 195 218
total 1 peptides
C1GF39
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VIRPLESLLTSYKR.I Y 45.53 1673.9828 14 -0.5 419.5028 4 75.92 4 43857 VEV_1_3_RA4_01_1235.d 4.47E4 1 1 262 275
R.TGHFTPIPAGC(+57.02)TPLKR.D Y 24.76 1751.9141 16 -6.6 438.9829 4 60.97 6 31142 VEV_3_3_RA6_01_1237.d 4.17E4 1 1 42 57 Carbamidomethylation
total 2 peptides
C1G0R5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IHLVR.W N 40.56 636.4071 5 -11.5 319.2072 2 25.51 4 10397 VEV_1_3_RA4_01_1235.d 7.76E5 1 1 29 33
R.GQEAEGTEVFGAK.G Y 34.66 1321.6150 13 -10.3 661.8080 2 51.95 6 25464 VEV_3_3_RA6_01_1237.d 1.82E5 2 2 87 99
total 2 peptides
C1FYF8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSYGSINSYGSR.D Y 43.78 1246.5579 12 -3.5 624.2840 2 47.21 4 23135 VEV_1_3_RA4_01_1235.d 5.57E4 1 1 607 618
R.GYSSNPGFSGGNR.N Y 27.59 1298.5640 13 25.6 650.3059 2 38.07 4 17549 VEV_1_3_RA4_01_1235.d 2.77E4 1 1 625 637
total 2 peptides
C1G3R3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KKEEDLLPTDLVVVDLR.M Y 57.52 1981.1095 17 -19.3 496.2751 4 79.97 6 45142 VEV_3_3_RA6_01_1237.d 1.02E5 2 2 99 115
total 1 peptides
C1GLG2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.APIKDETIDSLKNIIGELESR.V Y 48.51 2340.2537 21 -12.1 586.0636 4 85.88 4 51164 VEV_1_3_RA4_01_1235.d 4.27E5 3 3 2 22
K.TYHSQTAPIVGYYKK.T Y 17.79 1754.8992 15 4.6 585.9764 3 52.27 5 26601 VEV_2_3_RA5_01_1236.d 0 1 1 220 234
total 2 peptides
A0A0A0HUM5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGEYGPVPATAR.D Y 29.95 1217.6040 12 -17.2 609.7988 2 49.97 6 24283 VEV_3_3_RA6_01_1237.d 9.7E4 1 1 590 601
R.SSISVAVSPTSDRLQILK.A Y 28.74 1900.0629 18 -14.4 634.3524 3 74.82 5 42470 VEV_2_3_RA5_01_1236.d 3.19E4 1 1 505 522
R.AASIAR.D N 26.02 587.3391 6 -15.5 588.3373 1 18.47 4 6611 VEV_1_3_RA4_01_1235.d 0 1 1 349 354
K.KGEANSIVSSYNR.N Y 17.23 1423.7056 13 -3.8 475.5740 3 41.24 6 19212 VEV_3_3_RA6_01_1237.d 1.32E5 1 1 415 427
total 4 peptides
C1GIU3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AYEAYQQAVYR.D Y 57.25 1360.6411 11 -3.6 681.3254 2 60.64 4 31960 VEV_1_3_RA4_01_1235.d 7.16E4 1 1 364 374
total 1 peptides
C1GI92
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DRNDLITYLQNETK Y 57.06 1721.8584 14 -21.7 574.9476 3 77.47 6 43349 VEV_3_3_RA6_01_1237.d 2.9E5 2 2 143 156
total 1 peptides
C1GAB4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NVIIGQYGK.S Y 48.35 990.5498 9 -44.1 496.2603 2 56.00 4 28633 VEV_1_3_RA4_01_1235.d 0 1 1 295 303
K.NC(+57.02)YPENGIAR.I Y 17.34 1192.5295 10 -3.5 597.2700 2 40.77 6 18934 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 150 159 Carbamidomethylation
total 2 peptides
C1GA11
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAHLLQPQPQQSAHATGGGGGSSR.R Y 56.98 2312.1370 24 -1.8 579.0405 4 38.35 4 17724 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 662 685
total 1 peptides
C1G651
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AIDSSGGLSR.L Y 32.14 961.4828 10 -8.0 481.7449 2 30.23 4 13026 VEV_1_3_RA4_01_1235.d 4.9E5 2 2 477 486
R.SISGGFVSPIREDDAEVNGGK.T Y 27.51 2133.0337 21 1.8 712.0198 3 69.17 4 38571 VEV_1_3_RA4_01_1235.d 7.25E4 1 1 524 544
R.ELIQAQQTAR.S Y 21.56 1156.6200 10 -26.8 579.3018 2 38.95 4 18071 VEV_1_3_RA4_01_1235.d 0 1 1 374 383
R.TLSTLESVRPDIR.A Y 15.56 1485.8151 13 -13.6 496.2722 3 67.52 4 37257 VEV_1_3_RA4_01_1235.d 1.07E5 1 1 464 476
total 4 peptides
C1GDR7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TASQEQSEAPKTTPADAPTAVAR.G Y 40.39 2326.1401 23 -10.5 776.3792 3 50.06 4 24923 VEV_1_3_RA4_01_1235.d 3.69E4 1 1 34 56
K.TTPADAPTAVAR.G Y 32.49 1169.6040 12 -7.6 585.8048 2 40.71 4 19115 VEV_1_3_RA4_01_1235.d 2.22E5 2 2 45 56
total 2 peptides
C1G1Z9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPWVAVNDVQDVGLR.H Y 56.38 1653.8474 15 -9.5 827.9231 2 79.10 5 45457 VEV_2_3_RA5_01_1236.d 2.37E5 2 2 542 556
total 1 peptides
C1GAI2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSSSQPSPALSSR.K Y 42.15 1303.6367 13 -13.6 652.8168 2 29.64 5 13058 VEV_2_3_RA5_01_1236.d 3.01E4 1 1 790 802
K.AIKNSAGNHLGHGR.M Y 17.63 1430.7490 14 -46.4 716.3486 2 74.75 4 42935 VEV_1_3_RA4_01_1235.d 3.38E2 1 1 401 414
K.GVNRQLSAGGGKK(+226.08).L Y 15.52 1496.7881 13 -17.8 499.9277 3 62.41 5 33344 VEV_2_3_RA5_01_1236.d 0 1 1 276 288 Biotinylation
total 3 peptides
C1FZ10
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FALSVPNAAQGDQSFQHR.S Y 56.06 1971.9551 18 -5.4 658.3221 3 71.27 4 40220 VEV_1_3_RA4_01_1235.d 5.25E4 1 1 235 252
total 1 peptides
C1G6Y8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.VRGPVEDVSLR.N Y 42.46 1225.6779 11 -16.7 409.5597 3 56.51 6 28062 VEV_3_3_RA6_01_1237.d 3.38E5 3 3 2 12
R.NGSGDANVNADVALEK.M Y 26.85 1572.7379 16 -7.1 787.3707 2 57.18 4 29436 VEV_1_3_RA4_01_1235.d 2.11E4 1 1 13 28
total 2 peptides
C1G4L1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EAVDRQEPALQAPTQR.F Y 55.85 1807.9176 16 -20.6 603.6340 3 52.43 6 25722 VEV_3_3_RA6_01_1237.d 3.75E4 1 1 28 43
total 1 peptides
A0A0A0HVY6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVPAPGK.E N 34.84 654.3701 7 -8.6 655.3717 1 14.02 4 4304 VEV_1_3_RA4_01_1235.d 7.73E4 3 3 887 893
R.ALDPK.E N 31.42 542.3064 5 -19.7 543.3030 1 31.00 5 13833 VEV_2_3_RA5_01_1236.d 0 1 1 234 238
R.VLGPEEPVGR.T Y 15.11 1051.5662 10 -28.0 526.7756 2 51.82 4 26048 VEV_1_3_RA4_01_1235.d 0 1 1 428 437
total 3 peptides
C1GBS3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAAGGGRPAPAGIATVGSSPR.K Y 55.45 1835.9601 21 -6.9 612.9897 3 51.57 5 26118 VEV_2_3_RA5_01_1236.d 4.03E4 1 1 29 49
total 1 peptides
C1GIJ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IC(+57.02)LITADPQR.A Y 45.76 1185.6176 10 -13.2 593.8082 2 65.56 4 35717 VEV_1_3_RA4_01_1235.d 2.59E4 1 1 109 118 Carbamidomethylation
R.KSIGEEEPTK.S Y 18.99 1116.5662 10 -8.9 559.2854 2 37.29 5 17524 VEV_2_3_RA5_01_1236.d 0 1 1 336 345
total 2 peptides
C1G3Z9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AIANAYSPFFGR.E Y 42.52 1312.6564 12 -8.5 657.3299 2 76.73 4 44482 VEV_1_3_RA4_01_1235.d 2.41E5 3 3 80 91
K.ADQVGFWDQSR.A Y 25.16 1307.5895 11 14.5 654.8115 2 67.94 6 36339 VEV_3_3_RA6_01_1237.d 0 1 1 299 309
total 2 peptides
C1G0P8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VTNVSELAEEQEIRDMFER.F Y 43.83 2294.0847 19 -10.0 765.6945 3 80.94 4 47769 VEV_1_3_RA4_01_1235.d 5.03E4 1 1 212 230
R.IC(+57.02)SGEHFTAR.C Y 22.36 1176.5345 10 4.1 393.1871 3 29.75 4 12708 VEV_1_3_RA4_01_1235.d 4.87E4 1 1 136 145 Carbamidomethylation
total 2 peptides
C1G7R6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YGHAANFNLQPGFVASDGSR.R Y 54.73 2106.9871 20 -5.7 703.3323 3 70.95 6 38567 VEV_3_3_RA6_01_1237.d 1.72E5 1 1 431 450
total 1 peptides
C1GMM4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPAANADPVLK.Y Y 54.66 1081.5768 11 -16.0 541.7870 2 43.50 6 20515 VEV_3_3_RA6_01_1237.d 4.18E4 1 1 90 100
total 1 peptides
C1G294
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ANKPAVGFIAGISAPPGRR.M Y 39.43 1878.0587 19 8.4 470.5259 4 66.01 6 34893 VEV_3_3_RA6_01_1237.d 7.25E4 2 2 263 281
K.IGIMPGFIHQR.G Y 30.35 1267.6859 11 -31.9 423.5558 3 72.14 5 40572 VEV_2_3_RA5_01_1236.d 1.1E5 3 3 170 180
total 2 peptides
C1GBR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.STVHVTSPTSVAVDAPQGR.K Y 38.68 1907.9701 19 -9.2 636.9915 3 61.38 6 31435 VEV_3_3_RA6_01_1237.d 5.76E4 1 1 79 97
R.KDPTASLSTR.E Y 19.09 1074.5669 10 -59.0 538.2590 2 25.09 6 10268 VEV_3_3_RA6_01_1237.d 0 1 1 307 316
K.AAVSHSLETAR.A Y 19.07 1140.5887 11 14.5 571.3099 2 24.82 5 10385 VEV_2_3_RA5_01_1236.d 0 1 1 1281 1291
total 3 peptides
C1GE18
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LVEFSESYPNVAFYKVDVDEC(+57.02)PDIAQELGVR.A Y 54.54 3587.7129 31 -17.7 1196.8904 3 87.06 4 51916 VEV_1_3_RA4_01_1235.d 0 1 1 53 83 Carbamidomethylation
total 1 peptides
C1GKG6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ILPSAGVLSLDALNHGR.T Y 54.36 1731.9631 17 -28.7 578.3118 3 78.56 6 44119 VEV_3_3_RA6_01_1237.d 3.1E4 1 1 146 162
total 1 peptides
C1G5B1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ANPPRPQTDEYGNPVPR.E Y 54.30 1906.9285 17 -9.1 636.6443 3 55.19 4 28193 VEV_1_3_RA4_01_1235.d 1.47E5 1 1 671 687
total 1 peptides
C1GLM1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VPFLDKQFLEVSMGIDPQEK.M Y 41.78 2319.1819 20 -1.5 774.0668 3 85.18 4 50711 VEV_1_3_RA4_01_1235.d 1.15E5 1 1 407 426
K.STSAWGVEAR.V Y 24.63 1062.5094 10 1.4 532.2627 2 48.98 6 23738 VEV_3_3_RA6_01_1237.d 8.96E4 1 1 397 406
total 2 peptides
C1GCX1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GAKDDDDDEDADAKKLR.G Y 54.04 1875.8445 17 -4.3 469.9664 4 19.62 4 7220 VEV_1_3_RA4_01_1235.d 2.5E5 4 4 99 115
total 1 peptides
C1G3Q1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNQAAADVADAER.K Y 35.63 1342.6477 13 -2.3 672.3296 2 51.06 4 25552 VEV_1_3_RA4_01_1235.d 8.13E4 1 1 472 484
K.GMFSSLGISVGGPGK.F Y 25.29 1392.7072 15 -20.7 697.3464 2 80.09 4 47091 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 311 325
K.VGDITSSHIVYQVR.T Y 16.92 1572.8259 14 -8.3 525.2783 3 64.67 4 35017 VEV_1_3_RA4_01_1235.d 5.08E4 1 1 189 202
total 3 peptides
C1GFG3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLNSDLHTDEIAPEEDAAR.W Y 31.74 2081.9502 19 -4.9 694.9873 3 66.10 4 36136 VEV_1_3_RA4_01_1235.d 1.26E5 2 2 291 309
R.NLATDPEPHQHILSTIR.S Y 27.16 1941.0068 17 -9.3 486.2545 4 64.37 4 34784 VEV_1_3_RA4_01_1235.d 1.27E5 1 1 798 814
R.EKPVPIQESAALPDEILDERK.N Y 25.09 2376.2537 21 -3.4 793.0891 3 74.34 5 42126 VEV_2_3_RA5_01_1236.d 5.98E3 1 1 651 671
total 3 peptides
C1GF04
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.RPGVIAAGLGFNSPLHR.H Y 37.26 1760.9797 17 -18.3 441.2442 4 71.66 4 40528 VEV_1_3_RA4_01_1235.d 3.85E4 1 1 134 150
R.SATPSYDSPLR.H Y 32.69 1192.5724 11 -11.9 597.2864 2 56.97 5 29411 VEV_2_3_RA5_01_1236.d 2.74E5 2 2 34 44
total 2 peptides
C1GJ51
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAATTPTTSFEIGPGIHGGTIK.S Y 53.43 2142.0957 22 0.0 715.0392 3 71.08 4 40065 VEV_1_3_RA4_01_1235.d 1.24E5 2 2 118 139
total 1 peptides
C1GG46
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVEQTSSPLTPR.S Y 44.28 1300.6622 12 -13.9 651.3293 2 48.73 5 24371 VEV_2_3_RA5_01_1236.d 1.3E5 2 2 1158 1169
K.DSHPR.S Y 17.55 610.2823 5 1.6 611.2905 1 32.23 4 14132 VEV_1_3_RA4_01_1235.d 3.77E4 1 1 148 152
total 2 peptides
C1GAY3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AIVYSTYQAYLR.S Y 42.36 1446.7507 12 -12.6 724.3735 2 76.07 4 43968 VEV_1_3_RA4_01_1235.d 3.03E4 1 1 303 314
K.YLVWGTVGEC(+57.02)TR.Y Y 21.37 1439.6868 12 -4.5 720.8474 2 74.90 6 41467 VEV_3_3_RA6_01_1237.d 1.44E5 1 1 476 487 Carbamidomethylation
total 2 peptides
C1G726
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VTGFSNAEEGAVK.M Y 53.00 1307.6357 13 -13.8 654.8161 2 53.32 4 27004 VEV_1_3_RA4_01_1235.d 2.73E5 3 3 154 166
total 1 peptides
C1G6B9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALNDKAIEVSPSSSR.V Y 52.92 1572.8107 15 -16.9 525.2686 3 51.07 5 25796 VEV_2_3_RA5_01_1236.d 9.87E4 1 1 318 332
total 1 peptides
C1G3H0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IINIGSIDGLRVPSLETYAYSASK.A Y 52.83 2566.3643 24 -8.9 856.4544 3 84.80 4 50448 VEV_1_3_RA4_01_1235.d 1.83E5 3 3 145 168
total 1 peptides
C1G154
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAAQAAAQSLR.A Y 52.75 1056.5676 11 -2.6 529.2897 2 32.41 4 14246 VEV_1_3_RA4_01_1235.d 1.67E5 3 3 7 17
total 1 peptides
C1G3I9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALFGNIVLSGGSTLC(+57.02)R.G Y 34.86 1663.8716 16 -11.0 832.9339 2 82.20 4 48670 VEV_1_3_RA4_01_1235.d 3.97E4 1 1 299 314 Carbamidomethylation
R.AGFAGEDLPK.C Y 24.74 1003.4974 10 -2.9 502.7545 2 60.29 4 31758 VEV_1_3_RA4_01_1235.d 8.17E4 1 1 22 31
K.TGYVALDPK.K Y 15.63 962.5073 9 -9.5 482.2563 2 54.33 4 27646 VEV_1_3_RA4_01_1235.d 0 1 1 219 227
total 3 peptides
C1GF96
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLLIDIAPLFPISK.V Y 52.13 1551.9640 14 -31.2 776.9650 2 93.94 4 55784 VEV_1_3_RA4_01_1235.d 0 1 1 369 382
total 1 peptides
C1GM97
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLPAKDDSSTVR.V Y 39.72 1274.6466 12 -8.5 638.3251 2 23.04 4 9028 VEV_1_3_RA4_01_1235.d 4.12E4 2 2 21 32
R.YVGVC(+57.02)FADATVR.E Y 24.61 1356.6495 12 -8.1 679.3265 2 72.30 6 39599 VEV_3_3_RA6_01_1237.d 5.08E4 1 1 155 166 Carbamidomethylation
total 2 peptides
C1GHH4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GPDSVPGTLTGAEAR.T Y 38.13 1426.7052 15 -13.7 714.3501 2 61.50 4 32608 VEV_1_3_RA4_01_1235.d 0 1 1 516 530
R.NGVLPTPDELSAR.I Y 27.29 1367.7045 13 1.2 684.8604 2 71.84 6 39239 VEV_3_3_RA6_01_1237.d 0 2 2 199 211
total 2 peptides
C1GCP2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LPPYAFLNFDNFIQR.T Y 51.74 1853.9464 15 -12.9 618.9814 3 89.91 5 51835 VEV_2_3_RA5_01_1236.d 3.25E4 2 2 101 115
total 1 peptides
C1GLI3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLTNFDINQPQDR.M Y 42.87 1546.7375 13 -6.0 774.3714 2 69.01 4 38447 VEV_1_3_RA4_01_1235.d 6.41E4 1 1 139 151
R.YLGSGPR.C Y 17.07 748.3868 7 -20.4 375.1930 2 22.59 4 8762 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 408 414
total 2 peptides
C1GLX6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAYYIAFGPHGPR.A Y 51.27 1418.7095 13 -0.3 473.9103 3 68.68 4 38250 VEV_1_3_RA4_01_1235.d 8.88E4 1 1 113 125
total 1 peptides
C1FYS2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLTDHLHLLSEAR.K Y 42.54 1516.8362 13 -11.1 380.2121 4 72.14 4 40902 VEV_1_3_RA4_01_1235.d 7.85E4 1 1 140 152
R.FDPAYSDAR.A Y 16.98 1040.4563 9 7.8 521.2395 2 44.81 6 21303 VEV_3_3_RA6_01_1237.d 5.44E4 1 1 166 174
total 2 peptides
C1GC37
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GVVFNVSGNPAYGPGR.N Y 50.71 1589.7950 16 -13.7 795.8939 2 71.81 6 39220 VEV_3_3_RA6_01_1237.d 6.19E4 1 1 45 60
total 1 peptides
C1G8P1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AFNGVNIELIDLR.T Y 50.54 1472.7987 13 -20.4 737.3916 2 83.66 6 47607 VEV_3_3_RA6_01_1237.d 1.22E4 1 1 292 304
total 1 peptides
C1GIE5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ANTNC(+57.02)TIQESLER.I Y 50.53 1534.7046 13 -13.0 768.3496 2 58.15 6 29125 VEV_3_3_RA6_01_1237.d 1.58E5 2 2 163 175 Carbamidomethylation
total 1 peptides
C1GAG0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSRNEVVNSPY Y 50.41 1276.6411 11 -8.1 639.3226 2 58.33 5 30350 VEV_2_3_RA5_01_1236.d 2.09E5 2 2 796 806
total 1 peptides
C1FZ48
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IAIIK.L N 29.52 556.3948 5 -13.1 557.3948 1 47.33 5 23535 VEV_2_3_RA5_01_1236.d 3.65E5 3 3 715 719
R.LFDIR.Q N 21.04 662.3751 5 -19.6 332.1884 2 63.82 5 34404 VEV_2_3_RA5_01_1236.d 4.81E5 5 5 1640 1644
K.LGTSLAPQPTPK.R Y 18.65 1208.6765 12 -21.0 303.1700 4 25.16 5 10577 VEV_2_3_RA5_01_1236.d 0 1 1 821 832
R.GTVSM(+15.99)YIHYSLR.N Y 16.49 1441.7024 12 -2.4 361.4320 4 44.23 5 21680 VEV_2_3_RA5_01_1236.d 3.48E5 1 1 482 493 Oxidation (M)
total 4 peptides
C1GIT4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSLIDPDTPQSVR.S Y 49.83 1427.7256 13 -13.6 714.8604 2 65.00 5 35272 VEV_2_3_RA5_01_1236.d 1.98E5 3 3 233 245
total 1 peptides
C1G8T9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGEQVYQAPVGPPPTM(+15.99)NK Y 49.68 1898.9196 18 -0.5 633.9802 3 62.76 6 32460 VEV_3_3_RA6_01_1237.d 1.2E5 1 1 85 102 Oxidation (M)
R.AGEQVYQAPVGPPPTMNK Y 40.54 1882.9247 18 -9.0 942.4611 2 67.69 5 37295 VEV_2_3_RA5_01_1236.d 7.2E4 1 1 85 102
total 2 peptides
C1GGY2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VNSVSPGYVR.T Y 49.65 1076.5614 10 -9.9 539.2827 2 42.38 4 20145 VEV_1_3_RA4_01_1235.d 5.93E5 3 3 186 195
total 1 peptides
C1G8G5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AQQLELSDAFSR.L Y 49.48 1363.6731 12 -0.5 682.8435 2 72.03 4 40818 VEV_1_3_RA4_01_1235.d 9.06E4 1 1 223 234
total 1 peptides
C1G175
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLTEEEIDERLQAIAEKD Y 33.11 2088.0222 18 8.6 697.0207 3 79.01 6 44447 VEV_3_3_RA6_01_1237.d 0 1 1 237 254
R.LANINQVYTQR.A Y 32.36 1318.6993 11 7.0 660.3616 2 62.14 5 33146 VEV_2_3_RA5_01_1236.d 0 1 1 116 126
total 2 peptides
C1GN02
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LC(+57.02)VGIEDVDDLIDDLRR.A Y 49.25 2014.9993 17 -20.9 672.6597 3 87.97 5 50823 VEV_2_3_RA5_01_1236.d 1.37E5 2 2 406 422 Carbamidomethylation
total 1 peptides
C1FZJ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.PDNPSLNSQSAHSTATR.S Y 49.04 1781.8292 17 -12.8 594.9427 3 29.27 5 12851 VEV_2_3_RA5_01_1236.d 9.17E4 2 2 2 18
total 1 peptides
C1GIN4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLEADVQSDLSGDVK.A Y 49.04 1561.7471 15 -12.9 781.8707 2 74.23 6 41029 VEV_3_3_RA6_01_1237.d 1.16E5 2 2 291 305
total 1 peptides
C1G4A2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NVDLISC(+57.02)LLTSR.T Y 48.85 1389.7286 12 -20.7 695.8572 2 84.68 4 50367 VEV_1_3_RA4_01_1235.d 5.48E4 1 1 196 207 Carbamidomethylation
total 1 peptides
C1G2X0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SNVLSQTDGLFR.E Y 48.84 1335.6782 12 -8.4 668.8408 2 75.33 4 43391 VEV_1_3_RA4_01_1235.d 4.85E4 1 1 198 209
total 1 peptides
C1G2R2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IAASTTKNPTDLSASSR.V Y 48.82 1718.8799 17 -9.1 860.4394 2 44.58 4 21502 VEV_1_3_RA4_01_1235.d 1.19E5 2 2 158 174
total 1 peptides
A0A0A0HT60
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AATSHAATAKPLSSK.T Y 33.04 1439.7732 15 -11.0 720.8860 2 14.75 5 4893 VEV_2_3_RA5_01_1236.d 4.68E4 2 2 355 369
R.FIDNFSAGTR.G Y 30.53 1126.5406 10 -8.1 564.2730 2 63.95 4 34479 VEV_1_3_RA4_01_1235.d 1.46E5 1 1 70 79
total 2 peptides
C1GL98
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YGEITSASLSR.D Y 28.37 1182.5880 11 -18.1 592.2906 2 59.74 6 30257 VEV_3_3_RA6_01_1237.d 0 1 1 258 268
R.GGGGR.G N 27.39 402.1975 5 -0.6 403.2046 1 14.26 4 4423 VEV_1_3_RA4_01_1235.d 0 1 1 610 614
K.EATGGAGAVAGAASGGK.D Y 18.59 1330.6477 17 -12.4 666.3229 2 73.58 5 41583 VEV_2_3_RA5_01_1236.d 1.08E5 1 1 797 813
total 3 peptides
C1GA04
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MLSPNQIVSSGLDR.T Y 47.98 1515.7715 14 -10.8 758.8848 2 76.52 4 44316 VEV_1_3_RA4_01_1235.d 9.57E4 1 1 184 197
total 1 peptides
C1G215
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VLDKAPGEC(+57.02)IAVEDSK.S Y 38.08 1729.8556 16 -16.4 577.6163 3 59.76 4 31310 VEV_1_3_RA4_01_1235.d 1.2E5 1 1 202 217 Carbamidomethylation
R.AC(+57.02)EGATEELAK.L Y 19.75 1177.5284 11 -5.4 589.7683 2 31.77 6 13857 VEV_3_3_RA6_01_1237.d 1.59E5 2 2 129 139 Carbamidomethylation
total 2 peptides
C1G4Y3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FFIVPDMLR.N Y 47.86 1136.6052 9 -10.4 569.3040 2 85.25 4 50763 VEV_1_3_RA4_01_1235.d 2.27E5 2 2 75 83
total 1 peptides
C1GJT3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VC(+57.02)VIC(+57.02)PPDSR.A Y 39.41 1201.5583 10 -7.6 601.7819 2 58.52 4 30378 VEV_1_3_RA4_01_1235.d 2.58E5 2 2 125 134 Carbamidomethylation
K.MGTVVDNIAR.T Y 16.80 1074.5492 10 -12.1 538.2754 2 60.29 4 31703 VEV_1_3_RA4_01_1235.d 8.95E4 1 1 196 205
total 2 peptides
C1G5E4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HALGQFNQAVTMFEK.A Y 47.79 1719.8402 15 -10.6 574.2812 3 76.13 6 42365 VEV_3_3_RA6_01_1237.d 0 1 1 36 50
total 1 peptides
A0A0A0HRF5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LC(+57.02)RGELTATDVTLAYIKR.L Y 37.17 2079.1145 18 12.4 520.7924 4 72.88 4 41487 VEV_1_3_RA4_01_1235.d 0 1 1 67 84 Carbamidomethylation
M.PGLEPWQK.I Y 21.10 953.4970 8 -9.8 477.7511 2 60.65 4 31971 VEV_1_3_RA4_01_1235.d 5.98E4 1 1 2 9
total 2 peptides
C1GHU1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NFSSSTGYNEIR.A Y 47.67 1373.6211 12 -12.5 687.8093 2 58.77 6 29554 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 438 449
total 1 peptides
C1G4Y9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISSQSAGETISPR.S Y 36.46 1331.6681 13 -13.3 666.8325 2 42.29 5 20492 VEV_2_3_RA5_01_1236.d 1.4E5 2 2 168 180
K.FDGNVTVGQEK.L Y 22.12 1192.5724 11 -7.5 597.2890 2 31.88 4 13936 VEV_1_3_RA4_01_1235.d 1.22E5 1 1 565 575
total 2 peptides
C1FZP0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NNISGDDQQLTLK.A Y 35.04 1444.7158 13 -14.4 723.3548 2 59.69 6 30217 VEV_3_3_RA6_01_1237.d 5.26E4 1 1 416 428
K.SASAHIILGVVGYKPR.E Y 24.21 1666.9518 16 -5.5 417.7429 4 69.55 4 38862 VEV_1_3_RA4_01_1235.d 7.01E4 1 1 496 511
total 2 peptides
C1GLH5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.SPPALVAPGAGSAAK.D Y 47.15 1292.7087 15 -15.2 647.3518 2 57.23 5 29580 VEV_2_3_RA5_01_1236.d 1.22E5 2 2 2 16
total 1 peptides
C1G0G7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TTDPNPGVAATTLK.A Y 39.18 1384.7197 14 -13.5 693.3578 2 58.15 5 30215 VEV_2_3_RA5_01_1236.d 4.34E4 2 2 669 682
K.AM(+15.99)APLAAGAAWGR.G Y 15.88 1257.6288 13 -34.0 420.2026 3 27.98 6 11766 VEV_3_3_RA6_01_1237.d 0 1 1 1370 1382 Oxidation (M)
total 2 peptides
A0A0A0HW92
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DLYRPNSMLTFETASVLGTDAIIERLTGLPFQK.V Y 33.00 3695.9231 33 19.9 925.0065 4 96.65 4 57023 VEV_1_3_RA4_01_1235.d 0 1 1 78 110
R.LTGLPFQK.V Y 27.55 902.5225 8 -10.0 452.2640 2 67.25 5 36963 VEV_2_3_RA5_01_1236.d 4.96E5 3 3 103 110
total 2 peptides
C1GCN9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SNAAYDEKPLDR.T Y 46.60 1377.6523 12 -3.8 689.8308 2 35.94 4 16295 VEV_1_3_RA4_01_1235.d 4.49E4 1 1 215 226
total 1 peptides
C1G548
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NDGSAESAGRGSGIEGAGPR.K Y 46.56 1843.8408 20 -7.4 615.6163 3 34.38 5 15810 VEV_2_3_RA5_01_1236.d 4.64E4 1 1 89 108
total 1 peptides
C1G5V0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LRDVGSGSNETY Y 34.65 1296.5946 12 -14.9 649.2949 2 42.49 5 20614 VEV_2_3_RA5_01_1236.d 0 1 1 289 300
R.SNPEVKPNETIYIGNLFFEVTADDLKR.D Y 23.35 3108.5767 27 -7.9 778.1453 4 86.57 4 51610 VEV_1_3_RA4_01_1235.d 1.38E5 1 1 102 128
total 2 peptides
C1G056
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVKPLDVEAIIK.S Y 27.44 1310.7809 12 -18.8 437.9260 3 73.30 5 41384 VEV_2_3_RA5_01_1236.d 1.44E4 2 2 289 300
R.IGRDVTIVSLSR.C Y 26.82 1314.7620 12 -18.8 439.2530 3 65.15 6 34237 VEV_3_3_RA6_01_1237.d 0 1 1 251 262
K.THYMSGGIQPC(+57.02)NITFR.G Y 16.40 1880.8662 16 26.4 627.9792 3 70.18 4 39348 VEV_1_3_RA4_01_1235.d 0 1 1 148 163 Carbamidomethylation
total 3 peptides
C1GDT0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FVQDELDEYAK.Q Y 31.17 1355.6245 11 1.2 678.8204 2 69.18 4 38576 VEV_1_3_RA4_01_1235.d 6.51E4 1 1 143 153
K.TTLNEGYPNQEVK.E Y 30.12 1491.7205 13 -9.6 746.8604 2 53.80 4 27316 VEV_1_3_RA4_01_1235.d 9.48E4 2 2 208 220
total 2 peptides
C1GML4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGLFDTFSTTLK.S Y 46.11 1341.7180 12 -11.4 671.8586 2 85.14 4 50676 VEV_1_3_RA4_01_1235.d 0 1 1 115 126
total 1 peptides
C1GMN0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TPAEPLPLSYPQLPLPSTSDAGVAAEAIEAVSGGISLK.V Y 45.75 3745.9666 38 -11.1 1249.6489 3 96.03 6 54004 VEV_3_3_RA6_01_1237.d 4.99E4 1 1 292 329
total 1 peptides
C1FZC5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VQTDGQITPK.E Y 33.94 1085.5717 10 -7.9 543.7888 2 29.38 4 12534 VEV_1_3_RA4_01_1235.d 3.94E4 1 1 115 124
K.EYELR.K N 23.46 708.3442 5 -7.1 709.3465 1 29.10 4 12347 VEV_1_3_RA4_01_1235.d 2.8E4 1 1 148 152
total 2 peptides
C1GMD9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGSAPSTQPR.Q Y 37.90 1012.5302 10 -13.0 507.2658 2 24.47 5 10178 VEV_2_3_RA5_01_1236.d 9.73E4 2 2 39 48
K.AVETFGGGVHR.I Y 15.11 1128.5676 11 -14.7 565.2828 2 36.84 6 16684 VEV_3_3_RA6_01_1237.d 3.13E4 1 1 215 225
total 2 peptides
C1G2E6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSPSTLTSTDSTK.T Y 45.39 1324.6357 13 -13.3 663.3163 2 31.04 5 13857 VEV_2_3_RA5_01_1236.d 1.78E5 5 5 530 542
total 1 peptides
C1GLP0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TILPLAQDPWLLDTYLNSSGHIR.V Y 37.53 2622.3806 23 -15.1 875.1209 3 88.69 6 50627 VEV_3_3_RA6_01_1237.d 1.11E5 1 1 117 139
K.SAQIMQPQYR.N Y 15.47 1220.5972 10 -17.1 611.2954 2 52.71 4 26619 VEV_1_3_RA4_01_1235.d 8.28E4 1 1 320 329
total 2 peptides
C1GIL5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NVVSEVNGC(+57.02)LSTGK.E Y 30.29 1462.7086 14 -12.9 732.3522 2 64.92 4 35217 VEV_1_3_RA4_01_1235.d 6.06E4 1 1 169 182 Carbamidomethylation
K.DRDKYVTGEFR.F Y 19.52 1384.6735 11 -18.3 347.1693 4 52.90 4 26750 VEV_1_3_RA4_01_1235.d 0 1 1 216 226
M.AAEAK.V N 15.29 488.2594 5 -43.6 489.2454 1 46.40 6 22203 VEV_3_3_RA6_01_1237.d 0 1 1 2 6
total 3 peptides
C1G8K9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SNPPSILSDASAIFTDLR.I Y 37.56 1902.9686 18 -9.9 952.4822 2 90.37 4 53861 VEV_1_3_RA4_01_1235.d 0 2 2 186 203
K.AGELTPGITAR.E Y 15.11 1084.5876 11 -16.6 543.2921 2 55.57 6 27481 VEV_3_3_RA6_01_1237.d 1.15E5 1 1 66 76
total 2 peptides
C1GHW5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.AAGPDDASLLAEAK.N Y 45.03 1327.6619 14 -7.1 664.8335 2 65.96 4 36030 VEV_1_3_RA4_01_1235.d 7.45E4 2 2 2 15
total 1 peptides
C1GBX5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NNKDQEVELDGIGGVNIIVK.A Y 34.34 2153.1328 20 11.3 718.7263 3 78.14 4 45583 VEV_1_3_RA4_01_1235.d 0 1 1 329 348
R.AGYQVVGLPNYVVWHIDTK.E Y 20.52 2158.1211 19 -13.1 720.3715 3 82.81 6 47066 VEV_3_3_RA6_01_1237.d 9.86E4 1 1 379 397
total 2 peptides
C1G109
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ETSC(+57.02)DIVTGTR.Y Y 44.54 1237.5609 11 -8.3 619.7826 2 41.39 4 19542 VEV_1_3_RA4_01_1235.d 6.52E4 1 1 152 162 Carbamidomethylation
total 1 peptides
C1GAM6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VAVAPDGNGGIYQALLTSGVR.T Y 44.43 2057.0906 21 -22.1 686.6890 3 82.37 5 47576 VEV_2_3_RA5_01_1236.d 3.31E4 1 1 244 264
total 1 peptides
C1GJX2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.QTFHQSEIQDGDIIC(+57.02)FQR.Q Y 44.36 2221.0222 18 -5.1 741.3442 3 73.15 4 41705 VEV_1_3_RA4_01_1235.d 0 1 1 795 812 Carbamidomethylation
total 1 peptides
A0A0A0HV97
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GKDDDYVDEEEPDVHFEPVVR.L Y 34.46 2488.1030 21 12.6 623.0409 4 71.94 5 40418 VEV_2_3_RA5_01_1236.d 0 1 1 105 125
K.LSPNVGSDR.S Y 19.69 943.4723 9 0.7 472.7438 2 29.00 4 12314 VEV_1_3_RA4_01_1235.d 2.17E5 2 2 202 210
total 2 peptides
C1GEB6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VGGGFTAADYANIR.H Y 29.52 1410.6891 14 -7.5 706.3465 2 70.48 5 39348 VEV_2_3_RA5_01_1236.d 3.3E4 2 2 570 583
R.RGGALSSFLC(+57.02)GLR.V Y 18.10 1392.7296 13 -0.6 465.2502 3 78.03 4 45504 VEV_1_3_RA4_01_1235.d 1.17E5 1 1 537 549 Carbamidomethylation
K.AAQVTPSDQFR.L Y 16.96 1218.5992 11 -19.0 610.2953 2 48.04 5 23950 VEV_2_3_RA5_01_1236.d 0 1 1 631 641
total 3 peptides
C1G1J5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DLGIPFWAELYGDVK.Y Y 28.29 1721.8665 15 -13.8 861.9286 2 92.98 6 52751 VEV_3_3_RA6_01_1237.d 2.86E5 1 1 108 122
K.IGAHPGLPDLQGFGRR.E Y 21.26 1689.9062 16 -10.9 423.4792 4 68.96 6 37101 VEV_3_3_RA6_01_1237.d 1.6E5 1 1 15 30
K.GIPVFGLAGTNMEK.A Y 15.86 1432.7384 14 -17.5 717.3640 2 79.37 4 46535 VEV_1_3_RA4_01_1235.d 2.61E5 1 1 91 104
total 3 peptides
C1GEE6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGDAVSSGDLSGFSVGK.M Y 44.18 1568.7318 17 -10.3 785.3651 2 69.72 6 37647 VEV_3_3_RA6_01_1237.d 8.24E4 2 2 333 349
total 1 peptides
A0A0A0HVR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TLGGQGVAQMII Y 33.66 1186.6379 12 -21.5 594.3135 2 83.11 6 47271 VEV_3_3_RA6_01_1237.d 2.32E5 3 3 136 147
M.TIAEEFKSR.N Y 20.91 1079.5610 9 -14.3 360.8558 3 40.68 5 19515 VEV_2_3_RA5_01_1236.d 5.53E5 2 2 2 10
total 2 peptides
C1G1C3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVLVDNTSDPTVADAYPLFLSK.G Y 43.97 2335.1946 22 -15.0 1168.5870 2 85.10 6 48529 VEV_3_3_RA6_01_1237.d 4.8E4 1 1 93 114
total 1 peptides
C1GCG3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SLQLPTPSLELDFR.M Y 43.77 1614.8617 14 -9.0 808.4308 2 85.37 4 50845 VEV_1_3_RA4_01_1235.d 6.38E4 1 1 242 255
total 1 peptides
C1G5E1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGGGR.G N 27.39 402.1975 5 -0.6 403.2046 1 14.26 4 4423 VEV_1_3_RA4_01_1235.d 0 1 1 1134 1138
R.EPGPR.D N 21.85 554.2812 5 -21.9 555.2764 1 51.12 6 24938 VEV_3_3_RA6_01_1237.d 7.38E4 2 2 141 145
K.TSPGLSFASVPTGPR.A Y 15.95 1472.7623 15 5.4 491.9307 3 75.82 5 43190 VEV_2_3_RA5_01_1236.d 0 1 1 539 553
total 3 peptides
C1GGY3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLTNFC(+57.02)GKPPR.G Y 23.80 1301.6914 11 -1.4 434.9038 3 58.43 4 30311 VEV_1_3_RA4_01_1235.d 8.6E4 1 1 112 122 Carbamidomethylation
K.NPVPAGAKM(+15.99)PAPR.G Y 19.69 1320.6971 13 17.3 331.1873 4 37.10 4 16986 VEV_1_3_RA4_01_1235.d 0 1 1 290 302 Oxidation (M)
R.KNPVPAGAK.M Y 18.10 880.5130 9 -16.9 441.2563 2 12.34 5 3618 VEV_2_3_RA5_01_1236.d 1.27E4 1 1 289 297
R.DVLDK.T Y 15.68 588.3119 5 -13.2 589.3114 1 62.03 5 33059 VEV_2_3_RA5_01_1236.d 0 1 1 104 108
total 4 peptides
C1G5M0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASPAAPAPPSLPAR.S Y 36.02 1301.7091 14 -10.5 651.8550 2 62.90 4 33684 VEV_1_3_RA4_01_1235.d 0 1 1 133 146
K.AEGLR.E N 15.15 544.2969 5 -53.1 545.2753 1 75.01 6 41547 VEV_3_3_RA6_01_1237.d 5.78E4 1 1 387 391
total 2 peptides
C1GIS8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGTRPTSGGQVDSGAIVK.S Y 43.49 1685.8696 18 -6.0 562.9604 3 39.40 5 18766 VEV_2_3_RA5_01_1236.d 6.55E4 1 1 524 541
total 1 peptides
A0A0A0HV88
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M.TQLFDSSSGSASAAGSEKR.S Y 35.25 1884.8813 19 -3.6 629.2988 3 46.97 5 23302 VEV_2_3_RA5_01_1236.d 1.67E5 2 2 2 20
R.FLPTITR.N Y 16.36 846.4963 7 -20.2 424.2469 2 64.27 5 34726 VEV_2_3_RA5_01_1236.d 2.51E4 1 1 96 102
total 2 peptides
C1FZD3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DYGFNHLSAGDLLR.A Y 33.83 1576.7633 14 -5.9 526.5919 3 78.71 4 46026 VEV_1_3_RA4_01_1235.d 4.7E4 1 1 63 76
R.FLIDGFPR.K Y 19.10 963.5178 8 -14.8 482.7590 2 79.03 6 44465 VEV_3_3_RA6_01_1237.d 1.94E5 1 1 144 151
total 2 peptides
C1G7P8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NISASFTPFAAR.T Y 34.22 1280.6512 12 -18.2 641.3212 2 75.09 6 41607 VEV_3_3_RA6_01_1237.d 5.85E4 1 1 10 21
K.NVLDTPEPLRNLADLIAAQLEYHKK.S Y 18.22 2860.5447 25 -3.0 573.1145 5 89.23 6 50913 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 252 276
total 2 peptides
C1GN69
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ATEPAYTTASPLTATPK.G Y 26.56 1718.8727 17 -8.0 860.4368 2 66.35 4 36330 VEV_1_3_RA4_01_1235.d 3.29E4 1 1 751 767
R.LSTGGPIAASEESSPTVHLK.S Y 22.65 1980.0164 20 37.1 661.0372 3 65.64 6 34600 VEV_3_3_RA6_01_1237.d 0 2 2 249 268
K.GQHTK.N N 16.24 569.2922 5 -27.3 570.2839 1 27.73 5 11986 VEV_2_3_RA5_01_1236.d 0 1 1 29 33
total 3 peptides
C1GIS2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HQQRPYHISLDNLSSALGR.T Y 29.05 2191.1245 19 -16.8 548.7792 4 70.93 5 39677 VEV_2_3_RA5_01_1236.d 1.59E5 1 1 174 192
R.DSTYANGYAGEGR.E Y 28.49 1359.5691 13 0.7 680.7923 2 40.81 4 19167 VEV_1_3_RA4_01_1235.d 1.05E5 1 1 347 359
total 2 peptides
C1G837
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSASSFPSPYPPSR.S Y 43.10 1479.6993 14 -3.1 740.8547 2 64.56 5 34944 VEV_2_3_RA5_01_1236.d 1.18E5 2 2 102 115
total 1 peptides
C1GMI0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSGTAFTAPR.H Y 32.79 1019.5400 10 -14.1 510.7701 2 56.06 5 28800 VEV_2_3_RA5_01_1236.d 1.33E5 2 2 50 59
K.FNNSLFIAR.Q Y 20.23 1080.5715 9 -13.0 541.2860 2 71.13 4 40102 VEV_1_3_RA4_01_1235.d 3.95E4 2 2 260 268
total 2 peptides
C1GF72
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLTSDSSSLSPTR.Q Y 42.84 1362.6991 13 -10.1 682.3500 2 60.63 5 32017 VEV_2_3_RA5_01_1236.d 0 2 2 112 124
total 1 peptides
A0A0A0HTA9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSDYIPPPYKNEEAAR.A Y 42.76 1861.9209 16 -15.3 621.6381 3 63.64 6 33108 VEV_3_3_RA6_01_1237.d 1.31E5 1 1 707 722
total 1 peptides
C1FZQ1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SAAAAAAAAAQR.R Y 42.44 1028.5363 12 -5.7 515.2725 2 30.54 4 13152 VEV_1_3_RA4_01_1235.d 3.23E4 2 2 393 404
total 1 peptides
C1G4P9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYQAAGFSNAER.N Y 42.37 1299.5844 12 -0.2 650.7993 2 46.98 4 22993 VEV_1_3_RA4_01_1235.d 9.97E4 2 2 765 776
total 1 peptides
C1GCM9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FDSPQTPGDTPSR.Y Y 42.26 1403.6317 13 -7.5 702.8179 2 49.24 4 24402 VEV_1_3_RA4_01_1235.d 6.12E4 1 1 150 162
total 1 peptides
C1G8C8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SC(+57.02)PVVFIC(+57.02)R.N Y 33.05 1136.5471 9 -3.7 569.2787 2 67.51 5 37224 VEV_2_3_RA5_01_1236.d 8.67E4 1 1 257 265 Carbamidomethylation
R.NNGYAISTPTLEQYRGDGIASR.G Y 17.96 2382.1562 22 -2.5 795.0574 3 72.46 4 41158 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 266 287
total 2 peptides
C1G1V7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FSDQASLGSNYR.N Y 41.99 1343.6106 12 -15.0 672.8025 2 57.86 5 30022 VEV_2_3_RA5_01_1236.d 7.06E4 1 1 223 234
total 1 peptides
C1GKQ0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AVEPTALPQDGVR.Q Y 41.92 1351.7095 13 -14.6 676.8522 2 61.26 6 31346 VEV_3_3_RA6_01_1237.d 6.11E4 2 2 215 227
total 1 peptides
C1G7W8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NSPGNATSPVTPK.S Y 41.88 1268.6361 13 -15.6 635.3154 2 31.25 5 13996 VEV_2_3_RA5_01_1236.d 8.72E4 1 1 352 364
total 1 peptides
C1GC81
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASFVLPNFAR.K Y 41.82 1120.6029 10 -11.4 561.3024 2 78.69 4 46015 VEV_1_3_RA4_01_1235.d 3.49E5 3 3 260 269
total 1 peptides
C1G2W9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TPTTTTSHTNAKPTPR.S Y 41.67 1709.8696 16 -10.9 570.9576 3 15.74 4 5175 VEV_1_3_RA4_01_1235.d 1.11E4 1 1 273 288
total 1 peptides
C1GGA2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VTGGR.N N 19.30 488.2707 5 -14.2 489.2711 1 98.86 4 57827 VEV_1_3_RA4_01_1235.d 1.7E4 1 1 426 430
K.VPLNDR.D Y 18.65 712.3868 6 -23.3 357.1924 2 25.00 6 10197 VEV_3_3_RA6_01_1237.d 0 1 1 1646 1651
R.GGRPAR.R N 17.31 612.3456 6 -53.2 613.3203 1 74.73 6 41345 VEV_3_3_RA6_01_1237.d 0 1 1 1904 1909
K.ASGSK.K N 16.97 448.2281 5 -21.1 449.2260 1 25.02 5 10489 VEV_2_3_RA5_01_1236.d 9.18E4 1 1 267 271
R.AIVGPDLFGVFPLR.G Y 15.11 1499.8500 14 -20.4 750.9169 2 90.17 4 53751 VEV_1_3_RA4_01_1235.d 5.31E4 1 1 744 757
total 5 peptides
C1GE99
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FYEQGGDLDTAR.V Y 41.63 1370.6102 12 12.1 686.3207 2 57.48 5 29756 VEV_2_3_RA5_01_1236.d 3.44E4 1 1 431 442
total 1 peptides
C1G282
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSTPGEPAGPTFTASGR.Q Y 33.93 1644.8107 17 -10.6 823.4039 2 66.05 4 36096 VEV_1_3_RA4_01_1235.d 5.4E4 1 1 352 368
K.LPQASDHGQNGVI Y 15.12 1334.6578 13 -25.6 668.3191 2 56.42 4 28905 VEV_1_3_RA4_01_1235.d 0 1 1 681 693
total 2 peptides
C1G9W2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLFLGLDNAGK.T Y 41.43 1159.6600 11 -11.3 580.8307 2 80.82 4 47654 VEV_1_3_RA4_01_1235.d 6.61E4 2 2 22 32
total 1 peptides
C1GI19
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NLASDEKYQLEIVR.A Y 31.85 1676.8733 14 -15.1 559.9566 3 69.00 6 37127 VEV_3_3_RA6_01_1237.d 3.12E4 1 1 300 313
K.TIADK.N N 19.11 546.3013 5 -50.1 547.2812 1 80.78 4 47628 VEV_1_3_RA4_01_1235.d 1.18E5 1 1 538 542
total 2 peptides
C1G7I8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSTDQASSSDPYLR.R Y 41.37 1512.6692 14 -2.0 757.3404 2 46.91 4 22951 VEV_1_3_RA4_01_1235.d 1.22E5 2 2 346 359
total 1 peptides
C1G815
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KYTVTYTHPSTNPFR.T Y 41.27 1810.9001 15 -9.2 453.7281 4 61.02 4 32246 VEV_1_3_RA4_01_1235.d 7.55E4 1 1 194 208
total 1 peptides
C1G6E0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VVSC(+57.02)DGGGGPLGHPR.I Y 32.78 1463.6940 15 -1.2 732.8534 2 37.17 5 17451 VEV_2_3_RA5_01_1236.d 3.21E4 1 1 141 155 Carbamidomethylation
K.EKVVSC(+57.02)DGGGGPLGHPR.I Y 16.80 1720.8314 17 -3.9 574.6155 3 38.12 5 18011 VEV_2_3_RA5_01_1236.d 3.13E4 1 1 139 155 Carbamidomethylation
total 2 peptides
C1GBE7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGDKFYIGGDKLLPLEK.F Y 40.97 1879.0090 17 -8.7 470.7555 4 74.88 4 43035 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 110 126
total 1 peptides
C1GEM6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TPSPSSLSELQTR.T Y 40.67 1401.7100 13 -7.2 701.8572 2 64.18 4 34647 VEV_1_3_RA4_01_1235.d 4E4 1 1 212 224
total 1 peptides
C1G972
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSSIASSSATSTYSK.L Y 26.86 1476.6943 15 -9.4 739.3475 2 37.28 4 17094 VEV_1_3_RA4_01_1235.d 6.59E4 1 1 29 43
R.VGNIANNAR.L Y 17.22 927.4886 9 -20.6 464.7420 2 19.97 5 7714 VEV_2_3_RA5_01_1236.d 7.05E4 1 1 476 484
R.AIEHGK.G Y 15.06 653.3497 6 -49.3 654.3247 1 51.22 6 24999 VEV_3_3_RA6_01_1237.d 7.77E4 1 1 834 839
total 3 peptides
C1GMK0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ADAVFQQTVPSR.S Y 32.68 1317.6677 12 -14.1 659.8318 2 61.41 4 32544 VEV_1_3_RA4_01_1235.d 8.41E4 1 1 374 385
K.NIINR.D N 15.27 628.3657 5 -13.4 315.1859 2 50.71 4 25317 VEV_1_3_RA4_01_1235.d 0 1 1 5 9
total 2 peptides
A0A0A0HVJ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IETSLLTSGPRIR.N Y 40.25 1441.8252 13 -21.8 721.9042 2 83.52 6 47526 VEV_3_3_RA6_01_1237.d 5.08E5 3 3 415 427
total 1 peptides
C1G1Q6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.HSATNPIDAILPSVPIVQTK.I Y 40.19 2100.1580 20 0.2 701.0601 3 82.31 5 47540 VEV_2_3_RA5_01_1236.d 1.01E5 2 2 327 346
total 1 peptides
C1G9W1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GVSFTFGPDVVSR.F Y 40.16 1366.6881 13 -13.2 684.3423 2 78.30 6 43938 VEV_3_3_RA6_01_1237.d 2.47E5 3 3 51 63
total 1 peptides
C1GGX7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSPYNYFQDTR.D Y 27.39 1402.6517 11 -10.8 702.3256 2 72.85 6 39980 VEV_3_3_RA6_01_1237.d 0 1 1 238 248
R.STFYGASPPEK.G Y 25.45 1182.5557 11 -15.9 592.2757 2 52.12 5 26457 VEV_2_3_RA5_01_1236.d 7.73E4 1 1 376 386
total 2 peptides
C1GJK9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VPIAPPPDPNLDPAAYLR.S Y 39.95 1915.0203 18 -10.9 958.5070 2 82.99 4 49215 VEV_1_3_RA4_01_1235.d 1.08E4 1 1 55 72
total 1 peptides
C1G8H9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGAAAAAAGAGNR.A Y 39.88 1027.5159 13 -45.4 514.7419 2 15.84 5 5500 VEV_2_3_RA5_01_1236.d 1.35E5 1 1 168 180
total 1 peptides
C1GKX0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ELTFKEEGQEYAQVVK.M Y 39.82 1896.9469 16 -11.6 633.3156 3 69.79 4 39045 VEV_1_3_RA4_01_1235.d 7.74E4 3 3 25 40
total 1 peptides
C1GG39
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GPGMGAPLQSVAVAAR.M Y 27.52 1480.7820 16 -35.6 741.3719 2 71.31 4 40247 VEV_1_3_RA4_01_1235.d 2.49E4 1 1 84 99
R.TLHISNDPAPGYNIEQLAK.K Y 24.48 2080.0588 19 -17.3 694.3482 3 74.20 6 40959 VEV_3_3_RA6_01_1237.d 7.75E4 1 1 172 190
total 2 peptides
C1GHD0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NPEANVSGNQNSIPFHR.L Y 39.74 1879.8925 17 -14.6 627.6290 3 60.35 4 31749 VEV_1_3_RA4_01_1235.d 5.21E4 1 1 290 306
total 1 peptides
C1GIX9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LTPPSTADGSR.S Y 30.29 1100.5461 11 -13.9 551.2727 2 33.22 4 14697 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 1214 1224
K.TPEC(+57.02)PLYQR.R Y 18.03 1162.5441 9 -5.2 582.2763 2 48.18 4 23741 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 1497 1505 Carbamidomethylation
total 2 peptides
C1GJB9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LALLK.V N 29.52 556.3948 5 -13.1 557.3948 1 47.33 5 23535 VEV_2_3_RA5_01_1236.d 3.65E5 3 3 329 333
R.TGQGGGTSPR.W Y 19.43 916.4362 10 -22.8 917.4226 1 98.74 4 57786 VEV_1_3_RA4_01_1235.d 0 1 1 156 165
total 2 peptides
C1G6V9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGPESFYIVTNAGR.R Y 39.22 1522.7780 14 -10.8 762.3881 2 78.83 5 45271 VEV_2_3_RA5_01_1236.d 0 1 1 189 202
total 1 peptides
C1G3X8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGLLESEGYVDR.S Y 39.17 1307.6357 12 7.5 654.8301 2 67.64 4 37411 VEV_1_3_RA4_01_1235.d 7.19E4 1 1 177 188
total 1 peptides
C1GIF1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YIVDEEKDAINPSC(+57.02)R.G Y 39.15 1807.8411 15 -13.8 603.6127 3 62.28 6 32107 VEV_3_3_RA6_01_1237.d 1.48E4 1 1 298 312 Carbamidomethylation
total 1 peptides
C1GF56
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TESSLSSTEPSLVR.A Y 30.73 1491.7417 14 -8.4 746.8719 2 62.89 5 33705 VEV_2_3_RA5_01_1236.d 8.74E4 1 1 361 374
K.SSLIELMNTINSTDVHYIR.C Y 16.74 2205.1099 19 -6.8 736.0389 3 85.50 4 50917 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 653 671
total 2 peptides
C1G112
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IRFTTPAIITSSLK.L Y 29.70 1546.9082 14 -8.8 516.6388 3 77.23 5 44183 VEV_2_3_RA5_01_1236.d 3.34E4 2 2 604 617
R.LLEDALGVVR.Q Y 18.78 1083.6288 10 5.9 542.8249 2 75.75 4 43715 VEV_1_3_RA4_01_1235.d 0 1 1 14 23
total 2 peptides
C1G3I3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YTEIQDYPK.H Y 29.76 1155.5448 9 -13.5 578.7719 2 52.62 6 25889 VEV_3_3_RA6_01_1237.d 8.79E4 1 1 923 931
R.VLRPFLLR.R N 18.60 1012.6545 8 -12.2 338.5547 3 70.36 4 39494 VEV_1_3_RA4_01_1235.d 3.23E4 1 1 404 411
total 2 peptides
C1GDK9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGDGPDGVDGLLEQGR.G Y 38.99 1540.7117 16 -10.9 771.3547 2 71.33 6 38864 VEV_3_3_RA6_01_1237.d 7.6E4 1 1 445 460
total 1 peptides
A0A0A0HVG0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYEDAIAALNSLQSNFSTINAVR.T Y 38.90 2483.2292 23 -15.6 828.7374 3 90.16 5 51966 VEV_2_3_RA5_01_1236.d 6.54E4 1 1 31 53
total 1 peptides
C1GKT9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FSYVPWTK.E Y 29.61 1026.5175 8 -11.4 514.2601 2 74.17 5 42003 VEV_2_3_RA5_01_1236.d 7.05E4 1 1 16 23
K.LLNDFK.A Y 18.28 748.4119 6 11.7 749.4280 1 60.92 4 32177 VEV_1_3_RA4_01_1235.d 0 2 2 72 77
total 2 peptides
C1G471
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASTGVVWTTER.A Y 28.00 1205.6040 11 -5.2 603.8062 2 59.00 5 30823 VEV_2_3_RA5_01_1236.d 0 1 1 56 66
R.AGLIR.I N 21.47 528.3384 5 -33.8 529.3278 1 24.03 5 9918 VEV_2_3_RA5_01_1236.d 0 1 1 153 157
total 2 peptides
C1GLM8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NPSDIQGLTARPTQK.F Y 30.28 1624.8533 15 -14.3 542.6173 3 51.88 6 25403 VEV_3_3_RA6_01_1237.d 5.06E4 1 1 16 30
K.SYC(+57.02)VRPNSGR.I Y 16.85 1194.5564 10 -16.7 598.2755 2 20.71 6 7936 VEV_3_3_RA6_01_1237.d 4.39E4 1 1 67 76 Carbamidomethylation
total 2 peptides
C1GE65
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAGHTGPGSNAGPVR.S Y 38.66 1377.6749 15 -10.7 689.8373 2 17.82 5 6552 VEV_2_3_RA5_01_1236.d 6.53E4 2 2 366 380
total 1 peptides
C1GB11
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GRPDTC(+57.02)IGSR.G Y 30.16 1117.5298 10 -13.2 559.7648 2 19.38 5 7451 VEV_2_3_RA5_01_1236.d 2.84E4 1 1 485 494 Carbamidomethylation
R.AGGSFLPR.I Y 16.70 803.4290 8 -16.3 402.7152 2 51.98 4 26150 VEV_1_3_RA4_01_1235.d 1.96E5 1 1 362 369
total 2 peptides
C1GB77
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TFKDLDIEPAEISNLTFHYLQGYR.S Y 30.19 2869.4285 24 -2.9 718.3623 4 87.11 4 51946 VEV_1_3_RA4_01_1235.d 0 1 1 333 356
R.NTQSIEESVR.H Y 16.43 1161.5625 10 -10.3 581.7825 2 37.62 6 17130 VEV_3_3_RA6_01_1237.d 4.67E4 1 1 115 124
total 2 peptides
C1G1Z1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.WGADTNVDTSTGR.K Y 38.29 1378.6113 13 -13.2 690.3038 2 53.41 5 27256 VEV_2_3_RA5_01_1236.d 0 1 1 241 253
total 1 peptides
C1GID7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNDYINNMIFNDRLDYSNPSIR.S Y 22.39 2686.2810 22 -5.3 896.4296 3 82.74 4 49056 VEV_1_3_RA4_01_1235.d 9.83E4 1 1 364 385
K.NRPTYESASTR.K Y 19.18 1280.6108 11 -20.3 641.2997 2 17.47 6 6231 VEV_3_3_RA6_01_1237.d 3.58E4 1 1 461 471
R.VQAFQGYGK.G Y 17.69 996.5029 9 -2.1 499.2577 2 44.11 6 20884 VEV_3_3_RA6_01_1237.d 4.09E4 1 1 424 432
total 3 peptides
C1GGL3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IDILK.L N 26.09 600.3846 5 -24.1 601.3774 1 35.69 6 16060 VEV_3_3_RA6_01_1237.d 2.93E4 1 1 316 320
R.GSLAPGSIFADEDEIVPSPHVSIDSR.K Y 23.44 2694.3135 26 -18.7 899.0950 3 82.17 6 46655 VEV_3_3_RA6_01_1237.d 1.48E5 2 2 66 91
total 2 peptides
C1FYP7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DM(+15.99)ISVLDRGDANLRLFLWSKLK.R Y 28.13 2605.4050 22 -21.2 1303.6821 2 97.43 4 57295 VEV_1_3_RA4_01_1235.d 1.71E5 2 2 923 944 Oxidation (M)
R.NSSPVEVDDILDSLVDAIK.A Y 19.33 2028.0262 19 -19.3 1015.0009 2 95.08 4 56321 VEV_1_3_RA4_01_1235.d 1.35E5 1 1 1480 1498
total 2 peptides
C1G9Y0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.KFEAGVAGDGIAR.N Y 37.75 1289.6727 13 -7.9 430.8948 3 52.21 4 26304 VEV_1_3_RA4_01_1235.d 2.38E5 2 2 116 128
total 1 peptides
C1FZC3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YRPVSTGSGIQVGGNER.T Y 37.70 1775.8914 17 -8.2 592.9662 3 53.24 6 26204 VEV_3_3_RA6_01_1237.d 3E4 1 1 576 592
total 1 peptides
A0A0A0HUN4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSTPSDSTNSTPTK.A Y 37.70 1422.6475 14 -9.8 712.3240 2 18.66 6 6856 VEV_3_3_RA6_01_1237.d 7.63E4 2 2 133 146
total 1 peptides
C1G9N1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NQYVSGPGEGNALDKQPR.Q Y 37.69 1928.9340 18 12.1 643.9930 3 53.87 5 27517 VEV_2_3_RA5_01_1236.d 0 1 1 197 214
total 1 peptides
C1G1S4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAFQIPGDNSLR.I Y 37.60 1317.6677 12 -12.2 659.8331 2 71.86 5 40357 VEV_2_3_RA5_01_1236.d 1.6E5 2 2 387 398
total 1 peptides
C1FZH9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LQSNIGDPSFADVFISEGGLLK.L Y 37.51 2306.1794 22 -62.2 769.6859 3 89.30 6 50945 VEV_3_3_RA6_01_1237.d 0 1 1 28 49
total 1 peptides
A0A0A0HTB4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IIPGFMIQGGDFTR.G Y 37.41 1550.7915 14 -15.7 776.3909 2 81.97 5 47327 VEV_2_3_RA5_01_1236.d 8.92E4 1 1 128 141
total 1 peptides
A0A0A0HUV5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAFQLPGDAR.V Y 26.28 1074.5458 10 -12.4 538.2735 2 65.30 5 35506 VEV_2_3_RA5_01_1236.d 2.48E5 1 1 1432 1441
R.RPDIYELLSR.S Y 21.82 1260.6826 10 -12.8 421.2294 3 74.57 4 42810 VEV_1_3_RA4_01_1235.d 2.82E4 1 1 610 619
total 2 peptides
C1GD32
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ITEQANAAGVVAAH Y 37.05 1350.6892 14 -17.8 676.3398 2 53.27 4 26964 VEV_1_3_RA4_01_1235.d 3.21E4 1 1 738 751
total 1 peptides
A0A0A0HW94
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LNDTETLPGANNPK.T Y 29.29 1482.7314 14 -3.4 495.2494 3 58.48 5 30439 VEV_2_3_RA5_01_1236.d 1.17E5 1 1 912 925
R.DGVEVEIEGFVEEGR.R Y 15.51 1662.7737 15 10.4 416.7050 4 37.18 5 17460 VEV_2_3_RA5_01_1236.d 9.22E4 1 1 835 849
total 2 peptides
C1GLA2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IVEMSTSK.T Y 36.87 893.4528 8 -14.7 447.7271 2 26.07 5 11117 VEV_2_3_RA5_01_1236.d 5.51E4 1 1 44 51
total 1 peptides
C1GHP8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ANVGAPSHGRLMK.S Y 36.82 1336.7034 13 -2.7 335.1822 4 24.45 4 9822 VEV_1_3_RA4_01_1235.d 0 1 1 483 495
total 1 peptides
C1GCP8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KKPTSADNDEAPER.S Y 27.86 1556.7430 14 -3.5 519.9198 3 12.11 4 3353 VEV_1_3_RA4_01_1235.d 1.97E4 1 1 292 305
R.LEILR.A N 17.55 642.4064 5 -26.4 322.2020 2 53.85 6 26558 VEV_3_3_RA6_01_1237.d 1.39E5 1 1 1629 1633
total 2 peptides
C1G8C3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ALSTVSQQAPGR.S Y 36.59 1213.6415 12 -9.8 607.8221 2 37.80 4 17398 VEV_1_3_RA4_01_1235.d 3.62E4 1 1 167 178
total 1 peptides
C1GI15
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGASAANFSSTGALK.A Y 36.51 1381.6837 15 -9.0 691.8429 2 58.26 4 30188 VEV_1_3_RA4_01_1235.d 4.87E4 1 1 351 365
total 1 peptides
C1G784
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPASPSTGSTLKPETVLVAPVSPLR.Q Y 36.45 2490.3694 25 -21.2 831.1128 3 77.38 4 44991 VEV_1_3_RA4_01_1235.d 3.07E4 1 1 88 112
total 1 peptides
C1G020
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ITILNANYILSR.L Y 36.43 1389.7980 12 -46.7 695.8738 2 80.98 6 45843 VEV_3_3_RA6_01_1237.d 0 1 1 891 902
total 1 peptides
C1G0N4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IIPLLASSPPAVR.S Y 36.28 1332.8129 13 -68.3 667.3682 2 78.44 5 45016 VEV_2_3_RA5_01_1236.d 0 1 1 93 105
total 1 peptides
C1GFV7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ELQVTLEPELELINSR.V Y 36.24 1882.0048 16 -32.0 628.3221 3 85.57 5 49496 VEV_2_3_RA5_01_1236.d 5.95E4 3 3 112 127
total 1 peptides
C1G5C2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SALDVYGENVR.I Y 27.51 1221.5989 11 -6.2 611.8029 2 64.09 4 34579 VEV_1_3_RA4_01_1235.d 1.34E5 1 1 883 893
K.IVVSPADC(+57.02)R.S Y 17.27 1015.5120 9 -12.3 508.7570 2 42.19 4 20025 VEV_1_3_RA4_01_1235.d 1.04E5 1 1 792 800 Carbamidomethylation
total 2 peptides
C1GAT1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TLNDLTYFTR.A Y 36.13 1242.6244 10 -13.2 622.3113 2 75.92 6 42220 VEV_3_3_RA6_01_1237.d 3.01E5 2 2 254 263
total 1 peptides
C1GFL5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.INPSHPER.G Y 26.01 948.4777 8 -9.9 475.2415 2 14.60 4 4590 VEV_1_3_RA4_01_1235.d 3.22E5 2 2 479 486
K.TNVHQAIDKLLVLEK.Q Y 20.17 1719.9883 15 -3.0 431.0031 4 75.34 4 43394 VEV_1_3_RA4_01_1235.d 5.18E4 1 1 30 44
total 2 peptides
C1GD24
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISAADLETLASATAETK.A Y 35.99 1690.8624 17 -22.1 846.4198 2 80.81 6 45731 VEV_3_3_RA6_01_1237.d 5.04E4 2 2 186 202
total 1 peptides
C1GFV3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.RTENSPSSDEGGQAPR.K Y 35.76 1686.7557 16 -9.2 563.2540 3 16.46 4 5542 VEV_1_3_RA4_01_1235.d 1.41E4 1 1 289 304
total 1 peptides
A0A0A0HTS8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LNSVLSDESR.G Y 35.58 1118.5568 10 -41.7 560.2623 2 47.84 4 23530 VEV_1_3_RA4_01_1235.d 0 1 1 65 74
total 1 peptides
C1G182
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YLNEIEELYEDFNVVR.M Y 26.17 2043.9789 16 -2.7 682.3317 3 91.12 6 51887 VEV_3_3_RA6_01_1237.d 0 1 1 296 311
K.GGVGK.T N 18.20 416.2383 5 -38.9 417.2294 1 10.95 5 2935 VEV_2_3_RA5_01_1236.d 7.35E4 2 2 35 39
total 2 peptides
C1GJL5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ARGMLHKLGGALFAPHWAK.F Y 35.13 2060.1255 19 0.2 687.7159 3 81.23 6 46020 VEV_3_3_RA6_01_1237.d 0 1 1 178 196
total 1 peptides
C1GE04
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TSQVNPDFDWDKPSPVLTAR.L Y 35.09 2272.1123 20 -9.0 758.3712 3 75.98 4 43907 VEV_1_3_RA4_01_1235.d 6.54E4 1 1 156 175
total 1 peptides
C1GCG5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EGASVLMADISEPALER.A Y 35.06 1786.8771 17 -13.1 894.4341 2 80.49 6 45507 VEV_3_3_RA6_01_1237.d 4.06E4 1 1 29 45
total 1 peptides
C1FZE7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASLSDTSLGGNK.S Y 35.02 1148.5673 12 -3.3 575.2890 2 35.90 6 16186 VEV_3_3_RA6_01_1237.d 3.43E4 3 3 779 790
total 1 peptides
C1G9P6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SGAGGKVPGVK.A Y 22.12 955.5450 11 -22.4 478.7691 2 18.48 6 6755 VEV_3_3_RA6_01_1237.d 6.84E4 2 2 178 188
K.SGAGGK.V Y 15.50 475.2390 6 -23.8 476.2350 1 19.91 6 7508 VEV_3_3_RA6_01_1237.d 0 1 1 178 183
K.AVENGGTSIGIR.C Y 15.23 1172.6149 12 33.1 587.3341 2 49.69 5 24965 VEV_2_3_RA5_01_1236.d 0 1 1 49 60
total 3 peptides
C1FZQ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SYPVGSPAR.N Y 34.82 932.4716 9 -21.2 467.2332 2 33.08 6 14620 VEV_3_3_RA6_01_1237.d 3.59E5 4 4 533 541
total 1 peptides
C1GHU8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGNVDLVTLALNLYTQGISPK.V Y 34.82 2216.2053 21 1.6 739.7436 3 95.32 4 56438 VEV_1_3_RA4_01_1235.d 3.46E4 1 1 284 304
total 1 peptides
C1G8I3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.WDVLEALNSLFSYK.G Y 24.04 1683.8508 14 -20.2 562.2795 3 71.04 6 38639 VEV_3_3_RA6_01_1237.d 5.14E4 1 1 160 173
R.VILER.W N 21.52 628.3908 5 -72.7 315.1798 2 26.72 5 11510 VEV_2_3_RA5_01_1236.d 1.15E6 7 7 183 187
total 2 peptides
C1G4V8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GILANC(+57.02)YAR.N Y 25.59 1036.5123 9 -9.8 519.2584 2 57.68 6 28820 VEV_3_3_RA6_01_1237.d 1.79E5 1 1 33 41 Carbamidomethylation
R.NSTYGTGHTSY Y 18.40 1186.4891 11 17.9 594.2625 2 30.48 4 13120 VEV_1_3_RA4_01_1235.d 0 1 1 324 334
total 2 peptides
C1GFJ0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YEVALLVGAGIGVTPFASILK.S Y 34.56 2117.2136 21 -39.2 530.2899 4 76.24 6 42496 VEV_3_3_RA6_01_1237.d 9.46E3 1 1 410 430
total 1 peptides
C1G1D3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LKPSPSDPNAATSSR.T Y 26.25 1526.7688 15 -8.4 509.9259 3 28.67 5 12494 VEV_2_3_RA5_01_1236.d 1.26E5 1 1 553 567
R.SPSRNTSTAPSPSINPK.H Y 16.34 1739.8801 17 -6.5 580.9636 3 34.91 5 16120 VEV_2_3_RA5_01_1236.d 6.04E5 1 1 453 469
total 2 peptides
C1GI31
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LEQLSTADIQR.R Y 20.61 1272.6674 11 -12.7 425.2243 3 57.16 6 28469 VEV_3_3_RA6_01_1237.d 0 1 1 14 24
R.GGSLIASPNLSR.T Y 17.23 1170.6356 12 -50.1 586.2958 2 72.33 5 40710 VEV_2_3_RA5_01_1236.d 6.95E4 1 1 579 590
K.ITTEETMGQIR.R Y 15.53 1277.6285 11 -1.2 426.8829 3 76.31 5 43530 VEV_2_3_RA5_01_1236.d 0 1 1 402 412
total 3 peptides
C1FZA0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SPHAGANVLFLGTTR.S Y 34.40 1539.8158 15 -23.6 514.2671 3 68.13 6 36490 VEV_3_3_RA6_01_1237.d 0 1 1 59 73
total 1 peptides
C1GJW7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSDQGGGIPR.E Y 34.28 984.4988 10 -20.4 493.2466 2 29.11 5 12756 VEV_2_3_RA5_01_1236.d 3.03E5 2 2 313 322
total 1 peptides
C1G5D4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IVDTGLGNFGTPGFK.S Y 34.21 1521.7827 15 6.2 761.9033 2 77.79 4 45318 VEV_1_3_RA4_01_1235.d 0 1 1 531 545
total 1 peptides
C1G0D5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AELEEIEYFVNLEK.T Y 34.09 1724.8508 14 -20.6 863.4149 2 86.39 6 49306 VEV_3_3_RA6_01_1237.d 6.95E4 1 1 247 260
total 1 peptides
C1G8N0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
M(+15.99)PPGR.S Y 20.39 572.2740 5 15.7 573.2903 1 53.74 6 26497 VEV_3_3_RA6_01_1237.d 0 1 1 1 5 Oxidation (M)
K.DGISGAPR.D Y 16.77 771.3875 8 -9.7 772.3873 1 85.89 4 51173 VEV_1_3_RA4_01_1235.d 0 1 1 455 462
K.GIEM(+15.99)VK.A N 15.75 691.3574 6 28.0 346.6957 2 58.64 6 29472 VEV_3_3_RA6_01_1237.d 1.3E5 1 1 120 125 Oxidation (M)
total 3 peptides
C1GGB5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LSPSQLDELQK.A Y 33.91 1256.6611 11 -16.5 629.3275 2 65.70 6 34647 VEV_3_3_RA6_01_1237.d 7.58E4 1 1 8 18
total 1 peptides
C1G553
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IVSNESSEIIR.M Y 33.89 1245.6565 11 -12.3 623.8279 2 56.52 4 28968 VEV_1_3_RA4_01_1235.d 3.95E4 1 1 187 197
total 1 peptides
C1GLE2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VSNNIADIPK.A Y 33.88 1069.5768 10 -15.8 535.7872 2 56.51 4 28963 VEV_1_3_RA4_01_1235.d 1.71E5 2 2 86 95
total 1 peptides
C1G8V0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GEFSTPPAYGAR.V Y 33.82 1251.5884 12 -4.7 626.7985 2 59.84 4 31374 VEV_1_3_RA4_01_1235.d 9.48E4 2 2 310 321
total 1 peptides
C1G380
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SEDANANVQAPK.T Y 23.21 1242.5840 12 -9.5 622.2934 2 26.26 6 10865 VEV_3_3_RA6_01_1237.d 4.46E5 2 2 438 449
K.IASDASVEER.K Y 20.85 1075.5145 10 -9.1 538.7596 2 27.23 6 11376 VEV_3_3_RA6_01_1237.d 4.48E4 1 1 169 178
total 2 peptides
C1GH87
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSSLVGVSGER.S Y 33.46 1088.5825 11 -18.1 545.2887 2 51.24 5 25911 VEV_2_3_RA5_01_1236.d 7.63E4 1 1 163 173
total 1 peptides
C1GI40
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AATQGIALGSK.G Y 33.45 1015.5662 11 -10.1 508.7852 2 39.34 4 18299 VEV_1_3_RA4_01_1235.d 5.94E4 1 1 326 336
total 1 peptides
C1GIV4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IYNEYPPTR.I Y 25.61 1151.5610 9 -15.3 576.7790 2 47.55 6 22889 VEV_3_3_RA6_01_1237.d 1.67E5 1 1 99 107
R.ILVQDVAR.V Y 15.66 912.5392 8 -19.2 457.2681 2 56.36 5 28984 VEV_2_3_RA5_01_1236.d 0 1 1 108 115
total 2 peptides
C1GA60
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLLKDGSIPEAR.G Y 24.78 1310.7557 12 -13.2 437.9201 3 63.44 6 32953 VEV_3_3_RA6_01_1237.d 1.36E5 1 1 71 82
K.DGSIPEAR.G Y 17.25 843.4086 8 -14.9 422.7053 2 65.79 6 34719 VEV_3_3_RA6_01_1237.d 3.83E4 1 1 75 82
total 2 peptides
C1G072
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ALYTAIAGK.G Y 33.12 906.5175 9 -22.0 454.2560 2 58.60 6 29448 VEV_3_3_RA6_01_1237.d 3.32E4 1 1 136 144
total 1 peptides
C1G774
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.C(+57.02)ITPPRENLQSYAAK.S Y 24.56 1746.8723 15 -12.6 437.7198 4 65.77 6 34706 VEV_3_3_RA6_01_1237.d 0 1 1 381 395 Carbamidomethylation
R.ENLQSYAAK.S Y 16.93 1022.5032 9 -7.6 512.2550 2 71.16 5 39848 VEV_2_3_RA5_01_1236.d 6.13E4 1 1 387 395
total 2 peptides
C1GHY9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GGGVAHGPHPR.D Y 25.15 1040.5264 11 -6.0 521.2673 2 11.34 4 3002 VEV_1_3_RA4_01_1235.d 1.5E4 1 1 160 170
K.YSSQHLLLPLRR.D Y 15.63 1481.8467 12 -16.7 371.4628 4 63.94 4 34468 VEV_1_3_RA4_01_1235.d 4.14E4 1 1 94 105
total 2 peptides
C1GFI3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SIETGGAAR.S Y 24.03 860.4352 9 10.0 431.2292 2 30.99 5 13823 VEV_2_3_RA5_01_1236.d 4.5E5 1 1 158 166
R.RSIETGGAARSAFSTAR.E Y 17.65 1736.8917 17 -4.5 435.2283 4 36.13 5 16848 VEV_2_3_RA5_01_1236.d 0 1 1 157 173
total 2 peptides
C1GN20
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGGPDC(+57.02)LPSLAPR.V Y 32.82 1351.6918 13 -11.8 676.8452 2 73.04 4 41609 VEV_1_3_RA4_01_1235.d 0 1 1 192 204 Carbamidomethylation
total 1 peptides
C1G4X8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISNSLSSLASFAK.S Y 32.80 1323.7034 13 -22.6 662.8440 2 76.72 6 42796 VEV_3_3_RA6_01_1237.d 5.24E4 1 1 72 84
total 1 peptides
C1G6T6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.WADYFHLR.M Y 22.97 1106.5298 8 -12.1 369.8461 3 73.50 6 40444 VEV_3_3_RA6_01_1237.d 6.39E4 2 2 147 154
R.RADSAINVEKPSSR.I Y 19.45 1528.7957 14 -6.6 383.2037 4 28.37 4 11956 VEV_1_3_RA4_01_1235.d 0 1 1 183 196
total 2 peptides
C1G5K5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IFPTGDPTNSNFSPR.F Y 32.68 1648.7845 15 -17.9 550.5923 3 68.75 6 37015 VEV_3_3_RA6_01_1237.d 5.87E5 1 1 96 110
total 1 peptides
C1GLJ0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FSTLVDSPSVR.F Y 23.14 1206.6244 11 -18.3 604.3084 2 65.89 6 34869 VEV_3_3_RA6_01_1237.d 1.74E5 2 2 450 460
R.IGYESHSAR.N Y 18.94 1018.4832 9 -9.0 510.2443 2 17.14 5 6195 VEV_2_3_RA5_01_1236.d 0 1 1 1281 1289
total 2 peptides
C1GM93
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.KEIEGKSFTFRK Y 32.58 1468.8037 12 -34.8 490.5915 3 24.55 4 9872 VEV_1_3_RA4_01_1235.d 6.16E5 3 3 815 826
total 1 peptides
C1FZH1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TQLEK.V N 21.83 617.3384 5 -17.2 618.3351 1 70.00 4 39214 VEV_1_3_RA4_01_1235.d 0 1 1 227 231
K.YSVGDSPATFSAASKQPVASK.T Y 21.43 2097.0378 21 -10.3 700.0127 3 63.62 5 34312 VEV_2_3_RA5_01_1236.d 3.02E4 1 1 163 183
total 2 peptides
C1GAA4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISSPR.A N 23.89 558.3126 5 -16.1 559.3109 1 36.84 6 16678 VEV_3_3_RA6_01_1237.d 2.69E5 2 2 96 100
R.SVVVGLADKLK.T Y 17.29 1127.6914 11 -6.3 376.9020 3 65.69 4 35825 VEV_1_3_RA4_01_1235.d 2.02E4 1 1 255 265
total 2 peptides
C1GBC8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LWDIR.K N 22.15 701.3860 5 -16.6 351.6945 2 64.77 4 35095 VEV_1_3_RA4_01_1235.d 2.66E5 2 2 380 384
K.KIGGFSLC(+57.02)PSQPHLFATASLDR.F Y 20.74 2401.2212 22 -21.6 601.2996 4 71.68 4 40543 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 355 376 Carbamidomethylation
total 2 peptides
C1GE44
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVISLEDVNHAR.Y Y 32.46 1338.6892 12 -21.3 447.2275 3 62.37 4 33268 VEV_1_3_RA4_01_1235.d 1.1E5 1 1 238 249
total 1 peptides
C1GC91
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IATYSLSPNR.Q Y 32.43 1120.5876 10 -22.1 561.2887 2 57.59 6 28760 VEV_3_3_RA6_01_1237.d 4.11E4 1 1 28 37
total 1 peptides
C1GCG7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EIIYENLSADDVRR.M Y 32.35 1691.8478 14 -8.0 564.9520 3 66.96 5 36744 VEV_2_3_RA5_01_1236.d 2.32E5 2 2 641 654
total 1 peptides
C1GFE0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAQVQDGGLSEPRPK.H Y 32.33 1551.8004 15 -13.0 518.2673 3 38.97 5 18507 VEV_2_3_RA5_01_1236.d 1.15E5 2 2 308 322
total 1 peptides
C1GFZ5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VGDGC(+57.02)PQSIQGDKEDE Y 32.16 1732.7209 16 -7.4 867.3613 2 40.56 5 19444 VEV_2_3_RA5_01_1236.d 1.03E5 2 2 663 678 Carbamidomethylation
total 1 peptides
C1G2R8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SRPSIAELFK.W Y 21.58 1146.6396 10 -11.5 383.2161 3 70.07 4 39268 VEV_1_3_RA4_01_1235.d 6.19E4 1 1 1136 1145
R.DTATVSFGGFSK.M Y 21.03 1215.5771 12 -13.5 608.7877 2 70.59 4 39677 VEV_1_3_RA4_01_1235.d 1.55E5 1 1 489 500
total 2 peptides
C1GI29
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DASSLSTSAPESTNPKPQESITSR.H Y 32.06 2489.1880 24 -9.5 830.7288 3 61.00 4 32232 VEV_1_3_RA4_01_1235.d 7.87E4 2 2 315 338
total 1 peptides
C1GCS1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SIYTNDRVDGGC(+57.02)PK.R Y 31.82 1580.7252 14 5.6 791.3743 2 41.01 5 19719 VEV_2_3_RA5_01_1236.d 1.16E5 2 2 221 234 Carbamidomethylation
total 1 peptides
A0A0A0HR13
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGGVISVYGMTVSPK.M Y 22.57 1464.7646 15 -13.6 733.3796 2 75.98 4 43900 VEV_1_3_RA4_01_1235.d 4.39E4 1 1 271 285
R.DLFLR.Q N 18.44 662.3751 5 -10.7 332.1913 2 39.40 6 18149 VEV_3_3_RA6_01_1237.d 2.96E5 2 2 52 56
total 2 peptides
C1G029
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DGYTQNTTSQYIR.Q Y 31.72 1545.7059 13 -8.1 773.8540 2 60.58 4 31920 VEV_1_3_RA4_01_1235.d 6.31E4 1 1 429 441
total 1 peptides
C1GFR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YLEC(+57.02)SALTQR.N Y 31.69 1239.5918 10 -10.4 620.7968 2 59.92 4 31435 VEV_1_3_RA4_01_1235.d 6.53E4 1 1 160 169 Carbamidomethylation
total 1 peptides
C1G6V3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VTDNNNEVFFK.I Y 31.55 1325.6251 11 -9.0 663.8139 2 63.38 4 34046 VEV_1_3_RA4_01_1235.d 1.32E5 2 2 23 33
total 1 peptides
C1G845
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SHTELAPAPQLR.H Y 31.43 1318.6993 12 -8.9 440.5698 3 51.44 5 26034 VEV_2_3_RA5_01_1236.d 1.14E5 2 2 7 18
total 1 peptides
C1GC00
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AVVIIPNFELSTAK.A Y 31.42 1500.8551 14 -6.8 751.4297 2 82.25 4 48707 VEV_1_3_RA4_01_1235.d 4.37E4 1 1 192 205
total 1 peptides
C1GN28
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.WADNVYDRQPSGGGINR.S Y 31.38 1903.8925 17 -14.3 635.6290 3 60.78 5 32129 VEV_2_3_RA5_01_1236.d 4.77E4 1 1 283 299
total 1 peptides
A0A0A0HW75
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ITDFGNGEC(+57.02)FR.M Y 31.32 1314.5663 11 4.7 658.2935 2 64.49 5 34898 VEV_2_3_RA5_01_1236.d 4.97E4 2 2 302 312 Carbamidomethylation
total 1 peptides
C1G6T2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGIC(+57.02)DLDTSVTPPR.V Y 31.32 1500.7242 14 -6.5 751.3645 2 69.64 6 37594 VEV_3_3_RA6_01_1237.d 9.06E4 1 1 11 24 Carbamidomethylation
total 1 peptides
C1GMG5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LQASGPSEASR.A Y 31.16 1101.5414 11 -16.3 551.7690 2 22.88 6 9071 VEV_3_3_RA6_01_1237.d 3.5E4 2 2 43 53
total 1 peptides
C1GJ21
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGQLEFASSR.G Y 22.06 1094.5356 10 -7.4 548.2711 2 50.23 4 25020 VEV_1_3_RA4_01_1235.d 4.34E4 1 1 578 587
R.LLTPR.L N 18.18 598.3802 5 -11.0 300.1941 2 39.30 5 18692 VEV_2_3_RA5_01_1236.d 2.01E6 4 4 1206 1210
total 2 peptides
C1GET2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVASPHFQVAER.A Y 31.11 1326.6680 12 -30.1 664.3213 2 52.50 5 26688 VEV_2_3_RA5_01_1236.d 0 1 1 573 584
total 1 peptides
C1GEE1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SVQQLHVDEVPFTFALR.A Y 22.68 1985.0370 17 -26.8 662.6685 3 82.16 4 48640 VEV_1_3_RA4_01_1235.d 1.64E5 1 1 435 451
R.DAPVLSSK.A Y 16.86 815.4388 8 -14.3 816.4344 1 49.70 6 24129 VEV_3_3_RA6_01_1237.d 3.78E4 1 1 467 474
total 2 peptides
A0A0A0HXB0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LGAAGTGGTGGGIAHSTR.Q Y 31.06 1539.7754 18 -13.9 514.2586 3 33.70 5 15401 VEV_2_3_RA5_01_1236.d 0 1 1 124 141
total 1 peptides
C1GK54
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EREGGSASVGLR.T Y 30.94 1216.6160 12 7.7 406.5491 3 28.73 5 12577 VEV_2_3_RA5_01_1236.d 2.22E6 3 3 975 986
total 1 peptides
C1GAH4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EAQYGETSSYGRGEESYGTGR.S Y 30.91 2282.9675 21 -10.0 761.9888 3 51.78 6 25343 VEV_3_3_RA6_01_1237.d 3.85E4 1 1 784 804
total 1 peptides
C1GMQ0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ISSEKETGGSQDKAYNLEAAVSNTASSPLQR.K Y 30.86 3237.5750 31 -8.2 810.3943 4 69.92 6 37792 VEV_3_3_RA6_01_1237.d 1.19E5 1 1 51 81
total 1 peptides
C1GL57
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.STDPPESSC(+57.02)R.M Y 30.84 1134.4612 10 10.2 568.2437 2 14.79 4 4695 VEV_1_3_RA4_01_1235.d 0 1 1 43 52 Carbamidomethylation
total 1 peptides
C1G4V0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LITEPSHSILTQSYDSR.L Y 30.76 1945.9745 17 -15.6 649.6553 3 68.37 4 37933 VEV_1_3_RA4_01_1235.d 4.33E4 1 1 18 34
total 1 peptides
C1GJU9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSELNKDSPAAKTSTALNNSVRETEDR.T Y 30.53 2931.4534 27 -12.9 587.2904 5 69.69 5 38770 VEV_2_3_RA5_01_1236.d 0 1 1 278 304
total 1 peptides
C1G4T8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSGWGWLVR.Q Y 22.47 1016.5192 9 -9.9 509.2618 2 78.96 4 46220 VEV_1_3_RA4_01_1235.d 1.09E5 1 1 127 135
K.ALQDQAAAAK.E Y 16.11 985.5192 10 -11.6 493.7612 2 23.21 5 9456 VEV_2_3_RA5_01_1236.d 2.3E4 1 1 44 53
total 2 peptides
C1GJ13
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AHEYTSKEPESR.K Y 22.50 1432.6582 12 -10.0 478.5552 3 13.35 5 4153 VEV_2_3_RA5_01_1236.d 2.21E4 1 1 423 434
K.AFKTVNDTYIEPISFIVPR.R Y 15.86 2209.1782 19 -24.1 737.3823 3 83.57 5 48300 VEV_2_3_RA5_01_1236.d 8.09E4 1 1 339 357
total 2 peptides
A0A0A0HTY3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AGNNNSYWYAR.R Y 30.43 1314.5741 11 -7.3 658.2896 2 56.98 4 29287 VEV_1_3_RA4_01_1235.d 8.26E4 2 2 485 495
total 1 peptides
C1G2G2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LAPEDRQAIAVER.Q Y 22.57 1466.7841 13 -15.7 489.9276 3 50.59 5 25503 VEV_2_3_RA5_01_1236.d 6.39E4 1 1 48 60
R.SPIIIFSK.S Y 15.64 903.5429 8 -37.7 452.7617 2 71.23 4 40190 VEV_1_3_RA4_01_1235.d 0 1 1 130 137
total 2 peptides
C1GI72
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YDGAYGYVLKSLSPR.K Y 21.14 1687.8569 15 -38.6 422.9552 4 54.17 4 27544 VEV_1_3_RA4_01_1235.d 0 1 1 72 86
R.LVPTEPR.K Y 18.47 810.4599 7 -43.2 811.4322 1 98.81 5 55604 VEV_2_3_RA5_01_1236.d 0 1 1 519 525
total 2 peptides
C1G5N9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YVAISEEYR.N Y 30.29 1128.5450 9 -26.2 565.2650 2 37.54 4 17285 VEV_1_3_RA4_01_1235.d 4.79E5 1 1 158 166
total 1 peptides
C1GJ91
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLYAPFPEIIETYR.S Y 30.22 1773.8977 14 -0.4 887.9557 2 87.06 4 51915 VEV_1_3_RA4_01_1235.d 1.51E5 1 1 142 155
total 1 peptides
C1G3P7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NPDTGDVTLDVAQLLTGGLK.G Y 30.15 2026.0582 20 -15.7 1014.0204 2 91.02 6 51842 VEV_3_3_RA6_01_1237.d 6.6E4 1 1 57 76
total 1 peptides
C1FZT6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NSFYGDTWDVR.S Y 30.15 1358.5891 11 27.7 680.3206 2 72.94 4 41537 VEV_1_3_RA4_01_1235.d 0 1 1 246 256
total 1 peptides
C1G6I7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NNSSVSVGSFDGLVDK.D Y 30.05 1623.7740 16 -7.5 812.8882 2 80.36 6 45415 VEV_3_3_RA6_01_1237.d 1.58E5 2 2 99 114
total 1 peptides
C1G095
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSGLDTGRAPPPGR.Y Y 30.05 1380.7109 14 -17.4 461.2363 3 31.19 6 13522 VEV_3_3_RA6_01_1237.d 0 1 1 229 242
total 1 peptides
C1FYI5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YIQQAAALR.R Y 21.26 1032.5715 9 0.9 345.1981 3 51.13 6 24946 VEV_3_3_RA6_01_1237.d 2.38E4 1 1 238 246
K.LM(+15.99)LNR.I N 17.42 661.3582 5 -25.9 662.3483 1 99.11 4 57909 VEV_1_3_RA4_01_1235.d 2.07E5 1 1 499 503 Oxidation (M)
total 2 peptides
C1G6G4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GHAALADPTENIESSR.E Y 20.78 1666.7910 16 -36.8 556.5839 3 56.03 6 27750 VEV_3_3_RA6_01_1237.d 0 1 1 155 170
R.AAAPSESKGHAALADPTENIESSR.E Y 18.21 2408.1567 24 -18.7 603.0352 4 55.48 6 27424 VEV_3_3_RA6_01_1237.d 4.91E4 1 1 147 170
total 2 peptides
C1G581
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DLLEDNHVIPPERHHGK.A Y 29.88 2005.0129 17 -12.0 669.3369 3 60.92 4 32203 VEV_1_3_RA4_01_1235.d 1.62E5 2 2 88 104
total 1 peptides
C1GKQ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSVLEHLDTLAR.Y Y 20.64 1339.7096 12 -9.1 447.5731 3 71.39 4 40316 VEV_1_3_RA4_01_1235.d 6.97E4 1 1 198 209
R.GGVGK.D N 18.20 416.2383 5 -38.9 417.2294 1 10.95 5 2935 VEV_2_3_RA5_01_1236.d 7.35E4 2 2 615 619
total 2 peptides
C1G4I3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TNSPGDPIIPVSVAFEER.L Y 21.00 1926.9686 18 -10.2 964.4818 2 81.61 4 48255 VEV_1_3_RA4_01_1235.d 0 1 1 254 271
K.LGSFFTTGADEVR.Q Y 17.29 1398.6779 13 -16.3 700.3348 2 74.73 6 41347 VEV_3_3_RA6_01_1237.d 7.81E4 1 1 307 319
total 2 peptides
C1GCN2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NLISGGSSGGEGAIVR.A Y 29.64 1472.7583 16 -11.3 737.3781 2 64.56 4 34936 VEV_1_3_RA4_01_1235.d 6.73E4 1 1 199 214
total 1 peptides
C1GIL6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLSEGQSAVQQAK.A Y 29.63 1331.6681 13 -14.6 666.8316 2 34.33 6 15267 VEV_3_3_RA6_01_1237.d 1.85E4 1 1 311 323
total 1 peptides
C1GG53
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IFQVEYAQEAVK.Q Y 29.62 1423.7346 12 -22.3 712.8587 2 71.17 6 38737 VEV_3_3_RA6_01_1237.d 1.35E5 1 1 19 30
total 1 peptides
C1GD74
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GPPNTPGAQMSGK.A Y 29.61 1240.5870 13 -6.3 621.2969 2 27.53 6 11526 VEV_3_3_RA6_01_1237.d 0 1 1 580 592
total 1 peptides
C1G8R6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASAVAVPIANTVTR.S Y 29.40 1368.7725 14 -19.0 685.3805 2 67.35 5 37037 VEV_2_3_RA5_01_1236.d 1.41E4 1 1 290 303
total 1 peptides
C1G5R3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAQGIAGPQSK.N Y 29.20 1026.5458 11 -26.8 514.2664 2 19.62 6 7358 VEV_3_3_RA6_01_1237.d 0 1 1 239 249
total 1 peptides
C1GET9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LSPEAAEKLSSHFVSIR.K Y 21.60 1869.9948 17 -60.1 624.3014 3 75.71 4 43691 VEV_1_3_RA4_01_1235.d 2.18E4 1 1 561 577
K.GSSAAGLTASVQR.D Y 15.03 1203.6207 13 -5.6 602.8143 2 45.28 4 21940 VEV_1_3_RA4_01_1235.d 1.78E4 1 1 394 406
total 2 peptides
C1G7X1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SQLPALVDEYMTGK.L Y 28.98 1550.7650 14 -15.8 776.3776 2 81.20 6 45999 VEV_3_3_RA6_01_1237.d 1.02E5 1 1 325 338
total 1 peptides
C1G1W2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HAVEK.E N 21.39 582.3126 5 -67.1 583.2808 1 68.89 4 38345 VEV_1_3_RA4_01_1235.d 8.85E5 2 2 122 126
R.IRSSSSPPLNVSMRYR.H Y 15.08 1848.9628 16 -37.7 463.2305 4 98.54 5 55511 VEV_2_3_RA5_01_1236.d 7.39E3 1 1 312 327
total 2 peptides
C1G733
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SLLILGR.D Y 20.51 770.5014 7 -19.8 386.2504 2 73.20 4 41772 VEV_1_3_RA4_01_1235.d 1.14E6 4 4 299 305
R.ASIEYYVGQALK.A Y 16.75 1340.6975 12 -6.6 671.3516 2 78.59 5 45107 VEV_2_3_RA5_01_1236.d 5.43E4 1 1 891 902
total 2 peptides
C1FZT5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TLQSLSGSDAIK.A Y 28.85 1218.6455 12 -21.6 610.3169 2 59.50 6 30085 VEV_3_3_RA6_01_1237.d 1.35E5 3 3 93 104
total 1 peptides
C1GEY4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GTTGFSLDTLAR.Q Y 28.83 1237.6302 12 -20.9 619.8094 2 74.29 6 41025 VEV_3_3_RA6_01_1237.d 7.46E4 1 1 460 471
total 1 peptides
C1GDA6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LVGSGHR.L Y 28.81 724.3980 7 -39.4 725.3768 1 68.39 4 37950 VEV_1_3_RA4_01_1235.d 0 1 1 147 153
total 1 peptides
C1G5P3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HAEGQVVQPPRFPE Y 19.46 1589.7949 14 -3.4 530.9371 3 63.96 6 33340 VEV_3_3_RA6_01_1237.d 1.55E5 1 1 179 192
K.TVDPSTSPPTFQDIPIHEGSLFLLPANTPHC(+57.02)PVR.F Y 18.42 3739.8667 34 -6.2 935.9681 4 83.50 6 47510 VEV_3_3_RA6_01_1237.d 7.87E4 1 1 73 106 Carbamidomethylation
total 2 peptides
C1G7M3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLAER.V N 20.91 600.3595 5 -28.0 301.1786 2 18.52 6 6785 VEV_3_3_RA6_01_1237.d 1.5E5 2 2 339 343
R.TLLIC(+57.02)GYPNVGK.S Y 15.43 1333.7064 12 -23.6 667.8447 2 74.15 5 41990 VEV_2_3_RA5_01_1236.d 5.05E4 1 1 169 180 Carbamidomethylation
total 2 peptides
C1G7Y9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.HANVGIAM(+15.99)GKYGSDVAK.E Y 28.61 1732.8566 17 -10.4 434.2169 4 29.37 6 12528 VEV_3_3_RA6_01_1237.d 2.62E5 2 2 768 784 Oxidation (M)
total 1 peptides
C1GN14
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VASFYGPELQR.Y Y 19.72 1265.6404 11 -9.6 633.8214 2 67.87 4 37538 VEV_1_3_RA4_01_1235.d 7.46E4 1 1 46 56
K.SGLAR.V N 17.68 502.2863 5 12.0 503.2996 1 72.10 4 40868 VEV_1_3_RA4_01_1235.d 4.96E5 3 3 901 905
total 2 peptides
C1G4W6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NFFLFTPLLPSC(+57.02)TTGLIEHR.S Y 28.50 2362.2144 20 -10.4 788.4039 3 89.88 4 53597 VEV_1_3_RA4_01_1235.d 2.61E4 1 1 153 172 Carbamidomethylation
total 1 peptides
A0A0A0HXG7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NPERSKHLETATTR.M Y 20.32 1638.8438 14 -21.8 547.2766 3 59.60 5 31264 VEV_2_3_RA5_01_1236.d 7.62E4 1 1 225 238
R.TPMEPFQTFKDDPLR.V Y 16.12 1820.8767 15 16.9 456.2341 4 64.56 6 33783 VEV_3_3_RA6_01_1237.d 0 1 1 309 323
total 2 peptides
C1GHR3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AASTR.E N 19.56 504.2656 5 -3.1 505.2713 1 98.94 6 54960 VEV_3_3_RA6_01_1237.d 0 1 1 202 206
R.RTVQVEYVAPQSQTAR.G Y 17.61 1831.9540 16 -17.4 458.9878 4 48.39 5 24161 VEV_2_3_RA5_01_1236.d 0 2 2 686 701
total 2 peptides
A0A0A0HWT6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.NLEAVM(+15.99)TPRAGAGAGAGER.R Y 19.27 1842.9006 19 -14.1 461.7259 4 16.06 4 5349 VEV_1_3_RA4_01_1235.d 3.21E4 1 1 102 120 Oxidation (M)
K.ILTPR.Q N 18.18 598.3802 5 -11.0 300.1941 2 39.30 5 18692 VEV_2_3_RA5_01_1236.d 2.01E6 4 4 234 238
total 2 peptides
C1GFE4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GLALNAPAPK.T Y 28.27 950.5549 10 -42.2 476.2646 2 57.78 4 29856 VEV_1_3_RA4_01_1235.d 0 2 2 17 26
total 1 peptides
C1G4M6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SAPDR.R N 19.79 544.2605 5 33.3 545.2859 1 49.39 5 24780 VEV_2_3_RA5_01_1236.d 0 1 1 137 141
R.GSRDELDYGGGGIGETAR.S Y 16.92 1808.8289 18 1.6 603.9512 3 59.64 4 31224 VEV_1_3_RA4_01_1235.d 7.24E4 1 1 733 750
total 2 peptides
C1GE77
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.SPIMLLVGPPGTGK.T Y 28.12 1365.7689 14 -24.1 456.2526 3 73.02 6 40106 VEV_3_3_RA6_01_1237.d 5.26E4 1 1 475 488
total 1 peptides
C1GCZ7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SFSAQAILEIVHYIFR.S Y 28.08 1893.0148 16 -17.6 474.2526 4 76.88 5 43928 VEV_2_3_RA5_01_1236.d 8.14E4 1 1 81 96
total 1 peptides
C1G486
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VIQDTFSLQDVPK.E Y 28.05 1488.7823 13 -13.6 745.3883 2 76.47 4 44307 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 99 111
total 1 peptides
C1G6Q3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IQPPTAIGSAAR.G Y 28.01 1180.6564 12 -47.3 591.3076 2 59.04 5 30882 VEV_2_3_RA5_01_1236.d 6.62E4 3 3 17 28
total 1 peptides
C1GGW3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLATGAEDKQIR.V Y 18.82 1363.7095 12 -27.1 682.8435 2 39.96 4 18668 VEV_1_3_RA4_01_1235.d 0 1 1 345 356
R.SVC(+57.02)FSPDGR.Y Y 18.19 1023.4443 9 -9.0 512.7249 2 47.62 5 23714 VEV_2_3_RA5_01_1236.d 4.5E4 1 1 336 344 Carbamidomethylation
total 2 peptides
C1G4M0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YAQDQPLAGAR.I Y 19.28 1188.5887 11 -5.6 595.2983 2 41.11 4 19371 VEV_1_3_RA4_01_1235.d 4.18E4 1 1 40 50
K.SVQNIKPQVDR.F Y 17.26 1282.6993 11 -37.3 642.3330 2 34.33 6 15266 VEV_3_3_RA6_01_1237.d 0 1 1 320 330
total 2 peptides
C1G8A8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TNLMPK.F Y 19.87 702.3734 6 -30.0 703.3596 1 79.94 4 46974 VEV_1_3_RA4_01_1235.d 2.74E4 1 1 232 237
K.AELLR.S N 16.06 600.3595 5 0.0 301.1870 2 44.30 5 21737 VEV_2_3_RA5_01_1236.d 4.39E5 1 1 360 364
total 2 peptides
C1GF82
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NGSQGNIYKDSTPQQPQTPK.S Y 27.86 2187.0557 20 -12.3 730.0168 3 47.04 4 23031 VEV_1_3_RA4_01_1235.d 3.43E4 1 1 199 218
total 1 peptides
C1GKX2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NQAAEAASIASFQSLQKR.I Y 27.79 1918.9861 18 -22.7 640.6548 3 69.01 4 38443 VEV_1_3_RA4_01_1235.d 1.03E5 1 1 49 66
total 1 peptides
A0A0A0HTE6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NGAFR.G N 19.73 563.2816 5 -11.8 564.2822 1 67.99 4 37631 VEV_1_3_RA4_01_1235.d 1.64E5 3 3 2928 2932
R.VPGNDK.L Y 16.07 628.3180 6 -7.8 629.3204 1 74.69 6 41319 VEV_3_3_RA6_01_1237.d 4.44E4 1 1 2898 2903
total 2 peptides
C1G571
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DSSELVAQLR.V Y 20.09 1116.5775 10 -9.2 559.2909 2 67.47 6 35989 VEV_3_3_RA6_01_1237.d 4.41E5 1 1 468 477
K.IIGADADFFANMAVDAMQQVK.T Y 15.28 2254.0762 21 -10.4 752.3582 3 92.65 4 55123 VEV_1_3_RA4_01_1235.d 6.63E4 1 1 169 189
total 2 peptides
C1FZZ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YLINAEKAQG Y 27.63 1105.5768 10 -40.5 553.7733 2 50.97 4 25491 VEV_1_3_RA4_01_1235.d 0 1 1 157 166
total 1 peptides
C1G855
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSFTFDEGLPTPR.T Y 27.63 1452.6885 13 -7.3 727.3462 2 76.81 5 43884 VEV_2_3_RA5_01_1236.d 2.5E4 1 1 62 74
total 1 peptides
C1G6U3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SSLAAQAEQQHTDTSGQR.F Y 27.47 1913.8827 18 2.1 638.9695 3 34.74 4 15602 VEV_1_3_RA4_01_1235.d 2.64E4 1 1 966 983
total 1 peptides
C1GC76
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TTGITETLFELGQINFR.M Y 27.46 1939.0050 17 -13.6 647.3335 3 89.65 6 51133 VEV_3_3_RA6_01_1237.d 1.24E5 1 1 187 203
total 1 peptides
A0A0A0HTN8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VIPAEGDNQGAPK.S Y 27.46 1294.6517 13 9.0 648.3390 2 35.01 4 15789 VEV_1_3_RA4_01_1235.d 2.53E5 3 3 248 260
total 1 peptides
C1GG95
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TPDLDSFIKEVNTIPNNTYFR.I Y 27.43 2483.2332 21 22.0 828.7699 3 86.67 4 51667 VEV_1_3_RA4_01_1235.d 0 1 1 928 948
total 1 peptides
C1G1U8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VSLLGYLDPLENLSDTTR.K Y 27.36 2005.0367 18 -15.4 1003.5103 2 90.90 6 51779 VEV_3_3_RA6_01_1237.d 0 1 1 200 217
total 1 peptides
C1G243
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NVMDR.A Y 19.07 633.2905 5 -29.3 634.2792 1 30.71 5 13671 VEV_2_3_RA5_01_1236.d 2.06E5 1 1 1491 1495
K.ELFLR.E N 16.31 676.3907 5 -23.1 339.1948 2 56.46 6 28010 VEV_3_3_RA6_01_1237.d 7.38E4 1 1 300 304
total 2 peptides
C1FZX8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.EEETK.K N 18.85 634.2809 5 12.3 635.2960 1 27.01 4 11193 VEV_1_3_RA4_01_1235.d 6.64E4 1 1 292 296
K.YGKDDDHIAQIIELLGPFPK.S Y 16.64 2268.1790 20 -77.1 568.0083 4 87.12 4 51952 VEV_1_3_RA4_01_1235.d 0 1 1 488 507
total 2 peptides
C1GF30
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GDIGLYLGDIQDHVVTMMSNLGHFEK.M Y 19.13 2888.3838 26 -27.9 723.0831 4 92.58 4 55080 VEV_1_3_RA4_01_1235.d 0 1 1 551 576
K.NLYNENER.N Y 15.90 1050.4730 8 -2.7 526.2424 2 28.60 4 12074 VEV_1_3_RA4_01_1235.d 1.32E5 1 1 311 318
total 2 peptides
C1GGE8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TAEGLSGVKAEAR.G Y 18.39 1287.6782 13 -7.3 644.8417 2 35.47 4 16021 VEV_1_3_RA4_01_1235.d 2.52E4 1 1 394 406
R.ILQESLGGNSR.T Y 17.29 1172.6149 11 -4.5 587.3121 2 48.09 6 23216 VEV_3_3_RA6_01_1237.d 0 1 1 295 305
total 2 peptides
C1G3E7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TATTTATTLSSSPK.H Y 27.01 1365.6987 14 -37.8 683.8308 2 37.34 5 17551 VEV_2_3_RA5_01_1236.d 0 1 1 574 587
total 1 peptides
C1FYU0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.QPAPLSIPSR.S Y 18.05 1064.5978 10 -7.0 355.8707 3 33.85 6 14981 VEV_3_3_RA6_01_1237.d 6.34E5 2 2 103 112
K.SPSTVEPSNTPSTR.S Y 17.75 1458.6951 14 13.3 730.3645 2 33.18 4 14673 VEV_1_3_RA4_01_1235.d 1.27E4 2 2 1133 1146
total 2 peptides
C1GFZ8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SIPDGQSSVGSR.A Y 26.81 1188.5735 12 -13.1 595.2863 2 33.57 4 14906 VEV_1_3_RA4_01_1235.d 1.61E5 2 2 318 329
total 1 peptides
C1G914
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AAEIR.W N 18.24 558.3125 5 5.6 559.3229 1 27.91 5 12082 VEV_2_3_RA5_01_1236.d 0 2 2 439 443
R.YVLTAAK.E Y 16.80 764.4432 7 -10.5 765.4425 1 101.21 5 56411 VEV_2_3_RA5_01_1236.d 0 1 1 197 203
total 2 peptides
C1G7K1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DLGHSSSNGTK.K Y 17.92 1101.5050 11 4.0 551.7620 2 25.15 6 10279 VEV_3_3_RA6_01_1237.d 1.33E3 1 1 672 682
R.ITGAR.C N 17.35 516.3020 5 -76.5 517.2698 1 69.50 5 38631 VEV_2_3_RA5_01_1236.d 0 1 1 342 346
total 2 peptides
A0A0A0HV65
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VNLPC(+57.02)VDSR.T Y 26.59 1058.5178 9 -13.6 530.2590 2 60.15 6 30544 VEV_3_3_RA6_01_1237.d 0 1 1 82 90 Carbamidomethylation
total 1 peptides
C1FZR4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLSSEPLPDEFRDR.A Y 18.88 1672.8420 14 -36.5 558.6010 3 70.82 5 39596 VEV_2_3_RA5_01_1236.d 0 1 1 217 230
R.FAGGLTSESGDVK.K Y 15.37 1266.6091 13 -24.8 634.2961 2 51.20 6 24987 VEV_3_3_RA6_01_1237.d 0 1 1 46 58
total 2 peptides
A0A0A0HY15
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MPLVV Y 26.49 557.3247 5 -21.2 558.3202 1 84.86 4 50493 VEV_1_3_RA4_01_1235.d 3.46E3 1 1 57 61
total 1 peptides
C1GE38
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.DAEDILTATAQSSVPANR.V Y 26.49 1857.9067 18 -15.4 620.3000 3 76.40 6 42554 VEV_3_3_RA6_01_1237.d 1.33E5 1 1 163 180
total 1 peptides
C1G3P8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TVDFILDEPAIK.A Y 26.49 1359.7285 12 8.2 680.8771 2 79.91 4 46945 VEV_1_3_RA4_01_1235.d 0 1 1 294 305
total 1 peptides
C1G003
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GRGDQTPDIATR.K Y 26.36 1285.6375 12 -13.3 643.8174 2 28.21 5 12243 VEV_2_3_RA5_01_1236.d 6.9E4 1 1 368 379
total 1 peptides
A0A0A0HTT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MTVSNQAASR.G Y 18.18 1063.5081 10 -7.0 532.7576 2 21.44 5 8518 VEV_2_3_RA5_01_1236.d 4.71E4 1 1 34 43
K.QNTLR.T N 16.29 630.3449 5 4.1 316.1810 2 55.06 4 28092 VEV_1_3_RA4_01_1235.d 0 1 1 244 248
total 2 peptides
C1G462
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NNGEVYYVTGK.G Y 26.17 1242.5880 11 -12.4 622.2936 2 51.07 5 25800 VEV_2_3_RA5_01_1236.d 2.29E5 2 2 483 493
total 1 peptides
C1GB51
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TGPPSLGTLAQQR.T Y 18.40 1324.7098 13 -18.1 663.3502 2 65.87 5 35938 VEV_2_3_RA5_01_1236.d 5.27E4 2 2 416 428
R.VTGIDDGIHGISGGSDPGR.R Y 15.52 1808.8652 19 -23.4 603.9482 3 63.34 6 32882 VEV_3_3_RA6_01_1237.d 3.22E4 1 1 153 171
total 2 peptides
C1GCL9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TGSVERSLR.L Y 17.81 1003.5410 9 -5.3 502.7751 2 59.86 5 31447 VEV_2_3_RA5_01_1236.d 0 1 1 617 625
R.VDPSAVSSTTVPDAAHIDSR.S Y 16.55 2023.9810 20 -5.6 675.6638 3 75.66 5 43071 VEV_2_3_RA5_01_1236.d 0 1 1 1289 1308
total 2 peptides
C1G632
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IFAQPVGDGDDLTHLR.G Y 18.36 1752.8794 16 20.9 585.3126 3 72.87 4 41534 VEV_1_3_RA4_01_1235.d 0 1 1 29 44
R.LLGEP Y 15.21 527.2955 5 -19.8 528.2923 1 55.08 5 28223 VEV_2_3_RA5_01_1236.d 0 1 1 247 251
total 2 peptides
C1GIL8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SYTPISSDQETGYFDLLVK.A Y 25.96 2162.0420 19 -5.0 1082.0228 2 84.75 4 50418 VEV_1_3_RA4_01_1235.d 4.22E4 1 1 115 133
total 1 peptides
C1GFA1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ELPQVSLPDEYLPIDLEAAR.M Y 25.83 2267.1685 20 -7.4 1134.5831 2 88.55 6 50543 VEV_3_3_RA6_01_1237.d 4.64E4 1 1 353 372
total 1 peptides
C1GCZ4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DGLLLPIAFGK.S Y 25.78 1142.6699 11 -13.2 572.3347 2 86.43 5 49986 VEV_2_3_RA5_01_1236.d 1.86E4 1 1 70 80
total 1 peptides
C1GHI4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ASAGPDDIGAR.Y Y 25.69 1028.4886 11 -6.9 515.2480 2 31.33 4 13623 VEV_1_3_RA4_01_1235.d 2.07E5 1 1 617 627
total 1 peptides
C1GEK5
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LLPPDLEDSLPQTLDGTFDR.V Y 17.34 2241.1165 20 15.1 561.2949 4 93.37 4 55490 VEV_1_3_RA4_01_1235.d 1.28E5 1 1 478 497
R.TQGLAADQFR.L Y 16.37 1105.5516 10 19.9 553.7941 2 54.21 4 27563 VEV_1_3_RA4_01_1235.d 9.35E4 1 1 523 532
total 2 peptides
C1GGY0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLQADYLVGC(+57.02)DGAR.S Y 25.51 1535.7402 14 -12.7 768.8676 2 69.95 6 37819 VEV_3_3_RA6_01_1237.d 6.31E4 1 1 193 206 Carbamidomethylation
total 1 peptides
C1G3Y3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LPQELSIDPDALGSELYDSISQQSR.L Y 25.47 2760.3452 25 -27.4 921.0972 3 90.08 5 51926 VEV_2_3_RA5_01_1236.d 0 1 1 19 43
total 1 peptides
C1G4P6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VEINYEDNAVK.A Y 25.38 1292.6248 11 2.2 647.3210 2 61.44 6 31478 VEV_3_3_RA6_01_1237.d 1.32E5 1 1 227 237
total 1 peptides
C1GFA4
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.FIGDSLAAGQENTHPK.V Y 25.30 1683.8217 16 -9.5 562.2758 3 60.45 4 31827 VEV_1_3_RA4_01_1235.d 4.9E4 1 1 346 361
total 1 peptides
C1GES0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LINPSAVHFFNIAAPR.I Y 25.29 1765.9628 16 -18.9 589.6504 3 80.30 5 46245 VEV_2_3_RA5_01_1236.d 4.54E4 1 1 34 49
total 1 peptides
C1G6C3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.GFAVPEGAEGPVTR.V Y 25.26 1385.6938 14 -13.7 693.8447 2 66.89 6 35545 VEV_3_3_RA6_01_1237.d 1.34E5 2 2 328 341
total 1 peptides
C1G857
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VRPSDFAEEDGLYAEVLSR.G Y 25.23 2152.0435 19 3.9 718.3579 3 80.29 4 47245 VEV_1_3_RA4_01_1235.d 0 1 1 183 201
total 1 peptides
A0A0A0HU08
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DVDLPAIAYNAADVAFTLAR.D Y 25.23 2105.0793 20 -7.5 1053.5391 2 96.69 4 57036 VEV_1_3_RA4_01_1235.d 1.98E5 2 2 91 110
total 1 peptides
C1GKC8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AKAPAPANHVLVTPTQVAASAPPR.A Y 25.19 2363.3074 24 -37.2 591.8121 4 63.98 4 34503 VEV_1_3_RA4_01_1235.d 0 1 1 338 361
total 1 peptides
C1GL08
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VLTQPTGTDNPNHSASPSAGR.H Y 24.91 2106.0090 21 -9.1 703.0039 3 40.96 4 19271 VEV_1_3_RA4_01_1235.d 6E4 1 1 312 332
total 1 peptides
C1G9C9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AFDELGLTEAEIASLC(+57.02)R.W Y 24.70 1893.9142 17 -10.0 632.3057 3 49.30 4 24440 VEV_1_3_RA4_01_1235.d 5.94E4 2 2 82 98 Carbamidomethylation
total 1 peptides
C1GHB2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.LLQC(+57.02)TSNPSPK.I Y 24.66 1243.6230 11 5.8 622.8224 2 38.14 4 17594 VEV_1_3_RA4_01_1235.d 8.74E4 1 1 192 202 Carbamidomethylation
total 1 peptides
A0A0A0HU64
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LPFQR.K N 17.11 659.3755 5 -9.0 330.6920 2 37.51 4 17227 VEV_1_3_RA4_01_1235.d 3E5 2 2 468 472
R.NPYNNPPPPTR.R Y 15.04 1265.6152 11 -20.6 633.8019 2 59.28 4 30952 VEV_1_3_RA4_01_1235.d 0 1 1 363 373
total 2 peptides
C1G1B6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.EENPGISFGQVGK.V Y 24.60 1360.6622 13 -7.0 681.3336 2 66.42 6 35190 VEV_3_3_RA6_01_1237.d 2.1E4 1 1 13 25
total 1 peptides
C1G9Q3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.VAVLTHC(+57.02)NTGSLATAGYGTALGVIR.S Y 24.57 2501.3059 25 2.3 834.7778 3 78.29 4 45708 VEV_1_3_RA4_01_1235.d 9.34E4 1 1 169 193 Carbamidomethylation
total 1 peptides
C1GKI8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
MVTPNTTPYKPSPLSFGSTR.T Y 24.57 2180.0935 20 -16.1 546.0219 4 69.68 5 38757 VEV_2_3_RA5_01_1236.d 1E5 1 1 1 20
total 1 peptides
C1GIM6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.AGLAGGSGADVGFVGFK.K Y 24.48 1508.7623 17 -5.4 503.9253 3 61.57 4 32659 VEV_1_3_RA4_01_1235.d 2.28E5 1 1 572 588
total 1 peptides
C1G481
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GSQANEAQPQHQQVR.F Y 24.38 1676.7979 15 -7.8 559.9355 3 16.03 6 5480 VEV_3_3_RA6_01_1237.d 2.29E4 1 1 329 343
total 1 peptides
C1GHL6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.MSIASR.L N 16.32 663.3374 6 34.9 664.3678 1 85.59 6 48828 VEV_3_3_RA6_01_1237.d 0 1 1 159 164
K.AAQHGNLDLSTVSLGALR.M Y 16.02 1821.9697 18 -25.6 608.3149 3 75.84 6 42163 VEV_3_3_RA6_01_1237.d 9.8E4 1 1 141 158
total 2 peptides
C1GE06
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.DEGGRGDIINIGSIAGR.E Y 24.32 1698.8649 17 -6.0 567.2922 3 73.72 4 42141 VEV_1_3_RA4_01_1235.d 4.32E4 1 1 145 161
total 1 peptides
C1GIX1
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.ASAAAAQDFAYR.D Y 24.32 1240.5836 12 -7.5 621.2944 2 56.81 4 29169 VEV_1_3_RA4_01_1235.d 0 1 1 422 433
total 1 peptides
C1G352
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SEVAHTLAER.S Y 24.31 1111.5621 10 -12.5 556.7814 2 27.89 6 11723 VEV_3_3_RA6_01_1237.d 6.25E4 2 2 341 350
total 1 peptides
C1GKS3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.NENEKVLIEPSVNSVR.V Y 24.15 1825.9534 16 -44.6 609.6312 3 63.68 6 33137 VEV_3_3_RA6_01_1237.d 0 1 1 56 71
total 1 peptides
C1GA86
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AAAVGIGNSKPK.A Y 24.13 1111.6349 12 -46.9 556.7986 2 20.56 5 8040 VEV_2_3_RA5_01_1236.d 0 1 1 12 23
total 1 peptides
C1GMD2
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AFAQVDELLSEYSQWPFAR.R Y 24.00 2256.0850 19 -14.6 753.0246 3 92.62 6 52590 VEV_3_3_RA6_01_1237.d 4.6E4 1 1 287 305
total 1 peptides
C1GBA0
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.AEKGAAE Y 23.75 674.3235 7 -36.3 675.3063 1 51.44 4 25787 VEV_1_3_RA4_01_1235.d 8.81E4 1 1 228 234
total 1 peptides
C1GGS9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.YQSFPSAELLRK.E Y 23.72 1437.7616 12 -7.6 480.2575 3 68.16 4 37762 VEV_1_3_RA4_01_1235.d 1.78E5 1 1 152 163
total 1 peptides
C1GKK3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IASGSGSEQDIAEAKIELEVLESLQAALK Y 23.69 2998.5708 29 -11.1 1000.5198 3 92.25 5 53009 VEV_2_3_RA5_01_1236.d 4.68E4 1 1 137 165
total 1 peptides
C1GJZ9
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.SVTQFASR.F Y 23.62 894.4559 8 -18.5 448.2270 2 36.06 5 16858 VEV_2_3_RA5_01_1236.d 1.08E5 2 2 371 378
total 1 peptides
C1G3G3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.IC(+57.02)IGAGMPER.G Y 23.61 1102.5264 10 -57.7 368.4948 3 9.70 6 2375 VEV_3_3_RA6_01_1237.d 1.1E5 1 1 519 528 Carbamidomethylation
total 1 peptides
C1GDU6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.IADSRPDLVQR.W Y 23.58 1268.6836 11 -10.4 318.1749 4 28.07 6 11816 VEV_3_3_RA6_01_1237.d 0 1 1 815 825
total 1 peptides
C1GE89
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.FYLAQSSDTGVR.E Y 23.50 1342.6517 12 -2.9 672.3312 2 63.67 5 34293 VEV_2_3_RA5_01_1236.d 2.3E5 3 3 270 281
total 1 peptides
C1G8N6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.TSTSTSQPPLAQPR.S Y 23.38 1469.7474 14 -10.6 735.8732 2 41.82 5 20212 VEV_2_3_RA5_01_1236.d 1.19E5 2 2 913 926
total 1 peptides
C1GFT8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VFGATETGQK.V Y 23.36 1036.5189 10 -48.1 519.2418 2 21.91 6 8558 VEV_3_3_RA6_01_1237.d 6.03E4 1 1 45 54
total 1 peptides
C1GKC3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.LEESARAEFEDVLR.E Y 23.35 1662.8213 14 23.6 416.7224 4 65.94 5 35991 VEV_2_3_RA5_01_1236.d 0 1 1 93 106
total 1 peptides
C1G7L7
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.TAQGVQNLYDR.M Y 23.24 1263.6207 11 -11.3 632.8105 2 53.21 6 26185 VEV_3_3_RA6_01_1237.d 5.19E4 1 1 27 37
total 1 peptides
C1GF34
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.ESLQIHDGQER.G Y 23.22 1310.6215 11 9.1 656.3240 2 30.84 5 13743 VEV_2_3_RA5_01_1236.d 7.24E4 1 1 289 299
total 1 peptides
C1GCZ3
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
K.YAQQSVSGDQHER.V Y 23.17 1503.6702 13 2.7 502.2320 3 17.57 5 6417 VEV_2_3_RA5_01_1236.d 4.66E4 1 1 161 173
total 1 peptides
C1GBY8
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.VFNNTAR.Y Y 23.11 820.4191 7 -16.2 411.2102 2 17.76 5 6520 VEV_2_3_RA5_01_1236.d 6.02E4 1 1 303 309
total 1 peptides
C1GAQ6
back to list

| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Uniq -10lgP Mass Length ppm m/z z RT Fraction Scan Source File Area Virulento #Spec #Spec Virulento Start End PTM
R.GITSSENASVVR.S Y 23.03 1218.6204 12 -5.2 610.3143 2 43.60 4 20905 VEV_1_3_RA4_01_1235.d 5.22E4 1 1 31 42
total 1 peptides
Peptide List


 


Prepared with PEAKS ™ (bioinfor.com)